---

	Clinical pharmacy in response to social expectation Tatsuya Horiuchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 123-123, 2007.

---

	To provide chemotherapy safely Setsuko Anan Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 127-127, 2007.

---

	The medical problems and future in Japan Isao Tanabe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 128-128, 2007.

---

	We talk about an anticancer drug as patients with progressive cancer Takashi Yamamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 129-129, 2007.

---

	It is ... from a diseased child and the settings of ... childhood cancer treatment to support the family Ryota Hosoya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 130-130, 2007.

---

	The present conditions of the anticancer drug exposure in our country Shinichi Sugiura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 131-131, 2007.

---

	Safe handling of Hazardous Medications-Implications for the Pharmacy and Oncology Practice James A.Jorgenson Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 132-132, 2007.

---

	CLINICAL ASPECTS OF PHARMACOGENETICS AND PHARMACOGENOMICS:PRESENT AND FUTURE Urs A.Meyer Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 133-133, 2007.

---

	Problems and adherence improvement measures at use of inhalant Kunio Dobashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 134-134, 2007.

---

	To offer medical care of the expensive pawn Tsuguya Fukui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 135-135, 2007.

---

	A study on the construction of a prescription inspection, dispensing support system and sterile injectable mixture preparation, inspection support system using an electronic medical record 杉山正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 139-139, 2007.

---

	Establishment of the generic technology of the tailor maid formulation study support system by pharmacokinetics, the kinetic utilization Juichi Otani Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 140-140, 2007.

---

	29-S1-1 Development and Challenges for Hospital Pharmacy in China Dakui Li Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 143-143, 2007.

---

	29-S1-2 The Roles of Korean Hospital Pharmacists in the 21st Century-Project for Becoming the Best Hospital Pharmacists in the Future- Kyoung Ho Park Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 143-143, 2007.

---

	29-S1-3 Great Challenges of Japanese Hospital Pharmacists to the 21st Century Kazuo Matsubara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 144-144, 2007.

---

	Administration plan corresponding to the age changes of the 29-S2-1 pharmacokinetics Kazuyuki Ueno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 145-145, 2007.

---

	From the experience of the pharmacist specialized in elderly people in the 29-S2-2 United States ウォーン pole Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 145-145, 2007.

---

	Role ... of the pharmacist in the action ... pressure sore measures team of the 29-S2-3 Kunitachi longevity medical center pharmacy It is passed through old Masaru Den Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 146-146, 2007.

---

	Fur Matthew tical care to 29-S2-4 elderly people Yuki Ito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 146-146, 2007.

---

	Fur Matthew tical care to 29-S2-5 elderly persons living at home Yoko Inukai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 147-147, 2007.

---

	Management and medical treatment of 29-S3-1 elderly people hypertension Iwao Kuwajima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 148-148, 2007.

---

	Management and pharmacotherapy of 29-S3-2 elderly people hyperlipidemia Hidenori Arai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 148-148, 2007.

---

	Management and pharmacotherapy of 29-S3-3 elderly people diabetes Hiroshi Nakano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 149-149, 2007.

---

	Management and elderly people pharmacotherapy of 29-S3-4 chronic kidney disease (CKD) Sumio Hirata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 149-149, 2007.

---

	Management and pharmacotherapy of 29-S3-5 elderly people respiratory disease Kunihiko Yoshimura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 150-150, 2007.

---

	Invention to avoid problems and that of multidrug therapy in 29-S3-6 elderly people Autumn lower Masahiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 150-150, 2007.

---

	5-FU plasma concentration measurement ... in action ... esophageal cancer chemoradiotherapy to patients individualization in the 29-S4-1 cancer chemotherapy Nakamura job 1, Hirai green 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 151-151, 2007.

---

	Application to the cancer therapy of the 29-S4-2 genetic analysis The amount of Ariyoshi example Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 151-151, 2007.

---

	PK/PD of the immunosuppressive drug to make use of for 29-S4-3 organ transplantation Ikuko Yano 1, 2, Kenichi Inui 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 152-152, 2007.

---

	Action for early detection, the evasion of the adverse event with the 29-S4-4 anticancer drug Pond end Hiroaki, The Mishima one up, Uchida まやこ, Hiroyuki Watanabe, Masanori Sueyasu, Ryozo Oishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 152-152, 2007.

---

	Cooperation - of new action - ward of the 29-S4-5 cancer drug control instruction and the foreign instruction Masato Yonemura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 153-153, 2007.

---

	We examine illness from the situation of the 29-S5-1 hospital pharmacist and think about cooperation, the way of the medicine medicine cooperation Koichi Imamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 154-154, 2007.

---

	From a viewpoint providing information about the 29-S5-2 psychological care to a citizen Yuki Ishida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 154-154, 2007.

---

	29-S5-3 Or pharmacist can contribute to the equalizing of palliative medicine : From the standpoint of cooperation and hospital pharmacists and team medical practice 龍恵美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 155-155, 2007.

---

	Role of the pharmacist in the 29-S5-4 at-home psychological care 轡基治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 155-155, 2007.

---

	Awareness as the 29-S6-1 medical care person Toru Hashida, Kenichi Inui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 156-156, 2007.

---

	Training of the ability to respond to the heart of the 29-S6-2 patients Izumi Machida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 156-156, 2007.

---

	The communication technology that the 29-S6-3 healthcare setting overlooks Hirai green Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 157-157, 2007.

---

	Communication education in the 29-S6-4 School of Medicine and the problems Toshihiko Kinoshita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 157-157, 2007.

---

	Induction ... of utilization and the portfolio evaluation of action ... graduate school long term training that we applied to a pharmacy education six years system in the 29-S7-1 university hospital Hiromi Okazaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 158-158, 2007.

---

	Business training model core curriculum to regard as 29-S7-2 student Teruo Tsuchiya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 158-158, 2007.

---

	Having been understood using the check list of the model core curriculum for the hospital training (four weeks) in the 29-S7-3 municipal hospital Yoshihisa Takao Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 159-159, 2007.

---

	With the method of the drugstore training corresponding to the 29-S7-4 business training model core curriculum Naoki Uemura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 159-159, 2007.

---

	Exploring - to achievement of present conditions - model core curriculum of the 29-S7-5 family drugstore business training Atsuko Chikada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 160-160, 2007.

---

	Present conditions of role - this hospital which a pharmacist carries out for 29-S8-1 team approach in medical care and future problem - Shoichi Yamaga, Small piece Fumiyo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 161-161, 2007.

---

	Contribution - neurosurgery ward to a side effect evaluation and safety management in the 29-S8-2 cancer chemotherapy as a case - Old Takaaki Tawara, Kenichi Inui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 161-161, 2007.

---

	It is utilization ... of the physical condition flow check chart through a diet, excretion, sleep, the exercise by ... pharmacist with the role of the opening of an office pharmacist in the 29-S8-3 medical care Koji Osawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 162-162, 2007.

---

	Role of the pharmacist in the practice of the 29-S8-4 university hospital Yutaka Katayama next Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 162-162, 2007.

---

	Figure of a drugstore, the pharmacist from 29-S9-1 this Hisayuki Kato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 163-163, 2007.

---

	About 29-S9-2 treatment at home 岩月進 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 163-163, 2007.

---

	The way of the drugstore pharmacist as the 29-S9-3 school teacher Kiyokazu Sone Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 164-164, 2007.

---

	Support and adherence of the 30-S1-1 "consciousness of disease" Iwata relation life Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 165-165, 2007.

---

	Role - of - ward pharmacist thinking about adherence in the 30-S1-2 psychiatric practice Kenji Sato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 165-165, 2007.

---

	With the role as the 30-S1-3 second opinion failure case - to - schizophrenia patient family Kimiko Matsuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 166-166, 2007.

---

	On participating in 30-S1-4 panel discussion at the situation of the family Tokuo Uemori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 166-166, 2007.

---

	Mainly on 30-S2-1 resistant bacteria, nosocomial infection measures -MDRP and MRSA - Tachi field Kazuhiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 167-167, 2007.

---

	Switch therapy - in antibiotic chemical treatment - community-acquired pneumonia treatment from 30-S2-2 this Katsunori Yanagihara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 167-167, 2007.

---

	So that ... antimicrobial agent TDM and the problems perform TDM from business of the 30-S2-3 pharmacy effectively? Toshimi Kimura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 168-168, 2007.

---

	The topic effective safe administration method of administration of ... antimicrobial agent method these days is ... from the viewpoint of 30-S2-4 dosage regimen Moat Seiji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 168-168, 2007.

---

	30-S3-1 infection control and specialized pharmacist Takeshi Hirayama, Masaichi Kuroyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 169-169, 2007.

---

	Infection control based on the 30-S3-2 evidence Toshi Iwata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 169-169, 2007.

---

	30-S3-3 infection control and surveillance Sawa Akihiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 170-170, 2007.

---

	Proper use of the disinfectant in the 30-S3-4 infection control and the problems Shigeharu Oie Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 170-170, 2007.

---

	Systematization of the 30-S3-5 infection control and role of the pharmacist Tadashi Shiraishi, Yoshito Nakagawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 171-171, 2007.

---

	How do you evaluate the value of 30-S4-1 drug duties? Soichiro Isobe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 172-172, 2007.

---

	Practice example about the value evaluation of 30-S4-2 ward duties Yuki Ito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 172-172, 2007.

---

	Practice example about the value evaluation of 30-S4-3 drugstore duties Miwako Kamei Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 173-173, 2007.

---

	Practice example of the pharmacist duties in the 30-S4-4 critical care center ICU Junko Minemura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 173-173, 2007.

---

	Of the value evaluation of hospital in 30-S4-5 United States drug duties, actually 陳惠一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 174-174, 2007.

---

	To ride out a storm of medical - system reform in 30-S5-1 health care overhaul and the 21st century; ... Masaki Muto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 175-175, 2007.

---

	From the situation of the 30-S5-2 University Norio Matsuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 175-175, 2007.

---

	Importance of medical care and the clinical pharmacy that the 30-S5-3 nation finds Hideto Sekino Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 176-176, 2007.

---

	From the situation of the 30-S5-4 medicine manufacture industry Hiroshi Akimoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 176-176, 2007.

---

	From the situation of the 30-S5-6 medical care journalism Minoru Numata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 177-177, 2007.

---

	Importance ... of ethic - liberal arts of the pharmacist Hirai green 1, Ken Hazama solstice 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 178-178, 2007.

---

	Liberal arts to make use of in the ethic training of the 30-S6-1 pharmacist Jun Matsuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 178-178, 2007.

---

	30-S6-2 Compatibility of science and ethics in research drug treatment : Be required to pharmacist 古川裕之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 179-179, 2007.

---

	Morals dilemma to come across by 30-S6-3 pharmacist duties Kazumi Kawamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 179-179, 2007.

---

	Outlook on ethic of the pharmacist tried on the site of the 30-S6-4 treatment at home Ken Hazama solstice Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 180-180, 2007.

---

	About postgraduate education of the 30-S7-1 future Osamu Matsuya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 181-181, 2007.

---

	Postgraduate education in the 30-S7-2 six years system Hirotoshi Echizen Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 181-181, 2007.

---

	30-S7-3 member of society postgraduate education Junko Kitsu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 182-182, 2007.

---

	The postgraduate education that 30-S7-4 drug industry expects Teruo Takayanagi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 182-182, 2007.

---

	The postgraduate education that the 30-S7-5 healthcare setting overlooks Kenichi Inui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 183-183, 2007.

---

	The present conditions and problems by the pharmacotherapy of the 29-A2-10-1 mind neurological disease Daisuke Tashiro, Kazuya Ooi, Hiromi Sasaki, Akira Shirohata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2007.

---

	Likelihood of the pharmacist in the 29-A2-10-2 psychiatric practice 梅田賢太 1, Nobuko Todo 1, Kenichi Mishima 4, 末丸克矢 3, Katsunori Iwasaki 4, Hiroshi Araki positive 3, Michihiro Fujiwara 4, Shunichiro Ogawa 2, Naoto Kimura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2007.

---

	Change ... of prescription investigation - five years in 29-A2-10-3 psychiatric hospitals Shigeru Nishijima, Tomoda Motoko, Mami Yuki child Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2007.

---

	The way (through judgment hospitalization) of the pharmacist in the many types of job team in the 29-A2-10-4 law concerning medical observation It is looked at Atsushi Kawashima, Takuya Ishida, Arai just levator, Noriko Noborisaka, Emiko Murata, Sumiko Shimada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2007.

---

	About change of the consumption of the antipsychotics in the 29-A2-10-5 this hospital Takeki Yamamoto, Keizo Morimoto, 北村諭思 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2007.

---

	About the association of smoking and sex differences in the use of 29-A2-10-6 atypical antipsychotic agents Yuko Inoue, Bomura Kayoko, Noriko Kudo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2007.

---

Study on renal function degeneracy speed rating system doubling 29-A3-10-1 serum creatinine Noriko Takeuchi 1, Mika Tsuge 1, Ayano Kato 1, Takenoshita Minoru Eda 1, Emiko Iida 1, Yuko Tajima 1, Asako Terashima 1, Keita Kimura 2, Description of Hamano existence 2, Makoto Ogawa 2, Daiya Sakurada 1, Noboru Sato example 1, Shiro Ueda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2007.

---

Hypotensive effect of fenofibrate based on the 29-A3-10-2 home blood pressure measurement Satoshi Ishikawa 1, Taku Ohara 1, 2, Hiroki Kataoka 1, 花澤智大 1, Koji Tanaka 3, 芝宮拓 1, Rii Morito child 1, Takashi Asayama 2, Masahiro Kikutani 1, Takayoshi Okubo 2, 3, 戸恒和人 1, 2, Junichiro Hashimoto 2, 3, Jun Imai 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2007.

---

In use of medical supplies in examination - absolute irritation phase about the effect that the ethical drug which used during 29-A3-10-3 pregnancy gives to fetuses - Bamboo blind Takashi 1, Yano reason Rika 1, Kudo sheath or 1, Chisato Kitayama 1, Yasushi Morimoto intellect 1, Ken Nakajima 2, Daiya Sakurada 1, Kenji Kushida 2, Atsuko Murashima 3, Michihiro Kitagawa 4, Noboru Sato example 1, Shiro Ueda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2007.

---

	Construction of reporting system (PKDIC) of the pharmacokinetic change by the 29-A3-10-4 drug interaction Yoshiyuki Ono 1, Gutter slope Akihiro 2, Katsuyoshi Nakajima 1, Hiroshi Suzuki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2007.

---

	One discussion ... from an examination - insulin preparation freezing test about the storage method not to make 29-A3-13-1 insulin preparation freeze up Toshinari Asakura 1, Feeling field Hiroaki 2, Noriaki Yokou 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2007.

---

	29-A3-13-2 For efficiency of dispensing business by counting dispensing inspection support system introduced 土屋明美1, 福澤悦子1, 倉林豊1, 萩原正和1, 廣部英明2, 大村義人2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2007.

---

	Problems and remedy of the living guidance of patients with diabetes in the 29-A3-13-3 psychopathic ward Hiroshi Shirai 1, Mari Kasahara 1, Katsusane Tsurutani 1, Makiko Honma 1, Dotani 1-saving, Takashi Oda child 1, Akiko Takeya 1, Chieko Itagaki 2, High circle Yuji 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2007.

---

It is the recognition of 619 pharmacists the present conditions of the home blood pressure measurement in 29-A3-13-4 this country Koji Tanaka 1, Taku Ohara 2, 3, Mitsuru Kobayashi 2, 4, Masaru Takahashi joy 5, Norio Takahashi 5, Takayoshi Okubo 1, 3, 真野少 6, Straight appearance spring Taro 7, Jun Imai 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2007.

---

It is a preparation uniformity study the quality comparison of the forerunner, the generic drug of the 29-A3-13-5 clarithromycin dry syrup Takemoto Eri 1, Sachie Okada 1, New Kana Oka 1, Mayuko Hayashi 1, Tokuyama picture straight 1, Toshihiko Ishizaka 1, 2, Junji Mukai 1, 2, Takahiro Uchida 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2007.

---

	Scoring taking-related the quality comparison of the forerunner, the generic drug of the 29-A3-14-1 clarithromycin dry syrup: Sachie Okada 1, Takemoto Eri 1, New Kana Oka 1, Mayuko Hayashi 1, Tokuyama picture straight 1, Toshihiko Ishizaka 1, 2, Junji Mukai 1, 2, Takahiro Uchida 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2007.

---

	Smart evaluation of the forerunner, the generic drug of the theophylline dry syrup with the 29-A3-14-2 taste sensor Chika Kumagai, Rika Umino, Rumi Kudo, Tokuyama picture life, Takahiro Uchida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2007.

---

	Discussion from the hypoglycemia instruction to patients with team approach diabetes in the 29-A3-14-3 ethical pharmacy Masako Satake 1, Mitsuko Tanaka 1, 岩倉麻莉 1, Michiko Yoshizawa 1, Kazuyo Yasuda 1, 水野晃冶 1, Nishimura friend man 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2007.

---

	Investigation about the methylergometrine maleate which we used for 29-A3-14-4 after giving birth Hirokazu Yamashiro, Yoko Osawa, Yusuke Taki, Kusaka Toyoshi, 揚張真利子, Toshiaki Kitagawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2007.

---

Study on characteristics of the poor 29-A3-14-5 antihypertensive medications remedy compliance person and lifestyle Azusa Hara 1, 3, Takayoshi Okubo 2, 3, Masahiro Kikutani 1, Taku Ohara 1, 3, Koji Tanaka 2, Metoki Konin 1, 4, Megumi Utsuki 6, Takasuke Inoue 3, Takashi Asayama 3, Junichiro Hashimoto 2, 3, 戸恒和人 1, 3, Hiroshi Sato 3, 5, Jun Imai 1, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2007.

---

	Analysis of the affector to give to pyocyanic resistance to be isolated than 29-B1-10-1 inpatients Jin Tsukamoto 1, 2, Masanobu Imamura 4, 岩尾岳洋 1, Toshiaki Nakamura 1, Yoko Muroi 2, Masao Tobita 3, Masanobu Yamashita 2, 3, Hiromichi Iwasaki 2, Mikio Masada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2007.

---

	Action to proper use of the vancomycin teicoplanin Arbekacin by the 29-B1-10-2 TDM Satoshi Yokoyama, Naho Maeda, Seiko Chinen, Yukiko Hu, Original field Kazumi, Midori Kadoi, Hiroko Ota, Yasuji Morita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2007.

---

	Search ... of the proper dosage method by examination - MIC measurement and the PK/PD analysis of the efficacy for Pseudomonas aeruginosa of the 29-B1-10-3 antiMRSA medicine Arbekacin Takashi Yoshimoto 1, Shigeki Kishida 1, Keisuke Kitani 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2007.

---

	Establishment and application of a lot of 29-B1-10-4 carbapenem system antimicrobial agent assay Yuji Kurihara 1, Junko Kitsu 1, Moat Seiji 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2007.

---

	Significance of the 29-B1-10-5 vancomycin hydrochloride note (VCM) initial beginning of dosage less than 24 hours TDM enforcement Yoko Hayashi, Yasushi Taniguchi tree, Masaru Kawase period, Masahiko Kitagawa, 成尾千晶, Megumi Yamaguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2007.

---

	29-B2-10-1 The use situation and problem of the linezolid in the giving alm university hospital 北村正樹, 加文字理江, 中島清江, 加藤潤一郎, 菊野史豊 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2007.

---

	29-B2-10-2 Efforts about the linezolid proper use by the ICT 正畠和美, 前田奈穂, 知念聖子, 胡由希子, 角井碧, 横山聡, 大田博子, 森田保司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2007.

---

	Evaluation of the action of the antimicrobial agent proper use in the 29-B2-10-3 convalescent rehabilitation ward Look at Narai Kei; 1, Kaoruko Aoki 2, Shinobu Sekine 1, Miwa Nitta 1, Yukimi Kawaguchi 1, Kishino Chikashi 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2007.

---

	Case study - by action - ICT conference of the antimicrobial agent proper use in the 29-B2-10-4 Kochi medical center Yuki Okazaki 1, Land tax officer climb charges 1, 服部暁昌 1, Takamitsu Ito 2, Yasuo Fukui 3, Valley tree Toshikatsu 4, Teruo Tanaka 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2007.

---

	An attitude survey about the hand rough weather in the 29-B2-10-5 Imizu Municipal Hospital and choice of alcohol hand disinfectants Masayuki Wakita 1, Tomomi Hoshino 1, Hiromi Ito 2, Junko Satake 2, Koichi Nobata 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2007.

---

	About the efficiency of on admission initial interview duties and subsequent one week follow duties by the 29-B2-13-1 pharmacist Shigeru Yamada tree 1, Hiromi Sakai 1, 1 which is related to Nomura, House village Mai 1, Kana Kato 1, 鳥山高伸 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2007.

---

A case and the discussion that effects of the warfarin were reinforced by 29-B2-13-2 R-ESHAP therapy Koga eyes 1, Takaaki Suzuki 1, Amount of Ariyoshi example 1, Shingo Yamazaki 1, Kobayashi collar 1, Hiroaki Tanaka 2, Middle Tomoaki Seko 2, Hiroshi Nakamura justice 1, Koichi Kitada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2007.

---

	Pharmaceutical management of the bringing medicine by the on admission patients interview of the 29-B2-13-3 ward pharmacist Inou Kanako, Shinobu Hasebe, Hiromi Tamura, Tadaaki Ito, Masahiro Hayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2007.

---

	The sleep in the 29-B2-13-4 circulatory organ ward patients and investigation about the drug 八島加八, Yoshimasa Naomi, Sei Hattori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2007.

---

	Contribution of the pharmacist in the treatment of vancomycin for 29-B2-13-5 Clostridium difficile-positive patients and metronidazole Blue Takaaki 1, Yuichi Muraki 1, Corner Rieko 1, Naomi Hamaguchi 1, 2, Takuya Iwamoto 1, Shinko Okuda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2007.

---

	29-B2-14-1 Involvement of palliative care team launch and pharmacist : That is initiated from the ward responsible pharmacist 小林加寿子, 鷲頭辛次, 市川瞳, 松本智子, 石崎てるみ, 香月亮, 鶴田英夫, 岡忠之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2007.

---

	Inspection of the effect evaluation in the pharmacotherapy of the 29-B2-14-2 diabetes education hospitalization Setsuko Tomioka, 平岡輝余子, Risako Yamamoto, Fumihiko Sato, History of Tamura enthusiast, 弘世貴久, 綿田裕孝, Ryuzo Kawamori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2007.

---

	Action to raise the specialized viewpoint of the 29-B2-14-3 pharmacist, and to contribute to team approach in medical care positively Yukari Ogawa, 井上倫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2007.

---

	The present conditions of pharmacist duties for the bringing medicine for 29-B2-14-4 inpatients management Tatsuya Arai, Keisuke Osawa, Akihiro Miyazawa, Masato Takamori, Akizuki chapter Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2007.

---

	Difference in theophylline clearance in the 29-B4-10-1 age group Kenichi Manabe 1, Naoyuki Murakami 1, Makoto Tanaka 1, Naomi Kuroki 2, Yuki Ushio 1, Small thicket Makiko 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2007.

---

	29-B4-10-2 Impact of Tacrolimus after the Switch from Fluconazole to Voriconazole in Patients Receiving Allo-stem Cell Transplant 河添仁1, 3, 田中裕章1, 福岡憲泰1, 大西宏明2, 石田俊彦2, 滝口祥令3, 芳地一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2007.

---

Likelihood to biomarker of steroid weight loss, the secession based on the lymphocytes susceptibility of the endogenous cortisol in 29-B4-10-3 renal-transplant recipients Hiroki Takeuchi 1, Tadashi Matsuno mischief 3, Toshihiko Hirano 2, Katsuyama Kei greens child 2, Mari Yokota 1, Tiger stone Riyusuke 4, Kiyoshi Okuyama 4, 横山卓剛 3, Hirara Ichiro Sana 3, Kihara A 3, Konno law of nature 3, Jojima Maro 3 who praises it, 阿不都許庫尓米吉提 3, Yuki Nakamura 3, Hitoshi Iwamoto 3, Koichiro Hama 3, 葦澤龍人 3, Kayoko Senuma 1, 長尾桓 3, 畝崎榮 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2007.

---

	29-B4-10-4 The pharmacokinetic study of proper administration method of pazufloxacin mesylate in hemodialysis patients 古久保拓1, 和泉智1, 佐藤みのり1, 松永千春1, 根来早紀子1, 山川智之2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2007.

---

Comparison - of the pharmacokinetics with pharmacokinetics - renal-transplant recipients of immunosuppressive drug mycophenolic acid in patients with 29-B4-10-5 systemic lupus erythematosus Tomomi Matsushita 1, 2, Takafumi Naito 2, 見野靖晃 1, 2, Kimiyoshi Hirano 2, Atsushi Otsuka 3, Tomoki Ushiyama 3, Seiichiro Osono 3, Akira Hishida 4, Yoshiyuki Kagawa 1, Junichi Kawakami 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2007.

---

	Pharmacokinetics of injectable Ciprofloxacin in the 29-B4-10-6 patient on dialysis and the clinical response Hiroki Okawara 1, Tail bird Katsuya 1, 2, Masahiro Kobayashi 2, Yuko Taguchi 1, 2, Rumiko Kondo 2, Hajime Matsubara 2, Kazuo Yago 1, 2, 長場泰 3, Takashi Sakamoto up 3, 鎌田貢壽 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2007.

---

	About the action of the pharmacist in the 29-B4-13-1 chemotherapy department Shinji Takahashi 1, 2, Hiromi Sakai 1, 2, Akihiro Koyama 1, 2, Ayumu Ichimura 1, Kana Kato 1, Shigeru Yamada tree 1, Setsuo Utsunomiya 2, 鳥山高伸 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2007.

---

	With prevention of stomatitis in the 29-B4-13-2 cancer chemotherapy, actually Yasuko Aizawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2007.

---

Start the use of the medicine notebook as safety management - tool of the 29-B4-13-3 cancer chemotherapy; and ... Jun Hosoya 1, Tsuyoshi Kojima 1, Hiroko Okabe 1, Hiroshi Mashita 1, Masumi Watanabe 1, Yumi Negishi 1, Rieko Kawai 1, Mayumi Kobayashi 1, Junichi Tamura 1, Koichi Kojima 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2007.

---

Use fact-finding of the indomethacin spray for 29-B4-13-4 oral mucositis and effective evaluation Ikuko Shindo 1, Masato Honma 1, 2, Ebina court noble 1, Hiroyuki Hosono 1, 100 Kenji 1, 2, Yoshiharu Suzuki 1, 2, Yasuyuki Kanbayashi 1, Tree Yoshiyuki Sawa 2, Koda good luck direct 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2007.

---

	Use of drug evaluation based on the viewpoint of the medical economics in the 29-B4-13-5 cancer chemotherapy Ikemi Yasuaki, Toru Hashida, 深津祥央, Ikuko Yano, Masahiro Ishizu, Toshiya Katsura, Kenichi Inui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2007.

---

	About the interview induction to all patients by the pharmacist in the 29-B4-14-1 outpatient department chemotherapy room Hiromi Sakai 1, 2, Shinji Takahashi 1, 2, Akihiro Koyama 1, 2, Ayumu Ichimura 1, Kana Kato 1, Shigeru Yamada tree 1, Setsuo Utsunomiya 2, 鳥山高伸 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2007.

---

Evaluation - of the team activity based on the use of role - opioids preparation situation of the pharmacist in the 29-B4-14-2 pain relief team Akira Hotta Hiromi 1, 2, Mayumi Torimoto 2, Masayuki Miyazaki 2, Kazuhiro Ishikawa 2, Yukihiro Noda 2, 4, Yoshinori Hasegawa 3, Kazuki Nagasawa 1, 藤本貞毅 1, Toshitaka Nabeshima 2, 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2007.

---

Foreign cancer chemotherapy protocol management and application to a foreign cancer chemotherapy pass using 29-B4-14-3 Web Teruo Obata 1, Kazuhiko Nakayama 1, Sho Shimizu original 1, Takashi Masuno 1, Hiroyuki Akiba 1, 岩崎英久 1, Takao Kume 1, 櫻澤千世 1, Hiroyuki Horiguchi 1, Kazunori Ishii 1, Masayuki Tamura 1, Masatoshi Ishizaki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2007.

---

	Examination about the metrics making of the 29-B4-14-4 anticancer drug regimen Takeshi Ihoroi, Akiko Kuwahara, Nao Ishida, 大樹璃実, Makimoto Hiroo, 西口工司, Hirai green Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2007.

---

	Examination of arthralgia in the 29-B4-14-5 Weekly Paclitaxel therapy and peripheral neuropathy Tomoki Yoshioka, Naoyuki Hirakata, Ball Shiro Shima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2007.

---

	Interaction of 29-C1-10-1 warfarin and the SSRI Kuni Isobe finally, Tomoko Matsunaga, Satoko Nakamura, Taku Okabe, Chiho Murakami, Kazutaka Sakamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2007.

---

	It is the contribution of the excretory system transporter gastrointestinal absorption behavior of 29-C1-10-2 Coenzyme Q10 Akiko Ochiai 1, Masanori Kobayashi 2, Shiro Itagaki 2, Tsuyoshi Hirano 2, Mitsuru Sugawara 3, Takeshi Iseki 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2007.

---

	Effect of UGT2B7*3 which gives it to the carvedilol pharmacokinetics of the 29-C1-10-3 Japanese healthy subject Tadashi Taguchi up 1, Mutsuko Honda 1, Wakako Toyota 1, 堀内威佐男 1, Takako Shimizu 1, Yuichiro Kayano 1, Seiya Hashimoto 1, 能澤孝 2, Hiroshi Inoue 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2007.

---

	The elucidation of absorption dynamics of the 29-C1-10-4 lutein and examination for the oxidation disorder depression effect Sato evening period 1, Shibuya Tomomi 1, Masanori Kobayashi 2, Shiro Itagaki 2, Tsuyoshi Hirano 2, Takeshi Iseki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2007.

---

	Albuminous contribution in the liver transportation of the 29-C1-10-5 glycyrrhizic acid Tomoe mountain path child, The Oyanagi Tsu husband who congratulates it, Kenjiro Koga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2007.

---

Safe examination of oral beclomethasone based on a blood level for intestinal acute graft-versus-host disease after the allograft in the 29-C1-13-1 hematopoietic organ disease Kaori Watanabe 1, Tadaaki Ito 2, Nasu Izumi 2, Yumiko Uchida 2, History of Hisashi Yamamoto 3, Shuichi Taniguchi 3, Tomoji Yoshiyama 1, Motoko Kanke 1, Masahiro Hayashi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2007.

---

	Effect of the nutrition index (serum albumin level, the ideal weight ratio) which gives it to the febrile neutropenia in 29-C1-13-2 cancer chemotherapy patients Kenji Taniguchi, Hiroaki Matsuda, Mukaihara Rika, Ryosuke Kawase, Hiroki Mase, Takuya Iwamoto, Shinko Okuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2007.

---

	A side effect investigation of the cisplatin lipiodol suspension for the 29-C1-13-3 primary liver cancer and evaluation Kenji Miyazawa 1, 2, Seko mouth Noriko 1, Yuichi Muraki 1, Takuya Iwamoto 1, Hideaki Tanaka 3, Motoo Iwasa 3, Kenji Takei 3, Shinko Okuda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2007.

---

	Analysis about peripheral neuropathy and the background factor in patients who received paclitaxel carboplatin combination therapy of the 29-C1-13-4 gynecology Yu Murashima oneself child 1, 2, Hiroko Sugimoto 1, Takuya Iwamoto 1, Tsutomu Tabata 3, Norimasa Sagawa 3, Shinko Okuda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2007.

---

	Examination about the efficacy of the action of the pharmacist for peripheral neuropathy with the 29-C1-13-5 FOLFOX4 therapy and Ca and the Mg combination Yumiko Furuno 1, Sakie Kawahara 1, Storehouse Hiroshi Hara 2, Yoichiro Matsuo 2, Shinmura green 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2007.

---

	Action of the TS-1 patient compliance instruction for the safe cancer pharmacotherapy for the 29-C1-14-1 outpatient Hiromi Tanoe, Celebration Chikako, House Yongjia child, 慈幸麻里, Masahiko Kobayashi, Kazue Takahashi, 寺田智祐, Toru Hashida, Ikuko Yano, Kenichi Inui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2007.

---

	Analysis of the prescription support contents of the ward pharmacist for the 29-C1-14-2 cancer chemotherapy enforcement patients Winnow music Mayumi, Shinobu Hasebe, Hiromi Tamura, Tadaaki Ito, Masahiro Hayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2007.

---

	Examination of the factor affecting the hematotoxicity of 29-C1-14-3 gemcitabine Genei Shinya 1, Yasuhiko Ichida 1, 加藤裕芳 1, Atsushi Furuse 2, Fumio Itagaki 3, Koda good luck direct 3, Ichiji Endo 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2007.

---

Correlation of stage, response and prognosis in the 29-C1-14-4 esophageal cancer chemoradiotherapy Akiko Kuwahara 1, Mountain Hiroshi Morimoto 1, Makimoto Hiroo 1, 西口工司 1, Yagi Keiko 2, Tatsuya Okuno 3, 4, Teahouse Naoko Hara 3, 4, 三木生也 4, Takao Tamura 4, Hirai green 1, 3, Sakaeda Toshiyuki 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2007.

---

	Role of gemcitabine of the 29-C1-14-5 breast cancer chemotherapy Daisuke 1 out of the moat, Ayumi Tokita 1, 高野尊行 1, Akira Nakamaru 1, 稲瀬實 1, Junya Oguma 2, Shoichi Oka 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2007.

---

	Effect of the phytosterol which gives it to 30-A2-13-1 P - glycoprotein and breast cancer resistance protein Hirai green, Tomohiro Nabekura, Takeshi Yamaki, Kazuyuki Ueno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2007.

---

	Change of the P-glycoprotein expression with the food composition with the 30-A2-13-2 anticancer activity Kyoko Nakazawa, Tomohiro Nabekura, Kazuyuki Ueno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2007.

---

1 case of the individualization cancer chemotherapy of the IFL regimen chemotherapy based on 30-A2-13-3 UGT1A1 genetic polymorphism and the drug disposition kinetic Shigeru Tomiyama chapter 1, Masashi Fukunaga 1, 花田法久 2, Manabu Okumura 4, Tomomi Iwakiri 4, Muneaki Hidaka 4, Nao Setoguchi 4, Emi Ichihara 4, Kazuhiko Arimori 4, Rika Yoshimoto 3, Yoshihito Uchino 2, Chizuko Nakamura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2007.

---

	Ca2+ activation K+ channel gene expression in the 30-A2-13-4 human prostate cancer Satomi Niwa 1, 大矢進 1, Akira Ono Minoru 1, Yoshihiro Ojima 2, Shoichi Sasaki 2, Kenjiro Koori 2, Yuji Imaizumi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2007.

---

	ABC transporter expression change by the 30-A2-13-5 small intestine ischemia reperfusion Jiro Ogura 1, Masanori Kobayashi 2, Shiro Itagaki 2, Tsuyoshi Hirano 2, Takeshi Iseki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2007.

---

	Interaction of MRP-mediated transportation and valproic acid in the 30-A2-14-1 human erythrocyte membrane and carbapenem antibiotics Hot-bath resort Yoshiko, Keiko Yamakawa, Eri Kimura, Hamada is rare in the summer, Junya Nagai, Mikihisa Takano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2007.

---

Effect of the CYP3A5 genetic polymorphism which gives it to the blood level / dose ratio of the tacrolimus in the 30-A2-14-2 live donor liver transplant patients and consumption Yuichi Muraki 1, Masanobu Usui 2, It is 3 of Nakatani, Takuya Iwamoto 1, Isa place Hideji 2, Shinko Okuda 1, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2007.

---

	Expression of CYP3A in the 30-A2-14-3 DSS-induced ulcerative colitis model mouse and nuclear receptor change 早川由隆, Ryo Nomura, Kaori Endo, 高橋孟瑠, Yudai Toda, Rumi Takeda, Igarashi sincerity intellect, Kiyomi Ito, Kiyoshi Sugiyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2007.

---

	30-A2-14-4 Comparison of cortisol 6 β - hydroxylase activity by CYP3A4 and CYP3A5 高崎由樹子1, 有吉範高1, 2, 中村裕義2, 石井伊都子1, 北田光一1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2007.

---

	The extraction of the specific drug prescription patients using the 30-A3-09-1 clinical studies DB system and detection of the clinical test value abnormality Kubono Naoko, Yu Shibata joy, Yamakawa flower Akemi, History of moat male, Junichi Kawakami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2007.

---

	Comparison between the preparation by the PK analysis of the 30-A3-09-2 tulobuterol patch Tetsuo Watanabe 1, Akiko Miki 2, Moat foster child 2, Juichi Otani 2, Yasufumi Sawada 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2007.

---

	Expression of "the contraindication of the 30-A3-09-3 attachment document about kidney" and examination of the contraindicated drug use actual situation Finished river Satomi, Mika Kano, Seiki Koba, Daisuke Kadowaki, Sumio Hirata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2007.

---

	The need of the pharmacist intervention for the metildigoxin initial dose to 30-A3-09-4 elderly people Keiko Kobayashi, Yasuhiro Tsuji, Shinnichi Sado, Sone book Emi, Naoyuki Hirakata, Ball Shiro Shima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2007.

---

	Practice of the injection enforcement support task in the 30-A3-09-5 ward 林太祐, Maiko Karube, Yamada fine weather period, Kazuo Hattori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2007.

---

	Examination of 30-A3-13-1 quinolone antimicrobial hypersensitivity Manabu Abe 1, Yagi Motohiro 2, Katsuji Uno 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2007.

---

	Relation ... to nausea and vomiting measures in participation in planning - chemotherapy to the medical treatment of the 30-A3-13-2 pharmacist Hiroko Shinoda, Upper mound Tomoko, 有木宏宗, 坂上逸孝, Mieko Yokoyama, Keiso Masuhara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2007.

---

Cause investigation of the acute cholecystitis in 30-A3-13-3 ICU, the CCU Ayumu Nozaki 1, Ito greens wave 1, Moat Maki 2, Ryuji Yamamoto 2, Masahiro Mizobuchi 2, Funatsu Atsushi 2, Tsunemi Kotaro 3, Tomoko Kobayashi 2, Hirokazu Nakanishi 1, Enjoji Yoshihisa 2, Toshio Kurihara 3, Shigeru Nakamura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2007.

---

	One case of no thrombocythaemia that 30-A3-13-4 isepamicin, levofloxacin, lomefloxacin was thought to be associated with Shigeru Takahashi Expo 1, Toshihiko Takeno 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2007.

---

	Examination of 30-A3-13-5 synthesis cold preparation hypersensitivity Tomoyasu Furukawa 1, Yagi Motohiro 1, Manabu Abe 2, 斎藤幹央 2, Koike reason Expo 3, Katsuji Uno 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2007.

---

	Association of the ticlopidine-induced liver damage and CYP2B6 genetic polymorphism in the 30-A3-14-1 Japanese Amount of Ariyoshi example 1, Iga Yukako 2, Tsuyoshi Miura 1, Koichi Kitada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2007.

---

Examination about the effect of the oral alkalinization agent on diarrhea at 30-A3-14-2 FOLFIRI-3 therapy enforcement Kaori Miyamoto 1, Yasutaka Nakamura 1, Noriko Hashimoto 1, 仲佐啓詳 1, Takako Nakamura 1, Akira Ishii 1, Hiroshi Nakamura justice 1, Amount of Ariyoshi example 1, 宮内英聡 2, Koichi Kitada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2007.

---

	The actual situation of the consultation about pregnancy and the medicine in the 30-A3-14-3 fetuses outpatient department Kumi Katori 1, Masato Honma 1, 2, Yasuyuki Kanbayashi 1, Hiroshi Hamada true 2, Hiroyuki Yoshikawa 2, Koda good luck direct 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2007.

---

	Examination of hypersensitivity in the 30-A3-14-4 enzyme preparation 齊藤幹央 1, Tomoyasu Furukawa 2, Yagi Motohiro 2, Katsuji Uno 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2007.

---

A preparation and clinical evaluations of the lactoferrin component film agent for the purpose of coping to the disease in the 30-A3-14-5 oral cavity Kutsugi Emi 1, Willow Shinji sail 1, Aya Ichise 1, Hiromi Matsuda 1, Ichinokawa Yoshimi 2, Masateru Matsui 3, Keiko Yamaoka 3, Machiko Watanabe 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2007.

---

	One case of the chronic schizophrenia that a symptom improved with sudden weight loss in 30-B1-13-1 short term 大岩眞二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2007.

---

	The case that became able to leave the hospital by switching to 30-B1-13-2 second generation medicine alone Junji Uno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2007.

---

	Problems ... due to patient compliance instruction - anosodiaphoria to a schizophrenia patient of the 30-B1-13-3 onset Water of small depth Sae Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2007.

---

	Relation of the pharmacist aiming at 30-B1-13-4 adherence improvement Isurugi Ikuko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2007.

---

	Intervention case of the pharmacist to the schizophrenia patient who developed in 30-B1-13-5 minor Tomoko Honda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2007.

---

	An example of the patient compliance instruction for 30-B1-14-1 bipolar patients Koichi Sato, Takashi Yoshio Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2007.

---

	Relation to patients with depression who had the 30-B1-14-2 alcohol disorder Kenichi Yoshida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2007.

---

	Medication support to a case forced to frequent change of prescription by by the side effect of 30-B1-14-3 antidepressants Nakamura Sui child Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2007.

---

	Action of the pharmacist that we maintain the patient compliance instruction to patients with 30-B1-14-4 mood disorders Taki Toshio Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2007.

---

	Intervention to the prescription of patients with dementia to repeat 30-B1-15-1 fall Tensho era Masami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2007.

---

	Action to improvement of the substance abuse in patients with 30-B1-15-2 stimulant sequelae Miki Sonoda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2007.

---

	Example - that we felt the difficulty of being concerned with patients with patient compliance instruction - personality disorder to patients with 30-B1-15-3 borderline personality disorder Imperial garden Kazuko 1, 2, Kimiko Matsuda 1, Hara wide Ichiro 2, Kunihiko Asai 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2007.

---

	Relation with the patients with the 30-B1-15-4 personality disorder-like symptom Kimiko Matsuda 1, Kunihiko Asai 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2007.

---

	Perform meeting a demand of a prescription from 30-B1-15-5 psychiatry; and with patients in ... health insurance pharmacy is concerned; ... Masaru Sasahara life Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2007.

---

	Enforcement of the use of antiMRSA medicine report system in the 30-B2-09-1 this hospital 濱野公俊 1, 2, 坂上逸孝 1, Haruna Sugimura 1, Mieko Yokoyama 1, Tanaka ratio dew beauty 2, Haruko Takasaki 2, 3, Taeko Takagi 2, 4, Hidefumi Shimodaira 5, Hiroshi Takemura 2, 6, Keiso Masuhara 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2007.

---

	About liver dysfunction by the ticlopidine remedy after the 30-B2-09-2 cipher stent placement Yusuke Taki 1, Hirokazu Yamashiro 1, Kusaka Toyoshi 1, Yoko Osawa 1, 揚張真利子 1, Toshiaki Kitagawa 1, Yuji Matsumoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2007.

---

	Investigation of an effect, the side effect in the 30-B2-09-3 amiodarone doses change patients Yoshie Araki, Hiromi Iura, Hiroko Enota, Yoshie Nishiyama, Tomoko Shibata, Tomoko Yanagisawa, Hiromi Nagai, Kayoko Kikuchi, Kanako Sakashita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2007.

---

	Follow-up and discussion of patients receiving carvedilol for the 30-B2-09-4 chronic heart failure Yasushi Takai 1, Takeki Kajima 1, Hideo Nishikawa 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2007.

---

	The actual situation and the way of a sleeping drug, the tranquilizer administration in patients with 30-B2-09-5 rheumatism associated diseases Kiyomi Sadamoto, Mizuho Takahashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2007.

---

	Examination of the palatability of the alendronate once a week preparation in patients with 30-B2-13-1 rheumatic disease Izumi Shimada 1, Ikuko Tanaka 2, 玉置繁憲 3, Takako Yamauchi 1, Kazuko Koyama 1, Hiroki Mase 1, Koike former 1, Takeshi Noro 1, Suzuki Suehiro 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2007.

---

	Construction of the medical safe drug transportation system based on 30-B2-13-2 BSC theory Toshiyuki Onishi, Marie Nakamoto, Shingo Nakamura, Tomoko Higashiyama, 3, Nakayama Hayao Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2007.

---

Examination of the activity of the future pharmacist judging from the use situation of the antibiotics for the 30-B2-13-3 injection Mitsuru Sugiura 1, 2, 3, 4, Daisuke Kameshima 1, Yoichi Kondo 1, Sugawara sheath or 1, Daichi Shibata 1, 増岡勝悟 1, 足立守 1, Makoto Ito 4, Masaru Iwata 3, Yoshio Asano 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2007.

---

	About management, the handling of the gemeprost vagina suppository in the 30-B2-13-4 this hospital Field Takefu, Seiichi Sugimura, Osamu Kiyama, Noriko Suzuki, Kaoru Suzuki, Masami Nishihara, Hiroshi Tamai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2007.

---

Construction (the second report) of the ward drug duties system in the 30-B2-13-5 Osaka medical center Naoki Hayakawa, Takeshi Kuwahara, Yoshiko Fukuda, 梅原玲緒奈, 村田真依, Yuka Nakamoto, Akiko Kamiya, Maiko Naito, Toya Aiko, Hirokazu Kamata, Kozo Tatsumi, Michi Miyata, Aya Kajita, Miki Ota, Person of sea Akiko, Sanae Wataya, Makoto Saito, Takashi Maekawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2007.

---

	A change permission system to generic medicine by the 30-B2-14-1 prescription order and the operation situation Shinji Kawai 1, Toshitaka Fukai 1, Osamu Ogino 3, Mitsuru Sugawara 1, Sakurai Kotaro 2, Takeshi Iseki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2007.

---

It is ... for the skill up of team approach in medical care (medicine medicine cooperation) - pharmacist by 30-B2-14-2 hospital pharmacist and the ethical pharmacy pharmacist and medical quality improvement Kana Kato 1, 2, 3, Hiromi Sakai 1, Ayumu Ichimura 1, Takako Nakajima 1, Akihiro Koyama 1, 1 which is related to Nomura, Shinji Takahashi 1, Yuichiro Wada 1, Yoichi Sakakibara 1, Shigeru Yamada tree 1, 鳥山高伸 2, Miyaji Izumi 3, Takahiro Iida 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2007.

---

	We examine inside the hospital, illness in the 30-B2-14-3 diabetes patient education, and medicine medicine cooperation is established Junko Onishi 1, 3, Mariko Miwa 1, Yoko Hiramatsu 1, 占部彌昌 1, Eriko Suyama 1, Murakami Kazuharu 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2007.

---

	Construction of the inhalational instruction system by the 30-B2-14-4 medicine medicine cooperation Keiko Kitajima 1, Prince Taniguchi chapter 1, 藤井宏透 2, 益永紀子 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2007.

---

	An investigation and evaluation of progress, the improvement situation of the investigational enforcement, base maintenance of the 30-B2-14-5 whole country institution Masakazu Yamaguchi 1, Yoichi Ishikawa 2, Kenji Kushida 2, Hidefumi Nakamura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2007.

---

	Memory retention augmentation effect by the 30-B3-09-1 angiotensin-converting enzyme inhibitor Sachiko Kanazawa, Descent from a mountain Ritsuko, Kazuhiro Hosoi, Early hunting truth Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2007.

---

	Examination of the efficacy of the Yokukansan for BPSD of 30-B3-09-2 dementia Noriko Takeda 1, 濱邊秋芳 1, Aiko Yokoyama 2, Chieko Yamaguchi 2, Kohei Toyomura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2007.

---

	Examination of efficacy of the clopidogrel administration for the 30-B3-09-3 PCI enforcement case sulfate and the tolerability Yutaka Yamazaki boatman, Naoya Ashikawa, Tadashi Goto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2007.

---

	Effect of CGRP doses on 30-B3-09-4 septic shock model mouse Tsu storehouse Yuri, Yuko Takahata, Italy ヶ 崎由香, Daisuke Sasaki, Osamu Nakao incense, Takashi Kato children, Yoshio Ijiri, Kazuhiko Tanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2007.

---

	30-B3-09-5 Study on calcineurin inhibitor sensitivity of peripheral blood mononuclear cells in myasthenia gravis patients 中島佳奈子1, 田中祥子1, 斎藤豊和2, 若田宣雄3, 平野俊彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2007.

---

	The present conditions of the substitute compounding of medicines with the 30-B3-13-1 generic drug Yasuhiro Sugiyama 1, Miyashita quiet 1, Katsuji Uno 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2007.

---

	About the proper use of the 30-B3-13-2 antimicrobial agent from the situation of - risk management - Hiroko Ota, Naho Maeda, Seiko Chinen, Original field Kazumi, Yukiko Hu, Midori Kadoi, Satoshi Yokoyama, Mikami Historical Memoirs, Furutsuki Masako, Yasuji Morita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2007.

---

	The future prospects of the doubt inquiry as 30-B3-13-3 drug safety management duties Yoko Watanabe 1, Katsuji Uno 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2007.

---

	Examination of the inspection method in 30-B3-13-4 anticancer drug preparation duties Makoto Nakajima, Akira Takahashi, Takuya Goto, Yoshie Nomura, Yumi Suzuki, Kimio Wakabayashi, 加藤浩充, Shuichi Matsumoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2007.

---

Effect of preventive measures against dispensing errors which are main by 30-B3-13-5 ID number check 片倉道啓, Job field Takashi, Kikuko Oki, Country book Yusuke, Kazuya Takahashi, Katsuyuki Nakamura, Noriko Araya, Michiko Fujimori, 舩山幹男, Keiichi Okahara, Hiroshi Nakata is elegant, Rev. Noda plus, 鳥本勝, Atsushi Miyamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2007.

---

	Calculation - of the fact-finding - last inspection oversight rate of the 30-B3-14-1 cold water re-hat and dispensing error Hashimoto positive 1, Swamp part Kimiko 1, Tetsuro Koide 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2007.

---

	Examination of risk factor of delirium in the 30-B3-14-2 acute phase hospital Tomoko Nishiguchi 1, Hideko Kamikawa 2, Hiroki Osato 3, Setsuko Anan 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2007.

---

	About the case that a change of the 30-B3-14-3 hospitalization environment controlled nutritional status Masaru Kawase period, Yasushi Taniguchi tree, Yoko Hayashi, Masahiko Kitagawa, 成尾千晶, Megumi Yamaguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2007.

---

	It is ... through ... Oita Hospital Pharmacist Association infusion of nutrient workshop for the knowledge improvement about the nutrition care of the 30-B3-14-4 pharmacist Hiroko Abe 1, Hiroki Ito 2, Makoto Inoue 2, North Britain person 3, Hiromi Someya 1, Shoji Takeyama 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2007.

---

	30-B3-14-5 Effect to give to the immunocompetence of the fatty acid of ω-3 origin 岩瀬晴信1, 仮屋薗博子2, 池田龍二3, 有馬純子3, 藤崎裕子3, 重永明恵3, 石塚洋一5, 山田勝士3, 4, 中村和男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2007.

---

	Examination about a clinical response and the safety of the 30-B4-09-1 pravastatin preparation generic medicine Thin Masato, Makoto Hayashi, Koji Abe, Aspect shrine Koji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2007.

---

Epidemiological survey of hyperuricaemia that is a side effect of Pyrazinamide to use for intensive therapy in 30-B4-09-2 tuberculosis short term Waterfall Hisashi 1, Kenji Ogawa 2, Hiroki Mase 3, Takeshi Noro 3, 野秋清聖 4, Fumihiko Sato 4, Katsunori Tabuchi 5, Hiroshi Funaki 1, 堀部千治 1, Tatsuya Murakami 6, 二改俊章 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2007.

---

Examination of the utility of the biapenem pancreas local site intraarterial injection treatment for the 30-B4-09-3 severe acute pancreatitis Masaaki Watanabe 1, Yukihiro Hamada 2, Hiroshi Imaizumi 3, Yuko Taguchi 1, 2, Tail bird Katsuya 1, 2, Hiroshi Nishimaki 4, 西元寺克禮 3, Hajime Matsubara 2, Kazuo Yago 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2007.

---

	Examination of the natto intake as the 30-B4-09-4 metabolic syndrome prevention 守内匡 1, 高田加壽代 1, Satomi Asano 1, Osamu Tanaka 1, Hiromi Matsui 1, Yoshimi Matsuda 1, Yutaka Takehara 1, Sachiko Hori 2, Yoshie Yamada 2, Main village Hisako 2, Ikuo Kanemoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2007.

---

	Examination about the gastric-acid secretion depressant drug combination at the oral chalybeate administration for 30-B4-09-5 iron-deficiency anemia Keiko Miyakawa, Makoto Hayashi, Koji Abe, Aspect shrine Koji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2007.

---

	Activity of the pharmacist by the disaster relief of the 30-B4-13-1 Noto Peninsula earthquake Masami Kawahara, 東敬一朗, Katsuhiko Nagase, Yusuke Hara, Kazuki Takeda, Daizo Maeda, Hiroko Okawa, Kenichi Miyamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2007.

---

	About a discharge adjustment in the promotion of the 30-B4-13-2 treatment at home - medical institution and cooperation - of the drugstore Kazuki Kushida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2007.

---

	Examination of the cost effectiveness of the 30-B4-13-3 HMG-CoA reductase inhibitor Tatsuya Oda, Hoshina walnut, Takashi Yokoyama example, Tatsuya Kawai, Hideyuki Takahashi, Tadashi Tsuda University, Hiroshi Aoyama, Kenichi Sakamoto, Hideji Ohara, Hiroaki Watanabe, Katsuji Oura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2007.

---

Problems and action about the posterior input slip at the 30-B4-13-4 hospitalization order ring Maze Hisanori 1, 林千麗 1, 舛永佳代子 1, 1, Asuka, Nagao, Rie Miyakawa 1, Miki Nakai 1, 須山奈見子 1, Yasushi Ishida Satoko 1, Koda sweetfish beauty 1, Mihoko Mori 1, Takeshi Suematsu 1, Hiroko Sugimoto 1, Nagasaka tomorrow or 1, Yagi Hideo 2, Yoshiharu Tsukamoto 3, Shun Otsuki intellect 4, Ota fence Masashi 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2007.

---

	Research about 30-B4-13-5 type II diabetes mellitus association drug costs Mihoko Tesaki 1, Aya Fujinami 2, Koji Hasegawa 1, Saori Michishita 1, 向誠一郎 1, Hitoshi Okugawa 3, Michiko Hayakawa 4, Kenzo Ishihara 5, Mitsuhiro Ota 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2007.

---

	About stability in the simple suspension of 30-C1-09-1 temozolomide Toshiko Aramiya 1, Yuka Kobayashi 1, Yuki Mikami 1, Masako Yoshimura 1, Hirokazu Nakanishi 1, Shinya Nakanishi 2, Kazuki Nagasawa 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2007.

---

	Examination about the injection method of temozolomide aiming at the compliance improvement of patients with 30-C1-09-2 children brain tumor Tomoyuki Mizuno 1, 2, Old Takaaki Tawara 1, Hiromi Tanoe 1, Toru Hashida 1, Ikuko Yano 1, Kenichi Inui 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2007.

---

	Use experience of the 30-C1-09-3 F seal Minoru Kurihara man 1, Fujiwara season Yoshiko 2, Hachiya Tomomi 3, Setsuko Anan 4, Miki Inoue 4, Chika Fujii 4, Misako Fujino 4, Yukako Yasui 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2007.

---

	Evaluation of the new inactivating processor of the medical waste fluid including the 30-C1-09-4 antineoplastic 1, Toyofusa, Kobayashi, 2, Jun Hirose 2, 3, Koichi Sano 2, 4, Hironao tree 3, Hiroshi Tamai 1, 2, Hiroshi Takenaka 2, Takashi Nakano 2, 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2007.

---

	Utility of anticancer drug sensitivity testing (MTTassay) for 30-C1-09-5 carcinomatous peritonitis, the pleurisy 杵崎正典, Kiyo Mizukami light, Eitaro Nakatsuka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2007.

---

	Trial of evaluation tool making and the training evaluation based on the 30-C1-13-1 business training model core curriculum evaluation plan Kazuko Kubo 1, Yoko Moriyasu 1, 中本行宣 1, Izushi Keiji 2, Takashi Shibata 3, Kazutaka Makino 3, Daisuke Teshima 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2007.

---

	It is ... mainly on 30-C1-13-2 business training model core curriculum "action ... evaluation of the injection compounding of medicines" Keiko Hara 1, 2, Yumi Kimura 1, 才津恵 1, Yukako Ikeda 1, Noriko Kasahara 1, Harumi Harano 1, 大塚識稔 1, Eiji Sato 2, Seiji Eto 2, Hironori Yoshitomi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2007.

---

A construction and the trial second of the 30-C1-13-3 business training system of administration Daiya Sakurada 1, Noriko Kobayashi 2, Asako Terashima 2, Yoshiko Miyazaki 3, Tadao Inoue 4, Shigekazu Watanabe 5, 6, Ichiji Endo 7, Noboru Sato example 1, Shiro Ueda 1, Junko Kitsu 2, Toshiji Horie 1, Masataka Mochizuki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2007.

---

	The use of the Internet search engine in the 30-C1-13-4 six years system pharmacy education Osamu Fujishita 1, Calis Karim2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2007.

---

	30-C1-13-5 evaluates the use of "e-Learning for OTC medicine proper use" Tsukiji jasmin child, Minae Izawa, Noriko Kose, 崔吉道, Emi Nakajima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2007.

---

	We think about "throb training to be heated to be heated" in the 30-C1-14-1 Iida Hospital Masafumi Kinoshita, Light Risa Sawa child, Hiroko Matsumura, Kozue Okada, 林宜生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2007.

---

	Training contents evaluation research by the person of institution investigation about training contents in the pharmacist training specialized in 30-C1-14-2 cancer and training Koji Murakoshi, 牧野好倫, Hirohisa Kato, Taisuke Hojo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2007.

---

Action of the TDM duties induction promotion in the cottage-hospital in 30-C1-14-3 Kanagawa Toishima study 1, 2, Koji Fujimoto 1, Jun Inoue Expo 1, 1, Kotobuki, Sekine 1, Yuko Komura 1, Kawaguchi three major cities child 1, Kenji Saito 1, 嶋崎眞義 1, Yukiko Nakamura 1, Katsunori Hattori 1, Ayako Yamaura 1, Izumi Yoshida 1, Masayuki Morita 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2007.

---

	The change and the present conditions of the pharmacist duties in the 30-C1-14-4 capital municipal hospital Mikio Hayashi 1, 2, Tatsuo Tanaka 2, 3, Michio Usui 2, 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2007.

---

	We clear the way to the coming times Takeshi Iseki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 143-143, 2008.

---

	Dramatic change of peptic ulcer drug treatment : To complete recovery from healing 浅香正博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 147-147, 2008.

---

	Introduction of hospital pharmacist duties in China Pheasant 所迪 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 148-148, 2008.

---

	Professional service and the management of my pharmacy;present role and future contribution in the multi-disciplinary oncology team Susan M. Spivey Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 149-149, 2008.

---

	Disease prevention ... "to be healthy with a meal", and to learn from - Chinese medicine Kiyoshi Hotta Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 150-150, 2008.

---

	Because is inflected as improvement of school feeding ... "lifelike teaching materials"; ... Keiko Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 151-151, 2008.

---

	"A drug administration design of the childhood and the study on drug interactions" Hiroshi Nakamura justice Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 155-155, 2008.

---

	The pharmacokinetics change mechanism of the beta-blocker for the purpose of the individual pharmacotherapy of heart failure and elucidation of racial differences The Tadashi Taguchi up Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 156-156, 2008.

---

	The 20-S1-1 "expectation to the pharmacotherapy to a pregnant woman and a specialized pharmacist" Kodo Sato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 159-159, 2008.

---

	Evaluation and risk communication - of the 20-S1-2 "role - teratogenicity information of medication counseling and the pharmacist to a pregnant woman" Shigeo Takamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 160-160, 2008.

---

	The 20-S1-3 "expectation to pharmacotherapy to nursing mother and a specialized pharmacist" Hiroshi Tamai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 161-161, 2008.

---

	Evaluation and risk communication - of the 20-S1-4 "role - infants hazardousness information of medication counseling and the pharmacist to nursing mother" Ken Nakajima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 162-162, 2008.

---

	20-S2 "business training by Preceptors" (instruction pharmacist) Tomoji Yoshiyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 163-163, 2008.

---

	20-S2-1.2 A Guide to Precepting Pharmacy Students on Clinical Clerkship Michael A.Oszko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 164-164, 2008.

---

	Term "You are developing!" of the 20-S2-3 encouragement Atsumi Nishikiori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 165-165, 2008.

---

	20-S2-4 I learned from the discussion "knowledge + α" 上塚朋子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 166-166, 2008.

---

	Is the practical clinical practice of the student who does not have 20-S2-5 pharmacist qualification possible; role - of the clinic teacher, instruction pharmacist in - United States? Rie Kubota Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 167-167, 2008.

---

	Suggestion ... to the ethic education of professionalism - pharmacist in the 20-S3-1 medical care Yasushi Miyata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 168-168, 2008.

---

	The present conditions of the outlook on ethic of the pharmacist in the 20-S3-2 clinic Mitsuru Shiokawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 169-169, 2008.

---

	Critical comment - to limit - pharmacy education model core curriculum of the cultivation of aesthetic sensitivity named the 20-S3-3 humanism Jun Matsuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 170-170, 2008.

---

	Law and ethic for the 20-S3-4 pharmacist One Inaba Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 171-171, 2008.

---

	20-S4 opening remark Kenichi Miyamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 172-172, 2008.

---

	The thing which 20-S4-1 cancer professional training plan aims at Kazuhiro Araki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 173-173, 2008.

---

	Training of the cancer specialist by 20-S4-2 "cancer pro" 鳥本悦宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 174-174, 2008.

---

	The role of the nurse in the 20-S4-3 cancer medical care team and upbringing of the specialist Kawamura three rare child Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 175-175, 2008.

---

	Training and postgraduate education of the specialized pharmacist supporting 20-S4-4 altitude cancer medical care Kenichi Inui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 176-176, 2008.

---

	About the training of the pharmacist specialized in 20-S4-5 cancer action - of - National Cancer Center Ichiji Endo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 177-177, 2008.

---

	20-S5-1 Approach to ensuring medication safety in pregnancy and breastfeeding-The activities of the Hospital for Sick Children in Toronto- Mikio Kakumoto1, Midori Hirai2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 178-178, 2008.

---

	20-S5-2 The role of Hospital Pharmacists on the Pharmacy Education Systems in University of Mississippi Takehiro Yamada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 179-179, 2008.

---

	20-S5-3 International Cooperation How should we think about "International Cooperation" to improve problems in developing countries? Watanabe Shiomi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 180-180, 2008.

---

	Is it 20-S5-4 What expectation on pharmacists from community? Zhu Zhu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 181-181, 2008.

---

	20-S5-5 The roles of Clinical Pharmacy Specialists in Japan Sari Nakagawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 182-182, 2008.

---

	20-S5-6 The Roles of Korean Pharmacists in Changing Medical Circumstances and the Need for Cooperation between Pharmacists in China, Japan and Korea Bon-Ki Koo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 183-183, 2008.

---

	20-S5-7 How to satisfy expectation of patients? Zhao Limei Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 184-184, 2008.

---

	20-S5-8 "Disaster Relief Pharmacist" has what it takes to be a proactive disaster responder Eiko KOBAYASHI Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2008.

---

	The present conditions (than questionnaire findings) of the 20-S6-1 businessman teacher Ikuko Yano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2008.

---

	The thing which the businessman teacher in the 20-S6-2 pharmacy school aims at Hiroshi Yamamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2008.

---

	The present conditions and problems of the businessman teacher and drugstore pharmacist of 20-S6-3 drugstore origin Kamimachi Akiko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2008.

---

	Clinical medicine education by the 20-S6-4 medicine cooperation and construction of the clinical on-site pharmacy education Yukihiro Noda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2008.

---

	From a situation of thing - university hospital to expect of 20-S6-5 businessman teacher - Kiyobumi Yamada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2008.

---

	20-S6-6 "thing to expect of a businessman teacher" Takashi Kodama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2008.

---

	Thing to expect of 20-S6-7 businessman teacher 渡部廉弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2008.

---

	Coexistence - of thing - education and the business to expect of 20-S6-8 businessman teacher Hideto Sekino Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2008.

---

	20-S7-1 "role of the local Pharmacist Association in the insurance pharmacist education" Michiko Yamaguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2008.

---

	The actual situation and problems of the training of the 20-S7-2 chain drugstore Tokiko Okuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2008.

---

	The 20-S7-3 "pharmacist education in the small drugstore" Masatoshi Katsura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2008.

---

	20-S7-4 "cooperation of a pharmacist practice private supplementary school and the training in the company" Takashi Michigami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2008.

---

	20-S7-5 [Carrier creation of pharmacist sought to diversity era: To the future in a strategic and logical thinking have their own axes] 飯野直子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2008.

---

	Meaning of a presentation at the meeting and the article in the pharmacist authorization specialized in 20-S8-1 psychiatry Takashi Yoshio Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2008.

---

	20-S8-2 "announces the practice of the clinical psychiatry pharmacy in a society" 梅田賢太 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2008.

---

	How to write 20-S8-3 case report Junichi Senba Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2008.

---

	20-S8-4 "the situation - of article contribution capture law 1 - clinic" Tensho era Masami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2008.

---

	20-S8-5 "the situation - of article contribution capture law 2 - university" Yasuhiko Hashimoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2008.

---

	The 21-S9-1 "development of products in consideration of convenience of the patients" Yasushi Ochiai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2008.

---

	Information retrieval about the oral medicine suspension for 21-S9-2 medication support and experimental evaluation Shiro Ishida 1, Yoshiro Okano 1, Katsuaki Arai 2, 賀勢泰子 3, Tetsu Ando sincerity 4, Is Kurata; see it; 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2008.

---

	The medication support that was made in a viewpoint to protect ADL, the quality of life of the 21-S9-3 patients Tetsuji Kawazoe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2008.

---

	Do you not forget patient compliance instruction of the 21-S9-4 external preparation? 大谷道輝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2008.

---

	Induction of safety management and the simple suspension method of medication, the nutrient support tube feeding by 21-S9-5 NST(nutrition support team) Hirohiko Mochizuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2008.

---

	Patient compliance instruction until 21-S9-6 now, medication support in the future Is Kurata; see it Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2008.

---

	- close as a result of 21-S10-1 "present conditions - questionary survey of the pharmacist duties in critical care centers of the whole country" Kenji Nishizawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2008.

---

	Expectation to 21-S10-2 "extensive critical care center pharmacist involved in the clinical condition diagnosis of the emergency patient" 岩崎泰昌 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2008.

---

	From pharmacist duties - patients import in the 21-S10-3 emergency care to a discharge - Norikazu Kikuchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2008.

---

	Relation of the pharmacist to a renal function evaluation and the antimicrobial agent administration plan in 21-S10-4 ICU inpatients Akio Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2008.

---

	Role of the exclusive duty pharmacist in the 21-S10-5 this hospital intensive care unit Tamaki Kikuchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2008.

---

	Practice of PBL in 21-S11-1 Gifu College of Pharmacy and the result Teramachi eyes Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2008.

---

	Towards practice - pharmacy education's original PBL of the PBL induction in 21-S11-2 Hokkaido College of Pharmacy - Noro shallows Takahiko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2008.

---

	Action - of PBL- Meijo University in the 21-S11-3 pharmacy education Kazuhisa Matsuba Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2008.

---

	21-S11-4 The rffective PBL- Tutorial education : Introduction and its point of large classroom-type model 津田司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2008.

---

	For the treatment of depression that 21-S12-1 is appropriate including antidepressants and a suicide-related problem: Atsuo Nakagawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2008.

---

	The 21-S12-2 "mood disorders and correspondence that we saw from a pharmacist" Hiroko Baba Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2008.

---

	It is ... with the information that you should tell to the drug information ... patients of antidepressants helping 21-S12-3 practice Naoko Takeuchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2008.

---

	The truth of "depression" that there seems to be 21-S12-4 intellect and does not know Ritsuko Yamaguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2008.

---

	How do practice 21-S13-1 business training; including / questionnaire findings report? Takeshi Iseki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2008.

---

	It is ... for acceptance of ... business training about the induction promotion business of TDM duties under 21-S13-2 Kanagawa Toishima study Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2008.

---

	21-S13-3 "business training to work on in an area" 鹿村恵明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2008.

---

	21-S13-4 "thinks about a core curriculum from the actual situation of the drugstore" Choichiro Miyazaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2008.

---

	About "we eat it for teaching collection of for action authorization instruction pharmacists of the Tokyo Pharmacist Association for the 21-S13-5 core Cali LS problems" Naoki Uemura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2008.

---

	See hospital pharmacist activity of business training - United States for pharmacist upbringing in the 21-S13-6 next generation; and ... Yoshihiko Shibayama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2008.

---

	Knowledge - of the appropriate pharmacotherapy -TUE application in 21-S2-F1 sports 山澤文裕 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2008.

---

	21-S2-F2 "sports fur better strike authorization system" This node child Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2008.

---

	21-S2-F3 "participation in planning to prevention of doping activity as the hospital pharmacist" Kumiko Kasashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2008.

---

	Cooperation of 21-S2-F4 sportsdom and the pharmacist Seiko Hashimoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2008.

---

	Gene delivery ... due to contribution ... multifunctional envelope form nano structure body to Part 1 Nanomedicine Hideyoshi Harashima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2008.

---

	Part 2 "action to the present conditions and therapeutic drug development of the gastrointestinal disease practice" Hiroshi Takeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2008.

---

	Part 3 For the promotion of the translational research of the second 福原俊一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2008.

---

	From the situation of the Part 4 pharmacy Net Katsuo Oka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2008.

---

	Study policies from Part 5 fundamental researches to the hand of the patients Daisaku Sato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2008.

---

	Evaluation of 20 C-01 anticancer drugs regimen function induction Kenji Kimura, Akiko Yamagata, Kunio Ukon, Yoko Haga, Takahashi Setsuko, Akemi Nanun, Tatsuo Tanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2008.

---

	Chemotherapy protocol management in 20 C-02 injection order ring systems non-induction medical institution Naoko Kitamura 1, Nobutaka Sugano 1, Hiroshi Moriya 2, Tomoko Endo 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2008.

---

	20 C-03 Establishment of setting the inspection method of cancer chemotherapy discontinuation criteria by the inspection data 渡邊裕之1, 星育子1, 中井由佳1, 亀山雅男2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2008.

---

	Side effect of 20 C-04 cancer Japan Society of Chemotherapy systems of administration monitoring 當真房子 2, Saori Yamamoto 1, Terumi Nagahama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2008.

---

	Examination about the safety of the cisplatin /S-1 combination therapy at 20 C-05 renal function degeneracy 櫻井洋臣, Yasuhiko Ichida, 加藤裕芳, Ichiji Endo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2008.

---

	Action to cancer chemotherapy in 20 C-06 this hospital 眞田真樹, Yuji Funada, Yoko Tsutsui, Jin Machida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2008.

---

	About the utility of 20 C-07 anticancer drug preparations, inspection system Hiroyuki Ueno 1, Naoki Hayakawa 1, Makoto Saito 1, Kazuyo Matsuyama 1, Ayako Ono 1, 山内一恭 1, Yoshihisa Honda 1, Next Takeshi Hara 2, Katsuya Komori 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2008.

---

Radiation exposure situation investigation (1) of pollution and the person of the preparation environment with 20 C-08 anticancer drugs of preparation Toshihiro Hama, Tsuyoshi Aoyama, Hidetaro Higuchi, Kondo many children, Kakuda still, Wataru Toya, Former Taro Isami, Yasushi Nakamura life Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2008.

---

	About anticancer drug sterility preparation duties in 20 C-09 Fukui Prefectural hospital Mitsue Uno, 中村尚未, Shoichi Hotta, Takashi Hiraga, Yaeko Hondo, Toshiharu Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2008.

---

	An action and team approach in medical care to the appropriate cancer chemotherapy enforcement in 20 C-10 district hospitals Kazuyuki Sunada 1, 三阪高春 2, Fumiko Matsueda 3, Kishimoto truth 1, Ogyou Yukiko 1, Long ヶ Takuma Hara 1, Yoshimura truth 1, Hirofumi Wakamatsu 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2008.

---

	Consumption decrease and resistance ratio decrease of the carbapenem-based antimicrobial agent by the use of 20 C-11 antimicrobial agents report system induction Tetsuya Ueki 1, 4, Keiko Nagai 1, Shigehiko Ito 2, Kotaro Ichikawa 3, Miho Nakajima child 4, Mikiro Nakajima 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2008.

---

	Pyocyanic chemosensitive change by 20 C-12 carbapenem system antimicrobial agent report system induction 石田茂伸 1, Kayo Maeda 1, Hiroyuki Watanabe 1, Yuka Nakai 1, Junpei Sasaya 2, 山崎多江子 2, Toshio Oshima 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2008.

---

	A use of antimicrobial agent trend in 20 C-13 this hospital and chemosensitive surveillance Hiroko Ota 1, Kazumi Shirai 2, Original field Kazumi 1, Yasuji Morita 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2008.

---

	Examination of the use of antimicrobial agent situation and resistant bacteria measures in 20 C-14 this hospital Kenichi Manabe 1, Makoto Tanaka 1, Teruyuki Otsubo 1, Small thicket Makiko 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2008.

---

	The use of injectable antimicrobial agent situation of methicillin-resistant staphylococcus aureus-positive negative patients in 20 C-15 Matsuyo Nagano General Hospital Long Tawa person 1, 藤井宏亮 1, Tatsuya Arai 1, 金田武敬 2, Masato Takamori 1, 瀧澤好廣 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2008.

---

	We think about the use of the vancomycin hydrochloride (VCM) note in 20 C-16 this hospital Hiroshi Hara person, Hidetaka Hirano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2008.

---

	Examination about the initial administration plan of vancomycin hydrochloride note (VCM) in 20 C-17 elderly people Kazushige Sakano, Yu Yamauchi levator, Cresset Tadahiro, Yasuhiro Miki, Shunsuke Nakanishi, Maho Nojiri, Akiko Matsunami, 辻岡利都 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2008.

---

	20 C-18 A use situation investigation of linezolid and the effectiveness, investigation about the side effect 山崎浩二郎1, 西村あや子1, 宮本剛典1, 武隈洋2, 菅原満1, 井関健1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2008.

---

	About the development of catheter-associated blood flow infection situation in 20 C-19 this hospital 門脇督, Takayuki Tani, History of Takashi Yamada, Nagai Shoichiro, Junichi Kubo, 藪芳, Shunichiro Saito, Naoya Yoshida, 小原郁司, Toshihito Komiyama, Hiroaki Watanabe, Takahiro Sakuma Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2008.

---

	It is an action for no responder hepatitis B vaccine low responder in 20 C-20 this hospital Takeki Yamamoto, Keizo Morimoto, 北村諭思, 古川壮彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2008.

---

	The change of alcohol hand disinfectants for prevention of hand rough weather in 20 C-21 healthcare settings and the evaluation 波能満理惠 1, Masayuki Wakita 1, Tomomi Hoshino 1, Hiromi Fujioka 1, Risa Imamura 2, Hiromi Ito 3, Junko Satake 3, Koichi Nobata 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2008.

---

Present conditions and problem ... about the hand hygiene of the hospital pharmacist in action ... Tokai district of 20 C-22 Tokai district infection control meetings for the study Takayuki Inagaki 1, 2, Waterfall Hisashi 2, Mariko Aota 3, Yoshiaki Ikeda 4, Yuki Ito 5, Hiroki Inoue 2, 片山歳也 6, Tadao Kimura 7, Yoshikazu Kobayashi 8, Izumi Shimada 9, Shinichi Tamiya 5, Shigeki Nakane 10, Masashi Sakano 3, Hiroki Mase 9, Yuichi Muraki 11, Ken Mori 1, 7, 二改俊章 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2008.

---

	The action that the disinfection introduces instruction to eliminate the need for for the patients of 20 C-23 insulin self-administration Star Hatsumi 1, 古川恒昭 2, Hideko Kenmochi 3, Yoshiyuki Suzuki 4, Katsuya Fuse 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2008.

---

	Suspension fungus investigation in 20 C-24 University of Tokushima Hospital ward 柴田高洋 1, Hirofumi Shibata 4, Fushidani Hideji 3, Kazuyoshi Kawazoe 4, Masahiro Abe 4, Tomihiko Higuchi 4, Kazuo Mizuguchi 4, Shono sentence 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2008.

---

	Investigation of the hygienic hand-washing procedure acquisition degree of 20 C-25 pharmacy students 森茂彰 1, Masashi Sakano 2, 3, Mariko Aota 2, 3, 寺井文廣 2, Yuki Ito 3, Waterfall Hisashi 3, Izumi Shimada 3, Hiroki Mase 3, Ken Mori 3, 豊田行康 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2008.

---

Utility of the optimal trough blood level decision method in consideration of MIC and a tissue extraction rate of vancomycin hydrochloride in patients with 20 C-26 MRSA pneumonia Three branch families of the Tokugawa house Naoki 1, Takuya Suzuki 1, Kunio Tomita 1, 樹下成徳 1, 木田兼以 2, Kana Matsumoto 3, Kunihiko Morita 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2008.

---

	Investigation about the relation of the antiuse of MRSA medicine situation and pharmacist in 20 C-27 this hospital Tomoko Yoshida 1, Chizuru Inoue 1, Many Luo tail love 1, Katsushi Miyake 2, Ochi accounting office 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2008.

---

	Examination about the vancomycin administration for the CAPD patients whom 20 C-28 peritonitis developed in 浦嶋和也 1, Tomoyuki Yamada 1, Kaoru Suzuki 1, Masami Nishihara 1, Tsuyoshi Nishida 2, Italy husband your Naokazu 2, Hiroshi Tamai 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2008.

---

	Pharmacokinetics study of 20 C-29 bepridil 星聡 1, Kamakura Shiro 2, Kyoko Fukumoto 1, Kazuyuki Ueno 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2008.

---

	Pharmacokinetics study of the ceftriaxone sodium in 20 C-30 children Shiori Aida 1, Kyoko Fukumoto 1, Tomohiro Oishi 2, Kazuyuki Ueno 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2008.

---

	Comparison of the blood tacrolimus levels measurement using 20 C-31 MEIA method, CLIA method and ACMIA method Takashi Kitahara, Hiroo Nakagawa, Chieko Shimizu, 兒玉幸修, Tomoyuki Hamamoto, wisteria Hideto, Hitoshi Sasaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2008.

---

Contribution (action of the drug control instruction) of the pharmacist in the patients who presented with anaphylaxis thought about according to 20 D-01 vancomycin Hisao Ikeda 1, Obayashi fair name child 1, Hiroshi Nomura British 1, Noriko Ono 2, Hisashi Tanaka line 3, Koshin Yoshikawa 3, Katsuyoshi Hatanaka 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2008.

---

	Practice and evaluation of the pharmacotherapy support in 20 D-02 first aids, intensive care unit Chie Goto, Atsushi Watanabe, Yoshimasa Naomi, Yasuo Ogasawara, 長崎信浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2008.

---

	Role of the pharmacist carrying it out for the quality of life maintenance of patients with 20 D-03 coronary artery disease Yuji Hattori 1, Makoto Saito 1, 山内一恭 1, Yoshihisa Honda 1, Katsuya Komori 1, Yoshio Yasumura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2008.

---

	It is ... including an induction evaluation of the relation ... fondaparinux sodium preparation of the pharmacist to DVT precaution in 20 D-04 this hospital 舟越亮寛 1, Tsuyoshi Washiyama 1, Yoshiko Matsumoto 1, Tatsuya Oyama 2, Sanmatsu interest way 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2008.

---

20 D-05 pharmacist ward permanent residence for improvement of pharmaceutical management in becoming it Hiromi Sekimoto 1, Asako Kimura 1, Middle storehouse Ichiro 1, Bank of a moat Yayoi 1, Eri Nishiguchi 1, Hideki Morishita 1, 2 which is related to Kinugasa, Description of Noda world 2, Keiko Fujiwara 2, Jun Kobayashi Jiro 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2008.

---

	Trial of fact-finding and the standard bread fret making of the inhalational instruction in 20 D-06 health insurance pharmacy Akira Maruyama 1, Kazuaki Kojima 1, Shinobu Araya 1, North side Tomoyuki 2, Daisuke Toko 2, Koshiyama Setsuko 3, Noriko Miyawaki 4, Cheap place wide high 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2008.

---

	20 D-07 pharmacists, construction of the right insulin injection procedure instruction by the cooperation between nurses 神原康佑 1, Junko Onishi 1, Kazuki Ochi 1, Jun Fujii charges 1, Mieko Miyake 1, Toshi Hara child 1, Sachiko Okano 1, 増田憲俊 1, Mika Wakimoto 2, Lower Kanako Suga 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2008.

---

As a result of induction recommendation model choice to an usability evaluation and the patients of the insulin injector by the short time type procedure experience workshop for 20 D-08 pharmacists with body function disorder Eiko Hara 1, 7, Toru Yamada 2, 7, Kazuhiko Nagai 3, 7, Ayumu Katagiri 4, 7, Manabu Abe 5, 7, Toshinari Asakura 6, 7, Miho Kageyama 6, 7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2008.

---

Side effect investigation in the hematopoietic stem cell transplantation protocol using 20 D-09 mycophenolate mofetil It is Naho 1 in a circle, Temple former Mayumi 1, Masumi Hasegawa 1, Mountain Hiroshi Morimoto 1, Akiko Tanifuji 1, Kadoyama Kaori 1, Makimoto Hiroo 1, 西口工司 1, Atsushi Okamura husband 2, 松井利充 2, Hirai green 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2008.

---

	The enforcement of bringing medicine confirmation duties by 20 D-10 ward pharmacists and contents investigation of the bringing medicine Inou Kanako, Winnow music Mayumi, Shinobu Hasebe, Hiromi Tamura, Tadaaki Ito, Masahiro Hayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2008.

---

Relation as Infusion reaction incidence investigation in the trastuzumab adjuvant postoperative treatment in 20 D-11 outpatient department and the medical person 葉田昌生 1, Toshiko Oda 2, Tadashi Mikami 1, Yoichi Nakajima 1, Yoshiko Murakami 1, Mountainous district will 1 old, Wataru Shiraishi 1, Ikuhiro Nose 1, 田中眞紀 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2008.

---

	Analysis of inquiry duties in 20 D-12 outpatient department chemotherapy Akira Takagi Kei 1, 2, 吉田睦浩 1, 2, 山之内恒昭 1, Yasuhiko Mimura 1, Cake well Tatsuhiko 3, Atsushi Kato 1, Isao Adachi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2008.

---

	Action about the proper use promotion of antiemetics used by 20 D-13 outpatient department chemotherapy Maki Takimoto 1, Yuko Taguchi 2, Virtue comfort Masato 3, Satoshi Ushijima 3, Kenji Horii 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2008.

---

Fact-finding about the pain control for the cancer outpatient department chemotherapy application patients of 20 D-14 this hospital Shunichiro Saito, An original collar, Takeru Kawai, Takayuki Tani, Yukiko Honda, Mayumi Iwahori, 門脇督, 鈴木悠加, Nagai Shoichiro, Junichi Kubo, 鶴見里佐, 小原郁司, Takahiro Sakuma Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2008.

---

	An investigation and measures about the anticancer drug exposure at the cancer pharmacotherapy in 20 D-15 whirlpools Hospital Mari Mizuki 1, Kirai Hiromi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2008.

---

Application to the establishment of the rating system that assumed doxorubicin an index drug nosocomial pollution and healthcare worker radiation exposure with 20 D-16 antineoplastic and the investigation of the pollution status Keiji Matsumoto 1, 2, Takafumi Naito 1, 宮本康敬 1, History of moat male 3, Takashina Yoshiaki 1, Naoko Yoshida 1, Hiroshi Yamada 2, Junichi Kawakami 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2008.

---

	Physicochemical characteristic examination of the vinca alkaloid-based anticancer drug for 20 D-17 temperature changes Kazuaki Kojima 1, 寺田智祐 2, Shinko Tsuda 2, Toru Hashida 2, Ikuko Yano 2, Kenichi Inui 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2008.

---

	About the Error of measurement with the syringe in 20 D-18 anticancer drug preparations Eri Tada, Utsubo Yuko, Megumi Fujita, It is Naho in a circle, Toshihiko Yamaji, Mao Yamamoto, Shinto priest Mari, Atsushi Wada, Kadoyama Kaori, Makimoto Hiroo, 西口工司, Hirai green Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2008.

---

	20 D-19 Examination of the factor affecting the dose of imatinib 岸三重子1, 2, 河原昌美2, 高田直子3, 春木一伸4, 荒川雅美1, 宮本謙一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2008.

---

	The making of 20 D-20 cancer chemotherapy enforcement planned calendar and examination of the utility Kazuyo Aoyagi 1, Mayumi Kaise 2, Gutter bear Kinji 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2008.

---

	20 D-21 The combination of zoledronic acid hydrate and chemotherapy : Patients who obtained a therapeutic effect in the renal pelvis cancer 佐藤利之1, 泉浩司2, 滝沢明利2, 宇田川幸一2, 依田啓司1, 村井哲夫2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2008.

---

	Relation of the pharmacist in 20 D-22 team bell Quaid Takashi Sugizaki person, Takahashi volost, Description of basic truth, Hidetaro Higuchi, Chieko Kondo, Cheap Fujihana clip, Tomoko Hiraoka, Kazunori Kawakami, Toshihiro Hama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2008.

---

Observe ... M.D.Anderson Cancer Center thinking about the role of the pharmacist in 20 D-23 team approach in medical care; and ... 橋本浩伸 1, Yoichi Osato 2, Jun Takashima straight 3, Sugiyama (Yoshimura) Naoko 4, Hitomi Sato 5, Kitayama Sayuri 6, Hillary A.Prescott7, Jeffrey Bryan7, Naoto Ueno 8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2008.

---

	Comparison of the use of cancer pain therapeutic drug situation in this hospital before and after 20 D-24 psychological care team starts Hiroko Takahashi 1, Advancement in the world static 2, Setsuo Tsuchiya 1, 丹田滋 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2008.

---

	20 D-25 Supportive care of cancer: Mainly stomatitis 新井律子, 森田智子, 丹原敏男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2008.

---

	Action to an adverse event collection of process and patients feedback in 20 D-26 breast cancer chemotherapy Nabeta Izumi 1, Kazuyo Nakamura 1, Kimiko Asakura 1, Midori Kimura 1, Tsuneizumi Michiko 2, Kazuhiko Nakagami 2, 河原崎貴伯 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2008.

---

	Example that showed INR increase thought to be the interaction with the Gefitinib in 20 D-27 warfarin remedy patients Aihara Hideaki, Tomomi Omori, Kohei Ichikawa, Haruka Fujise, Masami Onishi, 前彰, Takao Akashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2008.

---

	Pro-evaluation of the oral mucosa disorder with 20 D-28 radiotherapy establishment Chie Nakata 1, Tsuyoshi Hirano 2, Rumi Takano 3, Masanori Kobayashi 2, Shiro Itagaki 2, Takeshi Iseki 2, 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2008.

---

	Investigation about the onset of stomatitis in patients with head and neck cancer given 20 D-29 cancer chemotherapy Shinya Suzuki, Kenji Kawazumi, Genei Shinya, Sonoko Furubayashi, 加藤裕芳, Ichiji Endo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2008.

---

	Application of the antioxidant material for the prevention of stomatitis in 20 D-30 cancer chemotherapy Rumi Takano 1, Tsuyoshi Hirano 2, Chie Nakata 2, Kumiko Kasashi 3, Mitsuru Sugawara 3, Masanori Kobayashi 2, Shiro Itagaki 2, It is 3 Takeshi Iseki 2, Toshiji Oe 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2008.

---

Examination of the angiogenesis factor gene expression in 20 D-31 hepatocellular carcinoma biopsy preparation Tamotsu Suzuki season 1, Chisato Kitayama 1, Osamu Ito greens 1, Daiya Sakurada 1, Masahiko Sunaga 2, Shoji Yoshikawa 3, 横須賀收 3, Fumio Nomura 4, Noboru Sato example 1, Shiro Ueda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2008.

---

	Innovator drug of 20 E-01 cefazolin sodium (CEZNa) notes, examination of the equivalency of the generic drug Your Orihara wide 1, Miwako Kamei 1, 櫻井康亮 2, Tomioka Mitsugu 2, Junichiro Murayama 2, Makoto Otsuka 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2008.

---

Effect on neutropenic frequency with the forerunner and the generic medicine of 20 E-02 hydrochloric acid epirubicin preparation Tomoko Suzuki 1, Kimura なつほ 3, Yuko Fukuda 1, Ayako Kato 1, Sei Suzuki Nako 1, Kadomura Shota 1, Mina Takeuchi 1, It is still 1 Asano, Takahiro Shiga 1, Tatsuya Ito 1, Law of nature authority 2, Prince Takashi Nakagawa 2, Shinichi Matsuoka 2, Koji Saito 3, Takemoto success 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2008.

---

	Pharmaceutics-like comparison between starting medical supplies and generic medicine of 20 E-03 micro emulsion-type cyclosporine preparation Ueda Kosuke 1, 武隈洋 2, 沖洋充 1, Suda example line 1, Mitsuru Sugawara 1, Takeshi Iseki 1, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2008.

---

Stability evaluation after the last packing opening a letter of a lot of 20 E-04 limaprost alfadex marketing preparation Tamami Hirayama 1, Hidetoshi Arima 2, Ichiro Inaba 1, Keiko Kinoshita 1, Quantity of Seo 3, Kenichiro Fujii 1, Shunei Maeda 1, Yuko Matsunami 1, Shigeyuki Miyamura 1, Aphananthe aspera Takayuki 1, Masato Yamamura 1, Tadashi Nomura 1, Junichi Saeki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2008.

---

	Examination about the quality in an innovator drug and the generic drug of 20 E-05 limaprost preparation and the stability Helmet slope Masashi 1, Kiyoto Edo 1, Fumiko Negishi 1, Keiji Maruyama 1, 河野博充 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2008.

---

	Inquiry, inquiry investigation from 20 E-06 patients, staff Masato Shindo 1, Yoko Shimada 1, Keiko Fujisawa 1, Tomoko Kawahara 1, Yoshizawa peak blue 1, Najima reason slop-bowl 1, Mitsue Shindo 2, Seigo Iwakawa 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2008.

---

	Information inflection of adverse event database AERS by the synonym solution to 20 E-07 medical supplies names Shuji Kaneko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2008.

---

	Construction of the additive search system in 20 E-08 ethical drugs Satoko Suzuki 1, Noriko Nakamura 5, Daiya Sakurada 1, 鈴木弘誉 4, Shigeyuki Yamada 4, Masahiro Fukushima 4, Net Katsuo Oka 3, Noboru Sato example 2, Shiro Ueda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2008.

---

	Development of poisoning information database by 20 E-09 Adobe Flex 2+ XML and diagnostic aid system (SPIA) Akira Inoue 1, Yuta Inoue 1, Yasuko Nakano 1, 戸部敞 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2008.

---

	Drop capacity and change factor of a lot of 20 E-10 infusion 橋本大佑, Junji Kaga, Kayoko Fujita, Tetsushi Iwamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2008.

---

	Fact-finding of the diabetes patient education in 20 E-11 opening of an office drugstores Hiroaki Nagata, Manabu Tanimura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2008.

---

	The medicine medicine cooperation that utilized 20 E-12 side effect conjugation monitor systems 本樫寿裕 1, Yuko Okamura 2, Yagi Nobuhiko 1, Tatsuya Yokoyama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2008.

---

The construction of the internal use anticancer drug checking prescription system using 20 E-13 treatment planning form and trial to the patients information bank attendant to the out of the hospital drugstore Toshiya Goto, Kazuaki Hirose, Kazuhide Tanaka, Masaki silver three, Akira Takada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2008.

---

	Recognition degree investigation about 20 E-14 cancer pain control Takeshi Miyake sentence, 須山奈見子, Saori Okamoto, Yoko Nakano, Kana Akahori, Otake A tree, Shizuka Takaoka, Ikuko Fukumoto, Takushi Morimoto, Maki Ushijima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2008.

---

	Examination of the oral anticancer drug orientation induction by 20 E-15 hospital pharmacists Yoichi Nakajima, Tadashi Mikami, Yoshiko Murakami, 山方志築, Wataru Shiraishi, 葉田昌生, Ikuhiro Nose Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2008.

---

	Present conditions report of the pharmacist training specialized in a cancer in 20 E-16 Tokyo Medical College Hospital Tomomi Omori, Hiroshi Soeda, Kanako Azuma, Yoichi Osato, Aihara Hideaki, Yasushi Naito period, 冨樫英晶, 前彰, Takao Akashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2008.

---

	Action for antimicrobial agent proper use based on 20 G-01 De-escalation enforcement investigations Nobuko Umemura 1, Masashi Sakano 2, 森茂彰 1, 豊田行康 1, Mariko Aota 2, 寺井文廣 2, Yuki Ito 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2008.

---

	Effect on residual quantity in the vial of 20 G-02 vancomycin hydrochloride notes and AUC and time above MIC Hiroshi Yamazaki 1, Shigeharu Oie 3, 園山裕靖 2, Hiroko Tanaka 2, Yasuhiko Sato 2, Naoyuki Miyano 1, Akira Kamiya 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2008.

---

	Contribution to proper use of the medicine by 20 G-03 ward permanent residence pharmacists Kazuya Fujita, 郡妙恵, Sumiko Inamura, Toru Shinohara, 並木路広, 大谷道輝, Kiichi Yamamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2008.

---

	It is a change of the dissolution by the heat denaturation the denaturation (the second report) due to the fever of 20 G-04 clarithromycin dry syrup Yasuhiro Matsumoto 1, Rie Kai 2, Kyuju U.S. tree Yoko 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2008.

---

It is ... from the settings of role - thrombolytic therapy (rt-PA therapy) of the pharmacist in the medical care for 20 G-05 stroke hyperacuteness period Aku Masami Sawa 1, Takeharu Nakane 1, Hiroyuki Sekiguchi 1, Tomoko Itano 1, Tomoyo Harada 1, Tomoharu Morita 1, Hiroyuki Tajima 1, Akiko Miura 1, God Takao Sawa 2, Beautiful master 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2008.

---

	Examination of the utility about 20 G-06 pioglitazone 7.5mg/day administration Mayuko Yamashita 1, Yasuko Ichikawa 1, Yasushi Fujii 1, Kenichiro Fujii 1, Katsutoshi Miyakawa 2, It is Taiji 2 in Seki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2008.

---

	Water absorptive examination of hydrochloric acid Seve Lamar and the carmellose by 20 G-07 healthy subjects Esaki hsiang tsai child 1, Kanai A Kei 1, Mika Kano 1, 濟川聡美 1, Kei Sato wound 2, Yoichi Ishizuka 3, Mitsuru Irikura 3, Toru Irie beauty 3, Daisuke Kadowaki 1, Sumio Hirata 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2008.

---

	Effect on laboratory values in front and back where we made change of prescription from 20 G-08 ticlopidine to clopidogrel Aya Kajita 1, Yuji Hattori 1, Makoto Saito 1, 山内一恭 1, Yoshihisa Honda 1, Katsuya Komori 1, Yoshio Yasumura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2008.

---

	Examination of the simple genetic polymorphism diagnostic procedure of UGT1A1 *28 which is necessary for Serious ADR prediction of 20 G-09 irinotecan Ayako Morita 1, Amount of Ariyoshi example 2, Koichi Kitada 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2008.

---

	Analysis - in examination - sun stage and the small positive stage of the utility of the Chinese medicine extract preparation for 20 G-10 common colds Yasuhiro Sugiyama 1, Miyashita quiet 2, 齋藤幹央 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2008.

---

	Induction and evaluation of the clinical pharmacy experience team type training in 20 H-01 Sino-Japanese traditional medicine basic education 日置智津子, Katsuhiko Arai, Takashi Masanori, Makoto Arai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2008.

---

	Examination of the learning result evaluation analytical procedure in the arrival target of 20 H-02 business training model core curricula Hidenori Sagara 1, Yoshihisa Kitamura 2, Hiromi Okazaki 3, Atsumi Nishikiori 3, Satoko Fujiwara 3, Sendo Toshiaki 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2008.

---

For improvement of the quality of 20 H-03 hospital pharmacists trial - of the - Nagano Hospital Pharmacist Association Masaru Nakajima 1, Okazawa incense Tsu child 1, Katsuo Tanaka 1, Kenji Kiyohara 1, 1, Kyoshi, Nakayama, Hatsutani University child 1, Mitsue Mizutani 1, Osamu Atobe 1, 六波羅孝 1, Akihiro Tada 2, 白澤吉哲 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2008.

---

	The evaluation of the postgraduate training pharmacist system in the hospital attached to 20 H-04 Osaka Medical College and the future prospects Masami Nishihara, Nishimura ankle purely, Toyofusa, Kobayashi, Tomoko Ueda, Osamu Kiyama, Noriko Suzuki, Kaoru Suzuki, Hiroshi Tamai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2008.

---

The situation of the trial education judging from questionnaire results in 20 H-05 Hospital training for 9 years and future problem Yoko Iguma 1, Old real name Tsu child 1, Spring fortune Manami 1, Tomoko Matsuyama 1, Ayumi Shida 1, Eriko Sato 2, Taeko Hashida 2, Matsui あや 2, Yoshiko Ishizuka 1, Ikuko Yano 1, Kenichi Inui 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2008.

---

	Conduct 20 H-06 visit drug control instruction Isurugi Ikuko, Miki Sato, 曽我師賢 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2008.

---

	The way of promotion and the discharge plan of 20 H-07 treatment at home Kazuki Kushida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2008.

---

	Action of DCST in 20 H-08 Saitama Red Cross Hospital Naoto Sugawara 1, Yoko Kamei 1, Kana Fukuda beauty 2, Hitomi Matsui 3, Hashizume English sentence 4, Yoshio Fujikake 1, Kazuyuki Ikui 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2008.

---

	Action to the smoking cessation support in 20 H-09 coronary stenting patients Nishiyama non-lawn 1, Yuri Ino 1, Yuka Tsutsui 1, 窪川渉一 2, Kazuya Kawai 2, Fumi Yoshinaga 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2008.

---

	It is ... from insulin preparation in 20 H-10 health insurance pharmacy and relation one - area, a hospital to the disposal of used needle, the present conditions of the drugstore Kenji Kobayashi 1, 2, Manabu Kumakura 1, 2, 林忍 1, 2, Toshinari Asakura 3, Yoshizo Kaneko enthusiast 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2008.

---

	The change and the present conditions (2007) of the pharmacist duties in 20 H-11 capital municipal hospitals Mikio Hayashi 1, 梶谷文裕文裕 2, Tatsuo Tanaka 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2008.

---

	Fact-finding of the use of medical supplies about the infectious gastroenteritis of 20 H-12 children Fumiyo Kita 1, Yu Shibata joy 2, 依藤亨 3, Junichi Kawakami 2, Koji Kawakami 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2008.

---

	Questionary survey about the dosage form design of the oral antimicrobial agent for 20 H-13 children Tomoyuki Ikehata 1, Yoichi Ishizuka 1, Mitsuru Irikura 1, Toru Irie beauty 1, Mitsuru Santo 2, 佐藤吉壮 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2008.

---

	About the number of the use and the use fact-finding of 20 H-14 antiinfluenza agent (Tamiflu (R), Relenza (R)) Akifumi Hayashi 1, Yuko Yoshioka 3, Go Kato 2, Kiyoshi Kuromiya 4, Hiroshi Yabe 5, Teru Yamamoto person 6, Tomoji Saito 7, Hajime Kikima 8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2008.

---

	20 H-15 The effectiveness and problem judging from the use situation of linezolid 北村正樹, 加文字理江, 中島清江, 奥津利晃, 加藤潤一郎, 赤石和久, 菊野史豊 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2008.

---

	20 H-16 Efficacy of Insulin detemir in Basal-Bolus therapy 西村博之1, 江口朝子1, 魚住多佳子1, 吉田陽1, 梶原敬三2, 陣内冨男2, 陣内秀昭2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2008.

---

	Image investigation of the insulin device for the self-administration that 20 H-17 insulin self-administration inexperienced patients hold Hiroyuki Deguchi 1, Tetsuro Koide 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2008.

---

The acceptance of the patients for 31 gauge 6mm needles for 20 H-18 insulin injectors and 32 gauge taper type 6mm needle and examination about a feeling of pain Miho Kageyama 1, Toshinari Asakura 1, Hiroaki Seino 2, Matsui A flower 3, Kazuhiko Sugiyama 4, Yoko Yoshida 5, Juichi Yamamoto 6, Makoto Nomura 7, Uchida University 8, Takashi Tanaka 9, Tsuyoshi Tanaka 9, Kazushi Ishida 10, Ryuzo Kawamori 11, Kohei Kaku 12, Noriaki Yokou 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2008.

---

	Fact-finding - for the adherence of adherence - once a week preparation of 20 H-19 bisphosphonate preparation Izumi Shimada 1, Ikuko Tanaka 2, 玉置繁憲 3, Kazuko Koyama 1, Hiroki Mase 1, Koike former 1, Suzuki Suehiro 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2008.

---

	About the clinical condition change in 20 H-20 chronic kidney disease (CKD) patients and a use drug investigation Shigeru Yamada tree 1, Kana Kato 1, Koki Kasuga 2, 鳥山高伸 2, Hiromi Sakai 1, Shinji Takahashi 1, Ayumu Ichimura 1, Takako Nakajima 1, 1 which is related to Nomura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2008.

---

	Follow-up of the use of 20 H-21 amiodarone injection case Emi Momiyama, Yoshie Araki, Yoshie Nishiyama, Tomoko Shibata, Hiromi Nagai, Kanako Sakashita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2008.

---

	Comparison of intermittent administration of furosemide in 20 H-22 heart failure patients and the effect of the continuous medication Hatamoto Keita 1, Yasuko Ichikawa 1, Yasushi Fujii 1, Kenichiro Fujii 1, Tsuneaki Sadanaga 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2008.

---

Examination of change effects from hydrochloric acid cevimeline in 20 H-23 Sjogren's syndrome to pilocarpine hydrochloric acid Hiroki Mase 1, Izumi Shimada 1, Kazuko Koide 1, Masako Watanabe 1, Takako Yamauchi 1, Shoji Hattori 1, Takeshi Noro 1, Ikuko Tanaka 3, 玉置繁憲 2, Suzuki Suehiro 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2008.

---

	Examination about efficacy of 20 H-24 liposome amphotericin B and the safety Yukihiro Hamada 1, 小松敏彰 1, Rumiko Kondo 1, Hajime Matsubara 1, Kazuo Yago 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2008.

---

	Through a role of the significance -NST public information of the publication of the NST newspaper by 20 I-01 pharmacists - Masahiro Okuno, Junko Miyazaki, Mai Fujimoto, Nobuko Takayanagi, Tomoko Sato, Manabu Nakata, Koichi Hosomi, Yoshiharu Umetani Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2008.

---

	It is ... through two cases of role - short bowel syndrome of the pharmacist in NST rounds in 20 I-02 surgery Junko Miyazaki, Masahiro Okuno, Mai Fujimoto, Tomoko Sato, Manabu Nakata, Koichi Hosomi, Yoshiharu Umetani Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2008.

---

	The pharmaceutical intervention in 20 I-03 NST duties and the effect Wataru Goto 1, Mountain Rieko Sawa 1, Umizuka Yasuro 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2008.

---

	The way of the NST pharmacist in the nutritional management of 20 I-04 advanced age patients on dialysis Mami Kiyokawa 1, Asahi Ueno 2, Yoko Ikeda 2, Suda example line 1, Masaya Watanabe 3, 石川康暢 4, Mitsuru Sugawara 1, Hiroshi Takeda 5, Takeshi Iseki 1, 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2008.

---

	To obtain induction - understanding of 20 I-05 simple suspension method; - Prince Taniguchi chapter, Tatsuya Sasaki, Kaifu Masayo, Noriko Fukuda, The Ishikawa immensity, Akihiro Kai, The Era right track, Keiko Kitajima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2008.

---

It is effect on immunocompetence with the slow administration of lipid microsphere in the nutrition care and nutritional status after 20 I-06 altitude invasive surgeries Ueda clothes texture 1, 加藤安宏 1, Satoru Minami 3, Tatsu Sakamoto Ichiro 3, Midori Kimura 3, 河原崎貴伯 3, Toshio Maeda 1, Hiroshi Yamada 2, Masakazu Takagi 4, Yoshiyuki Kagawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2008.

---

	Stable examination of aspirin at magnesium oxide combination in 20 I-07 intubation administration Yukio Shimizu 1, 2, Yunohara Ami 1, Junichi Iida 1, Igarashi sincerity intellect 1, Kiyomi Ito 1, Katsuko Yano 2, Takao Orii 2, Kiyoshi Sugiyama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2008.

---

	Examination of the base recover rate in the transluminal administration of 20 I-08 grammar reel (R) infinitesimal grains Junichi Iida 1, 2, Katsuko Yano 3, Igarashi sincerity intellect 2, Kiyomi Ito 2, Takao Orii 3, Kiyoshi Sugiyama 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2008.

---

It "is demanded 20 I-11 from pharmacist and supplement ... us!" Yasushi Amano 1, Yukiko Arakawa 1, Keiko Anzai 1, Noriko Azuma 1, Yukinori Oshima 1, Keiko Kawasaki 1, Koji Shibata 1, Takeshi Sugasawa 1, Awara Tomohito 1, Satoshi Mizuno 2, Toshihiro Noda 2, 3, Hirai green 2, 4, Takeshi Iseki 2, 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2008.

---

	Inhibitory effect for the onset of ischemic neuropathy of 20 I-12 Morinda citrifolia fruit juice from Okinawa Shinichi Harada 1, 濱邊和歌子 1, Will Tomoka Nako 1, Kohei Kamiya 2, Noriko Satake 2, It is still I 1 Tokuyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2008.

---

	Elucidation - of the decoloration mechanism of the carminic acid using the mechanism elucidation (the second report) - molecular orbital method of the photobleaching response in 20 I-13 five mini-(R) Tadashi Okubo 1, Mariko Tanaka 3, 7, Okubo branch 2, Miho Okubo 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2008.

---

	Effect of the light to give to stability of 20 I-14 trichlormethiazide preparation Yuki Matsushima 1, Reiko Teraoka 1, Tomomi Akita 1, Kana Mizoguchi 1, Isao Sugimoto 2, Fumie Kato 1, Kana Inoue 1, Shinya Morita 1, Shuji Kitagawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2008.

---

	Denaturization of the suspension insulin preparation which we left under 20 I-15 thermophile Toshinari Asakura 1, 神田循吉 2, Miho Kageyama 1, Noriaki Yokou 1, Hiroaki Seino 3, Hiroyuki Wakabayashi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2008.

---

	20 I-16 1 patients who use the hospital formulation Azunol Futhan ointment to the buttocks erosion formed by diarrhea to continue 竹本雄一1, 中島貴子1, 市村歩1, 山田成樹1, 澤田真紀2, 薗田信広2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2008.

---

	Quality evaluation of 20 I-17 hospital preparation rifampicin suppositories Seki Yuka village 1, Yu Yokoyama law of nature 1, Yu Haruki person 1, Sachiyo Kondo 1, 毎熊隆誉 2, Daisuke Teshima 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2008.

---

Preparation and evaluation (2) of the patch in the catechin component oral cavity for the patients with 20 I-18 xerostomia Jewel bug Kasumi 1, Willow Shinji sail 1, Isao Murakami 1, Hiroyuki Hosono 1, Sanae Shino 1, Hiroki Fukushima 1, Ichinokawa Yoshimi 2, Keiko Yamaoka 3, Machiko Watanabe 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2008.

---

	Development of 20 I-19 hydroquinone stabilization conditions and new hydroquinone component pigmentation therapeutic drug, utility to the hospital preparation Naoko Iimura, Yoko Ono, 柴澤京子, Description of Okubo sand, Takahiro Iida, Koichi Shinohara, Kazuhito Saiki, Kazuyuki Ueno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2008.

---

	About likelihood of the hospital preparation for the financial burden reduction of patients with 20 I-20 recurrence acute promyelocytic leukemia Mannen Takuya 1, Hiroki Ono 1, Masayuki Yuki 1, 富樫修弘 1, Toshiko Hosoya 1, Mountain Masayuki Sawa 2, 丘龍祥 3, 小嶋文良 3, Tadashi Shiraishi 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2008.

---

	Change of 20 I-21 LPS and digoxin pharmacokinetics in the CpG-DNA administration rat Takashi Kato children 1, Takako Irie 2, 楠川侑吾 2, 2, Asuka, Iwamoto, Yoshio Ijiri 1, Kazuhiko Tanaka 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2008.

---

	The effect that capsaicin gives to digoxin pharmacokinetics in 20 I-22 Lipopolysaccharide administration rat 楠川侑吾 1, Takako Irie 1, 1, Asuka, Iwamoto, Takashi Kato children 2, Yoshio Ijiri 2, Kazuhiko Tanaka 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2008.

---

	The effect that capsaicin in 20 I-23 LPS administration rat gives to CYP3A2 and total CYP expression 1, Asuka, Iwamoto, Takako Irie 1, 楠川侑吾 1, Takashi Kato children 2, Yoshio Ijiri 2, Kazuhiko Tanaka 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2008.

---

	Change of small intestine absorption dynamics at 20 I-24 small intestine ischemia reperfusion injury So Maruyama 1, Jiro Ogura 1, Masanori Kobayashi 2, Shiro Itagaki 2, Tsuyoshi Hirano 2, Takeshi Iseki 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2008.

---

	The organic anionic transporter expression change by 20 I-25 hepatectomies and effect on remote organ Tatsuro Fujii 1, Shiro Itagaki 2, Masanori Kobayashi 2, Tsuyoshi Hirano 2, Takeshi Iseki 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2008.

---

Change of a blood coagulation system, inflammatory reaction in the perioperative period of 20 I-26 dissecting aneurysm and abdominal aneurysms and the platelet function Your Nakamura existence 1, Harunobu Iwase 1, Kaya Hiroko Sono 2, Ryuji Ikeda 3, Junko Arima 3, Katsushi Yamada 3, 4, Ryuji Sakata 4, Kazuo Nakamura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2008.

---

	Change of the delayed-action nausea, vomiting measures prescription at the breast cancer chemotherapy by 21 C-01 pharmacist intervention Junichi Takano 1, Yuka Ito 1, Upper mound Tomoko 1, Yuko Shinmyo 2, Ogata fine weather tree 2, Hisahiro Yoshida 3, Keiso Masuhara 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2008.

---

	The expression situation of nausea, vomiting at the chemotherapy in 21 C-02 patients with nonsmall cell lung cancer and future problem 宅和真由美 1, Yoko Imoto 1, Keiko Sano 1, Noriko Otomo 1, Yoshishige Fujio 1, 笠松美宏 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2008.

---

	Side effect investigation in the cisplatin super selective intraarterial injection for 21 C-03 head and neck cancer Masaki Kumai 1, Asano order next 2, Kumiko Kasashi 1, Mitsuru Sugawara 1, Takeshi Iseki 1, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2008.

---

	Examination about the risk factor of the hiccup development in 21 C-04 cisplatin chemotherapy Makoto Hayashi 1, Hayato Sugimura 1, Kan Yukio 2, Masami Kawahara 2, Koji Abe 1, Aspect shrine Koji 1, Kenichi Miyamoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2008.

---

	Nausea, vomiting, the anorectic expression situation at gemcitabine monotherapy enforcement in 21 C-05 abdomen regions 野村充俊 1, Small Ido Keiichi 1, Toru Akagi 1, 牧野好倫 1, Koji Murakoshi 1, Nobuaki Yokote 1, Minoru Mori 1,000 kinds 2, Hideki Ueno 2, 奥坂拓志 2, Hiroshi Yamamoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2008.

---

	One case that treatment was able to continue safely by measuring blood platinum concentrations at the mFOLFOX6 enforcement of 21 C-06 patients on dialysis Tadashi Fujita will 1, Tetsuro Koide 2, Hiroaki Matsuda 4, 片山歳也 3, Yasushi Kataoka 1, Shinko Okuda 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2008.

---

	Fact-finding of the side effect expression in the mFOLFOX6 therapy in 21 C-07 this hospital Mayumi Iwahori, Bridge Ryosuke, Junichi Kubo, Shunichiro Saito, 鶴見里佐, Naoya Yoshida, 小原郁司, Toshihito Komiyama, Hiroaki Watanabe, Takahiro Sakuma Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2008.

---

	It is ... from the situation of real - pharmacist of the colorectal cancer chemotherapy in 21 C-08 this hospital Yasushi Nishiyama 1, Takeshi Abe reason 1, Minoru Oshima 2, Jun Teramoto 2, Seiji Mori 2, 因藤春秋 2, Morning market Takashi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2008.

---

	Examination of the background factor which has an influence on carboplatin hypersensitivity in patients with 21 C-09 gynecologic cancer Yu Murashima oneself child 1, Hiroko Sugimoto 1, Takuya Iwamoto 1, Tsutomu Tabata 2, Norimasa Sagawa 2, Shinko Okuda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2008.

---

	Evaluation of the carboplatin doses setting by the revision of 21 C-10 serum creatinine levels Katsuya Makihara 1, Hiroshi Okada 2, Hiroto Kishi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2008.

---

	Bioequivalence in healthy adults of 5 mg of 21 C-11 meloxicam tablets "Towa" and 10 mg of meloxicam tablets "Towa" Yoshiaki Itano, Hiroshi Morimoto, Takashi Matsui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2008.

---

Pharmaceutic equivalency evaluation (1) of the generic medicine using 21 C-12 gastrointestinal absorption prediction systems Descent from a mountain Tetsuya 1, Yuko Watanabe 1, Chiaki Yamamoto 1, Masanori Kobayashi 2, Shiro Itagaki 2, Mitsuru Sugawara 3, Tsuyoshi Hirano 2, Takeshi Iseki 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2008.

---

Evaluation - of the product made in by international guarantee of quality - dissolution test of 21 C-13 generic drugs Japan and the carbamazepine lock made in the United States Mari Fujimoto 1, 2, Kiyoshi Mihara 1, Jorgenson James A.3, Kuniko Otsuka 4, Tomi Kawata branch 1, Oil field Masaki 1, Junko Ishizaki 2, Kenichi Miyamoto 2, Makoto Otsuka 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2008.

---

	21 C-14 "attitude surveys about the generic drug of the patients and the health insurance pharmacy pharmacist" Yano reason Rika 1, Bamboo blind Takashi 1, Yasushi Morimoto intellect 1, Kudo sheath or 1, Daiya Sakurada 1, Net Katsuo Oka 2, Noboru Sato example 1, Shiro Ueda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2008.

---

	The present conditions of the change to the generic medicine in 21 C-15 out of the hospital prescriptions Yuki Meishin, Risa Oda, Etsuko Endo, Yuka Tsutsui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2008.

---

Medical economic discussion by the difference in preparing compound of 21 C-16 antibiotics Yutaka Hasegawa 1, Ota friend Rie 1, Minako Hino 1, Hiroaki Kishida 1, Takahashi sub-Mana 1, Riyusuke Rokusha 1, It is still 1 Tatsu Sada, Kenichi Hasuike 1, Hiroko Urushihara 1, Yukiko Uchiyama 1, Keigo Ezaki 1, Takahiro Uchida 2, Miki Chihiro 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2008.

---

	Can apply the effective improvement of drugstore duties in 21 C-17 this hospital and the management technique of consciousness reform - company in the drugstore; or - Yuki Mikami, Masako Yoshimura, Ito greens wave, 日置三紀, Ayumu Nozaki, Satoru Ueda, Hirokazu Nakanishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2008.

---

	21 D-01 How we should deal with the rapidly disintegrating tablet? : From questionnaire survey of fast disintegrating tablet that target pharmacist 内田享弘1, 奥原有希子2, 徳山絵生1, 吉田都1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2008.

---

	Remedy-related evaluation of a generic drug, the innovator drug using 21 D-02 taste sensors Tokuyama picture life, Haji River dance, Miyako Yoshida, Takahiro Uchida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2008.

---

	Quality evaluation - content uniformity of 21 D-03 clarithromycin dry syrup 12 preparations and remedy-related evaluation - Haji River dance 1, Miyako Yoshida 1, Tokuyama picture straight 1, Toshihiko Ishizaka 2, Junji Mukai 2, Takahiro Uchida 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2008.

---

	Remedy-related improvement effect with 21 D-04 Chinese medicine remedy jelly Miyako Yoshida 1, Tokuyama picture straight 1, Haji River dance 1, Takahiro Uchida 1, Fukui Atsuko 2, Takahiro Fujii 2, Kyuichi Sunada 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2008.

---

	About an advantage and problems in 21 D-05 simple suspension method induction and the measures Yuichiro Wada, Takako Nakajima, Nomura connection, Hiromi Sakai, Kana Kato, Shigeru Yamada tree, Yoichi Sakakibara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2008.

---

	We administer it for a day in construction - pharmacy of the administration system of administration of 21 D-06 inpatients and set it and pay it and work 鈴木敬秀, Yuka Kato, Masashi Toyama, Shinji Sasaki, Seki Mihoko, 近藤覚也, 貞川俊郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2008.

---

	Action for the safety management of 21 D-07 on admission bringing medicine Sambommatsu Yasutaka 1, Aya Fujii 1, Takuya Maruyama 1, Keiko Saito 1, Satoru Yamane 1, Yuki Tezuka 1, Tanaya Mitsugu 1, Yu Tanaka season 2, Kensho Sada 1, 森田眞樹子 1, Toshihito Komiyama 2, Hitoshi Komori 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2008.

---

	Improvement of the bringing medicine for 21 D-08 duties investigation for the purpose of the improvement of efficiency and the medical security Yoshiaki Hattori, Toshiro Sawada, Hiroshi Sakata, Hiroyuki Matsubara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2008.

---

	About screening of the preoperative cancellation medicine at the foreign consultation which considered the off-period of 21 D-09 surgery planned inpatients Hiroshi Hatano, Maki Nakabayashi, Shiho Enami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2008.

---

	The present conditions and problems of the bringing medicine management in 21 D-10 this hospital orthopedics inpatients Aya Ido Keiko 1, Fumio Yoshimoto 1, Hidehiko Suzuki 2, 笹哲彰 2, Kitasato spirit Ichiro 2, Hashimoto court official 2, Hiromi Kajiwara 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2008.

---

	Examination of the interaction of 21 D-11 Yokukansan and donepezil 一澤砂央里 1, Igarashi sincerity intellect 1, Kiyomi Ito 1, Junko Watanabe 2, Toshimi Morita 2, Kiyoshi Sugiyama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2008.

---

	Examination of the drug interaction with 21 D-12 compound oxycodone injection component hydrocotarnine Satoshi Sudo, Kobayashi hsiang tsai, Fumika Takasaki, Igarashi sincerity intellect, Kiyomi Ito, Kiyoshi Sugiyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2008.

---

	Examination of the effect degree of the combined medicine which gives it to digoxin clearance based on 21 D-13 population analysis Yuko Honma, Kyoko Fukumoto, Kazuyuki Ueno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2008.

---

3 cases in acknowledgment of peripheral neuropathy and thrombocytopenia that were remarkable by combination of 21 D-14 proteasome inhibitor bortezomib and itraconazole Miki Ishibashi 1, Takuya Iwamoto 1, Okamoto Meiji University 1, 奥村悟司 1, Yuka Sugimoto 2, Atsushi Fujieda 2, Kazuhiro Nishii 2, Naoyuki Katayama 2, Shinko Okuda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2008.

---

	Construction of the management information support system of 21 D-15 drug interaction Yoshiyuki Ono 1, Stave Akihiro 2, Katsuyoshi Nakajima 1, Hiroshi Suzuki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2008.

---

	The investigational present conditions in the Marunouchi Hospital attached to 21 D-16 Inst. for Adult Diseases Asahi Life Foundation 熊澤良祐 1, 2, Yukiko Onishi 2, Spring Kyoko Sawa 3, 豊田行康 1, Ichitomo Miwa 1, Masatoshi Kikuchi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2008.

---

	Examination (1) about the clinical activity that a pharmacist is involved in in 21 D-17 trials Mariko Ono 1, Masakazu Yamaguchi 2, Tetsuo Shinba 2, Toshi Iwata 2, Junko Kitsu 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2008.

---

	Examination (2) about the clinical activity that a pharmacist is involved in in 21 D-18 trials Masakazu Yamaguchi 1, Mariko Ono 2, Junko Kitsu 2, Tetsuo Shinba 1, Toshi Iwata 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2008.

---

	Enforcement experience of 21 D-19 MILES Trial (physician-led country conjugation trial) and the problem 廣畑和弘 1, Morizu Hiroki 1, Depths water Yoshie 1, Yumi Inoue 1, Akito Kubo 1, Tabuse course 2, Zenji Okada 1, Yoshikazu Inoue 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2008.

---

	About the introduction of IT of 21 D-20 trial secretariat duties Morihiro Nomura 1, 2, Miyoko Takara 1, 2, Yutaka Kuwano line 2, Kenzo Moriyama 2, Kazuhiko Nakagawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2008.

---

	Examination of the utility of the leukocyte migration test in 21 E-01 drug shock Katsuji Uno 1, Yagi Motohiro 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2008.

---

	Examination of 21 E-02 beta-lactam antibiotic hypersensitivity Manabu Abe 1, 齊藤幹央 2, Yagi Motohiro 3, Katsuji Uno 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2008.

---

	Examination of hypersensitivity in 21 E-03 alleviation of fever analgesia antiphlogistic 齊藤幹央 1, Manabu Abe 2, Tomoyasu Furukawa 3, Yagi Motohiro 3, Koike reason Expo 4, Katsuji Uno 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2008.

---

	2 cases of chemical thrombocytopenia with 21 E-04 sodium valproate 篠永浩 1, Tsutomu Kachi 1, 南木伸基 2, Eiji Mukai 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2008.

---

	Relation of the pharmacist for 21 E-05 drug-induced hepatic injury Hashimoto positive 1, Makoto Matsuda left child 1, Tetsuro Koide 2, Swamp part Kimiko 1, Shigeru Omori 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2008.

---

	Use experience of the magnesium oxide to 21 E-06 patients on dialysis 秋山和映 1, 3, Chinatsu Kaneshige 1, Daiya Sakurada 3, Noboru Sato example 4, Yasufumi Irie 2, Shiro Ueda 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2008.

---

	Examination of the tolerability of clopidogrel in patients in 21 E-07 this hospital sulfate Naoya Ashikawa, Hideaki Yanagisawa, Yuko Tanaka, Hideyuki Ishiguro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2008.

---

Action to a risk of developing investigation and development evasion of the necrosis of the jaw bone with the oral BP agent in 21 E-08 ethical pharmacy Yamamoto High School size 1, Takayuki Shimahara 2, Daisuke Matsubara 1, Masaru Kawabe inquiry 1, 高松諭志 1, Yutaka Oda 1, Paulownia forest Ichiro Azuma 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2008.

---

	Examination about the skin reaction with 21 E-09 molecular target drug Gefitinib Naoko Takada 1, 2, Naho Yamamoto 2, Masami Kawahara 2, 春木一伸 3, Mieko Kishi 4, Katsuyo Fujii 1, Kenichi Miyamoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2008.

---

	The case that produced hearing loss by 21 E-10 furosemide IV infusion Reiko Osanami, Minako Taguchi, Yuko Notoya, Tomoko Baba, Owada existence, Takehisa Hama Yoshiko, 蛭田千昭, Akihiro Tamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2008.

---

	To handle 21 G-01 Hazardous Drugs (critical drug) safely; comparison - of - international guidelines Setsuko Anan 1, 2, 3, 4, Yukako Yasui 1, Miyuki Sakurai 2, Emiko Kawano 4, Yuko Tokushima 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2008.

---

	- to send safety management to 21 G-02 high risk drug workshop - areas Keiko Kitajima 1, Tatsuya Sasaki 1, Kaifu Masayo 1, Noriko Fukuda 1, Ishikawa immensity 1, Akihiro Kai 1, Era right track 1, Prince Taniguchi chapter 1, Tomiko Sato 2, Ken Takakura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2008.

---

	Evaluation of preventive measures against dispensing errors judging from 21 G-03 compounding of medicines incident development situation Kazuhiko Teraoka, Toshi Nakamura oneself, Takafumi Umeda, Hisatsugi U.S. Toshihide, Kazuyoshi Kawazoe, Kazuo Mizuguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2008.

---

Trial - in effect (the second report) - hospital business training of preventive measures against dispensing errors which are main by 21 G-04 ID number checks 片倉道啓, Ayako Ito, Atsuko Kikuchi, Katsuya Omori, Akiko Sasaki, Job field Takashi, Country book Yusuke, Kazuya Takahashi, Masumi Kageyama, Naomi Sasaki, Toshie Yamazaki child, Noriko Araya, Michiko Fujimori, Keiichi Okahara, 舩山幹男, Hiroshi Nakata is elegant, Rev. Noda plus, Atsushi Miyamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2008.

---

	Example analysis with the dispensing error report system which intended 21 G-05 factor analysis Kazuyuki Yoshida 1, Koji Hayashi 1, Doi reason Yuko 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2008.

---

	21 G-06 About a method of the Distribution of medicine car SET of the oral medicine by pharmacists 榊原洋一, 中島貴子, 竹本雄一, 坂井裕美, 加藤香奈, 山田成樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2008.

---

	Risk management after 21 G-07 electronic chart induction Toshiyuki Onishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2008.

---

	Because 21 G-08 pre-Abo id exhibits a utility of classification and evaluation - drug control instruction of the disadvantageous evasion example; ... Makoto Nakajima, Takuya Goto, Akira Takahashi, Yoshie Nomura, Yumi Suzuki, Kimio Wakabayashi, 加藤浩充, Shuichi Matsumoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2008.

---

	It is inventory survey in Takatsuki-shi, Osaka recognition to participation awareness and accident avoidance behavior to the medical treatment of 21 G-09 outpatients Sachiko Nakamura 1, 2, 漆原尚巳 3, Kikuko Miyazaki 1, Takeo Nakayama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2008.

---

	Action of "the medical supplies safety management round" in 21 G-10 Kyushu welfare annuity hospitals Masayo Maeda 1, 2, Hidemi Ogura 1, Yoshikuni Kenji 1, Yoshiko Goto 2, Nobuyuki Yamashita 2, 3, Castle tail Kunitaka 2, 4, 峯本正夫 5, Takashi Akamatsu 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2008.

---

	21 H-01 Development of the comprehensive community medical care training by studying together with medical students 荒木良介1, 中嶋弥穂子1, 中里未央1, 2, 前田隆浩1, 2, 大園恵幸1, 青柳潔1, 塚元和弘1, 畑山範1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2008.

---

It is the comparison with the medical student a change of the consciousness for the remote island medical care of the pharmacy student by 21 H-02 remote island medical care, welfare, health training Miho Nakajima child 1, Ryosuke Araki 1, Mio Nakazato 1, 2, Takahiro Maeda 1, 2, Megumi Osono good luck 1, Kiyoshi Aoyagi 1, Mound former Kazuhiro 1, Hatayama example 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2008.

---

	To fill School of Medicine in Chinese medicine attitude survey - Chinese medicine education for 21 H-03 active play pharmacists and the gap of the pharmacy school; - Kazuyoshi Kawazoe 1, 2, Kumiko Sakamoto 2, Fushidani Hideji 2, Kazuo Mizuguchi 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2008.

---

	Relation of the pharmacist for the pharmacy education in 21 H-04 nursing technical schools Koichi Hasegawa, Teruhiro Kusumi, Nobuyuki Mamiya, Kaoru Wakabayashi, Takeshi Minami husband Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2008.

---

	Examination about the end-point in the patients reception problem in 21 H-05 pharmacy OSCE 窪田愛恵 1, Yoshitaka Yano 1, Tsuyoshi Morimoto 2, Kaori Takada 2, Susumu Seki 2, Yuko Maeda 3, Akinori Akaike 1, Atsushi Hiraide 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2008.

---

	Trial of the risk management training based on the experience of 21 H-06 students East beauty 1, Hino appearance Harumi 1, Miki Akane 1, Kazuhiko Teraoka 2, Hisatsugi U.S. Toshihide 2, Kazuyoshi Kawazoe 2, Kazuo Mizuguchi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2008.

---

Trial of the group training by the interhospital cooperation in 21 H-07 Kitami districts Mere field Koji 1, Kaoru Chiba 1, Michiya Kobayashi 1, Flat wisteria Masahiko 1, Koji Saito 1, Takao Kurosawa 1, Shigeru Uno 2, Kazuhisa Fujiwara 2, Yukihiro Yoshida 2, Yoshiyuki Okauchi 2, Inside easy Kazuhiko 2, Shun Arai 2, Kazuyuki Takayama 2, Katsuhiko Kizaki 2, Masaki Ohba 2, Michio Kubo 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2008.

---

- to investigate the cooperation with - businessman teacher for a lot of 21 H-08 University of Shizuoka pharmacy school business training acceptance Midori Kimura 1, Hideki Hayashi 2, 加藤安宏 3, Nabeta Izumi 1, Satoru Minami 1, Tatsu Sakamoto Ichiro 1, Kunihiko Ito 2, Yoshiyuki Kagawa 3, 河原崎貴伯 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2008.

---

	Examination of problems of the long-term business training that health insurance pharmacy cooperates with 21 H-09 University, and should be settled Chigusa Kikuchi, Toru Maeda, 木村和哲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2008.

---

Fix the eyes on a business training curriculum in the healthcare setting in 21 H-10 business training and a way of thinking -2.5 month called "the education division of labor" with the educational front; and - Tadashi Mikami, 小西偉雄, Yoshiharu Nakamura, Takeo Nakata, Tsutomu Mizukami, 野田能成 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2008.

---

	Relation of the pharmacist in 21 H-11 psychiatry team approach in medical care Naomi Okamoto 1, Chizuru Nakagawa 1, Paths of Yu Ogawa 2, Nobuaki Tomita 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2008.

---

	One case of chronic stage schizophrenia that we boiled switching from 21 H-12 risperidone to aripiprazole, and re-diazepam dependence was relieved Michiko Uchiyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2008.

---

	A pharmacist is concerned with the medication support to a person of 21 H-13 law concerning medical observation going to hospital treatment and It is looked at Atsushi Kawashima, Takuya Ishida, Arai just levator, Shigehiro Taira, Kayoko Kikuchi, Emiko Murata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2008.

---

	About association of 21 H-14 antipsychotics consumption and QT prolonged Yuko Inoue, Wide pillow Kayoko, Tsutomu Yamashita, Noriko Kudo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2008.

---

	Compliance of 21 H-15 inpatient cares and sleep agonist 嘉屋道裕 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2008.

---

Fact-finding of the second generation antipsychotics alone high dose therapy for refractory schizophrenia in the hospital attached to 21 H-16 Chiba University School of Medicine Tsukiji jasmin child 1, Tomoki Tanabe 1, 仲佐啓詳 1, Hiroshi Nakamura justice 1, Amount of Ariyoshi example 1, Koichi Kitada 1, Hiroyuki Watanabe 2, 伊豫雅臣 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2008.

---

	Change of the prescription situation in the inpatient with 21 H-17 schizophrenia Junji Uno, Miho Nakata, Shinichi Tojo, Saeko Yamahata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2008.

---

	A use situation investigation (from 2003 to 19) of the antipsychotics in 21 H-18 this hospital and change of prescription contents Reiko Saito, 新美詠彦, Yumiko Yada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2008.

---

	Prescription fact-finding of the schizophrenia patient in 21 H-19 Sapporo suburbs 9 institutions Willow Tomoyuki 1, Takako Toi 2, Kazue Sugimura 3, Mitsuru Takahashi village 4, Hiroshi Nishibe 5, Chiaki Tanaka 6, Isurugi Ikuko 7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2008.

---

	About quantity of prescription and laxative of 21 H-20 antipsychotics Mitsuru Takahashi village, Kuzuba Rina, Tooru Mori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2008.

---

	About 21 I-01 powdered milk and phthalate di-2-ethyl hexyl (DEHP) elution Harunobu Iwase 1, Your Nakamura existence 2, Kaya Hiroko Sono 3, 大磯茂 3, Nishizawa reason Norihiko 1, 5, Ken Sakurai 1, 4, Kazuo Nakamura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2008.

---

It is the evaluation after three hours after the cerebral infarction onset the comparison between alteplase and plasmin derivative in stroke treatment for 21 I-02 hyperacuteness period Yasuhiro Suzuki 1, Nobuo Nagai 2, Yamakawa flower Akemi 3, Harada Kosuke 1, 3, Desire Collen4, Junichi Kawakami 3, Kazuo Umemura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2008.

---

	Examination of the importance of the HbA1c level in 21 I-03 diabetic peripheral neuropathy onset 鈴木悠加, Takeru Kawai, Descent from a mountain Asako, Yu Tanaka season, Kayo Oikawa, Eiji Funaki, 小原郁司, Toshihito Komiyama, Hiroaki Watanabe, Takahiro Sakuma Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2008.

---

	Expression of intestinal aquaporin change with 21 I-04 saline laxative magnesium sulfate Fumika Takasaki, 宇敷隆, Toshihide Mochizuki, Yudai Toda, Igarashi sincerity intellect, Kiyomi Ito, Kiyoshi Sugiyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2008.

---

	Expression of aquaporin change by 21 I-05 Byakko-ka-ninjin-to Yutaka Ichikawa is flat, 鏡真依, Megumi Sugitani, Yudai Toda, Toshiyuki Kudo, Igarashi sincerity intellect, Kiyomi Ito, Kiyoshi Sugiyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2008.

---

	It is development and use experience of pharmacokinetic safety management system (PHACOSAM) the pharmacokinetic check in 21 I-06 drugstore windows Choichiro Miyazaki 1, Naoki Tomiyama 2, Kenji Matsuyama 3, Shun Higuchi 4, Yoshihiko Maehara 5, Shoji Sakamoto 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2008.

---

	Patient compliance instruction using the figure of 21 I-07 schemas, medication history management Masaji Furusawa 1, It is still 2 Sawamura, Shigeko Yokota 1, 2, Tamura overlapping patch 1, 2, Masayoshi Kimura 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2008.

---

It is making and the utilization example of the medicine notebook seal in the Warfarin patient compliance instruction for improvement of patient compliance instruction in 21 I-08 health insurance pharmacy (the seventh report) Yoshiaki Kimura, West Hatsue Hama, Kuniko Sugimoto, Mieko Itakura, 塗茂佳世, 廣部美佐子, Satomi Saga, Yoichi Kojima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2008.

---

	Role (the first report) of the pharmacist to pharmacotherapy of 21 I-09 dementia Hiroshi Tani child, Hiroko Saito, 上田飛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2008.

---

	To meet the medical needs by action - sex differences of the health insurance pharmacy in consideration for 21 I-10 sex differences medical care; - Junko Kasahara 1, Mari Satomi 1, Nobutaka Suzuki 1, Hayamizu Yoshio 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2008.

---

	Change of the pharmacokinetics of the basic drug quinidine in 21 I-11 experimental acute renal failure rat 出羽祐基, Junichi Kusaba, Ishikawa Nanase, 合葉哲也, Hiromi Kawasaki, Yuji Kurosaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2008.

---

	Change of the Cyp3a expression level by 21 I-12 birth and aging Tomoyuki Yoshida, Yudai Toda, Toshiyuki Kudo, Igarashi sincerity intellect, Kiyomi Ito, Kiyoshi Sugiyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2008.

---

	Elucidation of the pulmonary accumulation mechanism with 21 I-13 lutein chronic administrations Shibuya Tomomi 1, Sato evening period 1, Masanori Kobayashi 2, Shiro Itagaki 2, Tsuyoshi Hirano 2, Takeshi Iseki 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2008.

---

	Analysis of the interaction mechanism of 21 I-14 carvedilol and amiodarone Yoshiro Hirasaki, Kyoko Fukumoto, Kazuyuki Ueno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2008.

---

	UGT1A1 *6 using 21 I-15 real-time PCR device, examination of *28 genetic polymorphism analytical method Satoshi Yokoyama 1, Fukuoka kernel 2, Yasushi Usui 3, Yuka Shibata 4, Yasuji Morita 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2008.

---

	Construction of the compounding of medicines system using the 20-P1-001 handheld unit Atsuko Oshio, Chika Matsumoto, Yoji Kyotani, Hitoko Yoshida, Kazuyuki Ikeda, Setsuko Kajii, Yukiko Morita, North Keiji, Masayuki Uno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2008.

---

Trial of the compounding of medicines model (we prepare it on every 1st) that intended the 20-P1-002 safety management Channel Akiko, 志良堂 Arisa, 麻殖生知子, Chie Sato, Tomoko Yoshida, Tomoko Yanagawa, Chika Masumoto, Yumi Saito, Azusa Kishimoto, Junko Torii, Kyoko Wada, Hiroyuki Takahashi, 100 sea Yuji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2008.

---

It is effect ... by - electronic chart induction about the analysis of the 20-P1-003 compounding of medicines error (the second report) 右川浩 1, Kanichi Kawasaki 1, Needle ヶ valley Yoshihisa 2, Firewood Yuki 2, Hisashi Horikoshi graciousness 2, River 2, Sakae, Kishira, Yuka Adachi 2, Mieko Tanaka 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2008.

---

	Efficacy of the powder wrapping paper color printing system using 20-P1-004 Xana-2720EU Mountain Yuji Sawa 1, Kikuchi Shiori 1, Mai Onishi 2, Mami Shimakawa 2, Yoshiharu Yamada 1, Woodcut Nobuko 1, Wakako Honma 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2008.

---

Trial of the packeted error prevention system in the 20-P1-005 abstract automatic division packaging machine Inohira Kyoko 1, Natsuko Iida 1, Tetsuya Kudo 2, Toshiichi Seino 1, Hidetoshi Honda 1, Ryoji Yanagihara 1, Mt. town 1, Misato, Fumie Iijima 1, Katsuyoshi Nakajima 1, Hiroshi Ogasawara 3, Hiroshi Suzuki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2008.

---

	Basic examination for a lock, the capsules identification systems construction with the 20-P1-006 CCD camera 廣實清司 1, Keizo Ishimoto 1, Akira Kamiya 1, 大田喜代巳 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2008.

---

	A utility of the 20-P1-007 image observation equipment and future problem (the first report) Reiko Imaizumi, Yuko Kobayashi, Yoko Suzuki, 新井成俊, Kenichi Saito, Takaki Kitazawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2008.

---

	For, effectively utilizing it with 20-P1-008 doubt inquiry example collection of Kanda Kosuke, Eiji Ushijima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2008.

---

	Comparison of the circular lock and oval lock from the situation of 20-P1-009 user and the compounder with cleavage Taku Ogiwara man 1, Every field Chieko 2, Kaori Morimoto 1, 叶隆 1, Etsuko Miyamoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2008.

---

	Comparison of the pharmaceutical intervention in 20-P1-010 compounding of medicines duties and drug control instruction duties New Keiko Sako, Hiroko Wakasugi, Ikuyo Kawasaki, Yukiyo Yasuda, Rie Hiratsuka, Naomi Adachi, Ikuko Yano, Kenichi Inui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2008.

---

	Effect of the particle size distribution to give it to a mixed degree of the 20-P1-011 dry syrup preparation Yoshihisa Yamamoto 1, Suzuki Toyoshi 2, Mika Matsumoto 3, Shuichi Hayano 4, Kazuo Osaki 4, 深水啓朗 2, Shinji Hidaka 5, Mamoru Kamano 1, 大谷道輝 3, Kazuo Tomono 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2008.

---

	Utilization ... of "the support book" as action ... common knowledge method for the 20-P1-012 simple suspension method trial Ishiwatari beach 1, Kayo Tsuchiya 2, Hiromi Suzuki 2, Hirofumi Koike 2, 西川能治 2, Ryoichi Ariyama 2, Junko Kitsu 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2008.

---

	Examination of a utility and problems by the 20-P1-013 simple suspension method induction Yasushi Suzuki University, Yuko Osuka, Yoko Kobayashi, Sayaka Terui, Seki Rie, Takao Oki, Masami Nishiyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2008.

---

	Induction of the simple suspension method in 20-P1-014 neurosurgery, the oral surgery ward 宍戸紀与, Kaori Doi, Yusuke Sekine, One Fujitsuka, Takao Akashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2008.

---

	Questionnaire count results ... to attitude survey - whole country virtue bank meeting hospital 23 institution and this hospital nurse, pharmacist about an advantage and problems of the 20-P1-015 "simple suspension method" induction Koto Fujiwara, 敦見真由美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2008.

---

Attention - to the materials of the appliance to use for the suspension of other drugs case - drug dissolving polystyrene decomposition in 20-P1-016 Epadel S and an analysis and polystyrene Yutaka Asakura 1, Three department Masumi 1, Is Kurata; see it; 3, Takashi Ito 4, Michiko Amemiya 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2008.

---

	Construction of all protocol check systems including 20-P1-017 pre-medication and an oral medicine anticancer drug Masakazu Ozaki, Keizo Ishimoto, 廣實清司, Yasuaki Otsubo, Akira Kamiya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2008.

---

	Role of the pharmacist in the 20-P1-018 anticancer drug proper use Motoi Kurahashi still, Ai Hagiwara, Ayumu Takahashi, Mariko Inoue, Yukiko Tsukamoto, 小川賀偉 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2008.

---

	Examination about the administration of antiHIV medicine method for the patients having difficulty with 20-P1-019 internal use Aya Yoshida 1, Naoko Miyazaki 1, 2, Yosuke Kurokawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2008.

---

	Practice of the injection compounding of medicines for the 20-P1-020 NICU Tomomi Ando, Kenji Nishimura, Koji Moriya, Ko Tokuda period, Kazunobu Takayanagi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2008.

---

	20-P1-021 injectables preparations intended for the NICU : Analysis of prescription inspection-doubt inquiry 西村健二, 安東朋美, 森谷康志, 徳田衡紀, 高柳和伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2008.

---

	Evaluation of sterile preparation duties to see for 20-P1-022 transfusion prescription Wada Noda style 1, Masahiro Otsuka 1, Toshiaki Miura 2, Yutaka Murata 2, Naoko Takeuchi 2, Mitsuru Nozawa 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2008.

---

	Action for the 20-P1-023 TPN prescribed drug inspection system construction Suyama Akina, Toshiya Takeno, Kurumazuka Chiho, Takashi Yasushi Inoue, Yoshiyuki Goto, Kimito Sato, Hiroshi Tamura, Descent from a mountain Koichi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2008.

---

	A dosing rate of the 20-P1-024 lipid microsphere is examination about liver function and the effect to give to lymphocyte counts Shoji Sakakibara 1, Takashi Niwa 1, Akio Suzuki 1, Katsuhiko Matsuura 1, Yoshinori Ito 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2008.

---

	20-P1-025 Construction of injection drug dispensing audit system : Drip speed and concentration checks and residual liquid amount calculation 片山文子1, 石渡勝美1, 小林功1, 杉本誠1, 川口文誉1, 山本豊1, 小川智之2, 近藤直也2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2008.

---

	Action for the disposal decrease after the 20-P1-026 injection mixed preparation Naoki Shibata, Yoshiharu Mitsunaga, Yukiko Omura, The Furuya Sea beauty, Hiroko Arai, Suguru Kasahara Castle, Jun Hamada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2008.

---

	Compatibility investigation of 20-P1-027 injection scattering prevention closed ring system (PhaSeal(R) system) and the anticancer drug vial 中山季昭, Kazuyoshi Hosoya, Fumio Iwasaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2008.

---

	Effect - of pH to give content decrease mechanism - content decrease of the diazepam injection at use of 20-P1-028 PVC-TOTM tube Norihiro Watanabe, Yuka Tsukada, Mutsuko Sasaki, Kenji Kawano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2008.

---

	20-P1-029 Busulfex (R) injection of prefilled reduction and usage 瀬尾誠1, 片山志郎1, 浜田真向2, 土橋保夫2, 土橋朗2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2008.

---

	Effect on injection by the strength of the 20-P1-030 light (illuminance) Let go through; 幸市朗, Hajime Matsubara, Kazuo Yago Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2008.

---

	Revision - of examination - check seat about the incompatibility of the 20-P1-031 ointment Sakai Naoko 1, Kyoko Kojima 1, Kazue Soda 1, Mai Tanaka 1, Koichiro Iwata 1, Jun Kainuma 1, Takahiko Kagaya 1, Atsuta Koichiro 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2008.

---

	The enforcement situation of the laboratory study for 20-P1-032 information on adverse drug reactions management and side effect monitoring Hiroko Fujisaki, Takashi Oikawa, Osamu Kimura, Iwao life, Yasushi Endo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2008.

---

	About a construction of 20-P1-033 safety information retrieval site "relief prescription infobox" Shiro Yamaguchi 1, Toshihiro Hama 2, Mayumi Mochizuki 3, Toshiki Hirai 4, Katsuhisa Goto 1, Aya Furukawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2008.

---

	Analysis about the safe information to bring the behavior modification of the specialist in 20-P1-034 prescription Aya Furukawa 1, Aya Fukuda 1, Katsuhisa Goto 1, Toshihiro Hama 2, Mayumi Mochizuki 3, Toshiki Hirai 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2008.

---

It is ... through participation in application and medical resources proper use - graduate school ward training of the simple suspension method at use of 20-P1-035 anticancer drug Kazuko Sugihara 1, 大澄朋香 1, 貝崎明日香 1, Is Kurata; see it; 1, Sugiyama endowment 2, Ishikawa mere beauty 2, Kazuko Kato 2, Jun Murayama Ichiro 3, Miwako Kamei 1, 戸部敞 1, Takemi Yoshida 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2008.

---

	A study on proper use of the 20-P1-036 non-prescription drug (the first report) about an azelastine hydrochloride preparation: Fumiko Kawaguchi, Toyokichi Eri incense, Hitomi Mizuno, Chika Okajima, Taeyuki Oshima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2008.

---

	Proper use of the drug requiring testing using 20-P1-037 medical business data Jun Wada 1, Tetsuya Tsuji 3, Hideki Inouchi 2, Chieko Ozuku 1, Isao Matsumoto three 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2008.

---

	20-P1-038 About use of iron medicine, the human erythropoietin preparation in the pre-operative autologous blood donation 中村真一, 高越梨沙, 高尾豊 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2008.

---

	Comparison between vancomycin elution behavior and about the vancomycin preparation each cement intensity - brand of the 20-P1-039 vancomycin component bone cement Kuniko Terada 1, Kayoko Iwamoto 1, Mutsumi Kobayashi 1, Masashi Tsujino 1, Fumio Teraoka 2, 前田頼伸 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2008.

---

	Stable examination in the simple suspension method of the drug which is unstable for 20-P1-040 light Yuji Fujii 1, Hideki Mori 2, Zamami Yoshito 1, 古林呂之 3, Dongfeng 3, Tetsu Ando sincerity 4, Is Kurata; see it; 5, Sendo Toshiaki 6, Hiromi Kawasaki 1, Izushi Fumio 7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2008.

---

	20-P1-041 whole country public welfare consecutive hospital "questionary survey count results about the simple suspension method" and analysis Teruaki Okura 1, Toshio Kosuge 1, Takeshi Moriya 1, Nishizono Kenro 2, 賀勢泰子 2, Tetsu Ando sincerity 2, Is Kurata; see it; 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2008.

---

	Intervention to use of inappropriate drug which assumed Beers Criteria for 20-P1-042 Japan grounds Tomoyasu Watanabe, Megumi Yamazaki, Koichi Takatori, Tetsu Ando sincerity Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2008.

---

	Action for the use situation and the proper use of the on admission bringing medicine in the 20-P1-043 renal function degeneracy patients Junko Morioka, 田中亮裕, Shishino Yuki, Well hilum Keiko, 末丸克矢, Hiroshi Araki positive Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2008.

---

	Characteristics of the physical pharmacy of the 20-P1-044 cartridge type insulin preparation Mami Takigawa 1, Higher Kobayashi male 1, Teruhiro Nakamura 1, Taku Miyakawa 1, Yuri Takahashi 1, Tadashi Yamakawa 2, Masanori Iwata 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2008.

---

	Relation between the patients, a pharmacist, nurses in the 20-P1-045 insulin proper use Yuko Shimakura, Yasuko Bell, Hirotsugu Kita, Yukiko Kita, Haruhiko Sato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2008.

---

	The use of the 20-P1-046 antimicrobial agent of fitness and contribution of the pharmacist for the TDM Kayoko Maezawa 1, Asako Terashima 1, Yukiko Kato 1, Yuko Miyano 1, Moat Seiji 2, Junko Kitsu 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2008.

---

	Examination of the drug targeted for the study in the 20-P1-047 antimicrobial susceptibility test Maki Hanada 1, Description of Nishimura existence 1, 河野博充 1, 風間義顕 2, Yoshiko Kato 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2008.

---

	20-P1-048 Examination for the use situation and the proper use of the linezolid 水野理恵子1, 相山めぐみ1, 磯部聖子1, 浅原慶徳1, 大塚昇1, 中坊幸晴2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2008.

---

	20-P1-049 Retrospective study of linezolid use cases in the Ehime Prefectural Central Hospital : Evaluation based on the proper use criteria 稲見有1, 橘貴寛2, 出口順子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2008.

---

	Change of the antibiotic consumption before and after the use registration system induction of injection antibiotics in the 20-P1-050 this hospital Yoshiko Yamaguchi 1, Takashi Goto 1, Emi Hirakawa 1, Yoshida Nobumasa 1, Ken Yamaji 1, Yoshitaka Shiraki 1, Masashi Hashimoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2008.

---

The change of the antimicrobial agent prescription trend by the participation of the pharmacist in 20-P1-051 Gram stain and evaluation of the patients awareness Masako Maeda 1, Toshihiko Maeda 1, Kana Matsumoto 2, Megumi Kobayashi 2, Reina Kamioka 2, Ayako 2 out of the reed, Kunihiko Morita 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2008.

---

About a medication of the opioid analgesic for patients with refractory non-cancer pain that we examined from 20-P1-052 pharmacist Kumiko Okitsu 1, 岩瀬利康 1, Yoshio Ito 1, Masahiro Ishikawa 1, Keiko Shinozaki 1, Jobu truth Sae 1, Book shallows Yoko 1, Junko Miyakawa 1, Minoru Mori Tomoko 1, Chiaki Koshikawa 1, Shigeki Yamaguchi 2, Toshimitsu Kitajima 2, Shizue Sayama 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2008.

---

	Research about the utility of the adrenocorticosteroid used together by epidural injections for 20-P1-053 sciatica and the lumbago Nao Yasunaga, Shuji Shimada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2008.

---

	Study on color change of the 20-P1-054 oxytetracycline ointment Ryo Kosaka 1, Ryo Murata 2, Mitsuru Kobayashi 1, Keiko Mori 1, Kenro Sasaki 3, Fumihiko Yoshizaki 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2008.

---

	Estrangement in "how to catch of 20-P1-055 general public group and the pharmacist group risk to fetuses by the medication at pregnancy" Hiroki Masuda 1, Seiichi Maruyama 2, Satoshi Toyama 2, Hiroshi Sato 2, Akira Kikuchi 3, Koichi Takakuwa 3, Kenichi Tanaka 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2008.

---

It is support to an investigation and the proper use after production sale of first kind medical supplies, azelastine hydrochloride in the 20-P1-056 compounding of medicines juxtaposition type drugstore Takayanagi Yoshiji fruit, Mikio Sakakibara, Masaki Sato, Satoshi Okada, Keiji Arai, Jun Kuribayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2008.

---

Trial of the in-hospital catalogue of medicine system making aiming at the proper use support of 20-P1-057 high risk medical supplies Motoki Urata 1, Miyuki Ota 1, Manno good luck 1, Rie Matsubara 1, Maiko Matsumoto 1, Toshiko Matsumoto 1, Is Iguma; see it; 1, Toshiko Takayasu 1, Miyuki Yoshimura 1, Yuko Inoue 1, Yoshiko Kitamura 1, 初田泰敏 2, Masashi Ogawa 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2008.

---

	Examination of the flushing condition to evade incompatibility of 20-P1-058 hyperalimentation and the injection Yoshiyuki Kobayashi, Soichiro Kimura, Hideo Ueda, Yukihiko Numajiri, Yasunori Morimoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2008.

---

New rating system of the acute corneal problem for the purpose of the formulation study support of the 20-P1-059 medicine for ophthalmology Kenichiro Shimoda 1, Teshima infinity 1, Agematsu sacred book 2, Mao Kusano 2, Takashi Kitaoka 2, Takashi Kitahara 1, wisteria Hideto 1, Hitoshi Sasaki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2008.

---

	Invention to conduct a Warfarin lesson in Nishimoto Hospital adding 20-P1-060 old age assistance institution Naoki Hasegawa 1, White pine Takako 1, Takashi Nagata 2, Keiko Yamamura 2, Kazuo Nishimoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2008.

---

	Action about the proper use of the 20-P1-061 albumin preparation Katsuhiko Kitahara, Ogre Toshihide Kubo, Akira Shinohara ability, 白澤吉哲, 荻無里千史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2008.

---

	Adsorptive examination of the powder wrapping paper in the room temperature storage of the 20-P1-062 disulfiram Satoko Okamura 1, Yasuhiro Nakahara 2, Susumu Tauchi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2008.

---

A clinical response and safety of the immunosuppressive drug tacrolimus in the 20-P1-063 hematopoietic stem cell transplantation Ryoko Udagawa 1, Small Ido Keiichi 1, 橋本浩伸 1, Koji Murakoshi 1, 牧野好倫 1, Nobuaki Yokote 1, Hirohisa Kato 2, Kanari former 3, Shinichiro Mori 3, Takahiro Fukuda 3, Field Ryuji Nozaki 3, Yoichi Takaue 3, Hiroshi Yamamoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2008.

---

	Mainly on examination - cardiovascular surgery about the preoperative optimal cancellation time in the 20-P1-064 low-dose aspirin preparation remedy patients - Mikiko Goto 1, Hideki Kobayashi 2, Yusuke Matsumoto 1, Etsuko Shinohara 2, Toru Asayama 2, Kenji Matsuyama 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2008.

---

	Comparison between synthetic Xa coagulation factor inhibitor and danaparoid sodium in the deep vein thrombosis prevention after the 20-P1-065 lower limbs surgery Yukie Nagata 1, Takashi Osawa 2, Yosuke Shiraishi 2, Kenichi Miyamoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2008.

---

Decrease in insulin dose in patients with 20-P1-066 end stage renal failure and ... inappropriate in diabetes management HbA1c for an index of the glycemic controls Masayuki Tanaka, 打谷和記, Nishiyama rich person, Mayumi Inoue, Yukiko Inui, Furunaga Ikumi, Hisayo Kadoi, Yumiko Tsurumi, Yasuhiko Hirota Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2008.

---

	Evaluation of the incompatibility with a flurbiprofen axetil note and the various transfusion preparation using the 20-P1-067 light masking type automatic particulate measurement device 名徳倫明, Kenji Ikeda, 廣谷芳彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2008.

---

	Effect of the storage temperature to be it-releasing, and to give it to of the 20-P1-068 tulobuterol percutaneous absorption type preparation Hiroyuki Yamazaki, Takafumi Nagata, Fumika Ryu, Ikuko Ogata, Quantity of Seo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2008.

---

	Request to the actual situation and a packing of the abstract opening a letter in 20-P1-069 elderly people Kiyomi Sadamoto 1, Mizuho Takahashi 1, Hikota Emi 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2008.

---

The medical supplies proper use to an outpatient based on 20-P1-070 doubt inquiry record and medical safety measures 1, Kyoshi, Shimizu, Noriko Kuramochi 1, Mariko Kawano 1, 岩冨由江 1, Tomoko Fukuda 1, Kyoko Inoue 1, Koichi Nakamura 1, Kazuyuki Hara 2, Kenichi Tomomatsu 2, Kazuo Nosaka 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2008.

---

	In-hospital dose criteria setting in 20-P1-071 acyclovir, the rose acyclovir and the action Saeko Matsuno, Masato Yamakawa, Ayako Ito, Hitomi Iwase Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2008.

---

	Relation to the resident education by the pharmacist in the 20-P1-072 Anjo rebirth hospital Masayo Yamashita 1, 三浦崇則 2, Akio Katsumi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2008.

---

	Study on continuation, cancellation of the warfarin in the 20-P1-073 perioperative period and resumption Hideaki Tamaoki, 新美全剛, Megumi Mizuhara, Atsuko Oda, Masaaki Yamato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2008.

---

	Meta analysis for the patients factor about individual difference of 20-P1-074 statin high sensitivity CRP decrease effects Paulownia Mio Hayashi 1, 2, Masahiko Ichikawa 1, Yasunori Sakamoto 1, Hirotoshi Echizen 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2008.

---

	The actual situation of the use of drug in the 20-P1-075 care health center for the elderly Koji Okada 1, Satoshi Taniguchi 1, Jin Misawa 3, Itsuko Shiga 2, Saburo Nakamura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2008.

---

	The effect that 20-P1-076 orally disintegrating tablet (OD lock) gives for compliance and effect of treatment Dr. Shimazaki 1, Toru Hirashima 1, Kazuhiko Noro 1, Shoji Izumo 1, Measure Shigenori 1, Ryu Kawai beauty 1, Takahiro Shibata 3, Tokuyuki Namiki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2008.

---

	Incompatibility of 20-P1-077 oxytetracycline hydrochloride hydrocortisone composition ointment and the nadifloxacin ointment 川本庸太 1, 田山剛崇 2, Sawa Akihiro 2, Threshold Takami 1, Hiromi Nishikawa 1, Katsushi Miyake 2, Nobuyuki Morita 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2008.

---

	The remedy situation and attitude survey of the 20-P1-078 alendronic acid sodium preparation Yosuke Ito, Hiroko Nomura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2008.

---

	Proper use of the allopurinol for the tumor lysis syndrome in the 20-P1-079 hematopoietic tumor Shinichi Kitamoto, Yuko Yanagida, Kimiyoshi Kumano, Yasuo Ogasawara, 八島加八, 長崎信浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2008.

---

	Relation of the pharmacy to Pharmaceutical Affairs Council in the 20-P1-080 Toho University medical center Sakura Hospital Masaka Wataru, Member of Satoshi Doi, Prince Kaga, Ishii Toshihiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2008.

---

	Evaluation of the pharmacist ward permanent residence from 20-P1-081 doubt inquiry contents Ayano Tanzawa, 寺松剛, Fumihiko Kitta, Naomi Daita, Mika Hinohara, Tomoki Matsumura, Wakako Suzuki, Masahiko Suzuki, 花輪剛久, Toshio Oguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2008.

---

	Effect of ethanol which gives it to S-warfarin 7 - hydroxylated metabolism by 20-P1-082 human CYP2C9 and diclofenac 4' - hydroxylated metabolism 辰見明俊 1, 2, Ikegami friend group 3, Ryoko Morii 3, Masatoshi Sugiyama 1, Hilum Muneo Hayashi 2, Seigo Iwakawa 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2008.

---

	Investigation about the effect diminishment of the warfarin by the 20-P1-083 risperidone combination 板井進悟, It is moisture in the west, Kenichi Miyamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2008.

---

	Increase case of PT-INR by a 20-P1-084 fluorouracil system anticancer drug and the warfarin combination Yamamuro butterbur child, Izumi Tanaka, Kita Hiroki Oka, Wealth garden Haruna, 清水奈味, Masanori Mori, Katsuhisa Zaitsu, Sakae Sueyoshi will, Kondo New Year's Day, Shunei Maeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2008.

---

	Pharmacokinetics, kinetic model analysis about the persistent interaction between 20-P1-085 warfarin and the amiodarone Shingo Tanaka 1, Juichi Otani 1, Masaru Nakajima 2, Hiroki Sato 1, Akiko Miki 1, Moat foster child 1, Yasufumi Sawada 1, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2008.

---

	Drug interaction study of pranlukast and the clarithromycin in 20-P1-086 health adults 中出進 1, Akinori Yamauchi 1, Tsuneo Kodama 2, Mikio Ogawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2008.

---

	It is the meta analysis of dihydropyridine drugs and properties of matter correlation 20-P1-087 grapefruit juice interaction analysis 竹内崇浩 1, 植沢芳広 1, Koichi Takeuchi 2, Mori Kiminori 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2008.

---

	20-P1-088 A study on the interaction of the Siberian ginseng extract and drug 高橋恒久1, 佐藤隆司1, 渡辺一弘2, 佐藤重一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2008.

---

	About interaction with a constitution crude drug of the 20-P1-089 Chinese medicine and the Western medicine Muro Machiko, Chiaki Ogata, Shun Kanari Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2008.

---

An example of patients with allogeneic hematopoietic stem cell transplantation that interaction of the josamycin was regarded as the tacrolimus in 20-P1-090 children 中村真依 1, Tatsuya Mori 1, Takao Sawai 1, Kazumi Atsuta 1, Junko Yamanaka 2, 大熊喜彰 2, Matsushita bamboo next 2, Jiro Mikami 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2008.

---

	A mechanism and application of the cytotoxic augmentation by a 20-P1-091 azole system antifungal agent and the zinc combination Yoshiro Okano 1, Shiro Ishida 1, Shinichi Yokota 1, 木奈崎昭男 1, Yasuo Koyama 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2008.

---

One case of adult T cell leukemia guessed that diarrheal disease of the hydrochloric acid irinotecan induction became severe by combination of 20-P1-092 itraconazole 政賢悟 1, Ibara country charges 2, Wada greens cord child 3, Nosaka straight volost 3, Hiroaki Mitsuya 3, Junko Fujii 1, Yoshiteru Honda 1, Hideyuki Saito 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2008.

---

	The change of blood valproic acid levels by the 20-P1-093 panipenem / betamipron combination Masaru Kurata life, 久木留涼子, Yoko Hara, Kazumi Hasegawa, Hiroshi Araki, Shigenobu Maruno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2008.

---

	Investigation about the off-period when we change it from 20-P1-094 antidepressants to MAO-I 吉野達規, Toshiaki Sudo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2008.

---

	The 20-P1-095 banana reduces titre of acetaminophen 植沢芳広 1, Naotaka Tsuji 1, 2, Mori Kiminori 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2008.

---

	Effect on hypoglycaemia effect of insulin by the 20-P1-096 antihypertensive drug celiprolol Yamase University male, Hiromi Kondo, Makoto Miyazaki, Kazunori Iwanaga, Masao Kakemi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2008.

---

	About study on 20-P1-097 quinolone antibacterial and OTC Chinese medicine stomach and intestines drug interactions - inhibition of resorption remedy - Yasumasa Tsuda 1, Ryosuke Nakazawa 1, Takayuki Hanasaki 1, 赤瀬朋秀 2, Hisahiro Yoshida 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2008.

---

	Incompatibility (the first report) of the 20-P1-098 OTC ophthalmic solution Hisao Matsumura, Yuka Ogawa, 水島紫芳, Lower garden Takuo, Masanori Iwata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2008.

---

	It is one discussion ... about the saccadic sthenia of - SSRI communalization of the patients with 20-P1-099 mental disorder understanding and "the role" of the pharmacist (the 36th report) Satoru Ishida 1, Saso Akio 2, 3, Goro, Miura, Ayano Sasaki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2008.

---

	It is one discussion ... about sexual dysfunction by - SSRI communalization of the patients with 20-P1-100 mental disorder understanding and "the role" of the pharmacist (the 37th report) Saso Akio 1, Satoru Ishida 2, 3, Goro, Miura, Ayano Sasaki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2008.

---

	20-P1-101 [Role] of sharing and pharmacist of mental illness patient understanding (Part 38) SSRI problems and herbicide injury Ombudsperson efforts 三浦五郎1, 石田悟2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2008.

---

	Syndrome of inapp ADH secretion (SIADH) case with the paroxetine that 20-P1-102 postoperative transfusion management, hospitalization food triggered it Tetsuro Koide 1, Keiko Watanabe 1, Toru Wakabayashi 2, Matsuda law of nature 2, Horiike Ichiro Sana 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2008.

---

	The symptom of depression that occurred at the interferon reuse to the patients who had 20-P1-103 anxiety symptoms as underlying disease Seiji Sato, 畠山盛良 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2008.

---

An example of the acute lymphocytic leukemia that presented with acute renal failure by 20-P1-104 methotrexate (R) high dose therapy, and required haemodialysis, blood adsorption Kenji Miyazawa 1, Ryo Takagi 1, Akira Hagiwara person 2, Yokozawa Toshiya 2, Hirokazu Nagai 2, Kazue Sakano 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2008.

---

	Examination for the potential operated calcium channel electric current in 20-P1-105 paclitaxel-induced peripheral neuropathy Yoshiko Okamoto 1, Nobuyuki Katagiri 2, Yoshiko Shibata 2, Run Zakoji; 2, Hideaki Ikeshima 2, Iku Utsunomiya 2, Keiko Hoshi 2, Kyoji Taguchi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2008.

---

	We look at the rear of the side effect expression in the 20-P1-106 thalidomide therapy and analyze a mark 陶山登之, Ayako Nishimoto, Hiroki Tamaki, Nobuhiro Nishimura, 直良浩司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2008.

---

	Stomatitis development situation survey after the 20-P1-107 TS-1 remedy 浜元孝 1, 山之内恒昭 2, Tomomi Fujita 2, Yasuhiko Mimura 2, Isao Adachi 2, Takashi Shimizu 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2008.

---

	20-P1-108 One case that expressed thrombocytopenia by Sorafenib 岡崎美代子1, 岩村正嗣2, 新井万理子1, 松原肇1, 馬場志郎2, 矢後和夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2008.

---

	One case that overcame dose-dependent fever with 20-P1-109 imatinib Kentaro Ogata 1, 2, 内山将伸 2, Kenji Ishizuka 3, Kojiro Nikami 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2008.

---

Investigation about the myelosuppression at the S-1/CDDP combination therapy for patients with 20-P1-110 progressive stomach cancer Katsuya Tanizawa 1, Yoshiko Kiriyama 1, Keiko Taguchi 1, Tomoyuki Hirashita 1, Takehiko Kashiwa 1, Cedar wisteria good tree 1, Teramachi eyes 2, Teruo Tsuchiya 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2008.

---

	1 case that showed hypercalcemia and cardiac function failed during treatment of 20-P1-111 acute promyelocytic leukemia (APL) Kano sheath or 1, Masako Oshige 1, 有木宏宗 1, Mieko Yokoyama 1, Yasuyuki Inoue 2, Yorihisa Miura man 2, Keiso Masuhara 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2008.

---

About association with fact-finding of the dysosmia in the hospital outpatient department chemotherapy room attached to 20-P1-112 Kanazawa University and the taste disturbance 春木一伸 1, 2, Kan Yukio 2, 5, Mieko Kishi 2, 3, Naoko Takada 2, 4, Masami Kawahara 2, Tadaaki Yamashita 1, Kenichi Miyamoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2008.

---

	20-P1-113 Study of the anti-TNF drugs discontinuations in rheumatoid arthritis patients : And experienced 194 cases of infliximab and 157 cases of etanercept 寺西智子1, 岸本新作1, 福井利文1, 塩澤和子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2008.

---

	Safe examination in the 20-P1-114 temozolomide radiation combination therapy Tomomi Kataoka 1, Sanae Miyano 1, Satoshi Motokawa 1, Michihiro Shino 1, Satoshi Horiguchi person 2, Koichi Mitsuya 2, Nakasu Yoko 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2008.

---

	Search of the pharmaceutical intervention point in 20-P1-115 temozolomide maintenance, recurrent protocol Sanae Miyano 1, Tomomi Kataoka 1, Satoshi Motokawa 1, Michihiro Shino 1, Satoshi Horiguchi person 2, Koichi Mitsuya 2, Nakasu Yoko 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2008.

---

	20-P1-116 Investigation about thrombocytopenia by the linezolid 平下智之, 桐山佳子, 谷沢克弥, 新谷俊一, 柏毅彦, 杉藤善樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2008.

---

	20-P1-117 Factor analysis of thrombocytopenia expression by linezolid: Impact of renal function and administration dates 石原慎之, 玉木宏樹, 西村信弘, 直良浩司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2008.

---

	20-P1-118 Clinical examination of the background factor of the case that caused thrombocytopenia by the linezolid 松元加奈1, 石田茂伸2, 中井由佳2, 南野優子1, 中西由佳1, 森田邦彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2008.

---

	Safe investigation of the 20-P1-119 fondaparinux sodium Shuji Yamazaki, Samsung intellect, Kazuhiko Nagai, Rice month Yukinori, Hitoshi Yamada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2008.

---

	Fact-finding of the side effect of the 20-P1-120 fondaparinux sodium subcutaneous injection Mari Sakata 1, Kengo Matsumoto 1, Teruhiko Hoshino 1, Kazunori Shiozu 1, 2, Kyoshi, Ishii Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2008.

---

	Examination of gastrointestinal disturbance and the quality of life in the 20-P1-121 low-dose aspirin remedy patients Keiko Yajima 1, 保戸塚麻里 1, Kanako Takahashi 1, 冨 ヶ Yuki Hara 1, Takao Akashi 2, Takashi Kawai 3, Akira Yamashina 4, Junko Kitsu 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2008.

---

	Examination about the bone density decrease of the 20-P1-122 warfarin remedy patients 保戸塚麻里 1, Keiko Yajima 1, Takao Akashi 2, Kunihiro Sakoda 3, Akira Yamashina 3, Junko Kitsu 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2008.

---

	20-P1-123 An example of patients with severe renal failure that resulted in agranulocytosis by gatifloxacin administration 根来早紀子1, 古久保拓1, 松永千春1, 和泉智1, 前野芳史2, 山川智之2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2008.

---

	It is ... through an example of uniform management (collection of, analysis, reporting) - cholinergic crisis of the 20-P1-124 information on adverse drug reactions Motoko Funato, Akemasa Junko, Keiko Nitta, South Reiko, Oshino Valley fruit, Masaaki Mori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2008.

---

	20-P1-125 Pharmacoepidemiology (50) Examination for the purpose of cholinergic crisis avoidance by Ubretid tablet taking 大中博晶, 矢野良一, 塚本仁, 渡辺享平, 岩尾岳洋, 長谷川充, 中村敏明, 政田幹夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2008.

---

	Side effect evaluation of pharmacist duties (72) clopidogrel as the 20-P1-126 medical care person Hisashi Yamashita Yoshie, Toshiaki Nakamura, Jin Tsukamoto, Mikio Masada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2008.

---

	Impaired glucose tolerance and disorder of lipid metabolism in the 20-P1-127 cyclosporine administration rat Akira Sakata, Akira Suzuki person, Masami Hirai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2008.

---

	The present conditions of pulmonary artery-related pulmonary hypertension treatment and side effect of 20-P1-128 bosentan Junko Morihara 1, Eriko Kondo 1, Hanafusa Yukiyo 1, Yoko Ninomiya 1, Toshi Shibabe 1, Takahiro Kawamoto 2, Kiyoshi Yoshida 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2008.

---

	Investigation about a side effect and the child born of the 20-P1-129 early or threatened labour therapeutic drug Kazuko Uematsu 1, 4, Masanobu Odaka 1, Mitsuhiro Sugimoto 2, Tadashi Kawakami 3, Junko Kitsu 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2008.

---

	About prednisolone doses in the 20-P1-130 idiopathic interstitial pneumonia and the correlation of the side effect Otsu good luck, The Tabuse course, Hidemi Isago, Misato Tsuji, 岡所扶美, Yoko Ogawa, Mika Miyazaki, Hitomi Kuroiwa, 宮部貴識 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2008.

---

	One case that caused hypoxemia after 20-P1-131 erlotinib 150 mg remedy Inside many protons 1, Tomonori Hirashima 2, Gilt bronze Yoko 1, Keiko Matsui 1, Court Security Office Mika 1, Teruhisa Ishikawa 1, Noriko Abe 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2008.

---

	About the association between halfway awakening and fall accident after the 20-P1-132 sleeping drug remedy from inspection of - fall accident report - Toshihiko Takeno 1, Ai Sakuma 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2008.

---

	Background (respiratory disease) of 20-P1-133 mycotic stomatitis treatment Makoto Tanaka, Teruyuki Otsubo, Kenichi Manabe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2008.

---

	An example of the nephrotic syndrome with suspected rhabdomyolysis with 20-P1-134 cyclosporine Nishiyama rich person, Masayuki Tanaka, 打谷和記, Yukiko Inui, The Inoue pure white beauty, Furunaga Ikumi, Hisayo Kadoi, Yumiko Tsurumi, Yasuhiko Hirota Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2008.

---

	One discussion about the side effect of 20-P1-135 miglitol Keiko Hirai, Misa Uehara, Yasuyuki Matsumura, Hajime Kagaya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2008.

---

	Examination of the risk factor to be involved in the side effect expression of 20-P1-136 antituberculosis drug Yoshiaki Yamamoto 1, 2, Nobuyuki Mishima 1, Kenji Ogawa 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2008.

---

	Side effect investigation after the use of 20-P1-137 influenza therapeutic drug Relation bowl Hideo, Yoshiyuki Miyasaka, Maho Miyake, Spring Mayuko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2008.

---

	About the infection situation of hepatitis C after the cardiovascular surgery surgery that combined transfusion with 20-P1-138 "fibrin glue" Masayoshi Takada, Eriko Yajima, Noriko Yamada, Makiko Kubota, The Yasuda early sum Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2008.

---

Relative investigation with the central nerve side effect onset and the immunosuppressive drug in the 20-P1-139 lung transplantation patients Hiroki Fujiwara 1, Hidenori Sagara 2, Tomoaki Sato 3, It is still 3 Matsunaga, Sendo Toshiaki 3, 五味田裕 4, Fusako Takayama 5, Hiromi Kawasaki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2008.

---

	Action to information on adverse drug reactions collection of in the 20-P1-140 Fukuoka University Hospital Tomoko Yuda, Chika Yamamoto, 内山将伸, Kentaro Ogata, Yoshihiro Kawahara, Koji Washiyama, Kojiro Nikami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2008.

---

	Examination about the TPN-related liver damage in the 20-P1-141 Toho University medical center Sakura Hospital Satoshi Sato 1, Member of Satoshi Doi 1, Ishii Toshihiro 1, Masaka Wataru 1, Yasuo Suzuki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2008.

---

	Study on 20-P1-142 chemical nephritis interstitial, patients background of the chemical urine cell damage and symptom Junichi Takeda, Fumiko Otsu, Nobuyuki Goto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2008.

---

	Comparison evaluations such as the side effect incidence in 20-P1-143 Japan and the United States Miwa Yotsumoto, Chiaki Okamoto, Hiroshi Hori tree, Truth Naoyuki Eda, 石川友貴, Katsuhiko Takano, Sanae Fujiko, Teruaki Nakagawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2008.

---

	Bioequivalence of the itraconazole preparation which is available for 20-P1-144 suspension administration Takao Oshima, Ryoichi Sonoda, Morino Okuma Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2008.

---

	About a use of 20-P1-145 generic drug investigation and a future problem Koji Muto 1, Wataru Takizawa beauty 1, Yukiko Oshiki 1, Etsuko Miyamoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2008.

---

	Comparison - in approximately recognition investigation - fee-for-service revision for the generic drug of the 20-P1-146 outpatient Yamamoto lawn arrow incense 1, Naomi Takeda 1, 戒田文子 1, Yoshihiro Takaishi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2008.

---

	Recognition comparison between non-medical person and pharmacist for the use of the 20-P1-147 generic drug The Inoue third son, Izumi Machida, Tomoyo Sato, Akio Fujii Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2008.

---

	Quality study of the 20-P1-148 metformin film coating 3 preparation Reiko Shimada, New shellfish Hiroaki, Takashi Sasaki, Yuichi Takahashi, Kyoko Fukumoto, Kazuyuki Ueno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2008.

---

	Use pulse-taking of the generic medicine with the 20-P1-149 prescription style change Susumu Kudo, Comb mansion Yuko, 丹代恭太, Mai Kubo, Keita Umemura, 1, Sakae, Sasaki, Hirofumi Suzuki, 蒲澤一行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2008.

---

	Difference - between questionary survey - physician, the pharmacists for the 20-P1-150 generic drug Suzuki just argument 1, ウォーン pole 2, Junko Nagai 1, Tadanori Sasaki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2008.

---

	One discussion for the way of the 20-P1-151 generic drug medical supplies change Naoko Hayashi 1, Keiko Kishimoto 2, Yoshiko Kawamoto 1, Makiko Yoshimi 1, Two department Michiko 1, 2, Noriko Fukushima 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2008.

---

	The change situation to the generic medicine of the out of the hospital prescription in the 20-P1-152 this hospital Miki Watanabe, Toshikazu Kawasaki, Eri Hino, Upper Tomomi Nakai, Shinichi Ishizuka, Hiroko Sato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2008.

---

	Examination of the quality of the 20-P1-153 theophylline timed-release tablet Kimie Imai, Mao Tomita, Rieko Hamada, Naoya Suzuki, Ayano Iwasaki, Kunio Nakanishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2008.

---

	Clinical evaluation of the starting medical supplies and generic medicine of the 20-P1-154 pravastatin sodium 寺下朋江, Tega Eiji, Kojiro Takashima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2008.

---

	Use of drug evaluation of the generic medicine "re-duck (R)M lock" of the 20-P1-155 pravastatin preparation Takashi Nagata 1, Hiroaki Tsuchiya 1, Rina Kito 1, Naoki Hasegawa 2, White pine Takako 2, Akiyo Horie 2, Kazuo Nishimoto 2, Keiko Yamamura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2008.

---

Establishment - of the evaluation method to change evaluation - generic medicine of the preparation of the generic medicine of medical supplies "cyclosporine" requiring 20-P1-156 TDM, and to adopt it Rina Kito 1, Takashi Nagata 1, Takahiro Hayashi 2, Katsuaki Ozeki 2, Kazuko Nakano 2, Keiko Yamamura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2008.

---

	Comparison of laboratory values in the forerunner, the generic medicine of the 20-P1-157 sulbactam ampicillin injection Aspect shrine Koji 1, Keiko Miyakawa 1, Makoto Hayashi 1, Koichi Nagaoka 1, Koji Abe 1, North Toshiyuki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2008.

---

	Mainly on stability - generic drug of the gabexate mesylate in the dilute solution for the 20-P1-158 injection - Miyuki Sakurai 1, Kenji 2 who likes it in autumn, Yoko Saito 2, Junpei Inoue 3, Noboru Okamura 4, Kenji Matsuyama 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2008.

---

	About information about competitive review - generic medicine of the pharmaceutical literature database in 20-P1-159 Japan - Takumi Umemura 1, Nobuyuki Goto 1, Fumiko Otsu 1, Ukuru Watanabe flat 2, Toshiaki Nakamura 2, Mikio Masada 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2008.

---

	Intelligence and utilization about 20-P1-160 generic drug Landowner Takafumi 1, 9, 五戸薫 2, 9, Yoko Kobayashi 3, 9, Makoto Takahashi 1, 9, Yumiko Noguchi 4, 9, Hiroaki Hoshino 5, 9, Yumiko Mikami 6, 9, Tooru Mori 7, 9, Yuki Yamashita 8, 9, Kenzo Nishino 4, 9 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2008.

---

	Interview form comparison between innovator drug and generic drug in the 20-P1-161 vancomycin note Tetsuya Ito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2008.

---

	Prescription change after bringing medicine and the hospitalization in the 20-P1-162 medical treatment type hospital Hiromi Yamaguchi, Hiroko Koyama, Michi Ansaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2008.

---

	20-P1-163 Changes to the generics of the drug to be used for cancer chemotherapy: Impact on patients in levofolinate calcium introduced 敦見真由美, 藤原琴, 吉河絵美里, 藤本奈津子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2008.

---

	Comparison between safety and clinical response in the starting medical supplies and generic medicine of the 20-P1-164 paclitaxel preparation Kyoko Tadokoro 1, Tomohiro Miyake 1, Takashi Yamawaki fine weather 2, Hiroshi Yoshida 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2008.

---

	Fact-finding with the change to 20-P1-165 risperidone generic drug Hitomi Horikawa, Golden Reiko, Takako Toi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2008.

---

	Stability evaluation of the various nicorandil preparation when we saved it in a 20-P1-166 looseness and press through pack state Jin Miyamoto, Eri Mimura, Kanako Okazaki, Shuji Shimada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2008.

---

	Bioequivalence in healthy adults of 2.5 mg of 20-P1-167 amlodipine tablets "Towa" and 5 mg of amlodipine tablets "Towa" Kuniko Nakamura, Hiroshi Morimoto, Takashi Matsui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2008.

---

Comparison ... in the preparation of pharmaceutic equivalency evaluation (2) - BCS classification Class I of the generic medicine using the 20-P1-168 absorption prediction system and III Yuko Watanabe 1, Chiaki Yamamoto 1, Descent from a mountain Tetsuya 1, Masanori Kobayashi 2, Shiro Itagaki 2, Mitsuru Sugawara 3, Tsuyoshi Hirano 2, Takeshi Iseki 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2008.

---

	20-P1-169 Medicament evaluation of NSAIDs generic 田原雅子, 平昭圭介, 坪内知沙, 花田徳子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2008.

---

	Patients satisfaction investigation of the generic drug in the 20-P1-170 compounding of medicines juxtaposition type drugstore Tomoko Okumura 1, 3, Mikio Sakakibara 1, 3, Satoshi Okada 1, 3, Keiji Arai 1, 3, Toshitaka Nabeshima 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2008.

---

	About drug costs reduction by the use of 20-P1-171 generic drug and self-burden reduction Keiji Totsuka, Naoko Kawaguchi, Ishiguro forest husband, 岡村正巧 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2008.

---

	About the induction of the 20-P1-172 generic drug examination - to - evaluation and the systematization Abe going enthusiast 1, Yasuhiro Matsuzawa 1, Masaomi Tanaka 2, Masaru Fujii 3, Kazunori Yamada 4, Tadashi Maeda University 5, Hideki Sato 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2008.

---

	A present conditions analysis and fact-finding of the multidirectional generic medicine in the 20-P1-173 medical supplies market Hiroshi Hori tree, Chiaki Okamoto, Truth Naoyuki Eda, Miwa Yotsumoto, 石川友貴, Katsuhiko Takano, Sanae Fujiko, Teruaki Nakagawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2008.

---

	The change situation to the generic medicine in the drugstore attached to 20-P1-174 Gifu College of Pharmacy and patients attitude survey 高島英滋 1, Tetsuo Adachi 2, Yosuke Miwa 3, Akira Higashi incense 1, Suguru Kubota sentence 1, Tadashi Horiuchi 1, Naoki Inagaki 3, Teruo Tsuchiya 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2008.

---

Fact-finding of the generic medicine in the 20-P1-175 Shinpo place hard to pass system enforcement 尾崎加職 1, Masaki Manda 1, Small bath Takako 1, Yasuko Takinami 1, Miyuki Miyake 1, Naoko Tsuji 1, Keiko Noguchi 1, Hitomi Kawaguchi 1, Takami Fujii 1, 野際俊希 1, Fuminori Matsubara 1, Shinnya Inaba 2, Tetsuji Sakai 2, Kazuhiro Izawa 2, Masayasu Matsumoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2008.

---

	The change situation to the generic medicine with the 20-P1-176 fee-for-service revision Ashikari Saori, Hiroki Ito, Makoto Inoue, Fumihiko Katagiri, Sato male oneself, Shoji Takeyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2008.

---

The actual situation after the style change about "the change to generic medicine" of the 20-P1-177 prescription and patients attitude survey Koichi Otaki 1, 2, Toshio Awaya 1, Sayaka Fujimaru 1, Noriko Umezu 1, Katsuhisa Tahara 1, Hemp lower Tomoka 1, Kaori Koshiro 1, 安達知輝 1, Shinya Iida 1, Yuzuru Yamamoto 1, Yasushi Yamashita example 1, Toshiyuki Miyoshi 1, Yoshikazu Tazaki 1, Kazuo Matsubara 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2008.

---

A construction and use of the information standardization system of the out of the hospital prescription data between 20-P1-178 Hospital, the drugstore Hidetoshi Honda 1, 4, Katsuyoshi Nakajima 1, 4, Toshiichi Seino 1, Hiroshi Suzuki 1, Eiji Shiozaki 2, Hiroki Watanabe 3, 4, Kazuhiko Oe 3, So Koike one 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2008.

---

	Medicine medicine cooperation for use promotion of the 20-P1-179 generic medicine 戒田文子 1, Yamamoto lawn arrow incense 1, Naomi Takeda 1, Yoshihiro Takaishi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2008.

---

	Tendency of patients with acute poisoning in the 20-P2-181 Saitama Medical School comprehensive medical care center Naohiko Inoue 1, Katsunori Shinohara 1, Sawada mere beauty 1, Tomonori Oya 1, 原井賢秀 1, Motohiko Sano 1, Toru Kishino 1, Masayuki Kimura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2008.

---

	Intervention of the pharmacist in 20-P2-182 ICU, the CCU Ayumu Nozaki 1, Ito greens wave 1, 茂木孝裕 1, Tomoko Fujita 1, Hirokazu Nakanishi 1, Masafumi Morita 3, Enjoji Yoshihisa 2, Shigeru Nakamura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2008.

---

	Medical supplies proper use and safety management in the 20-P2-183 intensive care unit Emiko Kobayashi, 青山涼重, Fumio Okada, Kenichi Sagawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2008.

---

	Thorough injection management in the 20-P2-184 critical care center 畝本賜男, Kazuya Murata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2008.

---

	Role of the 20-P2-185 critical care center support task - permanent residence pharmacist Mayu Komada, 橋本昌宜, Hamura Koichi, Marutani good period, Satoshi Ichikawa, Satoru Nagata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2008.

---

	Injection management in the 20-P2-186 ICU Shigeki Nakane 1, Kaneji Miyahara 1, Yoshikatsu Mizutani 1, Tomohiro Kato ankle 2, Mitsuyo Kondo 2, Chiharu Kato 2, Izumi Uchiyama 2, Miyoko Kobayashi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2008.

---

	Make use of role - pharmacy-like technical knowledge of the operation region exclusive duty pharmacist in the 20-P2-187 team approach in medical care; and - Yuka Shibata 1, Your Kodama A 1, Rieko Tanaka 1, Kernel Hiroshi Inouchi 2, Furrow well Hiroko 1, Tree flat Kenji 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2008.

---

Drug control duties 1 in the 20-P2-188 operating room Yoshizaki sheath incense 1, 濱野公俊 1, Top division Mari 1, Aya Sakurai 1, Moe Takeuchi 1, Yuko Matsuhashi 1, Otsuka having fun 1, Mieko Yokoyama 1, Kyoko Saito 2, 3, Sakamoto tree 3, Tachi field Takeshi 3, Tsuyoshi Otsubo person 4, Keiso Masuhara 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2008.

---

Drug control duties 2 in the 20-P2-189 operating room Yuko Matsuhashi 1, 濱野公俊 1, Top division Mari 1, Aya Sakurai 1, Moe Takeuchi 1, Yoshizaki sheath incense 1, Otsuka having fun 1, Mieko Yokoyama 1, Kyoko Saito 2, 3, Sakamoto tree 3, Tachi field Takeshi 3, Tsuyoshi Otsubo person 4, Keiso Masuhara 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2008.

---

	Improvement of the medicine management method in the 20-P2-190 operating room Junichiro Kato, Harada University, Tamayo Takahashi, 奥津利晃, Noriko Ando, Eiko Kato, Masaki Kitamura, It is full of history of Kikuno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2008.

---

Intervention to the operating room drug control duties by the 20-P2-191 pharmacist Yoshie Takeda 1, Kayoko Takada 1, Rie Komoda 1, Miyoko Tsunoda 4, Yoshiko Yamamoto 3, Fujisato beauty 2, Masumi Abe 1, Miyoko Kobayashi 1, Akiko Otake 1, Tazuko Shibata 1, Kyoko Tamai 1, Toshi Shibabe 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2008.

---

	Induction and evaluation of the drug system of administration in conjunction with 20-P2-192 prescription order system Ai Aoki 1, Yasuyuki Kanbayashi 1, Hideaki Hiraga 1, Kosuke Toki 1, Shoji Miyamoto 1, 100 Kenji 1, 中尾滋久 1, Masato Honma 1, 2, Koda good luck direct 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2008.

---

	The present conditions and evaluation of the drug management that became 20-P2-193 electron Shinobu Yoshizawa, Yoshihisa Kawakami, Reiko Daita, 前島光廣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2008.

---

	Drug system of administration using 20-P2-194 electronic chart The single Motoyoshi beauty, Satoe Yamaoka, Mari Kawano child, Fuminori Shibuya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2008.

---

	About the effective medical supplies management for long holidays in the 20-P2-195 emergency hospital Seiji Koga, Ryu Onizuka, Kamikubo love, Minoru Yasunaga sand, Hirokazu Tanaka, Masaaki Hirakawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2008.

---

	Evaluation of the resident pharmacist duties in the 20-P2-196 operation region Tomoaki Doi, Yoshie Isobe, Shigeko Tsuji, Masato Kachi, Tomomi Kubo, Masato Asakura, Shoko Fujita, Masaki Ninomiya, 福岡憲泰, 芳地一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2008.

---

	Adoption means using 20-P2-197 antimicrobial susceptibility test Description of Nishimura existence 1, Maki Hanada 1, 河野博充 1, 風間義顕 2, Yoshiko Kato 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2008.

---

	20-P2-198 production lot and the construction of the medical supplies system of administration that enabled management on an expiration date and the use Hidenori Kitazawa 1, Koichi Tanabe 1, Satoko Takeuchi 1, Tomoaki Ikezaki 1, Goji Nakase 1, Masahiro Kawano 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2008.

---

Evaluation - about the efficiency of induction and duties of action -SPD to efficiency of the medical supplies administrative work in the 20-P2-199 Kochi medical center and the precision The Tanaka immensity, Misako Takeda, Yasuyo Fujisawa, Land tax officer climb charges, Hiroo Sumida, 服部暁昌, Teruo Tanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2008.

---

	Inflection of IC tag for the problem solving in the 20-P2-200 medical field Jin Matsumoto 1, Hiroyuki Sasagawa 2, Kunihiro Nitta 2, Ken Ogawa will 1, 3, Yasuo Watanabe 1, 3, Yoshinari Watanabe 1, 4, Daisuke Koide 1, 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2008.

---

Establishment of the 20-P2-201 Kitano Hospital heart center and relation of the pharmacy 1000, Aga Kyoko 1, Mami Shirakawa 1, Mariko Shirane 1, Hiroyuki Kawahara 1, Country original Junichi 1, Koji Ueyama 2, Harvest festival Akira Mori 2, Kunihiko Nagai 2, Takeshi Watanabe 2, Takashi Nohara 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2008.

---

	20-P2-202 Efforts to a use situation investigation and proper use of the linezolid 白石貴寿1, 坂本晃世1, 村橋重樹2, 岩武資善1, 中村泰士1, 横山博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2008.

---

	20-P2-203 Side effect of linezolid investigation of the myelosuppression 江口倫由, 小倉千奈, 河相景子, 藤川和大, 坪井菜野, 氏家澄絵, 堀田修次, 槙恒雄, 小川喜通, 中島弘光, 川上幹郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2008.

---

Promotion of the proper use of antiMRSA medicine vancomycin in the 20-P2-204 Higashihiroshima medical center Shuji Hotta, China Ogura, River aspect Keiko, Fujikawa sum size, 江口倫由, Tsuboi greens field, Kiyoshi Ujiie picture, Tsuneo Maki, Yoshimichi Ogawa, Hiromitsu Nakajima, Mikiro Kawakami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2008.

---

	Analysis of consumption change of the 20-P2-205 antiMRSA medicine and the affector Yuji Fukuchi 1, Sakiko Kurokawa 1, Eiji Tsutsumi 1, Nobuo Suzuki 1, Masahiro Sakamoto 2, Makoto Miki 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2008.

---

	Spreading effect to a physician by the TDM enforcement of the 20-P2-206 antiMRSA medicine Maruoka eyes, Tetsuo Funamoto, Motomu Sumitani Yoshiko, Misae Takase, 飴谷太 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2008.

---

	An action and result to TDM rate of use improvement of the 20-P2-207 antiMRSA medicine Momoko Horio 1, 3, Takafumi Omura 1, Matsushita sheath or 1, Yoshiteru Honda 1, 3, Juichi Miyakawa 2, 3, Nosaka straight volost 2, 3, Tatsuya Kawaguchi 2, 3, Hideyuki Saito 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2008.

---

	Action ... to proper use of activity ... antiMRSA medicine of the infection control team (ICT) in 20-P2-208 nosocomial infection measures Kenichi Kobayashi 1, Akemi Kawakami 2, Takeaki Nishibori 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2008.

---

	The use situation of the antimicrobial agent in the 20-P2-209 Niigata Prefectural hospital 15 institution and pyocyanic meropenem susceptibility Taeko Higuchi 1, Katsuyuki Tanaka 2, Junko Takazawa 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2008.

---

	Problems and problem of the use of specific antimicrobial agent registration system in preventive measures against 20-P2-210 resistance Masayuki Kobayashi, Your family Norio, Kenji Yokochi, Kana Fukazawa, Person of moat Natsumi, Posterior Fujimitsu good Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2008.

---

	Chemical sensitivity of 20-P2-211 clinic isolation Pseudomonas aeruginosa and the use situation of the antimicrobial agent Koya third son 1, Kosuke Baba 2, Koji Narui 3, 野口雅久 3, Masanori Sasatsu 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2008.

---

	About the use restrictions of the antimicrobial agent in the 20-P2-212 medical treatment type sickbed and a chemosensitive change Naoaki Shimizu 1, Masahiro Yasue 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2008.

---

	Making and use of antimicrobial agent situation investigation of the anti-biogram for the 20-P2-213 antimicrobial agent proper use 滝波昇悟 1, Auditor Hideo 1, Keiji Nishiyama 1, Kawai thickness line 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2008.

---

	Utility of the specific antimicrobial agent registration system in a 20-P2-214 carbapenem system antimicrobial agent and the antiMRSA medicine Yui Yoichi Sono 1, 入江徳俊 1, Takeshi Shimomura 2, Mayumi Yokota 2, 槙林智子 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2008.

---

	Multifaceted approach to a physician aiming at the proper use of the 20-P2-215 wide area antimicrobial agent Misato Mochizuki 1, Kamoto light person 3, Mizunuma Chihiro child 1, Koji Miwa 1, Kageno Takahiko 1, Yuji Ono 2, Masayuki Yamane 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2008.

---

	The designated antimicrobial agent registration system that the 20-P2-216 many types of job cooperated Tokuyama Kotomi 1, Noriko Kosaka 2, Yoshiyuki Ishii 1, Yoji Ogawa 1, Tomofumi Yano 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2008.

---

	Action and fact-finding questionnaire - personnel participation hand-washing training ... to infiltrate 20-P2-217 hand-washing Saori Hashiguchi 1, Motomura two 1 in total, Ikeda ability interest 1, Yoko Sugimoto 2, Ryuji Morishita 2, Tsuyoshi Machida 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2008.

---

	Use of primary irrigation, antiseptic turn of eventss by the primary antiseptic abolition of the 20-P2-218 medical device Masatoshi Saito 1, Morning wife Satomi 2, Hiroshi Nagoya 3, 渡邉彦 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2008.

---

	An antimicrobial agent consumption investigation using 20-P2-219 ATC/DDD System and examination about the drug resistance of the in-hospital detected bacteria Hideji Takeshita 1, Matsuyama solstice 1-resistant, Haruyo Narishima 2, Nobuyuki Kawai 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2008.

---

	Questionary survey for the understanding degree of the standard precaution to 20-P2-220 pharmacy school trainee, the external staff Yoshiro Sakai, Chiyoko Arima, Yuko Kubo, Mieko Tsuruta Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2008.

---

About the making of the 20-P2-221 "prevention of infection manual of the home health care" Hakuno positive original 1, 2, Keiko Nagano 1, 3, Amagasaki path of righteousness 1, 4, Katsuhiro Yorioka 1, 5, Michiko Matsuda 1, 6, Hiroshi Yamazaki 1, 7, Mikiya Hayashi 1, 8, Tadao Kawaguchi 1, 9, Yoshiya Matsuo 1, 10, Shinya Sato 1, 11, Shigeharu Oie 1, 12, Noriko Hirata 1, 13, Akira Kamiya 1, 12 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2008.

---

	Enforcement of the questionary survey about infection measures for 20-P2-222 inside the hospital personnels Michiko Adachi 1, 2, Asami Noda 1, Mari Kaneta 1, Infection measures committee committee 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2008.

---

	Relation of the pharmacist as the ICT in the 20-P2-223 Masuda Red Cross Hospital Saza book Tomoyuki, Nishizono Kenro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2008.

---

	Effect of VRE infection prophylaxis measures on MRSA infection prophylaxis of the 20-P2-224 CCU Toshiyuki Irie 1, Hiromi Mizoguchi 2, 道越淳一 3, 永山眞紀 3, Kazuhisa Masuda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2008.

---

	Side reaction investigation (2007-2008 season) after the 20-P2-225 Nomi-shi staff influenza immunization Yumi Ota 1, High branch Masayoshi 2, Akemi Yamauchi 3, Yoko Nakajima 3, 成橋和正 4, Kiyotsugu Mizuno 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2008.

---

	Action to mupirocin ointment proper use in the 20-P2-226 Hiroshima City Hiroshima Municipal Hospital Nobue Uetake, Takafumi Sugawara, Toshiharu Matsumoto, Hiroshi Wada, Open Koichi, Yonezawa sing, Yasuki Tomota Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2008.

---

	20-P2-227 Bacterial contamination investigation of the amino acid sweetened electrolyte infusion and peripheral venous route three-way stopcock 堀川俊二1, 只佐宣子1, 成井浩二2, 野口雅久2, 笹津備規2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2008.

---

The examination that is safe efficacy of the levofloxacin once a day administration in the neutropenic phase after the pharmacist duties (73) cancer chemotherapy as the 20-P2-228 medical care person Sana Hamazaki 1, Sakae, Toshiaki Igarashi 1, Jin Tsukamoto 1, Toshiaki Nakamura 1, Yoshimasa Urasaki 2, Takanori Ueda 2, Mikio Masada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2008.

---

	Discussion ... about blood mycophenolic acid concentrations change - trough value measurement significance in the 20-P2-229 liver transplantation patients Junko Fujii 1, Hideyuki Saito 1, Lake Aso Katsuhiro 2, 猪股裕紀洋 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2008.

---

	Examination of the utility of 20-P2-230 vancomycin initial administration guidelines Shigeyuki Miyamura, Aya Teramoto, Tomoko Ushijima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2008.

---

About a utility of the monitoring of vancomycin levels out of the cerebrospinal fluid for 20-P2-231 MRSA meningitis Naomi Hasegawa 1, Yukiko Narumi 1, 岩下佳敬 1, 中尾承司 1, Masako Fukumoto 1, Kimiyoshi Iwasaki 1, Chieko Kawahata 1, Yoshimi Yoshikawa 1, Yoshida Nanase 1, Kazuhisa Ishida 1, Osamu Miyanohara 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2008.

---

	Association of a trough blood level of vancomycin in patients with 20-P2-232 advanced age malignant tumor and the pharmacokinetic parameter Shinnichi Sado 1, 2, Yasuhiro Tsuji 1, Akiko Mizoguchi 1, Sone book Emi 1, Masami Murakami 1, Ball Shiro Shima 1, Mound former Kazuhiro 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2008.

---

	20-P2-233 Infusional pharmacokinetic examination of the linezolid in haemodialysis patients 辻泰弘1, 平木洋一2, 溝口晶子1, 佐道紳一1, 曽根本恵美1, 村上優美1, 神村英利3, 加留部善晴3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2008.

---

Examination about the ring from blood cyclosporine levels and the side effect in the 20-P2-234 same kind hematopoietic stem cell transplantation Hiromi Yoshida 1, Yutaka Nishikawa 1, Kanako Kawasaki 2, Takashi Kajita 1, Mutsumi Ueda light 1, Eitaro Nakatsuka 1, Fumihiko Nakamura 3, Satoru Koyanagi 2, 大戸茂弘 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2008.

---

	Effect of the aging to give to the carbamazepine pharmacokinetics in patients with 20-P2-235 epilepsy Pond Masayuki Nishi, Masatoshi Sano, Eitaro Nakatsuka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2008.

---

	The best case of the refractory ulcerative colitis that a drug blood trough value of the oral 20-P2-236 tacrolimus did not arrive at the appropriate value North Britain person 1, 永野俊玲 1, Tadahiko Kinoshita 2, Tetsuya Ishida 3, Toshiharu Asakura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2008.

---

	Examination about the initial warfarin potassium doses setting which assumed albumin concentrations out of the 20-P2-237 plasma an index Seiji Machida, Toshiaki Tomita, Masaru Fukushima friend, Kazuhisa Masuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2008.

---

	The effect that a system change of the 20-P2-238 blood drug concentration measurement business gives for a hospital income, medical safety management Fumihiko Katagiri, Makoto Inoue, Hiroki Ito, Shoji Takeyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2008.

---

	20-P2-239 Construction of cancer chemotherapy protocol creating and prescription audit system by commercial database software 山本優衣, 林仁子, 石崎真由美, 浅村梨沙, 中田久美, 角紀一郎, 後藤義之, 森戸敏志, 上田和雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2008.

---

	20-P2-240 electronic chart, safety management of the cancer chemotherapy in the order ring system non-induction institution Shuko Yuasa, Appearance tail Ayumi, The next treasure A is rare, Chiaki Taoka, Happiness and prosperity Hitoshi, Yoshiko Azuma, Hatsue Murakami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2008.

---

	20-P2-241 Construction of a system oriented safety management (1) The introduction of departmental systems with the aim of streamlining and standardization of regimen check 椎木芳和, 佐久間悦子, 涌嶋伴之助, 秦英司, 林原正和, 大坪健司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2008.

---

	Action to the in-hospital standardization of the correspondence procedure at shock, the extravasation with the 20-P2-242 anticancer drug Kishimoto truth 1, Kazuyuki Sunada 1, Long ヶ Takuma Hara 1, Yuko Nakamura 2, Fumiko Matsueda 2, Chiyoko Inomata 3, 三阪高春 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2008.

---

	Action to safety management in the 20-P2-243 cancer chemotherapy Sakiko Kurokawa 1, Rina Tabata 2, Eiji Tsutsumi 1, Nobuo Suzuki 1, Yuji Fukuchi 1, Yukimasa Suzuki 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2008.

---

	Action of the safe security in the 20-P2-244 cancer chemotherapy 井上梨恵, Kaori Tanaka, 岡冨亜紀, Noriko Iki, Hironobu Kodama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2008.

---

Combine a regimen management seat with action ... chemotherapy support system to safety management of the cancer chemotherapy in the 20-P2-245 this hospital pharmacy; and ... Joji Mori 1, Kenichi Shimada 2, Ikuyo Toyota 1, Ryuma Sato 1, Kyoko Ohara 1, Keiko Ono 1, Naoko Tosa 1, Tadaaki Ogawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2008.

---

	20-P2-246 pharmacist, attitude survey about the anticancer drug for nurses Maiko Koyama 1, 丘龍祥 3, Nobuyuki Saito 1, Naoki Soma 2, Absence Katsuyuki 2, Rei Oishi children 1, Tadashi Shiraishi 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2008.

---

	Action of anticancer drug preparation duties by the pharmacist in the 20-P2-247 pediatric ward 丘龍祥 1, Maiko Koyama 2, Mountain Masayuki Sawa 3, Mannen Takuya 4, Toshihiro Shida 1, Shinseki Masahiro 1, Shuji Takahashi 1, Tadashi Shiraishi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2008.

---

	Completely conduct action - anticancer drug sterility preparation duties to the cancer chemotherapy systems construction that 20-P2-248 is safe; and - Ground field Mikiko, Nami Matsui, Sakuma Miyuki, 猿谷淳, Yuka Nakano, 向一美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2008.

---

	Development of the 20-P2-249 cancer chemotherapy enforcement confirmation system Yoshihisa Kawakami, 前島光廣, Tomoho Yamada child, Toshika Yoshizawa, Junko Kodaira, Shinobu Yoshizawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2008.

---

Evaluation - of the patients with action - cancer drug control instruction manual of the 20-P2-250 Aichi Hospital Pharmacist Association on koro Gee meeting for the study Pine reason Koji 1, Hiroshi Okado 2, Saori Kato 3, Kushihara Hideyuki 4, 早見知浩 5, Kazuo Hotta 3, Kae Matsuoka 6, Watanabe eyes 7, Manabu Yokota 8, Itakura affinity 9, Kiyohide Takahashi 1, Hiroko Saito 10, Shin Hasegawa plan 11 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2008.

---

	Induction of the protocol check system for 20-P2-251 anticancer drug proper use Naoko Tsuji, Hitomi Kawaguchi, Yasuko Takinami, Small bath Takako, Masaki Manda, Miyuki Miyake, Kaori Ozaki, Keiko Noguchi, Takami Fujii, 野際俊希, Fuminori Matsubara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2008.

---

	Evaluation, examination - of the utility of the action - protocol check sheet for the communalization of the 20-P2-252 protocol information Koji Kashimoto, Chinami Ueno, Yoko Sakai, Masako Imada, 岡冨大輔, Kenichi Sakamoto, Noriko Takaya, Kyoko Sekimoto, Tamotsu Harada virtue Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2008.

---

	Construction of the section system in connection with 20-P2-253 electronic chart Kakinohana Makiko 1, Mikio Tomori 2, Virtue Keiko Mine 3, 勢理客成弘 1, Keiko Tomori 4, Takako Sunakawa 1, Yasuhiko Miyagi 1, Gushiken Koshin 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2008.

---

	It is ... about 20-P2-254 incident, evaluation - duties correspondence to chemotherapy duties judging from data change of the doubt inquiry and the role of the pharmacist Koji Moriya, Shinsuke Akagi, Kenji Nishimura, Ko Tokuda period, Takayanagi sum God Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2008.

---

	Evaluation of the cancer chemotherapy subtype regimen judging from the drug dose per the 20-P2-255 credit hour Hideaki Tokushima 1, Child 1 too rare Mochinaga, Egoe Masayoshi 1, Akiko Emoto 1, Masanobu Tazaki 1, Sawako Doi 2, Kazuhiro Hirano 1, 中野行孝 1, Fujito Expo 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2008.

---

	An effect of the pemetrexed + cisplatin chemotherapy on 20-P2-256 malignant pleural mesothelioma and adverse event Hiroyuki Kuwahara 1, Shizue Okubo 1, Mitsuru Tamura Expo 1, Yoshiyuki Yamauchi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2008.

---

	1 case that effects of the warfarin were reinforced by 20-P2-257 paclitaxel Mountain Masayuki Sawa 1, Yutaka Hattori 1, Flat Hiroyuki 1, Mannen Takuya, 小嶋文良, 丘龍祥, Tadashi Shiraishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2008.

---

	Examination about patients with cancer and fall, the fall in the 20-P2-258 this hospital Junko Hirai 1, Masahiko Tsunoda 1, 熊岸敬晃 1, Kozo Suwa 1, Hideki Mori 1, Etsuko Honda 1, Manager former man 1, Tamie Ishida 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2008.

---

	A change and peripheral neuropathy of the mean cell volume in the 20-P2-259 mFOLFOX6 therapy Yuka Isaka 1, Fumio Itagaki 1, Toshikazu Moriwaki 2, Akira Nakahara 2, 兵頭一之介 2, Masato Honma 1, 2, Koda good luck direct 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2008.

---

	Use investigation of Oxaliplatin for patients with colorectal cancer at the 20-P2-260 renal function degeneracy Ikuko Fukumoto 1, 寺田智祐 2, Toru Hashida 2, Ikuko Yano 2, Kenichi Inui 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2008.

---

	Examination of a use investigation and the proper use of the portable chronofuser in the 20-P2-261 colorectal cancer chemotherapy Yoko Hamaguchi, Tomohiro Miyake, Kyoko Tadokoro, Hiroaki Nagata, Keiki Mori, Manabu Tanimura, Hiroshi Yoshida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2008.

---

	Fact-finding about the planned end time excess in the colorectal cancer chemotherapy (FOLFOX4, FOLFIRI) using the 20-P2-262 transfusion pump 澤柳直樹, Kenichi Nomura, Tomokazu Fujii, Haruhiko Nakamura, 岩瀬定利, Hisashi Kamiya line Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2008.

---

	Examination of the factor affecting the flow of the 20-P2-263 in fuser pump Yoriko Wada, Minako Higuchi, Koichi Matsuo, Yoshimi Sasaki, Sanae Iwatsubo, Hiroaki Nishino Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2008.

---

	Comparison between 20-P2-264 metastasis, FOLFOX and administration order of FOLFIRI for recurrent colorectal cancer impossible of excision Aimi Goto 1, 2, Makoto Hosomi 1, 2, Masami Nishihara 1, 瀧内比呂也 2, Hiroshi Tamai 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2008.

---

Onset of side effect in patients with clinical validity and lung cancer of theoretical carboplatin doses based on a 20-P2-265 MDRD type and gynecologic cancer Yuka Tanaka 1, Toshie Matsumoto 2, 吉村知哲 3, Toshiya Nakao 3, Michio Kimura 3, 宇佐美英績 3, Okada sum intellect 3, Tadashi Yasuda 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2008.

---

	Fact-finding of the carboplatin dosage in the 20-P2-266 this hospital Fujiko 1 between the fortune, Mari Takahashi 1, Jun Iwakawa 2, Toshi Yoneta 3, Terahara wise man 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2008.

---

	Examination of the change of the dose by various calculating formulas of carboplatin (CBDCA) in the 20-P2-267 ovarian cancer TC therapy and the effect on hematotoxicity Tomohiro Miyake, Kyoko Tadokoro, Hiroshi Yoshida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2008.

---

	Discussion about neutropenia G3 in the 20-P2-268 CBDCA+WeeklyPTX therapy or more, onset of thrombocytopenia and administration criteria 高橋喜統 1, Yoshimasa Saito 1, Kayoko Yamaguchi 1, Takeo Shimazaki 2, Osamu Niwa 1, Koji Nishio 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2008.

---

	Inspection of the initial dose setting method of the Carboplatin+weekly Paclitaxel combination therapy for the 20-P2-269 non-small cell lung cancer Yoshimasa Saito 1, 成橋和正 3, Yuka Ikeda village 1, Kayoko Yamaguchi 1, 高橋喜統 1, Hijiwara Kazuma 2, Koji Nishio 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2008.

---

	Side effect investigation of the carboplatin +Weekly paclitaxel therapy in patients with 20-P2-270 non-small cell lung cancer Koji Nakao, 藤井広久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2008.

---

	Fundamental researches for appropriate dosages of 20-P2-271 antitumor agents carboplatin 1 rare in Hamada summer, Koharu Fujikawa 1, Ai Inoue 1, 峠越崇範 1, Yasuhiro Kimura 1, Tree flat Kenji 1, Fidelity Takahiro 2, Hisaya Fujiwara 2, Miki Kudo 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2008.

---

	Examination of the hematotoxicity with the platinum + gemcitabine combination therapy for the 20-P2-272 non-small cell lung cancer 計良貴之, Kyohei Mita, Tsuneaki Tanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2008.

---

	Examination of the use of division of the 20-P2-273 anticancer drug vial preparation and the drug cost reduction effect 濱宏仁 1, Manabu Kurokawa 2, Wasaburo Kataoka 3, Toru Hashida 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2008.

---

Economic effect by the adequacy of the injection standard choice in the 20-P2-274 outpatient department cancer chemotherapy Koichi Fukushima, 濱宏仁, Yayoi Tatsumi, Public hilum Noriko, Rice corner Toshihiko, Great sound Mieko, Shozo Tamura, Hirofumi Akase, Flat field Masaki, Toru Hashida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2008.

---

Comparison ... of the onset of taste disturbance situation in each onset of taste disturbance situation first report ... regimen in patients who received 20-P2-275 outpatient department chemotherapy Shiho Sugawara 1, Norio Takimoto 1, Akiko Iida 1, Takashi Sakakibara 1, Kenji Mori 1, Mitsuru Sugiura 1, Keiko Yamamura 2, 足立守 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2008.

---

Effect on quality of life ... of onset of taste disturbance situation second report - taste disturbance in patients who received 20-P2-276 outpatient department chemotherapy Norio Takimoto 1, Shiho Sugawara 1, Akiko Iida 1, Takashi Sakakibara 1, Kenji Mori 1, Mitsuru Sugiura 1, Keiko Yamamura 2, 足立守 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2008.

---

	Safety assessment by the nutrition index using BMI and Alb of the S-1+CDDP therapy for inability to 20-P2-277 excision, recurrent gastric cancer Michio Kimura, 宇佐美英績, Mina Iwai, Okada sum intellect, Toshiya Nakao, 吉村知哲, Tadashi Yasuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2008.

---

	Examination (2) of the quantity of preparation extraction of the 20-P2-278 docetaxel preparation Tetsuya Sakamoto, 岩瀬利康, Yoshio Ito, Chiaki Koshikawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2008.

---

	It is one patient receiving the tea S one for the 20-P2-279 gastric cancer surgery rejection patients Satoru Tamura 1, Hatakeyama chapter 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2008.

---

The use situation with Mohs paste and the metronidazole ointment for breast cancer that 20-P2-280 skin infiltrated and difference of the effect Kinuyo Matsuda 1, Yoshiyuki Tajima 1, Kaoru Shigeno 1, 閔貴善 1, Yukako Okude 2, Ikuko Abe 2, Kuniyoshi Sato 1, Mitsue Saito 2, Kazuhiro Sase 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2008.

---

Environmental pollution investigation at the 20-P2-281 anticancer drug preparation Yaeko Mishima, Naoko Hashiba, Taeko Saito, 銀杏麻維子, Kazuko Takahashi, Eri Isobe child, Fumi Mukoda, Eriko Hiruta, Naoko Kawashima, Homiki Ushigome, Keiko Sunakawa, Skilled miner Naomi, Aki Kuwahara, Keiko Takano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2008.

---

	About cancer chemotherapy regimen management every patients in the scale hospital out of 20-P2-282 Toshihiro Uenaka, Shuichi Kawashima, Sound Mai Kubo, Mt. Tadashi Maruyama, Hirase friendship, Hisashi Yagi Yoshiko, Oida chapter, Tadashi Doi reason Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2008.

---

	The 20-P2-283 generic anticancer drug is premature; is the inspection of problems by the multicenter questionary survey Hiroshi Nomura British 1, 青山利人 2, Chie Mochizuki 3, Kiyoko Tanimura 4, Setsuko Anan 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2008.

---

Problems of the information about the stability after decomposition, the attenuation of the anticancer drug that the 20-P2-284 healthcare setting is available Noriko Yamashita, Masami Tada, Reiko Muraoka, Mina Yanai, Kuniyoshi Tanaka, Mitsue Shindo, Tsuneo Hamaguchi, Hilum Muneo Hayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2008.

---

	It is the action for anticancer drug preparations in 20-P2-285 this hospital Mihoko Yoshikawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2008.

---

	Relation [the first report] of the present conditions and the pharmacist of the cancer chemotherapy in 20-P2-286 Akita Yoshikazu Koike 1, 5, Manabu Shoji 2, 5, Akiko Harada 3, 5, Higuchi meets; 4, 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2008.

---

Through an action to also accomplish 20-P2-287 cancer chemotherapy appropriately safely, making and the utilization of "the chemotherapy chart" in the digestive cancer treatment Pupil-maru Emi 1, Koji Iwamura 1, Yoshiteru Honda 1, Honda will deferred 3, Naoko Hayashi 2, 3, Nobutomo, Miyanari, Masayuki Watanabe 2, Hiroshi Takamori 2, Hideo Baba 2, Hideyuki Saito 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2008.

---

	Examination about the present conditions of the 20-P2-288 gemcitabine administration Goji Maeda, Hiroshi Sakata, Hiroyuki Matsubara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2008.

---

	Side effect investigation in the methotrexate, epirubicin, nedaplatin combination therapy for the 20-P2-289 progress urothelial carcinoma Hideko Kojima 1, Takashi Ogiwara 1, Katsumi Ishiwatari 1, Yutaka Yamamoto 1, Kazuki Kobayashi 2, Susumu Umemoto 2, Sumio Noguchi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2008.

---

	Pro-evaluation that paid its attention to an administration schedule of the 20-P2-290 breast cancer chemotherapy protocol establishment Eriko Hayashi 1, Tsuyoshi Hirano 2, Masanori Kobayashi 2, Shiro Itagaki 2, Takeshi Iseki 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2008.

---

	Role of the pharmacist in the 20-P2-291 protocol screening committee Masayo Ueno 1, Kentaro Ogata 1, Natsuki Korenaga 3, Kenzo Hida 1, Masako Wakita 1, Yoshihiro Kawahara 1, Seiya Takahira 2, Koji Washiyama 1, Kojiro Nikami 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2008.

---

	Examination - of the weight loss ratio in action (the second report) - cancer chemotherapy of the 20-P2-292 cancer chemotherapy regimen authorization chapter Hiroaki Sakurada 1, Yumiko Oshima 1, Hiroshi Hashimoto 2, Kazuhiko Morita 1, Aoyama Kei daylight 1, Kunio Kitamura 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2008.

---

	Examination of the utility of the anti-androgenic agent alternating therapy for 20-P2-293 relapse prostate cancer Ikuko Ogata 1, Hiroyuki Yamazaki 1, Tomoko Ishizuka 2, Tsuzaki Shoichiro 2, Takashi Ishimatsu 2, Hideo Hirayama 2, Quantity of Seo 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2008.

---

	It is a case with suspected interaction by combination of 20-P2-294 Warfarin and cancer chemotherapy including TS-1 Kazufumi Terui 1, Nao Odagiri 1, Kazuhiro Hosoi 1, Junya Sato 1, Takabata military exploit 2, Early hunting truth 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2008.

---

	An adverse event of the 20-P2-295 Bevacizumab combination therapy and examination of the expression time Boundary Saori, Kazufumi Iwata, Takako Baba, 合澤啓二, Eiko Fukunaga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2008.

---

	20-P2-296 Fact-finding of the hydrochloric acid amrubicin monotherapy in patients with lung cancer 安藤玲子1, 牧野好倫1, 山本昇2, 大江裕一郎2, 國頭英夫2, 関根郁夫2, 軒原浩2, 田村友秀2, 小井土啓一1, 村越功治1, 横手信昭1, 山本弘史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2008.

---

	Behavioral evaluation for peripheral neuropathy in the rat induced by 20-P2-297 oxaliplatin single dose Takeshi Yamamoto 1, Kazunori Kawakami 3, Nobuyuki Katagiri 2, 篠原史憲 1, Iku Utsunomiya 2, Keiko Hoshi 2, Toshihiro Hama 3, Kyoji Taguchi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2008.

---

	About relations with side effect expression and the BMI in the 20-P2-298 chemotherapy Chizuru Arakawa, Tadashi Watanabe, Naomi Sogabe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2008.

---

	Action of the foreign patient compliance instruction for the patient with breast cancer in the 20-P2-299 this hospital Depths Yukiko 1, Hiroshi Arai person 1, 栗原康彰 1, Now Yoichiro 1, Mari Watanabe 1, Makiko Kamata 2, Hiroyuki Suzuki 3, 三村進 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2008.

---

Examination of the alcohol levels (BRAC) change during the exhalation at the 20-P2-300 paclitaxel (PTX) administration Akiko Ban 1, 2, Tatsuya Hisada 2, 牛膓沙織 2, Mayumi Takeuchi 2, Mio Soga 2, Motoaki Ishikawa 2, Hideko Noto 2, Hiroki Arakawa 2, Yumiko Oshima 2, Kan Minako 2, Aimi Oya 2, Shinobu Nakayama 2, Yoshihiro Matsushita 1, Hiroko Saito 2, 3, Shin Hasegawa plan 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2008.

---

	Side effect investigation of postoperative adjuvant chemotherapy THP, C using the pirarubicin in 20-P2-301 breast cancer Tadashi Watanabe 1, Chizuru Arakawa 1, Naomi Sogabe 1, Yasuko Uchida 2, Hiroshi Honda 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2008.

---

	The present conditions of the 20-P2-302 well cancer agent exposure and future problem (the second report) Manabu Tanimura, Kyoko Tadokoro, Hiroaki Nagata, Keiki Mori, Tomohiro Miyake, Yoko Hamaguchi, Noriko Oyake Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2008.

---

Reporting - for prevention of route management - incompatibility at the polypharmacy in patients with 20-P2-303 leukemia Yasushi Aida, Naoko Shibata, Adachi texture to praise, Wakako Murata, Keiko Maruoka, Shiho Takamura, Hiroko Shibata, Yumiko Fukui, Fence tail Naomi, Junko Fujimoto, Kimiko Yasuda, Eiji Fukui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2008.

---

	Effect ... that standardization of the relation (2) - chemotherapy of the pharmacist in 20-P2-304 antineoplastic tumor injection mixed duties gives in doubt inquiry Kazuhisa Tsu Minoru, Tomohiro Otsuki, 佐蔭香織, Toshi Tanaka, Masuo Sato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2008.

---

	Fact-finding about the operational management of the 20-P2-305 cancer chemotherapy regimen Keiko Nikaido, Ishimaru wide knowledge, Kazuhiro Watanabe, Shinji Takayama, Shinano Hiromi, Mitsuru Shiokawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2008.

---

	Action to the cancer chemotherapy that utilized 20-P2-306 electronic chart Kenichi Nomura, Tomokazu Fujii, 澤柳直樹, Haruhiko Nakamura, 岩瀬定利, Hisashi Kamiya line Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2008.

---

Making ... of the patients with 20-P2-307 Aichi on koro Gee meeting for the study brochure based on the side effect analysis of the action ... LEED therapy 森章哉 1, Yayoi Hiraishi 2, Kengo Kimura 3, Sekido Izumi 4, Yuka Tanaka 5, Feather Katsuhiko Oka 6, Satoru Kato next 7, Toru Maeda 8, Hiroyuki Niimi 9, Keiji Mizuno 9, Yoshiaki Ikeda 9 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2008.

---

	For the safer preparation of the 20-P2-308 anticancer drug action - in - this hospital Noriko Okubo, Helmet slope Tomohiro, Osamu Nishida good luck, 尾之江剛樹, Seiichi Sawada, 舛重正人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2008.

---

Relation ... of the pharmacist in action ... inside the hospital chemotherapy authorization nurse of this hospital to provide 20-P2-309 chemotherapy safely 吉田昭昌 1, Emi Tokunaga 1, Aya Shinoda 1, Wakana Furuta 1, Emi Otani 1, Yoshihiro Murashige 1, Hiroko truth size 1, Kazuya Kimura 1, Kazushi Nakazawa beauty 1, Forestry 1, Kazuya Wada 1, Hiroshi Tachibana 1, Kazunobu Teratani 1, Yukio Motomura 3, Yano Izumi 4, Yukiko Kawazoe 4, Yoshiko Miyauchi 4, Morichika Toshiyuki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2008.

---

	Adoption strategy of the 20-P2-310 many standards anticancer drug Hisashi Ono 1, Toshio Awaya 1, Suno study 1, Hitomi Tsuzuki 1, Yasushi Yamashita example 1, Takehiro Yamada 1, Koichi Otaki 1, 2, Yoshikazu Tazaki 1, Kazuo Matsubara 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2008.

---

	Action to cancer chemotherapy regimen management using 20-P2-311 system Sanae Watanabe, Kana Okamura, Koichi Tamai, Mitsuyo Fujiwara, Junko Ono, Junko Deguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2008.

---

	Relation of the pharmacist in the hospitalization chemotherapy of the 20-P2-312 this hospital Satoshi Shinoda, Masae Kubo, Natsuko Tajima, Kazuma Yano, Hiroshi Hashiguchi, Keiichi Goto, Terumi Miyazato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2008.

---

	20-P2-313 Cancer chemotherapy support system using the ordering system is not introduced hospital, regimen by injection indication prescription and Microsoft Access 谷村紀代子, 荻野寿世, 菊井和伸, 高橋利江, 近本珠代, 高見美幸, 小林紀子, 須貝智子, 田中朋子, 高谷伸治, 市川雅美, 八木朝子, 臼井麻衣子, 恩田誠二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2008.

---

	Case who had pemphigus and the CMV enterocolitis paraneoplastic after 20-P2-314 FN treatment Yoko Iwanaga 1, Kentaro Ogata 2, Kojiro Nikami 2, Makoto Takahashi 3, Yoshimi Sasaki 4, 川野昭 5, 清水裕彰 6, Masako Inoue 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2008.

---

	Adverse event analysis of Erlotinib in patients with nonsmall cell lung cancer with a history of the use of 20-P2-315 Gefinib 大橋養賢 1, Kenichi Suzuki 1, Sakurai beauty 1, Kanako Sugimoto 1, Michihiro Shino 1, Toshiaki Takahashi 2, Nobuyuki Yamamoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2008.

---

Chemotherapy - as the unionization team approach in medical care of the action 5-anticancer drug regimen for the cancer chemotherapy adequacy in the 20-P2-316 this hospital Kimiko Nagata 1, Yuka Ito 1, Hiroko Shinoda 1, Lower volost Yumiko 1, Kunihiro Matsuzaki 1, 町島浩 1, Miho Nakamura 3, Koji Ando 4, Tatsuhiro Arai 2, Keiso Masuhara 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2008.

---

	Choice and side effect monitoring of the chemotherapy for patients with 20-P2-317 progressive stomach cancer Truth Rie Hara 1, Mio Takahashi 2, Junichiro Murayama 2, Akihiro Nakamura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2008.

---

	The making of "the diary in the 20-P2-318 cancer chemotherapy of patients" and the use Yoshihiko Sugino 1, Eriko Takeo 1, Akiyo Morita 1, Kimura Kei and 1, 大圓修身 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2008.

---

	About medical cooperation in the nutritional management of the 20-P2-319 cancer terminal patient Yumiko Sato 1, Akemi Kumazawa 2, Kanemitsu Shibata 3, Kazuhiro Ishikawa 4, Koichi Okamoto 4, Shuichi Noma 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2008.

---

	About preparation initiation of the hospitalization chemotherapy in the 20-P2-320 this hospital action - by the team approach in medical care for - smooth use Island Emi 1, 1, Kiyosumi, Hashimoto, Country east connection 1, Shuhei Yasufuku 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2008.

---

Action ... which aimed at the improvement of the quality of the reporting as making of the 20-P2-321 gynecologic cancer chemotherapy brochure and establishment - team of the reporting method Yoshiyuki Goto, The Azuchi greens beauty, Makoto Kurabayashi, Kurumazuka Chiho, 飛澤国広, Kimito Sato, Hiroshi Tamura, Descent from a mountain Koichi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2008.

---

	Effect of treatment prediction of platinum drugs in patients with 20-P2-322 hepatocellular carcinoma Chisato Kitayama 1, Tamotsu Suzuki season 1, Osamu Ito greens 1, Daiya Sakurada 1, Masahiko Sunaga 2, Shoji Yoshikawa 3, 横須賀收 3, Fumio Nomura 4, Noboru Sato example 1, Shiro Ueda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2008.

---

	Application to significance and cancer chemotherapy of the 20-P2-323 urinary Gurkha phosphoric acid measurement Shigeru Morimoto sentence 1, 好田稔規 4, Tomoki Suizu 4, 浦西龍之介 2, Yoshiharu Shono 3, Yoshiichi Fujita 4, Kenji Hasegawa 1, 田伏克惇 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2008.

---

Effect evaluation of the L-asparaginase which assumed an ex vivo ammonia increase level in patients with 20-P2-324 infantile acute lymphocytic leukemia a parameter Shizuka Watanabe 1, 4, Kumiko Miyake 2, 4, Matsumoto fine weather greens 4, Brook 1,000 up world 3, Daisuke Hasegawa 3, Jun Manabe 3, Junko Kitsu 4, Ryota Hosoya 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2008.

---

	Example that gave TS-1 which dissolved by the 20-P2-325 simple suspension method than intestinal fistula, and showed effective blood level change Yukako Yasui 1, Yasuhiro Miyazaki 2, 岸本朋乃 2, Hiroshi Imamura 2, Hiroyuki Yasui 3, Setsuko Anan 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2008.

---

	20-P2-326 Participation of the use situation and the pharmacist of the Erlotinib lock 大神正宏, 谷中敦美, 柳岡利一, 島田匡彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2008.

---

	For the standardization of the procedure of drug intubation administration, the enteral nutrient infusion in our 20-P2-327 medical center Akira Nomura 1, Tomohito Kondo 1, Straight Suiko 2, Kaoruko Katsura 3, Miwako Nakanishi 4, Hikaru Katayama 5, Tatsuya Ueno 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2008.

---

	Making of the intravenous alimentation support map to conduct the nutritional management that 20-P2-328 is appropriate Kiyotaka Omori 1, Nishimoto enthusiast children 1, Yoko Tokuyama 1, Masaaki Hasegawa 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2008.

---

One case that intervened in the present conditions and patients of the 20-P2-329 NST activity with nontuberculous skin acid-fast bacterium disease Mizuho Fukuhara 1, 2, Tomoko Teranishi 1, 2, Shinsaku Kishimoto 1, Toshifumi Fukui 1, Akiko Fujimoto 2, Chie Takagi 2, Akemi Onishi 2, Akishino Tatsuya 2, Kyosuke Ota 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2008.

---

	Role <NST of the pharmacist in the cooperation of the 20-P2-330 team approach in medical care and cooperation> with the pressure sore measures team Ogata Miyuki 1, 2, 3, Kakazu Kayoko 1, 2, 4, Yoshiko Sugiyama 1, 2, 5, Kaori Izumi 1, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2008.

---

	20-P2-331 Involvement of the pharmacist to the NST : That I learned about nutrition 山岡聡江, 河野茉里子, 渋谷文則, 片本吉美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2008.

---

Relation of a nutrition improvement effect and the pharmacist by the 20-P2-332 NST intervention Daisuke Ushijima 1, 2, Akiko Inoue 2, Kaori Shimizu 2, Kazuyo Sato 2, Yoshiaki Ogita 1, 2, Former house Kaori 2, Yoshiki Kawakita 2, Yuriko Miura 2, Tamiko Kotake 2, Reiko Kunisaki 2, Masanori Komatsu 2, Tadashi Yamakawa 2, Osamu Yamaguchi 2, Shinya Hashimoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2008.

---

	Study on weight fluctuation of 20-P2-333 psychoneurologist open ward inpatients 椎崇 1, Kuroda ちか 江 1, Tobita evening period 1, Yoshinobu Sasaki 1, 高橋賢成 1, Hiroko Ishihara 2, Noguchi ball child 2, Yasuo Arai 3, Masaichi Kuroyama 1, Hitoshi Miyaoka 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2008.

---

	20-P2-334 becomes calm, and the half solidity enteral nutrient by the use of agent does not have an influence on the rat growth Yuriko Nimura 1, Yui Ikeda 1, Miho Kawai 1, It is Mizuki 1 eight moves, 森茂彰 1, Yuki Ito 2, Kazunobu Kobayashi 2, 豊田行康 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2008.

---

	Utility of aminoleban EN100g sleep premedication LES in patients with 20-P2-335 cirrhosis and patients with hepatocellular carcinoma Akira Nagayama 3, Masako Kondo 3, Kazumi Morishita 3, Hiroko Miyakawa 2, 天神尊範 1, Noge Ichiro 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2008.

---

	Through the case with the relation sacral region giant pressure sore of the pharmacist as the NST member in the 20-P2-336 Hekinan Municipal Hospital Megumi Suzuki, Hiroyuki Suzuki, Itakura affinity, Minoru Nagata, Masayasu Kitazawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2008.

---

	Examination of the 20-P2-337 NST intervention case Masahiro Maruyama 1, 尾藤弘昌 1, Ippei Nakamura 2, Takeshi Kaneko 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2008.

---

	2 cases that psychological care was the center with 20-P2-338 palliative care unit Junichi Isogai, Shinji Ito, Reiko Konishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2008.

---

	Intervention of the psychological care team to 20-P2-339 regular hospital Shinji Ito, Junichi Isogai, Reiko Konishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2008.

---

	Invention in the electronic chart use with the 20-P2-340 psychological care team establishment Satoko Takeuchi, 大浦冬裕, Koichi Tanabe, Hidenori Kitazawa, Tasuku Takarada oneself child, Shinobu Kuroda, 霜知浩, Yoshinari newly with floor, Yasuko Tanada, Murakami wish Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2008.

---

	The manufacture of the preparation for 20-P2-341 xerostomia and the evaluation Yoshimi Otsuka 1, It is still 2 Matsunaga, Satoko Fujiwara 2, Hidenori Sagara 3, Kohei Kitagawa 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2008.

---

	As a member of the 20-P2-342 - eating, deglutition team the action to an eating function therapy by ... deglutition manual preparation Fumie Yamada 1, Tomoko Nakajo 2, Eriko Totsuka 3, Kenichi Osone 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2008.

---

Relation of the pharmacist to the 20-P2-343 pressure sore measures team Motoko Minemura 1, Hiroshi Kobayashi original 2, Eiji Suzuki 1, Noriko Machida 1, Yutaka Kubota 1, Yukiko Tsuchiya 1, Taeko Aoki 1, Takuya Furukawa 1, Takeshi Yamabe kernel 1, Kazuhiko Saito 1, Tokuko Shimizu 3, 斎木實 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2008.

---

Relation of the pharmacist to 20-P2-344 HIV infection treatment Country book Yusuke 1, Job field Takashi 1, Keiichi Okahara 1, 片倉道啓 1, Hiroshi Nakata elegant 1, Rev. Noda original 1, Yuko Sasaki 2, There is the most top, and cross it; 2, Yanaka Miyuki 3, Yoshimura Maiko 3, Yutaka Yasui 4, Tei Ishida husband 4, Atsushi Miyamoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2008.

---

Through patient compliance instruction in attitude survey and evaluation - mothers' class of the pregnant woman in the 20-P2-345 pharmacotherapy - Sawako Hosono 1, Maki Sato 2, Yuko Hiraki 1, Hidaka sweetfish beauty 1, Murao south seas child 1, Masakazu Miyachi 1, Iida relationship 1, Tetsuro Yumoto 1, Small well 3, Tomo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2008.

---

Role ... as the pharmacist in action ... team approach in medical care to intravenous flow orchid constant infusion therapy induction in patients with 20-P2-346 pulmonary artery-related pulmonary hypertension History of Sakuragi Kei 1, 杉浦宗敏 1, Miho Sano 2, Yumi Nakamura 2, Shie Ono 2, Hiromi Mori 2, Masaru Hatano 3, Hiroshi Suzuki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2008.

---

	It is weighed HbA1c in a course and the two weeks course for 20-P2-347 diabetes education hospitalization one week Kato Yue Loong 1, Hiroaki Saito 1, Akira Murayama 1, Mitsuru Ota 1, 丹村敏則 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2008.

---

Drug application preparations in anesthesiologist support task - operating room by the 20-P2-348 pharmacist Toshio Awaya 1, Yasushi Yamashita example 1, Twig Masayoshi 1, Koichi Otaki 1, 2, Yuichi Itagaki 1, Kuniko Yamamoto 1, Chieko Hara 1, It is still 1 Masaru Takahashi, Satoshi Ogawa 1, Suno study 1, Hisashi Ono 1, Takehiro Yamada 1, Kaori Koshiro 1, Shinya Iida 1, Inoue Seicho 1, Noriko Umezu 1, 安達知輝 1, Rope river Tomoyuki 1, Hitomi Tsuzuki 1, Seven field Tomomi 1, Hemp lower Tomoka 1, Toshiyuki Miyoshi 1, Kazuo Matsubara 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2008.

---

	Change - of the index of infection, the nutritional management in the result -10 year by 20-P2-349 infection measures team and a nutrient support team and the pressure sore measures team collaboration Yagi providential help 1, Hiroshi Ishii 2, Mie Ito 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2008.

---

	Relation of the pharmacist in the 20-P2-350 breast cancer patients association Tomohito Nakazawa 1, 軽部真粧美 2, Mutsuko Kikuchi 2, Uki law 3, Mikio Shiozawa 4, Megumi Takehara 5, Omoto sum 5, Toshiaki Sudo 1, Yasuo Hozumi 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2008.

---

Analysis of the incident that a nurse in the 20-P2-351 Dokkyo medical college Hospital is involved in 早乙女聡良 1, Tomoaki Toyama 1, Soichiro Nakata 1, 長岡匠 1, Miyoko Horie 1, Satoru Usui 1, Keiko Osodo 1, Yuko Yashiro 2, Kimie Okusa 2, Emi Ueno 2, Junko Oyama 2, Mika Suzuki 2, 後藤浩恵 2, Mitsuharu Omori 1, Yukinori Usui 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2008.

---

Analysis - of the drug information offer contents in action - ICU, the CCU ward to the risk management of the pharmacist in the 20-P2-352 acute phase medical care Takahiro Amemiya, Kazuo Takayama, Chopped burdock root cooked in soy and sesame oil hemp Tamako, Yukari Sankaku, Yuko Nakajima, History of Sakuragi Kei, Katsuyoshi Nakajima, Hiroshi Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2008.

---

	Examination such as drug for household delivery products of the 20-P2-353 emergency cart (emergency cart) Masami Honda 1, 岩瀬利康 1, Chiaki Koshikawa 1, Hisao Matsushima 2, Kazuyuki Ono 2, Hideaki Sakio 2, Kayoko Suzuki 3, Michiko Yoshida 3, Sanae Toyota 3, Shizue Sayama 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2008.

---

	20-P2-354 pharmacist, action to the consciousness improvement for the error of the physician Shuichi Aoyagi, Hiromi Otomo, Jiro Tsuruta Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2008.

---

Improvement of drug control, instruction business processes for the safe reinforcement of the 20-P2-355 pharmacotherapy Masayuki Nishihara 1, Yasuko Harada 1, Masako Yoshikawa 1, Masahiro Yasuhara 1, Akiko Taniguchi 1, Yoshimura eyes 2, Encounter wish person 3, Five disciplines Yukihiko 4, Nobuyoshi Okudaira 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2008.

---

	Present conditions investigation about the 20-P2-356 medical care security Yutaka Fukaya 1, Kenichi Sagawa 1, 4, Toru Hirashima 2, Ryu Kawai beauty 2, 4, Tomiko Katsumura 3, Toshi Shibabe 3, 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2008.

---

	Analysis of background and the applied medicine of the 20-P2-357 fall fall patients Kyoko Obayashi 1, 2, Etsuko Nomoto 1, 3, 廣村佳樹 1, 4, 中嶌広美 1, 3, Yayoi Nagai 1, 5, Masahiko Kurabayashi 1, 7, Yasushi Yamamoto Jiro 2, 6, 野島美久 1, 8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2008.

---

	Revision - of relation - "fall risk reporting book of the pharmacist in the fall accident prevention of 20-P2-358 elderly patients of the drug" Yuko Ishikura, Nao Katayama incense, Foot Hideki Oka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2008.

---

Action ... of the pharmacy about ward supervision of development of the administration support task by the 20-P2-359 ward pharmacist and evaluation - hospitalization prescribed drug Yuki Kobayashi 1, Wakako Nagao 1, Tsuyoshi Katagiri 1, Yasuko Kuriki 1, Akiko Kitano 1, Plum shrine Yumi 1, 平田司 1, Sum Chie Kita 1, Chiho Iwaki 1, Straight Katsumi Shiroyama 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2008.

---

	Analysis of the bringing medicine information for 20-P2-360 medical care security Akiko Emoto, Kazuhiro Hirano, 中野行孝, Fujito Expo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2008.

---

	Examination about the risk by the misconception of the bringing medicine divided into a half lock in the 20-P2-361 medical care security Kazuhiro Hirano, Akiko Emoto, Masanobu Tazaki, 中野行孝, Fujito Expo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2008.

---

	Relation to the risk management of the 20-P2-362 pharmacist Chie Kiryu, Ryohei Suga, Sho Momoi system, Makoto Katsuta, Tomoko Okawa, Person from Kurokawa High School Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2008.

---

	Questionary survey and examination about the medical supplies safety management workshop in the hospital attached to the 20-P2-363 Nippon University Matsudo school of dentistry Yasufumi Komatsuzaki 1, Field point Expo 1, Junko Kitsu 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2008.

---

	20-P2-364 Attempt of sharing of cooperation facilities, including Medicament allergies and side effects printed information 牛島智子, 宮村重幸, 上田奈穂, 森山かおり Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2008.

---

The situation for the evaluation of the disaster manual for patients with 20-P2-365 diabetes and the disaster in medical facilities under Ehime Takeichi Yoshiji 1, Well hilum Keiko 1, Risako Yamashita 1, 末丸克矢 1, Fujiko Ikeda 2, Manabu Amano 3, Jin Machida 3, Hiroaki Miyaoka 4, Haruhiko Osawa 5, Hiroshi Araki positive 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2008.

---

	The activity of medical safety management - medical supplies safety management person in charge in the 20-P2-366 Kochi medical center and future problem Teruo Tanaka 1, Yuki Okazaki 1, 服部暁昌 1, Rieko Matsumoto 2, Akio Takeda 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2008.

---

	Analysis of the factor structure about the safe climate of the 20-P2-367 drugstore Akiko Nakagawa 1, Tokiko Okuda 2, Downhill path static Kei 2, Nobuaki Takahashi 2, Motoyashiki Kayoko 2, Mitsuko Onda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2008.

---

To ward duties expansion in the 20-P2-368 Aichi Medical University Hospital wrestle; questionnaire findings - to a nurse before and after the (1)-pharmacist permanent residence Makoto Nakamura Tsu child, Nozomi Nishida Kushiro, Masanari Hagiwara, Maki Arakawa, Iku Kawamura person, Yukio Toyama, Hiroko Saito, Takaaki Hasegawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2008.

---

To ward duties expansion in the 20-P2-369 Aichi Medical University Hospital wrestle; pharmacist duties - in the (2)-operating room satellite pharmacy Masafumi Onishi 1, Tomoyuki Nonogaki 1, Noriko Sakaida 2, Hiroshi Ito 3, Toru Komatsu 3, Shunsuke Kurono 1, Hiroko Saito 1, Takaaki Hasegawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2008.

---

	To ward duties expansion in the 20-P2-370 Aichi Medical University Hospital wrestle; relation - to the ICU of the (3)-pharmacist Masanari Hagiwara 1, Kato Takahiro 1, Yukio Toyama 1, Tatsuya Muto 1, Hiroko Saito 1, Takaaki Hasegawa 1, Hiroko Ishibashi 2, Hiroshi Noguchi 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2008.

---

To ward duties expansion in the 20-P2-371 Aichi Medical University Hospital wrestle; about administration and TDM of phenobarbital in the (4)-NICU - Saori Kato 1, Tadao Kimura 1, Umaki Kato 1, Kana Ichihashi 1, Yukio Toyama 1, Tatsuya Muto 1, Hiroko Saito 1, Takaaki Hasegawa 1, Daisuke Muto 2, Atsuko Shibata 2, Masahide Nimura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2008.

---

To ward duties expansion in the 20-P2-372 Aichi Medical University Hospital wrestle; blood 5-FU level of (5)-sigmoid colon cancer 1 case - at bevacizumab combination Kazuo Hotta 1, Fumie Abe 1, Masanari Hagiwara 1, Masayuki Ejiri 1, Maki Arakawa 1, Iku Kawamura person 1, Yukio Toyama 1, Tatsuya Muto 1, Hiroko Saito 1, Takaaki Hasegawa 1, Field wave Toshiaki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2008.

---

To ward duties expansion in the 20-P2-373 Aichi Medical University Hospital wrestle, and is associated with use of the chemotherapy by the permanent residence pharmacist in the (6)-this hospital urology department ward; - Maki Arakawa 1, Kazuo Hotta 1, Saori Kato 1, Iku Kawamura person 1, Nozomi Nishida 1, Kushiro, Yukio Toyama 1, Tatsuya Muto 1, Hiroko Saito 1, Takaaki Hasegawa 1, Yoshiaki Yamada 2, Yasuaki Honda 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2008.

---

One - that we wrestled, and a local insulin allergy symptom developed in patients with (7)-type I diabetes mellitus to ward duties expansion in the 20-P2-374 Aichi Medical University Hospital Masayo Tanahashi 1, Tatsuya Muto 1, Yukio Toyama 1, Hiroko Saito 1, Takaaki Hasegawa 1, Koichi Kato 2, Chisato Inagaki 2, Otake cluster 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2008.

---

Medication actual situation - of the children who wrestled, and became clear by a use of (8)-drug situation investigation to ward duties expansion in the 20-P2-375 Aichi Medical University Hospital Sekido Izumi 1, Atsumi Sato 1, Yukio Toyama 1, Tatsuya Muto 1, Hiroko Saito 1, Takaaki Hasegawa 1, Megumi Aoyama 2, 堀壽成 3, Crane Seiji Sawa 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2008.

---

Example - of patients with extensive burns that wrestled, and suffered from administration plan of the (9)-teicoplanin to ward duties expansion in the 20-P2-376 Aichi Medical University Hospital Kato Takahiro 1, Masanari Hagiwara 1, Yukio Toyama 1, Tatsuya Muto 1, Hiroko Saito 1, Takaaki Hasegawa 1, Hiroko Ishibashi 3, Hiroshi Noguchi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2008.

---

1 case - that we wrestled and performed the headache monitoring with the (10)-Beraprost Na timed-release tablet to ward duties expansion in the 20-P2-377 Aichi Medical University Hospital Tomoe Sato 1, There is Nagase, and cross it; 1, Yukio Toyama 1, Tatsuya Muto 1, Hiroko Saito 1, Rika Hasegawa 2, Koji Wakita 2, Takaaki Hasegawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2008.

---

To ward duties expansion in the 20-P2-378 Aichi Medical University Hospital wrestle; (11)-warfarin and enteral feeding and interaction - of the intravenous hyperalimentation There is Nagase, and cross it; 1, Tomoe Sato 1, Yukio Toyama 1, Tatsuya Muto 1, Hiroko Saito 1, Fumitaka Isobe 2, Takaaki Hasegawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2008.

---

To ward duties expansion in the 20-P2-379 Aichi Medical University Hospital wrestle; present conditions investigation - of the painful rate and desensitization rate of patients with (12)-cancer Nozomi Nishida Kushiro, Yukio Toyama, Maki Arakawa, Saori Kato, Moat appearance Kazuo, Tatsuya Muto, Hiroko Saito, Takaaki Hasegawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2008.

---

One - that we wrestled and produced amenorrhea by (13)-docetaxel administration to ward duties expansion in the 20-P2-380 Aichi Medical University Hospital Yumiko Goto 1, Tomomi Funahashi 1, Hino black beauty 1, Hiroaki Kato 1, Forest pre-1, Shibi, Shoko Kinoshita 2, Takaaki Hasegawa 1, Eiji Mihara 3, Masakazu Nita 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2008.

---

To ward duties expansion in the 20-P2-381 Aichi Medical University Hospital wrestle; contribution - of the use situation and the pharmacist of the (14)-fondaparinux Na subcutaneous injection Masayuki Ejiri 1, Makoto Nakamura Tsu child 1, Yukio Toyama 1, Tatsuya Muto 1, Hiroko Saito 1, Morishima farsighted view 2, Shiro Hirose 2, Takaaki Hasegawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2008.

---

It is examination ... from ... laboratory values for the effective medication counseling for 20-P3-401 diabetes and patients with hypercholesterolemia Maki Egawa 1, Yui Ishimaru 1, Maho Doi 2, 石田茂 3, 村川公央 4, Kazuaki Shinomiya 1, 2, Hiromi Kawasaki 3, Sendo Toshiaki 4, Yoshihisa Kitamura 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2008.

---

For the effective medication counseling for 20-P3-402 diabetes and patients with hypercholesterolemia examination - from - disease degree of improvement Yui Ishimaru 1, Maki Egawa 1, Maho Doi 2, 石田茂 3, 村川公央 4, Kazuaki Shinomiya 1, 2, Hiromi Kawasaki 3, Sendo Toshiaki 4, Yoshihisa Kitamura 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2008.

---

	Examination - second report - of the drug which has an influence on the glycemic control of patients with 20-P3-403 diabetes Emiko Asakura 1, 久英男 1, 土屋辰司 2, Kazuko Otsuka 3, 横山道江 4, Yuko Fujiwara 5, Tsukahara sky 5, Tomomi Yoshida 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2008.

---

	Examination tertiary report of the drug which has an influence on the glycemic control of patients with 20-P3-404 diabetes 久英男 1, Emiko Asakura 1, 土屋辰司 2, 横山道江 3, Kazuko Otsuka 4, Yuko Fujiwara 5, Tsukahara sky 5, Tomomi Yoshida 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2008.

---

Examination 1 of the smoking cessation instruction using "the standard manual for smoking cessation treatment" in the 20-P3-405 family drugstore about the physical condition changes of subjects of the smoking cessation instruction: Satoyo Miyata 1, Kozue Shinozaki 1, Shinohara Keisuke 1, 高倉浩臣 1, Asami Matsumoto 1, Murakami truth road 1, Ryuichi Ogawa 2, Makoto Watanabe 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2008.

---

Examination 2 of the smoking cessation instruction using "the standard manual for smoking cessation treatment" in the 20-P3-406 family drugstore about exhalation carbon monoxide densitometry: Asami Matsumoto 1, Kozue Shinozaki 1, Shinohara Keisuke 1, 高倉浩臣 1, Satoyo Miyata 1, Murakami truth road 1, Ryuichi Ogawa 2, Makoto Watanabe 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2008.

---

Follow-up questionary survey of the subjects who received smoking cessation instruction examination 3 of the smoking cessation instruction using "the standard manual for smoking cessation treatment" in the 20-P3-407 family drugstore Murakami truth road 1, Asami Matsumoto 1, Kozue Shinozaki 1, Shinohara Keisuke 1, 高倉浩臣 1, Satoyo Miyata 1, Ryuichi Ogawa 2, Makoto Watanabe 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2008.

---

	Patients questionary survey about 20-P3-408 hypoglycemia Makiko Ogawa, 葛葉守, Reiko Nakano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2008.

---

Effect of the macrolide drugs which gives it to the hydrogen peroxide instruction cell death of 20-P3-409 Calu-3 cells Kusakabe young of sweetfish 1, Rocky mountain books for admonition 2, Keisuke Otsu 2, Yasushi Takahashi soldier 2, Design of turbulent waves Ryosuke 2, Yoshiko Tanbo 2, Eriko Murakami 1, 早勢伸正 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2008.

---

	Examination of the factor which has an influence on the clinical response of 20-P3-410 VCM Junko Ogura, Yasuhiro Nakano, 藤本希久加, Akira Kato example, Rie Kobayashi, Ayumi Ishioka, Wataru Arai, Yuichi Masuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2008.

---

	Utility examination of miglitol in patients with 20-P3-411 type II diabetes mellitus Satsuki Azuma 1, Miwako Watanabe 1, 福井宗憲 1, 弘世貴久 2, Noriyuki Sano 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2008.

---

	Examination of doxazosin for congestive heart failure patients with hypertension of the 20-P3-412 early morning Ayaka Shiozawa 1, Junko Narikawa 2, Hiroshi Tanaka period 2, 小林靖奈 1, Masashi Saito 2, Junichiro Murayama 3, 山元俊憲 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2008.

---

	20-P3-413 Compare on the usefulness of Insulin detemir and Insulin glargine intended for the type 1 diabetes patients 大谷寧次郎, 後藤昌 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2008.

---

	Examination of the fondaparinux administration after the 20-P3-414 total hip replacement enforcement Kazuko Yamanaka 1, Yasuyuki Saeki 1, Ryoko Mori 2, Takuma Yamazaki 3, Furrow well Hiroko 1, Kazumi Kitamura 2, Yuji Yasunaga 3, Yasuhiro Kimura 1, Tree flat Kenji 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2008.

---

	An effect of 20-P3-415 pioglitazone and fact-finding of the side effect expression Akiko Mizoguchi 1, Yukihiro Tsuji 1, Shinnichi Sado 1, Sone book Emi 1, Masami Murakami 1, Naoyuki Hirakata 1, Kazunari Matsumoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2008.

---

	Action of the pharmacist in the 20-P3-416 ITB treatment (intrathecal baclofen therapy) Yumi Yoshida 1, Kyoko Sato 1, Hidekazu Takamatsu 1, Akiji Arikawa 2, Shiro Miyata 2, Shinji Yamashita 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2008.

---

Examination of the simple suspension method application for the 20-P3-417 theophylline controlled release-related tablet Every field Chieko 1, Rika Sasaki 1, Michiko Sakai 1, Taniguchi lawn intellect 1, Haruka Tomita 1, Koji Muto 2, Wataru Takizawa beauty 2, Yukiko Oshiki 2, Kazuyuki Saito 1, Side shop Yoshibumi 1, Etsuko Miyamoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2008.

---

Examination about the proper use of the antimicrobial agent with the 20-P3-418 laparoscope lower cholecystectomy pass Your Ishikawa friend 1, Makoto Hayashi 2, Chiaki Okamoto 1, Hiroshi Hori tree 1, Truth Naoyuki Eda 1, Miwa Yotsumoto 1, Katsuhiko Takano 1, Sanae Fujiko 1, Koji Abe 2, Aspect shrine Koji 2, 黒阪慶幸 3, Teruaki Nakagawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2008.

---

	Genetic factor to influence efficacy of methotrexate in patients with 20-P3-419 articular rheumatism Hideki Hayashi 1, Chihiro Fujimaki 1, 坪井声示 2, 4, Kishi, Daimon, Matsuyama solstice 3-resistant, Kazuyuki Inoue 1, Kunihiko Ito 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2008.

---

	Study on symptom after the inhalational instruction of the 20-P3-420 antiasthmatic drug and patients satisfaction Rina Kishi 1, Yoko Kurata 1, 4, 山田真之亮 1, Masaya Hasegawa 2, Kiyobumi Yamada 2, Toshitaka Nabeshima 5, Yoshinori Hasegawa 3, Hiroaki Kume 3, Yukihiro Noda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2008.

---

	Utility of the lecture about the pharmacotherapy by the pharmacist for the nurse concerned with 20-P3-421 diabetes practice Aki Kubota 1, Eitaro Nakajima 2, 3, Aki Ito male 1, Jiro Nakamura 2, Kiyobumi Yamada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2008.

---

Effect expression of 20-P3-422 warfarin investigation Ito greens wave 1, Ayumu Nozaki 1, 茂木孝裕 1, Tomoko Fujita 1, Satoru Miyamoto seedling 2, Yutaka Muranishi true 2, Makoto Utsunomiya 2, Ryuji Yamamoto 2, Yutaka Mizobuchi 2, Atsushi Funatsu 2, Tsunemi Kotaro 3, 吉井康欣 3, Tomoko Kobayashi 2, Hirokazu Nakanishi 1, Masafumi Morita 3, Enjoji Yoshihisa 2, Shigeru Nakamura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2008.

---

The effect of the proton pump inhibitor on serum phosphorus level in the 20-P3-423 calcium carbonate remedy hemodialysis patient and relations of the genetic polymorphism Kanai A Kei 1, Mt. Hisagi Atsuko 2, Noboru Tazoe 3, 中山眞人 4, Nobuhiko Ikezaki 5, Motoko Tanaka 6, Hideo Hirayama 7, Hirofumi Kai 8, Tsuyoshi Shuto 8, Toru Irie beauty 9, Esaki hsiang tsai child 1, Daisuke Kadowaki 1, Sumio Hirata 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2008.

---

	Heart squama lesion investigation in the 20-P3-424 ergot system dopamine agonist preparation remedy patients Kazunori Yamada 1, Mai Onishi 1, Tomori Mizuguchi 1, Mami Shimakawa 1, Woodcut former 1, Nobuhito Murakami 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2008.

---

	Investigation - of a pain, the itching after spinal anesthesia - cesarean section using 20-P3-425 morphine hydrochloride Yoshie Nomura 1, Akira Takahashi 1, Shuichi Matsumoto 1, Yuichiro Takahashi 2, River fin Ichiro 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2008.

---

	Efficacy for haemodynamic unstable ventricular tachycardia of the preparation for the 20-P3-426 amiodarone hydrochloride IV infusion and the ventricular fibrillation and safe evaluation Jun Hirano, Eri Kinoshita, Morihiro Okada, Kazuhiro Ito, Kazue Sakano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2008.

---

	Patient compliance instruction in relation - proteinuria-positive patients of the pharmacist for the 20-P3-427 CKD prevention and importance - Kana Okumura 1, Toru Maeda 1, Chigusa Kikuchi 1, Atsushi Yoshida Expo 2, 木村和哲 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2008.

---

	Examination about the initial therapy for 20-P3-428 Clostoridium difficile-related diarrhea Mika Kusanagi, Naoko Isoda, Tomomi Mori, Takeshi Morimoto trunk, Upper ability Yuki, Yasushi Osato chapter, Yoshihiko Kida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2008.

---

	The combination of drugs in the HIV treatment in the 20-P3-429 this hospital and investigation examination of the drug change Mariko Arai 1, 斉京明子 1, Hiroyuki Tanaka 1, Ayako Wada 1, Mika Suguro 1, Hajime Matsubara 1, Yoko Takayama 3, Kazuo Yago 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2008.

---

	Meta analysis about an effect and the safe comparison between oral bisphosphonate and raloxifene for patients with 20-P3-430 postmenopausal osteoporosis 高地恵市 1, 2, Ryuichi Ogawa 1, Harumi Takahashi 1, Kazumi Goto 2, Hirotoshi Echizen 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2008.

---

	20-P3-431 benzodiazepine system, analysis using effect on postoperative delirium investigation ;Propensity Score of non-benzodiazepine drugs Yoko Ishiguro, Yasuhiro Miyakawa, Atsumi Nitta, Kiyobumi Yamada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2008.

---

	As relation - hospital pharmacist, diabetes medical treatment instruction person to the use of 20-P3-432 insulin patients - Miho Araki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2008.

---

	20-P3-433 Study of the usefulness of as neuronal differentiation-inducing agent of acute promyelocytic acute leukemia treatment Tamibarotene (Am80) 潮平英郎, 北岡明, 遠城寺宗近, 中島学 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2008.

---

	Quantity of Warfarin stability to predict from an INR rate of change in 20-P3-434 early stage 蝦名範嗣 1, Naoko Fujita 1, Yuki Kimura 1, Metoki Norifumi 2, 齊藤元太 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2008.

---

	Examination about the evaluation of the glycemic control in the treatment with 20-P3-435 oral hypoglycemics Kazuo Hattori 1, Takahashi greens child 2, Akihiko Ito 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2008.

---

	20-P3-436 Examination of the clinical response of the darbepoetin alpha 渡部達也, 石崎文子, 中村聡, 鈴木邦弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2008.

---

	20-P3-437 Comparison of the effect of treatment in epoetin alfa and the darbepoetin alpha 渡部優, 石谷麻里子, 関根有貴, 神田侑子, 松井七奈, 久保悠, 小財弘己, 今田深雪 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2008.

---

	The present conditions of 20-P3-438 myocardial infarction secondary prevention guidelines and the prescribed drug Hiromi Nagai, Hiroko Enota, Emi Momiyama, Yoshie Nishiyama, Yoshie Araki, Tomoko Shibata, Kanako Sakashita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2008.

---

	20-P3-439 Efficacy evaluation after Insulin detemir injection introduced in our hospital 船間みさ1, 小幡恵美1, 後藤啓之1, 工藤琢也1, 松田大輔2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2008.

---

	20-P3-440 Study by Basal Insulin change in Basal-Bolus therapy enforcement patient: From NPH Insulin to Insulin detemir 中島啓二1, 西脇加代1, 宇佐美英績1, 安田忠司1, 傍島裕司2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2008.

---

	Investigation about the blood test in patients with 20-P3-441 end stage renal failure and the use drug Tadashi Kitagawa, Takeshi Morimoto trunk, The Yasushi Yokoyama method, Kamiyoshi Noriko, Mika Kusanagi, Chika Sakano, Upper ability Yuki, Yasushi Osato chapter, Yoshihiko Kida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2008.

---

	Glycemic control after the insulin induction when a 20-P3-442 diabetes medical treatment instruction person licensed pharmacist (CDE pharmacist) was concerned Tiger shallows Kazuko 1, Mitsui sincerity fine weather 1, Sumie Fujii 2, Takashi Seta 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2008.

---

	Examination of the effect that 20-P3-443 benidipine hydrochloride gives to various kinds of protein urine excretion of the essential hypertension patients Tetsuya Fujimoto 1, Yoko Matsushita 1, Maiko Machida 1, 武智茂 2, Shigeo Kakigi 3, Koichi Kanda 4, Norikazu Nomura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2008.

---

	The change of the drug choice of the antiHIV therapy in the 20-P3-444 this hospital (ART) Small house Yoshiko 1, Tomomi Sato 1, Maki Sato 1, Tatsuya Goto 1, 諏江裕 1, Toshihiro Ito 3, Isao Sato 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2008.

---

	20-P3-445 A study on the effects of β-Lactglobulin for food allergic gastrointestinal symptoms induced model mouse 大島新司, 小熊良裕, 石井達也, 指田達也, 細谷治, 從二和彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2008.

---

Comparison between complications and lipids management target achievement quotient - secondary prevention case and high-risk primary prevention case - of 20-P3-446 dyslipidemia Ryu Nishiwaki wide 1, Mitsutoshi Sato 1, Fumihiko Yoshie 2, Daisuke Kishi 2, Koji Hamada 2, Keiko Fukuda 2, 雪吹周生 3, Kiyohiko Seino 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2008.

---

	Utility of darbepoetin alfa in anemia in renal disease treatment of the 20-P3-447 hemodialysis patient Chihiro Takatsu 1, 2, Old Taku Kubo 2, Satoshi Izumi 2, Chiharu Matsunaga 2, Negoro early Noriko 2, Maekawa Kiyoshi 3, Tomoyuki Yamakawa 3, Kazuhiko Tanaka 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2008.

---

Collaboration system - with clinical trials -SMO (trial site support organization) of a cancer region in the 20-P3-448 Kochi medical center and the emergency region Katsuya Yoshitani 1, Natsuko Kozaki 1, Okada indigo plant 1, Matsuki sand Wakako 1, Kayoko Okada 1, 服部暁昌 2, Teruo Tanaka 2, Junichi Fukada 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2008.

---

Investigation about examination results at new trial examination in 20-P3-449 many institutions Shinnichi Yokota 1, Yumiko Saito 1, 2, Kioroshi flourishing endlessly 3, Yoshinobu Sasaki 1, 2, Tomomi Nakamura 1, 2, Mizue Shida 1, 2, Mika Maeda 1, 2, Naoko Kamimiya 1, 2, Yukio Ogawa 1, 2, Masaichi Kuroyama 1, 2, Yuji Kumagai 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2008.

---

The present conditions of the trial secretariat duties in the 20-P3-450 clinical trials department and future problem Hajime Yamazaki, Mutsuko Tamura, Naomi Yamamoto, Megumi Harada, Natsumi Matsuda, Hideyuki Hayashi, Hiroko Shigematsu, Tomoyuki Iwasaki, Yoichi Yamamoto, Kazunori Asano, Sako field Saburo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2008.

---

From experience of correspondence - voluntary clinical trials support of the CRC for the 20-P3-451 ethic guideline revision - Mieko Hagiwara 1, Akiko Ito 1, Hiroyasu Sasahara 1, Seiichi Maruyama 1, Atsuko Nagasawa 1, Kumi Yamanaka 1, Yayoi Koyanagi 1, 鈴木由加利 1, Kazuhisa Sasahara 1, 吉澤弘久 1, Hiroshi Sato 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2008.

---

	Support of pharmacist TRC in 20-P3-452 alveolar bone reproduction clinical studies Minako Kawano 1, 2, Nakajima Ikue 1, 3, Kumiko Sumino 1, Kazushi Matsumoto 1, Yosuke Kurokawa 2, Hideaki Kakumu 4, 東條有伸 5, Fumitaka Nagamura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2008.

---

	Safety of medicine evaluation - chemotherapeutic agent - that we saw it from 20-P3-453 clinic dose, an exposure level and a nothing toxic level, an exposure level Arumi Hideto 1, Kazuyuki Saito 2, Shunsuke Ono 3, Hironobu Kodama 4, 中出進 5, Tsuneo Kodama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2008.

---

	The present conditions of the large-scale clinical trials enforcement about the 20-P3-454 circulatory system disease Chiaki Okamoto, Hiroshi Hori tree, Truth Naoyuki Eda, Miwa Yotsumoto, 石川友貴, Katsuhiko Takano, Sanae Fujiko, Teruaki Nakagawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2008.

---

	About the use corresponding to the clinical record seal in the 20-P3-455 electronic chart Keiko Fujita, Noriko Oyama, Yoshihiro Sakagami, Emiko Tanaka, 脇條康哲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2008.

---

The medical communication training using the simulated subjects for the staff engaging in 20-P3-456 trial Mitsuko Morita 1, 川村之則 1, Takashi Suzuki charges 1, Kayoko Uehara 1, Kurita beauty 1, Nae, 1000, Keta Emi 1, Shun Morita 1, Hajime Iijima 2, Kuniaki Fukushima 2, Kenji Chiyoda 2, Southern part sincerity 2, Toshihiko Hiraoka 2, Hiroshi Yamada 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2008.

---

	It is a pharmaceutical evaluation by the clinical judgment analytical procedure an optimal evaluation of the adjuvant endocrine therapy in patients with breast cancer after 20-P3-457 menopause Yoshiko Miyazaki 1, Hisashi Shimizu example 2, 野村久祥 3, Ichiro Arakawa 4, Tadao Inoue 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2008.

---

	Examination about antimicrobial agent costs by the pneumococcal pneumonia clinical path induction in the 20-P3-458 this hospital Mieko Suzuki 1, Upper ability Yuki 1, Yasushi Yokoyama method 1, Yasushi Osato chapter 1, Yoshihiko Kida 1, Yasushi Uryu chapter 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2008.

---

	Examination of the use actual situation of OTC medical supplies during 20-P3-459 pregnancy and the safe information science Bamboo blind Takashi 1, Kudo sheath or 1, Small Asami Noguchi 2, Trimming off Expo 3, Daiya Sakurada 1, Noboru Sato example 2, Shiro Ueda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2008.

---

	Seasonal examination of the INR target value control of the 20-P3-460 Warfarin remedy patients and the bleeding risk Eiji Hatakeyama 1, Yoshiko Kadota 2, Takashi Fukazawa 2, Yoichi Oe 2, Hajime Kagaya 2, Saruwatari power 4, Toru Sato 1, Tomoji Osawa 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2008.

---

	Research about the switching of the selective serotonin reuptake inhibitor (SSRI) using 20-P3-461 medication history data Kazumi Nagai 1, 2, Kunihiko Hayashi 2, Katsunori Nakamura 3, Tatsuya Horiuchi 1, 3, Yasushi Yamamoto Jiro 1, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2008.

---

	Use fact-finding (4) of antihypertensive medications using the medication history data of the 20-P3-462 wish star drugstore Takeshi Honma, Three fossa Kazuo, Toshimi Iizuka, Upper Yamawa road, Masami Horiguchi, Hideo Ishizuka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2008.

---

	Analysis of the returned goods medicine in the 20-P3-463 hospitalization prescription Tomoko Nagata, Hiroko Akasaka, Tajima Keiko, Kenzo Senzaki, Iku Tamura, Kayoko Ihara, Seki Kyoko, Takayuki Mizoguchi, 鹿間良弥, Takashi Inoue solstice, Fukuda Yasuaki, Yukinari Shiraishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2008.

---

	Comparison ... with investigation - medical institution consultation time about the economy of the self-medication with 20-P3-464 OTC medical supplies Shigeru Umeno intellect 1, Mikiro Nakajima 1, Michiko Ueda 2, Nobuya Ueda 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2008.

---

	20-P3-465 type II diabetes mellitus association drug costs and patients background, relations with the control situation Mihoko Tesaki 1, Aya Fujinami 2, Koji Hasegawa 1, 向誠一郎 1, Hitoshi Okugawa 4, Michiko Hayakawa 3, Kenzo Ishihara 5, Mitsuhiro Ota 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2008.

---

	Establishment of the assay with the liquid chromatography tandem mass spectrometer of 20-P3-466 pyrrole - imidazole polyamide Tomoyuki Watanabe 1, Takashi Nagashima 1, Akiko Fukazawa 1, Takahiko Aoyama 1, 上野高浩 2, Noboru Fukuda 3, Hiroki Nagase 3, Yoshiaki Matsumoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2008.

---

	Establishment of the rat biliary level of 20-P3-467 pyrrole - imidazole polyamide assay by the high performance liquid chromatography Akemi Shiotani 1, Takashi Nagashima 1, Akiko Fukazawa 1, Takahiko Aoyama 1, 上野高浩 2, Noboru Fukuda 3, Hiroki Nagase 3, Yoshiaki Matsumoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2008.

---

	Pharmacokinetics of fat-soluble model drug menatetrenone in the 20-P3-468 dyslipidemia rat Kumiko Ueda, Mayumi Yoshida, Maiko Ueda, 吉村善榮, Seigo Iwakawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2008.

---

	Effect of the phenytoin dosing period on instruction of CYP3A and P glycoprotein in 20-P3-469 rat liver and the small intestine 大鳥徹, Asami Oka, Atsushi Kawase, Mitsutaka Takada, Masahiro Iwaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2008.

---

Expression of drug transporter change in the liver of the 20-P3-470 endomorph diabetes model TSOD mouse Toshiyuki Kudo 1, Iori Igarashi 1, Abe Rieko 1, Mariko Yoshizawa 1, Yudai Toda 1, Tsutomu Shimada 2, Wataru Suzuki 2, Igarashi sincerity intellect 1, Kiyomi Ito 1, Oil field Masaki 2, Kiyoshi Sugiyama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2008.

---

	Enterobacterial effect to give to the expression of drug transporter in the 20-P3-471 liver Yudai Toda, Ooi plane, Double cross Shintaro, Tetsuya Ono, Igarashi sincerity intellect, Kiyomi Ito, Kiyoshi Sugiyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2008.

---

	Effect of sex differences on change of the cerebrospinal fluid transitivity of lithium with 20-P3-472 acute renal failure 坂江利恵, Atsuko Ishikawa, Koji Kobayashi, Two sect Tomoko, 合葉哲也, Hiromi Kawasaki, Yuji Kurosaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2008.

---

	The specific transportation promotion phenomenon that was observed in transport property analysis of ribavirin using the 20-P3-473 human erythrocyte membrane vesicle Eri Kimura, Hanada existence Utako, Junya Nagai, Positive former Yoshiko, Mikihisa Takano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2008.

---

	20-P3-474 Establish an evaluation system by differentiation single layer membrane model of human choriocarcinoma cell line JEG-3 with the aim of indicators of placental barrier drug permeation 池田賢二, 名徳倫明, 廣谷芳彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2008.

---

	Contribution of the oxidative stress that a plasma protein binding rate of the drug decreases under 20-P3-475 cancer clinical condition Ryo Matsushita 1, Yuya Kondo 2, Shino Hatta 2, Kenichi Miyamoto 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2008.

---

	Pharmacokinetics of Co-enzyme Q10 included in 20-P3-476 new combination software capsules Kunihiro Nitta 1, Hiroyuki Sasagawa 1, Yoko Kubota 2, Koji Kashima 3, Relation next fortune 4, Akihiko Isobe 5, Jin Matsumoto 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2008.

---

Effect of the digestive tract function in the acetaminophen desensitization effect by the 20-P3-477 PK/PD analysis Igarashi sentence 1, Takahiko Aoyama 1, Yumi Koyama 1, Hiroshi Kobayashi 1, Akira Mori 1, Hisashi Oshima 1, Takashi Suzuki 1, Takeshi Kikutani 2, Yoko Oe 3, Yoshiaki Matsumoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2008.

---

Efficacy change - of the pravastatin in consideration of pharmacometrics - circadian rhythm of the dyslipidemia therapeutic drug by the 20-P3-478 PK/PD analysis Takafumi Nagashima 1, Takahiko Aoyama 1, Tomoyuki Watanabe 1, Akemi Shiotani 1, 上野高浩 2, Noboru Fukuda 3, Yoshiaki Matsumoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2008.

---

	Effect to give efficacy and sleep of the 20-P3-479 statin Naoki Okamoto 1, Kazuo Hattori 1, Miyako Azuma 2, Akihiko Ito 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2008.

---

	Absorption change of cyclosporine with the 20-P3-480 digestive symptom Charcoal Masaki 1, Masaru Ota kernel 1, Hiroshi Konishi oneself 1, 2, Nobuo Hoshino 1, 蓑内徳蔵 1, Akira Yamaji 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2008.

---

Relations with a PK parameter and the clinical outcome of 20-P3-481 cyclosporine and the tacrolimus Hiroki Takeuchi 1, Hiroyuki Uchida 1, 5, Tiger stone Riyusuke 3, Kiyoshi Okuyama 3, Konno law of nature 2, Yuki Nakamura 2, Koichiro Hama 2, Hitoshi Iwamoto 2, 葦澤龍人 2, Tadashi Matsuno mischief 2, Toshihiko Hirano 4, 長尾桓 2, 畝崎榮 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2008.

---

	The evaluation of the teicoplanin free drug concentrations in patients with 20-P3-482 hypoalbuminemia and examination of the effect of treatment Hiromi Yanamoto 1, 寺松剛 1, Takeshi Moriguchi 2, Kenichi Matsuda 2, Masahiko Suzuki 1, 花輪剛久 1, Toshio Oguchi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2008.

---

Combination therapy - pharmacokinetics and clinical response - of tacrolimus and mycophenolic acid in 20-P3-483 renal-transplant recipients Valley Kumiko 1, Hiroaki Tanaka 1, Takashi Motoki University 1, Sumio Kimura 1, Kazuko Higuchi 1, Masaki Ninomiya 1, 福岡憲泰 1, Masashi Inui 2, Water pipe 2, Zengyo, 芳地一 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2008.

---

	Effect of the Byakko-ka-ninjin-to which gives it to pharmacokinetics of 20-P3-484 tetracycline and the ciprofloxacin Equal Kotaro 1, Masafumi Onishi 2, Shunsuke Kurono 2, Hiroko Saito 2, Miki Kato 1, Rough sea well Masayuki 1, Takaaki Hasegawa 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2008.

---

Micafungin pharmacokinetics in the febrile neutropenia of patients with 20-P3-485 hematopoietic organ malignant tumor City residence proton 1, Michiyoshi Kumi 1, Yasushi Nakagawa chapter 2, Kenji Suzuki 2, Nobuo Mochizuki 3, Keiko Ono 3, Satoshi Kishino 3, Yasuhiro Saeki 1, Masanobu Odaka 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2008.

---

	Effect to give serum urate concentration of the antiandrogen therapy in 20-P3-486 prostate cancer Kayo Yamashita 1, 川奈部英洋 1, Hatsue Nagakura 1, 山下与企彦 2, Akihiro Oka 2, Maki Kimura 3, Hosoyamada truth 3, Toshiaki Shibazaki 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2008.

---

PK/PD analysis - of action - progress, recurrent colorectal cancer chemotherapy of the 20-P3-487 Aichi Hospital Pharmacist Association on koro Gee meeting for the study Akiko Tsukada 1, 2, Masayuki Ejiri 2, Saza Hideya 2, Atsushi Suzuki 2, Masanari Hagiwara 2, Kazuo Hotta 2, Eiji Yoneyama 2, Hiroko Saito 1, 3, Takaaki Hasegawa 1, Shin Hasegawa plan 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2008.

---

	Comparison between construction and overseas data of the blood level trough value of the blood 20-P3-488 antiHIV medicine levels measurement support system Takeshi Kuwahara 1, 矢倉裕輝 2, 吉野宗宏 2, Katsuya Komori 2, Takuma Shirasaka 3, Sugiura Wataru 4, 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2008.

---

	It is a 1 case of the methyl bromide poisoning by the exposure of the defectiveness cylinder empty can the role of the pharmacist in the 20-P3-489 acute poisoning Hiroko Nomura 1, Kanbara Eicho 2, Noboru Okamura 3, Takahiro Uchida 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2008.

---

	One case of the chronic hemodialysis patients who caused QT prolonged with the 20-P3-490 pilsicainide hydrochloride Katsuji Shimizu 1, Nakano sentence kernel 1, Upper ability Yuki 1, Kanbara Eicho 1, Yasushi Osato chapter 1, Yoshihiko Kida 1, Sumio Hirata 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2008.

---

Bleeding event investigation by the combination of the proton pump inhibitor in the 20-P3-491 warfarin remedy patients Slope sum Sonoko 1, Hideki Hayashi 1, Misa Yoshizawa 1, Eri Sato 1, Masato Horino 1, Kazuyuki Inoue 1, Tashiro Kei straight 2, Midori Kimura 2, 河原崎貴伯 2, Hideaki Moriwaki 4, 秋本剛秀 3, Osamu Doi 4, Kunihiko Ito 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2008.

---

EGFR, K-ras mutation in the gene detection using the SMAP method for 20-P3-492 personalized medicine Yasumasa Mitani 1, 2, 清水公裕 3, 懸川誠一 3, Takuya Araki 4, Yasushi Yamamoto Jiro 4, Nako Hoshika 5, Hideki Takakura 5, Kenji Tatsumi 5, Jun Watanabe 5, Hiroshi Shimada 5, Lezhava Alexander1, Stone Takefumi Tao 1, 2, Taiji Kogo 1, 2, Yoshihide Hayashizaki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2008.

---

	Examination about the association between change and CYP2C19 genetic polymorphism of blood desmethyl clobazam levels by the 20-P3-493 stiripentol combination Sho Noguchi period, Yoshiaki Yamamoto, Nobuyuki Mishima, Yukitoshi Takahashi, Yushi Inoue Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2008.

---

	Case with the genotype of UGT1A1*6/*28 which developed Serious ADR with 20-P3-494 irinotecan and SLCO1B1*15/*15 Hiroshi Takane 1, Katsuyuki Kawamoto 2, 佐々木智啓 3, Kuniaki Moriki 1, Kazuyo Moriki 1, Hiromi Takeuchi 2, Shun Higuchi 3, Ichiro Ieiri 3, Kenji Otsubo 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2008.

---

	Promotion and present conditions ... of role - medicine notebook of the hospital pharmacist in the 20-P3-495 medicine - medicine cooperation Hirokazu Yamashiro, Yusuke Taki, Yoko Osawa, Kusaka Toyoshi, 揚張真利子, Kozue Kurihara, Toshiaki Kitagawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2008.

---

Examination ... of the utility by the induction of the patients with further action ... on admission information communication list of on admission pharmacist duties using 20-P3-496 medicine, medicine cooperation Yusuke Taki, Hirokazu Yamashiro, Yoko Osawa, Kusaka Toyoshi, 揚張真利子, Kozue Kurihara, Toshiaki Kitagawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2008.

---

	Pressure from the 20-P3-497 nation to the "medicine medicine cooperation" practice that we can get trust from and future problem Kimio Yasuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2008.

---

Fact-finding ... which we turned to problem - medicine, the medicine cooperation of the patient compliance instruction of the ethical pharmacy in the 20-P3-498 warfarin outpatient department induction Akiko Horikawa 1, Yoshino name Suiko 1, Masao Oguro 1, Fumiko Mochizuki 2, Iwade Kazunori 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2008.

---

Action aiming at acquisition rate improvement of the medicine notebook in 20-P3-499 medicine, the medicine cooperation Tomoaki Katayama 1, Kyoji Terasawa 1, Jun Okamoto 1, Jun Ota 2, Masami Tanaka 2, Tokuko Matsumoto 3, Beam Seiji 4, Hiroyuki Yuge 5, Kenichi Miyata 2, Tomoko Yamashita 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2008.

---

	Fact-finding of the 20-P3-500 medicine notebook utilization Mikako Senoo, Furrow well Hiroko, Yasuyuki Saeki, Yuka Shibata, Usui Kazuko Sana, We praise snipe Tae law of nature, Ai Inoue, Kajioka Kayo, 児玉優貴, Yasuhiro Kimura, Tree flat Kenji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2008.

---

	Relation of the pharmacist to temporary correspondence at the 20-P3-501 food allergy onset Shinichiro Fukushima 1, Komada indigo plant 1, Yuki Yamamoto 1, Motonori Ito 1, Takeshi Iritani 1, Mizuho Nagao 2, Takao Fujisawa 2, Mitsumasa Iguchi 2, Ihara Toshiaki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2008.

---

About medicine medicine cooperation in the treatment with internal use anticancer drug of 20-P3-502 these days Nomoto incense, 田中政康, Kazuo Komatsubara, It is still a person Tagashira, Yumiko Yamagiwa, Naruoka success, 小暮友毅, Katsuko Mabuchi, Kyoko Miyoshi, Matsuhisa Noriaki, Hisae Eguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2008.

---

	Public - of the pharmacist lecture training specialized in role - cancer of the 20-P3-503 metropolis and districts cancer practice base Hospital Rieko Miyashita, Fumiko Kawahara, Takako Nakano, Haruki Nagai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2008.

---

	20-P3-504 Okayama Hospital Pharmacist Association group method hospital business training trial Takako Oda 1, Hama Yu Tani line 2, Shinji Yamamoto 3, Takashi Hamasaki 4, Chie Miyamoto 5, Daisuke Teshima 6, 増田憲俊 7, Sendo Toshiaki 8, Yoshiyuki Ishii 9 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2008.

---

	About a long-term business training trial in the 20-P3-505 Okayama Hospital Pharmacist Association Muroyama Hideki 1, 7, Yoji Nakajima 2, Morimoto Katsu child 3, 坪井昭 4, Teruko Izawa 5, 増田憲俊 6, 7, Daisuke Teshima 8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2008.

---

	Action of the early on-site training (hospital) in the 20-P3-506 this school Taiko Masao, Katsuyuki Murakami, Ukyo Rieko, Kaori Kido, Takeshi Katsuyama, 齋田哲也, 前田共秀, Keiko Morita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2008.

---

	Action of the 20-P3-507 early stage on-site training "associated welfare university and inconvenient experience that cooperated" Keiko Morita, Taiko Masao, Katsuyuki Murakami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2008.

---

	Action of early on-site training - lifesaving first aid treatment in 20-P3-508 Kyoto Pharmaceutical University and future problem - Tsushima oneself good luck, 深田守, Tetsuo Nakata, Eiju Suzuki, Kazuki Nagasawa, Hiroshi Hamasaki, Masayuki Yamashita, Haruo Kanazawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2008.

---

From the questionary survey before and after the visit to evaluation (the second report) - hospital, drugstore of the early on-site training in 20-P3-509 Kyoto Pharmaceutical University - Eri Yasuda 1, Akira Takayama 1, 2, Tsutomu Hashizume 1, 2, Tsushima oneself good luck 1, 2, Nobuhiko Nakamura 1, Kazuo Kuroda 1, Masahiko Shibakawa 1, Haruo Kanazawa 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2008.

---

	20-P3-510 Analysis of evaluation of PBL Tutorial of implementation and product announcement [pharmaceutically use the medicine] first year 足立哲夫, 寺町ひとみ, 原宏和, 臼井茂之, 神谷哲朗, 葛谷有美, 土屋照雄, 平野和行, 永井博弌 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2008.

---

	The practice of the business training model core curriculum in the 20-P3-511 this hospital and the problems Now Yoshiko Takada, Shinichi Tamiya, Tomohiro Umemura, Tree Masaji, Saza Yaeko, Masashi Nakamura, Ikuro Suzuki, Tomohiko Aoyama, Kenji Tokui, Kazunobu Kobayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2008.

---

	- to use correspondence - information to 20-P3-512 business training model core curriculum definitely Fumiko Nakahara 1, 今田愛也 1, Kaori Honma 1, Mayuko Soma 1, Yoichi Sasaki 1, Akiko Iwakawa 2, Masashi Tomita 2, Mitsuhiro Okazaki 2, Tooru Hayakawa 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2008.

---

	20-P3-513 Aiming to promote PBL Tutorial education to increase the motivation of pharmacy students to be the leaders of the medical 飯田耕太郎, 半谷眞七子, 大津史子, 亀井浩行, 野田幸裕, 後藤伸之, 岡本光美, 森健, 吉田勉, 伊藤達雄, 松葉和久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2008.

---

	Action to "patient compliance instruction" training of the 20-P3-514 business training model core curriculum Hisano Kitayama 1, 2, Hiromi Ogasawara 1, 長堀司 1, Yudai Miyamoto 1, Fumio Nakajima 1, Hisashi Nakajima 1, County 2, Shuutoku Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2008.

---

	Four weeks training - that we adopted action - model core curriculum for the hospital business training for 20-P3-515 long term Miyoko Kurihara, Takayuki Ishimaru, Shinichiro Ando, Kazuaki Yonezawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2008.

---

Grasp - of problems of the curriculum achievement in inspection - training period 2.5 months to achieve 20-P3-516 Hospital business training model core curriculum Osamu Imakiire 1, Yukiko Inoue 2, Hama place Yuko 2, Mari Shuto 2, 安藝敬生 1, Yasushi Kataoka sentence 1, Masaaki Hirakawa 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2008.

---

	Practice of PDCA when we adopt 20-P3-517 model core curriculum for normal business routine Small Hill Akiko to congratulate, Asako Shinozaki, Nagayoshi eyes, Yukie Muroya, Forest 1,000 rice, Kinuyo Matsuda, Yoshiko Harada, Kuniyoshi Sato, Kazuhiro Sase Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2008.

---

	Mental attitude of the pharmacy student for the 20-P3-518 first aid treatment enforcement Takeo Nakamura, Eiji Ito, Tadashi Miyake is elegant, Hiroshi Kuwajima, Etsuko Murakami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2008.

---

Induction of the confirmation of vital signs in the 20-P3-519 bedside training and the pharmaceutical clinical skill Takamura rich person 1, Jin Tokunaga 1, Kenji Ogata 1, Hiroki Yoshida 1, Masashi Nagata 1, 2, Muneaki Hidaka 1, 2, Toshikazu Matsuoka 1, Seiji Ono 1, Ryuichi Yamamoto 1, Kazuhiko Arimori 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2008.

---

As a trial of the communication education to qualitative examination - pharmacy student of the role playing training about the 20-P3-520 informed consent scene - Etsuko Arita 1, 2, Jun Ujihara 2, Akiko Omori 2, Satoko Kamata 2, 東慧子 2, Nishijima incense 2, Masaharu Taga 2, Tatsuya Watanabe 2, Atsushi Yokoyama 1, Kanji Tsuchimoto 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2008.

---

	Construction of the communication education for lower grades pharmacy students to make the 20-P3-521 patients understood 半谷眞七子, Hiroyuki Kamei, Kotaro Iida, Kazuhisa Matsuba Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2008.

---

	Upbringing of the base of the medical person by the participation, practice type communication education in the 20-P3-522 lower grades Yuko Tomita 1, Kato Noriaki 1, Is Kurata; see it; 2, Miwako Kamei 2, Yuji Kiuchi 3, 戸部敞 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2008.

---

Investigation about enforcement of the patient compliance instruction training for 3 annual students in 20-P3-523 Kobe College of Pharmacy and the education effect Yuko Matsuda 1, Yagi Keiko 1, Chikako Numata 2, Yukiyo Nakao 3, Takashi Michigami 4, 長野恭久 4, Akeda Takeshi 5, Mihoko Taniguchi 1, Hiroe Mizutani 1, Toshiko Kiguchi 1, Kensho Emoto 1, Hirai green 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2008.

---

	Consciousness structure analysis of the student to worth doing for the 20-P3-524 patient compliance instruction Yukari Shibata, Akio Kochi, Toshiro Motoya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2008.

---

Evaluation of the quality of activity report - simulated patient (SP) of the 20-P3-525 west area of a castle international university pharmacy school simulation patients association Takashi Tomizawa 1, 2, Mika Ozawa 1, Chika Nakamura 1, 2, Takehira Rieko 1, 2, Hiroshi Kawai 1, 2, Yoshihisa Tomioka 1, 2, Shigeo Yamamura 1, Shinichiro Nakajima 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2008.

---

	It is ... for the medical healthcare worker who learns, and is better than one ... necessary for 20-P3-526 pharmacy student Maki Yamamoto 1, 2, Yokoi fathom sum 1, 2, Masaru Yuguchi 2, Kida sand sound village 2, Yoshihiro Nagai 2, Hiromi Okazaki 3, 名倉弘哲 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2008.

---

	Evaluation for the communication training by the Eiji mixing method in the learning before 20-P3-527 business true taking lessons Teramachi eyes 1, Yumi Kuzutani 1, Tetsuo Adachi 2, Teruo Tsuchiya 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2008.

---

	The on-site training raises motivation for the pharmacy in 20-P3-528 early stage, and help a future course design; or from results of the questionary survey: Toshitaka Nabeshima, Tadashi Taguchi cord, Mitsuyoshi Okamoto, Yukihiro Noda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2008.

---

	Development and practice of the effective method of education in the great lesson type lecture of the 20-P3-529 pharmacy school Tadashi Taguchi cord, Ichitomo Miwa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2008.

---

	Effect of the 1.2 annual on-site training in the 20-P3-530 pharmacist education Noriko Kobayashi, Junko Kitsu, Tadashi Kasahara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2008.

---

	The pharmacy student early stage on-site training that 20-P3-531 Haneshima Municipal Hospital aimed at Keiichi Goto, Suguru Nishimura still, Kazuhiro Asai, Watanabe method man, Eiji Yamamoto, Tadako Ohashi, Kimio Yasuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2008.

---

Based on the questionary survey of the present conditions and the evaluation -1 annual life, institution leader of the early on-site training in 20-P3-532 Tokushima Bunri University - Miki Iguchi, Shono sentence, Masami Tanaka, Shinya Suzuki, Hiroto Kaku, Yoichi Matsunaga, Toshihiro Hashimoto, Masao Toyota, Takashi Kuzuhara, Akemi Umeyama, Yasuyuki Yagi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2008.

---

	Questionary survey to an enforcement system and the student of the early on-site training in the 20-P3-533 Kyushu University pharmacy school Daisuke Kobayashi 1, Tomoko Okada 2, Takao Shimazoe 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2008.

---

	Accept an on-site training in 20-P3-534 early stage; and as a pharmacist of - care health center for the elderly and the general hospital - Rika Tomita 1, Reiko Nakamura 2, Chieko Murayama 2, Katsuhiko Okumura 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2008.

---

	Attitude survey of 2 annual students for the realistic problems in the 20-P3-535 healthcare setting 久岡清子 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2008.

---

	Problem solving type education in the 20-P3-536 Arizona University pharmacy school Jin Nakamura 1, Michael Katz2, Michinao Mizugaki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2008.

---

	The present conditions and expectation second report of the pharmacist function in the 20-P3-537 psychiatrist medical care Akio Fujii, Izumi Machida, Tomoyo Sato, The Inoue third son Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2008.

---

The evaluation by induction and the questionary survey of the voluntary learning support institution "training laboratory" in the 20-P3-538 Showa University pharmacy school The Takahashi Italy Tsu beauty, Mari Kogo, Koji Negoro, Eri Sugiyama flower, Tatsuya Kurihara, Yoshihiro Sano, Kenichi Saguchi, Junichi Mashita, 戸部敞, 山元俊憲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2008.

---

	Attitude survey for the Sino-Japanese traditional medicine of the 20-P3-539 Yokohama pharmacology university student It is the best among Komatsu, Miwako Saito, Toru Iizuka, Narita deferred good luck, Akio Nanba, Masahiro Washimi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2008.

---

	Attitude survey - of the study student for new dietetics - action to unfold for 20-P3-540 pharmacy six years system advanced education 豊田行康 1, Tadashi Takeda kernel 2, South Aki 3, Akira Tamura 3, Yukihiro Noda 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2008.

---

Enforcement of regional alliances program - summer vacation children color color experience school - in 20-P3-541 Kobe College of Pharmacy and evaluation Ikuko Yokoyama 1, Yukiko Nagamine 2, Naoko Tomita 1, Seigo Iwakawa 3, Isao Sugimoto 4, 辰見明俊 1, Takeshi Kotake 1, Masatoshi Sugiyama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2008.

---

	Outlook on ethic found by the pharmacist whom 20-P3-542 pharmacy student recognizes Yokoi fathom sum 1, Maki Yamamoto 1, Hidenori Sagara 2, Takashi Egawa 3, Kazuaki Shinomiya 4, Yoshihisa Kitamura 4, 名倉弘哲 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2008.

---

	Clinic by the active visit of the practice settings for students of 20-P3-543 small number of people Akira Suzuki person 1, Seiji Ono 1, Akira Sakata 1, Shinji Kawamura 2, Nagamachi Shigeki 3, Purple fence Seiya 2, Shozo Tamura 3, Masami Hirai 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2008.

---

	Attitude survey about the harmful effect of the 20-P3-544 pharmacy student Yuka Watanabe, Mountain volost Mayumi, Keiji Kuramoto, Toru Shoji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2008.

---

An action and result of the medical care person GP "participation type learning of Showa University which kept the characteristic of the 20-P3-545 medical care system university alive to realize a utility of the team approach in medical care" Yuji Kiuchi, 戸部敞, Akihiro Nakamura, Takashi Ito, Miwako Kamei, Is Kurata; see it, 山元俊憲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2008.

---

	About the need of the 20-P3-546 hospital pharmacy briefing session through - opening hospital automation pharmacy - Shinji Soeda, Hidemasa Koitabashi, Masayuki Watanabe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2008.

---

20-P3-547 Hokkaido College of Pharmacy medical care person GP "local experience-based type learning and support to bring up clinical competence" Hiroaki Ono, Design of turbulent waves Ryosuke, Tanaka three Eiko, Endo chrysanthemum Taro, Shimamori beauty light, Kenichi Komatsu, Tokumi Mizukami, Hiroshi Yamashita, Jun Takahashi, Koichi Sakurai, Sanae Muraoka, Yoshiko Tanbo, Koji Wada, Hidehiko Sakurai, Kazuhiro Watanabe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2008.

---

	The trial that "we learn about humanism" through 20-P3-548 art Kenichi Tanaka, Akiko Tamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2008.

---

	Practice of the practical pharmacy training that we did on the basis of preparations for lessons by e-learning on the 20-P3-549 Internet Takahiro Nishida 1, Foot Shintaro 1, Junzo Nakamura 1, Hidenori Maruta 2, Hitoshi Suzuki 2, Fujio Kurokawa 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2008.

---

	Conduct the injection compounding of medicines training of the 20-P3-550 pharmacy student Narita deferred good luck, Akio Nanba, Kyoko Sonoda, It is the best among Komatsu, Toru Iizuka, Mayu Araki, Masahiro Washimi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2008.

---

	About - combination impossibility, incompatibility to perform chemistry of 20-P3-551 compounding of medicines - Toshiaki Saito 1, Junichiro Murayama 2, Satoshi Toyama 3, 榛澤雄二 1, Kazuki Kushida 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2008.

---

	Investigation of consciousness and the vaccination history about the vaccination of the 20-P3-552 pharmacy school student Yumiko Komori 1, Mitsuyoshi Okamoto 2, Tatsuo Ito 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2008.

---

	Effect of the pharmacist duties visit by the 20-P3-553 pharmacy teacher Yukio Kishikawa 1, Nobuaki Miyagi 2, Yumiko Konno 1, Jin Nakamura 1, Fuminori Matsubara 2, Setsuo Tsuchiya 2, Michinao Mizugaki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2008.

---

	The penetrance of the company idea judging from consciousness for the lifetime education of the 20-P3-554 new employee and the importance Hideaki Kawanishi, Kazumi Kawamura, Mikio Sakakibara, Satoshi Okada, Keiji Arai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2008.

---

	20-P3-555 we are ... through the instruction (TDM training) to one or the pharmacist by ... pharmacy student who can grow up to where Osaki good luck, 猪川和朗, Kayo Ikeda, Keiko Kameda, Norifumi Morikawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2008.

---

	It is ... for the penetrance to hospital pharmacist duties publicity work - citizen using the 20-P3-556 commercial radio broadcast Hideyuki Nishida 1, Keiji 2 Kim, Yukiko Kawamoto 3, Yoshiro Suzuki 4, Hirai green 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2008.

---

Survey about the duties situation of the drug section under 20-P3-557 Kanagawa Tetsuro Yumoto, Yukino Ayabe, Junichi Iida, Large root Izumi, 岡田樹彦, Tatsuya Kato, Akitoku Kojima, Yoji Shimizu, Tamura harmony, reverence, purity and tranquility, The Hisashi Fujiwara up, Takuya Maeda, Hajime Matsubara, Takeshi Yamaya, Yoshiko Miyazaki, Masahisa Saito, Hajime Kagaya, Masayuki Morita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2008.

---

	Recognition comparison of a pharmacist, the non-medical person about the 20-P3-558 pharmacist function Tomoyo Sato, Izumi Machida, The Inoue third son, Akio Fujii Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2008.

---

	The construction of the personnel evaluation system that aimed at the nature improvement of the 20-P3-559 hospital pharmacist and evaluation one year after the induction Yoshiteru Honda, Hideyuki Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2008.

---

	About the upbringing of the pharmacist who can be active at 20-P3-560 disaster than the experience from <Japan Team for Disaster Relief medical care team workshop> 渡邉暁洋 1, Keiko Fukuda 1, Ayumi Kato 2, Kenji Nishizawa 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2008.

---

	Stare at the activity from the viewpoint of the 20-P3-561 TMAT disaster support activity [Union of Myanmar cyclone disaster] - pharmacist; and ... Haruhiko Sato 1, 2, Kazuyoshi Harano 2, 4, History of Hayata stand 2, 5, Hiromi Sekiguchi 2, Hirotsugu Kita 1, 伊波潔 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2008.

---

	About the setup of the lifesaving first aid support task of the pharmacist in the 20-P3-562 Shimane Prefectural center Hospital 寺西正充, Emiko Takano, Maki Nitta, Sachiyo Nagaoka, Makiko Ishida, Asozu Yuko, Kyohei Yamamoto, Mikiko Imaoka, Katsuki Yokote, Sumiko Goto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2008.

---

What kind of effect did the arts and sciences support task give the practice duties of the physician the new action first report called the 20-P3-563 arts and sciences support pharmacist? Tomoya Asada, Yosuke Oka, Emi Nagao, Mayumi Okazaki, Mitsugu Saegusa, 眞鍋伸次, 森由弘, Thickness well Bunichi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2008.

---

	The new action second report called the 20-P3-564 arts and sciences support pharmacist from the questionary survey for the arts and sciences support task: Mayumi Okazaki 1, Emi Nagao 2, Mitsugu Saegusa 2, Tomoya Asada 1, Shinji Manabe 1, 森由弘 3, Thickness well Bunichi 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2008.

---

	Joint ownership and professional ability appeal ... of action ... fur Matthew tical care practice contents to 20-P3-565 pre-Abo id report system 豊濱隆, 延藤勇, Koji Takai, Yoshinobu Kitao Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2008.

---

	The present conditions and problem of the simple suspension method in our 20-P3-566 corporation 2 institution Makoto Kyono 1, Madoka Ito incense 2, Kikuchi light 2, Teruko Komatsu 2, Yuichi Yoshida 2, Yoshikazu Koike 2, Nobuyuki Sugawara 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2008.

---

	Hypoglycemic action with the 20-P3-567 de novo synthesis thienyl alanine derivative 奥貞佳奈子 1, Rie Murakami 1, Mitsuru Nishida Kyoko 1, 濱邊和歌子 1, Makoto Asada 2, Toku Kitagawa Jiro 2, It is still I 1 Tokuyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2008.

---

	About an action to 20-P3-568 medical supplies safety management Kazuaki Yonezawa, Seiji Fujita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2008.

---

	Quality evaluation about the insoluble particulate matter of 20-P3-569 transfusion line, the injector Yasushi Suenaga 1, Maiko Nakao 2, Hideki Shuto 2, Yasushi Kataoka sentence 2, Osamu Imakiire 2, Masaaki Hirakawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2008.

---

	Inspection - of the drugstore duties efficiency by action - simple SPD induction to drugstore duties efficiency in the cottage-hospital in the 20-P3-570 area 和田匡央, Satoshi Hirota University, Maiko Higuchi, Hiromi Fujimoto, Yumiko Yamashita, Pornographic book Ayumi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2008.

---

	20-P3-571 Medication teaching of anti-epileptic drugs (Depakene (R) R Tablets 200mg) against minnow shifts workers 寺澤知彦1, 加藤隆寛2, 吉田勉1, 伊藤里奈1, 江崎秀樹1, 金田僚子1, 笹野央1, 灘井雅行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2008.

---

Education, the training is necessary for the maintenance improvement of the information security information security of the 20-P3-572 drug department; or - Mitsuru Kaneta Expo 1, Sanae Ida 1, Yasunori Nagano 1, Kazutoshi Terayama 1, 藍澤牧美 1, Satoshi Yamazaki 1, Kaori Saito 1, Tomoko Yamazaki 1, Akio Uchida 2, Junko Kitsu 3, Seko mouth studies 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2008.

---

	It is science and clinical fusion the future when the clinical pharmacy makes it Hitoshi Sasaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 153-153, 2009.

---

	It is neurodegenerative with a physiology of the prion protein Shigeru Katamine Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 157-157, 2009.

---

	For establishment of the true pharmacist professional ability Soichiro Isobe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 158-158, 2009.

---

	A cutting edge of the clinical pharmacy in four-dimensional world with thought: Mitsuru Hashida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 159-159, 2009.

---

	Cancer molecules target medicine and biomarker Kazuto Nishio Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 160-160, 2009.

---

	Today of the chronic liver disease practice Kazuhiko Nakao Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 165-165, 2009.

---

	Circulatory disease and circadian rhythm Koji Maemura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 166-166, 2009.

---

	Study on origin medicine detection of the drug allergy, clinical analysis and expression mechanism Katsuji Uno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 173-173, 2009.

---

	Of the drug economic assessment in the hospital pharmacy, actually Ise Yuya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 174-174, 2009.

---

	A construction and application of scientific grounds for a pharmacist to contribute to inhalation therapy Masashi Sakano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 175-175, 2009.

---

	Pharmacoepidemiologic example and research design Lower temple Minoru Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 179-179, 2009.

---

	Purpose of the seminar Shinko Okuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 180-180, 2009.

---

	Knowledge and point of the author at article contribution and revision to a learned journal The amount of Ariyoshi example Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 181-181, 2009.

---

	From the viewpoint of point - review person to write completeness and a reliable article more - Nobuyuki Goto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 182-182, 2009.

---

	Action - in S1-1 six years system pharmacy education - Hiroshima University Koichiro Ozawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2009.

---

	Construction of the training system educating a guidance-like pharmacist in the S1-2 future Kenji Matsuyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2009.

---

	S1-3 Clinical Practice Guidelines as Markers of Quality in Hospitals Michael A.Oszko1, Tomoji Yoshiyama 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2009.

---

	From the duties of S1-4 days to practical education from the situation of - opening of an office pharmacist - Taizo Nagata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2009.

---

	From the duties of S1-5 days to practical education from the situation of - hospital pharmacist - Hirai green Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2009.

---

	Is S2-1 why CKD a problem? Sumio Hirata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2009.

---

	Pharmacotherapy to do progress of S2-2 CKD slowly Akio Tanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2009.

---

	Drug proper use for complications of S2-3 CKD Motoki Urata, Miyuki Ota Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2009.

---

	A theory and matters that require attention of the pharmacotherapy in S2-4 CKD Old Taku Kubo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2009.

---

	Role - of the pharmacist in the S3-1 safety management general remarks - medical care security Fumito Tsuchiya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2009.

---

	From an administrative viewpoint about S3-2 medical care security Kazuhiko Mori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2009.

---

	Action for the medical care that S3-3 is safe Hiroyuki Kurihara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2009.

---

	Action of the drug industry to S3-4 medical care security Tsutomu Sonoda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2009.

---

	Elucidation of the cancer drug resistance mechanism by the S4-1 fur Mako proteomics analysis Sumio Otsuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2009.

---

	The diagnosis of S4-2 cancer and the use of the transporter activity to treatment 玉井郁巳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2009.

---

	DDS, development of the liposomal preparation to target S4-3 transferrin receptor Kazuo Maruyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2009.

---

	Safety management of the cancer pharmacotherapy that a pharmacist specialized in S4-4 cancer proposes Takuya Iwamoto, Shinko Okuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2009.

---

	S4-5 cancer pain treatment and opioid receptor Tsutomu Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2009.

---

	It is the pharmacist from this S5-PL basic tone lecture Tatsuya Horiuchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2009.

---

	The bedside training of the attack aiming at the improvement of the S5-1 pharmacist technology mainly on skill mixture: Takamura rich person, Jin Tokunaga, Kenji Ogata, Hiroki Yoshida, Nao Setoguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2009.

---

	For the practice of drug duties to learn from the S5-2 patients Tomonori Nakamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2009.

---

	The S5-3 pressure sore measures found likelihood of the pharmacist professional ability It is passed through old Masaru Den Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2009.

---

	We work on the evil that S5-4 psychiatric pharmacotherapy results in with the patients Kimiko Matsuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2009.

---

	To grow, and to make S6-PL participation type business training a certain The Toru Irie beauty Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2009.

---

	For S6-1 long-term business training (from the situation of the drugstore) Yutaka Takahashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2009.

---

	Problem (from the situation of the primarily basic hospital) for the success of the S6-2 pharmacy six years system long-term business training Kazuo Matsubara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2009.

---

	Action to S6-3 Gifu Hospital Pharmacist Association Seino block group type business training Tomoyuki Hosoe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2009.

---

	Term of the S7 organizer Takao Orii1, 2, Katsushi Yamada2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2009.

---

	S7-1 The Role of Hospital Pharmacist in Early-phase Clinical Trials in China Duan Jingli, Zhai Suodi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2009.

---

	S7-2 Pharmacists and Pharmacy Technicians:Looking to the Future of Pharmacy Care in Japan Shiho Yoshioka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2009.

---

	S7-3 The History of Clinical Pharmacy in Korea Wan Gyoon Shin Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2009.

---

	S7-4 Steady-State Pharmacokinetics of Lamivudine in Plasma following Administration of Lamivudine at 300 mg Once Daily and 150 mg Twice Daily in HIV-infected patients Ye Min1, Wang Lu2, Fu Qiang1, Zhu Zhu1, Li Taisheng2, Li Peng1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2009.

---

	S7-5 Training Human Resources to Support Self-Medication An Experiment in Academic-Industrial Collaboration Mitsuko Onda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2009.

---

	S8-PL basic tone lecture is scientific, and it keeps clinic pharmacokinetics information alive for rational medical treatment Hiroyasu Ogata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2009.

---

	S8-1 Prescription support based on a population theory in the neonates medical treatment 湯川榮二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2009.

---

	Practice - of pharmacokinetics theory - pharmacist to make use of in S8-2 clinic being able to do it Toshimi Kimura, Kenichi Sagawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2009.

---

	Around problems -PPI.clopidogrel of the S8-3 CYP2C19 genetic polymorphism - Takahisa Furuta 1, Kazuo Umemura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2009.

---

	Practice of the ward duties that made full use of S8-4 pharmacokinetics 前田頼伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2009.

---

	Patients becoming essential S9-PL basic tone lecture in future in a drugstore, a hospital-centered pharmaceutical care Takatsugu Kimura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2009.

---

	Unification of the pharmaceutical care of S9-1 drugstore, the hospital Tooru Hayakawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2009.

---

	Drugstore duties aiming at the S9-2 patients-centered pharmaceutical care 鹿村恵明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2009.

---

	An evaluation and medication support general for patients in the S9-3 medical treatment sickbed-centered pharmaceutical care - elderly people - 賀勢泰子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2009.

---

	Professional ability expansion aiming at the S9-4 patients-centered pharmaceutical care Is Kurata; see it Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2009.

---

	Drug information necessary for the S9-5 patients-centered pharmaceutical care Mayumi Mochizuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2009.

---

	How to use diabetes remedy which S10-PL basic tone lecture thinks about from pathophysiology 綿田裕孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2009.

---

	Message - from how to use S10-1 oral hypoglycemics - consulting room Yamasaki Hironori 1, 2, Katsumi Eguchi 2, 調漸 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2009.

---

	Take it, and, an oral S10-2 diabetes remedy, fare-thee-well uses insulin definitely definitely; and fare-thee-well. Tiger stone Kenichi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2009.

---

	Approaches from S10-3 opening of an office pharmacist to diabetes Kuniko Shinohara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2009.

---

	Development of the S10-4 diabetes injection Kazutoshi Ninomiya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2009.

---

	It is the next stage of NST in our country S11-PL basic tone lecture Eagle Takahiro Sawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2009.

---

	From point - diet of the S11-1 nutrition care to patients with organ damage - Shinichi Sugiura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2009.

---

	Role of the pharmacist in S11-2 transfusion, the nutritional management Toru Shoji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2009.

---

	Through the scientific evaluation of the nutrition care by the S11-3 pharmacist and nutritional management of suggestion - short bowel syndrome (ileocecal residual ileal 20cm) - Katsuji Hayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2009.

---

	Cooperation with NST practice, the pharmacist as the S11-4 dietitian Noboru Makabe 1, Yasushi Miyazawa 1, Masayuki Chikamori 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2009.

---

	S12-1 Identity of pharmacy : Let's take advantage of the chemical 外山聡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2009.

---

	We understand the function of drug from the structure of the S12-2 drug receptor Masaji Ishiguro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2009.

---

	The example that utilized chemistry about S12-3 drug information offer activity Tazuko Niwano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2009.

---

	We watch S12-4 compounding of medicines and a preparation in chemistry Ichiro Yasuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2009.

---

	Chemical system education to understand medicine in S12-5 pharmacy six years system education essentially Toshiaki Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2009.

---

	Bacteria, the resistant bacteria which is important in S13-1 clinic Tachi field Kazuhiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2009.

---

	Importance of PK-PD theory and the patient compliance instruction in the proper use of the S13-2 antimicrobial agent Kunihiko Morita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2009.

---

	S13-3 disinfectant summary Shigeharu Oie Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2009.

---

	Action for the infection control that S13-4 pharmacist is available for Terumasa Sata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2009.

---

	Large-scale randomized controlled trial "HOMED-BP study" based on S14-1 home blood pressure Takashi Asayama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2009.

---

	The clinical statistics that S14-2 pharmacist should know Chikuma Hamada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2009.

---

	Relation environment, system and pharmacist of clinical studies of S14-3 Japan Shunsuke Ono Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2009.

---

	S14-4 food effect study and pharmacist Yoshinobu Hirayama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2009.

---

	It is the role of lung cancer treatment and the pharmacist S15-PL basic tone lecture Yoichi Nakanishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2009.

---

	Role of treatment and the pharmacist for the S15-1 blood malignant tumor Takuya Fukushima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2009.

---

	Duties development of the pharmacist specialized in a cancer of the S15-2 future Toru Hashida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2009.

---

	It is an action in - Kyoto University hospital pharmacy for the upbringing of the pharmacist specialized in a cancer having high quality of S15-3 寺田智祐, Kazue Takahashi, Kenichi Inui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2009.

---

	Correspondence to a side effect in the S15-4 cancer chemotherapy Pond end Hiroaki, King Suetsugu table, Hiroyuki Watanabe, Uchida まやこ, The Mishima one up, Masanori Sueyasu, Nobuaki Egashira, Ryozo Oishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2009.

---

	It is many types of job cooperation in the at-home (area) medical care S16-1 basic tone lecture Takashi Kodama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2009.

---

	Examine at-home psychological care network - illness in S16-1 Nagasaki, and examine it, and examine it; cooperation and many types of job cooperation - It is full of gray mustaches Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2009.

---

	Many types of job cooperation in the instruction joint at an S16-2 discharge Nakata birth Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2009.

---

	From the cooperation with role - other types of job of a drugstore function and the pharmacist in the promotion of the S16-3 treatment at home - Kazuki Kushida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2009.

---

	Many types of job cooperation - "local project for the psychological care spread" and many types of job cooperation - in the S16-4 at-home (area) medical care Ritsuko Yoshihara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2009.

---

	Just before role - at-home revolution, daybreak of the drugstore in the many types of job cooperation of the S16-5 area - Tetsuji Kawazoe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2009.

---

	It is integrated molecules understanding of "pain" by the comprehensive study the significance of the algorithmic establishment and global pane research of the pharmacotherapy in the palliation medical care S17-PL basic tone lecture Narita year Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2009.

---

	Can speak the scholar of - experimental medicine for life improvement of the patients with the S17-1 palliation medical care Tamotsu Uesono kernel Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2009.

---

For quality of life improvement with the S17-2 palliation medical care from the situation of the doctor at - psychological care team - Shiro Tomiyasu 1, 2, Arata Uchida 2, 3, Akemi Morita 2, 4, Quantity lower Hiroko 2, 4, Tomiko Ogawa 2, 5, Toru Tsujimura 2, 6, Mariko Nakajima 2, 3, 橋口順康 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2009.

---

	To the member of participation in planning from the reporting to the use of S17-3 morphine patients to pain treatment and the psychological care team Michihiro Shino Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2009.

---

	It is managing of a side effect and the interaction from the situation of the S17-4 pharmacist Shiro Katayama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2009.

---

	Knowledge of the EBM that we want to know to understand S17-5 palliation medicine Tatsuya Morita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2009.

---

	The need of the pharmacist intervention in S18-1 schizophrenia treatment 梅田賢太 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2009.

---

	Importance of the pharmacist intervention to the pharmacotherapy in S18-2 mood disorders Hiroko Baba Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2009.

---

	Relation of the pharmacist to patients with S18-3 social anxiety disorder, patients given placebo Tensho era Masami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2009.

---

	About the proper use of the S18-4 psychotropic drug from the viewpoint of drug interactions: Yukihiro Noda, Side Yukari Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2009.

---

	It is a clinic, a diagnosis of AIDS and the research and development of the therapeutic drug S19-PL basic tone lecture Hiroaki Mitsuya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2009.

---

	The present situation of practice and the treatment of S19-1 HIV infection Akira Yasuoka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2009.

---

	Role of the pharmacist in S19-2 HIV infection treatment 吉野宗宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2009.

---

	Support - of the S19-3 sick person - antiHIV medicine medication to stop it without being stopped Kenichi Kojima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2009.

---

	The problems that the S20-1 healthcare setting has Hideki Arima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2009.

---

	Collection of and inflection of the S20-2 evidence Kaori Nomura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2009.

---

	Problems in the ethic in the S20-3 postmarketing surveillance Jun Terada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2009.

---

	What does the S20-4 drug industry demand? West Toshimichi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2009.

---

	What does the S20-5 regulator demand? Kaoru Misawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 241-241, 2009.

---

	The effect that maternal disease during S21-1 pregnancy gives to fetuses Ikuko Yokoo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2009.

---

	A representative drug and effect to use for treatment of the S21-2 complications pregnancy on fetuses Mariko Ishii Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2009.

---

	Growth of a merit and infants of the S21-3 maternal feeding Naoki Ito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2009.

---

	Effect on pharmacotherapy and infants of S21-4 breast-feeding women Teiko Toyoguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2009.

---

	S22-OV Overview:Impact of individualized medicine to pharmaceutical care Vinod P.Shah Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2009.

---

	S22-1 Pharmacogenomic consideration in clinical pharmacokinetics Jin-ding Huang Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2009.

---

	S22-2 Molecular diagnosis for pharmaceutical care Majid Moridani Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2009.

---

	S22-3 Pharmaco-proteomics and metabolomics for personalized medicine Yusuke Tanigawara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2009.

---

	S22-4 Pharmacokinetics and pharmacogenomics in esophageal cancer chemoradiotherapy Toshiyuki Sakaeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2009.

---

	S22-5 Personalised Medicine in 2020 Ross A McKinnon, Michael B Ward, Michael J Sorich Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2009.

---

	S23-PL Plenary Lecture:Genomic medicine Hiroyuki Aburatani Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2009.

---

	S23-1 Pharmacogenetic and biomarkers in oncology Kenji Tamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2009.

---

	S23-2 Imatinib resistance in CML patients Jung Mi Oh Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2009.

---

	S23-3 Molecular imaging of treatment for psychiatric disorder Ryosuke Arakawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2009.

---

	Exposure and NIOSH guidelines with the cosponsorship 1-2 anticancer drug Jin Yoshida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2009.

---

	The change of a preparation procedure with the cosponsorship 1-3 anticancer drug preparation manual revision and the procedure and the commentary 中山季昭, Tadashi Sannomiya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2009.

---

	Prevention of anticancer drug exposure of the cosponsorship 1-4 healthcare worker Reina Nishigaki, Hiroshi Yamamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2009.

---

	About an in paired performance of the cosponsorship 2-1 antihistamine (from the situation of the pharmacist) 大谷道輝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2009.

---

	About an in paired performance of the cosponsorship 2-2 antihistamine (from the situation of the physician) Yuji Kumagai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2009.

---

	Mainly on nephrotoxicity of cosponsorship 2-3 chemical renal failure - cyclosporine - Ken Sakai 1, Kimura Ito period 2, Kan Noriko 2, Aikawa thickness 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2009.

---

	About cosponsorship 2-4 drug-induced hepatic injury Hajime Takikawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2009.

---

	Relation of the pharmacist for patients with infection in O1-001 ICU/CCU Masanari Hagiwara 1, 2, Kato Takahiro 1, Yukio Toyama 1, Tatsuya Muto 1, Hiroko Saito 1, Hiroko Ishibashi 3, Takaaki Hasegawa 1, Hiroshi Noguchi 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2009.

---

	Mainly on use of Linezolid experience - long-term use case and thrombocytopenia in the O1-002 this hospital - Yoshiko Takahashi 1, Yoshio Takesue 1, Mika Ishihara 2, Sumiyo Tatsumi 2, Hilum Muneo Hayashi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2009.

---

Pay attention to the use of antimicrobial agent situation for the O1-003 injection and pro-examination - carbapenem about the drug-resistant Pseudomonas aeruginosa onset antimicrobial agent and imipenem resistance Pseudomonas aeruginosa; and - 藤井宏亮 1, Long Tawa person 1, Yukiko Machida 2, Masato Takamori 1, 瀧澤好廣 1, Akizuki chapter 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2009.

---

	Drug proper use and the problem that we saw from the use situation of the O1-004 carbapenem system antimicrobial agent and change of the pyocyanic drug susceptibility Masaki Kitamura, Long volost Chikako, Junichiro Kato, Kazuhisa Akaishi, Takashi Kawakubo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2009.

---

Evaluation of a construction and the antimicrobial agent proper use of the use registration system of the wide area antimicrobial agent which linked O1-005 Hospital information management system Yuichi Muraki 1, Masaki Tanabe 2, Akiko Nakamura 3, Yoshiko Matsushima 3, Masayuki Senoo 1, Midori Fukuda 2, Shinko Okuda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2009.

---

	It is ... for the effect by the report of use of O1-006 wide area antimicrobial agent presentation criteria change and promotion of the effect - de-escalation therapy Masafumi Ono 1, Mizuho Yoshioka 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2009.

---

An effect and problems of the educational intervention for the antimicrobial agent of carbapenem for the purpose of de-escalation by the O1-007 ICT origin Kosuke Miyoshi 1, Takahiro Muro 1, Yuichi Umeda 1, Shinsuke Takemoto 1, Nakamura right one 2, Hidetoshi Kamimura 3, Yoshiharu Karube 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2009.

---

	The in-hospital influenza outbreak that led to discovery from increase of the number of O1-008 antiinfluenza medicine prescriptions Haruka Watanabe 1, Tetsuya Hayashida 2, Yuko Takaichi 3, Hiroaki Miyaoka 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2009.

---

	Role of the pharmacist in O1-009 new influenza measures Middle bath Shinji, 田中詳二, Toru Hashida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2009.

---

For the upbringing of the hospital pharmacist with the O1-010 specialty trial second report - of the - Nagano Hospital Pharmacist Association Kenji Kiyohara 1, Okazawa incense Tsu child 1, Teruaki Okura 1, Osamu Atobe 1, 1, Kyoshi, Nakayama, Atsushi Miura 1, Hatsutani University child 1, Mitsue Mizutani 1, Masaru Nakajima 1, 六波羅孝 1, Akihiro Tada 2, 白澤吉哲 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2009.

---

1 case that was tied to diagnosis of bowel chalicosis that was a side effect of the magnesium oxide by remedy history confirmation by the O2-001 pharmacist 久保嘉靖 1, Masahiro Okuno 1, Manabu Nakata 1, Koichi Hosomi 1, Masahiro Yoshioka 2, Jun Mimura 2, Eiji Komori 2, Yoshiharu Umetani 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2009.

---

	Examination of O2-002 angiotensin II receptor blocker and the hyperkalemic onset 守内匡, Satomi Asano, Osamu Tanaka, Hiromi Matsui, Yoshimi Matsuda, 高田加壽代 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2009.

---

	Case control study on risk factor of the constipation onset in O2-003 inpatients Tetsuya Ueki 1, 3, Keiko Nagai 1, Sen Oe spring 2, Miho Nakajima child 3, Mikiro Nakajima 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2009.

---

	Examination of the risk factor to be associated with the occurrence of side effect of O2-004 antituberculosis drug Motoaki Nakao, Kensho Tamura, Ken Tachibana, Hidemi Isago Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2009.

---

Examination about the cyclosporine-induced renal failure frequency in the O2-005 hematopoietic stem cell transplantation patients and the factor Takaaki Suzuki, Jin Miyamoto, Chiaki Imai, Koga eyes, Mariko Takeda, Shingo Yamazaki, 仲佐啓詳, Hiroshi Nakamura justice, The amount of Ariyoshi example, Koichi Kitada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2009.

---

	The effect that O2-006 Capsaicin gives in an indomethacin-induced stomach injury model Osamu Nakao incense 1, Hiroko Nosaka 1, Yoshie Inada 1, Mitsuru Naruse 1, Takashi Kato children 2, Yoshio Ijiri 2, Kazuhiko Tanaka 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2009.

---

	Examination of hypersensitivity in the O2-007 amide-type local anesthetic 齊藤幹央 1, Manabu Abe 2, Tomoyasu Furukawa 3, Yagi Motohiro 3, Koike reason Expo 4, Katsuji Uno 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2009.

---

	Fact-finding ... of side effect of O2-008 pharmacist management first report - drug eruption Hashimoto positive 1, 澤部公子 1, Tetsuro Koide 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2009.

---

	caspase-3, -8 in the O2-009 CCl4-induced liver damage, change of -9 Yuka Hattori 1, 定松舞子 1, Hilum Takaaki Hayashi 1, Daisuke Sasaki 1, Mina Takano 1, Takashi Kato children 2, Yoshio Ijiri 2, Kazuhiko Tanaka 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2009.

---

	Examination - of the immunoreactive mechanism by the clinical applied (1)-PHA of RT-PCR in the O2-010 drug allergy Takafumi Nakagawa 1, Katsuji Uno 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2009.

---

	Compliance of antibiotics for the fever at the O3-001 outpatient department chemotherapy Shinya Suzuki, Reiko Matsui, Yoshizo Watanabe, Ichiji Endo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2009.

---

	Simple regimen prescription management using action ... Excel to O3-002 cancer chemotherapy Machiko Hiuga, Takahashi is constipated, Masashi Sasaya, The Senbongi pivot Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2009.

---

	Cancer history of treatment database ... which helps construction ... patients with foreign chemotherapy center support software communication using O3-003 Microsoft Access Tetsuya Katori, Miki Ishioka, Yu Ono, Takuya Shirohata, Takafumi Izumo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2009.

---

	Through 2 drug instruction bone marrow transplantation planned cases to the patients who are strong in anxiety for O3-004 anticancer drug Nobuko Takayanagi 1, Masahiro Okuno 1, Koichi Hosomi 1, Manabu Nakata 1, Yoshiharu Umetani 1, Shizuo Takamiya 2, High cover Toshiro 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2009.

---

	About the difference in dose by a Cockcroft-Gault type and the simple MDRD type at O3-005 carboplatin doses calculation Reiko Yokoyama 1, 2, Yoko Ichikawa 1, Small Ido Keiichi 2, Hiroshi Yamamoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2009.

---

Investigation about the administration postponement in O3-006 breast cancer postoperative preoperative chemotherapy regimen FEC75, FEC100 Toshihiro Uenaka 1, Eri Kashida 1, Sound Mai Kubo 1, Kozo Tatsumi 1, Mt. Tadashi Maruyama 1, Hirase friendship 1, Shuichi Kawashima 1, Shuhei Miyachi 1, Tadashi Doi reason 1, Kayo Enomoto 2, Powder river Yozo 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2009.

---

Search of action progress, the change factor to have an influence on the duration of recurrent colorectal cancer chemotherapy of the O3-007 Aichi Hospital Pharmacist Association on koro Gee meeting for the study Eiji Yoneyama 1, 2, 3, Masayuki Ejiri 2, Akiko Tsukada 2, Kazuo Hotta 2, Masanari Hagiwara 2, Saza Hideya 2, 金正煥 2, Manami Ichiki 2, Hiroko Saito 2, Akio Katsumi 1, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2009.

---

Method ... of trial - fact-finding and the contribution of the information sharing of the foreign chemotherapy patients that utilized O3-008 medicine notebook Shuichi Nawata 1, Takuya Sasaki 1, Nobuko Wada 2, Megumi Miyazaki 1, Yasushi Hamada Funato child 4, Mari Saito 3, 3, Kosugi Iyoko 1, Shinya Hashimoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2009.

---

HPLC of racemate of the O3-009 thalidomide and the optically active substance, development of the blood level assay by LCMS Shoji Fukushima 1, 田中詳二 2, Yoshie Tabata 3, Nakajima truth size 1, Tomoki Hatano 1, Shoko Matsushita 3, Takayuki Takahashi 3, Shuichi Kishimoto 1, Up Kazuko 2, Yukako Morita 2, Inotsume Nobuo 4, Toru Hashida 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2009.

---

	About rearranging, the review of the O3-010 cancer chemotherapy regimen 中村尚未, Mitsue Uno, Shoichi Hotta, Takashi Hiraga, Yaeko Hondo, Toshiharu Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2009.

---

	The likelihood that 6 main ingredients ratio of the O4-001 teicoplanin preparation gives to a clinical response Kayoko Iwamoto, Kuniko Terada, Makiko Doi, Satoshi Yamamoto, Hiroshi Ota, Chizuru Shirokami, 面田恵, 前田頼伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2009.

---

	Control mechanism ... which assumed carbohydrate metabolism control - PKC in the O4-002 skeletal muscle a target Katsuya Narumi 1, Furugen Ayako 1, Megumi Watanabe cloth 1, Masanori Kobayashi 2, Shiro Itagaki 2, Takeshi Iseki 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2009.

---

	Evaluation - with effect - absorption prediction system that O4-003 intragastric pH change gives to pharmacokinetics Yuko Watanabe 1, Naoki Inoue 1, Masanori Kobayashi 2, Shiro Itagaki 2, Takeshi Iseki 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2009.

---

	Pharmacokinetics and proper use of the O4-004 Orr pre-non Takashi Sasaki, Kyoko Fukumoto, Kazuyuki Ueno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2009.

---

	Examination of the cyclosporine proper dosage method in the O4-005 same kind hematopoietic stem cell transplantation Kano sheath or 1, Tomoko Mochizuki 1, 有木宏宗 1, Yuka Ito 1, Mieko Yokoyama 1, Yasuyuki Inoue 2, Yorihisa Miura man 2, Keiso Masuhara 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2009.

---

It is the application to the evaluation of the percutaneous absorption dynamics in patients with cancer the development of the quick assay of the residual quantity out of the matrix type patch of the O4-006 fentanyl Takashina Yoshiaki, Takafumi Naito, Yagi Tatsuya, Keisuke Yamamoto, Maruyama Shuya, Naoto Kanematsu, Junichi Kawakami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2009.

---

	Examination ... using examination - 12-lead electrocardiogram of efficacy at the O4-007 amiodarone administration and the safe predictor Yasushi Takai 1, Yorozu Suzuki law of nature 1, Takeki Kajima 1, Fumiya Uchida 2, Hideo Nishikawa 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2009.

---

	Examination of the standardization of a utility and the initial dose of the TDM enforcement within O4-008 VCM initial administration 24 hours Masaru Kawase period, Yasushi Taniguchi tree, Temple Tai incense, Yoko Kataoka, Masahiko Kitagawa, 成尾千晶, Megumi Yamaguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2009.

---

	Blood level anticipatory examination by the pharmaceutical company analysis software unlike the vancomycin hydrochloride generic medicine for the O4-009 injection The Yasushi Yokoyama method, Upper ability Yuki, Mieko Suzuki, 出羽祐基, Yasushi Osato chapter Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2009.

---

	Use of VCM fact-finding in the O4-010 this hospital Kishi, Matsuzaki, 坂本吉志維, 大槻千遥, Kana Yamazaki, Shuko Watanabe, Yasuko Mizuno, Uchida evening joy, Chiho Murata, Hiroyuki Hayashi, Akio Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2009.

---

	Importance of the reporting of the drug interaction by the active change of O5-001 CYP Yoshiyuki Ono 1, Gutter slope Akihiro 2, Katsuyoshi Nakajima 1, Hiroshi Suzuki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2009.

---

	Application to cyclopedic system (PISCS) to alert in consideration of clinical significance of the drug interaction by the inhibition of O5-002 CYP2C9 Riyo Yamaguchi 1, Yoshiyuki Ono 2, Gutter slope Akihiro 3, Katsuyoshi Nakajima 2, Hitoshi Nakamura 1, Hiroshi Suzuki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2009.

---

	Analysis of the interaction mechanism of O5-003 carvedilol and the amiodarone Yuichi Takahashi, Kyoko Fukumoto, Kazuyuki Ueno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2009.

---

	Pharmacokinetics study of the O5-004 candesartan New shellfish Hiroaki, Kyoko Fukumoto, Kazuyuki Ueno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2009.

---

	Monitoring of the interaction by the combination of O5-005 bosentan and warfarin Kadomura Shota, Tatsuro Fujii, Ayako Kato, Tomoko Suzuki, Sei Suzuki Nako, Mina Takeuchi, Yuko Fukuda, Asano still, Takahiro Shiga, Tatsuya Ito, Takemoto success Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2009.

---

	O5-006 Examination about the interaction of tacrolimus in heart-transplant recipients and Everolimus and carbamazepine 和田恭一1, 坂井美佳1, 野島香織1, 小島久仁子1, 越智浩之1, 岡田博1, 森下秀樹1, 小原延章1, 村田欣洋2, 簗瀬正伸2, 加藤倫子2, 中谷武嗣2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2009.

---

	Action of the resident pharmacist in the O5-007 regular hospital Makoto Tanaka, Shina Sogabe, Kenichi Manabe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2009.

---

	Trial of the pharmaceutical care that adopted the breath sounds auscultation in patients with O5-008 hospitalization asthma Mika Kusanagi, Upper ability Yuki, Friend gold A flower, Yasushi Osato chapter Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2009.

---

The drug application preparations duties in anesthesiologist support task (the second report) - operating room by the O5-009 pharmacist and the evaluation Yuzuru Yamamoto, Kawamorita early period, Seven field Tomomi, Rope river Tomoyuki, Katsuhisa Tahara, Makiko Morita, Kanzaki Ikuyo, Hisashi Ono, Shinya Iida, Suno study, Yasushi Yamashita example, Twig Masayoshi, Satoshi Ogawa, Chieko Hara, Kuniko Yamamoto, Yuichi Itagaki, Toshio Awaya, Toshiyuki Miyoshi, Yoshikazu Tazaki, Kazuo Matsubara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2009.

---

	Comparison ... of the treatment at home in impact - Japan and the United States which the "per Pharmacy" prescription system which became the key to O5-010 treatment at home gave for medical care Takae Tsujimoto 1, 3, Wasa Katsushi 2, Description of Toshi Ito 2, Etsuko Uejima 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2009.

---

	Action for the efficiency of O6-001 on admission bringing medicine differentiation duties Koki Yamashita, Mayumi Kaise, Willow Kimie Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2009.

---

Construction of the drug control system for the purpose of the bringing medicine information communalization in the O6-002 team approach in medical care Tamotsu Terunuma virtue 1, Naoko Miyakawa 1, Masahiro Sugiyama 1, Chinese bridge Katsuhiko 1, Katsumasa Suzuki 1, Oil locus Mami 1, Tomoko Mitsui 1, 荻野訓秀 1, Mihoko Kamihira 1, Yoshihisa Shiraishi 1, Kongoji Satomi 1, Toru Ozeki 1, Kazunari Nakamura 2, 若松伸洋 1, Toshihiro Sasaki 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2009.

---

	Risk aversion and economic effect by the O6-003 bringing medicine control center setting Country original Junichi 1, 2, Tomishima Kosuke 1, Miyake hemp sentence 1, 宮本直冶 1, Yozo Shimizu 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2009.

---

	Application to assay development and a quality study of the food dye out of the food for specified health use by the O6-004 HPLC method Tadashi Okubo 1, 2, Mariko Tanaka 2, 7, Okubo branch 1, Setsuko Okubo 3, Miho Okubo 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2009.

---

	One-year evaluation of the nutrient support team in the O6-005 this hospital Setsuko Tomioka 1, Nao Sato 2, Yasuko Sudo 2, Masaaki Oshita 3, Kodo Shoji 3, Satoshi Nagata 3, Toshiaki Shimizu 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2009.

---

Construction of the rating system of the antiplatelet action with O6-006 aspirin Haruko Yokoyama 1, Naoko Ito 1, Shinji Soeda 2, Kanbayashi bullet 3, Akira Ozaki University 3, Masayuki Watanabe 3, Emiko Kashiwakura 4, Tsutomu Kawada 4, Noriyuki Ikeda 4, Kentaro Tokuoka 5, Yasuhisa Kitagawa 5, Yasuhiko Yamada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2009.

---

	For use of O6-007 new medicine as an action of the pharmacists case report ... of ... pirfenidone Manabe tendon one, Makoto Tanaka, Shina Sogabe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2009.

---

	Meta analysis about the comparison between nicorandil and in efficacy, the safety antianginal drugs for O6-008 stable angina pectoris Yuki Hanai 1, Mitsuo Mita 2, Shigeru Hishinuma 2, Kenji Nishizawa 1, Kan Noriko 1, Shoji A 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2009.

---

	Manual preparation about the use of fitness of radiopharmaceuticals by the O6-009 pharmacist leadership Satomi Niwa 1, 2, Junko Kuroda 1, History of Nasu ear 1, Toshiaki Takeuchi 1, Tetsuo Ezaki 1, Kayo Koike 1, 木村和哲 1, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2009.

---

	O6-010 Skin hydration after the high water containing sheet application 二谷宜靖1, 中島法子2, 新開規弘2, 山内仁史2, 大井一弥3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2009.

---

	A real purpose of use of the O7-001 antiMRSA medicine and chemosensitive investigation Yukako Yasui 1, Tomoko Nishiguchi 1, Kimiko Kawano 1, Yoshihiro Niimi 2, Megumi Fujita 3, Noboru Okamura 3, Setsuko Anan 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2009.

---

	Action for the in-hospital standardization of the use of metronidazole for the O7-002 C.difficile-related enterocolitis, diarrhea Hidechika Ueda 1, Takayuki Inagaki 1, West sinus Masaki 1, Naoki Sakaguchi 1, Tatsuro Wakata 1, Masaru Nishio 2, Shiro Yoshioka 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2009.

---

	Discussion about the O7-003 antiMRSA medicine proper use and report of use presentation rate decrease Hiroshi Hara person, Kurita sentence, Hidetaka Hirano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2009.

---

	An effect of the O7-004 antiinfluenza medicine and examination about the compliance Tiger shallows Kazuko 1, South Kenichi 1, Katsuichiro Kamei 1, West Koichi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2009.

---

	O7-005 Evaluation of validity, efficacy, safety of drug selection in linezolid use 島本裕子1, 富成伸次郎2, 谷口智宏2, 坂東裕基2, 本田芳久1, 山内一恭1, 小森勝也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2009.

---

Use trend of the antimicrobial agent which gives it to resistance of O7-006 Pseudomonas aeruginosa Hiroshi Soeda 1, 3, Akiko Kaneko 1, 3, Inubushi thickness husband 1, Katsumi Chiba 2, 3, Kumi Sato 3, Yumiko Kusama 3, 中村造 3, Naohisa Matsunaga 3, Waist Kimito Hara 3, Tetsuya Matsumoto 3, Takao Akashi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2009.

---

	The effect that enlightenment of the oral antimicrobial agent proper use by O7-007 inside the hospital guidelines gives to chemical sensitivity Tanaka University 1, Suzuko Fukazawa 2, Tomomi Chimura 2, Satoshi Onoda 1, Madoka Kato 1, Yosuke Kawahara 1, Satoshi Mikoshiba Saint 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2009.

---

	Examination using the mixer revolution-type for O7-008 ointment preparation preparation the rotation Takashi Ito kernel 1, Takahiko Kagaya 1, Yuka Hikima 1, Takashi Inoue 2, Kensuke Usui 2, Atsuta Koichiro 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2009.

---

	Difference that O7-009 insurance pharmacist operation investigation - employment form is different and stops by according to sex, the marriage situation Keiichi Nakagome 1, Tortoise shop Toshihiko 2, Katsuhiko Fukai 3, Naoko Yamada 4, Atsushi Sugano 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2009.

---

	Benefit of taking before CABG technique enforcement O7-010 statin Kazuo Nakamura 4, Harunobu Iwase 1, Your Nakamura existence 1, Kaya Hiroko Sono 2, Kazuo Takahama 3, Riyuzo Sakata 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2009.

---

	Association with O7-011 pain and the K channel Takashi Kato children 1, 2, Asuka, Iwamoto, Eiji Kayano 2, Hilum Takaaki Hayashi 2, Bun Takagi virtue 2, Hiroko Nosaka 2, Wakako Miyachi 2, Yoshio Ijiri 1, Kazuhiko Tanaka 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2009.

---

	Action to bringing medicine in the O7-012 Yokohama City University center Hospital Mieko Miyazaki, Osamu Sakamoto, 3, Kosugi Iyoko, Shinya Hashimoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2009.

---

	An on admission bringing medicine information sharing and offer in the O7-013 Kamitsuga General Hospital Akira Nozawa, Seiki Kobayashi, Hisao Saotome Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2009.

---

	It is ... about the association to problems - aging in the O7-014 elderly people pharmacotherapy and a drug and a fall fall Tatsuya Otsubo, Kazumasa Ueda, 野田能成, 小西偉雄, Tadashi Mikami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2009.

---

	Association with the side effect expression of O8-001 high risk UGT1A1 genetic polymorphism and CPT-11 Masahide Onoe 1, 寺田智祐 1, Ikemi Yasuaki 1, 松本繁巳 2, Kazuhiro Yanagihara 2, Kenichi Inui 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2009.

---

	Protective efficacy of rebamipide for stomatitis with the anticancer drug component chemotherapy (breast region) of O8-002 Anthracycline origin Nabeta Izumi 1, Kazuyo Nakamura 1, Midori Kimura 1, 河原崎貴伯 1, Tsuneizumi Michiko 2, Kazuhiko Nakagami 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2009.

---

Pharmacokinetic examination ... by nephrotoxic - TDM with oxaliplatin in patients with O8-003 medium degree renal failure colorectal cancer Kozoe kernel 1, Hiroki Sugishita 2, Shinichi Watanabe 1, 田中亮裕 1, Junko Morioka 1, Yuji Watanabe 2, Kanji Kochi 2, 末丸克矢 1, Hiroshi Araki positive 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2009.

---

Trial of the side effect of bortezomib administration schedule change reduction for the O8-004 multiple myeloma Anna Kubo 1, 2, 3, 福島俊洋 2, Yoshimasa Saito 1, Small Masaru Hori 1, Yu Iwao 2, Akio Nakajima 2, Miyuki Miki 2, Tomoyuki Sakai 2, Shun Sawaki interest 2, Yasushi Masaki 2, Hisashi Umehara example 2, Takeo Shimazaki 3, Hideo Nakajima 3, Motoo Ryoji 3, Koji Nishio 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2009.

---

	Three cases of the multiple myeloma that showed peripheral neuropathy of grade3 by O8-005 bortezomib administration Horiuchi wish 1, 土手賢史 1, Toshiko Aramiya 1, Hirokazu Nakanishi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2009.

---

Examination of the side effect of change predictor of the serum bilirubin level before containing O8-006 hydrochloric acid irinotecan chemotherapy enforcement and two days later Kazumi Watanabe 1, Junko Kitsu 2, Junichi Koike 3, Kimihiko Funabashi 3, Masashi Watanabe 3, 菊池由宣 4, Kenji Nishizawa 1, Kan Noriko 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2009.

---

	Investigation of the G-CSF preparation administration in the O8-007 non-small cell lung cancer docetaxel chemotherapy 村永愛, Shinya Suzuki, Kenji Kawazumi, Reiko Matsui, Yoshizo Watanabe, Ichiji Endo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2009.

---

	Onset of leukopenia factor analysis during O8-008 gemcitabine administration Toshie Matsumoto 1, Hidenori Yokoyama 1, Daisuke Arakawa 1, Seigo Nakayama 1, Megumi Iwasaki Rina 1, Yuki Matsuya 1, Okada sum intellect 2, 吉村知哲 2, Takao Noda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2009.

---

	The onset of prolonged diarrhea situation of CPT-11 by the presence or absence of O8-009 intestinal tract oral alkalinization Kazuaki Kojima 1, Akira Maruyama 1, Miwa Takayuki 1, Relation Tadashi 1, Akihisa Fujimoto 2, 3, Shigeki Uchida 2, 篠置哲 2, Shinobu Araya 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2009.

---

	Three cases of the malignant tumor using the O8-010 low concentration Mohs ointment Yasuko Takemori 1, Takashi Toyota 1, Miho Abe 2, Yoshiko Okiyama 2, 佐藤勘治 2, 餐場伸作 2, Satoshi Kaneko 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2009.

---

	Side effect measures - stomatitis and mouth care - of the O8-011 cancer chemotherapy Iga Kumi, The Takashi Kawamura up Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2009.

---

	Renal function in the O8-012 Nedaplatin administration and evaluation of weight loss criteria Kazuko Kobayashi, Tomohiko Harada, 赤瀬朋秀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2009.

---

Safe examination when we started Erlotinib after having presented with serious liver dysfunction at O8-013 Gefitinib treatment 大橋養賢 1, Kenichi Suzuki 1, Sakurai beauty 1, Yutaka Ishikawa 1, Tomohisa Onishi 1, Michihiro Shino 1, Inner Toriyu dawn 2, Toshiaki Takahashi 2, Nobuyuki Yamamoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2009.

---

	O8-014 Proper use of nausea and vomiting incidence and antiemetic of hepatic artery in the intra-arterial chemotherapy with intra-arterial injection for IA-call 林豊, 小野田千晴, 村松えつ乃 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2009.

---

	About an opioid rotation conversion program using O9-001 HTML Hiroyuki Horiguchi 1, Satoshi Shimizu 1, Kazuhiko Nakayama 1, Sho Shimizu original 1, Takashi Masuno 1, 岩崎英久 1, Takao Kume 1, 桜澤千世 1, Teruo Obata 1, Masayuki Tamura 1, Okoshi Nagashima Hisao 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2009.

---

	Examination about the risk factor of hypocalcemia in O9-002 zoledronic acid hydrate treated patients Miho Hanamura 1, Takuya Iwamoto 2, 澤部公子 1, Shinko Okuda 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2009.

---

	Effective symptom management - with the support tool using construction - electronic chart of the cooperation system between the pharmacists in the O9-003 psychological care region Furukawa order chapter, Furrow Yoshiko, Masahiro Takada, Toshio Tanaka, Kenji Hasegawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2009.

---

	Conduct - questionary survey about the improvement of the regime of the O9-004 cancer chemotherapy; and - Motoi Kurahashi still, Ai Hagiwara, High Ayumu Tachibana, Mariko Inoue, Yukiko Tsukamoto, 小川賀偉 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2009.

---

	Inspection of the anticancer drug administration renal function evaluation by O9-005 eGFR Hiroaki Utsuki, 嘉屋道裕, Tashiro Kei life, Nabeta Izumi, Kimura relationship, Tatsu Sakamoto Ichiro, 河原崎貴伯 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2009.

---

Examination of the tumor singular immunotherapy using O9-006 MAGE-3 peptide pulse dendritic cells Shinji Abe 1, Yasuhiko Nishioka 2, Tree hotel Masatoshi 1, Saori Nakano 1, Your forest Tai 1, Kazuhiko Teraoka 1, Hisatsugi U.S. Toshihide 1, Kazuyoshi Kawazoe 1, 楊河宏章 3, Irahara Minoru 3, Saburo Sone 2, Kazuo Mizuguchi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2009.

---

	Effect of P-gp contributing to O9-007 cancer chemotherapy effect diminishment Kei Kuronuma 1, Masanori Kobayashi 2, Natsuko Takahashi 3, Shiro Itagaki 2, Takeshi Iseki 2, 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2009.

---

	It is ... in reference to future way - nanny state Denmark, Sweden of a drugstore, the pharmacist in the O9-008 treatment at home Hisayuki Kato 1, Yasunori Iijima 2, 岩月進 3, Terawaki University 4, Magabuchi Naoki 5, Yasufumi Terawaki 4, Hiroyuki Sakamaki 6, Toshiro Oda 7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2009.

---

	O9-009 Drug cooperation efforts in our hospital : Toward the uniformity of cancer and palliative medicine 近藤あい, 小林香奈, 野田菜穂子, 足垣亮介, 津田佳子, 平口晴子, 山口貴美子, 山本真世, 宮谷正哉, 勝井靖, 立道直美, 萌抜一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2009.

---

	For the group medication support in the O9-010 medicine, medicine, psychiatry cooperation - area - Ryuichiro Fujiwara 1, Emiko Kageyama 2, Haruyo Ninomiya 3, Chiaki Ueda 4, Mayumi Kamata 5, Koji Ono 5, Ayako Ouchi 5, Ark book jasmin 5, Kenichiro Watanabe 6, Takao Orii 7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2009.

---

	The situation of the evaluation of the disaster manual for patients with O9-011 circulatory disease and the anti-disaster measures in medical facilities under Ehime Takeichi Yoshiji, Junko Morioka, Well hilum Keiko, 末丸克矢, Hiroshi Araki positive Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2009.

---

	Action as the training institution for O9-012 to raise the clinician who became independent Satoko Kimura, Takanobu Sasamoto, Keiji Suda, Chieko Tsukada, Hideo Hamaguchi, Masanori Yarita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2009.

---

Suggestion of the O9-013 business training core curriculum participation type training program corresponding to "contribution to toxicologic medical treatment" Hemp lower Tomoka, Yoshikazu Tazaki, Takehiro Yamada, Koichi Otaki, Hitomi Tsuzuki, Yuzuru Yamamoto, Anna Kobayashi, Inoue Seicho, 安達知輝, Kaori Koshiro, 徳安剛, Masaru Takahashi still, Toshio Awaya, Toshiyuki Miyoshi, Kazuo Matsubara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2009.

---

	National Examination for Pharmacist (93 times, 94 times) that we saw from O9-014 settings pharmacist Megumi Kojima Yoshiko 1, 2, Aya Kawakami beauty 1, Taku Murata 2, Masako Moriya 3, Masada Keiko 4, Harumi Nakano 5, Storehouse former cool air 1, 安冨治長 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2009.

---

	Making of the reporting tool to the physician in the drug administration to O10-001 pregnant woman, nursing mother Suguru Kasahara Castle, Koyasu saliva lawn, Jun Hamada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2009.

---

A trend and effect of the postpartum medication by the change of the clinical path in the O10-002 obstetrics and gynecology department ward Kumiko Okitsu 1, 岩瀬利康 1, Keiko Shinozaki 1, 双樹恵 1, Yoshio Ito 1, Chiaki Koshikawa 1, Kimie Sato 2, Yukiko Horikoshi 2, Kayoko Masubuchi 2, Shizue Sayama 2, Hiroshi Watanabe 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2009.

---

	Examination about the use of hypnosis sedative during O10-003 pregnancy Bamboo blind Takashi 1, Kudo sheath or 1, Kazushi Masuda 2, Eriko Kobayashi 1, Daiya Sakurada 1, Noboru Sato example 2, Shiro Ueda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2009.

---

	Attitude survey of the pharmacist for the checking prescription of O10-004 elderly people Takeshi Miyake sentence, 須山奈見子, Saori Okamoto, Yoko Nakano, Kana Akahori, Otake A tree, Shizuka Takaoka, Ikuko Fukumoto, Takushi Morimoto, Maki Ushijima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2009.

---

	Examination using the rat for the constipation induced by O10-005 hydrochloric acid Seve Lamar Daisuke Kadowaki 1, 2, Misato Nagashima 1, 2, Ayaka Sota 1, 2, Finished river Satomi 1, 2, Mika Kano 1, 2, Sumio Hirata 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2009.

---

Dialysis induction prolonged effect of the erythropoietin in patients with O10-006 conservation period chronic renal failure Ayano Kato 1, Noriko Takeuchi 1, Takenoshita Minoru Eda 1, Hiroaki Tanaka 2, Takayuki Fujii 2, Osamu Suzuki will 2, Eriko Kobayashi 1, Daiya Sakurada 1, Noboru Sato example 1, Shiro Ueda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2009.

---

	About the effect that O10-007 angiotensin receptor blocker gives to the uric acid level Masayuki Hirose, Shigeru Yamada tree, Hiroshi Hozumi, Yuichiro Wada, Yuichi Takemoto, Ayumu Ichimura, Takako Nakajima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2009.

---

	O10-008 Inhibitory effect of factor Xa inhibitor coagulation on cell invasion and proliferation and angiogenesis in the peritoneal fibrosis model at the time of peritoneal dialysis 加藤こずえ1, 北本将幸1, 北村久代1, 上村和秀1, 野垣文昭2, 森典子3, 武田敏也4, 森本達也1, 小野孝彦1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2009.

---

	Role of the ICU/CCU permanent residence pharmacist prospective from O10-009 physician, a nurse Kato Takahiro 1, Masanari Hagiwara 1, Yukio Toyama 1, Tatsuya Muto 1, Hiroko Saito 1, Takaaki Hasegawa 1, Hiroko Ishibashi 2, Hiroshi Noguchi 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2009.

---

	You caught DPC data in the viewpoint of the hospital pharmacist targeted for O10-010 DPC, and how did you work on medical quality, cost? Kumi Nakamura 1, Tetsuya Takei 2, Kazunobu Miyata 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2009.

---

	Safety management using the computing system for patients with O10-011 HIV-positive Burkitt's lymphoma Yu Ito Yoshiko 1, Tomishima Kosuke 1, Country original Junichi 1, Yasushi Arima Kei 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2009.

---

	About the regimen order use situation of the electronic chart in the hospital attached to the O10-012 Oita University School of Medicine 西村文宏, Hiroki Ito, Sato male oneself, Tomohide Abe, Yosuke Suzuki, Shoji Takeyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2009.

---

	Stable examination under the humidification condition of O10-013 meloxicam tablets Takayuki Nagata, Shinichi Yoshikawa, Susumu Yoshida, The Takeshi Nemoto sum, Kazuko Murata, Ryo Murata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2009.

---

	Effective and safe comparison before and after an innovator drug of the O10-014 paclitaxel preparation and the generic article change Kazuo Hotta, Iku Kawamura person, Masafumi Onishi, Yukio Toyama, Tatsuya Muto, Hiroko Saito, Takaaki Hasegawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2009.

---

	From expectation - patients questionnaire results for the pharmacist of the O11-001 psychiatric patient - Shigeru Narui, Takashi Shimano person, Tomoko Nishina, Apology name Junko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2009.

---

	From the use of antipsychotics situation in effect - this hospital of smoking and sex differences to give it to use of O11-002 antipsychotics - Yuko Inoue, Yuki Oda, Noriko Kudo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2009.

---

	Action for the proper use of "the Yokukansan" for the peripheral symptom of O11-003 dementia Michiko Uchiyama, Hideshi Kobayashi, Sayuri Yoshioka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2009.

---

	Action to side effect measures using a check sheet in the O11-004 psychiatry outpatient department 谷藤弘淳 1, Tadashi Matoba 1, Shigeru Inamura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2009.

---

	Relation (contribution to the second report early detection) of the pharmacist to patients with O11-005 dementia Hiroshi Tani child Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2009.

---

Correlation ... with effect on recognition and compliance - psychological test to the side effect of the O11-006 mood disorders zone patients Yasuo Kubota 1, Toshiya Kimura 1, Noriko Watanabe 2, Akemi Osaki 3, Katsuharu Suzuki 2, Kumiko Kasashi 1, Mitsuru Sugawara 4, Tsukasa Koyama 2, Takeshi Iseki 1, 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2009.

---

	Formulation study ... by communalization of the patients with O11-007 mental disorder understanding and the cooperation work with role (the 40th report) ... patients of the pharmacist Satoru Ishida 1, Saso Akio 2, Ayano Sasaki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2009.

---

	The prescription situation of the mood stabilizer in the inpatient with O11-008 schizophrenia Junji Uno, Shinichi Tojo, Miho Nakata, Saeko Yamahata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2009.

---

	Activity report (2) of the pharmacist in the many types of job team approach in medical care in the O11-009 law concerning medical observation It is looked at Atsushi Kawashima, Ito Liao, Takuya Ishida, Shigehiro Taira, Kayoko Kikuchi, Emiko Murata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2009.

---

	About the medication support to the methylphenidate hydrochloride remedy patients in O11-010 AD/HD Makiko Yamazaki 1, Nobuyuki Funato 1, Kuni Tsunemi order 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2009.

---

	One case that the tremor of medicine Hara-related extrapyramidal symptoms relieved by the switching suggestion by the O11-011 pharmacist Yasuyuki Sakamoto 1, Measure taste Noriko 1, Taichi Hara 1, Yoshihiro Sagara 1, Arrow pan Fumio 1, Chiyo Shibazaki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2009.

---

	O11-012 area life support discharge program and the pharmaceutical discussion 杉沢諭 1, Chika Sano 1, Tomohiro Ikeda 2, Kazuhiro Yamamoto 2, Sei Sakamoto 3, Toshiaki Tsuneoka 4, Junko Inamoto 4, 礒嵜育朗 1, Junichiro Murayama 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2009.

---

	Continue the medication self-care instruction with action ... individual treatment characteristics after a discharge to the medication continuation of the O11-013 schizophrenia patient; and ... Hiroko Kito, Kunimi Miki, Cheap high Yuki, Masako Nagayama, 梅崎琴江, Yasumi Ishida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2009.

---

	A pharmacist can be concerned in the collective guidance for trial - discharge of the patient compliance instruction in the comeback to normal life classroom in O11-014 psychiatric hospitals how; or ... Tomoko Nakagawa, Ai Miki, Naomi Miyamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2009.

---

	Relation of the pharmacist to the insulin instruction for the outpatient including the O12-001 pregnant woman Hana Kobayashi south child, Yudachi Kyoko, Yukiko Murakami, Kenji Sada, Shozo Senba, Kiyoshi Hamada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2009.

---

	Investigation about the index of the insulin self-administration induction in our O12-002 institution Koichi Matsumoto 1, Kaoru Nagata 1, Toshiyuki Takahashi 1, Zennya Katsura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2009.

---

	O12-003 Comparison of insulin lispro 50/50 (M50) 1 three times a day injection method and ultra-fast-acting three times ± NPH insulin injection method at the time of foreign insulin introduction 福井宗憲1, 東さつき1, 佐野典之1, 弘世貴久2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2009.

---

	32 analysis that required an inpatient care for hypoglycemia in O12-004 this hospital Yasushi Otani Jiro, Akira Goto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2009.

---

	It is ... led by the use of patient compliance instruction - bevacizumab patients for patients with O12-005 diabetic retinopathy Motobayashi Yuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2009.

---

	Role of the pharmacist in the O12-006 rehabilitation medical care Toshie Yamaguchi 1, Tomoyuki Tanaka 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2009.

---

	Investigation about needs and the communications gap of the fomentation in the O12-007 orthopedics outpatient Hidenori Sagara 1, Hideki Mori 2, Mami Ishibashi 2, Izushi Fumio 3, Manager former man 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2009.

---

	Prescription fact-finding (2000-2008) of the O12-008 benzodiazepine system sleeping drug Kenji Fujita, Takashi Kasahara, Akira Komori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2009.

---

Present conditions and problems - generic medicine of being accelerated are received use of O12-009 generic drug by a pharmacist; is ... Ide Wakana 1, 2, 高橋眞生 1, Oil field Masaki 2, Naoko Ideguchi 2, Takafumi Ota 2, 大熊哲汪 2, Mitsuhiro Okazaki 2, Kuniko Shinohara 2, Kiyoshi Sugiyama 2, Masayuki Seya 2, 栂安雅満 2, Nishimura friend man 2, Yoshio Nozaki 2, Toshi Onodera 2, Shinichi Tashiro 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2009.

---

	Drugstore satisfaction investigation by the mask patients in the O12-010 (Corp.) Ueda Pharmacist Association Yasunori Iijima 1, Kiyokazu Sone 2, 合葉雅彦 2, Yoshiyuki Toshima 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2009.

---

	The change and the present conditions (2008) of the pharmacist duties in the O12-011 capital municipal hospital Mikio Hayashi 1, Tatsuo Tanaka 2, 梶谷文裕 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2009.

---

It is ... using a figure of schema that we added proper use - muscle, bones, tendon, ligament of the medicine for external application in the O12-012 orthopedics disease to Masaji Furusawa 1, 2, It is still 3 Sawamura, Nishikawa arch 3, Yoko Kato 1, Yuko Takahashi 2, Shigeko Yokota 1, 2, 3, Masayoshi Kimura 1, 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2009.

---

Comparison of action fondaparinux Na to the deep vein thrombosis prevention in the O12-013 this hospital orthopedics ward and the enoxaparin Na Aya Ido Keiko 1, 2, Fumio Yoshimoto 1, 2, Hidehiko Suzuki 1, 3, 笹哲彰 1, 3, Kitasato spirit Ichiro 1, 3, Hashimoto court official 1, 3, Hiromi Kajiwara 1, 4, 望月規央 1, 5, 瀬戸茂誉 1, 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2009.

---

	Fact-finding of the medication assistance in O12-014 elderly people Tsuyoshi Saeki, Ayako Ohara, Mizoguchi A, Mizuho Takahashi, Kiyomi Sadamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2009.

---

Factor analysis and preventive measures based on the compounding of medicines error example using O13-001 factor analysis tool 4M5E model Toshiaki Miyazaki, Nawa Hideki, Toshimitsu Onuma, Rieko Kawashima, Yoko Hayashi, Takashi Makita, Kazuhiko Yamaji, Nagamachi Tomoko, Atsushi Ogawa, Satoshi Kuroda, Matsunaga still, Sendo Toshiaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2009.

---

	Dispensing error analysis based on the prescription frequency ratio of the drug different in O13-002 standard Junichi Yamada, Yusuke Futaki, 佐藤友啓, Tsuyoshi Takahashi, 結城祥充, Hiroshi Kuronuma, Shinji Iwai, Katsumi Ito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2009.

---

	A tendency and analysis of the oral medicine doubt inquiry rate in the O13-003 Hokkaido University Hospital 齋藤佳敬 1, Hiroyasu Shiga 1, Masanori Kobayashi 2, Suda example line 1, Mitsuru Sugawara 2, Takeshi Iseki 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2009.

---

About a jet injection example of the intravenous remifentanil hydrochloride in an examination (1) transfusion tube of the O13-004 medical supplies-related medical accident Minoru Mori Tomoko 1, 岩瀬利康 1, Yoshio Ito 1, Tadashi Nagase 1, Tomoaki Toyama 1, Keiko Shinozaki 1, Kumiko Okitsu 1, Junko Miyakawa 1, 長岡匠 1, Miyuki Suehiro 1, 双樹惠 1, Chiaki Koshikawa 1, Shigeki Yamaguchi 2, Toshimitsu Kitajima 2, Misa Sakaguchi 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2009.

---

	O13-005 Support of risk aversion and the use by the change to Fentanyl MT patch of opioid aptitude 木村賢治, 山形亜紀子, 阿部奈保子, 田中達夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2009.

---

	Environmental exposure at the O13-006 anticancer drug preparation Reina Nishigaki 1, 2, Totsuka ゆ K 2, Keiji Wakabayashi 2, Hiroshi Yamamoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2009.

---

	The regimen check of the prescription including the oral O13-007 anticancer drug and future problem Yoshimi Taniguchi, Shinya Suzuki, Yoshiko Nishimura, Yasuhiko Ichida, Yoshizo Watanabe, Ichiji Endo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2009.

---

About adsorption to pledget of the examination (2) chlorhexidine gluconate of the O13-008 medical supplies-related medical accident associated with - intravenous feeding cooking ahead example - 長岡匠, 岩瀬利康, Junko Miyakawa, Tomoaki Toyama, Yoshio Ito, Tadashi Nagase, Keiko Shinozaki, Kumiko Okitsu, Miyuki Suehiro, 双樹恵, Minoru Mori Tomoko, Chiaki Koshikawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2009.

---

About adsorption to pledget of examination (3) benzalkonium chloride of the O13-009 medical supplies-related medical accident associated with - intravenous feeding cooking ahead example - Tomoaki Toyama, 岩瀬利康, 長岡匠, Junko Miyakawa, Yoshio Ito, Tadashi Nagase, Keiko Shinozaki, Kumiko Okitsu, Miyuki Suehiro, 双樹恵, Minoru Mori Tomoko, Chiaki Koshikawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2009.

---

About adsorption to pledget of examination (4) benzethonium chloride of the O13-010 medical supplies-related medical accident associated with - intravenous feeding cooking ahead example - Junko Miyakawa, 岩瀬利康, 長岡匠, Tomoaki Toyama, Yoshio Ito, Tadashi Nagase, Keiko Shinozaki, Kumiko Okitsu, Miyuki Suehiro, 双樹恵, Minoru Mori Tomoko, Chiaki Koshikawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2009.

---

Associated with examination - intravenous feeding cooking ahead example of problems and measures of the proper use information of the examination (5) disinfectant of the O13-011 medical supplies-related medical accident - 岩瀬利康, 長岡匠, Junko Miyakawa, Tomoaki Toyama, Yoshio Ito, Tadashi Nagase, Keiko Shinozaki, Kumiko Okitsu, Miyuki Suehiro, 双樹恵, Minoru Mori Tomoko, Chiaki Koshikawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2009.

---

	Effect of the commercial deglutition adjuvant jelly which gives it to adhesiveness and the remedy characteristics of the O13-012 Kremezin (R) infinitesimal grain Takahiro Uchida, Tamami Haraguchi, Haji River dance, Miyako Yoshida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2009.

---

	Evaluation according to the grain size of O13-013 clarithromycin DS Haji River dance, 盛崎友美, Kaori Fujii, Mio Tange, Tamami Haraguchi, Miyako Yoshida, Takahiro Uchida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2009.

---

	It is effect of the temperature the taste bitter evaluation of the O13-014 ambroxol tablets 10 preparation Yuka Sugino, Haji River dance, Tamami Haraguchi, Miyako Yoshida, Takahiro Uchida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2009.

---

	Advice ... of analysis - magnesium densitometry of renal function and the serum magnesium density of patients receiving O13-015 magnesium Yumiko Asai, Kenichi Saito, Takaki Kitazawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2009.

---

	Effect of the pharmaceutical intervention using the quality of life questionnaire in the O14-001 outpatient department cancer chemotherapy Tomoki Nozoe, Wataru Yasunaga, Atsushi Fukuzaki, Nesaki spring, Noriko Takeda, Higashitarumi Akiko, 牧角寛郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2009.

---

	Depression effect of Ca/Mg for peripheral neuropathy with O14-002 oxaliplatin Miki Takeshita 1, 3, Yoshiko Sakano 2, Teramachi eyes 1, Teruo Tsuchiya 1, Masashi Ishihara 3, Yoshinori Ito 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2009.

---

	Examination of the hematologic optimal test day of the weekly Paclitaxel/Carboplatin clinical path for the O14-003 non-small cell lung cancer Small thicket Makiko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2009.

---

	A change and actions to be taken of the serum magnesium level with O14-004 cetuximab Yasuko Watanabe, Gain book Shuji, Michiko Nishie, Shiho Kodera, Existence Reiko Sawa, Shinsuke Akagi, Kazunobu Takayanagi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2009.

---

Effect on diet of the digestive system adverse event in O14-005 outpatient department chemotherapy patients 篠原義剛 1, Hidehiro Kamachi 1, Tei Hara Expo 1, Hisae Nagahama 1, Hiroshi Hidaka 1, Toshihiko Ushio 1, Kojiro Takahashi 1, Mirror Seiji 2, Hiroaki Morimoto 2, Junji Iwashige 2, Junichi Tsukada 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2009.

---

	Study of the nanoacrylate structure body inhibiting the growth of the O14-006 culture cancer cell Yasushi Ueda 1, 2, Akiko Kaneko 1, Atsushi Yoshida 2, Akira Nakagawara flat 1, Yuki Fujiwara 1, Castle Shoichi Take 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2009.

---

An investigation about the body-surface area calculation in the treatment with O14-007 anticancer drug and calculation-style unification Masayuki Okada 1, 成末 Masami 1, Manami Matsuura 1, Yuka Sugimoto 1, Hideko Iwamoto 1, Pond end Hiroaki 2, Uchida まやこ 2, Hiroyuki Watanabe 2, Masanori Sueyasu 2, Ryozo Oishi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2009.

---

	Effect of the liver function to give to neutropenia of the weekly paclitaxel administration on patients with O14-008 gastric cancer Furrow Yoshiko 1, 2, 寺田智祐 1, Kazue Takahashi 1, Kenichi Inui 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2009.

---

	Role of the pharmacist at O14-009 newcomer regimen application Yasuhiko Sakata 1, Open Koichi 1, Yonezawa sing; 1, Hama well Chie 2, Yasuo Iwamoto 3, Yasuki Tomota 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2009.

---

	Action to cancer chemotherapy security use in the O14-010 this hospital Hiromi Yamaguchi, Masatoshi Ota, Tomohisa Okamoto, Yoshiyuki Ishii Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2009.

---

Development of a very small amount of analytical procedure of the vial surface contamination of the O14-011 platinum anticancer drug and evaluation of the preparation quality Naoya Suzuki 1, 2, Takafumi Naito 1, Keiji Matsumoto 1, Takashina Yoshiaki 1, Shuji Maruyama 1, Nobuhiko Takai 1, Tomohiro Yamamoto 1, Kimie Imai 2, Kunio Nakanishi 2, Junichi Kawakami 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2009.

---

Evaluation of of the pharmaceutics of the O15-001 high dose acetaminophen suppository and the clinical pharmacology Hiroko Noda 1, Takeura Hiroyuki 1, 3, Koji Tazoe 1, Yoichi Ishizuka 1, Mitsuru Irikura 1, Toru Irie beauty 1, Minoru Yoshida 2, Akiko Sadanaga 3, 永田浩泰 3, It is Sachiko 3 in a camp, Eiko Fukunaga 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2009.

---

	Prediction by the in vitro liver homogenate experiment system of the pharmacokinetic change at the O15-002 hypothermia therapy The Takashi Miyamoto sky, Satoshi Matsueda, Foot Shintaro, Mikiro Nakajima, Hitoshi Sasaki, Takahiro Nishida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2009.

---

Examination about the P-glycoprotein antagonism of the O15-003 Thai domestic plant ingredient, paclitaxel-resistant conquest effects and the anticancer activity Senmi Masashi 1, Hot-bath resort Yoshiko 1, History of Otani Kei 1, Junya Nagai 1, D Patanasethanont2, B Sripanidkulchai2, V Junyaprasert3, N Soonthornchareonnon3, Mikihisa Takano 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2009.

---

	Effect to give to renal function of acetaminophen using the O15-004 renal failure rat Finished river Satomi, Takeki Narita, Misato Nagashima, Ayaka Sota, Daisuke Kadowaki, Sumio Hirata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2009.

---

	O15-005 About pharmacokinetics of Mycophenolate mofetil in liver transplant patients 千崎康司1, 葛谷孝文1, 中村太郎2, 阪井裕介1, 木内哲也2, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2009.

---

The need of a very small amount of compounding of medicines in the treatment with O15-006 warfarin Mai Kondo 1, Tetsu Sugiyama University 1, Yuko Okada 1, Yu Haruki person 1, Seki Yuka village 1, Yu Yokoyama law of nature 1, Yoko Sunada 1, Silk field Emi 1, Akiko Sakuma 1, Sachiyo Kondo 1, Kazumasa Komatsubara 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2009.

---

	Study on pharmacokinetics of antibiotics at the O15-007 sustained hemofiltration dialysis enforcement Taketo Yamamoto 1, Shinko Yasuno 5, Gutter slope Akihiro 2, Norio Hanabusa 3, Shoichi Katada 6, Noiri Hideyo 3, Toshiro Fujita 3, 4, Hiroshi Suzuki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2009.

---

	TDM ... which the medical treatment intervention (1) - ward person in charge through the TDM by the O15-008 pharmacist receives Tomoko Mochizuki, Good luck Kagi connection, Sho Kamokawa, 有木宏宗, Mieko Yokoyama, Keiso Masuhara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2009.

---

	Examination ... about the initial administration plan of medical treatment intervention (2) - vancomycin through the TDM by the O15-009 pharmacist Sho Kamokawa, Tomoko Mochizuki, Good luck Kagi connection, 有木宏宗, Mieko Yokoyama, Keiso Masuhara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2009.

---

	TDM of the immunosuppressive drug in the case that small intestine was performed wide excision of after O15-010 renal transplant 8, Nango Keiko 1, Kokufu Takatoshi 2, Masahiko Okamoto 3, 吉村了勇 3, Yukako Ito 1, Nobuyuki Sugioka 1, Kanji Takada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2009.

---

	Examination about the effect that O15-011 Bilirubin gives in pharmacokinetics of irinotecan Wakako Miyachi 1, Hilum Takaaki Hayashi 1, 1, Asuka, Iwamoto, Eiji Kayano 1, Bun Takagi virtue 1, Hiroko Nosaka 1, Takashi Kato children 2, Yoshio Ijiri 2, Kazuhiko Tanaka 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2009.

---

	Trial of the hypothesis thinking process in the O16-001 six years system pharmacist education Masahiko Shimada 1, Market Misuzu 1, Yoshikazu Tanaka 1, Shunsuke Shiromizu 1, Haru Sato or 1, Kazunori Asai 1, Masaaki Machida 1, Shotaro Sakurai 1, Kiyoshi Sugiyama 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2009.

---

	For an effect and problems -6 age system business training of the O16-002 Hospital business training - Michiru Watanabe 1, 小清水治太 1, Kazu Kojima child 1, Mari Fujimoto 1, Tomoko Yoshii 1, Kenichi Negishi 1, Kiyoshi Mihara 1, Tomi Kawata branch 2, Oil field Masaki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2009.

---

	Business training preparations situation investigation by the O16-003 Fukuoka Hospital Pharmacist Association Takahiro Muro 1, 2, 篠原義剛 2, 3, Takayuki Ishimaru 2, 4, Kazue Tanaka 2, 5, Shoichi Shiotsuka 2, 6, Kojiro Nikami 2, 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2009.

---

	It is a report as a result of questionary survey in the ethical pharmacy under Oita the questionnaire about the action of an expectation image and the business training of the O16-004 six years system pharmacist Yasuhiro Matsumoto 1, Isshiyo Mori 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2009.

---

	It is ... about a training method to learn a general idea of business training measures - POS of the O16-005 hospital pharmacist Yoshiko Nishimura, Yui Yoichi Sono, 槇林智子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2009.

---

	Making of the nutrient menu making support tool for O16-006 pharmacist and a pharmacy student Ryuichi Fukuoka, Hisadome element, Yoshihisa Ishihara, Persimmon former Ikuyo, Taku Ando, Tadahisa Wada, Karasaki Yumi, Toru Tanabe, Sayaka Tanaka, Aya Horikiri Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2009.

---

	Relation as the medical supplies safety management person in charge to the O16-007 special elderly nursing home Masako Tahara 1, Masumi Hara 2, Takashi Narazaki male 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2009.

---

Drug control instruction duties for the home care person judging from O16-008 reporting book Mai Yamazaki 1, Kazuki Kushida 1, Yoshio Nakamura 2, Riku Watanabe child 2, Chie Tawara 2, Yoshiko Ueno 2, Yuji Takemoto 2, Hiroki Adegawa 2, Akiko Hirao 2, Hidekazu Fujikawa 2, Iwade Nobuyuki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2009.

---

	Examination about the need of the pharmaceutical management in the O16-009 treatment at home and the new directionality of pharmacist duties 中尾侑加 1, God Tomoko 2, Ichiro Inaba 2, Great Satoshi Kubo 3, Yoichi Ishizuka 1, Mitsuru Irikura 1, Toru Irie beauty 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2009.

---

	Nursing-care cost reduction example - by the review of case report - drug by the many types of job cooperation in the O16-010 treatment at home Mikiko Nakamura 1, 牧圭子 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2009.

---

	Construction of "the medicine medicine cooperation" for the O16-011 patients Junko Onishi 1, 2, 3, Tadashi Hiromoto 3, 4, Toshiko Terakawa 3, 5, Suguru Ohashi elegant 3, 6, Hitomi Tsuboi 7, Naoki Murao 3, 8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2009.

---

	Effect on hypoglycaemia effect of the diabetes therapeutic drug which O17-001 celiprolol brings Yamase University male, Makoto Miyazaki, Kazunori Iwanaga, Masao Kakemi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2009.

---

Questionary survey about use characteristics of the O17-002 pre-filled type insulin device Main room three picture 1, Yuko Kanezaki 1, Osamu Egawa 1, Akihiko Hirano 2, Kumiko Murakami 2, Satoko Egashira 2, Great Kusu Noriko 2, 渡辺利穂 2, Kumiko Imamura 2, Hideaki Kondo 3, Kiyoshi Ashizawa person 3, Motomori Izumi 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2009.

---

Visual disturbances simulated experience insulin injection inside the hospital training for the purpose of the standardization of the procedure instruction for the O17-003 visually impaired Hiroyuki Nishimura 1, Yoshida positive 1, Asako Eguchi 1, Takako Uozumi 1, Yoichi Ishizuka 2, Mitsuru Irikura 2, Toru Irie beauty 2, Keizo Kajiwara 3, Tomio Jinnai 3, Hideaki Jinnai 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2009.

---

	Problem of the hospital pharmacist in the O17-004 diabetes patient education Akiko Emoto 1, 7, Fumi Okada 2, 7, Kyo Kimura 3, 7, Bell mountain Naoto 4, 7, Reiko Yasunaga 5, 7, Tadashi Sakamoto 6, 7, Fujito Expo 1, 7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2009.

---

Intervention of the pharmacist at insulin induction to patients with foreign diabetes taking O17-005 oral hypoglycemic drug Hideko Iwamoto 1, 成末 Masami 1, Manami Matsuura 1, Masayuki Okada 1, Yuka Sugimoto 1, Ryoichi Baba 1, Shinichiro Mizumachi 1, Saki Jinnai picture 1, Mihoko Kawahara 1, Seibei Miyake 2, Fumi Murata 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2009.

---

	Action to the generic medicine in the basic hospital in O17-006 Saiki-shi Keiko Kitajima 1, Shrine Akihiro Ichiro 1, Maruyama Akina 1, Mimata Sayaka 1, Tatsuya Sasaki 1, Kaifu Masayo 1, 末安由拓 1, Akihiro Kai 1, Ishikawa immensity 1, Prince Taniguchi chapter 1, Ken Takakura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2009.

---

	Mitsuyasu qualitative analysis of the warfarin potassium generic drug crush thing using the O17-007 air conditioning 96 well Makoto Otsuka 1, Riding ground base (Horiguchi) picture non-1, Junichiro Murayama 2, Yoichi Ishikawa 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2009.

---

	Bioequivalence in healthy adults of 30 mg of O17-008 lansoprazole OD lock "Towa" Yoshiaki Itano, Koji Ogawa, Takashi Matsui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2009.

---

	Bioequivalence in the healthy adults of 10% of O17-009 ceph Neil infinitesimal grain children's use Kuniko Hayashi, Koji Ogawa, Takashi Matsui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2009.

---

	About examination - injectable cefotiam of the generic medicine clinical evaluations using O17-010 DPC data and imipenem - 濱邊秋芳 1, 森宗芳 2, Koichi Hirao 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2009.

---

	Generic medicine lectotype based on the O17-011 bioequivalence test data Masanobu Hayakawa 1, Takashi Yanagawa 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2009.

---

	Does the P1-001 stress increase a dispensing error? Akira Koyama period, Shinji Takayama, Kenichiro Kawana, Haruna Watanabe, Rumiko Hattori, Makiko Matsui, Kazumi Goto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2009.

---

	The fact-finding of the P1-002 dispensing error and evaluation of preventive measures against dispensing errors Koichiro Iwata 1, Kazue Soda 1, Sakai Naoko 1, Mayumi Iriya 1, Jun Kainuma 1, Takahiko Kagaya 1, Atsuta Koichiro 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2009.

---

	Wetting-related participation for the syrup attachment invulnerability for children in meter of a lot of P1-003 material Yoshihisa Yamamoto 1, 4, Suzuki Toyoshi 2, Hashizaki 3 required, Megumi Kawakita one 1, Masamichi Fukuoka 4, 深水啓朗 2, Kazuo Tomono 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2009.

---

	The present conditions and problem of the injection preparation in the P1-004 Saitama Medical School Hospital satellite pharmacy Shigeru Koizumi 1, Yuichi Hirano 2, Norio Kameoka 1, Riyoichi Yonezu 1, Morihiro Yamashita 1, Masami Kondo 1, Egusa Toshiaki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2009.

---

	Search of the factor predicting quantity of outpatient dispensing duties that assumed P1-005 compounding of medicines waiting time end-point Takehiko Tezuka, Forest pre-Shibi, Shunsuke Kurono, Hiroaki Yamanouchi, Hiroko Saito, Takaaki Hasegawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2009.

---

One patient who is addicted to carbamazepine with suspected disturbance of consciousness with the P1-006 drug hepatopathy Kenichi Ooe, Mai Higashimura, This Western philosopher, Shinji Honma, The long waterfall truth, Watanabe Kyoko, Masayo Takagi, Michiyo Terasawa, Hidekazu Kizaki, Kayo Saito, 川瀬泰裕, 澤谷佳美, Yasuhiko Hirota Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2009.

---

	About the examination of doubt inquiry criteria for P1-007 Axtos lock proper use Italy Sachi Haraki charges 1, Mitsugu Saegusa 1, Tomoya Asada 1, 眞鍋伸次 1, Ichiro Matsumoto 2, Yuichiro Takagi 2, 森由弘 3, Thickness well Bunichi 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2009.

---

	P1-008 Current Status and Problems of distribution drugs cart all ward simultaneous introduction: medical safety initiatives by ward pharmacists and nurses cooperation 二ノ倉浩之1, 2, 木南志朗1, 五十嵐一裕1, 小川洋司1, 村岡勝2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2009.

---

	Examination about the stability after the P1-009 gabapentin tablets crush Yuki Utsunomiya 1, Kenji Okada 1, Yusuke Miyamoto 1, Kazuya Harada 2, Kuwana Shiori 1, Toshimi Kimura 1, Mori Kiminori 2, Kenichi Sagawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2009.

---

	Development factor of "a standard error, the medicine difference" in the P1-010 health insurance pharmacy Tokiko Okuda 1, Downhill path static Kei 1, Nobuaki Takahashi 1, Motoyashiki Kayoko 1, 高坂直宏 1, Mitsuko Onda 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2009.

---

	Effect of the conservation condition to give it to stability after the crush at P1-011 aspirin end Kazuhiko Yamaji, Yoichi Kawasaki, Nawa Hideki, Satoshi Uejima, Tomoaki Sato, Matsunaga still, Sendo Toshiaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2009.

---

	Quantity of injection room duties investigation in the P1-012 Cancer Res. Inst. Ariake Hospital Former Taro Isami, Tsuyoshi Aoyama, Takashi Sugizaki person, Kondo many children, Daigo Shoji, Ryota Furuya, Akane Hagino, Anna Inoue, Kazunori Kawakami, Toshihiro Hama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2009.

---

	About bringing medicine management in the P1-013 Toku Chiba bank meeting Hospital - second report - Ko Ichihara, 福井宗憲, Noriyuki Sano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2009.

---

	A utility of the P1-014 image observation equipment and future problem (the second report) 小林万也孝, 新井成俊, Kenichi Saito, Takaki Kitazawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2009.

---

	About an injection compounding of medicines support system using a bar code check for prevention of P1-015 medical accident Minako Yoshida, Shoji Takagi, Tetsu Wakabayashi, Hideki Okamoto, Toshiko Okura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2009.

---

	Opioid management instruction duties in the P1-016 this hospital Yoshinori Kobayashi, Osamu Kitamura, Kazuo Katsumata, Hiroshi Kawaguchi fruit Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2009.

---

	P1-017 Construction and operation evaluation of injection drug dispensing inspection system using a new bar code display 新家恵子, 北川克美, 小野祐志, 倉光明美, 栗谷良孝, 西井諭司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2009.

---

	A construction and use of the drug conveyance system of administration in the P1-018 this hospital Atsushi Adachi, Junko Usami, Mikiko Akabane, Katsumi Kitagawa, Akemi Kuramitsu, Kuridani Yoshitaka, 西井諭司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2009.

---

	Development of the injection checking prescription system which we paid our attention to for dosage interval in the foreign injection administration using P1-019 new bar code (GS1-Databar) Kazunori Shimomura 1, Tadashi Suyama 1, Senaha Hiromasa 1, 名徳倫明 2, Shinichi Kawaguchi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2009.

---

	Use fact-finding of the P1-020 "drug which should perform liver function tests" Twig Nobuyuki, 永田智依世, Brook Mitsue, Koji Kishimoto, Tajima Shigetoshi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2009.

---

	P1-021 Enhancement, efficiency of the prescription checking by the review of the prescription indication 杉理江, 益本周治, 亀井健人, 徳田衝紀, 高柳和伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2009.

---

Inflection on the electronic chart of the check item which we extracted from the P1-022 "injection compounding of medicines inspection manual revision third edition" Hagiyama Hiroshi, Fukuo Kimura, Yu Nakahara, 西村篤弘, Fujiko Yamazaki, Kazunori Yamamoto, 緒万昭, Asako Nakagawa, Yutaka Uchida, Keizo Ishimoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2009.

---

	The development of the injection set inspection system which utilized P1-023 RSS cord and the operational actual situation Hiroki Nakazato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2009.

---

	An evaluation of the drug information for P1-024 neonates and construction of the dose check system Natsumi Tashiro, Ayako Suehiro, Takuya Suenaga, 岩尾恭寛, Yutaka Ueyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2009.

---

	Action to the risk management in the P1-025 anticancer drug preparation 岩尾恭寛, Yutaka Ueyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2009.

---

Investigation of problems about the compounding of medicines preservation of drug stability for P1-026 drugstore pharmacists Straight Katsumi Shiroyama 1, 2, 3, Yuki Kobayashi 3, Katsutoshi Takada 4, Takao Aoyama 5, Hiroshi Uno exhibition 6, 大澄朋香 1, Hisashi Iijima 1, Yoshikazu Ishino 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2009.

---

The incident analysis that the nurse in the nursing system is involved in at 7:1 in the P1-027 this hospital Soichiro Nakata 1, Tomoaki Toyama 1, 早乙女聡良 1, Koichi Hoshino 1, Keiko Osodo 1, Miyoko Horie 1, Mitsuharu Omori 1, 3, Yukinori Usui 1, Keiko Suzuki 2, 3, Emi Ueno 2, 3, Emiko Abe 2, 3, Yuko Suda 2, 3, Mayu Kaminaga light 2, 3, Kumiko Ode 2, 3, Shizue Sayama 2, Yu Nakatani oneself 3, Hiroshi Hirata country 3, Yuzo Suda 3, Chiaki Koshikawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2009.

---

	Examination of the P1-028 compounding of medicines double inspection utility Gentaro Nagae, Hiroyuki Naito, Kazuo Kaneko, Masashi Suzuki, Yasushi Kawatsu kernel Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2009.

---

	Utility evaluation of the medical supplies proper use support card making program in P1-029 risk management measures Yutaka Ito root 1, Tsuboi Mizuki 1, Shunsuke Kasai 1, Yuko Sasaki 1, Yasushi Matsuura 1, Takemoto Chihiro 2, Keiko Konishi 2, Koto Fujiwara 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2009.

---

	Present conditions and evaluation ... of set duties of the medicine to the administration cart by action ... pharmacist to the nursing service support by the pharmacist in the P1-030 this hospital Yosuke Kato, Masamitsu Matsuda, Toshihiro Osuka, Akira Goto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2009.

---

	Characteristic of the factor according to the type of the compounding of medicines error in the P1-031 health insurance pharmacy Akiko Nakagawa 1, Mitsuko Onda 1, Hidehiko Sakurai 2, Arakawa line straight 1, 早瀬幸俊 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2009.

---

	It is whole country virtue bank society hospital "questionary survey count result about the facility suspension method" P1-032 second report Koto Fujiwara 1, 敦見真由美 1, Satoshi Takahashi 2, Nishizono Kenro 3, Tetsu Ando sincerity 3, 賀勢泰子 3, Is Kurata; see it; 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2009.

---

	Attitude survey for the discrimination of the tablet divided into half in the P1-033 medical care security Kazuhiro Hirano, Akiko Emoto, 中野行孝, Fujito Expo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2009.

---

	Factor analysis of the compounding of medicines error using the P1-034 viewpoint measurement machine Hiroki Nakamura 1, Inooka Kyoko 1, Yuriko Murai 1, 2, 眞野成康 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2009.

---

	Than basic examination (2) - long-term storage about the storage condition of the P1-035 folding compounding of medicines medicine ... Toshi Tanaka, Masuo Sato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2009.

---

Action - pre-Abo id report promotion to promoting it campaigns pre-Abo id report in the P1-036 Kanagawa Hospital Pharmacist Association; and - Junichi Iida 1, Tetsuro Yumoto 1, Large pattern root Izumi 1, Tatsuya Kato 1, Akitoku Kojima 1, Tamura harmony, reverence, purity and tranquility 1, Hisashi Fujiwara up 1, Takuya Maeda 1, Takeshi Yamaya 1, Yukino Ayabe 1, Hajime Matsubara 1, Yoshiko Miyazaki 1, Body marsh Masami 2, Hajime Kagaya 1, Masayuki Morita 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2009.

---

	P1-037 Compounding changes that occur in Nicarpine (R) during constant speed intravenous injection from the side tube to the main root 岩渕安史1, 上井幸司2, 西和哉1, 阿部浩幸1, 我妻仁1, 鈴木常義2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2009.

---

	An investigation and examination of the factor to cause P1-038 high magnesium (Mg) blood disease Toishima study 1, Daisuke Takagi 1, Yukie Harigai 1, Koji Fujimoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2009.

---

	Analysis of fall, the fall accident that seemed to be due to P1-039 antihypertensive medications Yu Maeda ankle 1, 丹村貴之 1, Hiroyuki Mizuno 1, Kayo Koike 1, Reiko Yamada 3, 木村和哲 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2009.

---

	Patients renal function information mention (the second report) to a prescription that we use P1-040 GFR estimation type (eGFR) Tetsuya Ito, Yuka Okada, Toshie Hirano, Yoshiteru Tanaka, Hirotaka Hashizume Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2009.

---

	Database compilation and analysis of P1-041 doubt inquiry contents Hiroyuki Miyashita 1, Reiko Fujino 1, Yuko Sudo 1, Teruko Takano 1, Mai Tanaka 1, Jun Kainuma 1, Takahiko Kagaya 1, Atsuta Koichiro 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2009.

---

	Utility and problem - by the induction to trial - outpatient of the simple suspension method induction in the P1-042 Shizuoka cancer center Kaori Masuda, Tomohisa Onishi, Hiromi Iizuka, Hitoshi Hashimoto child, Satoshi Motokawa, Michihiro Shino Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2009.

---

	Content analysis and examination (the second report) of the doubt inquiry in the scale medical institution out of P1-043 Maho Kikuta, Makoto Shuto, Yumiko Hanawa, Nakamura three kinds of filial duties, Yoshiko Yamamoto, 新熊傳治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2009.

---

	Action to the drug control of P1-044 orthopedics inpatients Mihoko Tesaki, 瀧本美古, Nozomi Sato, 堀渕倫未, The Nakayama future, 向誠一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2009.

---

Problems obtained from the fact-finding of a medicine notebook and the practice reporting book in 9 institutions in P1-045 Yamaguchi Hiroyuki Watanabe, Mayuko Ito, Shiro Mitsubori, Tomoyuki Oka, Yasuaki Otsubo, Takaba University group, Hiroko Hiraoka, Light end Takayo, Gain Narihiro, Takeshi Yamamoto, Akira Kamiya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2009.

---

	Examination about the conservation method of P1-046 wettability medical supplies Yukihiko Numajiri 1, Yoshiyuki Kimura 2, Ai Kuwahara 2, Kuzuma Nobuaki 2, Yasunori Morimoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2009.

---

Action to risk aversion of the injection in the P1-047 drugstore Michi Iriyama, Italy Mariko Saji, Kanako Naoe, 桐越慶, Four wisteria Rika, Hiroyuki Ozaki, Tadashi Maeda University, Masahiro Yamagata, Tetsuro Hashimoto, Koji Matsubara, Lower Mizue Sawa, Takashi Oda child, Norio Sakuta, The new Tadashi Oka method Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2009.

---

Present conditions - of the role - Toho University medical center Sakura Hospital of the ward pharmacist in the proper use of P1-048 medical supplies and the medical safety management Kaoru Suzuki, Tsukuda Akiko, 穗苅郷美, Shinki Nakamura, Keiichi Hara, Ikuno Watanabe, Atsushi Urano, 佐野君芳, Ishii Toshihiro, Masaka Wataru Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2009.

---

	Mainly on a drug having high - risk to propel medical security from the P1-049 pharmacy - Now Yoshiko Takada, Shinichi Tamiya, Tomohiro Umemura, Tree Masaji, Saza Yaeko, Noriaki Araki, Tomohiko Aoyama, Kenji Tokui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2009.

---

	Injection risk management using the list of P1-050 administration attention medicine Yoko Minagawa, Satoshi Araki Eiko, Yuasa lap, Masaru Kawai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2009.

---

	P1-051 Risk mitigation and efficiency of oral medicine one encapsulated using the Medicament audit prescription and drug aggregate list 濱田武, 畑武生, 北川俊史, 鈴木典子, 鈴木薫, 西原雅美, 玉井浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2009.

---

	Additional mixed injection from bag mixed injection mouth in a utility, the safe report 3. risk management of the bag for the P1-0525 new hyperalimentation [TPN] preparation 深井康臣 1, 4, Nakazawa one net 1, History of Megumi Yamauchi 3, Shin Ota 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2009.

---

	Examination of the preparation error in the P1-053 anticancer drug preparation Makoto Nakajima 1, 2, Takuya Goto 1, Yoshie Nomura 1, Yumi Suzuki 1, Yukiko Shibata 1, Takahiro Kumagai 1, Shuichi Matsumoto 1, Shisui Masumi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2009.

---

	Examination of the dumb person who is mouth for the purpose of 1% of P1-054 itraconazole internal use liquid compliance improvement Mitsue Ishitani, Gain book Shuji, Taketo Kamei, Lake Aso Kazuyo, Kazunobu Takayanagi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2009.

---

	Analysis of the doubt inquiry example in the P1-055 anticancer drug injection prescription Mitsuhiro Hashimoto, Hiroshi Yamaguchi, Akihisa Koyanagi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2009.

---

	Action of the drug change in the P1-056 drug risk management Nao Katayama incense, Yuko Ishikura, Foot Hideki Oka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2009.

---

2 case ... which gave intubation of the antiHIV medicine by the examination (the second report) - facility suspension method about the administration of antiHIV medicine method for the patients who had difficulty with P1-057 internal use Aya Yoshida 1, Naoko Miyazaki 1, 2, Tadashi Kikuchi 3, Carp Tomohiko Fuchi 3, Tsuyoshi Fujii 3, Aikichi Iwamoto 3, Masaaki Takahashi 4, Yosuke Kurokawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2009.

---

	About the induction of the simple suspension method in the P1-058 Metropolitan Fuchu hospital 右川浩, Junko Hiroi, Masako Koike, Small Masayuki Aga, Setsuko Teraguchi, Kaori Ito, Junichi Suwa, Kanichi Kawasaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2009.

---

	Prime cause analysis of the insulin accident example that occurred in P1-059 this hospital Ground field Mikiko 1, Nami Matsui 1, Sakuma Miyuki 1, 猿谷淳 1, Yuka Nakano 1, 向一美 1, Hiroko Takahata 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2009.

---

	An action and problems to ward injection mixed preparation duties in the P1-060 this hospital satellite pharmacy Tree temple Yasuhiro 1, 2, Yasuyuki Tsukioka 1, Yuzuru Yamazoe 1, Kenzo Moriyama 1, Camellia Masahiro 2, Nishida measure three 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2009.

---

	Action to risk management in the P1-061 investigational new drug management Takashi Mizui term 1, 2, Osamu Umeda 1, 2, Katsutoshi Goto 1, Masamitsu Sakaida 1, 2, Kazushi Yoneta 1, 3, Oak mound Tomi man 2, 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2009.

---

	Analysis of the doubt inquiry example in the P1-062 injection compounding of medicines 澤藤園子, Hiroyuki Hayashi, History of laboratory of origin of soil, Kishi, Matsuzaki, Masahiro Kawai, Akio Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2009.

---

	For the purpose of sensory evaluation - dispensing error prevention about the P1-063-colored discrimination - Manami Kanda 1, 1, Asuka, Matsuda, Tokushuku Keiko 2, Body marsh Masami 1, Hitoshi Nakamura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2009.

---

	Examination of the medicinal solution plombage in the P1-064 portable constant infusion pump Senaha Hiromasa 1, 名徳倫明 2, Kazunori Shimomura 1, Shinichi Kawaguchi 1, Kenji Ikeda 2, 廣谷芳彦 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2009.

---

	Intervention - to role - safety measures working team of the pharmacist in the P1-065 medical care security Harumi Nakano 1, Atsuko Nakajima 2, Mami Nomura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2009.

---

	About preventive measures against false administration of critical medicine in the P1-066 Kyoto Municipal Hospital Kyoko Kumagai, Yasushi Meguro, Keiichi Ono, 村田龍宣, Hiromi Fujita, Shinji Honda, Masaru Ono, Yasushi Sunda, 平田敦弘, Imagawa grammar Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2009.

---

	Risk management for P1-067 iodine contrast media and the drug with the interaction Keiko Shimizu 1, Katsube law of nature early 2, Hiromi Okazaki 2, Sendo Toshiaki 1, 2, 合葉哲也 1, Yuji Kurosaki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2009.

---

	P1-068 Investigation about the ratio to receive injection drug formulations, prescription checking in pharmacy 古谷祥子, 徳田衡紀, 西村健二, 森谷康志, 高柳和伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2009.

---

	P1-069 The features and trends of the drug should be noted at the time of injection prescription inspecting seen from case analysis 森谷康志, 赤木晋介, 西村健二, 徳田衡紀, 高柳和伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2009.

---

	Association of the communication skill in the pharmacy management judging from P1-070 doubt inquiry example Yoko Watanabe, Ryota Tsukioka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2009.

---

	It is the incompatibility between the preparation in the parcel product for becoming it P1-071 one Tomikawa Naoko, Takeshi Kotake, Masatoshi Sugiyama, Isao Sugimoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2009.

---

	Effect - of pH to give the content decrease mechanism-2-content decrease of the diazepam injection at use of P1-072 PVC/TOTM tube Norihiro Watanabe, Mutsuko Sasaki, Kenji Kawano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2009.

---

	Study on TOTM elution mechanism from P1-073 PVC membrane Yuka Tsukada, Mutsuko Sasaki, Kenji Kawano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2009.

---

	Development of the pimobendan tablet that P1-074 is stable Hideshi Beppu 1, 竹縄恭恵 1, Tatsuya Ishikawa 1, Akihiko Nagai 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2009.

---

	One pack of P1-075 pimobendan tablets "TE" evaluates stability at becoming it Megumi Takada 1, 上戸啓巳 1, Ayano Komine 1, Matsumoto age world 1, 竹縄恭恵 2, Hideshi Beppu 2, Tatsuya Ishikawa 2, Masaaki Nakano 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2009.

---

	Examination about stability and the properties of matter evaluation of the P1-076 acetaminophen (AA) component OTC preparation Misuzu Ota 1, 2, 深水啓朗 3, Yuri Takahashi 4, Description of Motoi Arakawa 1, Masanori Iwata 4, Kazuo Tomono 3, Shinji Hidaka 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2009.

---

Utility of the electrophysiological experimental method as the corneal problem-related rating system at use of P1-077 eye drop Mikiro Nakajima 1, Shin Kitamura Hideko 1, Maiko Tsuji 1, Shigeru Umeno intellect 1, Takahiro Nishida 1, Junzo Nakamura 1, Teshima infinity 2, Hitoshi Sasaki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2009.

---

	The P1-078 ISO9001:2000 certification and action of the pharmacy Rie Aisaka, Takafumi Takeuchi, Ikuko Yoshida, Hizuru Kamata, Tomoko Suzue, Yamakawa Kazunori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2009.

---

	Reinforcement of the dose check function in the P1-079 electronic chart 清水俊洋 1, Hiroshi Fujita 2, Mitsumasa Shimizu 2, Takafumi Ide 2, Akemi Matsubayashi 2, Shun Nagai 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2009.

---

	Enforcement - of the measurement compounding of medicines from rebuilding - hospitalization second of the injection compounding of medicines system with the P1-080 electronic chart induction 六波羅孝 1, Junichi Hara 1, 唐澤頼勝 1, Naoto Hotta 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2009.

---

	We ride P1-081 electronic chart system EG-MAIN GX and are changed the section compounding of medicines system with the substitute Jun Wada, Tatsuya Nakagami, 荒井久暢, 東碧, Chieko Ozuku, Yuki Imaizumi, Tomoko Takeda, Michiko Fujioka, 山下彰良, Yoshiko Murayama, Koji Hasegawa, Taeko Murakami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2009.

---

	The simple suspension prescription order that linked P1-082 electronic chart Land-maru Mikio 1, Akemi Shigematsu 1, Shunsuke Kuroki 2, Shigeji Torigoe 3, Isshiyo Mori 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2009.

---

	Action to P1-083 anticancer drug regimen order and prescription publication system induction Kosaku Sasaki 1, Jun Taniguchi 1, 尾之江剛樹 1, Takanori Kobayakawa 1, Shunichi Hirayama 2, Shuichi Hanada 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2009.

---

	Of the drug control instruction incorporated in P1-084 all-in-one pass, actually Kazumi Morishita 1, Yuki Kato 1, Noge Ichiro 1, Descent from a mountain Katsuhito 2, 福長徹 3, Norikazu Urabe 4, Michiyo Hattori 5, Junko Watanabe 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2009.

---

	Construction of the drug control instruction support system which assumes P1-085 pharmacotherapy monitor the principal objective 打谷和記, Yumiko Tsurumi, Masayuki Tanaka, Nishiyama rich person, Ikejima Takahiro, Tatsuya Muranaka, Kenichi Ooe, Yasuhiko Hirota Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2009.

---

	Medication history investigation about the patients with food allergy correspondence in the healthcare setting around the P1-086 drugstore Kaori Kurata 1, Mari Nishizawa 1, Mitsuhiro Okazaki 2, Tei Nomoto 3, Akira Dobashi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2009.

---

	Action to uniform management of the drug allergy information in the P1-087 electronic chart transition Haruhiko Nakamura, 澤柳直樹, Tomokazu Fujii, Kenichi Nomura, 岩瀬定利, Hisashi Kamiya line Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2009.

---

Drug control ... before the construction (I) - hospitalization of the P1-088 bringing medicine system of administration for electronic chart Shie Nakagawa, Mutsumi Yoshioka exhibition, Yoshimi Ogawa, Noriko Morimoto, New Yasunori, The Hashimoto 100th, Sachimi Nishiyama, Sachiko Kaji, Takashi Tsuji, 渡雅克 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2009.

---

	Construction of drug use, the regime by the P1-089 electronic chart induction Masami Tanoe 1, Hidekatsu Fukuda 1, Yoshiro Suzuki 1, Kaori Kato 2, Sayoko Hirabayashi 2, Naomi 3 who resigns from the post Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2009.

---

	For P1-090 medical care security an action (duties improvement 3) of the duties expansion Kazuko Tanaka, Shrine gate Takanori, Kanako Maeda, Length well Nobutaka, Kimotsuki Miho, 中拂絵里香, The pond increase sweetfish beauty, Terumasa Sata, Tokiko Hanaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2009.

---

	Examination of the utility of the medical treatment management based on the fact-finding of the P1-091 asthma control Kozue Tanaka 1, Kayoko Nagahashi 1, Hiroya Masuda 1, Kaoru Kondo 1, Takashi Suzuka daylight 1, Takeshi Kimura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2009.

---

	Evaluation one year after the foreign patient compliance instruction induction to the P1-092 warfarin potassium long-term use patients Yasuko Kondo, Tomomi Yamade, Fujimoto A, Koto Fujiwara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2009.

---

	Comparison ... of effect - doubt inquiry of the pharmacist increase of the staff in the P1-093 outpatient department chemotherapy Akira Takagi Kei 1, Mitsuru Susa 1, 阿部充伸 1, 山之内恒昭 1, Yasuhiko Mimura 1, Atsushi Kato 1, Cake well Tatsuhiko 2, Isao Adachi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2009.

---

	Role ... of the pharmacist who P1-094 comes out, and is associated with meat phosphorus and smoking cessation situation - smoking cessation outpatient of the nicotine patch prescription patients Yutaka Takahashi, Toshio Maruyama, 昆貴志, Yukari Maeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2009.

---

	Device - of the medical treatment model of study - circulatory disease of the patient compliance instruction method using the P1-095 disease treatment model Shingo Mikami 1, Nakano gain charges 1, Takeshi Midorikawa 1, Toshi Umemura 2, Castle Shoichi Take 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2009.

---

	Practice of the fur Matthew tical care of the pharmacist in the P1-096 outpatient clinic and one discussion Tomoya Asada 1, Mika Kozai 1, Mayumi Okazaki 1, Mitsugu Saegusa 2, 眞鍋伸次 1, 森由弘 3, Thickness well Bunichi 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2009.

---

	About the action of the interview list in the outpatient specialized in P1-097 diabetes and a future problem Takako Nakajima 1, 1 which is related to Nomura, House village Mai 1, Kana Kato 1, Shigeru Yamada tree 1, Toshiaki Ishiguro 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2009.

---

	It is ... through a foot gangrene case in action ... ASO of the pharmacist in the P1-098 ASO outpatient department Yuriko Nimura 1, Takako Nakajima 2, Kana Kato 2, Shigeru Yamada tree 2, Yoshitaka Kumada 3, 豊田行康 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2009.

---

Examination ... of effect on serum phosphorus calcium concentrations management - parathyroid gland function of the contribution of the pharmacist in the P1-099 hemodialysis patient Yuka Onoe 1, Junko Onishi 2, 3, 4, Hoe mound Keiko 1, Plum Miyoshi 3, 石田茂 4, Kazuaki Shinomiya 1, Hiromi Kawasaki 4, Yoshihisa Kitamura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2009.

---

Examination ... from effect on serum phosphorus calcium concentrations management - laboratory values of the contribution of the pharmacist in the P1-100 hemodialysis patient Hoe mound Keiko 1, Junko Onishi 2, 3, 4, Yuka Onoe 1, Plum Miyoshi 3, 石田茂 4, Kazuaki Shinomiya 1, Hiromi Kawasaki 4, Yoshihisa Kitamura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2009.

---

	About questionary survey of the itching for the P1-101 patient on dialysis Shigeru Yamada tree 1, Kana Kato 1, Shinji Takahashi 1, 1 which is related to Nomura, Mika Shinoda 1, Ikue Terao 1, Koki Kasuga 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2009.

---

	Intervention effect of the actual situation and the pharmacist of the Helicobacter pylori sanitization treatment in the P1-102 this hospital 舟越亮寛 1, Tsuyoshi Washiyama 1, Kenji Kobayashi 2, Fumiaki Ueno 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2009.

---

	Relation of the pharmacist at the outpatient department in the P1-103 colonoscopic examination Shinichiro Fukushima 1, Prince Mamiya religion 1, Shigeru Yamada 1, Koichi Hirano 2, North Shuichi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2009.

---

	Construction of the foreign chemotherapy use method on the basis of the P1-104 Atsushi Tamura, Mika Saito, 江刺晶央, Hideo Chiba, Junichi Tamada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2009.

---

	Investigation about the PT-INR measurement in the warfarin remedy patients who started P1-105 outpatient department cancer chemotherapy Miwa Ohara 1, 矢野亨治 1, Yasuhiro Miyakawa 1, Saori Ota 1, Takashi Nagata 2, Keiko Yamamura 2, Kiyobumi Yamada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2009.

---

	About the relation of the pharmacist to patients who received P1-106 outpatient department chemotherapy Kenta Takahashi 1, Rumi Takano 1, Junji Asano 1, Hiroshi Sasaki enthusiast 1, Yuichi Sekizawa 1, Toshiji Oe 1, Katsuyuki Nakamura 2, Atsushi Miyamoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2009.

---

Action of the pharmacist in the P1-107 outpatient department chemotherapy room Slightly dried fish Yuka, Yusuke Terakado, Seiko Takeshita, Ayako Sakamoto, Mai Suzuki, Wataru Sato, Toshima incense, Eriko Otani, Saori Isa, Yuki Hagiwara, Risa Sakamoto, Mizuho Iida, Aya Chikamoto, 澤畠孝幸, Masayo Okawa, Masashi Onozaki, Sachiko Saito, Haruhisa Watanabe, Sanae Ehata, Yoshifumi Aoyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2009.

---

	Present conditions analysis about the communication of a pharmacist and patients in the P1-108 ethical pharmacy with cancer Motoko Kawase 1, 半谷眞七子 1, Hiroyuki Kamei 1, Kazuhisa Matsuba 1, Hitoshi Ohashi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2009.

---

	Action about the foreign initial induction instruction of oral anticancer drug TS-1 in the P1-109 digestive organ center Satsuki Abe 1, Yuri Nagai 1, Tomoko Tomishima 1, Country original Junichi 1, Nobuhiro Ozaki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2009.

---

	About UGT1A1 genetic polymorphism result of a measurement and the side effect evasion in the P1-110 irinotecan regimen Hiroyuki Kuwahara 1, Yuki Ogata 2, Miho Nitta 3, Miki Michigami 3, Hirotaka Kato 4, Masahiro Washimi 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2009.

---

	Examination - of onset of side effect of weekly Taxol+CPT-11 therapy - case in the patients with the P1-111 UGT1A1 *6 homozygote Koda Yuko 1, Yoshihiro Kikuchi 1, Hisashi Kita sum 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2009.

---

	Through pharmacist second training specialized in reporting - 2008 cancer to patients who received P1-112 outpatient department chemotherapy - Ishii Tsu two to congratulate, Keisuke Ito, Yumiko Senoo, Nobuyuki Yokota, Yumiko Oshikiri Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2009.

---

	Examination about the risk factor of the febrile neutropenia in the foreign R-CHOP therapy for the P1-113 malignant lymphoma Tetsushi Kanematsu 1, 宇佐美英績 2, 吉村知哲 2, Tadashi Yasuda 2, Mitsuru Takai 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2009.

---

	Medication support using Braille for patients with total blindness that P1-114 postoperative chemotherapy is introduced into Tomoko Takahashi 1, Manabu Sakurai 2, Hisashi Fujiwara up 2, Sachiko Tomioka 2, Junichiro Murayama 3, Akihiro Nakamura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2009.

---

	Nausea, vomiting measures ... of the utility - FEC100 therapy of the medicine notebook in the P1-115 medication explanation Eri Asago, Sachiko Iwai, Tomohiro Maruyama, Saito incense, Noboru Yoshizaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2009.

---

	Examination of the cancellation criteria about a white-cell count and the neutrophil count in the P1-116 outpatient department cancer chemotherapy Motoaki Ishikawa, 町支優和, Takahiro Ishida, Masumi Nakagami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2009.

---

	Trial of the injectable anticancer drug explanation documentation in the P1-117 Nagoya City University Hospital History of Nasu ear 1, Junko Kuroda 1, Katsuhiro Kondo 1, Rie Kimura 1, Saki Kimura 1, Tetsuo Ezaki 1, Takahiro Hattori 1, Neck charges green 2, Kayo Koike 1, 木村和哲 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2009.

---

	Making of the manual for patients based on an adverse event investigation of the P1-118 outpatient department cancer chemotherapy Keiko Shoji 1, Kazuhiro Ishikawa 1, Satomi Yamada 2, Yuichi Ando 2, Masayuki Umemura 3, Tomoko Tezuka 3, Kiyobumi Yamada 3, Yukihiro Noda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2009.

---

	The duties of the pharmacist in the P1-119 outpatient department cancer chemotherapy room and the evaluation Yoshifumi Komori 1, Iibaru University Minoru 1, Masashi Ishihara 1, Hironori Fujii 1, Koji Yasuda 1, Katsuhiko Matsuura 1, Senju Goto 1, Yoshinori Ito 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2009.

---

	Evaluation of the utility that P1-120 pharmacist outpatient gives to foreign cancer chemotherapy Imamura pasture employee, Harada seven ear, Kentaro Katayama, Hironori Matsui, Yukiko Ozaki, Natsuko Ikeda, 井上稚枝子, Chie Takemoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2009.

---

It is the trial of the side effect prediction every patients background using the cluster analysis, factor side effect monitoring in the P1-121 outpatient department cancer chemotherapy Tsuyoshi Mori 1, 2, 西迫寛隆 1, Toshi Nakamura oneself 1, 2, Yukiyo Miki 2, Horinouchi Hironari 1, 2, Takumi Sakurada 1, 2, Shinji Abe 1, Kazuhiko Teraoka 1, 2, Hisatsugi U.S. Toshihide 1, Kazuyoshi Kawazoe 1, Kazuo Mizuguchi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2009.

---

Effect of the reporting of making and the repetition of the explanation sheet about the mFOLFOX6/FOLFIRI therapy for the P1-122 outpatient department chemotherapy room patients Toshikazu Tsuji 1, 2, Hiroyuki Watanabe 1, Minoru Yoshida 1, Kazue Nakajima 1, 平川良宏 1, Nobuaki Egashira 1, Yoichi Nakanishi 2, Ryozo Oishi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2009.

---

	Examination about the hematotoxicity of hydrochloric acid gemcitabine which considered the P1-123 drug administration time Kazufumi Iwata, 合澤啓二, Boundary Saori, Takako Baba, Eiko Fukunaga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2009.

---

Making and monitoring effect of "the at-home symptom diary" which can continue by P1-124 outpatient department chemotherapy 岩下佳敬 1, 中尾承司 1, Naomi Hasegawa 1, Masako Fukumoto 1, Kimiyoshi Iwasaki 1, Yukiko Narumi 1, Chieko Kawahata 1, Yoshida Nanase 1, Shuttlecock field Shingo 1, Kazuhisa Ishida 1, Akihiko Sakamoto 2, Hiroshi Imamura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2009.

---

	Utility of the epirubicin late departure large-capacity preparation in P1-125 outpatient department chemotherapy FEC100 Ayaka Narita, Masako Suzuki, 野村眞美, Keiji Tsunoda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2009.

---

	Investigation of the enforcement situation and interruption criteria of the P1-126 outpatient department cancer chemotherapy Minako Sato, Masako Okazaki, Katsuyuki Nakamura, Hiroyuki Mashiko, 片倉道啓, Hiroshi Nakata is elegant, Rev. Noda plus, Atsushi Miyamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2009.

---

	P1-127 The randomized controlled trials for cancer chemotherapy patients targeted drug management guidance and self-efficacy 高山慎司1, 石丸博雅1, 塩川満1, 松井真樹子1, 後藤一美1, シャピロ美奈2, 小野寺久3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2009.

---

	P1-128 About mixing time shortening effect associated with the high standard Levofolinate formulation introduced 齋藤雅俊1, 月野木祥子1, 樋口敬子1, 小林彦登1, 斎藤太寿1, 松本忍1, 宮下博幸1, 伊東崇仁1, 引間有香1, 柴田壮一1, 貝沼潤1, 厚田幸一郎1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2009.

---

	Acceleration > of the effective patient compliance instruction < intelligence to P1-129 outpatient department chemotherapy patients Yukiko Okamoto, Yuka Mori, Needle ヶ valley Yoshihisa, Mieko Tanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2009.

---

	Construction of the P1-130 chemotherapy enforcement schedule system Tomiko Sunaga 1, Susumu Tominaga 2, Naramoto under-secretary 1, Yagi Akihiro 1, Yoshinori Suematsu 1, Chiba or 3 to fold, Harada sincerity ratio old 4, Mamoru Suzuki 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2009.

---

	About the action of the pharmacist in the P1-131 chemotherapy center Masahiro Ogami 1, Katsuki Kurosawa 1, Yutaka Kojima 2, Masahiko Shimada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2009.

---

	P1-132 Changes in the prescription inspection business content of pharmacists in outpatient chemotherapy associated with the anti-cancer drug regimen order introduced 加藤博史1, 手塚智子1, 梅村雅之1, 玉置紀子1, 宮崎雅之1, 熊倉康郎1, 阪井祐介1, 加藤善章1, 中尾泰子1, 山田千賀子1, 水野智博1, 山田里美2, 安藤雄一2, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2009.

---

Examination of the efficacy of the measurement of body weight in the P1-133 outpatient department chemotherapy Yusuke Sakai 1, Tomoko Tezuka 1, Masayuki Umemura 1, Noriko Tamaoki 1, Masayuki Miyazaki 1, Yasuro Kumakura 1, Kato good chapter 1, Yasuko Nakao 1, Hiroshi Kato 1, Chikako Yamada 1, Tomohiro Mizuno 1, Satomi Yamada 2, Yuichi Ando 2, Kiyobumi Yamada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2009.

---

	P1-134 The study on the efficacy and safety in the starting lineup goods and generic products of Levoforinate 藤井宏典1, 飯原大稔1, 渡邊千尋1, 石原正志1, 小森善文1, 松浦克彦1, 後藤千寿1, 高橋孝夫2, 吉田和弘2, 伊藤善規1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2009.

---

	Action ... to reporting by role - outpatient department chemotherapy of the pharmacist in the P1-135 breast cancer team approach in medical care 見上千昭, 平郡薫, Takashi Nishio, Hideya Sakurai, Kimiko Yasuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2009.

---

Start the anticancer drug preparation of both outpatient department, hospitalization in an action - outpatient department chemotherapy room of anticancer drug preparation duties in the P1-136 this hospital; and - Koji Akiyama 1, Kumiko Kawano 2, Tomoko Matsumoto 1, Mountain Rieko Sawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2009.

---

	Role ... of foreign cancer chemotherapy - pharmacist carried out by P1-137 team Minako Higuchi, Koichi Matsuo, Yoshimi Sasaki, Sanae Iwatsubo, Yoriko Wada, Sachi Imaizumi, Hiroaki Nishino Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2009.

---

	Action to P1-138 colorectal cancer chemotherapy Lower morning law of nature 1, Miki Takara 1, Tokuko Sasahara 1, Chrysanthemum Hisano Hara 1, Shuichi Iwami 1, 1 that is Zao, Yuko Kubo 1, Miwako Araki 2, Yutaka Ogata 3, Masatoshi Tanaka 4, Mieko Tsuruta 5, Michio Sada 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2009.

---

	Treatment continuity of the mFOLFOX6 therapy for P1-139 elderly patients and safe examination Koga 1 to bear, Child 2 too rare Mochinaga, 岡橋朋世 1, 中野行孝 2, Yoshihiko Kitajima 3, Fujito Expo 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2009.

---

	About regimen management and database compilation using the P1-140 FileMaker Upper deep water future 1, Kenji Kakehi 2, Masashi Hamada 1, Yasushi Fujii 1, Kenichiro Fujii 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2009.

---

	Infusion reaction in the P1-141 this hospital outpatient department chemotherapy and fact-finding of the anaphylactic expression Mieko Kishi, Toshiyuki Matsubara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2009.

---

Use of the foreign chemotherapy with the sickbed reservation system which incorporated a P1-142 regimen registration function Setsuko Hisada 1, Nobuko Okubo 1, 2, Eishin Takahata 2, Keiko Kawahara 3, Shinojima Noriko 1, 3, Seven Masami Sawa 3, Masao Niiyama 2, 又野禎也 4, Hisayuki Nakajima 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2009.

---

	About relations of P1-143 colorectal cancer chemotherapy and malnutrition Hiroyuki Hayashi 1, Small Hiroyuki Moriyama 2, 澤藤園子 1, 1, Kishi, Matsuzaki, Masahiro Kawai 1, Tsuyoshi Okudaira 1, 大槻千遥 1, Akio Saito 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2009.

---

Examination of the enforcement regimen based on the nutritional evaluation of P1-144 outpatient department chemotherapy patients Hiroyuki Ueno 1, Kazuyo Matsuyama 1, Hiroshi Shono 1, 1, Shibi, Shimada, Kenji Imanishi 2, Kinuyo Kajiwara 3, 山内一恭 1, Yoshihisa Honda 1, Hideyuki Mishima 4, Crossroads relation Toshimasa 4, Katsuya Komori 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2009.

---

For promotion of fact-finding - medicine medicine cooperation of the action for the cancer chemotherapy of P1-145 hospital pharmacist and the health insurance pharmacy pharmacist - Okazawa incense Tsu child 1, 2, Masato Wakabayashi 1, 3, Kei Matsuoka tree 1, 4, Shinichi Sasaki 1, 5, Hiroki Mizukoshi 1, 6, Emiko Takehara 1, 7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2009.

---

	Inspection of the P1-146 carboplatin initial dose setting and examination about the GFR estimation type Yokoyama Minoru thickness, Sachiko Koyama, Norihiko Naruse, Kazuhiro Mori, Kiyoshi Fujiyoshi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2009.

---

	A hiccup and association of the drug that patients with P1-147 blood disorder produced after high-dose adrenal cortical hormone administration Mayuko Mori, Takahiro Hirata, 野村浩英, Katsuyoshi Hatanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2009.

---

	About the renal failure in the adjuvant therapy CDDP+GEM every other week administration method after the P1-148 non-small cell lung cancer resection Takashi Goto, Makoto Ishibashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2009.

---

	Renal dysfunction and hearing loss of the P1-149 S-1+ cisplatin combination therapy Naoya Uto 1, Katsuhiko Inoue 2, Masaaki Yamato 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2009.

---

Fact-finding of the hematotoxicity in the esophageal cancer postoperative adjuvant chemotherapy using the P1-150 High dose division FP therapy Hayasaka state straight 1, Hiroko Yamamoto 1, Yu Ito rare 1, Hidenori Kitayama 1, Kazuya Takatsu 1, Fumie Kaido 1, Kimiyoshi Takeuchi 1, Osamu Ogino 1, 西田靖仙 2, Masao Hosokawa 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2009.

---

	Difference of the myelosuppression in the regimen of the P1-151 lung cancer chemotherapy 徳泉仁介 1, Rie Kaneko 2, Goro Ikushima 2, Keiji Mizuno 2, Yasui Yamahiro 3, Ryo Kimura 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2009.

---

	Examination ... of the vincristine stopping dosage case at the drug control instruction (the eighth report) - CHOP therapy in the P1-152 blood internal medicine 宇佐美英績, Michio Kimura, Okada sum intellect, Toshiya Nakao, Keiji Nakajima, 吉村知哲, Tadashi Yasuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2009.

---

	Examination about administration continuity and the safety of S-1 in the P1-153 gastric cancer postoperative adjuvant chemotherapy Michio Kimura 1, Morihata Kazuyo 2, Daisuke Ito 1, Mina Iwai 1, Okada sum intellect 1, 宇佐美英績 1, 吉村知哲 1, Tadashi Yasuda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2009.

---

	About an effect and a side effect of the bortezomib in the P1-154 this hospital Kazuhiro Nakamura 1, Hideaki Anzai 1, 井出眞 2, Kawachi Yasunori 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2009.

---

	Examination about the moisture load at the cisplatin administration in the P1-155 this hospital Hashimoto non-thunder, 三角紳博, Takashi Nishino, 舛重正人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2009.

---

Use ... of construction - mixed injection support seat of the P1-156 anticancer drug mixture preparation duties support system Satoshi Yamazaki 1, Sanae Ida 1, Kazutoshi Terayama 1, 藍澤牧美 1, Kaori Saito 1, Tomoko Yamazaki 1, Yu Inoue 1, 本加典子 1, Kenichi Yumura 1, Mitsuru Kaneta Expo 1, Junko Kitsu 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2009.

---

	Study on dose adjustment of the P1-157 FOLFOX, FOLFIRI therapy Mikiko Okazawa, Even Chieko, Mayu Suzuki incense, Mika Sato, Hirohiko Takano, Shuichi Sakata, Takao Orii Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2009.

---

	Participate in making and evaluation - graduate school ward training of the manual for patients of the P1-158 DC and TC therapy; and - Chie Yamamoto 1, Sayuri Matsumoto 2, Noriko Kamiyama 1, Junichiro Murayama 2, 山元俊憲 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2009.

---

	Trial - of the patient compliance instruction pharmacist surgical for more P1-159 cancer chemotherapy - patients for a hospital Miyanaga Minoru Miyuki, Tomoko Hiraiwa, Hiroshi Nakase Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2009.

---

Efficacy of the FOLFOX4 therapy for progress, recurrent colorectal cancer in the P1-160 general hospital and safe evaluation Kenichi Shimizu 1, Rie Tamaoki 1, Kazufumi Makino 1, Yuka Ando 1, Mari Kamiya 1, Kenichi Osanami 2, Kensuke Ishii 3, Nana Kawanishi 3, Nakajima ability Expo 3, Kyoko Kanazawa 3, Mariko Nakamura 4, Akiko Usami 4, 五日市宏 5, Tadashi Tamura 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2009.

---

	The childhood malignant glioma which tried administration of P1-161 temozolomide Oak shallows 1 to bear, Tomoko Kawai 1, Shun Ito elegant 1, Toshimi Kimura 1, Kenichi Sagawa 1, Yasuo Aihara 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2009.

---

	Examination about the regimen using the bortezomib for the P1-162 multiple myeloma Mitsutoshi Sato 1, Oguro Rieko 1, Chigusa Yamanaka 2, Katsutoshi Takada 2, Yasuhiro Matsuura 3, Noboru Akiba world beauty 2, 青墳信之 3, Yutaka Taniyoshi 2, Side 3, Taku Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2009.

---

	The time when the drug instruction in the cancer chemotherapy that the P1-163 patients expect is appropriate Chisato Matsumoto, Satomi Harima, Kondo is constipated, 河野吏恵, Tomoko Taniguchi, Kazue Toda, Taku Kitamura Maro, Susumu Wada, Miho Kojima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2009.

---

	Side effect investigation of the GC therapy for the P1-164 urothelial carcinoma Village shrine Kotobuki in total, Motohiko Sano, Yuka Uchida, Shinichi Kumakura, Naoko Watanabe, Toru Kishino Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2009.

---

	Analysis of nephropathic onset precipitants with the P1-165 cisplatin administration Katsuya Tanizawa 1, Yagi Kotobuki true 1, Keiko Taguchi 1, Kyoko Murayama 1, Takehiko Kashiwa 1, Hideji Endo 1, Tadashi Sugiyama 3, Teruo Tsuchiya 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2009.

---

One case of the unresectable intrahepatic bile duct carcinoma which became available for a hepatectomy by P1-166 Gemcitabine+Fluorouracil+Cisplatin(GFP) therapy Hitoko Miyazaki 1, Yuichi Muraki 1, Takuya Iwamoto 1, Seko mouth Noriko 1, Okamoto Meiji University 1, Hideaki Tanaka 2, Norihiko Yamamoto 2, Motoo Iwasa 2, Shinko Okuda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2009.

---

	Action at cancer chemotherapy explanation in the P1-167 this hospital digestive surgery Jun Naito 1, Takayuki Sakuma 1, History of Naganuma 2, Akinori Nakamura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2009.

---

	P1-168 An example of dasatinib use for chronic myeloid leukemia patients 島田浩1, 安田成男1, 玉置利香1, 藤重夫2, 金義浩2, 山下みゆき3, 丹原敏男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2009.

---

Example that became patient compliance instruction and the NST intervention of the unresectable progressive stomach cancer S-1+CDDP therapy in the P1-169 this hospital digestive organ internal medicine Satoshi Yamano Eiko 1, Zhuangzi summer cord village 1, Hitoshi Fukunishi 1, Tomoko Hatanaka 1, Sugimoto reason flat 1, Sanae Takada 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2009.

---

	P1-170 Attempt corrective to the standard dose in FOLFOX therapy aimed at cancer chemotherapy uniformity 藤井加容子1, 森本茂文1, 香川邦彦2, 北村良雄1, 田伏克惇3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2009.

---

	Side effect investigation of Bortezomib in the P1-171 this hospital Fujitani Masanori, Yuichi Koizumi, Satsuka Yuki, Mami Nomura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2009.

---

	Case report of the use of Zevalin (R) patients in the P1-172 Kurashiki center Hospital Sayo Kano child, The history of Torigoe sky, Tomomi Ando, Koji Moriya, Lake Aso Kazuyo, Kazunobu Takayanagi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2009.

---

	Investigation of the adverse event of patients who received P1-173 cancer chemotherapy and the quality of life Katsura Harada product 1, 2, Keiko Nagai 1, Harumi Yamada 2, Kotaki one 2, Mariko Asahi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2009.

---

	Development of drug control instruction duties in consideration of the characteristics of patients with P1-174 childhood cancer Mishima one up 1, Pond end Hiroaki 1, Takahiro Matsushita 2, Masanori Sueyasu 1, Nobuaki Egashira 1, Ryozo Oishi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2009.

---

	Action of a side effect investigation of the P1-175 R-CHOP(R-THP-COP) therapy and the manual making for patients on the basis of findings 政賢悟 1, Kano Tomoko 1, Ibara country charges 2, Nosaka straight volost 3, Hiroaki Mitsuya 3, Yoshiteru Honda 1, Hideyuki Saito 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2009.

---

	Action in the small and medium size hospital to be a pharmacist found for P1-176 cancer team approach in medical care Kenichi Ito 1, Kaori Miyazono 1, 先成玲美 1, Eri Muta summer 1, Shigeru Nagatomo 1, Furukawa incense 2, Naoko Mihara 2, Shirao uniformity 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2009.

---

It is ... about difference between P1-177 pyrimidine system anticancer drug and interaction in (S-1, UFT, 5-FU) between drug interactions - drug of the warfarin fluoride Hiroyuki Igarashi, Yasuhiro Maeda, Yoriko Kasamatsu, Kimiko Fukuyama, 寺下朋江, Hisako Ito, The Mizuno husband who congratulates it, Masaki Sano, Kojiro Takashima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2009.

---

	Fact-finding of the use of antiemetics for nausea of patients receiving P1-178 cisplatin and vomiting and the evaluation Kazumasa Koshikawa 1, Isobe mildness 2, Shinobu Hirayama 1, Kenji Nishizawa 1, Sakae Honma 2, Kan Noriko 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2009.

---

	Examination of the adverse event expression situation and the administration continuation in the P1-179 sunitinib administration Masatoshi Hayasaka 1, Kayo Sekikawa 1, Horikawa tomorrow or 1, Toshimitsu Nakayama 1, Noriko Miwa 1, Zenichi Yoshida 1, Satoru Takahashi 2, 丹正勝久 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2009.

---

	Report about the side effect of the molecular target drug for P1-180 renal cell carcinoma Kazumasa Yasui, Daisuke Suzuki, 市江敏和, 佐藤百合恵, Shogo Uchida, Akira Goto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2009.

---

	Proper use of the drug for skin reaction and the skin reaction by P1-181 EGFR-TKI Satoko Nagai 1, Tamotsu Horiuchi direct 1, Mariko Araki 1, Kawaguchi ともね 1, Masatsugu Ouchi 2, Takuya Fujita 2, Ryochi Ozaki 2, Shuhei Inoue 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2009.

---

	The making of the side effect monitoring sheet of the P1-182 Sioux tent capsule and the evaluation Misato, Kawasaki, Temple side Toshimitsu, Utsubo Yuko, Nobuko Omoto, Mikio Kakumoto, Makimoto Hiroo, Tsuyoshi Hirano, Hirai green Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2009.

---

	Problems for the use situation and the proper use of the G-CSF preparation in the P1-183 cancer chemotherapy Grass sincerity Harumi, Satomi Shiga, Hiromi Fujii, Auditor Hideo, Akemasa Imamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2009.

---

	Inspection of the prophylaxis of the vascular pain with the epirubicin hydrochloride for the P1-184 injection Yoshiaki Ochi 1, Fujitaka Rie 1, 五郎丸剛 1, Tei Hara Expo 2, Toshihiko Ushio 2, 篠原義剛 2, Kojiro Takahashi 2, Seiji Eto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2009.

---

	Research about hypomagnesemia with P1-185 cetuximab Shinki Yoshino 1, Prince Yasushi Takii 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2009.

---

Comparison of the effect on acute and delayed-action nausea, vomiting of a dexamethasone innovator drug and the generic drug in the P1-186 altitude emetic risk cancer chemotherapy Hideki Sato 1, Kengo Umehara 1, Yoshiko Wada 1, Keisuke Otsu 1, Pasture Azusa 1, First mountain Tae 1, Tooru Hayakawa 2, Inotsume Nobuo 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2009.

---

	The case that a xerostomia symptom after the P1-187 same kind hematopoietic stem cell transplantation improved by a gargle of the pilocarpine hydrochloride Masato Matsuura 1, Hitoshi Yoshida 1, Akie Kobayashi 1, Isono Junichi 1, Toru Sakura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2009.

---

	P1-188 The effectiveness of Bromazepam suppositories as antiemetic in outpatient cancer chemotherapy 柴田佳子1, 戸谷渡1, 瀧口友美1, 中野知代1, 中島生恵2, 高橋洋子2, 川地香奈子2, 横井麻珠美2, 伊藤良則3, 濱敏弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2009.

---

	Examination of weight loss criteria at onset of neutropenia in the P1-189 CBDCA+WeeklyPTX therapy Jin Arikawa period, Kimura Ito period, Kenji Nishizawa, Kan Noriko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2009.

---

	Examination of the injection method for vascular pain with the P1-190 vinorelbine and phlebitis evasion Yasuko Aizawa 1, Kumi Wada 2, Hisato Hiranuma 3, Yoshihiro Sato 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2009.

---

	Eruption measures of cetuximab using the side effect monitoring system in the P1-191 this hospital Saori Yamamoto, Noriko Moriwaki, 當真房子, Satoshi Taira, Terumi Nagahama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2009.

---

	Comparison of the injection of the 5-HT3 receptor blocker in the P1-192 lung cancer chemotherapy and the oral antinausea effect Yoshiko Wada 1, Kengo Umehara 1, Keisuke Otsu 1, Pasture Azusa 1, 初山多惠 1, Hideki Sato 1, Tooru Hayakawa 2, Inotsume Nobuo 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2009.

---

	One patient who was treated effectively with acetic acid octreotide for refractory diarrhea induced by P1-193 hydrochloric acid irinotecan Kushihara Hideyuki 1, Tomoe Miyasaka 1, Hiroko Kobayashi 2, 三輪眞純 1, Takeo Yamaguchi 2, Junichi Haruta 2, Kiyoshi Fujiyoshi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2009.

---

	Side effect investigation of the FEC therapy in patients with P1-194 breast cancer and the EC therapy Tomoe Miyasaka 1, Kushihara Hideyuki 1, Maiko Mukoyama 1, 三輪眞純 1, Noriko Kuwahara 2, Hama snipe Nagisa 2, Kiyoshi Fujiyoshi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2009.

---

	Correspondence to stomatitis to occur in head and neck cancer-treated patients in the P1-195 this hospital Hayato, Shibata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2009.

---

Action ... to side effect early detection in drug control instruction duties - cancer chemotherapy in the P1-196 this hospital urology department ward Harumi Teramoto, Yoko Ogawa, Shinichiro Matsuda, Riyo Kanbara, Reina Matsuda, Masumi Mitsui, Yuko Shimizu, Sakie Senoo, Mai Ito, Yoshihiro Inaoka, 田邨保之, Yuko Nakagawa, Takahiko Uno, Atsuko Inoue, Yu Okabayashi, Yasuhiro Haruna, 前岡翠, Chika Yamamoto, Kaoruko Onishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2009.

---

	Application of VAS to an anorexia evaluation with the P1-197 cancer chemotherapy Masako Aida 3, Noriko Yamashita 1, Mikami eyes 1, Maemura finding 1, Mina Yanai 1, Mitsue Shindo 1, Tsuneo Hamaguchi 1, Hilum Muneo Hayashi 1, Shingo Yamamoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2009.

---

	Evaluation of nausea with the polypharmacy cancer chemotherapy using P1-198 VAS Mina Yanai 1, Noriko Yamashita 1, Masako Aida 3, Mikami eyes 1, Mitsue Shindo 1, Tsuneo Hamaguchi 1, Hilum Muneo Hayashi 1, Shingo Yamamoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2009.

---

	P1-199 Use experience of the polaprezinc gargle water for stomatitis in the cancer chemotherapy 井上憲幸1, 中道晶子1, 渡邉亜貴1, 岩田有佳利1, 大野玲2, 山口友明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2009.

---

	Examination of the level classification of neutropenia according to the P1-200 regimen Open Koichi 1, Satoru Izumitani 2, 櫻下弘志 2, Yasuyuki Saeki 2, 吉田昭昌 3, Yasuhiko Sakata 1, Yonezawa sing; 1, Tree flat Kenji 2, Yasuki Tomota 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2009.

---

	Pain control of the patients who received P1-201 neck radiotherapy Noriko Tsuchiya 1, Seiji Abe 2, Yuji Odo 2, Junichiro Murayama 2, Yasuko Nakano 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2009.

---

	Examination and measures ... to numbness with the effect on P1-202 peripheral neuropathy - FOLFOX therapy of limaprost 枝廣茂樹 1, Toshio Matsunami 1, Kumagaya 1 required, Michiko Yamada 1, Mutsuko Okada 1, Genichi Nishimura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2009.

---

Effect such as the decomposition liquid on vascular pain to be caused during P1-203 hydrochloric acid gemcitabine administration Mika Hiraoka 1, Azusa Shimatani 1, 乗久雅子 1, 河原申弥 1, Hongo education 1, Akiko Higashiya 2, Ando spirit chapter 2, Tsutomu Bando 3, Shimamori beauty light 3, Seiji Sato 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2009.

---

	One case that mental neurologic symptoms developed during P1-204 mFOLFOX6 therapy enforcement, and came to have difficulty with chemotherapy continuation Takashi Yamahata 1, 藤澤守 1, Tetsuo Takebayashi 2, Masatoshi Sumiya 2, Naoya Fukuda 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2009.

---

	Frequency of hypomagnesemia by P1-205 Cetuximab and investigation of the expression time Eri Nakamoto, Yoji Imada, Maid of honor さあ village, Takashi Yokokawa, Kazunori Kawakami, Toshihiro Hama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2009.

---

	It is ... through participation in formulation study - graduate school ward training for nausea, vomiting with the P1-206 BEP therapy Haruka Ishizawa 1, Manabu Sakurai 2, Hisashi Fujiwara up 2, Sachiko Tomioka 2, 小林靖奈 1, Noriko Kamiyama 1, Junichiro Murayama 3, 山元俊憲 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2009.

---

	Examination of the factor to have an influence on the expression of the hematotoxicity with the carboplatin combination chemotherapy in patients with P1-207 lung cancer Yuji Konishi 1, Toshiyuki Matsuda 1, Yoshie Kanazawa 1, Kenji Matsuyama 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2009.

---

	Examination of psychroesthesia stimulation irritation induced by a single dose of P1-208 oxaliplatin Noriko Chiba 1, Takeshi Yamamoto 2, Upper part of a river Kazunori 3, Nobuyuki Katagiri 2, Iku Utsunomiya 2, Keiko Hoshi 2, Toshihiro Hama 3, Kyoji Taguchi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2009.

---

	Examination of P1-209 paclitaxel-induced peripheral neuropathy Satsuka 1, Mano, Nobuyuki Katagiri 2, Takeshi Yamamoto 2, Yoshiko Shibata 2, Kazunori Kawakami 3, Hideaki Ikeshima 2, Iku Utsunomiya 2, Keiko Hoshi 2, Kyoji Taguchi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2009.

---

One case that Olanzapine which we used for antinausea, a promotion of appetite purpose in patients with pancreas cancer during P1-210 chemotherapy responded to Natsuko Sugiyama 1, 3, Mitsue Masuda 1, Kaoru Hashimoto 1, Sugiura しず 恵 1, Reiko Oguma 1, Aiko Kanazawa 1, Isamu Hashimoto period 1, Kazuhiko Fujita 2, Komoda Masayo 1, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2009.

---

Examination about frequency and the risk factor of peripheral neuropathy in the P1-211 paclitaxel enforcement patient with breast cancer Yasumasa Tsuda 1, Kuniyoshi Sato 2, Yoshiko Harada 2, Yoshiyuki Tajima 2, Tetsushi Murayama 2, Kinuyo Matsuda 2, 閔貴善 3, Mitsue Saito 4, Hisahiro Yoshida 1, Kazuhiro Sase 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2009.

---

	The effect that withdrawal of oxaliplatin in the P1-212 mFOLFOX6 therapy gives to the onset of side effect Yuka Isaka 1, Masato Honma 1, 2, Toshikazu Moriwaki 2, Takeshi Shibahara 2, Akira Nakahara 2, 兵頭一之介 2, Koda good luck direct 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2009.

---

	Three cases of the anaphylactic symptom with P1-213 oxaliplatin Kabayama Tomoichi 1, 眞原達男 1, Hiroshi Morikawa 1, Michiko Matsumoto 1, Mikio Shiozawa 2, Katsumi Kurihara 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2009.

---

	Effect of sex differences to give it to hematotoxicity of the P1-214 gemcitabine hydrochloride monotherapy Atsushi Miura 1, 2, Masahide Onoe 1, 寺田智祐 1, Kazue Takahashi 1, Kenichi Inui 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2009.

---

	A comparison between P1-215 breast cancer and febrile neutropenia (FN) frequency for the hematologic cancer and analysis of the background factor Hiroyuki Sato 1, Mariko Aota 2, Masashi Sakano 2, 中村卓巨 3, Nobuko Umemura 1, 寺井文廣 2, 豊田行康 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2009.

---

Examination - of the efficacy of the transfusion warming law for phlebitis by action -Vinorelbine of the P1-216 Aichi Hospital Pharmacist Association on koro Gee meeting for the study Hideo Sasaki 1, Mariko Kobayashi 1, Tatsuya Hisada 2, 牛膓沙織 2, Hiroki Arakawa 2, Masahide Matsuzaki 2, Shinobu Nakayama 2, Atsushi Yoshida 1, Hiroko Saito 2, Akio Katsumi 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2009.

---

Action of the side effect investigation Aichi Hospital Pharmacist Association on koro Gee meeting for the study in the P1-217 paclitaxel carboplatin combination therapy Mai Ishikawa Yoriko 1, Saori Kato 2, Kushihara Hideyuki 3, Takashi Sakakibara 4, Yumiko Sone 5, 早見知浩 6, Pine reason Koji 7, Etsuko Mishima 1, Tomoe Miyasaka 2, Watanabe method man 8, Manabu Yokota 9, Itakura affinity 10, Hiroko Saito 11, Akio Katsumi 11 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2009.

---

	Examination about the side effect of administration method expression of P1-218 paclitaxel and the carboplatin combination chemotherapy Akira Hori charges 1, Eriko Takeo 1, Yoshihiko Sugino 1, 杢原香奈子 1, Kimura Kei and 1, Yuji Ito 2, 関剛 2, 大圓修身 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2009.

---

	Manual revision and measures - by measures - questionary survey in the P1-219 anticancer drug extravasation Hiroaki Sakurada 1, Miki Aoi 2, Masumi Yamamura 1, Aoyama Kei daylight 1, Interval Teruyuki 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2009.

---

	Examination of an investigation and the measures of the side effect in the use of P1-220 cetuximab patients Junichi Isogai, Shinji Ito, Reiko Konishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2009.

---

	1 case that experienced an allergic symptom during P1-221 docetaxel administration 早見知浩 1, Akihiro Saito 2, Masayoshi Tamaki 2, Takeshi Moriya 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2009.

---

	Examination about the beginning of dosage time of the magnesium oxide for the purpose of the prevention of constipation with the P1-222 (R-)CHOP therapy 森章哉 1, Takuya Iwamoto 2, Eiji Mitani 3, Tatsu Ito I 3, Megumi Kawakami group 3, Shinko Okuda 2, Yuko Nakamura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2009.

---

	One case that stomatitis with erlotinib improved with P1-223 betamethasone syrup 鹿浦香織 1, 野田能成 1, Yutaka Kubota 2, Hiroshi Hara 2, 小西偉雄 1, Tadashi Mikami 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2009.

---

	Present conditions ... in side effect expression of Bortezomib for the P1-224 multiple myeloma and measures - this hospital Kae Hanaoka 1, Takeshi Shimada 1, Valley water Kumiko 1, Masato Ishii 1, Yoshiaki Kita 1, Yasushi Hiramatsu 2, Atsuko Inoue 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2009.

---

	Action to a side effect investigation and proper use of the sunitinib in patients with P1-225 progress-related renal cell carcinoma Hiroki Tamaki 1, Noriko Komura 1, Tsuchie Kei incense 2, Satoshi Honda 3, Nobuhiro Nishimura 1, 直良浩司 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2009.

---

	Reduction of the injection site reaction (phlebitis) by the change of the P1-126 vincristine sulfate administration method Shinichi Kitamoto, Yuko Yanagida, 八島加八, 長崎信浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2009.

---

	P1-227 A study on the electrolyte fluctuations in antibody formulation cetuximab (Erbitux (R)) administration 吉田昭昌1, 櫻下弘志2, 開浩一3, 村瀬哲也2, 木村優美2, 立花広志1, 木平健治2, 寺谷一信1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2009.

---

About steroid administration for Infusion reaction reduction at the P1-228 Trastuzumab administration Naoko Tosa 1, Ryuma Sato 1, Kyoko Ohara 1, Ikuyo Toyota 1, Joji Mori 1, Satoko Fujiwara 2, Yukihiro Kawakami 2, It is still 2 Matsunaga, Ikegami English sentence 1, Sendo Toshiaki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2009.

---

	Seat making for P1-229 cetuximab side effect management and the utilization Tomoko Hara 1, Urashi Akiko 1, Virtue Yasumi Kazuko 2, Grass competitive game Kayo 2, Maki Yamamoto 2, 2 which is related to Nagano, 田中吏佐 3, Mitsugi Kenji 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2009.

---

	How do you cope with skin reaction of P1-230 cetuximab? 與田香奈子, Koichi Matsuo, Minako Higuchi, Saza book Yoshimi, Sanae Iwatsubo, Yoriko Wada, Hiroaki Nishino Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2009.

---

Action to peripheral neuropathy measures using neuropathy questionnaire (FACT/GOG-NtxV4.0) in the P1-231 bortezomib Koichi Matsumoto 1, Kazutaka Tsutsumi 1, Makoto Takahashi 1, Yuko Yoshimaru 1, Mieko Tsuruta 1, Hiroko Tsurusaki 2, Emiko Kawano 2, Keiko Suehiro 2, Tajima existence tree 2, Hiroko Miura 2, Rie Imamura 3, Michio Sada 1, Takashi Okamura 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2009.

---

	Blood pharmacokinetics and safety of oxaliplatin during mFOLFOX6 therapy in the P1-232 hemodialysis patient Kyoko Kimura 1, Rika Fukuda 1, Osamu Egawa 1, Masahiro Sakai 2, Tatsuhiko Nogawa 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2009.

---

	Trial of the sodium benzoate administration for the case that presented hyperammonemia by P1-233 5-FU 三角紳博 1, Great temple Masaharu 2, Takashi Nishino 1, 舛重正人 1, Tomisawa 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2009.

---

Fact-finding of the skin reaction at the P1-234 metastasis, chemotherapy of recurrent colorectal cancer impossible of excision West Kyoko Tsuji, 野間口寛, Reiko Kirino, Hisanobu Yukawa, Tomohiro Kakimoto, Takeshi Takahashi, Middle Yuka Kihara, Toyosumi Ayako, Kayo Ikemura, Morihiko Terashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2009.

---

	Invention of infusion reaction expression example and the dosing rate setting by P1-235 Cetuximab Kazuyuki Sunada 1, Kishimoto truth 1, Ogyou Yukiko 1, Long ヶ Takuma Hara 1, Yoshimura truth 1, Hirofumi Wakamatsu 1, Yayoi Shinmura 2, Zhongcheng Yuki 2, Fumiko Matsueda 2, 三阪高春 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2009.

---

	Fact-finding about the skin reaction in the P1-236 erlotinib remedy patients Makoto Hayashi 1, 2, Miwako Ogawa 1, Hayato Sugimura 1, Kenji Miyazawa 1, Akemasa Yamaya 1, Aspect shrine Koji 1, North Toshiyuki 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2009.

---

	Contribution of side effect peripheral neuropathy and the vitamin B12 deficiency of the P1-237 anticancer drug Nunotani Masako, Kaoru Kobayashi, Atsushi Kato, Yasuhiko Mimura, Isao Adachi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2009.

---

Making of the manual for the dietary counselling for the patients who induced eating disorders by P1-238 cancer chemotherapy Yumi Nagano 1, Kazuhiro Ishikawa 1, Harumi Takeuchi 2, Masami Sato 3, Masako Miura 3, Seishi Kondo 4, Yoshinori Hasegawa 4, Masayuki Miyazaki 5, Kiyobumi Yamada 5, Yukihiro Noda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2009.

---

	Comparison (a significant difference and noninferiority trial) about the effect of injection and the internal agent of antiemetics used at P1-239 chemotherapy Michiyoshi Kumi 1, City residence proton 1, Yasushi Nakagawa chapter 2, Kenji Suzuki 2, Yasuhiro Saeki 1, Masanobu Odaka 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2009.

---

	Side effect monitoring of the chemotherapy for patients with P1-240 S-shape colon cancer postoperative recurrent liver metastasis 高瀬槙子 1, 沼澤聡 1, Masayuki Yoshikawa 2, Yoko Ito 2, Junichiro Murayama 3, Takemi Yoshida 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2009.

---

	About medical narcotic change and cold water re-hat report in the P1-241 this hospital Rice month Yukinori, Hitoshi Yamada, Ken Suzuki, Samsung intellect, Shuji Yamazaki, Tatsuya Eguchi, Atsushi Sakai, Kazuhiko Nagai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2009.

---

	Questionary survey ... to use actual situation - palliative care unit and a regular hospital of the sedative adjuvant in P1-242 cancer pain Ise Mika Baba, Mizuho Takahashi, Kiyomi Sadamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2009.

---

	Opioid recognition investigation in the P1-243 this hospital Kenichi Osanami 1, Station Kyoko 2, Emiko Kashima 2, One straw Toyomi 3, Miki Hishi 3, Naoko Takaoka 4, Tadashi Tamura 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2009.

---

	It is ... through problem - questionary survey of the psychological care team activity in the P1-244 this hospital Hiroshi Kudo 1, 2, Aki Kuwajima 1, 3, Chiharu Hayashida 1, 3, Yuko Shinohara 1, 3, Yukiyo Funayama 1, Takeo Hashimoto 1, 4, Naoki Hatakeyama 1, 5, Taro Ono 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2009.

---

	The presence of change and the psychological care team of the use of medical drug in the P1-245 Fujinomiya Municipal Hospital and pharmacist duties Osamu Kitamura, Yoshinori Kobayashi, Hiroshi Kawaguchi fruit, Kazuo Katsumata, Toyohide Suzuki, Tatsuya Inaba, Takamitsu Kasai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2009.

---

	Evaluation ... of the penetrance of pulse-taking - WHO method cancer pain therapy of the cancer pain control in the outpatient of the P1-246 this hospital Takaki Mizutani, Shigeki Hirano, Yuko Deguchi, Aiko Fukui, Yamada Toru Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2009.

---

	Examination of the utility of octreotide for gastrointestinal obstruction of the P1-247 cancer terminally ill patients Watanabe method man 1, 3, 安村幹央 2, Takashi Uematsu 2, Shigeru Kiyama 2, Masatoshi Hayashi 2, 中尾真隆 1, Shigeto Abe 1, Keiichi Goto 1, Keiko Yamamura 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2009.

---

	Of the use trend of the opioid preparation in the P1-248 this hospital and the pain management, actually Akira Maruyama 1, Kazuaki Kojima 1, Miwa Takayuki 1, Yuko Isami 2, Emi Kishi 2, Michio Kimoto 3, Keiji Okada 4, Shinobu Araya 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2009.

---

	Change of the consumption of the opioid drugs by the psychological care team start in the P1-249 Saga Hospital Masashi Hashimoto, Higashijima good luck way, Tashiro early period, Aya Suzuki, Junko Ide, Yagi Hideaki, Yoshihiro Yasukawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2009.

---

	Example that somnolence was strongly seen in by combined medicine at P1-250 opioids increase in quantity Masayo Shimomura 1, Takashi Uemura 2, Takahiko Nakao 2, Toshiyuki Kadoi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2009.

---

	Comparison between skin reaction - reservoir model and MT type - after the pasting of the P1-251 percutaneous absorption type fentanyl preparation Chikako Numata 1, Reiko Teraoka 2, Kensho Emoto 3, Yagi Keiko 3, Hirai green 4, Shuji Kitagawa 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2009.

---

	Drug control instruction duties - cancer chemotherapy in the P1-252 this hospital obstetrics and gynecology department ward, relation ... to cancer pain relief care Yoko Ogawa 1, Harumi Teramoto 1, Shinichiro Matsuda 1, Yuko Nakagawa 1, Kyoko Kasahara 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2009.

---

	About a tendency to use of peripheral neuropathy with the P1-253 cancer chemotherapy and the sedative adjuvant Toshihito Komiyama, Yuka Nakamura, Of Aya Sugai, Deliverer of letters Yoshihito, Junichi Kubo, Yu Goto, Kaya Noriko, Descent from a mountain Koichi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2009.

---

	Efficacy of the oral naloxone at the P1-254 opioids administration, meta analysis about the safety 小松敏彰 1, Hiroki Okawara 1, Yuka Ishida 2, Mitsuhiro Sugawara 1, Mariko Arai 1, Hajime Matsubara 1, Kazuo Yago 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2009.

---

	The medical narcotic use situation in the P1-255 this hospital Yumiko Senoo, Akiko Asada, Tomoko Hayakawa, Nobuyuki Yokota, Yumiko Oshikiri Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2009.

---

	Activity report of the present conditions and the psychological care team charge pharmacist of the P1-256 this hospital psychological care team Kenji Goto 1, 2, Mariko Asai 1, 2, Tanaka reason princess 3, Rumi Yoda 3, Makoto Ishikawa flat 2, 酒井欣嗣 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2009.

---

	About the activities of the psychological care team in our P1-257 center Inside many protons 1, Gilt bronze Yoko 1, Tomonori Hirashima 2, Court Security Office Mika 1, Yoshie Tokuoka 3, Teruhisa Ishikawa 1, Nobuhisa Fukushima 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2009.

---

The activity of the mild medical project team in the P1-258 Inoue memory hospital and action of the pharmacy Yuki Kobayashi 1, 2, Tsuyoshi Katagiri 2, Hirotoshi Nakamura 1, Nobuhiro Imanaka 1, Tokuko Momose 1, Nihonyanagi Yasuko 1, Mayumi Kato 1, Kyoko Takei 1, 中山眞紀 1, Suda future 1, 立吉勝美 1, Yasuko Yoshimi 1, Junko Sasaki 1, 王伯銘 1, Straight Katsumi Shiroyama 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2009.

---

	Attitude survey about "the explanation" from a medical person at the P1-259 anticancer drug start of therapy Etsuko Arita 1, Satoshi Takeshita 2, Yukio Suzuki 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2009.

---

	The activity evaluation in the P1-260 psychological care team and problem of the future pharmacist Sumiko Hiura 1, 2, 3, Rei Kimura sand 1, Middle mountain village Tsu 1, 加藤裕芳 1, Toru Asayama 1, Ikumi Ito 2, Akira Nakamura city 3, Jiro Nagao 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2009.

---

	Relation (the second report) of the pharmacist to the P1-261 Toho University medical center Ohashi Hospital psychological care team Rei Kimura sand 1, Middle mountain village Tsu 1, Sumiko Hiura 1, 加藤裕芳 1, Toru Asayama 2, Ikumi Ito 2, Yoichi Nakamura 3, Jiro Nagao 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2009.

---

	The present conditions and problems of the end-of-life transfusion treatment judging from the transfusion guidelines for patients with P1-262 end-stage cancer West Yugo, Hiromi Motoyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2009.

---

	The case that tried control in internal use for pain of the last years of P1-263 rectal cancer Isao Yajima 1, Kumiko Ochiai 1, Natsumi Mukai 2, Takako Yajima 2, Tanaka Chihiro 3, Enomoto space arrow 3, Koichi Kubota 3, Yasuo Kumai 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2009.

---

	Comparison between opioid quantity of rotation - standard and real dose ... from P1-264 fentanyl patch to a morphine note Kenji Katsuragawa 1, Tatsuya Hisada 1, 牛膓沙織 1, 久保速三 2, Hideaki Ieda 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2009.

---

	Examination about the change of the use of opioid agent in the P1-265 palliative care unit Tatsuya Hisada 1, 牛膓沙織 1, Kenji Katsuragawa 1, 久保速三 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2009.

---

Examination - of the rescue dose using action - "rescue record list" of the P1-266 Aichi Hospital Pharmacist Association on koro Gee meeting for the study Mariko Asai 1, 2, Kenji Goto 1, 2, Tanaka reason princess 1, 2, Yasushi Yamamoto University 2, Mountain Seki wisdom 2, Maki Arakawa 2, Maiko Tanaka 2, Kani Kono 2, Yuka Maekawa 2, Yuri Terao 2, Suzuki sheath or 1, 2, Shogo Uchida 2, Iku Kawamura person 2, Yukio Toyama 2, Hiroko Saito 3, Akio Katsumi 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2009.

---

	Examination about the recognition of the pharmacist in the P1-267 cancer pain relief Hiroki Mase 1, Takuya Iwamoto 2, Kazuko Koyama 1, Masako Watanabe 1, Sachiko Kubo 1, 伊東貴利 3, Kenji Taniguchi 4, Tomohiro Miyake 5, 堀部千治 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2009.

---

	Examination of opioids and gabapentin doses in P1-268 cancer pain 宮部貴識 1, 2, 岡所扶実 1, Misato Tsuji 1, Kanako Kumagai 1, Yoko Ogawa 1, Morizu Hiroki 1, Mika Miyazaki 1, Sagisu Yoshiko 1, Oida chapter 1, Tabuse course 1, Storable duration ヒサ 2, Satoshi Kamiyama autumn 2, 所昭宏 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2009.

---

	Change of the opioid prescription after the P1-269 psychological care team organization Yoko Tokuyama 1, Kiyotaka Omori 1, Moat Kei foster child 1, Mika Maruyama 2, Shuichi 3 Kim, Yoshihiro Shimizu 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2009.

---

	Present conditions investigation of the early pain control in P1-270 cancer practice patients Naoko Tsuji, Masaki Manda, Small bath Takako, Yasuko Takinami, Miyuki Miyake, Kaori Ozaki, Keiko Noguchi, Hitomi Kawaguchi, Takami Fujii, 野際俊希, Fuminori Matsubara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2009.

---

Role of the activities of the P1-271 this hospital psychological care team and the psychological care team pharmacist Mizue Sato 1, Sachiko Koga 2, Kazumi Muta 2, Emiko Kaida 2, Sachi Nakamura 2, Tasuku Kimura Takako 3, Rika Fukuzawa 3, Manabu Koga 4, Eto ten thousand Yoshiko 4, Tatsu Tsukamoto straight 5, Yutaka Imamura 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2009.

---

The future problem that activity contents and the pharmacist of the psychological care team of the hospital attached to the P1-272 Saga University School of Medicine should achieve Sumiyo Iida 1, Mayuko Tanaka 2, 7, Megumi Fukuyama 3, 7, Chizuru Hayashi 4, 7, Yuji Ueki 5, 7, Hidetoshi Sato 6, 7, Fujito Expo 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2009.

---

	About the use situation of a mouth care drug and the anticancer drug in the P1-273 Nagasaki City municipal hospital Quantity lower Hiroko 1, Akemi Morita 1, Blackboard Noriaki 1, Arata Uchida 2, Shiro Tomiyasu 3, South Kazunori 4, 橋口順康 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2009.

---

	Present conditions investigation of the treatment with transfusion for patients with end-stage cancer in the P1-274 this hospital Kei Yamaguchi Taro, Naoya Uto, Masaru Nakagawa law of nature, Ichimura line celebration, Kuniko Sawada, Fukada chapter, Masaaki Yamato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2009.

---

	Activity evaluation of the P1-275 Fukuoka University Hospital psychological care team Kamura Motoki 1, Hisamitsu Takase 2, 7, 内山将伸 2, 7, Yuriko Nagatomo 3, Keisuke Kakihara 4, Kentaro Ogata 2, Ayami Hotta 5, 7, Kazunori Hirota 6, 7, Kojiro Nikami 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2009.

---

	Evaluation of the rescue dose judging from the prescription actual situation of the narcotic analgesic in the P1-276 this hospital Valley Daisuke 1, Toru Watanabe flat 1, Takashi Azuma 1, 岩尾岳洋 1, Side shop Yoshibumi 2, Toshiaki Nakamura 1, Mikio Masada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2009.

---

It is making and the examination of the transfusion treatment flow chart for gastrointestinal tract obstruction of patients with cancer the action of the P1-277 Aichi Hospital Pharmacist Association on koro Gee meeting for the study for terminal phase Sugawara sheath or 1, 2, Aiko Fukui 2, Chika Ieda 2, Mitsuru Suzuki 2, Masayo Tanahashi 2, Satoshi Hibi 2, Takeshi Maeda fine weather 2, Yukimi Matsuura 2, Koji Nakao 2, Teranishi 23s 2, Hiroko Saito 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2009.

---

	Clinical analysis - by polypharmacy effect - fentanyl patch and the morphine note combination of opioids for P1-278 cancer pain Toshihisa Hiraiwa, Minako Kumagai, 仙田典保 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2009.

---

	Gastrointestinal obstruction of patients with P1-279 progress, recurrent cancer, examination about an injection method and the efficacy of acetic acid octreotide Kiyoko Tanimura, Seiji Onda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2009.

---

	Activities after the psychological care team system change in the P1-280 this hospital Hitoshi Taniguchi 1, 2, Sono Kaji truth 1, 2, 市場泰全 1, Hideki Yoshida 2, Hiromi Oguchi 2, 岸口武寛 2, 大藤嘉洋 2, 下野玄英 2, Shoji Asakura 2, Keiichi Fujiwara 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2009.

---

	Effect of making and the formulation study support task of the opioid dose calculation sheet for the P1-281 PCA pump Koichi Tanabe 1, Tomoaki Ikezaki 1, Satoko Takeuchi 1, Jun Okubo 1, Kaori Yamaya 1, Hidenori Kitazawa 1, Keiko Murasugi 2, Murakami wish 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2009.

---

Examination of an apprentice of go, the psychological care education for the Shinnyu staffs that we obtained than P1-282 cancer professional education Yasuko Takeuchi 1, Kinuyo Matsuda 1, Taeko Suzuki 1, Saori Tominaga 1, Tetsushi Murayama 1, Masae Maruyama 2, Seiko Yamaguchi 2, Kuniyoshi Sato 1, Kazuhiro Sase 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2009.

---

	What do the patients who accepted P1-283 psychological care expect from a pharmacist? Shinji Ito, Junichi Isogai, Reiko Konishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2009.

---

	Construction of the prescription support system for the purpose of the proper use of the opioid analgesic for P1-284 cancer pain Tatsuo Nakagawa, Yoichi Hiraoka, Kazumi Kito, Akito Nagai, Takanobu Hashimoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2009.

---

	Suspension comparison with each apple juice in P1-285 temozolomide Satoru Tamura, Spring Masato, Koji Ito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2009.

---

	Use and evaluation of the checking prescription check system aiming at the safe use of the oral P1-286 anticancer drug Hitomi Ishigami, Eiji Yoneyama, Satoru Mase, Yuko Kuwayama, Toshiyuki Kubota, Yoji Sugiura, Akio Katsumi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2009.

---

	Making - of problems and invention - work manual obtained from the use of P1-287 thalidomide case Nozomi Nishida Kushiro, Mayumi Watanabe, Yukio Toyama, Tatsuya Muto, Hiroko Saito, Takaaki Hasegawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2009.

---

	The present conditions of the P1-288 anticancer drug exposure and future problem (the third report) Manabu Tanimura 1, Kyoko Tadokoro 1, Keiki Mori 1, Hiroaki Nagata 1, Yoko Hamaguchi 1, Tomohiro Miyake 1, Sessink P.J.M.2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2009.

---

	Inspection of the residual error to a lot of P1-289 anticancer drug preparation device 濱宏仁 1, Koichi Fukushima 1, Wasaburo Kataoka 2, Toru Hashida 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2009.

---

	P1-290 Construction of management and operation of THALED(R) capsule in the general hospital 上野千奈美1, 高谷紀子1, 坂本健一1, 宅江良隼1, 今田雅子1, 関本恭子1, 樫本考司1, 酒井洋子1, 原田保徳1, 片山雄太2, 麻奥英毅3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2009.

---

From the occurrence of doubt inquiry and incident situation in the evaluation -3 year of the P1-291 anticancer drug regimen order system - So Yamamoto one 1, Yusuke Takada 1, Chikako Sawada 1, Yasuyo Fujisawa 1, Yutaka Takahira 1, Norifumi Miyamoto 1, 服部暁昌 1, Hisano Ikeda 2, Crossroads daylight kernel 3, Morita Zhuang Jiro 4, Teruo Tanaka 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2009.

---

At P1-292 anticancer drug preparation evaluation - of examination -closed system(Clave(R)Oncology System) about preventive measures against pail radiation exposure and the economy Misako Takeda, The Tanaka immensity, So Yamamoto one, Yasuyo Fujisawa, Yusuke Takada, Norifumi Miyamoto, Yutaka Takahira, 服部暁昌, Teruo Tanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2009.

---

	Examination for safe cancer chemotherapy enforcement in the cottage-hospital out of P1-293 Yoichi Nakajima, 葉田昌生, Tadashi Mikami, Yoshiko Murakami, 山方志築, Wataru Shiraishi, Ikuhiro Nose Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2009.

---

	Analysis of the doubt inquiry about anticancer drug preparation in the P1-294 this hospital 谷之木佑歌, Hiroyuki Yamaguchi, Yasushi Sekiya, Ito wide commander, Shibata greens Satoko, North field Tomomi, Tomomi Iwakiri, Manabu Okumura, Kazuhiko Arimori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2009.

---

	Induction and use of the cancer chemotherapy regimen system that linked P1-295 electronic chart Hisae Shinichiro, 永野俊玲, Yusuke Sato, Toshiharu Asakura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2009.

---

	Construction of the registration criteria of the P1-296 cancer registration regimen and the operational system Osamu Abe Eiko, Funatsu Kumi, 工藤尚亨 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2009.

---

	Effect of the knowledge management of the anticancer drug by the P1-297 pharmacist Satoshi Sato, History of Sei Koshiba, Masaki Mizuguchi, Kan Yutaka Otaka, 松井佳彰, Takafumi Ichida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2009.

---

	How do make learn a preparation technology to P1-298 anticancer drug preparation inexperienced person; inspection - by - questionary survey? Reiko Koya, Hiroshi Hashiguchi, Kazuma Yano, Masae Kubo, Satoshi Shinoda, Terumi Miyazato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2009.

---

	About the use situation of the EGFR inhibitor in the P1-299 this hospital and the effect Masayuki Hoshino 1, Toshie Hoshino 1, Mayumi Yamada 1, Tomoko Umeno 1, Kiso Akira Hara 2, Tetsu Satohara 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2009.

---

	The actual situation of the initial dose in the treatment with P1-300 anticancer drug Takashi Otsuji, 胡井俊祐, Kiyomi Okazaki, Mitsuko Fujita, Yoshio Katsuyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2009.

---

Use situation investigation of the zoledronic acid for patients with P1-301 breast cancer Yukiko Goto 1, Ai Yoshida 1, Izumi Tanaka 1, Kita Hiroki Oka 1, 清水奈味 1, Yamamuro butterbur child 1, Masanori Mori 1, Katsuhisa Zaitsu 1, Non-Yoshiei will 1, Kondo New Year's Day 1, Shunei Maeda 1, Yasushi Okumura Expo 2, Great Tomofumi Sako 2, Nishimura law joy 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2009.

---

	Examination of the medical supplies adoption method for P1-302 drug purchase costs reduction Shoji Koiwa, Yasushi Akutsu, Uesugi chapter period, Ryo Kuroki Taro, Ryoji Kato, Toshiyuki Koga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2009.

---

	About the actual situation of the off-label use of the P1-303 antineoplastic Pine ヶ valley Kana 1, Marutani good period 1, Naho Ando 1, Satoshi Ichikawa 1, Satoru Nagata 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2009.

---

	Than an example authorized government affairs disaster by risk - occupational exposure of the healthcare worker who handled P1-304 ampoule anticancer drug ... Masako Kondo, Noriko Kawakami, Akira Nagayama, Kazumi Morishita, Toru Mano, Noge Ichiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2009.

---

	Examination about the handling of the antineoplastic tumor injection in the P1-305 healthcare setting Kanako Toyama 1, Tomoko Sakakura 1, Yukihiro Hamada 1, Rumiko Kondo 1, Hajime Matsubara 1, Kazuo Yago 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2009.

---

	Examination of the utility of eGFR in the P1-306 carboplatin doses setting Sumiyo Ito 1, Iku Kawamura person 1, 前田紗斗美 1, Kazuo Hotta 1, Masayuki Takeuchi 1, Masafumi Onishi 1, Saori Kato 1, Yukio Toyama 1, Hiroko Saito 1, Takaaki Hasegawa 1, Akihiko Wakatsuki 2, Etsuro Yamaguchi 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2009.

---

	Utility evaluation of the closed system system using the P1-307 anticancer drug preparation training kit Junya Sato, Kazufumi Terui, Nao Odagiri, Yumi Iwasaki, Emi Hosoya, Early hunting truth Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2009.

---

	P1-308 Cetuximab (Erbitux(R)) administration in our hospital and reporting of adverse reactions situation 此松晶子1, 2, 野口周作1, 宮内秀典1, 島田慰彦1, 2, 藤井さとみ2, 3, 吉野雅則4, 渡邊昌則2, 4, 高橋久美子3, 徳永昭4, 片岡博邦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2009.

---

	Reporting and problems ... about the excrement using action ... brochure of the pharmacist for the purpose of the P1-309 anticancer drug exposure reduction Kazuto Sato 1, Toshiyuki Hirai 1, Kenji Asai 1, Yasushi Akiyama 1, Seki Toshikazu 1, Kamiga Masahiro 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2009.

---

	Fact-finding about the present conditions of the P1-310 gemcitabine administration Goji Maeda, Hiroshi Sakata, Hiroyuki Matsubara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2009.

---

	Examination of the utility of closed ring system "cleveite on koro Gee system" and "PhaSeal" in the P1-311 anticancer drug preparation Maki Nakabayashi, Shiho Enami, Yoshiyuki Hayashi, Atsuko Koyama, Mihoko Shimizu, Hiroshi Hatano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2009.

---

	Examination about weight loss in the Gemcitabine monotherapy for P1-312 pancreatic cancer, the biliary tract cancer and the withdrawal change Hiroko Tai, Keiko Yamamoto, Kazunori Shimomura, Shinichi Kawaguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2009.

---

	Comparison - of examination - filtration device of the removal of the glass piece to mix at P1-313 glass ampule anticancer drug preparation Yuka Kobayashi 1, Hiroki Iwane 1, Ayumu Nozaki 1, 日置三紀 1, Ayako Kondo 1, Kazunari Ishii 2, Toshiko Aramiya 1, Hirokazu Nakanishi 1, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2009.

---

	Action for ensuring safety of the P1-314 cancer pharmacotherapy Masahide Sasaki 1, 伊林範裕 3, Tomoki Nakajima 3, Toshiaki Nakashima 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2009.

---

	Evaluation of "the cleveite (R) on koro Gee system" in the anticancer drug preparation that we included the priming by the P1-315 pharmacist in Takeshi Nakamura will, Hiromi Fujisawa, Tomoko Fukuda, Ayana Nakamura, Tsuneo Hamaguchi, Hilum Muneo Hayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2009.

---

	About regimen management and problems after the P1-316 chemotherapy Committee establishment Onaga Shinichiro, Rieko Murata, Sayaka Nakamura, Hamamoto good kernel, Takashi Chinen, Pre-night Miho, Tamotsu Hika Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2009.

---

	Relation of the pharmacist to cancer chemotherapy regimen examination in the P1-317 this hospital Mt. Ishii husband, Tsuyoshi Suzuki, Satoshi Yamada, Namba existence intellect, Ritsu Hashida, Kyan celebration, Consider among outsiders; a husband, 宇野司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2009.

---

	Examination -1 about the permeability of the antitumor agents in medical gloves to put on at P1-318 injection mixture preparation Fold Toyohito, Ryoji Yanagihara, Katsuhiko Nara, Toshihide Abe, Takashi Tomabechi, Taketo Yamamoto, Katsuyoshi Nakajima, Hiroshi Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2009.

---

	It is a 1 case receiving TS-1 for P1-319 patient on dialysis Shigeru Munemura, West Luo Teruo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2009.

---

	Examination of effect of treatment and the adverse event in P1-320 antiEGFR antibody Cetuximab Aki Kuwahara 1, Kawashima greens Yasuko 1, Taeko Saito 1, Naoko Hashiba 1, Yaeko Mishima 1, Keiko Takano 1, Yasuyuki Fukai 2, 芳賀紀裕 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2009.

---

	Construction of the cancer chemotherapy support system using the P1-321 marketing database The Atsushi Tomita sum, Tomoo Fujii, Katsuhiko Haneda, Masao Maeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2009.

---

	Examination of the accurate time of administration realization in the P1-322 5FU46 time continuous medication Yasushi Taniguchi tree, Masaru Kawase period, Temple Tai incense, Yoko Kataoka, Masahiko Kitagawa, 成尾千晶, Megumi Yamaguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2009.

---

About the anticancer drug pollution in the prevention of exposure objective saline packing administration set at the P1-323 anticancer drug bypass administration Shinya Nakanishi 1, 2, Fujitani Masanori 2, 3, Rie Bando 1, Miyako Kihara 1, 藤戸靖久 1, Yukiyo Monma 1, Hideko Iwasaki 1, Shinichi Sugiura 4, Hirokazu Nakanishi 5, 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2009.

---

	One patient whom serious drug eruption by P1-324 Sorafenib developed in Makoto Hosomi 1, Aimi Goto 1, Yu Miura 1, Masami Nishihara 1, Kohei Koyama 2, 稲元輝生 2, Masahiro Goto 3, 瀧内比呂也 3, Hiroshi Tamai 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2009.

---

	Cancer board in the P1-325 Kinki center Hospital Kayo Matsuura, Ryuta Urakawa, Sanae Hashimoto, 廣畑秀記, Eri Shibata, Katsunori Sakai, Katsuei Nanba, Yoshiro Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2009.

---

	P1-326 organized cancer chemotherapy regimen management and the effect Corner Yumiko Tsuji 1, Koji Moriya 1, Ko Tokuda period 1, Kiyonori Ueda 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2009.

---

	As compared with evaluation - other medical diseases for the medication medicine instruction to patients with P1-327 cancer - Utako Iwakiri 1, 2, Daisuke Kobayashi 2, Toshio Kubota 2, Rina Hidaka 1, Tottori part Kazuhiro 1, Keiji Suenaga 1, Takao Shimazoe 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2009.

---

Examination about the alcohol detection factor during the exhalation after the P1-328 paclitaxel administration 邉見 paste or 1, 谷口亮央 1, Sato male tree 1, Fujiko Kamata 1, Tomohiro Tada 1, Rie Kawamoto 1, Hatsumi Kikuta 1, Flat land tax 1, Jun Matsunami 1, Ryu Kobayashi 1, Yoshihiro Hashimoto 1, 柴波明男 1, Takao Murohashi 2, Muki Ryoji 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2009.

---

	Time series analysis of laboratory values in the P1-329 colorectal cancer chemotherapy 外石昇 1, 3, Shigeru Yako 1, Kazuhiko Yoshimatsu 2, Takao Katsube 2, Kenji Ogawa 2, Kozo Takayama 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2009.

---

	P1-330 Current status of Thaled(R) (Thalidomide) management and operation of in our hospital 渡辺麻理1, 2, 河井良智1, 長島章1, 荒井宏人1, 奥有紀子1, 松永貴志2, 佐原直日2, 入江誠治2, 三村進1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2009.

---

	P1-331 About use experience of Doxil (R) in the our hospital 奥有紀子1, 河井良智1, 長島章1, 荒井宏人1, 渡辺麻理1, 板橋香奈2, 香川秀之2, 三村進1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2009.

---

	Comparison of the adverse event expression situation according to the injection method of the P1-332 tea S one Taeko Saito, Aki Kuwahara, Skilled miner Naomi, Keiko Sunakawa, Homiki Ushigome, Kawashima greens Yasuko, Eriko Hiruta, Naoko Hashiba, Yaeko Mishima, Keiko Takano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2009.

---

Patients in P1-333 Aichi on koro Gee society for the study brochure making ... based on the adverse event analysis of Conditioning rejimen for action ... hematopoietic cells transplant Naoki Mukoyama 1, Yoshiaki Ikeda 1, Hiroyuki Niimi 1, Keiji Mizuno 1, 森章哉 2, Kenji Miyazawa 3, Ayumi Nakamura 4, Yuka Tanaka 5, Toru Maeda 6, Satoru Kato next 7, Katsuhiko Haneda 8, Kazuhiro Mori 1, Kiyoshi Fujiyoshi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2009.

---

	Making of the anticancer drug information paper for the P1-334 injection Yoshihiko Sugino 1, Akira Hori charges 1, Eriko Takeo 1, 杢原香奈子 1, Kimura Kei and 1, 大圓修身 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2009.

---

	P1-335 About impact on cetuximab (Erbitux (R)) clinical examination value at the time of administration 友井理恵子1, 下村好子1, 丁元鎮1, 桝喜恵1, 小枝伸行3, 山本幸子2, 屋木敏也2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2009.

---

	P1-336 Usage report of thalidomide in the treatment of multiple myeloma: Presentation of the problems at the time of introduction Thaled 野村浩英, 森真由子, 畑中勝義 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2009.

---

	Relation as the pharmacist to the chemotherapy in the P1-337 children region Miho Minami 1, Yoshiko Masaki 1, Kenji Takeda 1, Miwa Kishida 1, 近藤統 2, Masako Muroi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2009.

---

	The role of the pharmacist in the P1-338 colorectal cancer molecular target drug proper use team and the action Yusuke Noguchi 1, Yutaka Kawahara 1, Yoko Tokuyama 1, 3, Yoshida Noriko 2, Source Tomoyo beauty 3 to understand, Kiyoshi Uchiyama 4, Yoshihiro Shimizu 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2009.

---

	Inflection of the drug control system at the P1-339 thalidomide induction Takamitsu Ochiai, Aiko Fukui, Saori Nishiura, Tomonori Hayashi, Atsushi Hirata, Yutaka Matsuoka, Sada Tachibana sincerity Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2009.

---

	Examination of the factor which gives it to neutropenia of P1-340 docetaxel Miho Yamazaki 1, Yukiyo Funakoshi 1, Yasuyuki Saeki 2, Usui Kazuko Sana 2, Satoshi Sato person 2, Horizontal Kenji 2, Mamoru Nakamura 1, Katsuaki Takeda 1, Tadaaki Ogawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2009.

---

	The analysis of the doubt inquiry example in the P1-341 cancer chemotherapy and construction of the prescription support system Egoe Masayoshi 1, Child 1 too rare Mochinaga, Hideaki Tokushima 1, Koga 1 to bear, Sawako Doi 2, Kazuhiro Hirano 1, 中野行孝 1, Fujito Expo 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2009.

---

	Case study about 2 cases that showed hyperglycemia by colorectal cancer chemotherapy containing P1-342 oxaliplatin Kishimoto truth 1, Yoshihiko Shibayama 2, Kosaku Sasaki 3, Yoshimura truth 1, Kazuyuki Sunada 1, Ogyou Yukiko 1, Long ヶ Takuma Hara 1, Hirofumi Iwamatsu 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2009.

---

	Examination about Relative Dose Intensity of the AC therapy in the P1-343 breast cancer postoperative adjuvant chemotherapy Kenji Miyazawa 1, Makoto Hayashi 1, Hayato Sugimura 1, Akemasa Yamaya 1, Way ring Yoshio 2, Bamboo 2, Kawamo, Masato Kiriyama 2, Aspect shrine Koji 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2009.

---

	For successful execution of the P1-344 FEC100 therapy role - of - pharmacist 芦埜和幸 1, Takeshi Shibazaki 1, Nakamura incense Sumi 3, Yumiko Suzuki 3, Hijiwara life 2, Taku Asanuma 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2009.

---

	Action to patients with cancer explanation documentation by the P1-345 system induction Takae Koike, Yasuo Suzuki, 河内若代, Hiroko Miyake, Mitsuhiro Hatano, Yoshikuni Uchida, Takashi Hayashi clothes Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2009.

---

	Study on P1-346 granulocyte colony-stimulating factor-responsive affector 大中博晶, Jin Tsukamoto, Toshiaki Igarashi, Ryoichi Yano, Ukuru Watanabe is flat, Toshiaki Nakamura, Mikio Masada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2009.

---

	The present conditions of the intravenous alimentation management for the end-of-life cancer case that became poor in oral intake in the P1-347 this hospital Masashi Bando 1, Yuji Adachi 1, 田中育太 2, Hisai Hiroyuki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2009.

---

	P1-348 Study of platelet-derived growth factor α receptor (PDGFRα) gene expression in hepatocellular carcinoma 北山知里1, 伊藤理菜1, 小林江梨子1, 櫻田大也1, 須永雅彦3, 吉川正治4, 横須賀收4, 野村文夫5, 佐藤信範2, 上田志朗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2009.

---

Association with drug handling method and the workplace environmental pollution in the P1-349 anticancer drug preparation room Jin Yoshida 1, Keiko Miyajima 1, Toshiaki Yoshida 1, Shinji Kumagai 1, Shigeki Koda 2, Nishida measure three 3, Fujiwara season Yoshiko 4, Kenzo Moriyama 4, Yuzuru Yamazoe 4, 丁元鎭 5, Chie Mochizuki 5, Measure Kie 5, Makiko Hisada 6, Tomoko Takenaka 6, Kuridani Yoshitaka 6, 西井諭司 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2009.

---

	About an anticancer drug diffusion in the hospital pharmacy having a P1-350 anticancer drug preparation room Hiroyuki Nakano 1, Takahiro Sugimoto 1, Chie Mochizuki 1, 丁元鎭 1, 桝喜惠 1, Jin Yoshida 2, Keiko Miyajima 2, Toshiaki Yoshida 2, Shinji Kumagai 2, Shigeki Koda 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2009.

---

Environmental improvement case of the foreign chemotherapy room drug preparation room of this hospital by the P1-351 closed system infusion appliance induction Fujiwara season Yoshiko 1, Jin Yoshida 4, 古川諭 1, Island former Kenji 1, Tree temple Yasuhiro 1, 2, Valley Yoshihiro Mori 1, 2, Akira Kawaguchi example 1, Keiko Miyajima 4, Toshiaki Yoshida 4, Shinji Kumagai 4, Shigeki Koda 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2009.

---

	Making of the reporting booklet aiming at effective reporting of P1-352 Gefitinib and erlotinib Naoko Shibata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2009.

---

	Treatment evaluation of chronic myelogenous leukemia in the P1-353 Fukuoka University Hospital Kentaro Ogata 1, 2, Yasushi Takamatsu 3, 内山将伸 2, Kazuo Tamura 3, Kojiro Nikami 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2009.

---

	Participation of the intracellular signal transduction system in cisplatin resistance of P1-354 pharyngeal cancer cells KCP-4 大磯茂 1, Ryuji Ikeda 2, Kazuo Nakamura 3, Yasuo Takeda 2, 4, Shinichi Akiyama 2, 4, Katsushi Yamada 2, 4, Kaya Hiroko Sono 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2009.

---

	Fact-finding ... of the cancer medical care in action ... health drugstore of the P1-355 Kyoto cancer drug cooperation meeting Shinji Honda, Yasushi Meguro, Keiichi Ono, Yasushi Sunda, Imagawa grammar Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2009.

---

Likelihood to a relation of a medication observance of a contract degree check and the breast cancer recurrent prevention of patients with P1-356 breast cancer Iku Yamamoto reason, 駿田怜香, Makiko Fujiwara, Noriko Iwamoto, Hitomi Sumino, Sachiko Kimura, 舛野 Megumi, 宮宇地瞳, Akane Urata, Mariko Yamamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2009.

---

	If P1-357 procedure, environmental management is solid, the anticancer drug exposure is avoided? Ishimaru wide knowledge, Shinji Takayama, Keiko Nikaido, Mitsuru Shiokawa, Makiko Matsui, Kazumi Goto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2009.

---

	One or ... which may meet a spiritual pane at the patient compliance instruction of spiritual pane - why anticancer drug of P1-358 pharmacist and patients with cancer Kenichi in the new line Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2009.

---

The problems that were found from the use experience of the P1-359 closed system anticancer drug preparation system "cleveite (R) on koro Gee system" Shiota history on record 1, Junko Kuroda 1, Katsuhiro Kondo 1, Tetsuo Ezaki 1, Mototsugu Kojima 1, Shoko Shibamoto 1, Kayo Koike 1, 木村和哲 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2009.

---

	Examination about the effect of 50 mg of oxaliplatin preparation release judging from P1-360 economy, safety Yumi Tsuchiya, Masahiro Tsuda, Tadaharu Mukai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2009.

---

	Search of the anticancerous platinum chelate based on P1-361 exhaustive gene expression analysis-sensitive factor Thicket field Naoki 1, History of Hisashi Takara 2, 峯垣哲也 1, Kitada Noriaki 1, Masayuki Tsujimoto 1, 西口工司 1, Teru Yokoyama reason 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2009.

---

	Relation of a role and the pharmacist of P1-362 chemotherapy Committee Ryuta Urakawa, Kayo Matsuura, Sanae Hashimoto, 廣畑秀記, Eri Shibata, Katsunori Sakai, Katsuei Nanba, Yoshiro Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2009.

---

	Evaluation about the safety of the anticancer drug preparation in the P1-363 Kurashiki center Hospital Kanako Moriyasu, Kenji Nishimura, Koji Moriya, Ko Tokuda period, Kazunobu Takayanagi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2009.

---

	In P1-364 "gastric operations patients exchange meeting" the role of the pharmacist Michiko Nishie, Existence Reiko Sawa, Yasuko Watanabe, Kazunobu Takayanagi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2009.

---

	The present conditions and problem of the team approach in medical care in the immunoradiometric therapy with P1-365 ibritumomab tiuxetan (Zevalin) Minoru Hayashi exhibition, Motoaki Abe, 清水裕彰, Tomisawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2009.

---

	Action of the pharmacist in safety improvement and the efficiency of the cancer chemotherapy of the P1-366 this hospital 川野昭, Tatsuya Oishi, Hiroyuki Otake Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2009.

---

	Reporting of the cancer chemotherapy using the P1-367 medicine notebook and the evaluation Terumasa Sata, Kanako Maeda, Length well Nobutaka, Kimotsuki Miho, 中拂絵里香, The pond increase sweetfish beauty, Shrine gate Takanori, Kazuko Tanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2009.

---

	Evaluation of the permission system in the proper use of the P1-368 antimicrobial agent, report system induction Riding ground joy arch 1, Yoshiko Harada 1, Takako Okawa 1, Kazuyo Kondo 1, Kuniyoshi Sato 1, 堀賢 2, Kazuhiro Sase 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2009.

---

About P1-369 carbapenem system and usability of the antiMRSA medicine report system induction Hiroshi Matsumoto 1, 3, Takafumi Nagashima 2, Shigeo Hatta 1, Yuko Sakashita 1, 3, Toyoichi Miyamoto 3, Yo Sakurai fine weather 3, Yoshiko Nakatani 3, Fumiko Inoue 3, Hiroshi Tadokoro 3, Kyoji Yamada 3, Kazuhiko Matsushita 3, Yoshiaki Matsumoto 2, Keiso Masuhara 1, 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2009.

---

	The use situation and side effect investigation of the internal use sulfamethoxazole trimethoprim combination aiming at P1-370 proper use Shiho Enami, Yoshiyuki Hayashi, Wakimoto greens existence, Maki Nakabayashi, Hiroshi Hatano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2009.

---

	Use fact-finding of Linezolid in the P1-371 Fukuoka Red Cross Hospital Tatsuya Oishi, 川野昭, Hiroyuki Otake Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2009.

---

	P1-372 Study of factors affecting the expression of the decrease in platelets by linezolid : The need for dose adjustment 丹羽隆1, 2, 鈴木昭夫1, 大森智史1, 吉川武志2, 安田満2, 深尾亜由美2, 松浦克彦1, 後藤千寿1, 2, 村上啓雄2, 伊藤善規1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2009.

---

Antibacterial macromolecule nano structure body - that bacteriolysis does multiple drug same time resistant bacteria development -2 of the new antibacterial preparation for the P1-373 antibiotics resistant bacteria Asuka Hara, Masako Omura, Kazuto Otsuka, The Hisashi Shimizu up, Shingo Mikami, Castle Shoichi Take Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2009.

---

Newly antiresistant bacteria preparation - that development -3 of the new antibacterial preparation for the P1-374 antibiotics resistant bacteria used antimicrobial agent augmentation of the low, striped bamboo skillfully Yuki Fujiwara 1, 2, Akiko Kaneko 1, Jutaro Nakamura 1, Anabuki Eri 1, Hisashi Shimizu up 1, Eiichi Okada 2, Castle Shoichi Take 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2009.

---

	Reciprocity phenomenon - of the antibacterial activity that antibiotics conjugation nanocapsule shows development -1 of the new antibacterial preparation for P1-375 antibiotics Masako Omura, Asuka Hara, The Hisashi Shimizu up, Kazuto Otsuka, Castle Shoichi Take Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2009.

---

	The carbapenem-based antibiotic therapy to make the efficacy based on the P1-376 PK-PD theory contributes to pyocyanic selection pressure and spread restraint Yoshikazu Kobayashi 1, Yoshihiro Matsushita 2, Koji Ikuta 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2009.

---

	Examination about the administration method and the clinical response of the P1-377 ciprofloxacin injection Shinki Kasai 1, 2, 松尾和廣 2, 判治 fifth 1, Kimura Ito period 1, Tetsuya Hasegawa 1, Takayoshi Kosugi 1, Mitsutoshi Sato 2, Kenji Nishizawa 1, Kan Noriko 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2009.

---

	P1-378 Frequencies of the thrombocytopenia by the linezolid and examination about the recovery period 壁谷めぐみ, 湯浅周, 田尻千晴, 皆川葉子, 新木智映子, 加藤多恵, 河合優 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2009.

---

	Examination about the injection method of the Cefepim in consideration of MIC in P1-379 Febrile neutropenia Susumu Kudo 1, 丹代恭太 1, 蒲澤一行 1, Foot Miki Sawa 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2009.

---

	It is an action of the proper use of the antimicrobial agent using Etest in P1-380 PK/PD theory Takahashi sincerity 1, Takuya Ichikawa 1, Hiroko Otsubo 1, Riyoko Asami 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2009.

---

	P1-381 Pharmaceutical Intervention and its effect on multi-drug resistant prevention of Pseudomonas aeruginosa 新康憲1, 2, 吉岡睦展1, 2, 石村さおり2, 折田環2, 萩原裕子2, 春藤和代2, 児島正道2, 森亜子2, 渡雅克1, 竹中雅彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2009.

---

	A use of antimicrobial agent trend in the P1-382 this hospital and examination of the pyocyanic chemosensitive change 浅利伸朗 1, Takayuki Miyakoshi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2009.

---

	Action to P1-383 antimicrobial agent proper use Kazunori Yamada 1, Tatsu Tomabechi next 4, Woodcut former 1, Mitsuyoshi Ozaki 2, Satoshi Suzuki 2, Your Hisashi Tanaka 3, Tadashi Sekiguchi 2, Atsushi Hojo 2, Yasuharu Aimoto 3, Nobuhito Murakami 3, 岡亨治 2, 武田利兵衛 2, Tooru Hayakawa 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2009.

---

	Infection measures - 2007 report and evaluation - to wrestle in P1-384 area 田村健悦 1, Hiraga former 1, Hajime Nakai 2, Kazunari Nakamura 2, Kaoru Kobayashi 3, Ryohei Sakurai 3, 村上待一 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2009.

---

	Correspondence and antimicrobial agent proper use to the MRSA in the P1-385 orthopedics region Hiroshi Yamada group 1, 2, 3, Hiroshi Yamada length 1, Shuko Munakata 1, 宮崎晃臣 1, New Takuya Oka 1, Nobuko Kudo 2, Mutsuko Matsumiya 2, Masahiro Abe 1, New Taisuke Tobe 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2009.

---

	The making of the use of P1-386 inside the hospital antimicrobial agent guidebook and examination about the utility Yoshikazu Kobayashi 1, Mai Tanaka 1, Teruko Takano 1, Koji Masubuchi 1, Soichi Shibata 1, Yukio Suzuki 2, 3, Atsuta Koichiro 1, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2009.

---

	About the present conditions of the duration of P1-387 antiMRSA antimicrobial agent use Masahiro Someya, Yuko Ikeda, Kimishima Miyuki, 四方公亮, Toshiaki Murakami, Osamu Araki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2009.

---

	The use situation of the penicillin antimicrobial agent in the P1-388 2 Hospital Chie Okazaki 1, Keiko Morimoto 1, Keiko Yamaguchi 2, Chie Takahashi 2, Tadanori Suzuki 2, West Luo Teruo 2, Kazuyo Shimojima 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2009.

---

The intervention to P1-389 blood cultures-positive patients and medical economic effect by de-escalation of the antimicrobial agent Hiroshi Tanaka period 1, 2, Kazumi Taguchi 2, Mari Hirabayashi 1, 2, Mikako Namiki 1, 2, Kazuhisa Ugajin 2, Kenji Marumo 2, Rumiko Kawano 2, Toshiki Kikuchi 2, Toshitaka Takenouchi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2009.

---

	Examination of the injection method based on the PK/PD theory of the P1-390 carbapenem system antimicrobial agent meropenem Field stake Naoya 1, Hirofumi Fukushi 2, Kazuya Murata 1, Satoshi Kishino 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2009.

---

	Effect on resistant Pseudomonas aeruginosa isolation rate that P1-391 tazobactam / piperacillin gives Ryutaro Kawamoto 1, Yasuhiro Toda 1, Yuki Miyaki 2, Yamada Toru 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2009.

---

	Factor to affect the effect of treatment with the P1-392 antiMRSA medicine Kayo Sugimoto 1, Shoji Hashimoto 2, Yu Fujino person 3, Mitsuko Onda 1, Kazunori Asano 2, Arakawa line straight 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2009.

---

	Correspondence to infection consultation in the active relation antimicrobial agent use to infection treatment of the P1-393 pharmacist Nishimoto incense king village, Mari Nagatomo, South tree Arisa, 上山進 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2009.

---

Examination of the utility of the pharmacist intervention for the P1-394 antimicrobial agent proper use Toshihiko Ishizaka, Makoto Fukushima, 高橋直継, Masashi Nakagawa, Yukari Yoshihara, Hamada rabbitfish, Cape Ishibashi, Haruyo Okumura, Valley flat A Kei, Miyu Yonehara rice, Mika Kimoto, Miyatake wish, Junji Mukai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2009.

---

About the use situation of P1-395 LVFX and association of the quinolone resistant bacteria Yukari Yoshihara, Toshihiko Ishizaka, Makoto Fukushima, 高橋直継, Masashi Nakagawa, Cape Ishibashi, Hamada rabbitfish, Haruyo Okumura, Valley flat A Kei, U.S. Hara non-origin, Mika Kimoto, Miyatake wish, Junji Mukai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2009.

---

	Infection measures round to be possible even if P1-396 physician is absent Forest dynasty KIBUN Co., Ltd., Izuhara Satoe, Nakata eyes, Fumie Kamata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2009.

---

	Cooperation of P1-397 infection control specialty pharmacist and the ward pharmacist Kimihiro Ito, Shuji Nunokawa, 伊東利紗, Ryohei Sano, History of Satoshi Hori, Soil lower Yoshimasa, Kazuya Takeda, Hiroko Yamada, Yasuo Fujimura, Masaaki Kusumoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2009.

---

	P1-398 Examination of the effectiveness of the linezolid in the our hospital 阪野和重, 山内悠起子, 三木康弘, 中西俊介, 篝忠宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2009.

---

	About systematization of the blood cultures rate of use before the injectable antimicrobial agent administration according to the system in the P1-399 Shimane Prefectural center Hospital Katsuki Yokote, 滝雪歩, 森山史就, Sumiko Goto, 石野外志勝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2009.

---

	Fact-finding of P1-400 antimicrobial agent susceptibility and the use drug 滝波昇悟 1, Auditor Hideo 1, Akemasa Imamura 1, Kawai thickness line 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2009.

---

Effect of the intervention due to the infection control part which gives it to P1-401 antiMRSA medicine consumption 田中亮裕 1, 2, Shinichi Watanabe 1, 2, Kayo Nakano 2, Hitoshi Miyamoto 2, Kazuo Nakanishi 2, 流郷昌裕 2, Ryoji Ito 2, Hisashi Tauchi way 2, 守口淑秀 1, Yoshiro Ikegawa 1, 末丸克矢 1, Hitoshi Hasegawa 2, Kiyoshi Takada type 2, 相引眞幸 2, Masaki Yasukawa 2, Hiroshi Araki positive 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2009.

---

	Use situation evaluation of carbapenem system after the use of P1-402 registration system induction and the fourth generation cefem antimicrobial agent Yoshioka Nobumasa 1, Aki Kozono 1, Makoto Ishibashi 1, Ryozo Kobayashi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2009.

---

	Effect by the review of use antibiotics by the P1-403 orthopedic surgery Saori Hashiguchi 1, Motomura two 1 in total, Sadaji Irie 1, Koji Hashiguchi 2, Miyako Kanazawa 3, Tsuyoshi Machida 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2009.

---

	Action ... to the antiMRSA medicine proper use for patients with activity - infection with MRSA of the infection control team (ICT) in P1-404 nosocomial infection measures Kenichi Kobayashi 1, Akemi Kawakami 2, Takeaki Nishibori 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2009.

---

	Examination ... about the initial administration plan for all evaluation ... treated patients of the utility after the P1-405 antiMRSA medicine TDM system induction Hitoshi Suzuki, Yukiko Hayakawa, Katsuhiro Fuse, Yutaka Kamata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2009.

---

Use of antimicrobial agent experience to the patients whom multidrug-resistant Pseudomonas aeruginosa infection developed in after P1-406 cord-blood transplant all over the chronic GVHD course Hitoshi Yoshida 1, 2, First interview Naoko 2, Sachiko Sakurai 2, Mayumi Takase 2, Setsuko Hosobuchi 2, Teruo Yoshinaga 2, Isono Junichi 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2009.

---

	Making of the community-acquired pneumonia drug control instruction pass which adopted the monitoring of P1-407 vital signs Matsuda law of nature beauty 1, Satoshi Kataoka 1, Makoto Tanaka 2, Hidetoshi Tamura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2009.

---

	The consumption change of the P1-408 ethanol for disinfection product and the evaluation Noge Ichiro 1, 5, Kazumi Morishita 1, 5, Yuki Kato 1, Yoshiko Aoki 2, 5, Junko Watanabe 2, 5, Katsunori Sano 3, 5, Yasuhide Yoshida 4, 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2009.

---

	Examination of the infection prevention effect by the P1-409 hand lotion Mariko Aota, Masashi Sakano, 寺井文廣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2009.

---

	Mainly on P1-410 influenza measures questionnaire answer to infection control - from correspondence situation - 232 institutions of the whole country 高橋恭久 1, Yasuhisa Ozawa 2, Tetsuya Fukuda 1, Toshika Sato 3, Tei Yamaguchi husband 4, Taro Ono 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2009.

---

Use of multicenter antimicrobial agent pulse-taking (the first report) in the Tokai district using P1-411 Anatomical Therapeutic Chemical/Defined Daily Dose system Waterfall Hisashi 1, 2, Takumi Umemura 3, Yuichi Muraki 2, 4, 望月敬浩 2, 5, 片山歳也 2, 6, Ken Mori 2, 3, Takao Omagari 7, Nobuyuki Goto 3, 三鴨廣繁 8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2009.

---

An antimicrobial agent consumption investigation using ATC/DDD system in the P1-412 Tokai district and relations (the first report) of the pyocyanic carbapenem drugs-sensitive rate Takumi Umemura 1, Waterfall Hisashi 2, 8, 望月敬浩 3, 8, 片山歳也 4, 8, Yuichi Muraki 5, 8, Ken Mori 1, 8, Takao Omagari 6, Nobuyuki Goto 1, 三鴨廣繁 7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2009.

---

	About a hand-washing procedure and the hand washing situation in the P1-413 health insurance pharmacy Yoshio Mori 1, Ueno eyes 2, Naomi Ono 3, 4, Iko, Mayumi Inagaki 5, Kyoko Hayashi 6, Kazuyo Hashimoto 7, Reiko Okumura 7, Masashi Sakano 8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2009.

---

	An action to antimicrobial agent proper use by the intervention of the P1-414 pharmacist and the result Field road Akihiro 1, Yumiko Itani 1, Kunihiko Kagawa 2, Yoshio Kitamura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2009.

---

	Evaluation of the hand rough weather depression effect of the barrier type hand cream using making and that of P1-415 hand rough weather evaluation scale Risa Imamura 1, Masayuki Wakita 2, Tomomi Hoshino 2, Wave Noman Rie 2, Koichi Nobata 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2009.

---

	Comparison between influenza immunization situation and side reaction - in examination -2007/08 season and 2008/09 season of the P1-416 staff Toshiyuki Kaneko 1, 2, Mayumi Takahashi 1, Flat Hiroyuki 1, 後藤眞弥 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2009.

---

	Action of the citizen's comprehensive medical care center pharmacy attached to Yokohama City University in the P1-417 fever outpatient department Hiroko Abe, Eiji Azegami, Ishii great thinker, Shuichi Nawata, Mieko Miyazaki, Shinya Hashimoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2009.

---

	Study on problem in the TDM enforcement time utilization to have in P1-418 hospital information system Emiko Kageyama 1, Fukumoto piece beauty 1, Takao Orii 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2009.

---

	P1-419 acute leukemia, examination of the risk of the fungal infection onset for the patients with marrow aberrant type syndrome 土手賢史 1, 茂本孝裕 1, Ayumu Nozaki 1, Toshiko Aramiya 1, Hirokazu Nakanishi 2, Shoichi Doi 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2009.

---

	Comparison between Videofluorography and aspiration pneumonitis protective efficacy of the deglutition usability test by the language hearing person using P1-420 iohexol 樗木智聡 1, Satoshi Kamoshita 1, Tsuyoshi Yanagida 2, Kurihashi Hideaki 2, Masashi Shimomura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2009.

---

	Examination results ... in examination - VCM treated patients of the factor which has an influence on the effect of treatment of P1-421 MRSA pneumonia Junko Ogura, Akira Kato example, Rie Kobayashi, Wataru Arai, Yuichi Masuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2009.

---

	Chemical sensitivity and the use of antimicrobial agent situation (the second report) of P1-422 clinic isolation Pseudomonas aeruginosa Koya third son 1, Kosuke Baba 2, 野口雅久 3, Masanori Sasatsu 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2009.

---

	Examination about the use of the anti-biogram for P1-423 inside the hospital pneumonia The Minoru Watanabe beauty, Masaru Nakajima, Masako Oshima, Akiko Nakayama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2009.

---

	About antimicrobial agent by the increase of the P1-424 clinical path use patients-sensitive change Keiko Fujita 1, Yoko Yoshinaka 1, Hiroyo Masaki 1, Yoshihiro Sakagami 1, Emiko Tanaka 1, 脇條康哲 1, Tomoyuki Okada 2, Yoshikazu Sakagami 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2009.

---

Surveillance about the antimicrobial agent rate of use and the resistant bacteria isolation rate in the P1-425 Hiroshima throughout the prefecture 11 institution Masaaki Ikemoto, Yasuo Ogasawara, Taichi Okano, Salting Koji, Keiko Kawakami, Shintaro Kurihara, Takafumi Sugawara, 橋本佳浩, This Tawa ear, Toshiharu Matsumoto, 武郷徹, 八島加八, Masahiro Yasuhara, Masako Yasuhara, Kumi Yonezawa, Sawa Akihiro, Itoki Ryozo, Yutaka Tokushima, 三牧祐一, Tree flat Kenji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2009.

---

Action to infection measures improvement using P1-426 bacterial culture test result analysis tool Hidekazu Takamatsu 1, Takeki Nagatomo 2, 須志原陽子 3, Akira Tomita example 4, Kaoru Tateno 1, Kyoko Sato 1, Aratake Tomomi 1, Kaori Sato 1, 盛満博之 1, Akemi Nonaka 1, 盛満友美 1, Mari Kawasaki 1, Tomoko Kawakami 1, Takuya Sugiyama 1, Mai Iwamoto 1, Chiharu Mera 1, Chie Inoue 1, Taniguchi Maro beauty 1, Akiko Takemoto 1, Hama River Toshiaki 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2009.

---

	Antimicrobial agent proper use and evaluation for P1-427 postoperative infection prevention Maruoka eyes, Tetsuo Funamoto, Misae Takase, 飴谷太 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2009.

---

	Action to ICT activity and infection with MRSA surveillance in the P1-428 this hospital Yukiko Hayakawa, Hitoshi Suzuki, Katsuhiro Fuse, Yutaka Kamata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2009.

---

	P1-429 false puncture measures and preventive measures against occupation infection with the vaccination Hideyuki Yanagibashi 1, Tomoyuki Miyauchi 1, Nami Matsui 2, County Takayuki 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2009.

---

It is ... for ... basics disinfection confirmation enforcement from a present conditions investigation of P1-430 hand washing and the irrigation disinfection of the enteral feeding appliance Temple Tai incense, Yasushi Taniguchi tree, Masaru Kawase period, Yoko Kataoka, Masahiko Kitagawa, 成尾千晶, Megumi Yamaguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2009.

---

	Examination about the proper use of the antiseptic hand rub using the P1-431 hand washing checker Koji Muto 1, Wataru Takizawa beauty 1, Fujita Michiyo 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2009.

---

	About aspergillus measures with the P1-432 new ridge construction Takahashi fish to eat beauty 1, Atsushi Kubota 1, Koichi Mizuno 1, Jiro Mikami 1, This point Sumi 2, Emi Kuroda 2, Katsuji Teruya 2, Toshio Shimizu 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2009.

---

	About the detection situation of the MRSA in the P1-433 CCU Toshiyuki Irie 1, 道越淳一 2, 永山眞紀 2, Kazuhisa Masuda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2009.

---

P1-434 new influenza measures ... measures and new in-hospital system ... which we let you go through and obtained Mitsuru Machida 1, Maebara Kojiro 2, Hisashi Okada product 3, Katsue Hayashi 4, Teiko Ueda 4, Takuya Ebine 1, Naohisa Koseki 1, Orimoto 1, Katsura, Nihiko Sekine 1, Satomi Yoshida 1, Matsuyo Watanabe 4, Takumi Kubota 5, Shiro Sakamoto 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2009.

---

	A change of the injection antimicrobial agent consumption by the P1-435 DPC induction and effect on in-hospital isolate Masayuki Maeda 1, Miura Liao child 1, Chika Kawahara 2, Tadao Inoue 1, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2009.

---

Perform the questionary survey about infection measures in the health insurance pharmacy in action ... Higashiyodogawa-ku of infection measures in P1-436 regional alliances; and ... Kyoji Terasawa 1, Aiko Yamazaki 1, Ai Sakamoto 1, Uchiyama eyes 1, Tomoko Yamashita 1, Kitasato moral principles 2, Mayumi Yoshimura 3, Takashi Kochi 4, Ippei Morimoto 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2009.

---

	New influenza measures in the P1-437 fever ambulatory municipal hospital which there is not Takako Yuko, Yumiko Hara, Hosomi Kengo, Hiroki Sugita, Norio Masumoto, 大槻裕朗, Yoshihisa Takao Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2009.

---

Attitude survey for the authorized pharmacist system revision specialized in infection control by the P1-438 Nagasaki Hospital Pharmacist Association Tadayuki Harada 1, 2, Hiroo Nakagawa 1, 3, Saori Hashiguchi 1, 4, Yukiko Nagata 1, 5, Shinnichi Sado 1, 6, Koichi Kawasaki 1, 7, Takahide Araki 1, 8, Takashi Kitahara 3, Hitoshi Sasaki 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2009.

---

	The present conditions of infection measures in the health insurance pharmacy obtained from P1-439 questionnaire results Katsutoshi Takada 1, 2, Straight Katsumi Shiroyama 1, 3, Takao Aoyama 1, 4, 大澄朋香 1, Hiroshi Uno exhibition 1, Hisashi Iijima 1, Yoshikazu Ishino 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2009.

---

	Action for the P1-440 vaccination promotion Sangayama Hiroki 1, Emiko Kawano 1, Atsushi Ishida world 1, Ema Matsumoto 1, Naomi Nakamura 1, Hiroko Yasunaga 1, Etsuko Okuyama 1, Norio Takahashi 1, Shinsuke Mishima 2, Toshimasa Nishiyama 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2009.

---

	One discussion about new influenza measures in the P1-441 Hoshigaoka welfare annuity hospital Yoshiko Michishita 1, Takako Morita 1, Makoto Kimura plan 1, Mariko Tatsuno 1, Katsumi Oishi 2, Takato Nakamura 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2009.

---

	Correspondence to new influenza in the hospital pharmacy attached to the P1-442 Kobe University School of Medicine Hideaki Daimatsu, Takashi Ueda, Kazuhiko Yamashita, Nobuko Omoto, Mikio Kakumoto, Makimoto Hiroo, Tsuyoshi Hirano, Hirai green Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2009.

---

	Correspondence to new influenza (A/H1N1) of P1-443 seriously disabled child, the person institution and future problem Mika Arima, 大石美惠, Yamaguchi Miyuki, Takashi Mito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2009.

---

	The impact that P1-444 new influenza A(H1N1) gave in a hospital Rika Tomita, Michiko Kishimoto, Kumiko Ohara, Kanako Ukita, Hitomi Nomura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2009.

---

	About the making of the P1-445 "new influenza measures manual of the pharmacy" Yoshiyuki Tawada 1, Yukiko Kita 1, Hirotsugu Kita 1, 2, 伊波潔 2, Yuji Niisato 2, Koichi Ikehara 2, 与古田美智代 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2009.

---

	Measurement and analysis of measles, rubella, the mumps of the P1-446 new appointment healthcare worker and the serum antibody titer for the saricella virus Jun Hosoya 1, 2, Teiko Toyoguchi 1, 2, Tadashi Shiraishi 1, 2, Atsuko Omiya 2, Hiroyuki Umino 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2009.

---

	P1-447 Examination of prescription and characterization of severe wound treatment for a new formulation using Glyloid 6C (R) 廣瀬香織1, 笹津備尚2, 松本隆行3, 林太祐2, 4, 関根祐介5, 牛久保裕子6, 河野弥生2, 7, 原田寿7, 荻田義明2, 8, 堀川俊二9, 町田良治2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2009.

---

Participation of the pharmacist for the team approach in medical care in pressure sore due to P1-448 undernutrition Yusuke Nishinomiya 1, 名倉弘哲 2, 3, Yachiyo Sakamoto 3, Okuno sincerity branch 3, Yoko Sakagami 3, Takashi Senoo arrow 3, Kaori Miyake 3, Tree south Mika 3, It is still 1 Matsunaga, Sendo Toshiaki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2009.

---

	Intervention (the second report) to use of drug inappropriate potentially which assumed Beers Criteria for P1-449 Japan grounds Tomoyasu Watanabe 1, Megumi Yamazaki 1, Koichi Takatori 1, Tetsu Ando sincerity 1, Hirohisa Imai 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2009.

---

	Action of the pharmacist in the P1-450 dementia treatment ward Hiromichi Suzuki 1, Rika Suehiro 1, Tomoo Nakata 1, Shuzo Abe 2, Hironobu Kurita 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2009.

---

	Prescription investigation of elderly patients with dementia of the P1-451 this hospital Chikako Shimokawa, Kyoko Mori, Kazuko Yamada, April first day of a month Tomiji child, Seiichi Ishikawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2009.

---

	Safety assessment (the first report) of the magnesium preparation in P1-452 elderly people Yumi Akai 1, Tomoko Aoyama 1, Yukari Mihara 1, Shikishima Yayoi 1, Seven Jo connection 1, Flower shelf Akiko 1, Yoshiko Endo 2, History of country Yuichi 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2009.

---

Point to keep in mind in the safety assessment (the second report) of the magnesium preparation in P1-453 elderly people simple suspension method enforcement 賀勢泰子 1, Tomoko Aoyama 1, Yukari Mihara 1, Yumi Akai 1, Shikishima Yayoi 1, Seven Jo connection 1, Flower shelf Akiko 1, Yoshiko Endo 2, History of country Yuichi 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2009.

---

	Examination of the use drug for the standardization of the P1-454 mouth care Aya Wakamatsu incense 1, 2, North field Tomohide 1, Naomi Sogabe 1, Eriko Takano 2, Megumi Hashimoto 2, Hitomi Suzuki 2, Toshie Nagakura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2009.

---

	Analysis of the drug related factor to give to fall, the fall accident patients in the Mr. P1-455 care insurance institution 永瀬怜司 1, Mitsuru Iwasaki 2, Fujimura Hiroe 3, 植沢芳広 4, Okuyama immediate pupil 1, Mori Kiminori 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2009.

---

	Use situation investigation of second generation antipsychotics (SGA) in P1-456 psychiatry inpatients Long volost Chikako, Junichiro Kato, Kazuhisa Akaishi, Masaki Kitamura, Takashi Kawakubo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2009.

---

	Prescription fact-finding of the P1-457 antipsychotics It is still the beginning Tsuda, Jun Yoshizawa, Ai Takanashi, Kazutaka Nagashima, Shigeo Asai, Takashi Toyota Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2009.

---

	Retrograded investigation examination about the prescription situation of the P1-458 aripiprazole Tomoki Tanabe 1, Tsukiji jasmin child 1, 仲佐啓詳 1, Hiroshi Nakamura justice 1, Amount of Ariyoshi example 1, 伊豫雅臣 2, Koichi Kitada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2009.

---

	Fact-finding of antipsychotics and the mood stabilizer combination therapy in the P1-459 schizophrenia patient and analysis of problems Yuta Nakao 1, Yuika Takahashi 2, Kenichi Sagawa 2, Jun Ishigooka 3, Your Yu Akagi 1, Takao Aoyama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2009.

---

	Quit trial - triazolam and flunitrazepam of the P1-460 benzodiazepine drugs weight loss during adoption; and - Yuko Abe 1, Asako Endo 1, Koba Sani beauty 1, Kenzo Miyazaki 1, Koichi Oda 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2009.

---

	One patient who felt the need in consideration of interaction due to the P1-461 drug metabolism Yumiko Yada, 新美詠彦, Reiko Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2009.

---

	Relations of hyponatremia formation and the Ht level decrease in the P1-462 psychiatry region The Yasushi Mukai truth, Hideki Shiraiwa, Mitsuru Watanabe village, Long Mitsunori season Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2009.

---

	Analysis about the weight gain of atypical antipsychotic agents in the P1-463 University of Tokushima Hospital Yasushi Kirino 1, Kazuhiko Teraoka 1, Hisatsugi U.S. Toshihide 1, Kazuyoshi Kawazoe 1, Tetsuro Omori 2, Kazuo Mizuguchi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2009.

---

	Action of the pharmacist for the purpose of the prevention of the readmission in the P1-464 psychiatry Haruko Shimada 1, Kenji Doi 1, 山口長浩 2, Kaji tail a lot of years 1, Okada early period 1, Yuki Tokunaga 1, Yoko Fujii 1, Masako Ogawa 1, Hitoshi Harada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2009.

---

	Relation of the pharmacist to medication management, the education for patients in the P1-465 psychiatry hospitalization ridge Watanabe Tarou 1, 藏田康秀 1, Toshiyuki Imanaga 1, Miyoshi straight celebration 2, Shinji Isomura 3, 兼行浩史 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2009.

---

	Study on sodium valproate doses for P1-466 bipolar patients and therapeutic range Nagoshi hsiang tsai child 1, Yuki Tobita 1, 2, Takeshi Hirayama 1, 2, Chihiro Kawano 1, 2, Masaichi Kuroyama 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2009.

---

	About the effect that P1-467 smoking gives in the TDM of the psychotropic drug Satoru Koizumi child Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2009.

---

	Trial of the blood glucose monitoring in case of the P1-468 atypical antipsychotic agents administration Well bird Keiichi 1, Shu Hayashi Ichiro 2, Kazuhide Hayashi 2, Takashi Hayashi child 1, Tadashi Inomata 1, Kano South Seas child 1, Yumiko Ito 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2009.

---

	Report about the review of the antipsychotics using the CP reduced value in the P1-469 this hospital mind medical treatment ward Current Keita, Nagadome dance, Night Keiko, Hiroyuki Yoshinaga, Masazumi Imakiire, 中島泰廣, Hideya Samejima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2009.

---

About a serum magnesium level of patients with magnesium oxide preparation taking P1-470 Otaru City brain, circulatory organ, heart investigation in the medical center psychiatry Katsusane Tsurutani 1, 2, Ai Yokoyama 1, Mari Kasahara 1, Makiko Honma 1, Dotani 1-saving, Hiroshi Shirai 1, Akiko Takeya 1, High circle Yuji 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2009.

---

	Out of the hospital prescription situation investigation of the antipsychotics in the P1-471 schizophrenia outpatient Taisuke Fukushima 1, Toshie Ishii 1, Masako Kasahara 1, Koichi Watanabe 1, Ohira good luck 1, 恒木 Masami 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2009.

---

	Likelihood as antidepressants of P1-472 hydrophobicity dipeptide Leu-Ile Yoko Hibi 1, Atsumi Nitta 1, Takeshi Ikeda 2, Koji Morishita 2, Ebi Daisuke 1, Al cam torr loss 3, Toshitaka Nabeshima 3, Kiyobumi Yamada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2009.

---

	Construction of drug control instruction duties for the adherence improvement of the patients in P1-473 psychiatric hospitals Ball place Ai 1, Akira Sakai 2, Motoko Sato 2, Yukiko 2 between the pond, Kiyohide Matsuzaki 2, 田伏英晶 3, Yukihiro Noda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2009.

---

	The present conditions and problem of the P1-474 schizophrenia patient education (medicine classroom) Azusa Matsumoto, Yuichi Umeda, 進健司, Katsuji Hayashi, Shinsuke Takemoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2009.

---

Measurement of the stress-related material out of the saliva of patients with depression in the P1-475 psychiatry outpatient department Nobuaki Egashira 1, Naoki Uchida 2, Ayumi Ishibashi 3, Plover Shozo 2, Kenichi Mishima 3, Katsunori Iwasaki 3, Ryoji Nishimura 2, Ryozo Oishi 1, Michihiro Fujiwara 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2009.

---

	1 case that showed quality of life improvement by P1-476 team approach in medical care Miki Sato, 曽我師賢, Isurugi Ikuko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2009.

---

	Attitude survey of the pharmacy student for the schizophrenia patient with the P1-477 new curriculum induction Saito hundreds of branches beauty 1, Machiko Watanabe 1, Watanabe many Maki 1, Shigekazu Watanabe 1, 土屋雅勇 1, Keiko Yamaoka 1, Shinichi Niwa 2, Keizo Inoue 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2009.

---

About the questionary survey "background and consciousness of the seminar participant" about the pharmacist seminar specialized in psychiatry in the P1-478 Sapporo Hospital Pharmacist Association Isurugi Ikuko 1, 2, Takako Toi 2, 3, Miki Sato 1, 2, 斉藤嘉津彦 2, 4, Hongo education 2, 5, Kiyotaka Takeda 2, 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2009.

---

	Study - ever change about the media news (newspaper article) associated with the P1-479 sleeping drug for 20 years and discussion - Yoshinobu Sasaki 1, 堺慎太朗 2, Takeshi Hirayama 1, Field ヶ 谷浩邦 2, Masaichi Kuroyama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2009.

---

	Examination about division characteristics of the P1-480 suppository Asako Terashima, Kayoko Maezawa, Junko Kitsu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2009.

---

Questionary survey - Red Cross about the spread of P1-481 simple suspension methods, virtue County Council, Saiseikai, public welfare ream, count results ... of the medical treatment type Nishizono Kenro 1, 2, Koto Fujiwara 3, Junichi Iida 4, Teruaki Okura 5, 賀勢泰子 2, 6, Tetsu Ando sincerity 2, Is Kurata; see it; 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2009.

---

	It is ... for reevaluation - continuation-like inhalational instruction of the patient compliance instruction in the P1-482 inhalation steroid medicine 寺戸靖 1, Naoya Tanaka 2, Sumiko Kondo 1, Hidekazu Tanaka 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2009.

---

	About the Tocilizumab induction investigation for the RA patients in the P1-483 this hospital Yumiko Itani 1, Masao Nishida 1, Yoshio Kitamura 1, Shiro Oshima 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2009.

---

It is used fondaparinux in the VTE prophylaxis and the low molecular weight heparin properly after P1-484 cosmetic surgery procedures Hamada rabbitfish, Toshihiko Ishizaka, Makoto Fukushima, 高橋直継, Masashi Nakagawa, Cape Ishibashi, Yukari Yoshihara, Haruyo Okumura, Valley flat A Kei, U.S. Hara non-origin, Mika Kimoto, Miyatake wish, Junji Mukai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2009.

---

	About the association between use situation and change of the prophylactic antimicrobial agent cefazolin of the nonsteroidal pain-killer after the P1-485 operation on the heart Seiji Machida, Toshiaki Tomita, Masaru Fukushima friend, Kazuhisa Masuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2009.

---

	Relation of the pharmacist for the biological preparation induction pass hospitalization of patients with P1-486 articular rheumatism Tomoyo Nakajima 1, Asahara Minoru straight 1, Toshihiko Ushio 1, Kojiro Takahashi 1, Kazuhisa Nakano 2, Riyosai Tanaka 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2009.

---

	The use of opioids in the mild medical care of the P1-487 nerves intractable disease and the effect Natsuko Ishida 1, 佐野晃宏 1, Kazumasa Murakami 1, Chiho Ishida 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2009.

---

	Efficacy of clopidogrel for P1-488 patients with acute coronary syndrome and safe examination Ooi greens Yoshiko, Yukari Hayashi, Tsuyoshi Fujita is flat, Takahiro Murakami, Hiura Kazuya, Shuji Azuma, 高山範康, Takato Imai, Hiroshi Tamura, 目黒亨治, New home Kiminori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2009.

---

	Effect on effect of treatment of the P1-489 peginterferon weight loss and examination about weight loss criteria Fumiko Nagakura 1, Shigeo Hatta 2, Chisato Kawahata 2, Eiko Komiya 2, 浅見妥江 2, Yuko Sakashita 2, Keiso Masuhara 2, Ikuo Oike 1, Tomoji Osawa 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2009.

---

	A side effect evaluation at the P1-490 peginterferon ribavirin combination therapy and revision of the check list Katsuhiko Owada 2, Toru Numano 1, Yasuko Kumagai 1, Toshiaki Akatsu 1, Kato Kei Mizuki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2009.

---

	Comparison between characteristic - ticlopidine and clopidogrel of the onset of liver damage with the P1-491 thienopyridine system antiplatelet drug Naoki Shimomura 1, Mitsutoshi Sato 1, Daisuke Kishi 2, Koji Hamada 2, Keiko Fukuda 2, 雪吹周生 3, Kiyohiko Seino 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2009.

---

	Measures of the use situation and the side effect reduction of P1-492 temozolomide Kazuko Kawai 1, Satoru Kato next 1, Seiichi Ito 1, Takamitsu Akita 1, Noriyuki Maeda 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2009.

---

	P1-493 For the purpose of proper drug treatment of clinical Medicament business the way (23): Analysis of patient and a lot of drugs brought the remaining drugs number 神崎久美子1, 磯部芳江1, 鈴木聖1, 久保智美1, 樋口和子1, 小坂信二1, 福岡憲泰1, 飯原なおみ2, 二宮昌樹2, 芳地一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2009.

---

Consciousness - of the patients for way (24)- medication and the treatment of P1-494 clinical pharmacy duties for the purpose of the appropriate medical treatment Yoshie Isobe 1, Kumiko Kanzaki 1, Sei Suzuki 1, Sakae Matsuoka virtue 3, Masatoshi Kagawa 3, Shinji Kosaka 1, 福岡憲泰 1, Is Iibaru; see it; 2, Masaki Ninomiya 2, 芳地一 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2009.

---

	P1-495 Therapeutic effect and the viral kinetics of PEG-IFNα-2b and Ribavirin combination therapy for type 1 and high viral load chronic hepatitis C : Use the Rebound Index 笹瀬典子1, 中尾啓子1, 山本香織1, 志方真央1, 木村訓世1, 大谷綾1, 金啓二1, 浅田裕美子2, 白川祥実2, 黒田絵理2, 北河修治2, 門前縁3, 吉野伸3, 金守良4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2009.

---

A utility and safety of the double filtration plasma exchange (DFPP) combination IFN therapy for the P1-496 chronic hepatitis C intractable case Kaori Yamamoto 1, Keiko Nakao 1, Shikata Mao 1, Satoshi Kimura world 1, Aya Otani 1, Bamboo grass shallows Noriko 1, Keiji 1 Kim, Yumiko Asada 2, Sho Shirakawa true 2, Eri Kuroda 2, Shuji Kitagawa 2, Door front relationship 3, Shin Yoshino 3, 金守良 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2009.

---

	Efficacy of the rosuvastatin in P1-497 elderly people and safe evaluation Kazutaka Hiraga, Hiroshi Yamamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2009.

---

	Child dose of the renal excretion type drug based on P1-498 physiological fluid volume distribution and the renal function development Hiroyuki Miyazaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2009.

---

	Clinical significance of the foreign antimicrobial agent intravenous-injection treatment in the P1-499 community-acquired pneumonia Risa Takagoshi 1, Takao Shimizu 2, Shinichi Nakamura 1, Willow comfort intellect justice 2, Yoshihiko Kida 1, Ken Sano 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2009.

---

	It is ... through relation ... graduate school ward training to pharmacotherapy in the P1-500 ischemic heart disease Mari Ishikawa picture 1, Sayaka Takahashi 1, Sachiko Tanaka 1, 沼澤聡 1, 北原加奈之 2, Koji Karasawa 2, Junichiro Murayama 2, Takemi Yoshida 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2009.

---

	About the lipids improvement in the P1-501 insulin resistance improvement agent Kana Kato, Takako Nakajima, Yuichiro Wada, Sakaki source Yoichi, Eri Wakita, Shigeru Yamada tree Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2009.

---

	Examination of the effect of the bevacizumab intravitreal administration on P1-502 growth diabetic retinopathy Okuyama immediate pupil 1, 2, 永瀬怜司 2, Nozawa (Ishii) Reiko 3, Koichi Takeuchi 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2009.

---

	P1-503 anti-peptic ulcus agents sofalcone improves the inflammatory interaction of fat cells and the macrophage and restrains the differentiation of fat progenitor cells Kenji Onda, Hideaki Tanaka, Nakamura star, Tomoya Tazaki, Toshihiko Hirano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2009.

---

	Effect on examination - arteriosclerosis risk factor - of the medical treatment evaluation check seat of the drug control instruction duties standardization for P1-504 acute myocardial infarction inpatients Kyoko Nomura, 岡城彩, Kiyotaka Inoue Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2009.

---

	Examination and efficacy of the methotrexate (MTX) dose at renal dysfunction in the P1-505 articular rheumatism (RA) patients Aya Yoshida 1, Yukiko Ishii 2, 小林靖奈 1, Takeo Isozaki 3, Ryo Takahashi 3, Noriyuki Yajima 3, Yusuke Miwa 3, Tsuyoshi Kasama 3, Junichiro Murayama 4, 山元俊憲 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2009.

---

	Investigation of the factor influencing anticoagulant action of heparin in the P1-506 percutaneous transluminal coronary angioplasty Ito greens wave 1, Ayumu Nozaki 1, 茂木孝裕 1, Tomoko Fujita 1, Toshiko Aramiya 1, Hirokazu Nakanishi 2, Enjoji Yoshihisa 3, Shigeru Nakamura 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2009.

---

	Advantage of drug control instruction duties in National Cardiovascular Center where P1-507 medicine and surgery makes concomitance Yuta Kato 1, 小嶋文良 1, 2, Tomoya Sato 1, Teiko Toyoguchi 1, Tadashi Shiraishi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2009.

---

	Examination of the arteritis depression effect with the antiTNF - alpha therapy using the P1-508 kawasaki disease arteritis model Hiroshi Mamata 1, Seki, Ohara Toshiaki 2, Satoshi Muto 3, Mizuho Takahashi 1, Satoshi Takahashi 2, Kiyomi Sadamoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2009.

---

	Making of the P1-509 kawasaki disease fur Matthew tical care worksheet 詫間章俊 1, Hitomi Wakabayashi 2, Fuke Shunnya 2, Junichiro Murayama 2, Yasuko Nakano 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2009.

---

Trend of the use of chronic hepatitis type B therapeutic drug patients in the P1-510 this hospital Landowner Takafumi, Up valley Kana, Naoya Suzuki, Tomoaki Hatakeyama, Maiko Segawa, 嶽石茉里, Shohei Kawahara, Makoto Takahashi, Jin Hatanaka University, Hiroshi Iwamoto, Masaomi Tanaka, Tadahiro Aota Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2009.

---

Study of the peripheral T cells-related factor about utility of the cyclosporine therapy in P1-511 patients with myasthenia gravis Sachiko Tanaka 1, Nao Yamada 1, Kanako Nakajima 1, Masayuki Masuda 2, Nobuhiro Ido 2, Takashi Otsuka man 2, Masashi Nishida 2, Hironari Utsumi 2, Toshihiko Hirano 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2009.

---

	P1-512 Study of health-related QOL of PEG-IFNα-2a and PEG-IFNα-2b in patients with chronic hepatitis C 杉本智恵子1, 平野克治2, 玄田拓哉2, 市田隆文2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2009.

---

	Examination about the number of the concussion method of the P1-513 suspension type fixed-quantity aerosol-type inhalational steroid medicine and the necessary concussion Masashi Sakano 1, Izumi Shimada 2, Takasaki lawn world 3, 柏宗伸 4, Ryo Matsushita 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2009.

---

	Utility of the trainer, exercise device in the P1-514 inhalational instruction Mitsuyo Takemura 1, Fusa Honna beauty 1, Kyoko Kaga 1, Akira Kodama person 1, Shinsuke Mori 1, Appearance open Toyoko 1, Fumio Tsuji 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2009.

---

One case that used a cyclosporine ophthalmic solution together for eyes lesion in toxic epidermal necrolysis that progressed from P1-515 Stevens-Johnson syndrome Yagi Takahiko 1, Etsuko Honda 2, Hideki Mori 2, Masaru Inoue 3, Mutsuko Kato 4, Kazuaki Shinomiya 1, Sendo Toshiaki 5, Manager former man 2, Yoshihisa Kitamura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2009.

---

	Likelihood of weight loss, the cancellation of the steroid medicine internal use in infliximab treated patients of the P1-516 this hospital Akemi Nonaka, Kaoru Tateno, Aratake Tomomi, Kaori Sato, Hidekazu Takamatsu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2009.

---

	Examination of the pain relief by the P1-517 clonidine 盛満友美 1, Kyoko Sato 1, Hidekazu Takamatsu 1, Takeshi Uno 2, Shingo Tateyama 2, Ritsuko Ono 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2009.

---

	Hypotensive effect of ethyl icosapentate (EPA) for the patients who complicated P1-518 arteriosclerosis obliterans and hyperlipidemia Eri Sugiyama 1, Sato Bansei 2, Yukiko Takahashi 1, Daisuke Teraoka 1, Takafumi Nagatomo 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2009.

---

	Evaluation - of making and the utility of patient compliance instruction - medication manual for the P1-519 HIV outpatient Mariko Arai 1, Marie Nakamura 2, Hiroyuki Tanaka 1, Ayako Wada 1, 斉京明子 1, Hajime Matsubara 1, Kazuo Yago 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2009.

---

	The present conditions of the pharmacist intervention to foreign HAART in the P1-520 St. Marianna University School of Medicine Hospital Kanako Nakajima 1, Kano sheath or 1, 濱野公俊 1, Mieko Yokoyama 1, Yorihisa Miura man 2, Keiso Masuhara 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2009.

---

	About the present conditions and the problems of questions and answers about the pharmacotherapy to P1-521 pregnant woman, nursing mother Aya Hachisuka 1, Soichi Shibata 2, Teruko Takano 2, Kuwahara Funato charges 2, Koji Masubuchi 2, Atsuta Koichiro 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2009.

---

	Case control study about the use of antimicrobial agent during P1-522 pregnancy Kudo sheath or 1, Bamboo blind Takashi 1, Eriko Kobayashi 1, Daiya Sakurada 1, Noboru Sato example 2, Shiro Ueda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2009.

---

	Making of the brochure about nursing and the use for the P1-523 nursing mother of drug 丸田樹明, Katsuyo Akiko, Yuko Tanaka, Yasuhiro Tomita, Chiyoko Arima, Ikuo Nagata, Mieko Tsuruta, Michio Sada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2009.

---

	Attitude survey for medical supplies, the supplement of the pregnant woman who participated in the P1-524 mothers' class Yoshiyuki Miyasaka, Maho Miyake, Saori Takano, 山口茉都夏, Cheap Takeo, Relation bowl Hideo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2009.

---

	"Consciousness for the medicine" of P1-525 pregnant woman, the nursing mother and the related factor Takagi Kayoko 1, Iwaki Akifumi 2, Mitsuko Onda 1, Arakawa line straight 1, Naoki Nishikawa 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2009.

---

	From questionary survey in the P1-526 BFH Hospital (to the action program of the pharmacist) Iwaki Akifumi 1, Takagi Kayoko 2, Mitsuko Onda 2, Arakawa line straight 2, Naoki Nishikawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2009.

---

	Attitude survey for the self-medication of P1-527 pregnant woman, the nursing mother Tomoko Fujita 1, Kaoru Nakajo 1, Hiromi Kinoshita 1, Nakamoto celebration of longevity husband 2, It is still I 2 Tokuyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2009.

---

	Prediction of the milk transitivity using the properties of matter parameter of the P1-528 drug Koedo Taiki, 伊藤晃成, Hiroshi Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2009.

---

	Use experience of the low-dose aspirin in the P1-529 anti-phospholipid antibody syndrome Emi Honda 1, 今田愛也 2, Tail Asuka Sako 1, Mayuko Soma 1, Yoichi Sasaki 1, Hiroshi Yoshida 3, Noboru Sato example 4, Inotsume Nobuo 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2009.

---

	Investigation - in attitude survey - mother class about the medicine of the P1-530 pregnant woman Kazuko Uematsu 1, Eiko Kobayashi 1, Masanobu Odaka 1, Hiroko Imoto 2, Kana Hashimoto branch 2, Mitsuhiro Sugimoto 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2009.

---

	Relation of the pharmacist in the maternity ward of the P1-531 this hospital Saki Watanabe child 1, Tomura sum rare 1, West Tomoko 1, Let go through; Akiko 1, Teahouse Yukiko 2, Akemi Inoue 2, Hiromi Motoyama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2009.

---

	P1-532 Creating side effects expression situation and the patient for side effects description brochure of pregnant women who were administered Utemerin 増田はるか1, 小坂好男1, 漣由水1, 牧野仁美2, 正岡直樹3, 坂井昌人4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2009.

---

	Examination of usage and the blood magnesium level of P1-533 magnesium sulfate preparation Yoshie Nomura 1, Rock fence Shigeki 2, Takahiro Kumagai 1, Yukiko Shibata 1, Yumi Suzuki 1, Takuya Goto 1, Makoto Nakajima 1, Kimio Wakabayashi 1, 加藤浩充 1, Shuichi Matsumoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2009.

---

Fact-finding of the P, Ca level of the patient on dialysis by the P1-534 multicenter conjugation Shintaro Takayama 1, Kazuharu Fukuno 2, 10, Hideki 3 in the appearance, 10, Ryu Kobayashi 4, 10, Tatsuya Ito 5, 10, Masaru Fujii 6, 10, Kimito Oshita 7, 10, Takayuki Miyakoshi 2, 10, Hideki Sato 8, 10, Kiyotaka Takeda 3, 10, Michiya Kobayashi 9, 10, Koji Saito 9, 10 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2009.

---

	The renal function investigation of the patients in the P1-535 chronic disease internal medicine outpatient department and promotion of the appropriate administration 中村孝佑, Hiroshi Yamazaki man, Masanori Oda, Fumiaki Miyamae, Kawano table Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2009.

---

	Relation of fact-finding and the pharmacist of the chronic renal failure in the P1-536 acute phase ward Hiroshi Hori child, Yuko Kuroki, Kumagaya wish, 大汐欣輝, Junko Fukunaga, Kyoko Yamaguchi, Posterior Hiroyuki Sako Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2009.

---

	Effect to give to the serum potassium concentration of the drug in patients with renal failure for P1-537 conservation period Takenoshita Minoru Eda 1, Noriko Takeuchi 1, Ayano Kato 1, Eriko Kobayashi 1, Daiya Sakurada 1, Noboru Sato example 2, Shiro Ueda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2009.

---

	About the effect of treatment with the optimal dose by the P1-538 renal function degeneracy Takuma Oiwa, Hiroshi Sakata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2009.

---

	The present conditions and problem of the composition of the amino acid preparation in the parenteral nutrition performed in P1-539 blood maintenance patient on dialysis Yasushi Asai term, 東敬一朗, Hiroko Okawa, Sparrow good luck way, Kenichi Miyamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2009.

---

	Pharmaceutical management in medical treatment patients using the P1-540 CKD check sheet Junko Fukunaga, 大汐欣輝, Hiroshi Hori child, Posterior Hiroyuki Sako Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2009.

---

	Examination about the anemia in renal disease treatment manual in the P1-541 patient on dialysis 松井七奈 1, Masaru Watanabe 1, Yu Kubo 1, Miyuki Imada 1, Yumi Abe 2, Shunichi Fujita 2, 儀間充 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2009.

---

	About effect on renal function of ARB in the P1-542 CKD patients Hiroshi Hozumi, Masayuki Hirose, Yoichi Sakakibara, Yuichi Takemoto, Ayumu Ichimura, Hiromi Sakai, Shigeru Yamada tree Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2009.

---

	For support of the formulation study depending on CKD measures renal function by the P1-543 pharmacist Ema Matsumoto, Emiko Kawano, Sangayama Hiroki, Hiroko Yasunaga, Naomi Nakamura, Etsuko Okuyama, Niizaki Takao, Norio Takahashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2009.

---

	Examination of the efficacy of the China Cal Seto hydrochloride for the secondary hyperparathyroidism under the P1-544 maintenance dialysis 宮宗宏, Ayako Oka, Hiroshi Kita University, 横尾賢乗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2009.

---

	The effect that P1-545 calcium receptor agonist gives to the serum oxidative stress of patients with secondary hyperparathyroidism Hiroshi Watanabe 1, Akira Tokunaga oneself 1, Katsumi Mera 1, Motoko Tanaka 2, Masashi Fukagawa 3, Odagiri A tree 1, Toru Maruyama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2009.

---

	About the correspondence to the new style of the adverse event report with the P1-546 revised GCP enforcement Masami Kawahara 1, 2, Kenichi Miyamoto 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2009.

---

	The setting of the special germfree laboratory in conformity with the P1-547 investigational new drug GMP and the use Machiko Oka, Toyokuni cherry blossom Hideaki, Jun Yonezawa, 寺田智祐, Toshiya Katsura, Kenichi Inui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2009.

---

	Examination about the cost effectiveness of P1-548 clinical report coordinator duties Mizue Shida 1, 2, Yumiko Saito 1, 2, Mika Maeda 1, 2, Naoko Kamimiya 1, 2, 高橋賢成 1, 2, Yukio Ogawa 1, 2, 佐藤士朗 2, Yasuhiko Ikeda 2, Yuji Kumagai 2, Masaichi Kuroyama 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2009.

---

	The review of pharmacy trial duties as the P1-549 trial core Hospital and the result and future role Ikuyo Ueda, Naoki Kondo, Funasaki Hideki, Genei Shinya, Mai Itagaki, Tomoko Ogawa, Yoshizo Watanabe, Ichiji Endo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2009.

---

	About trial secretariat duties with the making of the summary of the record of the meeting of the P1-550 IRB Hajime Yamazaki, Sakiko Ichijo, Yoko Kawamura, Naomi Yamamoto, Megumi Harada, Hideyuki Hayashi, Kazunori Asano, Sako field Saburo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2009.

---

	An action to the trial enlightenment to the patients using P1-551 trial brochure and the evaluation Naomi Kawabata 1, Bell Yuko 1 old, Saeko Naito 1, Hiroki Tamaki 1, 2, Yoshitomo Nozu 1, Nobuhiro Nishimura 2, 直良浩司 1, 2, Hideyuki Kawauchi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2009.

---

About the making of environment for P1-552 clinical studies enforcement of trial management room in -179 beds of acute phases Hospital and clinical Research Department wrestle; - Depths Jo Makiko 1, Fumi Inada 2, Ishikawa Nanase 2, Mika Kozai 2, Yosuke Oka 2, Mayumi Okazaki 2, Tomoya Asada 2, 眞鍋伸次 2, 森由弘 3, Thickness well Bunichi 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2009.

---

	Epicritic difference in new bar code by the P1-553 bar code leader Inui ratio Isano, Makiko Nakano, Nishisato Yuri, Rika Kiyokawa, Kazuyuki Ikeda, Yukiko Morita, North Keiji, Masayuki Uno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2009.

---

	P1-554 A study on the distribution drugs confirmation of pharmacist : In the orthopedic ward 岡田志保, 下川福子, 山内祐人, 森本由美, 野口久美子, 川嵜英二, 安本祥子, 堀川泰清, 韓秀妃 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2009.

---

Action to "physician - pharmacist collaboration type medical information training" in the P1-555 School of Medicine clinic training Fumiko Suzuki 1, Iida A Taro 1, Yotaro Matsumoto 1, Tomoko Uenishi 1, Yuriko Murai 1, 2, Shigeru Asada period 3, Satoshi Arai line 4, Miki Shimada 1, 眞野成康 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2009.

---

	Recognition investigation of the democracy about the role of the P1-556 pharmacist Suzuko Kubo 1, Miwako Kamei 2, Reiko Motojima 3, Yoichi Hasegawa 4, Ichiji Endo 5, 七海朗 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2009.

---

	About P1-557 Tris(2-ethylhexyl)Trimellitate and the degradation product Harunobu Iwase 1, Fumio Soeda 2, 大磯茂 3, Flower garden Megumi 2, Eagle head Asami 2, Ryuji Ikeda 4, Kaya Hiroko Sono 3, Kazuo Takahama 2, Kazuo Nakamura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2009.

---

	Intraoral collapse (OD) film with P1-558 heat seal characteristics 廣永麻貴, Takeshi Miyata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2009.

---

	Examination of the contributing factor to achievement of LDL-Cholesterol target value for hypercholesterolemia of the P1-559 statin remedy patients 藤戸靖久, Miyako Kihara, Yukiyo Monma, Yutaka Ichikawa oneself, Shinya Nakanishi, Hideko Iwasaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2009.

---

	It is the discussion based on data in 2008 in this hospital the examination about the factor about the improvement of the P1-560 patient compliance instruction efficiency Masako Ieda, Morihiro Nomura, Yasuyuki Tsukioka, Ken Yamazoe, Yutaka Kuwano line, Kenzo Moriyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2009.

---

	Role of the ward permanent residence pharmacist in the quality improvement of the P1-561 medical care Yasuaki Ide, Takishima sheath, Mieko Tanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2009.

---

	It is ... through overseas support activity - Red Cross Bogor hospital pharmacy duties support by the P1-562 pharmacist in Indonesia Sakawa hardy 1, Eiko Kobayashi 1, 槙島敏治 2, Masanobu Odaka 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2009.

---

	Evaluation of the utility in the package of the P1-563 bisphosphonate once a week remedy preparation Mizoguchi A 1, Takashi Tomizawa 2, 倭文啓恵 1, Motoi Makoto Wada 3, Kiyomi Sadamoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2009.

---

Information exchange with the dialysis room staff to push forward through P1-564 exchange diary 酒井孝征 1, Yusuke Watanabe 1, Chiaki Yasui 1, Aki Kuwahara 1, Takashi Joko person 1, Taka Hayashi child 1, Okuda Kei three 1, Depths Asami 2, Fujihashi quiet 2, Yoko Morioka 2, Eiko Tsutsumi 2, Silk river Ayano 3, Kunimi Nagasaka 3, Masashi Izawa 3, 西崇男 4, Watarida Shoji 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2009.

---

	Clinical pharmacy to return from a clinic to a learning clinic Koichi Kitada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 163-163, 2010.

---

	A way of thinking and common practice of life-style related diseases Yasushi Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 167-167, 2010.

---

	Mental disorder and weak gene DISC1 Toshitaka Nabeshima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 168-168, 2010.

---

	For practice - East-West medical fusion of Japanese and Chinese practice studies - 寺澤捷年 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 169-169, 2010.

---

	As a leading figure of the regional medicine of prospective pharmacist image ... super aged society of the near future ... Ken Hazama solstice Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 173-173, 2010.

---

	We think about pharmacist duties from a physicochemical viewpoint Hideko Kanazawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 174-174, 2010.

---

	The ethical procedure that is demanded from the clinical studies of the pharmacist Hiroyuki Furukawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 175-175, 2010.

---

	Message to diabetes reserve army of people: Encouragement of human experimentation 鎌滝哲也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 179-179, 2010.

---

	Laughter and an impression draw likelihood Kazuo Murakami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 180-180, 2010.

---

	A design and evaluation: of "the preparation which is kind to the patients" -Polyethylene oxide (PEO) -Iota (ι) -Applied - to the hospital preparation basis of the carrageenan mixture 花輪剛久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 183-183, 2010.

---

	The expression mechanism of the side effect with the cancer medical treatment and study on factor analysis Takuya Iwamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 184-184, 2010.

---

	Construction of the evidence for the medical treatment management that assumed the TDM of the immunosuppressive drug a base Takafumi Naito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2010.

---

	To a study to change the settings from the study for studies to Shunichi Fukuhara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2010.

---

	Way of thinking, how to build studies for the medical supplies proper use Nobuyuki Goto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2010.

---

	Matters that require attention in an ethic and the article writing of clinical studies Yasushi Yamamoto Jiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2010.

---

	It is an outline at the S1-PL beginning Junichi Kawakami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2010.

---

	With the evaluation of the fur Matthew tical care judging from S1-1 fee-for-service Hiroshi Sato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2010.

---

	To visualize result of the S1-2 medical supplies management Mitsuko Onda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2010.

---

	The impact that S1-3 pharmaceutical intervention gives to the financing index of the hospital 赤瀬朋秀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2010.

---

	The economic effect that S1-4 pharmacotherapy protocol making and the collaboration by the ward pharmacist result in Masahiro Hayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2010.

---

	The S1-5 fur Matthew tical care for what for whom? Makiko Kusama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2010.

---

	Of the ward activity of the pharmacist in the S2-1 children special hospital, actually Hidemi Tokunaga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2010.

---

	Thing to hope for as a fact and a pharmacist of the S2-2 child care Mari Saikai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2010.

---

	Of the pediatric care settings of the S2-3 area pharmacist, actually Hiroyuki Sugiyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2010.

---

	About a pharmacist found in S2-4 NICU ward with "a childhood authorized pharmacist system" 河田興 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2010.

---

	As for anyone, it is ... by illness medicine cooperation everywhere in illness medicine cooperation ... using S3-1 "medication reporting book" Chie Yoshimura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2010.

---

	Because ... psychological care pharmacotherapy is provided about the cooperation system in the S3-2 Tokyo Women's Medical Coll. hospital; cooperation system ... with the community pharmacy Shun Ito is elegant Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2010.

---

	The present conditions and problem of the mild fur Matthew tical care in the S3-3 drugstore Harikae eyes Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2010.

---

	As the thing ... patients family who saw through S3-4 at-home mild medical care as health insurance pharmacy pharmacist ... Mayumi Oe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2010.

---

	Importance and specialty of the medical treatment in the S4-1 pressure sore practice Isogai good storehouse Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2010.

---

	Utility of the pressure sore measures team participation in planning of the S4-2 pharmacist Sulcular Fumihiro God Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2010.

---

	Practice of a relation and the team approach in medical care of the pharmacist to pressure sore treatment in the S4-3 Hospital Taku Morikawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2010.

---

	Role of the pharmacist to patients with S4-4 at-home pressure sore Masako Mizuno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2010.

---

	Battle front - of S5-PL basic tone lecture - diabetes treatment Ryuzo Kawamori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2010.

---

	Trial - of the study - insulin non-injection preparation development of the diabetes remedy in the S5-1 basics pharmacy Mariko Morishita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2010.

---

	Practice of the diabetes medical treatment instruction in the S5-2 hospital pharmacy Junichi Shimizu 1, Tsuyoshi Horii 2, Takeshi Minami husband 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2010.

---

	Practice of the diabetes medical treatment instruction in the S5-3 health insurance pharmacy Masako Satake Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2010.

---

	Trial - for induction - side effect evasion of the physical assessment to S6-1 psychiatry acute phase Koji Kase Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2010.

---

	For consciousness reform of - medical staff recording the wind of the prescription that is simple for S6-2 psychiatry chronic stage - Hiroko Baba Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2010.

---

	S6-3 Latest findings for the drug therapy of refractory cases : Pharmacist can do for proper use 高橋結花 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2010.

---

	Thing - that support results after - discharge that S6-4 patients association, family society demands it Yoko Hashimoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2010.

---

	The mission of the pharmacist specialized in S7-1 cancer and authorized trend Yusuke Tanigawara 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2010.

---

	Of S7-2 lung cancer standard medical treatment and the pharmaceutical intervention, actually Hiroki Miyata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2010.

---

	Of S7-3 gastric cancer standard medical treatment and the pharmaceutical intervention, actually 橋本浩伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2010.

---

	Of S7-4 colorectal cancer standard medical treatment and the pharmaceutical intervention, actually Hisashi Shimizu example Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2010.

---

	Of S7-5 breast cancer standard pharmacotherapy and the pharmaceutical intervention, actually Masato Yonemura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2010.

---

	Of S7-6 hematologic cancer standard medical treatment and the pharmaceutical intervention, actually The Mishima one up, Uchida まやこ, Pond end Hiroaki, Ryozo Oishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2010.

---

	About the purpose of the S8-PL symposium Tadashi Shiraishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2010.

---

	Pharmacist as the S8-1 infection management representative Naoto Onodera Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2010.

---

	Resistant bacteria measures and TDM duties to become the part of the S8-2 team approach in medical care Masahiro Igarashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2010.

---

	Infection management as the S8-3 team approach in medical care Yoshiko Takahashi, Yoshio Takesue Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2010.

---

	Way as the pharmacist specialized in S8-4 infection in the future Tadao Kimura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2010.

---

	The S9-1 physician hopes that a pharmacist shows the true value in NST Eiji Yamanaka 1, Yasuhide Yasuda 2, Kazuki Sugimoto 2, Ueda exhibition charges 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2010.

---

	To show the true value of the pharmacist in S9-2 NST; from the situation of - nurse - Ito seven Nako, Thistle Noriyo, Hunting Noe Rika, Tadatoshi Machida, Yayoi Sudo, 原澤健, Kazutoshi Maejima, Tetsushi Ogawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2010.

---

	To show the true value of the pharmacist in S9-3 NST; from the situation of - pharmacist - Akira Ogino Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2010.

---

	The place that - NST pharmacist aims at from the situation of - pharmacist to show the true value of the pharmacist in S9-4 NST Nobuyuki Muroi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2010.

---

	So that a pharmacist shows the true value in S9-5 NST Hiroyuki Hayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2010.

---

	S10-1 Pre-licensure Pharmacy Education in the University of Tokyo Makiko Kusama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2010.

---

	S10-2 Clinical Practice Experience in KOREAN Hospital for Pharmacy Education KIM JAE-YOUN Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2010.

---

	S10-3 Clinical Training for Pharmacy Students in the Six-year Course Newly Started in Japan： An example in Gunma University Hospital Tomonori Nakamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2010.

---

	S10-4 Overview and Prospects of Academic Education for Clinical Pharmacy in China XiaoHui XIE Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2010.

---

	S10-5 Education of Pharmacists to improve Japanese Healthcare System Kiyohito Nakai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2010.

---

	S10-6 The status of clinical trial in Korea from hospital pharmacists' perspective Sun Choi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2010.

---

	S10-7 Current clinical pharmacy mode and practice in China Health Care System Zhangqin Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2010.

---

	S10-8 Evaluation of Adverse Drug Reactions in the Medical Intensive Care Unit and Preliminary Development of Signals for Early Detection of ADR Park Sojin1, Kim Eunyoung1, In Yongwon1, Sohn Kieho1, Suh Jiyoung2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2010.

---

	S10-9 Overview of Pharmacy Intravenous Admixture Service Practice of China Rongsheng Zhao Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2010.

---

	S10-10 Molecular mechanism for neuropathic pain induced by anti-cancer drug paclitaxel Yasuo Takeda, Kentaro Nishida, Katsushi Yamada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2010.

---

	Result of the S11-1 ICT utilization and the evaluation 杉原多公通 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2010.

---

	Inflection - of humanism education - learning support system of the S11-2 pharmacy student Shiro Iijima, Satoko Ishikawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2010.

---

	The evaluation that utilized S11-3 portfolio Miho Utsumi 1, Hiroshi Onishi High School 2, Yumiko Yamaoka 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2010.

---

	Examination of the education effect using the S11-4 text mining Itsuko Ishii Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2010.

---

	Why S12-1 is CKD now; is definition and problems ... of ... CKD Makoto Ogawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2010.

---

	Strategies for treatment of S12-2 CKD Shiro Ueda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2010.

---

	Drug administration design of the S12-3 CKD patients Yoshiyuki Ono 1, Taketo Yamamoto 1, Gutter slope Akihiro 2, Hiroshi Suzuki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2010.

---

	Change of the extrarenal clearance in patients with S12-4 renal failure Masayuki Tsujimoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2010.

---

	Relation of practice and the pharmacist of the drug proper use of the S12-5 CKD patients Old Taku Kubo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2010.

---

	The medication support that S13-1 ethical pharmacy works on Hideki Kanai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2010.

---

	Collaboration - of a medication support - medication history list prescription and the medicine calendar in the S13-2 ward activity Katsuaki Arai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2010.

---

	Psychological support to an at-home outpatient demanded from S13-3 pharmacist Naoko Takeuchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2010.

---

	Expectation - to team approach in medical care - pharmacist whom S13-4 physician thinks about Kazuhiro Akiyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2010.

---

	Proposal - from a pharmacist with medication support - hearing impairment that the S13-5 patients demand Kumi Hayase Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2010.

---

	We think about S13-6 "patients center" some other time Is Kurata; see it Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2010.

---

	S14-1 Based on the Medicine to grow of the hypercholesterol plasma therapeutic drug 花輪正明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2010.

---

	When society talks with S14-2 medical supplies Toshiko Kikkawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2010.

---

	After the marketing of S14-3 medical supplies about the importance of safety measures Straw bag tree Tomiko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2010.

---

	"The scientific power of observation" that thing, it which are demanded from S14-4 pharmacist do not miss the signal from the patients Hiroyuki Furukawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2010.

---

	Relief, - to think from the present conditions of the team approach in medical care in - this hospital for a safe medical offer to patients with S15-1 diabetes Michiko Aoki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2010.

---

	All medical persons cross a team and will examine S15-2 diabetes Masaki Shinomiya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2010.

---

	Medication support for adherence improvement in the S15-3 health insurance pharmacy and pharmaceutical management Sanno Naoko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2010.

---

	S15-4 regional medicine cooperation pass and pharmacist Yoshiko Miyazaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2010.

---

	Side effect and pharmacogenomics of the S16-1 anticancer drug Yoshiro Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2010.

---

	Gene marker of the S16-2 serious case drug eruption Kaniwa Nahoko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2010.

---

	The kidney transition mechanism of S16-3 aminoglycoside system antibiotics and nephrotoxic defense based on it Junya Nagai, Mikihisa Takano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2010.

---

	It is the approach using the nano beads technology teratogenic molecular mechanism with the S16-4 thalidomide Taku Ito water 1, Hideki Ando 2, 山口雄輝 2, Hiroshi Handa 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2010.

---

	We think about the role of the pharmacist from the viewpoint that S17-1 is global Atsumi Nishikiori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2010.

---

	It is ... for practice of reclamation - protocol of S17-2 clinic duties Makiko Iwasawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2010.

---

	Way of thinking necessary for S17-3 medical treatment monitoring and clinical skill - case study - Upper mound Tomoko 1, Atsumi Nishikiori 2, Aya Ueda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2010.

---

	The impact that S17-4 ICU pharmacist gives for medical treatment 前田幹広 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2010.

---

	Pharmacotherapy of the S18-1 epilepsy complications pregnant woman Keiko Minato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2010.

---

	Medical treatment of the S18-2 hyperthyroidism pregnant woman We cannot look at Tada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2010.

---

	Pharmacotherapy of the S18-3 diabetes merger pregnant woman Yoko Maeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2010.

---

	Pharmacotherapy of the S18-4 ulcerative colitis merger pregnant woman Seiichi Maruyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2010.

---

	S19-1 through relation - cooperation with patients with cancer in being at home - Masahiko Kimura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 241-241, 2010.

---

	Examine S19-2 cancer regional alliances network - illness; cooperation and other types of job cooperation - Yasushi Nomoto 1, Hiroyuki Hirakawa 2, Haruko Ishikawa 2, Sakiko Nagae 3, Mitsuru Otake Expo 4, Katsuya Sugawara 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 241-241, 2010.

---

	- to think about the role of the nurse from activity of cooperation - last year from the situation of the S19-3 nurse Satoko Yamagishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2010.

---

	One or - that a pharmacist can do it in patients with S19-4 at-home cancer - cooperation to where Hideki Yamaguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2010.

---

	Clinical significance of the SLCO1B1 genetic polymorphism in the S20-1 irinotecan individualization treatment Hiroshi Takane Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2010.

---

	Utility of the genetic polymorphism diagnosis in the treatment with S20-2 warfarin individualization The amount of Ariyoshi example Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2010.

---

	Application to the azathioprine pharmacotherapy in patients with SLE of the S20-3 ITPA genetic polymorphism analysis Tomonori Nakamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2010.

---

	Individualization therapy to S20-4 renal-transplant recipients and patients with chronic myelogenous leukemia 三浦昌朋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2010.

---

	Trial of the thalidomide proper use in consideration of S20-5 genetic polymorphism Katsunori Nakamura, Naoki Matsuzawa, Sakae Omori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2010.

---

	CYP2D6 and SCN5A genetic polymorphism analysis in the TDM of S20-6 flecainide Masato Honma 1, 2, Kosuke Toki 1, Kazutaka Aonuma 2, Koda good luck direct 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2010.

---

	The role that a businessman teacher should achieve in the pharmacy education that S21-1 is new Junko Kitsu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2010.

---

	The role that a prior learning businessman teacher for the business training that S21-2 is smooth achieves Akira Takayama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2010.

---

	Practice and businessman teacher of the S21-3 team approach in medical care Mari Kogo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2010.

---

	Practice and businessman teacher of the S21-4 regional medicine Eight folds of Tetsuji 1, Hiroshi Araki positive 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2010.

---

	Practice of clinical studies patients-oriented by the cooperation with the S21-5 healthcare setting Strong marsh Masami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2010.

---

	- to regard health service study - pharmacist usability test as S22-PL pharmacist Hiroyuki Sakamaki 1, Nobuo Yamamoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2010.

---

	The need and problem of the S22-1 pharmacist health service study Hiroyuki Sakamaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2010.

---

	Summary and results - of health service study - asthmatic outcome study based on S22-2 regional alliances Miwako Kamei Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2010.

---

	Standardization - asthma inhalational instruction of the pharmacist duties in the S22-3 health service study for a case - Masaya Hasegawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2010.

---

	The need of the S22-4 health service study and the utilization policy Soichiro Isobe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2010.

---

	The future way of S22-5 health service study and the pharmacist Nobuo Yamamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2010.

---

5-FU-related elevated blood pressure mainly on the O1-01 FOLFOX/FOLFIRI therapy and investigation examination about the factor Toyoji Otani 1, Eiji Hata 1, 涌嶋伴之助 1, Kuniaki Moriki 1, Chisato Iwai 1, Sasaki Nanase 1, Hasegawa general 1, Kainoki Keisuke 1, Yoshikazu Shiiki 1, Masakazu Hayashibara 1, Kenji Otsubo 1, 堅野国幸 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2010.

---

	Tolerability of the docetaxel / cyclophosphamide therapy in the O1-02 breast cancer postoperative chemotherapy Hiroto Tanaka 1, Sonoko Furubayashi 1, Yoshizo Watanabe 1, Ichiji Endo 2, Junko Kitsu 3, Satoshi Izumi Shiro 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2010.

---

	Fact-finding of the olfactory function disorder with the O1-03 cancer chemotherapy Kan Yukio 1, 北出紘規 2, Atsushi Kawagishi 3, Kazuki Takeda 3, Yuri Sakaguchi field 1, Junko Ishizaki 1, 崔吉道 3, Kenichi Miyamoto 3, Arai country three 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2010.

---

	Relations of a neutrophil count and the febrile neutropenia of the day of O1-04 chemotherapy 宮本康敬, Kyoko Sumiya, Toru Watanabe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2010.

---

Comparison of primary therapy in Bevacizumab, Carboplatin, the Paclitaxel combination chemotherapy for the O1-05 progress-related non-small cell lung cancer and the non-primary therapy Makoto Nakajima 1, 2, Takahiro Kumagai 1, Takuya Goto 1, Yoshie Nomura 1, Yumi Suzuki 1, Yukiko Shibata 1, Shuichi Matsumoto 1, Tatsuo Kato 3, Tadashi Sugiyama 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2010.

---

	The effect that blood pressure just before the initial administration in patients receiving O1-06 bevacizumab gives to subsequent blood pressure control Takahiro Sakai 1, Genei Shinya 1, Yoshihiro Aoyagi 1, Naoki Kondo 2, Yoshizo Watanabe 1, Satoshi Izumi Shiro 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2010.

---

Examination about the effect prediction of patients with bevacizumab administration colon that assumed O1-07 elevated blood pressure an index, rectal cancer Horinouchi Hironari 1, 2, Takumi Sakurada 1, Toshi Nakamura oneself 1, 2, Tsuyoshi Mori 1, 2, 小中健 1, 2, Yukiyo Miki 2, Soichiro Tajima 1, 西迫寛隆 1, Shinji Abe 1, Kazuyoshi Kawazoe 1, Kazuo Mizuguchi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2010.

---

	Examination about the protective efficacy of the antihistamine for the hypersensitivity symptom at the O1-08 paclitaxel administration Mio Koike, Kenta Tanaka, Sect Ayako, Atsushi Wada, Manabu Kume, Makimoto Hiroo, Tsuyoshi Hirano, Hirai green Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2010.

---

An antinausea effect with 3mg/body administration and the 1mg/body administration of granisetron injection in patients with O1-09 hematopoietic organ malignant tumor and adverse event Shinya Motohashi 1, History of moat male 1, 2, Takaaki Ono 2, 3, Kazunori Onishi 2, 3, Junichi Kawakami 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2010.

---

	Comparison of nausea, vomiting before and after delayed emesis measures by the cisplatin component regimen in O1-10 lung cancer Hiroyuki Watanabe 1, Star Ikuko 1, Yuka Nakai 1, Beam Hisashi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2010.

---

	Examination about the effect of aprepitant on O1-11 cisplatin divided doses Misato, Kariya, Kenta Tanaka, Kumiko Matsumoto, Manabu Kume, Makimoto Hiroo, Tsuyoshi Hirano, Hirai green Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2010.

---

	Efficacy of aprepitant in the O1-12 outpatient department chemotherapy and safe examination Corner Shintaro 1, Child 1 too rare Mochinaga, Egoe Masayoshi 1, 中野行孝 1, Every bear Keiko 2, Arrow ヶ part Tomomi 3, 4, Naoko Arakane 4, Shinya Kimura 4, Fujito Expo 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2010.

---

	Evaluation of the utility of aprepitant for the lung cancer chemotherapy with the O1-13 caloric intake situation as an index Hayasaka state straight 1, Hiroko Yamamoto 1, Kimiyoshi Takeuchi 1, Osamu Ogino 1, Shigeo Yamazaki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2010.

---

Standardization of the NK1 receptor antagonism type antiemetics aprepitant combination regimen in the antinausea management after the administration such as O1-14 altitude emetic risk anticancer drugs Chiyoko Yamada, Miwa Yonezawa, South Kenichi, Yukiyo Kinoshita, Country book Sae, Katsuichiro Kamei Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2010.

---

	Examination about the stratification of the antinausea therapy with aprepitant at the O1-15 colorectal cancer chemotherapy enforcement Kazuaki Fukazawa 1, Ayano Nakazawa 1, Masato Matsuura 1, Riyusuke Aihara 2, Yasushi Mochida 2, Hirayama success 3, Isono Junichi 1, Yasuo Hosonai 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2010.

---

	Nausea, vomiting with the O2-01 cancer chemotherapy and examination of the utility of aprepitant for anorexia Koji Okada, Yuji Koyanagi, Hidekazu Takahashi, 小笠原信敬, Katsuhiko Sato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2010.

---

	Utility evaluation for cancer chemotherapy-induced nausea and vomiting of O2-02 new antiemetics aprepitant Toshiaki Teratani 1, Takehiro Yamada 2, Toru Kawagishi 2, 斎藤佳敬 2, Takayuki Nagata 2, Yasuo Kubota 2, Kumiko Kasashi 2, Takeshi Iseki 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2010.

---

	Clinical response after the O2-03 aprepitant induction Kazuaki Kojima 1, Miwa Takayuki 1, Relation Tadashi 1, Akira Maruyama 1, Kan law of nature fine weather 2, Hideo Kita 3, Shinobu Araya 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2010.

---

	Examination about the O2-04 childhood cancer treatment vomiting expression investigation and effect of NK1 receptor blocker aprepitant to be able to put It is Naho in a circle, Kumiko Matsumoto, Atsushi Wada, Manabu Kume, Makimoto Hiroo, Tsuyoshi Hirano, Hirai green Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2010.

---

	About an effect when we extended Aprepitant dosing period in O2-05 same patient from 3rd to 5th Atsushi Shirai, Yuko Kudo, Kenichi Suzuki, Michihiro Shino Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2010.

---

	Derivation and evaluation of the physiology, child dose estimate method that considered a biochemical development of O2-06 children Shinya Suzuki 1, 2, Yu Murayama Kei 1, Eri Sugiyama flower 1, Masao Sekiyama 2, Hitoshi Sato 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2010.

---

From the viewpoint of carboplatin doses difference by risk factor - calculating formula of the myelosuppression expression in the O2-07 carboplatin / paclitaxel therapy Aiko Hashimoto 1, Small Ido Keiichi 1, Ryuuto Yasuaki 1, Noriyuki Katsumata 2, Koji Murakoshi 1, Nobuaki Yokote 1, Yasuhiro Fujiwara 2, Hiroshi Yamamoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2010.

---

	The effect that O2-08 circadian rhythm disorder gives in PK-PD of the diabetes therapeutic drug The autumn Yamahana world, Makoto Miyazaki, Kazunori Iwanaga, Masao Kakemi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2010.

---

	Examination about the circadian rhythm of the Everolimus in O2-09 heart-transplant recipients 和田恭一1, 野島香織1, 中野一也1, 越智裕之1, 岡田博1, 小原延章1, 堀由美子2, 藤田知之3, 戸田宏一3, 村田欣洋4, 瀬口理4, 簗瀬正伸4, 中谷武嗣4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2010.

---

	Prediction based on the fur Mako kinetics transitional from head to foot of the O2-10 ketoprofen tape forerunner, the generic medicine Awa Keisuke 1, Hiroki Sato 1, Moat foster child 1, 2, Yasufumi Sawada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2010.

---

	The factor which affects the AUC of the O2-11 vancomycin hydrochloride Keiko Ikeda 1, Chie Ikeda 2, Katsuhiro Kato 3, Naoki Tomiyama 4, Sumio Matsuno 5, Kenji Matsuyama 5, Noboru Okamura 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2010.

---

	Examination about the administration plan of vancomycin hydrochloride in patients with O2-12 blood system cancer Umaki Kato 1, Tadao Kimura 1, 2, Nozomi Nishida 1, Kushiro, Kiyo Kawazumi 1, 2, Hiroko Saito 1, Takaaki Hasegawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2010.

---

	The polymethyl methacrylate membrane to use in O2-13 persistent hemofiltration dialysis adsorbs teicoplanin Toshiyuki Irie 1, 道越淳一 2, Kazuhisa Masuda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2010.

---

	Examination about the absorption delay of mitiglinide by the rise in O2-14 intragastric pH 浦嶋庸子, 有本諭司, Eiji Kayano, Takashi Kato children, Yoshio Ijiri, Kazuhiko Tanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2010.

---

	Examination of the anti-inflammatory action of Capsaicin for O2-15 Lipopolysaccharide-induced inflammation Yu Yamamoto, 楠川侑吾, Takashi Kato children, Yoshio Ijiri, Kazuhiko Tanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2010.

---

The effect that combination of clopidogrel and proton pump inhibitor in the O3-01 coronary-artery stenting patients gives to a clinical outcome Masayuki Tanaka, Yukiko Inui, Haruna Kita, Aya Nakano, Hiromi Utsumi, Ryohei Fujii, Atsuko Utsunomiya, Yuko Adachi, Yuko Kuhara, Yumi Nakano, Mayumi Inoue, Nishiyama rich person, Furunaga Ikumi, Hisayo Kadoi, 打谷和記, Yasuhiko Hirota Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2010.

---

	The effect that antacids give for antitumor effect of the Gefitinib in O3-02 patients with nonsmall cell lung cancer Kohei Tanaka 1, Shigeru Hishinuma 1, Mitsuo Mita 1, Yutaka Fukaya 2, Kanemura Toshinori 3, Shoji A 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2010.

---

	Effect of the Loxoprofen Sodium which gives it to antiplatelet action of O3-03 aspirin and the workaround Your Yu Akagi 1, Kenta Shibata 1, Shuji Shimada 1, Akinori Yanaka 1, Kaichi Hikami 1, Takashi Tsuchiya period 1, 2, Yoshiro Kubota 3, Takao Aoyama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2010.

---

	The effect that CYP2D6 antagonism by O3-04 China Cal Seto gives to the metabolism of the cardiovascular disease therapeutic drug Takeki Narita 1, Daisuke Kadowaki 1, Satoshi Shibata intellect 2, Lower stone Kazuki 3, 飛野幸子 2, Eiko Fukunaga 3, Sumio Hirata 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2010.

---

	Examination about the valproic acid blood level that induction of O3-05 hyponatremia costs Tetsuro Koide 1, 2, Takuya Iwamoto 2, 3, Katsuhiro Tanaka 4, Kaoru Kuroki line 4, Masatoshi Muramatsu 4, Shinko Okuda 2, 3, Keiko Watanabe 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2010.

---

	Examination about the nephrotoxicity of calcineurin inhibitor (CNI) in the renal biopsy periodical after O3-06 kidney transplantation 桑原達朗1, 酒井謙2, 河村毅2, 宍戸清一郎3, 水入苑生2, 長谷川昭4, 相川厚2, 定本清美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2010.

---

	Examination of the constipation mechanism induced by O3-07 hydrochloric acid Seve Lamar Misato Nagashima, Ayaka Sota, Daisuke Kadowaki, Sumio Hirata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2010.

---

	The case that thrombocytopenia was prolonged by O3-08 adalimumab administration for a long term Sone book Emi 1, 2, Yasuhiro Tsuji 1, Nozomi Iwanaga 3, Yukitaka Ueki 3, Kenichiro Nakajima 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2010.

---

	An example of the haemolytic uraemic syndrome (HUS) that occurred in patients who received renal transplant from living donors during O3-09 immunosuppressive drug cyclosporin administration Kentaro Tani 1, 2, Koichi Kozaki 1, 3, Sei Yajima 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2010.

---

	2 cases that was able to prevent side effect becoming severe of the warfarin potassium by the cooperation with the O3-10 test department early Kazutaka Hiraga 1, Hiroshi Yamamoto 1, Masaharu Kakegawa 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2010.

---

	Association with the actual situation and the side effect expression of the prophylaxis of the O3-11 sulfamethoxazole trimethoprim combination Hiromi Yokoo, Akiko Emoto, 中野行孝, Fujito Expo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2010.

---

A side effect simultaneous investigation of the O3-12 antiinfluenza medicine and the statistical analysis Tsuyoshi Nakanishi light 1, Shinnya Muto 2, Tomoko Matsukawa 3, Nakamura joy Ichiro 4, Shoji Takei 5, Depths corner Takahisa beauty 6, Ikuko Asano 7, Ainoki Kenji 8, Koichi Tabata 9, East Takashi Kubo 10, Ken Hirota authority 11, Hattori truth 12 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2010.

---

	Does the O3-13 lanthanum carbonate improve the digestive symptom of the hemodialysis patient for a long term? Daisuke Suzuki 1, Shogo Uchida 1, Nakamura lawn intellect 1, Kazumasa Yasui 1, 市江敏和 1, Akira Goto 1, Satoshi Suzuki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2010.

---

	Pharmaceutical intervention for O3-14 heparin induced thrombocytopenia type II (HIT) Junko Kai 1, 大橋経昭 2, 京嶌和光 2, Shiro Nagasawa 2, Ei Tsuda light 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2010.

---

	Comparison between the preparation of the chemical burn incidence in the O3-15 10% povidone iodine solution Gentaro Nagae 1, Hiroyuki Naito 1, Michiko Komori 2, Akira Nakamaru 1, Yasushi Kawatsu kernel 1, Mitsu Tamura 3, Satoru Shiraishi 4, Masao Kojima 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2010.

---

	Evaluation of the hand rough weather protective efficacy of the barrier type hand cream using the O4-01 original hand rough weather evaluation scale 波能満理惠 1, Masayuki Wakita 1, Tomomi Hoshino 1, Tsutomu Kato 2, Risa Imamura 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2010.

---

	The use situation of the antimicrobial agent in the O4-02 west Sendai Hospital (chronic stage) and the susceptibility situation Koji Sato 1, Kikuyo Sakuma 1, Norio Kato 1, Mari Yamada 2, Yumiko Abe 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2010.

---

	Relation of the pharmacist for patients with infection in the O4-03 ICU Kato Takahiro 1, Masanari Hagiwara 1, Umaki Kato 1, Yukio Toyama 1, Tatsuya Muto 1, Hiroko Saito 1, Takaaki Hasegawa 1, Hiroko Ishibashi 2, Takashi Nakagawa 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2010.

---

	Practice of preventive measures against infection by the O4-04 pharmaceutical intervention Jun Taniguchi, Minato book Yasunori, Takanori Kobayakawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2010.

---

	Participation in planning of the pharmacist to O4-05 meningoencephalitis treatment Hiroshi Hara person Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2010.

---

	O4-06 For further promote the use of generic : District 5 Pharmaceutical Association survey results and future issues 井上茂一1, 田中大介1, 西村友男2, 坂口眞弓3, 土屋千雅子3, 一瀬信介4, 新井悟4, 中村清治5, 長井彰子6, 福澄重泰6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2010.

---

	For further reliable use promotion of the O4-07 generic medicine Prince Taniguchi chapter, 後藤志央, Shrine Akihiro Ichiro, Mimata Sayaka, Maruyama Akina, Tatsuya Sasaki, 末安由拓, Kaifu Masayo, Akihiro Kai, The Ishikawa immensity, Keiko Kitajima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2010.

---

	O4-08 pharmacist is the actual situation of intelligence, the transmission and the problem after the marketing of the generic drug which we looked at Moat foster child 1, 2, Hiroki Sato 2, Akiko Miki 2, Yasufumi Sawada 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2010.

---

	Effect of the injection inventory control using O4-09 electronic chart data 東禎二 1, Takeshi Yasuda 1, Koji Yamada 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2010.

---

	The construction of the appropriate inventory control system of the O4-10 cancer chemotherapeutic agent and stock amount of money depression effect Takeshi Abe, Kenichiro Kawana, Kazumi Goto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2010.

---

	Is there the preference of the patients to the device of the O4-11 DPI inhalant? Masashi Sakano 1, Izumi Shimada 2, Mariko Aota 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2010.

---

	Improvement of the asthmatic control by the O4-12 pharmacist outpatient department Inoue Seicho, Hisashi Ono, Kawamorita early period, Katsuhisa Tahara, Yuichi Itagaki, Ikuyo Kanzaki, Naoya Kamiyama, Kazuo Matsubara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2010.

---

	For the improvement of O4-13 drug control instruction electromagnetic record Hiromi Sekimoto, Minoru Kawai, 吉野宗宏, Naoki Hayakawa, Hiroyuki Ueno, Yasukazu Sakamoto, Makoto Saito, 山内一恭, Yoshihisa Honda, Katsuya Komori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2010.

---

	Examination ... by study on action and evaluation ... patients questionnaire of the O4-14 "telephone medication communication" Hisano Kitayama 1, Fumio Nakajima 1, Hisashi Nakajima 1, Hidehiko Sakurai 2, Shimamori beauty light 2, 早瀬幸俊 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2010.

---

	Case report (ward activity report second report) which contributed to discovery of the serious disease by O4-15 ward working full time pharmacist placement History of Yasushi Iwabuchi 1, Eiichiro Ikeno 2, 岩山忠輝 2, Hiroyuki Abe 1, Jin Wagatsuma 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2010.

---

	Relative examination with the application of counseling by a critical mind and the drugstore pharmacist of the health literacy of the O4-16 patients Island ノ 江千里 1, Kazuhiro Hirano 2, 中野行孝 2, Megumi Tanaka Taro 3, Fujito Expo 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2010.

---

	About drug control instruction in the O4-17 breast surgery outpatient department Hiroko Yabumoto, Keiko Fujita, Yuka Shibata, 櫻下弘志, Kazuko Yamanaka, Yuki Sekino, Yasuyuki Saeki, Furrow well Hiroko, Tree flat Kenji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2010.

---

	Pharmacist duties in the O4-18 neonates treatment room Saori Kato 1, Kato Takahiro 1, Yukio Toyama 1, Tatsuya Muto 1, Hiroko Saito 1, Takaaki Hasegawa 1, Harue Sato 2, Daisuke Muto 3, Riding ground etiquette three 3, Masahide Nimura 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2010.

---

	The present conditions and problem of the drug duties in the O4-19 ICU Wataru Goto, Mountain Rieko Sawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2010.

---

	The present conditions of drug control instruction duties in the emergency care judging from O4-20 DPC data Even study 1, Soma law of nature person 1, Yukiko Watanabe 1, Aki よしかわ 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2010.

---

	Change of the pharmacokinetics of digoxin at diuresis with O5-01 diabetes Masako Satake 1, 2, Igarashi sincerity intellect 1, 鏡真依 1, Yudai Toda 1, Yasushi Kobayashi 1, Ochiai sum 1, Kiyoshi Sugiyama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2010.

---

	An adverse event of the linezolid in patients with O5-02 impaired renal function and pharmacokinetic correlation 辻泰弘1, 平木洋一2, 松元加奈3, 溝口晶子1, 小林奨4, 曽根本恵美1, 佐道紳一1, 神村英利5, 森田邦彦3, 加留部善晴6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2010.

---

	Effect of aprindine which gives it to pharmacokinetics of the O5-03 bepridil Satoru Aida, Kyoko Fukumoto, Kazuyuki Ueno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2010.

---

It is the development of the quickness assay of human plasma and urinary gabapentin level an evaluation of the pharmacokinetics of the O5-04 neuropathic pain therapeutic drug gabapentin Yagi Tatsuya 1, Takafumi Naito 1, Takashina Yoshiaki 1, 見野靖晃 1, Kazuo Umemura 2, Junichi Kawakami 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2010.

---

	O5-05 Development of the simultaneous measurement of human plasma voriconazole and its N-oxide thereof by isocratic elution method 山田尚広, 見野靖晃, 八木達也, 田中紀章, 内藤隆文, 川上純一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2010.

---

	Study on excretory system transporter expression change in the O5-06 Type II diabetes mellitus model rat Megumi Watanabe cloth 1, Masanori Kobayashi 2, Jiro Ogura 2, Hiroaki Yamaguchi 2, Takeshi Iseki 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2010.

---

The CYP3A5 genetic polymorphism of the O5-07 live donor liver transplant patients is the comparison of the CLIA method and the ACMIA method effect to give to tacrolimus levels out of the whole blood Yuichi Muraki 1, Takuya Iwamoto 1, Enoki shop Tomoyuki 1, Masanobu Usui 2, It is 3 of Nakatani, Tsutomu Nobori 3, Isa place Hideji 2, Shinko Okuda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2010.

---

	Construction of the predictive model of the O5-08 triptan drugs reactiveness Yuki Sakairi 1, Masakazu Ishii 1, Yuika Naito 1, Ayumu Nagamine 1, Atsuko Imagawa 2, Joji Takahashi 2, Shunichi Shimizu 1, Yutaka Masuda 3, 4, Original one 2, Shino Usami 5, Yuji Kiuchi 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2010.

---

	Individualization of the administration of irinotecan based on the O5-09 UGT1A1 genetic analysis Masaru Yamazaki British 1, Mika Hiraoka 1, Hideto Yahagi 1, Fumiko Sugaya 2, Yoshiaki Narita 3, Noburu Kashimura one 4, Hiroyuki Moriya 5, 齊藤嘉津彦 5, Naoko Kurosawa 5, Seiji Sato 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2010.

---

	Effect of the CYP3A mutation in the gene to give to the tacrolimus in O5-10 renal-transplant recipients and blood kinetics of the main metabolite Kimiyoshi Hirano 1, Takafumi Naito 1, 見野靖晃 1, Shuji Maruyama 1, Tatsuya Takayama 2, Seiichiro Osono 2, Junichi Kawakami 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2010.

---

By the hearing investigation in the O5-11 ethical pharmacy come out; comparison and patient compliance instruction - of drug evaluation - adverse event incidence of meat phosphorus Nukui celebration of longevity male, Tree wearing for the first time, Satoshi Taniguchi, Asako Ohata, Otani Teppei Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2010.

---

	About examination - remedy feeling about the effective evaluation of 500 mg of O5-12 precipitated calcium carbonate tablets "Miwa" and a clinical response - Ikue Terao, Ayumu Ichimura, Masayuki Hirose, Yoichi Sakakibara, Shigeru Yamada tree, Shinji Takahashi, Yuichi Takemoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2010.

---

	Induction therapy in patients with O5-13 Crohn's disease Kana Umeda 1, Hideki Atsumi 1, Mikio Nishikawa 1, Hiroyuki Hanai 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2010.

---

	- with fact-finding - cholesterol level of patients who underwent percutaneous transluminal coronary angioplasty in the O5-14 this hospital concerned Adachi Naoya, Masaru Nakano, Yoshinobu Kawamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2010.

---

	Action of the inhalational instruction for patients with O5-15 infantile asthma Fumie Shimazu, Usui Naoko, Rie Tamura, Yuya Fukuchi, Stone gutter Yasuhiro, Court Security Office Mika, Gilt bronze Yoko, Nobuhisa Fukushima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2010.

---

	Effect with the single dose of promethazine, fexofenadine and the olopatadine on histamine-induced cutaneous symptom of the O5-16 healthy subject and psychokinesia function 亀井浩行1, 伊佐治亜美1, 野田幸裕1, 石川和宏2, 千崎康司2, 山田清文2, 杉浦一充3, 富田靖3, 鍋島俊隆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2010.

---

	Pharmacist-led type clinical trials about the O5-17 health drink continual medication Minae Izawa 1, Hiroyuki Ito 1, Noriko Kose 1, Tomohiro Nishimura 1, 登美斉俊 1, Mayumi Mochizuki 2, Emi Nakajima 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2010.

---

	Safety of medicine evaluation - antineoplastic - that we saw it from O5-18 clinic dose, an exposure level and a nothing toxic level, an exposure level Arumi Hideto 1, Takaaki Yaginuma 2, Miyuki Fujita 2, Kazuyuki Saito 3, Shunsuke Ono 4, Tsuneo Kodama 2, Tomoji Yoshiyama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2010.

---

Exploratory controlled trial (the first report) of the delayed-action diarrhea protective efficacy with the oral alkalinization agent and Hangeshashinto for patients who received O5-19 FOLFIRI-3 therapy Kaori Yamazaki 1, 宮内英聡 2, Noriko Kanetani 1, Akira Yamamoto flat 1, Manabu Ohira 2, Yasuo Yoneyama 2, Yasutaka Nakamura 1, 3, Amount of Ariyoshi example 1, 仲佐啓詳 1, Hiroshi Nakamura justice 1, 松原久裕 2, Koichi Kitada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2010.

---

	Exploratory study ... which aimed at the factor - individualization treatment to have an influence on the dose intensity decrease of the O5-20 gemcitabine hydrochloride Katsuya Makihara, Miki Ota, 中山実智惠, Hirokazu Ueno, Ichiro Hama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2010.

---

Evaluation of the utility of the fondaparinux proper use check sheet for O6-01 physician, nurses Yoshihisa Ishihara 1, Taku Ando 1, Persimmon former Ikuyo 1, Kaori Fukushima 2, 廣津匡隆 2, Tomomi Hamada 3, Tadahisa Wada 1, Karasaki Yumi 1, Toru Tanabe 1, Aya Horikiri 1, Sayaka Tanaka 1, Ryuichi Fukuoka 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2010.

---

A digital camera is useful in the O6-02 "the number of medicine is different!" patients objection measures "whom medicine is not!" in Masakazu Kinoshita 1, Sachiko Tanaka 1, Michiko Kano 1, Sawai one 1, Ritsuko Matsuo 1, Yukiko Akamine 1, Akiko Miki 2, Hiroki Sato 2, Moat foster child 2, 3, Yasufumi Sawada 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2010.

---

	Evaluation of the exposure to O6-03 antitumor agents prevention device that considered administration, the disposal from a mixed preparation Ryoji Yanagihara 1, Takashi Tomabechi 1, Yasuko Kataoka 2, Chieko Komiyama 2, Katsuyoshi Nakajima 1, Hiroshi Suzuki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2010.

---

About relations of O6-04 pharmacist and the number of incidents about contribution of the safety management in the number of - ward pharmacists and ward duties - Mariko Nagao, Shigeru Yamada tree, Kana Kato, Nomura connection, Yuichiro Wada, Hiromi Sakai, Hiroshi Hozumi, Mika Shinoda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2010.

---

	It is ... through the process that led to package insert revision of ... September, 2009 about crack occurrence of intralipid infusion R by the O6-05 infusion set needle insertion 久保嘉靖1, 奥野昌宏1, 梅谷義晴1, 坂本弘子2, 柴田佑子2, 藤井一雄3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2010.

---

Patients who received cancer chemotherapy support and contribution to team approach in medical care that utilized O6-06 bringing medicine management Otsu good luck, Shigeru Morimoto sentence, Yuko Horikawa, Field road Akihiro, Ayako Nakanishi, Hirase friendship, Kayoko Fujii, Yumiko Itani, Akiko Kamiya, Mai Murata, Masayuki Ishizuka, Yoshio Kitamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2010.

---

	Economic effect by the bringing medicine management use in the O6-07 ward permanent residence pharmacist Yasushi Yamamoto University, West love, Yukio Toyama, Tatsuya Muto, Hiroko Saito, Takaaki Hasegawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2010.

---

	Construction of the bringing medicine system of administration by the O6-08 electronic chart Yuka Tsutsui 1, Yuki Meishin 1, Nobuo Nagayama 2, Satomi Kubota 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2010.

---

	Incidence of the pre-Abo id associated with the O6-09 bringing medicine Aya Ido Keiko, Fumio Yoshimoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2010.

---

	About the use of the department in drug "bringing medicine team" aiming at shortening of the O6-10 bringing medicine administrative work 山本清司1, 上野朋子1, 小島基嗣1, 松尾一典1, 松本晴年1, 浅野知子1, 近藤勝弘1, 黒田純子1, 江崎哲夫1, 小池香代1, 木村和哲1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2010.

---

	Example that supported the psychological care of O7-01 outpatient department chemotherapy patients by medicine medicine cooperation Eri Ito Kei, Shigeru Yamada tree, Shinji Takahashi, Yuichi Takemoto, 吉田雅彩, Ayumu Ichimura, Masayuki Hirose, Yoichi Sakakibara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2010.

---

	From an example of pharmaceutical support - psychological care based on the O7-02 EBM - Yuko Kanbayashi 1, 2, Keisuke Yomo 1, Yoko Konishi 1, 2, Fujimoto early Kazuko 2, 3, Koji Okada 1, Hideyuki Konishi 4, Toyoshi Hosokawa 2, 5, Toshiichi Yoshikawa 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2010.

---

	Likelihood of the occupational exposure in the calculation compounding of medicines to O7-03 cyclophosphamide vial preparation 濱宏仁, Flat field Masaki, Koichi Fukushima, Toru Hashida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2010.

---

	Comparison of the preparation quality between between the standards that assumed quantity of vial surface contamination of the O7-04 anticancer drug an index and the preparation Takashi Osawa, Takafumi Naito, Naoya Suzuki, Tadashi Kadoguchi kernel, Junichi Kawakami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2010.

---

	Pollution investigation to come from other than O7-05 anticancer drug preparation work Reina Nishigaki 1, Totsuka ゆ K 2, Mitsue Hirano 1, 軍司剛宏 1, Satoru Otsuka sincerity 1, Nobuaki Yokote 1, Hiroshi Yamamoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2010.

---

Examination before and after the O7-06 closed system anticancer drug preparation aid beginning to use Junko Kuroda 1, Katsuhiro Kondo 1, Shiota history on record 1, Kazunori Yoshikawa 1, Ichihara greens one a month, Shoko Ueda 1, Yu Maeda ankle 1, Kaori Tsuji 2, Hirokazu Komatsu 3, 木村和哲 1, 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2010.

---

	It is ... through action ... closed ring system induction as the pharmacist for becoming it reduction of the anticancer drug exposure to whole O7-07 inside the hospital Hama name Noriko, Fujishima Wakana, Yuzo Kajita child, Yukiko Yamashiro, Reed Chitose, Kawai order meter Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2010.

---

	Action for the improvement of the O7-08 anticancer drug preparation Kabayama Tomoichi, 眞原達男, Emi Horiguchi, Hiroshi Morita, Michiko Matsumoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2010.

---

	The practice results and evaluation of the pharmacist outpatient department "support outpatient department" for patients with O7-09 cancer Imamura pasture employee, 武本千惠 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2010.

---

	About the role of the pharmacist in O7-10 cancer pharmacotherapy Committee Hiroyuki Ueno, Naoki Hayakawa, Minoru Kawai, 吉野宗宏, Yasukazu Sakamoto, Makoto Saito, Hiromi Sekimoto, 山内一恭, Yoshihisa Honda, Katsuya Komori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2010.

---

The effect that a wearing method of the O7-11 portable chronofuser gives to flow Hisashi Ono 1, Kaori Koshiro 1, Hitomi Tsuzuki 1, Inoue Seicho 1, Hemp lower Tomoka 1, Yasushi Yamashita example 1, Twig Masayoshi 1, Yuichi Itagaki 1, Kuniko Yamamoto 1, Satoshi Ogawa 1, Shu Kimura old 1, Ikuyo Kanzaki 1, Kawamorita early period 1, 安達知輝 1, Seven field Tomomi 1, Katsuhisa Tahara 1, Yuzuru Yamamoto 1, Shinya Iida 1, Suno study 1, Chieko Hara 1, Koichi Otaki 1, 2, Toshio Awaya 1, Yoshikazu Tazaki 1, Kazuo Matsubara 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2010.

---

	About pump explosion for the carrying at use of O7-12 4% morphine hydrochloride injection New branch Maiko 1, Hiroki Iwane 2, Yuka Kobayashi 2, Toshiko Aramiya 2, Tomori Nishina 1, Hirokazu Nakanishi 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2010.

---

	Likelihood - of the interaction with examination -Alb about the protein binding of the O7-13 platinum Takashi Kato children 1, Takushi Sato 2, Misa Tsuchiya 2, 1, Asuka, Iwamoto, Yamasaki swamp 1, Yoshio Ijiri 1, Kazuhiko Tanaka 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2010.

---

	Additional analysis for the constipation in the granisetron intravenous administration of the O7-14 2 dose 秋田賢宏 1, Masato Yonemura 1, Noriyuki Katsumata 2, Satoshi Izumi Shiro 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2010.

---

	Examination about a drug control procedure in the treatment with O7-15 lenalidomide and the safe security Hana Arima one a month, Yukako Morita 1, Up Kazuko 1, Kitada Noriaki 1, 田中詳二 1, Takayuki Takahashi 2, Toru Hashida 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2010.

---

	Examination about the neutrophilic decrease at O8-01 pemetrexed alone and the carboplatin combined medication Kenichi Manabe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2010.

---

	About correspondence to neutropenia in the O8-02 FEC100 therapy Kazuyo Matsuyama 1, Hiroyuki Ueno 1, Shigeru Morimoto sentence 2, Kinuyo Kajiwara 3, 山内一恭 1, Yoshihisa Honda 1, Yoshio Kitamura 2, Shin Masuda three 4, Katsuya Komori 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2010.

---

	The side effect expression situation in the Gemcitabine/Cisplatin combination chemotherapy for the O8-03 urothelial carcinoma Noriko Komura, Hiroki Tamaki, Naoyuki Komura, Nobuhiro Nishimura, 直良浩司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2010.

---

	Examination of the factor associated with the side effect expression of the O8-04 paclitaxel carboplatin combination therapy Yasushi Habu 1, Yoshihiko Kimura 1, 2, Ikuko Yano 1, Toshiya Katsura 1, Kenichi Inui 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2010.

---

	Effect on premature diarrhea with the scopolamine butylbromide prophylaxis at the O8-05 hydrochloric acid irinotecan administration Shin Taguchi 1, Fukidani Kazuko 1, 向井想一 1, Muto law of nature 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2010.

---

	Three cases of the depressive disorders that became the stopping dosage by a side effect after beginning of dosage of O8-06 mirtazapine early Akira Yoshikawa 1, Akiko Yasunaga 1, Miwa Watanabe 1, Open Koichi 1, Takeshi Wada 2, Yonezawa sing; 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2010.

---

	Action of the pharmacy where there was the potential side effect extraction of the schizophrenia patient with O8-07 serum prolactin level measurement Takako Suzuki, 成田妃重, Tomomi Matsumoto, Kimiko Yamamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2010.

---

1 case - of schizophrenia that improvement of the medication situation was seen in through report - patient compliance instruction and the prescription suggestion about the utility of the home care patient visit drug control instruction in the O8-08 psychiatry region Hidenori Kuwahara 1, Seiko Ikemoto 2, Kyohei Konuma 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2010.

---

	"The antipsychotics weight loss, single agent of the ward wrestles to becoming it by the treatment adequacy committee O8-09 for a psychiatry chronic stage" Shunsuke Sato 1, 1 which is related to Fukuo, Kimiko Matsuda 1, Kunihiko Asai 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2010.

---

	It is ... from proper use and role - agreement explanation assistance of the O8-10 clozapine of the pharmacist to side effect monitoring Tomoki Baba, Mika Iwamoto, Kenji Sasaoka, Hasegawa Azusa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2010.

---

	Examination toward the medication self-care of the prolonged hospitalization patients in the O8-11 mind regular hospital Masazumi Ando 1, 2, Shigeru Ishiwatari elegant 2, Hisahiro Yoshida 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2010.

---

	The use situation of mirtazapine in the O8-12 this hospital Michiko Uchiyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2010.

---

	The prescription actual situation with the cf. attached document system in O8-13 psychiatric hospitals of a check Junji Uno, Miho Nakata, Shinichi Tojo, Saeko Yamahata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2010.

---

It is ... through a use evaluation of psychiatric pharmacotherapy support - risperidone sustained release injection by the cooperation with the O8-14 physician Yuko Inoue 1, Noriko Kudo 1, Ken Matsuno product 1, Miwako Yokoyama 1, Atsuko Funakoshi 1, Kimiko Shigematsu 1, Tsuyoshi Onoe 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2010.

---

Activity report of the pharmacist in the many types of job team approach in medical care in the family psychoeducation of the O8-15 schizophrenia patient 赤羽理也 1, Takahiko Inagaki 2, Mitsuko Ando 3, Autumn Dasein lawn 2, Mizuho Konishi 4, Upper Etsuyo Yamazaki 5, Koji Uenishi 1, 蓑内徳蔵 1, Naoto Yamada 2, 寺田智祐 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2010.

---

	Attitude survey for the anaphylatic shock of the O9-01 drug Keiko Kitajima 1, 丸山明莱 1, Tatsuya Sasaki 1, Kaifu Masayo 1, Ishikawa immensity 1, Prince Taniguchi chapter 1, Kaifu Michiyo 2, Ken Takakura 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2010.

---

	Questionary survey about the acquisition of a packing, the preparation change information in the O9-02 drugstore Tamaki Hirofumi 1, Moat foster child 1, 2, Hiroki Sato 1, Akiko Miki 1, Doi reason Yuko 3, Yasufumi Sawada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2010.

---

Do the O9-03 remote island inhabitants require the online sale of medical supplies? Masahiko Hirayama 1, Hidekazu Tanaka 1, Hitoshi Omura own 1, Masayoshi Nagase 1, Product former Seiji 1, Masanori Sugawara 2, Toshihiro Kitahara 1, Choichiro Miyazaki 1, Noboru Yamashita 3, Kiyomitsu Yoshitani 3, Hiroki Sato 4, Akiko Miki 4, Moat foster child 4, 5, 6, Yasufumi Sawada 4, 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2010.

---

	Investigation about the criteria for selection of eye drops judging from O9-04 questionnaire Yuko Hiraki 1, Masakazu Miyachi 1, Haru Sato or 2, Noriko Tsuchiya 1, Naoyuki Yakura 1, Ishiwatari beach 1, Junko Matsuoka 1, Well beauty relationship 1, Tetsuro Yumoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2010.

---

Examination of the effect of the action to control about the oseltamivir proper use based on the compounding of medicines information in the O9-05 ethical pharmacy 漆原尚巳 1, Doi reason Yuko 2, Masaru Arai 3, Toshiyuki Matsunaga 3, Yosuke Fujii 2, Naoko Iino 4, Takashi Kawamura 5, Koji Kawakami 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2010.

---

	Action ... of medication support - drugstore DOTS for patients with O9-06 tuberculosis Yoshiyuki Akimoto 1, Noriko Tamai 2, Hideko Ozaki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2010.

---

	A role and practice of the pharmacist in the O9-07 Onomichi method (regional medicine cooperation) Mitsue Mukai, 本嶋世紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2010.

---

	The present conditions and problem of the communication attitude toward foreign patients at the O9-08 patient compliance instruction Hama well Taeko 1, Fumiko Nagata 2, Takayo Yamada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2010.

---

	For the spread to out of the hospital of O9-09 simple suspension methods Makiko Miyatani, Taeko Kitano, Nobuko Mori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2010.

---

	Approach of "the pharmacist salon" toward the university where O9-10 was borderless 平田純生, 門脇大介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2010.

---

Action for the pharmacy six years system hospital business training leader text making in O9-11 Kumamoto Shigeyuki Miyamura 1, Satoshi Shibata intellect 2, Masayasu Kino 3, 宮本晋治 4, Naoyuki Suematsu 5, Kondo New Year's Day 6, Yasushi Fujii 7, Quantity of Seo 8, Toru Irie beauty 9, 濱田哲暢 4, Hideyuki Saito 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2010.

---

Trial of the "list of essential drugs" utilization in the O9-12 six years system business training Keiko Hirano 1, Midori Kimura 1, Nabeta Izumi 1, 高橋鉄治 1, Satoru Minami 1, Tashiro Kei straight 1, Hiroaki Utsuki 1, Nakata season furrow 1, Tatsu Sakamoto Ichiro 1, Tomoki Tsuji 2, Kazuhito Kosuge 2, 宮嵜靖則 2, Yoshiyuki Kagawa 2, 河原崎貴伯 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2010.

---

It is the trial to the effective cooperation construction with a member of ... pharmacy and the businessman teacher for a lot of O9-13 six years system business training acceptance Midori Kimura, Keiko Hirano, Nabeta Izumi, Satoru Minami, 高橋鉄治, Miwa Saegusa, Kimiko Asakura, Yoko Ikoma, Tatsu Sakamoto Ichiro, 河原崎貴伯 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2010.

---

	Action of the long-term student training in the cottage-hospital out of O9-14 Makoto Tanaka, Shina Sogabe, Kenichi Manabe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2010.

---

	Activity of the businessman teacher in the O9-15 North Carolina University pharmacy school Maiko Machida 1, Yamashita beauty princess 1, Williams Dennis2, Eckel Stephen3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2010.

---

	Examination about the efficacy of the skin warming for alopecia by O10-01 Cyclophosphamide Sanae Shino 1, Fumio Itagaki 1, Shigeto Suzuki 2, Junichi Kurihara 2, Hideaki Niwata 1, Hiroyuki Hosono 1, Machiko Watanabe 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2010.

---

	Examination of the predictor of the hypersensitivity reaction expression in O10-02 carboplatin Toshiya Goto, Takayashiki Nana, Kazuaki Hirose, Tomomi Matsushita, Akira Takada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2010.

---

Investigation about the actual situation and the prognosis of hepatitis B virus reactivation measures in the cancer chemotherapy using O10-03 rituximab Sanae Imamura 1, Kitada Noriaki 1, Yoshi Suginoshita tree 2, Flat field Masaki 1, 田中詳二 1, Tetsuro Iguma 2, Takayuki Takahashi 3, Toru Hashida 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2010.

---

	About a utility of the oral pyrimidine drugs supplementation after the O10-04 colorectal cancer postoperative adjuvant chemotherapy fluoride Kenji Taniguchi, Rika Nakajima, Noriyuki Shimoi, Hiroya Fukunaga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2010.

---

	Effect of Growth Factor to give metabolism of O10-05 CPT-11 Akira Takagi period, Manabu Okumura, Tomomi Iwakiri, Masashi Nagata, Yohei Kawano, Hiroyuki Yamaguchi, Yasushi Hirahara Kotobuki, Yasushi Sekiya, Kazuhiko Arimori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2010.

---

	Comparison of the adverse event of sorafenib in O10-06 hepatocellular carcinoma, renal cell carcinoma The description of Hama field existence beauty, Misato, Kariya, Hiromi flat for a period, Utsubo Yuko, Kumiko Matsumoto, Manabu Kume, Makimoto Hiroo, Tsuyoshi Hirano, Hirai green Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2010.

---

Importance - of the side effect of hypertensive - team treatment with O10-07 sorafenib management Grow of Oda; 1, Shinya Suzuki 1, Yoshiko Nishimura 1, Kayo Onoda 2, Funasaki Hideki 1, Relation place Kohei 3, Shuichi Mitsunaga 3, Satoshi Shimizu 3, Izumi Ono 3, Hideaki Takahashi 3, Yoshizo Watanabe 1, History of Prince Ikeda 3, Ichiji Endo 2, Satoshi Izumi Shiro 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2010.

---

HFSR risk factor of sorafenib in the O10-08 hepatoma patients Shinya Suzuki 1, Grow of Oda; 1, Hideaki Takahashi 2, Yoshiko Nishimura 1, Funasaki Hideki 1, Kayo Onoda 3, Satoshi Shimizu 2, Izumi Ono 2, Shuichi Mitsunaga 2, Relation place Kohei 2, Yoshizo Watanabe 1, History of Prince Ikeda 2, Ichiji Endo 3, Satoshi Izumi Shiro 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2010.

---

Study on aggregate contained in O10-09 marketing antibody preparation Satoshi Uchino sincerity 1, Yutaka Okawa charges 1, 宮嵜靖則 1, Hidehiro Honda 2, Ryoji Yanagihara 2, Masahiro Takahashi 3, Takayuki Yoshimori 4, Tomohiro Sakurai 5, Katsuyoshi Nakajima 2, Hiroshi Suzuki 2, Yoshiyuki Kagawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2010.

---

	Role of the pharmacist in the chemoradiotherapy of O10-10 lung cancer Misaki Takase tree 1, Way field Momoyo 1, Maruoka eyes 1, 飴谷太 1, Hiromi Hara 2, Miyuki Takahashi 2, Hiroshi Kotani 2, Kazuhiko Shibata 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2010.

---

Structure-activity relationship - in the photobleaching response of mechanism elucidation (the fourth report) - coloration pigment carminic acid of the photobleaching response in O11-01 five mini-(R) Tadashi Okubo 1, 2, Mariko Tanaka 2, 7, Okubo branch 1, Setsuko Okubo 3, Miho Okubo 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2010.

---

	The information that is necessary at fact-finding and the dosage form change of the change to the dosage form for O11-02 children Makoto Komura 1, Yoichi Ishikawa 1, Kenji Kushida 2, Kenichi Odaka 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2010.

---

	Examination of the continuation medication of the bisphosphonate preparation at fracture by the O11-03 document retrieval 守内匡, Satomi Asano, Osamu Tanaka, Hiromi Matsui, Yoshimi Matsuda, 高田加壽代 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2010.

---

It is ... about the education effect on study on understanding degree investigation method (I) - investigator of the attached document of the O11-04 non-prescription drug Hosaka indigo plant 1, Risa Kaneko 1, Masayuki Hashiguchi 1, Keiko Ueda 2, Mayumi Nakamura 2, Mikio Sakakibara 2, Mayumi Mochizuki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2010.

---

	O11-05 Research on the understanding of survey method of attachment of OTC drugs (II) : Comparison of two types of attachments with different formats of the same effect drugs 金子梨沙1, 保坂藍1, 橋口正行1, 小寺典子2, 植田恵子2, 中村眞弓2, 榊原幹夫1, 2, 望月眞弓1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2010.

---

	Action of the prescription adequacy of the renal function degeneracy patients who utilized O11-06 electronic chart system Tsuneo Kuwamura, Megumi Matsumoto, Takashi Akamatsu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2010.

---

	Action to patients waiting time shortening by the O11-07 prescription mini-medication history utilization Kaoru Miki daylight, Shinya Iwakawa, Tanaka Riyoko, Kazuyo Takayanagi, Takako Aoyama, Nitta Kei Satoko, Yasuhide Okumura, Mulberry well Yukio Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2010.

---

	Taste bitter prediction of the amlodipine OD lock 10 preparation using the O11-08 taste sensor Takahiro Uchida, Haji River dance, Miyako Yoshida, Tamami Haraguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2010.

---

	Effect of pH of the carbocysteine preparation which gives it to taste bitter of the O11-09 clarithromycin preparation or the ambroxol preparation Haji River dance, Tamami Haraguchi, Miyako Yoshida, Takahiro Uchida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2010.

---

	About contribution of effect - elution quantity and the taste bitter threshold of the temperature to give it to the taste bitter intensity of the O11-10 ambroxol tablets 10 preparation - Yuka Sugino, Haji River dance, Tamami Haraguchi, Miyako Yoshida, Takahiro Uchida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2010.

---

	The effect that the insulin self-administration procedure in the O12-01 outpatient gives for a glycemic control Tomoko Kawaguchi 1, Liujiang Masatsugu 1, Naomi Iwasaki 1, Tomomi Oda 1, Small thicket Kayoko 1, Yuji Hirose 1, Tetsuya Morita 1, 大野恭裕 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2010.

---

	Examination of the efficacy of the insulin intensive therapy using O12-02 CGMS Tomoyuki Saito 1, Kyoko Nomura 2, 金光宇 3, Satoru Yamada 4, Kaori Chiba 3, Kaoru Ichiyanagi 5, Small Hiroshi Sano 6, Kazuhiro Sase 1, Shunichi Yamauchi 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2010.

---

	Three cases of diabetes that lifestyle improvement was effective in addition to O12-03 medical treatment Miki Nakai, 大西稚香, Mika Yamada, Well fence Toshiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2010.

---

Examination of vanity and the instruction method in the visually impaired having difficulty in O12-04 insulin self-administration Hiroyuki Nishimura 1, Yoichi Ishizuka 2, Chiho Maeda 2, Yoshida positive 1, Asako Eguchi 1, Kumiko Tsuruta 1, Mitsuru Irikura 2, Toru Irie beauty 2, Fumio Miyamoto 3, Keizo Kajiwara 4, Tomio Jinnai 4, Hideaki Jinnai 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2010.

---

	The patients background factor which affects the glycemic control after the O12-05 diabetes education hospitalization Sekiguchi Machi child 1, Kaoru Wakabayashi 2, Takeshi Minami husband 2, Emi Nakajima 3, 登美斉俊 3, Tomohiro Nishimura 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2010.

---

	Comparison between the preparation of the O12-06 insulin crystal Setsuko Tomioka 1, 小佐野磨子 1, Takayuki Nagata 1, Shinichi Yoshikawa 1, Susumu Yoshida 1, Yuji Fukuchi 1, Shigenari Shinoda 3, Yukio Nohara 1, Hiroaki Kubo 1, Ryo Murata 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2010.

---

	Precision study of the O12-07 pre-filled type insulin device Main room three picture 1, Yuko Kanezaki 1, Osamu Egawa 1, Hideaki Kondo 2, Kiyoshi Ashizawa person 2, Motomori Izumi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2010.

---

	Fact-finding II (analysis according to the drawing blood site) of the explanation method about O12-08 self blood glucose measuring instrument and the puncture device of the whole country Tatsuya Muto 1, Reiko Nakano 2, Toshinari Asakura 3, Tiger stone Kenichi 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2010.

---

	The participation type training using the O12-09 drama, satisfaction of the diabetes theater Hiroshi Okada 1, Toshinari Asakura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2010.

---

	About usefulness of the O12-10 new antidiabetic drug DPP-4 inhibitor sitagliptin 岡本朋子1, 上田浩貴1, 塚本康彦1, 矢部大介2, 黒瀬健2, 濱口良彦1, 清野裕2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2010.

---

	Intervention to the lifesaving treatment in O13-01 emergency visit, the ward Satoshi Kataoka 1, Kyoko Kataoka 1, Tomoko Hirayama 1, Matsuda law of nature beauty 1, Makoto Tanaka 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2010.

---

	Role of the pharmacist in the O13-02 bone marrow transplantation team Kunihiro Saegusa, High Yoshihide Kubo, Reiko Hamamoto, Yasukazu Odaka, Koji Akasaka, Hiroko Mine that it is the way it goes Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2010.

---

	The actual situation and utility evaluation of the prescription brushing up by the O13-03 pharmacist Satoshi Shibata intellect 1, Toru Maruyama 2, 3, One field Hitomi 1, Yukiko Horikawa 1, Harumi Tanoe 1, Koichi Nakao 4, Hirayama unification 5, 飛野幸子 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2010.

---

	Contribution of the positive pharmacist in the O13-04 outpatient department hemodialysis patient Junko Onishi 1, 2, Plum Miyoshi 3, Yuka Onoe 4, Hoe mound Keiko 4, Akiyo Miyake 4, Yoshihisa Kitamura 4, Hiromi Kawasaki 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2010.

---

It is ... through the setup of mutual understanding between the types of job for the O13-05 team approach in medical care reinforcement and pursuit - team approach in medical care promotion special committee of the specialty Saito wish 1, Koji Kase 1, Kimiko Matsuda 1, Kunihiko Asai 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2010.

---

	Design of the new oral sustained release liquid drug using the O13-06 methyl cellulose / alginic acid mixture system Descent from a mountain Tetsuya, Kunihiko Ito, Asa Kimura group, Shozo Miyazaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2010.

---

	Development and skin transitivity evaluation of the emulsified lotion which combined O13-07 prednisolone Keiko Miura, Makiko Fujii, Shiori Aiuchi, Naoya Koizumi, 渡辺善照 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2010.

---

	AntiTNF - alpha action of capsaicin in the O13-08 CCI4-induced liver damage Mina Takano, Daisuke Sasaki, Takashi Kato children, Yoshio Ijiri, Kazuhiko Tanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2010.

---

	For the Residual medicine in the instillator at the O13-09 transluminal administration become calm; examination - lansoprazole orally disintegrating tablet ... of the effectiveness of the use of adjustment food 青木悠, 杉山昌秀, 依田一美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2010.

---

	Examination - of utility - pollen automatic measurement device (KH-3000) of Ministry of the Environment pollen observation system "Hanako" in patients with O13-10 sugi pollinosis Hiroyuki Nanba 1, 2, Reiko Kishikawa 3, 4, Yoshimitsu Higaki 2, Norio Sahashi 4, 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2010.

---

	Analysis of the doubt inquiry example in the P1-001 prescription order Hoshino Yugo, Kiyotaka Kawazumi, Yoshiharu Kato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2010.

---

	The present conditions and utility of the checking prescription with the double check system in the P1-002 Osaka Saiseikai Ibaraki Hospital Naoko Ueda, Masaaki Sano, 眞継賢一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2010.

---

	Examination about the present conditions of the checking prescription system in the P1-003 this hospital and the utility 河内山佳英, 永田浩泰, Mika Miyazaki, It is Sachiko in a camp, Eiko Fukunaga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2010.

---

	Action to the patients with P1-004 compounding of medicines medicine certification Hiromi Otomo, Sum chestnut Yuko, Mikio Uesugi, Yosuke Sudo, Miki Ito, Masae Samejima, Jiro Tsuruta Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2010.

---

Construction of the high-risk medicine (medicine for external application) compounding of medicines system which utilized P1-005 bar code Takeshi Kaneko 1, Hiroshi Muramatsu 1, Osamu Ikeya 1, Soichiro Tsuda 1, Yamakichi Yasuko 1, Tomohisa Hayakawa 1, Hiroshi Shiina good luck 1, Masaya Yamaguchi 1, Shunichi Kawamura 1, Shinichiro Okamoto 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2010.

---

	Improvement of the prescription checking precision by the introduction of the creatinine clearance guess level printing system to the prescription which linked P1-006 electronic chart 鈴木成実, 後藤千寿, 小森善文, 丹羽隆, 安田浩二, 松浦克彦, 伊藤善規 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2010.

---

	Questionary survey about collection of of the patients information in the P1-007 health insurance pharmacy and the computerization of the medicine notebook Hidetoshi Honda, Yoshiyuki Ono, Toshiichi Seino, Katsuyoshi Nakajima, 伊藤晃成, Hiroshi Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2010.

---

	Problem of the communication between the patients, a pharmacist, physicians seeing from P1-008 doubt inquiry example Takuya Nonaka 1, Yoshikawa Keiji 2, Akiko Miki 3, Moat foster child 3, 4, Hiroki Sato 3, Doi reason Yuko 2, Yasufumi Sawada 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2010.

---

Relation of the medical office pharmacist to the medical supplies safety management in the P1-009 outpatient clinic 1, Kyoshi, Shimizu, Noriko Kuramochi 1, Castle tail Mariko 1, 岩冨由江 1, Tomoko Fukuda 1, Kyoko Inoue 1, Koichi Nakamura 1, Kazuyuki Hara 2, Kenichi Tomomatsu 2, Kazuo Nosaka 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2010.

---

	Importance of the checking prescription in the P1-010 compounding of medicines process 本加典子, Noriko Hirano, Kenichi Yumura, Hidemi Hamada, Satoshi Yamazaki, Mitsuru Kaneta Expo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2010.

---

	Combination of P1-011 ceftriaxone and calcium component preparation Yoshiharu Mitsunaga, Well ノ 口岳洋, Yukiko Omura, Suguru Kasahara Castle, Jun Hamada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2010.

---

	Development of the prescription prescription to adapt to P1-012 order ring and an electronic chart Kazuko Kawai, Seiichi Ito, Takamitsu Akita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2010.

---

	About the effect that P1-013 system environment and mean hospitalization give to inpatient dispensing Tamiko Kimura, Yasuko Saito, Masahiro Iwasa, Masayuki Watanabe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2010.

---

	About the present conditions of induction and the use of the P1-014 drug management support system 天野二愉香, Yukie Okada, Naoteru Fujie, Mika Matoba, Yoshiko Shimomura, Kazuko Shimura, Yoshihiro Sakagami, Emiko Tanaka, 脇條康哲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2010.

---

	Action to the new administration cart development about the P1-015 internal use set Yukio Toyama, Tatsuya Muto, Hiroko Saito, Takaaki Hasegawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2010.

---

	Induction of the simple suspension method using P1-016 prescription data Toshiko Furukawa, Hideko Noto, Onishi rises, 東禎二, Takeshi Yasuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2010.

---

	Construction of the P1-017 simple suspension method compounding of medicines inspection system Chiharu Onoda 1, Keiko Makita 2, Misuzu Yamanashi 2, Keiko Okabe 2, Ikenotani deferred bunch 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2010.

---

	Construction of the database about suspension pH of the simple suspension method in the P1-018 Yokohama Asahi center general hospital Takekawa seven rebirths, Miyuki Ozawa, Takeshi Yamamoto, 牧村吏恵, 大澤眞希子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2010.

---

	Action to the simple suspension method in the P1-019 "oral medicine intubation administration handbook" non-publication medicine Kazuaki Sugio, Aya Komine, Mountain ノ Kawakatsu, Ishii Toshihiro, Masaka Wataru Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2010.

---

	Examination of the tablet crushing appliance in the P1-020 simple suspension method Yuko Kasuya 1, Kimiyoshi Kimura 2, Mayumi Mitsuhashi 2, Kazuko Shirosawa 1, Hideya Kokubun 1, Mariko Arai 1, Hajime Matsubara 1, Kazuo Yago 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2010.

---

	Comparison of the crush method and the simple suspension method about the incompatibility of P1-021 olmesartan prospect Kiso mil preparation and the metformin preparation 矢吹優1, 杉山恵理花1, 秋山滋男2, 倉田なおみ3, 斉藤清美1, 中村明弘3, 佐藤均1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2010.

---

	Effect - at basic study - other agents simultaneous suspension in the simple suspension of the P1-022 Valixa (R) lock 小川敦, 河崎陽一, 正岡康幸, 山路和彦, 名和秀紀, 佐藤智昭, 松永尚, 千堂年昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2010.

---

	About an effect of the P1-023 simple suspension method induction 右川浩, Junko Hiroi, Kaori Ito, Kanichi Kawasaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2010.

---

	Nasal transluminal tube passage characteristics of the oiliness oral medicine at the P1-024 simple suspension sermon line Shiro Ishida 1, 賀勢泰子 2, Yoshiro Okano 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2010.

---

	Advisability of a stability evaluation after the P1-025 aspirin tablet folding and the simple suspension parcel application 木奈崎昭男, Shiro Ishida, Katsuaki Arai, Yoshiro Okano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2010.

---

	Role of the pharmacist in the P1-026 ICU ward Hiroshi Matsuzawa, Mariko Negishi, Mari Hosaka, Noriko Ishii, Funatsu Kumi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2010.

---

	Relation of the pharmacist to P1-027 ICU team approach in medical care Harada University 1, Eiko Kato 1, Nami Suda 1, Junichiro Kato 1, Masato Murayama 1, Shigehiko Uchino 2, Masaru Takinami celebration 2, Takashi Kawakubo 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2010.

---

	Effect - of role - drug information offer of the ICU permanent residence pharmacist in the P1-028 team approach in medical care Hiromi Yanamoto, Fumihiko Kitta, Ai Endo tree, Keiji Kawata, Masahiko Suzuki, 花輪剛久, Toshio Oguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2010.

---

	From relation - intervention of the pharmacist judging from the pre-Abo id report in the P1-029 ICU after one year - Nobue Uetake, Toshiharu Matsumoto, Shinichi Miyamori, Open Koichi, Yonezawa sing Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2010.

---

It is ... about discussion - pharmacy central dispatching about the pharmaceutical management for P1-030 intensive care unit and the lifesaving ward admission patients and patients-specific management Kazumasa Ueda 1, Tatsuya Otsubo 1, Mitsuru Otsuka 1, Yoshiji Junko 1, Kyuutoku Emi 1, Naomi Iio 1, Yoshitaka Kato 1, Yasuyuki Nishikawa 2, 野田能成 1, Kazumasa Oda 3, Yumi Kito 3, Suzuki dies out; 3, Takeshi Shinozuka 3, Satoshi Higaki 3, Ryoji Iizuka 3, 小西偉雄 1, Tadashi Mikami 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2010.

---

	Of drug control instruction and the patients intervention in the P1-031 CCU ward, actually Jun Kawazoe 1, Yuika Naito 1, Miyamoto beach 2, Yuka Kashiwabara 1, Junko Minemura 1, Tetsuro Sakai 3, Yoichi Kobayashi 3, Junichiro Murayama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2010.

---

	The new duties development of the pharmacist in the P1-032 NICU and the evaluation Hiromi Tanoe 1, Ikemi Yasuaki 1, 深津祥央 1, Ikuko Yano 1, Masahiko Kawai 2, Toshiya Katsura 1, Kenichi Inui 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2010.

---

	Team approach of the pharmacist in the P1-033 NICU Ayako Fujita 1, Mayu Tomita 1, Miyuki Miyaguchi 1, Mikio Chiba 1, 寺田智祐 1, Shigeki Koshida 2, Yoshihiro Takeuchi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2010.

---

	The evaluation of drug control instruction duties in the P1-034 NICU and the future prospects Shinya Yoshida, 宇佐美英績, Michio Kimura, Tadashi Yasuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2010.

---

Analysis of drug control instruction duties - drug information offer contents in the P1-035 altitude critical care center and evaluation - Yoshiro Sakai 1, Maruta tree light 1, Yuko Yoshimaru 1, Kyoko Higuchi 1, Chiyoko Arima 1, Mieko Tsuruta 1, Shuhei Niiyama 2, Norio Yamashita 2, Teruo Sakamoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2010.

---

	Drug control instruction duties necessary for P1-036 critical care center Eiichi Maruta, Hiroko Shimada, Makiko Yamazaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2010.

---

	Action (the second report) of the resident pharmacist in the P1-037 regular hospital Shina Sogabe, Makoto Tanaka, Kenichi Manabe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2010.

---

	Action of the fur Matthew tical care in the P1-038 this hospital Tsubotani Ayako 1, Shigeo Hatta 1, Shibuya Tomoyo 1, Haji day Kaori 1, 浅見妥江 1, Yuko Sakashita 1, Keiso Masuhara 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2010.

---

Through pharmacist duties - ward permanent residence pharmacist duties carrying it in P1-039 team approach in medical care - Makoto Nakamura Tsu child, Ayumi Kondo, Masayo Tanahashi, Maki Arakawa, Nozomi Nishida Kushiro, Iku Kawamura person, Yukio Toyama, Tatsuya Muto, Hiroko Saito, Takaaki Hasegawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2010.

---

	Activity report of the ward exclusive duty pharmacist in the P1-040 this hospital Bell mountain Naoto, Hiroshi Tsujimura, Tatsuo Kai, Masatoshi Tadokoro, Kazuhiko Kawakita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2010.

---

	Examination about the management of the pharmacist duties in the P1-041 ward Akira Kitaoka, Junichi Iida, Yasuyuki Matsumura, Akihiko Yoshikawa, Hajime Kagaya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2010.

---

	The present conditions and problems of the drug control instruction in the P1-042 center of gravity institution Tsuyoshi Ebihara 1, Fumihiko Aida 2, Kazuki Kushida 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2010.

---

	About the development of emergency department duties mainly on the P1-043 bringing medicine confirmation Masahiro Someya, Setsuko Gamo, 千葉圭恵, Masako Nunokawa, Masaki Kitamura, Takashi Kawakubo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2010.

---

Action ... for the calculation of relation ... discharge drug information management instruction charges of the pharmacist until a discharge to be carried out using P1-044 medicine file 酒井孝征, Millet rice Miwa Hara, Ito graciousness, Tadaaki Okada, Sae Takii incense, Sayuri Tanaka, Tamae Ono, Kumi Kawano, Yuko Takada, Shiho Tanaka, Tomomi Matsumoto, Yono tree Katsuya, Nakagawa saturation, Yoshihiro Matsumoto, Junko Kai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2010.

---

	For the inflection of the medicine notebook at the P1-045 discharge guidance Akira Tsujimoto, 原知斉, Yoko Imamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2010.

---

About the way of the drug control instruction calculation to make we consider it and patient compliance instruction of the high risk medicine activated about the job evaluation of the P1-046 patient compliance instruction Masako Ieda, Morihiro Nomura, Naoko Matsuura, 角野雄亮, Koji Yoshida, Kitai Miwa, Hajime Asano, Yasuyuki Tsukioka, Yuzuru Yamazoe, Kenzo Moriyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2010.

---

	Action to the use of P1-047 high risk medicine situation and drug control instruction standardization We go to Saito, Yutaka Ito law of nature, Hiroto Ito, Katsuyuki Yoshioka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2010.

---

	Improvement of pharmaceutical management, discharge instruction of the high-risk medicine in the P1-048 circulatory organ ward Naoto Hirata, Shigeru Yamasaki, Nakazawa one purely Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2010.

---

	Actions of this hospital in the regime such as P1-049 medical supplies safety information Hiroaki Mizuno, Miki Segawa, Kimi Sakata, Masae Tsuji, Morihiro Okada, Haba Hisae, Origin of Takeda, It is moisture in the west Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2010.

---

Examination about the efficiency of the drug control instruction of the antitumor agents that P1-050 was based on "duties guidelines about the drug control instruction on high-risk medicine" Takahiro Arai, Taeko Saito, Eriko Hiruta, Fumi Mukoda, Kawashima greens Yasuko, Aki Kuwahara, Toshiaki Kogure, Yaeko Mishima, Yukiko Kashima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2010.

---

Relative - with the increase and decrease and drug duties of the calculation in effect on P1-051 drug control instruction charges calculation score - institution of the 2008 fee-for-service revision Tetsuro Yumoto 1, 2, Body marsh Masami 2, 3, Yukino Ayabe 2, Junichi Iida 2, Hideko Kojima 2, Left side of the stage Mariko 2, Akitoku Kojima 2, Shinji Soeda 2, Jun Takimoto 2, Tamura harmony, reverence, purity and tranquility 2, Masatoshi Nakamura 2, Hisashi Fujiwara up 2, Takuya Maeda 2, Hajime Matsubara 2, Yoshiko Miyazaki 2, Masahisa Saito 2, Hajime Kagaya 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2010.

---

	P1-052 The introduction of audit in drug management guidance business 坂本愛, 寺沢匡史, 山下朋子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2010.

---

	A consciousness change by Audit of the P1-053 drug control instruction record and examination of problems 原知斉, Akira Tsujimoto, 廣末毅, Yoko Imamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2010.

---

	The super support system afferent use situation in P1-054 drug control instruction duties Kazuhiro Nakata 1, Hidekazu Kishida 1, Kenji Saegusa 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2010.

---

	About a utility of the simulated patient (SP) participation type role playing training for P1-055 Shinnyu job pharmacists Toshiaki Miyazaki 1, Hiromi Okazaki 1, Kazuko Kubo 1, Junko Maeda 2, Sendo Toshiaki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2010.

---

	The evaluation of the medication self-care criteria that we made jointly with P1-056 nurse and future problem Kana Akahori, Otake A tree, Shizuka Takaoka, 須山奈見子, Saori Okamoto, Yoko Nakano, Ikuko Fukumoto, Takushi Morimoto, Maki Ushijima, Takeshi Miyake sentence Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2010.

---

Making of the patient compliance instruction tool of the antipsychotics in the P1-057 health insurance pharmacy Yosuke Kawano 1, Hiroshi Sato rare 2, Iwao Yamamoto 1, Tokuko Ito 1, Fumiko Koga 1, Miwa Takaichi 3, Emiko Mimura 3, Sachiko Omori 3, Tomoko Ikeda 3, Yoshiro Okayama 2, Toru Maruyama 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2010.

---

	About an action of this hospital in the P1-058 outpatient department medicine consultation window Fukushima sheath, Gain book Shuji, Yuriko Ishibe, Taketo Kamei, Kazunobu Takayanagi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2010.

---

For improvement of action - outpatient department patient compliance instruction of the P1-059 "pharmacist outpatient department" - Terukazu Nakajima 1, Kyoko Iwata 1, Hill-climbing 1,000 Saint 1, Kumaoka Maiko 1, Rie Shibue 1, Title prefecture reason officer 1, Hiroki Tajima 1, Tadao Inoue 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2010.

---

	Patient compliance instruction to the outpatient using the P1-060 medication support program Masaaki Shibata 1, 熊田顕浩 1, Eri Kinoshita 1, Jun Hirano 1, Masaaki Takahashi 1, Yokomaku ability line 1, 2, Sugiura Wataru 1, 2, Toshiharu Nomura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2010.

---

Action of the pharmacist outpatient department for patients with P1-061 HIV infection 吉野宗宏 1, 矢倉裕輝 1, Hiroyuki Kushida 1, Minoru Kawai 1, Naoki Hayakawa 1, Hiroyuki Ueno 1, Yasukazu Sakamoto 1, Makoto Saito 1, Hiromi Sekimoto 1, 山内一恭 1, Yoshihisa Honda 1, Katsuya Komori 1, Takuma Shirasaka 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2010.

---

	Role of the pharmacist by the P1-062 CKD education hospitalization Shinichiro Ando Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2010.

---

	Relation of an introduction and the pharmacist of the renal disease classroom in the P1-063 Fujinomiya Municipal Hospital Yutaka Kobayashi, Kazuo Katsumata, Hiroshi Kawaguchi fruit, Yoshinori Kobayashi, Osamu Kitamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2010.

---

	Action ... as education hospitalization program - team for patients with P1-064 serious case atopic dermatitis Court Security Office Mika 1, Fumie Shimazu 1, Nobuhisa Fukushima 1, Yoko Kataoka 2, Ken Tanaka enthusiast 3, Masako Nagase 3, Sonomi Nakajima 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2010.

---

	Action to standardization of systems construction and the instruction in the self-administration induction of the P1-065 G-CSF preparation Keiko Miyakawa, Izumi Shimada, Makoto Hayashi, Akemasa Yamaya, Aspect shrine Koji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2010.

---

For instruction of the colonoscopic examination pre-treatment medicine which can feel relieved to the P1-066 patients Kimotsuki Miho 1, 中拂絵里香 1, Pond increase sweetfish beauty 1, Shrine gate Takanori 1, Terumasa Sata 1, Kazuko Tanaka 1, Tail Saori Tsuji 2, As for the one of Nakagawa, it is beauty 2, Yuichi Nakamura 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2010.

---

	Improvement of the adherence by the instillation instruction intervention to the P1-067 cataract surgery patients Shinya Yamanaka 1, Ikuyo Sakai 2, Eriko Yamada 1, 森章哉 1, Yuko Nakamura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2010.

---

	Making of the brochure about the use of drug of P1-068 children Kasama A village, Tomoko Komatsu, Hideki Koyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2010.

---

Examination about the number of the administration-related cold water re-hat reports of the nurse by the ward permanent residence system of the P1-069 pharmacist Koichi Tanabe 1, Machiko Nakamura 1, Aya Handa 1, Kanako Shinohara 2, Fukiko Shiroyama 2, Murata Italy Noriko 3, Shizue Ishida 3, Tomoaki Ikezaki 1, Satoko Takeuchi 1, Hidenori Kitazawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2010.

---

P1-070 "duties change by the ward placement of the pharmacist and effect" Hiroyuki Nagasawa, True river Sachiko, Kyoko Takahashi, 眞鍋美由紀, Yoshiko Katsuta, New ear Yuko, 渡辺孔明, Masae Yoshizawa, Mami Kazaoka, Taeko Ono, Ayako Sato, Height of island Ichiro, Tomoko Kawasaki, Chie Yuasa, Makoto Hoshi Ichiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2010.

---

	An activity report and the prospects of the resident pharmacist in the P1-071 circulatory organ ward Noriko Tsuzuki, Daichi Shibata, Mitsuru Sugiura, 足立守 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2010.

---

	1 approach - - of a Distribution of medicine mistake and the drug department in the P1-072 ward 中井千絵, 山村恭子, 溝口知宏, 萩野訓子, 楠本薫, 畑中智子, 杉本由平 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2010.

---

	P1-073 Distribution drugs misses and Medicament department of efforts in the ward: Part 2 萩野訓子, 山村恭子, 溝口知宏, 中井千絵, 楠本薫, 畑中智子, 杉本由平 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2010.

---

	Use of the confirmation lecture safe for action ... five minutes to the medical security by the P1-074 pharmacist and evaluation ... Harumi Tanoe 1, Yukiko Horikawa 1, Tadahiro Tanaka 1, Yuki Fujimoto 1, 飛野幸子 1, Koichi Nakao 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2010.

---

Trial (a tendency and measures) of the drugstore risk management in the P1-075 this hospital Shinichiro Matsuda, Maze Hisanori, Harumi Teramoto, Reina Matsuda, Yuko Shimizu, Sakie Senoo, 田邨保之, Yuko Nakagawa, Takahiko Uno, Riyo Kanbara, Atsuko Inoue, Yu Okabayashi, Yasuhiro Haruna, 前岡翠, Chika Yamamoto, Chika Takagi, Nine mountain Reiko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2010.

---

	Action of the drug duties improvement using the P1-076 risk foresight training law Haruka Murase, Igawa summer fruit, Ejima Aoi, Yuka Oyama village, Chie Oda, Hitomi Ishigami, Masayo Yamashita, Hiroshi Yoshida, Yoji Sugiura, Akio Katsumi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2010.

---

	The P1-077 advanced high-risk drug workshop - fourth year begins; and ... Ishikawa immensity 1, 後藤志央 1, Shrine Akihiro Ichiro 1, Mimata Sayaka 1, Maruyama Akina 1, Tatsuya Sasaki 1, 末安由拓 1, Kaifu Masayo 1, Akihiro Kai 1, Prince Taniguchi chapter 1, Keiko Kitajima 1, Ken Takakura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2010.

---

	Analysis and evaluation about the incident development situation in the P1-078 new face education period Ishiwatari beach 1, Noriko Tsuchiya 1, Haru Sato or 2, Naoyuki Yakura 1, Yuko Hiraki 1, Junko Matsuoka 1, Masakazu Miyachi 1, Well beauty relationship 1, Tetsuro Yumoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2010.

---

Examination about the way of the offer of the information to the nurse for the purpose of the decrease in P1-079 drug-related error Kenji Doi 1, Yuki Tokunaga 1, Okada early period 1, Yoko Fujii 1, Masako Ogawa 1, Atsuko Iwama 1, Haruko Shimada 1, Tomoko Kataoka 2, Tadayuki Samura 2, Hideyuki Yoshizaki 2, Kazutaka Matsumoto 3, Hitoshi Harada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2010.

---

	Participation in planning as the medical supplies safety management person in charge to the nurse P1-080 new face training Masako Tahara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2010.

---

Method ... to alert for action ... nurse to the risk management of this hospital pharmacist for the P1-081 electronic chart induction Harumi Teramoto, Shinichiro Matsuda, Nine mountain Reiko, Reina Matsuda, Yuko Shimizu, Sakie Senoo, 田邨保之, Yuko Nakagawa, Takahiko Uno, Riyo Kanbara, Atsuko Inoue, Yu Okabayashi, Yasuhiro Haruna, 前岡翠, Chika Yamamoto, Chika Takagi, Maze Hisanori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2010.

---

	Action of the risk management in the P1-082 generic medicine adoption promotion Misao Arimura, Eri Kanazawa, Seiko Ishigami, Kohei Yamamoto, Helmet slope Tomohiro, Jun Taniguchi, 高田正温, Minato book Yasunori, Takanori Kobayakawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2010.

---

	Action for the safe use of the P1-083 high risk medicine River Chinese mustard cord, Kaori Kawahara, Kumiko Honma, Rie Ueda, Miyuki Sakurai, Eiji Fukui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2010.

---

	Making and use of the P1-084 high risk medicine monitor sheet Sachie Kawano 1, Yamashiro Sakae person 1, Period Masayuki 2, Tetsuji Sugata 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2010.

---

	About the construction of the P1-085 drug information database and the present conditions, a future problem Ryu Kobayashi, Shigeru Sato, Saori Fujiwara, Reina Toda, Yuichi Nakamura, Hatsumi Kikuta, 谷口亮央, Miki Katsuragawa, Jun Matsunami, 目黒亨治, Muki Ryoji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2010.

---

	The construction of the P1-086 doubt inquiry information sharing system and the fact-finding of the inquiry history and the measures Atsushi Hirata, Yutaka Matsuoka, Takamitsu Ochiai, Saori Nishiura, Sada Tachibana sincerity Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2010.

---

	Construction of the questions and answers database of P1-087 induction cost zero Jun Wada, Chieko Ozuku, 荒井久暢, 東碧, Yuki Imaizumi, Tomoko Takeda, Michiko Fujioka, 山下彰良, Yoshiko Murayama, Koji Hasegawa, Tatsuya Nakagami, Taeko Murakami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2010.

---

	Construction of the question-response database in the P1-088 regional medicine-response drugstore Mikio Sakakibara 1, 2, Jun Kuribayashi 2, Masahiko Amakawa 2, Michihiko Kido 2, Satoshi Okada 1, 2, Keiji Arai 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2010.

---

	Efficiency of DI room duties by the computerization of the P1-089 medical supplies document Masato Ishii, Hiroyuki Yamane, Takeshi Shimada, Kae Hanaoka, Valley water Kumiko, Koji Matsushita, Yoshiaki Kita, Atsuko Inoue Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2010.

---

About the count results of "the questionnaire about the computerization of drug information duties" by P1-090 Hiroshima Hospital Pharmacist Association, the investigation public information committee and a future problem Takayuki Arakawa, Toshiharu Matsumoto, Masahiro Yasuhara, Masahiro Hiura, This Tawa ear, Tree flat Kenji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2010.

---

	Examination of the utility of the drug information offer system with the cell-phone using P1-091 matrix type two dimensions cord (QR cord) 栗木沙希恵, Shinya Uchida, Naho Ikegami, Yoshiro Uchida, 三浦基靖, Riyoichi Takenaka, 田中紫茉子, 加藤安宏, Tokuyuki Namiki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2010.

---

It is ... for comparison ... appropriate drug information offer systems construction of the drug information database with P1-092 Japan and Europe and America Noriko Tanabe 1, 2, Natsuko Sugiyama 3, 4, Naoko Ishii 2, 5, Toshikazu Miyagishima 2, 高乗仁 2, Komoda Masayo 2, 4, Hiroshi Terada 2, 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2010.

---

	Construction of the data collection system of the drug information in the P1-093 drug information room and the side effect Machiya cheap period, Yuichi Koizumi, 覚前盟, Fujitani Masanori, Mami Nomura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2010.

---

	Construction of the drug information offer system corresponding to the P1-094 fee-for-service revision Nakanishi will child 1, Yoshihisa Watanabe 1, Satoshi Nagami 2, Well falcon Takashi 2, 福島規志 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2010.

---

	Reinforcement - of DI information sharing - medical supplies safety information management system inside the hospital using the P1-095 Excel-XML database Yoshiyuki Kosugi 1, 伏見幸浩 2, Masaharu Terasawa 2, Shigeki Akizuki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2010.

---

	Construction of the brief database of the medical supplies safety information using P1-096 Excel Takashi Hayasaka light 1, Koike Chihiro 2, Masahiro Ishii 3, Sato samisen 4, Eriko Murakami 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2010.

---

	Offer ... of the safe information that medical supplies safety information in the P1-097 Kochi medical center aimed at the improvement of regime - quickness characteristics and the certainty Step pine Masahiro, Masami Uchida, The Tanaka immensity, Yuki Okazaki, 服部暁昌, Teruo Tanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2010.

---

	The further improvement of P1-098 drug information offer and cooperation with drug control instruction duties Hajime Nakai, Kazunari Nakamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2010.

---

	Association between individual reporting and DSU to P1-099 physician 初田泰敏 1, 2, Ishinomaki Yasuhiro 2, Paulownia book Chika 2, Keiji Matsumoto 2, Hatadani Yoshimi 2, Silver Machiko 1, Toshiaki Tanaka 1, Fossa field wisdom 1, Masahiko Taniguchi 2, Masashi Ogawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2010.

---

	Analysis of the adverse event case of the antiplatelet drug using P1-100 FDA size scale adverse event spontaneous report (AERS) Koichi Hosomi, Charcoal floor Keita, Hideaki Miyamoto, Mitsutaka Takada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2010.

---

	It is ... through P1-101 medical supplies safety reporting and attached document revision about the interaction of evaluation - clopidogrel and omeprazole Motoko Funato, Keiko Nitta, Akemasa Junko, South Reiko, Kiyoshi Sasayama, Masaaki Mori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2010.

---

For destruction medicine zero by the P1-102 change of prescription action - in the - injection mixed preparation Keisuke Kiyomiya 1, Hiroshi Muramatsu 1, Shu Kojima 1, Naomi Nishimatsu 1, Jewel bug Kasumi 1, Saeko Takei 1, Yoshiyuki Matsuki 1, Asami Wakimoto 1, Masaya Yamaguchi 1, Shunichi Kawamura 1, Shinichiro Okamoto 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2010.

---

Action for the present conditions and the medical supplies purchase costs reduction of the quantity of preparation disposal anticancer drug in the P1-103 this hospital Yuichiro Kayano, 根來寛, Valley Daisuke, Ukuru Watanabe is flat, Jin Tsukamoto, Ryoichi Yano, Toshiaki Nakamura, Mikio Masada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2010.

---

Investigation about the use situation of donepezil based on the medication history information in the P1-104 health insurance pharmacy Shunya Matoba 1, Mitsuko Onda 1, Seven Kaiyo child 2, Rie Tanaka 1, Kenichi Tsubota 1, Hiroaki Mukai 1, Hidehiko Sakurai 3, Kosai Hayase 3, Arakawa line straight 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2010.

---

	Investigation about the factor associated with compliance and that of patients with P1-105 donepezil remedy Hiroaki Mukai 1, Mitsuko Onda 1, Seven Kaiyo child 2, Rie Tanaka 1, Kenichi Tsubota 1, Shunya Matoba 1, Hidehiko Sakurai 3, Kosai Hayase 3, Arakawa line straight 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2010.

---

Investigation about the intervention effect of the pharmacist based on the use of drug evaluation on donepezil in the P1-106 outpatient Kenichi Tsubota 1, Mitsuko Onda 1, Seven Kaiyo child 2, Rie Tanaka 1, Shunya Matoba 1, 向井祐亮 1, Hidehiko Sakurai 3, Kosai Hayase 3, Arakawa line straight 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2010.

---

	P1-107 surgery, opioid use investigation in the gynecology Misa Sato, Takashi Watanabe, Akio Tanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2010.

---

	Need ... of the consideration for present conditions - tooth caries of the P1-108 syrup sweetener Fold Ikuno 1, 浦裕之 1, 2, Mizuho Takahashi 1, Kiyomi Sadamoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2010.

---

Antimicrobial agent consumption investigation of the municipal hospital-affiliated institution using P1-109 ATC/DDD Mikako Nakano 1, Akiko Yamagata 2, Rumi Ishida 3, Pine Yoshimitsu child 4, Junichi Suwa 5, Yukiko Omura 6, Koichi Kawase 7, Small Saussurea Root Satoko 8, Takahashi sincerity 9, Yasuhiro Sasaki 10, Mariko Negishi 11, 鈴木礼乃 12, Yumiko Umezaki 3, Kumi Funatsu 11 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2010.

---

	Use situation investigation of medical institution-limited cosmetics in the P1-110 Fukuoka University Hospital Tadahiro Ikeuchi 1, Adachi るい 1, Yoshihiro Kawahara 1, Shoichi Kinoshita 1, Koji Washiyama 1, Jiro Takada 2, Kojiro Nikami 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2010.

---

	Prescription fact-finding (2000-2009: the second report) of the P1-111 migraine headache therapeutic drug Sachiko Imai 1, 2, 鈴木浩彰 2, Mari Nishizawa 1, Kenji Fujita 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2010.

---

	Use fact-finding for proper use of P1-112 aprepitant Grass sincerity Harumi 1, Satoko Fujiwara 2, Yukihiro Kawakami 2, It is still 2 Matsunaga, Sendo graduate apprentice 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2010.

---

	Administration fact-finding for the risperidone proper use for P1-113 delirium Tsukiji jasmin child 1, Mayuko Kawaguchi 1, 仲佐啓詳 1, Hiroshi Nakamura justice 1, Amount of Ariyoshi example 1, 伊豫雅臣 2, Koichi Kitada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2010.

---

	P1-114 Survey of Sitagliptin in Hokusetsu General Hospital 千葉知子, 加冶佐聖子, 松尾彬宏, 南宅梨沙, 辛永美, 榎南祥太, 東野友美, 佐藤千恵, 吉田智子, 柳川智子, 和田恭子, 高橋宏幸, 百海有二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2010.

---

	Use situation investigation about the procedure of SMBG and the insulin self-administration to P1-115 insulin self-administration patients Ken Kitamura is elegant, Hiroshi Kita University, Great Hisao Takeno, Noriko Ikeda, 横尾賢乗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2010.

---

	Physician-led making clinical path improvement suggestion from P1-116 case data analysis Kumi Nakamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2010.

---

	Effect ... by the presence or absence of fact-finding - lipid microsphere combination of the P1-117 TPN enforcement situation Takashi Yamazaki 1, Ayumu Nozaki 1, 茂木孝裕 1, 土手賢史 1, Ito greens wave 1, Yuka Kobayashi 1, Toshiko Aramiya 1, Hirokazu Nakanishi 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2010.

---

	Examination of the use situation and the resistant bacteria change of injectable antibiotics in the P1-118 Saga Hospital Masashi Hashimoto, Higashijima good luck way, Tashiro early period, Yagi Hideaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2010.

---

	Effect investigation by the antimicrobial agent cost-cutting measure enforcement of the P1-119 Fukuoka Red Cross Hospital Tatsuya Oishi, Yu Koga group, Tomohiko Takeno, Chie Gotanda, 川野昭, Noriko Nishimura, Rieko Fujinaga, Yoshida Hiroaki, Hiroyuki Otake Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2010.

---

	A comparison and examination of the consumption of the injectable tazobactam sodium piperacillin sodium between the P1-120 2 institution Tadanori Suzuki 1, Chie Takahashi 1, Kuniyoshi Sato 1, Chie Okazaki 2, Kazuyo Shimojima 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2010.

---

	Trial to a prescription investigation and proper use of P1-121 levofloxacin Hatamoto Keita, Hisafumi Morita, Yasuko Ichikawa, Yasushi Fujii, Kenichiro Fujii Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2010.

---

	It is hard to stop bleeding of the P1-122 cardiovascular surgery surgery and reports use of the genetically-modified active form blood clotting factor VII in the case Tomoyuki Gomi 1, Kenichi Horiuchi 1, Kazumi Yoda 1, Takahiro Takemura 2, Kazuaki Shiratori 2, 濱元拓 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2010.

---

	About the use situation and registration system induction of the albumin preparation in the P1-123 this hospital Mari Mizuki 1, Eiko Ueda 2, Tomoko Nishikawa 3, Itsuki Chiyoko 3, Saeko Sakamoto 3, Sakai well 1,000 Emi 4, Masami Takahashi 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2010.

---

	Fact-finding about the prescription of the P1-124 oral antihistamine Kayoko Maezawa 1, Asako Terashima 1, 秋田博伸 2, Moat Seiji 3, Junko Kitsu 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2010.

---

	It is J-HOME Morning study the present conditions of the diuretic use in the hypertensive practice of P1-125 Japan Ikeda back et al. 1, Taku Ohara 2, Kazuki Ishikura 3, Ai Yoshida koto 4, Yuka Kobayashi 1, Takayoshi Okubo 3, 5, Hiroshi Sato 1, Jun Imai 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2010.

---

	About an association between salt intake and remedy drug and BMI in P1-126 patients with hypertension Seiji Machida, Toshiaki Tomita, Masaru Fukushima friend, Kazuhisa Masuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2010.

---

	Trend of the statin prescription in the P1-127 ischemic stroke prevention of recurrence Tomiyasu 1, Mayuu, 90,000 field reason Takae 1, Yuki Fujimoto 1, Harumi Tanoe 1, Yuichiro Inatomi 2, Toshiro Yonehara 2, 飛野幸子 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2010.

---

	Work of the pharmacist in the opioid use of preparation situation investigation and proper use in the P1-128 University of Tokushima Hospital 西迫寛隆, Yoshiko Yoneta, 上村卓広, Tetsuya Mizoguchi, Shinji Abe, Kazuhiko Teraoka, Hisatsugi U.S. Toshihide, Kazuyoshi Kawazoe, Kazuo Mizuguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2010.

---

	"A prescription, the use actual situation of the nonsteroidal antiphlogistic analgetic (NSAIDS) patch" that we saw from P1-129 pharmacist Young Susumu Hayashi 1, Akiko Miki 2, Hiroki Sato 2, Sayo Matsuoka 2, Moat foster child 2, 3, Yasufumi Sawada 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2010.

---

	Use experience of the Fra fin hydrochloride becoming the fact-finding for the itch of the P1-130 patient on dialysis Eri Wakita, Shigeru Yamada tree, Hiromi Sakai, Hiroshi Hozumi, Mika Shinoda, Kana Kato, Nomura connection, Yuichiro Wada, 吉田雅彩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2010.

---

	Effect ... of examination - non-steroid-related antiphlogistic analgetic combination about the dose change of methotrexate in patients with P1-131 articular rheumatism Norio Masumoto 1, 2, Takako Yuko 1, 大槻裕朗 1, Yoshihisa Takao 1, Kazutaka Harada 3, Seigo Iwakawa 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2010.

---

	Examination of the drug costs reduction by the screening of the P1-132 prescription 鵜山泰詳 1, Yoshiko Yotsumoto 1, Fujii sheath or 1, Miyanooku Kei Tsu celebration 1, Ikuko Fukuoka 1, Yoko Nakamura 1, Kensuke Matsushita 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2010.

---

	It is ... based on approach - medical supplies purchase quantity for the P1-133 prescription of drug adequacy Yukio Kondo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2010.

---

	Review of the adoption drug which came from P1-134 business efficiency and economy North field Tomohide, Naomi Sogabe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2010.

---

	The P1-135 "effect of running it on late departure medicine change in the DPC Hospital" Taku Yamauchi, Yoshiko Onuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2010.

---

	Economic effect (investigation in the orthopedics ward) that the bringing medicine check by the P1-136 pharmacist results in Hideyuki Kakiuchi, Yoshihiro Nakata, Daisuke Tsuchimoto, Shigeki Hirano, Yamada Toru Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2010.

---

Change of drug costs by the "smallest price list use with the quantity of extraction" of the P1-137 anticancer drug, the preparation efficiency Hidekazu Fujita, Hamamoto right child, Yuko Hino, Noriko Nishimura, Rika Tanaka, Yuri Aoki child, Naoko Noguchi, Hiroshi Yamamoto, Koji Takai, Yoshinobu Kitao Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2010.

---

	Comparison between clinical evaluations and economy - erythropoietin ... of the P1-138 darbepoetin 堀哲史, 岩崎純子, 水岡大策, 布川修次, 伊東利紗, 佐野良平, 土下喜正, 伊藤公博, 藤村保夫, 楠本正明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2010.

---

	Effect of the calcium lactate which gives it to effect of treatment of the P1-139 levothyroxine Hiroyuki Miyazaki, Yoshinori Okubo, Takahiko Nakao Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2010.

---

	Examination of the drug interaction of cyclosporin A in the P1-140 hematopoietic stem cell transplantation 増田理央 1, Kan Yukio 1, Junko Ishizaki 1, Ryo Matsushita 1, 崔吉道 2, Kenichi Miyamoto 2, Arai country three 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2010.

---

	Examination of the downward titration method of warfarin doses in the P1-141 amiodarone induction patients Megumi Kurita 1, Keiko Ono 2, Tetsuro Ono 3, Jun Umemura 4, Satoshi Kishino 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2010.

---

	Examination of the patient factors about the rise in INR value at P1-142 warfarin and bucolome combination Momoko Tomioka 1, 植沢芳広 2, Mitsuhiro Saito 3, Tomio Matsumoto 3, Mori Kiminori 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2010.

---

	Examination of the medical supplies proper use from P1-143 warfarin bucolome combination case follow-up Emi Momiyama, Yoshie Nishiyama, Thin wave Tomoko, Hiromi Nagai, Kanako Sakashita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2010.

---

	Investigation about the anticoagulant action augmentation by the combination of P1-144 anticancer drug and warfarin Hiromi Nagai, Emi Momiyama, Yoshie Nishiyama, Thin wave Tomoko, Kanako Sakashita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2010.

---

	Study on interaction of warfarin and the proton pump inhibitor in the P1-145 common practice Kenta Sugiura 1, Keiko Ono 1, Tetsuro Ono 2, Jun Umemura 2, Satoshi Kishino 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2010.

---

	1 case - prescription fact-finding and future problem ... that it influenced anticoagulant effect of the warfarin to have switched from P1-146 hyperalimentation to tube feeding Chieko Suda 1, Yuko Inoue 1, Michio Tomita 1, Toshiyuki Matsuda 1, Daisuke Arai 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2010.

---

	It is ... through the poor case of examination - phenytoin control about the interaction of P1-147 warfarin potassium and the phenytoin 齋川善行, Masayuki Kaneta, Shuzo Fujita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2010.

---

	One case that a blood level of voriconazole was thought to show high level by P1-148 drug interactions Yukako Yanagihara 1, Megumi Yamauchi 1, Kiyotaka Iwai 1, Bank of a river Yuki man 2, Hiromasa Yamauchi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2010.

---

	One case that serum phenytoin levels increased by capecitabine administration in patients with epilepsy during P1-149 cancer chemotherapy enforcement Pond Masayuki Nishi 1, 林口剛泰 1, Masatoshi Sano 1, Mutsumi Ueda light 1, 樽野陽亮 2, 大鳥徹 3, Kenji Matsuyama 3, Eitaro Nakatsuka 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2010.

---

	Prediction of the drug interaction by the CYP2C9 instruction of P1-150 rifampicin Masaki Ueno 1, Yoshiyuki Ono 1, Gutter slope Akihiro 2, Taketo Yamamoto 1, Hiroshi Suzuki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2010.

---

	For "the cancer chemotherapy" that is effective in action - security avoiding the drug interaction of the P1-151 anticancer drug - Hiroko Shibata, Yohei Miyawaki, Naoko Shibata, Junko Tsujimoto, Manabu Kako, Hitoshi Okugawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2010.

---

	One case of prolidase deficiency that showed erythroderma by P1-152 stellate ganglion block Yamamoto high example 1, Atsushi Fukumura 2, Yoji Mitsui 1, Munekatsu Hotta 1, Tomoya Asaga 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2010.

---

	One case that was regarded as chemical pneumonia of the P1-153 paclitaxel induction Keiko Adachi 1, Kazuya Fujita 1, Yukako Hatanaka 1, Toshiaki Matsuki 1, Sho Nakata will 2, 郷間厳 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2010.

---

	One patient who raised myelosuppression during P1-154 sorafenib remedy Masashi Honma 1, Yukihiro Hamada 1, 大野凛太郎 2, Takeshi Hirayama 1, 2, Kazunori Furuta 3, Masahiko Watanabe 3, Masaichi Kuroyama 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2010.

---

	It is examined the case with suspected severe form drug eruption in P1-155 super elderly people Koike reason Expo 1, Tomoyasu Furukawa 2, Yagi Motohiro 2, 齊藤幹央 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2010.

---

	P1-155☆ Examination of hypersensitivity in X-rays contrast media 齊藤幹央1, 阿部学1, 影山美穂1, 朝倉俊成1, 影向範昭1, 古川智康2, 八木元広2, 宇野勝次3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2010.

---

	One patient who presented with tardive stent thrombosis by going to hospital interruption after P1-156 drug elution stent placement Kazuyuki Ito 1, Mika Wakayama 1, Keita Urasaki 1, Takamitsu Akita 1, Kamikubo Yosuke 2, Naoya Tsuboi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2010.

---

	An example of the nephrotic syndrome that developed de novo hepatitis B by an immunosuppressive action of P1-157 cyclosporine Star Hiroshi Noji 1, Aiko Hirano 1, Shinichi Miyazaki 2, Tsutomu Takeuchi 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2010.

---

	One patient who presented with severe dyslipidemia by P1-158 lansoprazole Yumiko Yada, 新美詠彦, Reiko Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2010.

---

	An example of toxic epidermal necrolysis (TEN) that had the report in the P1-159 information on adverse drug reactions center Makoto Nakazaki person 1, Mariko Kawana 1, Yutaka Kobori ankle 1, Junko Nagai 1, ウォーン pole 1, Kunihiko Araki 2, Tadanori Sasaki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2010.

---

	Action second report to information on adverse drug reactions collection of in the P1-160 information on adverse drug reactions center and evasion Mariko Kawana, Makoto Nakazaki person, Yutaka Kobori ankle, Junko Nagai, ウォーン pole, Tadanori Sasaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2010.

---

The hypermagnesemia that appeared during treatment of P1-161 cancer pain Flat dance, 澤谷佳美, Hidekazu Kizaki, Shinji Honma, Miki Akizuki, Kimoto good luck is rare, Miyuki Okada, This Western philosopher, The long waterfall truth, Watanabe Kyoko, Masayo Takagi, Michiyo Terasawa, Kayo Saito, 川瀬泰裕, Kenichi Ooe, Yasuhiko Hirota Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2010.

---

Study about side effect incidence and the risk factor with the ST mixture administration to patients with collagenosis during P1-162 high dose steroid administration Akiko Hayashi 1, Kazushi Masuda 1, 2, Michiko Imazeki 1, Masato Okubo 1, Satoshi Ikeda 3, 仲佐啓詳 1, Hiroshi Nakamura justice 1, Amount of Ariyoshi example 1, Yasushi Nakajima 3, Katsu Takabayashi day oneself 3, Koichi Kitada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2010.

---

	Rearward observational study about frequency and the risk factor of the thrombocytopenia by the use of P1-163 linezolid 中蔵伊知郎1, 2, 山下大輔1, 2, 高麗睦子1, 堀部明美1, 2, 森英人1, 和田恭一1, 岡田博1, 小原延章1, 嘉田晃子3, 朝倉正紀3, 佐田誠2, 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2010.

---

	Examination about expression of infusion reaction by P1-164 Rituximab and the association with the dosing rate 鈴木亜維, Miki Katsuragawa, Hiroyuki Komatsu, Tokutome chapter, Tomoko Abe, Ryu Kobayashi, 目黒亨治, Muki Ryoji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2010.

---

	Examination of the side effect (edema) factor of the P1-165 blood clotting inhibitor (fondaparinux sodium, enoxaparin sodium) Maki Shimizu 1, Satomi Kobayashi 1, 田島濔子 1, 眞鍋公二 2, Yoshihiro Ogasawara 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2010.

---

	Risk factor analysis from the fever at the P1-166 IFNβ-1a initial administration 越智香保1, 原田実1, 岡田弘康1, 大江田知子2, 澤田秀幸2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2010.

---

	Evaluation of celecoxib for the urinary frequency of P1-167 patients with nonsmall cell lung cancer Mariko Araki 1, Mari Hirabayashi 2, Yagi Satoshi 2, 小林靖奈 1, Toshitaka Takenouchi 2, Junichiro Murayama 1, 3, 山元俊憲 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2010.

---

	Examination of the cooling time for the nail disorder by P1-168 DOC Hiroyuki Shimizu 1, Eiko Yoneta 1, Kensuke Hirooka 1, Yumi Yamaguchi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2010.

---

	Examination about the side effect of P1-169 pemetrexed Shinohara Keisuke, Yutaka Ichikawa is flat Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2010.

---

	Examination about the liver damage onset of erlotinib for P1-170 progress non-small cell lung cancer Celebration Chikako 1, Ikuko Yano 1, Ryo Miyahara 2, Hiroshi Date solstice 2, Toshiya Katsura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2010.

---

Utility - of gemcitabine postoperative adjuvant chemotherapy - every other week administration in the P1-171 pancreatic cancer 平田大氣 1, Akihiko Tsuchida 2, Yongchuan Yuichi 2, 松土尊映 2, 許文聡 2, Takahisa Ikeda 2, Yoshiaki Suzuki 2, Kazuhiko Kasuya 2, Tatsuya Aoki 2, Kanako Azuma 3, Tomoko Takenaka 3, Masami Onishi 3, Takashi Kawaguchi 1, Hiroki Takeuchi 1, 畝崎榮 1, Takao Akashi 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2010.

---

	Investigation of the interstitial pneumonia by Gemcitabine in patients with P1-172 pancreatic cancer Yuji Ishio, 谷口亮央, Flat land tax, Tokutome chapter, Mihoko Sasaki, Fujiko Kamata, Sato male tree, Miki Katsuragawa, Jun Matsunami, Ryu Kobayashi, 目黒亨治, Muki Ryoji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2010.

---

	Making of the side effect check sheet based on the side effect investigation of CCRT (concurrent chemoradiotherapy) in P1-173 cervical cancer Yoko Sone 1, Yoko Hayashi 2, Shingo Takatori 1, Sendo Toshiaki 2, 川崎博已 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2010.

---

	About induction and a utility of the bringing medicine administrative work in the P1-174 this hospital Cheap tail Tetsuro, Three fence Tomoko, Tomoko Ohashi, Akemasa Imamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2010.

---

	Utility - of the on admission initial interview of fact-finding - pharmacist of the doubt inquiry at the P1-175 bringing medicine differentiation Misako Uchida 1, Teruhiko Hoshino 2, Rumiko Sugiyama 1, Kazunori Shiozu 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2010.

---

	Examination about the utility of the bringing medicine confirmation by the hospital day interview in the P1-176 orthopedics ward Kimiko Furukawa, Pupil-maru Emi, Yoshiteru Honda, Hideyuki Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2010.

---

	Contribution of the ward pharmacist for the bringing medicine management in the P1-177 this hospital Keita Urasaki 1, Jun Hisada straight 1, Kazuyuki Ito 1, Takamitsu Akita 1, Tatsuya Hibi 2, 弥政晋輔 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2010.

---

	Relation of bringing medicine management and the pharmacist in the P1-178 this hospital Wakana Kawada, Hatsuko Iwai, Chisato Matsumae, Kiyoe Kimura, Takefumi Hayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2010.

---

	Role of the pharmacist in the P1-179 convalescent rehabilitation ward Kazuya Shirai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2010.

---

	About the revision of the bringing medicine differentiation book in the P1-180 Kumamoto central Hospital and the effect 栗崎貴啓, 東矢恵, Satoko Nakamura, Rika Sakamoto, 續政哉, Yasushi Hirata Jiro, Yoshiharu Wada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2010.

---

	Evaluation of P1-181 on admission bringing medicine differentiation duties Natsuko Ano, Michiko Onozawa, Shinnichiro Yamamoto, Mitsumasa Kaneta Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2010.

---

	Evaluation of the bringing medicine complete management by the pharmacist in the hospital targeted for P1-182 DPC Minako Tsukada, One river Etsuko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2010.

---

	The error measures of P1-183 bringing medicine differentiation duties and the utility Kuniaki Moriki, Naoko Shimizu, Chisato Iwai, Tatsuya Kaneta, Kenji Otsubo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2010.

---

	Use of the bringing medicine to think about from an aspect of the P1-184 medical supplies safety management Yumi Niinuma, We see it with Yano, Yukiko Kotaki, Sato preference, Junko Kurimura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2010.

---

	Action to the risk aversion through the bringing medicine control center in the P1-185 this hospital Miyake hemp sentence 1, Kaoru Takemura 1, Hiroyuki Kawahara 1, Junpei Mizuta 1, Country original Junichi 1, Chisato Nishioka 2, Yasuda Wakana 2, Noboru Okamura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2010.

---

	Use of the P1-186 medical supplies check vote that cancellation is desirable preoperatively Yumi Ito 1, Tomoyuki Nonogaki 1, Masayuki Takeuchi 1, Yosuke Shiraishi 1, Iku Kawamura person 1, Masafumi Onishi 1, Hiroshi Ito 2, Yoshihiro Fujiwara 2, Hiroko Saito 1, Takaaki Hasegawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2010.

---

	Action - testing, preoperative bringing medicine confirmation - of the P1-187 pharmacist outpatient department Rie Shibue 1, Kyoko Iwata 1, Yasuko Yamamoto 1, Terukazu Nakajima 1, Kumaoka Maiko 1, Title prefecture reason officer 1, Hiroki Tajima 1, Tadao Inoue 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2010.

---

	Than on admission bringing medicine utility ... pre-Abo id report by the P1-188 pharmacist of a check ... Hiroko Arai, 岸本大裕, Suguru Kasahara Castle, Jun Hamada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2010.

---

	Appropriate prescription of drug support ... in prescription suggestion ... elderly people by the P1-189 pharmacist at admission Tetsuya Miyakawa 1, Koji Muto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2010.

---

	It is a change of the prescription situation and the blood pressure at change from P1-190 bringing medicine to an in-hospital alternative agent Midori Onoda 1, Teruhiko Hoshino 1, 2, Rie Tayama 1, Kazunori Shiozu 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2010.

---

Examination ... of this hospital adoption medicine by the present conditions - bringing medicine for bringing medicine differentiation analysis in the P1-191 this hospital Susumu Kaneshige, Miyuki Sakamoto, Descent from a mountain Machiko, Hidechika Uozumi, Namimatsu Hiroko, Shimomura connection, Yuko Hara, Noriko Karashima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2010.

---

A bringing medicine investigation and prescription intervention of the renal function degeneracy patients in the P1-192 on admission Yuri Nagai 1, Kaoru Takemura 1, 1000, Aga Kyoko 1, Miyake hemp sentence 1, Satsuki Abe 1, Hiroyuki Kawahara 1, Country original Junichi 1, Yasuda Wakana 2, Chisato Nishioka 2, Noboru Okamura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2010.

---

	Correspondence to patients with renal dysfunction in the P1-193 bringing medicine administrative work Hiroki Inoue, Yukari Nakase, Tetsu Fukatsu, Akira Takahashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2010.

---

	About disagreement of prescription information and the medication situation at the P1-194 bringing medicine confirmation Hiromi Tamura, Yumiko Uchida, Hiroyuki Fujii, Shinobu Hasebe, Tadaaki Ito, Masahiro Hayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2010.

---

	Discussion of the antimicrobial agent brought in P1-195 on admission Toru Nagai, Hiroshi Hara person Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2010.

---

Questionary survey about the safe use of the P1-196 generic medicine 為村聡彦 1, 2, Toshiaki Akatsu 1, 3, Kenji Kogo 1, 4, Yoshihiro Kondo 1, 5, Field stake Masako 1, 6, Teiko Nakahira 1, 7, Jujube Noriaki 1, 8, Takashi Minagawa 1, 9, 矢部勝茂 1, 10, Rie Naito 1, 11, Yoshio Kosaka 1, 12, Kimiko Matsuda 1, 13, Hideyuki Shimizu 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2010.

---

	Fact-finding about the generic medicine in medical facilities in P1-197 Kagoshima Tadashi Kanazawa intellect 1, 2, Kazuaki Matsumoto 2, 3, Fujiko 2 between the fortune, 4, Hiromi Tokunaga 2, 5, Seiichi Kawahara 2, 6, Kotobuki Shinichiro 1, 2, Katsushi Yamada 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2010.

---

	Questionnaire report second report about action ... generic medicine of the P1-198 - Mizusawa clinical pharmacy meeting for the study Takeshi Onodera 1, Kenji Minamikawa 1, Kumi Ishikawa 2, Yukiko Senda 3, Makoto Matsuura 4, Kiyoaki Miura 5, Toshihiro Miura 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2010.

---

	Enlightenment activity to the nation for the P1-199 generic medicine spread is enough; or the examination about the full degree of - public information Miyoko Fujimori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2010.

---

	It is as a result of company questionnaire that we conducted for P1-200 generic medicine adoption Kiyoko Ogino, Kana Koyama, Yasuhiro Aikawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2010.

---

	Action for the change to generic medicine by the P1-201 Hospital leadership Takanobu Hashimoto, Yoichi Hiraoka, Tatsuo Nakagawa, Kazumi Kito, Akito Nagai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2010.

---

	Investigation about the change situation to the generic medicine in the P1-202 out of the hospital prescription Yoshihiro Kakiuchi 1, Atsushi Yamashita 1, Hiromi Atsumi 1, Hiroki Nemoto 1, 薛寿栄 1, Natsumi Nakagawa 1, Masako Kume 1, Rii Takei 1, Aya Yoshida 1, Kae Toyama 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2010.

---

The present conditions about the change to the generic medicine in the out of the hospital prescription of the eastern part of P1-203 Saiseikai Yokohama-shi Hospital Keiko Atsumi, Yamashita excellent texture, Mayumi Fujii, Kenji Saito, Yu Shimomura Kei, 眞野匠智, Ochiai thread of logic, Megumi Ota, Kazuko Aoki, Imperial garden Mikiko, Jun Takimoto, Yuzo Eguchi, Hiroshi Sugano, 赤瀬朋秀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2010.

---

Attitude survey to the physician about the feedback method of the change information to the generic medicine in the P1-204 out of the hospital drugstore Kozo Tsuchiya, Kaori Yamazaki, Takaaki Suzuki, Makoto Kimura spring, 仲佐啓詳, Hiroshi Nakamura justice, The amount of Ariyoshi example, Koichi Kitada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2010.

---

	About the correspondence at action for the P1-205 generic medicine change and change and the enforcement of the in-hospital questionnaire Toshihiro Matsumoto, 高崎紘臣, Ryoko Yoshihara, Nishida beauty society child, Kumi Kawano, Hirotaka Suzuta, Kenji Matsumoto, Hiroshi Sakai virtue Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2010.

---

	Investigation to face each other to pass through reshuffling from a P1-206 forerunner pharmaceutical products anchor Ron lock to generic medicine amiodarone tablets "sand" 平川雅章 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2010.

---

	Investigation about the use of 5-HT3 antagonist injection generic drug in the P1-207 this hospital 日置三紀 1, Yuka Kobayashi 1, Ayako Nakamura 1, Ayumu Nozaki 1, Hiroki Iwane 1, Toshiko Aramiya 1, Hirokazu Nakanishi 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2010.

---

	Comparison of the side effect frequency for starting medical supplies of the generic medicine in P1-208 cisplatin Yutaka Kawahara, Yusuke Noguchi, Yoko Tokuyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2010.

---

	Use experience of generic medicine warfarin K infinitesimal grain 0.2% "YD" (R) in our P1-209 center Mariko Sato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2010.

---

	Three cases that generic medicine was effective in P1-210 autoimmune disease treatment Mami Yoshioka 1, Ayako Miyake 2, Shigeyuki Ohata 2, Yukihide Shibata 1, Hosoyamada truth 3, Suguru Saito paternal blood 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2010.

---

	Examination of the asthmatic exacerbation risk with the P1-211 generic medicine Koji Nakao, Sei Tanabe committee child, 藤井広久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2010.

---

	Person in charge of the pharmacist to the operating room in the cottage-hospital out of P1-212 Hideki Sato, Keisuke Otsu, Young book Azusa, Umehara Kengo, Yoshiko Wada, First mountain Tae Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2010.

---

	Development 2 of the set medicine inspection system of the operating room in the cottage-hospital out of P1-213 Yuka Saito 1, Yuka Watanabe 1, Shuichi Shimura 1, Noriaki Fujii 1, 齋藤進 1, Yasuko Sato 2, Takashi Matsukawa 3, 因泥栄一郎 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2010.

---

	Development of the P1-214 operating room set medicine system of administration Hiroki Ito 1, Masayo Otsuka 1, 西村文宏 1, 因泥栄一郎 2, Shoji Takeyama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2010.

---

	Contribution and refinement of the pharmacist to the operation region medical supplies management in the hospital attached to P1-215 Kanazawa University Katsuhiko Nagase 1, Ryota Kurosawa 1, Daizo Maeda 1, 崔吉道 1, Masako Sakao 2, Hironori Ito 3, Kenichi Miyamoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2010.

---

	Duties development of the pharmacist in the P1-216 operating room 藤田將嗣, Satoshi Yamamoto, Mutsumi Kobayashi, Chizuru Shirokami, Shiho Hirahara, Norifumi Nakajima, 面田恵, 前田頼伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2010.

---

The pharmacist duties in the operating room of the P1-217 this hospital and the evaluation 小林彦登 1, Sakai Naoko 1, Shinobu Matsumoto 1, Takashi Ito kernel 1, Futoshi Saito 1, Kotobuki, Keiko Higuchi 1, Month Sachiko Nogi 1, Soichi Shibata 1, Sato いね 2, Masanori Kashiwagi 3, Atsuta Koichiro 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2010.

---

	Drug control duties in the P1-218 intensive care unit Yosuke Kanazawa, 田村健悦, South Kazushi, Takako Miura, Origin of Hiraga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2010.

---

	Trial in this hospital for the P1-219 drug management Hiroshi Katsumata, Kan Yutaka Otaka, History of Sei Koshiba, Takafumi Ichida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2010.

---

	Construction of the drug system of administration in conjunction with P1-220 electronic chart system Kenichi Anjiki, Kazuo Takeshita, Naomi Kaneko, The Yumi Hara beauty, Tomohiro Sonoyama, Katsuki Yokote, Tabe princess Sachimi, Ei Hirano product, Sumiko Goto, 石野外志勝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2010.

---

Construction of the product system of administration derived from the specific organism which linked P1-221 electronic chart Toshiyuki Ozaki, Kenichi Anjiki, Yorimitsu runs, Emiko Fukuda, The Yumi Hara beauty, Tomohiro Sonoyama, Katsuki Yokote, 卜藏俊仁, Ei Hirano product, Sumiko Goto, 石野外志勝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2010.

---

	Examination of the exposure dose with the P1-222 PET drug handling 内田朋毅 1, Look at the piece; Toshihiko 1, 2, Susumu Onodera will 1, Takashi Yoshino Expo 1, Haruko Endo 1, Infield Fussa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2010.

---

	Relation of the present conditions and the pharmacist of the 11C- methionine composition for the PET in the P1-223 this hospital Hiroki Arakawa 1, Yohei Sakurai 1, 東禎二 1, Takeshi Yasuda 1, Yasuhisa Tsuchida 2, 成瀬広恭 2, Yoshinori Kato 2, Motoyuki Suzuki 2, 伊藤信嗣 2, Kawakado Yasuhiro 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2010.

---

	Examination of flow deferred depression effect and the side effect of P1-224 hospital preparation 5% scopolamine ointment Kenichiro Shimoda 1, Teruhiko Hoshino 1, 2, Rumiko Sugiyama 1, Morizaki Chongwen 1, Kazunori Shiozu 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2010.

---

	Effective case of the 3%Ara-A eye ointment for the P1-225 acyclovir eye ointment-resistant corneal herpes 牧秀美 1, Takahiro Hirata 1, Hisao Ikeda 1, Michihide Seguchi 2, Katsuyoshi Hatanaka 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2010.

---

Clinical evaluations about efficacy, the safety of the in-hospital special preparation mesalazine suppository in patients with P1-226 ulcerative colitis Hirokazu Takatsuka 1, Kazushi Masuda 1, 2, Jin Miyamoto 1, Tatsuya Suzuki 1, Kenichi Arai 1, 仲佐啓詳 1, Hiroshi Nakamura justice 1, Amount of Ariyoshi example 1, 中川倫夫 3, Toru Sato 3, Tatsuro Katsuno 3, 横須賀收 3, Koichi Kitada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2010.

---

	Examination of the efficacy of the surface anesthesia preparation for the new oral cavity which assumed P1-227 polyvinyl acetate a basis Takashi Ando kernel 1, 2, Lower tail Yoshiaki 3, Sei Nakazato possible 3, Hisahiro Yoshida 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2010.

---

The efficacy of the pilocarpine sodium alginate component liquid drug for the patients with xerostomia with the medicine for the P1-228 psychiatry and safe examination Hiroyuki Hosono 1, 1, Chisato, Yamada, Akira Wada 2, Shinichi Niwa 1, Saito hundreds of branches beauty 1, Fumio Itagaki 1, Machiko Watanabe 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2010.

---

Examination about skin permeability in the lidocaine preparation of P1-229 four kinds (hospital preparation) and the analgesic effect Watanabe many Maki 1, It is still world 2 Yamaoka, Keiji Maruyama 1, Shigekazu Watanabe 1, Yu Kato tree 2, Saito hundreds of branches beauty 1, Shinichi Hirabayashi 2, 土屋雅勇 1, Keiko Yamaoka 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2010.

---

	Blood micafungin levels assay using the P1-230 plasma direct injection-response HPLC column 浦西洋彰 1, Yukari Ikeda 2, Otsuka ten thousand Yuko 1, 中村弘揮 2, Mitsuhiro Nakamura 1, Teruo Tsuchiya 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2010.

---

	Establishment of the plasma concentration assay of P1-231 long-acting local anesthetic ropivacaine and levobupivacaine Yosuke Shiraishi 1, Masafumi Onishi 1, Tomoyuki Nonogaki 1, Atsushi Hashimoto 2, Yoshihiro Fujiwara 2, Hiroko Saito 1, Takaaki Hasegawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2010.

---

	Comparison of ACMIA method in the blood P1-232 sirolimus levels measurement, MEIA method and LC/MS/MS Yotaro Matsumoto, Masaya Fujiyoshi, Tomoko Uenishi, Mayumi Sato, Forest size, Miki Shimada, 眞野成康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2010.

---

	Comparison of fluorescence polarization immunoassay (FPIA method) and the chemiluminescence immunoassay (the CLIA method) in the P1-233 children specimen Ryohei Takahashi 1, Koichi Imai 1, 2, 新井康俊 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2010.

---

	The establishment of the HPLC-UV method assaying serum free form drug concentration of the P1-234 teicoplanin and application to TDM Yukako Yasui 1, Hayato Konishi 2, Yutaka Yoshikawa 2, Hiroyuki Yasui 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2010.

---

	Blood level evaluation of methotrexate with the P1-235 measuring assembly change and the tacrolimus 山口佳津騎, 福岡憲泰, Sumio Kimura, Kazuko Higuchi, Shigeko Tsuji, Valley Kumiko, Yoshie Isobe, Kenta Sumiyoshi, Shinji Kosaka, 芳地一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2010.

---

	Establishment of the appropriate conservation method in consideration of the stability in the blood sample of the P1-236 meropenem Relation corner Yukie, 西端麻莉, Marina Yamauchi, Kana Matsumoto, Kunihiko Morita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2010.

---

	Construction of the TDM management use system in connection with P1-237 order ring Ko Hiraide stone, Takako Imazeki, Yasushi Yokoyama, Emi Furui, Takeshi Kato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2010.

---

	Utility of the longitudinal contribution of the pharmacist in infection treatment through the P1-238 TDM analysis Mitsuru Otsuka 1, Yasuyuki Nishikawa 1, 2, Kazumasa Ueda 1, Yoshitaka Kato 1, Mikiko Tsujimura 1, 岡橋孝侍 1, Komori Tamao 1, 野田能成 1, 小西偉雄 1, Tadashi Mikami 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2010.

---

	Trial of the pharmacokinetic tool making for the purpose of the dose evaluation in the P1-239 high risk medicine Daisuke Ishigaki 1, Choichiro Miyazaki 2, Hideko Yamauchi 2, Rie Miyazaki 2, Rie Ikeda 1, Mitsuhiro Wada 1, Kenichiro Nakajima 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2010.

---

	Action for the P1-240 antimicrobial agent proper use promotion Minato Saint Ichiro, Yasuko Hayashi, Tomohiro Hayashi, Hirohiko Mishima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2010.

---

	The need of the TDM enforcement of the anticonvulsant in P1-241 elderly people Yoshimi Yoshikawa, Hidenori child, Kanako Torikai, Now hilum Sakiko, Ritsuko Sakoda, Ryuji Hagiwara, Akira Takada fruit Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2010.

---

	Investigation about P1-242 theophylline prescription and the blood level measurement Yuko Watanabe 1, 2, Kayoko Maezawa 2, Asako Terashima 2, Junko Kitsu 2, Hajime Kagaya 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2010.

---

	Digoxin population pharmacokinetics analysis in elderly people for P1-243 medical treatment individualization Ei Yukawa two 1, Miho Yukawa 2, Fumihiro Suematsu 3, Takako Takiguchi 1, Hiroto Ikeda 2, Aki Hatsumi 2, 峯本正夫 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2010.

---

	Pharmacokinetic analysis of the new tacrolimus sustained-release product in the P1-244 living renal transplantation Nami Yokoya 1, 2, Kokufu Takatoshi 3, Nobuyuki Sugioka 4, 奈邉健 1, Masahiko Okamoto 2, 吉村了勇 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2010.

---

	P1-244☆ Efforts to TDM standard administration plan of VCM 阪野和重, 三木康弘, 中西俊介, 山内悠起子, 奥本真巳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2010.

---

	Effect on blood enoxacin density of P1-245 enoxacin chelate baby at metal-containing antacid combination by the pivoxil esterification 今仲洸1, 大鳥徹1, 沖吉慶子1, 岡本佳世1, 瀬川雅彦1, 西脇敬二2, 川瀬篤史3, 岩城正宏3, 松山賢治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2010.

---

	Utility of the vancomycin component cement beads for the P1-246 renal function degeneracy MRSA patients Yukihiro Kawakami 1, Koji Asaumi 2, Toshifumi Ozaki 3, Sendo Toshiaki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2010.

---

	One patient who performed blood level analysis of Carboplatin in patients with uterine cancer under the P1-247 haemodialysis enforcement Kazufumi Iwata 1, 2, 合澤啓二 1, Boundary Saori 1, Takako Baba 1, Akiko Akiyoshi 1, Eiko Fukunaga 1, 濱田哲暢 2, 3, Hideyuki Saito 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2010.

---

Examination about the preparation properties of the P1-248 high dose acetaminophen suppository and the efficacy Koji Tazoe 1, Takeura Hiroyuki 1, 2, Hiroko Noda 1, Yoichi Ishizuka 1, Mitsuru Irikura 1, Toru Irie beauty 1, Minoru Yoshida 3, Akiko Sadanaga 2, 永田浩泰 2, It is Sachiko 2 in a camp, Eiko Fukunaga 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2010.

---

	5-FU pharmacokinetics after the TS-1 capsule administration from the nasotracheal tube by the P1-249 simple suspension method Shigeru Tomiyama chapter 1, Muneaki Hidaka 2, 花田法久 3, Chizuko Nakamura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2010.

---

	Examination about the gastrointestinal absorption promotion of the acyclovir with the P1-250 chitosan Ayumi Masuda, Yuko Goto, 合葉哲也, Yuji Kurosaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2010.

---

	Pharmacokinetics change of immunosuppressive drug mycophenolic acid in the P1-251 growth process Junko Ishizaki 1, 2, Tomoko Tsuda 1, Kan Yukio 1, 2, Arai country three 1, 2, 崔吉道 1, 3, Kenichi Miyamoto 1, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2010.

---

Comparison about the elution behavior between the dosage form in the P1-252 Efavirenz preparation 矢倉裕輝 1, Akiko Akasaki 2, Keiko Kaneko 2, Mayu Shibata 2, Reiko Teraoka 2, Shuji Kitagawa 2, Hiroyuki Kushida 1, 吉野宗宏 1, 山内一恭 1, Yoshihisa Honda 1, Katsuya Komori 1, Asako Kamihira 3, Takuma Shirasaka 3, Takeshi Kuwahara 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2010.

---

	Comparison ... of the plasma ivermectin level of P1-253 Stromectol lock change at examination 2 - simple suspension method of the factor to affect the effectiveness and the tablet administration 山本陽介, 河原匡秀, 宮嶋篤志, 大谷真理子, 小茂田昌代, 廣田孝司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2010.

---

	Expression of cytochrome P450 change in the P1-254 adiponectin transgenic mouse Kiyomi Saito 1, Kei Inoue length 1, Eri Sugiyama flower 1, Mutsumi Inada 2, Hitoshi Sato 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2010.

---

	Relative ... Exxon 19 (deletion) and Exxon 21 (L858R) ... of EGFR mutation in the gene and the Gefitinib therapy in P1-255 patients with nonsmall cell lung cancer Yasuhiro Maeda 1, Shinya Suzuki 2, Tomoko Ogawa 2, Yoshihiro Aoyagi 2, Kojiro Takashima 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2010.

---

	Investigation about weight loss and the cancellation in the CPT-11 administration before and after the P1-256 UGT1A1 genetic polymorphism measurement induction Tokutome chapter, 谷口亮央, Flat land tax, Yuji Ishio, Miki Katsuragawa, Jun Matsunami, Ryu Kobayashi, 目黒亨治, Muki Ryoji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2010.

---

	Association of a blood level and the side effect of irinotecan (CPT-11) in the P1-257 outpatient department chemotherapy Mizuho Kitamura 1, Koichi Hirose 1, Chihiro Takatsu 1, Tsuyoshi Yamashita Shiro 1, Eiji Maruo 1, Junichi Hasegawa 2, 面田恵 1, 前田頼伸 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2010.

---

	The development of the quick assay of P1-258 CYP2C9 and the CYP2C19 genetic polymorphism and clinical application to patients with childhood epilepsy Yoshiaki Yamamoto, Shigeko Nishimura, Nobuyuki Mishima, 幾見泰洋, Yukitoshi Takahashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2010.

---

	P1-259 CYP2C19 slow-up and the case that blood tacrolimus levels rose 5 times by changes from itraconazole to voriconazole in CYP3A5 defective Makoto Fujita charges will 1, Tomonori Nakamura 1, 2, Yuko Okada 2, Blue Tooru Mori 1, Takuya Araki 2, Yasushi Yamamoto Jiro 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2010.

---

	Role of patients needs and the pharmacist judging from the consultation record of patients with P1-260 cancer Tetsuya Yoshida 1, 中尾將彦 1, Naoki Yamazaki 1, Yasutaka Goto 1, Masashi Takeuchi 1, Miwako Yamanishi 2, Junko Ide 2, Koichi Taira 3, Shinya Tokunaga 3, 駄賀晴子 3, Koji Takeda 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2010.

---

	About the making of the tool of the reporting to the medical institution in P1-261 chemotherapy patients Daigo Suzuki 1, Atsushi Suzuki term 1, Akira Ogawa intellect 1, Goji Maeda 1, Hiroshi Sakata 1, Miho Furuta 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2010.

---

	Action of this hospital that we deal with P1-262 antineoplastic prescription management addition induction Toshiko Okura, Minako Yoshida, Hideki Okamoto, Kunio Takahashi, Shoji Takagi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2010.

---

	Examination of RDI (relative dose intensity) in the P1-263 outpatient department chemotherapy 中村卓巨 1, Yuji Hayakawa 1, Daisuke Kito 2, Motonori Ito 1, Koichi Okamoto 2, Toshiharu Nomura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2010.

---

	It is ... for burden on patients who received examination - R-CHOP therapy reduction about the mixed administration with P1-264 rituximab and other antineoplastic Tomiko Tachikawa 1, Takumi Yamaguchi 2, Well hilum Keiko 1, Takashi Egawa 3, 末丸克矢 1, 薬師神芳洋 4, Hiroshi Araki positive 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2010.

---

	About a pollution status of cyclophosphamide in the P1-265 outpatient department chemotherapy room and the platinum Atsuo Otsuka, Tetsuya Sakamoto, Shuzo Nakamura, Chiaki Koshikawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2010.

---

	Cancellation, examination of a change, the additional reason in the P1-266 this hospital outpatient department chemotherapy on that day 小笠原信敬, Akira Masuda, Sae Takahashi child, Yuji Koyanagi, Koji Okada, Katsuhiko Sato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2010.

---

	The action that aimed at the investigation about the TS-1 interruption reason of the P1-267 gastric cancer postoperative adjuvant chemotherapy and the treatment by side effect grade reduction continuation Yutaka Hayashi 1, Nabeta Izumi 2, Midori Kimura 2, 河原崎貴伯 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2010.

---

	Study on blood pressure fluctuation before and after the anticancer drug administration in the P1-268 outpatient department cancer chemotherapy 町支優和, Motoaki Ishikawa, Masaki Sato, Takahiro Ishida, Masumi Nakagami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2010.

---

	Examination about the elevated blood pressure at the bevacizumab administration in our P1-269 center Naoya Okumura, Kubokawa Naomi, Kazuhiro Fukami, It is passed through old Masaru Den, Takeshi Noro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2010.

---

Examination about the tolerability of the Cisplatin administration using short hydration in patients with P1-270 lung cancer Hideko Isozaki 1, Tomoaki Sato 1, Satoko Fujiwara 1, Satoshi Uejima 1, Kinoura Katsuyuki 2, Masahiro Tabata 2, Nagi Takigawa husband 2, Tanimoto light sound 2, It is still 1 Matsunaga, Sendo Toshiaki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2010.

---

	Safety assessment judging from renal function in the Cisplatin component regimen enforcement in the P1-271 outpatient department Okada sum intellect, Eri Abe, 吉村知哲, Daisuke Ito, Shino Adachi, Tomoko Matsuoka, 宇佐美英績, Michio Kimura, Toshiya Nakao, Tadashi Yasuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2010.

---

	Intervention of the pharmacist to the formulation study by the renal function evaluation in the P1-272 cisplatin outpatient department chemotherapy Hiromi Fujisawa, Takeshi Nakamura will, Ayana Nakamura, 竹内芙実, Mitsue Shindo, 室親明, Takeshi Kimura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2010.

---

	Examination - of the chemotherapy -bevacizumab + s de Gramont therapy in P1-273 progress, recurrent colorectal cancer Minako Higuchi, Koichi Matsuo, Yoshimi Sasaki, Sanae Iwatsubo, Yoriko Wada, Sachi Imaizumi, Hiroaki Nishino Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2010.

---

	An anaphylactic symptom with the mFOLFOX6 therapy enforcement in the P1-274 outpatient department chemotherapy and the measures Toshimitsu Nakayama, Masatoshi Hayasaka, Michiko Kishi, Tatsuya Hayama, Mayumi Takezawa, Zenichi Yoshida, 丹正勝久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2010.

---

	Action -XELOX therapy support to P1-275 colorectal cancer chemotherapy Lower morning law of nature 1, Chisa Emura up 1, Miki Takara 1, Tokuko Sasahara 1, Shuichi Iwami 1, 1 that is Zao, Yuko Kubo 1, Yutaka Ogata 2, Mieko Tsuruta 3, Michio Sada 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2010.

---

	Example that Rikkunshito was effective for anorexia with the P1-276 colorectal cancer chemotherapy 篠原義剛 1, Junji Iwashige 2, Hidehiro Kamachi 1, Tei Hara Expo 1, Kojiro Takahashi 1, Hiroaki Morimoto 2, Katsuragi Takefumi 2, Junichi Tsukada 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2010.

---

Action for the present conditions and proper use of the P1-277 cancer chemotherapy regimen management Satoshi Yamada sand Kei 1, Masahiko Kobayashi 1, Keiko Hayashi 1, 山際岳朗 1, Hideyuki Motohashi 1, Celebration Chikako 1, Naoto Gondo 1, Kazuhiro Yanagihara 2, Masakazu Toi 3, Toshiya Katsura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2010.

---

	Role ... of the pharmacist in promotion - liver cancer sectional meeting of the drug proper use in the cancer sectional meeting according to the P1-278 organ Hiroko Yamaji, Hiroyuki Watanabe, Pond end Hiroaki, Nobuaki Egashira, Ryozo Oishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2010.

---

"The sorafenib induction critical path" that P1-279 pharmacist played a key role and made Yasuko Watanabe 1, Existence Reiko Sawa 1, Gain book Shuji 1, Lake Aso Kazuyo 1, Tomoyuki Goto 2, Taste field lawn arrow child 3, Hiromi Fujiwara 3, Dohon Mayumi 4, Yuichi Nakajima 4, Kazunobu Takayanagi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2010.

---

	Relation of the pharmacist in the safe use of the P1-280 anticancer drug Hidekazu Sato, Takeshi Sasao, Masumi Mori, Yoshiharu Kato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2010.

---

	The example analysis that became the stopping dosage after the anticancer drug preparation instructions reputation in the P1-281 electronic chart Hiroshi Goto kernel, 彌冨恵, Ichiro Ota, Hirofumi Koike, 西川能治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2010.

---

	Relation to drug control instruction of the carboplatin paclitaxel bevacizumab combination therapy in P1-282 patients with nonsmall cell lung cancer Dozu Maiko 1, Yuka Kishimoto 1, Manabu Sakurai 1, Shuji Murakami 2, Tetsuro Kondo 2, 斎藤春洋 2, 尾下文浩 2, Kozo Yamada 2, Akemi Takada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2010.

---

	NET EXCEPTION Err: Could not connect to host 岩切詩子1, 2, 林田哲也3, 日高里奈4, 窪田敏夫2, 小林大介2, 林睦子1, 河野徳明1, 末永啓二1, 島添隆雄2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2010.

---

	Relation as the pharmacist to the chemotherapy in the P1-284 children region Yuka Tanaka 1, Nishizawa jasmin 2, Yokoyama skillful writing 2, Mari Takagi 2, Emi Kadoi 2, Great Xisha cord law of nature 2, Kuni Shinoda University 2, Takao light 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2010.

---

	Relation of the pharmacist for the treatment of the P1-285 malignant glioma Kenji Miyazawa 1, Hayato Sugimura 1, Makoto Hayashi 1, Akemasa Yamaya 1, Original seal Yoshio 2, Shuichi Akaike 2, 2, Kiyonobu, Ikeda, Aspect shrine Koji 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2010.

---

	1 case that a pharmacist was able to participate in for P1-286 cancer therapy positively 猿谷淳, Nami Matsui, Maeda Miyuki, Yuka Nakano, 向一美, Ground field Mikiko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2010.

---

	It is ... about a making - blood regimen of the made-to-order reporting book of the P1-287 cancer chemotherapy about internal medicine Hisashi Miyamori, Miwako Mukai, Mari Fujita, Akemi Takashima, Yumiko Inaba, Tomoyuki Okawa, Hideko Hashimoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2010.

---

	2 cases that was given PAD therapy to patients with P1-288 untreated myeloma Tatsuya Otsubo 1, Kazumasa Ueda 1, Yoshitaka Kato 1, 野田能成 1, Takashi Tanaka 2, Eri Kawata 2, Teru Akoogi chapter 2, Yutaka Kobayashi 2, 小西偉雄 1, Tadashi Mikami 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2010.

---

	Examination about the risk factor of the hiccup induced at the dexamethasone administration in patients with P1-289 multiple myeloma Tetsushi Kanematsu 1, 宇佐美英績 2, Mitsuru Takai 1, Hitoshi Yoshida 3, Takahiko Ito 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2010.

---

	Contribution and side effect investigation to selective cisplatin intraarterial injection treatment for P1-290 head and neck squamous cell carcinoma Kyoko Tadokoro, Tomohiro Miyake, Keiki Mori, Manabu Tanimura, Hiroshi Yoshida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2010.

---

About the experience of the pre-Abo id 3 case in action - outpatient department chemotherapy to the vascular pain reduction by the injection method change of the P1-291 anticancer drug - Masahiro Yasuda 1, Hiromi Ishihara 2, 坪井謙之介 3, Yumi Kuzutani 3, Osamu Umeda 1, Makoto Sahashi 1, Katsutoshi Goto 1, Teramachi eyes 3, Teruo Tsuchiya 3, Kazushi Yoneta 1, 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2010.

---

	The vascular pain at the P1-292 pirarubicin hydrochloride administration is significantly high by the instillation method Takashi Goto 1, Kazuki Tanimoto 2, Furumi Kazuhiro 1, Masahiro Nakano 3, Makoto Ishibashi 1, Seiichi Okamura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2010.

---

	Evaluation - by making of the anticancer drug extravasation label in the P1-293 Suzuka center general hospital and operational - CS analysis Daisaku Kuki 1, 森章哉 1, Shinya Yamanaka 1, Yuka Maekawa 1, Yukiko Kawamura 1, Yumiko Hasegawa 2, Takuya Iwamoto 3, Yuko Nakamura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2010.

---

Effect of the transfusion increase in quantity on vascular pain at the P1-294 oxaliplatin intravenous feeding Yumiko Goto 1, 2, Iku Kawamura person 1, Masayuki Ejiri 1, 2, Shoko Kinoshita 2, 3, Hiromi Ota 2, 3, Kazumi Yokoi 2, 3, Keiko Ota 2, 3, Hiroko Saito 1, Takaaki Hasegawa 1, Kazuyoshi Suzumura 4, Masahiko Miyachi 4, Field wave Toshiaki 4, Eiji Mihara 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2010.

---

	Examination of the vascular pain measures regimen in the P1-295 XELOX therapy Mika Tashiro, Hiroko Tai, Kazunori Shimomura, Keiko Yamamoto, Shinichi Kawaguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2010.

---

	The vascular associated algetic expression situation with the P1-296 XELOX therapy and the measures Atsushi Suzuki term 1, Daigo Suzuki 1, Akira Ogawa intellect 1, Goji Maeda 1, Miho Furuta 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2010.

---

	Evaluation of the simple transfusion warming law for the vascular pain-like symptom at the oxaliplatin administration in the P1-297 XELOX therapy Atsushi Tomita sum 1, Masahide Matsuzaki 2, Michiko Tatematsu 1, Mitsuyo Nishio 3, 室圭 4, Masao Maeda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2010.

---

	Single dexamethasone in P1-298 carboplatin combination chemotherapy patients; and is compared the antinausea effect of repeated doses Kozoe kernel, Shishino Yuki, Well hilum Keiko, 末丸克矢, Hiroshi Araki positive Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2010.

---

	... using evaluation - MASCC Antiemesis Tool(MAT) of antiemetics aprepitant in P1-299 practice medical care, the lung cancer cisplatin combination therapy Kazuo Komatsubara, Matsuhisa Noriaki, Hisae Eguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2010.

---

Examination about the efficacy of aprepitant for the digestive symptom (nausea, vomiting) with the P1-300 cisplatin (CDDP) administration Gilt bronze Yoko 1, Tomonori Hirashima 2, Court Security Office Mika 1, Masashi Kobayashi 2, Norio Okamoto 2, Hidekazu Suzuki 2, Yuka Matsuura 2, Shangdong Masumi 1, Yuya Fukuchi 1, Usui Naoko 1, Keiko Fujita 1, Nobuhisa Fukushima 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2010.

---

Inspection of the efficacy of aprepitant for nausea, vomiting at TS-1, the cisplatin combination therapy for patients with P1-301 gastric cancer Keiko Komori 1, Tomoi Rieko 1, Takahiro Sugimoto 1, Hiroyuki Nakano 1, Chie Mochizuki 1, 丁元鎭 1, 桝喜惠 1, Nana Aono 2, 吉波哲大 2, Your Akazawa 2 to be constipated, Yukiko Yamamoto 2, Daisuke Sakai 2, 杉本直俊 2, 屋木敏也 2, Fumio Imamura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2010.

---

	A use situation investigation of P1-302 aprepitant and examination about the efficacy Keisuke Seto, Yoshihiro Naito, Masahiko Takasaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2010.

---

	Evaluation of the antinausea therapy including aprepitant in patients receiving P1-303 altitude emetic risk anticancer drug 中尾將彦 1, Tetsuya Yoshida 1, Yoko Honda 2, Naoki Yamazaki 1, Yasutaka Goto 1, Noboru Okamura 2, Masashi Takeuchi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2010.

---

	Evaluation of aprepitant in the prevention of nausea, vomiting in the FEC100 therapy of patients with P1-304 breast cancer 芦埜和幸 1, Hijiwara life 2, Taku Asanuma 2, Takeshi Shibazaki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2010.

---

	About the adverse event that occurred at use of aprepitant in the chemotherapy of the P1-305 emetic risk moderate degree Kazunori Aoyama, Masahiro Ogami, Miyako Shibata, Atsumi Yanaka, Katsuki Kurosawa, Masahiko Shimada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2010.

---

	Efficacy of aprepitant in the P1-306 EC therapy Masahiro Ogami 1, Kazunori Aoyama 1, Shoichi Mitsuhashi 2, Masahiko Shimada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2010.

---

Making of P1-307 "Numazu Municipal Hospital antinausea therapy guidelines 2010" Masako Kondo 1, Akira Nagayama 1, Noriko Kawakami 1, Mitsuaki Suzuki 1, Toru Mano 1, Noge Ichiro 1, 福長徹 2, Masayuki Kimura 2, Tadashi Iioka religion 3, Masami Shinozaki 4, Kosugi sincerity fine weather 5, 金井督之 6, Norikazu Urabe 7, Ryuji Ishikawa 8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2010.

---

	Change of the side effect of antiemetics change symptom of the P1-308 gemcitabine monotherapy Mayumi Kaise 1, Shinki Yoshino 1, Yukiko Himeno 2, Hiroshi Hasegawa 2, Mt. end Expo man 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2010.

---

	Grasp ... of an evaluation and the problems after action (the second report) - antiemetics criteria for use of food additives application for the proper use of P1-309 cancer chemotherapy antiemetics Shinki Yoshino, Mayumi Kaise, Haruki Nagai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2010.

---

	Fact-finding of the antinausea therapy in the P1-310 nedaplatin component regimen and inspection of the emetic risk 兒玉幸修 1, 2, Norihide Higuchi 1, Egashira Kanoko 1, 2, Mikiro Nakajima 2, Tadahiro Nakamura 1, wisteria Hideto 1, Takashi Kitahara 1, Hitoshi Sasaki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2010.

---

	Examination of antinausea drug criteria for use of food additives, the modi operandi with the P1-311 aprepitant beginning to use 薬師寺信匡, Ko Tokuda period, Koji Moriya, Kazunobu Takayanagi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2010.

---

	Examination of the efficacy of aprepitant in the P1-312 breast cancer chemotherapy It is still person 1 Tagashira, Matsuhisa Noriaki 1, 原文堅 2, Shozo Osumi 2, Hisae Eguchi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2010.

---

Study about the effect on clinical outcome of the antinausea therapy for nausea and vomiting induced by the cancer chemotherapy in the P1-313 digestive cancer patients and quality of life Tomoya Komori 1, Chihiro Kawano 1, 2, Tobita evening period 1, 2, Takeshi Hirayama 1, 2, Wasaburo Koizumi 3, Masaichi Kuroyama 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2010.

---

Examination - of the medical economics of aprepitant in action - altitude emetogenicity anticancer drug administration of the P1-314 Aichi on koro Gee meeting for the study Masayuki Ejiri 1, 2, Tatsuya Hisada 2, Itakura affinity 2, Mountain Seki wisdom 2, Motoaki Ishikawa 2, Yumiko Oshima 2, 牛膓沙織 2, Yumiko Sato 2, 町支優和 2, Akio Katsumi 2, 3, Takaaki Hasegawa 1, Hiroko Saito 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2010.

---

	Evaluation of the aprepitant proper use in the P1-315 this hospital Masayuki Okada, Manami Matsuura, Yuka Sugimoto, Hideko Iwamoto, Ryoichi Baba, Shinichiro Mizumachi, Saki Jinnai picture, Risa Nagata, 成末 Masami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2010.

---

	Examination about the efficacy of aprepitant in the two-drug regimen containing P1-316 cisplatin Naoko Takada, Minato light will, Hideki Nishida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2010.

---

	Comparison of the antinausea effect before and after the use of NK1 receptor blocker in patients who received P1-317 CIC therapy (CDDP divided doses) Yoshiko Wada 1, Kengo Umehara 1, Keisuke Otsu 1, Young book Azusa 1, 初山多惠 1, Hideki Sato 1, Tooru Hayakawa 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2010.

---

	It is ... from the onset of nausea and vomiting situation in ... aprepitant three days administration to think about proper use of P1-318 new antiemetics Yuko Kudo, Kazuyuki Ito, Atsushi Shirai, Kenichi Suzuki, Toshiaki Kato, Michihiro Shino Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2010.

---

	It is ... using nausea investigation ... "nausea diary" of patients who received P1-319 gynecology chemotherapy Ryoko Inuzuka, Yasushi Yamamoto University, Yukio Toyama, Tatsuya Muto, Hiroko Saito, Takaaki Hasegawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2010.

---

	Action to in-hospital proper use based on P1-320 "antiemetics proper use guidelines" Keiichiro Matsuda, Nobukawa Masao, Saito order, Hiroyuki Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2010.

---

	About nausea, vomiting measures at the cancer chemotherapy in the P1-321 Fukui Prefectural hospital Mitsue Uno, 坂井伸成, 中村尚未, 佐澤佳彦, Takashi Hiraga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2010.

---

	Examination of the utility of olanzapine for nausea, vomiting in P1-322 cancer chemotherapy patients Maiko Arai, Takuya Furukawa, Yutaka Kubota, Kazuhiko Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2010.

---

	Cisplatin - doxorubicin combination therapy - in patients with 2 case - osteosarcomas which a digestive symptom improved by P1-323 aprepitant administration Yoko Hayashi, Tomoaki Sato, Matsunaga still, Sendo Toshiaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2010.

---

	Evaluation of the gastric cancer chemotherapy given triple-drug therapy of P1-324 aprepitant, palonosetron and dexamethasone 西八重乃, Yuko Fujisaki, Asami Tokutome, Hideki Sugawara, 下堂薗権洋, Tatsuya Yamaguchi, Yasuo Takeda, Katsushi Yamada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2010.

---

	About examination - effect and the side effect of the utility of P1-325 aprepitant - Yukiyo Funakoshi, Miho Yamazaki, Masataka Fukuzawa, Yuko Kubo, Matsuura relationship, Katsuaki Takeda, Tadaaki Ogawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2010.

---

One patient who responded to aprepitant for delayed-action nausea, vomiting in the MEA therapy for the P1-326 persistent trophoblastic disease Hiroyuki Isogai 1, Kaori Hirose 1, It is Yukiko 1 in a piece, Taku Miyakawa 1, Toru Koshiishi 1, Sachiko Harada 1, Kiyoshi Okuyama 1, 野平知良 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2010.

---

	Examination of the antinausea therapy at use of extensive emetogenic anticancer drug in the P1-327 lung cancer chemotherapy 1, Kawabata success 1, Pear Ayumi 1, 廣畑和弘 1, Inside many springs 1, Toshihiko Yamaguchi 2, Soichiro Yokota 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2010.

---

	Effect on hiccup frequency by the dexamethasone aprepitant combination in the P1-328 cisplatin component regimen Kenji Mori, Sugawara sheath, Sachiko Sahara, Norio Takimoto, 足立守 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2010.

---

	The present conditions of the use of antiemetics in the chemotherapy of the P1-329 head and neck cancer 藤戸靖久, Sachiko Oda, Ota fence Satoe, Yutaka Ichikawa oneself, 井上慎護, Rie Bando, Miyako Kihara, Hideko Iwasaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2010.

---

	Fact-finding about the antinausea therapy for P1-330 HEC and MEC Yumi Yabuta, Satoshi Yokoyama, Yuko Toyota, Kengo Utsubashi, 只佐正嗣, Akihiko Isogai, Keiko Nakajima, Chieko Ogawa, Yoshihiro still very much, Keiko Yoshida, Hiroko Ota Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2010.

---

	Fact-finding of nausea, vomiting in the P1-331 FEC therapy Makoto Hosomi 1, Aimi Goto 1, Masami Nishihara 1, Mitsuhiko Iwamoto 2, 瀧内比呂也 3, Hiroshi Tamai 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2010.

---

	Use situation investigation of aprepitant in the P1-332 this hospital Ayako Nakamura 1, Yuka Kobayashi 1, Takashi Yamazaki 1, 日置三紀 1, Ayumu Nozaki 1, Toshiko Aramiya 1, Hirokazu Nakanishi 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2010.

---

	P1-333 The use situation and usefulness of Aprepitant in the FOLFOX, FOLFIRI ± Bevacizumab therapy 岡澤美貴子, 折井孝男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2010.

---

	Comparison in approximately the antinausea therapy change in the P1-334 gastric cancer S-1/CDDP therapy Mayumi Ono 1, 外石昇 2, 古澤利紗 2, Akio Murakami 2, 石川稚佳子 1, Kentaro Yamaguchi 3, Takao Katsube 3, Kenji Ogawa 3, Kazunori Watanabe 2, Masahiko Obayashi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2010.

---

	Antiemetic inspection by the adjustment of steroid doses at the P1-335 chemotherapy enforcement 永野俊玲, Hisae Shinichiro, Yusuke Sato, Toshiharu Asakura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2010.

---

	Examination about the effect on patients with diabetes of the P1-336 aprepitant dexamethasone combination Kuni Imazu intellect, Hiroyuki Furuta, Masaru Sugawara, Kyoko Nakata, Hu field Masahiko, Masanori Takaoka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2010.

---

	Improvement effect ... by tardive nausea and vomiting measures - prescription unification of the P1-337 breast cancer chemotherapy Tsutomu Watanabe, Junichi Takano, 1, Morita, Megumi Aizawa, Yuka Ito, Emiko Yokoyama, Keiso Masuhara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2010.

---

	Evaluation of the antinausea therapy for P1-338 cisplatin-induced nausea, vomiting Eri Kurosaki 1, Yoichi Tanaka 1, 2, Kiyoshi Shibuya 1, 2, Takako Komiyama 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2010.

---

	An antinausea effect of aprepitant in patients who received P1-339 esophageal cancer FP therapy and effect on treatment Mieko Kishi, Toshiyuki Matsubara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2010.

---

	Effect on drug consumption and patients quality of life by the promotion of the P1-340 antiemetics proper use Yutaka Kubota, Takuya Furukawa, Kazuhiko Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2010.

---

	Association with a neutrophil count and the oral mucositis severity in the P1-341 esophageal cancer chemoradiotherapy Masahide Sugiyama, Fumi Aoki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2010.

---

	About association with the blood toxicity and the serum albumin concentration of the P1-342 hydrochloric acid amrubicin 大久保博史1, 高瀬久光2, 内山将伸2, 清水裕彰1, 林稔展1, 冨澤達1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2010.

---

	Examination of the febrile neutropenia risk factor in the P1-343 hematologic cancer Daisuke Kato 1, Hisakichi Nozawa 1, Masako Sato 2, Nomura order 3, Ishizawa sentence 2, Yagi Tomomi 1, Takeshi Katsuyama 1, Yukio Kishikawa 1, Jin Nakamura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2010.

---

	Side effect expression intensity with P1-344 erlotinib and association of the survival period Hitomi Kawaguchi 1, 2, 寺田智祐 1, 3, Matsubara grammar 2, Toshiya Katsura 1, Kenichi Inui 1, 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2010.

---

	Analysis of the blood sugar level fluctuation that the steroid medicine as antiemetics at the P1-345 cancer chemotherapy gives Sanae Iwatsubo, Koichi Matsuo, Minako Higuchi, Yoshimi Sasaki, Yoriko Wada, Sachi Imaizumi, Hiroaki Nishino Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2010.

---

The examination about the decrease effect of the neurotoxicity frequency with the oral azole-based antifungal agent temporary withdrawal at the P1-346 vinca alkaloid medicine administration sees the rear and analyzes a mark Yoichi Osato 1, Early part Hiroko 1, 宮松洋信 1, Yumiko Saito 1, Rina Kani child 1, Maki Natsume 1, 横山智央 2, Oyashiki Kazuma 3, Takao Akashi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2010.

---

Can P1-347 albumin become the proper use criteria of the platinum-based anticancer drug? Shunichi Aida 1, Naotake Takase 1, Gutter book Mayuko 1, Takashi Kato children 2, Yoshio Ijiri 2, Kazuhiko Tanaka 2, Hidenori Takahara 3, Tadashi Yokoyama 3, Shigeru Ono tree 3, Nobuyuki Muroi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2010.

---

	Examination about the background factor of the granisetron treated patients who developed P1-348 constipation Ability volost Hirohisa 1, 2, 植沢芳広 2, Original Hideki Sawa 1, Mori Kiminori 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2010.

---

	Examination about the coagulation ability change at P1-349 internal use fluorouracil system anticancer drug and warfarin combination Naoko Tosa, 森穣二, Ikuyo Toyota, Ryuma Sato, Ikegami English sentence Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2010.

---

	Examination of the kidney protection of the Mg for the P1-350 cisplatin nephrotoxicity Tatsuya Hayama, Masatoshi Hayasaka, Zenichi Yoshida, 丹正勝久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2010.

---

	Examination about the G-CSF preparation administration for the myelosuppression which S-1 at the P1-351 renal function degeneracy caused 牛膓沙織, Tatsuya Hisada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2010.

---

	Examination of the side effect frequency in consideration of the renal function in the P1-352 capecitabine remedy patients Mina Iwai, Michio Kimura, 吉村知哲, Tadashi Yasuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2010.

---

	Effect on renal function by the difference in hydration at the P1-353 cisplatin administration 伊藤剛貴, Seki Daisuke, Yoshiba Mayumi, Furihata cannot come, Shinya Miura, Toru Hibi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2010.

---

	Relations of a moisture loading dose and renal dysfunction in the P1-354 low dose cisplatin administration Hisashi Takahashi tree 1, Satoru Tamura 2, Manabu Shoji 3, Kozo Suzuki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2010.

---

	Action to rescue medicine management manual induction in the P1-355 this hospital Junko Nakanishi 1, 2, Yumi Kozai 1, 篠永浩 1, Tsunekazu Harada 1, Tsutomu Kachi 1, Eiji Mukai 1, Ritsuko Shirakawa 2, 3, Aiko Sato 2, 3, Hiroko Noda 2, 3, Atsushi Hosokawa 2, 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2010.

---

	The use situation and problems of the rescue dose for the P1-356 fentanyl patch Yusuke Hara 1, Makiko Takabayashi 1, Yoshiko Takahashi 1, 板井進悟 1, Keisuke Yamada 2, Akiko Marutani 3, 崔吉道 4, Kenichi Miyamoto 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2010.

---

	Evaluation for the rescue dose of the narcotic analgesic in the P1-357 this hospital Kayoko Yamaguchi, Naoko Takakuwa, 高橋喜統, Small Masaru Hori, Koji Nishio Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2010.

---

	The opioid rotation enforcement situation in patients with P1-358 cancer pain and the evaluation Harue Okada, Hiroki Tamaki, Norio Doi, Nobuhiro Nishimura, 直良浩司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2010.

---

	Relations of the rate of use and the clinical response of the P1-359 opioids rotation 織田梨恵 1, 2, Mikio Chiba 1, 2, 森井博朗 1, 2, Seiko Hattori 2, 遠藤善裕 2, 寺田智祐 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2010.

---

	Examination about the opioids-induced sedative resistance under P1-360 cancer pain Field road Akihiro 1, Hama table solstice 2, Kunihiko Kagawa 3, Yoshio Kitamura 1, 田伏克惇 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2010.

---

	Using fact-finding -Rome III about the constipation with the P1-361 opioid analgesic - Mai Nishihara, Yuichi Koizumi, Machiya cheap period, Fujitani Masanori, 禰占奈美江, Negoro early Noriko, Mami Nomura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2010.

---

	1 case that olanzapine worked for for nausea of the morphine sulfate timed-release tablet that P1-362 prochlorperazine was invalid Kenichi in the new line, Hideyuki Yanagibashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2010.

---

	The fact-finding of antiemetics used at the medical drug induction in the P1-363 outpatient and future problem Mariko Otsuka, Tomoko Nishimura, Maki Miyazaki, Ayako Ajioka, Koji Fukuda, Miki Imai, Keiko Sakurai, Hiroko Iijima, Osamu Tomishima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2010.

---

	One patient who showed subcutaneous bleeding in the P1-364 fentanyl MT patch pasting site Takuya Furukawa 1, Yutaka Kubota 1, Motoko Minemura 1, Tokuko Shimizu 2, Kazuhiko Saito 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2010.

---

	An administration route change conversion method of the ketamine hydrochloride in the P1-365 Shizuoka Prefectural Shizuoka cancer center and the evaluation Tomomi Kataoka 1, Tetsu Sato 1, Michihiro Shino 1, 相河明規 2, Iwao Osaka 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2010.

---

	One patient who was treated effectively with ketamine administration from gastric fistula for P1-366 cancer pain control Pre-night Miho 1, 2, Onaga Shinichiro 1, Tamotsu Hika 1, Seiichiro Niisato 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2010.

---

	Examination for the use of gabapentin adequacy as the sedative adjuvant in P1-367 cancer pain Masahiko Irie 1, Yasuhiko Ichida 2, Genei Shinya 2, Yoshihiro Aoyagi 2, Akinori Yanaka 1, Ichiji Endo 3, Shuji Shimada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2010.

---

	Use experience of bone metastases pain relaxant meta stolon (R) note (Sr-89) in the P1-368 this hospital Minoru Kurihara man Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2010.

---

	2 cases that used Mohs ointment for P1-369 advanced breast carcinoma, and obtained improvement of the quality of life Kazuhiro Muramoto 1, 2, Eri Yoshikawa 1, 2, History of Tadashi Hatakeyama 1, Yuko Kawakami 2, Ritsuko Honma 2, Noriko Nagase 2, Tsujimoto A 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2010.

---

	One case of the metastatic skin tumor that the Mohs gauze method which improved an application method of P1-370 Mohs' paste was useful Toshihiro Nakanishi 1, Masaru Kawai 1, Takeuchi 2, Aruki, Ken Ina next 3, Seiji Nagao 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2010.

---

	Examination and effect of treatment - of the pharmaceutics in the clinic of study on P1-371 hospital preparation -1 - Mohs ointment Yukiyo Hayakawa 1, Kenjiro Inaba 1, Madoka Kita 1, Haruhiko Someya 1, Makiko Fujii 2, 渡邊善照 2, Jun Arita 3, Yoshio Sakai 3, Mochizuki success 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2010.

---

	The analysis of the doubt introduction about P1-372 anticancer drug preparation and pre-Abo id report 谷之木佑歌, Hiroyuki Yamaguchi, Ito wide commander, Yasushi Sekiya, Rie Ono, Tomomi Iwakiri, Manabu Okumura, Kazuhiko Arimori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2010.

---

	Examination of the doubt inquiry contents in the anticancer drug sterility preparation using P1-373 electronic chart Side Yukari, 片山歳也, Asako Ito, Asuka Watanabe, Eri Ito, Momoko Hattori, Aspect pine Shinya, Araki A, Yuki Mizutani, Saori Kojima, 野々部崇哉, Mitsuru Fujioka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2010.

---

	Relation - as investigation - outpatient department chemotherapy and the team approach in medical care about the doubt inquiry in the anticancer drug sterility preparation in the P1-374 drug department Higashijima good luck way, Junko Ide, Masashi Hashimoto, Yagi Hideaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2010.

---

	Safety management and evaluation by the use of the P1-375 cancer chemotherapy individual regimen and the preparation memo Naoki Yoshikawa, Yuko Kobayashi, Nobumitsu Iizuka, Motohiko Seyama, Toshio Kosuge Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2010.

---

Making and evaluation of the in-hospital anticancer drug preparation manual for P1-376 pharmacist and other types of job Hiromi Hayashi 1, Nawa Hideki 2, Takeo Okada 2, Eiji Kawakami 2, Fine weather field Yusuke 2, Shiho Sugimoto 3, Toshihiro Koyama 1, Kazuaki Shinomiya 1, It is still 2 Matsunaga, Yoshihisa Kitamura 1, Sendo Toshiaki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2010.

---

	Development of the simple and easy anticancer drug preparation support system to install in the P1-377 existing safety cabinet Aida Toshie, 山村康比古, Takako Watanabe, 右川浩, Kaori Ito, Yasuda life, Junko Hiroi, Kanichi Kawasaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2010.

---

	A construction and evaluation of the P1-378 anticancer drug sterility preparation support system 大下直宏, Hiroki Kano, Seiko Koike, Natsumi Endo, Mizuho Goto Yasuko, Akira Ueda, 結城祥充, Hiroshi Kuronuma, Shinji Iwai, Katsumi Ito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2010.

---

	Stability of the dilute solution of paclitaxel in the TIP therapy for P1-379 progress-related germ cell tumors Hideaki Niwata 1, 2, Fumio Itagaki 1, 2, Hiroyuki Hosono 1, 2, Machiko Watanabe 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2010.

---

	Examination (3) of the quantity of preparation extraction of the P1-380 docetaxel preparation 双樹恵, 岩瀬利康, Yoshio Ito, Tadashi Nagase, Kumiko Okitsu, Mieko Morita, Junko Miyakawa, 長岡匠, Miyuki Suehiro, Minoru Mori Tomoko, Tomoaki Toyama, Chiaki Koshikawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2010.

---

	Examination about the decomposition method of P1-381 albumin-binding paclitaxel (oil xanthan gum (R)) 中山季昭 1, Motohiko Sano 2, Toru Kishino 2, Fumio Iwasaki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2010.

---

	Comparison of the starting drug and late departure drug with the P1-382 DPC induction 清水裕彰, Minoru Hayashi exhibition, Hiroshi Okubo, Tomisawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2010.

---

	P1-383 The investigation against the possibility of glass pieces mixed into the Infusor pump 橋本直弥, 望月英明, 竹元友佳子, 若杉裕子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2010.

---

	Examination of the P1-384 5FU in fuser pump method of dispensing Black liman Takako 1, Tomofumi Okamura 1, Hiroshi Yamazaki 1, 小川丈彦 1, Naoyuki Miyano 1, Shigeharu Oie 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2010.

---

	Effect of the capacity control type transfusion pump to give to intravenous feeding speed at the P1-385 anticancer drug administration Takeshi Nakamura will 1, Hiromi Fujisawa 1, Masahiro Nakayama 1, Tsuyoshi Azuma 1, Tsuneo Hamaguchi 2, Takeshi Kimura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2010.

---

Examination of the precision of the portable chronofuser in the P1-386 colorectal cancer chemotherapy Tomoko Suzuki 1, Kotaro Kawamoto 2, Ayako Kato 1, Tatsuro Fujii 1, Seina Noda child 1, Kadomura Shota 1, Mina Takeuchi 1, Yuko Fukuda 1, It is still 1 Asano, Takashi Aoki 2, Tatsuya Ito 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2010.

---

	P1-387 Study of the usefulness of "ChemoCLAVE System" (Part 2): About leakage quantitative test using potassium permanganate solution 波多野博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2010.

---

	Approach for the elimination of radiation exposure recognition and knowledge, the maneuver of the pharmacist in the P1-388 anticancer agent germfree preparation 小暮友毅1, 河添仁2, 井門敬子2, 村上通康3, 浅川隆重4, 井上智喜5, 末丸克矢2, 荒木博陽2, 江口久恵1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2010.

---

	From present conditions - questionary survey of the prevention of anticancer drug exposure in the P1-389 three folds throughout the prefecture Hospital - Tomohiro Miyake 1, 2, Mitsuru Fujioka 2, 3, Masahide Mori 2, 4, Yasushi Kataoka 2, 5, Shinko Okuda 2, 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2010.

---

	Examination -2 about the permeability of the antitumor agents in medical gloves to put on at P1-390 injection mixture preparation Fold Toyohito 1, 2, Ryoji Yanagihara 1, Katsuhiko Nara 1, Toshihide Abe 1, Takashi Tomabechi 1, Katsuyoshi Nakajima 1, Takao Aoyama 2, Hiroshi Suzuki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2010.

---

It is 2 about the anticancer drug pollution in the prevention of exposure objective saline packing administration set at the P1-391 anticancer drug bypass administration Tomori Nishina 1, New branch Maiko 1, Yuka Kobayashi 2, Hiroki Iwane 2, Yukiko Yoshikawa 3, Kazuki Nagasawa 3, Shinichi Sugiura 4, Hirokazu Nakanishi 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2010.

---

Safe examination for the radiation exposure of the person of preparation in the 111In of P1-392 ibritumomab tiuxetan (Zevalin (R)) and 90Y-labeled preparation Yasushi Yoshikawa period, Kinuyo Matsuda, Taeko Suzuki, Noro Mizuki, Shinji Kojima, Artificial pond Mika, Megumi Sugitani, Nagayoshi eyes, West Luo Teruo, Kazuhiro Sase Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2010.

---

	Utility of the operation to recap for the prevention of P1-393 anticancer drug exposure Takeo Okada, Nawa Hideki, Eiji Kawakami, Fine weather field Yusuke, Atsushi Ogawa, Yoichi Kawasaki, Kazuhisa Yao, Sendo Toshiaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2010.

---

	Examination of the residual anticancer drug resolution in the safety cabinet using P1-394 photocatalyst Junya Sato 1, 2, Kenzo Kudo 1, 2, Takimoto success 3, Three Masayuki Hayashi 4, Pheasant nose Ichiro 5, Katsuo Takahashi 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2010.

---

	Utility of the closed system system in a series of work from an anticancer drug preparation in the cottage-hospital out of P1-395 to the disposal Izumi Ouchi, Katsuaki Arai, Kaoru Nakamura, Noriko Shimizu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2010.

---

Closed quantitative examination in the P1-396 closed system drug mixture appliance 宮松洋信 1, Yoichi Osato 1, Tanaka 1,000 greens beauty 1, Sachiyo Sudo 1, Fumiko Maruyama 1, Iga Chinatsu 1, Early part Hiroko 1, Momoko Tomioka 1, Komi Yoshiyuki 1, Akira Miyazato bud 1, Toshihiko Hirano 2, Takao Akashi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2010.

---

	It fluctuates at preparation usability, preparation time with the P1-397 anticancer drug closed system preparation system induction and investigates it Takashi Motoki, 菊池謙宏, Yasuhiro Tanaka, Kiyoto Watanabe, 千田泰健, Hiroyuki Shinagawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2010.

---

	Examination of the performance of the P1-398 PhaSeal(R) system new model protector "protector so RAS" Kazuo Sugita, Akane Hagino, Wataru Suzuki, Tsuyoshi Aoyama, Toshihiro Hama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2010.

---

	Operation situation investigation after the P1-399 closed system drug mixed system induction Toshiko Hoshika 1, Takuya Yano 1, 福岡竜逸 1, Ochi success child 1, Takako Fujita 2, Mika Aoki 2, Kato three Eiko 2, 松原常起 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2010.

---

	Action for the prevention of anticancer drug exposure to P1-400 this hospital Taguchi poetry rare child 1, 菅原馨悟 1, Kei Sasaki 1, Jin Yoshida 2, Shigeki Koda 3, Hisao Kanazawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2010.

---

	Setting ... of reconfirmation and the evidence level of reevaluation - literature of the P1-401 cancer chemotherapy regimen City storehouse Daisuke 1, 2, Hisashi Shimizu example 3, 牧野好倫 4, Akiko Sakashita 5, Hiroshi Yamamoto 4, Minoru Sakata 1, Junichiro Murayama 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2010.

---

	The induction of the evidence level in the P1-402 regimen examination and the evaluation Kazuto Sato 1, Toshiyuki Hirai 1, Yasushi Akiyama 1, Seki Toshikazu 1, Kamiga Masahiro 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2010.

---

	Evaluation for the contribution of the pharmacist in the P1-403 cancer chemotherapy regimen registration 金素安, Naoki Kinjo, 閔貴善, Chie Okazaki, Kazuyo Shimojima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2010.

---

	Problems of the P1-404 cancer chemotherapy regimen order ring system induction Junko Arima 1, Yuka Arima 1, Yoshihiko Shibayama 1, 2, 下堂薗権洋 1, Yasuo Takeda 1, Yoshifumi Kawano 3, Katsushi Yamada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2010.

---

	About information sharing by the collection of P1-405 pocket edition chemotherapy regimens making Koga good luck greens 1, Ayumi Nakao 1, Rie Ueda 1, Miyuki Sakurai 1, Hideko Nakagoshi 2, Shino Hisashi Hara 3, Eiji Fukui 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2010.

---

	An action and evaluation of the pharmacist for the safety management of the P1-406 cancer chemotherapy Tomokazu Fujii 1, 2, Kenichi Nomura 1, 澤柳直樹 1, Haruhiko Nakamura 1, 岩瀬定利 1, Hisashi Kamiya line 1, Tetsuo Adachi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2010.

---

	Problems of the regimen use in the checking prescription duties (2) - this hospital in the P1-407 cancer chemotherapy and discussion ... A in the hill, Kazuhisa Tsu Minoru, Tomohiro Otsuki, Toshi Tanaka, Masuo Sato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2010.

---

	P1-408 Cancer chemotherapy optimized to the towards efforts Part 5 It can be seen from the enforcement frequency survey of adaptation regimen 中村勝之1, 2, 野田師正1, 2, 加藤淳二2, 3, 中田浩雅1, 宮本篤1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2010.

---

	Action of the chemotherapy regimen reporting through the P1-409 prescription Yumi Tsuchiya, Junko Shimomura, Masahiro Tsuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2010.

---

	P1-410 Safe comparison of the pre-print injection prescription and electronic chart system in the anticancer agent order 平野真健, 岸川春樹, 下河邉安妃子, 曽我弘道, 小田原由香, 増田和久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2010.

---

The making of the check sheet to perform the correct, effective checking prescription of the P1-411 temozolomide capsule and the evaluation Kiyotaka Omori 1, Akiko Kochi 1, Tomoko Shimazu 1, 杉本司 1, Yusuke Noguchi 1, Keiji Matsumoto 1, Yoko Tokuyama 1, Hiroyuki Takakura 2, Wicket Minoru Oka 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2010.

---

	For the establishment of the safety management system of the anticancer drug that P1-412 is new induction - of - identification management drug adoption registration system Satoru Kato next, 金正煥, Seiichi Ito, Takamitsu Akita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2010.

---

	It is systems construction to becoming it regimen order internal use, the injection in the P1-413 anticancer drug prescription at the same time Mt. Ishii husband, Tsuyoshi Suzuki, Namba existence intellect, Consider among outsiders; a husband, 宇野司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2010.

---

	About the protocol registration system induction in the oral P1-414 anticancer drug 正置耕一, Mutsumi Yoshioka exhibition, Kondo ten thousand Yumi, Tomoji Ishizu, Sachiko Kaji, Noriko Morimoto, Yoshimi Ogawa, 渡雅克 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2010.

---

	Use on the electronic chart without induction and the regimen system of the cancer chemotherapy regimen in the cottage-hospital out of P1-415 Kasumi Suzuki, Maiko Nakao, Yoshiko Ikeda, Mai Nishikawa, Tomoko Sakamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2010.

---

	Approach aiming at improvement of the quality of the P1-416 cancer chemotherapy prescription checking 星野真之, 星野寿恵, 梅野友子, 小池恭士, 郷原哲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2010.

---

	Examination (1) about the drug scattering to the gown at the P1-417 anticancer drug preparation Maiko Kondo, Risa Kuwahara, Naomi Nakajima, Shibata Kei greens child, 椿井朋, Makoto Nakao Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2010.

---

	A change of the injection antimicrobial agent consumption by induction of P1-418 DPC and the electronic chart induction and effect on susceptibility for Pseudomonas aeruginosa Kiyoko Tanimura, Seiji Onda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2010.

---

	P1-419 antimicrobial agent consumption and chemosensitive correlation 樗木智聡 1, Yuichi Izumi 1, Satoshi Kamoshita 1, Long Yuji Mine 2, Koji Fukuda 3, Mitsuru Kikuchi 4, 篠原由憲 1, Osamu Tomishima 3, Masashi Shimomura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2010.

---

Examination about the detection situation of the ESBLs-producing bacteria in the P1-420 East Hiroshima 8 institution and the factor Masako Yasuhara 1, Takeji Yokota 2, Kumiko Doi 3, Kumiko Urabe 4, Keiko Hara 5, Tetsuo Tomita 3, Tetsuko Ito 6, 武郷徹 7, Daisuke Hira 1, 橋本佳浩 1, Sawa Akihiro 8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2010.

---

The consumption of the antimicrobial agent in the P1-421 this hospital, the count of the dosage regimen and investigation of the chemosensitive rate Toshiaki Onuki, Yoshihiko Matsuki, Yumi Matsumoto, Asami Yasuda, Tatsuya Suzuki, Akiko Shinoda, Hiroko Asai, Takahashi Yuka, Noriko Mishima, Arinobu Yumi, Noriko Iwasa, Kemuyama Yukiko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2010.

---

Adoption of the antimicrobial agent using the P1-422 test for drug sensitivity Morihiko Terashi 1, 野間口寛 1, Reiko Kirino 1, Tomohiro Kakimoto 1, Takeshi Takahashi 1, Middle Yuka Kihara 1, Toyosumi Ayako 1, West Kyoko Tsuji 1, New top Kanako 1, Hiramatsu sheath or 1, Chikara Kuroki 2, Eiki light 2, Kaoru Yamazaki person 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2010.

---

The antimicrobial agent consumption in the P1-423 Kanagawa throughout the prefecture 6 institution and chemosensitive examination Shuichi Matsui 1, Shusaku Noguchi 2, Hinako Kosaka 1, Makoto Usuda 3, Ayako Suzuki 4, Ayumu Sato 5, Toru Morita 5, Yayoi Iwasaki 6, Junko Makino 6, Hiroshi Hara person 3, Hiroshi Tanaka period 7, Shun Igarashi 8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2010.

---

	A change of the injection antimicrobial agent consumption by the P1-424 generic medicine induction and effect on in-hospital isolate Masayuki Maeda 1, Miura Liao child 1, Chika Kawahara 2, Kentaro Uejima 1, Tadao Inoue 1, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2010.

---

The effect that the intervention of the P1-425 infection control team gave to antimicrobial agent consumption and Pseudomonas aeruginosa susceptibility 村田龍宣, Honda Azusa, Xiacheng Sayo, Shinnya Horie, History of Sanmatsu field, Yasushi Meguro, Kyoko Kumagai, Keiichi Ono, Mitsuhiro Yoshimura, Shinji Honda, Masaru Ono, 平田敦宏, Imagawa grammar Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2010.

---

	A consumption investigation and Pseudomonas aeruginosa resistance ratio of the injectable antimicrobial agent using ATC/DDD system in the P1-426 Tokai district 望月敬浩, Takumi Umemura, 片山歳也, Yuichi Muraki, Waterfall Hisashi, Takao Omagari, Yuka Yamagishi, 三鴨廣繁, Ken Mori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2010.

---

	The effect that induction of P1-427 Antibiogram gives to infection treatment Yukako Tomota 1, Akiko Kaneko 1, Inubushi thickness husband 1, Haruka Fujise 1, Hiroshi Soeda 1, 2, Katsumi Chiba 2, 3, 中村造 2, Kumi Sato 2, Yumiko Kusama 2, Takao Akashi 1, Tetsuya Matsumoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2010.

---

	Relative comparison between antiPseudomonas aeruginosa medicine consumption (AUD) and drug resistance between the P1-428 ward Akiko Watanabe 1, Kunio Kato 2, Ayako Sudo 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2010.

---

	Action to P1-429 carbapenem system antimicrobial agent proper use Manami Kurita 1, Aya Maeda 1, Ai Nakajima 1, Toshiyuki Kadoi 1, Atsuhiko Sakamoto 2, Toshitaka Muto 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2010.

---

	Examination about a dose, the number of dose of the P1-430 carbapenem system antimicrobial agent (meropenem) Aspect shrine Koji 1, Kenji Miyazawa 1, Makoto Hayashi 1, Akemasa Yamaya 1, North Toshiyuki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2010.

---

Associated evaluation of the use density of the carbapenem-based antimicrobial agent in P1-431 children, the neonatal ward and the resistant Pseudomonas aeruginosa detection Yasuhiro Saeki 1, 2, Kazuhito Imai 2, 3, Obtain Sugawara; Risa 2, Atsuko Moriya 2, 4, 安藤常浩 2, 4, Masanobu Odaka 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2010.

---

	Fact-finding of problems for the proper use of the P1-432 carbapenem system antimicrobial agent Kimiko Nakayama 1, Tsuyako Fujie 1, Kazuyo Sawaguchi 1, Keiichi Uemura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2010.

---

	Utility of an adequacy evaluation and the antimicrobial agent surveillance of the carbapenem-based antibiotic therapy using P1-433 PK-PD parameter Yoshikazu Kobayashi 1, Seiya Kamino 2, 土屋整也 3, Koji Ikuta 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2010.

---

About the utility of the permission system asking a specialist in infection for consulting with use of P1-434 carbapenem system antimicrobial agent application in the first time Kazuhiro Hirano 1, 2, 祖川倫太郎 1, Kawano sentence 1, 中野行孝 1, Zenzo Nagasawa 2, Yukiko Mihara 2, Asami Fukuoka 2, Yosuke Aoki 2, Fujito Expo 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2010.

---

	Use situation investigation for the purpose of the antifungal agent proper use based on P1-435 guidelines Aiso Hiroshi, Minako Mori, Haruka Iida, Seiichi Kobayashi, Emiko Iguchi, Takahashi Hiromitsu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2010.

---

	Effect of the macrolide small quantity chronic administration on respiratory infection of the P1-436 neuromuscular disease intractable disease prolonged hospitalization patients 佐野晃宏 1, Natsuko Ishida 1, Kazumasa Murakami 1, Kazuya Takahashi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2010.

---

	After P1-437 surgery about use situation - postoperative infection prevention antimicrobial agent of the antimicrobial agent in the ICU admission patients - Hiroshi Kawaguchi 1, Junko Abe 1, Takeshi Nishikawa 1, Katsuya Nagayama 1, Mountain village kernel 2, Fossa side Yasumitsu 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2010.

---

	Use fact-finding of the antifungal agent in P1-438 blood disorder Hitoshi Yoshida, Satoshi Aoyagi summer, Masato Matsuura, Akie Kobayashi, Isono Junichi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2010.

---

	Action by the many types of job that P1-439 antimicrobial agent consumption decreased Hidekazu Takamatsu 1, 宇都仁惠 2, Akemi Nonaka 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2010.

---

Action of this hospital ICT about the proper use of the P1-440 antiMRSA medicine Kuto chapter wide 1, 宮良高維 1, Shingo Hirakawa 2, Tomohide Matsushima 1, Hirofumi Toda 1, Yasuko Komiya 1, Motoi Nishio 3, Venus intellect world 3, U.S. book Keisuke 3, Kanako Miyachi 2, Masako Ieda 2, Yumiko Inoe 2, Morihiro Nomura 2, Kazu Tanaka beauty 1, Rika Yoshida 1, 山口逸弘 1, Yuzuru Yamazoe 2, Hiroyuki Morishima 3, Kenzo Moriyama 2, Yoshinori Takeyama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2010.

---

	Enforcement of the core ICT round using the P1-441 infection Web system Saori Hashiguchi, Fujiwara fine weather summer, Asami Mori, Miyako Kanazawa, Tomiko Wakiyama, Koji Hashiguchi, Tsuyoshi Machida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2010.

---

	About P1-442 MRSA surveillance Hideyuki Yanagibashi, Kenichi in the new line Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2010.

---

	Intervention for P1-443 blood cultures-positive patients 石田茂伸 1, Kayo Maeda 1, Yuka Nakai 1, 楠本茂雅 2, Toshio Oshima 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2010.

---

	Examination of the effect by the pharmacist participation in planning to P1-444 infection treatment Yuko Takada 1, Tomoko Matsuoka 1, Tadashi Yasuda 1, Hiroko Asano 2, Ishigo Shiomi 2, Atsushi Iriyama 2, Shindo length 3, Yoshinori Fujimoto 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2010.

---

	Use of injectable antimicrobial agent all patients utility by the P1-445 ICT pharmacist of a check Takashi Niwa 1, 2, Akio Suzuki 1, Satoshi Omori 1, Mitsuru Yasuda 2, 太田浩敏 2, Ayumi Fukao 2, Katsuhiko Matsuura 1, Satoshi Murakami male 2, Yoshinori Ito 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2010.

---

	Present conditions report of the ICT induction in the P1-446 Kusatsu General Hospital Gen Nakajima line, Kazushi Nishide, Hideko Iwasaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2010.

---

	Evaluation of the action for the P1-447 antimicrobial agent proper use Maiko Hashimoto 1, Katsuhiro Nagai 1, Yoshihiko Katsuyama 1, Eriko Kasuga 2, Shinichiro Kanai 2, Yasuyuki Momose 1, 1, Sakae, Omori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2010.

---

	Examination of the system aiming at the present conditions and rate of use improvement of the TDM enforcement of the P1-448 antiMRSA medicine Mariko Negishi 1, Mari Hosaka 1, Hiroshi Matsuzawa 1, Funatsu Kumi 1, Nigorigawa Hiroko 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2010.

---

	The use of P1-449 linezolid actual situation and pharmacist function 上田賢太郎, 塩地聖一, 水野恵司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2010.

---

	Introduce the check list by the ICT pharmacist at the beginning of effectiveness of the linezolid in the approach of the P1-450 proper use and safe evaluation - use; and ... 一ノ瀬直樹1, 2, 天野雅子1, 3, 横沢隆行1, 4, 土橋直子1, 5, 米沢牧子1, 2, 南山絹江1, 5, 芝崎健志1, 2, 青木茂行1, 3, 小林隆1, 6, 木津純子7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2010.

---

	Examination of the use of P1-451 linezolid situation and the proper use 北村正樹, 奥津利晃, 染谷雅弘, 川久保孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2010.

---

The in-hospital round enforcement by the ICT team aiming at prevention of role - drug resistance of the pharmacist in the P1-452 infection control, antimicrobial agent proper use promotion and the effect Takehiro Yamada 1, Tsuyoshi Miyamoto celebration 1, Hiroko Yamashita 2, Reiko Oyamada 2, Nobuhisa Ishiguro 2, Takeshi Iseki 1, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2010.

---

	Practice of the antimicrobial agent proper use based on P1-453 PK/PD theory and the effect Takeshi Kimura 1, 2, Worth Chongwen 1, 2, Naoko Takahashi 1, 3, Saikai life 2, Former river Rie 2, Masako Tsukada 2, Kimura Shuya 2, Hidemi Sasaki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2010.

---

	Intervention effect of the pharmacist to de-escalation for the proper use of the carbapenem-based antimicrobial agent in P1-454 serious case infection treatment Aono Hironao 1, Yagi Tatsuya 1, 2, Shiyo Yamada wide 1, 2, Yamakawa flower Akemi 1, Takafumi Naito 1, Junichi Kawakami 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2010.

---

Promotion of the antimicrobial agent proper use based on P1-455 infection measures committee, ICT, drug committee and PK/PD theory by the cooperation of drug control instruction duties Mai Okazaki 1, Sachiko Saito 1, Saori Isa 1, 澤畠孝幸 1, Slightly dried fish Yuka 1, Masashi Onozaki 1, Yoshifumi Aoyama 1, Takeshi Nawa 2, Atsushi Shinagawa 2, 後藤達宏 2, Yasunori Watanabe 2, Shinji Hirai 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2010.

---

	Action for the antimicrobial agent proper use based on the P1-456 PK-PD theory Daisuke Kameshima, Daichi Shibata, Mitsuru Sugiura, 足立守 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2010.

---

	Effect on renal function with the direction for use dose change of P1-457 Levofloxacin 丹代恭太, Susumu Kudo, 蒲澤一行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2010.

---

	Association between use pulse-taking and trend of the drug resistant bacterium of the oral P1-458 antimicrobial agent Masako Tsukada, Former river Rie, Takeshi Kimura, Worth Chongwen, Saikai life, Yoshiko Egashira, Kimura Shuya, Hidemi Sasaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2010.

---

	Trend of the use of P1-459 antimicrobial agent situation and levofloxacin-resistant Escherichia coli 滝波昇悟, Auditor Hideo, Akemasa Imamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2010.

---

About the present conditions of the HIV treatment in the P1-460 Himeji medical center about - HAART therapy - Shigeki Takematsu 1, 2, Yoriyuki Kawato 1, 2, Masamichi Shuji 1, 2, Katsuaki Kobayashi 1, 2, Kiyoko Fujii 1, 3, Yumiko Morita 1, 3, Tokiko Saegusa 1, 3, Atsushi Tsuda 1, 4, Mimori Yasuyuki 1, 5, Tomoko Katsuta 1, 5, Yoshiro Mochizuki 1, 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2010.

---

From present conditions and this of Clostridium difficile association diarrhea / enterocolitis (CDAD) treated patients in the P1-461 Nagaoka Red Cross Hospital Kenichi Kobayashi, Masanori Abe, Hiroshi Nakazawa, Star Shuichiro, Kumiko Nagai, Akemi Kawakami, Kumiko Shioiri, Kuniko Takahashi, Takeaki Nishibori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2010.

---

	Examination about the effect of the antituberculous combined medication in the VCM internal use treatment for the P1-462 C.difficile-related diarrhea Keiko Fujita, Hiroyuki Iwata, Rie Tamura, Court Security Office Mika, Gilt bronze Yoko, Teruhisa Ishikawa, Nobuhisa Fukushima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2010.

---

	Evaluation of the P1-463 teicoplanin high dose loading dose Mari Hirabayashi 1, 2, Kazumi Taguchi 2, Mikako Namiki 1, 2, Hiroshi Tanaka period 1, 2, Kazuhisa Ugajin 2, Your forest sect 2, Toshitaka Takenouchi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2010.

---

	Comparison ... of efficacy of the antiMRSA medicine in patients with P1-464 blood cultures-positive febrile neutropenia and safe - TEIC and VCM Hiroko Yamauchi, 野村久祥, West Keiji, 永井茂, Takao Shinohara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2010.

---

Examination about the treatment with antifungal agent to patients with central venous catheter-associated blood flow infection with P1-465 Candida Lower Ida Akina 1, 2, Makoto Kimura 1, 2, Satoshi Yamano group 1, 3, Taguchi chrysanthemum Hisako 1, 4, Tadashi Yoshida dragon 1, 5, Kaori Shibata 2, Chiharu Kagawa 2, Takashi Sawazaki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2010.

---

	One case that VRCZ internal use succeeded for switch therapy after the L-AMB administration for candidemia of the P1-466 ventriculoperitoneal shunt deuteropathy Keisuke Takada, Samura A, 1, Kotobuki, Sekine Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2010.

---

	The situation of patients with HIV infection and the patient compliance instruction in the P1-467 Aomori Prefectural center Hospital Ayaka Narita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2010.

---

Action for the hand hygiene of the P1-468 pharmacist and the procedure acquisition of the personal protector Katsutoshi Takada 1, 2, 3, Atsushi Hasegawa 1, 2, 4, Mutsumi Kawamura 1, 2, 5, Chizuru Komine 1, 2, 6, Eri Kamiya 1, 2, 7, Hitoshi Chiba 8, 仲佐啓詳 1, 4, 9, Tadanori Sasaki 1, 2, 10, Hideyuki Shimizu 1, 11 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2010.

---

	Examination of the nutritional management using the hyperalimentation kit preparation in the P1-469 perioperative period Akiko Yoshiike, Eiji Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2010.

---

	Examination of the necessary amount of energy in the TPN of P1-470 elderly people Asami Yasuda, Yumi Matsumoto, Toshiaki Onuki, Tatsuya Suzuki, Akiko Shinoda, Hiroko Asai, Takahashi Yuka, Noriko Mishima, Arinobu Yumi, Noriko Iwasa, Kemuyama Yukiko, Yoshihiko Matsuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2010.

---

	Attitude survey about the electrolyte administration in the P1-471 TPN preparation Akihiro Hayashi 1, Island ノ 江千里 2, 岡橋朋世 2, Toshihiko Mizuta 3, Fujito Expo 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2010.

---

	The present conditions and measures of the electrolyte abnormality with suspected the P1-472 chemical Satoko Kimura 1, 勝浦譽介 2, Ayako Kogo 3, Yasuko Kiuchi 4, Fusako Yoshino 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2010.

---

	The risk of the hypophosphatemia in the hyperalimentation for patients with P1-473 renal failure Satoshi Kosaka 1, Akiko Ueda 1, Kiyoshi Okuyama 1, Noriko Yoshikawa 2, Masaharu Yoshida 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2010.

---

	Two cases of the copper deficiency that occurred during P1-474 enteral feeding therapy enforcement Kunihito Kochi 1, Mountain Yuji Sawa 1, Wakako Honma 1, Takashi Fukui person 2, Hirohiko Nakamura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2010.

---

	Examination about the long-term nutritional management using P1-475 half solidity nourishing food recovery Newt lied (R) Yo Sato incense 1, Yutaka Inoue 1, Ikuo Kanemoto 1, 佐藤眞治 2, Harunobu Iwase 3, Kazuo Nakamura 3, Reiko Iwase 4, Masaaki Oshita 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2010.

---

	Basic study on gastric emptying by the half solidification of the P1-476 enteral nutrient 戸田州俊, Yuriko Nimura, 西岡宙太, Nobuko Umemura, Hiroyuki Sato, Risa Kanie, 豊田行康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2010.

---

The effect that a change gives to psychiatric symptoms, medication adherence and treatment satisfaction on risperidone sustained release injection from an oral agent of the P1-477 antipsychotics Kayoko Mizutani 1, 佐々木淳輝 1, Azusa Kato sand 1, Italy Ami Saji 1, 有満征伸 1, Ippei Takeuchi 1, Hiroyuki Kamei 1, Tsutomu Yoshida 1, Tadashi Nagamatsu 1, Koji Ezaki 1, Iwata relation straight 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2010.

---

	The use situation of the P1-478 risperidone sustained release injection Yuko Abe 1, Kenzo Miyazaki 1, Koba Sani beauty 1, Asako Endo 1, 趙岳人 2, Koichi Oda 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2010.

---

From the follow-up of 18 continuously administered in efficacy and safe - Oizumi Hospital of the P1-479 risperidone sustained release injection - Yasuko Matsuda 1, Mika Usuda 1, Miki Otsuki 1, Kyoko Nagai 1, Kazuko Nakajima 1, Chieko Miyawaki 1, Rumiko Chatani 1, Sawada method British 1, 2, Saito hundreds of branches beauty 3, Ko Watanabe Ichiro 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2010.

---

	Use of P1-480 new antipsychosis, medicine sustained release injection preparation investigation Takako Toi 1, Hitomi Horikawa 1, Tomoki Ichikawa 1, Kimiko Kitahara 2, Masato Suzuki 2, Naoki Iimura 2, Ritsuko Nishizaki 2, Koichi Ito 3, Ryoji Matsubara 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2010.

---

	P1-481 Comparison with the long-term administration test results and hospital prescription status of Risperdal Consta 木藤弘子, 国見美紀, 安高由起, 立松美代子, 山川琴江, 力丸友里, 石田保美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2010.

---

	P1-482 About actual use of Risperdal Consta injection in prefectural Dazaifu hospital 中川伴子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2010.

---

Remedy-related comparison - by the taste evaluation (1) - human sensory evaluation of the P1-483 risperidone internal use liquid Isurugi Ikuko 1, Mitsuru Takahashi village 2, Kazumi Hayashi 3, Chihiro Hayashi 4, Tooru Mori 2, Etsuko Arai 5, Masahiko Shida 6, Miki Sato 1, Koji Saito 7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2010.

---

Correlative evaluation - of taste evaluation (2) - human sensory evaluation and the taste sensor study of the P1-484 risperidone internal use liquid Mitsuru Takahashi village 1, Isurugi Ikuko 2, Yosuke Ohashi 3, Hiroshi Nishibe 4, 曽我師賢 2, 彦阪剛 5, Hitomi Horikawa 6, Well bird Keiichi 7, Koji Saito 8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2010.

---

A side effect and investigation about the cause that are hard to be manifested in the medical treatment of the P1-485 schizophrenia patient Azusa Kato sand 1, Italy Ami Saji 1, Kayoko Mizutani 1, 佐々木淳輝 1, 有満征伸 1, Ippei Takeuchi 1, Hiroyuki Kamei 1, Tsutomu Yoshida 1, Tadashi Nagamatsu 1, Koji Ezaki 1, Junji Uno 2, Kiyoshi Fujita 2, Goji Kitajima 3, Hiroshi Naito 3, Iwata relation straight 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2010.

---

	The thing which we saw than the side effect investigation to P1-486 schizophrenia patient Yasuhiko Hashimoto 1, 2, Satoshi Terawaki 2, Valley water Tomomi 2, Kazuhiko Saito 2, Tensho era Masami 3, Eri Masaki 2, Miki Takahashi 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2010.

---

	P1-487 The prescription situation of the sleeping drug of patients with schizophrenia in Wakahisa Hospital 中山智美1, 萩尾美代1, 生嶋つる江1, 田口美恵子1, 長友美保子1, 上妻万智子2, 神村英利3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2010.

---

	Prescription investigation about the medical treatment of P1-488 schizophrenia Megumi Shibuya 1, Kohei Kitagawa 2, 3, Yoshihisa Kitamura 2, It is still 1 Matsunaga, 3, Sendo Toshiaki 1, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2010.

---

	It is ... for the insulin therapy that is effective by attitude survey - security of the nurse about the P1-489 insulin therapy Rika Tomita 1, 2, Kumiko Ohara 1, Michiko Kishimoto 1, Kanako Ukita 1, Hitomi Nomura 1, Yukimi Kinugasa 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2010.

---

	The use trend of the P1-490 diabetes therapeutic drug and effect on effect of treatment Kazuhiko Okamura 1, Tomomi Naito 1, Aya Fujimoto 1, Masaaki Ikemoto 1, Ayako Ishida 1, 佐々木雄啓 1, Sanuki Hideko 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2010.

---

	Use investigation of the P1-491 DPP-IV inhibitor (sitagliptin acid salt hydrate) 野口景子, 葛葉守, 久嶋真紀子, 中野玲子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2010.

---

	An evaluation and patients background factor of the hypoglycemic action of the P1-492 DPP-4 inhibitor sitagliptin 武市佳己, 井門敬子, 末丸克矢, 荒木博陽 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2010.

---

	P1-493 Evaluation of the usefulness of sitagliptin in patients with type 2 diabetes 原直己 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2010.

---

	Change of dose of glimepiride with the use of the P1-494 sitagliptin and HbA1c 近藤洋一1, 宮津美紀1, 宮原留美1, 亀島大輔1, 滝本典夫1, 杉浦剛司1, 杉浦充1, 足立守1, 林良成2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2010.

---

	Examination about change and the side effect of HbA1c of P1-495 incretin association preparation Step Masaaki Hayashi 1, Anzai 1,000 folds child 1, Valley long Minako 1, Shogo Nakamura 1, 杉本更絵子 1, Yukihiro Hayakawa 1, Hiroshi Yasuda Ichiro 2, Kazue Takahashi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2010.

---

	Importance of the instruction method that performed assessment of a lifestyle and the adherence for P1-496 diabetes education inpatients Mera spirit Ichiro, Kamura Motoki, Naoya Ueno, Kioroshi Shiori, Natsuko Hashimoto, Hiroshi Yoshimatsu chapter, Fukushima connection Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2010.

---

	Analysis of sex differences of the effect to give to carbohydrate metabolism of the statin in patients with P1-497 type II diabetes mellitus and the factor Chigusa Kikuchi 1, Mari Kato 1, Moat Hideo 1, Takashi Kato 2, Imaeda Kenro 2, Naoji Okayama 2, 松永民秀 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2010.

---

	Elucidation of sthenia of the oxidative stress in the femoral artery of the P1-498 type I diabetes mellitus model rat and the mechanism Moat Hideo 1, Chigusa Kikuchi 1, 永味千枝 1, Masayoshi Takeuchi 2, 松永民秀 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2010.

---

	Effect by the change on Glimepiride from glibenclamide in the P1-499 this hospital Matsuda law of nature beauty 1, Kyoko Kataoka 2, Tomoko Hirayama 2, Satoshi Kataoka 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2010.

---

	P1-500 Basic study of the glycogenesis metabolism improvement effect of the nateglinide 佐藤寛之1, 二村由里子1, 梅村展子1, 戸田州俊1, 水谷佳成1, 三輪一智1, 北原吉朗2, 三浦恭子2, 豊田行康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2010.

---

	The proper use investigation for patients with renal failure of the P1-501 metformin hydrochloride and analysis of the risk factor of the onset of hypoglycemia Tomimatsu Noriko, Norihide Higuchi, Tadahiro Nakamura, wisteria Hideto, Takashi Kitahara, Hitoshi Sasaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2010.

---

Application ... to patients with early renal disease of participation in medical treatment - Kremezin (R) for the patients with diabetic nephropathy for the purpose of the P1-502 dialysis induction delay Kosuke Suzuki 1, Akihiro Nakamura 2, Masayuki Obayashi 1, 小林靖奈 1, Junichiro Murayama 3, 山元俊憲 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2010.

---

	Standardization of a pregnant woman, the nursing mother instruction using a P1-503 Kikukawa City general hospital and the brochure in the Ogasa Pharmacist Association health insurance pharmacy Kumi Matsushita 1, Tomio Yamazaki 2, Yuichi Aono 2, Toshiaki Kitagawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2010.

---

	Action to "nursing and the making of the medicine" explanation booklet that made an opinion of the P1-504 nursing mother reflected Yoshiko Fukazawa, Yoshida lily, Akira Goto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2010.

---

Action for the making of the P1-505 "in-hospital use guideline about the drug administration to a pregnant woman, nursing mother" Tatsuo Nakagawa 1, Yoichi Hiraoka 1, Kazumi Kito 1, Akito Nagai 1, Takanobu Hashimoto 1, Mikio Yamazaki 2, 牛越賢治郎 2, Osamu Okitsu 2, Tsuneo Mimura 2, Kazuo Inoue 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2010.

---

A construction and use of the confirmation procedure about the nursing advisability of the P1-506 drug use postpartum woman Sachiko Takagi 1, Tatematsu space 2, Yumi Taniguchi 2, Now Yoshiko Takada 1, 2 which is related to Nagata, Masako Kamio 2, Kenji Tokui 1, Tanaka 3, Taihei, Osamu Kurauchi 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2010.

---

	Investigation - in source of information - hospital pharmacist about P1-507 pregnancy and the medicine Ayumi Kayano 1, Yamahana Noriko 2, Mizuho Takahashi 1, Kiyomi Sadamoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2010.

---

	Comparison of the drug administration rating system to P1-508 nursing mother Teiko Toyoguchi, Kanako Takano, Asako Honda, Jun Hosoya, Tadashi Shiraishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2010.

---

Comparison - of the drug evaluation of the seventh edition and the eighth edition in examination -Lactation of the drug evaluation at nursing in P1-509 Drugs in Pregnancy and Lactation (Gerald G. Briggs. et al.) Young book Taro 1, Saori Kimura 1, Yuko Okada 1, Seiichi Maruyama 2, Satoshi Toyama 2, Hiroshi Sato 2, Hiroki Masuda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2010.

---

Comparison - of the drug evaluation of the seventh edition and the eighth edition in examination -Pregnancy category of the drug evaluation at pregnancy in P1-510 Drugs in Pregnancy and Lactation (Gerald G. Briggs. et al.) Saori Kimura 1, Young book Taro 1, Yuko Okada 1, Seiichi Maruyama 2, Satoshi Toyama 2, Hiroshi Sato 2, Hiroki Masuda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2010.

---

	Effect on blood glucose level of neonates with the ritodrine hydrochloride administration to P1-511 mother Yumi Suzuki, Yukiko Shibata, Takahiro Kumagai, Yoshie Nomura, Takuya Goto, Makoto Nakajima, Kimio Wakabayashi, 加藤浩充, Shuichi Matsumoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2010.

---

	Examination about the atropine premedication at the P1-512 cesarean section Yoshie Nomura, Yukiko Shibata, Yumi Suzuki, Takuya Goto, Makoto Nakajima, Kimio Wakabayashi, 加藤浩充, Takahiro Kumagai, Shuichi Matsumoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2010.

---

	Examination of the number of quantity of to give it to an effect of the P1-513 moisturizer application and application Mariko Otani 1, 大谷道輝 2, Akane Nozawa 2, Mika Matsumoto 2, Boulevard wide 2, Kiichi Yamamura 2, Komoda Masayo 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2010.

---

	About clinical application of the unpolished rice enzyme preparation for the P1-514 chronicity constipation Makoto Nakao 1, Takuya Ogawara 2, Tomoko Nakao 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2010.

---

	About the antibiotics susceptibility of the P1-515 sporulation-related butyric acid bacteria preparation Takafumi Kaneko, Tomohiro Nakayama, Naoki Tomiyama, 一川暢宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2010.

---

	About the in vitro antibacterial activity of the P1-516 burning shell and the clinical application (1) Risa Kuwahara, Maiko Kondo, Naomi Nakajima, Shibata Kei greens child, 椿井朋, Makoto Nakao Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2010.

---

	It is the quantitative analysis of the antioxidant action of the chitosan in the healthy subject application to the preventive health care of the P1-517 health food Makoto Anraku 1, Daisuke Kadowaki 2, Lower stone Kazuki 3, Odagiri A tree 2, 4, Toru Maruyama 2, Hisao Tomita 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2010.

---

	Correlation with cyclosporin A and the blood lipid levels in patients with P1-518 intractable ulcerative colitis Mika Yamazaki 1, Member of Satoshi Doi 2, Masaka Wataru 2, Yasuo Suzuki 3, Mitsutoshi Sato 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2010.

---

Pharmaceutical management of patients with advanced Parkinson's disease that used COMT inhibitor by P1-519 blood L-dopa and the L-dopa metabolite monitoring together Mayu Kogure true 1, Member of Satoshi Doi 2, Junko Hagino 3, Takatsugu Sakakibara 4, Masaka Wataru 2, Mitsutoshi Sato 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2010.

---

	An effect of the antiHIV therapy including P1-520 Raltegravir and examination about the fat metabolism Shinichi Hikasa 1, Satoshi Hikasa 2, 澤田暁宏 2, Tazuko Tokugawa 2, Takeshi Kimura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2010.

---

	Enterokinesis usability test of patients with Parkinson's disease that we applied P1-521 13C breath test to 1, Seiwa, Hirai, Member of Satoshi Doi 1, Ishii Toshihiro 1, Masaka Wataru 1, Mitsutoshi Sato 2, Hatta Hiroyuki 3, Takatsugu Sakakibara 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2010.

---

Report of the use case of tocilizumab in the castle man disease (PC type) patients which P1-522 district core Hospital experienced Foot fence Ryosuke, Kana Kobayashi, Naoko Noda, Yoshiko Tsuda, Haruko Hiraguchi, The Makoto Yamamoto world, Masaya Miyatani, Yasushi Katsui, Tatsumichi Naomi, Kondo meets Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2010.

---

	One case that P1-523 vancomycin shifted to in pleural effusion abundantly Kowata male solstice 1, 今浦将治 1, Kotaro Kobayashi 2, Hiroyuki Takahashi 2, 赤瀬朋秀 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2010.

---

	The case that a sodium benzoate note was effective for P1-524 hyperammonemia Hiroko Yamauchi 1, Masayo Shimomura 1, Rie Kihara 1, 井手飛香 1, Reina Ogata 2, Hiroshi Yamashita virtue 2, Toshiyuki Kadoi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2010.

---

Action for the smoking cessation foreign setup of the pharmacist-led type in the P1-525 this hospital and the establishment of the smoking cessation instruction method Noriko Ishida 1, 2, Tatsuya Ono 1, 2, Michiko Yoshino 1, Emiko Yamamoto 1, Ushidani Yumi 1, It is still I 2 Tokuyama, Hideyuki Nishida 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2010.

---

	The situation of the use of drug depending on the true clinic in the P1-526 premature infant region Akiko Kobayashi, Koji Moriya, Ko Tokuda period, Kazunobu Takayanagi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2010.

---

	About the change situation of the antiHIV medicine regimen in the P1-527 this hospital Chikako Shimokawa 1, Akiko Yasuda 1, Table Shiho 1, Katsuichiro Kamei 1, Mieko Yamada 2, 3, Mikio Ueda 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2010.

---

	Questionnaire results after the HFA-BDP nasal summons method instruction for asthma to be complicated with P1-528 nose lesion 表忍 1, Shimanuki sum lawn 1, Noriko Miyawaki 1, Tsuyoshi Matsumoto 1, Cheap place wide high 2, Makoto Hashimoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2010.

---

For the cooperation reinforcement of a hospital, the drugstore in the P1-529 area Shigeki Kanemaru 1, 西川能治 2, Hirofumi Koike 2, Kozo Takizawa 3, Yuki Fukuda 4, Kuniko Yamanaka 5, Terumi Miyazato 6, Oda arms and fields of battle 7, Mieko Shimizu 7, Kayo Horikawa 7, Tadashi Wakasugi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2010.

---

	Skill up ... of improvement and the pharmacist of the quality of medicine medicine cooperation - pharmacotherapy through the P1-530 combination conference 中尾圭裕 1, Takuya Suenaga 1, Hashida sweetfish beauty 2, Kazuo Watanabe 2, Yutaka Ueyama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2010.

---

	Attitude survey of the use actual situation and the hospital personnel in Masuda-shi of the P1-531 "medicine notebook" 西迫多重1, 猪股育夫1, 吉田勝好2, 郷原学2, 大庭信行3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2010.

---

	Relation to an action and regional medicine of the medicine medicine cooperation in the P1-532 this hospital Yoshihiro Watanabe, Ikuo Yoshihara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2010.

---

P1-533 Kyushu University Hospital cancer chemotherapeutic drug medicine cooperation seminar holding and the evaluation Hiroyuki Watanabe 1, Uchida まやこ 1, Pond end Hiroaki 1, Mishima one up 1, King Suetsugu table 1, Ayumi Kodama 1, Obayashi かよ 1, Hiroko Yamaji 1, Asami Yamaguchi 1, Asami Saito 1, Rumi Ishikawa Kei 1, Masanori Sueyasu 1, Nobuaki Egashira 1, Kazuhiro Mizumoto 2, Ryozo Oishi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2010.

---

Making ... of the document "reporting book between institutions" (mild version) which supports approach ... regional alliances of the P1-534 Aichi hospital pharmacist society on koro Gee meeting for the study 小島昌代1, 2, 鈴木善貴2, 小野田千晴2, 浅野幸子2, 竹原祐子2, 山本倫久2, 池田哲雄2, 岩田智樹2, 青山佳晃1, 斎藤寛子3, 勝見章男4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2010.

---

	Action of the medicine medicine cooperation in the cancer therapy of the P1-535 Kagawa Prefectural center Hospital Nakagawa spring, Hiromi Abe, Yuka Deguchi law of nature, Junko Nozaki, Akiko Nakajima, 寳田繁基, Masumi Miyakawa, Yasuyo Fukuda, Osamu Konishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2010.

---

	Medicine medicine cooperation ... of the oral anticancer drug with the action ... treatment information seal to reporting and medicine medicine cooperation by the inflection of the P1-536 medicine notebook Eri Asago, Sachiko Iwai, Toyodome Masae, 山下由季惠, Minako Matsumoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2010.

---

Trial about the quality improvement of the medicine medicine cooperation in the P1-537 cancer chemotherapy Akiko Taguchi 1, Tomoko Kawai 1, 2, Kuniko Nagakubo 3, Shun Ito elegant 1, 2, Akiko Hayashi 1, Yuichi Hattori 1, Rieko Ikoma 1, Slope Reiko Tanba 1, Kazuhiko Hayashi 4, Toshimi Kimura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2010.

---

	Civic attitude survey about the medicine medicine cooperation through the medium of "a medicine notebook" in the P1-538 cancer medical therapy 玉木宏樹, 井上昌樹, 陶山登之, 上村智哉, 西村信弘, 直良浩司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2010.

---

	Enjoy Pharmacists' Lifestyles Hirai green Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2-2, 2011.

---

	Mainly on expectation - to a medical future image and pharmacist particularly initiative medical care - Hiroo Imura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 3-3, 2011.

---

	Hospital management based on work-life balance Yoshiki Seino Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 4-4, 2011.

---

	Expectation to a pharmaceutical administrative problem and pharmacist Yoshinobu Hirayama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 5-5, 2011.

---

	We think about infection practice again Kentaro Iwata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 6-6, 2011.

---

	Individualization treatment of the cancer molecules target medicine Hiroshi Minami sincerity Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 7-7, 2011.

---

	Promotion of the medical supplies proper use by the application to development, a true clinic of the simple gene diagnosis The amount of Ariyoshi example Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 8-8, 2011.

---

	Analysis study of drug interactions, the side effect case aiming at medical supplies proper use Masato Honma Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 9-9, 2011.

---

	Utility ... of cystatin C in the initial administration plan of applied - vancomycin hydrochloride to a drug administration design using new renal function marker cystatin C 田中亮裕 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 10-10, 2011.

---

	Investigation - pharmacometrics of the proper dosage method of the antiMRSA medicine and clinical pharmacokinetic study - about the side effect analysis Yasuhiro Tsuji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 11-11, 2011.

---

	Because we do not go blind for glaucoma Akira Negi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 12-12, 2011.

---

	About Kobe low involvement cancer medical center Kazuro Sugimura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 13-13, 2011.

---

	New world ... which medical cloud battle front - smartphone and the fusion of the cloud draw Nakayama Olympics man Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 16-16, 2011.

---

	Regional medicine innovation to send it to from six years system pharmacy education and "medicine area" release - drugstore Ken Hazama solstice Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 17-17, 2011.

---

	It is the suggestion and practice medicine area release design Shinki Sugimoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 17-17, 2011.

---

	... that the expectation to a pharmacist increased in a thing about foreign chemotherapy - loanword in the small and medium size hospital Satoko Kimura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 18-18, 2011.

---

	Action for the pharmaceutical management of all patients and the safe outpatient department chemotherapy enforcement 日置三紀 1, Yuka Kobayashi 1, 土手賢史 1, Ayumu Nozaki 1, Hiroki Iwane 1, Toshiko Aramiya 1, Hirokazu Nakanishi 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 19-19, 2011.

---

	Participation in planning of the pharmacist to treatment strategy decision in the foreign cancer chemotherapy Group bridge Yuki, Yamakawa Kazunori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 19-19, 2011.

---

	The role that a pharmacist should achieve in the team approach in medical care in the foreign chemotherapy room Yoriko Wada, Koichi Matsuo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 20-20, 2011.

---

	Foreign chemotherapy patients support mainly on the side effect of pharmacist leadership management Okada sum intellect, 吉村知哲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 20-20, 2011.

---

	Facilitation of the role of the nurse in the foreign chemotherapy and duties by the cooperation with the pharmacist 平井代恵 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 21-21, 2011.

---

	Expectation to a role and the pharmacist of the nurse in the team approach in medical care by the foreign chemotherapy Mika Hirano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 21-21, 2011.

---

	Policy of the pharmacist authorized examination specialized in a cancer Yusuke Tanigawara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 22-22, 2011.

---

	Specific example (breast cancer) of the pharmaceutical intervention 吉村知哲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 23-23, 2011.

---

	Specific example (colorectal cancer) of the pharmaceutical intervention Masami Kawahara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 23-23, 2011.

---

	Specific example (lung cancer) of the pharmaceutical intervention Pond end Hiroaki, Hiroyuki Watanabe, Ryozo Oishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 24-24, 2011.

---

	Specific example (hematologic cancer) of the pharmaceutical intervention 牛膓沙織 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 24-24, 2011.

---

	With the pharmacoepidemiology Kiyoshi Kubota Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 25-25, 2011.

---

	Medical supplies administration and pharmacoepidemiology in the future Kazuhiko Mori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 26-26, 2011.

---

	Need - of the drug epidemiologist in need and pharmacy education - drug industry of the drug epidemiologist Akira Koga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 26-26, 2011.

---

	The need of the pharmacoepidemiology education that we saw from the healthcare setting Mikio Masada, Toshiaki Nakamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 27-27, 2011.

---

	Pharmacoepidemiology education in a pharmacy school and the medicine-based graduate school Mayumi Mochizuki, Masayuki Hashiguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 27-27, 2011.

---

	Methodology - to cancer pharmacotherapy and drug economics - clinic Toshiya Ikeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 28-28, 2011.

---

	Drug economics in the mild medical care Ise Yuya, Shiro Katayama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 29-29, 2011.

---

	A molecular target drug and drug economics Takeshi Shiraiwa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 29-29, 2011.

---

	After cancer chemotherapy and drug economics - marketing action - of the drug economics study in clinical trials Takashi Fukuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 30-30, 2011.

---

	It is ... from collection of, an evaluation of logistical support - medical information in the Pharmacist Association regional medicine cooperation room to utilization Hisashi Iijima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 31-31, 2011.

---

	Many types of job cooperation by cancer practice cooperation pass :s-net in Shizuoka-shi Masakazu Takagi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 32-32, 2011.

---

	Action in the foreign chemotherapy room in this hospital Tomoko Nonogaki 1, Toshie Matsumoto 2, Masahiro Kawaguchi 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 32-32, 2011.

---

	From the situation of smooth many types of job cooperation - university hospital in the at-home cancer therapy proposal - of practice and the information sharing of this hospital Shun Ito is elegant Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 33-33, 2011.

---

	From the situation of the nurse to be concerned with at the end of life in being at home Satsuki Uno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 33-33, 2011.

---

	Utility of a role and the many types of job cooperation of the drugstore pharmacist in the at-home psychological care Yoshiaki Kimura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 34-34, 2011.

---

	Report - from infection control activity investigation - arts and sciences fifth subcommittee in the Japanese Society of Hospital Pharmacists Masaki Kitamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 35-35, 2011.

---

	Action - Hokkaido District - of the infection control activity Just field Koji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 36-36, 2011.

---

	Action - Tokai district - of the infection control activity Ken Mori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 36-36, 2011.

---

	Action to infection control activity in Kyushu, Yamaguchi District Takashi Kitahara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 37-37, 2011.

---

	Low-volume hospital - out of action - to infection control activity 継田雅美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 37-37, 2011.

---

	The resistant bacteria which we want to know Tachi field Kazuhiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 38-38, 2011.

---

	Viewpoint :one point lesson of the chest X-ray Katsunori Yanagihara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 39-39, 2011.

---

	Knowledge of the microorganism test that we know it, and there is not the loss Takashi Kasahara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 39-39, 2011.

---

	An antimicrobial agent and therapy for the gram-negative bacteria Kazuaki Matsumoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 40-40, 2011.

---

	A therapeutic drug and TDM of infection with MRSA Masahiro Kobayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 40-40, 2011.

---

	Interventional method for antimicrobial agent proper use Yoshiko Takahashi 1, Yoshio Takesue 2, Takeshi Kimura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 41-41, 2011.

---

	Discharge adjustment of the home care patient acceptance drugstore 白石丈也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 42-42, 2011.

---

	Discharge adjustment of patients with a tube : It is necessary to realize the [want to go back] of the patient 伊東俊雅 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 43-43, 2011.

---

Should face decision aiding in the at-home psychological care for high treatment at home of technological assistance - medical care dependence how; or ... Mitsunori Nishikawa, Kazumitsu Nakajima, Naoya Okumura, Kubokawa Naomi, 洪英在, Toshihiro Matsuura, Yuriko Yokoe, The Mitsuru Ozaki world, Jun Takeda, 芝崎正崇, Kazuyoshi Senda, Hisayuki Miura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 43-43, 2011.

---

	About the role of the drugstore pharmacist in the regional medicine cooperation Noriko Koshikawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 44-44, 2011.

---

	What can the pharmacist speak in regional alliances? Hideki Yamaguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 44-44, 2011.

---

	About Japanese clinical ER doc society questionnaire findings and an emergency authorized pharmacist system Junko Minemura 1, Furrow well Hiroko 2, Takeshi Kuwahara 3, Kenji Nishizawa 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 45-45, 2011.

---

	Role of the pharmacist in the ER type emergency care Middle bath Shinji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 46-46, 2011.

---

	Role of the pharmacist in ICU/CCU Kato Takahiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 46-46, 2011.

---

	From the situation of role and many types of job cooperation - physician of the pharmacist in a first aid, the intensive care - The Jokou ocean Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 47-47, 2011.

---

	The role of emergency services and relations of medical supplies Shin Matsunaga male Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 47-47, 2011.

---

	From the situation of many types of job cooperation - nurse in a first aid, the intensive care - Emiko Asaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 48-48, 2011.

---

	From the situation of role and many types of job cooperation - clinical engineer of the pharmacist in a first aid, the intensive care - Hidetoshi Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 48-48, 2011.

---

	From the situation of the radiographer 坂下惠治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 49-49, 2011.

---

	Role of the social worker in the emergency care 水溜丹都子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 49-49, 2011.

---

	Basic knowledge of eating, dysphagia necessary for medication Eiichi Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 50-50, 2011.

---

	Treatment at home, regional alliances and the simple suspension method Koji Muto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 51-51, 2011.

---

	Cancer therapy and the simple suspension method Kaori Masuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 51-51, 2011.

---

	Knowledge (characteristic of the preparation to understand from an additive) of the additive necessary for a pharmacist Tsutomu Konno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 52-52, 2011.

---

	Latent energy of pharmacist: Correct dissemination of simple suspension method 倉田なおみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 52-52, 2011.

---

	It is ... from the experience of idea and practice - diabetes theater of the diabetes empowerment Ken Okazaki Taro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 53-53, 2011.

---

	With the medical treatment instruction that they want to receive again and again Sawako Tajima 1, Minoru Kimura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 54-54, 2011.

---

	Practice of the conference by the many types of job that made much of the psychological approach to patients with diabetes Yoriko Kato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 54-54, 2011.

---

	Likelihood of the diabetes medical treatment support in the health insurance pharmacy Hiroshi Okada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 55-55, 2011.

---

	We think about "empowerment", and let's take it in Toshinari Asakura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 55-55, 2011.

---

	Medical information system to support clinical pharmacy Fumito Tsuchiya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 56-56, 2011.

---

	It is ... in a pharmacist and medical information engineers in charge of a medical information system - drug information room from the situation of the pharmacist Young Susumu Hayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 57-57, 2011.

---

	Pharmacist who assumes ICT a weapon in the future Masaki Miyamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 57-57, 2011.

---

	A pharmacist and information system (from the situation of a medical information system section, other sections) 佐々木啓充 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 58-58, 2011.

---

	Medical information engineer - pharmacist tying medical care and an information system will know the medical information; is ... Kazuyuki Ikeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 58-58, 2011.

---

	Introduction Takao Orii1, Shigeru Ohmori2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 60-60, 2011.

---

	Medical Logistics -"Triage" of Essential Medicines in Emergency- Eiko Kobayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 61-61, 2011.

---

	Emergency Pharmacy Response: Christchurch Earthquake, 2011 Jane Dawson Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 61-61, 2011.

---

	Medication Therapy Management in Victims of Wenchuan Earthquake Zhang Qin Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 62-62, 2011.

---

	Australian Defence Force (ADF) Response to the Queensland Natural Disasters Dec 10 - Feb 11 Wendy Walker Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 62-62, 2011.

---

	The Activity Report of National Center for Global Health and Medicine Atsushi Kubota Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 63-63, 2011.

---

	Role of Pharmacists in the Frontline of Pharmacotherapy Tomohiro Terada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 63-63, 2011.

---

	Aims of the China-Japan Pharmacist International Forum Zhao Zhigang Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 64-64, 2011.

---

	Pharmacy Practice Research in Collaboration with Pharmacists and Universities Shigeo Yamamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 64-64, 2011.

---

	The making of learning environment that was conscious of - listener who designed participation type learning Makiko Iwasawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 65-65, 2011.

---

	We stimulate learning in clinical settings Upper mound Tomoko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 66-66, 2011.

---

	To sustain A "point" charming you by role playing in "line" Yoko Ino Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 66-66, 2011.

---

	We support B motivation charming you by role playing 前田幹広 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 67-67, 2011.

---

	To promote team approach in medical care Makoto Yano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 68-68, 2011.

---

	From the thing "viewpoint of patients safety officer and the nurse" to expect of a pharmacist Katsue Takayanagi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 69-69, 2011.

---

	Action - duties improvement and information sharing - of the pharmacy in the team approach in medical care Masami Nishihara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 69-69, 2011.

---

	Activity of the pharmacist in the treatment at home Reiko Utsunomiya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 70-70, 2011.

---

	About ward activity in this hospital Morihito Sako, Yoshiaki Kurata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 70-70, 2011.

---

	In order to promote team medical smoothly : What is needed is to understand each other 渡邉幸子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 71-71, 2011.

---

	It is ... from experience by role - Great East Japan Earthquake of disaster medical care and the pharmacist Akihiko Furuta Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 72-72, 2011.

---

	A change and the future of the role of the pharmacist in the most recent great earthquake disaster Takashi Kodama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 73-73, 2011.

---

	The team approach in medical care that we experienced by disaster hospital practice Tatsuya Ono Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 73-73, 2011.

---

	Disaster support activity and the result that we achieved as Okayama University medical care support team 名倉弘哲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 74-74, 2011.

---

	The present problems that the hospital side in medicine - medicine cooperation has Reiko Matsui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 75-75, 2011.

---

	The present problems that the opening of an office drugstore side in medicine - medicine cooperation has Emiko Akiyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 76-76, 2011.

---

	About the information sharing between pharmacists engaged in cancer using the mailing list Kentaro Yamaguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 76-76, 2011.

---

	About education, the training system which a new face pharmacist finds Kenji Koike Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 77-77, 2011.

---

	About education, the training system which a new face pharmacist finds (from the situation of the resident) Hata Kojiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 77-77, 2011.

---

	Education - action and problem ... of the cancer medical care in the general hospital Shuichi Nawata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 78-78, 2011.

---

	Mission ... of the pharmacist for the palliation in mission vision - cancer chemotherapy Iibaru University Minoru Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 79-79, 2011.

---

	Leadership, communication, trace of EBM - Japan team on koro Gee program ten years and future ... Yumiko Sato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 80-80, 2011.

---

	Team alignment ... which is pursued in team building - psychological care team Tomoko Izawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 80-80, 2011.

---

	It is ... for qualitative improvement of the ... antinausea therapy to make to use the evidence for Kenichi Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 81-81, 2011.

---

	A viewpoint and the nature that are found by leader next-generation on koro Gee Chikako Shimizu 1, Tomoko Izawa 2, Hiroshi Ueda 3, 佐治重衡 4, Naoto Ueno 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 81-81, 2011.

---

	- to regard a record as quality management from approach - clinic settings of the medical quality improvement by the clinical path Hidehisa Soejima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 82-82, 2011.

---

	Effective operational ... pass and team approach in medical care ... of the pass Funada Chiaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 83-83, 2011.

---

	The team approach in medical care that pass and NST: spread through more and more Eiji Yamanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 83-83, 2011.

---

	Action ... medicine medicine cooperation and clinical path ... to regional alliances pass Yoshiko Miyazaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 84-84, 2011.

---

	The hematapostema is different in "here" abstruseness in the physicians! Mitsuhisa Azuma Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 85-85, 2011.

---

	Nursing care - practice and education ... of patients with hematapostema Emi Fujii Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 86-86, 2011.

---

	As for the basics of the approach of thing - pharmacy that felt from care of patients with cancer, same; is ... Ayumi Yoshida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 86-86, 2011.

---

	Description of new face strenuous efforts in the hematopoietic cells transplantation center Naoki Mukoyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 87-87, 2011.

---

	Need ... of presence, the horizontal connection of role - comrade of the pharmacist in the blood medical ward Uchida まやこ 1, Pond end Hiroaki 1, Takayuki Ishimaru 2, Hiroyuki Watanabe 1, Mishima one up 1, Ryozo Oishi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 87-87, 2011.

---

	It is action ... of the multicenter cooperation the many types of job in ... Aichi for adequacy and improvement of the colorectal cancer chemotherapy 室圭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 89-89, 2011.

---

	Examination of the nursing intervention by the multicenter conjugation in the manual preparation 溝口真巨 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 89-89, 2011.

---

	Administration management in the colorectal cancer chemotherapy regimen Yumiko Sone Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 90-90, 2011.

---

	Nausea, vomiting measures in the colorectal cancer chemotherapy Hiroaki Sakurada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 90-90, 2011.

---

	Bowel control in the colorectal cancer chemotherapy Isao Hashimoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 91-91, 2011.

---

	Suggestion of cutis symptom measures with the antiEGFR antibody preparation in the colorectal cancer chemotherapy Katsuhiro Kondo 1, Koji Kozaki 2, Junpei Utsunomiya 3, 中村卓巨 4, Tree Masaji 5, Junko Kuroda 1, 木村和哲 1, 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 91-91, 2011.

---

	Hand foot syndrome in the colorectal cancer chemotherapy Masayuki Ejiri Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 92-92, 2011.

---

	Vascular pain-like symptom in the colorectal cancer chemotherapy Atsushi Tomita sum 1, Satoshi Hibi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 92-92, 2011.

---

	Stoma management during colorectal cancer chemotherapy Masayo Sofue 1, Ayako Honda 2, Satsuki Kuroki 3, Aiko Koide 4, Keiko Hirose 5, Megumi Oishi 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 93-93, 2011.

---

	Making of the medicine medicine cooperation tool supporting colorectal cancer chemotherapy Shigeki Nakane 1, Chie Yamaguchi 1, Toshiko Furukawa 2, Miyuki Suzuki 2, Kae Matsuoka 2, Etsuko Mishima 3, Mayumi Takeuchi 3, Michiko Tatematsu 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 93-93, 2011.

---

	About DPC and team approach in medical care and bringing medicine management Masaki Muto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 94-94, 2011.

---

	Role of the pharmacist in perioperative care 西澤延宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 95-95, 2011.

---

	Significance of the bringing medicine control center Miyake hemp sentence, Naoharu Miyamoto, Country original Junichi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 95-95, 2011.

---

	Bringing medicine management ... not to use self-institution prescription type bringing medicine - bringing medicine for Kazuyoshi Nakano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 96-96, 2011.

---

	Problems of the preoperative cancellation medicine management as the team approach in medical care that an operating room pharmacist receives and future development 畝本賜男, Shiro Katayama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 96-96, 2011.

---

	About a bringing medicine control center of this hospital Kenichi Horiuchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 97-97, 2011.

---

	Method of the questionary survey Junko Okuno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 98-98, 2011.

---

	Statistical basics to evaluate clinical studies data definitely Sato Yasunori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 99-99, 2011.

---

	Point of the document retrieval to push forward clinical studies Juichi Otani Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 99-99, 2011.

---

	Summary of the case research Masato Honma Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 100-100, 2011.

---

	Be tied to a study and summarize a question of the normal business routine in an article Toshiaki Nakamura, Mikio Masada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 100-100, 2011.

---

	Action for the life study as the scientific organization of the Pharmaceutical Society of Japan Norio Matsuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 102-102, 2011.

---

	Life study and specialized pharmacist Mayumi Mochizuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 102-102, 2011.

---

	Action introduction - of branch office activity of the Pharmaceutical Society of Japan and local activity and the life study - China Shikoku Branch (and the University of Tokushima) Yoshihisa Takaishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 103-103, 2011.

---

	Introduction - of Pharmaceutical Society of Japan Branch and a local action introduction: branch office activity of the Pharmaceutical Society of Japan and local activity and the action of pharmacist life study - Tokai branch office Tadashi Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 103-103, 2011.

---

	Six years system pharmacy education and pharmacist lifetime education 眞野成康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 104-104, 2011.

---

	Tohoku district of lifelong study of efforts : That it has sought the pharmacy pharmacist in the Great East Japan Earthquake 高橋寛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 104-104, 2011.

---

	How does the basic education help problem solving of the patients? Hiroshi Onishi High School Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 105-105, 2011.

---

	Where does the basic education of the pharmacy school go to? Tomohisa Yasuhara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 106-106, 2011.

---

	Role of the experimental medicine in the department cooperation type PBL tutorial Ryuta Kataoka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 106-106, 2011.

---

	Linkage of experimental medicine and the clinical medicine in the medical education model core curriculum Masami Tagawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 107-107, 2011.

---

	About the purpose of this symposium Yoshihisa Kitamura 1, Takashi Egawa 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 108-108, 2011.

---

About the joint education curriculum (medical system integrated education) of the medical system department in Kyushu University Takao Shimazoe 1, Yoshida bare sentence 2, Hisako Nakao 3, Ichiro Takahashi 4, Satoshi Morimoto 5, Toshio Kubota 1, Daisuke Kobayashi 1, Utako Iwakiri 1, 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 109-109, 2011.

---

	Action ... of the cause practice on-site training of the construction - Dr. instruction of the regional alliances advance program to practice ability for clinical application 名倉弘哲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 109-109, 2011.

---

Action of the advance clinical practice after the business training in the cooperation university hospital Hiroyuki Kamei 1, 半谷眞七子 1, Tsutomu Yoshida 1, Yoichi Hasegawa 1, Yukihiro Noda 1, Ken Mori 1, 牧原俊康 2, Masaya Masuda 2, Takahiro Hayashi 2, Hiroaki Yano 2, Iwata relation straight 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 110-110, 2011.

---

	The enforcement of the workshop of the cooperation education with the paramedical subject and the patients participation and educational discussion Naoko Ideguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 110-110, 2011.

---

	Action of Nagasaki pharmacy, the nursing commissure consortium that looked after medicine, and aimed at the realization of the many types of job team at-home support by the cooperation the term of the organizer Mikiro Nakajima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 111-111, 2011.

---

	Action ... of "the hydrangea net" which aimed at the quality improvement of value - regional medicine of the medical cooperation using ICT 松本武浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 112-112, 2011.

---

	The advice of the specialist in role ... meal of dentistry in the at-home practice Yasuko Kotani Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 112-112, 2011.

---

	What a pharmacist should do in a home medical care support team Teshima infinity Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 113-113, 2011.

---

	A home care support drugstore meeting for the study and activity of the nurse in the ethical pharmacy The Kawashima straight beauty Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 113-113, 2011.

---

	Home health care support by the manufacturing Takakazu Ishimatsu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 114-114, 2011.

---

	From the situation of - physician investigating the way of the team approach in medical care in the HIV infection practice - Asako Kamihira Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 115-115, 2011.

---

	From the situation of - nurse investigating the role of the pharmacist in the HIV infection practice and the way of the team approach in medical care - Petty official Arika Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 116-116, 2011.

---

	From the situation of - pharmacist investigating the way of the team approach in medical care in the HIV infection practice - 吉野宗宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 116-116, 2011.

---

	Problems and the conquest method of the small team Forest Shangyi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 117-117, 2011.

---

	Activity of the pharmacist in the HIV infection team of the Siwash Hospital Well hilum Keiko, Hiroshi Kimura, 末丸克矢, Hiroshi Araki positive Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 117-117, 2011.

---

	From the viewpoint of management - management plan of the team approach in medical care era - Karimata Ichiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 118-118, 2011.

---

	Technique of the hospital management to send from the drug section Tetsuro Yumoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 119-119, 2011.

---

	From the situation of practice - talented person management of the management in the medical care - Yuko Fukazawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 119-119, 2011.

---

	Role of the pharmacist in the CKD treatment Takeshi Kimura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 120-120, 2011.

---

	From the situation of the role physician of the pharmacist in the team approach in medical care of the chronic kidney disease 今井圓裕 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 121-121, 2011.

---

	We manage pharmacotherapy of glomerulonephritis, the vasculitis Satoshi Kosaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 121-121, 2011.

---

	Acquisition of CKD measures - renal function information carried out in health insurance pharmacy and patients-adaptive - Yuzuru Ito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 122-122, 2011.

---

	It becomes the total navigator of the pharmacotherapy in dialysis medical care Old Taku Kubo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 122-122, 2011.

---

	Skill of the pharmacist necessary for chronic kidney disease (CKD) measures Takeshi Miyake sentence Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 123-123, 2011.

---

	Team approach in medical care in the infection practice 大路剛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 124-124, 2011.

---

	Interactive communications of the microorganism test Tsuyoshi Yamamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 125-125, 2011.

---

	Upbringing of the pharmacist who can watch an antimicrobial agent 前田頼伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 125-125, 2011.

---

	A pharmacist being team approach in medical care Mutsumi Yoshioka exhibition Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 126-126, 2011.

---

	Chromosome 5 and 7 Abnormalities in Oncology Personnel Handling Anti-Cancer Drugs Melissa A.McDiarmid Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 128-128, 2011.

---

	Anti-cancer agent exposure and risk management 甲田茂樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 129-129, 2011.

---

	Suggestion of the check list utilization for safe anticancer drug preparations Jin Yoshida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 129-129, 2011.

---

	Pollution survey of the anticancer drug preparation environment of the laboratory of cancer Ariake Hospital Toshihiro Hama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 130-130, 2011.

---

	Examination about the effect of aprepitant on vomiting during vinorelbine / cisplatin combination therapy Nakamura light 1, Satoshi Yamada sand Kei 1, Hideyuki Motohashi 1, Celebration Chikako 1, Ikuko Yano 1, Makoto Sonobe 2, Hiroshi Date solstice 2, Toshiya Katsura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 132-132, 2011.

---

	Antinausea effect of aprepitant on carboplatin-based chemotherapy in lung cancer treatment 光家勉 1, Kunio Tomita 1, 樹下成徳 1, Akira Yamanaka 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 132-132, 2011.

---

	About drug choice for nausea, vomiting in the cancer chemotherapy antiemetics choice investigation (interim report) - by the patients at the - EC therapy Sekiya wisdom, Ryoko Maruyama, Tokie Kondo, Fumiko Tsujiuchi, Kanako Takahashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 132-132, 2011.

---

	Evaluation of the depression effect using VAS(Visual analogue scale) for nausea, vomiting with the cancer chemotherapy 篠原義剛 1, 2, Yoshifumi Nakayama 2, Takayuki Torigoe 2, 皆川紀剛 2, Koji Yamaguchi 2, Kojiro Takahashi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 132-132, 2011.

---

	An antinausea effect and economic effect by the change of nausea, vomiting measures in the cancer chemotherapy 兼行由佳 1, Kazunari Taniguchi 1, Fuminori Matsubara 1, Wasaburo Kataoka 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 132-132, 2011.

---

	Examination about the risk factor of nausea, vomiting in the CHOP(R-CHOP) therapy 南目祐希 1, Tomoko Saito 1, Akira Endo 2, Great residence Shinji 2, Taira Aoyama one 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 133-133, 2011.

---

	Comparison of a hydrochloric acid Inge Seto Ron lock and the granisetron hydrochloride injection in the EC, FEC therapy 櫻下弘志, Yasuyuki Saeki, Hiroshi Yoshikawa, Tetsuya Murase, Furrow well Hiroko, Yasuhiro Kimura, Tree flat Kenji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 133-133, 2011.

---

	Questionary survey about the antiemetics supplementation for cancer chemotherapy-induced nausea and vomiting Small Ido Keiichi 1, 2, Shuichi Oda 1, 3, Makiko Hamada 1, 4, Shoichi Miyata 1, 5, Hiroki Miyata 1, 6, Takako Kuroyanagi 1, 7, Hisashi Shimizu example 1, Tadao Inoue 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 133-133, 2011.

---

It is ... about association of an analysis - serum albumin level and the adverse event occurrence of predictor for the adverse event development of patients receiving cisplatin Akira Maeda light 1, Masahide Matsuzaki 1, 宇良敬 2, Tomoya Nagase 1, Shinji Takahashi 1, Michiko Tatematsu 1, Seiya Mizuno 1, Keiichi Kato 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 133-133, 2011.

---

Action ... in clinical studies - cure society cancer specialty pharmacist training first year about the antiemetics for patients with breast cancer that a pharmacist stands and nominates 1, Naoya, Hashimoto, Kazuyo Nakamura 2, Nabeta Izumi 2, Akiko Mochizuki 2, 中條倫成 2, Kuromi Mayu 2, Hiroaki Utsuki 2, Midori Kimura 2, 高橋鉄治 2, Tsuneizumi Michiko 3, Kazuhiko Nakagami 3, 河原崎貴伯 2, Takashi Suzuki charges 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 133-133, 2011.

---

	Effect to result in for the making of the cancer pain opioids induction clinical path by the pharmacist leadership and mild pharmacotherapy Noriko Kaneta, Hirohira Fukami, Kayoko Iwamoto, Tsuyoshi Yamashita Shiro, Koichi Hirose, Masatsugu Fujita, Junko Terada, 前田頼伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 134-134, 2011.

---

	Relation of prescription actual situation and psychological care Committee of the side effect preventive medicine combination at opioid induction Hiroki Tokutake 1, 2, Kawada Masakiyo 1, Takashi Maruoka good luck 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 134-134, 2011.

---

From utility - therapeutic stage when a pharmacist intervenes in patients with cancer continuously to the terminal phase; and - Misae Takase 1, 2, Hiromi Hara 1, Way field Momoyo 1, 2, Emi Ishikura 1, Yuki Fujii 1, Three possible Hiroshi 1, Masahiro Kikuta 1, Mutsumi Hayashi 1, 武島稔 1, Toshiro Nishimura 1, Kazuhiko Shibata 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 134-134, 2011.

---

	Examination of intravenous administration prescription of the octreotide injection and filter passage characteristics Reina Nishigaki 1, Hata Kojiro 1, Sanshiro Aizawa 1, Mari Saito 1, Totsuka ゆ K 2, Toru Akagi 1, 牧野好倫 1, Nobuaki Yokote 1, Hiroshi Yamamoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 134-134, 2011.

---

	1 case that was able to relieve morphine-resistant pain Narita good luck tree 1, Hiroshi Nakajima 1, Yutaka Kato Jiro 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 134-134, 2011.

---

	The use situation of the fentanyl citrate percutaneous absorption type preparation of the once a day pasting for cancer pain Chiyoko Yamada, Miwa Yonezawa, Shigeharu Kiyama, Takeshi Nishimori, 柏原宏暢, Katsuichiro Kamei Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 135-135, 2011.

---

	The handling actual situation of patients awareness and the home Residual medicine for the prescription of the nonsteroidal antiphlogistic balm patch 松岡紗代1, 三木晶子2, 佐藤宏樹2, 堀里子2, 3, 澤田康文2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 136-136, 2011.

---

	A hospital, the pressure sore problem in the nursing facility and development of the prevention of bedsore preparation Naoko Iimura 1, Yuki Endo 1, Akiko Sakamoto 1, 継田雅美 2, Yuriko Inada 2, Takashi Toyoshima thickness 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 136-136, 2011.

---

	Study on fact-finding of the medical treatment in the area medical circle 岩月進 1, Takahiro Kito 2, Mitsuhiro Okazaki 2, Tei Nomoto 3, Kaori Kurata 4, Akira Dobashi 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 136-136, 2011.

---

	Clinical proof experiment report of the health consultation in the drugstore using the extensive remote health consultation system Mitsuhiro Okazaki 1, Yoshicho Masako 2, Teruaki Goto 2, Shingo Tamura 3, Iwamaru Hiroaki 3, Tomoko Shimoda 4, 良村貞子 4, Katsuhiko Ogasawara 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 136-136, 2011.

---

	Examination about the drugstore function for self-health care in the regional medicine Yasuhiro Fukahori 1, 2, Yoshicho Masako 1, Teruaki Goto 1, Mitsuhiro Okazaki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 136-136, 2011.

---

	Recognition degree investigation of the drug information about aspiration pneumonitis, dysphagia in the caretaker Keisuke Yoshida 1, Kazuhito Nakamura 2, Kimihiko Urano 1, Kameyama seven ear 1, Takashi Katano University 1, Jun Watanabe 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 137-137, 2011.

---

	Examination of the utility of the inhalational check sheet in the Saga inclusion breathing rehabilitation cooperation 湯川潤輝 1, Akiko Emoto 1, Masaru Tanaka British 2, Kazuhiro Hirano 1, Shinichiro Hayashi 2, Fujito Expo 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 137-137, 2011.

---

	Using the practice regional collaboration tool of medicine cooperation [My medical record: catheter treatment of coronary artery disease] in the cardiovascular area 柴田啓智1, 一野仁実1, 堀川幸子1, 黒木多美子3, 坂本知浩2, 中尾浩一2, 田上治美1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 137-137, 2011.

---

	Of the medicine medicine cooperation of the patients becoming the treatment at home after a discharge wrestle, and participate in conjugation instruction at a - discharge; and - Takanobu Ichino 1, Yuji Noda 2, Toshiharu Nomura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 137-137, 2011.

---

	Action of pharmacotherapy managing (CDTM) in the Katsura, Kyoto Hospital blood internal medicine 土手賢史 1, Chiharu Murakami 1, Ayumu Nozaki 1, Yuka Kobayashi 1, Takeshi Hattori 4, Shoichi Doi 3, Toshiko Aramiya 1, Hirokazu Nakanishi 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 138-138, 2011.

---

	Examination of quality and the economic effect by the ward permanent residence of the pharmacist Kenichi Manabe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 138-138, 2011.

---

	Search of the likelihood in the ward duties expansion of the pharmacist Shoji Matsumoto 1, Yayoi Yoshida 1, Tadashi Mikami 2, Yasuyuki Kondo 1, 三木生也 1, Naoki Furukawa 1, Shigeto Mizuno 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 138-138, 2011.

---

	Fact-finding of the drug-related duties in the ward Naoki Furukawa 1, Yayoi Yoshida 1, Tadashi Mikami 2, Yasuyuki Kondo 1, 三木生也 1, Shoji Matsumoto 1, Shigeto Mizuno 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 138-138, 2011.

---

Duties reform of the Ogikubo Hospital drug department Minako Tsukada, One river Etsuko, Makiko Osawa, Two stone Naoko, Yumi Watanabe, Former Eriko, Yumi Kawabata, Matsushima greens, Reiko Yokota, The Yamamoto tomorrow beauty, 井上亜悠, Koshida texture incense, Atsuko Ueda, 前田真輝, Nagano one group, Junko Ota Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 138-138, 2011.

---

	Report of the examination for blood drug levels order enforcement for the bringing medicine by the pharmacist 古川静保, Katsuya Nakano, Yuka Tsutsui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 139-139, 2011.

---

	Induction examination of the duties support system using medical supplies bar code Takahiro Suzuki 1, 3, Fumito Tsuchiya 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 140-140, 2011.

---

	Dispensing error prevention system - using dispensing error measures - PDA in the municipal Sapporo hospital Kaoru Otani, Toshiaki Teratani, Naoko Ozaki, Yoko Makino, Momoko Shishido, Junichi Yamada, 佐藤友啓, Tsuyoshi Takahashi, 結城祥充, Goto Ninna, Hiroshi Kuronuma, Shinji Iwai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 140-140, 2011.

---

	Construction and inspection of the high-precision tablet inspection system (brand name: inspection range) which and is high efficiency 阿部武由1, 小西正晃1, 竹内敏己2, 安藤力3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 140-140, 2011.

---

	Incident measures and the effect to affect medical supplies Upper kudzu Yoshihiro 1, Akihiko Nimura 1, Tomomi Ito 1, Kenzo Shibata 1, Keiko Nozaki 1, Minako Kawakita 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 140-140, 2011.

---

	The present conditions and example analysis of the risk aversion (pre-Abo id) by the pharmacist Takahiro Goto, Aiko Koyanagi, Kozue Kurihara, 揚張真利子, Iwamizu proton, Kusaka Toyoshi, Yusuke Taki, Hirokazu Yamashiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 140-140, 2011.

---

	An effect investigation to pre-Abo id by the drug control instruction duties expansion and the analysis Riyo Tamura, Tomoaki Kawano, Rie Ozeki, Shinji Takayama, Kenichiro Kawana, Kazumi Goto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 141-141, 2011.

---

From the attitude survey results of two times about the safe handling of result - medical supplies of the continuous medical supplies safety management education to a nurse - Keiko Kitajima 1, 後藤志央 1, Shrine Akihiro Ichiro 1, Maruyama Akina 1, Tatsuya Sasaki 1, 末安由拓 1, Kaifu Masayo 1, Akihiro Kai 1, Ishikawa immensity 1, Prince Taniguchi chapter 1, Ken Takakura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 141-141, 2011.

---

	Actions from the adequacy of the prescription in the Mr. care institution to medical security Tomoki Nozoe 1, Wataru Yasunaga 1, Nakakubo Akiko 1, Toshiro Sonoda 2, Katsuro Orita 2, 牧角丞冶 2, Katsuhiro Ose 3, Mari Shimada cord 3, Ryo Imakiire 3, 牧角寛郎 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 141-141, 2011.

---

	Examination of the effect that a color difference gives to the appearance similarity ratio of the PTP sheet of medical supplies Tamaki Hirofumi 1, Hiroki Sato 1, Moat foster child 1, 2, Yasufumi Sawada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 141-141, 2011.

---

	Factor analysis to give a weight error in the half lock division of the tablet Naoto Ikeda 1, Yasutaka Nakamura 1, 大島幹弘 1, 3, Kazuhito Kosuge 2, Hiroshi Yamada 2, Matsuyama solstice 1-resistant Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 141-141, 2011.

---

	Benzodiazepine-based hypnosis, sedative during pregnancy, examination about the anxiolytic use Sakai wish 1, Megumi Tanaka non-1, Daiya Sakurada 1, Trimming off Expo 1, 2, Kazumi Goto 2, Tomonori Nakamura 3, Yasushi Yamamoto Jiro 3, Eriko Kobayashi 3, Noboru Sato example 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 142-142, 2011.

---

	Activity of Cytochrome P450 of the liver of the pup decreases when we take in high fat diet during pregnancy 岡庭健洋, 今堀由賀里, 猿田かな子, 石井敬, 戸田雄大, 五十嵐信智, 落合和, 杉山清 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 142-142, 2011.

---

	The duties contents of the lap product mother and the child center permanent residence pharmacist and the evaluation Sect Ayako, Chiaki Okamoto, Nobuko Omoto, Manabu Kume, Makimoto Hiroo, Tsuyoshi Hirano, Hirai green Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 142-142, 2011.

---

	Search of the laxative suitable for constipation induced by hydrochloric acid Seve Lamar Ayaka Sota, Misato Nagashima, Takeki Narita, Daisuke Kadowaki, Sumio Hirata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 142-142, 2011.

---

	Utility evaluation study of the multivitamin supplement for renal disease Tomoko Taira 1, Takashi Ishimatsu 2, Akihiko Sonoda 2, Hideo Hirayama 2, Takeki Narita 1, Daisuke Kadowaki 1, Sumio Hirata 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 142-142, 2011.

---

	Relation of the pharmacist to use of overactivity bladder therapeutic drug Hiroshi Tani child Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 143-143, 2011.

---

	It is predicted the consumption after the induction of the normal saline solution pre-filled syringe preparation for the securing of route based on the antimicrobial agent consumption Shiho in the ball, Yagi Tatsuya, 山田尚広, Takashi Osawa, Takafumi Naito, Junichi Kawakami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 143-143, 2011.

---

	Pediatric medication compliance change interim analysis with the growth 嘉屋道裕, Nabeta Izumi, Keiko Hirano, Takashi Suzuki charges Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 143-143, 2011.

---

Glaucoma in our drugstore, examination about the use of eye drops situation of patients with cataract Aya Ono 1, Junichi Okada 1, Rie Imura 1, Noriko Inoue 1, Your Satoshi Matsuzaki 1, Tomoya Miyauchi 1, Ayumu Yamaguchi 1, Hitomi Ochiai 1, Minoru Hamamoto good luck 1, Yoshie Nishizawa 1, Miki Nagao 1, 楫野知佐乃 1, Seiko Inada 1, Takemori Kimikatsu 1, Ryutaro Fujimoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 143-143, 2011.

---

	Attitude survey about the intervention of the care staff to drugstore - patients interval Hidekazu Tanaka 1, Masahiko Hirayama 2, Young Susumu Hayashi 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 143-143, 2011.

---

	Participate in activity - medical safe whole country conjugation behavior of the pharmacist in the medical safe promotion sectional meeting; and - Mitsuhiro Kaneta, Yuji Adachi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 144-144, 2011.

---

	The manual observance of the measurement syringe of the oral liquid drug and the cognitive situation Eiji Hotta 1, Nakane disputant 1, Tsutomu Tanaka 1, River Takashi 1 who likes it, Harumi Suzuki 2, Miho Sakurai 3, Michiko Hatanaka 2, Koichi Arita 4, Kojiro Takashima 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 144-144, 2011.

---

	Taste bitter prediction of the marketing ambroxol tablets which added temperature Haji River dance, Yuka Sugino, Tamami Haraguchi, Miyako Yoshida, Takahiro Uchida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 144-144, 2011.

---

	A preparing compound and emission characteristics of the wu-ling-san Yukiko Katagiri, 宮嵜靖則, Satoshi Uchino sincerity, Yoshiyuki Kagawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 144-144, 2011.

---

	One case that we made a levothyroxine suppository and used for patients with hypothyroidism that we were not able to take 鈴木渉太 1, 2, 3, Yutaka Okada 2, 伊藤有祐 3, 三木生也 1, Yasuyuki Kondo 1, 笠原優瑠 1, Shigeto Mizuno 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 144-144, 2011.

---

	The effect that intervention for the proper use of the albumin preparation gives to albumin preparation consumption Ise Yuya 1, Hisashi bearing fruit near the root tree 2, Kenji Tajika 3, Kiyoyuki Ogata 4, Shiro Katayama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 145-145, 2011.

---

	Recommendation according to the organ system for systemic medical treatment management in the intensive care region Kenichi Nakazono, 高野尊行, Osamu Usui, Manabu Sato, Yasushi Kawatsu kernel Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 145-145, 2011.

---

	Initial correspondence aiming at safe security including the common use medicine in patients in emergent admission Satsuma Yukari, Middle bath Shinji, 奥貞佳奈子, 高瀬友貴, Naoko Harada, Ayako Konishi, Kanamori Kengo, Eiki Torii, Kazuko Nishioka, 奥貞智, Kitada Noriaki, 田中詳二, Toru Hashida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 145-145, 2011.

---

	TDM of the vancomycin hydrochloride at persistent hemofiltration dialysis enforcement Takeshi Morimoto trunk, Katsuji Shimizu, Mieko Suzuki, 山本倫数, Yasushi Osato chapter Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 145-145, 2011.

---

	The comparison between ICU and blood level of valproic acid in the patients of the neurosurgical ward and effect of hypoalbuminemia Kazumasa Yasui, Nakamura lawn intellect, Water wisteria Hiroaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 145-145, 2011.

---

	One patient whom drug-resistant coronary spastic angina developed in during conservative treatment of the acute aortic dissection Naoto Hirata 1, Nobuyuki Totsuka 2, Yuka Yamazaki 1, 3, Nakazawa one net 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 146-146, 2011.

---

	Medication guide for patients in the medical supplies risk management Takako Igarashi, Takahiro Inoue, Tatsuo Kishi, Norihiko Yoda, Kazuhiko Mori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 147-147, 2011.

---

Fact-finding of tablet crush, the de-capsule compounding of medicines using receipt data Kaori Ouchi, Shinya Goto, Ryuichi Takamatsu, Ayumi Kawamata, Kyoichi Hayashida, Yasunari Mano, Iori Hirosawa, The Tajima Eastern Orthodox Church, Yoshinori Kato, Harumi Yamada, Kotaki one, Toshiya Ikeda, Mariko Asahi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 147-147, 2011.

---

	Is the attached document of the non-prescription drug beneficial? Setsuko Tomioka, Hyperplasia Naomi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 147-147, 2011.

---

	Action to the voluntary report promotion of the side effect using a medicine notebook Shinsuke Yuasa 1, Ryota Murayama 2, Yamamoto High School size 3, Daisuke Matsubara 4, Yumi Tanaka 5, Paulownia Yoshie Hayashi 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 147-147, 2011.

---

	Is the antimicrobial agent registration system necessary in the institution with the infection control working full time staff? Shingo Takubo 1, Yoshiko Takahashi 1, Yoshio Takesue 2, Mizuho Murakami 1, Mika Ishihara 1, Takashi Ueda 2, Takeshi Kimura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 148-148, 2011.

---

	Vancomycin hydrochloride powder daily doses standardization and evaluation of the efficacy with it Nobushi Yamamura, Tomoko Kitamoto, Yuka Tsutsui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 148-148, 2011.

---

	Attitude survey of patients with diabetes that a specialist recognized education hospitalization to be need Hiroko Akasaka, Myoudani Sanae, Tajima Keiko, Kenzo Senzaki, Kayoko Ihara, Seki Kyoko, Takayuki Mizoguchi, Tomoko Nagata, 鹿間良弥, Takashi Inoue solstice, Tadaaki Ogawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 148-148, 2011.

---

	The need of the HMG-CoA reductase inhibitor for the acute myocardial infarction patients Yuki Meishin, Yuka Tsutsui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 148-148, 2011.

---

	Investigation about the aprepitant proper use of this hospital 宅和真由美, Yoko Imoto, Kenji Murakami, Goto sheath, Keiko Sano, Noriko Otomo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 148-148, 2011.

---

	International comparison ... of problems - attachment document of alerting it of the high-risk drug interaction Riyo Yamaguchi 1, Yoshiyuki Ono 1, Gutter slope Akihiro 2, Katsuyoshi Nakajima 1, Hiroshi Suzuki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 149-149, 2011.

---

Effect - second report - that the combination of clopidogrel and proton pump inhibitor in the coronary-artery stenting patients gives to a clinical outcome Masayuki Tanaka, Yukiko Inui, Haruna Kita, Yuko Kuhara, Aya Nakano, Asami Miura, Hiromi Utsumi, Ryohei Fujii, Atsuko Utsunomiya, Yuko Adachi, Nishiyama rich person, Mayumi Inoue, Furunaga Ikumi, Hisayo Kadoi, 打谷和記, Yasuhiko Hirota Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 149-149, 2011.

---

	The effect that steroid administration gives for anticoagulant effect of the Warfarin in large quantities in the malignant lymphoma Kentaro Tani 1, Ikuyo Ota 2, 桂行孝 2, 吉田近思 2, Haruo Iwase 1, Takuya Yoneno 2, Yamanoi Kenichi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 149-149, 2011.

---

Pharmacokinetic model analysis of the interaction of phenytoin and capecitabine Hiroki Sato 1, Shohei Miyazaki 1, Pond Masayuki Nishi 3, Miyuki Sakurai 5, 林口剛泰 3, Masatoshi Sano 3, Mutsumi Ueda light 3, 樽野陽亮 4, Kaori Kawahara 5, Rie Ueda 5, Ryuhei Yamada 6, 大鳥徹 7, Kenji Matsuyama 7, Akiko Miki 1, Moat foster child 1, 2, Eiji Fukui 5, Eitaro Nakatsuka 3, Yasufumi Sawada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 149-149, 2011.

---

	Case of the serotonin syndrome that was thought to become severe by combination of amantadine and fluvoxamine Tetsuro Koide 1, 2, Takuya Iwamoto 2, 3, Katsuhiro Tanaka 4, Kaoru Kuroki line 4, Masatoshi Muramatsu 4, Shinko Okuda 2, 3, Keiko Watanabe 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 149-149, 2011.

---

	Induction of the cervical cancer prevention vaccine for the staff and side reaction survey Fumiko Kato 1, Fukuda incense ear 1, Yuka Tsutsui 1, Tatsuhiko Kitamura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 150-150, 2011.

---

	Study on clinical response - first report - of the new bisphosphonate preparation minodronate in patients with primary osteoporosis 廣瀬正幸1, 金山康秀2, 竹本雄一1, 土屋廣起2, 高木英希2, 岩田久3, 山田成樹1, 5, 鍋島俊隆4, 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 150-150, 2011.

---

	1 case that investigated dumping syndrome using CGMS (sustained blood glucose monitoring system) Koichi Matsumoto 1, Toshiyuki Takahashi 1, Zennya Katsura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 150-150, 2011.

---

	Than an analysis - "standard-like medical examination, health guidance program" interview for lifestyle improvement flow sheet trial manufacture for the pharmacy school lecture teaching materials - Masako Fukuda 1, Masaya Urakami 2, Minoru Kimura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 150-150, 2011.

---

	Team approach in medical care of health insurance pharmacy and the hospital for HIV infection Miki Nakamura, 平山淳恵, Kumiko Okuda, Castle Yoshie, Red field Takehiko, Yosuke Kashida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 150-150, 2011.

---

	Questionary survey about the action of the present conditions of the TS-1 patient compliance instruction in the health insurance pharmacy and the drug reporting 吉田幹宜 1, Masato Yonemura 1, Yasuhiko Ichida 1, Junko Kitsu 2, Satoshi Izumi Shiro 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 151-151, 2011.

---

	Trial of the medicine medicine cooperation in the foreign chemotherapy that a treatment diary used "chopsticks" Takahashi sand Yuri, Takeshi Iwasaki, Nabeta Izumi, Kazuyo Nakamura, Hiroaki Utsuki, Midori Kimura, 高橋鉄治, Takashi Suzuki charges Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 151-151, 2011.

---

Medicine medicine cooperation with the (Corp.) Hofu Pharmacist Association in the Yamaguchi Prefectural comprehensive medical care center outpatient department chemotherapy Akihiro Kawanaka 1, 2, Yasuko Matsuura 2, 3, Watanabe Tarou 1, 2, Excellent Wada Kosuke 1, 2, Blunt sword Hiroki 2, 4, It is finally 1 Kuni Isobe, 2, It is still 2 Minoru Yanagi, 5, Katsuhiro Yamada 1, 2, Hiroshi Kimura light 2, 3, Junko Fukuda 2, 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 151-151, 2011.

---

	What you should do next to medicine medicine cooperation - reporting means construction in the cancer chemotherapy is some ... Toshiya Goto 1, Kazuaki Hirose 1, Tomomi Matsushita 1, Akira Takada 1, 橋本久敬 2, Noriko Sawai 2, Yoshio Nakamura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 151-151, 2011.

---

	Think about the way of pharmacist in the future through disaster medical care; from experience in Minamisanriku-cho after the Great East Japan Earthquake: It is still 1 Takashi Hashimoto, 2, 3, 4, Hiroshi Sato 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 152-152, 2011.

---

	About DMAT dispatch of this hospital in the Great East Japan Earthquake Naoki Hara 1, Otsukawa Kazuto 2, Hideaki Murakami 3, Fumiko Mihara 3, Masami Saeki 3, Akie Ijiri 3, Naoto Mita 4, Shinya Hara 4, Kenzo Taguchi 4, 川嵜英二 1, Takashi Toyota 1, 中森智毅 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 152-152, 2011.

---

From the medical support for the stricken area of the Great East Japan Earthquake and establishment of the role -1 first-aid station of the pharmacist to withdrawal - Middle bath Shinji 1, 2, Shozo Tamura 1, Kitada Noriaki 1, 奥貞智 1, Rice corner Toshihiko 1, 濱宏仁 1, Flat field Masaki 1, Up Kazuko 1, Kenji Yamamoto 1, 田中詳二 1, Koichi Ariyoshi 2, Toru Hashida 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 152-152, 2011.

---

	An example of activity and the prescription contents investigation of the pharmacist in the temporary medical office of the stricken area Makoto Nakajima 1, Takuya Goto 1, Takahiro Kumagai 1, Yoshie Nomura 1, Yukiko Shibata 1, Shuichi Matsumoto 2, Nobuyuki Mishima 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 152-152, 2011.

---

	Formulations and medication counseling - 2011.3.11 Great East Japan Earthquake and massive tsunami disaster ... by the small refuge patrol practice that became the law fast 香取哲哉1, 小川直紀1, 中谷美緒1, 加藤恭平1, 3, 宮坂善之2, 3, 菅原圭司1, 出雲貴文1, 高橋智4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 152-152, 2011.

---

	The present conditions and problem of the infection measures that a pharmacist is concerned with by disaster support Naoki Ogawa 1, Keiji Sugawara 1, Tetsuya Katori 1, Kyohei Kato 1, Mio Nakatani 1, Takafumi Izumo 1, Yoshiyuki Miyasaka 2, 3, Satoshi Takahashi 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 153-153, 2011.

---

Comparison of the smoking cessation success rate before and after the instruction system review of the pharmacist Yu Tanabe Takako 1, 2, 3, 4, Takashi Yokochi 1, Aya Uchino beauty 1, Midori Hasegawa 1, Yu Ono Castle 2, Takuya Kudo 1, Chizuko Hamada 3, Noriko Yamagishi 3, Kohei Hashizume 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 154-154, 2011.

---

	The pharmacist outpatient who took advantage of medical examination waiting time Junko Onishi 1, 2, Plum Miyoshi 1, Hiroko Nakamura 3, Yoneta lawn cord village 3, Yoshihisa Kitamura 3, Hiromi Kawasaki 2, Humble house net 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 154-154, 2011.

---

Treatment with action ... diagnosis and treatment department cross-sectional cluster ... to education for patients aiming at treatment satisfaction improvement 櫻井洋臣 1, Noriko Beppu 1, Kenichi Ishizaki 1, Sayuri Nishio 1, Kensuke Matsuo 1, Hiroshi Muramatsu 1, Masaya Yamaguchi 1, Shunichi Kawamura 1, Shinichiro Okamoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 154-154, 2011.

---

	It is ... through a case of the role - lenalidomide + dexamethasone therapy of the pharmacist in the encounter to perform in a physician and a pharmacist Nobuko Takayanagi 1, Masahiro Okuno 1, 久保嘉靖 1, Manabu Nakata 1, Yoshiharu Umetani 1, High cover Toshiro 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 154-154, 2011.

---

	Report about the management of the aim therapeutic range of PT-INR in the warfarin therapy Motoaki Nakao, Hiroshi Kurokawa, Kumi Horikawa, 朴井三矢, Makoto Saito, Toshio Tanaka, Yoshio Kitamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 154-154, 2011.

---

Acceptability of the GEMOX therapy for the refractory pancreas cancer, biliary tract cancer Toyoji Otani 1, Eiji Hata 1, 涌嶋伴之助 1, Kuniaki Moriki 1, Chisato Iwai 1, Sasaki Nanase 1, Hasegawa general 1, Kainoki Keisuke 1, Yoshikazu Shiiki 1, Hiroshi Takane 1, Kenji Otsubo 1, Kazuo Yashima 2, Naga Takuji 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 155-155, 2011.

---

	Relation of the pharmacist to electronic system induction in the cancer chemotherapy 松高吏恵 1, Hamada midsummer 1, Yuka Tsutsui 1, Yosuke Tanaka 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 155-155, 2011.

---

	Action to safety management of the cancer chemotherapy Tomoko Matsumoto 1, Koji Akiyama 1, Mountain Rieko Sawa 1, Motoko Goto 2, Yuka Iwamoto 2, Kumi Azuma 2, Mayumi Ose 2, Junko Tanaka 3, Hideshi Azuma 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 155-155, 2011.

---

	Development of injection vial rubber stopper [MOREMASEN] prototype to prevent anti-cancer agent pollution 石渡俊二1, 多賀淳1, 藤田秀樹2, 3, 西田升三1, 喜多綾子1, 杉浦麗子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 155-155, 2011.

---

	The present conditions and problem of work environment and the safety measures of the anticancer drug preparation Kazuaki Mori 1, 2, Takahiro Yoshimi 1, Yumiko Fujita 2, Moat foster child 2, 3, Akiko Miki 2, Hiroki Sato 2, Yasufumi Sawada 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 155-155, 2011.

---

Renal carcinoma and 3 cases of the liver cancer that a cutis symptom relieved by reductive sensitizing therapy for polymorphism erythema with sorafenib 久保嘉靖 1, Masahiro Okuno 1, Mai Fujimoto 1, Hiroki Ueyama 2, 金丸聰淳 2, Satoshi Ito 2, Ayaka Sasaki 3, Kaori Nakata 4, Tatsuya Horikawa 4, Yoshiharu Umetani 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 156-156, 2011.

---

Investigation about the expression situation and the adherence of the diarrhea of the sorafenib remedy patients Megumi Maeda 1, Toshiaki Miyazaki 1, Sono Kaji truth 1, Satoko Fujiwara 1, Yoshiko Kitagawa 2, Hitomi Nishimoto 2, Shinichiro Nakamura 3, It is still 1 Matsunaga, Sendo Toshiaki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 156-156, 2011.

---

	Adverse event investigation of sorafenib in the hepatoma Mayuko Toda, Funasaki Hideki, Shinya Suzuki, Yasuhiko Ichida, Satoshi Izumi Shiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 156-156, 2011.

---

	Adverse event investigation of the biliary tract cancer GC therapy in this hospital Asuka Iwamoto, Funasaki Hideki, Satoshi Izumi Shiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 156-156, 2011.

---

	Comparison of the dermatopathy onset situation in cetuximab and the panitumumab 塩谷明央, 西山泰史, 阿部武由 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 156-156, 2011.

---

	About an approach of our hospital for the skin toxicity of the panitumumab and the effectiveness 今関稔, 中澤寛仁, 須藤俊明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 157-157, 2011.

---

	Onset of stomatitis protective efficacy of the Everolimus by the azulene gargle 志田敏宏1, 2, 加藤智幸2, 冨田善彦2, 豊口禎子1, 白石正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 157-157, 2011.

---

	Investigation of the regimen reason for change of the mFOLFOX6 therapy Akira Tsujimoto 1, 松野知寛 2, 篠原義剛 3, Kojiro Takahashi 3, Yoko Imamura 1, Yutaka Ueyama 2, Yoshifumi Nakayama 4, Takayuki Torigoe 4, Koji Yamaguchi 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 157-157, 2011.

---

Making of the "correspondence booklet for the side effect of the anticancer drug" aiming at the supportive care reactions of drugs solution improvement of the patients by the many types of job Shinya Suzuki 1, Yoko Yajima 2, Takehiko Kobayashi 2, Sonoko Furubayashi 1, Masato Yonemura 1, Reiko Matsui 1, Takashi Uemura 1, Yasuhiko Ichida 1, Ichiji Endo 3, Tahara sincerity 2, Satoshi Izumi Shiro 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 157-157, 2011.

---

Anticipatory evaluation of carboplatin hypersensitivity that assumed an expression level of membrane protein CD203c of the basophils an index Takuya Iwamoto 1, Koji Yuda 2, Tsutomu Tabata 3, Hiroko Sugimoto 1, ガバザ beauty treatment salon van 4, Hiroyuki Hirai 5, Shigeyuki Kojima 5, Shinko Okuda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 158-158, 2011.

---

Examination of the Japanese GFR estimation-style utility in the gynecologic cancer carboplatin doses setting Tree temple Yasuhiro 1, 2, 中尾將彦 3, Camellia Masahiro 1, 吉長正紘 2, 4, Mariko Nakao 2, 5, Watanabe Mizuki 2, 5, Haruyuki Morimoto 2, 4, Mika Sakano 4, 6, Hajime Asano 2, 5, Liujiang Masatsugu 1, 7, Fujiwara season Yoshiko 2, Masashi Takeuchi 3, 千葉康敬 8, Yuzuru Yamazoe 2, Nishida measure three 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 158-158, 2011.

---

Analysis about low K blood disease at the Shakuyakukanzoto administration for paclitaxel-induced peripheral neuropathy in patients with gynecologic cancer 大橋養賢 1, Hideyuki Kawabe 1, 望月敬浩 1, Toshiaki Kato 1, Kazuyuki Ito 1, Yasushi Arata 1, Michihiro Shino 1, Takekuma Munetaka 2, Yasuyuki Hirashima 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 158-158, 2011.

---

Effective - for clinical evaluations (the third report) - oral mucositis of the indomethacin water solution preparation 100 Kenji 1, 2, Masato Honma 1, 2, Tree Yoshiyuki Sawa 1, 2, Long Okahiro incense 2, Tamaki Sakurai 2, Yoshiharu Suzuki 1, 2, Tomoki Tsuchiya 2, Yasuyuki Kanbayashi 2, Koda good luck direct 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 158-158, 2011.

---

	Effect of the mutation in the gene of DRD2 which gives it to antiemetic activity of the prochlorperazine in patients with cancer and adverse effect Masataka Tashiro 1, 2, Takafumi Naito 1, Yoshiyuki Kagawa 2, Junichi Kawakami 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 159-159, 2011.

---

	Estimate of the CYP2C19 genetic polymorphism based on pharmacokinetics of clobazam Hiroshi Miyakawa 1, Yoshiaki Yamamoto 2, Shigeko Nishimura 2, Emiko Takao 2, Risa Kasai 2, Seiichi Koyama 1, Kazumi Matsuda 2, Yukitoshi Takahashi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 159-159, 2011.

---

	It is a randomized controlled trial for "the medical care of the unit" based on the genetic polymorphism in tuberculosis treatment Masako Ono 1, 2, Ryuji Kubota 2, Uemura sheath or 2, Soichiro Yokota 3, Takashi Nagai 4, 露口一成 5, 奥田恭久 6, 藤尾慈 2, Ayaka Maeyama 1, Junichi Azuma 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 159-159, 2011.

---

	Association between lung cancer onset risk and drug metabolizing enzyme genetic polymorphism Shinko Hiratsuka 1, Yu Tamaki Ichiro 1, Arai wealth straight 2, Haruhiko Sugimura 3, 平澤典保 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 159-159, 2011.

---

	An expression level of Cytochrome P450 and activity increase by gastrectomy Takashi Ishii, Yudai Toda, Taku Hayase, Asano Hotta, 澤谷枝里, Igarashi sincerity intellect, The Ochiai sum, Kiyoshi Sugiyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 159-159, 2011.

---

	Study on expression of ABCB1 gene control structure by microRNA 廣田豪, 安田知世, 山口晃平, 家入一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 160-160, 2011.

---

	Application to patients with achlorhydria of the methyl cellulose / alginic acid liquid drug Descent from a mountain Tetsuya, Kunihiko Ito, Person Maki, Kanako Kino, Michiya Kobayashi, Shozo Miyazaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 160-160, 2011.

---

	Specific phenytoin separation promotion effect ... with the mechanism elucidation (1) - glucose transfusion of the phenytoin injection incompatibility Yoshinori Onuki 1, Kazumi Ishizuka 1, Mayumi Ikegami 2, Kozo Takayama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 160-160, 2011.

---

	Scientific grounds ... of dilute phenytoin injection being stable with mechanism elucidation (2) - normal saline solution of the phenytoin injection incompatibility Kazumi Ishizuka 1, Yoshinori Onuki 1, Mayumi Ikegami 2, Kozo Takayama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 160-160, 2011.

---

	Fact-finding of the voluntary recall of the medical supplies by the drug industry in Japan Takuya Ishida, Takashi Osawa, Yamakawa flower Akemi, Takafumi Naito, Junichi Kawakami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 160-160, 2011.

---

About pharmacist antibiotic chemical treatment practice educational program in the Kansai area Yoshiko Takahashi 1, Yoshio Takesue 2, So Arakawa one 2, Kazunori Asano 2, Hirai green 2, Toshihiko Ishizaka 1, Mutsumi Yoshioka exhibition 1, Yukako Yasui 1, Yutaka Hasegawa 1, Yuichi Koizumi 1, Kazuhiko Yamashita 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 161-161, 2011.

---

	Fact-finding after the training for the pharmacist trainee specialized in a cancer Reiko Matsui 1, 加藤裕芳 2, Yoshizo Watanabe 3, Naoki Kondo 4, Atsushi Wada 5, Kentaro Yamaguchi 6, Masato Yonemura 1, Satoshi Izumi Shiro 1, Ichiji Endo 7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 161-161, 2011.

---

	Association to carbohydrate metabolism control through the PKC and MCT4 expression change Sho Otake 1, Katsuya Narumi 2, Masanori Kobayashi 1, Hiroaki Yamaguchi 2, Takeshi Iseki 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 161-161, 2011.

---

	Examination of the hyperoxide-producing increase mechanism in the femoral artery of the diabetes model rat and the chronic dosing effect of the pravastatin Moat Hideo 1, 2, 永味千枝 1, Chigusa Kikuchi 1, Masayoshi Takeuchi 3, 松永民秀 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 161-161, 2011.

---

	Search of ingredients made specially in Aomori showing hypotensive effect Shiro Itagaki 1, Descent from a mountain Ritsuko 1, Michiko Uchiyama 2, 3, Early hunting truth 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 161-161, 2011.

---

	Action to long-term business training in the Hyogo Prefectural hospital pharmacy Junko Hyodo, Kyoshi, Kashima, Kimiko Yasuda, Toshiaki Matsumoto, Eiji Fukui, Hitoshi Okugawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 162-162, 2011.

---

	Action of the medical safety education that featured the theme of the KCL note for the pharmacy school six years system 狩谷佳寛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 162-162, 2011.

---

	Analysis of the business training result in the Yokkaichi social insurance hospital Saori Kojima, 片山歳也, 野々部崇哉, Mitsuru Fujioka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 162-162, 2011.

---

	Role of the pharmacist resident as the Preceptor in the pharmacy business training 奥貞佳奈子, 薩摩由香里, 高瀬友貴, 原田奈生子, 小西絢子, 中西真也, 神垣有美, 今村早苗, 奥貞智, 北田徳昭, 田中詳二, 橋田亨 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 162-162, 2011.

---

It is by Tal, cardiopulmonary resuscitation, side effect management result and a problem of the prior training to breed the clinical thought of the pharmacy student, and to connect with business training Shiho Terada 1, It is still 2 Takashi Hashimoto, 4, 8, Takayoshi Okubo 2, 6, Nobuyuki Takahashi 2, Yuriko Murai 2, 5, Keiko Sato 1, Metoki Konin 3, Masahiro Kikutani 2, 平澤典保 2, Yoshihisa Tomioka 2, Masatoshi Ohba 7, 8, Jun Imai 2, Hiroshi Sato 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 162-162, 2011.

---

	Reactions of drugs that a nurses' aide is good at and reactions of drugs that we do not like Ide Wakana 1, 2, 高橋眞生 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 163-163, 2011.

---

	Practice of the clinical meeting by the pharmacy student which experienced business training Tomoji Yoshiyama 1, Fumiya Imai 1, Miki Shimizu 1, Tanaka evening K 1, Takahiro Oshima 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 163-163, 2011.

---

	Attitude survey by the questionnaire of the simulated patient in Kobe College of Pharmacy Yukie Okumura 1, Ikuko Yokoyama 2, Aya Ino 2, Chikako Numata 2, Tsuneo Hamaguchi 2, Yasuyuki Kondo 1, 三木生也 1, Shigeto Mizuno 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 163-163, 2011.

---

	Through embarrassment - steroid of the student by the difference in drug purpose of use in university education and the business training - 笠原優瑠 1, Ayako Tada 1, 鈴木渉太 1, Shoji Kochi 1, 2, Yutaka Hasegawa 2, Chikako Numata 2, Yasuyuki Kondo 1, 三木生也 1, Shigeto Mizuno 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 163-163, 2011.

---

	An action and evaluation of "the pharmacist outpatient department" in the cancer chemotherapy Yumiko Furuno 1, Persimmon former Mino 1, Muller Kana beauty 1, Hiroshi Masuda charges 1, Shinmura green 2, Tanegashima Iwao 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 164-164, 2011.

---

	It is ... from the record of the intervention - outpatient department drug instruction management book of the hospital pharmacist for the foreign cancer pharmacotherapy Yoichi Nakajima, 葉田昌生, Tadashi Mikami, Yoshiko Murakami, 山方志築, Wataru Shiraishi, Ikuhiro Nose Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 164-164, 2011.

---

	Flow chart making for the expression situation of the diarrhea with the foreign chemotherapy and safe correspondence Noriaki Kitami 1, Masato Yonemura 1, Mai Itagaki 1, Yoko Yamaguchi 2, Yasuhiko Ichida 1, Koichi Goto 2, Satoshi Izumi Shiro 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 164-164, 2011.

---

	Examination about "the thing anxious" in patients who received foreign chemotherapy Makoto Hayashi 1, Hayato Sugimura 1, Akemasa Yamaya 1, Aspect shrine Koji 1, Kiyomi Sakakura 2, Yayoi Hoshiba 2, North Toshiyuki 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 164-164, 2011.

---

	The actual situation of the fever consultation in the foreign chemotherapy hot line and investigation for pharmacist Motoko Kaneko, Masato Yonemura, Mai Itagaki, Yasuhiko Ichida, Satoshi Izumi Shiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 164-164, 2011.

---

	Examination of the exposure situation at anticancer drug preparation by the simulation using the fine particles visualization device Anna Kubo 1, Takeo Shimazaki 2, Hideo Tanaka 1, Takahiro Okamoto 3, 坂本数彦 3, Yuji Kawakita 3, Motoo Ryoji 2, Koji Nishio 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 165-165, 2011.

---

	Evaluation of the small quantity of portable constant infusion pump packing and flow in the FOLFOX/FOLFIRI therapy Eiji Fukada 1, Small Ido Keiichi 1, 牧野好倫 1, 2, Nobuaki Yokote 1, Hiroshi Yamamoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 165-165, 2011.

---

	Association with fact-finding of the dysosmia in patients who received cancer chemotherapy using the simple type olfactometry kit and the nutritional status Kan Yukio 1, 2, Yuri Sakaguchi field 1, Junko Ishizaki 1, 崔吉道 2, Kenichi Miyamoto 2, Arai country three 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 165-165, 2011.

---

	Development of communication skill training (CST) which adopted SPIKES for pharmacists corresponding to patients with cancer Yoshihiro Noji, 半谷眞七子, Mayu Sakurai, Yukari Yoshioka, Hiroyuki Kamei Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 165-165, 2011.

---

	Usefulness of insulin continuous subcutaneous infusion therapy with insulin lispro : Comparison of insulin frequent injection therapy by detemir 早川太朗1, 3, 中山英夫1, 石井通予2, 神内謙至2, 磯野元秀2, 西村亜佐子3, 芝田信人3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 166-166, 2011.

---

	Comparison of three kinds of needles for the pen type insulin injector by the pharmacist Chigusa Kikuchi 1, 永味千枝 1, Akira Saka exhibition 2, Mikiya Watanabe 3, 鐡野敦司 4, 松永民秀 1, Tadashi Suzuki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 166-166, 2011.

---

Insulin injector choice for that the patients with eye disease, visual disturbances feel relieved, and unit setting operation is possible Hiroyuki Nishimura 1, Yoichi Ishizuka 2, Yoshida positive 1, Asako Eguchi 1, Kumiko Tsuruta 1, Mitsuru Irikura 2, Toru Irie beauty 2, Fumio Miyamoto 3, Japanese barnyard millet island state male 4, Keizo Kajiwara 4, Tomio Jinnai 4, Hideaki Jinnai 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 166-166, 2011.

---

	Examination about the pollution at microbial mixture to GLP-1 analog preparation Hitomi Karasawa 1, Toshinari Asakura 1, Emi Kawasaki 1, Takeshi Kono 2, 齊藤幹央 1, Manabu Abe 1, Miho Kageyama 1, Hiroshi Urakami 3, Noriaki Yokou 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 166-166, 2011.

---

	Relations - of examination - storage environment and the mixture method about the suspensibility of the suspension insulin preparation in the clinical use Toshinari Asakura 1, Emi Kawasaki 1, Hitomi Karasawa 1, Miho Kageyama 1, Manabu Abe 1, 斎藤幹央 1, Noriaki Yokou 1, Hiroaki Seino 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 166-166, 2011.

---

	Action of the dispensing error prevention in the generic medicine compounding of medicines Naoko Yamauchi 1, Usutani Eri child 1, Shinya Tanaka 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 167-167, 2011.

---

	The generic drug promotion plan by the hospital pharmacist and the evaluation Masayuki Wakita 1, Tomomi Hoshino 1, 波能満理惠 1, Maki Tanada 1, Hiromi Fujioka 1, Rokuro Yoneyama 1, Risa Imamura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 167-167, 2011.

---

	For the reliable use promotion of the generic drug (the second report) The Ishikawa immensity, 後藤志央, Shrine Akihiro Ichiro, Maruyama Akina, 末安由拓, Tatsuya Sasaki, Kaifu Masayo, Akihiro Kai, Prince Taniguchi chapter, Keiko Kitajima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 167-167, 2011.

---

	Examination about efficacy, the safety of the cyclosporine generic drug in patients with collagenosis Sone book Emi 1, Nozomi Iwanaga 2, Tomori Kamiya child 1, Yasuhiro Tsuji 1, Kaoru Terada 2, Hironobu Sato 2, Yukitaka Ueki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 167-167, 2011.

---

Transduce differentiation before operational ... hospitalization of the bringing medicine in this hospital; and ... Yuta Sato 1, Miyoko Narita 1, Maiko Takahashi 1, Junko Ohara 1, Aoi, Tamura 1, Masayuki Ohara 1, Masato Kojima 1, Takahashi good luck 1, Masanori Sasaki 1, Shinji Ogawa 1, Masayuki Kimura 1, Hiroki Kawamura 1, Hitoshi Fujiwara 1, Etsuko Akatsuka 2, Yuko Sato 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 167-167, 2011.

---

	Examination about the use situation and the proper use of the carbapenem-based antimicrobial agent in this hospital Katsuya Nakano, Yuka Tsutsui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 168-168, 2011.

---

	Effect to carbapenem-based medicine proper use by the all cases grasp by the ICT Hiroshi Hara person, Toru Nagai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 168-168, 2011.

---

Analysis of the clinical response based on the Time above MIC of the beta-lactam system antimicrobial agent with antiPseudomonas aeruginosa activity Jitsukawa Orient 1, 4, Keiko Fukuda 1, Teruko Yagishita 2, Takayoshi Wakamatsu 2, Mitsunori Hino 3, Takahiko Aoyama 4, Yoshiaki Matsumoto 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 168-168, 2011.

---

	Action for the practice of the use of appropriate dose, antimicrobial agent by the dosage interval Takeshi Kimura 1, 2, Worth Chongwen 1, 2, Saikai life 2, Former river Rie 2, Masako Tsukada 2, Kimura Shuya 2, Naoko Takahashi 1, 3, Toru Miyakawa 1, 4, 源吉顕治 1, 5, Hidemi Sasaki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 168-168, 2011.

---

	What we learned from the vancomycin-resistant enterococci (VRE) outbreak case : The role of the pharmacist at the time of outbreak 柳橋秀行1, 宮内智行1, 松井奈美2, 郡隆之3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 168-168, 2011.

---

	Quinolone for the Helicobacter pylori control-sensitive surveillance Yutaka Bando 1, 三木生也 1, 2, Yasuyuki Kondo 1, 2, Hiroshi Uehara 1, Shigeto Mizuno 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 169-169, 2011.

---

	Analysis of efficacy and the gyrA mutation of levofloxacin in the Helicobacter pylori re-sanitization therapy Hiroshi Uehara 1, 三木生也 1, 2, Yasuyuki Kondo 1, 2, Yutaka Bando 1, Shigeto Mizuno 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 169-169, 2011.

---

	Start an infection round; and action ... in the ... Komaki Municipal Hospital Junpei Utsunomiya 1, 2, Daisuke Tsuchimoto 1, Ryutaro Kawamoto 1, Yasuhiro Toda 1, 2, Yamada Toru 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 169-169, 2011.

---

	Examination about candidemia treatment in the hospital attached to the Tottori University School of Medicine Yukiko Miyoshi 1, Hiroshi Takane 1, Hiromitsu Fujiwara 2, Katsuhiro Ogawa 1, Yoshikazu Shiiki 1, 堀井俊伸 3, Kenji Otsubo 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 169-169, 2011.

---

	The use situation of the liposomal amphotericin B preparation Hiroshi Tanaka period 1, Kazumi Taguchi 2, Ayako Suzuki 3, Mari Hirabayashi 3, Mikako Namiki 3, Your forest sect 4, Toshitaka Takenouchi 3, Junichiro Murayama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 169-169, 2011.

---

	In participation in psychology education report - family psychoeducation for the patients with ambulatory schizophrenia family, a pharmacist is ... with the role to achieve Tomoko Nakagawa, Naomi Miyamoto, Kenji Muta, Tomomi Ariyoshi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 170-170, 2011.

---

1 case - that we introduced role - risperidone sustained release injection of the pharmacist for the schizophrenia patient of the poor medication adherence Ippei Takeuchi 1, 2, Hiroyuki Kamei 1, Tomoya Asahi 1, Akihiro Iida 1, Tsutomu Yoshida 1, Tadashi Nagamatsu 1, Junji Uno 2, Iwata relation straight 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 170-170, 2011.

---

	Difference between schizophrenia attitude survey and disease recognition between pharmacy school life, other undergraduates Yamato trunk and branch 1, 2, Hiroko Sakaguchi 2, Tomomi Horino 1, Upper fence 1,000 1, Kitakoji study 1, Sumio Matsuno 1, Mitsutaka Takada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 170-170, 2011.

---

	Treatment-resistant schizophrenia treatment, usage of Clozapine 宇野準二, 中田美穂, 東城真一, 山畑佐枝子, 竹内一平 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 170-170, 2011.

---

	It is ... through the letter which drug instruction ... patients, the bereaved who took in a narrative bay strike medicine gave to me 奥野昌宏1, 高柳信子1, 藤本麻依1, 三浦恵理1, 久保嘉靖1, 梅谷義晴1, 磯部昌憲2, 高宮静男2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 170-170, 2011.

---

	Risperdal Consta intramuscular injection patient interviews the results reported in the Kansai youth sanatorium 藤井幸代, 三宅嘉子, 田中由美, 小西和子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 171-171, 2011.

---

	It is ... from an example of need - out reach of the action of the psychiatric hospitals pharmacist for patients with at-home mental disorder 谷口浩朗 1, 2, Yoshio Akimoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 171-171, 2011.

---

	Development of the transdermal absorbing form preparation of psychotropic drug milnacipran Shigeko Obata, Satoshi Sano, Watanabe University solstice, Kozo Takayama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 171-171, 2011.

---

	Use report of the tolvaptan in our hospital 阿部正樹, 木原理絵, 中筋千佳, 服部雄二, 関本裕美, 山内一恭, 本田芳久, 小森勝也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 171-171, 2011.

---

	A precision evaluation of the vancomycin TDM analysis support software and examination of the factor which has an influence on the effect of treatment Naoya Ueno, Kamura Motoki, Kioroshi Shiori, Natsuko Hashimoto, Mera spirit Ichiro, Hiroshi Yoshimatsu chapter, Fukushima connection Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 172-172, 2011.

---

	Improvement effect by a pharmacist consolidating the TDM of the vancomycin note Waterside Tetsuya 1, Yasuko Nakamura 1, Kenji Kinoshita 1, 松本佳剛 1, Ueda exhibition charges 1, Shinichi Matsuda 2, Kazue Shinno 2, 4, Atsuko Yoshino 3, Noriko Adachi 4, Eiji Yamanaka 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 172-172, 2011.

---

	Case report - based on examination - regimen about the vancomycin administration for the CAPD patients whom peritonitis developed in 浦嶋和也 1, Kaoru Suzuki 1, Kensho Kataoka 1, Kokichi window or 1, Masami Nishihara 1, Hayato Nomi 2, Haruhito Azuma 2, 瀧内比呂也 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 172-172, 2011.

---

	Effect of CYP3A5*3 which gives it to the cross reaction of blood tacrolimus measurements using the CLIA method in renal-transplant recipients Kimiyoshi Hirano 1, Takafumi Naito 1, 見野靖晃 1, Tatsuya Takayama 2, Seiichiro Osono 2, Junichi Kawakami 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 172-172, 2011.

---

	Through a comparison with utility -PEDA of TDM analysis software EasyTDM - Masaaki Konishi 1, 2, Takeshi Abe reason 1, 2, 福岡憲泰 1, 3, Toshi Takeuchi oneself 1, 4, 芳地一 1, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 172-172, 2011.

---

	Relations with a trough level and kidney, the liver dysfunction incidence of teicoplanin given for a long term Shiota history on record 1, 2, 3, Ichihara greens one a month, Kato tree Rie 1, Hiroyuki Mizuno 1, Junko Kuroda 1, Tetsuo Ezaki 1, Atsushi Nakamura 2, 木村和哲 1, 3, 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 173-173, 2011.

---

ampicillin/sulbactam proper dosage method under the use of heart-lung machine of the cardiovascular procedures patients Yuta Yokoyama 1, Kazuaki Matsumoto 2, Hiroyuki Yamamoto 3, Shore of well skillful writing 3, Hiroshi Imoto 3, 猪川和朗 4, Norifumi Morikawa 4, Shiro Ishida 5, Yoshiro Okano 5, Eri Watanabe incense 1, 下堂薗権洋 2, Yasuo Takeda 1, 2, Katsushi Yamada 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 173-173, 2011.

---

	Evaluation of blood corpuscle transitivity and blood kinetics properties of the bortezomib in patients with multiple myeloma Takashi Osawa 1, Takafumi Naito 1, Takashina Yoshiaki 1, 見野靖晃 1, Kazunori Onishi 2, Junichi Kawakami 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 173-173, 2011.

---

	Level of clarithromycin which gives it to a hydrogen peroxide inducer cells disorder in normal human bronchiole epithelial cells and time effect Rocky mountain books for admonition, Design of turbulent waves Ryosuke, Koichi Otaki, Yoshiko Tanbo, 早勢伸正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 173-173, 2011.

---

	Antioxidant action evaluation of the hyperuricaemia therapeutic drug benzbromarone Shoichi Sakaguchi 1, Daisuke Kadowaki 1, Yohei Miyamoto 1, Kei Sato wound 2, Toru Maruyama 1, Odagiri A tree 1, 3, Takeki Narita 1, Sumio Hirata 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 173-173, 2011.

---

	A fluorouracil plasma concentration and long term prognosis in the esophageal cancer chemoradiotherapy Akiko Kuwahara 1, 2, Mountain Hiroshi Morimoto 1, 2, 三木生也 2, Nakamura job 2, 西口工司 2, Takao Tamura 2, 3, Wasaburo Kataoka 1, Hirai green 2, Sakaeda Toshiyuki 2, 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 174-174, 2011.

---

	About the utility with the chronic administration of oral pyrimidine drugs after the colorectal cancer postoperative adjuvant chemotherapy fluoride Kenji Taniguchi, Noriyuki Shimoi, Inaguchi Hiroshi, Keiko Yamamoto, Hiroya Fukunaga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 174-174, 2011.

---

Examination of the pharmacokinetics of oral beclomethasone (BDP) for the allogeneic hematopoietic stem cell transplantation patients Tadaaki Ito 1, Kana Sunohara 3, History of Hisashi Yamamoto 2, Yumiko Uchida 1, Winnow music Mayumi 1, Masako Furusawa 1, Naoyuki Uchida 2, Masayuki Hashiguchi 3, Tadashi Nishio 2, Hideko Kanazawa 3, Mayumi Mochizuki 3, Shuichi Taniguchi 2, Masahiro Hayashi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 174-174, 2011.

---

	A preparation of the DOX connotation functionality improvement liposome preparation and examination of the anti-tumor activity of the in vitro liposomal preparation Masaka Wataru 1, 2, Riyosuke Imai 2, Your Koide A 2, River flight 2, Yagi Nobuhiro 2, Yu Yokoyama product 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 174-174, 2011.

---

	Examination of the utility of the caffeine/cisplatin combination chemotherapy using the cell line derived from human liver cancer in In vitro Takashi Kawano 1, Yohei Kawano 1, Masashi Mizuta 2, Tomomi Iwakiri 1, Manabu Okumura 1, Kazuhiko Arimori 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 174-174, 2011.

---

	Examination about the amrubicin(AMR) administration in the small-cell lung cancer (SCLC) patients Chinami Suzuki 1, Hiura Kazuya 1, Yuka Watanabe 1, Hitoshi Komori 1, Makoto Yamamoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 175-175, 2011.

---

It is ... for effective, safe chemotherapy with use and utility - team approach in medical care of the temozolomide worksheet on the electronic chart Kiyoshi Sasayama 1, Yukihiko Mitsuta 2, Chika Nabeshima 3, Reiko Muroi 3, Naoya Fujimoto 1, Keiko Nitta 1, Motoko Funato 1, Masaaki Mori 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 175-175, 2011.

---

	The one instance case that we managed pharmaceutical for treatment of the myelodysplastic syndrome using azacitidine Akira Yoshida 1, History of moat male 2, Takashina Yoshiaki 1, Yagyu Tomohiro 3, Mitsue Amo 4, Reiko Kikuchi 4, Kazunori Onishi 2, 3, Junichi Kawakami 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 175-175, 2011.

---

	Search of a causing agent about the intranasal stimulation at breast cancer chemotherapy enforcement and the risk factor Kiyokazu Takada 1, Koichi Tanabe 2, Tomoaki Ikezaki 2, Jun Okubo 2, Birutani Kazuhiko 1, Hidenori Kitazawa 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 175-175, 2011.

---

	About the use situation and usefulness of the sitagliptin in our hospital 友滝和人1, 田中麻衣子1, 加藤滋宏1, 高木佐苗2, 石川敦子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 176-176, 2011.

---

	Effect of the patients background in sitagliptin phosphate hydrate tablets 長尾真里子1, 石黒俊明2, 山田成樹1, 和田祐一郎1, 穂積廣1, 竹本雄一1, 坂井裕美1, 寺尾育恵1, 伊藤江里佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 176-176, 2011.

---

	1 case that induction of CGMS was useful in the consciousness improvement of patients with diabetes Masami Murakami 1, Keiichiro Fujishima 2, Akiko Mizoguchi 1, Tomori Kamiya child 1, Yasuhiro Tsuji 1, Kazunari Matsumoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 176-176, 2011.

---

Why do the patients with diabetes stop it; reason of the - treatment interruption and tendency -? Toshifumi Nakamura 1, Takafumi Arai 1, Sho Nomura 1, 伊藤稔宏 1, Yoshida lawn 1,000 child 1, Nobuaki Ikegami 1, Akira Ogawa Ichiro 2, Harumi Maeda 2, Misaki Miyata 2, Masanori Yoshida 2, 堀田美知成 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 176-176, 2011.

---

	About examination of the clinical condition improvement for the class for diabetics participation patients in this hospital 吉田雅彩, Shigeru Yamada tree, Kana Kato, Nomura connection, Yoichi Sakakibara, Mika Shinoda, Ayumu Ichimura, Masayuki Hirose, Eri Wakita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 176-176, 2011.

---

Consciousness for the non-prescription drug purchase of remote island inhabitants judging from the comparison between Internet user and nonuser Masahiko Hirayama 1, 2, Hidekazu Tanaka 1, 2, Shintaro Suzuki 1, 2, Hitoshi Omura own 1, Masayoshi Nagase 1, Product former Seiji 1, Masanori Sugawara 2, Toshihiro Kitahara 1, Choichiro Miyazaki 1, Noboru Yamashita 3, Kiyomitsu Yoshitani 3, Hiroki Sato 4, Akiko Miki 4, Moat foster child 4, 5, 6, Yasufumi Sawada 4, 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 177-177, 2011.

---

	One case that medication counseling using the coating was useful for patients with type II diabetes mellitus that medication adherence extremely had poor Field Masahiro 1, Ikuyo Imai 1, Tsutomu Igarashi 1, 貞廣克彦 2, Tomoki Sato 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 177-177, 2011.

---

	Trend of patients with diabetes in the medical treatment type hospital Hiromi Yamaguchi, 平澤佑実彦, Takidani Hiroko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 177-177, 2011.

---

	Research design and the Recruit situation of the randomized controlled trial COMPASS project for patients with type II diabetes mellitus Hiroshi Okada 1, Yasushi Nakagawa 1, Katsushi Fukuoka 2, Naoki Sakane 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 177-177, 2011.

---

	The instruction to the schizophrenia patient whom type I diabetes mellitus developed in and the evaluation Toshikazu Daito 1, 2, 3, Naoko Yoshida 2, Uyama Miki 2, Atsushi Kubo 3, Tadamichi Yoshimura 1, Yukiko Morita 1, North Keiji 1, Masayuki Uno 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 177-177, 2011.

---

	One patient who continued olanzapine internal use after the gestational diabetes onset Okazawa incense Tsu child 1, 山崎公久 1, Yoshie Nakayama 2, Atsuko Tsubone 2, Shigeru Minami 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 178-178, 2011.

---

Retrospective investigation about hallucinatory frequency with suspected association with voriconazole in the hematopoietic stem cell transplantation patients and the risk factor Tsu lower Mayumi 1, Daisuke Watanabe 1, Small Ido Keiichi 1, 牧野好倫 1, Nobuaki Yokote 1, Takahiro Fukuda 2, Hiroshi Yamamoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 179-179, 2011.

---

	Examination of the use situation, a side effect and the interstitial pneumonia case of erlotinib in the Toho University medical center Ohashi hospital surgery department Shinichi Masuda, Kaori Komatsu, 野村充俊, Sumiko Hiura, 加藤裕芳, Toru Asayama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 179-179, 2011.

---

	Analysis study of the incidence of adverse events derived from statin drugs inferred by the change of laboratory values Manami Ochiai 1, Masanori Kobayashi 1, Toru Kawagishi 2, Kumiko Kasashi 2, Hiroaki Yamaguchi 2, Takehiro Yamada 2, Takeshi Iseki 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 179-179, 2011.

---

	Changes in serum sodium value in our hospital Tolvaptan use patient 長谷川浩司, 幸村瑶子, 冨田健生, 濱口亜紀, 井上久美子, 岩城晃一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 179-179, 2011.

---

	Side effect case of gynecomastia to seem according to the morphine hydrochloride Kayoko Iwamoto, Noriko Kaneta, Hiroshi Ota, 前田頼伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 179-179, 2011.

---

	Report of the Tamiflu Relenza prescription patients questionnaire Katsuki Hara, Taro Takami, Taeko Fujii, Tomoyuki Fujimoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 180-180, 2011.

---

	1 case that pointed out carbamazepine as a cover suspicion medicine for Stevens-Johnson syndrome by remedy history confirmation by the pharmacist Kyoko Nomura, Keiko Ishikawa, Kiyotaka Inoue Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 180-180, 2011.

---

	Search of the risk factor to give it to the hemoglobin decrease in the patients using fondaparinux after artificial joint replacement Enoki shop Tomoyuki 1, Yuichi Muraki 1, Takuya Iwamoto 1, Masahiro Hasegawa 2, Satoshi Sudo wide 2, Shinko Okuda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 180-180, 2011.

---

	Relation of the actual situation and the pharmacist of the drug-induced hepatic injury Hashimoto positive 1, Makoto Matsuda left child 1, Shigeru Omori 2, 澤部公子 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 180-180, 2011.

---

	Action to the pharmacotherapy duties by the ward permanent residence pharmacist Yuki Nishitani 1, 久岡清子 1, 2, Aida sheath or 1, Kenji Sasaki 1, Naomi Akinaga 1, North residence Miki 1, Interval Chiharu 1, Kanuma Nao 1, Takashi Kameoka 1, Hisayuki Haji 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 180-180, 2011.

---

Correspondence (summary and pharmacy duties system of the 1)-earthquake disaster and support situation - to the various quarters of the Tohoku University hospital pharmacy in 0001 Great East Japan Earthquake Mayumi Sato, Kanehiko Hisamichi, Yasushi Wagatsuma line, Yuriko Murai, Miki Shimada, Hiroki Nakamura, 眞野成康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 182-182, 2011.

---

Correspondence (rebuilding - of failure and the outpatient clinic system of the 2)-communications network of the Tohoku University hospital pharmacy in 0002 Great East Japan Earthquake Yasushi Wagatsuma line, Kanehiko Hisamichi, Mayumi Sato, Yuriko Murai, Miki Shimada, Hiroki Nakamura, 眞野成康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 182-182, 2011.

---

Correspondence (securing of medical supplies - for maintenance and the stricken area support of the practice system of the 3)-senior Pope of the Tohoku University hospital pharmacy in 0003 Great East Japan Earthquake Kanehiko Hisamichi, Mayumi Sato, Yasushi Wagatsuma line, Yuriko Murai, Miki Shimada, Hiroki Nakamura, 眞野成康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 182-182, 2011.

---

Activity report as the basic hospital for disasters in 0004 Great East Japan Earthquake Noriyuki Kumagai 1, 名倉弘哲 5, Ube Hirohide 1, Hiroshi Tanaka 2, 鵜浦利江 1, Akiko Kikuchi 1, Tomoko Takahashi 3, Eiko Niinuma 1, Chika Ujiie 1, Eri Honma 1, Nanako Takahashi 1, Mitsuru Tamura Expo 4, Taku Kudo body 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 182-182, 2011.

---

	About correspondence and anti-disaster measures of the Sendai Municipal Hospital drug department at 0005 Great East Japan Earthquake Soichi Hozumi, Munetaka Hikichi, Tetsu Saeki, Hidetoshi Fukuya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 182-182, 2011.

---

	About course of the chemotherapy resumption of this hospital after 0006 Great East Japan Earthquake Tomomi Sato 1, Katsuyuki Suzuki 1, Ayumi Yoshida 1, 齋藤京之 1, Mikiko Yoshida 2, Takao Suzuki 3, Hiroyuki Yamanaka 1, 諏江裕 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 182-182, 2011.

---

	Relation of the drugstore in the treatment at home at 0007 earthquake disasters Yasushi Takahashi daylight, Kotaro Kurosawa, Hiroyuki Kosaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 183-183, 2011.

---

	The situation and problems of the hospital in Iwaki-shi at 0008 Great East Japan Earthquake Shinichi Yoshikawa 1, 2, 小佐野磨子 1, Takayuki Nagata 1, Yuichi Hasegawa 1, Susumu Yoshida 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 183-183, 2011.

---

	A problem and the action that we faced after the Great East Japan Earthquake in 0009 this hospital drugs department for two months 秦圭資, Naoko Toyoshima, Noriko Nikaido, Yasutomo Goto, Italy Hiroe Azuma, Shiori Kaneko, Kana Kimura, Hiromi Daicho, Akiko Ogata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 183-183, 2011.

---

	Role of the pharmacist in the disaster medical care support activity for 0010 Great East Japan Earthquake Step Masaaki Hayashi, Shogo Nakamura, 杉本更絵子, Yukihiro Hayakawa, Kazue Takahashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 183-183, 2011.

---

Participate in 0011 Showa University medical care rescue parties; and - activity report - Ishikawa mere beauty 1, 2, 3, 4, 5, 6, Jun Kawazoe 2, Ayumi Tsuchiya 3, Kazuhiro Shiota 4, Yagi Satoshi 4, 5, Ayako Ishii 1, 5, Fumiko Koizumi 1, Tatsuya Kurihara 5, 渥美聡孝 5, Tomoko Handa 5, Hitomi Hasegawa 5, Kajiwara flatters it; lawn child 5, Junna Ogiwara 5, Hideto Kuroiwa 5, Junko Minemura 2, Yuji Kiuchi 5, Yumi Kamijo 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 183-183, 2011.

---

	Inflection of the pre-medicine manufacture for the children in the medical relief squad of 0012 Great East Japan Earthquake Hideaki Tokushima, Kazuhiro Hirano, Koji Takeuchi, 中野行孝, Fujito Expo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 183-183, 2011.

---

	Role of the pharmacist in 0013 relief squads Shuji Endo, Tomoko Hiraiwa, Keita Ichikawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 184-184, 2011.

---

	Activity of the Haneshima Municipal Hospital in the Gifu medical care relief squad by 0014 Great East Japan Earthquake and role of the pharmacist Eiji Yamamoto 1, 中尾真隆 1, It is still 1 Suguru Nishimura, Yasushi Watanabe 2, Taichi Muto 3, Yoshiaki Ouchi 4, Shiro Omiya 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 184-184, 2011.

---

	Correspondence of the Fujinomiya Municipal Hospital in earthquake (3/15) which assumes 0015 East Shizuoka cause Osamu Kitamura 1, Kazuo Katsumata 1, Hiroshi Kawaguchi true 1, Yoshinori Kobayashi 1, Yutaka Kobayashi 1, Akira Komiyama 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 184-184, 2011.

---

	Pharmacist activity report to stricken area medical care support in 0016 Great East Japan Earthquake Akazawa wing, Katsuumi studies, Takao Sawai, Atsushi Kubota, Koichi Mizuno, Jiro Mikami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 184-184, 2011.

---

	Stricken area medical care support in 0017 Great East Japan Earthquake Daigo Suzuki 1, Keisuke Watanabe 2, Wataru Nagashima 2, Hiroyuki Matsubara 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 184-184, 2011.

---

	The role of the pharmacist in the DMAT activity with 0018 Great East Japan Earthquake and future problem (comparison medical for an acute phase and a sub-acute phase) Hidehito Takano, Hirokazu Ishizuka, 小守陽介, Morizaki くりみ, Junko Nagai, Tadanori Sasaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 184-184, 2011.

---

Go around role - Iriya, Minamisanriku district of the pharmacist in the regional medicine system convalescence in 0019 Great East Japan Earthquake, and give medical care; and ... It is still 1 Asano, 2, Kotaro Kawamoto 1, Shiyo Yamada branch 1, Your Sekine existence 1, Tatsuro Fujii 1, Ayako Kato 1, Tomoko Suzuki 1, Seina Noda child 1, Kadomura Shota 1, Mina Takeuchi 1, Yuko Fukuda 1, Tatsuya Ito 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2011.

---

	Role of the pharmacist in the disaster medical assistance team after 0020 Great East Japan Earthquake Satohiko Akamine 1, Toshiko Sasaki 2, Masahiro Kobayashi 2, Jun Kainuma 2, Miyuki Takahashi 1, Mariko Arai 1, Shingo Konno 4, Kazuo Yago 2, 3, Masaichi Kuroyama 1, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2011.

---

	Relief activities report of the pharmacist in 0021 Great East Japan Earthquake Toru Hasegawa, Kazuyuki Ito, Jun Hisada life, Keita Urasaki, Satoshi Isotani, Takamitsu Akita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2011.

---

	It is = for risk and measures = great scale disaster at 0022 rolling blackouts development 高橋眞生 1, Masumi Koda 1, Wakana Ide 1, Mitsuo Kuroki 1, Hisashi Iijima 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2011.

---

	The effect that a blackout caused by 0023 Great East Japan Earthquake and rolling blackouts resulted in in the healthcare setting Relation bowl Hideo, Yoshiyuki Miyasaka, Cheap Takeo, Akira Sekiguchi I Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2011.

---

	Examination of the hospital stock administration for 0024 disaster development Yuki Yamazaki 1, Yasuhiro Ujiie 1, History of laboratory of origin of soil 1, 飛川昭雄 1, Reiko Yasuda 1, Hideki Koyama 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2011.

---

	Discussion about the inflection of the medical supplies management at 0025 large-scale disasters and the drug information 村田実希郎, Masaki Takenouchi, 永瀬怜司, Jun Takimoto, Hiroshi Sugano, 赤瀬朋秀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2011.

---

	About the choice and the disaster pharmacist activity of the disaster relief medical supplies for the reserve relief squad in 0026 this hospital Miyanaga Minoru Miyuki 1, 市川騰 1, Shuji Endo 1, Stone Yoshiki Kubo 1, Tomoko Hiraiwa 1, Keita Ichikawa 1, 松本賢芳 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2011.

---

Medical support ... from pharmacist activity report (1) - acute phase in the Aichi Medical University Hospital in 0027 Great East Japan Earthquake to a sub-acute phase Masayuki Takeuchi 1, Yukio Toyama 1, Hiroyuki Shimada 1, Akiko Tsukada 1, Kato Takahiro 1, 2, Yasushi Yamamoto University 1, Hiroko Saito 1, Takaaki Hasegawa 1, Yoshihiro Yamada 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2011.

---

Medical support ... from pharmacist activity report (2) ... sub-acute phase in the Aichi Medical University Hospital in 0028 Great East Japan Earthquake to a chronic stage Akiko Tsukada, Yasushi Yamamoto University, Kato Takahiro, Hiroyuki Shimada, Masayuki Takeuchi, Yukio Toyama, Hiroko Saito, Takaaki Hasegawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2011.

---

From 0029 sub-acute phases through the disaster medical care support activity in role - Kesennuma-shi synthesis gymnasium of the pharmacist at the large-scale refuge in the chronic stage - Tomoki Kagiyama 1, Katsunori Shinohara 1, Hiroyuki Nagano 2, Suzuki good tree 2, Takao Asami 3, Junichiro Fukuhara 3, Takaki Kitazawa 2, Toru Kishino 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2011.

---

	Compare the Great East Japan Earthquake with the medical supplies demand - Niigata Chuetsu earthquake in the relief activities at 0030 stricken areas; and ... Kuniyoshi Tanaka, Masahiro Nakayama, Tsuyoshi Azuma, Takeshi Nakamura will, 室親明, Takeshi Kimura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2011.

---

	Role ... of the pharmacist in disaster hospital practice report - disaster medical care in 0031 Great East Japan Earthquake 阪上倫行, Kazuhiko Yamashita, Hideaki Daimatsu, Atsushi Wada, Kenta Tanaka, 熊岡穣, Hoshino Kengo, Manabu Kume, Makimoto Hiroo, Tsuyoshi Hirano, Hirai green Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2011.

---

	The relief activities that a pharmacist of the Kobe Red Cross Hospital in 0032 Great East Japan Earthquake conducted Yamagishi male good luck, Masaki Horibe, 池井健, Koichi Murakami, Asuka Ushio, Hideki Adachi, Teruhisa Matsubayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2011.

---

About medical support activity for the Great East Japan Earthquake as 0033 Hyogo Hospital Pharmacist Association and a future action Tatsuya Ono 1, 2, Satoko Katsuragi 1, 3, Tsuneo Hamaguchi 1, 4, Tsuyoshi Hirano 1, 5, Teruhisa Matsubayashi 1, 6, Yoshihisa Takao 1, 7, Yukiko Kawamoto 1, 8, Toru Hashida 1, 9, Hirai green 1, 5, Hideyuki Nishida 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2011.

---

Activity - logistical support of the virtue bank meeting medical care support corps in 0034 Great East Japan Earthquake arranges a pharmacist and medical supplies quickly how; or - Satoshi Takahashi 1, Yoshiko Tosa 1, Yoshiyuki Miyasaka 2, 6, Tsutomu Ogata 3, Takafumi Izumo 4, Hiromitsu Arakawa 5, Relation bowl Hideo 6, Takuya Kudo 7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2011.

---

Role ... of the pharmacist as the logistics in activity - advance party of the virtue bank meeting medical care rescue party in 0035 Great East Japan Earthquake Hiroyuki Goto 1, 5, Yoshiyuki Miyasaka 2, Takuya Kudo 1, Relation bowl Hideo 2, Tsutomu Ogata 3, Satoshi Takahashi 4, Yoshiko Tosa 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2011.

---

Importance ... of the pharmacist in activity report - reconstruction aid period (development one month later) of the pharmacist in the virtue bank meeting medical care rescue party of 0036 Tohoku great earthquake disasters 阪井田哲 1, 福井圭亮 1, Takashi Suzuka daylight 1, Yoshiyuki Miyasaka 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2011.

---

	Activity ... in Ofunato-shi, Iwate of activity ... sub-acute phase of the virtue bank meeting medical care rescue party in 0037 Great East Japan Earthquake 福井宗憲 1, Shingo Onuma 2, Takamitsu Negishi 3, Takafumi Izumo 4, Yoshiyuki Miyasaka 5, Satoshi Takahashi 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2011.

---

It is activity ... of the reconstruction aid period from the sub-acute phase in activity - Kesennuma-shi Motoyoshi district of the virtue bank meeting medical care support corps in 0038 Great East Japan Earthquake Kazuko Tateishi 1, Yuka Masuyama 1, 興田賢作 2, Kyohei Kato 3, Keiji Sugawara 3, Yutaka Shinohara 4, 川那邊絵里 5, Midori Araki 4, Yoshiyuki Miyasaka 4, 6, Satoshi Takahashi 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2011.

---

	Role ... of the pharmacist in the upstairs district of activity ... sub-acute phase of the virtue bank meeting medical care rescue party in 0039 Great East Japan Earthquake 萩原省武 1, Yoshiyuki Miyasaka 2, Masaaki Hirakawa 1, Satoshi Takahashi 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2011.

---

Medical supplies classification ... at role, disaster of the pharmacist in activity ... sub-acute phase / Minamisanriku-cho of the virtue bank meeting medical care support corps for 0040 Great East Japan Earthquake Hiroko Nomura 7, Wakugawa just the morning 1, Islet reason princess 2, 廣本昌英 3, Yuji Meguro 4, Kazuo Takayama 5, Masaaki Hirakawa 1, Yoshiyuki Miyasaka 6, Satoshi Takahashi 7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2011.

---

Action of this hospital which is hard to obtain medical supplies caused by 0041 Great East Japan Earthquake, and faces each other Rie Tsuchimoto 1, 2, Hirotsugu Kita 1, Yukiko Kita 1, Takami indigo plant 1, Chiharu Uehara 1, Shinya Watanabe 1, Ryota Nakamura 1, Yuta Komai 1, 櫻間和紗 1, Morimoto wish 1, Hilum three Mizuho 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2011.

---

	Difference ... Myanmar, Republic of Haiti of the medical supplies demand in the disaster support activity inside and outside 0042 countries, Tohoku district Pacific offing ... Haruhiko Sato 1, 3, Koichi Ikehara 3, 4, 渡慶次賀博 3, 4, 伊禮武 2, Katsuyo Uehara 1, 2, 知花幸仙 2, 伊波潔 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2011.

---

	Problems ... about the prescription at activity - disaster of the virtue bank meeting medical care support corps in 0043 Great East Japan Earthquake Sawa Takahashi person 1, 福井宗憲 2, Takamitsu Negishi 3, Yoshiyuki Miyasaka 4, Satoshi Takahashi 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2011.

---

Role ... of the pharmacist in activity - medium-and-long term disaster support of the virtue bank meeting medical care support corps in 0044 Great East Japan Earthquake 稲野祥宗 1, Tetsuya Katori 2, Satoshi Kubota 3, Yukiko Inoue 4, Wakugawa just the morning 4, Saori Okuda 5, Satoshi Kataoka 6, Yuka Yoneyama 3, Hiroshi Okuda 7, Yoshiyuki Miyasaka 3, 8, Satoshi Takahashi 9 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2011.

---

	The present conditions of the infection control in 0045 refuges Hideki Inagawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2011.

---

	Role of the pharmacist in "the psychological care team" for the victim of 0046 Great East Japan Earthquake 右川浩, Mieko Tanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2011.

---

Experience 0047 Great East Japan Earthquake; and in the ... Hitachi General Hospital is ... about establishment [pharmacist medicine outpatient department] Masashi Onozaki 1, Yoshifumi Aoyama 1, Sachiko Saito 1, Slightly dried fish Yuka 1, 澤畠孝幸 1, Eriko Terakado 1, Shimazaki incense 1, Wataru Sato 1, Mai Okazaki 1, Ayako Sakamoto 1, Yusuke Terakado 1, Masahiko Nemoto 1, Mai Yamamoto 1, Atsushi Shinagawa 2, Toshiro Kamoshita 2, Masakazu Tsutsumi 2, Tsuneo Fujita 2, Yasunori Watanabe 2, Shinji Hirai 2, 岡裕爾 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2011.

---

	The support activity of the pharmacist in 0048 Great East Japan Earthquake and education medical at a disaster Noro shallows Takahiko 1, Seiichi Furuta 2, 早瀬幸俊 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2011.

---

	Experiencing the volunteer activity at the stricken area caused by 0049 Great East Japan Earthquake, and having learned Satoshi Sakurai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2011.

---

	Action aiming at anticancer drug mixed preparation perfection enforcement in 0050 pharmacy Masami Maeda, Nishibeppu Hiroko, Tomoji Fushimi, Akiko Mizoguchi, Prince Sawamura will, Yoshiyuki Hotta, Toru Morita, Shun Igarashi, 高尾良洋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2011.

---

	Frequency and onset time of the adverse event in 0051 hospitalization cancer chemotherapy Chiho Hanaoka, Akira Maeda light, Masahide Matsuzaki, Motoi Ito Expo, Hideko Suzuki, Seiya Mizuno, Michiko Tatematsu, Keiichi Kato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2011.

---

	About promotion of a review and the proper use of the regimen in the Fukui that we went from examination of 0052 RDI(Relative Dose Intensity) Prefectural hospital 中村尚未, 坂井伸成, Hideaki Kato, Mitsue Uno, 佐澤佳彦, Takashi Hiraga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2011.

---

	3 cases (about the intervention of the side effect expression situation and the pharmacist) that was given bendamustine dexamethasone therapy in 0053 metropolitan Komagome hospitals Mariko Matsubayashi 1, Maho Miyazawa 1, Yukihisa Imaizumi 1, Yoshiharu Maeda 2, Rumiko Okamoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2011.

---

	Investigation of the use situation and the side effect expression of bendamustine in 0054 Katsura, Kyoto Hospital Chiharu Murakami 1, 土手賢史 1, Yuka Kobayashi 1, Ayumu Nozaki 1, Toshiko Aramiya 1, Hirokazu Nakanishi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2011.

---

	A side effect in 0055 bendamustine therapy and the measures Takashi Masuno 1, Hiroyuki Horiguchi 1, Teruo Obata 1, Bank Noriaki 1, Masayuki Tamura 1, Kotaro Toyama 2, Takahiro Jinbo 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2011.

---

	Examination about the renal failure of cisplatin by 0056 diuretics precedence Short hydration method Yuji Hayakawa 1, Michiko Tatematsu 2, 浦良敬 3, Toshiharu Nomura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2011.

---

	Investigation about the renal function of patients who received 0057 Low dose FP therapy Tetsushi Kanematsu 1, Yuki Kanematsu 2, Mitsuru Takai 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2011.

---

	Nephropathic comparison in the starting medical supplies and generic medicine of 0058 cisplatin Naoko Yasumori 1, Minoru Hayashi exhibition 1, 山中竹治 2, Takashi Seto 3, Ai Nakamura 1, 清水裕彰 1, Tomisawa 4, Takanori Kobayakawa 1, Kenji Sugio 3, Yukito Ichinose 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2011.

---

	Change of the antinausea therapy for the childhood cancer chemotherapy after 0059 aprepitant induction Maid of honor さあ village 1, Tsuyoshi Aoyama 1, Kazuo Sugita 1, Yasuhiro Nakano 1, Anna Inoue 1, Kazunori Kawakami 1, Seiichi Matsumoto 2, Toshihiro Hama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2011.

---

	Relation (the second report) as the pharmacist to the chemotherapy in 0060 children regions Yuka Tanaka 1, Moat jasmin 2, Yokoyama skillful writing 2, Mari Mori 2, Emi Kadoi 2, Great Xisha cord law of nature 2, Kuni Shinoda University 2, Takao light 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2011.

---

Investigation of efficacy and the adverse event of the bortezomib therapy in 0061 this hospital Chika Masumoto 1, Mayumi Matsumoto 1, Ryuji Nagae 1, Yuji Okamoto 1, Yuka Takenouchi 1, Ota friend Rie 1, Takahashi sub-Mana 1, Riyusuke Rokusha 1, It is still 1 Tatsu Sada, Kenichi Hasuike 1, Yukiko Uchiyama 1, Keigo Ezaki 1, Nariyama Shinichi 2, Masato Iida 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2011.

---

	1 case that FOLFOX6/FOLFIRI therapy was provided for a liver metastasis of 0062 rectal cancer in 1 course three weeks, and a good state was able to maintain 林田諭 1, Mayu Inoguchi 1, It is Mari 1 for a country, Naofumi Eriguchi 2, Toru Kume 3, 内藤壽則 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2011.

---

	Pharmaceutical management for thrombocytopenia in 0063 carboplatin +TS-1 combination therapy Hirotaka Shimota, Ayumi Sato, Tomohito Nakazawa, Toshiaki Sudo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2011.

---

Difference of the antinausea control by the difference in route of administration of the prednisolone in 0064 CHOP therapy 中村宏洋 1, North city Kiyoyuki 2, Masashi Ishihara 2, Iibaru University Minoru 2, It is still picture 3 Goto, Nobuhiro Kanemura 3, 笠原千嗣 3, Katsuhiko Matsuura 2, 3, Kotobuki, Tsurumi, Tadashi Sugiyama 1, Hisataka Moriwaki 3, Yoshinori Ito 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2011.

---

	The nutritional status of patients who received DCF therapy for 0065 esophageal cancer and association with the adverse event Sayaka Azuma 1, Yuta Watanabe 2, Katsuya Makihara 1, 山内一恭 1, Yoshihisa Honda 1, Katsuya Komori 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2011.

---

	Action of the ward pharmacist for 0066 adult T-cell leukemia / lymphomas Ken Hasuo product 1, 2, 村本慎悟 1, 眞田功 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2011.

---

	Discussion ... from examination - DA-EPOCH therapy about the dose at cancer chemotherapy enforcement for patients with 0067 elderly people malignant lymphoma Yoshiharu Mitsunaga 1, Kazuhisa Fujikawa 2, 趙龍桓 2, Hisae Yokoi 3, Suguru Kasahara Castle 1, Jun Hamada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2011.

---

	Examination about the change of the laboratory values by drug interactions of 0068 aprepitant and dexamethasone Shizuko Okabe 1, Yoshiaki Ikeda 2, Kazuhiro Mori 2, Kenji Kawata 3, Net Katsuo Oka 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2011.

---

	Making of the critical path based on the sorafenib side effect analysis in 0069 hepatocellular carcinomas Yukiko Kanbara 1, Sachiyo Morita 1, Katsuyasu Tsuda 1, Jun Suwaki three 1, Toshiyuki Takagi 2, Shinichi Fujioka 2, Shunya Osawa 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2011.

---

	The intervention that we made use of the specialty of 0070 cancer pharmacotherapy authorization pharmacists in Upper Tsu Saori, Kazufumi Iwata, 合澤啓二, It is Sachiko in a camp, Eiko Fukunaga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2011.

---

	About a utility of needs and the information sharing for the pharmacist of the nurse in 0071 cancer chemotherapy Corner Yoshiaki, 多賀允俊, Mikako Nishikawa, Yuka Tanimura village, Hiroyuki Totsuka, 高橋喜統, Small Masaru Hori, Koji Nishio Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2011.

---

	Research about the side effect expression situation every 0072 malignant lymphoma chemotherapy regimens 政賢悟 1, Kano Tomoko 1, Ibara country charges 2, Nosaka straight volost 3, Hiroaki Mitsuya 3, Yoshiteru Honda 1, Hideyuki Saito 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2011.

---

	It is investigated a side effect of doxorubicin liposome for 0073 recurrence ovarian cancer, peritoneal carcinoma Kamai Satoko, Tomohito Nakazawa, Toshiaki Sudo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2011.

---

	0074 Activities in the drug unit in the EMEND capsules adoption 芦崎雅之1, 室田裕大1, 沖山かおり1, 永村陽一郎1, 柴崎功1, 堀治1, 植野由記子2, 山崎龍王3, 中根実4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2011.

---

	Effect of aprepitant on acute emesis in 0075 breast cancer EC therapy Hiroshi Fukuma 1, Yukari Hara 1, Masayuki Itakura 2, Nobuhiro Nishimura 1, 直良浩司 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2011.

---

An antinausea effect of aprepitant in the outpatient who received 0076 moderate degree emetogenicity cancer chemotherapy and effect on quality of life Corner Shintaro 1, Child 1 too rare Mochinaga, Arrow ケ part Tomomi 2, Naoko Arakane 3, Ability castle Hirokazu 2, Shinya Kimura 3, Fujito Expo 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2011.

---

	Three cases that introduced aprepitant into patients with 0077 pediatric malignancies chemotherapy, and succeeded Hiroki Yoshida 1, Tree Masaji 1, Now Yoshiko Takada 1, Mutsuo Ishii 2, Kenji Tokui 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2011.

---

	An effect of aprepitant in 0078 hematopoietic tumors and safe examination Uchida まやこ 1, 2, 3, Kimiko Ichinose 2, Hiromi Hiraiwa 2, Asako Sakurai 2, Koji Kato 3, Miyamoto Toshihiro 3, Pond end Hiroaki 1, Masanori Sueyasu 1, Nobuaki Egashira 1, Ryozo Oishi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2011.

---

Aprepitant which we added 0079 nutritional status evaluations and performed, examination of the utility for the moderate emetogenic risk of palonosetron Eri Kurosaki 1, Yoichi Tanaka 1, 2, Kiyoshi Shibuya 1, 2, Jun Shibazaki 1, Rieko Hoshino 1, Akiko Nomoto 1, Hideyuki Nagashima 1, Yuka Kobayashi 1, Yasushi Kondo 3, Takako Komiyama 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2011.

---

	Examination about nausea, the vomiting reduction effect of the antiemetics in patients receiving 0080 altitude emetogenicity anticancer drugs Naoki Matsuzawa 1, Yasuyuki Momose 1, Satoru Koizumi exhibition 2, Hanako Momose 3, 1, Sakae, Omori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2011.

---

	Efficacy of aprepitant for the high and intermediate emetogenic platinum-induced digestive symptom in 0081 gynecology ward inpatients Hikaru Otsuka ear 1, Noriko Miyazaki 3, Rei Asai name 2, Taeko Higuchi 3, Yumiko Komori 1, 二改俊章 1, Kiyobumi Yamada 3, Yukihiro Noda 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2011.

---

	It is ... on the occasion of action ... aprepitant of the antiemetics standardization in 0082 registration regimen, palonosetron induction Makoto Hosomi 1, Aimi Goto 1, Masami Nishihara 1, 瀧内比呂也 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2011.

---

Examination of efficacy and the adverse event of the aprepitant palonosetron combination in 0083 cisplatin (CDDP) treated patients Usui Naoko 1, Gilt bronze Yoko 1, Tomonori Hirashima 2, Masashi Kobayashi 2, Naoko Morishita 2, Norio Okamoto 2, Hidekazu Suzuki 2, 田宮基裕 2, Yuka Matsuura 2, Shangdong Masumi 1, Yuya Fukuchi 1, Kazuko Shimura 1, Nobuhisa Fukushima 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2011.

---

Examination of the pre-medication for the anaphylactic expression in the docetaxel administration that used 0084 aprepitant together Sanae Miyano, Tatsuya Mori, Chiaki Ogawa, Hiroshi Kudo, Megumi Yatabe, Makoto Kobayashi Sachimi, Keiko Yoshino, Miyashita Kyuutoku, Yasuo Ide, Yoshihiko Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2011.

---

	Standardization and evaluation of 0085 antiemetics proper use guidelines 芦埜和幸, Takeshi Shibazaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2011.

---

	Comparison in approximately the antinausea therapy guidelines rule in the two-drug chemotherapy containing 0086 carboplatin Mariko Jinnai 1, Shinji Kimoto 1, Nishimura A 1, Toru Ohori 1, Hisashi Morikawa group 1, Mika Hoshino 2, 穴沢予識 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2011.

---

	Examination in the examination (1) severity of the Infusion Reaction expression factor with 0087 rituximab administration Masahiro Kawai 1, Shinichiro Suzuki 1, Hidetomo Yasujima 1, Hiroyuki Hayashi 2, Body marsh Masami 3, Hitoshi Nakamura 3, Akio Saito 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2011.

---

	Examination in the examination (2) expression symptom of the Infusion Reaction expression factor with 0088 rituximab administration Shinichiro Suzuki 1, Masahiro Kawai 1, Hidetomo Yasujima 1, Hiroyuki Hayashi 2, Body marsh Masami 3, Hitoshi Nakamura 3, Akio Saito 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2011.

---

	Comparative study of the side effect of difference in previous history of treatment (sorafenib and sunitinib) expression of 0089 renal cell carcinoma therapeutic drug Everolimus situation 角川幸男1, 木村貴1, 下辻恒久1, 望月千枝1, 中多陽子1, 丁元鎮1, 桝喜惠1, 武田健2, 垣本健一2, 新井康之2, 西村和郎2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2011.

---

	Side effect expression situation investigation in the Everolimus treated patients for 0090 renal cell carcinomas 沖野真季1, 河崎陽一2, 前田恵2, 八木健太1, 小松仁美1, 田坂健2, 松水尚1, 2, 千堂年昭1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2011.

---

	Relation of the pharmacist for the dermatopathy of 0091 panitumumab 増田博也, 田中こずえ, 阪井田哲, 木田朋子, 福井圭亮, 伴さやか, 鈴鹿隆晃 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2011.

---

	Hypomagnesemia and patients background by 0092 panitumumab 世古口眸, 佐久間隆幸, 中村昭宣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2011.

---

Examination about the utility of skin reaction preventive therapy and the skin care instruction for 0093 antiEGFR antibodies therapy Kondo ten thousand Yumi 1, 正置耕一 1, Old upturn child 1, Shibuya Nao 1, Shie Nakagawa 1, Mutsumi Yoshioka exhibition 1, Aiko Sakaguchi 2, New book Toshie 2, Norihisa Yamamoto 3, Jin Yoshizaki paternal blood 3, 渡雅克 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2011.

---

	The side effect situation in 0094 cetuximab administration Yamada cherry tree, Motoi Fujii Expo, Tomomi Kikuchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2011.

---

	The onset of nausea, vomiting symptom situation in the oxaliplatin base regimen for 0095 colorectal cancer Yosuke Ando 1, Hideki Ota 1, Kaori Ito 1, Satomi Kumazawa 1, Maiko Ando 1, Fukuura Kumiko 1, Hiroaki Yano 1, Hiroshi Matsuoka 2, Kotaro Maeda 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2011.

---

	Investigation about the side effect expression of the panitumumab therapy in 0096 Shimane Prefectural center Hospital 島林逸人, 頼光翔, 新山哲央, 原弓美, 原和輝, 園山智宏, 金子奈緒美, 平野榮作, 後藤澄子, 今岡友紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2011.

---

	follow-up investigation after the allergic onset situation with 0097 oxaliplatin administration and the onset Yohei Ikeno 1, Daisuke Arii 1, Kunihiko Murooka 1, Michi Nojima husband 1, Akio Kidokoro 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2011.

---

	Effective case of pregabalin for the peripheral nerve symptom to come from 0098 oxaliplatin Your Tsuyoshi Ito 1, Mayumi Yabuki 1, Seki Daisuke 1, Yoshiba Mayumi 1, Haga Shizue 1, Akito Mitsuoka 2, Hiroshi Kuwahara 2, Toru Hibi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2011.

---

	Examination for the reduction effect of Oxaliplatin-related peripheral neuropathy with 0099 Ca/Mg preparation administration Keiki Mori 1, 2, Yoko Hamaguchi 1, Kyoko Tadokoro 1, Tomohiro Miyake 1, Manabu Tanimura 1, Koji Fujii 2, Hiroshi Yoshida 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2011.

---

	One case that preventive treatment for the vascular pain of 100 oxaliplatin succeeded Kabayama Tomoichi 1, Atsushi Shimizu 2, Hiroshi Morita 1, Katsumi Kurihara 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2011.

---

Examination of the factor involved in the protein urine expression in patients receiving 0101 bevacizumab Teruo Tsuchiya 1, Hitomi Shiga 1, Masahiro Yasuda 2, Osamu Umeda 2, Akira Tamura person 1, Natsuki Komada 1, Taku Ota rare 1, Tatsuya Takahashi 1, Tomoya Tate 1, Senju Goto 2, Teramachi eyes 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2011.

---

	Effect to give renal function of bevacizumab in 0102 colorectal cancer chemotherapy Yuji Shirai 1, Nao Yamada 1, Saori Tsuchida 1, Rie Matsunaga 1, Eri Kodaira 1, Masayuki Morita 1, Hiroaki Aoki 2, 横田徳靖 2, Hideaki Kurihara 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2011.

---

	Side effect expression of sorafenib situation - in chemotherapy - hepatoma patients for 0103 liver cancer Yoshie Isobe, Sei Suzuki, Kenta Sumiyoshi, 山口佳津騎, Takashi Motoki University, Naoki Shinohara, Masato Kachi, Shinji Kosaka, 福岡憲泰, 芳地一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2011.

---

	Side effect expression investigation in patients receiving 0104 sorafenib Yagi Kenta 1, Yoichi Kawasaki 2, Natsu Takemura Kei 1, Maki Okino 1, It is still 2 Matsunaga, Sendo Toshiaki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2011.

---

	Examination about the antinausea effect of Granisetron 3 mg and Palonosetron 0.75 mg on 0105 FOLFOX enforcement case Jin Kimura 1, 2, Yuko Kudo 1, Yutaka Ishikawa 1, Toshiaki Kato 1, Michihiro Shino 1, Kentaro Yamazaki 2, Hiroshi Yasui 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2011.

---

	Comparison about the antinausea effect of Granisetron 3 mg and Palonosetron 0.75 mg on nausea, vomiting at 0106 FOLFIRI therapy enforcement Yutaka Ishikawa 1, Yuko Kudo 1, Jin Kimura 1, Toshiaki Kato 1, Machida wish 2, Hiroshi Yasui 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2011.

---

Sorafenib doses for patients with hepatocellular carcinoma in 0107 this hospital and adverse event investigation Katsuyuki Takahashi 1, 2, Mizuho, Nakamura 1, 小池敦資 1, Tokuwa eyes Atsushi 1, Satoshi Ikeura Expo 1, Noriko Kawakami 1, Light river Yasuko 1, Takeshi Nishikawa 1, Katsuya Nagayama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2011.

---

	An effect of palonosetron in 0108 outpatient department chemotherapy and examination of the side effect Yoko Suzuki 1, Etsuko Shinohara 1, Sumiko Hiura 2, 野村充俊 2, 加藤裕芳 2, 佐々木英久 1, 松尾和廣 1, Tomoko Watanabe 1, Takashi Yoshio 1, Toru Asayama 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2011.

---

Trial of the pharmaceutical intervention to qualitative improvement of the treatment with 0109 altitude emetogenicity risk anticancer drugs Kanai friend Norie 1, 2, Chika Fujii 1, 2, Misako Fujino 1, 2, Precincts of a shrine Shunji 2, 3, Tomomi Oshiro 2, 3, Yoshiko Hamaguchi 2, 4, Chihiro Iseki 2, 4, 八野芳巳 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2011.

---

	Examination of the antinausea therapy in 0110 colorectal cancer chemotherapy mFOLFOX6, FOLFIRI therapy Kazuhito Abe 1, Tetsuya Kajimoto 2, Yukiko Muramatsu 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2011.

---

	Effect comparison of the 5-HT3 receptor blocker in patients who received induction therapy of 0111 acute myeloid leukemia Foot on the side of a mountain Toshiaki 1, Masahiko Obata 1, Kazuhiro Ozawa 2, Niimi Kansho era 3, Hideki Fujita 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2011.

---

	Fact-finding of the proper use of antiemetics in the cancer chemotherapy of 0112 gynecology regions Star madder 1, 2, Iga Yukako 1, Hiromi Zama 1, Hisashi Shimizu example 1, Miki Morioka 3, Junichiro Murayama 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2011.

---

	Evaluation - using evaluation -VAS of the antinausea therapy by the difference in 0113 cancer chemotherapy regimen Mina Yanai 1, Noriko Yamashita 1, Midori Nishikawa 1, Sumiyo Tatsumi 1, Takeshi Kimura 1, Noboru Okamura 2, Toshihiko Tomita 3, Hiroto Miwa 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2011.

---

	Evaluation - using intervention -VAS of the pharmacist to supportive care for nausea with 0114 cancer chemotherapy Noriko Yamashita 1, Mina Yanai 1, Midori Nishikawa 1, Sumiyo Tatsumi 1, Takeshi Kimura 1, Noboru Okamura 2, Toshihiko Tomita 3, Hiroto Miwa 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2011.

---

	Relation of the ward pharmacist in the antinausea therapy adequacy promotion by 0115 gynecologic cancer chemotherapy Yasushi Yamamoto University, Yukio Toyama, Tatsuya Muto, Hiroko Saito, Takaaki Hasegawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2011.

---

	Comparison of the antinausea effect before and after the use of aprepitant in Carboplatin-based chemothrapy in patients with 0116 non-small cell lung cancer First mountain Tae, Miyamaru Akina, Keisuke Otsu, Kengo Umehara, Yoshiko Wada, Young book Azusa, Hideki Sato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2011.

---

	Nausea and vomiting depression effect evaluation after the transplant pre-treatment regimen review based on 0117 antiemetics proper use guidelines Sanae Watanabe, Kana Okamura, Koichi Tamai, 田渡智子, Satsuki Kubo, Tomohisa Kurata, Takeshi Okutsu, Junko Ono Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2011.

---

	We look at the rear about the malaise onset in the high-risk group of 0118 antiemetics proper use guidelines and examine a mark Flood Mutsuko, Hiroshi Ueda, Osawa Machi child, Satomi Chihara, Tsutomu Igarashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2011.

---

	Examination of antiemetics for 0119 Low dose FP therapy Yuki Kanematsu 1, Risa Omori child 1, Tetsushi Kanematsu 2, Chinatsu Hasebe 1, Yoshiyuki Miyabe 1, Takehiko Kashiwa 1, Mitsuru Takai 2, Kazuko Hotta 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2011.

---

0120 emetic risks are the onset situation of nausea, vomiting of the cancer chemotherapy with moderate degree, the injection classified mildly Tomohiro Kakimoto, 野間口寛, Reiko Kirino, Takeshi Takahashi, Middle Yuka Kihara, Toyosumi Ayako, West Kyoko Tsuji, New top Kanako, Hiramatsu sheath, Morihiko Terashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2011.

---

	Investigation about the use situation and the effect of palonosetron which we looked at according to 0121 emetic risks Naoya Uto 1, Kei Yamaguchi Taro 1, 北森靖隆 1, Shinichi Akaboshi 2, Yasushi Yoshida 2, Ichimura line celebration 1, Kazuhiro Yasukochi 1, Katsuhiko Inoue 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2011.

---

	Investigation about the utility after the palonosetron induction in 0122 middle and high schools emetic risks regimen 永瀬怜司 1, Tomohiko Harada 1, Nanako Kashiwagi 2, Tomohisa Egawa 3, 赤瀬朋秀 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2011.

---

Nausea, vomiting at 0123 chemotherapy and examination of the efficacy of Inge Seto Ron hydrochloride tablets for the diarrhea Yoko Iwanaga 1, Keisuke Kakihara 1, Tomoyuki Inoue 1, Hirakawa Tomonori 1, Flat defense of a castle 2, Kyoko Koga 3, Masako Inoue 4, Keiko Morita 5, Kunio 1 between the fronts, Hidenori Harada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2011.

---

	Palonosetron in the antinausea therapy this hospital in the treatment with 0124 anticancer drugs stands and tests a position and an effect Kumi Nakamura, Ogre Toshihide Kubo, Masato Nakamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2011.

---

	Action to antiemetics proper use in 0125 chemotherapy Tomomi Saito 1, Kaoru Suzuki 1, Hiroki Ono 2, Toshiko Hosoya 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2011.

---

	Examination of the need of the 5-HT3 receptor blocker for 0126 mild (emetogenicity) risk anticancer drugs Atsuko Hosokawa, Yoshimichi Ogawa, 中島寿久, Shizue Kimoto, History of pail east love, Kazuhiro Ozawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2011.

---

	Examination of short hydration using the Mg in 0128 CDDP administration case Sawa draw, 藤元彬宏, 平郡薫, Sayuri Sakura, Kaori Kawahara, Tatsuhiko Ishida, Rie Ueda, Miyuki Sakurai, Eiji Fukui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2011.

---

	Evaluation of the effect that the in-hospital unification of the moisture load method at 0129 cisplatin administration gives for renal function Nakagawa Takehiro 1, Takashi Goto 1, Keita Uchino 2, Makoto Ishibashi 1, Naotaka Sakamoto 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2011.

---

	Risk factor search of the side effect expression of the GC (Gemcitabine Cisplatin) therapy in 0130 urology department regions Fukunaga Toyomi 1, Masayuki Nishihara 1, Description of Morikawa way 1, West storehouse Noriko 1, Hara University truth 1, Tomoya Tanabe 1, Koji Kimura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2011.

---

	Appropriate evaluation of the renal function using a serum albumin level in patients with 0131 head and neck cancer Eri Yajima 1, 3, 植沢芳広 1, Reiko Nozawa 1, Chiaki Ogawa 2, Megumi Yatabe 2, Naoki Kondo 2, Shinichiro Saito 2, 4, Yoshihiko Suzuki 2, Mori Kiminori 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2011.

---

	Action for the proper use of 0132 zoledronic acid hydrate Kentaro Okita, Yoko Nagao, Kazuhiko Tamura, Ayako Moriyama, Nakajima A Ichiro, Mie Ogata, Shinseki green, Kazuhiro Kondo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2011.

---

	The need of the levofloxacin doses setting in consideration of renal function degeneracy after 0133 anticancer drug administration Fumiko Imai, Shinichi Hikasa, Mina Yanai, Maemura finding, 荻有希恵, Takeshi Kimura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2011.

---

	One patient who received GEM+CDDP therapy for the renal pelvic carcinoma metastases to lung of 0134 hemodialysis patients Teruhiko Kamiya 1, Shunichi Endo 1, Tabei spirit city 1, 奥木宏延 2, Hiroshi Okazaki 2, Toshiyuki Nakamura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2011.

---

	Adverse event investigation by the difference in GFR calculation method at 0135 carboplatin optimal dose calculation 和賀信継, White field Masanori, Taeko Saito, Miyuki Minamikawa, Toshihiro Kumagai, Mt. Chiba Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2011.

---

	Examination about the myelosuppression at the gemcitabine administration in 0136 renal function degeneracy patients Yuko Date 1, Minoru Hayashi exhibition 1, 清水裕彰 1, Tomisawa 2, Takanori Kobayakawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2011.

---

Present conditions investigation of the expression situation and the symptom measures of the hand-and-foot syndrome with capecitabine in 0137 patients with breast cancer Hata Kojiro 1, Ryoko Udagawa 1, Ryuuto Yasuaki 1, 牧野好倫 1, Nobuaki Yokote 1, Yasuhiro Fujiwara 2, Hiroshi Yamamoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2011.

---

	The onset of cutis symptom situation and measures by 0138 Cetuximab Bell book Naoya, Landowner Takafumi, 吉嶋抄苗, Yuko Watanabe, Yoshiko Sasaki, Tomoaki Hatakeyama, Maiko Tokumura, Shohei Kawahara, Makoto Takahashi, Masaomi Tanaka, Tadahiro Aota Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2011.

---

	Eruption measures of the case that panitumumab +FOLFOX4 therapy was provided for the liver metastases that occurred postoperatively, and hepatectomized 0139 colon cancer 中村美樹, 平田和也, 松本直之, 鈴鹿修平, 多胡和樹, 大津山裕美子, 堀家有美子, 黄前尚樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2011.

---

	Retrospective fact-finding about the rash with 0140 pemetrexed 廣上典和 1, Tomoko Ishikawa 1, Fukutake Junko 1, Stone Senmi Kei 1, Yoshihisa Ishiura 2, Takayuki Inao 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2011.

---

	It is examined the supportive care for a hand-and-foot syndrome, stomatitis in doxorubicin 0141 liposome Keiichiro Matsuda, Yabuki gets along with each other, Nobukawa Masao, Hiroyuki Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2011.

---

	Onset of eruption investigation at the gemcitabine hydrochloride / paclitaxel combination therapy enforcement in 0142 patients with breast cancer Kanako Nakayama, Sachiko Izumi, Masahiro Ueda, Middle side Seiichi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2011.

---

Side effect report ... of the PLD therapy in the hospital attached to chemotherapy - Kagawa University School of Medicine for 0143 recurrence ovarian cancer Nami Minagawa, Sei Suzuki, Chihiro Okada, Rie Yamamoto, Hot water wisteria Yuko village, 藤本高成, Tatsuya Inoue, Masato Asakura, Sumio Kimura, Shinji Kosaka, 福岡憲泰, 芳地一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2011.

---

	Examination of the eruption onset time of IMiDs in 0144 multiple myeloma treatment Ayumi Nakamura, Koichi Nagaoka, Toshiharu Nomura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2011.

---

	About an onset of skin reaction factor with the docetaxel administration in 0145 Kure medical center breast surgical patients Yoshimichi Ogawa 1, 中島寿久 1, Atsuko Hosokawa 1, Shizue Kimoto 1, Kazuhiro Ozawa 1, Hitoshi Taniguchi 2, China Ogura 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2011.

---

	It is ... mainly on side effect investigation - hand-and-foot syndrome about the oral medicine of 0146 anticancer drugs Grass sincerity Harumi, Akemasa Imamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2011.

---

	Examination of side effect of Bendamustin measures for the purpose of the maintenance of 0147 quality of life Hiroshi Kudo, Tatsuya Mori, Naoki Kondo, Sanae Miyano, Chiaki Ogawa, Keiko Yoshino, Makoto Kobayashi Sachimi, Megumi Yatabe, Miyashita Kyuutoku, Yoshihiko Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2011.

---

	The expression situation of the vascular pain with the intravenous 0148 anticancer drugs and the actions to be taken Eri Konno 1, Reina Nishigaki 1, 牧野好倫 1, Koji Murakoshi 2, Nobuaki Yokote 1, Hiroshi Yamamoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2011.

---

	Investigation of the protective efficacy with NSAIDs for the vascular pain with 0149 GEM intravenous administrations and opioids Yuri Sakaguchi field 1, Kan Yukio 1, Junko Ishizaki 1, 崔吉道 2, Kenichi Miyamoto 2, Arai country three 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2011.

---

	Safe examination of the meloxicam combination at 0150 pemetrexed (PEM) administration Daisuke Nakanishi 1, Mutsumi Daimon 1, Ayako Deguchi 1, 畑地治 2, Fumihiko Komada 2, 柳川泰裕 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2011.

---

	Examination about the initiation time of 0151 pemetrexed pre-medication Shinohara Keisuke Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2011.

---

The directionality of side effect measures of the cancer pharmacotherapy is ... about antihypertensive medications to use for hypertension treatment of obtained example - bevacizumab by 0152 cancer boards Masahide Matsuzaki, Akira Maeda light, Tomoya Nagase, Noritake Kana, Michiko Tatematsu, 水谷旭良, Keiichi Kato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2011.

---

	Adverse event investigation in 0153 this hospital bortezomib decaDelon therapy 斉藤匡昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2011.

---

	It is compared the onset of peripheral neuropathy by the administration a week with the administration for every paclitaxel three weeks in 0154 this hospital Misa Matsubara 1, 2, Harada sheath or 1, 2, Hidenori Ogawa 1, 2, Keiko Tanaka 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2011.

---

	0155 Usefulness of Lafutidine prophylaxis against peripheral neuropathy with Oxaliplatin 三本松泰孝1, 平田力1, 棚谷貢1, 高橋理絵2, 丸山卓哉1, 手塚悠希1, 稲垣育宏1, 青木貴徳3, 須野学4, 松原和夫4, 柴波明男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2011.

---

	Hypomagnesemia with 0156 cetuximab worsens peripheral neuropathy of oxaliplatin Machiko Satomi 1, Toru Kawano 2, Yoshiaki Ebisawa 2, Chisato Naoyuki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2011.

---

	Examination for the onset of acute Colin symptom case with 0157 hydrochloric acid irinotecan Masahiro Yasuda 1, Osamu Umeda 1, Hiromi Ishihara 2, Michiko Hayashi 2, Yasushi Matsui 3, Senju Goto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2011.

---

	A present conditions investigation and analysis of the taste disturbance with 0158 chemotherapy Yoshihiro Yamanaka 1, Nabeta Izumi 2, Midori Kimura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2011.

---

	Side effect onset in the lapatinib capecitabine combination therapy of 0159 progress, recurrent breast cancer and examination about the treatment continuity Daisuke Ito, Mina Iwai, Okada sum intellect, 宇佐美英績, Michio Kimura, Toshiya Nakao, 吉村知哲, Tadashi Yasuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2011.

---

Difference in adverse event expression ... by examination - epirubicin (EPI) dose in 0160 breast cancer chemotherapy Kaori Matsumoto 1, South Takayuki 1, Junichiro Wakatsuki 1, Mountain Kuni Shimoshige 1, Seiichi Yamamoto 1, Tahara child 1 in total, Kazushige Furuya 2, Hiroshi Nakagome 2, Yoshio Kanemaru 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2011.

---

The combination situation of the antimicrobial agent for 0161 cancer chemotherapy patients and the metal cationic preparation and the onset of fever situation Yukari Ono, Tetsuo Yamaguchi, Naomi Mizuta, Hideaki Daimatsu, Atsushi Wada, Manabu Kume, Makimoto Hiroo, Tsuyoshi Hirano, Hirai green Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2011.

---

	Examination of a use situation investigation and the proper use of the filgrastim in 0162 Katsura, Kyoto Hospital blood internal medicine Tortoise rank Kohei 1, 土手賢史 1, Ayumu Nozaki 1, Yuka Kobayashi 1, Toshiko Aramiya 1, Hirokazu Nakanishi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2011.

---

	Premedication - for action - sweating prevention to 0163 colorectal cancer chemotherapy 1 that is Zao, Lower morning law of nature 1, Miki Takara 1, Tokuko Sasahara 1, Naoko Komiya 1, Shuichi Iwami 1, Yuko Kubo 1, Yutaka Ogata 2, Mieko Tsuruta 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2011.

---

The examination of the stress caused by 0164 aromotherapy reduction effect and clinical application to side effect measures in the cancer chemotherapy Inferior branch Sadahiko 1, Tomomi Okamura 1, Okazawa incense Tsu child 2, Yoshikazu Seino 2, Hiroki Kubota 1, Natsumi Masuda 1, Saori Nakagawa 3, 大和進 3, Shin Ota 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2011.

---

Examination of the utility of the team approach in medical care using the joint ownership sheet between species jobs in 0165 outpatient department cancer chemotherapy 河野優芙 1, Kenjiro Inaba 2, Maho Taguchi 3, Madoka Kita 2, Miyuki Tsukahara 5, Jun Arita 4, Yoshio Sakai 4, Shigeo Nakajo 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2011.

---

	Stand on the action of the cancer chemotherapy in the comparison - DPC Hospital of the hematotoxicity in 0166 TC therapy and weekly TC therapy; and ... Hironori Matsui, Imamura pasture employee, 武本千惠 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2011.

---

	Effect of granisetron on vomiting at anthracyclines + cytarabine therapy enforcement in patients with 0167 acute myeloid leukemia Takashi Goto 1, 3, Kazuki Tanimoto 2, 3, Makoto Ishibashi 1, Seiichi Okamura 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2011.

---

	Examination of the risk factor of the neutrophil in patients receiving 0168 carboplatin and thrombocytopenia Rie Hirai 1, Kazumasa Koshikawa 1, Isobe mildness 2, Eriko Suzuki 1, Takayoshi Kosugi 1, Sakae Honma 2, Kenji Nishizawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2011.

---

	Relation of a side effect investigation and the pharmacist after the molecular target medicine induction in patients with 0169 renal cell carcinomas 遠原大地 1, Wataru Takahashi 2, Takahiro Wada 2, Masatoshi Eto 2, Tsuyoshi Kojima 1, Yoshiteru Honda 1, Hideyuki Saito 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2011.

---

	Investigation associated with the onset of diarrhea with the triple-drug therapy for 0170 non-small cell lung cancer Mami Kobayashi 1, Keiko Ono 2, Kiyoshi Mizusawa 1, Satoshi Kishino 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2011.

---

	Side effect investigation of the MAID strange law therapy in 0171 bones soft tissue sarcoma Goto total Taro 1, Shunichi Miyamoto 2, Miyoko Kato 2, Yukihisa Imaizumi 1, Takahiro Gojima 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2011.

---

	Examination about the hematotoxicity of the Docetaxel, Cisplatin, 5-FU combination chemotherapy (TPF therapy) for 0172 head and neck cancer 牛之濱風見, 二川俊隆, Shogo Masuda, Mariko Ohba, Mina Ushiyama, Junko Arima, Ryuji Ikeda, 下堂薗権洋, Tatsuya Yamaguchi, Yasuo Takeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2011.

---

	Investigation of steroid withdrawal symptoms with 0173 CHOP therapy Hiroki Sugiyama, Seishi Harada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2011.

---

	The effect that difference in quantity of hydration at 0174 Cisplatin administration gives for renal function 西村知恭, Megumi Matsumoto, Yoshinobu Saito, Mugwort stand Yoko, 天野賀弘, 崎山晃宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2011.

---

	Evaluation of the supportive care that a pharmacist suggested in 0175 large quantities methotrexate therapy Tsuyoshi Aoyama 1, Hajime Sugiyama 1, Kazuo Sugita 1, Wataru Suzuki 1, Kazunori Kawakami 1, Seiichi Matsumoto 2, Toshihiro Hama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2011.

---

The actual situation of the chemotherapy enforcement for patients with 0176 non-Hodgkin's lymphoma 75 years or older and the cancellation factor Kitazawa sentence 1, Fumitaka Ise 1, Corner proton 1, Kumi Ueda 1, Head of a village intellect 2, Chihiro Shimazaki 2, History of Hisashi Takara 3, Teru Yokoyama reason 3, 杉井彦文 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2011.

---

	About an effect of pregabalin on peripheral neuropathy with 0177 cancer chemotherapy Shinichi Kitamoto, Yuko Yanagida, Shizuka Fujii, Tomohiro Furuya, 長崎信浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2011.

---

	Promotion of a use situation investigation and the proper use of the G-CSF preparation in 0178 cancer chemotherapy Okazaki summer true 1, Yasuhiko Sakata 1, Toshiharu Matsumoto 1, Shinichi Miyamori 1, Yasuo Iwamoto 2, Motoki Ninomiya 3, Open Koichi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2011.

---

Fact-finding - of the emergency visit consultation by the adverse event expression of 0179 - cancer chemotherapy patients Norifumi Miyamoto 1, Yutaka Takahira 1, Yusuke Takada 1, Satoshi Tanaka 1, 服部暁昌 1, Teruo Tanaka 1, Kazu Kobayashi truth 2, Crossroads daylight kernel 2, Morita Zhuang Jiro 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2011.

---

	Side effect expression of 0180 Doxil situation investigation 小松香織, 野村充俊, 木村麗砂, 増田信一, 日浦寿美子, 加藤裕芳, 浅山亨 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2011.

---

	0181 docetaxel, investigation about infection measures at the cisplatin combination therapy Yasushi Habu 1, Fumiko Onizuka 1, 深津祥央 1, Ikuko Yano 1, Shield Ichiro Tani 2, Juichi Ito 2, Toshiya Katsura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2011.

---

One case that developed hyperammonemia by 5FU and anaphylaxis with cetuximab in 0182 colorectal cancer chemotherapy, and suffered from treatment 岩下佳敬 1, Naomi Hasegawa 1, 中尾承司 1, Kimiyoshi Iwasaki 1, Yukiko Narumi 1, Kanae Nakayama 1, Akihiro Sonoda 1, Horai Mai 1, Kazuhisa Ishida 1, Akihiko Sakamoto 2, Hiroshi Imamura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2011.

---

	About the side effect expression of 0183 lenalidomide situation Chikako Shimokawa, Yukiyo Kinoshita, Katsuichiro Kamei Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2011.

---

	Retrospective investigation about the expression situation of the side effect "diarrhea" in patients receiving 0184 lapatinib and the use situation of the antidiarrheal drug Junya Tsutsui 1, Michiko Tatematsu 2, Masahide Matsuzaki 2, Koji Iwata 3, 室圭 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2011.

---

Mainly on adverse event measures - supportive care medicine explanation brochure in 0185 pharyngeal cancer chemoradiation treatment - Yasushi Aida 1, Adachi texture 1 to praise, Fence tail Naomi 1, Junko Tsujimoto 1, Takashi Nishio 1, Shuko Hashiguchi 2, Setsuko Nishioka 2, 岩江信法 3, Shunsuke Soejima 4, Hitoshi Okugawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2011.

---

The case that camostat mesilate mouthwash was effective for stomatitis with 0186 molecules target medicine Naoko Ishii 1, 3, Kazuko Sugano 1, Seiki Fujii 1, Ryuzo Okuda 1, Yotaro Aida 1, Megumi Ogawa 1, City Toei three stones 1, Hamano reason Takako 1, Mikako Matsumoto 1, Osamu Suzuki kernel 2, Komoda Masayo 3, Kimiko Makino 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2011.

---

	The present conditions of this hospital in the cardiac activity evaluation at 0187 trastuzumab administration and new action Harada sheath or 1, Misa Matsubara 1, Hidenori Ogawa 1, Toshihiro Kawaguchi 1, Toshi Takao Mie 2, Keiko Tanaka 3, Yasushi Irie 4, Yoshihisa Tanaka 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2011.

---

Construction of the in-hospital system about the oral antimicrobial agent as 0188 febrile neutropenia measures Fence tail Naomi 1, Naoko Shibata 1, Keiko Maruoka 1, Yasushi Aida 1, Junko Tsujimoto 1, Takashi Nishio 1, Saori Miyamoto 2, Chinami Hino 2, Mitsunobu Matsumoto 3, 根來俊一 3, Hitoshi Okugawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2011.

---

Medication history management induction of the cancer pharmacotherapy including 0189 oral anticancer drug monotherapy and the effect Koichiro Iwata 1, Masatoshi Saito 1, Yoshikazu Kobayashi 1, Kazue Soda 1, Yuko Sudo 1, Shinya Abe 1, Shinobu Matsumoto 1, Masayoshi Nishi beauty 1, Futoshi Saito 1, Kotobuki, Koji Masubuchi 1, 椎崇 1, Atsuta Koichiro 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2011.

---

	Making of the side effect assessment sheet at 0190 outpatient department cancer chemotherapy Landowner Takafumi, Naoya Suzuki, Yoshiko Sasaki, Yuko Watanabe, 吉嶋抄苗, Tomoaki Hatakeyama, Maiko Tokumura, Shohei Kawahara, Makoto Takahashi, Masaomi Tanaka, Tadahiro Aota Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2011.

---

	Relation of the pharmacist in 0191 outpatient department chemotherapy Yasuhiko Sakata 1, Takafumi Sugawara 1, Shingu flower gathering 1, Okazaki summer true 1, Toshiharu Matsumoto 1, Shinichi Miyamori 1, Yasuo Iwamoto 2, Motoki Ninomiya 2, Open Koichi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2011.

---

	About the evaluation of the checking prescription method of 0192 oral anticancer drugs and a utility of the pharmacist outpatient department 田瀬徹, Hidetaro Higuchi, Satoshi Azuma one, Takashi Yokokawa, Yoshiko Shibata, Yuko Hoshino, Kazunori Kawakami, Toshihiro Hama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2011.

---

	Action to effective doubt inquiry enforcement in 0193 outpatient department chemotherapy Satoko Yoshimura, Takahiro Ibaraki, Sangayama Hiroki, Pine Satoko Muro, Nishida sheath, Chikako Fukunaga, Hiroshi Tomita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2011.

---

	About participation in foreign cancer chemotherapy by the pharmacist in 0194 this hospital Excellent Wada Kosuke 1, Akihiro Kawanaka 1, Watanabe Tarou 1, Kazuhiko Morita 1, Yoshiko Murata 2, Emiko Kuroki 2, Kazuko Yasumura 2, Ryuichiro Sudo 3, Katsuhiro Yamada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2011.

---

	Inflection of monitoring and the oral medicine check list of the side effect of pharmacist situation in 0195 outpatient department chemotherapy Takako Watanabe 1, Aida Toshie 1, Mariko Tachibana 1, Naoto Tanabe 2, 山村康比古 1, Mieko Tanaka 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2011.

---

Action ... in the adverse event correspondence of the outpatient from practice - distant place of the staff collaboration medical care in 0196 local morphology outpatient department cancer chemotherapy Ko Hiraide stone 1, 5, Italy Tetsuya Saji 2, 5, Tadashi Sugiyama child 2, 5, Yasushi Yokoyama 1, Kazu Fujii rare 3, Takako Imazeki 1, Takeshi Kato 1, Yutaka Ozeki 4, 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2011.

---

	Examination about the importance of the side effect monitoring in 0197 outpatient department cancer chemotherapy Sayo Maruyama 1, Chikako Matsumura 1, 2, Nobuhiko Nakamura 1, Yukio Aomatsu 2, 3, Akira Takayama 1, Yoshitaka Yano 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2011.

---

	Evaluation of treatment with anticancer drug diary "chopsticks" in 0198 outpatient department chemotherapy Takeshi Iwasaki, Nabeta Izumi, Takahashi sand Yuri, Kazuyo Nakamura, Hiroaki Utsuki, Midori Kimura, Takashi Suzuki charges Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2011.

---

	Relation of the pharmacist in 0199 outpatient department chemotherapy 中尾真隆 1, Watanabe method man 1, Takuya Yamada 2, Tsutomu Sakai 3, Chieko Fuwa 4, Slope Kimiyo 4, Kato wealth Tomoko 4, It is still 1 Suguru Nishimura, Shiro Omiya 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2011.

---

Role of the patients support task in the foreign chemotherapy room by 0200 pharmacists Yuichi Kinjo 1, Kazuya Yamashiro 2, East Onna Takako 3, Seiji Kinjo 1, Naomi Noguchi 1, Kakazu light Kei 1, Hiroshi Ueda 1, Mina Tamaki branch 1, 久場磨紀子 1, Chika Kinjo 1, Is Kinjo; arrive; 1, Hazuki Nakamura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2011.

---

	Utility of the pharmacist intervention in 0201 outpatient department chemotherapy room Megumi Yatabe, Chiaki Ogawa, Makoto Kobayashi Sachimi, Hiroshi Kudo, Keiko Yoshino, Sanae Miyano, Tatsuya Mori, Miyashita Kyuutoku, Yasuo Ide, Yoshihiko Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2011.

---

	Good use of instruction support seat in the health insurance pharmacy for patients who received 0202 outpatient department cancer chemotherapy Toshimi Iizuka 1, 2, Kiyoshi Osanai Kei 1, Small Yuta Nozawa 1, Mio Tanaka 1, Masami Horiguchi 1, Tomoji Yoshiyama 2, Hideo Ishizuka 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2011.

---

	We see the rear about the treatment continuation factor to intervene that a resident pharmacist is effective for 0203 outpatient department chemotherapy room and examine a mark Yusuke Noguchi, Rie Asano, Tile Hiroko, Kiyotaka Omori, Keiji Matsumoto, Yoko Tokuyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2011.

---

Medication counseling duties of the foreign cancer chemotherapy in the hospital attached to 0204 Shiga University of Medical Science School of Medicine Sudo Seicho 1, 森井博朗 1, Miki Sakanaka 1, Tetsushi Noda 1, Yoshinobu Wakasugi 1, Fukutake Noriko 2, Yuki Kawai 3, Weight Eiji 3, 寺田智祐 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2011.

---

	... which thinks about a new establishment and the action ... one step advanced pharmacist duties of 0205 outpatient department chemotherapy room to pharmacist permanent residence Yagi Makiko, Masahiro Takada, Kazumi Morishita, Masako Kondo, Noge Ichiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2011.

---

	Drug control instruction to 0206 outpatient department cancer chemotherapy patients Megumi Kawamura, 小川智孝, Yuko Soga, Note village Mai, Iwaki Akifumi, Naoki Nishikawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2011.

---

About the emergency visit of the patients receiving treatment with anticancer drug in 0207 outpatient department chemotherapy center and the consultation situation of the diagnosis and treatment department outpatient department Goji Maeda, Atsushi Suzuki term, Daigo Suzuki, Toshiaki Sawada, Hiroshi Sakata, Hiroyuki Matsubara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2011.

---

	Through role - telephone support (oasis call) of the pharmacist in 0208 outpatient department chemotherapy - Kumagaya 1 required, Toshio Matsunami 1, Kyomi Kaneta 3, Mutsuko Okada 1, Genichi Nishimura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2011.

---

	Difference - of way - neighborhood health insurance pharmacy of medicine, the medicine cooperation about 0209 oral anticancer drugs and the family drugstore Hiroaki Usui, 野村久祥, 川上英泰, Yuichiro Abiru, Kozue Nakayama, Tadashi Yoshida, Takao Shinohara, 永井茂 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2011.

---

	Inflection of the medicine notebook in 0210 outpatient department chemotherapy Minoru Matsumoto 1, Upper pond Kazuko 1, Character Mika Hara 2, Naomi Yamamoto 2, Yano light 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2011.

---

	The use of the QR cord in the communication of 0211 cancer chemotherapy Hama Wuqing example, Nobuhiko Nakamura, Chikako Matsumura, Yoshitaka Yano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2011.

---

	Examination about the incompatibility of 0212 panitumumab 和田敦, 久米学, 槇本博雄, 平野剛, 平井みどり Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2011.

---

	It is ... about trial ... automatic checking prescription systems construction and internal use anticancer drug regimen registration to 0213 internal use anticancer drug proper use 辻井聡容, Kise Daisuke, Tomoko Wada, 中永 fragrance, 花垣徹, Takafumi Ogaki, Shoji Tada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2011.

---

	Insomnia investigation of 0214 outpatient department chemotherapy patients Satoshi Sato 1, 2, History of Sei Koshiba 1, 2, Takuya Uematsu 1, Kazuyo Endo 2, Kan Yutaka Otaka 1, Takafumi Ichida 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2011.

---

	Examination about the onset of allergic symptom with the anticancer drug in 0215 outpatient department chemotherapy Tomoko Matsuoka, 吉村知哲, Shino Adachi, Okada sum intellect, Tadashi Yasuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2011.

---

	One case of progress colorectal cancer which resulted in rapid thrombocytopenia during 0216 mFOLFOX6+Bevacizumab therapy Masatoshi Nakamura 1, Hiroko Takebe 1, Yu Kikuchi season 1, Hikichi hsiang tsai child 1, Seiichi Yasui 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2011.

---

	The onset of peripheral neuropathy situation under the Ca/Mg agent combination in patients who received 0217 XELOX therapy Masahide Sugiyama, Fumi Aoki, Atsushi Miura, Kazumi Yoda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2011.

---

	0218 A study on the implementation status of XELOX ± Bevacizumab (BV) therapy and mFOLFOX6 ± BV therapy in outpatient 生駒利恵子1, 服部雄一1, 倉持英和2, 奥山隆二2, 川井朋子1, 山崎智司1, 川辺桂太郎1, 水野裕実子1, 伊東俊雅1, 小林恵美子1, 高橋賢成1, 林和彦2, 木村利美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2011.

---

	Induction and evaluation of telephone support system (XTRA) in 0219 XELOX therapy Sasaki Noriaki, Junko Takahashi, 古元俊徳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2011.

---

Examination of the factor affecting the anaphylactic expression of patients with oxaliplatin administration colorectal cancer using 0220 cluster analysis Horinouchi Hironari 1, 2, Yuki Katagiri 1, 小中健 1, 2, Tsuyoshi Mori 1, 2, Toshi Nakamura oneself 1, 2, Soichiro Tajima 1, Miyoko Yamaguchi 2, Yukiyo Miki 2, Kazuhiko Teraoka 1, Hisatsugi U.S. Toshihide 1, Kazuyoshi Kawazoe 1, Kazuo Mizuguchi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2011.

---

	A side effect comparison between 0221 XELOX and mFOLFOX6 and examination of the side effect measures support of XELOX Chiharu Onoda 1, Midori Kimura 2, Nabeta Izumi 2, Hiroaki Utsuki 2, Yutaka Hayashi 1, 河原崎貴伯 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2011.

---

	Examination about an effective volume of infusion and the setting of the intravenous feeding time in consideration of nephrotoxicity before and after the administration of 0222 cisplatin 永野俊玲, Hisae Shinichiro, Yusuke Sato, Toshiharu Asakura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2011.

---

	Examination of the side effect of 0223 CDDP combination chemotherapy 薬師寺信匡 1, Flat comb Shinya 1, Koji Moriya 1, Yohei Koorogi 2, 吉岡弘鎮 2, Ko Tokuda period 1, Kazunobu Takayanagi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2011.

---

	Nephrotoxic evaluation in the foreign administration of the cisplatin component regimen using 0224 Short hydration Flat comb Shinya 1, 薬師寺信匡 1, Koji Moriya 1, Yohei Koorogi 2, 吉岡弘鎮 2, Ko Tokuda period 1, Kazunobu Takayanagi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2011.

---

Transition to outpatient department chemotherapy of the high-dose CDDP therapy by the short hydration method which used 0225 oral supplementary water liquid OS-1 together Yusuke Kojima 1, 2, Koga good luck greens 1, 2, Castle old daylight 1, 2, Island Emi 1, 2, Seiko Yokota 1, Country east connection 1, 2, Tsukasa Nakatani person 1, Box tree Yuriko 2, Kyoko Amo 2, Futoshi Imada Yoshiko 2, Kusu Tomomi 2, Katsufumi Miyamoto 3, Suguru Matsuoka kernel 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2011.

---

	Medication continuation of sorafenib in 0226 progress hepatoma patients and examination of the affector to give to adverse event expression 下雅意彩 1, 2, Fukudo Masahide 1, 深津祥央 1, Ikuko Yano 1, Toshiya Katsura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2011.

---

	Example that caused arms peripheral motor neuropathy, haematospermia during 0227 Panitumumab monotherapy enforcement Daisuke Hirate 1, Akiko Higashiya 2, Toru Nakamura 3, Hideto Yahagi 1, Hongo education 1, Seiji Sato 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2011.

---

Adverse event monitoring of pemetrexed using 0228 patients entry type sheet Kenichi Sakamoto 1, Chinami Ueno 1, Yoko Sakai 1, Masako Imada 1, Koji Kashimoto 1, 宅江良隼 1, Kengo Doi 1, Masahiro Yamazaki 2, 小副川敦 3, Tetsuzo Tagawa 5, Koichi Awaya 6, Yukiko Tamaoki 4, Masatoshi Taniguchi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2011.

---

One case of postoperative breast cancer that significant phlebitis developed after administration in 0229 docetaxel first time, and presented moderate allergic reaction by administration on the next time 小笠原信敬 1, Koji Okada 1, Akira Masuda 1, Yuji Koyanagi 1, Yuko Furusawa 2, Maki Sasaki 2, Shin Usami 3, Katsuhiko Sato 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2011.

---

	Correspondence to allergic reaction of 0230 docetaxel + cyclophosphamide therapy Mieko Kishi, Toshiyuki Matsubara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2011.

---

	Fact-finding ... of perionychia, the fissure in the presence or absence of skin reaction - 5-FU combination by 0231 Cetuximab Kaoru Kobayashi, Akira Takagi Kei, Yasuhiko Mimura, Atsushi Kato, Isao Adachi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2011.

---

	Examination of the effective usage of 0232 Doxil (R) notes 今村牧夫, 尻無浜未佳, 武本千惠 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2011.

---

	Investigation of the side effect of bortezomib in 0233 elderly people institutions Naoya Okumura 1, Kazuhiro Fukami 1, Kubokawa Naomi 1, Miki Kobayashi 2, Katsumi chapter 2, Takeshi Noro 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2011.

---

	Induction of 0234 oil xanthan gum (R) therapy and the evaluation Yoshiko Shibata 1, Yuko Hoshino 1, Tomoyo Nakano 1, Hidetaro Higuchi 1, Yutaka Kato group 1, Tomoko Takahashi 1, Kazunori Kawakami 1, Yoshinori Ito 2, Toshihiro Hama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2011.

---

	One case that was effective in Gosha-jinki-gan after onset of 0235 neuropathy Yagi Hideaki, Masashi Hashimoto, Higashijima good luck way, Mutsumi Nishikawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2011.

---

	Example that we attended the informed consent of the physician in 0236 outpatient department, and a pharmacist was able to be involved in in therapy for appendix cancer choice 伊與田友和 1, 浦住幸治郎 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2011.

---

	About the expression situation and correspondence of hypersensitivity in 0237 outpatient department chemotherapy 小川丈彦 1, 渡壁美香 2, Kazuaki Kawano 3, Naoyuki Miyano 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2011.

---

From examination - patients background of the factor which has an influence on the usability of 0238 portable chronofuser - Kensuke Uemura 1, Mitsuru Susa 1, Yasuko Kotake 1, Mitsusachi Suzuki 1, Akiko Tamura 1, Yoshinori Ando 1, Yumi Takahashi 2, Kumiko Horikawa 2, Nobuyuki Musha 3, Teru Honma 4, Tomoteru Kamimura 5, 神田循吉 6, Hiroyuki Wakabayashi 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2011.

---

	Use fact-finding of the XC therapy in 0239 this hospital 北森靖隆 1, Naoya Uto 1, Kei Yamaguchi Taro 1, Ichimura line celebration 1, Kazuhiro Yasukochi 1, Hitomi Goto 2, Katsuhiko Inoue 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2011.

---

	Attitude survey of the medical staff for the psychological care team in 0240 Saga Hospital Masashi Hashimoto 1, Higashijima good luck way 1, 2, Yagi Hideaki 1, 2, Teruyo Hiwatari 1, 3, Akito Enjoji 1, 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2011.

---

A problem of the psychological care in this hospital judging from the use situation investigation of 0241 opioids and role of the pharmacist Kenta Takahashi 1, 5, Rumi Hiyama 1, Tomoko Matsuura 2, 5, Mayumi Sakagami 2, 5, Shigeto Sakuta 1, Yuichi Sekizawa 1, Kazuya Konishi 3, 5, Hideo Takayanagi 4, 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2011.

---

	Relation of psychological care and the ward pharmacist in 0242 Masuda Medical Association Hospital 西迫多重 1, 宅野真由美 2, Yuri Kawakami beauty 2, Bank high Namiko 3, Shinji Hattori 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2011.

---

	Cooperation systems construction of 0243 psychological care teams and nutrient support team Junko Nakanishi 1, 2, Sachiko Takahara 1, 3, 加福夏織 1, 篠永浩 1, 3, Tsunekazu Harada 1, Tsutomu Kachi 1, Eiji Mukai 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2011.

---

	Analysis of the psychological care team intervention effect in 0244 this hospital Kazuma Amino 1, 2, Aiko Fujimori 1, 2, Miwako Hayashi 1, Masayoshi Oguchi 1, 浜至寛 1, Osamu Atobe 1, Tomomi Sasaki 2, Mutsumi Hashizume 2, Kenji Takekawa 2, Kotaro Gomi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2011.

---

	Medical narcotic proper use by 0245 psychological care team intervention Ryoji Takahashi 1, Shiori Shimada 1, 松本佳剛 1, Ueda exhibition charges 1, Yukiko Yamaji 2, Yoshiyuki Onishi 2, Kazue Shinno 3, Michio Oda 4, Eiji Yamanaka 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2011.

---

	Action aiming at qualitative improvement of the psychological care in 0246 this hospital Shiho Takamura 1, Tomoyo Miyagi 1, Akiko Kuroda 1, Yumiko Fukui 1, Ueda 11 1, Noriko Terakawa 1, Kazumi Amano 2, Yoshie Fukushima 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2011.

---

It is ... for appropriate pharmacotherapy based on evaluation of the action after 0247 psychological care team operation and future problem - WHO method cancer pain therapy Yumi Matsumoto 1, Yoshihiko Matsuki 1, Toshiaki Onuki 1, Asami Yasuda 1, Tatsuya Suzuki 1, Akiko Shinoda 1, Hiroko Asai 1, Takahashi Yuka 1, Noriko Mishima 1, Noriko Iwasa 1, Arinobu Yumi 1, Kenichi Sugiura 1, Eriko Takahashi 1, Country Yasuhiro tree 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2011.

---

	Study on stability of 0248 high dose morphine hydrochloride water Ayumu Fujiwara 1, 2, Imamura pasture employee 3, Naoko Yamada 1, Hironori Matsui 3, Kentaro Katayama 3, Eizo Takahashi 4, Shin Hanioka light 4, 介 4 of Takashi Okamoto, Shizuo Narimatsu 4, 名倉弘哲 2, 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2011.

---

	Examination about the drug release of 0249 fentanyl percutaneous absorption type preparation Every field Chieko 1, Masada Kazuki 1, Yuichiro Kayano 2, Toshiaki Nakamura 2, Mikio Masada 2, Etsuko Miyamoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2011.

---

	Competitive review about an effect, the usability in the fentanyl patch of 0250 two kinds Kusakabe young of sweetfish 1, Bank former Maki 1, Nagasato, Miyazaki child 1, Momoko Fujise 1, Sato Kei sinter 1, Rika Fukui 2, Akeda Katsuyuki 3, Kazuki Kikuchi 1, Many islands Takahiro 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2011.

---

	Attitude survey about the fentanyl once a day pasting preparation by the questionnaire for 0251 nurses Keiko Hara 1, Chiyo deferred Takako 1, Shinji Yamaguchi 1, Toru Nakamura will 1, Kazuki Kashimoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2011.

---

One case that the number of rescue decreased by the changes from a type preparation to a daily type preparation on attitude survey and 3rd to a nurse after the type preparation induction on 0252 fentanyl 1st Yuichiro Baba 1, Kazuhiko Fujita 1, West Hikari 1, Saori Morita 2, Fumihiko Matsuno 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2011.

---

Utility of blood fentanyl densitometry in the use of 0253 fentanyl pasting preparations patients Ukuru Watanabe flat 1, Ryoichi Yano 1, Satoshi Takano early 2, 武澤江合子 1, Tomoe mountain path child 1, 根來寛 1, Kawamichi 1, Misato, Takashi Azuma 1, Toshiaki Igarashi 1, Yuichiro Kayano 1, Toshiaki Nakamura 1, Mikio Masada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2011.

---

Examination of the utility about the change to the induction of the fentanyl infusion for the patients needing pain relief in 0254 early stages and a fentanyl MT patch Watanabe method man 1, 4, 安村幹央 2, Takuya Yamada 3, Toyoo Nita 3, Shigeru Kiyama 3, Masao Niwa 3, Keiko Yamamura 4, It is still 1 Suguru Nishimura, Shiro Omiya 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2011.

---

	About the induction of the fentanyl citrate patch in 0255 this hospital Junko Ishimi, 森睦, Shinobu Arimoto, Yukako Ono, Middle Mie Hama, Yoshie Mori, Yukiko Shiraki, Eriko Harada, Kawabata Noriyoshi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2011.

---

	The investigation of the consciousness change for the medical drug for 0256 commoners and examination about the need of the enlightenment Kazuyoshi Manabe, Chikako Matsumura, Naho Matsuoka, 地嵜悠吾, Nobuhiko Nakamura, Akira Takayama, Yoshitaka Yano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2011.

---

	Patient compliance instruction to the use of drug patients for cancer pain in 0257 community pharmacy Naomi Yamaguchi 1, Tomoko Watanabe 1, Toshie Ota 2, Harumi Ito 2, Etsuko Shinohara 1, 佐々木英久 1, 松尾和廣 1, Takashi Yoshio 1, Akito Nonaka 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2011.

---

	A relation and image to the medical drug of the staff concerned with at-home practice judging from 0258 questionnaire results Koji Takizawa, Satomi Nishizawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2011.

---

	Cancer pain control in 0260 ward permanent residence Megumi Yoshida, Hiroshi Matsuzawa, Noriko Ishii, Mariko Negishi, Yoshiko Noji, Funatsu Kumi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2011.

---

Prescription pulse-taking - according to the drug clinical condition for cancer pain management - medical care in 0261 this hospital Tadami Chieko 1, Shun Ito elegant 1, 2, Katsura, Kawabe Taro 1, Tomoji Yamazaki 1, Mai Ishibashi 1, Toshinori Hirai 1, Maiko Nakao 1, 越智隆揮 1, Masako Miyazaki 1, 高橋賢成 1, Toshimi Kimura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2011.

---

	About clinical application for the purpose of effect on blood flow in study on 0262 Mohs paste - mouse and the hemostasis - Maho Taguchi 1, Nobuo Izumo 2, Yasuko Takemori 3, Takashi Toyota 3, Satoshi Kaneko 4, Keiko Tsuge 1, Mikio Hayashi 1, Masaki Ishikawa 1, Masato Shigeyama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2011.

---

	The preparation of the carbamazepine tablets connotation type suppository for the purpose of 0263 inside the hospital formulation and examination of the utility History of Ai Fukushima, Atsuko Saito, Isamu Murata, Yutaka Inoue, Masayuki Kimura, Ikuo Kanemoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2011.

---

Nausea, suggestion ... from use experience - this hospital psychological care team of aprepitant for vomiting which was not as effective with the antiemetics of 0264, etc. 南園奈七恵 1, 2, Tsuyoshi Hirayama 2, Katano bare sincerity 2, Shingo Ono 2, Miyuki Kuno 2, Noriko Terakado 2, Naoko Shimazu 2, Toshiyuki Takahashi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2011.

---

Attitude survey results for examination and the use of the use of zoledronic acid at the initial treatment in the bone metastases case for 0265 lung cancer and examination for the change of the consumption Gilt bronze Yoko 1, 田宮基裕 2, Tomonori Hirashima 2, Masashi Kobayashi 2, Norio Okamoto 2, Hidekazu Suzuki 2, Naoko Morishita 2, Yuka Matsuura 2, Shangdong Masumi 1, Yuya Fukuchi 1, Usui Naoko 1, Keiko Fujita 1, Kazuko Shimura 1, Nobuhisa Fukushima 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2011.

---

	Examination of the pain intensity at 0266 opioid analgesic initiation Kaoru Kato, Mt. Misen Hideyoshi, Hiroshi Tomita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2011.

---

	Clinical evaluation of pregabalin in 0267 cancer pain treatment Takeshi Nakamura will 1, Mikiko Mochizuki 1, Satoshi Fukunaga 2, Sakae, Inui your picture 2, Kazushige Murakawa 2, Takeshi Kimura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2011.

---

	0268 One case in which the sense of security, satisfaction could be migrated to the resulting home by pain control using the PCA pump 續木康夫1, 宮井絢美1, 中村慶1, 和田洋忠1, 山内紀美2, 山田麻美子3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2011.

---

	Examination from the reduced value in 0269 opioids rotations Chinatsu Hasebe, Risa Omori child, Yuki Kanematsu, Yoshiyuki Miyabe, Takehiko Kashiwa, Kazuko Hotta Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2011.

---

	1 case of the biliary tract cancer that prescribed it for 0270 cancer pain positively, and supported it, and was given opioid combination Kazutaka Hiraga, Hiroshi Yamamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2011.

---

	About the fluid therapy for patients with 0271 end-stage cancers Hiroshi Maki tree, Akito Hosoda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2011.

---

	Comparison of the closed system connection appliance at 0272 anticancer drug preparations Tatsuro Fujii, Tomoko Suzuki, Kotaro Kawamoto, Shiyo Yamada branch, 関根有貴, Ayako Kato, Seina Noda child, Kadomura Shota, Mina Takeuchi, Yuko Fukuda, Asano still, Tatsuya Ito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2011.

---

	0273 Attempt to anti-cancer agents exposure mitigation using the closed-type administration system (Chemosafe (R), ChemoCLAVE (R)) 秦英司, 栢木啓介, 大谷豊司, 椎木芳和, 高根浩, 大坪健司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2011.

---

	Problems of closed system instrumentation and the sterile preparation treatment charges in 0274 anticancer drug preparations 俣賀隆, Hideki Kinoshita, The Amagasaki path of righteousness Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2011.

---

	Examination of the safety improvement at anticancer drug preparation by the use of closed system connection appliance connection of 0275 two species 中山季昭, Tadashi Watanabe, Daisuke Takei, Chiaki Moriya, Toshiki Musha Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2011.

---

	Than present conditions and problem - questionary survey of the injectable anticancer drug preparation in 0276 Akita ... 菅原馨悟 1, Katsuhiro Saito 1, Taguchi poetry rare child 1, Jin Yoshida 2, Hisao Kanazawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2011.

---

Closed quantitative examination second report in 0277 closed system drug mixture appliances 宮松洋信 1, Yoichi Osato 1, Iga Chinatsu 1, Sachiyo Sudo 1, Momoko Tomioka 1, Early part Hiroko 1, Komi Yoshiyuki 1, Fumiko Maruyama 1, Akira Miyazato bud 1, Toshihiko Hirano 2, 横山智央 3, Takao Akashi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2011.

---

	Anticancer drug exposure to 0278 closed system connection appliances measures by the induction Shuhei Suzuka, Kazuya Hirata, Naoyuki Matsumoto, Kazuki Tago, Miki Nakamura, Great Yumiko Tsuyama, Person of moat Yumiko, Naoki before yellow Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2011.

---

	Role of the pharmacy in the closed system device choice at 0279 anticancer drug preparations Hiroko Takahashi, Shiro Hozumi, Nobuaki Miyagi, Hiromichi Sugawara, Hisakazu Sotooka, Takeharu Nakajima, Miho Suzuki, Yokohama Taeko, Takuji Watanabe, Megumi Ota, Rie Shoji, Setsuo Tsuchiya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2011.

---

	Attitude survey for 0280 anticancer drug exposures, education for patients Motoi Kurahashi still, 眞継賢一, Yuko Nakao, 上田浩貴, Tomoko Okamoto, Ken Koba, Yasuhiko Tsukamoto, Yoshihiko Hamaguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2011.

---

	Attitude survey about the anticancer drug exposure in 0281 this hospital Tomoya Nagase 1, Akira Maeda light 1, Masahide Matsuzaki 1, 中川千玲 1, Makiko Ohara 2, Kanae Tozaki 2, 水谷旭良 1, Keiichi Kato 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2011.

---

	About the induction of action - closed system system of preventive measures against 0282 anticancer drug exposures - Naoko Oikawa 1, Kunihiko Chiba 1, Kayoko Yoshida 2, Mayumi Sakamoto 2, 1000, Ibonai Keiko 2, Yumiko Chiba 2, Hiroshi Takahashi 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2011.

---

	Need - of the educational intervention about a relation and the prevention of of the pharmacist in 0283 cancer nursing workshops evaluation (the second report) - anticancer drug exposure Masato Wakabayashi 1, Etsuko Hatakeyama 2, Nakazawa one net 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2011.

---

	Pollution investigation of the anticancer drug preparation environment at use of 0284 closed system anticancer drug preparation appliance F seal systems Toshihiro Hama, Wataru Suzuki, Kazuo Sugita, Tsuyoshi Aoyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2011.

---

	0285 About enlightenment activity of the anticancer agent radiation exposure prevention in Kin-ikyo Central Hospital 菊池健1, 佐藤春香1, 郡淳二1, 瀬戸宏典1, 鶴山辰1, 岡本麻子2, 小澄悦子3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2011.

---

	A construction and evaluation of 0286 remote anticancer drug mixed injection support systems which we can inspect Koji Okada, 小笠原信敬, Yuji Koyanagi, Akira Masuda, Katsuhiko Sato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2011.

---

	Construction of 0287 anticancer drug mixed injection inspection systems Shigeru Kuramoto Ichiro 1, Rope book Masami 1, Daisuke Ogawa 1, Kawasaki Genko era 1, Yasushi Ooi 1, Hitoshi Taniguchi 1, 市場泰全 1, 國原将洋 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2011.

---

	The present conditions and problems of the regimen system of administration to think about from 0288 change of prescription examples Shinya Tamaki, Shinya Takada, Yoshihiro Naito, Masahiko Takasaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2011.

---

	Induction and action of the cancer chemotherapy regimen system in 0289 electronic charts 彌冨恵, Hiroshi Goto kernel, Lesser horn beauty Yuki, Yukiko Komiya, Ichiro Ota, Hirofumi Koike, 西川能治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2011.

---

	Induction of 0290 "drug information offer paper automatic output systems according to the cancer chemotherapy regimen" Tomoko Kawai, Slope Reiko Tanba, We bear the oak shallows, Yuichi Hattori, Yutaka Fukaya, 高橋賢成, Toshimi Kimura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2011.

---

	Approach toward the in-hospital elimination of the cancer chemotherapy information using 0291 inside the hospital LAN 高橋さおり, 我妻央陽, 大後友紀子, 吉村美恵子, 並木敏明, 桑原國男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2011.

---

	Making of the internal use anticancer drug manual to an outpatient being aware of the communication tool with 0292 patients Akihiro Noda, Kazuhiro Yamada, 眞下惠次, Kayo Kimura, Taki Kazuo, Katsuhiko Sakaguchi, Hiroko Hatai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2011.

---

	0293 Attempt to degrade various anti-cancer agent that remains using a photocatalyst in a safety cabinet : Usefulness of Chemo clean evaluation 佐藤淳也1, 2, 工藤賢三1, 2, 瀧本功3, 三林正幸4, 梅澤友和5, 雉鼻一郎6, 高橋勝雄1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2011.

---

	Action to 0294 cancer chemotherapy standardization Koto Fujiwara 1, 敦見真由美 1, Shinichi Nakamura 2, Hiroya Masuda 3, Nobuko Matsuura 4, Akiko Takagi 5, 更岡学 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2011.

---

	Relation of the pharmacist to cancer chemotherapy in the cottage-hospital out of one of 0295 order ring systems non-enforcement Kumiko Sako, Yoshiki Ayukawa, Tomoko Shiota Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2011.

---

	Chemotherapy duties ... regimen management using 0296 Microsoft Access and patient compliance instruction ... Tadashi Tazawa, Old Shigekazu Tanida, Hiromitsu Itakura, 円崎信也, Osamu Tomishima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2011.

---

	Systems construction - using action - spreadsheet for the efficiency of 0297 cancer chemotherapy-related duties 行本拓史, 徳丸茉理子, Yuka Sugimoto child Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2011.

---

	A tendency and evaluation of the doubt inquiry example in 0298 cancer chemotherapy electronic charts regimen system induction Atsushi Suzuki term, Daigo Suzuki, Goji Maeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2011.

---

	Making of the medication history management paper for anticancer drug checking prescriptions for 0299 injections Masumi Mori, Takeshi Sasao, Hidekazu Sato, Kiyotaka Kawazumi, Yoshiharu Kato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2011.

---

	Improvement of 0300 anticancer drug protocol registration methods and criteria for use of food additives Noriko Ishii 1, Osamu Abe Eiko 2, Yoshiko Noji 1, Funatsu Kumi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2011.

---

	The use that made chemotherapy critical path link a cancer chemotherapy support system in 0301 this hospital respiratory apparatus internal medicine Ogiwara enthusiast chapter 1, 神原康佑 1, Keiko Hara 1, 神原弥由 3, Ikuko Nishii 3, Toshiaki Okada 2, Shingo Harita 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2011.

---

	We estimate it as a construction of the support from 0302 chemotherapy to terminal phase Kenichi Ito 1, Yuki Mihara 1, 秋吉史久 1, Mika Shuto 1, Kaori Miyazono 1, Masanori Komaki 1, Eri Muta summer 1, Shirao uniformity 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2011.

---

Duties improvement - that we utilized anticancer drug injection mixed expansion and safety measures (the first report) - infection link nurse round of conducting affairs in 0303 health longevity medical center Mikio Shirota 1, Shunichi Miyamoto 1, Kaida Kosuke 1, 早舩美保子 1, Masanori Takigawa 1, Period flat Yuichi 1, Kagoshima Momoko 1, Miyoko Kato 1, Nami Tesaki 2, Eriko Kano 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2011.

---

	It is ... about an effect after the approach (the second report) - a lot of confirmation sheet introduction aiming at improvement of the quality of 0304 cancer chemotherapy prescription checking 星野真之, 小池恭士, 藤田恵子, 郷原哲, 篠塚一美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2011.

---

	Revision of the drug control instruction blotter of hospitalization, the outpatient in 0305 chemotherapy Hiroyuki Shimizu, Kensuke Hirooka, Eiko Yoneta, Tanaka pine Ichiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2011.

---

	About the review of 0306 cancer chemotherapy regimen Takashi Otsuji 1, 胡井俊祐 1, Shuhei Miyakawa 1, Naoki Yao 1, Toshihiko Yoshioka 1, Fumiaki Yotsumoto 2, Takashi Suzuki world 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2011.

---

	Effective regimen examination by the analysis of 0307 chemotherapy registration applications Takahiro Arai, Toshiaki Kogure, Eriko Hiruta, Fumi Mukoda, Aki Kuwahara, Taeko Saito, Yaeko Mishima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2011.

---

	Significance of the pharmacy leadership in the sectional meeting specialized in 0308 regimen examination Yasuyo Fukuda, Masumi Miyakawa, Nakagawa spring, Osamu Konishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2011.

---

	About the doubt inquiry by the pharmacist in 0309 cancer chemotherapy Mitsue Uno, 坂井伸成, Hideaki Kato, 中村尚未, 佐澤佳彦, Takashi Hiraga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2011.

---

	Contribution to cancer chemotherapy adequacy judging from the analysis of 0310 doubt inquiry examples Tomohiko Harada, 永瀬怜司, 赤瀬朋秀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2011.

---

	About a difference of the reception for the patient compliance instruction in patients with 0311 cancers and patients with other disease Utako Iwakiri 1, 2, Toshio Kubota 1, Daisuke Kobayashi 1, Keiji Suenaga 3, Takao Shimazoe 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2011.

---

	Fact-finding of the doubt inquiry in 0312 cancer chemotherapy Kaori Yamamoto, Yoko Okabe, Chikako Sawada, Yumi Yamada, Seiichi Takamatsu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2011.

---

	Action ... of the evaluation ... regimen system of administration non-induction institution of the utility of the cancer chemotherapy administration management table in 0313 this hospital Tokita spring Ichiro, 眞中章弘, Junichi Higuchi, Yukiko Sahashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2011.

---

Offer and feedback ... of action ... patients information of the medicine medicine cooperation in 0314 oral anticancer drugs Naoko Tsuji, Hitomi Kawaguchi, Masaki Manda, Miyuki Miyake, Kaori Ozaki, Keiko Noguchi, Takami Fujii, 野際俊希, Yasuko Takinami, Depths Kahori, Small bath Takako, Shigeo Asai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2011.

---

	Medication support to the molecular target drug remedy patients in 0315 ethical pharmacy Asami Takasawa, 小林詩朗, Minako Tsuchida, Naoto Niwa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2011.

---

	Discussion - that we saw it from a contribution article to present conditions - Japanese Society of Hospital Pharmacists magazine of the study about cancer medical care of 0316 hospital pharmacists and clinical pharmacy Emiko Okamoto 1, Masaichi Kuroyama 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2011.

---

	Examination about the adsorption to the transfusion filter of 0317 anticancer drugs 山之内恒昭, Yasuhiko Mimura, Atsushi Kato, Isao Adachi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2011.

---

Fact-finding about 0318 imatinib doses and proper use 合澤啓二 1, 11, Tomoko Kitaoka 2, 11, Naoya Uto 3, 11, 政賢悟 4, 11, Yasuaki Otsubo 5, 11, It is still 6 Matsunaga, 11, Kondo New Year's Day 7, 11, 濱田哲暢 4, 11, Eiko Fukunaga 1, Toshiyuki Matsuda 8, 11, Hiraga former 9, 11, 寺田智祐 10, 11, Hideyuki Saito 4, 11 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2011.

---

	Examination of the example that became the disposal after an anticancer drug preparation in 0319 this hospital Yoshimi Eguchi, Korekawa koto picture, Mayumi Hatano, Shigeru Ishii Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2011.

---

Fact-finding about the interaction in 0320 warfarin and pyrimidine system antineoplastic combination patients fluoride Kuni Isobe finally, Yasuaki Otsubo, Mayuko Ito, Hiroko Hiraoka, Tomoyuki Oka, Kunihiro Tsukahara, Light end Takayo, Gain Narihiro, Hiroyuki Watanabe, Shiro Mitsubori, Takeshi Yamamoto, 俣賀隆 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2011.

---

	Effect of the rhea apothecaries measure by the difference of the needle at 0321 injection preparations Jun Taga 1, Shunji Ishiwatari 1, Hideki Fujita 2, 3, Nishida measure three 1, Ayako Kita 1, Reiko Sugiura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2011.

---

Analysis and drug control instruction of the adverse event of the lenalidomide therapy for 0322 multiple myeloma Katsuyuki Nakamura 1, Rev. Noda original 1, Yutaka Yasui 2, Hiroshi Ikeda 2, Toshiaki Hayashi 2, Tei Ishida husband 2, 篠村恭久 2, Kazuyuki Murase 3, 井山諭 3, Tsutomu Sato 3, 瀧本理修 3, Small boat Masayoshi 3, Junji Kato 3, Hiroshi Nakata elegant 1, Atsushi Miyamoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2011.

---

	Examination of weight loss, the cancellation factor of capecitabine in 0323 colon cancer postoperative adjuvant chemotherapy Miwa Yonezawa, Chiyoko Yamada, South Kenichi, 柏原宏暢, Katsuichiro Kamei Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2011.

---

	It is a 1 case using Mohs'paste for the advanced breast carcinoma that 0324 disintegrated Miho Yamazaki 1, Yukiyo Funakoshi 1, Side Taiken 1, Katsuaki Takeda 1, Yasushi Nakamura 1, Mamoru Takahashi 2, Akira Hirashima straight 3, Akemi Koshino 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2011.

---

	The effect that an assay date and the time lag of the marker date and time give to a marker rate in 0325 Zevalin markers Gain book Shuji 1, Flat comb Shinya 1, 薬師寺信匡 1, Ko Tokuda period 1, 石守崇好 2, Kazunobu Takayanagi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2011.

---

	Examination about the effect of the DNA demethylation inhibitor in colorectal cancer cells in consideration of 0326 circadian rhythm Natsuko Matsumoto, 田中章太, Hitomi Matsumoto, 水野顕慶, Mao Ogawa, Mika Ikehata, Kumiko Ueda, Seigo Iwakawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2011.

---

	One case of the childhood adrenocortical carcinoma that blood level monitoring was useful in postoperative adjuvant chemotherapy with 0327 mitotane Kuniaki Moriki 1, 2, Hiroshi Takane 1, Kazuko Inoue 1, Yoshikazu Shiiki 1, Kenji Otsubo 1, 鞁嶋有紀 2, Keisuke Okuno 2, Junichi Ueyama 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2011.

---

	Example that an erlotinib repeated dose for 0328 lung adenocarcinoma was effective Hitoshi Taniguchi 1, Rope book A true 1, Daisuke Ogawa 1, 市場泰全 1, Keiichi Fujiwara 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2011.

---

Action of the pharmacist for the cancer chemotherapy appropriate management including 0329 internal use anticancer drugs Terumasa Sata 1, 2, Satoshi Yamaji ordinary 1, Kimotsuki Miho 1, Pond increase sweetfish beauty 1, Shrine gate Takanori 1, Kazuko Tanaka 1, 2, 3, Kayoko Maruyama 2, Uemura eyes 2, 3, Hiroyuki Nagahama 2, Hiroshi Nishijima male 2, 3, 前之原茂穂 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2011.

---

Correspondence to the crazing of the transfusion line with 0330 fluorouracil sustained injection Tatsu Sada still, Mayumi Matsumoto, Ryuji Nagae, Yuji Okamoto, Chika Masumoto, Yuka Takenouchi, Ota friend Rie, Takahashi sub-Mana, Riyusuke Rokusha, Kenichi Hasuike, Yukiko Uchiyama, Keigo Ezaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2011.

---

Fact-finding about 0331 sorafenib doses and proper use Yasuaki Otsubo 1, 11, Toshiyuki Matsuda 2, 11, 合澤啓二 3, 11, 政賢悟 4, 11, It is still 5 Matsunaga, 11, Tomoko Kitaoka 6, 11, Naoya Uto 7, 11, Hiraga former 8, 11, Kondo New Year's Day 9, 11, 濱田哲暢 4, 11, Hiroyuki Furukawa 1, 寺田智祐 10, 11, Hideyuki Saito 4, 11 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2011.

---

Evaluation of the patient education in consideration for patients costs burden of 0332 antineoplastic Kamura Motoki 1, Natsuko Hashimoto 1, Naoya Ueno 1, Tomoko Kubota 2, Saori Ogata 3, Mera spirit Ichiro 1, Kioroshi Shiori 1, Hiroshi Yoshimatsu chapter 1, 1 which is related to Fukushima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2011.

---

	Change of the quality of life affector before and after the adjuvant postoperative treatment of 0333 patients with breast cancer Your Onodera evening 1, Tetsu Iwase 2, 3, Takashi Kawaguchi 1, 2, Megumi Umeda 2, Hiroki Takeuchi 1, Yoshinori Nanun 2, 畝崎榮 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2011.

---

	Examination about the consumption change of the G-CSF preparation for 0334 colorectal cancer chemotherapy regimens 古元俊徳, Sasaki Noriaki, Junko Takahashi, 宮之下美穂 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2011.

---

	Relation of the pharmacist in the postoperative pharmacotherapy induction of the patient with breast cancer with 0335 underlying disease Hiroshi Hashimoto season 1, Kyoko Shinozaki 4, Ikuko Yamaguchi 4, Takaaki Tanaka 2, 村上通康 1, Shozo Senba 1, Yumi Oshiro 3, Hiromichi Inoue 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2011.

---

	Than the investigation of cancellation, the change example of comparison ... treatment of 0336 mFOLFOX6 therapy and XELOX therapy ... Katsuya Tanizawa, Makiko Takaya, Keiko Taguchi, Miura A, Koji Matsunami, Hideji Endo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2011.

---

	The present conditions of evaluation criteria of "alcohol irritation" associated with 0337 paclitaxel administration and one discussion Yoshiharu Kuroi 1, Katsuhiro Kondo 1, Junko Kuroda 1, Tetsuo Ezaki 1, Tetsu Kimura sum 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2011.

---

Examination of the utility of eGFR in 0338 zoledronic acid administration situation investigation and renal function evaluation Liujiang Masatsugu 1, 2, Mariko Nakao 3, Fujiwara season Yoshiko 3, Camellia Masahiro 2, Yuji Hirose 1, Tetsuya Morita 1, Yuzuru Yamazoe 3, Nishida measure three 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2011.

---

Examination ... of the cyclophosphamide resolution out of the air with trial - photocatalyst air cleaner of the anticancer drug being bombed reduction of 0339 healthcare workers Kenzo Kudo 1, 2, Junya Sato 1, 2, Takahiro Hirano 3, Takayuki Kuwajima 3, Kazuhiko Sato 4, Katsuo Takahashi 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2011.

---

	Examination about the white agglutinate removal to occur after 0340 L-asparaginase decomposition 中島寿久, Yoshimichi Ogawa, Atsuko Hosokawa, 森貞尚之, Shuichi Nishizawa, Kazuhiro Ozawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2011.

---

	Examination of the risk factor of the onset of hyperammonemia in 0341 mFOLFOX6 therapy 三角紳博, Hiroki Oishi, The Takashi Miyoshi method, Fish well Miyuki, Furumi Kazuhiro, Hiroko Yamauchi, Kazuaki Ueda, Toshihiro Matsumoto, Makoto Ishibashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2011.

---

	Effect of nonsteroidal antiinflammatory drug (NSAIDs) which gives it to 0342 pemetrexed Masako Ito 1, Masayuki Miyazaki 1, Seishi Kondo 2, Yoshinori Hasegawa 2, Taku Nagai 1, Kiyobumi Yamada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2011.

---

	Search of the prognostic factor of 0343 erlotinib remedy patients Carpenter Naomi Hara 1, Atsushi Miura 1, 両角延聡 2, Kazumi Yoda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2011.

---

Action for the sorafenib medication continuation to patients with 0344 liver cancer Fujiko 1 between the fortune, 2, Terumasa Sata 2, Satoshi Yamaji ordinary 2, Kimotsuki Miho 2, Pond increase sweetfish beauty 2, Shrine gate Takanori 2, Kazuko Tanaka 2, Kayoko Maruyama 3, Flat Seiya Mine 4, Yoshiro Baba 4, 前之原茂穂 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2011.

---

Onset of myelosuppression and infection situation investigation in patients receiving 0345 lenalidomide Rina Ito 1, 2, Ayumi Nakamura 2, Aiko Fukui 2, Naoki Mukoyama 2, Tetsushi Kanematsu 2, Atsushi Tomita sum 1, 2, Kenji Miyazawa 2, 森章哉 2, Yuka Tanaka 2, Katsuhiko Haneda 1, 2, Yoshiaki Ikeda 2, Satoru Kato next 2, Masao Maeda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2011.

---

	Association of leukopenia and the recurrence in the adjuvant postoperative treatment (UFT/LV therapy) of 0346 colorectal cancer Tomiko Sunaga 1, Shuji Suzuki 2, 小池伸定 2, Naramoto under-secretary 1, Yagi Akihiro 1, Harada sincerity ratio old 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2011.

---

	It is ... from economic effect - granisetron by the antinausea therapy review of 0347 cancer chemotherapy of 3 mg to 1 mg from economic effect - granisetron by the antinausea therapy review of 0347 cancer chemotherapy Kenji Katsuragawa 1, 牛膓沙織 1, Fumihiko Yoneyama 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2011.

---

	Association between 0348 Body Mass Index and side effect expression in the mFOLFOX6 therapy Keiichi Ono 1, 2, 寺田智祐 1, 3, Toshiya Katsura 1, Kenichi Inui 1, 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2011.

---

	1 case that presented hyperammonemia during 0349 mFOLFOX6 therapy Chisato Kawahata 1, Maiko Akatsu 1, Tsubotani Ayako 1, Hiroshi Matsumoto 1, Shigeo Hatta 1, Yuko Sakashita 1, Kyoji Yamada 2, Keiso Masuhara 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2011.

---

	About the anticancer drug doses to 0350 obese patients and association with the adverse event expression Tsuyoshi Miyahara 1, 2, Child 1 too rare Mochinaga, 奥平献 2, Fujito Expo 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2011.

---

	We give R-CHOP therapy in divided doses in patients with malignant lymphoma of 0351 advanced age and are experienced the case avoiding Serious Adverse Event Chika Aruga, Lower Shigemitsu example, 伊與田友和 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2011.

---

	About the use situation of antiemetics (NK1 receptor blocker and new 5HT3 antagonist) in 0352 this hospital Tetsuya Sakamoto, Tomoaki Toyama, Atsuo Otsuka, Chiaki Koshikawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2011.

---

	Rituximab + bendamustine combination therapy - for use case study - non-Hodgkin's lymphoma of the new anticancer drug for 0353 blood disorder Koji Moriya, 薬師寺信匡, Ko Tokuda period, Kazunobu Takayanagi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2011.

---

	Association with time and laboratory values to determine cancellation of 0354 cancer chemotherapy Kazuto Sato 1, Toshiyuki Hirai 1, Seki Toshikazu 1, Kamiga Masahiro 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2011.

---

Comparison of Relative Dose Intensity in 0355 progress, mFOLFOX6 therapy and XELOX therapy introduced by first-line treatment for recurrent colorectal cancer Kazuyuki Sunada 1, 三阪高春 2, Kishimoto truth 1, Ogyou Yukiko 1, Long ヶ Takuma Hara 1, Yoshimura truth 1, Yayoi Shinmura 3, Zhongcheng Yuki 3, Michiyo Taniguchi 3, Hirofumi Wakamatsu 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 241-241, 2011.

---

	Quality of life investigation of colorectal cancer hospitalization chemotherapy patients in 0356 this hospital Kensuke Hirooka, Hiroyuki Shimizu, Eiko Yoneta, Tanaka pine Ichiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 241-241, 2011.

---

	About the effect that vibration gives to 0357 etoposide crystallization Toshihiro Otani 1, Manabu Hisamatsu 2, Color river Masanori 1, Kondo good luck 1, History of Shigeru Inose 1, Seiichi Shimizu 3, Shinichi Ueno 2, Kenichi Horikoshi 1, Tokiwa English sentence 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 241-241, 2011.

---

	Relation of the pharmacist to the lenalidomide remedy patients in 0358 this hospital Kazuhiro Nakamura 1, Hideaki Anzai 2, 井出眞 3, Kawachi Yasunori 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 241-241, 2011.

---

Classification of the chemotherapy regimen by the scoring of the preparation degree of difficulty of 0359 anticancer drugs Yuji Ishio, 谷口亮央, Shigeru Sato, Tokutome chapter, Mari Kashimura, Hatsumi Kikuta, Miki Katsuragawa, Jun Matsunami, Ryu Kobayashi, Hideji Ohara, 目黒亨治, Muki Ryoji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 241-241, 2011.

---

	Making of the drug duties manual in 0360 lenalidomide (Revlimid (R)) treatment Masanobu Ogawa, Tomoki Yoshioka, Takayoshi Tsuruta, Mariko Kinoshita, Ayumi Ozeki, Mayumi Yamashita, Akemi Morita, Quantity lower Hiroko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 241-241, 2011.

---

	About the apoptotic instruction effect of the new Vitamin K3 derivative on 0361 leukemia cell line Takashi Kawakubo 1, 2, Satoru Asami 1, Maya Arai 1, Masaharu Toriyama 1, Zenichi Yoshida 3, Shigeyasu Motohashi 1, Takashi Suzuki 1, 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2011.

---

Fact-finding about 0362 erlotinib doses and proper use Minoru Hayashi exhibition 1, Tomoko Kitaoka 2, 12, Naoya Uto 3, 12, Hiraga former 4, 12, Kondo New Year's Day 5, 12, Yasuaki Otsubo 6, 12, 政賢悟 7, 12, 合澤啓二 8, 12, Toshiyuki Matsuda 9, 12, Takanori Kobayakawa 1, 濱田哲暢 7, 12, It is still 10 Matsunaga, 12, 寺田智祐 11, 12, Hideyuki Saito 7, 12 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2011.

---

	Reciprocity effect of the curcumin which gives it to 0363 anticancer drug susceptibility Shimada Mikiko, 峯垣哲也, Comb village Rie, Hiroko Kawano, Kana Fujibayashi, Atsushi Mizumoto, Tomoyo Tsuzuki, Tadashi Takashi Sumida, Asuka, Yamamoto, Masayuki Tsujimoto, 西口工司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2011.

---

	Effect of the prescribed drug which gives it to the fall fall accident in patients with 0364 cancers and various kinds of risk factors Keisuke Takahata 1, 2, 植沢芳広 2, Reiko Nozawa 2, Original Hideki Sawa 3, Mori Kiminori 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2011.

---

	Development of the injectable pirarubicin hydrochloride (for the TERAL vicine injection) dissolving in 0365 normal saline solutions immediately Junichi Kaneshige 1, Teruhisa Yoshizawa 1, Takashi Murata 2, Hisashi Watanabe 2, Daisen truth 2, Masato Ota 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2011.

---

	Examination of the effective intervention method for the purpose of 0366 carbapenem system antimicrobial agent proper use 舩越真理 1, Yuko Miyabe 1, 森麻巳 2, Masahiro Tsuda 1, Seiko Ono 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2011.

---

	Inspection of carbapenem antibiotics doses judging from 0367 PK/PD 穴田充孝, Kumi Narita, Eri Ishida, Mina Matsuoka, Kunihiko Murooka, Michi Nojima husband Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2011.

---

	Action for the proper use of the carbapenem-based medicine antimicrobial agent in 0368 JA Yoshida General Hospital 只佐宣子 1, Chinatsu Shigemori 2, Shinya Kajitani 1, Kazuya Tokumoto 1, 要田芳代 1, Keiko Kawakami 1, Bamboo increase Mayumi 1, Keiko Hirahara 2, Shunji Horikawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2011.

---

	Comparison of the survival rate by the difference of the duration of 0369 carbapenem system antimicrobial agent use Ryota Uehara, Rie Kobayashi, Satoshi Otake Noriko, Yuka Kitagawa, Wataru Arai, Yuichi Masuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2011.

---

	Attitude survey of the prescription situation and the physician of 0370 antiinfluenza medicine Yukako Yasui 1, 2, Takuji Fujimoto 2, Takayuki Okamura 2, 八野芳巳 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2011.

---

We investigate making and an observance rate of the administration guideline for 0371 antiinfluenza medicine proper use Manabu Yokota 1, 2, High Suma Rina 1, 2, Makoto Hashimoto Kiyo 2, Hitoshi Murase 2, Komaki Hirose 2, Yuka Sugiura village 2, Forest good luck 2, Tsuyoshi Takeuchi 2, 松野匡克 2, Terumi Suzuki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2011.

---

	Approach to fact-finding of the use of 0372 peramivir and proper use 米沢牧子1, 2, 一ノ瀬直樹1, 2, 土橋直子1, 3, 小田智三1, 4, 芝崎健志1, 2, 青木茂行1, 5, 小林隆1, 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2011.

---

	Intervention effect for the proper use of levofloxacin based on 0373 renal function Shiori Takahashi, Yuji Okamura, Shinichi Ohara, Shiro Itagaki, Early hunting truth Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2011.

---

Effect of the high-dose preparation (500 mg of Cravit (R) locks) induction to give to the use situation and the chemical sensitivity of 0374 levofloxacin tablets Takayoshi Tsuruta 1, Tomoki Yoshioka 1, Kazuhisa Kinoshita 2, Mariko Kinoshita 1, Masanobu Ogawa 1, Ayumi Ozeki 1, Mayumi Yamashita 1, Akemi Morita 1, Quantity lower Hiroko 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2011.

---

	Comparison of the effect of treatment for starting medical supplies of the generic medicine in the ciprofloxacin for 0375 injections Aspect shrine Koji 1, Kenji Miyazawa 1, Makoto Hayashi 1, Akemasa Yamaya 1, North Toshiyuki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2011.

---

	Intervention based on the protocol by the pharmacist for 0376 vancomycin hydrochloride proper use and the effect 石川友貴, Izumi Shimada, Naoko Iwaki, Mizuho Onishi, Akemasa Yamaya, Aspect shrine Koji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2011.

---

	An action and evaluation of the pharmacy for 0377 antiMRSA medicine proper use Masashi Tomita, Takashi Motoki, Masahiro Takayanagi, 千田泰健 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2011.

---

	Standardization of administration plan and the proper use evaluation of 0378 antiMRSA medicine 小川智孝, 80 Shizuka Shima, 平野雅予, Yuko Soga, Small wasabi, Akira Iwaki sentence, Naoki Nishikawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2011.

---

	Pharmacist intervention effect to drug choice in 0379 Clostridium difficile-related diarrhea Koji Fukuda, Ayako Ajioka, Osamu Tomishima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2011.

---

Examination of the factor affecting the full dose of the vancomycin hydrochloride powder in treatment, the sanitization of 0380 Clostridium difficile infection or patients suspected of infection 佐々木雄啓 1, Aya Fujimoto 1, Ayumi Kochi 1, Kosuke Mukoda 1, Masaaki Ikemoto 1, Hitomi Hirata 2, Sawa Akihiro 2, Toyohisa Tsukamoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2011.

---

	Fact-finding of the prophylactic antimicrobial agent in 0381 laparoscopic cholecystectomy Tomoji Ishizu 1, Mutsumi Yoshioka exhibition 1, New Yasunori 1, Triangular pile Masakazu 1, Spring Fujiwa charges 2, Tamaki Orita 3, 渡雅克 1, Atsuko Kobayashi 3, Masahiko Takenaka 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2011.

---

	Cerebrospinal fluid transitivity of vancomycin for 0382 bacterial meningitis 山本倫数, Takeshi Morimoto trunk, Mieko Suzuki, The Yasushi Yokoyama method, Naoko Isoda, Yasushi Osato chapter Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2011.

---

	Effect of the hearing investigation from the pharmacist by the use of 0383 investigation system to a physician Yumi Kubo 1, 4, Katsumi Hirata 2, 4, Yumi Matsushima 3, 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2011.

---

Examination of the factor affecting the treatment of 0384 Clostridium difficile toxin-positive patients and the recurrence Naoko Kanazawa 1, 2, Kazuaki Matsumoto 1, 2, 茂見茜里 1, 2, 郡山豊泰 2, Hiroaki Miyanohara 2, Hideki Kawamura 2, Michiyo Orita 2, Junnichiro Nishi 2, 猪川和朗 3, Norifumi Morikawa 3, 下堂薗権洋 1, Yasuo Takeda 1, Katsushi Yamada 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2011.

---

	Examination about the chemical sensitivity of antimicrobial agent consumption for 0391 proper use and the main clinical separation germ 近藤匡慶 1, Field stake Naoya 1, 菅谷量俊 1, Keiko Ono 2, Satoshi Kishino 2, Kazuya Murata 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2011.

---

	An action to 0392 antimicrobial agent proper use and change of AUD by the generic drug induction Yoshiyuki Tate 1, Oyama reason Takae 1, Inside light Mikio 1, Katsumi Asano 1, Eishin Takahata 1, Yuko Muramoto 2, 又野禎也 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2011.

---

	We examine result of the use intervention of the report system antimicrobial agent in 0393 ICT 市川騰 1, Tomoko Hiraiwa 1, Yumiko Yano 2, Hisao Takahashi 3, Circle Sumiyo 4, 友安浩 5, Keita Ichikawa 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2011.

---

The injectable use of antimicrobial agent all patients practice by the pharmacist specialized in 0394 of a check and the evaluation Yasutaka Shinoda 1, 3, Takashi Niwa 1, 2, Akio Suzuki 1, Satoshi Omori 1, Mitsuru Yasuda 2, 太田浩敏 2, Ayumi Fukao 2, North city Kiyoyuki 1, Katsuhiko Matsuura 1, Satoshi Murakami male 2, Tadashi Sugiyama 3, Yoshinori Ito 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2011.

---

	Relation to the antimicrobial agent proper use by 0395 ICT charge pharmacists Atsushi Ishida world 1, 2, Naomi Nakamura 1, Emiko Kawano 3, Sangayama Hiroki 1, Harumi Takenouchi 2, Hideo Nakaya 2, 4, Hiroshi Tomita 1, Koya Masaki 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2011.

---

Injectable antimicrobial agent consumption change and susceptibility rate (from an investigation for 3 years) of 0396 Tohoku District Rousaibyoins Hajime Nakai 1, Kazunari Nakamura 1, Katsuhiro Sekino 2, Koji Ito 2, Takuji Watanabe 3, Setsuo Tsuchiya 3, Tamotsu Terunuma virtue 4, Kazumasa Kaneta 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2011.

---

	We weigh it about change of the use of antimicrobial agent situation in 0397 this hospital and the susceptibility Hironori Seto 1, Haruka Sato 1, Takeshi Kikuchi 1, County Junji 1, Crane mountain dragon 1, Hiroko Morishita 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2011.

---

	Examination about the efficacy of the cefotiam using local data in 0399 children upper respiratory infection 丹代恭太, Susumu Kudo, 蒲澤一行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2011.

---

	Examination of the effect of treatment of ceftazidime for 0400 febrile neutropenia and the cefepime Kaori Sakurai 1, 森章哉 1, Rika Nakajima 1, Yukiko Kawamura 1, Yuji Bessho 2, Yuko Nakamura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2011.

---

Effect of treatment for a use trend and the pneumonia case of 0401 tazobactam / piperacillin Chie Yamaguchi 1, Shigeki Nakane 1, Kaneji Miyahara 1, Yoshinori Nakata 1, Tomoko Sato 1, Yoko Tawada 1, 石本昌裕 1, Yoshikatsu Mizutani 1, 朝日慈津子 2, Akihiro Matsushita 3, Kazuhiko Machida 3, Masaki Matsuo 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2011.

---

	We look at the rear about the use actual situation of the tazobactam piperacillin in 0402 this hospital and investigate a mark Mariko Sugita, Toshiyuki Matsubara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2011.

---

	Examination about use fact-finding of 0403 Tazobactam/piperacillin and the proper use The flat tomorrow beauty, It is Sachiko in a camp, Yukino Urata, Lower stone Kazuki, Eiko Fukunaga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2011.

---

If the prescription support of the patients with the renal function degeneracy is demanded a new face pharmacist 0404; about administration plan of GFR level in - antimicrobial agent administration and MEPM - Toshihiko Ishizaka, Mika Kimoto, Hamada rabbitfish, Yukari Yoshihara, Makoto Fukushima, 高橋直継, Masashi Nakagawa, Miyatake wish, U.S. Hara non-origin, Haruyo Matsunaga, Tokuyama picture life, Naoki Ogawa, Junji Mukai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2011.

---

	Use fact-finding of the linezolid in 0405 left ventricle ventricular assist device wearing patients 藤末慎1, 越智裕之1, 和田恭一1, 老田章1, 小原延章1, 藤田知之2, 戸田宏一2, 宍戸稔聡3, 堀由美子4, 瀬口理4, 村田欣洋4, 簗瀬正伸4, 中谷武嗣4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2011.

---

	It is a 2 case using the linezolid for the MRSA deep part infection after 0406 spinal operations 迫田菜穂, 永原紀子, 坂口智香, 奥田みどり, 奥田佳子, 吉田正一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2011.

---

	One case that a blood level increased 0407 Arbekacin after administration in articular muscle Small thicket Makiko, Makoto Ishibashi, Hiroki Oishi, Nozomi Arima, Toshihiro Matsumoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2011.

---

	The prospects from the use of teicoplanin actual situation in 0408 this hospital It is still the beginning Tsuda, Aiko Onda, Otsuki swamp male, Parent pine Takahiro, 川嵜英二, Takashi Toyota Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2011.

---

	Proper use investigation of MEPM using 0409 Time above MIC analysis software Aya Omuro 1, Mt. Kobayashi 1, 2, Kazuhiro Hayakawa 1, 2, Yuichi Yano 1, Mitsuo Sakamoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2011.

---

	Use situation investigation of the antifungal agent for the candida blood flow infection in 0410 Hiroshima City Hiroshima Municipal Hospital Takafumi Sugawara, 村上礼隆, Nobue Uetake, Toshiharu Matsumoto, Hiroshi Wada, Shinichi Miyamori, Open Koichi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2011.

---

	It is ... along antifungal agent proper use - candidemia guidelines in 0411 this hospital Naoko Shirane, Toshiko Ota, Sumiko Hiura, 加藤裕芳, Toru Asayama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2011.

---

	Comparison between effect of treatment - oral ivermectin and transluminal administration - for the duration of treatment in 0412 scabies treatment Naoaki Shimizu 1, Masahiro Yasue 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2011.

---

	Present conditions investigation of 0413 drug resistance gram-negative bacilli 滝波昇悟, Auditor Hideo, Akemasa Imamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2011.

---

	Examination of the factor to affect during the use of antimicrobial agent situation in 0415 urinary tract infection and a light period Masaaki Ikemoto, Kosuke Mukoda, 佐々木雄啓 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2011.

---

	1 case that we made de-escalation from carbapenem system to aminoglycoside system from a point of view of 0416 antimicrobial agent proper use Emiko Tanaka, Shiho Hirahara, Chizuru Shirokami, Tomoko before good luck, Tasuku Kawai levator, Norifumi Nakajima, Junko Terada, 前田頼伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2011.

---

	Likelihood of the antimicrobial agent proper use to be able to see from 0417 AUD level and chemosensitive rate 篠原由憲 1, Yuichi Izumi 1, Long Yuji Mine 2, Satoshi Kamoshita 3, Seki Yukiko 4, Minako Tsukada 5, 樗木智聡 1, Masashi Shimomura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2011.

---

	Review of the vaccination program for 0418 staff risk of infection reduction High Suma Rina 1, 2, Manabu Yokota 1, 2, Makoto Hashimoto Kiyo 2, Hitoshi Murase 2, Komaki Hirose 2, Yuka Sugiura village 2, Forest good luck 2, Tsuyoshi Takeuchi 2, 松野匡克 2, Terumi Suzuki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2011.

---

	Ophthalmological infection rounds afferent utility in 0419 medical treatment wards Toshiaki Nakajima 1, 常友盛勝 1, Asako Ide 1, Ball Shiro Shima 1, Hidetoshi Kamimura 3, Eriko Fujiwara 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2011.

---

	Investigation of the onset of infection situation in patients with 0420 methotrexate remedy articular rheumatism Morihiro Okada, Miki Segawa, Kimi Sakata, Masae Tsuji, Haba Hisae, Hiroaki Mizuno, Origin of Takeda, It is moisture in the west Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2011.

---

	The expansion of 0421 TDM enforcement drugs and effect by the drawing blood order induction for TDM Satoru Takeyama will 1, 2, Tadashi Tahara cord beauty 1, 八本聖秀 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2011.

---

	The content change after the subdivision preparation of 0422 marketing sterilization finished benzalkonium chloride practical use concentrations liquid and study about the microbial contamination Kazuaki Takishima, Yukihiro Hamada, Yoshinobu Sasaki, Masaichi Kuroyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2011.

---

	Action to an adoption product change of 0423 sodium hypochlorite preparation Oyama reason Takae 1, Yoshiyuki Tate 1, Masao Niiyama 2, Eishin Takahata 1, Yuko Muramoto 3, 又野禎也 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2011.

---

Antimicrobial agent consumption investigation (the second report) of the Tokyo-affiliated institution using 0424 ATC/DDD systems Mikako Nakano 1, Junichi Suwa 2, Mariko Kurosawa 3, Pine Yoshimitsu child 4, Miki Horiuchi Expo 5, Mariko Oe 6, Koichi Kawase 7, Small Saussurea Root Satoko 8, Takahashi sincerity 9, Yasuhiro Sasaki 10, Look at Shimazaki Kei; 11, Mariko Negishi 12, Mamoru Sato 13, Yumiko Umezaki 3, Funatsu Kumi 12 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2011.

---

The use trend of the antimicrobial agent using 0425 ATC/DDD systems and appropriate management by the ward pharmacist Aida sheath or 1, 久岡清子 1, 2, Kenji Sasaki 1, Yuki Nishitani 1, Naomi Akinaga 1, North residence Miki 1, Interval Chiharu 1, Kanuma Nao 1, Takashi Kameoka 1, Upper teacher Hisayuki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2011.

---

	Examination about consumption and the susceptibility of the antimicrobial agent in the acute phase elderly people special hospital using 0426 ATC/DDD systems Masanori Takigawa 1, Mikio Shirota 1, Mamoru Sato 1, 鈴木礼乃 4, Eriko Kano 2, 稲松考思 3, Miyoko Kato 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2011.

---

	Change of the antimicrobial agent consumption before and after 0427 antimicrobial agent report system induction Akira Katayama rare 1, Jitsukawa Orient 1, Keiko Fukuda 1, Mitsunori Hino 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2011.

---

	Examination of the antibiotics proper use using 0428 AUD 大島良康 1, Maiko Kaji 1, 宮森勇昌 1, Yohei Mizuguchi 1, Kawabuchi Kumiko 2, Mari Sasaki 2, Mai Kawai 2, Keiko Kanda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2011.

---

Action of the antimicrobial agent consumption surveillance in 0429 Ehime 田中亮裕 1, Inami existence 2, Yuki Shinohara 3, Mayumi Nakahira 4, Masafumi Ono 5, Takashige Asakawa 6, Jin Machida 7, It is still person 8 Tagashira, Ryosuke Akizuki 9, Hisashi Otsuka 10, Shozo Senba 11, Hideki Mukai 12, Fukumoto piece beauty 13, Shinichi Watanabe 1, 末丸克矢 1, Hiroshi Araki positive 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2011.

---

The effect that 0430 anti bio grams and antibiotic regimen support using the Gram stain gave to antibiotic consumption and Pseudomonas aeruginosa susceptibility Yoshihiko Matsuki, Toshiaki Onuki, Yumi Matsumoto, Asami Yasuda, Akiko Shinoda, Tatsuya Suzuki, Hiroko Asai, Takahashi Yuka, Noriko Mishima, Arinobu Yumi, Noriko Iwasa, Kenichi Sugiura, Eriko Takahashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2011.

---

	The number of the antimicrobial agent in 0431 this hospital of use, the use days, the count of the dosage regimen and investigation of the chemosensitive rate Toshiaki Onuki, Yumi Matsumoto, Asami Yasuda, Akiko Shinoda, Tatsuya Suzuki, Yoshihiko Matsuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2011.

---

	Change of antimicrobial agent consumption and the susceptibility with 0432 generic drug changes Mariko Aota, Masashi Sakano, Hajime Sano group Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2011.

---

Questionnaire findings - about activity report - ICT of 0433 2010 Ishikawa infection control special committees and TDM activities Miyuki Ishida 1, 2, Saeko Kondo 3, Ayumi Miyazaki 3, Hiroyuki Ikeda 1, 4, Satsuki Ito 1, 5, Yoshiyuki Goto 1, 6, Kiyoshi Sasayama 1, 7, Hiroaki Mizuno 1, 8, Kenji Miyazawa 1, 9, Yasuhiko Yamamoto 1, 10, It is moisture 1 in the west, 8, Aspect shrine Koji 1, 9, Kenichi Miyamoto 1, 5, Akihiro Tada 1, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2011.

---

	The need of the use of antimicrobial agent intervention of the pharmacist judging from a use of 0434 antimicrobial agents report book presentation rate Matsushima greens, One river Etsuko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2011.

---

	Fact-finding about 0435 infection control and the action Ayako Sugiyama, Koichi Hirose, 斎藤孝啓, Look at the field seedling; Erika, Kazumi Kuribayashi, Ichiro Arakawa, Sakae, Adachi tree, 安西偕二郎, Yoko Kubota Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2011.

---

	Fact-finding about activity and the action of the pharmacist in 0436 infection control Koichi Hirose, Ayako Sugiyama, Kazumi Kuribayashi, Ichiro Arakawa, Sakae, Adachi tree, 安西偕二郎, Yoko Kubota Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2011.

---

	Action ... to the antiMRSA medicine proper use for patients with activity - infection with MRSA of the infection control team in 0437 nosocomial infection measures Kenichi Kobayashi 1, Akemi Kawakami 2, Star Shuichiro 3, Takeaki Nishibori 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2011.

---

	0438 ICT inauguration first anniversary : Ingenuity of cooperation with it, other occupations that have been working 原田七穂, 武本千恵 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2011.

---

	Examination of the risk factor about 0439 Clostridium difficile-related diarrhea Komura sum Keiko 1, 2, Long Akira Shima 3, Hiroyuki Uchida 4, Ryuichi Ogawa 2, Yoshiyuki Ishii 4, Toshiko Aramiya 1, Hirotoshi Echizen 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2011.

---

	The present conditions of C.difficile associated diarrhea(CDAD) in 0440 this hospital and future measures Shuji Ono 1, Takeshi Kashiwabara 1, Tomoko Inoue 1, Kimiyoshi Yoshida 1, Motoi Fujii Expo 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2011.

---

	Investigation about the patients with 0441 Clostridium difficile-related diarrhea background 朴井三矢, Naoko Fujimura, Yu Kumi, Motoaki Nakao, Makoto Saito, Toshio Tanaka, Yoshio Kitamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2011.

---

	Examination of the factor about 0442 Clostridium difficile-related diarrhea Kishi, Matsuzaki, Yasuko Mizuno, Shinichiro Suzuki, 澤藤園子, Akio Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2011.

---

	Present conditions investigation about the antibiotic exposure of 0443 children community-acquired pneumonia treatment Michiya Tanuma 1, Naoko Furuya 1, Toshiki Saito 1, Yukihiro Yuhara 2, Takahashi Hiro beauty 2, Yoshizo Watanabe 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2011.

---

	Investigation about the use situation of 0444 tazobactam / piperacillin Middle storehouse Ichiro 1, 2, Daisuke Yamashita 1, 2, Akemi Horibe 1, 2, Kyoichi Wada 1, Oida chapter 1, Small Hara deferred chapter 1, Makoto Sada 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2011.

---

	About the present conditions of the tetanic prophylactic treatment to patients with trauma in 0445 Nagoya memory hospitals Aino Yuri 1, Takeuchi 2, Aruki, Toshihiro Nakanishi 1, Kikuchi sentence 1, Satoshi Araki Eiko 1, Masaru Kawai 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2011.

---

	Bacteria pollution status of the shading bag for 0446 hyperalimentation Hosomi Kengo 1, Yumiko Hara 1, Hiroki Sugita 1, Sachiko Komaki 1, Norio Masumoto 1, Takako Yuko 1, Hiroaki Otsuki 1, Yoshihisa Takao 1, Offing former Kyoko 2, 名徳倫明 3, 廣谷芳彦 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2011.

---

	About fact-finding and the fur Matthew tical care for a treatment outcome and the infection related to infliximab of 0447 articular rheumatism Kenichi Nomura 1, Ryoko Morii 2, Tomokazu Fujii 2, 澤柳直樹 2, Haruhiko Nakamura 2, 岩瀬定利 2, Hisashi Kamiya line 2, 牧野勇 1, Masao Maeda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2011.

---

	One case that we intervened in through drug control instruction for infective endocarditis suspicion by 0448 E.coli Samura A, Naoki Hirose, Koibuchi Hiroyuki, Takenori Kurata, Naoko Matsuda, Toshiko Ogawa, 1, Kotobuki, Sekine Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2011.

---

	Study on risk factor of 0449 substrate specificity expansion type β - lactamase (ESBL)-producing bacteria infection 池田義明1, 5, 西山秀樹2, 5, 高坂久美子3, 5, 宮村耕一4, 5, 森一博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2011.

---

	Examination of the utility of professional calcitonin in 0450 bacterial infection treatment Hiroyuki Sakano, Maiko Tsukada, Takanori Akiba, Reiko Okazaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2011.

---

Pneumonia protective efficacy with the 23 values pneumococcus vaccine inoculation to the patients with 0451 chronic respiratory disease Yamashiro Sakae person 1, 4, Harumi Iwasaki 4, Taeko Eto 4, Mayu Okamoto 4, Minako Kawasaki 4, Jikumaru Aiko 4, Takeda Fumi 4, Naoko Todaka 4, Chiharu Matsuda 4, Jin Ayabe person 4, Jun Eto 4, Chiemi Kikuchi 4, Miho Yamamura 4, Shiho Tada beauty 4, Iwamoto Wakana 4, Tomohiro Yamamoto 4, Hirofumi Kajiwara 1, Tetsuji Sugata 2, Naoki Hagimoto 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2011.

---

	Intervention effect to the initial treatment for blood cultures-positive patients by 0452 pharmacists Jin Tsukamoto 1, 2, Takashi Azuma 1, Toshiaki Igarashi 1, Toshiaki Nakamura 1, Masao Tobita 2, Yoko Muroi 2, Pond ヶ 谷諭史 3, Kazuki Takagi 3, Hiromichi Iwasaki 2, 3, Mikio Masada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2011.

---

	The carbapenem-based antimicrobial agent proper use using 0453 clinical paths and pyocyanic resistant trend 高野尊行 1, Kenichi Nakazono 1, Keiichiro Usui 2, Yasushi Kawatsu kernel 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2011.

---

	Fact-finding of cleaning duties by the trust supplier worker whom we looked after from the viewpoint of 0454 environment infection management Michiyo Okada 1, Minako Yasuda 1, Okada sum intellect 2, 村井邦充 1, Takayuki Seko 1, 山田一聡 1, Hiroshi Hotta 1, Yoshihiro Ito 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2011.

---

An action of this hospital in preventive measures against 0455 norovirus inside the hospital multiple infections and the evaluation Koike reason Expo 1, West Kyoko 1, Satoshi Sugai 1, Toshiyuki Koyanagi 2, Yagi Motohiro 2, Shigeru Yamashita 2, Igarashi civil virtues 3, Block Hidetoshi 3, Masao Okamura 3, 齊藤幹央 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2011.

---

	Action to the safe use of medical supplies in 0456 this hospital Tomoko Kanemitsu 1, Emiko Kawano 1, Citizen of Hiroshi Yamashita 1, Spring wisteria incense 1, Yukari Ito 1, Mayumi Morikawa 1, Michiko Sekita 1, Yasuo Takayama 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2011.

---

	Role of the pharmacist in incident report analysis in 0457 this hospital and the medical security Tomoaki Ikezaki, Koichi Tanabe, Machiko Nakamura, Tamura A enthusiast, Aya Handa, Jun Okubo, Kanako Shinohara, Satoko Takeuchi, Hidenori Kitazawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2011.

---

	Preventive measures against 0458 different group blood transfusion (triggered by an incident report) Junichi Shimizu 1, Takeshi Minami husband 1, Satoshi Nakamura 2, Medical safety management Committee 3, Transfusion therapy executive committee 3, Computer Committee 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2011.

---

	Applied - to the picking of improvement - first report compounding of medicines section of the medical security using 0459 handy terminals 伊藤護之, Masaru Arai, 眞壁秀樹, Osamu Sugimoto, Takaki Kitazawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2011.

---

	Contribution to the medical security by 0460 ward exclusive duty duties Bell mountain Naoto 1, Hiroshi Tsujimura 2, Kazuki Matsunaga 3, Tomoko Kano 3, Cedar light Hatsumi 3, Kazuhiko Kawakita 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2011.

---

	Analysis ... (the second report) of contribution ... pre-Abo id report to the medical security by 0461 drug control instruction duties Hiroshi Tsujimura 1, Bell mountain Naoto 2, Naomi Kuroki 1, Kazuhiko Kawakita 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2011.

---

	Role of the pharmacist to 0462 medical care security promotion activity 廣末毅 1, Yoko Imamura 1, Deer pot Hisako 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2011.

---

	For a problem for 0463 out of the hospital prescription entire surface publication and an offer of security, the reliable pharmacotherapy to action - inpatients - 廣實清司 1, Yutaka Uchida 1, Hiroyuki Furukawa 1, Naoki Kasai 2, Kenji Suizu 2, Miyuki Sugiyama 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2011.

---

	Risk management measures and practice in 0464 low-volume hospitals Great posterior Yukiko, Hiroshi Wagatsuma positive, Mieko Yoshimura, Saori Takahashi, Toshiaki Namiki, Kunio Kuwahara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2011.

---

	0465 Evaluation of the usefulness in patients trouble cases and risk management through the introduction of dispensing recorder "Choreco" 鈴木紀誉昭1, 桜井純蘭1, 沖畠里恵1, 水野善郎2, 土屋文人3, 原澤秀樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2011.

---

	Utility of 0466 outpatient department prescription inspection Satoshi Sato boatman, Akiko Sandai, Okinoshima Yuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2011.

---

	The compounding of medicines support of poison, the psychotropic drug (injection) using 0467 bar code and construction of the system of administration Toshi Ito Kazuko, Naoko Yoshinaga, 大山高廣, Tomoko Murayama, Takashi Uchida, 木永舞, Naomi Tanoe, Tsuyoshi Kojima, Hideyuki Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2011.

---

	Epicritic difference in medical supplies bar code by the difference in 0468 background colors 和田良浩, 藤金永美, 橋本茉耶子, Kazuyuki Ikeda, Yukiko Morita, North Keiji, Masayuki Uno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2011.

---

About a present conditions report and the preventive measures of the cold water re-hat affecting use of 0469 generic medicine promotion against risks Tadashi Hagiwara daylight 1, Hosokawa Kei period 1, Seiji Nakajima 1, Kazuya Yamauchi 1, 新井裕訓 1, Middle member of a village triad one 1, Atsuya Matsumoto 1, Mikio Sakakibara 2, Satoshi Okada 2, Shinya Sugiura 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2011.

---

	0470 Efforts to hospital Medication errors due to multidisciplinary consultation : The role of the pharmacist in the medical safety management office 石渡渚1, 4, 佐藤はるか2, 宮地正和1, 井美縁1, 湯本哲郎1, 4, 川手佳子3, 二ツ神典子3, 加藤幸子3, 菅原るみ子3, 4, 工藤龍彦4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2011.

---

	A construction and evaluation of the online incident report system which made much of 0471 breaking news characteristics Hiroshi Kanda kernel 1, 1, Sakae, Omori, Sumio Murase 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2011.

---

	Preventive measures against dispensing errors using the envelope with the image of 0472 medical supplies Takashi Watanabe, 百合草憲勇, Tetsuji Maruno, Yoshinori Nakata, Akio Tanaka, Shigeki Nakane, Kentaro Moriwaki, Tomoko Sato, 渡久川敦子, 石本昌裕, Yoshikatsu Mizutani Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2011.

---

	Analysis about the incident occurrence of 0473 internal use prescriptions factor Yoko Kitano, 田中三広 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2011.

---

	It is ... for construction - simple and easy and precise prescription checking duties of the "prescription checking sheet" publication system which linked 0474 electronic charts 白川哲, 中尾圭裕, 岩尾恭寛, 植山寛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2011.

---

	Examination - of output - utility of the eGFR level to 0475 out of the hospital prescriptions Kazuhiro Kondo, Kazuhiko Tamura, Kentaro Okita, Ayako Moriyama, Nakajima A Ichiro, Yoko Nagao, Mie Ogata, Shinseki green Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2011.

---

	For the proper use of 0476 medical supplies trial - of the testing information printing to - prescription Yukio Kamiya, Toshiaki Igarashi, Aya Konno, White waves shallows Masaki, Old Takaaki Tawara, Toshiaki Nakamura, Mikio Masada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2011.

---

	Effect on formulations inspection duties by the change of 0477 medicine bag indication contents 上條佳世, 小泉史子, 坂田穣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2011.

---

	Making of the prescription for exclusive use of the ophthalmology that we applied 0478 medication histories list pattern prescription to 前原梨恵, Katsuaki Arai, Kaoru Nakamura, Noriko Shimizu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2011.

---

	Effect of all automatic tablet packaging machine compounding of medicines to give to the properties of matter of 0479 orally disintegrating tablets Shojiro Kyotani 1, 山下記承 1, Miki Iguchi 1, Takeo Nakamura 2, Seiichi Izumi 3, Seiji Zushi 4, Hisashi Hiramatsu 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2011.

---

Incompatibility aspect of the forerunner, the late departure injection which you should recognize at 0480 checking prescriptions and stability Hiroshi Matsuya 1, Yutaka Uchida 2, Yu Nakahara 3, Fujiko Yamazaki 4, Asako Nakagawa 5, Hagiyama Hiroshi 6, Akira Ogata 7, Kazunori Yamamoto 8, 西村篤弘 9, Fukuo Kimura 10, Keizo Ishimoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2011.

---

	Utilization - of laboratory study data, drug history in 0481 hospitalization, outpatient, approach of the prescription checking which added patients information and evaluation - prescription check seat 岩崎友美, 小原信一, 福士涼子, 内山和倫, 花田和大, 藤田祥子, 板垣史郎, 早狩誠 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2011.

---

Construction of the checking prescription system in the internal use anticancer drug requiring 0482 off-period Taniguchi male person, Ooi greens Yoshiko, Shintaro Koshida, Junichi Kubo, Takeshi Nishimaki, Eiji Funaki, Hiroyasu Sato, Yoshihiro Hashimoto, Shigeki Tanaka, Hitoshi Komori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2011.

---

	Analysis and last year comparison of the doubt inquiry example in 0483 prescription order Hoshino Yugo, Kiyotaka Kawazumi, Yoshiharu Kato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2011.

---

	Development of the application for smartphone of 0484 drug information search website "relief prescription infobox(R)" and the evaluation Aya Furukawa 1, Young Susumu Hayashi 2, Mari Takayama Michiko 1, Hiroe Shimane 1, Katsuhisa Goto 1, Country branch Masaki 1, Toshiki Hirai 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2011.

---

	The construction of 0485 new doubt inquiry databases and the evaluation 小形瑛, Masahide Onoe, Old Takaaki Tawara, Hiroki Sato, Hideki Yoshino, Yuka Kageyama, 深津祥央, Ikuko Yano, Toshiya Katsura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2011.

---

	Effect of the electric charge to give it to a weight error at 0486 abstract folding 田山剛崇 1, 川本庸太 2, Hiromi Harada 2, Yasuyuki Saeki 3, Shizuko Maeda 1, Sugihara number beauty 1, Katsushi Miyake 1, Look at temple Shigetaka; 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2011.

---

Investigation about consciousness and the attribute of the pharmacist for management instruction duties about 0487 high risk medicine Yusuke Nakayama 1, Mitsuko Onda 1, Seven Kaiyo child 2, Kato eugenic 1, Makoto Watanabe Yoriko 1, Rie Tanaka 1, Kenichi Tsubota 1, Shunya Matoba 1, Hiroaki Mukai 1, Manabu Akazawa 3, Arakawa line straight 1, Hirohisa Imai 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2011.

---

An action of the pharmaceutical management instruction about the high-risk medicine in 0488 health insurance pharmacy and the related factor Kato eugenic 1, Mitsuko Onda 1, Seven Kaiyo child 2, Yusuke Nakayama 1, Makoto Watanabe Yoriko 1, Rie Tanaka 1, Kenichi Tsubota 1, Shunya Matoba 1, Hiroaki Mukai 1, Manabu Akazawa 3, Arakawa line straight 1, Hirohisa Imai 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2011.

---

Association between calculation reason and enforcement situation of instruction contents becoming the addition grounds of 0489 specific drug management instruction addition Makoto Watanabe Yoriko 1, Mitsuko Onda 1, Seven Kaiyo child 2, Kato eugenic 1, Yusuke Nakayama 1, Rie Tanaka 1, Kenichi Tsubota 1, Shunya Matoba 1, Hiroaki Mukai 1, Manabu Akazawa 3, Arakawa line straight 1, Hirohisa Imai 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2011.

---

Association between calculation situation and management instruction contents of 0490 specific drug management instruction addition calculation Seven Kaiyo child 1, Mitsuko Onda 2, Kato eugenic 2, Yusuke Nakayama 2, Makoto Watanabe Yoriko 2, Rie Tanaka 2, Kenichi Tsubota 2, Shunya Matoba 2, Hiroaki Mukai 2, Manabu Akazawa 3, Arakawa line straight 2, Hirohisa Imai 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2011.

---

	The analysis of 0491 cancer chemotherapy doubt inquiry contents and inspection of the prescription checking method 松岡加恵, 鈴木美由紀, 能登英子, 久田達也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2011.

---

	Action to the standardization for 0492 effective drug control instruction duties Hisako Yoshimoto, Kyoji Koda, Masanori Watanabe, 宮野早代, Yuko Nagasawa, Hiroyuki Furukawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2011.

---

	It is ... for a proposal to consideration - fee-for-service about the sterile preparation in 0493 medical treatment sickbeds Yukio Kondo, 奥野靖隆, Yoshinori Shimura, Yoko Kikuchi, Wife deer Hiromi, Takashi Ando kernel Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2011.

---

Effect by returning the present conditions and doubt content of the doubt inquiry of 0494 this hospital to a physician, a nurse New top Kanako, Morihiko Terashi, 野間口寛, Reiko Kirino, Tomohiro Kakimoto, Takeshi Takahashi, Middle Yuka Kihara, Toyosumi Ayako, West Kyoko Tsuji, Hiramatsu sheath Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2011.

---

	Risk management effect by 0495 ward pharmacists Keiko Adachi, Kazuya Fujita, Masayasu Ito, Yukako Hatanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2011.

---

	The suggestion of the procedure to gather fixed quantity with 0496 injectors effectively and the inspection 神谷貞浩, It is still soil Koike, Mika Ozawa, 小嶋文良 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2011.

---

	Suggestion of the "dosage regimen" mention method of the injection attachment document based on the correct answer rate comparison of 0497 dose calculations Naoya Nishikawa, Takasago Miwako, Saeko Ueda, Miho Yamada, Hiroyuki Furukawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2011.

---

	0498 About usefulness contraindicated to combination between an injection drug, the medicine for internal use using Injection drug handling business support systems of a check 堂東和生1, 久保みさき1, 齊藤暢子1, 加藤雅美1, 矢野裕章1, 高橋幸市2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2011.

---

To a compounding of medicines incident decrease in by the reexamination 0499 injection compounding of medicines procedures and compounding of medicines environment wrestle; for - human error zero - Yuka Arima, Junko Arima, House and estate Keiko, Upper Megumi Katahira, Takashi Furuta, 西八重乃, 下堂薗権洋, Yasuo Takeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2011.

---

	Effect (the third report) that 0500 injection volumes of infusion give for practice Toshi Tanaka 1, A 1 in the hill, Gamo Makio 2, Masuo Sato 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2011.

---

	It is ... about use of relation ... administration set filter of the pharmacist about the proper use of 0501 medical care materials Yuko Hino, Hidekazu Fujita, 豊浜隆, Koji Takai, Yoshinobu Kitao Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2011.

---

The effect that study (I) transfusion pump about the proper use of 0502 medical care devices and a transfusion tube give to intravenous feeding speed Masayuki Umemura 1, Hiroyuki Ono 1, 小野允也 1, 奥村慎悟 1, 加納章太 1, Takuya Yasuno 1, Hiroshi Mizuno group 1, Kazuto Hatakeyama 2, 矢野亨治 3, Tomoko Mori 3, Katsuo Shigeno 1, Side shop Yoshibumi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2011.

---

	Examination ... in the institution in the action ... simple suspension method induction eighth year of the incompatibility evasion of 0503 simple suspension method 細川浩輝, Yuko Sasaki, Takahiro Akatsuka, Basket island Masahiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2011.

---

	Duties improvement about the simple suspension in 0504 Tsuyama center Hospital Yuri Yokoyama 1, Midori, Nakamura 1, Akiko Sakuma 1, Yu Haruki person 1, Tetsu Sugiyama University 1, Yukihiro Kawakami 2, Sachiyo Kondo 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2011.

---

	Waking - of medical - millennium to stand in the forked road Hiroshi Sato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 151-151, 2012.

---

	A 24 fee-for-service revision and role of the pharmacist Shinya Koyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 152-152, 2012.

---

	A community medical care planning review and role of the pharmacist Masaki Muto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 153-153, 2012.

---

	Hot expectation to a hospital pharmacist Tatsuya Horiuchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 154-154, 2012.

---

	To hand future children an antimicrobial agent as effective medical resources; role - of the pharmacist in -Antimicrobial Stewardship Program (antimicrobial agent control program) Akihiko Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 155-155, 2012.

---

	Inflection policy of future and PMDA of the pharmacist Soichiro Isobe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 156-156, 2012.

---

	Medicine - antithrombotic drug (anticoagulation, antiplatelet drug) and NSAID wanting you to be careful by all means from the situation of the digestive organ physician and helicobacter pylori sanitization - Yuichi Sato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 157-157, 2012.

---

	For relief, safe medical care study on evaluation of - medical supplies and evasion - of the adverse event Toshiaki Nakamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 161-161, 2012.

---

	Promotion of the individualization medical therapy by the pharmacogenomics analysis 平塚真弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 162-162, 2012.

---

	Study on evaluation and offer of the drug information based on a clearance theory Yoshiyuki Ono Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 163-163, 2012.

---

	Study on adverse event evasion in the use of injection Yoichi Kawasaki, Sendo Toshiaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 164-164, 2012.

---

	Establishment and outcome evaluation of the complete enforcement system of the antimicrobial agent proper use promotion program (Antimicrobial Stewardship) Takashi Niwa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 165-165, 2012.

---

	A construction and clinical application of EGFR using PNA-clamp SmartAmp2 and the KRAS mutation in the gene analytical method Takuya Araki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 166-166, 2012.

---

	The elucidation of the onset of peripheral neuropathy mechanism with the anticancer drug and study on countermeasure Yudai Kawajiri Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 166-166, 2012.

---

	Physiology, the biochemical development of children and development of the new child dose estimate method in consideration of drug elimination course Shinya Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 167-167, 2012.

---

	CYP3A5 and effect of the ABCB1 genetic polymorphism to give to the onset of efficacy, side effect after the change on fentanyl patch Takashina Yoshiaki 1), Takafumi Naito 1), 見野靖晃 1), Yagi Tatsuya 1), Kazunori Onishi 2), Junichi Kawakami 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 167-167, 2012.

---

	Search of the disease developing mechanism, new treatment with peritoneal dialysis method of complications Tomohiro Mizuno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 168-168, 2012.

---

	A search and application of the molecular biologic index in the individualization immunosuppressive therapy promotion after the S1B-1-1 liver transplantation Satoshi Masuda point, Miwa Uesugi, Minoru Hosokawa cord, 新家遥, Shunsaku Nakagawa, Kazuo Matsubara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 171-171, 2012.

---

	Trial of the chemosensitive monitoring in the S1B-1-2 renal transplant Takafumi Kuzutani, Jun Takamatsu tree Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 171-171, 2012.

---

	Likelihood of the renal transplant tailor-made treatment by the sensitivity testing of the S1B-1-3 immunosuppressive drug Kentaro Sugiyama 1), Hiroyasu Sasahara 2), Tsukaguchi Maho up 2), Kazuya Isogai 2), Satoshi Toyama 2), Hiroshi Sato 2), Toshihiko Hirano 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 172-172, 2012.

---

	It is prevention, the measure of the side effect the drug interactions of the S1B-1-4 immunosuppressive drug Masato Honma, 幸田幸直 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 172-172, 2012.

---

	For the further spread of S1B-2-1 generic drugs Tsuyoshi Matsuno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 173-173, 2012.

---

	Distrust of the physician that S1B-2-2 grounds are ambiguous Isao Tanabe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 173-173, 2012.

---

	It is ... from the situation of present conditions and proposal - medical office pharmacist of the S1B-2-3 generic drug Akiko Kume Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 174-174, 2012.

---

	Trend of the diabetes diagnostic criteria and the HbA1c measurement standardization that S1B-3-1 is new Izumi Takei Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 175-175, 2012.

---

	Show S1B-3-2 diabetes and a testing viewpoint; one, how to use Meguro lap Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 175-175, 2012.

---

	Topic ... of S1B-3-3 glycoalbumin - these days Keiko Yasukawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 176-176, 2012.

---

	The latest treatment of S1B-3-4 diabetes Asako Sato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 176-176, 2012.

---

	For a fact and the future of the S1C-1-1 pharmacist outpatient department Reiko Matsui, Satoshi Izumi Shiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 177-177, 2012.

---

	The role that a pharmacist outpatient takes in S1C-1-2 tumor physician and a mild care physician absence hospital Imamura pasture employee Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 177-177, 2012.

---

	Action to the present conditions of "the pharmacist outpatient department" in the S1C-1-3 cancer medical treatment and "medicine medicine cooperation" in there Tomoki Nozoe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 178-178, 2012.

---

	When outpatient department is to the area more, to connect it from S1C-1-4 hospitalization Toru Hashida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 178-178, 2012.

---

	Expectation to the present conditions and a pharmacist of the promotion of the pharmaceutical products development from the S1C-2-1 academia 荒川義弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 179-179, 2012.

---

	Relation to a study drug preparation utilized the experience of the S1C-2-2 hospital preparation Ryoji Yanagihara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 179-179, 2012.

---

	Action of PMDA for the pharmaceutical products development from the S1C-2-3 academia 下川昌文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 180-180, 2012.

---

	Role of the S1C-2-4 institutional review board secretariat and a study drug, the information management charge pharmacist Atsushi Aoki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 180-180, 2012.

---

	From the action of the contribution - Kitasato University east Hospital trial control center to the innovative drug development through the S1C-2-5 early stage, search study - Mika Maeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 181-181, 2012.

---

	What was different from the S1C-3-1 disaster medical care - Chuetsu earthquake that changed in by the Great East Japan Earthquake; -? Naito ten thousand sand sentence Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 182-182, 2012.

---

	About the medical support at the S1C-3-2 disaster from the situation of the Japan Pharmaceutical Association Takashi Kodama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 182-182, 2012.

---

	Role of the pharmacist in the S1C-3-3 disaster acute phase 渡邉暁洋, Keiko Fukuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 183-183, 2012.

---

	Ward drug duties and the evaluation that S1D-1-1 psychiatry pharmacist conducts 谷藤弘淳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 184-184, 2012.

---

	Side effect evaluation ... to work on by trial - team of the S1D-1-2 psychiatric pharmacotherapy adequacy Yoko Hashimoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 184-184, 2012.

---

	A prescription rate and change of prescription rate of the high-risk medicine in the S1D-1-3 psychiatry sickbed Hiroko Kito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2012.

---

	The present conditions and formulation study of the change of prescription of inpatients in the S1D-1-4 this hospital Willow Tomoyuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2012.

---

	Pharmacotherapy of the pregnancy-induced hypertension syndrome to read from S1D-2-1 guidelines, and to solve Kayoko Kimura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2012.

---

	S1D-2-2 diabetes and pregnancy Tomoko Yashiro 1), Naoko Arata 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2012.

---

	S1D-2-3 maternal feeding and medicine We cannot look at Tada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2012.

---

	S1D-2-4 pregnancy, fetuses and radiation Kayoko Muraoka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2012.

---

	Treatment with Chinese medicine in the S1D-3-1 cancer practice Yoshihiro Imazu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2012.

---

	Cost effectiveness and Chinese medicine of the pharmacotherapy in the S1D-3-2 psychological care 赤瀬朋秀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2012.

---

	The advice of the use of Chinese medicine in S1D-3-3 cancer, the mild medical care Shun Ito is elegant Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2012.

---

	About the role of the pharmacist in the S1E-1-1 team approach in medical care Kenji Fujikawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2012.

---

	S1E-1-2 That you want in a team medical pharmacist : From nurses of position 竹股喜代子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2012.

---

	S1E-1-3 It should be the patient in the medical team, it can only to a patient : The "sickness cooperation" of the medical staff that has undergone the acquisition of appropriate medical care information 濱本満紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2012.

---

	A role and duties expansion of the hospital pharmacist for S1E-1-4 team approach in medical care promotion Junichi Kawakami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2012.

---

	From the viewpoint of the expectation to a pharmacist for the team approach in medical care promotion that S1E-1-5 is smooth and the role opening of an office pharmacist who should carry it Yoshihiro Abe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2012.

---

	About the foundation of the pharmacist system specialized in S1E-2-1 pharmacotherapy Ryozo Oishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2012.

---

	The rule of the pharmacist authorization system specialized in S1E-2-2 pharmacotherapy and authorized schedule Kiyobumi Yamada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2012.

---

	From the situation of expectation - physician for the pharmacist specialized in S1E-2-3 pharmacotherapy and the medical education Shintaro Ban Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2012.

---

	It is ... from expectation - pharmacist - nurse to a pharmacist specialized in S1E-2-4 pharmacotherapy, the comparison of the specialist system Funada Chiaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2012.

---

	The expectation to a pharmacist specialized in S1E-2-5 pharmacotherapy from the situation of the cancer specialty pharmacist: Kanako Azuma Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2012.

---

	The future directionality that S1E-2-6 Japan cure society aims at Mayumi Mochizuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2012.

---

	Role of S1E-3-1 CKD and the pharmacist Sumio Hirata, Daisuke Kadowaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2012.

---

Pharmacist duties - duties manual and introduction of the pioneer action that should be carried out for the S1E-3-2 CKD patients Satoshi Izumi 1), Yoshiyuki Ono 2), Tadashi Kamata Expo 3), Hiroki Takeuchi 4), Akio Tanaka 5), Isao Hasegawa 5), Takeshi Miyake sentence 6), Shigeyuki Miyamura 7) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2012.

---

	About mention of the dose depending on S1E-3-3 contraindication, renal failure, renal function Akio Tanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2012.

---

	Problems of mention of the drug administration design to the S1E-3-4 renal function degeneracy patients and the attached document Yoshiyuki Ono Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2012.

---

	The pharmaceutical cooperation that utilized S1E-3-5 CKD seal 寺田智祐 1), Your Utsu 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2012.

---

	Renal function evaluation by the autoserum creatinine measurement of elderly people in the S1E-3-6 health insurance pharmacy Tamotsu Matsumoto right 1), Hiroki Takeuchi 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2012.

---

	Is the present pharmacist image which S1F-1 citizen remembers happy for a pharmacist? Masao Onishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2012.

---

	The center of the S1F-1-2 team approach in medical care is a pharmacist 新井裕充 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2012.

---

	It is ... from this of the S1F-1-3 - pharmacist Hideto Sekino Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2012.

---

	It is make evidence ... in practice - smart of the clinical studies using the S1F-2-1 pass Satoshi Shibata intellect 1) 2), Toru Maruyama 2), Harumi Tanoe 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2012.

---

	Make use of the viewpoint of the S1F-2-2 pharmacist; and to the better clinical path Kumi Nakamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2012.

---

	About the pass induction to an antiMRSA medicine TDM system in the S1F-2-3 antimicrobial agent proper use Hitoshi Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2012.

---

	Relation - by pass - cardiovascular procedure center clinical path team which a pharmacist makes practice from S1F-2-4 today Rie Ozeki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2012.

---

	When when we expect it and make a pass, the S1F-2-5 physician uses it Katsuo Shinichi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2012.

---

	The effect that the participation in planning of the pharmacist gives to pass availability on S1F-2-6 pass Committee Strong marsh Masami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2012.

---

	Collaboration of S1F-3-1 DPC and the clinical path Shigeyuki Tamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2012.

---

	The choice of S1F-3-2 DPC and the generic drug and appropriate evaluation 飛野幸子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2012.

---

	S1F-3-3 DPC and ward duties Hiroko Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2012.

---

	It is ... the drug duties - of the S1F-3-4 DPC era from now on until now Toshiya Ikeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2012.

---

	The clinical index that utilized S1F-3-5 DPC data Mia Kobayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2012.

---

	About the new action of the S1G-1-1 medical supplies medical equipment reporting homepage Uichiro Kimura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2012.

---

	About S1G-1-2 medical information database base maintenance business 小川倫洋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2012.

---

	For the change of intelligence, an analysis, the offer after the S1G-1-3 production sale Kazuhiko Mori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2012.

---

	About S1G-1-4 medical supplies safety measures and medical supplies risk management plan Straw bag tree Tomiko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2012.

---

	Application to administration plan of the antiMRSA medicine using S1G-2-1 new renal function marker cystatin C 田中亮裕, Hiroshi Araki positive Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2012.

---

	Proper use and economic effect of the S1G-2-2 antimicrobial agent Takashi Niwa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2012.

---

	Practice of the proper use of the disinfectant in consideration of S1G-2-3 economy, the academic nature, regional alliances Hiroo Nakagawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2012.

---

	Practice of the S1G-2-4 antiMRSA medicine proper use Kenichi Kobayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2012.

---

	Practice of the S1G-2-5 infection control Masayo Tanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2012.

---

	Suggestion and practice in the opportunity -NST intervention case of "the transfusion power" of the S1G-3-1 pharmacist Katsuji Hayashi, Risa Hideshima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2012.

---

	How to use specialized professional ability of the S1G-3-2 pharmacist 杉田尚寛 1), Town piece Tamami 2), 山口浩輝 3), Hiroto Ishii 3), 室石豊輝 3), Mt. Echigo person 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2012.

---

	Transfusion formulation study (support) by the NST pharmacist in the S1G-3-3 this hospital 山下恒弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2012.

---

	Role of the pharmacist in S1G-3-4 regional alliances NST Mitsue Mukai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2012.

---

	The management of NST by the S1G-3-5 pharmacist Naoto Nakamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2012.

---

	A power of a pharmacist is necessary for S1G-3-6 NST! Akiko Tazaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2012.

---

	Commercial from S1H-1-1 hospital preparation is activity ... of ... Japanese Society of Hospital Pharmacists arts and sciences Committee to a preparation Shinko Okuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2012.

---

	The guideline that we saw from S1H-1-2 hospital pharmacy preparation (publication) Katsuyoshi Nakajima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2012.

---

	Relation with the fact and the guideline of the hospital preparation in the S1H-1-3 university hospital Toshiaki Nakamura, Yuichiro Kayano, Mikio Masada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2012.

---

	Relation of the university for the S1H-1-4 hospital preparation 花輪剛久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2012.

---

	About the process in the - "guideline (Version1.0) establishment about a preparation and the use of the hospital preparation" thinking about S1H-1-5 hospital preparation and contents - Fumito Tsuchiya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2012.

---

	Characteristics of the practice in S1I-1-1 first aid, the intensive care region Oda order Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2012.

---

	Practice of the pharmaceutical management in the S1I-1-2 sepsis case Kato Takahiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2012.

---

	Pharmaceutical management in the S1I-1-3 heart and the lungs brain resuscitation Masayuki Chuman, Toru Imai, Toru Kitano, Takako Sakagami, Norikazu Kikuchi, Morio Kaburagi, Zenichi Yoshida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2012.

---

	Practice of the pharmaceutical management in the S1I-1-4 acute drug intoxication 山崎晃憲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2012.

---

	Education, research activities (activity in the Nagoya University Hospital) to expand pharmacy, the pharmacist education in the S1I-2-1 healthcare setting Yukihiro Noda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2012.

---

	Trial for the foundation of the S1I-2-2 breast cancer outpatient department clinic pharmacist training program Komoda Masayo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2012.

---

	Role of the pro-clinic in S1I-2-3 Kyoto Pharmaceutical University teacher Akira Takayama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2012.

---

	Activity (activity in the hospital operation room) and study instructional activity as the teacher to reclaim the new pharmacist professional ability in the S1I-2-4 healthcare setting Masanori Kobayashi, 山田勇磨, Sato evening period, Takeshi Iseki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2012.

---

	Relation of the pharmacist to ethic examination about the use of S2B-1-1 unlicensed drug and medical supplies out of the adaptation Katsuhiko Matsuura, Yoshinori Ito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2012.

---

	Role of the pharmacist in the clinical trials using the S2B-1-2 off-label use drug Katsuhiko Nagase Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2012.

---

	Use of the hospital preparation in the hospital attached to the S2B-1-3 Gunma University School of Medicine Tomonori Nakamura, Yasushi Yamamoto Jiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2012.

---

	Hospital drug duties support system by S2C-1-1 SPD Tsuneaki Tanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2012.

---

	It is ... with the significance of existence of standardization - pharmacist of drug duties to take quality of the S2C-1-2 medical care on Tadanori Sasaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2012.

---

	S2C-1-3 pharmacist support system and registration distributor Takashi Naito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2012.

---

	Drugstore pharmacist support system in S2C-1-4 foreign countries Hisayuki Kato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2012.

---

	Medical economic evaluation of the information system about S2C-1-5 medical supplies Hiroyuki Sakamaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2012.

---

	New times - cooperation of the cooperation pass of S2D-1-1 cancer is way ... of the cancer medical care from Keyword this Funada Chiaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2012.

---

	S2D-1-2 "problem to the cooperation pass establishment of cancer Valley water Masato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2012.

---

	Need - medical care care of way - medicine medicine cooperation of the special hospital pharmacist cannot be over only in a hospital in the times when the cooperation pass of S2D-1-3 cancer is new! Matsuhisa Noriaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2012.

---

	Utility of the local pharmaceutical cooperation pass in the examination for S2D-1-4 urology department outpatient Hiroshi Nagae 1), Former Sunao Hori beauty 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2012.

---

	Because a ward pharmacist shows a role by S2D-1-5 General Hospital pharmacist and clinical path - cancer pharmacotherapy; - Ryoji Takahashi, 梅村佳永, Mayumi Kato, 松本佳剛, Ueda exhibition charges Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2012.

---

	From the situation of the nurse at role - medical office of the medical office in S2D-1-6 cancer practice regional alliances Piece valley end season Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2012.

---

	Significance to announce S2D-2-1 results of research as a treatise Yasushi Yamamoto Jiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2012.

---

	Manners when we make S2D-2-2 science article Nobuyuki Goto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2012.

---

	We are not accepted by these S2D-2-3 forms Juichi Otani Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2012.

---

	S2D-2-4 I write an article in this way Takuya Araki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2012.

---

	S2D-2-5 I wrote an article in this way Takaaki Yamada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2012.

---

	From the situation of cooperation - physician with S2E-1-1 HIV infection authorization, specialized pharmacist - expanse and pharmacy service under health insurance drugstore Yoshinari Tanabe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2012.

---

	Relation of the HIV patients and the pharmacist in S2E-1-2 Niigata Toru Yamada, Mariko Uchiyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2012.

---

	AntiHIV medicine management and problems in the S2E-1-3 large hospital Masayuki Senda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2012.

---

	Cooperation - with S2E-1-4 HIV infection authorization, specialized pharmacist - pharmacy service under health insurance drugstore 吉野宗宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2012.

---

	CYP3A gene expression adjustment of human fetal liver cells by the S2F-1-1 partial pressure of oxygen Eiji Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2012.

---

	Evaluation of prescription checking, the formulations for the parenteral injection prescription of S2F-1-2 premature infant, the neonates treatment room (NICU) and the doubt inquiry 西村健二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2012.

---

	Pediatric warfarin PK/PD study based on S2F-1-3 blood vitamin K concentrations and the genetic polymorphism analysis Keita Hirai 1), Hideki Hayashi 2), Yasushi Ono straight 3), Tatsu Sakamoto Ichiro 1), Kunihiko Ito 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2012.

---

	In S2F-1-4 normal business routine through correspondence to "oneself being able to do it now" -A(H1N1) pandemic 2009 - Middle bath Shinji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2012.

---

	Development of the injection inspection system using S2F-1-5 new bar code Kazunori Shimomura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2012.

---

	Examination about the sterility of the hyperalimentation at use of S2F-1-6 clean bench We run the plum bottom, Kazuhiko Igarashi, Masami Kawahara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2012.

---

	Examination - about safety measures - volatilization quantity of the anticancer drug with the S2F-1-7 volatility Yuichi Koizumi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2012.

---

	Reduction of phlebitis by the change of the S2F-1-8 vincristine sulfate administration method Shinichi Kitamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2012.

---

	A trend and examination policy of the pharmacist authorization specialized in S2G-1-1 cancer Yusuke Tanigawara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2012.

---

	A fact and case summary (gastrointestinal carcinoma) of the S2G-1-2 pharmaceutical intervention Kitada Noriaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2012.

---

	A fact and case summary (breast cancer, outpatient department Japan Society of Chemotherapy) of the S2G-1-3 pharmaceutical intervention Junko Kuroda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2012.

---

	A fact and case summary (hematologic cancer) of the S2G-1-4 pharmaceutical intervention Description of basic truth Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2012.

---

	A fact and case summary (mild medical care) of the S2G-1-5 pharmaceutical intervention Hiroki Iwane 1), Yuka Kobayashi 1), Toshiko Aramiya 1), Hirokazu Nakanishi 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 241-241, 2012.

---

	The S2G-2-1 "ward drug duties to learn from a precedent of the past" and "a clinical act in future at-home" (pressure sore in particular) Ryoju Miwa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2012.

---

	Action of the physical assessment education for the pharmacist in the S2G-2-2 Kyushu health welfare university pharmacy school and the pharmacy student Jin Tokunaga 1), Takamura rich person 1), Kenji Ogata 1), Nao Setoguchi 1), Miho Utsumi 2), Kei Sato wound 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2012.

---

	Education and practice of the physical assessment by the pharmacist in the S2G-2-3 Gunma University Hospital Kyoko Obayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2012.

---

	With physical assessment education that S2G-2-4 is at home and is usable, actually Teshima infinity Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2012.

---

	Role of OTC medical supplies in the S2I-1-PL regional medicine Mikio Yamazaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2012.

---

	The event that a clinician expects in a drugstore, a drug store in S2I-1-1 medical care cooperation Norio Tada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2012.

---

	Role of the local drugstore, pharmacist in the making of health of the S2I-1-2 nation, the consultation support Hidenori Fujiwara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2012.

---

	S2I-1-3 drugstore, drug store at the starting point of the regional medicine cooperation! Toshiaki Nakamura, Mikio Masada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2012.

---

	A function and role of the community pharmacy in S2I-1-4 foreign countries High middle Koichiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2012.

---

	About the role of a drugstore, the pharmacist in the S2I-1-5 regional medicine Taihei Tanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2012.

---

	Including a system commentary of tendency and measures - Australia of the pharmacist lifetime education in the S2I-2-1 world - Odaka, Kobayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2012.

---

	Educational program - mental health region for pharmacist intervention in S2I-2-2 Australia for a case - Claire O'Reilly Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2012.

---

	Action of the pharmacist lifetime education business in the S2I-2-3 Ueda Pharmacist Association Yasunori Iijima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2012.

---

	Action to pharmacist lifetime education of the S2I-2-4 Japan Pharmaceutical Association Straight appearance spring Taro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2012.

---

	Role of the pharmacist in the S2I-2-5 area History of Yamamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2012.

---

	CJK-PL Contribution of Pharmacists in Pharmaceutical Healthcare and Sciences Takao Ori1), Hitoshi Sasaki2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2012.

---

	CJK-1 Total Quality Management (TQM) in Seki Chuo Hospital Sako Yuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2012.

---

	CJK-2 Application of PBL (Problem Based Learning) for 6-year Pharmacy education in Korea Jung Tae Kim Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2012.

---

	CJK-3 Population pharmacokinetics of piperacillin/tazobactam in neonates and young infants Zhiping Li1), Yewei Chen1), Qin Li1), Di Cao1), Wenjing Shi2), Yun Cao2), Dan Wu1), Yi Wang3), Chao Chen2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2012.

---

	CJK-4 The assessment of statin-associated severe muscle toxicity in Japancohort study by using claims database with laboratory information Chia-Hsien Chang Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2012.

---

	CJK-5 Pharmaceutical care of clinical pharmacists for critical patients in medical oncology You haisheng Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2012.

---

	CJK-6 A review for the role of pharmacist according to relationship Yun Hee Park Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2012.

---

	The future prospects of the clinical pharmacy Junichi Kawakami 1), Homare Ueyama daylight 2), Depths Naoto 1), Shinko Okuda 4), Kazuo Matsubara 5), Kiyobumi Yamada 6), Yasuhiko Yamada 7) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2012.

---

	Correspondence to a side effect to see well on the site 継田雅美 1), 齊藤幹央 2), Koji Muto 3), Tomoyuki Sekiguchi 4), Keiko Kurihara 5), Tomoyasu Furukawa 1), Kazuhiko Nagai 6), Toshihiko Takeno 7), Katsuji Uno 8) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2012.

---

	Does the current pharmacist education meet a pharmacist image pursued in the settings? Taeyuki Oshima 1), Rough sea well Masayuki 2), Atsumi Nitta 3), Sakaeda Toshiyuki 4), Shoji Fukushima 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2012.

---

	For Tours of the pharmacist for workshop - patients understanding of the practical quality of life rating system to share by a many types of job care team - Takashi Nakajima 1), Etsuko Arita 2), Naoko Ideguchi 3), Keiko Goto 4), Yoko Nanun 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2012.

---

	... which a pharmacist can intervene in from today if we know point - this of three pharmacotherapy that a pressure sore is cured early Old Masaru Den trans1), Fossa Fumihiro God 2), Kinoshita Tomoyasu 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2012.

---

	Action to the ward drug duties less than 20 hours a week in the P1-001 care mix type hospital Yukio Kondo, 奥野靖隆 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2012.

---

	The evaluation of the document for the P1-002 renal transplant patient compliance instruction and revision Asami Saito, Satoyo Yasuda, Hiroyuki Watanabe, Pond end Hiroaki, Nobuaki Egashira, Ryozo Oishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2012.

---

	Action of the ward exclusive duty pharmacist of the P1-003 this hospital Yumiko Asai, 唐澤匠太, 新井成俊, Junichiro Fukuhara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2012.

---

	Attitude survey of the ward staff for P1-004 pharmacist ward exclusive duty duties Toshihiko Kojima 1), Yokozawa Daisuke 2), Toshiyuki Kaneko 1), Takashi Hatae 3), Tsutomu Takeda 1), Eriko Aoki 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2012.

---

	The effect that a difference of the quantity of clinical duties of the P1-005 hospital pharmacist gives to team approach in medical care Tsuneaki Tanaka 1), Masahisa Saito 2), Kiyotaka Inoue 3), Imagawa grammar 4), Masashi Takeuchi 5), Seiji Uchikawa 6), Yukihisa Imaizumi 7) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2012.

---

	About assistance to patient compliance instruction with the DVD for the P1-006 on admission orientation 右川浩 1), Mieko Tanaka 1), Right river one sail 2), Tomoko Minowa 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2012.

---

	Examination of the utility of the ward drug duties by the P1-007 blood medical ward permanent residence pharmacist Masahiro Yasuda 1), Osamu Umeda 1), New Akiko 2), Ikumi Saeki 2), Fuseya Yoko 2), Hirose 50 child 2), Hideko Goto 3), 笠原千嗣 3), Takeshi Takahashi 3), Senju Goto 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2012.

---

	P1-008 drug duties improvement project "team minimalism is activity and ward permanent residence pharmacist of the medicine edition" and drug SPD introduction 濱名則子, 藤嶋若奈, 梶田祐三子, 山城幸子, 葭ちとせ, 濱田晶子, 古出直子, 柏木佑貴, 真砂聖, 河井順計 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2012.

---

	Analysis of propylene glycol - glucose interaction that used NMR fundamental researches about the incompatibility of the dilute phenytoin injection with P1-009 glucose transfusion Yoshinori Onuki 1), Mayumi Ikegami 2), Shigeko Obata 1), Kozo Takayama 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2012.

---

	Participation in planning to the ward rounds of the pharmacist in the P1-010 circulatory organ ward Yoshio Ueno 1), Mitsugu Saegusa 1), Tomoya Asada 1), 眞鍋伸次 1), Yuichiro Takagi 2), 森由弘 3), Thickness well Bunichi 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2012.

---

	Action to ward drug duties enforcement addition by the P1-011 ward exclusive duty pharmacist two placement Tortoise rank Kohei, 茂木孝裕, Yumiko Furuta, Ayumu Nozaki, Yuka Kobayashi, Toshiko Aramiya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2012.

---

A role and professional ability development of the pharmacist in continuous practice, regional alliances of P1-012 HIV infection and the pharmaceutical management Naomi Tanoe 1), Yumi Hashiguchi 1), Takashi Shinohara 2), Ayumi Kimura 3), Hiroshi Nakata intellect 4), Juichi Miyakawa 4), Shuzo Matsushita 5), Hiroaki Mitsuya 4), Hideyuki Saito 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2012.

---

	Ward drug duties enforcement agonizing reappraisal in the P1-013 this hospital and the future prospects Masako Morimoto, Keisuke Shimizu, Satoshi Kaneko, Tomohiko Mori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2012.

---

	The duties change that fixed its eyes on P1-014 ward drug duties enforcement addition and evaluation History of Satoshi Takahashi, 枝廣茂樹, Chisato, Nakamura, Toshio Matsunami, Hiroko Okawa, Mutsuko Okada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2012.

---

Support of the safe pharmacotherapy by the side effect development situation in P1-015 inside the hospital and the new ward duties system Naoya Ueno 1), Kamura Motoki 1), Kioroshi Shiori 1), Natsuko Takahashi 1), Hiroshi Yoshimatsu chapter 1), 1 related to Fukushima), Ryoichi Nakai 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2012.

---

	Relation ... with the patients who cannot do it with drug control instruction duties - mutual understanding in the P1-016 artificial breathing ward Okada Chihiro 1), Motoko Funato 1), Keiko Nitta 1), Asao Takamatsu 2), 塗谷栄治 3), Yasushi Matsumoto product 3), Masaaki Mori 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2012.

---

	Efficiency of drug control instruction, the ward drug duties using the P1-017 check sheet Shoichi Hayami 1), Tone Yuriko 1), Emi Yamada 1), Taneda hsiang tsai 1), 坂本和央 1), Sho Okano 1), Toshiji Oe 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2012.

---

	P1-018 A study on the safety of LED irradiation after Verteporfin use 佐藤裕紀1), 矢野育子2), 中西晴香2), 土生康司1), 祝千佳子1), 米澤淳1), 深津祥央1), 松原和夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2012.

---

	Duties contents in the ward of the P1-019 pharmacist Manami Ichiki, Futoshi Uemura, Mika Kato, Keiko Matsuki, Toru Hasegawa, Jun Hisada life, Kazuko Kawai, Kazuyuki Ito, Satoshi Isotani Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2012.

---

	Action ... which we turned to - efficiency-like ward drug duties about ward resident duties in the P1-020 Himeji medical center (the second report) Sakakura immensity 1), 金川明裕 1), Tomishima Kosuke 1), Katsuaki Kobayashi 1), Hideaki Ito 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2012.

---

	Action in this hospital to P1-021 ward drug duties enforcement addition calculation 上村忠聖, Shinya Suzuki, Masao Sekiyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2012.

---

	P1-022 Doxil note (R) treatment 阿曽沼和代1), 高柳和伸1), 山崎尚也2), 上田恭典2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2012.

---

	Action of the ward permanent residence pharmacist in the P1-023 Kure medical center, Chinese cancer center Atsuko Hosokawa, 森貞尚之, Tomomi Kotani, Fumiaki Miyamae, Shizue Kimoto, 国冨留美, History of pail east love, Yoshimichi Ogawa, 市場泰全 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2012.

---

	The suggestion of the procedure to gather fixed quantity with P1-024 injector effectively and inspection by the hospital pharmacist 神谷貞浩, Completion right Kazushi, Mika Ozawa, Hiroko Sada, 小嶋文良 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2012.

---

Analysis ... by fact-finding - text mining of the consultation contents which patients with type II diabetes mellitus approach you with for the patients at P1-025 patient compliance instruction Katsura Nishida University 1), Mitsuko Onda 1), Hiroshi Okada 2), Masaki Shoji 1), Yuka Tanaka 1), 東浦崇光 1), Satoshi Tamura 1), Arakawa line straight 1), Naoki Sakane 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2012.

---

	Present conditions investigation of the pharmacist intervention to the appointed hour prescribed drug in the P1-026 digestive surgery ward Mari Yokota, Junichi Takano, Upper mound Tomoko, Keiso Masuhara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2012.

---

	Contribution of the pharmacist in the P1-027 transplant ambulatory team approach in medical care Kazufumi Iwata, 合澤啓二, Kentaro Ueda, It is Sachiko in a camp, Eiko Fukunaga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2012.

---

Discussion in an investigation and ward duties of the development of hallucinosis situation at the voriconazole administration to patients with P1-028 hematopoietic tumor Marie Yamawaki, The Tanaka immensity, Takashi Kawada, Yukari Asakura, Masa Hashida, Kaori Shimomoto, Yutaka Takahira, Well west Chika, Norifumi Miyamoto, 服部暁昌 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2012.

---

	Discharge drug information management instruction and the medicine medicine cooperation that utilized P1-029 medicine notebook Uchida Kei greens child 1), 西尾益冶 1), Atsushi Yamashita 1), Akihiko Shinagawa 2), Osamu Tomita 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2012.

---

	The making of the patient compliance instruction tool to P1-030 patient with ischemic heart disease and investigation of the efficacy understanding degree Sachiko Oda, Old samurai family Yoshimi, Yutaka Kuboi, Yoshimatsu good luck, Takashi Kishino, Shinya Ito, Hideko Iwasaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2012.

---

	Effect by the blood medical ward permanent residence of the P1-031 pharmacist Ritsuko Miyajima, Hideya Kokubun, Rumiko Kondo, Hajime Matsubara, Kazuo Yago Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2012.

---

	About the way of the ward drug duties in the P1-032 medical treatment type ward Hoshizaki Hiroko 1), Shiori Fukuda 1), Seiji Utsumi 1), 新枦義之 1), Toishima study 1), Koji Fujimoto 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2012.

---

For ward pharmacist duties (2) ... "pharmacist to see in the P1-033 Asahikawa Red Cross Hospital," it will be ... with the present conditions in future Yoshie Kawaguchi, 紙谷章基久, 宮崎祐加, Ken Tamura Taro, Yosuke Inoue, Masaki Suzuki, Tomoyuki Kondo, Makise wisdom, Mitsuo Hashimoto, Goto Yoshinobu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2012.

---

Setup - economic effect of the drug department HIV team in the scale HIV practice base Hospital out of P1-034 and qualitative improvement - Makiko Osawa 1), 前田真輝 1), 井上亜悠 1), Taima Atsuko 1), Yawata window 1), Kazuaki Okada 1), One river Etsuko 2), Hideji Hanabusa 3), Azusa Nagao 3), Kenichi Kojima 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2012.

---

	Difference between consultation support - physician and nurse - to the medical staff by the P1-035 pharmacist 計良貴之, Yasushi Nagatani, Tsuneaki Tanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2012.

---

Relation of the pharmacist at triple-drug therapy induction of P1-036 chronic hepatitis C Ayako Koike 1), Nobuyuki Hanabusa 1), Hideki Mori 1), Inner halls of a palace Chikako 2), Yuriko Makihara 2), Ayako Makihara 3), Hiroshi Nagao 3), Kenji Hashimoto 4), Age Junichi Mori 5), Haruhiko Kobashi 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2012.

---

	Ward drug duties in P1-037 heart internal medicine, the surgical ward Miki Nakamura, Tomoko Katsube, The Aya Yamamoto beauty, Kazuya Hirata, Naoyuki Matsumoto, Shuhei Suzuka, Kazuki Tago, Great Yumiko Tsuyama, Person of moat Yumiko, Naoki before yellow Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2012.

---

It is the active intervention to an investigation after production sale of the chronic hepatitis C triple-drug therapy by the P1-038 ward pharmacist Takashi Ito kernel 1), Masatoshi Saito 1), Satoko Kamata 2), Tsunematsu law 3), Kiyoka Iguchi 3), We merely obtain a forest 3), Akiko Omori 2), Jun Ujihara 1) 2), Atsuta Koichiro 1) 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2012.

---

	The construction of all ward enforcement systems of P1-039 ward drug duties and the operational effect Yasuro Kumakura, Chizaki Yasushi, Mayumi Torimoto, Yusuke Sakai, Aki Kubota, Noriko Kiriyama, Ayano Kojima, Akane Kurachi, Kazuhiro Ishikawa, Kiyobumi Yamada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2012.

---

	About the use of medicine notebook suggestion training which we applied P1-040 benefit suggestion narration in Fumitoshi Sano 1) 2), Tomohiro Okumura 2) 3), Kunihiro Hisada 2) 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2012.

---

	Action to the affiliated 8 hospital pharmacy, duties standardization in the drugstore of P1-041 Showa University Hiroshi Shimamura 1), 石下宏征 2), Hiroshi Tanaka period 2), Joji Sasahara 3), Ko Ikeda 4), Manabu Okada 5), Toshitaka Takenouchi 2), Junichiro Murayama 6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2012.

---

	The action of ward drug duties in the P1-042 this hospital and the future prospects Shinichiro Matsuda, Harumi Teramoto, Sakie Senoo, Yuko Nakagawa, Yu Okabayashi, 前岡翠, Chika Yamamoto, Chika Takagi, Keiko Nakatani, Yukiko Ito, 城尾晃太, Akira Miyazaki, 近谷理恵子, Maze Hisanori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2012.

---

Mutual inspection between the clinical pharmacists for the whole body control of the P1-043 patients Yukari Hara 1), Kernel tail Yuta 1) 2), Yuri Fujimura incense 1), Masahiro Usuda 1) 2), Masaoki 1 Kim), Jun Kawazoe 1), 北原加奈之 1) 2), Yuka Kashiwabara 1), Junko Minemura 1), Junichiro Murayama 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2012.

---

The system construction for P1-044 ward drug duties and intervention to pharmacotherapy Terumasa Sata 1), Yumi Uehara 1), Yoshiko Suehiro 1), Junpei Shinkawa 1), Satoshi Yamaji ordinary 1), Pond increase sweetfish beauty 1), Shrine gate Takanori 1), Kazuko Tanaka 1), Uemura eyes 2), 庄幸彦 3), Hiroshi Nishijima male 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2012.

---

	Trial and evaluation of the pharmacist permanent residence in the P1-045 orthopedics ward Saori Narita 1), Yukari Hidaka 1), Toru Arino 1), Shigeru Aoyagi 1), Hiromi Yoshida 1), Masashi Nagata 1), Masakazu Nezu 1), 安原眞人 1), Jun Okawa 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2012.

---

	Protocol of the acting injection order input of the drug in the operation region by the P1-046 pharmacist and the muscle relaxant and the evaluation The Goto attendant beauty, Sato male oneself, Hiroki Ito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2012.

---

	Usage of the medical supplies report by a deliberative committee in P1-047 drug control instruction duties Taku Miyakawa, Hiroyuki Isogai, Kiyoshi Okuyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2012.

---

	About prevention of deep part thromboembolism using the blood clotting inhibitor in patients who underwent P1-048 lower limbs orthopedic surgery History of Kumagai reason 1), 松本千聡 1), Rie Shoji 1), Long Akira Shima 1), Setsuo Tsuchiya 2), Koji Ito 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2012.

---

	Management, unionization and problems of the regimen of the P1-049 cancer chemotherapy Kazumi Miyanaga, Masayoshi Nishino, Hiroyuki Sakuta, 久保勝, 1, Sakae, Ota, 傳吉朗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2012.

---

	Examination of the P1-050 cancer chemotherapy regimen order system modi operandi 野村浩英, Mayuko Mori, Shrine Makiko, 牧秀美, Takahiro Hirata, Atsuko Matsuda, Ryo Yoshioka, Yukiko Inui, Hisao Ikeda, Katsuyoshi Hatanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2012.

---

Construction of the chemotherapy medication history regime that utilized P1-051 drug control instruction support system PICS Koichi Tamai, Sanae Watanabe, History of Takeshi Korenaga, Nishihata friend fathom, Takako Ichikawa, 石田佳裕, Satsuki Kubo, Tomohisa Kurata, Takeshi Okutsu, Junko Ono Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2012.

---

	A construction and evaluation of the information sharing system about patients who received foreign chemotherapy in the P1-052 this hospital Yukiko Horiuchi, 政賢悟, 宮本晋治, Yuki Hamanabe, 坂本慎弥, 遠原大地, Koji Iwamura, Tsuyoshi Kojima, Yoshiteru Honda, Hideyuki Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2012.

---

	Effect on cisplatin nephrotoxicity by the standardization of the P1-053 moisture load regimen Ayumi Yoshida, Tomomi Sato, Katsuyuki Suzuki, Keiko Minato, Mizunuma lap city, 諏江裕 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2012.

---

	Validity - after examination - regimen unification about the method of the moisture load at the P1-054 high dose CDDP administration Miho Yamazaki, Yukiyo Funakoshi, Masataka Fukuzawa, Yuko Kubo, Katsuaki Takeda, Yasushi Nakamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2012.

---

	About the cancer chemotherapy regimen that we reviewed on the occasion of P1-055 electronic chart induction Dragon official Maiko, Natsue Yoshioka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2012.

---

	Regimen examination for the cancer chemotherapy with a little P1-056 histories of treatment Ko Tokuda period 1), Koji Moriya 1), Michiko Nishie 1), Yuriko Ishibe 1), Kiyonori Ueda 2), Kazunobu Takayanagi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2012.

---

	The side effect expression situation in the carboplatin + pemetrexed + bevacizumab combination therapy for the P1-057 non-squamous epithelium non-small cell lung cancer High Kado Take, Makoto Tanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2012.

---

	One case of recurrent ovarian cancer which desensitization succeeded in for the carboplatin long time for patients with P1-058 multiple drug drug allergy This pine Akiko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2012.

---

	Safety assessment of irinotecan + platinum (IP) therapy for the P1-059 prostate small cell carcinoma 薬師寺信匡, Ko Tokuda period, Kazunobu Takayanagi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2012.

---

	Action of the P1-060 outpatient department chemotherapy clinical path induction Sakiko Kurokawa 1), Kyoko Fujieda 1), Nobuo Suzuki 1), Rina Kimura 2), Osamu Fukuhara 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2012.

---

	Reevaluation of 5 drug regimen regimen for the Ewing's sarcoma in P1-061 adults Hiroaki Matsumoto, Ko Tokuda period, Koji Moriya, Michiko Nishie, Yuriko Ishibe, Kazunobu Takayanagi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2012.

---

	Analysis of the dose setting rule factor in the P1-062 outpatient department breast cancer chemotherapy Four Jo Megumi 1), Inferior branch Sadahiko 1), Ashizaki Masayuki 2), Yoichiro Nagamura 2), 堀治 2), Shin Ota 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2012.

---

	From P1-063 cancer chemotherapy regimen management to medicine notebook pasting, it is built reporting and the safety management system Mayuko Ito 1), Yasuo Nagami 1), Kei Murayama 2), Kazunori Yamamoto 1), 沖田敏宜 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2012.

---

	An action and many types of job cooperation to foreign chemotherapy in the P1-064 this hospital Yoshihiro Watanabe, Imuta A, Ikuo Yoshihara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2012.

---

	The effect that was led by a pharmacist, and was given P1-065 cancer chemotherapy regimen management Taizo Fukui, Junko Kamiya, Toshiyuki Kojima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2012.

---

The effect that the reinforcement of the advance notice system in the P1-066 cancer chemotherapy gives with drug disposal amounts of money Futoshi Saito 1, Kotobuki), Sakai Naoko 1), Teruko Takano 1), 小林彦登 1), Hiroyuki Miyashita 1), Soichi Shibata 1), Masatoshi Saito 1), Atsuta Koichiro 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2012.

---

	Experience action ... case in the municipal hospital in the cisplatin short hydration method of P1-067 lung cancer; and ... 宅和真由美 1), Yoko Imoto 1), Kenji Murakami 1), Goto sheath or 1), Keiko Sano 1), 平田敦宏 1), Yu Kasamatsu 2), 笠松美宏 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2012.

---

	"The handmade medicine medicine cooperation" that we saw from P1-068 drugstore pharmacist Akiko Miki 1), Hiroki Sato 1), Moat foster child 1) 2), Yasufumi Sawada 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2012.

---

Action by the many types of job team for the practice of the high quality patients care in the P1-069 outpatient department chemotherapy Yoshimichi Ogawa 1), Satoshi Nagashima 1), Atsuko Hosokawa 1), Keita Kameda 1), 武良卓哉 1), 市場泰全 1), 木場崇剛 2), Hiromi Shintani 3), Yuko Okada 3), Takako Taniguchi 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2012.

---

Action to the inflection of the cancer chemotherapy regimen function in the P1-070 this hospital and communalization of the regimen information 濱元孝 1), 上島聖秀 1), Ability Makiko Sawa 1), Shintaro Takahashi 1), Reiko Miyajima 2), 炭田恵 2), Katsuhiro Yoshimoto 3), Satoshi Kawasaki 4), Koichiro Takeuchi 4), Ryo Kawai intellect 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2012.

---

	Contribution of the positive pharmacist in the P1-071 outpatient department chemotherapy Asako Nakagawa, Nobuaki Ohata, Tomoyuki Oka, Kaori Tsubone, Yuji Hirano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2012.

---

	Investigation for the safety management of the cancer chemotherapy before and after the P1-072 electronic chart induction Kana Sunohara 1), Yu Nakamura 1), Mitsuhiro Sugawara 1), Yukio Ogawa 1), Hajime Matsubara 1), Kazuo Yago 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2012.

---

	Change of the use actual situation of the collection of cancer chemotherapy regimens for the P1-073 inside the hospital exhibition 宅江良隼, Chinami Ueno, Kengo Doi, Kenichi Sakamoto, Masako Imada, Koji Kashimoto, Yoko Sakai, Masatoshi Taniguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2012.

---

	About short hydration induction of cisplatin in the P1-074 this hospital Nishimura Masaji 1), Toshiki Ishigaki 1), Kiyoshi Kawaguchi 2), Koji Wada 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2012.

---

Safe examination for elderly people of the Gemcitabine monotherapy in P1-075 pancreas, the biliary tract cancer Naomi Hashimoto 1), 岩下佳敬 1), Horai Mai 1), 中尾承司 1), Kimiyoshi Iwasaki 1), Yukiko Narumi 1), Kanae Nakayama 1), Akihiro Sonoda 1), Mulberry crane hemp charges 1), Kazuhisa Ishida 1), Akihiko Sakamoto 2), Hiroshi Imamura 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2012.

---

	About P1-076 security and regimen use for smooth pharmacotherapy Toshiko Hoshika 1), Takuya Yano 1), 福岡竜逸 1), Takako Fujita 2), Kaori Ito 2), Kato three Eiko 2), 松原常起 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2012.

---

Action as the health insurance pharmacy to a pilot study aiming at cancer therapy cooperation in the P1-077 Hospital Masahisa Kato 1), Erina Kaneko 1), Kenji Kusaba 1), Tomohiro Inoue 1), Shinsuke Karube 1), Manabu Yoshikawa 1), Hideki Fukuoka 1) 2), Kentaro Ogata 3), Yasushi Takamatsu 4), Takashi Seo 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2012.

---

	About the adverse event report system with regimen management and the anticancer drug in the P1-078 this hospital 平郡薫, Sayuri Sakura, Tatsuhiko Ishida, Seiko Yokota, Rie Ueda, Eiji Fukui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2012.

---

	Effect of the age to give it to an adverse event of the weekly TC therapy in patients with P1-079 gynecologic cancer Hideto Takatori 1) 2), Flat field Masaki 2), Kitada Noriaki 2), Kenji Yamamoto 2), North Masato 3), Mulberry well Yukio 1), Toru Hashida 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2012.

---

	Questionary survey about the intervention of the standard regimen enforcement situation and pharmacist in P1-080 this country Iku Nishimura person 1), Shinya Suzuki 2), Kenji Kawazumi 2), 櫻井洋臣 3), Ichiji Endo 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2012.

---

	Discussion about the postoperative supporting XELOX therapy in the P1-081 this hospital Takuya Shirohata, Kana Suzuki, Miki Ishioka, Tetsuya Katori, Takafumi Izumo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2012.

---

	Induction of the check sheet in the P1-082 cancer chemotherapy regimen examination Momoyo Sonobe, Toyohiko Kurosawa, Masahiro Ogami, Atsumi Yanaka, Nara Keitaro, Masahiko Shimada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2012.

---

It is ... for the registration of a more appropriate than activity ... of the pharmacist for P1-083 anticancer drug regimen reexamination and safe anticancer drug regimen Prince Sawamura will, Nishibeppu Hiroko, Tomoji Fushimi, Akiko Mizoguchi, Igarashi sentence, Okada seven Tsu child, 望月優佑, Junko Mamiya, Ayumu Sato, Kumiko Yano, Chika Ichida, Tamaki Akimoto, Toru Morita, Shun Igarashi, 高尾良洋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2012.

---

	Present conditions report after the clinical path induction for the P1-084 cancer chemotherapy standardization Mayumi Shimizu 1), Masayasu Amano 1), Naoko Takabayashi 2), Sakiko Aoki 2), Yukiko Uryu 2), 村田実希郎 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2012.

---

	Safety assessment of the short hydration in the cisplatin administration with the P1-085 respiratory apparatus internal medicine Takashi Yamazaki, Ayumu Nozaki, Yuka Kobayashi, Toshiko Aramiya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2012.

---

	Utility of the standardization of the P1-086 cancer chemotherapy regimen check 龍田涼佑, Sato male oneself, Hiroki Ito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2012.

---

	About induction and the problems of the P1-087 regimen order ring system 春木一伸, Yayoi Azuma, Hiroko Kinpara, Tadaaki Yamashita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2012.

---

	About the management of the foreign cancer chemotherapy by the pharmacist beginning in the P1-088 consulting room Blue Takaaki, 佐々木暢琢, Keiko Yamakawa, Tomohiko Kondo, Keiko Takeuchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2012.

---

	Intervention of the pharmacist to P1-089 cancer chemotherapy Mika Tashiro 1), Hiroko Tai 2), Kazunori Shimomura 1), 大河万顕 1), Shinichi Kawaguchi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2012.

---

	Investigation of the cancellation, change case of the day of the foreign chemotherapy enforcement in the P1-090 Kyoto medical center Court official Kayoko, 北宅良祐, Furrow Yoshiko, Hiroyuki Ueno, Kei Nakamura, Yoshio Kitamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2012.

---

Trial of the side effect of information sharing management using the P1-091 outpatient department chemotherapy interview sheet Junji Asano 1), Izumi Murata 2), Takaaki Shirakawa 1), Rumi Hiyama 1), Kenta Takahashi 1), History of Kei Abe 1), Shigeto Sakuta 1), History of Mitsuru Nishio 3), Yuichi Sekizawa 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2012.

---

	The enforcement situation of the biliary tract cancer gemcitabine cisplatin combination therapy in the P1-092 this hospital Toshiko Okura, Kunio Takahashi, Shoji Takagi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2012.

---

Patients questionary survey to a pharmacist having a talk before the encounter of the P1-093 physician in advance Takahiro Sakai 1), Sonoko Furubayashi 1), Hayasaka University 2), Yoshimi Fujikura 3), Yoshihiro Aoyagi 1), Offering to a priest wish 4), Shigeo Yamamura 5), Yoshizo Watanabe 6), Satoshi Izumi Shiro 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2012.

---

	About the medicine medicine cooperation that is good on the occasion of the out of the hospital prescription issue of oral P1-094 anticancer drug (questionary survey) Reiko Matsui 1), Body marsh Masami 2), Masataka Otsuka 3), Hiroshi Yamamoto 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2012.

---

	Examination of the calculation method of anticancer drug doses in patients with non-Hodgkin's lymphoma with the P1-095 obesity 岡橋朋世 1), Child 1 too rare Mochinaga), Hideaki Tokushima 1), 中野行孝 1), Shinya Kimura 2), Fujito Expo 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2012.

---

	P1-096 Development introduction of pediatric infusion root in the preparation, administration integrated-closing connection equipment (Chemosafe (R)) 島崎博士1), 石村淳1), 原田大1), 奥津利晃2), 安藤尚美1), 北村正樹1), 加藤潤一郎3), 川久保孝1), 鈴木由香4), 前川要5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2012.

---

	Investigation about the ingredient remaining to the P1-097 injection anticancer drug container surface Yasuaki Otsubo, 廣實清司, Kyoji Koda, Yutaka Uchida, Hiroyuki Furukawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2012.

---

Questionary survey about the vial surface contamination of the P1-098 anticancer drug (injection) 吉田昭昌 1) 2), Morichika Toshiyuki 1) 2), 西川大亮 1) 3), China Ogura 1) 4), Tagashira still person 1) 5), Shigeru Kuramoto Ichiro 1) 6), Tsuneo Maki 1) 7), Masahiro Abe 1) 8), Matsuhisa Noriaki 1) 9) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2012.

---

	Evaluation of the benefit by the full-scale change to P1-099 5-Fluorouracil vial preparation 津野丈彦, Kanako Tajima, Koji Fujimoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2012.

---

	Investigation, examination about the artificial error inducer at the P1-100 anticancer drug preparation Koji Nakao, Takashi Iwase, 新美全剛, Fukuda Yasuaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2012.

---

	Evaluation of the policy (disposable type foot cover) not to take the pollution that P1-101 anticancer drug preparation is in a room outside Satoshi Azuma one, Toshihiro Hama, Kazuo Sugita, Yuichi Minowa, Narumi Ito, Wataru Suzuki, Tsuyoshi Aoyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2012.

---

	Performance investigation of in fuser pump (R) in the P1-102 5-FU continuous medication 牧智恵子 1), Manami Goto 1), Makoto Hosomi 1), Masami Nishihara 1), Masahiro Goto 2), Motoki Yoshida 2), Period Takayuki 2), Buddhist monk feeling 2), Jin Nishitani 2), Toshihiro Katsumata 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2012.

---

	Action of the pharmacist for P1-103 anticancer drug preparation ensuring safety Takuto Miyamoto, Takeshi Sasao, Masumi Mori, Hidekazu Sato, Yoshiharu Kato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2012.

---

As a result of microanalysis - companies paclitaxel preparation of the vial surface contamination of the P1-104 anticancer drug - Koichi Matsuo 1), Takashi Egawa 2), Kenichi Shimada 2), Kenichi Mishima 3), Yoriko Wada 1), Minako Higuchi 1), Yoshimi Sasaki 1), Sanae Iwatsubo 1), 五味田裕 2), Michihiro Fujiwara 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2012.

---

	Inspection to shortening and costs reduction of the CPA preparation time using the P1-105 closed system drug mixture system Yohei Ikeno 1), Daisuke Arii 1), Hiroshi Nakajima 1), Kunihiko Murooka 1), Michi Nojima husband 1) 2), Akio Kidokoro 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2012.

---

	Investigation about the work environment pollution of the anticancer drug which assumed P1-106 5-FU an index Takuya Furukawa 1), Kazuhiko Saito 1), 松岡佑弥 2), Kaneda under-secretary 2), Akihiro Tada 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2012.

---

Investigation of the germfree preparation time when we fixed our eyes on ward drug duties enforcement addition in the P1-107 Tokyo medical center Sanae Miyano, Tatsuya Mori, Hiroshi Kudo, Chiaki Ogawa, Megumi Yatabe, Makoto Kobayashi Sachimi, 赤木祐貴, Miyashita Kyuutoku, Yasuo Ide, Yoshihiko Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2012.

---

	As P1-108 simulation anticancer drug quantitative analytical procedure of the quantity of scattering using the fluorescein Na 勝野晋哉 1) 2), 鷹見繁宏 1), Michiko Tatematsu 3), Norio Kaneta 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2012.

---

	Study of the exposure situation at the anticancer drug administration by the P1-109 nurse 東恩納司 1), Nawa Hideki 1), Yoichi Kawasaki 1), Yukie Matsushima 2), Hitomi Nishimoto 2), Kazuhisa Yao 1), Sendo Toshiaki 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2012.

---

	Should the P1-110 safety cabinet operate consecutively for 24 hours? 宮松洋信, Yoichi Osato, Masami Onishi, Iga Chinatsu, Sachiyo Sudo, Early part Hiroko, Komi Yoshiyuki, Maki Natsume, Takao Akashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2012.

---

P1-111 Anti-cancer agents prepared operational efficiency to the efforts (1): Anti-cancer drugs automatic preparation device "CytoCare (R)" and the negative pressure isolator "ChemoSHIELD (R)" cost reduction effect by the introduction 黒井美晴1), 黒田純子1), 近藤勝弘1), 竹本将士1), 鬼頭典子1), 江崎哲夫1), 木村和哲1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2012.

---

	P1-112 Efforts and study to anti-cancer agents prepared operational efficiency (3): CytoCare (R) and ChemoSHIELD (R) of standby time of anti-cancer preparation person by introducing change and the questionnaire survey 鬼頭典子1), 黒田純子1), 竹本将士1), 黒井美晴1), 山本清司1), 江崎哲夫1), 木村和哲1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2012.

---

	P1-113 Anti-cancer agents prepared operational efficiency to efforts (2): Examination of the need for negative pressure isolator "ChemoSHIELD (R)" at the time of use-closing preparation aids 竹本将士1), 前田康博2), 山本清司1), 鬼頭典子1), 黒井美晴1), 黒田純子1), 近藤勝弘1), 木村和哲1)2)3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2012.

---

	Examination of the nurse anticancer drug exposure decrease by the priming of the P1-114 pharmacist Motoi Kurahashi still, Yuko Nakao, 眞継賢一, 上田浩貴, Hayato Kuroiwa, Yasuhiko Tsukamoto, Yoshihiko Hamaguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2012.

---

	Examination of the procedure to reduce a medicinal solution leakage risk from the rubber stopper at the P1-115 anticancer drug preparation 中山季昭 1), Atsushi Shiotsuki 2), Shuichi Haruyama 2), Kinzo Sudo 2), Yoshinori Tsuji 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2012.

---

	P1-116 about an action of the prevention of antineoplastic exposure in being at home 舛甚路子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2012.

---

	Examination about the effect of the alcohol included in P1-117 one Taxotere (R) Yasuhiko Sakata 1), Yasuo Iwamoto 2), Takafumi Sugawara 1), Keisuke Abe 1), Megumi Akagi 1), Shinichi Miyamori 1), Mitsuru Ito arrow 3), Akira Otani Ichiro 3), Kenji Higaki 3), Open Koichi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2012.

---

Analysis by the structure equation modeling of the psycho status of patient before the P1-118 breast cancer pharmacotherapy induction Takashi Kawaguchi 1), Tetsu Iwase 2), Body marsh Masami 3), Hiroki Takeuchi 1), Megumi Umeda 4), Tadashi Matsunaga east 4), Yoshinori Nanun 4), 畝崎榮 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2012.

---

	Reporting and action to medicine medicine cooperation using a medicine notebook in the P1-119 outpatient department chemotherapy Upper pond Kazuko, Minoru Matsumoto, 邑岡俊明, Yano light Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2012.

---

	Action of the drug department in the out of the hospital prescription of the P1-120 internal use anticancer drug Needle ヶ valley Yoshihisa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2012.

---

Examination of exclusive duty pharmacist duties about the medical security in the P1-121 outpatient department chemotherapy room and the patients quality of life improvement Fish well Miyuki 1), Takashi Goto 1), Keita Uchino 2), Chiharu Kawanabe 3), Takashi Miyoshi method 1), Hiroko Yamauchi 1), Kazuaki Ueda 1), Saito giant tree 1), 三角紳博 1), Takashi Nishino 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2012.

---

Construction ... of fur Matthew tical care - efficiency-like efficacy, safety confirmation system for the patients with whole internal use anticancer drug remedy in the P1-122 outpatient department window Ashizaki Masayuki 1), Ayumi Kato 2), Takuya Sakamoto 3), Heron valley Akiko 4), Taeko Futaki 5), Measure Shigenori 6), Yuri Masuda 7), Yuki Yoshikawa 8), Mio Endo 9), Mikiko Okazawa 10) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2012.

---

	Side effect investigation of the non steroidal anti-inflammatory agent combination at the P1-123 pemetrexed administration Yoshimi Sasaki, Koichi Matsuo, Minako Higuchi, Sanae Iwatsubo, Yoriko Wada, Sachi Fukuhara, Tomori Kawano, Hiroaki Nishino Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2012.

---

The understanding degree of patients with cancer for the P1-124 medication explanation and the contributing factor Kaori Endo 1), Kanako Azuma 1), Sayuri Motegi 1), Yusuke Sekine 1), Aihara Hideaki 1), Takashi Kawaguchi 2), Body marsh Masami 3), Hiroki Takeuchi 2), 畝崎榮 2), Takao Akashi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2012.

---

The effect that the medication explanation of the pharmacist gives the tangle that patients with cancer receiving treatment with P1-125 anticancer drug have Kanako Azuma 1), Takashi Kawaguchi 2), Aihara Hideaki 1), Michiko Eda 1), Masami Onishi 1), 山口拓洋 3), Body marsh Masami 4), Hiroki Takeuchi 2), 畝崎榮 2), Takao Akashi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2012.

---

P1-126 "tangle standard (DCS) of the decision making" Japanese edition making and examination of the reliability and the validity Yoko Sano 1), Hiroshi Soeda 1), Yasuko Hamada 1), Kanako Azuma 1), Takashi Kawaguchi 2), 山口拓洋 3), Kenji Onda 4), Eric sky yeah 5), Hiroki Takeuchi 2), 畝崎榮 2), Takao Akashi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2012.

---

	Role of the pharmacist in the chemotherapy containing P1-127 pemetrexed Minako Higuchi, Koichi Matsuo, Yoshimi Sasaki, Sanae Iwatsubo, Yoriko Wada, Sachi Fukuhara, Tomori Kawano, Hiroaki Nishino Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2012.

---

Utility of a medication explanation seat in the P1-128 cancer chemotherapy and the side effect check seat Emi Watanabe 1), Yumiko Ando 2), Ritsu Kamoto 2), Field part Masako 2), Ota Shoichiro 3), Shuji Munakata 4), Katsumasa Ishii 5), Toshihisa Suzuki 6), Masayuki Watanabe 7), Shinko Yasuno 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2012.

---

	Support - side effect measures and nutritional evaluation - to patients with cancer in the P1-129 health insurance pharmacy Toshimi Iizuka 1) 2), Kiyoshi Osanai Kei 1), Small Yuta Nozawa 1), Mio Tanaka 1), Masami Horiguchi 1), Tomoji Yoshiyama 2), Hideo Ishizuka 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2012.

---

	About lenalidomide initial agreement explanation and drug control instruction by the P1-130 pharmacist Tachibana Kengo, 足立真保, Tetsuya Konishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2012.

---

	Side effect investigation of the docetaxel bevacizumab combination therapy in P1-131 patients with nonsmall cell lung cancer Dozu Maiko 1), Yuka Kishimoto 1), 京谷充崇 1), Manabu Sakurai 1), Shuji Murakami 2), Tetsuro Kondo 2), 齋藤春洋 2), 尾下文浩 2), Kozo Yamada 2), Mayumi Nagano 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2012.

---

	Examination about the proper use of the TS-1 monotherapy in the P1-132 this hospital Yoko Iwanaga, Keisuke Kakihara, Tomoyuki Inoue, Shiizaki Masahide, Hirakawa Tomonori, Katsue Kabashima, Crane Keiko, Kunio between the fronts, Hidenori Harada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2012.

---

	The need of the drug control instruction that continued for a long term in the P1-133 outpatient department chemotherapy Yuko Nakajima, 巽香菜, Akira Nozawa, Keiji Nakata, Osamu Takahashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2012.

---

	Reporting to the ethical pharmacy in the P1-134 outpatient department chemotherapy Yukiko Yamahata, Small materials Naoto, Noriko Ito, Shoichi Yamaga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2012.

---

Gemcitabine in the P1-135 progress biliary tract cancer impossible of excision, the adverse event expression situation of the cisplatin combination therapy and the future prospects Yoko Tsutsui 1), Haruna Kameoka 1), Tagashira still person 1), 小暮友毅 1), 鵜池敏令 1), Corner British 1), Asagi Akinori 2), Rough sea field adults 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2012.

---

Side effect expression situation investigation in the cisplatin pemetrexed bevacizumab combination therapy to P1-136 patients with nonsmall cell lung cancer 京谷充崇 1), Dozu Maiko 1), Tomohiko Harada 1), Yuka Kishimoto 1), Shuji Murakami 2), Tetsuro Kondo 2), 齋藤春洋 2), 尾下文浩 2), Kozo Yamada 2), Mayumi Nagano 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2012.

---

	Action of the oral anticancer drug drug control instruction in the P1-137 outpatient department Ogura Takafumi, Ishizuka beauty Europe, Tomoko Kawasaki, Rieko Nagatani, 島田朋弥, Takeba Kazuyo, Takayoshi Matsumoto, Yusuke Matsumoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2012.

---

	Role of the working full time pharmacist in the P1-138 outpatient department chemotherapy room Tomoko Kitaoka 1), Aiko Yamashita 1), Ken Nishi Taro 1), Saori Azuma 2), Boundary Kenji 3), Harumi Tanoe 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2012.

---

	Relation of the pharmacist in the oral P1-139 anticancer drug remedy patients Mountain Seki wisdom, Yasushi Otani Jiro, 市江敏和, Inoue lily, Yoshiko Fukazawa, Yoko Natsume, Mana Muto charges, Eiji Nakayama, Yoji Sugiura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2012.

---

It is ... from a viewpoint of the number of examination - order changes and the number of about the utility of drug control instruction duties to conduct on all intravenous feeding anticancer drug administration day in the P1-140 outpatient department Japan Society of Chemotherapy course Takeshi Midorikawa, Shiro Kawada, Shin Iizuka solstice, Yoshihiro Honda, Takuya Maeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2012.

---

	Use experience of everolimus for the P1-141 pancreatic neuroendocrine tumor Masato Matsuura, Kazuya Arai, Hitoshi Yoshida, Isono Junichi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2012.

---

	Example of the pharmaceutical intervention that seemed to contribute to safe securing of P1-142 cancer chemotherapy Hirotaka Shimota, Tomohito Nakazawa, Toshiaki Sudo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2012.

---

	The patients decision making method using the Analytic Hierarchy Processes (AHP) in the P1-143 cancer chemotherapy Hama Wuqing example, Nobuhiko Nakamura, Yoshitaka Yano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2012.

---

	Making of the manual for patients based on the side effect expression of P1-144 azacitidine situation Naoki Mukoyama 1), Yoshiaki Ikeda 1), Koichi Miyamura 2), Kazuhiro Mori 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2012.

---

	A change and evaluation of the prescription suggestion contents of the pharmacist by the P1-145 cancer pain palliation assessment Ryuichi Hishinuma, Kanae Sakakibara, Kyohei Mita, Masateru Kojima, Tsuneaki Tanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2012.

---

	Patients questionary survey for the medicine notebook induction in the P1-146 breast cancer chemotherapy Shrine way 1, Futaba), Hideya Kokubun 1), Watanabe Koji 1), Ritsuko Miyajima 1), Rumiko Kondo 1), Hajime Matsubara 1), Norihiko Sengoku 2), Makiko Kato 3), Kazuo Yago 1) 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2012.

---

	The serious drug interactions case that led to discovery by P1-147 ward permanent residence Even Chieko, Takao Orii Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2012.

---

	Investigation of the use situation and the side effect expression of azacitidine in the P1-148 this hospital Mio Endo 1), Daisuke Hirate 1), Masami Tenma 1), Hideto Yahagi 1), Hongo education 1), Ando spirit chapter 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2012.

---

	Relation of the pharmacist in the P1-149 outpatient department chemotherapy Toshiaki Watanabe, Misako Endo, Shin Oda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2012.

---

	About the effect on side effect of drug interactions of aprepitant and dexamethasone in the P1-150 MonthlyTC therapy and laboratory values Shinichi Kitamoto, Tomohiro Furuya, Yuko Yanagida, Shizuka Fujii, 長崎信浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2012.

---

	Use experience of aprepitant and Foss aprepitant in the P1-151 this hospital 渡部寿康, Toshio Yamaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2012.

---

	Discussion for the vasculitis due to P1-152 Fosaprepitant 齊藤麻衣子1), 服部豊1), 山澤真之1), 鈴木真彦2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2012.

---

Investigation about nausea and vomiting in gemcitabine + cisplatin combination therapy for the P1-153 biliary tract cancer Ryoko Udagawa 1), 森實千種 2), 牧野好倫 1), Nobuaki Yokote 1), Hideyuki Hayashi 2), Yasunari Sakamoto 2), Shunsuke Kondo 2), Hideki Ueno 2), 奥坂拓志 2), Hiroshi Yamamoto 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2012.

---

	Examination that it points out the effect by the antiemetics review in the P1-154 this hospital cancer chemotherapy Tomomi Sato, Ayumi Yoshida, Katsuyuki Suzuki, Mizunuma lap city, 諏江裕 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2012.

---

	Examination about nausea, the vomiting reduction effect of the antiemetics in patients receiving P1-155 cisplatin Katsunori Sakai, 廣畑秀記, Ryuta Urakawa, Kayo Matsuura, Hidekatsu Fukuda, Katsuei Nanba Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2012.

---

The nutritional status in the stage IV patients with nonsmall cell lung cancer using the P1-156 carboplatin regimen and prognostic relative examination Kazumasa Koshikawa 1), Isobe mildness 2), Akiko Kurosawa 3), Kozono Kouki 1), Takayoshi Kosugi 1), Kiyomi Yamada 3), Kenji Nishizawa 1), Sakae Honma 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2012.

---

	The use situation of emetic risk classification and aprepitant of the P1-157 regimen Masayo Shimomura, 上村宅司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2012.

---

	Fact-finding and evaluation in the dose of the P1-158 hydrochloric acid amrubicin and antiemesis therapy 秋山耕治, 山澤理恵子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2012.

---

A utility of aprepitant in the P1-159 transplantation of autologous hematopoietic stem cells pre-treatment and safe examination King Suetsugu table 1), Uchida まやこ 1), Pond end Hiroaki 1), Saori Uchida 1), Koji Kato 2), Miyamoto Toshihiro 2), Hiroyuki Watanabe 1), Masanori Sueyasu 1), Nobuaki Egashira 1), Ryozo Oishi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2012.

---

	Comparison of nausea, the vomiting frequency in the P1-160 colorectal cancer cancer chemotherapy regimen Norio Takimoto, Shiho Sugawara, Takashi Sakakibara, Kenji Mori, Yoichi Kondo, Sugawara sheath, Noriko Tsuzuki, Mariko Ando, Hoshizaki Yui, 足立守 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2012.

---

	Examination of the efficacy of antiemetics at P1-161 altitude, the moderate emetogenic anticancer drug administration 敦見真由美, Koto Fujiwara, Natsuko Fujimoto, Fujimoto A, Kotaki law of nature Yoriko, Yumi Iwasaki, Takashi Nakatani Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2012.

---

	Comparison between granisetron and palonosetron for the intermediate-risk anticancer drug in the P1-162 colorectal cancer first therapy mFOLFOX6 therapy Toshiyuki Hirai, Seki Toshikazu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2012.

---

	P1-163 Comparison of the antiemetic effect of the use of performance and Aprepitant of Proemend in Aichi Cancer Center Hospital 松崎雅英, 前田章光, 則竹香奈, 長瀬智也, 水谷旭良, 加藤恵一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2012.

---

	Efficacy of aprepitant for the digestive symptom with carboplatin in patients with P1-164 lung cancer Kaori Yamashita 1), Masayuki Miyazaki 2), Masako Ito 2), Shoko Tsuchiya 1), Seishi Kondo 3), Yoshinori Hasegawa 3), Kiyobumi Yamada 2), Teruhiro Mori 1), Yukihiro Noda 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2012.

---

	Inspection of the risk factor of nausea, vomiting at the P1-165 cancer chemotherapy Sanae Iwatsubo, Koichi Matsuo, Minako Higuchi, Yoshimi Sasaki, Yoriko Wada, Sachi Fukuhara, Tomori Kawano, Hiroaki Nishino Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2012.

---

Comparison of the antinausea effect of Granisetron 3 mg for nausea, vomiting in the P1-166 first line FOLFIRI therapy of progress, patients with recurrent colorectal cancer impossible of excision and Palonosetron 0.75 mg Yutaka Ishikawa 1), Yuko Kudo 1), Kobayashi village British 1), Jin Kimura 1), Toshiaki Kato 1), Michihiro Shino 1), Machida wish 2), Kentaro Yamazaki 2), Hiroshi Yasui 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2012.

---

	Comparison between P1-167 palonosetron and antinausea effect on oxaliplatin component regimen in granisetron Shiho Sugawara, Norio Takimoto, Takashi Sakakibara, Kenji Mori, Noriko Tsuzuki, Mariko Ando, Yusuke Yamanaka, Furukawa sand sail law of nature, Hoshizaki Yui, 足立守 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2012.

---

	Examination (examination of the effect of 2 addition drugs of the additional drug in the P1-168 aprepitant combination antinausea therapy Masahiro Kawai, Shinichiro Suzuki, Akio Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2012.

---

Action ... irinotecan to antiemetics proper use in the P1-169 cancer chemotherapy, evaluation ... by the colorectal cancer chemotherapy regimen containing oxaliplatin Yoriko Wada, Koichi Matsuo, Minako Higuchi, Yoshimi Sasaki, Sanae Iwatsubo, Sachi Fukuhara, Tomori Kawano, Hiroaki Nishino Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2012.

---

	Use fact-finding of the cisplatin short time transfusion regimen in the P1-170 Fukui Prefectural hospital 坂井伸成, Hideaki Kato, Mitsue Uno, 佐澤佳彦, Takashi Hiraga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2012.

---

Pharmacokinetic examination in the repeated doses in the palonosetron vein for severe P1-171 or moderate emetogenic antitumor agents administration cases Kentaro Ogata 1) 2), Yosuke Igari 3), Original Shuji 2), Akira Ishizu direct 3), Yasushi Takamatsu 3), Kazuo Tamura 3), Kojiro Nikami 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2012.

---

Quality of life evaluation of aprepitant in patients receiving lung cancer cisplatin using the P1-172 effect level Masayuki Ejiri 1) 2), Hiroki Arakawa 2), 牛膓沙織 2), Sumiyo Ito 2), Yumiko Sato 2), Iku Tsukiyama person 2), Tatsuya Hisada 2), Itakura affinity 2), Hiroko Saito 2), Akio Katsumi 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2012.

---

	Intervention - to anticipatory nausea, vomiting of the utility -FEC therapy of continuation support from P1-173 hospitalization chemotherapy to ambulatory treatment Miwa Yonezawa, Chiyoko Yamada, Yukiyo Kinoshita, 柏原宏暢 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2012.

---

	Example that P1-174 Olanzapine was effective for nausea, vomiting with the chemotherapy 松野知寛, Noriko Hanada, Yutaka Ueyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2012.

---

Evaluation of the change of the antinausea effect by the antinausea therapy standardization of the P1-175 outpatient department chemotherapy regimen Kazumi Yamaguchi 1), Mitsuhisa Azuma 2), Mizushima parent beauty 3), 杵崎正典 1), Yutaka Nishikawa 1), Hiroko Yamakawa 1), 山下加那子 1), Eisaku Tanaka 4), Eitaro Nakatsuka 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2012.

---

	Examination - in the action - moderate degree emetic risk regimen to antiemetics proper use in the P1-176 cancer chemotherapy Yuko Okuyama, Takako Miura, Kubota Masae, Yuko Fujii, Tanaka sunlight, Kazuki Ishikura, South Kazushi, Dove Natsuko, 田村健悦, Origin of Hiraga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2012.

---

A low dose for P1-177 head and neck cancer or prophylactic antiemetics in the chemoradiotherapy to use division cisplatin together at the same time 吉田幹宜 1), Shinya Suzuki 1), Tomohiro Enota 2), Sonoko Furubayashi 1), Inanimate object Hiroto 2), Ichiji Endo 3), Tahara sincerity 2), Satoshi Izumi Shiro 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2012.

---

	Examination about the utility of the use of palonosetron for the P1-178 breast cancer FEC therapy 森光保武 1), Yoshinori Okuno 1), Yu Takada product 1), 濱岡敬 1), Masahiko Ikeda 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2012.

---

	Fact-finding for nausea, vomiting of antiemetics used at P1-179 this hospital cancer chemotherapy Misaki Matsuo 1), Hidetoshi Miyake 1), Akihiro Sumida 1), Naoko Ishikawa 1), Noriko Mukai 2), Kyoko Koga 1), Kazuyo Hashimoto 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2012.

---

	Examination of the utility of the antinausea therapy standardization for nausea, vomiting with the P1-180 cancer chemotherapy Sato male oneself, 龍田涼佑, Ryosuke Nakahara, Hiroki Ito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2012.

---

The onset situation of nausea, vomiting of the cancer chemotherapy with the P1-181 moderate degree emetic risk injection Tomohiro Kakimoto, 野間口寛, Reiko Kirino, Takeshi Takahashi, Middle Yuka Kihara, Toyosumi Ayako, West Kyoko Tsuji, New top Kanako, Hiramatsu sheath, Morihiko Terashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2012.

---

	The use situation of aprepitant in the P1-182 this hospital Miki Watanabe, Tomoko Yamada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2012.

---

Investigation of the palonosetron antinausea effect in the TC therapy using the P1-183 treatment diary Keiko Kawakami 1), White Hiromi Sawa 1), Sayuri Takeuchi 2), Flat pond Mikako 1), Yoichi Hiraki 1), Kenichi Manabe 1), Takashi Nagai 3), Mika Takagi 3), Hiroshi Nishimura 3), Hiroyuki Mimori 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2012.

---

	Comparison of antiemetics in the combination therapy containing carboplatin of the P1-184 non-small cell lung cancer Hiroko Uchiyama, Tree south Shiro, Kazuhiro Igarashi, Two ノ storehouse Hiroyuki, 石本昌裕 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2012.

---

	Examination of the risk factor of the expression of fact-finding of the antinausea control of the P1-185 outpatient and nausea, vomiting Akiko Kawana, Osamu Amuro, Isesaki Tatsuya, Junko Nagai, Tadanori Sasaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2012.

---

	Use investigation of antiemetics for nausea, vomiting of P1-186 azacitidine Masato Matsuura, Small Makiko Aze, Hitoshi Yoshida, Isono Junichi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2012.

---

Examination of the antinausea effect by the aprepitant combination in patients who received P1-187 children chemotherapy Tatsuo Kataoka 1), 櫻下弘志 1), Truth Emiko Shida 1), Satoshi Sato person 1), Nakajima spring Kei 1), Mizuka Miki 2), Hiroshi Kawaguchi 2), Yasuyuki Saeki 1), Yasuhiro Kimura 1), Tree flat Kenji 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2012.

---

Randomized non-recessive controlled trial of the antinausea effect of azasetron oral medicine and the granisetron injection based on P1-188 5-HT3 receptor occupation theory Maya Yamada 1), Iibaru University Minoru 1), 遠渡純輝 2), North city Kiyoyuki 1), Katsuhiko Matsuura 1), Yasushi Ono 2), Yoshinori Ito 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2012.

---

	One patient who experienced administration for granisetron, aprepitant in P1-189 cisplatin divided doses, dexamethasone five days 錦織昌裕, Ryo Iwamoto, The Arai future, Masahiko Usuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2012.

---

Comparison of the antinausea effect before and after the use of palonosetron in patients with lung cancer given Cisplatin multidrug therapy of the P1-190 cleavage type Kengo Umehara 1), Ai Watanabe 2), Keisuke Otsu 1), Yoshiko Wada 1), Miyamaru Akina 1), Young book Azusa 1), First mountain Tae 1), Michiya Kobayashi 1), Hideki Sato 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2012.

---

Evaluation of the depression effect of granisetron for nausea, vomiting with the chemotherapy of the P1-191 malignant lymphoma 篠原義剛 1), Hiroaki Morimoto 2), Junji Iwashige 2), 東丈裕 2), Katsuragi Takefumi 2), Naho Nomura 2), Hidehiro Kamachi 1), Shiho Kikuta 3), Junichi Tsukada 2), Kojiro Takahashi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2012.

---

	Examination of the onset risk factor of the tumor lysis syndrome in the P1-192 hematopoietic tumor Naomi Noguchi 1), Mt. Ishii husband 2), Yuichi Kinjo 1), Tsuyoshi Suzuki 2), Namba existence intellect 2), We consider among outsiders husband 2), Seiji Kinjo 1), 宇野司 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2012.

---

	Use of antihypertensive agent fact-finding for patients receiving P1-193 bevacizumab Pebbly riverbed intellect Sae 1), Kana Sugitani 1), Keiko Komori 1), Chie Mochizuki 1), 丁元鎮 1), 桝喜惠 1), Mikio Mukai 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2012.

---

	1 case that responded to pregabalin for peripheral neuropathy with the P1-194 taxane system anticancer drug Satoko Amano, Takashi Imai, Atsushi Tsubochi, Yumiko Saeki, Michiko Kamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2012.

---

	Exanthematous examination to occur after P1-195 pemetrexed administration Takashi Imai 1), 西垣俊太 1), East Keiko Tsutsumi 2), Yumiko Saeki 1), Yutaka Otani 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2012.

---

	Relations of skin reaction and NSAIDs of P1-196 panitumumab Satomi Sugano 1) 2), Yutaka Ishikawa 2), Jin Kimura 2), Yuko Kudo 2), Kenichi Suzuki 2) 3), Toshiaki Kato 2), Megumi Konno 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2012.

---

	The adverse event of the administration method takes measures P1-197 recurrence for every albumin-binding paclitaxel three weeks for metastasis-related breast cancer Chiyoko Yamada, Miwa Yonezawa, Yukiyo Kinoshita, Shigeharu Kiyama, 柏原宏暢 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2012.

---

	The effect that example ... high dose dexamethasone of acute renal dysfunction that occurred during P1-198 multiple myeloma treatment gives patients with diabetes Takashi Masuno 1), Hiroyuki Horiguchi 1), Teruo Obata 1), Bank Noriaki 1), Masayuki Tamura 1), Takahiro Jinbo 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2012.

---

	Action to be given side effect monitoring of the P1-199 cancer chemotherapy effectively 和賀信継, Tamami Takahashi, Eri Sugano clothes, Kazufumi Sato, Miyuki Minamikawa, Kumiko Endo, Toshihiro Kumagai, Shoichi Murakami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2012.

---

	Investigation about the frequency of tardive phlebitis with P1-200 bendamustine Tetsuo Kume 1), 望月敬浩 1), Shigeyo Sakata 1), Michihiro Shino 1), Ogura sum outside 2), 池田宇次 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2012.

---

	Examination of the effect that ST mixture prophylaxis gives at R-THP-COP-21 therapy enforcement on P1-201 onset B-cell lymphoma Takashi Goto 1), Kazuki Tanimoto 2), Kazuaki Ueda 1), Fish well Miyuki 1), 三角紳博 1), Takashi Nishino 1), Seiichi Okamura 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2012.

---

	It is the factor analysis of complications after the subcutaneous burying type middle cardiac vein port custody in the P1-202 colorectal cancer chemotherapy Shinki Yoshino 1), Naoya Saito 1), Prince Yasushi Takii 2), Mayumi Kaise 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2012.

---

	Examination about the onset of skin reaction by P1-203 Panitumumab Yuko Kudo 1), Satomi Sugano 1) 2), Kobayashi village British 1), Yutaka Ishikawa 1), Jin Kimura 1), Toshiaki Kato 1), Michihiro Shino 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2012.

---

	Examination about the utility of pregabalin for peripheral neuropathy with P1-204 paclitaxel Takuya Fujimura 1), Yasuo Kubota 2) 3), Mayuko Soma 1), 今田愛也 1) 4), Yoichi Sasaki 1), Kumiko Kasashi 2), Takehiro Yamada 2), Takeshi Iseki 2) 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2012.

---

Evaluation of the situation and the correspondence of the P1-205 doxorubicin-related flare response 森章哉 1), Tomohiro Takahashi 1), Yuka Maekawa 1), Daisaku Kuki 1), Yoshihiro Nishikawa 1), Yumiko Hasegawa 2), Yoshihide Miyazaki 2), Tadashi Fujita will 1), Satoru Morita 1), Takuya Yamakawa 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2012.

---

	Inflection of the nephropathic evaluation and patients self measurement diary at the cisplatin administration using the P1-206 short hydration method Daisuke Nakanishi 1), Ayako Deguchi 1), Tadashi Naito University 2), 畑地治 2), 柳川泰裕 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2012.

---

	One case that produced tinea corporis by skin reaction measures of P1-207 Panitumumab Yoko Hanaoka 1), Yoshikazu Seino 1), Okazawa incense Tsu child 1), Kenichi Ikeda 1), Yoshiro Fujimori 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2012.

---

	Competitive review about the hiccup before and after the P1-208 aprepitant induction 金井貴充 1), Takuya Furukawa 2), Yutaka Kubota 2), Hirofumi Konjo 2), Salt Noiri length male 1), Kazuhiko Saito 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2012.

---

Utility of the glycemic control by the pharmacist under the search of the glycemic control method at the steroid administration for patients with hematopoietic tumor who had P1-209 diabetes and the joint medical treatment management 土手賢史 1), Description of Sawai hemp 1), Takeshi Hattori 2), Ayumu Nozaki 1), Yuka Kobayashi 1), Moriguchi Kotobuki virtue 3), Shoichi Doi 3), Hirokazu Nakanishi 4), Toshiko Aramiya 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2012.

---

	We look at the rear for a present conditions investigation and early detection about the adverse event of eyes part through P1-210 paclitaxel and examine a mark Yusuke Noguchi, Rie Nishimura, Tile Hiroko, Kiyotaka Omori, Keiji Matsumoto, Yoko Tokuyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2012.

---

	Investigation about the effect that an adverse event of the P1-211 XELOX therapy receives in glycemic control of diabetes Hiroaki Usui 1), 野村久祥 1), 川上英泰 1), Yuichiro Abiru 1), Yoko Kobayashi 1), Tadashi Yoshida 1), Atsushi Furuse 2), 1, Takao, Shinohara), 永井茂 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2012.

---

	P1-212 Comparison of side effects in Bortezomib subcutaneous administration and intravenous administration to patients with multiple myeloma 兼松哲史1), 高井満1), 吉田均2), 伊藤貴彦2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2012.

---

	One case that was treated effectively with methylene blue for P1-213 Ifomide encephalopathy Mikiko Matsuda 1), Yoshikazu Okuma 2), Junichiro Yuda 3), Main room りこ 4), Suguru Omoto Jiro 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2012.

---

	The analysis of the risk factor of the allergic reaction attributable to P1-214 Oxaliplatin and evaluation of the prophylaxis Retsu Shimada, Haruhiko Aikawa, Tomio Matsumoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2012.

---

	P1-215 Taxotere (about onset of vasculitis in preparation changes from R note to one Taxotere (R Miki Katsuragawa, Tokutome chapter, 谷口亮央, Hatsumi Kikuta, Ryu Kobayashi, Hideji Ohara, Muki Ryoichi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2012.

---

We are analyzed with a tendency of the myelosuppression at change from TC therapy in the P1-216 gynecologic cancer case to DC therapy Takahiro Arai 1), Makoto Fujita charges will 1), Taeko Saito 1), Fumi Mukoda 1), Tomoji Ibuki 2), Takashi Hirakawa 2), Kanuma Tatsuya 2), Yaeko Mishima 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2012.

---

	Risk factor of serious neutropenia with the P1-217 adriamycin - cisplatin combination therapy Masami Tada, Shinichi Hikasa, Takeshi Kimura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2012.

---

	Investigation of the onset of cutaneous symptom risk factor to lead to cancellation of the P1-218 panitumumab administration or weight loss 古田祐美子, 土手賢史, 溝手彩, 日置三紀, 野崎歩, 岩根裕紀, 小林由佳, 新宮とし子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2012.

---

	Examination of the kidney protection effect of magnesium in the patients considered that P1-219 cisplatin administration is high-risk Takahiro Murakami, Kazuyuki Nanba, Hiroko Yahata, Yuka Watanabe, Junichi Kubo, Eiji Funaki, Yoshihiro Hashimoto, Shigeki Tanaka, Hitoshi Komori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2012.

---

	Acyclovir prophylaxis for the herpes zoster in P1-220 malignancy blood disorder Yasuyuki Fujita 1), Shinichi Goto 2), Ikeda ability interest 1), Shuhei Harada 1), Sadaji Irie 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2012.

---

	Use fact-finding of the rasburicase in the P1-221 Fukui Prefectural hospital 加藤秀明, 坂井伸成, 宇野美津江, 佐澤佳彦, 平賀貴志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2012.

---

	Efficacy of the pre-medication for oxaliplatin hypersensitivity in the P1-222 this hospital Maki Takimoto 1), Chie Wakaki 2), Yuko Kitano 2), Virtue comfort Masato 3), Toku Mizukami Expo 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2012.

---

Effect of the expression situation and the vascular pain measures regimen of the vascular pain in patients who received P1-223 XELOX therapy Hideki Ezaki, Norio Takimoto, Shiho Sugawara, Takashi Sakakibara, Noriko Tsuzuki, Mariko Ando, Furukawa lawn sail village, Hoshizaki Yui, Yusuke Yamanaka, 足立守 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2012.

---

	Discussion for the hiccup of the P1-224 NK1 receptor blocker Kumagaya 1 required), Toshio Matsunami 1), 枝廣茂樹 1), Hiroko Okawa 1), Mutsuko Okada 1), Kyomi Kaneta 2), Genichi Nishimura 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2012.

---

	Contribution of the pharmacist with the one Taxotere (R) administration actual situation for patients with P1-225 alcohol irritation Hiroyuki Totsuka, 高橋喜統, 多賀允俊, Shizuyo Imagawa, Koji Nishio Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2012.

---

	About neutropenia every regimen that we considered from the use situation of the P1-226 G-CSF preparation Yoshikuni Kenji, Tsuneo Kuwamura, Takashi Akamatsu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2012.

---

Intervention of the pharmacist to skin care instruction aiming at the skin reaction prevention with P1-227 erlotinib Shigeki Ohata 1) 2), 中條倫成 2), Fumiyoshi Kato 2), Keiko Hirano 2), Akiko Mochizuki 2), Hiroaki Utsuki 2), Nabeta Izumi 2), Midori Kimura 2), Takashi Suzuki charges 2), Eto still 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2012.

---

	Effect of the polaprezinc / alginate sodium on stomatitis to be caused by salvage chemotherapy at the P1-228 hematopoietic stem cell transplantation pre-treatment 船渡三結1)2), 林寛子1), 石原正志1), 北市清幸1), 安田公夫2), 伊藤善規1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2012.

---

	About a utility of the moisture retention in patients receiving capecitabine in P1-229 colorectal cancer Mayumi Takeuchi 1), Etsuko Mishima 1), Manabu Yokota 1), Niimi Masanori 1), Yuka Takeuchi 2), Eiji Hayashi 3), Teruyuki Murakami 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2012.

---

Effect of pregabalin on peripheral neuropathy with the P1-230 cancer chemotherapy 小川晃宏 1) 2), Chiaki Yoshimi 2), Iibaru University Minoru 2), North city Kiyoyuki 2), Takahashi cocoon 3), Kurahashi small child 3), Takao Takahashi 4), Kazuhiro Yoshida 4), Tadashi Sugiyama 1), Yoshinori Ito 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2012.

---

One case of patients with head and neck cancer that anticoagulant therapy during cancer chemotherapy was managed appropriately by the intervention of the P1-231 pharmacist Shinji Honma, Miki Akizuki, This Western philosopher, Michiyo Terasawa, Hidekazu Kizaki, 川瀬泰裕, Kenichi Ooe, Yasuhiko Hirota Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2012.

---

	Examination about a side effect of P1-232 bendamustine and the measures Will intellect Saori 1), Mihoko Hirai 1), Jiyun Hayashi male 1), Yamase University male 1), Emi Shoji 1), Ikuko Kodaira 1), 籠本基成 1), Masahiro Ishizu 1), 通堂満 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2012.

---

It is the adverse event expression situation of the patients using azacitidine for treatment of the P1-233 marrow atypia syndrome White Hiromi Sawa 1), Flat pond Mikako 1), 1 related to Osono), Noriko Okubo 1), Shina Sogabe 1), Yoichi Hiraki 1), Kenichi Manabe 1), Hidetoshi Kamimura 2), Yoshiharu Karube 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2012.

---

Comparison of millimeters plastic Japanese spaniel (MPT) and cisplatin (CDDP) to look at for fever after P1-234 hepatic arterial infusion chemistry embolus treatment (TACE) The Kishimoto truth, Long ヶ Takuma Hara, Ogyou Yukiko, Mari Nishimoto, Kazuyuki Sunada, The Yoshimura truth, 佐久間弘匡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2012.

---

Examination - that we paid our attention to elucidation - internal cause nitric monoxide synthase inhibitor ADMA of the P1-235 cyclophosphamide-induced cystitis haemorrhagic mechanism of pathogenesis Yuka Hattori 1), Yu Hotta will 1), Yutaka Takahata 1), Yasuhiro Maeda 1), 木村和哲 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2012.

---

	Examination of urinary ADMA as the new diagnosis marker for the P1-236 cisplatin-induced renal failure 久野亜耶奈 1), Masae Ono 1), Yu Hotta will 1), Yasuhiro Maeda 1), Katsuhiro Kondo 2), 木村和哲 1) 2) 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2012.

---

	Effect of the rebamipide ointment on cheilitis by the side effect of the P1-237 anticancer drug Yasuko Aizawa 1), Aya Okubo 1), Kazuhiro Fujii 2), Arima success 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2012.

---

	Study on onset with the P1-238 irinotecan hydrochloride of dry skin and prevention Satoshi Yokoyama 1), 伊奈田宏康 2), Masahiko Hayashi 3), Kazuya Ooi 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2012.

---

	The use actual situation of the tetracyclines antimicrobial for the dermatopathy of the cetuximab panitumumab in the P1-239 St. Marianna University School of Medicine Hospital 磯部瞳1), 森田一1), 横田真里1), 湊川紘子1), 伊藤由香1), 友野亜妃子2), 京盛千里2), 津田享志3), 増原慶壮1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2012.

---

	Action of the pharmacist for folic acid, the vitamin B12 combination in the P1-240 pemetrexed therapy Fujiko Yamazaki, Takayuki Miyakawa, Fumiko Sasaki, Masato Hikichi, Matsuhisa Noriaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2012.

---

Non-small cell lung cancer treatment - eruption mild objective weight loss administration and effect of treatment - using P1-241 erlotinib Naoki Takashima 1), Tomoki Kimura 2), Takahiro Watanabe 2), Takumi Umemura 1), 勝野晋哉 1), Nishiyama law of nature 3), Yasuhiro Kondo 2), Hiroyuki Taniguchi 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2012.

---

	P1-242 1 case of cancer chemotherapy in implementation drug-induced thrombocytopenia due Sarpogrelate has improved in the involvement of the pharmacist 大久保節子1), 大久保正2), 田中真理子3), 大久保七枝2), 大久保美穂4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2012.

---

	Examination of the renal failure protective efficacy with the magnesium administration for the P1-243 initial FP therapy Shiho Hirai 1), Tadaaki Ito 1), Shinobu Hasebe 1), Kaida Sachiko 2), Masanori Ueno 2), Seishi Udagawa 2), Masahiro Hayashi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2012.

---

	Protective efficacy of phlebitis by vascular exposure time shortening of the P1-244 epirubicin hydrochloride and safe examination Kazuya Isoda 1), Kan Yukio 2), Kazuki Takeda 1), Hiroyuki Furukawa 3), Masashi Iguchi 3), 崔吉道 1), Kenichi Miyamoto 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2012.

---

	Utility inspection (the first report) of the automatic warmer for the transfusion which we used in a symptom reduction purpose for the vascular pain that resulted from P1-245 Oxaliplatin administration 高橋典哉 1), Fumiko Takahashi 2), 小笠原信敬 1), Akito Nagashima 1), Shinsuke Honjo 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2012.

---

	The expression situation of the circulatory system side effect in the P1-246 5FU+ cisplatin combination chemotherapy and association with laboratory values Mayumi Kaise 1), Shinki Yoshino 2), Haruki Nagai 3), Shunya Sasaki 4), Yuji Okura 4), Yoichi Maruyama 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2012.

---

	Investigation about the onset of adverse event situation in the P1-247 XELOX therapy Toshiaki Kato 1), Shigeyo Sakata 1), Yutaka Ishikawa 1), Jin Kimura 1), Yuko Kudo 1), Kobayashi village British 1), Michihiro Shino 1), Kentaro Yamazaki 2), Hiroshi Yasui 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2012.

---

	It is an investigation about the decollement expression at the docetaxel therapy for every P1-248 three weeks Mami Kobayashi 1), Hiroko Suzuki 2), Kiyoshi Mizusawa 1), Joji Okamoto 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2012.

---

	Onset of Colin symptom situation analysis with P1-249 irinotecan Kaori Matsumoto 1) 2), Midori Kimura 2), Nabeta Izumi 2), Hiroaki Utsuki 2), Takashi Suzuki charges 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2012.

---

About likelihood of the investigation about sleep disorders of patients with P1-250 cancer and the pharmaceutical intervention Ko Hiraide stone 1) 2), Yoshihiro Miyamoto 1), Chika Ichihara 1), Yoko Kobayashi 2) 3), Italy Tetsuya Saji 2) 3), Fumiko Suzuki 2) 3), 江 ノ sweet sake beauty 2) 3), Takako Imazeki 1), Takeshi Kato 1), Yutaka Ozeki 2) 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2012.

---

	Examination to a cancellation reason of the P1-251 outpatient department chemotherapy (colorectal cancer) and foreign drug duties Akira Takagi Kei 1) 2), Kaoru Kobayashi 1) 2), Koichi Tanabe 1) 2), Yasuhiko Mimura 1), Atsushi Kato 1), Isao Adachi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2012.

---

The expression situation and measures of the skin reaction with cetuximab in patients who received P1-252 outpatient department cancer chemotherapy Tanaka 1, Mayuu) 2), Iibaru University Minoru 1), North city Kiyoyuki 1), Takahashi cocoon 3), Kurahashi small child 3), Takao Takahashi 4), Kazuhiro Yoshida 4), Kimio Yasuda 2), Yoshinori Ito 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2012.

---

	A side effect and measures of P1-253 myelodysplastic syndrome therapeutic drug azacitidine (AZA) Chizuko Ooka 1), Your Teramura early 1), Sakedani Hiromi 2), Mayumi Sato 2), Mayumi Katsuki 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2012.

---

	The effectiveness, safe examination of the rasburicase for the tumor lysis syndrome with the chemotherapy in P1-254 blood tumor 大坪達弥, 大塚充, 上田和正, 鹿浦香織, 神田英一郎, 岡橋孝侍, 西川靖之, 藤田敦夫, 野田能成, 小西偉雄, 三上正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2012.

---

	Efficacy of pregabalin in peripheral neuropathy with the P1-255 breast cancer chemotherapy 西村知恭 1), Megumi Matsumoto 1), Fujiwara University 1), Yoshinobu Saito 1), 天野賀弘 1), Chigusa 2 resigning from the post), Hiroki Ueda 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2012.

---

	Evaluation of the regimen intervention of the pharmacist for renal dysfunction of P1-256 cisplatin Hayato Sugimura, Makoto Hayashi, Kenji Miyazawa, Satoru Onishi picture, Akemasa Yamaya, Hiroshi Funaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2012.

---

Compare the non-elderly people (74 years old or younger) with safe evaluation ... elderly people (75 years old or older) of the XELOX+Bevacizumab(BV) therapy in the P1-257 this hospital; and ... Shun Kawai 1), Shoichi Hattori 2), Shunsuke Hamasaki 2), Yuji Hashimoto 1), Sue Katsuyuki 1), Sosuke Kogure 1), Yuji Sato 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2012.

---

	Effect on supplementation of P1-258 S1/CDDP therapy, aprepitant and the Mg preparation and renal function by the weight loss of hydration Kiyoko Tanimura 1), 菊井利伸 1), Seiji Onda 1), Fumihiko Kimura 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2012.

---

	Examination of the factor about onset of proteinuria with P1-259 bevacizumab 福本慈, 野村充俊, Sumiko Hiura, 加藤祐芳, Toru Asayama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2012.

---

	New trial to hypersensitivity, extravasation correspondence in the P1-260 cancer chemotherapy Maiko Saito 1), Yuka Kobayashi 2), Hidekazu Arai 1), Ikuyo Takahashi 3), Harumi Sudo 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2012.

---

	Infusion Reaction expression situation investigation at the P1-261 rituximab initial administration and comparison of the pre-medication Fujitani Masanori, Satsuka Yuki, Akiko Kitayama, Yuichi Koizumi, Mami Nomura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2012.

---

	Skin reaction measures with the P1-262 EGFR-TKI medicine Shinohara Keisuke 1), Atsushi Miura 1), Kazumi Yoda 1), Kiyomi Kurosawa 2), Yuko Maruyama 2), Hiromi Nakajima 2), Naomi Yoda 2), 大浦也明 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2012.

---

Medical supplies (study implementation situation - in examination of hepatitis B virus - this hospital with the administration of anticancer drug with the P1-263 immunosuppressive action Kentaro Okita, Shinseki green, Mie Ogata, Kazuhiko Tamura, Ayako Moriyama, Nakajima A Ichiro, Tomohiro Habu, Kazuhiro Kondo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2012.

---

	It is an example with suspected chemical thrombocytopenia during P1-264 colorectal cancer chemotherapy Kenji Miyazawa, Hayato Sugimura, Makoto Hayashi, Akemasa Yamaya, Hiroshi Funaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2012.

---

	For the side effect of cancer chemotherapy data collection that is more correct than P1-265 induction - to revision and the hospitalization of the - side effect check sheet 廣畑秀記, Ryuta Urakawa, Katsunori Sakai, Kayo Matsuura, Katsuei Nanba Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2012.

---

	Examination of the factor about hematotoxicity augmentation of P1-266 pemetrexed Hiroshi Hashiguchi, Hitomi Iimura, Masae Kubo, Satoshi Shinoda, Divine power Reiko, Kazuma Yano, Terumi Miyazato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2012.

---

1 case of liver dysfunction that resulted from the intervention uterine cancer postoperative chemotherapy (AP therapy and TC therapy) of the pharmacist to liver dysfunction at the treatment with P1-267 anticancer drug Kazuyuki Ito 1), 大橋養賢 1), Yasushi Arata 1), Michihiro Shino 1), Takekuma Munetaka 2), Yasuyuki Hirashima 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2012.

---

	A comparison and measures of the adverse event of Cetuximab and Panitumumab in the P1-268 this hospital Kenta Takahashi 1), Takaaki Shirakawa 1), History of Kei Abe 1), Junji Asano 1), Izumi Murata 2), Shigeto Sakuta 1), Yuichi Sekizawa 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2012.

---

	Evaluation of the correspondence after the anaphylactic expression with P1-269 oxaliplatin Mieko Kishi, Liquor mouth Hiromitsu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2012.

---

	The side effect of gemcitabine chemoradiotherapy expression situation for the P1-270 liver pancreatic cancer Yoichi Tanaka 1) 2), Kiyoshi Shibuya 1) 2), Tei Takahashi person 3), Takako Komiyama 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2012.

---

	The expression situation of the hand-and-foot syndrome with P1-271 molecules target medicine sorafenib and the measures Satoshi Taira, Noriko Moriwaki, 當真房子, Saori Yamamoto, Terumi Nagahama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2012.

---

Analysis and drug control instruction (2) of the adverse event of the lenalidomide therapy for the P1-272 multiple myeloma Katsuyuki Nakamura 1), Rev. Noda original 1), Toshiaki Hayashi 2), Tei Ishida husband 2), 篠村恭久 2), Koichi Takada 3), 井山諭 3), Junji Kato 3), Hiroshi Nakata elegant 1), Atsushi Miyamoto 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2012.

---

	The expression situation and actions to be taken of the vascular pain with P1-273 paclitaxel Noriko Moriwaki, 當真房子, Saori Yamamoto, Satoshi Taira, Terumi Nagahama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2012.

---

	Examination about the reactiveness with various menstruum of the P1-274 platinum Takashi Kato children 1), Yu Yamamoto 1), Michiko Kanamori 1), Mizuho Miyake 1), Mikiko Endo 1), 吉開晶一 1), Takushi Sato 2), Yoshio Ijiri 1), Kazuhiko Tanaka 3), Tetsuya Hayashi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2012.

---

	Examination about the effectiveness of the rasburicase for the tumor lysis syndrome prevention in P1-275 blood-forming organ tumor and the safety 大里洋一1), 伊賀千夏1), 鮎原秀明1), 藤本涼子1), 石井文雄1), 宮松洋信1), 横山智央2), 明石貴雄1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2012.

---

	Examination of the improvement effect on constipation / diarrhea with the chemotherapy of P1-276 functional foods bifidus bacillus end BB536 徳毛孝至 1), Keiko Hara 1), Toru Kiguchi 2), Hyperplasia Taro 2), Takeshi Kanbara 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2012.

---

	Action to measures and patients correspondence after the onset of allergy-like symptom in patients who received P1-277 TC therapy Aya Sugimoto 1), Noriko Kiriyama 2), 椿井朋 3), Masayuki Miyazaki 2), Masayuki Hiramatsu 1), Teruhiro Mori 4), Kiyobumi Yamada 2), Yukihiro Noda 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2012.

---

	Investigation about the dermatopathy by cetuximab in patients with P1-278 colon cancer and the panitumumab 神山紀子1), 鈴木亜実1), 福田萌美1), 渡邊徹2), 岡崎敬之介2), 村山純一郎2), 佐藤温3), 小西一男4), 山元俊憲1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2012.

---

	2 cases that presented Serious ADR with P1-279 oxaliplatin Kaoru Shirai, The number of Yutaka Hashimoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2012.

---

	Use experience of pemetrexed in the P1-280 renal function degeneracy patients Nakagawa spring 1), Mizuho Kamata greens 1), Yutaka Ueda 2), Osamu Konishi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2012.

---

Example that it showed the protraction of the large blood glucose level increase, hyperglycemia state by use of dexamethasone as the antiemetics for patients with P1-281 diabetes Shiro Kawada 1), Jun Sato person 2), Takeshi Midorikawa 1), Shin Iizuka solstice 1), Yoshihiro Honda 1), Takuya Maeda 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2012.

---

	Examination about measures of hyponatremia during the P1-282 FAP therapy enforcement Hilum pond Kaori, Fukuko Shimokawa, Sachiko Yasumoto, Yohei Hayashi, Shunsuke Kawabata, Kumiko Noguchi, Kayoko Watanabe, Atsushi Matsumoto, Kazunari Taniguchi, Fuminori Matsubara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2012.

---

	1 case that GFO(R) was effective for severe diarrhea with the P1-283 TPF therapy Kensuke Hirooka, Hiroyuki Shimizu, Eiko Yoneta, Tanaka pine Ichiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2012.

---

	Start use of the P1-284 Mohs paste Toyomi Murakami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2012.

---

	An action to reduction of the vascular pain in the P1-285 XELOX therapy and the evaluation Hikino Mayumi 1), Kenji Sato 2), Akihiko Osaki 3), Hiroshi Nakamura 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2012.

---

	Evaluation of the tramadol proper use in the P1-286 inside the hospital psychological care team Ayumi Kato 1) 2) 3), Ise Yuya 1) 3), Yumiko Hayashi 1) 2) 4), Shiro Katayama 1) 2) 3), Kazuhiro Nakanishi 1) 2) 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2012.

---

To practice cooperation ... substantial mild medical care between the pharmacists using P1-287 "information sharing sheet"; ... Miyatake wish 1) 2), Tokuyama picture straight 1), Hamada rabbitfish 1), Makoto Fukushima 1), Sowa Emi 3), Masato Ikeda 2) 4), Takuya Kitada 2) 5), Toshihiko Ishizaka 1), Junji Mukai 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2012.

---

	One case that used it, and was able to remit appropriate for respiratory depression with the P1-288 oxycodone with naloxone Fumie Koresawa 1), Yuichi Umeda 1), Katsuji Hayashi 1), Takehiko Makino 2), Shinsuke Takemoto 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2012.

---

	P1-289 One case that can be improved is refused drugs in the intervention of the pharmacist distrust for strong patient to the opioid 原敦子, 山下和海 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2012.

---

	About enlightenment activity about opioids, the sedative adjuvant in the P1-290 this hospital Kusakabe young of sweetfish 1), Bank former Maki 1), Sato Kei sinter 1), Rika Fukui 2), Akeda Katsuyuki 3), Kazuki Kikuchi 1), Toshiji Oe 4), Eri Ezoe 2), Many islands Takahiro 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2012.

---

	Three cases that olanzapine was effective for the P1-291 prochlorperazine nausea control bad patients of invalid opioids Kenichi in the new line Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2012.

---

	One case of the lower chin rhabdomyosarcoma which obtained the local control of tumor by P1-292 Mohs ointment Kamura Motoki 1), Naoya Ueno 1), Hiroshi Yoshimatsu chapter 1), Kioroshi Shiori 1), Natsuko Takahashi 1), 1 related to Fukushima), Mahiro Beppu 2), Tetsuro Ishigami 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2012.

---

About the side effect expression situation and measures after the P1-293 foreign initial opioid instruction and desensitization satisfaction Masato Suzuki, Mari Teramachi, Yuko Takahara, Tetsushi Maeda, The Amano apricot south, Mika Takeuchi, Look at Imai; Yasuko, Yoshihiro Kawade, Tree Masaji, Tomohiko Aoyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2012.

---

	P1-294 cases paroxetine has responded to phantom limb pain after amputation 岡本明大1)2), 岩本卓也1), 松峰昭彦3), 佐藤佳代子2), 鈴木大2), 中村喜美子2), 奥田真弘1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2012.

---

	Comparison about preparation properties of the P1-295 fentanyl percutaneous absorption type preparation (usability investigation) Akemi Noguchi, Hisashi Tsuru Seiko, Hiroko Fukue, Tomoko Ishikawa, Kazutaka Tsutsumi, Mieko Tsuruta Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2012.

---

	One case that efficacy of the Juzen-taiho-to was suggested in myelosuppression with the chemotherapy of the P1-296 small-cell lung cancer Ai Kuriyama 1), Keisuke Azuma 2), 伊與田友和 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2012.

---

	The efficacy of the midazolam intravenous dosage for the purpose of the securing of night sleep in the P1-297 cancer terminally ill patients and safe examination Yuri Okuno, Kato Daisuke, 長谷川久巳, Tadaaki Ito, Winnow music Mayumi, Yoshiko Yamaura, Kazuma Kishi, Masahiro Hayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2012.

---

	Effect on stability of the octreotide acetate by the mixture with the P1-298 morphine hydrochloride injection preparation Atsushi Wada child 1), Koichi Tanabe 2), Atsumi Nitta 1), Jun Okubo 2), Tomoaki Ikezaki 2), Mai Tanaka 2), Murakami wish 3), Hidenori Kitazawa 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2012.

---

	The preparation of the P1-299 gabapentin suppository and evaluation of the bioavailability Reed mouth sub-Rina, Isamu Murata, Yutaka Inoue, Masayuki Kimura, Ikuo Kanemoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2012.

---

	Use experience of the Juzen-taiho-to to myelosuppression with the chemoradiotherapy for P1-300 head and neck cancer Chika Aruga 1), Tsutomu Koitabashi 2), Hisashi Takeda Hitomi 2), 伊與田友和 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2012.

---

	Blood transition of metronidazole which we applied for the purpose of P1-301 cancer-related bad smell palliation Junichi Iida 1) 2), Toshiyuki Kudo 1), Satoshi Hasegawa 3), Pond Hideyuki 3), Toru Sato 2), Hajime Kagaya 2), Kiyomi Ito 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2012.

---

	Retrospective study on onset of chemical delirium in patients with P1-302 malignant tumor Masatoshi Saito 1), Hitomi Nakamura 2), 椎崇 1), Kensuke Usui 1) 2), Kazue Soda 1), Satoshi Takeshita 3), Atsuta Koichiro 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2012.

---

	Examination about the pregabalin remedy using the P1-303 simple suspension method Kaori Masuda, Umetsubo Shota, Tomohisa Onishi, Hitoshi Amada child, 河邊秀幸, Mayumi Murata, Tetsu Sato, Michihiro Shino Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2012.

---

	Fact-finding of the opioid initiation time in patients with P1-304 cancer Kaori Yamamoto 1), Shinya Suzuki 1), Ikuyo Ueda 1), Yasuhiko Ichida 1), Ichiji Endo 2), Satoshi Izumi Shiro 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2012.

---

	The case that chronically administered Chinese medicine suppository two drugs to P1-305 oral administration patients who received difficult ovarian cancer chemotherapy Takahiro Hirata, Hisao Ikeda, Mayuko Mori, Ryo Yoshioka, 野村浩英, Katsuyoshi Hatanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2012.

---

	Drug adoption situation investigation of the neighborhood institution in consideration of P1-306 regional alliances Osamu Kitamura, Kazuo Katsumata, Hiroshi Kawaguchi fruit, Yoshinori Kobayashi, Yutaka Kobayashi, Mariko Ijiri, Naoto Uchida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2012.

---

	Fact-finding and evaluation of the opioid rotation based on the P1-307 WHO method cancer pain therapy Mayu Osaka true 1), Etsuko Shinohara 1), Rei Kimura sand 2), 佐々木英久 1), 松尾和廣 1), Tomoko Watanabe 1), 加藤裕芳 2), Toru Asayama 2), Takashi Yoshio 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2012.

---

	Example that opioids became needless for the pain control of patients with cancer by the intervention of the P1-308 psychological care team Mari Kawano child 1), Mayumi Seino 1), Maki Sakamaki 1), Makoto Hasegawa 1), Shintaro Nomura 1), Nishioka Taro Gen 1), Fuminori Shibuya 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2012.

---

	An intracerebral delivery of morphine decreases at the P1-309 neuropathic pain Mitsumasa Kaneta 1), Marina Nagae 1), Risa Yanagida 1), Ayumi Mineo 1), 増川太輝 2), Igarashi sincerity intellect 1), Ochiai sum 1), Narita two a year), Tsutomu Suzuki 2), Kiyoshi Sugiyama 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2012.

---

	An example of head and neck cancer which was able to contribute to cancerous bad smell reduction by joining P1-310 treatment Hadame proton, Hiromi Suzuki, Kiyo Kawazumi, Iku Tsukiyama person, Yukio Toyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2012.

---

	One case of progress lung cancer that an opioid rotation succeeded from P1-311 high dose morphine constant infusion, and was able to leave the hospital Takako Murayama, Hiroko Amano, Emi Nanun, Hidenori Kawakami, Mt. end Expo man Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2012.

---

The present conditions and problems of the medical narcotic dispensing of the P1-312 Suwa local health insurance ethical pharmacy Kazuma Amino 1), Aiko Fujimori 1), Junko Taniguchi 1), 登内盛治 1), Osamu Atobe 1), Tomomi Sasaki 2), Mutsumi Hashizume 3), Kotaro Gomi 4), Hiroshi Kawanishi High School 5), Kazuyoshi Fujimori 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2012.

---

	About effect of dexamethasone which gives it to the glycemic control of patients with P1-313 diabetes merger cancer Tomokazu Fujii 1) 2), Hiroshi Suzuki 1), 澤柳直樹 1), Haruhiko Nakamura 1), Hisashi Tsukamoto 1), Kotaro Shibata 1), Tetsuo Adachi 2), Hisashi Kamiya line 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2012.

---

	One case of colon cancer who had the chronic renal failure that P1-314 FOLFIRI repeated dose was effective 北出紘規 1), Takeo Shimazaki 2), 北国憲剛 1), Mitsue Mori 1), Kimiko Shintaku 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2012.

---

	Examination of the toxic epidermal necrolysis (TEN) case by P1-315 Bendamustine Koji Okada 1), Masayuki Omura 1), Jun Oikawa 2), Kyoko Sakurada 3), Wano Masaharu 4), Katsuhiko Sato 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2012.

---

	Development of the remote inspection system supporting the anticancer agent preparation at the P1-316 satellite drugstore 佐藤淳也1)2), 森恵1), 佐々木拓弥1), 二瓶哲1), 於本崇志1), 山内敏司1), 祝偉裕3), 雉鼻一郎3), 工藤賢三1)2), 高橋勝雄1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2012.

---

	Investigation with the actual situation and the regimen of the cancellation reason in the P1-317 outpatient department cancer chemotherapy room Hiroshi Suzuki, Authority of Takashi Uchida, Yoko Sasaki, Katsuhiko Inomata, Yoshio Fujikake Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2012.

---

	Effect on blood phenytoin levels of P1-318 fluorouracil hepatic arterial infusion and the mFOLFOX6 therapy 前島光廣, Mitsuru Koizumi, Masako Oshima, Masaru Nakajima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2012.

---

	Relations of a survival period and the medication of patients with P1-319 progress recurrence colorectal cancer 續木康夫, Field road Akihiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2012.

---

	Conference before treatment by pharmacist leadership in the P1-320 outpatient department cancer chemotherapy room and the evaluation Hiroaki Hatakeyama 1), Kurasawa Hiroki 1), Aki Ichikawa 2), Izumi Morii Sayuri 2), Yoko Yui 2), Noriko Terao 2), Kaori Tanaka 2), Toru Ooi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2012.

---

	Examination - methotrexate high dose therapy ... about the injection preparing compound in consideration of P1-321 medical care security 梅原玲緒奈, Naoki Hayakawa, Ayako Ono, Interval Mari, Katsuya Makihara, 1, Kawabata success, 廣畑和弘, 山内一恭, Katsuya Komori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2012.

---

	Effect on everyday life of patients with breast cancer receiving P1-322 chemotherapy Sekiya wisdom, Kanako Takahashi, Ryoko Maruyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2012.

---

	Can (PFS) become the substitute index of (OS) for a survival period for the progression-free survival period of the P1-323 molecular target drug; analysis - by -Bayes Regression model? Tadao Inoue 1) 2), Hisashi Shimizu example 3), Wataru Yamamoto 2), Upper mound Yoshiro 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2012.

---

	About the patients side factor that a dose change is required after start of therapy 25 mg of P1-324 lenalidomide hydrate Corner proton 1), Kitazawa sentence 1), Fumitaka Ise 1), Kumi Ueda 1), Chihiro Shimazaki 2), History of Hisashi Takara 3), 杉井彦文 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2012.

---

It is an evaluation of the cancer pharmacotherapy by the clinical judgment analytical procedure scientific choice and evaluation of the P1-325 COX in progress, patients with recurrent colorectal cancer impossible of excision and SOX therapy Tadao Inoue 1) 2), 永瀬怜司 3), Hiroshi Sugano 3), 赤瀬朋秀 4), Ichiro Arakawa 1), Upper mound Yoshiro 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2012.

---

	Examination of the NST intervention patients in the P1-326 cancer special hospital Tagashira still person 1), 鵜池敏令 1), Yukie Asano 2), Michiyo Tanaka 3), Feather wisteria Shinji 4), Corner British 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2012.

---

	Activity of an intervention example and the pharmacist about the renal function evaluation at the P1-327 chemotherapy induction Hiroshi Hashimoto season, 村上通康, Junya Miyaoka, Kyohei Yamaguchi, Shozo Senba Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2012.

---

	Effect on hypersensitivity, anaphylaxis inspection of the pre-medication due to P1-328 oxaliplatin Tomoji Fushimi, Prince Sawamura will, Nishibeppu Hiroko, 高尾良洋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2012.

---

	Attitude survey for the cancer chemotherapy of the P1-329 healthy subject Kanako Takahashi, Sekiya wisdom, Ryoko Maruyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2012.

---

	The treatment situation for recurrent refractory multiple myeloma that we experienced in P1-330 this hospital Ken Hasuo product 1), 村本慎悟 1), 眞田功 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2012.

---

	1 case that secured safety by the intervention of induction - pharmacist of the mFOLFOX6 therapy to P1-331 chronic heart failure patients Mariko Matsubayashi 1), Maho Miyazawa 1), Yukihisa Imaizumi 1), Eisaku Sasaki 2), Yoshiharu Maeda 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2012.

---

To get rid of a difference of the cancer therapy between the P1-332 area pharmacist; trial (the first report) ... of the ... Fukushima Hospital Pharmacist Association Kooriyama Branch Tomohiro Suzuki 1), 岩上泰崇 1), Masahiro Kusano 2), Keita Watanabe 2), Yuko Ishida 3), Mikiya Takanashi 4), 5, Kishi, Aitsu), Mamiko Saito 4), Chika Aruga 6), 伊與田友和 6) 7) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2012.

---

We look at P1-333 Cetuximab and the rear about the change of the serum electrolyte level in Panitumumab treated patients and examine a mark Morimoto ability kernel 1), 野村久祥 1), Tadashi Yoshida 1), 川上英泰 1), Hiroaki Usui 1), Yuichiro Abiru 1), 1, Takao, Shinohara), 永井茂 1), Atsushi Furuse 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2012.

---

	The usability investigation after the portable chronofuser adoption change in the P1-334 colorectal cancer chemotherapy and examination of the time of administration 浦瀬剛嗣, Yuka Miyazaki, Tadayuki Harada, Yosuke Nakaji, Yoshiki Matsuoka, Ichiro Mori, Shigenori Koba Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2012.

---

Onset after the postoperative adjuvant chemotherapy enforcement in patients with P1-335 colorectal cancer of neutropenia and prognostic relations Tomiko Sunaga 1), Shuji Suzuki 2), Yagi Akihiro 1), History of Kaji law of nature 2), 小池伸定 2), Mari Kogo 3), Tatsuya Kurihara 4), Harada sincerity ratio old 2), Mamoru Suzuki 2), Yuji Kiuchi 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2012.

---

Propriety distinction of the simple suspension method in the P1-336 internal use anticancer drug Manabu Amano 1), West comfort Takeshi 1), Cheap Tomomi 1), Ratio intellect shop Hiroyuki 1), History of Tadashi Kiyohara 1), Takanori Nakamura 1), Kurata we see it 2), Mamoru Seto 3), Sachiko Kamiyama 4), Ichio Tanaka 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2012.

---

On making a notebook for exclusive use of the P1-337 cancer chemotherapy; about the patients during cancer chemotherapy enforcement, the attitude survey for the chemotherapy notebook of each medical staff Kenichi Matsui 1) 2), 齋田正和 2), Book Yumi 2), Chie Okamoto 2), Koichi Hirose 2), Hideyuki Kanemoto 3), Toshiya Ikeda 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2012.

---

	Side effect investigation of Bendamustine in the P1-338 Kurashiki center Hospital Sayo Kano child 1), Yuka Nagao 1), Cedar Rie 1), Junko Takahashi 1), Shinsuke Akagi 1), Lake Aso Kazuyo 1), Kazunobu Takayanagi 1), Kiyonori Ueda 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2012.

---

	Treatment outcome of the P1-339 progress, IRIS therapy in the third treatment for recurrent colorectal cancer impossible of excision Toshihisa Hiraiwa, Hiroyuki Okada, It is still a thought Sawada, Ryo Koike and, Takashi Nakayama Miya, 仙田典保 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2012.

---

	Questionary survey for the medicine medicine cooperation construction of the treatment with anticancer drug in the P1-340 Yamaguchi Red Cross Hospital Hideki Kinoshita, The Amagasaki path of righteousness, 俣賀隆 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2012.

---

	Analysis of the pharmaceutical intervention example by the P1-341 outpatient department chemotherapy exclusive duty pharmacist 日置三紀 1), Yuka Kobayashi 1), Yumiko Furuta 1), 土手賢史 1), Ayumu Nozaki 1), Hiroki Iwane 1), Toshiko Aramiya 1), Hirokazu Nakanishi 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2012.

---

	Safety assessment of the TS-1 alternate-day administration in the P1-342 digestive cancer patients Yusuke Ikeda 1), Shinnichi Sado 1), Tadashi Iwamura arrow 1), Akiko Mizoguchi 1), Yasuhiro Tsuji 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2012.

---

	Does aprepitant attenuate efficacy of the warfarin in the patients during P1-343 chemotherapy? Toshimitsu Kurokawa 1), Kenichi Suzuki 1) 2), Michihiro Shino 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2012.

---

	Safety assessment of the multi-tyrosine kinase inhibitor for P1-344 progress, recurrent renal cell carcinoma Michio Kimura, 宇佐美英績, Daisuke Ito, Mina Iwai, Okada sum intellect, Toshiya Nakao, 吉村知哲, Tadashi Yasuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2012.

---

	Examination of the factor which gives it to RDI decrease in the P1-345 Bendamustine alone 宇佐美英績, Michio Kimura, Akihiro Moriya, Shoya Takenaka, Okada sum intellect, Toshiya Nakao, 吉村知哲, Tadashi Yasuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2012.

---

	Examination about the side effect of NSAIDs combination expression at the P1-346 pemetrexed administration Kondo good luck, Color river Masanori, Toshihiro Otani, History of Shigeru Inose, 比氣明子, Takahashi dynasty tree, Kenichi Horikoshi, Tokiwa English sentence Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2012.

---

	The analysis of laboratory values confirmation contents in the P1-347 outpatient department chemotherapy and outcome investigation of the doubt inquiry criteria pertinence case Akira Masuda, Koji Okada, Masayuki Omura, Miho Osawa, Sae Takahashi child, Katsuhiko Sato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2012.

---

	NET EXCEPTION Err: Could not connect to host 永村陽一郎1), 芦崎雅之1), 下枝貞彦2), 堀治1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2012.

---

Discussion about the blood level after the methotrexate administration for the purpose of the graft-versus-host disease prevention after the P1-349 hematopoietic stem cell transplantation Yumiko Uchida 1), Naoyuki Uchida 2), Masanori Tsuji 2), Kazuya Ishiwata 2), Hiroyuki Fujii 1), Hiromi Tamura 1), Tadaaki Ito 1), Shuichi Taniguchi 2), Masahiro Hayashi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2012.

---

	Analysis of the case that resulted in hypophosphatemia due to the P1-350 Tumor genesis syndrome Yoko Inukai 1), Naoyuki Uchida 2), Yumiko Uchida 1), Tadaaki Ito 1), Hiroyuki Fujii 1), Hiromi Tamura 1), Shuichi Taniguchi 2), Masahiro Hayashi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2012.

---

	Two patients who presented with hepatic encephalopathy due to hyperammonemia with the P1-351 colorectal cancer chemotherapy mFOLFOX6 therapy Kazuhito Abe 1), Tetsuya Kajimoto 2), Kyohei Abe 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2012.

---

	Examination about the safety of the P1-352 cisplatin generic drug preparation Liujiang Masatsugu 1), Camellia Masahiro 2), Mariko Nakao 1), Fujiwara season Yoshiko 1), Hajime Asano 1), Tetsuya Morita 1), Morihiro Nomura 1), Yuzuru Yamazoe 1), Nishida measure three 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2012.

---

	Case study of the malignant lymphoma given P1-353 immunity thermochemicaltherapy (ITC) 林田諭 1), Shigeru Hayashida 2), 内藤壽則 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2012.

---

	It is ... about use situation investigation - efficacy and problems of the P1-354 Mohs paste Keisuke Seto, Shinya Tamaki, Yoshihiro Naito, Masahiko Takasaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2012.

---

	P1-355 Cases of the crizotinib (Xalkori (R)) capsule swallowing difficult lung cancer patients who had oral with desalted capsule: About examination of the oral method 浅野知沙1), 前田章光1), 千葉眞人2), 波戸岡俊三2), 塩田亜由美3), 田内里香3), 山田美佐子3), 水野靖也1), 加藤恵一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2012.

---

Comparison of the renal function degeneracy in Pemetrexed+Carboplatin combination therapy and the Paclitaxel+Carboplatin combination therapy for the P1-356 non-small cell lung cancer Takashi Sakakibara 1), Hideki Ezaki 1), Naoya Takeda 2), Norio Takimoto 1), Yoichi Kondo 1), Sugawara sheath or 1), Shiho Sugawara 1), Kenji Mori 1), Mitsuru Sugiura 1), 足立守 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2012.

---

	Examination about the safety of the pemetrexed monotherapy for patients with P1-357 renal failure Mari Takagi, Yukie Okada, Kana Yamaji, Yuko Inamoto, Naoteru Fujie, Naomi Tachikawa, Mika Matoba, Hisafumi Yoshida, Court Security Office Mika, 脇條康哲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2012.

---

Styptic treatment of the inflammatory carcinoma of the breast using P1-358 epinephrine dilute solution and the sodium alginate solution Tatsuya Ishikawa 1), Keiko Morimoto 1), Hiroko Kida 2), Mina Kawazoe beauty 2), 舛重奈苗 1), Gold bare cheap 1), 閔貴善 1), Chie Okazaki 1), Fujisawa Minoru 3), Kazuyo Shimojima 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2012.

---

	Association of hypertensive history and ARB for the onset of proteinuria time of patients receiving P1-359 bevacizumab Akira Maeda light 1), 宇良敬 2), Masahide Matsuzaki 1), Seiya Mizuno 1), Keiichi Kato 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2012.

---

Check list making and evaluation to standardize knowledge and a procedure about the P1-360 anticancer drug handling Satoko Meguro 1), Kayo Sanada 1), Shinichiro Komai 1), Misaki Kurosawa 1), Tomomi Saito 1), Hiroyuki Hasegawa 1), 岡田樹彦 1), Yasukazu Yamauchi 1), Tsuyoshi Aoyama 2), Wataru Suzuki 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2012.

---

	Examination about a side effect and the treatment continuity of P1-361 progress, recurrent breast cancer therapeutic drug eribulin 伊藤大輔1), 浅野裕紀2), 安達志乃2), 松岡知子2), 岡田和智2), 宇佐美英績2), 木村美智男2), 中尾俊也2), 吉村知哲2), 安田忠司2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2012.

---

	Use experience of the Mohs ointment for the local advanced breast carcinoma which was exposed to the P1-362 skin surface 芦埜和幸 1), Bank cotton 2), Yoshihiro Saito 3), Takeshi Shibazaki 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2012.

---

	The holding of P1-363 "on koro Gee expert course workshop" two years and the evaluation Koto Fujiwara 1), Kazuyoshi Sakamoto 2), Tanihata Hirohiko 3), Makimoto Shinichiro 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2012.

---

	Examination of the risk factor of the allergic reaction with the P1-364 FOLFOX therapy 細田敦規 1), Furrow Yoshiko 2), 辻琢己 1), Shunsuke Okazaki 3), Hisashi Yasui daylight 3), Takeyuki Kawano 1), Yoshio Kitamura 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2012.

---

	Investigation about the change of the treatment adaptation based on the change of P1-365 breast cancer practice guidelines Hironori Matsui, Toshikazu Takatori, Imamura pasture employee, Chie Takemoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2012.

---

	P1-366 Construction of the anticancer agent preparation duties support system in consideration of Residual liquid amount 長谷川晃司, 和田淳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2012.

---

	Effective and safe examination at the P1-367 rasburicase readministration 山浦佳子1), 伊豆津宏二2), 内田ゆみ子1), 伊藤忠明1), 藤井博之1), 田村宏美1), 谷口修一2), 林昌洋1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2012.

---

	P1-368 linear fuser DIB(C)(R) (TERUMO CORPORATION) usability questionary survey Satoru Tamura 1), Kazuhiro Karasawa 2), Shinichi Fujita 2), Yoshiaki Natsume 2), Hajime Nakai 3), Kazunari Nakamura 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2012.

---

	The inspection of the pre-Abo id contents in P1-369 outpatient department chemotherapy duties and future problem Hideo Sasaki, Keiko Nakahira, Oishi collar, Yoshio Miyake, Kiyoshi Haneda, Atsushi Yoshida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2012.

---

	Construction of the operational system of administration in P1-370 anticancer drug mixed preparation duties Tsurusaki University, 深滝利也, Ryo Saegusa is it lower, Shori Takahashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2012.

---

	The examination of the prognostic factor for patients with esophageal cancer after the P1-371 chemoradiotherapy enforcement and construction of the predictive model Ayako Suzuki 1), Mari Kogo 2), Tomiko Sunaga 3), Kazuhiro Kaneko 4), Keiichiro Yoneyama 5), Yuji Kiuchi 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2012.

---

	An action and evaluation for the proper use of the oral P1-372 anticancer drug Saito order, Keiichiro Matsuda, Nobukawa Masao, Koichi Arai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2012.

---

Fact-finding of the chemical interstitial pneumonia in the P1-373 cancer pharmacotherapy Takumi Sakurada 1), Soichiro Tajima 1) 2), Satoshi Kakiuchi 3), Taku Uematsu 4), Tsuyoshi Mori 1), Horinouchi Hironari 1), Kazuyoshi Kawazoe 1) 4), Yasuhiko Nishioka 3), 楊河宏章 2), Kazuo Mizuguchi 1) 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2012.

---

	Examination about the proper use of the treatment with P1-374 zoledronic acid Takuya Fukazawa, 永瀬怜司, Megumi Ota, Jun Takimoto, Hiroshi Sugano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2012.

---

Example that DOC+TS-1 therapy succeeded for the unresectable progressive gastric cancer with P1-375 peritoneal metastases, and ascitic fluid disappeared Takenori Ichimura 1), Masayuki Obayashi 1), Yagi Satoshi 1) 2), Kazushi Shimamoto 2), Hiroshi Nemoto 3), 小林靖奈 1), Kenji Hibi 3), 山元俊憲 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2012.

---

About an investigation about the anaphylactic expression situation in the P1-376 outpatient department chemotherapy and the correspondence, evaluation Atsushi Suzuki term 1), Daigo Suzuki 1), Toshiaki Sawada 1), Goji Maeda 1), Hiroshi Sakata 1), Hiroyuki Matsubara 1), Hamaguchi 2, Katsura), Miho Furuta 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2012.

---

	Risk management for the safe administration of P1-377 anticancer drug Hiroko Tai 1), Kazunori Shimomura 2), Mika Tashiro 2), 大河万顕 2), Shinichi Kawaguchi 2), 上田真愉未 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2012.

---

	P1-378 Effects of phytochemicals on breast cancer stem cells 山本明日香, 峯垣哲也, 都築知代, 角田隆紀, 宇野順騎, 高梨仁美, 福島沙織, 森岡千尋, 辻本雅之, 西口工司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2012.

---

	It is examined the monitoring method of the patients receiving the hCG preparation after P1-379 suprasellar region germinoma treatment Oak shallows 1 to bear), Yasuo Aihara 2), 三木伸泰 3), 高橋賢成 1), Yoshikazu Okada 2), Toshimi Kimura 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2012.

---

	Generic medicine induction and choice of gemcitabine in the P1-380 this hospital Yutaka Hattori, Maiko Saito, Mountain Masayuki Sawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2012.

---

	Fact-finding about peripheral neuropathy of P1-381 oxaliplatin and examination of the patients background Hiromi Fujimori 1), Megumi Maeda 2), Sono Kaji truth 2), Satoko Fujiwara 2), Matsunaga still 3), Yukihiro Kawakami 2), Sendo Toshiaki 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2012.

---

	Examination of the anaphylactic recurrence after the change to nedaplatin of patients with P1-382 carboplatin hypersensitivity 額田淳, Nawa Hideki, Yoichi Kawasaki, Kazuhisa Yao, Sendo Toshiaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2012.

---

	About tolerability of the pemetrexed monotherapy for elderly people with the P1-383 renal function degeneracy Kuni Imazu intellect, Chiaki Nishikawa, West Yuji, Eri Kuwata, Yutaka Shigemura, Masaru Sugawara, Kyoko Nakata, Masanori Takaoka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2012.

---

One patient who gave bevacizumab combination mFOLFOX6 therapy in patients with colorectal cancer during P1-384 maintenance haemodialysis 1 related to Osono), White Hiromi Sawa 1), Flat pond Mikako 1), Nagano 1, Makyuu), Noriko Okubo 1), Yoichi Hiraki 1), Kenichi Manabe 1), 尾上公浩 2), Hidetoshi Kamimura 3), Yoshiharu Karube 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2012.

---

	Examination of the oxaliplatin optimal dose in patients with P1-385 chronic renal failure Tsuyoshi Yamashita Shiro 1), Koichi Hirose 1), Noriko Kaneta 1), Kayoko Iwamoto 1), Mizuho Kitamura 1), Hiroshi Ota 1), 金浩敏 2), Junichi Hasegawa 2), 前田頼伸 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2012.

---

	A use case investigation of P1-386 antineoplastic bendamustine and examination about the adverse event Takashi Kimura, Yukio Kadokawa, Kozo Takahashi, Tree Narumi Sawa, Inside many protons, 桝喜惠 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2012.

---

	Utility - of the workshop of action - discussion pattern of the medicine medicine cooperation in the P1-387 outpatient department chemotherapy Hanada sum size, Kazufumi Terui, Nao Odagiri, Junichi Nakagawa, Yuji Okamura, Shiori Takahashi, Shiro Itagaki, Early hunting truth Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2012.

---

	Experience two cases that caused anaphylaxis with premedication ranitidine of P1-388 breast cancer chemotherapy PTX+HER Kayo Kimura, 眞下惠次, Akihiro Noda, Hiroko Hatai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2012.

---

	Interaction at combination judging from P1-389 INR of aprepitant and warfarin 野田能成, Eiichiro Kanda, 鹿浦香織, Tadashi Mikami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2012.

---

	Attitude survey - of grasp - new establishment floor nurse of the nursing needs at the P1-390 hospitalization cancer chemotherapy enforcement West Kazuya 1), Akihiko Furuta 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2012.

---

	Comparison of the eGFR estimation type in the carboplatin doses setting of the P1-391 urology department region Naoki Shibata 1), Eiji Niwa 1), Yukiko Omura 1), Hiroko Ogino 1), 酒井繁彰 1), Nobuyuki Sekita 2), Kazuo Mikami 2), Suguru Kasahara Castle 1), Jun Hamada 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2012.

---

	Effect of various culture conditions to give it to a growth rate of the cancer cell line derived from P1-392 human Komiya hills and rivers intellect 1), Kenji Ikeda 2), Yu Kokubo rare 1), Yoshiko Terao 1), 浦嶋庸子 1), Masashi Ogawa 2), 廣谷芳彦 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2012.

---

	Pharmacist permanent residence to the P1-393 outpatient department chemotherapy center estimates the utility as becoming it Furrow Yoshiko 1), Masako Baba 1), Hiroyuki Ueno 1), Kei Nakamura 1), Hisashi Yasui daylight 2), Yoshio Kitamura 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2012.

---

	Relation (the third report) as the pharmacist to the chemotherapy in the P1-394 children region Yuka Tanaka 1), Mika Tokuda 2), Shiho Yasue 2), Yokoyama skillful writing 2), Mari Mori 2), Emi Kadoi 2), Great Xisha cord law of nature 2), Kuni Shinoda University 2), Takao light 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2012.

---

	Examination about the PT-INR change with P1-395 warfarin potassium and the FU agent Hidekazu Arai 1), Yuka Kobayashi 2), Maiko Saito 1), Ikuyo Takahashi 3), Harumi Sudo 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2012.

---

	Investigation of the allergic expression of P1-396 oxaliplatin (L-OHP) situation in the first time or the reintroduction 宮崎晃臣, Ebina truth existence, Masahiro Abe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2012.

---

	Anticancer drug in a cancer cell and nerve cells derived from a lot of P1-397 tissue-sensitive difference Yu Kokubo rare 1), Kenji Ikeda 2), Komiya hills and rivers intellect 1), Yoshiko Terao 1), 浦嶋庸子 1), Masashi Ogawa 2), 廣谷芳彦 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2012.

---

	Investigation of the thesis about the support of the cancer chemotherapy-related duties with the computing system in P1-398 this country Makoto Nakajima 1), Yoshie Nomura 1), Takuya Goto 1), Rie Mori 1), Yuka Aizawa 1), Nobuyuki Mishima 1), Tadashi Sugiyama 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2012.

---

	Investigation about chemical hypersensitivity of the P1-399 antitumor agents Kentaro Katayama, Imamura pasture employee, 武本千惠 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2012.

---

	Resident placement - first report of the pharmacist in the outpatient department of the P1-400 tumor chemotherapy part shortening - in waiting time: Yusuke Aizawa 1), 南真進 1), Yukihiro Shimizu 1), 守岩美紀 2), 須口由希 2), 高橋威洋 3), Ichikawa degree 3), Sone Wataru Hara 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2012.

---

	Analysis of the bevacizumab-induced high blood pressure in patients with P1-401 colon, rectal cancer 岩井美奈, 木村美智男, 吉村知哲, 安田忠司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2012.

---

	Examination of the injection method for the oral P1-402 tretinoin difficulty patients Hiroe Takeuchi 1), Kobe Kaori 1), Kazue Yamane 1), 牧問美和子 1), Yoshimura table 1), Takuya Otsubo 1), Takayuki Tanaka 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2012.

---

	Elucidation of the docetaxel resistance-gaining mechanism of P1-403 non-small cell lung cancer A549 cells Jun Taniguchi 1), Ryuji Ikeda 2) 3), Nishizawa reason Norihiko 3), Akira Higashijima person 4), Yasuo Takeda 2) 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2012.

---

	Try the medical supplies safety management person in charge training by the P1-404 e- learning Masako Tahara 1), Yasuko Shinozaki 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2012.

---

	Action to recurrent prevention for the purpose of an analysis and the consciousness improvement of the P1-405 incident development factor Takashi Shiraishi Kotobuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2012.

---

	Association of P1-406 fall, a fall risk and the internal use situation of the sleep inducer 三角紳博 1), Toshihiro Matsumoto 1), Kazuhiro Yamawaki 1), Yui Inoue 1), Takashi Nishino 1), Adachi るい 1), Yagawa Yuko 1), Hideki Sato 1), 小籔真紀子 1), Mitsuko Inoue 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2012.

---

	Examination of the use in inside the hospital of the P1-407 fentanyl patch once a day preparation Tamura wise person, Tomoichi Kaneko, Makoto Kaneko, Young sea eight states male, Takayuki Matsui, Hideaki Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2012.

---

	Result of the mini-lecture to the nurse in the P1-408 ward The Ishikawa immensity, 後藤志央, Shrine Akihiro Ichiro, 末安由拓, Tatsuya Sasaki, Kaifu Masayo, Akihiro Kai, Prince Taniguchi chapter, Takahiro Rikitake Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2012.

---

	Comparison ... of the internal medicine in observance situation and our well-known degree investigation ... House of Japanese diabetes society Recommendation in the P1-409 sitagliptin and other clinical departments 小林理栄, 新井亘, 大島聡子, 紙屋めぐみ, 笹山祐布子, 坂下舞, 難波由里子, 増田裕一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2012.

---

	Construction of the cancer chemotherapy plan making system which linked P1-410 electronic chart Tree Masaji 1), Tatsuya Suzuki 2), 松浦美聡 3), Yuko Takahara 1), Amano apricot south 1), Hiroki Yoshida 1), Mari Teramachi 1), Yoshihiro Kawade 1), Toshiki Uchida 2), Michinori Ogura 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2012.

---

	Examination about the safety of the order input by the P1-411 pharmacist Star Hiroshi Noji, Akira Nakamoto University, 豊島佳那子, Keisuke Oshima, Aiko Hirano, Yumiko Matsumoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2012.

---

	About P1-412 cold water re-hat example decrease measures Tomoko Yamazaki, Yasunori Nagano, Naoyuki Watanabe, Koji Kamiya, Mitsuru Kaneta Expo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2012.

---

	The effect that difference between color difference and size of the multiple sites of the P1-413 PTP sheet gives to a subjective appearance similarity ratio Tamaki Hirofumi 1), Hiroki Sato 2), Moat foster child 2) 3), Yasufumi Sawada 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2012.

---

	Action to risk management by the child dose check system induction in the P1-414 Kitasato University Hospital God one dream 1), Toshiko Sasaki 1), Megumi Seki 1), Tomoko Suzuki 1), Jun Kainuma 1), Rumiko Kondo 1), Hajime Matsubara 1), Kazuo Yago 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2012.

---

	A construction and evaluation of the injection cancellation confirmation system which linked P1-415 electronic chart 行本拓史 1), Kaori Kimura 1), Matsuo Kimiko 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2012.

---

	A characteristic and measures of the incident in the P1-416 business training Rumiko Amano 1), 新井成俊 2), Junichiro Fukuhara 2), Yutaka Inoue 1), Isamu Murata 1), Masayuki Kimura 1), Ikuo Kanemoto 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2012.

---

	Action of the pharmacist in the medical safety education for the nurse P1-417 new face Ayako Tsuda 1), Keizo Kato 1), Hiromi Fujimori 1), Kazuko Yamamoto 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2012.

---

	Evaluation of the utility of the injection automatic return device in the disposal of injection work returned by the P1-418 ward Satoshi Shimizu way, Ryoji Yanagihara, Toshihide Abe, Katsuyoshi Nakajima, Hiroshi Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2012.

---

	Distribution of medicine cart set duties by the P1-419 pharmacy 森光恵, 北出紘規, 木戸裕美, 北国憲剛, 中川貴史, 栂谷内良枝, 中村紗季, 塚本佳奈子, 新田千恵, 新宅君子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2012.

---

	Adequacy of the IV line at the P1-420 cancer chemotherapy Keisuke Abe 1), Yasuhiko Sakata 1), Takafumi Sugawara 1), Shinichi Miyamori 1), Misako Sasaki 2), Open Koichi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2012.

---

	A tendency and remedy of the incident of the physician in the P1-421 outpatient department prescription Shinya Watanabe, Takami indigo plant, Yuta Komai, 櫻間和紗, Rie Tsuchimoto, Ryota Nakamura, Yukiko Kita, Hirotsugu Kita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2012.

---

	P1-422 Medical safety improvement of using the bar code of ethical drug : Part 2 Application to injection drug inspection 宇都宮暁, 小泉盛, 伊藤護之, 眞壁秀樹, 杉本修, 北澤貴樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2012.

---

	Need - two levels bag transfusion preparation ... of the assessment of the P1-423 medical supplies body indication 廣實清司 1), Hiroyuki Furukawa 1), Chizuru Hanada beauty 2), Yuko Tokunaga 3), Kazuo Ukita 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2012.

---

	The environmental maintenance enlightenment document of being accelerated will be easy to be understood use of P1-424 generic medicine; is the examination about the difference of - producer Miyoko Fujimori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2012.

---

	New construction of an evaluation, the reporting of medical supplies by the P1-425 clinical trials Profile induction Mariko Kawana 1), Yutaka Kobori ankle 1), Makoto Nakazaki person 1), Junko Nagai 1), 陳惠一 2), Tadanori Sasaki 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2012.

---

	About ward resident duties in the P1-426 Himeji medical center (the fifth report) action - for - drug information offer Tsubosaka Naoko, Yuka Takahara, Yoriyuki Kawato, Hiroshi Hashimoto, Katsuaki Kobayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2012.

---

	Analysis of the thyroid function abnormality event using the P1-427 adverse event spontaneous report database Koichi Hosomi, Aya Fukuda, Mitsutaka Takada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2012.

---

	Action to prevention of the incompatibility in the P1-428 simple suspension method Muko Yuko 1), Miwa Ishihara 1), Tomoko Sasaki 1), Kayoko Baba 1), Mayumi Mochizuki 2), Muko Yoshio 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2012.

---

	About ward resident duties in the P1-429 Himeji medical center (the fourth report) about communalization of the drug information in - Himeji medical center - Yoriyuki Kawato, 金川明裕, Tsubosaka Naoko, Yuka Takahara, Tomishima Kosuke, Hiroshi Hashimoto, Katsuaki Kobayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2012.

---

	An action and follow-up results to P1-430 safety reporting 延藤勇, 豊浜隆, Koji Takai, Yoshinobu Kitao Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2012.

---

	Action - in database compilation of P1-431 drug information and nurse duties using a database and the cottage-hospital in upbringing support - area 和田匡央, Atsuko Takada, Satoshi Hirota University, Hiromi Fujimoto, Nakata is quiet Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2012.

---

It is making ... of a ... incompatibility list, shading bag attachment criteria for safe use of the P1-432 injection Kazuki Tago, Naoki before yellow, Fujita Aoi, The Aya Yamamoto beauty, Kazuya Hirata, Naoyuki Matsumoto, Shuhei Suzuka, Miki Nakamura, Great Yumiko Tsuyama, Person of moat Yumiko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2012.

---

	Competitive review of the drug information book for public patients in P1-433 Japan, the United States and Europe Aya Furukawa 1) 2), Hiroki Sugimori 3), Michiko Yamamoto 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2012.

---

	- made with a review and the system of the drug information administrative work for paradigm shift - ward drug duties of the P1-434 drug information administrative work The Tanaka immensity, Step pine Masahiro, Takashi Kawada, Marie Yamawaki, Naoko Matsumoto, So Yamamoto one, 服部暁昌 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2012.

---

	Construction of the safe information database about the treatment with Chinese medicine of P1-435 pregnant woman, the nursing mother Iwade Ayumi 1), Nao Yoshida 1), Kumiko Sakamoto 2), Yoichi Sato 1), Aiko Yamauchi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2012.

---

	Demand for information in the P1-436 drug information management room and analysis of the offer Junichi Masuda, The Takahashi fish to eat beauty, 中村真依, Atsushi Kubota, Koichi Mizuno, Jiro Mikami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2012.

---

	General evaluation of ARB as the antihypertensive drug on the basis of the discussion about physicochemical characteristics of P1-437 ARB from literatures Shiro Itagaki, Hideki Noro, Descent from a mountain Ritsuko, Sachiko Fujita, Early hunting truth Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2012.

---

	Residual medicine investigation in outpatients taking P1-438 antiHIV medicine 森下和美1), 野毛一郎1), 吉田康秀2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2012.

---

	Action to use of contraindicated medicine evasion in patients with P1-439 prostatic hyperplasia Tomohiro Takahashi, 森章哉, Tadashi Fujita will, Satoru Morita, Takuya Yamakawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2012.

---

	Attitude survey for the handling of the medical equipment to P1-440 health insurance pharmacy pharmacist and the sale 曽賀千智 1) 2), Kiyoto Edo 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2012.

---

	Action for the present conditions of the simple suspension method in the P1-441 this hospital and the in-hospital unionization Yoshimi Imada, Kanako Tsujimura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2012.

---

	The use situation of the P1-442 bringing medicine drug and future problem Akira Nagayama, Masako Kondo, Tomiko Inoue, Kazumi Morishita, Masaya Sato, Yagi Makiko, Yumi Kanetani, Noge Ichiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2012.

---

	The actual situation of the use of attached document information at prescription in the P1-443 specialist Kayoko Maezawa 1), Asako Terashima 1), 木村一幾 1), Yuri Ohashi 1), 秋田博伸 2), Moat Seiji 3), Junko Kitsu 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2012.

---

	Analysis of the factor in the management insufficiency case of the anticoagulant therapy for P1-444 patients with atrial fibrillation Hiroki Nakano 1), Motoaki Nakao 2), Hiroyuki Ueno 2), Kei Nakamura 2), Yoshio Kitamura 2), 辻琢己 1), Takeyuki Kawano 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2012.

---

	Investigation about pharmacist awareness and the patients satisfaction for the drugstore service of the P1-445 ethical pharmacy 岡遼太郎, Castle self denial, Daiya Sakurada, Eriko Kobayashi, Noboru Sato example Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2012.

---

	Use situation investigation of pioglitazone in the P1-446 eight City municipal hospital Dove Natsuko, 田村健悦, South Kazushi, Yuko Okuyama, Teru Saito still, Yuko Fujii, Tanaka sunlight, Isao Miura Taro, Kazuki Ishikura, Origin of Hiraga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2012.

---

	Examination to a use of P1-447 dabigatran situation investigation and proper use 竹内仁, 小林千恵, 白澤吉哲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2012.

---

	Use situation investigation of the peramivir in the P1-448 Kurashiki center Hospital 赤木晋介, 加納沙代子, 高橋順子, 長尾由佳, 高柳和伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2012.

---

	A use of P1-449 dabigatran situation investigation and construction of the management method 水野由紀子1), 柴田大地2), 杉浦充2), 足立守2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2012.

---

	Examination about economic effect in the P1-450 ARB/CCB compounding agent induction and the role of the pharmacist Yoichi Hiraoka 1), Tatsuo Nakagawa 2), Kazumi Kito 1), Akito Nagai 1), Takanobu Hashimoto 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2012.

---

It is ... from the attitude survey of ... nurse for the future action of the P1-451 psychological care team Your Tsuyoshi Ito 1) 2), Aimi Matsukura 1), Chiaki Matsumoto 1), Mai Iida 1) 2), Junko Kurata 2) 3), Shigeyoshi Uchida 2) 4), Kumiko Umeda 2) 5), Miyoko Tanaka 2) 5), Kazuko Matsunaga 1), Shigeo Isaka 2) 6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2012.

---

	A prescription investigation and examination of the antipsychotics in the P1-452 this hospital Mieko Morita, 岩瀬利康, Yoshio Ito, Junko Miyakawa, Koichi Hoshino, Miyuki Suehiro, 双樹恵, Tomoko Koyama, Tomoaki Toyama, Yuki Tsukada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2012.

---

	We look at the rear of the factors associated with efficacy, the side effect of the P1-453 new antiMRSA medicine daptomycin and investigate a mark 小曳恵里子1), 安藤基純2), 北田徳昭1)3), 中浴伸二1), 柏木裕子1), 山本健児1), 西岡弘晶4), 橋田亨1)3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2012.

---

	The combination situation with the medicine for dyslipidemia judging from the prescription fact-finding of P1-454 antihypertensive medications Young Susumu Hayashi 1), 1, Takao, Shinohara), 永井茂 1), Nobukazu Tanaka 2), Junichi Hayashi 2), Minoru Yamamoto 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2012.

---

	About proper use of the P1-455 hypertonic albumin preparation 滝浪由季乃, Aiko Iguchi, Junko Totsuka, Yoshiyuki Shibayama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2012.

---

	About the reason why a combination (an angiotensin II receptor antagonist and diuretic) was deleted by P1-456 this hospital adoption medical supplies Keiji Totsuka, Kazuya Matsushita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2012.

---

	P1-457 Consciousness change of pharmacists such as through the use of service tools in drug stores: Preliminary investigation with the aim of customer service capacity building 森達哉1), 鶴見健2), 恩田光子1), 金岡世晃1), 田方裕梨1), 森川祥彦1), 岡本昌樹1), 荒川行生1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2012.

---

	Analysis of the sales promotion factor in the P1-458 drugstore Ken Kamata 1), Yuko Itakura 2), 植沢芳広 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2012.

---

Prognosis investigation after the OTC medical supplies purchase in the dweller of the P1-459 cold-like symptom 田方裕梨 1), Takeshi Tsurumi 2), Mitsuko Onda 1), Tatsuya Mori 1), Kaneoka world daylight 1), 1, Sawa, Tokai), Masaki Okamoto 1), Yoshihiko Morikawa 1), Arakawa line straight 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2012.

---

Gap analysis between patients - pharmacists for the pharmaceutical management instruction of the high-risk medicine in the P1-460 health insurance pharmacy Yoshi Hashimoto tree 1), Mitsuko Onda 1), Inner book Hideki 1), Iwasaki future 1), Yuka Tanaka 1), Arakawa line straight 1), Miho Murakami 2), 早瀬幸俊 2), Hidehiko Sakurai 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2012.

---

	Use situation investigation about the tuberculosis prophylaxis administration of isoniazid in the P1-461 neonates department Tadashi Kitagawa 1), Chika Teraoka 1), Masako Muroi 1), 望月成隆 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2012.

---

	Present conditions of examination - combination contraindication medicine about the combination contraindication in the P1-462 this hospital and future action ... Koji Okanishi, Seiji Kominami, Rikio Tsuji, Yukiko Morita, North Keiji, Masayuki Uno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2012.

---

	About the effect of the bucolome on P1-463 warfarin potassium doses and test value 飛澤国広, Shunsuke Fuchigami, Takayuki Mita, The Azuchi greens beauty, Suyama Akina, Takashi Yasushi Inoue, Takato Imai, Hiroaki Watanabe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2012.

---

	It is a case with suspected onset of the serotonin syndrome by combination of P1-464 tramadol mirtazapine fluvoxamine Noriko Kaneta, Hirohira Fukami, Tsuyoshi Yamashita Shiro, 藤田將嗣, Koichi Hirose, Satoshi Yamamoto, Tsuyoshi Oda, Tsuyoshi Oda, 前田直就, 前田頼伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2012.

---

	Combination of P1-465 warfarin potassium and interaction case - after real - atrial fibrillation catheter ablation in the amiodarone combination Takada Australia, Toshihiro Otani, Kenichi Horikoshi, Tokiwa English sentence Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2012.

---

	Effect of the baicalin combination in the de-conjugation response of hydrochloric acid irinotecan metabolite (SN38G) through P1-466 beta-glucuronidase Old Takaaki Tawara, Takashi Azuma, Yutaka Negoro, Watanabe Toru is flat, Ryoichi Yano, Toshiaki Nakamura, Mikio Masada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2012.

---

	Investigation about the expression time of the INR increase in P1-467 Warfarin and the S-1 combination patients Kei Yamaguchi Taro, Naoya Uto, 北森靖隆, Ichimura line celebration, Hideaki Tamaoki, Hideaki Ishida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2012.

---

Effect on flavor at decomposition, the suspension with luxury goods of P1-468 Mukoda in (R)DS50% and stability of the L-carbocysteine Akira Takagi period, Manabu Okumura, Tomomi Iwakiri, Rie Ono, Ai Minoda, Kazuya Yasuda, Yuko Matsumoto, North field Tomomi, Kenji Nakanishi, Kazuhiko Arimori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2012.

---

	1 case that anticoagulant action of the warfarin was prolonged by the miconazole gel which P1-469 preceded Miyako Kawamura 1), Daisuke Matsubara 1), Akira Takada 1), Kazuki Tanaka 2), Yasuda Yorimasa 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2012.

---

	The case that measurement of 6-TGN was useful in a diagnosis of the myelosuppression with the P1-470 azathioprine Hiroshi Watanabe plan, Kuni Isobe finally, Miyoshi straight celebration, Katsuhiro Yamada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2012.

---

	Pharmacokinetic model for interaction evasion with P1-471 phenytoin and TS-1 Takumi Shinpo 1), Hiroki Sato 1), Akiko Miki 1), Moat foster child 1) 2), Toshiaki Nakamura 3), Mikio Masada 3), Yasufumi Sawada 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2012.

---

	1 case that interaction with P1-472 Warfarin and Vincristine was strongly suspected of Tetsuro Koide 1) 2), Takuya Iwamoto 2) 3), Megumi Fukazawa children 4), Kaoru Kuroki line 4), Masatoshi Muramatsu 4), Shinko Okuda 2) 3), Keiko Watanabe 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2012.

---

	Examination of the appropriate warfarin dose at the P1-473 bath comb supply cancellation Koji Endo, Toshihiro Otani, Kenichi Horikoshi, Tokiwa English sentence Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2012.

---

	The resolution of the beta-lactam antibiotic with the P1-474 L-cysteine Yukiko Katagiri 1), Chie Kudo 1), Fumio Itagaki 1), 忍足鉄太 2), 高橋秀依 3), 夏苅英昭 2), Hideaki Niwata 1), Machiko Watanabe 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2012.

---

	Examination of the discussion of the factor of the Serious ADR case in specialists in citizen of P1-475 Osaka and future measures Miyuki Matsumoto 1), Yoshiko Yamauchi 2), 吉原由治 3), Yumiko Teranishi 4), Kamiura Mana true 5), Small appendix Tetsuya 6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2012.

---

	The P1-476 atrioventricular block complete patients are cases with suspected induction of torsades de pointes by sulpiride internal use Atsushi Miura 1), Masayuki Ogiwara 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2012.

---

	The polymerization initiator of the mixture out of the injection induces apoptosis for P1-477 human peripheral-blood mononuclear cells Minoru Mori Miwa 1), Yoichi Kawasaki 2), Chiaki Tsuboi 1), Sendo Toshiaki 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2012.

---

	Examination about the hypophosphatemia to occur after P1-478 linezolid administration 八木仁史1)2), 氏家秀太2), 宮本渚2), 渡邊徹1), 齋藤勲1), 竹ノ内敏孝2), 村山純一郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2012.

---

	One patient who had a diagnosis of Reiter syndrome with the infusion in the BCG bladder by P1-479 pharmacist intervention 久保嘉靖 1), Masahiro Okuno 1), 金丸聰淳 2), Satoshi Ito 2), Yoshiharu Umetani 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2012.

---

	Search of the hemorrhagic side effect expression of P1-480 new anticoagulant dabigatran factor 木村嘉彦, 尾上雅英, 川田将義, 橋本恵美奈, 小形瑛, 津田真弘, 吉野秀紀, 佐澤瑞穂, 森田洋亮, 増田智先, 矢野育子, 松原和夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2012.

---

	The onset of Colin symptom situation with the P1-481 irinotecan hydrochloride Naoya Suzuki, 吉嶋抄苗, Yuko Watanabe, Yoshiko Sasaki, Maiko Tokumura, Shohei Kawahara, Landowner Takafumi, Makoto Takahashi, Tadahiro Aota Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2012.

---

	Present conditions investigation of the expression situation and symptom measures of the skin reaction in the P1-482 chronic hepatitis C triple-drug therapy Akiko Nishimura, Koji Akiyama, Tomoko Matsumoto, Mountain Rieko Sawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2012.

---

	Construction of the uniform management system of P1-483 adverse drug reaction, the allergic information Kanae Sakakibara, Hanako Kohata, Tsuneaki Tanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2012.

---

	Preventive measures of the P1-484 dabigatran against side effects and the effect 鈴木美奈1), 冨田道夫1), 坂本拓也1), 須田智栄子1), 松田俊之1), 酒井英行2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2012.

---

	Age difference examination of acetaminophen hypersensitivity by P1-485 LMT Kenichi Shimizu 1), Tomoyasu Furukawa 1), Manabu Abe 2), 斎藤幹央 2), Yagi Motohiro 3), Koike reason Expo 4), 継田雅美 1), Katsuji Uno 5), Susumu Ozaki 6), Takashi Toyoshima thickness 7) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2012.

---

	One case of liver dysfunction with P1-486 mosapride citrate (Gasmotin (R)) Megumi Mizuno, Kazuyuki Ito, Keita Urasaki, Kazuko Kawai, Satoshi Isotani Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2012.

---

	Examination of NSAIDs hypersensitivity by P1-487 LMT-chamber Tomoyasu Furukawa 1), Manabu Abe 2), 齋藤幹央 2), Yagi Motohiro 3), Koike reason Expo 4), 継田雅美 1), Katsuji Uno 5), Katsumi Enomoto 6), Susumu Ozaki 7), Takashi Toyoshima thickness 8) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2012.

---

	One patient whom hepatic dysfunction developed in by P1-488 edoxaban 森英樹1), 金井美緒1), 熊岸奈緒1), 小池彩子1), 大道淳二1), 諏訪耕三1), 中山集1), 歳森淳一2), 小橋春彦2), 東原信七郎3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2012.

---

	Fact-finding of the onset of liver dysfunction with the P1-489 acetaminophen dosage regimen change 澤柳直樹, Tomokazu Fujii, Kato Yue Loong, Haruhiko Nakamura, Hisashi Tsukamoto, Hisashi Kamiya line Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2012.

---

	Analysis of DLST positive rate and the effect factor in the P1-490 drug hepatopathy Itsumi Sasaki, Toshiaki Nakamura, Mikio Masada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2012.

---

	Retrospective investigation about the effect of the renin angiotensin system effects drug in the blood pressure fluctuation at the P1-491 general anesthesia induction Chihiro Ito 1) 2), Takeshi Hashimoto Shiro 1), Kensuke Usui 1) 2), Masanori Kashiwagi 3), Atsuta Koichiro 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2012.

---

Examination - in comparison between en bloc administration and side effect - ovarian cancer weekly TC(paclitaxel+carboplatin) of P1-492 Carboplatin in divided doses Tomoki Yoshioka 1), Mariko Kinoshita 1), Ayumi Ozeki 1), Masanobu Ogawa 1), 森善洋 1), Takayoshi Tsuruta 1), Mayumi Yamashita 1), Kohei Kodera 2), Quantity lower Hiroko 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2012.

---

	The cancellation of the P1-493 Kress Thor lock and side effect investigation for weight loss cases 櫻間和紗, Rie Tsuchimoto, Tomoko Kitamura, Hiroko Okano, Yusuke Komatsu, Shiohira Saki, 田中紋乃, Cherry blossom viewing Yuko, Yuriko Hitomi, Yuka Murase, Hirotsugu Kita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2012.

---

	Fact-finding of the acute adverse event in the P1-494 outpatient department chemotherapy room Takeru Kawai, Shunichiro Saito, Shuji Azuma, Juria Kaneko, Yukiko Honda, Yu Goto, 小原郁司, Ryuji Kodera, Descent from a mountain Koichi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2012.

---

Investigation of the side effect expression of P1-495 terra pre-building situation aiming at proper use Hirohira Fukami, Koichi Hirose, Noi Asami, Tasuku Fujiwara season, 藤田將嗣, Tsuyoshi Yamashita Shiro, Satoshi Yamamoto, Mizuho Kitamura, Tasuku Kawai levator, Takashi Inoue solstice, 前田頼伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2012.

---

	Experience of the drug-related diarrhea improved by the change of prescription of the P1-496 proton pump inhibitor (PPI) Nobukazu Ryu 1) 2), Norimasa Takahashi 1), Kazuhisa Naoi 1), Yasuhiko Mimura 1), Atsushi Kato 1), Isao Adachi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2012.

---

	P1-497 One case that has brought severe thrombocytopenia by garenoxacin (Geninax (R)) taking 中村豪志, 藤澤浩美, 中村綾奈, 大北直美, 木村健 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2012.

---

	P1-498 Recognition survey of sitagliptin side effects and patients and doctors 寺西由美子1), 松本ミユキ2), 山内美子3), 吉原由治4), 神浦茉奈実5), 小垂徹也6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2012.

---

Elucidation of the cytotoxic augmentation mechanism of statin drugs with the indoxyl sulfate in P1-499 human striated muscle model cells Tomoko Oda 1), Masayuki Tsujimoto 1), Jin Ogino non-1), New book only 1), Takuya Yoshida 2), Old Taku Kubo 2), Satoshi Izumi 2), Tomoyuki Yamakawa 3), 峯垣哲也 1), 西口工司 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2012.

---

	1 case that prevented progression of lithium intoxication by the intervention of the P1-500 psychological care team pharmacist Masaki Kumai 1), Mami Kiyokawa 1), Kumiko Kasashi 1), Takehiro Yamada 1), Takeshi Iseki 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2012.

---

	Trial of the economic evaluation of the P1-501 ADE(Adverse Drug Events) evasion Tomohiko Igawa 1), Hisae Murata 2), Yukiko Enomoto 2), Chiho Komai 2), Nakano Chihiro 2), Wild moat early period 2), Yoko Okayama 2), Mai Fujinami 2), Okamoto law of nature tree 1), Mitsuko Onda 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2012.

---

Investigation about an opinion and the experience for the reporters in the side effect report from the P1-502 patients Michiko Yamamoto 1), Kiyoshi Kubota 2), Mitsuhiro Okazaki 3), Akira Dobashi 4), Masayuki Hashiguchi 5), Suka Machi 6), Masahiko Hayashi 1), Hideaki Takasu 1), Mayumi Mochizuki 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2012.

---

Utility of the nitroprusside note for the reperfusion injury of the P1-503 acute myocardial infarction patients Shunichi Aida 1), Hiroaki Abe 2), Naotake Takase 1), Keisuke Yonezawa 1), Branch 1 early on Nakata day), Ikuko Miki 1), 千崎昭輝 1), Gutter book Mayuko 1), Takashi Fujii 2), Nobuyuki Muroi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2012.

---

Pharmaceutical treatment with P1-504 blood L-DOPA and L-DOPA metabolite monitoring management of patients with advanced Parkinson's disease that used MAO-B inhibitor together Yumi Tsuruoka 1), Kuzuu Ami 1), Member of Satoshi Doi 2), Masaka Wataru 2), Takatsugu Sakakibara 3), Mitsutoshi Sato 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2012.

---

	Study on allergic onset with the additive derived from the food included in the P1-505 ethical drug Mitsuhiro Okazaki 1), Mikami window or 1), Koji Itagaki 2), Tetsuko Teshima 2), Reiko Teshima 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2012.

---

	The correspondence to the elderly people with dementia case that drank P1-506 S-1 by mistake in large quantities and the course Miki Kobayashi 1), 六波羅孝 1), Masayuki Kitahara 1), 唐澤頼勝 1), Shinichiro Ohashi 2), 3 in Nakayama) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2012.

---

	An evaluation and problem of the bringing medicine management in the P1-507 Fujinomiya Municipal Hospital Yoshinori Kobayashi, Mariko Ijiri, Yutaka Kobayashi, Hiroshi Kawaguchi fruit, Kazuo Katsumata, Osamu Kitamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2012.

---

	The bringing medicine operational investigation which assumed medical security after the electronic chart system transition in the P1-508 this hospital an index 栗崎貴啓 1), Chiharu Nakahara 2), Yoshiharu Wada 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2012.

---

	Utility of the bringing medicine copying system in the P1-509 cancer base Hospital Hayasaka state life, Hidenori Kitayama, Kimiyoshi Takeuchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2012.

---

	Examination about the quick differentiation of the bringing medicine using the P1-510 portable Raman spectrometer Kazuo Tomono 1), 深水啓朗 1), Yoshihisa Yamamoto 1) 2), Hiroshi Hisada 3), Tatsuo Koide 4), Noriko Katori 4), Suzuki Toyoshi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2012.

---

	Investigation about the information tool which is effective for confirmation of the patients medication situation judging from P1-511 bringing medicine investigation Noriko Ito, Shoichi Yamaga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2012.

---

	Bringing medicine management using an electronic chart system in the P1-512 this hospital River Chinese mustard cord, Matting Toshika Fuchi, Adachi texture to praise, Junko Tsujimoto, Takashi Nishio, Hitoshi Okugawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2012.

---

	The comparison of the duties in the bringing medicine control center before and after the P1-513 electronic chart system induction and the evaluation Yutaka Hatakeyama child 1), Kenichi Horiuchi 1), Kazumi Yoda 1), 納誠人 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2012.

---

	It is ... through relation ... pre-Abo id example of bringing medicine management and the pharmacist in the P1-514 cancer special hospital Koki Yamashita 1), Maki Abe 1), Shinki Yoshino 1), Naoya Saito 1), Mayumi Kaise 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2012.

---

	An evaluation and problem of the bringing medicine management using P1-515 hospital information system 小暮友毅 1) 2), Corner British 1), Valley water Masato 2) 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2012.

---

Action to safe medical treatment mainly on the patients bringing medicine confirmation in the P1-516 hospitalization and release, medical cooperation center Shoji Izumo, Manami Kanda, 四方公亮, Misa Sugano tree, Kaori Sato, Yuki Inoue, Miyako Shoda Noriko, Toru Hirashima, Hideo Hasegawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2012.

---

	Investigation of the adverse event in the patients who changed the P1-517 anticancer drug from the starting medical supplies to the generic medicine Megumi Kadoi Yoshiko, The Yoshimura spring beauty, Junya Ogawa, Koji Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2012.

---

	What you should think about at the reshuffling to P1-518 transfusion generic drug (with Fischer liquid for a case) Keiji Kuramoto 1), Takako Suzuki 2), Takashi Hatae 3), Toru Shoji 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2012.

---

	Desensitization of the forerunner, the generic medicine of the ST mixture in patients with P1-519 HIV infection and product comparison 矢倉裕輝 1), 吉野宗宏 1), Hiroyuki Kushida 1), 廣畑和弘 1), 山内一恭 1), Asako Kamihira 2), Katsuya Komori 1), Takuma Shirasaka 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2012.

---

	Competitive review of P1-520 gemcitabine Ryoko Maruyama, Sekiya wisdom, Kanako Takahashi, Masae Hirasawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2012.

---

	Differentiation of the white petrolatum basis used for a lot of P1-521 clobetasone butyric acid ester ointment Yoshihisa Yamamoto 1) 2), 深水啓朗 2), Eyes bird Koichi 2), Yoshinori Onuki 3), Tatsuo Koide 4), Noriko Katori 4), Suzuki Toyoshi 2), Kazuo Tomono 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2012.

---

	It is ... for a case with nondestructive evaluation - amlodipine preparation using the near-infrared light of the P1-522 Generic drug 大鳥徹, Yoshi Hashimoto good luck, Kenji Matsuyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2012.

---

	Efficacy, safe and medical economical examination for hypercholesterolemia when we changed it to atorvastatin tablets "EE" from P1-523 Lipitor tablets Jun Okubo, Tomoaki Ikezaki, Mai Tanaka, Satoko Takeuchi, Koichi Tanabe, Hidenori Kitazawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2012.

---

	Side effect investigation of the P1-524 iopamidol injection generic drug 小茂池潤太 1), Yasuaki Hashimoto 1), Shinji Taniguchi 2), Kojiro Awano 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2012.

---

	Comparison about the preparation evaluation of the P1-525 rebamipide component lock Every field Chieko 1), Koji Muto 2), Tetsuya Miyakawa 3), Yuka Tanaka 1), Hideyuki Sumita 1), Akemi Machino 1), Interest village Keiko 1), Etsuko Miyamoto 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2012.

---

	Taste bitter evaluation of a generic drug, the donepezil hydrochloride orally disintegrating tablet using the P1-526 taste sensor Midori Sota 1), Takashi Nagata 1), 内藤悦伸 2), Hidekazu Ikezaki 2), Keiko Yamamura 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2012.

---

Examination of stability of the P1-527 hospital preparation 0.5% ganciclovir instillation and the efficacy Kanda Kosuke 1), 坂元利彰 1), 兒玉幸修 1), Hiroo Nakagawa 1), Kentaro Yamaguchi 1), Fujikawa sub-month tea 2), Norihide Higuchi 1), Tadahiro Nakamura 1), Takashi Kitahara 1), Hitoshi Sasaki 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2012.

---

	Stability of the P1-528 nimustine hydrochloride lotion Yasushi Sekiya, Manabu Okumura, Yohei Kawano, Akira Takagi period, Tomomi Iwakiri, Kazuhiko Arimori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2012.

---

	About the change of rheology properties with the mixture with P1-529 white petrolatum and an additive or the cream Megumi Fujiwara, Yuta out of the offing, Yudani Reiko, Reiko Teraoka, Shuji Kitagawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2012.

---

	Change of the rheological nature with the mixture with P1-530 ointment and the cream Yuta 1 out of the offing), Megumi Fujiwara 1), Yudani Reiko 1), Reiko Teraoka 1), Shunichi Aida 2), Nobuyuki Muroi 2), Shuji Kitagawa 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2012.

---

	Lability test of the P1-531 hospital preparation vitamin K1 ointment 原茉梨絵, Reiko Makihara, Takako Yanai, 橋本浩伸, 牧野好倫, Nobuaki Yokote, Hiroshi Yamamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2012.

---

	Examination about the adsorption to an injector of P1-532 Bevacizumab Hiroshi Kudo 1), Tatsuya Mori 1), Nobue Sato 1), 足立茂 2), Sanae Miyano 1), Chiaki Ogawa 1), Megumi Yatabe 1), Makoto Kobayashi Sachimi 1), Miyashita 1, Kyuutoku), Yasuo Ide 1), Yoshihiko Suzuki 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2012.

---

	1 case that the repeated doses of the desiccated thyroid gland suppository in patients with P1-533 hypothyroidism were effective Sugimoto lapis lazuli, Toshiyuki Hirai, Seki Toshikazu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2012.

---

Approach from characteristics of the physical pharmacy for the in-hospital formulation of the P1-534 mianserin suppository Takanori Nakajima 1), Masanori Iwata 2), Shuichi Nawata 3), Your Nakamura existence 1), Hiroshi Saito 1), 小林靖奈 3), 山元俊憲 3), Yoshikazu Matsuda 1), Masayuki Kimura 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2012.

---

	Examination about the method of dispensing of the P1-535 7% lidocaine gel Your Shun Nakamura 1), Hiroyuki Miyashita 1), Soichi Shibata 1), Kensuke Usui 2), Takahiko Kagaya 1), Atsuta Koichiro 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2012.

---

Utility - of the single use therapy at clinical evaluations - remission maintenance therapy of the hospital preparation mesalazine suppository in the P1-536 proctitis type ulcerative colitis Michihiro Yamaguchi 1), Hiroshi Muramatsu 1), Masaya Yamaguchi 1), Shunichi Kawamura 1), Asako Terashima 2), Kayoko Maezawa 2), Junko Kitsu 2), Matsuoka Katsuyoshi 3), Toshifumi Hibi 3), Shinichiro Okamoto 1) 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2012.

---

	P1-537 Stomatitis after chemotherapy will heal and licking candy : Development of Polaprezinc candy (P candy) formulation 日比徹, 矢吹真弓, 中野遥, 日笠淳一, 渡辺正教, 菊地丈, 河治智美, 吉羽真由美, 中沢修司, 大木崇弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2012.

---

	Nondestructiveness, non-contact assay by the far-red spectroscopy of the active ingredient out of the crude drug component ointment as the P1-538 hospital preparation Makoto Otsuka 1), Peerapattana Jomjai2), Kuniko Otsuka 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2012.

---

	1 case that responded to a tramadol combination lock for a pain control of the umbilical hernia to repeat P1-539 exacerbation, reduction Masahiro Okada 1), Description of Hiroshi Sugihara 1), Precincts of a shrine Erina 1), Yoshinari Kawai 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2012.

---

	Utility of the electrocardiogram evaluation by the P1-540 pharmacist Hiroshi Onoe 1), Kazue Nakata 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2012.

---

	Application of the inhalational pattern measuring assembly for the proper use of the P1-541 inhalant Flat 1, Taiki) 2), Okuda resourceful general 2), Shinya Morita 1), 寺田智祐 1), Koichi Okamoto 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2012.

---

	2 cases that we introduced a fentanyl MT patch into from a tramadol hydrochloride / acetaminophen combination lock for P1-542 intractable nature neuropathic pain Noriko Nagahara, Nao Sakoda, Chika Sakaguchi, Yoshiko Okuda, Shoichi Yoshida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2012.

---

	Examination ... from action ... incident report to in-hospital staff knowledge improvement of the P1-543 inhalational instruction Takaaki Nakajima, Hiroaki Tabata, Takami Sato, Nami Sugimura, Maeda Miyuki, 猿谷淳, 向一美, Ground field Mikiko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2012.

---

	Examination about the efficacy of P1-544 pregabalin 佐藤裕資, Miho Michishita, 門脇督, Flat land tax, Tanaya Mitsugu, Yutaka Kanetani, Chinami Suzuki, Hirokazu Tabata, 柴波明男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2012.

---

Galanthamine in the P1-545 this hospital, effect of treatment and side effect of memantine Akari Tanikawa 1), Satoshi Suda 1), Yukiko Kaieda 1), Shintaro Mochizuki 1), Ueda bare reason 1), Takeshi Murai 1), Yoshiko Onuki 1), Keiko Hagiwara 2), Yoshinobu Akiyama 2), Tsutomu Shimada 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2012.

---

	Development and examination of Japanese edition MISS-21modified evaluating patients satisfaction in the correspondence of the OTC medicine of the P1-546 pharmacist Mayu Sakurai, 半谷眞七子, Yukari Yoshioka, Hiroyuki Kamei, Takuji Kawamura, Megumi Ogawa Rina Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2012.

---

	Evaluation (the third report) of the folic acid combination situation to patients with articular rheumatism during P1-547 methotrexate administration Toru Miyazaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2012.

---

	Examination about exercise tolerability and the dose in the P1-548 carvedilol internal use patients Azusa Yamamoto 1), Yukiko Yokota 1), Junko Hirai 1), Mami Ishibashi 1), Osamu Ichikawa 2), Tamaki Ono 3), Masaki Kataoka 4), Hironori Saito 3), Hideki Mori 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2012.

---

	Examination of safety, the effectiveness in the P1-549 tolvaptan long-term use 阿部正樹, 村井彩紗, 木原理絵, 中蔵伊知郎, 服部雄司, 関本裕美, 廣畑和弘, 山内一恭, 小森勝也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2012.

---

	Use fact-finding of the infliximab increase in quantity for the P1-550 articular rheumatism 森澤貴啓, Taniguchi male person, Tsuyoshi Fujita is flat, Ooi greens Yoshiko, Tadashi Tsuda University, Hideaki Izumi, Yoshihiro Hashimoto, Shigeki Tanaka, Hitoshi Komori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2012.

---

Examination about the utility of delirium treatment using the Chinese medicine to patients with P1-551 femoral neck fracture 内川晶裕, Yoko Akamatsu, Hiromi Azuma, Kazumi Kuwahara, Keiko Yamamoto, Ayaka Amano, Akihiro Maruo, Field road Akemi, Tsutomu Hamanaka, Ichio Tanaka, Norio Yamada, Sachimi Moriyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2012.

---

Examination about adalimumab therapy and the immunomodulator combination for Crohn's disease in the P1-552 Sapporo welfare hospital Sudo University male, Yuka Uemura, Drunk Mariko, Tokutome chapter, Muranaka one size, Rie Kawamoto, Hatsumi Kikuta, Ryu Kobayashi, Hideji Ohara, Muki Ryoji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2012.

---

	NET EXCEPTION Err: Could not connect to host 出口綾子1), 中西大介1), 畑地治2), 柳川泰裕1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2012.

---

	Effect to give to P1-554 probucol, blood pressure plethysmography (CAVI) of the cilostazol Keiichi Hara 1), Hideki Kobayashi 1), Hidetoshi Kawana 2), Endo Valley 2), Koji Shirai 3), Ichiro Tatsuno 2), Masaka Wataru 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2012.

---

Examination of the terra pre-building weight loss factor in the triple-drug therapy for P1-555 chronic hepatitis C Shigeru Sato 1), Tetsuya Hirose 1), Mihoko Sasaki 1), Hatsumi Kikuta 1), Miki Katsuragawa 1), Hideji Ohara 1), Ryu Kobayashi 1), Muki Ryoji 1), Ozeki solstice 2), Yoshiyasu Kano 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2012.

---

	The cerebral infarction onset situation by the cancellation of P1-556 antiplatelet drug, the anticoagulant Yoriko Kasamatsu, Kojiro Takashima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2012.

---

	About the effect that patient compliance instruction before the medication initiation of the P1-557 antiHIV medicine gives to regimen choice, adherence Chikako Shimokawa, Akiko Yasuda, Table Shiho, 柏原宏暢 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2012.

---

	Problems in an international comparison for the proper use of the P1-558 emergency contraceptive and the do-it-yourself importing Kuniko Otsuka 1) 2), Hajime Yasuhara 2), Naoki Uchida 2), Shinichi Kobayashi 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2012.

---

	Aldose reductase antagonism of the P1-559 All-trans- retinoic acid 石川稚佳子 1), Midori Ito 2), 小野田稔久 2), Kaiden Mariko 3), Masaka Wataru 2), Masahiko Obayashi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2012.

---

	Present conditions investigation of the orthopedics postoperative pain control in the P1-560 this hospital Kazutoshi Terayama 1), Taeko Ogata 1), Daisuke Sato 1), Kengo Kuroda 1), Kikuo Kato 1), Kunihisa Miura 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2012.

---

	It is ... using approach - short play in heart of patients with P1-561 Niigata pharmacist diabetes network actograph (1) diabetes Ayumu Maruyama 1), Tatsushi Saito 2), Kazuhiko Nagai 3), Eiko Hara 4), Toru Yamada 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2012.

---

	Want to know P1-562 Niigata pharmacist diabetes network actograph (2) here; is ... from exercise therapy - theory of diabetes to practice Kazuhiko Nagai 1), Tatsushi Saito 2), Eiko Hara 3), Ayumu Maruyama 4), Toru Yamada 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2012.

---

	Are P1-563 Niigata pharmacist diabetes network actograph (3) you all right; "diabetes at first a diet ...?" Tatsushi Saito 1), Kazuhiko Nagai 2), Eiko Hara 3), Ayumu Maruyama 4), Toru Yamada 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2012.

---

	... that ... I regard P1-564 Niigata pharmacist diabetes network actograph (4) as "the test value that a physician pays attention" to in this way Toru Yamada 1), Tatsushi Saito 2), Kazuhiko Nagai 3), Eiko Hara 4), Ayumu Maruyama 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2012.

---

	Diabetes education ... to learn by P1-565 Niigata pharmacist diabetes network actograph (5) "toss queen crab Ann" - game Eiko Hara 1), Tatsushi Saito 2), Kazuhiko Nagai 3), Ayumu Maruyama 4), Toru Yamada 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2012.

---

	Transtime change by the blood mixture to P1-566 insulin preparation Takeshi Sekino, Yukiko Tanaka, Naohiro Yoshida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2012.

---

The effect that the fruit juice which attached to P1-567 finger gives to the blood glucose level with the simple blood glucose measuring instrument Satomi Harima 1), Aya Saito 1), Chisato Matsumoto 1), 小金井要治 1), Saori Takemoto 1), Ai Oshima 1), Aiba Koichi 1), 上野彩恵 1), Kazumasa Hasegawa 1), Masayuki Arakawa 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2012.

---

	Combined effect of the sitagliptin for patients with diabetes during P1-568 insulin therapy 野口景子, 葛葉守, 久嶋真紀子, 中野玲子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2012.

---

The effect that cilnidipine administration gives to vascular elastic CAVI on patients with type II diabetes mellitus during P1-569 ARB remedy Minoru Morimoto 1), 佐々木英久 1), 松尾和廣 1), Tomoko Watanabe 1), Etsuko Shinohara 1), 齋木厚人 2), Ichiro Tatsuno 2), Koji Shirai 2), Masaka Wataru 3), Takashi Yoshio 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2012.

---

The effect that combination of valsartan and hydrochlorothiazide gives to arteriosclerosis on patients with P1-570 type II diabetes mellitus Tomoko Tsuzuki 1), 佐々木英久 1), 松尾和廣 1), Tomoko Watanabe 1), Etsuko Shinohara 1), 齋木厚人 2), Ichiro Tatsuno 2), Masaka Wataru 3), Takashi Yoshio 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2012.

---

	Examination about change cases from P1-571 pioglitazone to sitagliptin 堅石法子, 中村雅敏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2012.

---

Study on effect that a dosage regimen of the P1-572 oral hypoglycemics gives in the adherence of patients with type II diabetes mellitus Taketo Okubo 1), Mitsuko Onda 1), Hiroshi Okada 2), Masaki Shoji 1), Yuka Tanaka 1), Tomoharu Oda 1), Saki Kato 1), Arakawa line straight 1), Naoki Sakane 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2012.

---

	Improvement ... of the hypoglycemia instruction by the active intervention of hypoglycemia instruction - ward pharmacist who P1-573 pharmacist collaborates with a nurse, and is carried out Shin Aoyama is flat, Yu Tomita product, Nakajima Mizuki, Yoshitsugu Sano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2012.

---

	About the attitude survey health food of patients with P1-574 diabetes Katsura Harada product 1), Yoshiko Miyano 1), Yoshiko Sakamoto 1), Keiko Nagai 1), Sen Oe spring 2) 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2012.

---

Analysis of the factor affecting the blood glucose level improvement by the glucose supplementation jelly intake at P1-575 hypoglycemia Yu Tanaka season 1), Kaoru Makita 1), Descent from a mountain Asako 1), Yuka Nakamura 1), Plains sum 2), Takeru Kawai 1), Bridge Ryosuke 1), Maiko Suda 2), Hiroko Kaido 2), Descent from a mountain Koichi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2012.

---

	Examination about the effect of alogliptin 25 mg in patients with P1-576 type 2 diabetes 井上稚枝子, 小川大介, 武本千惠 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2012.

---

	Examination of the HbA1c improvement effect at the new introduction, supplementation, change administration of the sitagliptin in patients with P1-577 type 2 diabetes 岩本英子, 奥野知美, 江口貴俊, 永田梨紗, 水町信一郎, 馬場亮一, 杉本悠花, 岡田昌之, 松浦まなみ, 成末まさみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2012.

---

	It is examined HbA1c at supplementation in sitagliptin by P1-578 glimepiride 石橋真実1), 大村祐加1), 砂場亜希1), 森英樹1), 宮下雄博2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2012.

---

	Factor about effect of treatment of the DPP-4 inhibitor sitagliptin in patients with P1-579 diabetes 早苗富士子1), 笹谷知美1), 喜多香菜1), 赤松紗奈江1), 日下部千晶1), 辻昌江2), 岡田守弘2), 西上潤2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2012.

---

The use of insulin fact-finding of patients with P1-580 elderly people diabetes and examination about effectively utilizing it of the aid Ono Hiroshige 1), Yoko Moriyasu 2), Naoki Matsumura 1), Shoko Okazaki 1), Aki Kawakami 1), Kenichi Shimada 3), Takashi Egawa 3), Takashi Shibata 3), Masashi Takahashi 2), 五味田裕 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2012.

---

	Induction and evaluation of the sponge for the P1-581 insulin injection instruction Takashi Kamata will, Naoko Ooi, Kusajima Kohei, Takuya Sato, Daisuke Ishikawa, Daisuke Tanaka, Kazuto Abe, 佐藤導 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2012.

---

	Examination about the utility of the new insulin induction in the P1-582 outpatient department Shigeo Akiyama 1), Small Makiko Aze 1), Hitoshi Yoshida 1), Akie Kobayashi 1), Isono Junichi 1), Tomoyuki Aoki 2), Takayuki Ogiwara 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2012.

---

	Comparison II of patients with poisoning in the critical care center of P1-583 two Eiichi Maruta 1), 上山進 2), Nishimoto incense king village 2), Second place Chihiro 3), 辰見明俊 3), 韓秀妃 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2012.

---

	Questionary survey about P1-584 emergency care and the pharmacy education Shiro Hatakeyama, Yagi Tomomi, Takeshi Katsuyama, Yukio Kishikawa, Jin Nakamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2012.

---

	About a case with suspected participation of the common use medicine in new inpatients in P1-585 lifesaving emergency ward and ICU 寺西正充, 森山史就, Kenichi Anjiki, Tomohiro Sonoyama, Katsuki Yokote, Ei Hirano product, Sumiko Goto, Yuki Imaoka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2012.

---

	Relation of the pharmacist at the P1-586 cardiopulmonary resuscitation The Ogasawara history, Kazuko Tateishi, Kazue Nakamura, Yuka Masuyama, Yukiko Okura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2012.

---

	Present conditions investigation about the disposal of injection in the P1-587 ICU Harada University 1), Nami Suda 1), Tamayo Takahashi 1), Dr. Shimazaki 1), Masaki Kitamura 1), Shigehiko Uchino 2), Masaru Takinami celebration 2), Takashi Kawakubo 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2012.

---

	Specific example of the pharmacist intervention in the P1-588 neonatal intensive care unit Tsujimura Imperial attendance, 安間保恵, Katsuya Hirose, Taku Yamauchi, Kazumi Kawamura, Mitsuru Shiokawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2012.

---

	Examination ... which was made from ... questions and answers with the information that P1-589 operating room staff required Sakai Naoko 1), Teruko Takano 1), 小林彦登 1), Futoshi Saito 1, Kotobuki), Soichi Shibata 1), Atsuta Koichiro 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2012.

---

Practice of the precedence-like pharmaceutical management in P1-590 first aid, the intensive care region Mitsuru Otsuka 1), Shinji Sawada 1), Kazumasa Ueda 1) 2), Tatsuya Otsubo 1), Eiichiro Kanda 1), Horiuchi tomorrow incense 1), Komori Tamao 1), Yasuyuki Nishikawa 1), 小西偉雄 1), Tadashi Mikami 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2012.

---

Job analysis by the thyme study of the clinical pharmacy duties in P1-591 Kochi medical center, the critical care center Satoshi Tanaka 1), Tadashi Kadoguchi kernel 1), Takashi Kawada 1), Norifumi Miyamoto 1), So Yamamoto one 1), Kazuhiko Sugimoto 2), Murata thickness husband 2), 服部暁昌 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2012.

---

	About the mixed preparation use of the action - cardiovascular surgery preoperative preparations drug to a specialist in P1-592 anesthesia medical department support task - Koji Moriya, Existence Reiko Sawa, Ko Tokuda period, Shinsuke Akagi, Toshikatsu Okuda, Kazunobu Takayanagi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2012.

---

Than the investigation of present conditions investigation - 2011 Ministry of Health, Labour and Welfare team approach in medical care proof business 202 institutions about the pharmacist duties in the P1-593 operating room of the whole country - Yuka Shibata 1), Furrow well Hiroko 1), Masashi Kawamoto 2), Tree flat Kenji 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2012.

---

	Pharmacist duties in the P1-594 operating room Tokumitsu Horii, Daisuke Masuda, 杉山一覚, Tomio Matsumoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2012.

---

	For medicine medicine cooperation promotion in the P1-595 cancer chemotherapy Masahide Sugiyama, Atsushi Miura, Kazumi Yoda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2012.

---

	Research about the utility of the present conditions of the medication assistance in patients with P1-596 dementia and patch agent Ise Yuya 1), Shiro Katayama 1), Hiroshi Nakano 2), Kenzo Ohba 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2012.

---

	It is ... from the questionary survey to ... physician, a dentist investigating a problem and measures for the P1-597 medicine notebook spread Katsura Maeda I, Tsuchiya 1,000 Masako, Takaaki Ishii, Mayumi Sakaguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2012.

---

Making of medicine medicine cooperation - format by the medicine notebook utilization for patients who received P1-598 outpatient department cancer chemotherapy and use investigation - for the health insurance pharmacy Hiroki Miyata 1) 2), Yuri Ito 3), Ono A rare child 4), Chigusa Kaneko 5), Chihiro Kawakami 6), Yasushi Kondo etiquette 7), Tsurusaki University 8), Mari Hosaka 9), Shuhei Moriyama 10), Hisashi Shimizu example 2) 11), Toshihiro Hama 2), Takao Akashi 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2012.

---

Questionary survey for the problems improvement of the medicine medicine cooperation through the medicine notebook for patients with P1-599 cancer Hiroki Mase 1), Kazuko Koyama 1), Tatsuya Kobayashi 2), Satoyo Horisawa 1), Sachiko Kubo 1), Yumi Konishi 1), Keiko Kondo 1), Masako Watanabe 1), Takahiro Yajima 1), Naoya Inukai 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2012.

---

	Example that the physical evaluation of the P1-600 pharmacist led to visit practice Yamaguchi High School 1), 金児潔 2), Mayumi Maruyama 1), Mao Nakamura 1), Hiroki Nagashima 1), Shinsuke Higuchi 1), Wife Valley Tami charges 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2012.

---

	Mediation ... with action ... hospital and the local health insurance ethical pharmacy of the hospital pharmacist for P1-601 treatment at home cooperation promotion Kinoshita Tomoyasu 1), 上地小与里 2), Takanobu Ichino 1), Kazuhiro Ito 1), Old Masaru Den trans1) 3), Hisayuki Miura 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2012.

---

	1 case report which was connected by the drug control instruction duties to patients with P1-602 tongue cancer from pain care to treatment at home Takeshi Tanaka group, 枝重満希, 森田祐加, 古味章乃, Masaaki Kimura, Kazue Takeichi, 田處香澄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2012.

---

Consciousness of the citizen for the treatment at home that P1-603 pharmacist participates in Tomomi Horino 1), Yamato trunk and branch 1), Forest ten Hisako 2), Kamoike Shinji 3), Kazuhiko Saeki 4), Mitsuru Kishida straight 5), Naoko Takahashi 1), Kitakoji study 1), Sumio Matsuno 1), Mitsutaka Takada 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2012.

---

	Development and utility evaluation of new one Dors package (GTpack) with the P1-604 medication support jelly Eriko Kimura, 于琳, 孟媛, 張玉, 楊偉燕, Mayumi Joko, Mikako Nishiyama, Masao Nozaki, Yutaka Sakuma, 盛本修司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2012.

---

Unification ... of the patients with medicine medicine cooperation information sharing paper to use in action ... 2 institution in the oral P1-605 anticancer drug Naoko Tsuji 1), Masaki Manda 1), 野際俊希 1), Shigeo Asai 1), Katsufumi Okamoto 2), 澤本成史 2), Makoto Kimura 2), Hideo Maruyama 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2012.

---

About an action of "oral managed care cooperation model business" (medicine, teeth, medicine cooperation) around the P1-606 Aichi cancer center center Hospital Noritake Kana 1), Ayako Hasegawa 1), Michiko Tatematsu 1) 2), Keiichi Kato 1), Chiharu Ito 3), Yasuhisa Hasegawa 4) 5), Hiroshi Nishikawa 6), Tamamizu truth 6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2012.

---

Examination for effective inhalational instruction promotion by the illness medicine cooperation using the P1-607 inhalation procedure evaluation vote Imai wealth Noriko 1), 東敬一朗 1), 宇夛裕基 1), Kazuhiko Igarashi 1), We run the plum bottom 1), 藺上圭子 1), Masahide Yasui 2), 中積泰人 2), Masami Kawahara 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2012.

---

	Role of the health insurance pharmacy pharmacist in the patient on dialysis entering P1-608 pay old man institution 山村彩 1) 2), Toru Maeda 1), Atsuko Inagaki 2), Hiroko Suzuki 2), Yukihisa Kurono 2) 3), 黒野加直子 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2012.

---

	Questionary survey about the impression for the pharmacist of patients who received P1-609 at-home fluid therapy, the caregiver Nakayama etiquette field 1), 中野宜範 2), Yuka Taguchi 2), Tetsu Inoue Tarou 2), Hidemi Kawano 2), Ueno Hiromi Sana 2), 行川淳 2), 植沢芳広 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2012.

---

	Investigation about the use situation of the emergency communication card taking P1-610 disease medicine cooperation Goji Maeda, Atsushi Suzuki term, Daigo Suzuki, Akira Ogawa intellect, Hiroshi Sakata, Hiroyuki Matsubara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2012.

---

Association between enforcement presence or absence of at-home duties and drugstore attribute in the P1-611 health insurance pharmacy Masako Tanaka 1), Mitsuko Onda 1), Shinya Hirata 1), Makoto Takamatsu 1), Hidekazu Tanaka 1), Yuta Kataoka 1), Seven Kaiyo child 2), Yuka Tanaka 1), Yukio Arakawa 1), Hirohisa Imai 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2012.

---

1 case - that we supported home care transition in cooperation with the relation II- drugstore pharmacist of the hospital pharmacist in the P1-612 medicine medicine cooperation 高柳論也 1), Motoyuki Watanabe 1), Takeshi Sugai people 1), Mitsunori Akimoto 2) 3), Megumi Akiyoshi storehouse 3), Yoshio Kosaka 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2012.

---

	Cooperation ... with the wide area Hospital through evaluation and examination - inhalation instruction request book of the inhalational instruction by the P1-613 insurance pharmacist Saori Mizusawa 1), Koji Okubo 1) 2), Manabu Fujiki 1) 2), Shigeru Yamada 1), Masatomo Murohashi 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2012.

---

	Trial of medicine, the medicine cooperation in the P1-614 inhalational instruction 1, Shizu, Asano), Junko Hirai 1), 河村茉衣 1), Azusa Yamamoto 1), Megumi Mukai 1), Hideki Mori 1), Yamaguchi sum truth 2), Masaru Inoue 2), Koji Narahara 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2012.

---

Effect - that construction - second report inhalation instruction study session of the inhalational instruction cooperation in P1-615 Suita-shi gives to consciousness and the behavior of the pharmacist Akira Kodama person 1), Mitsuyo Takemura 1), Azusa Miki 1), Iwatate Chizuko 1), Fusa Honna beauty 1), Shinsuke Mori 1), Fumio Tsuji 2), 岡橋義弘 3), Suma Kazuo 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2012.

---

Hold present conditions and problem - physical assessment workshop for the duties development of the physical assessment by the P1-616 pharmacist; and ... Akiko Emoto 1) 2), Kenji Sakamoto 3), Pine snow trunk one 3), Koji Takeuchi 1) 2), West Kazuya 1) 2), Yukiko Takemori 1) 2), Tsuyoshi Miyahara 2) 4), 湯川潤輝 1) 2), Naosuke Yoshitomi 5), Fujito Expo 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2012.

---

	The medicine medicine cooperation that began with P1-617 at-home transfusion Megumi Takahashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2012.

---

	The case that led to visit drug control instruction by the suggestion from P1-618 pharmacist Yoshihiro Okada 1), Oshiyama Takamitsu 1), Megumi Takahashi 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2012.

---

Association to affect the at-home visit by the P1-619 drugstore pharmacist between quantity of duties and outcome Yuta Kataoka 1), Mitsuko Onda 1), Shinya Hirata 1), Makoto Takamatsu 1), Hidekazu Tanaka 1), Masako Tanaka 1), Seven Kaiyo child 2), Yuka Tanaka 1), Arakawa straight husband 1), Hirohisa Imai 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2012.

---

	From the viewpoint of present conditions and problem - medical supplies offer of the P1-620 treatment at home - Kazuki Kushida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2012.

---

	Construction of the business training visit support system by the use of P1-621 i-Pad Makoto Ishibashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2012.

---

	Induction of the communication educational program using the character analysis for the P1-622 business trainee Kozoe kernel 1), 末丸克矢 2), Mamoru Tanaka 1), Hiroshi Araki positive 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2012.

---

The presentation of the results of the study of the business trainee in the P1-623 this hospital and evaluation of the business training schedule obtained from the questionnaire Nobuko Takayanagi 1), Masahiro Okuno 2), Yuko Ogawa 1), Takayuki Yamazaki 1), Manabu Nakata 2), Yoshiharu Umetani 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2012.

---

It is ... (2) from the situation of the student who finished the hospital training of drug instruction (through a case of the malignant pleural mesothelioma) - 11 weeks for patients with P1-624 cancer Chiaki Kataoka 1), Masahiro Okuno 2), Nobuko Takayanagi 3), Manabu Nakata 2), Yoshiharu Umetani 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2012.

---

It is ... (1) from the situation of the student who finished the hospital training of need (through 3 cases of the terminal) - 11 weeks of the drug instruction in the medical care for P1-625 terminal phase Taku Kurata light 1), Nobuko Takayanagi 2), Masahiro Okuno 3), Manabu Nakata 3), Yoshiharu Umetani 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2012.

---

	An evaluation and improvement of the business training in the P1-626 Tokushima Red Cross Hospital Matsushima flourishing endlessly, Group bridge Yuki, Rie Aisaka, Atsuko Horimoto, Otani eyes, Tomoko Suzue Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2012.

---

Step of the business training result briefing session where we invited university teachers in the P1-627 group training to for 2 years Hirokazu Someya 1) 2), Shin Oda 2) 3), 岡田樹彦 2) 4), Kenjiro Kimura 2) 5), 奈良部修弘 2) 6), Akiko Sakai 2) 7), Tomoko Hirose 2) 8), Akiko Nagaki 2) 4), Haruyuki Sakuma 2) 4), Yasukazu Yamauchi 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2012.

---

	Action for self-assessment type anticancer drug preparation training systems construction in the P1-628 pharmacy school business training Hiroyuki Fujii, Rock texture Reiko, Keiko Ogasawara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2012.

---

	It is analyzed the cause about the arrival degree insufficient training item in P1-629 drugstore training Ayako Terada, Miki Nakamura, Kazuhiro Watanabe, Akito Takano, 廣原正宜, Shibuya Fuminori, Kyoji Taguchi, Tomoyuki Hamamoto, Yoshie Horiguchi, Jun Toda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2012.

---

About contents about the fact finding - on the university side and the hospital side to hope for for business training for P1-630 long term particularly anticancer drug treatment - Tsuyoshi Suzuki 1), Mt. Ishii husband 1), Namba existence intellect 1), Isagawa Sayaka 1), Yukako Shimabukuro 2), Shinichiro Maeda 2), 比嘉義太 2), Yuri Aragaki 2), We consider among outsiders husband 1), 宇野司 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2012.

---

	About the business training instruction pharmacist upbringing lecture in the P1-631 Keio University pharmacy school Kazuko Fujimoto, Juichi Otani, Junko Kitsu, Yutaka Hattori, Masahiko Masuno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2012.

---

	It is analyzed the cause about the arrival degree insufficient training item in P1-632 Hospital training Miki Nakamura, Ayako Terada, Kazuhiro Watanabe, Akito Takano, 廣原正宜, Shibuya Fuminori, Kyoji Taguchi, Tomoyuki Hamamoto, Yoshie Horiguchi, Jun Toda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2012.

---

	Induction of the critical foresight training for the P1-633 pharmacy trainee Yamase University male, Takashi Doi still, Ryoko Nakanishi, Hama Tsu Yoriko, The autumn Yamahana world, 籠本基成, Masahiro Ishizu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2012.

---

	Construction of action - training system to long-term business training in the P1-634 this hospital and improvement - Chiaki Yokota 1), Kazuhito Hirota 2), Masato Tateishi 2), Takahiko Nakao 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2012.

---

Questionary survey about the long-term business training in the P1-635 Himeji Dokkyo University pharmacy school Cheap Tomomi 1), Manabu Amano 1), Hiroaki Kachi 1), Jun Kinoshita 1), Ratio intellect shop Hiroyuki 1), History of Tadashi Kiyohara 1), Fusa Komada husband 1), Aki Amano 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2012.

---

Trial of the clinical judgment skill evaluation using the patients image sheet in the P1-636 long-term business training Hiroki Inoue 1), Yuzuru Saito one 2), Jun Hirano 2), Yamaguchi cloth sand 1), Satoru Yoshida reason 1), Sanji Sato 1), Shunsuke Kurono 3), Yoichi Hasegawa 3), Akira Takahashi 2), Toshiharu Nomura 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2012.

---

	The action for "TDM duties" in the P1-637 Hospital long-term business training and the evaluation Yodoshi Masahiro 1), Hiroyuki Morishima 2), Morihiro Nomura 1), Yuzuru Yamazoe 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2012.

---

Action of the business training instruction in a first aid, the intensive care region by the P1-638 pharmacy school teacher Shinji Abe 1), Natsuko Ise 2), Kenji Ikuta 2), Naoto Okada 2), Satoyoshi Yoshiko 1), Hirofumi Shibata 1), Kazuyoshi Kawazoe 2), East beauty 1), Kazuo Mizuguchi 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2012.

---

	Action of the pharmacy business training third year aiming at the cooperation reinforcement with the P1-639 University of Shizuoka businessman teacher Midori Kimura, Nabeta Izumi, 嘉屋道裕, Hiroaki Utsuki, Satoru Minami, Takeshi Sakurai, Keiko Hirano, 角入寿彦, Takashi Suzuki charges Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2012.

---

It is change in the annual of the operational evaluation of "a business training teachers' textbook" aiming at homogenization of the P1-640 business training and efficiency and "the training book" Hideo Nakata 1), Matsuoka sentence 1), Soichiro Tsuda 1), Takeshi Kaneko 1), Hiroshi Shiina good luck 1), Yamakichi Yasuko 1), Osamu Ikeya 1), Kyoko Nashimoto 1), Shunichi Kawamura 1), Shinichiro Okamoto 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2012.

---

	The consciousness of the student facing the P1-641 business training and the change The east beauty, Satoyoshi Yoshiko, Shinji Abe, Hirofumi Shibata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2012.

---

Than problems - questionary survey of the communicative competence in the business training that saw from P1-642 student and Small group discussion using the KJ method - Noriko Kobayashi 1), Aono Izumi 1), Yoshiko Kadota 1), Sayo Suzuki 1), Naoko Otsuka 1), Shuku Tezuka person 1), Juichi Otani 1), Junko Kitsu 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2012.

---

	Satisfaction and the understanding degree of program evaluation - learner of the business training in the P1-643 drugstore and the contribution factor Hiroshi Onishi High School 1), Miho Utsumi 2), Sachi Hirano 2), Yuki Fujii 2), Hiroshi Yamamoto 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2012.

---

	Education about the medical security in the learning before P1-644 business true taking lessons Keiko Morita, Taiko Masao, Junji Iwashita, Katsumi Kido, Megumi Iimori Yoshiko, Shinichiro Ando, 前田共秀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2012.

---

	The construction of the advanced PBL class with the unification type curriculum in the P1-645 sixth grader and the evaluation Teramachi eyes 1), Tomoya Tate 1), Tadashi Horiuchi 2), 保住功 3), Tadashi Sugiyama 4), Teruo Tsuchiya 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2012.

---

	Attitude survey for patients with mental disorder of the pharmacy student by the P1-646 new education curriculum induction Ono sand lily 1), Hiroshi Tanaka 1), Cates Marshall2), 半谷眞七子 1), Hiroyuki Kamei 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2012.

---

	A scholastic ability investigation and inspection of the biology (high school course) for the P1-647 this school new student Katsuya Koike, Strong marsh Masami, Hitoshi Nakamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2012.

---

	Making and evaluation of the training manual for the P1-648 new face pharmacist Aya Ishihara, Megumi Mizuno, Eiko Hishida, Keita Urasaki, 金正煥, Kazuko Kawai, Kazuyuki Ito, Satoshi Isotani Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2012.

---

	Effect of the simulated patient to give in the consensual manner of the P1-649 pharmacy student 毎熊隆誉 1) 2), Kenichi Shimada 1), Ono Hiroshige 1), Takashi Egawa 1), Takashi Shibata 1), Tamiko Nishimura 1), Sumiko Shiota 1), Junko Maeda 2), 五味田裕 1), Daisuke Teshima 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2012.

---

	Result of the practice using the simulator to develop ability for P1-650 clinical judgment Shunsuke Kurono, Aki Ito male, Fumiko Otsu, Shigeyuki Yamada, Yoichi Hasegawa, Tadashi Nagamatsu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2012.

---

	Development of the international exchange in the P1-651 pharmacy six years system education Miyoshi Kawakami, Arumi Hideto, Tomoji Yoshiyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2012.

---

Training - with the scenario based on enforcement of the physical assessment training for the P1-652 6 annual student and the case of evaluation (the second report) - healthcare setting 廣原正宜 1), Tomoyuki Hamamoto 1), Kazuo Takayama 2), Ayako Terada 1), Miki Nakamura 1), Yoshiko Chiba 1), Shibuya Fuminori 1), Kyoji Taguchi 1), Jun Toda 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2012.

---

	What is the ability that a pharmacy student is demanded from for medical person training in the P1-653 University? Takeshi Kotake 1), Masaru Matsumoto Rika 1), Satoyo Noguchi 1), Tomomi Inoue 1), Mitsutaka Takada 1), Kakehi Kazuaki 1), Morihiro Nomura 2), Yuzuru Yamazoe 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2012.

---

Construction of the physical assessment, CBL unification type training in the P1-654 business training post-education and evaluation - tertiary report Hisakuni Hashimoto 1), Takanori Nakajima 1), Hiroshi Saito 1), Your Nakamura existence 1), Itsumi Yoshimura 2), Tetsuya Hayashi 1), Yoshikazu Matsuda 1), Masayuki Kimura 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2012.

---

	Medical system integrated education - for students by informed consent - student plan as the P1-655 medical care system department joint class Yagi Ryuta Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2012.

---

	About a social pharmacy class of 2 annual in the P1-656 pharmacy education six years system 久岡清子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2012.

---

	Examination of the utility in the drug preparation by the water-soluble formulation of the P1-657 time of use decomposition anticancer drug Ogre Toshihide Kubo 1) 2), Kumi Nakamura 1) 2), Akira Shinohara ability 3), Hiroaki Takagi 3), 白澤吉哲 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2012.

---

	Examination about the germfree preparation duties efficiency of the P1-658 hyperalimentation Makiko Ota, 3, Hiji, Matsuda, Osamu Asai line, 寺部保成, Fukuura Kumiko, Shigeru Yamada tree Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2012.

---

	Cross sectional study for hypertension of patients with P1-659 Japanese HIV infection Shinichi Hikasa 1), Megumi Yasuda 1), 秀田恭子 1), Satoshi Hikasa 2), 澤田暁宏 2), Tazuko Tokugawa 2), Takeshi Kimura 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2012.

---

	Evaluation of the understanding degree for the medicine before and after the P1-660 heart failure classroom participation Asako Nozawa 1), Noriko Yamashita 1), Mina Yanai 1), Junko Nishida 2), Tooru Masuyama 3), Takeshi Kimura 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2012.

---

About the association with the P1-661 inside the hospital adoption medicine number of articles and the institution attribute Takuya Maeda 1), Body marsh Masami 1) 2), Hisashi Fujiwara up 1) 3), Junichi Iida 1), Tetsuro Yumoto 1) 4), Hajime Matsubara 1), Masahisa Saito 1), Hajime Kagaya 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2012.

---

	Fact-finding about the hospital information disclosure in the hospital homepage judging from P1-662 patients viewpoint Hiromi Yoshino, Fumiko Otsu, Nobuyuki Goto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2012.

---

	Competitive review of the contents in the P1-663 Japan and the United States Hospital Pharmacist Association magazine article 3, Tajima lawn child 1), Shinya Suzuki 1), Naoki Kondo 2), Cho Soo Min3), 山口拓洋 4), Satoshi Izumi Shiro 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2012.

---

	Examination of the utility about the reporting using the P1-664 multifunctional cell-phone Ryota Tsukioka 1), Jinguji Hideyuki 1), Koji Omae 2), Sakon Yasutaka 2), Doi reason Yuko 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2012.

---

	About the guidelines on pneumocystis pneumonia preventive medicine observance in the medication in P1-665 HIV-positive patients Megumi Yasuda, Shinichi Hikasa, 秀田恭子, Takeshi Kimura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2012.

---

	Estimate of the condition to forward required for the substitution of the bypass infusion drug in the P1-666 intravenous feeding route Nozawa (Ishii) Reiko 1), Satoko Ando 2), Makoto Hiraide 2), 植沢芳広 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2012.

---

	The inspection that is useful as a workshop for the authorized pharmacist acquisition specialized P1-667 Shizuoka Hospital Pharmacist Association workshop Emi Takeda 1) 2), Manabu Watanabe 2) 3), Michihiro Shino 2) 4), Yoshihiro Yamada 1), Junichi Kawakami 2) 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2012.

---

	P1-668 Usefulness of lithium to Tauopathy 島田侯陛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2012.

---

	New pharmacological effect of the P1-670 nucleus transitivity inhibitor of angiotensin converting enzyme Early hunting truth, Sachiko Kanazawa, Descent from a mountain Ritsuko, Sachiko Fujita, Shiro Itagaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2012.

---

	Through P2-001 1 case, we think about the medication adherence of elderly people 守内匡, Satomi Asano, Osamu Tanaka, Hiromi Matsui, Yoshimi Matsuda, 高田加壽代 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2012.

---

	P2-002 Influence the operation of the Spiriva Respimat is on COPD control 坂野昌志, 佐野元基, 青田真理子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2012.

---

	Many types of job evaluation of a physician, the nurse by the induction of the P2-003 ward drug duties enforcement addition Masami Murakami 1), Noriko Takahara 1), Shinnichi Sado 1), Akiko Mizoguchi 1), Yasuhiro Tsuji 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2012.

---

	About the systems construction of P2-004 pharmacist ward placement duties Yuko Shimamoto, Kaori Yamanishi, Narumi Matsumura, Hiromi Hashizume, Akemi Horibe, Kyoichi Wada, Oida chapter, Takeshi Kuwahara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2012.

---

	The present conditions and problem of the use of P2-005 dabigatran capsule situation 成田千香子, 八代佳子, 一関美江子, 金美紀, 吹谷真紀子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2012.

---

	Triple-drug therapy ... including the proper use management - terra pre-building by the P2-006 pharmacist Tokuyama picture straight 1), Miyatake wish 1), Hiroki Sakaguchi 2), Takuya Kitada 2), Makoto Fukushima 1), Toshihiko Ishizaka 1), Junji Mukai 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2012.

---

	About the oral medicine management in the ward by the P2-007 pharmacist 礒口 Yuki, Aya Suzuki, Reiko Yasuda, Hideki Koyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2012.

---

	The present conditions and problem of the ward drug duties enforcement in the P2-008 Kyoto medical center Motoaki Nakao, Noriko Takahata, Hiroyuki Ueno, Kei Nakamura, Yoshio Kitamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2012.

---

	Of the drug control instruction in the triple-drug therapy including the terra pre-building for P2-009 chronic hepatitis C, actually Yurina Shimada 1), Miyaze Shiho 2), Fukunaga still world 1), Hiroko Miyamoto 1), Shigetoshi Fujiyama 2), Junko Morioka 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2012.

---

Utilization - of style improvement and the DI question record vote of examination - ward drug log book of the intelligence means for an analysis, an evaluation to present P2-010 ward drug duties Teruo Tanaka, Aya Takasaki, It is Hashimoto dirt, Yusuke Nakagawa, Miwa Tadokoro, Rie Yoshioka, Makiko Ichiyoshi, Yagi Akiko, Megumi Komatsu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2012.

---

	For the new oral medicine induction of the P2-011 multiple sclerosis therapeutic drug Kazuko Kawai 1), Kazuyuki Ito 1), Satoshi Isotani 1), Kenichiro Fujishiro 2), Land Shigeo 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2012.

---

	It is ... through action ... physician, a nurse midwife of the pharmacist permanent residence to P2-012 maternity ward, the questionnaire results for the pharmacist from a nurse Kyoji Terasawa, Haruko Yui, Ai Sakamoto, Tomoaki Katayama, Tomomi Kimura, Tomoko Yamashita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2012.

---

	Can change the recognition of action ... parent of the pharmacist for the P2-013 childhood immunization spread; or ... Yuki Mikami, 日置三紀, Takashi Yamazaki, Ayumu Nozaki, Yuka Kobayashi, Toshiko Aramiya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2012.

---

For improvement of the quality of P2-014 ward drug duties Yuki Nishitani, 久岡清子, Aida sheath, Aya Furushima charges, Kenji Sasaki, Naomi Kawakami, North residence Miki, Interval Chiharu, Takashi Kameoka, Kanuma Nao, Mai Rikitake, Tadashi Adachi, Tray child Hara is free, Hisayuki Haji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2012.

---

	Induction of the conference in the duties time for the purpose of the information sharing of the P2-015 pharmacist Ai Sakamoto, Kyoji Terasawa, Tomoaki Katayama, Haruko Yui, Tomomi Kimura, Uchiyama eyes, Tomoko Yamashita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2012.

---

	Trial ... of the DIC treatment flow chart making by action ... pharmacist of the pharmacotherapy by the many types of job cooperation in the cottage-hospital out of P2-016 Noriko Shimizu, Katsuaki Arai, 前原梨恵, Person of truth Yusuke, Maki Kikuchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2012.

---

	1 case that experienced an allergic symptom during P2-017 furosemide administration Yukiko Matsuda 1), Keiko Nitta 1), Motoko Funato 1), Satoshi Konya 2), Masaaki Mori 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2012.

---

	Electrocardiogram monitor management by the P2-018 pharmacist Kazuyuki Ito 1), Keita Urasaki 1), Kazuko Kawai 1), Satoshi Isotani 1), Hiroshi Murakami 2), Naoya Tsuboi 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2012.

---

	Rheumatic patients satisfaction investigation in the drug control instruction using the P2-019 touch panel type information terminal Junichi Mizumachi, Yoshihiro Nakagawa, Sayuri Takeuchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2012.

---

	About the relation of the pharmacist of the terra pre-building induction in the P2-020 this hospital Well Keisuke Hata, Tanbara Toshio Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2012.

---

	Contribution of the P2-021 ward permanent residence type pharmacist to a smooth discharge adjustment Toru Hasegawa, Keita Urasaki, Tomoko Asai, Sachiko Tsujimoto, Yasuo Ukai, Jun Hisada life, Kazuko Kawai, Kazuyuki Ito, Satoshi Isotani Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2012.

---

	Utility of the on admission patients interview by the P2-022 ward charge pharmacist Hiromi Atsumi, Keiko Mitsui, Kumiko Shimada, Miho Takano, Atsushi Yamashita, Yoshihiro Kakiuchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2012.

---

	Activity report of the pharmacist in the P2-023 collagenosis rheumatism center Yasuo Ukai 1), Keiko Matsuki 1), Keita Urasaki 1), 金正煌 1), Kazuko Kawai 1), Kazuyuki Ito 1), Satoshi Isotani 1), Masaya Kodera 2), Aoyama success 3), Hideki Yasuma 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2012.

---

	Relation of the pharmacist to chronic hepatitis C treatment using the P2-024 terra pre-building Misako Yamaguchi 1), Akiko Emoto 1), Kazuhiro Hirano 1), 中野行孝 1), Eguchi existence Ichiro 2), Fujito Expo 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2012.

---

	Change after drug control instruction duties and the exclusive duty pharmacist placement in the P2-025 CCU Fumiko Kato, Yuki Meishin, Yuka Tsutsui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2012.

---

	The enforcement situation and evaluation of P2-026 ward drug duties Masaki Manda, Yasuko Takinami, Miyuki Miyake, Keiko Noguchi, Kaori Ozaki, 野際俊希, Takami Fujii, Naoko Tsuji, Shigeo Asai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2012.

---

	Good use of action - assessment sheet - for P2-027 efficiency-like ward drug duties Kawai wish, Tomoko Kitamoto, Katsuya Nakano, Yuka Tsutsui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2012.

---

The enforcement situation and problems of ward drug duties in the P2-028 Kitasato Inst. Hospital Reiko Fujino 1), Masayoshi Nishi beauty 1), Takashi Ito kernel 1), Shinya Abe 1), Takamitsu Fujioka 1), Yoshikazu Kobayashi 1), Soichi Shibata 1), Masatoshi Saito 1), Atsuta Koichiro 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2012.

---

Action ... to efficiency of construction - log book making, the management of the P2-029 ward drug log book system Yoshikazu Kobayashi 1), Masayoshi Nishi beauty 1), Takashi Ito kernel 1), Shinya Abe 1), Takamitsu Fujioka 1), Reiko Fujino 1), Soichi Shibata 1), Masatoshi Saito 1), Atsuta Koichiro 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2012.

---

	Examination of the utility of the P2-030 ward pharmacist conference Aiko Koyanagi, Takahiro Goto, Kozue Kurihara, Kusaka Toyoshi, Yusuke Taki, Hirokazu Yamashiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2012.

---

	The ward drug duties in the P2-031 medical treatment ward contribute to team approach in medical care and the duties burden reduction of the physician Tomoko Otani, Tomoko Aoyama, Yukari Mihara, Yayoi Kamioka, Akiko Kumano, Shoko Omori, Mami Higuchi, 賀勢泰子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2012.

---

It is ... with the needs of other types of job to the action Vol.1 - ward exclusive duty pharmacist of the drug section in the small and medium size hospital with the new establishment of the P2-032 ward drug duties enforcement addition Kenjiro Inaba 1), Body marsh Masami 2), Motomu Kobayashi 1), Tetsuro Yumoto 1) 3), 赤瀬朋秀 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2012.

---

Judging from ward pharmacist duties (1) - prescription suggestion example in the P2-033 Asahikawa Red Cross Hospital, it is ... Many ground Takanori, Yuki Nakaoka, Keiko Saito, Minoshima arch non-child, Eiichi Nishimura, Downhill path Kazufumi, Takayuki Itokawa, White prefecture Toshihiro, Goto Yoshinobu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2012.

---

	It is discussion about the satisfaction of the patients after consciousness and the instruction of the P2-034 pharmacist Yuriko Watanabe 1), Wataru Arai 2), Kazumasa Hasegawa 3), 矢吹直寛 4), Miki Yajima 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2012.

---

Intervention ... to the medical security by the role (15) - ward permanent residence pharmacist of the pharmacist in the P2-035 team approach in medical care Senaha Hiromasa 1), 名徳倫明 2), Akiko Nakanishi 1), Chiaki Iwamoto 1), Field river Miyuki 1), Fumiko Konishi 1), Erina Konishi 1), Field Akiko 1), Yumi Tomita 1), Shinichi Kawaguchi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2012.

---

	Reexamination of nausea, the vomiting prevention after the neurosurgery by the P2-036 pharmacist Kana Yamazaki 1), Hidetomo Yasujima 1), Ayumu Nakamura rare 2), Hiroyuki Hayashi 3), Yoshio Taguchi 2), Akio Saito 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2012.

---

	The present conditions and problems of ward exclusive duty pharmacist duties in the P2-037 this hospital 倉繁正勝, Toshi Tanaka, Hiromi Ito, Shinsuke Sato, 齊木敦子, Masuo Sato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2012.

---

	For the enforcement of P2-038 ward drug duties examination - about the oral medicine management in - mixture ward Ayumu Hirata, Miki Kubo, Kayo Shiraishi, Saburo Yoshioka, Michihiko Miyamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2012.

---

	Trial of the periodical prescription collaboration input by P2-039 pharmacist and the physician Ko Yamaguchi tree 1), Tsuyoshi Miura 1), Akira Ishii 1), Keiichi Ishida 2), 仲佐啓詳 1), Hiroshi Nakamura justice 1), Goro Matsumiya 2), Amount of Ariyoshi example 1), Koichi Kitada 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2012.

---

	Action of this hospital for the P2-040 ward drug duties enforcement addition calculation 殿塚早百合, Nozomi Iida Rika, 加藤七奈, Tsurukawa lily, Hiroshi Tomiyama field, Hiroko Nakamura, 吉田羽奈, Watanabe friend levator, Hiroki Miyata, Shiro Katayama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2012.

---

	Standard model construction of the drug duties in the P2-041 ward Hisako Yoshimoto, Kyoji Koda, Masanori Watanabe, Yuko Nagasawa, Tomohiro Nishikawa Kei, 廣實清司, Hiroyuki Furukawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2012.

---

	Duties contents in the P2-042 ward drug duties enforcement addition calculation and future problem Prince Taniguchi chapter, 後藤志央, Shrine Akihiro Ichiro, 末安由拓, Tatsuya Sasaki, Kaifu Masayo, Akihiro Kai, The Ishikawa immensity, Takahiro Rikitake Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2012.

---

	Examination second report of the problem to the pharmacist whom P2-043 "ward drug duties enforcement addition" brings 矢吹直寛, Katsura Orimoto, Naohisa Koseki, Nihiko Sekine, Satomi Yoshida, Tomokazu Yoshida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2012.

---

	About the present conditions of ward drug duties in the P2-044 this hospital Parent pine Takahiro, 川嵜英二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2012.

---

	Examination - from the case that we experienced through examination - ward drug duties for the participation in planning to the medical treatment in the P2-045 orthopedics ward Toshiko Ogawa, Takenori Kurata, Rina Osato, Samura A, 1, Kotobuki, Sekine Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2012.

---

	Construction of the ward drug duties by the additional post with P2-046 center duties Charcoal Masaki, Sudo Seicho, Koji Uenishi, Nobuo Hoshino, Shinya Morita, 寺田智祐 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2012.

---

	Examination of the effect by the acting pharmacist input in the P2-047 constant placement medicine management 隅岡瞳, Yasuyuki Saeki, Furrow well Hiroko, Yasuhiro Kimura, Tree flat Kenji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2012.

---

	Action of ward drug duties in the P2-048 Toku Matsubara bank meeting Hospital Kishii Akito, Shinichi Nakamura, Yoshihiko Kida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2012.

---

	It is considered 3 cases that led to cancellation after a change from P2-049 VCM, TEIC to DAP Hiroaki Arakawa, Yukie Suzuki, Akiko Komori, Kayo Murai, Yasuhiro Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2012.

---

	Effective intervention to make use of P2-050 pharmacist bundle (one for all, all for one) antimicrobial agent Toshihiko Ishizaka, U.S. Hara non-origin, Mika Kimoto, Hamada rabbitfish, Morita connection, Miyatake wish, Tokuyama picture life, Naoki Ogawa, Junji Mukai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2012.

---

	Contribution of the pharmacist in the P2-051 antimicrobial agent doses adequacy Takeshi Kimura 1) 2), Worth Chongwen 1) 2), Saikai life 1), Former river Rie 1), Masako Yamamoto 1), Kimura Shuya 1), Hidemi Sasaki 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2012.

---

	The adequacy of the transurethral endoscopy clinical path antimicrobial agent by the P2-052 pharmacist leadership and the evaluation Sachiko Sahara, Kenji Mori, Daichi Shibata, Mitsuru Sugiura, 足立守 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2012.

---

	Multicenter investigation about the TDM enforcement situation and the clinical response of the P2-053 infection with MRSA therapeutic drug Hiroshi Takane 1) 2), Yukiko Miyoshi 1), 堀井俊伸 2) 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2012.

---

	Examination about a dose, the number of dose of the P2-054 carbapenem system antimicrobial agent (meropenem) Aspect shrine Koji 1), Kenji Miyazawa 2), Makoto Hayashi 2), Akemasa Yamaya 2), Hiroshi Funaki 2), North Toshiyuki 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2012.

---

	Activity and outcome to TDM perfection enforcement at the P2-055 antiMRSA medicine administration Junpei Yamamoto, Masaki Kubo, Takeshi Yoshimoto Saburo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2012.

---

	Problems for the antimicrobial agent proper use judging from a drug resistance ratio of P2-056 Pseudomonas aeruginosa Yukiyo Funakoshi 1), Kunihiko Kohama 2), Shinji Fukuhara 1), Shizuko Ono 1), Katsuaki Takeda 1), Yasushi Nakamura 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2012.

---

	Examination ... of action ... use situation investigation and the registration system for the proper use of the P2-057 carbapenem system antimicrobial agent Kenji Goto 1), Shinya Aoyama 1), Makoto Ishikawa flat 1), 酒井欣嗣 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2012.

---

	P2-058 Dosage determination of antibacterial agents in empiric treatment of bacterial meningitis and drug selection at the time of De-escalation, the case About the pharmacist it was intervention 鈴木峻輔1), 上田恵子1), 松山明日香1), 酒井裕介1), 松橋明子1), 小久保由美子1), 新井亘2), 町田充1), 矢嶋美樹3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2012.

---

	It is investigation ... of ... use situation for proper use of the P2-059 antiMRSA medicine Yoshiko Yamaguchi 1) 2), Horiuchi Kotobuki will 2) 3), Yasukochi still up 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2012.

---

	1 case that responded to arbekacin for pneumonia by P2-060 metallo- β - lactamase-producing Pseudomonas putida 榎屋友幸1)2), 村木優一1)2), 中村明子2), 山田絵梨2), 岩下義明3), 今井寛3), 岩本卓也1), 奥田真弘1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2012.

---

	Examination of the clinical risk factor associated with the Escherichia coli of P2-061 levofloxacin-sensitive rate Hajime Nakai 1), Kasumi Kudo 1), Yoshida Yasunori 2), Sato good luck cord 3), Akira Takahashi 1), Kazunari Nakamura 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2012.

---

	Utility of the in-hospital information paper issue for the proper use of P2-062 levofloxacin Kasumi Kudo 1), Hajime Nakai 1), Yoshida Yasunori 2), Sato good luck cord 3), Akira Takahashi 1), Kazunari Nakamura 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2012.

---

	P2-063 Changes in antibiotic usage and bacterial susceptibility by promoting appropriate empiric treatment 後藤拓也1)2), 森理惠1), 中島誠1), 野村美枝1), 相澤佑佳1), 若林公夫1)2), 熊谷隆浩1), 三島信行1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2012.

---

	Fact-finding about the P2-064 cephalexin prescription patients Kunio Naruse 1), 伊藤匡伸 1), Jun Naito 2), Yoshio Miyake 1), Kiyoshi Haneda 1), Atsushi Yoshida 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2012.

---

	Evaluation of the P2-065 wide area spectrum antimicrobial agent registration system induction Saori Nagatsuka, Satoru Kaneko reason, Hiroyuki Kageyama, Katsumata Harumi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2012.

---

	Examination of sulfamethoxazole trimethoprim doses for the P2-066 pneumocystis pneumonia Hiroyuki Iwata, Keiko Fujita, Rie Ueda, Satoshi Hasegawa, Gilt bronze Yoko, Kazuko Shimura, Nobuhisa Fukushima, Tomonari Matsumoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2012.

---

	MEPM proper use investigation in the P2-067 Hirosaki stroke, rehabilitation center 倉内寿孝, 蝦名範嗣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2012.

---

	Proper use of the daptomycin to learn from a P2-068 adverse event case and role of the pharmacist 内田裕之1), 三木智子2), 前野努2), 前田正3), 岡秀昭2), 石井嘉之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2012.

---

	Clinical benefit of the starting medical supplies and generic medicine of the Cefepim for the P2-069 febrile neutropenia Imai and your 1), Akira Kodama person 1), Azusa Miki 1), Iwatate Chizuko 1), Takako Morita 2), Yoneta Italy product 3), Takeshi Kotake 4), Shinsuke Mori 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2012.

---

	Comparison ... with the fact-finding - carbapenem system antimicrobial agent for the proper use of the P2-070 tazobactam / piperacillin 近藤匡慶, Field stake Naoya, 菅谷量俊, Kazuya Murata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2012.

---

	Examination about the effectiveness of the P2-071 antiMRSA medicine linezolid and the safety 小川美希1), 松尾和廣1), 木村伊都紀2), 平山忍2), 佐々木英久1), 渡辺朋子1), 篠原悦子1), 小杉隆祥2), 西澤健司2), 吉尾隆1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2012.

---

	Cholangitis in the P2-072 this hospital, the use situation of the antimicrobial agent for the cholecystitis 白石史遠, Tetsuya Sugihara, Tsuneo Kuwamura, Takashi Akamatsu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2012.

---

	Examination about candidemia treatment in the cottage-hospital out of P2-073 Mariko Aota, Masashi Sakano, 寺井文廣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2012.

---

	Examination of the initial dose for the P2-074 Clostridiumu difficile-related diarrhea Emi Takeuchi, Iga Masanori, Katsuhiko Inomata, Yoshio Fujikake Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2012.

---

	P2-075 Evaluation of the efficacy and safety of doripenem high-dose administration 槙田芳, 吉田直哉, 中村友香, 鈴木悠加, 田中悠季, 亀井浩二郎, 小原郁司, 小寺隆二, 下山光一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2012.

---

	Examination of the factor affecting thrombocytopenia with the P2-076 linezolid administration 石田茂伸, 前田佳代, 西尾千尋, 中井由佳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2012.

---

	Effect to give to resistant bacteria expression of the antimicrobial agent choice based on P2-077 anti bio gram 冨山育朗 1), Susumu Kudo 1), Kentaro Tanaka 2), 丹代恭太 1), 蒲澤一行 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2012.

---

	Examination about use fact-finding of the P2-078 meropenem and the individual administration plan Aya Omuro 1) 2), Mt. Kobayashi 1) 2), Kazuhiro Hayakawa 1) 2), Yuichi Yano 1), Mitsuo Sakamoto 2) 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2012.

---

	Result of the antibiotic proper use by the P2-079 ICT round Ryota Nakamura 1) 2) 3), Yukiko Kita 1) 2) 3), Hirotsugu Kita 1) 2) 4), Yuji Niisato 1) 3) 5), Koichi Ikehara 1) 3) 5), 与古田美智代 1) 4) 6) 7), 伊波敬 1) 3) 8), Groundwork wing 1) 3) 8) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2012.

---

Making, evaluation (the second report) of the pocket edition "ICT recommendation antimicrobial agent doses table" for P2-080 proper use Megumi Yoshida 1), Mariko Negishi 1), 中村造 2) 3), Yuko Sagara 2), Haruko Kazama 4), Chisato Sugiyama 5), Hiroshi Matsuzawa 1), Funatsu Kumi 6), Akira Fukuda 7), Keiko Kotake 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2012.

---

	Discussion of the philology about the efficacy of the adjuvant to use for antiMRSA medicine for P2-081 sepsis, pneumonia 入口慎史 1), Toru Imai 2), Takao Orii 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2012.

---

	Examination of the case that an antimicrobial agent was continuously used at P2-082 Clostridium difficile(toxinA/B) positive Hiroshi Kawasaki 1), Hiromi Suzuki 2), Mukozaka Motohide 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2012.

---

	About the pre-medication of patients receiving P2-083 vancomycin hydrochloride powder Kazuhiro Nakamura, Nobuhiro Tsutsui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2012.

---

	Investigation of the efficacy by the change of hydrochloric acid banco machine powder doses in the P2-084 Clostridium difficile-related diarrhea Hiromi Tsuchiya, 庄司知摩, 佐藤導 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2012.

---

	P2-085 Clinical study of the combination drug and drug change of antiretroviral therapy (ART) to the key drag the anti-HIV drugs raltegravir 沖中美奈子1)2), 大澤麻貴子1), 前田真輝1), 當麻厚子1), 井上亜悠1), 川端佑美1), 花房秀次3), 小島賢一3), 長尾梓3), 越前宏俊2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2012.

---

	Efficacy and safety of the amikacin once a day administration method in P2-086 elderly people Yoshihiko Matsuki, Toshiaki Onuki, Yumi Matsumoto, Asami Yasuda, Keiko Fujioka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2012.

---

	The enforcement of the hand-washing classroom in the P2-087 nursery school and the evaluation Koji Okubo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2012.

---

	The use of antimicrobial agent situation of the cancer terminally ill patients in the P2-088 Ichinomiya City municipal hospital and the analysis Mountains Noriaki, Masako Yoshida, Mountain village gain oneself, Aoyama Kei daylight Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2012.

---

	Action for the proper use by the induction of the use of P2-089 antimicrobial agent registration system Michiya Tanuma 1), 上野将臣 2), Toshiki Saito 1), Naoko Furuya 1), Yoshizo Watanabe 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2012.

---

Factor of the decrease of the initial number of onset and rate of recurrence of Clostridium difficle association diarrhea / enterocolitis (CDAD) treated patients in the P2-090 Nagaoka Red Cross Hospital Kenichi Kobayashi 1), Akemi Kawakami 2), Star Shuichiro 3), Takeaki Nishibori 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2012.

---

	Relations from P2-091 core ICT to an antimicrobial agent to send Saori Kawajiri 1) 2), Yuki Nishimura 1), Shogo Kanda 1), Wakigawa Fumiko 2) 3), Miyako Kanazawa 2) 4), Koji Hashiguchi 2) 5), Tsuyoshi Machida 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2012.

---

	Examination about the risk factor of ESBL-producing Escherichia coli detected in P2-092 urine Takafumi Sugawara 1), Nobue Uetake 1), Toshiharu Matsumoto 1), Shinichi Miyamori 1), 木村公重 2), Open Koichi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2012.

---

	Questionary survey about "the operation limit rule at infection affection" in the hospital in P2-093 Kyushu Yamaguchi District Yuichi Umeda 1), Takahiro Muro 2), Mamoru Uchida next 1), Kosuke Miyoshi 1), Shinsuke Takemoto 1), Nakamura right one 3), Hidetoshi Kamimura 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2012.

---

	Risk factor of the P2-094 substrate specificity expansion type beta lactamase (ESBL)-producing Escherichia coli infection Yoshiaki Ikeda 1) 2), Hideki Nishiyama 1) 3), Kumiko Kosaka 1) 4), Koichi Miyamura 1) 5), Kazuhiro Mori 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2012.

---

	About the effect of the use of P2-095 wide area antimicrobial agent registration system and a change of the antimicrobial agent consumption Yoko Kitano, Minako Yoshii, 田中三広 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2012.

---

Antimicrobial Useand Resistance(AUR) surveillance in the P2-096 Nagano throughout the prefecture 7 institution Takeshi Kubota 1), Kenji Kiyohara 1), Nobuhiro Yasuoka 2), Maruyama fine weather straight 3), Kazuno Shohei 4), Kenji Tanaka 5), Kei Matsuoka tree 6), Sachiko Otsuka 7), Masaru Hori good luck 8) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2012.

---

Improvement ... by the enlightenment activity of action ... ICT to two sets of examination of blood cultures sampling promotion aiming at P2-097 antimicrobial agent proper use Hidechika Ueda 1), Takayuki Inagaki 1), Yasuyo Goto 2), Capital bamboo Chikako 2), 橋渡彦典 3), Atsushi Hosoe celebration 4), Masaru Nishio 4), Shiro Yoshioka 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2012.

---

The antimicrobial agent consumption for the P2-098 whole country 203 institution and Pseudomonas aeruginosa-resistant surveillance 2011 Japanese Society of Hospital Pharmacists arts and sciences fifth subcommittee report Yuichi Muraki 1), Masaki Kitamura 2), 前田頼伸 3), Takashi Kitahara 4), Ken Mori 5), Ikegami English sentence 6), 継田雅美 7), Mere field Koji 8), Takashi Akamatsu 9), Katsutoshi Takada 10), Takehiro Yamada 11), Tadashi Shiraishi 12), Shinko Okuda 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2012.

---

	Utility ... of the testing order enforcement by participation in P2-099 antiMRSA medicine proper use - pharmacist Akira Fujii, Naoki Hayashi, Masahiro Yasunaga, Kazunari Uchida, Castle former Naoko, Naoko Fujiwara, 小礒克己, Emiko Harada, Akira Ogata, Takeshi Yamamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2012.

---

	1 case that intervened in treatment of the septic bursitis with P2-100 Peptostreptococcus Kazutaka Nakata, 中島満尭, Misa Matsumiya, Makoto Morizumi, Chiyoko Sakamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2012.

---

	Examination of the use of antimicrobial agent case in the P2-101 convalescent rehabilitation ward Naoki Soma 1), Absence Katsuyuki 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2012.

---

Relation - of the ward pharmacist for the severe infection with one - myelodysplastic syndrome that suffered from medical treatment of the prosthetic valve endocarditis that P2-102 surgery had difficulty with Samura A 1), 腰岡桜 1), Koibuchi Hiroyuki 1), Toshiko Ogawa 1), Naoko Yamaguchi 1), 1, Kotobuki, Sekine 1), Tsurumi Yukio 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2012.

---

	Bacteria detection pulse-taking from opening of a Diet session in the P2-103 Hirosaki stroke, rehabilitation center 蝦名範嗣, Kumeda Kazuyoshi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2012.

---

	Making and the susceptibility situation of the anti-biogram for the P2-104 antimicrobial agent proper use Kumeda Kazuyoshi, 蝦名範嗣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2012.

---

	Intranasal resident flora investigation of the staff engaged in P2-105 treatment at home Shunji Horikawa 1), Yozo Takeyama 2), 中南秀将 2), 野口雅久 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2012.

---

Investigation, analysis of the cause to give it to annual usage increase of P2-106 vancomycin 坂元利彰 1), Takashi Kitahara 1), Hiroo Nakagawa 1), Noriko Matsunaga 1), Katsunori Yanagihara 2), Masanobu Imamura 1), Takahiro Muro 1), Tadahiro Nakamura 1), Norihide Higuchi 1), Hitoshi Sasaki 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2012.

---

	MRSA infection measures - using the PCR for infection control - elective surgery patients that P2-107 pharmacist is carried out Yoshiko Takahashi 1), Yoshio Takesue 2), Kaoru Ichiki 2), Sumiyo Tatsumi 1), Shingo Takubo 1), Takashi Ueda 2), Takeshi Kimura 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2012.

---

The situation of the long-term use of the antimicrobial agent targeted for a report in the P2-108 Nissei Hospital and the intervention situation of the ICT Hisao Ikeda 1) 2), Takahiro Hirata 1), Hiroshi Nomura British 1), Nao Takigawa 1), Akihiko Asano 2), Noriko Ono 2), Yukiko Arai 2), Ikuko Fujita 2), 角田道久 2), Katsuyoshi Hatanaka 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2012.

---

	Effect ... of the intervention to use of chemosensitive change - identification antimicrobial agent with P2-109 regional alliances Yukako Hatanaka 1) 2), Kazuya Fujita 1) 2), Keiko Adachi 1) 2), Naoyuki Kitamura 2), Zamami Yoshito 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2012.

---

Antimicrobial agent consumption in approximately the antimicrobial agent registration system induction using P2-110 AUD and chemosensitive examination Kengo Yamazaki 1), Yuichi Hirashima 1), Takeshi Nakaya 1), Your history of Terahara 1), Hoshina walnut 1), Kimito Sato 1), Hiroshi Tamura 1), Field Yuri 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2012.

---

The construction of the use of P2-111 identification antimicrobial agent report system and antimicrobial agent consumption change after the induction Takehiro Yamada 1) 2), Nobuhisa Ishiguro 2), Tsuyoshi Miyamoto celebration 1) 2), Kumiko Kasashi 1), Toshitaka Fukai 1), Takeshi Iseki 1) 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2012.

---

Action effect by the ICT for the dosage interval adequacy at the daily multiple administration in the P2-112 identification antimicrobial agent Yui Yoichi Sono 1) 2), 入江徳俊 1) 2), Ai Sumita 1) 2), Kenji Suenaga 2), Takeshi Shimomura 2), Daisuke Yoshimura 2), Yoji Nagasaki 2), 槇林智子 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2012.

---

	Report of the simultaneous inoculation of 23 values pneumococcus vaccine and the influenza vaccine by the P2-113 pharmacy leadership 眞継賢一, Hayato Kuroiwa, 上田浩貴, Yoshihiko Hamaguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2012.

---

	P2-114 Thermal Stability Evaluation of tenofovir disoproxil fumarate for the application of simple suspension method: In the case of two agents simultaneous application 大野靖子1), 矢倉裕輝2), 大歳菜美子1), 湯谷玲子1), 寺岡麗子1), 北河修治1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2012.

---

	Effect on antiseptic effect of the alcohol-based hand rub at use of P2-115 hand cream Risa Kanie, Mariko Aota, Masashi Sakano, 寺井文廣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2012.

---

	For preventive measures against P2-116 infection addition 1 calculation action - of the pharmacist in the scale institution out of - Emi Momiyama, Chie Shinohara, Aiko Saito, Kazumi Kimura, Keiko Sunakawa, Yumiko Iijima, Thin wave Tomoko, Hiromi Nagai, Kanako Sakashita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2012.

---

	Action of our House for the proper use of the antiMRSA medicine daptomycin that P2-117 is new 染谷雅弘, 篠崎陽一, 行川洋平, 北村好申, 北村正樹, 川久保孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2012.

---

	Examination of the dialysis extraction ratio for the proper use of vancomycin in the P2-118 hemodialysis patient Yuichi Kumaki 1), Wild Hideki Oka 2), Masahiro Igarashi 1), Tadaaki Ito 1), Hiroyuki Fujii 1), Yumiko Uchida 1), Hiromi Tamura 1), Akiko Yoneyama 2), Masahiro Hayashi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2012.

---

Example that helped P2-119 ward drug duties and infection treatment of the MDRP patients by the cooperation of the ICT Sachiko Saito 1), Ayako Sakamoto 2), 澤畠孝幸 1), Slightly dried fish Yuka 1), Masashi Onozaki 1), Yoshifumi Aoyama 1), Yoshibumi Akatsu 3), Hideyuki Mishima 4), Tsunehiko Maruyama 4), Kazumitsu Ueda 4), Yasunori Watanabe 4), Shinji Hirai 4), Okumura Minoru 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2012.

---

	About a sterile effect in the clean bench caused by P2-120 peracetic acid system antiseptic Ryo Sugawa, Ayumu Nakamura, Miki Takenaka, 小門諒平, Suzuki hsiang tsai charges, Manabu Takegami, Masako Oishi, Yoshihiro Miwa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2012.

---

	Use trend of P2-121 antimicrobial agent ten years Mayumi Kato, 小畑伯子, Wariden Masako, Chikako Aoki, Kazuko Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2012.

---

	Action of the antimicrobial agent proper use promotion group activity in the P2-122 Kitasato University east Hospital ICT (infection control team) Mariko Arai 1), Yoko Matsuoka 1), Yukihiro Hamada 1), Yoshie Ohara 1), Takeshi Hirayama 1) 2), Masaichi Kuroyama 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2012.

---

	Examination of the carriage risk factor in the P2-123 VRE outbreak Goto will celebration, Mikiya Hayashi, Yamane A is rare, Midori Ito, 乗安久晴, Junko Akasaki, Castle former Keiji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2012.

---

It is ... using the use of antimicrobial agent situation and resistant bacteria development turn of eventss - anti bio gram and the ATC/DDD system by the action to report of use of P2-124 antimicrobial agent revision Taku Kitamura Maro 1), Aya Saito 1), Naoki Azuma 2), Yuko Kikuchi 2), Aiba Koichi 1), Day Takaaki Nozawa 1), 上野彩恵 1), 神谷力嗣 1), Tatsuya Shimamura 1), Kazumasa Hasegawa 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2012.

---

	Examination of the prophylactic antimicrobial agent in the P2-125 transrectal prostate biopsy Cheap place Toshiyuki 1), Hiroyuki Fujiwara 1), Nanun Noriaki 1), Akihiko Abe 2), Togashi Kotobuki sentence 2), Shunya Ishida 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2012.

---

	Development of the P2-126 anti bio gram making web application -Chans- server-free version 初田泰敏, Sono Kawanishi charges, Kenji Ikeda, 名徳倫明, 西井諭司, Masashi Ogawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2012.

---

	The use situation of antibiotics in P2-127 pneumococcal infection Makoto Tanaka, High Kado Take Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2012.

---

	Retrospective research about the risk factor of the P2-128 Clostridium difficile-related diarrhea onset Takashi Uno, Ayako Sato, Kyoko Fujieda, Gutter ground Megumi, Eiji Tsutsumi, Nobuo Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2012.

---

	Infection consultation duties effect of the pharmacist in the P2-129 this hospital Hiroshi Hara person, Toru Nagai, Makoto Usuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2012.

---

Establishment of the inspection procedure in the measurement compounding of medicines of the injection which put the P2-130 weight inspection method and the direct surveillance method together Hisashi Ono, Ikuyo Kanzaki, Tomomi Tanikawa, History of Takashi Yamada, Katsuhisa Tahara, 木村周古, Hemp lower Tomoka, Twig Masayoshi, Toshio Awaya, Yoshikazu Tazaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2012.

---

	Incident decrease with the PDA which we introduced into P2-131 compounding of medicines system newly Hoshino Yugo, Yoko Kamiya, Kiyotaka Kawazumi, Yoshiharu Kato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2012.

---

	Improvement of the remaining of the active principle in the simple suspension method of the P2-132 soft capsule Ai Yoshino 1), Masato Takahashi 1), Kurata we see it 2), Akihiro Nakamura 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2012.

---

	Compounding of medicines duties using all P2-133 automatic seat withdrawal device (robo-pick) and drug system (MONET) Hiroyuki Kawahara, Masako Ido, Junpei Mizuta, Country original Junichi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2012.

---

	Action for the simple suspension method induction in the P2-134 Kyushu medical center Nakagawa Takehiro 1), Toshihiro Matsumoto 1), Hama place Akiko 2), 三角紳博 1), Makoto Ishibashi 3), Takashi Nishino 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2012.

---

	Action of the simple suspension method induction in the P2-135 Morioka friendship hospital Shintaro Abe, Shiori Sasaki, Shino village five child, Toshinari Nakajima, Hideki Omori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2012.

---

	Retrospective observational study about the medication history management method of the P2-136 tea S one Makoto Maeda, Yoshimasa Saito, Haruhiko Sakamoto, 牧野好倫, Nobuaki Yokote, Hiroshi Yamamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2012.

---

	The construction of the P2-137 child dose inspection system and evaluation of the utility Setsuko Ihara, Keita Hirai, Hiroyasu Hasegawa, 高橋成隆, Tatsu Sakamoto Ichiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2012.

---

	Evaluation of the prescription checking in consideration of renal function for P2-138 levofloxacin tablets proper use 舘知也1), 浅野祥子1), 田中和秀2), 福田聖啓2), 大澤友裕2), 青山智2), 水井貴詞2), 後藤千寿2), 寺町ひとみ1), 土屋照雄1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2012.

---

	Basic study on medication method of the P2-139 internal use mixture Asoh cool air, Maki Inoue, Masahiro Sugino, Oshima Shinji, Osamu Hosoya, 從二和彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2012.

---

	Report of problems and the end run of the P2-140 electronic chart bringing medicine order system Tadahiro Tanaka, Harumi Tanoe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2012.

---

	About an action of pharmacy from P2-141 order ring system and electronic chart system induction to after operational initiation Yukie Yamamoto, Mina Kamei, 行本拓史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2012.

---

	From construction - compounding of medicines of the medication system by the simple suspension method in the P2-142 artificial breathing special hospital to irrigation - Kazuhiko Takeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2012.

---

	Analysis - second report - of the doubt inquiry for the injection prescription with the P2-143 order ring system Midori Ito, The Hogari volost beauty, Satoshi Sato, Aya Komine, Kiyoshi Sakuma, Hideki Kobayashi, Masaka Wataru Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2012.

---

	Electrostatic charge-related effect of the drug to give quantity of Residual medicine in the P2-144 divided powder plane 櫨川舞, 大砂瑞穂, 原口珠実, 吉田都, 内田享弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2012.

---

	Taste bitter prediction of the ambroxol tablets 10 preparation using the P2-145 taste sensor Takahiro Uchida, Haji River dance, Tamami Haraguchi, Miyako Yoshida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2012.

---

	Precision criteria to weigh of the syrup which added P2-146 dry syrup Piece bridge beauty princess 1), Yasuko Ono 2), Yudani Reiko 2), Reiko Teraoka 2), Shuji Kitagawa 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2012.

---

	About an action about the proper use of the high-risk medicine in the P2-147 this hospital Jun Matsunami 1), Masae Fujino 1), Makoto Kurabayashi 1), Yuka Igarashi village 1), Junko Takagi 1), 池井良貴 1), Hidetoshi Yamada 1), Shimamori beauty light 2), 早瀬幸俊 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2012.

---

Change of the P2-148 automatic PTP sheet safety and compounding of medicines efficiency that we pay it, and a device brings Hironari Honma 1), Oshiyama Takamitsu 1), Yoshihiro Okada 1), Yoichi Kumaki 1), Mai Nakazawa 1), Masaki Terasawa 2), Takuya Ohira 2), Hideaki Nagasawa 1), Megumi Takahashi 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2012.

---

	Examination of alerting it in inside the hospital with the attached document revision of the P2-149 aliskiren fumarate Igarashi sentence, Toru Morita, Shun Igarashi, 高尾良洋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2012.

---

	Action to the safe medication to the eating dysphagia user in the P2-150 seriously disabled child institution Atsuo Kuramoto, Kazushi Abe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2012.

---

	Relation of the pharmacist to fall, a fall accident of the P2-151 this hospital 高田加壽代, Satomi Asano, Osamu Tanaka, Hiromi Matsui, Yoshimi Matsuda, 守内匡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2012.

---

	Examination - of the indication design which is effective for what about P2-152 injection label indication in - safety management an eye is attracted, and where you confirm Hiroyuki Furukawa 1), Fumito Tsuchiya 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2012.

---

	It is the making of the Anjo rebirth hospital version withdrawal agreement an action to standardization with an examination for P2-153, treatment, the surgery for withdrawal Negi Tawa original 1), Yoji Sugiura 2), Watarai Masato 3), Akio Katsumi 1), Yoshitaka Ono 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2012.

---

	We contribute to risk management in the P2-154 drug master maintenance 六波羅孝, Junichi Hara, Miki Kobayashi, Koichiro Takano, 唐澤頼勝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2012.

---

	Systems construction of compounding of medicines misinvestigation collection of, the analysis tool in P2-155 risk management measures Person of box Yuko 1), Tsutsui Mizuki 1), Yutaka Ito root 1), Takemoto Chihiro 2), Koto Fujiwara 2), Yoshiaki Fujimura 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2012.

---

	Evaluation of the incompatibility of ozagrel sodium injection and calcium which assumed P2-156 solubility product an index Mio Tange, Umeki friend Rie, Rie Tanaka, Kana Matsuda, Miyako Yoshida, Haji River dance, Tamami Haraguchi, Takahiro Uchida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2012.

---

	Construction of the present conditions and the administration management of the tolvaptan administration to patients with P2-157 heart failure 柴田大地, 水野由紀子, 杉浦充, 足立守 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2012.

---

	We promote ward drug duties from P2-158 pre-Abo id report Now Yoshiko Takada, Shinichi Tamiya, Tomohiko Aoyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2012.

---

	Fall risk in P2-159 sleeping drug, anxiolytics and the hospital Long Tawa person 1), Saori Miyamoto 1), 藤井宏亮 1), Satoshi Nishimura Kei 1), Masato Takamori 1), 瀧澤好廣 2), Akizuki chapter 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2012.

---

	Usefulness evaluation of the anticancer agent coinfusion inspection system using the P2-160 point checker 新井雄一朗1), 鈴木紀誉昭1), 桜井純蘭1), 沖畠里恵1), 深山智子1), 渡部真由美1), 水野善郎2), 原澤秀樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2012.

---

	Action for the proper use of the tolvaptan lock in the eastern part of P2-161 Saiseikai Yokohama-shi Hospital 江口裕三1), 新倉白朗1), 渥美景子1), 竹之内正記1), 山谷武司1), 滝村英幸2), 中野雅嗣2), 伊藤良明2), 村松俊哉2), 菅野浩1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2012.

---

	Analysis of the ascertainment behavior in the powder compounding of medicines using the P2-162 viewpoint measurement machine Hiroki Nakamura 1) 2), Iida A Taro 2), Inooka Kyoko 2), Yuriko Murai 2) 3), 眞野成康 2) 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2012.

---

	Epicritic evaluation (the seventh report) of the P2-163 tablet, capsules body Keiko Nakano, 徳良嘉将, Masahiro Iwasa, Double cross Shintaro, Masayuki Watanabe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2012.

---

	Action to an inquiry and risk aversion between the team approach in medical care in the P2-164 operating room 藤田將嗣, Tsuyoshi Oda, Satoshi Yamamoto, Mutsumi Kobayashi, Chizuru Shirokami, Shiho Hirahara, Norifumi Nakajima, Takashi Inoue solstice, 前田頼伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2012.

---

	Examination of the risk of the insoluble particulate matter in the P2-165 injection intravenous administration Takuya Sugawara 1), Keiichiro Matsuda 1), Keiji Kuramoto 2), Koichi Arai 1), Tadashi Shiraishi 3), Toru Shoji 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2012.

---

	Nosocomial action and effect for the evasion of the surgery cancellation with the P2-166 drug Yuika Naito 1), Akira Kawakami three 1), Jun Kawazoe 1), Akiko Fukunaga 1), Mayumi Ishibashi 2), Fukuchi book Harumi 2), Takashi Nagai 3), Junko Minemura 1), Junichiro Murayama 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2012.

---

	Analysis of the associated incident of the medical supplies in P2-167 children 見野靖晃, Takafumi Naito, Kazuka Kasahara, Kimiyoshi Hirano, Nobuhiko Takai, Aono Hironao, Hiroko Terasaka, Junichi Kawakami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2012.

---

Effect to give to the intravenous feeding speed of the type transfusion pump that a study on proper use administration set of the P2-168 medical care device flow controls Masayuki Umemura 1), Hiroyuki Ono 1) 2), Ikenoo Yuya 1), 市江純治 1), 伊藤彰洋 1), Shoko Kazaki 1), Akito Yada 1), 山田迅 1), Tetsuya Yoshioka 1), Katsuo Shigeno 1) 3), Side shop Yoshibumi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2012.

---

	The surface decrease in the administration set intravenous feeding pipe at P2-169 May Ron (R) IV hydration and the measures 泉伯枝, Kenji Aihara, Hideki Sato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2012.

---

	P2-170 [Proper use of warfarin : It was towards risk avoidance by contraindication food initiatives] 森田智恵子1), 川井美和1), 久保道也2), 篠田健一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2012.

---

	About the fall risk with the side effect of P2-171 psychotropic drug case sleeping drug Hosokawa law of nature Expo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2012.

---

Comparison - in the preparation product of evaluation - muscle relaxant and the antitumor agents of the risk of the high-risk medicine which assumed quantity of component / mouse LD50 of the P2-172 preparation product an index Kazuki Nagashima 1), Fumio Itagaki 2), History of Shigeru Kishimoto 3), Ryosuke Iijima 4), Machiko Watanabe 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2012.

---

	Examination about the dissolution of the disintegration film preparation in the P2-173 oral cavity Mai Tanida, Masashi Hamada, Kayo Fukatsu, Makoto Shigematsu, Osamu Takeshita example, Masako Ono, Satoko Katsuragi, Masahiro Moriyama, Hilum Muneo Hayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2012.

---

	A prediction of the depression time of the glass piece using the Stokes' formula to P2-174 marketing injection and the risk The Okayama future, Nozomu Matsumoto, Corner Midori Mori, Kazuhiro Nakajima, Masanori Sueyasu, Nobuaki Egashira, Ryozo Oishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2012.

---

	Examination about the preparation docimasy reflecting a feeling of taking P2-175 amlodipine orally disintegrating tablet Hiroyuki Yamazaki, Yui Aoki, Middle bear Ayaka, Kenichi Fukumitsu, Mizuyo Kubo, Quantity of Seo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2012.

---

Comparison of the vial surface contamination of the cisplatin preparation circulating in P2-176 Japan Takashi Osawa 1), Takafumi Naito 1), Naoya Suzuki 1) 2), Toshiya Goto 3), Akira Takada 3), Hidenori Nakamichi 4), Yoshiko Onuki 4), Kimie Imai 2), Kunio Nakanishi 2), Junichi Kawakami 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2012.

---

	Examination about the stability (storage temperature) of the TSW suppository used for nausea, vomiting at the P2-177 opioids administration Kenji Ogata 1), Masahiko Usuda 2), Hiroyuki Ueyama 1), Jin Tokunaga 1), Nao Setoguchi 1), Toyotaka Nishio 3), Takamura rich person 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2012.

---

	Examination about the elution behavior of the drug in the P2-178 simple suspension method Shigeto Arai 1), Field basket Mihoko 2), Hidekazu Kishida 1), Akihiko Ito 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2012.

---

	About the stability in the open system of the P2-179 art celebrity (R) cerebrospinal surgical irrigation perfusate Shigeto Sekimoto, Sagi River Naohiko, 張間香, Nago Yuka, Kenji Aihara, Hideki Sato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2012.

---

	Examination of the utility of the clause of "the administration to elderly people" of P2-180 ethical drug attachment document Mei Kuribayashi, 山下槙子, Daiya Sakurada, Eriko Kobayashi, Noboru Sato example Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2012.

---

	Study on warning way in the P2-181 ethical drug attachment document Atsushi Kawasaki, Chikako Kurosawa, Daiya Sakurada, Eriko Kobayashi, Noboru Sato example Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2012.

---

	Construction of the drug control instruction guidance database for the P2-182 high risk medicine Itsuko Ono, Junko Abe, Rieko Shibata, 宮村信輝, Sugidaira Naoko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2012.

---

	Information sharing in the P2-183 drug information management room Yumi Niinuma, Yoko Kamo, Sato preference, We see it with Yano, Junko Kurimura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2012.

---

	Construction of the contraindicated name of disease database in the proper use of the P2-184 medicine Teruko Kurihara 1), 奥覚子 1), Satoko Suzuki 1), Kenzo Kudo 2), Noboru Sato example 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2012.

---

A construction and use of the simple suspension advisability information database of the oral medicine corresponding to the P2-185 incompatibility information Masahiro Watanabe, Norimatsu truth size, Shigeko Tsuji, Sumio Kimura, Kenta Sumiyoshi, 藤本高成, Hiromi Ichinose, Hot water wisteria Yuko village, Shinji Kosaka, 福岡憲泰, 芳地一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2012.

---

	Construction of the injection incompatibility intelligence system in P2-186 ward duties Toshinari Uematsu, Kyoji Koda, Hisako Yoshimoto, Aya Inoue, Miho Yamada, Yutaka Uchida, Hiroyuki Furukawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2012.

---

	Construction of the initial symptoms database for P2-187 Serious ADR discovery 奥覚子 1), Teruko Kurihara 1), Satoko Suzuki 1), Kenzo Kudo 2), Noboru Sato example 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2012.

---

Development and evaluation of the contraindicated database with P2-188 medical supplies and laboratory values Hashimoto Anri, Takeshi Yokoyama Ichiro, Masato Okubo, Toru Matsushima, Kaori Yamazaki, Ko Yamaguchi tree, 仲佐啓詳, Hiroshi Nakamura justice, The amount of Ariyoshi example, Koichi Kitada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2012.

---

	Research about the main literature of P2-189 ethical drug attached document mention Hyodo fort, Isamu Murata, Yutaka Inoue, Ikuo Kanemoto, Masayuki Kimura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2012.

---

	Likelihood of the information on adverse drug reactions acquisition of the injectable antimicrobial agent by the retrospective analysis of P2-190 multicenter medical business accounts data Sunlight intellect love 1), Ryo Matsushita 2) 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2012.

---

	A drug information offer and problems about the medical treatment depending on P2-191 patients background Katsuhiro Ogawa, Makiko Adachi, Tatsuya Kaneta, Yoshikazu Shiiki, Hiroshi Takane, Kenji Otsubo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2012.

---

	The registration of the P2-192 questions and answers database "pharmacist notebook" and analysis of the access situation Takayuki Arakawa 1) 2), 豊見敦 2), Toyomi Masafumi 2), Barrel valley Yoshihisa 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2012.

---

	Factor - of the analysis - number of questions and answers examples increase in the P2-193 DI room Maruoka eyes 1), Motomu Sumitani Yoshiko 1), Yasuko Yanase 2), Yuji Okada 1), Tetsuo Funamoto 1), Misae Takase 1), 飴谷太 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2012.

---

	Use fact-finding about P2-194 ARB/ diuretics and the ARB/Ca antagonist Tatsuya Takahashi 1), Teramachi eyes 1), Tomoya Tate 1), Hiroyuki Nagasawa 1), Takashi Mizui term 2), Senju Goto 2), Teruo Tsuchiya 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2012.

---

	Cut medicine finely, and the P2-195 patients of how much keep it; is a storage situation investigation of the medicine and an evaluation of the accidental ingestion measures PTP Matsumoto Masaakira 1), Noriko Tamai 2), Hideko Ozaki 2), 廣島真一 3), 山之内崇紘 3), Masaki Takeda 4), 大矢善亨 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2012.

---

	Investigation about the tolvaptan introduction situation and the proper use in our P2-196 House 藤井浩毅1), 山下まゆ子1), 上淵未来1), 濱田政司1), 市川康子1), 藤井裕史1), 上村孝史2), 小出俊一2), 藤井憲一郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2012.

---

	Study on reporting to the children for the feeling of remedy change between P2-197 drug, the food and drink Moe Hosaka 1), Megumi Tanaka non-1), Kumi Yabe 1), Eriko Kobayashi 1), Daiya Sakurada 1), Noboru Sato example 1), Hisashi Iijima 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2012.

---

	It is ... through an attitude survey for the examination - et al. post training about the reinforcement of the mutual understanding between the types of job for the P2-198 team approach in medical care promotion Tide Mikiko, Tsuyoshi Matsumaru, Takekawa seven rebirths, Takuya Maeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2012.

---

	Attitude survey for "the medicine" for public primary schoolchildren under P2-199 Iwate Makoto Matsuura 1), Tezuka A 2), Atsushi Sanbe 2), Hideo Nishigoori 2), Satsuka Yasuyuki 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2012.

---

	Prescription suggestion using the inhalational device evaluation questionnaire and findings for the P2-200 inhalant-free patients Yoko Sone 1), Mitsugu Saegusa 1), Tomoya Asada 1), 眞鍋伸次 1), 森由弘 2), Thickness well Bunichi 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2012.

---

	With the establishment of the use confirmation method of the P2-201 fixed-quantity aerosol-type inhalant, actually Mika Ozawa, Mayumi Yamamoto, 神谷貞浩, Hiroko Sada, 小嶋文良 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2012.

---

	An action and use situation investigation to safe use of the P2-202 new oral anticoagulant drug dabigatran 小財弘己, 八巻美和, 岩堀文香, 信太寛和, 松井七奈, 久保悠, 多田知弘, 今田深雪 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2012.

---

Utilization ... of the testing leak count results by the action ... side effect automatic monitoring system of the omission of testing improvement using a public information magazine for P2-203 inside the hospital Azusa Matsushima, Toshiaki Igarashi, Aya Konno, Saiki Akiko, Miyuki Uno, Yosuke Morita, Toshiaki Nakamura, Mikio Masada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2012.

---

	The simple suspension method of the P2-204 soft capsule (the second report) Mariko Kato 1), Ai Yoshino 1), Masato Takahashi 1), Kurata we see it 2), Akihiro Nakamura 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2012.

---

It is ... from factor - pharmacy student affecting the quantity of the medicine feeling that there is much P2-205, the questionary survey for non-medical care system students Megumi Saito 1), Noriko Tanabe 1), Igarashi hemp intellect 1), Yutaka Ishii 1), Hiroshige Inazumi 2), Reveal well Naoko 3), Etsuko Arita 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2012.

---

	Questionary survey about management, the storage of the patients for the P2-206 drug 植沢芳広 1), Mai Nishitani 1), Matashige Shuichi 2), Akane Koyama 2), Naoko Mizuta 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2012.

---

	Attitude survey of the pharmacist about the application to clinical studies information and pharmacotherapy of the P2-207 aromatherapy Shiho Inoue 1), Sincerity field Akemi 1), Minae Izawa 1), 登美斉俊 1), Takuya Sasaki 2), Emi Nakajima 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2012.

---

	Fact-finding of the MR activity of the P2-208 this hospital Takashi Fukazawa 1), Fumiko Yamaguchi 1), Yuko Watanabe 1), Yasuyuki Matsumura 1), Toshio Kawaguchi 2), Toru Sato 1), Hajime Kagaya 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2012.

---

	About sleep disorders and the quality of life in the asthmatic patients who had the P2-209 allergic rhinitis Yuko Nakatake 1), Reiko Utsunomiya 1), Ken Hirota authority 2), Ono Hirofumi 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2012.

---

	Use fact-finding of the antiplatelet drug to P2-210 patients with Kawasaki disease Moat Akiko 1), Yuji Suzuki 1), Ichiro Takakura 2), Yuichiro Tomita 3), 王廉雅 3), Yasuhiko Yamada 4), Haruko Yokoyama 4), Masayuki Watanabe 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2012.

---

	A cognitive degree investigation for the vitamin K component food of the P2-211 warfarin remedy patients and the analysis Hidesuke Yoshikawa 1), Tadashi Suzuki 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2012.

---

	Examination for the use actual situation and the proper use in this hospital of P2-212 Dabigatran (Prazaxa (R)) Kashiwano Yuko 1), Mami Usami 1), Keiko Hasebe 1), Kenji Shibasaki 1), Atsushi Honma 2), Inner liman Masanobu 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2012.

---

	About problems with the P2-213 generic name prescription publication Kazuhiro Hirano, Masaaki Ogata, Akihiro Hayashi, 中野行孝, Fujito Expo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2012.

---

	Investigation about the use situation and the side effect expression of P2-214 new anticoagulant dabigatran 永野真久1), 白澤宏美1), 大窪典子1), 橋本崇広1), 大園ゆかり1), 平木洋一1), 真鍋健一1), 神村英利2), 加留部善晴3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2012.

---

	Comparison between P2-215 Terumi sultan and lipid-related test value by the dose of the irbesartan 野澤彰1), 野澤(石井)玲子2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2012.

---

	For the full-scale induction of the simple suspension method in the P2-216 this hospital Asami Fujita, Sanae Kawamura, Tei Wagatsuma, 渡部寿康, Toshio Yamaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2012.

---

	It is the examination in a medication counseling present conditions investigation and health drink clinical trials the study on P2-217 clinical response and psychic control structure Shimizu, Shimizu, Eri Miyashita, Sincerity field Akemi, Minae Izawa, 登美斉俊, Emi Nakajima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2012.

---

Neutropenia after the S-1 therapy enforcement in patients with P2-218 progress pancreatic cancer and prognostic relative examination Tatsuya Kurihara 1), Yuna Miki 1), Mari Kogo 1), Kazuo Konishi 2), City storehouse Daisuke 1), Chikako Miyamoto 3), Masahiro Usuda 1), Shunichi Shimizu 1), Keiichiro Yoneyama 4), Yuji Kiuchi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2012.

---

Relations of neutropenia and the vital prognosis after the platinum administration for patients with P2-219 progress lung cancer Hiroshi Kitashima branch 1), Mari Kogo 2), Tatsuya Kurihara 1), Shibuya green 2), Megumi Sugano 1), Yusuke 3 between the deer), Keiichiro Yoneyama 4), Yuji Kiuchi 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2012.

---

	It is the daily drug cost of 1mmHg glaucoma eye drops to make it drop by P2-220 ocular tension 櫻下弘志 1), Hiroaki Ikeda 1), Yasuyuki Saeki 1), Takashi Tomita 1), Hidetoshi Tsukamoto 2), Tree flat Kenji 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2012.

---

	Simplifying it and drug costs reduction of the medication management by the pharmacist intervention of the internal use prescription of the P2-221 medical treatment ward Harumi Sakakida, Nobuko Shiratori, 川奈部英洋, Naoko Hiraoka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2012.

---

Reactive examination - to examination - neuropathic pain of the factor to contribute to opioid reactivity to P2-222 cancer pain Yasuha Ogawa 1), Megumi Omura 1), Tatsuya Kurihara 1), Mari Kogo 1), Mami Saito 2), Higuchi ratio up true 3), Masakazu Ishii 1), Shunichi Shimizu 1), Keiichiro Yoneyama 4), Yuji Kiuchi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2012.

---

	Impact ... of medical supplies joint purchase produce in P2-223 Oshu-shi and effect - increased income 100 million yen Takeshi Onodera 1) 2) 3), Kenji Minamikawa 1), Chika Sato 4), Yuichiro Mikami 5), Toshihiro Miura 6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2012.

---

Relative examination of neutropenia and the vital prognosis after the CRT enforcement in patients with P2-224 esophageal cancer Mari Kogo 1), Takahito Imagawa 1), Tatsuya Kurihara 1), Tomiko Sunaga 2), Ayako Suzuki 3), Kazuo Konishi 4), Masakazu Ishii 1), Shunichi Shimizu 1), Keiichiro Yoneyama 5), Yuji Kiuchi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2012.

---

	Analysis of the side effect-related hospitalization in the acute phase medical institution using the P2-225 DPC survey data Shino Imai ぶ 1), Kiyohide Fushimi 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2012.

---

	Exploratory study on drug costs reduction of the P2-226 anticancer drug Ryo Seto religion 1), Yu Nakamura 1), Mitsuhiro Sugawara 1), Yukio Ogawa 1), Hajime Matsubara 1), Kazuo Yago 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2012.

---

	Statistical examination about the effectiveness and the safety of linezolid and vancomycin in patients with P2-227 MRSA pneumonia 栗林歩, 岸川幸生, 八木朋美, 勝山壮, 中村仁 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2012.

---

	Strategic study on optimization of the injection sale standard that pointed to P2-228 medical cost suppression Takeshi Yokoyama Ichiro, Takako Nakamura, 仲佐啓詳, Hiroshi Nakamura justice, The amount of Ariyoshi example, Koichi Kitada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2012.

---

	Investigation about the disposal of P2-229 inpatients drug Keiko Yamaguchi, 島田侯陛, Chie Suzuki, Akito Ito, Tadanori Suzuki, Mayumi Inoue Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2012.

---

	One discussion of anticancer drug mixed duties in consideration of P2-230 drug costs reduction Tomohiko Harada, 甲斐維子, Manabu Sakurai, 齋木一郎, Mayumi Nagano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2012.

---

The catharsis effects are not increased even if they use P2-231 osmotic pressure-related laxative and large intestine irritative diarrhea together Igarashi sincerity intellect, Now Risako, Ayako Mimura, Iizasa Tomohiko, Arrowhead crest green, Chika Nagoya, Takashi Ishii, Yudai Toda, The Ochiai sum, Kiyoshi Sugiyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2012.

---

	Examination about drug interactions of salazosulfapyridine and methotrexate in patients with P2-232 articular rheumatism Morihiro Okada 1), Kan Yukio 2), Masae Tsuji 1), Yu Kanetani 1), Kimi Sakata 1), Hisae Miyata 1), Hiroaki Mizuno 1), Taketa former 1), In the west moisture 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2012.

---

	The effect that P2-233 gastric-acid secretion depressant drug gives to efficacy and safety of erlotinib Kazuki Ishikura, 田村健悦, Yuko Okuyama, Teru Saito still, Yuko Fujii, South Kazushi, Isao Miura Taro, Tanaka sunlight, Dove Natsuko, Origin of Hiraga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2012.

---

	Adsorptive examination of the combination drug for P2-234 polystyrene sulfonate drugs Tsuyoshi Kuramochi 1), 柳浦麻未 1), Naoki Uemura 1) 2), Yukie Kanazawa 3), Kunio Sugiura 4), Takafumi Ota 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2012.

---

	It is one patient using the dabigatran for pulmonary embolism due to the P2-235 DVT 植村太志1), 伊藤和幸1), 浦崎圭太1), 河井和子1), 磯谷聡1), 加田賢治2), 坪井直哉2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2012.

---

	P2-236 Interaction at the time of the simple suspension method enforcement of Proton pump inhibitor "Nexium (R) cupsules" 新井克明1), 石田志朗2), 山下あずさ2), 神崎姫奈2), 越野優希2), 岡野善郎2), 清水範子1), 前原梨恵1), 真家佑介1), 菊地麻希1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2012.

---

	Adsorption to a dietary fiber of the P2-237 pravastatin sodium 上間渉, Ayano Iwasaki, Kimie Imai, Kunio Nakanishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2012.

---

	Effect of the magnesium oxide which gives it to gastrointestinal absorption of the gabapentin in patients with P2-238 cancer pain Yagi Tatsuya 1), Takafumi Naito 1), 見野靖晃 1), Kazuo Umemura 2), Junichi Kawakami 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2012.

---

	Effect of the levofloxacin combination to give to anticoagulant ability of the P2-239 warfarin Riding ground Asato, Kayoko Sato, Hiroo Nakagawa, 兒玉幸修, Tadahiro Nakamura, Norihide Higuchi, Takashi Kitahara, Hitoshi Sasaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2012.

---

	Problems and proposal of the mention method of the drug interaction information in the P2-240 attachment document Riyo Yamaguchi 1), Yoshiyuki Ono 1), Gutter slope Akihiro 2), Hiroshi Suzuki 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2012.

---

	Internal change change of the linezolid at the P2-241 rifampicin combination 崔吉道1), 本田恭子1)2), 藤田浩平1)2), 宮地佑佳1), 伊藤さつき1), 澤本一樹1), 宮本謙一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2012.

---

	Examination about the interaction of P2-242 bosentan and the warfarin Junichi Terashima 1), Tetsuya Yamada 1), 勝野晋哉 1), 鷹見繁宏 1), Masazumi Ajioka 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2012.

---

	One case that showed PT-INR increase after P2-243 warfarin withdrawal Jun Hirano 1), Yuzuru Saito one 1), Akira Takahashi 1), Mariko Hasegawa 2), Taku Nakagawa 2), Kenji Ogawa 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2012.

---

The present conditions and problem of P2-244 warfarin potassium and the pyrimidine system anticancer drug combination fluoride Katsuyuki Takahashi 1) 2), Hisami Shimizu charges 1), Description of Yasushi Suda 1), Hiroshi Kawaguchi 1), Yasutaka Nakamura 1), Noriko Kawakami 1), Light river Yasuko 1), Takeshi Nishikawa 1), Katsuya Nagayama 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2012.

---

	Examination about the effect of the renal function in the serum Na change by the P2-245 tolvaptan 六車龍介1), 丸山貴生2), 永江隆二1), 岡本勇二1), 桝本知佳1), 太田友里恵1), 高橋亜麻奈1), 佐田竜尚1), 内山幸子1), 江崎圭吾1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2012.

---

	The impurities detected in medical supplies container made of P2-246 plastic bring about cytotoxicity Chiaki Tsuboi 1), Yoichi Kawasaki 2), Minoru Mori Miwa 1), Sendo Toshiaki 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2012.

---

	Adverse event investigation of thienopyridine drugs in the P2-247 Hiroshima City Hiroshima Municipal Hospital circulatory organ internal medicine Toshiharu Matsumoto 1), Mari Sasaki 2), Kayo Yoshida 1), Sho Ishida 1), Shinichi Miyamori 1), Open Koichi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2012.

---

Investigation of the factor involved in the excessive PT-INR increase of the P2-248 warfarin administration patient on dialysis Takuya Yoshida 1), Old Taku Kubo 1), Chiharu Matsunaga 1), Mizuho Miyake 1), Satoshi Izumi 1), Kenjiro Yamakawa 2), Shigeru Shoji city 2), Tomoyuki Yamakawa 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2012.

---

	The development of Cefepim-induced mental neurologic symptoms situation in the P2-249 this hospital Kato good chapter 1) 2), Mitsutaka Iguchi 2) 3), Masato Yamamoto 1) 2), Tetsuya Yagi 2) 3) 4), Kiyobumi Yamada 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2012.

---

	Examination of the onset of cholinergic crisis factor by the P2-250 distigmine Shinichiro Suzuki, Kishi, Matsuzaki, Hidetomo Yasujima, Akio Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2012.

---

	Investigation about satisfaction of the expression situation of hyperprolactinemia induced by the antipsychotics for P2-251 schizophrenia patients and the antipsychotics Asai village Hidemi 1), 佐藤慎祐 1), Hiroyuki Baba 2), 青木治亮 2), 半谷眞七子 1), Hiroyuki Kamei 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2012.

---

Investigation of the use of amiodarone situation and the thyroid function aberrant expression frequency in the P2-252 LVAS wearing patients Kazuya Nakano 1) 2), Hiroyuki Ochi 1) 2), Kyoichi Wada 1) 2), Oida chapter 1) 2), Takeshi Kuwahara 1) 2), 宍戸稔聡 1) 3), Seguchi law of nature 1) 4), 村田欣洋 1) 4), Masanobu Yanase 1) 4), Takeshi Nakatani 1) 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2012.

---

	Examination about the onset of side effect of P2-253 vancomycin note (VCM) chronic administration Yukino Urata, It is Sachiko in a camp, Eiko Fukunaga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2012.

---

	1 adult case that presented low carnitine blood disease by P2-254 cefditoren pivoxil Kuni Isobe finally, Miyoshi straight celebration, Katsuhiro Yamada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2012.

---

	Investigation of the side effect of allergy to P2-255 information registration system report situation Mamoru Uchida next, Yuichi Umeda, 進健司, Yasushi Kanazawa example, Shinsuke Takemoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2012.

---

	Search of the factor influencing fact-finding and the treatment continuance rate of the P2-256 topiramate long-term use patients 矢澤嶺 1), Yoshiaki Yamamoto 2), Kazuyuki Inoue 1), Katsumi Imai 2), Tomoki Tsuji 1), Hideki Hayashi 1), Yukitoshi Takahashi 2), Kunihiko Ito 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2012.

---

	Effect on renal function by the P2-257 pregabalin remedy 晴山知拓, Hiroyasu Sato, Harumi Ishida, Maki Tanaka, Yusuke Kanetaka, Yuichi Nakamura, Takeshi Nishimaki, Gold house Asako, Shigeki Tanaka, Hitoshi Komori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2012.

---

P2-258 comes out and is examined nausea measures in meat phosphorus smoking cessation-treated patients Ryota Torii 1), Mariko Domae 1), Kayoko Okuyama 1), 黒井扶美恵 1), Yasuyuki Tsukioka 1), Yuzuru Yamazoe 2), Saori Kawakami 3), Warabino eyes 3), Makoto Shimada Jiro 4), Junkichi Hama 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2012.

---

	Examination of the cancellation case due to the infection in patients with use of P2-259 biological preparation rheumatism Tomoko Ido 1) 2), Shinsaku Kishimoto 1), Koichi Takahashi 2), Kazuko Shiozawa 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2012.

---

	One case that presented a hallucination by P2-260 valacyclovir hydrochloride Yasushi Tsurusaki, Makiko Hatada, Hanada sacred book, Yoshihiro Nakagawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2012.

---

	Contribution of the pharmacist in the TD onset evasion of elderly people with the P2-261 sulpiride Hiroshi Tani child Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2012.

---

	Action of the use of side effect of P2-262 medicine medicine cooperation signal detection system promotion Kyoji Koda, Yuko Nagasawa, Naomi Uematsu, Chieko Hino, Hisako Yoshimoto, Hiroyuki Furukawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2012.

---

	3 cases of the atypical shaft of femur fracture that occurred during P2-263 Bisphosphonate drugs remedy Hanada sacred book 1), Yasushi Tsurusaki 1), Yoshihiro Nakagawa 1), Takeshi Yamashita 2), Shallows form Takeki 2), Kensuke Yonemura 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2012.

---

	Side effect expression of P2-264 lipid microsphere investigation about the dosing rate Tsuyoshi Oda, 前田直就, Hirofumi Takada, 馬島務, Ayaka Nakai, Noi Asami, Tasuku Fujiwara season, 前田頼伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2012.

---

	Side effect onset of P2-265 chronic hepatitis C investigation in the treatment (triple-drug therapy) Yukiyo Fujisaki, Chiyoko Yamada, Miwa Yonezawa, Shino Taga, 柏原宏暢 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2012.

---

	2 cases that heart failure was exacerbated by taking P2-266 non-steroid-related antiinflammatory analgesic Misako Kimura 1), Teruhiko Hoshino 1) 2), Yuji Mizuno 3), Eisaku Harada 3), Kazunori Shiozu 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2012.

---

	The making of the treatment diary for the patients of the P2-267 terra pre-building +PEG-IFNα2b+ ribavirin combination therapy and investigation of the side effect expression situation 平池美香子1), 白澤宏美1), 川上恵子1), 平木洋一1), 真鍋健一1), 牧野公治2), 尾上公浩3), 中田成紀3), 杉和洋3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2012.

---

	Of renal dysfunction in the triple-drug therapy of P2-268 chronic hepatitis C, actually Mihoko Sasaki 1), Tetsuya Hirose 1), Shigeru Sato 1), Hatsumi Kikuta 1), Miki Katsuragawa 1), Ryu Kobayashi 1), Hideji Ohara 1), Muki Ryoji 1), Ozeki solstice 2), Yoshiyasu Kano 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2012.

---

	A factor and the measures to influence side effect expression of P2-269 dabigatran 山西香織1), 増田瑠美子1), 田中佑佳1), 生駒佳織1), 和田恭一1), 老田章1), 桑原健1), 清水渉2), 鎌倉史郎3), 長束一行4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2012.

---

	Examination about the food in patients with P2-270 drug hypersensitivity and drug allergy history rate 齊藤幹央 1), Manabu Abe 1), Tomoyasu Furukawa 2), Yagi Motohiro 3), Koike reason Expo 4), Katsumi Enomoto 5), Yutaka Wakasugi 5), Katsuji Uno 6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2012.

---

	It is examined the risk factor about the ... adverse event expression to use P2-271 dabigatran more safely and appropriately 上村裕美, 鷲見佳子, 芦川直也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2012.

---

	Clinical evaluations in change cases from the spironolactone for P2-272 heart failure patients to eplerenone Keiji Nakajima 1), 宇佐美英績 1), Eri Abe 1), Tadashi Yasuda 1), Hideyuki Tsuboi 2), Takahito Sone 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2012.

---

	Fact-finding of the ACE inhibitor in the P2-273 aliskiren fumarate remedy patients or the ARB combination and examination of the side effect expression situation Shino Taga, Shigeharu Kiyama, 柏原宏暢 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2012.

---

Taste bitter evaluation of P2-274 zopiclone tablets (Amo van tablets (R)) and S zopiclone tablets (Rene studio lock (R)) Atsushi Uda 1), Tamami Haraguchi 2), Miyako Yoshida 2), Satoshi Mukai 1), Kazuhiro Yamamoto 1), Manabu Kume 1), Makimoto Hiroo 1), Tsuyoshi Hirano 1) 3), Takahiro Uchida 2), Hirai green 1) 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2012.

---

	It is an action of this hospital for the proper use of the antiarrhythmic drug the electrocardiogram monitoring by the P2-275 pharmacist Hirofumi Kajiwara 1), 波津久崇幸 2), 菅野公浩 2), Tetsuji Sugata 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2012.

---

We look at the expression situation of the side effect of P2-276 tocolytic agent ritodrine hydrochloride injection administration and the rear about the affector and research a mark Naoki Shibatani 1) 2), Shiho Sato 2), Kitada Noriaki 1) 3), North Masato 4), Kenji Yamamoto 1), Shuichi Kishimoto 2), Shoji Fukushima 2), Toru Hashida 1) 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2012.

---

	Intervention effect of the outpatient clinic support by the pharmacist in the P2-277 terra pre-building induction patients 舟越亮寛 1), Daisuke Negishi 1), Miyara Ayako 1), Shogo Iwabuchi 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2012.

---

	Medication inspection duties of the anticoagulant by the intervention of the pharmacist for P2-278 surgery adaptation planned outpatients 永野俊玲, 佐藤雄介, 西明子, 朝倉俊治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2012.

---

	About the utility of the bringing medicine differentiation system "medicine model" in the P2-279 children special hospital Kyoko Saito, Sachi Sugai, Masumi Nakamura, Ryohei Takahashi, Fumio Iwasaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2012.

---

	Action to drug proper use about Lyrica (R) which assumed P2-280 renal function an index and Prazaxa (R) Ogata Miyuki 1), Kaori Izumi 1), Michiyo Makino 1), Tomomi Kakimoto 1), 服部文忠 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2012.

---

	The need of testing, the preoperative oral medicine management for the patients taking P2-281 anticoagulant, an antiplatelet drug 早舩美保子, Mikio Shirota, Yoshiko Mori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2012.

---

	About an action of the withdrawal differentiation instruction in the orthopedics outpatient department of the P2-282 this hospital Maiko Matsuda, 登内盛治, Osamu Atobe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2012.

---

	Contribution to a drug economic merit of the P2-283 bringing medicine management and medical security Hiroki Ito, Junko Nakajima, Ko Hiraide stone, Takako Imazeki, Takeshi Kato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2012.

---

	Risk management by the bringing medicine check in the cottage-hospital out of P2-284 Great posterior Yukiko, 小野朗弘, Hiroshi Wagatsuma positive, Mieko Yoshimura, Saori Takahashi, Kunio Kuwahara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2012.

---

It is ... from contribution - bringing medicine confirmation to the medical security and economic effect through P2-285 ward pharmacist duties to discharge teachers' textbook making Shuhei Suzuka, Tomoko Katsube, Fujita Aoi, Kazuya Hirata, Naoyuki Matsumoto, Kazuki Tago, Miki Nakamura, Great Yumiko Tsuyama, Person of moat Yumiko, Naoki before yellow Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2012.

---

	Induction of the bringing medicine management using a P2-286 electronic chart "bringing medicine management capability" system and future problem 宮里弥篤, The Hiroshi Kawakami shallows, Onaga Shinichiro, Tamotsu Hika Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2012.

---

	The present conditions of the inpatients bringing medicine management in the P2-287 IHI Harima Hospital Tatsuya Ono 1) 2), Noriko Ishida 1) 2), Hideyuki Nishida 1), Tokuyama still I 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2012.

---

	An action and evaluation of bringing medicine confirmation duties to conduct in P2-288 ward Hiroko Sugimoto, Corner Rieko, Noriko Sasaki, Miki Ishibashi, Seko mouth Noriko, Hiroaki Matsuda, Takuya Iwamoto, Shinko Okuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2012.

---

	Action about the oral medicine management of perioperative (preoperative) in the P2-289 Tsuyama center Hospital Akiko Sakuma 1), Tetsu Sugiyama University 1), 杉山浩江 1), Yukihiro Kawakami 2), Sachiyo Kondo 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2012.

---

	Analysis of the intellectual property rights dispute example to affect P2-290 generic medicine Kazuno Shohei Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2012.

---

	Investigation - by effect - self entry method questionnaire that the difference in technique of the preparation about the taste of the P2-291 donepezil hydrochloride orally disintegrating tablet gives in the palatability of the patients 柏宗伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2012.

---

	Examination about the blood level of the patients who started treatment with P2-292 amiodarone generic drug Daisuke Yamashita 1), Rei Ikeda 1), Kaori Ikoma 1), Akemi Horibe 1), Kyoichi Wada 1), Oida chapter 1), Takeshi Kuwahara 1), Wataru Shimizu 2), Kamakura Shiro 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2012.

---

	Fact-finding of the substitute compounding of medicines to generic medicine before and after the P2-293 generic name prescription induction Shiori Morishita, Reina Nishimoto, 北村友乃, 菊池紗恵, Yukiko Kiyama, Masaki Hirakawa, Goro Ikushima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2012.

---

	Examination of the equivalency with an agent Kremezin infinitesimal grain and the generic medicine for the P2-294 chronic renal failure Junko Miyakawa, 岩瀬利康, Yoshio Ito, Koichi Hoshino, Miyuki Suehiro, 双樹恵, Tomoko Koyama, Tomoaki Toyama, Osamu Suzuki ear, Yuki Tsukada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2012.

---

	Action of the generic name prescription in the P2-295 Kitasato University Kitasato Inst. Hospital Koji Masubuchi 1), Ito Funato charges 1), Soichi Shibata 1), Atsuta Koichiro 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2012.

---

	Properties of matter evaluation of the starting medical supplies and generic medicine in the P2-296 triamcinolone acetonide ointment preparation Maeda Rikimaru, Kayoko Furuya, Yutaka Inoue, Isamu Murata, Tanaka Toru, Masayuki Kimura, Ikuo Kanemoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2012.

---

	Investigation about the substitute compounding of medicines to the generic medicine in the out of the hospital prescription of the P2-297 this hospital publication Yuka Iwaki, Hiromi Ieda, 星野真輝, Miki Aoki, 仙田典保 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2012.

---

	Comparison - of pharmaceutic evaluation - forerunner medical supplies and six items of generic medicine of the P2-298 fluticasone propionate ester nasal drop Chinatsu Kawashima, Minami Sanpei, Shoko Tsukahara, Shuji Shimada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2012.

---

	For contribution to action - hospital management about the reduction of the P2-299 stock amount of money and the adoption promotion of the generic medicine - Yuko Ichiki 1) 2), Kazuya Koreki 2), Ichiro Yoshimizu 2), Daisuke Kobayashi 1), Toshio Kubota 1), Takao Shimazoe 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2012.

---

	Stability after the conservation of P2-300 steroid ointment and the mixed ointment of the moisturizer and release-related evaluation Tsuneyoshi Suzuki 1) 2), Satoshi Uchino sincerity 1), 宮嵜靖則 1), Yoshiyuki Kagawa 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2012.

---

	Comparison between the product of the disintegration of the P2-301 donepezil hydrochloride component orally disintegrating tablet Eriko Sano, Yu Sato pear, 村山信浩, Is Kurata; see it, Akihiro Nakamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2012.

---

	It is disintegration at remedy with the water of the P2-302 donepezil hydrochloride component orally disintegrating tablet Hironori Kobayashi, Mariko Kobayashi, Nakamura is constipated, Osamu Genda period, 村山信浩, Is Kurata; see it, Akihiro Nakamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2012.

---

	Development 3 of the set medicine inspection system of the operating room in the cottage-hospital out of P2-303 齋藤進 1), Yuka Watanabe 1), Yuka Saito 1), Shuichi Shimura 1), Yasuko Sato 2), Shigeo Katsumi 3), Takashi Matsukawa 4), Noriaki Fujii 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2012.

---

	Construction second report of the product system of administration derived from the specific organism which linked P2-304 electronic chart Toshiyuki Ozaki, Kenichi Anjiki, Yorimitsu runs, Emiko Fukuda, 卜蔵俊仁, Kazuo Takeshita, Ei Hirano product, Sumiko Goto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2012.

---

Establishment of the operation region medicine administrative work which we introduced the storage of P2-305 fingerprint attestation ceremony medicine storage into and the evaluation Field Takefu, Cutting the ears of rice Reiko, Kazuko Yamana, Ichiei Ooi, Noriko Suzuki, Kaoru Suzuki, Masami Nishihara, 勝間田敬弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2012.

---

Difference (2)-PTP, medical supplies body - with the indication that a fact and a pharmacist of the indication of P2-306 medical supplies hope for Mayumi Suzuki 1), 芦野優佑 1), Many Nei Shigeharu 2), Shuji Yamashita 3), Shiho Miyahara 1), Nami Mizukami 1), Kawashima A season 1), Tadashi Sugiyama 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2012.

---

	Difference (1)- outer box - with the indication that a fact and a pharmacist of the indication of P2-307 medical supplies hope for 芦野優佑 1), Mayumi Suzuki 1), Many Nei Shigeharu 2), Shuji Yamashita 3), Kawashima A season 1), Nami Mizukami 1), Shiho Miyahara 1), Tadashi Sugiyama 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2012.

---

	The actual situation and problems of the Residual medicine which we extracted from P2-308 literature 大澄朋香1)2), 飯嶋久志1), 渡邉文之2), 亀井美和子2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2012.

---

Evaluation of the action of the resident pharmacist for the risk management of SPD induction effect and the medical supplies management in the P2-309 operating room Azusa Nakajima 1), Tomohisa Hayakawa 1), Aki Nakahara 1), Taste Yumi Sawa 1), Yamakichi Yasuko 1), Osamu Ikeya 1), Hiroshi Shiina good luck 1), Door Emi Nako 1), Shunichi Kawamura 1), Shinichiro Okamoto 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2012.

---

It is induction ... of the injection individual set about inventory control of the injection in the P2-310 this hospital for ... 24 hours Kaori Sato, Asako Higuchi, Keiko Arimura, Yuki Arai, Yuzuru Watanabe, Shoji Izumo, Yuki Inoue, Miyako Shoda Noriko, Toru Hirashima, Hideo Hasegawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2012.

---

	Construction of the drug regime that P2-311 is new Yasushi Miyamoto 1), Ueno English sentence 1), Kurashima 2, Kyuutoku), Koichi Onishi 3), Three soil Chieko 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2012.

---

	Induction of the inventory control system using P2-312 PDA terminal Ryota Yamamura, 西村文宏, Makibara Yoko, Yosuke Katayama, Kanako Fujisaki, Wild Owa reason, Hiroki Ito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2012.

---

Action of the operation region permanent residence pharmacist who contributed to improvement of P2-313 medicine management and the hospital management Masashi Matsuda 1), Hiromi Teraoka 1), Miyuki Miyaguchi 1), Michiyo Matsuo 1), Yoshihiro Horie 1), Okamoto positive incense 1), Chiaki Hasegawa 1), Yumi Kitawaki 2), Shuichi Nosaka 3), 寺田智祐 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2012.

---

	The expiration date for use management situation of Epinephrine autoinjector injection (R) after the P2-314 drug grant 戸田康裕1), 土本大輔1), 福井愛子1), 水谷貴樹1), 宮川佐和子1), 宇都宮純平1), 出口裕子1), 平野茂樹1), 小川裕2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2012.

---

	About the action of PCA pump drug preparation duties by the P2-315 this hospital operating room pharmacist Sachiko Hiraki 1), Junko Oketani 1), Small Reiko Ikeda 1), Akiko Soga 1), Yusuke Tanimura 1), Rika Sasaki 1), 成徳理代 1), Takashi Okada 1), Hideaki Tsuchida 2), Koji Nishio 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2012.

---

	Examination of the method of dispensing in the P2-316 hydroquinone cream Hiroyuki Miyashita 1), Kensuke Usui 2), Teruko Takano 1), Futoshi Saito 1, Kotobuki), Takahiko Kagaya 1), Atsuta Koichiro 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2012.

---

	A comparison and examination of the old and new MET synthesizers in our P2-317 institution Yasushi Yokoyama 1), 福山誠介 2), Takeshi Kato 3), Kentaro Hatano 4), Toshitaka Nabeshima 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2012.

---

	Effect of the indomethacin spray on stomatitis pain at the P2-318 cancer chemotherapy Ikumi Sugiyama, 遠藤智宇, Kenzo Kudo, Satsuka Yasuyuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2012.

---

	About a study of the pharmaceutics of the study on P2-319 Mohs' paste (the third report) -Mohs' paste - Yuko Inagaki 1), Mari Kobayashi 2), Maho Taguchi 3), Kenji Onodera 1), 山本浩充 2), Masato Shigeyama 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2012.

---

It is examined the - second report - girls power improvement effect towards the health insurance pharmacy that can contribute to regional medicine through P2-320 Chinese medicine preparations manufactured by pharmacy 高島英滋 1), 坂京彙子 2), Tomomi Sugiyama 3), Emiko Asakura 2), Tetsuya Ohashi 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2012.

---

	Development of the P2-321 meloxicam percutaneous absorption type preparation Shigeko Obata, Sureewan Duangjit, Satoshi Sano, Shingo Kikuchi, Yoshinori Onuki, Kozo Takayama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2012.

---

	The actual situation of the use of the urinastatin pessary in the P2-322 this hospital Ai Tsukada 1), Rumi Ishida 1), Junko Momiyama 1), Rock appendix Kazuko 1), Kan book Rie 1), Yoshito Tobaru 2), Shiro Abe 2), Funatsu Kumi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2012.

---

	Effect on rheological property that a storage temperature gives it to of the P2-323 methyl cellulose liquid drug and drug delivery Descent from a mountain Tetsuya, Miyagi reason Riko, 浦木睦, Aya Takahashi, Kunihiko Ito, Michiya Kobayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2012.

---

	About a change of color change by the combination with P2-324 acetaminophen preparation and the magnesium oxide Osamu Suzuki ear, 岩瀬利康, Yoshio Ito, Mieko Morita, Koichi Hoshino, Miyuki Suehiro, 双樹恵, Tomoko Koyama, Tomoaki Toyama, Yuki Tsukada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2012.

---

	Examination of the gelation hospital preparation of acetaminophen for the purpose of the P2-325 intubation administration Risa Takahashi, Hiromi Okada, Yutaka Inoue, Isamu Murata, Ikuo Kanemoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2012.

---

	A preparation and evaluation of the intraoral attachment film for stomatitis treatment using the P2-326 xyloglucan Manami Ono Rina 1), 笹津備尚 1), Yayoi Kawano 1) 2), Kaori Hirose 1) 3), Toshimi Kimura 2), Satoshi Onishi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2012.

---

	Action to the improvement of the preparation duties that intended P2-327 medical care security Makoto Seo 1), Yurika Kimura 2), Yoshiko Mori 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2012.

---

	A preparation of the P2-328 flurbiprofen enclosure vesicle and the characterization Matsumoto ゆいこ, Satoshi Uchino sincerity, 宮嵜靖則, Yoshiyuki Kagawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2012.

---

	Investigation of three MRSA pneumonia treatment with the antiMRSA medicine given P2-329 TDM Kazushige Sakano, Yasuhiro Miki, Yu Yamauchi levator, Shunsuke Nakanishi, Motomi Okumoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2012.

---

	Inspection (comparison, evaluation with antimicrobial agent TDM guidelines) of antimicrobial agent TDM duties in the P2-330 this hospital Toshiya Takemura 1), 下雅意彩 1), Kimi Ikuta 1), Kyoko Okuno 1), Hirose wealth period 2), Kitsunezuka good tree 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2012.

---

	Examination about the increase in quantity method using the proportion calculation of vancomycin for P2-331 children Junichi Suwa, Haruka Sasaki, Risa Aoki, Miyako Sekizuka Yoshiko, It is still understood Kudo, Makiko Yoshida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2012.

---

	Blood level of the linezolid may not increase in the patients with P2-332 altitude obesity 辻泰弘1), 平木洋一2), 松元加奈3), 溝口晶子4), 佐道紳一4), 森田邦彦3), 湯川栄二5), 神村英利6), 加留部善晴6), 藤秀人1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2012.

---

Examination of the vancomycin administration regimen for the P2-333 continuous hemodialysis embodiment Takashi Ueda 1), Yoshio Takesue 1), Kazuhiko Nakajima 1), Kaoru Ichiki 1), Miyuki Komatsu 1), Yasushi Wada direct 1), Toshie Tsuchida 1), Yoshiko Takahashi 2), Mika Ishihara 2), Takeshi Kimura 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2012.

---

	Methotrexate serum concentration by P2-334 Dimension and clinical evaluation Teiko Toyoguchi, Takeshi Kobayashi, Noboru Konno, Toshihiro Shida, 丘龍祥, Kato Yuta, Kanako Takano, Aya Tominaga, Shinseki Masahiro, Tadashi Shiraishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2012.

---

	Examination of a trough level and the clinical response in the P2-335 teicoplanin initial administration plan Takayuki Seko 1), Yanase non-season 1), 山田一聡 1), 村井邦充 1), Mai Shirakawa 1), Minako Yasuda 1), Hiroshi Hotta 1), Yoshihiro Ito 1), Michiyo Okada 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2012.

---

Pharmacokinetics of the vancomycin hydrochloride in cytopenia period of the P2-336 hematopoietic stem cell transplantation Eiji Fukada 1), Small Ido Keiichi 1), Daisuke Watanabe 1), Yoshimasa Saito 1), 冲中敬二 2) 3), 牧野好倫 1), Nobuaki Yokote 1), Takuya Yamashita 2), Takahiro Fukuda 2), Hiroshi Yamamoto 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2012.

---

	Development of the teicoplanin simple administration method using the P2-337 Monte Carlo simulation Takaaki Yamada 1), Takahisa Yano 1), Yudai Kawajiri 1), Toshio Kubota 1) 2), Nobuaki Egashira 1), Toshiharu Nonaka 3), Ryozo Oishi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2012.

---

Result analysis - second report - of Vancomycin Therapeutic Drug Monitoring by the pharmacist in the gate Hospital of the P2-338 tiger Yoshiji Kei ear village 1), Tadaaki Ito 1), Yuichi Kumaki 1), Masahiro Igarashi 1), Hiromi Tamura 1), Shinobu Hasebe 1), 木村宗芳 2), Wild Hideki Oka 2), Akiko Yoneyama 2), Masahiro Hayashi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-435, 2012.

---

	Intervention of the pharmacist for the P2-339 TDM enforcement reinforcement Masako Ieda, Morihiro Nomura, Yodoshi Masahiro, Hajime Asano, 角野雄亮, Takeshi Ito, Zhongcheng Misako, Sowa Tomoko, Yuzuru Yamazoe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2012.

---

	Utility of the patients pool specimen in the blood P2-340 tacrolimus levels measurement accuracy management Takahisa Yano 1), Takaaki Yamada 1), Yudai Kawajiri 1), Nobuaki Egashira 1), Toshiharu Nonaka 2), Ryozo Oishi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2012.

---

	Effect on valproic acid serum concentration with P2-341 cyclosporin A 守作美咲 1), Junko Ishizaki 1) 2), East summer evening 1), Shiho Kawabe 1), Kan Yukio 1) 2), Arai country three 1) 2), 崔吉道 1) 3), Kenichi Miyamoto 1) 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2012.

---

A stomach discharge function evaluation and blood L-DOPA levels evaluation (the second report) of patients with Parkinson's disease using the P2-342 13C breath test Member of Satoshi Doi 1), 1, Seiwa, Hirai), Masaka Wataru 1), Kuzuu Ami 2), Yumi Tsuruoka 2), Mitsutoshi Sato 2), Ishii Toshihiro 2), Takatsugu Sakakibara 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2012.

---

	A construction of the TDM modi operandi in consideration of the duties burden on P2-343 nurse and the evaluation 霍間尚樹 1), 細川浩輝 2), Hiroshi Nakamura 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2012.

---

	Comparison of the vancomycin TDM prediction precision of the P2-344 perioperative patients and the non-perioperative patients Chiharu Murakami, Mariko Takayama, 茂木孝裕, Ayumu Nozaki, Yuka Kobayashi, Toshiko Aramiya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2012.

---

	For P2-345 neonates Staphylococcal scalded skin syndrome (SSSS), it is one patient using vancomycin hydrochloride Tatsuo Kai, Manami Kurita, Shun Iwamatsu period Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2012.

---

	It is efficacy and a safe evaluation 1 case receiving the sunitinib to P2-346 patient on dialysis Tetsushi Noda 1), Shigeru Kubota 2, Kotobuki), Current Teruhiko 2), Tetsuya Yoshida 2), 影山進 2), Kei Okamoto straight 2), Yusaku Okada 2), Shinya Morita 1), 寺田智祐 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2012.

---

Pharmacokinetic examination at the itraconazole internal use liquid administration to patients with P2-347 hematopoietic stem cell transplantation and acute leukemia Mariko Sugita 1), Hiroshi Okumura sum 2), Kana Matsumoto 3), Kunihiko Morita 3), Liquor mouth Hiromitsu 1), Takashi Yoshida 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2012.

---

	One patient who experienced acute tubulointerstitial nephritis by the vancomycin hydrochloride and thrombocytopenia by the linezolid during P2-348 purulent spondylitis treatment 黄前尚樹, 堀家有美子, 勝部智子, 藤田葵, 平田和也, 松本直之, 鈴鹿修平, 多胡和樹, 中村美樹, 大津山裕美子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2012.

---

	TDM duties of the Arbekacin in the P2-349 this hospital Sato Kei sinter 1), Bank former Maki 1), Kusakabe young of sweetfish 1), Akeda Katsuyuki 2), Yoshinobu 3 in the willow), Kazuki Kikuchi 1), Toshiji Oe 4), Eri Ezoe 3), Many islands Takahiro 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2012.

---

	Examination of the factor affecting the initial trough level of vancomycin in patients with P2-350 MRSA pneumonia Akira Ogawa straight 1), Forest eight Keiko 1), Naohiko Fuchigami 1), Masanori Endo 1), House Masaru Den 1), Masayuki Tsujimoto 2), 西口工司 2), Toshiaki Ono 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2012.

---

	Inspection of P2-351 VCM and the TEIC nomogram Kuniaki Sano, Takashi Okuda, Shin Suzuki will, Tomio Matsumoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2012.

---

	Blood level prediction precision of vancomycin using P2-352 TDM analysis software EasyTDM(R) 山口佳津騎 1), Mari Kawano 1), Hiromi Ichinose 1), Sumio Kimura 1), Naoki Shinohara 1), Takeshi Abe reason 2), Toshi Takeuchi oneself 3), Shinji Kosaka 1), 福岡憲泰 1), 芳地一 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2012.

---

	About the TDM rate of use of the antiMRSA medicine by the P2-353 operational change Middle Yuka Kihara, 野間口寛, Reiko Kirino, Tomohiro Kakimoto, Takeshi Takahashi, Toyosumi Ayako, West Kyoko Tsuji, New top Kanako, Hiramatsu sheath, Morihiko Terashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2012.

---

	Investigation about patients background at the P2-354 vancomycin administration and the TDM enforcement Origin of Harada, Shigeharu Oie, Hiroyuki Furukawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2012.

---

	PK/PD analysis about the antiplatelet action of the P2-355 nonsteroidal antiinflammatory drug Midori Arai 1), Hitoshi Shimomura 1), Shuji Shimada 1), Your Yu Akagi 2), Yasushi Yamamoto Jiro 3), Takao Aoyama 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2012.

---

	Active intervention of the pharmacist in the P2-356 TDM enforcement drug Nobue Yoshinari, Masayo Tanaka, Tetsuya Kudo, Hitomi Aruga, Ota あや incense, Takao Orii Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2012.

---

	P2-357 Study of biliary excretion behavior of tazobactam-piperacillin hydrate and aspoxicillin 内村綾菜, 小田雅子, 青木志織, 伊藤舞, 寺嶋望, 百瀬祥人, 市村祐一, 齊藤浩司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2012.

---

	Analysis of TDM of Vancomycin in the P2-358 this hospital and the associated renal failure development situation Masashi Katagiri, Kayo Noguchi, 篠永浩, Tsutomu Kachi, Eiji Mukai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2012.

---

	Examination of the initial loading dose of vancomycin aiming at P2-359 high trough value Kazutaka Oda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2012.

---

	Evaluation of urinary excretion dynamics of the fentanyl in the P2-360 postoperative patient and the metabolite Noriaki Tanaka 1), Takafumi Naito 1), Yagi Tatsuya 1), Kimiyoshi Hirano 1), Matsuyuki Doi 2), Shigehito Sato 3), Junichi Kawakami 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2012.

---

	Examination for the practical use of the TDM by the P2-361 very small amount blood collection method Jun Nakano is rare, Kaori Fujimaki, Akiko Yasunaga, Nobuo Mochizuki, Kunihiro Matsumoto, Keiko Ono, Satoshi Kishino Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2012.

---

	Urinary indomethacin densitometry in the use patients of the P2-362 indomethacin mist preparation 100 Kenji, Masato Honma, Tree Yoshiyuki Sawa, Long Okahiro incense, Yasuyuki Kanbayashi, 幸田幸直 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2012.

---

	About a teicoplanin loading dose and a trough value in the P2-363 Toho University medical center Sakura Hospital Kazuaki Sugio, Kazuki Fukawa, Ikuno Watanabe, Hideki Kobayashi, Masaka Wataru Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2012.

---

	The effect that the high fat diet intake of the P2-364 gestation period gives for the expression of each Cytochrome P450 molecular specie of the pup 田島正教1)2), 岡庭健洋1), 今堀由賀里1), 猿田かな子1), 今理紗子1), 楠欣己1), 戸田雄大1), 石井敬1), 五十嵐信智1), 落合和1), 山田治美2), 杉山清1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2012.

---

	The serum creatinine level is ... about the factor that became clear from examination - laboratory study data of the case that rose after the vancomycin hydrochloride administration for the P2-365 injection Daisuke Negishi, Suguru Kimura daylight, Naoko Kawajiri Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2012.

---

It is examined the dialysis extraction ratio of 2 cases receiving arbekacin aulfate and the administration design by P2-366 hemodialysis patient Kiyomi Ueyama 1), Naomi Iwasaki 2), Etsuko Nishio 1), Kuto chapter wide 1), Hiroyuki Morishima 3), Morihiro Nomura 2), Tetsuya Morita 2), Rui Tamura 4), Naohiko Moriguchi 5), Yuzuru Yamazoe 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2012.

---

	Examination of the injection method of the teicoplanin in the P2-367 hemodialysis patient Mariko Kobayashi, 樋山芙裕子, Kana Matsuzaki, Harumi Sudo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2012.

---

Participation in planning to the treatment of the pharmacist mainly on the blood cyclosporine levels monitoring in the P2-368 hematopoietic stem cell transplantation Tomonori Hayashi 1), Aiko Fukui 1), People long A 1), Masaru Matsumoto Kyoko 1), Saori Nishiura 1), Yutaka Matsuoka 1), Keigo Sano 2), Fujita jasmin child 2), Takashi Iizuka 2), Yoshiko Yamazaki 2), Jin Hanamoto 2), Yagi Hideo 2), 椿和央 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2012.

---

	The effect that P2-369 cerebrospinal fluid drainage gives to a pharmacokinetic parameter of vancomycin 市江敏和 1) 2) 3), Kimihiko Urano 2), Daisuke Suzuki 1), Yoji Sugiura 1), Takeshi Okada 4), Nozomu Kobayashi 4), Takashi Katano University 2), Tadashi Sugiyama 3), Keiko Yamamura 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2012.

---

	Elution behavior control of the enteric beclomethasone capsule for the purpose of the P2-370 graft host disease (GVHD) treatment Satsuka Yasuyuki 1), Ikumi Sugiyama 1), Junya Sato 2), Kenzo Kudo 1) 2), Katsuo Takahashi 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2012.

---

	Effect of the anoxia exposure to give to the oxidation, conjugation metabolism to P2-371 carvedilol The Tadashi Taguchi up, Miki Fukao, Shizuka Yamaura, Kazuya Ishida, Seiya Hashimoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2012.

---

	Evaluation of the Warfarin administration nomogram for the deep vein thrombosis after P2-372 cosmetic surgery procedures Horiuchi wish, 茂木孝裕, Ayumu Nozaki, Yuka Kobayashi, Toshiko Aramiya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2012.

---

	Basic examination of the L-cysteine which has an influence on the free form level of P2-373 cisplatin Ryu Sugimoto star 1), Jin Tokunaga 1), Ai Okazaki 1), Tokuko Matsuo 1), Kenji Ogata 1), Nao Setoguchi 1), Toyotaka Nishio 2), Takamura rich person 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2012.

---

	Effect of the inhibitor under the long time coexistence on uptake to colorectal cancer cells of the DNA methylation inhibitor through the P2-374 nucleic acid transporter Kumiko Ueda, Kanae Fujitani, Mika Ikehata, Seigo Iwakawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2012.

---

	Examination of the vancomycin trough value in patients with P2-375 cancer Akinori Mori, Tomomi Fujii, Masaki Sato, 坂部米治, Motoaki Ishikawa, Takahiro Ishida, Masumi Nakagami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2012.

---

About renal function estimation type (eGFR) and patients background to influence blood level prediction precision of P2-376 vancomycin Emi Tanaka 1), Akihiro Kai 1), Kuroki Noriaki 1), Yasuyuki Koorogi 1), Eri Ogawa 1), Sho Iwase branch 1), Kenji Ogata 2), Nao Setoguchi 2), Takamura rich person 2), Chiyo Susumu Tanda 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2012.

---

	The analysis of the digoxin pharmacokinetics parameter in the Japanese of the P2-377 majority and examination of the initial administration nomogram Kyoko Fukumoto 1), Soil lower Yoshimasa 2), Yasuo Fujimura 2), Naruyuki Kojima 3), Kazuyuki Ueno 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2012.

---

	Development of blood level guess support application "tinyPK" for the P2-378 mobile terminal Yasuyuki Koorogi 1), Kenji Ogata 2), Akihiro Kai 1), Kuroki Noriaki 1), Eri Ogawa 1), Emi Tanaka 1), Sho Iwase branch 1), Jin Tokunaga 2), Takamura rich person 2), Chiyo Susumu Tanda 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2012.

---

Contribution - to utility - serious liver damage evasion and treatment continuation of the TDM for fungal infection treatment with P2-379 voriconazole Carefully pine Kazuko 1), Kazuaki Matsumoto 1), 茂見茜里 1), Naoko Kanazawa 1), Eri Watanabe incense 1), Yuta Yokoyama 1), 猪川和朗 2), Norifumi Morikawa 2), Yasuo Takeda 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2012.

---

	Action of the TDM duties induction promotion in the cottage-hospital in P2-380 Kanagawa Toishima study 1) 2), Yukiko Nakamura 3), Yuko Komura 3), Jun Inoue Expo 3), Koji Fujimoto 3), Hajime Kagaya 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2012.

---

	Comparison of the teicoplanin surface coverage due to the ultrafilter of the P2-381 persistent hemocatharsis method Toshiyuki Irie 1), 道越淳一 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2012.

---

Examination of the simultaneous assay of the plasma concentration of sildenafil, bosentan, tadalafil in the P2-382 pulmonary artery-related patient with pulmonary arterial hypertension and ambrisentan 田中紫茉子 1), Shinya Uchida 1), Yukiko Miyakawa 2), Naoteru Inui 2), Kazuhiko Takeuchi 2), Yuji Watanabe 2), Tokuyuki Namiki 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2012.

---

	To use the information of the P2-383 renal excretion contribution ratio for the administration plan of patients with renal failure effectively Maiko Yamada 1), Yoshiyuki Ono 1), Gutter slope Akihiro 2), Hiroshi Suzuki 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2012.

---

	P2-384 About blood drug concentration analysis of molecular targeted therapy (Imatinib, Nilotinib, Dasatinib) in chronic myeloid leukemia (CML) patients 中原良介, 津田浩和, 緒方正男, 伊東弘樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2012.

---

	Association ... with clinical response of tazobactam/piperacillin in patients with P2-385 medical care, care-related pneumonia and side effect - pharmacokinetics Nobuhiro Nishimura 1), Fumi Kano 1), Noriyuki Ishihara 1), 猪川和朗 2), Takeshi Isobe 3), Norifumi Morikawa 2), 直良浩司 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2012.

---

	Examination of the 14C-oxaliplatin serum concentration assay using P2-386 accelerator mass spectrometry (AMS) Takeshi Kobayashi 1), Teiko Toyoguchi 1), Kazuhiro Kato 2), Hilum Kano Fuyuki 2), Tadashi Shiraishi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2012.

---

	TDM of the new antiMRSA medicine daptomycin by the P2-387 gradient HPLC-UV analytical procedure 安井友佳子1), 山本圭城1), 八野芳巳1), 藤本卓司2), 今村博司3), 安井裕之4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2012.

---

	Establishment of the quick assay of P2-388 human plasma and urinary daptomycin levels 山田尚広, 内藤隆文, 八木達也, 石田卓矢, 川上純一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2012.

---

	Examination of the factor affecting the pharmacokinetics of P2-389 clobazam and N-desmethyl clobazam Yoshiaki Yamamoto 1) 2), Hiroshi Miyakawa 1), Yukitoshi Takahashi 1), Katsumi Imai 1), Kazumi Matsuda 1), Yushi Inoue 1), Yoshiyuki Kagawa 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2012.

---

	Effect of the UGT1A1 genetic polymorphism heterozygote which gives it to P2-390 irinotecan doses adjustment Naoya Ishibashi, Masahide Onoe, Tadehara Masami, Yuka Kageyama, Makoto Terao, Satoshi Masuda point, Ikemi Yasuaki, Kazuo Matsubara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2012.

---

	Development of the simple quick genetic polymorphism diagnostic method of the P2-391 humans IgG type Fcγ receptor 渋谷彩1), 松本准2), 有吉範高1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2012.

---

	Effect of the CYP3A5 genetic polymorphism which gives it to the bioavailability of the P2-392 tacrolimus once a day oral administration preparation 加賀谷英彰 1), 三浦昌朋 1), New Takenori Oka 1), Mitsuru Saito 2), Kazuyuki Numakura 2), Tomonori Habuchi 2), Shigeru Sato 2) 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2012.

---

	Individual difference of the methotrexate-related genetic expression level in P2-393 human peripheral-blood mononuclear cells Kanako Takashima, Naotaka Tsumura, Satoshi Muto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2012.

---

	Comparison between P2-394 monocytes and expression level of the methotrexate-related drug transporter in lymphocytes Katsuto Mochizuki, We congratulate Hachiya reason, 堀口瑛司, Satoshi Muto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2012.

---

	Comparison of the effect of treatment with hydroquinone and the kojic acid to P2-395 chloasma Akiko Kume 1), Hitomi Kato 2), Seiko Soeda 3), Fuminori Shibuya 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2012.

---

	Meta-analysis about cancer inhibition by the P2-396 NSAIDs remedy and the effect of the COX genetic polymorphism 長尾麻以, Yoichi Sato, Aiko Yamauchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2012.

---

	Dose change, side effect expression of irinotecan situation investigation - second report ... in the P2-397 UGT1A1 genetic polymorphism analysis patients Keinosuke Okazaki 1) 2), Ayumu Kawashima 1) 2), Kosuke Suzuki 1) 2), Toru Watanabe 1), Junichiro Murayama 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2012.

---

	Efficacy of the Xa inhibitor to use for prevention of P2-398 venous thromboembolism and safe examination 出石恭久 1), 中村孝佑 1), Hitoshi Taniguchi 1), Kuwata gain rare 1), Takuma honest 1), Tadashi Shiota 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2012.

---

	Coefficient of viscosity change by the water addition of the P2-399 half solidification nutrient preparation 秦毅司, Ancient ceremony Tomomi, Yuriko Nimura, Nakayama first arrow child, Masayo Hashizume, 川合甲祐, Hitoshi Kakumu, Nakano truth line Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2012.

---

	Action of the preoperative oral rehydration therapy in the P2-400 this hospital orthopedics ward Kanako Miyake 1), Noriko Matsui 1), Mukai light Ichiro 1), 櫻間啓基 1), Kazutaka Sakamoto 1), Teruyo Ikegami 2), Mizue Oga 2), Toshiko Mizumoto 2), Kazuko Murakami 1), Koichi Matsuo 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2012.

---

	Action of the hyperalimentation preparation mixed injection in the P2-401 pharmacy Junko Sugawara 1), Tomoko Komatsu 1), Miho Horie 1), Reiko Yasuda 1), Hideki Koyama 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2012.

---

	About a test value change with the P2-402 lipid microsphere Naoko Katayama 1), Tomozawa Akinori 2), Yellow former Naoki 3), Country relation Kayoko 2), Akiko Kuwahara 4), Mountain Hiroshi Morimoto 4), Kadoyama Kaori 5), Makoto Miura 1), Sakaeda Toshiyuki 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2012.

---

About the use situation of the lipid microsphere judging from an inquiry sent to the P2-403 transfusion DI center Ryo Iwahara fine weather, Yu Takebayashi flower, Noriko Suganuma, Yoshioka small Satoko, Star spring, Sayuri Watanabe, 淺賀慎一, Mayumi Fukuda, Hironori Kawano, Taro Matsuno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2012.

---

	The future role that activity contents and a pharmacist of NST in the hospital attached to the P2-404 Saga University School of Medicine should achieve Akihiro Hayashi 1), Mayumi 2 between the fronts), Toshihiko Mizuta 3), Atsushi Miyoshi 4), Fujito Expo 1), Koji Miyazaki 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2012.

---

	Examination of the intervention results of the pharmacist of the P2-405 NST addition first year Absence Katsuyuki 1), Arata Nakamura 1), Naoki Soma 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2012.

---

About the association of nutritional evaluation and the infection for infants with P2-406 intestinal tract deficiency (in Hirschsprung affinity disease) Kyoko Fujieda 1), Large stick male size 1), Sakiko Kurokawa 1), Takashi Uno 1), Nobuo Suzuki 1), Tomoko Takeda 2), Taichi Fukuzawa 3), Takafumi Endo 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2012.

---

	Relation of the present conditions, a problem and the pharmacist of the P2-407 NST activity Takako Chino Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2012.

---

	Change of the nutrition index with the Infliximab high dose (10 mg/kg) administration at the P2-408 Crohn's disease relapse exacerbation Yuji Ogawa, Atsushi Urano, 小野田稔久, Midori Ito, Kiyoshi Sakuma, Hideki Kobayashi, Masaka Wataru Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2012.

---

	Effect of the turnover rate to give it to elution behavior of the gliclazide which mixed with half solidification water to use for P2-409 enteral feeding therapy 巖西真, 名徳倫明, Akaho, Nagano, The Matsuyama up, 浦嶋庸子, 廣谷芳彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2012.

---

	Effect of the coefficient of viscosity to give it to elution behavior of the gliclazide which mixed with half solidification water to use for P2-410 enteral feeding therapy Akaho, Nagano, 名徳倫明, 巖西真, The Matsuyama up, 浦嶋庸子, 廣谷芳彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2012.

---

	Examination about selenium in the intravenous hyperalimentation patients for a long term at-home P2-411 烏望枝奈 1), 松尾和廣 1), Kozono Kouki 2) 3), 佐々木英久 1), Tomoko Watanabe 1), Etsuko Shinohara 1), Takayoshi Kosugi 2), Kenji Nishizawa 2), Eagle Takahiro Sawa 3), Takashi Yoshio 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2012.

---

	Examination of the nutritional management in the postprandial hyperglycemia patients after the P2-412 gastrectomy Yutaka Inoue 1), Risa Takahashi 1), Akihiro Uchida 2), Strong arrow Kazuko 3), Isamu Murata 1), Ikuo Kanemoto 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2012.

---

	The relation of the pharmacist in NST of the P2-413 this hospital and future problem Keisuke Ito, Junichi Otsuka, Hiroyuki Kageyama, Katsumata Harumi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2012.

---

	Examination about the safety in the P2-414 glutamine bolus dose 1, Kishi, Matsuzaki) 2), Shunya Ishii 2) 3), 澤藤園子 1) 2), Shinichiro Suzuki 1), Hidetomo Yasujima 1), Misako Mori 2) 4), Kawahata sub-K 2) 4), Shibata rises 2) 5), Aya Onoe 2) 5), Akio Saito 1), Hiroshi Nakano 2) 6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2012.

---

	The present conditions and problem of P2-415 acute phase hospital NST Tomoko Yamano, It is Sachiko in a camp, Eiko Fukunaga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2012.

---

	Prescription suggestion of berizym combination granules in NST for patients with P2-416 intractable diarrhea Nobuyuki Wakii, Shunichi Utsumi, Mitsui Miyuki, Yuichi Yano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2012.

---

	Enforcement of the appropriate nutritional management for patients with chronic renal failure by the P2-417 NST intervention Shunichi Utsumi, Nobuyuki Wakii, Mitsui Miyuki, Yuichi Yano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-448, 2012.

---

	We found from a screening sheet of each medical care team in the P2-418 City Kawanishi Hospital; and about the association with the team Hosomi Kengo 1), 久井裕美子 1), Hiroki Sugita 1), Sachiko Komaki 1), Norio Masumoto 1), Takako Yuko 1), 大槻裕朗 1), Yoshihisa Takao 2), Shuichi Nozaki 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-448, 2012.

---

	Blood level prediction of vancomycin for the P2-419 CKD patients Yukari Haneda 1), Yuichi Kikuchi 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-448, 2012.

---

Support - to action - Aichi regional medicine reproduction research business of the pressure sore training workshop for P2-420 pharmacists Kotaro Iida 1) 2), Masako Mizuno 2), Yasuhiro Noda 2), Old Masaru Den trans2), Yoshihiro Kondo 2), Minoru Nagata 2), Yoshihiro Kawade 2), Taku Morikawa 2), Yoko Nohara 2), Akihiro Aoyama 2), Keiko Yamaguchi 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-448, 2012.

---

	Examination of the alternate-day administration of the China Cal Seto hydrochloride for the P2-421 second-related hyperparathyroidism Height of island Ichiro 1), Hiroyuki Nagasawa 1), Taku Tokuda 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-448, 2012.

---

	Mention of the most recent renal function to a medicine notebook that we use P2-422 Microsoft Excel Tetsuya Ito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-448, 2012.

---

	Relation of the pharmacist for the P2-423 outpatient department patient on dialysis Lower stone Kazuki 1), Ueki Soichi Hara 2), Eiko Fukunaga 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 449-449, 2012.

---

	Change examination from P2-424 hyperkalemia improvement agent Ca-resin to Na-resin Shintaro Mochizuki 1), Satoshi Suda 1), Akari Tanikawa 1), Yukiko Kaieda 1), Ueda bare reason 1), Takeshi Murai 1), Yoshiko Onuki 1), Kaori Ashizawa 2), Koichi Uchida 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 449-449, 2012.

---

	Examination of the change of gender-related eGFR in the P2-425 ethical pharmacy Mitsuru Suzuki 1), Takahiro Maeda 1), Miho Wada 2), Shiro Araki 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 449-449, 2012.

---

	Examination about P2-426 silver colloid and the new vulnerary covering material using the xyloglucan Kaori Hirose 1) 2), 笹津備尚 2), Nao Nakamura 3), 中南秀将 3), Yusuke Sekine 4), Yayoi Kawano 2) 5), 野口雅久 3), Kiyoshi Okuyama 1), Satoshi Onishi 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 449-449, 2012.

---

It is satisfaction investigation ... using ... customer satisfaction analysis (CS analysis) about an evaluation of the simple suspension method induction in the P2-427 this hospital Kenji Doi 1), Yuki Oogi 1), Hideyuki Yoshizaki 2), Kazumi Matsumoto 2), Kenji Araki 2), Sumie Uchino 2), Hitoshi Harada 1), Kazutaka Matsumoto 3), 松本純隆 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 449-449, 2012.

---

	Prescription examination of the preparation for severe wound treatment using the P2-428 xyloglucan Kenichi Tomikawa 1), 笹津備尚 1), Kaori Hirose 1) 2), Yayoi Kawano 1) 3), Yusuke Sekine 4), 林太祐 5), Yoshiaki Ogita 6), Shunji Horikawa 7), Satoshi Onishi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 449-449, 2012.

---

	Use situation investigation of the febuxostat for patients with P2-429 severeness impaired renal function 森山亜矢子, 羽生智弘, 仲島優一郎, 沖田健太郎, 尾形美絵, 田村和彦, 新関みどり, 近藤和宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2012.

---

	Relation of the pharmacist to P2-430 CKD-MBD 福井圭亮, Hiroya Masuda, 阪井田哲, Yuko Sakaguchi, We are constipated and congratulate three temples, Takashi Suzuka daylight Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2012.

---

	Comparison of the renal function rating system in P2-431 renal-transplant recipients Kentaro Ueda, Kazufumi Iwata, 合澤啓二, It is Sachiko in a camp, Eiko Fukunaga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2012.

---

	Relation of the pharmacist in pressure sore treatment of the P2-432 this hospital Rie Shoji 1), Masumi Saito 2), Muneo Tanida 3), Long Akira Shima 1), Koji Ito 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2012.

---

	Blood pressure evaluation of patients with chronic kidney disease in P2-433 consulting room and the health insurance pharmacy Ono prospers 1), Hiroshi Izumi world 1 Kim), Yumiko Sakurai 1), Kayoko Yamamoto 1), Takahiko Ono 2), Islet spring period 3), Koshin Ishikawa 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2012.

---

	Action of the pharmacist to the medical supplies proper use that assumed P2-434 renal function an index Mina Ushiyama 1), Akie Shigenaga 1), Takashi Furuta 1), 下堂薗権洋 1), Ryuji Ikeda 1) 2), Yasuo Takeda 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2012.

---

Importance of the prescription suggestion about the phosphate binder in the early stage of the hospitalization of the P2-435 patient on dialysis Takayuki Okada 1) 2), Buddhism Junko 1), Michiko Kamo 1), Yoshio Takagi 1), Aze well Koichi 1), Nakamoto celebration of longevity husband 2), Shinichi Harada 2), Tokuyama still I 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2012.

---

	Comparison of the microalbuminuria by the immunoassay in P2-436 patients who received renal transplant from living donors and the gel filtration chromatography Nobuhiro Fujiyama 1), Katsuya Sasaki 1), Shotaro Kato 1), 三浦昌朋 1), Shigeru Sato 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2012.

---

	About an intervention investigation of the serum Mg level in the long-term use patients of P2-437 magnesium oxide Takako Notomi, Seiko Shimada, Noriko Takeda, 濱邊秋芳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2012.

---

	Efficiency of pressure sore treatment by the visualization of P2-438 DESIGN-R Takashi Furuno will 1), 小林賢滋 1), Yagita Mikako 1), Spring Mayuko 1), Kaori Hayakawa 2), Yutaka Okino 2), Hiroshi Okuyama 3), Shinko Endo 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2012.

---

	Prescription suggestion enforcement situation investigation of the pharmacist in the P2-439 psychopathic ward 進健司, Yuichi Umeda, Side former Kazuaki, Tatsuro Otani, Mamoru Uchida next, Shinsuke Takemoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2012.

---

	Effect of the education for patients which gives it to the medication adherence in the ward for P2-440 psychiatry acute phase 福山雄卯介 1), Hirotaka Suzuta 1), Fujita good memory 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2012.

---

About the effect that the informed consent using the P2-441 explanation document gives to satisfaction of the antipsychotics in bipolar patients and a medication manner Hideki Ito 1), Hiroyuki Kamei 1) 2), Ono sand lily 1), 半谷眞七子 1), Ippei Takeuchi 1) 3), Junji Uno 3), Masaya Masuda 4), Takahiro Hayashi 4), Shigeru Yamada tree 4), Iwata relation straight 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2012.

---

Examination from the prescribed drug investigation of P2-442 depression and the depressive state patients Takayuki Kobayashi 1) 2), Masahiko Shida 2) 3), Yosuke Ohashi 2) 4), Katsusane Tsurutani 2) 5), Mitsuru Takahashi village 2) 6), Willow Tomoyuki 2) 7), Isurugi Ikuko 2) 8), Ryoji Matsubara 9) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2012.

---

	Use of P2-443 lamotrigine situation investigation Yukihiro Kaneko, Hiroyuki Isobe, Aya Kamegawa, History of best male Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2012.

---

	The effect that simultaneous smoking cessation by the smoking cessation in the P2-444 site gives to schizophrenia inpatients Yuko Abe 1), Kenzo Miyazaki 1), Koba Sani beauty 1), Asako Endo 1), Nobuko Hiraki 1), Shinya Kawauchi 2), 趙岳人 1), Koichi Oda 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2012.

---

	The prescription fact-finding of the antidepressants in the P2-445 newcomer patients and consecutive examination Masako Wada, Mamoru Tanaka, Akio Okai, Hiroshi Araki positive Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2012.

---

	Use investigation of a sleeping drug, the anxiolytics in P2-446 antidepressants Kazuhiko Gomi 1), Takako Takemura 1), 羽場昇 1), Masakazu Maezawa 1), Toigake Tadahiko 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2012.

---

	The management of the medicine for patients with P2-447 Alzheimer disease (AD) therapeutic drug remedy and an investigation and case introduction of the side effect expression situation Satoko Ogawa, Naoto Niwa, Asami Takasawa, Mari Miura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 453-453, 2012.

---

	Action of the pharmacist in the P2-448 delirium prophylaxis team Satoko Aizawa 1), Yoko Okada 1), Atsushi Adachi 1), Shinge Keiko 1), Kuridani Yoshitaka 1), Kazusane Okubo 2), Great Seiyu Yuko 3), Tokuyama window or 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 453-453, 2012.

---

	About the activity of the pharmacist in P2-449 stress care ward "ward program" Original well Junko, Okada view enthusiast, Toshifumi Kido Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 453-453, 2012.

---

	A comparison and examination before and after the P2-450 psychiatry clinical path enforcement Mitsuru Takahashi village 1), Tooru Mori 1), Yoshiko Ishizuka 1), Hidekazu Yahagi 2), Sect charges next 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 453-453, 2012.

---

Mainly on the suit for investigation - sexual function about the side effect using the check sheet for the P2-451 ambulant follow period schizophrenia patient - Tomomi Seta 1), Junko Kishimoto 1), Koshu Yasuhiro 1), Nozomi Shinohara child 1), Yusuke Nakamura 1), 1, Asuka, Kaneko), Masayuki Osako 2), 大野基恵 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 453-453, 2012.

---

	Risk analysis of the patients associated with fall, the fall in the P2-452 psychopathic ward Kaori Nakai 1), Sae Sasaki beauty 1), Flat Hiromi 1), Hajime Nakai 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 453-453, 2012.

---

	Relation of the pharmacist in the P2-453 psychiatric day care Keiko Hara, Akira Ichikawa, Ikuo Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 454-454, 2012.

---

	P2-454 Medicinal properties of methylphenidate hydrochloride extended-release tablets to pervasive developmental disorder accompanied by AD / HD symptoms 浜田茂明1), 森本真仁1), 島川清司2), 橋本俊顕2), 波多江崇3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 454-454, 2012.

---

	As compared with the prescription investigation of prescription situation - clinical psychiatry pharmacy meeting for the study of the antipsychotics in the inpatient with P2-455 schizophrenia ... Go Kato, Makoto Suda, Masayuki Inaba Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 454-454, 2012.

---

	Intervention ... from the P2-456 psychiatry region to fall, the fall with medical safety management - benzodiazepine drugs by the ward pharmacist whom we looked after Shintaro Takahashi 1), 上島聖秀 1), 濱元孝 1), Yoshiyuki Komori 2), 久保雅寛 3), Ryo Kawai intellect 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 454-454, 2012.

---

	Phosphorus revision and whole body control in the re-supplementation therapy of patients with P2-457 anorexia nervosa 杉沢諭 1), Ishikawa mere beauty 2), Yagi Satoshi 1), 平藤彰 1), Ishiyama evening Kei 2), 東一成 3), Aoki hemp pear 3), Minoru Sakata 2), Isao Saito 1), Junichiro Murayama 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 454-454, 2012.

---

An example (case report) that showed aggressiveness to antiwine by P2-458 material coexistence characteristics disorder therapy program Isao Saito 1), Toshiaki Tsuneoka 2), Tomohiro Ikeda 3), Rie Ishizaka 4), Noriko Takagi 4), Junko Inamoto 2), Nobumasa Kato 2), Junichiro Murayama 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 454-454, 2012.

---

	Successive prescription investigation actual situation - first report ... for the bipolar disorder in P2-459 Hiroshima Chie Bessho 1) 2), Masashi Shintaku 2) 3), Yumiko Ishii 4), Yoko Hashimoto 2) 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-455, 2012.

---

	Use of lamotrigine in the P2-460 bipolar disorder and fact-finding of the onset of skin reaction and the action West Yugo 1), 吉邨善孝 2), Hiroshi Sugano 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-455, 2012.

---

	Successive prescription investigation actual situation - tertiary report ... for the bipolar disorder in P2-461 Hiroshima Yumiko Ishii 1), Chie Bessho 2), Masashi Shintaku 3), Yoko Hashimoto 4) 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-455, 2012.

---

	The evaluation of P2-462 psychopathic ward pharmacist duties and future problem Long volost Chikako, Yoichi Shinozaki, Junichiro Kato, Masaki Kitamura, Takashi Kawakubo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-455, 2012.

---

	Inspection about efficacy and the side effect for the behavioral disorder of children and adolescents of the P2-463 aripiprazole Rikiya Sato 1), Natsuko Ishida 1), 多田淑央 2), Kazumasa Murakami 1), Ichiro Ono 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-455, 2012.

---

	Adequacy of the P2-464 antipsychotics Fujita good memory 1), Hirotaka Suzuta 2), 福山雄卯介 2), 三角紳博 1), Toshihiro Matsumoto 1), Takashi Nishino 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-455, 2012.

---

	Relation of the pharmacist to the psychology education for the P2-465 alcohol addict Junichi Miyaura 1), Okusa English sentence 2), Masahide Okuda 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 456-456, 2012.

---

	Attitude survey to other healthcare occupations about visit drug control instruction duties of the pharmacist in the P2-466 psychiatry regional medicine Hidenori Kuwahara, 水野眞俊 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 456-456, 2012.

---

	For the adherence improvement of relation - patients to team approach in medical care of the P2-467 psychiatric hospitals pharmacy - Arrow Eri, Kaori Nishida, Misaki gain charges Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 456-456, 2012.

---

	We investigate a medicine notebook after the discharge in the P2-468 psychiatry region Kozue Kurihara, Yusuke Taki, Kusaka Toyoshi, Aiko Koyanagi, Takahiro Goto, Hirokazu Yamashiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 456-456, 2012.

---

	Prescribed drug investigation for P2-469 outpatient department bipolar patients Kyoko Mori, Kazuko Yamada, Masami Takeda, Akiko Shimizu, Koto slope Sachihiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 456-456, 2012.

---

	One patient whom fibromyalgia was suspected in from chronic pain complicated with mental disease at patient compliance instruction in the P2-470 ethical pharmacy Yukiyo Yamamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 456-456, 2012.

---

	It is ... for the efficiency of trial - duties of the drug control instruction using "a drug control instruction, side effect check sheet" in P2-471 psychiatric hospitals Tomohito Wada 1), Ikuko Kimura 1), Yuka Ito 1), Hasada Yoshihiro 1), Naomi Ito 1), Kohei Fujita 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-457, 2012.

---

	Successive prescription fact-finding - second report ... for the bipolar disorder in P2-472 Hiroshima Masashi Shintaku 1) 2), Chie Bessho 2) 3), Yumiko Ishii 2) 4), Yoko Hashimoto 2) 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-457, 2012.

---

Association between immunosuppressive drug susceptibility and lipids abnormality of patients with P2-473 minimal change type nephrotic syndrome Kenichi Ikeya 1), Sachiko Tanaka 1), Kenji Onda 1), Kentaro Sugiyama 1), Sayuri Shirai 2), Satoshi Kosaka 3), Noriko Yoshikawa 4), Iwao Nakabayashi 4), Masaharu Yoshida 4), Toshihiko Hirano 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-457, 2012.

---

	Physical assessment ... in examination - heart failure acute phase case about injection choice and the drug properties for P2-474 ventricular arrhythmias Yasushi Takai 1), Tamami Yamamoto 1), Takeki Kajima 1), Masashi Kato 2), Akio Iwata 2), Hiroyuki Suzuki 2), Hideo Nishikawa 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-457, 2012.

---

	A venous thromboembolism prophylaxis effect after the orthopedics surgery using the P2-475 edoxaban (re-comb hole (R) lock) and inspection of the side effect 三枝芳1), 松本浩1), 阿部宏志1), 八田重雄1), 坂下裕子1), 増原慶壮1)2), 植原健二3), 新井賢一郎3), 松下和彦3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-457, 2012.

---

	The effectiveness of the HbA1c level drop effect in patients with type 2 diabetes with the P2-476 low dose sitagliptin administration 高場亜貴1), 山村麻里1), 八田信朗2), 立石博信3), 牛島美香4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-457, 2012.

---

	P2-477 Study of the proper use by Dabigatran etexilate methanesulfonate prescription patient survey 大串篤史1), 越前宏俊2), 並木淳郎3), 石井嘉之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 458-458, 2012.

---

	Effect of the benzodiazepine drug on patients with P2-478 blepharospasm Yakichi Kuniko, Junko Kikuchi, Tomoko Ogaki, Makiko Hamano, 荒佐夜香 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 458-458, 2012.

---

	The instillation observance and patients satisfaction at use of P2-479 glaucoma combination eye drops Makiko Hamano, Junko Kikuchi, Yakichi Kuniko, Tomoko Ogaki, 荒佐夜香 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 458-458, 2012.

---

	Evaluation about the safety of the use of terra pre-building case in the P2-480 this hospital Daisuke Maehara 1), Akiko Kuroda 1), Kumiko Honma 1), Yumiko Fukui 1), Noriko Terakawa 1), 1, Kotobuki, Fukushima 2), Yoshiaki Inui 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 458-458, 2012.

---

	A use situation investigation of the deep vein thrombosis preventive medicine in the P2-481 lower limbs orthopedic surgery and comparison of each drug Yukiko Takemori 1), 祖川倫太郎 1), Yutaka Yonekura 2), 井手衆哉 2), 中野行孝 1), Masaaki Mawatari 2), Fujito Expo 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 458-458, 2012.

---

	Pharmacist educational program for the OTC medicine triage ability development that utilized P2-482 simulation customer Yukari Yoshioka, 半谷眞七子, Mayu Sakurai, Hiroyuki Kamei, Yoko Hamada, Juri Maeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 458-458, 2012.

---

	The effectiveness of the P2-483 new oral anticoagulant drug edoxaban and safety 森崎崇文1), 星野輝彦2), 塩津和則1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2012.

---

About the relations with the CD4-positive lymphocyte counts and nutrition index after the P2-484 antiHIV therapy Shigeki Takematsu 1), Tomishima Kosuke 1), Yoriyuki Kawato 1), Katsuaki Kobayashi 1), Kiyoko Fujii 2), Tokiko Saegusa 2), Mimura party 3), Mimori Yasuyuki 3), Tomoko Katsuta 3), Yoshiro Mochizuki 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2012.

---

Investigation of the side effect of the peginterferon ribavirin terra pre-building triple-drug therapy for the P2-485 chronic hepatitis C Saito giant tree 1), Kokufu Island Nobuyuki 2), Hiroki Oishi 1), Yagawa Yuko 1), Naoko Ishikawa 1), 三角紳博 1), Takashi Nishino 1), Makoto Nakamuta 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2012.

---

	Comparison between anti-peptic ulcus agents, polaprezinc and effect that zinc chloride gives to thymocyte containing P2-486 zinc 岡野善郎1), 緒方郁子2), 瀬尾量2), 石田志朗1), 小山保夫3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2012.

---

Examination about the initial terra pre-building reduction administration example in the triple-drug therapy for P2-487 chronic hepatitis C Tetsuya Hirose 1), Mihoko Sasaki 1), Shigeru Sato 1), Hatsumi Kikuta 1), Miki Katsuragawa 1), Ryu Kobayashi 1), Hideji Ohara 1), Muki Ryoji 1), Ozeki solstice 2), Yoshiyasu Kano 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2012.

---

	Action of the pharmacist outpatient department for the P2-488 terra pre-building remedy patients Shigeki Tachihara 1), Mikiko Yamada 1), Kazunori Aoyama 1), Atsumi Yanaka 1), Toyohiko Kurosawa 1), Masahiko Shimada 1), 荒木眞裕 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2012.

---

	P2-489 infliximab, tocilizumab, fact-finding about the Abatacept enforcement 河野友里, 松尾宏一, 和田依子, 吉田宣政, 福原佐知, 樋口美奈子, 佐々木好美, 岩坪沙奈恵, 西野弘章 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-460, 2012.

---

	P2-490 The blood pressure improvement effect by Micombi (R) Combination Tablets BP introduced 山岡和幸, 黒岩遥香 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-460, 2012.

---

	Participation of the use situation and the pharmacist of the tolvaptan for patients with P2-491 heart failure 田中泉1), 山室蕗子1), 吉田愛1), 末吉栄志1), 近藤元三1), 伊藤彰彦2), 森上靖洋2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-460, 2012.

---

Research about the thromboembolism incidence under the low-dose warfarin control in the P2-492 valvular disease postoperative patient and the side effect Yuko Enomoto 1), Etsuko Shinohara 1), Tatsuo Chiba 2), Uekusa Shusuke 2), 佐々木英久 1), 松尾和廣 1), Akiko Watanabe 1), 加藤裕芳 2), Toru Asayama 2), Takashi Yoshio 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-460, 2012.

---

	Example that the phantom pain of the P2-493 patient on dialysis responded to pregabalin Daisuke Kito, Makoto Hayashi, Kenji Miyazawa, Akemasa Yamaya, Hiroshi Funaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-460, 2012.

---

	Examination about the risk factor of deep vein thrombosis embolism to occur after P2-494 total hip replacement, total knee replacement Satohiko Akamine 1), Yukihiro Hamada 1), Takeshi Hirayama 1) 2), Tadashi Kawamura 3), 高平尚伸 4), Masaichi Kuroyama 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-460, 2012.

---

	Example that pregabalin was effective for refractory itching with the P2-495 dialysis Shunsuke Kawabata 1), Sachiko Yasumoto 1), Fukuko Shimokawa 1), Shiho Okada 1), Naoko Omoto 1), Hilum pond Kaori 1), Kazunari Taniguchi 1), Takashi Yamanaka 2), Fuminori Matsubara 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2012.

---

	Use situation investigation of the terra pre-building in P2-496 chronic hepatitis C treatment 安澤雄生, Hiroshi Okamura, Hiroshi Goto kernel, Tadashi Wakasugi, 西川能治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2012.

---

	P2-497 Teriparatide (Forteo (TM)) evaluation and issues of foreign introduction path 荒木隆一1), 竹田美佳1), 大成一誓2), 朝田尚宏2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2012.

---

	Level of clarithromycin in P2-498 normal bronchiole epithelial cells and influence for the time Rocky mountain books for admonition, Junpei Kimura, Shota Horiuchi, Rope field Takahiro, Design of turbulent waves Ryosuke, Koichi Otaki, Yoshiko Tanbo, 早勢伸正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2012.

---

Examination of the drug evaluation about the medication at pregnancy in P2-499 Physicians' Desk Reference and the Drugs in Pregnancy and Lactation eighth edition (Gerald G. Briggs. et. al.) Hiroki Masuda 1), Ayaka Takeya 1), Mari Fukamachi picture 1), Satoshi Ohba 1), Eri Maeda 1), Yuko Okada 1), Saori Kimura 2), Seiichi Maruyama 3), Satoshi Toyama 3), Hiroshi Sato 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2012.

---

Examination of the drug evaluation about the medication at P2-500 ethical drug attachment document (JAPAN-PI) and nursing in Drugsin Pregnancy and Lactation 8th ed.(Gerald G. Briggs. et al.) Eri Maeda 1), Tomonori Sekiguchi 1), Hideyuki Wakahara 1), Haruka Asami 1), Yuko Okada 1), Hiroki Masuda 1), Young book Taro 2), Seiichi Maruyama 2), Satoshi Toyama 2), Hiroshi Sato 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2012.

---

Examination about the risk assessment to a pregnant woman in P2-501 ethical drug attachment document and the Drugsin Pregnancy and Lactation eighth edition Yuko Okada 1), Ayaka Takeya 1), Mari Fukamachi picture 1), Manure Aya Tano 1), Eri Maeda 1), Hiroki Masuda 1), Saori Kimura 2), Seiichi Maruyama 3), Satoshi Toyama 3), Hiroshi Sato 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 462-462, 2012.

---

Examination of the drug evaluation about the medication at nursing in P2-502 Physicians' Desk Reference and the Drugsin Pregnancy and Lactation eighth edition (Gerald G. Briggs. et. al.) Hiroko Iino 1), Tomonori Sekiguchi 1), Hideyuki Wakahara 1), Eri Maeda 1), Yuko Okada 1), Young book Taro 2), Seiichi Maruyama 2), Satoshi Toyama 2), Hiroshi Sato 2), Hiroki Masuda 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 462-462, 2012.

---

Evaluation of the milk transitivity of amlodipine in the nursing mother of the P2-503 pregnancy-induced hypertension syndrome Kubono Naoko 1), Takafumi Naito 1), Kimiyoshi Hirano 1), Shuhei Deguchi 2), Masahisa Sugihara 2), Toshiyuki Uchida 3), Hajime Suzuki existence 3), Hiroaki Ito 3), Kanayama Hiroshi Shou 3), Junichi Kawakami 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 462-462, 2012.

---

	Experience, an evaluation and the future problem that were given "a lecture about the pharmacotherapy to pregnant woman nursing mother" for P2-504 business training Chihiro Iwasa 1), Takashi Sato 2), Etsuko Oyamada 3), Jun Hamada 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 462-462, 2012.

---

	It is drug control in the lactation from P2-505 late pregnancy Aiko Imamoto 1), Motoko Funato 1), Keiko Nitta 1), Toshihiko Iura 2), Masaaki Mori 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 462-462, 2012.

---

	Examination of the action for a pregnant woman, the nursing mother pharmacotherapy support in the P2-506 Kurashiki adult disease center Mari Sugihara, Chie Takemoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 462-462, 2012.

---

	Examination about the effect that magnesium sulfate doses give to neonates on P2-507 mother Yumi Konishi 1) 2), Takako Yamauchi 3), Masanori Takeuchi 1), Masako Watanabe 1), Hiroki Mase 1), Tray Tadashi Nomoto 2), Naoya Inukai 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 463-463, 2012.

---

	Collagen diseases of lung high blood disease merger pregnant one case that was able to give birth by use of P2-508 epoprostenol safely Emi Otani 1), Keiko Fukunaga 1), Kuwata gain rare 1), Takuma honest 1), Katsuhiko Tada 2), 更科俊洋 3), Hiroshi Matsubara oneself 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 463-463, 2012.

---

	P2-509 1 case of valacyclovir treatment lactating women who avoid the termination of breast-feeding by the proposal of pharmacist : Consideration from pharmacokinetics prediction of acyclovir administration infant through breast milk 大久保正1), 田中真理子2), 大久保七枝3), 大久保節子4), 大久保美穂5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 463-463, 2012.

---

	An attitude survey for the pregnant woman nursing mother of the pharmacist in the P2-510 this hospital and future problem Bush clover Ayumi, Group bridge Yuki, Tomoko Suzue Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 463-463, 2012.

---

	Relation of the pharmacist to vascular pain in the use of the mug cent (R) note for the P2-511 early or threatened labour Masae Tsuji, Morihiro Okada, Yu Kanetani, Kimi Sakata, Hisae Miyata, Hiroaki Mizuno, Origin of Takeda, It is moisture in the west Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 463-463, 2012.

---

	About an effect of the ritodrine hydrochloride in the P2-512 early or threatened labour Eriko Nakano 1), Noboru Okamura 2), Kazumoto Nakamura 2), Keiko Teshima 1), 小川智孝 1), Iwaki Akifumi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 463-463, 2012.

---

	Use fact-finding of medical supplies in P2-513 pregnant woman and the nursing mother 平舩寛彦 1), Takeshi Chiba 2), Soichiro Kimura 3), Hideo Ueda 3), Yasunori Morimoto 3), Katsuo Takahashi 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 464-464, 2012.

---

	Pregnant woman in the P2-514 night emergency visit, prescription investigation of the nursing mother 小川智孝 1), Keiko Teshima 1), Eriko Nakano 1), Small wasabi 1), Yuko Soga 1), Iwaki Akifumi 1), Naoki Nishikawa 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 464-464, 2012.

---

	Relation of the pharmacist for the P2-515 nursing mother Yuri Yoshino picture, Akira Hori charges, Suzuki sheath, Tanaka reason princess, Yoko Yonekawa, 酒井欣嗣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 464-464, 2012.

---

	P2-516 Comparison of neo-percamin (R) S and Marcaine (R) 0.5% in caesarean section during spinal anesthesia 野村美枝1), 後藤拓也1), 中島誠1), 森理惠1), 相澤佑佳1), 熊谷隆浩1), 三島信行1), 高橋雄一郎2), 川鰭市郎2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 464-464, 2012.

---

Search of the instruction method for the purpose of the uneasy reduction to the medication of the P2-517 pregnant woman 石田諭史 1), Noriko Tsuchiya 2), Haru Sato or 1), Naoyuki Yakura 2), Junko Matsuoka 2), Motomu Kobayashi 2), Masakazu Miyachi 2), Tetsuro Yumoto 1) 2), Shotaro Sakurai 1), Kenjiro Inaba 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 464-464, 2012.

---

	The present conditions of the folic acid supplement intake in the P2-518 pregnant woman Yuka Kobayashi 1), Taku Ohara 2) 3), Yuriko Murai 2) 4), Metoki Konin 3), Hiroshi Sato 1), Jun Imai 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 464-464, 2012.

---

	Case study about the effect on milk transitivity and infants of P2-519 lamotrigine Makiko Morita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 465-465, 2012.

---

	Discussion of questionary survey and the improvement policy for the medicine of P2-520 pregnancy, the nursing mother Fumiko Miyoshi, Nao Matsushige, Takafumi Izumo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 465-465, 2012.

---

	Making of the continuous care seat and individual guidance tool for the medicine remedy patients for diabetes in the P2-521 health insurance pharmacy Tomoko Miyazaki, Tanaka evening K, Miyoshi Kawakami, Tomoji Yoshiyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 465-465, 2012.

---

	Hypoglycemic recognition investigation in patients with P2-522 diabetes Toshifumi Miyamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 465-465, 2012.

---

	Action to drug control instruction using P2-523 CGM results Taku Ito 1), Kazuhiro Yoshida 2), 今田愛也 1) 3), Yayoi Otani 1), Jun Ozawa 1), Mayuko Soma 1), Yoichi Sasaki 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 465-465, 2012.

---

	P2-524 Clinical evaluation of the DPP-4 inhibitor vildagliptin : Study in switching patients from sitagliptin phosphate hydrate 長橋かよ子1), 田中裕子1), 杉本三千代2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 465-465, 2012.

---

	Action of the diabetes pharmacotherapy support by the pharmacist in the P2-525 convalescent rehabilitation ward Kato Toyonori, 高井希依, Ai Uno, Shinobu Tsukatani, Naoko Shinoda, Megumi Sakashita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 466-466, 2012.

---

	About effect of the oral hypoglycemics on P2-526 Alzheimer disease Satoshi Shimizu, Hiroyuki Horiguchi, Masayuki Tamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 466-466, 2012.

---

	About the combination of P2-527 liraglutide and SU medicine situation 森祐美子1), 杉山喜久1), 山西香織1), 和田恭一1), 老田章1), 小原延章1), 桑原健1), 槙野久士2), 岸本一郎2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 466-466, 2012.

---

Significance of HDL - cholesterol reduction by the lipid-lowering medication probucol for P2-528 patients with diabetic nephropathy Ishida early Sachimi 1), 佐々木英久 1), Kiyoshi Sakuma 2), Endo Valley 3), 松尾和廣 1), Tomoko Watanabe 1), Etsuko Shinohara 1), Masaka Wataru 2), Koji Shirai 3), Takashi Yoshio 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 466-466, 2012.

---

	Elucidation of hyperoxide-producing increase by terminal saccharification product (AGEs) in P2-529 diabetes and the depression effect mechanism with the pravastatin 永味千枝 1), Moat Hideo 2), Chigusa Kikuchi 3), Masayoshi Takeuchi 4), 松永民秀 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 466-466, 2012.

---

	Examination of the use situation and the usefulness of the P2-530 DPP-4 repressor alogliptin 山下真由美1), 吉岡大樹1), 藤田有紀子1), 藤田成裕2), 嵩下浩子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 466-466, 2012.

---

	Action to a medication continuation plan at disaster development for patients with P2-531 diabetes Rina Suzuki 1), Hidenori Nakamichi 1), Kazumi Kawamura 1), Mitsuru Shiokawa 1), Genma Rieko 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 467-467, 2012.

---

For qualitative improvement of ... diabetes medical treatment instruction to think about the efficacy of the P2-532 "DM theater" Keiko Imai 1) 2), Masako Morimoto 1) 3), Ueda Kosuke 1) 4), Yutaka Maruyama virtue 1) 5), Hiroshi Sasaki enthusiast 1) 6), Mayumi Kitajima 1) 7), Takahiro Shiga 1) 8), Motoki Miyashita 1) 9), Reiko Nakano 1) 10) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 467-467, 2012.

---

	Screening investigation about diabetes of patients who received P2-533 cancer chemotherapy 冨 ヶ Yuki Hara 1), Shuichi Nawata 1), Tokumaru falcon flat 1), Nobuko Wada 2), Yuki Iwasaki 2), Mieko Miyazaki 1), Tadashi Yamakawa 3), Shinya Hashimoto 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 467-467, 2012.

---

	Examination of the clinical response of sitagliptin and the glimepiride combination therapy in patients with P2-534 type 2 diabetes 大島聡子, 坂下舞, 難波由里子, 紙屋めぐみ, 笹山祐布子, 新井亘, 増田裕一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 467-467, 2012.

---

	Contribution to the instruction by the pharmacist at the P2-535 GLP-1 analog induction and the effect of treatment improvement Noriko Ishida 1) 2), Tatsuya Ono 1) 2), Tokuyama still I 2), Hideyuki Nishida 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 467-467, 2012.

---

	Examination of the utility of the class for diabetics in P2-536 diabetes education inpatients Harumi Teramoto 1), Yuko Nakagawa 1), 城尾晃太 1), Shinichiro Matsuda 1), Sakie Senoo 1), Maze Hisanori 1), Yuki Ichihashi 2), Megumi Ito 2), Persimmon castle Yasuyuki 2), Maho Kikuta 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 467-467, 2012.

---

	Evaluation after the business training of the diabetes pharmacotherapy on-site training in the P2-537 prior learning Chigusa Kikuchi, 松永民秀, Tadashi Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 468-468, 2012.

---

Evaluation about the diabetes management from the laboratory values of patients receiving DPP4 inhibitor by the P2-538 multicenter conjugation 竹内崇浩 1) 2), Ito Atsuo 1) 2), Sayaka Azuma 1) 2), Hirokuni Kataoka 1), 石下宏征 2) 3), Minoru Sakata 3), Toshiko Ogawa 2) 4), 1, Kotobuki, Sekine 2) 4), Yuki Nishimura 2) 5), 河野博充 2) 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 468-468, 2012.

---

	Examination about the index of the insulin secretional capacity in the P2-539 drug choice Kazutoshi Fukumori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 468-468, 2012.

---

	The case that a glycemic control came to have poor by the self-administration to the P2-540 induration site Takao Koyama 1), 舩瀬芳子 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 468-468, 2012.

---

	P2-541 Research and discussion of changes in the HbA1c by prescription change from Sitagliptin to Alogliptin 廣瀬浩一1), 齋田正和1), 本由美1), 松井健一1), 岡本智枝1), 金本秀之2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 468-468, 2012.

---

	Attitude survey for hypoglycemia in the P2-542 this hospital Great Yumiko Tsuyama, Shuhei Suzuka, Fujita Aoi, The Aya Yamamoto beauty, Kazuya Hirata, Naoyuki Matsumoto, Kazuki Tago, Miki Nakamura, Person of moat Yumiko, Naoki before yellow Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 468-468, 2012.

---

	Examination about the efficacy of DPP-4 inhibitor building Doug re-Putin in patients with P2-543 type II diabetes mellitus Step Masaaki Hayashi, Rie Ueno, Anzai 1,000 folds child, Shogo Nakamura, 杉本更絵子, Yukihiro Hayakawa, Kazue Takahashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 469-469, 2012.

---

	P2-544 EBM of TETOHUXTLE: Challenge from trace blood samples of multi-item clinical examination 富岡節子, 村田和子, 久保博昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 469-469, 2012.

---

	A questionnaire about the insulin proper use in the P2-545 Fujinomiya Municipal Hospital and the correspondence Mariko Ijiri, Osamu Kitamura, Kazuo Katsumata, Hiroshi Kawaguchi fruit, Yoshinori Kobayashi, Yutaka Kobayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 469-469, 2012.

---

	Induction of the simple suspension method in the P2-546 critical care center Rie Hirai 1), Kozono Kouki 1), One Makoto Hayashi 2), Oyamada Hanako 3), Hazuki Sakamoto 3), Eriko Suzuki 1), Washisawa Takahiro 4), Mitsuru Honda 2), Katsunori Yoshihara 2), Kenji Nishizawa 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 469-469, 2012.

---

	About the drug information offer in the P2-547 lifesaving ward Hiroshi Tanaka period 1) 2), Tadashi Nanba intellect 1), Your forest sect 1), Toshitaka Takenouchi 1), Isao Saito 2), Junichiro Murayama 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 469-469, 2012.

---

	Contribution and evaluation to team approach in medical care by the NICU permanent residence of the P2-548 pharmacist Akiko Tomota 1), Misako Suzuki 1), Ritsuko Miyajima 1), Hideya Kokubun 1), Rumiko Kondo 1), Hajime Matsubara 1), Kazuo Yago 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 469-469, 2012.

---

	Activities of the pharmacist in the team approach in medical care in the P2-549 this hospital ICU 赤羽理也 1), Eriko Tanimoto 1), Charcoal Masaki 1), Yasuyuki Tsujita 2), Yutaka Eguchi 2), 寺田智祐 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 470-470, 2012.

---

	Comparison of two kinds of urinary drug screening kits (try age DOA and Monitect-9) in the P2-550 acute poisoning Masayuki Chuman, Toru Imai, Takako Sakagami, Toru Kitano, Norikazu Kikuchi, Morio Kaburagi, Zenichi Yoshida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 470-470, 2012.

---

	About the contribution of the pharmacist in the P2-551 intensive care unit Hiroshi Tsujimura, 橋冨 Yayoi, Jun Taniguchi, Atsushi Nakamura, Naomi Kuroki, 吉野裕統 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 470-470, 2012.

---

	Relation of the pharmacist in the P2-552 second emergency care organization Junichi Isogai 1), Shinji Ito 1), Hiroyuki Matsunaga 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 470-470, 2012.

---

	About the action of the pharmacist in the P2-553 ICU half day permanent residence Valley water Kumiko, Hiroyuki Yamane, Takeshi Shimada, 邑上達也, Masato Ishii, 萩原眞理, Yoshiaki Kita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 470-470, 2012.

---

	Participation of the pharmacist in rt-PA intravenous-injection treatment for the P2-554 ischemic cerebrovascular disease acute phase 1 related to Kiuchi), Yumiko Kikuchi 2), Mieko Kuroiwa 2), Toru Ooi 1), Takashi Higuchi 3), Akiko Goto 4), Shozo Goto 4), Kazuo Nakajima 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 470-470, 2012.

---

	Change ... of contribution - drug information offer number and the number to the patients security of the P2-555 ICU permanent residence pharmacist of pre-Abo id examples Yuka Ogi, 熊倉裕昌, Wataru Arai, Yuichi Masuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 471-471, 2012.

---

	Contribution to the medical security by the P2-556 ICU charge pharmacist and a medical cost reduction effect 今浦将治 1), Kowata male solstice 1), Takashi Igarashi 1), Takeshi Yamaya 1), Hiroyuki Takahashi 2), Hiroshi Sugano 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 471-471, 2012.

---

	Action of the resident pharmacist for the incompatibility to occur in P2-557 ICU Shoichi Imanaka, Takeshi Yamamoto, 三浦幹剛, Hideyuki Shimizu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 471-471, 2012.

---

	Injection sterility preparation duties in the P2-558 NICU satellite pharmacy Ayumi Sanada 1), Keita Hirai 1), Emiko Senoo 2), Masako Yonekura 2), Tatsu Sakamoto Ichiro 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 471-471, 2012.

---

	Improvement of the drug-related duties of the operation region by the intervention of the P2-559 pharmacist Sato Shiori, Junko Arima, 下堂薗権洋, Yasuo Takeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 471-471, 2012.

---

	Drugstore duties improvement by the P2-560 joint medical treatment management (CDTM) induction 小川壮寛 1) 2), 中島利裕 1), Yoko Moriyasu 1), Akira Matsushita 3), Kenichi Shimada 2), Takashi Egawa 2), 五味田裕 2), Masashi Takahashi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 471-471, 2012.

---

About the TDM duties induction by the many types of job using P2-561 electronic chart system Tomoyuki Kato 1), Stone Kenji Hama 1), Tomoko Narishima 1), Furukawa first arrow incense 1), Mika Shiotsuka 2), Capital storehouse Hiroko 3), Minoru Doi 4), Takahiro Shimizu 4), 本郷偉元 5), 堀治 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 472-472, 2012.

---

	P2-562 Humira introduction by pharmacists and their effects : Questionnaire after the introduction results and analysis of consultation contents 益成宏1), 豊岡慶子1), 大森義朗1), 佐伯久美子1), 山本佐和子1), 野原寛章2), 斉藤満2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 472-472, 2012.

---

	Questionnaire findings about the way for the doubt inquiry of P2-563 physician and the pharmacist The Iioka cord beauty Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 472-472, 2012.

---

	Action of the perioperative glycemic control by the pharmacist for patients in P2-564 orthopedics department 古川静保 1), Nobushi Yamamura 1), Katsuya Nakano 1), Maki Nomoto 1), Yuka Tsutsui 1), Yukinobu Nishii 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 472-472, 2012.

---

	Active contribution and MBD treatment algorithm making of the pharmacist in the P2-565 outpatient department patient on dialysis Junko Onishi, Yuichiro Hayashi, Plum Miyoshi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 472-472, 2012.

---

Prescription input - of action - pharmacist to the pain control in the P2-566 orthopedics region Takamitsu Fujioka 1), Masatoshi Saito 1), Yoshikazu Kobayashi 1), Takashi Ito kernel 1), Masayoshi Nishi beauty 1), Reiko Fujino 1), Shinya Abe 1), Koji Masubuchi 1), Takashi Inoue 1) 2), Atsuta Koichiro 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 472-472, 2012.

---

Action ... of the new duties development Hitachi General Hospital Pharmaceutical Affairs Bureau of the pharmacist in the team approach in medical care-shaped in the P2-567 Pharmaceutical Care rounds - next generation Yoshifumi Aoyama 1), Sachiko Saito 1), 澤畠孝幸 1), Masayo Okawa 1), Slightly dried fish Yuka 1), Masashi Onozaki 1), Shusaku Ito 2), Tsuyoshi Ando 2), Hideyuki Mishima 2), Tsunehiko Maruyama 2), Yasushi Usami virtue 2), Toshiro Kamoshita 2), Kazumitsu Ueda 2), Yasunori Watanabe 2), Shinji Hirai 2), Okumura Minoru 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 473-473, 2012.

---

	Confirmation ... of the effect loss of the drug in one - declare of brain death associated with brain death lower organ donation as P2-568 pharmacist Yuichi Hanada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 473-473, 2012.

---

About P2-569 Himeji medical center ward pharmacist resident duties (the third report) action - of in connection with - CRC with the ward charge pharmacist Yuka Takahara 1), Morishita Kumiko Hara 2), Yoko Nakata 2), Hiroshi Beppu kernel 3), Hisashi Yagi Yoshiko 1) 2), Katsuaki Kobayashi 1) 2), Yasuo Wada 2), Shinki Nishimura 4), Yoshiro Mochizuki 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 473-473, 2012.

---

	Safety of medicine evaluation - antitumor agents (hematologic cancer) - that we saw it from P2-570 clinic dose, an exposure level and a nothing toxic level, an exposure level Tsuneo Kodama 1), Nao Oguri 2), Okada auspicious sign 2), Kazuyuki Saito 3), Shunsuke Ono 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 473-473, 2012.

---

	Action to a trial in the P2-571 psychiatry Hirotaka Suzuta 1), 福山雄卯介 1), Fujita good memory 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 473-473, 2012.

---

Utilization ... of system maintenance and the tool checked at action ... investigational new drug administration time of the pharmacist to conduct P2-572 injection anticancer drug trial safely Yoko Iguma 1), Old real name Tsu child 1), 1 related to Kamiyama), Bird mouth Naoko 2), Shiori Yoshida 2), 因藤伊織 2), Natsu Matsumoto period 2), Yoshiko Ishizuka 1), Toshiya Katsura 1), Kazuo Matsubara 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 473-473, 2012.

---

	The introduction of IT of P2-573 trial secretariat duties and application of database Akio Tanaka, Yukiko Ishizuka, 百合草憲勇, 栗原康彰, Isao Hasegawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 474-474, 2012.

---

	Consideration to P2-574 investigational new drug temperature management deviation correspondence Rieko Miyashita, Chiaki Tagawa, Katsuyuki Tanaka, Motoko Munemura, Naoya Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 474-474, 2012.

---

	Examination of the CRC duties efficiency using P2-576 iPad Katsuya Yamashita, Junichiro Hayashi, Yukako Okuyama, City lower Yumi, Kaoru Yoshii, Miho Miyamoto, Masayo Atsuko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 474-474, 2012.

---

Action for the construction of the clinical studies enforcement support system in the hospital attached to P2-577 Nippon Medical School 1, Chinaga, Takase), Asuka Sekiguchi 1), Yukiko Sakamoto 1), Yuki Manda 1), Michiko Sakata 1), Kumi Yoshii 1), Naomi Takamura 1), Yoichi Sato 1), Shiro Katayama 1), 2), Masahiro Yasutake 1), 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 474-474, 2012.

---

	Regional medicine cooperation of Masuda-shi that did communication of the Rev. P2-578 three society thickly Nishizono Kenro 1), Takahiro Ohba 2), Hiroshi Takamura 2), Takashi Naito period 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 474-474, 2012.

---

	Development of medical care, the care information communalization software in the treatment at home by the P2-579 university-industry research collaboration Arai country three 1), Masako Hashimoto 1), Matsuzaki A 1), Kanako Hashimoto 1), 加茂川慶吾 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 475-475, 2012.

---

It is ... through illness medicine cooperation - inhalation instruction check seat in the inhalational instruction of the P2-580 outpatient Hirata detailed child 1), Hanao Norihide 1), Yukari Omae 2), Yoshiko Washimi 3), Kuramoto clothes beauty 4), Masaru Yoshimura 4), West horse illumination 4), Onishi still 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 475-475, 2012.

---

	Examination about the way of the actual situation of the receipt of "the drug control summary" in the P2-581 health insurance pharmacy and the future illness medicine cooperation Kazuhiro Watanabe 1), 千島巳幸 2), Kazuhiro Aga 3), Tomoyuki Hamamoto 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 475-475, 2012.

---

It is ... led by patients with action ... asthma bronchial of the illness medicine cooperation in the P2-582 this hospital Yayoi Kuroyanagi 1), Chie Yoshimura 2), Kazuko Nagasawa 3), Shinichi Sumimoto 4), Hirokazu Horikoshi 5), Harue Kinoshita 1), Mikiko Fujii 1), True 1 between the small), Takashi Doi still 1), Masahiro Ishizu 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 475-475, 2012.

---

	Action ... of compliance investigation - medicine medicine cooperation after the renal disease education hospitalization in the P2-583 this hospital Maiko Tanaka 1), Misaki Watanabe 2), Manabu Yokota 3), Friend waterfall Kazuto 1), Chie Suzuki 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 475-475, 2012.

---

	Future problem toward significance and the drugstore duties enhancement to perform meeting a demand of the prescription which P2-584 laboratory study information was attached to Yoshiaki Kimura, Mieko Itakura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 475-475, 2012.

---

Investigation about the utility of "the drug "management" reporting book" which we sent for high quality medical care without interruption by P2-585 security for local medical care and a welfare institution Akiko Sandai 1), Hiroki Ogata 2), Chika Kai 3), Ichihara length person 1), Okinoshima Yuki 1), 茂亨嘉 1), Satoshi Sato boatman 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 476-476, 2012.

---

	Action to P2-586 children treatment at home Yoshiyuki Akimoto 1), Bridge Eriko Oka 1), Noriko Tamai 2), Hideko Ozaki 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 476-476, 2012.

---

	Trial of the inhalational instruction medicine medicine cooperation for children with P2-587 children asthma bronchial Minako Mori 1), Harvest festival Hanae 1), Emiko Iguchi 1), Takahashi Hiromitsu 1), Jun Isozaki 2), Mitsumasa Yamagata 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 476-476, 2012.

---

	About the present conditions of the case that became the changing hospital using P2-588 stroke regional medicine cooperation pass Sukeyuki Tsuchiya 1), Hiroyuki Fujimura 1), 牛越聡 2), Koji Teratani 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 476-476, 2012.

---

	About medicine medicine cooperation about the proper use of patients receiving P2-589 terra pre-building Misa Takenaka, Tei Hara Expo, Takayuki Kinoshita, Hiroshi Hidaka, Toshihiko Ushio, Kojiro Takahashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 476-476, 2012.

---

	P2-590 Osaka Prefectural respiratory apparatus, present conditions of the inhalational instruction in the allergic medical center neighborhood health insurance pharmacy Fumie Shimazu, Keiko Fujita, Saya Komiyama Kei, Gilt bronze Yoko, Kazuko Shimura, Nobuhisa Fukushima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 476-476, 2012.

---

	It is ... for proper use of action ... dabigatran of the medicine medicine cooperation that we maintain the joint study session with the P2-591 local health insurance drugstore 瀧祐介, 松下久美, 日下豊史, 栗原梢, 小柳愛子, 後藤貴裕, 安藤奈津子, 山城博和 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 477-477, 2012.

---

	Relation of the pharmacist in the P2-592 smoking cessation outpatient department Momose Hazu child 1), Toshi Yokoyama period 1) 2), Jun Sasaki 1), Haneda enthusiast example 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 477-477, 2012.

---

The making of a part of the medicine medicine cooperation in the P2-593 outpatient department chemotherapy and the information communalization tool which we did and use Seiko Fujii 1), Tatsuya Hayama 1), Onuma sprouting 1), Kentaro Uejima 1), Tomoko Nakata 1), Daisuke Tsutsumi 1), Ogre storehouse Kazuyo 2), Moe Otani 3), Masatoshi Hayasaka 1), Zenichi Yoshida 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 477-477, 2012.

---

	Than ... warfarin and a combination case thinking about importance of the medicine medicine cooperation from P2-594 drug interactions of the miconazole gel ... Kazumi Kimura, Hiroko Iwamura, Hiromi Nagai, Kanako Sakashita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 477-477, 2012.

---

The medicine notebook bringing enlightenment motion of P2-595 Yodogawa Christianity hospital and investigation of the medicine notebook bringing rate 琢磨寛孝 1), Kyoji Terasawa 1), Tomoaki Katayama 1), Inoue sacred night child 1), Uchiyama eyes 1), Tomoko Yamashita 1), Kenichi Miyata 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 477-477, 2012.

---

Making - of action (the first report) - brochure, the home medical care support drugstore map to home medical care support in P2-596 treatment at home promotion Committee Yu Aoki 1) 2), Makoto Iwashita 2) 3), Edge Hiroaki Sawa 2) 3), Yasushi Kuramoto 2) 3), Takeshi Omori 2) 3), Kazue Hayashi 2) 3), Miwa Tanaka 1) 2), Ryo Komatsu 2) 3), Mikiro Hanaoka 3), Kazumi Yoda 1) 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 477-477, 2012.

---

	The example that we inquired of about a doubt in the patients whom renal function degeneracy was seen in by eGFR described in P2-597 out of the hospital prescription Miki Yamamoto, Masayuki Okada, Shiho Kato, Yamagata Natsumi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 478-478, 2012.

---

Present conditions investigation of the inhalational instruction by the pharmacist under P2-598 Kagawa 篠永浩 1) 2) 3), Hiroki Kondo 1), Sakae Matsuoka virtue 4), Yasushi Nishiyama 5), Yohei Maruyama 2) 6), Yutaka Nimura 2) 3) 6), Seiji Nagaoka 7), Hiroyuki Nakamura 3) 8), 南木伸基 3) 9), Tadashi Kamei 3) 10) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 478-478, 2012.

---

Result of the physician, pharmacist collaboration "periodical health consultation" for P2-599 mountains depopulated area inhabitants Tomishige Eri lawn 1), Akio Kochi 1), Masaharu Hori 2), Fuminori Ezaki 1), Mika Nakagawa 1), Capital Ryoichi 1), Keiko Narumi 1), Junichiro Sonoda 1), Kei Sato wound 3), Toshiro Motoya 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 478-478, 2012.

---

	The present conditions of the action to treatment at home in the P2-600 health insurance pharmacy and future problem 高橋恵美利 1), Misato Kurabayashi 1), Kaoru Kimura 2), Yuko Okada 1), Kayo Murata 1), Masayuki Sekizuka 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 478-478, 2012.

---

Examine P2-601 disease; the examination about the way of the information on adverse drug reactions management for the medicine medicine cooperation Seiichi Kobayashi, Uchida Kei greens child, Hitomi Hakamada, Kurita A, Moeko Hara, Keiko Iwasa, 長嶋一泰, Takashi Adachi, Atsushi Yamashita, 西尾益治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 478-478, 2012.

---

Action of the medicine medicine cooperation in the P2-602 outpatient department cancer chemotherapy Koji Ichiki 1), Tomoyo Nakajima 1), Yorikazu Furuya 1), Moji Keiko 1), 井手飛香 2), Ishii Yuta 3), Fumihiro Morishige 3), Masaharu Takahashi 3), Kojiro Takahashi 2), Asahara Minoru straight 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 478-478, 2012.

---

	The present conditions and problem of infection measures at the at-home fluid therapy in the P2-603 this hospital Kazuko Takahashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 479-479, 2012.

---

	Present conditions of the action ... acute phase Hospital in P2-604 Kumamoto stroke cooperation pass, pharmacist section and new development ... Akira Tokunaga oneself 1), Takayuki Taniguchi 2), Etsuko Toyonaga 3), 楊祈恵 4), History of Kashima 4), Yuki Fujimoto 1), Harumi Tanoe 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 479-479, 2012.

---

	Action ... in inflection method - this hospital of the P2-605 medicine notebook Person of moat Yumiko, Tomoko Katsube, Fujita Aoi, Kazuya Hirata, Naoyuki Matsumoto, Kazuki Tago, Shuhei Suzuka, Great Yumiko Tsuyama, Miki Nakamura, Naoki before yellow Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 479-479, 2012.

---

	It is the activity in the triage area in the institution other than the early days in the P2-606 stricken area Koji Takizawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 479-479, 2012.

---

	The polypharmacy patients whom it became the change of prescription triggered by P2-607 earthquake disaster, and a side effect reduced Shinobu Sugiyama 1), Yasufumi Sawada 2), Doi reason Yuko 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 479-479, 2012.

---

	... which prevents future pharmacist image ... avoided death that it showed from P2-608 Great East Japan Earthquake hospital practice report and the reflection point 坂京彙子, Emiko Asakura, Tetsuya Ohashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 479-479, 2012.

---

	Action of the storage medical supplies use for a P2-609 size scale disaster Masaki Mizuguchi 1), Kan Yutaka Otaka 1), Motohiro Ishibashi 2), Takafumi Ichida 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 480-480, 2012.

---

P2-610 ... [you work on Republic of Turkey size scale earthquake disaster medical care support in 2011 and report it] ... (make use of experience by the republic, Republic of Haiti dispatch in Myanmar) Haruhiko Sato 1) 2), 高力俊策 2) 3), Koichi Ikehara 2) 4), 渡慶次賀博 2) 4), 伊禮武 5), Katsuyo Uehara 1), 知花幸仙 5), 伊波潔 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 480-480, 2012.

---

	Relations with dust and the cough symptom after the tsunami in the P2-611 Great East Japan Earthquake Hiroyuki Nanba 1), 江谷勉 2), Hideshige Takada 3), Satoshi Suzuki 4), Kunihiro Fukushima 5), Mitsuhiro Okano 5), Norio Sahashi 6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 480-480, 2012.

---

About prescription correspondence in the early period of Great East Japan Earthquake in the P2-612 this hospital Takashi Sasaki 1), Yuta Suzuki 1), Sugano sum 1), Tetsushi Takeda 1), History of Yasushi Iwabuchi 2), Lacquer Tachi rare 3), 追木正人 1), Hiroyuki Abe 1), Jin Wagatsuma 4), Akihiko Furuta 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 480-480, 2012.

---

	Practical skill identification test (initial interview) for the P2-613 trainee 角岡 is elegant, Flatter; up size Jiro, Tomoko Okamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 480-480, 2012.

---

	An investigation and evaluation about the compounding of medicines error of the trainee in the P2-614 long-term business training Naomi Nishioka, Yu Ono will, Junko Usami, Katsumi Kitagawa, Shiho Ishida, Shinge Keiko, Kuridani Yoshitaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 480-480, 2012.

---

	The present conditions investigation for the P2-615 long-term business training end student and the evaluation Osamu Takeshita example, Makoto Shigematsu, Masako Ono, Satoko Katsuragi, Masahiro Moriyama, Hilum Muneo Hayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 481-481, 2012.

---

	Than the questionary survey to effect - trainee and the instruction pharmacist whom P2-616 business training brought ... Chika Okumura, Junko Totsuka, Yoshiyuki Shibayama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 481-481, 2012.

---

	Fact-finding about the abstract in the P2-617 business training institution and the mixture measurement compounding of medicines method Kunihiko Fujiwara 1), Makoto Matsuura 2), Takeshi Chiba 1), Katsuo Takahashi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 481-481, 2012.

---

	Investigation about the achievement degree evaluation of a trainee and the instruction pharmacist in the P2-618 Hospital business training Shigekazu Watanabe, Eri Nakamura, Watanabe many Maki, Isao Murakami, The Saito hundreds of branches beauty, 土屋雅勇 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 481-481, 2012.

---

The action of the resident teacher in the business training in the hospital attached to the P2-619 Nagoya University School of Medicine thinks about medical treatment from resuscitation / living body information monitor, auscultation training 椿井朋 1) 2), Yukihiro Noda 2), Teruhiro Mori 2), Sakiko Nishikawa 3), Yoko Hibi 4), Masaya Hasegawa 4), Kiyobumi Yamada 4), Makoto Nakao 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 481-481, 2012.

---

	Advance training due to the infection control part of the P2-620 six years system pharmacy student 野口雅久 1), Ippei Tanaka 1), 中南秀将 1), History of Sen Matsunaga 2), Yutaka Nasu 2), Yoko Yamada 2), Kanako Yamada 2), Naoto Koike 2), Kenta Utsumi 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 481-481, 2012.

---

Utility of the information exchange society between a university, the hospital about the P2-621 Hospital business training Hideo Kurosawa 1), Yukiko Kasatani 2), 3, Toyofusa, Kobayashi), Yoshikatsu Shinoda 4), Hiroko Tai 5), Kyoji Terasawa 6), 長谷圭悟 7), 野村剛久 1), Hiroko Matsui 8), Eiichi Maruta 9), Tajima Shigetoshi 7) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 482-482, 2012.

---

Action ... using evaluation ... automatic medication record bottle (MEMS bottle) of the antiHIV medicine simulated medication experience-based training in the P2-622 long-term business training Hiroshi Kimura 1), Well hilum Keiko 1), Mamoru Tanaka 1), 末丸克矢 2), Hiroshi Araki positive 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 482-482, 2012.

---

	Examination of the student questionnaire findings for the P2-623 clinic business training and future problem Manabu Abe, Toshinari Asakura, Naoko Iimura, Kazuyuki Ueno, Kenji Kawano, 齊藤幹央, 本澤忍, Noriaki Yokou, Hiroyuki Wakabayashi, Kenichi Watanabe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 482-482, 2012.

---

	An action and evaluation of the pharmacy student business training in the P2-624 this hospital Yuki Itagaki, Hideko Maki, Akiko Ishiyama, Koji Wada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 482-482, 2012.

---

	Result of the practice of pharmaceutical problems to be carried out by P2-625 individual work Michiru Watanabe 1), Naoko Takeda 1) 2), Tomoko Yoshii 1), Kazu Kojima child 1), 小清水治太 1), Junko Ogawa 1), Junichi Tajima 1), Kiyoshi Mihara 1), Oil field Masaki 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 482-482, 2012.

---

Action of the business training in the cottage-hospital out of one of P2-626 equivalence corporation 川岸諭佳 1), Emi Watanabe 1), Sei Ikegami 1), Kengo Umehara 2), Keisuke Otsu 2), Miyamaru Akina 2), Yoshiko Wada 2), Young book Azusa 2), Shintaro Takayama 2), First mountain Tae 2), Masato Kazama 2), Hideki Sato 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 482-482, 2012.

---

	Development of the teaching materials tool for the mixture compounding of medicines acquisition using iPad for the P2-627 pharmacy school trainee Sada light, Kazuhiko Yamaji, Ida Hiromi, Shin Matsubara, Hiroki Ichikawa, Sendo Toshiaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 483-483, 2012.

---

It is ... from the results of the attitude survey of ... pharmacist with the role of the pharmacist participating in P2-628 "business true taking lessons previous learning" Akiko Murata 1) 2), Yukiyo Nakao 1) 3), Yuko Matsuda 1), South Eriko 1) 4), Chika Yamanaka 1) 5), Takashi Hatae 1), Chikako Numata 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 483-483, 2012.

---

Analysis using the structure equation modeling of the factor to influence student satisfaction in the P2-629 Hospital training Hideki Hayashi 1), Shinji Koshio 2), Tomoki Tsuji 1), Kazuyuki Inoue 1), Satoshi Uchino sincerity 1), Kazuhito Kosuge 1), 宮嵜靖則 1), Hiroshi Yamada 1), Kunihiko Ito 1), Yoshiyuki Kagawa 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 483-483, 2012.

---

	Of the antineoplastic preparation for the pharmacy school business trainee in the P2-630 this hospital, actually Upper ノ step Tomori 1), 権玲奈 1), Yoshida Matsumi 2), Maeda Yuka 1), Takahiro Kurokawa 1), Tamami Tomita 1), Koichi Nawata 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 483-483, 2012.

---

	Identification test (the last inspection) of the P2-631 business training Flatter; up size Jiro, 角岡 is elegant, Tomoko Okamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 483-483, 2012.

---

Problems of the six years system business training by the P2-632 student questionnaire and future problem examination Hiroshi Ohara 1), Taku Ohara 2), Nobuyuki Midorikawa 1), Takashi Hatae 3), Keiji Kuramoto 1), 伊藤鍛 1), Akiko Sato 1), Hitoshi Tada 1), Toru Shoji 1), Masataka Hayasaka 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 483-483, 2012.

---

	Fact-finding of a hospital about the patients personal information protection in the P2-633 long-term business training and the medicine-based university Yasuyuki Saeki, 垰越崇範, Takashi Tomita, Kiyomi Shinohara, Furrow well Hiroko, Yasuhiro Kimura, Tree flat Kenji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 484-484, 2012.

---

	Satisfaction and the understanding degree of program evaluation - learner of the business training in the P2-634 Hospital and the contribution factor Miho Utsumi 1), Hiroshi Onishi High School 2), Sachi Hirano 1), Yuki Fujii 1), Hiroshi Yamamoto 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 484-484, 2012.

---

	An action in the improvement of the ward duties training for the P2-635 pharmacy school life and the evaluation Yuka Kobayashi 1) 2), Kazushi Masuda 1) 3), 仲佐啓詳 1), Hiroshi Nakamura justice 1), Amount of Ariyoshi example 1), Koichi Kitada 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 484-484, 2012.

---

	Examination of the likelihood of the physical assessment application using the P2-636 attachment document information Fuminori Shibuya, Yoshiko Chiba, Miki Nakamura, Ayako Terada, 廣原正宜, Kyoji Taguchi, Jun Toda, Tomoyuki Hamamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 484-484, 2012.

---

Evaluation of the physical assessment education stratagem by the PBL type simulator practice in the P2-637 pharmacy school advanced subject Takashi Egawa 1), Kenichi Shimada 1), 小川壮寛 1) 2), Mitsuru Kishimoto Rina 1), Tomishige hemp Saki 1), Junko Tomita 1), Ono Hiroshige 1), Takashi Shibata 1), Masashi Takahashi 2), 五味田裕 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 484-484, 2012.

---

Learning will investigation of the student by P2-638 vital signs training having changed the disease simulation treatment using the tall handloom ability patients simulator to "a practice type" from "a visit type" Takashi Hashimoto still 1), Nobuyuki Takahashi 2), Emiko Sato 2), Yuriko Murai 2), 平澤典保 2), Yoshihisa Tomioka 2), Tochikubo Katsuyuki 1), Hiroshi Sato 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 484-484, 2012.

---

	Attitude survey of the pharmacy student for the schizophrenia patient with the new curriculum induction of the P2-639 psychiatry region Saito hundreds of branches beauty 1), Machiko Watanabe 1), 土屋雅勇 1), Shinichi Niwa 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 485-485, 2012.

---

	Examination of the interactive class style in the great lesson type lecture aiming at the class will improvement of the P2-640 pharmacy student Tadashi Taguchi cord 1), Ichitomo Miwa 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 485-485, 2012.

---

	Evaluation of the early on-site training that adopted the vital signs education in the P2-641 pharmacy school Masahiko Hayashi, Yoshihiro Nishimura, Satoshi Yokoyama, Fence Hidefumi Azuma, Kazuya Ooi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 485-485, 2012.

---

	Recognition investigation of the simple suspension method for the nurses of the P2-642 cancer chemotherapy nursing authorization nurse course Maho Miyazawa 1), Saori Miura 2), Yukihisa Imaizumi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 485-485, 2012.

---

	P2-643 About the clinical practice in the community-acquired medical facilities of the Sojo University Pharmacy 6 annual student and the effect 瀬尾量1), 藤井績1), 吉岡優一2), 平井信孝3), 後藤慶次4), 緒方健一5), 杉野茂人6), 内田友二1), 松倉誠1), 小田切優樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 485-485, 2012.

---

Follow-up three years after the P2-644 3 annual "medicine-based internship volunteer experience-based training" student attending a lecture Kurio Wasa child, Motomi Konishi, Satoshi Okuno, Yu Yamamoto fruit, Chie Nishikawa, Tomohisa Yasuhara, Kazuo Yanagida, Nakamura three kinds of filial duties, Satoru Sone way, Takeyuki Kawano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 485-485, 2012.

---

A workshop reports the action of the pharmacy education by the P2-645 medicine medicine cooperation "what is made as a pharmacist at a disaster?" Toru Imai 1), Isobe good luck 1), Yoko Ito 2), Norikazu Kikuchi 1), Seiichi Saito 3), Takashi Saji 4), Hiruma Kojiro 5), Yuko Yoshiki 6), 1, Sakae, Ishigaki 7), Zenichi Yoshida 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 486-486, 2012.

---

It is ... more as a result of three years of continuation learning which aimed at the ... patients center medical care practitioner what kind of behavior modification the composite learning of P2-646 EBM X PBL brought a pharmacist Etsuko Tange 1), Masayo Takeuchi 2), Yuriko Matsue 1), Noriko Fujikawa 1), Yukiko Kasatani 1), Kazuyo Maeda 1), Old corner Yuka 1), Matsusaka Tomomi 1), Keiko Matsumoto 1), 高垣伸匡 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 486-486, 2012.

---

	Evaluation of the inconvenient on-site training in connection with P2-647-related welfare University Taiko Masao, Junji Iwashita, Katsumi Kido, Megumi Iimori Yoshiko, Shinichiro Ando, 前田共秀, Keiko Morita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 486-486, 2012.

---

The education effect of the student in the P2-648 physical assessment training and search (the first report) of the potential consciousness Masaaki Machida 1), Body marsh Masami 2), Kazumi Ishizuka 1), Yoshikazu Tanaka 1), Shunsuke Shiromizu 1), Haru Sato or 1), Masahiko Shimada 1), Tetsuro Yumoto 1), Shotaro Sakurai 1), Kiyoshi Sugiyama 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 486-486, 2012.

---

It is result and a problem in the first year a P2-649 medical care system department, the drugstore pharmacist training training to contribute to team approach in medical care by the affiliated hospital cooperation Tadashi Suzuki 1), Satoshi Fujii 1), Keiko Akashi 2), Hirotaka Ohara 3), 木村和哲 1) 4), 金兌勝 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 486-486, 2012.

---

Enforcement of the continuous set training aiming at improvement of the ability in the P2-650 JA Hokkaido public welfare ream for fur Matthew tical care plan making and the ability for discussion Hiroyasu Sato 1) 2), Ryu Kobayashi 1) 3), Hideji Ohara 1) 3), Yu Tanaka season 1) 4), Hiroaki Watanabe 1) 5), Descent from a mountain Koichi 1) 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 486-486, 2012.

---

	Examination of the pharmacist training program using the P2-651 TERUMO medical plastic neck Water pond love, 前田幹広, Minatogawa Hiroko, Upper mound Tomoko, Keiso Masuhara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 487-487, 2012.

---

Practice and evaluation of the measurement art of dispensing education for the P2-652 pharmacy school six years system postgraduate training life Masato Katsuura, Katsuhiro Fujimoto, Mitsunori Nishikawa, Miho Yamaguchi, 村地康, Yuko Kinugasa, Manabu Takegami, Masako Oishi, Yoshihiro Miwa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 487-487, 2012.

---

	P2-653 Re-evaluation of the knowledge and skills of Hospital long-term practical training [injection preparation] of pharmacy education 6-year one graduating class : That it seemed to accept the new positions who 石塚寛和, 花澤恵美, 永井淳子, 佐々木忠徳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 487-487, 2012.

---

	The intervention to the initial physician clinical practice program by the P2-654 pharmacist and prospective effect 佐藤紀宏 1), Kumiko Kasashi 1), Takehiro Yamada 1), Yoshihiko Shibayama 1), Junko Yamada 1), Yasushi Miyata 2), Toshitaka Fukai 1), Takeshi Iseki 1) 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 487-487, 2012.

---

	For a pharmacist resident system as the P2-655 six years system postgraduate training Koji Washiyama, Makoto Otsuka, Kojiro Nikami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 487-487, 2012.

---

The anticancer drug handling situation (questionary survey for the training participation pharmacist) with the cancer medical institution of the P2-656 our country 牧野好倫 1) 2), Ryoko Udagawa 1), Toru Akagi 1), Reina Nishigaki 1), Small Ido Keiichi 1), Mitsue Hirano 1), 橋本浩伸 1), Haruhiko Sakamoto 1), Genei Shinya 3), Masato Yonemura 3), Reiko Matsui 3), Yasuhiko Ichida 3), Satoshi Izumi Shiro 3), Hiroshi Yamamoto 3), Masashi Kato 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 487-487, 2012.

---

	Accidental ingestion materials of the patients coming to the hospital in accidental ingestion for P2-657 emergency pediatric service are various Tsutomu Tsujimoto, Tetsuo Nishimoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 488-488, 2012.

---

	Role ... of the medical information engineer of thing - pharmacist whom a pharmacist has for the P2-658 introduction of IT era Kazuyuki Ikeda, Rikio Tsuji, Yukiko Morita, North Keiji, Masayuki Uno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 488-488, 2012.

---

	Study on inhabitants attitude survey about the P2-659 influenza vaccination and prophylactic intervention 1000, Yokota beauty 1), Yuji Otake 2), Tadashi Eguchi light 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 488-488, 2012.

---

	Effect of the DMSO which gives it to the expression of drug metabolizing enzyme of P2-660 human liver cancer cells 牧寛子, Tomomi Watanabe, Chiaki Fukagawa, Satoshi Muto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 488-488, 2012.

---

	The thing which we see from patient related consultation and the other medical institutions consultation situation during P2-661 hospitalization Jun Wada, Chieko Yamanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 488-488, 2012.

---

	Evaluation of the circadian rhythm of Parkinson's disease using the P2-662 symptom diary Naoto Nakagawa, Miki Yamamoto, Yuka Takebayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 488-488, 2012.

---

	Characteristic of the patients hospitalized with P2-663 heart failure repeatedly Yukiko Uchiyama 1), Mariko Ooka 1), Akihiro Ihara 1), Mayumi Matsumoto 1), Takahashi sub-Mana 1), Riyusuke Rokusha 1), Tatsu Sada still 1), Keigo Ezaki 1), Tamami Teranishi 2), Takao Maruyama 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 489-489, 2012.

---

	Dissolution after the simple suspension of the P2-664 sustained release drug Adalat L lock 越野優希, 石田志朗, 椎野愛子, 神崎姫奈, 山下あずさ, 岡野善郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 489-489, 2012.

---

	Inhibition of resorption of strontium with the P2-665 alginic acid and cesium and eliminant effect Hitomi Harada 1), Yoko Idota 1), Kaori Morimoto 1), Akiko Kobayashi 2), Kakinuma 1, Chihaya), Chihiro Miyajima 3), Kasahara sentence good 3), Taku Ogiwara man 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 489-489, 2012.

---

	Attitude survey of the student athlete about the P2-666 doping The Ikeda future, 初田泰敏, Kenji Ikeda, Sono Kawanishi charges, 西井諭司, Masashi Ogawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 489-489, 2012.

---

	Fact-finding of the P2-667 medical supplies Internet sale Hironari Mizuta, 初田泰敏, Kenji Ikeda, Sono Kawanishi charges, 西井諭司, Masashi Ogawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 489-489, 2012.

---

	Action of the health insurance pharmacy that affected the increase of P2-668 smoking cessation-treated patients Eiji Hotta 1), Takasaki lawn world 1), River Takashi 1 liking it), 向畠卓哉 1), Hisako Ito 1), Hideyuki Shinoda 2), Kojiro Takashima 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 489-489, 2012.

---

	We used P2-669 medical appointment data and are built the prescription publication reservation system in the hospital visiting Kazuaki Hirao 1), Blue Tooru Mori 1) 2) 3), Masaki Abe 1), Keiko Iizuka 1), Tomonori Nakamura 1) 2), Yasushi Yamamoto Jiro 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 490-490, 2012.

---

	Trial of the new face education through the P2-670 new hiring medical supplies investigation Takawa Hiroshi, Yusuke Tanaka, Takashi Araki University, 金光祥臣, Akiko Ito, Hiroyasu Sasahara, Keiko Arakawa, Seiichi Maruyama, Satoshi Toyama, Hiroshi Sato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 490-490, 2012.

---

	CJK-P-01 Appling Metabolomics to the Investigation on Anti-Sport Fatigue Effects of Korean Ginseng Given to Professional Athletes Bei Yan1)2), Jiye A1), Guangji Wang1), Ying Zhang1), Weibin Zha1), Linsheng Liu1), Hu xin2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 493-493, 2012.

---

	CJK-P-02 Cyclosporine therapeutic drug monitoring in nephrotic syndrome: which time point to use for a generic product? Du Xiaoli1), Wang Haiyun2), Fu Qiang1), Wang Ke2), Chen Limeng2)3), Li Xuemei2), Zhu Zhu1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 493-493, 2012.

---

	CJK-P-03 EFFECT OF CO-ADMINISTRATION ATENOLOL ON THE RENAL EXCRETION OF ORAL EXCRETION OF ORAL HYPOGLYCEMIC AGENT METFORMIN HYDROCHLORIDE IN RATS J.X. Ren, Y. Zhou, Y.H Wei, X.A. Wu, G.Q. Zhang, J.P. Zhang Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 493-493, 2012.

---

	CJK-P-04 EFFECTS OF PYRIDOXINE ON THE INTESTINAL ABSORPTION AND PHARMACOKINETICS OF ISONIAZID IN RATS Y. Zhou, J.X. Ren, D. Wang, F. Zhang, Y.H. Wei, XA Wu, G.Q. Zhang, H.G. Duan, L.J. Wang Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 494-494, 2012.

---

	CJK-P-05 A Systematic Evaluation of Ginkgo Biloba Leaves Injection’s Effect on Coronary Heart Disease Yang Yiheng, Zhang Mengsen Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 494-494, 2012.

---

	CJK-P-06 Preliminary Study on Thetreatment Mechanism of Yin-Zhi-Huang Granules to Rat Cholestasis Inducedby Estrgen G.Q. Zhang, Y. Zhou, J.X. Ren, J.P. Zhang, F. Zhang, Y.H. Wei, XA Wu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 494-494, 2012.

---

	CJK-P-07 Issues in Prescription Analysis and Recognition of Inappropriate Prescription Wang Hailian, Yan Suying Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 495-495, 2012.

---

	CJK-P-08 Effects of Pluronic(R) F68 and PEF400 on the biliary excretion and urine excretion of rifampicin J. Zhao, Y.H. Wei, G.Q. Zhang, X.A. Wu, J.X. Ren Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 495-495, 2012.

---

	CJK-P-09 THE PHARMACOKINETICS OF RIFAMPICIN, CARBAMAZEPINE AND METFORMIN HYDROCHLORIDE IN MICE WITH CHOLECYSTECTOMY Y.H. Wei, X.A. Wu, F. Zhang, Y. Zhou, D. Wang, G.Q. Zhang, J.P. Zhang Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 495-495, 2012.

---

	CJK-P-10 Improve Hypertension Patient Education Material’s Quality using illustration and animation:a randomized study. GONG Jue1)2), ZHAI Suodi1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 496-496, 2012.

---

	CJK-P-11 Assessment of drug induced liver injury and the relevant factors; Fluconazole and Voriconazole Ah Young Jeon, Go Wun Choi, Yoon Sook Cho, Hyang Sook Kim, Hye Suk Lee Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 496-496, 2012.

---

	CJK-P-12 Analysis of outpatient medication use in elderly patients and adequacy assessment Hyun-Hee Pako, Hui-Gyeong Woo, Eun-Jeong Shin, Jeong-Mi Lim, Hyang-Suk Kim, Hye-Suk Lee Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 496-496, 2012.

---

	CJK-P-13 Review of pharmacists’drug prescription double check method - Based on split / grinding prescription Joo Kyoung Kim, Yun Hee Jo, Sun Hoi Jung, Hye Sook Lee Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 497-497, 2012.

---

	CJK-P-14 The Analysis of Adverse events and The Assessment of Risk factor of Anti-Tumor Necrosis Factor (TNF) Jung Eun Kim, Sun Hyo Jeong, Hye Suk Lee Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 497-497, 2012.

---

	CJK-P-15 Modification of Warfarin Dosing in Korean Patients with Mechanical Heart Valves before Teeth Extraction Moon Jin Kim1), Kyung Ae Kim1), Jung Mi Lim1), Hyang Sook Kim1), Hye Suk Lee1), Kyung Hwan Kim2), Ki Bong Kim2), Hyuk Ahn2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 497-497, 2012.

---

	CJK-P-16 L-asparaginase hypersensitivity reactions in Korean pediatric acute lymphoblastic leukemia patients. Su Hyun Ryu, Jung Ran Lee, Kui Sook Kim, Yong Hwa Lee, Hye Suk Lee Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 498-498, 2012.

---

	CJK-P-17 Development of a Simple Suspension Method for New Drugs Yasuyuki Masaoka, Akane Takemoto, Atsushi Ogawa, Satoru Ezumi, Yoichi Kawasaki, Toshiaki Sendo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 498-498, 2012.

---

	CJK-P-18 Cytotoxicity of Three Polymerization Agents on Human Monocytes Yoichi Kawasaki, Chiaki Tsuboi, Miwa Morizane, Toshiaki Sendo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 498-498, 2012.

---

	CJK-P-19 Outcome of nutrition support team intervention in patients with diarrhea Yukari Shibata, Tomohide Fukamizu, Yasuo Takeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 499-499, 2012.

---

	CJK-P-20 A survey on communication skills for the trainees pharmacy practice Yoshihiro Shimodozono, Keiko Yaji, Ryuji Ikeda, Yasuo Takeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 499-499, 2012.

---

	CJK-P-21 The effects of pharmacists’ active intervention in Therapeutic Drug Monitoring Hitomi Ariga, Nobue Yoshinari, Tetsuya Kudo, Ayaka Ohta, Masayo Tanaka, Takao Orii Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 499-499, 2012.

---

	CJK-P-22 Practical use of a large-scale database for safety measures Takao Orii Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 500-500, 2012.

---

	Revival, reconsideration, the medical future of the wound no hearing best 眞野成康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 30-30, 2013.

---

	Challenge to realization and the spread of regenerative therapy 岡野光夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 31-31, 2013.

---

	About creating the future, and describing it 瀬名秀明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 32-32, 2013.

---

	For establishment of the pharmacist professional ability 北田光一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 33-33, 2013.

---

	Drug reaction-related individual difference 鈴木洋史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 34-34, 2013.

---

	The adverse event of the molecular target drug: Around a gastrointestinal carcinoma domain 結城敏志1), 小松嘉人2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 35-35, 2013.

---

	Pneumonia that was obtained more in Japanese cause of death third position! Where does the antibiotic exposure advance to? 渡辺彰 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 36-36, 2013.

---

	Future in Healthcare：new opportunities for Pharmacists Jacqueline Surugue Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 37-37, 2013.

---

	Establishment of the elucidation of the drug interactions of glaucoma eye drops and the costs minimization analysis of the instillation therapy 池田博昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 38-38, 2013.

---

	The search of the objective metrics of hospital infection measures: Antimicrobial consumption in Japan and drug-resistant relations 村木優一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 39-39, 2013.

---

	Study on risk factor of the neutropenia with the cancer medical therapy 矢野良一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 40-40, 2013.

---

	Study on preparation development in consideration of internal change properties of the functional foods ingredient 佐藤夕紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 41-41, 2013.

---

	Study on peripheral neuropathy with the anticancer agent and retching, vomiting 辰島瑶子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 42-42, 2013.

---

	Pharmacokinetic change at the administration between nutrient for intestinal administration long terms 東敬一朗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 43-43, 2013.

---

	Study on application to the development of the human inhalational pattern reproduction device and the proper use of the inhalant 平大樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 44-44, 2013.

---

	Search of the internal change change factor of molecular target medicine imatinib for the purpose of the individualization administration plan in the chronic myelogenous leukemia 山川裕司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 45-45, 2013.

---

	About the safety of so-called health food and supplement 畝山智香子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 46-46, 2013.

---

	Life of structure and us of the safety assessment of food and the medicine 山添康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 47-47, 2013.

---

	The revival situation of soil -1-S1-1 Miyagi 大久保久美子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 50-50, 2013.

---

	Action of Tohoku University for the community medical care system maintenance after the soil -1-S1-2 Great East Japan Earthquake 石井正, 奈良正之, 金村政樹, 高山真, 田中淳一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 51-51, 2013.

---

	Receive tsunami damage of the soil -1-S1-3 Great East Japan Earthquake 小室一生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 51-51, 2013.

---

	About a problem and the subsequent revival measures that it showed from soil -1-S1-4 pharmacist dispatch 小野俊一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 52-52, 2013.

---

	Revision of the soil -1-S1-5 anti-disaster measures manual 小野真士 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 52-52, 2013.

---

	Community medical care care welfare cooperation by soil -1-S1-6 MMWIN 中谷純 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 53-53, 2013.

---

	Soil -2-S2-1 renal function and the evaluation 高松典通1)2), 土井俊夫2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 54-54, 2013.

---

	Soil -2-S2-2 chronicity kidney disease 美馬晶, 土井俊夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 55-55, 2013.

---

	Soil -2-S2-3 acute renal failure (AKI) and drug 木村秀樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 55-55, 2013.

---

	Proper use of the drug in the soil -2-S2-4 renal failure 齋藤秀之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 56-56, 2013.

---

	Let's perform "reconsideration" of cancer medical therapy! It is ... from invention of ... preparation to the development of the by Osh mirror 河原昌美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 57-57, 2013.

---

	Point of the evaluation about quality, the effectiveness, the safety in the approval application of soil -2-S3-1 by Osh mirror antibody pharmaceutical products 新見伸吾 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 58-58, 2013.

---

	Action - Europe and America, the domestic present situation to soil -2-S3-2 by Osh mirror development, medical care, economic needs and risk management 南部静洋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 58-58, 2013.

---

	The exposure to soil -2-S3-3 anticancer agent and the measures 中西弘和1), 岩根裕紀1)2), 小林由佳1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 59-59, 2013.

---

	Development of the improved preparation of paclitaxel using soil -2-S3-4 human serum albumin 山谷英利 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 59-59, 2013.

---

	Expectation and problems from the healthcare setting to invention of the soil -2-S3-5 pharmaceutics 林昌洋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 60-60, 2013.

---

	Research and development of DDS which pointed to soil -2-S3-6 cancer treatment 石田竜弘, 際田弘志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 60-60, 2013.

---

	Look after a specialist in soil -2-S4-1; action ... to the information sharing by medicine medicine cooperation ... many types of job 立松三千子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 61-61, 2013.

---

	The prescription drugstore where soil -2-S4-2 was not closely related to: Helping medicine, and having changed through medicine medicine cooperation 佐藤洋造 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 62-62, 2013.

---

	Look after a specialist in soil -2-S4-3; the result by a role and the action of the nurse in the medicine medicine cooperation 小原真紀子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 62-62, 2013.

---

	Role of the health insurance pharmacy in soil -2-S4-4 cancer treatment 秋山理恵 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 63-63, 2013.

---

	Action in cooperation - ethical pharmacy spreading out by soil -2-S4-5 small invention 佐藤由美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 63-63, 2013.

---

	We look after a specialist in soil -2-S4-6 and survey it with result of the medicine medicine cooperation 室圭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 64-64, 2013.

---

	Role of the team approach in medical care in the soil -3-S5-1 CKD-MBD management 小岩文彦1), 緒方浩顕2), 衣笠えり子2), 溝渕正英3), 秋澤忠男3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 65-65, 2013.

---

	It is ... from the situation of importance - nurse of the self-care management continuation support of the team cooperation that we were able to see from a recognition investigation of soil -3-S5-2 phosphorus 奥野晴美, 辻本保子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 66-66, 2013.

---

	It is ... from the situation of skill - dietitian who demands it from an action and a pharmacist of CKD-MBD in the soil -3-S5-3 maintenance dialysis 平賀恵子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 66-66, 2013.

---

	Relation ... of the CKD-MBD measures - pharmacist wrestling by soil -3-S5-4 team 溝手彩1), 中西麻由香1), 野崎歩1), 小林由佳1), 新宮とし子1), 近藤麻紀子2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 67-67, 2013.

---

	The fact of CKD-MBD in our soil -3-S5-5 House and pharmaceutical management 矢野未来 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 67-67, 2013.

---

	How can the pharmacist in the hospital be associated with CKD-MBD for soil -3-S5-6 acute phase? 鈴木大介, 杉浦洋二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 68-68, 2013.

---

	An effect of diabetic nephropathy treatment with the soil -3-S6-1 team approach in medical care (renal function improvement outpatient department) and the role of the pharmacist and future problem 海津嘉蔵1)2), 牧野以佐子3), 細川緑3), 松本史郎3), 相馬正義1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 69-69, 2013.

---

	Action of the team approach in medical care in the soil -3-S6-2 diabetes dialysis prophylactic instruction 岩崎真宏1), 北谷直美1), 安原章浩2), 矢部大介1)3), 黒瀬健3), 清野裕4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 70-70, 2013.

---

	It is ... from the situation of thing - nurse who expects it of a pharmacist when we support the patients in soil -3-S6-3 diabetes medical care team 豊島麻美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 70-70, 2013.

---

	Role of the pharmacist in the soil -3-S6-4 diabetes dialysis prophylactic instruction 小林庸子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 71-71, 2013.

---

	A reaction and possibility of the soil -3-S6-5 diabetes pharmacist outpatient department 三上有希, 新宮とし子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 71-71, 2013.

---

	We think about the proper use of pharmaceutical products to protect kidney of soil -3-S6-6 diabetes 三宅健文, 岡本早織, 宇野葵, 牛嶋麻紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 72-72, 2013.

---

	A summary and the present conditions of the pharmacist system specialized in soil -4-S7-1 medical therapy 山田清文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 73-73, 2013.

---

	The practice of soil -4-S7-2 medical treatment duties based on the high specialty and personnel training of the extensive generalist 内藤隆文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 74-74, 2013.

---

	Activity case as the pharmacist specialized in soil -4-S7-3 medical therapy 千崎康司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 74-74, 2013.

---

	Relation to medical therapy in soil -4-S7-4 lifesaving first aid, the intensive care 関本裕美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 75-75, 2013.

---

	Thing to expect of a pharmacist specialized in medical therapy judging from the viewpoint of the soil -4-S7-5 cancer medical therapy specialist 加藤俊介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 75-75, 2013.

---

	Let's acquire a pharmacist specialized in soil -4-S7-6 medical therapy! 河原昌美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 76-76, 2013.

---

	土-4-S7-7 The present conditions and the future prospects of the pharmacist specialized in medical therapy - About a future system design (additional authorization) - 望月眞弓 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 76-76, 2013.

---

	Are soil -4-S8-1 medical care security and the medical information engineer of information system - why pharmacist necessary? 土屋文人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 77-77, 2013.

---

	The relation with the role other types of job of the pharmacist in the soil -4-S8-2 medical information system and medical security 木下元一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 78-78, 2013.

---

	土-4-S8-3 Efforts of a pharmacist, the medical information engineer in the drug section - Relation to user education - 関谷泰明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 78-78, 2013.

---

	It is ... from the situation of the pharmacist combining with a ... medical care information room to soil -4-S8-4 medical information system introduction and maintenance 岡橋孝侍 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 79-79, 2013.

---

	土-4-S8-5 A medical information system and pharmacist - What is the medical information engineer? - 池田和之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 79-79, 2013.

---

	A diagnosis and treatment of patients with poisoning in the soil -4-S9-1 emergency care 伊関憲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 80-80, 2013.

---

	It is ... mainly on poisoning analytical point - simple technique to be helpful when there is soil -4-S9-2 intellect 藤田友嗣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 81-81, 2013.

---

	The role of the soil -4-S9-3 Japan poison control center and pharmaceutical reporting, data accumulation 黒木由美子, 遠藤容子, 波多野弥生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 81-81, 2013.

---

	Practice of the pharmaceutical approach in the soil -4-S9-4 poisoning 佐藤智人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 82-82, 2013.

---

	土-4-S9-5 Practice of the pharmaceutical management in patients with poisoning - Poisoning analysis duties of the Niigata Municipal Hospital - 野澤まゆ, 塩田浩平, 島田祐子, 藤澤真奈美, 堀寧, 小田明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 82-82, 2013.

---

	Soil -5-S10-1 I am ... towards ideal pharmacist image and basic medical knowledge - mutual respect to think of 大八木秀和 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 83-83, 2013.

---

	Approach of the infection domain that soil -5-S10-2 ward pharmacist practices 山田和範 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 84-84, 2013.

---

	The clinical knowledge that is necessary in soil -5-S10-3 first aid, an intensive care domain 中馬真幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 84-84, 2013.

---

	Viewpoint from the soil -5-S10-4 circulatory organ domain 梶原洋文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 85-85, 2013.

---

	With the nutrition therapy demanded from soil -5-S11-1 pharmacist 杉浦伸一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 86-86, 2013.

---

	土-5-S11-2 Role to expect of a pharmacist - From the situation of the nurse - 森みさ子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 87-87, 2013.

---

	Role of the therapeutist specialized in knowledge and NST of the nutrition therapy necessary for soil -5-S11-3 pharmacist 吉中千佳, 久道周彦, 眞野成康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 87-87, 2013.

---

	土-5-S11-4 The nutrition therapy that a pharmacist should wear - Three power to be obtained from there - 東敬一朗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 88-88, 2013.

---

	Battle front of the nutrition therapy in the soil -5-S11-5 relaxation medical care 二村昭彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 88-88, 2013.

---

	Soil -5-S11-6 inside the hospital, an institution, the thing that a pharmacist should do to tie at-home NST is construction ... of the nourishment support system in ... area 増田修三 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 89-89, 2013.

---

	Expect it as soil -5-S11-7 physician 宮田剛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 89-89, 2013.

---

	土-5-S12-1 The present conditions in the cancer practice cooperation base Hospital - Japanese Society of Hospital Pharmacists academic third subcommittee questionnaire results - 松尾宏一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 90-90, 2013.

---

	Directionality of pharmacist duties in the soil -5-S12-2 outpatient department chemotherapy 吉村知哲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 91-91, 2013.

---

	Action of the pharmacist in the foreign cancer chemotherapy that we aim at soil -5-S12-3 safety and the improvement of the quality of life 地主隆文, 青田忠博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 91-91, 2013.

---

	Contribution and problem ... to the patients thinking from an action with medicine medicine cooperation - five years mainly on the medicine notebook in the soil -5-S12-4 cancer chemotherapy 縄田修一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 92-92, 2013.

---

	Pharmacist at the Front Line ... specialized in function and role - cancer that a pharmacist outpatient specialized in soil -5-S12-5 cancer is possible 今村牧夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 92-92, 2013.

---

	Action of the pharmacist in the foreign chemotherapy that adopted soil -5-S12-6 CDTM 阪田安彦, 開浩一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 93-93, 2013.

---

	Expectation for a characteristic and the implementation of RMP for soil -6-S13-1 Japan 森和彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 94-94, 2013.

---

	The expectation to implementation and the pharmacist of the soil -6-S13-2 risk management plan: To be better by risk minimization 古閑晃 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 95-95, 2013.

---

	Relation of the hospital pharmacist to soil -6-S13-3 risk minimization 林昌洋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 95-95, 2013.

---

	Risk management plan of the medical therapy made in the viewpoint of the soil -6-S13-4 patients 花井十伍 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 96-96, 2013.

---

	土-6-S14-1 The PBL education by medical simulator target the fifth grade before practical practical training[Machine Translation] (実務実習前の5年生を対象にした医療用シミュレーターによるPBL教育) 江川孝, 島田憲一, 高見陽一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 97-97, 2013.

---

Participation in planning of the pharmacy school sixth grader who finished business training to action (knob medicine bag motion) of the Fukuoka-shi pharmacist society who assumed "the Residual medicine" of the soil -6-S14-2 outpatient a problem 島添隆雄1), 小柳香織1)2), 打越英恵1), 小林大介1), 窪田敏夫1), 三井所尊正2), 吉田武夫2), 木原太郎2), 高木淳一2), 瀬尾隆2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 98-98, 2013.

---

	The construction of the advanced PBL class with the unification type curriculum in the soil -6-S14-3 sixth grader and the evaluation 寺町ひとみ1), 舘知也1), 堀内正2), 保住功3), 杉山正4), 土屋照雄5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 98-98, 2013.

---

	土-6-S14-4 Co-education programs for clinical judgment capacity building : How to learn from the virtual case 長谷川洋一1), 大津史子1), 後藤伸之1), 黒野俊介1), 伊東亜紀雄1), 永松正1), 早川伸樹1), 脇田康志1), 半谷眞七子1), 藤崎和彦2), 亀井浩行1), 野田幸裕1), 森健1), 灘井雅行1), 岡本浩一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 99-99, 2013.

---

	The example that soil -6-S15-1 drug affected the IV line and the thing which we saw from the correspondence 松田千恵子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 100-100, 2013.

---

	About the combination attention example introduction about the medical materials which need attention when soil -6-S15-2 drug is given and an offer of the proper use information to the settings 三田哲也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 101-101, 2013.

---

	The way of the combination example of soil -6-S15-3 drug and medical materials and the risk management 石井健介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 101-101, 2013.

---

	The actual situation and problem of the soil -6-S15-4 medical care device management 杉浦伸一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 102-102, 2013.

---

	Who is it to manage the medical materials for soil -6-S15-5 medication? 荒井有美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 102-102, 2013.

---

	About basic knowledge of the pain relief postoperative during art of soil -7-S16-1 伊藤健二, 鈴木利保 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 103-103, 2013.

---

	Significance of Patient controlled analgesia (PCA: patients autoregulation painkilling) in the soil -7-S16-2 postoperative pain relaxation 橋口さおり Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 104-104, 2013.

---

	It is a way of thinking of the postoperative pain relaxation by recovery reinforcement) program after an operation soil -7-S16-3 ERAS(Enhanced Recovery After Surgery 太田博文, 真貝竜史, 松永寛紀, 福永浩紀, 豊田泰弘, 野間俊樹, 吉岡節子, 吉岡晶子, 北條茂幸, 大東弘明, 前浦義市 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 104-104, 2013.

---

	Postoperative pain relaxation (as a nurse) to work on by soil -7-S16-4 team 遠藤みどり Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 105-105, 2013.

---

	Postoperative pain relaxation (as a pharmacist) to work on by soil -7-S16-5 team 柴田ゆうか Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 105-105, 2013.

---

	The present conditions and problems of the soil -7-S17-1 children medical therapy 石川洋一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 106-106, 2013.

---

	Action of ward placement duties in the soil -7-S17-2 NICU 遠藤美緒 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 107-107, 2013.

---

	Action of ward placement duties in the soil -7-S17-3 infants ward 中野一也, 木村麻子, 橋詰宏美, 堀部明美, 中村慶, 桑原健 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 107-107, 2013.

---

	Expectation from soil -7-S17-4 physician to a pharmacist for the childhood medical therapy that we saw 佐藤篤 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 108-108, 2013.

---

	The ward drug duties enforcement addition in the soil -7-S18-1 psychopathic ward 横山茂 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 109-109, 2013.

---

	Intervention example to an action and patients of the soil -7-S18-2 psychology education with bipolar disorder 木藤弘子, 国見美紀, 石田保美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 110-110, 2013.

---

	Intervention example by the team for patients with mental disorder having difficulty with soil -7-S18-3 correspondence 梅田賢太 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 110-110, 2013.

---

	A role and intervention example of the pharmacist in the safety management of soil -7-S18-4 clozapine 高橋結花 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 111-111, 2013.

---

	Pharmacist duties and intervention example of the psychiatry domain in the soil -7-S18-5 community medical care 桑原秀徳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 111-111, 2013.

---

	Expectation to a pharmacist in soil -12-S19-1 team approach in medical care, the community medical care 中井清人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 112-112, 2013.

---

	We investigate joint medical treatment management for Japan from factorial experiments of the change of prescription in the soil -12-S19-2 medical office 源川奈穂 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 113-113, 2013.

---

	We investigate directionality of the new duties expansion from factorial experiments of the change of prescription in the soil -12-S19-3 Hospital 山内泰一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 113-113, 2013.

---

	Not coming by - practice from factorial experiments of the change of prescription in the soil -12-S19-4 health insurance pharmacy, the thing that you should perform 小林満 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 114-114, 2013.

---

	Importance of the education for disease control in the soil -12-S19-5 area 富岡佳久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 114-114, 2013.

---

	Possibility of the clinical reasoning in the soil -12-S20-1 pharmacist 川口崇 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 115-115, 2013.

---

	Multicenter attitude survey ... in one or ... university hospital where the soil -12-S20-2 clinical reasoning includes the needs 北原加奈之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 116-116, 2013.

---

	... to learn by the talks with the soil -12-S20-3 bedside clinical reasoning - primary physician 徳田安春 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 116-116, 2013.

---

	The 72 years old woman that was urgently conveyed by disturbance of consciousness of the soil -12-S20-4 sudden onset 今井徹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 117-117, 2013.

---

	71 years old man of the gastric cancer which presented soil -12-S20-5 nausea, anorexia, drift 東加奈子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 117-117, 2013.

---

	From the expectation to a pharmacist thinking about soil -12-S20-6, the viewpoint of the physician 岸田直樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 118-118, 2013.

---

	Soil -12-S21-1 high risk medicine and ward drug duties 山室蕗子, 近藤元三 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 119-119, 2013.

---

	Action for the enforcement of soil -12-S21-2 efficiency-like ward drug duties 合澤啓二, 岩田一史, 浦田由紀乃, 河内山佳英, 平田憲史郎, 上田賢太郎, 宮里麻友美, 平明日美, 山野朋子, 陣上祥子, 福永栄子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 120-120, 2013.

---

	Action of ward drug duties and the regional alliances for the soil -12-S21-3 CKD patients 宮村重幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 120-120, 2013.

---

	For the new development of soil -13-S22-1 parenteral injection duties 東海林徹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 121-121, 2013.

---

	Theoretical discussion about the soil -13-S22-2 parenteral injection incompatibility 内田享弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 122-122, 2013.

---

	Alien substance development and adverse event derived from soil -13-S22-3 parenteral injection container 千堂年昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 122-122, 2013.

---

	The basics and risk management of the soil -13-S22-4 electrolyte infusion 倉本敬二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 123-123, 2013.

---

	Development of ward drug duties by the soil -13-S22-5 parenteral injection proper use 室井延之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 123-123, 2013.

---

	The present conditions of the soil -13-S22-6 anticancer agent mixed preparation 松原肇 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 124-124, 2013.

---

	We take the soil -13-S22-7 anticancer agent and take the measures with the problem at handling 杉浦伸一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 124-124, 2013.

---

	Introduction Takao Orii1), Hitoshi Sasaki2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 126-126, 2013.

---

	土-13-S23-1 Palliative care for patients by interdisciplinary team on outpatient cancer chemotherapy Makoto Kajizono, Yoshihisa Kitamura, Toshiaki Sendo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 126-126, 2013.

---

	土-13-S23-2 Pharmacy Location and Professional in Hospital Ma Manling Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 127-127, 2013.

---

	土-13-S23-3 Satisfaction assessment survey on the ward-based clinical pharmacy specialist service Yong-hyun Moon1), Eun-ha Park1), Seong-sim Ahn1), Soon Joo Kim1), Hyen O La2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 128-128, 2013.

---

	土-13-S23-4 Patient Safety and Quality Control of Hospital Pharmacy Medication Administration Rongsheng Zhao Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 128-128, 2013.

---

	土-13-S23-5 Oxaliplatin-induced hypersensitivity reactions in colorectal cancer treated with mFOLFOX6 Young Mi Lim1), Lee Jung Won1), Mi Jin Kim1), Ae Ryoung Park1), Soon Joo Kim1), Hyen O La1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 129-129, 2013.

---

	土-13-S23-6 Economic effect of the pharmacist in the operation part Junko Arima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 129-129, 2013.

---

	土-13-S23-7 Role and Value of Chinese Pharmacists in Medical Teams Zhao Zhi-gang Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 130-130, 2013.

---

	New development of the dementia medical care in soil -14-S24-1 Japan: Based on orange plan 森啓 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 131-131, 2013.

---

	Progress and the future prospects of the medical treatment in soil -14-S24-2 Alzheimer's disease 荒井啓行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 132-132, 2013.

---

	Intellect love of music of the soil -14-S24-3 dementia care 山崎英樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 132-132, 2013.

---

	The present conditions and problems of inspection and the reporting for the outside Parliament prescription including the soil -14-S25-1 anticancer agent 渡部一宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 133-133, 2013.

---

	土-14-S25-2 Efforts of the hospital pharmacist for the outside Parliament prescription issue of anticancer agent - In a middle scale hospital - 宮崎美子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 134-134, 2013.

---

	It is ... in action ... university hospital of the hospital pharmacist for the soil -14-S25-3 outside Parliament prescription publication 政田幹夫, 中村敏明, 五十嵐敏明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 134-134, 2013.

---

	Expectation to a role and the hospital pharmacist of the drugstore pharmacist in the outside Parliament prescription formulations of the soil -14-S25-4 anticancer agent 太田愛子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 135-135, 2013.

---

	土-14-S25-5 About a relation of the hospital pharmacist for the outside Parliament prescription issue of anticancer agent - Than various questionnaire findings - 濃沼政美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 135-135, 2013.

---

	Role of the pharmacist in the soil -14-S26-1 care health center for the elderly 幸坂英明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 136-136, 2013.

---

	Ward drug duties in the soil -14-S26-2 person with a disability regular hospital 山田英俊 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 137-137, 2013.

---

	Practice and cooperation of the pharmaceutical management in the soil -14-S26-3 medical treatment ward 武藤浩司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 137-137, 2013.

---

	The need of the ward drug duties in the soil -14-S26-4 convalescent rehabilitation sickbed 樋島学 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 138-138, 2013.

---

	It is practiced the pharmaceutical care for hospitalization and the discharge before soil -14-S26-5 hospitalization 栗林左知 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 138-138, 2013.

---

	Testing order and medical therapy evaluation by the soil -14-S26-6 ward pharmacist 棗則明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 139-139, 2013.

---

	Basics of a response and the communication technology of the heart of patients with day -1-S27-1 cancer 内富庸介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 140-140, 2013.

---

	Present conditions and problems ... by relation ... delirium treatment of the hospital pharmacist in the field of day -1-S27-2 mind tumor 市田泰彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 141-141, 2013.

---

	Care of the heart of patients with cancer to consider in the situation of the pharmacist specialized in -1-S27-3 psychiatry on a day 梅田賢太 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 141-141, 2013.

---

	The relation pharmacist who included the mental follow to -1-S27-4 home care patient and the family on a day 竹内尚子, 野田和多流, 森雅哉, 前田崇之, 小池崇史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 142-142, 2013.

---

	Mentation change with the anticancer agent administration to guess from -1-S27-5 fundamental researches on a day 北村佳久, 千堂年昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 142-142, 2013.

---

	To make hospital in -2-S28-1 addition 1 institution and addition 2 institution cooperation important on a day 高山和郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 143-143, 2013.

---

	Approach from the pharmacist to day -2-S28-2 environment round 山田和範 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 144-144, 2013.

---

	The hand hygiene that -2-S28-3 pharmacist takes on a day 坂野昌志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 144-144, 2013.

---

	Hint of the surveillance activity utilized the pharmacist power of the cottage-hospital out of day -2-S28-4 片山歳也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 145-145, 2013.

---

	Proper use of the antimicrobial carried out in cottage-hospital out of -2-S28-5 on a day 三星知 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 145-145, 2013.

---

	It is the activity process of - Japanese Society of Hospital Pharmacists arts and sciences seventh subcommittee for -2-S29-1 Safe Handling of Hazardous Drugs on a day 櫻井美由紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 146-146, 2013.

---

	Pollution investigation due to the excrement of day -2-S29-2 cancer chemotherapy patients 森本茂文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 147-147, 2013.

---

	Problem of the day -2-S29-3 oral anticancer medicine 石丸博雅 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 147-147, 2013.

---

	It is ... from the situation of action ... nurse to prevention of day -2-S29-4 exposure 平井和恵 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 148-148, 2013.

---

	From the situation of the Safe Handling - physician whom we looked at from the viewpoint of -2-S29-5 medical care security on a day 青儀健二郎1), 小暮友毅2), 鵜池敏令2), 角英2), 岸田恵3), 森ひろみ3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 148-148, 2013.

---

	Summary of day -2-S29-6 guidelines 阿南節子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 149-149, 2013.

---

	Expectation to day -3-S30-1 perioperative care team project and a pharmacist 落合亮一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 150-150, 2013.

---

	Project "ESSENSE" which the surgical staff thinks about to promote recovery after -3-S30-2 technique on a day 宮田剛1), 石橋生哉2), 海堀昌樹3), 谷口英喜4), 深柄和彦5), 若林秀隆6), 鷲澤尚宏7) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 151-151, 2013.

---

	Recent topic about the day -3-S30-3 perioperative use medicine 前原康宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 151-151, 2013.

---

	Fur Matthew tical care to make use of in medical care for the -3-S30-4 perioperative period on a day 柴田ゆうか Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 152-152, 2013.

---

	日-3-S30-5 We think that a pharmacist should carry it by perioperative medical care - From a viewpoint of the risk management - 畝本賜男, 武田弘太郎, 長原新太郎, 杉山未緒, 玉井理大, 鈴木藍, 菅谷和也, 宋静香, 片山志郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 152-152, 2013.

---

	With the physician pharmacist joint medical treatment management which there is on a day for Japan in the -3-S30-6 perioperative period 舟越亮寛1)3), 吉野和子1), 河合典子1), 石井弘幸1), 美濃口洋一2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 153-153, 2013.

---

	The use of the genetic polymorphism for the purpose of the individualization medical therapy of the day -3-S30-7 postoperative pain 内藤隆文, 田中紀章, 川上純一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 153-153, 2013.

---

	We think about -4-S31-1 antihypertensive medications on a day 鈴木亜矢子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 154-154, 2013.

---

	We think about -4-S31-2 alleviation of fever anti-inflammatory analgesics (containing acetaminophen) on a day 西村あや子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 155-155, 2013.

---

	We think about -4-S31-3 benzodiazepine drugs on a day 中島研 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 155-155, 2013.

---

	The pregnancy and diabetes therapeutic drug to read from -4-S31-4 prescription on a day, and to untie 土屋晃三 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 156-156, 2013.

---

	Infection practice of the person with day -4-S32-1 immunodeficiency 大曲貴夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 157-157, 2013.

---

	日-4-S32-2 How to find HIV infection - Because we do not miss HIV hiding behind in influenza-like symptoms or a malignant lymphoma - 伊藤俊広 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 158-158, 2013.

---

	Attention point of the opportunistic infection therapeutic drug in day -4-S32-3 drug duties 佐藤麻希 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 158-158, 2013.

---

	日-4-S32-4 Role of a point and the pharmacist of the postexposure prophylaxis - Let's become a pharmacist relied on at a needle pad accident - 増田純一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 159-159, 2013.

---

	Revision and examination policy of the pharmacist authorized system rule specialized in day -5-S33-1 cancer 谷川原祐介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 160-160, 2013.

---

	A fact and case summary (foreign chemotherapy) of the day -5-S33-2 pharmaceutical intervention 松尾宏一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 161-161, 2013.

---

	A fact and case summary (hepatocytes cancer and stomach cancer) of the day -5-S33-3 pharmaceutical intervention 松波奈緒美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 161-161, 2013.

---

	日-5-S33-4 Efforts to the systemic management of the side effect - Parvocellular lung cancer, kidney cancer - 高田慎也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 162-162, 2013.

---

	A fact and case summary (colon cancer) of the day -5-S33-5 pharmaceutical intervention 土屋雅美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 162-162, 2013.

---

	A fact and case summary (non-Hodgkin's lymphoma) of the day -5-S33-6 pharmaceutical intervention 葉山達也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 163-163, 2013.

---

	Art of the day -5-S33-7 case summary form 濱敏弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 163-163, 2013.

---

	Questionary survey about the day -6-S34-1 clinical system teacher (businessman teacher) 野田幸裕 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 164-164, 2013.

---

	-6-S34-2 University expect it of a clinical system teacher on a day 杉原多公通 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 165-165, 2013.

---

	日-6-S34-3 Expect it of a clinical system teacher from the healthcare setting - In the case of a university hospital - 山田清文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 165-165, 2013.

---

	The activity as the day -6-S34-4 clinical teacher and future problem 村井ユリ子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 166-166, 2013.

---

	日-6-S34-5 Activity report from a clinical teacher - Introduction of a pharmacy education, the study in first aid, the intensive care domain - 名倉弘哲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 166-166, 2013.

---

	The present conditions of the simulation education in the day -6-S35-1 pharmacy school 内海美保1), 徳永仁2), 山元弘1), 高村徳人2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 167-167, 2013.

---

	Action of the active pharmacy education feeding the pharmaceutical reason that utilized -6-S35-2 living body simulator on a day 別生伸太郎1), 濱田真向1), 井上みち子1), 戸張裕子1), 亀山俊2), 滝澤健司2), 相原佑希2), 三溝和男1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 168-168, 2013.

---

	It is tried the physical assessment training of experiencing it -6-S35-3 on a day 朝波省吾 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 168-168, 2013.

---

	Physical assessment by the pharmacist to practice by -6-S35-4 treatment at home on a day 手嶋無限 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 169-169, 2013.

---

	The practical pharmacy education which you should convey by -6-S35-5 simulation education on a day 名倉弘哲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 169-169, 2013.

---

	It is performed the advanced OSCE using ... living body simulator for new development for the professional ability improvement of the -6-S35-6 pharmacist on a day 徳永仁, 高村徳人, 緒方賢次, 瀬戸口奈央, 佐藤圭創 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 170-170, 2013.

---

	Trial of "the class for diabetics for the staff" in day -7-S36-1 Fushimi-ku 井上里絵 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 171-171, 2013.

---

	Ogori, diabetes enlightenment activity in the Tachiarai district that the -7-S36-2 various types of job conduct in solidarity on a day 赤司朋之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 172-172, 2013.

---

	Diabetes regional alliances through the participation type workshop by the pharmacist of day -7-S36-3 Kumamoto 西村博之1)2), 山崎康晴2)3), 佐伯英康2)4), 秋吉明子2)5), 永田浩泰2)5), 村上義幸2)6), 西村久2)7), 廣田有紀2)8), 吉田陽1)2), 大久保達也2)9), 石塚洋一2)10), 宮村重幸2)3), 齋藤秀之2)11) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 172-172, 2013.

---

	Day -7-S36-4 "diabetes theater" 岡田浩1), 河本一真2), 大澤理代3), 佐藤和生4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 173-173, 2013.

---

	Way of thinking ... called may - diabetes empowerment that the patients are professionals of one's diabetes so that -7-S36-5 pharmacist is a professional of the medicine on a day 岡崎研太郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 173-173, 2013.

---

	Medical treatment of the pressure sore based on the EBM that the -7-S37-1 pharmacist was concerned with on a day 溝神文博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 174-174, 2013.

---

	Action ... in the regular physician absence institution specialized in pressure sore treatment - pressure sore that -7-S37-2 pharmacist is concerned with on a day for 10 years 宮川哲也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 175-175, 2013.

---

	Action ... to the pressure sore medical therapy that kept the characteristic of relation ... drug of the pharmacist to pressure sore treatment of our -7-S37-3 House alive on a day 庄司理恵 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 175-175, 2013.

---

	Day -7-S37-4 loanword (at home), relation hospital pharmacist for pressure sore measures in the institution 森川拓 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 176-176, 2013.

---

	How did the pressure sore measures of our House change by -7-S37-5 WOCN and the collaboration with the pharmacist on a day; five years by ... specialist absence? 荒木玲子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 176-176, 2013.

---

	Action of the pressure sore treatment of the pharmacist resulting in a healing period and improvement of the cost in an institution of the -7-S37-6 specialist absence on a day 長谷川雅子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 177-177, 2013.

---

	Regular Tolly science of the day -7-S37-7 pressure sore therapeutic drug 野田康弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 177-177, 2013.

---

	Role of the pharmacist whom the -12-S38-1 nation expects on a day 新井裕充 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 178-178, 2013.

---

	It is breeding ... of upbringing and the customer viewpoint of ... specialty pharmacist for hospital pharmacist expected -12-S38-2 from on a day 矢嶋美樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 179-179, 2013.

---

	Introduction and person fortune upbringing ... of the day -12-S38-3 way - life training authorized system to a found pharmacist 姉崎千津子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 179-179, 2013.

---

	"Power to decide" to support -12-S38-4 team approach in medical care on a day and "power to convey" 三谷宏治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 180-180, 2013.

---

	Human resources development (upbringing example of the leader in Novartis) that -12-S38-5 company thinks about on a day 三谷智雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 180-180, 2013.

---

	The histology of the -12-S38-6 pharmacy obeys a strategy of the pharmacy on a day 赤瀬朋秀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 181-181, 2013.

---

	Day -13-S39-1 "questionary survey results about the actual situation grasp of the transluminal drug administration" 近藤幸男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 182-182, 2013.

---

	As relation ... NST exclusive duty pharmacist of the pharmacist for the day -13-S39-2 undernourished patient ... 竹村恵里奈, 長谷川裕矢, 松本利恵, 野田孝夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 183-183, 2013.

---

	日-13-S39-3 Point to feel uneasy about for transluminal administration - From a point of view of the preparation - 大島孝雄, 大熊盛之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 183-183, 2013.

---

	The number of patients to receive medicine reporting paper of the -13-S39-4 parenteral injection on a day? The needs? 倉田なおみ1), 近藤直樹2), 西園憲郎3), 松井周一4), 岡田寛征5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 184-184, 2013.

---

	日-13-S39-5 About publication of the injection drug feeling and an enforcement method - We think from a necessary timing - 岸本真 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 184-184, 2013.

---

	日-13-S39-6 For dignitary recapture of the tube feeding patients - Yells from a physician to a pharmacist - 今里真 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2013.

---

	Evasion of the severe drug eruption based on -13-S40-1 pharmacogenomics information on a day 莚田泰誠 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2013.

---

	Construction of the leading next-generation pharmacist upbringing program that was familiar with -13-S40-2 PGx on a day 平塚真弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2013.

---

	The present conditions of the pharmacogenomics which -13-S40-3 pharmacist carries on a day 青森達1)2), 山本康次郎2), 中村智徳1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2013.

---

	A genetic polymorphism diagnosis in the day -13-S40-4 practice: New pharmacist duties as the team approach in medical care 有吉範高 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2013.

---

	Ethical problem of the day -13-S40-5 pharmacogenomics 武藤香織 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2013.

---

	The present conditions and possibility of the pharmacogenomics in the day -13-S40-6 academia 中谷中 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2013.

---

	The thing to buy to the present conditions and a pharmacist of the -14-S41-1 disaster medical care on a day 近藤久禎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2013.

---

	Problem in pharmacist upbringing in the day -14-S41-2 disaster medical care 森野一真 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2013.

---

	A thing bought on a day by support - pharmacist in the victim viewpoint in the disaster medical care of -14-S41-3 Japan is ... 石井美恵子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2013.

---

	About a lesson and the disaster essential drug list which the pharmaceutical products supply in the -14-S41-4 Great East Japan Earthquake stricken area requires on a day 奥村順子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2013.

---

	Importance and upbringing of the disaster pharmaceutical affair coordinator in the day -14-S41-5 community medical care, future expectation 土居祥孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2013.

---

	Upbringing of the pharmacist who is strong in day -14-S41-6 disaster 渡邉暁洋, 福田恵子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2013.

---

	Purpose of the young person symposium plan 大野能之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2013.

---

	Role of the pharmacist in day -14-S42-1 community medical care, the life rehabilitation 森直樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2013.

---

	We learn with education of the intention in the -14-S42-2 future on a day 藤井基博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2013.

---

	It is ... mainly on thing - clinical studies that patients with -14-S42-3 cancer have a pharmacist on a day 東加奈子1), 川口崇2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2013.

---

	Cooperation of the medical person beyond the fence realizing -14-S42-4 patients whole body management on a day 北原加奈之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2013.

---

	Pharmacoepidemiologic research design and example 明山武嗣1), 鈴木泰三1), 赤沢学2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2013.

---

	New development (the present conditions and problem of the gastrointestinal carcinoma) of the individualization treatment of H-5-SS-1 cancer 石岡千加史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2013.

---

	New development (the present conditions and problem of the breast cancer) of the individualization treatment of H-5-SS-2 cancer 坂東裕子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2013.

---

	The side effect management based on H-5-SS-3 antiemetic proper use guidelines 今村知世 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2013.

---

	H-5-SS-4 febrile neutropenia 高橋佳子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2013.

---

	The management of the hand-and-foot syndrome beyond the limit of the H-5-SS-5 type of job 矢野琢也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2013.

---

	H-5-SS-6 peripheral neuropathy 河原昌美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2013.

---

	Construction of soil -8-O1-01 cancer chemotherapy regimen application, examination, making, the registration system 伊東真由子, 永見康男, 中村知子, 野原真吾, 豊田智恵, 福岡誠司, 井向雅美, 山本哲子, 松田恵子, 山本和宜, 沖田敏宜 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2013.

---

	Improvement and problems by soil -8-O1-02 regimen order and the system of administration introduction 大窪典子1), 平池美香子2), 白澤宏美3), 大園ゆかり4), 曽我部志奈5), 川上恵子1), 真鍋健一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2013.

---

	Examination of the usefulness of the checking prescription in the soil -8-O1-03 cancer chemotherapy 敦見真由美, 藤原琴, 藤本奈津子, 藤本優, 小滝理依子, 岩崎友美, 中谷孝史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2013.

---

	Anticancer agent prescription present conditions and problem in our House in soil -8-O1-04 childhood cancer treatment of a check 工藤尚亨, 松本智子, 前川輝美, 横山智, 金塚明子, 西山まゆみ, 諏訪淳一, 清水秀男, 内川清次 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2013.

---

	Making of a survey of the use of soil -8-O1-05 denosumab and the use of the optimal electrolyte check system 石塚友一1), 山本圭祐1), 伊藤瞳1), 本田勝亮1), 星山佳代1), 渡邊真由美1), 佐原百合名1), 山内拓1), 中道秀徳1), 川村和美1)4), 磯崎泰介2), 金容壱3), 塩川満1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2013.

---

	Role ... of the pharmacist in making ... many types of job cooperation of the in-hospital general manual of the prevention, the treatment strategy for the dermatopathy of the soil -8-O2-06 EGFR inhibitor 上ノ段友里1), 権玲奈1), 吉田まつみ2), 岸原文明3), 縄田好一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2013.

---

	Action for the safety management systems construction of the soil -8-O2-07 temozolomide chemotherapy 笹山潔1), 光田幸彦2), 藤本直也1), 階戸美和1), 今庄恵子4), 新居田千佳3), 室井令子3), 森正昭1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2013.

---

	The role that a blood tumor department exclusive belonging pharmacist in the soil -8-O2-08 cancer medical care achieves for risk aversion 丹田雅明1)2), 池内彩1), 松井礼子1), 市田泰彦1), 和泉啓司郎1)3), 齊藤真一郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2013.

---

	The need of the medicine teeth medicine cooperation that we were able to see from soil -8-O2-09 oral cavity managed care cooperation model business 則竹香奈1), 長谷川彩子1), 立松三千子1)2), 水谷旭良1), 玉水誠3), 西川弘嗣3), 鍋島俊隆4)5), 長谷川泰久6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2013.

---

	Difference between hospital pharmacist and needs of the health insurance pharmacy pharmacist by the soil -8-O2-10 chemotherapy study session needs investigation questionnaire 佐藤由美子1), 稲垣淳2), 諸角一成1), 牧原明秀1), 中島有佳子1), 荒川友恵1), 黒田純子3), 小松弘和4), 脇田充史2), 鈴村宏5), 木村和哲3), 山田浩一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2013.

---

	Competitive review of the environmental pollution with the anticancer agent before and after the introduction of the soil -8-O3-11 negative pressure type isolator "ChemoSHIELD" and the exposure to the human body 山本清司1)2), 竹本将士1), 前田康博2), 黒田純子1), 江崎哲夫1), 木村和哲1)2)3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2013.

---

	The present conditions and problem of anticancer agent handling environment and the safety measures by the soil -8-O3-12 nurse 吉見隆宏1), 藤田優美子2), 堀里子3)4), 佐藤宏樹4), 三木晶子4), 森和明1), 澤田康文4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2013.

---

	土-8-O3-13 Relationship of the understanding degree of a medication explanation enforcement item and the patients by the pharmacist - For individualization of the medication explanation - 鮎原秀明1), 東加奈子1), 中原紀子2), 川口崇2), 佐野陽子1), 遠藤かおり1), 江田理子1), 斉藤裕美子1), 早部紘子1), 竹内裕紀2), 畝崎榮2), 明石貴雄1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2013.

---

Role (through the prescription suggestion in an outpatient clinic, a ward, the dispensary) of the pharmacist attending the medical examination of the physician in the outpatient department of soil -8-O3-14 anticancer agent-treated patients 高柳信子1), 山崎彬史1), 山崎貴之1), 三浦恵理1), 久保嘉靖1), 奥野昌宏1), 中田学1), 浅野仁2), 高蓋寿朗2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2013.

---

	Listening before the explanation of the soil -8-O3-15 anticancer agent 新行内健一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2013.

---

	Investigation about the predictor of the retching vomiting expression in the chemotherapy of the soil -8-O4-16 moderate degree emetogenicity risk 藤井宏典1), 飯原大稔1), 石原正志1), 高橋孝夫2), 吉田和弘2), 伊藤善規1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2013.

---

	Fact-finding of retching, vomiting with the cancer chemotherapy using MAT in our soil -8-O4-17 center 菅田英二1), 原康人1), 今村真弓1), 松永直子1), 柳田晶彦1), 上野美里2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2013.

---

Double-blind randomized controlled trial (TRIPLE study) of granisetron and palonosetron for vomiting at the extensive emetic chemotherapy including soil -8-O4-18 CDDP 松井礼子1), 後藤功一1), 橋本浩伸2), 島田俊一3), 関順彦3), 坂田幸雄4), 山室蕗子5), 野村久祥6), 中村勝之7), 矢野琢也8), 島田安博2), 荒田康司9), 瀧口友美10), 大柳文義10), 山中竹春11), 鈴木賢一＾910), 山本信之9) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2013.

---

	Examination about the effectiveness of the telephone support program for the XELOX therapy in our soil -8-O4-19 House 遠藤征裕1)2)3), 齋藤鈴子2), 森川和夫1), 橋本正治3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2013.

---

	1 case of malignant soft part tumor which examined discontinuation, resumption time in soil -8-O4-20 molecules target medicine and radiation combination therapy 岡西康治1), 池田和之1), 片山絵美子2), 辻力夫1), 森田幸子1), 山添雅之1), 宇野雅之2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2013.

---

	Two cases of the EGFR mutation-positive lung adenocarcinoma where soil -8-O5-21 low dose erlotinib treatment was effective for a long term 北出紘規1), 北国憲剛1), 森光恵1), 矢野聖二2)3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2013.

---

	Use experience of the molecular target medicine in the pancreas neuroendocrine tumor in the soil -8-O5-22 Kansai Electric Power Hospital 眞継賢一1), 倉橋基尚1), 細田洋平2), 萩隆臣3), 池田温至3), 江嵜秀和3), 河本泉3), 井上直也3), 粟根雅章3), 恒川昭二3), 滝吉郎3), 今村正之3), 濱口良彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2013.

---

	Examination about treatment continuity and the Ccr level of S-1 in soil -8-O5-23 elderly people 丸山昌広1), 横井佳博2), 板垣千華1), 金子猛2), 澤柳智樹2), 綿引洋一2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2013.

---

	The treatment situation of bendamustine in our soil -8-O5-24 House 石川大介, 田中大輔, 阿部和人, 鎌田敬志, 佐藤導 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2013.

---

	Tendency to prescription investigation of the soil -8-O6-25 oxycodone hydrochloride hydrate injection (oxycodone (R) note) 杉原弘記1), 神垣江里奈1), 岡田昌浩1), 渡辺陽子2), 黒河香織2), 上塚大一3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2013.

---

	The medication counseling system to patients with foreign initial opioid introduction that was able to contribute to evasion of the soil -8-O6-26 consultation out of the reservation 葛谷真理, 川出義浩, 鈴木雅人, 竹内美佳, 福岡絵里, 前田哲志, 高原悠子, 天野杏南, 吉田弘樹, 今井視保子, 木全司, 中村正史, 青山智彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2013.

---

	土-8-O6-27 Case of the pain control using the carrying-type continual infusion PCA in fuser pump in the cancer relaxation medical care - Hospitalization and efforts in the outpatient department - 金田典子1), 小林睦1), 山下剛史郎1), 廣瀬孝一1), 深海広平1), 北村瑞穂1), 丸尾栄次1), 矢部充英2), 松延さゆり3), 南橋薫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2013.

---

	Factor analysis of the end-of-life delirium (hyperactivity type) in patients with cancer using the soil -8-O6-28 order logistic-regression analysis 神林祐子1)2), 羽多野裕2)3), 畑譲2)3), 森田達也4), 四方敬介1), 福居顯二3), 細川豊史2)5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2013.

---

	A change of the carbapenem-based antimicrobial consumption in our soil -9-O7-01 House and trend of the resistant rate of Pseudomonas aeruginosa 宗佐博子1)2), 加藤英明2), 杉山嘉史2), 河原春代2), 森雅亮2), 橋本真也1), 金子猛2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2013.

---

	Intervention effect for the dosing period of the soil -9-O7-02 carbapenem system antimicrobial 石坂敏彦1)2), 小野原未由来1), 森陽子2), 坂田博2), 村上城子2), 向井淳治1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2013.

---

	Examination about the use dose of the meropenem for the soil -9-O7-03 antimicrobial proper use 森田淳介, 伊藤典子, 山賀章一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2013.

---

	Safe examination of the meropenem which we divided into soil -9-O7-04 low-dose group and high-dose group and the Doripenem 田島美沙1), 山内弘子1), 西圭史2), 篠原高雄1), 永井茂1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2013.

---

	Discussion from a use situation investigation of the carbapenem-based antimicrobial for the soil -9-O7-05 infection of childhood 伊藤千恵, 岸田美和, 南美穂, 大垣智子, 石川照久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2013.

---

	The use situation of the antiMRSA medicine daptomycin in our soil -9-O8-06 House and discussion 後藤渉, 山澤理恵子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2013.

---

	Application to the blood level measurement and clinical practice of the soil -9-O8-07 antiMRSA medicine daptomycin 安井友佳子1)2), 山本圭城1)2), 八野芳巳1), 藤本卓司2), 川端良平2), 和泉多映子2), 安井裕之3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2013.

---

	Examination of the risk factor about the onset of impaired renal function in patients receiving soil -9-O8-08 vancomycin 大室綾1)2), 小林岳1)2), 早川和宏1)2), 飯島尚志1), 坂本光男2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2013.

---

	About loading dose, maintenance doses fact-finding of TEIC, F-FLCZ, VRCZ in our soil -9-O8-09 House and an action of the pharmacy 大野凛太郎, 大塚昌宏, 渡部義和, 小林義美, 山下博一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2013.

---

	Evaluation of the soil -9-O8-10 levofloxacin IV/PO switch protocol 田中広紀1)4), 國分二三男2), 柳原麻里1), 並木美加子1), 池田裕一3), 竹ノ内敏孝1), 向後麻里1)4), 村山純一郎4)5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2013.

---

	A present conditions evaluation and patient background of the antimicrobial for soil -9-O9-11 ESBL-producing Escherichia coli bloodstream infections 菅原隆文, 村上礼隆, 植竹宣江, 松本俊治, 宮森伸一, 開浩一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2013.

---

	Search of the factor to affect for the duration of treatment of soil -9-O9-12 children mycoplasmal diseases (pneumonia) 高岡雄一1), 鈴木理恵1), 本田勝亮1), 松林正2), 川村和美1)3), 塩川満1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2013.

---

	The tissue transitivity of the linezolid in soil -9-O9-13 thoracic cavity and the mediastinal cavity is high 辻泰弘1), 橋本亘2), 谷口真一郎3), 溝口晶子4), 平木洋一5), 松元加奈6), 森田邦彦6), 神村英利7), 加留部善晴7), 藤秀人1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2013.

---

	Skin, soft tissue infection related to multidrug-resistant Acinetobacter baumannii where soil -9-O9-14 ABPC/SBT-MEPM combination therapy was effective 井上大奨1), 吉田真由美2), 益田洋子2), 平木洋一2), 真鍋健一2), 河野文夫2), 辻泰弘3), 神村英利4), 加留部義晴5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2013.

---

	Action to antimicrobial proper use using soil -9-O9-15 yellow card and the foul out of the game 芹沢哲郎1), 鈴木高弘1)2)3), 高橋峰子3), 篠永正道3), 野口雅久4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2013.

---

	Usefulness investigation of the soil -9-O9-16 ICT antimicrobial round 吉田奈央1), 野口周作1)2), 此松晶子1), 東さやか1), 宮内秀典1), 竹内崇浩1), 笠原英城1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2013.

---

	Use of antimicrobial turn of eventss by the soil -9-O9-17 ICT activity 鴨志田聡1), 石川明日香1), 崎浜智子2), 秋月浩光3), 関由紀子4), 伊藤陽子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2013.

---

	Report of the education lecture using the hospital infection pocket manual to the initial medic by the soil -9-O9-18 pharmacist 小杉卓大1)2), 大塚朋子1)2), 安里美奈1)2), 伊集睦美2), 平良あかり2), 大城彩子2), 島添亜依子2), 石川美根子2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2013.

---

	Action ... to role - antimicrobial proper use of the pharmacist in the soil -9-O9-19 hospital infection prophylaxis 勝田誠1)2), 伊藤仁1)2), 大熊智子1), 長井直人2), 高草木伸子2), 松本孝夫2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2013.

---

	土-9-O9-20 Survey and Evaluation of inhalation guidance in Laninamivir octanoate acid ester 本石寛行1), 鈴木慶介1), 木村好伸1), 木村直也1), 源川良一1)2), 芳澤正士2)3), 巣鴨一正2)4), 長谷川毅5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2013.

---

	Effective evaluation of the influenza immunization in soil -9-O11-21 children 小原拓1)2), 島崎信次郎3), 金子健二3), 福田純3), 中村泰之3), 眞野成康2), 栗山進一1), 八木直人3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2013.

---

	Action to the uterine cervix cancer prophylactic spread in the soil -9-O11-22 Hitachi General Hospital 齋藤祥子1), 青山芳文1), 布川晋子2), 本井真也3), 輿石真4), 渡辺泰徳4), 平井信二4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2013.

---

	土-9-O11-23 Detect resistant Acinetobacter baumannii - Than a genetic analysis and a case - 荒川裕明1)2), 鈴木ゆきえ1), 林靖子2), 金子美千代3), 中山晴夫2)4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2013.

---

	Multidrug-resistant Acinetobacter baumannii which showed the sensitivity that soil -9-O11-24 was interested in 平木洋一1)3), 松井真理2), 吉田真由美1), 益田洋子1), 井上大奨3), 真鍋健一3), 辻泰弘4), 神村英利5), 加留部善晴6), 河野文夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2013.

---

	Study about the antibacterial prophylaxis period in the soil -9-O11-25 endoscopic mucosa of large intestine lower layer detachment technique 室高広1), 岸川礼子1), 宮永圭1), 岡田みずほ2), 松本武浩2), 中尾一彦3), 安岡彰4), 北原隆志1), 佐々木均1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2013.

---

	Result judging from enforcement and a questionnaire of the nutrition-related training for soil -9-O12-26 pharmacists and future problem 大木麻己子1), 上塚朋子1), 高野純一1), 鈴木真里1), 今井みどり2), 増原慶壮1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2013.

---

	Action to conduct the better nourishment management in soil -9-O12-27 ward drug duties 高橋晶子1), 福山博務1), 藤谷竜磨1), 八木原栄1), 丸山道生2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2013.

---

	Questionary survey of the simple suspension method for the many types of job staff of the soil -9-O12-28 community medical care cooperation institution 向井弘恵, 岡崎和子, 岡田昌浩, 村上史承 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2013.

---

	Evaluation of transitivity to mother's milk of the antineoplastic in the soil -9-O12-29 nursing mother and the invulnerability 久保野尚子1)2), 内藤隆文1), 小杉崇1), 阪原晴海2), 川上純一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2013.

---

	Study on grasp of the pregnant antimicrobial prescription situation based on soil -9-O12-30 receipt data 堀川いずみ1), 小原拓2)3), 目時弘仁3)4), 大久保孝義5), 八重樫伸生4), 眞野成康2), 佐藤博1), 栗山進一3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2013.

---

	Study on clinical response of the new bisphosphonate preparation minodronate in patients with soil -10-O13-01 origin characteristics osteoporosis 廣瀬正幸1), 金山康秀2), 竹本雄一3), 土屋廣起4), 高木英希5), 山田成樹6), 鍋島俊隆7)8) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2013.

---

	Association with blood bepridil levels and atrial fibrillation prevention of recurrence after the catheter ablation for the soil -10-O13-02 durability atrial fibrillation 福森史郎1)2)3), 村木優一2), 岩本卓也2), 藤井英太郎3), 伊藤正明3), 奥田真弘2), 辻泰弘4), 藤秀人4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2013.

---

	About usefulness of the propranolol internal use therapy for the soil -10-O13-03 infants hemangioma 山下和彦1), 赤澤由子1), 山口由加里1), 平瀬敏志1), 加藤威2), 山本暢之2), 久保川育子2), 森健2), 矢内友子2), 久米学1), 槇本博雄1), 平野剛1), 早川晶2), 平井みどり1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2013.

---

	土-10-O13-04 The preparation study that aimed at the medical treatment at time - Design of the nuclear lock of the time delayed release type preparation - 小林令奈, 今村有沙, 島田友幸, 小泉直也, 藤井まき子, 渡辺善照 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2013.

---

	Effect of benzbromarone on oxidative stress of the soil -10-O13-05 high blood pressure model rat 村谷菜々子1), 門脇大介1)2), 北村健一郎3), 成田勇樹1)2), 丸山徹2)4), 小田切優樹5), 平田純生1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2013.

---

	In vitro examination about the uratic effect on sorafenib transportation in soil -10-O14-06 gastrointestinal tract epithelial cells 前嶋隆弘1), 大川星美2), 近藤泰輝3), 下瀬川徹3), 久道周彦1), 松浦正樹1), 島田美樹1)2), 眞野成康1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2013.

---

	A placental permeability evaluation of soil -10-O14-07 fluvoxamine and construction of the fetal blood level predictive model 佐藤宏樹1), 松岡紗代2), 堀里子1)3), 藤井知行4), 澤田康文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2013.

---

	Examination about the Teiko plastic Nin pharmacokinetics at the CHDF enforcement using soil -10-O14-08 In vivo and the In vitro model 入江利行1)3), 道越淳一2)3), 日高正剛3), 後藤孝治3), 畑中美博4), 井上覚4), 野口隆之3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2013.

---

	It is use ... of absorption improvement - cholesterol transportation bearer NPC1L1 of the difficulty absorbent material by becoming it soil -10-O14-09 emulsion 竹川悠人1), 佐藤夕紀2), 鷲見正人2), 武隈洋2), 菅原満2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2013.

---

	Internal change in children of the oral soil -10-O14-10 lungs vasodilator Tadalafil 田口雅登1), 河野寛之1), 高広理佳子1), 石田和也1), 秋田千里2), 中村常之2), 芳村直樹3), 小澤綾佳4), 廣野恵一4), 市田蕗子4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2013.

---

	Effect on anticoagulant effect in the warfarin remedy patients by soil -10-O15-11 piperacillin/tazobactam 門村将太, 福田由布子, 井藤達也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2013.

---

	Examination of the secondary carnitine deficiency of the seriously disabled child (person) during soil -10-O15-12 antiepileptic drug administration 中村豪志1), 中村良子1), 和田一也1), 八本久仁子1), 大森啓充2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2013.

---

	Effect of the concomitant drug administration to give it to uremic toxin adsorption with the soil -10-O15-13 spherical carbonaceous adsorbent preparation 新田弥生1), 高橋直之2), 阿部浩之2), 服部祐介1), 大塚誠1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2013.

---

	Effect of the antimicrobial which gives it to antiblood clotting ability of soil -10-O15-14 warfarin 平尾顕正, 八木達也, 見野靖晃, 内藤隆文, 川上純一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2013.

---

	Examination of the drug interactions with the antiemetic in the soil -10-O15-15 rat cocktail study 桜田なつき, 田中紫茉子, 笹野知海, 内田信也, 並木徳之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2013.

---

	Simultaneous assay of paclitaxel in a patient serum by soil -10-O16-16 LC/ESI-MS/MS and a metabolite and carboplatin 中村昌由1), 鈴木裕之2), 森大2), 内田敬2), 前川正充2), 島田美樹1)2), 眞野成康1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2013.

---

	Blood level simultaneous analytical procedure of the drug used by soil -10-O16-17 cancer chemotherapy regimen 庄司依莉子1), 前川正充2), 森大2), 鈴木裕之2), 島田美樹1)2), 眞野成康1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2013.

---

	Evaluation of the lithium densitometry in the soil -10-O16-18 own institution 赤羽理也1), 上西幸治1), 野田哲史1), 平大樹1), 稲垣貴彦2), 高橋正洋2), 森田幸代2), 星野伸夫1), 森田真也1), 山田尚登2), 寺田智祐1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2013.

---

	Development of the interaction evasion support application between the phenytoin tea S one equipped with soil -10-O16-19 pharmacokinetics analysis system 新保拓未1), 佐藤宏樹1), 三木晶子1), 堀里子1)2), 澤田康文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2013.

---

	Construction of the dose design method of vancomycin for peritoneal dialysis patients using the soil -10-O16-20 pharmacokinetics model 山本武人1), 樋坂章博2), 宮田優希1), 鈴木洋史1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2013.

---

	Introduction effect of the soil -10-O17-21 Teiko plastic Nin high dose regimen 行本拓史, 杉本有佳子, 堀川泰清 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2013.

---

	Examination of the clinical usefulness of the soil -10-O17-22 vancomycin initial administration chart 竹市朱里1)2), 丹羽隆1), 林寛子1), 今西義紀1), 外海友規1), 岡安伸二1), 北市清幸1), 安田公夫2), 伊藤善規1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2013.

---

	土-10-O17-23 One case that low-dose VCM administration was effective for penicillin-resistant pneumococcus - For the standardization of vancomycin TDM duties - 柳橋秀行, 宮内智行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2013.

---

	Blood soil -10-O17-24 vancomycin levels are the examination about TDM predicted value and the factor to become estranged 多賀允俊, 松森智士, 岡田隆史, 山本康彦, 西尾浩次 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2013.

---

	Examination about the adequacy of the rate of application of the soil -10-O17-25 lipid microsphere 小田剛史1), 高田宏文1), 金田典子1), 幸前智子1), 寺田久仁子1), 前田直就1), 馬島務1), 中井彩香1), 前田頼伸2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2013.

---

	Relations with long term prognosis and the VEGF genotype after the soil -10-O18-26 cancer of the esophagus chemoradiotherapy application 真鍋友紀1), 田村孝雄2)3), 桑原晶子3)4), 山森元博3)4), 西口工司3)5), 中村任3)6), 奥野達也1), 三木生也3), 栄田敏之1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2013.

---

	Effect of the genetic polymorphism on treatment with topiramate continuance rate in patients with soil -10-O18-27 Dravet syndrome 矢澤嶺1), 山本吉章2), 井上和幸1), 今井克美2), 高橋俊樹1), 辻大樹1), 林秀樹1), 高橋幸利2), 伊藤邦彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2013.

---

	Association between treatment continuance rate and CYP2C9 and CYP2Cl9 genetic polymorphism of phenytoin for patients with soil -10-O18-28 children epilepsy 山本吉章1)2), 宮川紘1), 高橋幸利1), 今井克美1), 小山誠一1), 賀川義之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2013.

---

	Analysis of the drug metabolizing enzyme gene by the direct TaqMan-PCR method for the soil -10-O18-29 pharmacogenomics realization 大田智子, 石井みのり, 林田真梨子, 増見恭子, 村田成範, 木下健司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2013.

---

	The role of the pharmacist in the soil -11-O19-01 psychiatry liaison team: Action of the Kariya Toyota General Hospital 森健司1)2), 徳倉達也2)3), 足立康則2)4), 鈴木名保美2), 中里美保2), 辻正憲2), 中村公樹2), 滝本典夫1), 足立守1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2013.

---

	Drug instruction for children with soil -11-O19-02 eating disorders and the parent 奥野昌宏, 高柳信子, 久保嘉靖, 山崎貴之, 三浦恵理, 中田学 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2013.

---

	Satisfaction investigation of the medicine at discharge for patients with soil -11-O19-03 mental disorder 高橋満里, 石塚淑子, 森亨 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2013.

---

	Effect of a pharmacist participating in soil -11-O19-04 psychiatry temporary nursing at home 内山道子, 小林秀史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2013.

---

	Medication support ... by the cooperation of positive intervention ... patients family, physician, drugstore pharmacist who does not make the dropout of the soil -11-O19-05 stole terra done 荒川佳子1), 仲原朋子1), 天广玲華1), 藤代美和子1), 川村和美2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2013.

---

	It is the prescription analysis of patients with mental disorder in being at home and the outcome soil -11-O20-06 石橋大克 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2013.

---

	Medical therapy of BPSD in the inpatient with soil -11-O20-07 dementia 宇野準二, 中田美穂, 東城真一, 竹内一平 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2013.

---

	Delirium prediction using soil -11-O20-08 NEECHAM 宮川泰宏1), 横山幸浩2), 福澤翔太1), 矢野亨治1), 永井拓1), 梛野正人2), 山田清文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2013.

---

	Attitude survey of stigmata prejudice, the discrimination about the psychiatry medical therapy for soil -11-O20-09 mind person with a disability and families 谷藤弘淳1), 大城布美子2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2013.

---

	The prescription change in patients with pervasive developmental disorder of soil -11-O20-10 children: Examination based on receipt data 佐藤倫広1), 小原拓1)2), 大場延浩3), 森川和彦4), 石黒真美2), 目時弘仁5), 西郡秀和6), 菊谷昌浩2), 眞野成康1), 栗山進一7) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2013.

---

	Mutual application of various pharmaceutical products databases by the soil -11-O21-11 patients and the healthcare worker 奥覚子1)4), 高櫻祐規2), 鍋田啓太1), 鈴木聡子1), 木村昌臣2), 佐藤信範3), 網岡克雄4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2013.

---

	The construction of the drug reporting book making system corresponding to soil -11-O21-12 3 power national language and examination about the usefulness 村田龍宣, 大橋正和, 吉村光弘, 村岡淳二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2013.

---

Making of the collection of collection of in-hospital pharmaceutical products interlocking movement type inside the hospital protocol using soil -11-O21-13 ward drug duties support software 栗林左知1)2), 川上朋弘1)3), 藤川尚義2), 岡田典子2), 藤山玲子1)4), 山中啓子1)5), 藤井順子1)6), 柴崎智行1)7), 金丸祐子2), 松本ひろみ2), 江本篤2), 原田百恵2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2013.

---

	Report of making of the soil -11-O21-14 ward drug duties support software and the present conditions investigation about soft use environment 川上朋弘1)2), 栗林左知1)3), 藤山玲子1)4), 柴崎智行1)5), 藤井順子1)6), 山中啓子1)7), 古川裕之8) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2013.

---

	Present conditions investigation about the items mentioned of the children in the soil -11-O21-15 attachment document 高橋良平1)2), 岩崎文男1), 吉田久博2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2013.

---

	How to catch Residual medicine from the viewpoint of the soil -11-O22-16 pharmacist and the confirmation situation to the patients 大澄朋香1)2), 木下達也1), 栗原元気1), 矢後香織1), 渡邉文之1), 亀井美和子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2013.

---

	Residual medicine investigation in the patients's house by the drugstore pharmacist for soil -11-O22-17 pharmaceutical products proper use promotion 木村菜月1), 三木晶子2), 佐藤宏樹2), 堀里子2)3), 澤田康文2), 平山匡彦4), 矢吹久美子5), 山口裕次6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2013.

---

	The change of the recognition about the generic medicine in the soil -11-O22-18 pharmacist 佐藤倫広1), 小原拓1)2)3), 高橋則男3), 猪狩有紀恵2)3), 眞野成康1), 早坂正孝3), 高橋將喜3), 北村哲治3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2013.

---

	Recognition investigation about the heredity reactions of drugs in the soil -11-O22-19 health insurance pharmacy pharmacist 小原拓1)2), 阿部真也3), 佐藤倫広1), 吉町昌子3), 後藤輝明3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2013.

---

	It is ... from an attitude survey of our ... House floor nurse for the future action of the soil -11-O22-20 palliative care team pharmacist 林隼輔, 安藤尚美, 石井賀津二, 染谷雅弘, 平島徹, 川久保孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2013.

---

	Prescription fact-finding of urination disorder treatment by soil -11-O23-21 CISA data 橋本佳奈子1), 橋本昌子1), 松崎優1), 長瀬啓介2), 荒井國三1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2013.

---

	Administration of soil -11-O23-22 lithium carbonate tablets fact-finding 藤森完爾1), 齋藤玄一1), 木村律子1), 大和行男2), 栗田征武2), 長南謙一3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2013.

---

	The need of the periodical renal function evaluation in the soil -11-O23-23 dabigatran internal use patients 上村裕美, 岩田晃佳, 鷲見佳子, 芦川直也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2013.

---

	Proper use investigation of the soil -11-O23-24 hyperuricaemia therapeutic drug febuxostat 清川真美1), 杉山恵美子1), 熊谷卓博1), 宮本剛典1), 深井敏隆1), 笠師久美子1), 山田武宏1), 井関健1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2013.

---

	Inspection about the effectiveness of the clarithromycin small quantity chronic administration for the chronic inflammatory disease based on the prescription actual situation of the soil -11-O23-25 macrolides antimicrobial 岩山訓典1), 堀内翔太2), 粟屋敏雄1), 大滝康一1)2), 田崎嘉一1), 早勢伸正2), 松原和夫3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2013.

---

	土-11-O24-26 Investigation about the tendency of the disposal of inpatient drug - Discussion for the drug costs reduction - 高岡絵里1), 冨澤淳1), 小林昌宏1), 坂倉智子1), 小川幸雄1), 厚田幸一郎1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2013.

---

	Reduction of the contribution - disposal of soil -11-O24-27 pharmacist medicine to medical economy 島田侯陛, 伊藤明人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2013.

---

	Use fact-finding of the biological drug for the psoriasis in the soil -11-O24-28 Tokyo communication hospital 中島由紀1)3), 大谷道輝1), 山村喜一1), 杉浦宗敏3), 上嶋祐太2), 江藤隆史2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2013.

---

	It is effect on renal function by the NSAIDs remedy and the evaluation after soil -11-O24-29 technique 山村恭子1), 相馬沙希1), 川邊優貴1), 山本智永子1), 尾垣光彦1), 岩本千絵1), 岩井由佳1), 萩野訓子1), 森垣和馬1), 喜多美佳1), 近藤裕志1), 田中聡之1), 斉藤昌彦2), 重松浩司2), 松本憲和2), 石崎嘉孝2), 畑中智子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2013.

---

	The change of the recognition about the generic medicine in the day -8-O25-01 pharmacist 佐藤倫広1), 小原拓1)2)3), 高橋則男3), 猪狩有紀恵3), 眞野成康1), 早坂正孝3), 高橋將喜3), 鎌田裕3), 北村哲治3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2013.

---

	According to -8-O25-02 pharmacist, should the appearance of the generic drug be similar to starting pharmaceutical products on a day? 玉木啓文1), 高橋斉2), 佐藤宏樹2), 三木晶子2), 堀里子2)3), 澤田康文2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2013.

---

	Are the side effect symptom based on "the talk" of patients with day -8-O25-03 breast cancer and the correspondence with "a side effect name" during an attached document possibility? 三木晶子1)2)3), 菊地慧2), 佐藤宏樹1), 佐藤(佐久間)りか3), 別府宏圀3), 澤田康文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2013.

---

	日-8-O25-04 Study on the drinking alignment between the beverage and food of Cefcapene Pivoxil pediatric granules 原田綾子1), 北村雅弘2), 中川知哉1), 徳永雄二1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2013.

---

	Safe examination of rivaroxaban in our day -8-O25-05 House patients 鷲見佳子, 岩田晃佳, 上村裕美, 芦川直也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2013.

---

	日-8-O26-06 Side effect investigation of pharmaceutical products - Examination in other institutions - 田淵紀彦, 風早美幸, 宇野勝次, 福長将仁 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2013.

---

	It is analyzed the adverse event of the antipsychotics in the children using the -8-O26-07 FDA size scale adverse event spontaneous report database on a day 木村豪仁1), 角山香織1), 多門啓子2), 奥野恭史3), 栄田敏之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2013.

---

	It is ... using an information registration system contraindicated to the drug of action and fact-finding - electronic chart for the day -8-O26-08 information on adverse drug reactions 山口文子, 平間盛吾, 深沢貴志, 北岡晃, 松村泰之, 佐藤透 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2013.

---

	Examination ... of the usefulness with the development (1) - generic drug of the day -8-O26-09 new drug-related human liver damage risk prediction method (the T-LEXTM method) 中嶋幹郎1), 江頭かの子1), 中嶋弥穂子2), 島田卓3), 長塚伸一郎4), 榎本初音5), 立木秀尚5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2013.

---

	Applied ... to the quality evaluation of the development (2) - generic drug of the day -8-O26-10 new drug-related human liver damage risk prediction method (the T-LEXTM method) 榎本初音1), 立木秀尚1), 島田卓2), 長塚伸一郎3), 中嶋弥穂子4), 江頭かの子5), 中嶋幹郎5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2013.

---

	The inspection of the onset of hypocalcemia factor with the day -8-O27-11 denosumab administration and examination of the reduction plan 笠師久美子1), 山本千秋1), 高岡知代1), 山田武宏1), 大泉聡史2), 山下啓子3), 井関健1)4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2013.

---

	Search of the factor involved in onset of hypocalcemia by the -8-O27-12 denosumab on a day 岡田直人, 森剛志, 小中健, 川添和義, 寺岡和彦, 久次米敏秀, 水口和生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2013.

---

	It is examined the risk factor about the overextension (APTT) for activated partial thromboplastin time at the -8-O27-13 dabigatran administration on a day 田中雅幸1)2), 西山徳人1), 藤井良平1), 打谷和記1), 米山雅紀2), 荻田喜代一2), 妹尾健3), 廣田育彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2013.

---

	Analysis of the side effect of day -8-O27-14 sunitinib expression mechanism 雨宮貴洋, 本間雅, 苅谷嘉顕, 中島克佳, 鈴木洋史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2013.

---

	An example of the patients on dialysis whom hypotension with -8-O27-15 pregabalin was found in on a day 藤本直也1), 近澤芳寛2), 山岸晃一1), 笹山潔1), 森正昭1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2013.

---

	Examination about the setting dose of cisplatin in the day -8-O28-16 gastric cancer chemotherapy 庄野裕志, 槇原克也, 山田雄久, 廣畑和弘, 中多泉 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2013.

---

	Renal function investigation before and after the day -8-O28-17 cisplatin component regimen unification 野村充俊, 植草秀介, 小松香織, 上岡彩佳, 福本慈, 木村麗砂, 日浦寿美子, 横井妙子, 加藤裕芳, 浅山亨 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2013.

---

	Myelosuppression predictor search after the BEP therapy for day -8-O28-18 testicular tumors 高田慎也, 玉木慎也, 川口啓之, 高崎雅彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2013.

---

	The effect second report that the expression situation of -8-O28-19 oxaliplatin origin-related peripheral neuropathy and cumulative dose give on a day 鈴木直哉, 吉嶋抄苗, 地主隆文, 福井美規子, 猪俣雅之, 渡辺祐子, 佐々木佳子, 徳村麻衣子, 高橋誠, 青田忠博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2013.

---

	日-8-O28-20 The management of the dermatopathy with the EGFR repressor - Efforts in the Kumamoto center Hospital - 堀尾美世1), 本田修一1), 宮村重幸1), 野中由美子2), 松本恵2), 牛島淳3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2013.

---

	One case that presented with acute renal failure by -8-O29-21 tw-TC therapy on a day, but accomplished treatment by changing it to w-TC therapy 大谷隆之, 石井嘉之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2013.

---

	It is examined the effectiveness of the administration on the day before dexamethasone in the -8-O29-22 breast cancer TC therapy on a day 玉木慎也1), 高田慎也1), 渡邊健一1), 高橋將人2), 高崎雅彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2013.

---

	About the effect that subcutaneous administration of the bortezomib in patients with -8-O29-23 multiple myeloma gives to a side effect on a day 黒川咲子1), 鈴木伸男1), 福原修2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2013.

---

	An example of the malignant lymphoma which they presented with acute renal failure after -8-O29-24 large quantities methotrexate therapy on a day and adsorbed haemodialysis and blood and were able to save 諸角一成1), 佐藤由美子1), 稲垣淳2), 小椋啓加2), 鈴木信吉3), 脇田充史2), 山田浩一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2013.

---

	An acid-secreting antagonist and effect of the gastrectomy to give to a digestive organ symptom in the -8-O29-25 TS-1 singularity chemotherapy on a day 地嵜悠吾1)2), 野田哲史2), 平大樹2), 森田真也2), 矢野義孝1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2013.

---

	Making and HBV screening results ... of hepatitis B measures - inside the hospital guidelines to occur by -8-O30-26 chemotherapy on a day 小川大介1), 今村牧夫2), 武本千恵1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2013.

---

	Automatic HBV reactivation risk management by the day -8-O30-27 practice information coding 五十嵐弘幸1), 井関真理子1), 小林靖久1), 前田康裕1), 佐野正毅1), 高嶋孝次郎1), 塗茂裕一2), 石森公章3), 真田拓4), 中山俊5), 野ツ俣和夫4), 田中延善4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2013.

---

	Action in our House for the reactivation (de novo hepatitis B) of hepatitis B to occur by -8-O30-28 immunodepression, chemotherapy on a day 井上敦介1)2), 岡部崇記2)3), 瀬戸口由1)2), 山崎里花2), 和田順也2), 宮地修平1), 山本佳司2)4), 岡田博1), 加藤道夫4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2013.

---

	Effect on renal function with the chronic administration of day -8-O30-29 imatinib 篠原義剛1), 岩重淳司2), 森本浩章2), 東丈裕2), 井手飛香1), 塚田順一2), 浅原稔生1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2013.

---

	Infusion choice in day -8-O30-30 hematopoietic stem cell transplantation regimen FM140 and examination about the electrolyte change 米山英二, 杉山惠亮, 築山奈央, 市川合郁, 粟田浩文, 上條史帆里, 万塩裕之, 中村和行, 間瀬悟, 荒川麻紀子, 勝見章男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2013.

---

	Measures for the day -9-O31-01 ward drug duties addition acquisition and the effect 奥村知香, 戸塚淳子, 橋本有可子, 柴山芳之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2013.

---

	Evaluation of ward pharmacist duties by the analysis of the day -9-O31-02 pharmaceutical intervention record vote 田原克寿1), 飯田慎也1), 谷川知美1), 原千恵子1), 麻下智加1), 井上正朝1), 吉田光一1), 都築仁美1), 小枝正吉1), 大滝康一1)2), 山本香緒里1), 木村周古1), 山下恭範1), 宮本智美1), 太田千春1), 粟屋敏雄1), 小川聡1), 山本久仁子1), 田崎嘉一1), 松原和夫1)3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2013.

---

	Examination third report to the problem of the pharmacist whom the -9-O31-03 ward duties enforcement addition brings on a day 織本桂, 関根仁彦, 吉田友和, 清水裕, 矢吹直寛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2013.

---

	About the action of day -9-O31-04 ward drug duties and a future problem 真鍋健一, 大窪典子, 井上大奨, 高田正温, 平木洋一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2013.

---

	Construction and the inflection of the day -9-O31-05 ward log book system 鳴川貴司, 堤克成, 奥村知香, 柴山芳之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2013.

---

	Introduction and present conditions ... of the ward drug duties that aimed at ward permanent residence action ... "pharmacist whom a face was seen" whom we sent to becoming it of the -9-O32-06 pharmacist on a day 井上稚枝子, 小川大介, 片山健太郎, 松井裕典, 原田七穂, 武本千惠 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2013.

---

	Application of standardization, unionization of day -9-O32-07 ward drug duties and medical information, computer-aided system 村田久枝, 大井美和, 寺本有里, 竹内敦美, 笹平絵美, 佐竹佑美, 榎本幸子, 駒井千穂, 荒堀早紀, 前田英加, 益田佑輔, 板倉生佳, 北口剛吉, 村井扶, 藤尾みどり, 藤吉徹也, 山根淳子, 山本克己 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2013.

---

	日-9-O32-08 With the pharmacist who is actually found by ward resident duties - Opinion from a pharmacist engaged in the settings - 近藤洋右, 佐藤巌晃, 飯干高明, 桑野淳, 上村忍 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2013.

---

	Action to the ward drug duties in the day -9-O32-09 existence floor medical office 渡部直樹, 佐藤等, 西村仁美, 布谷直美, 江戸由希子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2013.

---

	The present conditions of pharmacist duties in our day -9-O32-10 House intensive care center 田中大輔, 鎌田敬志, 庄司知摩, 佐藤導 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2013.

---

	Consciousness change of the day -9-O33-11 pharmacist and change 4 of duties contents 矢吹直寛1), 渡辺百合子2), 新井亘3), 長谷川正和4), 岡添進5), 矢嶋美樹6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2013.

---

	It is change ... after discussion second report - customer intention breeding training about the satisfaction of the patients after consciousness and the instruction of the -9-O33-12 pharmacist on a day 渡邉百合子1), 新井亘2), 長谷川和正3), 矢吹直寛4), 岡添進5), 矢嶋美樹6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2013.

---

	About the effect that the administration of biological drug for patients with -9-O33-13 rheumatoid arthritis gives to internal use prescription on a day 桑原美果1), 舩木文子1), 村上公美1), 渡邉一則1), 中村篤司2), 井上靖雄2), 神戸克明2), 千葉純司2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2013.

---

	日-9-O33-14 An example corresponding to the mixed ratio measurement request of the brought phenobarbital phenytoin mixture powdered medicine 深山靖夫1), 足立茂2), 加納茉里1), 木村有揮1), 西村富啓1), 近藤直樹1), 久保田篤司1), 井出泰男1), 鈴木義彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2013.

---

	The effect that a withdrawal of the oral antimicrobial in the orthopedics surgery by the -9-O33-15 ward pharmacist gave an SSI incidence and medical economy costs on a day 砂田結希乃1), 多賀允俊1), 比嘉大輔1), 岡田隆史1), 堀内智子1), 杉森端三2), 西尾浩次1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2013.

---

	The enforcement situation after the vital sign training by the day -9-O34-16 pharmacist and future problem 長谷川フジ子1)2), 狭間研至3)4), 池田俊也1), 武田弘志1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2013.

---

	Action of joint medical treatment management (CDTM) of insomnia treatment in the day -9-O34-17 internal medicine clinic 伊藤光, 平松哲夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2013.

---

	rFVIIa administration experience to the duodenal GIST surgery patients who had day -9-O34-18 inborn character-related FVII deficiency 稲田寛之1), 原田匡一2), 中野順隆3), 岡部格4), 関利一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2013.

---

	One ... of the participation - organo-phosphoric pesticide poisoning of the pharmacist in the day -9-O34-19 first aid 三輪耕次, 岩崎明子, 齋藤真慈, 廣瀬正幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2013.

---

	It is ... through the questionnaire of factor - study session of adjuvant chemotherapy refusal, the secession patients after day -9-O34-20 breast cancer technique 佐々木俊則1), 水谷三浩2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2013.

---

	Pharmacist permanent residence to the -9-O35-21 chemotherapy center evaluates usefulness by becoming it on a day 辻直子1), 野際俊希1), 落合実2), 浅井茂夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2013.

---

It is ... from the hearing investigation that we continued at search - medication counseling of the factor which -9-O35-22 comes out on a day, and is involved in the smoking cessation treatment result using meat phosphorus tablets 林すみれ1), 山本健1), 小野陽子1), 右田幸子2), 前田あや子1), 前田拓哉1), 樋川志織3), 三上二郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2013.

---

	Proposal ... for the inhalation instruction construction to be able to aim at examination - side effect evasion of the rule factor of "the oral trouble" to develop in the -9-O35-23 antasthmatic remedy patients on a day 腰山節子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2013.

---

	Role ... of the intervention and telephone monitoring before pharmacist support - medical examination in the day -9-O35-24 outpatient department urination disorder care 前堀直美1), 永江浩史1), 岩崎智奈美2), 安田公夫2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2013.

---

	It is ... mainly on effect to give to practice ... patients satisfaction of the telephone symptom monitoring for patients with foreign urination disorder by the -9-O35-25 pharmacy student on a day 岩崎智奈美1), 安田公夫1), 前堀直美2), 永江浩史3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2013.

---

	Examination of the enlightenment technique for the actual situation of storage, the carrying of the insulin preparation in the day -10-O36-01 winter season and the appropriate storage 西村博之1), 吉田陽1), 鶴田久美子1), 岩下薫子1), 石塚洋一2), 入倉充3), 入江徹美1), 稗島州雄4), 杉山正悟4), 梶原敬三1), 陣内冨男4), 陣内秀昭4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 241-241, 2013.

---

	Action to find the problems of the injection maneuver of the insulin pre-filled / kit preparation in our -10-O36-02 House on a day, and to aim at the in-hospital unification of the maneuver 斎藤彩1), 播磨里美1), 長谷川和正2), 荒川将之3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 241-241, 2013.

---

	Examination of the sitagliptin combined effect in day -10-O36-03 type 2 diabetes insulin therapy patients 福井宗憲1), 佐野典之1), 吉原知明2), 畠山貴司1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 241-241, 2013.

---

	Examination of the insulin secession case in the initial insulin introduction of patients with day -10-O36-04 type 2 diabetes 山口麻理子1), 佐々木英久1), 松尾和廣1), 渡辺朋子1), 篠原悦子1), 真坂亙2), 龍野一郎3), 吉尾隆1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 241-241, 2013.

---

	Action ... which aimed at action ... medication ad peer Lance improvement of the diabetes medical therapy support by the pharmacist in the rehabilitation ward for -10-O36-05 convalescence on a day 加藤豊範, 高井希依, 塚谷忍, 篠田尚子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 241-241, 2013.

---

	Pharmacokinetics judging from day -10-O37-06 insulin crystallization 富岡節子1), 野原幸男1), 信田重成2), 久保博昭1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2013.

---

	One case that hypoglycemic action attenuation of insulin was confirmed with the injection to the -10-O37-07 insulin pole part on a day 齋藤真慈, 宮崎和浩, 廣瀬正幸, 岩崎明子, 三輪耕次 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2013.

---

	Effect of the blood sugar level fluctuation on arteriosclerotic disease of patients with day -10-O37-08 diabetes 菊池千草1), 今枝憲郎2), 岡山直司2), 松永民秀1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2013.

---

It is ... for quality improvement of the diabetes medical treatment instruction of the whole aggressive participation in planning - area of the health insurance pharmacy to -10-O37-09 Ogori cycloid type diabetes cooperation pass on a day 石井美帆1), 百枝尚2), 水口真一3), 白木秀和4), 下田亮5), 西岡恵子6), 赤司朋之7) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2013.

---

	Example analysis of the doubt inquiry based on -10-O37-10 "CKD seal" on a day 磯野哲一郎1), 佐々木恭子1), 宇津貴2), 松尾陽介3), 星野伸夫1), 寺田智祐1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2013.

---

	Result analysis of the team approach in medical care that we included the pharmacist in the renal failure classroom in for -10-O38-11 preservation period on a day for 2 years 小島さおり1), 片山歳也1), 三輪陽子2), 平岡めぐみ3), 安田芳樹4), 三宅真人5), 小寺仁5), 水谷安秀5), 松田浩明1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2013.

---

	Of the prescription suggestion of the pharmacist for patients with day -10-O38-12 decreased renal function, actually 長谷川裕矢, 塚田絢子, 重田和也, 江島ちひろ, 高木美沙, 松本利恵, 野田孝夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2013.

---

	An effect of the febuxostat in day -10-O38-13 haemodialysis patients and the individual difference 吉田拓弥1), 古久保拓1), 田中千春1), 三宅瑞穂1), 隅野和美1), 田中梨惠1), 和泉智1), 庄司繁市2), 山川智之2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2013.

---

	1 case that team approach in medical care cooperation was effective about appropriate taking -10-O38-14 antiinfluenza medicine on a day 小原道子1), 駒形清則2), 三村明美3), 鈴木夢都子4), 池田雄太1), 渡辺謹3), 澤田菜裕1), 高橋清哲1), 大西孝宣1), 古川恵美1), 永田久幸1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2013.

---

	Systematic review about the association of a fall, a fall and the drug in day -10-O38-15 elderly people 朴恵林, 三木晶子, 佐藤宏樹, 澤田康文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2013.

---

	Effect to medical security by the introduction of the universal design font to day -10-O39-16 prescription 丸山修治, 三浦基靖, 等浩太郎, 平野久美, 青野浩直, 高井伸彦, 川上純一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2013.

---

	For day -10-O39-17 pharmaceutical products proper use promotion the way of "do not make medication counseling" 荒井基晴1)2), 木村昌史1), 前田一人1), 三木晶子2), 佐藤宏樹2), 澤田康文2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2013.

---

	Incident accident example analysis by the rear factor posture Creator for day -10-O39-18 medication misprevention 岡元大輔1), 堀里子2)3), 三木昌子2), 佐藤宏樹2), 澤田康文2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2013.

---

	Activity and the evaluation of the meeting for the study that -10-O39-19 simulated patient, an ombudsman, a medical mediator collaborated on a day 末松文博1), 佐藤浩二2), 森淳一2), 日隈武治2), 栗秋良子3), 梅尾さやか4), 田中克典5), 井上龍誠6), 森照明7), 犀川哲典8), 和田仁孝9) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2013.

---

	The accident services of the fentanyl patch in the day -10-O39-20 Nagoya memory Hospital and subsequent effect 壁谷めぐみ1), 湯浅周1), 古賀千晶2), 松島真弓2), 吉良三富美3), 石川尚武4), 長谷川真司5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2013.

---

	日-10-O40-21 Can the effective manner education be carried out by prior learning? - The present conditions and evaluation of "the manner training" in Hoshi University - 湯本哲郎1), 濃沼政美2), 石塚和美1), 白水俊介1), 佐藤はるか1), 島田雅彦1), 田中嘉一1), 町田昌明1), 浅井和範3), 櫻井正太郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2013.

---

Introduction and evaluation ... of the objective study using action ... physical assessment model to learning on a day before business true taking lessons for the purpose of the ability for -10-O40-22 pharmaceutical judgment improvement 田中嘉一, 湯本哲郎, 石塚和美, 白水俊介, 佐藤はるか, 島田雅彦, 町田昌明, 櫻井正太郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2013.

---

	We estimate a -10-O40-23 practice type casebook as making of "the pharmaceutical management by the pharmacist learning from a disaster current events case" on a day 堀里子1)2), 三木晶子2), 佐藤宏樹2), 澤田康文2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2013.

---

	Evaluation of the medical system three department joint education by the student of the day -10-O40-24 most upper grades 木津純子1), 森田夏実2), 門川俊明3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2013.

---

A trial of the super generalist fur better strike training education in the Doctoral degree course in day -10-O40-25 Tohoku University pharmacy graduate course four years system: Participation in School of Medicine clinical training 瀬川良佑1), 高橋亜希1), 平塚真弘1), 眞野成康1)2), 富岡佳久1), 佐藤博1)3), 平澤典保1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2013.

---

	Basic study on new medication method 3 - clinical application -> of the solution for day -11-O41-01 < 須田充彦1), 林靖子2), 都筑朋英1), 島田喬3), 長島学4), 長島直子4), 杉野雅浩2)4), 大島新司2), 細谷治2), 從二和彦2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2013.

---

	A taste bitter evaluation of bridegroom studio (R) eye drops UD2 % (rebamipide) using the day -11-O41-02 taste sensor and effect of food and drink 原口珠実, 宮崎愛里, 吉田都, 櫨川舞, 内田享弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2013.

---

	Examination about the taking-related prediction of the disintegration test device (OD-mate) for the day -11-O41-03 orally disintegrating tablet and amlodipine OD lock 10 preparation using the taste sensor 吉田都, 櫨川舞, 原口珠実, 内田享弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2013.

---

	Prescription optimization of the day -11-O41-04 duloxetine percutaneous absorption type preparation 小幡誉子, 赤木千夏, 大貫義則, 高山幸三 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2013.

---

	Pharmaceutical management to consider from the use situation of the new anticoagulant in -11-O42-05 circulatory organ internal medicine and the neurology on a day 市川洋一1), 徳永晃己1), 柴田啓智1)2), 丸山徹2), 藤本由紀1), 田上治美1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2013.

---

	Action to the proper use of the day -11-O42-06 anticoagulant 菅原亮輔1), 清川真美1), 山田武宏1), 宮本剛典1), 深井敏隆1), 笠師久美子1), 井関健1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2013.

---

	A change of the number of inquiry with the change of the day -11-O42-07 doubt inquiry system and the breakdown 木下友里, 郡司聖子, 増田純一, 水野宏一, 和泉啓司郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2013.

---

	Establishment of the program for the staff training for the purpose of the reduction of the exposure dose by day -11-O42-08 FDG quality control duties 加藤真也1), 山田尚広1), 石田卓也1), 内藤隆文1), 間賀田泰寛2), 川上純一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2013.

---

	Burden reduction of the physician by the day -11-O43-09 prescription suggestion type bringing medicine differentiation 渡辺智康1), 難波良平1), 山崎恵1), 高取孝一1), 安藤哲信1), 世良庄司2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2013.

---

	Introduction and the present conditions of the bringing medicine system of administration of the many types of job participation type using the day -11-O43-10 electronic chart 関屋裕史, 奥村学, 岩切智美, 山口博行, 平原康寿, 有森和彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2013.

---

	Action aiming at safe bringing medicine management during day -11-O43-11 hospitalization 守内匡, 浅野聡美, 田中治, 松井ひろみ, 松田芳美, 高田加壽代 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2013.

---

	The actual situation of the medication of patients with Parkinson's disease judging from the on admission bringing medicine confirmation in our day -11-O43-12 House neurology ward 北浦円, 安藤陽子, 森岡想, 斉藤郁夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2013.

---

	Usefulness of the foreign time bringing medicine confirmation to the day -11-O43-13 surgery purpose hospitalization plan patients 篠崎陽一, 行川洋平, 中嶋亮介, 伊藤圭介, 長郷千香子, 染谷雅弘, 北村正樹, 平島徹, 川久保孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2013.

---

	It is ... towards action (the second report) - Chita Peninsula treatment at home cooperation model area of the hospital pharmacist for day -11-O44-14 treatment at home cooperation promotion 木ノ下智康1), 上地小与里4), 市野貴信1), 伊藤一弘1)3), 古田勝経2), 三浦久幸2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2013.

---

	Monitoring of the medication support equipment for the purpose of the medication ad here Lance improvement of day -11-O44-15 at-home medication elderly people 鈴木亮二1), 武政文彦2), 高橋武3), 阿部一郎3), 長谷川高志1), 鎌田弘之4), 小川晃子5), 酒巻哲夫6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2013.

---

	The periodical health consultation in the day -11-O44-16 mountains doctorless region public hall and community medical care support by the pharmacist 冨重恵利紗1), 河内明夫1), 堀雅晴2), 清原絵利加1), 小畑晴香1), 脇田翔子1), 園田純一郎1), 鳴海恵子1), 佐藤圭創3), 本屋敏郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2013.

---

	The action of the liver disease class for the area using the day -11-O44-17 Web pattern and the evaluation 大滝康一1)2), 大竹孝明3), 阿部真美3), 澤田康司3), 前田重明3), 中嶋駿介3), 横井由紀子1), 小川聡1), 山本久仁子1), 粟屋敏雄1), 柴田千恵子4), 高後裕3), 田崎嘉一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2013.

---

	The trial of "examination for drugstore POCT duties" for health care of the day -11-O44-18 patients and local inhabitants and the usefulness 河内明夫1), 冨重恵利紗1), 岸信行2), 村上貴哉3), 遠田慶介2), 平川一郎2), 富井健司2), 福森三明2), 福森正郎2), 吉森建一4), 堀雅晴5), 佐藤圭創6), 本屋敏郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2013.

---

	Effect of the feedback information with the day -11-O45-19 chronic hepatitis C treatment regional alliances pass 飯塚敏美1)3), 堀口雅巳1), 江口裕三2), 菅野浩2), 吉山友二3), 石塚英夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2013.

---

	日-11-O45-20 Regimen communalization by the medicine medicine cooperation of the oral anticancer agent which discontinuation is necessary for - After a start after four years - 濱口良彦1), 上田浩貴1), 倉橋基尚1)4), 西田修司1), 中尾祐子1)4), 塚本泰彦1), 井上直也2)4), 柳原一広3)4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2013.

---

	Construction ... of care from the beginning of relation in trial - palliative care domain to day -11-O45-21 patients cooperation to end-of-life care 長谷川真澄1), 奥川彰子5), 秋山洋二1), 浅野志津3)4), 平井淳子3)4), 諏訪耕三3), 長谷川亜紀4), 渡辺啓太郎4), 喜多嶋拓士4), 田村浩1), 有賀裕子2), 森英樹3)4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2013.

---

	Keep experience by role and preparations - republic, Republic of Haiti, Republic of Turkey dispatch of the pharmacist at -11-O45-22 size scale disaster in Myanmar alive on a day; and ... 佐藤晴彦1)3), 池原康一2)3), 渡慶次賀博2)3), 伊禮武4), 上原克代1), 知花幸仙4), 伊波潔2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2013.

---

	The actual situation of the support activity of the pharmacy student in the day -11-O45-23 Great East Japan Earthquake 南絢子, 阿部誠也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2013.

---

	Construction of the in-hospital public information site for active reporting in the soil -P1-001 Tohoku University Hospital 前川麻央1), 草場美津江1), 小原拓1)2), 尾崎芙実1), 中川直人1), 佐藤真由美1), 久道周彦1), 松浦正樹1), 我妻恭行1), 眞野成康1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2013.

---

	Construction of soil -P1-002 pharmacy Web Information System and the evaluation 佐藤弘康, 晴山知拓, 谷口雄人, 八幡弘子, 池田静奈, 稲垣育宏, 橋本義宏, 小森均 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2013.

---

	It is ... for the rebuilding of investigation - drug information duties of the attached document revision information acquisition situation in our soil -P1-003 House 南園奈七恵, 長田薫, 山本佐栄子, 松本晃一, 高橋利幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2013.

---

	About maintenance duties of the electronic chart in the change to soil -P1-004 generic medicine and the drug-related system 福田裕子, 菊地幸子, 長澤祥子, 森本拓也, 加地真, 山口洋子, 網野祥子, 道下佳子, 辰野眞理子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2013.

---

	The need that a pharmacist is involved in in the pharmaceutical products master management of the soil -P1-005 medical information system 谷口美悠1), 秋本義雄2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2013.

---

土-P1-006 Summary of a drug, the preparation account book management by M-control(R) derived from a specific organism - Automatic registration of the withdrawal information by the participation of the medical information engineer improves becoming it and business efficiency - 冨岡謙二1), 中本幸成1), 井上愛美1), 松原千明1), 野口賀代1), 北嶋佳織1), 前田貴絵1), 寺本忠弘1), 小林聡子1), 佐藤竜馬1), 大原京子1), 森譲二1), 土佐直子1), 今田篤1), 吉村正則1), 増田玲子1), 中村泰士1), 村山慶2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2013.

---

	土-P1-007 About the discontinuation of the antithrombotic drug in the digestive organ endoscope practice - Cooperation with utilization and the bringing medicine center by the systematization - 西條雅美1)2), 池田譲1), 本田一春1)2), 町田道郎1), 芝崎健志1)2), 武田雄一3)4), 上西紀夫5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2013.

---

	Soil -P1-008 team approach in medical care system of administration (Bundles-TM) construction and role of introduction and the pharmacist 山本貴彦1), 冨田奈津子1), 安則真佐子1), 堤麻美1), 鶴田久史2), 伊藤吏司2), 奥野識1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2013.

---

	Medicine medicine cooperation using the construction of the soil -P1-009 community medical care cooperation system 小枝伸行1), 米田勇太2), 植田真理2), 南野麻衣2), 田中待希2), 小川充恵2), 香川雅一2), 山崎肇2), 朴井晃1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2013.

---

	It is ... about the way of the reporting that is more precise than needs of the drug information for soil -P1-010 physician, a nurse, the pharmacist, acquisition course, investigation ... of the grasp situation 加藤彩香, 高橋リエ, 伊達絢一郎, 坪内清貴, 高林真貴子, 谷本定子, 増江俊子, 原祐輔, 崔吉道, 宮本謙一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2013.

---

	Investigation about the acquisition, transmission, inflection situation of the pharmaceutical products safety information in soil -P1-011 medical institution, the drugstore 平松彩佳1), 前田雄太1), 飯村康夫1), 渡邊伸一1), 池田三恵1), 森和彦2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2013.

---

	Investigation about the reporting of "the document described in soil -P1-012 ethical drug attachment document in the company" 中村昇平, 吉良美里, 櫻田大也, 小林江梨子, 佐藤信範 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2013.

---

	The way of the information about other attention in the soil -P1-013 ethical drug attachment document 山本ゆりえ, 櫻田大也, 小林江梨子, 佐藤信範 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2013.

---

	Examination about the electronic management of the document in soil -P1-014 drug information duties 田村賢士, 金子智一, 鈴木秀昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2013.

---

	Offer of the proper use information along the needs of the pharmacist in the soil -P1-015 company web site 藤井信栄, 石井恵子, 中村淳子, 福永樹里, 飯田暢子, 若林康子, 中村恵未 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2013.

---

	Making of the log book aiming at the cooperation of soil -P1-016 ward drug duties and drug information duties 海老根香里, 小島麻里, 海老澤美幸, 佐藤和人, 関利一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2013.

---

	Grasp and information sharing of the soil -P1-017 in-hospital side effect that occurred 新沼佑美, 佐藤このみ, 矢野とおみ, 加茂陽子, 阿部誠也, 関さやか, 栗村淳子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2013.

---

	The analysis of the consultation contents in the soil -P1-018 Himeji medical center and future problem 壷阪直子, 川戸順之, 濱上賀正, 井上咲姫, 高原由香, 田中三晶 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2013.

---

	Investigation about the inquiry associated with the medicine which our House staff received after the soil -P1-019 Great East Japan Earthquake 吉中千佳1), 小原拓1)2), 草場美津江1), 松浦正樹1), 眞野成康1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2013.

---

	The change of the question contents of most recent ten years in the soil -P1-020 product information room 原田大1), 中島清江1), 野呂和彦2), 北村正樹1), 平島徹1), 川久保孝1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2013.

---

	Discussion ... from the reference situation of inquiry about the infusion put to the soil -P1-021 DI center and background - office question and answer 堀越由里, 竹林佑花, 菅沼典子, 佐々木美由紀, 星泉, 渡邉小百合, 吉岡小都子, 福田まゆみ, 河野裕則, 岩原良晴, 松野太郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2013.

---

	Consultation example in the soil -P1-022 68th winter season national polity speed skating venue anti doping booth 米田励希1), 町野紳2), 島貫英二3), 佐藤善嗣4), 阿部悟5), 石澤洋史6), 波多江崇7) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2013.

---

	Advisability of the use at the soil -P1-023 decreased renal function, the simple suspension method, the crush, making of the collection of in-hospital pharmaceutical products described the dosage form photograph in 伊藤哲也, 田中義輝, 岡田由加, 橋爪博隆 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2013.

---

	Filter permeability investigation of the soil -P1-024 parenteral injection 生司愛弓1), 五十嵐俊2), 森田徹2), 難波昭雄1), 高尾良洋2), 鷲見正宏1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2013.

---

	Fact-finding of 500 mg of combination therapy for the azithromycin infusion that we applied technique of the soil -P1-025 pharmacoepidemiology in 昆貴志1), 森雅之1), 橋本貴尚1), 飯島秀弥2), 栃窪克行1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2013.

---

	Examination of the adoption pharmaceutical products evaluation method in the soil -P1-026 Shonan Kamakura General Hospital 仲鉢英夫, 長岡和徳, 錦佑輔 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2013.

---

	Investigation about the mention contents about references cited of soil -P1-027 DSU 平山優花, 櫻田大也, 小林江梨子, 佐藤信範 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2013.

---

	How will the patients become able to describe an interview sheet enough soil -P1-028? 藤森美代子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2013.

---

	Investigation about recognition about the pharmaceutical products safety assessment of the soil -P1-029 hospital pharmacist and the practice 飯田優太郎1)2), 小原拓1)2)3), 尾崎芙実1)2), 高田紀子1)2), 鈴木理紗子1)2), 佐藤倫広1), 青木良子4), 天沼喜美子4), 大久保孝義5), 松浦正樹1)2), 佐藤真由美1)2), 眞野成康1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2013.

---

	The use situation of the medicine notebook in our soil -P1-030 House inpatient and attitude survey 桃井祥制, 小野由紀子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2013.

---

	Making of the medication support document for infants using soil -P1-031 medicine notebook 池田静奈1), 渡部由佳1), 西牧武志2), 佐藤弘康1), 稲垣育宏1), 橋本義宏1), 小森均1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2013.

---

	The use of medicine notebook situation of the children who came to the hospital in an emergency institution in the early period of soil -P1-032 children 木村誠 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2013.

---

	Attitude survey of a pharmacist about the compounding of medicines prescription suggestion in the soil -P1-033 decreased renal function patients and the physician 舘知也1), 加藤未紗1), 甲田明英2), 大澤友裕2), 福田聖啓2), 田中和秀2), 青山智2), 安田昌宏2), 水井貴詞2), 後藤千寿2), 寺町ひとみ1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2013.

---

	The use of diabetes therapeutic drug situation in the soil -P1-034 severeness decreased renal function patients 羽生智宏, 嶋崎千絵, 長澤欣弘, 仲島優一郎, 森山亜矢子, 尾形美絵, 田村和彦, 新関みどり, 近藤和宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2013.

---

	About a ratio and a future action of the generic name prescription in our soil -P1-035 House 宮本拓人, 星野有吾, 川澄清孝, 加藤喜春 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2013.

---

	An action to returned goods disposal of soil -P1-036 prescribed medicine and the fact-finding 高橋努, 三枝良安 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2013.

---

	土-P1-037 Attitude survey of the patients for pharmaceutical products - Examination in other institutions - 田淵紀彦, 内田朋美, 宇野勝次, 福長将仁 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2013.

---

	Questionary survey about the taking well virus chemotherapeutant situation in soil -P1-038 children 霍間尚樹1), 三星知2), 植木淳一1), 菅原里恵1), 長谷川高弘1), 池田勲3), 大平和雅4), 中村博1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2013.

---

	Examination of the effect of the medication counseling by medication jelly and the pharmacist on soil -P1-039 children 宮原由香里, 青山幸枝, 草深純一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2013.

---

	The revision of the booklet for protectors about the medication of soil -P1-040 children and the evaluation 中村友香, 福田耕太郎, 本多有希子, 槙田芳, 高橋秀幸, 亀井浩二郎, 吉田直哉, 小原郁司, 小寺隆二, 下山光一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2013.

---

	Attitude survey of the drug industry about the soil -P1-041 new pharmaceutical products sale system 加藤大和1), 鈴木俊之1), 上田夏実1), 中山蓉子1), 西端友里1), 梅津亮冴1), 土屋照雄2), 中村光浩1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2013.

---

	Investigation to the registration distributor about the soil -P1-042 new pharmaceutical products sale system 上田夏実1), 鈴木俊之1), 加藤大和1), 中山蓉子1), 西端友里1), 梅津亮冴1), 土屋照雄2), 中村光浩1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2013.

---

	The use situation of the Chinese medicine in the soil -P1-043 drugstore and attitude survey 日置智津子1), 稲垣承二2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2013.

---

	Questionary survey about the new pharmaceutical products sale system for soil -P1-044 drugstore pharmacists and the registration distributor placement 鈴木俊之1), 中山蓉子1), 上田夏実1), 加藤大和1), 西端友里1), 梅津亮冴1), 土屋照雄2), 中村光浩1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2013.

---

	Investigation about the recognition for the present conditions and the decision aiding of the relation to soil -P1-045 staying alone, lone wolf 辻村行啓1), 川村和美1)2), 塩川満1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2013.

---

	Economic effect by a prescription trend and the pharmacist intervention of the appointed hour medicine in the soil -P1-046 care health center for the elderly 岡田康志1), 谷口聡1), 淡下玲子2), 石原照夫2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2013.

---

	Proper use of the dabigatran in the soil -P1-047 City Sapporo hospital and situation investigation of the side effect expression 二木祐輔, 尾崎尚子, 大下直宏, 川本由加里, 後藤仁和 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2013.

---

	Evaluation ... of prescription fact-finding - side effect (bleeding, digestive organ symptom) and the patients background factor of the dabigatran in our soil -P1-048 House 芳賀貴史1), 伊東孝子1), 村上弘則2), 本郷文教1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2013.

---

	Examination of the effect on use of carbapenem-based antimicrobial situation by the soil -P1-049 DPC introduction 伊藤匡伸, 成瀬国男, 藤井里奈, 吉田厚志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2013.

---

	The use situation of the tramadol / acetaminophen combination lock in the soil -P1-050 peripheral arterial disease 清水裕行, 安本祥子, 下川福子, 野口久美子, 渡邊佳世子, 林洋平, 川端俊介, 澤田奈津子, 松原史典 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2013.

---

	Change of the number of the combination drugs with the antihypertensive medications combination drug judging from the prescription fact-finding of soil -P1-051 antihypertensive medications 若林進1), 篠原高雄1), 永井茂1), 田中伸和2), 林潤一2), 山本実2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2013.

---

	About the making of the use of tolvaptan situation for patients with heart failure in our soil -P1-052 House and the clinical pass 寺崎展幸, 横田聖子, 上田里恵, 福井英二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2013.

---

	Use fact-finding of the sitafloxacin lock in our soil -P1-053 House respiratory organs department of internal medicine 楠本将裕1), 山室蕗子1), 喜多岡洋樹1), 赤池公孝2), 永野潤二2), 岸裕人2), 岩越一3), 福田浩一郎2), 末吉栄志1), 近藤元三1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2013.

---

	Investigation about the use of injectable levofloxacin in our soil -P1-054 House 尾崎裕之, 伊佐治麻里子, 直江可奈子, 前田直大, 橋本哲郎, 入山美知, 松原浩司, 下澤みづえ, 小田貴実子, 作田典夫, 新岡正法 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2013.

---

	Soil -P1-055 ARB and the ACE inhibitor cause intraoperative hypotension 中尾耕治, 杉山かおり, 西尾益治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2013.

---

	It is ... using examination - SF-36 of the healthy quality of life in Peglnterferon/Telaprevir triple-drug therapy patients for soil -P1-056 chronic hepatitis C 鈴木光幸1)2)3)4)5), 佐久間愛1), 石川達2), 吉田俊明2), 阿部弘子3), 野口博人3), 深沢尚子1), 廣澤宏5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2013.

---

	The onset of use fact-finding and side effect situation of the tram set combination lock in our soil -P1-057 House 高見藍, 儀間美乃里, 喜多幸子, 渡部真哉, 仲村亮太, 土本理恵, 北村知子, 駒井勇太, 岡野紘子, 小松祐輔, 潮平沙貴, 田中紋乃, 花見佑子, 人見百合子, 村瀬友香, 石井英之, 関野富久, 田仲祐子, 羽山紗樹乃, 喜多洋嗣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2013.

---

	Proper use of the soil -P1-058 asking a preposterous price albumin preparation 三角真由, 上原美佐, 松村泰之, 佐藤透 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2013.

---

	Use fact-finding of the Lobi on note at the soil -P1-059 surgery 北村渉1), 齋藤圭佑1), 尾崎昌大1), 添田真司1), 鈴木優司2), 渡邊昌之1), 横山晴子3), 高柳理早3), 山田安彦3), 北川泰久4), 福山東雄5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2013.

---

	Attitude survey about the concomitant drug of the soil -P1-060 dutasteride capsule internal use patients and the medication 金野由香1), 太田香1), 尾形勉2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2013.

---

	Soil -P1-061 comes out; a side effect investigation of meat phosphorus and the questionary survey to the patients, a physician, a pharmacist 神浦茉奈実1), 松本ミユキ1), 寺西由美子3), 田中亜紀4), 岩永絵梨奈5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2013.

---

	Use situation investigation of the deep vein thrombosis preventive preparation in the soil -P1-062 lower limbs orthopedics surgery 御牧紗代, 秋山美和, 櫻井悠紀子, 森淑子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2013.

---

	The use situation and awakening fact-finding of midazolam in the soil -P1-063 digestive organ endoscopy 長澤宏之1)2), 土屋良成3), 木村典夫3), 志田勝義3), 折笠亜矢子3), 飯嶋久志1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2013.

---

	Examination (followup) about the effect difference by the dosage form change in soil -P1-064 lanthanum carbonate hydrate 安田貢1), 吉川真一1)2), 竹下光弘4), 松本耕太1), 吉田温子1), 波立亜沙美1), 山口宗之1), 阿部若恵1), 坂本智美1), 阿部仁美1), 吉田進2), 小佐野磨子2), 永田隆之2), 鈴木隆広1), 中野広文3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2013.

---

	Role of the use situation and the pharmacist of the antirheumatic drug mainly on methotrexate in patients with soil -P1-065 rheumatoid arthritis 森岡淳子1), 須古杏子1), 宮本浩子1), 高岡宏和2), 中村正2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2013.

---

	Examination of the inhalational instruction for patients with COPD using soil -P1-066 in check and the inhalational check list and asthma 三上祥博1), 村中美幸1), 前川雅代1), 堀良行1), 河田清志1), 小松裕輔1), 畑中紀世彦1), 新野智与1), 山木利恵子1), 菅原夏実1), 杉谷祐紀1), 高橋政明2), 藤田結花2), 山崎泰宏2), 藤内智2), 藤兼俊明2), 武田昭範1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2013.

---

	The asthmatic control in patients with soil -P1-067 infantile asthma and relations with factors 新敷祐士1), 西本久美子1), 酒井十月1), 水島教之1), 田端祐一2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2013.

---

	The present conditions and problems of the use of PCA for the postoperative pain in our soil -P1-068 House 後藤瑠里, 大谷俊裕, 高橋朝樹, 椿浩之, 堀越建一, 常盤英文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2013.

---

	Association of quality of life and the depression of the soil -P1-069 outpatient 興野友見1), 平野泰子1)4), 増田達仁1), 吉成徹1), 大根田亨1), 大塚勤2), 天野託3)4), 古泉幸直1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2013.

---

	Use situation investigation of soil -P1-070 "omeprazole sodium note 20" 阿登大次郎, 岡本知子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2013.

---

	Possibility of the improvement by a change and the tablet prescription of the soil -P1-071 children compliance 嘉屋道裕1), 浅井萌子1), 原崎正士2), 中川剛2), 甲原貴子3), 田中大喜2), 角入壽彦1), 鈴木崇代1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2013.

---

	Examination to a use investigation and the proper use of the anticoagulant for the soil -P1-072 new diagnosis atrial fibrillation case 堀内望, 茂木孝裕, 伊藤菜浪, 野崎歩, 小林由佳, 新宮とし子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2013.

---

	Attitude survey to a physician, a nurse for the physical assessment by the soil -P1-073 pharmacist 池邉晋一朗, 今西孝至, 赤尾優輔, 高山明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2013.

---

	The use of the reserve drug in soil -P1-074 doctor copter, an emergency visit and the ICU and participation of the pharmacist 赤阪未来, 向原里佳, 村木優一, 岩本卓也, 奥田真弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2013.

---

	Attitude survey of a student, the teacher about the smoking in the site of the university with the soil -P1-075 pharmacy school 長久保匡男1), 渡辺朋子1), 松尾和廣1), 佐々木英久1), 篠原悦子1), 斉藤百枝美2), 吉尾隆1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2013.

---

	Questionary survey to examine effect of the soil -P1-076 MR visit regulation 舩越真理, 土谷有美, 原田益弘, 津田正博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2013.

---

	土-P1-077 Outlook and efforts to Balanced Scorecard introduced in Yims group drug section Part 2 飯塚真至1)4), 前田拓哉1)4), 小田切正美1)4), 大久保淑子2)4), 山内泰一3)4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2013.

---

	土-P1-078 For the proper use of the sleeping drug - Investigation of the medication situation in the health insurance pharmac - 芥田賀奈子1), 河野修治1), 津島己幸1), 橋詰勉1), 渡辺翠2), 小寺隆幸2), 高山明1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2013.

---

	Analysis of the study on drug economy trend in the soil -P1-079 our country 森川加奈子, 後藤伸之, 大津史子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2013.

---

	Estimation of the medical economic effect to be obtained from the pharmaceutical intervention by the soil -P1-080 pharmacist 田坂祐一, 田中亮裕, 井門敬子, 田中守, 荒木博陽 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2013.

---

	Medical economical evaluation of pharmacist duties about patients with soil -P1-081 cancer 松岡加恵1), 荒川裕貴1), 中西敏博1), 久田達也1), 辻秀樹2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2013.

---

	Inspection of the evaluation method of the adoption situation using the scoring in the injectable anticancer agent of the soil -P1-082 many standards bundle selling 矢島愛理1), 瀬戸良教1), 中村優1), 菅原充広1), 小川幸雄1), 厚田幸一郎1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2013.

---

	Test calculation of the drug costs reduction effect by the generic medicine introduction of the soil -P1-083 anticancer agent 瀬戸良教1), 矢島愛理1), 中村優1), 菅原充広1), 小川幸雄1), 厚田幸一郎1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2013.

---

	Cost effect analysis for medicine charge calculation of the soil -P1-084 new medicine: A COPD therapeutic drug as a case 長谷川彩1), 五十嵐中2), 赤沢学1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2013.

---

	Cost effectiveness of the soil -P1-085 steroid-resistant idiopathic thrombocytopenic purpura (ITP) treatment 菊地佳代子1), 宮川義隆2), 佐藤裕史1), 池田俊也3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2013.

---

	Action for bringing Kuzuri in our soil -P1-086 House 落合愛子, 細見亜里沙, 茅本道子, 池田香奈江, 荻本靖子, 中井聖子, 森史衣, 古田有紀子, 平井満子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2013.

---

	Bringing medicine administrative work and economic effect in our soil -P1-087 House 川原園淳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2013.

---

	The bringing medicine management that cooperated with the ward exclusive duty pharmacist with the soil -P1-088 bringing medicine differentiation system 井上和洋, 蓮輪博嗣, 横尾賢乗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2013.

---

	Action to bringing medicine confirmation duties in consideration of soil -P1-089 risk management 佐藤仁宣, 藤倉めぐみ, 舛田未奈子, 野村理恵, 山口正和, 加藤一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2013.

---

	Bringing medicine management in ward drug duties in the cottage-hospital out of soil -P1-090 宮崎智子, 橋本奈穂, 服部俊広, 藏田充智子, 宮崎優美子, 金澤恵, 永井國男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2013.

---

	Action of the bringing medicine for inpatient management in our soil -P1-091 House 筒井美月, 池田優衣, 箱家優子, 山田英貴, 伊藤裕根 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2013.

---

	Comparison of the in-hospital pharmaceutical products-related adverse event incidence by the soil -P1-092 bringing medicine use or nonuse 溝口優, 太田哲徳, 青山幸枝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2013.

---

	The effect that a soil -P1-093 bringing medicine discriminant operational change gives to the duties of the pharmacist 大谷寧次郎1)2), 上田恒治1)2), 杉浦洋二1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2013.

---

	Examination to the fact-finding of identification of the soil -P1-094 inpatient bringing medicine and report duties and future ward drug duties 萩原研, 須賀理絵, 大坂奈央子, 伊勢雄也, 宮田広樹, 片山志郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2013.

---

	Fact-finding of the source of information in the soil -P1-095 bringing medicine differentiation 市原航1), 田辺寿一2), 福井宗憲1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2013.

---

	土-P1-096 You promote efficiency of confirmation duties of the on admission bringing medicine how, and do you improve quality? - The ward permanent residence of the pharmacist for becoming it - 中原薫, 徳和目篤史, 安部順子, 岡本麻理子, 中村瑞穂, 森下久恵, 福間郁美, 辰野香里, 西川武司, 永山勝也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2013.

---

	Investigation about the acquisition, transmission, inflection situation of the pharmaceutical products safety information of the bringing medicine in the soil -P1-097 medical institution 前田雄太1), 平松彩佳1), 飯村康夫1), 渡邊伸一1), 池田三恵1), 森和彦2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2013.

---

	土-P1-098 Duties contents second report in the ward of the pharmacist - Pharmaceutical care report about the bringing medicine - 水野めぐみ, 伊藤和幸, 松下直樹, 石原彩, 一木万奈美, 植村太志, 浅井倫子, 加藤美香, 鵜飼泰夫, 藤川景子, 長谷川徹, 久田純生, 河井和子, 磯谷聡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2013.

---

	Soil -P1-099 ward permanent residence about a change of the prescription suggestion by becoming it 池田麗1)2), 森祐美子1), 島本裕子1), 和田恭一1), 岩川精吾2), 中村慶1), 桑原健1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2013.

---

	Actions from the foreign consultation of the soil -P1-100 hospitalization planned patients to preoperation cancellation medicine management 早川朋子, 浅井小百合, 勝俣はるみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2013.

---

	An evaluation and problem of bringing medicine confirmation duties before surgery, the testing in the soil -P1-101 Nagano Municipal Hospital 峯村素子, 林部千寿, 関野陽子, 荒井麻衣子, 清野美佐子, 斉藤和彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2013.

---

	Benefit ... of present conditions - medicine notebook of the bringing medicine use in the soil -P1-102 Masuda Red Cross hospital 宅江孝修1), 村上裕葵1), 吉田勝好1), 郷原学1), 西迫多重2), 西園憲郎3), 大庭信行3), 高村洋3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2013.

---

	Action of the common use medicine for patients with soil -P1-103 outpatient department initial diagnosis investigation 井口幸子, 松崎雅英, 高橋新次, 則武香奈, 梶田正樹, 水谷旭良 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2013.

---

	Effect of the prescription suggestion in the soil -P1-104 convalescent rehabilitation ward 相馬直記1), 倉本貴子1), 留守克之2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2013.

---

	Development of the duties progress grasp system in soil -P2-105 compounding of medicines duties 五十嵐文, 森田徹, 望月優佑, 岡田七津子, 五十嵐俊, 高尾良洋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2013.

---

	Introduction and evaluation of the formulations progress management system of the internal use prescribed medicine using soil -P2-106 RF-ID 竹中美貴1), 阿部正樹1), 鳥飼幸太2), 小野理恵1), 中村浩規1)3), 飯塚惠子1), 荒木拓也1)3), 山本康次郎1)3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2013.

---

	An action and evaluation of the injection drug compounding of medicines duties efficiency for the soil -P2-107 ward drug duties support 佐々弥栄子, 鬼頭克暢, 葛谷真理, 今井視保子, 木下元一, 青山智彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2013.

---

	The examination of instructions mention to an injection prescription using soil -P2-108 Panasonic injection order system and the effect 藤森和則, 近藤有, 藤井里奈, 白石彩乃, 近藤貴也, 成瀬国男, 川井正光, 三宅芳男, 吉田厚志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2013.

---

	It is simplified the prescription contents confirmation at the soil -P2-109 change 菊井利伸, 荻野寿世, 谷村紀代子, 高谷伸治, 高橋利江, 近本珠代, 高見美幸, 小林紀子, 田中朋子, 須貝智子, 市川雅美, 八木朝子, 臼井麻郁子, 牧亜由美, 波多野友希, 土生早紀子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2013.

---

	Prescription checking of pharmaceutical products needing the laboratory study that it is like soil -P2-110 regularly 千葉淳, 田村健悦, 南和志, 平賀元 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2013.

---

	土-P2-111 Analysis first report of doubt inquiry contents - A tendency and analysis of the doubt inquiry in the daily service zone - 後藤麻佑子, 松下直樹, 佐々木宏徳, 辻真由子, 石原彩, 水野めぐみ, 神野堅司, 菱田栄子, 浦崎圭太, 河井和子, 伊藤和幸, 磯谷聡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2013.

---

	土-P2-112 Analysis second report of doubt inquiry contents - A tendency and measures of the doubt inquiry in the overtime practice - 辻真由子, 後藤麻佑子, 松下直樹, 佐々木宏徳, 神野堅司, 菱田栄子, 浦崎圭太, 河井和子, 伊藤和幸, 磯谷聡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2013.

---

	Evaluation about the improvement of the quality of the doubt inquiry by having introduced SBAR into doubt inquiry to soil -P2-113 injection drug prescription 平櫛真也, 森谷康志, 徳田衡紀, 高柳和伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2013.

---

	About directionality of a change and the prescription checking of the doubt introduction contents for the soil -P2-114 outside Parliament prescription 垣内祥宏, 内田尚紀, 木村彩乃, 本郷尚子, 緑川拓也, 吉田彩, 渥美弘美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2013.

---

	Checking prescription using the renal function table of the inpatient in the soil -P2-115 dispensary 速水章一1), 森山真実1), 伊藤桂子1), 坂本和央1), 岡野翔1), 大江利治2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2013.

---

	Action for pharmaceutical products proper use by the checking prescriptions in consideration of soil -P2-116 renal function 田中佑喜子, 平賀元, 田村健悦, 齊藤照尚, 南和志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2013.

---

	Investigation about drug information offer duties in the soil -P2-117 dispensary 浦崎圭太, 佐々木宏徳, 松下直樹, 後藤麻佑子, 辻真由子, 石原彩, 神野堅司, 菱田栄子, 河井和子, 伊藤和幸, 磯谷聡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2013.

---

	Confirmation method of the allergic information of the patients in the soil -P2-118 pharmacy service under health insurance drugstore 笹倉麻未1), 飯嶋久志2), 小林江梨子1), 佐藤信範1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2013.

---

	Fact-finding of formulations for the soil -P2-119 PTP sheet mis-deglutition 町田美紀子, 渋谷沙千加, 宇都宮美穂, 飯田安紀子, 栗林和美, 山本佳久, 水野恵司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2013.

---

	Effect (2) of the electric charge to give it to a weight error at the soil -P2-120 powders divided powder 田山剛崇1), 前田志津子1), 杉原数美1), 三宅勝志1), 佐伯康之2), 川本庸太3), 寺重隆視4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2013.

---

	Soil -P2-121 package the environmental research (1) in formulations 飯田安紀子, 宇都宮美穂, 渋谷沙千加, 町田美紀子, 山本佳久, 栗林和美, 水野恵司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2013.

---

	Introduction of the simple suspension method in the soil -P2-122 order ring systematization 安田美奈子, 柳瀬未季, 山田一聡, 瀬古高行, 村井邦充, 白川舞, 堀田宏, 伊藤嘉浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2013.

---

	Usefulness examination of the medication method automatic mention system of the soil -P2-123 simple suspension method 脇田恵里, 平島学, 平野淳, 伊藤誠紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2013.

---

	An action and evaluation of the simple suspension method introduction by the soil -P2-124 pharmacist leadership 岩田杏子1), 高野あすか1), 細山寛代1), 佐藤慶三1), 高橋伸夫1), 岸田有希子3), 中村裕義1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2013.

---

	Comparison of the division characteristics of the tablet which there is no soil -P2-125 secant in and the content with crush formulations 角佳亮1), 針木亜沙子2), 丸一泰雅1), 多賀允俊3), 小藤恭子2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2013.

---

	Examination about the division of the soil -P2-126 acetaminophen bougie 徳田真実1), 井上舞鳥1), 増田克哉1), 寺島朝子1)2), 前澤佳代子1), 渡辺裕子1), 木津純子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2013.

---

	Examination of the moisturizing effect about the dilution of the soil -P2-127 heparinoid from animal organ preparation 眞部遥香1), 大谷道輝1), 野澤茜1), 野々山真衣1), 西村恵里子1), 山村喜一1), 江藤隆史2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2013.

---

	Evaluation of the disintegration of the commercial donepezil hydrochloride orally disintegrating tablet using the soil -P2-128 artificial saliva 櫨川舞, 原口珠実, 吉田都, 内田享弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2013.

---

	Basic study on new medication method 2 of the solution for soil -P2-129 林靖子1), 須田充彦2), 杉野雅浩1), 大島新司1), 細谷治1), 從二和彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2013.

---

	It is ... to the enforcement record in construction ... reliable electronic chart of use, the regime of the fixed number placement medicine by the soil -P2-130 rotation method 田上雅美1), 福田英克1), 南波勝栄1), 安田まゆみ2), 下野茂樹2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2013.

---

	About the efficiency of duties by the connection of the used pharmaceutical products automatic recognizer (SPASER) and electronic chart in the soil -P2-131 operating room 蘇原由貴1), 中田総一郎1), 恩田寿美子1), 柴田秀郎1), 本田雅巳2), 大隈恵治3), 越川千秋1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2013.

---

	A job evaluation of the pharmacist working full time placement in the soil -P2-132 surgery part and future problem 牧野新輝, 藤居賢, 山崎紀恵子, 中田浩雅, 野田師正, 宮本篤 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2013.

---

	Action to soil -P2-133 surgery part pharmaceutical products management 内山将伸, 今村健, 岡崎美和, 藤金治雄, 鷲山厚司, 二神幸次郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2013.

---

	Action for the utilization of the soil -P2-134 emergency cart medicine 青田真理子, 坂野昌志, 寺井文廣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2013.

---

	Soil -P2-135 About the present conditions of the handling of the drug for the withdrawal medical care - The second report - 角山政之, 友田江美, 新藤清美, 戸田智美, 木村優美, 木村康浩, 木平健治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2013.

---

	Having seen it than a questionnaire about the expiration date for use of the drug for the soil -P2-136 medical care 東裕美子1), 武智宣佳2), 綱本優美3), 形部文寛1), 山崎富士子4), 林俊吾5), 八本久仁子6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2013.

---

	About management of thalidomide and lenalidomide in our soil -P2-137 House 安間浩子, 栗原千絵子, 寺田高子, 妹尾裕美子, 勝俣はるみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2013.

---

	The prescription of the soil -P2-138 bifidus bacillus medicine for intestinal disorders and problems about formulations and the correspondence 羽太光範, 和田幸治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2013.

---

	Study on uniformity of the principal ingredient in the acetaminophen bougie which heated soil -P2-139 to melt 山本佳久1), 小島理美1), 竹内理紗2), 深水啓朗2), 小出達夫3), 香取典子3), 鈴木豊史2), 伴野和夫2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2013.

---

	Efficiency of pharmacist duties by the soil -P2-140 SPD utilization 片山文子, 石渡勝美, 小林功, 平間百合子, 河原英子, 鈴木怜志, 森井理貴, 吉川明彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2013.

---

	Examination of pharmaceutical products stock quantities possible of maintenance and the stricken area support of the hospital function at soil -P2-141 size scale disaster 寺岡知寿, 穂積雅人, 北村奈央子, 岸川友紀, 松浦正樹, 佐藤真由美, 久道周彦, 眞野成康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2013.

---

	Action Vol. to safety management of the hospital preparation in our soil -P2-142 House and quality control 1 - urinastatin vagina bougie as a case ... 松岡順子1), 関根令奈1), 土屋宣子1), 薄井俊幸3), 勝沼潤子4), 内田能安4), 小井戸茂4), 湯本哲郎1)2), 稲葉健二郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2013.

---

	Action Vol. to safety management of the hospital preparation in our soil -P2-143 House and quality control 2 中西瞳1), 小名木彩水2), 佐々木優1), 宮地正和1), 湯本哲郎1)2), 櫻井正太郎2), 稲葉健二郎1), 島田早苗3), 田中聡子4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2013.

---

	Action for guideline (Version1.0) about a preparation of the soil -P2-144 hospital preparation and the use 宮下博幸1), 小林彦登1), 斎藤太寿1), 柴田壮一1), 松原肇1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2013.

---

	Compare it with the present conditions of hospital preparation duties in the soil -P2-145 Saiseikai Niigata second Hospital and a guideline about a preparation of problem - hospital preparation and the use; and ... 須佐充, 上村賢介, 内坪誉歳, 田村晶子, 安藤嘉範 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2013.

---

	Examination of the pharmaceutics about the soil -P2-146 hospital preparation olanzapine bougie 木村覚1)2)3), 高橋健市1), 寺島朝子1)2), 渡辺裕子1), 前澤佳代子1), 元永伸也3), 木津純子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2013.

---

	The preparation of the soil -P2-147 pregabalin bougie and evaluation of the bioavailability 櫻井利成1), 新井成俊2), 村田勇1), 井上裕1), 木村昌行1), 金本郁男1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2013.

---

	The in-hospital formulation of the soil -P2-148 levetiracetam bougie and evaluation of the pharmaceutics 武者愛美1), 丸宗孝1), 桑原清人2), 石原優2), 浅子恵利2), 松本美奈子3), 井内俊彦4), 櫻田大也1), 佐藤信範1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2013.

---

	Soil -P2-149 Study on Mohs' paste (the seventh report) - Properties of matter change by the dosage form design of the Mohs' paste - 岡田賢二1), 小川法子3), 田口真穂2), 村田実希郎4), 津田泰之1), 山本浩充3), 重山昌人1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2013.

---

	Evaluation of water absorptivity of the soil -P2-150 CMC-Na component Mohs paste and the expansibility 山本千鶴子, 岡山未来, 松本望, 中島和博, 園田正信, 川重誠, 江頭伸昭, 大石了三 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2013.

---

	土-P2-151 Development of the Nobile Japanese spaniel drug for external use for the purpose of acne vulgaris treatment - Examination of the Nobile Japanese spaniel solubilization technique - 佐々木彩乃1), 内野智信1), 浅川倫宏2), 菅敏幸2), 宮嵜靖則1), 賀川義之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2013.

---

	Evaluation of the indometacin component oral mucosa adhesion lock for the purpose of sharp pain treatment of soil -P2-152 stomatitis 池内由里, 須田綾香, 笹津備尚, 大西啓 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2013.

---

	Examination of the background factor influencing a value, a PT-INR level in an aPTT at the soil -P2-153 dabigatran administration 上島麻衣1), 東丸貴信2), 土井啓員3), 真坂亙3), 石井敏浩1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2013.

---

	土-P2-154 Usage of Dabigatran in our hospital (trade name; Prazaxa) 中井聖子, 古田有紀子, 平井満子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2013.

---

	About the use situation and side effect expression of soil -P2-155 dabigatran 中嶋丈晴, 長島章, 伊藤功治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2013.

---

	Research about clot embolus incidence and the side effect under the dabigatran administration in patients with soil -P2-156 non-valvular atrial fibrillation 星野祐司1)2), 篠原悦子1), 千葉達夫2), 佐々木英久1), 松尾和廣1), 渡辺朋子1), 加藤裕芳2), 浅山亨2), 吉尾隆1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2013.

---

	Hypocalcemia prevention internal use quantity in the soil -P2-157 orchid mark subcutaneous injection 松本浩明, 徳田衡紀, 森谷康志, 高柳和伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2013.

---

	Examination of the expression situation and the risk factor of the hypocalcemia in soil -P2-158 denosumab treated patients 多賀志乃, 木山茂春, 柏原宏暢 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2013.

---

	Examination about the hypocalcemia by the soil -P2-159 denosumab 川端俊介, 下川福子, 安本祥子, 岡田志保, 林洋平, 清水裕行, 澤田奈津子, 野口久美子, 松原史典 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2013.

---

	The actual situation of theophylline convulsions in the soil -P2-160 our country 渡辺裕子, 前澤佳代子, 木津純子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2013.

---

	Analysis of the Churg-Strauss syndrome onset risk in the antasthmatic remedy case using the soil -P2-161 FAERS database 西端友里1), 梅津亮冴1), 鈴木俊之1), 上田夏実1), 中山蓉子1), 加藤大和1), 鈴木悠起也1), 田中宏幸2), 原英彰3), 紀ノ定保臣4), 中村光浩1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2013.

---

	Examination of the expression situation and the risk factor of the adverse event by the soil -P2-162 edoxaban 安達るい, 大石裕樹, 三原由記, 三角紳博, 西野隆 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2013.

---

	Analysis of the bleeding risk factor in patients who underwent artificial joint replacement given soil -P2-163 Edoxaban tosilate acid salt water vegetables with dressing 西本辰徳1), 坂田光平1), 佐伯芙佑希1), 林稔展1), 斎藤正幸3), 田口清章2), 近藤豊1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2013.

---

	Adverse event investigation of the GEM+CBDCA therapy for soil -P2-164 urothelium cancer 平田力, 手塚悠希, 棚谷貢, 鈴木千波, 田畑裕和, 柴波明男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2013.

---

	It is examination about the frequency of the vascular pain after the change from soil -P2-165 Cem Saar injection business to generic drug gemcitabine infusion liquid "sand" 難波有智 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2013.

---

	Examination about the side effect at use of high-dose methotrexate in our soil -P2-166 House 丸山真吾1), 今泉敦子1), 鶴見奈都代1), 我妻眞澄1), 白川雅子1), 松橋めぐみ2), 谷村一秀2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2013.

---

	2 cases of the rheumatoid arthritis that caused myelosuppression by soil -P2-167 methotrexate 荻原宏美, 三浦篤史, 油井信明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2013.

---

	Risk factor analysis of the serious neutropenia by the amrubicin in patients with soil -P2-168 progress, recurrent lung cancer 渡邊裕之1), 池末裕明1), 大城真里奈2), 永田健一郎1), 三嶋一登1), 高田敦史1), 末次王卓1), 末安正典1), 江頭伸昭1), 大石了三1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2013.

---

	One case with suspected neutropenia tardive by rituximab administration at the kidney transplantation in soil -P2-169 children 石原彩1), 久田純生1), 河井和子1), 伊藤和幸1), 磯谷聡1), 山田晃郎2), 柴田元博2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2013.

---

	About effect on AKI when we used soil -P2-170 diuretic, ACEI or ARB and NSAIDs together 岡田七津子, 五十嵐文, 望月優佑, 五十嵐俊, 高尾良洋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2013.

---

	Examination about the onset of side effect factor by the aliskiren fumarate combination in patients with diabetes during soil -P2-171 ACE inhibitor or ARB remedy 府川和樹, 原敬一, 杉尾和昭, 佐野君芳, 真坂亙 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2013.

---

	土-P2-172 Study on the expression frequency in the original drugs and generic vascular disorders by Nicardipine Hydrochloride Injection 尾竹真由美1), 井上祐貴1), 加藤万理1), 早川裕二2), 吉田知由1), 佐藤賛治1), 松本修一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2013.

---

	The case that produced platelet count decrease by soil -P2-173 bosentan 三浦篤史1), 宮崎信也1), 市川裕平1), 篠原佳祐1), 土屋ひろみ2), 油井信明1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2013.

---

	Reduction of the injection site reaction with the soil -P2-174 Fosaprepitant administration 吉岡大樹1), 森善洋1), 木下真理子1), 尾関あゆみ1), 鶴田孝義1), 藤田有紀子1), 山下真由美1), 佐道紳一1), 小坂幹子2), 小寺宏平3), 吉村敏朗1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2013.

---

	The injection site reaction that resulted from administration before Fosaprepitant in the soil -P2-175 EC therapy 名和田幸介1), 川中明宏1), 渡邊太朗1), 守田和彦1), 村田佳子2), 黒木恵美子2), 須藤隆一郎3), 三好生典1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2013.

---

	One case that confirmed a remarkable rise of the creatinine phosphokinase after four days of soil -P2-176 daptomycin administration, and became the administration cancellation 阿部正樹, 森田知子, 中蔵伊知郎, 服部雄司, 河合実, 山田雄久, 廣畑和弘, 中多泉 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2013.

---

	Examination of the risk factor about the serum Na level drop with the soil -P2-177 linezolid administration 藤井良平1), 田中雅幸1)2), 西山徳人1), 打谷和記1), 廣田育彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2013.

---

	Examination of the rise in thrombocytopenia frequencies with the linezolid administration to the soil -P2-178 decreased renal function patients 松下直樹, 浦崎圭太, 長谷川徹, 河井和子, 伊藤和幸, 磯谷聡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2013.

---

	About 2 cases that produced false gallstones with soil -P2-179 Ceftriaxione administration 山口布沙1), 井上裕貴1), 龍華庸光2), 吉田知由1), 佐藤賛治1), 松本修一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2013.

---

	Examination about initial dosage and the adverse event of the terra blurring building in the triple-drug therapy for the soil -P2-180 chronic hepatitis C 村上恵里子1), 高橋宏和1), 藤本英哲1), 高橋翔子1), 長岡裕樹1), 村井いずみ1), 佐野元彦1), 斎藤健一1), 山口菜緒美2), 山本龍一2), 名越澄子2), 屋嘉比康治2), 岸野亨1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2013.

---

	Investigation about the hepatic dysfunction in the high dose of soil -P2-181 acetaminophen user 白石史遠, 松本恵, 杉原徹哉, 桑村恒夫, 赤松孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2013.

---

	Investigation about the onset of hepatic dysfunction by the high-dose prescription of soil -P2-182 acetaminophen 大田栄一1), 南出博香1), 西山郁雄1), 傳吉朗1), 中村眞二2), 高澤宏太郎2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2013.

---

	Investigation of the onset of liver damage situation with a high dose, the chronic administration of the acetaminophen preparation in our soil -P2-183 House 臼井悟, 岩瀬利康, 越川千秋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2013.

---

	3 cases after the cerebrovascular disorder that presented drug-related delirium by soil -P2-184 H2 blocker 佐藤誠太郎, 井出直仁, 平野茂子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2013.

---

Investigation of the thyroid function abnormality frequency of amiodarone in the soil -P2-185 LVAS wearing patients and patients with heart failure 中野一也1)2)3)4), 和田恭一1), 松田紗知1), 越智純子1), 中村慶1), 桑原健1), 大原貴裕2), 宍戸稔聡3), 堀由美子4), 稗田道成4), 渡邉琢也1), 角南春樹4), 佐藤琢真4), 村田欣洋4), 瀬口理4), 簗瀬正伸4), 中谷武嗣4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2013.

---

	Action to prevent the onset of the soil -P2-186 bisphosphonate-related necrosis of the jaw bone, and to conduct early detection 深見和宏1), 木ノ下智康1), 市野貴信1), 伊藤一弘1), 小澤総喜2), 角保徳2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2013.

---

	One case of the methemoglobinemia that was thought to be caused by oral soil -P2-187 ethyl aminobenzoate 日沖雅人, 森尚義 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2013.

---

	Side effect analysis for the cancellation case of soil -P2-188 brimonidine tartrate eye drops 弥吉久仁子, 菊池順子, 栩木美乃里 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2013.

---

	Analysis of the fever event that was thought to occur by prophylactic administration of G-CSF preparation which we gave after the soil -P2-189 FEC therapy enforcement 和賀信継, 鈴木敦, 中城いづみ, 佐藤和文, 熊谷敏宏, 澤田潤, 村上正一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2013.

---

	One case of the hypermagnesemia that led to early detection by soil -P2-190 drug control instruction duties 本間光三1), 亀田貴子1), 本間直美1), 堀川誠也2), 齊藤幹央3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2013.

---

	Participation of the hypothyroidism in anemia with the soil -P2-191 renin-angiotensin system inhibitor 佐藤和幸1), 佐藤博1), 高橋信行1), 佐藤倫広2), Aing Heak1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2013.

---

	Effect on PT-INR by the degree of the diarrhea that developed during soil -P2-192 warfarin remedy 平島学, 平野淳, 伊藤誠紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2013.

---

	Two patients who evaded the shrubbery of the pacemaker by soil -P2-193 bringing medicine check 伊藤和幸1), 浦崎圭太1), 河井和子1), 磯谷聡1), 墨卓哉2), 加田賢治2), 坪井直哉2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2013.

---

	One patient whom dermatopathy and hepatic dysfunction developed in after a change to soil -P2-194 generic medicine 高橋誠1), 猪俣雅之1), 福井美規子1), 吉嶋抄苗1), 渡辺祐子1), 佐々木佳子1), 鈴木直哉1), 徳村麻衣子1), 地主隆文1), 青田忠博1), 高林健2), 目黒高志3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2013.

---

	Search of the risk factor of soil -P2-195 drug-related visual disturbances and patients background for early detection, an origin drug and the symptom 長瀬翔子, 大津史子, 矢野玲子, 榊原仁作, 後藤伸之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2013.

---

	The drug control instruction duties fever cause that intervened, and became clear for the soil -P2-196 antimicrobial invalidity UTIs suspicion patients 佐藤則泰1), 小池由博1), 西香子1), 須貝聡1), 徳重綾2), 和田茂胤3), 古川智康4), 齊藤幹央5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2013.

---

	The in-hospital side effect report investigation in our House judging from soil -P2-197 a variety of viewpoints and future expectation 田畑寛明, 中嶋孝明, 杉村奈美, 前田みゆき, 猿谷淳, 向一美, 地野幹子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2013.

---

	Analysis of the hypersensitivity symptom using the soil -P2-198 drug allergy (side effect) card 藤谷憲一1)2), 加藤安宏1)3), 池谷真佑子1)4), 落合敏明1)5), 篠道弘1)6), 賀川義之1)3), 川上純一1)7) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2013.

---

	Adverse event analysis of the leukotrienes receptor blocker using soil -P2-199 FAERS 中山蓉子1), 西端友里1), 梅津亮冴1), 鈴木俊之1), 上田夏実1), 加藤大和1), 阿部純子2)4), 田中宏幸3), 永澤秀子4), 紀ノ定保臣5), 中村光浩1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2013.

---

	An example of the action to recurrent preventive measures in the soil -P2-200 allergic property side effect 小池由博1), 佐藤則泰1), 西香子1), 須貝聡1), 徳重綾2), 和田茂胤3), 古川智康4), 齋藤幹央5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2013.

---

	土-P2-201 Visualization and analysis of the information on adverse drug reactions to supplement the correspondence manual according to the serious side effect disease - Using a Japan-U.S. adverse event spontaneous report database - 細見光一, 福田亜矢, 藤本麻依, 高田充隆 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2013.

---

	Study on onset of steroid diabetes in the use of soil -P2-202 high dose steroid patients 久保拓己1), 佐々木英久1), 松尾和廣1), 篠原悦子1), 渡辺朋子1), 真坂亙2), 松澤康雄3), 龍野一郎4), 吉尾隆1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2013.

---

	Analysis of "a side effect, the infection report" based on soil -P2-203 the Drugs, Cosmetics and Medical Instruments Act 池田博昭1)2), 櫻下弘志1), 小島美樹子2), 井田裕美1)2), 亀田美保1)2), 後藤志保2), 深川恵美子1)2), 古屋由加2), 宮井ふみ子1)2), 宮中桃子1)2), 山中恵子2), 粟屋智一2), 沈永新1), 川上由育2), 平川勝洋1), 木平健治1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2013.

---

	To prevent soil -P2-204 side effect recurrence; side effect monitor activity report ... in the ... Matsue consumers' cooperative Hospital 上田香織, 内田有紀, 足岡規子, 村上伸介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2013.

---

	Analysis of the adverse event with the preparation of Shirokane using the soil -P2-205 adverse event spontaneous report database origin 梅津亮冴1), 西端友里1), 鈴木俊之1), 加藤大和1), 上田夏実1), 中山蓉子1), 宮村信輝2), 関谷泰明2)3), 中村光浩1), 紀ノ定保臣2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2013.

---

	Effect to give to the mouse active movement of the soil -P2-206 H1 receptor blocker 坂本靖宜1), 島田亜由美1), 寺島朝子3), 前澤佳代子1), 渡辺裕子1), 堀誠治2), 木津純子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2013.

---

	Examination of the drug fever (drug fever) by the soil -P2-207 leukocyte migration test 古川智康1), 阿部学2), 斎藤幹央2), 八木元広3), 小池由博4), 継田雅美1), 尾崎進5), 豊島宗厚6), 宇野勝次7) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2013.

---

	Study on mutagenesis of the polymerization initiator detected from all over soil -P2-208 injection drug 高井真理子1), 河崎陽一2), 谷本雄亮3), 江角悟2), 有元佐賀惠3), 北村佳久2)3), 千堂年昭2)3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2013.

---

	Side effect of pharmacist investigation (3) in the soil -P2-209 critical care center 丸田栄一1), 森朝紀文1), 上山進2), 西本香王里2), 若狭加奈子3), 猪野彩3), 韓秀妃3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2013.

---

	Analysis of the characteristic of the drug according to soil -P2-210 multi-compartment model 植沢芳広, 加賀谷肇 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2013.

---

	Examination about the factor of the real time-related infusion reaction expression in the infliximab administration to patients with soil -P2-211 inflammatory bowel disease 庄司雅基1), 日笠真一1), 田中邦佳1), 室親明1), 中村志郎2), 木村健1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2013.

---

	S-(4-nitrobenzyl) for the endocytosis of the uridine, DAC in soil -P2-212 humans colon cancer cell line HCT116 cells -Effect of 6-thioinosine 上田久美子, 藤谷佳苗, 新里和也, 池畑美香, 岩川精吾 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2013.

---

	Examination about the proper use of the immunosuppressive drug after the kidney transplantation of patients with soil -P2-213 diabetes-related renal failure 石野愛弓1), 宮崎綾1), 国府孝敏2), 牛込秀隆3), 吉村了勇3), 福島恵造1), 杉岡信幸1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2013.

---

	Study on prediction of the dialysis extraction coefficient of the drug in consideration of soil -P2-214 haemodialysis enforcement condition 宮田優希, 山本武人, 鈴木洋史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2013.

---

	Change of the uric acid level of the patients changed in febuxostat from soil -P2-215 other agents 大岩拓馬, 伊東和真, 坂田洋, 松原弘幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2013.

---

	Change of the blood corpuscle extraction rate of cyclosporine under the soil -P2-216 oxidative stress condition of a patient 宮崎綾1), 石野愛弓1), 大西優里1), 国府孝敏2), 牛込秀隆3), 吉村了勇3), 福島恵造1), 杉岡信幸1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2013.

---

	The blood level of the soil -P2-217 amiodarone hydrochloride is affected by blood lipid concentrations 奥主仁1), 室山香織1), 鮎澤慶一2), 川合明彦2), 潮木守1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2013.

---

	One case that absorption inhibition of sorafenib was suggested by sodium aiginate in patients with soil -P2-218 hepatocytes cancer 片岡佑太1), 久道周彦1), 近藤泰輝2), 松浦正樹1), 田坂英久1), 下瀬川徹2), 島田美樹1), 眞野成康1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2013.

---

	Analysis of the interaction with soil -P2-219 metal cationic component supplement and Celecoxib 若狭愛子1), 高見陽一郎1), 窪田千春1), 山西誠人1), 小川壮寛1)2), 森山圭1), 山川直樹1), 島田憲一1), 守安洋子2), 高橋正志2), 五味田裕1), 江川孝1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2013.

---

	Evaluation of the interaction with soil -P2-220 metal cationic component supplement and ciprofloxacin 山西誠人, 高見陽一郎, 窪田千春, 若狭愛子, 島田憲一, 五味田裕, 江川孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2013.

---

	土-P2-221 Examination about the interaction of phenytoin and the nutrient for intestinal administration - About the adsorption to a tube for the enteral feeding - 浦嶋和也1), 浦嶋庸子2), 倉地果純1), 鈴木薫1), 西原雅美1), 名徳倫明2), 廣谷芳彦2), 勝間田敬弘1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2013.

---

	Drop of the in vitro agent amount of resources of the biguanide diabetes therapeutic drug by the soil -P2-222 dietary fiber 岩崎綾乃, 中川みなみ, 今井公江, 中西邦夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2013.

---

	One case that an effect of warfarin was reinforced by soil -P2-223 carboplatin + etoposide therapy 吉田宣政, 楠瀬雄三, 樋口美奈子, 檜山智子, 中野行孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2013.

---

	Examination about the effect that amiodarone combination gives for anticoagulation of soil -P2-224 warfarin 河村美弥子, 松原大祐, 長谷奈那子, 正木銀三 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2013.

---

	One case of the atrial fibrillation that control of warfarin by the soil -P2-225 S-1 combination became difficult and introduced dabigatran into 芳賀洋祐1), 井本剛史1), 渡邊苑子1), 山口修2), 吉田典行3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2013.

---

	Examination of the effect that WF discontinuation, weight loss gives on INR extension by the soil -P2-226 S-1/WF combination 藤田強記, 三角紳博, 西野隆 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2013.

---

	Effect on anticoagulant effect of Warfarin with the soil -P2-227 oral anticancer agent 茂木孝裕, 辰島瑶子, 野崎歩, 小林由佳, 新宮とし子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2013.

---

	Examination about the drug interactions of soil -P2-228 warfarin potassium and the tapir Rita long pipe 荒井秀和1), 齋藤麻衣子1), 小林由夏2), 須藤晴美1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2013.

---

	About effect of the tolvaptan to give a clinical response of soil -P2-229 warfarin 田中宏尚, 大野育美, 陶山明菜, 車塚千穂, 井上靖隆, 飛澤国広, 今井隆人, 渡辺浩明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2013.

---

	Examination of the interaction with soil -P2-230 warfarin and levofloxacin 久保庸子, 小森美佳, 酒井義朗, 有馬千代子, 鶴田美恵子, 佐田通夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2013.

---

	Effect on PT-INR of the warfarin remedy patients by the soil -P2-231 amiodarone combination 前田朱香, 町田聖治, 福島将友, 富田敏章, 曽我弘道, 清水誉志, 川井友美子, 岸川春樹, 細川秀則, 入江利行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2013.

---

	The case that caused the rise in remarkable blood cyclosporine levels by combination with imatinib after soil -P2-232 living renal transplantation 森章典, 坂部米治, 柳沼妙子, 石田隆浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2013.

---

	An example (the second report) of the myasthenia gravis with suspected drug interactions of soil -P2-233 tacrolimus and the azole-based antifungal agent 大畑瞳1), 鈴木嘉治1), 石井亜紀子2), 玉岡晃2), 本間真人1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2013.

---

	Effect on serum uric acid level by the combination of soil -P2-234 angiotensin 2 receptor blocker (ARB) and diuretics 押尾洋佑, 稲野祥宗, 高橋佐和士 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2013.

---

	The effect that combination of the soil -P2-235 proton pump inhibitor gives to blood level of high-dose methotrexate 梅原玲緒奈, 藤田晃介, 槙原克也, 川端一功, 山田雄久, 廣畑和弘, 中多泉 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2013.

---

	H2 blocker, effect of the PPI to give to chalasia of soil -P2-236 magnesium oxide 山崎美保, 船越幸代, 松田翔平, 村中美香, 細川文, 今津智子, 竹田克明, 前田頼伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2013.

---

	Examination ... by the blood poison-related competitive review - Cal Bob Latin dance + pemetrexed therapy of soil -P2-237 bevacizumab combination chemotherapy and the non-combination chemotherapy 高武嘉道, 溝田愛子, 中島文, 坂本やよい, 竹添達也, 山道研 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2013.

---

	An example of the children whom blood level of clobazam increased by soil -P2-238 bortezomib combination 奥田拓也1), 福島紘子2)3), 福島敬2)3), 須磨崎亮2)3), 本間真人1)3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2013.

---

Examination of the pharmacodynamic interaction of the calcineurin inhibitor in the peripheral-blood mononuclear cells cells (PBMC) inhibitory effect of the soil -P2-239 Everolimus 秋山晋一1), 竹内裕紀1), 田中祥子2), 平野俊彦2), 虎石竜典4), 岩本整3), 中村有紀3), 今野理3), 木原優3), 千葉斉一3), 横山卓剛3), 高野公徳3), 川口崇1), 奥山清4), 河地茂行3), 島津元秀3), 畝崎榮1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2013.

---

	1 case that took clarithromycin after soil -P2-240 living renal transplantation, and caused a rise in blood level of tacrolimus 太田あづさ1), 横山歩美1), 高村志保1), 辻本純子1), 福井由美子1), 中谷宰士1), 西村憲二2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2013.

---

	One case that blood phenytoin levels increased after a change from soil -P2-241 S-1 to UFT 根來寛, 松岡大晃, 東高士, 渡辺享平, 五十嵐敏明, 矢野良一, 中村敏明, 政田幹夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2013.

---

	Is the alkalinization ability of the soil -P2-242 bicarbonic acid Na addition Ringer's solution all right? 鈴木孝司1), 菊地紘2), 福舛萌真2), 倉本敬二2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2013.

---

	Plasma microRNA expression in patients with soil -P2-243 colon cancer 柴山良彦1), 地主隆文2), 青田忠博2), 堀田彰一2), 井関健3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2013.

---

	Pharmaceutical management by the soil -P2-244 TDM and reflection to treatment 松田翔平, 福田結彩, 今津智子, 細川文, 福原伸治, 中村護, 竹田克明, 前田頼伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2013.

---

	The intervention to the blood drug levels measurement subject patients in the soil -P2-245 inpatient and the evaluation 下田亮, 清水良美, 平井祐子, 脇田麻由, 日永田麻美, 大池貞治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2013.

---

	The need that a pharmacist intervenes in for performance evaluation - performance evaluation of the TDM measurement reagent "nano peer TDM" for the soil -P2-246 frequent use autoanalyzer― 吉年正宏1), 丸瀬ちほ2), 金星智世2), 森嶋祥之2), 野村守弘1), 中江健市2), 山添譲1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2013.

---

	The conversion factor according to the patients generation is necessary for soil -P2-247 eGFR and the conversion of the renal function level by the Cockcroft-Gault method 宮原兼二1), 中根茂喜1), 田中章郎1), 山口智江1), 多和田陽子1), 平松久典1), 長谷川功1), 水谷義勝2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2013.

---

	Examination of the use of nomogram in the soil -P2-248 vancomycin initial administration plan 上田理絵1), 藤田敬子2), 長谷川聡司1), 岩田浩幸1), 植田有希1), 小宮山紗也佳1), 碓氷尚子1), 福地祐哉1), 嶋津史恵1), 砂川奈芳子1), 山東真寿美1), 金銅葉子1), 志村和子1), 田中恵美子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2013.

---

	Experience of the blood vancomycin levels monitoring in the soil -P2-249 both lower extremities cutting obesity patients 西山徳人1), 池嶋孝広1), 田中雅幸1)2), 藤井良平1), 寺澤美智代1), 打谷和記1), 廣田育彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2013.

---

	Change of advisability and the treatment successful execution rate of the acceptance of the dose revision plan based on the actual value after the soil -P2-250 VCMTDM all cases intervention 佐野元基, 坂野昌志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2013.

---

	Examination about target value and the actual value in the initial administration plan of soil -P2-251 vancomycin 二石直子, 松島菜々, 藤井奨, 村井信二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2013.

---

	Discussion about the usefulness of the serum creatinine level revision in the TDM of the soil -P2-252 vancomycin hydrochloride 工藤由起1), 齊藤麻衣子1), 平浩幸1), 丘龍祥2), 山澤真之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2013.

---

	Formulation study suggestion ... that we maintain 1 pharmaceutical case - VCM, GM where we intervened in, TDM of TEIC to patients with soil -P2-253 infective endocarditis 久保嘉靖, 奥野昌宏, 中田学 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2013.

---

	Examination about the proper use of the vancomycin note by the soil -P2-254 TDM 山路加奈, 西部香, 立川奈保美, 吉田尚史, 石樋康浩, 左近美佳, 高木麻里, 藤田敬子, 坂上嘉浩, 室井政子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2013.

---

	About soil -P2-255 vancomycin initial loading Dors and nephropathic relations 宮本朋佳, 上野幸祐, 山原慶子, 富士谷昌谷, 覚前盟, 小泉祐一, 野村真美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2013.

---

	Discussion about the vancomycin hydrochloride administration method for soil -P2-256 elderly people 小嶋希望, 坪田晃司, 宮本康史, 新崎祐馬, 堀本ふみ, 横山朝子, 上野英文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2013.

---

	Examination about the safety when we maintained a trough level of soil -P2-257 Teiko plastic Nin than 20 μg/mL 小林誠一, 長嶋一泰, 銭場愛彦, 袴田仁美, 伊与田萌子, 原幸子, 坂口修治, 岩佐桂子, 内田佳菜子, 足立孝, 山下敦志, 菅野和彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2013.

---

	Examination about the early period of soil -P2-258 Teiko plastic Nin administration drug concentration prediction 小林亮, 大友慎也, 儘田洋, 荒川昌史, 海老沼慶一, 須藤俊明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2013.

---

	Usefulness of the Teiko plastic Nin initial administration plan enforcement by the soil -P2-259 pharmacist 春木祐人1), 佐久間晶子1), 和田朋子1), 杉山哲大1), 川上恭弘2), 近藤祥代1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2013.

---

	Examination of the Teiko plastic Nin initial loading dose in the soil -P2-260 respiratory organs internal medicine 小林貴志, 茂木武, 横山裕貴, 鈴木萌, 山口友里, 高橋成博, 田村晶子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2013.

---

	Measurement accuracy evaluation of blood Teiko plastic Nin concentrations using soil -P2-261 Dimension Xpand Plus 松田紘子, 岩本卓也, 山崎大輔, 榎屋友幸, 村木優一, 奥田真弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2013.

---

	Examination of the Teiko plastic Nin early days administration plan for patients with hypoalbuminemia in the treatment density of soil -P2-262 new antimicrobial guidelines area 野白有里子1), 佐藤智昭2), 沖野真季1), 河崎陽一2), 北村佳久1)2), 千堂年昭1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2013.

---

	Evaluation of the administration method based on transitional examination to cerebrospinal fluid in 0.5 g of soil -P2-263 meropenem and 1 g of administration and site-specific PK-PD 矢田尚子1)2)3), 猪川和朗1), 津村龍2), 渡邉真央1), 池田佳代1), 森川則文1), 渋川正顕3), 飯田幸治2), 栗栖薫2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2013.

---

	土-P2-264 Study of the creation and Meropenem of the optimal method of administration PD-PD analysis program due to the R 並木孝哉1), 日谷直子1), 石川稚佳子1), 佐古謙一＾2), 高遠節夫3), 大林雅彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2013.

---

	Blood level assay of the daptomycin using soil -P2-265 column switching LCIESI-MS/MS 相馬真志, 柳利樹, 前川正充, 鈴木裕之, 松浦正樹, 久道周彦, 島田美樹, 眞野成康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2013.

---

	One case that blood level of voriconazole decreased just after soil -P2-266 same kind cord-blood transplant 鈴木裕之1), 北村奈央子1), 柳利樹1), 相馬真志1), 佐藤祐司1), 前川正充1), 石澤賢一2), 張替秀郎2), 島田美樹1), 眞野成康1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2013.

---

	One case that a rise in blood tacrolimus levels was found in after soil -P2-267 voriconazole infusion single dose 潮平英郎1), 山田智史1), 赤嶺由美子1), 上原仁1), 外間惟夫1), 植田真一郎2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2013.

---

	Evaluation of the effect that the preparation maneuver of the soil -P2-268 injection drug gives in tacrolimus TDM at the childhood allogeneic hematopoietic cells transplant 川道美里, 五十嵐敏明, 寺澤優子, 服部圭子, 中村敏明, 政田幹夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2013.

---

	Examination of early period of Everolimus doses in soil -P2-269 tacrolimus combination kidney transplantation maintenance period 山本和宏, 田中健太, 宇田篤史, 久米学, 槇本博雄, 平野剛, 平井みどり Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2013.

---

	The relations of a factor and the side effect to give to the mycophenolic acid serum concentration in soil -P2-270 renal-transplant recipients and examination of LSS 佐藤慶子1), 豊口禎子1), 小林武志1), 志田敏宏1), 白石正1), 西田隼人2), 富田善彦2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2013.

---

	Blood level analysis of each anticancer medicine in the soil -P2-271 DCF therapy (docetaxel, cisplatin, 5-FU combination therapy) 山口浩明1), 藤川あす歌1), 田中伸明1), 伊藤創1), 椎田成美1), 山田武宏2), 本間理央3), 清水康3), 竹内啓3), 天野虎次3), 木下一郎3), 秋田弘俊3), 井関健1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2013.

---

	Usefulness as the TDM estimation of the monetary value of housework of the 5-FU densitometry out of the cells intercellular fluid using the soil -P2-272 micro needle 鶴田弘明, 河渕真治, 田崎智大, 稲垣勇斗, 伊藤由佳子, 高田寛治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2013.

---

	Relations of blood level and the side effect of the sunitinib in soil -P2-273 renal cell carcinoma treatment 永田将司1), 石渡泰芳1), 安原眞人1), 齋藤一隆2), 藤井靖久2), 木原和徳2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2013.

---

	1 case that measured blood sunitinib levels of soil -P2-274 patients on dialysis 高崎新也1), 柳利樹1), 鈴木裕之1), 斉藤英郎2), 伊藤明宏2), 鈴木文子1), 松浦正樹1), 荒井陽一2), 島田美樹1), 眞野成康1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2013.

---

	Construction of the blood level assay of Axitinib by soil -P2-275 LC/ESI-MS/MS 柳利樹1), 高崎新也1), 鈴木裕之1), 前川正充1), 齋藤英郎1), 伊藤明宏2), 荒井陽一2), 久道周彦1), 松浦正樹1), 島田美樹1), 眞野成康1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2013.

---

	土-P2-276 ELISA development of with the aim of dabigatran blood concentration measurement 大磯茂, 森永紀, 合六貴昭, 山口祐平, 正山征洋, 仮屋薗博子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2013.

---

	Establishment of the high sensitive assay of the Doripenem out of the soil -P2-277 plasma 伊東健太郎1), 佐藤雄己1), 大地嘉史2), 鈴木陽介1), 西村文宏1), 安田則久2), 日高正剛2), 後藤孝治2), 伊東弘樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2013.

---

	Examination of the paroxetine blood drug concentration assay using the soil -P2-278 high performance liquid chromatography 森田美紀, 井澤香, 石川稚佳子, 大林雅彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2013.

---

	Making and evaluation of the soil -P2-279 fosphenytoin injection administration plan simple table 渡来和宏1)2), 長澤梢1), 生島五郎1), 庄古知久2), 平本龍吾2), 小島重幸2), 鳥谷博英2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2013.

---

	Factor analysis in patients receiving phenytoin which showed soil -P2-280 abnormality fur Mako kinetics 平田憲史郎1), 岩田一史1), 浦田由紀乃1), 四郎園巧1), 上田賢太郎1), 合澤啓二1), 陣上祥子1), 榎木裕紀2), 前田仁志2), 猿渡淳二3), 渡邊博志2), 丸山徹2), 福永栄子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2013.

---

	Comparison between estimate and actual value ... at inspection ... doses change of the TDM analysis software (Easy TDM) in the drug concentration monitoring of the soil -P2-281 lithium carbonate 阿部武由1), 福岡憲泰2)5), 渡邊政博3)5), 山口佳津騎3)5), 元木貴大3)5), 川見洋史4)5), 芳地一3)5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2013.

---

	The case that resulted in gastrointestinal perforation by high exposure to sunitinib in Japanese patients with mutation of soil -P2-282 ABCG2 and ABCB1 野田哲史1), 富田圭司2), 吉田哲也2), 平大樹1), 影山進2), 岡本圭生2), 岡田裕作2), 森田真也1), 寺田智祐1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2013.

---

	Relative examination with ABCB1 genetic polymorphism and the onset of patients with soil -P2-283 AC therapy enforcement breast cancer of neutropenia 池田翠1), 辻大樹1), 山本圭祐2), 金容壱3), 亀里真那1), 羽鳥正浩1), 幕田龍1), 林秀樹1), 井上和幸1), 中道秀徳2), 塩川満2), 伊藤邦彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2013.

---

	It is compared the internal change of tacrolimus once a day preparation and the twice a day preparation in one year after soil -P2-284 kidney transplantation 加賀谷英彰1), 新岡丈典1), 齋藤満2), 沼倉一幸2), 羽渕友則2), 佐藤滋2)3), 三浦昌朋1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2013.

---

	Examination about irinotecan recommendation doses by the soil -P2-285 UGT1A1 genetic polymorphism 上野直哉, 嘉村基樹, 高橋奈津子, 福島ゆかり Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2013.

---

	Meta-analysis about the effect of the cancer-causing risk inhibitory effect and PPARγ genetic polymorphism by the soil -P2-287 NSAIDs remedy 長尾麻以, 佐藤陽一, 山内あい子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2013.

---

	Association between soil -P2-288 antidepressant responsiveness and BDNF and CREB1 genetic polymorphism 井上和幸1), 室伏琢磨1), 長岡翔1), 袴田康弘2), 鈴木晶子2), 木村緑3), 鈴木崇代3), 辻大樹1), 林秀樹1), 伊藤邦彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2013.

---

Report second about the association with the soil -P2-289 inside the hospital adoption medicine number of articles and the institution attribute 前田拓哉1)2), 濃沼政美1)3), 藤原久登1)4), 綾部由紀乃1), 上手真梨子1), 河原英子1), 小島昌徳1), 添田真司1), 瀧本淳1), 田村和敬1), 中村雅敏1), 中山はるみ1), 金田光正1), 飯田純一1), 湯本哲郎1)5), 高尾良洋1), 齋藤昌久1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2013.

---

	Report example about alerting it to the physician of the soil -P2-290 pharmaceutical products change 家田正子, 野村守弘, 山添譲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2013.

---

	The pharmacy management using the balun strike scorecard in the soil -P2-291 Kikuna memory hospital 金田昌之1), 奈良部修弘1), 畠山英司1), 藤田明宏1), 舟越亮寛2)4), 赤瀬朋秀3)4), 大久保淑子5), 山内泰一6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2013.

---

Analysis ... of the strategic map in action and result eighth report - hospital pharmacy gate for the BSC introduction for soil -P2-292 hospital pharmacist 赤瀬朋秀1)2), 井口恵美子1), 上原君男1), 岡添進1), 小田切正美1), 吉川明彦1), 小林岳1), 菅野豪輝1), 関口信香1), 大幸淳1), 中村葉月1), 根岸大輔1), 舟越亮寛1), 佐藤透1), 齋藤昌久1), 濃沼政美2), 湯本哲郎2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2013.

---

	土-P2-293 Trial of the drugstore management practice using balun strike scorecard (BSC) - Result of the BSC seminar attendance for the hospital pharmacy gate - 大幸淳1), 菅野浩1), 舟越亮寛2)3), 赤瀬朋秀2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2013.

---

	Action for ethanol concentrations reduction in the work environment at soil -P2-294 injection drug mixed preparation 守谷顕人1), 神農理衣1), 植野聖子1), 村上賢次1), 王宏維1), 小森正貴1), 三木郁帆1), 井本陽子1), 山口千賀子1), 津田里香1), 宅和真由美1), 遠藤真紀子2), 渡辺徹志3), 平田敦宏1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2013.

---

	The significance that soil -P2-295 pharmacist performs inhalational instruction in 小宮山紗也佳1), 嶋津史恵1), 藤田敬子2), 植田有希1), 碓氷尚子1), 福地祐哉1), 上田理絵1), 砂川奈芳子1), 長谷川聡司1), 山東真寿美1), 岩田浩幸1), 金銅葉子1), 志村和子1), 田中恵美子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2013.

---

	土-P2-296 Efforts of "見える化" of hospital pharmacist duties - Analysis of the monthly report item of the drug section in the Saiseikai Hospital of the whole country - 礒野淳一1), 佐藤透1), 清水淳一1), 菅野浩1), 加賀谷肇1)2), 大屋葵3), 濃沼政美3)4), 湯本哲郎4), 稲葉健二郎4), 岡本敬久4), 赤瀬朋秀1)4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2013.

---

	About the action of the pharmacist in the soil -P2-297 heart vascular disease classroom 木本美香1), 保米本愛美1), 河瀬吉雄2), 石坂敏彦1), 向井淳治1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2013.

---

	Prediction of a feeling of taking famotidine orally disintegrating tablet with the soil -P2-298 electron taste system 合原嘉寿, 竹下愛美, 中村豪之, 杉浦健, 内田信也, 並木徳之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2013.

---

	You drink, and match it with a taste bitter evaluation of the Ebina's Japanese spaniel hydrochloride dry syrup using the soil -P2-299 taste sensor 曽田翠1), 近藤美沙1), 長田孝司1), 楠清美2), 内藤悦伸3), 池崎秀和3), 山村恵子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2013.

---

	Fact-finding about medication ad peer Lance of the primary sanitization medicine in the soil -P2-300 Helicobacter pylori sanitization treatment 天方奉子1), 志良堂千都留1), 坂本豊伸1), 松島真理1), 新屋美保1), 本山有佳子1), 榎田泰介1), 山下嘉昭1)2), 稲葉一郎1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2013.

---

	One case of the systemic lupus erythematosus given desensitization for soil -P2-301 sulfamethoxazole trimethoprim (formulates it with ST) allergy 藤田有紀子1), 吉岡大樹1), 佐道紳一1), 鶴田孝義1), 溝上明成2), 吉村敏朗1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2013.

---

	Example that was associated with short bowel syndrome of soil -P2-302 survival small intestine 20cm 辻村啓史, 蓮輪博嗣, 横尾賢乗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2013.

---

	Difference of the subjective dangerous consciousness of a pharmacist for the use in the medical field of the soil -P2-303 radioactive material and general inhabitants 中村武夫1), 伊藤栄次1), 安部雅之2), 大橋芳子2), 伊内秋夫2), 田村隆教3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2013.

---

	Action of the pharmacist with the foreign chemotherapy room establishment in our soil -P2-304 House 増野貴司1), 堀口裕之2), 田村昌行2), 小幡輝夫1), 堤教明1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2013.

---

	Relation of the ward permanent residence pharmacist in the soil -P2-305 treatment 上原友美1), 赤星真広1), 前村由佳1), 末廣淑子1), 菱川真衣1), 山路智凡1), 石神誠子1), 池増鮎美1), 神門孝典1), 佐多照正1), 田中和子5), 福崎伊豆美2), 小倉芳人3), 西島浩雄4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2013.

---

	土-P2-306 CDTM in the cancer chemotherapy - Regimen history management by the pharmacist - 柳田祐子, 北本真一, 古谷智裕, 白木政博, 長崎信浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2013.

---

	The anticancer agent regimen representation input by the soil -P2-307 pharmacist and the effect 山口智江1), 中根茂喜1), 宮原兼二1), 万塩倫子1), 平松久典1), 長谷川功1), 後藤真澄2), 石川玲3), 橋本瑞生3), 坂口憲史3), 菅谷将一4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2013.

---

	Development of the sickness benefit calculation tool for the purpose of the decision aiding before the soil -P2-308 cancer chemotherapy introduction 橋本浩季, 村上通康, 仙波昌三 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2013.

---

	Examination of the medical economic effect in the quantity of injection anticancer agent prescription adjustment by the soil -P2-309 pharmacist 浅野寿規, 桜田宏明, 大島有美子, 川瀬洋次, 山村益巳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2013.

---

	Promote efficiency of duties through soil -P2-310 team approach in medical care; an action to foreign chemotherapy center medication counseling in one hour a day 今井陽介1), 小林茂1), 吉元哲也1), 城知子2), 土橋俊文1), 松林和幸1), 上野雄一郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2013.

---

	Evaluation of the practice support by the soil -P2-311 pharmacist 浦川龍太, 橋本早苗, 廣畑秀記, 酒井克紀, 松浦佳代, 福田英克, 南波勝栄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2013.

---

	Fact-finding of the waiting time in the soil -P2-312 outpatient department cancer chemotherapy and the correspondence 松本千明1), 伊藤剛貴1), 竹之下枝実1), 松倉愛実1), 福森瑛里子1), 澤原裕美子2), 渋谷久美2), 鹿野由美子2), 向後香織2), 松永和子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2013.

---

	Role of the pharmacist in the soil -P2-313 chemotherapy center conference 結城正幸1), 鈴木薫1), 萬年琢也1), 小野裕紀1), 小林由佳2), 佐藤弘子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2013.

---

	Soil -P2-314 medicine medicine cooperation and intervention report (in a foreign chemotherapy room) 佐藤真也, 大森義朗, 高橋由希子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2013.

---

	Action to information sharing between a hospital and the health insurance pharmacy in the soil -P2-315 cancer chemotherapy 菊地正史1), 日野沙綾香1), 高田紀子1), 中川直人1), 木皿重樹1), 松浦正樹1), 久道周彦1), 我妻恭行1), 山田卓郎2), 加藤俊介3), 石岡千加史3), 佐々木孝雄2), 眞野成康1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2013.

---

	It is ... about adjuvant chemotherapy regimen after a pharmacist and physician introduction - colon cancer technique in the soil -P2-316 chemotherapy introduction of the explanation tool which we made jointly 光永義治1), 小林つば紗1), 鈴木弘文2), 濱田潤1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2013.

---

	Use experience of the agent for the carmustine intracerebral custody for the soil -P2-317 malignant glioma 杉谷香奈1), 岡本由佳梨1), 高橋幸三1), 木村貴1), 小森桂子1), 福島宣久1), 米澤秀美2), 望月千枝3), 丸野元彦4), 鈴木強4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2013.

---

	Establishment and activity of "the pancreatic cancer classroom" by the soil -P2-318 many types of job cooperation 原祐輔1)10), 中川原寿俊2), 大坪公士郎3), 高仲強4), 金田礼三5)10), 山田圭輔6)10), 徳丸季聡7), 浦麻衣子8), 福間明美9), 大森晶子9), 藤村隆2), 崔吉道1), 宮本謙一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2013.

---

	It is examined the present conditions of adjuvant chemotherapy S-1 and the usefulness of the pharmacist preliminary examination after gastric cancer technique in our soil -P2-319 House 畑裕基1), 森本茂文1), 仲谷芙美1), 庄野嘉治2), 堀内哲也2), 山崎邦夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2013.

---

	About the action by the many types of job at the soil -P2-320 autologous peripheral blood stem cell transplantation introduction 足垣亮介, 足立圭司, 村上由樹, 真下智行, 川見里奈, 堀雅博, 山本真世, 宮谷正哉, 勝井靖, 立道直美, 近藤あい Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2013.

---

	Action of the pharmacist for patients with multiple myeloma in the outpatient department in our soil -P2-321 House 小野裕紀1), 大熊良和1), 結城正幸1), 萬年琢也1), 鈴木薫1), 松田美樹子2), 佐藤弘子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2013.

---

	Relation of the pharmacist for the purpose of the soil -P2-322 smooth internal use temozolomide therapy 菊地幸子, 福田裕子, 網野祥子, 道下佳子, 辰野真理子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2013.

---

	Team intervention for the dermatopathy prophylactic management with the soil -P2-323 chemotherapy 樋本繭子1), 中田日早枝1), 三木育子1), 高瀬尚武1), 衛藤里沙1), 米澤圭祐1), 井上祐子2), 岸元美樹2), 浅田佳代2), 植田悦美2), 末次弘実3), 高原秀典3), 室井延之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2013.

---

	Usefulness of the pharmaceutical intervention in the conference before soil -P2-324 hematopoietic stem cell transplantation and the characteristic with the choice regimen 角陽子1), 北澤文章2), 淵田真一2), 岡野晃2), 初瀬真弓2), 村頭智2), 島崎千尋2), 上田久美1), 杉井彦文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2013.

---

	Joint medical treatment management using soil -P3-325 FOLFIRI and the at-home PT-INR self measurement and Internet for the warfarin combination patients 船橋美和1), 矢野亨治1), 重野克郎2), 日比陽子1), 宮川泰宏1), 田中千恵3), 小寺泰弘3), 山村恵子4), 山田清文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2013.

---

	One case that racked its brains about control of retching by the soil -P3-326 crizotinib 藤井宏美1), 監物英男1), 瀧川奈義夫2), 今村明正1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2013.

---

	Action ... of the Shizuoka cancer center pharmacy ... Shizuoka Prefectural about activity of soil -P3-327 team Regorafenib 石川寛1), 工藤祐子1), 木村仁1), 加藤敏明1), 篠道弘1), 根上リサ2), 濱内諭3), 山崎健太郎3), 吉川周佐4), 清原祥夫4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2013.

---

	Examination about the usefulness of the side effect measures manual of the denosumab administration for the soil -P3-328 metastases to bone case 山東真寿美1), 金銅葉子1), 田宮基裕2), 平島智徳2), 岡本紀雄2), 鈴木秀和2), 山鳥忠弘2), 森下直子2), 白山敬之2), 坪井常美3), 良田紀子4), 岩田香4), 大和章宏5), 志村和子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2013.

---

	Making of relation ... inside the hospital procedure of the pharmacist to HBV reactivation measures during soil -P3-329 immunodepression, cancer chemotherapy and operational ... 伊藤典子1)2), 山畑幸子1), 山賀章一1), 内藤浩2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2013.

---

	One case that was able to accomplish supporting AC therapy after breast cancer technique during soil -P3-330 maintenance haemodialysis in outpatient department 中西敏博1), 荒川裕貴1), 久田達也1), 松岡加恵1), 辻秀樹2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2013.

---

	Action by the team in the internal use anticancer agent introduction of patients with soil -P3-331 breast cancer 宇都宮純平1), 溝口真巨2), 高木真由美2), 土本大輔1), 加藤伸一1), 和田応樹3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2013.

---

	One patient who they presented with impaired renal function during the FP therapy enforcement for soil -P3-332 uterine cervix cancer, but was able to continue chemotherapy 荒川裕貴1), 中西敏博1), 松岡加恵1), 小口秀紀2), 久田達也1), 辻秀樹1)3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2013.

---

	Examination of an investigation in the occupational exposure with the soil -P3-333 anticancer agent and the pollution of the workplace environment and the measures 日比聡1)2)3)4), 皆川葉子1), 壁谷めぐみ1), 加藤多恵1), 城川優子2), 古賀千晶2), 粥川哲3), 伊奈研次4), 片岡孝江3), 湯浅周1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2013.

---

	In our soil -P3-334 House and is investigated an anticancer agent pollution status of the human body environmentally 野澤寿吉, 櫻井淳二, 黒沼圭, 佐藤昌子, 中井紋, 阿部順, 武者栄美子, 菅原泰典, 石澤文章 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2013.

---

	Environmental exposure investigation of soil -P3-335 cyclophosphamide 河原陽介1), 池崎寿子1), 浅野知美2), 御子柴智聖1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2013.

---

	The effect that a difference of the soil -P3-336 portable chronofuser gave 和久津稔, 小原竜, 半沢秀樹, 田中敏, 佐藤益男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2013.

---

	Change ... of duties before and after the action ... negative pressure type isolator introduction of the anticancer agent injection drug germfree preparation in our soil -P3-337 House 秋山耕治, 山澤理恵子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2013.

---

	The closed system anesthesia instrumentation in the anticancer agent preparation in our soil -P3-338 House and an investigation and evaluation of germfree preparation processing charges 坂田希美, 竹田元, 水野宏昭, 宮田久恵, 岡田昌江, 岡田守弘, 金谷悠, 西上潤 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2013.

---

	We investigate the present conditions of the radiation exposure in the process until administration enforcement after soil -P3-339 anticancer medicine preparation 鈴木寿樹1), 森大1), 高橋哉子2), 小笠原喜美子2), 木皿重樹1), 石岡千加史2), 島田美樹1), 眞野成康1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2013.

---

	土-P3-340 Safe administration management for prevention of occupational exposure with the anticancer agent - Invention at introduction of the Terui-type infusion circuit by the combination of infusion set and T shape stopcock - 朝倉寛達1), 秋山真二1), 土橋和久1), 牛山志保2), 小野友子2), 雨宮美智子3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2013.

---

	About preventive measures against anticancer agent exposure by the soil -P3-341 priming enforcement 中村真一, 深井利光, 渡部里紗, 井上智恵子, 木田好彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2013.

---

	Establishment of preventive measures against exposure to 5FU ointment in the bedside in the soil -P3-342 spinocellular carcinoma 鈴木涼子1), 渡辺富士夫1), 村上大貴2), 又吉武光3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2013.

---

	About the Residual medicine in the measurement container after the Cyclophosphamide administration for oral soil -P3-343 and the inactivating law 小林由佳1)2), 岩根裕紀1)2), 野崎歩1), 新宮とし子1), 中西弘和2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2013.

---

	Development of the soil -P3-344 tall handloom ability anticancer medicine automatic mixed preparation device 正木拓陽1), 白石有紗1), 岸川友紀1), 高崎新也1), 田中明＾2), 斉藤数弘2), 加藤雅之2), 前川正充1), 島田美樹1), 木皿重樹1), 佐藤真由美1), 松浦正樹1), 久道周彦1), 眞野成康1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2013.

---

	Safety and efficiency in the parenteral injection remote inspection system introduction in soil -P3-345 anticancer agent preparation duties 宅和真由美, 村上賢次, 植野聖子, 小森正貴, 守谷顕人, 井本陽子, 平田敦宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2013.

---

	Compatibility evaluation for the clinical introduction of soil -P3-346 anticancer injection drug automatic preparation device APOTECA 森川琢也1), 岩本卓也1), 中島裕之2), 江上篤2), 樋口耕平2), 守隆宏3), 村木優一1), 松田浩明1), 奥田真弘1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2013.

---

	The anticancer agent preparation maneuver training for the soil -P3-347 pharmacist and attitude survey 秋山美和1), 城田幹生2), 瀧川正紀1), 早船美保子1), 甲斐田浩輔1), 島崎良知1), 森淑子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2013.

---

	Thorough test value confirmation by the pharmacist at soil -P3-348 anticancer agent germfree preparation 渡邊太朗1), 川中明宏1), 守田和彦1), 名和田幸介1), 村田佳子2), 黒木恵美子2), 三好生典1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2013.

---

	Making of the information sharing tool for appropriate anticancer agent treatment to be provided in soil -P3-349 outpatient department chemotherapy 浅井浩子1), 松本佑美1), 大貫敏明1), 安田麻美1), 高橋優香1), 岩佐典子1), 杉浦健一1), 藤岡敬子1), 中村友美1), 布施智子1), 松木祥彦1), 岡部智2), 斉木仁2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2013.

---

	The pharmaceutical intervention by the soil -P3-350 chemotherapy center exclusive duty pharmacist is medical care security and an effect to give the quality of life of the patients 西村知恭, 嶋本めぐみ, 藤原大, 山田里恵, 堀川侑美, 齊藤喜宣, 天野賀弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2013.

---

	Intervention from the pharmacist medication counseling in the soil -P3-351 outpatient department chemotherapy room to the problems that it showed 安田陽子, 田村美奈子, 相馬沙希, 山本智永子, 宮田昭, 畑中智子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2013.

---

	About the foreign medication counseling of the oral anticancer agent in our soil -P3-352 House 齋藤智美, 松田美樹子, 遠藤尚美, 大滝善樹, 後藤恵子, 緒方操, 高梨伸司, 武田直子, 川越由美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2013.

---

	Relation of the pharmacist to the cancer chemotherapy in our soil -P3-353 House 太田哲徳, 金森大祐, 溝口優, 青山幸枝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2013.

---

	Action to drug history book improvement for the effective side effect management in the soil -P3-354 cancer chemotherapy 鈴木朋克, 樋口泰子, 奥主仁, 潮木守 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2013.

---

	Pharmaceutical participation about the safe security in the soil -P3-355 outpatient department cancer chemotherapy 嘉村基樹, 上野直哉, 高橋奈津子, 福島ゆかり Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2013.

---

	Medication counseling for patients who received soil -P3-356 outpatient department chemotherapy 陸丸幹男1), 菅田佳子1), 重松明美1), 夏田裕子2), 大野栄治3), 森一生1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2013.

---

	Action for medicine, the medicine cooperation of the foreign cancer chemotherapy in our soil -P3-357 House 高橋久樹, 佐藤浩保, 高橋克子, 遠藤佳奈子, 小野寺綾, 鈴木幸造 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2013.

---

	Action for the internal use anticancer agent instruction in the soil -P3-358 outpatient department 島田健, 福山雅人, 大里勇二, 喜多吉昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2013.

---

	Analysis about the importance of the pharmaceutical management for patients with soil -P3-359 cancer 岩切詩子1)2), 小林大介2), 窪田敏夫2), 佐藤英次郎2), 石原絵理2), 菅原尚子2), 島添隆雄2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2013.

---

	Examination about the intervention effect of the pharmacist on patients who received soil -P3-360 outpatient department cancer chemotherapy 若杉吉宣1), 森井博朗1), 須藤正朝1), 阪中美紀1), 野田哲史1), 薮田直希1), 三上貴子1), 河合由紀3), 目片英治3), 寺田智祐1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2013.

---

	Usefulness of intervention duties before medical examination by the pharmacist for soil -P3-361 outpatient department cancer chemotherapy patients 橋本直弥, 望月英明, 若杉祐子, 青木望, 勝山徹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2013.

---

	For the cooperation in the side effect management area of the soil -P3-362 outpatient department chemotherapy 辻本朗, 廣末毅, 原知斉, 今村陽子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2013.

---

	Problems in the education for patients at the soil -P3-363 chemotherapy: From the results of the side effect understanding degree investigation 古田知子1), 山添喜久雄1), 中嶋早苗2), 久米真2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2013.

---

	Examination of the effectiveness of the day after day enforcement of the medication counseling for patients who received soil -P3-364 cancer chemotherapy 谷口潤, 村田健司, 樋口薫, 吉野裕銃 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2013.

---

	The introduction of the soil -P3-365 patients charge system and the evaluation 伊東健一, 秋吉史久, 林加奈恵, 雀ヶ野史織, 宮園かおり, 小牧雅典, 牟田恵理夏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2013.

---

	About the construction of the support system mainly on the medication counseling at internal use anticancer agent introduction for the soil -P3-366 outpatient 鈴木雅人, 葛谷真理, 笠井翼, 原田萌, 高原悠子, 前田哲志, 天野杏南, 竹内美佳, 畑本章子, 福岡絵里, 吉田弘樹, 今井視保子, 川出義浩, 木全司, 今高多佳子, 中村正史, 青山智彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2013.

---

	In reference to operational ... cancer chemotherapy work-sheet in making and the electronic chart of the brochure for patients with soil -P3-367 elderly people cancer 上淵未来1), 塩塚雄基1), 守田尚史1), 筧賢治2), 濱田政司1), 市川康子1), 藤井裕史1), 藤井憲一郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2013.

---

	Examination of the instruction to patient usefulness of the day of the treatment in the soil -P3-368 outpatient department chemotherapy room 川村広明, 照井一史, 中川潤一, 小田桐奈央, 高橋志織, 阿保成慶, 板垣史郎, 早狩誠 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2013.

---

	土-P3-369 Efforts in the outpatient department for an anticancer agent and the opioid use patients - Patients support and medical treatment support by the drug monitoring - 井原将太, 粟田浩文, 上條史帆里, 近藤水生, 多賀麻衣, 野澤孝子, 中村和行, 万塩裕之, 大野愛, 勝見章男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2013.

---

	Examination about the effect that the pharmaceutical management of the soil -P3-370 cancer chemotherapy charge pharmacist gives in symptom improvement and medical expenses reduction 永瀬怜司1), 深澤拓也1), 今浦将治1), 柏木奈々子2), 清水邦彦2)3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2013.

---

	The need of the pharmacist outpatient department for the soil -P3-371 Bcr-Abl tyrosine kinase inhibitor remedy patients 奥貞佳奈子1), 山本千代1), 登佳寿子1), 北田徳昭1), 石川隆之2), 橋田亨1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2013.

---

	The need of the side effect monitoring in the ambulant treatment of the oral soil -P3-372 multi-kinase inhibitor 郷真貴子, 鈴木宣雄, 松岡知子, 木村美智男, 吉村知哲, 森博美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2013.

---

	Questionary survey about the pharmacist intervention to patients with soil -P3-373 foreign oral anticancer agent remedy 小倉敬史, 吉田美欧, 松本貴義, 川崎智子, 西村理恵子, 島田朋弥, 竹場和代, 松本雄介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2013.

---

	It is two patients using the Aki Shichi nib in our soil -P3-374 House 鈴木さやか, 堀晃代, 酒井欣嗣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2013.

---

	The construction of the education for patients system for the soil -P3-375 EGFR-TKI introduction patients and the evaluation 三牧沙織, 渡邊裕之, 池末裕明, 江頭伸昭, 大石了三 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2013.

---

	Analysis of the chronic administration case of sorafenib in patients with soil -P3-376 progress liver cancer impossible of excision 筒井陽子1), 安波真莉子1), 田頭尚士1), 小暮友毅1), 鵜池敏令1), 角英1), 上杉和寛2), 浅木彰則2), 灘野成人2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2013.

---

	About the combination of the proton pump inhibitor in the soil -P3-377 erlotinib remedy patients and the H2 blocker 深尾彰平, 村田和也, 高山喜光, 吉田真人, 近藤匡慶, 堀川佳津美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2013.

---

	2 cases that we followed up continuous for dermatopathy with the soil -P3-378 Mogamulizumab administration 宮本俊一, 鷲足ひろみ, 吉岡まみ, 甲斐田浩輔, 森淑子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2013.

---

	The relation of the unresectable progress, pharmacist by the Trastuzumab combination therapy for the recurrent gastric cancer with positive soil -P3-379 HER2 and future action 足立茂樹, 守屋猛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2013.

---

	The Serious ADR expression situation in the soil -P3-380 lung cancer chemotherapy and the discussion 渡邊卓嗣, 庄司理恵, 穂積史朗, 宮城宣明, 長島章, 伊藤功治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2013.

---

	Examination of the off-period to the second cycle of bendamustine in soil -P3-381 senior Popes 中村和宏1), 筒井信博1), 福本哲也2), 井出眞2), 大西宏明2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2013.

---

	Development to drug control instruction duties in the soil -P3-382 VTD therapy 近森綾子, 内田まやこ, 末次王卓, 渡邊裕之, 池末裕明, 國分千代, 金谷朗子, 末安正典, 江頭伸昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2013.

---

	Use experience of eribulin mesylic acid for the soil -P3-383 metastasis-related breast cancer 山田千代子, 米澤美和, 柏原宏暢 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2013.

---

	Adverse event investigation from patients symptom diary in soil -P3-384 outpatient department breast cancer chemotherapy FEC therapy, EC therapy, the TC therapy 小松香織, 野村充俊, 植草秀介, 木村麗砂, 日浦寿美子, 横井妙子, 加藤裕芳, 浅山亨 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2013.

---

	土-P3-385 The enforcement situation of the examination of HBV with the cancer chemotherapy - About a study implementation trend before and after the reporting from the pharmacy - 鈴木敦詞1), 前田剛司1), 坂田洋1), 松原弘幸1), 古田美保2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2013.

---

	Use experience of the molecular target medicine to patients with renal cell carcinoma during soil -P3-386 maintenance haemodialysis 大岡千寿子1), 寺村早貴1), 北川裕之1), 塚晴俊2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2013.

---

	Examination about the effect of the alcohol included in soil -P3-387 one Taxotere (R) 石川元章1)2), 佐々木英雄2), 伴晶子2), 大島有美子2), 三島江津子2), 築山郁人2), 久田達也2), 板倉由縁2), 勝見章男3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2013.

---

	1 case that was given medication counseling for an index of the gastric cancer condition of a patient with soil -P3-388 lactate dehydrogenase (LDH) activity 大久保節子1), 大久保正2)3), 田中真理子3), 大久保七枝4), 久保田洋子5), 大久保美穂6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2013.

---

	The present conditions and problem judging from fact-finding of vomiting, nausea for the soil -P3-389 outpatient department chemotherapy enforcement patients 小柴聖史1)2), 遠藤和代2), 森脇稔2), 磯知輝1)2), 菅尾高裕1), 市田隆文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2013.

---

	Action of the antiemetic drug proper use along soil -P3-390 guidelines 柴田直子1), 伊勢原祐子1), 佐野隆太1), 大谷祐子1), 見上千昭1), 辻本純子2), 西尾孝1), 奥川斉1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2013.

---

	Action for the medication compliance improvement of the oral antiemetic drug in the soil -P3-391 outpatient department chemotherapy 出口綾子, 中西大介, 柳川泰裕 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2013.

---

	Examination about the antiemesis effect of dexamethasone in the soil -P3-392 cisplatin liver intraarterial injection therapy 彦坂麻美, 島田泉, 阿部康治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2013.

---

	Examination of the emetic risk of the soil -P3-393 cisplatin liver intraarterial injection therapy 新井隆広1), 小田真澄1), 赤津奈々子1), 藤田行代志1), 齊藤妙子1), 野川秀之2), 三島八重子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2013.

---

	Evaluation of the antiemetic drug for the millimeters plastic Japanese spaniel intraarterial injection therapy in our soil -P3-394 House 谷村紀代子, 高橋利江, 菊井利伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2013.

---

	Fact-finding of the supportive care at the hepatic artery chemistry embolus therapy (TACE) enforcement for the soil -P3-395 hepatocellular carcinoma 仁尾祐太1)2), 北原加奈之1)2), 原由香理1), 大戸祐治1)2), 内藤結花1), 鈴木康介1)2), 柏原由佳1), 峯村純子1), 村山純一郎1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2013.

---

	Investigation of retching, the vomiting expression situation with the use of platinum regimen in the soil -P3-396 lung cancer chemotherapy 岡崎夏実, 阪田安彦, 宮森伸一, 開浩一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2013.

---

	Investigation about the retching vomiting expression situation according to soil -P3-397 cisplatin doses and the effectiveness of the antiemetic 芝崎由美子, 中山季昭, 中村益美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2013.

---

	Comparison of the clinical response in approximately the antiemesis therapy change in the soil -P3-398 cisplatin component regimen 谷澤範彦, 山本康太, 安藤和也, 大森丈, 角井惠美子, 寺本敏清, 吉村はる美, 小川純也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2013.

---

	Effective comparison of the antiemetic drug in the soil -P3-399 lung cancer carboplatin combination therapy 宮崎雅之1), 土屋翔子2), 山下加織1)2), 吉島夕貴2), 伊藤真子1), 市川和哉1), 近藤征史3), 長谷川好規3), 野田幸裕2), 山田清文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2013.

---

	Examination of the optimal antiemesis therapy in the soil -P3-400 carboplatin weekly regimen 中條倫成, 中村和代, 嘉屋道裕, 宇津木博明, 櫻井健史, 望月亜希子, 木村緑, 鈴木崇代 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2013.

---

	Randomized controlled trial to test usefulness of the aprepitant combination for retching, vomiting with the chemotherapy containing soil -P3-401 carboplatin 中尾將彦1), 吉田徹也1), 山崎直樹1), 中川朋美1), 竹内昌司1), 岡田秀明2), 金原史郎2), 勝島詩恵2), 津谷あす香2), 平良高一2), 徳永伸也2), 駄賀晴子2), 武田晃司2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2013.

---

	5HT3 receptor blocker by the FOLFOX, FOLFIRI therapy in our soil -P3-402 House, examination of the use situation and the antiemesis effect of aprepitant 鶴崎大, 深滝利也, 三枝良安 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2013.

---

	Examination of frequency of the hiccups induced at soil -P3-403 aprepitant administration and the background 松野知寛, 花田紀子, 植山寛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2013.

---

	We look at the rear about the proper use of aprepitant in our soil -P3-404 House and study a mark 桝茂典, 室伏孔樹, 榊景子, 岡田悠美, 中川隼一, 赤石和久, 村上敏明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2013.

---

	Effect of the aprepitant administration on leukopenia after the soil -P3-405 EP therapy 木村雄太, 田中寛之, 川口啓之, 高崎雅彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2013.

---

	Usefulness of the aprepitant five days administration for the 5-day anticancer agent regimen in soil -P3-406 children and safe examination 井上裕貴1), 服部浩佳2)3), 福島直子1), 前田尚子2), 秋田直洋2), 市川瑞穂2), 早川裕二4), 松本修一1), 斉藤明子3), 堀部敬三2)3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2013.

---

	The effectiveness of the Fosaprepitant note in the soil -P3-407 breast cancer FEC100 therapy and safe examination 渡邊桂子1), 菊地正史1), 木皿重樹1), 小笠原喜美代2), 久道周彦1), 石田孝宣3), 鈴木直人4), 村井ユリ子1), 島田美樹1), 富岡佳久4), 石岡千加史2), 眞野成康1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2013.

---

	Examination of vascular pain measures and the effect factor by the soil -P3-408 Fosaprepitant 上村賢介1), 小竹泰子1), 須佐充1), 横山裕貴1), 鈴木光幸1), 田村晶子1), 高橋由美2), 堀川久美子2), 武者信行3), 安藤嘉範1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2013.

---

	Investigation about the onset of vascular pain situation by the Fosaprepitant in our soil -P3-409 House 渡邉悦子, 相川晴彦, 嶋田烈, 松本富夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2013.

---

	Injection site disorder measures of the Fosaprepitant in patients with solid cancer given soil -P3-410 chemotherapy 辺見光利1), 和久井章男1), 近藤達郎1), 浅野幸代2), 粟田恭子2), 山田千賀子2), 菊池敏枝2), 戸倉英之3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2013.

---

	Effect of palonosetron under the aprepitant combination in the soil -P3-411 M-VAC therapy 奥道理佐1), 丹田雅明2), 小池美緒2), 丸上奈穂2), 平田佐智2), 濱口常男3), 岩川精吾3), 太田光煕3), 棚橋孝雄3), 北河修治3), 久米学2), 槇本博雄2), 平野剛2), 平井みどり2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2013.

---

	It is the comparison about the antiemesis effect of Granisetron 3 mg and Palonosetron 0.75 mg on adjuvant chemotherapy XELOX enforcement case after soil -P3-412 technique 木村仁1), 石川寛1), 加藤敏明1), 工藤祐子1), 篠道弘1), 山崎健太郎2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2013.

---

	Examination of the usefulness of the use of palonosetron for the soil -P3-413 CINV expression patients 杉山昌秀1), 篠原徹1), 篠原佳祐1), 三浦篤史1), 宮田佳典2), 油井信明1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2013.

---

	Side effect of antiemetic drug change expression turn of eventss in the soil -P3-414 gemcitabine monotherapy 村中一大, 植村由香, 畑侑里, 石尾有司, 徳留章, 小林龍, 小原秀治, 妻木良二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2013.

---

	Usefulness, safe examination of olanzapine for retching, vomiting of the chemotherapy in the soil -P3-415 urology department 作山佳奈子, 青沼安希子, 丸山弘子, 井出貴之, 松澤直樹, 神田博仁, 山折大, 大森栄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2013.

---

	The effectiveness of the 5-HT3 receptor blocker for retching after the soil -P3-416 L- asparaginase administration 一木万奈美1), 伊藤和幸1), 長谷川徹1), 河井和子1), 磯谷聡1), 足立佳也2), 山本起代子2), 足立達哉2), 津下圭太郎2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2013.

---

	Role of the peripheral substance P in the delayed vomiting expression with the soil -P3-417 methotrexate administration 高塚千恵1), 町田麻依子1), 町田拓自2), 平藤雅彦2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2013.

---

	Examination of the usefulness of the Fosaprepitant IV preparation in patients who received soil -P3-418 M-CHOP therapy 中本秋彦1), 小川敦1), 黒住和彦2), 上利崇2), 市川智継2), 村川公央1), 矢尾和久1), 北村佳久1), 伊達勲2), 千堂年昭1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2013.

---

	Effect comparison of the antiemetic drug in the vomiting risk moderate degree regimen of soil -P3-419 colon cancer 山本紗織, 當真房子, 森脇典子, 平良智, 長濱照美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2013.

---

	Examination about the nourishment intervention effect using the ingredient nutrient preparation during the chemotherapy in patients with lung cancer for soil -P3-420 advanced stage 越川一誠1), 磯部和順2), 黒澤亮子3), 小園幸輝1), 鏑木教平2), 小杉隆祥1), 山田清美3), 本間栄2), 西澤健司1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2013.

---

	About the advantage by changes from soil -P3-421 fentanyl patch 3rd type preparation to daily type preparation and the factor 田中裕章, 立道貴清, 鈴木聖, 一瀬ひろみ, 元木貴大, 渡邊政博, 山口佳津騎, 朝倉正登, 辻繁子, 篠原尚樹, 水川奈己, 小坂信二, 芳地一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2013.

---

	Examination of the effectiveness and the acceptability at opioid introduction with the soil -P3-422 fentanyl patch 三好孝法1)2), 山内浩子1)2), 三角紳博1), 甲斐祭生2), 吉田絵衣子2), 西野隆1), 蓮尾泰之2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2013.

---

	The effect that the nutritional status of patients with soil -P3-423 cancer gives to the sharp pain control with the fentanyl patch 菊地聡美1), 高橋来実1), 千葉健史1), 高橋宏彰2), 平舩寛彦2), 木村祐輔3), 若林剛3), 高橋勝雄1), 工藤賢三1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2013.

---

	Study on effect on side effect of difference in number of daily administration of soil -P3-424 oxycodone sustained-release tablet 川野千尋1)2), 西垣哲太2), 平山武司1)2), 三重野浩朗3), 渡邊昌彦3), 佐々木徹4), 小泉和三郎4), 黒山政一1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2013.

---

	The side effect expression of patients with soil -P3-425 oxycodone (R) lock introduction situation according to the renal function 長山晃, 木下優子, 八木真希子, 高田正弘, 鈴木光明, 近藤昌子, 川上典子, 野毛一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2013.

---

	Fact-finding of the sedative adjuvant combination of the opioid use patients in our soil -P3-426 House 土元研史, 氏家靖博, 安田礼子, 小山秀樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2013.

---

	The use situation of soil -P3-427 and the supportive care medicine and future problem 細見誠1), 稲野祥子1)3), 小笠原明美1)3), 高橋智恵子1)3), 牧智恵子1), 後藤愛実1)2), 西原雅美1), 長えき美奈子3)4), 有田由美2)4), 桑門心2)3), 後藤昌弘2), 勝間田敬弘1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2013.

---

Effect ... that pharmacist participation in - palliative care gives to opioid use density from the fact-finding about the drug in the member of soil -P3-428 Miyagi hospital pharmacist society institution [the first report] 今野耕英1)6), 野澤寿吉2)6), 櫻井淳二2)6), 木皿重樹3)6), 岸川幸生4)6), 尾形勉5)6), 後藤美紀子1)6), 石澤文章2)6), 眞野成康3)6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2013.

---

It is ... about the present conditions and problems - second report Okaya pharmacist society of the medical narcotic dispensing of the soil -P3-429 Suwa local health insurance ethical pharmacy 網野一真1)2), 米澤亮1)2), 谷口純子1)2), 登内盛治1), 林美和子1), 小口正義1), 浜至寛1), 跡部治1), 佐々木智美2), 五味光太郎3), 井上君子4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2013.

---

	Introduction to a use situation investigation and the revision of the soil -P3-430 rescue medicine self-care manual and all wards 中西順子, 片桐将志, 篠永浩, 原田典和, 加地努, 向井栄治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2013.

---

	An action to the hospitalized patients self-care of the drug (rescue medicine) for the soil -P3-431 medical care and the evaluation 柿元郁代1), 福留るみ1), 松若元子2), 福岡龍一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2013.

---

	About an action and the introduction situation for the use of the self-care of the drug (rescue dose) for the soil -P3-432 medical care 高橋健太1)3), 浦田理華1), 白川貴章1)3), 松浦智子2)3), 関沢祐一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2013.

---

	Instruction, increase in quantity of the drug for the soil -P3-433 medical care, relation until a rotation 伊藤慎二, 村瀬貴子, 小西麗子, 磯貝潤一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2013.

---

	One case that rotations from a lidocaine continuous intravenous infusion to mexiletine internal use succeeded for soil -P3-434 neuropathic scoliosis sharp pain 中村俊貴1), 阿部真也1), 齋藤雅俊1), 松原肇1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2013.

---

	Experience use experience - complete response case of the Hangeshashinto for the palliation of oral mucositis due to soil -P3-435 cancer chemotherapy; is information dispatch ... to inside the hospital 船戸元子1), 新田圭子1), 笹山潔1), 森正昭1), 中野達夫2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2013.

---

	It is two patients using ketamine for a soil -P3-436 skin measures ache 篠原佳祐1)4), 三浦篤史1)4), 中島文香2), 大塚菜美2)4), 油井信明1), 山本亮3)4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2013.

---

	Examination about the initial administration plan of pregabalin for patients with soil -P3-437 cancer 三田恭平1), 中村春世2), 渡邊美智留2), 田中恒明1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2013.

---

	Example that pharmaceutical intervention was effective for soil -P3-438 intractable vomiting 谷健太郎1), 海老原牧子2), 稲毛芳永2), 片桐正孝1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2013.

---

	Action to soil -P3-439 orchid mark subcutaneous injection proper use 村木麻理1), 草場美津江1), 尾崎芙実1)2), 鈴木直人1), 菊地正史1), 中川直人1), 佐賀利英1)3), 久道周彦1), 佐藤真由美1), 木皿重樹1), 松浦正樹1)2), 眞野成康1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2013.

---

	Trial in the ward rounds of the soil -P3-440 Okayama Red Cross hospital palliative care team 浅野志津1), 平井淳子1), 長谷川亜樹2), 渡辺啓太郎2), 喜多嶋拓士2), 大道淳二1), 小池彩子1), 花房伸幸1), 森英樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2013.

---

	Relation of the pharmacist to the palliative care in our soil -P3-441 House 前田弘志1), 野妻俊也1), 高崎紘佑1), 荒木梢2), 波多江正紀2), 山口辰哉1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2013.

---

	Relation of activities investigation and the pharmacist of the palliative care team in our soil -P3-442 House 北森靖隆1)5), 市村行典1)5), 岡山浩子2)5), 福島珠美2)5), 平嶋和代2)5), 橋本正博3)5), 石田英明1), 伊藤清隆4)5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2013.

---

	Examination ... of the stress reduction effect by the difference of the examination - plural species aroma oil of the relaxation effect that assumed soil -P3-443 stress marker an index 金子明日美1), 増田夏実1), 岡部友紀代1), 下枝貞彦1), 中川沙織2), 大和進2), 太田伸1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2013.

---

	Examination ... of the stress reduction effect by the use of examination - long-term aroma oil of the relaxation effect that assumed soil -P3-444 stress marker an index 岡部友紀代1), 金子明日美1), 増田夏実1), 下枝貞彦1), 中川沙織2), 大和進2), 太田伸1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2013.

---

	土-P3-445 Survey about "Time to death from the chemotherapy of last moments" in our hospital - Examination of the quality in the palliative care - 梶原徹, 小川洋司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2013.

---

	Invention ... of the learning society tied to the increase of action ... participant of the soil -P3-446 inside the hospital palliative care learning society and the continuation 宮武望1)4), 松岡弘子3)4), 佃博2)4), 向井淳治1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2013.

---

	The questionnaire results about the pocket manual for the carrying for soil -P3-447 medics and future problem 玉井宏一, 渡部早苗, 是永壮史, 西畑友尋, 織田高子, 石田佳裕, 久保さつき, 倉田知久, 奥津武志, 大野純子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2013.

---

	Risk factor of the blood toxicity expression in the soil -P3-448 pemetrexed - carboplatin (PEM-CBDCA) therapy 多田雅美, 日笠真一, 木村健 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2013.

---

	CBDCA doses calculation-style examination by CBDCA and the GEM combination regimen in soil -P3-449 non-small cell lung cancer treatment 水上皓喜, 高山良, 吉本浩子, 山田啓太, 福島信雄, 日浦和徳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2013.

---

	Examination of the CockCroft-Gault-type eligibility criteria in patients receiving soil -P3-450 carboplatin 工藤直嗣, 岡部真由子, 鈴木康之, 渡部道雄, 土田望, 吹谷佳奈子, 長谷川和泉, 伊藤紫野, 阿部充弘, 平泉美奈子, 鈴木あさ子, 川村浩樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2013.

---

	An evaluation of the renal function in the administration of soil -P3-451 carboplatin and investigation about the side effect expression 渡部善博, 井無田優, 吉原郁夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2013.

---

	It is the treatment situation using the JALSG ALL202U regimen for ALL pubertal in our soil -P3-452 House 蓮尾憲作1), 村本慎悟1), 眞田功2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2013.

---

	Examination of the clinical response of the mogamulizumab for 2 cases of soil -P3-453 CCR4-positive ATL 畑武生1), 片岡憲昭1), 細見誠1), 杉村成一1), 増田友紀2), 三好拓児2), 高山文美2), 平田裕二2), 横手耐治2), 鈴木薫1), 西原雅美1), 勝間田敬弘1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2013.

---

	It is considered the case receiving the mogamulizumab for soil -P3-454 adult T cell leukemia 松尾美希1)2), 長谷川万喜1), 北野勝義1), 丹羽英二1), 藤川一寿2), 濱田潤1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2013.

---

	The use situation and side effect investigation of soil -P3-455 bendamustine 丸山卓哉, 手塚悠希, 棚谷貢, 鈴木千波, 田畑裕和, 柴波明男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2013.

---

	About problems and a problem in the subcutaneous administration for the soil -P3-456 bortezomib injection 田村悟1), 布袋屋せい子1), 柄沢一弘2), 夏目義明2), 金田一誠1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2013.

---

	The expression situation of the local injection site reaction in the soil -P3-457 bortezomib subcutaneous administration 兼松哲史1), 高井満1), 吉田均2), 伊藤貴彦2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2013.

---

	Can an upper arm be given the subcutaneous administration of the soil -P3-458 bortezomib safely, too? 石川広大1), 木村美智代2), 卯野規敬3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2013.

---

	Examination of the injection site reaction in the soil -P3-459 bortezomib upper arm part subcutaneous administration 大井康史1), 小倉千奈1), 谷口仁司1), 角南一貴2), 琢磨律儀1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2013.

---

	土-P3-460 Adverse event evaluation of lenalidomide + Dexamethasone therapy to the super-aged patients with multiple myeloma 谷口仁司1), 小倉千奈1), 中村孝佑1), 大井康史1), 大倉裕祐1), 琢磨律儀1), 角南一貴2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2013.

---

	Examination of the effect factor to give to the blood toxicity expression of patients with multiple myeloma that we introduced soil -P3-461 lenalidomide and dexamethasone combination therapy into 清水康雅1), 篠塚文子1), 渡邊茂樹2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2013.

---

	Analysis and drug control instruction (3) of the adverse event of the lenalidomide therapy for the soil -P3-462 multiple myeloma 中村勝之1), 野田師正1), 高田弘一2), 井山諭2), 佐藤勉2), 瀧本理修2), 小船雅義2), 加藤淳二2), 安井寛3), 池田博3), 林敏昭3), 石田禎夫3), 篠村恭久1), 中田浩雅1), 宮本篤1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2013.

---

	Present conditions investigation of hydration at the CDDP administration by stomach cancer treatment in our soil -P3-463 House 吉野名穂子, 佐橋幸子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2013.

---

	Examination of the usefulness as the renal function marker of serum cystatin C at the soil -P3-464 cisplatin (CDDP) hydration 関礼輔1), 矢野絹子1), 田島紳介1), 高田佐織2), 横山琢磨2), 篠原高雄1), 永井茂1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2013.

---

	Exploratory study on safety and acceptability of the cisplatin (CDDP) hydration using the oral soil -P3-465 supplementary water liquid (ORS) 矢野絹子1), 関礼輔1), 田島紳介1), 高田佐織2), 横山琢磨2), 篠原高雄1), 永井茂1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2013.

---

	Examination about safety and the treatment continuity of the second .3 next treatment (PTX, CPT-11) in soil -P3-466 progress, recurrent stomach cancer 木村美智男1), 宇佐美英績1), 吉村知哲1), 森博美1), 杉山正2), 寺町ひとみ3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2013.

---

	Side effect investigation of the pazopanib treated patients in our soil -P3-467 House 赤瀬麻希1), 後藤総太郎1), 前波麻里子1), 今泉幸久1), 五嶋孝博2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2013.

---

	The use situation and adverse event expression investigation of the Aki Shichi nib in the soil -P3-468 Nagano Municipal Hospital 今城宏文, 古川卓也, 久保田豊, 斉藤和彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2013.

---

	Investigation about the onset of use situation and low Ca blood symptom of the denosumab in the soil -P3-469 Nagano Municipal Hospital 古川卓也, 久保田豊, 今城宏文, 斉藤和彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2013.

---

	It is changed properties of matter by becoming it warming of the soil -P3-470 liver cancer therapeutic drug millimeters plastic Japanese spaniel preparation and emulsion 岸本修一, 齊藤智美, 足立真吾, 鈴木亮佑, 福島昭二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2013.

---

	Investigation about the use actual situation of the Everolimus in patients with soil -P3-471 kidney cancer 新迫恵子1), 矢野育子1), 田中惇子1), 福土将秀1), 津田真弘1), 片田佳希1), 中石真由美1), 小林恭2), 大久保和俊2), 神波大己2), 吉村耕治2), 小川修2), 松原和夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2013.

---

	It is investigated the cancellation case of the regimen including L-OHP in the adjuvant chemotherapy after soil -P3-472 StageIII colon cancer technique 阿部多一1), 落合里枝1), 柳井亮祐1), 井口恵美子1), 長田俊一2), 高橋弘充1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2013.

---

	Examination about the effect on renal function with the soil -P3-473 oxaliplatin administration 岩下佳敬, 橋本直美, 中尾承司, 岩崎公美, 薗田晃弘, 宝来麻衣, 桑鶴麻代, 川畑綾, 永田春香, 石田和久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2013.

---

	An example of colon cancer which there was the tolerability for the soil -P3-474 fluorouracil note, but developed Serious ADR after a capecitabine change 前島光廣1)2), 小泉充1), 萩原剛1), 中島勝1), 平栗学2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2013.

---

	Examination about the side effect expression according to the renal function of capecitabine in soil -P3-475 colon cancer 古元俊徳, 佐々木紀彰, 高橋淳子, 熊澤崇 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2013.

---

	Examination of the effect on soil -P3-476 biliary cancer factor about adverse effect analysis and the treatment continuation of the gemcitabine + cisplatin therapy 高橋克之1)2), 尾上雅英1), 福土将秀1), 池見泰明1), 小林政彦1), 深津祥央1), 矢野育子1), 永山勝也2), 松原和夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2013.

---

	Effect of the myelosuppression on gemcitabine administration in the soil -P3-477 GC therapy 久枝真一郎, 永野俊玲, 佐藤雄介, 朝倉俊治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2013.

---

	Examination of the prognostic factor in patients with soil -P3-478 gemcitabine enforcement pancreatic cancer impossible of excision 羽鳥正浩1), 辻大樹1), 多久佳成2), 大門貴志3), 亀里真那1), 池田翠1), 幕田龍1), 林秀樹1), 井上和幸1), 伊藤邦彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2013.

---

	The construction of the system in the soil -P3-479 malignant glioma therapeutic drug temozolomide administration and participation of the pharmacist 田辺絢子1), 勝田未来1), 藤井亮1), 山澤裕司1), 本間和加子1), 伊東民雄2), 佐藤憲市2), 中村博彦3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2013.

---

	土-P3-480 Study of glioma therapeutic applications of photodynamic therapy using Talaporfin Sodium 三木雄一1), 小俣裕之1), 秋元治朗2), 別府正敏1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2013.

---

	Change of the PSA of patients with prostate cancer which took the methenolone ester acetate lock which was medicine contraindicated to soil -P3-481 岡崎美代子1), 佐藤威文2), 田畑健一2), 黒坂眞二2), 坂倉智子2), 小川幸雄2), 岩村正嗣2), 厚田幸一郎2)3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2013.

---

	One patient who received systemic chemotherapy with the etoposide + cisplatin therapy for soil -P3-482 bladder origin neuroendocrine tumor 畠山朋樹1), 稲田佑亮1), 村田恵美1), 服部恵1), 宮川佳子1), 神澤太一2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2013.

---

	One case that gave TC therapy safely while conducting blood level monitoring for haemodialysis patients who had soil -P3-483 ovarian cancer 山本泰大1), 築山郁人1), 大西克浩2), 灘井雅行2), 松浦克彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2013.

---

	Change of the quality of life before and after the foreign cancer chemotherapy in patients with soil -P3-484 breast cancer 浅野祥子1), 田中和秀2), 舘知也1), 横井貴文1), 大澤友裕2), 川島あずさ1), 安田昌宏2), 水井貴詞2), 棚橋純子3), 中田琢巳4), 後藤千寿2), 土屋照雄5), 寺町ひとみ1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2013.

---

	Convalescence evaluation of the anthracycline chemotherapy in consideration of the adverse event in patients with breast cancer of the soil -P3-485 advanced age 中村暢彦, 地嵜悠吾, 松尾綾, 松村千佳子, 矢野義孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2013.

---

	The effect on convalescence addition survey that Relative Dose Intensity in the soil -P3-486 breast cancer adjuvant postoperative treatment gives 永松秀紹1)10), 伴晶子2)10), 三島江津子1)10), 大島有美子3)10), 桂川健司4)10), 佐々木俊則5)10), 吉岡祐貴2)10), 築山郁人6)10), 久田達也7)10), 板倉由縁8)10), 村上照幸1), 勝見章男9) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2013.

---

	Examination about the eribulin administration for patients with recurrence, progress breast cancer with the soil -P3-487 hepatic dysfunction 福司佳穂里1), 伊藤忠明1), 下村昭彦2), 古澤正子1), 箕曲真由美1), 内田ゆみ子1), 田村宏美1), 長谷部忍1), 陶山浩一2), 三浦裕司2), 川端英孝3), 三浦大周3), 高野利実2), 林昌洋1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2013.

---

	The expression situation of eye disorders by the soil -P3-488 tea S one and risk factor analysis 前田康裕, 山岸利隆, 高橋裕治, 小林靖久, 五十嵐弘幸, 伊藤妃佐子, 佐野正毅, 高嶋孝次郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2013.

---

	Report of the 2 case that a large rise of PTINR was found for soil -P3-489 S-1 and examination and a Hb drop and the same period about drug interactions with warfarin 川田史朗1), 緑川武志1), 飯塚真至1), 山本健1), 中原大貴1), 本多義弘1), 前田拓哉1), 白畑敦2), 鈴木哲太郎2), 三上二郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2013.

---

	Use experience of the denosumab in our soil -P3-490 House 財間富士子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2013.

---

	Examination about the risk factor to have an influence on the serum calcium concentrations drop with the denosumab administration in patients with soil -P3-491 lung cancer 東里花1), 中村豪志2), 中山雅裕2), 田中邦佳2), 室親明2), 木村健2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2013.

---

	Comparison ... by the presence or absence of onset of hypocalcemia situation - zoledronic acid history of treatment in soil -P3-492 denosumab treated patients 畠山智明, 伊藤健剛, 登谷佳奈, 吉川香理, 徳永和浩, 石村彰啓, 鈴木拓也, 佐藤真生, 梶原孝弘, 吉田有香, 高瀬雅司, 石山としえ, 中田昌樹, 篠原一宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2013.

---

	Examination about the potassium revision to hypokalemia by soil -P3-493 Liposomal Amphotericin B 宇佐美英績1), 木村美智男1), 守屋昭宏1), 竹中翔也1), 中島啓二1), 松岡知子1), 吉村知哲1), 森博美1), 杉山正2), 寺町ひとみ3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2013.

---

	Role of the present conditions and the pharmacist of hepatitis B measures to occur by immunodepression, the chemotherapy in our soil -P3-494 House 冨田敦和, 藤井知郎, 伊藤里奈, 種村繁人, 羽田勝彦, 野村賢一, 野田直樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2013.

---

	It is ... for the improvement of examination - testing rate about the examination for HBV situation in soil -P3-495 cancer chemotherapy patients and the intervention effect of the pharmacy, HBV reactivation zero 三田景子, 山中理, 早川太朗, 中山英夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2013.

---

	It is examined HBV reactivation measures at the beginning of soil -P3-496 chemotherapy 落合里枝, 森美奈子, 阿部多一, 柳内亮祐, 井口恵美子, 高橋弘充 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2013.

---

	Fact-finding in our soil -P3-497 "hepatitis B House to occur by an anticancer agent" 當真房子, 森脇典子, 山本紗織, 平良智, 長濱照美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2013.

---

	土-P3-498 Factors that influence from Oxycodone Hydrochloride extended-release tablets to switch conversion amount when opioid rotation to fentanyl adhesive patch 佐々木雄啓1), 横田智美1), 横山峻太1), 高橋尚倫1), 高橋栄子1), 池本雅章1), 芳野直矢2), 高橋和磨2), 佐和章弘2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2013.

---

	For reliable security of the soil -P3-499 coronary arteries catheter therapy 佐多照正1), 赤星真広1), 前村由佳1), 上原友美1), 末廣淑子1), 石神誠子1), 山路智凡1), 池増鮎美1), 神門孝典1), 後迫章子2), 徳永弘恵2), 平峯靖也3), 田中和子4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2013.

---

	土-P3-500 Analysis of factors affecting the residual liquid amount of a portable disposable infusion pump 牧智恵子1), 後藤愛実1), 細見誠1), 西原雅美1), 後藤昌弘2), 吉田元樹2), 紀貴之2), 桑門心2), 西谷仁3), 勝間田敬弘1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2013.

---

Accommodative evaluation of the simple suspension method for the promotion of the treatment with safe anticancer medicine for soil -P3-501 transluminal treated patients 天野学1)2)3)4)5)6)7), 比知屋寛之2), 大竹祐貴子3), 東薫3), 伴英里香3), 筧幸子3), 安智美3), 清原義史3), 座間味義人4), 井上徹雄5), 田中一穂5), 木原零6), 倉田なおみ7), 森山雅弘1), 駒田富佐夫3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2013.

---

	About the dose of the injection anticancer agent of the initial chemotherapy for soil -P3-502 elderly people 前田剛司, 鈴木大吾, 坂田洋, 松原弘幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2013.

---

	Representation input of the order different in the standard of the anticancer agent by the soil -P3-503 pharmacist and duties reduction of the physician 荒木哲也, 小田怜史, 三好康介, 竹本伸輔 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2013.

---

	Usefulness of the prescription checking after the enforcement decision in the soil -P3-504 outpatient department chemotherapy 坂井由紀, 三澤昭彦, 荒川圭子, 外山聡, 佐藤博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2013.

---

	Investigation about cancellation, the postponement reason of the foreign chemotherapy in the soil -P3-505 City Nagahama Hospital 寺村早貴, 池田遼太, 大岡千寿子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2013.

---

	The intervention of the pharmacist to the foreign chemotherapy in our soil -P3-506 House and future problem 長能優子, 浜屋正志, 佐々木良子, 柳原由香子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2013.

---

	The present conditions and problems of the cancer medical therapy in our soil -P3-507 House 永友由里子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2013.

---

	About doubt inquiry in the soil -P3-508 cancer chemotherapy 若月淳一郎, 小林義文, 松本香織, 向山明彦, 南貴之, 田原計子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2013.

---

	Medicine medicine cooperation in the soil -P3-509 cancer medical therapy 松浦佳代1), 橋本早苗1), 廣畑秀記1), 酒井克紀1), 浦川龍太1), 福田英克1), 南波勝栄1), 金森隆一2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2013.

---

	Trial of making and the use of the cancer medical therapy cooperation tool which utilized soil -P3-510 medicine notebook 浅野順治, 米澤衣里子, 白川貴章, 高橋健太, 阿部佳史, 作田重人, 関沢祐一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2013.

---

	About prescription making for exclusive use of the chemotherapy in our soil -P3-511 House and the situation enforcement start a half year later 齊藤有希1), 片山達朗1), 染谷洋和1), 日野眞子2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2013.

---

	With the pharmacist whom patients with soil -P3-512 cancer family hopes for 滝澤康志, 西澤さとみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2013.

---

	Evaluation of the usefulness by the revision of the anticancer agent treatment planning form in the soil -P3-513 Ageo Chuo General Hospital 国吉央城1), 西垣玲奈2), 土屋裕伴1), 中里健志1), 備前綾1), 長谷川真弓1), 坂下舞1), 牧野好倫2), 岩瀬治雄2), 林憲一2), 増田裕一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2013.

---

	Examination of screening of the food composition for the purpose of the soil -P3-514 antitumor effect reinforcement and the killer cells effect 佐塚泰之, 早坂望, 宮下宙子, 杉山育美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2013.

---

	Does the safety improve by the check list making of the soil -P4-515 anticancer chemotherapy regimen? 森山傑, 山崎勇輝, 堀江美保, 安田礼子, 小山秀樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2013.

---

	Rebuilding of the regimen system with the soil -P4-516 clinical record introduction 桑崎綾子1), 森伸子1), 古城かほる1), 栗崎貴2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2013.

---

	Examination for the participation of the pharmacist in the soil -P4-517 cancer chemotherapy regimen management 元木孝, 渡邊清人, 高柳昌宏, 千田泰健 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2013.

---

	Relation of the pharmacist to soil -P4-518 anticancer agent regimen quickness examination 石井岳夫1), 鈴木毅1), 難波有智1), 外間惟夫1), 植田真一郎2), 長井裕3), 増田昌人4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2013.

---

	Problems in the soil -P4-519 cancer chemotherapy regimen order system use and the solution 内田充恵1), 五十嵐佳子1), 萩原謙2), 鈴木武樹2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2013.

---

	It is ... from the viewpoint of inspection - pharmacist of the soil -P4-520 cancer chemotherapy regimen order system 山内可南子, 磯辺浩和, 坂井由紀, 三澤昭彦, 荒川圭子, 外山聡, 佐藤博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2013.

---

	Evaluation of the approval system by the pharmacist of the soil -P4-521 cancer chemotherapy order 六車裕一, 野村浩英, 池田久雄, 乾有希子, 吉岡亮, 森真由子, 宮麻紀子, 瀧川奈央, 辻俊美, 松元麻美, 畑中勝義 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2013.

---

	About the change of the management method of the cancer medical therapy in the soil -P4-522 City Kushiro General Hospital and the effect 佐藤方彦, 鎌沢弦, 本川聡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2013.

---

	The development of the anticancer agent inspection support system based on soil -P4-523 anticancer agent prescription and usefulness 村津圭治, 田中亮, 南野優子, 國森恵梨, 畑裕基, 森本茂文, 政道修二, 石塚正行, 山崎邦夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2013.

---

	Enforcement and evaluation-adaptive on the holiday of anticancer agent preparation duties for all soil -P4-524 inpatients 村地康, 勝浦正人, 西川満則, 山口みほ, 衣笠裕香, 藤村茉由子, 竹上学, 大石雅子, 三輪芳弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2013.

---

	Safe examination of short hydration in the soil -P4-525 CDDP combination chemotherapy 鈴木拓也, 畠山智明, 篠原一宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2013.

---

	A rise by the hydration after the Cisplatin administration in the soil -P4-526 head cervical cancer chemoradiotherapy in blood symptom creatinine level and investigation about the hyponatremia 大久保有起, 橋本早苗, 廣畑秀記, 浦川龍太, 酒井克紀, 水野純男, 松浦佳代, 勝浦知恵, 福田英克, 南波勝栄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2013.

---

	About the acceptance system of high-dose cisplatin in the soil -P4-527 outpatient department chemotherapy center 吉田弘樹, 木全司, 川出義浩, 高原悠子, 鈴木雅人, 青山智彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2013.

---

	Examination of Relative Dose Intensity of L-OHP in our soil -P4-528 House 田代美佳, 田井浩子, 下村一徳, 瀬名波宏昌, 岡貴美, 大河万顕, 川口進一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2013.

---

	Examination about treatment postponement and the weight loss in the TC(PTX+CBDCA) therapy for soil -P4-529 gynecology cancer 浅野裕紀, 伊藤大輔, 岡田和智, 安達志乃, 宇佐美英績, 木村美智男, 中尾俊也, 吉村知哲, 森博美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2013.

---

	Action for the proper use of the soil -P4-530 Fosaprepitant 西村雅次1), 金谷典子1), 石垣俊樹1), 田代陽子2), 羽太光範1), 和田幸治1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2013.

---

	Experience the cancer medical therapy in the soil -P4-531 remote island remote place 石岡美樹1), 中村由美子3), 香取哲也2), 白幡拓也2), 出雲貴文2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2013.

---

	Investigation about the onset of side effect of soil -P4-532 Bendamustine situation 上田和明, 三角紳博, 西野隆 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2013.

---

	Blood poison-related and toleration-related examination that we arrive of the pemetrexed monotherapy in the soil -P4-533 decreased renal function patients 吉田理, 草野淳一, 佐伯佳奈, 鈴木信也, 関山正夫, 安藤栄輝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2013.

---

	Examination of the factor which gives it to the blood toxicity, effect of treatment at the Pemetrexed treatment in patients with soil -P4-534 existing treatment lung adenocarcinoma 八頭司正稔1), 宮原強1), 仲真美恵1), 岩永健太郎2), 松永尚1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2013.

---

	Safe examination of chemotherapy and the NSAIDs combination containing soil -P4-535 pemetrexed 杉枝里香, 安森奈緒子, 林稔展, 坂本由希子, 佐々木由香, 古海和博, 小早川高徳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2013.

---

	Evaluation of the protective efficacy of dexamethasone for the rash with soil -P4-536 pemetrexed 碓氷尚子1), 金銅葉子1), 平島智徳2), 岡本紀雄2), 鈴木秀和2), 山鳥忠宏2), 田宮基裕2), 森下直子2), 白山敬之2), 植田有希1), 福地祐哉1), 山東真寿美1), 志村和子1), 田中恵美子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2013.

---

	Relation to a side effect investigation and drug control of the carboplatin / pemetrexed / bevacizumab combination therapy for patients with soil -P4-537 non-small cell lung cancer 梅原健吾1), 若本あすさ1), 川岸諭佳2), 初山多恵1), 佐藤秀紀1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2013.

---

	Investigation about the use of G-CSF preparation after the carboplatin combination therapy in patients with soil -P4-538 lung cancer 倉本成一郎, 國原将洋, 西澤修一, 小澤秀弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2013.

---

	About the onset of hypersensitivity situation in the soil -P4-539 carboplatin weekly regimen 宇津木博明, 中村和代, 嘉屋道裕, 中條倫成, 望月亜希子, 木村緑, 鈴木崇代 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2013.

---

	Examination about the allergic frequency and risk factor with the soil -P4-540 Oxaliplatin administration 山内浩子1), 後藤隆2), 魚井みゆき1)3), 川鍋ちはる3)4), 松永美香子3)4), 高吉琴絵3)5), 内野慶太3)5), 三角紳博1), 西野隆1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2013.

---

	Investigation of the expression situation of the hiccups at use of soil -P4-541 oxaliplatin and the factor, examination of the supportive care 盛満博之1), 米良千春1), 日高大輔1), 高松秀和1), 岩村威志2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2013.

---

	About the cisplatin administration to patients with soil -P4-542 carboplatin hypersensitivity 細田美穂, 鎌田瑞菜, 仲川三春, 安部浩美, 宮川真澄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2013.

---

	Usefulness of the oral supplementary water liquid in the hydration at the chemotherapy using soil -P4-543 cisplatin 佐藤淳也1)2), 日野和夫3), 高橋勝雄2), 工藤賢三1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2013.

---

	Nephropathic comparison with the starting pharmaceutical products and generic medicine of soil -P4-544 cisplatin 口町恵里子1), 齋藤雅俊1), 伊藤岐代1), 増渕幸二1)2), 柴田壮一1), 薄井健介1)3), 伊藤千裕1)3), 松原肇1)3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2013.

---

	About proper use of the infusion for the renal failure prevention with soil -P4-545 cisplatin 山田菜央実1)2), 鈴木昭夫1), 今西義紀1), 仲野正博3), 安田公夫2), 伊藤善規1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2013.

---

	Fact-finding of the onset of hyponatremia with the cisplatin component regimen chemotherapy for the soil -P4-546 lung cancer 西出洋志, 坂井伸成, 加藤秀明, 宇野美津江, 佐澤佳彦, 平賀貴志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2013.

---

	Examination about renal failure at the soil -P4-547 high dose CDDP combination chemotherapy and low Na blood symptom measures 林洋平1), 下川福子1), 枝崎香織1), 澤田奈津子1), 野口久美子1), 植平紗矢香1), 川端俊介1), 清水裕行1), 南原誠1), 安本祥子1), 谷口一成1), 竹野淳2), 谷口博一2), 田村茂行2), 松原史典1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2013.

---

	The Mg addition of the soil -P4-548 high dose CDDP regimen and nephropathic examination in the diuretic precedent administration 安森奈緒子1), 林稔展1), 瀬戸貴司2), 竹之山光広2), 一瀬幸人2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2013.

---

	Examination about the onset of peripheral neuropathy in the soil -P4-549 paclitaxel carboplatin therapy 関根均1)2), 嶋崎広典1), 井澤典子1)2), 芝崎健志1), 武知公博4), 金内一2)3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2013.

---

	Examination of the risk factor to cause myelosuppression by soil -P4-550 gemcitabine therapy 嶋田烈, 相川晴彦, 松本富夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2013.

---

	The eruption frequency investigation in patients who received soil -P4-551 breast cancer TC therapy and examination of the expression-related factor 畠山浩明1), 古川卓也2), 久保田豊2), 今城宏文2), 大井徹1), 斉藤和彦2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2013.

---

	Examination about a dose and the side effect of irinotecan in the soil -P4-552 colon cancer chemotherapy 岸本真, 砂田和幸, 長ヶ原琢磨, 西本真理, 田中沙耶香, 荻尾夕起子, 吉村真, 佐久間弘匡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2013.

---

	土-P4-553 Efforts for the reduction of the vascular pain with the gemcitabine hydrochloride administration - Reduction of the vascular pain by the dilution of the gemcitabine hydrochloride - 北本真一, 柳田祐子, 古谷智裕, 白木政博, 長崎信浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2013.

---

	Epidemiological examination of the peripheral neuropathy aggravation factor with soil -P4-554 paclitaxel 土屋直彦1), 下枝貞彦1), 永村陽一郎2), 堀治2), 太田伸1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2013.

---

	Investigation about the expression situation and actions to be taken of peripheral neuropathy in the soil -P4-555 oil xanthan gum therapy 小林真美1), 鈴木弘子2), 水澤清1), 岡本譲二3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2013.

---

	Examination of the effect of the lafutidine on peripheral neuropathy by the soil -P4-556 paclitaxel 島田泉1), 井上裕貴2), 石川友貴3), 間瀬広樹4), 山谷明正5), 阿部康治1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2013.

---

	We look at a present conditions investigation of the onset of dermatopathy with the docetaxel + cyclophosphamide therapy in the soil -P4-557 breast cancer and the palliative rear and examine a mark 野口裕介, 鶴島真子, 瓦比呂子, 大森清孝, 徳山洋子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2013.

---

	Use of pain-killer situation survey at the CDDP+RT therapy in soil -P4-558 head and neck tumor 友井理恵子1), 小森桂子1), 木澤成美1), 望月千枝2), 中多陽子1), 丁元鎭1), 福島宣久1), 藤井隆3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2013.

---

	Use investigation of the development situation and the gargle of stomatitis by the soil -P4-559 TS-1 remedy 渡辺祐子, 地主隆文, 猪俣雅之, 福井美規子, 吉嶋抄苗, 佐々木佳子, 鈴木直哉, 徳村麻衣子, 高橋誠, 青田忠博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2013.

---

	Fact-finding of the dose depending on renal failure of the soil -P4-560 tea S one 鈴木大吾, 前田剛司, 坂田洋, 松原弘幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2013.

---

	1 case that was treated effectively with oxycodone hydrochloride for intractable diarrhea induced by soil -P4-561 S-1+CDDP therapy 渡邊法男1), 山田卓也2), 仁田豊生2), 辻本浩人2), 杉本琢哉2), 川村紘三2), 西村英尚1), 大宮史朗1), 山村恵子3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2013.

---

	土-P4-562 Examination about the every other day medication of TS-1 in the breast cancer chemotherapy - Efforts to adverse event reduction - 児玉裕文1), 高崎彩子2), 三根明1), 壱岐のり子1), 井上梨恵1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2013.

---

	Side effect of denosumab investigation in the cancer-carrying patient led by soil -P4-563 elderly people 鷲足ひろみ, 宮本俊一, 甲斐田浩輔, 吉岡まみ, 森淑子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2013.

---

	Discussion about the use situation and the proper use of the denosumab in our soil -P4-564 House 石田耕太, 近藤佐代子, 清水里紗, 植松和子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2013.

---

	A risk minimization plan for denosumab preparation proper use by the pharmacists in our soil -P4-565 House and the effect 越智良明1), 天野しのぶ1), 石野郁美1), 吉野和子1), 舟越亮寛1), 大渕徹2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2013.

---

	Examination (or the substitute with the medical active form vitamin D preparation and calcium preparation is possible) of the serious hypocalcemia evasion by the soil -P4-566 denosumab 小山田聡1), 岡田絵梨子1), 成島俊輔1), 木村有希1), 津田晃央1), 鈴木敬久1), 野村明広2), 井坂彰一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2013.

---

	A side effect of the mogamulizumab therapy in our soil -P4-567 House and the measures 遠藤美央, 矢萩秀人, 本郷文教 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2013.

---

	One case that IR was found at initial mogamulizumab therapy for soil -P4-568 adult T cell leukemia administration, but was able to accomplish good administration by a regimen change 津曲恭一1), 前田宏一2), 田所正年1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2013.

---

	Relations of the blood toxicity and sex differences in the R-CHOP therapy for the soil -P4-569 non-Hodgkin's lymphoma 風間正1), 北田徳昭2), 長谷川豊1), 橋田亨2), 濱口常男1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2013.

---

	Inspection of the usefulness of low Mg blood symptom measures with the antiEGFR antibody medicine of our soil -P4-570 House pharmacy 佐久間隆幸, 中村昭宣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2013.

---

	The situation of the management of the dermatopathy with cetuximab in patients with soil -P4-571 head and neck cancer 三上貴弘, 土屋雅美, 猪岡京子, 高村千津子, 鈴木幹子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2013.

---

	Effect of the honey component moisture retention cream on dermatopathy with the EGFR receptor repressor of patients with soil -P4-572 progress colon cancer 里見眞知子1), 河野透2), 山崎弘貴1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2013.

---

	The development of stomatitis with the panitumumab administration for the soil -P4-573 progress colon cancer case 河野美那子1), 磯部めぐみ1), 安武夫1), 渡邊文1), 谷澤健太郎2), 釣田義一郎2), 篠崎大2), 黒川陽介1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2013.

---

	Investigation about the infusion reaction expression at the soil -P4-574 Rituximab initial administration 安田昌宏1), 梅田道1), 臼井一将2), 舘知也2), 寺町ひとみ2), 高橋健3), 後藤千寿1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2013.

---

	One case of patients with non-small cell lung cancer that the periodical measurement of soil -P4-575 D-dimer led to early detection of pulmonary embolism through bevacizumab 中島誠1)2)3), 大西涼子4), 加藤達雄4), 三島信行2), 寺師守彦1), 杉山正3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2013.

---

	Effect of ARB on soil -P4-576 bevacizumab-induced protein urine 二瓶哲1)3), 佐藤淳也1)3), 木村聡元2), 柏葉匡寛2), 工藤賢三1)3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2013.

---

	Usefulness of the prophylactic medication in the soil -P4-577 cetuximab-induced dermatopathy 岩田一史, 合澤啓二, 平田憲史郎, 上田賢太郎, 江島智彦, 陣上祥子, 福永栄子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2013.

---

	Action of our House about the dermatopathy management of the soil -P4-578 molecules target drug 池田宗彦1), 山中早苗1), 中村文美2), 江見泰徳3), 由井薗陽一1), 槙林智子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2013.

---

	One case that was able to be given Panitumumab for the patients whom Infusion Reaction by soil -P4-579 Cetuximab developed in safely 西健太郎1), 北岡朋子1), 山下愛子1), 森北辰馬2), 田上治美1), 境健爾2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2013.

---

	Side effect evaluation of the molecular target medicine in soil -P4-580 head and neck cancer 野村浩英, 森真由子, 宮麻紀子, 松元麻美, 牧秀美, 平田貴宏, 吉岡亮, 乾有希子, 池田久雄, 畑中勝義 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2013.

---

	Effect of the minocycline on acneform rash by the soil -P4-581 panitumumab 鈴木麻由美1)2), 藤井宏典1), 山田摩耶1), 吉見千明1), 西垣美奈子1), 石原正志1), 北市清幸1), 杉山正2), 伊藤善規1), 吉田和弘3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2013.

---

	Examination about the treatment continuity of the bevacizumab combination therapy in soil -P4-582 progress recurrence colon cancer impossible of excision 曽我祐子1), 伊藤大輔2), 浅野裕紀2), 郷真貴子2), 岩井美奈2), 岡田和智2), 松岡知子2), 安達志乃2), 宇佐美英績2), 木村美智男2), 中尾俊也2), 吉村知哲2), 小川智孝1), 岩城晶文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2013.

---

	1 case that developed hiccups with oxycodone during sunitinib discontinuation for soil -P4-583 gastrointestinal stromal tumor, and changed it to llama Dole, and was effective 清水浩幸1), 廣岡賢輔1), 米田栄子1), 山代豊2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2013.

---

	The expression situation of the dermatopathy of erlotinib for patients with pancreatic cancer in our soil -P4-584 House and the use situation of the drug for external use 高橋新次1), 前田章光1), 高畑知帆子2), 今岡大3), 水谷旭良1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2013.

---

	Side effect investigation of the crizotinib administration case for the soil -P4-585 ALK fused gene-positive lung cancer 中西大介1), 内藤雅大2), 畑地治2), 柳川泰裕1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2013.

---

	Role of the pharmacist in preventive measures against soil -P4-586 HBV reactivation 木全司1), 鈴木達也2), 松浦美聡4), 石間伏由紀4), 吉田弘樹1), 川出義浩1), 日下部篤宣3), 折戸悦郎3), 内田俊樹2), 小椋美知則2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2013.

---

	Construction and evaluation of the examination for HBV attention awakening system in conjunction with an order ring system at the soil -P4-587 chemotherapy enforcement 藤原沙緒里, 小原秀治, 上戸真理子, 谷口亮央, 小林龍, 妻木良二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2013.

---

	Examination about the thrombocytopenia in the IA-call (R) liver intraarterial injection therapy for soil -P4-588 hepatocytes cancer 先崎健造, 関恭子, 明谷早苗, 赤坂寛子, 但馬慶子, 井原加代子, 溝口貴幸, 長田知子, 鹿間良弥, 小川忠明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2013.

---

	The monitoring situation of a hepatitis virus marker at use of soil -P4-589 anticancer agent and the liver function test 田村和彦, 新関みどり, 尾形美絵, 森山亜矢子, 仲島優一郎, 羽生智宏, 嶋崎千絵, 長澤欣弘, 近藤和宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2013.

---

	Theoretical analysis of the effect of treatment of the rasburicase for the hyperuricaemia with the soil -P4-590 cancer chemotherapy 木村耕二, 兼平尚美, 高柳理早, 横山晴子, 山田安彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2013.

---

	About the need of the specimen cooling in the uric acid level measurement after the soil -P4-591 rasburicase administration 大坪達弥, 大塚充, 鹿浦香織, 神田英一郎, 岡橋孝侍, 藤田敦夫, 西川靖之, 野田能成, 三上正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2013.

---

	Action of the ward pharmacist for the soil -P4-592 tumor lysis syndrome 北野勝義1), 長谷川万喜1), 丹羽英二1), 藤川一壽2), 趙竜桓2), 濱田潤1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2013.

---

	Examination of the administration days of the rasburicase for the tumor lysis syndrome with the soil -P4-593 cancer chemotherapy 隅田章弘1), 橋本和代1), 古賀恭子1), 三宅秀敏1), 藤崎千恵1), 松尾美咲1), 今村豊2), 城島浩人2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2013.

---

	Examination of the G-CSF preparation medication method in the FOLFOX therapy for soil -P4-594 progress, recurrent colon cancer 高橋恵1), 篠原悦子1), 野村充俊2), 佐々木英久1), 松尾和廣1), 渡辺朋子1), 加藤裕芳2), 浅山亨2), 吉尾隆1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2013.

---

	土-P4-595 Preventive measures of injection site reaction by Fosaprepitant 相川晴彦1)2), 嶋田烈1), 天野恵2), 加藤弥生2), 古屋まゆみ2), 松本富夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2013.

---

	Examination of the usefulness of the prophylactic use of the G-CSF preparation in patients who received soil -P4-596 cancer of the esophagus chemotherapy 北村真奈巳, 毛利順一, 尾鳥勝也, 木村公美, 石田有香, 須田哲史, 向井潤一, 矢後和夫, 厚田幸一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2013.

---

	1 case of the multiple myeloma treated effectively with a gargle of Hangeshashinto (TJ-14) for stomatitis with the soil -P4-597 chemotherapy 石倉久美子1), 宮尾美佐欣1), 松浦仁志1), 橋村光晴2), 平井学2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2013.

---

	About the effect of a high K blood symptom and the potassium adsorbent after the soil -P4-598 lung cancer chemotherapy 中島優子, 巽香菜, 野澤彰, 中田啓二, 高橋治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2013.

---

	土-P4-599 Vascular pain measures and evaluation at the time of fosaprepitant and epirubicin administration 平出耕石1)4), 竹内賢2), 坂下文夫2), 小林洋子3)4), 鈴木文子3)4), 伊佐治哲也3)4), 今関孝子1), 加藤武司1), 尾関豊2)4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2013.

---

	Use stocktaking for the proper use of the soil -P4-600 G-CSF preparation 松田圭一郎, 延川正雄, 齋藤順, 荒井浩一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2013.

---

	Examination about the risk factor of the myelosuppression expression in the soil -P4-601 urothelial carcinoma GC therapy 平井成和1), 増田雅行1), 佐野君芳1), 真坂亙1), 神谷直人2), 鈴木啓悦2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2013.

---

	About blood sugar level fluctuation at use of dexamethasone in the chemotherapy of patients with soil -P4-602 diabetes merger cancer 近藤篤1), 川原裕2), 丁元鎭3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2013.

---

	Action of the collaboration medical treatment plan by the foreign chemotherapy for patients with soil -P4-603 diabetes merger cancer 桜田宏明, 浅野寿規, 川瀬洋次, 大島有美子, 山村益巳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2013.

---

	Example that soil -P4-604 stomatitis was treated effectively with rebamipide, internal use of the Hangeshashinto 清水真弓, 天野正康, 矢部勝茂 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2013.

---

	The association of taste disturbance and the serum zinc level in patients with soil -P4-605 digestive organ cancer and the effectiveness of the polaprezinc orally disintegrating tablet 薮田直希1), 森井博朗1), 須藤正朝1), 阪中美紀1), 若杉吉宣1), 三上貴子2), 稲富理3), 河合由紀4), 目片英治4), 森田真也1), 寺田智祐1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2013.

---

	Usefulness investigation of the oral iron medicine for anemia with the soil -P4-606 breast cancer adjuvant chemotherapy 於本崇志1), 朝賀純一1), 佐藤淳也1)2), 岩渕修1)2), 柏葉匡寛3), 川口さち子1), 工藤賢三1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2013.

---

	土-P4-607 New trial to anticancer agent extravasation measures - 見える化,使える化 does a manual - 栗山愛1), 伊與田友和1), 田村美香1)2), 先崎千恵子2), 北畠健敏1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2013.

---

	Use actual situation questionary survey of the health food in day -P1-001 diabetes-treated patients 丹代恭太1), 工藤晋1), 福田健二1), 菊池光太1), 佐藤良香1), 高橋歩衣1), 鈴木聖子2), 宮崎由梨3), 蒲澤一行1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2013.

---

	Analysis of drug interactions based on pro--P1-002 CYP2D6 activity inhibition evaluation construction and the use fact-finding of the health food on a day 佐々木瞳, 佐々木崇光, 稲見敬太, 熊谷健, 永田清 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2013.

---

	Effect of the Chinese artichoke on day -P1-003 de-ischemic learning, memory impairment 原田慎一1), 中本賀寿夫1), 森隆治2), 徳山尚吾1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2013.

---

	It is ... about consumer awareness investigation - student for the -P1-004 OTC medicine on a day 坂田菜摘1), 黒沢智佳子1), 網岡克雄2), 小林江梨子1), 佐藤信範1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2013.

---

	It is ... about consumer awareness investigation - company duty person for -P1-005 OTC pharmaceutical products on a day 黒沢智佳子, 小林江梨子, 佐藤信範 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2013.

---

	Fact-finding about the self-medication in day -P1-006 public area inhabitants 岩森紗希1), 松本章裕1), 佐藤倫広2), 原梓3), 菊谷昌浩4)5), 小原拓2)4)5), 目時弘仁5), 廣瀬卓男5), 井上隆輔6), 浅山敬1), 高橋信行1), 眞野成康2), 佐藤博1), 今井潤1), 大久保孝義1)7) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2013.

---

	Effect of the self-medication promotion by the HbA1c measurement at the day -P1-007 drugstore store 外ノ池文乃1), 鈴木匡1), 榊原幹夫2), 榊原明美1)3), 鍋谷伸子4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2013.

---

	Trial of the self-medication enlightenment by the pharmacist who utilized -P1-008 finger-tip biochemical test on a day 横繁智子1), 池田佳代1), 猪川和朗1), 岡本達明2), 赤川信一郎3), 志賀誠司4), 比嘉浩一5), 小松正典6), 竹光茂樹7), 西村信一8), 石本晃一郎9), 中元智子1), 吉川智史1), 森川則文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2013.

---

	Attitude survey about "the education about pharmaceutical products" for the leader of the elementary and junior high school of day -P1-009 Gifu-shi 寺町ひとみ1), 香田由美2), 寺田幸広1), 高橋竜也1), 舘知也1), 土屋照雄4), 勝野眞吾1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2013.

---

	Fact-finding of the pharmaceutical products safety management in the day -P1-010 whole country capital municipal hospital 120 institution 田中恒明1), 齋藤昌久2), 竹内昌司3), 内川清次4), 今泉幸久5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2013.

---

	The remedy that pharmacy was associated with for the drug-related incident accident that occurred -P1-011 inside the hospital on a day 新上香奈子, 野間口寛, 桐野玲子, 柿本智広, 瀧下恭子, 高橋武士, 中木原由佳, 豊住綾子, 平松さやか, 中島誠, 福元裕介, 池ノ上知世, 坂元優太, 寺師守彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2013.

---

	Action for the prevention of incident in the day -P1-012 Toku Fukuoka bank meeting hospital 古賀誠司, 西原由里子, 日高美緒, 柳原佳奈, 杉山徳洋, 小林知香, 竹下龍次, 浦田朋子, 安倍ひろみ, 野村浩子, 平川雅章 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2013.

---

	Effect to incident reduction by the duties expansion (ward working full time leader pharmacist) of the day -P1-013 ward pharmacist 佐藤智人1), 鴫田江理嘉1), 佐伯康之1), 櫻下弘志1), 増田有紀1), 林華代1), 友田江美1), 畝井浩子1), 黒崎達也2), 栗栖智3), 中村マリ子4), 菅田智子5), 山崎香織5), 谷川攻一5), 木村康浩1), 木平健治1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2013.

---

	Action to the analysis of the incident accident in the day -P1-014 charge ward and medical security 稲倉和幸, 辻本朗, 原知斉, 今村陽子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2013.

---

	The effect that -P1-015 clinical duties give to the number of the incident development on a day 山田英紀, 荒木良介, 塚田泰隆, 田中恒明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2013.

---

	Grasp, examination and measures of the drug-related incident example in the ward by the day -P1-016 ward permanent residence pharmacist 船越幸代, 中村護, 大野静子, 脇泰見, 久保有子, 松田翔平, 竹田克明, 前田頼伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2013.

---

	The incident measures in the day -P1-017 pharmacy business trainee and the evaluation 永井直樹1), 新井成俊2), 福原純一郎2), 村田勇1), 井上裕1), 木村昌行1), 金本郁男1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2013.

---

	Analysis of the pre-Abo id report contents in our day -P1-018 House 増田晃, 岡田浩司, 鈴木千絵, 松井伯之, 佐藤勝彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2013.

---

	Make -P1-019 on a day, and is; the pre-Abo id report in the chisel center drugstore and the utilization 土屋辰司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2013.

---

	Construction of the safe medication system by the cooperation of day -P1-020 electronic chart and the section system 佐藤香織1), 四方公亮1), 菅野美紗樹1), 加藤潤一郎1), 平島徹2), 金澤智裕3), 杉村昌弥3), 長谷川英雄1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2013.

---

	Practice report of the medical safety measures by the day -P1-021 pharmacist 清水ゆかり1), 藤沢敏子2), 矢嶋ちか江2), 大井徹1), 仲井淳2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2013.

---

	Registration of the information contraindicated to the drug to the order ring system by the -P1-022 ward pharmacist on a day and the effect 田村宏美1), 内田ゆみ子1), 藤井博之1), 伊藤忠明1), 林昌洋1), 若本恵子2), 布袋屋修2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2013.

---

	日-P1-023 Improvement of the medical security using bar code - Progress report of the third report formulations section and the injection section - 眞壁秀樹, 伊藤護之, 永野浩之, 宇都宮暁, 新井優, 北澤貴樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2013.

---

	Action to the medical security by the day -P1-024 industry 池田賢一, 田中修一, 正木久典, 多田義孝, 坂本勝博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2013.

---

	Inspection of the day -P1-025 DI NEWS 20th year 田原雅子, 平昭圭介, 花田徳子, 玉城翼 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2013.

---

	Action to the present conditions and prevention of that are handled as day -P1-026 cancer collecting medicine from a doctor's dispensary exposure 西迫多重1), 大垣久江2), 土佐めぐみ3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2013.

---

	Action of the Tohoku University Hospital about the information on adverse drug reactions common knowledge of the antimicrobial with the day -P1-027 "pivoxil basis" 尾崎芙実1)2), 前川真央1), 中川直人1), 松浦正樹1)2), 久道周彦1), 眞野成康1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2013.

---

	日-P1-028 Approach in the Tokyo Women's Medical College Hospital for the proper use of benzodiazepine drugs (the first report) - Relation of pharmaceutical products safety management Committee - 高橋賢成1), 高橋結花1), 稲田健2), 石郷岡純2), 木村利美1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2013.

---

	Action (the second report) in the Tokyo Women's Medical College Hospital for the proper use of day -P1-029 benzodiazepine drugs 高橋結花1), 高橋賢成1), 稲田健2), 石郷岡純2), 木村利美1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2013.

---

	Examination of day -P1-030ω1 receptor selectivity and the fall risk from literatures 阿部和史1), 平島由香2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2013.

---

	Action of the prevention of pharmaceutical products drinking by mistake of children in the ethical pharmacy using day -P1-031 DosePak 紅谷歩1), 尾崎秀子2), 玉井典子2), 山之内崇紘3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2013.

---

	Information sharing ... between the many types of job by medical safety measures - information notice about the day -P1-032 anticoagulant 嶋田聖子, 納富貴子, 武田典子, 福野美紀, 浜邊秋芳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2013.

---

	Intervention to the safety management of the renal excretion type drug to learn from -P1-033 side effect onset example on a day 下石和樹, 陣上祥子, 山野朋子, 宮崎蓉子, 福永栄子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2013.

---

	Examination about the mixture of the blood in the insulin cartridge for the day -P1-034 pen type instillator 長岡匠, 岩瀬利康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2013.

---

	Evaluation after the day -P1-035 anticancer agent-related pre-Abo id example and regimen order operation 國重志都, 長塚さおり, 蔭山博之, 勝俣はるみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2013.

---

	Change of the rate of application in the optimal administration of study on proper use docetaxel preparation range of the day -P1-036 medical care device 梅村雅之, 大石瑞樹, 森智彩貴, 新井大地, 竹下永利子, 脇屋義文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2013.

---

	Construction of the Bleeding Risk Score list of the anticoagulant to use for venous thromboembolism prophylaxis after the -P1-037 surgery on a day 冨澤淳1), 黒岩政之2), 高平尚伸3), 平田光博4), 荒井有美5), 川谷弘子5), 小川幸雄1), 厚田幸一郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2013.

---

	Trial to the in-hospital unification of discontinuation, the perioperative use, resumption of the day -P1-038 antithrombotic drug (antiplatelet anticoagulant) 田畑裕和1)2)3)4), 山口くみ子2), 手塚悠希1), 棚谷貢1), 鈴木千波1), 松本英樹3), 早川拓治4), 柴波明男1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2013.

---

	日-P1-039 Construction 1 of in-hospital "Discontinuation manual of the antiplatelet anticoagulant" based on new guidelines - About discontinuation manual revision - 六車龍介, 伊原明宏, 大岡真梨子, 松本真由美, 太田友里恵, 桝本知佳, 永江隆二, 岡本勇二, 内山幸子, 江崎圭吾 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2013.

---

日-P1-040 Construction 2 of in-hospital "Discontinuation manual of the antiplatelet anticoagulant" based on new guidelines - The internal use situation and bleeding evaluation of the endoscopy time antithrombotic drug - 内山幸子1), 高橋亜麻奈1), 六車龍介1), 佐田竜尚1), 江崎圭吾1), 永井千文2), 池脇由美2), 谷口君代2), 北島明美2), 前田哲男3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2013.

---

	Relative examination of hyponatremia and the fall risk in the day -P1-041 acute phase hospital 横井貴文1), 舘知也1), 浅野祥子1), 高橋竜也1), 梅田道2), 安田昌宏2), 水井貴詞2), 南谷美朱3), 後藤千寿2), 土屋照雄4), 寺町ひとみ1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2013.

---

	Concentrations in solution when we combined May Ron with -P1-042 infusion on a day carbonate 泉伯枝, 豊田太一, 相原健司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2013.

---

	Upbringing of the ability for risk management of the pharmacist by the day -P1-043 risk foresight training introduction 平井和浩, 桑名由紀, 長谷川一将, 涌嶋伴之助, 金田達也, 椎木芳和, 高根浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2013.

---

	The present conditions of day -P1-044 Japan and foreign dispensing doctor 森田夕貴, 村田勇, 井上裕, 沼尻幸彦, 池田祐子, 杉林堅次, 金本郁男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2013.

---

	About a case problem solving ability training effect of the electronic teaching materials utilization for the clinical pharmacy learning in the learning before day -P1-045 business true taking lessons 小竹武1), 野口知世1), 井上知美1), 高田充隆1), 掛樋一晃1), 野村守弘2), 山添譲2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2013.

---

	It is ... from the results of the attitude survey of - student and the pharmacist with the role of the pharmacist participating in -P1-046 "business true taking lessons previous learning" on a day (the second report) 村田明子1)2), 中尾幸代1)3), 松田裕子1), 南恵理子1)4), 山中智香1)5), 波多江崇1), 沼田千賀子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2013.

---

	Action of the pharmacy student hospital business training in our day -P1-047 House 土師日香里1), 松本浩1), 赤津真衣子1), 加藤利康1), 須貝瑶子1), 坪谷綾子1), 濱野公俊1), 奥平毅1), 坂下裕子1), 増原慶壮1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2013.

---

	日-P1-048 Efforts for the high quality ward business training system construction - Through a comparison until 2012 for 3 years - 久保和子, 猪田宏美, 錦織淳美, 村川公央, 矢尾和久, 北村佳久, 千堂年昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2013.

---

	Evaluation of the portfolio program in the day -P1-049 hospital business training 安高勇気1)2), 中島章雄1)2), 鷲山厚司2), 二神幸次郎1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2013.

---

	Effect ... of the tensile ... problem base type learning and business training of the ability for day -P1-050 medical treatment practice 廣原正宜, 渡部一宏, 寺田綾子, 中村美樹, 浜本知之, 澁谷文則, 戸田潤, 大澤友二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2013.

---

	Problem of the hospital business training judging from day -P1-051 training diary 向井淳治, 石坂敏彦, 福嶋誠, 高橋直継, 濱田藍子, 中川雅史, 宮武望, 木本美香, 徳山絵生, 小川直希, 小野原未由来, 保米本愛美, 豊田和, 中野由紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2013.

---

	Examination of the self-assessment of the student about the day -P1-052 business training 町田昌明, 石塚和美, 佐藤はるか, 白水俊介, 島田雅彦, 田中嘉一, 湯本哲郎, 櫻井正太郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2013.

---

	Establishment of the evaluation method in the day -P1-053 student business training 畠山英司, 三田村朋, 北澤恵里子, 石毛聡子, 金田昌之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2013.

---

	Evaluation of the hospital business training program by the satisfaction, understanding degree investigation for day -P1-054 pharmacy students 鈴木美穂, 熊谷史由, 太田恵, 庄司理恵, 渡邊卓嗣, 宮城宣明, 長島章, 伊藤功治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2013.

---

	Written examination for the day -P1-055 trainee 角岡みやび, 阿登大次郎, 岡本知子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2013.

---

	Questionary survey about the long-term business training for day -P1-056 sixth grader first graduates 伊藤真紀子, 仲角幸恵, 橋本実穂, 北川久美子, 仲由美子, 毛利美也子, 細木慈子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2013.

---

	Introduction of the smoking cessation foreign training program in the day -P1-057 pharmacy education business training 長郷あかね1)2), 今給黎修1)2), 首藤英樹1), 古川桂子2), 田中博和2), 野村浩子2), 宮津大輔2), 平川雅章2), 二神幸次郎1), 片岡泰文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2013.

---

	Investigation of the knowledge acquisition degree about the proper use of the medical drug in the day -P1-058 hospital business training 土屋翔子, 小谷悠, 椿井朋, 永井智子, 谷口将之, 小池孝洋, 鈴木守人, 浅井玲名, 平林彩, 室崎千尋, 鵜飼麻由, 荻野由里恵, 櫛田真由, 後藤綾, 山下加織, 肥田裕丈, 宮崎雅之, 毛利彰宏, 野田幸裕 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2013.

---

	Action ... using evaluation (2) ... automatic medication record bottle (MEMS bottle) of the medication experience-based training simulated for an antiHIV medicine long term in the day -P1-059 business training 木村博史, 井門敬子, 田中亮裕, 荒木博陽 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2013.

---

	A trial of the palliative care education in the day -P1-060 trainee and the effect 飛鷹範明, 田中亮裕, 荒木博陽 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2013.

---

	Through a visit experience of the day -P1-061 psychiatry single department Hospital about psychiatry and the consciousness conjugation of the pharmacy school student for the mental disorder 小林純子1), 吉田知由1), 松本修一1), 中井正彦2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2013.

---

	Acceptance and questionnaire results of the student training in the day -P1-062 intensive care unit 堀川幸子, 田上治美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2013.

---

	Development and evaluation of the camp type business training program in the day -P1-063 Oshu-shi National Health Insurance true heart Hospital 小野寺健, 南川賢治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2013.

---

	日-P1-064 Trial of the clinical judgment skill evaluation using the patients image sheet in the long-term business training - The second report - 吉田知由, 井上裕貴, 山口布沙, 安藤舞, 佐藤賛治, 松本修一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2013.

---

The action of the resident teacher in the business training at the hospital attached to the day -P1-065 Nagoya University School of Medicine: Resuscitation / living body information monitor, examination by a stethoscope training 椿井朋1)2), 野田幸裕2), 毛利彰宏2), 西川佐紀子3), 日比陽子4), 長谷川雅哉4), 山田清文4), 中尾誠1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2013.

---

	The action for the business trainee in the day -P1-066 Okayama University hospital trial promotion department and the evaluation 土井原夕貴, 西原茂樹, 蔵田靖子, 上田久美子, 成本由佳, 庵谷亜希子, 齋藤まど香, 川島理恵子, 田中三紀子, 川上恭弘, 千堂年昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2013.

---

	Effect on student training by the day -P1-067 drugstore pharmacist resident 清水美希1), 飯塚敏美1)2), 有海秀人2), 宮崎智子2), 川上美好2), 西郷勝行1), 吉山友二2), 石塚英夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2013.

---

	Suggestion for problems of the OTC medicine training in the day -P1-068 drugstore business training and the improvement 剱田侑希1), 今井奈津美1), 桑原亜記1), 松元美奈子1), 吉田彩1), 高木彰紀1), 手塚淑人1), 小林典子1), 青森達1), 鈴木小夜1), 門田佳子2), 大谷壽一1), 中村智徳1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2013.

---

	Internship hospital training result report ... in the day -P1-069 "campus Asia" core base support project report (the first report) - doctoral course graduate student 龍伸和1)2), 松原利行1), 新山雅夫1), 周徳軍1), 徐承姫1), 酒口弘光3), 高畑英信4), 今中常雄1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2013.

---

	It is compared the drug information business training in -P1-070 Tohoku University hospital pharmacy and the American nova south eastern university pharmacy school on a day 中川直人1)2)3), 草場美津江1), 尾崎芙実1), 前川麻央1), 松浦正樹1), 久道周彦1), 村井ユリ子1)3), Gershman Jennifer2), Lai Leanne2), 眞野成康1)3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2013.

---

	Simulated patient (SP) participation type practice for the day -P1-071 pharmacy school first grader 竹平理恵子, 佐田宏子, 小澤実香, 小嶋文良, 山村重雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2013.

---

	Trial of the industry-university cooperation education in the day -P1-072 prior learning 竹平理恵子1), 小澤実香1), 小嶋文良1), 佐田宏子1), 神谷貞浩1), 松本かおり1), 高田智生2), 朝比奈恵美2), 大竹一禎2), 草間賢司3), 内野章3), 羽石理3), 山村重雄1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2013.

---

	Trial of the visit to early experience-based hospital training for the day -P1-073 pharmacy school third grader 篠原高雄, 若林進, 小林庸子, 永井茂 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2013.

---

	Attitude survey about the medical equipment for the pharmacy school fourth grader by the day -P1-074 questionnaire 曽賀千智1)2), 江戸清人1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2013.

---

It is ... for improvement of the consciousness for handling of construction - source of pollution of the effective gloves putting on and taking off training in the learning before day -P1-075 business true taking lessons and the gloves that it can be 前澤佳代子1), 寺島朝子1)2), 渡辺裕子1), 木津純子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2013.

---

	日-P1-076 Construction of the professional training curriculum of the psychiatry domain in the pharmacy six years system - Consciousness change of prejudice, the discrimination against patients with mental disorder of the pharmacy student - 齋藤百枝美1), 渡邊真知子1), 土屋雅勇1), 丹羽真一2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2013.

---

	日-P1-077 Trial for the mental care of the student in the long-term business training (the first report) - Examination and evaluation of the screening method by the prior learning - 白水俊介1), 濃沼政美2), 湯本哲郎1), 石塚和美1), 佐藤はるか1), 島田雅彦1), 田中嘉一1), 町田昌明1), 櫻井正太郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2013.

---

	Effect of consciousness about the smoking cessation support of the day -P1-078 pharmacy school student and the smoking cessation lecture 相澤政明1), 鷲見正宏2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2013.

---

	Change of the maneuver by the basic life support (BLS) class enforcement in the day -P1-079 pharmacy school 井上知美1), 大畑柊穂1), 野々木宏2), 小竹武1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2013.

---

	Examination of the communication style of the pharmacy student for the simulated patient having a feeling of resistance for medication using -P1-080 RIAS on a day 工藤善哉, 池谷博美, 田辺記子, 有田悦子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2013.

---

	Construction of the evaluation model of the cognitive domain in PBL where we introduced -P1-081 SGD into on a day 佐藤はるか1), 濃沼政美2), 湯本哲郎1), 石塚和美1), 白水俊介1), 島田雅彦1), 田中嘉一1), 町田昌明1), 櫻井正太郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2013.

---

	Practice of the physical assessment education by the day -P1-082 two ways talks type PBL practice 高見陽一郎1), 島田憲一1), 小川壮寛1)2), 江川孝1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2013.

---

	Day -P1-083 self study, participation type "medicine-based internship volunteer experience-based training:" Effect in the paths of next generation decision who is a graduate 栗尾和佐子, 小西元美, 奥野智史, 中尾晃幸, 木村朋紀, 辻琢己, 山室晶子, 山本祐実, 西川智絵, 安原智久, 柳田一夫, 中村三孝, 曽根知道, 河野武幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2013.

---

	Making of systematic practice contents for the understanding improvement of the day -P1-084 statistical analysis 西田孝洋, 平田春奈, 下川研太, 吉川直樹, 宮元敬天, 麓伸太郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2013.

---

	About the day -P1-085 Canada pharmacy training 大光正男1), エップ デニース2), 曲渕直喜3), 森田桂子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2013.

---

	Activity contents and education system of the day -P1-086 United States clinical pharmacy training 成井浩二1), 別生伸太郎1), 杉浦宗敏1), 林良雄1), 野水基義1), Kayser Steven R.2), 笹津備規1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2013.

---

	Action ... experience type learning ... of the day -P1-087 Saitama hospital pharmacist society area training sectional meeting west block 黒下龍二1)6), 新井成俊2)6), 鍵山智樹3)6), 古高裕子4)6), 渡邉絵美5)6), 安野伸浩5)6), 井澤正義6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2013.

---

The present situation of the medical therapy workshop by day -P1-088 University of Shizuoka, hospital, the community pharmacy cooperation 伊藤邦彦1)2), 井上和幸1), 辻大樹1), 賀川義之2), 山田浩2), 浅倉候子2), 井上達秀2), 北村修2), 坂本達一郎2), 柴山芳之2), 菅谷純子2), 鈴木崇代2), 中野真汎2), 並木徳之2), 松山耐至2), 森本達也2), 山田静雄2), 山本勝央2), 今井康之2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2013.

---

	Construction and evaluation of the learning on a day before business true taking lessons for the -P1-089 hearing loss student 石塚和美, 白水俊介, 佐藤はるか, 島田雅彦, 田中嘉一, 湯本哲郎, 町田昌明, 櫻井正太郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2013.

---

	Knowledge arrival degree of the pharmacologic tendency to questions and nurses' aide in the day -P1-090 nurse national examination 井手若奈1)2), 高橋眞生1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2013.

---

	日-P1-091 New face pharmacist education in the Miyakonojo Hospital - Making of introduction and the goal setting sheet of the preceptorship - 田所正年, 津曲恭一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2013.

---

	State of stress of the six years system new college graduate pharmacist under the day -P1-092 Preceptor system 佐原敏之1), 大津山裕美子2), 白井秀典1), 黄前尚樹2), 三浦誠1), 榎堀徹1)3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2013.

---

	The new face training in our day -P1-093 House, action second report of the lifetime education 赤津真衣子1), 坪谷綾子1), 土師日香里1), 藤本知代1), 東しずか1), 松本浩1), 濱野公俊1), 奥平毅1), 坂下裕子1), 増原慶壮1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2013.

---

	Evaluation of the pharmacist training system in the day -P1-094 accession 5 annual 草薙みか1), 村尾奈苗2), 加藤貴由3), 橋詰めぐみ4), 宮森勇昌2), 山本哲也5), 奥野健一6), 西村知朗7), 近藤薫8), 亀本浩司6), 岸井昭人9), 松浦靖10), 橋本昌幸7), 松野純男11), 大里恭章1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2013.

---

	Practice and evaluation of the injection preparation technical education specialized in an anticancer agent for the -P1-095 pharmacy school six years system postgraduate training life on a day 勝浦正人, 山口みほ, 村地康, 衣笠裕香, 藤村茉由子, 竹上学, 大石雅子, 三輪芳弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2013.

---

	Action 4 of the Saitama hospital pharmacist society about day -P1-096 cancer medical therapy and the specialized pharmacist 源川良一1)2), 川田亮1)3), 鈴木栄1)4), 中山季昭1)5), 小田まゆみ1)6), 伊藤剛貴1)7), 島田雅弘1)8), 岸野亨1)9), 堀口久光1)4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2013.

---

日-P1-097 It is an approach of the Aichi hospital pharmacist society for pharmacist qualification specialized in a cancer - The case report making that is easy to come - 板倉由縁1)11), 久田達也2)10), 築山郁人3)10), 牛膓沙織4)10), 荒川裕貴2)10), 三島江津子5)10), 伴晶子6)10), 大島有美子7)10), 佐藤由美子8)10), 佐々木英雄9)10), 勝見章男11) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2013.

---

	The evaluation of the day -P1-098 Tokyo Women's Medical College hospital cancer clinical pharmacy meeting for the study and the future prospects 只見智恵子, 勝見重昭, 石橋麻衣, 菅原直子, 長尾友紀子, 柏瀬しのぶ, 深谷寛, 大野朋子, 高橋麻利子, 伊東俊雅, 高橋賢成, 木村利美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2013.

---

	Effect by an education problem and the training about the injection drug preparation maneuver of the day -P1-099 pharmacist 足立美菜子1), 秦英司1), 栢木啓介1), 加藤淳2), 山岡宮子3), 森田俊博4), 金田達也1), 椎木芳和1), 高根浩1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2013.

---

	日-P2-105 Try the pharmacist intervention to the ICU - What is expected in team approach in medical care - 内田有紀, 杉原請香, 上田香織, 片山奈央香, 樋野玲子, 村上伸介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2013.

---

	An action of the pharmacist placement to the day -P2-106 ICU and the effect 高梨愛1), 清野尚美1), 原直己1), 津田尚始1), 永嶋一貴1), 川嵜英二1), 松田俊之1), 西澤英雄2), 馬場葉子3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2013.

---

	Examination of drug control instruction duties in the day -P2-107 ICU ward 佐藤あゆ美, 甲賀麻里子, 平野茂子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2013.

---

	Development of day -P2-108 NICU pharmacist duties to be able to employ 松浦詩麻, 木苗あゆみ, 平井啓太, 坂本達一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2013.

---

	Change of the number of doubt inquiry before and after the ward permanent residence in the day -P2-109 pediatric intensive care unit 後藤宏明, 諏訪淳一, 西山まゆみ, 松本智子, 内川清次 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2013.

---

	Pharmacist participation in planning to the day -P2-110 neonatal intensive care unit (NICU) 吉田直恵, 礒元啓吾, 片山晴子, 織邊聡, 寺川則子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2013.

---

	Participation in initial treatment in our day -P2-111 House and intensive care 佐野邦明1), 高木雄一1), 松本富夫1), 浅香えみ子2), 池上敬一2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2013.

---

	Role of the pharmacist in the day -P2-112 operating room 加藤典華, 岩崎明子, 矢野有香, 三輪耕次 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2013.

---

	About the pharmacist duties in the day -P2-113 operating room 白澤由香1), 熊谷学1), 内山英二1), 虎岩知志2), 渋澤雅和2), 北山泰子3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2013.

---

	It is ... mainly on the cooperation with role - ward charge pharmacist of the operating room charge pharmacist in the medical therapy for the -P2-114 perioperative period on a day 堀井徳光1), 増田大輔1), 高木雄一1), 松本富夫1), 上田幹子2), 山内尚也3), 新井丈郎4), 奥田泰久4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2013.

---

	Result and problem of the day -P2-115 operating room satellite drugstore introduction 浜津頼子1), 雪本江里子1), 藤井幹子1), 桑野彰浩1), 籠本基成1), 桐島通子2), 尾崎千佳子2), 西美幸2), 中村玲子2), 内海潤3), 石津雅弘1)4), 小林政彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2013.

---

	About the construction of the pharmacist duties in the day -P2-116 Hitachi General Hospital critical care center 根本昌彦1), 齋藤祥子1), 佐藤渉1), 松崎宣裕1), 青山芳文1), 寺田直子2), 中村謙介3), 藤田恒夫3), 奥村稔3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2013.

---

	About the role of the pharmacist in the emergency visit in our day -P2-117 House 岩崎明子, 齋藤真慈, 三輪耕次 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2013.

---

	Good use of emergency pediatric service drug sheet in the day -P2-118 children lifesaving center 栃倉尚広1), 佐々木祐樹1), 阪上貴子1), 坂神宏1), 菊池憲和1), 鏑木盛雄1), 吉田善一1), 守谷俊2), 木下浩作2), 丹正勝久2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2013.

---

	About the drug which you should be careful about associated with -P2-119 swoon on a day 黒川央, 中尾元紀, 森英人, 藤末慎, 上野裕之, 玉田太志, 北村良雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2013.

---

	Usefulness and safety of Paravertebral block with ropivacaine in the day -P2-120 pneumoscope lower pneumonectomy 後藤拓也1), 小松輝也2), 野村美枝1), 相澤佑佳1), 曽和晃正2), 高橋耕治2), 藤永卓司2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2013.

---

	2 cases with suspected abnormal high level of the β-D-glucan level with the day -P2-121 Daikenchuto 大塚充, 澤田真嗣, 大坪達弥, 堀内あす香, 小森玉緒, 西川靖之, 三上正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2013.

---

	One case with suspected transfusion-associated pulmonary disorder (TRALI) which occurred after -P2-122 red blood cell dope transfusion start on a day 平岩歳久, 澤田尚孝, 岡田裕之, 星野真輝, 中山貴美也, 小池良且, 家田浩美, 仙田典保 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2013.

---

	日-P2-123 Proper use of the therapeutic drug in the mamushi bite case - From the use situation investigations such as the detoxification, blocker for the past 3 years - 田中聡1), 服部暁昌1), 門口直仁1), 宮本典文1), 山本創一1), 野島剛2), 石原潤子2), 田中公章2), 斎坂雄一2), 喜多村泰輔2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2013.

---

	日-P2-124 Clinical drug duties in the acute intoxication medical care - Poisoning case using the hydroxocobalamin (set for the cyanokit (R) injection) - 門口直仁1), 田中聡1), 野島剛2), 宮本典文1), 山本創一1), 服部暁昌1), 田中公章2), 喜多村泰輔2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2013.

---

	Study on adsorption of midazolam in the day -P2-125 ECMO circuit 武本あかね1), 座間味義人2), 小沼利光1), 田坂健1), 西宮祐輔1), 江角悟1), 河崎陽一1), 飯田淳義3), 市場晋吾3), 林久美子3), 定金典明1), 北村佳久1), 氏家良人3), 松木範明4), 千堂年昭1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2013.

---

	日-P2-126 Efforts for the pain relief of neonates - Examination for the hospital preparation of the simple syrup 4 times dilution and the manufacture - 加藤さおり1), 梅岡希美恵2), 山田恭聖3), 川澄紀代1), 末松寛之1), 築山郁人1), 松浦克彦1), 辻悦子2), 竹下覚3), 武藤大輔3), 二村真秀3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2013.

---

	It is enforcement ... of the emergency simulation using ... first aid drug box for the -P2-127 pharmacist who can play an emergency role on the site on a day 木村初, 覺前盟, 禰占奈美江, 小泉祐一, 野村真美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2013.

---

	Assay of the patients waiting time using day -P2-128 queue theory 斉藤芳敬, 藤田剛平, 八幡弘子, 金高勇介, 中村裕一, 金住麻子, 稲垣育宏, 橋本義宏, 小森均 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2013.

---

	Establishment of the pharmacist outpatient department for the use of oral day -P2-129 molecules target medicine patients 佐原祥子1), 森健司1), 滝本典夫1), 足立守1), 田中國晃1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2013.

---

	日-P2-130 Exploring of the possibility of the pharmacist in the foreign instruction - Based on the results in the palliative care outpatient department - 伊藤剛貴, 小林義幸, 竹之下枝実, 松倉愛実, 松本千明, 松永和子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2013.

---

	Examination for the present conditions and the improvement of the foreign inhalational instruction in the day -P2-131 Komaki Municipal Hospital 水谷貴樹1), 福岡智宏1), 松田麻奈1), 柴田久美子1), 土本大輔1), 宮川佐和子1), 堀尾秀明1), 林浩之1), 宇都宮純平1), 出口裕子1), 戸田康裕1), 神間康1), 岩田晋2), 小島英嗣2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2013.

---

	Foreign inhalational instruction and confirmation in the day -P2-132 Fujinomiya Municipal Hospital 中川由里可, 井尻真理子, 小林豊, 小林義典, 川口洋実, 勝又一雄, 北村修 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2013.

---

	Action of our House by the DOTS introduction for the day -P2-133 active tuberculosis 佐藤可奈1), 福島さやか1), 亀井健人1), 真砂さおり2), 橋本徹3), 高柳和伸1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2013.

---

	We examine the need of the continuation instruction for the -P2-134 outpatient department insulin introduction patients on a day 大島聡子, 難波由里子, 坂下舞, 紙屋めぐみ, 新井亘, 増田裕一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2013.

---

	Medication counseling in the patients who assumed -P2-135 atopic dermatitis and the accessory symptom main complaint on a day 室生真千子1), 坂田幸治1), 緒方千秋1), 花輪壽彦1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2013.

---

	About the medication counseling to the antithrombotic drug warfarin potassium remedy patients consuming -P2-136 tea on a day 沼尻幸彦1), 石川麻友美1), 秋山(山王丸)靖子1), 田島敬一2), 新津勝1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2013.

---

	日-P2-137 The workshop which makes the communication of a physician and the pharmacist better - Doubt inquiry in topics - 飯岡緒美1), 富澤崇2), 大西弘高1), 大生定義3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2013.

---

	About the action for proper use and the assessment decrease in drug by the collaboration with day -P2-138 drugstore and the medical affairs section 三枝貢1), 浅田智哉1), 眞鍋伸次1), 川田悟2), 合田昌人2), 夛田良行2), 前田剛3), 森由弘3), 厚井文一3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2013.

---

Making of the emergency care experience-based program that the emergency team personnel training system many types of job of the -P2-139 many types of job collaboration are associated with on a day 玉造竜郎1), 峯村純子1), 井上蓉子1), 塩田一博1), 福田安津子2), 外山夏子2), 宮川誠一郎3), 家泉桂一4), 中野順子5), 多田弘美6), 佐佐木彩佳7), 門馬秀介8), 中村俊介8), 三宅康史8), 村山純一郎1), 有賀徹8) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2013.

---

	Action between nurses at action (the second report) physician - pharmacist - institution for joint medical treatment management (CDTM) in the day -P2-140 community medical care 小川壮寛1)2), 松下明3), 井口千恵美4), 藤本浩之1), 金子恭子1), 福嶋寛子1), 守安洋子1), 川上茂利1), 高見陽一郎2), 島田憲一2), 江川孝2), 五味田裕2), 高橋正志1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2013.

---

	Action to the pharmacist skill up in our day -P2-141 House 押賀充則, 山口正和, 加藤一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2013.

---

	About drug department duties development using the day -P2-142 four screen thinking process 鶴居勝也1), 波多晶子1), 三谷和恵1), 窪田真弓1), 平野尚瑞1), 山口裕幸2), 山城清二3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2013.

---

	The operating room duties that we included the anesthetic order by the -P2-143 pharmacist in on a day 鈴木めぐみ, 永田実, 加藤直紀, 片山広美, 鈴木裕之, 板倉由縁 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2013.

---

	Usefulness ... of the intervention to action -1 - inhalation therapy to the inhalation therapy by the day -P2-144 pharmacist 伊藤稔宏, 中村敏史, 佐藤裕介, 野村翔, 新井孝文, 堀田美知成 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2013.

---

	Evaluation ... of the staff education by the action -2 - inside the hospital asthma, inhalation therapy instruction person authorization precision establishment to the inhalation therapy by the day -P2-145 pharmacist 中村敏史1), 後藤康洋2), 丹下麻衣子3), 小沢直也2), 中村裕子3), 伊藤稔宏1), 山本雅史2), 堀田美知成1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2013.

---

	Usefulness evaluation of the pain control protocol in the day -P2-146 orthopedics domain 藤岡貴光1)2), 齋藤雅俊1), 小林義和1), 斎藤太寿1), 伊東崇仁1), 阿部真也1), 町田美香1), 八木澤啓司1), 柴田壮一1), 井上岳1)2), 松原肇1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2013.

---

	About the relation of the pharmacist at the day -P2-147 alteplase use 杉本恵理1), 山川恵子1), 青孝明1), 岡田直子2), 濱田和秀3), 木村匡男1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2013.

---

	Two cases of contribution - PTP sheet mis-deglutition to health care of the ward staff by the day -P2-148 ward pharmacist and the cat bite as an example ... 花田雄一, 溝上和寿, 太田学, 中島恵美子, 磯本則章 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2013.

---

	Intervention report to the athlete by the pharmacist in the day -P2-149 Kumamoto function Hospital 田山理恵1), 星野輝彦1)2), 松本健吾1), 塩津和則1), 高橋修一朗1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2013.

---

	The> which reports mixing route connection duties of the injection drug by the -P2-150 ward pharmacist <second on a day 八木真希子, 高田正弘, 佐藤雅也, 井上登美子, 鈴木光明, 野毛一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2013.

---

	About an offer method of the drug information for day -P2-151 physician duties burden reduction 久岡清子, 佐々木健志, 合田さやか, 西谷友紀, 古島彩代, 川上尚美, 間千晴, 植谷未稀, 亀岡喬, 鹿沼奈央, 足立雅, 盆子原唯, 力武舞, 川村大輔, 土師久幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2013.

---

	Examination of myelosuppression of the day -P2-152 linezolid and the risk factor 佃晶子, 平井成和, 増田雅行, 佐野君芳, 真坂亙 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2013.

---

	Examination about the myelosuppression by the day -P2-153 antiMRSA medicine linezolid 東綾香1), 松尾和廣1), 小川美希2), 北條有紗1), 木村伊都紀3), 佐々木英久1), 平山忍3), 植草秀介2), 横尾卓也3), 花井雄貴3), 渡辺朋子1), 篠原悦子1), 小杉隆祥3), 西澤健司3), 吉尾隆1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2013.

---

	Examination of the expression factor about thrombocytopenia with the day -P2-154 linezolid administration 堀田修次, 舟田有里, 西川大亮, 藤田智子, 船隠恵子, 中山やちよ, 佐藤加奈子, 延平早美, 田阪武志, 立花広志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2013.

---

	Examination of the factor affecting the thrombocytopenia by the linezolid in our -P2-155 House on a day 市江敏和1)2), 鈴木大介1)2), 安井一正1), 高橋弘泰1), 松田雅光1), 杉浦洋二1), 杉山正2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2013.

---

	Drop of thrombocytopenia frequencies by the dose adjustment of the linezolid based on the presence or absence of -P2-156 risk factor on a day 丹羽隆1)2), 渡邉珠代2), 鈴木昭夫1), 外海友規1)2), 土屋麻由美2), 鈴木智之2), 太田浩敏2), 岡安伸二1), 北市清幸1), 村上啓雄2), 伊藤善規1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2013.

---

	An action and evaluation about the proper use of the use of day -P2-157 limit antimicrobial 宮部芳之1)2), 長谷部千夏1), 兼松友紀1), 佐藤和也1), 加藤早紀1)2), 宇佐見文隆1), 柏毅彦1), 佐藤哲男2), 久津見彩子2), 川口知己2), 伊藤浩明2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2013.

---

	The effect that a use trend change of the -P2-158 carbapenem system antimicrobial gave in chemosensitivity of Pseudomonas aeruginosa on a day 若松健太郎, 福竜太朗, 内村仁美, 岩下健一, 永瀬ゆり子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2013.

---

	A present conditions investigation about the long-term use of the day -P2-159 identification antimicrobial and future problem 篠崎浩司1), 萩谷政明2), 今中翔一1), 島崎良太1), 清水秀行1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2013.

---

	A change of the antimicrobial usage by the operational change of the report of use of day -P2-160 identification antimicrobial and chemosensitive comparison for Pseudomonas aeruginosa of the meropenem 河田武志1), 渡壁太一1), 近藤華枝1), 仙波靖士1), 成岡功2), 清水ゆき1), 坂本聡1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2013.

---

	An action to wide area antimicrobial proper use in the day -P2-161 pharmacy and the effect 稲垣啓太1)5), 渡嘉敷俊介1)5), 鳴川貴司1), 下村綾子1)5), 橋本有可子1)5), 颯田千絵子2)5), 中村みどり2)5), 釋悦子3)5), 志智大介1)5), 柴山芳之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2013.

---

	About the use actual situation of the carbapenem-based antimicrobial in our day -P2-162 House 桑村恒夫, 上原奈緒, 杉原徹哉, 白石史遠, 赤松孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2013.

---

	Trend of the antibiotics consumption by the registration system introduction of day -P2-163 carbapenem system antibiotics 阿部純也1), 鈴木涼子1), 小林誠一2), 佐藤良子2), 大村真理子2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2013.

---

	The introduction of the use of carbapenem medicine registration system in the day -P2-164 Tohoku University hospital and the effect 鈴木博也1)2), 飯田優太郎1), 久道周彦1)2), 徳田浩一2)3), 賀来満夫3), 眞野成康1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2013.

---

	Chemosensitivity of the carbapenem-based antimicrobial consumption in the day -P2-165 Tonami, Toyama district and Pseudomonas aeruginosa 舘美幸1), 高田加壽代2), 岩崎幹茂3), 池上陽久3), 守内匡2), 酒井由貴江1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2013.

---

	Investigation about the association between consumption and Pseudomonas aeruginosa-resistant rate of the day -P2-166 carbapenem system antimicrobial 草野春香1), 金子卓也1), 青木良悦2), 菅原真理子3), 紫桃君子4), 岸川幸生1), 勝山壮1), 八木朋美1), 中村仁1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2013.

---

	Examination of the effectiveness of the flomoxef for the day -P2-167 ESBL-producing Escherichia coli patients 児玉暁人1), 今井兼貴1), 米田伊作2), 中田淑子3), 森信介1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2013.

---

	Analysis of the risk factor to influence a serum creatinine rise by the -P2-168 ST medical mixture on a day 宗村盛1), 高野賢児1), 鈴木豊史2), 島田侯陛1), 井上真由美1), 川井龍美3), 深水啓朗2), 伴野和夫2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2013.

---

	The use situation of an onset factor and the treatment antimicrobial of Clostridium difficile-related loose bowels in our day -P2-169 House 樋口聖人1), 冨永等2), 横山茂1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2013.

---

	An action to day -P2-170 Ctostridium difficile infection therapeutic drug proper use and the evaluation 岡田美智代, 五藤里奈, 水口芳信, 伊藤源基, 熊田克幸, 金森伸夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2013.

---

	Examination of the Clostridium difficite association loose bowels incidence with the day -P2-171 antimicrobial administration 小薮真紀子1), 真鍋健一2), 後藤隆3), 川田希1), 岸原康浩4), 小田原美樹4), 田中沙希恵4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2013.

---

	Fact-finding of Clostridium difficile infection treatment in the hospital attached to day -P2-172 Sapporo Medical College 藤居賢, 國本雄介, 中田浩雅, 野田師正, 宮本篤 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2013.

---

	Stool infusion therapy for patients with day -P2-173 recurrent intractable Clostridium difficile infection 森下和美1), 高田正弘1), 野毛一郎1), 佐野克典2), 青木よし子3), 笠松伸吾4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2013.

---

	Examination of the risk factor in the day -P2-174 Ctostridium difficile infection 山崎晃憲1)2), 芳賀貴史1), 佐藤由美子2), 本郷文教1), 本田仁3), 熊谷章2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2013.

---

	Role of introduction and the pharmacist of the day -P2-175 joint medical treatment management (Collaborative Drug Therapy Management: CDTM) 中居肇1), 工藤香澄1), 松田俊之2), 中村一成1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2013.

---

	Factor analysis in the decreased renal function expression by day -P2-176 Liposomal-Amphotericin B 齋藤佑輔1)2)3), 上阪友基2), 細田清美3), 高嶋孝次郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2013.

---

	The making of of the pharmacist intervention system and the effect on use of day -P2-177 vancomycin note case 三枝邦廣, 浜本麗子, 平野泰健, 谷口とおる, 高橋敏夫, 鈴木恵以子, 香川大樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2013.

---

	1 case that was suspected of acute renal failure by -P2-178 VCM on a day 中西俊介1)2), 阪野和重1), 奥本真巳1), 谷畑悠起子1), 三木康弘1), 木下博之2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2013.

---

	Investigation of the effective trough value and impaired renal function of the vancomycin hydrochloride note in our day -P2-179 House 朴井三矢1), 藤村尚子1), 福田良子1), 上野裕之1), 玉田太志1), 北村良雄1), 志馬伸朗2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2013.

---

	About the acute renal failure with the day -P2-180 vancomycin hydrochloride note 阪野和重, 中西俊介, 谷畑悠起子, 奥本真巳, 三木康弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2013.

---

	One case of the drug fever with the neutropenia by day -P2-181 Tazobactam(TAZ) 吉岡祐貴1), 小林義和1), 小島義博1), 生田宏治2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2013.

---

	The effect that PIPC-TAZ administration based on -P2-182 PK-PD theory gives to the clinical test value of elderly people on a day 藤裕美1), 片山直子1), 黄前尚樹2), 角山香織3), 桑原晶子4), 山森元博4), 三浦誠1), 栄田敏之3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2013.

---

	Effect on clinical response by the effectiveness and the nutritional status of the day -P2-183 amikacin sulfate once a day administration method 松木祥彦1), 松本佑美1), 大貫敏明1), 安田麻美1), 浅井浩子1), 高橋優香1), 岩佐典子1), 杉浦健一1), 藤岡敬子1), 中村友美1), 布施智子1), 細山田真2), 渡部多真紀3), 渡辺茂和3), 土屋雅勇3), 矢嶋美樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2013.

---

	The use situation of day -P2-184 amikacin sulfate and clinical examination 寺尾麻希, 青孝明, 佐々木暢琢, 川口奈緒美, 木村匡男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2013.

---

	1 case that showed Daptomycin hyposensitivity for -P2-185 intractable MRSA infection on a day 中川舞子1), 和田恭一1), 松田紗知1), 越智純子1), 中村慶1), 桑原健1), 野上毅2), 山下保喜2), 堀由美子3), 稗田道成3), 渡邉琢也5), 角南春樹3), 佐藤琢真3), 村田欣洋3), 瀬口理3), 簗瀬正伸3), 中谷武嗣3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2013.

---

	It is examined the use of daptomycin case in the -P2-186 orthopedics domain on a day 平田備子1)7), 山本真子1)7), 中尾英樹2)7), 西野雅美3)7), 伊藤研二郎6), 木南佐織4)7), 大西尚5)7), 吉田和也6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2013.

---

	About the background of patients with day -P2-187 daptomycin use and the effectiveness 岩切啓太1), 丸山久美子1), 森口美琴2), 安道誠3), 深田章1), 石田英明1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2013.

---

	Examination about the dosing period of the meropenem in day -P2-188 elderly people 相宮光二1), 田淵克則2), 林誠2), 舟木弘2), 北俊之3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2013.

---

	The effect that the introduction of the -P2-189 ICT antimicrobial proper use round gives to use of antimicrobial on a day 松島菜々1), 二石直子1), 飯干恵子2), 細渕達3), 佐藤久美4), 辻晋也5), 藤井奨5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2013.

---

	Inspection of the effect by an investigation of the patients background of the patients targeted for day -P2-190 antimicrobial round and the round enforcement 三浦義彦1), 根井貴仁1), 森洵子2), 藤田昌久1), 中川仁美1), 片山志郎2), 前田美穂1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2013.

---

	The enforcement situation of the antimicrobial round in our day -P2-191 House 宇都宮純平, 土本大輔, 宮川佐和子, 戸田康裕 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2013.

---

	Fact-finding about the prophylaxis for the maintenance of preventive measures against day -P2-192 influenza hospital infection 花田聖典1)2), 小園亜希1), 中村和芳2), 水上智之2), 田中亮子2), 鶴崎泰史3), 中川義浩1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2013.

---

	Discussion from the use situation of the antiinfluenza medicine in the day -P2-193 here level 荒川弘光 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2013.

---

	Examination about the effectiveness of day -P2-194 antiviral drug ganciclovir and the safety 北條有紗1), 松尾和廣1), 久保田由美2), 東綾香1), 木村伊都紀3), 佐々木英久1), 平山忍3), 植草秀介4), 横尾卓也3), 花井雄貴3), 渡辺朋子1), 篠原悦子1), 小杉隆祥3), 西澤健司3), 吉尾隆1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2013.

---

	The effect that -P2-195 antimicrobial cycling therapy gives to resistant bacteria development on a day 別府博仁1)2), 戸波由香利2), 田島直行2), 斎藤貢2), 見附保彦3), 津谷寛3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2013.

---

	Use fact-finding of the antimicrobial in patients with day -P2-196 decreased renal function 山下友輝, 南ちひろ, 須藤大雄, 小松弘幸, 菊田初美, 小林龍, 小原秀治, 妻木良二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2013.

---

	Of the peramivir administration in the day -P2-197 decreased renal function case, actually 浦田元樹, 池田尚弘, 北村芳子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2013.

---

	Fact-finding about anaphylactic measures of the day -P2-198 medication medicine 河口義隆1)2), 尼崎正路3), 白野陽正1), 山崎博史1), 松尾義哉1), 佐伯久美子1), 河村明美1), 白木尚美1), 藤井章1), 前田久美子1), 平田紀子1), 尾家重治1)2), 古川裕之1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2013.

---

	The colistin sensitivity for isolates of day -P2-199 multidrug-resistant Pseudomonas aeruginosa and antimicrobial 2 combined effect 榎屋友幸1)2), 中村明子2)3), 村木優一1)2), 岩本卓也1), 奥田真弘1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2013.

---

	Proper use promotion and secular variation of the oral antimicrobial in day -P2-200 UTIs 荒川隆之, 坪井菜野, 三戸田大, 九門実加, 河村真徳, 金森美由紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2013.

---

	It is an example of patients with psoriasis with suspected Toxic shock syndrome during -P2-201 antiTNF alpha preparation dosing period on a day 佐道紳一1), 鶴田孝義1), 藤田有紀子1), 木下真理子1), 吉岡大樹1), 吉村敏朗1), 塚元和弘2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2013.

---

	Association of the prophylaxis of the pulmonary aspergillosis onset and the antifungal agent in the day -P2-202 blood internal medicine domain 水井貴詞1)2), 駒田奈月2), 舘知也2), 大澤友裕1), 青山智1), 梅田道1), 安田昌宏1), 高橋健3), 土屋照雄4), 寺町ひとみ2), 後藤千寿1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2013.

---

	About the medical treatment choice for patients with day -P2-203 non-HIV-related pneumocystis pneumonia 鈴木渉太1), 星野賢吾2), 山下和彦2), 西岡達也2), 濱口常男3), 岩川精吾3), 太田光煕3), 棚橋孝雄3), 北河修治3), 久米学2), 槇本博雄2), 平野剛2), 平井みどり2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2013.

---

	Examination of patients background of day -P2-204 medical care, care-related pneumonia and the factor about the initial therapeutic drug and aggravation 小林義和1), 吉岡祐貴1), 土山宗彦1), 小島義博1), 土屋整也2), 生田宏次3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2013.

---

	About the present conditions of the antibiotic exposure for the day -P2-205 pneumococcal pneumonia 白石貴寿, 坂本晃世, 中村宏, 安河内一弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2013.

---

	1 case that was able to control revival using tobramycin in-hospital inhalational preparation for pseudomonas pneumonia to repeat -P2-206 on a day 内田裕之1)3), 黒崎裕一郎2), 角田誠一1), 岡秀昭3), 石井嘉之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2013.

---

	The case that diazoxide succeeded in serious hypoglycemia happened in the whole -P2-207 pentamidine administration on a day 井口仁美, 志野訓之, 野村泰生, 堂上孝至 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2013.

---

	Resistant bacteria measures based on use and AUD, the anti-biogram of the outcome registration system of the day -P2-208 identification antimicrobial 難波良平1), 渡辺智康1), 山崎恵1), 高取孝一1), 安藤哲信1), 加藤忠彦2), 西塚享3), 島田憲一4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2013.

---

	日-P2-209 Characteristic of the antimicrobial consumption of the Nissei Hospital - Comparison with the whole country - 池田久雄, 平田貴宏, 野村浩英, 乾有希子, 吉岡亮, 瀧川奈央, 畑中勝義 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2013.

---

	Examination about the resistant rate of injectable antimicrobial consumption and Pseudomonas aeruginosa in our day -P2-210 House 小坂隆介1), 橋本雅司1), 松尾祐一2), 大庭友香1), 木村滋1), 太田千春1), 河野宏枝1), 鳥山純司1), 村上直幸1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2013.

---

	It is undergone a change of antimicrobial consumption of 4 years and the Pseudomonas aeruginosa-resistant rate on a day by -P2-211 past 山本諭1), 前田頼伸2), 南橋薫1), 太田基博1), 中島燈子1), 清水潤三1), 川村尚久1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2013.

---

	Action of the antimicrobial proper use in our day -P2-212 House 後藤啓之1)2), 吉井智1)2), 長谷川翠1)2), 工藤琢也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2013.

---

	Action to the antifungal agent proper use in our day -P2-213 House 石田達彦, 寺崎展幸, 横田聖子, 上田里恵, 福井英二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2013.

---

	Comparison in the antimicrobial consumption in the day -P2-214 Hekinan municipal hospital and chemosensitive children and adults 天野哲史1), 松本薫1), 黒田信行1), 佐藤篤郎1), 山崎均2), 土井悟3), 板倉由縁1)3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2013.

---

	All use of carbapenem system antimicrobial case monitor link and intervention ... to perform by action ... infection measures team for the proper use of the -P2-215 carbapenem system antimicrobial on a day 中蔵伊知郎1), 河合実1), 米本仁史3), 小川吉彦2), 上平朝子2), 山田雄久1), 廣畑和弘1), 中多泉1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2013.

---

	Outcome evaluation of the pharmaceutical approach for the proper use of the day -P2-216 carbapenem system antimicrobial 八木祐助, 岡崎雅史, 檜垣宏美, 松本一郎, 宮村充彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2013.

---

	Action of the pharmacy for the initial report rate improvement of the day -P2-217 identification antimicrobial registration system 岡田美香1), 笹野央1), 吉田恵1), 松本雅弘1), 馬場喜弓1), 原田好子1), 近藤成美1), 堀賢3), 佐瀬一洋1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2013.

---

	The use situation of the day -P2-218 antibiotic and bacterial chemosensitive change 山口佳子1)2), 堀内寿志2), 安河内尚登1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2013.

---

	Examination about the chemosensitivity of consumption and resistant bacteria of the antimicrobial in the day -P2-219 Saiseikai Futsukaichi hospital 中野祐樹, 大竹野久雄, 蓮輪博嗣, 横尾賢乗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2013.

---

	An effect and problems of the action for the day -P2-220 antimicrobial proper use 成島俊輔1), 岡田絵梨子1), 臺美恵子2), 井坂彰一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2013.

---

	Examination about day -P2-221 antimicrobial consumption and the substrate specific expansion type β - lactamase (ESBL)-producing bacteria rate of detection 櫻井淳二1), 岸川幸生2), 黒沼圭1), 佐藤昌子1), 中井紋1), 阿部順1), 武者栄美子1), 菅原泰典1), 野澤寿吉1), 石澤文章1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2013.

---

	Evaluation of the administration situation and the cancellation standard of the oral ST medical mixture as the day -P2-222 pneumocystis pneumonia preventive preparation 丸岡ひとみ1), 船本哲生1), 高瀬美咲枝2), 飴谷太1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2013.

---

	C. in the day -P2-223 Yokohama Asahi Chuo General Hospital Action second report for the improvement of difficile-related loose bowels 竹川七生1), 本多義弘1), 前田拓哉1), 高橋賢右2), 内田美穂子3), 樋川志織4), 三上二郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2013.

---

	Examination about the incompatibility of the day -P2-224 high dose vancomycin hydrochloride 清水啓1), 小幡輝夫1), 田中和浩2), 堤教明1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2013.

---

	Action to the antimicrobial proper use by the day -P2-225 infection measures team (ICT) 寺本晴美1), 城尾晃太1), 松田真一郎1), 福田一毅2), 菊田真穂2), 馬瀬久宜1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2013.

---

	The result of the action to the antimicrobial proper use in the day -P2-226 ICT clinical record round and future problem 福田良子, 朴井三矢, 上野裕之, 玉田太志, 北村良雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2013.

---

	Construction of the day -P2-227 ICT infection round sheet making system 山澤裕司1)2), 山田眞弓1)3), 小野優子1)4), 大里俊明1)5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2013.

---

	The activity of the infection control team (ICT) concerned with the preventive measures against -P2-228 infection addition on a day and role of the pharmacist 田村彩, 渡邊卓嗣, 長島章, 伊藤功治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2013.

---

	Fact-finding about preventive measures against hospital infection duties in the day -P2-229 hospital pharmacist 鶴見成亮1), 大原宏司1), 千葉博暁2), 小原拓3), 丹野亮平1), 早坂正孝1), 塩川秀樹4)5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2013.

---

	Investigation about the risk factor of the day -P2-230 endogenous mycotic endophthalmitis onset 香取祐介1), 鯰江麻耶子2), 正田菜留美2), 平山武司1)2), 市邉義章3), 黒山政一1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2013.

---

	Relation as the pharmacist to the patients with suspected day -P2-231 NDM-1 (New Delhi metallo- β - lactamase 1)-producing multidrug-resistant bacteria 吉澤亜紗美, 野澤正徳, 三浦毅, 畔柳敏弥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2013.

---

	The HBV vaccination situation in the day -P2-232 pharmacist 稲川秀樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2013.

---

	Action to DI reporting in the day -P2-233 adult vaccination 伊藤真也, 徳岡夕香, 渡邉歩, 岩崎秀子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2013.

---

	Investigation about the candidemia treatment situation in our day -P2-234 House 高橋弘泰, 市江敏和, 鈴木大介, 杉浦洋二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2013.

---

	Examination about antimicrobial administration and the nutritional status for day -P2-235 pneumonia 中野えり子, 小川智孝, 岩城晶文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2013.

---

	The fact-finding of the aspect each other round between the institutions in preventive measures against day -P2-236 infection regional alliances and attitude survey of the pharmacist 中村翔吾1)6), 寺沢匡史1)6), 久保友美2)6), 井上都3)6), 安井友佳子4)6), 上田浩貴5)6), 濱口良彦5)6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2013.

---

	Action of the pharmacist to prevention of infection measures addition 1 calculation in the cottage-hospital out of day -P2-237 高松真衣, 野澤正徳, 三浦毅, 畔柳敏弥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2013.

---

Local joint surveillance about use of antimicrobial density and the resistant bacteria separation rate with the day -P2-238 Hiroshima throughout the prefecture 24 institution 華山博子, 荒川隆之, 池本雅章, 伊藤孝史, 小笠原康雄, 岡田麻衣子, 岡野太一, 川上恵子, 木村友美, 栗原晋太郎, 滝雪歩, 田原直緒美, 土井久美子, 日浦昌洋, 武郷徹, 藤井秀一, 堀田修次, 増田博久, 松本俊治, 宮田篤, 向田俊司, 安原昌子, 山口伸二, 山本明子, 木平健治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2013.

---

	Intervention to an administration of day -P2-239 antiMRSA medicine schedule by the in-hospital use situation and ICT, pharmacist 杉田真理子1), 彼谷裕康2), 五十嵐登3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2013.

---

	It is ... in questionary survey first report - pharmacy school students about the usability of the -P2-240 new combined chlorine-based sanitization, wipe preparation for the washing on a day 高木奏1), 杉山哲也1), 寺島朝子1)2), 渡辺裕子1), 前澤佳代子1), 金田充博3), 堀誠治1), 木津純子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2013.

---

	It is ... in questionary survey second report - healthcare workers about the usability of the -P2-241 new combined chlorine-based sanitization, wipe preparation for the washing on a day 山崎智史1), 石井忠司1), 高木奏2), 杉山哲也2), 渡辺裕子2), 前澤佳代子2), 金田充博1), 堀誠治3), 木津純子2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2013.

---

	It is evaluated education of the proper use of the waterless finger disinfectant by the -P2-242 hand hygiene reinforcement team and the practice on a day 石原義久1)2), 中野智子2), 平川尚宏1), 栗原恵2), 長倉周作2), 長元加奈2), 東直樹2), 瀬戸梢2), 川上雅之2), 福岡龍一1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2013.

---

	Action to hepatitis B measures in patients who received day -P2-243 immunodepression, chemotherapy 藤井章1)2), 藤部純子2)3), 宇山郁代3), 野見山淳2)4), 田中裕子4), 山本武史1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2013.

---

	The enforcement of the medical epidemiology workshop using the day -P2-244 case study and future problem 松木祥彦1)3)4), 高田勝利1)3)5), 長谷川敦1)3)6), 神谷英里1)3)7), 河村睦美1)3)8), 吉田眞紀子9), 仲佐啓詳1)2)10), 佐々木忠徳1)3)11), 清水秀行1)12) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2013.

---

	About the sterilization effect in the in-hospital sterile preparation preparation area caused by -P2-245 peracetic acid and mixed gases with hydrogen peroxide on a day 須川涼, 中村歩, 竹中美樹, 西川満則, 鈴木香菜代, 森本啓太, 竹上学, 大石雅子, 三輪芳弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2013.

---

	About the use situation of the antiHIV medicine in our day -P2-246 House 右川浩, 田中三枝子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2013.

---

	The fact-finding about the regimen change of the day -P2-247 antiHIV therapy and the evaluation 松本圭祐1), 田中博之1), 友田吉則1), 勝呂美香1), 和田達彦2), 松山晃代3), 斉藤聡子3), 田村和敬1), 近藤留美子1), 厚田幸一郎1)4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2013.

---

	It is comparison about the packeted time for formulations apparatus a package of the -P2-248 antiHIV medicine on a day 矢倉裕輝, 櫛田宏幸, 服部雄司, 河合実, 吉野宗宏, 山田雄久, 廣畑和弘, 中多泉 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2013.

---

	The problems in the outside Parliament prescription issue of day -P2-249 antiHIV medicine and the action 吉野宗宏1), 植田孝介2), 國本雄介3), 井上正朝4), 佐藤麻希5), 山田徹6), 齋藤直美7), 丸山一郎8), 下川千賀子9), 柴田雅章10), 畝井浩子11), 松本俊治12), 松浦清隆13), 大石裕樹14), 増田純一15), 千田昌之15), 三上二郎16) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2013.

---

	Stability evaluation of the suspension of day -P2-250 ritonavir tablets and crush product 大歳菜美子1), 矢倉裕輝2), 和田美紀1), 湯谷玲子1), 寺岡麗子1), 北河修治1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2013.

---

	1 case that Atovaquone hyposensitization succeeded in for patients with HIV-positive pneumocystis pneumonia that -P2-251 treatment suffered from on a day 成田綾香 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2013.

---

	The analysis of the pharmacist intervention example in day -P2-252 HIV infection treatment and the evaluation 國本雄介1), 任田宜史1), 中田浩雅1), 野田師正1), 池田博2), 石田禎夫2), 宮本篤1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2013.

---

	About an administration of pneumocystis pneumonia preventive preparation end standard in the day -P2-253 HIV infected person 安田恵, 日笠真一, 秀田恭子, 木村健 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2013.

---

	Drug-related impaired renal function development situation investigation by the day -P2-254 tenofovir 安武夫1)2), 峰岸園恵1), 杉石あや1), 黒川陽介1), 鯉渕智彦2), 古賀道子2), 中村仁美2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2013.

---

	One case of the HIV infection pregnant woman who showed a blood level drop of -P2-255 Fosamprenavir on a day 森尚義1), 高橋昌明2), 谷口晴記3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2013.

---

	About a change of the number of the CD4-positive T lymphocytes by the day -P2-256 mullah biRoch addition 下川千賀子, 安田明子, 林志穂, 柏原宏暢 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2013.

---

	Cross sectional study about the day -P2-257 antiHIV medicine tenofovir and renal tubules phosphorus reabsorption rate 日笠真一1), 安田恵1), 秀田恭子1), 日笠聡2), 澤田暁宏2), 徳川多津子2), 木村健1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2013.

---

	Role of the grasp situation and the medicine notebook of the drug knowledge necessary for a day at the disaster in the -P2-258 antiHlV medicine remedy patients 大澤麻貴子1), 前田真輝1), 當麻厚子1), 三浦直子1), 山本有佳里1), 小島賢一2), 長尾梓2), 花房秀次2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2013.

---

	日-P2-259 Watch over the patient's side effects by the medical institution, pharmacist, patient IT cooperation : The way of system construction 飯原なおみ1)2)3)4)5)6)7), 桐野豊1), 真鍋励次郎2), 菅朋子3), 冨岡謙二4), 正木浩二5), 岩本明彦6), 安西英明7), 中山幸子8) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2013.

---

	Role ... of the pharmacist through introduction ... new system of the electronic chart system to day -P2-260 doctorless region patrol practice 川田敬1), 公文登代1), 岡崎由紀1), 山本創一1), 服部暁昌1), 澤田努2), 北村和之3), 町田尚敬3), 早瀬仁美4), 濱田敬子5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2013.

---

	Present conditions investigation about the pharmaceutical cooperation in day -P2-261 medical office and the ethical pharmacy 榊原隆志1), 江崎秀樹1), 山中祐介1), 滝本典夫1), 近藤充1), 足立守1), 加藤聡之2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2013.

---

	Pharmaceutical cooperation in the day -P2-262 at-home palliative care 秋元義幸1), 倉橋孝予1), 玉井典子2), 尾崎秀子2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2013.

---

日-P2-263 Efforts (the second report) to company house medical care support in treatment at home promotion Committee - Maintenance of the medical drug (drug) information and good use of tool - 青木悠1)2), 岩下誠2)3), 渕澤宏明2)3), 倉本泰志2)3), 大森健2)3), 林和枝2)3), 田中美和1)2), 小松良2)3), 竹内裕子1), 花岡幹郎3), 油井信明1)3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2013.

---

	2 cases that a subcutaneous implantation-type central venous catheter blocked up in -P2-264 at-home central venous feeding method on a day 鈴木英二1), 久保田豊1), 関野奈穂2), 成本壮一3), 斉藤和彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2013.

---

	Realistic problems in the health insurance pharmacy in the acceptance of the day -P2-265 at-home central venous hyperalimentation therapy (HPN) patients 高島英滋1), 朝倉恵美子1), 武山則行2), 大橋哲也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2013.

---

	Pharmaceutical approach to the aspiration prevention that utilized the deglutition physical assessment of the pharmacist in the -P2-266 treatment at home on a day 中島郁枝1), 大西孝宣1), 本橋勝1), 見原瞬1), 古川恵美1), 守山聖美2), 後藤詩織2), 増田伴史2), 鈴木孝之2), 鈴木大3), 永田久幸1), 池野隆光1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2013.

---

	The discovery hint of the inapparent aspiration using the deglutition physical assessing men of the drugstore pharmacist in the day -P2-267 treatment at home and pharmaceutical approach 大西孝宣1), 中島郁枝1), 本橋勝1), 鈴木大2), 鈴木孝之3), 永田久幸1), 池野隆光1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2013.

---

	The attitude survey that assumed a motor function, going to hospital means for the -P2-268 treatment at home introduction and elderly people general usability test an index on a day 福嶋寛子1), 小川壮寛1)2), 川上茂利1), 中島利裕1), 杉浦聡1), 安倉央1), 守安洋子1), 高見陽一郎2), 島田憲一2), 江川孝2), 五味田裕2), 高橋正志1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2013.

---

	Action (the third report) of Seino regional alliances for the day -P2-269 inhalational instruction standardization 中尾俊也1), 浅野裕紀1), 郷真貴子1), 伊藤実沙子1), 西川智子1), 森博美1), 白木晶2)6), 安部崇2)6), 進藤丈2)6), 西脇了3)6), 安田美奈子4), 古井秀彦5)6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2013.

---

	日-P2-270 The present conditions and problem of the pharmaceutical products offer for institution residents - A drugstore is joint management of an institution and the medical treatment to give - 一條直1), 大内香織1), 神奈川博史1), 斉藤俊昭2), 串田一樹3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2013.

---

	Report about a present conditions investigation and the construction of the prescription support system for a pharmacist to intervene in the -P2-271 special elderly nursing home on a day 増田多加子, 堀内珠代, 有馬裕紀子, 文元佑, 藤澤重樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2013.

---

	日-P2-272 Cooperation of care manager and the pharmacist - Approach first report for Suita-shi Residual medicine zero - 岡橋義弘1), 三田康子2), 児玉暁人3), 辻文生4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2013.

---

	An action and medicine medicine cooperation of germfree formulations in the day -P2-273 health insurance pharmacy 池崎友明1), 大久保純1), 竹内都子1), 山谷香織1), 田中真衣1), 高島留美1), 雨宮陽子1), 北澤英徳1), 中川加代子2), 村上望1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2013.

---

	Construction and evaluation of the waiting time predictive model in the day -P2-274 ethical pharmacy 内田明宏1), 小山茜2), 宇田川三男3), 武田直子3), 富澤崇3), 植沢芳広4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2013.

---

Action to outside Parliament prescription publication night on a day on a holiday in the -P2-275 Hitachi General Hospital 青山芳文1), 影山忠雄2), 石井浩之2), 安倍精一2), 鈴木勝俊2), 大曾根洋子2), 岩崎健一2), 高橋晃太郎2), 菊池孝徳2), 鯉渕静夫2), 野田礼子2), 岡山崇2), 石川慎祐2), 浅井誠也2), 石井浩之2), 四十物由香1), 齋藤祥子1), 江幡早苗1), 戸倉恵子2), 藤田恒夫3), 奥村稔3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2013.

---

	Clinical studies about the physical assessment skill class using the patients with day -P2-276 COPD simulator and the allied vital sign acquisition 西尾廣昭1), 土谷大樹1), 小嶋英二朗1), 田中哲郎1), 数野博2), 孫尚孝3), 尾上洋3), 濱本優里3), 田頭亜紀4), 石岡敏之5), 岡田昌浩6), 横田武治7), 徳毛孝至8), 上敷領淳1), 杉原成美1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2013.

---

	Practice of the medicine medicine cooperation in our day -P2-277 House 小林里美1)2)3)4)5), 有川朗子1), 山崎寿浩1), 長野一勢4), 長浜美智穂2), 橘井由香2), 奥村政彦3), 大野実5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2013.

---

	Start the use of the -P2-278 medicine medicine cooperation "reporting book to the discharge ethical pharmacy" on a day 伊東美歩, 加藤幸三, 栗本美里, 泉雄介, 平原一也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2013.

---

	Action of a possession situation investigation and the spread promotion of the day -P2-279 medicine notebook 三谷和恵, 窪田真弓, 波多晶子, 平野尚瑞, 鶴居勝也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2013.

---

	Action of the medicine medicine cooperation promotion in the day -P2-280 Uozu, Toyama district 上島聖秀1), 畠山規明2), 高橋慎太郎1), 浜元孝1), 能澤真希子1), 森谷道生1), 野口結香2), 炭岡孝志3), 清河雄介4), 細江律子1), 田中みずほ1), 林靖子1), 林隆博1), 河井良智1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2013.

---

	Relation of the pharmacist to the Kyoto cancer regional alliances critical path in our day -P2-281 House 大野恵一, 本多伸二, 目黒裕史, 三松史野, 村田龍宣, 荒田美帆子, 實光由香, 吉村光弘, 山本直宏, 寸田靖, 村岡淳二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2013.

---

	Action (the second report) to day -P2-282 regional alliances fur Matthew tical care network construction 野添大樹1), 佐多照正2), 今出唯史3), 佐藤康行4), 中村真之5), 永田芳郎6), 岸本真7), 牧角寛郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2013.

---

	Making of the in-hospital standard format of the day -P2-283 Chiba common use stroke community medical care cooperation pass "drug sheet" 高柳論也1)2)3), 塚野聡1), 杉山栄美1), 飯嶋久志2), 大橋高志3), 小坂好男1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2013.

---

	A setup and problem of the inhalational support using day -P2-284 illness medicine cooperation 高田正弘1), 川上典子1), 長山晃1), 金谷有美1), 加藤有希1), 森下和美1), 野毛一郎1), 吉田康秀2), 千秋到3), 秋山雅子4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2013.

---

	日-P2-285 Construction of the inhalational instruction cooperation in Suita-shi - The third report, Result of the inhalational instruction enlightenment activity - 高橋文香1), 児玉暁人1), 岩田智津子1), 本名房美1), 竹村充代1), 森信介1), 辻文生2), 三田康子4), 岡橋義弘4), 松本祐子3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2013.

---

	The result of regional alliances about the day -P2-286 inhalational instruction and future problem 土屋広行1), 百瀬泰行2), 神田博仁1), 山折大1), 藤本圭作3), 大森栄1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2013.

---

	System construction and problem of the inhalational instruction cooperation with the health insurance pharmacy in the hospital attached to the day -P2-287 Mie University School of Medicine 世古口典子1), 村木優一1), 畑中知笑美3), 大野真之4), 松田浩明1), 岩本卓也1), 田口修2), 奥田真弘1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2013.

---

	Action of problems and the medicine medicine cooperation in the day -P2-288 teriparatide self injection preparation 工藤香澄, 中居肇, 田名部和代, 高橋明, 中村一成 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2013.

---

It is the action of the refill a cancellation medicine package by discontinuation instruction and the medicine medicine cooperation of the cancellation medicine in the preoperation in patients with day -P2-289 ambulatory surgery plan 香河里江子1), 植野孝子1), 西嶋博子1), 林祥子1), 平岡ひろ子1), 木村仁美1), 福田倫代1), 倉光智子1), 藤川雄也1), 徳永知世1), 河井臣吾2), 松岡宏1), 平田紀子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2013.

---

	The follow system after the day -P2-290 outpatient department introduction teriparatide initial instruction and the examination 松田舞子, 古畑文, 登内盛治, 跡部治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2013.

---

	Medical cooperation and medication support of the day -P2-291 hepatitis C triple-drug therapy 土田美奈子1), 岩瀬裕治1), 鯨明美1), 丹羽直人1), 長田薫2), 高橋利幸2), 池上正3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2013.

---

	It is ... for further adequacy of practice of the -P2-292 "micro TDM" and the medical treatment management by inspection - drugstore pharmacist on a day 池田佳代1), 猪川和朗1), 横繁智子1), 中元智子1), 吉川智史1), 中谷有吾2), 岡本達明3), 堀淵浩二3), 小笠原英敬4), 勝谷隆4), 森川則文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2013.

---

	It is cooperation) with 4 - Misato-shi, Saitama pharmacists society and interchange ... with the citizen for -P2-293 area conclusion type medical care on a day 町田充1), 小林真人2), 神谷譲2), 奥津剛2), 三浦明則2), 上田恵子1), 酒井祐介1), 笹原明子1), 矢嶋美樹3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2013.

---

	Action to cancer chemotherapeutic drug medicine cooperation in the day -P2-294 Saiseikai Fukuoka General Hospital 山中早苗, 川野研, 池田宗彦, 由井薗陽一, 槇林智子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2013.

---

	The present conditions investigation after the medicine medicine cooperation start in the day -P2-295 oral anticancer agent and future problem 篠原徹, 杉山昌秀, 三浦篤史, 油井信明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2013.

---

	Medicine medicine cooperation about the oral anticancer medicine in the day -P2-296 Kahoku, Yamagata district 松田美樹子, 齋藤智美, 遠藤尚美, 大滝善樹, 後藤恵子, 緒方操, 高梨伸司, 武田直子, 川越由美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2013.

---

It is ... about the attachment of the cancer chemotherapy reporting seal to action ... medicine notebook of the medicine medicine cooperation in our -P2-297 House and information sharing with the ethical pharmacy on a day 齊藤直美1)2), 飯沼正彦1), 川村竜矢1), 大島理英子1), 渡邉宏美1), 蓬田隆治1), 武田梢1), 江戸崇人1), 阿部悟1), 遠藤正光2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2013.

---

	Action of the medicine medicine cooperation in our House for patients with day -P2-298 cancer 佐倉小百合1), 平郡薫1), 寺崎展幸1), 横田聖子1), 上田里恵1), 吉住智奈美2), 福井英二1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2013.

---

	Information sharing ... of one step - supportive care of the medicine medicine cooperation next in the day -P2-299 outpatient department chemotherapy 池田隆, 板倉朋恵, 金田美咲緒, 阪本康典 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2013.

---

	Pain control ... with action ... opioid as the health insurance pharmacy to a pilot study aiming at cancer treatment cooperation in the day -P2-300 Hospital 加藤正久1), 金子絵里菜1), 草場健司1), 井上智博1), 加留部信介1), 吉川学1), 福岡英樹1)2), 緒方憲太郎3), 高松泰4), 瀬尾隆2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2013.

---

	Action ... of the Hekinan Municipal Hospital pharmacy to promote the treatment at home participation in planning of administration - drugstore pharmacist of the -P2-301 experience type study session (P-net club) on a day 片山広美, 永田実, 鈴木厚志, 加藤直紀, 鈴木めぐみ, 天野哲史, 榊原ゆかり, 板倉由縁 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2013.

---

	It is ... from prescription analysis of pulse-taking - Great East Japan Earthquake of the use pharmaceutical products at -P2-302 size scale disaster on a day 稲野祥宗1)3), 宮坂善之2)3), 野口幸洋3), 高橋佐和士1)3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2013.

---

	Questionary survey about the correspondence of the health insurance pharmacy at the day -P2-303 Great East Japan Earthquake 我妻恭行1), 小原拓2)3), 佐藤倫広2), 井筒隆宏4), 佐々木孝雄4), 鈴木常義1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2013.

---

	日-P2-304 Drug duties enforcement survey in Miyagi - Effect of the earthquake disaster to see for a questionnaire - 石田和1)11), 佐藤庸一2)11), 小林美奈子3)11), 松浦夏子4)11), 小野寺昭宏5)11), 山寺文博6)11), 外岡久和7)11), 岸川幸生8)11), 岩崎雅弘9)11), 紫桃君子10)11), 眞野成康3)11) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2013.

---

	Problem in a consciousness change and the support of the pharmacist in the recovery process local on a day from -P2-305 size scale natural disaster 谷口美保子, 中山和彦, 八木敬子, 江本憲昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2013.

---

	Maintenance of the pharmaceutical products supply system which can inflect at -P2-306 disaster on a day 柴田隼人1)2), 杉野善彦2), 井尾公治1), 大久保貴仁1), 高木省治1), 石川真平2), 酒井欣嗣2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2013.

---

	Relation of the pharmacist for the disaster medical care in our day -P2-307 House 植村太志1), 長谷川徹1), 浦崎圭太1), 伊藤和幸1), 河井和子1), 磯谷聡1), 酒井智彦2), 上山昌史2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2013.

---

	Comparison between a stricken area, the non-stricken areas for a common tool for day -P2-308 disaster and the tool according to the disease 南谷怜亜1), 今西孝至1), 佐々木孝雄2), 高山明1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2013.

---

	The system and problem for the drug grant at the day -P2-309 major earthquake disaster development 戸田康裕1), 松田麻奈1), 福岡智宏1), 柴田久美子1), 土本大輔1), 水谷貴樹1), 宮川佐和子1), 堀尾秀明1), 林浩之1), 宇都宮純平1), 出口裕子1), 神間康1), 小川裕2), 木全勝彦3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2013.

---

	Atmosphere environmental research one year in the day -P2-310 Great East Japan Earthquake later 難波弘行1), 高田秀重2), 鈴木聡3), 江谷勉4), 福島邦博5), 岡野光博5), 佐橋紀男6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2013.

---

	Investigation to examine the present conditions of the university hospital in the investigation and appropriate costs after -P2-311 production sale on a day 有馬秀樹, 篠崎寛一, 日野千恵子, 幸田恭治, 古川裕之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2013.

---

	Action for the base construction of the day -P2-312 Saiseikai combination trial system and the trial enforcement in medical facilities 小森由理子1)2)3)4)5), 高橋一栄1), 和田幸治2), 佐藤透3), 中林真紀4), 福島紘司5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2013.

---

	日-P2-313 The safety of medicine evaluation that we saw from a clinical dose, exposure level and avirulent quantity, exposure level - Antitumor agents (blood cancer (second report)) - 児玉庸夫1), 斉藤和幸2), 小野俊介3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2013.

---

	Examination about the clinical evaluations of the phase I study in the day -P2-314 antitumor agents 川崎尚徳, 荒川基記, 日高慎二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2013.

---

	Role of the CRC in the day -P2-315 anticancer agent phase I study 玉木理衣1), 葛岡美津子2), 山本文2), 野中彩子2), 里内美弥子2), 松本光史2), 根来俊一2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2013.

---

	The subjects entry support in the trial for on a day for -P2-316 24 hours and action to prevention of deviation 山下克也, 林淳一郎, 奥山由佳子, 市下由美, 吉井薫, 宮本美穂, 正代敦子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2013.

---

	Questionary survey to a physician about the trial results reporting to day -P2-317 subjects 川端奈緒美1)2), 三浦佳江1)2), 宇越郁子1), 田邊倫子1), 渡部真紀1), 野津吉友1), 西村信弘2), 直良浩司1)2), 山口修平1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2013.

---

	Examination of the trial secretariat duties efficiency which used -P2-318 iPad on a day 林淳一郎, 奥山由佳子, 山下克也, 高本由紀子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2013.

---

The participation of the pharmacy service under health insurance drugstore in the hypertensive management of patients with hypertension in the day -P2-319 treatment: J-HOME-Morning study 小原拓1)2), 小林由香3), 池田うらら3), 保坂実樹4), 佐藤倫広1), 菊谷昌浩2), 目時弘仁5), 井上隆輔6), 大久保孝義7), 眞野成康1), 栗山進一8), 今井潤4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2013.

---

	Change of rheology properties by the mixture with day -P3-325 salicylic acid vaseline and the cream 吉本晃一, 湯谷玲子, 寺岡麗子, 北河修治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2013.

---

	Effect of the storage temperature to give it to rheological property of the -P3-326 methylcellulose / gellan gum solution and drug controlled release characteristics on a day 下山哲哉, 平田萌, 畠恵梨, 宮城由莉子, 伊藤邦彦, 小林道也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2013.

---

	日-P3-327 Development of the sedative antiphlogistic using an ion pair compound - A preparation and evaluation of the ion pair compound - 石川亜佑美, 内野智信, 宮嵜靖則, 賀川義之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2013.

---

	Properties of matter of the S/O nanoparticles component hospital preparation by the day -P3-328 self emulsification method 射場有沙, 阿部皓一, 芦澤一英, 服部祐介, 大塚誠 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2013.

---

	Effect of the mixture to give to rheology properties of -P3-329 ointment, the gel on a day 東佑輔, 湯谷玲子, 寺岡麗子, 北河修治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2013.

---

	Examination about the adsorption to the filter of the protein ingredient included in day -P3-330 autoserum eye drops 徳田篤志, 柳原良次, 中島克佳, 鈴木洋史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2013.

---

	A preparation and examination of the gelation hospital preparation of day -P3-331 acetaminophen 岩崎友香, 高橋里沙, 村田勇, 井上裕, 木村昌行, 金本郁男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2013.

---

	Effect of the Nepeta japonica component indometacin spray on day -P3-332 hamster stomatitis model 杉山育美, 遠藤智宇, 佐塚泰之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2013.

---

	日-P3-333 Influence of test solution temperature on the disintegration time of the oral disintegrating tablet tester TRICORPTESTER 飯村智也, 八木俊輔, 内田信也, 並木徳之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2013.

---

	Nondestructiveness, non-contact measurement evaluation of the quantity of acetaminophen bougie component drug by the day -P3-334 far-red spectrum and X-rays CT method 大塚邦子1), 内野智裕2), 大塚誠2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2013.

---

	Incompatibility of the Amuro dibottle besylic acid salt preparation in the day -P3-335 simple suspension method and comparison between the preparation 濱田美輝, 峯垣哲也, 若林未稀, 伯井理恵子, 藤井尚子, 湯月翔太, 信太恵理菜, 中島香織, 不破徹, 辻本雅之, 西口工司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2013.

---

	Examination of the pharmaceutics about the preservation stability of the day -P3-336 tulobuterol percutaneous absorption type preparation 山崎啓之1)2), 永田貴文1), 笠文香1), 田口和明1), 瀬尾量1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2013.

---

	Stable examination of the oral preparation in the day -P3-337 looseness state 萩原健弘1), 齊藤早知1), 井戸田陽子1), 崔吉道2), 荻原琢男1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2013.

---

	Examination of the solution condition that -P3-338 Carboplatin changes to cisplatin on a day 藤本亜弓1), 加藤隆児1), 佐藤卓史2), 岡田龍二1), 吉開晶一1), 遠藤幹子1), 井尻好雄1), 三野芳紀1), 林哲也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2013.

---

	Accuracy of the scale in the day -P3-339 central venous hyperalimentation infusion solution bag 奥野靖隆, 安藤崇仁, 永田文恵, 妻鹿宏美, 志村吉徳, 近藤幸男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2013.

---

	日-P3-340 Problem about the proper use of the generic medicine - From bioequivalence - 鈴木謙吾1), 渡辺朋子1), 松尾和廣1), 佐々木英久1), 篠原悦子1), 山形光正2), 吉尾隆1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2013.

---

	It is ... from problem - dispensing fee charges about the proper use of the -P3-341 generic medicine on a day 富永美緒1), 渡辺朋子1), 松尾和廣1), 佐々木英久1), 篠原悦子1), 大谷勇作2), 山形光正3), 吉尾隆1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2013.

---

	Relation of the pharmacist in the day -P3-342 generic drug introduction 堀川侑美, 藤原大, 西村知恭, 吉田薫, 齊藤喜宣, 江崎旬子, 天野賀弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2013.

---

	Convenience of the day -P3-343 generic medicine pharmaceutical company homepage 河野真紀, 武川祥, 和田晶子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2013.

---

	Inflection of G-DAT in the generic medicine choice of the day -P3-344 ethical pharmacy 渡邉啓子1), 島田和彦2), 杉原陽子3), 高橋健二4), 寺下真人5), 高橋千恵子4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2013.

---

	Effect examination on the occasion of changes from starting pharmaceutical products of day -P3-345 doxazosin to generic medicine 福原千津1), 小林江梨子1), 大庭千夏2), 秋山和映2), 入江康文3), 佐藤信範1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2013.

---

	It is ... for a case by the comparison of 2 products for relation ... vancomycin hydrochloride infusion of the pharmacist in the day -P3-346 generic medicine adoption examination 菊地麻希, 新井克明, 清水範子, 須藤寛, 真家佑介, 杉山奈津子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2013.

---

	Examination of active ingredient elution properties in the day -P3-347 ketoprofen patch generic drug 及川みのり1), 佐藤淳也1)2), 高橋勝雄1), 藤原邦彦3), 工藤賢三1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2013.

---

	Quality evaluation using GC/MS of the day -P3-348 ethyl icosapentate preparation 常風興平, 船戸裕樹, 横田淳子, 吉岡三郎, 宮村充彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2013.

---

	日-P3-349 Inspection of the bioequivalent validity of examining it for adult subjects healthy with a high-dose psychotropic drug - Examination in Pramipexole - 松木俊二1), 小川幸司2), 名取和一2), 松隈京子1), 田中明日香1), 渡辺聴正1), 樋口朋恵1), 木村美由紀1), 入江伸1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2013.

---

	Epicritic evaluation (the eighth report) of the day -P3-350 tablet, capsule body 中野敬子, 渡辺亜衣子, 太原舞衣, 添田真司, 渡邊昌之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2013.

---

	Examination about the antiinflammatory effect of the ketoprofen patch using the day -P3-351 carrageenan induction sole of the foot edema model 河野倫也1), 杉山哲也1), 坂本靖宜1), 島田亜由美1), 寺島朝子1)2), 渡辺裕子1), 前沢佳代子1), 木津純子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2013.

---

	We estimate -P3-352 ward permanent residence as the change of ward drug duties by becoming it on a day 赤坂寛子, 明谷早苗, 但馬慶子, 先崎健造, 井原加代子, 関恭子, 溝口貴幸, 長田知子, 鹿間良弥, 小川忠明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2013.

---

	Outcome investigation by the pharmacist before and after the start of day -P3-353 ward drug duties 鈴木正論, 桝田浩司, 松本早矢香, 永井淳子, 佐々木忠徳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2013.

---

	Participation in planning ... to medical treatment by the discussion with development - physician of the ward drug duties in our day -P3-354 House 町田聖治, 曽我弘道, 富田敏章, 福島将友, 前田朱香, 清水誉志, 川井友美子, 岸川春樹, 細川秀則, 入江利行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2013.

---

	Inspection of the duties contents of the ward drug duties in our day -P3-355 House 大久保純, 田中真衣, 山谷香織, 森田真裕子, 池崎友明, 竹内都子, 北澤英徳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2013.

---

	Action to conduct -P3-356 ward drug duties effectively on a day 池森明, 長井昭人, 木藤一美, 平岡陽一, 橋本隆信 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2013.

---

	The present conditions investigation of ward drug duties in the day -P3-357 country verge medical care welfare University Mita Hospital and the future prospects 前田恵里子1), 足高有理子1), 岩田杏子1), 竹井麻衣2), 細山寛代1), 高野あすか1), 藤田弥生1), 坂入由貴1), 中村裕義1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2013.

---

	Effect on construction and prescription adequacy of the ward drug duties in the hospital attached to the day -P3-358 Mie University School of Medicine 杉本浩子, 村木優一, 角里恵子, 世古口典子, 高崎美和, 石橋美紀, 山田真帆, 佐々木典子, 岩本卓也, 奥田真弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2013.

---

	Day -P3-359 [evaluation after the ward drug duties enforcement addition acquisition start] 新垣愛, 浜元善仁, 翁長真一郎, 比嘉保 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2013.

---

	Action to the ward drug duties enforcement addition calculation in our day -P3-360 House 高木雄一, 新田純加, 奥田隆史, 佐野邦明, 上野正夫, 松本富夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2013.

---

	日-P3-361 The enforcement situation and problem of ward drug duties in the Gunma Chuo General Hospital (1) - Efforts to intelligence for effective drug history grasp - 大熊範和, 小材直人, 田子尚史, 小保方浩子, 村田文, 森田淳介, 山畑幸子, 國分真理, 新木美枝, 飯塚博子, 田子加代子, 伊藤典子, 山賀章一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2013.

---

	日-P3-362 The enforcement situation and problem of ward drug duties in the Gunma Chuo General Hospital (2) - Through pharmaceutical intervention - 小材直人, 大熊範和, 田子尚史, 小保方浩子, 村田文, 田子加代子, 伊藤典子, 山賀章一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2013.

---

	System construction and present conditions analysis to the day -P3-363 ward duties enforcement addition 和田淳, 山中知恵子, 今泉有希, 神山三佳, 東碧, 山下彰良, 荒井久暢, 武田智子, 村山佳子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2013.

---

The thing that -P3-364 perfection outside Parliament was seen in the point of becoming it on a day? Development and evaluation ... of the ward duties mainly on ... bringing medicine differentiation duties 平松久典, 中根茂喜, 中田吉則, 田中章郎, 百合草憲勇, 渡辺貴志, 佐藤美砂, 成田麻理子, 安田早織, 山口智江, 宮原兼二, 万塩倫子, 多和田陽子, 永田和裕, 渡久川敦子, 栗原康彰, 長谷川功 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2013.

---

	Action to promote -P3-365 ward drug duties on a day 今高多佳子, 田宮真一, 鈴木雅人, 木全司, 佐々弥栄子, 荒木憲昭, 中村正史, 鈴木育郎, 青山智彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2013.

---

	Approach to the actual situation and the problem solution to ward drug duties in the day -P3-366 Mazda hospital 西原昌幸, 原田靖子, 内海敦志, 矢吹尚子, 西倉教子, 大成綾子, 福長豊己 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2013.

---

	Change of the pharmaceutical intervention after the day -P3-367 ward drug duties enforcement addition new establishment 杉尾和昭, 小林加寿子, 増田雅行, 佐野君芳, 真坂亙 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2013.

---

	We introduce the invention of our House to conduct ward drug duties while maintaining -P3-368 ward drug instruction on a day 市川騰1), 平岩知子1), 市川敬太2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2013.

---

Ward drug duties investigation in the association of day -P3-369 Japanese private medical college chief pharmacist 2012 pharmacist practitioner workshop participation institution hosted by a meeting 鍵山智樹1), 篠原克典1), 真壁秀樹2), 永野浩之2), 新井成俊3), 唐澤匠太3), 高橋喜統4), 伊藤好夫5), 高木雄一6), 北澤貴樹2)8), 福原純一郎3)8), 西尾浩次4)8), 越川千秋5)8), 松本富夫6)8), 片山志郎7)8), 二神幸次郎7)8), 岸野亨1)8) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2013.

---

	Other types of job satisfaction investigation about day -P3-370 ward drug duties 青柳和代, 丸山寛貴, 姫野友紀子, 岩田真子, 高橋克栄, 川端良徳, 清水靖, 星初美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2013.

---

	It is action ... to ... injection drug prescription for the further improvement of day -P3-371 ward drug duties 西谷友紀, 久岡清子, 合田さやか, 佐々木健志, 古島彩代, 川上尚美, 植谷未稀, 間千晴, 亀岡喬, 鹿沼奈央, 足立雅, 盆子原唯, 力武舞, 川村大輔, 土師久幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2013.

---

	The action that fixed its eyes on the -P3-372 ward drug duties enforcement addition on a day 中平桂子, 五十嵐真祐, 吉田厚志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2013.

---

	Ward drug duties in the day -P3-373 Mita Municipal Hospital 矢野有里子, 藤田一弘, 勅使河原眞也, 森美樹, 田中佳江, 酒井宏徳, 岡本和久, 石本ユミ, 吉川昌志, 櫻井美由紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2013.

---

	日-P3-374 Outcome evaluation of ward drug duties in the Fujimi Heights Hospital - An evaluation about the medical security and physician, nurse questionnaire findings - 大倉輝明1), 吉田明日香2), 丸山昌孝2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2013.

---

	日-P3-375 Efforts to ward drug duties - Construction of "the prescription checking system" - 木村麗砂, 日浦寿美子, 横井妙子, 加藤裕芳, 浅山亨 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2013.

---

	日-P3-376 Attitude survey of the pharmacist by the ward drug duties enforcement addition introduction in Kinki District (1) - Effect of the institution background - 波多江崇1), 志方敏幸1), 長谷川豊1), 依藤健之介3), 西濱輝美4), 金啓二5), 福井利文6), 西田英之7), 但馬重俊8), 濱口常男1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2013.

---

日-P3-377 Attitude survey of the drug by the ward drug duties enforcement addition introduction in Kinki District (2) - Judgment factorial experiments of "the need of the physical assessment" - 依藤健之介1)2)3)4)5)6)7)8), 西濱輝美2), 志方敏幸3), 長谷川豊4), 波多江崇4), 金啓二5), 福井利文6), 西田英之7), 但馬重俊8), 濱口常男4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2013.

---

	日-P3-378 Attitude survey of the pharmacist by the ward drug duties enforcement addition introduction in Kinki District (3) - "Smooth duties" and the factorial experiments that we judged - 西濱輝美1), 志方敏幸2), 長谷川豊3), 依藤健之介4), 波多江崇3), 金啓二5), 福井利文6), 西田英之7), 但馬重俊8), 濱口常男3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2013.

---

日-P3-379 Attitude survey of the pharmacist by the ward drug duties enforcement addition introduction in Kinki District (4) - The factorial experiments that we judged "to be able to contribute to team approach in medical care" - 志方敏幸1), 長谷川豊2), 依藤健之介3), 西濱輝美4), 波多江崇2), 金啓二5), 福井利文6), 西田英之7), 但馬重俊8), 濱口常男2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2013.

---

	日-P3-380 Attitude survey of the pharmacist by the ward drug duties enforcement addition introduction in Kinki District (5) - The factorial experiments that we judged "to lead to skill up" - 長谷川豊1), 依藤健之介2), 西濱輝美3), 志方敏幸4), 波多江崇1), 金啓二5), 福井利文6), 西田英之7), 但馬重俊8), 濱口常男1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2013.

---

	An action and problem of day -P3-381 ward drug duties 内田佳菜子, 袴田仁美, 伊予田萌子, 小林誠一, 岩佐桂子, 長嶋一泰, 坂口修治, 足立孝, 山下敦志, 菅野和彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2013.

---

	Ward drug duties in the day -P3-382 Chikamori Hospital 橋田能明, 北本知子, 中野克哉, 筒井由佳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2013.

---

	A process and outcome until a calculation start of the day -P3-383 ward drug duties enforcement addition 長谷川晃一, 若林薫, 鈴木知則, 南武夫, 清水淳一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2013.

---

	Premeditated introduction of day -P3-384 standard ward drug duties 吉本久子, 幸田恭治, 植松俊成, 原田元, 渡邊正規, 長澤悠子, 廣實清司, 内田豊, 古川裕之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2013.

---

	Attitude survey ... of action ... ward staff to the day -P3-385 ward drug duties enforcement addition 角田健, 小室治孝, 喜古康博, 宇田川雅子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2013.

---

	The activity of the -P3-386 pharmacist aims at the team approach in medical care having high ... contribution degree with the prospective ward duties on a day; and ... 小川衣里1), 徳永仁2), 甲斐晃弘1), 黒木教彰1), 興梠靖幸1), 田中恵美1), 岩瀬祥枝1), 橋口志帆1), 高村徳人2), 千代反田晋3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2013.

---

	The investigation of day -P3-387 ward drug duties and future problem 足岡秀樹, 石倉優子, 飯塚和文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2013.

---

	The present conditions of the ward drug duties in our day -P3-388 House and future problem 高橋成博, 鈴木光幸, 須佐充, 内坪誉歳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2013.

---

	The present conditions of the ward drug duties in our day -P3-389 House 川崎美紀, 早野絢子, 平田千賀子, 田代ともみ, 中野愛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2013.

---

	Representation input such as action ... commuter pass prescription to the ward drug duties in the day -P3-390 medical treatment ward and pharmaceutical management ... 小松めぐみ, 高崎彩, 山科あかね, 中川雄介, 田所美和, 吉岡りえ, 市吉真貴子, 八木亜紀子, 田中照夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2013.

---

	Action in the model ward for the day -P3-391 ward drug duties enforcement addition calculation 安尾哲郎, 野崎皓子, 渡辺麻里子, 滝波昇悟, 監物英男, 今村明正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2013.

---

	Action to day -P3-392 ward drug duties 加納茉里1), 西村富啓1), 森達也1), 宮下久徳1), 久保田篤司1), 井出泰男1), 鈴木義彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2013.

---

	The ward drug duties enforcement situation in the day -P3-393 Kumamoto re-spring Zhuang Hospital 小園亜希1), 千場美奈1), 山部美千子1), 水町純一1), 竹内小百合1), 畑田万紀子1), 花田聖典1), 鶴崎泰史2), 浦本邦弘1), 中川義浩1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2013.

---

	日-P3-394 Commitment to safe use of the burden and pharmaceuticals such as a doctor : Remaining number management of drugs brought and agency input of continued prescription 田中照夫, 高崎彩, 山科あかね, 中川雄介, 田所美和, 吉岡りえ, 市吉真貴子, 八木亜紀子, 小松めぐみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2013.

---

	日-P3-395 The present conditions and problem of the ward drug duties enforcement addition in Saitama - Than the questionnaire findings in the addition calculation 46 institution - 北畑智英, 新井隆広, 木村直也, 小林万也孝, 篠塚一美, 多田幸子, 中田淑子, 矢島美友紀, 山内雅夫, 中澤道宣, 相澤鉄也, 堀口久光 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2013.

---

	Realization and problem ... of the ward drug duties in all wards by the ward drug duties (1) - duties improvement in the day -P3-396 Sendai public welfare Hospital 本田弘1), 武田真美1), 田中清隆1), 中島繁美1), 鎌田恵美子2), 菅原俊一1)3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2013.

---

	Construction ... of the ward drug log book simple input system using ward drug duties (2) - Microsoft Office Excel in the day -P3-397 Sendai public welfare Hospital 武田知明1), 本田弘1), 中島繁美1), 菅原俊一1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2013.

---

	Relation ... of the pharmacist for the hypocalcemia prevention by ward drug duties (3) - denosumab in the day -P3-398 Sendai public welfare Hospital 遠藤真理1), 佐藤亜希1), 本田弘1), 中島繁美1), 菅原俊一2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2013.

---

	About the intervention effect by -P3-399 pharmacists having always attended the place of the prescription instructions of the ward on a day 木村俊也, 阿部理映, 大北麻友美, 池滝瞳, 黒畑美津枝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2013.

---

	Securing of quality of the medical therapy by the introduction of the day -P3-400 ward drug duties sheet 大木稔也1), 宮崎美子2), 庄野あい子3), 今井博久4), 佐藤秀昭1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2013.

---

	日-P3-401 Examination about consultation meeting a demand, the inquired contents in ward drug duties - Examination of the contents in approximately several system shifts in the circulatory organ ward - 腰岡桜, 佐村優, 内田仁樹, 川名絢子, 関根寿一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2013.

---

	Action about the improvement of the clinical practice in day -P3-402 ward duties vs. the stress 佐村優, 倉田武徳, 廣瀬直樹, 鯉淵寛之, 山口直子, 小川寿子, 関根寿一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2013.

---

	Effect analysis to the medical security that -P3-403 ward drug duties result in on a day and the evaluation 川名賢一郎1), 河野友昭1), 尾関理恵1), 大出幸子2), 後藤一美1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2013.

---

	Ward drug duties and outcome to the long-term inpatient in the day -P3-404 medical treatment ward 大森章子, 青山智子, 三原由加里, 上岡弥生, 熊野晶子, 大谷知子, 樋口真美, 賀勢泰子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2013.

---

	It is an action of becoming it the ward pharmacist permanent residence in the -P3-405 pediatric ward on a day 清水啓道, 本多秀俊, 大野能之, 長瀬幸恵, 鈴木洋史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2013.

---

	Trial of the duties burden reduction of the day -P3-406 physician and the Do prescription input by the ward exclusive duty pharmacist for the purpose of the safety improvement 河合知喜1), 橋本恵美奈1), 高橋有1), 吉田優子1), 尾上雅英1), 米澤淳1), 藤本康弘2), 上本伸二2), 松原和夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2013.

---

	Relation to bringing medicine management and the medication plan by the day -P3-407 ward permanent residence pharmacist 寺沢匡史, 數野智恵子, 坂本愛, 山下朋子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2013.

---

	Ward duties ... evaluation and improvement ... in the day -P3-408 Shimmatsudo Chuo General Hospital 大久保淑子, 叶内至, 大野弘貴, 田中統子, 坂井安希子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2013.

---

	Action of the ward permanent residence of the pharmacist in the day -P3-409 Saga Hospital 近藤讓, 東島幸道, 渡辺健二, 鶴崎泰史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2013.

---

	Action of ward drug duties in the day -P3-410 digestive organ medical service 清水誉志, 新治嘉一, 平野真健, 福島将友, 長谷悠紀, 山口静, 下河辺安妃子, 小田原由香, 岸川春樹, 細川秀則, 入江利行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2013.

---

	The present conditions of the ward duties that we saw from pre-Abo id report in the -P3-411 Shimane Prefectural center Hospital on a day 尾崎俊幸, 新山哲央, 金子奈緒美, 園山智宏, 横手克樹, 平野榮作, 後藤澄子, 岩成治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2013.

---

	The need of ward drug duties judging from day -P3-412 pre-Abo id report 三代朗子, 茂亨嘉, 沖島由季, 佐藤智加子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2013.

---

	Ward activity evaluation judging from the trial of day -P3-413 ward drug duties and pre-Abo id example 中井優作, 八代哲也, 小牟田豊, 辻本亜理沙, 衛藤広士, 田代真理子, 古谷真依子, 濱口健一, 泉川博子, 福田晴美, 北川有希, 村中宏一, 東海秀吉 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2013.

---

	Inspection of the pre-Abo id example report in our day -P3-414 House 喜多洋嗣, 喜多幸子, 高見藍, 渡部真哉, 北村知子, 仲村亮太, 土本理恵, 駒井勇太, 岡野紘子, 小松祐輔, 潮平沙貴, 田中紋乃, 花見祐子, 人見百合子, 村瀬友香, 儀間美乃里 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2013.

---

	Analysis ... of a change and report contents of the number of contribution ... pre-Abo id reports to the patients security of the ward pharmacist with the day -P3-415 ward drug duties enforcement addition calculation 上村忠聖, 鈴木信也, 関山正夫, 安藤栄輝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2013.

---

	Making ... of the role (16) - ward drug duties check seat of the pharmacist in the day -P3-416 team approach in medical care 瀬名波宏昌1), 名徳倫明2), 冨田由美1), 村山洋子1), 中西晶子1), 岩本千晶1), 田河みゆき1), 小西史子1), 畑暁子1), 小角麻衣1), 小畑紋菓1), 川口進一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2013.

---

	Relation of the pharmacist in day -P3-417 respiratory organs internal medicine rounds 宍倉啓介, 根岸真利子, 小高佑美菜, 岡野芳彦, 相曽啓史, 野地良子, 小竹慶子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2013.

---

	About the fact-finding of the drug-related duties of the ward in the day -P3-418 IHI Harima Hospital 小野達也1)3), 笹山貴央2), 長谷川豊2), 石田詞子1)3), 西田英之1), 濱口常男2), 徳山尚吾3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2013.

---

	Pharmaceutical products proper use promotion effect to patients with impaired renal function by the day -P3-419 ward exclusive duty pharmacist 樋口則英, 坂元利彰, 佐藤加代子, 安藝敬生, 有吉貴美代, 嶺豊春, 北原隆志, 佐々木均 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2013.

---

	While listening to the story of a protector, the patients in ... pediatric ward for the ad here Lance improvement in -P3-420 children on a day; ... 都築はる奈1), 柳橋秀行1), 星野知子1), 大竹美恵子1), 西村秀子2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2013.

---

	About the ward drug duties in the day -P3-421 obstetrics and gynecology department single department ward and the change 乾有希子, 野村浩英, 池田久雄, 森真由子, 平田貴宏, 宮麻紀子, 牧秀美, 松元麻美, 畑中勝義 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2013.

---

	Inspection of the chart about day -P3-422 ward drug duties 新井亘, 大島聡子, 増田裕一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2013.

---

	Prevention effect of the incident occurrence by the introduction of day -P3-423 ward drug duties 鈴木洋子1), 庄野あい子2), 大山恵子3), 竹内由美3), 今井博久4), 佐藤秀昭1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2013.

---

	Correspondence and intervention example report of the pharmacist in day -P3-424 ward drug duties 坂本和央1), 森山真実1), 伊藤桂子1), 岡野翔1), 速水章一1), 大江利治2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2013.

---

	Action for the ward drug duties enforcement using the technique of the day -P3-425 TQM 松本勝城, 高橋浩子, 鈴木美和, 冨田道夫, 小西裕二, 坂本拓也, 井上優子, 山田智栄子, 鈴木美奈, 中村雄一, 嶋田恵, 奥田和貴, 松田俊之, 福澤祐幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2013.

---

	Possibility of contribution to physician duties burden reduction by the day -P3-426 administration finished prescription representation input and the medical quality improvement 高橋怜史, 枝廣茂樹, 大川浩子, 岡田睦子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2013.

---

	Construction and use of the day -P3-427 ward drug log book system 松原慎, 山路和彦, 村川公央, 北村佳久, 千堂年昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2013.

---

	Pharmaceutical care report about the day -P3-428 prescription suggestion 浅井倫子, 伊藤和幸, 松下直樹, 石原彩, 水野めぐみ, 一木万奈美, 植村太志, 加藤美香, 鵜飼泰夫, 藤川景子, 長谷川徹, 久田純生, 河井和子, 磯谷聡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2013.

---

	Standardization of the prescription suggestion using the list of alternative agents of the day -P3-429 bringing medicine 長橋かよ子, 田中裕子, 生野万里子, 高橋由季, 坂本麻衣, 中谷公美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2013.

---

	Action for the drug control instruction intervention rate increase to the drug application patients for the day -P3-430 medical care 松澤直樹1), 神田博仁1), 百瀬泰行2), 山折大1), 大森栄1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2013.

---

	Action to the joint rounds with the emergency comprehensive medical care part in our day -P3-431 House 喜多洋嗣1), 喜多幸子1), 高見藍1), 渡部真哉1), 北村知子1), 仲村亮太1), 土本理恵1), 駒井勇太1), 岡野紘子1), 小松祐輔1), 潮平沙貴1), 田中紋乃1), 花見祐子1), 人見百合子1), 村瀬友香1), 儀間美乃里1), 比嘉信喜2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2013.

---

	Action of the postoperative round by the day -P3-432 operating room pharmacist 上野幸佑1), 宇埜可南子1), 山原慶子1), 小林由佳1), 小泉祐一1), 野村真美1), 福喜多邦夫2), 中澤直2), 十河大悟2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2013.

---

	The pharmacist intervention about receipts and payments duties of the drug to use in -P3-433 surgery center on a day and the effect 中村和行1), 久保田敏行1), 万塩裕之1), 荒川麻紀子1), 米山英二1), 吉田浩1), 勝見章男1), 岡田密恵2), 佐伯悟三3), 八田誠4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2013.

---

	It is ... for more appropriate medical treatment after examination - hospitalization about the usefulness of by to the -P3-434 surgery reservation patients hospitalization front and the medicine medicine cooperation on a day 瀧祐介, 岩水陽子, 小柳愛子, 山城博和 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2013.

---

	About an action to effective collection and information communalization of the day -P3-435 inquiry doubt inquiry 豊田真史, 若林千草, 益子里美, 佐山千春, 植田生織, 内藤梨奈, 川迫睦美, 松本麻美, 秋本円香, 木村絢果, 川島千夏, 太田和歌, 清宮麻美, 深瀬優子, 和貝直亮, 栗原康広, 遠藤れい子, 岡部佳郎, 川崎寛一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2013.

---

	Examination of the pharmaceutical intervention in the ward-related duties that we saw from age and the sex of -P3-436 physician and the pharmacist on a day 植木哲也1)4), 坂本佳子2), 長井惠子2), 山田真貴1), 中嶋弥穂子3), 中嶋幹郎4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2013.

---

	About usefulness of the autoregulation pain relief by the day -P3-437 psycho status of patient 伊藤千裕1)2), 坂倉裕佳1), 薄井健介1)2), 井上岳1)2), 柏木政憲3), 松原肇1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2013.

---

	It is ... for prescription review and prescription suggestion ... appropriate medical therapy by the pharmacist at the -P3-438 change ridge on a day 川上尚美1), 久岡清子1), 合田さやか1), 古島彩代1), 佐々木健志1), 西谷友紀1), 植谷未稀1), 間千晴1), 亀岡喬1), 鹿沼奈央1), 足立雅1), 盆子原唯1), 力武舞1), 川村大輔1), 土師久幸1), 吉村隆喜2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2013.

---

	Approach> in base construction <model ward of the ward drug duties in the day -P3-439 cranial nerve unit 小川敦1), 村川公央1), 眞鍋博明2), 星野美帆3), 小野佳子3), 前川珠季4), 定金典明1), 北村佳久1), 伊達勲2), 千堂年昭1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2013.

---

	Examination of the usefulness of the resident pharmacist placement in day -P3-440 blood, the tumor medical service 折山豊仁, 大野能之, 山本武人, 奈良克彦, 山口諒, 城山亮輔, 長瀬幸恵, 鈴木洋史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2013.

---

	Investigation ... about renal function and the drug dose of patients with examination - on admission bringing medicine for need management enforcement of the drug dose adequacy for patients with day -P3-441 decreased renal function 小林豊, 吉岡雅代, 中川由里可, 井尻真理子, 増田朋弘, 青木洋史, 北村修 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2013.

---

	Relation of the pharmacist in the day -P3-442 2 days and 1 night PCI critical path 古井恵美, 為保樹理, 今関孝子, 加藤武司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2013.

---

	Investigation about the medication confirmation of the antithrombocytic agent before the day -P3-443 cardiac catheterization 石原裕介, 森山史就, 島田杏子, 横手克樹, 安食健一, 園山智宏, 平野榮作, 後藤澄子, 岩成治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2013.

---

	Intervention and result of the pharmacist for the glucose tolerance follow-up at the day -P3-444 non-fixed form antipsychotics prescription 坪内清貴1), 菅幸生2), 田平裕美子1), 増江俊子1), 武淵裕貴1), 前田大蔵1), 崔吉道1), 宮本謙一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2013.

---

	For development and the luck of the medication explanation support application for the tablet type terminal for day -P3-445 children and the refinement 永井絵里子1), 初田泰敏2), 後藤真千子3), 小川雅史2), 室井政子4), 石川照久1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2013.

---

	About the present conditions of day -P3-446 Hospital and the medicine notebook in the health insurance pharmacy 佐藤知香1), 横田学2), 田中麻衣子1), 友滝和人1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2013.

---

	An action and job evaluation of the day -P3-447 tumor center ward permanent residence pharmacist 陶山登之, 玉木宏樹, 井上昌樹, 小村直之, 西村信弘, 直良浩司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2013.

---

	Examination - second report ... about the vial surface pollution of the day -P3-448 anticancer medicine (injection) 吉田昭昌1), 高見陽一2), 森近俊之1), 窪田千春2), 山西誠人2), 若狭愛子2), 島田憲一2), 江川孝2), 松久哲章1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2013.

---

	A very small amount of analysis of an ampoule of the day -P3-449 anticancer agent 5-FU (5-FU) parenteral injection and the vial surface pollution 窪田千春1), 冨田順子1), 高見陽一郎1), 青山満理奈1), 冨重麻沙希1), 山西誠人1), 若狭愛子1), 島田憲一1), 吉田昭昌2), 森近俊之2), 五味田裕1), 松久哲章2), 江川孝1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2013.

---

	Internal use instruction of the day -P3-450 vitamins Kay two and questionnaire survey about the compliance 横山雅子1), 上村信江1), 鈴木晶子1), 阪口悟志1), 川嵜英二1), 松田俊之1), 笠井こずゑ3), 瀧谷樹美3), 松井美優2), 飛彈麻里子2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2013.

---

	Case ... that participation of mesylic acid nafamostat was suggested as a cause of confirmation - dialysis-related fever of the side effect based on the state observation of the -P3-451 patients on a day 坪谷綾子1), 松本浩1), 濱野公俊1), 奥平毅1), 坂下裕子1), 金城永幸2), 横山健2), 今野雄介2), 増原慶壮1)3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2013.

---

	Study on biological drug in day -P3-452 rheumatoid arthritis treatment and body function evaluation 浅井和範1), 沢田亜幸2), 外石昇3), 伊勢馬場美香3), 千葉純司4), 神戸克明4), 渡邉一則3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2013.

---

	One patient who introduced patients hair blunder in (R) subcutaneous injection with the -P3-453 double vision on a day 近藤あゆみ1), 中尾直樹2), 築山郁人1), 松浦克彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2013.

---

	About a dose design through the blood level measurement of the day -P3-454 pilsicainide and the subsequent course 村中美香, 福田結彩, 濱崎浩一, 大野静子, 久賀谷幸昌, 福澤正隆, 竹田克明, 前田頼伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2013.

---

	Pharmaceutical intervention in the heart failure center for patients with day -P3-455 chronic cardiac insufficiency 櫻下弘志1), 増田有紀1), 林華代1), 畝井浩子1), 佐伯康之1), 北川知郎2), 木阪智彦2), 内田直里3), 田代尚範4), 天野加奈子5), 水川真理子6), 木村康浩1), 木原康樹2), 木平健治1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2013.

---

	Active participation of the ward pharmacist for day -P3-456 treatment patients with difficult ulcerative colitis 木村詩愛, 松谷洋, 上田華昌子, 石本敬三 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2013.

---

	Qualitative evaluation of the ward drug duties that assumed the pharmaceutical intervention for drug interactions of -P3-457 rifampicin an index on a day 吉田優子, 米澤淳, 河合知喜, 杉本充弘, 山際岳朗, 土生康司, 矢野育子, 松原和夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2013.

---

	The effect that the involved site of patients with -P3-458 cerebrovascular disorder gives for medication self-discipline on a day 藤原久登1)2), 向後麻里1)3), 田中絵里子2), 大川桂子2), 泉真由美2), 渡邊徹1)5), 齋藤勲1)6), 和田真一7), 水間正澄7), 野村茂2), 竹ノ内敏孝2)3), 村山純一郎1)4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2013.

---

	Relation of the pharmacist at triple-drug therapy introduction including the day -P3-459 terra pre-building 小池慶子, 柳沼妙子, 町支優和, 鈴木利規, 森章典, 西井玲奈, 石田隆浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2013.

---

	Investigation about the drug-related sharp pain to develop in the use of -P3-460 azacitidine patients on a day 田中広大, 山脇まり絵, 井西千香, 川田敬, 下内由加里, 橋田真佐, 高平豊, 宮本典文, 山本創一, 服部暁昌 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2013.

---

	Examination of the drug control instruction duties contents which cooperated with -P3-461 NST on a day 中村新, 留守克之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2013.

---

	Correlation of the necessary amount of energy and quantity of in the TPN of day -P3-462 elderly people protein 杉浦健一, 松本佑美, 大貫敏明, 安田麻美, 浅井浩子, 高橋優香, 岩佐典子, 藤岡敬子, 中村友美, 布施智子, 松木祥彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2013.

---

	NST activity - study session report (the second report) ... of the pharmacist in the day -P3-463 area 山岡和幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2013.

---

	An action for the proper use of the day -P3-464 lipid microsphere and the evaluation 八木仁史1)2)3), 向後麻里1)2), 氏家秀太2)3), 宮本渚2)3), 佐藤千秋3), 加藤信明3), 林誠3), 竹ノ内敏孝2), 村山純一郎1)4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2013.

---

	About prescription checking significance of the day -P3-465 lipid microsphere rate of application 深水知英, 中目順子, 柴田由香里, 松元一明, 下堂薗権洋, 池田龍二, 武田泰生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2013.

---

	For promotion and adequacy of the day -P3-466 lipid microsphere use 森住誠, 井上博之, 松宮美沙, 吉田絵美香, 池田理沙, 池原茉理, 坂本千代子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2013.

---

	Fact-finding about the rate of application of the lipid microsphere in our day -P3-467 House 坂本亜沙美, 渡邊悦富, 井上光鋭, 三輪涼子, 鶴田美恵子, 佐田通夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2013.

---

	Usefulness of the Hangebyakujutsutemmato in the inappetence case after the day -P3-468 brain surgery 矢野とおみ, 新沼佑美, 佐藤このみ, 加茂陽子, 阿部誠也, 関さやか, 栗村淳子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2013.

---

	Examination of the risk factor to result in the onset of the -P3-469 Refeeding syndrome on a day 松田純和1)2), 木明貴幸2), 比嘉耕基2), 武田契巳2), 早坂敬明1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2013.

---

	An example of the nourishment management in the day -P3-470 both thighs amputee 吉田愛1), 山室蕗子1), 園田亮子2), 浦田享子2), 松尾彰宜2), 櫨川岩穂2), 末吉栄志1), 近藤元三1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2013.

---

	日-P3-471 Evaluation of the ward drug duties in the psychopathic ward - The consultation situation of the healthcare worker and the meeting a demand situation of the exclusive duty pharmacist - 脇元一彰, 進健司, 梅田勇一, 大谷達郎, 牛島悠一, 内田守次, 竹本伸輔 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2013.

---

	日-P3-472 Evaluation of the ward drug duties in the psychopathic ward - Evaluation of prescription suggestion, the side effect discovery situation and the physician by the exclusive duty pharmacist - 進健司1), 梅田勇一1), 脇元一彰1), 大谷達郎1), 牛島悠一1), 久保陽平1), 内田守次1), 竹本伸輔1), 神村英利2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2013.

---

	It is examination ... from the analysis of ... inquiry example about usefulness of the pharmacist placement to -P3-473 psychopathic ward on a day 栗原梢, 瀧祐介, 日下豊史, 岩水陽子, 小柳愛子, 後藤貴裕, 安藤奈津子, 山城博和 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2013.

---

	DIPESS introduction and prescription investigation by the day -P3-474 pharmacist 金子幸弘, 磯部浩之, 亀川綾, 最上雄史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2013.

---

	The present conditions of bringing medicine, the patient related consultation medicine administrative work in our day -P3-475 House 和田智仁1), 木村郁子1), 伊藤由香1), 羽佐田祥浩1), 伊藤直美1), 藤田康平2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2013.

---

	日-P3-476 Prescription investigation about the medical therapy of patients with dementia - Report by Sapporo-shi and the meeting of the suburban mental hospital duty pharmacist - 山本勇樹1), 笠原真理2)8), 齋木良太3)8), 林昂子4)8), 白井博2)8), 林一美5)8), 高橋満里6)8), 小林貴幸3)8), 石動郁子7)8) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2013.

---

	Examination of the clinical usefulness of the side effect evaluation using the day -P3-477 self-entry-style physical symptom check sheet 安部一秀1), 池本桂子2), 沓沢有希子2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2013.

---

	Examination about the relations of a drug and a fall, the fall in patients with schizophrenia during day -P3-478 mental hospital hospitalization 中居香織1), 中居肇2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2013.

---

	Survey of the minor patients in the mental hospital of the single department of the day -P3-479 child psychiatrist absence 中川伴子, 宮本奈緒美, 川端智美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2013.

---

It is association ... with the onset of delirium after relation ... bringing medicine of the pharmacist in the -P3-480 delirium measures team and patients background and an operation on a day 村川公央1)3), 本郷志帆2), 四宮一昭2), 土山璃沙3), 馬場華奈己3), 小田幸治3), 井上真一郎3), 伊藤真理3), 足羽孝子3), 矢尾和久1), 北村佳久1), 千堂年昭1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2013.

---

	About fact-finding of the medication situation of the antidepressant in patients with day -P3-481 depression 蜂須賀美沙子1), 澤田健作1), 小野沙百合1), 伊藤秀輝1), 半谷眞七子1), 亀井浩行1), 岩田仲生2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2013.

---

	Questionary survey about the actual situation of the medication counseling and the mental burden on patients with the mental disorder for pharmacists of the day -P3-482 health insurance pharmacy 坂本修1), 小杉三弥子1), 小田原俊成2), 平安良雄1)3), 橋本真也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2013.

---

	The intervention by the team for dysphagia of patients with day -P3-483 dementia and change of the antibiotics consumption 島田治子1), 小嶺京子2), 工藤早紀1), 扇有紀1), 藤井曜子1), 小川正子1), 中村賢広1), 山口尚子1), 長畑葉子3), 山本美保3), 山口直子3), 坂井孝行2), 本上友理香2), 岩永千恵美4), 土井健志1), 原田均1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2013.

---

	Trial of the medication counseling for patients with mental disorder using the day -P3-484 tablet type information terminal 福山雄卯介1), 後藤史子1), 鈴田浩孝2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2013.

---

	We report medication counseling of -P3-485 mirtazapine about enforcement that we use iPad-mini on a day 成井繁 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2013.

---

	Effect on prolactin level in day -P3-486 antipsychotics 五味和彦1)2), 酒井晶子1), 樋口宗裕1), 重盛由文1), 羽場昇1), 樋掛忠彦2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2013.

---

	About the blood level measurement of patients with day -P3-487 lithium carbonate remedy 後藤史子1)2), 福山雄卯介1), 上釜恭子1), 鈴田浩孝2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2013.

---

	Search of the blood lamotrigine levels change factor of patients with day -P3-488 bipolar disorder 寺澤美穂1), 山折大1), 勝山善彦1), 丸山順也1)2), 北山美乃里3), 市川かおり3), 田中章3), 荻原朋美3), 杉山暢宏3), 鷲塚伸介3), 大森栄1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2013.

---

	It is a 1 case of treatment-resistant schizophrenia receiving lithium carbonate and the adenine for leukopenia with -P3-489 clozapine on a day 濱田武1), 鈴木薫1), 西原雅美1), 勝間田敬弘1), 西口昌樹2), 米田博2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2013.

---

	The effectiveness of the scopolamine butylbromide for the salivary hypersecretion with day -P3-490 clozapine and safe examination 志治輝1), 竹内一平1)2), 半谷眞七子1), 亀井浩行1), 宇野準二2), 藤田潔2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2013.

---

	The onset of side effect situation with the treatment with clozapine in our day -P3-491 House 上西幸治1), 赤羽理也1), 星野伸夫1), 森田真也1), 高橋正洋2), 森田幸代3), 山田尚登2), 寺田智祐1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2013.

---

	Use fact-finding and discussion of lamotrigine for patients with day -P3-492 bipolar disorder 吉川明良1)2), 北村佳久2)3), 合葉哲也2), 和田健4), 森田幸孝4), 岩本崇志1), 開浩一1), 千堂年昭2)3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2013.

---

	One case with suspected hypoglycemia with the drug-related carnitine deficiency with the day -P3-493 antiepileptic drug administration 中山智美1), 牧野有砂1), 生嶋つる江1), 田口美恵子1), 萩尾美代1), 神村英利2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2013.

---

	Construction of the new database in the day -P3-494 pregnancy and the medicine information center 中島研1)2), 八鍬奈穂1)2), 石井真理子1)2), 渡邉央美1), 荒田尚子1)3), 村島温子1)3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2013.

---

	Usefulness of the database study for the evaluation of the medication risk of the day -P3-495 pregnant woman 岡田裕子, 飯野浩子, 前田恵里, 増田寛樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2013.

---

	Discussion about the drug becoming the uneasy materials in -P3-496 pregnant woman on a day 湊敬子1)2), 名取裕子2), 明城光三3), 小山田光孝2), 中村浩規1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2013.

---

	Examination for the drug evaluation at pregnancy in the day -P3-497 Prescribing medicines in Pregnancy 4th edition 前田恵里1), 浅見晴香1), 飯野浩子1), 武田あかり1), 角田義典1), 若本太郎2), 外山聡2), 佐藤博2), 岡田裕子1), 増田寛樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2013.

---

	Examination for Recommendation in day -P3-498 Drugs in Pregnancy and Lactation(Gerald G. Briggs, et al.) 増田寛樹1), 大場怜1), 永井香織1), 宮下由理1), 前田恵里1), 岡田裕子1), 木村沙織2), 若本太郎3), 外山聡3), 佐藤博3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2013.

---

	Introduction of the after giving birth instruction in our day -P3-499 House obstetrics and gynecology department ward and future problem 高儀佳代子, 清水圭子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2013.

---

	Investigation of inquiry contents about the day -P3-500 nursing and the use of drug 尾崎芙実1)2), 小原拓2), 前川真央1), 吉中千佳1), 草場美津江1), 中川直人1), 飯田優太郎1), 鈴木文子1), 島田美樹1), 佐賀利英1), 佐藤真由美1), 久道周彦1), 松浦正樹1), 眞野成康1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2013.

---

	Fact-finding about the use of antiasthmatic drug during the day -P3-501 pregnancy 坪木侑, 小林江梨子, 佐藤信範 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2013.

---

	Possession situation investigation of the rubella antibody titers in the day -P3-502 pregnant woman 相澤佑佳, 野村美枝, 後藤拓也, 二宮春日, 大島由莉, 横田智香, 高橋雄一郎, 川鰭市郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2013.

---

	Study on grasp of the prescription situation of the antiasthmatic drug for the day -P3-503 pregnant woman 保坂実樹1), 小原拓2)3), 目時弘仁4), 佐藤倫広3), 大久保孝義5), 八重樫伸生4), 眞野成康3), 栗山進一6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2013.

---

	Recognition about the importance of the perinatal folic acid intake in the day -P3-504 health insurance pharmacy pharmacist 阿部真也1), 小原拓2)3), 佐藤倫広2), 吉町昌子1), 後藤輝明1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2013.

---

	Recognition about the importance of the perinatal folic acid intake in the day -P3-505 student nurse 小野木弘志1), 佐藤倫広2), 小原拓2)3), 佐藤喜根子4), 村井ユリ子2)5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2013.

---

	About the role of the pharmacist at heparin calcium subcutaneous injection syringe introduction for the day -P3-506 pregnant woman 大野愛1), 石上仁美1), 内藤美紀1), 祢宜田和正1), 小島良子2), 佐伯悟三3), 戸田繁4), 勝見章男1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2013.

---

	Examination and use of the information science of the antiinfluenza medicine about the day -P3-507 pregnant woman of antiinfluenza medicine during pregnancy 森田理恵子1), 刈込博2), 櫻田大也1), 小林江梨子1), 佐藤信範1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2013.

---

	Labetalol levels and neonates views out of the umbilical blood in patients with day -P3-508 pregnancy-induced hypertension syndrome 植松和子1)4), 小林映子1), 勝本絵美1), 鴻丸晴菜1), 川合聡子1), 杉本充弘2), 川上義3), 前澤佳代子4), 木津純子4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2013.

---

	Risk assessment of the nursing and infants during the day -P3-509 lamotrigine internal use 橋本真梨1), 鈴木亜矢子1), 山下恵1), 大本暢子1), 久米学1), 槇本博雄1), 平野剛1), 森田宏紀2), 山田秀人2), 柴田暁男3), 飯島一誠3), 平井みどり1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2013.

---

	Discussion about the patients who explained the ritodrine hydrochloride note before administration and early in -P3-510 obstetrics and gynecology department ward on a day 高野聖子, 有川朗子, 森島寿賀子, 山崎寿浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2013.

---

	Examination about the mother's milk shift of day -P3-511 cyclophosphamide 川邉桂1), 小池博文1), 粒来拓2), 浜之上はるか2), 岸本大河3), 井畑淳3), 藤田秀次郎4), 西巻滋4), 平原史樹2), 西川能治1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2013.

---

	The action that we applied to the pharmacist duties establishment of the maternity ward by the -P3-512 pharmacist resident on a day 金澤温子1), 塩見めぐみ1)2), 久保田理恵1)2), 田中庸一1)2), 青木学一1)2), 渋谷清1)2), 安藤航1)2), 佐々木たい子3), 栗林みどり3), 小宮山貴子1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2013.

---

	An action and the evaluation that introduced role playing training into "training about the medical therapy to a pregnant woman nursing mother" in the -P3-513 business training on a day 岩佐千尋, 濱田潤 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2013.

---

	Experience given the pharmacy sponsorship regional alliances study session in our -P3-514 House on a day and theme ... about future problem - pregnant woman nursing mother and medicine 安立沙織, 岩佐千尋, 濱田潤 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2013.

---

	Examination about patients background and the drug of the case that was urgently hospitalized with seriously ill hypoglycemia for -P4-515 past five years on a day 水谷舞1), 早川伸樹1)2), 堀実佐子3), 林高弘1)3), 福井愛子1), 亀井浩行1), 鈴木敦詞2), 伊藤光泰2), 山田成樹3), 田中斎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2013.

---

	The hypoglycemic understanding degree investigation in the use of medicine patients for day -P4-516 diabetes and examination of the instruction method 橋亮介, 鈴木悠加, 下山あさ子, 田中悠季, 及川華代, 嘉屋則子, 小原郁司, 小寺隆二, 下山光一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2013.

---

Factor and examination ... by the associated ... patients attribute with contents of the medication counseling which patients with day -P4-517 diabetes feel saying "a drugstore contributes to prevention of improvement, aggravation of illness" 庄司雅紀1), 恩田光子1), 入江佑紀1), 中園満1), 荒川行生1), 早瀬幸俊2), 櫻井秀彦2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2013.

---

	Relation of the insulin management of the day -P4-518 circulatory organ outpatient 成田千香子, 八代佳子, 金美紀, 吹谷真紀子, 篠田菜美子, 佐藤恵葉 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2013.

---

	Action of the blood sugar control team conference by the pharmacist leadership in the day -P4-519 orthopedics 大年加純1), 古川静保1), 片岡聡1), 野本真紀1), 筒井由佳1), 西井幸信2), 公文義雄3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2013.

---

	Action by the diabetes outpatient department instruction by the pharmacist by day -P4-520 "diabetes team" 小川充恵1), 香川雅一1), 小枝伸行2), 小川義高3), 山崎肇1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2013.

---

	An attitude survey and problems for the hypoglycemia for the day -P4-521 diabetes education inpatient 福田順也, 松本千聡, 田村彩, 中嶋丈晴, 長島章, 伊藤功治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2013.

---

	The change of the diabetes therapeutic drug in day -P4-522 patients on dialysis 西正浩, 松井法子, 向井光一朗, 三宅加奈子, 櫻間啓基, 上田晶, 坂本一貴, 羽田野桂史, 石炭兼征 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2013.

---

	The chic D instruction in patients with day -P4-523 diabetes and the evaluation 栗崎貴啓1), 和田吉晴1), 西山公恵2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2013.

---

	The effect that sustained-release insulin and a change to oral hypoglycemic drug combination therapy give to blood sugar control from the insulin therapy with the -P4-524 multiple times injection on a day 中島啓二1), 柴田大河2), 宇佐美英績1), 安部絵里1), 森博美1), 傍島裕司2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2013.

---

	Examination ... of the change of the error report before and after making of day -P4-525 insulin guidelines and evaluation ... use 佐藤澄子, 金沢久男, 鈴木剛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2013.

---

	Comparison ... of the internal medicine in our action ... House of the diabetes society Recommendation observance for the day -P4-526 DPP-4 inhibitor in Japan and other clinical departments 小林理栄, 新井亘, 増田裕一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2013.

---

	Study on change of the blood test value in patients with day -P4-527 DPP-4 inhibitor alogliptin remedy 住居慶子, 河崎陽一, 宮本理史, 江角悟, 市川裕規, 定金典明, 北村佳久, 千堂年昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2013.

---

	Investigation of the DPP-4 inhibitor remedy patients in our day -P4-528 House 笹谷政史, 城野加奈子, 木村文貴, 千本木要 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2013.

---

	Correlation with HbA1c and LDL cholesterol in patients with day -P4-529 DPP-4 inhibitor internal use 杉山直也1), 河崎陽一2), 江角悟2), 北村佳久1)2), 千堂年昭2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2013.

---

	Comparison for the HbA1c improvement effect of the day -P4-530 DPP-IV inhibitor 3 preparation 久保有子, 細川文, 浜崎浩一, 畝知己, 山崎美保, 西園寺真二, 竹田克明, 前田頼伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2013.

---

	Active intervention of the pharmacist for patients with day -P4-531 CSII (sustained subcutaneous insulin infusion therapy) introduction 石田詞子1)2), 小野達也1)2), 徳山尚吾2), 西田英之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2013.

---

	Effect to give to lipid of -P4-532 Sitagliptin on a day 石橋真実1), 大森麻江1), 山本梓1), 大村祐加1), 宮下雄博2), 森英樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2013.

---

	The intervention of the pharmacist about insulin and the sitagliptin combination therapy in patients with day -P4-533 type 2 diabetes and examination of the usefulness 永田浩泰, 秋吉明子, 陣上祥子, 福永栄子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2013.

---

	Effect to give to -P4-534 sitagliptin and carbohydrate metabolism, lipid metabolism of the statin drugs combination on a day 増本憲生1)4), 細見健悟1), 杉田裕貴1), 小牧佐知子1), 高子優子1), 大槻裕朗1), 高尾宜久2)4), 古賀正史3), 岩川精吾4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2013.

---

	Questionary survey of the day -P4-535 insulin device "flextime touch" 久嶋真紀子, 野口景子, 葛葉守, 中野玲子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2013.

---

	Examination about the association of the effectiveness, safety and the concomitant drug of the day -P4-536 GLP-1 analog preparation liraglutide 永井大地, 段林正明, 杉本更絵子, 早川幸宏, 高橋一栄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2013.

---

	Examination of the use situation and the clinical response of the day -P4-537 liraglutide 砂川恵子, 長谷川智津, 木村和美, 飯島由美子, 細田宏美, 坂下可奈子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2013.

---

	Examination about the patients choice in the day -P4-538 liraglutide administration 塩見めぐみ1)2), 中村麻美3), 田中庸一1)2), 青木学一1)2), 坂本将規1), 安藤航1)2), 渋谷清1)2), 久保田理恵1)2), 小宮山貴子1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2013.

---

	The effect that changes from -P4-539 mitiglinide or nateglinide to repaglinide give to blood sugar control on a day 蜜田哲也, 中島啓二, 宇佐美英績, 木村美智男, 森博美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2013.

---

	It is the report about the change of the occasional blood sugar change after the change from existing special effect type insulin preparation in patients with day -P4-540 diabetes to insulin Degludec 原敬一1), 佐藤悠太2), 今村榛樹2), 川名秀俊2), 龍野一郎2), 真坂亙1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2013.

---

	日-P4-541 Survey of the side effects of gastrointestinal symptoms by METGLUCO (R) Tablets 関野健史, 田中幸子, 吉田直弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2013.

---

	Examination about effect of treatment and the side effect after the day -P4-542 metformin increase in quantity 川口博資1), 中村安孝1), 須田泰記1), 高橋克之1), 西川武司1), 絵本正憲2), 稲葉雅章2), 永山勝也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2013.

---

	Effect by the blood mixture on day -P4-543 self injection preparation 吉原博夢1), 朝倉俊成2), 北川幸己1), 浅田真一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2013.

---

	Trial of "the DM theater" as the learning tool of the day -P4-545 diabetes medical treatment instruction 佐々木弘好1)2), 森本雅子1)3), 植田孝介1)4), 丸山裕徳1)5), 今井佳子1)6), 北島真由美1)7), 志賀隆博1)8), 宮下元樹1)9), 中野玲子1)10) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2013.

---

	Standardization of the doubt inquiry of the drug at the day -P4-546 decreased renal function 松宮美沙, 石原美加, 小笠原陽子, 森住京子, 藤原沙希, 中田一孝, 森住誠, 吉田絵美香, 池田理沙, 冨田有香, 応治比呂美, 坂本千代子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2013.

---

	About standardization of the doubt inquiry for patients with day -P4-547 decreased renal function 桐野玲子, 寺師守彦, 野間口寛, 柿本智広, 瀧下恭子, 高橋武士, 中木原由佳, 豊住綾子, 新上香奈子, 平松さやか, 中島誠, 福元裕介, 池ノ上知世, 坂元優太 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2013.

---

	Action of the side effect measures that cooperated with other types of job for the -P4-548 decreased renal function patients on a day 早川兼司, 松崎加奈, 村越南, 鈴木美千代, 長谷川里佳, 多田哲也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2013.

---

	Action of the pharmacist in the kidney disease classroom of the day -P4-549 Oita Red Cross hospital 岩崎慎也1), 金田幸司2), 副田明美3), 浜野香奈4), 徳丸茂史5), 永野俊玲1), 朝倉俊治1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2013.

---

	Questionary survey about the appropriate medical therapy to patients with chronic kidney disease in day -P4-550 Yamaguchi 塚原邦浩1)11), 礒部邦彌2)11), 岡智之3)11), 木下秀樹4)11), 伊東真由子5)11), 平岡ひろ子6)11), 光末尚代7)11), 佐藤真也8)11), 山本武史9)11), 古川裕之10)11) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2013.

---

	Analysis of the factor to influence rehospitalization after a discharge of the -P4-551 renal failure education purpose hospitalization on a day 安泰成1), 小瀬英司2), 吉川明彦1), 林宏行2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2013.

---

	Examination of effect of treatment of the anemia in renal disease in the change to EpoetinβPegol for day -P4-552 haemodialysis patients and drug costs 建部宏子, 高井宏幸, 中村雅敏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2013.

---

	Investigation about the proper use of famotidine based on the renal function of the day -P4-553 outpatient 菊池大輔, 布施克浩, 福士素子, 阿部友紀, 土屋節夫, 畑中貞雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2013.

---

	Proper use of the DPP-4 inhibitor to patients with day -P4-554 renal failure 西川桃子, 増田博也, 木田朋子, 碓井真紀, 坂口裕香, 堀井夏子, 鈴鹿隆晃 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2013.

---

	日-P4-555 Use actual condition survey of dabigatran 森田啓嗣1)2), 洲脇純三1), 津田綾子1), 近藤淳2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2013.

---

	One case that we intervened in active for the decreased renal function patients during day -P4-556 pregabalin remedy 堀内香里, 市川裕平, 荻原宏美, 杉山昌秀, 油井信明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2013.

---

	Examination about the use of the amphotericin B ribosome preparation in patients with day -P4-557 renal failure 和地徹1), 岸川幸生1), 千葉貴志2), 阿部清彦2), 八木朋美1), 勝山壮1), 中村仁1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2013.

---

	One case of the renal-transplant recipients whom blood level of tacrolimus increased by -P4-558 diarrhea temporarily on a day 市川裕平1), 村上穣2), 池添正哉2), 油井信明1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2013.

---

	Change of the pharmacist to patients with pressure sore in our day -P4-559 House 佐藤このみ, 新沼佑美, 矢野とおみ, 加茂陽子, 阿部誠也, 関さやか, 栗村淳子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2013.

---

	Examination, measures of day -P4-560 measures 仲井修一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2013.

---

	The use actual situation of the day -P4-561 pressure sore drug for external use and future problem 佐藤康子1), 本間絵里1), 高橋秀和1), 菅野絵里衣1), 岡田浩司1), 佐藤勝彦1), 森康記2), 小野寺喜代3), 瀬川さゆり4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2013.

---

	Examination about the usefulness of the pharmaceutical cooperation using the day -P4-562 asthma management notebook 真志田絵美子1)3), 櫻下弘志1)3), 田川茉希1)3), 増田有紀1)3), 林華代1)3), 友田江美1)3), 鴫田江理嘉1)3), 春田吉則2)3), 佐伯康之1), 畝井浩子1), 木村康浩1), 木平健治1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2013.

---

	It is ... for proper use in triple-drug therapy - outpatient department including the -P4-563 terra pre-building on a day 徳山絵生1), 宮武望1), 坂口浩樹2), 石坂敏彦1), 向井淳治1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2013.

---

	Examination of the usefulness of the terra pre-building weight loss administration in the day -P4-564 chronic hepatitis C triple-drug therapy 岡冨大輔1), 谷口雅敏1), 高木慎太郎2), 森奈美2), 相坂康之2), 吉良臣介3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2013.

---

	Evaluation of the triple-drug therapy with peginterferon, ribavirin in patients with day -P4-565 chronic hepatitis C and the terra pre-building 深海広平, 土井麻記子, 山下剛史郎, 山本諭, 幸前智子, 河合佐起子, 井上隆至, 南橋薫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2013.

---

	Examination about the initial terra pre-building reduction dosage case in the triple-drug therapy for day -P4-566 chronic hepatitis C 廣瀬哲也1), 須藤美穂子1), 八木佐保里2), 藤井達也2), 谷口亮央2), 小林龍2), 小原秀治2), 柴波明男1), 妻木良二2), 小関至3), 狩野吉康3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2013.

---

	Examination of impaired renal function and the blood ribavirin levels in the triple-drug therapy of day -P4-567 chronic hepatitis C 松川雅子1), 西部幸一1), 佐藤裕美1), 新木誠1), 羽田好範1), 佐々木淳1), 今井桂子1), 古家乾2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2013.

---

	The pharmaceutical intervention for the day -P4-568 chronic hepatitis C triple-drug therapy and the evaluation 伊藤有美1), 菅原さやか1), 森健司1), 榊原隆志1), 滝本典夫1), 杉浦充1), 足立守1), 仲島さより2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2013.

---

	Effective and safe fact-finding of the apomorphine hydrochloride note for the off symptom of day -P4-569 Parkinson's disease 杉山留美子1)2)3), 松永薫2), 星野輝彦1)3), 塩津和則1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2013.

---

	Effect of H2 receptor blocker nizatidine on upper part lower digestive tract motor function of patients with day -P4-570 Parkinson's disease 土井啓員1), 平井成和1), 真坂亙1), 佐藤光利2), 石井敏浩2), 榊原隆次3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2013.

---

	The effectiveness of the venous thromboembolism preventive preparation after the day -P4-571 lower limbs artificial joint replacement and safe examination 中村孝佑1), 出石恭久1), 谷口仁司1), 琢磨律儀1), 塩田直史2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2013.

---

	The effectiveness of the venous thromboembolism preventive preparation in the day -P4-572 lower limbs orthopedics surgery and safe examination 中田一孝, 松宮美沙, 今岡寛美, 坂本千代子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2013.

---

	Comparison about the effectiveness of the deep vein thrombosis embolism preventive preparation occurring after -P4-573 lower limbs cosmetic surgery procedures on a day and the safety 赤嶺聡彦1), 平山武司1)2), 河村直3), 高平尚伸4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2013.

---

	Examination about administration start time of the edoxaban after the day -P4-574 total knee replacement and the dose 森崎崇文1), 星野輝彦2), 塩津和則1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2013.

---

	Clinical response of the Abatacept for the day -P4-575 rheumatoid arthritis 曽根本恵美1), 紙谷友里子1), 溝口晶子1), 辻泰弘2), 藤秀人2), 植木幸孝3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2013.

---

	Evaluation (fourth report, last report) of the folic acid combination situation to patients with rheumatoid arthritis during day -P4-576 methotrexate administration 宮崎徹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2013.

---

	Change of blood tacrolimus levels and the renal function by the Everolimus introduction in day -P4-577 heart-transplant recipients 松田紗知1), 和田恭一1), 中川舞子1), 越智純子1), 坂東加容子1), 山西香織1), 中村慶1), 桑原健1), 堀由美子2), 稗田道成2), 渡邊琢也2), 角南春樹2), 佐藤琢真2), 村田欣洋2), 瀬口理2), 簗瀬正伸2), 中谷武嗣2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2013.

---

	It is examined the usefulness of the tolvaptan for the heart failure after -P4-578 cardiovascular surgery surgery on a day 宮本拓也1), 木場久恵1), 鶴田亮2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2013.

---

	Participation of the pharmacist for the antithrombotic therapy in the day -P4-579 left ventricle ventricular assist device device patients 越智純子1), 稗田道成2), 松田紗知1), 中川舞子1), 坂東加容子1), 和田恭一1), 中村慶1), 桑原健1), 堀由美子2), 瀬口理2), 村田欣洋2), 簗瀬正伸2), 中谷武嗣2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2013.

---

	日-P4-580 Factors affecting the effectiveness by clopidogrel sulfate administration after PCl enforcement against ischemic heart disease 武野俊也, 渕上俊介, 三田貴之, 安土菜美, 樋浦一哉, 稲垣貴裕, 今井隆人, 渡辺浩明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-448, 2013.

---

	Theoretical analysis about the clinical response of the beta-blocker to use before an examination of -P4-581 coronary arteries CT contrasting on a day 藤戸香理, 高柳理早, 木村耕二, 横山晴子, 山田安彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-448, 2013.

---

	It is relative examination ... with TTR estimate method - INR number of measurement and the TTR prediction precision using % INR in the warfarin potassium internal use case after day -P4-582 mechanical valve replacement 木村和美1), 細田宏美1), 坂下加奈子1), 山下英治2), 中谷洋介2), 大島茂2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-448, 2013.

---

	About the effect of treatment of disopyramide for the paroxysmal atrial fibrillation in the day -P4-583 perioperative period 渡邉雄貴, 宮川泰宏, 久保田亜希, 矢田郁実, 水野聖子, 後藤知子, 竹内典子, 山田清文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-448, 2013.

---

	Examination about a low-dose rivaroxaban prescription rate in the day -P4-584 non-valve-related atrial fibrillation and the reason 中山七海1), 大串篤史1), 並木淳郎2), 越前宏俊3), 石井嘉之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-448, 2013.

---

	Effective evaluation of the facilitated PCI using the t-PA preparation for day -P4-585 ST rising type acute myocardial infarction (STEMI) 江口雄太郎, 嶋田修治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-448, 2013.

---

	It be sultry the actual feeling of the effect at the -P4-586 indacaterol inhalation and the inhalational maneuver on a day; the effect that includes it 江崎秀樹1), 榊原隆志1), 武田直也2), 滝本典夫1), 杉浦充1), 足立守1), 加藤聡之2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 449-449, 2013.

---

	About the onset of bronchospasm situation of the pentamidine isethionate inhalation of the day -P4-587 pneumocystis carini pneumonia prevention 赤岩保明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 449-449, 2013.

---

	An effect of the inhalational instruction using the day -P4-588 inspiratory flow rate measuring instrument and examination of the predictor of the inspiratory force lack 山本圭城1), 安井友佳子1), 赤星美雅1), 河野公美子1), 柳下祐貴子1), 山本明紀1), 金井友規恵1), 柳澤有子1), 豊田絵美奈1), 宇高歩1), 八野芳巳1), 郷間厳2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 449-449, 2013.

---

	The effectiveness of the tolvaptan administration in patients with day -P4-589 pulmonary hypertension 森川純1), 福永桂子1), 桑田益希1), 琢磨律儀1), 小川愛子2), 松原広己2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 449-449, 2013.

---

	Kawasaki's disease is diagnosed at -P4-590 12 years old on a day; the case received the gamma globulin 関口展貴, 跡部治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 449-449, 2013.

---

	Effect to give to the zinc ion change in cells of -P4-591 clioquinol on a day 岡野善郎1)2), 石田志朗2), 小山保夫3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 449-449, 2013.

---

	One report that a left auricle clot disappeared by -P4-592 dabigatran and heparin on a day 井本剛史1), 芳賀洋祐1), 佐藤雅之2), 佐藤善之3), 塩田友香1), 渡邊苑子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2013.

---

	About combination with the food of the day -P4-593 triclofos sodium 10% syrup (avian black reel syrup 10% (R)) 加藤さや香, 天野幸恵, 牧原俊康, 山田成樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2013.

---

	Examination of 3 cases in the day -P4-594 tolvaptan low dose administration start 鈴木一志, 松本晃一, 高橋利幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2013.

---

	Investigation about usefulness and the safety of the day -P4-595 febuxostat 金子樹利亜, 河合武尊, 岩堀真弓, 後藤悠, 東修司, 高木明彦, 小原郁司, 小寺隆二, 下山光一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2013.

---

	Example that the effectiveness and safety were suggested by administration in -P4-596 romiplostim (Romiplostim) once in two weeks on a day 仲鉢英夫1), 久保田聡1), 日高寿美2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2013.

---

	日-P4-597 Study of the efficacy and safety of Apixaban tablets in Kushiro clinical pharmaceutical research Association 長崎淳彦1), 玉川淳一2), 山口顕司3), 福田健吾4), 千田泰健5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2013.

---

	Effect of the carrot juice on day -P4-598 hyperammonemia lat 今井公江1), 稲葉麻衣1), 橋田知可子1), 岩崎綾乃1), 中西邦夫1), 上野山周雄2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2013.

---

	Effective evaluation of the urate synthesis inhibitor for patients with gout of the day -P4-599 hyperuricaemia 原美友紀, 嶋田修治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2013.

---

	It is examined the posttransfusion hyperferremia in the -P4-600 childhood cancer domain on a day 田中佑佳1), 豊島由佳2), 野田美香2), 安江志保2), 横山能文2), 山下達也2), 門井絵美2), 大西沙緒理2), 篠田邦大2), 鷹尾明2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2013.

---

	Examination about the quality change of the anticoagulation therapy of Warfarin by the day -P4-601 new oral anticoagulant drug introduction 大串篤史1), 並木淳郎2), 越前宏俊3), 石井嘉之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2013.

---

	日-P4-602 New scabies therapy: Examination of the animal experiment of the ivermectin full bath method - About safety, the effectiveness - 湯澤薫, 吉増孝嗣, 宮嶋篤志, 廣田孝司, 小茂田昌代 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2013.

---

	Usefulness of the aPTT monitoring after the dabigatran reshuffling that assumed -P4-603 renal function an index on a day 村上優美1), 井上慶子1), 田中香織1), 岩村直矢1), 池田祐輔1), 溝口晶子1), 平木洋一2), 辻泰弘3), 藤秀人3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2013.

---

	Discussion about use and the medication counseling of the day -P4-604 fast acting property nitric acid medicine 宇野洋司1), 縄田修一1), 齋藤佳奈1), 齊藤祥子1), 宮崎三恵子1), 木村一雄2), 橋本真也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2013.

---

	Evaluation of blood tacrolimus levels for the day -P4-605 ulcerative colitis 佐々木紀彰, 熊澤崇, 高橋淳子, 古元俊徳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2013.

---

	About a problem of the control situation of warfarin in our day -P4-606 House and the measures 加茂陽子, 新沼佑美, 佐藤このみ, 矢野とおみ, 阿部誠也, 関さやか, 栗村淳子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2013.

---

	Examination about the attack protective efficacy of the antiepileptic drug after the day -P4-607 brain tumor enucleation 河端志保, 中村安孝, 川口博資, 須田泰記, 高橋克之, 西川武司, 永山勝也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2013.

---

	Day -P4-608 Reexamination of the evidence for medication counseling support The second report - About the coloration of the reusable soft contact lens at the rifampicin remedy - 中島慶子1), 島田泉2), 坂野昌志3), 松下良4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2013.

---

	Recognition about the home hemodynamometry in the day -P4-609 health insurance pharmacy pharmacist 山口浩1), 小原拓2)3), 佐藤倫広2), 阿部真也1), 吉町昌子1), 今井潤4), 後藤輝明1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2013.

---

	IN-01 Experiment of Cytotoxicity by methyl 2-benzoylbenzoateon human monocytes Chiaki Tsuboi1), Yoichi Kawasaki2), Yoshihisa Kitamura1)2), Toshiaki Sendo1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 454-454, 2013.

---

	IN-02 A combination of chlorinated hydrocarbon and photoinitiator has increased cytotoxicity to human normal embryonic lung fibroblasts Kenta Yagi1), Yoichi Kawasaki2), Yasuyuki Masaoka2), Yoshihisa Kitamura1)2), Toshiaki Sendo1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 454-454, 2013.

---

	IN-03 The role of vaults in resistance to anti-cancer agents Ryuji Ikeda1), Yusuke Tajitsu1), Yukihiko Nishizawa1), Hironori Mataki1), Katsushi Yamada2), Yasuo Takeda1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 454-454, 2013.

---

	IN-04 Experiment of apoptosis by photoinitiators on human blood peripheral mononuclear cells Yoichi Kawasaki1), Chiaki Tsuboi2), Kenta Yagi2), Yoshihisa Kitamura1)2), Toshiaki Sendo1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-455, 2013.

---

	IN-05 Effect of estrogenic activity by photoinitiators Toshiaki Sendo1)2), Yoichi Kawasaki2), Miwa Morizame1), Yoshihisa Kitamura1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-455, 2013.

---

	IN-06 Development and operation of the system by using the“PMDA Medi-nabi”to transmit the drug information in hospital Y Shimodozono, A Shigemi, J Arima, R Ikeda, Y Takeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-455, 2013.

---

	IN-07 Study of the safe and secure use of electronic medical record data in hospitals Takao Orii1), Michihiro Ogawa2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 456-456, 2013.

---

IN-08 International Exchange Committee activities report 2012 in The Japanese Society of Hospital Pharmacists Takao Orii, Yasuo Takeda, Hiroko Ota, Hitoshi Sasaki, Naomi Sogabe, Hiromitsu Takahashi, Yoshikazu Tasaki, Makoto Hayakari, Satohiro Masuda, Keishiro Izumi, Kazuo Matsubara, Toshiaki Yasuoka, Mitsukazu Kitada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 456-456, 2013.

---

	IN-09 Medical aid activities by hospital pharmacists after the Tohoku-Pacific Ocean Earthquake Toshiaki Yasuoka1), Nariyasu Mano2), Mitsukazu Kitada3), Ryuya Horiuchi4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 456-456, 2013.

---

	IN-10 Evaluation of the drugs utilization of COPD patients by DUR and DUE Zhang Jinping1), Zhang Haixia1), Meng Long2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-457, 2013.

---

	IN-11 Role of clinical pharmacists in management of glucocorticoid in patients LAO Hai-yan1), WANBO1), TANG LIRONG2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-457, 2013.

---

	IN-12 Application of “The so-called p-five method” in outpatient pharmacy standardization management Zhou Haiyun, Xiao Lei, Liu Jiatao, Xu Dujuan Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-457, 2013.

---

	IN-13 Meta analysis of the treatment for lower respiratory tract infection with Aztreonam in China Wang Limei1), Yao Ming1), Xu Gongbin2), Han Ming1), Fu Xiujuan2), Zhu Dasheng2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 458-458, 2013.

---

	IN-14 UFLC-MS/MS determination of antipyrine in placental perfusate HUANG Hua1), YAO Qin1), YAN Chen2), ZHENG Qiao-ling1), WANG Jing-jing1), ZHANG Jun1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 458-458, 2013.

---

	IN-15 Establishment of standard education mode of inhaler technique and practice of pharmaceutical care in the respiratory wards Zhou Su-qin Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 458-458, 2013.

---

	IN-16 Use of Non-benzodiazepine Hypnotic drug is associated with decreased risk of ischemic stroke Jia Qi, Hai Tao Liu, Lixia Li, Jia Zhou, Shu Hong Bo, Jian Zhang Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2013.

---

	IN-17 Method and experience of the clinical pharmacist in pharmacy practice WEN Xiao-na, LIU Wen-sheng, MAO Jing-yi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2013.

---

	IN-18 Retrospective Investigation on Decrease in Plasma Fibrinogen Levels Caused by Sodium Valproate in Beijing Tiantan Hospital Huang Jia1), Zhu Xiao-yu2), Zhao Zhi-gang1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2013.

---

	IN-19 A Comparative Evaluation of the Quality of Generic Telmisartan Tablets with the Brand Zhang Bikui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-460, 2013.

---

	IN-20 Intestinal Permeability of Glycosides(aglycone)from Rhociola in the Human Caco-2 Cell Monolayer Model Tian-Xiang Ma, Jiu-Hong Wu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-460, 2013.

---

	IN-21 Drug Utilization Analysis and Safety of elderly inpatients with cerebral infarction in Xuanwu Hospital, Capital Medical University in 2011 LIU Chen1), WANG Yu-qin1), SHENG Qin1), LI Xiao-ling1), Jiang De-chun2), LI Xing-wei1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-460, 2013.

---

	IN-22 Effect of clinical pharmaceutical care in patients with cancer paln patients in China XIE Zheng-zheng1), ZHAI Suo-di2), SUN Lu-lu1), Suozhong Yuan1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2013.

---

	IN-23 The pathogens of prelabour rupture of membranes in China：a systematic review Linan Zeng1), Lingli Zhang1), Jing Shi1), Liling Gu2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2013.

---

	IN-24 Pharmacists’Role in the Management of Chronic Disease YANG Ting, LU Min, ZHOU Ying, CUI Yimin Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2013.

---

	Medical therapy of the pressure sore that a pharmacist is concerned with 古田勝経1), 木ノ下智康2), 溝神文博2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 468-468, 2013.

---

	The clinical pharmacy frontier which opens up new age 奥田真弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 3-3, 2014.

---

	It is ... from a viewpoint of recollection of 1 clinical pharmacy and fine-view - healthcare setting and academia 乾賢一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 4-4, 2014.

---

	2 Leading the Pharmacy Enterprise to Ensure Continuity of Patient Care Scott J.Knoer Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 5-5, 2014.

---

	New flow of 3 cancer immune therapy 珠玖洋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 6-6, 2014.

---

	About 1 new pharmacy education model core curriculum 太田茂 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 7-7, 2014.

---

	1 revision pharmacy education model core curriculum <F pharmacy clinical practice and business training> which turn big 鈴木匡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 8-8, 2014.

---

	As for 2 hospital pharmacist regular Tolly science 平山佳伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 9-9, 2014.

---

	Prescription adequacy by the pharmacokinetic analysis of the side effect case 前田頼伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 10-10, 2014.

---

	Improvement of the quality of pharmacist duties in the cancer medical therapy and study on clinical evaluations 中島誠 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 11-11, 2014.

---

	Mechanism elucidation of the side effect expression that assumed PK-PD theory a base and search of the risk factor 永田将司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 12-12, 2014.

---

	Pharmaceutical intervention about antimicrobial medicine proper use, Clinical application of pharmacokinetics-pharmacodynamics 浜田幸宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 13-13, 2014.

---

	Role of large intestine aquaporin 3 in the catharsis effect of osmotic laxative magnesium sulfate and large intestine irritant cathartic bisacodyl 五十嵐信智 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 14-14, 2014.

---

	Study about decomposing it of the pharmaceutical products waste fluid using the electrolysis 小林豊英 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 15-15, 2014.

---

	Pharmacokinetic and pharmacodynamic clinical studies of prochlorperazine in patients with opioid analgesic administration cancer 田代将貴 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 16-16, 2014.

---

	Study on role of the mTOR course in exacerbation and the restoration of the renal tubule lesion 中川俊作 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 17-17, 2014.

---

	Learning from CDTM of the 27-A-S1-1 United States 中井清人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 22-22, 2014.

---

	Introduction ... of the formula Lee introduction case in our practice ... House of the medical treatment by local formula Lee in the 27-A-S1-2 U.K. 上田彩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 22-22, 2014.

---

	Of the CDTM education in the 27-A-S1-3 University, actually 山下美妃 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 23-23, 2014.

---

	The fact and problem of the duties in the 27-A-S1-4 drugstore 飯島康典 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 23-23, 2014.

---

	Point on taking the good communication with the 27-A-S2-1 patients 藤崎和彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 25-25, 2014.

---

	To face sense of values of the each 27-A-S2-2 patients; the educational inflection of the talk of health and the illness 後藤惠子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 25-25, 2014.

---

	Introduction of communication skill training (CST) which utilized the way of 27-A-S2-3 simulated patient who put the principal objective to return 半谷眞七子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 26-26, 2014.

---

	Development and the inflection of the communication skill measure in the 27-A-S2-4 pharmacist 寺町ひとみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 26-26, 2014.

---

	27-A-S3-1 International contribution of Japan's pharmaceutical administration 日本の薬事行政の国際貢献 Yasuhiro Araki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 28-28, 2014.

---

	27-A-S3-2 Establishment and Application for the Rational Drug Use Management Platform Zhao Zhigang Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 28-28, 2014.

---

	27-A-S3-3 Survey for the experience of Hospital Pharmacy hands-on training in Korea Hyewon Han Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 29-29, 2014.

---

	27-A-S3-4 The role of therapeutic drug monitoring (TDM) in pharmaceutical service of China Zhao Li Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 29-29, 2014.

---

	27-A-S3-5 Clinical trial implementation system at Okayama university hospital Nagai Miki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 30-30, 2014.

---

	27-B-S4-1 perioperative medical care and pharmacist, the next move 落合亮一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 32-32, 2014.

---

	We think about the figure which should have the remedy medicine pharmaceutical management in preoperation in 27-B-S4-2 perioperative care 舟越亮寛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 32-32, 2014.

---

	How long can 27-B-S4-3 pharmacist be concerned with the management in the operation? 小西寿子, 木村利美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 33-33, 2014.

---

	27-B-S4-4 postoperative patients follow-up technique 柴田ゆうか, 木平健治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 33-33, 2014.

---

	We join pharmaceutical management together until discharge adjustment before 27-B-S4-5 hospitalization 奥貞智 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 34-34, 2014.

---

	A physician demand it from a pharmacist in 27-B-S5-1 ambulatory practice 岸田直樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 36-36, 2014.

---

	27-B-S5-2 cancer survivor expect it from a pharmacist 溝口綾子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 36-36, 2014.

---

	Action to the treatment at home by the 27-B-S5-3 opening of an office pharmacist 中野正治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 37-37, 2014.

---

	Pharmacist outpatient department for patients with 27-B-S5-4 diabetes 大西順子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 37-37, 2014.

---

	Action - of pharmacist interview - joint management in the 27-B-S5-5 respiratory organs / sleep outpatient department 伊藤光 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 38-38, 2014.

---

	The present conditions and directionality of the pharmacist duties in the 27-B-S6-1 outpatient department chemotherapy room 松尾宏一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 40-40, 2014.

---

	Evidence by a pharmacist being associated with 27-B-S6-2 outpatient department chemotherapy 林稔展 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 40-40, 2014.

---

	Role (1) of the pharmacist in the 27-B-S6-3 outpatient department chemotherapy - Duties - that a pharmacist should be carried out 組橋由記 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 41-41, 2014.

---

	Role (2) of the pharmacist in the 27-B-S6-4 outpatient department chemotherapy - Duties - necessary for team approach in medical care 黒田純子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 41-41, 2014.

---

	Role (3) of the pharmacist in the 27-B-S6-5 outpatient department chemotherapy - Duties - that we went step further 吉村知哲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 42-42, 2014.

---

	In hope of the extermination of specialty, the harmful effect to expect of a pharmacist from the situation of the 27-C-S7-1 patients and 金田和子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 44-44, 2014.

---

	Expectation to a pharmacist in the 27-C-S7-2 acute phase medical care team 足立裕史1, 沼口敦1,2, 宮川泰宏3, 阪井祐介3, 松田直之4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 44-44, 2014.

---

	Specialty to expect of a pharmacist from the situation of the 27-C-S7-3 nurse 荒井有美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 45-45, 2014.

---

	Specialty of the pharmacist judging from the viewpoint of the specialized pharmacist according to 27-C-S7-4 domain, the disease 吉村知哲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 45-45, 2014.

---

	Specialty of the pharmacist judging from the viewpoint of the pharmacist specialized in 27-C-S7-5 medical therapy 三浦篤史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 46-46, 2014.

---

	Evaluation of CDTM to practice in pharmacist outpatients (support outpatient department) specialized in 27-C-S8-1 cancer 今村牧夫1,2, 松井裕典1, 上原孝2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 48-48, 2014.

---

	27-C-S8-2 joint medical treatment management: Dispatch of competency and the evidence of the clinical pharmacist necessary for practice 土手賢史, 澤井麻記, 野崎歩, 小林由佳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 48-48, 2014.

---

	Outcome evaluation of the pharmacist duties in the 27-C-S8-3 ward 鈴木昭夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 49-49, 2014.

---

	Outcome evaluation of the pharmacist outpatient department for the 27-C-S8-4 oral anticancer agent 松井礼子, 川澄賢司, 森田智子, 齊藤真一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 49-49, 2014.

---

	The pharmaceutical management and the outcome evaluation aiming at risk aversion of the 27-C-S8-5 perioperative period 北田徳昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 50-50, 2014.

---

	Value ... of the pharmacist outpatient department support that we saw from outcome evaluation - physician of the joint medical treatment management (Japanese type CDTM) in the 27-C-S8-6 OAB treatment 永江浩史1, 前堀直美1, 安田公夫2, 岩崎智奈美1,2, 重山昌人3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 50-50, 2014.

---

	Matters that require attention at the drug administration for patients with 27-D-S9-1 renal failure: It is the role to be assumed by the pharmacist in chronic kidney disease (CKD) practice 安田宜成, 柴田佳菜子, 松尾清一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 52-52, 2014.

---

	The medical therapy for patients with 27-D-S9-2 diabetic nephropathy: Prevention of extension of the diabetic nephropathy 秋吉明子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 52-52, 2014.

---

	Prevention of the decreased renal function with the appropriate immunosuppressive therapy for 27-D-S9-3 autoimmunity-related renal disease, renal-transplant recipients 竹内裕紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 53-53, 2014.

---

	For the prevention of the decreased renal function due to the 27-D-S9-4 drug-related renal failure 平田純生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 53-53, 2014.

---

	Summary of 27-D-S10-1 kidney disease medical therapy specialty, the authorized pharmacist 木村健 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 55-55, 2014.

---

	Pharmaceutical management for the decreased renal function patients early for 27-D-S10-2 CKD stage G1, stage 2 平田純生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 55-55, 2014.

---

	27-D-S10-3 CKD stage stage G3: Pharmaceutical management for the moderate decreased renal function patients 大野能之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 56-56, 2014.

---

	27-D-S10-4 CKD stage G4, stage G5: Pharmaceutical management for the extensive decreased renal function patients 古久保拓 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 56-56, 2014.

---

	27-D-S10-5 CKD stage stage G5D: Pharmaceutical management - group management for patients on dialysis and individual medication counseling ... 浦田元樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 57-57, 2014.

---

	The present conditions and importance of the antimicrobial surveillance in the 27-D-S11-1 inside and outside the country 笠原敬1, 重田純一2, 岡西康治2, 三笠桂一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 59-59, 2014.

---

	The results of the antimicrobial consumption surveillance of the nosocomial infection measures meeting attached to the 27-D-S11-2 country public university and future problem 西村信弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 59-59, 2014.

---

	Method of the antimicrobial surveillance to work on in 27-D-S11-3 area and how to use results 室高広, 北原隆志, 佐々木均 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 60-60, 2014.

---

	Inflection of a summary and data of the 27-D-S11-4 Ministry of Health, Labour and Welfare hospital infection measures surveillance (JANIS) business 鈴木里和 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 60-60, 2014.

---

	The practice management at the 27-E-S12-1 immune function drop 今村顕史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 62-62, 2014.

---

	27-E-S12-2 immunodeficiency and HIV infection 横幕能行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 62-62, 2014.

---

	27-E-S12-3 malignant tumor and immunodeficiency 石原正志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 63-63, 2014.

---

	27-E-S12-4 elderly people complications and HIV infection 関根祐介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 63-63, 2014.

---

	Positioning of the medical treatment in 27-E-S13-1 pressure sore treatment 磯貝善蔵 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 65-65, 2014.

---

	Because seamless medical treatment is provided for 27-E-S13-2 pressure sore 川崎美紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 65-65, 2014.

---

	Relation of the pharmacist to pressure sore treatment in the 27-E-S13-3 care mix type hospital 飯塚雄次 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 66-66, 2014.

---

	The pressure sore team approach in medical care that 27-E-S13-4 pharmacist has begun to be associated with 坪井憲江1, 浅野康彦2,4, 棚橋康子3, 大草さとこ3,4, 佐藤由紀4, 福岡愛実4, 池内祐子3,4, 村山紋子3,4, 竹山浩子3,4, 鈴木麻里3,4, 宮里志穂美3,4, 春田博美3,4, 神戸智子3,4, 足利久代3,4, 有馬豪5, 古田勝経6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 66-66, 2014.

---

	About the result by the relation of many types of job cooperation in the pressure sore medical care of our 27-E-S13-5 House and the authorized pressure sore pharmacist 岡戸京子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 67-67, 2014.

---

	Pit fall of the 27-E-S14-1 intravenous alimentation therapy 林勝次 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 69-69, 2014.

---

	Point of the 27-E-S14-2 infusion formulation study 丘龍祥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 69-69, 2014.

---

	The present conditions of the pharmacy education about the 27-E-S14-3 intravenous alimentation therapy 井上岳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 70-70, 2014.

---

	We work on the practice in the hospital for 27-E-S14-4 acute phase 中村直人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 70-70, 2014.

---

	We work on the practice in 27-E-S14-5 small and medium size, the medical treatment sickbed 樋島学 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 71-71, 2014.

---

	27-E-S14-6 generalization 林宏行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 71-71, 2014.

---

	About importance of the 27-F-S15-1 many types of job cooperation education 亀井浩行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 73-73, 2014.

---

	Employment cooperation educational program - using action - Interprofessional PBL of the employment cooperation education in 27-F-S15-2 Tsukuba University 前野貴美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 73-73, 2014.

---

	Systematic, graded team approach in medical care education curriculum utilized the characteristic of the university of specialist in 27-F-S15-3 line 木内祐二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 74-74, 2014.

---

	For construction of the team approach in medical care education utilized the 27-F-S15-4 medicine cooperation: Practice (Inter Professional Education & Practice: IPEP) of the many jobs cooperation education 野田幸裕1, 半谷眞七子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 74-74, 2014.

---

	Home care patient, family participation type many types of job cooperation education in the 27-F-S15-5 area 阿部恵子1, 半谷眞七子2, 野田幸裕2, 亀井浩行2, 會田信子3, 内山靖4, 末松三奈1, 安井浩樹1, 植村和正5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 75-75, 2014.

---

	The thing which 27-F-S16-1 new model core curriculum aims at 寺門成真 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 77-77, 2014.

---

	For 27-F-S16-2 new core curriculum: A problem and correspondence of the Japanese Society of Hospital Pharmacists 松原和夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 77-77, 2014.

---

	About the business training of the drugstore corresponding to the 27-F-S16-3 new core curriculum 生出泉太郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 78-78, 2014.

---

	Training evaluation of the existing model core curriculum for the 27-F-S16-4 new core curriculum 望月正隆 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 78-78, 2014.

---

	A pharmacist image and the systematic clinic expectation and problem that 27-F-S16-5 new core curriculum aims at 木内祐二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 79-79, 2014.

---

	It is an action to becoming it hospital preparation marketing by the 27-G-S17-1 hospital pharmacist 政田幹夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 81-81, 2014.

---

	Research necessary for the marketing to join the drug which 27-G-S17-2 society demands together to becoming it 後藤伸之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 81-81, 2014.

---

	Information of the healthcare setting necessary for the pharmaceutical products development that 27-G-S17-3 drug industry demands 中川祥子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 82-82, 2014.

---

	Correspondence to an unlicensed drug, medicine having high need in the 27-G-S17-4 medical care out of the adaptation 益山光一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 82-82, 2014.

---

	TPN therapy to think about from 27-G-S18-1 medical care security 東海林徹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 84-84, 2014.

---

	Risk of the 27-G-S18-2 parenteral injection mixture and parenteral injection material 千堂年昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 84-84, 2014.

---

	Risk about the 27-G-S18-3 parenteral injection titer drop 内田享弘1, 高子優子1, 吉田都1, 志野訓之2, 野村泰生2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 85-85, 2014.

---

	Risk management in the 27-G-S18-4 antibiotic exposure 石坂敏彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 85-85, 2014.

---

	The total management of the chemotherapy in 27-G-S18-5 ward drug duties 室井延之1, 高瀬尚武1, 樋本繭子1, 米澤圭祐1, 田中智也1, 原美紀2, 井上祐子2, 末次弘実3, 小野成樹3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 86-86, 2014.

---

	Risk aversion by the reporting about the parenteral injection mixed preparation of the 27-G-S18-6 anticancer agent 松原肇 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 86-86, 2014.

---

	Risk aversion about the 27-G-S18-7 anticancer medicine pollution and exposure 濱宏仁 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 87-87, 2014.

---

	The thing which 27-G-S19-1 Japanese clinical tumor Pharmaceutical Society aims at 本田泰斗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 89-89, 2014.

---

	Basic knowledge of the 27-G-S19-2 regional alliances system 小枝伸行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 89-89, 2014.

---

	About the medical cooperation that 27-G-S19-3 Kure medical center regional alliances network used "a wave and a wind net" 小川喜通1, 小川弘太1, 平本敦大2,5, 大塚茂雄3,5, 大塚幸三4,5, 市場泰全1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 90-90, 2014.

---

	Significance of grasping the name of disease, the test value using the cooperation system in the 27-G-S19-4 drugstore 山村万里子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 90-90, 2014.

---

	Electronic prescription, pharmaceutical cooperation proof business in 27-G-S19-5 Kagawa District and the problem 飯原なおみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 91-91, 2014.

---

	27-G-S19-6 Approach of the Sado community medical care cooperation network "Sado sunflower net" 佐藤賢治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 91-91, 2014.

---

	From the viewpoint of role - physician of the pharmacist in the 27-H-S20-1 children medical therapy - 中村秀文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 93-93, 2014.

---

	Relation one - present conditions and problem ... of 27-H-S20-2 children medical therapy and the pharmacist 冨家俊弥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 93-93, 2014.

---

	Intervention to the childhood medical therapy of the pharmacist in the 27-H-S20-3 university hospital 鳥本真由美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 94-94, 2014.

---

	Intervention to the childhood medical therapy of the pharmacist in the 27-H-S20-4 General Hospital 藤村尚子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 94-94, 2014.

---

	Optimum doses of 27-H-S21-1 UGT1A1 genetic polymorphism and irinotecan 安藤雄一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 96-96, 2014.

---

	Pharmacogenetics-like action to be possible as 27-H-S21-2 pharmacy school clinical system teacher 中村克徳, 鈴木匡, 松永民秀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 96-96, 2014.

---

	Pharmacogenetics-like action in the 27-H-S21-3 Hospital 渡邉淳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 97-97, 2014.

---

	An effect and CYP2D6 genetic polymorphism of tamoxifen in patients with 27-H-S21-4 breast cancer 今村知世 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 97-97, 2014.

---

	The effect that the CYP genetic polymorphism of the 27-H-S21-5 hematopoietic stem cell transplantation patients gives to tacrolimus levels out of the whole blood 岩本卓也, 奥田真弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 98-98, 2014.

---

	Application to the innovative drug development of 27-H-S21-6 genetic results 鎌谷直之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 98-98, 2014.

---

	Directionality of the clinical studies as the 27-H-S22-1 pharmacist 今村知世 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 100-100, 2014.

---

	The introduction of the use of identification antimicrobial report system which linked an order ring system 27-H-S22-2 example introduction 1 and the usefulness 山田武宏1, 石黒信久2, 井関健1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 100-100, 2014.

---

	It is interaction with terra pre-building and cyclosporine in the hepatitis C youngest case after a liver transplant 27-H-S22-3 example introduction 2 増田智先1,4, 奥田有紀1, 西岡由貴1, 菊池実緒1,5, 上杉美和1, 端幸代1, 中川俊作1, 松原和夫1, 上田佳秀2, 千葉勉2, 海道利実3, 上本伸二3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 101-101, 2014.

---

	It is the retrospective study about the risk factor of the hypersensitivity symptom with the oxaliplatin administration 27-H-S22-4 example introduction 3 関恭子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 101-101, 2014.

---

	A design and data analysis of 27-H-S22-5 clinical studies 森田智視 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 102-102, 2014.

---

	About the publication of 28-A-S23-1 JPHCS 桂敏也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 104-104, 2014.

---

	Mental attitude to 28-A-S23-2 English article making 武田泰生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 104-104, 2014.

---

	The making of the 28-A-S23-3 English article: From experience in the municipal hospital 辻泰弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 105-105, 2014.

---

	The making of the 28-A-S23-4 English article: From the situation of the university 高野幹久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 105-105, 2014.

---

	Expectation to a summary and the pharmacist of the 28-A-S24-1 risk management plan 磯崎正季子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 107-107, 2014.

---

	Offer of the pharmaceutical products safety information in the 28-A-S24-2 pharmaceutical products medical equipment reporting homepage 中村悟 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 107-107, 2014.

---

	Of 28-A-S24-3 pharmaceutical products risk management plan (RMP), actually 新井寿久2, 小林幹英1, 山本郁男1, 滝田諭1, 宇田恒信2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 108-108, 2014.

---

	Of the risk management plan in the cottage-hospital out of 28-A-S24-4, actually 荒木隆一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 108-108, 2014.

---

	Role of the hospital pharmacist in 28-A-S24-5 RMP 伊藤忠明, 林昌洋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 109-109, 2014.

---

	Outcome of team approach in medical care and the community medical care that 28-B-S25-1 pharmacist takes 吉山友二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 111-111, 2014.

---

	The demanded function of the drugstore on the basis of the social conditions of 28-B-S25-2 late years and the figure which there should be 田宮憲一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 111-111, 2014.

---

	For the drugstore which the 28-B-S25-3 nation expects, expect it from a drugstore pharmacist 山口育子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 112-112, 2014.

---

	The economic effect that promotion of the community medical care with 28-B-S25-4 family drugstore function results in 櫻井秀彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 112-112, 2014.

---

	About a drugstore function on the basis of the social conditions of 28-B-S25-5 late years 山本信夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 113-113, 2014.

---

	About the basic system and enforcement of the medical therapy that 28-B-S25-6 drugstore should include 安部好弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 113-113, 2014.

---

	Role of the pharmacist in the 28-B-S25-7 community medical care 藤秀人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 114-114, 2014.

---

	The pharmacoepidemiology that we applied a 28-B-S26-1 medical care system database in, a clinical epidemiology study and development to medical care 川上浩司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 116-116, 2014.

---

	28-B-S26-2 pharmacoepidemiology study and National receipt data 頭金正博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 116-116, 2014.

---

	Application of 28-B-S26-3 size scale side effect spontaneous report database case (JADER example) 坂田洋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 117-117, 2014.

---

	Application of 28-B-S26-4 size scale side effect spontaneous report database case (FAERS example) 中村光浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 117-117, 2014.

---

	Inflection (MIHARI project) to safety measures of the 28-B-S26-5 electron practice information 山本弘史1, 竹内由則2, 宇山佳明2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 118-118, 2014.

---

	- to think about a psychiatric element necessary for treatment preferences, drug control instruction in the mental health for management - perinatal period of the 28-D-S27-1 mental disorder merger pregnant woman 鈴木利人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 120-120, 2014.

---

	Medication counseling to 28-D-S27-2 schizophrenia merger pregnant woman 刈込博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 120-120, 2014.

---

	Medication counseling to 28-D-S27-3 depression merger pregnant woman 山田総 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 121-121, 2014.

---

	Medication counseling to 28-D-S27-4 epilepsy merger pregnant woman 八鍬奈穂 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 121-121, 2014.

---

	When, at 28-D-S28-1 new anticancer medicine introduction, we evaluate information on adverse drug reactions 清水久範 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 123-123, 2014.

---

	Significance ... of clinical studies that ... pharmacist predominates when evidence to become the 28-D-S28-2 background is poor and performs 辻大樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 123-123, 2014.

---

	When we make use of 28-D-S28-3 basics-like pharmaceutical knowledge in the latest cancer medical therapy 大谷道輝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 124-124, 2014.

---

	When we grasp 28-D-S28-4 going to hospital treatment average and a side effect symptom at being at home 川上和宜 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 124-124, 2014.

---

	Do olanzapine which was placed in the antiemesis therapy guidelines of ... foreign countries when new evidence was sent from the 28-D-S28-5 foreign countries for a case; and ... 矢内貴子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 125-125, 2014.

---

	Imaging in the tissue of the antitumor agents using the 28-E-S29-1 mass microscope 新間秀一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 127-127, 2014.

---

	Cancer diagnosis development to review from the 28-E-S29-2 protein measurement 大槻純男, 平山未央, 伊藤慎悟 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 127-127, 2014.

---

	The present conditions and problem of anticancer medicine preparation duties in the 28-E-S29-3 healthcare setting 森川琢也, 岩本卓也, 奥田真弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 128-128, 2014.

---

	It is ... mainly on development trend - kinase of the 28-E-S29-4 molecules target medicine 吉野公一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 128-128, 2014.

---

	The present conditions of the DDS preparation contributing to 28-E-S29-5 cancer treatment 菊池寛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 129-129, 2014.

---

	The prospects to result and the clinical application of the genetic analysis of the 28-E-S30-1 multiple factor disease 田原康玄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 131-131, 2014.

---

	Utilization to the health care using an examination for 28-E-S30-2 telomere, the examination for microRNA 田原栄俊 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 131-131, 2014.

---

	Making of rule - FDA guidelines for 28-E-S30-3 personalized medicine and international standardization - 中江裕樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 132-132, 2014.

---

	Human resources utilization and pharmacist duties in 28-F-S31-1 British clinical settings 渥美景子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 134-134, 2014.

---

	Utilization of the intern resident in 28-F-S31-2 American clinical settings 前田幹広 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 134-134, 2014.

---

	Medical safe promotion by defense strategy - pharmacist of the 28-F-S31-3 United States healthcare setting 岩澤真紀子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 135-135, 2014.

---

	Action of the journal club in the 28-F-S31-4 Tohoku University Hospital 中川直人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 135-135, 2014.

---

	Human resources utilization and duties efficiency for the future prospects and measures - ward duties promotion of 28-F-S31-5 Japan 木村利美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 136-136, 2014.

---

	About importance of the team approach in medical care in the 28-F-S32-1 basic tone lecture intensive care 松田直之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 138-138, 2014.

---

	About the relation of the pharmacist in the intensive care domain in the 28-F-S32-2 Ogura memory hospital 福島将友 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 138-138, 2014.

---

	Intervention of the pharmacist to the nourishment management of patients with 28-F-S32-3 serious case 野崎歩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 139-139, 2014.

---

	Viewpoint ... of sedative management - pharmacist in the 28-F-S32-4 intensive care 前田幹広 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 139-139, 2014.

---

	The role that a drugstore, the pharmacist in the 28-G-S33-1 area inclusion care system should take 中井清人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 141-141, 2014.

---

	The difference between 28-G-S33-2 Japan and at-home duties of the United States and the future prospects 恩田光子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 141-141, 2014.

---

	Role of importance and the pharmacist of the many types of job cooperation in the 28-G-S33-3 treatment at home 高瀬義昌 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 142-142, 2014.

---

	Action of 28-G-S33-4 Hospital and the other types of job cooperation 岩崎清隆 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 142-142, 2014.

---

	It is ... about other types of job cooperation model business using present conditions and need - information sharing system of the opening of an office drugstore for 28-G-S33-5 24 hours 松浦惠子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 143-143, 2014.

---

	Testing request based on the protocol in the 28-G-S34-1 psychiatry 馬場寛子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 145-145, 2014.

---

	The appropriate medical therapy of the habit-forming drug in the 28-G-S34-2 psychotropic drug and the management: Method to reduce the use of benzodiazepine drugs 高橋結花 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 145-145, 2014.

---

	It is ... for the infection measures that gangs are different from infection measures - regular hospital in the 28-G-S34-3 psychiatry domain in 別所千枝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 146-146, 2014.

---

	The prescription intervention case study of the 28-G-S34-4 psychiatry pharmacist: For a reduced risk and a benefit rise of the medical therapy 永田健一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 146-146, 2014.

---

	Role of the pharmacist carrying it out for medical therapy management in the 28-G-S34-5 psychiatry community medical care 桑原秀徳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 147-147, 2014.

---

	The master management that 28-H-S35-1 does not fail in 谷口美悠 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 149-149, 2014.

---

	Invention of the 28-H-S35-2 formulations support system 佐藤弘康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 149-149, 2014.

---

	Bar code utilization example using the mobile terminal in the 28-H-S35-3 formulations system 荒義昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 150-150, 2014.

---

	Electronic management of the drug, specific organism origin preparation of the operating room which is not performed 28-H-S35-4 order ring use of 冨岡謙二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 150-150, 2014.

---

	Invention of the 28-H-S35-5 bringing medicine management 高橋正明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 151-151, 2014.

---

	The system which supports 28-H-S35-6 clinical studies 青柳吉博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 151-151, 2014.

---

	28-H-S35-7 usable information system architectural invention 木下元一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 152-152, 2014.

---

	28-H-S36-1 We will regard remedy characteristics as dosage form of the oral medicine once again - Concrete suggestion, overseas mini-tablet introduction of the taste bitter inhibition - 内田享弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 154-154, 2014.

---

	It is ... from the situation of invention - hospital pharmacist for medication ad here Lance improvement and maintenance of 28-H-S36-2 children 中井由佳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 154-154, 2014.

---

	It is ... from the situation of invention - drugstore pharmacist for medication ad here Lance improvement and maintenance of 28-H-S36-3 elderly people 政田啓子, 永井佳代子, 平田ひとみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 155-155, 2014.

---

	28-H-S36-4 medication ad here Lance and medication adjuvant jelly 福居篤子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 155-155, 2014.

---

	Remedy characteristics and taste bitter masking evaluation of the 28-H-S36-5 dry syrup 吉田都, 原口珠実, 櫨川舞, 内田享弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 156-156, 2014.

---

	Remedy-related evaluation of the collapse film preparation in the 28-H-S36-6 oral cavity 竹内淑子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 156-156, 2014.

---

	Clinical functionality of the orally disintegrating tablet promoting 28-H-S36-7 medication ad here Lance improvement 並木徳之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 157-157, 2014.

---

	Point of a trend and the system official regulations revision of the pharmacist authorization specialized in 28-C-ES-1 cancer 谷川原祐介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 162-162, 2014.

---

	A fact and case summary (stomach cancer) of the 28-C-ES-2 pharmaceutical intervention 末次王卓 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 162-162, 2014.

---

	A fact and case summary (non-small cell lung cancer) of the 28-C-ES-3 pharmaceutical intervention 浅野裕紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 163-163, 2014.

---

	A fact and case summary (breast cancer) of the 28-C-ES-4 pharmaceutical intervention 縄田修一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 163-163, 2014.

---

	A fact and case summary (biliary cancer) of the 28-C-ES-5 pharmaceutical intervention 高瀬美咲枝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 164-164, 2014.

---

	The art of the 28-C-ES-6 case summary form: Inappropriate example 濱敏弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 164-164, 2014.

---

	How to write case summary for authorized application of the pharmacists specialized in 28-WS-1 medical therapy (psychiatry domain) 千崎康司1, 亀井浩行2,3, 山田清文1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 166-166, 2014.

---

	How to write case summary for authorized application of the pharmacists specialized in 28-WS-2 medical therapy (digestive organ domain) 山崎美保1, 前田頼伸1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 166-166, 2014.

---

	How to write case summary for authorized application of the pharmacists specialized in 28-WS-3 medical therapy (heart, vascular disease domain) 錦織淳美1, 千堂年昭1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 167-167, 2014.

---

	How to write case summary for authorized application of the pharmacists specialized in 28-WS-4 medical therapy (internal secretion, metabolism domain) 岡田守弘1,2, 河原昌美3,4, 西上潤1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 167-167, 2014.

---

	How to write case summary for authorized application of the pharmacists specialized in 28-WS-5 medical therapy (blood and blood-forming organ disease domain) 安武夫1, 黒川陽介1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 168-168, 2014.

---

	How to write case summary for authorized application of the pharmacists specialized in 28-WS-6 medical therapy (infection domain) 吉田優子1, 矢野育子1,2, 松原和夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 168-168, 2014.

---

	How to write case summary for authorized application of the pharmacists specialized in 28-WS-7 medical therapy (circulatory organ domain) 登佳寿子, 橋田亨 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 169-169, 2014.

---

	Examination of the racial differences between 27-O1PM-01 warfarin and hemorrhagic side effect in the dabigatran 小川喜寛, 伊東真紀, 河合加奈, 西川良平, 頭金正博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 173-173, 2014.

---

	Examination of the onset of dermatopathy factor with the cytarabine administration in patients with 27-O1PM-02 blood-forming organ tumor 森尾佳代子1,2, 水木満佐央3, 寒水孝司4, 上島悦子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 174-174, 2014.

---

	Fact-finding of the hepatoscopy level abnormality with the 27-O1PM-03 sulbactam / cefoperazone preparation 下田賢一郎1, 星野輝彦1,2, 塩津和則1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 174-174, 2014.

---

	Effect of the fact-finding of the side effect of 27-O1PM-04 clozapine and the intervention by the pharmacist 八田眞菜美1, 重面雄紀1, 山本将太1, 萱野勇一郎1, 大村友博1, 矢野育子1, 諏訪太朗2, 村井俊哉2, 松原和夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 175-175, 2014.

---

	An action to safe breaking news about the serious hypocalcemia by the 27-O1PM-05 orchid mark (denosumab) and the result 小田泰弘, 伊藤忠明, 福司佳穂里, 熊木雄一, 箕曲真由美, 藤井博之, 内田ゆみ子, 田村宏美, 林昌洋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 175-175, 2014.

---

	The trial that we compile the outside Parliament prescriptions which a 27-O1PM-06 University outbuilding, internal secretion internal medicine metabolism department published into a database, and the actual situation analyzes diabetes medical therapy 富田基郎1, 竹之内敏孝2, 中野泰子1, 谷山松雄3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 176-176, 2014.

---

	Study on detection of the agranulocytosis as the side effect that we applied 27-O1PM-07 medical care information database in 山田健人1, 渡邊崇1, 木村通男2, 堀雄史3, 川上純一3, 頭金正博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 177-177, 2014.

---

	Examination of the measures by all case registration systems and many types of job teams of Serious Adverse Event (SAE) which needed hospitalization after 27-O1PM-08 outpatient department chemotherapy 浅子恵利1,2, 石原優1,2, 近藤芳弘1,2, 熊谷匡也2,3, 味八木寿子2,4, 山田みつぎ1,5, 鎌形幸子1,5, 中澤裕子1,5, 辻村秀樹2,6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 177-177, 2014.

---

	The drug residual actual situation and the risk factor to have an influence on the 27-O1PM-09 endoscopy upper gastrointestinal tract 伊勢文孝1, 安藤貴志2, 今本栄子2, 北澤文章1, 東克彌1, 上田久美1, 杉井彦文3, 長井克人4, 小西廣己4, 国府孝敏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 178-178, 2014.

---

	Modified simple suspension method 2 that used 27-O1PM-10 supersonic wave vibration together 松村久男, 飯田美奈子, 松田佳和, 木村正幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 178-178, 2014.

---

	The effect that wall Invasion depth of the primary tumor in the 27-O2PM-01 cancer of the esophagus chemotherapy gives to retching, vomiting with the chemotherapy 早坂州生1, 佐藤佑一朗1, 竹内公美1, 高橋宏明3, 細川正夫2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 179-179, 2014.

---

	Examination of the risk factor due to the candidiasis infection onset after the chemotherapy for patients with 27-O2PM-02 malignant lymphoma 小室雅人, 松井礼子, 高橋邦雄, 市田泰彦, 齋藤真一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 180-180, 2014.

---

	One case that suggested an index to predict hyperammonemia attributable to the 27-O2PM-03 5-FU hypermetabolism and the expression 池村健治1, 永春圭規2, 山下芳樹2, 石橋美紀1, 水野聡朗2, 村木優一1, 岩本卓也1, 片山直之2, 奥田真弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 180-180, 2014.

---

	Identification of the risk factor of vincristine-induced early peripheral neuropathy in 27-O2PM-04 R-CHOP therapy and the R-CHOP-like therapy 岡田直人1, 花房剛志2, 寺岡和彦1, 中村敏己1, 川添和義1, 水口和生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 181-181, 2014.

---

	Examination of the total bilirubin levels that can become the dose setting standard of irinotecan in patients with 27-O2PM-05 gastrointestinal carcinoma 東さやか, 槙原克也, 川戸順之, 上野裕之, 中多泉 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 181-181, 2014.

---

	Examination about the risk factor of the hypocalcemia onset in 27-O2PM-06 denosumab treated patients 計良貴之, 持田理菜, 塚田泰隆, 山岡結, 荒木良介, 田中恒明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 182-182, 2014.

---

	Association with dermatopathy frequency, the disease severity of 27-O2PM-07 STAT3 genetic polymorphism and the molecular target drug 山本和宏1, 平田佐智1, 山口徹郎1, 須野学2, 三宅秀明3, 藤澤正人3, 尾藤利憲4, 錦織千佳子4, 西岡達也1, 久米学1, 槇本博雄1, 中川勉1, 平野剛1, 平井みどり1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 183-183, 2014.

---

	Factor analysis of the hands and feet skin test with sorafenib using the 27-O2PM-08 order logistic-regression analysis 神林祐子1,2, 細川豊史2, 安居幸一郎3, 本郷文弥4, 山口寛二3, 森口理久3, 四方敬介1, 三木恒治4, 伊藤義人3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 183-183, 2014.

---

	We see a clinical factor and the rear of the glomerular filtration rate calculation method affecting the serious blood toxicity expression of the 27-O2PM-09 gynecology cancer carboplatin combination chemotherapy and analyze a mark 岡田浩司, 大村雅之, 高橋紗英子, 菊池亮大, 増田晃, 松川幸市 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 184-184, 2014.

---

	The dihydropyrimidinase genetic polymorphism of the patients who developed a serious side effect by 27-O2PM-10 capecitabine administration and the family and urinary pyrimidine analysis 平塚真弘1,2,3, 山下洋2, 赤井文香1, 細野寛貴1, 平澤典保1, 森隆弘3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 184-184, 2014.

---

	Construction of medical treatment management (PBPM) based on a physician, a pharmacist collaboration protocol in the 27-O3PM-01 HIV outpatient department and the evaluation 石橋美紀1, 浦野公彦1,2, 松本剛史3, 大石晃嗣3, 村木優一1, 岩本卓也1, 奥田真弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2014.

---

	It is examination about the usefulness of the pharmacist outpatient department by the adjuvant chemotherapy after 27-O3PM-02 stomach cancer technique 洞澤智至, 松井礼子, 川澄賢司, 市田泰彦, 高橋邦雄, 齊藤真一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2014.

---

	It is ... through 569 times of number of role - medical examinations of the pharmacist examining with a physician in the outpatient department of the 27-O3PM-03 lenalidomide remedy patients, 27 case 高柳信子1, 久保嘉靖1, 奥野昌宏1, 中田学1, 浅野仁2, 田中康博2, 新里偉咲2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2014.

---

	Development of the lifesaving practical skill practice for pharmacy students which intended pharmaceutical intervention to the Primary care in the 27-O3PM-04 emergency visit 座間味義人1, 相良英憲2, 今井徹3, 原直己4, 小山敏広5, 武本あかね6, 北村佳久6, 千堂年昭6, 名倉弘哲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2014.

---

	Construction of the doubt inquiry protocol by the cooperation with the physician in the 27-O3PM-05 outside Parliament prescription 吉田宗広, 船戸元子, 奥村雅美, 階戸美和, 井藤俊, 森正昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2014.

---

	27-O3PM-06 Disclosure of the regimen name to outside Parliament prescription aiming at reporting of the better cancer chemotherapy ･･Thing to see from a meeting a demand drugstore questionnaire･･ 徳永晃1,2,3,4, 末松耕輔1, 中山貴夫1, 松永尚1, 佐保澄子2, 嬉野紀夫3,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2014.

---

	We examine illness using 27-O3PM-07 tracing report (medication reporting book) and are promoted the medicine cooperation 礒本唯, 萱野勇一郎, 池見泰明, 杉本充弘, 大村友博, 米澤淳, 深津祥央, 松原和夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2014.

---

	An inhalational instruction foreign action and the evaluation to be carried out by 27-O3PM-08 health insurance pharmacy and collaboration 寺尾真琴1,2, 杉本充弘1, 萱野勇一郎1, 蓼原昌美1, 木村嘉彦1, 小形瑛1, 都築徹教1, 山際岳朗1, 吉田優子1, 今井哲司1, 矢野育子1, 佐藤晋2, 松本久子2, 室繁郎2, 松原和夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2014.

---

	Trial of the medical support by the pharmacist dispatch to depopulated area Hospital of the 27-O3PM-09 pharmacist absence 石橋直哉1, 津田真弘1, 佐藤裕紀1, 池見泰明1, 松田裕也1, 八田眞菜美1, 小枝正吉3, 高橋和也4, 大原雄希4, 志賀弘康5, 中川俊作1, 深津祥央1, 米澤淳1, 田崎嘉一3, 宮本篤4, 井関健5, 白井正信2, 松原和夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2014.

---

	Cost effectiveness analysis of the long time effect type bronchodilator in patients with COPD of the 27-O3PM-10 climax 長谷川彩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2014.

---

	Examination of the clinical features of the in-hospital onset bloodstream infections in patients with 27-O4PM-01 solid carcinoma and the prognostic factor 塚本仁1,2, 新谷智則1, 飛田征男2,3, 室井洋子2, 池ヶ谷論史2, 岩崎博道2, 中村敏明1, 政田幹夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2014.

---

	Risk factor of the preoperation MRSA intranasal carrying germ in the 27-O4PM-02 inflammatory bowel disease (IBD) patients 高橋佳子1, 竹末芳生2, 辰己純代1, 田久保慎吾1, 木村健1, 植田貴史2, 内野基3, 池内浩基3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2014.

---

	Enforcement situation investigation of the 27-O4PM-03 HBV reactivation initial screening test 清水倫子1, 津田真弘1, 池見泰明1, 深津祥央1, 石塚良子1, 米澤淳1, 松村由美2, 松原和夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2014.

---

	Improvement ... of the risk management awareness by HBV reactivation measures - HBView introduction in the 27-O4PM-04 cancer chemotherapy 真川明将1,2, 竹本将士1, 伊豆田美晴1, 黒田純子1, 江崎哲夫1, 木村和哲1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2014.

---

Examination about the association with the herpesvirus infection onset after the R-CHOP therapy start in patients with 27-O4PM-05 diffuse large-cell B-cell lymphoma and the index of immunity 伊藤佳織1,2, 岡本昌隆2, 安藤舞子1, 辻井奈保1, 屋良枝利1, 岡本晃直2, 稲熊容子2, 徳田倍将2, 加藤さや香1, 牧原俊康1, 赤塚美樹2, 恵美宣彦2, 山田成樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2014.

---

	Analysis of the new onset mechanism of the 27-O4PM-06 morphine-induced constipation 今理紗子, 五十嵐信智, 早川晃央, 羽賀裕介, 笛木愛華, 北岡諭, 落合和, 杉山清 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2014.

---

	Analysis of the onset mechanism of 27-O4PM-07 oxaliplatin-induced acute peripheral neuropathy: Participation of redox-sensitive TRPA1 中川貴之1,2, 趙萌2, 中村彩希2, 三宅崇仁2, 宗可奈子2, 白川久志2, 金子周司2, 松原和夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2014.

---

	Expression of skin change of aquaporin 3 at the 27-O4PM-08 diabetes-related xeroderma 五十嵐信智, 今理紗子, 豊田絵理, 中村麻里奈, 高橋悠太, 内藤春香, 落合和, 杉山清 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2014.

---

	Search of the new treatment target molecule of the chronic renal failure that assumed 27-O4PM-09 molecular clock mechanism a base 松永直哉1, 池田恵理子1, 濱村賢吾1, 近藤英明2, 一町和史1, 池山久子1, 徳重和孝1, 古市葉子1, 吉田優哉1, 小柳悟1, 大戸茂弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2014.

---

	Examination about the effect of the apolipoprotein E genetic polymorphism which gives it to the effectiveness of the thiazolidine dione system medicine in patients with 27-O4PM-10 Alzheimer type dementia 池谷怜, 大野恵子, 松本邦洋, 岸野吏志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2014.

---

	The actual situation and intervention effect of the non-proper use that blood level measurement enforcement based on the protocol for the new inpatient during 27-O5PM-01 digitalis remedy shows 岸田充弘1, 森優子1, 金子真弓1, 村木優一2, 奥田真弘2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2014.

---

	Prescription suggestion associated with the collaboration with the physician about the medication instructions by the 27-O5PM-02 ward pharmacist 唐澤暁代, 箕曲真由美, 熊木雄一, 内田ゆみ子, 藤井博之, 田村宏美, 伊藤忠明, 林昌洋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2014.

---

	Effect of the ward drug duties enforcement addition calculation for the hospitalization of the 27-O5PM-03 inpatient 濃沼政美1,4, 礒野淳一2,3, 稲葉健二郎4,5, 菅野浩-1,2,6, 佐藤透2,7, 清水淳一2,8, 加賀谷肇2,9, 赤瀬朋秀2,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2014.

---

	Medical economic effect ... by the action of the ward drug duties in the 27-O5PM-04 otolaryngology ward and the prevention of evaluation - adverse event and the effect of treatment 小林亮, 鈴木昭夫, 飯原大稔, 岡安伸二, 伊藤善規 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2014.

---

	Support systems construction and action as the team approach in medical care aiming at adequacy of the 27-O5PM-05 posttransfusion hyperferremia practice 冨田敦和1, 惠谷里奈1, 吉本一恵2, 河野彰夫3, 森下剛久3, 野村賢一1, 野田直樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2014.

---

	Examination ... about analysis - effectiveness of the clinical response about the VCM initial loading dose design in the 27-O5PM-06 serious case infection concerned 實川東洋1,2, 片山皓希1, 渡邉暁洋1, 福田恵子1, 若松孝嘉3, 齋藤伸行2,4, 八木貴典4, 原義明4, 松本尚4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2014.

---

	Population pharmacokinetics analysis of the linezolid in patients with 27-O5PM-07 impaired renal function (adults) and clinical inspection 辻泰弘1, 湯川栄二2, 平木洋一3, 太田幸雄1, 山本善裕4, 藤秀人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2014.

---

	The establishment of the separation assay of erlotinib out of the 27-O5PM-08 human plasma and metabolite OSI-413 and OSI-420 and clinical applicable evaluation 石田卓矢1, 内藤隆文1, 須田隆文2, 川上純一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2014.

---

	AUC estimate-style development of mycophenolic acid which considered the 27-O5PM-09 renal transplantation future 榎屋友幸1, 西川晃平2, 村木優一1, 岩本卓也1, 杉村芳樹2, 奥田真弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2014.

---

	An antiemesis effect of prochlorperazine in patients with 27-O5PM-10 cancer and evaluation of the factor to give it to adverse effect 田代将貴1, 内藤隆文1, 賀川義之2, 川上純一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2014.

---

	The analysis of pre-Abo id collected through 27-O1AM-01 ward drug duties and the prescription suggestion example and the joint ownership 林淳雄1, 木下里紗1, 松村友和1, 西崎恵利3, 籠本基成1, 杉山正敏2, 小林政彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2014.

---

	Usefulness of the cooperation of ward drug duties and dispensary duties based on the 27-O1AM-02 pharmaceutical products safety information 山田直香, 平野公美, 青野浩直, 堀雄史, 八木達也, 丸山修治, 川上純一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2014.

---

	Examination of the liver function test time at the 27-O1AM-03 pharmaceutical products prescription 佐藤雄己, 遠山泰崇, 西村文宏, 唐川聖司, 伊東弘樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2014.

---

	Problems in the role of MR and the drug industry in the 27-O1AM-04 drug information transmission 生島五郎, 亀田圭輔, 長澤梢, 一色靖洋, 渡来和宏, 高橋憲二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2014.

---

	We consider 27-O1AM-05 with the confirmation investigation about "the drug with mentions such as prohibition such as the driving" and examination for alerting it 長谷部啓子, 一ノ瀬直樹, 芝崎健志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2014.

---

	Action for 27-O1AM-06 generic medicine adoption promotion and the evaluation of the generic medicine 真鍋健一, 井上大奨, 高田正温, 大窪典子, 田代早紀, 橋本崇広, 永野真久, 平木洋一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2014.

---

	Effect on human liver gene expression analysis of the valacyclovir preparation using the 27-O1AM-07 humans hepatocytes chimera mouse 中嶋幹郎1, 江頭かの子1, 大脇裕一1, 中嶋弥穂子2, 島田卓3, 長塚伸一郎4, 榎本初音5, 立木秀尚5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2014.

---

	Comparison of the frequency of renal failure, other adverse events with 27-O1AM-08 cisplatin (CDDP) innovator drug and the generic drug 植田有希1, 金銅葉子3, 鈴木秀和2, 平島智徳2, 岡本紀雄2, 森下直子2, 田宮基裕2, 白山敬之2, 口分田章典1, 碓氷尚子1, 福地裕哉1, 山東真寿美1, 志村和子1, 田中恵美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2014.

---

	Utilization and application of the universal test of the 16th revised Japanese Pharmacopoeia publication for the 27-O1AM-09 commercial pharmaceutical products adoption 冨岡貢1,6, 小林智子1, 齋藤勲2,6, 向後麻里3,6, 坂田穣5, 渡邉徹4,6, 渡部直木9, 杉浦宏美10, 大塚誠11, 中村明弘8, 木内祐二12, 山元俊憲7, 村山純一郎1,6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2014.

---

	Effect of the foreign element derived from the ceftriaxone which gives it to incompatibility of 27-O1AM-10 ceftriaxone sodium and calcium 丹下美緒, 吉田都, 櫨川舞, 原口珠実, 内田享弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2014.

---

	Fact-finding in the use of 27-O1PM-11 electronic edition medicine notebook and examination about the usefulness 市橋哲平, 清水俊樹, 長南謙一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2014.

---

	The inflection situation of activity and the medicine counselor's office as the pharmacist specialized in HIV infection in the 27-O1PM-12 health insurance pharmacy 中村美紀, 佐藤真基子, 城尾秀和 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2014.

---

	Prescription fact-finding of the osteoporotic therapeutic drug after the proton pump inhibitor remedy in the 27-O1PM-13 health insurance pharmacy 濱田光洋, 彼末桃子, 有馬和希, 勝田剛史, 妹尾波枝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2014.

---

	The 27-O1PM-14 patients choose an OD lock; or in the case of - pitavastatin - 星野輝彦, 中尾美希 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2014.

---

	Inspection of the formulations maneuver in a very small amount of preparation with the 27-O1PM-15 powders automatic packeted plane 木下佳苗1,2, 長谷川裕子1,2, 菊地智恵里1,2, 玉井典子1,2, 小池一男3, 佐藤忠章3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2014.

---

	The workshop which regards a countermeasure as problems aiming at consciousness improvement in the medication assistance for the 27-O1PM-16 care staff 朴恵林1, 三木晶子1, 佐藤宏樹1, 馬来秀行2, 浅井康平2, 小西ゆかり2, 澤田康文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2014.

---

	Attitude survey about the communication of the pharmacist in the 27-O1PM-17 healthcare setting 原伸輔1, 谷向仁2, 松井智子3, 上森美和子4, 岡本禎晃5, 三輪芳弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2014.

---

	Examination of consciousness and the job evaluation of the pharmacist of the 27-O1PM-18 chronic phase hospital 岡添進1, 渡邉百合子2, 新井亘3, 矢吹直寛4, 矢嶋美樹5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2014.

---

	Change - second report ... of a consciousness change and the duties contents of the 27-O1PM-19 pharmacist 新井亘1, 渡邉百合子2, 岡添進3, 矢吹直寛4, 矢嶋美樹5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2014.

---

	Development and inspection of the 27-O1PM-20 new face pharmacist educational program 笠師久美子, 宮本剛典, 原田幸子, 熊井正貴, 深井敏隆, 山田武宏, 井関健 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2014.

---

	Enforcement of the benchmark about antimicrobial consumption and the chemosensitivity between the preventive measures against 27-O2AM-01 infection addition 1.2 cooperation hospital 石田茂伸1,2, 楠本茂雅1, 太田真希1, 笹谷純平1,3, 京和里枝1,2, 竹村陽介1,3, 田中まこと1,3, 川村真代1,3, 大島利夫1,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2014.

---

	Difference in Defined Daily Dose and Prescribed Daily Dose at the 27-O2AM-02 antimicrobial consumption evaluation 宮崎元康, 坂元佑哉, 川田哲史, 田中麻衣子, 山廣胤之, 井上貴文, 島田安希子, 西美樹, 松尾宏一, 神村英利 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2014.

---

	It is examined the antibiotic for the surgical site infection prevention after the stomach cancer surgery in 27-O2AM-03 elderly people 深見和宏1, 間瀬広樹1, 木ノ下智康1, 溝神文博1, 藤崎浩太郎2, 北川雄二3, 深田伸二3, 伊藤一弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2014.

---

	Importance to think about 27-O2AM-04 antimicrobial proper use from a clinical situation 松永宣史1, 畑中絵里子1, 池田寿昭2, 上野琢哉2, 須田慎吾2, 奥山清1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2014.

---

	Use fact-finding for the azithromycin infusion for 27-O2AM-05 elderly people pneumonia 昆貴志1, 森雅之1, 橋本貴尚1, 飯島秀弥2, 栃窪克行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2014.

---

	Three cases with suspected bradyarrhythmia with the 27-O2AM-06 donepezil hydrochloride 木下真理子, 吉岡大樹, 廣兼誠, 森善洋, 藤田有紀子, 佐道紳一, 吉村敏朗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2014.

---

	Analysis of carbohydrate metabolism, the electrolyte abnormality risk factor of the 27-O2AM-07 steroid (hydrocortisone succinic acid ester sodium) pulse therapy 児玉暁人1, 吉野新太郎1, 岩田智津子1, 高橋文香1, 八尾祥子1, 森信介1, 小竹武2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2014.

---

	The situation of the prophylactic administration of osteoporotic medicine for the steroidal osteoporosis in our 27-O2AM-08 House 佐藤幸恵, 龍田涼佑, 槇原洋子, 佐藤雄己, 伊東弘樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2014.

---

	Investigation about the onset of sleep loss by the steroid introduction in the 27-O2AM-09 collagenosis internal medicine 藤田強記, 福山雄卯介, 松尾圭祐, 三角紳博, 西野隆 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2014.

---

	Study on improvement effect of the eicosapentaenoic acid which gives it to onset of impaired glucose tolerance mechanism in the cyclosporine administration for 27-O2AM-10 long term 真島崇1, 佐々木一樹2, 大原宏司2, 高橋則男2, 関健二郎2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2014.

---

	Investigation analysis of the central nervous system side effect of pregabalin in 27-O2PM-11 haemodialysis patients 隅野和美1, 古久保拓1, 吉田拓弥1, 三宅瑞穂1, 田中梨惠1, 小田智子1, 庄司繁市2, 山川智之2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2014.

---

	Safe examination of rivaroxaban in the 27-O2PM-12 decreased renal function case 宮村大佑1,2, 芦川直也2, 鷲見佳子1, 上村裕美1, 岩田晃佳1, 石黒英行2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2014.

---

	One patient who succeeded in treatment continuation by hyposensitization for the 27-O2PM-13 rifampicin liver damage suspicion 仲鉢英夫1, 簑島隆仁1, 齋藤佳苗1, 松浦亮2, 守矢英和2, 日高寿美2, 大竹剛靖2, 小林修三2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2014.

---

	Present conditions report in pseudoaldosteronism with the 27-O2PM-14 Glycyrrhiza preparation and our House 吉澤亜紗美, 野澤正徳, 三浦毅, 畔柳敏弥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2014.

---

	Usefulness of the pharmacist participation in the early diagnosis of the 27-O2PM-15 drug induced hepatic injury 橋本陽1, 大森茂2, 松田真左子1, 石川久高1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2014.

---

	Analysis of the infusion reaction onset risk factor with 27-O2PM-16 rituximab 雨宮貴洋, 本間雅, 長瀬幸恵, 鈴木洋史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2014.

---

	Examination about the effectiveness and the safety of 27-O2PM-17 rasburicase 安藤舞子1, 岡本昌隆2, 伊藤佳織1,2, 辻井奈保1, 屋良枝利1, 岡本晃直2, 稲熊容子2, 徳田倍将2, 蟹江匡治2, 加藤さや香1, 牧原俊康1, 赤塚美樹2, 恵美宣彦2, 山田成樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2014.

---

	It is ... mainly on proper use of intervention - rasburicase of the pharmacist about tumor lysis syndrome measures in the 27-O2PM-18 our hospital 中川隼一, 伊藤あゆみ, 桝茂典, 岡田悠美, 村上敏明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2014.

---

	Examination of the onset of hypocalcemia predictor with the 27-O2PM-19 denosumab subcutaneous injection 松本浩明, 奥田敏勝, 森谷康志, 徳田衡紀, 高柳和伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2014.

---

	Examination of the onset of hypocalcemia by the decreased renal function at use of 27-O2PM-20 denosumab 石田耕太, 清水里紗, 植松和子, 遠藤巌 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2014.

---

	27-O3AM-01 The prescription situation in patients with schizophrenia in our hospital - Comparisons from 2011 to 2013 - 加藤剛1, 北川綾子1, 唐澤佳孝2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2014.

---

	Use of clozapine experience for treatment-resistant schizophrenia in our 27-O3AM-02 House and action of the pharmacist 吉村優1, 岡田孝司1, 馬場浩一2, 馬場信二2, 亀井聖史2, 坂本成映2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2014.

---

	Attitude survey of the medication self-care introduction in the 27-O3AM-03 psychiatry clinical pass 高橋満里, 森亨, 石塚淑子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2014.

---

	Retrograded investigation in the medication continuation of the 27-O3AM-04 donepezil hydrochloride 渡邉ゆきの1, 松田公子1, 加瀬浩二1, 秀野武彦2, 浅井邦彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2014.

---

	About patients with Alzheimer's dementia that led to improvement of the drug compliance by many types of job cooperation in 27-O3AM-05 at-home visit medication counseling 成井繁 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2014.

---

	Examination of the sitagliptin in the 27-O3AM-06 obesity type 2 diabetes model mouse and the usability for the diabetes progress by the pitavastatin combination 廣谷芳彦, 奥村香利, 尾崎望, 浦嶋庸子, 名徳倫明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2014.

---

	Comparison - second report - between the preparation of the 27-O3AM-07 DPP-4 inhibitor 富岡節子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2014.

---

	Effect and examination of the patients background factor that administration gives to lipid metabolism of the 27-O3AM-08 liraglutide 藤田有紀子1, 吉岡大樹1, 佐道紳一1, 木下真理子1, 森善洋1, 川崎英二2, 森内昭江2, 吉村敏朗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2014.

---

	Examination about the usefulness of the DPP-4 inhibitor sitagliptin in 27-O3AM-09 type 2 diabetes treatment 出羽祐基, 有本諭司, 坂野千賀, 松浦暢子, 大里恭章 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2014.

---

	About the construction of the contraindicated medicine prescription order check system according to the 27-O3AM-10 renal function and the use 野々内裕紀, 眞継賢一, 黒岩勇人, 上田浩貴, 古場建, 岡本朋子, 西田修司, 久保しおり, 塚本泰彦, 大石容司, 濱口良彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2014.

---

	The development of the 27-O3PM-11 ward drug duties support system ("a doubt inquiry traceability system") and utilization report to pre-Abo id 坂上嘉浩, 藤江直輝, 竹田健志, 菅田優子, 的場美香, 石樋康浩, 大津由美子, 高木麻里, 藤田敬子, 室井政子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2014.

---

	About an action of the pre-Abo id activity visualization in our 27-O3PM-12 House and the effect 宮尾美佐欣, 石倉久美子, 松浦仁志, 有田順子, 北田尚子, 松本チサ子, 楠本臣彌, 小槻典子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2014.

---

	Reevaluation of the 27-O3PM-13 internal use anticancer agent check system 尾崎正和, 廣實清司, 内田豊, 古川裕之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2014.

---

	Change of the prescription incident by the continuous drug reporting to 27-O3PM-14 physician 山下敦哉, 仲鉢英夫, 小澤康久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2014.

---

	About the enforcement of doubt inquiry content analysis and the once quantity input restrictions after the quantity of 27-O3PM-15 one time order start 山下和彦, 吉田幸洋, 山岡慶子, 池田佳那子, 西岡達也, 久米学, 槇本博雄, 平野剛, 平井みどり Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2014.

---

	Intervention to the sleeping drug proper use by the pharmacist aiming at 27-O3PM-16 fall, fall accident decrease 重面雄紀1, 八田眞菜美1, 山本将太1, 山縣有子2, 萱野勇一郎1, 石塚良子1, 中川貴之1, 矢野育子1, 杉原玄一3, 村井俊哉3, 松原和夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2014.

---

	Analysis - using - diazepam conversion of a dosage and the fall rate of the 27-O3PM-17 sleep inducer of relationships 小田真司1, 平井覚2, 井上智喜1, 渡邊良平3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2014.

---

	Usefulness of personal sheet in the biological drug for the 27-O3PM-18 rheumatoid arthritis 三柳直子1, 香川仁美1, 井澤裕子2, 三柳政道2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2014.

---

	Action aiming at improvement of the antithrombotic drug off-period at the 27-O3PM-19 digestive organ endoscope enforcement 三戸田大1, 金森美由紀1, 九門実加1, 河村真徳1, 荒川隆之1, 向田一敏2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2014.

---

Investigation about the difference with the side effect that the subjective side effect and chief physician of the patients in the outside Parliament prescription of our 27-O3PM-20 in-hospital clothes anticancer agent described 桂英之1, 北出紘規2, 森光世3, 筒井伸幸4, 酒井淳志5, 高田直子1, 城座圭子6, 石田外樹1, 湊明志1, 西田秀樹1, 山本裕実子7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2014.

---

	It is change ... by discussion third report - customer-oriented breeding about the satisfaction of the patients after consciousness and the instruction of the 27-O4AM-01 pharmacist 渡邉百合子1, 新井亘2, 岡添進3, 矢吹直寛4, 矢嶋美樹5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2014.

---

	The action for 27-O4AM-02 ward drug duties and the evaluation 中西涼子, 林淳雄, 山瀬大雄, 福島智子, 小松絵美, 畔柳弥生, 平井三保子, 松村友和, 山田邦義, 小平いく子, 籠本基成, 土井孝尚, 小林政彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2014.

---

	The example that led to early detection, the becoming severe evasion of the side effect in conference with 27-O4AM-03 ward exclusive duty pharmacist and the drug information supervising pharmacist 井出直仁, 甲賀麻里子, 佐竹啓彰, 平野茂子, 澤口和代 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2014.

---

	Examination of the factor influencing the drug self-care in patients with cerebrovascular disorder that is hospitalized at a rehabilitation ward for 27-O4AM-04 convalescence 細野真吾, 堀浩子, 松崎奈津子, 磯野礼果, 山崎崇 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2014.

---

	Examination about contents of doubt inquiry and the consultation meeting a demand in 27-O4AM-05 ward drug duties 杉本崇, 中村安孝, 外間まみ, 中川貴弘, 児玉典子, 西川武司, 永山勝也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2014.

---

	Examination of the pharmaceutical intervention method by the injection situation grasp sheet improvement in 27-O4AM-06 ward drug duties 田口美菜子, 鐵尚美, 篠崎希望, 土居美幸, 大和田有, 濱武久美子, 蛭田千昭, 田村明広 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2014.

---

	Study on simple and easy PT-INR monitoring for the 27-O4AM-07 warfarin remedy patients and pharmaceutical intervention 近藤昭志, 原田和彦, 岩澤真紀子, 和田恭一, 粉川俊則, 中村慶, 桑原健 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2014.

---

	Action of the ward pharmacist for the appropriate antiplatelet therapy for 27-O4AM-08 elective PCI case 寺島純一1, 梅村拓巳1, 勝野晋哉1, 山田哲也1, 鷹見繁宏1, 味岡正純2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2014.

---

	It is ... mainly on action ... pharmaceutical support of the ward drug duties in the 27-O4AM-09 Ogura memory hospital and the use of FileMaker 町田聖治1, 曽我弘道1, 富田敏章1, 福島将友1, 小田原由香1, 前田朱香1, 川井友美子1, 新治嘉一1, 長谷悠紀1, 相部真希1, 山下悟史1, 入江利行1, 津口正勝2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2014.

---

	The pharmaceutical intervention in 27-O4AM-10 ward drug duties is an effect on effectiveness of the medical therapy and safety improvement 木幡雄至, 永瀬怜司, 今浦将治, 西悠吾, 安藤純子, 山谷武司, 菅野浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2014.

---

	Examination of a pharmacist job evaluation and the skill mixture in the 27-O4PM-11 perioperative care team 阿部猛1, 川名賢一郎1, 小川真由美2, 片山正夫3, 宮坂勝之3, 後藤一美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2014.

---

	Evaluation of an action to the perioperative antimicrobial proper use by the 27-O4PM-12 ICT pharmacist and the intervention effect 加藤豊範, 高井希依 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2014.

---

	The perioperative prophylactic antimicrobial guidelines revision in cooperation with the 27-O4PM-13 physician and examination of the observance rate and the surgical site infection rate 石原義久, 平川尚宏, 柿元郁代, 安藤卓, 田邉徹, 向井俊貴, 福岡龍一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2014.

---

	Effect on infection frequency by the oral antibiotic deletion of the 27-O4PM-14 cataract surgery clinical pass 寺澤邦子1, 廣戸照龍2, 中島由紀2, 杉浦宗敏2, 大谷道輝1, 山村喜一1, 善本三和子3, 松元俊3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2014.

---

	Usefulness of the COPD simple test in the 27-O4PM-16 ethical pharmacy 畑中知笑美1, 内田佳久1, 藤田恵美子1, 草川美乃1, 津幡理恵1, 富田郁子1, 末澤千恵1, 須藤早百合1, 村木優一2, 奥田真弘2, 野田明雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2014.

---

	27-O4PM-17 The logistical support system by pharmacy SPD - Trial to showing the professional ability of the pharmacist - 宅和真由美1, 守谷顕人1, 橋本恵梨花1, 寺井易子1, 岸本侑子1, 入山奈央1, 植野聖子1, 村上賢次1, 神農理衣1, 小森正貴1, 三木郁帆1, 井本陽子1, 吉田尚史1, 津田里香1, 西山絵美理2, 深谷覚志2, 吉川政利2, 平田敦宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2014.

---

	Outcome evaluation - long-term medication continuance rate of the joint medical treatment management (Japanese type CDTM) in the 27-O4PM-18 OAB treatment and effect ... which gives it to shortening in the consultation hours 前堀直美1, 永江浩史2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2014.

---

	Extraction ... of the problem in the practice (2) - formulation study of the telephone symptom monitoring for patients with foreign urination disorder by the 27-O4PM-19 pharmacy student 鈴木結衣1, 安田公夫1, 前堀直美2, 永江浩史3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2014.

---

	For fact-finding - prescription representation input introduction of the prescription suggestion in the 27-O4PM-20 going to hospital treatment center - 龍島靖明1, 板垣麻衣1, 後藤功一2, 吉野孝之3, 池田公史4, 齊藤真一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2014.

---

	Effect on retching, vomiting examination of aprepitant with liver intraarterial injection chemistry embolus treatment using 27-O5AM-01 platinum drugs 岸本真, 長ヶ原琢磨, 田中沙耶香, 砂田和幸, 吉村真, 佐久間弘匡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2014.

---

	The effectiveness of the aprepitant palonosetron combination for the 27-O5AM-02 HEC, MEC regimen 小島一晃1, 美和孝之1, 濱武清範1, 奥村茜子1, 小西史子1, 中西和樹1, 北英夫2, 菅理晴3, 千葉渉4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2014.

---

	Effect of the sodium azulene sulfonate gargle on stomatitis with the 27-O5AM-03 sunitinib 志田敏宏1, 遠藤裕司1, 加藤智幸2, 冨田善彦2, 豊口禎子1, 白石正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2014.

---

	Examination of oral mucositis prophylaxis of the chemoradiotherapy in patients with 27-O5AM-04 head and neck cancer and the pain relief effect 坂本卓也, 斎藤和悦, 渡部義和, 小林義美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2014.

---

	Present conditions recognition investigation of the hypertriglyceridemic expression with 27-O5AM-05 capecitabine 野口裕介, 三谷卓哉, 瓦比呂子, 徳山洋子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2014.

---

	Examination of the effectiveness and the optimum doses of the steroid as the eruption prevention with 27-O5AM-06 pemetrexed 櫻田巧1, 柿内聡司2, 堀ノ内裕也1, 森剛志1, 西迫寛隆1, 寺岡和彦1, 中村敏己1, 川添和義1,3, 西岡安彦2, 水口和生1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2014.

---

	It is ... through the intervention by dermatopathy management - pharmacist in the 27-O5AM-07 EGFR inhibitor 上ノ段友里1, 吉田まつみ2, 上原英雄3, 藤井及三3, 岸原文明3, 縄田好一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2014.

---

	Hand-and-foot syndrome measures in the 27-O5AM-08 XELOX therapy 中村久美, 鬼窪利英, 中村将人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2014.

---

	Operational ... of the relation ... Regorafenib assessment sheet of the pharmacist in the oral 27-O5AM-09 molecular target drug 鈴木直哉, 地主隆文, 吉嶋抄苗, 福井美規子, 渡辺祐子, 徳村麻衣子, 高橋誠, 青田忠博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2014.

---

	Effect of the Goshajinkigan on peripheral neuropathy in 27-O5AM-10 paclitaxel 遠藤拓未, 坪井久美, 神谷晴敏, 渡邉進士 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2014.

---

	The evaluation of the pain using the sharp pain assessment sheet for the use of medical drug patients in the 27-O5PM-11 on admission and the future prospects 林隼輔, 安藤尚美, 須田奈美, 石井賀津二, 染谷雅弘, 平島徹, 川久保孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2014.

---

	National survey about the duties contents of the pharmacist assigned to the 27-O5PM-12 palliative care team 伊勢雄也1, 森田達也2, 木澤義之3, 片山志郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2014.

---

	Medical therapy support to the delirium patients by the 27-O5PM-13 palliative care team pharmacist 中村博子1,2, 鈴木藍1,2, 長谷綾1,2, 輪湖理絵1,2, 加藤あゆみ1,2, 池田征史2,3, 鈴木規仁2,4, 片山志郎1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2014.

---

	Examination of the factor to affect during the medication period of the tramadol oral formulation for the 27-O5PM-14 cancer sharp pain 八木貴彦, 坪井久美, 川口千香, 渡邉進士 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2014.

---

	Use of the 27-O5PM-15 fentanyl citrate oral mucosa absorption preparation (E fen buccal tablet) and fact-finding of the pharmaceutical care 畠山織江1, 近藤泰礼1, 伊藤麻子1, 矢口まりな1, 永吉ひとみ1, 岡田美香1, 岡崎千絵1, 田嶋美幸1, 佐藤邦義1, 西羅輝雄1, 竹田省2, 高橋和久3, 梶山美明4, 代田浩之1,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2014.

---

	Examination of the improvement effect of the chronic constipation by 27-O5PM-16 Lubiprostone 木寺康裕1,2, 川口明範1, 藤原季美子1, 野村守弘1, 西田升三2, 山添譲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2014.

---

	Research about the use situation of onset of mucositis and the opioid analgesic in the 27-O5PM-17 craniocervical part cancer cisplatin combination chemoradiotherapy 金剛圭佑1, 吉田幹宜1, 和田敦1, 古川美緒1, 小寺克典1, 脇下大樹1, 西村英輝2, 岡田秀明3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2014.

---

	Evaluation of the management method change of the naloxone hydrochloride note in the 27-O5PM-18 operating room 新井聡子1, 小井土啓一1, 牧野好倫1, 岩瀬治雄1, 佐藤哲文2, 林憲一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2014.

---

	Examination about the terminally ill cancer patients given the 27-O5PM-19 antinarcotic 上葛義浩1,2, 東口高志2, 二村昭彦1,2, 伊藤彰博2, 大原寛之2, 中川理子2, 阿波宏子2, 三吉彩子2, 最上恵子1, 伊東知美1, 前川ゆか1, 岩佐雅子1, 吉岡京子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2014.

---

	27-O5PM-20 Analgesic effect part density of opioid immediate release simulation for patients with cancerous sharp pain - Oral morphine deceleration time release formulation - 齋藤明子, 久保直子, 神谷絵梨奈, 壁谷めぐみ, 日比聡, 横井沙緒里, 湯浅周 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2014.

---

	Examination ... in our comparison ... House of the effect of treatment by the difference of the immunoglobulin preparations in the 28-O1AM-01 Kawasaki's disease 木原理恵1, 後藤降1, 尾上泰弘2, 上村宅司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2014.

---

	Symptom improvement of acute pericarditis, the pleurisy in 28-O1AM-02 colchicine alone and prevention of recurrence effect 上村裕美1, 芦川直也2, 岩田晃佳1, 宮村大佑1, 鷲見佳子1, 石黒英行2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2014.

---

	Evaluation about the effect of clindamycin phosphate which gives it to taste of the mother's milk using the 28-O1AM-03 taste sensor 吉田都1, 中井由佳2, 原口珠実1, 櫨川舞1, 内田享弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2014.

---

	A nourishment evaluation and side effect investigation in patients who received 28-O1AM-04 rt-PA IV therapy 大津幸, 山崎邦夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2014.

---

	Study on blood pressure fluctuation of 28-O1AM-05 sitagliptin treated patients 高井靖1, 伊藤涼子1, 梶間勇樹1, 鈴木啓之2, 宮原眞敏2, 西川英郎2, 大井一弥3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2014.

---

	Investigation about the drug participation in patients with 28-O1AM-06 bradycardia 小林由香, 高野尊行, 中丸朗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2014.

---

	Medication fact-finding results in the 28-O1AM-07 BP agent remedy patients 佐古有紀1, 桐林東一郎2, 河野弥生3,4, 花輪剛久3,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2014.

---

	One case that developed allergic by agents type change from 28-O1AM-08 tocilizumab infusion preparation to an automatic injector (pen type instillator) (injection site reaction) 臺裕子1, 平林史子1, 佐藤理仁2, 西村幸治2, 青木和利2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2014.

---

	About validity of the prior purchase judging from 28-O1AM-09 Eculizumab dosage interval change factor 中山裕一, 石橋正祥, 折井孝男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2014.

---

	Optimization of 28-O1AM-10 ward drug duties and the formula Lee management by the cooperation of the pharmaceutical products administrative work 高井伸彦, 佐野慎亮, 石田卓矢, 大江未来広, 丸山修治, 青野浩直, 川上純一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2014.

---

	Interaction analysis of lamotrigine for patients with 28-O1AM-11 children epilepsy 山本吉章1,2, 中井正彦1, 高橋昌明1, 今井克美1, 高橋幸利1, 賀川義之2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2014.

---

	Case - pharmacokinetic analysis and basic examination ... which caused interaction of 28-O1AM-12 kidney cancer therapeutic drug sunitinib and warfarin 野田哲史1, 佐村和紀2, 大塚凌3, 堀江美弥1, 平大樹1, 藤原遼4, 河内明宏4, 生城真一5, 榊利之5, 森田真也1, 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2014.

---

	Interaction of etodolac and mycophenolic acid which paid attention to the competition in the drug-binding site of 28-O1AM-13 albumin 坂元利彰, 森塚暁裕, 松永典子, 林佳奈, 川鍋早紀, 北原隆志, 佐々木均 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2014.

---

	Effect of the gastric-acid secretion inhibitor to give to blood MTX concentrations at the 28-O1AM-14 high dose methotrexate (MTX) administration 鳴海克哉1, 樋口一世1, 難波正志1, 山田順子1, 笠師久美子1, 山田武宏1, 豊嶋崇徳2, 井関健1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2014.

---

	Analysis of the factor influencing 28-O1AM-15 blood lithium concentrations 赤羽理也1, 上西幸治1, 野田哲史1, 平大樹1, 星野伸夫1, 森田真也1, 稲垣貴彦2, 高橋正洋2, 森田幸代2,3, 山田尚登2, 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2014.

---

	Than an attitude survey for treatment at home, the many types of job cooperation of the importance recognition - Kyoto Medical Association position physician of the physician for pharmacist duties in the 28-O1PM-01 treatment at home ... 小村富美子, 荒井秀典 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2014.

---

	Medical therapy management by the pharmacist physical assessment in the 28-O1PM-02 nursing facility 須田潤1, 市川隆之2, 杉山憲司2, 杉浦伸哉2, 大井一弥3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2014.

---

	It is an action toward becoming it improvement of 28-O1PM-03 treatment at home 西園憲郎1,2, 大庭信行3, 大庭隆弘1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2014.

---

	Development of the high-speed simple suspension, infusion bag for the 28-O1PM-04 transluminal administration 盛本修司, 松永祐士, 野崎雅男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2014.

---

	Thing ... which we saw from the questionary survey to role - cooperation physician of the hospital pharmacist in the 28-O1PM-05 PCI regional alliances pass 西野真代, 米田勝晃, 生川賀代, 増田晶子, 西尾佳奈 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2014.

---

	Effect of the water transport protein aquaporin which gives it to the gastrointestinal absorption of the 28-O1PM-06 drug 北岡諭, 名古屋智香, 五十嵐信智, 梶原小百合, 齊藤雅代, 川端あかね, 今理紗子, 落合和, 杉山清 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2014.

---

	Possibility as the TDM estimation of the monetary value of housework of the vancomycin densitometry out of the cells intercellular fluid with the 28-O1PM-07 solubility micro needle 稲垣勇斗1, 宇野智哉1, 谷口真優1, 林明日香1, 河渕真治1, 伊藤由佳子1, 高田寛治2, 栄田敏之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2014.

---

	Examination about the correlation of measuring equipment TDxFLx analyzer and blood methotrexate levels between TBA-25FR using the 28-O1PM-08 immunoassay method 金子哲也, 藤岡孝志, 鈴木陽介, 佐藤雄己, 伊東弘樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2014.

---

	Examination of the simple and easy liver metabolic capacity rating system by the HPLC method which assumed 28-O1PM-09 4β-hydroxycholesterol an index 佐野芽衣, 笠原美那子, 浅見麻由佳, 須賀梓, 望月伸夫, 松本邦洋, 大野恵子, 岸野吏志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2014.

---

	Effect of the transporter genetic polymorphism which gives it to the blood level of the 28-O1PM-10 mycophenolic acid glucuronic acid metabolite 加賀谷英彰1, 新岡丈典1, 齋藤満2, 沼倉一幸2, 羽渕友則2, 佐藤滋2,3, 三浦昌朋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2014.

---

	The establishment of the simultaneous assay of free form piperacillin out of the 28-O2AM-01 human plasma and tazobactam levels and evaluation of the clinical applicability 八木達也1, 内藤隆文1, 山田尚広1, 土井松幸2,3, 佐藤重仁3, 川上純一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2014.

---

	1 case - that we made transitional - synovectomy to a knee joint of 28-O2AM-02 gentamicin 大石博史1, 山形真一1, 佐藤陽昨2, 大神降行1, 井原和彦2, 冨澤達1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2014.

---

	Development ... of construction and the simulation tool of individualization medication - PGx-PK-PD population model of voriconazole based on the 28-O2AM-03 clinical Pharmacometrics 猪川和朗1, 松元一明2, 茂見茜里2, 金澤直子2, 渡辺英里香2, 右川博明1, 横山雄太1,2, 森川則文1, 武田泰生2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2014.

---

	Search of the factor influencing a blood early tacrolimus levels change after 28-O2AM-04 liver transplant 後藤綾1,2, 亀井秀弥3, 千崎康司1, 小原美和1, 毛利彰宏2, 大西康晴3, 野田幸裕2, 小倉靖弘3, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2014.

---

Analysis with blood level and the choler quantity at oral preparation and the IV preparation administration of cyclosporine in 28-O2AM-05 liver-transplant recipients concerned 早川智久1, 池谷修1, 笠井雄佑1, 篠田昌宏2, 日比泰造2, 石川春樹1, 山吉康子1, 板野理2, 尾原秀明2, 北郷実2, 阿部雄太2, 八木洋2, 松原健太郎2, 戸枝美奈子1, 山口雅也1, 星野健2, 黒田達夫2, 北川雄光2, 岡本真一郎1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2014.

---

	Compatibility evaluation of analysis software and TDM guidelines in the initial administration plan on 28-O2AM-06 vancomycin 中島誠1,2, 中木原由佳1, 野間口寛1, 林秀樹2, 寺師守彦1, 杉山正2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2014.

---

	Evaluation of the usefulness of the high-dose Teiko plastic Nin loading dose in the 28-O2AM-07 blood internal medicine domain 山口諒, 山本武人, 折山豊仁, 鈴木洋史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2014.

---

	Examination of the Teiko plastic Nin administration regimen for the 28-O2AM-08 sustained hemofiltration dialysis embodiment 植田貴史1, 竹末芳生1, 中嶋一彦1, 一木薫1, 和田恭直1, 今本千絵1, 土井田明弘1, 高橋佳子2, 石原美佳2, 木村健2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2014.

---

	One case that a multifaceted viewpoint was required in the Vayko streptomycin administration plan for patients with 28-O2AM-09 children bacterial meningitis 竹田真理子, 山崎伸吾, 鈴木達也, 高塚博一, 鈴木貴明, 岸本路子, 中村貴子, 有吉範高, 石井伊都子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2014.

---

	Construction of the initial administration of vancomycin nomogram for the febrile neutropenia complicated with 28-O2AM-10 blood malignant disorder 鈴木陽介1,2, 時松一成2, 森永裕子1, 佐藤雄己1,2, 橋永一彦2, 高野久仁子3, 幸野和洋3, 緒方正男3, 平松和史2, 伊東弘樹1, 門田淳一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2014.

---

	The effectiveness of PIPC / TAZ in pneumonia and the UTIs due to 28-O2AM-11 ESBL production bacteria 柴田祐希1, 眞中章弘1, 後藤智彦2, 小林亮治2, 百武宏志1, 小林明信1, 高木章次1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2014.

---

	The ESBL-producing bacteria investigation that was detected than 28-O2AM-12 medical treatment ward long-term inpatient 継田雅美1, 石井美帆1, 細川泰香1, 山口利男2, 尾崎京子3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2014.

---

	Treatment and the effect on adult ESBL-producing bacteria detection patients in our 28-O2AM-13 House 山本圭城1,2, 安井友佳子1,2, 塚本あゆみ1,3, 大谷典子1, 和泉多映子2, 石坂敏彦1, 八野芳巳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2014.

---

	Conversion ... from change - meeting room by the interventional method change to 28-O2AM-14 wide area antimicrobial proper use to the settings 長谷川浩司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2014.

---

	An effect and problem of the action to the antimicrobial proper use that 28-O2AM-15 small and medium size hospital pharmacist is concerned with 齋田正和1,2, 東陽一郎2, 松井健一1, 廣瀬浩一1, 金本秀之2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2014.

---

	The onset of adverse effect situation of the FOLFIRINOX therapy for patients with pancreatic cancer in our 28-O2PM-01 House 高橋新次, 前田章光, 松崎雅英, 水谷旭良 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2014.

---

	Fact-finding of the onset of hyponatremia with cisplatin in the 28-O2PM-02 solid cancer and examination about the risk factor 北国憲剛, 北出紘規, 森光恵 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2014.

---

	Examination about the need of the nedaplatin doses adjustment depending on 28-O2PM-03 renal function 岩水秀敬1, 荒木理沙1, 片岡智美1, 熊倉康郎1, 宮崎雅之1, 安藤雄一2, 永井拓1, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2014.

---

	Analysis of the factor to have an influence on the gemcitabine doses to 28-O2PM-04 elderly people 宮崎俊明1, 田中洋輔2, 筒井由佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2014.

---

	Examination of the effectiveness of the primary prophylaxis of the G-CSF for the febrile neutropenia with the 28-O2PM-05 TPF therapy 山本圭祐1,3, 石塚友一1, 川村和美1,2, 辻大樹3, 中道秀徳1, 梅原毅4, 袴田桂4, 塩川満1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2014.

---

	Examination of the liver damage aggravation expectation possibility by the 28-O2PM-06 regorafenib 久保杏奈, 米澤美和, 山田千代子, 柏原宏暢 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2014.

---

	Various GFR estimate-style comparisons on the 28-O2PM-07 electronic chart and examination of the factor affecting the difference 袰岩靖子1, 田口伸1, 鈴木翔子1, 佐藤優弥1, 吹谷和子1, 齋藤裕之2, 佐藤宏和3, 七海泰彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2014.

---

	Cytoreductive effect on intracranial abscess (meningioma) of the 28-O2PM-08 antimammary gland tumor agent (mepitiostane) 洞口拓也1, 竹中勝信2, 加藤雅康2, 野中裕康2, 吉岡史郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2014.

---

	It is examined the tolerability in the S-1 therapy as the adjuvant chemotherapy after 28-O2PM-09 pancreatic cancer technique 魚住真哉1, 篠原旭1, 小林美沙樹1, 宇田川涼子1, 大野泉2, 市田泰彦1,2, 高橋邦雄1, 池田公史2, 齋藤真一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2014.

---

	Example that 28-O2PM-10 uterine leiomyosarcoma was given docetaxel / gemcitabine combination therapy 眞継賢一1, 倉橋基尚1, 濱口良彦1, 芦原由香2, 勝矢聡子2, 谷和光2, 竹森和正2, 松本里佳3, 柳原一広4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2014.

---

	From a setup of the action - outpatient department chemotherapy center of the cancer authorization pharmacist of the 28-O3AM-01 Chiba west general hospital to regimen management and side effect measures - 香取哲哉, 河本怜史, 白幡拓也, 出雲貴文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2014.

---

	Practice of the pharmacist outpatient department based on Collaborative Drug Therapy Management in the 28-O3AM-02 outpatient department chemotherapy 奥田泰考, 荒川昌史, 深谷裕之, 須藤俊明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2014.

---

	Role of the pharmacist in the foreign chemotherapy room judging from 28-O3AM-03 intervention content 上田綾佳, 倉橋基尚, 林万紀子, 野々内裕紀, 黒岩勇人, 眞継賢一, 塚本泰彦, 濱口良彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2014.

---

	The intervention results of the pharmacist in the 28-O3AM-04 outpatient department chemotherapy room and questionary survey of the patients 草野淳一, 佐伯佳奈, 吉田理, 鈴木信也, 関山正夫, 安藤栄輝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2014.

---

	Evaluation after the by physician consultation front start in the 28-O3AM-05 outpatient department chemotherapy 野村充俊, 上岡彩佳, 齋藤結, 日浦寿美子, 木村麗砂, 横井妙子, 加藤裕芳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2014.

---

	Construction and the expression situation of the serious adverse event report system associated with the cancer chemotherapy in our 28-O3AM-06 House 内田充恵1, 川田祐一2, 椎木淳2, 飯塚香2, 萩原謙3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2014.

---

	Effect of treatment of early peginterferon alone of the hepatitis C virus infection patients by the 28-O3AM-07 needle pad accident 齋藤真慈1, 大橋憲嗣2, 加藤典華1, 小木曽真由美1, 三輪耕次1, 森昭裕2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2014.

---

	Relations with the number of hand hygiene per number of patients and patients with positive Clostridium difficile Toxin A in the 28-O3AM-08 Nagaoka Red Cross hospital with hospitalization 100 小林謙一1,5, 塩入久美子2,5, 永井久美子3,5, 西堀武明4,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2014.

---

	Construction of a side effect, interaction intelligence, analysis, the evaluation system in the 28-O3AM-09 community pharmacy, construction of the evaluation algorithm of a side effect, the interaction by the drugstore pharmacist 中嶋瞳1, 佐藤宏樹1, 笹島勝2, 澤田康文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2014.

---

	Fact-finding of the voluntary recall of the generalist medicine in 28-O3AM-10 Japan 山本千琴, 石田卓矢, 大澤隆志, 内藤隆文, 川上純一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2014.

---

	Use fact-finding of the nonsteroidal antiinflammatory drug drug for external use during the 28-O3AM-11 pregnancy 西順也1, 持永早希子1, 田崎正信1, 橋口真理子2, 横山正俊2, 藤戸博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2014.

---

	Evaluation of the exposure prevention effect using a closed ring system "neo-shield" for the product made in 28-O3AM-12 JMS Co., Ltd. anticancer agent 賀川裕貴1, 渡部匡史1, 藤室雅弘1, 竹内正彦2, 沖山忠2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2014.

---

	The worker exposure to 28-O3AM-13 anticancer agent preparation room and indoor environment pollution investigation 飯田純一1, 藤野晴互2, 安岡晋吾1, 山口文子1, 生田和之1, 加賀谷肇3, 内藤信忠2, 佐藤透1, 西沢正人2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2014.

---

	28-O3AM-14 Development for prevention of anti-cancer agent contamination "もれま栓キャップ" 石渡俊二1, 多賀淳1, 藤田秀樹2, 井上知美1, 小竹武1, 長谷川満3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2014.

---

	Possibility of the exposure through the push child to syringe at the 28-O3AM-15 cyclophosphamide preparation 前田章光1, 高畑知帆子2, 小原真紀子2, 高橋新次1, 松崎雅英1, 梶田正樹1, 水谷旭良1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2014.

---

	Examination of rate of application and the infection onset risk of the lipid microsphere in the 28-O3PM-01 low weight patients 堀田栄治1, 高崎紗世1, 中根論士1, 山岸利隆1, 好川隆志1, 伊藤幸男1, 伊藤妃佐子1, 宗本義則2, 津田豪太3, 高嶋孝次郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2014.

---

	The examination that is safe the use actual situation of metronidazole and an effect on 28-O3PM-02 intraperitoneal infections disease 佐藤和人, 猪瀬裕亮, 稲田寛之, 小川和奈, 海老根香里, 秋山裕史, 関利一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2014.

---

	Safety assessment of azithromycin for the 28-O3PM-03 infusion 田中広紀1,2, 林誠3, 林宗貴4, 向後麻里1,2, 村山純一郎2,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2014.

---

	A ratio and the course of the pancytopenia by linezolid (LZD) in 28-O3PM-04 patients on dialysis 加藤秀雄1,2, 浜田幸宏1,2, 萩原真生1,2, 川澄紀代1,2, 平井潤2,3, 山岸由佳2,3, 三鴨廣繁2,3,4, 松浦克彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2014.

---

	Examination of the risk factor of thrombocytopenia with the 28-O3PM-05 linezolid administration 泉澤友宏1, 金子知由1, 水之江亜美1, 勝俣はるみ1, 吉田正樹2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2014.

---

	Evaluation of a blood culture-positive patients round by 28-O3PM-06 Antimicrobial stewardship team and the outcome 前田真之1, 詫間隆博2, 峯村純子3, 宇賀神和久4, 内藤結花3, 土屋亜由美5, 大戸祐治6, 小司久志2, 石野敬子1, 二木芳人2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2014.

---

	Effect of Antimicrobial Stewardship Program (ASP) in the pediatric hospital which assumed 28-O3PM-07 Days of therapy (DOTs) an index 諏訪淳一1, 佐々木晴香1, 樋口浩2, 伊藤健太3, 堀越裕歩3, 内川清次1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2014.

---

	An action and effect of symptom minute description making adjuvant four years by the 28-O3PM-08 pharmacist 原弘士, 永井徹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2014.

---

	Evaluation of a dose and the effectiveness of micafungin for the 28-O3PM-09 Candida bloodstream infection 菅原隆文1, 岡本良一2, 開浩一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2014.

---

	Is the delactation of the nursing mother at the 28-O3PM-10 levofloxacin administration really necessary? 大久保正1,2, 田中真理子2, 大久保七枝3, 大久保節子4, 大久保美穂5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2014.

---

Introduction of the joint medical treatment management by a physician, a medical technologist, the pharmacist about the HBV reactivation prevention with the 28-O4AM-01 cancer chemotherapy 内畠久美子1, 尾崎誠一1, 高橋恭平1, 村上輝明1, 谷口仁司1, 田阪武司1, 森近俊之1, 小澤秀弘1, 吉田昭昌5, 二五田基文6, 花本公津枝2, 石田克成2, 宮下真奈備3, 久山彰一4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2014.

---

	Action of our House to the HBV reactivation for the 28-O4AM-02 S-1 new remedy start patients 菅原さやか, 滝本典夫, 杉浦充, 足立守 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2014.

---

	We work on a change of the examination for HBV situation for patients who received chemotherapy in our 28-O4AM-03 House and the enlightenment by the pharmacist 磯田祥1, 後藤隆1, 下村真代2, 阪元孝志1, 上村宅司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2014.

---

	Use and usefulness of the temozolomide bevacizumab combination therapy worksheet in the 28-O4AM-04 team approach in medical care 階戸美和1, 笹山潔1, 藤本直也1, 光田幸彦2, 谷口香3, 山鍬清美3, 森正昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2014.

---

	Examination about the effectiveness of the regimen observance by the pharmacist intervention in the 28-O4AM-05 cancer chemotherapy 林誠1,2, 長岡宏一1, 舟木弘1, 崔吉道2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2014.

---

	Duties in the 28-O4AM-06 initial treatment room 佐野邦明1, 高木雄一1, 松本富夫1, 太内田房子2, 浅香えみ子2, 池上敬一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 241-241, 2014.

---

	Examination ... in study on pneumonia (aspiration pneumonia in particular) onset risk factor - ICU inpatients of 28-O4AM-07 elderly people 松島彩音1, 黒川央2, 辻琢己1, 河野武幸1, 河合実2, 玉田太志2, 上野裕之3, 志馬伸朗4, 北村良雄2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 241-241, 2014.

---

	Inspection about the medical treatment intervention by the 28-O4AM-08 altitude critical care center charge pharmacist 藤江直輝1, 佐藤了1, 竹田健志1, 高木麻里1, 藤田敬子1, 坂上嘉浩1, 藤見聡2, 室井政子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 241-241, 2014.

---

	1 case that we managed pharmaceutical for terminal phase in the 28-O4AM-09 emergency care 九鬼大作, 藤田征志, 山中祐治, 山川卓哉 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 241-241, 2014.

---

	The enforcement of the ward drug duties in the 28-O4AM-10 neonatal intensive care unit and drug control instruction duties and evaluation of the usefulness 大原早織, 等浩太郎, 八木達也, 原内智慧, 久保野尚子, 内藤隆文, 川上純一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 241-241, 2014.

---

	Construction of the 28-O4AM-11 disaster support pharmaceutical products supply system of administration 加藤寛1, 北小路学1, 石渡俊二1, 安藤和佳子2, 安達秀樹2, 鵜山泰詳3, 櫻田ゆかり4, 井上知美1, 松山賢治1, 小竹武1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2014.

---

	Relation of the pharmacist to domestic disaster medical care support to learn from support activity to 28-O4AM-12 Philippines typhoon damage 加藤あゆみ1,6, 浅川淳2,6, 森田貴子3,6, 惠谷誠司4,6, 涌嶋伴之助5,6, 片山志郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2014.

---

Participate in the large-scale disaster medical care support activity caused by the typhoon in Philippines in 28-O4AM-13 2013; and of the pharmacist in the large-scale disaster medical care support activity in ... foreign countries is associated; ... 佐藤晴彦1,2, 高力俊策2, 池原康一1,2, 村上楽2,3, 伊禮武1, 上原克代1, 知花幸仙1, 伊波潔1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2014.

---

	Medical correspondence of our House in 28-O4AM-14 "Fukuchiyama-shi fireworks display stall explosion accident" 立道直美, 藤本華衣, 芦田理沙, 足立圭司, 村上由樹, 真下智行, 川見里奈, 堀雅博, 足垣亮介, 山本真世, 宮谷正哉, 勝井靖, 近藤あい Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2014.

---

	Simulation at new stock index and inland earthquake of the antimicrobial for the 28-O4AM-15 injection 安田千賀, 寺岡知寿, 岸川有紀, 鈴木博也, 松浦正樹, 佐藤真由美, 久道周彦, 眞野成康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2014.

---

	Introduction of the joint medical treatment management (PBPM: Protocol-Based Pharmacotherapy Management) in the 28-O4PM-01 MRSA treatment and the effect 中居肇1, 工藤香澄1, 松田俊之2, 中村一成1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2014.

---

	About usefulness of safety and the blood level monitoring of the 28-O4PM-02 antiMRSA medicine daptomycin 安藤基純1, 小曳恵里子2, 中浴伸二2, 柏木裕子2, 北田徳昭2, 亀井博紀3, 園諭美3, 西岡弘晶3, 福田剛史4, 橋田亨2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2014.

---

	Examination ... about analysis - renal failure of the clinical response about the initial loading dose design of VCM in the 28-O4PM-03 serious case infection of relationships 片山皓希1, 實川東洋1,2, 渡邉暁洋1, 福田恵子1, 若松孝嘉3, 齋藤伸行2,4, 八木貴典4, 原義明4, 松本尚4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2014.

---

	Improvement of the treatment result of the use of antiMRSA medicine case with all 28-O4PM-04 injectable antimicrobial surveillance systems 鈴木景子1, 丹羽隆1,2, 外海友規1, 渡邉珠代2, 太田浩敏2, 土屋麻由美2, 安田浩二1, 村上啓雄2, 伊藤善規1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2014.

---

	It is an investigation about the onset of renal failure of the glycopeptide-based antimicrobial in the patients after hematopoietic stem cell transplantation during 28-O4PM-05 tacrolimus administration 中川裕司1, 榎屋友幸1, 石橋美紀1, 村木優一1, 門間文彦2, 藤枝敦史2, 片山直之2, 岩本卓也1, 奥田真弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2014.

---

	Search of the patients side factor which gives it to the hoarse onset with the 28-O4PM-06 inhalant and the pharmaceutic factor 平大樹1, 腰山節子2, 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2014.

---

	Indirect comparison of the effect of treatment of the long-term effect type bronchodilator for the 28-O4PM-07 chronic obstructive pulmonary disease (COPD) patients 茂木まどか, 長谷川彩, 赤沢学 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2014.

---

	Action of the pharmacist to 28-O4PM-08 inhalant ad here Lance improvement 鶴居勝也1, 波多晶子1, 三谷和恵1, 中尾大介1, 窪田真弓1, 斎田真紀2, 松川珠絵2, 瀧本文恵2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2014.

---

	Long-term evaluation of the asthmatic inhalational instruction by the 28-O4PM-09 pharmacist 内山直樹1, 井上正朝1, 長嶋恵1, 桜庭好祐1, 川崎裕世1, 寒藤雅俊1, 大井希美1, 小川聡1, 粟屋敏雄1, 福土将秀1, 松原和夫2, 田崎嘉一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2014.

---

	Comparison between use actual situation - internal medicine and otolaryngology ... of the antiallergic agent used for 28-O4PM-10 allergic property cough treatment 石坂悠1, 武隈洋2, 吉村恵理3, 吉田憲史3, 小嶋希望3, 上野英文3, 菅原満2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2014.

---

	About an action and the effect of the medicine medicine cooperation on oral 28-O5AM-01 anticancer agent single agent 遠藤征裕, 齋藤雅隆, 森川和夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2014.

---

	Action about the cooperation with the local health insurance drugstore by our 28-O5AM-02 House outpatient department chemotherapy room pharmacist 外石昇1,3, 大友雅子4, 村岡周一4, 村上明男1,3, 吾妻美香1, 堀部聖1, 山賀亮祐1, 長久保久仁子5, 山口健太郎2,3, 渡邉一則1, 吉松和彦2,3, 成高義彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2014.

---

	The information communalization by regimen mention of the 28-O5AM-03 anticancer agent prescription and action by the medicine medicine cooperation 小林篤史1, 池上摩弥1, 武田智子2, 長谷川晃司2, 乙黒万喜子3, 小曽部毅4, 箕輪圭一郎5, 和田淳2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2014.

---

	Attitude survey of the health insurance pharmacy pharmacist for the prescription including the 28-O5AM-04 internal use anticancer agent 渡部一宏1, 千島己幸2, 縣和宏2, 平子庸志3, 芳川圭治3, 大石美也3, 濃沼政美4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2014.

---

	Action of the community pharmacy that we went to support 28-O5AM-05 CKD seal 氏内圭一, 木下美香, 栃本真理子, 安田亜衣, 山本真司, 杉山憲司, 杉浦伸哉 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2014.

---

	Consciousness change for the psychiatry of the student by the short-term business training at the 28-O5AM-06 psychiatry single department hospital 黒住由依, 谷口律子, 馬場大樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2014.

---

	Trial of the business training that classified 28-O5AM-07 pharmacy education model core curriculum revision into the field 岡崎彰仁, 西川かおり, 石坂忠博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2014.

---

	Suggestion (the second report) about business training instruction curriculum improvement that we thought about based on the training result of the 28-O5AM-08 past 久保みさき1, 林高弘1,2, 福井愛子2, 早川伸樹2, 山田成樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2014.

---

	The insulin self injection practice that utilized 28-O5AM-09 elderly people simulated experience set 小野浩重, 毎熊隆誉, 松山祐, 吉川雄貴, 秋山咲絵, 藤江郁, 加地弘明, 柴田隆司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2014.

---

	Does it induce the interest for the gene to have shown the handmade animation which extracts DNA from a broccoli in 28-O5AM-10 first grader basic biology lecture? 佐藤亜希子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2014.

---

	Analysis of the pre-Abo id example by the 28-O5AM-11 outpatient department chemotherapy center permanent residence pharmacist 畝佳子1, 北宅良祐1, 田邨保之1, 物部加容子1, 馬場雅子1, 上野裕之2, 河合実1, 北村良雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2014.

---

	Action of the pharmacist for the perioperative patients in the 28-O5AM-12 admitting department 矢川結香, 居塚しのぶ, 桑村恒夫, 末松文博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2014.

---

	Action of the pharmacist outpatient department for patients with diabetes in our 28-O5AM-13 House 宮原留美1, 江坂美保2, 田中理恵1, 天野博之1, 近藤洋一3, 服部麻美3, 足立守3, 大川内幸代4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2014.

---

	It is the role of the pharmacist in the follow-up outpatient department to the patients after 28-O5AM-14 hematopoietic stem cell transplantation 平井三保子1, 藤井理絵2, 松浦典子2, 籠本基成1, 通堂満3, 小林政彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2014.

---

	The administration results of Regorafenib in our 28-O5AM-15 House and action of the pharmacist preliminary examination 畑裕基1, 南野優子1, 宮部貴識1, 堀内哲也2, 山崎邦夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2014.

---

	Fact-finding of the INR management of patients with non-valvular atrial fibrillation in the warfarin therapy using 28-O5PM-01 TTR 芳賀洋祐1, 井本剛史2, 吉田丘1, 紺野恵3, 佐藤雅之4, 山口修5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2014.

---

	About the evaluation of the platelet function using the 28-O5PM-02 simple platelet function measuring instrument 本間三絵1, 江川修1, 原口渉2, 北川直毅2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2014.

---

	28-O5PM-03 It is one patient receiving cilostazol for bradycardia patients on dialysis 園田利広1, 山合耕一2, 諸隈太郎3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2014.

---

	Point of the pharmaceutical management to consider from the case that developed cerebral infarction during use of 28-O5PM-04 new oral anticoagulant drug (NOAC) 徳永晃己1, 柴田啓智1, 甲斐光1, 市川洋一1, 田中忠宏1, 永沼雅基2, 米原敏郎2, 中尾浩一3, 田上治美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2014.

---

	Examination of the tolerability of the rivaroxaban in the 28-O5PM-05 dabigatran intolerance case 岩田晃佳1, 上村裕美1, 芦川直也2, 宮村大佑1, 鷲見佳子1, 石黒英行2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2014.

---

	The choice of the 28-O5PM-06 new oral intestinal tract cleaner and examination about the usefulness 高山直樹1, 野田恵加2, 中村文保2, 西村大2, 冨樫弘一2, 野一色真弓3, 野洌孝二1, 大岡千寿子1, 多賀俊明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2014.

---

	Examination of the diuresis effect by the administration time of the 28-O5PM-07 tolvaptan 廣瀬正幸1, 田中伸享2, 高木翔1, 石原弘貴2, 川上徹2, 大野泰良2, 三輪耕次1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2014.

---

	28-O5PM-08 For usage as well as the side effects occurrence of Tolvaptan in Saiseikai Yamaguchi General Hospital 後藤志典1, 赤川英三2, 赤崎淳子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2014.

---

	An example of patients with chronic pain that the thinking disturbances with the 28-O5PM-09 high dose fentanyl patch were found in 大東敏和, 佐伯康之, 畝井浩子, 木村康浩, 木平健治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2014.

---

	One case of patients with impaired renal function that resulted in myasthenia due to the overdose of 28-O5PM-10 cibenzoline succinate tablets 中川義浩1,2, 山部美千子1, 竹内小百合1, 上山秀嗣2, 石崎雅俊2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2014.

---

	Relations with crystallinity and the dissolution of the drug out of the 27-P1AM-001 preparation: About itraconazole 安藝初美1, 向井千晶1, 山田楊太1, 溝部健2, 川原光喜1, 湯川美穂1, 湯川栄二3, 池田浩人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2014.

---

	Comparison between innovator drug and side effect in the acute phase with the generic drug of 27-P1AM-002 cisplatin 渡嘉敷俊介, 鳴川貴司, 川合麻未, 長浦宏之, 柴山芳之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2014.

---

	Comparison of preparation properties of the 27-P1AM-003 lidocaine tape 三上充宏1, 杉野雅浩1, 細谷治1, 太田昌一郎1, 安野伸浩2, 從二和彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2014.

---

	Study on quality of the generic medicine of the 27-P1AM-004 isosorbide dinitrate tape 大野貴之, 下村斉, 青山隆夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2014.

---

	Comparison between starting pharmaceutical products and quantity of skin transmission of the generic medicine of the clobetasol using the 27-P1AM-005 hairless rat keratin injury skin 木下聡美1, 中島由紀1, 杉浦宗敏1, 松元美香2, 大谷道輝2, 山村喜一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2014.

---

	Change by the innovator drug in the 27-P1AM-006 dexamethasone propionate ester ointment, the difference in rheology properties of the generic drug and the preservation 山下優太, 湯谷玲子, 寺岡麗子, 北河修治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2014.

---

	Mixed difference with the innovator drug of the 27-P1AM-007 difluprednate ointment, the rheology properties of the generic drug and the cream 小谷隆一, 内田梓, 湯谷玲子, 寺岡麗子, 北河修治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2014.

---

	Report ... first than the consultation drugstore settings of the 27-P1AM-008 eye drops attitude survey - town 佐藤友恵1, 河津みとり1, 佐藤孔治1, 小出美穂子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2014.

---

	It is ... generic medicine index 72% ... for proper use reliable with 27-P1AM-009 generic drug 甲斐章裕, 石川広大, 谷口公章, 力武隆浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2014.

---

	Investigation about the prescription situation of the 27-P1AM-010 generic medicine 今泉瑛那, 平野裕美, 小幡貴子, 神野堅司, 浦崎圭太, 菱田栄子, 河井和子, 伊藤和幸, 磯谷聡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2014.

---

	Research about the action of the health insurance pharmacy in the 27-P1AM-011 generic medicine recommendation 金丸朗1, 野呂瀬崇彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2014.

---

	Action to generic medicine adoption promotion using the 27-P1AM-012 lectotype 赤木圭太 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2014.

---

	Action to the incident inhibition at 27-P1AM-013 generic medicine formulations 川野雅1, 山崎さやか1, 宮本晃圭1, 窪内雅也1, 三浦鉄平1, 宅間大祐1, 竹村和泰1, 濱田篤秀1, 平松久嗣1, 京谷庄二郎2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2014.

---

	Invention ... of the prescription data screen in examination - electronic chart for smooth changes to 27-P1AM-014 generic medicine 押賀充則1, 赤木圭太1, 佐藤仁宣1, 本郷知世1, 平野光枝1, 関口昌利2, 山口正和3, 伊藤博1, 加藤一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2014.

---

	Action to in-hospital generic name prescription with the 27-P1AM-015 generic medicine adoption 福田泰代1, 中筋美保1, 中島弘毅1, 小野順子1, 田中毅彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2014.

---

	Application of the T-LEX(R) method to the pharmacologic action evaluation in the human liver at the 27-P1AM-016 generic drug administration 榎本初音1, 立木秀尚1, 島田卓2, 長塚伸一郎3, 中嶋弥穂子4, 中嶋幹郎5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2014.

---

	Problems in the information on adverse drug reactions of the 27-P1AM-017 generic medicine anticancer agent 篠原義剛, 井手飛香, 蒲池英博, 斎藤暢人, 日高博司, 浅原稔生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2014.

---

	It is compared Japan with Sweden about 27-P1AM-018 generic medicine policy 今井志乃ぶ1, Andersson Sundell Karolina2, 伏見清秀3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2014.

---

	Is "the Orange Book" not necessary for 27-P1AM-019 infusion preparation? (the first report) 武井佐和子, 影山美穂, 別生伸太郎, 濱田真向, 戸張裕子, 井上みち子, 三溝和男, 倉本敬二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2014.

---

	It is an 8 case using filgrastim BS note "Mochida" at the chemotherapy enforcement for the 27-P1AM-020 malignant lymphoma 大坪達弥1, 中川ゆかり1, 堀西祐太1, 藤田将輝1, 大塚充1, 鹿浦香織1, 神田英一郎1, 岡橋孝侍1, 藤田敦夫1, 西川靖之1, 川本晃男1, 野田能成1, 友金幹視1, 小林裕2, 三上正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2014.

---

	It is investigated the consumption by the change to by Osh mirror in the 27-P1AM-021 G-CSF preparation 仁田美保子, 中林真紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2014.

---

	About systems construction and the effectiveness to share 27-P2AM-001 drug information in many institutions 山内拓1, 川村和美1, 榊原里依子1, 藤田俊之3, 松下紘輔2, 塩川満1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2014.

---

	Construction of the simple suspension system for for 24 hours suitable for a hospital for 27-P2AM-002 acute phase 岩尾恭寛, 植山寛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2014.

---

	About the inventive idea that utilized the section system in the electronic chart system for 27-P2AM-003 package 池井健, 堀部正記, 村上功一, 遊見裕子, 安田喜美子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2014.

---

	Use of the medication explanation support application for the tablet type terminal in the 27-P2AM-004 children drug control instruction and investigation about the effectiveness 永井絵里子1, 初田泰敏3, 後藤真千子2, 小川雅史3, 室井政子4, 石川照久1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2014.

---

	Construction of the 27-P2AM-005 ward drug log book system 池田敦1, 加藤隆2, 谷口聡1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2014.

---

	Contribution to ward drug duties by the 27-P2AM-006 checking prescription system introduction 増田信一, 植草秀介, 綿貫陽一, 斎藤結, 木村麗砂, 小林秀樹, 横井妙子, 加藤裕芳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2014.

---

	Construction and evaluation of the antimicrobial proper use check system at the 27-P2AM-007 impaired renal function 佐藤篤郎1,2, 鈴木厚志1, 加藤直紀1, 黒田信行1, 片山広美1, 天野哲史1, 松本薫1, 榊原ゆかり1, 坂田洋2, 板倉由縁1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2014.

---

	The construction of the inside the hospital website for the purpose of securing of constant quality in the 27-P2AM-008 drug information offer and the efficiency of duties and evaluation of the usefulness 石澤佑樹1, 萬谷みゆき1, 坂田拓也2, 佐藤陽1, 奥ヶ谷教1, 久米央子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2014.

---

	Analysis of the reading situation by the medical staff of 27-P2AM-009 online pharmaceutical products information retrieval system (MD-view) and the factor analysis 上林里絵, 川瀬亮介, 村木優一, 本多立, 杉本浩子, 岩本卓也, 奥田真弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2014.

---

	Development of the general-purpose model of the 27-P2AM-010 English version medicine reporting book publication system 井上幹雄1, 西尾優作2, 宮本菜摘1, 瀧裕子1, 吉野翠1, 福田喜彦3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2014.

---

	Setup of the 27-P2AM-011 in-hospital product drug information magazine "to have you read" 落合愛子1, 島津英昌2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2014.

---

	System maintenance about the registration of the allergic cover suspicion medicine to 27-P2AM-012 electronic chart and examination of problems 佐々木寿子1, 椎崇1, 関めぐみ1, 鈴木智子1, 八木宏之1, 近藤留美子1, 厚田幸一郎1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2014.

---

	Efficiency of the information on adverse drug reactions collection by the management tool making in the 27-P2AM-013 University of Tokushima hospital pharmacy 石田俊介1, 前田和樹1,2, 伏谷秀治1, 渡邉美穂1, 寺岡和彦1, 川添和義1,3, 水口和生1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2014.

---

	The database making of pharmaceutical products considered to require attention for 27-P2AM-014 driving and analysis 寺内恭平, 宮村信輝, 柴田里枝子, 大野逸子, 杉平直子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2014.

---

	Construction of a drug information sharing and the database using 27-P2AM-015 electronic chart 白府敏弘, 山本笑子, 武藤芳和, 駒澤愛, 畑中愛美, 田村研太郎, 井上陽介, 近藤智幸, 下道一史, 糸川貴之, 後藤吉延 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2014.

---

	Construction of the 27-P2AM-016 ward drug duties assistance database tool 板東達也, 多和田敏朗, 水野善晴, 佐藤嘉孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2014.

---

	Analysis about the association of interstitial pneumonia and the pharmaceutical products in the 27-P2AM-017 American large scale database 松井利亘1, 梅津亮冴1, 鈴木俊之1, 上田夏実1, 加藤大和1, 中山蓉子1, 羽根由基1, 阿部純子1,2, 紀ノ定保臣3, 中村光浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2014.

---

	Analysis of the nephrogenic diabetes using the 27-P2AM-018 FDA-AERS database 中山蓉子1, 梅津亮冴1, 鈴木俊之1, 加藤大和1, 上田夏実1, 阿部純子1,2, 紀ノ定保臣3, 中村光浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2014.

---

	Analysis of the hyperglycemia onset of the antipsychotics using the 27-P2AM-019 adverse event spontaneous report database 加藤大和1, 梅津亮冴1, 鈴木俊之1, 上田夏実1, 中山蓉子1, 阿部純子1,2, 紀ノ定保臣3, 中村光浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2014.

---

	The effect that information to alert of the 27-P2AM-020 dabigatran gives to an adverse event database 阿部純子1,2, 梅津亮冴1, 鈴木俊之1, 上田夏実1, 加藤大和1, 中山蓉子1, 紀ノ定保臣3, 中村光浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2014.

---

	Evaluation of the adverse event expression of new anticoagulant time using the adverse event spontaneous report database of 27-P2AM-021 Japan and the United States 今野彩1, 五十嵐敏明1, 中村敏明1, 日野村靖2, 上原恵子2, 政田幹夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2014.

---

	Investigation of the adverse event report in 27-P2AM-022 hepatitis C treatment 上田夏実1, 梅津亮冴1, 鈴木俊之1, 中山蓉子1, 加藤大和1, 阿部純子1,2, 紀ノ定保臣3, 中村光浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2014.

---

	Analysis of the angioedema in ACE inhibitor using 27-P2AM-023 FDA-AERS and ARB 羽根由基1, 梅津亮冴1, 鈴木俊之1, 上田夏実1, 加藤大和1, 中山蓉子1, 松井利亘1, 阿部純子1,2, 紀ノ定保臣3, 中村光浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2014.

---

	Angiotensin receptor blocker using 27-P2AM-024 JADER, analysis of the adverse event in the thiazide system diuretics combination therapy 野口義紘, 江崎宏樹, 浅野祥子, 横井貴文, 臼井一将, 加藤未紗, 齊藤康介, 舘知也, 寺町ひとみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2014.

---

	Investigation of the tendency to adverse event development of the nonprescription drug using 27-P2AM-025 JADER 梅津亮冴1, 鈴木俊之1, 阿部純子1,2, 中山蓉子1, 上田夏実1, 加藤大和1, 紀ノ定保臣3, 中村光浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2014.

---

	Example of the excellent action in acquisition, transmission, the inflection of the 27-P2AM-026 pharmaceutical products safety information 平松彩佳1, 中常恵美1, 飯村康夫1, 渡邊伸一1, 山本弘史2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2014.

---

	Medication guide - for patients whom utilization is expected of as - reporting tool how you tell information of the 27-P2AM-027 safety breaking news (blue letter) to the patients 岩崎裕佳里, 五十嵐崇子, 高松昭司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2014.

---

	Attitude survey - of the healthcare worker for the 27-P2AM-028 study on attached document - attachment document model (plan) of the new ethical drug 阿部智美1, 鳥山五月2, 服部洋子2, 浅田和広2, 小林江梨子1, 佐藤信範1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2014.

---

	Effect, overdose, clinical results, examination - of the mention point of other attention to give it to study on attached document - laboratory study results of the ethical drug that 27-P2AM-029 is new 川上明三1, 岩瀬万里子2, 安原一3, 佐藤信範4, 村山純一郎1,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2014.

---

	Study on attached document - "attention in the application" of the ethical drug that 27-P2AM-030 is new examination - about the mention point of "the attention in the handling" 工藤賢三1,2, 櫻田大也3, 平舩寛彦1,2, 小林江梨子3, 佐藤信範3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2014.

---

	Discussion about the references of the 27-P2AM-031 ethical drug attachment document 阿部和史1, 平島由香2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2014.

---

	Analysis of the questions and answers in the 27-P2AM-032 drug information room 原田大, 中島清江, 北村正樹, 川久保孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2014.

---

	Follow-up report about the information provided by a 27-P2AM-033 drug information room 橘淳, 原竜太郎, 長谷川豊, 塗木勇介, 戸鹿野美織, 濱浦睦雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2014.

---

	The analysis of questions and answers, the doubt inquiry accumulation example in the 27-P2AM-034 cancer special hospital and future problem 坂本由希子, 宮本聖子, 佐々木由香, 林稔展, 小早川高徳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2014.

---

	Evaluation of the usefulness for the information dispatch by the 27-P2AM-035 institution crossing-like DI activity 吉川飛鳥1,2, 相良克海1,3, 関根由香理1,4, 駒井信一郎1,5, 高塚亮1,6, 叶内至1,7, 河野薫里1,8, 上野拓1,9, 森下奈緒1,10, 須藤貴博1,11, 大平優1,5, 小田慎1,3, 三上二郎1,8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2014.

---

	Evaluation of the drug information offer for 27-P2AM-036 outpatients 栗原千絵子1, 安間浩子1, 厚見恵1, 尾崎真由子1, 妹尾裕美子2, 勝俣はるみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2014.

---

	How will the patients become able to describe an interview sheet enough 27-P2AM-037? - 2 for solution 藤森美代子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2014.

---

Investigation about the medication method of the antimicrobial for patients with childhood otitis media in the 27-P2AM-038 pharmacy service under health insurance drugstore and the allergic therapeutic drug 加藤芳徳1, 小野村直紀1, 石井浩二2, 阿部倫明1, 柿沼直利1, 船山将栄1, 真野泰成1, 大内かおり1, 前澤佳代子1, 百瀬泰行1, 旭満里子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2014.

---

	Change second report of the number of the combination drugs with the antihypertensive medications combination drug judging from the prescription fact-finding of 27-P2AM-039 antihypertensive medications 若林進1, 篠原高雄1, 永井茂1, 林潤一2, 山本実2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2014.

---

	For the improvement of examination - PMDA reporting homepage of the publication page of the 27-P2AM-040 "guide to a vaccinated person" - 樋口昇大1, 五十嵐崇子1, 佐藤大介1, 八田真美子1, 中村悟2, 高松昭二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2014.

---

	To have a person and the family receiving 27-P2AM-041 "guide - vaccination to a vaccinated person" understand a vaccine formulation; - 三浦百合香, 五十嵐崇子, 樋口昇大, 佐藤大介, 八田真美子, 高松昭司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2014.

---

	Role of the pharmacist in the 27-P2AM-042 legal declare of brain death 友田明子1, 椎崇1, 近藤留美子1, 厚田幸一朗1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2014.

---

	About the introduction of the simple suspension method in our 27-P2AM-043 House 増尾直亮, 品田奈津美, 工藤吏恵, 須藤頌, 曽我部直美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2014.

---

	Analysis and evaluation of the ward duties results before and after the "ward drug duties enforcement addition" calculation in the southern part of 27-P2AM-044 Saiseikai Yokohama-shi Hospital 北岡晃, 金子美玲, 安岡晋吾, 平間盛吾, 山口文子, 生田和之, 三角真由, 鈴木奈津子, 佐藤透 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2014.

---

	Drug epidemiological investigation by the changes from the antihypertensive medications which assume 27-P2AM-045 valsartan an active ingredient to other antihypertensive medications 田中正臣1, 田中彰一1, 濱克徳1, 杉村ゆかり1, 高橋秀聡1, 前田健太1, 後藤圭介1, 星貴薫1, 武田瑛司1, 水戸麻未1, 宮越貴之1, 佐藤秀紀2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2014.

---

	Investigation of the prescription actual situation of the NSAIDs drug for external use during pregnancy using 27-P2AM-046 receipt data 塩原千尋, 岡田裕子, 前田恵里, 増田寛樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2014.

---

	Evaluation of the tablet division by 27-P2AM-047 various kinds of fractionation 横山郁子, 竹下治範, 河内正二, 猪野彩, 辰見明俊, 波多江崇, 田内義彦, 沼田千賀子, 杉山正敏, 濱口常男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2014.

---

	Analysis of the adverse event of the antiallergic agent which became switch OTC using 27-P2AM-048 JADER 江崎宏樹, 野口義紘, 浅野祥子, 横井貴文, 臼井一将, 加藤未紗, 齊藤康介, 舘知也, 寺町ひとみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2014.

---

	27-P2AM-049 The effect that the number of the preparation standards of the injectable anticancer agent gives to the waste ratio of the left liquid 菱沼隆一, 山村翔, 荒木良介, 小島正照, 三田恭平, 山田英紀, 田中恒明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2014.

---

	Report ... of the reduction effect that we gave to drug costs by the intervention from intervention - early days to the medical therapy of the pharmacist in the rehabilitation ward for 27-P2AM-050 convalescence 妻鹿宏美, 安藤崇仁, 奥野靖隆, 志村吉徳, 永田文恵, 近藤幸男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2014.

---

	The effect that a medication investigation before hospitalization in the rehabilitation ward gives to drug costs after the hospitalization for 27-P2AM-051 convalescence 金井紀仁, 大野智裕 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2014.

---

	Economic evaluation for the prevention of fall by the correction of the high-dose prescription of the 27-P2AM-052 sedative hypnotic 横井貴文1, 舘知也1, 梅田道2, 浅野祥子1, 臼井一将1, 加藤美紗1, 野口義紘1, 安田昌宏2, 水井貴詞2, 南谷美朱3, 後藤千寿2, 寺町ひとみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2014.

---

	A disease severity classification and costs estimation of the COPD using 27-P2AM-053 receipt data 町井徹1, 岩崎宏介2, 赤沢学1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2014.

---

	Evaluation of the pharmaceutical intervention for the 27-P2AM-054 cancer chemotherapy 松岡加恵, 中西敏博, 荒川裕貴, 桂川健司, 藤岡美穂, 久田達也, 辻秀樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2014.

---

	27-P3AM-001 [case report] Action of the methotrexate (MTX) side effect evasion in the rheumatoid arthritis (RA) treatment 宮崎徹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2014.

---

	Participation and evaluation to cancellation medicine before surgery in the 27-P3AM-002 preoperation patients support center 楠本梨賀, 満田正樹, 佐向美帆子, 中谷亮介, 野際俊希, 野口恵子, 尾崎加織, 三宅美有紀, 瀧浪靖子, 浅井茂夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2014.

---

	Of the 27-P3AM-003 surgery, testing purpose is going to be hospitalized; an action of the common use medicine confirmation in the outpatient department to the patients 木村智美, 寺沢匡史, 片山智章, 北山尚子, 内山ひとみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2014.

---

	About the evaluation of the remedy medicine investigation before surgery in the 27-P3AM-004 outpatient department 石本彩乃, 神谷真悟, 岡村智文, 黒潟貴子, 梅野尚生, 小川丈彦, 柴田文規, 水橋直人, 竹田克明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2014.

---

	Action of the pharmacist in the 27-P3AM-005 reservation hospitalization support center 鈴山直人, 永江一徳, 潟永安亘, 植村隆, 田中誠, 東島彰人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2014.

---

	The intervention of the circulatory organ physician and the effect on antithrombotic drug discontinuation instruction in the 27-P3AM-006 pharmacist outpatient department 藤吉正哉1, 戸村幸貴1, 伊藤菜美1, 里田栄美1, 三浦遼子1, 森智之1, 野澤美香1, 高橋伸夫1, 生山野々子1, 石川温子1, 岩田杏子1, 中村裕義1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2014.

---

	27-P3AM-007 "pharmacist outpatient department" introduction - outpatient edition ... 大河万顕, 田井浩子, 下村一徳, 辻陽子, 辻川円, 田代美佳, 冨田由美, 川口進一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2014.

---

	27-P3AM-008 "pharmacist outpatient department" introduction - ward: Effect ... to ward drug duties 畑暁子, 田井浩子, 下村一徳, 瀬名波宏昌, 大河万顕, 冨田由美, 川口進一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2014.

---

	Inflection of the LINQ questionnaire to the inhalational instruction for patients with 27-P3AM-009 COPD 中西大介1, 出口綾子1, 伊藤健太郎2, 内藤雅大2, 畑地治2, 柳川泰裕1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2014.

---

	Inhalational instruction by our 27-P3AM-010 House pharmacy and the effect measurement investigation 能登啓介, 鈴木有紀, 中尾治香, 松本優香子, 島谷悠里, 新屋悠, 山岸三紗, 平田敦士, 西浦早織, 松岡寛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2014.

---

	27-P3AM-011 Establishment of the pharmacist instruction outpatient department in Nagoya Ekisaikai Hospital - In the inhalational introduction patients and diabetes medical treatment patients of asthma, the COPD - 中村敏史1, 後藤康洋3, 池上信昭1, 吉田昌則2, 山本雅史3, 堀田美知成1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2014.

---

	Relation ... DOTS use ... of the pharmacist for patients with foreign tuberculosis in our 27-P3AM-012 House 佐藤可奈, 福島さやか, 亀井健人, 高柳和伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2014.

---

	Analysis of doubt inquiry and the prescription suggestion by the pharmacist intervention to 27-P3AM-013 outpatient department chemotherapy 田島博樹, 高野洋平, 石田華奈子, 川口照雄, 長谷川恵一, 山田裕之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2014.

---

	Change ... of the needs of the patients by the questionary survey (2) - duration of treatment about the reporting for the patients with whole 27-P3AM-014 outpatient department chemotherapy enforcement 檀和貴1, 依藤健之介2,4, 木田圭祐2, 堀端真次2, 大上寛子2, 浜本麗子2, 長谷川豊2, 波多江崇3, 江本憲昭4, 平野泰健2, 濱口常男3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2014.

---

	Questionary survey about the reporting for the patients during the 27-P3AM-015 outpatient department chemotherapy enforcement 依藤健之介1,4, 檀和貴2, 木田圭祐1, 堀端真次1, 大上寛子1, 浜本麗子1, 長谷川豊1, 波多江崇3, 江本憲昭4, 平野泰健1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2014.

---

	Parenteral injection preparation duties in 27-P3AM-016 outpatient department rheumatoid arthritis treatment 森山傑, 山崎勇輝, 安田礼子, 三代貴康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2014.

---

	About "the pharmacist outpatient department" in our 27-P3AM-017 House 島谷桜子1, 坪谷綾子1, 白土阿貴恵1, 浅見妥江1, 松本浩1, 小宮詠子1, 赤津真衣子1, 東しずか1, 金井知子1, 坂下裕子1, 増原慶壮1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2014.

---

	27-P4AM-001 Examination of the output usefulness of the test value to a prescription, injection prescription 新関みどり, 長澤欣弘, 嶋崎千絵, 羽生智宏, 森山亜矢子, 尾形美絵, 田村和彦, 近藤和宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2014.

---

	Practice of the appropriate medical treatment by the test value indication to 27-P4AM-002 prescription 高橋義弥, 石川由香理, 高橋豊, 丸山俊夫, 飯坂美香, 七尾亮子, 谷田拓也, 櫻井正之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2014.

---

	Action of the 27-P4AM-003 renal function evaluation seal introduction 西尾剛1, 川路明人1, 酒井貞子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2014.

---

	Action to raise the examination of the pharmaceutical products rate of use needing the testing that it is like 27-P4AM-004 regularly 長水正也, 岡本有紀子, 工藤正治, 竹内敏明, 中村康夫, 鈴村宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2014.

---

	Proper use of the drug for patients with hepatic dysfunction based on 27-P4AM-005 Child-Pugh classification 福元裕介, 野間口寛, 桐野玲子, 柿本智広, 高橋武士, 中木原由佳, 新上香奈子, 平松さやか, 中島誠, 池ノ上知世, 坂元優太, 平田りか, 寺師守彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2014.

---

	We conduct the doubt inquiry for the renal excretion type drug after renal function mention in 27-P4AM-006 prescription and investigate it 内田守次, 草野充裕, 石田佳織, 金子華子, 藤本真由美, 進健司, 梅田勇一, 中嶋弘之, 金澤康範, 竹本伸輔 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2014.

---

	Tendency of the doubt inquiry in the analysis third report overtime practice of 27-P4AM-007 doubt inquiry contents 平野裕美1,2, 今泉瑛那1, 辻真由子1, 小幡貴子1, 神野堅司1, 浦崎圭太1, 菱田栄子1, 河井和子1, 伊藤和幸1, 磯谷聡1, 露木幹人2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2014.

---

	Usefulness and problems of the checking prescription system in the 27-P4AM-008 doubt inquiry 平明日美, 上田賢太郎, 合澤啓二, 宮崎美香, 陣上祥子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2014.

---

	Action to a prescription correction for the doubt inquiry prescription by the 27-P4AM-009 pharmacist 尾崎俊幸, 金子奈緒美, 島田杏子, 湯山千明, 安食健一, 寺西正充, 平野榮作, 横手克樹, 竹下和男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2014.

---

	Examination of the quality of the injection compounding of medicines duties that assumed 27-P4AM-010 doubt inquiry contents an index 佐々弥栄子, 木下元一, 青山智彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2014.

---

	Qualitative quantity-like change of the doubt inquiry that an action for the purpose of the efficiency of inpatient dispensing duties in the 27-P4AM-011 Mie University Hospital for the past 5 years resulted in 堀内桂子, 榎屋友幸, 村木優一, 本庄絵美, 水口恵理, 岩本卓也, 奥田真弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2014.

---

	Analysis of the doubt inquiry contents in 27-P4AM-012 prescription formulations 永野烈, 小島庸子, 能登英子, 山口美穂, 高岡龍蔵, 安藤彰冶, 久田達也, 辻秀樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2014.

---

	Action for the quality improvement of the doubt inquiry duties in 27-P4AM-013 prescription formulations 能登英子, 永野烈, 小島庸子, 山口美穂, 高岡龍蔵, 安藤彰治, 久田達也, 辻秀樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2014.

---

	Change of the doubt inquiry associated with the renal function by displaying 27-P4AM-014 test value in a prescription 赤崎淳子, 中西裕美, 山崎博子, 林幹也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2014.

---

	Difference between pharmacist and misfrequency of the nurse in the 27-P4AM-015 name of medicine similarity 田川慎二, 辻敏和, 入佐俊弘, 國分千代, 金谷朗子, 末安正典, 江頭伸昭, 増田智先 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2014.

---

	As a result, it is reported with measures for the incident at the formulations in our 27-P4AM-016 House, the accident decrease 佐藤達也, 林誠一, 鈴木信也, 関山正夫, 安藤栄輝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2014.

---

	Decrease in formulations incident by the 27-P4AM-017 formulations inspection system introduction 力武隆浩, 甲斐章裕, 石川広大, 谷口公章 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2014.

---

	System rebuilding for the quality improvement of injection drug compounding of medicines duties with the new ward move of 27-P4AM-018 pharmacy and the evaluation 野田晋司, 日置三紀, 村木優一, 榎屋友幸, 岩本真拡, 三輪倫加, 須藤宏文, 岩本卓也, 奥田真弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2014.

---

	Construction of the product system of administration derived from the specific organism using the 27-P4AM-019 electronic chart 陸丸幹男1, 柴田七奈1, 重松明美1, 御幡省三2, 清水達紀3, 黒木俊輔3, 宮本誠二4, 森一生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2014.

---

	Evaluation of compounding of medicines duties using the 27-P4AM-020 bar code authentication system 森本重輝, 園部俊輔, 関口麻未, 青山剛, 樋口秀太郎, 中野泰寛, 鈴木賢一, 濱敏弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2014.

---

	Development and effect of the automatic RP division function that we accepted in a remedy start timing with the 27-P4AM-021 hospitalization oral medicine order 高橋翠, 五十嵐敏明, 今野彩, 宇野美雪, 松嶋あづさ, 中村敏明, 政田幹夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2014.

---

	27-P4AM-022 Evaluation of the outside Parliament prescription inspection system which utilized clinical test value 鶴田洋平, 幸村瑤子, 上田武司, 西川かおり, 岡崎彰仁, 石坂忠博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2014.

---

	Construction and evaluation of 27-P4AM-023 ointment, the solution label printing system 梅田道, 大澤友裕, 水井貴詞, 甲田明英, 大野佑城, 市橋厚司, 安田昌宏, 小林健司, 佐橋誠, 後藤千寿 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2014.

---

	Availability of all automatic tablet withdrawal machine (Tiara) in the 27-P4AM-024 Tokyo Women's Medical College Hospital 前浩史, 深谷寛, 坂丹波礼子, 高橋賢成, 木村利美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2014.

---

	Action to the 27-P4AM-025 efficiency-like simple suspension method 三砂義敬, 大久保嘉則, 植村ちひろ, 中尾瑞穂, 床島英雄, 鈴田浩孝, 草葉一友 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2014.

---

	Elution behavior of levofloxacin in the 27-P4AM-026 simple suspension method and examination about the antimicrobial activity 松浦誠1, 川又歩1, 西谷直之2, 佐塚泰之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2014.

---

	Incompatibility of the dantrolene sodium in 27-P4AM-027 bulk powder 矢島愛理1, 小松敏彰2, 田中博之3, 石田有香1, 尾鳥勝也1, 厚田幸一郎1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2014.

---

	Incompatibility of the 27-P4AM-028 ceftriaxone sodium preparation and examination about the insoluble particulate matter 太田品子, 渡邉温子, 杉山恵理花, 齊藤清美, 佐藤均 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2014.

---

	27-P4AM-029 Blending change and adequacy of the simple suspension method enforcement of Amitiza capsule 石田志朗1, 岡本育子1, 山川和宣1, 渡辺智康2, 安藤哲信2, 鈴江朋子3, 岡野善郎4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2014.

---

	Examination about the acidifier in consideration of suspension stability and taking 27-P4AM-030 van cancer synchronized swimming building hydrochloride tablets 齊藤順平1, 栗原陽介2, 中島英規3, 寺門浩之1, 石川洋一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2014.

---

	How do show a division position examination ... of the 27-P4AM-031 bougie division method; ...? 玉岡翔弥, 岡野愛子, 田山剛崇, 三宅勝志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2014.

---

	Examination of the need of the preservative addition to the solution after 27-P4AM-032 addition water formulations 長浦宏之, 江藤公美, 奥村知香, 柴山芳之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2014.

---

	Analysis of the present conditions and problems of the mixture of the skin drug for external use by the 27-P4AM-033 questionary survey 野々山真衣, 大谷道輝, 眞部遥香, 松元美香, 並木路広, 山村喜一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2014.

---

	Investigation about the asymmetry of the information between pharmacist - patients about the merit of the 27-P4AM-034 medicine notebook 入江佑紀1, 庄司雅紀1, 岩出賢太郎2, 恩田光子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2014.

---

	About an association between inflection and blood pressure control of the patients of the 27-P4AM-035 medicine notebook 隅田侑希1, 手塚璃里子1, 榎本真美1, 庄司雅紀1, 岩出賢太郎2, 恩田光子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2014.

---

	Basic study on measurement method of the valganciclovir in the 27-P4AM-036 children domain 正岡康幸1, 菊岡亮2, 河崎陽一1, 江角悟1, 北村佳久1, 千堂年昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2014.

---

	Proper use investigation of quetiapine in the 27-P4AM-037 Kumamoto Red Cross hospital 江島智彦1, 岩田一史1, 上田賢太郎1, 合澤啓二1, モーエン 智子3, 采田志麻2, 武井宣之2, 吉田稔2, 陣上祥子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2014.

---

	The drug loss at the pediatric dose formulations of 50% of 27-P4AM-038 E Keppra dry syrup and packeted error 浜田茂明1, 石田志朗2, 森本真仁1, 山川和宣2, 岡野善郎3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2014.

---

	About mention of the medication date and time of the 27-P4AM-039 methotrexate capsule 2 mg packing sheet action - for - duties burden reduction 佐藤裕資, 棚谷貢, 鈴木千波, 田畑裕和, 越田晋太郎, 手塚悠希, 柴波明男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2014.

---

	Making of the quantity of minimum disposal for the quantity of prescription, cheapest medicine charge combination list of anticancer agent, biological drugs using 27-P4AM-040 Microsoft Excel 渡来和宏, 亀田圭輔, 齋藤友彦, 干川克巳, 生島五郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2014.

---

	Effect of the foscarnet which gives it to an internal change of lithium in the 27-P4AM-041 rat 上井優一, 有馬亮輔, 高津千裕, 古田涼, 川嵜達也, 鍋倉智裕 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2014.

---

	The effect that a change of the quantity of essential micro element in the 27-P4AM-042 living body gives to a CYP3A4 function 北山陽菜, 辻本雅之, 寺尾彩, 福田智哉, 川端美穂, 廣川愛, 山田有里子, 峯垣哲也, 西口工司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2014.

---

	Effect of xanthine oxidase and the aldehyde oxidase activity on allopurinol metabolism in 27-P4AM-043 rat in vivo 田山剛崇1, 杉原数美1, 三宅勝志1, 北村繁幸2, 太田茂3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2014.

---

	Examination - using effect - rat of the eating time to give it to the hypoglycemia effect of the 27-P4AM-044 sulfonyl urea system diabetes therapeutic drug 堂本泰大, 宮崎誠, 森幸代, 宮宗悠嗣, 岩永一範, 永井純也, 掛見正郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2014.

---

	Basic study on adsorption saturation to ultrafilter of 27-P4AM-045 Teiko plastic Nin 入江利行1,3, 福島将友1, 富田敏章1, 町田聖治1, 道越淳一2,3, 萩原聡3, 日高正剛3, 後藤孝治3, 畑中美博4, 井上覚4, 野口隆之3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2014.

---

	Examination about the proper use of the 27-P4AM-046 rivaroxaban 河内山佳英, 下石和樹, 陣上祥子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2014.

---

	The use situation and patients background in our House of the 27-P4AM-047 new oral anticoagulant drug (NOAC) rivaroxaban 木村順平1, 原田瑞記1, 小林夕紀子1, 藤井亮1, 板木元1, 本間和加子1, 中村博彦2, 山澤裕司3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2014.

---

	Use situation investigation of the patients who reduced Apixaban in the 27-P4AM-048 Saga University Hospital 竹内耕治, 持永早希子, 藤戸博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2014.

---

	Present conditions analysis of the warfarin control using 27-P4AM-049 Time in Therapeutic Range (TTR) 吉原郁夫1, 山崎伯都1, 渡部善博1, 村里嘉信1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2014.

---

	The use situation of the 27-P4AM-050 heparin protocol 藤岡貴光1,2, 左右田和枝1, 伊藤千裕1,2, 阿部真也1, 齋藤雅俊1, 柴田壮一1, 松原肇1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2014.

---

	Use fact-finding (for the making of the proper use guideline) of the 27-P4AM-051 new oral anticoagulant drug 小嶋俊輝, 柴田大地, 近藤洋一, 滝本典夫, 杉浦充, 足立守 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2014.

---

	Use situation investigation of the 27-P4AM-052 new oral anticoagulant drug 藤井洋介, 神宮寺秀幸, 長谷川佳孝, 月岡良太, 森澤あずさ, 大石美也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2014.

---

	Analysis of the use situation and the patients background of the 27-P4AM-053 oral anticoagulant drug 平田尚人1, 臼井達也2, 東裕子1, 大竹真莉絵1, 牛山利昭1, 矢嶋明1, 和田秀一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2014.

---

	Examination about the remedy situation and the background factor of the antithrombotic drug in patients with 27-P4AM-054 cerebral hemorrhage 白石貴寿, 古田悦郎, 宇都宮奈々, 長谷川将, 植中英恵, 上林麻恵, 坂本晃世, 田口みどり, 森田佳博, 中村宏, 面田恵 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2014.

---

	Examination about the use situation and the adverse event expression of edoxaban in patients with 27-P4AM-055 femoral neck fracture 佐々木貴之1, 日沖雅人1, 森尚義1, 北尾淳2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2014.

---

	Attitude survey of the patients whom 27-P4AM-056 direct thrombin repressor, oral Xa factor repressor were prescribed for 武田啓尊1,3, 齋藤誠2, 樋口彰2, 大元宏子2, 柏原通孝2, 竹原伸2, 中山圭一2, 青野章3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2014.

---

	Examination of the drug choice that we regarded as the use situation investigation of the anticoagulant in the 27-P4AM-057 Tsurumakionsen Hospital from a characteristic of the preparation 仲里梨紗, 福田詩織, 新枦義之, 樋島学 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2014.

---

	Examination about use fact-finding of the 27-P4AM-058 azithromycin IV infusion medicine and the dilution dissolution apothecaries measure reducing effect 春木祐人1, 萩谷英大2, 春木麻衣1, 杉山哲大1, 川上恭弘3, 近藤祥代1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2014.

---

	Relation of the pharmacist to 27-P4AM-059 Helicobacter pylori sanitization treatment 笠原典子, 平井文, 藤岡瑞恵, 眞柴英子, 原野晴美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2014.

---

	Use of antimicrobial situation investigation in the community-acquired pneumonia inpatient using 27-P4AM-060 DPC data 梅村拓巳1, 坂田洋2, 山田哲也1, 勝野晋哉1, 鷹見繁宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2014.

---

	Consumption change of catecholamine in our House with the change of 27-P4AM-061 guidelines 結城沙英子, 大谷美奈子, 垣尾尚美, 岸本靜佳, 松本敏明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2014.

---

	It is ... from the questionnaire results of action situation investigation - Toyama throughout the prefecture 31 institution of the pharmacist for 27-P4AM-062 antimicrobial proper use 河井良智1, 舘美幸1, 加藤貴子1, 窪田佳代子1, 岩本智子1, 江尻真理子1, 棚田真紀1, 柳原由香子1, 丸岡ひとみ1, 高田加壽代1, 山本善裕2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2014.

---

	Fact-finding of the treatment for Clostridium difficile infection in our 27-P4AM-063 House 大塚真理子, 飯嶋友美, 酒井理菜, 山下春香, 田澤匡, 宮崎真紀, 川崎昌子, 福田光司, 原信田努, 冨島修 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2014.

---

	The short-term and long-term use situation of the tolvaptan to patients with heart failure in our 27-P4AM-064 House 九鬼亜衣子, 西浦佳代子, 松本芳信, 川原裕, 佐野雅昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2014.

---

	Safe evaluation in the tolvaptan lock internal use for 27-P4AM-065 elderly people 御牧紗代1, 田中旬2, 小松俊介2, 鉄谷祥子3, 吉岡まみ1, 平山晶子1, 村田七海1, 前田陽平1, 森淑子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2014.

---

	It is the relation of the use situation and the ward pharmacist of the pain-killer after the operation for the 27-P4AM-066 decreased renal function patients 永野浩之1, 小岩まの1, 野田幸一1, 貝嶋亮1, 長島章1, 阿曽秀美1, 宮原宣博1, 立川恵美子1, 眞壁秀樹1, 河野義彦2, 井上勉3, 織田弘美2, 北澤貴樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2014.

---

	Action to the proper use of 27-P4AM-067 gadolinium contrast media 長澤欣弘, 嶋崎千絵, 羽生智宏, 森山亜矢子, 尾形美絵, 田村和彦, 新関みどり, 近藤和宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2014.

---

	Use situation investigation of the aciclovir injection in the 27-P4AM-068 Kumamoto forest metropolis General Hospital dermatology ward 畑田万紀子, 須古杏子, 宮本浩子, 森岡淳子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2014.

---

	Study implementation situation investigation of the drug needing the testing that it is like 27-P4AM-069 regularly 上岡彩佳, 山崎由美子, 千葉達夫, 木村麗砂, 日浦寿美子, 横井妙子, 加藤裕芳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2014.

---

	Analysis of the proper use risk factor based on the questionary survey for the use of 27-P4AM-070 patch patients 竹下絵梨香1, 橋本はるみ2, 山根由恵2, 寺本あゆみ2,3, 松寺友里恵2,3, 植沢芳広1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2014.

---

	About an injection at study on consciousness - eating out of the insulin nonuser for the 27-P4AM-071 insulin self injection - 堀尾理紗, 河野修治, 津島美幸, 橋詰勉, 高山明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2014.

---

	The drug use situation of patients with type 2 diabetes in the 27-P4AM-072 Okayama Red Cross hospital 石橋真実1, 大森麻江1, 宮下雄博2, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2014.

---

	Action of the bringing medicine management in our 27-P4AM-073 House 大石貴裕, 柏田匡広, 池田浩和, 高橋浩二郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2014.

---

	Bringing medicine database construction and use in our 27-P4AM-074 House 北川禎二, 冨田祐作, 林真三子, 中島瑞紀, 松浦ゆきみ, 伊東健司, 金原亜紀, 佐藤真理子, 佐野吉嗣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2014.

---

	Action to safe security about the bringing medicine in our 27-P4AM-075 House 三宅麻文, 伊東祐喜子, 阿賀千香子, 高橋友梨, 門脇祐子, 近藤瑛子, 岡島万記子, 尾上雅英 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2014.

---

	Risk aversion by the 27-P4AM-076 bringing medicine administrative work and medical economic effect 北浦円, 安藤陽子, 森岡想 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2014.

---

	About use of the bringing medicine in the 27-P4AM-077 University of Occupational and Environmental Health Hospital 井手飛香, 篠原義剛, 蒲池英博, 齋藤暢人, 實松絵美子, 日高博司, 浅原稔生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2014.

---

	Action of the bringing medicine management in the cottage-hospital out of 27-P4AM-078 前嶋由里子, 橋爪雅代, 古儀智美, 中山甲矢子, 秦毅司, 川合甲祐, 各務均, 中野真行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2014.

---

	About bringing medicine duties in the 27-P4AM-079 Yasuo society Takeda Hospital than ... physician, the questionary survey to a nurse ... 舛井美奈子, 荒井早穂, 矢沢麻貴, 林千麗, 吉村尋典 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2014.

---

	Estrangement with bringing medicine and the document information in the 27-P4AM-080 bringing medicine management 清川明慶, 西川眞佐人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2014.

---

	Bringing medicine management in the 27-P4AM-081 district core local government Hospital and medical safety management 田中敏, 佐藤益男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2014.

---

	Examination of deadline time setting for the purpose of the 27-P4AM-082 bringing medicine discriminant efficiency and the effect 羽賀博昭, 上村賢介, 間宵聖太, 瀬野雄太, 鈴木光幸, 高橋成博, 横山裕貴, 茂木武, 内坪誉歳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2014.

---

	About an action for the bringing medicine of the planned inpatient in our 27-P4AM-083 House 辻村啓史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2014.

---

	Problems of a drug and the information in 27-P4AM-084 bringing medicine differentiation duties 大久保利成, 飯島直樹, 古田涼, 唯野晃弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2014.

---

	Action to 27-P4AM-085 hospitalization and release, confirmation in preoperation in the medical cooperation center before medical examination of the cancellation medicine 佐藤香織, 四方公亮, 菅野美紗樹, 出雲正治, 加藤潤一郎, 長谷川英雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2014.

---

	Safety management ... by confirmation and the doubt inquiry such as the appropriate discontinuation instructions of duties - antithrombotic drug in the 27-P4AM-086 bringing medicine center 蓑谷環, 西條雅美, 向後絢, 宇佐見まみ, 四宮奈津美, 飯田真由巳, 湯浅美智代, 三室純子, 本田一春, 芝崎健志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2014.

---

	Relation of the pharmacist in the remedy medicine differentiation investigation before surgery, testing in the 27-P4AM-087 outpatient department 橋田真衣1, 佐々木善江1, 大成政揮1, 小野雅文1, 松下香織1, 伊丹元治1, 福田博音1, 真鍋憲司1, 面田恵2, 川嵜英二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2014.

---

	About problems of the on admission bringing medicine confirmation in our 27-P4AM-088 House circulatory organ department of internal medicine 田中聡之, 岩井由佳, 福西均, 安田陽子, 尾垣光彦, 岩本千絵, 萩野訓子, 森垣和馬, 畑中智子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2014.

---

	One case of the chronic myelogenous leukemia that supported the fertility hope of the 27-P4AM-089 imatinib remedy patients 大澤友裕1, 高橋健2, 安田昌宏1, 梅田道1, 長屋雄大1, 舘知也3, 水井貴詞1, 小林健司1, 佐橋誠1, 後藤英子4, 笠原千嗣4, 寺町ひとみ3, 後藤千寿1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2014.

---

	Example that participated in the 27-P4AM-090 crizotinib introduction patients 中野祐樹, 井上和洋, 蓮輪博嗣, 横尾賢乗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2014.

---

	The need of discussion and the TDM about the clinical dose and blood level of the 27-P4AM-091 Aki Shichi nib 大久保節子1, 大久保正2,3, 田中真理子3, 大久保七枝4, 久保田洋子5, 大久保美穂6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2014.

---

	Aki Shichi nib case analysis in the 27-P4AM-092 Kyoto Municipal Hospital 熊谷恭子, 目黒裕史, 本多伸二, 寸田靖, 村岡淳二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2014.

---

	A side effect investigation and measures in the 27-P4AM-093 R-CHOP and R-THP-COP therapy 祖父江伸匡, 堀敦雄, 西嶋長 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2014.

---

	The clinical experience and adverse event expression situation of the crizotinib in our 27-P4AM-094 House 名坂輝子1, 新井裕子1, 石原真一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2014.

---

	A present conditions investigation and patients support of the taste disturbance in the patients during the 27-P4AM-095 chemotherapy enforcement 若月淳一郎1,2, 木村緑1, 中條倫成1, 中村和代1, 内田亮1, 松本香織2, 田原計子2, 磯部克彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2014.

---

	Examination about the consciousness for medication ad here Lance and the medicine of the 27-P4AM-096 oral anticancer agent 中尾俊也1, 木村美智男1, 宇佐美英績1, 岩井美奈1, 吉村知哲1, 森博美1, 寺町ひとみ2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2014.

---

	The actual situation of the medication counseling by the nurse at oral opioid analgesic introduction in the 27-P4AM-097 metropolis and districts cancer practice cooperation base Hospital 片倉佐央里1,2, 濱本洋子2, 佐藤鈴子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2014.

---

	The present conditions of the doubt inquiry in our 27-P4AM-098 House going to hospital treatment center 眞下惠次1,2, 藤原大一朗1,2, 木村佳世1, 野田明宏1, 武田朋也2, 椿正寛2, 西田升三2, 阪口勝彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2014.

---

	Examination of the patients needs in the medication counseling of the 27-P4AM-099 chemotherapy 古田知子1, 山添喜久雄1, 中嶋早苗2, 久米真2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2014.

---

	Action of the pharmacist cancer chemotherapy team in the 27-P4AM-100 area cancer practice cooperation base Hospital 安達亮平, 木本真司, 熊谷修一, 石崎勝彦, 河原史明, 香内綾, 安齊泰裕, 長野満帆, 塩川秀樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2014.

---

	The duties support tool making based on 27-P4AM-101 cancer practice guidelines and investigation of the usefulness 平松久典1,10, 江崎秀樹2,10, 齋藤明子3,10, 土田大輔4,10, 寺西二三代5,10, 遠山幸男6,10, 山本倫久7,10, 長谷川功1, 板倉由縁8,10, 勝見章男9 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2014.

---

	Relation of the pharmacist in the chemotherapy introduction of the 27-P4AM-102 HBs antigen (+) patients 杉村奈美1, 向一美1, 地野幹子1, 森下実2, 坂下俊樹3, 増永高晴3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2014.

---

	Preference for a level of the patience of the side effect in patients with 27-P4AM-103 cancer and the high-risk treatment 飯原なおみ1,2, 西尾貴之2,3, 桐野豊1,2, 合田哲子4, 六車浩史4, 住吉加奈4, 安西英明4,5, 松岡栄徳6, 香川雅俊6, 磯部芳江7, 鈴木聖7, 水川奈己7, 芳地一7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2014.

---

	Examination of the day after day medication counseling in 27-P4AM-104 breast cancer FEC therapy patients 谷口潤, 山口絢子, 築田晃直, 溝田繁治, 吉野裕統 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2014.

---

	Introduction of the safe FOLFIRINOX therapy using the pass for the 27-P4AM-105 patients 金井友規恵1, 藤井千賀1, 柳下祐貴子1, 安井友佳子1, 山本為義2, 石坂敏彦1, 八野芳已1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2014.

---

	Pharmaceutical intervention investigation for patients who received 27-P4AM-106 outpatient department cancer chemotherapy 松本奈都美, 幕内麻里, 藤田真理維, 湊川紘子, 伊藤由香, 増原慶壮 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2014.

---

	Evaluation of the pharmaceutical intervention example in the 27-P4AM-107 outpatient department chemotherapy room 柿本秀樹1, 西田恵美1, 久保田知佳1, 上田裕1, 内山将伸1, 川原義弘1, 福田まひる2, 小田真由美2, 茂木愛3, 田中俊裕3, 高松泰3, 田村和夫3, 緒方憲太郎4, 二神幸次郎1,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2014.

---

	Evaluation of drug control instruction duties to perform on all intravenous feeding anticancer agent administration day for 27-P4AM-108 outpatient department cancer chemotherapy patients 川田史朗, 林すみれ, 緑川武志, 山本健, 飯塚真至, 本多義弘, 中村彰子, 池田裕太郎, 前田悠佑, 前田拓哉, 三上二郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2014.

---

	Timing of supportive care support and the intervention by the pharmacist in the 27-P4AM-109 outpatient department chemotherapy 坂井由紀, 山内可南子, 外山聡, 佐藤博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2014.

---

	Examination about the need of the drug control instruction for patients with 27-P4AM-110 outpatient department cancer 川尻尚子, 今井洋志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2014.

---

	We look at the rear about the need of the pharmacist intervention in the 27-P4AM-111 outpatient department cancer instruction to patient and investigate a mark 大澤万智子, 上田宏, 五十嵐努 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2014.

---

	An action and examination of the pharmacist outpatient department for the cancer chemotherapy in the scale hospital out of 27-P4AM-112 中條恵美, 生田紀美, 下雅意彩, 竹村敏也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2014.

---

	Action to CDTM of the foreign cancer chemotherapy in the small hospital out of 27-P4AM-113 清水範子1, 新井克明1, 杉山奈津子1, 真家佑介1, 菊地麻希1, 須藤寛1, 加藤貴康2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2014.

---

	About usefulness of the pharmacist intervention in the treatment with oral molecular target medicine in the 27-P4AM-114 outpatient department 渡邉貴子, 阿部理映子, 羽田真理子, 山口麻美, 田中三枝子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2014.

---

	The present conditions of our House about the 27-P4AM-115 cancer instruction to patient management charges 3 calculation 辻直子, 大本奈緒子, 浅井茂夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2014.

---

	Action to 27-P4AM-116 cancer care instruction charges calculation 浦川龍太, 橋本早苗, 廣畑秀記, 酒井克紀, 松浦佳代, 福田英克, 南波勝栄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2014.

---

	Requirements maintenance and problem of the cancer instruction to patient administrative work utilized the experience of the 27-P4AM-117 pharmacist outpatient department 平畠正樹, 森本茂文, 山本晴菜, 北田徳昭, 橋田亨 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2014.

---

	Action to the calculation acquisition with the new establishment of 27-P4AM-118 "cancer instruction to patient management charges" 田井浩子, 田代美佳, 大河万顕, 下村一徳, 川口進一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2014.

---

	Action of the medicine medicine cooperation in the 27-P4AM-119 outpatient department chemotherapy room 中島彩子, 宮崎和浩, 吉村和晃, 岩崎明子, 三輪耕次 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2014.

---

	Construction of the offer documentation tool in the 27-P4AM-120 cancer care instruction charges calculation 畠山卓, 目黒正明, 植木芳明, 重松恭祐, 八木原栄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2014.

---

	Examination about the tolerability of the crizotinib in the 27-P4AM-121 true clinical practice 藤井良平1, 田中雅幸1,2, 打谷和記1, 廣田育彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2014.

---

	Example that tolvaptan was useful for a low Na blood symptom due to the 27-P4AM-122 syndrome of inapp ADH secretion 高橋紗英子, 岡田浩司, 大村雅之, 増田晃, 松川幸市 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2014.

---

	Examination of the factor involved in positioning and myelosuppression expression of paclitaxel (albumin suspension type) by the lung cancer chemotherapy in our 27-P4AM-123 House 鈴木訓史, 後藤達也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2014.

---

	1 case that was given combination chemotherapy of carboplatin and etoposide to haemodialysis patients who had the 27-P4AM-124 small-cell lung cancer 高崎美和1, 杉本浩子1, 河原佑樹1, 藤原研太郎2, 浦田健太郎2, 村木優一1, 岩本卓也1, 田口修2, 奥田真弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2014.

---

	Elucidation of the cytotoxic mechanism for the human cancer of the esophagus cell line of 27-P4AM-125 bisphosphonate drugs 峯垣哲也, 森岡千尋, 福島沙織, 高梨仁美, 宇野順騎, 辻栞, 山本知志, 渡邉愛梨, 辻本雅之, 西口工司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2014.

---

	Clinical evaluations of MTC meta-analysis for cancer medical treatment using 27-P4AM-126 Bayes statistics 伊與田友和1,2, 山本渉3, 上塚芳郎2, 井上忠夫4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2014.

---

	Examination of the usefulness of the DCS therapy in the 27-P4AM-127 progress stomach cancer impossible of excision 船越幸代1, 山崎美保1, 福澤正隆1, 畝知己1, 松本篤1, 久賀祥男2, 守屋尚2, 前田頼伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2014.

---

	The effect that hydronephrosis due to the 27-P4AM-128 gastric cancer gives to side effect expression of irinotecan 橋本千明1, 高林真貴子1, 原祐輔1, 木下淳2, 尾山勝信2, 伏田幸夫2, 崔吉道1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2014.

---

	27-P4AM-129 Investigation of the safety of trastuzumab combination chemotherapy in HER2-positive advanced gastric cancer 小林安里奈1, 市倉大輔1, 杉沢諭2, 小林功治3, 齊藤佑介3, 滝西安隆3, 関川高志3, 坂田穣1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2014.

---

	Examination about usefulness and the acceptability of two regimens varying in a dose intensity in 27-P4AM-130 stomach cancer treatment 荒川裕貴, 中西敏博, 松岡加恵, 桂川健司, 藤岡美穂, 久田達也, 辻秀樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2014.

---

	The 27-P4AM-131 SP in progress, patients with recurrent stomach cancer impossible of excision and clinical evaluations of the XP therapy 永瀬怜司1, 菅野浩1, 伊與田友和2, 上塚芳郎3, 井上忠夫4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2014.

---

	Adverse event expression and the treatment continuation situation in 27-P4AM-132 regorafenib treated patients 安藤純子1,2,3, 丸山真一1, 吉野早紀1, 建持岳史2, 江川智久3, 菅野浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2014.

---

We look at the duration of treatment of the administration method and the every other week administration method and the rear about the safety in 27-P4AM-133 cetuximab every week and investigate a mark 市倉大輔1,2, 縄田修一1,2, 清水久範3, 石井亜矢子2, 杉沢諭2, 小林功治4, 齋藤佑介4, 滝西安隆4, 関川高志4, 坂田穣1, 村山純一郎2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2014.

---

	A change of blood pressure Grade2 due to the 27-P4AM-134 ABBA's Japanese spaniel or less and proteinuria, change of eGFR 石崎文子, 相原敏彦, 三塚晴彦, 増尾昌則 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2014.

---

	Examination of the setting between the CA 19-9 rate of decline golden periods in patients with 27-P4AM-135 gemcitabine enforcement pancreatic cancer impossible of excision 羽鳥正浩1, 辻大樹1, 多久佳成2, 池田翠1, 幕田龍1, 大嶽亜季1, 横井茉里1, 平井啓太1, 井上和幸1, 伊藤邦彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2014.

---

	Association between treatment rate of discontinuation and renal function in the 27-P4AM-136 gemcitabine hydrochloride monotherapy 能登数馬, 谷口知明, 新家麻美, 山下友輝, 須藤大雄, 道下美穂, 佐久間孝博, 田中悠季, 小林龍, 小原秀治, 下山光一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2014.

---

	Participation for patients with unresectable progress recurrent pancreatic carcinoma which 27-P4AM-137 FOLFIRINOX was indicated for 木村謙吾, 坂倉由美, 伊藤健人, 市川照文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2014.

---

	Examination of introduction of the FOLFIRINOX therapy for patients with 27-P4AM-138 pancreatic cancer impossible of excision and the pharmaceutical management 石川雄大, 龍伸和, 三村泰彦, 加藤敦, 足立伊佐雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2014.

---

	1 case of the allergy to beef history that 27-P4AM-139 cetuximab caused moderate hypersensitivity reaction 下村由貴1, 池田知子1, 持永早希子1, 嶋崎絵里子2, 門司幹男2, 倉富勇一郎2, 荒金尚子1,3, 木村晋也3, 藤戸博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2014.

---

	Side effect comparison between 27-P4AM-140 nab- paclitaxel and paclitaxel 谷沢克弥1, 仲村美帆1, 足立茂樹2, 新谷俊一1, 遠藤秀治1, 長尾育子3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2014.

---

	Relation of the drug department in the 27-P4AM-141 breast cancer merger pregnant woman 鶴崎泰史, 渡辺健二, 東島幸道 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2014.

---

	Investigation of the adverse event to become cancellation, the postponement in the eribulin administration in progress recurrent breast cancer treatment in our 27-P4AM-142 House 阿部多一, 住谷達也, 柳内亮祐, 落合里枝, 井口恵美子, 猪股克彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2014.

---

	Examination of the effect on 27-P4AM-143 breast cancer factor about adverse effect analysis and the treatment continuation of the eribulin therapy 高橋克之1, 橋野美穂2, 豕瀬諒1, 川口博資1, 須田泰記1, 中村安孝1, 西川武司1, 高島勉3, 永山勝也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2014.

---

	Examination of the investigation of the adverse event to affect cisplatin and the successful execution rate in the 27-P4AM-144 uterine cervix cancer of the radiation simultaneous combination therapy and the measures 木瀬大輔1, 藤原聡子2, 鍛冶園誠2, 蔵田靖子2, 佐田光2, 川上恭弘3, 千堂年昭2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2014.

---

	Tolerability investigation of patients with malignant glioma given 27-P4AM-145 bevacizumab temozolomide combination radiotherapy 伊藤健人, 樋口浩輔, 坂倉有美, 木村謙吾, 市川照文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2014.

---

	Examination about the taking Tegafur gimeracil oteracil potassium combination lock period by the 27-P4AM-146 nutrient for intestinal administration combination 古元俊徳, 佐々木紀彰, 熊澤崇 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2014.

---

	Fact-finding about the feeling of remedy and taking 27-P4AM-147 tea S one combination OD lock method 草谷朋子, 長佐古和子, 川上恭弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2014.

---

	Fact-finding of S-1 doses depending on the renal function in the 27-P4AM-148 outpatient 高橋久樹1, 佐藤浩保2, 鈴木幸造1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2014.

---

	The construction of the HBV marker check system at the 27-P4AM-149 tea S one start and the evaluation 山下愛子, 市川洋一, 西健太郎, 佐々扶美, 北岡朋子, 田上治美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2014.

---

	Imatinib body change at the imatinib 100 mg / day administration in patients with 27-P4AM-150 progress, recurrent GIST 冨山成章1, 日高宗明3, 田實裕介1, 中村千鶴子4, 鈴木彰人3, 花田法久2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2014.

---

	Management of the treatment with oral anticancer agent by the unionization of 27-P4AM-151 clinical record mention 小島唯1, 辻村秀樹2, 石原優1, 浅子恵利1, 近藤忠3, 近藤芳弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2014.

---

	Action of relation and medicine - medicine cooperation of the pharmacist for the 27-P4AM-152 foreign oral anticancer medicine prescription 川原裕, 西塔志織, 佐野雅昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2014.

---

	Relation (a present conditions investigation and the prospects that assumed internal use TS1 a case) of the pharmacist in the 27-P4AM-153 outpatient department chemotherapy 河野健1,2,3,4,5, 佐々木優1, 沢田亜幸1, 櫻谷美貴子2, 稲葉博之3, 村上優4, 湯本哲郎1,5, 稲葉健二郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2014.

---

	Use experience of the regorafenib in the 27-P4AM-154 our hospital and participation of the pharmacist 益田宏代, 古野由美子, 合田明博, 田中和子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2014.

---

	Analysis of the factor to have an influence on the treatment continuation of the 27-P4AM-155 sunitinib 宮原志帆1, 大野雄太2, 今西義紀2, 小林亮2, 鈴木昭夫2, 杉山正1, 伊藤善規2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2014.

---

	Examination about the sorafenib early cancellation factor in patients with 27-P4AM-156 hepatocellular carcinoma impossible of excision 槇田崇志, 神崎浩孝, 正岡康幸, 北村佳久, 千堂年昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2014.

---

	Examination about the expression situation and the prevention of the low Ca blood symptom by the 27-P4AM-157 denosumab 波多野真弓, 江口善美, 合田愛美, 伊藤香苗, 石井茂 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2014.

---

	Tolerability investigation of the cisplatin combination chemotherapy by the 27-P4AM-158 shortstop hydration method 有賀敦1, 立松三千子2, 大久保吉弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2014.

---

	Examination for the vascular pain in the 27-P4AM-159 hydrochloric acid gemcitabine liquid introduction 渥美仁1, 浅井澄子1, 中山貴美子1, 澤口和代1, 岡田みどり2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2014.

---

	About the intervention of the testing situation and the pharmacist with the cancer chemotherapy in the 27-P4AM-160 outpatient department chemotherapy 近藤万友美1, 正置耕一1, 森田聡子1, 橋本百世1, 吉田こずえ2, 清水義文3, 岡本隆弘3, 辻隆志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2014.

---

	Examination about the effectiveness and dermatopathy of 27-P4AM-161 cetuximab and the readministration 清水幸宏, 相澤雄介, 南真進, 矢島功, 曽根原亘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2014.

---

	An enforcement investigation and measures about the HBV-related marker screening in the 27-P4AM-162 cancer chemotherapy 近藤貴也, 佐々木英雄, 成瀬国男, 中尾圭介, 伊藤匡伸, 大石えりか, 中平桂子, 藤井里奈, 吉橋幸美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2014.

---

	Effect to give neutrophils with the oxaliplatin administration at the 27-P4AM-163 decreased renal function and a platelet count 岩下佳敬, 中尾承司, 岩崎公美, 薗田晃弘, 桑鶴麻代, 川畑綾, 永田春香, 高田侑那 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2014.

---

	One discussion about the 27-P4AM-164 infusion reaction expression situation 大信紀明, 黒澤亮太, 齋藤真理, 色川正憲, 大谷俊裕, 猪瀬成史, 堀越建一, 常盤英文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2014.

---

	Examination of the factor which has an influence on the thrombocytopenia in 27-P4AM-165 temozolomide, the radiation combination therapy 市江敏和1,3, 高橋弘泰1, 山関智恵1, 鈴木大介1,3, 岡田健2, 小林望2, 林秀樹3, 杉浦洋二1, 杉山正3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2014.

---

	Investigation, examination of the adverse event expression situation and the expression factor to need an administration schedule change in the 27-P4AM-166 Bortezomib treatment 山下良子1, 神山秀一1, 結城祥充1, 上田晃1, 川本由加里1, 後藤仁和1, 山本聡2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2014.

---

	Investigation of the background factor by the administration cancellation in the 27-P4AM-167 cancer chemotherapy 渡邉基之, 小倉洋平, 諸星総一, 男鹿宏和, 小坂好男, 倉持英和 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2014.

---

	Examination about the effect to a survival period by the difference in cancellation reason of patients with 27-P4AM-168 progress recurrence colon cancer 田路章博1, 山本裕美4, 小市海鈴4, 山元弘4, 福島昭二4, 續木康夫3, 森田吉多佳2, 関本裕美1, 岡田博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2014.

---

	Effect to give to drug interactions - blood clotting ability of 27-P4AM-169 gemcitabine and warfarin 櫛原朋恵1, 櫛原秀之1, 天野真由美2, 濱嶋なぎさ2, 近藤千紘3, 長瀬通隆3, 福井佳明1, 水谷年男1, 野村史郎3, 森一博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2014.

---

	One case that produced a use investigation of the denosumab for the metastases to bone of patients with 27-P4AM-170 cancer and serious hypocalcemia 榎南祥太, 牧沢志保, 安倍知里, 高田奈央, 森智沙, 長谷川広樹, 笹倉青葉, 松尾彬宏, 和田恭子, 高橋宏幸, 百海有二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2014.

---

	Examination of the short hydration in the 27-P4AM-171 malignant lymphoma - GDP therapy 上手真梨子1, 椙山聡一郎1, 藤澤信2, 橋本真也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2014.

---

	A dose evaluation by the VCD induction therapy for the 27-P4AM-172 multiple myeloma and safe examination 水上皓喜1, 櫻下弘志2, 泉谷悟2, 佐伯康之2, 日浦和徳1, 木平健治2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2014.

---

	Study on effect on doubt inquiry by the 27-P4AM-173 anticancer agent doses calculation supporting system introduction 長屋雄大, 牧野哲平, 大澤友裕, 青山智, 川島あずさ, 安田昌宏, 梅田道, 渡邉久高, 大野佑城, 市橋厚司, 水井貴詞, 後藤千寿 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2014.

---

	Investigation about the dose of the anticancer agent for patients with 27-P4AM-174 obesity cancer 藤井友和, 西川隆一, 辻博幸, 塚本久之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2014.

---

	The dose of the anticancer agent in patients with 27-P4AM-175 obesity and safe investigation 富士谷昌典1, 小泉祐一1, 野村真美1, 中多陽子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2014.

---

	Investigation of the actual situation and the deferasirox administration situation of the posttransfusion hyperferremia in our 27-P4AM-176 House 水野貴仁1, 深津昌弘1, 梅村拓巳1, 山田哲也1, 竹内達哉3, 大野稔人2, 鷹見繁宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2014.

---

	The effect that a side effect in the 27-P4AM-177 breast cancer outpatient department chemotherapy gives to daily activity, costs loss 田中和秀1,2,3,4, 浅野祥子2, 舘知也2, 大澤友裕1, 川島あずさ1, 安田昌宏1, 水井貴詞1, 中田琢巳3, 土屋照雄4, 寺町ひとみ2, 後藤千寿1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2014.

---

	The present conditions and problem of the medicine medicine cooperation in our 27-P4AM-178 House 鈴木薫1, 松田美樹子1, 小野裕紀1, 結城正幸2, 小林由佳3, 押切翼1, 萬年琢也1, 佐藤弘子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2014.

---

	About the emergency consultation of 27-P4AM-179 cancer chemotherapy patients 星野真之1, 星野寿恵1, 生田直人1, 小池恭士1, 藤田恵子1, 澁川知成1, 伊藤祐太1, 鈴木伶織1, 堀井春美2, 富岡葉子2, 大塚園子2, 篠塚一美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2014.

---

	Action of the pharmacist for the high quality medical system in the 27-P4AM-180 outpatient department chemotherapy room 川野昭, 上杉聡美, 福重昇吾, 平野俊訓, 大石泰也, 大竹弘之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2014.

---

	Change of the quality of life by conducting patients explanation before 27-P4AM-181 chemotherapy introduction 清水浩幸, 廣岡賢輔, 米田栄子, 前田祥花 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2014.

---

	Pharmacist questionary survey before 27-P4AM-182 cancer medical therapy start about 田村悟, 小森谷友宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2014.

---

	The exclusive duty pharmacist intervention effect to cancer chemotherapy patients in the core Hospital in 27-P4AM-183 remote place and future problem 神山知也, 中村直美, 平松剛, 吉水秀子, 藤村由紀子, 小田仁子, 大和未果, 延東正一, 笠波生也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2014.

---

	Case of patients with rheumatoid arthritis that developed a lymphoproliferative disorder during 27-P4AM-184 methotrexate remedy 蓮尾憲作1, 村本慎吾1, 眞田功2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2014.

---

	About the line anticancer medicine pollution of the pump for the 27-P4AM-185 fluorouracil (5-FU) note continual infusion 辻井愛香1, 小林由佳1,2, 岩根裕紀1,2, 中西弘和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2014.

---

	Competitive review of the 27-P4AM-186 5-FU portable chronofuser 野口祥紀1, 三宅知宏1, 中西由衣1, 前山恵里加1, 服部公紀1, 伊藤美南子1, 和田亜希1, 中村晴代2, 谷村学1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2014.

---

	The case that became the administration interruption by incompatibility of the 27-P4AM-187 docetaxel preparation 永渕学, 冨岡隆史, 野中愛美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2014.

---

	Examination of the response pattern in the water solution of 27-P4AM-188 anticancer drug cisplatin 小畠大輝1, 加藤隆児1, 小川恭平1, 小川高広1, 香川祐哉1, 佐藤卓史2, 井尻好雄1, 三野芳紀2, 林哲也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2014.

---

	Examination of survival, the increase through the Wnt signal course in 27-P4AM-189 stromal dependent leukemia cell line TRL-01 丹羽洋介1,2,3, 南陽介2,4, 安部明弘2,5, 早川文彦2, 山田清文3, 直江知樹2,6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2014.

---

	Examination about the use situation and the proper use of the daptomycin in our 27-P4AM-190 House 伊藤智一, 阪上貴子, 中川綾, 鈴木信也, 関山正夫, 安藤栄輝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2014.

---

	Use fact-finding of the antiMRSA medicine daptomycin in the 27-P4AM-191 Iizuka Hospital 梅田勇一, 内田守次, 金澤康範, 竹本伸輔 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2014.

---

	Use evaluation of the 27-P4AM-192 daptomycin 太田登志子1, 大塚昌信2, 中山晴雄2, 加藤裕芳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2014.

---

	Examination of the adverse event with the 27-P4AM-193 daptomycin administration 清治翔伍, 藤居賢, 國本雄介, 中田浩雅, 野田師正, 宮本篤 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2014.

---

	About the result that the active intervention to patients receiving 27-P4AM-194 vancomycin results in 井出和男1, 加藤英明2, 西村富啓1, 佐橋幸子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2014.

---

	27-P4AM-195 Examination of the proper use of the vancomycin hydrochloride for Clostridium difficile-related loose bowels 石井杏奈1, 松尾和廣1, 平山忍2, 木村伊都紀2, 横尾卓也2, 花井雄貴2, 佐々木英久1, 渡辺朋子1, 篠原悦子1, 小杉隆祥2, 西澤健司2, 吉尾隆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2014.

---

	Examination about the proper use of vancomycin hydrochloride (VCM) for the 27-P4AM-196 MRSA infection 木村佳美1,6, 小田真澄1, 安原梨恵1, 中田早苗1, 稲葉佳南1, 藤田昌美2,6, 渡邉英子3,6, 矢木真一4,6, 森幸威5,6, 市川大介1,6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2014.

---

	The thrombocytopenia in the 27-P4AM-197 linezolid administration case and examination about the administration days 竹内絵美, 伊賀正典, 小塊夏紀, 藤掛佳男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2014.

---

	Use investigation of our 27-P4AM-198 House antiMRSA medicine 朴井三矢1, 藤村尚子1, 福田良子1, 河合実1, 玉田太志1, 北村良雄1, 志馬伸朗2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2014.

---

Examination for the effect of an investigation of the use situation of the antiMRSA medicine by the 27-P4AM-199 infection control team and the intervention to a long-term use case 廣瀬祥子1,2, 木村有揮1,2, 西村富啓3, 石志絋2, 青木康子2, 尾本健一郎2, 森伸晃2, 福元大介2, 柏倉佐江子2, 黒田美徳2, 樋口晶子2, 香川成人2, 吉田ひろみ2, モリソン 朋子2, 近藤直樹1, 久保田篤司1, 千田昌之1,2, 鈴木義彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2014.

---

	The antimicrobial consumption change by intervening in a drug targeted for a use of 27-P4AM-200 antimicrobial registration system and effect on resistant bacteria 杢保貴幸1,4, 徳竹裕貴1, 石井康友2,4, 植田宏冶3,4, 石原一惠1,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2014.

---

	Pharmacist intervention for 27-P4AM-201 antimicrobial proper use and the evaluation 加藤未紗1, 松岡知子2, 森卓之2, 吉田真也2, 大橋健吾2, 篠田康孝2, 臼井一将1, 浅野祥子1, 横井貴文1, 野口義紘1, 舘知也1, 吉村知哲2, 森博美2, 寺町ひとみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2014.

---

	Inspection of the antimicrobial proper use that assumed 27-P4AM-202 AUD an index 池崎友明, 小関真樹, 山谷香織, 北澤英徳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2014.

---

	Investigation about the change of the use of antimicrobial by the use of 27-P4AM-203 antimicrobial registration system change 小林義和1, 藤岡貴光1, 阿部真也1, 松原肇1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2014.

---

	Action of the 27-P4AM-204 antimicrobial proper use conference 瀬戸崇光1,2, 中村翔吾1, 北里実義2, 寺沢匡史1, 内山ひとみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2014.

---

	About an effect by the pharmacist intervention of the use of non-appropriate drug by the 27-P4AM-205 outpatient department antimicrobial IV therapy 田井達也, 山口佳津騎, 田中裕章, 篠原尚樹, 渡邊政博, 谷久美子, 山本理恵, 小坂信二, 芳地一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2014.

---

	Inspection ... of the effect of action ... use registration system and ward drug duties to antimicrobial proper use in the cottage-hospital out of 27-P4AM-206 石倉久美子, 有田順子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2014.

---

	Action of our House for the 27-P4AM-207 levofloxacin proper use 猪狩千恵1, 比佐孝之1, 横山千秋1, 山内真理1, 阿部俊介1, 田口景子1, 内田智1, 加藤陽子2, 田中啓幹3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2014.

---

	Action to the antimicrobial proper use in our 27-P4AM-208 House 相川祐貴 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2014.

---

	About intervention to infection treatment that utilized the physical assessment in the 27-P4AM-209 medical treatment sickbed 倉林誠1, 高倉みなみ1, 高木淳子1, 池井良貴1, 山田英俊1, 赤石康弘2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2014.

---

	Investigation of compliance and the effect of treatment of pneumonia guidelines by the 27-P4AM-210 ICT round enforcement 山下知香1, 上田浩貴2, 辰見明俊1, 眞継賢一2, 濱口常夫1, 濱口良彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2014.

---

	Safe examination in the 27-P4AM-211 Gentamicin administration 山崎晃憲, 芳賀貴史, 山中崇史, 本郷文教 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2014.

---

	The present conditions of the medical treatment of the infective endocarditis in the hospital attached to the 27-P4AM-212 Hirosaki University School of Medicine 太田真帆1, 岡村祐嗣1, 板垣史郎1, 萱場広之2, 早狩誠1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2014.

---

	Evaluation report of the sensitive rate of injectable antimicrobial consumption and Pseudomonas aeruginosa in our 27-P4AM-213 House 久田瑛吉, 野澤正徳, 三浦毅, 畔柳敏弥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2014.

---

	The effect that intervention gives to Pseudomonas aeruginosa sensitivity on specific antimicrobial long-term use by the cooperation of 27-P4AM-214 ICT and the ward pharmacist 大澤雄一郎1,2, 村井いずみ1, 天野永生1, 長山直実1, 米丸明子1,2, 岸野亨1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2014.

---

	Use situation investigation for the 27-P4AM-215 azithromycin infusion 岩切啓太1, 丸山久美子1, 田中麗苗2, 安道誠2, 深田章1, 石田英明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2014.

---

	To make the hospital pharmacy where 27-P4AM-216 resists; - to effectively utilize it of - BSC (balun strike scorecard) 川名賢一郎1,2, 小山晃紀1, 眞保淳子1, 高山慎司1, 阿部猛1, 後藤一美1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2014.

---

	Reflection of the pharmacy management - first year using balun strike scorecard (BSC) for the 27-P4AM-217 hospital pharmacy gate and discussion ... toward the second year 金田昌之1, 奈良部修弘1, 畠山英司1, 藤田明宏1, 田邉晃子1, 三田村朋1, 小野絢子1, 舟越亮寛2, 赤瀬朋秀3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2014.

---

	Inflection ... of action ... balun strike scorecard (BSC) for the common management tool introduction in the 27-P4AM-218 group hospital pharmacy gate 飯塚真至1,4, 小田切正美1,4, 前田拓哉1,4, 大久保淑子1,2, 三上二郎1,4, 山内泰一1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2014.

---

	Result and the results of the pharmacy management using 27-P4AM-219 Shimmatsudo Chuo General Hospital balun strike scorecard (BSC) to be able to put 大久保淑子, 大野弘貴, 田中統子, 坂井安希子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2014.

---

	27-P4AM-220 Evaluation of the drug department of management by Balanced Scorecard introduced in IMS Memorial Hospital : The results of six months after the BSC introduction 田中秀典1, 伊藤仁美1, 片桐高子1, 定村洋士1, 中村葉月2, 赤瀬朋秀3,4, 大久保淑子5, 山内泰一6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2014.

---

	Action to duties improvement using balun strike scorecard (BSC) in the 27-P4AM-221 Yokohama new capital city department of neurosurgery Hospital 小串興平, 根本郁子, 関澤奈実子, 後藤卓哉 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2014.

---

	Result and problems of the balun strike scorecard (BSC) introduction in our 27-P4AM-222 House pharmacy 清水淳一1, 間宮伸幸1, 赤瀬朋秀2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2014.

---

	An action and problem (for crush formulations 0) that were carried out after 27-P4AM-223 BSC seminar in Tsurukawa sanitarium Hospital 関本司, 山崎麻里, 山田文子, 森かをり Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2014.

---

	Practice of the drugstore management that utilized 27-P4AM-224 balun strike scorecard (BSC) 井口恵美子1, 平田周祐1, 高橋弘充2, 猪股克彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2014.

---

	Evaluation of duties using balun strike scorecard (BSC) in the 27-P4AM-225 Kushiro Red Cross hospital pharmacy 渡邊清人, 近江令司, 澁谷基宏, 田中康裕, 元木孝, 高柳昌宏, 千田泰健 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2014.

---

	A new action for the securing of pharmacist in the hospital attached to the 27-P4AM-226 Mie University School of Medicine and the effect 佐々木典子, 村木優一, 岩本卓也, 奥田真弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2014.

---

	The effect that the system establishment of ward drug duties to begin after 27-P4AM-227 accession gives for securing of staff 黄前尚樹, 中村美樹, 仲西未佳, 平田貴大, 岸敬子, 松山芽衣, 谷車彩夏, 常村弥生, 西田彩織, 廣本真里, 勝部智子, 宮崎彩花, 多胡和樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2014.

---

	Search of the factor necessary for the present conditions and the addition acquisition of the 27-P4AM-228 ward drug duties enforcement addition acquisition 前田拓哉1,2, 濃沼政美1,3, 藤原久登1,4, 瀧本淳1, 小林求1, 飯田純一1, 綾部由紀乃1, 湯本哲郎1,5, 金田光正1, 宮崎美子1, 高尾良洋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2014.

---

	Proper use of the glycopyrronium bromide / indacaterol in the 27-P1PM-001 COPD and situation investigation of the side effect expression 三上祥博1, 河田清志1, 杉谷祐紀1, 堀良行1, 金野衣久美1, 村中美幸1, 小松裕輔1, 畑中紀世彦1, 新野智与1, 前川雅代1, 山木利恵子1, 菅原夏実1, 藤内智2, 武田昭範1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2014.

---

	About the use situation of the beta 2 stimulant drug in the 27-P1PM-002 Fukui Prefectural hospital 辻愛美, 吉川弘毅, 佐澤佳彦, 平賀貴志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2014.

---

	Can push the fixed-quantity aerosol-type inhaler in the 27-P1PM-003 children bronchial asthma with oneself from how old; or is ... for the independence from ... protector 青木彩, 青野珠可 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2014.

---

	Study about a change of a feeling of remedy with the drug in 27-P1PM-004 children and the medication counseling to patients with allergy 鳥井真緒1, 飯嶋久志2, 小林江梨子1, 佐藤信範1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2014.

---

	Action - medication situation investigation - of the pharmacist for 27-P1PM-005 children medication ad here Lance improvement 佐々木美織, 佐藤圭吾, 西和哉, 阿部浩幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2014.

---

	About a problem of a tendency to prescription and the medication counseling of the 27-P1PM-006 methotrexate preparation 畠山規明, 大萱豊秋, 松野英子, 桑原泰則, 星谷卓男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2014.

---

	Use of osteoporotic therapeutic drug situation investigation in the patients during 27-P1PM-007 steroid long-term use 森内葉子1, 白井僚一1, 大丸英昭1, 塩孜2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2014.

---

	Use fact-finding of the 27-P1PM-008 teriparatide subcutaneous injection kit 平嶋優一1, 寺原史貴2, 保科くるみ2, 西牧武志2, 勝股祐美2, 齋藤俊一郎2, 佐藤公人2, 田村広志2, 下山光一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2014.

---

	Consciousness for the use of medicine notebook with 27-P1PM-009 ethical drug, a nonprescription drug and the supplement 浅野祥子1, 舘知也1, 吉田達彦2, 横井貴文1, 加藤未紗1, 臼井一将1, 野口義紘1, 水井貴詞3, 後藤千寿3, 寺町ひとみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2014.

---

	Participate in relation ... summer camp of patients with 27-P1PM-010 hemophilia and the pharmacist; and ... 三浦直子, 平尾鮎子, 加賀谷隆彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2014.

---

	We estimate 27-P1PM-011 as analysis about the "visualization of the pharmacist" and "pharmacist with a view of the face" exercise 小野寺健1,3, 南川賢治1,3, 三浦清明2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2014.

---

	Consciousness change for the 27-P1PM-012 new pharmaceutical products sale system 鈴木俊之1, 梅津亮冴1, 加藤大和1, 中山蓉子1, 上田夏実1, 阿部純子1,2, 土屋照雄3, 中村光浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2014.

---

	Use fact-finding of hydroxyethylated starch preparation and the albumin preparation in the 27-P1PM-013 operating room 中澤香子1, 吉野太朗1, 牛木隆志2, 三澤昭彦1, 荒川圭子1, 外山聡1, 佐藤博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2014.

---

	Fact-finding - by action - inventory survey that the 27-P1PM-014 patients manage the information about one's health 田代朋子1, 折井孝男2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2014.

---

	Fact-finding about the amount of drinking at the 27-P1PM-015 pharmaceutical products remedy 首藤誠1, 宮崎珠美1, 小森浩二1, 中嶋香里2, 東川伸一2, 堀口道子2, 牧敬太郎3, 藤田知子3, 木村真弓4, 星山雄大4, 榎本初音5, 立木秀尚5, 恩田光子6, 山下伸二7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2014.

---

	Prescription fact-finding of 120 mg of denosumab preparation in our 27-P1PM-016 House 青山一紀, 立原茂樹, 谷中敦美, 黒澤豊彦, 武井敬司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2014.

---

	Use fact-finding of the rasburicase in the 27-P1PM-017 our hospital 島田友里奈1, 宮本浩子1, 藤本哲広2, 下村泰三2, 鈴島仁2, 森岡淳子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2014.

---

	Use situation investigation of the aperient in the use of oral opioid analgesic patients in our 27-P1PM-018 House 高山喜光, 深尾彰平, 吉田真人, 近藤匡慶, 淡路健作, 堀川佳津美, 村田和也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2014.

---

	The laboratory study enforcement situation of the drug that 27-P1PM-019 needs testing regularly 鈴木悠加, 臼窪一平, 中村友香, 下山あさ子, 亀井浩二郎, 高木明彦, 小原郁司, 小寺隆二, 妻木良二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2014.

---

	Present conditions report in hypermagnesemia with the 27-P1PM-020 magnesium oxide preparation and our House 末吉真樹, 野澤正徳, 三浦毅, 畔柳敏弥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2014.

---

	Comparison of the examination of coronary contrasting hospitalization pass in the 27-P1PM-021 neighborhood 7 Hospital 中島優子1, 赤木祐貴2, 池田祐司3, 伊奈川愛理2, 榎木瑞穂4, 小河原由佳4, 木村有揮2, 清水忠洋5, 武石愛子6, 千葉達夫6, 葉梨美和7, 加藤裕芳6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2014.

---

	Analysis based on the questionary survey of the pharmacist duties enlightenment activity to give to an allowable standard of the waiting time in the 27-P1PM-022 ethical pharmacy 久保田健人1, 寺田洋2, 植沢芳広1, 服部豊示1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2014.

---

	Investigations such as the test value that a dosage form change of the carnitine preparation in 27-P2PM-001 haemodialysis patients gives it to 小沼絵美, 池上聖, 川岸輸佳, 高山慎太郎, 風間正人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2014.

---

	Search of the factor associated with the C/D ratio of the tacrolimus preparation in the 27-P2PM-002 hematopoietic stem cell transplantation patients 三村享1,2, 池村憲明3, 松澤直樹3, 勝山善彦3, 山折大2,3, 大森栄1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2014.

---

	Relation of the pharmacist in the 27-P2PM-003 convalescent rehabilitation hospital 金子守1, 岡添進1, 矢嶋美樹2, 林宏行3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2014.

---

	Examination of the need of the pharmacist intervention in the use of sleeping drug security for 27-P2PM-004 elderly people 磯田明宏1,2,3, 井上裕2, 岩崎友香2, 金本郁男2, 勅使河原正敏3, 井澤正義1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2014.

---

	Action (the second report) of our House for the 27-P2PM-005 generic name prescription addition 星野有吾, 宮本拓人, 森真澄, 川澄清孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2014.

---

	Action of the group preoperation explanation in our House for the patients undergoing 27-P2PM-006 cataract surgery 颯田真子, 野澤正徳, 三浦毅, 畔柳敏弥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2014.

---

	Inflection in the use situation and the ward of the Chinese medicine in the hospital attached to the 27-P2PM-007 Tokai University School of Medicine 矢野忠1, 平綿洋子1, 橋本昌宜1, 岸川悦子1, 市川訓1, 宮坂宗男1, 日置智津子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2014.

---

	About an action given information sharing with a specialist based on the investigation of the ward pharmacist about the use of the dopamine agonist to patients with 27-P2PM-008 Parkinson's disease 近藤水生1, 多賀麻衣1, 岡田恵果1, 桑山結子1, 大野愛1, 米山英二1, 久保田敏行1, 川上治2, 勝見章男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2014.

---

	About successive change and factorial experiments of the dispensing error development by the introduction of the 27-P2PM-009 bar code formulations system 上野ひとみ1,2,3,4,5,6,7,8,9, 廣田憲威2, 北條雄也3, 松村直美4, 伊戸郷美5, 山本京6, 冨士代真希7, 玉城由実加8, 梅津怜恵9 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2014.

---

	The effect that the hue of the 27-P2PM-010 hyperalimentation preparation container gives in the visibility at formulations 安藤崇仁1, 佐藤栄輔2, 貝澤正浩3, 近藤幸男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2014.

---

	Examination of pre-Abo id report contents by the 27-P2PM-011 ward drug duties introduction 増田晃, 岡田浩司, 白畑政憲, 鈴木千絵, 松井伯之, 松川幸市 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2014.

---

	Effect on drug control instruction duties by promoting 27-P2PM-012 ward drug duties and drug-related incident 田中恒明1, 竹内昌司2, 橋田亨3, 小竹慶子4, 内川清次5, 今泉幸久6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2014.

---

	The trend of the incident report before and after the ward exclusive duty pharmacist placement in the hospital attached to the 27-P2PM-013 Mie University School of Medicine and future problem 濱口直美1,2, 村木優一1, 水谷泰子2, 兼児敏浩2, 岩本卓也1, 奥田真弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2014.

---

	An investigation and analysis of the incident report by the 27-P2PM-014 pharmacy business trainee 金田絢子1, 新井成俊2, 佐伯俊明2, 村田勇1, 井上裕1, 木村昌行1, 金本郁男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2014.

---

	Analysis ... of a change and report contents of the number of contribution second report ... pre-Abo id reports to the patients security of the ward pharmacist with the 27-P2PM-015 ward drug duties enforcement addition calculation 上村忠聖, 鈴木信也, 関山正夫, 安藤栄輝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2014.

---

	Evaluation of the ward drug duties in the medical treatment sickbed judging from 27-P2PM-016 pre-Abo id report 足岡秀樹, 石倉優子, 柳原美夏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2014.

---

	Contribution - to medical security by the 27-P2PM-017 pre-Abo id, present conditions investigation of the pharmaceutical intervention case and the enforcement of utilization - case conference 辻佑香里, 高森智敬, 安尾哲郎, 滝波昇悟, 監物英男, 今村明正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2014.

---

	Contribution to the patients by the 27-P2PM-018 "ward drug duties enforcement addition" 矢吹直寛, 織本桂, 関根仁彦, 吉田友和, 岡平将志, 吉田憲司, 清水裕 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2014.

---

	Approach - from an action - medical care security room to Distribution of medicine duties for the drug cold water re-hat decrease in the 27-P2PM-019 ward 我妻禎1,2, 渡部洋一2, 阿部美幸2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2014.

---

	Incident measures of the self-care medicine by the 27-P2PM-020 ward exclusive duty pharmacist 赤城那奈, 大谷道輝, 松元美香, 稲村澄子, 並木路広, 山村喜一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2014.

---

	The examination of the oral medicine management method in the 27-P2PM-021 surgery system mixture ward and future problem 神谷法子, 近藤洋一, 滝本典夫, 杉浦充, 足立守 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2014.

---

	Inspection of an action to the oral medicine incident decrease by the 27-P2PM-022 ward safety measures team and the effect 飯田慎也1, 小野尚志1, 細井美奈子2, 伏見亜由美2, 金絵理2, 古澤亜矢子2, 石関哉生3, 齋藤司4, 金田豊子2, 山下恭範1, 原千恵子1, 小川聡1, 粟屋敏雄1, 福土将秀1, 松原和夫5, 田崎嘉一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2014.

---

	The effect that 27-P2PM-023 ward drug duties give to doubt inquiry 井坂由佳, 前島多絵, 渡邊雅明, 堀内学, 細野智美, 小西久美, 鈴木嘉治, 中島綾, 中島正人, 熊田美由紀, 神林泰行, 本間真人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2014.

---

	Action to prevention of bringing medicine-related incident in the 27-P2PM-024 cosmetic surgery ward 小林義政1,2,3, 今高多佳子1, 高木祥子1, 田宮真一1, 青山智彦1, 世木直喜2, 安藤智洋2, 林悟司3, 長尾佳世子3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2014.

---

	From the viewpoint of medical security with action ... bringing medicine of the ward permanent residence of the pharmacist in the 27-P2PM-025 Saga Hospital 副島啓司, 渡辺健二, 東島幸道, 鶴崎泰史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2014.

---

	Evaluation for bringing medicine initial instructions by the pharmacist in the 27-P2PM-026 pharmaceutical viewpoint 伊藤美南子, 山口高雅, 瀬田尚子, 大谷徹, 中井貴映子, 三宅知宏, 森慶喜, 谷村学 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2014.

---

	It is ... mainly on contribution to ward drug duties - medical therapy in the 27-P2PM-027 Ogura memory hospital cardiovascular surgery 曽我弘道, 前田朱香, 富田敏章, 福島将友, 町田聖治, 入江利行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2014.

---

	Remedy of fact-finding and the omission of of the drug needing the preoperation discontinuation in the cardiovascular surgery ward of our 27-P2PM-028 House discontinuation 金澤正智, 中野公, 寿伸一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2014.

---

	Action of the checking prescription for the decreased renal function patients in 27-P2PM-029 ward drug duties 菅野美紗樹, 一杉俊輔, 四方公亮, 佐藤香織, 出雲正治, 加藤潤一郎, 長谷川英雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2014.

---

	Comparison - of search - logistic-regression analysis and the decision tree analysis of the analytical procedure necessary for the medication self-care introduction of patients with 27-P2PM-030 stroke 藤原久登1,2, 向後麻里1,3, 田中絵里子2, 大川桂子2, 泉真由美2, 水間正澄4, 鈴木寛子2, 村山純一郎1,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2014.

---

	Examination of the pre-Abo id report about the 27-P2PM-031 anticancer medicine 原田哲彦, 西井玲奈, 町支優和, 隅田徹, 鈴木善貴, 石川元章, 石田隆浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2014.

---

	Summary of the pre-Abo id report of 27-P2PM-032 two years 中村和宏, 筒井信博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2014.

---

	Evaluation of the remedy about the present conditions and the bringing medicine discriminant cold water re-hat of the 27-P2PM-033 inspection time cold water re-hat 池ノ上知世, 野間口寛, 桐野玲子, 柿本智広, 高橋武士, 中木原由佳, 新上香奈子, 平松さやか, 中島誠, 福元裕介, 坂元優太, 平田りか, 寺師守彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2014.

---

	The early detection of side effect by pharmacist in the 27-P2PM-034 team approach in medical care and intervention effect on becoming severe evasion 今浦将治, 山谷武司, 菅野浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2014.

---

	Action about the change of the hypnotic drug for the purpose of the fall accident prevention in the 27-P2PM-035 inpatient 岩田一史1, 江島智彦1, 上田賢太郎1, 平田憲史郎1, 合澤啓二1, モーエン 智子2, 采田志麻3, 武井宣之3, 吉田稔3, 陣上祥子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2014.

---

	Examination about preventive measures against re-falls about search and pharmacist duties of the 27-P2PM-036 re-fall factor 藤井信大郎1, 佐原篤1, 大野正裕1, 三角ひかる1, 長谷川豊1, 波多江崇1, 福田英克2, 南波勝栄2, 濱口常男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2014.

---

	The activity of the fall fall measures team in the 27-P2PM-037 Kanazawa Red Cross hospital and participation (the first report) of the pharmacist 高橋怜史1, 大川浩子1, 山口亜矢1, 岡田睦子1, 川原繁2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2014.

---

	Attitude survey about the administration for the nurse of the 27-P2PM-038 national hospital mechanism Kumamoto south Hospital 西本辰徳1, 垣瀬順予2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2014.

---

	Attitude survey of the label with the 27-P2PM-039 second piece 浦西洋彰, 和田良浩, 池田和之, 辻力夫, 山添雅之, 森田幸子, 梶井節子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2014.

---

	Accident prevention using the mishaps in medical practice example database by the report from 27-P2PM-040 whole country medical institution, search of the factor to be serious, and to lead to evasion 愛知佑香, 大津史子, 後藤伸之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2014.

---

Construction and evaluation ... of enforcement and the action (1) - prescription mention standardization-response system of the 27-P2PM-041 oral medicine prescription mention method standardization of the pharmacy 椎木芳和1, 安達真紀子1, 金田達也1, 小川勝弘1, 涌嶋伴之助1, 森木邦明1, 村田貴弘2, 寺本圭2, 佐藤裕也3, 高根浩1, 島田美樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2014.

---

	Enforcement of the 27-P2PM-042 oral medicine prescription mention method standardization and medical safety measures in the action (2) - pharmacy of the pharmacy and evaluation ... 安達真紀子1, 椎木芳和1, 小川勝弘1, 金田達也1, 足塚則子2, 齋藤憲輝2, 池口正英2, 高根浩1, 島田美樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2014.

---

	Importance ... of enforcement of the 27-P2PM-043 oral medicine prescription mention method standardization and the action (3) - medicine medicine cooperation of the pharmacy 金田達也1, 涌嶋伴之助1, 長谷川真紀2, 平井和也3, 氏原浩善4, 椎木芳和1, 安達真紀子1, 小川勝弘1, 高根浩1, 島田美樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2014.

---

	Evasion ... of the polypharmacy in effect - convalescence rehabilitation ward which the prescription review by the 27-P2PM-044 pharmacist gives for prescription adequacy 秋田章裕, 福田詩織, 新枦義之, 樋島学 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2014.

---

	Examination about the method of alerting it to floor nurse such as the 27-P2PM-045 high risk medicine 田村賢士1,2, 金子智一1, 若海八州雄1,2, 鈴木秀昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2014.

---

	Review, improvement ... of the style such as preventive measures against mishaps in medical practice - prescriptions about pharmaceutical products of our 27-P2PM-046 House 三木郁帆, 植野聖子, 入山奈央, 岸本侑子, 寺井易子, 橋本恵梨花, 神農理衣, 村上賢次, 小森正貴, 井本陽子, 吉田尚史, 山口千賀子, 守谷顕人, 津田里香, 宅和真由美, 平田敦宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2014.

---

	Safety measures (the fourth report) in the 27-P2PM-047 drug section - Reliability (from a series system) of compounding of medicines duties - 添田真司, 原尚美, 木村康人, 堀明子, 尾崎昌大, 渡邊昌之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2014.

---

	- that one is necessary for one tablet or thinks about the bar code of the 27-P2PM-048 pharmaceutical products sheet from the present conditions of the - tablet sheet 池田和之, 辻力夫, 山添雅之, 森田幸子, 梶井節子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2014.

---

	Construction of the anticancer medicine parenteral injection formulations support system which utilized ethical drug bar code for 27-P2PM-049 medical care security 外山智章, 岩瀬利康, 森田美江子, 伊藤好夫, 越川千秋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2014.

---

	The real condition of the medical safety management system in the hospital under 27-P2PM-050 Kagoshima 屋地慶子1,2, 福岡龍一1,3, 中村千鶴子1,4, 岸本真1,5, 立和田ともね1,6, 百原譲治1,7, 山本佳代子1,8, 武田泰生2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2014.

---

	Hospital Evaluation of function general hospital 1 <3rdG from a viewpoint of the 27-P2PM-051 medical care security: Ver.1.0> Action of the auditee 田原雅子, 平昭圭介, 花田徳子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2014.

---

	Effect to give to the intravenous feeding speed of the type infusion pump that study polyvinyl chloride about the proper use of the 27-P2PM-052 medical care device and infusion set made of polybutadiene flow control 梅村雅之1, 新井大地1, 前田佳奈絵1, 重野克郎2, 脇屋義文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2014.

---

	The use situation investigation of the medical pump by the 27-P2PM-053 patrol and promotion of the appropriate administration of injection drug 阿藤友美1, 大沢幸嗣1,3, 大谷道輝1, 木村裕之2, 山村喜一1, 寺島裕夫3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2014.

---

	Action of preventive measures against malpractice by the 27-P2PM-054 infusion industry 藤冨徹, 広野敏博, 福岡誠次, 田中修一, 正木久典, 多田義孝, 籾井明, 坂本勝博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2014.

---

	Application to renal failure treatment of the 27-P3PM-001 health food: Quantitative analysis of the antioxidant action of the chitosan in patients on dialysis 安楽誠1, 田中元子2, 南雲恒平3, 渡邊博志3, 庵原大輔1, 平山文俊1, 丸山徹3, 小田切優樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2014.

---

	Effect to give to a longevity-related gene of the black vinegar made with 27-P3PM-002 pot and non-alcoholic fatty liver 柴山良彦1, 長野正信2, 藤井暁2, 橋口和典2, 菱田直人2, 井関健3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2014.

---

	Effect of the dietary fiber on in vitro agent amount of resources of the 27-P3PM-003 diabetes therapeutic drug 岩崎綾乃, 中川みなみ, 今井公江 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2014.

---

	Safety profile in the cells level of the quercetin which is 27-P3PM-004 flavonoid 岡野善郎1, 石田志朗2, 小山保夫3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2014.

---

	It is ... about patients with consumer awareness investigation ... next situation for 27-P3PM-005 OTC pharmaceutical products 木村美咲1, 坂田菜摘1, 黒沢智佳子2, 幸田真純1,3, 黒木光良3, 高橋眞生3, 小林江梨子1, 佐藤信範1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2014.

---

	Attitude survey about the reporting at the 27-P3PM-006 nonprescription drug sale 川崎淳史1, 加茂恵代2, 澤田康裕2, 小林江梨子1, 佐藤信範1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2014.

---

	Factor investigation of the OTC sales promotion in the 27-P3PM-007 health insurance pharmacy 横井正之1,2, 古田佳典2, 水野ちはる3, 田邉甫樹3, 一川暢宏3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2014.

---

	Consumers questionnaire - about palatability - taste bitter of a feeling of remedy and the consumers of the 27-P3PM-008 nonprescription drug 山崎啓之1, 西本光宏2, 田口和明1, 瀬尾量1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2014.

---

	A milk concentration and infants views of labetalol in patients with 27-P3PM-009 pregnancy-induced hypertension syndrome 植松和子1, 勝本絵美1, 鴻丸晴菜1, 小林映子1, 川合聡子1, 安藤一道2, 杉本充弘2, 川上義2, 木津純子3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2014.

---

	Making of the mother's milk transitivity information information database for the 27-P3PM-010 nursing mother 木下里紗1,2, 森田真樹子2, 萱野勇一郎2, 矢野育子2, 小林政彦1, 松原和夫2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2014.

---

	Role of a pregnant woman, the nursing mother medical therapy authorization pharmacist in the 27-P3PM-011 mother's milk class 清水ゆかり1, 古清水浩子2, 大井徹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2014.

---

	Examination of the drug evaluation about the medication at nursing in 27-P3PM-012 Drugs in Pregnancy and Lactation (GeraldG. Briggs, et al.) 増田寛樹1, 井上拓也1, 永井香織1, 角田義典1, 宮下由理1, 前田恵里1, 岡田裕子1, 若本太郎2, 外山聡2, 佐藤博2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2014.

---

	Study on use of antidiabetic drug during the 27-P3PM-013 pregnancy 高安芽衣子1, 栗林芽衣1, 刈込博2, 後藤一美2, 櫻田大也1, 小林江梨子1, 佐藤信範1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2014.

---

	The present conditions and the prospects of the medical therapy for the digestive organ symptom during the 27-P3PM-014 pregnancy 野村文香1, 阪中美紀1, 金本賢枝1, 林香里2, 辻俊一郎2, 小野哲男2, 石河顕子2, 喜多伸幸2, 寺田智祐1, 村上節2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2014.

---

	Use fact-finding of pharmaceutical products postpartum before the product in our 27-P3PM-015 House pregnant woman 三角真由, 北岡晃, 齋藤亜紗子, 佐藤透 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2014.

---

	It is investigation ... about the mother's milk transitivity of the use pharmaceutical products in ... operation for improvement of preoperation reporting to patients who underwent 27-P3PM-016 cesarean section 堀井徳光, 松本富夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2014.

---

	Examination about the sewing spare frequency due to phlebitis with the 5% carbohydrate solution and 5% xylitol liquid in 27-P3PM-017 ritodrine hydrochloride continuous infusions 佐藤裕美, 諸岡真梨子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2014.

---

	Examination of the effect on children with the ampicillin sodium administration at the 27-P3PM-018 delivery 松下久美1, 後藤貴裕1, 福井佳重2, 嵯峨こずえ3, 瀧祐介1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2014.

---

	A tendency and analysis of the consultation example in "the pregnancy and the medicine outpatient department" of our 27-P3PM-019 House 渡邊真理恵1, 川邉桂1, 小池博文1, 浜之上はるか2, 平原史樹2, 西川能治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2014.

---

	Examination about the rubella vaccine inoculation based on the rubella antibody titers of the 27-P3PM-020 pregnant woman 金光佳織1,3, 北田徳昭1, 森本茂文1, 青木卓哉2, 北正人2, 片岡和三郎3, 橋田亨1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2014.

---

	Action of our center for the 27-P4PM-001 ward drug duties enforcement addition 成田千香子, 八代佳子, 金美紀, 吹谷真紀子, 篠田菜美子, 佐藤恵葉, 鈴木ひとみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2014.

---

	Evaluation of a physician for the pharmacist duties improvement with the 27-P4PM-002 ward drug duties enforcement and the nurse 長崎志津1, 森田靖代1, 野村政孝1, 岡崎雅史1, 小松仁美1, 齋藤雅恵1, 岡崎萌水1, 依岡千恵子1, 仲井めぐみ1, 八木祐助1, 橋田和佳1, 門田亜紀1, 楠瀬正彦1, 市原和彦1, 横田淳子1, 吉岡三郎2, 宮村充彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2014.

---

	The role of the pharmacist in rounds duties of the 27-P4PM-003 digestive organ surgery and evaluation from other types of industry 菊池大輔1, 布施克浩1, 阿部友紀1, 福士素子1, 伊藤佳代1, 上岡泰弘1, 紫桃裕造1, 日野弥栄子2, 岩指元3, 畑中貞雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2014.

---

	Physician, nurse evaluation of ward drug duties in the 27-P4PM-004 Tokyo health medical care public corporation 6 Hospital 松本啓一1, 八木原栄2, 越田晃3, 廣井順子4, 中村英子5, 小竹慶子6, 川崎寛一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2014.

---

	Action of the ward drug duties in our 27-P4PM-005 House 佐藤佳華1, 藤原陽子1, 堀金妙子1, 岸元麻紀1, 日下部鮎子1, 菊池一樹1, 大江利治4, 明田克之3, 江副英理2, 八十島孝博2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2014.

---

	27-P4PM-006 ward permanent residence about the questionary survey for ward drug duties after becoming it 永井賢作, 石原留美子, 金城雄一, 金城清二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2014.

---

	Action to the ward drug duties through the oral medicine system of administration in the 27-P4PM-007 convalescent rehabilitation ward 西塚亨1, 小土井亮介1, 宮原美保2, 真辺和文3, 平松和嗣久3, 田原雅子4, 安藤哲信5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2014.

---

	Action of drug incident analysis in the 27-P4PM-008 circulatory organ medical service and future ward duties 中村愛, 永野真久, 高田正温, 平木洋一, 真鍋健一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2014.

---

	Evaluation (from a physician) from other types of job before the 27-P4PM-009 "ward drug duties enforcement addition" introduction 大西祥代, 安藤智美, 高儀佳代子, 細川朋弘, 清水けいこ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2014.

---

	Making of the high-risk medicine side effect monitoring sheet in 27-P4PM-010 ward drug duties 渡辺智康, 難波良平, 山崎恵, 高取孝一, 安藤哲信 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2014.

---

	The present conditions and problems of NST, the nourishment management in 27-P4PM-011 ward duties 田中大輔, 佐藤拓也, 田中庸, 鎌田敬志, 佐藤導 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2014.

---

	Action to on admission bringing medicine for 27-P4PM-012 pharmacist management by the essential function 高塚亮1, 富岡佳久2, 武藤浩司3, 金親正知4, 今井博久5, 佐藤秀昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2014.

---

	Enforcement of the conference in the duties time of the 27-P4PM-013 pharmacist and the evaluation 寺沢匡史, 坂本愛, 鈴木愛美, 片山智章, 中村翔吾, 内山ひとみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2014.

---

	About the essential function of the pharmacist by the investigation analysis of the change of prescription of the 27-P4PM-014 inpatient 大木稔也1, 庄野あい子2, 土屋文人3, 加勢泰子4, 山内泰一5, 鈴木洋子1, 今井博久6, 佐藤秀昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2014.

---

	Action for the skill up of 27-P4PM-015 ward drug duties 西谷友紀, 久岡清子, 合田さやか, 佐々木健志, 川上尚美, 植谷未稀, 間千晴, 亀岡喬, 鹿沼奈央, 足立雅, 盆子原唯, 川村大輔 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2014.

---

	Examination of the drug control method at the 27-P4PM-016 hospitalization 市原航1, 田辺寿一2, 福井宗憲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2014.

---

	Trial of the analysis of the prescription intervention contents in 27-P4PM-017 ward drug duties and the medical treatment management based on the protocol 佐村優, 倉田武徳, 廣瀬直樹, 鯉淵寛之, 石井淳一, 南雲史雄, 腰岡桜, 育木均文, 八木下純子, 内田仁樹, 関根寿一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2014.

---

	Analysis of the pharmaceutical intervention in 27-P4PM-018 ward drug duties and future problem 小材なおと, 大熊範和, 橋本碧, 田子尚史, 村田文, 森田淳介, 田子加代子, 新木美枝, 伊藤典子, 山賀章一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2014.

---

	Action to the bringing medicine prescription order representation by the 27-P4PM-019 ward exclusive duty pharmacist 溝田繁治, 中村敦士, 谷口潤, 吉野裕統 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2014.

---

	About the ward drug duties in the 27-P4PM-020 orthopedics ward 中田恭子, 笠原庸子, 今津邦智, 森田眞吾, 前田昌徳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2014.

---

	Examination of the contribution to the pharmaceutical products proper use by the start of the drug information offer in the 27-P4PM-021 electronic chart 牛島智子, 本田修一, 宮村重幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2014.

---

	27-P4PM-022 otolaryngology, ward drug duties in the head and neck surgery ward 西村健二, 阿曽沼和代, 高柳和伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2014.

---

	Relation to the use of valproic acid Na patients in 27-P4PM-023 ward drug duties 後藤渉, 山澤理恵子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2014.

---

	The prescription suggestion in 27-P4PM-024 ward drug duties and the evaluation 延川正雄, 西村孝一郎, 松田圭一郎, 菅原拓也, 齋藤順, 関口徳志, 後藤純一, 江口亜耶, 佐東未咲, 荒井浩一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2014.

---

	An action and evaluation to 27-P4PM-025 ward drug duties 門脇裕子1, 山本智也1,2, 小西智恵1, 山上聡子1, 細川祐岐1, 杉浦知佳1, 衣笠裕香1, 粂紀衣1, 谷原愛加1, 新谷拓也1, 薮野佳小里1, 小門諒平1, 村地康1, 川本祐子1, 関菜美1, 山口みほ1, 井上頌子1, 岡谷梨沙1, 中塚美穂1, 上野耕司1, 原伸輔1, 有持潤子1, 澤田昌良1, 竹上学1, 三輪芳弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2014.

---

	The ward permanent residence of the 27-P4PM-026 pharmacist produces result it or more at time 山室栄一, 遠山幸男, 桜井陽平, 久田達也, 辻秀樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2014.

---

	Trial - of the ward drug duties standardization by the suggestion example analysis at action - drug control instruction for the ward drug duties enforcement in the 27-P4PM-027 Kochi medical center 高平豊, 橋田真佐, 川田敬, 田中広大, 松本尚子, 岡崎弘志, 宮本典文, 山本創一, 服部暁昌 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2014.

---

	The present conditions of the ward drug duties of our 27-P4PM-028 House 佐藤拓也, 鎌田敬志, 佐藤導 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2014.

---

	Action to prescription participation by the ward placement of the 27-P4PM-029 pharmacist 新田亮1, 古川順章1, 水津智樹2, 坂本泰一1, 小林勝昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2014.

---

	Effect of ward drug duties judging from 27-P4PM-030 change of prescription example 山瀬大雄, 林淳雄, 中西涼子, 小平いく子, 籠本基成, 土井孝尚, 小林政彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2014.

---

	1 case that developed drug-induced thrombocytopenia by Oxaliplatin during 27-P4PM-031 mFOLFOX6 therapy 長谷康史, 加藤加奈恵, 計良貴之, 田中恒明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2014.

---

	2 cases that produced an adverse event of the bleeding by 27-P4PM-032 Cetuximab administration 竹田健志, 藤江直輝, 仲野千恵, 佐藤了, 新井花緒, 阿久津亜紀子, 谷本祐子, 高木麻里, 藤田敬子, 坂上嘉浩, 室井政子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2014.

---

	One case that we presented with drug-related interstitial pneumonia with 27-P4PM-033 lenalidomide and changed to thalidomide 田中広大, 山脇まり絵, 岡崎弘志, 松本尚子, 川田敬, 橋田真佐, 高平豊, 宮本典文, 山本創一, 服部暁昌 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2014.

---

	One case of the interstitial pneumonia with suspected interaction of 27-P4PM-034 sunitinib and the radiation exposure 本西哲, 本間信次, 大植謙一, 廣田育彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2014.

---

	Adverse event report (led by a liver damage, a fatal case due to the interstitial pneumonia) of the 27-P4PM-035 regorafenib 坪谷綾子1, 小形厚貴1, 町野怜子1, 白土阿貴恵1, 坂下裕子1, 朝倉武士2, 増原慶壮1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2014.

---

	One patient who was thought to present with interstitial pneumonia by G-CSF administration after the docetaxel therapy for the 27-P4PM-036 prostate cancer 佐道紳一1, 植木菜美1, 鶴田孝義1, 藤田有紀子1, 森善洋1, 木下真理子1, 吉岡大樹1, 吉村敏朗1, 松尾信子2, 塚元和弘3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2014.

---

	Research of the side effect development situation of the mogamulizumab using 27-P4PM-037 adverse drug reaction database (JADER) 井口祐美子, 小川喜寛, 頭金正博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2014.

---

	Relative examination of an adverse effect in the antitumor agents for the 27-P4PM-038 injection and the physicochemical nature 板垣文雄, 高谷淑麗, 米沢梨加, 中川幸子, 飯島亮介, 渡邊真知子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2014.

---

	In malignant glioma treatment in our 27-P4PM-039 center about a tendency of the lymphocyte counts decrease at temozolomide and radiotherapy combination 小西敦子, 田中あゆみ, 金川明裕, 吉野宗宏, 橋本博史, 田中三晶 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2014.

---

	Onset of liver damage situation investigation with flutamide in our 27-P4PM-040 House 加納沙代子, 長尾由佳, 赤木晋介, 高柳和伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2014.

---

	One case that developed Fanconi syndrome by chronic administration of the 27-P4PM-041 Adefovir 喜多春菜1, 田中雅幸1,2, 打谷和記1, 廣田育彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2014.

---

	Examination of the valganciclovir prophylaxis depending on the renal function in the 27-P4PM-042 lung transplantation patients 川西秀明1, 村川公央1, 北村佳久1, 岡田真典2, 三好健太郎2, 杉本誠一郎1, 山根正修2, 大藤剛宏2, 千堂年昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2014.

---

	Liver function test situation investigation at the pharmaceutical products administration with the 27-P4PM-043 immunosuppressive action 吉田陽子, 宍野友紀, 田中亮裕, 田中守, 荒木博陽 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2014.

---

	It is one patient of patients with tuberculosis with suspected heparin origin-related thrombocytopenia by 27-P4PM-044 heparin lock 松下直樹1, 長谷川徹1, 久田純生1, 河井和子1, 伊藤和幸1, 磯谷聡1, 龍華祥雄2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2014.

---

	Investigation about the onset situation of 27-P4PM-045 heparin origin-related thrombocytopenia 宇野洋司, 徳丸隼平, 牛島大介, 上手真梨子, 菊池雄一, 小島昌徳, 橋本真也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2014.

---

	Investigation about the prescription actual situation of the rivaroxaban in the 27-P4PM-046 City Sapporo hospital and the bleeding event 二木祐輔, 安田美咲, 尾崎尚子, 大下直宏, 上田晃, 川本由加里, 後藤仁和 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2014.

---

	The effect that a taking 27-P4PM-047 dabigatran method gives to an alimentary system adverse event 雪田拓1,2, 渕上俊介1, 安土菜美1, 陶山明菜1, 樋浦一哉1, 稲垣貴裕2, 今井隆人1, 渡辺浩明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2014.

---

	Examination ... to use situation second report - recommended administration of the dabigatran in our 27-P4PM-048 House 中井聖子, 平井満子, 古田有紀子, 佐藤倫由 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2014.

---

	Side effect investigation of the 27-P4PM-049 argatroban cerebral thrombosis acute phase therapy 河野祐輔1, 松尾美幸1, 中尾恵美1, 石橋章2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2014.

---

	Platelet body change at 27-P4PM-050 drug-related thrombocytopenia 福永修司, 佐伯康弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2014.

---

	Search of the symptom for a risk factor and early detection of the 27-P4PM-051 drug-related extrapyramidal disorder 岸早奈恵1, 大津史子1, 矢野玲子2, 榊原仁作1, 後藤伸之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2014.

---

	Effect to give to the motor behavior of the mouse of the 27-P4PM-052 H1 receptor blocker 小原成晃1, 天神久実1, 黒田裕子1, 松元一明1, 堀誠治2, 木津純子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2014.

---

	The side effect of 27-P4PM-053 Prescription Sequence Symmetry Analysis (PSSA) signal detection of the lower urinary tract functional disorder cause medicine 橋本昌子1, 橋本佳奈子1, 長瀬啓介2, 荒井國三1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2014.

---

	Examination about the blood level of L-DOPA in patients with advanced Parkinson's disease that used 27-P4PM-054 amantadine hydrochloride together and the L-DOPA metabolite 佐藤光利1, 葛生亜美1, 平井成和2, 土井啓員2, 真坂亙2, 榊原隆次3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2014.

---

	Investigation about patients with onset of the haemorrhagic ulcer due to 27-P4PM-055 NSAIDs administration 藤田仁美1,2, 濱宏仁2, 巽弥生2, 嶋本藍2, 福島昭二1, 新眞理子1, 田中詳二2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2014.

---

	Study on small intestine inflammation model and dry skin expression with the 27-P4PM-056 indometacin administration 小山真由, 平本恵一, 小川文歌, 浅野竜之介, 横山聡, 大井一弥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2014.

---

	Side effect expression of diclofenac local site cutaneous administration preparation using the large-scale data of the 27-P4PM-057 drugstore and examination about the risk factor 大山勝宏1,3, 高橋真二2, 福岡勝志2, 清水万紀子3, 山崎浩史3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2014.

---

	One case of aplastic anemia that showed the rise of a liver enzyme level and the serum ferritin level during 27-P4PM-058 hyperferremia treatment 内海裕美1, 西山徳人1, 田中雅幸1,2, 打谷和記1, 廣田育彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2014.

---

	Examination about the risk factor of the onset of hepatic dysfunction with 27-P4PM-059 Caspofungin 名賀梨沙, 中村豪志, 田中邦佳, 室親明, 木村健 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2014.

---

	Examination of the risk of the liver damage with the 27-P4PM-060 proton pump inhibitor administration 山田梨紗子1, 脇田真実子1, 柴北健佑1, 岡田佑輔1, 松村治穂1, 近藤勝弘3, 江崎哲夫3, 木村和哲3, 飯田真介4, 頭金正博1, 中村克徳2,5, 松永民秀2,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2014.

---

	Interaction of 27-P4PM-061 morphine and diclofenac 無量井昂樹1, 栗山航一1, 木村嘉明2, 尾崎紀之3, 荒井國三1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2014.

---

	Retrospective study investigation about the effect of the proton pump inhibitor about the excretion delay of the methotrexate in the 27-P4PM-062 Miyakonojo Hospital 西村尚芳, 福石和久, 津曲恭一, 田中基稔, 大津貴寛, 吉田裕生, 末永亘, 戸切祥恵, 古里あかね Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2014.

---

	Investigation about the interaction of 27-P4PM-063 pyrimidine system anticancer agent and warfarin tablets fluoride 草信晴美, 水嶋萌美, 監物英男, 今村明正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2014.

---

	1 case of the GIST with suspected effect reinforcement of warfarin with 27-P4PM-064 imatinib 羽生智宏, 尾形美絵, 嶋崎千絵, 長澤欣弘, 森山亜矢子, 田村和彦, 新関みどり, 近藤和宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2014.

---

	The case that an anticoagulant effect was prolonged by combination of 27-P4PM-065 alleviation of fever sedative antiphlogistic and warfarin 渡辺篤, 佐々木麻里, 藤井静香 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2014.

---

	Change investigation of the PT-INR level in 27-P4PM-066 Fosaprepitant and the warfarin combination case 吉野新太郎, 児玉暁人, 今井兼貴, 竹村充代, 野村文子, 岩田智津子, 高橋文香, 高田文, 上原哲, 遠藤雅久, 八尾祥子, 森信介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2014.

---

	Comparison of the prescription actual situation and the solidification ability of 27-P4PM-067 warfarin and the proton pump inhibitor combination 須藤頌, 前淳之介, 若松亜耶香, 曽我部直美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2014.

---

	The effect that use of the linezolid gives for warfarin control in the 27-P4PM-068 left ventricle ventricular assist device wearing patients 木下佐昌子1,2, 和田恭一1, 松田紗知1, 越智純子1, 岩澤真紀子1, 粉川俊則1, 中村慶1, 桑原健1, 坪井志穂2, 堀由美子2, 中島誠子2, 角南春樹2, 佐藤琢真2, 瀬口理2, 簗瀬正伸2, 中谷武嗣2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2014.

---

	May 27-P4PM-069 linezolid and the interaction of warfarin occur? 田村勝彦, 西圭史, 篠原高雄, 永井茂 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2014.

---

	Examination about the anticoagulant effect reinforcement of warfarin at the 27-P4PM-070 TS-1 combination 河村美弥子, 鈴木直哉, 正木銀三 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2014.

---

	The effect that 27-P4PM-071 antirheumatic drug iguratimod gives to warfarin metabolism 作山佳奈子1, 山折大1,2, 高見健3, 塩澤彩香1,2, 松澤直樹1, 大森栄1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2014.

---

	27-P4PM-072 Impact on the thyroid hormone by the simultaneous ingestion of levothyroxine and polaprezinc 加藤さや香1, 水谷実佐子2, 牧原俊康1, 林高弘1, 山田成樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2014.

---

	Effect of zinc which gives it to the interaction with the metal cation of the 27-P4PM-073 new quinolone antibacterial 井上結夏1, 高見陽一郎1, 兼光朝子1, 川本英子1, 長瀬彩花1, 浜原安奈1, 山本温子1, 花田貴恵1, 小川壮寛1,2, 島田憲一1, 江川孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2014.

---

	Effect on internal change of valproic acid with 27-P4PM-074 cyclosporine 守作美咲1, 石崎純子2, 東夏宵1, 菅幸生2, 崔吉道3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2014.

---

	Examination of the factor that blood cyclosporine levels increased from one case of the 27-P4PM-075 interstitial pneumonia remarkably 金子憲太郎, 杉本誠, 吉川明彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2014.

---

	Interaction of cyclosporine and itraconazole in patients with 27-P4PM-076 aplastic anemia 山室蕗子1, 喜多岡洋樹1, 吉田愛1, 田中泉1, 後藤由起子1, 末吉栄志1, 近藤元三1, 平野太一2, 辻隆宏2, 山崎浩2, 津田弘之2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2014.

---

	1 case of the renal-transplant recipients whom combination of aprepitant was thought to influence for the rise in blood tacrolimus levels at the 27-P4PM-077 oral administration 小田都紀子1, 山崎大輔1, 西川晃平2, 村木優一1, 岩本卓也1, 杉村芳樹2, 奥田真弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2014.

---

	One case that a blood tacrolimus levels drop by the 27-P4PM-078 Caspofungin combination was found in 中山大輔, 山本真悠子, 藤本佳那子, 池嶋孝広, 村中達也, 廣田育彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2014.

---

	The case that developed lithium poisoning by the combination with the 27-P4PM-079 Aziru sultan 山本飛翔, 上塚朋子, 坂上逸孝, 横山美恵子, 増原慶壮 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2014.

---

	Examination of the secondary carnitine deficiency of the seriously disabled child (person) during 27-P4PM-080 antiepileptic drug administration 中村豪志1, 中村良子1, 林俊吾1, 八本久仁子1, 大森啓充2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2014.

---

	Effect of the calcium lactate which gives it to levothyroxine replacement therapy after the 27-P4PM-081 thyroid cancer extraction 宮崎浩行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2014.

---

	Adsorptive analysis of the combination attention drug for the 27-P4PM-082 high phosphorus blood symptom therapeutic drug 安部有紀1, 伴野拓巳2, 秋山滋男3,4, 井戸田陽子1, 矢野健太郎1, 荒川大1, 礒野淳一3,4, 林正弘2,4, 荻原琢男2,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2014.

---

	2 cases of the drug-related long QT syndrome with suspected drug interaction of the 27-P4PM-083 clarithromycin 門口直仁, 田中聡, 服部暁昌 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2014.

---

	Safety management of the cancer chemotherapy patients that 27-P4PM-084 new anticoagulant is combined with 新井孝文1,9, 鈴木善貴2,9, 佐藤琢磨1,9, 江崎秀樹3,9, 寺西二三代4,9, 遠山幸男5,9, 山本倫久6,9, 池上信昭1, 板倉由縁7,9, 勝見章男8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2014.

---

	Examination about the effect of the dihydropyridine-based calcium-channel blocker on myelosuppression in the 27-P4PM-085 carboplatin paclitaxel combination therapy 畠山史朗, 豊口禎子, 白石正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2014.

---

	One patient who raised serious delirium by the drug interactions with the 27-P4PM-086 tram set combination lock 塚田由紀1, 岩瀬利康1, 越川千秋1, 山口重樹2, 山崎龍太郎3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2014.

---

	The effect that the combination of the 27-P4PM-087 azole system antifungal agent gives to a side effect symptom of oxycodone 渡邊雅明1, 百賢二1,2, 小原直2, 千葉滋2, 本間真人1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2014.

---

	The effect that 27-P4PM-088 concomitant drug gives for a calming effect of midazolam 平田憲史郎1, 大柿滋2, 岩田一史1, 浦田由紀乃1, 合澤啓二1, 丸山徹2, 陣上祥子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2014.

---

	1 case that required increase in quantity of midazolam by cancellation of 27-P4PM-089 voriconazole 中蔵伊知郎, 藤尾弥希, 川戸順之, 上野裕之, 中多泉 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2014.

---

	A drinking condition and effect of the physicochemical characteristic of the drug to give to 27-P4PM-090 grapefruit juice interaction 植沢芳広1, 高橋雅弘2, 小野澤慧2, 小川竜一2, 越前宏俊2, 加賀谷肇1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2014.

---

	Comparison evaluation of the predictive index for the AUC change of the drug by 27-P4PM-091 grapefruit juice drinking 高橋雅弘1, 小川竜一1, 植沢芳広2, 越前宏俊1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2014.

---

	Factor of the content drop to be caused when we dilute a liquid for 27-P4PM-092 Aripiprazole with a green tea drink 池田浩人1, 山中雅智1, 高橋翔太1, 川原光喜1, 湯川美穂1, 藤澤雅夫2, 湯川栄二3, 安藝初美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2014.

---

	Basic examination about the solubility of the donepezil hydrochloride which assumed the remedy with the 27-P4PM-093 tea leaves drink 畑武生1,2, 岩永一範1, 中西祐介1, 宮崎誠1, 西原雅美2, 勝間田敬弘2, 永井純也1, 掛見正郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2014.

---

	Action of the ICT pharmacist for the 27-P4PM-094 TDM enforcement reinforcement 浅川由希子1, 古川順章1, 坂本泰一1, 小林勝昭1, 大槻登季子2, 富田睦美2, 露口一成3, 鈴木克洋3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2014.

---

	Action of the vancomycin TDM by the 27-P4PM-095 pharmacist intervention 深堀研二1, 縄田英子2, 高田加奈恵4, 平原賢次3, 赤木哲也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2014.

---

	Action for drawing blood order and the TDM all cases enforcement by the 27-P4PM-096 pharmacist 星崎寛子, 福田詩織, 高木大輔, 新枦義之, 樋島学 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2014.

---

	Order TDM rate of use and cancellation reason when we had it substitute by drawing blood for 27-P4PM-097 antiMRSA medicine TDM enforcement a pharmacist 霍間尚樹, 野口まゆみ, 中村博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2014.

---

	Action of the TDM duties introduction promotion in the cottage-hospital in 27-P4PM-098 Kanagawa 蛭田剛俊1,2, 佐村優2, 樋島学2, 小村裕子2, 井上順博2, 高尾良洋3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2014.

---

	Examination of the VCM doses which 27-P4PM-099 pharmacist suggests 大久保真由美, 組橋由記, 堀本厚子, 鈴江朋子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2014.

---

	Action of the injectable vancomycin proper use by the cooperation of 27-P4PM-100 infection charge pharmacist and the ward charge pharmacist 松井環, 南和志, 田中悠子, 田村健悦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2014.

---

	The present conditions of the TDM in our 27-P4PM-101 House and future problem 飯尾志帆1, 川根隆志2, 竹原朗2, 亀山礼子2, 船屋諭史2, 八木浩志2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2014.

---

	Effect on MRSA infection treatment of intervention contents in the TDM of the 27-P4PM-102 vancomycin hydrochloride 森田俊博1,2, 大田麻紀2, 山本夕美子2, 田中宏明2, 家入一郎3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2014.

---

	Examination about the effect of treatment of an MIC level and MRSA pneumonia of 27-P4PM-103 vancomycin 岩村直矢, 池田祐輔, 曽根本恵美, 溝口晶子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2014.

---

	Examination of the pulmonary tissue levels simulation after the 27-P4PM-104 vancomycin hydrochloride intravenous administration 鈴木彩香, 田尻千晴, 長岡雅敏, 井上博貴, 和知野千春, 高嶋麻貴, 湯浅周 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2014.

---

	Examination about the risk factor of the rise in trough value during 27-P4PM-105 vancomycin administration 川島悠吾, 徳山洋子, 大森清孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2014.

---

	Examination of vancomycin doses and the blood level in the 27-P4PM-106 Kikukawa City general hospital 後藤貴裕, 安藤奈津子, 山崎愛子, 栗原梢, 揚張真利子, 日下豊史, 松下久美, 瀧祐介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2014.

---

	Inspection of the vancomycin monitor Ling's method for the infusion in the 27-P4PM-107 chronic liver disease 酒井果林1, 松尾史1, 若林巨樹2, 井上知美2, 石渡俊二2, 小竹武2, 吉村尋典1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2014.

---

	Examination of the concentrations simulation out of the ascitic fluid after the 27-P4PM-108 vancomycin hydrochloride intravenous administration 高嶋麻貴, 田尻千晴, 長岡雅敏, 井上博貴, 和知野千春, 鈴木彩香, 湯浅周 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2014.

---

	Pharmacokinetic examination of vancomycin in the 27-P4PM-109 very low birth weight infant 宗佐博子1,2, 椙山聡一郎1, 加藤英明2, 杉山嘉史2, 牛島大介1, 森雅亮2, 金子猛2, 関和男3, 橋本真也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2014.

---

	Glomerular filtration rate prediction-style evaluation using cystatin C in the 27-P4PM-110 vancomycin initial administration plan 大山裕紀子1, 田中亮裕2, 大塚尚3, 井上智喜3, 末丸克矢1, 荒木博陽2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2014.

---

	Search of the factor contributing to the effectiveness of vancomycin for the febrile neutropenia complicated with 27-P4PM-111 blood malignant disorder and safety 森永裕子1, 鈴木陽介1,2, 時松一成2, 佐藤雄己1,2, 高野久仁子3, 幸野和洋3, 緒方正男3, 平松和史3, 伊東弘樹1, 門田淳一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2014.

---

	Enforcement of the use situation of 27-P4PM-112 vancomycin and the initial loading 丸岡邦啓, 東朋代 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2014.

---

	Initial dose setting ... of VCM by the multiple regression analysis of estimated renal function level evaluation (1) - D/C by the TDM analysis of 27-P4PM-113 VCM 山口智江1, 宮原兼二1, 中根茂喜1, 平松久典1, 伊藤功治2, 水谷義勝3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2014.

---

	Risk ... of eGFR in the estimated renal function level evaluation (2) - drug administration design by the TDM analysis of 27-P4PM-114 VCM 宮原兼二1, 中根茂喜1, 山口智江1, 平松久典1, 伊藤功治2, 水谷義勝3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2014.

---

	Interpretation ... of dose guidelines according to the renal function in estimated renal function level evaluation (3) ... elderly people by the TDM analysis on 27-P4PM-115 VCM 中根茂喜1, 宮原兼二1, 山口智江1, 平松久典1, 伊藤功治2, 水谷義勝3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2014.

---

	Antimicrobial VCM template introduction as the 27-P4PM-116 Antimicrobial Stewardship promotion and the effect 平井浩二, 桑名史織, 小西寿子, 青山涼重, 中村誓子, 高橋賢成, 木村利美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2014.

---

	Comparison of impaired renal function frequencies by the effective time of the blood 27-P4PM-117 vancomycin levels analysis 大塩崇次, 川崎浩, 宮川佳子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2014.

---

	One case that MRSA became VISA during TDM enforcement for 27-P4PM-118 VCM 片桐将志, 近藤宏樹, 篠永浩, 加地努, 向井栄治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2014.

---

	Examination of the kidney protection effect at the cisplatin administration by being administered daily of oral 27-P4PM-119 magnesium agent 有田仁紀1, 工藤彰2, 牧野好倫2, 岩瀬治雄2, 林憲一2, 小杉隆祥1, 西澤健司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2014.

---

	Effect of the quality of the infusion in the renal failure with 27-P4PM-120 cisplatin 中西敏博, 桂川健司, 荒川裕貴, 松岡加恵, 藤岡美穂, 久田達也, 辻秀樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2014.

---

	Effect on renal failure by the difference in hydration regimen in the 27-P4PM-121 cisplatin combination chemotherapy 石井和美, 若林雅人, 矢嶋明, 和田秀一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2014.

---

	Investigation of the effect on renal function by the short hydration at the 27-P4PM-122 CDDP administration 桑原清人1, 木内直美1, 浅子恵利1, 近藤芳弘1, 新行内雅斗2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2014.

---

	Examination of the usefulness as the renal function marker of serum cystatin C at the 27-P4PM-123 cisplatin hydration 関礼輔1, 矢野絹子1, 田島伸介1, 高田佐織2, 横山琢磨2, 篠原高雄1, 永井茂1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2014.

---

	Was lactic acid Ringer's solution 500mL appropriate as hydration at the 27-P4PM-124 CDDP 20 mg/m2 administration? 太田一郎, 小池博文, 西川能治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2014.

---

	Examination of the protective efficacy for the Cisplatin-induced renal failure of the 27-P4PM-125 magnesium preparation administration 吉開晶一, 赤木晋介, 亀井健人, 徳田衡紀, 高柳和伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2014.

---

	About acute renal failure protective efficacy and an onset of high Mg blood symptom risk of the FP therapy by the 27-P4PM-126 Mg supplement 杉本亜弥1, 熊倉康郎1, 深谷昌秀2, 梛野正人2, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2014.

---

	Examination (the second report) about renal failure at the 27-P4PM-127 high dose CDDP combination chemotherapy and low Na blood symptom measures 林洋平1, 下川福子1, 澤田奈津子1, 野口久美子1, 川端俊介1, 岡田志保1, 清水裕行1, 小山拓弥1, 南原誠1, 安本祥子1, 谷口一成1, 田村茂行2, 池上英文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2014.

---

	Examination of the usefulness of magnesium for the renal failure in the 27-P4PM-128 cisplatin +S-1 therapy 竹内玲奈, 若林雅人, 矢嶋明, 和田秀一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2014.

---

	Examination of the appropriate supportive care for infusion load quantity and prevention of in the 27-P4PM-129 S1+ cisplatin therapy edema, weight gain 金田典子, 小田剛史, 高田宏文, 河合佐起子, 深海広平, 山下剛史郎, 廣瀬孝一, 丸尾英次, 北村瑞穂, 南橋薫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2014.

---

	We look at the rear of the impaired renal function with the GC therapy for patients with 27-P4PM-130 biliary cancer and investigate a mark 洞澤智至1, 小林美沙樹1, 篠原旭1, 清水怜2, 池田公史2, 市田泰彦1, 高橋邦雄1, 齊藤真一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2014.

---

	The effect that the complications in patients with 27-P4PM-131 progress recurrent lung cancer give to the cisplatin origin renal failure onset 平池美香子, 三好孝法, 三原由記, 三角紳博, 西野隆 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2014.

---

	Investigation about the side effect of nutrition index and cancer chemotherapy expression of patients with 27-P4PM-132 progress recurrence lung cancer 三原由記, 三好孝法, 平池美香子, 三角紳博, 西野隆 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2014.

---

	Clinical examination about 27-P4PM-133 bevacizumab-induced proteinuria 沖田健太郎, 近藤真由, 栗原江未, 臼井和明, 中山久美子, 宗本佐知子, 上地純子, 奥美和, 岩武資善, 中村宏, 面田恵 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2014.

---

	Protective efficacy with the actual situation and the RAS inhibitor of the proteinuria development with 27-P4PM-134 bevacizumab 二瓶哲1,2, 佐藤淳也1,2, 森川直人3, 山内広平3, 川口さち子1, 工藤賢三1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2014.

---

	Examination of the onset of proteinuria factor in the 27-P4PM-135 Aki Shichi nib internal use patients 遠藤裕司, 志田敏宏, 豊口禎子, 白石正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2014.

---

	1 case of the malignant glioma which developed impaired renal function by 27-P4PM-136 Temozolomide 成田綾香 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2014.

---

	Example that tolvaptan was effective for syndrome of inapp ADH secretion due to the 27-P4PM-137 small-cell lung cancer 遠藤菜緒1, 伊藤拓1, 小澤純1, 相馬まゆ子1, 今田愛也1,2, 佐々木洋一1, 猪爪信夫2, 藤野通宏3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2014.

---

	The effect that osmotic pressure of the 27-P4PM-138 oxaliplatin solution gives to vascular pain 前田真奈美1, 菅幸生1, 石崎純子1, 坂口百合野1, 崔吉道2, 松下良1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2014.

---

	Vascular pain measures and the effectiveness of oxaliplatin in our 27-P4PM-139 House 阿部理映子, 渡邉貴子, 羽田真理子, 山口麻美, 田中三枝子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2014.

---

	About vascular pain due to infusion after the 27-P4PM-140 carboplatin administration 堀部正記, 池井健, 大谷仁士, 安田喜美子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2014.

---

	Osmolar effect of vascular pain and the dissolution liquid during 27-P4PM-141 gemcitabine administration 米山英二1, 万塩裕之1, 杉山惠亮1, 築山奈央1, 井原将太1, 野沢孝子1, 中村和行1, 粟田浩文1, 上條史帆里1, 石上仁美1, 間瀬悟1, 有馬順子2, 鈴木景子3, 勝見章男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2014.

---

	Evaluation for the onset of vascular pain by the generic medicine change of the 27-P4PM-142 gemcitabine hydrochloride 北本真一, 柳田祐子, 古谷智裕, 白木政博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2014.

---

	Examination of the refrigeration in phlebitis at the docetaxel administration of the 27-P4PM-143 non-small cell lung cancer 佐々木幸作1, 脇田由紀子2, 立山佳奈子2, 是枝快房3, 中野幸助1, 尾之江剛樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2014.

---

	Development of vasculitis investigation by the Fosaprepitant by the 27-P4PM-144 epirubicin / cyclophosphamide combination therapy 島田泉, 大野晴香, 彦坂麻美, 阿部康治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2014.

---

	New prophylaxis of the injection site reaction by the Fosaprepitant in the 27-P4PM-145 EC therapy 相川晴彦1, 嶋田烈1, 加藤弥生2, 天野恵2, 古屋まゆみ2, 松本富夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2014.

---

	One patient who detected a skin ulcer by 27-P4PM-146 bortezomib subcutaneous administration 佐藤舞1, 中村あゆみ1, 古田美紀2, 後藤拓也1, 宮澤憲治1, 山本秀行3, 飯田浩充3, 永井宏和3, 松本修一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2014.

---

	Examination about the extravasation at hospitalization cancer chemotherapy enforcement in the 27-P4PM-147 urology department, the tumor internal medicine mixture ward 金明俊, 利根川小春, 黒須智博, 小笠原拓也, 立石朝子, 内田佳菜子, 松田俊之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2014.

---

	The onset of hypersensitivity symptom situation with the readministration after the 27-P4PM-148 Oxaliplatin discontinuation 酒井繁彰, 光永義治, 田中嘉一, 濱田潤 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2014.

---

	Investigation about the onset of allergic reaction situation and the reintroduction of oxaliplatin in the 27-P4PM-149 outpatient department cancer chemotherapy 渡辺祐子, 地主隆文, 鈴木直哉, 藤林遼, 菊地義明, 福井美規子, 吉嶋抄苗, 佐々木佳子, 徳村麻衣子, 高橋橋誠, 青田忠博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2014.

---

	Examination of the allergic measures in the use of Oxaliplatin (L-OHP) regimen in our 27-P4PM-150 House 田代美佳, 田井浩子, 大河万顕, 下村一徳, 川口進一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2014.

---

	Risk review of hypersensitivity with cisplatin in patients with 27-P4PM-151 gastric cancer and cancer of the esophagus 八田喬史, 根來寛, 前田彩菜, 渡辺享平, 矢野良一, 中村敏明, 政田幹夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2014.

---

	Example that presented Stevens-Johnson syndrome during cisplatin administration for 27-P4PM-152 hypopharyngeal cancer 戸水尚希, 安達尚哉, 林誠, 長岡宏一, 後藤一純, 舟木弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2014.

---

	Analysis of the factor which has an influence on the onset of hypersensitivity with the 27-P4PM-153 Docetaxel administration 池野洋平1, 有井大介1, 原田理香1, 箱守和美1, 室岡邦彦1, 野島美知夫1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2014.

---

	Investigation of the allergy-like symptom onset at the 27-P4PM-154 docetaxel administration 佐々木好美, 岩坪沙奈恵, 和田依子, 樋口美奈子, 檜山智子, 中野行孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2014.

---

	Evaluation of the predictor to affect Infusion reaction expression at the administration in the 27-P4PM-155 Rituximab first time 臼井一将1, 舘知也1, 安田昌宏2, 梅田道2, 加藤未紗1, 浅野祥子1, 横井貴文1, 野口義紘1, 後藤英子3, 笠原干嗣3, 高橋健3, 後藤千寿2, 寺町ひとみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2014.

---

	Evaluation of the pre-medication for the purpose of the prevention of infusion reaction in the 27-P4PM-156 mogamulizumab therapy 津曲恭一1, 前田宏一2, 林稔展3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2014.

---

	Examination of the rate of application about the expression of infusion reaction prevention in the 27-P4PM-157 ofatumumab administration 樋口眞宏1, 井上由紀子1, 八木聖子1, 野崎貴之1, 宇野敦子1, 志村和穂2, 野村一之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2014.

---

	Intervention effect of the pharmacist in infusion reaction measures with 27-P4PM-158 cetuximab 岡本明大1, 濱口直美1, 須藤宏文1, 石永一2, 竹内万彦2, 村木優一1, 岩本卓也1, 奥田真弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2014.

---

	The effectiveness of duloxetine for peripheral neuropathy of 27-P4PM-159 anticancer agent origin characteristics 林万紀子, 倉橋基尚, 里岩勇人, 上田綾佳, 野々内裕紀, 古場建, 上田浩貴, 眞継賢一, 塚本泰彦, 濱口良彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2014.

---

	Onset of L-OHP origin-related peripheral neuropathy situation investigation in our 27-P4PM-160 House 平良智, 當真房子, 森脇典子, 山本紗織, 長濱照美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2014.

---

	Investigation of the development of peripheral neuropathy situation in the paclitaxel preparation of 27-P4PM-161 two kinds 一島知樹, 長谷川晃司, 和田淳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2014.

---

	Peripheral neuropathy measures of breast cancer nab-PTX by 27-P4PM-162 preventive preparation set prescription and pressurization stockings sleeve (3S) 古岡大樹1, 森善洋1, 木下真理子1, 藤田有紀子1, 佐道紳一1, 小坂幹子2, 大野毅3,4, 吉村敏朗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2014.

---

	Examination about the effectiveness and the safety of the febuxostat in the 27-P4PM-163 tumor lysis syndrome prevention 長谷悠紀, 岸川春樹, 曽我弘道, 川井友美子, 山口静, 坪根未歩, 平野真健, 町田聖治, 入江利行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2014.

---

	Effect of the uric acid level after the chemotherapy enforcement in 27-P4PM-164 blood-forming organ tumor 東修司1, 中村友香1, 田中悠季2, 鈴木悠加1, 本多有希子1, 後藤悠1, 吉田直哉1, 小原郁司1, 小寺隆二1, 妻木良二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2014.

---

	One discussion of the individualization treatment for the hyperuricaemia of the 27-P4PM-165 oncolysis 簑原豪人1,2, 真家紘一郎3, 小原直3, 千葉滋3, 久賀圭祐1, 本間真人2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2014.

---

	Hepatitis B measures to occur by immunodepression, the chemotherapy in the patients after 27-P4PM-166 hematopoietic stem cell transplantation 八木祐子1, 平畠正樹1, 伊藤浩樹2, 野村洋道1, 中西真也1, 松下章子3, 橋田亨1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2014.

---

	It is the attitude survey for pharmacists toward the self-care introduction of the drug for the 27-P4PM-167 medical care 阿久井千亜紀1, 波多江崇2, 中村豪志1, 高橋幹子1, 岡村佐紀1, 福永智栄3, 乾貴絵3, 木村健1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2014.

---

	About the prescription of drug situation of the 27-P4PM-168 palliation and prognostic association 金銅葉子1, 嶋田和貴2, 二神寿美子3, 山東真寿美1, 合屋将2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2014.

---

	Use fact-finding of the 27-P4PM-169 oxycodone parenteral injection 花城理人1, 岡本禎晃2, 田中育子2, 明石延子2, 竹井清純2, 中嶋真一郎2, 進藤喜予2, 中川左理1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2014.

---

	The actual situation and usefulness, safety of the midazolam administration in sleep disorder of patients with 27-P4PM-170 end-stage cancer 木村隆志, 杉浦宗敏, 中島由紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2014.

---

	Proper use situation investigation of 27-P4PM-171 methadone hydrochloride tablets 塚本早百合, 逸見結衣, 渡邊小百合, 濱谷安希子, 伊勢原祐子, 藤原正幸, 安達嘉織, 小田中みのり, 柴田直子, 中晴徹, 大前隆広, 川高菜緒, 大谷祐子, 見上千昭, 吉田直恵, 奥川斉 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2014.

---

	The comparison between high-dose acetaminophen bougie and acetaminophen injection in the 27-P4PM-172 palliative care unit and examination of the usefulness 櫛引智子1,2, 宮澤正幸1,2, 平田司1,2, 片町守男2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2014.

---

	Morphine for dyspnea in patients with 27-P4PM-173 cancer, investigation about the palliation of the fentanyl 西川隆一1, 藤井友和1, 楠泰臣2, 辻博幸1, 塚本久之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2014.

---

	Examination of the usefulness of the flow chart which we made for understanding improvement of the 27-P4PM-174 fentanyl sublingual tablet direction for uses 牧野哲平1, 田中佑佳1,2, 石黒崇2, 長谷川貴昭2, 田村量哉2, 葛谷命2, 杉山保幸2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2014.

---

	Use fact-finding of tramadol in patients with 27-P4PM-175 cancer sharp pain and examination about the merit 竹内美緒1, 加藤博史2, 宮崎雅之2, 椿井朋1, 肥田裕丈1, 毛利彰宏1, 山田清文2, 野田幸裕1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2014.

---

	Evaluation of the sharp pain control after the 27-P4PM-176 tramadol capsule beginning to use 長谷部千夏, 山口雄士, 上田志穂, 佐野彩女, 兼松友紀, 宮部芳之, 柏毅彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2014.

---

	It is ... from the questionary survey to competitive review results - nurse about the use of rescue medicine in 27-P4PM-177 cancer sharp pain treatment 清水けいこ, 大西祥代, 細川朋弘, 高儀佳代子, 安藤智美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2014.

---

	A present conditions investigation and problems of the drug rescue self-care in the 27-P4PM-178 inpatient 山崎富士子1,7, 林俊吾2,7, 武智宣佳3,7, 綱本優美4,7, 東裕美子5,7, 形部文寛6,7, 八本久仁子2,7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2014.

---

	Action in our House for the patients self-care of the 27-P4PM-179 rescue dose 東裕美子1, 形部文寛2, 八本聖秀1, 淺野耕助3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2014.

---

	Use experience of the fentanyl rescue medicine for the 27-P4PM-180 cancer prominence ache 山田千代子, 米澤美和, 久保杏奈, 虎瀬和子, 柏原宏暢 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2014.

---

	About the setup of the palliative care team by the 27-P4PM-181 pharmacist leadership 八本久仁子1,4, 藤野和子2,4, 池田政宣3,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2014.

---

	Cooperation of 27-P4PM-182 palliative care team and the ward pharmacist 牛膓沙織1, 吉川朝子2, 安江敦3, 家田秀明3, 池上信昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2014.

---

	Action ... for the examination - ward drug duties enforcement about the cooperation of 27-P4PM-183 palliative care team pharmacist and the ward pharmacist 田島紳介1,4, 関礼輔1,4, 矢野絹子1,4, 畔蒜祐一郎1,4, 窪田靖志2,4, 正保智恵美3,4, 篠原高雄1, 永井茂1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2014.

---

	Trial in the ward rounds of the 27-P4PM-184 Okayama Red Cross hospital palliative care team 浅野志津1, 大道淳二1, 長谷川亜樹2, 渡辺啓太郎2, 喜多嶋拓士2, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2014.

---

	Construction of the many types of job cooperation system by the active intervention of the pharmacist in the opioid analgesic introduction of patients with 27-P4PM-185 outpatient department cancer sharp pain 山田正実1, 松村千佳子1,2, 地丸裕美1, 上野理恵1, 矢野義孝2, 高橋一栄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2014.

---

	Examination about the role of the palliative care team exclusive duty pharmacist in the 27-P4PM-186 palliative care internal medicine outpatient department 小野あゆみ1, 和久井卓1, 高橋通規2, 高橋紀子2, 矢吹まゆみ2, 水沼周市1, 大塚誠二1, 小山田光孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2014.

---

	Questionary survey about opioid prescription support tool [OpiTool] using 27-P4PM-187 electronic chart terminal and revision based on the findings 笹尾武史, 森真澄, 川澄清孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2014.

---

	Examination - of the case that the introduction with opioid introduction - fentanyl patch for the patients with impaired the 27-P4PM-188 passage was conducted 三好孝法1,2, 山内浩子3, 三角紳博1, 甲斐祭生2, 吉田絵衣子2, 西野隆1, 蓮尾泰之2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2014.

---

	1 case that a tight military ration using the oxycodone hydrochloride hydrate parenteral injection by the 27-P4PM-189 palliative care team was successful, and was able to leave the hospital 関裕佳里1, 青木純子2, 長岡佑子1, 濱田健太3, 杉山哲大1, 川上恭弘4, 野中泰幸5, 近藤祥代1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2014.

---

	The case that an objective evaluation of the 27-P4PM-190 sharp pain strength was difficult, and led to opioid overdose 新崎孝夫, 弥山秀芳, 岡田玲子, 米田篤司, 富田浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2014.

---

	Pharmaceutical intervention to side effect measures in the 27-P4PM-191 tramadol hydrochloride capsule remedy patients 松下尚弘1, 羽田野明子1, 古賀清弘1, 池綾子1, 石丸隆之1, 野口玉枝2, 福島由紀2, 鵤聡子2, 野中敏治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2014.

---

	The expression situation of the drug-related akathisia symptom in our 27-P4PM-192 House and the measures 斉藤匡昭1, 田口舞子1, 江刺家朋美1, 高橋朋子1, 佐々木智子1, 加賀谷明日美1, 相場悠樹1, 鎌田靖子1, 竹原美都子1, 国安美和1, 小松田徹1, 太田寿孝1, 小松英樹2, 大河弘子2, 新田リエ2, 秋山博実2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2014.

---

	Inspection of retching, the vomiting factor in the 27-P4PM-193 pancreatic cancer Gemcitabine combination proton radiotherapy 團優子1, 柴田博子1, 寺嶋千貴2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2014.

---

	Trial (the first report) of the basis change for the convenience improvement of the 27-P4PM-194 Mohs paste 茂庭美希1, 佐藤淳也1,2, 藤澤晨1, 工藤賢三1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2014.

---

	Trial (the second report) of the basis change for the convenience improvement of the 27-P4PM-195 Mohs paste 藤澤晨1, 佐藤淳也1,2, 茂庭美希1, 工藤賢三1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2014.

---

	One case that clindamycin (CLDM) mouth wash was effective for a bad smell with the 27-P4PM-196 mouth floor cancer 北森靖隆1,5, 市村行典1,5, 守田夏希1,5, 岡山浩子2,5, 福島珠美2,5, 平嶋和代2,5, 橋本正博3,5, 玉置秀成1, 石田英明1, 伊藤清隆4,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2014.

---

	Usefulness evaluation of the diclofenac gargle (hospital preparation) for the sharp pain in the 27-P4PM-197 oral cavity 野村浩英, 宮麻紀子, 六車裕一, 松元麻美, 牧秀美, 平田貴宏, 吉岡亮, 乾有希子, 池田久雄, 畑中勝義 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2014.

---

	Evaluation about the effect of the diclofenac sodium gargle on 27-P4PM-198 radiation-related oral mucositis 檜垣宏美, 渡邉真一, 田中亮裕, 荒木博陽 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2014.

---

	Comparison and examination ... of the stress reduction effect by the long-term use of the examination - plural species aroma oil of the relaxation effect that assumed 27-P4PM-199 stress marker an index 坂口佐穂子1, 大塚沙穂里1, 岡部友紀代1, 金子明日美1, 下枝貞彦1, 中川沙織2, 大和進2, 太田伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2014.

---

	Examination of stress inhibitory effect and the immunity enhancement effect with the gamma-aminobutyric acid which assumed the IgA out of 27-P4PM-200 saliva an index 大塚沙穂里1, 坂口佐穂子1, 金子明日美1, 岡部友紀代1, 下枝貞彦1, 中川沙織2, 大和進2, 太田伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2014.

---

	27-P4PM-201 Analgesic effect part density of opioid immediate release simulation for patients with cancerous sharp pain - About oral oxycodone immediate release - 横井沙緒里, 壁谷めぐみ, 日比聡, 斉藤明子, 久保直子, 神谷絵梨奈, 湯浅周 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2014.

---

	27-P4PM-202 Analgesic effect part level of opioid real time-releasing preparation simulation for patients with cancerous sharp pain 〜About immediately fentanyl-releasing preparation〜 神谷絵梨奈, 壁谷めぐみ, 日比聡, 齋藤明子, 久保直子, 横井沙緒里, 湯浅周 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2014.

---

	Search of the risk factor to have an influence on the sharp pain control of the 27-P4PM-203 fentanyl patch use patients 平舩寛彦1,2, 高橋宏彰2, 千葉健史1, 工藤賢三1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2014.

---

	Effect on bowel movement - preliminary investigation report ... by the changes from 27-P4PM-204 oxycodone controlled-release tablet to a fentanyl patch 衛藤智章, 林稔展, 古海和博, 小早川高徳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2014.

---

	Examination of the conversion ratio and the analgesic effect of the oxycodone injection preparation in the 27-P4PM-205 opioid rotation 山本明紀, 藤井千賀, 石坂敏彦, 八野芳已 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2014.

---

	Change of the change to the opioid injection drug with the 27-P4PM-206 oxycodone (R) note 秦毅司1,10, 渡辺貴志2,10, 中村敏史3,10, 野村翔3,10, 後藤健志4,10, 櫻井まりこ4,10, 伴竜典4,10, 中原典絵4,10, 白木小百合4,10, 寺西二三代5,10, 遠山幸男6,10, 山本倫久7,10, 板倉由縁8,10, 勝見章男9 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2014.

---

	Example that switched from 27-P4PM-207 oxycodone to acetaminophen, and followed the good course 大津貴寛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2014.

---

	The effectiveness in the fentanyl patch introduction for 27-P4PM-208 generic medicine 3rd and safe examination 塚本泰彦1, 梶山徹2, 倉橋基尚1, 眞継賢一1, 岡本朋子1, 古場建1, 市原しのぶ3, 垣見亮4, 濱口良彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2014.

---

	The effect that the attaching person of the 27-P4PM-209 fentanyl patch gives to a fentanyl survival rate 川口恵1, 沼田千賀子1, 寺岡麗子1, 湯谷玲子1, 岡本禎晃2, 平野剛3, 冨田猛3, 平井みどり3, 北河修治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2014.

---

	Examination about the difference of consciousness, the maneuver of the fentanyl survival rate of the use of 27-P4PM-210 finished fentanyl patch and the attaching person 奥田麻有1, 沼田千賀子1, 寺岡麗子1, 湯谷玲子1, 岡本禎晃2, 平野剛3, 冨田猛3, 平井みどり3, 北河修冶1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2014.

---

	Examination of the usefulness of the introduction sheet in the 27-P4PM-211 fentanyl oral mucosa absorption preparation 立松三千子1,2, 美濃屋亜矢子3, 尾崎千鶴3, 栗木玲子2,4, 秦毅司2,5, 松崎雅英1, 平島佳代1, 橋本直弥1, 前田美恵子1, 長谷川彩子1, 新田都子3, 下山理史6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2014.

---

	Comparison (the second report) using 27-P4PM-212 fentanyl sublingual tablet and the preparation example in the buccal tablet 遠山幸男, 中村千加弘, 石川亜未, 高岡龍蔵, 久田達也, 辻秀樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2014.

---

	Action for the proper use of the 27-P4PM-213 fentanyl quick-release preparation 彦坂麻美, 島田泉, 渡邉幸雄, 阿部康治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2014.

---

	27-P4PM-214 Difficulty and the usefulness that we experienced by use of the fentanyl immediate release 和久井卓1,2, 小野あゆみ1,2, 水沼周市1, 大塚誠二1, 小山田光孝1, 高橋紀子2, 高橋通規2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2014.

---

	Effect to give to PT-INR by the combination of 27-P4PM-215 tramadol hydrochloride capsule and warfarin potassium 皆元文恵, 梅田勇一, 金澤康範, 竹本伸輔 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2014.

---

	Action second report of the storage pharmaceutical products use for a 27-P4PM-216 size scale disaster 川口亮1, 水口雅貴1, 菅尾高裕1, 小池道明1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2014.

---

Questionary survey about the association of 27-P4PM-217 Japanese private medical college chief pharmacist meeting sponsorship 2013 pharmacist practitioner workshop participant disaster medical care 白瀧肇1, 鈴木優司1, 添田真司2, 渡邊昌之2, 横山直3, 平綿洋子3, 丸谷善紀3, 市川訓3, 宮坂宗男3, 川口さち子4, 工藤賢三4, 野村守弘5, 山添譲5, 片山志郎6, 二神幸次郎6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2014.

---

	About participation in disaster support of the 27-P4PM-218 pharmacy school first grader, rescue operation awareness 中村武夫1, 伊藤栄次1, 田村隆教2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2014.

---

	Evaluation of the pharmaceutics of the micellar particle diameter and particle count in the 27-P4PM-219 lipid microsphere 長谷川豊1, 依藤健之介1, 波多江崇2, 倉本敬二3, 濱口常男2, 平野泰健1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2014.

---

	Diachronic change of effect and sTNF, sTNF-R1, -R2 of Capsaicin in the 27-P4PM-220 LPS administration mouse 小林由佳, 加藤隆児, 井尻好雄, 林哲也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2014.

---

	Action of the open conference enforcement to a local pharmacist in our 28-P1AM-001 House psychiatric care center 冨ヶ原由季1, 坂本修1, 小杉三弥子1, 宮崎三恵子1, 川島千明2, 小田原俊成3, 橋本真也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2014.

---

	Action to medicine medicine cooperation with 28-P1AM-002 Gunma center Hospital and the Maebashi-shi pharmacist society 新木美枝1, 伊藤典子1, 草間敏子2, 永井和己3, 木村薫3, 濱田えり子3, 井上拓民3, 大島由喜夫3, 内藤浩2, 山賀章一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2014.

---

	About information cooperation activity between the pharmacy with the hospitalization and release in the 28-P1AM-003 corporation 嶋田聖子1, 濱邊秋芳1, 納富貴子1, 武田典子1, 溝口晶子2, 曽根本恵美2, 小林恵子2, 岩村直也2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2014.

---

	Example of the excellent action about the cooperation of a medical institution working for the safe use of 28-P1AM-004 pharmaceutical products and the drugstore 中常恵美1, 平松彩佳1, 飯村康夫1, 渡邊伸一1, 山本弘史2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2014.

---

	Examine the illness in the outside Parliament prescription of foreign cancer chemotherapy patients in the 28-P1AM-005 eight Municipal Hospital; examination about the usefulness of the medicine cooperation system 小川充恵1,2, 植田真理1, 山崎肇1, 小枝伸行2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2014.

---

	Evaluation of the usefulness of the medicine medicine cooperation introduction in the treatment with oral anticancer agent of the 28-P1AM-006 outpatient 吉田徹也1, 中尾將彦1, 山崎直樹1, 中川朋美1, 木村仁美1, 岡本優美1, 勝島詩恵2, 津谷あす香2, 徳永伸也2, 駄賀晴子2, 武田晃司2, 松井優子3, 吉川眞知子3, 竹内昌司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2014.

---

	Medicine medicine cooperation in the oral anticancer agent using the 28-P1AM-007 outside Parliament prescription 阿部雅雄1, 成定宏之2, 岩崎由香1, 中園武宣1, 芳野美和1, 森康弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2014.

---

	Practice support and medicine medicine cooperation by the intervention to 28-P1AM-008 outpatient department internal use cancer chemotherapy 相良克海, 森山愛子, 吉川聡美, 小田慎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2014.

---

	Usefulness of the medicine medicine cooperation using the Internet and FAX in the treatment with 28-P1AM-009 oral anticancer agent 間俊男, 川崎玄博, 竹葉美香, 藤近拓弥, 示野健介, 谷幸美, 西村さやか, 宮村憲明, 水野李絵, 三浦雅典 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2014.

---

	Patients support with the information communication book between institutions including the telephone support for foreign chemotherapy patients in the 28-P1AM-010 drugstore 角佳亮1, 水野宏昭2, 樋口敦1, 西上潤2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2014.

---

	About making and the use of the patients reporting tool in the 28-P1AM-011 cancer chemotherapy 日沖雅人, 山川智一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2014.

---

	Questionary survey about the instruction to patient of the cancer chemotherapy to a pharmacist working in 28-P1AM-012 Sakai-shi 渡邊裕之1, 藤井千賀2, 安井友佳子2, 北村瑞穂3, 金田典子3, 藤原季美子4, 古川順章5, 三盃範晃6, 桐子雄志7, 東田美奈8, 金田仁孝9, 高山宏10 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2014.

---

	The present conditions of the medicine medicine cooperation with the visit pharmacist in the Yachiyo medical center attached to 28-P1AM-013 Tokyo Women's Medical College 高柳論也1, 須貝壮衆1, 渡邉基之1, 金谷法好2, 小川智弘3, 濃沼政美4, 小坂好男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2014.

---

	It is ... for held - medicine medicine cooperation of the "palliative care" workshop for the 28-P1AM-014 local health insurance ethical pharmacy 梶原徹, 中村智, 小川洋司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2014.

---

Attitude survey of the pharmacist after the workshop attendance for the purpose of the 28-P1AM-015 medicine medicine cooperation 鈴木大吾1,4, 石井秀明1,4, 松原怜1,4, 伊東和真1,4, 浅野嘉之1,4, 鈴木敦詞1,4, 川村まりこ1,4, 栗本夕夏1,4, 奥田ユミ1,4, 牛田誠2,4, 林きよみ2,4, 山田智美2,4, 河村智美2,4, 市原敬大2,4, 小畑秀夫2,4, 服部雄太3,4, 前田剛司1,4, 坂田洋1,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2014.

---

	Usefulness of hospitalization and release drugstore judging from the attitude survey to 28-P1AM-016 pharmacist, the hospital cooperation workshop 松田千恵1, 大津山裕美子2, 須崎宏子3, 新田朋弘4, 小畑友紀雄5, 安原智久1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2014.

---

	Questionary survey about the actual situation of the medicine medicine cooperation for a hospital, the health insurance pharmacy of 28-P1AM-017 Hokkaido 戸根佑馬1, 野呂瀬崇彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2014.

---

	Examination about effective mention of the 28-P1AM-018 medicine notebook 宮本康敬1,12, 下條浩史2,12, 塩野州平3,12, 富田治4,12, 伊藤譲5,12, 曽布川美登理6,12, 高橋聡7,12, 下山大地8,12, 杉山裕司9,12, 奥村知香10,12, 柴山芳之10,12, 渡邉進士11,12, 塩川満3,12 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2014.

---

	Questionnaire survey ... of the cooperation - Munakata, Fukuoka pharmacist society germfree preparation workshop with the health insurance pharmacy about the 28-P1AM-019 germfree preparation 月野木祥子1, 三嶋一登1, 秦晃二郎1, 中嶋一惠1, 村岡香代子1, 入佐俊弘1, 江頭伸昭1, 安東恵津子2, 増田智先1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2014.

---

	28-P1AM-020 The making of the general inhalational instruction prescription in the Nagoya southern part and the evaluation 中根茂喜1, 宮原兼二1, 山口智江1, 平松久典1, 松尾正樹2, 伊藤稔宏3, 中村敏史3, 後藤康洋4, 山本雅史4, 松下直樹5, 諸澤美佳6, 野崎裕広6, 松波晋平7, 大津稔彦7, 中村純子7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2014.

---

We can approach treatment by cooperation with the 28-P1AM-021 hospital pharmacy in the ethical pharmacy! It is ... by medical therapy by ... inhalational instruction more surely 古島彩代1, 飯森早苗1, 濱出晴美1, 金岡砂那恵1, 東香織1, 小松潤奈1, 向紗矢香1, 國富薫1, 朴善美1, 藪下りよ子1, 平尾広子1, 大山伸子1, 土師久幸2, 久岡清子2, 佐々木健志2, 栗原直嗣3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2014.

---

	Use of medicine medicine cooperation - antipsychotics durability parenteral injection information sharing - in the 28-P1AM-022 psychiatry 佐野知子1, 石田理恵1, 佐々木元子1, 滝澤理貴1, 島森美光2, 黒澤菜穂子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2014.

---

	One case of the psychotropic drug excessive quantity medication that a pharmacist cured before 28-P2AM-001 first aid import and suggested 河村聡志1, 佐藤史織1, 山代栄士1, 上野悦子1, 中島竜太2, 稲垣伸洋2, 森一生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2014.

---

	Survey of the acute intoxication accident patients in the 28-P2AM-002 third emergency hospital 末延道太1, 上野悦子1, 佐藤史織1, 麻生真由美1, 重松明美1, 中島竜太2, 稲垣伸洋2, 森一生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2014.

---

	About the 4 case of our 28-P2AM-003 House addicted to organic phosphorus 佐藤誠一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2014.

---

	Example that caused hypoglycemia by combination of 28-P2AM-004 SU agent and quinolone antibacterial, and led to hospitalization 大塚充, 大坪達弥, 澤田真嗣, 小西麻美子, 石田曜子, 堀内あす香, 西川靖之, 三上正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2014.

---

	28-P2AM-005 Efforts and Effects of Pharmacists Allocation to ICU in Two Hospitals Takanashi Megumi1, Funakoshi Sachiyo2, Ishida Akiko1, Hara Naoki1, Kase Katsuya1, Maeda Yorinobu2, Matsuda Toshiyuki1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2014.

---

	Intervention - injection drug management ... of the pharmacist in the 28-P2AM-006 critical care center ICU 村上仁志1, 鈴木善貴1, 清田綾子2, 夏目文子2, 森山明美2, 三浦敦子2, 鈴木伸行3, 中山雅人3, 石田隆浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2014.

---

	Enforcement situation investigation of the ward drug duties in the 28-P2AM-007 ICU 鈴木太一, 金城梢, 若杉正, 西川能治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2014.

---

	Role of the pharmacist in the PCPS introduction team by the 28-P2AM-008 many types of job cooperation 坂井孝行1, 北林浩2, 大橋慎一郎2, 伊藤美穂3, 前田美香子3, 小椋信二4, 笹岡真矢5, 伊藤陽一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2014.

---

	Investigation of prescription, the problems of formulations that became clear by common use medicine for 28-P2AM-009 emergency ward inpatient confirmation 後藤千栄, 小笠原康雄, 藤井静香 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2014.

---

	Analysis of the adverse drug reaction related information offer in 28-P2AM-010 first aid, the intensive care domain 田中聡, 門口直仁, 宮本典文, 山本創一, 服部暁昌 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2014.

---

	28-P2AM-011 Construction of the pharmacist duties in the Oita City Medical Association Almeyda Hospital critical care center 佐藤史織1, 山代栄士1, 河村聡志1, 重松明美1, 中島竜太2, 稲垣伸洋2, 森一生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2014.

---

	Usefulness evaluation of the parenteral injection incompatibility chart in the 28-P2AM-012 intensive care unit 石田茂, 尾川理恵, 武田真樹, 池末裕明, 渡邊裕之, 江頭伸昭, 増田智先 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2014.

---

	About an effect by the pharmacist placement to 28-P2AM-013 ICU, CCU 出雲正治2, 四方公亮1, 佐藤香織1, 井上由紀1, 加藤潤一郎1, 岩井健一2, 長谷川英雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2014.

---

	Pharmacist duties in the 28-P2AM-014 CCU ward 池谷健一1, 平井啓太2, 木苗あゆみ1, 山崎友朗1, 宇津木博明1, 平野桂子1, 坂本達一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2014.

---

	Medical therapy protocol making for a sleep disorder, the delirium in the 28-P2AM-015 SCU ward and action of CDTM 川田敬1, 山崎好恵1, 大崎美幸1, 高平豊1, 宮本典文1, 山本創一1, 服部暁昌1, 岩本尋世2, 福田真紀3, 岡田憲二3, 福井直樹3, 森本雅徳3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2014.

---

	Evaluation of the paramedical rounds in the 28-P2AM-016 intensive care domain 赤崎瞳1, 廣岡晃子1, 浜元善仁1, 翁長真一郎1, 松野寛子2, 安里あきの2, 仲間清美2, 東恩納のぞみ3, 比嘉保1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2014.

---

	Participation of the pharmacist for the stress ulcer prevention in the 28-P2AM-017 ICU 吉廣尚大1, 桜谷正明2, 平田旭2, 河村夏生2, 吉田研一2, 大田博子1, 橋本佳浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2014.

---

	Examination of the insulin adsorption prevention in the 28-P2AM-018 neonates glucose insulin therapy 小西友美, 中村梨余, 小林加奈, 中村卓巨, 市野貴信, 犬飼直也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2014.

---

	An action of the pharmacist placement to 28-P2AM-019 NICU and the effect 横山雅子, 高梨愛, 中島明日香, 鈴木晶子, 松田俊之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2014.

---

	Usefulness of the allergy to patients check using the yellow card by the 28-P2AM-020 surgery part exclusive duty pharmacist 向原里佳1, 高倉歩美1, 本多立1, 倉田朋彦1, 赤阪未来1, 清水恵1, 岩本卓也1, 宮部雅幸2, 村木優一1, 奥田真弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2014.

---

	Duties and the evaluation that were improved in a 28-P2AM-021 surgery part by the intervention of the pharmacist 柴田みづほ, 川口真由子, 橋本杏里, 渡辺健太, 石川雅之, 新部陽子, 中村貴子, 鈴木貴明, 有吉範高, 石井伊都子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2014.

---

	Duties development in the operating room of the 28-P2AM-022 pharmacist 野田貴義1, 水口雅貴1, 杉本智恵子1, 勝又博司1, 菅尾高裕1, 小池道明1,2, 岡崎敦3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2014.

---

	About the action of the recent ward drug duties in our 28-P2AM-023 House and the result 松田真一郎, 寺本晴美, 岡林悠, 山本智香, 神原千佳, 中谷恵子, 伊藤有紀子, 城尾晃太, 宮崎晃, 近谷理恵子, 小林佳奈, 田中慎, 土井彩愛, 弘田真澄, 淵田悠一郎, 安田将樹, 高野優子, 木俣章, 馬瀬久宜 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2014.

---

	The present conditions and problem of ward duties in HCU in the 28-P2AM-024 Asahikawa Red Cross hospital 田村研太郎, 吉田さゆり, 里利恵子, 紙谷章基久, 中岡由貴, 宮崎祐加, 山田淑恵, 多地貴則, 増渕幸二, 鈴木正樹, 簑島弓未子, 西村栄一, 牧瀬英知, 橋本光生, 後藤吉延 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2014.

---

	About the present conditions and the evaluation of ward drug duties in the 28-P2AM-025 Kitakyusyu General Hospital 中島一, 池田浩和, 大治万喜子, 柏田匡広, 溝口千秋, 大石貴裕, 高橋浩二郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2014.

---

	Ward drug duties in the hospital intensive care unit attached to 28-P2AM-026 Kanazawa University 磯田和也, 三坂恒, 中出順也, 高林真貴子, 板井進悟, 原祐輔, 崔吉道 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2014.

---

	It is ... for benefit improvement of the outside Parliament inspection work of prescription by action ... hospital pharmacist to the number of doubt inquiry reduction that we applied 28-P2AM-027 QC technique in 奥村雅美, 船戸元子, 吉田宗広, 階戸美和, 井藤俊, 森正昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2014.

---

	Drugstore duties improvement by the action (the third report) CDTM introduction for joint medical treatment management (CDTM) in the 28-P2AM-028 community medical care 小川壮寛1,2, 松下明3, 福嶋寛子1, 佐々木萌子1, 中尾直1, 守安洋子1, 川上茂利1, 島田憲一2, 江川孝2, 高見陽一郎2, 高橋正志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2014.

---

	Proper use ... of action ... vancomycin for the protocol making in the affiliated 8 hospital in 28-P2AM-029 Showa University 鈴木絢子1, 須永登美子1,9, 田中絵里子2, 今井佳世3, 櫻井康亮4, 仁尾祐太5,9, 平藤彰6,9, 屋城由樹7,9, 吉川雅之4, 和田紀子5, 齋藤勲8,9, 向後麻里1,9, 村山純一郎5,9 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2014.

---

	It is CDTM in the prevention of recurrence from the onset of the 28-P2AM-030 stroke 廣岡駿, 栗林和美, 山本佳久, 水野恵司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2014.

---

	Introduction and drug, effect to give to medical material cost reduction of injection drug preparation duties by the 28-P2AM-031 operating room working full time pharmacist 倉田朋彦1, 向原里佳1, 高倉歩美1, 清水恵1, 赤阪未来1, 岩本卓也1, 宮部雅幸2, 村木優一1, 奥田真弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2014.

---

	Enforcement of pharmacist "training that is strong in 28-P2AM-032" first aid and the evaluation 家田正子1, 野村守弘1, 吉田宏二1, 吉長正紘1, 山添譲1, 窪田愛恵2, 田口博一2, 西内辰也2, 平出敦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2014.

---

	One case of the prevention of doping activity in the 28-P2AM-033 hospital pharmacist (sports fur better strike) 小出賢吾, 野沢正徳, 三浦毅, 畔柳敏弥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2014.

---

	Role of the pharmacist in the implantation (homograft) of the 28-P2AM-034 cardiovascular surgery domain 五味知之1, 堀内賢一1, 柳沢国道1, 油井信明2, 竹村隆広3, 津田泰利3, 西澤延宏4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2014.

---

	Action of the ward pharmacist for the use of drug patients inducing the QT prolonged using the 28-P2AM-035 ambulatory ECG 山岡慶子, 大本暢子, 山本和宏, 西岡達也, 久米学, 槇本博雄, 平野剛, 平井みどり Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2014.

---

	Practice and effect of the physician burden reduction by the 28-P2AM-036 pharmacist 佐多照正1, 中村有莉恵1, 赤星真広1, 前村由佳1, 上原友美1, 山路智凡1, 池増鮎美1, 神門孝典1, 宮原広典2, 前之原茂穂3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2014.

---

	Enforcement of the testing order by the ward pharmacist based on 28-P2AM-037 medical therapy protocol 棗則明, 米川英宏, 鈴木美穂, 湯澤幸久, 小池健太, 一本木之人, 臼井沙耶香, 新井友紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2014.

---

	Role prospective in a pregnant woman, nursing mother-related drug reporting in the 28-P2AM-038 kidney internal medicine for a pharmacist 内山耕作, 横井里奈, 野村賢一, 野田直樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2014.

---

	Fact-finding of the renal excretion type drug for the patients less than eGFR30ml/min/1.73m 2 in the 28-P2AM-039 bringing medicine 森田啓嗣, 角南陽子, 洲脇純三, 川上恭弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2014.

---

	Intervention fact-finding to the on admission bringing medicine adequacy to the 28-P2AM-040 decreased renal function patients 鈴木雄太, 佐藤圭吾, 追木正人, 西和哉, 阿部浩幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2014.

---

	Effect of the renal function to give side effect expression at the 28-P2AM-041 liraglutide introduction 磯野哲一郎1,2,3, 平大樹1, 佐々木恭子1, 宇津貴2, 前川聡3, 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2014.

---

	Uric acid drop effect of the febuxostat in the 28-P2AM-042 decreased renal function patients 三星知1, 山田仁志1, 長井一彦1, 岡島英雄2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2014.

---

	Evaluation - of the change situation and the physician of renal function evaluation and prescription suggestion - prescription of the inpatient by the 28-P2AM-043 ward pharmacist 小松めぐみ, 青木佐菜, 市川麻美, 山科あかね, 田所美和, 吉岡りえ, 市吉真貴子, 八木亜紀子, 田中照夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2014.

---

	Investigation of the usefulness with changes from allopurinol which we looked at according to 28-P2AM-044 renal function to febuxostat 湯淺有香子1, 高木明子2, 辨野知子1, 柳川晴菜1, 橋本昌幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2014.

---

	Effect of carnitine on anemia in renal disease in 28-P2AM-045 patients on dialysis and line symptom 中村晋也, 向井賢司, 齋藤友季子, 貴志直哉, 龍田京子, 中村能子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2014.

---

	About usefulness of the new constipation therapeutic drug agate Pross ton to 28-P2AM-046 haemodialysis patients 望月真太郎1,2, 村松望2, 太田侑宏2, 須田智2, 大貫よし子2, 藤澤浩二1, 高田亜希子1, 牧野和也1, 二宮大和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2014.

---

	Example that opioid preparation was effective for sharp pain with the lower limbs gangrene of 28-P2AM-047 patients on dialysis 坂本愛1, 相地誠2, 高下智子1, 内山ひとみ1, 吉田俊子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2014.

---

	It is ... led by comparison between agate Pross ton and use situation - patients on dialysis in other aperient in the 28-P2AM-048 City Nagahama Hospital 大岡千寿子, 野洌孝二, 高山直樹, 田中祐輔, 干井香織, 多賀俊明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2014.

---

	Action of the pharmacist in the serum P, revision Ca levels management of 28-P2AM-049 maintenance patients on dialysis 富田敏章, 下河邉安妃子, 相部真希, 萩原里実, 町田聖治, 曽我弘道, 前田朱香, 福島将友, 清水誉志, 入江利行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2014.

---

	An action of the many types of job cooperation in the 28-P2AM-050 CKD outpatient department and the effect 椿井朋1, 柴田佳菜子1,2, 濱田昌実3, 水谷友4, 安田宜成2, 加藤佐和子5, 後藤資実6, 林睦晴7, 中尾誠1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2014.

---

Search of the factor to have an influence on for effect of treatment of the red blood cell hematopoietic stimulating factor preparation in anemia in renal disease treatment of patients with chronic renal failure for 28-P2AM-051 preservation period 松下紋子1,2,3, 林高弘2, 水野智博1,3, 野口彩香1, 加藤里奈1, 西部星来2, 湯澤由紀夫3, 山田成樹2, 永松正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2014.

---

	Two cases that we changed to oral cyclophosphamide therapy from cyclophosphamide pulse therapy for 28-P2AM-052 ANCA-related nephritis 稲秀士1, 佐藤光1, 中原千恵1, 宮川佳子1, 児玉美緒2, 井野純2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2014.

---

	Role ... of the pharmacist in trial - End Of Life Care Team of the palliative care team which added the elderly people disease to a subject 28-P2AM-053 non-cancer 久保川直美1,4, 横江由理子2,3, 西川満則3,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2014.

---

	The effect that 28-P2AM-054 becomes calm, and adjustment food gives to remedy medicine 山口博美, 落合葵, 滝谷広子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2014.

---

	Preparation of the film derived from 28-P2AM-055 active carbon component nature polysaccharides 湯川美穂1, 上川畑篤1, 東屋敷史織1, 川原光喜1, 池田浩人1, 湯川栄二2, 安藝初美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2014.

---

	Comparison between on admission and number of at discharge the drugs and drug costs in the hospital old age internal medicine attached to the 28-P2AM-056 Nagoya University School of Medicine 渡邉雄貴1, 横山雄一1, 市川和哉1, 梅垣宏行2, 葛谷雅文2, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2014.

---

	Association of the hyperammonemia onset and the genetic polymorphism with 28-P3AM-001 valproic acid 高橋俊樹1, 井上和幸1, 鈴木絵莉1, 山本吉章2, 高橋幸利2, 今井克美2, 宮川紘2, 井上有史2, 辻大樹1, 伊藤邦彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2014.

---

	Analysis of the KRAS/BRAF genetic polymorphism in patients with Stage IV colon cancer given 28-P3AM-002 FOLFOX/XELOX + C-mab combination therapy 小林靖奈1, 梅本岳宏2, 大林真幸1, 神山紀子1, 田中淳一2, 山元俊憲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2014.

---

	A maintenance dosage, responsiveness of the 28-P3AM-003 antidepressant and association with the ABCB1 genetic polymorphism 長岡翔1, 井上和幸1, 袴田康弘2, 鈴木晶子2, 木村緑3, 辻大樹1, 伊藤邦彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2014.

---

	Change of the pharmacy school freshman education effect in the 28-P3AM-004 early on-site training 池田賢二, 小西廣己, 浦嶋庸子, 長井克仁, 川西園代, 初田泰敏, 名徳倫明, 廣谷芳彦, 西井諭司, 小川雅史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2014.

---

	Construction ... of the atrial fibrillation model based on simulation education (2) - true clinical practice in the 28-P3AM-005 pharmacy school 高上美詞1, 竹市朱里1, 山本英治2, 大角幸男3, 安田公夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2014.

---

	Using learning effect - marker scenario of the simulation education using 28-P3AM-006 e-PDE - 山下裕己, 大津史子, 後藤伸之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2014.

---

	Extraction of problems of the physical assessment training by 28-P3AM-007 CS analysis, the factor analysis 大鳥徹, 松野純男, 金裕生, 松山賢治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2014.

---

	Examination ... of problems and the remedy that - student feels with the role of the pharmacist participating in 28-P3AM-008 "business true taking lessons previous learning" (the third report) 村田明子1, 中尾幸代1,2, 松田裕子1, 南恵理子1,3, 山中智香1,4, 波多江崇1, 沼田千賀子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2014.

---

	The present situation of the medical therapy workshop by 28-P3AM-009 University of Shizuoka, hospital, the community pharmacy cooperation 内野智信1,2, 宮嵜靖則1,2, 秋山欣三2, 浅倉侯子2, 伊藤邦彦2, 井上達秀2, 坂本達一郎2, 柴山芳之2, 菅谷純子2, 鈴木崇代2, 中野眞汎2, 並木徳之2, 北村修2, 松山耐至2, 森本達也2, 山田静雄2, 山田浩2, 賀川義之1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2014.

---

	Association with learning will after satisfaction and the attendance of the 28-P3AM-010 "medicine-based internship volunteer experience-based training" and the after graduation course 栗尾和佐子, 小西元美, 奥野智史, 中尾晃幸, 木村朋紀, 辻琢己, 山室晶子, 山本祐実, 西川智絵, 串畑太郎, 柳田一夫, 安原智久, 河野武幸, 曽根知道 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2014.

---

	Study introduction effect to pharmacy school life by the 28-P3AM-011 graduate student-led "statistics seminar" enforcement 庄司雅紀, 恩田光子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2014.

---

	Change of the recognition for the team approach in medical care of the pharmacy student which participated in 28-P3AM-012 many types of job cooperation education 佐藤琢哉1, 半谷眞七子1, 野田幸裕1, 毛利彰宏1, 阿部恵子2, 安井浩樹2, 末松三奈2, 亀井浩行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2014.

---

	A study on communication third report between the 28-P3AM-013 pharmacist - patients: Communication analysis using RIAS 仲山千佳1,3, 木全栞1, 大嶋耐之1, 加藤文子1,2, 新田淳美3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2014.

---

	Attitude survey (the third report) of the Chinese medicine for the pharmacy student just after the 28-P3AM-014 entrance to school - Comparison - between the subjects in the Yokohama college of pharmacy pharmacy school 田子美佐子, 金成俊 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2014.

---

It is research ... of pharmacist education system and the national examination system of each ... country and the medical administration system about a pharmacy education, the pharmacist image which is desirable for the Japanese medical care from 28-P3AM-015 this 小林俊博, 池田祐子, 沼尻幸彦, 井上裕, 新津勝, 金本郁男, 杉林堅次 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2014.

---

	Difference in pharmacist image by the quantity of the opportunity to understand 28-P3AM-016 pharmacist professional ability image 伊原千晶1, 三保紀裕2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2014.

---

	Construction of the medical English library of medicine, the pharmacy domain by the 28-P3AM-017 text mining 中村光浩1, 梅津亮冴1, 鈴木俊之1, 加藤大和1, 上田夏実1, 中山蓉子1, 羽根由基1, 松井利亘1, 阿部純子1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2014.

---

	Recognition of the nurses' aide about 28-P3AM-018 pharmacist duties 井手若奈1,2, 高橋眞生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2014.

---

	28-P3AM-019 pharmacy school pharmacology, the present conditions and comparison of the education about the field of international health medical care in the School of Medicine medicine department 加藤茉悠子1, 野呂瀬崇彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2014.

---

	Examination about the document making available for a summary of the basic pharmaceutical knowledge before the 28-P3AM-020 drugstore business training 寺下真人1, 角本幹夫2, 岡野友信2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2014.

---

	Development of the physical assessment learning teaching materials for the pharmacist that the confirmation of an evaluation, the side effect of the efficacy in the 28-P3AM-021 ward can train 今田美里, 徳永仁, 小笹彩花, 小森佳奈子, 小野知佐, 西村秋恵, 緒方賢次, 瀬戸口奈央, 佐藤圭創, 松岡俊和, 高村徳人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2014.

---

	Investigation of the doubt inquiry in approximately the 28-P4AM-001 chemotherapy regimen order system introduction 宮崎晃臣, 阿部昌宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2014.

---

	Trial to the quality of life improvement of team approach in medical care by the improvement of 28-P4AM-002 cancer chemotherapy regimen and the patients 河野茉里子1,2, 久保田祐1, 高橋真理1, 小倉崇裕1, 高橋哲三1, 小池綾子2,3, 竹之内信2,4, 中島敦夫2,5, 渋谷文則6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2014.

---

	Action for standardization of 28-P4AM-003 cancer chemotherapy regimen, the supportive care and the database management 桝茂典1, 岡田悠美1, 廣瀬俊昭1, 中川隼一1, 高橋真一1, 杉野由依1, 伊藤あゆみ1, 齋藤加奈1, 室伏孔樹1, 上村苑子1, 柴原麻未1, 赤石和久2, 村上敏明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2014.

---

	The electronic chart of the regimen confirmation matter for the purpose of the 28-P4AM-004 information sharing about becoming it 北野陽子, 細谷嘉行, 田中崇, 長田麻未, 田中三広 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2014.

---

	The evaluation of the 28-P4AM-005 cancer chemotherapy regimen system of administration and safety management by the pharmacist 上野陽介1, 岡田悠加1, 藤原和彦1, 国東ゆかり1, 辻本勉1, 松岡英仁2, 楠知美3, 居上和代3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2014.

---

	Introduction of the anticancer agent cumulative dose system of administration in the 28-P4AM-006 electronic chart 青野真弓1, 中田千博1, 實川東洋1, 三上麻衣子2, 高市直子2, 丸山美穂子2, 福田恵子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2014.

---

	Role of the present conditions and the pharmacist of the cancer chemotherapy regimen examination registration in the hospital attached to 28-P4AM-007 Kawasaki Medical School 槇枝大貴1,4, 二宮洋子1, 笹本奈美2,4, 岡脇誠3, 山口佳之3,4, 玉井恭子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2014.

---

	The rebuilding of the 28-P4AM-008 chemotherapy regimen deliberation system and reevaluation of the registration regimen 大竹明美1, 千葉博暁1, 伊藤千鶴1, 貴田岡徳子1, 湊敬子1, 氏家美帆1, 武田昇1, 加藤裕也1, 舘田要樹1, 伊藤薫2, 石岡千加史3, 中村浩規1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2014.

---

	Improvement of the care by development, the introduction of the 28-P4AM-009 cancer chemotherapy support system 築田晃直, 谷口潤, 吉野裕統 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2014.

---

	Relation of systems construction and the pharmacist of the 28-P4AM-010 malignant glioma therapeutic drug 平田亜希 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2014.

---

	28-P4AM-011 Operation of Stivarga introduction path toward becomes severe avoidance of side effects 林美和子1, 面高みどり1, 古畑文1, 米澤亮1, 網野一真1, 濱至寛1, 跡部治1, 五味邦之2, 島田宏2, 三原基弘2, 梶川昌二2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2014.

---

	Evaluation of the effect that weight loss of the water load at the 28-P4AM-012 cisplatin administration gives for renal function 辻井大輔, 松本陽子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2014.

---

	Examination about the effect of dilution concentrations in the Infusion reaction expression at the 28-P4AM-013 rituximab administration 金素安1, 立沢正臣1, 有高奈々絵2, 下嶋和代1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2014.

---

	Effect of the team approach in medical care in the 28-P4AM-014 outpatient department cancer chemotherapy 松崎雅英1, 佐内俊志1, 長谷川彩子1, 前田美恵子1, 橋本直弥1, 水谷旭良1, 高畑知帆子2, 小原真紀子2, 室圭3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2014.

---

	Action for the construction of the cooperation with the 28-P4AM-015 outpatient department chemotherapy room 沼崎香, 鯨明美, 岩瀬裕治, 丹羽直人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2014.

---

	Utilization ... of introduction - dosage previous assessment seat of the team approach in medical care in the 28-P4AM-016 outpatient department cancer chemotherapy 原竜太郎1, 戸鹿野美織1, 橘淳1, 山本晋平1, 上野麻衣子2, 青山樹理2, 田嶋政之3, 濱浦睦雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2014.

---

	Evaluation of the nurse about the cancer medical therapy study session in the 28-P4AM-017 blood medical service 安田昌宏1, 梅田道1, 舘知也2, 大澤友裕1, 長屋雄大1, 市橋厚司1, 伏屋洋子3, 廣瀬五十子3, 寺町ひとみ2, 後藤千寿1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2014.

---

	The activity of the pharmacist in the pancreatic cancer classroom to make with 28-P4AM-018 medical care team and the evaluation 松田紘子1,2, 世古口典子1, 村木優一1, 岸和田昌之2, 杉本浩子1, 岩本卓也1, 伊佐地秀司2, 奥田真弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2014.

---

	28-P4AM-019 physician, pharmacist, examination about the usefulness of "the joint screening by the nurse before cancer chemotherapy enforcement" 吉岡祐貴1, 伴晶子1, 岡戸洋1, 小林義和1, 小島義博1, 小林和子2, 若狭幸子2, 白石久美子2, 織田元3, 生田宏次4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2014.

---

	It is ... for 28-P4AM-020 nurse, construction - continuation-like patients with pharmacist joint ownership support of the foreign chemotherapy "treatment record control system" 六波羅孝1, 北原正之1, 野上こまき1, 上原亜紀子2, 渡辺まゆ美2, 戸田智恵美2, 矢野いずみ2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2014.

---

	Evaluation of the intervention effect of the pharmacist in the 28-P4AM-021 palliative care team 阿部健太郎1, 赤木徹2, 元永伸也1, 的場元弘3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2014.

---

	Introduction of CDTM for the supportive care of the 28-P4AM-022 cancer chemotherapy 村上通康, 橋本浩季, 山口恭平, 塩坂育子, 仙波昌三 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2014.

---

	Action to standardization and the information communalization of 28-P4AM-023 anticancer agent preparation duties 三谷和恵, 窪田真弓, 波多晶子, 中尾大介, 鶴居勝也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2014.

---

	Action to the side effect information sharing using the chemotherapy interview sheet by the foreign cancer chemotherapy in the 28-P4AM-024 Itabashi Chuo General Hospital 目黒聡子1, 高山裕子2, 酒井由希子1, 駒井信一郎1, 岡山和広1, 竹内由美2, 山内泰一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2014.

---

	Action in dermatopathy measures to patients who received 28-P4AM-025 chemotherapy 上原友美1, 中村有莉恵1, 赤星真広1, 前村由佳1, 山路智凡1, 石神誠子1, 池増鮎美1, 神門孝典1, 佐多照正1, 坂口育美2, 中島三郎3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2014.

---

	Introduction and evaluation of the anticancer agent check list based on the 28-P4AM-026 questionnaire 日下部鮎子1, 藤原陽子1, 堀金妙子1, 岸元麻紀1, 佐藤佳華1, 菊池一樹1, 大江利治4, 明田克之3, 江副英理2, 八十島孝博2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2014.

---

	About intervention results of the pharmacist outpatient department in the oral 28-P4AM-027 molecules target medicine and a future action 坂本莉紗1, 四十物由香1, 平川寛之1, 根本昌彦1, 佐藤渉1, 齋藤祥子1, 青山芳文1, 城向富由子2, 丸山常彦3, 鴨志田敏郎4, 堤雅一5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2014.

---

	Inspection of the effect by the interview before medical examination of the pharmacist in the 28-P4AM-028 outpatient department chemotherapy 勝又一雄, 内田直人, 川口洋実, 小林義典, 北村修 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2014.

---

	Problems and construction of the future medicine medicine cooperation to have of the health insurance pharmacy in 28-P4AM-029 Tegafur gimeracil oteracil potassium combination anticancer agent (TS-1) formulations 古野龍也1, 持永早希子1, 江本晶子1, 柏田知美2, 荒金尚子1,2, 木村晋也2, 藤戸博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2014.

---

	Evaluation of the antiemesis therapy of 28-P4AM-030 myelodysplastic syndrome therapeutic drug azacitidine 中村勝之1, 野田師正1, 沖田憲司2, 高田弘一3, 井山諭3, 佐藤勉3, 瀧本理修3, 小船雅義3, 加藤淳二3, 池田博4, 林敏昭4, 石田禎夫4, 篠村恭久4, 中田浩雅1, 宮本篤1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2014.

---

	The thing which we saw from the fact-finding of patients who received 28-P4AM-031 cancer chemotherapy 小林誠一1, 内田佳菜子1, 新井三紗子1, 銭場愛彦1, 丸岡浩太1, 梅澤仁美1, 伊代田萌子1, 原幸子1, 岩佐桂子1, 長嶋一泰1, 足立孝1, 坂口修治1, 山下敦1, 富沢裕之1, 西尾益治3, 菅野和彦1, 加賀野井純一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2014.

---

	Fact-finding of our House in the 28-P4AM-032 moderate emetic risk regimen 倉橋基尚1, 上田綾佳1, 中尾祐子1, 眞継賢一1, 上田浩貴1, 黒岩勇人1, 林万紀子1, 塚本泰彦1, 松本里佳2, 柳原一広3, 濱口良彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2014.

---

	Look at the rear in the present conditions of our examination ... House about the need of aprepitant in the 28-P4AM-033 breast cancer AC therapy; discussion ... from a mark investigation 後藤敏也, 高屋敷奈々, 廣瀬和昭, 鈴木直哉, 正木銀三 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2014.

---

	Examination about the protective efficacy of the hot compress for vascular disorder of the 28-P4AM-034 Fosaprepitant 今津邦智, 中田恭子, 中野愛子, 岩見裕信, 前田昌徳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2014.

---

	About a risk factor of retching, the vomiting expression in patients who received 28-P4AM-035 (R-)CHOP therapy first time 小松弘幸, 加藤梢, 石尾有司, 藤原沙緒里, 八幡弘子, 桂川みき, 小林龍, 小原秀治, 下山光一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2014.

---

	Presence or absence of fact-finding - retching vomiting expression of antiemetic about the proper use at the 28-P4AM-036 cancer chemotherapy enforcement and factor analysis - 佐藤麻美子1, 杉浦宗敏1, 中島由紀1, 大谷道輝2, 山村喜一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2014.

---

	Examination of the factor to contribute to the effectiveness of the antiemetic drug to 28-P4AM-037 moderate degree emetogenicity risk TC therapy 栗原竜也1, 向後麻里2, 安田礼美1, 持田早織1, 東野真弓1, 山下祥子3, 佐々木瞳1, 奥山裕美4, 石井正和1, 米山啓一郎5, 中村清吾4, 木内祐二3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2014.

---

	Examination of the factor to contribute to the effectiveness of the antiemetic drug to 28-P4AM-038 altitude emetogenicity risk FEC therapy 栗原竜也1, 東野真弓1, 持田早織1, 安田礼美1, 佐々木瞳1, 山下祥子2, 向後麻里3, 奥山裕美4, 石井正和1, 米山啓一郎5, 中村清吾4, 木内祐二2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2014.

---

	Backward investigation about CINV in the hematopoietic stem cell transplantation previous treatment that we included 28-P4AM-039 elderly people in 宮本俊一1, 宮本鋼2, 小島理絵3, 吉岡まみ1, 佐藤衛1, 森淑子1, 宮腰重三郎3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2014.

---

	Evaluation of the expression situation and the quality of life of the adverse event at the 28-P4AM-040 hepatic artery chemistry embolus therapy (TACE) enforcement 原田桂作1,3, 末吉宏成1,3, 米倉紀子1, 坂本佳子1, 野口純也2,3, 木戸川秀生2,3, 岡本好司2,3, 村本眞由美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2014.

---

	Examination about the effectiveness of olanzapine to use in 28-P4AM-041 antiemesis purpose 田中喜倫1, 久保田康生2, 熊井正貴2, 齋藤佳敬2, 河合祐輔1, 笠師久美子2, 山田武宏2, 上野英文1, 田巻知宏3, 井関健2,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2014.

---

	Examination about the effect of the antiemesis therapy for the moderate emetic risk chemotherapy in patients with 28-P4AM-042 progress, recurrent colon cancer 小山佐知子1,7, 荒川裕貴2,7, 佐藤由美子3,7, 牛膓沙織4,7, 江尻将之5,7, 築山郁人5,7, 久田達也2,7, 板倉由縁6,7, 森一博1, 勝見章男8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2014.

---

	Examination about the effectiveness of the antiemetic drug in 28-P4AM-043 bone, the soft part tumor chemotherapy 堀勇太1, 坂本昭夫2, 安藤翔治3, 後藤隆1, 山下愛登1, 上村宅司1, 下村真代4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2014.

---

	Comparison of the antiemesis effect of palonosetron and granisetron with the diet intake situation in the 28-P4AM-044 cancer of the esophagus FP therapy as end-point 佐藤佑一朗1, 早坂州生1, 竹内公美1, 高橋宏明3, 細川正夫2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2014.

---

	Antiemesis effect investigation of granisetron and palonosetron in the 28-P4AM-045 colon cancer chemotherapy (moderate emetic risk) 足立茂樹1, 谷沢克弥2, 遠藤秀治2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2014.

---

	Effect on carboplatin combination therapy comparison of granisetron and palonosetron in patients with 28-P4AM-046 lung cancer 橋本早苗, 松浦佳代, 廣畑秀記, 酒井克紀, 浦川龍太, 福田英克, 南波勝栄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2014.

---

	The use actual situation of high-dose granisetron for retching, vomiting at the cancer chemotherapy in patients with 28-P4AM-047 infantile acute lymphocytic leukemia 中尾將彦, 吉田徹也, 山崎直樹, 大谷司, 竹内昌司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2014.

---

	1 case that caused an anaphylactic symptom by 28-P4AM-048 5HT3 receptor blocker administration 加藤秀明, 辻愛美, 白崎由貴, 西出洋志, 坂井伸成, 中村尚未, 宇野美津江, 佐澤佳彦, 平賀貴志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2014.

---

	Injection site disorder measures second report of the Fosaprepitant in patients with solid cancer given 28-P4AM-049 chemotherapy 辺見光利1,2,3, 和久井章男1, 近藤達郎1, 遠藤美貴子2, 浅野幸代2, 戸倉英之3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2014.

---

	Examination of the effect of aprepitant on chemotherapy-induced retching, vomiting in patients with 28-P4AM-050 AC therapy enforcement breast cancer 幕田龍1, 辻大樹1, 金容壱2, 山本圭祐3, 池田翠1, 羽鳥正浩1, 横井茉里1, 大嶽亜季1, 井上和幸1, 平井啓太1, 中道秀徳3, 塩川満3, 伊藤邦彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2014.

---

	Examination about the choice of the NK1 receptor blocker for the purpose of the vascular disorder reduction at 28-P4AM-051 epirubicin component regimen enforcement 平出耕石1, 竹内賢2, 坂下文夫2, 小林洋子3,4, 鈴木文子3,4, 篠崎里水3,4, 今関孝子1, 櫻井賢治郎1, 加藤武司1, 尾関豊2,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2014.

---

	Examination of the usefulness of aprepitant in the 28-P4AM-052 cervical cancer CCRT therapy 守屋千秋1, 芝崎由美子1, 中山季昭1, 横田治重2, 中村益美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2014.

---

	It is the effect of the change to the palonosetron hydrochloride for the 28-P4AM-053 moderate degree emetogenicity risk anticancer agent 柿本智広, 野間口寛, 桐野玲子, 中島誠, 高橋武士, 中木原由佳, 新上香奈子, 平松さやか, 福元裕介, 池ノ上知世, 坂元優太, 平田りか, 寺師守彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2014.

---

	Examination of dexamethasone optimum doses after the chemotherapy next day with the anticancer agent with 28-P4AM-054 moderate degree and the extensive emetic risk 高林真貴子, 樋口真衣子, 志村裕介, 橋本千明, 大井佳子, 平原佑季子, 原祐輔, 崔吉道 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2014.

---

	Effect to give to blood glucose level of dexamethasone to use together by the cancer chemotherapy in patients with 28-P4AM-055 diabetes merger cancer 福田耕太郎, 嘉屋則子, 東修司, 槙田芳, 岩堀真弓, 金子樹利亜, 小原郁司, 小寺隆二, 妻木良二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2014.

---

	Action for the onset prevention of the HBV reactivation in the 28-P4AM-056 Hiroshima west medical center 形部文寛1, 山根有美子2, 平崎奈美枝2, 新美寛正2, 下村荘司2, 八本聖秀2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2014.

---

	Action to preventive measures against hepatitis B reactivation with immunodepression, the chemotherapy in 28-P4AM-057 Rousaibyoin, Yamaguchi 小川丈彦1,5, 渡壁美香2,5, 黒川典枝3,5, 河野和明4,5, 竹田克明1,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2014.

---

	Examination about the PCP onset prevention by the ST medical mixture remedy at 28-P4AM-058 R-CHOP therapy enforcement 宮部芳之1, 土本暁斗1, 山口雄士1, 佐藤和也1, 佐野彩女1, 兼松友紀1, 長谷部千夏1, 柏毅彦1, 岩井雅則2, 花村明利2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2014.

---

	The pre-Abo id example that hepatitis B reactivation measures to occur by immunodepression, the chemotherapy in our 28-P4AM-059 House and a ward pharmacist were involved in 阿部真也1, 齋藤雅俊1, 斎藤太寿1, 小林彦登1, 岩田耕一郎1, 松原肇1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2014.

---

	Review and many types of job cooperation ... of action ... supportive care for the dermatopathy reduction of the 28-P4AM-060 cetuximab panitumumab 高取裕司1,2, 牛膓沙織1,2, 新井孝文1,2, 岸田清子1,3, 桂川健司4, 安藤与里子5, 池上信昭2, 米山文彦1,6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2014.

---

	Effect of the pharmacist intervention on dermatopathy of the use of antiEGFR medicine patients in 28-P4AM-061 colon cancer 小柴聖史1,2, 磯知輝1,2, 堀井一輝1, 菊地麻里2, 今田春子2, 原美里2, 高橋啓子2, 根上真理2, 菅尾高裕1, 飯島克順2, 小池道明1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2014.

---

	Approach to the dermatopathy with the 28-P4AM-062 EGFR inhibitor 水上康弘, 田村健悦, 石倉一樹, 平賀元 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2014.

---

	Action to standardization of dermatopathy treatment with the 28-P4AM-063 epidermal growth factor receptor tyrosine kinase repressor 竹内小百合1, 畑田万紀子2, 小園亜希1, 中川義浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2014.

---

	Inspection of the prophylactic effect of the moisturizer application for the purpose of the reduction of the dermatopathy with 28-P4AM-064 erlotinib 宗村盛1, 鈴木豊史2, 藤井瑞恵1, 井上真由美1, 長島修3, 深水啓朗2, 伴野和夫2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2014.

---

	Making and evaluation of the 28-P4AM-065 "cutaneous symptom check sheet" (Iressa Erlotinib) 佐藤知香1, 横田学2, 田中麻衣子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2014.

---

	Example that a change to capecitabine cisplatin trastuzumab combination therapy was effective in the 28-P4AM-066 eruption onset after S-1 cancellation 緑川武志1, 山本健1, 川田史朗1, 林すみれ1, 本多義弘1, 中村彰子1, 町田亜美1, 上野恵美子1, 前田拓哉1, 木村祐2, 西沢春彦3, 三上二郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2014.

---

	28-P4AM-067 cetuximab, the expression situation of the hypomagnesemia by the panitumumab and future problem 七條ゆかり, 組橋由記, 鈴江朋子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2014.

---

	1 case that continued cetuximab while repeating a low Mg blood symptom of 28-P4AM-068 Grade3 小林馨, 格谷美奈子, 高木昭佳, 高橋則正, 屋木裕太, 三村泰彦, 加藤敦, 足立伊佐雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2014.

---

	The expression situation of the hypomagnesemia by the 28-P4AM-069 panitumumab and examination about the treatment success period 小中健, 森剛志, 柴田高洋, 西迫寛隆, 中村敏己, 寺岡和彦, 川添和義, 水口和生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2014.

---

	Examination about the expression situation and measures of the hypocalcemia in 28-P4AM-070 denosumab treated patients 櫻下弘志, 増田有紀, 真志田絵美子, 佐伯康之, 木村康浩, 木平健治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2014.

---

	Examination of the important factor affecting the onset of hypocalcemia in 28-P4AM-071 denosumab treated patients 横山峻太, 岡村和彦, 佐々木雄啓 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2014.

---

	Examination of the risk factor of the onset of hypocalcemia in 28-P4AM-072 denosumab treated patients 工藤香澄, 中居肇, 猪股英幸, 高橋明, 中村一成 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2014.

---

	1 case with suspected cardiotoxicity with 28-P4AM-073 5-FU 牧智恵子1, 後藤愛実1, 細見誠1, 花房加奈恵1, 西原雅美1, 勝間田敬弘1, 寺沢哲志2, 後藤昌弘2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2014.

---

	Examination of the cardiotoxic expression situation with the 28-P4AM-074 epirubicin administration and the need of the cardiac activity evaluation 藤田さやか1, 松原美紗1, 稲益里映2, 藤丸博紹1, 馬場美樹3, 田中喜久3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2014.

---

	Usefulness of the cardiac activity monitoring system at the 28-P4AM-075 trastuzumab administration 稲益里映1, 松原美紗2, 原田さやか3, 藤田さやか2, 埋金朋子6, 高尾壽美恵4, 堤えり子5, 田中喜久7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2014.

---

	Fact-finding of the TPF therapy as the induction chemotherapy for the 28-P4AM-076 advanced head and neck cancer and report of the side effect expression situation 芦崎雅之1, 早坂州生1, 北山秀則1, 柴田由美1, 田中怜奈1, 千葉里織1, 出町拓也1, 竹内公美1, 渡邉昭仁2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2014.

---

	Toxic examination at the 28-P4AM-077 pemetrexed chronic administration 佐々木由香1, 杉枝里香1, 安森奈緒子2, 坂本由希子1, 林稔展1, 瀬戸貴司3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2014.

---

	Side effect investigation according to the bevacizumab dose for patients with 28-P4AM-078 colon cancer 松谷和子1,2, 松尾多恵1, 廣瀬幸一2, 山下剛史郎2, 北村瑞穂2, 池永雅一3, 木村真策1, 南橋かおる2, 長谷川順一3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2014.

---

	Investigation about the side effect expression situation of the FOLFIRINOX therapy in the 28-P4AM-079 Sapporo public welfare hospital 須藤大雄1, 小原秀治1, 小林龍1, 下山光一1, 高橋栄2, 阿部雅一3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2014.

---

	Examination about the non-blood toxicity of the preoperation / introduction Docetaxel + Cisplatin + 5-Fluorouracil (DCF) therapy for the 28-P4AM-080 squamous cell carcinoma of esophagus 坂本かおり1, 菅原充広1, 堅田親利2, 厚田幸一郎1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2014.

---

	Analysis of the dose setting rule factor in the 28-P4AM-081 FEC therapy 杉本佳澄1, 宮地紗央1, 下枝貞彦1, 里村藍子2, 永村陽一郎2, 若林雅人3, 滝沢康志4, 堀治2, 太田伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2014.

---

	28-P4AM-082 The onset of acute phase side effect situation in our hospital outpatient department cancer chemotherapy 天野佑, 渡瀬美登里, 柏田匡広, 池田浩和, 高橋浩二郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2014.

---

	Investigation about the symptom after the millimeters plastic Japanese spaniel administration for the 28-P4AM-083 hepatocellular carcinoma 安藤舞, 宮澤憲治, 後藤拓也, 井上裕貴, 竹内正紀, 吉田知由, 松本修一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2014.

---

	Examination about the side effect expression of vincristine situation which the combination with the 28-P4AM-084 azole system antifungal agent gives it to 渡邊詩由子1, 金子るみ2, 下枝貞彦1, 里村藍子3, 永村陽一郎3, 堀治3, 太田伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2014.

---

	About hiccups expression with the 28-P4AM-085 cancer chemotherapy and the correspondence 西和哉, 阿部浩幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2014.

---

	Example that pregabalin was effective for intractable hiccups with the 28-P4AM-086 cancer chemotherapy 田中麻理子1, 明石直子1, 平岡暖子1, 吉野宗宏1, 田中三晶1, 鏡亮吾2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2014.

---

	Example that showed hiccups at the 28-P4AM-087 DCF therapy enforcement, but followed the good course by suggestion of the appropriate supportive care 吉田裕生, 津曲恭一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2014.

---

	Investigation about the risk factor of the hiccups induced at CHOP in patients with 28-P4AM-088 malignant lymphoma and the CHOP homeotherapy enforcement 兼松哲史1, 森章哉2, 向山直樹3, 加藤知次4, 羽田勝彦5, 冨田敦和5, 惠谷里奈5, 宮澤憲治6, 中村あゆみ6, 田中佑佳7, 池田義明8, 福井愛子9, 横山聡10, 中村英明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2014.

---

	Analysis of the taste alteration with the 28-P4AM-089 breast cancer chemotherapy 田頭尚士1, 岡崎ちか2, 松本梨早2, 河内啓子2, 原文堅3, 石川徹4, 二五田基文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2014.

---

	Relation of the pharmacist to the mouth care of patients who received 28-P4AM-090 cancer chemotherapy 畠山浩明1,2, 倉澤弘樹1, 大井徹1, 奥山秀樹2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2014.

---

	28-P4AM-091 Usage and side effects expression status of Regorafenib Hydrate in our hospital 上森美和子1, 杉浦孝司2, 朴美和3, 加藤文3, 坂井大介4, 佐藤太郎4, 林太郎3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2014.

---

	1 case that is given Dasatinib / Nilotinib alternating therapy for side effect reduction for 28-P4AM-092 Imatinib-resistant CML-CP 馬場祐一郎1, 西ひかり1, 古賀友香里1, 藤田和彦1, 松野文彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2014.

---

	The case that was hard to take medicine, and became able to take medicine by the blood level monitoring by the pharmacist for patients with GIST by the 28-P4AM-093 imatinib side effect 西迫多重1, 服部晋司2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2014.

---

	Trial investigation ... in intervention ... many institutions of the pharmacist using the treatment support tool for the 28-P4AM-094 hand-and-foot syndrome 藤堂真紀1, 梅村由香利2, 鈴木善貴3, 山本倫久4, 伴竜典5, 筒井裕子6, 田中麻衣子7, 鈴木さやか8, 横田学9, 寺西二三代10, 遠山幸男11, 松浦克彦1, 勝見章男12 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2014.

---

	Use fact-finding of the rasburicase in the 28-P4AM-095 our hospital 宮脇未来1, 藤井千賀1, 安井友佳子1, 松浦愛2, 石坂敏彦1, 八野芳巳1, 柴野賢2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2014.

---

	Investigation about drug costs used as measures medicine for mucositis, dermatitis to be caused at the CDDP + RT therapy enforcement of the 28-P4AM-096 head and neck cancer domain 藤原大一朗1,2, 眞下惠次1,2, 木村佳世1, 野田明宏1, 武田朋也2, 椿正寛2, 西田升三2, 阪口勝彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2014.

---

	Participation of the pharmacist in treatment with cetuximab for 28-P4AM-097 head and neck cancer 森善洋1, 吉岡大樹1, 藤田有紀子1, 木下真理子1, 佐道紳一1, 岩永哲2, 吉村敏朗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2014.

---

	Usefulness of telephone support (Xtra) to the 28-P4AM-098 capecitabine internal use patients 熊澤崇, 佐々木紀彰, 古元俊徳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2014.

---

	Relation to a side effect investigation and drug control before and after the bevacizumab combination to carboplatin / pemetrexed therapy in patients with 28-P4AM-099 non-small cell lung cancer 高田寛奈1, 梅原健吾1, 池本舞2, 若本あずさ1, 初山多恵1, 佐藤秀紀2, 早川達2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2014.

---

	Relation of the supportive care to 28-P4AM-100 XELOX therapy patients 堀敦雄1, 祖父江伸匡1, 佐野亜紀2, 西嶋長1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2014.

---

	Risk factor analysis of the serious neutropenia with 28-P4AM-101 carboplatin and the pemetrexed combination therapy 平野めぐみ1, 渡邊裕之1, 池末裕明1, 池田宗彦1,2, 近森綾子1, 山田剛3, 江頭伸昭1, 増田智先1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2014.

---

	Grasp of the blood toxicity and the intensity of treatment in the initial FEC100 therapy in our 28-P4AM-102 House 住谷達也, 阿部多一, 落合里枝, 柳内亮祐, 井口恵美子, 猪俣克彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2014.

---

	Effect on myelosuppression by the simultaneous combination of 28-P4AM-103 chemoradiotherapy and tubercle bacillus heated water extract (answer note) 細井一広1, 中川潤一1, 太田真帆1, 阿保成慶1, 川村広明1, 照井一史1, 板垣史郎1,2, 早狩誠1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2014.

---

	Examination about the case that anticancer agent administration affected PT-INR in patients with gynecologic malignancy with the 28-P4AM-104 venous thromboembolism 吉田理, 草野淳一, 佐伯佳奈, 鈴木信也, 関山正夫, 安藤栄輝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2014.

---

	Fact-finding of the prophylaxis situation of the antithrombotic drug in the 28-P4AM-105 lenalidomide administration and the test value monitor situation of solidification, the fibrinolytic system 高橋誠, 別府竜弥, 堤一貴, 松本浩一, 中垣春美, 三輪涼子, 有馬千代子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2014.

---

	The effect that 28-P4AM-106 serum albumin gives to the clinical response of antibiotics 松木祥彦, 大貫敏明, 安田麻美, 浅井浩子, 高橋優香, 岩佐典子, 杉浦健一, 中村友美, 畦元智子, 藤岡敬子, 小関崇文, 小林健太郎, 西關由梨子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2014.

---

	Examination about the effectiveness of 28-P4AM-107 levofloxacin and the safety 冬頭美加1, 松尾和廣1, 平山忍2, 木村伊都紀2, 横尾卓也2, 花井雄貴2, 佐々木英久1, 渡辺朋子1, 篠原悦子1, 小杉隆祥2, 西澤健司2, 吉尾隆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2014.

---

	Examination about the substrate specific expansion type beta lactamase production bacteria and antimicrobial choice in our 28-P4AM-108 House 小川直紀1, 佐藤渚1, 谷古宇修平1, 新井直子2, 香取哲哉1, 出雲貴文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2014.

---

	Investigation of the incidence of 28-P4AM-109 injection antimicrobial and Clostridium difficile-related loose bowels 松本芳信1,2,3, 佐野雅昭1, 平田勝美2, 松島由美3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2014.

---

	Fact-finding of Clostridium difficile infection treatment in our 28-P4AM-110 House 岡村祐嗣1, 高橋志織1, 津山博匡1, 木村正彦2, 板垣史郎1, 萱場広之2, 早狩誠1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2014.

---

	Action for the proper use for the 28-P4AM-111 C.difficile symptom (CDAD) treatment 安井友佳子, 大谷典子, 山本圭城, 塚本あゆみ, 石坂敏彦, 八野芳巳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2014.

---

	It is ... for the making of use situation - inside the hospital dosage guideline of the Clostridium difficile association loose bowels therapeutic drug in our 28-P4AM-112 House 後藤啓之, 吉井智, 長谷川翠, 工藤琢也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2014.

---

	About the outbreak of the Clostridium difficile infection that we experienced with a change of the infection prophylaxis antimicrobial after 28-P4AM-113 technique 柳橋秀行, 都築はる奈, 林昭子, 宮内智行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2014.

---

	Examination of the infection risk factor in patients with 28-P4AM-114 rheumatoid arthritis 若松健太郎, 内匠紘子, 福竜太朗, 内村仁美, 岩下健一, 永瀬ゆり子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2014.

---

	Examination of aciclovir note appropriateness doses for the 28-P4AM-115 elderly patients herpes zoster 鶴島克将, 安井友佳子, 石坂敏彦, 八野芳巳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2014.

---

	Use of antimicrobial situation investigation in the 28-P4AM-116 perioperative period 吉田奈央1, 野口周作1,2, 宮田広樹2, 此松晶子1, 東さやか1, 宮内秀典1, 竹内崇浩1, 望月徹1, 笠原英城1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2014.

---

	Evaluation of the surgical-site infections protective efficacy by weight differences and 28-P4AM-117 cefazolin treated patients 中村友香1, 東修司1, 田中悠季2, 吉田直哉1, 河合武尊1, 岩堀真弓1, 小原郁司1, 小寺隆二1, 妻木良二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2014.

---

	Investigation, examination about the use of pediatric DAP case in our 28-P4AM-118 House 小山智代1, 岡村央1,2, 小池博文1, 西川能治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2014.

---

	Pharmaceutical intervention example to patients with purulent spondylitis in the 28-P4AM-119 orthopedics ward 高田正弘, 井上登美子, 鈴木光明, 高梨真希子, 木下優子, 加藤有希, 森下和美, 野毛一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2014.

---

	One case that they presented with 28-P4AM-120 epidural abscess, and suffered from treatment 川口奈緒美1, 佐々木暢琢1, 武田真輔2, 福島達樹2, 木村匡男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2014.

---

	One patient who controlled TEIC with a high trough value for purulent spondylitis by the MRSA with suspected the 28-P4AM-121 DAP insusceptibility, and cured 工藤正治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2014.

---

	The use situation of the linezolid in the 28-P4AM-122 cranial nerve center 落合愛子, 細見亜里沙, 平井満子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2014.

---

	1 case that linezolid was effective for MRSA osteomyelitis after 28-P4AM-123 bone fusion 栗崎貴啓1, 和田吉晴1, 久米慎一郎2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2014.

---

	One case that supported a super old fulminant form skin soft tissue infection in cooperation with the 28-P4AM-124 other types of job early 藤原信二1, 綺田尚久1, 三田村由枝2, 中村忠之3, 増田鋼冶4, 原田吉将5, 西嶋長1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2014.

---

	Examination of the ethanol lock therapy for the catheter-associated bloodstream infection related to Candida sp. which developed in the indwelling patients for 28-P4AM-125 central venous catheter long term 福田詩織1,2, 小澤美紀2, 小杉依子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2014.

---

	One case that produced tongue discolouration, dysgeusia by linezolid administration for the 28-P4AM-126 suppuration-related discitis 中村翔吾1, 瀬戸崇光1, 中村有理1, 寺沢匡史1, 仁田史人2, 内山ひとみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2014.

---

	1 case that was given a Mu col symptom during induction therapy for 28-P4AM-127 ALL for a high-dose long term of suspicion L-AMB 大橋養賢1, 木村有揮1, 廣瀬祥子1, 森達也1, 小川千晶1, 宮野早苗1, 高橋郷1, 工藤浩史1, 矢田部恵1, 佐藤信恵1, 五十嵐彩香1,2, 佐藤美佳子1, 朴載源2, 上野博則2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2014.

---

	Evaluation of the antimicrobial proper use promotion activity by the ICT round that linked 28-P4AM-128 antimicrobial registration system 三浦遼子1, 並木弥生2, 上田竜大3, 川原千香4, 永井香織4, 佐藤哲夫3, 中村裕義1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2014.

---

	It is built the antimicrobial regime in connection with ICT led by 28-P4AM-129 ward charge pharmacist 山村伸枝, 中野克哉, 筒井由佳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2014.

---

	Inhibition measures of the carbapenem system antimicrobial consumption by the cooperation reinforcement of the 28-P4AM-130 drug department, infection department and the effect 塩田智子1,3, 谷長美菜子1, 高橋一栄1,3, 堀田剛2, 高倉俊二2,3, 足立幸人3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2014.

---

	Role of the ICT pharmacist for the treatment of the purulent spondylitis in the 28-P4AM-131 cerebral blood vessel medical center 永井徹, 原弘士 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2014.

---

	It is evaluated the effectiveness with the early administration method and prophylaxis method of the antiviral drug for the prevention of the cytomegalovirus infection after 28-P4AM-132 kidney transplantation 山下浩平, 嶋田修治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2014.

---

	Factor search to give to a clinical response of antithrombin preparation for the 28-P4AM-133 sepsis-related DIC and the recombinant thrombomodulin combination therapy 森川祥彦1, 榎屋友幸1, 村木優一1, 岩下義明2, 畑田剛2, 今井寛2, 岩本卓也1, 奥田真弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2014.

---

	The use situation of the antiinfluenza medicine in the 28-P4AM-134 pediatric initial emergency institution 木村誠1, 石橋和人2, 石田明人2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2014.

---

	Examination of the antimicrobial proper use in the active intervention by the 28-P4AM-135 infection prevention team 平田備子1,7, 山本真子1,7, 中尾英樹2,7, 西野雅美3,7, 木南佐織4,7, 大西尚5,7, 戸部智6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2014.

---

	Intervention effect of the pharmacist to 28-P4AM-136 ICT antimicrobial conference 菅野雄太1,2, 中谷紀之1,2, 塚本英範1, 小林俊之1, 三宮乙恵1, 土師美和1, 米澤和彦1, 高橋文彦3, 本川聡2, 森本淳2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2014.

---

	The action of the infection measures team about preventive measures against 28-P4AM-137 infection duties and role of the pharmacist 後藤義之, 増林千尋, 西上真, 深見聖也, 若林奈織子, 鈴木里佳子, 本田太朗, 永森理美, 石崎真由美, 岡田久美, 角紀一郎, 森戸敏志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2014.

---

	Making and evaluation of the round sheet for the 28-P4AM-138 patients-centered infection measures 土屋亜由美1, 峯村純子2, 内藤結花2, 大戸祐治5,7, 吉川雅之1, 前田真之3, 宇賀神和久4, 詫間隆博6, 石野敬子3, 二木芳人6, 村山純一郎2,7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2014.

---

	The proper use round enforcement of the injectable antimicrobial administration case by the 28-P4AM-139 pharmacist and the effect 北村好申1,2, 篠崎陽一1, 北村正樹1, 河野真二2, 中澤靖2, 川久保孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2014.

---

	The need of the intervention of extraction and the ICT of problems for ESBL detected in our 28-P4AM-140 House 城尾晃太1, 寺本晴美1, 近谷理恵子1, 田中慎1, 菊田真穂2, 北垣瞬2, 石原由貴2, 砂町美沙2, 馬瀬久宜1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2014.

---

	1 case that complicated L4/5 purulent spondylitis following MRSA sepsis that 28-P4AM-141 ICT intervened in continuously 村松英彰1,9, 小林美絵1,9, 田村純2, 西田達也3, 神田明浩4,9, 鈴木裕子4,9, 鈴木こなみ5,9, 牧田道明1, 小林政英6, 佐藤雅樹7,9, 柴田幸信8,9 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2014.

---

	Proper use of the 28-P4AM-142 perioperative infection prophylaxis antimicrobial 違口晴子, 谷川まり子, 大西加奈子, 高見一徳, 寺元真那, 吉田善子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2014.

---

	Appropriate effect of prophylactic antimicrobial administration and SSI treatment on 28-P4AM-143 spinal operations SSI 松永智子1, 吉田豊1, 福井良枝2, 今村昌美3, 志水貴1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2014.

---

	Effect on in-hospital guideline compliance and sensitivity rate by the support function addition to 28-P4AM-144 injection instructions input screen 新山哲央, 森山史就, 安食健一, 園山智宏, 福田恵美子, 横手克樹, 平野榮作, 竹下和男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2014.

---

	Approach for the antimicrobial proper use using 28-P4AM-145 infection management support system (BACT Web (R)) 大橋健吾, 松岡知子, 森卓之, 吉田真也, 大塚崇史, 篠田康孝, 高田裕子, 森博美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2014.

---

	About a held effect of the antibacterial chemotherapy learning society for 28-P4AM-146 new face pharmacists 鳥取部和弘1, 寺町文宏1, 三浦尚子1, 楠田絵梨1, 齋藤友亮1, 有島勉1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2014.

---

	Activity of the link staff in our 28-P4AM-147 House 饗庭孝一1, 菊池裕子2, 北村卓麿1, 斎藤彩1, 長谷川和正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2014.

---

	28-P4AM-148 "preventive measures against infection in the psychopathic ward" 小口正義1,2, 池上由美子2, 藤森愛子1,2, 小口はるみ2, 依田祐介2, 藤森洋子2, 跡部治1, 立花直樹2, 蜂谷勤2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2014.

---

	Examination of the satisfaction of addition category and the staff for preventive measures against 28-P4AM-149 infection 三浦布紗子1, 木村修徳1, 永野真久1, 安森奈緒子1, 井上大奨1, 平木洋一1, 辻泰弘2, 神村英利4, 加留部善晴3, 河野文夫5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2014.

---

	Relations with the consumption of the same POT type detection ward and finger disinfectant of 28-P4AM-150 Pseudomonas aeruginosa 森下拓哉1, 後藤拓也1, 早川恭江2, 松本修一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2014.

---

	Investigation of the number of the MRSA detection and the number in our 28-P4AM-151 center of hand hygiene enforcement 枦秀樹, 菅野彩那, 鈴木俊一郎, 青山幸枝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2014.

---

	For vaccination rate improvement for the staff less than the personal titration and normal value of measles, rubella, chickenpox, the mumps in our 28-P4AM-152 hospital personnel 尾形和哉1, 橋本隆信1,2, 竹内亜紀2, 岸由希枝2, 西谷百里子2, 中園雅彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2014.

---

Operational improvement by the antiHIV medicine offer system and community medical care cooperation after a needle pad cut wound, the skin mucous membrane exposure that collaborated with 28-P4AM-153 local government 田上直美1,2, 市川康子1, 嘉村基樹1, 下村光一1, 中村嘉久太1, 松井法子1, 木村亜由美2, 中田浩智2, 宮川寿一2, 松下修三3, 友枝沙紀4, 財津和宏4, 満屋裕明2, 齋藤秀之2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2014.

---

	Fact-finding in the oseltamivir prophylaxis to the 28-P4AM-154 staff 立川奈保美, 岩崎瑛子, 伊藤千恵, 大津由美子, 藤田敬子, 坂上嘉浩, 室井政子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2014.

---

	Action to hepatitis B vaccination for the 28-P4AM-155 hospital personnel 森田淳介1,2, 井川紗希子2, 安野朝子2, 伊藤典子1, 山賀章一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2014.

---

	It is a change by the pharmacist intervention about the pneumococcal vaccine inoculation of the patients after the splenectomy in our 28-P4AM-156 outside Parliament course 山崎洋平1, 鐵野麻美1, 新沼芳文1, 本郷文教1, 中村文隆2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2014.

---

	Evaluation - from the present situation and the physician questionnaire of our role - House of the pharmacist in the 28-P4AM-157 foreign tour vaccination 渡辺暁子, 兒玉美奈子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2014.

---

	Contribution of the pharmacist to the 28-P4AM-158 de novo hepatitis B measures guidelines observance 筒井健一, 後藤志典, 林幹也, 山崎博子, 赤崎淳子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2014.

---

	1 case of HIV infection with the 28-P4AM-159 dissociative disorder 大道淳二1, 石橋真実1, 横田幸子1, 佐久川亮2, 別所昭宏2, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2014.

---

	Examination about the change over time of the 28-P4AM-160 antiHIV medicine tenofovir and renal tubules phosphorus reabsorption rate 日笠真一1, 安田恵1, 秀田恭子1, 日笠聡2, 澤田暁宏2, 徳川多津子2, 木村健1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2014.

---

	Report of the use of studio (R) combination lock case to rebuild in our 28-P4AM-161 House 藤井健司1, 藤田啓子1, 畝井浩子1, 山崎尚也2, 斉藤誠司2, 藤井輝久2, 木村康浩1, 木平健治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2014.

---

	Fact-finding about the effect that pharmacist intervention in the 28-P4AM-162 HIV infection practice results in to the medical person side 國本雄介1, 吉野宗宏2, 大石裕樹3, 原田幸子4, 井上正朝5, 内山真理子6, 齋藤直美7, 丸山一郎8, 下川千賀子9, 畝井浩子10, 松本俊治11, 千田昌之12, 増田純一13, 佐藤麻希13, 和泉啓司郎13, 宮本篤1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2014.

---

	Concomitant drug investigation of the 28-P4AM-163 antiretroviral therapy (ART) patients 下川千賀子, 安田明子, 林志穂, 柏原宏暢 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2014.

---

	Fact-finding of the medical therapy for HIV infection in our 28-P4AM-164 House 二宮洋子1,2,3, 黒川温子1, 玉井恭子1, 渡邉三恵子2, 西村瑞穂2, 徳永博俊3, 和田秀穂3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2014.

---

	Stability evaluation of mullah biRoch to apply the 28-P4AM-165 simple suspension method 和田美紀, 矢倉裕輝, 湯谷玲子, 寺岡麗子, 北河修治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2014.

---

	The role to be assumed by the pharmacist for patients on dialysis using 28-P4AM-166 nutrient for intestinal administration and the practice 岡田孝之1,3, 法橋純子1, 世良有雅1, 加茂美智子1, 青山恵未2, 高木好夫1, 原田慎一3, 中本賀寿夫3, 阿瀬井宏一1, 徳山尚吾3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2014.

---

	An intervention effect and pharmacist intervention example of NST for the 28-P4AM-167 decreased renal function patients 早川兼司, 村越南, 鈴木美千代, 小島圭太, 多田哲也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2014.

---

	1 case that caused hyperglycemic hyperosmolar coma during 28-P4AM-168 enteral feeding management 宮田治奈, 平岩歳久, 仙田典保 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2014.

---

	Fundamental researches about the gastric emptying of 28-P4AM-169 half solidification enteral feeding materials and the blood sugar change 豊田行康1, 加藤顕子1, 笹原詩織1, 二村由里子2, 戸田州俊3, 加藤隆文4, 伊藤由紀4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2014.

---

	Evaluation of the enteral feeding tube occlude prevention using the 1% sodium bicarbonate solution in the 28-P4AM-170 digestive organ surgery ward 村地康1, 若林亜耶1,2, 森本啓太1,2, 勝浦正人1,2, 中土居智子3, 門脇裕子1, 竹上学1, 大石雅子2,4, 和佐勝史2, 三輪芳弘1,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2014.

---

	28-P4AM-171 Experiment about the evasion of the tube obstruction in the simple suspension method About Aspara potassium 長尾彰太, 新康憲, 森田聡子, 辻隆志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2014.

---

	About the effect that rate of application of the 28-P4AM-172 lipid microsphere gives to a liver enzyme, C-reactive protein and lymphocyte counts 大塚淳一, 平間明子, 蔭山博之, 勝俣はるみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2014.

---

	One case that vitamin K included in the 28-P4AM-173 lipid microsphere was thought to affect the anticoagulant action of warfarin 鈴木美央, 湯川玲奈, 柳原良次, 奈良克彦, 高田龍平, 中島克佳, 鈴木洋史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2014.

---

	Action avoiding 28-P4AM-174 warfarin and interaction of the natto 高橋望月, 岩佐千尋, 小林つば紗, 田中嘉一, 濱田潤 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2014.

---

	The effect that 28-P4AM-175 preoperative alimentation of immunity gives to the immune system of patients with gastrointestinal carcinoma 鈴木彰人1, 白尾一定2, 本吉佳世3, 武田朋子3, 花牟禮富美雄4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2014.

---

	Examination about the dose of vitamin B1 at long-term central venous hyperalimentation enforcement in 28-P4AM-176 elderly people 阿部孝行1, 倉林誠1, 高木淳子1, 池井良貴1, 山田英俊1, 小村博昭2, 櫻谷憲彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2014.

---

	Use situation investigation of the cyanocobalamin parenteral injection to the total gastrectomy patients in our 28-P4AM-177 House 石原祥史1, 久松大介1, 松本智史1, 大澤啓子1, 林昌俊2, 林晴美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2014.

---

	The need of NST in the 28-P4AM-178 abdominal aortic aneurysm stent graft treatment 加藤恭平, 香取哲哉, 出雲貴文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2014.

---

	Effect ... of the intervention to the aggressive pressure sore measures team of activity - pharmacist of the pressure sore measures team in the 28-P4AM-179 Tsurumakionsen Hospital 高橋麻衣, 新枦義之, 仲里梨紗, 樋島学 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2014.

---

	Examination about the cost-effectiveness of the iodoform gauze in 28-P4AM-180 pressure sore treatment 有泉牧人1, 西村富啓1, 熊井佳代2, 三谷あずさ2, 牧野麻希子2, 佐橋幸子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2014.

---

	Examination of the physical property of the skin protection powder for the 28-P4AM-181 perianal region sore 廣瀬香織1,5, 土田学2, 村山由美子2, 関徹也3, 笹津備尚5, 関根祐介4, 磯貝博之1, 大西啓5, 奥山清1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2014.

---

	Use experience of the Japanese hawfinch pre-building triple-drug therapy in 28-P4AM-182 chronic hepatitis C 小池彩子1,2, 花房伸幸1, 歳森淳一2, 小橋春彦2, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2014.

---

	Safety, the effectiveness of the triple-drug therapy including the Japanese hawfinch pre-building for the 28-P4AM-183 chronic hepatitis 鎌田宏和1, 橋本佑香1, 富士芳美1, 田中陽子1, 木村貴1, 高木麻里1, 藤田敬子1, 坂上嘉浩1, 室井政子1, 井上敦雄2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2014.

---

	The effectiveness and side effect evaluation of the PEG-IFN / RBV / TMC combination therapy for 28-P4AM-184 chronic hepatitis C 於本崇志1, 塩山亜紀1, 山口英美1, 朝賀純一1, 岩渕修1, 佐藤文彦1, 宮坂昭生2, 滝川康裕2, 川口さち子1, 工藤賢三1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2014.

---

	Problems ... of the DPI inhalational instruction in comparison between discus (R) (DPI) and aerosol - infantile asthma judging from 28-P4AM-185 long-term peak expiratory flow record 青野珠可1, 山本崇晴2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2014.

---

	Examination of the dissolution at simple suspension in the 28-P4AM-186 theophylline controlled release dry syrup 秋山滋男1, 毎田千恵子2, 中田いちこ3, 宮東利恵3, 武藤浩司4, 岡村正夫5, 興村桂子2, 久保田洋子2, 西尾浩次3, 礒野淳一1, 宮本悦子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2014.

---

	Clinical efficacy analysis based on β 3 receptor binding occupation of the 28-P4AM-187 new hyperactivity bladder therapeutic drug Mirabegron 渡井健, 高柳理早, 木村耕二, 横山晴子, 山田安彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2014.

---

	Evaluation of the therapy with 28-P4AM-188 prostatic hyperplasia and selective alpha-1 adrenergic receptor blocker and anticholinergic agent for the patients complicated with a hyperactivity bladder 岩野友香, 嶋田修治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2014.

---

	Search of the factor associated with the effectiveness of the tolvaptan for the 28-P4AM-189 hepatic induced oedema 加藤麻理乃1,2,3, 犬塚涼子2, 築山郁人2, 松浦克彦2, 斎藤寛子3, 大津史子1, 後藤伸之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2014.

---

	Administration starting dose examination of the tolvaptan in our 28-P4AM-190 House heart blood vessel center and the evaluation 網野一真1, 神戸千紘1, 宮崎雄紀1, 跡部治1, 筒井洋2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2014.

---

	1 case that tolvaptan had a complete response to for 28-P4AM-191 end stage renal failure furosemide-resistant heart failure 空田洋祐, 山崎博史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2014.

---

	Is the change of volume of urine by the 28-P4AM-192 tolvaptan, serum Na and the serum K affected by the renal function? 中西遼, 今泉有希, 和田淳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2014.

---

	Effective and safe examination of the febuxostat in 28-P4AM-193 children 高本光次郎1, 日笠真一2, 田中邦佳2, 室親明2, 高木信明3, 木村健2, 西本哲男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2014.

---

	The effectiveness of the febuxostat to be able to put according to 28-P4AM-194 CKD stage and safe examination 鈴木一志, 松本晃一, 高橋利幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2014.

---

	Examination about the effectiveness of the tocilizumab subcutaneous injection preparation for the 28-P4AM-195 rheumatoid arthritis 曽根本恵美1, 紙谷友里子1, 溝口晶子1, 辻泰弘2, 藤秀人2, 植木幸孝3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2014.

---

	28-P4AM-196 Questionnaire survey of rheumatoid arthritis patients who have the device change to the etanercept subcutaneously pen-type 西山博隆1, 大島幹弘3, 坪井声示2, 塩浦朋根2, 松山耐至1, 荒木博陽3, 田中亮裕3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2014.

---

	Examination of the effectiveness and the onset risk factor of the venous thromboembolism preventive preparation in the 28-P4AM-197 lower limbs orthopedics surgery 松本千聡, 宮城宣明, 長島章, 伊藤功治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2014.

---

	The effectiveness of the drain clamp method using tranexamic acid in the 28-P4AM-198 total knee replacement 森崎崇文1, 星野輝彦2, 塩津和則1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2014.

---

	The use trend of the 28-P4AM-199 rheumatoid arthritis therapeutic drug and action of our House 植田裕也1,2, 宮武敦子1, 三好奈美瑛1, 近藤洸1, 渡邉秀之2, 古川貴弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2014.

---

	Fact-finding of the case using multiple biological drugs in 28-P4AM-200 rheumatoid arthritis treatment 大原雄希, 國本雄介, 佐々木直美, 中田浩雅, 野田師正, 宮本篤 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2014.

---

	The effectiveness, safe examination of the PTH preparation for the 28-P4AM-201 steroid-related osteoporosis 佐々木柚香1, 佐々木英久1, 松尾和廣1, 篠原悦子1, 渡辺朋子1, 真坂亙2, 松澤康雄3, 龍野一郎4, 吉尾隆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2014.

---

	It is result ... after ... ward drug duties start about correspondence to 28-P4AM-202 "antithrombotic therapy in the perioperative period" 山部美千子1, 浦本邦弘1, 小園亜希1, 柴田義浩2, 中川義浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2014.

---

	Relative examination ... (the second report) with TTR estimate method - INR number of measurement and the TTR prediction precision using %INR in the 28-P4AM-203 warfarin potassium internal use case 木村和美1, 細田宏美1, 坂下可奈子1, 山下英治2, 大島茂2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2014.

---

	Relation of the pharmacist for the warfarin potassium proper use that 28-P4AM-204 is easy to fluctuate 川上尚美1, 久岡清子1, 土師久幸1, 吉村隆喜2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2014.

---

	One case of PBPM which enabled a discharge by the 28-P4AM-205 at-home PT-INR self measurement in the early stage of PT-INR control delinquent patients with the combination of warfarin and miconazole 岡島亜衣1, 矢野亨治1, 紙谷博子2, 葛谷雅文2, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2014.

---

	One case that a pharmacist was associated with in 28-P4AM-206 warfarin overdosage 杉本佳世1, 小林真菜1, 小西恵里香1, 笹谷佳菜子1, 木村訓世1, 大谷綾1, 中尾啓子1, 笹瀬典子1, 金啓二1, 金守良2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2014.

---

	Research about clot embolus incidence and the side effect under the dabigatran chronic administration in patients with 28-P4AM-207 non-valvular atrial fibrillation 西堀優香1, 篠原悦子1, 千葉達夫2, 佐々木英久1, 松尾和廣1, 渡辺朋子1, 横井妙子2, 加藤裕芳2, 吉尾隆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2014.

---

	One case that was given dry person blood clotting ninth factor complex preparation for an intracranial hemorrhage-related lesion during 28-P4AM-208 anticoagulation in preoperation 松原ミキ, 内山良子, 鏑木めぐみ, 林千麗, 吉村尋典 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2014.

---

	The present conditions of association and the epilepsy medical therapy of the factors of the 28-P4AM-209 seriously disabled child (person) 森本真仁1,2, 橋本俊顕2, 浜田茂明2, 京谷庄二郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2014.

---

	Evaluation of the effectiveness of the therapeutic drug for the 28-P4AM-210 restless legs syndrome 細田拓矢, 嶋田修治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2014.

---

	One case of Parkinson's disease that hydrochloric acid apomorphine subcutaneous injection was effective for off symptom at the 28-P4AM-211 getting up 辻倫子1, 石田翔1, 浜田真二1, 上利大2, 開浩一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2014.

---

	Example that we were able to reintroduce into by driving home to patients with Parkinson's disease that canceled the use of the Rotigotine patch by 28-P4AM-212 application site response skin care instruction 奥野幸子1,3, 木村隆2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2014.

---

	28-P4AM-213 New onychomycosis treatment : Development of Efinaconazole liquids for external use 奥村智広1, 落合明子1, 巽良之2, 薗田良一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2014.

---

	Manufacture of the in vitro model that paid its attention to a chronic exacerbation factor of 28-P4AM-214 atopic dermatitis 中山洋輔, 毎熊隆誉, 三谷祐生, 岡崎敏幸, 青井功恭, 手嶋大輔 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2014.

---

	Improvement of the usability of the 28-P4AM-215 petrolatum album and the evaluation 高谷甲波, 大谷道輝, 野澤茜, 山村喜一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2014.

---

	Effect on moisturizing effect that a basis and concentrations in the 28-P4AM-216 urea preparation give 高尾斎昭1, 大谷道輝1, 眞部遥香1, 野澤茜1, 山村喜一1, 江藤隆史2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2014.

---

	Problems in the do-it-yourself importing of the product that Helicobacter pylori infection testing medicine and a therapeutic drug through the 28-P4AM-217 Internet were set 大塚邦子1,2, 内田直樹2, 安原一3, 小林真一2, 細野哲司1, 鈴木啓太郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2014.

---

	1 case ... which we were associated with as relation ... ward charge pharmacist of the pharmacist to treatment with pirfenidone in patients with 28-P4AM-218 idiopathic pulmonary fibrosis 花房伸幸1, 佐久川亮2, 別所昭宏2, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2014.

---

	One patient who was treated effectively with tolvaptan for syndrome of inapp ADH secretion due to 28-P4AM-219 chronic necrosis-related pulmonary aspergillosis 中島文, 高武嘉道, 溝田愛子, 坂本やよい, 竹添達也, 山道研 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2014.

---

	One case of the phaeochromocytoma that the good course was obtained by 28-P4AM-221 dexmedetomidine 井上大奨1, 迫田和樹1, 橋本章子2, 橋本聡3, 平木洋一1, 真鍋健一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2014.

---

	1 case that used Dimethyl sulfoxide (DMSO) for 28-P4AM-222 bladder amyloidosis percutaneously, and was effective 上田浩貴1, 丹生亜希子1, 木村博子2, 橋村孝幸3, 濱口良彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2014.

---

	It is evaluated protective efficacy of retching vomiting by the Droperidol note addition in IV-PCA and the safety after 28-P4AM-223 technique 石塚寛和1, 川名真理子1, 永井淳子1, 廣井麻代2, 完戸香3, 吉沼裕美4, 関根龍一5, 佐々木忠徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2014.

---

	Drug composition of PCEA after the 28-P4AM-224 pneumoscope lower lungs malignant tumor surgery and examination of the analgesic effect and the side effect 長谷川哲也1, 落合亮一2, 寺田享志2, 大岩彩乃2, 滝口一彦3, 花井雄貴1, 酒井正博4, 小杉隆祥1, 西澤健司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2014.

---

	The effect that intravenous autoregulation pain relief after the 28-P4AM-225 peritoneoscope lower enucleatic myomectomy or epidural autoregulation pain relief gives to postoperative pain and nausea post-operative, vomiting 伊藤千裕1,2, 上田絢子1, 井上岳1,2, 柏木政憲3, 松原肇1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2014.

---

	Analysis about the effect to rocuronium in consideration of the mechanism of action of 28-P4AM-226 sugammadex sodium and vecuronium 木村耕二, 北見茉利英, 横山晴子, 高柳理早, 山田安彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2014.

---

	Usefulness of the Everolimus introduction in 28-P4AM-227 heart-transplant recipients 松田紗知1, 和田恭一1, 越智純子1, 岩澤真紀子1, 中村慶1, 桑原健1, 堀由美子2, 坪井志穂2, 中島誠子2, 角南春樹2, 佐藤琢真2, 瀬口理2, 簗瀬正伸2, 中谷武嗣2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2014.

---

	Literature documentation of RCT which evaluated the intervention of the 28-P4AM-228 pharmacist 鈴木拓真, 牧原玲子, 牧野好倫, 岩瀬治雄, 林憲一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2014.

---

	The enforcement situation of a being on the register roll institution and the duties of the specialized pharmacist in each 28-P4AM-229 domain and the authorized pharmacist 大森尚美, 長島昌嗣, 加藤将朗, 星隆弘, 菅田和也, 安岡俊明, 佐藤博, 柴川雅彦, 土屋文人, 北田光一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2014.

---

	About usefulness of the 28-P4AM-230 placenta therapy (human placenta cilia split-product injection) 山岡和幸, 高橋美香, 高井大輔, 大山麻由美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2014.

---

	The treatment example that we practiced by the collaboration with the 28-P4AM-231 physician 重成大介1, 速水章一1, 岡野翔1, 坂本和央1, 伊藤桂子1, 森山真実1, 北島彩郁1, 清水勇基1, 川上麻衣子1, 太田明秀1, 佐賀美裕樹1, 大江利治2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2014.

---

	Efficiency of trial secretariat duties in the 28-P4AM-232 iPad introduction 鈴田浩孝1, 福山雄卯介2, 藤田強記2, 後藤史子3, 植村ちひろ1, 大久保嘉則1, 中尾瑞穂1, 三砂義敬1, 床島英雄1, 草葉一友1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2014.

---

	Action of the clinical experimental medicine management of the ICH-GCP conformity in the hospital attached to the 28-P4AM-233 Mie University School of Medicine 太田康之1,2, 小寺真由美1,2, 村木優一1, 田丸智巳2, 西川政勝2, 奥田真弘1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2014.

---

	The introduction of the temperature uniform management system in the 28-P4AM-234 clinical experimental medicine temperature management and the effect 神田紘介, 室高広, 城正士, 一瀬菜摘, 高比良理愛, 中村忠博, 佐々木均 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2014.

---

	Action for clinical studies, the investigational activation and promotion in the hospital attached to the 28-P4AM-235 Mie University School of Medicine 小寺真由美1,2, 太田康之1,2, 村木優一1, 田丸智巳2, 西川政勝2, 奥田真弘1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2014.

---

	A shift to 28-P4AM-236 Performance Based Payment and subsequent problem 山下克也, 林淳一郎, 高本由紀子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2014.

---

	Is in charge of a trial and IRB from problem - 1996 when the trial to think about from 28-P4AM-237 benefit reciprocity has it; and - 小野敦央, 足立伊佐雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2014.

---

	Safety of medicine evaluation - antitumor agents (blood cancer (third report)) judging from 28-P4AM-238 clinical dose, exposure level and avirulent quantity, exposure level - 窪田幸恵1, 斉藤和幸2, 小野俊介3, 児玉庸夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2014.

---

	Clinical trial about the use of the 28-P4AM-239 antiscabietic Stromectol lock [1] - Effect - that administration gives to the effectiveness and safety after a meal 吉増孝嗣1, 英太一1, 木暮聖2, 杉岡晃仁2, 野口航2, 福沢正男3, 廣田孝司1,2, 小茂田昌代1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2014.

---

	Clinical trial about the use of the 28-P4AM-240 antiscabietic Stromectol lock [2] 英太一1, 吉増孝嗣1, 木暮聖2, 杉岡晃仁2, 野口航2, 福沢正男3, 小茂田昌代1,2, 廣田孝司1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2014.

---

	We effectively utilize it with the introduction of storage systems of administration such as the poison which linked 28-P1PM-001 order 森光恵, 北出紘規, 北国憲剛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2014.

---

	Action to the inventory control improvement using the 28-P1PM-002 medicine inventory control system 鈴木由奈, 鎌滝真永, 泉雄介, 伊東美歩, 平原一也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2014.

---

	Preventive measures against medicine expiration in our 28-P1PM-003 corporation 酒井欣嗣1,2, 伴竜典2, 鈴木さやか1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2014.

---

	Construction and use of the 28-P1PM-004 pharmaceutical products system of administration 梶田貴司1, 西川実希子1, 上床知佐奈1, 西川豊1, 黒松誠1, 林口剛泰1, 雪矢良輔1, 久保美和1, 福田祐子1, 大鳥徹2, 上田睦明1, 中塚英太郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2014.

---

	Examination of the duties efficiency of the drug administrative work by changes from Microsoft Excel in our 28-P1PM-005 House to Microsoft Access 谷村紀代子, 臼井麻郁子, 菊井利伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2014.

---

	The construction of the appropriate management method of the gemeprost component vagina bougie using 28-P1PM-006 electronic chart and the evaluation 水谷栄梨1, 濱口直美1,2, 村木優一1, 森實かおり3, 小林恵美子3, 神元有紀4, 池田智明4, 岩本卓也1, 奥田真弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2014.

---

	Construction and use situation investigation of the regime of the fentanyl percutaneous absorption type preparation for "chronic pain" by the 28-P1PM-007 electronic chart introduction 小宮孝俊, 野口朱美, 岩越有美, 中垣春美, 有馬千代子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2014.

---

	Construction of the automatic request by the pharmaceutical products system of administration using 28-P1PM-008 prescription order data and the effect 山本晃平, 川口真由子, 宮本仁, 増田和司, 横山威一郎, 中村貴子, 鈴木貴明, 有吉範高, 石井伊都子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2014.

---

	Cooperation ... of construction - measures order of use, the management of fixed number placement pharmaceutical products by the 28-P1PM-009 SAVEpH introduction 谷口公章, 甲斐章裕, 石川広大, 力武隆浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2014.

---

	Construction of the muscle relaxant use system based on the prescription in the 28-P1PM-010 operating room 佐々木宏徳1, 影本渉1, 鵜飼泰夫1, 金正煥1, 河井和子1, 伊藤和幸1, 磯谷聡1, 森川千恵美2, 金日成3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2014.

---

	Real-time medicine system of administration introduction in the 28-P1PM-011 surgery center 武知和子, 森谷康志, 奥田敏勝, 高柳和伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2014.

---

	Examination (the first report) to the introduction of the drug, locking management medicine automatic withdrawal device (Inteligent-Cabinet SYSTEM(R)) in the 28-P1PM-012 surgery part 只見智恵子, 宮崎雅子, 金田純子, 野村亜紀, 山口芳幸, 林勇輔, 沼尾恵里, 長屋美香子, 高橋賢成, 木村利美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2014.

---

	It is an action of becoming it the antibiotic fixed number placement in the 28-P1PM-013 operating room 高瀬美希, 米井太志, 加藤梓沙, 齊藤暢子, 加藤雅美, 三木久子, 鈴木竜太, 林高弘, 山田成樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2014.

---

	Uniform management of the pharmaceutical products by the set & tray combination method in the 28-P1PM-014 operating room 中村美樹, 多胡和樹, 勝部智子, 西田彩織, 廣本真里, 常村弥生, 谷車彩夏, 仲西未佳, 平田貴大, 岸敬子, 松山芽衣, 宮崎彩花, 黄前尚樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2014.

---

	Efficiency of the drug regime by the interlocking movement with the 28-P1PM-015 surgery support system (Orsi's) 西園寺真二1,2,3, 中村護1, 福原伸治1, 畝知己1, 松本篤1, 前田頼伸1, 前迫一洋2, 日高昌三3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2014.

---

	Action for the appropriate management of the medicine targeted for the regulation in the 28-P1PM-016 operating room 中村俊貴1, 小林彦登1, 庄野浩子1, 八木澤啓司1, 宮下博幸1, 柴田壮一1, 松原肇1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2014.

---

	Drug control duties - PCA (Patient Controlled Analgesia) pump in the 28-P1PM-017 operating room, intervention ... of the epidural anaesthesia preparation 長谷川恭子1,2,3,4, 松橋裕子1, 神谷真衣1, 工藤真弓1, 池田早織1, 大塚一興1, 坂上逸孝1, 横山美恵子1, 村弘子2, 坂本三樹3, 舘田武志3, 大坪毅人4, 増原慶壮1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2014.

---

	Uniform management of the albumin preparation of our 28-P1PM-018 House 篠原章能1, 小林幸子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2014.

---

	Action of the pharmacist in the pharmaceutical products management of the practice in front of 28-P1PM-019 Hospital 大谷美奈子, 結城沙英子, 垣尾尚美, 岸本静佳, 松本敏明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2014.

---

	Relation of the outpatient dispensary pharmacist for the cancellation medicine before surgery, testing in the 28-P1PM-020 orthopedics domain 赤嶺聡彦1, 宇野真理子1, 竹下さおり1, 小林由佳1, 細井祥生2, 山村昌紀1, 平塚公己1, 太田智博1, 横山浩子1, 川野千尋1,3, 飛田夕紀1,3, 本間雅士1, 小原美江1, 高平尚伸4, 黒山政一1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2014.

---

	Study on factor of the principal ingredient segregation to result from the heating fusion in the 28-P1PM-021 acetaminophen bougie 山本佳久1, 足立真希1, 大貫義則2, 深水啓朗3, 小出達夫4, 香取典子4, 鈴木豊史3, 伴野和夫3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2014.

---

	Simple identification technique of oral solid pharmaceutical products using the far-red spectrometry for 28-P1PM-022 forged pharmaceutical products distinction 大塚誠1, 瀬古友里恵1, 服部祐介1, Peerapattana Jomjai2, 大塚邦子3, 江口欣也4, 坂本知昭5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2014.

---

	Importance of the free form drug level altered in patients with 28-P2PM-001 liver damage 松岡紗代1, 大野能之1, 樋坂章博2, 山口諒1, 鈴木洋史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2014.

---

	Contribution to poisoning treatment of the pharmacist by the establishment of the 28-P2PM-002 acetaminophen system of measurement 三谷健人1, 曽田翠1, 伊藤昭夫2, 吉田省造3, 小倉真治3, 伊藤善規2, 北市清幸1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2014.

---

	Backward investigation about the effect that a dose per body-surface area of the 28-P2PM-003 Gefitinib gives for a clinical response and side effect expression 入江慶1, 片上信之2, 岡田裕1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2014.

---

	Examination about the blood propofol levels assay at the 28-P2PM-004 TCI administration 平田和希1, 栗原二葉2, 小田真也2, 冨山直樹1, 河原幸恵1, 角本幹夫1, 川前金幸2, 岡野友信1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2014.

---

	PK/PD analysis of the K+ channel inhibitory action by 28-P2PM-005 SSRI and SNRI 伴野拓巳1, 橋場弘武2,3, 矢野健太郎4, 井戸田陽子4, 荒川大4, 林正弘1,2, 荻原琢男1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2014.

---

	Qualitative analysis of the G-CSF bio follower product by 28-P2PM-006 LC/TOF-MS 松村健吾1,2, 大谷祐基1, 大村友博1, 米澤淳1, 津田真弘1, 吉貴達寛2, 松原和夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2014.

---

	Carbohydrate chain analysis of antibody pharmaceutical products using 28-P2PM-007 LC/TOF-MS 大谷祐基, 松村健吾, 米澤淳, 大村友博, 津田真弘, 中川貴之, 松原和夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2014.

---

	Report of use of 28-P2PM-008 identification antimicrobial system introduction is use of carbapenem system medicine and effect to give to the bacteria rate of detection 倉内寿孝, 久米田一喜 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2014.

---

	Proper use of the antimicrobial by the management method review of the 28-P2PM-009 report antimicrobial and improvement effect of the sensitivity rate 佐々木康弘1, 山田透2, 宮本智恵子3, 矢野雅隆4, 八木原栄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2014.

---

	About association with use index (AHI) of the Pseudomonas aeruginosa in the 28-P2PM-010 blood tumor department ward-sensitive rate and antimicrobial and use density (AUD) 藤澤宗央1,2,3,4,5, 佐伯康弘1, 堀田尚子2, 遠藤康伸2, 中村明世3, 小川綾子3, 青墳信之4, 野口博史5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2014.

---

	The effect that a change of the 28-P2PM-011 antimicrobial consumption gives to the antimicrobial sensitivity of gram-negative bacilli 小関崇文, 松木祥彦, 大貫敏明, 安田麻美, 浅井浩子, 高橋優香, 岩佐典子, 杉浦健一, 畦元智子, 中村友美, 藤岡敬子, 小林健太郎, 西關由梨子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2014.

---

	Examination about consumption and the chemosensitivity of the antimicrobial in the 28-P2PM-012 Morioka friendship hospital 阿部慎太郎, 登坂理恵, 中島稔也, 大森英樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2014.

---

	Action to antimicrobial proper use by the 28-P2PM-013 antimicrobial round introduction 佐々木暢琢1,2, 藤井愛理1,2, 木村匡男1,2, 岡宏次2, 横田和美2, 鈴木由香2, 宮崎伸子2, 田中公2, 加藤公2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2014.

---

	About the use situation of the injectable antimicrobial in our 28-P2PM-014 House 久米田一喜, 倉内寿孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2014.

---

	The use situation of the antimicrobial judging from effect of the preventive measures against 28-P2PM-015 infection addition 中村伸也, 塚元夏苗, 井上公博, 谷山康子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2014.

---

Local joint surveillance about use of antimicrobial density and the resistant bacteria separation rate with the 28-P2PM-016 Hiroshima throughout the prefecture 29 institution 池本雅章, 伊藤孝史, 小笠原康雄, 川上恵子, 木村友美, 栗原晋太郎, 先森満子, 正畠和美, 菅原隆文, 滝雪歩, 華山博子, 日浦昌洋, 武郷徹, 藤井秀一, 船越幸代, 細川宜嗣, 堀田修次, 増田博久, 光廣貴紀, 宮田篤, 安原昌子, 山口伸二, 余越芳子, 米津亜希子, 木平健治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2014.

---

	The separation situation and the acquisition of resistance situation of Acinetobacter spp. in 28-P2PM-017 this country 木村修徳1, 松井真理2, 鈴木里和2, 鈴木仁人2, 柴山恵吾2, 三浦布紗子1, 永野真久1, 安森奈緒子1, 井上大奨1, 平木洋一1, 真鍋健一1, 河野文夫3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2014.

---

	Enlightenment activity of the 28-P2PM-018 blood culture sampling and the evaluation 上條泰弘1,3, 鎌倉明美2,3, 篠原章能1, 保科滋明1,3, 忠地花代2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2014.

---

About the observance situation of effect of the antimicrobial consumption to give the number of the methicillin-resistant staphylococcus aureus bacteria carriers in the 28-P2PM-019 Tokai Municipal Hospital and the standard precaution 小林義和1,6, 吉岡祐貴1,6, 山田昌矢2,6, 佐野菊絵3,6, 浅井雅彦3,6, 織田元4,6, 下川高賢3,6, 生田宏次5,6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2014.

---

	Discussion about a risk of developing factor of the impaired renal function with 28-P2PM-020 vancomycin and the reversibility 小嶋希望, 坪田晃司, 宮本康史, 新崎祐馬, 横山朝子, 河合祐輔, 吉田憲史, 倉島弘道, 田中喜倫, 高野陽平, 上野英文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2014.

---

	Identification and property analysis of the isolated MRSA clinical in 28-P2PM-021 Tsuyama center Hospital 内田多恵子1, 和田朋子2,3, 塩津あかり1, 福島大貴1, 三好暁1, 見尾光庸1,2, 藤岡充史4, 黒田照夫5, 塩田澄子1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2014.

---

	Improvement of the TDM rate of use of the antiMRSA medicine which utilized 28-P2PM-022 system 山口佳津騎, 田井達也, 樋口和子, 田中裕章, 乗松真大, 山本高成, 水川奈己, 高橋功一, 朝倉正登, 小坂信二, 芳地一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2014.

---

	Property examination of the daptomycin-resistant MRSA isolated in our 28-P2PM-023 House 和田朋子1,2, 三好暁3, 内田多恵子3, 山田陽一4, 工藤季之5, 塩田澄子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2014.

---

	28-P2PM-024 Efforts to influenza infection by ICT 多田緑1,2, 大坊佳子1,2, 佐藤久美1, 岡本満希1, 原田典明1, 小山恭正1, 續敬之1, 結城秀樹1, 高畠啓輔2, 三田村敬子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2014.

---

	About the development situation of Clostridium difficile-related loose bowels in the 28-P2PM-025 Kumamoto Red Cross hospital and the factor 四郎園巧, 浦田由紀乃, 下石和樹, 合澤啓二, 陣上祥子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2014.

---

	Action for an investigation and the standardization of the prescription intervention of the infection in the 28-P2PM-026 neurosurgery ward 倉田武徳, 石井淳一, 山本隼也, 佐村優, 関根寿一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2014.

---

	A study on fluoroquinolone tolerance of 28-P2PM-027 Pseudomonas aeruginosa isolates and application to hospital infection measures 磯崎未帆1,4, 福田達也4, 小林秀樹2,4, 寺井幸子3, 内野卯津樹3, 増田雅行3, 長島誠3, 真坂亙1, 安齊洋次郎4, 加藤文男4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2014.

---

	Questionary survey about the levofloxacin medication method in the 28-P2PM-028 area 大久保嘉則, 中尾瑞穂, 三砂義敬, 床島英雄, 植村ちひろ, 鈴田浩孝, 草葉一友 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2014.

---

	Measures after the 28-P2PM-029 S.maltophilia inside the hospital development and examination of the risk factor 田中基稔1, 津曲恭一1, 大津貴寛1, 吉田裕生1, 西村尚芳1, 成田千穂2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2014.

---

	Clinical examination according to the age hierarchy for the patients that MRSA was detected in our 28-P2PM-030 House outpatient department 坂元佑哉1, 宮崎元康1, 永田忍彦2, 松尾宏一1, 神村英利1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2014.

---

	Investigation about the development situation of bloodstream infections with the Bacillus genus in our 28-P2PM-031 House and the use situation of the low-concentrated sugar addition amino acid infusion preparation 瀬名波宏昌1, 名徳倫明3, 小角麻衣1, 菅野紫2, 河田夫美代2, 橋本重樹2, 川口進一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2014.

---

	Examination of the clinical background and prognostic factor of patients with iliopsoas muscle abscess in our 28-P2PM-032 House 櫻川さほり, 塚本仁, 高橋翠, 新谷智則, 中村敏明, 政田幹夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2014.

---

	Activity evaluation of the infection control pharmacist in the cottage-hospital out of 28-P2PM-033 守内匡1, 浅野聡美1, 田中治1, 松井ひろみ1, 松田芳美1, 白井亜紀2, 高田加壽代3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2014.

---

	Action to antimicrobial proper use by the 28-P2PM-034 ICT 潮平英郎1,2, 仲松正司1,3, 武加竹咲子1, 富島美幸1, 上地幸平1,4, 芦塚陵子1, 柴田馨日2, 福島裕貴2, 山内祐子1,2, 比嘉太1,3, 大湾知子1,5, 健山正夫1,3, 外間惟夫2, 植田真一郎6, 藤田次郎1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2014.

---

	Example that Thyradin suppository succeeded to the patients after the total thyroidectomy which came to have difficulty with 28-P2PM-035 internal use 齋藤暢人1, 篠原義剛1, 蒲池英博1, 實松絵美子1, 日高博1, 浅原稔生1, 井上譲2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2014.

---

	Examination of the usefulness of the rotation, the revolution-type mixer in the 28-P2PM-036 vagina bougie preparation 山本有佳里, 加賀谷隆彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2014.

---

	Evaluation of the combination ratio and the bioavailability of the greasy base to use for 28-P2PM-037 pregabalin bougie 秋本純矢, 村田勇, 井上裕, 木村昌行, 金本郁男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2014.

---

	Efficiency of the ointment preparation with a lot of 28-P2PM-038 preparation apparatus 宮下博幸1, 八木澤啓司1, 柴田壮一1, 松原肇1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2014.

---

	Examination of the Mohs ointment preparation method using 28-P2PM-039 "what like that kneading on fire Taro" 長岡匠, 臼井悟, 越川千秋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2014.

---

	Examination at the rotation, the mixed time when the revolution-type mixer is appropriate in the ointment mixture preparation using the 28-P2PM-040 hydrozincite ointment 蝦名勇樹, 棚谷貢, 佐藤裕資, 廣瀬哲也, 越田晋太郎, 管大地, 鈴木千波, 田畑裕和, 柴波明男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2014.

---

	Examination about the preservation method of the polaprezinc candy agent used for stomatitis treatment treatment after the 28-P2PM-041 chemotherapy and the intraoral zinc level 宮澤映里花1,2,3, 中島孝則1, 齋藤博1, 大河内真弓2, 日比徹2, 岩田政則3, 森本一洋1, 松田佳和1, 木村正幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2014.

---

	About usefulness of the ST medical mixture encapsulation using examination - simple type capsule filler about the ad here Lance improvement for children during 28-P2PM-042 chemotherapy - 田中裕章, 朝倉正登, 元木貴大, 渡邊政博, 山口佳津騎, 立道貴清, 辻繁子, 磯部芳江, 木村若菜, 野崎孝徒, 小坂信二, 芳地一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2014.

---

	The taste bitter masking of the intraoral film for stomatitis treatment using 28-P2PM-043 loperamide and the preparation 齋藤裕香1, 笹津備尚1, 河野弥生2,3, 花輪剛久2,3, 大西啓1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2014.

---

	Stability at masking reagent addition of 28-P2PM-044 antiHIV medicine TDV 田所諒子1, 笹津備尚1, 関根祐介2, 明石貴雄2, 大西啓1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2014.

---

	Examination about the making of the 10% w/v APAP suspension in the 28-P2PM-045 cancer pain relaxation 梅下翔, 瀧本紫乃芙, 藺上圭子, 宇夛裕基, 河原昌美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2014.

---

	Effect of the storage temperature to be rheological property of the 28-P2PM-046 xyloglucan solution and drug-releasing, and to give it to 下山哲哉, 前川英輝, 宮城由莉子, 伊藤邦彦, 小林道也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2014.

---

	Examination of the dissolution of the enteric capsule to prepare 28-P2PM-047 inside the hospital 奈良克彦, 河合正矩, 柳原良次, 中島克佳, 鈴木洋史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2014.

---

	Examination about adsorption and the preparation method to the filter of the protein ingredient included in 28-P2PM-048 autoserum eye drops 徳田篤志, 柳原良次, 中島克佳, 鈴木洋史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2014.

---

	Examination about the sterilitas of the hospital preparation made under clean environment by the use of 28-P2PM-049 clean zonal generation device KOACH 村瀬哲也, 泉谷悟, 垰越崇範, 岡本知子, 須川涼, 西垣内亮, 森下麻里, 木平健治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2014.

---

	A search and reactions of drugs evaluation of the optimal prescription in the 28-P2PM-050 psychotropic drug component percutaneous absorption type preparation development 赤木千夏, 小幡誉子, 大貫義則, 山本章午, 池上めぐみ, 池田弘子, 亀井淳三, 高山幸三 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2014.

---

	Development of the 28-P2PM-051 hospital preparation management support system 舟橋智美1, 木下功1, 川澄紀代1, 高橋直希2, 津村直樹2, 鳥井拓也3, 松浦克彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2014.

---

	The collapse time for 28-P4PM-001 orally disintegrating tablet and examination about the hardness 岡山未来, 山本千鶴子, 辻和敏, 末安正典, 江頭伸昭, 増田智先 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2014.

---

	Examination of the pharmaceutics of the 28-P4PM-002 tamsulosin hydrochloride orally disintegrating tablet 白石久, 平田歩, 船戸裕樹, 阿部譲朗, 常風興平, 横田淳子, 宮村充彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2014.

---

	Dosage form design of the opal mon lock for the purpose of the stability improvement under the 28-P4PM-003 high humidity 井上靖雄1, 関屋昇1, 片山和格1, 鳴瀧壮二1, 山本政信1, 武田和久2, 須藤眞生3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2014.

---

	Study on change of the elution rate of the indomethacin capsule in the 28-P4PM-004 room temperature preservation 栗林和美, 板井裕樹, 遠藤友梨, 齋藤里砂, 吉村沙織, 阿部麻衣, 関場美香, 吉田継親, 山本佳久, 水野恵司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2014.

---

	Factor to have an influence on the elution rate of the 28-P4PM-005 indomethacin capsule 庄司聖, 湯谷玲子, 寺岡麗子, 北河修治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2014.

---

	Preparation stability evaluation of the cream using 28-P4PM-006 MRI 大貫義則, 長谷川直毅, 黄田千尋, 鮒谷千明, 小幡誉子, 高山幸三 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2014.

---

	Discussion of the possibility of ward drug duties by the 28-P4PM-007 prescription intervention example analysis 高坂聡, 川辺千苗美, 畑中絵里子, 石塚久仁子, 吉元公一, 奥山清 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2014.

---

	Examination about the way of the ward drug duties in the ward specialized in patients with 28-P4PM-008 cancer 日比野英幸1,2, 牧野好倫2, 岩瀬治雄2, 秋好健志1, 今岡鮎子1, 大谷壽一1, 林憲一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2014.

---

	Content analysis of the pharmaceutical intervention after the ward drug duties enforcement addition calculation in the 28-P4PM-009 Gifu Municipal Hospital 大橋洵1, 水井貴詞1, 説田英利子1, 大野祐城1, 大澤友裕1, 土田陽子1, 福田聖啓1, 田中和秀1, 田中佑佳1, 市橋厚司1, 舘知也2, 安田昌宏1, 小林健司1, 佐橋誠1, 後藤千寿1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2014.

---

	Action to the qualitative improvement of 28-P4PM-010 ward drug duties 田子尚史, 小材直人, 大熊範和, 田子加代子, 森田淳介, 村田文, 橋本碧, 新木美枝, 伊藤典子, 山賀章一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2014.

---

	About the good use of prescription suggestion seat as the outcome of 28-P4PM-011 ward drug duties 辻本朗, 佐山祐香, 廣末毅, 茂山真悠子, 原知斉 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2014.

---

	Outcome investigation after the 28-P4PM-012 ward drug duties start 羽村康一, 平綿洋子, 矢野忠, 市川訓, 宮坂宗男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2014.

---

	Examination about the need of the pharmacist placement in the 28-P4PM-013 convalescent rehabilitation ward 瀧祐介, 日下豊史, 揚張真利子, 栗原梢, 山崎愛子, 後藤貴裕, 安藤奈津子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2014.

---

	Significance of the patient monitoring for use of safe injection drug which assumed IPSG in the 28-P4PM-014 JCI certification an index 松本早矢香, 鈴木正論, 桝田浩司, 永井淳子, 佐々木忠徳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2014.

---

	Contribution to medical security of the pharmacist ward permanent residence to see in 28-P4PM-015 pre-Abo id report 川島千夏, 益子里美, 佐山千春, 植田生織, 内藤梨奈, 松本麻美, 川迫睦美, 秋本円香, 陳内博之, 若林千草, 豊田真志, 太田和歌, 清宮麻未, 和貝直亮, 藤本菜奈, 川崎寛一, 岡部佳郎, 松本啓一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2014.

---

	The change to the 28-P4PM-016 ward pharmacist placement 1 ward 1.5 two weeks change system and the effect 吉田有貴子, 成川祥子, 高橋恭子, 勝田良子, 新穂祐子, 渡辺孔明, 吉澤雅恵, 風岡真実, 小野妙子, 川崎智子, 佐藤綾子, 島盛一郎, 倉橋祥子, 山内たきよ, 上村彩子, 中嶋一恵, 小林貴志, 桜井美杏, 湯浅智恵, 長澤宏之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2014.

---

	Development of the ward drug duties that utilized 28-P4PM-017 balun strike scorecard 高瀬尚武1, 中田日早枝1, 三木育子1, 千崎昭輝1, 樋本繭子1, 木村有子1, 新免徹1, 合田俊一1, 相楽友香1, 尾上由華1, 塩江真代1, 松岡詩子1, 米澤圭祐1, 遠藤幹子1, 川上辰三1, 田中智也1, 赤瀬朋秀2, 室井延之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2014.

---

	Ward job evaluation after the ward exclusive duty system start by the analysis of the pharmaceutical intervention contents in the 28-P4PM-018 surgery system ward 冨田昌志, 渡邊清人, 高柳昌宏, 千田泰健 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2014.

---

	An action to the ward drug duties introduction in the scale hospital out of 28-P4PM-019 and the outcome evaluation 宗村雅男, 濱宏仁, 公門法子, 赤瀬博文, 田中詳二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2014.

---

	About the prescription suggestion in 28-P4PM-020 ward drug duties 宍倉啓介, 野地良子, 安嶋優, 松本侑季, 小竹慶子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2014.

---

	Action of the efficiency of drug control instruction duties using 28-P4PM-021 drug control instruction support system 細野由佳1, 徳武静香1, 菅原順子1, 安田礼子1, 三代貴康2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2014.

---

	The effect that the development of the drug duties by the 28-P4PM-022 ward full-time union official gives to prescription intervention 山田真帆, 小田都紀子, 村木優一, 中本亜樹, 杉本浩子, 岩本卓也, 奥田真弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2014.

---

	Change of 28-P4PM-023 Japanese Society of Hospital Pharmacists medicine political situation long notice duties to see from "the present conditions investigation of the hospital pharmacy gate" 加藤将朗, 長島昌嗣, 大森尚美, 星隆弘, 菅田和也, 安岡俊明, 佐藤博, 柴川雅彦, 土屋文人, 北田光一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2014.

---

	Relation of the discharge medication counseling in our 28-P4PM-024 House 鈴木さやか1, 竹尾恵理子2, 後藤健志2, 酒井欣嗣1, 石川真平2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2014.

---

	Evaluation (from a nurse) from other types of job before the 28-P4PM-025 "ward drug duties enforcement addition" introduction 清水けいこ, 大西祥代, 細川朋弘, 高儀佳代子, 安藤智美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2014.

---

	About an evaluation after the present conditions and the enforcement of the ward drug duties in our 28-P4PM-026 House 古俵孝明, 新谷智則, 矢野良一, 五十嵐敏明, 渡辺享平, 上谷幸男, 今野彩, 佐々木逸美, 中村敏明, 政田幹夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2014.

---

	Effect of the ward drug duties introduction in 28-P4PM-027 pharmaceutical products proper use and the risk aversion 新谷智則, 古俵孝明, 田嶋恭典, 福岡奈央, 今野彩, 中村敏明, 政田幹夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2014.

---

	Grasp of the enforcement situation of the ward drug duties that use and application performed of 28-P4PM-028 electronic chart system and future problem 町谷安紀, 甲田和恵, 池宮安葵子, 黒田絵里香, 山下恵, 浦瀬友絵, 薗村雅代, 中埜晴美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2014.

---

	Relation of the pharmacist for the 28-P4PM-029 nursing necessary degree 池田絢, 井上尚彦, 百武宏志, 小林明信, 高木章次 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2014.

---

	We prevent contraindicated medication in 28-P4PM-030 pre-instructions check list 中尾耕治, 西本辰也, 杉山かおり, 田邊聖委子, 松本哲哉, 森春樹, 丹羽寿, 岩瀬崇, 西尾益治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2014.

---

	One case that showed ALP high level by 28-P4PM-031 alendronic acid Na tablets and teriparatide subcutaneous administration 櫻井晴奈, 濱宏仁, 石本学司, 田中詳二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2014.

---

	Analysis about the onset report of Stevens-Johnson syndrome using the 28-P4PM-032 adverse event spontaneous report database and the toxic epidermal necrolysis 又木香那子1,2, 梅津亮冴1, 鈴木俊之1, 阿部純子1,3, 上田夏実1, 中山蓉子1, 加藤大和1, 原英彰2, 紀ノ定保臣4, 中村光浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2014.

---

	Examination and application of the 28-P4PM-033 quickness allergy diagnostic method 安高勇気1,2, 芝口浩智2,3, 今給黎修1,2, 二神幸次郎1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2014.

---

	Examination of the allergic expression of patients with amoxicillin (LMT positive) drug eruption mechanism by the cytokine mRNA analysis using 28-P4PM-034 RT-PCR 本田真知子1, 田淵紀彦1, 古川智康2, 継田雅美2, 大石智洋3, 福長将仁1, 宇野勝次1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2014.

---

	The actual situation of the hyperuricaemia with pyrazinamide in our 28-P4PM-035 House 右川浩, 田中三枝子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2014.

---

	Comparison between Japan and judging from 28-P4PM-036 adverse event spontaneous report database (FAERS) side effect onset risk of isoniazid in the United States 河合加奈, 小川喜寛, 西川良平, 頭金正博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2014.

---

	About the present conditions and safety measures of the thrombosis with the oral 28-P4PM-037 female sex hormone preparation 兼松美和, 井澤唯史, 阿部和佳子, 米谷美穂, 飯村康夫, 高松昭司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2014.

---

	An example of the hyperammonemia derived from valproic acid restored by 28-P4PM-038 levocarnitine preparation 近藤勝弘1, 奥苑朱加2, 江崎哲夫1, 森義徳3, 木村和哲1,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2014.

---

	One case that the tremor relieved by 28-P4PM-039 famotidine cancellation 廣岡賢輔, 前田祥花, 清水浩幸, 國森公明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2014.

---

	About blood sugar abnormality with 28-P4PM-040 levofloxacin 上田伊吹1, 志野訓之2, 野村泰生2, 河野修治1, 津島美幸1, 橋詰勉1, 高山明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2014.

---

	Factor analysis of the husky voice expression that is a side effect of 28-P4PM-041 inhalation steroid medicine 岡田章1, 松本結希1, 山越達也2, 西川誠2, 福島恵造1, 杉岡信幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2014.

---

	Onset of low Ca blood symptom situation investigation by the 28-P4PM-042 denosumab (orchid mark note) 金子綾乃, 平井成和, 土井啓員, 増田雅行, 佐野君芳, 真坂亙 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2014.

---

	Risk factor of the hypermagnesemia in the 28-P4PM-043 magnesium oxide preparation 畑中由香子, 足立恵子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2014.

---

	Background investigation of the hyperkalemic inpatient in the 28-P4PM-044 Kasugai Municipal Hospital 田中伸明, 沢田俊朗, 伊東和真, 服部芳明, 坂田洋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2014.

---

	Relative examination of fixed-quantity of coumalin in Chinese medicine containing the 28-P4PM-045 cinnamon bark and coumalin total intake and the liver damage 内田愛子1, 貝沼茂三郎2, 岩田直大1, 大園沙保子1, 菅原尚子1, 小林大介1, 窪田敏夫1, 島添隆雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2014.

---

	It is investigated the interruption reason of the use of PCA patients after the operation in our 28-P4PM-046 House 北森翔子, 吉岡大樹, 藤本智大, 石田あい, 上田華世, 喜多川緑, 田中比奈子, 松尾多恵, 久保智士, 山崎瑞貴, 鶴崎亮, 青木美沙, 松谷和子, 中川巌, 三嶋仁美, 木村真策 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2014.

---

	Effect of the cancer chemotherapy on central nervous system side effect expression of 28-P4PM-047 opioid 土江晴江, 土井教雄, 玉木宏樹, 西村信弘, 直良浩司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2014.

---

	About the association of 28-P4PM-048 cramps in the calves and the drug 竹下秀司1, 北川禎子1, 村松宗2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2014.

---

	Examination about the evaluation method of the renal function estimate in the 28-P4PM-049 dabigatran remedy patients 森田真裕子, 大久保純, 池崎友明, 北澤英徳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2014.

---

	About the effect that age and sex differences give for the effectiveness and adverse event expression of 28-P4PM-050 febuxostat 彦坂紗世1, 水野智博1,2, 林高弘3, 島袋優花1, 村瀬真穂1, 高橋和男2, 林宏樹2, 湯澤由紀夫2, 山田成樹3, 永松正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2014.

---

	28-P4PM-051 Drug treatment support in Janus kinase (JAK) inhibitor XELJANZ tablet taking patients 八木下敏彰1, 長谷川佳孝2, 太田孝一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2014.

---

	Uniform management of the information on adverse drug reactions using 28-P4PM-052 adverse drug reaction development report and content analysis 門村将太, 林祐希, 西倉奈央, 川本康太郎, 山田尚枝, 関根有貴, 藤井達郎, 鈴木智子, 野田聖奈子, 竹内美奈, 福田由布子, 井藤達也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2014.

---

	Analysis of the safe related information of the infusion put to the DI center in 28-P4PM-053 2013 津田朋枝1, 堀越由里1, 竹林佑花1, 佐々木美由紀1, 吉岡小都子1, 星泉1, 福田まゆみ1, 河野裕則1, 岩原良晴1, 松野太郎2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2014.

---

	Than the serious side effect case - citizen medicine ream side effect monitor activity that occurred in 28-P4PM-054 grade 3 case and the decreased renal function patients - 田中亜紀1, 神浦茉奈実2, 山内美子3, 森吉男4, 廣田憲威5, 松本ミユキ6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2014.

---

	About a side effect of 28-P4PM-055 unregulated drug and cosmetics report 井澤唯史, 兼松美和, 阿部和佳子, 米谷美穂, 飯村康夫, 高松昭司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2014.

---

	The effectiveness of the Teiko plastic Nin administration plan based on 28-P4PM-056 antimicrobial TDM guidelines 杉田裕貴, 田中絵美, 細見健悟, 小牧佐知子, 稲田智子, 高子優子, 増本憲生, 大槻裕朗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2014.

---

	Examination of the optimal initial administration of Teiko plastic Nin judging from blood level of the 28-P4PM-057 simulation 青木有希1, 塩田有史2,3, 中村敦2, 木村和哲1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2014.

---

	Examination of the Teiko plastic Nin aim trough value in the 28-P4PM-058 Enterococcus faecium blood infection treatment 岡冨大輔1,2, 宅江良隼1, 山西紀子1, 谷口雅敏1, 岡谷健史2, 板垣充弘2, 麻奥英毅2, 許泰一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2014.

---

	Presence or absence of 28-P4PM-059 Cancer bearing and relations of the Teiko plastic Nin blood level 佐々木紀彰, 熊澤崇, 古元俊徳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2014.

---

	Development and application ... of the PK-PD analysis - MRSA treatment support tool aiming at 28-P4PM-060 daptomycin administration optimization 石原慎之1,2, 西村信弘1, 猪川和朗2, 右川博明2, 岡崎美香1, 玉木宏樹1, 森川則文2, 直良浩司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2014.

---

	Examination of the optimal medication method of the daptomycin by 28-P4PM-061 statistics software R 長井日生1, 並木孝哉1, 金子真隆2, 松尾和廣3, 佐古兼一4, 大林雅彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2014.

---

	Clinical pharmacokinetic examination for the proper use of the 28-P4PM-062 amikacin 森脇世奈1, 橋本直人1, 佐古兼一1, 松木祥彦2, 大貫敏明2, 矢嶋美樹2, 河村剛至1, 松田佳和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2014.

---

	Examination of the effect on TDM of the arbekacin by the 28-P4PM-063β- lactam drugs combination 茂木武, 小林貴志, 高橋成博, 横山裕貴, 山口友里, 内坪誉歳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2014.

---

	Improvement of the linezolid HPLC assay by the 28-P4PM-064 acetonitrile processing 三浦剛, 山崎伸吾, 中村貴子, 鈴木貴明, 有吉範高, 石井伊都子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2014.

---

	Search - second report - of the blood lamotrigine levels change factor of patients with 28-P4PM-065 bipolar disorder 寺澤美穂1, 山折大1, 勝山善彦1, 北山美乃里2, 市川かおり2, 二村緑2, 田中章2, 荻原朋美2, 杉山暢宏2, 鷲塚伸介2, 大森栄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2014.

---

	Clinical pharmacokinetic examination for the use of 28-P4PM-066 valproic acid fitness 谷田理奈1,2,3,4, 吉野のぞみ1, 佐古兼一1, 嶋野仁1, 柘植昂太1, 臼井沙織1, 松木祥彦2, 大貫敏明2, 町田充3, 上田恵子3, 新井亘4, 小林理栄4, 矢嶋美樹5, 河村剛至1, 松田佳和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2014.

---

	Clinical pharmacokinetic examination for the 28-P4PM-067 zonisamide proper use 柘植昂太1, 佐古兼一1, 町田充2, 上田恵子2, 小林理栄3, 新井亘3, 増田裕一3, 嶋野仁1, 谷田理奈1, 臼井沙織1, 橋本直人1, 矢嶋美樹4, 河村剛至1, 松田佳和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2014.

---

	Analysis of the blood level change factor at tacrolimus route of administration change in the 28-P4PM-068 hematopoietic stem cell transplantation 末次王卓1, 内田まやこ1, 槇原洋子2, 池未裕明1, 渡邊裕之1, 矢野貴久1, 大畠俊一1, 宮本敏浩3, 江頭伸昭1, 増田智先1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2014.

---

	Blood tacrolimus levels analysis in patients with 28-P4PM-069 rheumatoid arthritis 吉村美里1, 須古杏子1, 高岡宏和2, 中村正2, 森岡淳子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2014.

---

	It is ... about a correction of the clearance during enforcement - administration of the TDM in the immunosuppressive drug administration after the 28-P4PM-070 hematopoietic stem cell transplantation 椙山聡一郎1, 上手真梨子1, 藤澤信2, 橋本真也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2014.

---

	1 case of the pemphigus vulgaris that needed pharmaceutical invention for CyA administration in enzyme induction of 28-P4PM-071 RFP 久保嘉靖1, 奥野昌宏1, 堀川達弥2, 中田学1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2014.

---

	Construction of the blood level assay of mycophenolic acid using 28-P4PM-072 column switching LC/ESI-MS/MS 相馬真志1, 菊地正史1, 前川正充1, 鈴木裕之1, 久道周彦1, 山口浩明1, 島田美樹1,2, 眞野成康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2014.

---

	Blood level monitoring after the busulfan once a day administration in the transplant pre-treatment of the 28-P4PM-073 acute leukemia in childhood 石渡泰芳1, 永田将司1, 高橋弘充1, 富澤大輔2, 青木由貴2, 宮脇零士2, 森尾友宏2, 安原眞人3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2014.

---

	Study on blood level and effectiveness of imatinib in patients with 28-P4PM-074 chronic myelogenous leukemia and safety 瀬戸良教1, 小松敏彰1, 石田有香2, 国分秀也1, 近藤留美子1, 厚田幸一郎1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2014.

---

	Examination of the administration plan by the 28-P4PM-075 dabigatran blood level measurement 松田翔平1,2, 今津智子1,2, 濱崎浩一1, 村中美香1, 中村護1, 松本篤1, 村上照夫2, 前田頼伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2014.

---

	Action of the anticancer agent preparation support system IMRS-TCA development using the 28-P4PM-076 weight inspection method 手嶋由加1, 與田賢作1, 柳原佳奈1, 日高美緒1, 野村浩子2, 平川雅章1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2014.

---

	Inspection for the introduction of the anticancer agent preparation support system in the hospital attached to the 28-P4PM-077 Mie University School of Medicine 須藤宏文, 森川琢也, 村木優一, 山本弥里, 河原佑樹, 岩本卓也, 奥田真弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2014.

---

	Introduction and evaluation of the inspection system using the network camera in 28-P4PM-078 injection anticancer agent germfree preparation duties 北出紘規, 北国憲剛, 森光恵 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2014.

---

	Usefulness of the anticancer agent preparation inspection using the 28-P4PM-079 digital camera and examination of the effect to preparation time 元木孝, 足立浩, 渡邊清人, 高柳昌宏, 千田泰健 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2014.

---

	About automation and the inflection of the 28-P4PM-080 cancer chemotherapy preparation plan 玉井宏一, 渡部早苗, 西畑友尋, 石田佳裕, 奥津武志, 大野純子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2014.

---

	Exposure investigation with the IMRS-TCA introduction in 28-P4PM-081 anticancer agent preparation duties 與田賢作1, 手嶋由加1, 柳原佳奈1, 日高美緒1, 野村浩子2, 平川雅章1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2014.

---

	Pollution degree investigation for the clinical introduction of the 28-P4PM-082 anticancer agent mixture preparation robot 丹田雅明1, 水田直美1, 槇本博雄1, 山口徹郎1, 家田啓史2, 西岡達也1, 久米学1, 平野剛1, 平井みどり1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2014.

---

	Improvement for the purpose of the compatibility improvement of 28-P4PM-083 anticancer injection drug automatic preparation device APOTECA and the evaluation 森川琢也1, 杉本紗梨1, 岩本卓也1, 宮田知明2, 稲葉友之2, 江上篤2, 樋口耕平2, 守隆宏3, 村木優一1, 奥田真弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2014.

---

	Formula in our House of 100 mg for the 28-P4PM-084 oil xanthan gum (R) infusion 黒田健吾, 寺山和利, 佐藤亜衣, 佐藤大輔, 加藤菊郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2014.

---

	Fact-finding about the administration time after the anticancer medicine preparation that is unstable after 28-P4PM-085 dissolution 宇佐美英績, 木村美智男, 守屋昭宏, 竹中翔也, 岡田和智, 吉村知哲, 森博美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2014.

---

	Comparison between the product about the speed of the 28-P4PM-086 portable constant infusion pump 宮本仁1, 山崎伸吾1, 鈴木達也1, 仲佐啓詳2, 中村貴子1, 鈴木貴明1, 有吉範高1, 石井伊都子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2014.

---

	One case using the suspension method simple in 28-P4PM-087 Valixa (R) lock remedy 高橋愛未1, 寺岡知香1, 望月千枝2, 井尻夏1, 永井絵里子1, 北川直1, 石川照久1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2014.

---

	Examination of the formula of the endoxan bulk for oral 28-P4PM-088 市東優美, 高橋良平, 嶋崎幸也, 佐々木孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2014.

---

	Examination for the quantity of exposure to 28-P4PM-089 anticancer medicine in the simple suspension method 朴美姫1, 池本憲彦1, 戸屋成未1, 奥山美結樹1, 畠山和子1, 河崎陽一2, 倉田なおみ3, 清原義史4, 駒田富佐夫4, 大野雅子1, 桂木聡子1, 重松誠1, 森山雅弘1, 天野学1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2014.

---

	Action to prevention of exposure to oral medicine with teratogenicity, the mutagenesis in 28-P4PM-090 children 井尻夏1, 寺岡知香1, 望月千枝2, 高橋愛未1, 永井絵里子1, 北川直1, 石川照久1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2014.

---

	Examination - of prevention of environmental pollution measures - scattering and the powdered medicine divided powder plane cleaning method with the 28-P4PM-091 powdered medicine anticancer agent 永井浩章, 愛甲佳未, 高本光次郎, 中山淳司, 籾井佳奈, 池田絵里佳, 三輪祐太朗, 廣瀬晃子, 福田朝恵, 赤松規子, 合田泰志, 福井由美子, 西本哲男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2014.

---

	Decoration pollution with 28-P4PM-092 volatilization-related anticancer agent oral medicine cyclophosphamide and examination of the prevention method 花田貴惠1, 高見陽一郎1, 森山圭1, 大呂真史2, 小川壮寛1,2, 守安洋子2, 井上結夏1, 兼光朝子1, 川本英子1, 長瀬彩花1, 浜原安奈1, 山本温子1, 島田憲一1, 高橋正志2, 江川孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2014.

---

	Investigation of the PTP sheet pollution status of the 28-P4PM-093 5-FU oral medicine 川本英子1, 高見陽一郎1, 森山圭1, 花田貴恵1, 小川壮寛1,2, 井上結夏1, 兼光朝子1, 長瀬彩花1, 浜原安奈1, 山本温子1, 江川孝1, 島田憲一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2014.

---

	Examination - third report ... about the vial surface pollution of the 28-P4PM-094 anticancer medicine 吉田昭昌1, 高見陽一郎2, 森近俊之1, 花田貴恵2, 島田憲一2, 江川孝2, 松久哲章1, 二五田基文3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2014.

---

	Conduct an exposure to anticancer agent investigation by the 28-P4PM-095 sampling sheet method 高梨真希子, 高田正弘, 佐藤雅也, 長山晃, 角田一成, 川上典子, 野毛一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2014.

---

	Adsorptive evaluation of the work sheet to use at 28-P4PM-096 anticancer agent preparation 佐藤淳也1,2, 菊地聡美2, 工藤賢三1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2014.

---

	Fact-finding of the work environmental pollution with the 28-P4PM-097 anticancer agent and action to prevention of human body exposure using the ozone water 都築大輔, 中川典江, 増田都子, 水野馨子, 小林理枝子, 阿部正博, 木内司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2014.

---

	An environmental pollution investigation with the anticancer medicine in the hospital built 28-P4PM-098 and future measures 三宅知宏, 野口祥紀, 服部公紀, 中西由衣, 前山恵里加, 伊藤美南子, 和田亜希, 谷村学 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2014.

---

	The introduction of the anticancer agent exposure prevention tool of 28-P4PM-099 four and the evaluation 西健太郎1, 佐々扶美1, 山下愛子1, 北岡朋子1, 飯島愛梨1, 東小織3, 中村いずみ4, 境健爾2, 田上治美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2014.

---

	Investigation of anticancer agent exposure to 28-P4PM-100 cancer chemotherapy nursing authorization nurse course measures for nurses 宮澤真帆1, 石丸博雅2, 三浦里織3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2014.

---

	Simulation anticancer agent preparation class for 28-P4PM-101 area pharmacists 柿原圭佑1,2,3, 葉田昌生1,2,3, 堤一貴2,3,4, 畑瀬圭佐2,3,5, 岩永陽子2,3,6, 林田栄一2,3,7, 三宅秀敏2,3,8, 黒崎一博2,3,9, 桑野淳2,3,10, 前田健一2,3,11, 松原美紗2,3,12, 有馬千代子2,3,4, 野瀬育宏1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2014.

---

	To prevention of anticancer agent radiation exposure for the floor nurse in our 28-P4PM-102 House wrestle 堀江都1, 堀江達夫1, 水本一生3,4, 杉本奈々絵2, 胡摩田千春2, 橘由香2, 高橋正彦1, 石橋博司1, 野宗義博3,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2014.

---

	Start the use of 28-P4PM-103 "handlings such as the cytotoxic waste, excrement at the anticancer agent administration"; and the attitude survey of the patients, the healthcare worker (hospital, ethical pharmacy) 伊東美歩1, 加藤幸三1, 泉雄介1, 海老原貴之1, 柄澤珠貴1, 宮城彩音1, 大森和美2, 田中紀子2, 山本勝枝2, 平原一也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2014.

---

	Examination about the method for measurement of the quantity of anticancer agent pollution of the restroom due to the excrement of patients who received 28-P4PM-104 chemotherapy 兼光朝子1, 高見陽一郎1, 林瑶子2, 名和秀起2, 井上結夏1, 川本英子1, 長瀬彩花1, 浜原安奈1, 山本温子1, 花田貴恵1, 北村佳久2, 千堂年昭2, 江川孝1, 島田憲一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2014.

---

	Examination of the technical evaluation of the anticancer medicine preparation training using the 28-P4PM-105 fluorescein sodium 大森崇行, 石丸博雅, 高山慎司, 川名賢一郎, 後藤一美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2014.

---

	Medical economic effect - in setting and the use of the mixed preparation duties - chemotherapy room of the 28-P4PM-106 antitumor agents of division of the antitumor agents 源川良一1,2,5, 伊藤幸1,2, 増田怜平1, 下川淳子1, 酒井慎治1,2, 木村直也1,2, 鎌田成芳2,3, 厚田幸一郎4,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2014.

---

	Action of the aperient proper use in the 28-P4PM-107 psychopathic ward 木村伊都紀1, 五月女祐一2, 齋藤百枝美3, 小杉隆祥1, 西澤健司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2014.

---

	Relation of the ward pharmacist for the proper use of the 28-P4PM-108 lithium carbonate 安食健一, 勝部直美, 福田恵美子, 園山智宏, 横手克樹, 平野榮作, 竹下和男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2014.

---

	Person in charge of a trend and the pharmacist of the 28-P4PM-109 risperidone sustained-release injection (RLAI) injection patients 五味和彦1, 酒井晶子1, 和田美由紀1, 前澤正和1, 羽場昇1, 樋掛忠彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2014.

---

	Action (1) of the health insurance pharmacy pharmacist for the 28-P4PM-110 benzodiazepine dependent evasion 谷博子, 宮崎直子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2014.

---

	About drug choice in the psychiatry sleeplessness treatment judging from 28-P4PM-111 fall, a fall accident 中居香織1, 中居肇2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2014.

---

	About an action of the drug department for the polypharmacy of the foreign outside Parliament prescription with the 28-P4PM-112 fee-for-service revision 伊藤直美1, 和田智仁1, 伊藤由香1, 羽佐田祥浩1, 藤田康平2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2014.

---

	Effect of drug deprivation of benzodiazepine drugs by the brochure distribution to 28-P4PM-113 neuropsychiatry outpatient 進健司1, 梅田勇一1, 大谷達郎1, 牛島悠一1, 内田守次1, 天津透彦2, 金澤康範1, 竹本伸輔1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2014.

---

	Usefulness of the blood glucose level monitoring at the drugstore store which cooperated with 28-P4PM-114 psychiatrist 堀場亜佐子1,2, 藤田直希2, 森道成1, 鈴木匡2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2014.

---

	Role of the pharmacist in the 28-P4PM-115 alcohol detoxification 森京子, 竹中克之, 竹田正美, 山田和子, 琴坂幸広 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2014.

---

	It is ... through the questionnaire of the medical therapy attitude survey - drug reporting book of the 28-P4PM-116 psychopathic ward inpatient 栗原梢, 日下豊史, 揚張真利子, 山崎愛子, 後藤貴裕, 安藤奈津子, 松下久美, 瀧祐介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2014.

---

	Evaluation of the pharmacist-led type conference in the 28-P4PM-117 psychopathic ward 大谷達郎, 進健司, 牛島悠一, 金澤康範, 竹本伸輔 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2014.

---

	Prescription investigation of the 28-P4PM-118 Alzheimer type dementia therapeutic drug remedy patients 金子幸弘, 最上雄史, 磯部浩之, 亀川綾 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2014.

---

	28-P4PM-119 hospitalization and comparison of the medical therapy in patients with schizophrenia during ambulant treatment 福山雄卯介1,2,3,4, 後藤史子2, 福山順子3, 福嶋翔3, 鈴田浩孝4, 西野隆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2014.

---

	Medical treatment for BPSD of patients with 28-P4PM-120 dementia 保科くるみ, 寺原史貴, 西牧武志, 勝股祐美, 齊藤俊一郎, 佐藤公人, 田村広志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2014.

---

	28-P4PM-121 The use situation of the psychotropic drug in the Fukuoka University Hospital 大塚誠1, 土倉史香1, 上野雅代1, 有元明恵1, 塩塚昭一1, 脇田昌子1, 鷲山厚司1, 今給黎修1,2, 二神幸次郎1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2014.

---

	The prescription situation of the paliperidone palmitate sustained-release suspension injection (PP) in the 28-P4PM-122 Yawata public welfare hospital 柴田木綿, 高橋麻美, 木村愛子, 園田美樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2014.

---

	It is fact-finding of continuously using it for 28-P4PM-123 risperidone sustained-release parenteral injection 36 months 新宅将史1, 小谷裕子1, 住吉久子1, 長尾正嗣2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-448, 2014.

---

	Attitude survey of the patients for the treatment with clozapine of the 28-P4PM-124 treatment-resistant schizophrenia therapeutic drug 伊藤美那子1,2,3, 竹内一平1,2, 大谷早也佳1, 杉浦貴哉1, 半谷眞七子1, 宇野準二2, 天野雄平3, 藤田潔2, 亀井浩行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-448, 2014.

---

	Comparison between psychotropic drug prescription actual situation and psychotropic drug prescription fact-finding in Toyama of our 28-P4PM-125 House 高城正利, 高橋理紗子, 新喜昌子, 平井邦彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-448, 2014.

---

	Fact-finding about a psychotropic drug and the drug costs in the 28-P4PM-126 clozapine introduction case 柏宗伸1,2, 宮川慶子1, 加藤浩充1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-448, 2014.

---

	Fact-finding in the proper use of treatment-resistant schizophrenia therapeutic drug clozapine for 28-P4PM-127 physician and pharmacists 大谷早也佳1,2,3, 竹内一平1,2, 伊藤美那子1, 杉浦貴哉1, 半谷眞七子1, 宇野準二2, 天野雄平3, 藤田潔2, 亀井浩行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-448, 2014.

---

	Use of antipsychotics fact-finding in patients with schizophrenia during 28-P4PM-128 hospitalization 市川暁1, 原恵子1, 鈴木秀則1, 田島芳夫1, 斉藤郁夫2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-448, 2014.

---

	28-P4PM-129 memantine improves amyloid beta-induced cognitive functional disorder 日比陽子, 山田清文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 449-449, 2014.

---

	Examination of the factor influencing the lamotrigine long-term use in the 28-P4PM-130 psychiatry domain 祖川倫太郎1, 持永早希子1, 門司晃2, 藤戸博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 449-449, 2014.

---

	Epidemiological investigation of the ivermectin blanket operation to the scabies outbreaks in the 28-P4PM-131 psychiatry closedown ward 永井努1,2, 齋藤勲1,2, 杉沢諭1,2, 池ヶ谷訓章2, 平藤彰1,3, 内倉健1,4, 稲本淳子5,6, 村山純一郎1,4, 加藤進昌2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 449-449, 2014.

---

	It is visual testing about the absorbency at becoming it one 28-P4PM-132 paliperidone lock (in Vega (R) lock) 木藤弘子1, 神村英利2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 449-449, 2014.

---

	Examination about a clinical response and the side effect expression of 28-P4PM-133 GLP-1 receptor agonist 別當知佐, 中西大介, 出口綾子, 柳川泰裕 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 449-449, 2014.

---

	Examination of a diabetes onset factor at the 28-P4PM-134 adrenal cortical hormone administration and the appropriate diabetes therapeutic drug 赤羽美香1, 佐々木英久1, 松尾和廣1, 渡辺朋子1, 篠原悦子1, 真坂亙2, 龍野一郎3, 古尾隆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 449-449, 2014.

---

	Examination about the estrangement of HbA1c in patients with 28-P4PM-135 diabetes and glycoalbumin 六車龍介1, 内山幸子1, 佐田竜尚1, 岡本勇二1, 永江隆二1, 土井真弓2, 大塚章人3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2014.

---

	Effect on type 2 diabetes nephropathy with the 28-P4PM-136 molecularity hydrogen component water administration 李静1, 薬師寺史厚2, 定本清美3, 柳川忠二1, 佐藤芳雄2, 細矢睦子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2014.

---

	Evaluation - for the need of report - pharmacist participation second about the need that a pharmacist is associated with for 28-P4PM-137 diabetes dialysis prophylactic instruction management 益成宏1, 實近彩子2, 飯塚晶子2, 田畑真弓2, 田中佳江3, 畑尾克裕4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2014.

---

	Meta analysis about the effectiveness and the safety of water-soluble and fat-soluble statin in patients with type 2 diabetes to be complicated with 28-P4PM-138 dyslipidemia 石黒友紀1, 向井潤一1, 須田哲史1, 尾鳥勝也1, 毛利順一1, 春日井(木村)公美1, 石田有香1, 矢島愛理1, 厚田幸一郎1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2014.

---

	Examination about the factor influencing bleeding, subcutaneous haemorrhage at the self-injection in patients with 28-P4PM-139 diabetes 二神咲子, 由井薗陽一, 槙林智子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2014.

---

	It is ... for the drug proper use in patients with ... elderly people diabetes about the combination actual situation of the drug which has an influence on the 28-P4PM-140 hypoglycemic action 千田泰健1, 元木孝1, 黒澤菜穂子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2014.

---

	Examination of an action and the instruction effect to 28-P4PM-141 diabetes dialysis prophylactic instruction 藤本綾 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2014.

---

	Fact-finding of the medication self interruption in patients with 28-P4PM-142 diabetes 中島啓二1, 宇佐美英績1, 安部絵里1, 森博美1, 傍島裕司2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2014.

---

	We analyze a risk factor of the blood sugar control aggravation after the discharge in patients with 28-P4PM-143 type 2 diabetes 川島優季1, 岡安伸二2, 原田紗希2, 西田承平2, 鈴木昭夫2, 小林亮2, 杉山正1, 伊藤善規2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2014.

---

	Study on patients self-care support program by the drugstore pharmacist for the purpose of the aggravation prevention of patients with 28-P4PM-144 diabetic nephropathy (the first report) 井上岳1, 飯岡緒美2, 森貴幸3, 浅田美子3, 松本千鶴4, 古川綾4, 厚田幸一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2014.

---

	The study on patients self-care support program by the drugstore pharmacist for the purpose of the aggravation prevention of patients with 28-P4PM-145 diabetic nephropathy (the second report): Mainly on patients satisfaction 飯岡緒美1, 井上岳2, 森貴幸3, 浅田美子3, 松本千鶴4, 古川綾4, 厚田幸一郎2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2014.

---

	Use experience report of the insulin Degludec in our 28-P4PM-146 House 中辻崇子, 村上とよみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2014.

---

	Examination about diabetes merger dyslipidemia and the small intestine morphological functional change in the 28-P4PM-147 type I diabetes mellitus model rat 小塩浩子1, 高野美菜1, 川瀬寛子1, 木村美保子1, 高橋唯1, 藤田純佳1, 宮崎誠2, 島本史夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2014.

---

	Treatment with insulin preparation prognostic comparison for patients with 28-P4PM-148 type I diabetes mellitus 桐谷拓磨1, 佐々木英久1, 松尾和廣1, 渡辺朋子1, 篠原悦子1, 真坂亙2, 龍野一郎3, 吉尾隆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2014.

---

	Examination of the important factor affecting the treatment result by the 28-P4PM-149 sustained-release insulin analog preparation Degludec 佐々木雄啓, 横田智美, 伊藤瑠美, 玉理千晴, 横山峻太, 谷後友絵, 高橋栄子, 藤本綾 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2014.

---

	Questionary survey of the insulin pen type instillator (pre-filled type) in the 28-P4PM-150 working member of society 久嶋真紀子, 野口景子, 葛葉守, 中野玲子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2014.

---

	Action of the pharmacist to the diabetes education inpatient in our 28-P4PM-151 House 岡田衣里子1, 中谷成美1, 山崎肇1, 小川義高2, 辻真由美2, 木戸里佳2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2014.

---

	Insulin instruction and intervention result to the other courses inpatient by the 28-P4PM-152 diabetes team pharmacist 小林華南子1, 山口恭平1, 須藤久実1, 佐田賢二1, 松本早苗1, 相良英憲2, 近藤しおり3, 仙波昌三1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2014.

---

	It is examination with the HPLC of the insulin stability at acid sodium sulfite addition to 28-P4PM-153 insulin solution 興村桂子, 山田洵也, 宮本悦子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 453-453, 2014.

---

	Examination about the effect of sediment development and the preservative at blood mixture on 28-P4PM-154 insulin preparation 関野健史1, 田中幸子1, 住谷賢治2, 吉田直弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 453-453, 2014.

---

	Effect of building Doug re-Putin in 28-P4PM-155 patients on dialysis and the teneligliptin 西正浩, 松井法子, 畑加奈子, 向井光一朗, 櫻間啓基, 上田晶, 坂本一貴, 羽田野桂史, 石炭兼征, 亀丸明莉 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 453-453, 2014.

---

	Examination about the effect of the linagliptin in the 28-P4PM-156 decreased renal function patients 辻香里1, 彦坂麻美1, 島田泉1, 渡邉幸雄1, 阿部康治1, 百々修司2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 453-453, 2014.

---

	Examination of the effect on blood pressure of the 28-P4PM-157 DPP-4 inhibitor 難波静奈, 中野史也, 晴山知拓, 石田陽美, 佐藤弘康, 稲垣育宏, 橋本義宏, 小森均 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 453-453, 2014.

---

	Comparison of HbA1c between the 28-P4PM-158 DPP-4 inhibitor 4 preparation and the dyslipidemia improvement effect 高橋希望1, 早川伸樹1,2, 桑原宏貴3, 津川透2,3, 林高弘1,3, 福井愛子1, 亀井浩行1, 鈴木敦詞2, 伊藤光泰2, 山田成樹3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 453-453, 2014.

---

	Examination of the second invalidity in the 28-P4PM-159 DPP-4 repressor 松野下絢子, 田村未香, 大倉幸子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 454-454, 2014.

---

	Elucidation of the vascular disorder inhibition mechanism through the NADPH oxidase activity inhibition of the 28-P4PM-160 DPP-4 inhibitor anagliptin 野田雅人1, 菊池千草2, 永味千枝1, 堀英生2, 松永民秀2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 454-454, 2014.

---

	Study on kidney protection of the DPP-4 inhibitor (linagliptin) for patients with 28-P4PM-161 diabetes 田渕寿美1, 横山晋一郎2, 竹松茂樹2, 辻琢己1, 河野武幸1, 玉田太志2, 河合実2, 上野裕之4, 坂根直樹3, 北村良雄2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 454-454, 2014.

---

	Investigation of the prescription situation and the effect by the renal function distinction of sitagliptin and building Doug re-Putin in our 28-P4PM-162 House 武重彩子1, 池滝晶子1, 石川紗耶香1, 加藤小織1, 林慶人1, 西村富啓1, 佐橋幸子1, 松下啓2, 宇治原誠3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 454-454, 2014.

---

	Investigation of a dose and the clinical response depending on renal function of the 28-P4PM-163 sitagliptin 中山英明, 小林庸子, 篠原高雄, 永井茂 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 454-454, 2014.

---

	The use situation of building Doug re-Putin in our 28-P4PM-164 House 駒井勇太, 小松祐輔, 人見百合子, 喜多洋嗣, 則武隆佑, 松田絵理菜 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 454-454, 2014.

---

	Examination of the proper use judging from a use of DPP-4 inhibitor situation investigation in our 28-P4PM-165 House 中埜梓1, 木村麻紀1, 林千麗1, 桝田出2, 吉村尋典1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-455, 2014.

---

	Discussion - from questionnaire results in understanding degree - diabetes education hospitalization about the medicine of the 28-P4PM-166 diabetes education inpatient 内山幸子1, 六車龍介1, 本多優江2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-455, 2014.

---

	About an association between dementia evaluation scale and medication compliance in patients with 28-P4PM-167 type 2 diabetes 岡田志保1, 林洋平1, 下川福子1, 清水裕行1, 谷口一成1, 池上英文1, 山本恒彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-455, 2014.

---

	Summary of a role and the action of the pharmacist in the medical care team in the prevention of 28-P4PM-168 diabetes-related medical accident 守谷顕人1, 原山拓也2, 山口美裕紀3, 村上由美4, 山西妙子5, 平田敦宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-455, 2014.

---

	Action for the at-home self-injection introduction addition acquisition by the 28-P4PM-169 pharmacist 石田詞子1,2, 小野達也1,2, 西田英之1, 徳山尚吾2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-455, 2014.

---

	Inflection - of action - diabetes conversation map R to the class for diabetics as the 28-P4PM-170 diabetes team pharmacist 宮永幸実1,2,3, 平岩知子1, 北里博仁2, 市川敬太3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-455, 2014.

---

	About an association between number of the prescription drugs and glycemic control of the hypoglycemic agent in patients with 28-P4PM-171 outpatient department type 2 diabetes 石川麻利絵1, 齊藤達郎1, 蛭田剛俊1, 川口良人2, 森田雅之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 456-456, 2014.

---

	Relation of the present situation and the pharmacist of the 28-P4PM-172 diabetes round 白石彩乃1,2, 戸倉由美子1, 志賀千恵子1, 草野仁美1, 山本舞1, 平岩あずさ1, 塚本由美子1, 小杉明日香1, 田中映美1, 吉田厚志1, 加藤大也2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 456-456, 2014.

---

	Appropriate choice of the simple self-blood sugar measuring instrument in patients with 28-P4PM-173 anemia 島祐子1, 辻晶子1, 林美由紀2, 山本優子2, 太田正之3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 456-456, 2014.

---

	Usefulness of the HbA1c screening using the simple measuring instrument to perform at 28-P4PM-174 drugstore 榊原明美1,2, 石黒雅江1, 三浦進也1, 鈴木匡2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 456-456, 2014.

---

	1 case of the medical treatment ward which came to have good glycemic control by the intervention of the 28-P4PM-175 ward pharmacist 中川貴史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 456-456, 2014.

---

	Example that we gave Everolimus for 28-P4PM-176 insulin production pancreas neuroendocrine tumor, and hypoglycemia improved 原敬一1, 山口崇2, 渡辺怜奈2, 龍野一郎2, 真坂亙1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 456-456, 2014.

---

	Elucidation of hyperoxide-producing increase by AGEs in the 28-P4PM-177 type 2 diabetes model rat femoral artery and the inhibitory effect mechanism with pravastatin 堀英生1,2, 永味千枝3, 菊池千草1,3, 竹内正義4, 松永民秀1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-457, 2014.

---

	An effect of the aspirin which gives it to the platelet agglutinating capacity of the 28-P4PM-178 diabetes rat and effect with the insulin sustained administration 早勢伸正1, 松井愛子1, 鹿野宏大1, 野坂貴文1, 寺本愛子3, 駒澤愛4, 加納誠一朗2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-457, 2014.

---

	28-P4PM-179 prevents a side effect in the physical assessment enforcement in being at home 岡本龍徳1,2,3, 武内幾夫2, 大井一弥3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-457, 2014.

---

	Physical assessment for patients with COPD wannabees excavation by the 28-P4PM-180 pharmacist 西尾廣昭1, 土谷大樹1, 小嶋英二朗1, 田中哲郎1, 数野博2, 孫尚孝3, 尾上洋3, 谷田恭洋3, 森広亜紀4, 山田真弘5, 岡田昌浩6, 横田武治7, 徳毛孝至8, 横田いつ子9, 荒川隆之10, 上敷領淳1, 杉原成美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-457, 2014.

---

	Action of the pharmacist for the Operation asthmatic death zero in 28-P4PM-181 Okayama 森英樹1,2,5, 監物英男2,5,6, 山根隆志2,3, 立野朋志5,7, 小笠原加代5,8, 小山敏章5,9, 赤澤昌樹5,10, 木村五郎11,12, 谷本安11,12, 宗田良11,12, 千堂年昭2,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-457, 2014.

---

	Action of the compliance improvement for patients with dementia by the 28-P4PM-182 visit drug control instruction 篠崎希望, 鐵尚美, 田口美菜子, 大和田有, 土居美幸, 濱武久美子, 蛭田千昭, 田村明広 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-457, 2014.

---

	Support to a healthcare worker, the patients who utilized 28-P4PM-183 "Shiga diabetes net" 佐々木恭子1, 磯野哲一郎1, 松田雅史1, 森田真也1, 森本明子2, 宮松直美2, 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 458-458, 2014.

---

	Usefulness of the blood pressure management at the drugstore with the 28-P4PM-184 home blood pressure remote management system (medical link) 松本千鶴1,2, 水野智博1, 鍋谷伸子2, 安田宜成3, 永松正1, 梅村紀匡2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 458-458, 2014.

---

Action (the third report) to home medical care support in 28-P4PM-185 treatment at home promotion Committee - Evaluation - of maintenance and the systems construction of the community medical care system information 青木悠1,2, 岩下誠2,3, 渕澤宏明2,3, 倉本泰志2,3, 大森健2,3, 林和枝2,3, 田中美和2,4, 小松良2,3, 竹内裕子5, 花岡幹郎3, 小松裕和6, 由井俊文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 458-458, 2014.

---

	It is (1) about the introduction of a 28-P4PM-186 cloud type electronic chart and the single dose prescription order ring - Present conditions and problems - of the home care patient visit drug control instruction in our House 福森和俊1, 越智麻友1, 猪田幸邦1, 小澤一夫1, 光根緑2, 築田恵2, 宮本美千代2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 458-458, 2014.

---

	Difference of the action situation to the treatment at home by the scale of the 28-P4PM-187 drugstore 秋山真里奈1, 前川史門1, 柏木宏仁1,2, 浅井秀星2, 加藤光史2, 知花聖尚2, 竹内正幸2, 合田和志1, 山下修司1, 林秀樹1, 杉山正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 458-458, 2014.

---

	Recognition investigation of the drugstore function for 28-P4PM-188 separation of pharmacy and clinic 池田未来1, 村杉紀明2, 冨山直樹1, 角本幹夫1, 岡野友信1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 458-458, 2014.

---

	An investigation and examination of the thing prospective by the at-home visit instruction of the 28-P4PM-189 pharmacist 森厚司1,3, 森智彩貴2, 浅見麻莉子1, 太田淳子1, 成瀧知佳1, 松本直美1, 丹羽良子1, 吉田和美1, 伊藤由美3, 山田隆博3, 澤田敏成3, 三枝勇夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2014.

---

	Investigation about prescription contents and the medication support of the house call patients whom 28-P4PM-190 Muscat drugstore performs meeting a demand of 福嶋寛子1, 小川壮寛1,2, 川上茂利1, 守安洋子1, 高見陽一郎2, 島田憲一2, 江川孝2, 高橋正志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2014.

---

	It is ... based on the Residual medicine investigation in the basic hospital in mountains out of examination ... of the factor which has an influence on 28-P4PM-191 medication ad here Lance and a questionnaire 山本直子1, 神庭隆1, 木戸脇久美1, 山口浩一2, 櫃田豊3, 大谷眞二4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2014.

---

	About the pharmaceutical products offer system medical for ergonomy, evolution - acute phase of the 28-P4PM-192 treatment at home - 串田一樹1,2,3, 白石丈也2, 前田桂吾3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2014.

---

	Usefulness of the PCA pump in the 28-P4PM-193 at-home palliative care 大久保純1, 池崎友明1, 森田真裕子1, 竹内都子1, 田辺公一2,3, 北澤英徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2014.

---

	The need of the common recognition of the patients and the caretaker for appropriate medical care to be provided in 28-P4PM-194 treatment at home 柏木宏仁, 浅井秀星, 今里啓二, 脇元一彰, 遠藤文人, 竹内正幸, 宮本洋行, 知花聖尚 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2014.

---

	Construction and practice of the clinical competence upbringing program of the pharmacist taking 28-P4PM-195 treatment at home 長嶺幸子1, 杉浦佳子1, 中村治正2, 百道敏久2, 太田光熙1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-460, 2014.

---

	Development of the medication deglutition adjuvant jelly kit for 28-P4PM-196 oral intake 三上大帆, 野崎雅男, 盛本修司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-460, 2014.

---

	Research 1 about the occurrence of adverse event situation judging from the main disease of the 28-P4PM-197 home care patient 青木友紀1, 恩田光子1, 藤井真吾1, 廣岡真理1, 生田貴広1, 倉橋絢子1, 宮村実沙紀1, 七海陽子2, 荒川行生1, 今井博久3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-460, 2014.

---

	Pay the attention to patients with research 2 - dementia about the occurrence of adverse event situation judging from the main disease of the 28-P4PM-198 home care patient; and ... 廣岡真理1, 恩田光子1, 藤井真吾1, 青木友紀1, 生田貴廣1, 倉橋絢子1, 宮村実沙紀1, 七海陽子2, 荒川行生1, 今井博久3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-460, 2014.

---

Pay the attention to research 3 - arthritis deformans about the occurrence of adverse event situation judging from the main disease of the 28-P4PM-199 home care patient, patients with rheumatoid arthritis; and ... 生田貴廣1, 恩田光子1, 藤井真吾1, 青木友紀1, 廣岡真理1, 倉橋絢子1, 宮村実沙紀1, 七海陽子2, 荒川行生1, 今井博久3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-460, 2014.

---

	Relation (the first report) of the hospital pharmacist to the 28-P4PM-200 HPN introduction patients 熱海幸恵, 尾崎昌大, 添田真司, 渡邊昌之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-460, 2014.

---

	The present conditions and problem of the action of the pharmacist for the 28-P4PM-201 treatment at home 前川史門1, 秋山真里奈1, 柏木宏仁1,2, 浅井秀星2, 加藤光史2, 知花聖尚2, 竹内正幸2, 合田和史1, 山下修司1, 林秀樹1, 杉山正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2014.

---

	The effect that participation of the conference before 28-P4PM-202 discharge gives for visit drug control instruction 柴田賢三, 宇野達也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2014.

---

	Than practice - ward pharmacist of the medicine for patients with 28-P4PM-203 dementia medicine cooperation which aimed at the stable home medical treatment ... 添田美季1, 木ノ下智康1, はじ丈一郎2, 伊藤一弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2014.

---

	Than practice ... support pharmacist at home of the medicine for patients with 28-P4PM-204 dementia medicine cooperation which aimed at the stable home medical treatment ... 木ノ下智康1, 添田美季1, はじ丈一郎2, 古田勝経3, 伊藤一弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2014.

---

	Than practice ... visit pharmacist at home of the medicine for patients with 28-P4PM-205 dementia medicine cooperation which aimed at the stable home medical treatment ... 櫨丈一郎1,2, 木ノ下智康2, 添田美季2, 伊藤一弘2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2014.

---

	Action ... to a hospital, the drug industry internship of the 28-P4PM-206 "campus Asia" core base support project report (the second report) - doctoral course graduate student 龍伸和1,2, 松原利行1, 新山雅夫1, 周徳軍1, 徐承姫1, 酒口弘光3, 高畑英信4, 今中常雄1, 細谷健一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2014.

---

	Action to 28-P4PM-207 participation type long-term business training 漆舘希, 若本瑞穂, 伊藤宏彰, 櫻井良平 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 462-462, 2014.

---

	Action to the pharmacy business training in our 28-P4PM-208 House 太田哲徳, 枦秀樹, 金森大祐, 宮原由香里, 青山幸枝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 462-462, 2014.

---

	Action for the business training enhancement in the hospital attached to the 28-P4PM-209 Mie University School of Medicine 河原佑樹, 池村健治, 村木優一, 岩本卓也, 奥田真弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 462-462, 2014.

---

	Result of the kidney disease medical therapy education in the 28-P4PM-210 pharmacy student hospital business training 吉沢純, 原直己, 大月沢雄, 松田俊之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 462-462, 2014.

---

	The construction of the foreign chemotherapy training program in the 28-P4PM-211 business training and the evaluation 舘知也1,2, 大澤友裕2, 田中和秀2, 安田昌宏2, 水井貴詞2, 棚橋純子3, 野口義紘1, 後藤千寿2, 寺町ひとみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 462-462, 2014.

---

	A trial of the palliative care education in the 28-P4PM-212 trainee and the effect (the second report) 飛鷹範明, 木村博史, 和田昌子, 井門敬子, 田中亮裕, 荒木博陽 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 462-462, 2014.

---

	A learning effect and stress of the business training in the 28-P4PM-213 Fukuoka University Chikushi Hospital 田中麻衣子1,2, 松尾宏一1,2, 後藤美和2, 山廣胤之2, 金子朋博2, 五十嵐保陽2, 神村英利1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 463-463, 2014.

---

	Change of the consciousness of the business trainee for the 28-P4PM-214 palliative care 藤本伸一郎, 伊藤武志, 藤原季美子, 古川諭, 木寺康裕, 川口明範, 淺野肇, 柳江正嗣, 野村守弘, 山添譲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 463-463, 2014.

---

	Attitude survey for the pharmacy school fourth grader about the ward training of the 28-P4PM-215 cancer domain 曽賀千智1,2, 江戸清人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 463-463, 2014.

---

	Analysis of the factors such as the education or training instruction system before training to give to an acquisition degree of the student of the 28-P4PM-216 business training 橋本久邦, 河村剛至, 有冨桂子, 中島孝則, 松田佳和, 木村正幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 463-463, 2014.

---

	Confirmation of the training result in the preparation, injection room training of the 28-P4PM-217 pharmacy school fifth grader and future problem 柳野紗智子, 小園幸輝, 渡辺和美, 長谷川哲也, 濱田真紀子, 池田貴之, 今川貴仁, 大谷隼斗, 尾栢有美, 馬渕匠, 越川一誠, 小杉隆祥, 西澤健司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 463-463, 2014.

---

	Present conditions investigation - SBO about the evaluation of achievement of the 28-P4PM-218 business training and relative - of the number of evaluations 千葉健史1, 松浦誠2, 前田智司3, 佐塚泰之2, 工藤賢三1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 463-463, 2014.

---

	Inspection ... by the questionary survey from 28-P4PM-219 2011 to summary and problem - student of the long-term business training in the 2013 Tsurumakionsen hospital 新枦義之, 福田詩織, 内海誠司, 樋島学 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 464-464, 2014.

---

	Questionary survey - for examination - staff of the usefulness of the hospital training team in our 28-P4PM-220 House 寺山和利, 若木麻由, 岡田侑子, 佐藤亜衣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 464-464, 2014.

---

	Study on usefulness of the homepage in the intelligence of the training for the 28-P4PM-221 business training 諏訪祥太郎1, 関根令奈1, 東千里2, 石塚和美2, 櫻井正太郎2, 湯本哲郎1,3, 稲葉健二郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 464-464, 2014.

---

	Usefulness of the antiMRSA medicine TDM pass in the 28-P4PM-222 drug monitoring training 鈴木仁志1, 上岡泰弘1, 野上佳奈子1, 土屋節夫1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 464-464, 2014.

---

	Diabetes education curriculum introduction and the effect on 28-P4PM-223 business trainee 長谷川裕矢, 奈良由里絵, 山田義明, 松本利恵, 野田孝夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 464-464, 2014.

---

	Relation (the second report) to the business training in the 28-P4PM-224 mental hospital 笠原真理1,6, 鶴谷勝実1,6, 白井博1,6, 佐藤芳惠2,6, 高橋満里3,6, 石動郁子4,6, 齊藤浩司5,6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 464-464, 2014.

---

	An action and evaluation of the field of emergency intensive care, disaster medical care in the 28-P4PM-225 pharmacy education business training 原直己1, 高梨愛1, 加瀬和也1, 座間味義人2, 金明俊1, 大月沢雄1, 石田明子1, 永嶋一貴1, 内田佳菜子1, 松田俊之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 465-465, 2014.

---

	Prior explanation for the 28-P4PM-226 effect-like business training 小林典子, 鈴木小夜, 青森達, 手塚叔人, 中村智徳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 465-465, 2014.

---

	Refinement of the lecture for the business trainee of the 28-P4PM-227 hospital pharmacist 齊藤康介1, 舘知也1, 江崎宏樹1, 臼井一将1, 加藤未紗1, 浅野祥子1, 横井貴文1, 野口義紘1, 後藤千寿2, 寺町ひとみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 465-465, 2014.

---

Investigation about the present conditions in the long-term business training at the hospital attached to the 28-P4PM-228 Kumamoto University School of Medicine and the resident teacher 成田勇樹1,2, 宮本晋治2, 城野博史2, 政賢悟2, 上田泰子2, 木永舞2, 野正孝子2, 片野田朋美2, 内田隆2, 齊藤綾子2, 橋口ゆみ2, 山下諒祐2, 門脇大介1, 齋藤秀之2, 平田純生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 465-465, 2014.

---

	Trial of the good use of to duties ward drug duties manual which 28-P4PM-229 new face pharmacist made and self-assessment check sheet 植田真理1, 和田佳世子1, 米田勇太1, 南野麻衣1, 田中待希1, 小川充恵1, 森本千穂1, 中谷成美1, 長谷圭悟1, 香川雅一2, 小枝伸行3, 山崎肇1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 465-465, 2014.

---

	The construction of the duties acquirement degree check list in the hospital pharmacy attached to the 28-P4PM-230 Mie University School of Medicine and the evaluation 村木優一, 岩本卓也, 奥田真弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 465-465, 2014.

---

	Construction of the education system for the early duties acquisition for the 28-P4PM-231 new face pharmacist 佐藤仁宣1, 押賀充則1, 駒井信子2, 本郷知世1, 平野光枝1, 伊藤博1, 山口正和3, 加藤一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 466-466, 2014.

---

	The new face training in our 28-P4PM-232 House, action third report of the lifetime education 須貝瑶子1, 坪谷綾子1, 加藤利康1, 土師日香里1, 松本浩1, 濱野公俊1, 坂下裕子1, 増原慶壮1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 466-466, 2014.

---

	Examination of the factor to affect ad here Lance by the simulated experience of the pharmacist of the 28-P4PM-233 diabetes medical therapy 藤田直希, 菊池千草, 松永民秀, 鈴木匡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 466-466, 2014.

---

	Practice and attitude survey of the clinical power improvement program of the 28-P4PM-234 pharmacist 金正興1, 川添潤1, 嶋村久美子1, 遠藤美緒2,3, 星茜1,3, 塩田一博1, 北原加奈之1,3, 増島絵里子4, 垂水庸子5, 峯村純子1, 村山純一郎1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 466-466, 2014.

---

	About the clinic of the pharmacist in the 28-P4PM-235 Hyogo Prefectural Awaji medical center 国東ゆかり, 岩根奈緒美, 青井直樹, 岡田悠加, 畑祥平, 嶋田友香, 辻本勉 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 466-466, 2014.

---

	Experience the 28-P4PM-236 Thomas Jefferson University paramedics training 宮原由香里, 青山幸枝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 466-466, 2014.

---

	Action ... experience type learning 2014 ... of the 28-P4PM-237 Saitama hospital pharmacist society area training sectional meeting west block 渡邉絵美1,6, 安野伸浩1,6, 新井成俊2,6, 鍵山智樹3,6, 黒下龍二4,6, 古高裕子5,6, 井澤正義6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 467-467, 2014.

---

	Action aiming at 28-P4PM-238 inhalational instruction unification 今岡寛美, 井上博之, 榎本美幸, 飯野倫子, 池原茉理, 石原美加 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 467-467, 2014.

---

	The effect that a palliative care study session in the 28-P4PM-239 pharmacy gives to the knowledge equalization of the pharmacist 佐藤亮, 岡本明大, 濱口直美, 赤阪未来, 須藤宏文, 水谷栄梨, 宮本明希, 岩本卓也, 村木優一, 奥田真弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 467-467, 2014.

---

	Action of medicine-based universities, graduate schools for the 28-P4PM-240 cancer professional training of the whole country 青森達1, 望月眞弓2, 中村智徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 467-467, 2014.

---

	27-P5-IN001 The Effect of Patient's Satisfaction with Medication Counseling throughout Administration on Medication Compliance and Reporting Side effects Kim Soyoung, Im Taehwan, Choi In Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 471-471, 2014.

---

	27-P5-IN002 Evaluation of Antimicrobial Use in Chemotherapy - induced Febrile Neutropenia SeolHee Jeon, HyunJung Choi, SoHyun Lee, YoungMi Kim Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 471-471, 2014.

---

	27-P5-IN003 Evaluation of Delirium Management and Assessment Team in Surgical Patients Kiminaka Murakawa1,2, Yoshihisa Kitamura1,3, Saori Watanabe3, Shiho Hongo3, Shinitirou Inoue2, Kazuaki Shinomiya3, Toshiaki Sendo1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 471-471, 2014.

---

	27-P5-IN004 Toxicology of Photoinitiators Found in Intravenous Injection Solution Yoichi Kawasaki1, Chiaki Tuboi2, Noriko Kuhara2, Miwa Morizane2, Mariko Takai2, Kenta Yagi2, Satoru Esumi1, Yoshihisa Kitamura1,2, Toshiaki Sendo1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 472-472, 2014.

---

27-P5-IN005 Assessment of Pharmaceutical Intervention by Ward Pharmacists for Inpatients' Drug Therapy Ko-ichi Ohtaki1,2, Toshio Awaya1, Tomomi Tanikawa1, Shinya Iida1, Chieko Hara1, Yasunori Yamashita1, Takashi Ono1, Masatomo Inoue1, Norihisa Kimura1, Katsutoshi Tahara1, Tomoka Asashita1, Ko-ichi Yoshida1, Kaori Yamamoto1, Kuniko Yamamoto1, Satoshi Ogawa1, Masahide Fukudo1, Kazuo Matsubara3, Yoshikazu Tasaki1, Kaori Yamamoto1, Kuniko Yamamoto1, Satoshi Ogawa1, Masahide Fukudo1, Kazuo Matsubara3, Yoshikazu Tasaki1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 472-472, 2014.

---

	27-P5-IN006 Drug tracebility system using IC tags in hospitals - Construction of a trace model system through effective application of electronic tags - Takao Orii1, Chikayuki Ochiai2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 472-472, 2014.

---

27-P5-IN007 International Exchange Committee activities report 2013 - 2014 in The Japanese Society of Hospital Pharmacists Takao Orii, Yasuo Takeda, Hiroko Ota, Hitoshi Sasaki, Naomi Sogabe, Hiromitsu Takahashi, Yoshikazu Tasaki, Makoto Hayakari, Satohiro Masuda, Keishiro Izumi, Kazuo Matsubara, Toshiaki Yasuoka, Mitsukazu Kitada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 473-473, 2014.

---

	27-P5-IN008 Tacrolimus medication management for patients with nephrotic syndrome by clinical pharmacists Bing Shao, Gaofeng Liu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 473-473, 2014.

---

	27-P5-IN009 Association between methylenetetrahydrofolate reductase polymorphisms and the relapse of acute lymphoblastic leukemia : a meta-analysis Jun Lu, Hai-Rong He, Mao-Yi Wang, Ya-Lin Dong Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 473-473, 2014.

---

	27-P5-IN010 Chemical Profile- and Pharmacokinetics - Based Investigation of the Synergistic Property of Platycodonis Radix in Traditional Chinese Medicine Formula Shengxian Decoction Feng Zhang, Qin Zhan, Wan-Sheng Chen Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 474-474, 2014.

---

	27-P5-IN011 Exploration and Experience of Training Pediatric Clinical Pharmacist Liu Ying Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 474-474, 2014.

---

	27-P5-IN012 A Survey of Off - label Drug Use Prescriptions in Pediatrics Outpatient in Peking University People's Hospital Li Ying, Huang Lin Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 474-474, 2014.

---

	27-P5-IN013 Building a model of Objective Structured Clinical Examination in a Medical Center in Taiwan. Mei-Chu Huang1,2, Jui-Ling Fu1, Yow-Wen Hsieh1, Hui-Yun Chang2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 475-475, 2014.

---

	27-P5-IN014 Analysis of Off-label Drug Use in Hospitalized Children in Department of Endocrinology in Our Hospital Meng Yao Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 475-475, 2014.

---

	27-P5-IN015 Rapid and Sensitive LC-MS/MS Method for the Analysis of Paclitaxel, Docetaxel, Vinblastine and Vinorelbine in Human Plasma Shouhong Gao, Jingya Zhou, Wansheng Chen Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 475-475, 2014.

---

	27-P5-IN016 Utilization of National Essential Drugs in Community Medical Institutions of Beijing Si Yanbin, Zhao Zhigang Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 476-476, 2014.

---

	27-P5-IN017 A simple and accurate method for voriconazole concentration determination in human plasma with UHPLC-MS/MS Wang Jing-jing, Zhou Qiong, Yao Qin, Huang Hua, Zheng Qiao-ling, Zhang Jun Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 476-476, 2014.

---

	27-P5-IN018 Inhibition of Atorvastatin on the catalytic activity of human UDP-glucuronosyltransferases Wu Yuan, Dong Rui-hua, Liu Ze-yuan Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 476-476, 2014.

---

	27-P5-IN019 Analysis of 88423 Prescriptions from Outpatient and Emergency Departments in My Hospital Yan Han, LI Chao Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 477-477, 2014.

---

	27-P5-IN020 Determination of Oseltamivir and Oseltamivir Carboxylate in Placental Perfusate by HPLC-MS/MS Yao Qin, Huang Hua, Zheng Qiao-ling, Wang Jing-jing, Zhang Jun Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 477-477, 2014.

---

	Pharmacoepidemiologic research design and example 赤沢学 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 481-481, 2014.

---

	28-C-SS-1 oral anticancer medicine and ad here Lance 安藤雄一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 483-483, 2014.

---

	Examination ... of the pharmacist outpatient department usefulness in the treatment with practice ... oral molecules target medicine for team approach in medical care of the collection of 28-C-SS-2 study 四十物由香 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 484-484, 2014.

---

	Example - in multidirectional action - public general hospital by the pharmacist specialized in a cancer in the 28-C-SS-3 cancer medical therapy 木村美智男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 484-484, 2014.

---

	The medicine medicine cooperation that utilized 28-C-SS-4 area unification type medicine notebook "society Tsu medicine notebook" 木本真司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 485-485, 2014.

---

	For the quarter of century of progress of the clinical pharmacy and future - next - 安原眞人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2-2, 2015.

---

	The progress of 1 drug administration technique and future medical care 橋田充 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 3-3, 2015.

---

	For display of the true value of 2 pharmacists 森和彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 4-4, 2015.

---

	The thing which is bought by medical care and us from 3 of this 福井次矢 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 5-5, 2015.

---

	We press a mystery of 4 automatic fuzzy 水島昇 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 6-6, 2015.

---

	5 Standards for Clinical Pharmacy Practice Wafa Y.Dahdal Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 7-7, 2015.

---

	We think about the way of 6 medical care in economics 井伊雅子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 8-8, 2015.

---

	Study aiming at a scientific base of the TDM and clinical application expansion 谷川原祐介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 9-9, 2015.

---

	Optimization support and the side effect management of the medical treatment that assumed clinical Pharmacometrics a base 猪川和朗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 10-10, 2015.

---

	Study on disease and side effect that paid their attention to a role of MCT 小林正紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 11-11, 2015.

---

	Qualitative improvement of the cancer medical therapy by discovery, an evaluation, the prophylaxis of the side effect having low recognition of the medical person 菅幸生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 12-12, 2015.

---

	Drug interactions analysis of the antiepileptic drug for patients with refractory epilepsy 山本吉章 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 13-13, 2015.

---

	Study on intervention effect of the pharmacist to the medical therapy in the intensive care unit 今浦将治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 14-14, 2015.

---

	Study of the clinical pharmacy for the chemotherapy support to patients with blood-forming organ tumor 宇佐美英績 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 15-15, 2015.

---

	The coinhibition of EGFR/Met/VEGFR2 overcomes EGFR-TKI tolerance by the HGF of the EGFR mutation lung cancer 中出順也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 16-16, 2015.

---

	Study on contribution of multidrug resistance-associated protein (MRP) in the extracellular release process of Eicosanoid 古堅彩子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 17-17, 2015.

---

	About suggestion of the aggressive medical therapy from a pharmacist in pressure sore treatment and the usefulness 溝神文博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 18-18, 2015.

---

	About the future of the pharmacy education which saw from innovative drug development person upbringing education face chirognomy - of - medicine 大高章 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 19-19, 2015.

---

	Pharmacy education plan supporting producing of "name pharmacist" 賀川義之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 20-20, 2015.

---

	As need - pharmacy education leader of the integrated education in the pharmacy education from the situation of the patients - 北河修治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 20-20, 2015.

---

	The past, the present, the future of the pharmacy education in Kitasato University 伊藤智夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 21-21, 2015.

---

	23-1-SP-1 The future that the pharmacist working in the medical field draws : What pharmacists should do in cancer treatment 川上和宜 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 25-25, 2015.

---

	How should there be the development of the field of pharmacy from 23-1-SP-2 this; through the activity in ... area? 手嶋無限1),2),3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 25-25, 2015.

---

	Construction of the new evidence by 23-1-SP-3 Pharmacist scientist 松元一明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 26-26, 2015.

---

	Systems construction and personnel training ... for support - pharmaceutical products proper use, Ikuyaku promotion by the academia to 23-1-SP-4 community medical care, care, health care 堀里子1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 26-26, 2015.

---

	Contribution and expectation to the low invasive medical treatment, preparation development of the 23-1-SP-5 drug, nucleic acid service technology 高島由季 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 27-27, 2015.

---

	The recent topic about the pharmacist of 23-1-SP-6 drugstore and the medical institution and future expectation 安川孝志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 27-27, 2015.

---

	21-10-IS-1 Advancing Direct Patient Care (DPC) Through Postgraduate Pharmacy Residency/Fellowship Program Suphat Subongkot Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 29-29, 2015.

---

	21-10-IS-2 Characteristic Factors and Prescription Patterns that Affect Regimen Complexity in Parkinson Patients, Using Medication Regimen Complexity Index (MRCI) Score Tool Jae Eun Han, Hyo Sim Back, Yung Hee Lee Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 29-29, 2015.

---

	21-10-IS-3 The development of evidence-based medicine research capabilities Suodi Zhai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 30-30, 2015.

---

	21-10-IS-4 Current status and future progress of pharmaceutical care and sciences in Japan Hisakazu Ohtani Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 30-30, 2015.

---

	The general remarks of 21-2-S1-1 diabetic nephropathy 田中元子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 32-32, 2015.

---

	Pharmaceutical management of patients with 21-2-S1-2 early diabetic nephropathy 西村博之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 32-32, 2015.

---

	We think about the usage of the oral diabetes therapeutic drug which is effective for patients with 21-2-S1-3 diabetic nephropathy, and is safe 柴田啓智1),2), 田上治美1), 丸山徹2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 33-33, 2015.

---

	How to use insulin to patients with 21-2-S1-4 diabetic nephropathy 堀井剛史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 33-33, 2015.

---

	How to use diabetes therapeutic drug to 21-2-S1-5 patients on dialysis 平田純生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 34-34, 2015.

---

	The present conditions and the latest information of the 21-2-S2-1 anti doping 浅川伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 36-36, 2015.

---

	It is ... from the situation of role ... university teacher of the pharmacist in the 21-2-S2-2 anti doped region 鳴海克哉 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 36-36, 2015.

---

	21-2-S2-3 pharmacy student and sports pharmacy 佐塚泰之, 杉山育美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 37-37, 2015.

---

	About information dispatch for 21-2-S2-4 pharmaceutical products proper use 鳥井真由美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 37-37, 2015.

---

	It is ... from the situation of the pharmacist belonging to appropriate medical treatment in the 21-2-S2-5 sports domain and role - competition group of pharmacists (Japan Table Tennis Association, International Ping-Pong Federation) 岡田拓朗1), 松尾史朗2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 38-38, 2015.

---

	An anti doping activity and future pharmacist image to send from the 21-2-S2-6 Iwate pharmacist society 本田昭二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 38-38, 2015.

---

	About the precaution of the study for people from 21-2-S3-1 有吉範高 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 40-40, 2015.

---

	About benefit reciprocity (COI) at the 21-2-S3-2 article contribution 濱敏弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 40-40, 2015.

---

	Let's post it on 21-2-S3-3 official journal of a scientific society "clinical pharmacy" 山田清文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 41-41, 2015.

---

	Do you not post it on 21-2-S3-4 English sentence magazine JPHCS? 寺田智祐 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 41-41, 2015.

---

	Efforts for the 21-2-S3-5 first article contribution 肥田裕丈1), 毛利彰宏2), 野田幸裕1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 42-42, 2015.

---

	It is a contribution to becoming it and JPHCS English of 21-2-S3-6 results of research 鍛治園誠, 北村佳久, 千堂年昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 42-42, 2015.

---

	The need of the risk and safety measures of the 21-3-S4-1 anticancer medicine exposure 中山季昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 44-44, 2015.

---

	Because the 21-3-S4-2 anticancer medicine exposure measures think about the whole - environment carried out by a team, and an effect is higher 櫻井美由紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 44-44, 2015.

---

	"The present conditions of exposure measures" judging from the questionnaire for the 21-3-S4-3 anticancer agent exposure measures council pharmacist 小林由佳1),2),3), 中西弘和1),3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 45-45, 2015.

---

	A fact and problem of exposure measures of the nurse in the 21-3-S4-4 cancer medical therapy 飯野京子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 45-45, 2015.

---

	With the exposure measures to recommend in 21-3-S4-5 guidelines? (from the situation of the pharmacist) 野村久祥1), 森田智子1), 日浦寿美子2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 46-46, 2015.

---

	With the exposure measures to recommend in 21-3-S4-6 guidelines? (from the situation of the nurse) 平井和恵 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 46-46, 2015.

---

	Because 21-3-S4-7 anticancer medicine exposure measures "utilize joint guidelines" 杉浦伸一1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 47-47, 2015.

---

	We think about the medical future from the public hospital for a chronic phase for 21-3-S5-1 acute phase 小枝伸行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 49-49, 2015.

---

	The nourishment management of 21-3-S5-2 elderly people and adequacy of the medical treatment 大井一弥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 49-49, 2015.

---

	Polypharmacy measures in the 21-3-S5-3 chronic phase medical care 小田慎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 50-50, 2015.

---

	Outcome of the ward drug duties in the 21-3-S5-4 medical treatment ward 棗則明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 50-50, 2015.

---

	Relation of 21-3-S5-5 end of life care and the pharmacist 久保川直美1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 51-51, 2015.

---

	The present of the pharmacist system specialized in 21-3-S6-1 medical therapy 河原昌美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 53-53, 2015.

---

	Training guidelines for the pharmacist training specialized in 21-3-S6-2 medical therapy and intensive lecture 百瀬泰行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 53-53, 2015.

---

	Three viewpoints (infection domain) not to overlook 21-3-S6-3 problems 吉田優子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 54-54, 2015.

---

	For qualitative improvement of the 21-3-S6-4 medical therapy (surgical domain) 山崎美保 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 54-54, 2015.

---

	Point (blood domain) of the mention improvement of the 21-3-S6-5 case summary 鈴木貴明, 石井伊都子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 55-55, 2015.

---

	Expect it of a pharmacist specialized in 21-3-S6-6 medical therapy 松原和夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 55-55, 2015.

---

	The present conditions of the physical assessment education in the 21-9-S7-1 University 大鳥徹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 57-57, 2015.

---

	Development of the virtual physical assessment learning teaching materials for 21-9-S7-2 pharmacy student, pharmacists 徳永仁, 高村徳人, 緒方賢次, 瀬戸口奈央, 佐藤圭創 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 57-57, 2015.

---

	Skill physical assessment to raise a 21-9-S7-3 hospital pharmacist power 大林恭子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 58-58, 2015.

---

	Prescription suggestion utilized the physical assessment to practice in cottage-hospital out of 21-9-S7-4 川崎美紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 58-58, 2015.

---

	Revolution chain ... which a series of 21-9-S7-5 miracles was necessity or chance or ... physical assessment, and occurred 坂井美千子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 59-59, 2015.

---

	What is the purpose of the physical assessment of the 21-9-S7-6 pharmacist? 狭間研至1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 59-59, 2015.

---

	With the next step on the basis of the physical assessment that you should work on in the whole 21-9-S7-7 pharmacy 高村徳人, 徳永仁, 緒方賢次, 瀬戸口奈央 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 60-60, 2015.

---

	Significance to describe test value in ... prescription by team approach in medical care to 21-9-S8-1 outpatient 松原和夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 62-62, 2015.

---

	The efforts which utilizes the clinical test value that we attached to outside Parliament prescription in 21-9-S8-2 Fukui 矢野七恵 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 62-62, 2015.

---

	Inflection of "clinical test value" that we thought about pharmaceutical products proper use in the 21-9-S8-3 health insurance pharmacy 松尾陽介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 63-63, 2015.

---

	The medicine medicine cooperation that utilized FAX for proper use of the 21-9-S8-4 oral anticancer medicine 黒岩勇人, 眞継賢一, 上田綾佳, 倉橋基尚, 濱口良彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 63-63, 2015.

---

	Inflection of "outside Parliament prescription" improving precision of the 21-9-S8-5 pharmaceutical products proper use 松田雅史, 炭昌樹, 田淵陽平, 佐々木恭子, 星野伸夫, 森田真也, 寺田智祐 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 64-64, 2015.

---

	We think about validity of the prescription by utilizing 21-9-S8-6 clinical test value 三宅健文, 日置透子, 國枝亜矢香, 塩見紗和子, 東野公亮, 辻芙美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 64-64, 2015.

---

	Sedation, sedative management in the 21-9-S9-1 intensive care 前田幹広 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 66-66, 2015.

---

	Efforts to 21-9-S9-2 postoperative pain management 宮坂善之1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 66-66, 2015.

---

	Sedative sedation in 21-9-S9-3 cancer treatment, the mild medical domain 岸田悦子1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 67-67, 2015.

---

	Sedative management judging from 21-9-S9-4 psychiatry medical therapy 中村友喜 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 67-67, 2015.

---

	It is ... from the situation of efforts - nurse of the sedative sedative management in the 21-9-S9-5 childhood cancer domain 木須彩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 68-68, 2015.

---

	The business training in the pharmacy education model core curriculum that 21-10-S10-1 is new: Purpose explanation 野田幸裕 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 70-70, 2015.

---

	Aim of guidelines about the 21-10-S10-2 pharmacy business training 前島一実 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 70-70, 2015.

---

	For promotion of the business training along guidelines about the 21-10-S10-3 pharmacy business training 鈴木匡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 71-71, 2015.

---

	Efforts of the adjustment mechanism for the business training based on the 21-10-S10-4 new model core curriculum 伊東明彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 71-71, 2015.

---

	About realization of the cooperation to be able to put of guidelines about the pharmacy business training at the 21-10-S10-5 drugstore 山田純一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 72-72, 2015.

---

	For realization of the new pharmacy business training in the 21-10-S10-6 Hospital 石井伊都子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 72-72, 2015.

---

	21-10-S11-1 HIV infection to the times of the comprehensive medical care 青木眞 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 74-74, 2015.

---

	Thing to buy to HIV infection practice and the pharmacist whom the 21-10-S11-2 primary physician thinks about 赤石雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 74-74, 2015.

---

	From the situation of pharmaceutical care - hospital pharmacist as the generalist for patients with 21-10-S11-3 HIV infection 國本雄介, 宮本篤 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 75-75, 2015.

---

	It is ... from the situation of pharmaceutical care - drugstore pharmacist as the generalist for patients with 21-10-S11-4 HIV infection 田橋美佳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 75-75, 2015.

---

	A viewpoint and skill necessary for intervention to 21-11-S12-1 infection practice 高倉俊二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 77-77, 2015.

---

	We evaluate the condition of a patient and the renal function of the 21-11-S12-2 CKD patients and think about validity of the antimicrobial proper use 田中麻衣子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 77-77, 2015.

---

	The individual administration plan based on the 21-11-S12-3 antimicrobial standard administration method and the evaluation 小川暁生1),2), 淵上尚彦1),2), 遠藤正憲1),2), 谷田仁司2), 近澤秀己2), 林沼聖子2), 白井直美2), 津田智樹2), 近江弘一郎2), 吉田忍2), 辻本雅之3), 西口工司3), 塚本有子1),2), 高橋良一2), 宮下浩明2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 78-78, 2015.

---

	Approach to the candidemia that there is simply because it is 21-11-S12-4 pharmacist 眞継賢一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 78-78, 2015.

---

	Approach to the bacteremia case that resulted in acute renal failure during 21-11-S12-5 cancer chemotherapy 上田覚 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 79-79, 2015.

---

	Case ... of sepsis in patients with precaution - CKD which is "feeling" in the 21-11-S12-6 antibacterial chemotherapy "kidney" 門村将太 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 79-79, 2015.

---

	Infection measures in 21-11-S13-1 medical treatment bed and the elderly people institution 足岡秀樹1),2), 石倉優子1),2), 柳原美夏2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 81-81, 2015.

---

	21-11-S13-2 I will not give up at the psychiatric hospital! Infection control: What a pharmacist can do to advance one step ahead 別所千枝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 81-81, 2015.

---

	Efforts of infection measures in the 21-11-S13-3 health insurance pharmacy 大久保耕嗣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 82-82, 2015.

---

	Relation of infection measures and the pharmacist by the 21-11-S13-4 treatment at home 本田泰斗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 82-82, 2015.

---

	Infection management in the 21-11-S13-5 old age assistance institution 辻明良 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 83-83, 2015.

---

	From the viewpoint of the specialty physician of the antibiotic exposure for the 21-11-S14-1 infection of childhood 宮入烈 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 85-85, 2015.

---

	21-11-S14-2 Infantile infection Be careful with hospitalization care From a pharmacist's point of view 諏訪淳一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 85-85, 2015.

---

	Human pharmacology of the 21-11-S14-3 cold medicine 田中敏博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 86-86, 2015.

---

	21-11-S14-4 Infantile infection Be careful with outpatient treatment From a pharmacist's point of view 木村誠 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 86-86, 2015.

---

	The latest information of the 21-12-S15-1 health medical care welfare information system industry society 池田和之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 88-88, 2015.

---

	Point to keep in mind when we use 21-12-S15-2 good use master 岡橋孝待 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 88-88, 2015.

---

	Efforts based on figure "which should have" prescription mention for the purpose of the 21-12-S15-3 big data utilization 柴崎淳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 89-89, 2015.

---

	Optimization of the injection prescription mention contents in the changes from a 21-12-S15-4 clinical record to an electronic chart 岸本真 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 89-89, 2015.

---

	Problem of the quantity of one time of 21-12-S15-5 electronic chart prescription 木下元一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 90-90, 2015.

---

	Shifts from 21-12-S15-6 electronic chart daily dose prescription input to once quantity prescription input 野村浩子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 90-90, 2015.

---

	Trend of computerization and the standardization of the 21-12-S15-7 prescription 土屋文人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 91-91, 2015.

---

	Significance of the present conditions of the psychiatric practice of 21-12-S16-1 Japan and the out reach 伊藤弘人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 93-93, 2015.

---

	The present conditions and problem of the 21-12-S16-2 Chiba Univ. psychiatry temporary nursing at home 森内加奈恵 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 93-93, 2015.

---

	Way - of the cooperation with setup - hospital of the out reach of the 21-12-S16-3 mental hospital pharmacist and other organizations 加藤剛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 94-94, 2015.

---

	Practice report of the out reach by the 21-12-S16-4 psychiatry pharmacist 佐合絵里 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 94-94, 2015.

---

	The present conditions and problem of the medical treatment for 21-12-S17-1 dementia 朝田隆 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 96-96, 2015.

---

	The family wants information patients with 21-12-S17-2 dementia; is result ... of ... pharmacist outpatient department 渡邉ゆきの Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 96-96, 2015.

---

	How do you see through 21-12-S17-3 drug-related delirium? 橋本保彦1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 97-97, 2015.

---

	Efforts to medical treatment for 21-12-S17-4 BPSD 鈴木弘道 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 97-97, 2015.

---

	About the duties of the pharmacist in the 22-2-S18-1 perioperative care team 落合亮一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 99-99, 2015.

---

	We think about a strategic theme from the national fact-finding results about patients and pharmacist duties in the operating room for the 22-2-S18-2 perioperative period 舟越亮寛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 99-99, 2015.

---

	Drug duties to join change, a discharge together before 22-2-S18-3 hospitalization for the perioperative period 橋田亨 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 100-100, 2015.

---

	22-2-S18-4 The needs of the perioperative management team and what to do as a pharmacist : The progress and future of our hospital surgeons 阿部猛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 100-100, 2015.

---

	Significance - of the making of system and the pharmacist intervention of post-operative pain management - Acute Pain Service carried out by 22-2-S18-5 team 長谷川哲也1), 寺田享志2), 大岩彩乃2), 結束さやか2), 落合亮一2), 池田貴之1), 馬渕匠1), 花井雄貴1), 疋田真理1), 小杉隆祥1), 西澤健司1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 101-101, 2015.

---

	How do you obtain up to date - information of the 22-2-S19-1 first aid intensive care? 織田順 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 103-103, 2015.

---

	22-2-S19-2 Let's learn from case Infusion control of shock 添田博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 103-103, 2015.

---

	22-2-S19-3 Learn from case : Management of sepsis 今浦将治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 104-104, 2015.

---

	Expectation to importance and a pharmacist of the many types of job cooperation in the 22-2-S20-1 intensive care domain 氏家良人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 106-106, 2015.

---

	We think about many types of job cooperation for palliative care promotion in the 22-2-S20-2 circulatory organ intensive care 立野淳子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 106-106, 2015.

---

	Role of the pharmacist in the intensive care unit of the 22-2-S20-3 area core hospital 中薗健一, 横山美恵子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 107-107, 2015.

---

	Than a viewpoint of 22-2-S20-4 medical care security and the management of the quality the intervention of the pharmacist in the intensive care unit 堀川幸子, 田上治美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 107-107, 2015.

---

	Crosstalk of many types of job cooperation and the specialty in the 22-2-S20-5 intensive care domain 中馬真幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 108-108, 2015.

---

	Knowledge of the genome pharmacology necessary for 22-3-S21-1 pharmacist 平井みどり Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 110-110, 2015.

---

	Individual difference and genetic information in main effect and the side effect of the 22-3-S21-2 medicine 石川和宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 110-110, 2015.

---

	Examination for SNP of the drug reply gene using the 22-3-S21-3 nucleic acid black mark 山下裕樹, 小郷和彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 111-111, 2015.

---

	The dose adjustment of CPT-11 by the 22-3-S21-4 UGT1A1 genetic polymorphism is useful; or attempt - by the pancreatic cancer FOLFIRINOX therapy of - our hospital 小林美沙樹1), 篠原旭1), 入澤愛1), 梅本久美子2), 高橋秀明2), 池田公史2), 齊藤真一郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 111-111, 2015.

---

	Practice example - in search study - urology department of the side effect genome marker aiming at application and the cooperation to 22-3-S21-5 ward drug duties 山本和宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 112-112, 2015.

---

	Example - of genome marker search - serious case drug eruption for the onset evasion of the serious side effect in the 22-3-S21-6 Japanese and the rhabdomyolysis 佐井君江, 中村亮介, 斎藤嘉朗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 112-112, 2015.

---

	From the results of the student questionnaire about the 22-3-S22-1 business training 高橋秀依 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 114-114, 2015.

---

	Mediation education (from the situation of the organic chemistry) of a 22-3-S22-2 basics pharmacy and the clinical pharmacy 宮田興子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 114-114, 2015.

---

	Is it a chemical structural formula in the settings of 22-3-S22-3 formulations? ? 柴田奈央1), 浅井考介2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 115-115, 2015.

---

	The pharmacy basic knowledge that is made use of in treatment with 22-3-S22-4 molecules target anticancer medicine 石川和宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 115-115, 2015.

---

	The present conditions and problem of the 22-3-S22-5 Hospital training 石井伊都子, 大久保正人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 116-116, 2015.

---

	Efforts ... of the pharmacist specialized in prophylaxis - Shizuoka of the dermatopathy with the 22-3-S23-1 anticancer medicine Prefectural Shizuoka cancer center cancer 石川寛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 118-118, 2015.

---

	Participation in planning of the medical treatment from 22-3-S23-2 pressure sore treatment to the skin domain that developed 森川拓 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 118-118, 2015.

---

	Basic information and clinical application to help 22-3-S23-3 drug for external use proper use 松元一明, 木津純子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 119-119, 2015.

---

	Dermatopathy and the prevention with the patch which 22-3-S23-4 dry skin expression brings 大井一弥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 119-119, 2015.

---

	You read, and how do you solve 22-9-S24-1 "case?" Thought process ... which leads to the patients care that fixed its eyes on ... treatment GOAL 蔵田靖子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 121-121, 2015.

---

	How to get along understanding and Systematic review ... of ... GRADE system knowing 22-9-S24-2 Systematic review 五十嵐俊 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 121-121, 2015.

---

	With the practice guidelines that 22-9-S24-3 is reliable? ... thing that we want to know to use it 南郷栄秀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 122-122, 2015.

---

In 22-9-S24-4 settings, how do you make use in patients care? Does problem - pharmacist of the patients with ... practice care whom we saw from circulation utilize the practice that how about practice guidelines and a systematic review? ... ... which finds it, and examines it closely, and acts 伊藤武志, 山添譲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 122-122, 2015.

---

	The present conditions and the problem that a pharmacist of the cottage-hospital out of 22-9-S25-1 saw in foreign cancer chemotherapy patients's house in the medical care in remote area 岸本真 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 124-124, 2015.

---

	It is a problem of the cottage-hospital in the need of the at-home team approach in medical care in the 22-9-S25-2 cranial nerve disease domain 荒川隆之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 124-124, 2015.

---

	... which thinks about a breakthrough of the intervention from pharmaceutical management ... case to reduce rehospitalization of the 22-9-S25-3 elderly people heart failure 高井靖 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 125-125, 2015.

---

	Because it is at home a required pharmacist 22-9-S25-4; is ... based on an activity as of ... 中村薫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 125-125, 2015.

---

	Pharmacist ... which we saw from 22-9-S25-5 user-oriented pharmacist - user 黒沢愼五 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 126-126, 2015.

---

	Let's jump out of the drugstore which an area buys in 22-9-S25-6 now! 加賀田茂子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 126-126, 2015.

---

	Wish as mother of the 22-10-S26-1 children patient 横幕真紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 128-128, 2015.

---

	Dosage form of the 22-10-S26-2 pediatrics domain and present conditions - of medication support - clinical practice and the development 石川洋一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 128-128, 2015.

---

	Research of the 22-10-S26-3 orally disintegrating tablet 倉田なおみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 129-129, 2015.

---

	Dosage form design for patients with 22-10-S26-4 difficulty in swallowing and dementia with the adherence 原田努 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 129-129, 2015.

---

	Proper use of the hospital preparation to the 22-10-S26-5 condition of a patient 大谷道輝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 130-130, 2015.

---

	Globalization of the 22-10-S26-6 dosage form and the medication support that is asked for 内田享弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 130-130, 2015.

---

	How are you concerned with an NOAC administration case as 22-10-S27-1 pharmacist? 芦川直也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 132-132, 2015.

---

	Role of 22-10-S27-2 warfarin introduction nomogram and the pharmacist 五十嵐正博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 132-132, 2015.

---

	Safe securing of 22-10-S27-3 antiarrhythmic drug by the therapeutic drug monitoring (TDM) in consideration of an internal change 松尾和廣1), 小杉隆祥2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 133-133, 2015.

---

	Pharmaceutical approach to an atrial fibrillation case in the 22-10-S27-4 first aid intensive care domain 今井徹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 133-133, 2015.

---

	How is a pharmacist concerned with an atrial fibrillation case in 22-10-S27-5 regular hospital? 細田宏美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 134-134, 2015.

---

	Pharmaceutical approach for the proarrhythmic effect with the 22-10-S27-6 antiarrhythmic drug 高井靖 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 134-134, 2015.

---

	Hospital preparation duties in the hospital attached to the 22-10-S28-1 Nagoya University faculty of medicine 宮崎雅之, 山田清文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 136-136, 2015.

---

	The hospital preparation which supports the medical therapy of the 22-10-S28-2 pediatrics domain 石川洋一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 136-136, 2015.

---

	It is ... based on preparation management of hospital preparation - our hospital supporting the 22-10-S28-3 patients 篠原章能 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 137-137, 2015.

---

	Evidence-Based Hospital Formulation (EBHF) to send it to from the 22-10-S28-4 University 河野弥生, 花輪剛久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 137-137, 2015.

---

	Clinical basic pharmacy-like study approach - by explanation - pharmacist of the 22-11-S29-1 symposium purpose 松尾宏一1), 林稔展2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 139-139, 2015.

---

	Study on anaphylactic prediction approach with the 22-11-S29-2 anticancer medicine 岩本卓也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 139-139, 2015.

---

	Approach - from cognitive function with the 22-11-S29-3 anticancer agent administration and mentation change - fundamental researches 北村佳久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 140-140, 2015.

---

	Practice - of clinical studies by the cooperation with risk factor analysis - pharmacy of the adverse effect expression that utilized 22-11-S29-4 genetic polymorphism information 辻大樹1), 塩川満2), 鈴木賢一3), 伊藤邦彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 140-140, 2015.

---

	Search of the therapeutic drug for stomatitis induced by 22-11-S29-5 cancer chemotherapy, radiotherapy 渡邉真一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 141-141, 2015.

---

	Summary - of the authorized examination such as pharmacists specialized in policy and trend - 2014 cancer of the pharmacist authorized examination specialized in 22-11-S30-1 cancer 濱敏弘1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 143-143, 2015.

---

	A fact and case summary (colon cancer) of the 22-11-S30-2 pharmaceutical intervention 三島江津子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 143-143, 2015.

---

	A fact and case summary (pancreatic cancer) of the 22-11-S30-3 pharmaceutical intervention 丹田雅明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 144-144, 2015.

---

	A fact and case summary (lung cancer) of the 22-11-S30-4 pharmaceutical intervention 藤原季美子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 144-144, 2015.

---

	A fact and case summary (leukemia) of the 22-11-S30-5 pharmaceutical intervention 宇佐美英績 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 145-145, 2015.

---

	A tendency and questions intention of the pharmacist authorized study specialized in 22-11-S30-6 cancer 寺田智祐 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 145-145, 2015.

---

	Background and process of the 22-12-S31-1 immunosuppressive drug TDM standardization guidelines development 谷川原祐介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 147-147, 2015.

---

	22-12-S31-2 calcineurin inhibitor: Kidney transplantation domain 竹内裕紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 147-147, 2015.

---

	22-12-S31-3 calcineurin inhibitor: Liver transplant domain 増田智先 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 148-148, 2015.

---

	The present conditions of the TDM of 22-12-S31-4 mycophenolic acid and directionality in the future 内藤隆文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 148-148, 2015.

---

	22-12-S31-5 Everolimus 本間真人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 149-149, 2015.

---

	Characteristic of a blood level assay and the each apparatus of the 22-12-S31-6 immunosuppressive drug 三浦昌朋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 149-149, 2015.

---

	Ethic examination of clinical epidemiologic studies in the 22-12-S32-1 clinical pharmacy 飯嶋久志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 151-151, 2015.

---

	The present conditions of clinical studies in the 22-12-S32-2 hospital pharmacy 土岐浩介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 151-151, 2015.

---

	Conduct a pharmacist-led clinical study using 22-12-S32-3 OpenClinica 小茂田昌代 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 152-152, 2015.

---

	The present conditions and problem of the 22-12-S32-4 medicine system ethic examination 東丸貴信 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 152-152, 2015.

---

	Importance of the 22-12-S32-5 informed consent 山下洋一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 153-153, 2015.

---

	Expect it of a pharmacist from a summary of the 22-12-S33-1 hematopoietic stem cell transplantation and the situation of the blood physician 齋藤文護 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 155-155, 2015.

---

	Expect it of a role and the pharmacist of the nurse in the 22-12-S33-2 hematopoietic stem cell transplantation 守屋佳美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 155-155, 2015.

---

	Role of the pharmacist in the 22-12-S33-3 hematopoietic stem cell transplantation team 内田ゆみ子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 156-156, 2015.

---

	Construction and development ... of ward drug duties in medical treatment support - University of Tokyo Hospital by the pharmacist in the 22-12-S33-4 hematopoietic stem cell transplantation treatment 折山豊仁 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 156-156, 2015.

---

	It is ... from practice by pharmacist duties - clinical practice of the hematopoietic stem cell transplantation in the 22-12-S33-5 Kunitachi cancer research center center Hospital to education, a study 小井土啓一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 157-157, 2015.

---

	We regard dose correlation as teratogenicity of 23-2-S34-1 fluconazole 山根律子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 159-159, 2015.

---

	We regard dose correlation as teratogenicity of the 23-2-S34-2 methotrexate 中島研 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 159-159, 2015.

---

	We regard dose correlation as the teratogenicity of the 23-2-S34-3 antiepileptic drug 刈込博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 160-160, 2015.

---

	We regard dose correlation as effect on nerve development of the 23-2-S34-4 sodium valproate 小西久美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 160-160, 2015.

---

	From the situation of the 23-2-S35-1 university hospital: Practice of the team approach in medical care in the outpatient 矢野育子1),2), 松原和夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 162-162, 2015.

---

	From the situation of the 23-2-S35-2 medical office mainly on - outpatient department chemotherapy - 宮本康敬 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 162-162, 2015.

---

	Way of thinking that the medical treatment in the treatment at home is necessary from the situation of the 23-2-S35-3 opening of an office pharmacist 大木一正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 163-163, 2015.

---

	Essential function of the pharmacist by the 23-2-S35-4 patients information sharing 今井博久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 163-163, 2015.

---

	The present conditions and problems of the Chinese medicine education in the 23-3-S36-1 medical education 間宮敬子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 165-165, 2015.

---

	The present conditions and problems of the Chinese medicine education in the 23-3-S36-2 pharmacy education 伊藤美千穂 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 165-165, 2015.

---

	A fact and problems of the Chinese medicine utilization in the 23-3-S36-3 ward 川添和義 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 166-166, 2015.

---

	Expect it of a problem and a pharmacist of the 23-3-S37-1 inhalation therapy 福井基成 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 168-168, 2015.

---

	It is ... from the situation of attempt - hospital pharmacist of the 23-3-S37-2 inhalation instruction network 三井克巳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 168-168, 2015.

---

	Role of the drugstore pharmacist in regional alliances of the 23-3-S37-3 inhalational instruction 金子雅好1),2), 古川晴浩2), 稲葉眞也2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 169-169, 2015.

---

	Attempt of the 23-3-S37-4 multicenter interval inhalational instruction unification 山下悠希 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 169-169, 2015.

---

	Efforts as the 23-3-S37-5 area pharmacist society 上田憲司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 170-170, 2015.

---

	From 23-3-S37-6 inside the hospital to inhalation therapy to support by illness medicine cooperation 嶋津史恵 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 170-170, 2015.

---

	Through step of practice - Oita hospital pharmacist society infusion of nutrient workshop Committee of the collaboration medical care to snuggle up to the 23-9-S38-1 patients - 北英士 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 172-172, 2015.

---

	It is ... with the optimal nourishment management after clinical nutrition - operation on the heart taught by the 23-9-S38-2 patients 井上真 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 172-172, 2015.

---

	For an offer and cooperation of the nourishment management that is better than 23-9-S38-3 role - of the pharmacist in - clinical nutrition 藤谷竜磨 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 173-173, 2015.

---

	- that Hospitality - I whom 23-9-S38-4 pharmacist should have entrust a pharmacist to here 鶴知光1),4), 長嶋フクヱ2),4), 小野沙織2),4), 黨久瑠美2),4), 岩屋祐子3),4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 173-173, 2015.

---

	23-9-S38-5 clinical nutrition and team approach in medical care, role of the pharmacist 丸山道生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 174-174, 2015.

---

	With the physical assessment to be able to make use of in 23-9-S39-1 nutrition therapy? (prologue) 増田修三 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 176-176, 2015.

---

	The need of the physical assessment in the 23-9-S39-2 at-home nutrition therapy 杉浦伸一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 176-176, 2015.

---

	Physical assessment about the elderly people dehydration in the 23-9-S39-3 treatment at home 齊藤直裕 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 177-177, 2015.

---

	Physical assessment in the nourishment management of the 23-9-S39-4 chronic phase patients 井上俊 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 177-177, 2015.

---

	Physical assessment in the nourishment management that we saw from the pharmacist of the hospital for 23-9-S39-5 acute phase 小園幸輝1),2), 西澤健司1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 178-178, 2015.

---

	The physical assessment that we saw from the nurse of the hospital for 23-9-S39-6 acute phase 朝倉之基 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 178-178, 2015.

---

	Physical assessment in the nourishment management that we saw from the physician of the hospital for 23-9-S39-7 acute phase 鷲澤尚宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 179-179, 2015.

---

	Physical assessment epilog (unification) in the 23-9-S39-8 nutrition therapy 林宏行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 179-179, 2015.

---

	Problem of the community medical care network where 23-10-S40-1 pharmacist participates in 小枝伸行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 181-181, 2015.

---

	Relation of the present conditions and the pharmacist of the 23-10-S40-2 Miyagi medical care welfare information network council 中村浩規1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 181-181, 2015.

---

	Relation of the pharmacist in the 23-10-S40-3 hydrangea net 七種均1), 天本耕一郎2), 神近竜二3), 山口健太郎4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 182-182, 2015.

---

	The electronic proof business of the prescription in the medical care net which we go to 23-10-S40-4, and it is impossible to do and the future prospects 田能村祐一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 182-182, 2015.

---

	23-10-S40-5 Expectation for pharmacists in Fujinokuni virtual mega hospital (Fujinokuni net) 森典子1), 角入壽彦2), 鈴木貴也2), 木村緑2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 183-183, 2015.

---

	Thing - present conditions and problem ... which 23-10-S41-1 area inclusion care system aims at 片岡佳和 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2015.

---

	The present conditions and problem of the pharmaceutical management by a drugstore, the pharmacist in the 23-10-S41-2 area inclusion care system and the at-home medication support 坂巻弘之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2015.

---

	23-10-S41-3 What you expect from your family pharmacy, pharmacist : Report from the field 井益雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2015.

---

	It is the participation in planning of a drugstore, the pharmacist to making it the town where old age is reached in peace in 23-10-S41-4 area 山浦知之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2015.

---

	Efforts - of the exploring - Yamato Ayase pharmacist society of 23-10-S41-5 settings 加藤久幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2015.

---

	Approach to the decreased renal function patients in the scale hospital out of 23-11-S42-1 佐古守人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2015.

---

	"Continuous" pharmaceutical management - young intervention ... in patients with 23-11-S42-2 renal failure 吉田拓弥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2015.

---

	23-11-S42-3 nothing? What would you do? Treatment with anticancer agent at impaired renal function 小井土啓一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2015.

---

	Strategy ... to patients with antimicrobial doses setting - serious case in the 23-11-S42-4 acute renal failure 前田幹広 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2015.

---

	Extension of the 23-12-S43-1 antibody pharmaceutical products development: Expectation and problem in cancer treatment 石井明子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2015.

---

	23-12-S43-2 Antibody engineering for cancer immunotherapy 井川智之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2015.

---

	Process made by 23-12-S43-3 new immune checkpoint inhibitor antiPD-1 antibody nivolumab - wound and future development ... 吉田隆雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2015.

---

	The present conditions and problem of the antibody pharmaceutical products in the 23-12-S43-4 healthcare setting 花輪剛久1), 河野弥生1), 河田圭司2), 手塚春樹2), 鈴木正彦2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2015.

---

	An allergic reaction with 23-12-S43-5 antibody medicine: Individualization prophylactic possibility 岩本卓也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2015.

---

	Usefulness of the Teiko plastic Nin high dose loading dose in the 21-4-O1-01 decreased renal function patients 植田貴史1), 竹末芳生1), 中嶋一彦1), 一木薫1), 土井田明弘1), 和田恭直1), 高橋佳子2), 石原美佳2), 木村健2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2015.

---

	Association with clinical response - MIC of Teiko plastic Nin in the 21-4-O1-02 MRSA bacteremia 鏡圭介1), 山田武宏1),2), 今井俊吾1),2), 福元達也2), 石黒信久2), 井関健1),3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2015.

---

	Analysis of the convalescence-related factor by the clinical and molecular epidemiologic approach in the 21-4-O1-03 MRSA bacteremia 前田真之1), 小司久志2), 白倉哲郎3), 詫間隆博2), 宇賀神和久4), 福地邦彦5), 石野敬子1), 二木芳人2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2015.

---

	Improvement of the clinical response of the blood culture-positive case with the surveillance system of all 21-4-O1-04 injectable antimicrobial 丹羽隆1),2), 渡邉珠代2), 後藤貴之1), 太田浩敏2), 中山麻美2), 鈴木景子1), 土屋麻由美2), 安田浩二1), 村上啓雄2), 伊藤善規1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2015.

---

	Examination of blood level in the 21-4-O1-05 fosphenytoin chronic administration and the optimal dose 大野雄太1), 平井啓太2), 丹羽隆1), 鈴木景子1), 大畑紘一1), 大竹真梨花1), 廣瀬智恵美1), 鈴木昭夫1), 伊藤善規1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2015.

---

	In the transplacental antiarrhythmic drug (digoxin, sotalol) administration for the 21-4-O2-06 fetuses tachyarrhythmia is pharmacodynamic; about pharmacokinetic approach 小竹武1), 玄番瑛子1), 井上知美1), 石渡俊二1), 桑原健2), 和田恭一2), 橋詰宏美2), 三好剛一3), 桂木真司4), 左合治彦5), 前野泰樹6), 池田智明7) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2015.

---

	The development of the dexmedetomidine concentrations assay in out of the 21-4-O2-07 human plasma and mother's milk and the clinical application 中西里佳1), 須野学1),2), 伊藤雄大1), 国沢卓之3), 吉村学4), 青木和葉1), 黒澤温3), 菅原亜美3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2015.

---

	Blood transitional quantitative evaluation of the chloramphenicol vaginal tablet in the pregnant woman of the 21-4-O2-08 bacterial vaginosis 原内智慧1), 大澤隆志1), 久保野尚子1), 内藤隆文1), 伊東宏晃2), 金山尚裕2), 川上純一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2015.

---

	1 case that blood level monitoring of the nilotinib was useful in 21-4-O2-09 chronic myelogenous leukemia treatment 炭本隆宏1), 中原良介1), 藤岡孝志1), 田中遼大1), 佐藤雄己1), 緒方正男2), 伊東弘樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2015.

---

	Effect of blood tacrolimus levels on antiHLA antigens expression of 21-4-O2-10 kidney transplantation one year 藤山信弘1),2),3), 奥山慎1), 斎藤満2), 井上高光2), 新岡丈典3), 加賀谷英彰3), 三浦昌朋3), 羽渕友則2), 佐藤滋1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2015.

---

	Obese effect to have an influence on the internal change of 21-4-O3-11 5-FU 児玉亮二1), 春名真理子1), 河渕真治1), 伊藤由佳子1), 田村孝雄2), 栄田敏之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2015.

---

	Development of the new cultured cell system for expression, a function of alien substance discharge pump P-gp in the 21-4-O3-12 alveolar epithelium and the analysis 西本沙央里1), 佐々木佳寛2), 仲亮輔1), 青木彩子2), 湯元良子2), 高野幹久2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2015.

---

	Transitional comparison between 21-4-O3-13 antiMRSA medicine vancomycin and linezolid to cells intercellular fluid 宇野智哉1), 稲垣勇斗1), 佐々木健二1), 河渕真治1), 伊藤由佳子1), 高田寛治2), 栄田敏之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2015.

---

	Inspection of the effect that the protein-binding rate of the drug using the 21-4-O3-14 haemodialysis model rat gives to dialysability 福永雅樹1), 門脇大介1), 成田勇樹1), 田中遼大2), 渡邊博志1), 山崎啓之3), 田口和明3), 伊東弘樹2), 丸山徹1), 小田切優樹3), 平田純生1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2015.

---

	Establishment of simple and easy plasma piperacillin concentrations assay using the 21-4-O3-15 HPLC 三谷健人1), 曽田翠1), 宮原有里1), 片桐七海1), 鈴木昭夫2), 小林亮2), 丹羽隆2), 鈴木景子2), 吉田省造3), 小倉真治3), 伊藤善規2), 北市清幸1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2015.

---

	Population kinetic analysis of mizoribine in consideration of individual difference of the 21-4-O4-16 bioavailability 坂井友里絵, 深尾美紀, 橋本征也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2015.

---

	The effect that accumulation of 21-4-O4-17 CYP3A5 genetic polymorphism and the indoxyl sulfate gives for recovery of the CYP3A activity after the living renal transplantation 村谷菜々子1), 鈴木陽介1), 藤岡孝志1), 佐藤文憲2), 松本邦洋3), 田中遼大1), 佐藤雄己1), 大野恵子3), 三股浩光2), 岸野吏志3), 伊東弘樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2015.

---

	One patient who measured valproic acid levels out of the 21-4-O4-18 mother's milk, and examined safety in the colostrum 乾有希子1),2),3),4),5),6), 池田久雄1), 平田貴宏1), 宮麻紀子1), 大西秀美1), 六車裕一1), 松元麻美1), 江川功3), 尾上昌世2), 佐伯典厚2), 中西康詞4), 赤木幹弘4), 中野博明5), 安田穣6), 野村浩英1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2015.

---

	Theoretical consideration about the advisability of the administration to a nursing mother of the 21-4-O4-19 Laninamivir 大久保正1), 田中真理子2), 大久保七枝3), 大久保節子4), 阿部慧5), 大久保美穂5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2015.

---

One case of the children who used bosentan together with tacrolimus while conducting the blood level measurement for pulmonary hypertension due to the interstitial pneumonia after the 21-4-O4-20 peripheral blood stem cell transplantation 神山直也1),2), 杉本昌也3), 畠山直樹3), 谷香苗1), 福土将秀1), 東寛3), 田崎嘉一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2015.

---

	Examination about the incompatibility of meropenem parenteral injection and the amino acid preparation under the administration condition of the 21-5-O5-01 NICU 若杉陽子, 村岡香代子, 石田茂, 富松裕美, 山田孝明, 池末裕明, 渡邊裕之, 江頭伸昭, 増田智先 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2015.

---

Usefulness of the pharmacist intervention for the treatment using the 21-5-O5-02 antiMRSA medicine: A clinical response by medical treatment management and the many types of job intervention based on the protocol and medical economic effect 岡田直人1), 伏谷秀治1),2), 東桃代2), 中村敏己1), 寺岡和彦1), 川添和義1),3), 石澤啓介1),3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2015.

---

	Intervention to polypharmacy using STOPP criteria version 2 by the 21-5-O5-03 pharmacist 木村丈司, 小倉史愛, 澤田有記美, 宇田篤史, 赤澤由子, 野間千尋, 野崎晃, 山本和宏, 五百蔵武士, 西岡達也, 久米学, 槇本博雄, 平井みどり Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2015.

---

	Improvement of the stress ulcer protective efficacy by the practice of the medical treatment management based on 21-5-O5-04 protocol 池村舞1),2), 中浴伸二2), 藤原秀敏2), 土肥麻貴子2), 瀬尾龍太郎3), 渥美生弘3), 有吉孝一3), 橋田亨2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2015.

---

	Examination of the effect that the change of prescription by the 21-5-O5-05 ward pharmacist gives 加藤隆寛, 岩澤瞳, 甚目陽子, 築山郁人, 松浦克彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2015.

---

	Examination of the liver damage onset risk in the antiphthisic drug multidrug therapy using the 21-5-O6-06 adverse event spontaneous report database 河合加奈, 小川喜寛, 頭金正博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2015.

---

	Analysis of the taste disturbance with the multiple myeloma therapeutic drug administration using the 21-5-O6-07 FDA size scale adverse event spontaneous report database 井野場郁乃1), 角山香織1), 南景子1),2), 多門啓子3), 津田真弘1), 栄田敏之1),4), 奥野恭史5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2015.

---

	The examination of the risk factor about the dermatopathy of the 21-5-O6-08 lamotrigine and investigation of the expression time 傍示幸1), 祖川倫太郎1), 持永早季子1), 島ノ江千里2), 田崎正信1), 原英夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2015.

---

	Effect of the fluid intake recommendation to give to the adverse event of the allergy-like symptom with 21-5-O6-09 nonionic agent characteristics iodine contrast media 鋒山香苗1), 元井玲子1), 矢野育子1), 尾崎淳子1), 山本崇2), 深津祥央1), 石塚良子1), 松村由美2), 谷口正洋3), 東村享治3), 松原和夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2015.

---

	The actual situation and evaluation of the drug-related fall in the pay nursing home with the 21-5-O6-10 care 朴恵林1), 三木晶子1), 佐藤宏樹1), 漆原尚巳2), 澤田康文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2015.

---

	Investigation about the malnourished situation by the combination of 21-5-O7-11 cancer cachexia staging and GPS evaluation 辻本貴江1), 渡邊亜紀穂1), 入江慶2), 岡田裕2), 片上信之3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2015.

---

	It is usefulness of the fat-containing nutrient preparation in the early stage after 21-5-O7-12 cancer of the esophagus technique 佐藤佑一朗1), 早坂州生1), 平田力1), 竹内公美1), 小川聖子2), 北原裕子3), 川島有美子3), 吉川智宏4), 高橋宏明5), 細川正夫4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2015.

---

	About examination and the actions to be taken of the cause of the low Na blood symptom in the 21-5-O7-13 nutrient for intestinal administration 中川義浩1),2), 横田千明1), 水町純一1), 桑原貴美子1), 藤野祥1), 山形真一1), 幸邦憲1), 小園亜希2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2015.

---

	Evaluation ... of the rehospitalization of patients with 21-5-O7-14 heart failure and effect on nourishment of investigation - drug about medication, the nourishment and the pharmaceutical intervention 高井靖1), 前田雄太郎1), 木本珠美1), 伊藤涼子1), 梶間勇樹1), 鈴木啓之2), 宮原眞敏2), 西川英郎2), 大井一弥3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2015.

---

	Role of the pharmacist in the 21-5-O7-15 childhood cancer nourishment project team 甲斐維子1), 熊坂治1), 和田碧2), 後藤裕明3), 高増哲也4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2015.

---

	21-5-O8-16 Examination of moisturizing effect by white petrolatum sodium bicarbonate of Hirudoid(R) Soft Ointment 眞部遥香, 野澤茜, 松元美香, 大谷道輝, 山村喜一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2015.

---

Attempt of the interactive type drug instruction for the construction of the understanding degree visualization in the epoprostenol continuous intravenous infusion therapy for patients with 21-5-O8-17 pulmonary hypertension 高橋智子1),3), 杉本浩一2),3), 義久精臣2),3), 中里和彦2),3), 竹石恭知2),3), 赤羽沙織3), 渡部ますい3), 尾形浩2),3), 鳥羽衛3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2015.

---

	Effect to give to an extension of the EPA preparation on patients with 21-5-O8-18 heart failure 上田浩貴1), 山本真里江2), 辰見明俊2), 上田綾佳1), 丹生亜希子1), 小正晃裕3), 芝本恵3), 永井崇博3), 浅田聡3), 多田英司3), 巣山環3), 濱口常男2), 石井克尚3), 濱口良彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2015.

---

	Role of a summary and the pharmacist of the rheumatoid arthritis medical treatment with the 21-5-O8-19 biological drug 大原雄希, 遠藤千夏, 中田浩雅, 野田師正, 宮本篤 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2015.

---

	Stability of the principal ingredient in the application to the simple suspension method of the 21-5-O8-20 tram set (R) combination lock 高岡昌司1), 津郷佑規2), 中村承平2), 坂本宜俊2), 田頭尚士1), 二五田基文1), 湯淺宏2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2015.

---

	Efforts (the first report) to off-label use management in the 21-6-O9-01 Tokyo Women's Medical University Hospital 高橋麻利子, 高橋結花, 大石智春, 渋谷陽子, 高橋賢成, 木村利美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2015.

---

	Problem - pharmacist to 21-6-O9-02 securing of pharmaceutical products safety in the medical environment to change dynamically is ... from incident analysis to be concerned with 松川周平1),2),3), 藤本勝博1), 古角幸太1), 山上聡子1), 安田宗一郎1),2), 田中宏明3), 門脇裕子1), 中島和江3), 三輪芳弘1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2015.

---

	Effect of the part of doubt inquiry unnecessary protocol in the 21-6-O9-03 outside Parliament prescription 安達昂一郎, 櫻井香織, 尾崎淳子, 木村嘉彦, 松村勝之, 西脇布貴, 萱野勇一郎, 深津祥央, 矢野育子, 松原和夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2015.

---

	Simulation education - Simulation training for Clinical Pharmacist - in the 21-6-O9-04 clinical pharmacist 大澤晋1), 小川敦2), 白石奈緒子2),4), 山地民恵2), 日野隼人2), 武本あかね2), 西宮祐輔2), 川島理恵子2), 蔵田靖子2), 勝部理早2), 大川恭昌2), 川崎元弘5), 福永桂子5), 名和秀起2), 錦織淳美2), 万代康弘3), 北村佳久2), 佐野俊二1), 千堂年昭2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2015.

---

	Construction and evaluation ... of the business training program for upbringing (the fifth report) - EBM practice method acquisition of the pharmacist carrying the 21-6-O9-05 next generation 江角悟, 河崎陽一, 北村佳久, 千堂年昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2015.

---

	Multicenter questionary survey about the job satisfaction of the 21-6-O10-06 hospital pharmacist 植木哲也1),11), 橋口靖1), 村本眞由美2), 竹本伸輔3), 金澤康範3), 山澤理恵子4), 浅原稔生5), 溝口玄一郎6), 川崎美紀7), 小田桂子8), 中嶋弥穂子9), 城戸宏史10), 中嶋幹郎11) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2015.

---

	The effect that 21-6-O10-07 thickness adjustment food gives to the collapse of the fast disintegration tablet of the nonprescription drug 後藤英和1), 富田隆1), 住谷賢治2), 中西利恵1), 小島千賀子1), 米島美穂子1), 吉田正3), 田中勝也4), 幸田幸直1),5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2015.

---

	Effect of CYP3A5 giving it to drug interactions with tacrolimus and itraconazole in patients with 21-6-O10-08 collagenosis and the ABCB1 genetic polymorphism 新岡丈典1), 富樫賢2), 小松田敦2), 奈良瑞穂2), 奥山慎3), 面川歩4), 鐙屋舞子1), 涌井秀樹5), 高橋直人2), 三浦昌朋1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2015.

---

	Construction and evaluation of the examination for 21-6-O10-09 pharmacogenomics system 赤羽理也1), 野田哲史1), 磯野哲一郎1), 池田義人1), 平大樹1), 森田真也1), 堀江稔2), 寺田智祐1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2015.

---

	Elucidation of the factor having an influence on the internal change of mycophenolic acid before and after the 21-6-O10-10 kidney transplantation 加賀谷英彰1), 新岡丈典1), 齋藤満2), 沼倉一幸2), 羽渕友則2), 佐藤滋3), 三浦昌朋1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2015.

---

	Examination by the difference of the evaluation method of associated ... meta-analysis of treatment response and the genetic polymorphism of the methotrexate in patients with 21-6-O11-11 rheumatoid arthritis 袴田潤1), 橋口正行1), 清水美貴子2), 丸山順也1), 望月眞弓1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2015.

---

	Association with the stomatitis onset and the MDR1 genetic polymorphism by the 21-6-O11-12 Everolimus 渡邉愛未1),2), 山本和宏2), 四宮一昭3), 平田佐智2), 石村武志4), 横山直己4), 三宅秀明4), 藤澤正人4), 中川勉1),2), 平野剛5), 平井みどり1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2015.

---

Establishment of CYP3A5 genetic polymorphism diagnostic method aiming at 21-6-O11-13 clinical application and the screening of the drug that CYP3A5 is associated with metabolism 松本准1), 岸隆斗1), 鬼頭佑太朗1), 佐藤輝1), 竹沢麻奈未1), 杉山奈津子1), 廣澤伊織1), 加藤芳徳1), 福田八寿絵1), 前澤佳代子1), 百瀬泰行1), 中村裕義1),2), 山田治美1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2015.

---

	Analysis of the individual difference factor of the onset of postoperative pain in fentanyl treated patients in the 21-6-O11-14 technique and nausea 八木達也1), 加藤弘美2),3), 田中紀章1), 石田卓矢1), 平野公美1), 加藤孝澄2),3), 佐藤重仁2),3), 内藤隆文1), 川上純一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2015.

---

	Examination about the Daclatasvir / Asunaprevir combination therapy in the 21-6-O11-15 true clinical practice 中村淳二, 永島貴裕, 市原航, 福井宗憲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2015.

---

	Significance of the PNPLA3 mutation in the gene in the non-pycnic type for the 21-6-O12-16 non-alcoholic fat-related liver disease prevention 鬼木健太郎1), 武藤奈瑠美1), 守田和憲1), 居塚智子1), 梶原彩文1), 坂田美咲1), 北愛矢菜1), 熊谷直樹1), 大竹宏治2), 緒方康博2), 中川和子1),3), 猿渡淳二1),3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2015.

---

See the rear in patients with side effect expression investigation - UGT1A1 genetic polymorphism analysis of the FOLFIRINOX therapy for the 21-6-O12-17 pancreatic cancer impossible of excision; mark examination ... 南晴奈1), 田島壮一郎1), 川尻雄大1), 石田茂1), 中島貴史1), 秦晃二郎1), 池末裕明1), 渡邊裕之1), 江頭伸昭1), 増田智先1), 李倫學2), 伊藤鉄英2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2015.

---

	Effect of ABC to give it to 21-6-O12-18 cisplatin-induced impaired renal function and the SLC transporter genetic polymorphism 藤田一馬1), 本山悟2), 新岡丈典1), 三浦昌朋1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2015.

---

	Effect of a drug transporter and the drug metabolizing enzyme genetic polymorphism on 21-6-O12-19 Clozapine body change 赤嶺由美子1), 菊池結花2), 新岡丈典1), 古郡規雄3), 宇野司4), 清水徹男2), 三浦昌朋1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2015.

---

	Effect to give a serum lipid level of genetic polymorphism and the ezetimibe of small intestine cholesterol transporter NPC1L1 in patients with dyslipidemia of the 21-6-O12-20 Japanese 柏原由佳1), 小林靖奈2), 木庭新治3), 神山紀子2), 大林真幸2), 小林洋一3), 山元俊憲2), 佐々木忠徳1),4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2015.

---

A multicenter retrospective study about the proteinuria protective efficacy of the inhibitor of Renin-Angiotensin for patients with 21-7-O13-01 Bevacizumab administration non-small cell lung cancer origin: NJLCG1303 岡田浩司1), 二瓶哲2), 久山彰一3), 鈴木俊郎4), 斎藤佳敬5), 木皿重樹6), 原田敏之7), 横田敦子8), 土屋雅美9), 照井一史10), 田所佑実子11), 佐藤淳也2), 守義明1), 森川直人2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2015.

---

	We look at the rear about eye disorders with 21-7-O13-02 oxaliplatin and examine a mark 野口裕介, 川島悠吾, 瓦比呂子, 徳山洋子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2015.

---

	The zoledronic acid-induced nephropathic risk factor analysis that paid its attention to the physicochemical characteristic of the HMG-CoA reductase inhibitor in patients with 21-7-O13-03 cancer 大畠俊一, 池末裕明, 秦晃二郎, 渡邊裕之, 江頭伸昭, 増田智先 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2015.

---

	Examination of the immune-mediated adverse effect in the nivolumab treatment for the 21-7-O13-04 malignant melanoma 山本将太1), 長谷川真理1), 吉良俊彦1), 池見泰明1), 大村友博1), 矢野育子1), 藤澤章弘2), 椛島健治2), 松原和夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2015.

---

	Effect of the CYP3A4 inhibitor combination to give to an onset of febrile neutropenia risk by the 21-7-O13-05 docetaxel 槙原克也1),2), 東さやか2), 上野裕之2), 中多泉2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2015.

---

	Prophylaxis of butylscopolamine for the dysarthria with the 21-7-O14-06 FOLFIRINOX therapy 小林大祐1), 大坪達弥1), 荻野仁未1), 福田喬士1), 加藤良隆1), 白川敦史2), 河端秀明2), 柿原直樹3), 山口明浩3), 野田能成1), 友金幹視1), 藤田敦夫1), 三上正1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2015.

---

	Multicenter observational, prospective study of retching vomiting in the 21-7-O14-07 slightness emetic risk cancer chemotherapy 鳥山陽子1), 三原由記2), 石橋由佳3), 塩田喜美子4), 上田和明5), 下澤那津6), 丸田基史7), 渡辺健二8), 川俣洋生9), 後藤隆10), 鶴崎泰史8), 小薮真紀子11), 下川元継12), 林稔展3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2015.

---

	Examination of the risk factor of retching, vomiting in the 21-7-O14-08 elderly people lung cancer Carboplatin combination therapy 市川和哉1), 森瀬昌宏2), 宮崎雅之1), 亀島理沙1), 長谷哲成2), 近藤征史2), 長谷川好規2), 山田清文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2015.

---

	Palonosetron, aprepitant for the prevention of retching, vomiting with the 21-7-O14-09 cisplatin day after day administration, open-label non-control phase II study of the dexamethasone 五百蔵武士1), 久米学1), 平田佐智1), 打保裕子1), 古川順也2), 三宅秀明2), 西岡達也1), 槇本博雄1), 藤澤正人2), 平井みどり1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2015.

---

	The effectiveness of the aprepitant administration extension in 21-7-O14-10 FP therapy and the BEP therapy and the cost effectiveness analysis 加藤優1), 大野雄太2), 小林亮2), 飯原大稔2), 鈴木昭夫2), 林秀樹1), 杉山正1), 伊藤善規2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2015.

---

	Investigation about the antiemesis therapy of the Doxorubicin, Ifosfamide combination therapy for 21-7-O15-11 malignancy soft part tumor 佐野智望1), 小林英介2), 遠藤誠2), 丹澤義一2), 中谷文彦2), 川井章2), 橋本浩伸1), 大塚知信1), 中馬広一2), 林憲一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2015.

---

	Phase II clinical trial of the olanzapine + palonosetron + dexamethasone combination antiemesis therapy for retching, vomiting by the 21-7-O15-12 cisplatin 前田章光1), 宇良敬2), 堀尾芳嗣3), 尾瀬功4), 梶田正樹1), 長谷川郁恵1), 平島佳代1), 高橋新次1), 長谷川彩子1), 栗原幸司1), 伊藤裕子1), 下村一景1), 伊藤基博1), 岩田修一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2015.

---

	Examination of the 5HT3 blocker for the malignant lymphoma regimen including the 21-7-O15-13 high dose steroid 中川隼一1), 岡田悠美1), 桝茂典1), 上村苑子1), 伊藤あゆみ1), 生井加奈1), 伊沢景子1), 高橋真一1), 土橋史明2), 塩田祐子2), 大場理恵2), 蔭山博之1), 村上敏明1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2015.

---

	It is ... for further progress of the anorectic expression situation investigation - antiemesis therapy with the 21-7-O15-14 cancer chemotherapy 杉山弘樹1),2), 嘉屋道裕1), 望月亜希子1), 原田晴司2), 木村緑1), 角入壽彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2015.

---

	Usefulness - multicenter study - of aprepitant in the 21-7-O15-15 CHOP therapy 江尻将之1), 宮崎雅之2), 佐藤由美子2), 町支優和2), 大島有美子2), 小山佐知子2), 荒川裕貴2), 近藤有2), 佐々木英雄2), 壁谷めぐみ2), 間瀬広樹2), 横山聡2), 築山郁人1),2), 久田達也2), 板倉由縁2), 勝見章男3), 松浦克彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2015.

---

	Comparison about the expression of chemotherapy-induced retching vomiting (CINV) time in the NK1 receptor blocker using the 21-7-O16-16 tendency score 古野龍也1), 傍示幸1), 持永早希子1), 與田幸恵2), 鈴木久美子3), 上田純二2),3), 柏田知美3), 荒金尚子1),3), 田崎正信1), 木村晋也3), 原英夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2015.

---

	Comparison between palonosetron and effectiveness of the ramosetron at aprepitant combination for the five days cisplatin regimen of patients with 21-7-O16-17 testicular tumors 高田慎也, 玉木慎也, 遠藤雅之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2015.

---

	An investigation of the stomatitis onset to be caused by according to the 21-7-O16-18 cytarabine administration method and measures of the risk factor 藤田真一1), 太田一郎2), 小池博文2), 西川能治2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2015.

---

	Effect on effectiveness and neutrophils of the Hangeshashinto for oral mucositis with the 21-7-O16-19 hematopoietic stem cell transplantation 佐野尚平1), 嶋本めぐみ1), 西村知恭1), 園部比呂志1), 岩城久弥1), 花岡伸佳2),3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2015.

---

	The present conditions and problem of HBV reactivation measures for patients receiving 21-7-O16-20 rituximab 土手賢史1), 古田祐美子1), 土井章一2), 野崎歩1), 小林由佳1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2015.

---

	Optimal preparation environment of the dacarbazine parenteral injection which assumed 21-8-O17-01 photodegradation article levels an index and conditional examination 田代将貴, 内藤隆文, 山本千琴, 加藤真也, 川上純一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2015.

---

	Examination for the proper use of 21-8-O17-02 BD PhaSeal TM protector P55 内田任仁弘1), 矢ヶ部良太1), 竹内耕治1), 細矢和久1), 持永早希子1), 田崎正信1), 原英夫1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2015.

---

	Preparation precision criteria of the 21-8-O17-03 full automation type anticancer medicine preparation support equipment 三嶋一登1), 入佐俊弘1), 秦晃二郎1), 渡邊裕之1), 首藤洋幸2), 海藤壽彦2), 関口重夫2), 田坂茂二3), 村上宏彰3), 野村正行3), 大野誠樹3), 増田智先1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2015.

---

	21-8-O17-04 Survey on the actual situation of spill kit usage at anticancer drug contamination 飯村洋平1), 杉田一男1), 岩本寿美代2), 蓑輪雄一1), 長崎礼子2), 黒田直子2), 横井麻珠美2), 濱敏弘1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2015.

---

	Search of the risk factor about the onset of neutropenia in the 21-8-O17-05 pemetrexed Carboplatin combination therapy 荒木良介, 計良貴之, 加藤加奈恵, 菱沼隆一, 山田英紀, 田中恒明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2015.

---

	Possibility ... which attenuates antitumor effect of oral 21-8-O18-06 melphalan and drug interaction - melphalan of the gastric-acid secretion antagonist 北澤文章1), 角陽子1), 上田久美1), 国府孝敏1), 淵田真一2), 岡野晃2), 初瀬真弓2), 村頭智2), 高良恒史3), 島崎千尋2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2015.

---

	Study on payment intention for the 21-8-O18-07 medication counseling 東加奈子1), 川口崇2), 山口拓洋3), 佐野陽子1), 下平智秀1), 鳥居綾子1), 鮎原秀明1), 山田裕理1), 岩瀬哲4), 山田公人5), 松永忠東6), 竹内裕紀2), 畝崎榮2), 明石貴雄1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2015.

---

	Usefulness as the prostate cancer treatment target of 21-8-O18-08 Ca2+ activation K+ channel KCa2.2 丹羽里実1), 内木拓2), 佐々木昌一2), 高橋智3), 大矢進1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2015.

---

	Usefulness of the TS-1-induced side effect discovery rate and side effect monitoring sheet in the 21-8-O18-09 outpatient department chemotherapy 中村知弘1), 河添仁2), 高取真吾1), 矢野安樹子2), 済川聡美2), 田中守2), 田中亮裕2), 難波弘行1), 湯淺宏1), 荒木博陽2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2015.

---

Clinical studies (the clinical second aspect study) of safety and the effectiveness of the L-leucine therapy for 21-8-O18-10 myelodysplastic syndrome (MDS) 伊藤佳織1),2), 安藤舞子2), 安藤洋介2), 柘植雅大2), 加藤貴大2), 増田雅也2), 鈴木慎二2), 加藤さや香2), 牧原俊康2), 林高弘2), 稲熊容子1), 柳田正光1), 水田秀一1), 岡本昌隆1), 山田成樹2), 恵美宣彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2015.

---

	Examination about the problem solving judging from the consultation example between medical persons in the 21-8-O19-11 cancer chemotherapy 坪井久美, 遠藤拓未, 平野公美, 小菅和仁, 渡邉進士 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2015.

---

	One case of thyroid cancer which hyposensitization by the steroid combination succeeded in for erythema multiforme that 21-8-O19-12 sorafenib caused 倉田玲奈1), 林孝子2), 加藤彩2), 清水真3), 佐藤康幸2), 松本修一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2015.

---

	Construction of the cancer instruction to patient administrative work in the cottage-hospital out of 21-8-O19-13 大上寛子1), 仲由美子1), 細木慈子1), 植田実樹2), 末次知子2), 濱田拓男3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2015.

---

	21-8-O19-14 physician and a pharmacist are the changes of the understanding degree of the patients by the treatment with hormone classroom after breast cancer technique to collaborate 猪熊容子1), 山本浩貴1), 池見泰明1), 石塚良子1), 深津祥央1), 大村友博1), 中川俊作1), 今井哲司1), 鈴木栄治2), 竹内恵2), 戸井雅和2), 松原和夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2015.

---

	Relations from the hospitalization of patients with 21-8-O19-15 blood tumor to the outpatient department 小川智孝, 川村めぐみ, 矢敷祐子, 川畑大輔, 八十嶋しづか, 高松祐子, 井上味波, 矢野沙幸, 酒井千尋, 西居祐美, 和下田真美, 手島慶子, 岩城晶文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2015.

---

	It is ... mainly on the role of the HBV infection screening study implementation present situation - pharmacist at the 21-8-O20-16 our hospital chemotherapy 稲益里映1), 藤田さやか2), 埋金朋子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2015.

---

	Add many types of job cooperation - clinical phycologist, dietitian in the 21-8-O20-17 outpatient department chemotherapy center; and ... 木村緑1),2), 芹澤陽子3), 高木綾4), 藤巻奈緒美1),5), 須山由佳子2), 萩倉翔2), 内田亮2), 永峰槇子2), 中村和代1),2), 中條倫成1),2), 嘉屋道裕2), 中垣繁2), 遠藤一美1),5), 江藤尚1),6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2015.

---

	Intervention as the ward pharmacist in the 21-8-O20-18 thyroid cancer newcomer treatment medicine "Ren drumstick nib" use case 石川雄大, 龍伸和, 三村泰彦, 加藤敦, 足立伊佐雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2015.

---

	Relation of the pharmacist for IV (CV port) puncture nurse upbringing in the 21-8-O20-19 cancer chemotherapy 入江貞治1), 原田周平1), 井上知哉1), 福原香奈子2), 北崎健3), 福田正明3), 谷口英樹4), 藤田靖之1), 町田毅1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2015.

---

	Exploring of the joint medical treatment management (CDTM) introduction in the 21-8-O20-20 Prefectural Hiroshima Hospital tumor center 西川千晶1), 今津邦智1), 奈須ゆき2), 木下真由美2), 大山紀美江2), 前田昌徳1), 篠崎勝則3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2015.

---

	Result ... of the non-expert skill training that we transduced in all consideration fourth report ... official posts and ranks about the satisfaction of the patients after consciousness and the instruction of the 22-4-O21-01 pharmacist 渡邉百合子1), 新井亘2), 岡添進3), 矢吹直寛4), 長谷川和正5), 矢嶋美樹6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2015.

---

	Efforts of the consciousness change of the 22-4-O21-02 pharmacist and setting and the organization and methods of the clinical index in change - third report - AMG pharmacy of duties contents 新井亘1), 岡添進2), 矢吹直寛3), 長谷川和正4), 渡邉百合子5), 矢嶋美樹6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2015.

---

	Effect on consciousness and duties contents - second report ... of the pharmacist of the 22-4-O21-03 chronic phase hospital 岡添進1), 渡邉百合子2), 新井亘3), 矢吹直寛4), 長谷川和正5), 矢嶋美樹6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2015.

---

	About efforts and new duties development of the ward drug duties improvement in the 22-4-O21-04 Kokura memory hospital 町田聖治, 清水誉志, 萩原里実, 富田敏章, 福島将友, 樽善久, 入江利行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2015.

---

	The database construction for the intervention example of the ward pharmacist in the 22-4-O21-05 medical therapy and data analysis 大谷寧次郎, 齊藤宏明, 杉浦洋二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2015.

---

	Than efforts of 22-4-O22-06 ward drug duties and evaluation ... is ... for enhancement 才津恵, 岡田淳芳, 石井一也, 原景子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2015.

---

	Intervention ... of the pharmacist in hepatitis B reactivation measures in examination - cancer chemotherapy about the usefulness of the 22-4-O22-07 ward drug duties enforcement addition 宮崎美佳1), 末松那実子1), 古川順章1), 永井聡子1), 安宅信二2), 小林勝昭1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2015.

---

	Prescription support by the pharmacist as 22-4-O22-08 Yokohama City ward drug duties in a stroke, the nerve backbone center 臼田誠1), 永井徹1), 青野壮1), 荒居典子1), 石橋直子1), 一澤里枝1), 加藤鮎子1), 小林留奈1), 櫻塲秀一1), 白井克子1), 須藤葉子1), 原弘士1), 間瀬尚子1), 高橋浩二1), 五十嵐俊1), 市田千佳2), 平野秀隆1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2015.

---

	Clinical practice - of effect - polypharmacy improvement and the drugstore pharmacist of the bedside prescription suggestion by the pharmacist company to rounds in 22-4-O22-09 medical treatment bed, the Care health center for the elderly 新井克明, 清水範子, 菊地麻希, 須藤寛, 佐々木真澄, 郡司幸代 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2015.

---

	Understanding degree investigation ... for the sleeping drug of suggestion and the nurse of the sleeping drug proper use from efforts - ward pharmacist to the reduction of 22-4-O22-10 fall, the delirium risk to a physician 古川大樹1), 清水智也1), 村瀬貴子1), 川口美香2), 長谷川雅哉1), 柴田浩範3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2015.

---

	The continuous intervention for patients who received 22-4-O23-11 outpatient department cancer chemotherapy and the evaluation 陶山登之, 松井頌明, 渋江理恵, 土井教雄, 井上昌樹, 上村智哉, 玉木宏樹, 西村信弘, 直良浩司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2015.

---

	Fact-finding in the 22-4-O23-12 outpatient department chemotherapy hot line for pharmacist 出町健1), 龍島靖明1), 板垣麻衣1), 野村久祥1), 市田泰彦1), 池田公史2), 齊藤真一郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2015.

---

	The present conditions of the efforts to the pharmacist outpatient department in the 22-4-O23-13 lung cancer EGFR-TKI treatment 早坂州生1), 芦崎雅之1), 平田力1), 竹内公美1), 平岡圭2), 山崎成夫2), 鈴木康弘2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2015.

---

	Dermatopathy - during side effect management - Afatinib medication in the 22-4-O23-14 pharmacist outpatient department 古川順章1), 浅川由希子1), 宮崎美佳1), 小林勝昭1), 安宅信二2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2015.

---

	By 22-4-O23-15 pharmacist medical examination front can contribute to XELOX therapy successful execution! 組橋由記1), 福島ゆかり1), 石倉久嗣2), 鈴江朋子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2015.

---

	Usefulness of the pharmacist outpatient department in the 22-4-O24-16 molecules target medicine internal use treatment and future problem 高瀬美咲枝, 小川浩平, 柴田和彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2015.

---

	Research of the medication compliance of the 22-4-O24-17 regorafenib 副島梓1), 川上和宜1), 杉田一男1), 横川貴志1), 杉崎崇人1), 瀧口友美1), 鈴木賢一1), 井上彩花2), 町田昌明2), 末永光邦3), 水沼信之3), 山口俊晴3), 濱敏弘1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2015.

---

It is ... through the pilot case which a pharmacist attended in report - encounter of the process that led to new establishment and the pharmacist outpatient department start of the consulting room for exclusive use of the pharmacist in the 22-4-O24-18 our hospital 高柳信子1), 久保嘉靖1), 奥野昌宏1), 中田学1), 新里偉咲2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2015.

---

	Medication management of TAS102 in the 22-4-O24-19 pharmacist outpatient department 奥田泰考1), 須藤俊明1), 藤井博文2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2015.

---

	Role of the 22-4-O24-20 pain clinic pharmacist outpatient department 中川左理1), 岡本禎晃2), 柴田政彦3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2015.

---

	About fact-finding and an effect of the perioperative pharmacist intervention in the 22-4-O25-21 anesthesiology outpatient department 大森崇行1), 阿部猛1), 川名賢一郎1), 片山正夫2), 宮坂勝之3), 後藤一美1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2015.

---

	Efforts of the pharmacist in the 22-4-O25-22 hospitalization support center 古荘恵里, 佐藤大惣, 山内豊和, 山澤理恵子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2015.

---

	Have hospital pharmacist for certain outpatient department medical therapy by security from 22-4-O25-23 久岡清子, 合田さやか, 佐々木健志, 澤口友紀, 亀岡喬, 間千晴, 鹿沼奈央, 足立雅, 盆子原唯, 川村大輔, 大荒政志, 浜野憲子, 平野真衣, 清居孝正, 吉川真央 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2015.

---

	Establishment of the pharmacist outpatient department for the patients during interferon freelance treatment with 22-4-O25-24 hepatitis C and the evaluation 山本晴菜1), 山本香織1), 左近絢子1), 池村舞2), 鄭浩柄3), 杉之下与志樹3), 猪熊哲朗3), 橋田亨1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2015.

---

	Efforts - check sheet introduction of the SGLT2 inhibitor proper use in the 22-4-O25-25 pharmacist outpatient department and progress report ... 佐久間智子, 今井晴恵, 宇佐美勝, 池田弘毅 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2015.

---

	Intervention effect of the pharmacist in the medical treatment management of the lithium carbonate to 22-4-O26-26 outpatient 山田尚広1), 見野靖晃1), 佐野慎亮1), 内藤隆文1), 森則夫2), 川上純一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2015.

---

	Representation answer - of the pharmacist by the doubt efficiency - doubt comprehensive instructions that are inquiry-free in the 22-4-O26-27 outside Parliament prescription for inquiry 小松めぐみ, 前田奈保, 宇都宮可奈, 青木佐菜, 市川麻美, 田所美和, 吉岡りえ, 市吉真貴子, 八木亜紀子, 田中照夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2015.

---

	Effect of the medicine classroom on person with 22-4-O26-28 congenital hearing disorder 俵口奈穂美2), 小林大介1), 窪田敏夫1), 島添隆雄1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2015.

---

	The efforts of the pharmacist for the 22-4-O26-29 preoperation patients and the result 矢川結香1), 居塚しのぶ1), 桑村恒夫1), 末松文博1), 有村博江2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2015.

---

	Intervention and evaluation for PONV by the 22-4-O26-30 operating room permanent residence pharmacist 大田泉, 阪上倫行, 明珍かおり, 辻美知瑠, 田中健太, 西岡達也, 久米学, 槇本博雄, 平井みどり Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2015.

---

	Prescription contents to diabetes are various by the 22-5-O27-01 prescription database analysis, but the correlation with the hemoglobin A1c level is low 嶋村弘史1), 田中広紀2),3), 向後麻里2),3), 竹ノ内敏孝4), 中野泰子5), 富田基郎5), 村山純一郎5), 谷山松雄6), 平野勉7) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2015.

---

	Introduction and effect of the sustained Exenatide for the purpose of the weight control in the 22-5-O27-02 obesity case 板東達也1), 奥村中2), 浅野昇悟2), 佐久間晶基1), 辻若子1), 多和田敏郎1), 小木曽梓1), 荻野由里惠1), 水野善晴1), 佐藤嘉孝1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2015.

---

	The drug use situation of patients with diabetes with the 22-5-O27-03 ischemic heart disease 石橋真実1), 大森麻江1), 向井めぐみ1), 金井美緒1), 宮下雄博2), 森英樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2015.

---

	Inflection of the bringing medicine differentiation report aiming at the proper use of 22-5-O27-04 oral hypoglycemics 中村栄子1), 竹之下博正2), 茨木一夫2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2015.

---

	Importance of the equalization in the 22-5-O27-05 suspension insulin analog preparation 富岡節子1), 信田重成2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2015.

---

	The effect that the change of the insulin regimen gives to the quality of life of patients with type 1 and type 2 diabetes on 22-5-O28-06 Degludec 岡田守弘1),2), 岡田昌江1), 西上潤1), 山秋直人3), 大山公典3), 古川健治3), 嶋田努2),4), 崔吉道2),4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2015.

---

	It is the questionary survey to hemocatharsis therapy center ambulatory patient three years after the change to 22-5-O28-07 one-touch ultra view TM and one-touch writing 鎌田敬志, 佐藤拓也, 石川大介, 田中大輔, 阿部和人, 佐藤導 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2015.

---

	Effect of a liver function change and the insulin measures of the NAFLD (nonalcholic fatty liver disease) model mouse in the 22-5-O28-08 hyperglycemia state 小畑友紀雄1), 原田慎一1), 中本賀寿夫1), 森本泰子2), 金啓二3), 金守良4), 徳山尚吾1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2015.

---

	Construction and usefulness evaluation of the new educational program of the diabetes-related field for 22-5-O28-09 young person pharmacists 斉藤麻美, 峯昌敏, 佐々木恵一, 福田未音, 中嶋一惠, 村岡香代子, 月野木祥子, グリム理恵子, 國分千代, 渡邊裕之, 江頭伸昭, 増田智先 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2015.

---

	22-5-O28-10 Investigation report on the effectiveness of selective SGLT2 inhibitor Tofogliflozin 久嶋真紀子, 野口景子, 葛葉守, 中野玲子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2015.

---

	Comparison about hemorrhagic complications of 22-5-O29-11 dabigatran and the apixaban 向井優太朗1),2), 竹中裕美1), 内堀聡子1), 藤本麻依3), 細見光一3), 和田恭一1),2), 粉川俊則1), 早川直樹1), 桑原健1),2), 高田充隆2),3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2015.

---

	Search of the risk factor giving it to the hemoglobin drop in the patients using the edoxaban after 22-5-O29-12 artificial joint replacement 森川祥彦1), 榎屋友幸1), 長谷川正裕2), 宮本明希1), 村木優一1), 岩本卓也1), 須藤啓広2), 奥田真弘1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2015.

---

	Usefulness in oral administration and the simple suspension method transluminal administration of 22-5-O29-13 rivaroxaban and apixaban NOAC2 agent and safe examination 鳥谷部翔1),2), 花田和大1), 船水梨沙1), 阿部早苗1), 高瀬公子1), 久米田一喜1), 倉内寿孝1), 藤田尚子2), 萩井譲士3), 佐々木都子3), 清野聡3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2015.

---

	A pharmacist being able to be involved in proper use of NOAC and Warfarin to look back toward from the experience of five 22-5-O29-14 hemorrhagic complications 宮崎文子1), 金子伸吾2), 浅川隆重1), 今井智重子1), 織田佳人1), 伊藤誠3), 山内康照4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2015.

---

	It is examined the use of NSAIDs situation in the patients and the factor associated with the acute renal failure after 22-5-O29-15 artificial joint replacement 矢ヶ部良太1),2), 傍示幸1), 江口弘晃1), 園畑素樹2), 田崎正信1), 馬渡正明2), 原英夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2015.

---

	Safe examination of edoxaban in the 22-5-O30-16 our hospital 宮村大佑1), 芦川直也2), 岩田晃佳1), 高橋麻美1), 石黒英行1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2015.

---

	Safe examination of triple therapy by 22-5-O30-17 DAPT+NOAC 岩田晃佳1), 芦川直也2), 宮村大佑1), 高橋麻美1), 石黒英行1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2015.

---

	Search of the phlebitis onset factor in the 22-5-O30-18 nicardipine undiluted solution periphery administration 澤田真嗣, 大塚充, 中西裕明, 堀内あす香, 藤田敦夫, 友金幹視, 三上正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2015.

---

	Examination about 22-5-O30-19 amiodarone-induced thyroid function abnormality and amiodarone and the amiodarone metabolite blood level 大和幹枝1),2), 和田恭一1),2), 粉川俊則1), 早川直樹1), 安斉俊久3), 藤本麻依2), 細見光一2), 高田充隆2), 桑原健1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2015.

---

	Search of the factor associated with the onset of rhabdomyolysis period attributable to the 22-5-O30-20 HMG-CoA reductase inhibitor 高木彰子1), 小林統2), 橋本知貴1), 清野敏一1), 中村均1), 濃沼政美1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2015.

---

	Comparison of adverse event frequencies in Monthly TC therapy and the dose22-dense TC therapy for 22-5-O31-21 ovarian cancer, the cancer of endometrium 前田知穂, 橋本未雷, 大園ゆかり, 林淳一郎, 平山俊一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2015.

---

	Taste in the 22-5-O31-22 bortezomib administration mouse-sensitive change 大石晃弘, 宮本花凜, 今井瑞香, 中西椋子, 小林恭子, 林亜希子, 西田健太朗, 長澤一樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2015.

---

	An example of the patients on dialysis who 22-5-O31-23 Aki Shichi nib was given, and presented with an acute hepatitis severe form and cardiopulmonary arrest 岩崎瑛子, 岩本明日香, 藤江直輝, 綛谷哲也, 竹田健志, 小森桂子, 石樋康浩, 的場美香, 山東真寿美, 高木麻里, 藤田敬子, 坂上嘉浩, 室井政子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2015.

---

	About the onset of adverse event situation with azacitidine in the 22-5-O31-24 myelodysplastic syndrome 西村栄一, 近藤智幸, 紙谷章基久, 吉田さゆり, 増渕幸二, 簑島弓未子, 下道一史, 橋本光生, 後藤吉延 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2015.

---

	Examination of the associated factor of the excessive change of the serum Na level by the 22-5-O31-25 tolvaptan 廣瀬正幸1), 田中伸享2), 矢野裕子1), 吉田夕貴1), 寺本智彦2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2015.

---

	22-5-O32-26 physician, the pharmacist arrest you, and how do they report information on adverse drug reactions? 佐藤宏樹, 澤田康文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2015.

---

	Construction (the second report) of information on adverse drug reactions collection, analysis, the evaluation system in the 22-5-O32-27 community pharmacy 中嶋瞳1), 佐藤宏樹1), 笹嶋勝2), 澤田康文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2015.

---

	Role of the actual situation of the 22-5-O32-28 drug induced hepatic injury and the pharmacist 橋本陽1), 長谷川真左子1), 大森茂2), 小出哲朗1), 石川久高1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2015.

---

	About the questionnaire results about the uterine cervix cancer vaccine second response in the specialist in citizen of 22-5-O32-29 Shizuoka consecutive drug committee and future correspondence 聞間明子1),2), 濱口祥子1), 竹端尚美2), 吉岡優子3), 中村ほなみ3), 米澤由希子4), 唐木良子5), 林昭文6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2015.

---

	The 2 symptom that produced hyponatremia by administration of the 22-5-O32-30 linezolid 穂積廣, 位田裕美, 竹本雄一, 水谷愛音 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2015.

---

	Measures and improvement effect in the drug control that raised an extraction rate of the 22-6-O33-01 generic medicine 室宮智彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2015.

---

	Examination and evaluation about the change of the 22-6-O33-02 generic medicine 関屋裕史, 奥村学, 岩切智美, 有森和彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2015.

---

	The clinical effect on drug duties that a drug name printing design of the 22-6-O33-03 tablet gives and attitude survey of the patients 松本芳, 岡村央, 小山智代, 小池博文, 西川能治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2015.

---

	What is 22-6-O33-04 "added value?" "Wish" that we put to ... naftopidil OD lock "Sawai" ... 河井嶺男1), 梅村香織2), 野沢健児2), 柳敏宏2), 徳永雄二2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2015.

---

	Dosage form design of 22-6-O33-05 candesartan OD lock "Sawai" 福原康史, 中川知哉, 菊岡広晃, 徳永雄二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2015.

---

	Generic drug lectotype using the 22-6-O34-06 cluster analysis 早川正信, 柳川堯 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2015.

---

	Correlative evaluation with the usability of physicochemical data and humans of the 22-6-O34-07 heparinoid from animal organ-containing semisolid preparation 杉山育美1), 松本智典2), 伊藤勝彦2), 佐塚泰之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2015.

---

	The "safe rating system video of the generic drug" appreciation in the 22-6-O34-08 pharmacy education and the effect 中嶋幹郎1), 大山要1), 榎本初音1),2), 西村奈緒恵2), 立木秀尚2), 中嶋弥穂子3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2015.

---

	A change and fact-finding of the number of the generic name prescription of the foreign outside Parliament prescription in the hospital attached to 22-6-O34-09 Nippon Medical School 萩原研, 大坂奈央子, 齊藤まみ, 伊勢雄也, 片山志郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2015.

---

	Efforts of the skill up multicenter through a choice evaluation of the 22-6-O34-10 generic medicine 廣井順子1), 舩津久美2), 樅山淳子3), 山田啓美3), 大工原ゆかり1), 森田理恵子1), 塩地園代4), 安藤恵5), 小竹慶子6), 石井紀子6), 大山修7) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2015.

---

	It is suggested intelligence and the utilization system after marketing by the MS of the 22-6-O35-11 wholesaler of drug 澤田康文1), 佐藤宏樹1), 浅野貴代2), 増田眞由美2), 渡辺涼香2), 内藤温子2), 三浦康正2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2015.

---

	Needs investigation to 22-6-O35-12 remote island, the use of OTC pharmaceutical products actual situation in the urban area and a pharmacist 三木晶子, 佐藤宏樹, 澤田康文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2015.

---

	Ethnography in the 22-6-O35-13 home Residual medicine 木村菜月1), 三木晶子2), 花輪りつ3), 矢吹久美子4), 平山匡彦5), 山口裕次6), 佐藤宏樹2), 澤田康文2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2015.

---

	An attitude survey and the present conditions of the pharmacist for the 22-6-O35-14 Residual medicine adjustment 図師清二1), 北村通康1), 井上真理1), 松岡亜由美1), 宮本章平1), 東野純一1), 濱田篤秀1),2), 平松久嗣1), 京谷庄二郎2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2015.

---

	22-6-O35-15 Awareness survey on proper use of drugs for elementary school students and efforts of medicine class 大林真幸1),2), 中山真織子1), 安井紗緒里1), 飯田謙司1), 早坂幹生2), 宮本千鶴子2), 平岡千英1), 神山紀子1), 石田伸一2), 金子敦美2), 山元俊憲1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2015.

---

	We investigate the problem of the pharmacist from the prescription trend of the osteoporosis treatment injection drug of the 22-6-O36-16 our hospital 中島恵子, 角井碧, 得能千晶, 瀧口幸子, 永田佳子, 清上和也, 大田博子, 橋本佳浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2015.

---

	The use actual situation and safety assessment of the edoxaban in 22-6-O36-17 venous thromboembolism treatment 佐藤信恵, 大橋養賢, 勝海学, 千田昌之, 谷地豊 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2015.

---

	The prescription situation of 22-6-O36-18 prescribed medicine and the driving prohibition medicine in the driving 1 general hospital outpatient department 春日章宏1), 大森一郎2), 打田佑人3), 石井千加2), 斉藤晴彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2015.

---

	International comparison between 22-6-O36-19 prescribed medicine and attention contents about the driving in the driving 2 package insert 大森一郎1), 春日章宏2), 石井千加1), 打田佑人3), 斉藤晴彦2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2015.

---

	Correspondence second report to the prescription of pharmaceutical products having an influence on the 22-6-O36-20 driving 木津純子1), 高橋佑介1), 黒田裕子1), 松元一明1), 山田純一2), 永田泰造2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2015.

---

	Fact-finding about the oral medicine management of patients with 22-6-O37-21 dementia 本樫寿裕, 小山遥, 横地由仁 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2015.

---

	Role of many types of job cooperation approach - pharmacist for patients with proximal 22-6-O37-22 thighbone bone fracture and pharmaceutical management ... 萩行正博1), 宮田志生1), 重本顕史2), 澤口毅2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2015.

---

	Significance, the actual situation, problems and countermeasure of the cooperation between a pharmacist, the care people in the 22-6-O37-23 nursing facility 白石朗1), 古泉良1), 小田玲子1), 新海成美1), 加藤洋一1), 舟橋健一1), 馬来秀行2), 佐藤宏樹3), 三木晶子3), 小西ゆかり2), 臼井順信1), 澤田康文3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2015.

---

	Problems at inhalational instruction from the questionary survey on the 22-6-O37-24 whole country scale to understood elderly people 平大樹1), 小熊哲也2), 腰山節子3), 堀江健夫4), 吉村千恵5), 百瀬泰行6), 白木晶7), 寺田智祐1), 駒瀬裕子8) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2015.

---

	Examination of the possibility that 22-6-O37-25 thickness adjustment food disturbs drug collapse 山島糸, 瀧本紫乃芙, 森野真由, 鳥羽英理子, 河原昌美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2015.

---

	Discharge prescription investigation of patients with depression in the 22-6-O38-26 fine weather sum hospital 遠藤洋1), 稲垣中2),3), 稲田俊也1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2015.

---

	For the medical treatment that is effective by efforts - security of the consultation before medical examination by the pharmacist for patients receiving 22-6-O38-27 sustained-release antipsychotics parenteral injection - 菅野ゆみか, 平野弘美, 山下由季惠, 大谷美子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2015.

---

	Usefulness of the SCAP method in the class of patients of the 22-6-O38-28 our hospital 加藤昭一, 福士陽子, 上川原麻弥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2015.

---

	Ward drug duties - for patients with relation - chronic phase schizophrenia of the pharmacist in the 22-6-O38-29 mind medical treatment ward 細木加寿子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2015.

---

	Efforts of the proper use of a 22-6-O38-30 benzodiazepine system antianxiety drug (antianxiety drug of BZ origin), the hypnotic drug 亀山聡美1),6), 竹内松美5),6), 松岡恵理香5),6), 岡部まどか5),6), 小林正則1),6), 横山道江2),6), 渡邉貴博3),6), 岩井雄司4),6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2015.

---

	It is sleep hygiene instruction ... in ... health insurance pharmacy for the 22-6-O38-31 benzodiazepine system hypnotic drug reduction 岡部まどか1), 竹内松美1), 松岡恵理香1), 片田知花2), 山田菜央実1), 亀山聡美2), 土屋辰司1), 青山栄司1), 渡邉貴博3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2015.

---

	Examination about the change of the needs to the pharmacist of other types of job by the 22-7-O39-01 drug control instruction duties start 龍田涼佑, 内匠幸恵, 村谷菜々子, 佐藤雄己, 伊東弘樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2015.

---

	Improvement of the pharmacist duties using the 22-7-O39-02 incompatibility list 山口泰弘, 川俣洋生, 林淳一郎, 平山俊一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2015.

---

	Examination about the usability of the 22-7-O39-03 percutaneous absorption antiphlogistic balm and document making 菅大地, 三上大貴, 佐藤裕資, 越田晋太郎, 手塚悠希, 鈴木千波, 田畑裕和, 柴波明男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2015.

---

	The category grant to drug information contents for 22-7-O39-04 patients, citizens and the evaluation 香川由美1), 堀里子1),2), 三木晶子1), 佐藤宏樹1), 澤田康文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2015.

---

	Fact-finding of the warning information of the ethical drug package insert in 22-7-O39-05 Japan 大城隼也, 見野靖晃, 上田香織, 山田尚広, 内藤隆文, 川上純一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2015.

---

	It is ... through the role of the drug information room newspaper which became the periodical binding nine times and the questionary survey of the physician of evaluation - 99 for 22-7-O40-06 17 years 奥野昌宏, 久保嘉靖, 中田学 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2015.

---

	Present conditions investigation of the patients outcome with the operational start of the 22-7-O40-07 tracing report 畑中知笑美1), 村木優一2), 内田佳久1), 梅本彩加1), 草川美乃1), 津幡理恵1), 末澤千恵1), 須藤早百合1), 奥田真弘2), 野田明雄1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2015.

---

	Construction of the drug control instruction system superior in 22-7-O40-08 cost performance 飯田優太郎1), 佐々木貴寛1), 伊藤香織1), 相馬真志1), 中村悦子1), 小川義敬1), 中嶋俊之2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2015.

---

	Does the 22-7-O40-09 patients basics information accord between drugstores? It is ... from the competitive review between ... plural drugstores 佐々木智美, 田中秀樹, 福岡勝志, 三津原庸介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2015.

---

	Construction of the 22-7-O40-10 ward drug duties support server 安福修平1), 森田紗代1), 田畑佳祐1), 池尾崇志1), 齋藤翔太1), 數田素子1), 雀部貴美代1), 石田達彦1), 吉田直恵1), 斉藤善久2), 丸尾原義3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2015.

---

	Rebuilding of the anticancer agent preparation support system with the 22-7-O41-11 preaudit screen 和田良浩, 池田和之, 吉村忠道, 吉川一吾, 辻力夫, 森田幸子, 梶井節子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2015.

---

	Decontamination effect of the anticancer medicine pollution environment using 22-7-O41-12 ozone water and the sodium hypochlorite 濱宏仁1),2), 橋田亨2), 田中詳二1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2015.

---

	The use situation after 22-7-O41-13 closed system anesthesia mixed preparation appliance [chemosafe] introduction of 5 years 中村美樹, 今井美恵子, 岡本安紀, 寺崎実希, 戸川尚美, 中森光子, 小倉朋子, 岸敬子, 仲西未佳, 平田貴大, 松山芽衣, 谷車彩夏, 常村弥生, 廣本真里, 多胡和樹, 黄前尚樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2015.

---

	Properties of matter change of the preparation with the 22-7-O41-14 polypharmacy and proper use of the drug 飯村菜穂子, 桐山和可子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2015.

---

	Study on insoluble particulate matter derived from 22-7-O41-15 injection syringe (the second report) 菅原拓也1), 荒井浩一1), 倉本敬二2), 東海林徹3), 白石正4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2015.

---

	Examination of the simultaneous assay using the solid-phase sampling of immunosuppressive drug Cyclosporine, Tacrolimus, Sirolimus, Everolimus four drugs by the 22-7-O42-16 LC-MS method 島崎花梨, 田内淳子, 亀和田有紗, 阿部昌代, 藤井千香子, 飯塚瑞穂, 西村友希, 歌田優佳, 松本邦洋, 大野恵子, 岸野吏志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2015.

---

	Examination of the LC/MS/MS analysis system of the 22-7-O42-17 poison in medicine thing poisoning causative agent 前川正充1), 小梶哲雄2), 菊地正史1), 田中雅樹1), 中曽根正皓1), 野田あおい1), 矢内一成1), 鈴木博也1), 赤坂和俊1), 久道周彦1), 山口浩明1), 眞野成康1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2015.

---

	Examination about the effect of blood tacrolimus levels in the acute GVHD prevention after the 22-7-O42-18 hematopoietic stem cell transplantation 今井奈津美1), 小井土啓一1), 渡部大介1), 西渕由貴子1), 橋本浩伸1), 大塚知信1), 金成元2), 山下卓也2), 福田隆浩2), 林憲一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2015.

---

	The comparison of the blood level assay of the 22-7-O42-19 methotrexate and clinical evaluation 畠山史朗, 佐藤一真, 豊口禎子, 白石正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2015.

---

	One case that 22-7-O42-20 pharmacist contributed to phenytoin doses adequacy of patients on dialysis with the hypoalbuminemia 岡田孝之1),2), 法橋純子1), 小山由美子1), 世良有雅1), 加茂美智子1), 高木好夫1), 阿瀬井宏一1), 徳山尚吾2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2015.

---

	It is a case with suspected onset of neuromuscular blocking action by amikacin of the blood level in the 22-7-O43-21 therapeutic range 山形真一1), 久米正純2), 大石博史3), 井口ミサヲ4), 重松絹子4), 加藤愛子5), 幸邦憲1), 中川義浩1), 大神隆行3), 武藤庸一2), 冨澤達3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2015.

---

	Examination of the Teiko plastic Nin medication method in patients with 22-7-O43-22 febrile neutropenia 堀哲史1), 須田恭弘1), 澤井健太1), 多賀野正嗣1), 竹田和也1), 藤村保夫1), 熊野麻衣子2), 高木和貴3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2015.

---

	Examination about the initial administration plan of 22-7-O43-23 vancomycin 中田一孝, 冨田有香 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2015.

---

	Change of our hospital Vancomycin TDM with the introduction of 22-7-O43-24 antimicrobial TDM guidelines 平野龍一1), 坂本勇一2), 山本章二1), 工藤久美子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2015.

---

	Inspection of the use of vancomycin hydrochloride injection drug change of a situation by the 22-7-O43-25 antimicrobial round enforcement 大石泰也1), 西村紀子1), 東めぐみ1), 鷲見理恵1), 川野昭1), 田嶋信子2), 石丸敏之3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2015.

---

	Evaluation of the use of antiMRSA medicine patients round in the 22-7-O44-26 Nagaoka Red Cross hospital 小林謙一1), 西堀武明2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2015.

---

	Examination of the efforts contents by the ICT round in the 22-7-O44-27 our hospital 田中順子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2015.

---

	The effect that a person coming to the hospital gives to 22-7-O44-28 inside the hospital MRSA distribution 柴田高洋1), 岡田直人1), 伏谷秀治1), 柴田洋文3), 川添和義1),2), 石澤啓介1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2015.

---

	Search of the risk factor of UTIs to assume 22-7-O44-29 ESBL-producing E.coli origin bacteria 橋本麻衣子1), 瀬角りほ2), 三村享3), 春日恵理子4), 松本剛4), 本田孝行4), 濱本知之2), 山折大1), 大森栄1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2015.

---

	Examination about construction and the effect of the antimicrobial stewardship promotion system in the scale hospital out of 22-7-O44-30 佐村優, 倉田武徳, 廣瀬直樹, 石井淳一, 南雲史雄, 鯉淵寛之, 腰岡桜, 青木均文, 内田仁樹, 山本隼也, 川名絢子, 井上純樹, 関根寿一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2015.

---

	Evaluation - of the use of antimicrobial fact-finding - oral switch therapy of the perioperative patients in the 22-7-O44-31 dentistry domain 吉田謙介1), 磯辺浩和1), 新木貴大1), 中川裕介1), 石田みなみ1), 田村隆1),4), 船山昭典2), 児玉泰光3),4), 小林正治2), 高木律男3), 田邊嘉也4), 外山聡1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 241-241, 2015.

---

	Usefulness of the workshop for the drugstore pharmacist to support 22-8-O45-01 outside Parliament prescription test value indication 田中瑠美1), 渡邊裕之1), 秦晃二郎1), 末次王卓1), 田島壮一郎1), 大畠俊一1), 福田未音1), 了戒百合子1), グリム理恵子1), 金谷朗子1), 高木淳一2), 瀬尾隆2), 増田智先1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2015.

---

	Usefulness evaluation of the outside Parliament prescription which printed 22-8-O45-02 clinical test value 萱野勇一郎, 深津祥央, 木村嘉彦, 尾崎淳子, 石塚良子, 矢野育子, 松原和夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2015.

---

	About efforts to the clinical test value and cancer chemotherapy protocol name indication to 22-8-O45-03 outside Parliament prescription 神原康佑1), 池田由香子1), 佐原理沙1), 大石知枝美1), 原景子1), 村上信行2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2015.

---

	It is efforts ... of ... Iwakuni pharmacist society and the NHO Iwakuni medical center about the test value notation of the outside Parliament prescription which determined 22-8-O45-04 enforcement duties and the effect 尾崎誠一1), 中村嘉孝1), 河田尚己2), 村中扶美子2), 廣子真大2), 渡邉宗男2), 小澤秀弘1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2015.

---

	Efforts of the medicine medicine cooperation in the 22-8-O45-05 anticancer agent prescription 秋葉由華1), 小林篤史1), 武田智子2), 長谷川晃司2), 和田淳2), 乙黒万喜子3), 古曽部毅4), 箕輪圭一郎5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2015.

---

	We support 22-8-O46-06 depopulated old local drugstore activity using a prescription database 富田基郎1), 大林秀樹2), 瀬川正昭2), 藤原真治3), 田中正巳4), 中野泰子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2015.

---

	Case of Alzheimer's dementia that led to medication compliance, neurologic manifestation, the improvement of clinical manifestations by the intervention of the pharmacist in 22-8-O46-07 treatment at home care 成井繁 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2015.

---

	About introduction and the usefulness of the efforts - anticoagulant information cooperation sheet of the hospital pharmacy Monma information cooperation in the 22-8-O46-08 Sasebo district - 濱邊秋芳1), 嶋田聖子1), 納富貴子1), 武田典子1), 岩村直矢2), 溝口裕子3), 井福隆史4), 谷口一成5), 日置浩一郎6), 小島敏行3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2015.

---

	Efforts to Residual medicine adjustment by the 22-8-O46-10 medicine medicine cooperation 市野貴信1),2),3),4),5), 松田明里紗1), 勝弘毅1), 尾上涼馬1), 小林竜也2), 野間誠司3), 伊豆川愛4), 犬飼直也5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2015.

---

	Proper use situation ... of 1 pharmaceutical products risk minimization plan - cinacalcet in the 22-8-O47-11 Kurashiki center Hospital 赤木晋介, 木村洸, 加納沙代子, 長尾由佳, 亀井健人, 高柳和伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2015.

---

	22-8-O47-12 Minimization plan for drug risk at Kurashiki Chuo Hospital Part 2 : Proper usage of Seroquel(R) tablets, Zyprexa(R) tablets 加納沙代子, 木村洸, 赤木晋介, 長尾由佳, 亀井健人, 高柳和伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2015.

---

Indication ... of the test value to the prescription which stood on the use situation of 3 pharmaceutical products risk minimization plan - our hospital in the 22-8-O47-13 Kurashiki center Hospital 木村洸1), 加納沙代子1), 奥田亜希子1), 杉島佑美1), 財満奈央子1), 森美佳子1), 吉開晶一1), 村山慶2), 亀井健人1), 赤木晋介1), 高柳和伸1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2015.

---

	Effect on cancellation, weight loss ... at examination - serum potassium level drop of the effect factor to give to the proper use of the 22-8-O47-14 serum potassium remover 岡本伸也, 村上史承, 岡田昌浩, 杉原弘記, 後藤裕香, 星野祥儀, 神垣江里奈, 山田理恵, 岡崎和子, 向井弘恵, 竹井英介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2015.

---

	22-8-O47-15 Prescription status of RELVAR(R) ELLIPTA(R) and guidance situation survey at insurance pharmacy 林万紀子, 眞継賢一, 塚本泰彦, 濱口良彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2015.

---

	The future prospects including construction and the medicine medicine cooperation of the drug management system which was useful in palliative care team rounds in the 22-8-O48-16 our hospital 平野光枝, 鈴木博晃, 佐藤仁宣, 朝日仁美, 手渡和子, 米持奈津美, 石田琢人, 豊田康義, 加藤一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2015.

---

	Approach ... for making - delirium of in-hospital delirium guidelines based on 22-8-O48-17 evidence 小川大介1), 中島美穂1), 武本千惠1), 今村牧夫2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2015.

---

	Proper use promotion of the fentanyl sublingual tablet by the 22-8-O48-18 fentanyl tight military ration protocol 杉山惠亮, 中村和行, 粟田浩文, 井原将太, 上條史帆里, 石川歩未, 鈴木穂奈美, 米山英二, 勝見章男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2015.

---

	Activity of the pressure sore medical treatment workshop in 22-8-O48-19 Chiba 柏倉康治1),2), 飯塚雄次2), 小池彩子2), 森本数子2), 本澤葉留美2), 飯嶋久志3), 棗則明2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2015.

---

	Role of the pharmacist in the 22-8-O48-20 heart failure team 林慎二, 大西順子, 李美淑 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2015.

---

	Attempt of medical treatment management (PBPM) based on the protocol of the oxybutynin hydrochloride patch by the 22-8-O49-21 area medicine cooperation 三橋悠希1),2),4), 永江浩史3), 前堀直美1),3), 清水義充1),5), 鈴木愛1),6), 森英祐1),7), 譲原康夫1),8), 鈴木常義1),9), 大森類1),10), 曽布川洋平1),2), 増井俊充1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2015.

---

	Work of the pharmacist changing in 22-8-O49-22 report, a prescription 杉田康1), 松岡由美子1), 大津裕美1), 南達也1), 畑谷侑希1), 狭間研至1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2015.

---

	Two cases that reached the change of prescription by the active intervention of the 22-8-O49-23 pharmacist 松岡由美子1), 狭間研至2), 南達也1), 畑谷侑希1), 大津裕美1), 杉田康1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2015.

---

	To support community medical care cooperation aiming at patients with 22-8-O49-24 staying alone adherence improvement 上村忍1), 桑野淳1), 力丸龍二2), 立山勝規3), 鬼塚一郎4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2015.

---

	Fact-finding of the pharmacist participating in the oral anticancer medicine in the 22-8-O49-25 cancer practice cooperation base Hospital neighborhood drugstore 川澄賢司1), 鈴木真也1), 櫻井洋臣2), 山口雅也2), 齊藤真一郎1), 遠藤一司3),4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2015.

---

	22-8-O50-26 Approach to cooperation of disease medicine in Daklinza, Sunvepra combination therapy using drug information management shared sheet 井上裕貴1),2),3), 上床遙1), 石井ゆに香1), 平嶋昇2), 吉田知由3), 山口布沙1), 竹内正紀1), 島田昌明2), 松本修一1), 岩瀬弘明2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2015.

---

	Efforts of the medicine medicine cooperation aiming at adherence improvement of the 22-8-O50-27 teriparatide self injection preparation 三谷和恵1), 波多晶子1), 中澤美樹子1), 窪田真弓1), 高崎可奈2), 中田郁子2), 五十嵐健太郎3), 鶴居勝也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2015.

---

	DPI preparation proper use investigation of the outpatient who assumed the inspiratory flow rate of the 22-8-O50-28 in check an index 本田愛実1), 尾崎誠一1), 河田尚己2), 村中扶美子2), 廣子真大2), 中村嘉孝1), 寺山恵子1), 田阪武志1), 渡邉宗男2), 小澤秀弘1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2015.

---

Examination ... from a questionnaire targeted for efforts of the pharmaceutical cooperation in the 22-8-O50-29 respiratory system inhalant and inhalational instruction study session - neighborhood health insurance pharmacy pharmacist 米田勝晃1),2), 高谷友里1), 生川賀代1), 徳永奈都子1), 西野真代1), 田辺涼1), 西尾佳奈1), 藤井久美子1), 増田晶子1), 中谷早希1), 小林厚2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2015.

---

The evaluation of the discharge teachers' textbook for the purpose of the promotion of the medicine medicine cooperation with the 22-8-O50-30 Nakagyo pharmacist society and questionary survey for the treatment at home 黄前尚樹1), 内藤舞2), 今井美恵子1), 岡本安紀1), 寺崎実希1), 戸川尚美1), 中森光子1), 岸敬子1), 仲西未佳1), 平田貴大1), 松山芽衣1), 常村弥生1), 谷車彩夏1), 廣本真里1), 小倉朋子1), 多胡和樹1), 中村美樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2015.

---

	The inflection of the 22-8-O50-31 Hitachinaka health IT network and the usefulness 名越ソッヴィリヤック ヴァッティ1),2), 玉井典子1),2), 関利一3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2015.

---

	Association with the expression situation and the effect of treatment of hypomagnesemia by the antiEGFR monoclonal antibody in patients with 23-4-O51-01 metastasis colon cancer and the acneform rash 藤井宏典1), 飯原大稔1), 石原正志1), 松橋延壽2), 高橋孝夫2), 吉田和弘2), 伊藤善規1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2015.

---

	Measures to an allergic reaction at the 23-4-O51-02 Docetaxel administration 西村知恭1), 嶋本めぐみ1), 佐野尚平1), 園部比呂志1), 岩城久弥1), 下野千草2), 上田弘樹2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2015.

---

	About association with thrombocytopenia and APRI (AST to Platelet Ratio Index) in patients receiving oxaliplatin for patients with 23-4-O51-03 colon cancer 谷口賢二1), 和田祐一1), 上田愛1), 小林一彦2), 岩田真3), 福永浩也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2015.

---

	It is an administration dose intensity of oxaliplatin of mFOLFOX6 treated patients in the adjuvant chemotherapy and association with the progression-free survival period after 23-4-O51-04 colon cancer technique 地主隆文, 鈴木直哉, 前川英輝, 菊地義明, 藤林遼, 福井美規子, 吉嶋抄苗, 徳村麻衣子, 高橋誠, 青田忠博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2015.

---

	Examination of the dose of D-mannitol in the short hydration method of the 23-4-O51-05 cisplatin 今井千晶1), 佐伯宏美1), 栗本遼太2), 江畑貴大2), 岩澤俊一郎2), 堺田惠美子3), 鈴木貴明1), 有吉範高1), 滝口裕一2), 石井伊都子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2015.

---

	Investigation about the risk factor of the 23-4-O52-06 ifosfamide encephalopathy 川田将義1), 中川俊作1), 西村綾1), 矢野育子1), 中川貴之1), 岡本健2), 松田秀一2), 松原和夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2015.

---

Self-control controlled trial - VANQUISH trial - about the protective efficacy of the vitamin K1-containing cream for the 23-4-O52-07 cetuximab-related cutaneous symptom 加藤敏明1), 山崎健太郎2), 多久佳成3), 對馬隆浩2), 吉田幸生2), 濱内諭2), 吉川周佐4), 八木宏明5), 木村仁1), 石川寛1), 木村緑6), 中條倫成6), 坂田茂代1), 増島広幸1), 宮澤綾1), 斎藤加織6), 伊澤真木子7), 石見香8), 山中竹春9), 清原祥夫4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2015.

---

	The establishment of the side effect prevention system for the 23-4-O52-08 Afatinib remedy patients and the evaluation 小森由理子1),2), 清水克次1), 中多陽子1), 高橋一栄2), 福島宣久1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2015.

---

	The expression situation of the hypothyroidism with the 23-4-O52-09 molecules target medicine and the enforcement situation of thyroid function tests 頼光翔1), 島林逸人1), 山田弓美1), 園山智宏1), 平野榮作1), 横手克樹1), 竹下和男1), 村瀬哲也2), 泉谷悟2), 櫻下弘志2), 西垣内亮2), 佐伯康之2), 松尾裕彰2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2015.

---

	Onset of neutropenia investigation in the 23-4-O52-10 modified FOLFIRINOX therapy 中村匡志, 鈴木賢一, 渡邉大至, 柴田直樹, 濱敏弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2015.

---

	The expression situation of the cholinergic syndrome with 23-4-O53-11 irinotecan and the measures 久保杏奈, 米澤美和, 山田千代子, 柏原宏暢 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2015.

---

	Evaluation of the expression situation and the risk factor of edema induced by 23-4-O53-12 pemetrexed 遠藤拓未1), 伊藤大輔2), 浅野裕紀2), 岩井美奈2), 安達志乃2), 岡田和智2), 宇佐美英績2), 吉村知哲2), 石原祥史3), 坪井久美3), 平野公美1), 小菅和仁1), 渡邉進士1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2015.

---

	Relations with a hand-and-foot syndrome and the temperature in 23-4-O53-13 docetaxel treated patients and the steam pressure 内田敬, 土屋雅美, 猪岡京子, 高村千津子, 鈴木幹子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2015.

---

	The effect that steroid to use for 23-4-O53-14 cancer chemotherapy gives in start of therapy time for febrile neutropenia 宇夛裕基, 河原昌美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2015.

---

	About the adaptability to elderly patients of the 23-4-O53-15 gemcitabine / dexamethasone / cisplatin (GDP) relief therapy 片山実佳1), 北澤文章1), 角陽子1), 上田久美1), 初瀬真弓2), 島崎千尋2), 高良恒史3), 国府孝敏1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2015.

---

	The production of the video for patients introducing 23-4-O54-16 pharmacist duties and the evaluation 玉木啓文1),2), 佐藤宏樹1),2),3), 三木晶子1),2),3), 三浦康正2), 藤原眞理子2), 澤田康文1),2),3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2015.

---

The change of the number of trial trust and duties contents in the hospital attached to the 23-4-O54-17 Kyoto University faculty of medicine in these 10 years 吉田詩織1),2), 老本名津子1),2), 松山倫子1),2), 神山ゆかり1),2), 緒方奈津紀1),2), 因藤伊織1),2), 佐藤栄里子1),2), 松尾和美2), 石橋茜2), 猪熊容子1), 石塚良子1), 米澤淳1),2), 中川貴之1),2), 松原和夫1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2015.

---

	About a risk factor of the 23-4-O54-18 hypermagnesemia and eligibility criteria of the magnesium preparation 幸邦憲, 山形真一, 中川義浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2015.

---

	Examination in the prospective study of the serum creatinine level revision method to use for a 23-4-O54-19 renal function estimation type 森住誠1), 松野純男2), 松宮美沙1), 今岡寛美1), 池田理沙1), 金丸絵理1), 石原美加1), 松田光弘3), 北小路学2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2015.

---

	The understanding situation and problem of the pharmacist of hepatitis B reactivation measures guidelines with 23-5-O55-01 immunodepression, the chemotherapy 伊東真由子1),2), 岡智之1),3), 尾崎正和1),4), 木下英樹1),5), 藏田康秀1),6), 塚原邦浩1),7), 平岡ひろ子1),8), 光末尚代1),9), 山本武史1),10), 佐藤真也1),11), 古川裕之1),4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2015.

---

	Hepatitis B measures to occur by 23-5-O55-02 immunodepression, chemotherapy 大沢幸嗣1),2),3), 高家心人5), 光井洋4), 橋本直明4), 秦宏樹3), 大谷道輝1), 佐藤孝雄6), 寺島裕夫2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2015.

---

	Efforts to the hepatitis B virus reactivation measures that functionalized 23-5-O55-03 PDCA cycle 木全司1), 吉田弘樹1), 鈴木雅人1), 天野杏南1), 高原悠子1), 山室理2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2015.

---

	Evolution to drugstore pre-Abo id of the 23-5-O55-04 doubt inquiry example 長谷川佳孝1), 藤枝正輝1), 野中琢哉2), 林愛子1), 藤井洋介1), 月岡良太1), 森澤あずさ1), 大石美也1), 佐藤宏樹3), 澤田康文3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2015.

---

	About construction and the introduction effect of the traceability system which utilized 23-5-O55-05 pharmaceutical products GS1 bar code 木戸圭晋1), 上田宏1), 五十嵐努1), 矢野啓子2), 中田精三3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2015.

---

	Inflection in medicine manufacture settings of appearance similarity ratio evaluation system (PTPases) of the 23-5-O56-06 press through pack 高橋斉1),2), 玉木啓文3), 佐藤宏樹2), 今堀悦郎1), 井黒ひとみ1), 澤田康文2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2015.

---

	A fall, the fall in the 23-5-O56-07 inpatient and relative investigation of the prescribed medicine 諌見圭佑1), 小園亜希1), 塩田喜美子1), 津曲恭一1), 木山聡子2), 永野真久2), 井上大奨2), 平木洋一3), 中川義浩2), 神村英利4), 山道研1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2015.

---

	Development of the next-generation tablet packing (ESOP) for 23-5-O56-08 PTP mis-deglutition accident prevention 盛本修司, 野崎雅男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2015.

---

	Efforts ... to maintenance - HBV reactivation measures of the cancer practice system using the PDCA cycle in the 23-5-O56-09 Aichi cancer practice cooperation base Hospital 黒田純子1),6), 木全司2),6), 楠本茂3), 小松弘和3),6), 河田健司4),6), 室圭5),6), 木村和哲1),7),8) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2015.

---

	A start and efforts of the 23-5-O56-10 healthcare setting and the next-generation pharmaceutical products packing technology development team "Atami project" connected directly with 宮川雅樹1), 鈴木高弘1),2), 相本恒陽1), 豊浦基雄3),4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2015.

---

	About efforts of the Relief System for Sufferers from Adverse Drug Reactions education in the 23-6-O57-01 pharmacy business training 橋本義宏, 金住麻子, 久保淳一, 津田雅大, 土井佳子, 三本松泰孝, 船木映二, 佐藤弘康, 和泉秀明, 小森均 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2015.

---

	Preliminary investigation about the correspondence to a representative disease of the pharmacy business training in the 23-6-O57-02 group training 小野浩重1), 雛元悦子2), 監物英男3), 滝波昇悟3), 安藤公江4), 貝原徹5), 加地弘明1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2015.

---

	Education effect of the emergency intensive care domain learning in the 23-6-O57-03 pharmacy education business training 原直己1), 座間味義人2), 内田佳菜子1), 松田俊之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2015.

---

	Change of the impression for the psychiatry of the trainee by having introduced experience-based training in 23-6-O57-04 psychopathic ward 佐々木典子1),2), 池村健治1), 三輪高市2), 河原佑樹1), 村木優一1), 岩本卓也1), 奥田真弘1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2015.

---

	Make it, and use a text for ... business training for better mild medical education in the 23-6-O57-05 business training; and ... 形部文寛1), 八本久仁子2), 八本聖秀3), 武智宣佳4), 山崎富士子5), 中村孝佑6), 林俊吾7), 増田都子8) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2015.

---

	Usefulness of the backer-up introduction by the learning before business true taking lessons for the student with 23-6-O58-06 hearing disorder 真島崇1), 大原宏司2), 倉本敬二3), 伊藤鍛2), 早坂正孝2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2015.

---

	Role of the pharmacist of a pharmacy education curriculum and the community medical care of the 23-6-O58-07 at-home team approach in medical care promotion studies lecture 小林篤史1),2), 杉山正1), 林秀樹1), 神林純二2), 宇野進2), 北川靖3), 渡辺康介3), 上原春男3), 神野君夫3), 土井正樹3), 山脇正永4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2015.

---

	Obesity, alcohol metabolism-related genetic screening seminar for pharmacy school students aiming at the genetic information contribution as the 23-6-O58-08 pharmacist 池田佳代1), 細井徹1), 吉井美智子1), 杉山政則2), 小澤光一郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2015.

---

	23-6-O58-09 Epinephrine autoinjector training program development 万代康弘1), 石原慎2), 近藤康人3), 松井俊和2), 岡本陽4), 筒井和美4), 白井正康5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2015.

---

	Introduction (to see power to think about) of the problem contents that a correct answer person was one person in a study of the 23-6-O58-10 first grader basic biology 佐藤亜希子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2015.

---

	The effectiveness of the injectable acetaminophen preparation in the 23-7-O59-01 thoracic surgery postoperative pain management and safe evaluation 新海大智1), 澤田和久1), 粟田浩文1), 奥平正美2), 勝見章男1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2015.

---

	Attitude survey of the pharmacist before and after the class of the use of 23-7-O59-02 basic life support, automated external defibrillator 田村亮1), 高山慎司1), 川名賢一郎1), 石松伸一2),3), 後藤一美1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2015.

---

	Safe examination of the vancomycin 24 hours continuous intravenous infusion therapy in 23-7-O59-03 neonates 辻村行啓1), 犬飼康子1), 大木茂2), 塩川満1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2015.

---

	Research of the effect of herbal medicinal products on delirium in the 23-7-O59-04 first aid domain 野田治代1), 名倉弘哲1),2), 平山敬浩2), 氏家良人2), 千堂年昭3), 波多野力1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2015.

---

	Analysis of the drug information offer by the pharmacist in the 23-7-O59-05 ICU 橋本直明, 飯塚史織, 齊藤麻加, 木村あおい, 柿崎詩野, 中島正人, 堀内学, 土岐浩介, 神林泰行, 本間真人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2015.

---

	Taste bitter prediction of the compound agent using the 23-7-O60-06 taste sensor 原口珠実, 中村早貴, 白石早祐子, 竹下華子, 小島穂菜美, 吉田都, 内田享弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2015.

---

	Quality evaluation of the 23-7-O60-07 clarithromycin dry syrup 小島穂菜美, 福留夢姫, 松本早織, 原口珠実, 吉田都, 内田享弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2015.

---

	23-7-O60-08 Promotion of appropriate use of hepatitis C drug Daklinza Tablets, Sunvepra Capsules by utilizing check sheet 加藤誠一1), 田中直哉2), 近藤澄子1), 矢島毅彦3), 田中秀和1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2015.

---

	Contribution to medical treatment by the prescription checking before compounding of medicines based on the 23-7-O60-09 drug history management 川崎好人, 橋本陽, 小出哲朗, 石川久高 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2015.

---

	Investigation of the PTP sheet pollution status with the 23-7-O60-10 5 α - inverting ferment inhibitor oral medicine 松岡哲史1), 高見陽一郎1), 岡崎大祐1), 小川壮寛1),2), 佐藤展子1), 森翔馬1), 酒井将弘1), 中川碧1), 江川孝1), 島田憲一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2015.

---

	It is> mainly on the activity of the relation <Japan Team for Disaster Relief medical care team second corps of the pharmacist in the medical service for the 23-7-O61-11 Nepal earthquake damage 江川孝1),5), 萬年琢也2),5), 加藤あゆみ3),5), 涌嶋伴之助4),5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2015.

---

	Relation ... to the nation's first outdoor operating room function in the ... Nepal earthquake disaster reconsidering the medical support of the pharmacist at the 23-7-O61-12 disaster 加藤あゆみ1), 涌嶋伴之助2), 江川孝3), 萬年琢也4), 片山志郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2015.

---

	Usefulness at development and disaster of the 23-7-O61-13 drug identification support system (medicine fast for iOS) 木村敦, 木村真也, 逢坂智美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2015.

---

	Hold 23-7-O61-14 Japanese Red Cross Society disaster medical care relief squad - disaster relief pharmacist workshop; and ... 滝澤康志1),9), 小林映子2),9), 原田真理3),9), 近藤智之4),9), 追木正人5),9), 安藤和佳子6),9), 大塚万記子7),9), 下石和樹8),9) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2015.

---

	Effect of factor DDS preparation and the patients side factor CYP3A5 genetic polymorphism of the preparation giving it to costs in the 23-7-O62-15 tacrolimus year 加藤正太郎1), 新岡丈典1), 加賀谷英彰1), 佐々木克也1), 佐藤滋2), 三浦昌朋1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2015.

---

	Does sequential treatment in the 23-7-O62-16 Helicobacter pylori sanitization become the Japanese standard therapy? 岡崎彰仁 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2015.

---

	Inspection of the medical expenses reduction effect that the standard adequacy of oral 23-7-O62-17 pharmaceutical products results in 白石奈緒子1),2), 小山敏広1), 座間味義人1), 建部泰尚2), 大島礼子1), 千堂年昭2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2015.

---

	Inspection of the equivalency of a 5-FU innovator drug, the generic drug in the 23-8-O63-01 infusor pump continuation dosage law 小島一晃1), 美和孝之1), 仲忠士1), 松本弘誠1), 濱武清範1), 奥村優介1), 小西史子1), 飯田有香1), 足立那々緒1), 酒井ちひろ1), 福井美礼1), 千葉渉1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2015.

---

	Prescription suggestion of the pharmacist in patients with 23-8-O63-02 blood-forming organ tumor 南貴之, 風間静香, 花輪和己, 小林義文, 山本誠一, 磯部克彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2015.

---

	Comparison of the portable constant infusion pump varying in a flow quantity control system in the 23-8-O63-03 outpatient department chemotherapy 丸山卓哉1),2), 門脇督1), 蝦名勇樹1), 藤井達也1), 森田眞樹子1), 手塚悠希1), 鈴木千波1), 田畑裕和1), 佐藤明子2), 高橋理絵2), 柴波明男1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2015.

---

	Comparison of the antitumor effect by the combination of antihypertensive medications in 23-8-O63-04 basalioma treatment 中村希1), 門脇大介1), 高森紀衣1), 成田勇樹1), 小田切優樹2), 丸山徹1), 平田純生1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2015.

---

	23-8-O63-05 Experience in using trifluridine, tipiracil hydrochloride (Lonsurf(R)) after tertiary therapy for advanced, recurrent colorectal cancer 辻井聡容1),2), 大垣孝文2), 中永かおり2), 今井清隆2), 木瀬大輔2), 多田章二2), 天野学1), 森山雅弘1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2015.

---

	Case study of TAS- 102 (Ron surf (R)) for inability to 23-8-O64-06 curative resection progress, recurrent colon cancer 菊地寛子1), 内山由貴1), 西脇瑞紀1), 養田裕行1),2),3), 関根佳代1), 浅子恵利4), 傳田忠道5), 松本美奈子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2015.

---

	The neutropenic expression of TAS-102 (Ron surf (R)) in the renal failure that assumed 23-8-O64-07 creatinine clearance an index situation 内山由貴1), 菊地寛子1), 西脇瑞紀1), 養田裕行1),2),3), 関根佳代1), 浅子恵利4), 傳田忠道5), 松本美奈子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2015.

---

Inspection of the effectiveness of the cancer-specific antigenic peptides opsonic therapy for patients with 23-8-O64-08 progress-related head and neck squamous cell carcinoma 城野博史1), 吉武義泰2),3), 福間大喜2), 湯野晃2),4), 平山真敏2),4), 中山秀樹2), 小島拓2), 中根未季2), 尾木秀直2), 平木昭光2), 濱田哲暢5), 齋藤秀之1), 西村泰治4), 中村祐輔6), 篠原正徳2),3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2015.

---

	About the dose examination in the elderly people in the 23-8-O64-09 lung cancer CBDCA (AUC 4) + weekly nab-PTX (80 mg/m2 of day 1, 8, 15) therapy 長谷川英利1), 上中敏弘1), 松井駿亮1), 川端一功1), 田中巧1), 上田桂子2), 大内政嗣2), 尾崎良智2), 井上修平2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2015.

---

	Examination of the effectiveness of the pharmacist regimen observance intervention in the 23-8-O64-10 cancer chemotherapy 林誠1),2), 井上裕貴1), 松本修一1), 崔吉道2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2015.

---

	One case with suspected rise in lithium concentration by the interaction of 23-8-O65-11 lithium carbonate and the Terumi sultan 生島繁樹, 早見めぐみ, 前川聡美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2015.

---

	One case of progress colon cancer in acknowledgment of PT-INR rise with suspected interaction with 23-8-O65-12 Regorafenib and warfarin 北出紘規1), 北国憲剛1), 森光恵1), 矢野聖二2),3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2015.

---

	Example that an antiblood clotting effect of the warfarin reinforced at 23-8-O65-13 regorafenib combination 熊澤里美, 伊藤佳織, 安藤洋介, 安藤舞子, 太田秀基, 山田成樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2015.

---

	The case that caused significant extension of PT-INR by combination of 23-8-O65-14 high dose acetaminophen and warfarin 尾崎正和1), 幸田恭治1), 福田裕次郎2), 堀健志2), 植松俊成1), 古川裕之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2015.

---

	Effect of 23-8-O65-15 triazolam and menthol giving it to an internal change of the phenytoin 五十嵐信智, 星野心広, 廣部隆太, 楠欣己, 今理紗子, 落合和, 杉山清 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2015.

---

	Effect of the diet on drug interactions of amlodipine and the active carbon in the 23-8-O65-16 gastrointestinal tract 関耕平, 秋好健志, 今岡鮎子, 大谷壽一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2015.

---

	It is ... mainly on drug interactions with ... amiodarone through prescription support of the 23-8-O65-17 warfarin 塚井麻実1), 小松敏彰1), 小林昌宏1), 国分秀也1), 近藤留美子1), 厚田幸一郎1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2015.

---

	Examination of the method to alert on the in-hospital prescription for the quality improvement of the P0001-21-PM formulations inspection 前田力丸, 山野邉裕子, 田村賢士, 金子智一, 鈴木秀昭, 松井孝之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2015.

---

	Efforts for the simple suspension method spread in the P0002-22-AM our hospital 志田里志1), 齋藤尚子1), 佐藤貴大1), 松田千佳1), 池本真紀2), 高橋美香子3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2015.

---

	Study on preservation stability of the mixture consisting of P0003-21-PM W/O type moisture retention cream preparation and the adrenal cortical steroid ad usum externum preparation 山本佳久1), 久米谷萌水1), 大貫義則2), 深水啓朗3), 小出達夫4), 鈴木豊史5), 伴野和夫5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2015.

---

	Construction ... of the formulations shelf label making system using efforts - Microsoft Access to P0004-22-AM formulations environmental management 奥村俊一, 高沢真央, 岡部由幸, 剱田侑希, 前波麻里子, 塩地園代, 白石範子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2015.

---

	About the efficiency of compounding of medicines duties by the P0005-21-PM tablet inspection support system introduction 久保祐太, 阿部孝行, 倉林誠, 池井良貴, 山田英俊 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2015.

---

	It is examination about the stability in formulations the package of P0006-22-AM ursodeoxycholanic acid tablets 毎田千恵子1),2), 秋山滋男3), 礒野淳一3), 玉井郁巳2), 松下良2),5), 宮本悦子4),5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2015.

---

	Result and problem by the practice of the pharmaceutical instruction to P0007-21-PM outpatient 冨岡謙二, 淀川進也, 小田若那 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2015.

---

	A decision of the P0008-22-AM outpatient department prescription inquiry simplification operation and the effect 内田雅士, 新井さやか, 山崎香織, 竹田真理子, 鈴木貴明, 有吉範高, 石井伊都子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2015.

---

Analysis of the inquiry contents from the pharmacy service under health insurance drugstore for the P0009-21-PM outside Parliament prescription 正原東良1), 渋谷文則2), 江藤壮志2), 新倉卓2), 黄暁華2), 巣山郁子2), 村上瑛莉香2), 田嶋梓2), 滋田伊世2), 藤本菜奈2), 山崎智世2), 田中義幸2), 木村絢果2), 土屋純一2), 市川卓哉2), 櫻井恵理2), 内藤梨奈2), 小久保智裕2), 八巻俊哉2), 高橋信2), 廣井順子3), 中島由紀1), 杉浦宗敏1), 内川清次2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2015.

---

	About the effect that the representation input by the pharmacist at the P0010-22-AM doubt inquiry gives in change of prescription 岸敬子, 黄前尚樹, 今井美恵子, 岡本安紀, 戸川尚美, 寺崎実希, 中森光子, 仲西未佳, 平田貴大, 松山芽衣, 谷車彩夏, 常村弥生, 廣本真里, 小倉朋子, 多胡和樹, 中村美樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2015.

---

	The effectiveness of the doubt inquiry using a section system at the P0011-21-PM initial administration 山本恭平, 岩瀬由枝, 野澤孝子, 大野愛, 吉田浩, 山下雅代, 勝見章男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2015.

---

	The operation of the test value printing system for the P0012-22-AM efficiency-like checking prescription and future examination 井上理香子, 廣澤真優, 稲垣孝行, 平岩真理子, 福澤翔太, 井上由佳梨, 野村英宏, 倉地茜, 太田小織, 鳥本真由美, 山田清文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2015.

---

	About the formulations of the P0013-21-PM public corporate judicial person Fukui pharmacist society narcissus drugstore and a prescription checking support system 平賀貴志1), 福岡美紀1), 杉本訓子1), 有田奈美1), 山口洋枝1), 服部はるか1), 塗茂佳世1), 安野さとみ1), 木村嘉明2), 高畠栄一3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2015.

---

	Recognition investigation of the patients for the risk of P0014-22-AM drug remedy and the driving 今泉瑛那, 土橋安純, 平野裕美, 浦崎圭太, 菱田栄子, 河井和子, 伊藤和幸, 磯谷聡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2015.

---

	Fact-finding of the doubt inquiry in the P0015-21-PM health insurance pharmacy 高道二千香1), 十万佐知子1), 植田愛1),2), 奥田浩人1), 三木知博1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2015.

---

	The relation of the pharmacist in the P0016-22-AM outpatient department cataract surgery and future problem 吉田尚子1), 多田亜矢1), 目良りか4), 沼慎一郎3), 松井孝明2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2015.

---

	Efforts and usefulness evaluation of the doubt inquiry based on the P0017-21-PM renal function evaluation 青木健祐, 夏目義明, 齊藤政利, 渡辺重雄, 柄沢一弘, 中條睦子, 藤田真一, 美濃川香世子, 星野貴子, 田邉梨恵, 水澤彩乃 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2015.

---

	The situation and analysis of the doubt inquiry in the P0018-22-AM health insurance pharmacy 中島由香里1), 石川道佳1), 松尾浩民2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2015.

---

	The effect that a test value mention gives to doubt inquiry contents on P0019-21-PM outside Parliament prescription 野口亜樹, 山崎美保, 中下愛, 木村竜司, 今津智子, 西園寺真二, 松本篤, 前田頼伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2015.

---

	The utilization situation and problem about the test value indication to P0020-22-AM outside Parliament prescription 齊藤美聡, 横山威一郎, 山口洪樹, 山崎香織, 橋本杏里, 新井さやか, 中村貴子, 鈴木貴明, 有吉範高, 石井伊都子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2015.

---

	Construction and evaluation of the formulations medicine inspection system which utilized bar code indication of the P0021-21-PM drug for external use 小野祐志, 赤羽美樹子, 大江彰彦, 村田充弘, 新家恵子, 栗谷良孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2015.

---

	Dispensing error prevention by the P0022-22-AM image inspection support system introduction effect 硲真悟, 新嶋茂正, 松橋裕子, 阿部宏志, 神谷友理子, 大塚一興, 町島浩, 伊藤由香, 坂上逸孝, 増原慶壮, 横山美恵子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2015.

---

	The error decrease effect with the P0023-21-PM newly automatic tablet formulations system and examination of the formulations speed 小林武志, 高橋修二, 須藤将裕, 豊口禎子, 白石正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2015.

---

	About construction and the trial situation of the formulations medicine inspection image recording system using P0024-22-AM Web camera 赤羽美樹子, 小野祐志, 徳山絵生, 上野ひとみ, 上ノ山江利子, 大江彰彦, 竹中智子, 村田充弘, 新家恵子, 栗谷良孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2015.

---

	The way of a factor investigation and preventive measures to lead to P0025-21-PM normalization bias against future blunders 山田和正1), 高橋志朗1), 井上幹雄2), 小林範博3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2015.

---

	In the P0026-22-AM dispensary take; the fact-finding of the mistake 鮫島絵莉子, 進健司, 梅田勇一, 内田守次, 橋本政弘, 金澤康範 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2015.

---

	Inspection ... of the appropriate crush degree of the drug which is hard to collapse which we saw from efforts - nurse questionnaire for the problems improvement of the P0027-21-PM simple suspension method 松原満裕, 川崎奈美江, 岸脇由衣, 天生浩子, 竹内祐介, 安田光都子, 根来早紀子, 西井有希, 木村初, 小泉祐一, 野村真美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2015.

---

	Usefulness of the personal digital assistant (PDA) in P0028-22-AM calculation compounding of medicines duties 小沼利光, 神崎浩孝, 天野杏, 金聖暎, 西宮祐輔, 丸尾陽成, 田中雄太, 定金典明, 北村佳久, 千堂年昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2015.

---

	About the stability of isosorbide dinitrate tablets in the P0029-21-PM automatic packeted plane rotor cassette 林真優1), 高橋謙太1), 沼尻幸彦1), 大島新司1), 新津勝1), 古地壯光1), 小林大介1), 秋山滋男2), 礒野淳一2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2015.

---

	It is an effect of the introduction by P0030-22-AM drug management system (Narcotic Stage) 谷口公章, 北村仁, 伊藤ちか恵, 鶴田瑛典, 宮明洋一郎, 佐々木達也, 海部真代, 甲斐章裕, 力武隆浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2015.

---

	Efforts to generic medicine introduction for the contribution to P0031-21-PM Hospital management 本郷知世, 加藤一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2015.

---

	Comparison between the stable preparation becoming durability of P0032-22-AM magnesium oxide tablets and one 里加代子, 稲岡奈津子, 松本章, 佐々木均, 北原隆志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2015.

---

	Change efforts to a product (domestic product) derived from domestic blood donation of the isotonicity albumin preparation in conformity with a basic idea, basic policy of P0033-21-PM Blood Law 本田義輝, 齋藤秀之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2015.

---

	The effect that temperature of the warm water to use at the P0034-22-AM simple suspension method enforcement gives to Cravit tablets collapse 石田志朗1), 原隆志1), 山川和宣1), 渡辺智康2), 安藤哲信2), 新井克明3), 岡野善郎4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2015.

---

	Through P0035-21-PM enteral feeding tube a Valproic Acid infinitesimal grain a throw pre-; a workaround of the obstruction to occur when did it 浜田茂明1), 石田志朗2), 岡田清花2), 山川和宣2), 森本真仁1), 鈴江朋子3), 岡野善郎4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2015.

---

	Intervention ... to operating room intervention example report - PCA germfree preparation duties of the pharmacist in the scale hospital out of P0036-22-AM 栗崎貴啓1), 園田美智代2), 相方靖史3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2015.

---

	It is ... as part of review ... ward drug duties of the P0037-21-PM ward fixed number medicine 十文字菜穂, 矢作栄男, 小林庸子, 中山英明, 長澤知徳, 泉亮介, 辻健作, 安齋枝里, 篠原高雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2015.

---

	About efforts to pharmaceutical products management adequacy with the operating room permanent residence of the P0038-22-AM pharmacist 猪狩賢蔵, 鈴木信也, 野村嘉奈子, 林誠一, 安藤栄輝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2015.

---

	Introduction of the drug, locking management medicine automatic withdrawal device (Inteligent-Cabinet SYSTEM(R)) in the P0039-21-PM surgery part 長屋美香子, 只見智恵子, 山口芳幸, 林勇輔, 森敬子, 坂丹波礼子, 高橋賢成, 木村利美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2015.

---

	Efficiency of the duties by the review of P0040-22-AM inventory control duties 鈴田浩孝1), 大久保嘉則2), 三砂義敬2), 床島英雄2), 加茂章弘1), 仲村早紀1), 小迫晶寛1), 小薮真紀子1), 草葉一友2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2015.

---

	It is ... for the realization of ... imagination cassette about usefulness by the introduction of the P0041-21-PM returned goods medicine withdrawal machine 高橋功一, 樋口和子, 山口佳津騎, 水川奈己, 立道貴清, 野崎孝徒, 篠原尚樹, 小坂信二, 芳地一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2015.

---

	Examination about the effect when we changed the P0042-22-AM pharmaceutical products purchase to a little packing 角山政之1), 冨永雅枝2), 柳田徳栄2), 垰越崇範2), 松尾裕彰2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2015.

---

	Match a sublingual tablet with P0043-21-PM fentanyl buccal tablet; risk management at adoption 宮崎あゆみ, 原祐輔, 板井進悟, 高林真貴子, 平原佑季子, 嶋田努, 崔吉道 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2015.

---

	About unification of the pharmaceutical products temperature management using P0044-22-AM network 鈴木薫, 濱田武, 坂本朱里, 西原雅美, 勝間田敬弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2015.

---

	Management such as a drug, the poison in the P0045-21-PM operating room, relation of the pharmacist to operation 小出哲朗1), 山野惣平1), 吉野正康1), 西川佐喜代2), 藤代陽子2), 伊澤英次3), 玉置秀成1), 松原史典1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2015.

---

	Efforts in our hospital for P0046-22-AM Abstral sublingual tablet proper use 徳田憲治1),2), 西村絵実1),3), 川原成一2), 貴島文雄1),4), 小野原信一1),5), 柳政行1),4), 古川いづみ1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2015.

---

	Anesthesia set management in the operating room by the cooperation with the P0047-21-PM anesthesiologist 坂本有加1),2), 田中陽一郎1), 今成得恵1), 櫻井雄太1), 湯野川隻2), 武田昌子2), 郡彰一2), 松川公一2), 中村裕義1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2015.

---

	Efforts to reduction of the immovable stock in the scale hospital out of P0048-22-AM and the significance 唐橋久恵, 藤島ひとみ, 平尾尚之, 佐藤直樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2015.

---

	Efforts to pharmaceutical products inventory control efficiency in the P0049-21-PM Tsuchiura practice medical examination center 宇津木敦子, 伊藤春子, 阿部加奈子, 小野崎昌史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2015.

---

	Inspection of the effect after the P0050-22-AM pharmaceutical products digestion payment system introduction 深見徹郎, 岡亜矢子, 久原紀子, 横尾賢乗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2015.

---

	Examination and preparation stability evaluation of the formula of P0051-21-PM hospital preparation 0.033% PA, iodine eye drops 西川満則, 中村歩, 八木裕太, 細川祐岐, 森本啓太, 田邉沙織, 百崎久恵, 勝浦正人, 門脇裕子, 三輪芳弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2015.

---

	Examination second report of the Mitsuyasu qualitative analysis of P0052-22-AM Lambert-Eaton myasthenic syndrome therapeutic drug 3,4-diaminopyridine and photodegradation thing 小林恵里奈1), 上田真理1), 内山正彦2), 福吉修一3), 石田奈津子1), 舟木弘1), 松下良3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2015.

---

	Examination of the infusion preparation using P0053-21-PM KOACH C645-F 長岡匠, 鈴木理穂, 越川千秋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2015.

---

	Examination of the pharmaceutics of the new stomatitis therapeutic drug using P0054-22-AM mesalazine 石破佳永子, 下村斉, 河野弥生, 花輪剛久, 青山隆夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2015.

---

	The use situation of the Yokukansan suppository which we gave at surgery for the purpose of the delirium prevention after P0055-21-PM technique 京由美子, 吉岡亮, 乾有希子, 池田久雄, 野村浩英 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2015.

---

	Examination of stability and the usefulness of the sterilization 5% iodine stain used in P0056-22-AM gynecology at uterine cervix cancer surgery 渋谷文則1), 巣山郁子1), 村上瑛莉香1), 江藤壮志1), 内藤梨奈1), 八巻俊哉1), 高橋信1), 廣井順子2), 池田さやか3), 工藤一弥3), 櫻庭瑛4), 山口翔平4), 工藤敏之4), 伊藤清美4), 内川清次1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2015.

---

	Examination about the usefulness for stomatitis with chemistry, the radiotherapy of the P0057-21-PM hospital preparation HACHIAZULE professional Mac D Xylocaine mouth wash 吉元公一1),2), 峰島宏枝1), 輿石徹1), 塚原清彰2), 小川恭生2), 奥山清1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2015.

---

	Examination about preparation properties of the P0058-22-AM polyvinyl alcohol addition oral mucosa adhesion lock 戸田紗衣1), 池内由里1), 石原千津子2), 伴孝仁1), 三浦英里佳1), 大西啓1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2015.

---

	Basic pharmaceutical properties of matter evaluation - of the study on P0059-21-PM Mohs' paste (the tenth report) - prescription improved Mohs' paste 田口真穂1),3), 伊東奈保美2), 小川法子2), 高橋知里2), 村田実希郎1), 礒部隆史1), 埴岡伸光1), 重山昌人1), 山本浩充2), 寺町ひとみ3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2015.

---

	The establishment of the Mohs paste use protocol in P0060-22-AM this museum and 1 case 西村美里, 宮原強, 松永尚, 竹内恵, 黒部健太郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2015.

---

	One case that used P0061-21-PM polymyxin B inhalation therapy to multidrug-resistant Pseudomonas aeruginosa pneumonia of the patients in the maintenance dialysis 村津圭治1), 橘憲2), 大津幸1), 佐光留美1), 覺野律1), 本田芳久1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2015.

---

	Examination of the preparation method of the P0062-22-AM hospital preparation selenium injection 若月淳一郎, 松本香織, 向山明彦, 南貴之, 長谷川美雪, 中根優, 花輪和己, 磯部克彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2015.

---

	It is evaluated the rheological property of the xyloglucan solution P0063-21-PM emulsion 下山哲哉, 宇野早也香, 小野夏実, 佐藤倫亮, 伊藤邦彦, 小林道也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2015.

---

	A preparation and preparation properties of the gelation preparation of the P0064-22-AM hinokitiol 釣みずき, 鈴木莉奈, 村田勇, 井上裕, 金本郁男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2015.

---

	The effect that P0065-21-PM acceleration condition gives to an elution rate of the indomethacin capsule 栗林和美, 阿部麻衣, 関場美香, 山本佳久, 水野恵司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2015.

---

	Comparison of the P0066-22-AM magnesium oxide tablets generic medicine 遠藤裕司, 丘龍祥, 豊口禎子, 白石正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2015.

---

	Competitive review of inside the hospital about the property of the ointment preparation for the P0067-21-PM oral cavity and the outside Parliament drugstore 牧田久美子, 石道陽子, 星子謙, 原澤秀樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2015.

---

	Comparison evaluation of the physicochemical property of the P0068-22-AM acetaminophen preparation 井上裕, 鈴木健吾, 池田貴司, 角田結菜, 小野田弘崇, 菅原光希, 土屋侑瑛, 釣みずき, 恵沢敏成, 金本郁男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2015.

---

	Diachronic examination about the peroxide generation in the lipid microsphere for the P0069-21-PM IV infusion 北小路学1), 林智洋2), 三島裕彦2), 大鳥徹1), 松山賢治1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2015.

---

	It is examined the storage container for the purpose of the prevention of moisture absorption of the formulations medicine P0070-22-AM package 脇屋義文, 渡部文菜, 平野匡哉, 梅村雅之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2015.

---

	P0071-21-PM Mechanism of moisture stabilization and its stabilization mechanism of OPALMON tablets meeting the needs of dispensing medicines at medical sites 関屋昇1), 井上靖雄2), 片山和格2), 鳴瀧壮二2), 山本政信1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2015.

---

	Effect - with examination - PTP of the color change of pharmaceutical products under a lot of P0072-22-AM lighting 山下修司1),2), 井口和弘1),2), 野口義紘1),2), 堺千紘1),2), 伊野陽子1),2), 中村光浩1),2), 寺町ひとみ1),2), 杉山正2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2015.

---

	Intervention effect to the administration duties by the ward pharmacist in the P0073-21-PM medical treatment ward 安藝智子1), 小原麻由1), 溝口千鶴2), 田平潤1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2015.

---

	A trial and evaluation of the prior confirmation of the appointed hour prescription by the P0074-22-AM ward permanent residence pharmacist 藤田早織1), 早船彩花1), 竹節七美1), 永田将司1), 高橋弘充1), 安原眞人2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2015.

---

	Approach report of the internal use self-care support that cooperated with P0075-21-PM nurse 伊藤知行1), 陰山敦美1), 島岡藍1), 日谷直子1), 宮原由香里1), 太田哲徳1), 鈴木智子2), 市川典子2), 細谷仁美2), 山崎千絵2), 高木恵子2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2015.

---

	Inspection of introduction and the usefulness of the medicine calendar in the P0076-22-AM stroke department ward 塚田藍, 西村英子, 石塚友一, 塩川満 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2015.

---

	Efforts for the safe use of the P0077-21-PM Mohs ointment 小角麻衣1), 瀬名波宏昌1), 田代美佳1), 大河万顕1), 冨田由美1), 名徳倫明2), 川口進一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2015.

---

	Present conditions investigation about the prescription participation in planning by P0078-22-AM ward drug duties 宮内秀典, 野口周作, 宮田広樹, 若城由美子, 笠原英城 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2015.

---

	A present conditions report and outcome evaluation of P0079-21-PM ward drug duties 吉田仁志, 秋山滋男, 礒野淳一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2015.

---

	P0080-22-AM About the present condition and evaluation of ward drug business in Kitakyushu General Hospital 2nd report: What I saw from the ward drug service daily 今村陽子, 中島一, 大治万喜子, 堂薗吉彬, 鮫島恵介, 福田恭輔, 岡仁美, 松尾麻美, 坂井蘭, 大石貴裕, 池田浩和, 高橋浩二郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2015.

---

	About the efforts of the ward drug duties in the P0081-21-PM neonates treatment ridge 米田奈美, 木原理恵, 鶴崎泰史, 高島伸也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2015.

---

	The enforcement situation of the prescription intervention in P0082-22-AM ward duties and clinical outcome 福島史織, 星野輝彦, 松本健吾, 塩津和則 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2015.

---

	Effect of the pharmacist intervention in the P0083-21-PM intensive care unit 河野洋平, 浦田修平, 外山智章, 田崎智也, 大野梨絵, 関屋裕史, 岩切智美, 奥村学, 有森和彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2015.

---

	Relation of the pharmacist for the patients who did a change ridge in a regular hospital from the P0084-22-AM ICU 安井一正, 高橋弘泰, 大谷寧次郎, 杉浦洋二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2015.

---

	P0085-21-PM NICU, pharmacist duties in GCU 田中庸, 富樫敦子, 阿部和人, 鎌田敬志, 庄司知摩, 佐藤導 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2015.

---

	Efforts of ward drug duties in P0086-22-AM NICU, GCU 田中翔子, 久本佳奈, 山田美穂, 日野千恵子, 水津知葉, 廣實清司, 古川裕之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2015.

---

	About efforts for the promotion of the pharmaceutical instruction in the P0087-21-PM Osaka railroad hospital pharmacy correspondence - to 2 of - Pharmacist Law Article 25 小牟田豊, 辻本亜理沙, 衛藤広士, 吉田友里, 河野有希, 古谷真依子, 中井優作, 福田晴美, 八代哲也, 東海秀吉 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2015.

---

	It is efforts in our hospital to the pharmaceutical products with mention about the examination that is periodical in a warning column of the P0088-22-AM package insert 澤口友紀, 合田さやか, 亀岡喬, 鹿沼奈央, 足立雅, 盆子原唯, 川村大輔, 大荒政志, 浜野憲子, 平野真衣, 久岡清子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2015.

---

	Ward activity in the P0089-21-PM ward drug duties enforcement addition non-calculation institution 清川明慶, 西川眞佐人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2015.

---

Evaluation - of the usefulness of the internal use commuter pass prescription representation input in practice - orthopedics ward of PBPM in the hospital attached to the P0090-22-AM Nagoya University faculty of medicine 田上聖実1), 濱田恭2), 千崎康司1), 宮崎典子1), 久米初枝1), 杉本亜弥1), 矢野亨治1), 酒井忠博3), 西田佳弘3), 山田清文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2015.

---

	Construction of the aspiration pneumonia protocol in the P0091-21-PM neurosurgery ward 佐藤悠太1), 木村正行1), 藤原斉1), 太田原康成2), 遠藤英彦2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2015.

---

	Efforts (the first report) before and after the surgery by the pharmacist in the P0092-22-AM autoregulation pain relief out of the endocranium 平田一耕1), 鎌野公実1), 鈴木正論1), 永井淳子1), 吉沼裕美2), 舟越亮寛1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2015.

---

	Efforts of ward drug duties in the P0093-21-PM our hospital 佐藤佳華1), 藤原陽子1), 堀金妙子1), 遠藤麻紀1), 日下部鮎子1), 菊池一樹1), 明田克之2), 江副英理3), 八十島隆博3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2015.

---

	Efforts in the discharge support conference in the P0094-22-AM synthesis clinical department ward 福島奈津美, 櫻井登代子, 伴具也, 福田亜矢, 菱田啓介, 三浦誠 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2015.

---

	Construction and efforts of the training program for the purpose of the improvement of the quality of P0095-21-PM ward drug duties 花澤迪子, 片山皓希, 渡邉暁洋, 福田恵子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2015.

---

	Duties reform of the small and medium size hospital which aimed at the improvement of P0096-22-AM clinical drug duties 横山敏紀1), 大森恭子1), 中村宜央1), 江口美夏1), 吉玉幸弘3), 五十嵐知文2), 中島茂夫2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2015.

---

	Change after the working full time pharmacist placement in P0097-21-PM ward drug duties 高儀佳代子, 谷浩成, 安藤智美, 清水圭子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2015.

---

	Analysis of the pharmaceutical intervention by the P0098-22-AM ward charge pharmacist 鵜飼麻由, 松本茂, 山田哲也, 鷹見繁宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2015.

---

	Ward drug log book making system in 1 new system introduction electronic chart with the P0099-21-PM ward drug duties enforcement addition calculation 村田七海, 島崎良知, 甲斐田浩輔, 早舩美保子, 瀧川正紀, 田中達郎, 前田陽平, 深野光司, 横井妙子, 森淑子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2015.

---

	Examination of the usefulness in the doubt inquiry item addition of 2 new system introduction ward log book systems with the P0100-22-AM ward drug duties enforcement addition calculation 早舩美保子, 深野光司, 瀧川正紀, 島崎良知, 横井妙子, 森淑子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2015.

---

	Construction of 3 new system introduction pharmaceutical products "information sharing systems" with the P0101-21-PM ward drug duties enforcement addition calculation 田中達郎, 瀧川正紀, 甲斐田浩輔, 早舩美保子, 村田七海, 前田陽平, 深野光司, 島崎良知, 横井妙子, 森淑子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2015.

---

	Construction of the drug duties support system which utilized P0102-22-AM tablet terminal 村田久枝, 寺本有里, 大井美和, 高木友莉, 林田佳愛, 長山優介, 北村美穂, 藤波舞, 廣本早紀, 秋田幸子, 駒井千穂, 前田英加, 益田敦美, 浅場幸子, 北口剛吉, 藤吉徹也, 山本克己 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2015.

---

	Pharmacist in ward duties of the P0103-21-PM our hospital, practice nurse, the present conditions of the joint participation in planning of the nurse 渡邊由梨香, 筑井菜々子, 枦秀樹, 太田哲徳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2015.

---

	Construction of the side effect monitoring system of the high-risk medicine which utilized P0104-22-AM FileMaker (R) 小土井亮介1), 河原光1), 酒井照美1), 西塚亨1), 渡辺智康2), 安藤哲信2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2015.

---

	About the present conditions of ward drug duties in the P0105-21-PM our hospital and the evaluation 古賀清弘, 江崎舞, 天野佳奈, 池綾子, 大竹由希子, 町田梨絵子, 五反田智恵, 竹永早百合, 原友子, 松下尚弘, 石丸隆之, 藤田誠二, 野中敏治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2015.

---

	Construction of the P0106-22-AM ward drug duties support system 須田泰記, 中村安孝, 信田佳克, 西川武司, 永山勝也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2015.

---

	Result of the pre-Abo id report promotion in the P0107-21-PM Yokohama medical center 石川紗耶香, 神長雅浩, 西村富啓, 佐橋幸子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2015.

---

	Efforts of the drug instruction about driving attention, the prohibition of the car in our hospital with the P0108-22-AM revision Pharmacist Law 舌間清晃1),2), 安部有香1), 光安靖子1), 藤田あゆ美1), 長岡麻由1), 藤啓子1), 江崎信子1), 小池城司2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2015.

---

	P0109-21-PM Kagawa University nose and ears pharynx department, dermatology, plastic surgery, questionnaire for ward drug duties in dentistry 田井達也, 山口佳津騎, 山本高成, 加地雅人, 篠原尚樹, 水岡大策, 越野優希, 冨田淳子, 立道貴清, 小坂信二, 芳地一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2015.

---

	Questionary survey to the nurse about P0110-22-AM ward drug duties 吉川慧, 村井華代, 荒川裕明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2015.

---

	Relation of the pharmacist for patients with rheumatoid arthritis in the P0111-21-PM Kurume University Hospital 野口朱美, 堤一貴, 田中和江, 中垣春美, 有馬千代子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2015.

---

Relative - with present conditions - ward sojourn time and the pharmaceutical products proper use of the P0112-22-AM ward drug duties enforcement addition acquisition institution 瀧本淳1),2), 濃沼政美1),3), 前田拓哉1), 藤原久登1),4), 小林求1), 湯本哲郎1),5), 綾部由紀乃1), 金田光正1), 笠原英城1), 宮崎美子1), 高尾良洋1), 佐藤透1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2015.

---

	The use fact-finding of the P0113-21-PM bisoprolol patch and proper use 武石愛子, 植草秀介, 千葉達夫, 木村麗砂, 酒井正博, 小林秀樹, 加藤裕芳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2015.

---

	Approach for an evaluation and the problem from a physician, the nurse for P0114-22-AM ward pharmacist duties 神崎浩孝, 小沼利光, 森下陽介, 村川公央, 槇田崇志, 正岡康幸, 田中雄太, 天野杏, 金聖暎, 西宮祐輔, 定金典明, 北村佳久, 千堂年昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2015.

---

	Evaluation of a physician for the P0115-21-PM ward drug duties enforcement and the nurse 長崎志津, 森田靖代, 小松仁美, 西雅恵, 岡崎萌水, 橋田和佳, 野村政孝, 常風興平, 門田亜紀, 横田淳子, 宮村充彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2015.

---

	Change of the role in ward duties in the P0116-22-AM our hospital 古浜健一1), 小林求1), 河野健1), 湯本哲郎1),2), 稲葉健二郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2015.

---

	The future problem that we were able to see from the fact-finding of the prescription suggestion example in P0117-21-PM ward duties 平田やよい, 松田理美, 宮里弥篤, 佐次田頌, 翁長真一郎, 比嘉保 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2015.

---

	We correspond to the pharmacist duties in the P0118-22-AM ward, and it is evaluated by the type of job 井上稚枝子, 高田星羅, 武本千惠 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2015.

---

	Efforts to a rise in contribution degree for the medical treatment by the P0119-21-PM ward drug duties start 鈴木博晃, 野村理恵, 内田里香, 長濱貴恵, 加藤一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2015.

---

	Fact-finding about the consistency of a practice reporting book and the bringing medicine by the P0120-22-AM ward exclusive duty pharmacist 新貝弘明1), 阿部真也1), 小林義和1), 藤岡貴光1), 斎藤太寿1), 小林彦登1), 高野照子1), 町田美香1), 齋藤雅俊1), 松原肇1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2015.

---

	P0121-21-PM third emergency designation, stocktaking of ward drug duties in the local cancer practice cooperation base Hospital 陸丸幹男, 河村聡志, 末延道太, 柴田七奈, 菅田佳子, 佐藤史織, 重松明美, 森一生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2015.

---

	Start relation - ward drug duties of the pharmacist until a discharge before the hospitalization to patients with P0122-22-AM cataract surgery plan; and - 野村理恵, 内田里香, 岩村瞳, 赤木圭太, 長濱貴恵, 加藤一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2015.

---

	Bringing medicine discriminant positioning in P0123-21-PM ward drug duties 長濱貴恵, 野村理恵, 内田里香, 鈴木博晃, 加藤一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2015.

---

	Efforts for safety management and the proper use of the P0124-22-AM bringing medicine 永井亜美, 寺沢匡史, 中村翔吾, 内山ひとみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2015.

---

	The efforts of ward drug duties in the P0125-21-PM our hospital and future problem 木藤貴弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2015.

---

	Intervention to the medical therapy of the pharmacist in the P0126-22-AM orthopedics ward 中出奈津子, 東昌代, 梅元晃美, 中村美紀, 多保田千佳子, 高畠恵美, 道下孝恒, 石田美由紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2015.

---

	The efforts which contributed to an omission of special diet calculation of the P0127-21-PM pharmacist 山脇聡, 渡部寿康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2015.

---

	Efforts for the P0128-22-AM ward drug duties enhancement 小坂井加奈, 古川裕美子, 岩崎明子, 三輪耕次 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2015.

---

	Medicine management after the pharmacist intervention in the P0129-21-PM operating room and adequacy of the cost 北森翔子, 井上美穂, 今市沙有美, 岡紗智子, 二見早希, 石田あい, 上田華世, 松下比奈子, 藤本智大, 久保智士, 山崎瑞貴, 松尾多恵, 鶴崎亮, 青木美沙, 松谷和子, 三嶋仁美, 木村真策 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2015.

---

	What is found in other types of job on the treatment intervention of the P0130-22-AM ICU ward pharmacist 飯田遥, 男全昭紀, 井口恵美子, 猪股克彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2015.

---

	The present conditions in the viewpoint of ward drug duties in the hypothermia therapy management after the P0131-21-PM cardiopulmonary arrest revival 田中大輔, 草島宏平, 佐藤拓也, 石川大介, 阿部和人, 鎌田敬志, 佐藤導 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2015.

---

	About the efforts of the ward drug duties in the P0132-22-AM ICU ward 上ノ山和弥, 高橋有, 三井克巳, 三宅麻文, 河原宏之, 石川弘子, 尾上雅英 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2015.

---

	Findings by the introduction of the delirium evaluation in the P0133-21-PM ICU and the evaluation 福田聖啓1), 水井貴詞1), 大橋洵1), 大野佑城1), 吉田南2), 長谷川直美2), 青山智1), 安田昌宏1), 大畠博人3), 後藤千寿1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2015.

---

	Reporting about the antimicrobial in the P0134-22-AM our hospital critical care center 西島正人, 植原佳代子, 宇佐美千佳子, 齋藤俊郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2015.

---

	1 case that a plasma exchange was thought to influence to blood sodium valproate levels of patients with P0135-21-PM thrombotic thrombocytopenic purpura 山口美紗子1), 久保陽平1), 祖川倫太郎1), 今長谷尚史2), 進藤岳郎3), 原英夫4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2015.

---

	Intervention example of the pharmacist in the P0136-22-AM North America type ER first aid practice 利根川小春, 原直己, 金明俊, 高梨愛, 加瀬和也, 永嶋一貴, 内田佳菜子, 松田俊之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2015.

---

	About the pharmacist duties in the ICU of the P0137-21-PM children special hospital 石賀圭, 日野洋明, 中井啓, 二木彰 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2015.

---

	Enforcement and evaluation of the pharmaceutical management in P0138-22-AM NICU, GCU 横山智子, 尾栢有美, 鈴木えり子, 山西由里子, 加藤有香, 越川一誠, 飯久保尚, 小杉隆祥, 西澤健司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2015.

---

	Record style of ward drug duties and drug control instruction charges 1 in P0139-21-PM our hospital HCU 渡邉悦子, 佐野邦明, 高木雄一, 松本富夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2015.

---

	Fact-finding of the delirium patients in the P0140-22-AM ICU 赤崎瞳, 浜元善仁, 翁長真一郎, 比嘉保 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2015.

---

	Role of the pharmacist in the drug information offer of the P0141-21-PM our hospital intensive care unit 内藤久志1), 尾崎昌大1), 北村渉1), 坂和園子1), 添田真司1), 松陰崇2), 渡邊昌之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2015.

---

	Objective evaluation of the ward drug duties in the P0142-22-AM NICU/GCU ward 山辺雄太, 宮本晋治, 本田義輝, 齋藤秀之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2015.

---

	One case that the P0143-21-PM Nasal high flow refusal patients were able to evade intubation using dexmedetomidine 中村敬之, 市川照文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2015.

---

	Construction of pharmacist duties in the perioperative period when we cooperated with P0144-22-AM anesthesiologist 古谷一平, 土川拓也, 山里久子, 平下智之, 谷沢克弥, 遠藤秀治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2015.

---

	Efforts by inspection and the team of the pharmaceutical background for patients with P0145-21-PM stroke 高森智敬, 安尾哲郎, 滝波昇悟, 井上剛, 監物英男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2015.

---

	Fact-finding of the patients whom it presented a hyperglycemia state in the P0146-22-AM second emergency designated hospital and was conveyed first aid to 昆貴志1), 森雅之1), 橋本貴尚1), 茂泉善政2), 栃窪克行1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2015.

---

	Usefulness evaluation of the sustained sedative medicinal solution preparation in the operation by the P0147-21-PM pharmacist 柴田みづほ, 小林由佳, 川口真由子, 橋本杏里, 渡辺健太, 新部陽子, 新井健一, 中村貴子, 鈴木貴明, 石井伊都子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2015.

---

	Efforts ... of risk management - pharmacist resident in P0148-22-AM ICU, CCU 根来加菜子1), 岡田美香1), 田内千賀1), 横山晶子1), 大城靖1), 荒川隆太郎1), 丈達泰史1), 宮崎哲郎2), 稲田英一3), 天野篤4), 代田浩之2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2015.

---

	Fact-finding report of the suicide attempt patients who had P0149-21-PM acute intoxication 末延道太1), 上野悦子1), 佐藤史織1), 麻生真由美1), 重松明美1), 中島竜太2), 稲垣伸洋2), 森一生1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2015.

---

Present conditions of duties that it passes after process, opening of a Diet session until setup - opening of a Diet session of a critical care center, the intensive care section of the P0150-22-AM new hospital for one year and future problem ... 五味知之1), 渡部修2), 岡田邦彦2), 竹村隆広3), 斉藤まゆみ4), 由井俊文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2015.

---

	Examination to stocktaking of the inhalational instruction to P0151-21-PM outpatient and the construction of the instruction system 堀場さゆり1), 葛谷真理1), 今高多佳子1), 青山智彦1), 小笠原智彦2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2015.

---

Examination ... of the storage of the instruction record with the present conditions report of the medication counseling record to an outpatient in the P0152-22-AM our hospital and 2 revisions of future fine-view - Pharmacist Law Article 25 大久保淳史1), 森本景子1), 高橋信矢1), 立沢正臣1), 下嶋和代1), 宮崎招久1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2015.

---

	Efforts to instruction based on the pharmaceutical knowledge for the P0153-21-PM outpatient 宮崎衛江, 大澤千鶴子, 芦埜和幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2015.

---

	Efforts of the discontinuation instruction in the P0154-22-AM our hospital heart blood vessel center 神戸千紘1), 石井有紀1), 宮崎雄紀1), 網野一真1), 跡部治1), 山本高照2), 高橋耕平2), 河野哲也2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2015.

---

	Active intervention to the pharmaceutical management of the perioperative patients in the P0155-21-PM our hospital 山田奈緒1), 左右田和恵1), 太田久美子1), 田村睦弘2), 金澤美也子3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2015.

---

	Efforts (the first report) to establishment and the duties burden on ward pharmacist reduction of the pharmacist duties of the P0156-22-AM admitting department 柴田大地, 木下照常, 北川加寿子, 高橋詩織, 渡邉彰己, 菅原志穂, 杉浦友美, 近藤洋一, 滝本典夫, 杉浦充, 足立守 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2015.

---

	Questionary survey about drug explanation, instruction duties in the P0157-21-PM outpatient department 鵜池敏令, 泉谷悟, 岡本直樹, 笠原庸子, 柴田ゆうか, 常友盛勝, 松本俊治, 光廣貴紀, 新井茂昭, 荒川隆之, 佐々木雄啓, 谷口雅敏, 日浦和徳, 中村徹志, 木平健治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2015.

---

	It is ... through efforts - pharmacist outpatient department establishment of our hospital in the P0158-22-AM pharmacist outpatient department 神田英一郎, 鹿浦香織, 野田能成, 大坪達弥, 加藤良隆, 中川ゆかり, 小川博史, 小林大祐, 福田喬士, 藤田敦夫, 友金幹視, 三上正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2015.

---

	About P0159-21-PM Daclatasvir, the pharmacist outpatient department introduction for patients who received Asunaprevir combination therapy 中島瑶子1), 松崎貴志1), 松村泰斗1), 有木宏宗1), 石井俊哉2), 佐藤明2), 横山美恵子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2015.

---

	Thing - Okayama fine weather fine weather DOTS notebook operation ... which we saw from efforts of P0160-22-AM area DOTS 佐藤可奈1), 福島さやか1), 亀井健人1), 橋本徹2), 高柳和伸1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2015.

---

	P0161-21-PM Drug status survey of Daclatasvir (Daklinza(R)), Asunaprevir (Sunvepra(R)) at our hospital 隅田英幸1), 伏見友里1), 藤井悠1), 岸田佳恵1), 高井美和1), 高橋沙希1), 玉井恭子1), 二宮洋子1), 勝村登美子1), 小野眞代1), 日野啓輔2), 仁科惣治2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2015.

---

	Efforts to fact-finding and the adequacy of the polypharmacy patients in the P0162-22-AM outpatient department 上野良夫1), 三枝貢1), 浅田智哉1), 眞鍋伸次1), 前田剛2), 森由弘2), 厚井文一2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2015.

---

	In P0163-21-PM outpatient department pharmacist duties is going to be hospitalized; the present conditions and a problem of the bringing medicine for patients confirmation 菊池大輔, 大内竜介, 早川幸子, 布施克浩, 畑中貞雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2015.

---

	Efforts of the pharmacist in the P0164-22-AM Saiseikai Fukuoka General Hospital hospitalization support center 阿曽沼伸一, 入江徳俊, 由井薗陽一, 二神咲子, 眞弓志乃, 五反田利恵, 住田愛, 阿部聡子, 池田宗彦, 圓福優子, 松下祥子, 山田正紀, 槇林智子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2015.

---

	Efforts of the common use medicine confirmation (bringing medicine outpatient department) in the P0165-21-PM our hospital and the evaluation 新島大輔1), 高橋郷1), 宮野早苗1), 矢田部恵1), 岩崎景子1), 赤木祐貴2), 勝海学1), 千田昌之1), 谷地豊1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2015.

---

	Intervention significance before hospitalization to the perioperative patients in the P0166-22-AM our hospital pre-operative examination center 藏本裕信, 粂裕子, 山本麻央, 山口沙織, 長谷川豊 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2015.

---

	Role of the pharmacist in the center before P0167-21-PM hospitalization 川柳大翔, 岩崎明子, 澤田佳克, 三輪耕次 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2015.

---

	Confirmation and instruction ... of confirmation - hospitalization previous cancellation medicine of the common use medicine by the pharmacist in the P0168-22-AM outpatient department 片山智章, 木村智美, 辰巳典子, 廣田麻衣子, 中村有理, 内本典子, 北山尚子, 寺沢匡史, 内山ひとみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2015.

---

	Efforts of the pharmacist outpatient department in P0169-21-PM chronic hepatitis C treatment and intervention ... to case report - Daclatasvir Asunaprevir combination therapy 河南有友子, 吉田純也, 丹羽しおり, 平塚愛加, 橋本さや香, 宮本裕子, 新嶋茂正, 大塚一興, 伊藤由香, 坂上逸孝, 増原慶壮, 横山美恵子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2015.

---

	An advantage and problem of the pharmacist outpatient department before the medical examination for the use of P0170-22-AM outpatient department chemotherapy room patients 伴晶子1), 岡戸洋1), 佐藤知香1), 吉岡祐貴1), 小林義和1), 小島義博1), 生田宏次2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2015.

---

Practice - pharmacist of the team approach in medical care to support patients with P0171-21-PM outpatient department cancer is foreign, and establish cancer nursing outpatient department at the same time; and ... 浅川由希子1),2), 宮崎美佳1), 古川順章1), 飯田幸恵2), 内藤潤2), 手塚健志3), 所昭宏4), 安宅信二5), 小林勝昭1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2015.

---

	It is ... through the cooperation between usefulness - pharmacists of by medical examination front of the pharmacist outpatient department in the treatment with P0172-22-AM Aki Shichi nib case 鹿浦香織1), 加藤良隆1), 神田英一郎1), 野田能成1), 中村雄一2), 伊藤吉三2), 友金幹視1), 三上正1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2015.

---

	The present conditions and problem of the cancer instruction to patient management charges 3 calculation acquisition in the P0173-21-PM JCHO Kyushu Hospital 上津沙織, 桑村恒夫, 吉国健司, 末松文博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2015.

---

	Medication counseling and side effect monitoring to the internal use anticancer agent remedy patients in the P0174-22-AM outpatient department 田中庸一1),2), 瀬川聖奈1), 青木学一1),2), 塩見めぐみ1),2), 渋谷清1),2), 田村実紀2), 久保田理恵1),2), 小宮山貴子1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2015.

---

	Grasp of efforts and problems of the drug control instruction to P0175-21-PM outpatient department cancer chemotherapy patients 宮脇未来1),2), 藤井千賀1),2), 柳下祐貴子1), 安井友佳子1), 神垣俊二2), 木村豊2), 石坂敏彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2015.

---

	Efforts to side effect evaluation and the pharmacist outpatient department introduction of P0176-22-AM outpatient department chemotherapy patients 桝茂典, 岡田悠美, 櫻井彩乃, 中川隼一, 上村苑子, 高橋真一, 鈴木由依, 蔭山博之, 村上敏明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2015.

---

	The present conditions and problem of the P0177-21-PM "cancer support outpatient department" 牧智恵子, 後藤愛実, 細見誠, 花房加奈恵, 早坂大, 片岡憲昭, 西原雅美, 勝間田敬弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2015.

---

	Effect of the pharmaceutical management that hospital pharmacist performs in P0178-22-AM diabetes outpatient 一木裕子1),2), 是木一也2), 大園沙保子1), 小林大介1), 窪田敏夫1), 島添隆雄1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2015.

---

	It is the participation of the pharmacist in the instruction management in patients after P0179-21-PM transplant 宮坂優人1), 小林昌宏1), 稲野寛1), 吉田一成2), 石井大輔3), 竹内康雄4), 池田成江5), 野口文乃5), 田中美樹5), 厚田幸一郎1),6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2015.

---

	P0180-22-AM Relationship between LINQ questionnaire and inhalation technique degree of acquisition, adherence in Breezhaler type inhaled medicine 高橋光明1), 中西大介1), 畑地治2), 柳川泰裕1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2015.

---

	The case that treatment-resistant hyperuricaemia improved by the living guidance by the P0181-21-PM pharmacist 大久保七枝1), 大久保正2), 田中真理子3), 大久保節子4), 阿部慧5), 大久保美穂5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2015.

---

	Attempt to the pharmacist outpatient department in the P0182-22-AM orthopedics outpatient department 高橋えりか1), 亀田敬子1), 木本信介1), 山田周平1), 西田直史1), 初田輝1), 山下敦志1), 大西英生2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2015.

---

	P0183-21-PM pharmacist foreign establishment and usefulness consideration aiming at introduction of the smooth hepatitis C therapeutic drug 家永嘉子1), 萱野勇一郎1), 杉本充弘1), 吉田優子1), 山本崇1), 野口葉子1), 今井哲司1), 深津祥央1), 石塚良子1), 矢野育子1), 上田佳秀2), 丸澤宏之2), 松原和夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2015.

---

	Investigation about the number of investigations before surgery in the P0184-22-AM outpatient department and the presence or absence of surgery postponement 牧なつみ, 沢田俊朗, 前田剛司, 坂田洋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2015.

---

	Analysis using the technique of the text mining of the patients information hearing by the many types of job in the P0185-21-PM pain center 西村明子1),2), 今井徹1), 鈴木慎一郎1), 早坂正敏1), 吉田善一1), 加藤実2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2015.

---

	Efforts of the pharmacist in vaccination duties in the P0186-22-AM pediatrics outpatient department 有本忍, 森睦, 尾野由佳子, 中濱美恵, 森佳恵, 白木幸子, 宮崎千尋, 魚住有沙美, 横野祐未, 宮川明宏, 山本ひとみ, 石見淳子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2015.

---

	The delirium prophylactic protocol making in patients with P0187-21-PM stroke and the evaluation 川田敬1), 太田剛史2), 山崎好恵1), 端茉美1), 高平豊1), 田中聡1), 山本創一1), 森本雅徳2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2015.

---

	Result and problem of the joint medical treatment management (CDTM) introduction in the P0188-22-AM Taketa synthesis hospital 熊谷修一, 木本真司, 安達亮平, 河原史明, 香内綾, 安齊泰裕, 大竹伸知, 外島真, 遠宮賢二, 塩川秀樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2015.

---

	Attempt of the inhalational instruction using the P0189-21-PM "examination by a stethoscope breath sounds that we visualized" 田代千明1), 福田萌美1), 平田周祐1), 井口恵美子1), 猪股克彦1), 河崎勉2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2015.

---

	Medication support in the institution using the use change protocol by P0190-22-AM CDTM 小川壮寛1),2), 松下明3), 井口千恵美4), 守安洋子1), 福嶋寛子1), 佐々木萌子1), 中西由恵1), 河南真依1), 藤谷直明5), 賀來敦3), 島田憲一2), 江川孝2), 高見陽一郎2), 高橋正志1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2015.

---

	Input support of the periodical prescription of the oral medicine by the P0191-21-PM pharmacist: Enforcement and the evaluation 細野智美1), 井坂由佳1), 井坂江吏香1), 横田裕之1), 三木俊一郎2), 山本哲哉2), 塚本俊太郎3), 原明弘3), 福永潔3), 神林泰行1), 土岐浩介1), 大河内信弘3), 松村明2), 本間真人1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2015.

---

	Hold ... "meeting learning physical assessment" about the physical assessment class to P0192-22-AM pharmacist; and ... 浅野志津1), 大道淳二1), 石橋真実1), 諏訪耕三1), 藤原孝子2), 河原宣裕2), 磯村治樹2), 松山哲史3), 齋藤博則4), 森英樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2015.

---

	The use situation and problems of the P0193-21-PM adrenalin self injection drug (Epinephrine autoinjector) 野澤彰1), 野村良子1), 野澤玲子2), 高橋治1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2015.

---

	About a proper use investigation of P0194-22-AM new oral anticoagulant drug (NOAC) 西村文宏, 牛島智子, 宮村重幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2015.

---

	Importance of the warfarin control in patients with P0195-21-PM atrial fibrillation 本田哲也, 吉原郁夫, 渡部善博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2015.

---

	The use situation and clinical response of the tolvaptan for the fluid retention in the P0196-22-AM heart failure 坂元優太, 中島誠, 野間口寛, 桐野玲子, 瀧下恭子, 高橋武士, 中木原由佳, 新上香奈子, 平松さやか, 福元裕介, 池ノ上知世, 平田りか, 寺師守彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2015.

---

	Examination of the albumin consumption by the P0197-21-PM Hydroxyethylated starch infusion 6% introduction 舩越真理1), 原田益宏1), 津田正博1), 平田学2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2015.

---

	Way ... of the drug control instruction to be understood from ... patients questionnaire to reconsider P0198-22-AM drug control instruction 中埜梓, 矢沢麻貴, 荒井早穂, 林千麗, 吉村尋典 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2015.

---

	Led by a relation and the patients of the pharmacist in the use of edoxaban after the P0199-21-PM orthopedics lower limbs surgery with safe examination - impaired renal function - 小岩まの, 永野浩之, 伊藤護之, 北澤貴樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2015.

---

	P0200-22-AM On the Usage of Phosribbon(R) for Prematurity Metabolic Bone Disease (MBD) in Our College 楠川侑吾1), 大橋正和1), 三松史野1), 村田龍宣1), 塩見梢2), 村岡淳二1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2015.

---

	Examination about the nicardipine injection proper use to be used for P0201-21-PM sustained depression 春日井理恵1), 柴田隼人1), 酒井欣嗣2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2015.

---

	Research about the confirmation technique of the P0202-22-AM medication amount of drinking 家治川真代1), 小北純也1), 藤田知子1), 中嶋香里2), 東川伸一2), 西村奈緒恵3), 榎本初音3), 立木秀尚3), 宮崎珠美4), 小森浩二4), 首藤誠4), 山下伸二4), 恩田光子5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2015.

---

	Present conditions investigation about the medication counseling of the P0203-21-PM NSAIDs patch 松浦誠1), 野舘敬直2), 畠山和也2), 佐塚泰之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2015.

---

	Patients attitude survey about the prescription change to P0204-22-AM non-vitamin K inhibition oral anticoagulant drug (NOAC) 柴山紗貴子1), 藤井洋介2), 福田喜彦3), 藤枝正輝2), 中澤祐輔2), 長谷川佳孝2), 月岡良太2), 森澤あずさ2), 大石美也2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2015.

---

	About efforts of the generic name prescription in the P0205-21-PM Okinawa Hospital 小迫晶寛1), 加茂章弘1), 仲村早紀1), 小薮真紀子1), 鈴田浩孝1), 大嶺彩3), 八木秀明2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2015.

---

	Competitive review of the P0206-22-AM "application (electronic edition medicine notebook common throughout the whole country) for the patients to manage the health by oneself" 田代朋子1), 本田卓也1), 折井孝男2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2015.

---

	The use situation and problem extraction of the English drug reporting document for P0207-21-PM foreigner patients 上市敦子1), 神宮寺秀幸1), 瀧裕子1), 吉野翠1), 田代和子1), 西澤満里子2), 長谷川佳孝2), 月岡良太2), 森澤あずさ2), 大石美也2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2015.

---

	Change third report of the number of the combination drugs with the antihypertensive medications combination drug judging from the prescription fact-finding of P0208-22-AM antihypertensive medications 若林進1), 篠原高雄1), 岡本晋2), 林潤一2), 山本実2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2015.

---

	Investigation about the acquisition situation of the pharmaceutical products safety information in the P0209-21-PM medical institution 星野絵里, 中常恵美, 平松彩佳, 鳥井真由美, 近藤恵美子, 俵木登美子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2015.

---

Investigation second report of the pharmacoepidemiology by the changes from the antihypertensive medications which assume valsartan in the P0210-22-AM Sapporo Tokushukai Hospital an active ingredient to other antihypertensive medications 田中正臣, 田中彰一, 杉村ゆかり, 高橋秀聡, 前田健太, 後藤圭介, 武田瑛司, 星貴薫, 水戸麻未, 宮越貴之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2015.

---

	In prescription situation - new taking oral anticoagulant drug start cases for patients with P0211-21-PM cerebral infarction - 白石貴寿, 田口みどり, 中山久美子, 栗原江未, 安河内寿成, 中村宏, 面田恵 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2015.

---

	Use fact-finding of the albumin preparation in the surgery of heart, great vessels after the P0212-22-AM hydroxyethylated starch preparation adoption origin 谷口仁孝1), 徳村博子1), 田中美智子1), 山本彩佳1), 猪山友香1), 千葉恵美子1), 渡邉美樹1), 小原祐子1), 谷口和孝2), 加納みゆき1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2015.

---

	Consideration about the change of prescription reason of the P0213-21-PM oral anticoagulant drug and the patients background 宇都宮奈々, 白石貴寿, 中山久美子, 植中英恵, 臼井和明, 中村宏, 面田恵 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2015.

---

	Comparative study of the effect that P0214-22-AM generic name prescription and generic medicine prescription give to formulations of the health insurance pharmacy 越塚宏美, 宮野正広, 八木仁史, 遠藤美緒, 屋城由樹, 大村恵, 高橋あい理, 山田えり, 渡邊徹, 佐々木忠徳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2015.

---

	Present conditions investigation about the taking oral medicine situation in the case that had a diagnosis of peptic ulcer by P0215-21-PM endoscopy upper gastrointestinal tract 栗原江未1), 長谷川将1), 白石貴寿1), 宗本佐知子1), 近藤真由1), 今村寿宏2), 中村宏1), 面田恵1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2015.

---

	Subjective sleep evaluation to the case that we changed from P0216-22-AM zopiclone to S zopiclone 福田翔一1), 雪田拓1), 田中宏尚1), 安土菜美1), 樋浦一哉2), 今井隆人1), 小原郁司1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2015.

---

	The use situation of the peg filgrastim in the P0217-21-PM our hospital 實光由香, 本多伸二, 浜田久美子, 荒田美帆子, 三松史野, 目黒裕史, 大野恵一, 村田龍宣, 寸田靖, 村岡淳二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2015.

---

	Prescription fact-finding of various opioid preparation in the P0218-22-AM Higashisapporo Hospital 日置陽子1), 加藤遥平1), 中脇誠一1), 照井健2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2015.

---

	Investigation of the use situation and the adverse event of the sorafenib in the P0219-21-PM hepatocellular carcinoma 陣内優, 畑瀬圭佐, 西田修 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2015.

---

	Comparison ... with the use fact-finding results in 18 hospitals attached to use of antimicrobial situation - private institution dental college in the hospital attached to the P0220-22-AM Ohu University school of dentistry 緑川信幸1),2), 長嶋友美1),2), 浅倉聖岳1),2), 中村郁子1),2), 東海林徹3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2015.

---

	Evaluation of our hospital antimicrobial consumption by P0221-21-PM Defined daily dose (DDD) and days of therapy (DOT) 平川尚宏, 石原義久, 渡部由起, 柿元郁代 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2015.

---

	Use of antimicrobial situation investigation using DPC data for the P0222-22-AM antimicrobial proper use 杉井麻耶1), 大迫朗子1), 鶴見彩1), 萩原奈央1), 八田部良子1), 相曽啓史1), 森美奈子1), 永田将司1), 高橋弘充1), 安原眞人2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2015.

---

	DPC data utilization to a use of P0223-21-PM antimicrobial situation investigation 佐瀬裕子1), 相曽啓史2), 鳥羽三佳代1), 森脇睦子1), 貫井陽子3), 高橋弘充2), 伏見清秀1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2015.

---

	Nutrient preparation Heine E gel and drug combination in the P0224-22-AM medical treatment ward 土元研史, 安田礼子, 三代貴康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2015.

---

	Investigation about the change of the quantity of prescription of an antianxiety drug in the P0225-21-PM our hospital and the sleeping drug 田代佳生, 木苗佑介, 浅井萌子, 浅倉侯子, 名倉基雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2015.

---

	Use fact-finding of the selective SGLT2 inhibitor in all P0226-22-AM Yokohama municipal institutions and the Red Cross hospital 男全昭紀1),2), 飯田遥1), 井口恵美子1), 猪股克彦1), 澤口達也2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2015.

---

	The use situation of the oral anticoagulant drug in the P0227-21-PM our hospital 向井弘恵1), 岡田昌浩1), 星野祥儀1), 池亀芳野1), 岡本伸也1), 神垣江里奈1), 烏尾和恵1), 村上史承1), 杉原弘記1), 竹井英介1), 岩崎淳2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2015.

---

	Efforts for the P0228-22-AM eldecalcitol proper use 三木芳晃1), 塚本啓介1), 奥村裕英1), 桑井幸雄1), 嶋津啓二2), 田中敬雄2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2015.

---

	Examination about the estimate of the incidence that we applied Poisson distribution to about serious dermatopathy from adverse event spontaneous report database (JADER) of P0229-21-PM Japan 四釜亮太, 松本直人, 曽根原亘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2015.

---

	Result and problem - of practice - introduction second year of the drugstore management using balun strike scorecard (BSC) in the P0230-22-AM Kushiro Red Cross hospital 渡邊清人, 近江令司, 澁谷基宏, 田中康裕, 元木孝, 高柳昌宏, 千田泰健 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2015.

---

	Evaluation of construction and the outcome of the information sharing system about the pharmaceutical intervention in P0231-21-PM Hospital and the health insurance pharmacy 田坂祐一1),2), 安永大輝1),2), 田中守1),2),3), 田中亮裕1),2),3), 浅川隆重2),3), 堀尾郁夫3), 宮内芳郎3), 荒木博陽1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2015.

---

	Search of the pharmacoepidemiology of the private business pharmaceutical products which there is possibility of the becoming severe of the drug-related adverse event in P0232-22-AM elderly people in 野口義紘, 杉田郁人, 林勇汰, 吉田阿希, 江崎宏樹, 齊藤康介, 臼井一将, 加藤未紗, 舘知也, 寺町ひとみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2015.

---

	Examination about the cost effectiveness according to the drug which we used for initial treatment for P0233-21-PM community-acquired pneumonia 山田英紀, 荒木良介, 山村翔, 田中恒明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2015.

---

	Figure of the drugstore for community medical care promotion judging from P0234-22-AM geographical information and institution standard 吉原幹詞1), 倉田香織2), 山浦克典1), 岸本桂子3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2015.

---

	Medical economic evaluation of the P0235-21-PM new hyperactivity bladder therapeutic agent Mirabegron 山西由里子1),2), 山西友典3), 田島博樹4), 池田俊也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2015.

---

	Efforts of the prescription suggestion by the electronic chart representation input for appropriate hospitalization prescription shifts of the P0236-22-AM bringing medicine 西迫多重, 齋藤茉梨絵, 猪股育夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2015.

---

	Construction of bringing medicine differentiation, the prescription instructions system in the P0237-21-PM electronic chart introduction 田口みどり1), 森田佳博1), 白石貴寿1), 上地純子1), 大石丸美1), 平岡剛2), 神原昇3), 中村宏1), 面田恵1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2015.

---

	The problem that was seen from bringing medicine differentiation and the medicine notebook bringing rate for all inpatients in the P0238-22-AM size scale hospital 多賀允俊, 丹羽修 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2015.

---

	The development of the prescription input support function using P0239-21-PM common use medicine information and investigation about the usefulness 石原裕介, 安食健一, 横手克樹, 園山智宏, 平野榮作, 竹下和男, 小阪真二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2015.

---

	Approach in our hospital to connect P0240-22-AM bringing medicine with inpatient care appropriately 鶴崎泰史1), 松島薫1), 副島啓司2), 高島伸也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2015.

---

	Safety management of the bringing medicine using P0241-21-PM oral medicine prescription calendar function 新崎孝夫, 弥山秀芳, 氏家玲奈, 澤井綾佳, 矢野裕子, 岡田玲子, 若原由佳, 西田さやか, 米田篤司, 久保悦子, 安永浩子, 阪口博保, 富田浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2015.

---

	Compliance investigation of the bringing medicine in the patients admitted to the P0242-22-AM lifesaving emergency ward 倉田歩, 藤裕美, 岩内大佑, 山口佳代, 三浦誠 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2015.

---

	Evaluation - second report ... from an attempt and a physician of the bringing medicine bottle power support by the P0243-21-PM pharmacist 村上理沙子, 江川裕之, 矢野裕士, 吉澤美香, 中丸沙弥香, 岡本祐二, 佐藤千比呂, 高橋和紗, 江崎さやか, 鈴木優司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2015.

---

	Relation of the ward pharmacist to bringing medicine operation in the P0244-22-AM Kitakyusyu General Hospital 鮫島恵介, 今村陽子, 中島一, 堂薗吉彬, 大治万喜子, 福田恭輔, 岡仁美, 坂井蘭, 松尾麻美, 小橋亮, 柏田匡広, 大石貴裕, 池田浩和, 高橋浩二郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2015.

---

	Making and operation of the protocol that a ward pharmacist judges cancellation, the continuation for the bringing medicine of the P0245-21-PM planned inpatient 日下部華子, 福崎由里絵, 植竹緑, 西本悦美, 林憲子, 青柳京子, 中島みゆき, 森美奈子, 金内幸子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2015.

---

	Role of the P0246-22-AM outpatient department bringing medicine discriminant introduction and pharmacist 中野有瑛1), 中居肇2), 青山崇1), 工藤香澄1), 佐々木友見1), 中村一成1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2015.

---

	Investigation about bringing medicine management room duties in the P0247-21-PM Saku medical center 畠山裕実子, 堀内賢一, 田中美和, 清水彩子, 橋詰さやか, 由井俊文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2015.

---

	Efforts of the bringing medicine management using the cooperation system that the bringing medicine management in the P0248-22-AM electronic chart is soft 原栄子, 近藤喜代子, 高橋貴子, 松林瑠美, 吉田雄一, 後藤友里, 宮下和也, 安田カオル, 齋藤真司, 川島優花 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2015.

---

	Construction and evaluation of the bringing medicine probate system which we incorporated in P0249-21-PM electronic chart 増田由香, 平田淑子, 小澤和子, 加藤純, 林豊, 小野田千晴, 名倉理央, 池谷延房 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2015.

---

	Development and usefulness of the P0250-22-AM bringing medicine management system (medicine fast for Windows) 木村真也, 木村敦, 逢坂智美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2015.

---

	Fact-finding about the P0251-21-PM preoperation cancellation medicine 中村俊貴1), 小林由布子1), 八木澤啓司1), 左右田和枝1), 宮下博幸1), 柴田壮一1), 松原肇1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2015.

---

	The effect that P0252-22-AM medicine notebook gives to confirmation duties of the bringing medicine, use medicine at admission 舘知也1),2), 齊藤康介1), 林勇汰1), 吉田阿希1), 杉田郁人1), 江崎宏樹1), 加藤未紗1), 臼井一将1), 野口義紘1), 福田聖啓2), 安田昌宏2), 水井貴詞2), 後藤千寿2), 寺町ひとみ1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2015.

---

	It is an attempt of becoming it the on admission bringing medicine reduction in P0253-21-PM elderly patients 河上卓弥, 松谷洋, 石本敬三 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2015.

---

	Efforts and evaluation of the bringing medicine investigation in the P0254-22-AM our hospital 出水睦子, 千原里美, 上田宏, 五十嵐努 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2015.

---

	Bringing medicine information management in the P0255-21-PM district acute phase hospital 田中敏, 佐藤益男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2015.

---

	Hypertensive management - excessive depression ... after the P0256-22-AM femoral neck fracture surgery 麻生美佐子1), 宇夛裕基2), 河原昌美2), 辻未希子1), 中野正人3), 浜手ひとみ1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2015.

---

	To do P0257-21-PM bringing medicine management appropriately more safely 馬場礼治, 鮎川美奈子, 永田和美, 小笹朝美, 屋久直紀, 小原優佳, 伊集院聖司, 寺澤麻梨恵, 柿元美乃, 益田宏代, 田中和子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2015.

---

	Investigation about efforts and the blunder of our hospital at the change checking prescription from P0258-22-AM bringing medicine 浅川唯, 前田剛司, 沢田俊朗, 稲垣由加利, 水草博希, 坂田洋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2015.

---

	Efforts and problems to bringing medicine check duties in the P0259-21-PM Iizuka Hospital 内田守次, 岡松沙哉佳, 小野貴絵, 川崎千尋, 川波宏隆, 鮫島美里, 野間口順哉, 橋本政弘, 古市佳奈, 進健司, 梅田勇一, 金澤康範, 竹本伸輔 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2015.

---

	The construction of the bringing medicine management system in the P0260-22-AM our hospital and the result 泉雄介, 栗本美里, 行木晃洋, 目連里江, 加藤幸三, 鮫島美和, 伊東美歩, 平原一也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2015.

---

	Doxorubicin hepatotoxic reduction by the P0261-21-PM theanine combination 長井克仁, 福野修平, 小田彩乃, 小西廣己 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2015.

---

	Effect of pravastatin and the chitosan on P0262-22-AM blood cholesterol and liver weight 岩崎綾乃, 片山雄貴, 矢野広将, 吉野祐太郎, 今井公江 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2015.

---

	Development of the application for iPad supporting the proper use of herbal medicinal products for the P0263-21-PM public 浅野孝1), 岡崎光洋2), 橋口正行3), 藤井勲1), 望月眞弓3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2015.

---

	About the role that an insurance pharmacist should fulfil at P0264-22-AM OTC sale 伊藤学1), 佐々木奈那1), 井上幹雄2), 小林範博3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2015.

---

	Participation of the pharmacist in consumers to consider from the effect that P0265-21-PM OTC medicine television CM gives 岸本桂子1), 福島紀子2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2015.

---

	Attitude survey for the self-medication of P0266-22-AM area inhabitants 村上美穂, 今川尚美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2015.

---

	Attitude survey for the smoking cessation support of the P0267-21-PM drugstore pharmacist 葛城静菜1), 恩田光子1), 堀口道子2), 小林春菜1), 吉川洸平1), 荒川行生1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2015.

---

	Examination about the knowledge of the drugstore pharmacist for the P0268-22-AM smoking cessation support and the associated factor 森元李早1), 恩田光子1), 堀口道子2), 永田祥子1), 隅田侑希1), 荒川行生1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2015.

---

	Fact-finding for problem extraction for P0269-21-PM "smoking cessation support promotion" 堀口道子1),2), 恩田光子2), 斉藤由里2), 荒川行生2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2015.

---

	Investigation of the side effect of P0270-22-AM contrast media expression situation 臼井和明1), 田口みどり1), 宗本佐知子1), 沖田健太郎1), 吉田悦朗1), 松田裕一郎2), 守屋雅光2), 中村宏1), 面田恵1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2015.

---

	The experience of patients with myasthenia gravis with suspected respiratory failure by the P0271-21-PM cibenzoline and consideration from literatures 宮本明希1), 榎屋友幸1), 石川英洋2), 島田拓弥2), 谷口彰2), 岡本隆二3), 村木優一1), 岩本卓也1), 奥田真弘1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2015.

---

	It is ... through side effect investigation - ward pharmacist duties in the P0272-22-AM pentamidine inhalation 久保嘉靖, 奥野昌宏, 中田学 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2015.

---

	Example that changes from warfarin in P0273-21-PM venous thromboembolism treatment to edoxaban were effective 岩崎景子1), 大橋養賢1), 勝海学1), 千田昌之1), 金宇慶2), 森田陽子2), 谷地豊1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2015.

---

	One case with suspected drug evocation-related insulin autoimmune syndrome with P0274-22-AM clopidogrel 砂川恵子, 木村和美, 飯島由美子, 細田宏美, 坂下可奈子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2015.

---

	One patient whom rhabdomyolysis developed in during P0275-21-PM levetiracetam remedy 小西敦子, 飯沼公英, 田中あゆみ, 岸本歩, 吉野宗宏, 田中三晶 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2015.

---

	Investigation about side effect expression and the risk factor of the fentanyl sustained intravenous administration for the P0276-22-AM postoperative pain 政賢悟1), 堀尾桃子1), 大島壽和子1), 橋口ゆみ1), 尾田一貴1), 前田克史1), 相澤実里1), 田上直美1), 西村千恵美2), 本田義輝1), 笠岡俊志3), 齋藤秀之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2015.

---

	It is one patient with suspected rhabdomyolysis onset after a change to atorvastatin from P0277-21-PM rosuvastatin 植村太志, 伊藤和幸, 河井和子, 磯谷聡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2015.

---

	7 cases that was able to intervene in drug-related liver damage suspicion in P0278-22-AM ward drug duties 千場美奈1), 諌見圭佑1), 田川幸1), 吉本有里1), 竹内小百合1), 山部美千子1), 塩田喜美子1), 小園亜希1), 花田聖典3), 中川義浩2), 津曲恭一1), 山道研1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2015.

---

	Analysis of the paradoxical response expression risk factor by the midazolam in P0279-21-PM neonates, infants 櫻井愛1), 本間雅2), 雨宮貴洋1), 田中陽子1), 長瀬幸恵1), 鈴木洋史1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2015.

---

	Examination of the factor influencing P0280-22-AM Daclatasvir, onset of hepatic dysfunction in the use of Asunaprevir patients 松崎貴志1), 有木宏宗1), 中島瑶子1), 松村泰斗1), 石井俊哉2), 佐藤明2), 横山美恵子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2015.

---

	It is ... for a case with examination - diclofenac local site cutaneous administration preparation about the expression tendency of the side effect in the different local cutaneous administration preparation of the P0281-21-PM dosage form 大山勝宏1),2), 高橋真二2), 井上みち子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2015.

---

	The actual situation of the lamotrigine adverse event using P0282-22-AM adverse drug reaction database (JADER) 黒田裕子, 安藤剛, 伊藤基泰, 坂本和紀, 西野夏希峰, 土生章太郎, 飛田悠里加, 横野加那子, 吉村拓音, 松元一明, 木津純子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2015.

---

	Fact-finding ... based on information of change - PMDA of the side effect report with the consumption increase of the P0283-21-PM Chinese medicine 松本すずか1), 加藤鈴1), 山本伸一2), 湯本哲郎1),3), 稲葉健二郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2015.

---

	Search of the symptom for a risk factor and early detection of the P0284-22-AM drug-related dysfunction thyroid 杉山菜々1), 大津史子1), 矢野玲子3), 榊原仁作1), 後藤伸之2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2015.

---

	Search of the symptom for a risk factor and early detection of the P0285-21-PM drug induced hepatic injury 岡田侑子1), 大津史子1), 矢野玲子2), 榊原仁作1), 後藤伸之3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2015.

---

	Examination about the effect factor of the treatment with P0286-22-AM rivastigmine patch continuation 寺澤真理子1), 安高勇気1),2), 合馬慎二3), 今給黎修1),2), 鷲山厚司1), 坪井義夫3), 二神幸次郎1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2015.

---

	Fact-finding of hepatic dysfunction in the P0287-21-PM Daclatasvir Asunaprevir combination therapy 松川雅子1), 福野和治1), 西部幸一1), 今井桂子1), 古家乾2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2015.

---

	The use situation of new oral anticoagulant drug (NOACs) in the P0288-22-AM our hospital and the side effect expression situation 佐藤伸輔1), 櫻井淳二1), 笹森友理恵2), 岡田優1), 佐藤昌子1), 阿部順1), 石澤文章1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2015.

---

	Safe investigation of the Juzentaihoto in the P0289-21-PM child surgery patients 宮原由香里1), 草深純一2), 太田哲徳1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2015.

---

	Effective and safe examination of the edoxaban low dose administration in the P0290-22-AM Total Hip Arthroplasty 奥田直之, 梅原玲緒奈, 朴井三矢, 土井敏行, 上野裕之, 山崎邦夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2015.

---

	Analysis of the hearing investigation contents which went in the case of an inquiry about the extravasation of the P0291-21-PM infusion 岩原良晴, 堀越由里, 竹林佑花, 津田朋枝, 吉岡小都子, 佐々木美由紀, 福田まゆみ, 星泉, 河野裕則 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2015.

---

	Use situation investigation of the tolvaptan in P0292-22-AM children 石原彩, 藤川景子, 河井和子, 伊藤和幸, 磯谷聡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2015.

---

	One case that an erethism-like symptom developed at the P0293-21-PM steroid pulse therapy enforcement, but was able to accomplish treatment without reaching it by the participation of the pharmacist seriously 渡邉雄貴1), 田窪桜子1), 伊藤瑞規2), 祖父江元2), 山田清文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2015.

---

	Use fact-finding (the second report) of the nitric acid agent in patients with P0294-22-AM prostatic hypertrophy or the nitric oxide grant agent 甲田明英, 梅田道, 大澤友裕, 大野佑城, 馬淵温子, 青山智, 安田昌宏, 水井貴詞, 後藤千寿 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2015.

---

	Study on human liver damage risk prediction of the anticancer agent using the P0295-21-PM T-LEX(R) method 西村奈緒恵1), 榎本初音1),4), 立木秀尚1), 島田卓2), 長塚伸一郎3), 中嶋幹郎4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2015.

---

	The analysis of the epithelium mesenchyma conversion trigger mechanism by the P0296-22-AM methotrexate and search of the defense target of the drug-related pulmonary disorder based on it 原林六華1), 宮本未緒花2), 川見昌史2), 湯元良子2), 高野幹久2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2015.

---

	Bradycardia with the P0297-21-PM phenytoin administration, 1 case with suspected cardiac arrest 橋本貴広, 大森俊和, 太田裕, 藤村一軌, 仲鉢英夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2015.

---

	One case that taste perversion developed after P0298-22-AM linezolid administration 松井侑子1), 田中雅幸1),2), 打谷和記1), 廣田育彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2015.

---

	Dangerously ill low Na blood symptom with P0299-21-PM thiazide and the duloxetine combination 森実優1), 小出哲朗2), 今西義紀1), 松井佑梨世3), 松田理3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2015.

---

	One case that dermatopathy and rhabdomyolysis were thought to complicate by P0300-22-AM lamotrigine 藤井晶子, 近藤あゆみ, 村田義明, 築山郁人, 松浦克彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2015.

---

	Adverse event investigation in the proper use of the P0301-21-PM lamotrigine 佐藤菜月1), 井上裕貴1), 林誠1), 竹内正紀1), 松本修一1), 小林麗2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2015.

---

	Side effect investigation of the P0302-22-AM chronic hepatitis C therapeutic drug protease inhibitor 土田美奈子, 岩瀬裕治, 鯨明美, 丹羽直人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2015.

---

	Correspondence to circulation inhibition by the dexmedetomidine at P0303-21-PM large intestine ESD 稲田寛之1), 川上香恵2), 増山静代2), 廣島良規3), 間宮孝4), 関利一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2015.

---

	Pharmaceutical consideration for the case that developed disturbance of consciousness after P0304-22-AM famciclovir internal use 宮内綾子1), 平出耕石1), 今関孝子1), 加藤武司1), 小山純司2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2015.

---

	Effect of the silver sulfadiazine giving it to an internal change of the P0305-21-PM cisplatin 小田祐一郎1), 日高宗明1), 大小田晃2), 土肥聡子2), 大橋あゆみ2), 鈴木彰人1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2015.

---

	Effect of lithium giving it to P0306-22-AM kidney existence machine anion transportation system 上井優一, 柘植みさと, 東海雄太, 川嵜達也, 鍋倉智裕 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2015.

---

	Effect of the deoxycytidine kinase knockdown on deoxycytidine uptake in P0307-21-PM humans colon cancer cell line HCT116 cells 枡田文沙, 金原未佳, 細川美香, 上田久美子, 岩川精吾 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2015.

---

	Examination about the solubility of the fexofenadine hydrochloride in the P0308-22-AM apple juice 岩永一範, 池田光, 宮崎誠, 永井純也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2015.

---

	Diagnosis before administration to predict a diuresis effect of furosemide using the P0309-21-PM nephrosis rat 黒田浩昭1), 緒方賢次1), 内田光祐1), 徳永仁1), 瀬戸口奈央1), 小川修2), 高村徳人1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2015.

---

	Problems about rat serum vancomycin densitometry using the P0310-22-AM enzyme immunoassay and the solution 小西廣己1), 福野修平1), 地村拓也1), 伊賀幾美1),2), 長井克仁1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2015.

---

	Examination ... in effect - clinical density of aldehyde oxidase activity to give it to allopurinol metabolism in P0311-21-PM rat in vivo 田山剛崇1), 杉原数美1), 三宅勝志1), 北村繁幸2), 太田茂3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2015.

---

	Effect of the Bakumondoto giving it to P0312-22-AM drug metabolizing enzyme activity 柏木健宏1), 安原昌子1),2), 田山剛崇1), 佐和章弘1), 三宅勝志1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2015.

---

	Study on internal change of diuretics furosemide in the P0313-21-PM ascitic fluid liver cancer rat 内田光祐, 緒方賢次, 黒田浩昭, 徳永仁, 瀬戸口奈央, 高村徳人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2015.

---

	About correspondence to on admission patients bringing medicine of P0314-22-AM NOAC 三島裕彦, 林智洋, 中澤百合子, 松元一隆, 孫栄淑, 西川美香, 黒田陽子, 水野彩里 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2015.

---

	Comparison of the blood level change by the genetic polymorphism of the Aki Shichi nib for patients with P0315-21-PM progress-related renal cell carcinoma 加藤博史1), 佐々直人2), 宮崎雅之1), 竹内美緒3), 浅井美穂3), 岩井茜3), 野田幸裕3), 山田清文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2015.

---

	The pharmacokinetic prediction in P0316-22-AM children: Antiepileptic drug phenytoin as a case 中山哲1), 杉山雄一2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2015.

---

	Establishment of the simultaneous assay of paclitaxel for pharmacokinetic analysis in P0317-21-PM oil xanthan gum treated patients and the main metabolites 友田麻耶1), 田井紀江1), 前田真一郎1),2), 木島貴志3), 安田宗一郎1),2), 三輪芳弘2), 藤尾慈1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2015.

---

	Investigation about the effectiveness and the renal failure frequencies that assumed AUC/MIC of P0318-22-AM vancomycin hydrochloride (VCM) an index 高橋愛加1), 伊藤正輝1), 鈴木正論1), 舟越亮寛1), 佐々木忠徳2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2015.

---

	Comparison between P0319-21-PM lanthanum carbonate chewable tablet and citric acid second iron tablets 佐野祐子1), 望月真太郎1), 須田智1), 村松望美1), 海江田由樹子1), 山内拓1), 内田光一2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2015.

---

	P0320-22-AM Factor Xa inhibitor Edoxaban reduces active factor VII in the trough phase and potentiates anticoagulant action 畑中由香子1), 根本禎久2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2015.

---

	The drug interactions check in the P0321-21-PM order ring system: The setting that is contraindicated to the combination in AUC regulation indication and the institution 伊藤哲也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2015.

---

	The antimicrobial activity in reaction products of P0322-22-AM meropenem hydrate and the L-cysteine and cytotoxic examination 中川幸子, 板垣文雄, 飯島亮介, 山本瑠璃子, 油井聡, 渡邊真知子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2015.

---

	Stability of pharmaceutical products at nutrient for intestinal administration combination in the P0323-21-PM simple suspension method 田中扶美1), 藤原由梨2), 綿本有希子2), 豊原朋子1), 桑原晶子1),2), 上田幹子3), 片岡和三郎1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2015.

---

	One patient who worked on P0324-22-AM vincristine and the management of drug interactions with voriconazole 堀井麻衣1), 安武夫1), 黒川陽介1), 川俣豊隆2), 大野伸広2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2015.

---

	Examination of the background factor of the case that a rise of PT-INR was found in during P0325-21-PM warfarin remedy 吉田悦朗, 白石貴寿, 沖田健太郎, 宇都宮奈々, 近藤真由, 中村宏, 面田恵 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2015.

---

	Investigation about the combination of cyclosporin A and HMGCoA inverting ferment inhibitor case in the P0326-22-AM Iwata City general hospital 河村美弥子, 広瀬和昭, 松原大祐, 上甲佳奈, 正木銀三 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2015.

---

	Evaluation using DIPS for 2 cases with suspected interaction of P0327-21-PM azithromycin single dose preparation and the warfarin 相馬直記, 留守克之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2015.

---

	Structure to give it to the interaction with P0328-22-AM new quinolone antibacterial and the metal cation-containing supplement 岡崎大祐1), 高見陽一郎1), 松岡哲史1), 佐藤展子1), 小川壮寛1),2), 酒井将弘1), 中川碧1), 森翔馬1), 島田憲一1), 江川孝1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2015.

---

	2 cases that accepted cerebral infarction and intraatrial thrombus by interaction with the P0329-21-PM warfarin 大野凜太郎1), 新井隆之2), 斎藤和悦1), 渡部義和1), 小林義美1), 戸邉豊総2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2015.

---

	Examination about the effect that antimicrobial gives to a P0330-22-AM PT-INR level 小西麻美子, 澤田真嗣, 折笠奈津希, 藤田敦夫, 友金幹視, 三上正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2015.

---

	Effect and retrospective study investigation (the second report) of the proton pump inhibitor about the excretion delay of the methotrexate in the P0331-21-PM Miyakonojo medical center 西村尚芳1),2),3), 福石和久1), 津曲恭一2), 田中基稔3), 大津貴寛1), 吉田裕生1), 末永亘1), 戸切祥恵1), 古里あかね1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2015.

---

	Effect of metronidazole giving it to mRNA expression of cytochrome P450 in P0332-22-AM humans hepatocytes and tinidazole 工藤敏之, 木林英彦, 遠藤由実子, 谷津雅美, 伊藤清美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2015.

---

	Examination of the interaction with P0333-21-PM methotrexate and the glycyrrhizic acid 中野智尋1), 石崎純子1), 北川佳奈1), 三坂恒1),2), 菅幸生1), 崔吉道2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2015.

---

	Examination about the interaction of P0334-22-AM rifampicin and the antacids containing the metal cation 茂野絢子1), 下村斉1), 島田洋輔2), 後藤了2), 青山隆夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2015.

---

	A prediction of the drug interaction at the P0335-21-PM impaired renal function: DPP-4 inhibitor Tenelia as a case 清水秀俊1), 仲丸善喜1),2), 山崎浩史2), 久米俊行1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2015.

---

	1 case that was able to control PT-INR under warfarin, bucolome, amiodarone combination for metabolism enzyme induction with P0336-22-AM rifampicin 高瀬友貴1), 土肥麻貴子1), 藤原秀敏1), 登佳寿子1), 森本茂文1), 早坂朋彦2), 植田浩司2), 池村舞3), 橋田亨1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2015.

---

	P0337-21-PM morphine and sedative adjuvant, prediction of the interaction with NSAIDs 柴田実香1), 無量井昂樹1), 木村嘉明2), 尾崎紀之3), 荒井國三1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2015.

---

	1 case that evaluated cyclosporine and drug interaction of the miconazole gel in P0338-22-AM children 南智香子1), 祖川倫太郎1), 大塚泰史2), 持永早希子1), 田崎正信1), 松尾宗明2), 原英夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2015.

---

	Examination about drug interactions of P0339-21-PM warfarin and tramadol 溝口夏海1), 宮原強1), 塩川裕美1), 植松大智1), 小杉寿文2), 松永尚1), 佐藤英俊3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2015.

---

	It is ... about three-drug combination of 1 case - phenytoin, warfarin and 5-fluorouracil with suspected drug interaction during the P0340-22-AM chemotherapy enforcement 西川豊, 梶田貴司, 山下加那子, 和田彩, 堀内映里, 黒松誠, 雪矢良輔, 上田睦明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2015.

---

	The case that PT-INR fluctuated by P0341-21-PM TS-1 and warfarin combination 高松竜一1), 安部一秀1), 佐藤和則2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2015.

---

	1 case that showed a significant neutropenia by paclitaxel for the P0342-22-AM double cancer and interaction of the letrozole combination 徳島英明1), 持永早希子1), 江越正芳1), 細矢和久1), 江本晶子1), 田崎正信1), 原英夫1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2015.

---

	We analyze the side effect of 5 cases receiving the sorafenib for patients with P0343-21-PM thyroid cancer 須藤宏文1), 岡本明大1), 濱口直美1), 佐々木典子1), 西田幸平2), 竹内万彦2), 村木優一1), 岩本卓也1), 奥田真弘1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2015.

---

	Examination about drug interactions at Caspofungin and calcineurin inhibitor combination in the P0344-22-AM same kind hematopoietic stem cell transplantation and the safety 徳和目篤史1), 西本光孝2), 高橋正也1), 中村安孝1), 康秀男2), 中前博久2), 西川武司1), 日野雅之2), 永山勝也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2015.

---

	About the decrease in PTINR level by the combination of P0345- 21-PM warfarin and intravenous lipid microsphere 黒川建吾1), 汐見紘明2), 湊聖一郎1), 松野純男2), 北小路学2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2015.

---

	Rearward medical record investigation about the effect on phosphorus level inorganic in blood by the gastric-acid secretion antagonist combination in haemodialysis patients during P0346-22-AM calcium carbonate preparation remedy 立沢正臣1), 小川竜一2), 大久保淳史1), 前田国見3), 下嶋和代1), 宮崎招久1),4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2015.

---

	Rearward observational study about the drug interaction of P0347-21-PM rifampicin and amlodipine 櫻井健史1), 平井啓太2), 杉山慎一1), 伊藤邦彦2), 角入壽彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2015.

---

	Drug interactions of ezetimibe and the warfarin through the absorption inhibition of P0348-22-AM vitamin K 高田龍平, 山梨義英, 山本武人, 豊田優, 山本英明, 田中悠介, 小峰瞳子, 鈴木洋史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2015.

---

	Basic examination about the effect of the high phosphorus blood symptom therapeutic drug in lipid dysbolism treatment of patients with P0349-21-PM chronic renal failure 小田雅子, 星麻美子, 村上柚季, 市村祐一, 齊藤浩司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2015.

---

	The case that blood cyclosporine concentrations decreased by P0350-22-AM Caspofungin combination 伊藤あゆみ, 中川隼一, 高橋真一, 桝茂典, 岡田悠美, 蔭山博之, 村上敏明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2015.

---

	Examination of the usefulness of the new disease activity evaluation MBDA score in the P0351-21-PM early rheumatoid arthritis diagnosis, effect of treatment judgment 樋浦一哉1), 皆上翔太郎2), 新穂彩2), 浅山りん2), 城田愛理2), 宮川千珠2), 伊藤萌子2), 竹田剛3), 渡辺浩明1), 渡辺泰裕2), 江川 (岩城) 祥子2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2015.

---

	A use situation investigation of vancomycin for the P0352-22-AM injection and future problem 窪田真弓, 三谷和恵, 波多晶子, 中澤美樹子, 鶴居勝也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2015.

---

	Intervention ... of the pharmacist through examination - testing order representation about TDM duties in the P0353-21-PM our hospital 秋場孝則, 森村春菜, 米岡祐貴, 中野一男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2015.

---

	Risk ... of the blood use experience - phenytoin levels drop of fosphenytoin for patients with P0354-22-AM children status epilepticus 宮津大輔, 田中博和, 後藤貴央, 立石裕樹, 平川雅章 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2015.

---

	Efforts about the TDM enforcement in the P0355-21-PM outpatient 鎌滝真永, 加藤幸三, 平原和也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2015.

---

	About the efforts of antimicrobial representation order duties targeted for the TDM by the P0356-22-AM pharmacist 須貝瑶子1), 松本浩1), 宿谷光則1), 坪谷綾子1), 濱野公俊1), 坂下裕子1), 増原慶壮2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2015.

---

	Improvement of the multiple drug simultaneous assay of plasma antiphthisic drug by P0357-21-PM LC-MS 伊藤瑚乃美1), 深澤弘樹1), 宮下真美1), 西村麻由1), 鈴木純子2), 松井弘稔2), 蛇澤晶2), 吉田久博1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2015.

---

	Possibility ... of basic examination - sustained administration about the meropenem resistant bacteria onset inhibition strategy using the P0358-22-AM Monte Carlo method 尾田一貴1), 堀尾桃子1), 橋口ゆみ1), 田上直美1), 本田義輝1), 城野博史1),2), 齋藤秀之1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2015.

---

	A prediction and inspection of the vancomycin clearance using the glomerular filtration rate that we derived than the serum creatinine level in P0359-21-PM children 齊藤順平, 小村誠, 寺門浩之, 石川洋一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2015.

---

	Administration plan based on the blood level of the P0360-22-AM dabigatran and examination of the blood level change factor 松田翔平1),2), 今津智子1), 浜崎浩一1), 中村護1), 松本篤1), 村上照夫2), 前田頼伸1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2015.

---

	Population pharmacokinetics analysis of vancomycin note (VCM) in P0361-21-PM children 浦田由紀乃1), 小野達昌2), 平田憲史郎1), 猿渡淳二2), 陣上祥子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2015.

---

	Examination of the drawing blood method to medication method of the P0362-22-AM cyclosporine 久保拓己1), 高山寿里1), 徳永秀美1), 寺門浩之1), 中澤裕美子2), 後藤文洋2), 河合利尚2), 小野寺雅史2), 石川洋一2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2015.

---

	Examination about the factor affecting P0363-21-PM amiodarone metabolite concentrations 山本舞, 井上健, 坪井伸治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2015.

---

	An example of patients with renal cell carcinoma which the blood level of the P0364-22-AM Aki Shichi nib did not increase 野田あおい1), 田中雅樹1), 高崎新也1), 鈴木裕之1), 菊地正史1), 川崎芳英2), 伊藤明宏2), 久道周彦1), 山口浩明1), 荒井陽一2), 眞野成康1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2015.

---

	Evaluation of the blood tacrolimus levels assay of dimension Xpand Plus-HM using the P0365-21-PM new reagent 水谷栄梨, 岩本卓也, 小田都紀子, 村木優一, 奥田真弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2015.

---

	Application effect of the generalization linear mixed effect model in the initial administration plan of P0366-22-AM vancomycin 興梠靖幸1),2), 緒方賢次2),3), 田中恵美1), 甲斐晃弘1), 徳永仁2),3), 瀬戸口奈央3), 千代反田晋1), 高村徳人2),3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2015.

---

	About usefulness of blood busulfan levels monitoring - low dose trial administration in P0367-21-PM children - 石渡泰芳1), 永田将司1), 瀧川加奈子1), 高橋弘充1), 今井耕輔2), 高木正稔2), 金兼弘和2), 森尾友宏2), 安原眞人3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2015.

---

	Search of the Cpeak arrival time for aminoglycoside derivative antimicrobial by the 2-compartment model using the P0368-22-AM Easy TDM 山口佳津騎1), 阿部武由2), 渡邊政博3), 竹内敏己4), 土屋浩一郎5), 高橋功一1), 元木貴大1), 田中裕章1), 朝倉正登1), 小坂信二1), 芳地一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2015.

---

	Suggestion at the time of the recommended drawing blood at population pharmacokinetics analysis and TDM measurement of P0369-21-PM vancomycin 金丸達哉1), 松村千佳子1), 塩田智子2), 高橋一栄2), 矢野義孝1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2015.

---

	Usefulness of the institution original population parameter facing P0370-22-AM TDM enforcement 岡田章1), 上野幹生1), 金森美咲1), 小阪直史2), 国府孝敏3), 牛込秀隆4), 吉村了勇4), 笠井英史5), 福島恵造1), 杉岡信幸1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2015.

---

	Search of the factor contributing to onset of hepatic dysfunction with the voriconazole administration in patients with P0371-21-PM blood malignant disorder 森永裕子1), 鈴木陽介1),2), 時松一成3), 田中遼大1),2), 佐藤雄己1),2), 緒方正男4), 平松和史2), 伊東弘樹1), 門田淳一2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2015.

---

	Examination of an IV infusion, the oral voriconazole optimum dose in P0372-22-AM children 茂見茜里1), 渡辺英里香1), 松元一明2), 横山雄太3), 猪川和朗3), 金澤直子1), 梅崎靖弘1), 竹下鮎美1), 池田龍二1), 森川則文3), 武田泰生1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2015.

---

	Evaluation of the blood tacrolimus levels measurement using the P0373-21-PM new ACMIA method 田渕祐輔, 牧野洸太朗, 越智尚子, 小阪直史, 四方敬介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2015.

---

	Inspection of the usefulness of the point of recommended drawing blood chart at the P0374-22-AM vancomycin TDM measurement 塩田智子1), 松村千佳子2), 谷長美菜子1), 金丸達哉2), 矢野義孝2), 高橋一栄1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2015.

---

	Two cases of patients with lymph vessels myoma symptom that a trough level of sirolimus showed high level by combination of P0375-21-PM itraconazole 菊地正史1), 野田あおい1), 田中雅樹1), 高橋阿希子1), 松田安史2), 星川康2), 久道周彦1), 山口浩明1), 岡田克典2), 眞野成康1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2015.

---

	Intervention effect to vancomycin initial administration plan by the P0376-22-AM ward permanent residence pharmacist 水岡大策, 山口佳津騎, 馬場亨, 久保裕香理, 河野真梨, 立道貴清, 田井達也, 一瀬ひろみ, 住吉健太, 冨田淳子, 小坂信二, 芳地一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2015.

---

	Examination of the diarrhea expression risk factor early after transplant with mycophenolic acid in the P0377-21-PM lung transplantation patients 伊藤雄大1), 須野学1),2), 坂本健太1), 吉崎祐太1), 川西秀明3), 千堂年昭3), 三好健太郎4), 山根正修4), 杉本誠一郎4), 大藤剛宏4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2015.

---

	Application to the Viva-E system of the P0378-22-AM nano peer (R) eTDM methotrexate measurement kit 松下尚弘, 谷川昇, 大竹由希子, 竹永早百合, 安藤千裕, 青柳裕美, 江崎舞, 古賀清弘, 石丸隆之, 野中敏治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2015.

---

	Comparison between antigen antibody immune reaction assay and traditional approach using the My5-FU reagent in blood 5-FU densitometry in P0379-21-PM TS-1 treated patients 野田哲史1), 稲富理2), 平大樹1), 池田義人1), 赤羽理也1), 安藤朗2), 森田真也1), 寺田智祐1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2015.

---

	Examination of the initial administration plan method using the vancomycin parameter varying in P0380-22-AM 鈴木伸志, 井田真仁, 佐野邦明, 松本富夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2015.

---

	Examination of the decreased renal function frequency according to the renal function in the P0381-21-PM vancomycin administration 杉慎介, 大石泰也, 川野昭, 東めぐみ, 鷲見理恵, 西村紀子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2015.

---

	Decision of the treatment strategy based on a characteristic of the vancomycin TDM analysis software which paid its attention to P0382-22-AM renal function 春木祐人1), 広本篤2), 毎熊隆誉2),3), 岡泰江1), 春木麻衣1), 増田展年4), 杉山哲大1), 手嶋大輔2),3), 近藤祥代1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2015.

---

	Nephropathic risk factor analysis with the P0383-21-PM vancomycin hydrochloride administration 薗田晃弘, 中尾承司, 岩崎公美, 桑鶴麻代, 川畑綾, 永田春香, 高田侑那, 浜園龍, 宝来留美, 岩下佳敬, 石田和久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2015.

---

	Examination of the nephropathic expression situation and risk factor in the P0384-22-AM vancomycin administration 只佐宣子1), 梶谷真也1), 徳本和哉1), 要田芳代1), 川上恵子1), 三島基靖1), 竹増まゆみ1), 只佐正嗣1), 堀川俊二2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2015.

---

	Role of introduction and the pharmacist of PBPM for P0385-21-PM antiMRSA medicine proper use 渡邊卓嗣, 田村彩, 伊藤亮太, 中居肇, 伊藤功治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2015.

---

	Examination of the usefulness of the VCM, TEIC initial administration plan using the P0386-22-AM TDM implementation manual 久保智士, 二見早希, 今市沙有美, 岡紗智子, 井上美穂, 松下比奈子, 石田あい, 松尾多恵, 藤本智大, 山崎瑞貴, 鶴崎亮, 北森翔子, 青木美沙, 松谷和子, 三嶋仁美, 木村真策 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2015.

---

	Factor - of consideration - initial administration plan deviation of the case that deviated from a therapeutic range from initial administration plan of P0387-21-PM vancomycin 高橋静香1), 松村直樹2), 横濱妙子1), 高松謙1), 渡邊卓嗣1), 長島章3), 中居肇1), 伊藤功治1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2015.

---

	Comparison of the pharmacokinetic parameter at the vancomycin hydrochloride infusion between the P0388-22-AM cancer species 大塚亮, 中島寿久, 小井土啓一, 佐野智望, 西垣玲奈, 橋本浩伸, 大塚知信, 林憲一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2015.

---

	Association between blood vancomycin levels and effect of treatment in P0389-21-PM children 近藤美貴, 中川俊作, 米澤淳, 矢野育子, 中川貴之, 松原和夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2015.

---

	1 case that was given continuous infusions of vancomycin for the bacterial meningitis of P0390-22-AM children 喜多岡洋樹1), 後藤由起子1), 山室蕗子1), 末吉栄志1), 近藤元三1), 久冨雄一郎2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2015.

---

	The effectiveness and problems of the arbekacin administration plan based on P0391-21-PM antimicrobial TDM guidelines 杉田裕貴, 田中絵美, 細見健悟, 小牧佐知子, 稲田智子, 高子優子, 増本憲生, 大槻裕朗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2015.

---

	Future problem in the TDM of P0392-22-AM VCM 堀本厚子, 組橋由記, 大久保真由美, 鈴江朋子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2015.

---

	Examination about the vancomycin administration plan during the P0393-21-PM sustained hemofiltration dialysis enforcement 溝田繁治, 下澤那津, 花田聖典, 谷口潤, 東島彰人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2015.

---

	Examination of the blood vancomycin levels optimum measurement interval in the adult case except the P0394-22-AM special condition of a patient 坂倉広大1),2), 中蔵伊知郎1),2), 土井敏行1), 上野裕之1), 山崎邦夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2015.

---

	Operation of the vancomycin TDM duties flow by P0395-21-PM ward charge pharmacist and the TDM charge pharmacist 佐藤浩太郎, 古川早矢香, 飯田遥, 梶野哲, 岩崎希, 井口恵美子, 猪股克彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2015.

---

	Renal function evaluation using predictive precision and cystatin C in the P0396-22-AM vancomycin doses design 塩田喜美子, 吉本有里, 田川幸, 諌見圭佑, 千場美奈, 竹内小百合, 山部美千子, 小園亜希, 津曲恭一, 山道研 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2015.

---

	One case that we intervened in pharmaceutical to the patients that P0397-21-PM MRSA was detected 千原亜紀子, 池田久雄, 平田貴宏, 岡安唯, 野村浩英 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2015.

---

	Examination about the contribution degree to the medical care by the in-hospital measurement shift of blood drug levels in the cottage-hospital out of P0398-22-AM 鳥羽英理子, 藺上圭子, 宇夛裕基, 山島糸, 河原昌美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2015.

---

	The administration method of vancomycin for P0399-21-PM haemodialysis patients and the clinical evaluations 大仁田哲修, 石原慎之, 岡崎美香, 井上昌樹, 玉木宏樹, 西村信弘, 直良浩司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2015.

---

	Population efficacy change model analysis of the febuxostat using the P0400-22-AM daily life clinical data (electronic chart) 森木邦明1), 高根浩1), 重松沙希2), 深江真登2), 加唐誠剛東2), 島田美樹1), 家入一郎2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2015.

---

	Insurance examination assessment situation investigation of Teiko plastic Nin in the P0401-21-PM Nagasaki University Hospital 松永典子, 森塚暁裕, 吉永萌, 里加代子, 北原隆志, 佐々木均 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2015.

---

	Fact-finding ... to an attitude survey and a practitioner to Mayor of TDM questionnaire survey - section in P0402-22-AM Kanagawa 蛭田剛俊1),3), 濃沼政美2),4), 佐村優3), 樋島学3), 小村裕子3), 井上順博3), 佐藤透4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2015.

---

	P0403-21-PM Asian, blacks, population pharmacokinetics analysis of the warfarin for whites and evaluation of the administration algorithm 久保佳奈1), 大原みなみ1), Cavallari LH2), Lee MTM3), Scordo MG4), 宮嶋篤志1), 高橋晴美1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2015.

---

	Study on blood tramadol optical isomer levels and clinical response according to the P0404-22-AM CYP2D6 genetic polymorphism 須野学1), 伊藤雄大2), 山本健人2), 吉崎祐太2), 中西里佳2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2015.

---

	Search of the risk factor for chemotherapy-induced retching, vomiting in patients with P0405-21-PM AC therapy enforcement breast cancer 幕田龍1), 辻大樹1), 金容壱2), 山本圭祐3), 横井茉里1), 大嶽亜季1), 中森春美1), 井上和幸1), 平井啓太1), 中道秀徳3), 塩川満3), 伊藤邦彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2015.

---

	About the platelet function measurement in the P0406-22-AM our hospital and the choice of the antithrombocytic agent using the CYP2C19 genetic polymorphism 廣田あゆ子1), 浅野志津1), 松本和也1), 山本梓2), 金井美緒1), 花房伸幸1), 難波悠介3), 福家聡一郎3), 佐藤哲也3), 森英樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2015.

---

	FCGR3A gene -158V/F polymorphic frequency analysis in the P0407-21-PM Japanese 木村耕二, 小林大悟, 横山晴子, 高柳理早, 山田安彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2015.

---

	The construction of the cancer chemotherapy management system using the P0408-22-AM frequent use database software and the evaluation 木津茂, 米川恭史, 光家勉, 太田正美, 渡部なおみ, 富田国男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2015.

---

	Development of the explanation documentation system which established a viewpoint for the comparison of the P0409-21-PM breast cancer regimen 広田瑞季, 大西優香里, 鈴木信世, 松井布美, 石井杏奈, 西岡佐和子, 河原栞, 小茂田昌代 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2015.

---

	Construction of the regimen system including the oral medicine by the P0410-22-AM electronic chart 金子誠1), 山崎博之2), 松井孝之1), 今井弘之1), 赤沼浩明1), 石川靖治3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2015.

---

	Safety Management and convenience of the chemotherapy treatment planning form that practiced medical treatment management (PBPM) based on P0411-21-PM protocol 齋藤裕子, 菊池大輔, 齊藤美帆, 高橋透, 畑中貞雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2015.

---

	About making and the operation of the management sheet for P0412-22-AM anticancer agent proper use 龍官真生子1), 吉岡奈津恵1), 尾崎智規1), 北村芽衣子2), 小林真也3), 渡辺明彦4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2015.

---

	Enforcement of the UGT1A1 genetic screening in the P0413-21-PM irinotecan administration and fact-finding about the dose 久枝真一郎1), 西口幸代2), 浜野峰子1), 宗広樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2015.

---

	Evaluation of hepatitis B reactivation measures at chemotherapy start in the P0414-22-AM our hospital 林豊1), 富野浩光1), 名倉理央1), 小野田千晴1), 加藤純1), 小澤和子1), 増田由香1), 平田淑子1), 増田仁美1), 後藤治子1), 池谷延房1), 小平誠2), 平松毅幸3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2015.

---

	Evaluation after the hydration unification of the cisplatin regimen in the P0415-21-PM Beppu medical center 鶴田南奈子1), 鳥山陽子1), 梅野なるみ2), 橋本典也3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2015.

---

	A problem and the remedy that we were able to see from doubt inquiry about the clinical test value in the P0416-22-AM cancer chemotherapy 高橋透, 齋藤裕子, 齊藤美帆, 菊池大輔, 畑中貞雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2015.

---

	Usefulness by the electronic order system registration of the P0417-21-PM childhood cancer chemotherapy regimen 渡邉美菜子1), 丹羽洋介1), 矢田郁実1), 冨安真史1), 大庭真弓1), 伊藤槙智子1), 野村英宏1), 鳥本真由美1), 森智子1), 村松秀城2), 高橋義行2), 小島勢二2), 山田清文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2015.

---

	Efficiency of the anticancer agent regimen inspection using P0418-22-AM Microsoft Excel 瀧平純一, 島田惇司, 岡田和博, 金子知由, 大塚淳一, 伊藤やす江, 安間浩子, 長塚さおり, 勝俣はるみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2015.

---

	Significance in the electronic order ring systems construction of the P0419-21-PM childhood cancer chemotherapy regimen and the medical security 冨安真史1), 丹羽洋介1), 森智子1), 渡邉美菜子1), 大庭真弓1), 伊藤槙智子1), 矢田郁実1), 野村英宏1), 石塚雅子1), 鳥本真由美1), 村松秀城2), 高橋義行2), 小島勢二2), 山田清文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2015.

---

	An evaluation and improvement for the P0420-22-AM inside the hospital adoption anticancer agent table 水木麻里, 寺内さつき, 中山真知, 長江萌菜美, 富田かおり, 柏木優香, 鈴江香織, 岡峰亜希菜, 大村ふみ, 森吉雅代, 中川朱美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2015.

---

	Introduction of by encounter front by the pharmacist for the P0421-21-PM oral anticancer agent 杉野善彦1), 前川由佳2), 小島圭太郎1), 蓑島謙一3), 山羽正義2), 堀江正宣2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2015.

---

	Efforts to oral anticancer agent therapy support for the outpatient in the P0422-22-AM Itabashi Chuo General Hospital 目黒聡子1), 高山裕子2), 酒井由希子1), 岡山和広1), 山内泰一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2015.

---

	Role of the foreign chemotherapy conference by the P0423-21-PM pharmacist leadership 山室蕗子1),2), 後藤由起子1),2), 喜多岡洋樹1), 楠本将裕1), 吉田愛1), 田中泉1), 末吉栄志1), 近藤元三1), 辻隆宏2), 奥村恭博2), 岸裕人2), 山崎浩2), 津田弘之2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2015.

---

	Efforts to cancer instruction to patient management charges 3 in the P0424-22-AM our hospital 古林園子1), 小沼大祐1), 岩村瞳1), 伊藤博1), 中野茂治2), 鈴木正人2), 加藤一郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2015.

---

	P0425-21-PM AC, fact-finding of the foreign chemotherapy hot line consultation from patients with CEF therapy enforcement breast cancer 原茉梨絵1), 橋本浩伸1), 文靖子1), 近藤俊輔2), 上原智子3), 矢野美穂3), 朝鍋美保子3), 田村研治4), 大塚知信1), 林憲一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2015.

---

	1 case that the opioid continuous intravenous infusion introduction with the P0426-22-AM PCA pump allowed home discharge 高橋晶子1),2),3),4), 藤谷竜磨1), 岡嶋絵里香1), 赤嶺千秋1), 藤屋華織2), 藤本和美2), 浦野美雪2), 熊倉佐代子2), 片岡学4), 高田淳子3), 越田晃1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2015.

---

	Efforts for quality and safety improvement of the cancer chemotherapy that we followed for the PDCA cycle by the P0427-21-PM chemotherapy team 日比聡1), 井上博貴1),5), 城川優子2),5), 壁谷めぐみ5), 長岡雅敏1), 横井沙緒里1), 鈴木彩香1), 丹羽絵梨奈1), 松浦三恵子3), 伊奈研次4), 湯浅周1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2015.

---

	Patients intelligence using the patients with cancer screening in the P0428-22-AM outpatient department chemotherapy center 宮松洋信1), 東加奈子1), 鮎原秀明1), 宮里明芽1), 夏目真紀1), 川島美由紀2), 鈴木康予2), 明石貴雄1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2015.

---

	Relation of the drug department in the P0429-21-PM cancer board 大原正之, 小川信二, 藤原斉 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2015.

---

	Efforts to the emergency consultation of the cancer chemotherapy enforcement patients in the P0430-22-AM City Nagahama Hospital 大岡千寿子, 野洌孝二, 寺村早貴, 池田遼太, 元持正樹, 多賀俊明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2015.

---

	Construction of the local medicine medicine cooperation system in the P0431-21-PM breast cancer adjuvant postoperative treatment 松原怜, 鈴木大吾, 田中伸明, 鈴木敦詞, 牧なつみ, 稲垣史郎, 前田剛司, 坂田洋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2015.

---

	The examination of the preparation method of the allopurinol gargle agent and the effect on stomatitis with the P0432-22-AM cancer chemotherapy 藤井芳範1), 長谷部忍1), 山浦佳子1), 小田泰弘1), 内田ゆみ子1), 五十嵐正博1), 伊藤忠明1), 宇田川晴司2), 林昌洋1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2015.

---

	Effect of the renal function on side effect frequencies in the P0433-21-PM Ron surf (R) treatment 角川幸男, 高橋靖治, 石床知佐江, 岩西雄大, 高橋幸三, 澤井祐樹, 杉本貴洋, 清水克次, 望月千枝, 中多陽子, 福島宣久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2015.

---

	The effectiveness, safe examination of the peg filgrastim in the P0434-22-AM malignant lymphoma R-CHOP therapy 櫻井淳二, 宮内康夫, 佐藤伸輔, 野上佳奈子, 武者栄美子, 石澤文章 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2015.

---

	P0435-21-PM peg filgrastim subcutaneous injection proper use and investigation of the effectiveness 仁田美保子, 中林真紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2015.

---

	Study on venous thrombosis and patients background by P0436-22-AM Bevacizumab 早川裕二1), 小山一子1), 森下拓也2), 小林智晴1), 大津史子3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2015.

---

	Fact-finding of acute renal failure (AKI) in the P0437-21-PM cisplatin (CDDP) combination chemotherapy and search of the risk factor 阿部真紀, 吉野真樹, 山下弘毅, 田中克幸, 佐々木奈穂, 田川千明, 田中佳美, 加藤克彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2015.

---

	An evaluation of the prophylaxis of the vascular pain with P0438-22-AM oxaliplatin and analysis of the risk factor 池田菜々1), 菅幸生1), 前田真奈美1), 岡田守弘2), 桂英之3), 北出紘規4), 米澤美和5), 石崎純子1), 嶋田努6), 柏原宏暢5), 崔吉道6), 松下良1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2015.

---

	Examination of the onset of hypomagnesemia situation by the P0439-21-PM panitumumab 平池美香子, 林稔展, 西野隆 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2015.

---

	We look at the use situation for the second prevention of the P0440-22-AM peg filgrastim and the rear about the onset of pyrogenic neutropenia and investigate a mark 櫻下弘志1), 佐伯康之1), 畝井浩子1), 杉山一彦2), 松尾裕彰1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2015.

---

	Examination about the effect of treatment of the irsogladine maleate for the P0441-21-PM acetic acid-induced stomatitis model 佐藤光利1), 赤石美生1), 今村綾乃2), 河野弥生2), 花輪剛久2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2015.

---

	Of the prophylaxis of the sustained G-CSF preparation for the P0442-22-AM head and neck cancer TPF therapy, actually 平田力1), 北山秀則1), 村紗苗1), 出町拓也1), 佐藤佑一朗1), 芦崎雅之1), 早坂州生1), 竹内公美1), 渡邉昭仁2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2015.

---

It is the actual situation of peripheral neuropathy in the adjuvant chemotherapy Capecitabine/Oxaliplatin combination (XELOX) therapy after colon cancer technique using the evaluation tool of plural P0443-21-PM 杉崎崇人1), 川上和宜1), 横川貴志1), 瀧口友美1), 杉田一男1), 中本恵理1), 末永光邦2), 水沼伸行2), 山口俊晴2), 濱敏弘1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2015.

---

	The nephrotoxic evaluation of the short hydration method at the P0444-22-AM cisplatin administration and examination of the tolerability 高山智行, 田邉直人, 田沼道也, 高野浩彦, 折井孝男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2015.

---

	Effect of "the paclitaxel to preload" giving it to P0445-21-PM "vascular pain during Carboplatin administration" 堀部正記, 池井健, 大谷仁士 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2015.

---

	Investigation of the adverse event with the trastuzumab M tongue Shin administration in patients with P0446-22-AM HER2-positive breast cancer 須川涼, 泉谷悟, 西垣内亮, 垰越崇範, 佐伯康之, 畝井浩子, 松尾裕彰 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2015.

---

	About plasma platinum concentrations in the P0447-21-PM Weekly cisplatin combination concurrent chemoradiotherapy and acute nephropathic association 山本健人1), 須野学1),2), 浅野匡彦1), 伊藤雄大1), 中西里佳1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2015.

---

	It is ... about examination - small-cell lung cancer CDDP+CPT-11 therapy of the risk factor about dose regulation factor of P0448-22-AM irinotecan 椎名俊介1),2), 平井成和2), 渡辺和美3), 土井啓員2), 増田雅行2), 佐野君芳2), 田中芳夫1), 真坂亙2), 石井敏浩4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2015.

---

	The HBV reactivation measures that utilized a regimen sheet in the P0449-21-PM cancer chemotherapy 米北浩人1), 黒津愛奈美2), 森健治3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2015.

---

	Effect to hepatitis B reactivation risk reduction by the pharmacist inspection at the P0450-22-AM cancer chemotherapy enforcement 藤岡美穂, 中西敏博, 桂川健司, 久田達也, 辻秀樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2015.

---

	Examination of the renal failure protective efficacy with the Mg administration in the P0451-21-PM cancer of the esophagus FP therapy 藤川翠1), 宮原強1), 嬉野紀夫2), 松永尚1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2015.

---

	The onset of hypomagnesemia situation and intervention effect in the P0452-22-AM cetuximab panitumumab 杉浦央, 斎藤由起子, 加藤ゆか, 近藤覚也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2015.

---

	One case that came by treatment continuation by correspondence such as the weight loss for hepatic dysfunction of the P0453-21-PM that mouth nib 楠本将裕1), 山室蕗子1), 喜多岡洋樹1), 後藤由起子1), 末吉栄志1), 近藤元三1), 岸裕人2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2015.

---

	One patient who presented with sex hypersensitivity from delayed type hypersensitivity by P0454-22-AM oxaliplatin immediately 青孝明, 近藤智彦, 山川恵子, 木村匡男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2015.

---

	Efforts for the establishment of the side effect expression situation and the supportive care by the P0455-21-PM Afatinib 越野優希, 立道貴清, 冨田淳子, 久保裕香里, 河野真梨, 馬場亨, 田井達也, 水岡大策, 田中裕章, 小坂信二, 芳地一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2015.

---

	We look at the rear about the side effect of P0456-22-AM clofarabine expression and investigate a mark 疋田絵梨1), 清美奈1), 米窪恭子1), 大橋一輝2), 白石範子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2015.

---

	Evaluation of the expression situation and measures of the dermatopathy by P0457-21-PM cetuximab and the panitumumab 斎藤由起子, 杉浦央, 加藤ゆか, 菅野崇淑, 近藤覚也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2015.

---

	The use situation and side effect management of the P0458-22-AM Afatinib 櫻井登代子1), 伴具也1), 坂口才2), 土谷美知子2), 三浦誠1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2015.

---

	Choice of the appropriate supportive care for the P0459-21-PM FOLFIRINOX therapy and the case that was thereby available for long-term treatment 金田典子, 山下剛史郎, 廣瀬孝一, 高田宏文, 馬島務, 丸尾栄次, 北村瑞穂, 角田誠一, 南橋薫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2015.

---

	Differences between P0460-22-AM docetaxel, trastuzumab combination therapy and infusion reaction frequencies by the trastuzumab monotherapy 中嶋陽一1),2), 柿原圭佑1), 葉田昌生1), 松崎雄1), 白石亘1), 佐伯衣里佳1), 米倉博知1), 三上忠司1), 野瀬育宏2), 田中眞紀2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2015.

---

	The effect that the nutritional status at P0461-21-PM Eribulin administration start gives to intensity of treatment 横山雄一1),3), 今井一輝2),3), 矢野亨治3), 杉原輝洋1), 井上潔1), 今村健郎3), 篠原義剛1), 日高博司1), 山田清文3), 浅原稔生1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2015.

---

	The effect that a characteristic and the difference in regimen using the high-dose cisplatin in the P0462-22-AM each clinical department give to renal function, volume of urine, onset of side effect 杉原輝洋, 横山雄一, 井上潔, 今村健郎, 篠原義剛, 日高博司, 浅原稔生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2015.

---

	The effect that the low-dose cisplatin administration in P0463-21-PM outpatient department chemotherapy patients gives to renal function 今村健郎, 横山雄一, 杉原輝洋, 井上潔, 篠原義剛, 日高博司, 浅原稔生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2015.

---

	Effect to give to protective efficacy and Dose Intensity of the febrile neutropenia with the P0464-22-AM peg filgrastim administration 井上潔, 横山雄一, 杉原輝洋, 篠原義剛, 日高博司, 浅原稔生, 今村健郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2015.

---

	Examination of the durability density for normal humans of gargle water using the P0465-21-PM tricyclic antidepressant (amitriptyline) 江口智子1), 佐々木寿子2), 国分秀也2), 坂本真依子1),3), 矢島愛理1), 尾鳥勝也1), 厚田幸一郎1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2015.

---

	Vascular pain measures of the P0466-22-AM Fosaprepitant and the evaluation 藤井友和, 西川隆一, 澤柳直樹, 荒木寛也, 坂柳悦章, 辻博幸, 塚本久之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2015.

---

	1 case that was given hyposensitization of P0467-21-PM oxaliplatin 山際一也1), 三浦華歩2), 二瓶大輔1), 五味祐介1), 高田みゆき1), 地引綾2), 中村智徳2), 山本聖一郎3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2015.

---

	Analysis of the risk factor about the thrombocytopenia of patients receiving P0468-22-AM lenalidomide 安田昌宏1),2), 舘知也2), 梅田道1), 長屋雄大1), 大澤友裕1), 川島あずさ1), 牧野哲平1), 甲田明英1), 市橋厚司1), 後藤英子3), 笠原千嗣3), 高橋健3), 後藤千寿1), 寺町ひとみ2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2015.

---

	It is examined the need of the serum electrolyte monitoring until eight weeks after administration cancellation in the P0469-21-PM antiEGFR antibody preparation 桜田宏明, 川瀬洋次, 浅野寿規, 染原渉, 伊藤弘美, 山村益己 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2015.

---

	One patient who presented with hyperammonemia after a change from P0470-22-AM FOLFOX4 to mFOLFOX6 古田知子1), 高橋有和2), 中嶋早苗2), 久米真2), 岡安伸二1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2015.

---

	About the need of the specimen cooling in the uric acid level measurement after the P0471-21-PM rasburicase administration (the second report) 大坪達弥1),2),3), 杉山忠章2), 眞釼彩子1), 中川ゆかり1), 友金幹視1), 藤田敦夫1), 魚嶋伸彦3), 小林裕3), 三上正1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2015.

---

	The effect that a merger of the P0472-22-AM heart disease gives to cisplatin renal failure 三好孝法1), 三角紳博2), 平池美香子3), 三原由記4), 平木洋一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2015.

---

	New predictor of nail disorder expression time by P0473-21-PM Docetaxel and the becoming severe 高畑英信1),2),3), 田辺公一4),5), 高木昭佳3), 久田勢津子1), 山之内恒昭3), 三村泰彦3), 新田淳美2), 安田初奈4), 菓子井達彦4), 足立伊佐雄3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2015.

---

	Efforts for the hepatitis B reactivation in the P0474-22-AM our hospital and future problem 山中義裕1), 横山正人1), 佐竹路子1), 野竹秀幸1), 西山雅善1), 朝日恵美2), 日比知志3), 竹内隆浩4), 田村圭浩5), 岡本好史6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2015.

---

	It is a 2 case receiving the Afatinib for patients with non-small cell lung cancer with a history of the liver damage by P0475-21-PM EGFR-TKI 中西大介1), 出口綾子1), 畑地治2), 柳川泰裕1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2015.

---

	Examination of the usefulness of the G-CSF preparation prophylactic administration in the P0476-22-AM outpatient department chemotherapy 岩坪沙奈恵, 樋口美奈子, 佐々木好美, 和田依子, 山口竜一, 中野行孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2015.

---

	Protective efficacy of magnesium for the renal failure at the cisplatin administration in patients with P0477-21-PM progress recurrent lung cancer 牛島知実1), 三好孝法2), 山脇一浩1), 林稔展1), 西野隆1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2015.

---

	Example that secondary prophylaxis of the P0478-22-AM peg filgrastim prevented neutropenia during the progress cancer of endometrium DC therapy enforcement for stage 3, and contributed to burden on patients reduction 山下悟史, 岸川春樹, 長谷悠紀, 曽我弘道, 平野真健, 町田聖治, 入江利行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2015.

---

	The participation of the pharmacist in marker screening for the HBV reactivation prevention during P0479-21-PM cancer chemotherapy and the result 川畑綾, 岩下佳敬, 薗田晃弘, 中尾承司, 岩崎公美, 桑鶴麻代, 永田春香, 高田侑那, 浜園龍, 宝来留美, 石田和久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2015.

---

	The possibility that the dosage of Pregabalin reinforces improvement and an effect of Chlorpromazine for intractable hiccups with the P0480-22-AM cancer chemotherapy 鈴木毅1), 柴田馨日1), 下地滋子2), 石井岳夫1), 難波有智1), 若松菜摘1), 外間惟夫1), 中村克徳1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2015.

---

	1 case that a platelet suddenly decreased after P0481-21-PM Oxaliplatin administration 本多伸二1),2), 大野恵一1), 三松史野1), 浜田久美子1), 荒田美帆子1), 實光由香1), 目黒裕史1), 村田龍宣1), 寸田靖1), 伊藤鉄夫2), 村岡淳二1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2015.

---

	Examination - about the adsorption of the anticancer agent for development - infusion set of the simple assay of pharmaceutical products using P0482-22-AM 1H-NMR 梅村雅之, 新倉伶奈, 吉松昂大, 岩井香穂, 松尾はるか, 松村美紀, 平野匡哉, 脇屋義文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2015.

---

	Investigation of the hepatitis B screening enforcement situation using P0483-21-PM DWH and Microsoft Access 廣岡賢輔1),2),3), 松岡聡2), 清水浩幸1), 國森公明1), 満田朱理3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2015.

---

	Inspection of the usefulness of the drug costs calculation tool in the P0484-22-AM breast cancer medical therapy 橋本浩季1), 村上通康1), 篠崎恭子3), 川口英俊2), 西崎隆4), 仙波昌三1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2015.

---

	Present conditions investigation of the quantity of disposal of anticancer agent in the P0485-21-PM our hospital 森田美江子, 岩瀬利康, 坂本鉄弥, 野澤孝章, 瀧山慈絵, 大澤千恵, 池田真菜美, 小山朋子, 木村美貴, 星野浩一, 宮川潤子, 大塚敏弘, 伊藤好夫, 越川千秋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2015.

---

	Examination about the effectiveness and the safety of the starting pharmaceutical products and generic medicine in the P0486-22-AM breast cancer chemotherapy 山崎美保1), 野口亜樹1), 中下愛1), 木村竜司1), 松本篤1), 高橋護2), 前田頼伸1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2015.

---

	Examination of the high blood pressure of the P0487-21-PM Bevacizumab administration case, the onset of thromboembolism situation and the d-dimer level 丸山昌広 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2015.

---

	The chemotherapy-induced neutropenia in patients with gemcitabine enforcement pancreatic cancer with the P0488-22-AM distant metastasis and related examination with the survival period 大嶽亜季1), 辻大樹1), 多久佳成2), 幕田龍1), 横井茉里1), 中森春美1), 井上和幸1), 平井啓太1), 伊藤邦彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2015.

---

	Safety of the TPF therapy in P0489-21-PM head and neck cancer 小池麻由, 平岩歳久, 家田浩美, 仙田典保 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2015.

---

	Frequencies of infusion reaction by the difference in dilution level of P0490-22-AM rituximab and safe examination 細見誠1), 稲野祥子1), 早坂大1), 後藤愛実1), 西原雅美1), 横手耐冶2), 勝間田敬弘1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2015.

---

	P0491-21-PM Study on the effect of kidney function on the incidence of hypocalcemia in patients receiving RANMARK(R) in combination with DENOTAS(R) 橋爪孝弘, 篠道弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2015.

---

	About mLSG15 therapy for P0492-22-AM 70 years old or more 戸切祥恵, 福石和久, 尾之江剛樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2015.

---

	Risk factor analysis of the low Ca blood symptom by the P0493-21-PM denosumab 植村隆1), 下澤那津1), 高田正温1), 田中誠2), 東島彰人1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2015.

---

	Participation of deoxycytidine kinase in effect of decitabine in P0494-22-AM colon cancer cells 池田奈津希, 細川美香, 上田久美子, 岩川精吾 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2015.

---

	Combination of P0495-21-PM Erlotinib and gastric-acid secretion antagonist fact-finding 山口竜司1), 樋口美奈子1), 佐々木好美1), 和田依子1), 岩坪沙奈恵1), 古藤洋2), 松尾宏一3), 中野行孝1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2015.

---

	The effect that antacids give for EGFR tyrosine kinase inhibitor effect of treatment in the P0496-22-AM non-small cell lung cancer 酒井鉄平1), 小井戸啓一2), 牧原玲子2), 橋本浩伸2), 大塚知信2), 林憲一2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2015.

---

	Examination - of the effect by lenalidomide administration - renal function on patients with P0497-21-PM multiple myeloma 山本圭城1),3), 安井友佳子1), 上島悦子3), 石坂敏彦1), 柴野賢2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2015.

---

	Examination about the excretion delay factor at the P0498-22-AM large quantities methotrexate administration 片岡達夫, 櫻下弘志, 垰越崇範, 西垣内亮, 村瀬哲也, 泉谷悟, 佐伯康之, 畝井浩子, 松尾裕彰 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2015.

---

	Use experience of the Docetaxel (TXT) + Bevacizumab (BV) combination therapy for the P0499-21-PM progress non-small cell lung cancer 相澤佑佳1),2), 大西涼子2), 浅野幸市2), 鱸稔隆2), 安田成雄2), 佐野公泰2), 加藤達雄2), 梅村実希1), 梶田実穂1), 大島由莉1), 横田智香1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2015.

---

	Use case of the denosumab note for hypercalcemia in the P0500-22-AM our hospital 越智良明1), 根岸大輔1), 石井弘幸1), 舟越亮寛3), 大渕徹2), 雨宮厚2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2015.

---

	Two patients who presented with impaired renal function by P0501-21-PM high dose cisplatin (100 mg/m2) administration 大園ゆかり1), 川俣洋生1), 吉永里香子1), 山口泰弘1), 林淳一郎1), 松崎勉2), 西元謙吾2), 吉福考介2), 平山俊一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2015.

---

	It is the effect in S-1 treated patients by the test value repousse introduction to P0502-22-AM prescription 向井光一朗, 羽田野桂史, 亀丸明莉, 松井法子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2015.

---

	The present conditions of the FOLFIRINOX therapy in the P0503-21-PM our hospital 白井敦史1), 埋橋賢吾1), 藪田ゆみ1), 山崎貴司1), 中島恵子1), 橋本佳浩1), 藤本佳史2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2015.

---

	Research about the present conditions of the disposal of anticancer agent in the P0504-22-AM healthcare setting and the economic loss 元山瞳1), 大津史子1), 佐々木忠徳2), 濱宏仁3), 原田幸子4), 松浦克彦5), 山川雅之6), 渡辺享平7), 後藤伸之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2015.

---

	Investigation, analysis of doubt inquiry contents in the P0505-21-PM cancer chemotherapy 濱武清範1), 小島一晃1), 美和孝之1), 仲忠士1), 松本弘誠1), 奥村優介1), 小西史子1), 飯田有香1), 足立那々緒1), 酒井ちひろ1), 福井美礼1), 千葉渉1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2015.

---

	Efforts of the pharmacist for the P0506-22-AM cancer instruction to patient management charges 3 calculation 田尾勇治, 香川千春, 上田裕子, 高田健司, 甲斐千晴, 藤原央樹, 内橋宣裕, 衛藤里沙, 小本晴香, 小田代知佐美, 高倉千晶, 宝諸あい, 熊谷美香, 前川文乃, 沢崎高志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2015.

---

	Efforts of the excretion instruction during P0507-21-PM colon cancer chemotherapy 小山拓弥1), 下川福子1), 南原誠1), 賀川義規2), 弘岡貴子3), 立原敦美3), 船越幸代1), 池上英文1), 加藤健志2), 田村茂行2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2015.

---

	Efforts ... in the cottage-hospital out of intervention ... to the foreign cancer chemotherapy that utilized P0508-22-AM electronic chart 原竜太郎, 戸鹿野美織, 橘淳, 濱浦睦雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2015.

---

	Inspection of an evaluation and the intervention effect by the round before chemotherapy of the pharmacist in the P0509-21-PM blood tumor internal medicine 加瀬くりみ1), 桝田浩司1), 安室修1), 伊勢崎竜也1), 川名晶子1), 鈴木正論1), 石塚寛和1), 永井淳子1), 舟越亮寛1), 末永孝生2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2015.

---

	About the standardization of the intravenous feeding route assembling method in the P0510-22-AM cancer chemotherapy 大野裕之, 渡部実咲, 平下智之, 谷沢克弥, 遠藤秀治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2015.

---

Analysis - of the questionnaire results at the joint symposium with present conditions of the anticancer medicine preparation in the P0511-21-PM healthcare setting and pharmaceutic problem 1 - Academy of Pharmaceutical Science and Technology, Japan 荻原琢男1), 石田竜弘2), 河原昌美3), 宇都口直樹4), 大槻純男5), 宮本祐司6), 中田雄一郎7), 岩本卓也8) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2015.

---

Receive the present conditions of the anticancer agent preparation in the P0512-22-AM healthcare setting and the enforcement of the roundtable session in pharmaceutic problem 2 - Academy of Pharmaceutical Science and Technology, Japan annual convention; and - 石田竜弘1), 河原昌美2), 宮本祐司3), 荻原琢男4), 大槻純男5), 宇都口直樹6), 中田雄一郎7), 岩本卓也8) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2015.

---

	Examination of the antineoplastic administration using P0513-21-PM syringe pump 川崎智子, 成川祥子, 高橋恭子, 勝田良子, 新穂祐子, 渡辺孔明, 吉澤雅恵, 風岡真実, 小野妙子, 佐藤綾子, 島盛一郎, 吉田有貴子, 山内たきよ, 上村彩子, 中嶋一恵, 桜井美杏, 佐野文香, 湯浅智恵, 今村涼子, 長澤宏之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2015.

---

	The effectiveness in the change cases from P0514-22-AM zoledronic acid note to a denosumab note and safe evaluation 前田剛司, 坂田洋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2015.

---

	Patients satisfaction investigation of the pharmacist concerned with P0515-21-PM "cancer instruction to patient management charges 3" 田村悟, 小森谷友宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2015.

---

	The use situation of the oil xanthan gum /GEM combination therapy in the P0516-22-AM our hospital 小阪圭治, 土谷有美, 井岡真佐夫, 塚本真裕子, 大林巧志, 津田正博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2015.

---

	Evaluation of pharmacist duties in the P0517-21-PM outpatient department chemotherapy 伊藤実里, 阪田安彦, 阿部圭輔, 村上礼隆, 岡崎夏実, 菅原隆文, 北本真一, 開浩一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2015.

---

	Use experience of the Ron surf (R) combination lock in the P0518-22-AM our hospital 田島博樹1), 加藤秀明2), 伊藤錬磨3), 竹内恵美1), 山田裕之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2015.

---

	Investigation about the use situation and the side effect expression of regorafenib for P0519-21-PM colon cancer 竹内玲奈, 若林雅人, 矢嶋明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2015.

---

	P0520-22-AM Survey on the use situation and side effects of trifluridine, tipyirasyl hydrochloride and pharmacist's approach 樋口弓都, 若林雅人, 矢嶋明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2015.

---

	The case that was daptomycin refractoriness for the revival of the P0521-21-PM MRSA infection 藤田将輝, 澤田真嗣, 中西裕明, 友金幹視, 藤田敦夫, 三上正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2015.

---

	Efforts to a use situation investigation and the proper use of the P0522-22-AM Clostridium difficile association loose bowels therapeutic drug 長橋かよ子1),2), 植田正2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2015.

---

	Cooperation with use of antimicrobial situation investigation after the P0523-21-PM infection internal medicine setting and drug department and the hospital infection measures team 鈴木朋克1),2), 大森美里1),2), 山本泰子1),2), 岡英昭2),3), 黒川正美2),4), 田中慶彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2015.

---

	Examination about antimicrobial consumption in the P0524-22-AM our hospital and the Pseudomonas aeruginosa-resistant rate 遠山泰崇1), 尾野恵2), 甲斐誠美2), 木元亜里沙2), 伊東佳子2), 後藤忍2), 井上真1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2015.

---

	Effect of the renal function to give to the platelet level of P0525-21-PM linezolid treated patients 久保悠1),2), 多田知弘1), 小財弘己1), 今田深雪1), 今田愛也2), 猪爪信夫2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2015.

---

	The side effect assessment that developed in a use of P0526-22-AM antimicrobial aptitude case 高橋知孝1), 東佑輔1), 山本みどり1), 岸本靜佳1), 鹿島孝子1), 兵頭純子1), 西村翔2), 松尾裕央3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2015.

---

	The effect of the Clostridium difficile infection treatment manual of the P0527-21-PM our hospital and safe examination 柳橋秀行, 都築はる奈, 林昭子, 宮内智行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2015.

---

	The change of prescription situation by TDM analysis of vancomycin hydrochloride (VCM) by the P0528-22-AM ward pharmacist and the administration suggestion 伊藤嘉英1), 清水智也1), 長谷川雅哉1), 中尾彰宏2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2015.

---

	The observance of the use of vancomycin hydrochloride (VCM) registration system using P0529-21-PM electronic chart system and investigation of the use of VCM situation 清水智也1), 伊藤嘉英1), 長谷川雅哉1), 中尾彰宏2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2015.

---

	The best consideration about the effect that the difference of P0530-22-AM children, adults gives thrombocytopenia derived from linezolid 平田憲史郎, 浦田由紀乃, 四郎園巧, 合澤啓二, 陣上祥子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2015.

---

	Examination about the appropriate administration method of the vancomycin hydrochloride for the purpose of the P0531-21-PM SSI prevention 宮田慎也1), 今浦将治1), 高橋宏行2), 伊藤努3), 菅野浩1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2015.

---

An example of an iliopsoas muscle abscess and the vertebral body discitis due to M. fortuitum which secured aim concentrations, and was treated with the amikacin administration before the P0532-22-AM dialysis start 加藤智之1), 鳴島智子1), 古川早矢香2), 本郷偉元3), 丹羽一貴4), 有馬丈洋5), 都倉広子6), 堀治1), 山崎隆志7) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2015.

---

	A CK rise with the P0533-21-PM daptomycin administration and examination about the plasma concentration 平野淳1), 井上裕貴1), 間瀬弘樹2), 高橋昌明3), 柴田雅章4), 稲吉隆行1), 後藤拓也1), 垣越咲穂5), 林誠1), 山谷明正6), 松本修一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2015.

---

	We look at the rear of the P0534-22-AM sustained MRSA bacteremia and examine a mark 宗佐博子1),2), 加藤英明2), 杉山嘉史2), 橋本真也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2015.

---

	Daily doses of the P0535-21-PMβ lactam system wide area antimicrobial, the number of administration, examination of AUD 内木義泰1), 征矢佳輔2), 矢野博之2), 伊藤新司1), 坂井孝行1), 竹内信道3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2015.

---

	A doubt inquiry rate change and the present conditions by the ICT intervention method change to the use of P0536-22-AM daptomycin patients 岡冨大輔1),4), 宅江良隼1),4), 山西紀子1),4), 谷口雅敏1),4), 明見能成2),4), 許泰一3),4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2015.

---

	Examination about P0537-21-PM Staphylococcus aureus bacteremia treatment 池田浩幸1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2015.

---

	Mortality comparison of meropenem administration and the cefmetazole administration for patients with P0538-22-AM ESBL-producing Escherichia coli bacteremia 高野尊行1), 小林由香1), 倉井岳史1), 中丸朗1), 薄井啓一郎2), 百瀬薫2), 藤田明美3), 仲澤恵3), 池野義彦4), 阿久津郁夫5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2015.

---

	One case that we showed improvement by having suggested antimicrobial according to P0539-21-PM principle and stopped 津曲恭一1), 有村真一郎2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2015.

---

Than the questionnaire findings to a member of present conditions - Wakayama hospital pharmacist society institution of the antiinfluenza medicine prophylaxis at the P0540-22-AM inside the hospital outbreak ... 木村真1), 阪口勝彦1), 崎山晃宏1), 赤木和由1), 中西町代1), 小山貴久1), 阪野和重1), 中山博文1), 満田正樹1), 野口恵子1), 柏木秀美1), 加藤渓1), 那須明弘2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2015.

---

	P0541-21-PM A study on the dose of Vancomycin hydrochloride administered to Clostridium difficile related diarrhea in our hospital 加戸義大, 奥村佳史, 山田浩一, 熊代桂子, 森田孝子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2015.

---

	Use fact-finding of the ganciclovir note in the P0542-22-AM our hospital 沢仁美, 山本真史, 浅野智央, 野口泰菜 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2015.

---

	Fact-finding (2) of Clostridium difficile enterocolitis treatment in the hospital attached to P0543-21-PM Sapporo Medical University - Change after the intervention of the pharmacist and effect - 藤居賢, 國本雄介, 益子寛之, 山崎紀恵子, 中田浩雅, 野田師正, 宮本篤 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2015.

---

	The present conditions of the antibiotic exposure for P0544-22-AM ESBL-producing Escherichia coli bloodstream infections 石田茂伸1),2), 楠本茂雅2), 太田真希2), 笹谷純平2),3), 浅野里枝1),2), 星育子1), 中井由佳1), 川村真代2),3), 大島利夫2),4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2015.

---

	Introduction of the multicenter antimicrobial surveillance using ATC/DDDsystem in P0545-21-PM Toyama 舘美幸1), 飯尾志帆1), 高野雄介1), 高橋慎太郎1), 脇田真之1), 船本哲生1), 守内匡1), 加藤貴子1), 窪田佳代子1), 杉田真理子1), 福島恵1), 河井良智1), 辻泰弘2), 山本善裕3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2015.

---

	Safety assessment of the Atovaquone for the P0546-22-AM pneumocystis pneumonia 常友盛勝1), 菅原隆文1), 壁村嘉恵1), 開浩一1), 辻泰弘2), 神村英利3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2015.

---

	Usefulness of the empiric administration of Micafungin sodium in the P0547-21-PM antifungal prophylaxis patients 菊池光太, 工藤晋, 丹代恭太, 蒲澤一行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2015.

---

	Examination of 2 cases that daptomycin-resistant MRSA was detected in P0548-22-AM our hospital 小池彩子1),5), 花房伸幸1),5), 廣田あゆ子1),5), 小原香那1),5), 岡崎忠治2),5), 大山智之2),5), 小川一恵3),5), 奥格4),5), 森英樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2015.

---

	Examination of the clinical usefulness at the azithromycin administration under the treatment with P0549-21-PM low dose macrolide 小薮真紀子, 小迫晶寛, 仲村早紀, 加茂章弘, 鈴田浩孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2015.

---

	An example of sepsis by Edwardsiella tarda which responded to P0550-22-AM tazobactam / piperacillin well 田子尚史, 森田淳介, 國分真理, 山賀章一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2015.

---

	Effect on antimicrobial consumption and Pseudomonas aeruginosa chemosensitivity by the rearranging of the P0551-21-PM adoption injection antimicrobial 藤原信二1), 綺田尚久1), 速水亮一2), 西村さとみ2), 中川文一2), 中村忠之3), 原田吉将4), 西嶋長1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2015.

---

	Intervention effect by the ward exclusive duty pharmacist based on the protocol on Clostridium difficile infection that occurred after P0552-22-AM antibiotic start 山村亮太, 山崎悠, 脇田翔子, 柴田麻美, 菅田哲治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2015.

---

	It is efforts to the qualitative improvement of ward duties by becoming it PBPM of the use of P0553-21-PM identification antimicrobial registration system 岩崎希, 古川早矢香, 井口恵美子, 猪股克彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2015.

---

	Examination about the medical application of the P0554-22-AM cleanliness space formation device (table coach) 佐伯康弘, 藤澤宗央, 加藤雄也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2015.

---

	Consumption investigation ... of the visualization of the contact part using practice - fluorescent paint of contact infection measures in P0555-21-PM ward drug duties and the mobile finger disinfectant 中谷亮介, 満田正樹, 野際俊希, 楠本梨賀, 佐向美帆子, 稲葉静香, 石本昌裕 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2015.

---

	Fact-finding of the treatment suggestion associated with the P0556-22-AM antimicrobial 佐藤誠太郎, 中山貴美子, 澤口和代 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2015.

---

	Evaluation - using effect - Defined daily dose (DDD) and days of therapy (DOT) of the decreased renal function patients in the P0557-21-PM antimicrobial consumption count 浦田元樹1),2), 永田眞美2), 姜裕2), 北村芳子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2015.

---

	About efforts for the proper use of the antimicrobial in the P0558-22-AM emergency visit 島村竜也, 饗庭孝一, 北村卓磨, 岡平将志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2015.

---

	Use investigation of the ST medical mixture for the purpose of the PCP prophylaxis to the immunodepression patients in the P0559-21-PM Himeji medical center respiratory organs internal medicine 中西剛志, 山口崇臣, 岸本歩, 吉野宗宏, 田中三晶 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2015.

---

	Intervention and effect with the medicine notebook to the P0560-22-AM antimicrobial remedy patients 池増鮎美1), 中島理恵1), 中村有莉恵1), 赤星真広1), 上原友美1), 石神誠子1), 神門孝典1), 佐多照正1), 宮脇武徳2), 前之原茂穂3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2015.

---

	The effect that the P0561-21-PM "preventive measures against infection addition" gives to a management cost price and a quality (safely) standard and a total quality cost price 小林義和1),5), 吉岡祐貴1),5), 山田昌矢2),5), 織田元3),5), 生田宏次4),5), 浅野昌彦4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2015.

---

	Examination of introduction and the effect of the antimicrobial round for the P0562-22-AM antimicrobial proper use 杢保貴幸1), 徳竹裕貴1), 石井康友2), 植田宏治3), 松岡裕士4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2015.

---

	Effect on MEPM consumption, sensitivity rate by the P0563-21-PM ICT intervention 石川智子1), 野澤寿吉1), 加藤由香里1), 網谷智輝1), 舟瀬和美1), 稲生隆行1), 百石祐一朗2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2015.

---

	One case that affected infection control of the P0564-22-AM intractable MRSA from pharmaceutical approach 伊藤貴史1), 正木智久1), 川上浩基2), 岩崎吉津3), 近藤正子3), 田島崇4),5), 寶亀登4), 鈴木正彦1),6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2015.

---

	Questionary survey of the staff prophylaxis of oseltamivir phosphate for P0565-21-PM influenza 後藤義之, 増林千尋, 西上真, 深見聖也, 若林奈織子, 鈴木里佳子, 本田太朗, 永森理美, 石崎真由美, 岡田久美, 角紀一郎, 森戸敏志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2015.

---

	Intervention to the antimicrobial proper use that P0566-22-AM small and medium size hospital pharmacist is available for 坪内理恵子, 大倉輝明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2015.

---

	Antimicrobial stewardship team activity in the P0567-21-PM our hospital 山口景子1), 島田侯陛1), 川上剛明2), 宗村盛1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2015.

---

	About increase of the clinical intervention of the pharmacist obtained by the cooperation with the specialist in P0568-22-AM infection 井出和男1), 加藤英明2), 西村富啓1), 佐橋幸子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2015.

---

	Wastage and extinction of P0569-21-PM antimicrobial resistance Pseudomonas aeruginosa 山田陽一1), 森下博史2), 桑元愛衣2), 石角彩2), 谷口愛2), 塩田澄子1), 土屋友房2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2015.

---

	Efforts - pharmacist sectional meeting activity report ... to local infection measures in the P0570-22-AM KAWASAKI area infection control council 野口周作1),6), 濱野公俊2),6), 小林加寿夫3),6), 小林岳4),6), 向山雅士5),6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2015.

---

	Investigation ... about the adoption situation of antibacterial chemotherapy duties fact-finding report - antimicrobial in the P0571-21-PM KAWASAKI area infection control council member institution 松本浩1),5), 濱野公俊1),5), 吉田純也2),5), 向山雅士3),5), 野崎惠4),5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2015.

---

	It is ... about antibacterial chemotherapy duties fact-finding report - identification antimicrobial surveillance in the P0572-22-AM KAWASAKI area infection control council member institution 内田裕之1),5), 小林加寿夫2),5), 長井美知子3),5), 野口周作4),5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2015.

---

	It is ... about use and application of the use of antibacterial chemotherapy duties fact-finding report - antimicrobial density in the P0573-21-PM KAWASAKI area infection control council member institution 安次嶺ゆか1),6), 岡田紳哉2),6), 小林岳3),6), 佐藤樹里4),6), 沢辺正和5),6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2015.

---

	Use turn of eventss of the designated antimicrobial in the P0574-22-AM City Tonami General Hospital 旭美樹1), 舘美幸1), 酒井由貴江1), 釣真之1), がけ晋太郎1), 坂本歩美1), 高畑英信1), 山本知代美2), 村本由子3), 又野禎也3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2015.

---

	P0575-21-PM surgical-site infections and perioperative antimicrobial proper use 竹内都子1), 池崎友明2), 村上真樹2), 山谷香織2), 北澤英徳1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2015.

---

	About the change of use antimicrobial in the P0576-22-AM our hospital and the anti-biogram 笹木範子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2015.

---

	Association of PPI to the Clostridium difficile-related enterocolitis onset in the P0577-21-PM Yasuo society Takeda Hospital and the H2 blocker 酒井果林1),2), 松尾史1),2), 桑原宏臣2), 藤井香緒利2), 神谷一利2), 林千麗1), 吉村尋典1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2015.

---

	Examination of the intervention method for construction and the proper use of the antimicrobial report system for the P0578-22-AM injection 加藤善章1), 山本雅人1), 稲垣孝行1), 手塚宜行2), 森岡悠2), 平林亜希2), 井口光孝2), 加藤大三2), 冨田ゆうか2), 八木哲也2), 山田清文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2015.

---

	Intervention and use of antimicrobial trend of the antimicrobial usage in the P0579-21-PM clinical department conference, evaluation of the effect on resistant bacteria generating 太田登志子1), 白根尚子1), 大塚昌信2), 中山晴雄2), 小林秀樹1), 加藤裕芳1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2015.

---

	Examination about the usefulness of long-term use surveillance duties of the specific antimicrobial in the P0580-22-AM our hospital 川田彰彦, 伊藤貴亮, 佐藤圭吾, 高橋直希, 菅野和, 早坂昭一, 佐賀利英 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2015.

---

Local duties support - Hokkaido, efforts ... in the Eastern Hokkaido district of the P0581-21-PM hospital pharmacist 佐賀美裕樹1), 佐々木千花1), 石成凌1), 岩崎正宏1), 天童有香1), 森村あゆみ1), 若林麻衣1), 大村侑平1), 粟澤一聖1), 平野あゆみ1), 太田明秀1), 川上麻衣子1), 清水勇基1), 北島彩郁1), 森山真実1), 伊藤桂子1), 坂本和央1), 重成大介1), 岡野翔1), 石田恵理2), 速水章一1), 大江利治3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2015.

---

	Relation (the second report) to the PD duties by the P0582-22-AM pharmacist 酒井理予, 尾崎昌大, 添田真司, 渡邊昌之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2015.

---

	GIS analysis (the Kanto Koshinnetsu district) about the appropriate placement of the drugstore with the P0583-21-PM health station function 倉田香織1), 岸本桂子2), 土橋朗1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2015.

---

	An attitude survey about the COPD with the P0584-22-AM lungs age measurement and evaluation of the COPD-related risk factor 西尾廣昭1), 土谷大樹2), 小嶋英二朗1), 田中哲郎1), 数野博3), 福田豊4), 尾上洋4), 谷田恭洋4), 森広亜紀5), 山田真弘4), 岡田昌浩6), 徳毛孝至7), 横田いつ子8), 荒川隆之9), 大森亮太10), 瀬尾誠1), 上敷領淳1), 杉原成美1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2015.

---

	Fact-finding of the person of next situation consultation in the P0585-21-PM local health insurance drugstore 宮田祥一1), 岡田賢二2), 井上朋法1), 幸地拓也1), 執行俊彦1), 堤一晃1), 藤原三沙子1), 宮田英理1), 山上千子1), 山本雅裕1), 藤原英憲1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2015.

---

	Development of the lifestyle swing return marks instruction using the check sheet at the P0586-22-AM drugstore and the usefulness inspection 藤田直希1), 井上渉1), 菊池千草1), 渡邉幹哉2), 高尾雅春3), 鍋谷伸子4), 田中美葉子5), 鈴木匡1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2015.

---

	1 case - that we caused depressed level of consciousness by efforts - instruction of the home care patient visit drug control instruction in the P0587-21-PM our hospital 福森和俊1), 越智麻有1), 猪田幸邦1), 小澤一夫1), 光根緑2), 築田恵2), 宮本美千代2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2015.

---

	Evaluation experiment in elderly persons living at home and the welfare institution of the P0588-22-AM medication support equipment 鈴木亮二1), 武政文彦2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2015.

---

	Qualitative study on psychological process in the P0589-21-PM end-of-life care 大和田真未, 有田悦子, 荒井きより, 池谷博美, 田辺記子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2015.

---

	About physical assessment and the need practicing by P0590-22-AM visit drug instruction 長友孝純, 的場つかさ, 楠本結香, 高橋唯, 森江遥, 平田有佳理 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2015.

---

	The present conditions and problem of P0591-21-PM at-home pharmacist duties 八木澤啓司1), 岩田耕一郎1), 宮下博幸1), 左右田和枝1), 中村俊貴1), 小林由布子1), 柴田壮一1), 松原肇1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2015.

---

	At first it is one step of ... to practice - pressure sore team approach in medical care of the ad usum externum therapy in being at home P0592-22-AM 舛甚路子, 阿部恵, 西村美和, 李沢敏明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2015.

---

	Pharmaceutical cooperation of osteoporosis treatment that we applied P0593-21-PM health insurance pharmacy in 荒井國三1), 山本憲男2), 正源寺美穂3), 杉原信4), 石野洋4), 今庄恵子5), 綿谷敏彦5), 兼田春生5), 木村嘉明1), 柴田実香1), 吉田綾乃1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2015.

---

	Understanding degree investigation for the treatment at home of the P0594-22-AM patients 高島敬子1), 吉川泰博2), 北小路学2), 奥村隆司1), 田辺博章1), 奥村兼三1), 大鳥徹2), 松山賢治2), 小田典央1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2015.

---

	Hold a study session thinking about P0595-21-PM treatment at home by regional alliances 後藤千寿, 安田昌宏, 土田陽子, 説田英利子, 川島あずさ, 甲田明英, 長屋雄大, 水井貴詞 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2015.

---

	An example of the home medical treatment management instruction of the Parkinson's disease patients who cooperated with P0596-22-AM health visitor 榊原ゆかり1),2), 片山広美1), 鈴木めぐみ1), 鈴木厚志1), 黒田信行1), 天野哲史1), 鈴木裕之1), 松本薫1), 土井英樹2), 板倉由縁1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2015.

---

	An approach and evaluation of the vital sign monitoring by the drugstore pharmacist after the P0597-21-PM vital sign training 武井政陛1), 長谷川フジ子1),2), 池田俊也2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2015.

---

	About the present conditions of the pharmaceutical cooperation with the neighborhood clinic in P0598-22-AM horsetail ethical pharmacy Akutami store 森厚司1), 丹羽知恵子1), 丹羽良子1), 吉田和美1), 山本有人1), 内田眞一郎2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2015.

---

	Present conditions investigation - of the treatment at home of the health insurance pharmacy in efforts - Ishikawa for the P0599-21-PM treatment at home promotion 興村桂子1), 大柳賀津夫2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2015.

---

	The example that health insurance pharmacy pharmacist worked on toward P0600-22-AM area inclusion care 高橋康晃, 川添翼, 黒澤幸太郎, 田村多真美, 小坂浩之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2015.

---

	Investigation about the request of the consciousness to the at-home duties of the health insurance pharmacy pharmacist resident in P0601-21-PM Hokkaido and the postgraduate education support 柳本ひとみ1), 梅田純代2), 古田精一1), 黒澤菜穂子2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2015.

---

	Attitude survey about "the discharge clothing characteristic of an age medicine teachers' textbook" to the P0602-22-AM pharmacy service under health insurance drugstore 角田健, 小室治孝, 宇賀神咲美, 瀬川亮, 喜古康博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2015.

---

	Efforts based on medicine - medicine cooperation in the oral dual therapy for P0603-21-PM chronic hepatitis C 守屋真美1), 沼田恵実1), 王泰範1), 湯浅友美1), 出口由紀子1), 村田恵美2), 山田元3), 長谷川豊4), 平野泰健4), 岩出賢太郎5), 下路静佳5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2015.

---

	Questionary survey for fact-finding and application of medicine for patients who received cancer chemotherapy notebook direction for uses in the P0604-22-AM Tokachi district 村上智香, 門野冴美, 大平英美, 斉藤芳敬, 石田陽美, 谷口雄人, 船木映二, 和泉秀明, 橋本義宏, 小森均 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2015.

---

	Efforts aiming at bringing rate improvement of the P0605-21-PM medicine notebook 伊藤緑, 佃晶子, 平井成和, 原敬一, 増田雅行, 佐野君芳, 真坂亙 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2015.

---

	About the efforts of injection anticancer agent administration contents mention in P0606-22-AM regional alliances 安樂早希, 熊谷範之, 宮本亜希, 鈴木正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2015.

---

	Usefulness evaluation of the new pharmaceutical medicine cooperation model who introduced side effect of P0607-21-PM telephone monitoring 住吉加江1), 牧原玲子1), 橋本浩伸1), 佐藤洋子3), 波田野小百合4), 小原茜4), 渡辺典子5), 吉野麻結5), 飯田左知5), 三木晶子2), 牧野好倫1), 大塚知信1), 林憲一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2015.

---

	Questionnaire findings report about the internal use anticancer agent that we conducted by P0608-22-AM cancer chemotherapeutic drug medicine cooperation ordinary assembly 中山和彦, 増野貴司, 堀口裕之, 小幡輝夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2015.

---

	Inventive idea to make a P0609-21-PM injection anticancer medicine medicine notebook seal issued automatically 福本真利江, 香取哲哉, 出雲貴文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2015.

---

	The present conditions and problem about the efforts to oral anticancer agent proper use by the P0610-22-AM medicine medicine cooperation 武田智子1), 長谷川晃司1), 小林篤史2), 秋葉由華2), 乙黒万喜子3), 古曽部毅4), 蓑輪圭一郎5), 和田淳1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2015.

---

	We help medicine medicine for the side effect management in the P0611-21-PM oral anticancer agent and are built the cooperation 鈴木智博1), 町島由美2), 菅野友美3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2015.

---

	1 case that medicine medicine cooperation functioned for a shift to P0612-22-AM at-home mild medical care effectively 樋口眞宏1),2), 鈴木恵美子1), 八木聖子1),2), 山田圭子3), 武田絵里子2),3), 松川香織2), 西村豊4), 宇野敦子1), 野村一之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2015.

---

	Problems extraction and illness medicine cooperation seminar holding - that efforts - health insurance pharmacy to illness medicine cooperation in the P0613-21-PM relaxation medical therapy has it 田中里佳1), 中村豪志2), 田中邦佳2), 室親明2), 木村健2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2015.

---

Efforts medication counseling present conditions investigation of the illness medicine cooperation to the medication counseling improvement of the palliative care domain in the P0614-22-AM Saku, Nagano area 畠山浩明1), 篠原佳祐2), 杉山昌秀2), 三浦篤史2), 中尾美香3), 清水誠4), 井出香織4), 井上南4), 大森健4), 小林潤5), 小松富美男5), 市川輝幸1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2015.

---

	Investigation about the patients contribution of the patients information sheet to the hospital from the P0615-21-PM health insurance pharmacy 菅野里美1), 吉田丘2), 紺野恵1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2015.

---

	About an evaluation, improvement for the practical use of "my treatment notebook" which we made in P0616-22-AM our hospital 藤本愛理, 伊藤政祥, 西本辰徳, 橋本崇広 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2015.

---

	Efforts of medicine - medicine cooperation that realized interactive reporting in the P0617-21-PM foreign oral anticancer medicine prescription 川原裕, 西塔志織, 九鬼亜衣子, 衞藤麻里子, 中尾佳人, 宮崎宏美, 佐野雅昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2015.

---

	Promotion of the medicine medicine cooperation in the foreign cancer chemotherapy using the P0618-22-AM medicine notebook 山口恭平, 橋本浩季, 村上通康, 仙波昌三 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2015.

---

	Investigation about reporting contents between a hospital and the health insurance pharmacy in the P0619-21-PM colon cancer medicine medicine cooperation 鈴木大吾, 石井秀明, 松原怜, 伊東和真, 浅野嘉之, 鈴木敦詞, 村山まりこ, 栗本夕夏, 奥田ユミ, 前田剛司, 坂田洋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2015.

---

	Promotion of the medicine medicine cooperation using the P0620-22-AM anticancer agent side effect monitoring sheet 羽生智宏, 尾形美絵, 嶋崎千絵, 長澤欣弘, 森山亜矢子, 田村和彦, 新関みどり, 近藤和宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2015.

---

	Thing ... which we saw from ... attitude survey for further development of P0621-21-PM medicine, the medicine cooperation 中村敏史1), 伊藤稔宏1), 新井孝文1), 牛膓沙織1), 上原有夏2), 福岡一貴2), 大川哲司2), 高橋典男2), 吉田昌則2), 池上信昭1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2015.

---

	Efforts based on medicine - medicine cooperation in the oral dual therapy for P0622-22-AM chronic hepatitis C 長谷川豊1), 村田恵美2), 守屋真美3), 平野泰健1), 山田元4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2015.

---

	Examination of the usefulness of the medicine medicine cooperation with P0623-21-PM hospital pharmacist and the drugstore pharmacist instructing between the at-home visit drug 高柳論也, 須貝壮衆, 渡邉基之, 小林恵美子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2015.

---

	Examine P0624-22-AM disease; an investigation about the medicine notebook information inflection of the medical institution classification in the medicine cooperation 伊藤明人1), 千葉俊介2), 伊藤嵩1), 高橋道子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2015.

---

	About efforts of the local medicine, medicine cooperation in the oak hospital pharmacy attached to the P0625-21-PM Jikei University School of Medicine 長郷千香子, 渡邊譲, 松本明子, 長塚さおり, 島崎博士, 勝俣はるみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2015.

---

	Fact-finding of the health insurance pharmacy cooperation in the P0626-22-AM community medical care cooperation system 小川充恵1),2), 植田真理1), 山崎肇1), 小枝伸行2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2015.

---

	Attempt ... of the clinical test value indication to medicine medicine cooperation - outside Parliament prescription aiming at P0627-21-PM pharmaceutical products proper use 佐藤友美, 荒木隆一, 藤長宏昌, 西島勝之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2015.

---

	Efforts of the Okayama pharmacist society aiming at promotion of medicine, the medicine cooperation for P0628-22-AM young person pharmacists 加地弘明1),2), 森英樹1),3), 松山哲史1),4), 鍛治園誠1),5), 名賀石繁1),6), 藤原孝子1),7), 小笠原加代8), 千堂年昭8), 大森宏真8), 石井美江8), 三宅修8), 赤澤昌樹8) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2015.

---

	About the relation of the ward pharmacist in the instruction joint at a P0629-21-PM discharge 金井知子1), 坪谷綾子1), 竹田桂子1), 東しずか1), 濱野公俊1), 坂下裕子1), 増原慶壮3), 岡田みちよ2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2015.

---

	Efforts to the medicine medicine cooperation with the P0630-22-AM Gunma Prefectural heart blood vessel center and local health insurance drugstore 木村和美, 砂川恵子, 飯島由美子, 細田宏美, 坂下可奈子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2015.

---

	Introduction of the municipal Ikeda Hospital community medical care network system enabling P0631-21-PM medicine medicine cooperation 大河万顕1),2), 下村一徳1), 梶本幸彦2), 藤本智裕2), 川口進一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2015.

---

	About the start of the medicine medicine cooperation meeting for the study in the P0632-22-AM Saga Hospital 渡辺健二, 中溝卓, 鶴崎泰史, 高島伸也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2015.

---

	The establishment and activity report of the P0633-21-PM North Saitama medicine medicine cooperation council 須賀宏之, 内田宜伯, 麻生一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2015.

---

	Examine the illness using the P0634-22-AM medicine notebook; efforts to medicine cooperation 田村和彦, 嶋崎千絵, 長澤欣弘, 羽生智宏, 森山亜矢子, 尾形美絵, 新関みどり, 近藤和宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2015.

---

	Investigation about the effect that the clinical test value publication in the P0635-21-PM outside Parliament prescription gives to the proper use of pharmaceutical products 権平由貴, 瀧本淳, 石福奈々, 永瀬怜司, 今浦将治, 菅野浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2015.

---

	Than questionary survey to evaluation - neighborhood health insurance pharmacy of the outside Parliament prescription which described P0636-22-AM test value ... 菱田栄子, 浦崎圭太, 河井和子, 伊藤和幸, 磯谷聡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2015.

---

	For medicine reporting and the regional alliances that are better than - about the education for patients about the P0637-21-PM medicine notebook and the availability ratio - 樋口純一, 青山乃莉子, 阿曽沼和代, 高柳和伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2015.

---

	Examination of the medical expenses reduction effect by the Residual medicine adjustment in the P0638-22-AM regional alliances hospital 森朝紀文1), 中川直樹1), 泉原里絵1), 西井拓人1), 松山達登1), 中川貴弘1), 野上浩實2), 南尚孝3), 土井義仁3), 池喜章4), 梅田卓也4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2015.

---

	It is ... for the inhalational instruction that is better than examination ... from questionnaire results about the P0639-21-PM inhalational instruction 平田備子1), 渡辺真穂1), 宮本敬子1), 大前由香利7), 北畑香里6), 鷲見佳子5), 梅澤佳乃子4), 西馬照明3), 大西尚2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2015.

---

It is efforts ... to construction and the spread of communalization of the patients information such as ... test results for promotion of the local team approach in medical care by the P0640-22-AM patients participation type 大木稔也1), 富岡佳久2), 庄野あい子3), 山内泰一4), 平野道夫5), 金親正知6), 今井博久7), 佐藤秀昭1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2015.

---

	Fact-finding ... to effect on P0641-21-PM outside Parliament prescription - neighborhood health insurance pharmacy by the clinical test value indication 土師日香里1), 坪谷綾子1), 小宮詠子1), 松本浩1), 浅見妥江1), 濱野公俊1), 坂下裕子1), 増原慶壮2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2015.

---

	Efforts of the pharmacist in the P0642-22-AM Chiba joint ownership stroke community medical care cooperation pass 太田洋貴, 生島五郎, 高橋憲二, 干川克己, 帰山由紀子, 上野朱里, 武田澄香, 鈴木乃乃子, 井上佳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2015.

---

	The effect that one application formulations rate of use improvement of the P0643-21-PM injection drug gives in an incident report 浅田留奈, 加藤善章, 服部亜衣, 北原裕子, 清水久美子, 玉置紀子, 山田清文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2015.

---

	It is ... to zero by tablet filling mismeasures ... false filling using P0644-22-AM Excel limitlessly 新舍美貴, 大内一希, 岩田裕貴, 佐藤康雄, 舟橋智広 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2015.

---

	Introduction ... of construction and usefulness - Mediceo Hospital Innovative Logistics (McHIL) of the safely appropriate management system of P0645-21-PM pharmaceutical products 小菅健志1), 平嶋志穂1), 大塚幸彦1), 佐藤純一4), 若林明4), 中田芳秋4), 鈴木寛子3), 向後麻里1),2), 佐々木忠徳2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2015.

---

	Preventive measures against dispensing errors ... using construction and usefulness - bar code of security, the appropriate management system of P0646-22-AM pharmaceutical products 平嶋志穂1), 小菅健志1), 大塚幸彦1), 佐藤純一4), 若林明4), 中田芳秋4), 鈴木寛子3), 向後麻里1),2), 佐々木忠徳2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2015.

---

	Role of the pharmacist in the P0647-21-PM clinical practice designation hospital 浦崎圭太1), 菱田栄子1), 河井和子1), 伊藤和幸1), 磯谷聡1), 露木幹人2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2015.

---

	Investigation of the dispensing error with the P0648-22-AM outside Parliament outpatient department prescription issuance 添田真司, 倉野恵美, 渡邊昌之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2015.

---

	It is ... to development ... information to come because we tell of "TO DO CARD" in P0649-21-PM drug duties 越智文也, 高砂美和子, 吉本久子, 廣實清司, 古川裕之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2015.

---

	Efforts toward the medicine unionization of the P0650-22-AM emergency cart 柘植麻里奈1), 杉本恵理1), 堀部緑1), 寺田雄亮2), 山川恵子1), 青孝明1), 木村匡男1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2015.

---

	Receive the incident about all P0651-21-PM automatic tablet packaging machines 谷田有花, 佐賀嘉英, 門脇隼也, 小田智晴, 塩見明日香, 藤本華衣, 芦田理沙, 足立圭司, 村上由樹, 川見里奈, 堀雅博, 足垣亮介, 宮谷正哉, 勝井靖, 山本真世, 立道直美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2015.

---

	The enforcement situation of the drug training for the P0652-22-AM nurse 上田温子, 田山理恵, 星野輝彦, 塩津和則 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2015.

---

	Effect by the ward permanent residence that we were able to see from an incident report in the P0653-21-PM Saiseikai Futsukaichi Hospital 蓮輪博嗣, 深見徹郎, 大竹野久雄, 北村憲雅, 中野祐樹, 辻村啓史, 横尾賢乗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2015.

---

	About the effect of the introduction of the P0654-22-AM Distribution of medicine cart and the Distribution of medicine contents check by the ward pharmacist 渡邉武明, 今井洋志, 町田洋平, 川尻尚子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2015.

---

	The present conditions of the failure example in the P0655-21-PM discontinuation instruction 和地徹1), 藤井梨紗1), 千葉里菜1), 川田彰彦1), 伊藤貴亮1), 佐藤圭吾1), 追木正人1), 遊佐洋子1), 西和哉1), 阿部浩幸1), 小原拓2),3), 佐賀利英1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2015.

---

	To quantity of P0656-22-AM one time prescription about the change of doubt inquiry contents of the outside Parliament prescription with the shift 山足敏昭, 才野壽子, 吉井加奈子, 柏木明美, 森田みどり, 佐々木亜也, 大井康史, 八本久仁子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2015.

---

	The introduction of the child dose check function for the prevention of false prescription by the quantity of P0657-21-PM one time prescription introduction and the evaluation 安達真紀子1), 椎木芳和1), 小川勝弘1), 金田達也1), 森木邦明1), 井上和子1), 門脇美智子1), 足塚則子2), 齋藤憲輝2), 池口正英2), 高根浩1), 島田美樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2015.

---

	About the investigation of HBV reactivation measures using the coding of examination for P0658-22-AM data 長坂篤志1), 村井宏通1),2), 佐藤力哉1),2), 加藤修1), 伊藤友一3), 辻健史2),4), 浅岡峰雄2),5), 小林伸三1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2015.

---

	Efforts second report to risk management by the child dose check system introduction in the P0659-21-PM Kitasato University Hospital 八木宏樹1), 友田明子1), 坂本かおり1), 松本圭祐1), 椎崇1), 近藤留美子1), 岩崎俊之2), 厚田幸一郎1),3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2015.

---

	Communalization of efforts - information to P0660-22-AM risk management and utilization ... 大久保淑子1), 長谷弘子1), 大野弘貴1), 斎藤大佑1), 松永静恵2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2015.

---

	Efforts associated with the medicine explanation that P0661-21-PM driving is prohibited in it 田原雅子1),2), 平昭圭介1), 花田徳子2), 新谷茂之1), 中村亮1), 大知正典2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2015.

---

	Fact-finding of the instructions record about the rate of application of the P0662-22-AM injection drug 臼窪一平, 中村友香, 橋亮介, 下山あさ子, 亀井浩二郎, 嘉屋則子, 稲垣育宏, 小寺隆二, 妻木良二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2015.

---

	The pre-Abo id report situation of our hospital which we compared from P0663-21-PM Japanese Society of Hospital Pharmacists report example 日野亜莉沙, 小林理栄, 熊倉裕昌, 新井亘, 増田裕一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2015.

---

	It is ... using patients of efforts - electronic chart profile avoiding P0664-22-AM warfarin and interaction of the natto 高橋望月, 岩佐千尋, 田中嘉一, 濱田潤 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2015.

---

	Examination of the usefulness of the pharmaceutical products security workshop by the P0665-21-PM pharmacist 上村円香, 喜多香菜, 田畑寛明, 杉村奈美, 猿谷淳, 向一美, 地野幹子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2015.

---

	Examination about the effect to give to the fall of P0666-22-AM cardiovascular system disease and the therapeutic drug 河内正二1), 三角ひかる1), 藤井信大郎2), 福田英克3), 南波勝栄3), 濱口常男1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2015.

---

	The activity of the fall fall measures team in the P0667-21-PM Kanazawa Red Cross hospital and participation (the second report) of the pharmacist 高橋怜史1), 大川浩子1), 枝廣茂樹1), 山口亜矢2), 川原繁2),3), 西村泰行2),4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2015.

---

	Efforts of the experience-based safety measures workshop for P0668-22-AM personnels 星子謙1),2), 礒部隆史2), 宮本智行2),3), 竹内周平4), 深山治久2),3), 原澤秀樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2015.

---

	Examination about the relations of P0669-21-PM sleeping drug remedy and a fall, the fall 石郷友之, 高田遼, 中野敬太, 野々山雅俊, 藤居賢, 山崎紀恵子, 中田浩雅, 野田師正, 宮本篤 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2015.

---

	Introduction of the medical treatment management based on the P0670-22-AM protocol and the effect 浜崎浩一, 山崎美保, 福原伸治, 福澤正隆, 大野静子, 脇泰見, 松本篤, 前田頼伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2015.

---

	Reach efforts - high risk drug workshop ninth year of the medical security in the P0671-21-PM Nankai medical center; ... 甲斐章裕1), 北村仁1), 伊藤ちか恵1), 鶴田瑛典1), 宮明洋一郎1), 佐々木達也1), 海部真代1), 谷口公章1), 梅木正純2), 渡邉薫3), 力武隆浩1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2015.

---

	Duties fact-finding of "the pharmaceutical products security administrator" in the P0672-22-AM Osaka hospital pharmacist society 田中義人1),9), 菊田裕規2),9), 中林真紀3),9), 梅永真弓4),9), 西原雅美5),9), 高尾知佳6),9), 渡邉幸子7),9), 河瀬留美8),9), 但馬重俊10) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2015.

---

	About the contribution to medical security and compounding of medicines duties by the database compilation of P0673-21-PM doubt inquiry 井上博貴1), 壁谷めぐみ1), 坂口麻貴1), 湯浅周1), 竹口恵2), 松島真弓2), 松浦三恵子3), 石川尚武3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2015.

---

	Efforts for the prevention of malpractice of the P0674-22-AM infusion preparation council 藤冨徹, 早田和生, 福岡誠次, 田中修一, 多田義孝, 籾井明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2015.

---

	Measures in our hospital in the adverse event that resulted from combination of P0675-21-PM warfarin and miconazole gel 田淵陽平, 佐々木恭子, 生野芳博, 野村文香, 金本賢枝, 寺田智祐 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2015.

---

	Efforts for the drug incident decrease in P0676-22-AM drug potentially serious medical errors example by the collection 菅野彩那, 宮原由香里, 太田哲徳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2015.

---

	We evaluate it after experience-based (early exposure) enforcement in the specialties early stage for the P0677-21-PM young person pharmacist 岸川礼子, 安藝敬生, 稲岡奈津子, 能勢誠一, 山下祐未, 一瀬菜摘, 北原隆志, 佐々木均 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2015.

---

	About efforts of the simulation education by the P0678-22-AM pharmacist 川崎元弘, 古賀和馬, 福永桂子, 吉田昭昌, 大倉裕祐, 木内司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2015.

---

	Usefulness of the many types of job cooperation education (Interprofessional Education: IPE) for the practice of the P0679-21-PM team approach in medical care 後藤綾1), 半谷眞七子2), 肥田裕丈1), 長谷川章1), 椿井朋1), 毛利彰宏3), 末松三奈4), 阿部恵子4), 安井浩樹4), 亀井浩行2), 野田幸裕1),3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2015.

---

	Attempts from the study drafting for the young pharmacist who utilized the cooperation between P0680-22-AM institutions to announcement 竹野伸洋1), 有野徹2), 早川真希2), 秋葉政宏1), 橋本幸輝1), 本尾美樹1), 鈴木賢一1), 清水淳一2), 濱敏弘1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2015.

---

	Statistical analysis by usefulness of the case study by the P0681-21-PM world cafe and evaluation - SPSS 中西昭人, 大塚充, 木天麻衣子, 小西邦生, 田中志穂, 林良壮, 藤裕美, 堀哲史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2015.

---

	Analysis - of discommunication - present conditions about P0682-22-AM pharmacist 伊原千晶1), 亀井美和子2), 松島哲久3), 松村人志3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2015.

---

	Investigation about consciousness and the attitude toward passive smoking of P0683-21-PM pharmacy school first grader and the fourth grader 村上勲, 齋藤百枝美, 鈴木義彦, 渡辺茂和, 土屋雅勇 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2015.

---

The present situation of the medical therapy workshop by P0684-22-AM University of Shizuoka, hospital, the community pharmacy cooperation 井上和幸1), 辻大樹1), 平井啓太1), 浅倉候子2), 井上達秀2), 賀川義之2), 角入壽彦2), 北村修2), 柴山芳之2), 菅谷純子2), 中野眞汎2), 並木徳之2), 平野桂子2), 松山耐至2), 森本達也2), 山田静雄2), 山田浩2), 山本勝央2), 伊藤邦彦1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2015.

---

	P0685-21-PM carrier formation education: An evaluation and improvement of "the self-study, participation type learning program" 栗尾和佐子, 小西元美, 中尾晃幸, 米山雅紀, 小森浩二, 邑田裕子, 稲冨由香, 山室晶子, 山本祐実, 西川智絵, 串畑太郎, 安原智久, 曽根知道 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2015.

---

	Understanding degree investigation (2) about the oral P0686-22-AM supplementary water liquid 宮本悦子1), 興村桂子2), 毎田千恵子2), 梶愛2), 金子智美2), 木田美沙希2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2015.

---

	The practical training (On the Job Training: OJT) in the hospital of the P0687-21-PM Keio University pharmacy school clinical system teacher 青森達1), 池谷修2), 鈴木小夜1), 丸山順也3), 山口雅也2), 中村智徳1), 岡本真一郎2),4), 望月眞弓1),3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2015.

---

	Effect to introduce education about the risk of the use of Internet about the health information into pharmaceutical products education class of P0688-22-AM Junior High School more 淺川大樹1), 大柳賀津夫2), 沼田一也3), 松下良2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2015.

---

	New face pharmacist educational program Preceptor system introduction in the P0689-21-PM Sapporo east Tokushukai Hospital and future problem 比嘉耕基, 田中佑樹, 前川静香, 石川香奈子, 廣橋千恵子, 金崎修治, 山下友也, 齋藤靖弘, 徳留章, 早坂敬明, 武田契巳, 武田清孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2015.

---

	Hold P0690-22-AM "children pharmacist experience event" 田淵沙織1), 雑賀真央1), 藤原大1), 土井光則1), 西村知恭1), 吉田薫1), 岩城久弥1), 天野賀弘2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2015.

---

	Attempt of the P0691-21-PM pharmacy original "medication inconvenient experience-based training" 藪本千鶴1),2), 仁木一順1), 上田幹子3), 上島悦子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2015.

---

	P0692-22-AM Tokyo Saiseikai center Hospital, examination of the usefulness in the laboratory of cancer Ariake Hospital both pharmacy cooperation combination meeting for the study 間宮伸幸1), 早川真希1), 高綱唯2), 杉田一男2), 中田順子1), 萩野茜2), 有野徹1), 中野泰寛2), 川上和宜2), 鈴木知則1), 鈴木賢一2), 濱敏弘2), 清水淳一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2015.

---

	The case that was associated with a young woman of the deep vein thrombosis as P0693-22-PM ward permanent residence pharmacist 鹿沼奈央1), 浜野憲子1), 久岡清子1), 山本干城2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2015.

---

	The acquisition of the ward drug duties enforcement addition in the P0694-23-AM neurology ward 原暦1), 安高勇気1),2), 今給黎修1),2), 鷲山厚司1), 二神幸次郎1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2015.

---

	One patient who suspected rhabdomyolysis by the P0695-22-PM colchicine internal use, and suggested internal use cancellation 水野めぐみ, 伊藤和幸, 河井和子, 磯谷聡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2015.

---

	The effect that pain relief after the operation under laparoscopy in the P0696-23-AM ovarian cystoma gives to postoperative pain and nausea post-operative, vomiting 伊藤千裕1),2), 関野知恵1), 井上岳1),2), 柏木政憲3), 松原肇1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2015.

---

	The case that suspected a side effect of amiodarone than P0697-22-PM anamnesis and image views, and suggested administration cancellation 伊藤和幸1), 浦崎圭太1), 河井和子1), 磯谷聡1), 吉田雅博2), 加田賢治2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2015.

---

	Fact-finding of the pharmaceutical intervention by the ward pharmacist for the purpose of the P0698-23-AM side effect evasion 橋詰淳哉, 里加代子, 内田隆寛, 赤松隼人, 佐々木均, 樋口則英 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2015.

---

	Examination of the pharmacist intervention in the P0699-22-PM blood medical service 宮崎晶, 植木哲也, 和田佳菜子, 松田亜希子, 高橋昭弘, 橋口靖 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2015.

---

	Intervention of the pharmacist at the P0700-23-AM hepatitis C dual therapy (Daclatasvir Asunaprevir) introduction 鹿島彩絵, 垣尾尚美, 結城紗英子, 植木彩, 若林よう子, 土井本和久, 瀬川和子, 國東ゆかり Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2015.

---

	Efforts and evaluation to the cooperation with a physician, the nurse by the P0701-22-PM cancer exclusive duty ward person in charge 元木孝, 高柳昌宏, 千田泰健 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2015.

---

	Inspection of the effect of the immunosuppressive drug formulation study support by the pharmacist in the P0702-23-AM blood medical service 折山豊仁1), 湯澤薫1), 山本武人2), 長瀬幸恵1), 鈴木洋史1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2015.

---

	About the participation of the pharmacist in septic shock patients in the P0703-22-PM regular hospital 高橋弘泰, 安井一正, 杉浦洋二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2015.

---

	Questionary survey about the pharmacist duties in the P0705-22-PM obstetrics and gynecology department ward 江橋優香1), 小室治孝1), 田中大1), 佐治晴哉2), 喜古康博1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2015.

---

	The crisis of cerebral apoplexy prediabetes treatment situation and the need of the pharmaceutical intervention that it showed from P0706-23-AM ward drug duties 倉内寿孝1), 目時典文2), 阿部早苗1), 久米田一喜1), 高瀬公子1), 花田和大1), 船水梨沙1), 藤田尚子3), 鳥谷部翔1),3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2015.

---

	Examination and problem of the ward duties case in the P0707-22-PM JCHO Sendai Hospital kidney internal medicine, hypertensive diabetes department ward 安部真一, 鈴木英則 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2015.

---

	P0708-23-AM mild mental retardation, one case of the medication management instruction for the renal-transplant recipients with the hearing loss 松岡有紗1), 永井絵里子1), 高橋愛未1), 古川夏2), 金銅葉子1), 矢澤浩治3), 石川照久1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2015.

---

	Efforts of the ward pharmacist to polypharmacy in the P0709-22-PM kidney disease special hospital 大津山裕美子1), 岡本祐子1), 山本絢美1), 谷口瑠里子1), 濱崎匡子1), 岡田悠子1), 中村智宏2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2015.

---

	It is the prescription intervention competitive review in approximately eight weeks after the hospitalization in P0710-23-AM ward drug duties (medical treatment ward) 渡辺智康, 難波良平, 山崎恵, 高取孝一, 安藤哲信 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2015.

---

	Number of the prescription drugs decrease and examination of the economic burden reduction that the pharmaceutical management in the P0711-22-PM medical treatment ward results in 久田亜紗美, 野澤正徳, 三浦毅, 畔柳敏弥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2015.

---

	Make P0712-23-AM children medication adjuvant brochure 寺田芳弘1), 近藤千恵2), 勝又庸行3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2015.

---

	Of the perioperative heparin substitution using P0713-22-PM inside the hospital guidelines, actually 天野杏南1), 荒木憲昭1), 加藤康子1), 青山智彦1), 坂本英至2), 加藤道子3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2015.

---

	About the efforts as establishment - children group of the ward drug duties of NICU, GCU, the children's ward in the P0714-23-AM our hospital 秋山直子, 春田倫代, 松岡由利子, 井手飛鳥, 日高博司, 浅原稔生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2015.

---

	The present conditions and VTE onset inhibitory effect of the Edoxaban tosilate acid salt hydrate administration in the P0715-22-PM our hospital orthopedics 寺下朋江, 高嶋孝次郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2015.

---

	The making of the medication counseling manual for circulatory organ ward charge pharmacists by the P0716-23-AM 6 institution combination and the evaluation 清水忠洋1), 青木裕希子2), 赤木祐貴3), 伊奈川愛理2), 植草秀介5), 榎木瑞穂4), 小河原由佳4), 笠原孝宣2), 木村有揮2), 武石愛子5), 千葉達夫5), 中島優子6), 葉梨美和7), 加藤裕芳5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2015.

---

	The prescription intervention contents in P0717-22-PM ward drug duties and the evaluation 武田なつ美, 光川由佳子, 小林早苗, 石井茂 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2015.

---

	Pharmaceutical suggestion and adoption rate in P0718-23-AM ward drug duties 岩切貫太, 池田隆, 板倉朋恵, 阪本康典 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2015.

---

	Usefulness of the anticoagulant therapy which used edoxaban together with enoxaparin for the deep vein thrombosis prevention after the P0719-22-PM artificial joint replacement 古庄弘和1), 片渕咲也香1), 下石和樹1), 宮本和彦2), 陣上祥子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2015.

---

	Duties standardization with administration of medication and the check sheet using the critical path in the P0720-23-AM PCI 古井恵美, 為保樹理, 西原早紀, 平出耕石, 今関孝子, 加藤武司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2015.

---

	About the importance of the ward drug duties to the use of P0721-22-PM tolvaptan patients 塚田寛子, 草葉一友 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2015.

---

	The operation of the simple suspension method that utilized the information sharing tool by the P0722-23-AM ward pharmacist and the effect 白濱和加子, 前田美由紀, 飛田修康, 祖川倫太郎, 林章浩, 持永早希子, 田崎正信, 原英夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2015.

---

	Present conditions investigation after the P0723-22-PM simple suspension method introduction 細江律子, 田中みずほ, 河井良智 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2015.

---

	Intervention example by enforcement and the ward pharmacist of a ward pharmacist, the DI meeting that started with P0724-23-AM ward drug duties enforcement addition calculation 鈴木景就, 小野徹, 柴田麻里子, 中村圭介, 芦名正生, 佐々木梨絵, 寺嶋望, 青木有希子, 一野勇太 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2015.

---

	It is ... through a .1 case taking advantage of examination ... at-home support center setting about the medication support of the patients after a discharge using P0725-22-PM ward duties 大久保嘉則, 床島英雄, 三砂義敬, 一ノ瀬由衣, 田中基稔, 村野仁美, 塚田寛子, 宮崎靖之, 草葉一友 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2015.

---

	Usefulness evaluation - of efforts - prescription support to the medical safe improvement by the P0726-23-AM ward pharmacist 於本崇志1), 朝賀純一1), 岩渕修1), 川口さち子1), 工藤賢三1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2015.

---

	Drug reporting ... by examination - acute phase ward charge pharmacist about the medication management at the change ridges from P0727-22-PM acute phase ward to a convalescent ward 中田早苗1), 小田真澄1), 安原梨恵1), 木村佳美1), 稲葉佳南1), 大西優菜1), 齋藤文佳1), 加納由美2), 武森三枝子2), 市川大介1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2015.

---

	About the potentially serious medical errors incident analysis before and after P0728-23-AM ward drug duties 宗田一記, 三瓶台智, 高橋由香, 岩上泰崇, 猪狩政則, 景山亮平, 佐久間淳一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2015.

---

	The operational situation of the preoperation protocol in the P0729-22-PM cardiovascular surgery ward and the evaluation 金澤正智, 野間口愛, 野田麻未, 高橋梨奈, 中野公, 寿眞一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2015.

---

	About resumption situation confirmation of the P0730-23-AM preoperation cancellation medicine 山下涼子, 在本麻由加, 宮川祐子, 安倍さつき, 三宅麻文, 河原宏之, 石川弘子, 尾上雅英 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2015.

---

	From the choice of examination - drug about the standardization of the thromboembolism preventive preparation through the ward drug duties in the P0731-22-PM orthopedics ward to protocol operation - 腰岡桜, 倉田武徳, 八木下純子, 佐村優, 関根寿一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2015.

---

	Device of the confirmation matter at ward duties enforcement that utilized P0732-23-AM pre-Abo id 中島誠1),2), 山本泰大3), 高橋朗4), 後藤拓也5), 小南美枝6), 小西友美7), 柴田有希子8), 寺師守彦1), 林秀樹2), 杉山正2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2015.

---

	Efforts to clinical reasoning power improvement of the pharmacist mainly on the P0733-22-PM vital sign 上村忠聖, 伊藤智一, 鈴木信也, 関山正夫, 安藤栄輝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2015.

---

	Consideration about the clinical experience and pharmacist education of the pharmacist about the P0734-23-AM patients correspondence 明神有希1), 見元尚1), 尾原喜美子2), 筒井由佳1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2015.

---

	Efforts to drug control using P0735-22-PM Distribution of medicine cart 田辺亮子, 森山傑, 徳武静香, 菅原順子, 安田礼子, 三代貴康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2015.

---

	Activities (the first report) of the ward pharmacist in the P0736-23-AM Saitama Red Cross hospital - Effect - in the electronic chart introduction 伊賀正典, 興野克典, 町田充, 藤掛佳男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2015.

---

	The calculation present conditions of the ward drug duties enforcement addition in the P0737-22-PM whole country capital municipal hospital and future problem 喜古康博1), 橋田亨2), 小竹慶子3), 舩津久美4), 向井淳治5), 田中恒明6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2015.

---

	Prescription suggestion with the placement development of the P0738-23-AM ward pharmacist and quantitative qualitative evaluation of the consultation meeting a demand example 小久江伸介, 大野能之, 折山豊仁, 山口諒, 徳田篤志, 長瀬幸恵, 鈴木洋史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2015.

---

	Good use of accumulation and evaluation - ward drug duties outcome collection sheet ... of the outcome in P0739-22-PM ward drug duties 佐向美帆子, 満田正樹, 野際俊希, 楠本梨賀, 中谷亮介, 稲葉静香, 尾崎加織, 石本昌裕 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2015.

---

	Information sharing ... using construction and evaluation - cooperation seat of the cooperation method of P0740-23-AM floor nurse and the exclusive duty pharmacist 楠本梨賀1), 満田正樹1), 野際俊希1), 中谷亮介1), 稲葉静香1), 尾崎加織1), 染谷由紀2), 山本有美2), 石本昌裕1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2015.

---

	Comparison between working full time pharmacist and duties contents to engage in P0741-22-PM ward drug duties of the additional post pharmacist 清水けいこ, 高儀佳代子, 安藤智美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2015.

---

	Examination about the change of the drug duties in the P0742-23-AM area inclusion care ward shift 田中真衣, 竹内都子, 松井雄一, 北澤英徳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2015.

---

	About a list of remedy medicine for the purpose of the facilitation at the P0743-22-PM hospital transfer adjustment 前田祐果, 碓井紗知, 大谷寧次郎, 杉浦洋二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2015.

---

	A new system for grasp of the P0744-23-AM efficiency-like medication injection situation and the effect 飛田修康1),2), 前田美由紀1), 祖川倫太郎1), 持永早希子1), 田崎正信1), 三原由起子2), 原英夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2015.

---

	About the relation P0745-22-PM pharmacist in the Distribution of medicine (administration cart) 布施克浩, 紫桃裕造, 福士素子, 篠村五子, 上岡泰弘, 藤本佳代, 倉田奈央子, 菊池大輔, 畑中貞雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2015.

---

	Transmission of the drug information in P0746-23-AM electronic chart, the prescription 金原寛子, 近澤明, 中本富士子, 山下忠明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2015.

---

	Pharmaceutical products choice mistake preventive measures at the P0747-22-PM prescription order 田尻千晴1), 壁谷めぐみ1), 小澤いくこ2), 松島真弓2), 松浦三恵子3), 石川尚武4), 湯浅周1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2015.

---

	Development of the foreign medication counseling support system for the purpose of the reduction of the P0748-23-AM medication counseling record work 亀井健人1), 城戸晴加1), 杉島佑美1), 益本周治1), 中野勝昭2), 高柳和伸1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2015.

---

	The use actual situation of the electronic edition medicine notebook in the P0749-22-PM Kurashiki center Hospital and future problem 黒川佳津子1), 亀井健人1), 木村桃子1), 月岡良太2), 西口孝広3), 板倉正明3), 藤本健一4), 村山慶5), 高柳和伸1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2015.

---

	Efforts of the drug reporting for patients using P0750-23-AM smartphone 大下萌1), 亀井健人1), 村山慶2), 黒川佳津子1), 佐藤可奈1), 高柳和伸1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2015.

---

	Construction ... of the system which linked ... electronic chart for compounding of medicines duties reinforcement at the P0751-22-PM ward pharmacist absence 岩尾恭寛, 植木亮磨, 工藤真裕 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2015.

---

	A bringing medicine differentiation system and electronic chart cooperation in the P0752-23-AM Univ. of Toyama Hospital 川尻憲行1), 三村泰彦1), 足立伊佐雄1), 中川肇2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2015.

---

	Construction of the local drug related information joint ownership system which assumed the P0753-22-PM Internet a base 寺松剛1),2), 寺島朝子1),2), 丹沢彩乃1),2), 石田昭義1),3), 豊岡坑一1), 小野俊治1),4), 柏木賢治1),5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2015.

---

	Effect of the automatic multidirectional approach on screening test of the P0754-23-AM HBV reactivation 山中理1),2), 益澤明3), 中山英夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2015.

---

	About system repair to be able to edit the P0755-22-PM electronic chart system, and to make a use as a new use on the formulations support system side automatically at any time 松隈匠子, 高橋誠, 坂本亜沙美, 堤一貴, 有馬千代子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2015.

---

	Medicine investigation ... including the animal raw materials which we cannot eat for reasons of progress report - religion top of the P0756-23-AM cow pig-containing pharmaceutical products database making project 大山実, 酒井望, 中込哲, 村田恵美, 谷口聡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2015.

---

	Construction of the P0757-22-PM injection management room duties system 宮下博幸1), 中村俊貴1), 小林由布子1), 八木澤啓司1), 左右田和枝1), 柴田壮一1), 松原肇1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2015.

---

	Construction of monitoring duties using pharmaceutical products risk management (RMP) which cooperated with a P0758-23-AM plan DI room, a ward pharmacist 大島幹弘, 田中守, 加戸佳己, 飛鷹範明, 田坂友紀, 田中亮裕, 荒木博陽 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2015.

---

	Examination about the optimal reporting judging from P0759-22-PM questions and answers record 小島庸子, 山口美穂, 久田達也, 辻秀樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2015.

---

	Analysis of questions and answers data about the drug information (DI) in the P0760-23-AM our hospital 尾浜直子, 三浦誠 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2015.

---

	Utilization ... of an availability ratio and the information of the database compilation of questions and answers and document, literature - drug information room by the computerization for the P0761-22-PM drug information room 小橋亮, 今村陽子, 池田浩和, 高橋浩二郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2015.

---

	Construction of the side effect comparison system which utilized P0762-23-AM big data 佐藤篤郎, 鈴木厚志, 天野哲史, 松本薫, 板倉由縁 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2015.

---

	Database construction of the comprehensive administration of P0763-22-PM antimicrobial index 笠井雄佑1), 池谷修1), 早川智久1), 石川春樹1), 山口雅也1), 岡本真一郎1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2015.

---

	Study on use actual situation by the hospital pharmacist of P0764-23-AM DPC/PDPS 逸見佳代, 和泉啓司郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2015.

---

	Comparison of the adverse event report in the new oral anticoagulant drug using P0765-22-PM JADER 渡邉慶剛1), 坂田洋2), 酒井隆全3), 大津史子4), 後藤伸之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2015.

---

	Examination about P0766-23-AM influenza vaccine Q&A and the evaluation 海上玲子1), 柴田壮一1), 齋藤雅俊1), 松原肇2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2015.

---

	Efforts to prevention of injection drug incompatibility in the P0767-22-PM our hospital 平田健志, 宇津木博明, 井原摂子, 扇麻衣子, 板倉美奈, 池谷健一, 平野桂子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2015.

---

	The recognition, good use of risk communication tool situation in the P0768-23-AM medical institution 平松彩佳, 中常恵美, 星野絵里, 鳥井真由美, 近藤恵美子, 俵木登美子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2015.

---

	Inquiry to collection of P0769-22-PM Hospital pharmaceutical products mention contents and a drug information room 大塚誠, 川原義弘, 上野雅代, 甲斐田唯, 藤金治雄, 塩塚昭一, 脇田昌子, 鷲山厚司, 今給黎修, 二神幸次郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2015.

---

	The present conditions of the side effect report of the P0770-23-AM our hospital 加藤洋介, 小笠原聡子, 前田直希, 牧野勇 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2015.

---

	Usefulness - of technique - DLST testing history surveillance and the new hiring medicine side effect questionary survey to collect more P0771-22-PM inside the hospital information on adverse drug reactions 岡本有紀子, 工藤正治, 服部慈久, 土屋翔子, 中村康夫, 鈴村宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2015.

---

	Consideration about the reporting of the precautions for use about the sleepiness of the P0772-23-AM antiallergic agent 明石威徳, 守屋友加, 黒野俊介, 伊東亜紀雄, 山田重行, 長谷川洋一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2015.

---

	Analysis about the onset report of the severe drug eruption using the P0773-22-PM adverse event spontaneous report database 阿部純子1),2), 梅津亮冴3), 又木香那子4), 加藤大和1), 上田夏実1), 中山蓉子1), 松井利亘1), 池田浩治3), 原英彰4), 紀ノ定保臣5), 稲垣直樹6), 中村光浩1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2015.

---

	Rearranging and processing of the information for the use and application of risk management plan (RMP) in the P0774-23-AM drugstore 加藤正久1), 金子絵里奈2), 草場健司1), 井手純司1), 加留部信介1), 園田正信1), 吉川学1), 山野徹3), 瀬尾隆3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2015.

---

	Construction of the side effect monitoring management tool which assumes P0775-22-PM clinical test value an index 石田俊介1), 伏谷秀治1), 坂本久美子1), 中村敏己1), 寺岡和彦1), 川添和義1),2), 石澤啓介1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2015.

---

Investigation about the association with the patients with otitis media patients and seasonal variation level to come to the hospital in the P0776-23-AM Tochigi north area 加藤芳徳1), 市山一樹1), 勝山繁佳1), 倉永勇希1), 本木絵梨奈1), 渡邉理基1), 真野泰成2), 大内かおり1), 前澤佳代子1), 鈴木雅史3), 橋本秀雄3), 生野登4), 旭満里子1), 百瀬泰行1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2015.

---

	Efforts to drug allergy registration in the P0777-22-PM our hospital 立石裕樹1), 井上幸子1), 古賀みゆき2), 後藤佑里3), 山内晋一郎4), 斉藤律子5), 平川雅章1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2015.

---

	Relation of the pharmacist for the P0778-23-AM anti doping activity 庄司理恵1), 長島章2), 中居肇1), 伊藤功治1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2015.

---

	Fact-finding about the effectiveness of P0779-22-PM Polyethylene glycol plus ascorbate solution and the safety 丹代恭太1), 工藤晋1), 菊池光太1), 藤原隆雄2), 蒲澤一行1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2015.

---

	Fact-finding about the combination of the Chinese medicine extract preparation for the P0780-23-AM medical care 井口智恵1),2), 竹治優紀1), 伊藤千裕1),2), 井上岳1),2), 清原寛章3), 松原肇1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2015.

---

	Use investigation of the torr vav tongue in the P0781-22-PM Nishio Municipal Hospital 山本亮子1), 川澄清孝1), 齋藤誠2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2015.

---

	From the viewpoint of efforts - protector of the pharmacist for P0782-23-AM children medication adherence improvement - 佐々木美織, 比毛有理子, 佐藤圭吾, 西和哉, 阿部浩幸, 佐賀利英 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2015.

---

	P0783-22-PM Survey on the use situation of isradifylline for patients with Parkinson's disease in our hospital 奥野幸子1),3), 木村隆2),3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2015.

---

	Use situation investigation of the apixaban in the P0784-23-AM our hospital 今泉有希, 長谷川晃司, 神山三佳, 和田淳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2015.

---

	P0785-22-PM Evaluation of three drug combination therapy using Bonoprazan in H. pylori eradication therapy 福野和治1), 松川雅子1), 西部幸一1), 今井桂子1), 小泉忠史2), 定岡邦昌2), 古家乾2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2015.

---

	Disease insight for P0786-23-AM cerebral infarction prevention of recurrence, investigation about the medicational self-understanding 鈴木亮平1), 柴田有希子1), 垣越咲穂1), 小島あゆみ1), 杉村勇人1), 平野淳2), 伊藤誠紀1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2015.

---

	Use of antihypertensive medications fact-finding in the P0787-22-PM practice practice 後藤渉1), 山澤理恵子1), 土橋卓也2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2015.

---

	About the present conditions of the use of "the dry person blood clotting factor IX complex" in the P0788-23-AM our hospital 星吉行1), 和田健太郎1), 長岡和徳1), 大森俊和1), 仲鉢英夫1), 渡辺剛史2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2015.

---

	Efforts to situation of the polypharmacy in the P0789-22-PM our hospital and pharmacist awareness improvement 多胡和樹, 黄前尚樹, 今井美恵子, 岡本安紀, 戸川尚美, 寺崎実希, 中森光子, 岸敬子, 仲西未佳, 平田貴大, 松山芽衣, 谷車彩夏, 常村弥生, 廣本真里, 小倉朋子, 中村美樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2015.

---

	Examination of the serum calcium requiring attention with P0790-23-AM serum potassium remover administration and serum sodium level situation investigation 村上史承, 岡本伸也, 岡田昌浩, 杉原弘記, 後藤裕香, 星野祥儀, 神垣江里奈, 山田理恵, 岡崎和子, 向井弘恵, 竹井英介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2015.

---

	Daclatasvir for P0791-22-PM chronic hepatitis C, use experience of the oral Asunaprevir dual therapy 小林晃子, 石原泰子, 益本周治, 阿曽沼和代, 高柳和伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2015.

---

	Proper use investigation of the lamotrigine induction in the hospital attached to the P0792-23-AM Nagoya University faculty of medicine 高橋一世, 竹内典子, 鳥本真由美, 野村英宏, 千崎康司, 矢野亨治, 山田清文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2015.

---

	The enforcement situation of the blood test including the differential white blood count of the P0793-22-PM thiamazole tablet remedy patients 阿登大次郎, 岡本知子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2015.

---

	Present conditions analysis about alerting it such as the driving by the P0794-23-AM physician and the measures 青木美歌, 築地茉莉子, 長内理大, 横山威一郎, 山口洪樹, 大久保正人, 中村貴子, 鈴木貴明, 有吉範高, 石井伊都子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2015.

---

	It is an evaluation of the withdrawal and a future problem together with one application of the P0795-22-PM injection drug 脇田恵里1), 杉村勇人1), 平野淳2), 伊藤誠紀1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2015.

---

	Relations with the drug which should consider polypharmacy and the cancellation in P0796-23-AM health center for the elderly residents 志方敏幸1),2), 近藤純1), 吉田憲史1), 浅原康代1), 三浦友里1), 木下佳彦1), 坂本淳一2),3), 小林学3), 畑中緑子1), 辻野健2),4),5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2015.

---

	Examination of the drug information contents which P0797-22-PM protector transmits to the staff of a school of a kindergarten, the nursery school 吉次紗也加, 田山剛崇, 三宅勝志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2015.

---

	Attitude survey of the physician about the Chinese medicine prescription in the P0798-23-AM our hospital digestive organ surgery 中塚美穂1), 山本智也1), 原伸輔1), 勝浦正人1), 門脇裕子1), 山崎誠2), 江口英利2), 萩原圭祐3), 三輪芳弘1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2015.

---

	Use fact-finding of the edoxaban in the P0799-22-PM our hospital 廣兼誠, 佐道紳一, 木下真理子, 森善洋, 吉岡大樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2015.

---

	Heeltap medicine investigation of the patients in P0800-23-AM Kochi 吉岡三郎1), 乾朱里1), 吉澤麻里奈1), 京谷庄二郎1), 川添哲嗣2), 西森康夫2), 土居祥孝3), 西森郷子3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2015.

---

	Examination of the dose in the effectiveness of P0801-22-PM gene recombination thrombomodulin α and the decreased renal function 田實裕介, 冨山成章, 鳴海由希子, 橋元良枝, 松ヶ野聡美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2015.

---

	Use situation investigation for the proper use of the P0802-23-AM recombinant thrombomodulin 花田聖典, 下澤那津, 高田正温, 植村隆, 東島彰人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2015.

---

	It is the actual situation of the efforts of the pharmaceutical company in the prevention of doping carelessly P0803-22-PM 堺千紘1),2), 大久保沙知1),2), 岩本理央1),2), 山下修司1),3), 野口義紘1),4), 伊野陽子1),2), 井口和弘1),2), 寺町ひとみ1),4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2015.

---

	The literature documentation of the drug making P0804-23-AM resilience fluctuate and recognition investigation of the hospital pharmacist 生津弘毅, 井澤美苗, 西村友宏, 登美斉俊, 中島恵美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2015.

---

	Prescription investigation before and after the levetiracetam monotherapy approval in the P0805-22-PM our hospital 中野智実1), 北村緋奈1), 吉田美咲1), 武田龍馬1), 原田瑞記1), 藤井亮1), 青沼光映1), 山澤祐司2), 本間和加子1), 中村博彦3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2015.

---

	The use of placebo medicine situation in relations of P0806-23-AM placebo effect and the genetic polymorphism and the clinical practice 山口有貴, 井澤美苗, 西村友宏, 登美斉俊, 中島恵美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2015.

---

	The use situation and patients background in our hospital outpatient of the P0807-22-PM new oral coagulant (NOAC) apixaban 中山久美子, 森田佳博, 奥美和, 上地純子, 中村宏, 面田恵 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2015.

---

	The effect that in-hospital adoption of the generic medicine in the P0808-23-AM Hospital gives to formulations of the generic medicine in the health insurance pharmacy 齊藤康介1), 舘知也1),2), 後藤千寿2), 吉田阿希1), 杉田郁人1), 林勇汰1), 江崎宏樹1), 臼井一将1), 加藤未紗1), 野口義紘1), 牧野哲平2), 安田昌宏2), 水井貴詞2), 寺町ひとみ1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2015.

---

	About the smooth efforts from P0809-22-PM forerunner pharmaceutical products to a generic medicine change 富田敏章, 福地祐亮, 村井悠紀, 萩原里実, 曽我弘道, 小田原由香, 下河邉安妃子, 町田聖治, 樽善久, 入江利行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2015.

---

	Change to the generic drug in P0810-23-AM remote island and the Hansen sanatorium 田所正年 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2015.

---

	About the generic drug choice of the anticancer agent in the P0811-22-PM our hospital - gemcitabine and etoposide - 森田聡子, 近藤万友美, 西山祐美, 澁谷奈穂, 長尾彰太, 下村美穂, 中川史絵, 新康憲, 橋本百世, 森本典子, 小川佳美, 正置耕一, 辻隆志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2015.

---

	The human sensory evaluation using the P0812-23-AM cromoglicic acid Na fine granule and comparison of preparation properties 岩崎徹, 船渡俊一, 村田勇, 井上裕, 金本郁男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2015.

---

	Examination about the preparation of the P0813-22-PM docetaxel infusion (alcohol-free preparation) 板倉祥嗣, 舩越真理, 土谷有美, 小阪圭治, 井岡真佐夫, 竹内美智, 宮川由季, 津田正博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2015.

---

	About the effectiveness of the new storage medicine in the use promotion of the P0814-23-AM generic medicine 加藤寿規, 三原可奈恵, 大井夏樹, 市川敏太, 渡邊啓介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2015.

---

	About the use situation changing to generic drug pharmaceutical products in P0815-22-PM inside the hospital 古川大輔, 岡村央, 佐々木優太, 伊藤紗代, 小池博文, 西川能治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2015.

---

	Evaluation of the ingredient content ratio in the starting pharmaceutical products and generic medicine of the P0816-23-AM Teiko plastic Nin parenteral injection 柴田寛子, 吉田寛幸, 伊豆津健一, 合田幸広 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2015.

---

	Examination of the therapeutic equivalence of a lot of P0817-22-PM rebamipide preparation 常風興平, 阿部譲朗, 平田歩, 船戸裕樹, 石田七生, 仲井めぐみ, 飯塚美知郎, 白石久, 八木祐助, 門田亜紀, 尾木恭子, 横田淳子, 宮村充彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2015.

---

	Evaluation of the clinical functionality of a lot of P0818-23-AM atorvastatin preparation 西雅恵, 石田七生, 船戸裕樹, 平田歩, 阿部譲朗, 白石久, 常風興平, 尾木恭子, 森田靖代, 横田淳子, 宮村充彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2015.

---

	Questionary survey with the P0819-22-PM generic medicine change 高橋文香1), 八尾祥子1), 上原哲1), 高田史1), 今井兼貴1), 竹村充代1), 児玉暁人1), 岩田智津子1), 栗本尚子1), 藤本真美加1), 水庫彩1), 角明香里1), 森信介1), 田端朋美2), 小竹武2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2015.

---

	One consideration about the P0820-23-AM generic drug choice 志村賢一1), 木村朋貴2), 中村康之3), 柳澤奈緒樹4), 山口大輔4), 現海卓也5), 和田昭宏6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2015.

---

	Consideration about the evaluation at the P0821-22-PM generic medicine change 新沼芳文, 芳賀貴史, 田牧直也, 伊東彩奈, 清水麻衣, 本郷文教, 佐藤誠二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2015.

---

	50 mg of Utemerin (R) notes in the P0822-23-AM our hospital, adverse event comparison of 50 mg of ritodrine hydrochloride infusion liquid "Nichi-Iko Pharmaceutical" treated patients 青柳修一, 大友ひろ美, 鶴田治郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2015.

---

	About effect to give to the effectiveness by the reshuffling, safe and medical economy on generic medicine of the P0823-22-PM Edaravone preparation 市江敏和1),2), 高橋弘泰1), 眞野加奈子1), 鈴木大介1),2), 齋藤宏明1), 岡田健3), 小林望3), 林秀樹2), 杉浦洋二1), 杉山正2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2015.

---

	Comparison of safety and the effect factor in the starting pharmaceutical products and generic medicine of the ritodrine hydrochloride preparation for the P0824-23-AM injection 鈴木千波1), 樋浦一哉2), 越田晋太郎1), 門脇督1), 柴波明男1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2015.

---

	Side effect frequencies and drug costs reduction effect after the P0825-22-PM contrast media generic medicine introduction 長尾愛1), 細田美穂1), 安部浩美1), 都村いつこ1), 橋本幸子1), 塩田知子2), 宮川真澄1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2015.

---

	From problem - bioequivalence about the proper use of the P0826-23-AM generic medicine (inspection with the anticancer agent) - 迫田卓也1), 渡辺朋子2), 田中博之2), 松尾和廣1), 佐々木英久1), 篠原悦子2), 山形光正3), 吉尾隆1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2015.

---

	The effect that the explanation of the pharmacist gives the change of the generic medicine recognition rate of the P0827-22-PM patients and the impression of the patients with generic medicine of the antineoplastic 平井利幸, 秋山裕史, 寺門祐介, 関利一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2015.

---

	The use situation of the P0828-23-AM filgrastim bio follower product and effective and safe evaluation 元木貴大, 田中裕章, 朝倉正登, 山口佳津騎, 高橋功一, 一瀬ひろみ, 三崎彩香, 安宅可南美, 小坂信二, 芳地一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2015.

---

	Examination of the usefulness of the filgrastim by Osh mirror for the neutropenia in patients with P0829-22-PM solid cancer 須釜由香, 洞澤智至, 川澄賢司, 齊藤真一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2015.

---

	An example with suspected cholinergic abdominal pain by P0830-23-AM irinotecan and the distigmine combination 四藤大介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2015.

---

	Example that produced paronychia of Grade3 by P0831-22-PM pertuzumab + trastuzumab combination therapy 三浦篤史1), 篠原佳祐1), 杉山昌秀1), 渡邊将隆1), 由井俊文1), 石毛広雪2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2015.

---

	One patient whom portal hypertension developed in after P0832-23-AM oxaliplatin administration 和田祐一1), 谷口賢二1), 岩田真2), 福永浩也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2015.

---

	Side effect onset of eye manifestation investigation of the tea S one in the P0833-22-PM our hospital 森脇典子, 山本紗織, 平良智, 福大哉, 長濱照美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2015.

---

	Examination of the cytomegalovirus infection risk factor of the P0834-23-AM transplant non-adaptation ATLL patients 吉田裕生1), 福石和久1), 西村尚芳1), 尾之江剛樹1), 津曲恭一2), 前田宏一3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2015.

---

	Pharmaceutical management of P0835-22-PM trastuzumab M tongue Shin treated patients 後藤由起子1), 山室蕗子1), 喜多岡洋樹1), 末吉栄志1), 近藤元三1), 奥村恭博2), 村上敬一2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2015.

---

	Regorafenib side effect of P0836-23-AM pharmacist outpatient management 原祐輔1), 川岸篤史1), 菅幸生2), 中村慶史3), 嶋田努1), 崔吉道1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2015.

---

	Examination of the adverse event in the patients given paclitaxel and albumin suspension type paclitaxel in adjuvant chemotherapy after P0837-22-PM lung cancer technique 古里あかね, 福石和久, 尾之江剛樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2015.

---

	Anaphylaxis with P0838-23-AM rituximab 一木万奈美, 河井和子, 伊藤和幸, 磯谷聡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2015.

---

	Comparison of side effect expression and the effect of treatment of FOLFIRINOX therapy and the mFOLFIRINOX therapy to patients with P0839-22-PM pancreatic cancer impossible of excision 黒部健太郎1), 宮原強1), 秋山巧2), 嬉野紀夫3), 松永尚1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2015.

---

	Information management and the inflection of the antimicrobial side effect history in the P0840-23-AM Sendai public welfare hospital 加藤大輔, 川守田早紀, 武田知明, 佐藤亜希, 本田弘, 中島繁美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2015.

---

	Onset of hyperkalemia in pneumocystis pneumonia onset inhibition treated patients of P0841-22-PM sulfamethoxazole / trimethoprim 梅田道, 安田昌宏, 大澤友裕, 甲田明英, 大野佑城, 青山智, 水井貴詞, 後藤千寿 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2015.

---

	Study on elucidation of the pathogenesis of thrombocytopenia by the P0842-23-AM linezolid 田島正教, 高塩有希, 鈴木茉莉子, 山本真央, 松本准, 廣澤伊織, 加藤芳徳, 山田治美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2015.

---

	Drug-related evaluation of acute hepatic dysfunction that occurred after P0843-22-PM daptomycin administration 飯田慎也1), 大滝康一1),2), 山本譲1), 筒井真博3), 菊池信介3), 内田恒3), 田原克寿1), 山下恭範1), 都築仁美1), 井上正朝1), 山田峻史1), 小野尚志1), 小川聡1), 福土将秀1), 粟屋敏雄1),4), 東信良3), 田崎嘉一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2015.

---

	Examination of medication method, a dose and the side effect in the ST medical mixture administration for the P0844-23-AM pneumocystis pneumonia onset prevention 山内花, 和田淳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2015.

---

	Examination ... of the problems by giving priority to the example - aim trough level that caused neutropenia and thrombocytopenia during P0845-22-PM vancomycin administration 宮崎元康1), 森脇典弘1), 永田良三郎2), 坂田俊文2), 松尾宏一1), 神村英利1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2015.

---

	About side effect expression in the P0846-23-AM linezolid (about thrombocytopenia) 駒井勇太, 喜多洋嗣, 喜多幸子, 高見藍, 仲村亮太, 森智子, 小松祐輔, 潮平沙貴, 田中紋乃, 人見百合子, 石井英之, 田仲祐子, 羽山沙樹乃, 則武隆佑, 松田絵理菜, 泉優貴, 菅真理子, 村雲智久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2015.

---

	Consideration of one case and the article that caused hypoglycemia by P0847-22-PM levofloxacin 大野静子, 中村護, 福原伸治, 久保有子, 木村竜司, 中下愛, 野口亜樹, 松本篤, 前田頼伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2015.

---

	Examination about the drug adverse effect in the elderly people who received P0848-23-AM emergency visit 井上大奨1), 迫田和樹1), 山形真一1), 幸邦憲1), 高橋毅2), 中川義浩1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2015.

---

	Examination of patient factors about side effect expression of P0849-22-PM antirheumatic drug iguratimod 亀山俊1),2), 栗原沙織1), 飯塚敏美1),2), 堀口雅巳1), 平野俊彦2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2015.

---

	One case of the drug-related rhabdomyolysis that occurred after P0850-23-AM acute myocardial infarction 木下真理子1), 吉岡大樹1), 廣兼誠1), 森善洋1), 古殿真之介2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2015.

---

	One case of the rheumatoid arthritis that presented pancytopenia during P0851-22-PM methotrexate and iguratimod combination 山下博民1), 河野えみ子1), 金光盟子1), 関田理子1), 河田彩乃1), 辻みゆき2), 高山康夫2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2015.

---

	Factor analysis about the impaired renal function by P0852-23-AM Liposomal-Amphotericin B 中山大輔, 山本真悠子, 碓井崇人, 元村朱里, 藤本佳那子, 池嶋孝広, 村中達也, 廣田育彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2015.

---

	Pharmaceutical management of patients with severe burn that resulted in iodine poisoning by P0853-22-PM iodine-containing ointment preparation large doses 齋塲千紗登1), 竹内正幸2), 築山郁人2), 寺島嗣明3), 梶田裕加3), 青木瑠里3), 井上保介3), 三木靖雄3), 松浦克彦2), 斎藤寛子1), 脇田康志1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2015.

---

	Safe examination in the Daclatasvir / Asunaprevir combination therapy for patients with P0854-23-AM hepatitis C 山本英晶1), 川上恭弘1), 藤岡真一2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2015.

---

	Safe comparison between NOAC continuation and heparin substitution in the P0855-22-PM atrial fibrillation catheter ablation perioperative period 土田大輔, 新井孝文, 和泉邦彦, 早瀬友和, 二神諒子, 岡部静子, 池上信昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2015.

---

	Fasting effect to give to the blood clotting ability of the P0856-23-AM warfarin potassium remedy patients 滝久美子1), 杉野雅浩1), 細谷治1), 安野伸浩2), 從二和彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2015.

---

	The situation of the osteoporotic therapeutic drug prophylaxis for the steroidal osteoporosis in the P0857-22-PM our hospital 安部智英, 浜野峰子, 宗広樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2015.

---

	1 case with suspected cholinergic crisis by the distigmine with the P0858-23-AM postoperative decreased renal function 岩川真也1), 本間美由紀1), 浦田元樹1), 北村芳子1), 嶋田裕2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2015.

---

	1 case that was given the identity test of the allergy-induced drug for P0859-22-PM liver damage suspicion 安高勇気1),2), 芝口浩智2),3), 今給黎修1),2), 鷲山厚司2), 二神幸次郎1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2015.

---

	Examination about the side effect actual situation of the P0860-23-AM oseltamivir phosphate capsule 多賀野正嗣, 澤井健太, 神谷量子, 銭瑶子, 足立易子, 藤村保夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2015.

---

	Comparison ... with PMDA in the side effect report of analysis - lansoprazole of the side effect report in the P0861-22-PM our hospital 村山和真1), 清田憲吾2), 鈴木正論2), 舟越亮寛2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2015.

---

	Collection and East Shizuoka side effect meeting for the study of the information on side effects of drugs in the P0862-23-AM Fujinomiya Municipal Hospital 北村修, 勝又一雄, 鈴木豊秀, 川口洋実, 小林義典, 小林豊, 井尻真理子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2015.

---

	An investigation of the onset of hypocalcemia situation by the P0863-22-PM denosumab and examination of the risk factor 加藤貴志, 山崎将英, 國本雄介, 益子寛之, 中田浩雅, 野田師正, 宮本篤 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2015.

---

	Evaluation of the side effect monitoring that utilized a P0864-23-AM check sheet 清水悠司1), 高木勝弘1), 野々川裕斗1), 石川将也2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2015.

---

	Investigation - second report - about the onset of sleep loss by the steroid introduction in the P0865-22-PM collagenosis internal medicine 藤田強記1), 林稔展1), 三角紳博2), 西野隆1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2015.

---

	The remedy cancellation situation of duloxetine in patients with P0866-23-AM chronic pain and the factor analysis 豊山美琴, 藤澤浩美, 庄司雅基, 中村豪志, 田中邦佳, 室親明, 木村健 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2015.

---

	About the investigation of the report data in the trial period of the P0867-22-PM patients side effect report 岡本麻依, 久保田史佳, 鳥井真由美, 佐藤玲子, 近藤恵美子, 高松昭司, 俵木登美子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2015.

---

	Comparison of the adverse event of the phlebothrombosis preventive preparation in the P0868-23-AM colon cancer perioperative period 丸山真一, 安藤純子, 永瀬怜司, 今浦将治, 菅野浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2015.

---

	Relations of afterbleeding and antithrombotic drug taking P0869-22-PM bleeding high risk in the treatment with lower digestive tract endoscope 佐藤将嗣1), 平田淳1), 大部智栄子2), 指山浩志3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2015.

---

	Poison in medicine thing analysis report of the case that fell into multiple organ failure by P0870-23-AM risk drug intake 井上嘉余子, 齋藤健一, 篠原克典, 原竜也, 藤村沙織, 岸野亨 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2015.

---

	P0871-22-PM 6-Mercaptopurine Hydrate 10% survey on actual condition on dispersant method 三ツ木英子, 池田優子, 石丸博雅, 刈込博, 眞保淳子, 高山慎司, 川名賢一郎, 後藤一美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2015.

---

	Investigation about the anticancer agent content in the air generated at P0872-23-AM anticancer agent preparation 中山季昭1), 松坂和正1), 齋藤博2), 松田佳和2), 中村益美1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2015.

---

	Participation in planning to hepatic artery chemistry embolus therapy by the pharmacist in the P0873-22-PM our hospital 永島貴裕1), 中村淳二1), 市原航1), 古川将利1), 浅原新吾2), 福井宗憲1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2015.

---

	Fact-finding about preventive measures against exposure to internal use drug with the cytotoxicity in the P0874-23-AM pediatrics domain 市東優美1),6), 佐々木孝1),6), 中尾將彦2),6), 松本美奈子3),6), 森一博4),6), 石川洋一5),6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2015.

---

	The construction of the complete enforcement system of the injectable anticancer agent preparation by the P0875-22-PM pharmacist and the usefulness 中川朋美, 中尾將彦, 岡本優美, 山崎直樹, 吉田徹也, 竹内昌司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2015.

---

	Instruction to patient of preventive measures against exposure from P0876-23-AM excrement 堀江都1), 堀江達夫1), 増本和子2), 須田浩一2), 坂野茂3), 水本一生4), 本田聡4), 山形真吾4), 野宗義博4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2015.

---

	Present conditions multicenter questionnaire report of the radiation exposure of the P0877-22-PM anticancer agent and the nonproliferation 野村浩英1), 宮麻紀子1), 六車裕一1), 平井三保子2), 倉橋基尚3), 尾上雅英4), 藤田英一5), 渡邊裕之6),8), 宅和真由美7), 平田敦宏7) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2015.

---

	About the construction of the P0878-23-AM anticancer agent preparation remote inspection system 及川尚子, 川村晴彦, 菊池英, 田中博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2015.

---

	Development of the new work sheet to use under P0879-22-PM anticancer agent preparation 佐藤淳也1),2), 吉田翔2), 古川美咲2), 掘田靖則3), 佐藤加奈3), 工藤賢三1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2015.

---

	Efforts to anticancer agent exposure measures in the P0880-23-AM our hospital 名坂輝子1), 栗原康弘1), 新井裕子1), 山崎美穂2), 石原真一3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2015.

---

	Examination of the Taxotere division dissolution law for patients with P0881-22-PM alcohol erethism 大澤友裕, 市橋厚司, 安田昌宏, 梅田道, 牧野哲平, 川島あずさ, 長屋雄大, 甲田明英, 水井貴詞, 小林健司, 佐橋誠, 後藤千寿 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2015.

---

	Effective evaluation of the closed system anesthesia preparation appliance "chemo cleveite" in the P0882-23-AM anticancer agent preparation 中川雅史, 金子淳一, 西出貴義, 泉本裕美, 狩谷佳寛, 樫葉利人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2015.

---

	Attempt of an attitude survey and the education about the anticancer medicine exposure to P0883-22-PM non-medical care tech job 牧野麻里, 小宮幸子, 太田一郎, 岡村央, 小池博文, 西川能治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2015.

---

	Conduct an exposure to anticancer medicine investigation by the P0884-23-AM sampling sheet method; and - second report - 川上典子, 近藤昌子, 栃山義徳, 長山晃, 佐藤雅也, 高田正弘, 高梨真希子, 野毛一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2015.

---

	Examination of the appropriate bed bath method for the restroom pollution with the anticancer agent of P0885-22-PM excrement 林瑶子1), 名和秀起1), 兼光朝子2), 高見陽一郎2), 島田憲一2), 江川孝2), 北村佳久1), 千堂年昭1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2015.

---

	P0886-23-AM Attempt to create a spill kit as a countermeasure against anti-cancer drug exposure 氏家靖博, 山崎勇輝, 堀江美保, 安田礼子, 三代貴康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2015.

---

	The anticancer agent exposure reduction using the P0887-22-PM sampling sheet efforts (the second report) for becoming it 中川ゆかり, 石田曜子, 大坪達弥, 友金幹視, 藤田敦夫, 三上正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2015.

---

	Examination of the anticancer medicine ingredient bed bath effect of Toraysee (R) in the P0888-23-AM injection drug preparation environment 吉田昭昌1), 高見陽一郎2), 田頭尚士1), 岡崎大祐2), 松岡哲史2), 佐下橋伸寧3), 島田憲一2), 江川孝2), 木内司1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2015.

---

	Anticancer agent preparation duties in the P0889-22-PM rest holiday: An estimate and analysis of duties contents 石川美由紀1), 渡邊雅明1), 飯塚史織1), 木村あおい1), 金子卓也1), 鈴木嘉治1), 神林泰行1), 土岐浩介1),2), 本間真人1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2015.

---

	Examination of the duties efficiency by the inflection of the P0890-23-AM anticancer medicine preparation robot 金野昇, 新関昌宏, 片桐彩喜, 今村優哉, 水落翔太, 青木一真, 豊口禎子, 白石正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2015.

---

	Leak study of the saline plastic bottle preparation which used P0891-22-PM elastomer for a rubber stopper 大澤千恵, 岩瀬利康, 坂本鉄弥, 森田美江子, 野澤孝章, 木村美貴, 瀧山慈絵, 池田真菜美, 小山朋子, 宮川潤子, 星野浩一, 大塚敏弘, 伊藤好夫, 越川千秋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2015.

---

	Stable examination after the dilution by the use of infusion pump of the P0892-23-AM etoposide parenteral injection and generic drug 鈴木悠平, 折山豊仁, 奈良克彦, 徳田篤志, 長瀬幸恵, 高田龍平, 鈴木洋史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2015.

---

	Is P0893-22-PM not clogged up? Trouble, cause investigation ... at azacitidine - azacitidine subcutaneous administration 畑暁子, 田井浩子, 田代美佳, 瀬名波宏昌, 大河万顕, 村山洋子, 下村一徳, 川口進一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2015.

---

	One case that the patients with P0894-23-AM dysphagia were given a that mouth nib by the simple suspension method, and was effective 鈴木大介1),2), 久野亜耶奈1), 市江敏和1),2), 林秀樹2), 杉浦洋二1), 杉山正2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2015.

---

	Break P0895-22-PM anticancer agent exposure; examination about the clinical use of scattering prevention label packing "vial protection pack 2" 鈴木高弘1),2), 諏訪紀衛1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2015.

---

	P0896-23-AM Consideration of one anticancer drug vial superior in unsealability, cushioning, and disposability for individual packaging boxes 河西麻祐子1), 溝口優2), 太田哲徳1), 村田実希郎2), 定本清美2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2015.

---

	Efforts about anticancer agent preparation duties of the P0897-22-PM Kanazawa Medical University Hospital 高桑直子, 中田いちこ, 山口加代子, 高橋喜統, 丹羽修 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2015.

---

	Use evaluation of "the R-CHOP brochure" which can continue even P0898-23-AM outpatient department chemotherapy 坂野博紀1), 鈴木善貴1), 町支優和1), 石川元章1), 原田靖彦2), 奥野真吾2), 鈴木弘太郎2), 西脇聡史2), 倉橋信悟2), 杉浦勇2), 石田隆浩1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2015.

---

	To take it in as pharmacist duties by effect - outpatient department chemotherapy that the P0899-22-PM cancer instruction to patient management charges 3 acquisition gives to drugstore duties; - 鈴木善貴1), 町支優和1), 石川元章1), 吉原基2), 平松和洋2), 杉浦勇3), 加藤岳人2), 石田隆浩1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2015.

---

	Side effect management in by medical examination front in patients with P0900-23-AM cancer and the effect 堀晃代1), 田中和秀1), 大澤友裕1), 安田昌宏1), 水井貴詞1), 棚橋純子2), 中田琢巳3), 後藤千寿1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2015.

---

	Efforts for the enforcement of the cancer instruction to patient administrative work in the P0901-22-PM outpatient 冨田敦和, 藤井知郎, 惠谷里奈, 種村繁人, 今井邦行, 羽田勝彦, 野村賢一, 野田直樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2015.

---

	Having seen it from the P0902-23-AM chemotherapy pharmacist outpatient department 田代美佳, 田井浩子, 大河万顕, 村山洋子, 川口進一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2015.

---

	Efforts of the drug instruction improvement to patients who received foreign cancer chemotherapy using the P0903-22-PM check sheet 齋藤麻衣子, 荒井秀和, 小林祥子, 須藤晴美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2015.

---

	Efforts and the present conditions to P0904-23-AM cancer instruction to patient management charges 3 calculation 大羽美津子, 森秀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2015.

---

	Calculation - of intervention - cancer instruction to patient management charges 3 of the pharmacist to P0905-22-PM outpatient department cancer chemotherapy patients 森善洋1), 吉岡大樹1), 廣兼誠1), 木下真理子1), 小坂幹子2), 峯孝志3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2015.

---

	PT-INR level change at combination of P0906-23-AM warfarin and capecitabine 伊東輝美1), 藤村拓也1), 相馬まゆ子1), 佐々木洋一1), 今田愛也2), 猪爪信夫2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2015.

---

	One case that a ward pharmacist was able to intervene in for interstitial pneumonia by the P0907-22-PM Afatinib in the second year 西尾佳奈1), 生川賀代1), 小林厚2), 米田勝晃1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2015.

---

	1 case of patients with head and neck cancer which presented withdrawal symptom by the P0908-23-AM opioid 小原香那1),2),3),4), 大道淳二1), 姫井健吾2), 渡辺啓太郎3), 喜多嶋拓士3), 小山貴久4), 石原久司4), 竹内彩子4), 赤木成子4), 森英樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2015.

---

	About a side effect of P0909-22-PM Brentuximab Vedotin and the prevention 霜多博孝, 篠原梨絵, 荒川昌史, 須藤俊明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2015.

---

	The case that caused activities of daily living (ADL) drop for tardive eruption in the P0910-23-AM regorafenib administration 常友友紀1), 泉早苗1), 横田早苗1), 江口真知子2), 大橋一郎3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2015.

---

	Usefulness of the supportive care suggestion in the P0911-22-PM outpatient department cancer chemotherapy room 坪井伸也, 葉山達也, 内池明博, 小林直子, 堤大輔, 山本裕子, 早坂正敏, 吉田善一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2015.

---

	Role of the pharmacist in the treatment with P0912-23-AM colon cancer internal use anticancer agent 牛膓沙織, 高取裕司, 野村翔, 新井孝文, 中村敏史, 池上信昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2015.

---

	Examination ... of the appropriate patients explanation for the generic medicine (injection drug) by questionary survey - pharmacist about the patients explanation of the P0913-22-PM cancer chemotherapy 野村久祥1),3), 吉尾隆2),3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2015.

---

	Examination ... of the satisfaction of the patients about questionary survey - generic medicine (injection drug) about the use of the anticancer medicine in patients with P0914-23-AM breast cancer 吉尾隆1),3), 野村久祥2),3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2015.

---

	Efforts to cancer instruction to patient management charges 3 in the P0915-22-PM outpatient department 石岡美樹, 賀川智子, 針ヶ谷義久, 廣井順子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2015.

---

	P0916-23-AM Examination of bone marrow suppression status and termination cause in Trifluridine, Tipiracil administered patients 山田剛1), 都留君佳1), 大森由紀1), 長谷川綾美1), 神代竜一2), 梅田健二2), 米村祐輔2), 坂東登志雄2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2015.

---

	The present conditions of the prescription suggestion at patients medication counseling in the P0917-22-PM outpatient department chemotherapy room 菊池昌之1), 早坂望1), 山田廉1), 千葉侑希1), 西村忠晃1), 小笠原尚紀1), 齋藤純哉2), 藤原真智子1), 高橋果奈1), 高濱志保1), 奥尚1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2015.

---

	Questionary survey for the chemotherapy explanation tool improvement that matched P0918-23-AM patients needs 樋本繭子1), 中田日早枝1), 三木育子1), 高瀬尚武1), 田中智也1), 村井良平1), 米澤圭祐1), 遠藤幹子1), 浅田佳代2), 辻聡子2), 原美紀2), 喜多川千種2), 末次弘実3), 高原秀典3), 高尾雄二郎3), 井谷淳3), 横山正3), 小野成樹3), 室井延之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2015.

---

	Efforts investigation of the pharmacist about P0919-22-PM cancer instruction to patient management charges 3 中川麻子1),2), 植松俊成1),3), 久保田厚子1),4), 宮川貴行1),5), 玉一久美1),6), 永見康男1),7), 村上輝明1),8), 守田和彦1),9), 藤田亜弓1),10), 松久哲章1),11), 古川裕之3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2015.

---

	The present conditions of the doubt inquiry in the P0920-23-AM our hospital outpatient department chemotherapy room 岩永陽子, 平川智規, 前間邦生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2015.

---

	1 case that a side effect appeared by P0921-22-PM crizotinib administration, and became hard to cure, but succeeded after a change to a that mouth nib 金子憲太郎1), 杉本誠1), 川口文誉1), 吉川明彦1), 夏目一郎2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2015.

---

	The present conditions of EGFR mutation in the gene-positive progress non-small cell lung cancer treatment in the P0922-23-AM our hospital 上原友美1), 中島理恵1), 中村有莉恵1), 赤星真広1), 石神誠子1), 池増鮎美1), 神門孝典1), 佐多照正1), 副島賢忠2), 西島浩雄3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2015.

---

	Relation of the pharmacist in the regorafenib case which we stopped use of by P0923-22-PM liver damage 平瀬陽子1), 青柳京子1), 金内幸子1), 栗原直人2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2015.

---

	Telephone support in the P0924-23-AM oral anticancer agent remedy patients 熊谷要1), 枝廣茂樹1), 西島弘二2), 二上文夫2), 西村元一2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2015.

---

	P0925-22-PM "Efforts towards the calculation and implementation of cancer patient guidance management fee 3 at our hospital : Enhancement of cancer patient guidance management" 殿村直也, 高沢真央, 赤瀬麻希, 高木茂実, 大釜真美, 横山礼子, 塩地園代, 白石範子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2015.

---

	Usefulness of pharmacist duties by the P0926-23-AM cancer instruction to patient management charges 3 calculation 岸本早百合, 多々見俊輔, 遠藤由里香, 逸見結衣, 渡邊小百合, 伊勢原祐子, 菰渕利香, 藤原正幸, 小田中みのり, 安達嘉織, 佐倉小百合, 中晴徹, 大前隆広, 川高菜緒, 大谷祐子, 見上千昭, 柴田博子, 松本敏明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2015.

---

	Construction and the calculation enforcement situation of the medicine manual making system corresponding to the calculation of P0927-22-PM "cancer instruction to patient management charges 3" 薮田直希, 森井博朗, 須藤正朝, 阪中美紀, 野田哲史, 若杉吉宣, 山本優, 井堀仁美, 野村文香, 星野伸夫, 寺田智祐 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2015.

---

	About the calculation situation of cancer instruction to patient management charges 3 in the P0928-23-AM our hospital 島田健, 瀧真由子, 大里勇二, 福山正人, 山口くき, 大谷知奈美, 高嶋梨恵, 西田優香, 喜多良昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2015.

---

	The case that P0929-22-PM gefitinib EGFR gene-resistant (T790M) became clear, and shifted to Carboplatin and pemetrexed combined treatment 大久保節子1), 大久保正2),3), 田中真理子3), 大久保七枝4), 阿部慧5), 角田美佐子6), 大久保美穂5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2015.

---

	The case that alternate-day administration of S-1 by the suggestion of the P0930-23-AM pharmacist relieved a side effect, and became available for medication continuation 大久保美穂1), 大久保節子2), 大久保正3), 田中真理子4), 大久保七枝5), 角田美佐子6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2015.

---

	Analysis of the calculation situation and doubt inquiry contents of cancer instruction to patient management charges 3 in the hospital attached to the P0931-22-PM Chiba University faculty of medicine 佐伯宏美, 今井千晶, 横山威一郎, 中村貴子, 鈴木貴明, 有吉範高, 石井伊都子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2015.

---

	Treatment intervention case ... by the cooperation with the medication support - outpatient department chemotherapy room to patients with foreign chemotherapy enforcement in the P0932-23-AM health insurance pharmacy 沼崎香, 岩瀬裕治, 鯨明美, 丹羽直人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2015.

---

Medicine medicine cooperation ... which used a hospital and present conditions investigation - Internet and FAX of the information sharing with the health insurance pharmacy at the beginning of the treatment with P0933-22-PM oral anticancer medicine 間俊男, 川崎玄博, 竹葉美香, 藤近拓弥, 示野健介, 谷幸美, 宮村憲明, 三浦雅典 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2015.

---

	Unification and evaluation of the antiemesis therapy in the P0934-23-AM hepatic artery chemistry embolus therapy 塩坂育子, 平野和加, 村上通康, 仙波昌三 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2015.

---

	Examination of the palonosetron, aprepitant,dezamethasone3 agent combination antiemesis therapy at the autologous peripheral blood stem cell transplantation in the P0935-22-PM multiple myeloma 斎藤理恵1), 磯田淳2), 小松史法1), 眞中章弘4), 大澤則八寿1), 石川哲也2), 宮澤悠里2), 松本守生2), 澤村守夫3), 蟻川勝1), 横手信昭1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2015.

---

	Efforts to adequacy of the use of antiemetic drug in the cancer chemotherapy of the P0936-23-AM our hospital 一色靖洋, 相川優子, 大室直樹, 生島五郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2015.

---

Multicenter observational, prospective study about retching, vomiting under 5HT3 receptor blocker and the dexamethasone combination with the P0937-22-PM moderate degree emetogenicity chemotherapy 原田知彦1), 松井礼子2), 清水哲1), 鈴木賢一3), 瀧口友美3), 西尾誠人3), 小池健志2), 林稔展4), 瀬戸貴司5), 小暮友毅6), 野上尚之6), 藤原季美子7), 金田裕靖7), 木村仁8), 剱持広知8), 下川元継5), 後藤功一2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2015.

---

	Examination about the antiemesis effect of the dexamethasone in the cisplatin liver intraarterial injection therapy using P0938-23-AM retching, the vomiting evaluation tool 彦坂麻美1), 島田泉1), 新井三紗子1), 間瀬広樹2), 林誠3), 阿部康治1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2015.

---

	About the use situation investigation of the antiemetic before the P0939-22-PM CHOP therapy enforcement and the effect 長谷悠紀, 岸川春樹, 曽我弘道, 山下悟史, 新治嘉一, 前田朱香, 坪根未歩, 平野真健, 町田聖治, 入江利行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2015.

---

	Effect of aprepitant by the TC therapy in retching, the vomiting risk factor with the P0940-23-AM chemotherapy 阿部一仁1), 伊藤敏谷2), 岸本彩子2), 矢田大輔2), 鈴木康之2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2015.

---

	Investigation of the effectiveness for the antiemesis therapy to patients who received P0941-22-PM cisplatin + docetaxel therapy 及川嵩人, 高橋典哉, 和賀信継, 村上正一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2015.

---

	Symptom control and antiemesis measures for the case that P0942-23-AM bevacizumab and Fosaprepitant caused an infusion reaction symptom 平出耕石1),4), 今井直基2), 小林洋子3),4), 鈴木文子3),4), 今関孝子1), 加藤武司1), 尾関豊2),4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2015.

---

	Examination of the usefulness of aprepitant in gemcitabine and the low-dose cisplatin therapy for the P0943-22-PM biliary cancer 杉本智哉1), 藤野泰孝1), 矢野亨治1), 菅原元2), 梛野正人2), 山田清文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2015.

---

	Examination of the antiemetic in P0944-23-AM hydrochloric acid gemcitabine and the albumin suspension type paclitaxel combination therapy 亀島理沙, 片岡智美, 宮崎雅之, 熊倉康郎, 山田清文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2015.

---

	P0945-22-PM Comparison of gastrointestinal toxicity such as antiemetic effect and diarrhea of Indisetron and Tropisetron in combination with Carboplatin + Irinotecan 小岡亜矢1), 梅原健吾2), 高田寛奈2), 若本あずさ2), 初山多恵2), 佐藤秀紀1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2015.

---

	Evaluation of the expression situation and uneasiness, the depression of the adverse event at the P0946-23-AM hepatic artery chemistry embolus therapy (TACE) enforcement 原田桂作1),3),4), 末吉宏成1),3), 山本朗子1), 坂本佳子1), 野口純也2),3), 木戸川秀生2),3), 岡本好司2),3), 村本眞由美1), 名倉弘哲4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2015.

---

	Evaluation - second report - of the prophylactic hot compress for the vascular pain at the Fosaprepitant administration in patients who received P0947-22-PM AC/FEC therapy 今津邦智, 西川千晶, 中野愛子, 岩見裕信, 中田恭子, 前田昌徳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2015.

---

	Examination of the risk factor about the onset of retching with the P0948-23-AM FEC75 therapy 長谷康史, 加藤加奈恵, 木幡華子, 荒木良介, 田中恒明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2015.

---

	Contents of the antiemetic drug reinforcement for retching, vomiting in the P0949-22-PM uterine cervix cancer cisplatin +5-FU therapy and the effectiveness 久米初枝1), 宮崎典子1), 市川和哉1), 田上聖実1), 杉本亜弥1), 矢野亨治1), 梶山広明2), 吉川史隆2), 山田清文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2015.

---

	We weigh usefulness of aprepitant against the Fosaprepitant for patients with P0950-23-AM gastric cancer 清水浩幸1), 廣岡賢輔1), 前田祥花1), 米田栄子1), 牧問美和子2), 滝田敬子3), 川西幸一4), 熊谷務3), 澤山友里3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2015.

---

	Effective comparison between palonosetron and granisetron + metoclopramide lorazepam prophylaxis for nausea vomiting at the P0951-22-PM cisplatin administration 森本清香1), 三好孝法2), 林稔展1), 西野隆1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2015.

---

	Effect of the aprepitant extension administration on retching of the P0952-23-AM breast cancer chemotherapy 近藤祐樹1), 松山奈央2), 鬼頭典子1), 黒田純子1), 木村和哲1),2),3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2015.

---

	Association between carnitine change and lassitude in the P0953-22-PM cisplatin-containing chemotherapy 池崎友明1), 鈴木健介4), 神原健太3), 猪又峰彦3), 岡澤成祐3), 安田初奈2), 梶浦新也2), 三輪敏郎2), 田辺公一5), 菓子井達彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2015.

---

	Examination of the nephropathic risk factor by the cisplatin under the P0954-23-AM Mg administration 須藤頌, 三浦惇史, 前淳之介, 荒川ちづる, 曽我部直美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2015.

---

	Examination about RDI of P0955-22-PM CHOP and the cyclophosphamide in the CHOP homeotherapy 兼松哲史1), 山田佳代1), 中村英明1), 吉田均2), 伊藤貴彦2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2015.

---

	Fact-finding of the drug choice for the esophagitis with the P0956-23-AM cancer of the esophagus chemoradiotherapy 滝田美紀子1), 野村久祥1), 鳩貝健2), 牧陽介3), 小島隆嗣2), 齊藤真一郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2015.

---

	Examination about the expression situation of the vascular pain with P0957-22-PM bendamustine and the measures 中山順子, 鎌田瑞菜, 細田美穂, 沖上朋美, 仲川三春, 宮川真澄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2015.

---

	Effect of the weight loss by the platinum system anticancer agent enforcement in patients with P0958-23-AM progress lung cancer 森尾佳代子1), 南俊行2),3), 寒水孝司4), 仁木一順1), 木島貴志2), 上島悦子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2015.

---

	Screening of hepatitis B by P0959-22-PM cancer chemotherapy and the pharmacist 西塔志織, 川原裕, 九鬼亜衣子, 衞藤麻里子, 中尾佳人, 宮崎宏美, 佐野雅昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2015.

---

	Investigation about the prophylaxis of steroid eye drops in the equivalent cytarabine therapy out of P0960-23-AM 米窪恭子, 疋田絵梨, 清美奈, 白石範子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2015.

---

	Examination of the administration according to the risk classification of RAS yellowtail gauze in P0961-22-PM senior Popes 中村和宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2015.

---

	Evaluation of the therapeutic drug for the hiccups by the P0962-23-AM cisplatin 山本知佳1), 波多野義純1), 鷲山厚司1),2), 今給黎修1), 二神幸次郎1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2015.

---

	Positive hepatitis B reactivation measures by the P0963-22-PM pharmacist 松田圭一郎, 延川正雄, 齋藤順, 荒井浩一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2015.

---

	Examination of vasculitis measures by the raw diet flash after the epirubicin administration in the P0964-23-AM EC therapy 前田祥花, 廣岡賢輔, 米田栄子, 清水浩幸, 國森公明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2015.

---

	Examination of the usefulness of the mild cathartic prophylaxis in the P0965-22-PM CHOP therapy 大畑紘一1), 林寛子1), 石原正志1), 小林亮1), 鈴木昭夫1), 中村信彦2), 中村博2), 北川順一2), 鶴見寿2), 伊藤善規1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2015.

---

	The effect expression situation of use experience of the peg filgrastim in the P0966-23-AM our hospital and the other G-CSF preparation supplementation 森川由梨, 牛之濱風見, 池田龍二, 山下八重乃, 岡島隼輔, 新田美奈, 武田泰生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2015.

---

	A use case and examination of the Goshajinkigan in P0967-22-PM nab-Paclitaxel treated patients 眞木秀子1), 金谷典子1), 西村雅次1), 和田幸治1), 太田圭治2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2015.

---

	Examination of the impaired renal function protective efficacy with the magnesium administration in the P0968-23-AM head and neck cancer TPF therapy 北山秀則1), 坪内孝敏1), 出町拓也1), 村紗苗1), 芦崎雅之1), 平田力1), 早坂州生1), 竹内公美1), 渡邉昭仁2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2015.

---

	Research about the elevated blood pressure in the sorafenib therapy for patients with P0969-22-PM progress hepatocytes cancer 高橋亨1), 篠原悦子2), 宇田川涼子3), 田中博之2), 松尾和廣1), 佐々木英久1), 渡辺朋子2), 篠原旭3), 小林美沙樹3), 齊藤真一郎3), 池田公史4), 吉尾隆1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2015.

---

	Investigation of the side effect expression situation of the nab-paclitaxel+gemcitabine therapy in the P0970-23-AM Sapporo public welfare hospital and the intensity of treatment 能登数馬1), 小原秀治1), 小林龍1), 渡辺浩明1), 高橋栄2), 阿部雅一3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2015.

---

	More than role - 8 cycles of the pharmacist for the side effect management of P0971-22-PM FOLFIRINOX, it is ... through 3 cases that we conducted to PD 三浦恵理, 奥野昌宏, 中田学 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2015.

---

	Prophylactic skin treatment ... of dermatopathy measures - steroid drug for external use of the P0972-23-AM cetuximab panitumumab 高取裕司1),2), 牛膓沙織1),2), 新井孝文1),2), 野村翔1),2), 田中亜喜美193), 池上信昭2), 米山文彦1),4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2015.

---

	Investigation about the onset of diarrhea situation in the concurrent chemoradiotherapy for P0973-22-PM cervical cancer 木永舞1),2),3), 政賢悟1), 本田万里子2), 本原剛志3), 本田義輝1), 齋藤秀之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2015.

---

	We look at the rear about the side effect of difference in medication method expression of P0974-23-AM nanoparticles albumin-binding paclitaxel and examine a mark 石原祥史1), 遠藤拓未2), 浅野まゆみ3), 岩井美奈4), 浅野裕紀4), 伊藤大輔4), 安達志乃4), 岡田和智4), 宇佐美英績4), 吉村知哲4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2015.

---

	Development of stomatitis situation analysis with the Everolimus lock in the P0975-22-PM Fukui Prefectural hospital 宇野美津江, 坂井伸成, 加藤秀明, 中村尚未, 森富男, 佐澤佳彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2015.

---

	Use situation investigation of the conventional and sustained G-CSF preparation in P0976-23-AM blood-forming organ tumor 薮内由里香1), 衛藤智章1), 魚井みゆき1), 杉枝里香2), 林稔展2), 三角紳博1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2015.

---

	P0977-22-PM Study of safety by kidney function of Trifluridine / Tipiracil monotherapy 庄野裕志, 中村さやか, 宮城和代, 宮部貴識, 土井敏行, 上野裕之, 山崎邦夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2015.

---

	Inhibitory effect of the steroid for the fever by P0978-23-AM bleomycin, the bleomycin at the etoposide, cisplatin (BEP) therapy 牛之濱風見, 森川由梨, 池田龍二, 山下八重乃, 岡島隼輔, 新田美奈, 武田泰生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2015.

---

	The effectiveness of the P0979-22-PM peg filgrastim and proper use fact-finding 京谷充崇, 原田知彦, 櫻井学, 楠原義宏, 菊地正孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2015.

---

	Effect of aprepitant at the hypersensitivity prophylaxis of the P0980-23-AM dexamethasone 山崎将英1),2), 菊池敦子1), 中村勝之1), 佐々木直美1), 戸田貴大2), 山崎紀恵子1), 中田浩雅1), 野田師正1), 宮本篤1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2015.

---

	Examination of the white-cell count change by the use of peg filgrastim in the CHOP like regimen in the P0981-22-PM Higashisapporo Hospital 小池奈穂1), 加藤遥平1), 中脇誠一1), 町野孝幸2), 平山泰生2), 照井健2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2015.

---

	Examination of the expression situation about proteinuria derived from P0982-23-AM Bevacizumab 青木望1),2), 中村和代1), 嘉屋道裕1), 木村緑1), 角入壽彦1), 勝山徹2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2015.

---

	Examination of the protective efficacy that is lower than 200 mg/day of aciclovir for the herpes zoster by the P0983-22-PM bortezomib 田中広大, 山脇まり絵, 松本尚子, 山崎好恵, 高平豊, 川田敬, 岡崎弘志, 橋田真佐, 田中聡, 岡崎由紀, 宮本典文, 山本創一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2015.

---

	Comparison with the effectiveness and the lenograstim of the peg filgrastim in the P0984-23-AM breast cancer FEC100 therapy 藤原大一朗1),2), 眞下惠次1),2), 木村佳世1), 野田明宏1), 多喜和夫1), 武田朋也2), 椿正寛2), 西田升三2), 阪口勝彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2015.

---

	Examination of stress inhibitory effect and the immunity reinforcement effect with the aromatherapy that assumed the IgA out of P0985-22-PM saliva an index 中田彩花1), 下枝貞彦1), 酒井優花1), 坂口佐穂子1), 中川沙織2), 大和進2), 太田伸1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2015.

---

	Examination about the usefulness of the magnesium supplement for the renal failure at the P0986-23-AM Cisplatin+S-1 therapy 渥美仁, 加藤安宏, 浅井澄子, 中山貴美子, 澤口和代 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2015.

---

	Examination of the onset of electrolyte abnormality with expression situation and that of hypomagnesemia by the P0987-22-PM panitumumab 島田泉, 彦坂麻美, 阿部康治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2015.

---

	Investigation of the patients background in the onset of vascular pain with P0988-23-AM oxaliplatin 坂本和央1), 久保田康生2), 速水章一1), 大江利治3), 齋藤佳敬2), 熊井正貴2), 笠師久美子2), 山田武宏2), 小松嘉人4), 柴山良彦2), 小林正紀5), 井関健2),5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2015.

---

	Efforts of the pharmacist to hepatitis B (HBV) reactivation measures in the P0989-22-PM Fukuoka Red Cross hospital 川野昭, 上杉聡美, 福重昇吾, 平野俊訓, 大石泰也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2015.

---

	About cisplatin-related renal failure inhibitory effect by the P0990-23-AM magnesium supplement 立道貴清, 越野優希, 山本高成, 山口佳津騎, 磯部芳江, 田中裕章, 小坂信二, 芳地一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2015.

---

	Efforts based on hepatitis B measures guidelines to occur by P0991-22-PM immunodepression, chemotherapy 遠藤篤, 山崎有子, 國分洋, 小村裕子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2015.

---

	Examination about the use situation, side effect expression of sustained G-CSF (peg filgrastim) in the P0992-23-AM Konan public welfare hospital and the contribution to intensity of treatment maintenance 今井邦行, 藤井知郎, 種村繁人, 惠谷里奈, 冨田敦和, 羽田勝彦, 野村賢一, 野田直樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2015.

---

	Examination of stress inhibitory effect and the immunity reinforcement effect with the gamma-aminobutyric acid which assumed IgA out of the P0993-22-PM liquid an index 酒井優花1), 下枝貞彦1), 中田彩花1), 大塚沙穂里1), 中川沙織2), 大和進2), 太田伸1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2015.

---

	Side effect investigation of the Afatinib for patients with chemotherapy existing treatment EGFR mutation in the gene-positive non-small cell lung cancer including EGFR-TKI in the P0994-23-AM our hospital 梅原健吾1), 高田寛奈1), 後藤桂輔1), 若本あずさ1), 初山多恵1), 佐藤秀紀2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2015.

---

	Patients explanation booklet making about the mouth care during use of P0995-22-PM Everolimus and the evaluation 原田沙枝子1), 下川福子1), 澤田奈津子1), 川端俊介1), 安本祥子1), 船越幸代1), 尾崎清香2), 松岡裕大2), 北村龍二2), 池上英文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2015.

---

	Report about the case that used P0996-23-AM Saireito together at MTX massive dose therapy 木内直美, 関根佳代, 松本美奈子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2015.

---

	Examination of the risk factor of the serious neutropenia with the S-1+CDDP therapy for patients with P0997-22-PM progress stomach cancer 栗原竜也1), 山口天士1), 向後麻里1), 加藤和佳奈1), 石井正和1), 石橋正祥1), 久保田祐太郎2), 米山啓一郎3), 吉田仁2), 木内祐二1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2015.

---

	One patient who presented with hyperammonemia during the P0998-23-AM mFOLFOX6 enforcement 池井健, 堀部正記, 大谷仁士 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2015.

---

	Examination about the expression situation of peripheral neuropathy in the P0999-22-PM paclitaxel (albumin suspension type) and the factor 鈴木訓史, 後藤達也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2015.

---

	Consideration about the actual situation of a blood pressure change and the onset by the P1000-23-AM bevacizumab of proteinuria 沖田健太郎, 奥美和, 植中英恵, 長谷川将, 末武亜依子, 中村宏, 面田恵 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2015.

---

	Use fact-finding of the peg filgrastim in the P1001-22-PM our hospital 佐々扶美, 山下愛子, 市川洋一, 田上治美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2015.

---

	Relation of the pharmacist in the proper use of P1002-23-AM pegfilgrastim 荻原好章, 神原康佑, 石井一也, 河本敏貴, 大塚識稔, 原景子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2015.

---

	About CDTM about proper use of the oral P1003-22-PM molecules target medicine and the usefulness 鈴木敦詞, 鈴木大吾, 前田剛司, 坂田洋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2015.

---

	Intervention ... in role - HBV reactivation prevention of the pharmacist in the P1004-23-AM our hospital cancer chemotherapy 平川裕美子, 早野絢子, 川崎美紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2015.

---

	Than the good use of consideration - side effect check seat about the association of adverse event and the EGFR mutation in the gene type of the P1005-22-PM Afatinib ... 上ノ段友里1), 倉光絵梨奈3), 渡辺抄子2), 波呂祥3), 縄田好一1), 福山康朗3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2015.

---

	Possibility ... of the treatment with Kamikihito administration continuation maintenance for attempt - thrombocytopenia to continue P1006-23-AM pancreatic cancer chemotherapy effectively 龍伸和, 石川雄大, 三村泰彦, 加藤敦, 足立伊佐雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2015.

---

	Rearward investigation about the effectiveness when we used fludroxycortide tapes as paronychia symptom measures by the P1007-22-PM Afatinib 渕崎加奈絵, 入江慶, 増田義雄, 岡田裕 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2015.

---

	Example that vascular pain with the P1008-23-AM vinorelbine reduced by anteroposterior administration of prednisolone 合津貴志, 伊與田友和, 渡邊弘枝, 渡部照美, 田崎政則 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2015.

---

	Supportive care in both regimens enforcement equivalence patients of P1009-22-PM cisplatin and the Carboplatin, comparison analysis of the test value 塚本あゆみ1),2), 長楽寿子1),2), 安井友佳子1), 石坂敏彦1), 八野芳巳1), 田端朋美2), 井上知美2), 石渡俊二2), 小竹武2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2015.

---

	About hepatitis B reactivation measures of the P1010-23-AM our hospital and the present conditions 尾垣光彦1), 相馬沙希1), 佐々木恭子1), 近藤裕志1), 森垣和馬1), 田中聡之1), 椿正寛2), 西田升三2), 高垣佳史1), 畑中智子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2015.

---

	Examination of the FN protective efficacy in the P1011-22-PM continuation type G-CSF preparation administration 根岸由貴1), 斎藤理恵1), 大澤則八寿1), 蟻川勝1), 松本守生2), 横手信昭1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2015.

---

	Change of the renal function by the difference in Mg doses to use by the short hydration method in the P1012-23-AM CDDP combination chemotherapy 西和哉, 川田彰彦, 和地徹, 佐藤美里, 高橋舞, 菊地慶, 樫村まどか, 佐藤圭吾, 佐々木崇, 鈴木雄太, 追木正人, 阿部浩幸, 佐賀利英 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2015.

---

	Phase II study about the 1.35%menthol application protective efficacy for the peripheral neuropathy onset by P1013-22-PM Oxaliplatin 鬼窪利英1), 中村久美1), 内堀和也1), 中村将人2), 田内克典3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2015.

---

	Use experience of the valproic acid Na bougie in the P1014-23-AM Shonan center Hospital palliative care unit 宮澤正幸1), 櫛引智子1), 片町守男2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2015.

---

	The use fact-finding of the fentanyl sublingual tablet in the P1015-22-PM our hospital and making of the management sheet 日下部鮎子1), 藤原陽子1), 堀金妙子1), 遠藤麻紀1), 佐藤佳華1), 福井里佳2), 菊池一樹1), 明田克之3), 江副英理2), 八十島孝博2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2015.

---

	Use of steroid investigation in patients with P1016-23-AM end-stage cancer 野際俊希, 辻直子, 石本昌裕 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2015.

---

	Examination in the transluminal administration of P1017-22-PM Okiko Don controlled release capsule 後藤愛実1),2), 今井麻里子2),3), 桑門心2),4), 高橋智恵子1),2), 牧智恵子1), 樫木淑恵2), 河邑真衣2), 西原雅美1), 勝間田敬弘1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2015.

---

	Effect on bowel movement ... multicenter study ... by changes from oral P1018-23-AM oxycodone preparation to fentanyl patch 衛藤智章1), 林稔展2), 福山雄卯介2), 築田晃直3), 仲田浩成4), 山下愛登5), 糸永昇平6), 大園ゆかり7), 小薮真紀子8), 三角紳博1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2015.

---

	Opioid example that rotated from tramadol capsule 400mg/Day of P1019-22-PM High School doses to Osh codon controlled release capsule 松井駿亮1), 上中敏弘1), 長谷川英利1), 川端一功1), 田中巧1), 北村将司3), 上田桂子2), 大内政嗣2), 尾崎良智2), 井上修平2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2015.

---

	Case report about opioid switching by the oral methadone difficulty of the terminally ill patients in the P1020-23-AM palliative care unit 増田多加子1), 藤澤重樹1), 後藤珠代1), 文元佑1), 我喜屋成香1), 竹井清純2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2015.

---

	P1021-22-PM Preparation of protocol for introduction of oral mucosa absorption immediate release opioid rescue preparation 海老根香里1), 平井利幸1), 神谷未加2), 神賀正博3), 関利一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2015.

---

	For all human painful relaxation with making - team approach in medical care of the P1022-23-AM oxycodone introduction pass - 池田宗彦1), 阿曽沼伸一1), 藤井美沙2), 二神咲子1), 江見泰徳3), 鹿田康紀2), 由井薗陽一1), 槇林智子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2015.

---

	Examination of the usefulness of the pain evaluation sheet common throughout P1023-22-PM inside the hospital 黒岩彩乃1), 高柳論也1), 大場拓史2), 平井栄一3), 諸星総一1), 小林恵美子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2015.

---

	It is ... about fact-finding - pharmacist background and an instruction booklet of the medication counseling of the opioid analgesic for the P1024-23-AM cancer pain 榎南祥太1), 原伸輔2), 吉野新太郎3), 榎本幸子4), 前田一石5), 百海有二1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2015.

---

	Efforts to the electronic chart mention unification that utilized a template in the use of drug for the P1025-22-PM medical care 高橋典哉, 及川嵩人, 佐藤和文, 和賀信継, 熊谷敏宏, 村上正一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2015.

---

	One case that the prophylaxis of the P1026-23-AM fentanyl sublingual tablet succeeded for a body movement ache with the diet 鶴島克将, 山本明紀, 安井友佳子, 石坂敏彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2015.

---

	Effect of the cancer cachexia on pain control with the P1027-22-PM fentanyl patch 千葉健史1), 高橋宏彰2), 平舩寛彦1),2), 長澤佳昭2), 工藤賢三1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2015.

---

	1 case that P1028-23-AM hospital pharmacist intervened, and started a fentanyl citrate sublingual tablet in outpatient department 上島聖秀, 浜元孝, 細江律子, 高橋慎太郎, 河井良智 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2015.

---

	The use situation and the effectiveness of the internal use antiemetic drug for nausea, vomiting at the P1029-22-PM opioid introduction 坂井良美, 馬場奈津美, 瀬川和子, 垣尾尚美, 國東ゆかり Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2015.

---

	Examination about the effectiveness of the diclofenac gargle water for the P1030-23-AM oral mucosa disorder 枝廣茂樹, 高橋怜史, 大川浩子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2015.

---

	Efforts of a use situation investigation and the proper use of the Abstral (R) lower lock in the P1031-22-PM our hospital 神原諒, 山中理, 中山英夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2015.

---

	Example that quetiapine was given for P1032-23-AM delirium and a drug-related akathisia symptom, and followed the good course 勝又一雄, 小林義典, 川口洋実, 北村修 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2015.

---

	One case of the progress breast cancer that was useful in quality of life improvement by combination with P1033-22-PM Mohs ointment and the metronidazole ointment 益子里美1), 市川由美子2), 須田篤博1), 豊田真史1), 藤井美代子2), 松本啓一1), 西村和彦3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2015.

---

	Use experience of the P1034-23-AM tapentadol hydrochloride extended-release 山田千代子, 米澤美和, 久保杏奈, 台蔵剛士, 中川敏, 柏原宏暢 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2015.

---

	The uneasiness, interest matter of the patients in the drug medication counseling for the P1035-22-PM medical care and the change over time 原伸輔1), 榎南祥太2), 吉野新太郎3), 榎本幸子4), 前田一石5), 山本智也1), 勝浦正人1), 門脇裕子1), 三輪芳弘1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2015.

---

	Use experience of the tolvaptan for the intractable fluid retention with the P1036-23-AM advanced cancer 芦崎雅之1), 早坂州生1), 出町拓也1), 北山秀則1), 平田力1), 竹内公美1), 奥田博介2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2015.

---

	Cancerous prominence ache treatment by the P1037-22-PM fentanyl citrate sublingual tablet and the evaluation 増田博也, 福井圭亮, 鈴鹿隆晃 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2015.

---

	About the usefulness of the oxycodone continuous intravenous infusion for the pain due to the oral mucosa disorder after the P1038-23-AM hematopoietic stem cell transplantation 曽我弘道, 長谷悠紀, 町田聖治, 岸川春樹, 平野真健, 福地祐亮, 村井悠紀, 入江利行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2015.

---

	Use experience of the tapentadol in the P1039-22-PM our hospital 後藤健志, 西村美馨子, 伴竜典, 竹尾恵理子, 石川真平 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2015.

---

	The effectiveness of sterilization adjustment talc for the P1040-23-AM malignant pleural effusion and safe examination 表忍1),2),3), 松本剛1), 嶋貫和紗1), 辰巳秀爾2), 山下直己3), 橋元誠1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2015.

---

	Use experience of the tapentadol in the P1041-22-PM our hospital 伊藤洸介1), 吉澤忍1), 山田武志2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2015.

---

	Making of the palliative care "medicine and palliative care" brochure which P1042-23-AM pharmacist receives 中永かおり1), 赤木徹2), 林憲一2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2015.

---

	The effect that precedent introduction of P1043-22-PM tramadol gives for cancerous pain control 三田恭平, 荒木良介, 小島正照, 田中恒明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2015.

---

	Use fact-finding of the peg filgrastim in the hospital attached to P1044-23-AM Nippon Medical School 長谷綾1), 鈴木藍1), 岸田悦子1),2), 輪湖哲也1),2), 片山志郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2015.

---

	1 case that relieved pain by the preprandial administration of P1045-22-PM fentanyl buccal tablet at body movement 関裕佳里1), 杉山哲大1), 青木純子2), 徳田佳之3), 野中泰幸5), 川上恭弘4), 近藤祥代1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2015.

---

	Examination and problem of the effect of opioid rounds in the P1046-23-AM our hospital 遠藤征裕1), 山田郁恵1), 鈴木聡子2), 山崎豊3), 森川和夫1), 橋本正治4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2015.

---

	Use fact-finding of the P1047-22-PM fentanyl sublingual tablet 奥田隆史, 高木雄一, 米澤摩衣子, 松本富夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2015.

---

	It is ... through at-home visit instruction by efforts - hospital pharmacist aiming at support without the break to patients with cancer by the P1048-23-AM pharmacist 片山広美, 榊原ゆかり, 鈴木めぐみ, 永田実, 板倉由縁 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2015.

---

	Efforts to stocktaking and entrenchment of the drug knowledge in the P1049-22-PM drug department 川畑大輔, 和下田真美, 井上味波, 矢敷祐子, 川村めぐみ, 小川智孝, 岩城晶文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2015.

---

	Investigation of the expression situation of retching in all aprepitant patients introduction of the P1050-23-AM bladder cancer preoperation GC therapy and the preoperative nutritional status 堀尾秀明, 寺澤麻実, 松田麻奈, 水谷貴樹, 宮川佐和子, 林浩之, 宇都宮純平, 戸田康裕, 神間康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2015.

---

	Side effect of bevacizumab combination expression situation investigation in the P1051-22-PM ovarian cancer Carboplatin + paclitaxel therapy 細田美穂, 長尾愛, 鎌田瑞菜, 中山順子, 仲川三春, 安部浩美, 橋本幸子, 宮川真澄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2015.

---

	Hepatitis B reactivation measures and the reactivation development situation in the P1052-23-AM our hospital 祖父江彰, 山本桂子, 森仁美, 堀内保孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2015.

---

	The effectiveness of the THP-COP therapy for the P1053-22-PM diffuse-related large B-cell lymphoma and safe examination 渡瀬美登里1),2),3), 篠原義剛2), 高橋浩二郎1), 東丈裕3), 塚田順一3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2015.

---

	Investigation of the nutritional status change with the P1054-23-AM head and neck radiation combination chemotherapy 川俣洋生, 大園ゆかり, 山口泰弘, 山元光平, 林淳一郎, 平山俊一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2015.

---

	About an edematous expression case in our hospital under the maintenance therapy by the pemetrexed after the P1055-22-PM platinum combination 石崎文子, 相原敏彦, 岩本留奈, 増尾昌則 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2015.

---

	About a relationship with a dose and the efficacy of the P1056-23-AM rasburicase 山瀬大雄1), 平井三保子1), 岩本義弘1), 松本早織1), 能木沙織1), 平田藍1), 籠本基成1), 土井孝尚1), 今田和典2), 小林政彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2015.

---

	A neutropenic onset risk by the difference in medication method of the P1057-22-PM taxane system antineoplastic drug: Examination using the technique of Meta-analysis 本西哲, 大植謙一, 廣田育彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2015.

---

	Examination about the expression situation and measures of the vascular pain by the saline route flash after the P1058-23-AM Carboplatin administration 永瀬怜司1), 深澤拓也1), 上原望1), 藤森律子2), 相澤雄介3), 曽根原亘3), 菅野浩1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2015.

---

	Side effect investigation in the P1059-22-PM clofarabine etoposide cyclophosphamide combination therapy 赤松規子, 永井浩章, 蝉川由美, 小林知世, 中山淳司, 籾井佳奈, 愛甲佳未, 坂本有里恵, 三輪祐太朗, 北村晃子, 藤永仁美, 上田里恵, 福井由美子, 加古学 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2015.

---

	Investigation of the enforcement situation and the side effect expression situation of the treatment with P1060-23-AM ibritumomab tiuxetan 吉川博, 櫻下弘志, 泉谷悟, 佐伯康之, 垰越崇範, 畝井浩子, 松尾裕彰 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2015.

---

	Examination of the usefulness of the sustained G-CSF preparation in the P1061-22-PM MAID strange law therapy 赤瀬麻希1), 鈴木礼乃1), 綿田陽子1), 白石範子1), 五嶋孝博2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2015.

---

	Evaluation about the enforcement situation of the P1062-23-AM colon cancer adjuvant postoperative treatment 岩井美奈1), 木村美智男1), 伊藤大輔1), 浅野裕紀1), 安達志乃1), 岡田和智1), 宇佐美英績1), 吉村知哲1), 寺町ひとみ2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2015.

---

	The effect that P1063-22-PM renal function gives to adverse event occurrence of the pemetrexed 村井淑恵1),2),3), 安藤洋介2), 氏田萌子1), 太田秀基2), 林高弘2), 山田成樹2), 河田健司3), 池田義明1), 安田公夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2015.

---

	Examination of safety and the effect in the weight loss administration of the hippopotamus diTaki cell in patients with P1064-23-AM prostate cancer 羽田勝彦, 冨田敦和, 野村賢一, 野田直樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2015.

---

	About the fact-finding of the cancellation reason of the foreign chemotherapy in the P1065-22-PM our hospital 浜元孝1), 上島聖秀1), 細江律子1), 高橋慎太郎1), 森谷道生1), 能澤真希子1), 田中みずほ1), 宮島玲子2), 河井良智1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2015.

---

	An example of recurrent urothelium cancer which examined Carboplatin medication method under the haemodialysis based on a P1066-23-AM actual survey AUC level 近藤勝弘1), 山本優子2), 田代雄祐1), 杉山洋介1), 内木拓3), 小松弘和4), 木村和哲1),5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2015.

---

	Nephropathic investigation with the chronic administration of the GC therapy for the P1067-22-PM biliary cancer 大本奈緒子1), 辻直子1), 石本昌裕1), 西村知恭2), 岩城久弥2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2015.

---

	Examination of the validity of the second prophylactic administration of pegfilgrastim in P1068-23-AM FEC follow by DTX 米澤美和, 久保杏奈, 山田千代子, 柏原宏暢 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2015.

---

	P1069-22-PM Survey on the use of Enzartamide, Avirateron for castration-resistant prostate cancer in our hospital 鈴木薫1),2), 松田美樹子2), 小野裕紀1), 小林由佳1), 遠藤尚美1), 押切翼1), 武田彰1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2015.

---

	Investigation of the renal failure development situation in our hospital at the P1070-23-AM cisplatin administration 渡部早苗, 松岡葉子, 玉井宏一, 烏谷政和, 久保さつき, 倉田知久, 藤原光代 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2015.

---

	1 case that was treated effectively with tolvaptan for SIADH in the P1071-22-PM small-cell lung cancer 宮武望1), 小野原未由来2), 岸和2), 向井淳治2), 長谷川喜一3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2015.

---

	Analysis of the factor contributing to the sleeplessness that occurred in the patients during the P1072-23-AM cancer chemotherapy enforcement 岡村和彦, 池本雅章, 佐々木啓雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2015.

---

	Adverse event frequencies at bevacizumab addition to the temozolomide + radiotherapy in patients with P1073-22-PM malignant glioma 藤井良平1), 田中雅幸1),2), 今井雄介1), 西山徳人1),2), 打谷和記1), 廣田育彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2015.

---

	Diachronic quality of life change with the foreign cancer chemotherapy in patients with P1074-23-AM breast cancer 田中和秀1), 堀晃代1), 大澤友裕1), 安田昌宏1), 水井貴詞1), 中田琢巳2), 後藤千寿1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2015.

---

	One case of the patients who received Bevacizumab combination capecitabine therapy for a colon cancer multiple metastases case with whole P1075-22-PM haemodialysis enforcement 本間信次, 大植謙一, 廣田育彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2015.

---

	Examination of the dose regulation factor of the P1076-23-AM Afatinib 魚井みゆき1), 瀬戸貴司2), 三角紳博1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2015.

---

	Application to a malignant meningioma of the rays dynamics therapy using the P1077-22-PM talaporfin 三木雄一1), 前田潤1), 市川恵2), 秋元治朗2), 藤原泰之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2015.

---

	Examination about bortezomib treatment continuity and the relief therapy in patients with P1078-23-AM multiple myeloma 福岡智宏1), 宇佐美英績2), 岡田和智2), 木村美智男2), 吉村知哲2), 土本大輔1), 宇都宮純平1), 神間康1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2015.

---

	The cisplatin-resistant conquest that assumed P1079-22-PM amino acid transporter a target 中山優子1), 深澤郁也1), 木下淳2), 峯垣哲也3), 山本和宏4), 高良恒史1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2015.

---

	The present conditions of the treatment with chemotherapeutic drug of elderly patients in the P1080-23-AM our hospital 土谷有美, 小阪圭治, 井岡真佐夫, 板倉祥嗣, 津田正博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2015.

---

	Examination about the onset of mucositis risk in the P1081-22-PM head and neck cancer chemoradiotherapy 永谷明子1),2), 田口由美子1),2), 須永登美子1),2), 藤居直和3), 岡部尚行5), 橋本東児4), 向後麻里1),2), 佐々木忠徳1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2015.

---

	Cost effectiveness analysis ... in drug economic examination - sunitinib of the molecular target medicine in P1082-23-AM progress nephrocyte cancer vs. interferon alpha 戸村和希1),2), 内藤由貴1),2), 須永登美子1),2), 栗原竜也3), 佐々木春明4), 向後麻里1),2), 佐々木忠徳1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2015.

---

	Effect of bisphosphonate drugs giving it to an increase of the human cancer of the esophagus cell line under the P1083-22-PM hypoxia environment 道家雄太郎, 峯垣哲也, 戀木沙耶, 山根千尋, 鈴木藍, 森美里, 辻本雅之, 西口工司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2015.

---

	The examination that P1084-23-AM nab- paclitaxel (for the oil xanthan gum (R) infusion) has an influence on the serum albumin level 長山晃, 森下和美, 近藤昌子, 川上典子, 高田正弘, 野毛一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2015.

---

	Examination about the preparation method of the P1085-22-PM albumin suspension type paclitaxel 鶴久阿矢佳1), 西田恵美1), 守田研一1), 柿本秀樹1), 真島宏太1), 川田哲史1), 萩原知佳1), 鷲山厚司1), 今給黎修1),2), 二神幸次郎1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2015.

---

	One case that a β-D-glucan level became the high level for P1086-23-AM Candida glabrata fungal infection, and treatment suffered from because of severe impaired renal function and allergy to micafungin 出町拓也1), 芦崎雅之1), 坪内孝敏1), 北山秀則1), 平田力1), 早坂州生1), 竹内公美1), 澄川宗祐2), 佐々木邦明2), 久須美貴哉2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2015.

---

	Relation for the vancomycin chronic administration case in the P1087-22-PM our hospital 福井圭亮, 増田博也, 片山貴久美, 北野恵莉子, 奥澤文敏, 山下紗希, 鈴鹿隆晃 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2015.

---

	We look at the rear for the acute prostatitis that occurred after P1088-23-AM transrectal prostate biopsy and examine a mark 中村翔吾, 基村佳代, 三浦裕介, 瀬戸崇光, 寺沢匡史, 内山ひとみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2015.

---

	The effectiveness of ampicillin for the P1089-22-PM children respiratory organs infection 冨山育朗1), 工藤晋1), 丹代恭太1), 田中健太郎2), 蒲澤一行1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2015.

---

	Efforts and effect of pharmacy leadership type Antimicrobial Stewardship using P1090-23-AM CDTM 伊藤広樹1), 今関孝子1), 平出耕石1), 石原哲2), 加藤武司1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2015.

---

	1 case that was associated with pyogenic arthritis due to P1091-22-PM intractable Pseudomonas aeruginosa 仲井修一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2015.

---

	Investigation of antimicrobial consumption and chemosensitivity, the resistant bacteria change with the P1092-23-AM sulbactam / ampicillin high dose 中本晶大1),2), 星野路弘1), 菊本直樹2),3), 木村町子2),4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2015.

---

	Comparison of the antibiotic exposure in the febrile neutropenia of patients with P1093-22-PM solid carcinoma 坂本拓也1), 奥田和貴1), 土佐直子1), 松田俊之2), 福澤祐幸1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-448, 2015.

---

	The detection situation of consumption of the carbapenem-based antimicrobial in the P1094-23-AM Iizuka Hospital and carbapenem-resistant Pseudomonas aeruginosa and substrate expansion type beta lactamase-producing bacteria 梅田勇一1), 内田守次1), 金澤康範1), 吉野麻衣2), 中村権一2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-448, 2015.

---

	The use of antimicrobial situation according to the disease severity for P1095-22-PM acute cholangitis, the cholecystitis 藤本真美加1), 高橋文香1), 児玉暁人1), 岩田智津子1), 山崎恭平1), 木下佐昌子1), 森信介1), 小竹武2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-448, 2015.

---

	Examination of thrombocytopenia in the P1096-23-AM antiMRSA medicine linezolid 浅野愛1), 松尾和廣1), 花井雄貴1),2), 日下部太一3), 木村伊都紀2), 平山忍2), 東綾香2), 小川美希4), 佐々木英久1), 渡辺朋子5), 篠原悦子5), 小杉隆祥2), 西澤健司2), 加藤恵介3), 吉尾隆1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-448, 2015.

---

	Did you result in a change for treatment of the aspiration pneumonia by adopting P1097-22-PM high dose SBT/ABPC? 山崎恭平1), 児玉暁人1), 今井兼貴1), 瓦侑馬1), 藤本真美加1), 水庫彩1), 森信介1), 小竹武2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-448, 2015.

---

	The present conditions and evaluation of the treatment for ESBL-producing bacteria in the P1098-23-AM our hospital 竹内祐介1),2), 覚前盟1), 川崎奈美江1), 小泉祐一1), 野村真美1), 改田幸子2), 河村美里2), 畑中重克2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-448, 2015.

---

	Examination about the use situation of a risk factor and the antifungal agent of the P1099-22-PM candidemia 滝波昇悟1), 矢島尚子2), 織田慶子3), 監物英男1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 449-449, 2015.

---

	The use situation of the metronidazole IV preparation in the P1100-23-AM our hospital 實松絵美子, 日高博司, 浅原稔生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 449-449, 2015.

---

	One case of the MRSA bacteremia that got tolerance in daptomycin during P1101-22-PM daptomycin administration 草島宏平1), 大井直子1), 若松由紀子2), 安在冬虹3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 449-449, 2015.

---

	Efforts to appropriate drug choice in the P1102-23-AM bacteremia 石田篤世1),3), 河野えみ子2), 中村奈緒美1), 三箇山宏樹1), 藤井由美子3), 中矢秀雄3),4), 富田浩1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 449-449, 2015.

---

	Relations of Pseudomonas aeruginosa in the P1103-22-PM Sapporo public welfare hospital-sensitive rate and use of antimicrobial density (AUD) 谷口知明, 高橋英里, 能登数馬, 樋浦一哉, 桂川みき, 小林龍, 小原秀治, 渡辺浩明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 449-449, 2015.

---

	Efforts of the antimicrobial proper use promotion by the format change of the report of use of P1104-23-AM antimicrobial 青田真理子, 坂野昌志, 寺井文廣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 449-449, 2015.

---

	The ICT in P1105-22-PM carbapenem-resistant Enterobacteriacae bacteria measures and efforts of the pharmacy 花房伸幸1), 小池彩子1), 廣田あゆ子1), 小原香那1), 小川一恵2), 奥格3), 森英樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2015.

---

	Examination of ICT duties for P1106-23-AM Antimicrobial Stewardship 相曽啓史1),2), 森美奈子1), 佐瀬裕子3), 永田将司1), 貫井陽子2), 高橋弘充1), 安原眞人4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2015.

---

	Examination of the factor having an influence on the clinical response of the amikacin sulfate once a day administration method in P1107-22-PM elderly people 松木祥彦1), 矢嶋美樹1), 細山田真2), 渡部多真紀3), 渡辺茂和3), 土屋雅勇3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2015.

---

	The present conditions of the septicemic treatment in the cottage-hospital out of P1108-23-AM 坂野昌志, 青田真理子, 佐野元基, 寺井文廣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2015.

---

	Efforts of the antimicrobial proper use promotion in the P1109-22-PM mental hospital 小黒夏子, 清水俊洋, 川邉東子, 中村陽子, 櫻山智子, 灘谷聡昭, 井戸澤弘美, 湯村守, 寺口勝久, 石井正巳, 伊藤信, 川瀬公一, 與田美穂子, 中野佐紀子, 西宮美保, 山村康比古 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2015.

---

	P1110-23-AM Experience of using Delamanid against multidrug-resistant tuberculosis bacteria at our hospital 右川浩, 阿部和史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2015.

---

	We look at the rear about the effectiveness of SBT/ABPC and CTRX for the P1111-22-PM aspiration pneumonia and examine a mark 寺原史貴1), 横川祐美1), 田村広志1), 木佐健悟2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2015.

---

	The present conditions of the treatment for the drug-resistant tubercle bacillus patients of the P1112-23-AM our hospital 三森竜司1), 永江朋子1), 小川佳亮2), 中川幹也1), 高橋恭久1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2015.

---

	Comparison of the effectiveness by the antimycotic spectrum in the treatment with empirical antifungal agent for patients with P1113-22-PM febrile neutropenia 入口慎史1), 今井徹2), 折井孝男1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2015.

---

	Examination of the critical path in P1114-23-AM transurethral bladder tumor resection and the transurethral prostatectomy 福石和久, 尾之江剛樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2015.

---

	Efforts and result of the pharmacist to P1115-22-PM Antimicrobial Stewardship (AMS) promotion 菅野雄太1),2), 中谷紀之1),2), 塚本英範1), 小林俊之1), 三宮乙恵1), 土師美和1), 川口泰1), 米澤和彦1), 森本淳2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2015.

---

	Early intervention and clinical response to vancomycin administration suggestion by the P1116-23-AM pharmacist 瓜智都1), 菅野雄太1),2), 森本淳1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2015.

---

	The round enforcement situation to blood culture-positive patients in the P1117-22-PM our hospital and the evaluation 天野哲史1),2), 生田幸江1),3), 山崎均1),4), 佐藤篤郎2), 稲塚信郎1),5), 杉浦誠治1),5), 板倉由縁2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2015.

---

	The effect that P1118-23-AM ASP results in to the incidence of fungemia 杉生雅和1), 新康憲1), 石津智司1), 若松雄太1), 小林敦子2), 辻隆志1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2015.

---

	The methicillin resistance is not a risk factor of the poor prognosis in P1119-22-PM Staphylococcus aureus bacteremia 新谷智則1), 塚本仁1),2), 東高士1), 飛田征男2), 室井洋子2), 西村一美2), 池ヶ谷諭史2), 中村敏明1), 岩崎博道2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2015.

---

	About association of number of P1120-23-AM methicillin-resistant staphylococcus aureus bacteria carriers and antimicrobial consumption and An antibiotic homogeneity index (AHI) 吉岡祐貴1),6), 小林義和1),6), 山田昌矢2),6), 浅井雅彦3),6), 織田元4),6), 生田宏次5),6), 浅野昌彦5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2015.

---

	Relative examination with multidrug resistance and the antimicrobial consumption of P1121-22-PM Pseudomonas aeruginosa 佐藤和人1),2), 猪瀬祐亮1), 稲田寛之1), 小川和奈1), 中根智美2), 関利一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2015.

---

	It is 1 case in consultation with the many types of job about P1122-23-AM antibiotic exposure 平田貴宏, 池田久雄, 吉岡亮, 野村浩英 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2015.

---

	Efforts and problem of our hospital for the promotion of P1123-22-PM Antimicrobial Stewardship 潮平英郎1),2), 仲松正司2), 鍋谷大二郎2),3), 健山正男2),3), 外間惟夫1), 植田真一郎4), 藤田次郎2),3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 453-453, 2015.

---

	Antimicrobial of P1124-23-AM in-hospital ESBL-producing E.coli-sensitive rate investigation 久田瑛吉, 野澤正徳, 畔柳敏弥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 453-453, 2015.

---

	Intervention effect of the ICT on P1125-22-PM antimicrobial long-term use 香川真徳1),2),3),4),5),6),7), 三浦隆2), 香川浩一3), 添田徹4), 徳永裕一5), 稲田志信6), 黒瀬孝二7), 梶原直美1), 永野俊玲1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 453-453, 2015.

---

	An antimicrobial of P1126-23-AM gram-negative bacilli-sensitive change and effect of resistant bacteria 小関崇文, 松木祥彦, 大貫敏明, 安田麻美, 松木浩子, 高橋優香, 杉浦健一, 畦元智子, 中村友美, 藤岡敬子, 小林健太郎, 西關由梨子, 芦澤由佳, 浦邉恵里, 笠井洋輝, 安西美咲, 加藤由紀, 小杉英恵 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 453-453, 2015.

---

	Examination of the ESBL-producing Escherichia coli risk factor with the strain derived from urine samples in the P1127-22-PM our hospital 末永拓也1), 岩尾恭寛1), 工藤真裕1), 植山寛2), 高橋康一3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 453-453, 2015.

---

	Examination of the background factor in P1128-23-AM Clostridium difficile-related loose bowels 飯尾志帆1),2), 八木浩志2), 亀山礼子2), 船屋諭史2), 竹原朗2), 川根隆志2), 蛭谷一彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 453-453, 2015.

---

	We look at promotion of the P1129-22-PM antimicrobial proper use and the rear about the association with the number of the detection of metalloβ-lactamase production bacteria and examine a mark 中蔵伊知郎1),2), 坂倉広大1),2), 廣田和之2), 上平朝子2), 多和昭雄2), 土井敏行1), 上野裕之1), 山崎邦夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 454-454, 2015.

---

	Development of the P1130-23-AM epidemicity virus disease antibody titers management software and examination of the titration method 尾形和哉1), 橋本隆信1),2), 竹内亜紀2), 岸由希枝2), 西谷由里子2), 中園雅彦2), 山本高也3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 454-454, 2015.

---

	Comparison of the use of antimicrobial situation by prescription restrictions of the P1131-22-PM identification antimicrobial and the report book prior presentation imposition 根岸大輔1),2), 木村英晃1),2), 川尻尚子1), 寺嶋毅2),3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 454-454, 2015.

---

	It is the fact of measures after HIV exposure in the antiHIV medicine and occupation in the hospital in P1132-23-AM Toyama 成田綾香1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 454-454, 2015.

---

	The introduction of comprehensive hospital infection measures mainly on the proper use of the waterless hand disinfectants by the P1133-22-PM pharmacist and the effect 森直樹1), 吉森友紀1), 有水かなみ1), 門脇大介2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 454-454, 2015.

---

	Present conditions report of the prophylaxis of the antiinfluenza medicine of our hospital in the P1134-23-AM H26/27 season 後藤恵利佳, 野澤正徳, 三浦毅, 畔柳敏弥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 454-454, 2015.

---

	Examination of the risk factor to affect the development situation and the occurrence of aspiration pneumonia in the P1135-22-PM D2 receptor blockade remedy patients 佐々木雄啓1), 横田智美1), 伊藤瑠美1), 岡村和彦1), 池本雅章1), 上田充展2), 川島英史2), 中村寛2), 佐和章弘2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-455, 2015.

---

Making of "use of disinfectant guidelines 2015" by the P1136-23-AM J infection control network supervision 中居肇1), 荒川裕明2), 岡村祐嗣3), 金子俊幸4), 工藤香澄5), 工藤晋6), 後藤敏晴7), 齋藤梢8), 齊藤伸7), 杉山昌宏9), 平浩幸10), 丹代恭太6), 田村健悦11), 千葉博暁12), 十日市文子13), 西村孝一郎14), 花房喜子2), 本間絵里15), 由良温宣16), 平賀元17), 白石正18), 賀来満夫19) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-455, 2015.

---

	Proper use promotion of the antimicrobial led by the P1137-22-PM ward pharmacist 北村好申1),2), 篠崎陽一2), 河野真二1), 中澤靖1), 北村正樹2), 川久保孝2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-455, 2015.

---

	Usefulness of the modi operandi called the pharmacist subcommittee in the preventive measures against P1138-23-AM infection hospital cooperation combination conference 池田久雄1), 平田貴宏1), 須摩恵子2), 大隅奈奈3), 矢倉裕里3), 丸山潔4), 乾有希子1), 吉岡亮1), 千原亜紀子1), 野村浩英1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-455, 2015.

---

	Measures of the HBV reactivation in the P1139-22-PM Saiseikai Yamaguchi General Hospital and the evaluation 後藤志典, 林幹也, 山崎博子, 赤崎淳子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-455, 2015.

---

	Examination about the CR-BSI infection in the P1140-23-AM Hokuriku center Hospital 守内匡, 浅野聡美, 田中治, 松井ひろみ, 松田芳美, 西恵子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-455, 2015.

---

	Activity report (the first report) of the ICT position pharmacist in the P1141-22-PM our hospital 塚本貴庸子, 岩本凌, 荒井未来, 岩田沙紀, 薄田昌彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 456-456, 2015.

---

	About calculation of examination of the index in the P1142-23-AM antimicrobial consumption evaluation and Days of Therapy (DOT) 亀田敬子1), 高橋えりか1), 木本信介1), 山田周平1), 西田直史1),2), 初田輝1), 重高正行2), 下津武津美2), 山下敦志1), 赤坂聡一郎2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 456-456, 2015.

---

	Standard precaution improvement - Pharmaceutical Affairs Bureau hand hygiene compliance target 100% of pharmacists ... by the P1143-22-PM Pharmaceutical Affairs Bureau ICT team 鈴木大地, 齋藤祥子, 樫村拓也, 松崎宣裕, 田口綾, 宮下潤子, 鈴木貴弘, 赤津義文, 野原美代子, 大森友子, 小宅泰郎, 名和健, 渡辺泰徳, 青山芳文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 456-456, 2015.

---

	About fever 2-day after an operation in the P1144-23-AM SSI surveillance 違口晴子1), 前岡良輔2), 木村ひとみ3), 佐野唯4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 456-456, 2015.

---

	About a simultaneous facility suspension method application of a liquid for P1145-22-PM lopinavir ritonavir combination or combination lock and the abacavir sulfate, Lamivudine combination tablet 坪田有加1), 松尾理世1), 寺岡麗子1), 矢倉裕輝2), 湯谷玲子1), 北河修治1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 456-456, 2015.

---

	The present conditions of the ART start time of the P1146-23-AM outpatient and the intervention time of the pharmacist 下川千賀子1), 安田明子1), 辻典子2), 柏原宏暢1), 中谷安宏3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 456-456, 2015.

---

	The lipid control situation including apolipoprotein of patients with P1147-22-PM HIV infection 日笠真一1), 秀田恭子1), 安田恵2), 日笠聡3), 澤田暁宏3), 徳川多津子3), 柳井美奈1), 木村健1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-457, 2015.

---

	Case study about the medical treatment considered in P1148-23-AM HIV case conference 中山梢, 小林庸子, 若林進, 西圭史, 篠原高雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-457, 2015.

---

	Liver function level change investigation at the P1149-22-PM lipid microsphere administration 川道直子, 花沢直子, 荒井美織, 日高博司, 浅原稔生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-457, 2015.

---

	One case that vitamin K included in the lipid microsphere was thought to affect for anticoagulant action of the P1150-23-AM warfarin 日浦亜実, 石橋真実, 横田幸子, 大森麻江, 森英樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-457, 2015.

---

	The nourishment evaluation of elderly patients in the P1151-22-PM community pharmacy: For a liaison pharmacist 相宮幸典, 植田恵子, 指宿城, 糸川知沙, 中島広貴, 滝岡由美, 奥田まなみ, 榎本友紀, 大西姿子, 松田隆太郎, 横井貴明, 山田侑奈, 杉浦伸哉 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-457, 2015.

---

	Efforts for simple suspension method introduction promotion in the P1152-23-AM Kanazawa Medical University Hospital 中田いちこ1),2),3),4), 宮東利恵1), 鷹見沙八佳1), 平木祥子1), 相川正則1), 今川静代1), 高桑直子1), 桶谷純子1), 西川美香子1), 小池田玲子1), 高橋喜統1), 丹羽修1), 中村光宏2), 毎田千恵子3), 宮本悦子4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-457, 2015.

---

	Examination about the use situation in the clinical practice of the amino acid for the P1153-22-PM renal failure 倉地果純, 島本玲奈, 鈴木薫, 西原雅美, 勝間田敬弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 458-458, 2015.

---

	The ferritin measurement during P1154-23-AM trace element-containing central venous hyperalimentation therapy and fact-finding of the iron excess 今川貴仁, 小園幸輝, 小杉隆祥, 西澤健司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 458-458, 2015.

---

	Use fact-finding of the lipid microsphere in the intravenous alimentation for the nutrition therapy that P1155-22-PM is appropriate 植平紗矢香1), 竹野淳2), 柳智恵子3), 吉野加那枝3), 渡邊佳世子1), 澤田奈津子1), 小山拓弥1), 船越幸代1), 池上英文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 458-458, 2015.

---

	P1156-23-AM Studies on defecation control by ingestion of fruit oligosaccharide 小島俊彦1),2), 大巻良子3), 海老名勇2), 後藤敬仁4), 遠藤雅史4), 松村美栄4), 金子俊幸1), 安部晶子1), 齋藤秀樹3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 458-458, 2015.

---

	P1157-22-PM Survey on side effects and usage of ENEVO after use 恩田愛子, 高梨愛, 稲田佑亮, 吉沢純, 加瀬和也, 内田佳菜子, 松田俊之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 458-458, 2015.

---

	Examination about the combined effect of the enterokinesis accelerating agent (mosapride citrate) giving it to P1158-23-AM half solidification fluid food 相澤優子1), 赤沼かおり1), 井上尚彦1), 阿部康代2), 廣井明夫1), 寺山昌宏1), 高橋邦雄1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 458-458, 2015.

---

	Making of Nutritional Chemotherapy Assessment Sheet for the nourishment evaluation elimination of the P1159-22-PM cancer chemotherapy 相良克海1), 吉川聡美1), 関口知紗2), 柴田愛3), 小田慎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2015.

---

	Relations of modified Glasgow Prognostic Score (mGPS) and a survival period, the adverse event in patients who received P1160-23-AM stomach cancer chemotherapy 森千夏1), 小暮友毅1), 二五田基文1), 岡崎ちか2), 彦坂亜美3), 高松寿4), 浅野由紀江4), 羽藤慎二5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2015.

---

	Examination of the preoperative nutrition evaluation using the CONUT method for the P1161-22-PM perioperative hypothermia 奥村佳史, 木村麻奈加, 加戸義大, 森田孝子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2015.

---

	Fact-finding of clostridium difficile-related loose bowels in the P1162-23-AM Fukuoka University Hospital 上田裕1),2), 高木聡子1),2), 岡崎美和1),2), 大倉野将広1),2), 青柳邦彦2),3), 二神幸次郎1),4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2015.

---

	It is undergone a change of the hospitalization after the days and intervention until the intervention of the patients targeted for NST in P1163-22-PM elderly people 佐野元基, 寺井文廣, 坂野昌志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2015.

---

	Many types of job cooperation ... which changes a fault of the activity - single department Hospital in NST team in the P1164-23-AM psychiatry single department hospital into a plus 小林真美1), 小林重太2), 平山麻実子3), 馬場真佐美3), 木戸敏文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2015.

---

	One case that overall status and a pressure sore improved by P1165-22-PM NST intervention 大西秀美1),2), 乾有希子1), 池田久雄1), 居平典久2), 出口暁子2), 田中敬子2), 大野典子2), 片岡宏一郎2), 野村浩英1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-460, 2015.

---

	Effect on diarrhea risk of the flavor for the P1166-23-AM ingredient nutrient preparation (the second report) 武井佐和子, 影山美穂, 戸張裕子, 別生伸太郎, 濱田真向, 大山勝宏, 勝山壮, 井上みち子, 倉本敬二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-460, 2015.

---

	One bowel control by the P1167-22-PM glutamine addition 大津貴寛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-460, 2015.

---

	P1168-23-AM Evaluation of renewed Aminoleban EN blended proprietary flavor 矢嶋隆宏1), 佐藤友香2), 池田知子2), 三田地泉美2), 武内泰司郎2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-460, 2015.

---

	High-speed simple suspension, development of the disposable infusion bag for the P1169-22-PM transluminal administration 北村滋郎, 兼次眞貴子, 野崎雅男, 盛本修司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-460, 2015.

---

	Examination of the secondary carnitine deficiency by an antiepileptic drug and the nutritional status of the P1170-23-AM seriously disabled child (person) 加藤貴之1), 山本秀紀1), 佐々木みずえ1), 仙波靖士1), 山本宏1), 伊藤道徳2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-460, 2015.

---

	The effectiveness of the jellification of the P1171-22-PM ingredient nutrient preparation 辻由梨子1), 高良美紀1), 志垣奏子2), 野明俊裕3), 荒木靖三3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2015.

---

	Analysis of the doubt inquiry example in the P1172-23-AM General Hospital psychiatry 福山雄卯介1), 大波多友規2), 西野隆1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2015.

---

	Prescription situation investigation of the P1173-22-PM Clozapine (clozapine (R)) 濱田武, 畑武生, 鈴木薫, 西原雅美, 勝間田敬弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2015.

---

	Efforts about the prescription order representation in the P1174-23-AM psychopathic ward and the evaluation 進健司, 梅田勇一, 大谷達郎, 牛島悠一, 橋本政弘, 川波宏隆, 草野充裕, 内田守次, 金澤康範 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2015.

---

	Prescription suggestion enforcement situation investigation of the pharmacist in the P1175-22-PM psychopathic ward protection room case conference 大谷達郎, 進健司, 牛島悠一, 金澤康範 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2015.

---

	Efforts to the blood lithium carbonate levels measurement in the P1176-23-AM outpatient department: Introduction of the lithium measurement card 島田治子1), 角本亮二1), 辻慶子2), 岩野輝次2), 浦瀬千恵2), 森芳乃3), 西脇健三郎4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2015.

---

	It is efforts toward becoming it the single agent of antipsychotics in the P1177-22-PM Dazaifu Hospital 宮本奈緒美, 中川伴子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 462-462, 2015.

---

	Effect of the medical service fees revision on psychotropic drug polypharmacy of the P1178-23-AM Shimane Prefectural center Hospital 勝部直美, 安食健一, 原直之, 寺西正充, 平野榮作, 横手克樹, 竹下和男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 462-462, 2015.

---

	One patient who raised hypoglycemia with the bringing medicine for patients with mental disorder with P1179-22-PM body complications 小林泰子1), 大塚桂子1), 鈴木利人2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 462-462, 2015.

---

	Analysis of the risk factor of the weight gain that antipsychotics by the data mining using P1180-23-AM JADER were associated with 畑武生, 濱田武, 鈴木薫, 西原雅美, 勝間田敬弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 462-462, 2015.

---

	Examination of the factor of the hyperammonemia in the P1181-22-PM valproic acid remedy patients 今岡広輔, 岩元陽香, 大仁田哲修, 曽田重人, 中元隆浩, 難波優里, 春木ちひろ, 村上正樹, 玉木宏樹, 西村信弘, 直良浩司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 462-462, 2015.

---

	Examination of the fall risk of antipsychotics and the benzodiazepine system medicine in the P1182-23-AM psychiatry chronic phase ward 和田智仁1),4), 伊藤由香1), 羽佐田祥浩1), 南出孝雄3), 中村友喜4), 伊藤直美1), 三輪高市4), 藤田康平2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 462-462, 2015.

---

	Examination about the effect on infection in the use of P1183-22-PM antipsychotics 新保一, 勝俣寛成, 山田昌彦, 山口正和 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 463-463, 2015.

---

	Efforts to the lifestyle improvement program by the many types of job in the P1184-23-AM psychiatry daycare 松野憲作, 横山美和子, 尾頭芳郎, 桂昭博, 木村あや, 井上裕子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 463-463, 2015.

---

	Relation of use experience and the pharmacist of the Clozapine in the P1185-22-PM Fukui Prefectural hospital 川崎美雪1), 笠嶋悠1), 下山祐依1), 森富男1), 佐澤佳彦1), 平賀貴志2), 水野智之3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 463-463, 2015.

---

	Attitude survey about the medical treatment in the P1186-23-AM alcohol addict 宮浦淳一1), 畑尾由佳1), 大草英文2), 奥田正英3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 463-463, 2015.

---

	Intervention of the pharmacist for the present conditions investigation of the dose of medicine in the P1187-22-PM chronic phase psychopathic ward and the proper use 玉地亜衣1), 加瀬浩二1), 松田公子1), 儘田孝2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 463-463, 2015.

---

	A remedy continuance rate of the P1188-23-AM acamprosate preparation and going to hospital continuance rate 後藤史子1), 福山雄卯介2), 福嶋翔3), 鈴田浩孝4), 宮崎敦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 463-463, 2015.

---

	The abdominal supersonic wave views, blood test views in the P1189-22-PM alcohol addict and correlation with the drinking period 池澤舞1), 高野美菜1), 北廣優実1), 郷原宏章1), 富田保子1), 山口哲史1), 岡村武彦2), 藤原祥子3), 後山尚久3), 島本史夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 464-464, 2015.

---

	Correlation of long-term alcohol intake and complications in the P1190-23-AM alcohol addict 北廣優実1), 高野美菜1), 池澤舞1), 郷原宏章1), 富田保子1), 山口哲史1), 岡村武彦2), 藤原祥子3), 後山尚久3), 島本史夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 464-464, 2015.

---

	Change of the age distribution to be able to put in the past 26 years of the P1191-22-PM alcohol addict and the upper gastrointestinal tract disease 富田保子1), 高野美菜1), 池澤舞1), 北廣優実1), 郷原宏章1), 山口哲史1), 内藤雅人1), 岡村武彦2), 島本史夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 464-464, 2015.

---

Medicine medicine cooperation questionary survey of P1192-23-AM mental hospital and the pharmacy service under health insurance drugstore 齋木良太1), 石動郁子2),13), 高橋満里3),13), 柳智之4),13), 鶴谷勝実5),13), 山本勇樹6),13), 志田雅彦7),13), 藤野知美2),13), 林千尋8),13), 石塚淑子3),13), 上野太佑9),13), 飯田美桜10),13), 根岸健太11),13), 齊藤浩司12),13) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 464-464, 2015.

---

	Association of a fall, a fall and benzodiazepine drugs according to the time in the P1193-22-PM psychiatry medical treatment ward 赤瀬川豊1), 武田龍一郎2), 井上雅文3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 464-464, 2015.

---

	Subanalysis - about the usefulness of pharmacist, the psychiatry medical therapy authorization pharmacist specialized in questionary survey - psychiatry about the pharmacist duties in the P1194-23-AM mental hospital 永田健一郎1), 齋藤百枝美2), 馬場寛子3), 桑原秀徳4), 野田幸裕5), 高橋結花6), 村野哲雄7) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 464-464, 2015.

---

	Evaluation of the medication adherence using DAI-10 in the P1195-22-PM psychiatry acute phase ward 堀田彰悟1), 千崎康司1), 伊藤教道1), 村松千鶴1), 尾崎紀夫2), 山田清文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 465-465, 2015.

---

	It is investigated the delirium onset after the operation of the benzodiazepine system (BZ system) sleeping drug in the P1196-23-AM artificial joint replacement 松本拓真1), 田頭尚士1), 吉田昭昌1), 大倉裕祐1), 塩田直史2), 木内司1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 465-465, 2015.

---

	The medicine classroom holding of mom and the baby about the use of commercial drug during the P1197-22-PM nursing and examination of the usefulness 古谷未希1), 安間保恵1), 中村光世2), 爪田久美子2), 大木茂3), 村越毅4), 塩川満1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 465-465, 2015.

---

	Efforts aiming at standardization of the medical treatment for the constipation of the P1198-23-AM early or threatened labour patients 木村純子1), 高木祥子1), 立松あき2), 江口美智2), 青山智彦1), 加藤紀子3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 465-465, 2015.

---

	Correspondence of the pharmacist at obstetric critical bleeding in the P1199-22-PM our hospital 板垣有紀1),2), 遠藤清香1), 和田幸治1), 阪西通夫2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 465-465, 2015.

---

	Examination about the drug administration advisability to P1200-23-AM breast-feeding mother 松岡加恵, 能登英子, 久田達也, 辻秀樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 465-465, 2015.

---

	The present conditions of the reporting about the nursing carried out for P1201-22-PM psychotropic drug remedy pregnant woman 八島一史1), 中川直人1), 小原拓2), 千葉和美3), 山本美由紀3), 西郡秀和4), 加藤佳子1), 松浦正樹1), 秋山志津子5), 菊地紗耶6), 小林奈津子6), 久道周彦1), 眞野成康1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 466-466, 2015.

---

	Fact-finding of the prescription for the women whom there is possibility of the pregnant woman nursing mother in the emergency visit in in the P1202-23-AM night 萩歩美, 組橋由記, 鈴江朋子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 466-466, 2015.

---

	Attitude survey about the pregnancy and the medicine for patients with rheumatic disease in the P1203-22-PM our hospital 大城真理奈1),2), 橋本孝夫1), 潮平芳樹2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 466-466, 2015.

---

	Use situation investigation of the Cenozoic era antiepileptic drug in women of the P1204-23-AM childbearing age 西村あや子1), 高村茂生1), 古堅彩子2), 黒川瞳1), 小林正紀2), 笠師久美子1), 山田武宏1), 井関健1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 466-466, 2015.

---

	The actual situation of the reporting for a pregnant woman, the nursing mother by the P1205-22-PM hospital pharmacist and the future prospects 永澤佑佳1), 鈴木敬雄1), 小山田光孝1), 佐藤秀子2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 466-466, 2015.

---

	One case that gave information to use of sentinel lymph node biopsy identification medicine for the P1206-23-AM breast cancer merger pregnancy patients 平原亮 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 466-466, 2015.

---

	Efforts and evaluation to mother's milk child care rate improvement by the P1207-22-PM pharmacist 山下恵, 山岡慶子, 鈴木亜矢子, 橋本真梨, 木村丈司, 西岡達也, 久米学, 槇本博雄, 平井みどり Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 467-467, 2015.

---

A tendency to consultation and present conditions investigation of the use of drug nursing in the P1208-23-AM pregnancy and the medicine information center 三大寺紀子1),2), 中島研1),2), 八鍬奈穂1),2), 石井真理子1), 石川洋一1),2), 渡邉央美1), 伊藤直樹1), 後藤美賀子1),3), 肥沼幸1), 鈴木朋1),3), 和田友香1),3), 三戸麻子1),3), 村島温子1),3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 467-467, 2015.

---

	Fact-finding about the medication counseling to a pregnant woman, a nursing mother in the P1209-22-PM health insurance pharmacy 松井実美, 中島勝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 467-467, 2015.

---

	The need of the reporting to consider from the use situation of medicine, the supplement during the P1210-23-AM nursing and an attitude survey for the use 松下久美, 瀧祐介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 467-467, 2015.

---

	A consultation example in the medical treatment of the P1211-22-PM nursing mother and future problem 櫛屋敷裕子, 鈴木弘文, 蒲澤一行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 467-467, 2015.

---

	Usefulness examination of the 24 hours blood pressure monitoring of patients with P1212-23-AM pregnancy-induced hypertension syndrome 勝本絵美1), 鴻丸晴菜1), 市川絵美子1), 植松和子1), 鈴木恵子2), 宮内彰人3), 安藤一道3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 467-467, 2015.

---

	One case of the pregnant woman using the P1213-22-PM carperitide 奥野真里絵, 賀来文治, 桑間直志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 468-468, 2015.

---

	Examination of problems when we investigate the P1214-23-AM pregnancy and the effect on children of the specific drug in the medicine information center 八鍬奈穂1),2), 中島研1),2), 三大寺紀子1),2), 石井真理子1), 石川洋一1),2), 渡邉央美1), 伊藤直樹1), 後藤美賀子1),3), 肥沼幸1), 鈴木朋1),3), 和田友香1),3), 三戸麻子1),3), 村島温子1),3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 468-468, 2015.

---

	Example that making of the P1215-22-PM insulin technical aid allowed a self-injection 河村紳介1),2),3),4), 飯野和美3), 鈴木智恵子4), 鈴木貴宏2), 後藤良重3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 468-468, 2015.

---

	1 case that we experienced by self-injection maneuver confirmation in the P1216-23-AM diabetes outpatient department 小山貴夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 468-468, 2015.

---

	The effect of the hypoglycemic agent in patients with P1217-22-PM outpatient department diabetes and investigation about the medicine charge 堅石法子, 西尾明香, 菊地佑季, 高井宏幸, 中村雅敏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 468-468, 2015.

---

	Introduction of the prescription representation protocol (joint medical treatment management: PBPM) of the P1218-23-AM insulin-related prescription 小田千枝1), 濱石華乃子1), 中村和行1), 米山英二1), 山下雅代1), 秀野功典2), 石川孝太3), 水谷直広3), 近藤國和3), 勝見章男1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 468-468, 2015.

---

	Adverse event investigation of the hyperglycemia with the leuprorelin acetate which utilized P1219-22-PM PMDA side effect spontaneous report 田中伸明, 沢田俊朗, 鈴木敦詞, 村山まりこ, 服部芳明, 前田剛司, 坂田洋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 469-469, 2015.

---

	Examination - by actual situation - questionary survey of the folk remedy in the clinic specialized in P1220-23-AM diabetes 向井潤一1), 平塚優加1), 金森晃2), 尾鳥勝也1), 厚田幸一郎1),3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 469-469, 2015.

---

	The effectiveness in the changes from P1221-22-PM alogliptin to other DPP-4 inhibitors and safe examination 草野仁美1), 戸倉由美子1), 白石彩乃1), 猪子美保1), 坪井伸治1), 加藤大也2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 469-469, 2015.

---

	Questionary survey and analysis about the satisfaction of the P1222-23-AM insulin device change patients 梶本佑輔, 下田剛志, 笹尾武史, 川澄清孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 469-469, 2015.

---

	An evaluation of the insulin preparation in the P1223-22-PM health insurance pharmacy and patients satisfaction investigation 飯塚敏美, 内籐卓也, 宮北寛也, 吉川昌美, 中野匡介, 小塩真以子, 穂田美由季, 小鷹篤, 三堀賢太郎, 堀口雅巳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 469-469, 2015.

---

	Investigation about lipohypertrophy in the use of P1224-23-AM insulin patients 今井智重子1), 金子由梨2), 浅川隆重1), 宮崎文子1), 織田佳人1), 伊藤三恵1), 金子伸吾3), 鳥巣真幹2), 大森拓朗2), 岡田眞一2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 469-469, 2015.

---

	Effect to give to a blood sugar control improvement effect and the life of the P1225-22-PM SGLT2 inhibitor 中島啓二1), 宇佐美英績1), 安部絵里1), 吉村知哲1), 柴田大河2), 傍島裕司2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 470-470, 2015.

---

	Development of the preparation aiming at improvement of the bioavailability of morin which was a P1226-23-AM shortage solution antioxidation material 寒川瑶子1), 池内由里1), 石原千津子2), 大西啓1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 470-470, 2015.

---

	Development of the emulsion preparation aiming at improvement of the bioavailability of P1227-22-PM morin 村井万莉菜1), 池内由里1), 石原千津子2), 大西啓1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 470-470, 2015.

---

	Examination about frequency and the patients risk factor of the digestive organ symptom of the P1228-23-AM GLP-1 agonist 黒崎友亮, 中川博雄, 内田隆寛, 樋口則英, 中村忠博, 佐々木均, 北原隆志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 470-470, 2015.

---

	Comparison of the DPP-4 inhibitor in patients with P1229-22-PM stroke 高瀬公子1), 花田和大1), 船水梨沙1), 阿部早苗1), 久米田一喜1), 倉内寿孝1), 鳥谷部翔1),2), 藤田尚子2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 470-470, 2015.

---

	P1230-23-AM Frequency of dehydration caused by taking Tofogliflozin and survey of concomitant drugs 松尾多恵, 二見早希, 今市沙有美, 岡紗智子, 井上美穂, 松下比奈子, 石田あい, 久保智士, 藤本智大, 山崎瑞貴, 鶴崎亮, 北森翔子, 青木美沙, 松谷和子, 三嶋仁美, 木村真策 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 470-470, 2015.

---

	Examination about the effectiveness when we used DPP-4 inhibitor together during P1231-22-PM insulin medical treatment newly 原美由紀1), 早川伸樹1),2), 桑原宏貴3), 戸田貴洋3), 林高弘1),3), 福井愛子1), 亀井浩行1), 牧野真樹2), 鈴木敦詞2), 山田成樹3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 471-471, 2015.

---

	The effect that P1232-23-AM DPP-4 inhibitor gives to renal function and examination about the association with the patients attribute 江崎宏樹1), 舘知也1),2), 後藤千寿2), 杉田郁人1), 林勇汰1), 吉田阿希1), 齊藤康介1), 臼井一将1), 加藤未紗1), 野口義紘1), 大野佑城2), 青山智2), 安田昌宏2), 水井貴詞2), 寺町ひとみ1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 471-471, 2015.

---

	Change comparison between HbA1c and LDL - cholesterol that paid its attention to combination and BMI of statin in patients with P1233-22-PM sitagliptin remedy start type 2 diabetes 岩川精吾1), 青木万穂1), 越川奈菜1), 細川美香1), 上田久美子1), 増本憲生1),2), 大槻裕朗2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 471-471, 2015.

---

	The effectiveness of the DPP-4 inhibitor addition therapy for patients with adult type 2 diabetes that blood sugar control is insufficient by P1234-23-AM insulin therapy and safe evaluation 澁木克也, 嶋田修治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 471-471, 2015.

---

	Effective and safe evaluation of the SGLT2 inhibitor for P1235-22-PM type 2 diabetes 久保実季, 嶋田修治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 471-471, 2015.

---

	Examination of the effect on blood lipid in the P1236-23-AM teneligliptin remedy patients 増田晃, 岡田浩司, 白畑政憲, 本間絵里, 浅沼智美, 信田磨堯, 松川幸市 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 471-471, 2015.

---

	P1237-22-PM Clinical efficacy of selective SGLT2 inhibitor a Plug Frozin for Type 2 diabetic patients in our hospital 高森愛子1), 清水一紀2), 森田孝子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 472-472, 2015.

---

	Examination about merger dyslipidemia with the insulin therapy using the P1238-23-AM type 2 diabetes model rat and the small intestinal morphological functional change 高橋唯1), 高野美菜1), 川瀬寛子1), 木村美保子1), 藤田純佳1), 鎌野安紀子1), 堀口まり奈1), 渡邉直美1), 宮崎誠2), 島本史夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 472-472, 2015.

---

	Examination about merger dyslipidemia with the low fat dietary cure using the P1239-22-PM type 2 diabetes model rat and the small intestinal morphological functional change 川瀬寛子1), 高野美菜1), 木村美保子1), 高橋唯1), 藤田純佳1), 鎌野安紀子1), 堀口まり奈1), 渡邉直美1), 宮崎誠2), 島本史夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 472-472, 2015.

---

	The case that we introduced SGLT2 inhibitor into under P1240-23-AM hospitalization 松田千佳1), 志田里志1), 佐藤貴大1), 齋藤尚子1), 坂本昌也2),3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 472-472, 2015.

---

	A factor and tendency of the rehospitalization in patients with P1241-22-PM diabetes 小畑紋菓, 瀬名波宏昌, 中西晶子, 下村一徳, 田井浩子, 冨田由美, 川口進一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 472-472, 2015.

---

	Report about the use situation of the SGLT2 inhibitor in the P1242-23-AM our hospital 濱里真耶, 村上とよみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 472-472, 2015.

---

	About prescription fact-finding at the DPP-4 inhibitor introduction for the P1243-22-PM outpatient and cooperation with the health insurance pharmacy 辻未希子1), 麻生美佐子1), 吉川英里1), 浜手ひとみ1), 蜂谷春雄2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 473-473, 2015.

---

	About the need to confirm an insulin maneuver at P1244-23-AM diabetes dialysis prevention instruction 益成宏1),2),3),4), 實近彩子2), 飯塚晶子2), 田中佳江3), 畑尾克裕4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 473-473, 2015.

---

	About carbon in patients with P1245-22-PM type 2 diabetes hair and a nitrogen stable isotope and trace element analysis 藤野陵二1), 堀田洋平2), 木村治3), 佐藤英二1), 遠藤哲也3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 473-473, 2015.

---

	Use experience in our hospital of the P1246-23-AM SGLT-2 inhibitor 稲田庸平1), 澤田和紀1), 星野史朗1), 並木愛1), 後喜多綾香1), 横田洋子1), 石田恵子1), 荻野啓子2), 出倉良美2), 最上康生3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 473-473, 2015.

---

	All inpatient diabetes practice management (hospitalwide diabetes management, HDM) by P1247-22-PM CDE-J 伊藤隆哉1),2),3),4),5),6), 小山貴夫1), 高見由理1), 中野和佳1), 矢野目英樹2), 石津美紀3), 武井哲也4), 田内克典5), 山内恵史6), 相澤徹6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 473-473, 2015.

---

	-related examination of the serious side effect of the important identified risk and package insert prescribed to the pharmaceutical products risk management plan in the P1248-23-AM DPP-4 inhibitor 千田泰健 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 473-473, 2015.

---

	Efforts for the medical therapy adequacy of the P1249-22-PM decreased renal function patients 藤野優子, 柴田陽子, 原幸世, 広江智子, 大坪博子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 474-474, 2015.

---

	Inspection of the effectiveness by renal function test value mention to P1250-23-AM prescription 多賀志乃, 野口絢加, 台蔵剛士, 下川千賀子, 柏原宏暢 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 474-474, 2015.

---

	The present situation of the steroid mental disease in the kidney medical service of the P1251-22-PM our hospital 田中理子, 千崎康司, 山田清文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 474-474, 2015.

---

	Efforts to the renal function evaluation of the P1252-23-AM inpatient and dose confirmation of the renal function attention medicine 波多晶子, 中澤美樹子, 三谷和恵, 窪田真弓, 鶴居勝也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 474-474, 2015.

---

	Efforts of the drug proper use conference of the P1253-22-PM decreased renal function patients 大熊範和, 小材直人, 土屋敦史, 山本未来, 橋本碧, 田子尚史, 村田文, 森田淳介, 千吉良幸子, 新木美枝, 田子加代子, 山賀章一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 474-474, 2015.

---

	Tolvaptan introduction case to patients with autosomal dominant polycystic kidney with the P1254-23-AM decreased renal function 池田瑞季1), 成田勇樹1),2), 山根亜美1), 内田朋子1), 中村有紀子1), 成田さわな1), 政賢悟1), 藤本大介3), 平松晶子3), 城野博史1),4), 向山政志3), 齋藤秀之1),4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 474-474, 2015.

---

	Examination of the concomitant drug affecting the serum magnesium (Mg) in consideration of the renal function in the P1255-22-PM magnesium oxide (MgO) preparation internal use patients 森田啓嗣, 川上恭弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 475-475, 2015.

---

	Use trend of the digitalis preparations in the P1256-23-AM our hospital 大岩拓馬, 浅野嘉之, 伊東和真, 坂田洋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 475-475, 2015.

---

	Investigation of the thrombocytopenia to stop by according to renal function of P1257-22-PM linezolid (LZD) 阪野和重, 中西俊介, 奥本真巳, 武内恭範, 篝忠弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 475-475, 2015.

---

	1 case using the Teiko plastic Nin note high-dose for patients with renal failure sex after P1258-23-AM kidney 中西俊介, 阪野和重, 奥本正巳, 武内恭範, 篝忠宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 475-475, 2015.

---

	Use of the DPP-4 inhibitor in the P1259-22-PM our hospital 武内恭範1),2), 喜多薫1), 阪野和重1), 中西俊介1), 篝忠宏1), 吉本航2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 475-475, 2015.

---

	The need of the pharmacist intervention for the seriously ill hypoglycemia prevention of the P1260-23-AM decreased renal function patients 鈴木雄太1), 和地徹1), 佐藤美里1), 佐藤圭吾1), 菅野和1), 追木正人1), 西和哉1), 竹内陽一2), 松田謙2), 長澤将2), 佐賀利英1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 475-475, 2015.

---

	Examination of the usefulness of the carnitine preparation administration in P1261-22-PM patients on dialysis 星貴薫, 渡邉雅紀, 後藤圭介, 佐賀敬太, 水戸麻未, 武田瑛司, 田中正臣, 宮越貴之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 476-476, 2015.

---

	One patient who received desensitization for renal-transplant recipients with the P1262-23-AM sulfamethoxazole trimethoprim (formulates it with ST) allergy history 大城瑠奈1), 大田守仁2), 橋本孝夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 476-476, 2015.

---

	Safe examination of the agent for MOVIPREP R combination for the colonoscopic examination pre-treatment in patients on dialysis of the P1263-22-PM our hospital 和田祐一郎1), 北沢望美1), 穂積廣1), 加藤香奈1), 栗本拓也2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 476-476, 2015.

---

	Prescription drug investigation of elderly people in the P1264-23-AM Swertia Herb station 竹下秀司1), 鈴木孝史1), 芦川祐貴子1), 安藤誠2), 前嶋克幸2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 476-476, 2015.

---

	Stocktaking of our hospital which caught safe medical therapy guidelines on P1265-22-PM elderly people 2015 (plan) 小出賢吾, 野澤正徳, 三浦毅, 畔柳敏弥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 476-476, 2015.

---

	May it be said that MMSE is useful for the efficacy evaluation of the dementia therapeutic agent of the P1266-23-AM pharmacist as a tool? 妻鹿宏美, 近藤幸男, 奥野靖隆, 永田文恵 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 476-476, 2015.

---

	Present conditions investigation of the list of drugs pertinence drug needing careful administration for elderly people in the P1267-22-PM Joetsu community health center Hospital 宮川哲也, 山田潤也, 清水岳広 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 477-477, 2015.

---

	Examination of the time crush method as the pitch prescription method at P1268-23-AM dysphagia for 古川俊子, 遠山幸男, 久田達也, 辻秀樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 477-477, 2015.

---

	It is ... from a point of medical - nourishment, condition of a patient, polypharmacy to surround patients with femoral cervical bone fracture of the P1269-22-PM our hospital 川尻さおり, 入江貞治, 藤田靖之, 池田能利子, 町田毅 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 477-477, 2015.

---

	Intervention effect to pressure sore treatment by the P1270-23-AM medical treatment ward permanent residence pharmacist 細野真吾1), 森彩矢香1), 矢野理沙2), 遠藤秀竜1), 河村千晶1), 堀浩子1), 山崎崇1), 久野治人3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 477-477, 2015.

---

	Use situation investigation of the drug for external use in P1271-22-PM pressure sore treatment 篠崎聡, 大谷道輝, 並木路広, 山村喜一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 477-477, 2015.

---

	P1272-23-AM Usage situation survey of Lubiprostone (Amitiza(R)) at our hospital 北森靖隆, 市村行典, 深田章, 澤田邦子, 中山志織, 可徳桃子, 石田英明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 477-477, 2015.

---

	The present conditions and problems of the use of the P1273-22-PM sleeping drug 戸村文郁, 金子知紘, 松元美香, 並木路広, 大谷道輝, 山村喜一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 478-478, 2015.

---

	You experience P1274-23-AM thyroid crisis, and learn as a pharmacist 簑島隆仁, 桃井歩, 長岡和徳, 山下敦哉, 大森俊和, 仲鉢英夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 478-478, 2015.

---

	P1275-22-PM A case of considering change to baniprevir at the time of total bilirubin increase by simprevir 松元麻美1), 池田久雄1), 乾有希子1), 吉岡亮1), 居平典久2), 中村秀次2), 野村浩英1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 478-478, 2015.

---

	Examination about the drug control instruction duties that we performed to the patients who were operated on in P1276-23-AM oral surgery, and were hospitalized 武田恵美1), 小野間麻実1), 牧田道明1), 山本庸介2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 478-478, 2015.

---

	Examination about the convalescence rule factor in the P1277-22-PM acute spinal cord injury 小林由香, 倉井岳史, 高野尊行, 中丸朗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 478-478, 2015.

---

	Be associated with the inhalational instruction of patients with bronchial asthma indicating the nitric oxide concentration (FeNO) high level during the P1278-23-AM expiration 神浦茉奈実1), 宇都宮励子1), 廣田憲威1), 大野啓文2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 478-478, 2015.

---

	Treatment support ... in intervention - pharmacist outpatient department to DAAs (direct anti-viral agents) therapy for the P1279-22-PM hepatitis C 島谷桜子1), 坪谷綾子1), 工藤真弓1), 小宮詠子1), 浅見妥江1), 濱野公俊1), 坂下裕子1), 増原慶壮2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 479-479, 2015.

---

	Efforts (the second report) of the pharmacist for the Operation asthmatic death zero in P1280-23-AM Okayama 監物英男1),2),3), 森英樹2),3),4), 小野浩重2),5), 立野朋志2),6), 小笠原加代2),7), 出石啓治2),5),8), 赤澤昌樹2),9), 木村五郎10),11), 谷本安10),11), 宗田良10),11), 千堂年昭3),12) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 479-479, 2015.

---

	Fact-finding in the outside Parliament prescription of the P1281-22-PM new anticoagulant 井上優子, 吉田知広, 土佐直子, 福澤祐幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 479-479, 2015.

---

	Investigation about the method of consciousness and the medication counseling of the patients in P1282-23-AM high blood pressure treatment 宇野洋司, 菊池雄一, 橋本容子, 笹瀬優斗, 小島昌徳, 橋本真也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 479-479, 2015.

---

	Research about the thromboembolism onset and the side effect under the rivaroxaban administration in patients with P1283-22-PM non-valvular atrial fibrillation 秋元祐香1), 篠原悦子2), 千葉達夫3), 田中博之2), 佐々木英久1), 松尾和廣1), 渡辺朋子2), 横井妙子3), 加藤裕芳3), 吉尾隆1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 479-479, 2015.

---

	Research about the use of the low dose pill for the P1284-23-AM premenstrual syndrome 川口友理1), 渡辺朋子2), 田中博之2), 松尾和廣1), 佐々木英久1), 篠原悦子2), 竹下直樹4), 真坂亙3), 木下俊彦4), 吉尾隆1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 479-479, 2015.

---

	Rise in effect of treatment by the pharmacist intervention to the inhalation therapy of patients with P1285-22-PM chronic obstructive pulmonary disease 伊東佳美1), 池元洋平2), 村上美穂1), 島森美光1), 坂東勉1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 480-480, 2015.

---

	Inhalational adherence investigation of the tiotropium bromide hydrate preparation using P1286-23-AM medical service fees data 前澤佳代子1), 伊藤藍1), 鈴木里香1), 田村文香1), 永井美帆1), 三関彩友美1), 大内かおり1), 加藤芳徳1), 真野泰成2), 百瀬泰行1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 480-480, 2015.

---

	Effect of the inhalational pattern visual instruction on P1287-22-PM dry powder inhaler (DPI) without experience 増尾昌則, 近藤哲理, 高嶋友理, 小島香奈 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 480-480, 2015.

---

	The mouthpiece shape of P1288-23-AM dry powder inhaler (DPI) does not affect the maximal intake speed. 高嶋友理, 近藤哲理, 小島香奈, 増尾昌則 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 480-480, 2015.

---

	Examination of the edoxaban dosage after the P1289-22-PM total hip replacement 間宵聖太, 小林貴志, 内坪誉歳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 480-480, 2015.

---

Present conditions investigation about the pain relief treatment of the P1290-23-AM amyotrophic lateral sclerosis (ALS) patients 熊野文香1),2), 本郷修也2), 八田裕之1),2), 蛭谷牧子3), 座光寺伸幸3), 河合眞弘4), 山本吉章1),4), 青野裕史1),5), 對木萌絵1),6), 熊田顕浩6), 鈴木亮平1),7), 柴田有希子7), 花満裕1),8), 若杉栄作9), 高橋昌明9), 石田奈津子1),2),10), 山谷明正1),11) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 480-480, 2015.

---

	Examination of the associated factor about cardiac activity in P1291-22-PM acute myocardial infarction and the tolerability of the beta-blocker 南雲成, 小川一歩, 中村千佳子, 舩津久美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 481-481, 2015.

---

	Investigation of the P1292-23-AM chronic hepatitis C DCV+ASV combination therapy 齋藤巨樹1), 宮崎靖之2), 高田正温1), 植村隆1), 東島彰人1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 481-481, 2015.

---

	Effect on PT-INR by P1293-22-PM vitamin K doses 長岡和徳, 仲鉢英夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 481-481, 2015.

---

	New introduction - of efforts - inhalant explanation document to inhalational instruction unionization in the P1294-23-AM our hospital 安田陽子1), 林恵子1), 浅利貴奈1), 一戸麻以子1), 中田潤子2),3), 玉置淳3), 越田晃1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 481-481, 2015.

---

	Effect of the oxidative stress in the cells level of P1295-22-PM nonionic detergent Clemo fall EL 岡野善郎1), 石田志朗2), 木奈崎昭男2), 小山保夫3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 481-481, 2015.

---

	Examination - about the factor having an influence on the internal use rate of triple-drug therapy - ribavirin of P1296-23-AM chronic hepatitis C 柴田久美子1), 平野茂樹1), 近藤綾子1), 神間康1), 舘佳彦2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 481-481, 2015.

---

	Study on side effect to lead to P1297-22-PM azathioprine administration cancellation 山下友輝1), 加藤梢1), 畑侑里1), 道下美穂1), 八幡弘子1), 山本千秋1), 田中悠季1), 小林龍1), 小原秀治1), 宮川麻希2), 那須野正尚2), 田中浩紀2), 本谷聡2), 渡辺浩明1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 482-482, 2015.

---

	About association with tolvaptan and the renal function in patients with P1298-23-AM cirrhosis 野村祐司1),2), 櫛原秀之1), 櫛原朋恵1), 河瀬洋平1), 成瀬徳彦1), 水谷年男1), 土居崎正雄2), 春田純一2), 森一博1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 482-482, 2015.

---

	Examination about the effect to give to blood pressure, the pulse of the P1299-22-PM Yokukansan 横山匡1), 小野孝彦2), 浅原慶徳1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 482-482, 2015.

---

	Examination of the factor affecting the change of the thyroid function in the P1300-23-AM Graves' disease treatment 安藤ゆかり1), 早川伸樹1),2), 桑原宏貴3), 戸田貴洋3), 林高弘1),3), 福井愛子1), 亀井浩行1), 平塚いづみ2), 鈴木敦詞2), 山田成樹3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 482-482, 2015.

---

	Examination of the risk factor of the hypernatremia with the P1301-22-PM tolvaptan administration 難波和行, 小森均, 橋本義宏, 和泉秀明, 村上貴洋, 金高勇介, 中野史也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 482-482, 2015.

---

	PBPM activity about the P1302-23-AM digoxin preparation remedy 嶋田聖子, 納富貴子, 武田典子, 濱邊秋芳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 482-482, 2015.

---

	Examination about the usefulness of the tiotropium preoperation intervention for the P1303-22-PM lung cancer surgery case 藤田剛平, 石王麻里乃, 久保淳一, 津田雅大, 和泉秀明, 橋本義宏, 小森均 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 483-483, 2015.

---

	The effectiveness and safety of old and new triple-drug therapies for P1304-23-AM chronic hepatitis C 森尚義1), 森谷勲2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 483-483, 2015.

---

	One case that raised medication adherence by the viscosity adjustment of the liquid for ITCZ in patients with P1305-22-PM dysphagia 小西喜昭1), 森章哉1), 黒川公恵1), 下地康雄2), 中谷理恵3), 森川静香3), 山川卓哉1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 483-483, 2015.

---

	Association of refractory epilepsy and the oxidative stress of the P1306-23-AM seriously disabled child (person) 森本真仁1),2), 里村茂子2), 橋本俊顕2), 浜田茂明2), 吉岡三郎1), 京谷庄二郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 483-483, 2015.

---

Examination of analgesic effect and the side effect risk of the fentanyl which we used together in Ropivacaine of autoregulation epidural analgesia method (PCEA) after the P1307-22-PM cesarean operation surgery technique 池田貴之1), 長谷川哲也1), 寺田享志2), 大岩彩乃2), 花井雄貴1), 馬渕匠1), 結束さやか2), 落合亮一2), 小杉隆祥1), 西澤健司1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 483-483, 2015.

---

	Effect of sex hormone and statin on adiponectin production of the P1308-23-AM humans fat cell 川合結乃1), 菊池千草1),2), 壁谷知樹2), 堀英生2),3), 松永民秀1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 483-483, 2015.

---

	1 case that fentanyl patch succeeded, and patients on dialysis with the P1309-22-PM chronic pain were able to be discharged from at home 原圭子, 岸本千絵, 田畑貴康, 山口伸二, 中村徹志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 484-484, 2015.

---

	One case of hepatitis C treatment in patients with P1310-23-AM living renal transplantation plan 廣瀬雅人, 小川光広, 樋口浩輔, 木村謙吾, 市川照文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 484-484, 2015.

---

	Examination about the renal function change by taking P1311-22-PM SGLT2 inhibitor 九鬼亜衣子, 西塔志織, 松本芳信, 川原裕, 佐野雅昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 484-484, 2015.

---

	The use situation of ferric citrate in the P1312-23-AM our hospital 足立圭司, 佐賀嘉英, 門脇隼也, 塩見明日香, 小田智晴, 谷田有花, 大槻和也, 藤本華衣, 芦田理沙, 村上由樹, 川見里奈, 堀雅博, 足垣亮介, 宮谷正哉, 勝井靖, 山本真世, 立道直美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 484-484, 2015.

---

	Examination of the renal function improvement effect by the P1313-22-PM serum uric acid level drop 鈴木一志, 松本晃一, 高橋利幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 484-484, 2015.

---

	Relation of a treatment result and the pharmacist of the Daclatasvir / Asunaprevir in the P1314-23-AM our hospital 横田千明1), 眞弓健介1), 杉和洋2), 安森奈緒子1), 幸邦憲1), 山形真一1), 中川義浩1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 484-484, 2015.

---

	For prevention of P1315-22-PM drug abuse: Problems in the acquisition of the smart drug through the Internet 大塚邦子1),2), 奈良政寿1), 内田直樹2), 安原一2), 細野哲司1), 篠塚達雄1), 鈴木啓太郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 485-485, 2015.

---

	About a treatment continuance rate of teriparatide in the P1316-23-AM our hospital 石川奈央佳, 野澤正徳, 三浦毅, 畔柳敏弥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 485-485, 2015.

---

	The present conditions of a prescription turn of eventss of the teriparatide preparation by the P1317-22-PM DPC introduction and the instruction system 森下槙子, 澤柳直樹, 藤井友和, 中村治彦, 辻博幸, 塚本久之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 485-485, 2015.

---

	One case of the juvenile idiopathic joint pain that complicated P1318-23-AM osteoporosis 星野有吾1), 神谷洋子1), 森真澄1), 川澄清孝1), 馬庭浩子2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 485-485, 2015.

---

	Use experience of the triple-drug therapy in a P1319-22-PM chronic hepatitis C genotype1 type, the high viral load 三澤延司1), 鳥巣勇一2), 中野真範2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 485-485, 2015.

---

	It is examined three cases receiving the Omalizumab for P1320-23-AM COPD merger asthma 高武嘉道, 竹添達也, 田口清章 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 485-485, 2015.

---

	Questionnaire research for the ethical pharmacy affecting a dentistry trouble and medication counseling content associated with the P1321-22-PM medication 上田幹子, 上田紘子, 戸田史恵, 森功美子, 大石美奈子, 高安敏子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 486-486, 2015.

---

	Related examination of PT-INR change and the thromboembolism onset during P1322-23-AM warfarin administration 岩本翔平1), 有山智博1), 東丸貴信2), 石井敏浩1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 486-486, 2015.

---

	One case that stent thrombosis prophylaxis was performed in with a clopidogrel single agent after the percutaneous transluminal coronary angioplasty (PCI) enforcement for the patients during P1323-22-PM apixaban administration 中島一1), 天野佑1), 今村陽子1), 大石貴裕1), 池田浩和1), 高橋浩二郎1), 近藤克洋2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 486-486, 2015.

---

	Usefulness of the methylprednisolone supplementation after the NASCIS2 protocol to patients with P1324-23-AM acute phase spinal cord injury 倉井岳史, 小林由香, 高野尊行, 中丸朗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 486-486, 2015.

---

	Example that tolvaptan was effective for fluid retention in the P1326-23-AM cirrhosis 内山良子, 木村麻紀, 林千麗, 吉村尋典 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 486-486, 2015.

---

	Inflection to the use situation and inhalational instruction of the inhalant in our P1327-22-PM center 西川友梨, 嶋津史恵, 植田有希, 黒岩沙也佳, 碓氷尚子, 上田理絵, 口分田章典, 中野寛之, 長谷川聡司, 岩田浩幸, 志村和子, 田中恵美子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 487-487, 2015.

---

	P1328-23-AM On the initial effects and side effects of Daglatasville + asnaprevil combination therapy for chronic hepatitis C 大谷綾1), 加藤愛梨1), 小林真菜1), 杉本佳世1), 笹谷佳菜子1), 中尾啓子1), 笹瀬典子1), 金啓二1), 金守良2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 487-487, 2015.

---

	Examination of the effectiveness for peripheral airway inflammation by the P1329-22-PM Flutiform inhalation 水口侑子1), 西川友梨1), 植田有希1), 碓氷尚子1), 嶋津史恵1), 口分田章典1), 中野寛之1), 長谷川聡司1), 木村貴1), 岩田浩幸1), 志村和子1), 田中恵美子1), 橋本章司2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 487-487, 2015.

---

	Maintenance of the support system by the trial center for P1330-23-AM efficiency-like clinical studies promotion 白澤宏美1), 山下克也1), 久保美紀子1), 山形真一2), 幸邦憲2), 中川義浩2), 芳賀克夫3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 487-487, 2015.

---

	Evaluation of the central IRB operation using P1331-22-PM iPad 寺師守彦1), 鳥居博行1), 野間口寛1), 稲森恵弥子2), 黒木沙織2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 487-487, 2015.

---

	Database making aiming at duties efficiency such as subjects progress management, the costs request of the P1332-23-AM trial 山下克也1), 林淳一郎2), 白澤宏美1), 高本由紀子1), 久保美紀子1), 山形真一3), 幸邦憲3), 中川義浩3), 芳賀克夫4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 487-487, 2015.

---

	Inspection of the pharmaceutical products storage for the disaster in the P1333-22-PM tsunami damage hospital 早瀬友和, 和泉邦彦, 二神諒子, 土田大輔, 岡部静子, 池上信昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 488-488, 2015.

---

	Preliminary investigation about the people of the P1334-23-AM Great East Japan Earthquake stricken area expecting it from a pharmacist 小倉未来1), 有田悦子1), 田辺記子1), 荒井きより1), 池谷博美1), 大坂敏夫2), 金野良則2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 488-488, 2015.

---

	Questionary survey about consciousness and the education to face each other at emergency, the disaster of the P1335-22-PM pharmacy student 久保田洋子1), 中野将志1), 南角明歩1), 笠羽平誉1), 石井里佳1), 毎田千恵子1), 杉山朋美1), 北山朱美2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 488-488, 2015.

---

	It is ... from the viewpoint of ... pharmacist about a role of our hospital in P1336-23-AM Chiba for disaster 勝田恵, 渡邉暁洋, 福田恵子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 488-488, 2015.

---

	Usefulness of the action card for the unification of the early period of P1337-22-PM disaster behavior 八木啓太, 篠原克典, 神田茜, 松本嵩史, 松村隆, 鍵山智樹, 齋藤健一, 岸野亨 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 488-488, 2015.

---

	Trial of the IPE pharmacy education program to cultivate ability for P1338-23-AM team approach in medical care practice 大津友紀1), 首藤英樹2), 平川雅章3), 片岡泰文2), 二神幸次郎1),4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 488-488, 2015.

---

Report ... of the instruction pharmacist class for 1 - instruction technology improvement (the fourth report) with the role of the pharmacist participating in P1339-22-PM "business true taking lessons previous learning" 南恵理子1),2), 中尾幸代1),3), 松田裕子1), 村田明子1),4), 山中智香1),5), 波多江崇1), 沼田千賀子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 489-489, 2015.

---

Inspection ... of the improvement effect by problems and the class that 2 - students feel with the role of the pharmacist participating in P1340-23-AM "business true taking lessons previous learning" (the fourth report) 村田明子1),2), 中尾幸代1),3), 松田裕子1), 南恵理子1),4), 山中智香1),5), 波多江崇1), 沼田千賀子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 489-489, 2015.

---

	About a knowledge acquisition effect about the diabetes medical treatment instruction in the P1341-22-PM Hospital business training 椿井朋1),3), 久保田亜希2), 野田幸裕3), 山田清文2), 中尾誠1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 489-489, 2015.

---

	The case contents which upbringing (the first report) - trainee of the pharmacist carrying the P1342-23-AM next generation experiences during training: Analysis ... from a disease 猪田宏美, 久保和子, 林瑶子, 北村佳久, 千堂年昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 489-489, 2015.

---

	The case contents which upbringing (the second report) - trainee of the pharmacist carrying the P1343-22-PM next generation experiences during training: Analysis ... from medical treatment 久保和子, 猪田宏美, 林瑶子, 北村佳久, 千堂年昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 489-489, 2015.

---

	Efforts ... to the business training in upbringing (the third report) ... super acute phase ward (ICU, EICU, NICU) of the pharmacist carrying the P1344-23-AM next generation 田坂健, 武本あかね, 日野隼人, 勝部理早, 大川恭昌, 猪田宏美, 久保和子, 林瑶子, 北村佳久, 千堂年昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 489-489, 2015.

---

	Attempt ... using the association map to deepen patients understanding necessary for upbringing (the fourth report) - prescription suggestion of the pharmacist carrying the P1345-22-PM next generation 名和秀起, 猪田宏美, 林瑶子, 久保和子, 北村佳久, 千堂年昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 490-490, 2015.

---

Learning effect of the lecture for the purpose of knowledge about the cancer treatment for the student having uneasiness in the relation with patients with P1346-23-AM cancer and the technical improvement 高橋喜統1), 山口加代子1), 多賀允俊1), 野村政明2), 尾山治2), 久保田洋子2), 高瀬久光2), 大本まさのり2), 岡本晃典2), 毎田千恵子2), 丹羽修1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 490-490, 2015.

---

	It is ... for the regional alliances pharmacy business training & education with the from P1347-22-PM Oshu-shi, Iwate "pharmacy education gold strategy in Iwate" - characteristic 小野寺健1),6), 石川久美2),6), 南川賢治1),6), 松浦誠3),6), 三浦清明4),6), 三浦俊弘5),6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 490-490, 2015.

---

	The consciousness change of the trainee before and after examination - training schedule modification of the pharmacy student long-term business training schedule in the institution specialized in P1348-23-AM cancer for an index - 大西早紀, 槇恒雄, 二五田基文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 490-490, 2015.

---

	Association between framework of business training and self-assessment of the pharmacy student about the arrival degree of the basic nature of the P1349-22-PM act 黒野俊介, 守屋友加, 伊東亜紀雄, 山田重行, 長谷川洋一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 490-490, 2015.

---

	Attitude survey of the trainee using the revision of the efforts training curriculum to the hospital business training in the P1350-23-AM Kyoto medical center 水津智樹1), 畑裕基1), 竹松茂樹1), 辻琢己2), 河合実1), 玉田太志1), 北村良雄1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 490-490, 2015.

---

	Efforts to the P1351-22-PM pharmaceutical clinical reasoning training 川口崇1),15), 東加奈子2),15), 今井徹3),15), 岩井大4),15), 臼井浩明5),15), 小久江伸介6),15), 北原加奈之7),15), 小暮宗介8),15), 添田博2),15), 平井浩二9),15), 高橋良10),15), 岸田直樹11),15), 柴田喜幸12),15), 徳田安春13),15), 源川奈穂14),15), 明石貴雄2),15) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 491-491, 2015.

---

	Construction - second report ... of the education system for the early duties acquirement for the P1352-23-AM new adoption pharmacist 佐藤仁宣, 小沼大祐, 本郷知世, 古林園子, 伊藤博, 加藤一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 491-491, 2015.

---

	Efforts of the pharmacist resident system in the P1353-22-PM civilian Hospital 寺沢匡史, 中村翔吾, 三浦裕介, 廣田麻衣子, 中村有理, 瀬戸崇光, 内山ひとみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 491-491, 2015.

---

	Extraction of an evaluation and the improvement item of the physical assessment class for pharmacists by the P1354-23-AM CS analysis (Customer Satisfaction analysis) 大鳥徹1), 井上知美1), 細見光一1), 伊藤栄次1), 中山隆志1), 和田哲幸1), 石渡俊二1), 船上仁範1), 中村真也1), 平出敦2), 窪田愛恵2), 松山賢治1), 西田升三1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 491-491, 2015.

---

The training system that fixed its eyes on the authorized acquisition from new face education in the P1355-22-PM metropolitan association institution Hospital 舩津久美1),2),3), 白石範子2),3), 阿部和史2),3), 安藤恵2),3), 石原溶子2),3), 内川清次2),3), 木内智香子2),3), 越田晃2),3), 小竹慶子2),3), 田中三枝子2),3), 中村英子2),3), 林みどり2),3), 廣井順子2),3), 松本啓一2),3), 八木原栄2),3), 山村康比古2),3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 491-491, 2015.

---

	Efforts - second report ... of the clinical competence improvement program of the P1356-23-AM pharmacist 川添潤1), 金正興1), 嶋村久美子1), 星茜1),2), 塩田一博1), 北原加奈之1),2), 高橋良3), 垂水庸子4), 峯村純子2),5), 佐々木忠徳1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 491-491, 2015.

---

	Instruction upbringing to the Shinnyu staff for P1357-22-PM ward drug duties 宍倉啓介, 渕真由子, 松澤弘志, 野地良子, 小竹慶子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 492-492, 2015.

---

	Introduction ... of the medical treatment management based on 1 relation - protocol of the pharmacist in the P1358-23-AM stroke support team 清水誉志, 萩原里実, 丸子浩, 福島将友, 前田朱香, 町田聖治, 入江利行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 492-492, 2015.

---

	Questionary survey ... about regional alliances (medicine medicine cooperation) in 2 relation - stroke practice of the pharmacist in the P1359-22-PM stroke support team 萩原里実, 清水誉志, 丸子浩, 福地祐亮, 村井悠紀, 町田聖治, 入江利行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 492-492, 2015.

---

	About an evaluation of the P1360-23-AM drug-related QT prolonged examination - of the unevenness between the comparison between - viewing law and tangent line method and gaugers 尾上洋1), 中田和枝2), 伊丹久美子2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 492-492, 2015.

---

	Efforts of the experience-based training instruction of the injection drug mixed preparation for the P1361-22-PM resident 守谷顕人, 村上賢次, 森のどか, 橋本恵梨花, 井本陽子, 吉田尚史, 宅和真由美, 平田敦宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 492-492, 2015.

---

	The prospects to the future for P1362-23-AM balun strike scorecard (BSC) making and the utilization 吉川飛鳥, 柏崎友紀江, 田村真代, 吉川円, 齋藤義貴, 定村洋士 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 492-492, 2015.

---

	Facilitator upbringing ... in efforts - balun strike scorecard introduction to the P1363-22-PM pharmacy management 小串興平1),2), 前田拓哉1),3), 大久保淑子1),4), 山内泰一1),5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 493-493, 2015.

---

	The drugstore management by the balun strike scorecard (BSC) introduction in the P1364-23-AM Tokyo kidney urinary organ center Yamato Hospital 廣實愼吾, 森田はづき, 折本小夜子, 上野拓 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 493-493, 2015.

---

	Efforts and result tenth report for the BSC introduction for P1365-22-PM hospital pharmacist 井口恵美子1),2), 赤瀬朋秀1), 上原君男1), 小田切正美1), 小林岳1), 菅野豪輝1), 関口信香1), 大幸淳1), 根岸大輔1), 吉田博史1), 岡添進1), 中村葉月1), 舟越亮寛1), 佐藤透1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 493-493, 2015.

---

	Of the P1366-23-AM balun strike scorecard introduction third year look back; change ... of the ... strategy target 金田昌之1), 奈良部修弘1), 畠山英司1), 田邉晃子1), 三田村朋1), 米澤禎貴1), 藤田明宏2), 赤瀬朋秀3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 493-493, 2015.

---

	Evaluation by the number about the efforts to the duties improvement using the balun strike scorecard in the P1367-22-PM light law of nature society Chuo General Hospital 今井由恵, 星佳代子, 染谷洋和, 菊池昌彦, 廣澤達哉 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 493-493, 2015.

---

	Factor to have an influence on the at-home return of patients with stroke in the rehabilitation ward for P1368-23-AM convalescence 細田矢佳1), 岡添進1), 矢嶋美樹2), 小瀬英司3), 林宏行3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 493-493, 2015.

---

	Inspection of the usefulness by the proof experiment in the institution of the autonomy conveyance robot in the P1369-22-PM Hospital 植野聖子1), 小森正貴1), 神農理衣1), 王宏維1), 村上賢次1), 三木郁帆1), 守谷顕人1), 津田里香1), 宅和真由美1), 村井亮介2), 酒井龍雄2), 平田敦宏1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 494-494, 2015.

---

	For the enlightenment activity at research - pharmacy service under health insurance drugstore of the food poisoning by the false meal of the P1370-23-AM poisonous plant - 國正淳一, 堺陽子, 宮松史人, 浦野公彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 494-494, 2015.

---

	P1371-22-PM A case of tyrosinemia type I with good course due to long-term administration of nicothinone 中山幹子1), 藤本千安紀1), 藤田由香1), 佐々木みずえ1), 山本宏1), 伊藤道徳2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 494-494, 2015.

---

	Study on accumulation characteristics of the polymerization initiator to mix in P1372-23-AM parenteral injection 河崎陽一1), 久原典子2), 三浦太郎2), 江角悟1), 北村佳久1),2), 千堂年昭1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 494-494, 2015.

---

	Upbringing ... of relationship of mutual trust improvement and the chief pharmacist with the P1373-22-PM Quality Improvement in the Department of Pharmacy 6 - subordinate 小木篤仁, 池田鮎美, 石井友恵, 内海綾, 田中友佳, 長島真洋, 蓮池由夏, 本藤真太郎, 見崎昭子, 武笠裕優, 矢島里菜, 安村吉彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 494-494, 2015.

---

	IN-01 Reason analysis and countermeasures on long waiting time in automated outpatient pharmacy CHEN Rong1), ZHU Jian2), GU Bao-Chen1), BAO Jian-An1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 496-496, 2015.

---

	IN-02 Clinical risk factors associated with postoperative delirium in lung and esophageal cancer patients Yoshihisa Kitamura1),2), Kiminaka Murakawa1), Shiho Hongo2), Toshiaki Sendo1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 496-496, 2015.

---

	IN-03 Two kinds of treatments of breast cancer after chemotherapy granulocytopenia disease clinicalcurative effect evaluation We YU, Ruixiang XIE, Fang FAN Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 497-497, 2015.

---

	IN-04 Photoinitiators initiated estrogenic activity in human breast cancer cell line MCF-7 Yoichi Kawasaki1), Miwa Morizane2), Taro Miura2), Satoru Esumi1), Yoshihisa Kitamura1),2), Toshiaki Sendo1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 497-497, 2015.

---

	IN-05 Pharmacogenomics and personalized medicine of immunosuppressant Yan Mei-Ling, Liu Li-Wei, Zhang Yi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 498-498, 2015.

---

	IN-06 Development of proper Simple Suspension Method of valganciclovir medication Yasuyuki Masaoka1), Yoichi Kawasaki1), Ryo Kikuoka2), Atsushi Ogawa1), Satoru Esumi1), Yoshihisa Kitamura1),2), Toshiaki Sendo1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 498-498, 2015.

---

	IN-07 Analysis of Medication Compliance and Influnencing in Patients Liu wensheng, Wen xiaona Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 499-499, 2015.

---

	IN-08 The toxicity and the rational use of Chinese patent medicine containing heavy metal LIU YING, FAN Xiu-rong, LV Zhi-hui, LI Zhen-quan Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 499-499, 2015.

---

	IN-09 Research Progress in Chinese medicine treatment of coronary heart disease Liang Shuang Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 500-500, 2015.

---

	IN-10 2014-2015 Activities Report of the Japanese Society of Hospital Pharmacists Takao Orii, Yoshikazu Tasaki, Emiko Iguchi, Itsuko Ishii, Keishiro Izumi, Akio Katsumi, Yasuo Takeda, Satohiro Masuda, Kojiro Yamamoto, Kazuo Matsubara, Mitsukazu Kitada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 500-500, 2015.

---

	The participation of the pharmacist starting academic F-01 polypharmacy measures and research of the usefulness 武藤浩司1),2), 小田慎1),3), 佐藤康一1),4), 樋島学1),5), 吉岡睦展1),6), 別所千枝1),7), 澁田憲一1),8) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 503-503, 2015.

---

	It is examination about the investigation support after production sale of the hospital pharmacist for the academic F-02 pharmaceutical products risk management plan 有馬秀樹1), 近藤直樹2), 近藤智子3), 田崎正信4), 寺元剛5), 水井貴詞6), 渡邉達也7) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 504-504, 2015.

---

	Research about the pharmaceutical management of the academic F-03 perioperative patients and the pharmacist duties in the operating room 舟越亮寛1), 柴田ゆうか2), 小西寿子3), 柴田みづほ4), 堀内賢一5), 佐藤裕紀6), 古谷一平7) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 504-504, 2015.

---

	Research about the appropriate medical therapy to patients with academic F-04 mental disorder 齋藤百枝美1), 馬場寛子2), 桑原秀徳3), 永田健一郎4), 野田幸裕5), 高橋結花6), 村野哲雄7) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 505-505, 2015.

---

	Research about the intervention of the pharmacist in the proper use of a vein, the nutrient for intestinal administration which is academic F-05 pharmaceutical products 増田修三1), 林宏行2), 樋島学3), 林勝次4), 中村直人5), 杉浦伸一6), 松原肇7) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 505-505, 2015.

---

	Research about the interaction between a drug, medical materials in the academic F-06 medication 中村浩規1), 杉浦伸一2), 荒井有美3), 古田康之4), 金澤佐知子5), 石井健介6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 506-506, 2015.

---

	Research about the duties development of the pharmacist in the academic F-07 outpatient department chemotherapy 松尾宏一1),2), 吉村知哲3), 飯原大稔4), 岩本卓也5), 緒方憲太郎1), 川上和宜6), 組橋由記7), 黒田純子8), 林稔展9), 米村雅人10) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 507-507, 2015.

---

	Research about the medical therapy that is appropriate by the security to academic F-08 transluminal treated patients 倉田なおみ1), 新井克明2), 近藤幸雄3), 藤原琴4), 宮川哲也5), 岸本真6), 石田志朗7) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 507-507, 2015.

---

	We conduct research for becoming it the marketing of the drug necessary for the academic F-09 healthcare setting 渡辺享平1),2), 後藤伸之3), 佐々木忠徳4), 濱宏仁5), 原田幸子6), 松浦克彦7), 山川雅之8) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 508-508, 2015.

---

	Proper use and side effect management ... in LS1 immunity checkpoint inhibitor - true clinical practice 吉川周佐 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 510-510, 2015.

---

	The prevention, therapeutic drug development of Alzheimer's dementia based on the LS2 condition of a patient 小野賢二郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 511-511, 2015.

---

	Real ... of team approach in medical care - pharmacist outpatient department in the LS3 gastrointestinal carcinoma chemotherapy 高張大亮, 式部さあ里 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 512-512, 2015.

---

	It is medication support ... for ... deglutition functional disorder patients for internal use, the medication management that LS4 is safe 岸本真 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 513-513, 2015.

---

	One or - that the physician of drug choice - settings of the LS5 circulatory organ physician thinks about what and prescribes it how 香坂俊 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 514-514, 2015.

---

	Expectation to a jelly agent as the LS6-1 universal preparation 花輪剛久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 515-515, 2015.

---

	How to use therapeutic drug to think about from true clinical practice of LS6-2 osteoporosis treatment and bone metabolic turnover 沖本信和 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 515-515, 2015.

---

	LS7-1 heart failure and way of thinking of diuretics - nowadays 猪又孝元 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 516-516, 2015.

---

	The condition of a patient and treatment of the LS7-2 polycystic kidney 乳原善文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 516-516, 2015.

---

	Knowledge - of the Sino-Japanese traditional medicine necessary for LS8 hospital pharmacist particularly commentary - from a practice case of the cooperation of team approach in medical care and the Chinese medicine 丹村敏則 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 517-517, 2015.

---

	LS9 drug-related nephropathic non-invasive urinary biomarker 増田智先 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 518-518, 2015.

---

	Recent progress ... problem that should be settled in the proper use of the LS10 antimicrobial is some ... 堀誠治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 519-519, 2015.

---

	LS11 osteoarthritis: Domestic and foreign treatment guidelines and the future prospects 川口浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 520-520, 2015.

---

	A diagnosis and treatment of the LS12 inflammatory bowel disease: Mainly on the effect of the biological drug 松本主之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 521-521, 2015.

---

	Point to use Everolimus in LS13 breast cancer treatment 坂東裕子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 522-522, 2015.

---

	About the present conditions of the LS14 community medical care design and the future prospects 遠藤久夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 523-523, 2015.

---

	It is ... about "behavior aim W realizes the workplace environment that there is not of the anticancer agent exposure" LS15 anticancer medicine exposure measures and medical safe national joint behavior ... 中西弘和 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 524-524, 2015.

---

	LS16 eating, dysphagia and dosage form of medicine 倉田なおみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 525-525, 2015.

---

	Side effect - vascular pain, lassitude, taste disturbance that are a gap in the LS17 cancer medical therapy, hiccups ... 野村久祥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 526-526, 2015.

---

	Point - that you should note generic medicine adoption from the viewpoint of use of LS18 generic medicine and medical safe - medical care security 土屋文人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 527-527, 2015.

---

	Thing - hospital pharmacy where there is pharmacy for management contribution for LS19 2025 is ... from the cost center to the profit center 工藤高 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 528-528, 2015.

---

	The new prospects of the treatment strategy with the change of the LS20 advanced stage melanoma treatment and the molecular target medicine 中村泰大 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 529-529, 2015.

---

	The inflection of the pharmacist loanword aiming at LS21 anticancer agent adherence improvement! 橋田亨 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 530-530, 2015.

---

	The role of the pharmacist in the team approach in medical care of the LS22 cancer domain and the future prospects 橋本浩伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 531-531, 2015.

---

	In one focal as for directional - "separation of pharmacy and clinic" of the medical care, the care system reform to see to LS23 large-boned 2015 - 高橋進 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 532-532, 2015.

---

	Cost effectiveness and drug choice of the drug in the LS24-1 relaxation medical care 児玉佳之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 533-533, 2015.

---

	Role of the insurance pharmacist in LS24-2 cancer treatment 秋山理恵 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 533-533, 2015.

---

	Role - hospital pharmacist of directionality and the hospital pharmacist of the LS25 health care overhaul is ... from the viewpoint of latest information and plasma derivative proper use that you should know 谷澤正明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 534-534, 2015.

---

	The latest treatment of LS26 chronic hepatitis C 高口浩一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 535-535, 2015.

---

	Efforts of the pharmacist who fixed the eyes on qualitative improvement and medical service fees in the LS27 cancer team approach in medical care 吉村知哲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 536-536, 2015.

---

	Knowledge - antiarrhythmic drug and new oral anticoagulant drug - to help the atrial fibrillation medical treatment that LS28 pharmacist should know 志賀剛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 537-537, 2015.

---

	We change at human front ridge water shift transtime of a lot of LS29-1 latanoprost instillation preparation 関根祐子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 538-538, 2015.

---

	The present conditions and problem of LS29-2 glaucoma eye drops 相原一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 538-538, 2015.

---

	A negative chain of periphery immunity increase aggravation and the cranial nerve immune network which LS30 pain brings: Dynamic "homeostasis restorative effect" with the pain-killer 成田年 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 539-539, 2015.

---

	Importance - cancer instruction to patient management charges 3 of the role that a basic tone lecture pharmacist should fulfil in cancer treatment is set why, and result in what kind of benefit to the patients; or ... 千堂年昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 542-542, 2015.

---

	Efforts and the present conditions of the example introduction 1 cancer instruction to patient management 中本恵理 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 543-543, 2015.

---

	Systems construction and the present conditions for cancer instruction to patient management for patients who received example introduction 2 outpatient department cancer chemotherapy 若杉吉宣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 543-543, 2015.

---

	An example introduction 3 cancer treatment working full time pharmacist is involved from regimen choice positively and utilizes cancer instruction to patient management 増田裕一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 544-544, 2015.

---

	Team approach in medical care annual convention long greetings to make tomorrow in the 26th Japan cure society annual convention holding 松原和夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 3-3, 2016.

---

	Team approach in medical care to make tomorrow 松原和夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 172-172, 2016.

---

	The present conditions and problem of the PD-1 checkpoint inhibition cancer immune therapy 湊長博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 172-172, 2016.

---

	Precision Medicine and Cardiovascular Therapeutics : An Individualized Approach Towards Optimizing Drug Selection and Use Robert J.Straka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 173-173, 2016.

---

	The Impact of Clinical Pharmacy Services on Cancer Care Richard Tizon Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 173-173, 2016.

---

	We design a study in response to an on-site question 福原俊一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 174-174, 2016.

---

	Let's shine life Japanese medical medicine society - Team medical center is pharmacist - 邉見公雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 174-174, 2016.

---

	To develop new pharmacist work - Let's think about legal interpretation - 赤羽根秀宜 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 175-175, 2016.

---

	Clinical pharmacy study on proper use of the anticancer agent and medical therapy improvement 有森和彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 175-175, 2016.

---

	Development of the individualization therapy of the immunosuppressive drug in renal-transplant recipients 加賀谷英彰 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 176-176, 2016.

---

	Study on clinical pharmacy that assumed - inventory survey technique a base for establishment of the fur Matthew tical care to lead to the quality of life improvement of the patients and clinic - 舘知也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 176-176, 2016.

---

	Study on effectiveness, side effect predictor of the molecular target drug for nephrocyte cancer 山本和宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 177-177, 2016.

---

	A pharmacokinetic change of Teiko plastic Nin in the patients with hyperglycemia and the hypoalbuminemia: Effect of the glycosylation of albumin to give albumin combination of Teiko plastic Nin 榎屋友幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 177-177, 2016.

---

	Study of the human pharmacology on effectiveness of aminophylline in treatment, the prevention of the premature baby apnea and safety 近藤智子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 178-178, 2016.

---

	Evaluation of a side effect, the effectiveness based on the blood sunitinib levels monitoring in patients with nephrocyte cancer 野田哲史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 178-178, 2016.

---

	The metabolism saturation of becoming it causes non-linear pharmacokinetics of voriconazole in the clinical dose N oxide of voriconazole 山田尚広 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 179-179, 2016.

---

	Study on prevention, therapeutic drug of stomatitis to occur at cancer chemotherapy / radiotherapy 渡邉真一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 179-179, 2016.

---

	We examine 1 disease and are promoted the team approach in medical care in the area by the medicine cooperation 今井博久, 矢野育子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 182-182, 2016.

---

	We talk about tomorrow of 2 hospital pharmacist 松原和夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 182-182, 2016.

---

	We regard innovative drug development as the new medical care using 3 iPS cells 中川貴之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 182-182, 2016.

---

	Disaster medical care support report in the Kumamoto earthquake 渡邉暁洋, 眞野成康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 183-183, 2016.

---

	New and prospective profession of pharmacists in medical team Yasuo Takeda, Takao Orii Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 183-183, 2016.

---

	Display ... of the professional ability in side effect management "- team approach in medical care of" cancer medical therapy that only 1 pharmacist has 松尾宏一, 野村久祥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 184-184, 2016.

---

	Approach of the prior learning that fixed its eyes on 2 revision core Cali 野田幸裕, 木津純子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 184-184, 2016.

---

	Construction and development ... of many types of job cooperation ... new pharmacist duties to utilize genome information for 3 pharmacist duties 平井みどり, 山本和宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 184-184, 2016.

---

	Personnel training of the next-generation pharmacist who can take four teams medical care 松尾宏一, 吉村知哲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 184-184, 2016.

---

	Role of the pharmacist in the treatment of patients with advanced age diabetes to support in five teams 三宅健文, 三浦彰久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2016.

---

	How do you connect the clinical question of 6 pharmacists with a research question? 内藤隆文, 新岡丈典 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2016.

---

	What a pharmacist should do by the team approach in medical care of 7 children domains, the significance of existence 冨家俊弥, 小高賢一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2016.

---

	The present conditions and problem of the in-hospital governance of 8 high risk medicine management 三宅健文, 渡邉幸子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2016.

---

	It is ... starting from the clinical analysis of 9 pharmaceutical products safe sexological advice - pharmaceutical products adverse effect 宇野勝次, 佐藤光利 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2016.

---

	It is consideration to ... future and fine-view ... about the cooperation between an activity and pharmacists of the each team approach in medical care by 10 many types of job cooperation 西原雅美, 八木達也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2016.

---

	New development of the team approach in medical care that a pharmacist challenges in 11 next generation 小林政彦, 尾上雅英 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2016.

---

	With the role that a pharmacist should fulfil in team approach in medical care to support 12 cardiovascular disease case? 野崎歩, 芦川直也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2016.

---

	An art and theory to evaluate 13 renal function definitely 平田純生, 小林道也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2016.

---

	Role ... which a pharmacist achieves for the cooperation to cooperation duties - health insurance pharmacy, the hospital transfer institution which started from 14 ward exclusive duty pharmacists 三上正, 橋田亨 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2016.

---

	Ad usum externum therapy for pressure sore that 15 pharmacists practice 宮地良樹, 関根祐介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2016.

---

	We regard a tool as knowledge necessary for a pharmacist confronting 16 resistant bacteria measures! - How do you make use of Japan Antimicrobial Consumption Surveillance (the JACS)? - 北原隆志, 村木優一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2016.

---

	17 Is disease cooperation really useful? - Effects of inhalation support collaboration and what has been visible from it - 篠永浩, 百瀬泰行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2016.

---

	One or ... that inspiration - pharmacist for 18 pharmacists to survive the smart platinum era is concerned with information cooperation how 小枝伸行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2016.

---

	... which let's promote the work life management of 19 pharmacists, and thinks about coexistence support in ... Japan and Europe rice, reinstatement support and various ways of working 岩澤真紀子, 上塚朋子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2016.

---

	... which thinks about technique to perform religious austerities in winter of theory and practice ... enlarging drug duties of 20 drugstore management premeditatedly 赤瀬朋秀, 加賀谷肇 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2016.

---

	... which thinks about perioperative safety management and practice of the patients care to take by 21 perioperative care teams and operating room drug duties - team which a pharmacist receives 舟越亮寛, 落合亮一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2016.

---

	The mission of the pharmacist who showed 22, and should carry it out by cancer palliative care and way to advance to 高橋一栄, 祝千佳子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2016.

---

	How is pharmacoepidemiology - safety of medicine not to be able to hear 23 now evaluated? A study in the practical medical care and institutional problem 漆原尚巳, 中川俊作 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2016.

---

	Role ... of the academia for practice - team approach in medical care promotion of clinical studies by the cooperation with 24 pharmacy schools and hospital, drugstore 辻大樹, 林秀樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2016.

---

	Practice ... of quantitative approach - clinical Pharmacometrics to make 25 medical treatment adequate individually 西村信弘, 猪川和朗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2016.

---

	... which thinks about a student evaluation in ... business training for pharmacist upbringing in response to needs of 26 society 千堂年昭, 寺町ひとみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2016.

---

	The safe system, safety measures to affect use of 27 pharmaceutical products: With hospital governance reform and the decision-making figure which there should be? 川上純一, 堀雄史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2016.

---

	28 Let's learn from past cases and think about disaster medical system - Spread information from a pharmacist - 渡邉暁洋, 西澤健司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2016.

---

	Improvement of the medical treatment effect by 29 pre-Abo id new stage (the world of style 3) formulation study, suggestion 笠原英城, 舟越亮寛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2016.

---

	Way of thinking - of one or the side effect using - pharmaceutical clinical reasoning to reason in 30 adverse events and causation of pharmaceutical products how 川口崇, 岸田直樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2016.

---

	How does the pharmacist utilize safe medical therapy guidelines on issue of polypharmacy - elderly people 2015 to surround 31 elderly people medical therapy? - 溝神文博, 平井みどり Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2016.

---

	... which regards the gap of the healthcare setting as contraindicated - regulation of 32 pharmaceutical products 佐藤博, 寺田智祐 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2016.

---

	Many types of job cooperation education (IPE) which supports 33 teams medical care: We will spread IPE! 野田幸裕, 杉山正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2016.

---

	Anything is necessary so that 34 pharmacists do prospective clinical studies; or is ... from the making of system beyond ... type of job to a design, an ethic 山口拓洋, 東加奈子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2016.

---

	To show a role and the usefulness of promotion - pharmacist of clinical studies in 35 community pharmacy; - 荒井國三, 赤沢学 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2016.

---

	Peripheral neuropathy with 36 anticancer agents: The actions to be taken and recent study trend 石田竜弘, 岩本卓也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2016.

---

	Proper use of 37 transdermal absorbing form preparation and future development 北河修治, 大谷道輝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2016.

---

	Summary of a fact and the case summary of the pharmaceutical intervention in 38 cancer medical therapy 濱敏弘, 谷川原祐介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2016.

---

	Relation of the pharmacist in 39 Nuclear medicine domains 土屋文人, 間賀田泰寛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2016.

---

	The Pharmacometrics which contributes to the solution to 40 clinical on-site questions, problems 永田将司, 本間雅 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2016.

---

	One or - that - pharmacist thinking about medical therapy is associated with 41 mother's milk child care how 石川洋一, 植松和子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2016.

---

	We think about 42 drug-related renal failure 竹内裕紀, 古久保拓 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2016.

---

	43 We think about the future of dementia treatment - what pharmacists can and shold do the future - 伊東弘樹, 永冨将寛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2016.

---

	The present and the future of 44 "family pharmacists, drugstores" 宮崎長一郎, 吉山友二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2016.

---

	How should the pharmacist be concerned with the proper use of 45 antifungal agents? 新岡丈典, 西村信弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2016.

---

	Polypharmacy ... to regard as problems over 46 polypharmacy by landing point ... many types of job 武藤浩司, 増田修三 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2016.

---

	Long-term medication management ... which is carried out by HIV infection - team as 47 chronic diseases 尾崎淳子, 矢倉裕輝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2016.

---

	Construction of the safe measures for the LS1-1 / LS1-2 immunity checkpoint inhibitor 永井宏樹, 清水克次 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2016.

---

	Suggestion - of the illness cancer pain treatment in LS2 outpatient department cancer treatment that we examined it and matched with medicine cooperation - lifestyle 鹿田康紀, 池田宗彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2016.

---

	Is the LS3 SGLT2 inhibitor same as sugar restrictions? 福井道明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2016.

---

	It is some ... with the role of LS4 elderly people medical therapy and Polypharmacy measures - pharmacist 竹屋泰 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2016.

---

	... including an example, the attention awakening of the proper use ... amount of Mg blood symptom of the laxative for patients with LS5 elderly people, kidney disease 平田純生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2016.

---

	Mainly on strategic - cancer medical care of five to show an LS6 pharmacist power - 吉村知哲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2016.

---

	It is ... including proper use and the evaluation of directional - plasma derivative of LS7 health care overhaul and the hospital pharmacist evaluation 谷澤正明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2016.

---

	Anticancer medicine exposure measures judging from LS8 United States Pharmacopeia of Japan 濱宏仁 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2016.

---

	LS9 Handling standards for sterile preparations and hazardous drags: Learn about the US Pharmacopoeia (USP) <797> and <800> - Talking in the position of the US Pharmacopoeia (USP) - Ryan A.Forrey Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2016.

---

	Collective strength of the pharmacist coordinating LS10 team approach in medical care 山本克己 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2016.

---

	Is the LS11 SGLT2 inhibitor higher-risk than DPP-4 inhibitor? 栄田敏之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2016.

---

	Experience the pharmacist training specialized in cancer in - other institutions about a pharmacist training institution specialized in LS12-1 cancer; and - 大辻貴司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2016.

---

	As a viewpoint to accept a pharmacist intern specialized in a cancer from - other institutions about a pharmacist training institution specialized in LS12-2 cancer - 濱敏弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2016.

---

	LS13 Mechanisms and Management of drug-drug interactions with Direct Acting Antivirals in Hepatitis C treatment David Back Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2016.

---

	Next-generation preparation - for latent energy - medication characteristics improvement of the LS14 pharmacist 倉田なおみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2016.

---

	LS15 drugstore pre-Abo id and medicine medicine cooperation 澤田康文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2016.

---

	Making of medical therapy support - various calculation, conversion tools that we utilized LS16 inside the hospital intranet and operational - 篠道弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2016.

---

	Thing - that it seemed that role - surgeon of a drugstore, the pharmacist in the LS17 area inclusion care system returned to the drugstore 狭間研至 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2016.

---

	LS18 pharmacist-related policy trend and use promotion of the generic drug 川上純一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2016.

---

	LS19 Colon cancer chemotherapy to make team medicine successful - What pharmacists can do with doctors - 石橋敬一郎, 佐野元彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2016.

---

	With the cost effectiveness evaluation of the LS20 medicine? Situation of ... foreign countries and domestic future ... 五十嵐中 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2016.

---

	You aim at the prescription of treatment with Chinese medicine - physician carried out by the LS21 many types of job, and are you found? ... 間宮敬子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2016.

---

	LS22 locomotive syndrome and osteoarthritis 星野雄一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2016.

---

	After LS23 stomach cancer, an operation in colon cancer about adjuvant chemotherapy and the management 山口研成 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2016.

---

	Invention ... for point - adherence improvement of LS24 life-style related diseases treatment that we want to suppress 桝田出 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2016.

---

	It is ... from adequacy of the LS25 medical therapy and role - instruction of the pharmacist to behavior 中村敏明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2016.

---

	ADPKD practice from LS26 this 瀬田公一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2016.

---

	In the LS27 new antiepileptic drug, the TDM is necessary! - Message - from a clinician to a pharmacist 岩崎俊之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2016.

---

	cost and value of LS28 lung cancer treatment 國頭英夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2016.

---

	To shine as a deepening, breeding - medical care person of the pharmacist power that clinical pharmacy opens up in the 27th Japan cure association annual convention holding more; ... 大森栄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2-2, 2017.

---

	For development of the clinical pharmacy 佐々木均1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 127-127, 2017.

---

	Medical ethic and study ethic 福嶋義光1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 130-130, 2017.

---

	Application to the neurologic regenerative therapy of the iPS cells technology and a disease study 岡野栄之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 131-131, 2017.

---

	About the review of the medical safety management system in the special functioning hospital 山手政伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 132-132, 2017.

---

	Practice of the cancer precision medicine by the exhaustive cancer genetic screening 西原広史1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 133-133, 2017.

---

	University hospital administration of the future intention 山本修一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 134-134, 2017.

---

	Medical practice ... based on patients-centered polypharmacy measures - decision-making joint ownership and sense of values 宮田靖志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 135-135, 2017.

---

	Development - as the social infrastructure technology of clinical application - next generation of the next-generation medical ICT generic technology 矢作尚久1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 142-142, 2017.

---

	Pharmaceutical intervention in the foreign chemotherapy and clinical outcome of the interactive information sharing 河添仁1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 143-143, 2017.

---

	Relations with blood fentanyl levels and 4β-hydroxylation cholesterol level based on the CYP3A5 gene type in patients with cancerous pain and sex differences 石田卓矢1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 144-144, 2017.

---

	The Teicoplanin initial administration plan in the decreased renal function patients: Examination of the usefulness of the high-dose loading dose 植田貴史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 145-145, 2017.

---

	Study on application to identification and the side effect prophylaxis construction of the onset of drug-related side effect predictor 岡田直人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 146-146, 2017.

---

	Application to development and clinical practice of the agent diagnostic using the radioactivity label 加納大輔1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 147-147, 2017.

---

	Study on side effect measures in the use of the Clozapine which aimed at the recovery of patients with treatment-resistant schizophrenia 竹内一平1,2, 半谷眞七子2, 宇野準二1, 藤田潔1, 亀井浩行2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 148-148, 2017.

---

	Study on pharmaceutical products evaluation in the cancer chemotherapy using the mathematics model 地嵜悠吾1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 149-149, 2017.

---

	3-9-SP1-1. Efforts - of the personnel training - Ogaki Municipal Hospital by "a team system" and "visualization" 吉村知哲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 151-151, 2017.

---

	3-9-SP1-2. Duties, education, a study: Way of raising of pharmacist human resources based on a tissue idea and a policy 川上純一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 152-152, 2017.

---

	3-9-SP1-3. Thought - as activated - chief pharmacist of upbringing and the tissue of the clinical pharmacist 佐藤透1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 153-153, 2017.

---

	3-9-SP1-4. It is made with personnel training and tissue in Showa University 佐々木忠徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 154-154, 2017.

---

	4-13-SP2-1. The leadership that is sought by a pharmacist: The current situation and problem 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 155-155, 2017.

---

	4-13-SP2-2. Art of the leader of only 1% which people are not doing of 99% 河野英太郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 156-156, 2017.

---

	4-13-SP2-3. From efforts of leadership COML making we raise the motivation of the member and power concentrated 山口育子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 157-157, 2017.

---

	4-13-SP2-4. Leadership - to tie - specialty and tissue when we think about a female leader daringly 石井伊都子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 158-158, 2017.

---

	4-13-SP2-5. Mental attitude to show - strong leadership to tear a frame 松原和夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 159-159, 2017.

---

	5-13-SP3-1. We understand AI definitely and open up the future 澤智博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 160-160, 2017.

---

	5-13-SP3-2. The current situation and possibility of the AI drug discovery 奥野恭史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 161-161, 2017.

---

	5-13-SP3-3. Application of the artificial intelligence (AI) in the cancer genomic medicine 東條有伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 162-162, 2017.

---

	5-13-SP3-4. New pharmacist support tool utilizing the AI 木村隆夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 163-163, 2017.

---

	3-4-IS1-1. Critical care pharmacists in Japan Mikihiro Maeda1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 168-169, 2017.

---

	3-4-IS1-2. Retrospective study of the effects of rhTPO and rhIL-11 on chemotherapy induced thrombocytopenia in solid tumors Li Huan1,2, Zhang Zhi-Sheng1,2, Yu Bo2,3, Zhai Qing2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 170-170, 2017.

---

	3-4-IS1-3. Clinical Pharmacist Interventions in Intensive Care Units in Korea. Yu-Ri Choi1, Hyo-Jung Park1, Yong-Won In1, Young-Mee Lee1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 171-171, 2017.

---

	3-4-IS1-4. Delivering value of Clinical Pharmacists in Oncology Care : The Singapore Experience Lita Chew Sui Tjien1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 172-172, 2017.

---

	3-4-IS2-1. Pharmacokinetic / pharmacodynamic evaluation of sulbactam against Acinetobacter baumannii infections Kazuaki Matsumoto1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 173-174, 2017.

---

	3-4-IS2-2. Molecular basis for resistance to anti-cancer drugs and development of agents that reverse the resistance Ryuji Ikeda1, Yasuo Takeda2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 175-175, 2017.

---

	3-4-IS2-3. Utilization of laboratory data at community pharmacy in Japan Yoko Ino1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 176-176, 2017.

---

	3-4-IS2-4. The role of pharmacists for effective inhalation therapy Junko Tsukamoto1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 177-177, 2017.

---

	3-4-IS2-5. The current situation surrounding medical services and a role of family pharmacist / pharmacy Mai Itagaki1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 178-178, 2017.

---

	3-4-IS2-6. The role of community pharmacists in cancer therapy : current situation and future perspective Yuko Kanazawa1, Minori Yamaguchi1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 179-179, 2017.

---

	3-1-S1-1. Clinical reactions of drugs of the immune checkpoint inhibitor 寺田智祐1, 須藤正朝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 180-180, 2017.

---

	3-1-S1-2. Clinical experience of the immune checkpoint inhibitor 藤阪保仁1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 181-181, 2017.

---

	3-1-S1-3. Efforts in clinical department for the cancer immune therapy and type of job crossing-like support Keio University Hospital 浜本康夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 182-182, 2017.

---

	3-1-S1-4. Role of the pharmacist for proper use promotion of the immune checkpoint inhibitor 渡邊裕之1, 秦晃二郎1, 佐田裕子1, 増田智先1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 183-183, 2017.

---

	3-1-S2-1. Way - Introduction ... to the supportive care individualization that a pharmacist opens up 鈴木賢一1, 辻大樹2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 184-184, 2017.

---

	3-1-S2-2. Individualization of infusion reaction measures 葉山達也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2017.

---

	3-1-S2-3. Individualization of retching, vomiting measures 辻大樹1, 清水久範2, 鈴木賢一3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2017.

---

	3-1-S2-4. Individualization for the neutropenia to raise Dose intensity 野村久祥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2017.

---

	3-1-S2-5. Possibility to individualization judging from the pazopanib pharmacokinetics in malignant soft part tumor and renal cell carcinoma 青山剛1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2017.

---

	3-1-S3-1. To become a pharmacist shining in first aid, an intensive care domain; of - book symposium aim; - 中馬真幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2017.

---

	3-1-S3-2. We think about route management, phlebitis in first aid, the intensive care domain 中野貴文1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2017.

---

	3-1-S3-3. Have a pharmacist in bedside; is grasp of the hemodynamics and intervention to medical treatment 川口奈奈子1, 木戸圭晋1, 上田宏1, 五十嵐努1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2017.

---

	3-1-S3-4. We think about the acute renal failure in first aid, the intensive care domain and pharmaceutical intervention in the TDM! 段林正明1, 高橋一栄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2017.

---

	3-1-S3-5. Pain, unrest, delirium 橋本麻衣子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2017.

---

	3-1-S3-6. Medical treatment intervention based on the systemic evaluation in first aid, the intensive care 添田博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2017.

---

	3-2-S4-1. In antimicrobial proper use - AMR measures, the front of it linking the area - 継田雅美1, 浅田真一1, 齊藤幹央1, 冨塚江利子1, 宮下しずか1, 安藤昌幸1, 高津徳行1, 小林靖奈1, 杉原多公通1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2017.

---

	3-2-S4-2. Hospital pharmacist for the antimicrobial proper use in the area and cooperation of the health insurance pharmacy 寺沢匡史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2017.

---

	3-2-S4-4. Background of "non-" appropriate use of the antimicrobial in the treatment at home 齊藤直裕1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2017.

---

	3-2-S4-5. Antimicrobial proper use in the area 大曲貴夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2017.

---

	3-2-S5-1. Perioperative duties of the pharmacist in the operating room 板井進悟1, 磯田和也1, 本田恭子1, 原祐輔1, 嶋田努1, 崔吉道1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2017.

---

	3-2-S5-2. It is venous thromboembolism management ... after the operation to work on after the operation by pharmaceutical management - team in patients 冨澤淳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2017.

---

	3-2-S5-3. With the role that a pharmacist should take for preoperative evaluation - perioperative period for the surgery patients - 阿部猛1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2017.

---

	3-2-S5-4. Role of the health insurance pharmacy pharmacist in the management before operation of the surgery patients 柄澤忍1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2017.

---

	3-3-S6-1. Deglutition of the condition of a patient and the medicine for eating dysphagia 藤島一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2017.

---

	3-3-S6-2. At-home pressure sore and nourishment 塚田邦夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2017.

---

	3-3-S6-3. Of eating dysphagia in being at home, actually 戸原玄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2017.

---

	3-3-S6-4. The thing which we see from "how do you take medicine?" 小原道子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2017.

---

	3-3-S6-5. The thickness adjustment food influences expression of collapse, the elution of the fast disintegration tablet including the orally disintegrating tablet and the efficacy 富田隆1, 幸田幸直2, 工藤賢三1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2017.

---

	3-3-S7-1. Medical treatment aiming at long-term renal graft survival 牛込秀隆1, 大東真理子2, 広中梨沙2, 大坂雅史1, 原田俊平1, 中村緑佐1, 昇修治1, 飯田拓1, 四方敬介2, 吉村了勇1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2017.

---

	3-3-S7-2. The pharmaceutical management in the Nagoya second Red Cross hospital and problem about the seamless cooperation 安田知弘1, 木全司1, 木下元一1, 今井美登子2, 後藤憲彦3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2017.

---

	3-3-S7-3. Approach about the carelessness medicine in renal-transplant recipients 林八恵子1, 高道恵理子1, 塚本有子1, 秋岡清一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2017.

---

	3-3-S7-4. A fact and problem of efforts and the medicine medicine cooperation of the kidney transplantation self-care notebook making in the Tomigusuku center Hospital 大城瑠奈1, 上原あかね1, 上原千晶1, 屋嘉部生子2, 前原礼子3, 大田守人4, 橋本孝夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2017.

---

	3-3-S7-5. Efforts at the health insurance pharmacy in the medicine medicine cooperation of renal-transplant recipients 齋藤譲二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2017.

---

	3-3-S7-6. Efforts of the pharmacist for the purpose of the seamless medical therapy in the kidney transplantation 平田憲史郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2017.

---

	3-3-S8-1. The faculty of medicine, the current situation and problem of the clinical nutrition education in the NST educational facility 田中芳明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-217, 2017.

---

	3-3-S8-2. It is ... from the situation of efforts, current situation ... university, the clinic of the clinical nutrition education in the pharmacy education 鈴木彰人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2017.

---

	3-3-S8-3. Consideration from current situation and problem - Japan and the United States comparison of the life (before graduation and after graduation) education of Japanese dietitian 雨海照祥1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2017.

---

	3-3-S8-4. Role ... of clinical nutrition - prefectural hospital pharmacist meeting learning on the site 伊東弘樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2017.

---

	3-3-S8-5. Efforts to a vein, the enteral feeding management for the purpose of the pharmacist clinic 池永真子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2017.

---

	3-4-S9-1. Quantitative predictive - repaglinide of the drug interactions based on the physiologic pharmacokinetics model for a case - 工藤敏之1, 伊藤清美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2017.

---

	3-4-S9-2. The pharmacokinetic interaction of pharmaceutical products and the drink: The mechanism analysis based on the gastrointestinal physiology and quantitative prediction 白坂善之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2017.

---

	3-4-S9-3. Drug interactions of the new mechanism: The effect reinforcement of the warfarin through the absorption inhibition of vitamin K by the ezetimibe 高田龍平1, 山梨義英1, 山本武人1, 豊田優1, 鈴木洋史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2017.

---

	3-4-S9-4. Prediction of choler excretion inhibition and the liver damage with the drug 関根秀一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2017.

---

	3-9-S10-1. Construction of the pharmacist education system for physical assessment practice 嶺豊春1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2017.

---

	3-9-S10-2. From the viewpoint of simulation education - physician to a pharmacist aiming at the multi-type of job collaboration - 大澤晋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2017.

---

	3-9-S10-3. The current situation and problem of the clinical skill education in the pharmacy school 内海美保1, 徳永仁2, 高村徳人2, 白川晶一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2017.

---

	3-9-S10-4. We make use of the assessment ability that we learned in daily duties and make use in community medical care 橋本貴尚1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2017.

---

	3-9-S10-5. Joint ownership ... of the process of thinking that used cooperation - simulation education of a nurse and the pharmacist in the surgical system mixture ward 瀬浪典子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2017.

---

	3-9-S11-1. Specialty of the pharmacist whom we constitute cancer team approach in medical care, and the type of job expects 濱敏弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2017.

---

	3-9-S11-2. We evaluate the job of the pharmacist specialized in medical therapy 河原昌美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2017.

---

	3-9-S11-3. Relation with the research activities of the pharmacist specialized in medical therapy and the staff education 内藤隆文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2017.

---

	3-9-S11-4. Acquire an authorized pharmacist specialized in American medical therapy 佐藤暖子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2017.

---

	3-9-S11-5. A specialty and synthesis: The pharmacist image that society seeks 安原眞人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2017.

---

	3-10-S12-1. Process and assay to lead to guidelines revision 三浦昌朋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2017.

---

	3-10-S12-2. A calcineurin inhibitor: Kidney transplantation 竹内裕紀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2017.

---

	3-10-S12-3. A calcineurin inhibitor: Pancreas transplantation 上杉美和1, 松原和夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2017.

---

	3-10-S12-4. A calcineurin inhibitor: Liver transplantation 福土将秀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2017.

---

	3-10-S12-5. A calcineurin inhibitor: Lung transplantation 河崎陽一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2017.

---

	3-10-S12-6. Mycophenolic acid 見野靖晃1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 241-241, 2017.

---

	3-10-S12-7. Everolimus and a calcineurin inhibitor: Heart transplant 増田智先1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2017.

---

	3-10-S12-8. Inflection of the genetic information 新岡丈典1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2017.

---

	3-10-S12-9. The actual situation of the use of generic medicine of the immunosuppressive drug 本間真人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2017.

---

	3-11-S13-1. Significance and role of Academic Detailing for the optimal medical treatment 山本美智子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-246, 2017.

---

	3-11-S13-2. To push forward the proper use of pharmaceutical products 磯部総一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2017.

---

	3-11-S13-3. Expectation to an academic D tailing 齊藤光江1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2017.

---

	3-11-S13-4. It is ... from the situation of future way - company of the pharmaceutical company MR 土井貞1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2017.

---

	3-11-S13-5. Practice of the academic D tailing utilizing the pharmaceutical products comparison system 小茂田昌代1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2017.

---

	3-12-S14-1. One form that a pharmacist of the cottage-hospital out of the district thought about in efforts for the proper use of pharmaceutical products in a local inclusion care system 岸本真1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-252, 2017.

---

	3-12-S14-2. Development of hospital pharmacist duties reflecting the image of treatment at home 荒川隆之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2017.

---

	3-12-S14-3. Relation ... to at-home palliative care by the hospital pharmacist working in role - district core hospital of the hospital pharmacist in the local inclusion care 辻井聡容1,2, 大垣孝文1, 中永かおり1, 今井清隆1, 木瀬大輔1, 上坂一行1, 森山雅弘2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2017.

---

	3-12-S14-4. In a local inclusion care system, how should the hospital pharmacist be associated with pressure sore treatment? 宮川哲也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2017.

---

	3-12-S14-5. In a local inclusion care system, how does the pharmacist manage a psychotropic drug? 別所千枝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2017.

---

	3-12-S14-6. How is the pharmacist associated with nutrition therapy in a local inclusion care system? 樋島学1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2017.

---

	3-12-S14-7. Expectation to the medical care, care integration offer system plan and a pharmacist in Sado 佐藤賢治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2017.

---

	3-12-S15-1. How to gather drug information in the childhood medical therapy 清水啓道1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2017.

---

	3-12-S15-2. I need this to thing - pharmacist who cannot explain it only in physicians 福家辰樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2017.

---

	3-12-S15-3. Instruction to patient to seek to a pharmacist from a child life specialist 原田香奈1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2017.

---

	3-12-S15-4. Education for patients to learn from pediatric allergic educator (PAE) 神林弾1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2017.

---

	3-12-S16-1. About a vaccination system and recent efforts 佐々木康輔1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2017.

---

	3-12-S16-2. Importance of the perinatal vaccination 山口晃史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2017.

---

	3-12-S16-3. Importance of the childhood vaccination 石川洋一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2017.

---

	3-12-S16-4. Preparation chemistry of the vaccine 西圭史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2017.

---

	3-13-S17-1. Expectation to AMR measures and a pharmacist 大曲貴夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2017.

---

	3-13-S17-2. Response of the drugstore pharmacist in AMR measures 宮崎長一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2017.

---

	3-13-S17-3. How do you practice Antimicrobial stewardship as hospital pharmacist? 小阪直史1,2, 四方敬介1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2017.

---

	3-13-S17-5. Clinical Pharmacometrics for antimicrobial proper use support (Antimicrobial Stewardship) 辻泰弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2017.

---

	3-13-S17-6. How are you concerned with surveillance of the use of antimicrobial? 村木優一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2017.

---

	3-13-S18-1. Anaphylactic pathogenesis with the drug, onset factor and evasion measures 宇野勝次1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-274, 2017.

---

	3-13-S18-2. Practice of the drug-related liver damage assessment 前田頼伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2017.

---

	3-13-S18-3. The nephropathic pathogenesis with the drug, the onset factor and the correspondence 平田純生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2017.

---

	3-13-S18-4. The diagnosis support of the cardiovascular system side effect of pharmaceutical products and the correspondence 長沼美代子1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2017.

---

	3-13-S19-1. The purpose explanation that "thinks about the adverse event that cannot be settled of the anticancer therapeutic drug from the cut end of the brain science" 野村久祥1, 松尾宏一2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2017.

---

	3-13-S19-2. Cranial nerve dysfunction with the anticancer medicine 三島健一1, 入江圭一1, 山下郁太1, 松尾宏一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2017.

---

	3-13-S19-3. Image of mentation change in the chemotherapy to examine from a model animal and condition of a patient 北村佳久1, 千堂年昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2017.

---

	3-13-S19-4. Cognitive dysfunction (chemobrain) with the cancer medical therapy 小川朝生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2017.

---

	3-14-S20-1. Can the pharmacist become advance care planning facilitator (ACPF) as the interpersonal support job? 西川満則1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-283, 2017.

---

	3-14-S20-2. Relation to ACP of the hospital pharmacist in the team approach in medical care (EOL care team) 土井直美1, 小林理穂2, 西川満則3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2017.

---

	3-14-S20-3. It is ... from experience of the ACP as need - Care manager of the advance care planning (ACP) as the interpersonal support job 大城京子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2017.

---

	3-14-S20-4. Relation of the pharmacist to "the thought of patients, the family" in the at-home palliative care 白石丈也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2017.

---

	3-14-S20-5. Efforts of "the family drugstore" utilizing the relation ... drug remedy history management blotter to the advance care planning that a drugstore is done 宇都宮励子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2017.

---

	3-14-S21-1. Trend of the genome information utilization support system development 松下まゆみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2017.

---

	3-14-S21-2. An evaluation and problem of the usefulness of the genome information utilization support system 山本和宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2017.

---

	3-14-S21-3. Inflection of the genome information utilization support system by the pharmacist 岩本卓也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2017.

---

	3-14-S21-4. An electronic medical chart and study of the section system to support genomic medicine 安藝理彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2017.

---

	3-14-S21-5. Joint project with construction - United States Stanford University of the database supporting genomic medicine 橋本康弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2017.

---

	4-1-S22-1. Examination ... about the effect of the pharmacist intervention from position of the hospital pharmacist to patients with ... outpatient department cancer pain 山田正実1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2017.

---

	4-1-S22-2. It is ... about the current situation and problems in the medication counseling of the drug for ... medical care from position of the hospital pharmacist 原伸輔1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2017.

---

	4-1-S22-3. Analytical technique ... of clinical studies data associated with the mild medical care by ... pharmacist from the position of the analysis person in charge 矢野義孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2017.

---

	4-1-S22-4. Attempt ... of the outcome evaluation by the pharmaceutical support and pharmacist intervention from the situation of the physician of the palliative care to the patients who expect it of ... pharmacist 端裕之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2017.

---

	4-1-S23-1. Diabetes, high blood pressure 嶋村弘史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2017.

---

	4-1-S23-2. Nephritis, nephrotic syndrome, vasculitis 高坂聡1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2017.

---

	4-1-S23-3. Complications - anemia, bone ... which needs management 高山慎太郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2017.

---

	4-1-S23-4. Key to understanding of the medical treatment evidence and applied - adequacy ... 鈴木大介1,2, 畔柳敏弥1, 杉山正2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2017.

---

	4-1-S23-5. Medical treatment instruction and specialized pharmacist - hospital pharmacist and skill ... which a health insurance pharmacy pharmacist is demanded from 小泉祐一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2017.

---

	4-1-S24-1. Authorized examination results and trends such as pharmacists, and the like specialized in a 2016 cancer 濱敏弘1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2017.

---

	4-1-S24-2. Summary (1) of the summary of the case 市川和哉1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2017.

---

	4-1-S24-3. Summary (2) of the case summary 坂田茂代1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2017.

---

	4-1-S24-4. Summary (3) of the case summary 前田章光1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2017.

---

	4-1-S24-5. Summary (4) outpatient department chemotherapy (pancreatic cancer) of the case summary 市田泰彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2017.

---

	4-1-S24-6. Summary (small cell lung cancer of elderly people) of a fact and the case summary of the pharmaceutical intervention 組橋由記1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2017.

---

	4-2-S25-1. Definition/concept of sepsis and pathophysiological update 志馬伸朗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2017.

---

	4-2-S25-2. Update 2017 of painkilling, the sedative management in sepsis 吉廣尚大1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2017.

---

	4-2-S25-3. Nourishment management up date in the septicemic treatment 安藝敬生1, 山野修平2, 若杉和美1, 坂元利彰1, 北原隆志1, 佐々木均1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2017.

---

	4-2-S25-4. Circulation management in sepsis 原直己1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2017.

---

	4-2-S25-5. Update of infection treatment in sepsis 前田幹広1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2017.

---

	4-2-S26-1. A dicow yl infection and congenital problem 高崎智彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2017.

---

	4-2-S26-2. Management of a toxoplasma infection and mother children 山崎香織1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2017.

---

	4-2-S26-3. Management of a cytomegalovirus infection and mother children 長谷川まゆみ1, 山根律子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2017.

---

	4-2-S26-4. Management of an influenza virus infection and mother children 八鍬奈穂1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2017.

---

	4-3-S27-1. Control of resilience engineering theory ... complicated adaptation system to fluctuate 中島和江1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2017.

---

	4-3-S27-2. The description of the hospitalization dispensary duties based on the resilience engineering theory and analysis 木下徳康1,2, 上間あおい1, 原伸輔2, 勝浦正人2, 徳永あゆみ1, 北村温美1, 門脇裕子2, 三輪芳弘2, 中島和江1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2017.

---

	4-3-S27-3. Pharmaceutical products safety management from the tissue cross-sectional viewpoint using the incident report 荒井有美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2017.

---

	4-3-S27-4. A practice case: Polypharmacy outpatient department as the multi-type of job cooperation intervention 矢吹拓1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2017.

---

	4-3-S28-1. Mental attitude in the circulatory organ domain 佐古守人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2017.

---

	4-3-S28-2. Possibility of the intervention by the pharmacist in the ischemic heart disease domain 上田浩貴1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2017.

---

	4-3-S28-3. Possibility in the arrhythmia disease 梶原洋文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2017.

---

	4-3-S28-4. Possibility in the heart failure disease 堀内望1, 岸田有希子1, 野崎歩1, 小林由佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2017.

---

	4-3-S28-5. Thing to buy to a pharmacist concerned with the circulatory organ domain as a circulatory organ specialist 大八木秀和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2017.

---

	4-3-S29-1. Approach of the prescription review from a physician 竹屋泰1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2017.

---

	4-3-S29-2. It is ... mainly on pharmaceutical viewpoint - pharmacokinetics and drug interactions in the polypharmacy of elderly people 大野能之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2017.

---

	4-3-S29-3. Efforts to the prescription review by the polypharmacy reduction team 宮澤憲治1, 溝神文博1, 早川裕二1, 加藤雅斗1, 真野澪1, 平野隆司1, 荒井秀典2, 高橋朗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2017.

---

	4-3-S29-4. Communication necessary for a prescription review 平井みどり1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2017.

---

	4-3-S29-5. Including cooperation of way of thinking - medical care, the care of the medication support necessary for a prescription review 川添哲嗣1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2017.

---

	4-4-S30-1. Approach to the medical therapy adequacy in children 齊藤順平1, 石川洋一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2017.

---

	4-4-S30-2. It is the medical treatment of the antiepileptic drug in the stage AYA from childhood 山本吉章1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2017.

---

	4-4-S30-3. Drug administration support in the stage AYA with the pregnancy 赤嶺由美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2017.

---

	4-4-S30-4. The safety management of the elderly people medical therapy 溝神文博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2017.

---

	4-4-S30-5. About the drug administration design support accompanied with the organ ability drop by the aging 松元一明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2017.

---

	4-8-S31-1. The adherence management of the oral therapeutic drug which is able because it is a pharmacist 川上和宜1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2017.

---

	4-8-S31-2. Approach for the improvement in medication adherence which a local drugstore practices 手嶋無限1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2017.

---

	4-8-S31-3. Importance of the adherence evaluation of the HIV therapeutic drug 増田純一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2017.

---

	4-8-S31-4. Practice of the adherence evaluation of the oral anticancer medicine 小林一男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2017.

---

	4-8-S31-5. Effect of the medical treatment management based on the protocol in the COPD inhalation therapy 塩飽英二1, 土手賢史1, 金子忍1, 小林由佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2017.

---

	4-8-S31-6. Keep adherence; and is ... hepatitis C pharmacist outpatient department ... the maximization of the treatment result 山本晴菜1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2017.

---

	4-9-S32-1. An origin and the times background of the Choosing Wisely campaign 小泉俊三1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2017.

---

	4-9-S32-2. From efforts of global expanse - Australia of Choosing Wisely - 山本美智子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2017.

---

	4-9-S32-3. Efforts in the university hospital 西岡達也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2017.

---

	4-9-S32-4. Communication of Choosing Wisely and medical person, patients 北澤京子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2017.

---

	4-9-S32-5. Choosing Wisely to regard as medical security from a clinical ethic 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2017.

---

	4-9-S33-1. Correspondence to a safe information report system such as pharmaceutical products, medical equipment, and the like bought by a pharmacist 太田美紀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2017.

---

	4-9-S33-2. The current situation and problems of the operation of the safe information report system such as pharmaceutical products, medical equipment, and the like 小原拓1,2,3, 眞野成康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2017.

---

	4-9-S33-3. The accumulation of the information such as the side effects, and the like of pharmacist specialized in a cancer and evaluation of JADER 土屋雅美1,2, 小原拓3, 眞野成康2,3, 高村千津子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2017.

---

	4-9-S33-4. Practice of RMP in the local core hospital and reinforcement of the side effect report system 舟越亮寛1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2017.

---

	4-9-S33-5. Expectation to the promotion of the side effect of pharmacist report 益山光一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2017.

---

	4-11-S34-1. Mitochondrial quality control and adaptation expansion with cilnidipine 西田基宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2017.

---

	4-11-S34-2. The drug repositioning study which utilized large-scale medical information, and intended improvement in survival rate of patients with cardiopulmonary arrest 座間味義人1,2, 小山敏広3, 石澤有紀4, 新村貴博1,4, 今西正樹2, 武智研志5, 堀ノ内裕也4, 桐野靖2, 中村敏己2, 寺岡和彦2, 池田康将4, 藤野裕道6, 土屋浩一郎7, 玉置俊晃4, 石澤啓介1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2017.

---

	4-11-S34-3. Drug repositioning study for anticancer medicine-induced peripheral neuropathy 牛尾聡一郎1, 江角悟1, 北村佳久1, 千堂年昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2017.

---

	4-11-S34-4. Application of the drug repositioning study in oral mucositis treatment 渡邉真一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2017.

---

	4-11-S34-5. A systematic review and drug repositioning study using the adverse drug reaction database 今井徹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2017.

---

	4-11-S35-1. It is ... mainly on the efforts in preparation invention - on koro Gee domain of the generic drug 野沢健児1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2017.

---

	4-11-S35-2. A characteristic of the pharmaceutics of the inhalational powdered drug and new development 岡本浩一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2017.

---

	4-11-S35-3. A characteristic and development trend of the percutaneous absorption preparation 勝見英正1, 山本昌1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2017.

---

	4-11-S35-4. Attempt of the posterior eyes therapy by instillation prescription and the preparation invention that are kind to eyes 長井紀章1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2017.

---

	4-11-S35-5. The intranasal administration of the drug: Characteristic of the distribution after absorption and the administration of drug 坂根稔康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2017.

---

	4-11-S35-6. With the characteristic of the pharmaceutics of the clinical injection drug bought on the site 神谷貴樹1, 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2017.

---

	4-12-S36-1. From <before graduation education> new pharmacy school education to pharmacist lifelong learning 鈴木匡1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2017.

---

	4-12-S36-2. The current situation and problems of the after graduation initial training of the pharmacist 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2017.

---

	4-12-S36-3. The life training of the pharmacist: About a Japanese Society of Hospital Pharmacists hospital pharmacy authorization pharmacist system 本間真人1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2017.

---

	4-12-S36-4. Efforts to pharmacist lifelong learning in the Japan Pharmaceutical Association 宮崎長一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2017.

---

	4-12-S36-5. Authorization, specialized pharmacist system and third party evaluation 松原和夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2017.

---

	4-12-S37-1. Schizophrenia medical treatment guidelines: Practice by the EGUIDE project 橋本亮太1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2017.

---

	4-12-S37-2. Adequacy and antipsychotics reduction 亀井浩行1,2, 岩田仲生2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2017.

---

	4-12-S37-3. About the adequacy of the antiparkinson agent and the pro-anticholinergic drug antiparkinson agent reduction using weight loss - DIEPSS - 佐藤康一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2017.

---

	4-12-S37-4. Adequacy and weight loss of an antianxiety drug, the sleeping drug prescription 吉尾隆1,2, 松尾和廣1, 宇都宮守2, 鶴岡揚大1, 福島美里1, 中谷真樹1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2017.

---

	4-12-S38-1. About a new model core curriculum and the education of the psychiatry domain 三輪高市1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-374, 2017.

---

	4-12-S38-2. Training in the psychiatry neurology ward in the university hospital 佐々木典子1, 池村健治1, 岩本卓也1, 奥田真弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2017.

---

	4-12-S38-3. Finish business training at psychiatry single department hospital; and from the position of ... student - 亀崎仁矢1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2017.

---

	4-12-S38-4. Preparations and problem to accept pharmacy business training 中村友喜1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2017.

---

	4-12-S38-5. To become the occupational therapist who is helpful by current situation - clinical practice of the bedside teaching in the psychiatry domain; ... 村尾利之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2017.

---

	4-12-S38-6. Efforts of the training acceptance burden reduction in the mental hospital 三宅彩香1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2017.

---

	4-13-S39-1. The pharmacy management utilizing BSC in the local acute phase hospital and future problem 礒野淳一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2017.

---

	4-13-S39-2. Efforts to the pharmacy management in the middle scale hospital 小串興平1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2017.

---

	4-13-S39-3. Practice of the pharmacy management in the Seki center Hospital 酒向幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2017.

---

	4-13-S39-4. We aim at the pharmacy that raises management participation in planning awareness by BSC introduction, and acts powerfully 千田泰健1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2017.

---

	4-14-S40-1. It is ... for inflection of evaluation of clinical studies and applied - evidence 飯嶋久志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-385, 2017.

---

	4-14-S40-2. Role of the pharmacist in the multicenter study 橋本浩伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2017.

---

	4-14-S40-3. Why are the medical statistics necessary? ? 山本紘司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2017.

---

	4-14-S40-4. Let's practice clinical studies for the problem solving of the medicine! 小茂田昌代1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2017.

---

	4-14-S40-5. Drug economy evaluation to work on by the multi-type of job 池田俊也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2017.

---

	4-14-S41-3. For the appropriate medication of the nursing facility resident who practiced the cooperation between a pharmacist, the care staff, nurses 白石朗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2017.

---

	4-14-S42-1. Efficacy kinetic analysis of the diabetes therapeutic drug based on clinical record information 前間邦生1,2, 玉城瑶子2, 加唐誠剛東2, 深江真登2, 木下怜子2, 廣田豪2, 家入一郎2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2017.

---

	4-14-S42-2. Inflection of the Pharmacometrics for efficacy, pharmacokinetic evaluations in the true clinical practice 平大樹1,2, 寺田智祐2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2017.

---

	4-14-S42-3. Maintenance of the diabetes therapeutic drug proper use information based on Model-Based Meta-Analysis (MBMA) 家入一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2017.

---

	4-14-S42-4. Medical optimization by the inflection of MBMA 樋坂章博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2017.

---

	5-1-S43-1. Diabetes aggravation prophylactic usefulness by the drugstore pharmacist 井上岳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2017.

---

	5-1-S43-2. Aggravation prevention business of diabetic nephropathy utilizing the community pharmacy in Matsumoto-shi 日野寛明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2017.

---

	5-1-S43-3. Diabetes aggravation prophylactic significance by the multi-type of job cooperation 宮本高秀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2017.

---

	5-1-S43-4. The approach of the country for the diabetic nephropathy aggravation prevention and the national situation 米丸聡1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2017.

---

	5-1-S43-5. Modeling of the diabetes aggravation prevention utilizing community medical care resources 古川綾1,2, 佐藤朝子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2017.

---

	5-1-S44-1. How to use steroid 田中廣壽1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-404, 2017.

---

	5-1-S44-2. - to take a pioneer role of immunosuppressive therapy - immunologic renal disease treatment in the kidney transplantation 竹内裕紀1, 岩本整2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2017.

---

	5-1-S44-3. Problem of the immunosuppressive therapy in the minimal change type nephrotic syndrome 高坂聡1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2017.

---

	5-1-S44-4. Immunosuppressive therapy in the systemic lupus erythematosus 池内秀和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2017.

---

	5-2-S45-1. About team approach in medical care, treatment at home of the heart failure 高野博之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2017.

---

	5-2-S45-2. Examine illness of the heart failure; the role of the pharmacist in the medicine medicine cooperation 森川剛1,2, 久保田健1, 岡澤香津子1, 渡辺徳2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2017.

---

	5-2-S45-3. Attempt of the multi-type of job cooperation by the treatment at home using the ICT system 加藤悠1, 菅原鉄矢2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2017.

---

	5-2-S45-4. It is ... from the position of role ... nurse of the pharmacist in the team approach in medical care of the heart failure 富山美由紀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2017.

---

	5-2-S45-5. Efforts of pharmacy school life, the pharmacist education in Chiba University 関根祐子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2017.

---

	5-3-S46-1. How do practice it in clinical studies ... busy settings "", to solve a problem; ... 川田敬1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2017.

---

	5-3-S46-2. The clinical studies in the emergency domain and application to medical treatment 中野貴文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2017.

---

	5-3-S46-3. - to think from drug economic examination by the regimen observance of clinical studies - cancer chemotherapy for the outcome improvement that a pharmacist conducts 林誠1, 井上裕貴1, 杉村勇人2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2017.

---

	5-3-S47-1. tips (art) and training of the pharmaceutical intervention 橋田亨1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2017.

---

	5-3-S47-2. We can do it at the small and medium size hospital. Relation ... to infection treatment to put up ... motivation, and to be able to work on 橋口亮1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2017.

---

	5-3-S47-3. To make use of blood practice - drug levels of Therapeutic Drug Monitoring definitely; ... 山田智之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2017.

---

	5-3-S47-4. How do you apply it in the patients before utilization - eyes of the drug information in the ward? ... 佐村優1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2017.

---

	5-3-S47-5. ... to challenge in the relation - pharmacist bullet to the decreased renal function patients 浦田元樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2017.

---

	5-3-S47-6. Point to conduct ward duties to be the clinical pharmacist who can contribute to medical treatment 寺沢匡史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2017.

---

	5-4-S48-1. The way of the community medical care cooperation in the super aging society 荒木隆一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2017.

---

	5-4-S48-2. Drug duties and regional alliances in the convalescent bed 樋島学1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2017.

---

	5-4-S48-3. Drug duties and regional alliances in the chronic phase bed 棗則明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2017.

---

	5-4-S48-4. Drug duties and regional alliances in the care health center for the elderly 足岡秀樹1,2, 石倉優子1,2, 柳原美夏1, 嘉本玲子2, 足岡規子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2017.

---

	5-4-S48-5. Cooperation of medical care, the care in the acute phase bed by the information sharing system utilization 小枝伸行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2017.

---

	5-5-S49-1. A young person pharmacist and clinical pharmacy study to think about from an example of our hospital 鈴木陽介1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2017.

---

	5-5-S49-2. Practice of the study based on the drug duties in clinical settings 末次王卓1, 渡邊裕之1, 増田智先1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2017.

---

	5-5-S49-3. Process of clinical studies by the hospital pharmacist 見野靖晃1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2017.

---

	5-5-S49-4. Construction of the information sharing network for development and the "quality of the study" improvement of the "medical quality" improvement-oriented clinical pharmacy study 尾田一貴1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2017.

---

	5-5-S49-5. The clinical pharmacy study that unfolded from "the whisper of the healthcare worker" 田中遼大1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2017.

---

	5-11-S50-1. About the setting of an academic committee and the subcommittee 佐々木均1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2017.

---

	5-11-S50-2. About the action program of the academic subcommittee and a member questionnaire result 伊藤清美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2017.

---

	5-11-S50-3. An evaluation and the management of the drug interactions in the healthcare setting 大野能之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2017.

---

	5-11-S50-4. About drug interactions guidelines revision 樋坂章博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2017.

---

	5-11-S50-5. About the correspondence example to the drug interactions in the healthcare setting 木村丈司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2017.

---

	5-11-S51-1. Problem of an ethic and the PMS of the observational study 松井健志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2017.

---

	5-11-S51-2. Problem of the healthcare setting about securing of ethicality of the postmarketing surveillance 林昌洋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2017.

---

	5-11-S51-3. It is a questionnaire survey about the patients agreement acquisition, the ethic examination in the investigation after the production and sales for the pharmaceutical company 白ケ澤智生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2017.

---

	5-11-S51-4. It is the investigation about ethic examination and the subjects agreement in the trust of the investigation and the enforcement after the production and sales 漆原尚巳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2017.

---

	5-12-S52-1. Summary of three medicine cooperation trials between hospital, drugstore, universities in Keio University 山浦克典1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-443, 2017.

---

	5-12-S52-2. Cooperation trial with Keio hospital pharmacy and the affiliated drugstore 別府紀子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2017.

---

	5-12-S52-3. Examination ... of the tool which is necessary for cooperation - cooperation with hospital, university which we saw from the drugstore 塩津愼二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2017.

---

	5-12-S52-4. Efforts of medicine, medicine, the medicine cooperation in Showa Pharmaceutical University (specialty college) for the revision model core curriculum business training 渡部一宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2017.

---

	5-12-S52-5. From the situation of the university hospital accepting the business training student from the several colleges of pharmacy 木村利美1, 川辺桂太郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2017.

---

	5-12-S53-1. Plan intention of the symposium 北條泰輔1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-452, 2017.

---

	5-12-S53-2. From the situation of - university hospital regarding personnel training as the role of the pharmacist to make drug discovery, clinical studies accelerate - 寺元剛1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 453-453, 2017.

---

	5-12-S53-3. A role and expectation of the pharmacist to accelerate clinical studies 中井清人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 454-454, 2017.

---

	5-12-S53-4. From the situation of - company regarding personnel training as the role of the pharmacist to make drug discovery, clinical studies accelerate - 稲垣治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-455, 2017.

---

	5-12-S53-5. It is ... through ... AMED support projects, and the like to regard personnel training as the role of the pharmacist to make drug discovery, clinical studies accelerate 河野典厚1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 456-456, 2017.

---

	5-14-S54-1. Cooperation with other organizations for disaster medical care 若井聡智1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-458, 2017.

---

	5-14-S54-2. Efforts of the pharmacist society 堀越博一1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2017.

---

	5-14-S54-3. Efforts of the local cooperation hospital 但馬重俊1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-460, 2017.

---

	5-14-S54-4. From the situation of cooperation - public hospital with the administration - 田中恵美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2017.

---

	5-14-S54-5. Efforts of the local basic hospital for disasters 雪本江里子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 462-462, 2017.

---

	5-14-S54-6. Cooperation and personnel training of the pharmacist engaged in a disaster 小林映子1, 佐川剛毅1, 安藤和佳子2, 井上陽平3, 追木正人4, 大塚万記子5, 近藤智幸6, 下石和樹7, 滝澤康志8, 原田真理9, 雪本江里子10, 石田耕太1, 森一博11 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 463-463, 2017.

---

	To prevent effect - fatigue and a pain of the stretching for the making of health, and to dissolve; ... 山本利春1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 482-482, 2017.

---

	Academic F1-1. It is examination about the investigation support after the production and sales of the hospital pharmacist for the pharmaceutical products risk management plan 有馬秀樹1,2, 近藤直樹3, 田崎正信4, 寺元剛5, 水井貴詞6, 渡邉達也7, 近藤智子8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 486-486, 2017.

---

	Academic F1-2. "The research about the pharmaceutical management of the perioperative patients and the pharmacist duties in the operating room" 舟越亮寛1,2, 柴田ゆうか3, 柴田みづほ4, 小西寿子5, 堀内賢一6, 佐藤裕紀7, 古谷一平8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 487-487, 2017.

---

	Academic F2-1. The participation of the pharmacist starting polypharmacy measures and research of the usefulness 武藤浩司1,2, 小田慎3, 佐藤康一4, 澁田憲一5, 樋島学6, 別所千枝7, 吉岡睦展8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 488-488, 2017.

---

	Academic F2-2. Participation of the hospital pharmacist in medical therapy in the convalescence in the local inclusion care system and research of the usefulness 岸本真1,2, 荒川隆之3, 宮川哲也4, 溝神文博5, 藤原久登6,7, 酒向幸8, 川崎美紀9 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 489-489, 2017.

---

	Academic F2-3. Research about the handling of the medical information of the pharmacist accompanied with the revision of the Personal Information Protection Law 池田和之1,2, 岡橋孝侍3, 小枝伸行4, 高田敦史5, 関谷泰明6, 青柳吉博7, 黒田知宏8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 490-490, 2017.

---

	Academic F2-4. We conduct research for becoming it the marketing of the drug necessary for the healthcare setting 渡辺享平1,2, 大津史子3, 後藤伸之2, 佐々木忠徳4, 原田幸子5, 山川雅之6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 491-491, 2017.

---

	LS1-1. Role of the hospital pharmacist sought by community medical care 荒木隆一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 493-493, 2017.

---

	LS1-2. The communicative competence that is demanded from hospital pharmacist in the local inclusion care system 杉本なおみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 494-494, 2017.

---

	LS2. The management of the immune checkpoint inhibitor in Kyushu University Hospital team iCI 渡邊裕之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 495-495, 2017.

---

	LS3. How to use Chinese medicine deepening theory - Chinese medicine to begin with the evidence, use - 飯塚徳男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 496-496, 2017.

---

	LS4. It is ... mainly on generic safety of medicine - country combination research result of the anticancer agent 永井純正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 497-497, 2017.

---

	LS5. Than the example of polypharmacy - Tochigi medical center settled by the multi-type of job - 菅原健一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 498-498, 2017.

---

	LS6. Change, thing ... in there It is ... from ... drug control instruction to ward drug duties 後藤一美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 499-499, 2017.

---

	LS7. We think about adherence of the elderly people atrial fibrillation from the viewpoint of the pharmacist 山村恵子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 500-500, 2017.

---

	LS8. Mainly on strategy and personnel training - cancer medical care to show a pharmacist power - 吉村知哲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 501-501, 2017.

---

	LS10. Operation, management of the treatment with immune checkpoint inhibitor facing it by a team 小泉知展1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 503-503, 2017.

---

	LS11. Tracing report ... as pharmacist duties - information infrastructure which one step stepped into for 2025 萱野勇一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 504-504, 2017.

---

	LS12. Mainly on medical therapy - polypharmacy measures of elderly people - 秋下雅弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 505-505, 2017.

---

	LS13-1. Around team approach in medical care - Rash Management in the lung cancer molecules target treatment from the situation of the physician - 西野和美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 506-506, 2017.

---

	LS13-2. Around team approach in medical care - Rash Management in the lung cancer molecules target treatment than the position of the pharmacist - 中多陽子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 507-507, 2017.

---

	LS14. A stakeholder and risk communication in the cancer medical therapy 濱敏弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 508-508, 2017.

---

	LS15. ... pharmacist searching optimal antiemesis therapy is ... with being able to do it 林稔展1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 509-509, 2017.

---

	LS16. Relation ... that ... production and the quality are close to the production of biomedicine 大政健史1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 510-510, 2017.

---

	LS17. Having learned through sepsis 遠藤重厚1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 511-511, 2017.

---

	LS18. Including the relation of form - pharmacist of medical care and care in the future - 佐々木淳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 512-512, 2017.

---

	LS19. Medical therapy and supportive care of cancer 加藤俊介1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 513-513, 2017.

---

	LS20. Is the team approach in medical care self-satisfaction of the medical person? 川口英俊1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 514-514, 2017.

---

	LS21-1. Paradigm shift of the condition of a patient and the treatment of the gonarthrosis 渡辺淳也1,2, 青木保親1,3, 中嶋隆行1,3, 高澤誠1,3, 久保田剛1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 515-515, 2017.

---

	LS21-2. Medicamentosus nephropathic expression mechanism 増田智先1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 516-516, 2017.

---

	LS22. ... which thinks about heart failure pandemic - ideal-like elderly people heart failure treatment in this country 元木博彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 517-517, 2017.

---

	LS23. How do you explain a generic drug to the nation? ... which deepens the understanding to ... individual differences 澤田康文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 518-518, 2017.

---

	LS24. - to think about the treatment that fixed its eyes on an importance - great vessels disorder of blood sugar, blood pressure, the lipid change in patients with diabetes 坂本昌也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 519-519, 2017.

---

	LS26. The step of the pharmacist authorization system specialized in a cancer and the future prospects 谷川原祐介1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 522-522, 2017.

---

	LS27. Discussion over "G-CSF proper use guidelines" 高野利実1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 523-523, 2017.

---

	LS29. Medical expenses reduction effect by Drug Vial Optimization of the anticancer medicine and anticancer medicine closed system anesthesia drug transportation system (CSTD) 濱宏仁1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 525-525, 2017.

---

	LS30. Glaucoma and instillation adherence 本庄恵1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 526-526, 2017.

---

	LS31-1. Paradigm shift in multiple myeloma treatment 内山倫宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 527-527, 2017.

---

	LS31-2. Medication management to push forward multiple myeloma treatment smoothly 網野一真1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 528-528, 2017.

---

	3-5-O1-01. Relative examination with midazolam blood level and the consciousness evaluation scale in the sedative patients with the liver, the impaired renal function 種田靖久1, 森光輝1, 篠田康孝1, 松村知洋1, 中尾俊也1, 宇佐美英績1, 山口均2, 吉村知哲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 535-535, 2017.

---

	3-5-O1-02. Population pharmacokinetics/pharmacodynamic analysis of the apixaban in patients with atrial fibrillation 上島智1, 平大樹2, 冨塚知歩1, 野村実希1, 木村悠馬1, 山根拓也1, 田淵陽平2, 伊藤英樹3, 大野聖子3, 小澤友哉3, 堀江稔3, 寺田智祐2, 桂敏也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 536-536, 2017.

---

	3-5-O1-03. Blood change of pregabalin in patients with cancer and analysis of the individual differences factor of the onset of central nerve symptom 吉川望美1, 内藤隆文1, 八木達也1, 川上純一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 536-536, 2017.

---

	3-5-O1-04. Examination of the incompatibility with sodium benzoate and other agents and examination of the efficacy change of the agent 林八恵子1, 吉田忍2, 伊藤由佳子3, 門居久嗣1, 遠藤正憲1, 塚本有子1, 西澤嘉四郎2, 河渕真治3, 栄田敏之3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 537-537, 2017.

---

	3-5-O1-05. Effect of CYP3A5 genetic polymorphism giving it to the change between the individual of the quantity of tacrolimus body exposure in renal-transplant recipients and the Everolimus 加賀谷英彰1, 新岡丈典1, 齋藤満2, 井上高光2, 沼倉一幸2, 羽渕友則2, 佐藤滋3, 三浦昌朋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 537-537, 2017.

---

	3-5-O2-06. Effect of the gastric-acid secretion inhibitor to give to pharmacokinetics of the gefitinib 横田隼人1, 小林裕幸1, 佐藤一洋2, 奥田佑道2, 伊藤宏2, 三浦昌朋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 538-538, 2017.

---

	3-5-O2-07. Evaluation of the side effect expression of bosentan by the clarithromycin combination 岩男元志1, 鈴木陽介1, 佐藤雄己1, 伊東弘樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 539-539, 2017.

---

	3-5-O2-08. Inspection of the effect that CYP2C19 genetic polymorphism gives to drug interaction of etizolam and itraconazole 山本武人1,2, 降旗謙一3,4, 樋坂章博5, 森豊隆志6, 大越和章3, 草山静子3, 本橋慧樹7, 森敬子1, 岩坪威7,8, 鈴木洋史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 539-539, 2017.

---

	3-5-O2-09. The change of blood tacrolimus levels early after the renal transplantation: Effect of the CYP3A gene expression with interleukin-6 榎屋友幸1, 池村健治2, 濱田裕悟2, 西川晃平3, 岩本卓也1,2, 杉村芳樹3, 奥田真弘1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 540-540, 2017.

---

	3-5-O2-10. Analysis ... of the CYP3A expression of fundamental researches - liver drop mechanism about the pharmacokinetic safety of the highly-concentrated green tea polyphenol 五十嵐信智1, 小川壮介1, 廣部隆太1, 今理紗子1, 楠欣己1, 山下真鈴1, 水上七帆1, 金子未歩1, 杉山清1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 540-540, 2017.

---

	3-5-O3-11. Comparison of the usefulness of the non-fixed form antipsychotics for the Parkinson's disease patients by the Bayes style meta analysis 池谷怜1, 川崎洋平1,2, 山田浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 541-541, 2017.

---

	3-5-O3-12. Usefulness of the examination of blood clotting for the hemorrhagic side effect of apixaban 梅山遥1,2, 片田佳希1, 中川俊作1, 丸山志穂子1, 松田裕也1, 尾崎淳子1, 齋藤成達2, 米澤淳1, 中川貴之1, 松原和夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 542-542, 2017.

---

	3-5-O3-14. The blood toxicity with the SP therapy is a useful predictor of a survival period and the pathological tissue response rate 奈良克彦1, 山下裕玄2, 山本武人3, 大久保聡1, 高田龍平1, 瀬戸泰之2, 鈴木洋史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 543-543, 2017.

---

	3-5-O3-15. The manufacture of the new hospital preparation seleno orally disintegrating tablet and the evaluation 中尾元紀1, 土江亜季1, 松尾世為子1, 畝佳子1, 覺野律1, 吉岡千晶2, 植松勇伍2, 緒方文彦2, 川崎直人2, 長井紀章2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 543-543, 2017.

---

	3-5-O4-16. Estimate of the cutoff value of the rescue use that can distinguish presence or absence of continuous pain in the use of fentanyl quick-release preparation patients 城山亮輔1,2, 山本武人1, 穂積淳2, 岡村知美1,2, 金井良晃2, 高田龍平1, 長瀬幸恵1, 住谷昌彦2, 鈴木洋史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 544-544, 2017.

---

	3-5-O4-17. Examination of the new diabetes onset risk in the statin remedy patients 加藤正太郎1, 三浦昌朋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 545-545, 2017.

---

	3-5-O4-18. Association between perioperative volume of infusion and ileus in the large intestine resection 西健太郎1,2, 守田和憲1, 田上治美1, 高森啓史2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 545-545, 2017.

---

	3-5-O4-19. Suggestion of the new instillation prescription using mineral nanoparticles: Improvement in bioavailability of water-soluble drug carteolol 大竹裕子1, 本田茜1, 岡森那々海1, 上野祥奈1, 岡本紀夫2, 下村嘉一2, 長井紀章1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 546-546, 2017.

---

	3-5-O4-20. Examination - using effect on erectile dysfunction - salt sensitive hypertension model rat of the eplerenone associated with the high blood pressure 浅野岳人1, 片岡智哉2, 岸本大輝3,4, 堀田祐志1, 前田康博1, 川出義浩1, 金山博臣3, 木村和哲1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 546-546, 2017.

---

	3-5-O5-21. Attempt of the governance of the pharmaceutical products-related master in MID-NET 高田敦史1, 朴珍相1, 山下貴範1, 野尻千夏1, 伊豆倉理江子1, 平山ふみ1, 堀田多恵子2, 康東天2, 中島直樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 547-547, 2017.

---

	3-5-O5-22. Of the in-hospital drug information in the drug information room collect it and effectively utilize it 山田千代子1, 小野陽介1, 台蔵剛士1, 藤崎幸代1, 南憲一1, 安田明子1, 山田留美子1, 岡田ちひろ1, 稲垣沙織1, 才田絢加1, 南川知央1, 渡辺真梨奈1, 吉田正暢1, 久保杏奈1, 北侑未1, 米澤美和1, 虎瀬和子1, 下川千賀子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 548-548, 2017.

---

	3-5-O5-23. It is compared the haemorrhage symptom with oral anticoagulant drug (DOAC) with the warfarin by the data mining using adverse drug reaction database (JADER) directly 島戸茜1, 波多野正和1, 山田成樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 548-548, 2017.

---

	3-5-O5-24. Development and clinical evaluations of the side effect monitoring management tool for antipsychotics 石田俊介1, 坂東寛1, 武智研志2, 今西正樹1, 座間味義人1,3, 桐野靖1, 中村敏己1, 寺岡和彦1, 石澤啓介1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 549-549, 2017.

---

	3-5-O5-25. About efforts to conduct attention instruction such as the driving, and the like surely 岩瀬由枝1, 鶴田昌吾1, 山本恭平1, 伊藤友恵1, 大野愛1, 久保田敏行1, 杉浦洋二1, 勝見章男2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 549-549, 2017.

---

	3-5-O6-26. Is there the gender gap in the efforts of the pharmacist for a pregnant woman, the nursing mother? - Thing - that we were able to see it from questionary survey 加藤祥世1, 井出和希2,3, 小林豊1, 北村修1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 550-550, 2017.

---

	3-5-O6-27. The reporting with the drug information offer duties (1) - inside the hospital E-mail in the hospital is transmitted to the staff for local acute phase; or ... 和久津稔1, 黒田和1, 村上絢美1, 佐々木海1, 根本詩織1, 田中敏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 551-551, 2017.

---

	3-5-O6-28. Collection and evaluation of the daily life term of the patients about the side effect using the crowdsourcing 臼井美紗1, 荒牧英治2, 若宮翔子2, 川口美咲3, 丸山順也3, 早川智久3, 青森達3, 望月眞弓3,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 551-551, 2017.

---

	3-5-O6-29. It is examined extraction and the solution to problems in the intelligence after the pharmaceutical products marketing by the MS using the workshop 壁矢健司1, 佐藤宏樹2,3, 堀里子3, 三木晶子3, 三浦康正4, 澤田康文3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 552-552, 2017.

---

	3-5-O6-30. Construction of intelligence, the offer system for OTC pharmaceutical products proper use for registration distributors 望月美里1, 堀里子2, 三木晶子2, 佐藤宏樹2,3, 吉田豊4, 石川香織4, 大石美也4, 澤田康文2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 552-552, 2017.

---

	3-6-O7-01. The anticholinergic load has an influence on the ADL of the rehabilitation to patients with old stroke in the convalescent rehabilitation ward 小瀬英司1, 草間基之1, 平井利幸2, 関利一2, 林宏行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 553-553, 2017.

---

	3-6-O7-02. Examination about the factor affecting the akathisia expression by the Aripiprazole 白濱雅史1, 有村洋平1, 永田健一郎1, 石田茂1, 齊藤麻美1, 渡邊裕之1, 江頭伸昭1, 宮崎恭輔2, 増田智先1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 554-554, 2017.

---

	3-6-O7-03. Fundamental researches about fundamental researches about the dry skin mechanism at anticancer agent Erlotinib remedy 金子未歩1, 横山貴俊1, 吉野真花奈1, 今理紗子2, 楠欣己1, 水上七帆1, 五十嵐信智1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 554-554, 2017.

---

	3-6-O7-04. Investigation about the blood glucose level change of neonates in the indometacin administration 大久保翔1, 赤嶺由美子1, 安達裕行2, 高橋勉2, 三浦昌朋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 555-555, 2017.

---

	3-6-O7-05. Elucidation of neonatal hypoglycaemia frequencies and the risk factor after the impending premature birth treatment with the ritodrine hydrochloride 下川頌子1, 坂田明子1, 嶋田努1, 崔吉道1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 555-555, 2017.

---

	3-6-O8-06. About the effect that the medication counseling by the pharmacist in the child psychiatry outpatient department gives in adherence of the children patient 山下朋江1, 杉本篤言2,3, 吉永清宏2, 折目直樹4, 松崎陽子2, 今井朗子1, 佐藤裕英1, 川原史子1, 高橋栄一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 556-556, 2017.

---

	3-6-O8-07. Association of the medication adherence in patients during oral anticoagulant drug internal use for atrial fibrillation directly and the sick recognition 宮崎元康1, 中島章雄1, 仲村佳彦2, 坂元佑哉1, 後藤美和1, 内山将伸1, 岡村圭祐3, 光武良晃3, 浦田秀則3, 神村英利4, 松尾宏一1, 今給黎修1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 557-557, 2017.

---

	3-6-O8-08. Usefulness evaluation of the medicine medicine cooperation using the interactive tracing report in the treatment with oral anticancer agent 長谷川晃司1, 春名康裕1, 武田智子1, 和田淳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 557-557, 2017.

---

	3-6-O8-09. Result of the cooperation protocol with the local health insurance drugstore which assumed IT a base 平井利幸1, 寺門祐介1, 堀晴香1, 藤貫晴奈1, 渡邉文之2, 篠原久仁子3, 亀井美和子2, 関利一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 558-558, 2017.

---

	3-6-O8-10. The exploring of the new cloudiness factor for patients with Japanese cataract: Amyloid β accumulation aggravates cortex muddiness 長井紀章1, 真野裕1, 大竹裕子1, 柴田哲平2, 久保江理2, 佐々木洋2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 558-558, 2017.

---

	3-6-O9-11. Examination about the hemorrhagic adverse event of anti-platelet agent prasugrel 土井崇1, 芦川直也1, 渡邉操1, 川根誉代1, 佐合裕子1, 永田恵2, 窪田浩之2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 559-559, 2017.

---

	3-6-O9-12. Safe examination of the loading dose of the rivaroxaban apixaban in the deep vein thrombosis 吉田紗理1, 藤江直輝1, 立川奈保美1, 伊藤千恵1, 三島芳枝1, 的場美香1, 高木麻里1, 吉田智江1, 田中恵美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 560-560, 2017.

---

	3-6-O9-13. Analysis of the risk factor of the hypomagnesemia 西村文宏1, 宮村重幸1, 大嶋秀一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 560-560, 2017.

---

	3-6-O9-14. Examination of the factor associated with the side effect expression of nintedanib in our hospital 名取世津子1, 土屋裕伴1, 腮尾成美1, 新井亘1, 増田裕一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 561-561, 2017.

---

	3-6-O9-15. Study on proper use of the transdermal absorbing form preparation in the Parkinson's disease 安高勇気1,2, 藤岡伸助3, 芝口浩智4, 清見文明5, 原暦2, 緒方憲太郎1,2, 坪井義夫3, 神村英利1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 561-561, 2017.

---

	3-6-O10-18. Comparison of the onset of anemia situation by treatment with interferon bass and the treatment in the genotype type 2 hepatitis C with Sofosbuvir bass 大滝康一1,2, 久保靖憲2, 新田悠一朗2, 鈴木智之2, 小竹斗志之2, 三嶋一登2, 小野尚志2, 小川聡2, 福土将秀2, 田崎嘉一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 563-563, 2017.

---

	3-6-O10-19. Comprehensive examination of the physical frailty and drug adverse effect in the elderly inpatient 川上瑛子1,2,3, 大山茜2, 竹屋泰2, 小泉美希1, 中嶋恒男2, 竹屋美幸2, 武田朱公3, 鷹見洋一2, 山本智也1, 伊東範尚2, 山本浩一2, 杉本研2, 三輪芳弘1, 楽木宏実2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 564-564, 2017.

---

	3-6-O10-20. About the polypharmacy measures of the elderly patients in the neurology ward 西田承平1, 林祐一2, 鈴木昭夫1, 小林亮1, 吉見千明1, 犬塚貴2, 伊藤善規1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 564-564, 2017.

---

	3-6-O11-21. Efficiency of promotion and compounding of medicines duties of the pharmaceutical products proper use that the prescription input support task by the pharmacist results in 森木邦明1, 高橋真巳1, 長谷川一将1, 金田達也1, 高根浩1, 島田美樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 565-565, 2017.

---

	3-6-O11-22. The current situation investigation (multicenter study) end results report of the polypharmacy in Tokyo 林太祐1,2, 安武夫2, 城田幹生3, 関礼輔4, 齋藤雅俊5, 新倉卓6, 古屋順一7, 堀井剛史8, 屋城由樹9, 伊藤芳弘10, 奥野靖隆11, 南雲成12, 阿部和史13, 濃沼政美14 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 566-566, 2017.

---

	3-6-O11-23. Risk of developing polypharmacy and associated - multicenter study - in Tokyo of drug control instruction duties 堀井剛史1,2, 安武夫3, 南雲成4, 屋城由樹7, 奥野靖隆5, 古屋順一6, 新倉卓8, 林太祐10, 齋藤雅俊9, 関礼輔11, 城田幹生12, 伊藤芳弘13, 阿部和史15, 濃沼政美14 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 566-566, 2017.

---

	3-6-O11-25. The intervention of the pharmacist is useful in time in therapeutic range control of the warfarin: Retrospective cohort study 安泰成1, 小瀬英司2, 島津明日香2, 吉川明彦1, 林宏行2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 567-567, 2017.

---

	3-6-O12-26. The actual situation of the polypharmacy at blood medical patients hospitalization 諸角一成1, 稲垣淳2, 菊池隆希2, 木下滉子1, 丹村貴之1, 長谷川和徳1, 大矢美緒1, 川合結乃1, 中村康夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 568-568, 2017.

---

	3-6-O12-27. Efforts to the polypharmacy cancellation by the ward permanent residence pharmacist 豊田倫之1, 富施哲也1, 松谷直樹1, 根岸美由紀1, 麻生一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 569-569, 2017.

---

	3-6-O12-28. Screening of the polypharmacy using the bringing medicine evaluation template and analysis of the usefulness 荻上尚樹1, 小久江伸介1, 大野能之1, 白根達彦1, 長瀬幸恵1, 小島太郎2, 秋下雅弘2, 鈴木洋史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 569-569, 2017.

---

	3-6-O12-29. Burden on nurse reduction effect accompanied with the bringing medicine initial intervention by the pharmacist 伊賀正典1, 齋藤彩子1, 亀井陽子1, 井上朋子1, 高野温志1, 向井夏紀1, 松沼篤1, 興野克典1, 藤掛佳男2, 町田充1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 570-570, 2017.

---

	3-6-O12-30. The current situation of the "disease severity for the regular hospital, medical care, nursing necessary degree" of the bringing medicine evaluation 南目梨江1, 柴田智恵1, 南目祐希1, 渡辺美恵子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 570-570, 2017.

---

	3-7-O13-01. Medical safety measures in the mention method standardization enforcement of the oral medicine prescription and the evaluation 小川勝弘1, 安達真紀子1, 涌嶋伴之助1, 金田達也1, 森木邦明1, 秦英司1, 椎木芳和1,2, 島田美樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 571-571, 2017.

---

	3-7-O13-02. Analysis and preventive measures of the incident in the ethical pharmacy against dispensing errors 福士真由美1, 種村菜奈枝1, 漆原尚巳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 572-572, 2017.

---

	3-7-O13-03. About the communalization of doubt inquiry contents 中川義浩1, 大橋邦央1, 桑原貴美子1, 浮池聡子1, 眞弓健介1, 鶴崎泰史1, 山形真一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 572-572, 2017.

---

	3-7-O13-04. Efforts to the preoperation heart ischemia evaluation in the non-operation on the heart patients 平田備子1, 森本さとみ2, 永井京子1, 黒田優5, 坂本元3, 中村洋一郎4, 林太郎6, 大西尚7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 573-573, 2017.

---

	3-7-O13-05. Pharmacist duties in the Aichi Medical University Hospital hospitalization and release support center 井戸田麻由1, 野々垣知行1, 宇野英理子1, 山之内博明1, 大西正文1, 斎藤寛子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 573-573, 2017.

---

	3-7-O14-06. The making of the injection drug dilution set for the purpose of the drug accident decrease and the effect 田中怜1, 大坂巌2, 佐藤哲観2, 對馬隆浩3, 岩本由美子4, 藤井真理子4, 柴本薫4, 三木直子4, 森川歩4, 篠道弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 574-574, 2017.

---

	3-7-O14-07. Establishment of the doubt inquiry system in the foreign chemotherapy 松岡秀和1, 高橋佳代1, 桑原清人1, 石原唯1, 木内直美1, 松岡美樹2, 関根佳代1, 吉田善紀1, 辻村秀樹1, 大谷美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 575-575, 2017.

---

	3-7-O14-08. As for the specialist in nonrecognition newcomer medicines, and the like in the Aichi Medical University Hospital, it is setting, the operation of the evaluation section and example 黒瀬優輔1, 深谷さおり1, 野々垣知行1, 宇野英理子1, 大西正文1, 斎藤寛子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 575-575, 2017.

---

	3-7-O14-09. Efforts in the Aichi Medical University Hospital for the safe use reinforcement of pharmaceutical products out of the adaptation 宇野英理子1, 野々垣知行1, 深谷さおり1, 黒瀬優輔1, 山之内博明1, 大西正文1, 斎藤寛子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 576-576, 2017.

---

	3-7-O14-10. Specialist in nonrecognition newcomer medicine, construction of the in-hospital surveillance system about contraindications, the off-label use 池谷修1, 青森達2, 中田英夫1, 戸枝美奈子1, 山口雅也1, 望月眞弓1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 576-576, 2017.

---

	3-7-O15-12. Investigation about weight loss, the discontinuation situation in the Lenvatinib therapy 恒川龍二1, 前勇太郎2, 横川貴志2, 鈴木亘2, 鈴木賢一2, 高橋俊二3, 須貝威1, 濱敏弘2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 578-578, 2017.

---

	3-7-O15-13. Usefulness of the comprehensive management from an early stage in the foreign pazopanib treatment of the progressive renal carcinoma 藤堂真紀1, 高橋美賀1, 池田勧1, 眞壁秀樹1, 小山政史2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 578-578, 2017.

---

	3-7-O15-14. Examination of ten EGFR mutation-positive non-small cell lung cancer where we introduced Osimertinib into 金永進1, 南貴之1, 筒井俊晴1, 宮下義啓1, 花輪和己1, 小林義文1, 山本誠一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 579-579, 2017.

---

	3-7-O15-15. Investigation ... about the anxiety about challenge (the eighth report) - outpatient department oral chemotherapy to a drugstore, the pharmacist future 大石学1, 末次祐子1, 中尾妃佐1, 光吉杏美香1, 中野一樹1, 祖川由樹1, 栗原朝子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 579-579, 2017.

---

	3-7-O16-16. The effect that intensity of treatment of the GC therapy in the progressive urothelial carcinoma and myelosuppression give to prognosis 笹野知海1, 山本圭祐1, 都甲海1, 中道秀徳1, 矢部勝茂1, 米田達明2, 塩川満1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 580-580, 2017.

---

	3-7-O16-17. Fact-finding of the polypharmacy in patients who received colon cancer chemotherapy 地主隆文1, 鈴木直哉1, 前川英輝1, 木下愛1, 山本翔太1, 藤田果那1, 庄崎沙耶1, 田中耕太1, 山田将悟1, 菊地義明1, 藤林遼1, 高橋誠1, 青田忠博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 581-581, 2017.

---

	3-7-O16-19. The effectiveness and safety in the GEM + nab-PTX therapy 濱武清範1, 小西史子1, 足立那々緒1, 奥村優介1, 美和孝之1, 仲忠士1, 松本弘誠1, 中西輝1, 岩井真里絵1, 福井美礼1, 小島一晃1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 582-582, 2017.

---

	3-7-O16-20. Examination about cost effectiveness and the safety of the ramucirumab + paclitaxel therapy for progress, recurrent stomach cancer 西川智子1, 木村美智男1, 宇佐美英績1, 吉村知哲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 582-582, 2017.

---

	3-7-O17-21. Taste bitter masking of pharmaceutical products by the small molecule peptide 森本栞1, 原口珠実1, 小島穂菜美1, 吉田都1, 内田享弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 583-583, 2017.

---

	3-7-O17-22. The taste bitter masking effect with the drink of zopiclone tablets using the taste sensor and examination of the mechanism 吉田都1, 宇田篤史2, 原口珠実1, 小島穂菜美1, 山本和宏2, 平井みどり3, 内田享弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 584-584, 2017.

---

	3-7-O17-23. Examination about the formulations with the division appliance of the secantless tablet 久志田郁1, 滝町友惠1, 清水善仁1, 高瀬文超1, 多賀允俊1, 山本康彦1, 丹羽修1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 584-584, 2017.

---

	3-7-O17-24. Enhancement and evaluation of the prescription inspection system of the new oral anticoagulant drug utilizing the check sheet 石川直人1, 押切華映1, 坪井真友子1, 高崎新也1, 菊地正史1, 小原拓1, 赤坂和俊1, 木皿重樹1, 松浦正樹1, 山口浩明1, 眞野成康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 585-585, 2017.

---

	3-7-O17-25. Efforts to the physician burden reduction for doubt inquiry 上吹越夕輝1, 伊藤光輝1, 佐野元基1, 堂園陽子1, 村瀬真理子1, 坂野昌志1, 中島博文1, 杉浦茂樹1, 山田洋治1, 寺井文廣1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 585-585, 2017.

---

	3-7-O18-26. An association between experience, knowledge and consciousness about the package insert of the instruction to patient about the driving: Questionary survey 1 quantitative data for staff of general hospital 春日章宏1, 大森一郎1, 山口裕之1, 古川源1, 斉藤晴彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 586-586, 2017.

---

	3-7-O18-27. An association between experience, knowledge and consciousness about the package insert of the instruction to patient about the driving: Questionary survey 2 qualitative data for staff of general hospital 山口裕之1, 大森一郎1, 春日章宏1, 古川源1, 斉藤晴彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 587-587, 2017.

---

	3-7-O18-28. The approach that promoted proper use of the zolpidem tartrate, and reduced a fall fall risk 城田幹生1, 林恵子2, 若杉有希3, 遠藤真理子4, 梅澤正美5, 佐藤英吾6, 佐藤浩子3, 林星舟5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 587-587, 2017.

---

	3-7-O18-29. Investigation of the psychotropic drug involved in the fall in the inpatient 阪岡倫行1, 桑原秀徳1, 静村知恵1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 588-588, 2017.

---

	3-7-O18-30. Proper use promotion ... of construction - midazolam injection of the emphasis management high-risk medicine setting and regime 篠田健一1,2, 桧物拓也1, 松本俊明1, 森田智恵子1, 五十嵐諭二1, 高堂昌子2, 野々村誠2, 風間泰蔵2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 588-588, 2017.

---

	3-8-O19-01. Examination about the effectiveness of the loxoprofen Na for the EGFR tyrosine kinase inhibitor-induced eruption 飯村洋平1, 下村斉1, 今中景子1, 山口学2, 川崎徳仁2, 小中千守2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 589-589, 2017.

---

	3-8-O19-02. The alkalinization agent prevents an irinotecan-induced neutropenia 濱野裕章1, 三井茉綸2, 座間味義人1,2, 新村貴博2, 武智研志3, 岡田直人1, 今西正樹1, 桐野靖1, 中村敏己1, 寺岡和彦1, 石澤啓介1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 590-590, 2017.

---

	3-8-O19-03. Examination - using the order of peg filgrastim administration elligibility cases logistic-regression analysis that paid its attention to predictive - RDI 神林祐子1,2,3, 石川剛2,4, 金沢元洪2, 中嶋佑樹1,2, 河野留美2, 井原憲彦1,2, 田渕祐輔1, 吉田直久4, 細川豊史3, 高山浩一5, 四方敬介1, 田口哲也2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 590-590, 2017.

---

	3-8-O19-04. Comparison with plasma oxaliplatin levels and total platinum concentration about the onset of oxaliplatin-induced accumulation-related peripheral neuropathy prediction 武田茉子1, 武貞和希1, 河渕真治1, 伊藤由佳子1, 栄田敏之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 591-591, 2017.

---

	3-8-O19-05. Effect of IL-6 giving it to thrombocytopenia of the chemoradiotherapy induction using the platinum and the MCP-1 genetic polymorphism 藤田一馬1, 新岡丈典1, 本山悟2, 三浦昌朋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 591-591, 2017.

---

	3-8-O20-06. Experimental examination about the scattering characteristics in the restroom of urinary excreted anticancer medicine 佐藤淳也1, 工藤賢三2, 篠道弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 592-592, 2017.

---

	3-8-O20-07. Examination of the filter method introduction for anticancer medicine exposure monitoring in the work environment of the healthcare worker 中山由理恵1, 入佐俊弘1, 秦晃二郎1, 中嶋一惠1, 橋本昂介1, 石田茂1, 渡邊裕之1, 江頭伸昭1, 増田智先1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 593-593, 2017.

---

	3-8-O20-08. Efforts to a safe examination no bacteria guarantee in the anticancer agent stock of pharmaceutical preparation making for coinfusion duties facilitation 森本麻友1,2, 加納大輔1, 望月伸夫1, 吉野名穂子1, 田中将貴1, 山口卓哉2, 久野真理2, 山口正和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 593-593, 2017.

---

3-8-O20-09. Costs investigation of pharmaceutical economic assessment - TRIPLE study of the standard three-drug antiemesis therapy for the highly emetic chemotherapy in our country 清水久範1, 鈴木賢一2, 内倉健3, 大橋養賢4, 山中竹春5, 橋本浩伸6, 後藤功一7, 松井礼子8, 関順彦9, 島田俊一10, 池田俊也11, 池上直己12, 濱敏弘2, 山本信之13, 佐々木忠徳3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 594-594, 2017.

---

	3-8-O20-10. Prescription suggestion and medical expenses reduction effect in the pharmacist outpatient department on oral anticancer medicine remedy patients 郷真貴子1, 木村美智男1, 川地志緒里1, 川地雄基1, 浅野裕紀1, 岩井美奈1, 宇佐美英績1, 吉村知哲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 594-594, 2017.

---

	3-8-O21-11. The establishment of the absolute level of human serum cetuximab assay which applied electron impact mass spectrometry and comparison with the immunologic assay about the fixed-quantity characteristic 柴田海斗1, 内藤隆文1, 岡村純2, 細川誠二2, 峯田周幸2, 川上純一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 595-595, 2017.

---

	3-8-O21-13. The effect that use of aprepitant at the hematopoietic stem cell transplantation pre-treatment gives in pharmacokinetics of tacrolimus 湯澤薫1, 折山豊仁1, 山本武人1,2, 大野能之1, 鈴木洋史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 596-596, 2017.

---

	3-8-O21-14. Effect of the CYP3A5 genetic polymorphism on blood tacrolimus levels measurements by the ACMIA, CLIA, ECLIA, LTIA method 赤嶺由美子1, 加賀谷英彰1, 佐藤滋2, 三浦昌朋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 597-597, 2017.

---

	3-8-O21-15. Acute rejection after the brain death lung transplantation and examination about the association of blood tacrolimus levels 福井彩香1, 佐藤裕紀1, 杉本充弘1, 中川俊作1, 中川貴之1, 濱路政嗣2, 本山秀樹2, 青山晃博2, 陳豊史2, 伊達洋至2, 松原和夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 597-597, 2017.

---

	3-8-O22-16. Initial dose setting of vancomycin in consideration of the membrane oxygenator for children, the priming volume at sustained hemofiltration dialysis enforcement 諏訪淳一1, 村田美帆1, 熊谷祐梨1, 藤田幹生1, 石原溶子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 598-598, 2017.

---

	3-8-O22-17. The effectiveness and safety of the vancomycin loading dose in the decreased renal function patients 杉田裕貴1,2, 田中絵美1, 久井裕美子1, 細見健悟1, 小牧佐知子1, 稲田智子1, 高子優子1, 増本憲生1, 大槻裕朗1, 岡村昇3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 599-599, 2017.

---

	3-8-O22-18. Factorial experiments of the Ganciclovir-induced neutropenia using the data mining technique 今井俊吾1, 山田武宏1, 小林正紀1, 笠師久美子1, 井関健1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 599-599, 2017.

---

	3-8-O22-19. The identification of the factor involved in onset of hypokalemia with the amphotericin B preparation liposome: Usefulness of the prophylactic potassium preparation administration 岡田直人1, 今西正樹1, 座間味義人1,2, 桐野靖1, 中村敏己1, 寺岡和彦1, 石澤啓介1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 600-600, 2017.

---

	3-8-O22-20. Evaluation of the medicinal solution preparation environment in the ward which assumed atmospheric fine particles and a floating live germ an index 矢野貴久1, 森日登美1, 安永幸枝1, 服部佳奈子2, 諸熊由子1,2, 清祐麻紀子1,2, 神野俊介1, 豊田一弘1, 下野信行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 600-600, 2017.

---

	3-8-O23-21. The system to snuggle up to hope of the medical drug self-care of the palliative care unit inpatient 椎崎正秀1,2, 前間邦生1,2, 原口勝3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 601-601, 2017.

---

	3-8-O23-22. The search of the factor affecting hypercalcemia indicating the resistance for zoledronic acid and the correspondence 有田仁紀1, 坂本真紀1, 大津秀一2, 小杉隆祥3, 西澤健司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 602-602, 2017.

---

3-8-O23-23. Examination of the cancellation time of oral hypoglycemics in consideration of the hypoglycemia risk of the use of strong opioid patients in the cancer terminal phase 岩津慎次郎1,2, 鎌田理沙子2, 高瀬冴子2, 土井綾子2, 西村美馨子2, 本間崇正2, 松丸沙織2, 後藤健志2, 遠山幸男2, 岩田智樹2, 川合甲祐2, 山口智江2, 中根茂喜2, 鷹見繁宏1, 板倉由縁3, 木村和哲4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 602-602, 2017.

---

	3-8-O23-24. Comparison with other opioid of out of the blood after the hydromorphone intravenous administration using the effect part compartment model and the effect part concentrations change 壁谷めぐみ1,2, 湯浅周1,2, 長尾清治2, 久保直子1,2, 日比聡1, 長谷川慎一2,3, 伊奈研次2,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 603-603, 2017.

---

	3-8-O23-25. Factor analysis of the polypharmacy in elderly people with the cancerous pain 森尾佳代子1, 前田一石2, 横田勲3, 仁木一順1, 上島悦子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 603-603, 2017.

---

	3-8-O24-26. Examination about the expression situation and the antiemesis therapy of retching, vomiting at the Carboplatin combination therapy in patients with gynecologic cancer 三好孝法1, 松尾尚美1, 鶴田南奈子1, 川俣洋生1, 弓削乃利人2, 平木洋一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 604-604, 2017.

---

	3-8-O24-27. Example that suffered from side effect measures including chemotherapy-induced retching vomiting (CINV) in the BEP therapy for AYA generation patients 藤本伸一郎1, 吉田宏二1, 中村友紀1, 淺野肇1, 柳江正嗣1, 藤原季美子1, 黒井扶美恵1, 月岡康行1, 森嶋祥之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 605-605, 2017.

---

	3-8-O24-28. Examination about the effectiveness of our hospital antiemetic drug set at the cisplatin administration 上ノ段友里1, 折田博之2, 倉光絵里奈3, 福山康朗3, 富田珠美1, 永田茂之2, 甲斐成一郎2, 縄田好一1, 是永大輔2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 605-605, 2017.

---

	3-8-O24-29. Examination about the dosage of the cisplatin giving poor control of retching 藤井宏典1, 飯原大稔1, 石原正志1, 小林亮1, 鈴木昭夫1, 田中善宏2, 山口和也2, 吉田和弘2, 伊藤善規1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 606-606, 2017.

---

	3-8-O24-30. Digestive organ symptom protective efficacy with the antiemetic at hepatic artery chemoembolisation enforcement using the epirubicin 坂本達彦1, 齋藤佳敬1, 小林正紀1, 山田武弘1, 笠師久美子1, 中井正人2, 小川浩司2, 井関健1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 606-606, 2017.

---

	3-10-O25-01. For business training to connect with fact-finding - lifelong learning of the EBM education in the hospital business training - 榎本貴一1,5, 野澤 (石井) 玲子2, 小坂鎮太郎3,5, 木村泰4,5, 福永貴志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 607-607, 2017.

---

	3-10-O25-02. The efforts of the resident teacher in the business training: Introduction and improvement of the case base type learning in resuscitation/living body information monitor, the examination by a stethoscope training 梅村朋1, 吉見陽1, 白松貴子2, 日比陽子3, 伊藤教道3, 山田清文3, 野田幸裕1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 608-608, 2017.

---

	3-10-O25-03. Attitude survey about the genetic screening for the drugstore in Hiroshima-shi 池田佳代1, 細井徹1, 吉井美智子1, 杉山政則2, 小澤光一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 608-608, 2017.

---

	3-10-O25-04. Change of the consciousness by the attitude survey for the psychiatry prescription to a drugstore pharmacist and the patients in psychiatry communication workshop enforcement 成井繁1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 609-609, 2017.

---

	3-10-O25-05. Analysis of the questionnaire results of the pharmacist upbringing class that can play an active part in the treatment at home of patients with heart failure 大沢沙弓1, 橋本直子1, 石井貴浩1, 三浦剛2, 関根祐子3, 高野博之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 609-609, 2017.

---

	3-10-O26-06. Significance of the follow-up training of the non-expert skill for the accession second year 新井亘1, 増田裕一1, 矢嶋美樹2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 610-610, 2017.

---

	3-10-O26-07. The education training for the pharmacist staff and the construction of the personnel training support system and the evaluation 山本知広1, 八木達也1, 加藤文美1, 青野浩直1, 高井伸彦1, 見野靖晃1, 堀雄史1, 内藤隆文1, 川上純一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 611-611, 2017.

---

	3-10-O26-08. Construction of a pharmacist education ladder, the educational program and examination of problems 井口恵美子1, 阿部多一1, 猪股克彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 611-611, 2017.

---

	3-10-O26-09. Activity contents of the Shiga cancer medical therapy conference aiming at the formation and the personnel training of the network between institutions and the effect 大辻貴司1, 野田哲史2, 須藤正朝2, 光家勉3, 原口久義4, 近藤博紀5, 大岡千寿子6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 612-612, 2017.

---

	3-10-O26-09. Reinforcement of training enforcement and anti-disaster measures in the pharmacy for the disaster 安田親由1, 蜜田哲也1, 種田靖久1, 浅野裕紀1, 松村知洋1, 松岡知子1, 吉村知哲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 612-612, 2017.

---

	4-4-O27-01. The shifts from the carbapenem-based licensing system under the intervention reinforcement system by the pharmacist to a use registration system and evaluation of the usefulness 小野祐志1, 新家恵子1, 村田充弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 613-613, 2017.

---

	4-4-O27-02. Clinical outcome evaluation of the antimicrobial surveillance system in patients receiving carbapenem-based antimicrobial 藤林彩里1, 丹羽隆1,2, 竹市朱里1,2, 鈴木景子1,2, 太田浩敏2, 中山麻美2, 土屋真由美2, 畠山大二郎2, 鈴木昭夫1, 村上啓雄2, 伊藤善規1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 614-614, 2017.

---

	4-4-O27-03. Relations of use metrics of the carbapenem-based antimicrobial in our hospital and the Pseudomonas aeruginosa-resistant rate 三好由希子1, 高根浩1,2, 岡田健作2,3, 森下奨太2,4, 室田博美4, 中本成紀3, 美甘由雅子2, 上灘紳子2, 島田美樹1, 千酌浩樹2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 614-614, 2017.

---

	4-4-O27-04. Examination about ESBL-producing Escherichia coli bloodstream infection treatment 藤居賢1,3, 品川雅明2, 國本雄介1, 清治翔伍1, 木明智子1, 中田浩雅1, 野田師正1, 高橋聡3,4, 宮本篤1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 615-615, 2017.

---

	4-4-O27-05. Chemosensitive change of Escherichia coli under antimicrobial restrictions in our hospital 武田龍馬1, 木村順平1, 半澤里佳1, 原田瑞記2, 山田和範2, 本間和加子1, 中村博彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 615-615, 2017.

---

	4-4-O28-06. An effect and safety of examination - linezolid and quinupristin - dalfopristin of the therapeutic drug for the vancomycin resistant enterococcus bacteremia: Meta analysis ... 渡部智貴1,2, 半田智子2, 新藤学1, 加藤一郎1, 加藤裕久2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 616-616, 2017.

---

	4-4-O28-07. Risk factor of the onset of renal failure with vancomycin 植木哲也1,2,5, 實松絵美子1, 篠原義剛1, 村上由花2, 宮崎晶2, 坂本佳子2, 眞柴晃一3, 中嶋弥穂子4, 中嶋幹郎5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 617-617, 2017.

---

	4-4-O28-08. Clinical outcome evaluation by the proper use intervention to all patients received the antifungal agent parenteral injection 竹市朱里1,2, 丹羽隆1,2, 鈴木景子1,2, 藤林彩里1, 太田浩敏2, 中山麻美2, 土屋真由美2, 山本昌代2, 畠山大二郎2, 鈴木昭夫1, 村上啓雄2, 伊藤善規1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 617-617, 2017.

---

	4-4-O28-09. Examination about the onset situation and the course of the fungal diseases in blood medical patients 岸孝行1, 中川雅史1, 西出貴義1, 中村純子1, 喜多由紀1, 泉本裕美1, 樫葉利人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 618-618, 2017.

---

	4-4-O28-10. Evaluation of the prescription surveillance by the pharmacist for all injectable antimicrobial 大橋健吾1, 松岡知子1, 篠田康孝1, 吉田真也1, 新井かおり1, 竹中梨恵1, 加藤未紗1, 森卓之1, 林秀樹2, 杉山正2, 吉村知哲1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 618-618, 2017.

---

	4-4-O29-11. The use situation in our hospital of the drug that seriously ill hypoglycemia is felt uneasy about 中村栄子1, 竹之下博正2, 茨木一夫3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 619-619, 2017.

---

	4-4-O29-12. Investigation about the use situation and the understanding degree of the medicine for external application for a foot, the nail tinea of patients with diabetes 後藤綾1, 魚住由貴1, 伊藤純子2, 吉川昌江1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 620-620, 2017.

---

4-4-O29-13. The body water rate decrease in the body composition does not occur in four weeks in the early period of SGLT2 inhibitor administration with the water to drink instruction in patients with Japanese type 2 diabetes 西村博之1, 吉田陽1, 塩山由紀1, 守田彩文1, 杉山正悟2, 栗並昇2, 稗島州雄2, 梶原敬三2, 陣内克紀2, 陣内冨男2, 陣内秀昭2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 620-620, 2017.

---

	4-4-O29-14. Look at the rear about the concomitant drug of patients taking SGLT2 inhibitor; a mark observational study 森悠太1, 橋本直子1, 峯昌吾1, 廣瀬雅教2, 長谷川洋2, 高野博之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 621-621, 2017.

---

	4-4-O29-15. The effect that polypharmacy gives for blood sugar control 石郷友之1, 中田圭2, 木明智子1, 中田浩雅1, 野田師正1, 宮本篤1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 621-621, 2017.

---

	4-4-O29-16. Analysis of the onset mechanism of the diabetic xeroderma that paid its attention to water transport protein 水上七帆1, 金子未歩1, 吉野真花奈1, 横山貴俊1, 今理紗子2, 楠欣己1, 五十嵐信智1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 622-622, 2017.

---

	4-4-O30-17. Effect on valacyclovir-induced renal failure comparison of the combination pain-killer using adverse event spontaneous report database FAERS 近藤悠希1, 鶴橋智子1, 赤石彩乃1, 岩崎慎也1, 稲葉一郎1,2, 石塚洋一1, 入江徹美1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 623-623, 2017.

---

	4-4-O30-18. Safe examination of the tolvaptan in patients who had the renal failure 小武和正1, 川上恭弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 624-624, 2017.

---

	4-4-O30-19. The analysis of the antioxidant action of acetaminophen and the metabolite and application to chronic kidney disease treatment 兵藤沙耶1, 門脇大介2, 成田勇樹1, 平田純生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 624-624, 2017.

---

	4-4-O30-20. Examination about the remedy situation and the decreased renal function inhibitory effect of AST-120 三宅健文1, 塩見紗和子1, 松吉延之2, 山村健太2, 田近友美3, 黒田一成3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 625-625, 2017.

---

	4-5-O31-01. Evaluation of the medication counseling to Kawasaki's disease immunoglobulin therapy 綾部ゆか1, 前原美桜1, 佐古有紀1, 田中和行1, 渡辺美和1, 松本俊治1, 佐藤友紀2, 兵藤純夫3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 626-626, 2017.

---

	4-5-O31-02. Look back, and have experience for - Langerhans' cell histiocytosis with pharmaceutical intervention to the orphan disease in the municipal hospital pediatric ward; and - 近藤素代1, 堀内保孝1, 梅沢洸太郎3, 西澤和倫2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 627-627, 2017.

---

	4-5-O31-03. Efforts to medication counseling contents standardization using pediatric medication counseling Tours 富松裕美1, 若杉陽子1, 村上裕子1, 石田茂1, 齊藤麻美1, 渡邊裕之1, 江頭伸昭1, 増田智先1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 627-627, 2017.

---

4-5-O31-04. It is ... through role - drug instruction and the prescription suggestion of the pharmacist for the case that was able to leave suddenly in just before the end-of-life later stage, death period with there not being it of the relation for mild medical care 奥野昌宏1, 高柳信子1, 中田学1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 628-628, 2017.

---

	4-5-O31-05. Efforts and evaluation of medical treatment management (PBPM) based on the protocol of the chemotherapy in the surgery ward 福田未音1, 石田茂1, 益口賢1, 齊藤麻美1, 渡邊裕之1, 中西良太2, 沖英次2, 増田智先1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 628-628, 2017.

---

	4-5-O32-06. The current situation and problem of the pharmacist duties in the convalescent rehabilitation ward 中嶋淑枝1, 箱崎歩美1, 豊澤敦1, 牛尾幸子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 629-629, 2017.

---

	4-5-O32-07. Process before leading to the ward drug duties start in the small and medium size hospital 平野泰健1, 横山佳寿子1, 石垣智加1, 杉本ひろみ2, 竹中ゆかり3, 森信早穂子4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 630-630, 2017.

---

	4-5-O32-08. Efforts (interhospital cooperation in the public corporation Hospital) second report to the education about ward drug duties 畠山卓1, 吉田みず季1, 陳内博之2, 松本麻美2, 滝島さやか3, 新倉卓4, 市川卓哉4, 根岸真利子5, 橋本理恵子6, 星谷佐江子6, 松本智子1, 中村英子7, 松本啓一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 630-630, 2017.

---

	4-5-O32-09. It is ... about the cooperation with a role and multi-type of job cooperation - osteoporosis medical treatment and the doctor of the pharmacist in the orthopedics ward of our hospital at old clinical department 萩行正博1, 重本顕史2, 澤口毅2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 631-631, 2017.

---

	4-5-O32-10. For the cooperation with current situation - ward pharmacist in the pharmaceutical intervention of the operating room pharmacist - 中村将之1, 恩地紀美江1, 松村早希子1, 阪口勝彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 631-631, 2017.

---

	4-5-O33-11. Efforts - of the drug department in appearance care - cancer special hospital which the professional of the anticancer agent provides 田中侑希1, 疋田絵梨1, 清美奈1, 堀口和美2, 白石範子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 632-632, 2017.

---

	4-5-O33-12. Efforts of CDTM in the cancer chemotherapy 高瀬美咲枝1, 清水雅子2, 藤井友紀1,3, 高橋美由喜3, 小川浩平1,4, 経田克則5, 原拓央6, 柴田和彦1,7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 633-633, 2017.

---

	4-5-O33-13. Examination of the intervention effect of the pharmacist on bevacizumab-induced high blood pressure 後藤慎平1, 二瓶哲1,2, 千葉健史1,2, 高橋宏彰1, 木村聡元3, 岩渕修1, 佐藤文彦1, 工藤賢三1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 633-633, 2017.

---

	4-5-O33-14. Examination of the benefit for the encounter improvement in medication adherence by the sitting pharmacist 池川貴和子1,2, 鎌田隼1, 鈴木秀隆1, 出町健1, 五十嵐隆志1, 須釜由香1,3, 鈴木真也1, 高橋邦雄2, 山口正和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 634-634, 2017.

---

	4-5-O33-15. Construction and evaluation of the patients with cancer support system by the pharmacist cooperation 奥田泰考1, 本田泰斗2, 大島香菜3, 加藤誠一4, 大塚祥貴5, 前原央奈6, 稲見玲子7, 高田節子8, 米澤亜耶9, 森美鈴10, 山中都起子10, 山口博紀10, 藤井博文10, 中澤寛仁1, 須藤俊明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 634-634, 2017.

---

	4-5-O34-16. Efforts and evaluation for the Azacitidine appropriate administration 水野貴仁1,3, 深津昌弘1, 小崎耕自1, 梶口智弘2, 大津史子3, 鷹見繁宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 635-635, 2017.

---

	4-5-O34-17. It is an investigation about neutrophil count and the febrile neutropenia before the administration in the paclitaxel therapy of the administration for every three weeks in the ovarian cancer 渡邊裕之1, 吉井由美2, 木村錦子1, 和田良浩1, 久保直子1, 寺田知恵子1, 神野正敏2, 梶井節子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 636-636, 2017.

---

	4-5-O34-18. Approach of the pharmacy using the PDCA cycle in the cancer medical therapy 木全司1, 鈴木雅人1, 高原悠子1, 牧原明秀1, 松丸沙織1, 吉田弘樹1, 木下元一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 636-636, 2017.

---

4-5-O34-19. Examination (multicenter fact-finding) for the commonization of the confirmation item of the pharmacist in the cancer medical therapy regimen 大橋養賢1, 太田貴洋2, 鈴木真也2, 篠原旭2, 元茂拓法3, 植木大介4, 小沼大祐5, 龍島靖明6, 宇田川涼子7, 田路章博8, 家岡昌弘9, 小暮友毅10, 平池美香子11, 魚井みゆき12, 吉野名穂子2, 川崎敏克2, 山口正和2, 谷地豊1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 637-637, 2017.

---

	4-5-O34-20. Is the CDDP short hydration method safe? 小島一晃1, 濱武清範1, 小西史子1, 美和孝之1, 仲忠士1, 松本弘誠1, 中西輝1, 奥村優介1, 飯田有香1, 北英夫2, 菅理晴3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 637-637, 2017.

---

	4-5-O35-21. Intervention of the ward pharmacist to use of ω 3 system lipid microsphere in the NICU 松野薫1, 花井美月1, 横山稔厚1, 向山直樹1, 平井孝典1, 成瀬徳彦1, 水谷年男1, 森一博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 638-638, 2017.

---

4-5-O35-22. One case - that we contributed to lifesaving from pancytopenia by participation in planning - pharmaceutical intervention to team approach in medical care by the pharmacist permanent residence to the ICU 内田淳1, 福嶋知樹1, 橘田文彦1, 原田大希2, 菅原久徳2, 高三野淳一2, 針井則一2, 森口武史2, 手塚春樹1, 河田圭司1, 松田兼一2, 鈴木正彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 639-639, 2017.

---

	4-5-O35-23. The effect that intervention gives to Days of therapy and chemosensitivity on antimicrobial choice in the intensive care unit 澤田真嗣1, 藤田将輝1,2, 中西裕明1, 大山翔1, 堀内あす香1, 近藤大志2, 小野保2, 村木優一3, 岡橋孝侍1, 藤田敦夫1, 下間正隆2, 友金幹視1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 639-639, 2017.

---

	4-5-O35-24. Effect by the pharmacist assignment to the intensive care unit 岡田和博1, 國重志都1, 島崎博士1, 勝俣はるみ1, 鹿瀬陽一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 640-640, 2017.

---

	4-5-O35-25. About intervention to vancomycin initial administration plan in the intensive care unit 曽我弘道1, 福島将友1, 前田朱香1, 福地祐亮1, 清水誉志1, 富田敏章1, 町田聖治1, 入江利行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 640-640, 2017.

---

	4-5-O36-26. Pharmacist intervention effect after the discontinuation protocol introduction for epidural anaesthesia 平井瑞希1, 坂本江里1, 吉田綾奈1, 久保村優1, 長原真梨子1, 岡田慧1, 三浦義彦1, 伊勢雄也1, 片山志郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 641-641, 2017.

---

	4-5-O36-27. Efforts to operating room drug duties in our hospital 日江井和英1, 渡邉裕斗1, 松下隆行1, 安田翔1, 佐藤和也1, 塚原民夫1, 宇佐見文隆1, 堀内正1, 高木久美子2, 梶川真樹3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 642-642, 2017.

---

	4-5-O36-28. Relations of remedy medicine and the delirium onset for acute phase before hospitalization in the ward 細谷龍一郎1,2, 佐藤洋平3, 石田恵充佳4, 鎌田智幸5, 戸根修3, 日野斉一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 642-642, 2017.

---

	4-5-O36-29. Held ... of efforts - Kinki first aid fur Matthew tical rally for the training of the pharmacist who can contribute to emergency care 松井俊典1, 藤江直輝2, 大谷美奈子3, 川口博資4, 服部雄司5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 643-643, 2017.

---

	4-5-O36-30. The current situation and measures of the caffeinism in the lifesaving center 廣瀬正幸1,2, 平川昭彦3, 平岩歳久1,2, 竹本雄一1,2, 今井一輝1,2, 白石洋輔1,2, 加藤貴大1,2, 山田成樹1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 643-643, 2017.

---

	4-6-O37-01. The multi-type of job perception F and efforts to the prescription adequacy in the psychiatry medical treatment ward using the attendance to a physician medical examination 門田善法1, 小原尚利2, 渡辺周3, 堀輝4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 644-644, 2017.

---

	4-6-O37-02. Examination of the effectiveness of the suvorexant for the medical treatment of the delirium 小川博史1, 福田喬士1, 中島悠介1, 前田貴子1, 澤田真嗣1, 村木優一2, 岡橋孝侍1, 藤田敦夫1, 友金幹視1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 645-645, 2017.

---

	4-6-O37-03. Relations of a benzodiazepine system/non-benzodiazepine system sleep inducing drug and the delirium 加藤豊範1, 加藤亜起1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 645-645, 2017.

---

	4-6-O37-04. 1 case ... which was able to contribute to relation ... neurologic manifestation control with patients with at-home advanced age cancer admitted to the mental hospital 加藤剛1,4, 宗像彩香1, 澤口真紀1, 北川綾子1, 鈴木隆晴2, 小野田忠3, 鈴木順子4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 646-646, 2017.

---

	4-6-O37-05. Effect of the CYP2D6 genetic polymorphism giving it to onset of extrapyramidal symptoms in patients with schizophrenia 伊藤雄大1, 山本和宏1, 西岡達也1, 久米学1, 槇本博雄1, 大塚郁夫2, 菱本明豊2, 曽良一郎2, 平井みどり1, 矢野育子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 646-646, 2017.

---

	4-6-O38-06. Effect of the cerebral fluid transitivity in the treatment with vancomycin on patients with childhood bacterial meningitis 甚目陽子1, 中島優子1, 加藤美樹1, 見崎知子1, 竹内正幸1, 山之内博明1, 大西正文1, 斎藤寛子1, 上甲眞宏2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 647-647, 2017.

---

	4-6-O38-07. One case of the infants who conducted vancomycin medical treatment monitoring under the sustained dialysis enforcement 潮平英郎1,2, 伊差川サヤカ1, 山田智史1, 砂川智子1, 仲松正司2,3, 与那覇房子1, 外間惟夫1, 藤田次郎2,3, 中村克徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 648-648, 2017.

---

	4-6-O38-08. Examination of the initial administration plan in the Teicoplanin administration 堀内あす香1, 澤田真嗣1, 藤田将輝1, 中西裕明1, 村木優一2, 岡橋孝侍1, 藤田敦夫1, 友金幹視1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 648-648, 2017.

---

	4-6-O38-09. Development of the renal function monitoring tool in the psychiatry special hospital 北村郁1, 早船真弘2, 川瀬公一1, 石井正巳1, 岩爪昭子1, 與田美穂子1, 山村康比古3, 越田晃1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 649-649, 2017.

---

	4-6-O38-10. Rearward investigation of a dose and the administration continuance of the pazopanib 田中寛之1,2, 平賀博明3, 武隈洋4, 三浪圭太5, 橋下浩紀1, 原林透5, 永森聡5, 遠藤雅之1, 菅原満4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 649-649, 2017.

---

	4-6-O39-11. The Takayasu's arteritis one case that blood infliximab densitometry contributed to the condition of a patient control 増井翔1,2, 米澤淳1,2, 大谷祐基1, 佐野慎介1,2, 朝倉佳代子1, 谷口理沙1, 山田早紀3, 西谷真彦3, 井澤和司3, 河合朋樹3, 西小森隆太3, 松原和夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 650-650, 2017.

---

	4-6-O39-12. 2 case of patients with severe impaired renal function that we analyzed pharmacokinetic in the intensive care unit after the voriconazole transluminal administration 衛藤大輝1, 金子哲也1, 田中遼大1, 甲斐真也2, 鈴木陽介1, 佐藤雄己1, 大地嘉史2, 安田則久2, 後藤孝治2, 伊東弘樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 651-651, 2017.

---

	4-6-O39-13. Theoretical consideration about the lactational safety in the rizatriptan administration nursing mother 大久保正1,2, 田中真理子2, 大久保七枝3, 大久保節子4, 大久保美穂5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 651-651, 2017.

---

	4-6-O39-14. The pharmacokinetic examination that intended individualization medical therapy of the Donepezil (donepezil tablets) 阿部武由1, 森崎訓明2, 溝川ゆみ子3, 山口佳津騎4, 渡邊政博5, 土屋浩一郎6, 二宮昌樹7, 中妻章7, 石川一朗8, 村尾孝児9, 中村祐8, 芳地一4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 652-652, 2017.

---

	4-6-O39-15. The intake of the green tea reduces plasma nadolol levels in the healthy volunteer in the single time 尾形浩1, 阿部理1,2, 大野雄康1, 小野委成1, 三坂眞元1, 三浦至2, 色摩弥生3, 矢部博興2, 下村健寿1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 652-652, 2017.

---

	4-6-O40-16. The CYP2J2 activity inhibition with antihypertensive medications and analysis of the action mecha-nism 池村憲明1,2, 山折大1,2, 小林千夏3, 上条しのぶ2, 大森栄1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 653-653, 2017.

---

	4-6-O40-17. Effect on CYP4F2 activity of the concomitant drug raising a side effect onset risk of the Fingolimod, CYP4F2 inhibitory action of the HMG-CoA reductase inhibitor 渡辺宏晃1,2, 山折大1,2, 上条しのぶ2, 大森栄1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 654-654, 2017.

---

	4-6-O40-18. We look at the rear about the effect of the proton pump inhibitor giving it to a methotrexate excretion delay and study a mark 清宮啓介1, 津田壮一郎1, 森毅彦2, 清水隆之2, 加藤淳2, 菊池拓2, 櫻井政寿2, 甲田祐也2, 外山高朗2, 岡本真一郎2, 望月眞弓1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 654-654, 2017.

---

	4-6-O40-19. Effect of a concomitant drug giving it to an internal change of the new antiepileptic drug Perampanel and the liver damage 淺野理子1, 米澤淳1, 山本将太1, 廣住育美1, 杉本充弘1, 中川俊作1, 池田昭夫2, 松原和夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 655-655, 2017.

---

	4-6-O40-20. Effect of the CYP3A5 genetic polymorphism giving it to interaction of calcineurin inhibitor tacrolimus and fluconazole in the heart transplant remoteness period 高吉真弥1, 和田恭一1,2, 松田紗知1, 寺田侑加1, 老田章1, 高田充隆2, 瀬口理3, 簗瀬正伸3, 福嶌教偉3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 655-655, 2017.

---

	4-6-O41-21. About the case that reached the change of prescription by doubt inquiry based on the examination data with the Hitachinaka health IT - network 砂押直樹1, 玉井典子2, 関利一3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 656-656, 2017.

---

	4-6-O41-22. Examination of doubt inquiry after the prescription issuance with the test value in the JCHO Kyushu Hospital 小倉秀美1, 川久保充章1, 釘原瑤子1, 上津沙織1, 吉国健司1, 桑村恒夫1, 末松文博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 657-657, 2017.

---

	4-6-O41-23. Usefulness evaluation of the group work holding to utilize the clinical test value that we displayed in a prescription 岸田義博1, 貴島幸子2, 兼重晋1, 山村伸也1, 竹野将行1, 高木淳一1, 丸野重信1, 増田智先2, 瀬尾隆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 657-657, 2017.

---

	4-6-O41-24. Simplification of doubt inquiry based on the prior agreement at a hospital and the health insurance pharmacy 讓原千広1, 小川紗知1, 波多晶子1, 中澤美樹子1, 橋爪和恵1, 窪田真弓1, 鶴居勝也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 658-658, 2017.

---

	4-6-O41-25. A doubt inquiry of the substitute prescription for the bringing medicine principle nonuse and reporting to the health insurance pharmacy 台蔵剛士1, 山田留美子1, 北侑未1, 島岡純平1, 渡辺真梨奈1, 南川知央1, 才田絢加1, 竹森麻美1, 岡田ちひろ1, 諸田真由美1, 寺佳帆理1, 安田明子1, 下川千賀子1, 山田千代子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 658-658, 2017.

---

	4-6-O42-26. Polypharmacy measures that a pharmacist collaborates with a physician and works on in an area 末松文博1, 折口秀樹2, 小倉秀美1, 吉国健司1, 藤本裕司3, 成重賢司4, 星野正俊4, 有吉俊二4, 脇園隆二4, 土橋卓也5, 後藤渉6, 太崎博美7, 村本眞由美8, 植木哲也9, 日高博司10, 入江利行11, 園田美樹12, 江本伸哉13 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 659-659, 2017.

---

	4-6-O42-27. Correspondence to polypharmacy by the multicenter collaboration and examination of the solution 阿登大次郎1, 小牟田豊1, 八代哲也1, 田中雅隆2, 枡井純子3, 岩佐ミユキ3, 金ソッセ4, 三木芳晃5, 萱野勇一郎5, 辻本喜則6, 小林政彦6, 東海秀吉1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 660-660, 2017.

---

	4-6-O42-28. Examine illness in the chemotherapy of patients with malignant brain tumor; construction of the cooperation and the usefulness 渡邉美菜子1, 熊倉康郎1, 矢野亨治1, 石井沙也加1, 大岡史治2, 本村和也2, 夏目敦至2, 若林俊彦2, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 660-660, 2017.

---

	4-6-O42-29. The cooperation reinforcement between pharmacists by the operation of the pharmacist medical care reporting book and analysis of the usefulness 渡邉雄貴1, 西垣和香2, 市川和哉1, 鈴木裕介3, 千崎康司1, 伊藤瑞規4, 勝野雅央5, 葛谷雅文3, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 661-661, 2017.

---

	4-6-O42-30. [Residual medicine adjustment PBPM which if local, we shared for Residual medicine zero] Analysis of ... one year and future problem ... 寺門祐介1, 平井利幸1, 高村浩亮2, 渡邉文之3, 亀井美和子3, 樗木昭4, 篠原久仁子5, 関利一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 661-661, 2017.

---

4-7-O43-01. Examination and practice ... by reinforcement - workshop of the cooperation between a pharmacist, the care staff, nurses aiming at the appropriate medication of the nursing facility resident 鳥居雄治1, 白石朗1, 馬来秀行2, 三木晶子3, 堀里子3, 佐藤宏樹3,4, 笹川賢一1, 加藤洋一1, 舟橋健一1, 山本大輔2, 小西ゆかり2, 浅井康平2, 臼井順信1, 澤田康文3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 662-662, 2017.

---

	4-7-O43-02. Usefulness of the at-home visit drug instruction by the pharmacist of the pharmacist outpatient department 上野良夫1, 後藤美恵子2, 玉木真紀子3, 伊原木沙智代1, 三枝貢1, 眞鍋伸次1,3, 前田剛4, 森由弘4, 厚井文一4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 663-663, 2017.

---

	4-7-O43-03. It is ... for proper use from a relation to efforts - bringing medicine of the pharmacist in the local inclusion care ward 加瀬浩二1, 松田公子1, 坂間淳孝2, 秀野武彦2, 浅井禎之2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 663-663, 2017.

---

	4-7-O43-04. Outcome evaluation of the CKD seal developed in whole Shiga for five years 磯野哲一郎1,2, 國津侑貴1, 増田恭子1, 平大樹1, 荒木久澄2, 荒木信一2, 宇津貴2, 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 664-664, 2017.

---

4-7-O43-05. Approach - for the member drugstore of the attempt - Nagasaki-shi pharmacist society of the medical treatment support system maintenance by an attitude survey and the grouping organization to the transfer between narcotics retail dealers 手嶋無限1, 丸木寿郎1, 河内梨恵1, 西村泰徳1, 南野潔1, 神近竜二1, 松尾英俊1, 井石政之1, 七嶋和孝1, 井手陽一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 664-664, 2017.

---

	4-7-O44-06. Role of the pharmacy service under health insurance drugstore pharmacist in the at-home palliative care 田邉一尊1, 藤田隆司2, 木村寛子1, 横田修1, 船橋信吾1, 桑原智江1, 小次紀子1, 山本新一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 665-665, 2017.

---

	4-7-O44-07. Consideration about the electrocardiogram utilization in the pharmaceutical management 尾上洋1, 中田和枝1, 坂田直哉1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 666-666, 2017.

---

	4-7-O44-08. Efforts (the second report) of the pharmacist in the treatment at home (fluid therapy) 藤田由1, 西美佐1, 橋本昌子2, 杉田尚寛3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 666-666, 2017.

---

	4-7-O44-09. Study on effect on utilization behavior in health care by usefulness of the lipid measurement in the drugstore and the consultation encouragement 丸山順也1, 長谷川菖子1, 多田紀夫2, 橋口正行1, 望月眞弓3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 667-667, 2017.

---

	4-7-O44-10. At fact-finding - disaster of the disaster prevention measures for the pharmacy service under health insurance drugstore in Iwate, to make duties continue; ... 大森英美1, 島田真衣1, 富田隆1, 畑澤博巳2, 工藤賢三1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 667-667, 2017.

---

	4-7-O45-11. Evaluation after the efforts and the introduction to duties visualization of pharmaceutical products SPD for 3 years 関屋裕史1, 緒方豊2, 梶原隆広3, 長友隆雄1, 奥村学1, 岩切智美1, 池田龍二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 668-668, 2017.

---

	4-7-O45-12. The adoption pharmaceutical products choice from a point of view of running it in the hospital targeted for DPC 脇田真之1, 岡村吏華1, 吉井千菊1, 渡辺恵美1, 棚田真紀1, 星野智美1, 波能満理惠1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 669-669, 2017.

---

	4-7-O45-13. Management contribution by the simple poking each other of pharmaceutical products leaving a shed amount and the medical affairs calculation amount 佐藤昌博1, 設樂誉1, 千葉光1, 阿部優1, 鈴木康弘1, 佐藤真凡1, 庄司晃2, 鈴木康弘2, 熊谷智惠子1, 齋藤利彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 669-669, 2017.

---

	4-7-O45-15. We study the search of the syndrome therapeutic drug after the cardiopulmonary resuscitation that assumed drug repositioning a cut end 新村貴博1, 座間味義人1,2, 小山敏広3, 武智研志4, 今西正樹1,2, 堀ノ内裕也5, 石澤有紀5, 池田康将5, 藤野裕道6, 土屋浩一郎7, 玉置俊晃5, 石澤啓介1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 670-670, 2017.

---

	4-7-O46-17. The search of the optimum doses of the hospital preparation levothyroxine sodium bougie and stable examination 南いく子1, 志田あゆみ1, 山際岳朗1, 大村友博1, 中川貴之1, 中川俊作1, 矢野育子1, 松原和夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 672-672, 2017.

---

	4-7-O46-18. Clinical pharmacokinetic study of the mianserin bougie in Japanese healthy elderly men 市倉大輔1,5, 縄田修一1,5, 神山紀子2, 清水愛美1,5, 肥田典子3,4, 山崎太義4, 竹ノ下祥子4, 内田直樹3,4, 峯村純子1,5, 佐々木忠徳5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 672-672, 2017.

---

	4-7-O46-19. Examination about the placebo setting of the soft plaster in the researcher-led clinical study 米村雅人1,2, 岡野朋果2, 竹野美沙樹2, 石川寛4, 橋本浩伸8, 川崎敏克2, 金澤秀子7, 清原祥夫5, 横田知哉6, 全田貞幹3, 齊藤真一郎2, 山口正和2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 673-673, 2017.

---

	4-7-O46-20. The problem of a plan, the analytical technique of the conventional clinical study and suggestion of the substitute technique 堀口みき1, 竹内正弘1, 宇野一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 673-673, 2017.

---

	4-7-O47-21. Importance - of efforts - cholesterol compartmentation utilizing the electrophoretic compartmentation wave pattern aiming at the proper use of the dyslipidemia therapeutic drug and the lipoprotein fraction 吉年正宏1, 西村恵美2, 森口美華子2, 家田正子1, 前田和成2, 月岡康行1, 中江健市2, 森嶋祥之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 674-674, 2017.

---

	4-7-O47-22. Use effect of the PCSK9 inhibitor 大宮寛子1, 吉田夕貴1, 三輪耕次1, 田中伸享2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 675-675, 2017.

---

	4-7-O47-23. 2 cases that was effective in the distance walked and the hemodynamics for six minutes in the low number of times administration of inhalational type pulmonary hypertension therapeutic drug iloprost 村津直子1, 和田恭一1, 向井優太朗1, 寺川伸江1, 川端一功1, 老田章1, 大郷剛2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 675-675, 2017.

---

	4-7-O47-24. Examination of the itching onset factor in patients with varicose veins of lower extremities 高井靖1, 西村善幸2, 平本恵一3, 大井一弥3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 676-676, 2017.

---

	4-7-O47-25. Relative examination with Health Assessment Questionnaire and the drug-taking behavior disorder in patients with rheumatoid arthritis 佐々木恵一1, 近森綾子1, 柳原有希1, 木本泰孝2, 堀内孝彦2, 橋本昌文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 676-676, 2017.

---

	4-7-O48-26. 2-Hydroxypropyl-β-cyclodextrin intraventricular administration therapy for the inborn character dysbolism Niemann-Pick disease C type 石塚洋一1, 深浦まど香1, 近藤悠希1, 竹尾透2, 中潟直己2, 江良択実3, 東大志1, 本山敬一1, 有馬英俊1, 倉内祐樹1, 香月博志1, 亀井竣輔1, 首藤剛1, 甲斐広文1, 松尾宗明4, 檜垣克美5, 大野耕策6, 入江徹美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 677-677, 2017.

---

	4-7-O48-27. Investigation analysis of the glucose insulin (GI) therapy for the hyperkalemia 本多美佳子1, 吉岡大樹1, 佐道紳一1, 吉野走1, 岡正拓1, 永延佳子2, 鎌田昭江2, 樋口則英1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 678-678, 2017.

---

	4-7-O48-28. Look at the rear about the heart failure condition of a patient of patients with tolvaptan remedy heart failure; a mark observational study 峯昌吾1, 橋本直子1, 森悠太1, 廣瀬雅教2, 長谷川洋2, 高野博之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 678-678, 2017.

---

	4-7-O48-29. Treatment response in the congestive heart failure of copeptin and usefulness by the tolvaptan administration decision making 岩下菜摘子1,2, 奈良典子1, 佐藤亮佑1, 中戸川知頼1, 小林俊一1, 座間さゆり1, 前川喜代司1, 三田充男2, 菱沼滋2, 庄司優2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 679-679, 2017.

---

	4-7-O48-30. Effect of the new epilepsy medicine giving it to the oxidative stress, serum albumin level of a seriously disabled child, the person 森本真仁2, 北岡泰介2, 橋本俊顕1, 浜田茂明1, 京谷庄二郎2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 679-679, 2017.

---

	4-8-O49-01. Case-control study about the risk factor of CINV with the CHOP therapy 奥野雅樹1, 土手賢史1, 上島未友紀1, 野崎歩1, 小林由佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 680-680, 2017.

---

	4-8-O49-02. It is ... about cost-effectiveness of evaluation - Fosaprepitant of the antiemesis therapy for the moderate emetic risk regimen that assumed oral intake calorie an index 野崎孝徒1, 立道貴清1, 三崎彩香1, 高橋咲衣1, 岩澤春奈1, 山口佳津騎1, 田中裕章1, 篠原尚樹1, 元木貴大1, 北岡陸男2, 小坂信二1, 芳地一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 681-681, 2017.

---

	4-8-O49-03. Evaluation of the late start period retching vomiting expression risk factor in the slight emetic risk cancer chemotherapy 平池美香子1, 鳥山陽子2, 横田千明3, 谷口潤4, 花田聖典5, 津曲恭一6, 大窪典子7, 高武嘉道8, 坂田光平9, 川俣洋生10, 後藤隆11, 鶴崎泰史12, 小薮真紀子1, 下川元継13, 林稔展1,14 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 681-681, 2017.

---

	4-8-O49-05. Case-control study about the tolerability of duloxetine for chemotherapy-induced peripheral neuropathy 金子忍1, 塩飽英二1, 土手賢史1, 野崎歩1, 小林由佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 682-682, 2017.

---

	4-8-O50-06. Use of G-CSF preparation fact-finding in patients who received chemotherapy in the Kasugai Municipal Hospital 冨田庸介1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 683-683, 2017.

---

	4-8-O50-07. Usefulness of the Pegfilgrastim second prophylactic administration of the febrile neutropenia in the breast cancer adjuvant chemotherapy 柿原圭佑1, 葉田昌生1, 三上忠司1, 中嶋陽一1, 松崎雄1, 寺松早紀1, 蔵王なつか1, 大塚弘子2, 山口美樹2, 三輪啓介3, 藤井裕史1, 田中眞紀2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 684-684, 2017.

---

	4-8-O50-08. Effect of dexamethasone doses giving it to the skin toxicity with the docetaxel/cyclophosphamide (TC) therapy for the breast cancer 北澤文章1, 藤田佳史2, 角陽子1, 上田久美1, 中山優子3, 高良恒史3, 佐原敏之1, 国府孝敏4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 684-684, 2017.

---

	4-8-O50-09. Construction of the situation of eye disorders with the cancer chemotherapy and the ophthalmology practice cooperation system 関根佳代1, 吉田善紀1, 大谷美子1, 辻村秀樹2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 685-685, 2017.

---

	4-8-O50-10. We look at the rear about the risk factor of eye disorders by the paclitaxel and examine a mark 野口裕介1, 川島悠吾1, 丸山恵未1, 瓦比呂子1, 徳山洋子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 685-685, 2017.

---

	4-10-O51-01. Examination of the risk factor of the side effect of nivolumab 太田明秀1, 元茂拓法2, 高田慎也3, 岡野翔1, 遠藤雅之3, 大江利治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 686-686, 2017.

---

	4-10-O51-02. Association with eruption and the effect of treatment by the nivolumab in the non-small cell lung cancer 下村一景1, 清水淳市2, 橋本直弥1, 大矢由子2, 古田裕美2, 香川友祐2, 渡辺尚宏2, 山口哲平2, 上村剛大2, 堀尾芳嗣2, 稲熊一英1, 樋田豊明2, 水野靖也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 687-687, 2017.

---

	4-10-O51-03. An example of the non-small cell lung cancer with suspected polymyalgia rheumatica symptom by the nivolumab 今井雄介1, 内海裕美1, 田中雅幸1, 藤井良平1, 西山徳人1,2, 打谷和記1, 岡崎和一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 687-687, 2017.

---

	4-10-O51-04. 1 case that developed acute myocardial infarction during nivolumab administration 長谷川浩司1, 岩城晃一1, 石坂忠博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 688-688, 2017.

---

	4-10-O51-05. Look at the rear about the immune-mediated adverse event of the nivolumab; mark investigation 中川佳子1, 竹本将士1, 鬼頭典子1, 伊豆田美晴1, 手崎世織1, 田代雄祐1, 森川琢也1, 青木有希1, 奥苑朱加1, 井口祐美子1, 黒田純子1, 木村和哲1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 688-688, 2017.

---

	4-10-O52-06. One case of head and neck cancer which caused IRRs of Gr3 in pre-medication DEX 13.2 mg, the FP + Cmab therapy received APR, Chlorpheniramine 5 mg 堀之内藍1, 鈴木真也1, 池川貴和子1, 鎌田隼1, 魚住真哉1, 田原信2, 山口正和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 689-689, 2017.

---

	4-10-O52-07. One patient whom myocardial infarction by the red thrombus developed in during XELOX + bevacizumab therapy 土岐真路1, 前田幹広1, 坂上逸孝1, 田中恒明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 690-690, 2017.

---

	4-10-O52-08. TS-1 and an example of mass taking oxycodone 野澤彰1, 巽香菜1, 篠田公夫2, 知久毅2, 野澤 (石井) 玲子3, 加賀谷肇3, 高橋治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 690-690, 2017.

---

	4-10-O52-09. About the analysis of a trace element and carbon in one report patients hair of the selenium lack by the long-term intravenous alimentation management and the nitrogen stable isotope 藤野陵二1, 村松博士2, 木村治3, 佐藤英二1, 遠藤哲也3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 691-691, 2017.

---

	4-10-O52-10. The side effect management at methotrexate excessive quantity internal use 山本飛翔1, 前田幹広1, 坂上逸孝1, 増原慶壮2, 田中恒明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 691-691, 2017.

---

	4-10-O53-11. Improvement - of the medication counseling in hepatitis C treatment of the evaluation - IFN-free of the medication counseling 高橋佐和1, 見元尚1, 筒井由佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 692-692, 2017.

---

	4-10-O53-13. Outcome evaluations such as serum calcium concentrations monitoring and the prescription suggestion, and the like in the denosumab enforcement outpatient 木村周古1, 新田悠一朗1, 相馬亮太1, 飯田慎也1, 小野尚志1, 三嶋一登1, 福土将秀1, 田崎嘉一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 693-693, 2017.

---

	4-10-O53-14. Relation of the pharmacist at the radioactive anticancer agent radium 223 outpatient department administration to patients with castration-resistant prostate cancer with metastases to bone 望月伸夫1, 加納大輔1, 中村直樹2, 中神佳宏3, 松原伸晃4, 根本幸一5, 柳澤かおり5, 野村恵一5, 山口正和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 694-694, 2017.

---

	4-10-O53-15. Patients satisfaction investigation for the pharmacist duties in the foreign chemotherapy room 畠山織江1, 岩川悟1, 齊藤有希1, 志賀隆1, 佐藤邦義1, 荒川隆太郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 694-694, 2017.

---

	4-10-O54-16. It is duties about the stopping medicine and the evaluation during the preoperation of the resident pharmacist in the admitting department 加藤梓沙1,2, 伊藤佳織1, 波多野正和1, 石戸谷その1, 上野美幸1, 阿部幸恵1, 角里恵子1, 荒川悠樹1, 友松恵子1,2, 森舞子1, 覚前有希子1, 平岩歳久1, 加藤さや香1, 牧原俊康1, 津川透1, 鈴木孝幸1, 山田成樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 695-695, 2017.

---

	4-10-O54-17. Fact-finding of the pharmacist outpatient department for the small molecule type molecular target drug 早坂州生1, 芦崎雅之1, 出町拓也1, 北山秀則1, 竹内公美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 696-696, 2017.

---

	4-10-O54-18. Usefulness of the pharmacist outpatient department in the medical treatment to the IBD patients 中村健志1, 土江晴江1, 土井教雄1, 石原慎之1, 玉木宏樹1, 西村信弘1, 直良浩司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 696-696, 2017.

---

	4-10-O54-19. Examination of the usefulness of the pharmacist outpatient department for the stroke prevention of recurrence 藤田将輝1, 西村暢子1, 中西裕明1, 堀内あす香1, 神田英一郎1, 村木優一2, 岡橋孝侍1, 藤田敦夫1, 友金幹視1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 697-697, 2017.

---

	4-10-O54-20. Construction of the pharmacist duties in the pregnant woman nursing mother medical therapy domain 小川智孝1, 大西莉加1, 山本里香1, 小椋千絵1, 長谷川聡子2, 小南伸子2, 上田智弘3, 横山直樹4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 697-697, 2017.

---

	4-10-O55-21. Questionary survey about the duties that the encounter by the pharmacist sits 須釜由香1,2, 五十嵐隆志1, 池川貴和子1, 鎌田隼1, 鈴木秀隆1, 出町健1, 鈴木真也1, 山口正和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 698-698, 2017.

---

	4-10-O55-22. Prescription suggestion - at efforts - biological drug introduction of the pharmacist outpatient department by the rheumatic registration pharmacist 雪矢良輔1, 奥田佳子1, 畠中英理子1, 梶田貴司1, 奥野智之1, 上田睦明1, 石丸裕康2, 八田和大2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 699-699, 2017.

---

	4-10-O55-23. Our hospital large intestine ERAS revision by the pharmacist-led multi-type of job conference and effect on failure of the sutures 中澤孝文1, 山本晃平1, 川口真由子1, 山崎香織1, 鶴岡裕太2, 中村貴子1, 鈴木貴明1, 宮内英聡3, 石井伊都子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 699-699, 2017.

---

	4-10-O55-24. Examination about the drug global assessment adjustment addition results of the haemodialysis introduction patients 浦嶋和也1,2, 森南沙那恵1, 鍵谷真希2,3, 平野一2,3, 能見勇人2,3, 鈴木典子1, 鈴木薫1, 西原雅美1, 東治人2,3, 勝間田敬弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 700-700, 2017.

---

	4-10-O55-25. Construction ... of the system about efforts - injection high risk medicine of the proper use of the syringe pump essential drug by the other types of job collaboration 喜久山有沙1, 大城匡史1, 三田井菜菜子1, 高見洋二4, 池川智子5, 上原直美3,5, 國分千代1, 新崎修2,5, 橋本孝夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 700-700, 2017.

---

	4-10-O56-26. It is an investigation about the compliance of guidelines on infection prophylaxis antimicrobial after the operation in the Mie University faculty of medicine hospital 中川裕司1, 森川祥彦1, 水谷栄梨1, 岡本明大1, 本多立1, 岩本卓也1, 奥田真弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 701-701, 2017.

---

	4-10-O56-27. Example ... of the denosumab used for efforts - solid cancer metastases to bone to proper use by the in-hospital use situation investigation and reporting of pharmaceutical products 於本崇志1, 朝賀純一1, 青木朋彦1, 長澤佳昭1, 佐藤文彦1, 工藤賢三1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 702-702, 2017.

---

	4-10-O56-28. The combination of statin and heart disease therapeutic drug situation investigation 岡崎彰仁1, 山根真也1, 岩城晃一1, 石坂忠博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 702-702, 2017.

---

	4-10-O56-29. Attempt of the antipsychotics weight loss in the outpatient based on a 2016 medical service fees revision 坂本靖之1, 助川鶴平2, 佐藤康一1, 三島直也3, 門野恵莉4, 堀浩政1, 光山忠史4, 西川正直5, 永見幸人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 703-703, 2017.

---

	4-10-O56-30. Study on use fact-finding of the sleep inducing drug for elderly people and medication support based on PK/PD 原田桂作1,2, 多田遼太郎3,4, 村木理英4, 村本眞由美1, 名倉弘哲2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 703-703, 2017.

---

	5-4-O57-01. Evaluation about the thromboembolism in bevacizumab treated patients using adverse drug reaction database (JADER) of PMDA 松村千佳子1, 地嵜悠吾1, 矢野義孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 704-704, 2017.

---

	5-4-O57-02. Associated factor of proteinuria in the Bevacizumab administration 藤林遼1, 鈴木直哉1, 地主隆文1, 藤田果那1, 木下愛1, 庄崎沙耶1, 田中耕太1, 山本翔太1, 前川英輝1, 山田将悟1, 菊地義明1, 高橋誠1, 青田忠博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 705-705, 2017.

---

	5-4-O57-03. Retrospective cohort study about stomatitis with the antiEGFR antibody combination colon cancer chemotherapy 板倉祥嗣1, 土手賢史3, 亀位耕平2, 津田正博1, 小林由佳3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 705-705, 2017.

---

	5-4-O57-04. The effect that renal function and the evaluation method give for colon cancer postoperative CapeOX therapy 伊藤文香1, 市川和哉1, 宮崎雅之1, 岡島亜衣1, 近藤舞子1, 茂木俊樹1, 安藤雄一2, 千崎康司1, 永井拓1, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 706-706, 2017.

---

	5-4-O57-05. Investigation about the onset of hypersensitivity of oxaliplatin 松由幸司1, 山口雄士1, 佐藤和也1, 保母泰斗1, 近藤章吾1, 桜井由美子2, 塚原民夫1, 堀内正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 706-706, 2017.

---

	5-4-O58-06. Effective evaluation of the Short Hydration method for the nephrotoxicity with the etoposide cisplatin therapy 稲田顕慶1, 山際岳朗1, 池見泰明1, 今井哲司1, 祝千佳子1, 家永嘉子1, 石橋直哉1, 深津祥央1, 金永学2, 永井宏樹3, 平井豊博2, 松原和夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 707-707, 2017.

---

	5-4-O58-07. Examination about the body-surface area revision of the renal function index in the cisplatin administration 槙原克也1, 寺沢匡史1, 内山ひとみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 708-708, 2017.

---

	5-4-O58-08. Effect of lassitude and the carnitine excretion with the cisplatin administration 池崎友明1,2, 鈴木健介4, 神原健太3, 梶浦新也2, 三輪敏郎2, 田辺公一5, 菓子井達彦2, 北澤英徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 708-708, 2017.

---

	5-4-O58-09. Examination of the adverse event expression situation and the effect predictor of the nivolumab in the Minami-3-jo, Sapporo Hospital 梅原健吾1, 島田歩2, 岡山有希1, 野表しおり1, 東田貴之1, 後藤桂輔1, 岡崎泰香1, 高田寛奈1, 若本あずさ1, 初山多恵1, 佐藤秀紀2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 709-709, 2017.

---

	5-4-O58-10. Examination of the risk factor of the dermatopathy with lenalidomide in patients with multiple myeloma 杉富行1, 中村香織2, 西上泰生1, 才郷博久1, 花井誉1, 華見3, 井上盛浩3, 萩原政夫3, 高畠啓輔1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 709-709, 2017.

---

	5-5-O59-01. Questionary survey about the use of the restroom for men during anticancer medicine administration 景秀典1, 井野川徹1, 高山慎司1, 河野友昭1, 細川恵子2, 山内照夫3, 後藤一美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 710-710, 2017.

---

	5-5-O59-02. Maintenance ... of the practice system using the PDCA cycle in the multicenter questionary survey - Aichi cancer practice cooperation base Hospital about anticancer agent exposure measures 宇都宮純平1, 黒田純子2, 鈴木大吾3, 山関智恵4, 間瀬悟5, 米山英二6, 河田健司7, 室圭8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 711-711, 2017.

---

	5-5-O59-03. Attitude survey of the pharmacist in 67 hospitals about the negative pressure vial 高子優子1, 細見健悟1, 関佳世1, 吉間美保子1, 山尾多鶴子1, 田中絵美1, 久井裕美子1, 杉田裕貴1, 小牧佐知子1, 稲田智子1, 増本憲生1, 大槻裕朗1, 岡本禎晃2, 金啓二3, 名徳倫明4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 711-711, 2017.

---

	5-5-O59-04. Investigation of the pollution status of the person of preparation gloves in the cyclophosphamide preparation using Vildagliptin shield (EQUASHIELD) and the surrounding environment 前田章光1, 下村一景1, 栗原幸司1, 高橋新次1, 橋本直弥1, 長谷川彩子1, 小原真紀子2, 高畑知帆子2, 稲熊一英1, 水野靖也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 712-712, 2017.

---

	5-5-O59-05. Examination ... in the multicenter anticancer agent exposure investigation - cancer practice cooperation base Hospital in foreign chemotherapy room 7 institution 田代雄祐1, 黒田純子1, 松田日出三2, 太田秀基2, 河田健司3, 室圭4, 木村和哲5,6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 712-712, 2017.

---

	5-5-O60-07. Inspection of the quantity of exposure decrease effect by the use of closed system system for the anticancer medicine preparation 濱宏仁1, 成橋和正2, 杉浦伸一2, 中西弘和2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 714-714, 2017.

---

	5-5-O60-08. It is ... from full-scale introduction and evaluation ... anticancer agent preparation of closed system anesthesia drug transportation system (CSTD) to administration management 松田圭一郎1, 延川正雄1, 齋藤順1, 菅原拓也1, 荒井浩一1, 山口しのぶ2, 二瓶祥子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 714-714, 2017.

---

	5-5-O60-09. Usefulness of the plastic needle for the foreign insoluble matter occurring at a paclitaxel preparation 八木健太1, 武田達明1, 牛尾聡一郎1, 江角悟1, 鍛治園誠1, 北村佳久1, 千堂年昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 715-715, 2017.

---

	5-5-O60-10. Examination of "the quality" of the foreign chemotherapy person in charge of treatment with safe anticancer medicine pharmacist in response to needs 伊藤武志1,3, 上田綾佳1,3, 山下知香1, 横井恵1, 黒岩勇人1, 野々内裕紀1, 勝島詩恵2,3, 柳原一宏2,3, 濱口良彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 715-715, 2017.

---

	5-6-O61-01. An evaluation of the doubt inquiry protocol about the antimicrobial consumption and analysis 川村和宏1, 南和志1, 石倉一樹1, 田村健悦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 716-716, 2017.

---

	5-6-O61-02. Examination of the background factor in Clostridium difficile antigen-positive patients 大柿滋1, 田上恵梨2, 牛島智子1,2, 宮村重幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 717-717, 2017.

---

	5-6-O61-03. Examination about the time to antimicrobial administration start in sepsis and the consciousness of the healthcare worker 遠山泰崇1, 堀光愛子1, 福島祐子1, 新宮裕美1, 幸沙和1, 末延裕海1, 小野友香理1, 井上真1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 717-717, 2017.

---

	5-6-O61-04. Intermediate evaluation and problem of the AMR action plan result target in the chronic phase medical treatment Hospital 水谷一寿1, 佐藤貴範2, 本間友香3, 齋藤美緒3, 森岡まゆみ3, 上田修4, 中谷玲二4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 718-718, 2017.

---

	5-6-O61-05. Effect on antimicrobial doses and culture submission according to the renal function of non-intervention case by the introduction of the antimicrobial round 杢保貴幸1, 徳竹裕貴1, 大西優里1, 石井康友2, 植田宏治3, 松岡裕士4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 718-718, 2017.

---

	5-6-O62-06. We look at the rear of the effect on liver, renal function views with the meropenem hydrate generic drug administration and examine a mark 中蔵伊知郎1,2,3, 坂倉広大1,2, 今西嘉生里1,2, 岩川精吾3, 福田利明1, 佐光留美1, 山崎邦夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 719-719, 2017.

---

	5-6-O62-07. Effect of expression time and the other agents combination of the drug-related QT prolonged with the new quinolone antibacterial 松尾純1,2, 山折大1,2, 村井健太郎1,2, 三村享1,2, 大森栄1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 720-720, 2017.

---

	5-6-O62-08. Investigation about the relationship of renal function and the thrombocytopenia in the short-term administration of the linezolid 平塚公己1, 川村充史2, 小松敏彰1, 厚田幸一郎1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 720-720, 2017.

---

	5-6-O62-09. One patient who presented with metronidazole (MNZ) encephalopathy in the young people whom we discovered by team approach in medical care early 内木義泰1,4, 征矢佳輔2,4, 池田淳司3, 伊藤陽一1, 清水雄策3, 竹内信道4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 721-721, 2017.

---

	5-6-O62-10. An example of patients with ulcerative colitis who had the cytomegalovirus enterocolitis that showed dermatopathy with the foscarnet Na hydrate 橋本陽1, 小出哲朗1, 着本望音2, 石川久高1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 721-721, 2017.

---

	5-7-O63-01. Attitude survey about the behavioral disorder in the use of nonprescription drug of the consumers using the focus group interview 立矢由佳1, 堀里子2, 三木晶子2, 佐藤宏樹2,3, 高橋亜貴子4, 澤田康文2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 722-722, 2017.

---

	5-7-O63-02. The phototoxicity of the preventive measures against ultraviolet rays product and the measures 富岡節子1, 山崎直毅2, 山崎勝弘2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 723-723, 2017.

---

	5-7-O63-04. About the current situation of the use of generic medicine promotion and a future problem 尾形梨名1, 佐谷怜子1, 福山宗宏1, 佐谷圭一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 724-724, 2017.

---

	5-7-O63-05. About the efforts toward 80% of generic medicine rate of use and a future problem 佐谷怜子1, 尾形梨名1, 福山宗宏1, 佐谷圭一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 724-724, 2017.

---

	P0001-3-PM. Correspondence and consideration of the Epinephrine autoinjector injection 0.3 mg voluntary recall (class 1) 萱野勇一郎1, 高柳和代1, 岡千恵1, 山本聖子1, 後藤卓也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 726-726, 2017.

---

	P0003-3-PM. About the efforts of the alert indication function at "pharmaceutical products needing a laboratory study" prescription 小口正義1, 宮崎雄紀1, 水谷妙子1, 唐澤綾1, 田中文1, 神戸千紘1, 山崎夕貴1, 登内盛治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 727-727, 2017.

---

	P0005-3-PM. About the administration of the evaluation department such as specialist in nonrecognition newcomer medicines, and the like in the Ehime University faculty of medicine hospital 高田裕介1,2, 徳田力3, 田坂祐一1,4, 飛鷹範明1,2, 山田文哉1,4,5, 鈴木純1,4, 田中亮裕1,2, 泉谷裕則1,5, 田中守1,2,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 727-727, 2017.

---

	P0007-3-PM. Analysis of the medicine damage situation and efforts of the pharmacy 青柳和代1, 岩田真子1, 貝瀬眞由美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 728-728, 2017.

---

	P0009-3-PM. Effect and problem to the ward by the ward fixed number medicine review 鈴木博晃1, 小沼大祐1, 新藤学1, 加藤一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 728-728, 2017.

---

	P0011-3-PM. Efforts ... to operating room pharmacist duties - efficiency 竹ノ内早紀子1, 柳沢京子1, 朝日仁美1, 古林園子1, 新藤学1, 加藤一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 729-729, 2017.

---

	P0013-3-PM. Of the dead stock antitumor agents about effectively utilizing it 中村武夫1, 蒲谷亘2, 増田信也2, 佐藤優子2, 木村えり2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 729-729, 2017.

---

	P0002-4-AM. The construction of the ordering management support system using injection order data and the effect 渡辺健太1, 齊藤美聡1, 山本健一1, 樺澤恵美1, 山本晃平1, 須藤知子1, 松島徹1, 石井晃1, 横山威一郎1, 中村貴子1, 鈴木貴明1, 石井伊都子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 730-730, 2017.

---

	P0004-4-AM. Efforts to reduction of the bad stock in the middle scale hospital and the significance 唐橋久恵1, 藤島ひとみ1, 平尾尚之1, 壽崎佳輔1, 眞鍋雄一郎1, 佐藤直樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 731-731, 2017.

---

	P0006-4-AM. Cost cut by the construction of the parenteral injection supply system in PIH Health Hospital - Whittier 松浦誠1,2, Shunsuke Toyoda1,3, 小野寺健1,4, Chang Carmen3, Mccowan Diane3, 高橋寛1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 731-731, 2017.

---

	P0008-4-AM. About correspondence at the pharmacist absence in the institution belonging to association of Kumamoto medical corporation chief pharmacist society 川崎裕美1, 谷口隆幸2, 森伸子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 732-732, 2017.

---

	P0010-4-AM. Current situation ... of the pharmaceutical products bar code indication to proposal - pillow packing for use of pharmaceutical products bar code 増井里紗1, 池田和之1, 吉川一吾1, 辻力夫1, 杉山幸正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 732-732, 2017.

---

	P0012-4-AM. An evaluation and attitude survey about the pharmaceutical products administrative work in the operating room by the intervention of the pharmacist 柳澤京子1, 竹ノ内早紀子1, 朝日仁美1, 古林園子1, 新藤学1, 加藤一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 733-733, 2017.

---

	P0014-4-AM. Maintenance of the medicine regime for the clinical study for appropriate enforcement of the clinical study 有馬秀樹1,2, 豊田貴美子1,2, 篠崎寛一1,2, 構木泰信1,2, 近藤智子2, 丸本芳雄2, 内田豊1, 古川裕之1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 734-734, 2017.

---

	P0016-4-AM. Improvement of CRC duties in the Okinawa Hospital 岩尾卓朗1, 鈴田浩孝1, 上原智博1, 鈴木寛人1, 永野真久1, 則松郁香1, 中嶋浩太郎1, 河野大希1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 735-735, 2017.

---

	P0015-3-PM. Attempt of the precision regime maintenance about trial 鈴田浩孝1, 河野大希1, 中嶋浩太郎1, 岩尾卓朗1, 則松郁香1, 永野真久1, 鈴木寛人1, 上原智博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 736-736, 2017.

---

	P0017-3-PM. The attitude survey for the duties of the open-label pharmacist concerned with a trial and investigation in the real duties load 白澤宏美1, 山下克也3, 鶴崎泰史2, 高武嘉道1, 村田健司1, 山形真一2, 中川義浩2, 芳賀克夫4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 737-737, 2017.

---

	P0018-4-AM. Operation of the anticoagulant, antithrombocytic agent check sheet in our hospital 堂薗吉彬1, 棚田訓彰1, 安河内亮太1, 中島一1, 今村陽子1, 池田浩和1, 高橋浩二郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 738-738, 2017.

---

	P0020-4-AM. Management of the drugs for clinical test in the charge clinical department domain by the ward pharmacist 河濟泰生1, 下野梨麻1, 若林和貴1, 硲貴和子1, 有馬秀樹1, 内田豊1, 古川裕之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 739-739, 2017.

---

	P0022-4-AM. One case that had a diagnosis of Wilson disease during SLE treatment 立川奈保美1, 池下智之1, 吉田紗理1, 古川夏1, 石樋康浩1, 三島芳枝1, 的場美香1, 高木麻里1, 吉田智江1, 田中恵美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 739-739, 2017.

---

	P0024-4-AM. It is the intervention of the surgery ward pharmacist for patients with infection after the operation that showed a rise in serum potassium value 河上卓弥1, 馬場俊彰1, 堀友美1, 松谷洋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 740-740, 2017.

---

	P0026-4-AM. For the reduction of the incident accident in the emergency ward 加藤まゆ1, 安井一正1, 西澤圭祐1, 高橋弘泰1, 畔柳敏弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 740-740, 2017.

---

	P0028-4-AM. Point to keep in mind of the intervention of the ICU charge pharmacist after having done a change ridge in a regular hospital from the ICU 安井一正1, 高橋弘泰1, 畔柳敏弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 741-741, 2017.

---

	P0030-4-AM. The diffusion phenomenon that resulted from a very small amount of continuous intravenous infusion root that combined a syringe pump with an infusion pump 長井美樹1, 望月真維1, 伊藤裕司2, 菅島加奈子3, 三田浩子3, 加藤木玉江3, 石川洋一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 741-741, 2017.

---

	P0032-4-AM. Effect and the evaluation that the duties contents change that took advantage of the prescription input support by the pharmacist gives for ward drug duties 飯田慎也1, 井上正朝1, 寒藤雅俊1, 都築仁美1, 山下恭範1, 大滝康一1,2, 小川聡1, 福土将秀1, 粟屋敏雄3, 田崎嘉一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 742-742, 2017.

---

	P0034-4-AM. About efforts to improvement in ward drug control instruction duties in our hospital 永松秀紹1, 吉川直利1, 江本侑子1, 片岡万里奈1, 横田学1, 村上照幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 742-742, 2017.

---

	P0036-4-AM. The representation prescription situation that a pharmacist receives in the cardiovascular surgery ward 前川綾子1, 西村健二1, 益本周治1, 高柳和伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 743-743, 2017.

---

	P0038-4-AM. Examination (followup) of standardization, the efficiency of ward drug duties, the medication counseling in surgery, the oral surgery ward 加藤さやか1, 本木龍二1, 田村賢士1, 金子智一1, 松井孝之1, 寺田伊知郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 743-743, 2017.

---

	P0042-4-AM. Fact-finding about the pharmaceutical management of the high-risk medicine 中村俊貴1, 宮下博幸1, 小林義和1, 小林由布子1, 八木澤啓司1, 斎藤太寿1, 小林彦登1, 齋藤雅俊1, 松原肇1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 744-744, 2017.

---

	P0044-4-AM. Than the staff questionnaire after the evaluation - ward drug duties start of the ward pharmacist in the small and medium size hospital ... 石垣智加1, 横山佳寿子1, 平野泰健1, 服巻陽子2, 杉本ひろみ3, 白井孝則4, 中村守4, 竹中ゆかり5, 森信早穂子6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 745-745, 2017.

---

	P0046-4-AM. Look back on drug global assessment adjustment addition - start one year in our hospital; and - 野村理恵1,2, 森美穂2, 新藤学1, 加藤一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 745-745, 2017.

---

	P0048-4-AM. For improvement in number of the calculation of the drug global assessment adjustment addition 石野陽一1, 村山佳子1, 和田淳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 746-746, 2017.

---

	P0050-4-AM. Cooperation of a physician, the pharmacist for the promotion of the appropriate medical treatment 菅井千尋1, 原島久美1, 箱崎かおり1, 飯山久美子1, 田上明子1, 串田一樹2, 安藤浩巳1, 水村恒雄1, 山本健2, 廣原正宜2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 746-746, 2017.

---

	P0052-4-AM. Efforts to the antimicrobial proper use during the operation in our hospital 黒田幸佑1, 角本久美子1, 山原慶子1, 宇埜可南子1, 西井有希1, 小泉祐一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 747-747, 2017.

---

	P0054-4-AM. A pharmacist is an evaluation of the promotion of the ward antimicrobial medicine proper use by being stationed 大石博史1, 三角紳博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 747-747, 2017.

---

	P0056-4-AM. Effect ... of efforts - prescription checking standardization of the ward drug duties in the maternity ward and the foreign cooperation 木永舞1, 山本珠実1, 西郷智香1, 西口由梨亜1, 相澤実里1, 坂井恵理子1, 政賢悟1, 本田義輝1, 齋藤秀之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 748-748, 2017.

---

	P0058-4-AM. Efficiency of duties obtained from the making of the standard judgment chart for drug self-care of the inpatient and the utilization 尾崎正和1, 谷澤香名子1, 岡野智史1, 植松俊成1, 古川裕之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 748-748, 2017.

---

	P0060-4-AM. About ward drug duties and the current situation evaluation in Osaka University School of Dentistry Hospital 大石美奈子1, 戸田史恵1, 森功美子1, 高安敏子1, 上田紘子1, 上田幹子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 749-749, 2017.

---

	P0062-4-AM. Investigation of the drug-related incident contents in NICU/GCU ward 砂川由佳1, 瑞慶山にいな1, 伊差川サヤカ1, 与那覇房子1, 外間惟夫1, 中村克徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 749-749, 2017.

---

	P0064-4-AM. Evaluation method of the simple and easy, accurate internal use self-discipline by the pharmacist 辻屋朝美1, 西山啓介1, 三宅麻文1, 宮本直治1, 椎橋美月2, 楠本雅美2, 白田全弘3, 水野裕美子4, 河原宏之1, 石川弘子1, 尾上雅英1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 750-750, 2017.

---

	P0066-4-AM. Improvement report of the electronic edition internal use prescription system utilizing the bar code 桑田康宏1, 上田源治1, 徳永恵土2, 土肥大典1,3, 真壁秀樹1, 川井信孝3, 寺岡俊哉4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 750-750, 2017.

---

	P0019-3-PM. Efforts of the pharmacist for the "disease severity for the regular hospital, medical care, nursing necessary degree" evaluation 生越由美1, 田中奈桜1, 藤井克至1, 窪田彩花1, 北野祐香1, 宮部泰輔1, 黒川拓也1, 東達也1, 上田善美1, 田村憲昭1, 十田達也1, 安達克明1, 井上敦介1, 廣畑和弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 751-751, 2017.

---

	P0021-3-PM. Quality improvement (QI) activity in ward duties 鬼窪利英1, 三浦篤史1, 伊藤隆哉1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 752-752, 2017.

---

	P0023-3-PM. Introduction of the antithrombotic drug resumption protocol after the surgery in our hospital 秋山裕史1,2,3, 石崎直妙2, 袴塚康史2, 大和田万裕美2, 稲田寛之1, 海老根香里1, 川又亜由美1, 関利一1, 檜山和寛3, 中野順隆3, 神賀正博3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 752-752, 2017.

---

	P0025-3-PM. The effect that the combination of tramadol acetaminophen combination tablets gives to PT-INR on warfarin remedy patients 矢野賢明1, 飛鷹範明1, 橋本麻央1, 山下登1, 安永大輝1, 田中守1, 田中亮裕1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 753-753, 2017.

---

	P0027-3-PM. Relation of the pharmacist in the vitamin K preparation medication method change for neonates, the infants vitamin K deficiency hemorrhagic disease 岩崎瑛子1, 川下絵莉香1, 津田武典1, 竹田健志1, 菅田優子1, 伊藤千恵1, 的場美香1, 高木麻里1, 吉田智江1, 藤田敬子2, 田中恵美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 753-753, 2017.

---

	P0029-3-PM. Ogura Memorial Hospital ICU, investigation about the pharmaceutical support in the backward ward of CCU 前田朱香1, 福島将友1, 曽我弘道1, 福地祐亮1, 清水誉志1, 富田敏章1, 町田聖治1, 入江利行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 754-754, 2017.

---

	P0031-3-PM. Research about the association of cerebrospinal fluid reducing symptom and chemical sensitivity and electromagnetic wave hypersensitivity 鈴木高弘1, 中里直美2, 篠永正道3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 754-754, 2017.

---

	P0033-3-PM. Efforts for the qualitative improvement of drug control instruction duties 水津智樹1, 畑裕基2, 桶本幸2, 河合実3, 小林勝昭2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 755-755, 2017.

---

	P0035-3-PM. The effect that the ward duties of the pharmacist give for the mean hospitalization of the inpatient 吉戒渉1, 地嵜悠吾1, 松村千佳子1, 矢野義孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 755-755, 2017.

---

	P0037-3-PM. Role of the pharmacist in the urination care team 林剛史1, 古川大樹1, 梅山昌乃2, 森田睦美3, 長谷川雅哉1, 山本茂樹4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 756-756, 2017.

---

	P0039-3-PM. Investigation of the reporting duties of the working full time pharmacist in the extensive critical care center 東洋慶武1, 稲村広敏1, 國本雄介1, 藤居賢1, 益子寛之1, 木明智子1, 中田浩雅1, 野田師正1, 宮本篤1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 756-756, 2017.

---

	P0041-3-PM. Examination of the inhalant instruction using the check list in the respiratory medical service 肥田野綾1, 上村賢介1, 高橋成博1, 佐藤明美2, 寺田正樹3, 内坪誉歳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 757-757, 2017.

---

	P0043-3-PM. Efforts - second report ... for the pharmacist duties construction in the local inclusion care ward 佐藤伸輔1, 櫻井淳二1, 渡辺昌子1, 岡田優1, 野上佳奈子1, 宮内康夫1, 阿部順1, 武者栄美子1, 石澤文章1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 757-757, 2017.

---

	P0045-3-PM. Look back on the case that experienced about efforts of the drug global assessment adjustment addition in our hospital in ... ward; and ... 稲垣沙緒理1, 野村理恵1, 新藤学1, 加藤一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 758-758, 2017.

---

	P0047-3-PM. What is made by ward drug duties with electronic medical chart introduction? 中村和彦1, 中村嘉孝1, 山田圭子1, 大萱藍子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 758-758, 2017.

---

	P0049-3-PM. ... which was able to reduce 10% of the hospitalization bringing medicine in intervention result - orthopedics ward of the ward charge pharmacist to polypharmacy 山元孝俊1, 安井洋一2, 河野博隆2, 森川馨3, 中島圭佑1, 細野浩之4, 安野伸浩1,3, 渡邊真知子1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 759-759, 2017.

---

	P0053-3-PM. Efforts about the proper use of the pharmacist-led perioperative prophylactic antimicrobial in our hospital 栗崎貴啓1,2, 續政哉1, 相方靖史2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 760-760, 2017.

---

	P0055-3-PM. Questionary survey to 3 types of job about psychopathic ward drug duties in the Kusatsu Hospital 公文理紗子1, 大石千代1, 中村美貴1, 福田のぞみ1, 山田雅彦1, 宇治宏美1, 甲斐由起1, 桝井章典1, 栗原鑑三2, 別所千枝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 760-760, 2017.

---

	P0057-3-PM. The analysis of the doubt inquiry example in the merger mind center ward in the Kyushu medical center and the pharmacist image that is sought 藤田強記1, 福山雄卯介2, 林稔展3, 西野隆3, 中川義浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 761-761, 2017.

---

	P0059-3-PM. Effect of the pharmacist intervention by the ward drug duties start in neurology, the respiratory internal medicine, internal secretion, metabolism, diabetes medical service 田崎智也1, 大野梨絵1, 河野洋平1, 関屋裕史1, 岩切智美1, 奥村学1, 有森和彦1, 池田龍二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 761-761, 2017.

---

	P0061-3-PM. Fact-finding of the warfarin induction and future view 小西麻美子1, 澤田真嗣1, 山崎映美1, 堀内あす香1, 村木優一2, 岡橋孝侍1, 藤田敦夫1, 友金幹視1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 762-762, 2017.

---

	P0065-3-PM. Making and evaluation of the medical calculation tool 河村聡志1, 末延道太1, 梅野智美1, 岩崎和広2, 紀雅之3, 菅田哲治2, 森一生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 763-763, 2017.

---

	P0067-3-PM. The prospects of the Primary care duties for the patients addicted to the poison in medicine thing of the pharmacist 冨永麻里子1, 今浦将治1, 菅野浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 764-764, 2017.

---

	P0069-3-PM. Intervention and evaluation by the pharmacist at biological drug introduction in the psoriasis medical therapy 平出耕石1,2, 宮本義浩1, 古田愛果1, 安田憲隆1, 佐竹史章3, 大原満梨奈3, 森知花3, 岡田純子3, 加藤武司1, 神谷秀喜3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 765-765, 2017.

---

	P0071-3-PM. Examination - using data of effect - VISTA Project that the simple and easy intervention through the notebook gives in recognition for the medication counseling using the notebook of the pharmacist 清水麻里奈1, 庄司雅紀1, 荒川行生1, 恩田光子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 765-765, 2017.

---

	P0073-3-PM. Examination - using data of effect - VISTA Project which simple and easy intervention using the prescription notebook by the pharmacist gives in the appropriate use degree of the prescription notebook of patients 森田圭祐1, 庄司雅紀1, 荒川行生1, 恩田光子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 766-766, 2017.

---

	P0075-3-PM. Effect of the antimicrobial doses suggestion according to cancellation medicine's confirmation and the renal function by the pharmacist interview before our hospital prostate biopsy 清川明慶1, 齊藤亮1, 矢田康司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 766-766, 2017.

---

	P0077-3-PM. Efforts of the pharmacist concerned with common use medicine management before hospitalization in the admitting department 中根優1, 南貴之1, 遠藤愛樹1, 向山明彦1, 花輪和己1, 小林義文1, 山本誠一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 767-767, 2017.

---

P0079-3-PM. Evaluation and problem ... of the pharmacist duties in the examination ... patients synthesis support center about the factor of the observance situation and the discontinuation mistake of the discontinuation before surgery, examination 中下愛実1,2, 野澤まゆ1, 小林奈央1, 堀寧1,2, 山田徹1, 五十嵐洋子2, 内藤厚子2, 倉林工2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 767-767, 2017.

---

	P0081-3-PM. About outside Parliament information sharing through a start and the medicine medicine cooperation of confirmation of foreign bringing medicine before hospitalization duties 馬上雅光1, 上平美穂子1, 永山美佐枝2, 小野広枝2, 梶原徹1, 渡邉義久3, 高橋浩子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 768-768, 2017.

---

	P0083-3-PM. It is ... led by an importance - stomach ESD, EMR case of the cooperation in the on admission bringing medicine's confirmation from the outpatient department in front of the art 渡辺篤1, 宮森伸一1, 升田夏希1, 岩崎歩1, 柳田祐子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 768-768, 2017.

---

	P0085-3-PM. It is ... mainly on current situation - urology department of the suggestion to a physician in the pharmacist outpatient department 久保嘉靖1, 三浦恵理1, 高柳信子1, 奥野昌宏1, 中田学1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 769-769, 2017.

---

	P0087-3-PM. The system construction (pharmacist outpatient department) for the cancer instruction to patient management charges 3 calculation 鶴崎泰史1, 大橋邦央1, 丸田基史1, 後藤由起子1, 藤田強記1, 横田千明1, 山形真一1, 中川義浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 769-769, 2017.

---

	P0089-3-PM. About the relation of the pharmacist to cancer instruction to patient management charges 3 calculation and foreign chemotherapy 小笠原健1, 虻川詩希子1, 金沢久男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 770-770, 2017.

---

	P0091-3-PM. Relation (the second report) to the drug introduction patients in the pharmacist outpatient department 川久保充章1, 釘原瑶子1, 上津沙織1, 居塚しのぶ1, 小倉秀美1, 末松文博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 770-770, 2017.

---

	P0093-3-PM. The construction of the outside Parliament internal use anticancer agent instruction system and change of cancer instruction to patient management charges 3 鈴木雅人1, 木全司1, 松丸沙織1, 笠井翼1, 高原悠子1, 牧原明秀1, 吉田弘樹1, 山室理2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 771-771, 2017.

---

	P0095-3-PM. Operation of the pharmacist outpatient department for patients with lung cancer and the enforcement situation 前田剛司1, 鈴木敦詞1, 鈴木大吾1, 坂田洋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 771-771, 2017.

---

	P0097-3-PM. Examination about the cancer support pharmacist foreign current situation in our hospital and the usefulness 神原康佑1, 荻原好章1, 大塚識稔1, 原景子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 772-772, 2017.

---

	P0099-3-PM. The consultation of the pregnancy, the nursing domain is foreign 一木幸奈1, 勝野晋哉1, 山田哲也1, 鷹見繁宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 772-772, 2017.

---

	P0101-3-PM. Medication support of the pharmacist for Daclatasvir Asunaprevir combination therapy patients 山本恭平1, 鶴田昌吾1, 岩瀬由枝1, 新海大智1, 野澤孝子1, 渡辺裕之1, 中村和行1, 伊藤友恵1, 大野愛1, 久保田敏行1, 杉浦洋二1, 勝見章男2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 773-773, 2017.

---

	P0103-3-PM. Usefulness of the foreign medication counseling in the direct action type antiviral therapy for the hepatitis C 岡田莉奈1, 平野公美1, 冨田奈々1, 松本ゆいこ1, 杉山幸子1, 山川花朱美1, 宮本康敬1, 影山富士人2, 渡邉進士1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 773-773, 2017.

---

	P0105-3-PM. The effect that inspiratory flow rate reduction in the inhalation therapy of patients with bronchial asthma, COPD gives to hoarseness 森田淳一1, 金沢昂1, 大和田有1, 大内崇代1, 岩崎英次1, 長南達也2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 774-774, 2017.

---

	P0107-3-PM. Research about a question and the solution to medicine which patients have 山田航輔1, 富岡裕菜1, 大久保駿一1, 笹木拓郎1, 高橋雅也1, 沖垣圭亮1, 横川祐美1, 寺原史貴1, 齊藤俊一郎1, 船木映二1, 橋本義宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 774-774, 2017.

---

	P0109-3-PM. Operation and evaluation of the tracing report which outpatient department exclusive duty pharmacist intervened in positively 満田正樹1, 尾崎加織1, 石本昌裕1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 775-775, 2017.

---

	P0111-3-PM. Establishment of discontinuation instruction duties before operation based on a protocol in the orthopedics outpatient department 安東大智1, 山村亮太1, 五十川達哉1, 宮本弥生2, 永野俊玲1, 泊一秀3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 775-775, 2017.

---

	P0113-3-PM. Search of the factor associated with the onset of the delirium after the operation concerned 宮部泰輔1, 生越由美1, 黒川拓也1, 東達也1, 田村憲明1, 安達克明1, 井上敦介1, 廣畑和弘1, 結城奈津子2, 山野純弘3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 776-776, 2017.

---

	P0115-3-PM. Evaluation - of the check sheet for evaluation - adrenalin injection (Epinephrine autoinjector injection) instruction of explanation, instruction duties in the pharmacist outpatient department 見目英継1, 菊岡慶1, 寺田有希1, 小暮宗介1, 折井孝男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 776-776, 2017.

---

	P0068-4-AM. Examination about the drug confirmation duties for the preoperation patients in the outpatient department 萩歩美1, 組橋由記1, 福島ゆかり1, 鈴江朋子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 777-777, 2017.

---

	P0070-4-AM. Elba building in patients on dialysis, efforts in the foreign instruction of the Grazoprevir 如田真貴1, 後藤渉1, 大穂有恒2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 778-778, 2017.

---

P0072-4-AM. Analysis ... of an intervention case and the continuous intervention case from evaluation - outpatient department of an evaluation of the usefulness in the pharmacist outpatient department and the medical economic effect after the discharge 土屋裕伴1, 日野亜莉沙1, 光田恵里香1, 齋藤由貴1, 諸橋賢人1, 腮尾成美1, 新井亘1, 増田裕一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 778-778, 2017.

---

	P0074-4-AM. It is analyzed the factor with the time in the prehospital common use medicine's confirmation 祖川倫太郎1, 西村文1, 江越寿美代1, 木村早希子1, 田崎正信1, 成澤寛1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 779-779, 2017.

---

	P0076-4-AM. Efforts of the pharmacist for the discontinuation management before surgery of the outpatient 樽野麻依1, 梶田貴司1, 庄司賀子1, 木口真佐恵1, 佐藤香苗1, 野澤直美1, 久乗しのぶ1, 奥野智之1, 上田睦明1, 福田奈津子2, 原里美2, 林野泰明3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 779-779, 2017.

---

	P0078-4-AM. The effect that an outpatient in front of the anesthesiology art gave appropriate management and ward drug duties of the stop medicine in front of the art 土屋翔子1, 長水正也1, 鵜飼めぐみ1, 野田雅人1, 岡本有紀子1, 佐藤由美子1, 六鹿浩1, 森下修行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 780-780, 2017.

---

	P0080-4-AM. Efforts of the pharmacist in the hospitalization support 小林奈央1, 中下愛実1,2, 野澤まゆ1, 堀寧1,2, 山田徹1, 五十嵐洋子2, 内藤厚子2, 倉林工2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 780-780, 2017.

---

	P0082-4-AM. Intervention effect of the pharmacist for outpatients in front of the anesthesiology art 岡崎裕太朗1, 木村丈司1, 戸田飛鳥1, 阪上倫行1, 江口舞1, 西岡達也1, 久米学1, 槇本博雄1, 平井みどり1, 矢野育子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 781-781, 2017.

---

	P0084-4-AM. Evaluation of the practice system that a pharmacist attends the encounter of the physician in the foreign chemotherapy 北出紘規1, 北国憲剛1, 安藤友貴1, 森光恵1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 781-781, 2017.

---

	P0086-4-AM. About the effectiveness of the medicine medicine cooperation for protocol joint ownership in oral anticancer agent side effect measures 中川雅史1, 泉本裕美1, 岸孝行1, 宮内実奈絵1, 吉岡厚子1, 狩谷佳寛1, 樫葉利人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 782-782, 2017.

---

	P0088-4-AM. Activity evaluation of the foreign chemotherapy room exclusive duty pharmacist alone system for 3 years 合澤啓二1, 岩田一史1, 陣上祥子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 782-782, 2017.

---

	P0090-4-AM. Inspection of the usefulness of by medical examination front for the use of foreign drug patients by the pharmacist 今岡寛美1, 榎本美幸1, 伊藤友一1, 森住誠1, 石原美加1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 783-783, 2017.

---

	P0092-4-AM. Efforts of by drug medical examination front for the medical care for the outpatient 木村桃子1, 魚住菜月1, 亀井健人1, 石田直2, 高柳和伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 783-783, 2017.

---

	P0094-4-AM. It is ... through examination - pharmacist outpatient department of the future problem for the efforts to foreign cancer medical therapy, doubt inquiry in the chemotherapy center 神田英一郎1, 大坪達弥1, 加藤良隆1, 岡橋孝侍1, 藤田敦夫1, 友金幹視1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 784-784, 2017.

---

	P0096-4-AM. Effect of the Residual medicine adjustment in the pharmacist outpatient department 大原正之1, 斉藤匡昭1, 高山冴子1, 藤原斉1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 784-784, 2017.

---

	P0098-4-AM. Efforts to the group support program by the multi-type of job team in the outpatient specialized in dementia 古川公美子1, 堀田牧2, 小山明日香2, 丸山貴志2, 園田恵2, 遊亀誠二2, 石川智久2, 橋本衛2, 齋藤秀之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 785-785, 2017.

---

	P0100-4-AM. Real-time team approach in medical care in the dialysis rounds that a pharmacist and dietitian are accompanied by 中川聡1, 八城学1, 相澤政明1, 清水健史2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 785-785, 2017.

---

	P0102-4-AM. Examination of the method not to be choked, and to inhale dry powder preparation 中村敏史1, 伊藤稔宏1, 山本雅史2, 池上信昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 786-786, 2017.

---

	P0104-4-AM. Relation of the instruction situation and the pharmacist of the chronic hepatitis C therapeutic drug 永井智子1, 内田将吾1, 上田恒治1, 奥村明彦2, 畔柳敏弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 786-786, 2017.

---

	P0106-4-AM. Inhalation therapy support in the pharmacist outpatient department: It is unified inhalational instruction and evaluation methods 野田幸裕1, 浮貝真子1, 後藤綾1, 肥田裕丈2, 宮崎雅之2, 山田清文2, 吉見陽1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 787-787, 2017.

---

	P0108-4-AM. Efforts (the second report) for grasp and the improvement of the use of inhalant situation in our hospital in inhalational adherence 荒木寛也1, 坂柳悦章1, 西川隆一1, 澤柳直樹1, 藤井友和1, 辻博幸1, 塚本久之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 787-787, 2017.

---

	P0110-4-AM. About operation to confirm discontinuation instructions without posting a pharmacist in the hospitalization support center by exclusive duty 大谷寧次郎1, 畔柳敏弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 788-788, 2017.

---

	P0114-4-AM. Intervention of the use situation of the oral hepatitis C therapeutic drug in our hospital and the pharmacist 小倉功1, 竹下和輝1, 松山哲史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 789-789, 2017.

---

	P0116-4-AM. Evaluation of the prescription modified supporting duties in the surgery ward 山中真理1, 宮城明実1, 辻村行啓1, 荒川大輔1, 塩川満1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 790-790, 2017.

---

	P0118-4-AM. Development second report of the foreign present situation and pharmacist duties specialized in Oriental medicine to be in the faculty of medicine hospital 日置智津子1, 伊藤エミ1, 中井賀世子1, 宇高一郎1, 村重史子1, 椎名昌美1, 武田卓1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 791-791, 2017.

---

	P0120-4-AM. Improvement of doubt introduction duties by the efforts (the fifth report) CDTM introduction for joint medical treatment (CDTM) in the community medical care 小川壮寛1, 松下明2, 守安洋子1, 田中綾1, 河南真衣1, 中島利裕1, 中尾直1, 江川孝4, 島田憲一3, 高見陽一郎3, 高橋正志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 791-791, 2017.

---

	P0122-4-AM. The current situation of education and the teeth medicine cooperation using the high-performance patients simulator for the dentist 大月理恵子1, 小川敦1, 大川恭昌1, 勝部理早1, 蔵田靖子1, 日野隼人1, 白石奈緒子1, 錦織淳美1, 名和秀起1, 山口貴子2, 万代康弘2, 大澤晋3, 北村佳久1, 清水裕雄4, 那須保友2, 千堂年昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 792-792, 2017.

---

	P0124-4-AM. Improvement ... of the dramatic increase and generic drug availability ratio of strategy and evaluation - drug control instruction number using the balance scorecard 遠藤正憲1, 山口瑞彦1, 藤井重治1, 塚本有子1, 赤瀬朋秀2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 792-792, 2017.

---

	P0126-4-AM. It is tried the raising at the confirmation time by the pharmacist in the clinical path making 宗田一記1, 山口進1, 石井啓貴1, 佐久間淳一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 793-793, 2017.

---

	P0117-3-PM. The efforts to the germfree preparation duties of use of heart surgery pharmaceutical products by the operating room charge pharmacist and the evaluation 白石洋輔1, 竹本雄一1, 廣瀬正幸1, 平岩歳久1, 加藤貴大1, 今井一輝1, 太田秀基1, 山田成樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 794-794, 2017.

---

	P0119-3-PM. Efforts about the examination for protein urine protocol introduction at the bevacizumab ramucirumab administration and future problem 熊谷修一1, 目黒聡子1, 酒井由希子1, 野口真利1, 佐藤晃一1, 永倉史子1, 川口裕花1, 渡辺京彦1, 大川真里奈1, 高山裕子1, 山内泰一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 795-795, 2017.

---

	P0121-3-PM. Investigation about the Residual medicine adjustment of the outside Parliament prescription 塚元美江1, 富士谷昌典1, 西井有希1, 黒田幸佑1, 杤尾香奈1, 北山明子1, 小泉祐一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 795-795, 2017.

---

	P0125-3-PM. Consideration about the external environment analysis at balun strike scorecard making for hospital pharmacist 金田昌之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 796-796, 2017.

---

	P0127-3-PM. The review of the pharmacist duties in the operating room in our hospital and future examination 北川奈津子1, 桶谷純子1, 山口翔平1, 荒井涼子1, 小池田玲子1, 平木祥子1, 土田英昭2, 丹羽修1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 797-797, 2017.

---

	P0130-4-AM. Examination - of electronic prescription notebook use and application - two ways communication model for patients and a pharmacist 田代朋子1, 本田卓也1, 折井孝男2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 799-799, 2017.

---

	P0132-4-AM. Examination of the use master who should enroll in a drug-related system in the hospital managing by a handwritten prescription 谷口美悠1, 竹林太志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 799-799, 2017.

---

	P0134-4-AM. Efforts for the record making duties improvement by the template introduction 魚住秀親1, 水之江峻介1, 岡本美由紀1, 下山真智子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 800-800, 2017.

---

	P0129-3-PM. Examination of the prescription misdecrease effect by the customization of the pharmaceutical products master 浦崎圭太1, 植村太志1, 一木万奈美1, 長谷川徹1, 菱田栄子1, 久田純生1, 河井和子1, 伊藤和幸1, 磯谷聡1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 801-801, 2017.

---

	P0131-3-PM. Promotion and drug control instruction support of the antimicrobial proper use based on the expansion of the antimicrobial proper use check system at impaired renal function 松本薫1, 佐藤篤郎1, 永田実1, 加藤直紀1, 天野哲史1, 鈴木裕之1, 八並ゆかり1, 榊原奈美1, 伊藤昌美1, 鈴木厚志1, 板倉由縁1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 802-802, 2017.

---

	P0133-3-PM. The computerization of the drug application record in the Mie University faculty of medicine hospital and the evaluation 岡本明大1, 濱口直美1,2, 水谷栄梨1, 岩本卓也1, 安積良紀3, 奥田真弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 802-802, 2017.

---

	P0135-3-PM. The effect that the introduction of the database for the prescription check gives to the number of doubt inquiries 岩田一史1, 宮崎美香1, 合澤啓二1, 秋吉明子1, 陣上祥子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 803-803, 2017.

---

	P0137-3-PM. Inquired analysis about the off-label use put to the drug information room 村上ひろみ1, 金子美智子1, 天田斉子1, 橋爪孝弘1, 田中怜1, 篠道弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 804-804, 2017.

---

	P0139-3-PM. Effect on transluminal dose of clopidogrel sulfate tablets by the simultaneous suspension with magnesium oxide tablets 青木学一1,2, 加藤雅大2, 有馬志保1, 長井賢一郎1, 長光亨1, 尾鳥勝也1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 804-804, 2017.

---

	P0141-3-PM. Making of the antithrombotic drug off-period check tool in the digestive organ endoscope practice 若林千草1, 益子里美1, 秋本円香1, 植田生織1, 松本麻美1, 松本啓一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 805-805, 2017.

---

	P0143-3-PM. The construction of the database about the injection drug incompatibility information and evaluation of the usefulness 中川貴弘1, 伊藤健二1, 上田祥子1, 上見藍子1, 北庄司敦久1, 西井拓人1, 原義浩1, 宮本紅喜1, 宮本訓子1, 山地亜希1, 山道麻葉1, 薮内新平1, 森朝紀文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 805-805, 2017.

---

	P0145-3-PM. A medicine bag and efforts to English version making of the drug reporting paper 井上理咲子1, 赤沢翼1, 上山麻衣1, 瀬戸恵介1, 吉川至1, 増田純一1, 近藤直樹1, 坂本治彦1, 桑原健1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 806-806, 2017.

---

	P0149-3-PM. Efficiency of the bringing medicine report by the cooperation with the drug information management room 二上佳世子1, 松森智士1, 高野由美子1, 大越美根子1, 政氏藤玄1, 小堀勝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 807-807, 2017.

---

	P0151-3-PM. Analysis about the rhabdomyolysis, and the like of the new quinolone antibacterial using Japanese adverse event spontaneous report database (JADER) 太田涼介1, 平田敦士1, 畑武生2, 能登啓介1, 福井愛子1, 西原雅美2, 勝間田敬弘2, 松岡寛1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 807-807, 2017.

---

	P0153-3-PM. A relative evaluation of prostaglandin system eye drops and the asthma using JADER: Comparison with beta-blocker eye drops 大山勝宏1, 杉浦宗敏1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 808-808, 2017.

---

	P0155-3-PM. Research about the alcohol-containing drug 相良有里1, 齋藤雅俊1, 左右田和枝1, 松原肇1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 808-808, 2017.

---

	P0157-3-PM. Examination for HBV history confirmation using eXChart and regimen integration effect of the examination order tool 山中理1,2, 阿部史誉1, 益澤明3, 中山英夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 809-809, 2017.

---

	P0159-3-PM. The future way to regard as the mention contents of the pharmaceutical products risk management plan from update frequency 平山優花1, 相良克海1, 小田慎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 809-809, 2017.

---

	P0161-3-PM. About problems at reuse of the questions and answers record of the drug information room 関谷泰明1, 平下智之1, 谷沢克弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 810-810, 2017.

---

	P0163-3-PM. About the activities of the Fukui pharmacist society pharmaceutical affair information center 平賀貴志1, 矢野七恵2, 古俵美穂2, 山瀬美香2, 高畠栄一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 810-810, 2017.

---

	P0136-4-AM. "The secant design" of the tablet judging from a package insert, interview form 若林進1, 田中秀和2, 藤澤哲也3, 三上明子4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 811-811, 2017.

---

	P0138-4-AM. Use and application of the correspondence manual and PMDA adverse drug reaction database according to the serious side effect disease in pharmacist duties 冨田淳子1, 梁木美幸1, 立道貴清1, 越野優希1, 綾野武司1, 田中裕章1, 加地雅人1, 小坂信二1, 芳地一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 812-812, 2017.

---

	P0140-4-AM. Fact-finding of the risk minimization activity for patients for the enumeration risk of pharmaceutical products risk management plan 市江敏和1,2, 浅川博翔2, 鈴木大介1,2, 寺崎嘉正1, 林秀樹2, 畔柳敏弥1, 杉山正2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 812-812, 2017.

---

	P0142-4-AM. Making of the drug intoxication reporting application using package insert information data 田中正臣1, 田中彰一1, 武田瑛司1, 宮腰恵生1, 森野太一1, 山岡幸1, 竹内正真1, 宮越貴之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 813-813, 2017.

---

	P0144-4-AM. The construction of the existing intellect non-intellect automatic judgment system of the adverse event spontaneous report by the exhaustive mapping of the side effect term and inspection by SGLT2 多門啓子1, 吉川達也1, 五島誠1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 813-813, 2017.

---

	P0146-4-AM. Management and evaluation of off-label use pharmaceutical products 上田彩1, 杉村春奈1, 北山知里1, 望月智子1, 小野寺夕貴1, 坂上逸孝1, 田中恒明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 814-814, 2017.

---

	P0148-4-AM. Comparison between conventional signal detecting method and association analysis for the purpose of the search of the adverse event by the pharmaceutical products interaction 野口義紘1, 上野杏莉1, 大坪愛美1, 勝野隼人1, 杉田郁人1, 兼松勇汰1, 吉田阿希1, 江崎宏樹1,2, 舘知也1, 寺町ひとみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 814-814, 2017.

---

	P0150-4-AM. Investigation of the information about taste, the smell, and the like of the drug for children 花沢祐紀1, 佐田宏子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 815-815, 2017.

---

	P0152-4-AM. The construction of the information on adverse drug reactions uniform management method in our hospital and the analysis 北村憲雅1, 大竹野久雄1, 横尾賢乗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 815-815, 2017.

---

	P0156-4-AM. It is ... using RMP of investigation and problem - tolvaptan of the RMP utilization situation in our hospital 中村友哉1, 枦秀樹1, 宮原由香里1, 太田哲徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 816-816, 2017.

---

	P0158-4-AM. We develop the current situation investigation and the application of the inquiry record from the type of job other than at psychiatry single department hospital in Okayama 黒住由依1, 三木恵美1, 笹岡健二1, 三宅彩香1, 馬場大樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 817-817, 2017.

---

	P0160-4-AM. Construction and example analysis of the system managing a doubt inquiry and the consultation meeting a demand contents 田中義輝1, 岡田由加1, 橋爪博隆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 817-817, 2017.

---

	P0162-4-AM. Remedy-related evaluation at antimicrobial mixture for children by the sensory evaluation 田杭直哉1, 下道友莉恵1, 黒田香織1, 竹下絵梨香1, 長谷川茉莉子1, 吉田直樹1, 近藤匡慶1, 菅谷量俊1, 高瀬久光1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 818-818, 2017.

---

	P0164-4-AM. Efforts for the computerization of the collection of in-hospital pharmaceutical products 内藤哲哉1, 坂本亜沙美1, 執行素美1, 小森美佳1, 小宮孝俊1, 堤一貴1, 田中和江1, 三輪涼子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 818-818, 2017.

---

	P0165-3-PM. Attitude survey about the occupational exposure of the pharmacist at powders formulations 前田志津子1, 杉原数美1, 田山剛崇1, 三宅勝志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 819-819, 2017.

---

	P0169-3-PM. Association of a use and the adherence of the 5-aminosalicylic acid preparation in patients with inflammatory bowel disease 池田澪樺1, 高瀬友美1, 宮崎元康1, 中島章雄1, 坂元佑哉1, 藤木将勝1, 松尾宏一1, 今給黎修1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 820-820, 2017.

---

	P0171-3-PM. Examination about the remedy situation and the prescription trend of the antihypertensive medications in patients with cerebral hemorrhage and the antithrombotic drug 近藤真由1, 栗原江未1, 大石丸美1, 岩武幹乃1, 山村真貴子1, 臼井和明1, 植中英恵1, 森田佳博1, 白石貴寿1, 面田恵1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 821-821, 2017.

---

	P0173-3-PM. Evaluation to pharmacist intervention by the convalescent rehabilitation ward staff 小西愛1, 奥野靖隆1, 妻鹿宏美1, 永田文恵1, 梶原博視1, 外間健吾1, 近藤幸男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 821-821, 2017.

---

	P0175-3-PM. Attitude survey for the anti-doping in the environmental change of the business group team 村上達也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 822-822, 2017.

---

	P0177-3-PM. Examination of the choice reason at the DOAC change of patients with non-valvular atrial fibrillation in our hospital outpatient department prescription 早坂美希1, 千葉貴志1, 上村新吾1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 822-822, 2017.

---

P0179-3-PM. Questionary survey about acquisition, the transmission of the pharmaceutical products safety information in Hiroshima 桑原秀徳1, 川上恵子1, 光廣貴紀1, 岡本直樹1, 安原昌子1, 武郷徹1, 福原伸治1, 佐和章弘1, 池本雅章1, 中村亜由美1, 秋本伸1, 常友盛勝1, 鵜池敏令1, 内海敦志1, 中本匡美1, 柴田ゆうか1, 泉谷悟1, 豊見敦1, 松本俊治1, 谷口雅敏1, 日浦和徳1, 中村徹志1, 松尾裕彰1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 823-823, 2017.

---

	P0181-3-PM. Examination about the Helicobacter pylori sanitization success rate using the vonoprazan 篠原裕1, 武田良平2, 本多正彦3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 823-823, 2017.

---

	P0183-3-PM. Risk factor analysis of the non-alcoholic fatty liver disease in the clinical survey 数馬南美1, 伊藤千裕1,2, 清水清香3, 井上岳1,2, 氏原淳2, 山田悟4, 常松令3, 松原肇1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 824-824, 2017.

---

P0185-3-PM. It is ... about use of a relation and the bringing medicine to report - polypharmacy as a result of Kanagawa hospital pharmacist party duties investigation questionnaire 小林求1,2, 濃沼政美1,3, 前田拓哉1, 藤原久登1,4, 瀧本淳1, 芦塚拓也1, 湯本哲郎1,5, 飯田純一1, 長井真梨子1, 河原英子1, 小森智也1, 佐々木寿子1, 白鳥千穂1, 宮田広樹1, 佐藤透1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 824-824, 2017.

---

	P0187-3-PM. Use of generic medicine ratio investigation in the common use medicine of the staff of a school 守内匡1, 守内典子1, 松井ひろみ1, 田中治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 825-825, 2017.

---

	P0189-3-PM. The adverse event expression of pregabalin situation in initial recommended dose or less 前田知穂1, 末松直幸1, 後藤正道2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 825-825, 2017.

---

	P0191-3-PM. We work on risk minimization of the nintedanib on the basis of the use situation under the true clinical practice 柳本正憲1, 長尾由佳1, 益本周治1, 赤木晋介1, 高柳和伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 826-826, 2017.

---

	P0193-3-PM. Fact-finding about the Shakuyakukanzoto long-term continuous use patients 井口智恵1,2, 市田千穂1, 伊藤千裕1,2, 井上岳1,2, 清原寛章3, 松原肇1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 826-826, 2017.

---

	P0195-3-PM. Renal function during L-amphotericin B administration and fact-finding of blood K-value 末延道太1, 佐脇久美1, 穴井美玖1, 佐藤史織1, 原尻学志1, 森一生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 827-827, 2017.

---

	P0197-3-PM. Examination - second report - of the use of sleeping drug manual introduction aiming at proper use 嶋崎千絵1, 財津孝希1, 瀧内瑛輔1, 長澤欣弘1, 羽生智宏1, 尾形美絵1, 田村和彦1, 新関みどり1, 近藤和宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 827-827, 2017.

---

	P0199-3-PM. Investigation about the use situation and the side effect expression of Ledipasvir/Sofosbuvir combination tablets in the Toho University medical center Sakura Hospital 井澤香1, 土井啓員1, 佐野君芳1, 真坂亙1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 828-828, 2017.

---

	P0201-3-PM. Examination about the use dose of the ST medical mixture prophylaxis for the pneumocystis pneumonia 古賀清弘1, 石丸隆之1, 谷川昇1, 藤田玲奈1, 野中敏治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 828-828, 2017.

---

	P0168-4-AM. Do the antihypertensive medications influence a fracture site? - Inspection - of antihypertensive medications and the blood pressure in the fracture site 小野悠香里1, 渡邉啓太1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 830-830, 2017.

---

	P0170-4-AM. The treatment satisfaction investigation for the anticoagulant of patients with non-valvular atrial fibrillation in the Kosei society Takeda Hospital: Using Anti-Clot Treatment Scale (ACTS) 礒田果林1, 中埜梓1, 鏑木めぐみ1, 松田貴臣1, 林千麗1, 妹尾恵太郎2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 830-830, 2017.

---

	P0172-4-AM. The actual situation and measures of the polypharmacy in the medical treatment ward 土元研史1, 安田礼子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 831-831, 2017.

---

	P0174-4-AM. Attempt of the use fact-finding of the S zopiclone remedy patients and the intervention 福田翔一1, 馬原大志1, 渕上俊介1, 車塚千穂1, 今井隆人1, 小林龍1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 831-831, 2017.

---

	P0176-4-AM. Comparison about Japan and the drugstore business of the United States 蓮元憲祐1, 吉田綾乃2, 玉田美香2, 柴田実香2, 横井正之1,3, Roger K Thomas4, 荒井國三2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 832-832, 2017.

---

	P0178-4-AM. A side effect during use of rheumatoid arthritis therapeutic drug methotrexate and the situation investigation that used investigation - adverse drug reaction automatic monitoring system about the examination interval 五十嵐敏明1, 今野彩1, 矢野良一1, 塚本仁1, 後藤伸之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 832-832, 2017.

---

	P0180-4-AM. Apixaban in treatment of the venous thromboembolism and recurrent inhibition purpose, use fact-finding of the rivaroxaban 奥村浩樹1, 牧田亮1, 田中佳子1, 平下智之1, 谷沢克弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 833-833, 2017.

---

	P0182-4-AM. Questionary survey about the needs of the combination drug to look at from patients 亀井進太郎1, 佐藤雄己1, 小野優子1, 内匠幸恵1, 後藤伴美1, 田名網悠1, 岡部耕平1, 津下遥香1, 森永裕子1, 天田耕平1, 小野寛之1, 野々下航1, 炭元隆宏1, 衛藤大輝1, 鈴木芳1, 白岩健1, 藤原涼1, 伊東弘樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 833-833, 2017.

---

	P0184-4-AM. Change of the prescription trend by 70 pieces of fomentation restrictions in our center 淀川進也1, 黒崎由希子1, 小坂若那1, 冨岡謙二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 834-834, 2017.

---

	P0186-4-AM. Effect on studies of the migraine headache in the pharmacy student 平野貴法1, 石井正和1, 石橋正祥1, 加藤大貴2, 笹井英世3, 野田朋宏4, 井上剛4, 巖本三壽1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 834-834, 2017.

---

	P0188-4-AM. The use situation investigation of the rivaroxaban in our hospital 坂柳悦章1, 荒木寛也1, 西川隆一1, 澤柳直樹1, 藤井友和1, 辻博幸1, 塚本久之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 835-835, 2017.

---

	P0190-4-AM. Relation of the use situation and the pharmacist of vigabatrin in the Gifu comprehensive medical care center 井上壽江1, 篠田あすみ1, 村田庄司1, 谷沢克弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 835-835, 2017.

---

	P0192-4-AM. About the effectiveness and the safety of the chronic hepatitis C therapeutic drug 徳井志野1, 山口泰弘1, 赤崎大恭1, 浦本邦弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 836-836, 2017.

---

	P0194-4-AM. Investigation about the factor having an influence on hypotensive frequency by the carperitide and the expression 田實裕介1, 冨山成章1, 橋元良枝1, 前山瑞穂1, 松ヶ野聡美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 836-836, 2017.

---

	P0196-4-AM. The situation investigation of patients using pharmaceutical products having an influence on the driving 石井大輔1, 前澤佳代子1,2, 橋本竜1, 玉井一也1, 小林俊喜2, 渡邊鷹志2, 石井裕太2, 杉山奈津子1,2, 加藤芳徳2, 伊東岳2, 百瀬泰行1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 837-837, 2017.

---

	P0198-4-AM. In our hospital is the examination about the change of prescription reason of oral anticoagulant drug (DOAC) directly 中野敬太1, 石郷友之1, 藤居賢1, 木明智子1, 中田浩雅1, 野田師正1, 宮本篤1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 837-837, 2017.

---

	P0200-4-AM. Recognition investigation of the physician for pharmaceutical products having an influence on the driving 橋本竜1, 前澤佳代子1,2, 玉井一也1, 石井大輔1, 本多珠里都2, 石井裕太2, 小林俊喜2, 渡邊鷹志2, 杉山奈津子1,2, 加藤芳徳2, 伊東岳2, 百瀬泰行1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 838-838, 2017.

---

	P0202-4-AM. Rearward investigation about the side effect expression of pregabalin risk in the decreased renal function patients 宮澤秋子1, 高濱和弘1, 二川俊隆1, 松元真哉1, 稲葉るり1, 前川彩乃1, 谷真琴1, 松田絹代1, 武田泰生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 838-838, 2017.

---

	P0203-3-PM. Examination about an interruption reason and the quantity of disposal of the on admission bringing drug 森澤さおり1, 加藤正太郎1, 佐々木克也1, 三浦昌朋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 839-839, 2017.

---

	P0207-3-PM. Calculation of depression speed stabilization time of the Ca blocker based on large-scale postmarketing surveillance data 野田紗也香1, 佐藤倫広2,3, 鈴木裕之1, 八木朋美1, 村上任尚2, 目時弘仁2, 村井ユリ子1, 中村仁1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 840-840, 2017.

---

	P0209-3-PM. Use fact-finding about the lithium carbonate using receipt data 大場延浩1, 飯島桃子1, 川鍋未来1, 梅田貴史1, 北村菜穂1, 吉野成泰1, 小林直子1, 堤大輔1, 林宏行1, 久保田潔2, 福岡憲泰1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 841-841, 2017.

---

	P0211-3-PM. Estimate of the effect that a very small amount of adjustment of the dosage of the large amount anticancer medicine gives in medical expenses reduction 植木亮磨1, 横山雄一1, 篠原義剛1, 植木哲也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 841-841, 2017.

---

	P0215-3-PM. Study on standardization of prophylaxis, the therapy for the delirium in the inpatient 藤田ちひろ1, 宮竹香歩1, 内藤雅人1, 下雅意彩1, 竹村敏也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 842-842, 2017.

---

	P0217-3-PM. For investigation medical expenses reduction about the prescription situation of the injection anticancer agent in Aomori 兵藤塁1, 照井一史1, 中川潤一1, 横山明子1, 細井一広1, 明石真弓2, 佐藤和洋3, 神雅昭4, 田中南美英5, 田村健悦6, 中村一成7, 本間聖明8, 宮崎晃臣9, 矢田康司10, 山本章二11, 下山律子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 843-843, 2017.

---

	P0219-3-PM. The calculation situation investigation of the Yamaguchi prefecture institution after the 2016 medical service fees revision 植松俊成1, 守田和彦1, 久保田厚子1, 中川麻子1, 永見康男1, 藤田亜弓1, 宮川貴行1, 松久哲章1, 古川裕之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 843-843, 2017.

---

	P0204-4-AM. Investigation of the medicine charge reduction effect by the difference in standard optimization method of the anticancer agent and adoption standard 関川洋史1, 坂井由紀1, 三澤昭彦1, 鈴木直人1, 外山聡1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 844-844, 2017.

---

	P0206-4-AM. The dispensary duties efficiency using the PDCA cycle and cost reduction 三上友寛1, 林八恵子1, 小川暁生1, 高道恵理子1, 山口瑞彦1, 遠藤正憲1, 塚本有子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 845-845, 2017.

---

	P0208-4-AM. Examination of the adverse event of the SGLT2 inhibitor using an adverse event spontaneous report database 向井淳治1, 面谷幸子1, 長井克仁1, 初田泰敏1, 名徳倫明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 845-845, 2017.

---

	P0210-4-AM. The medical expenses reduction effect that quantity of prescription restrictions of the ad usum externum anti-inflammatory analgesics result in 山田ゆきの1, 長谷川佳孝2,3, 前田守2,3, 栗山健志2,3, 萩原毅2,3, 月岡良太2,3, 森澤あずさ2,3, 大石美也2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 846-846, 2017.

---

	P0212-4-AM. Costs minimization analysis of the antiMRSA medicine in MRSA pneumonia 中川直人1, Leanne Lai2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 846-846, 2017.

---

	P0214-4-AM. Examination of the validity evaluation technique of the injection vial standard in the pemetrexed preparation 中村暢彦1, 中嶋江美2, 森田直2, 岡田知子2, 籠本基成2, 小林政彦2, 矢野義孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 847-847, 2017.

---

	P0216-4-AM. Relative analysis with the childhood otitis media onset in Tochigi and a heat and cold difference and the virus outbreak 高橋彩花1, 加藤芳徳2, 鈴木和磨2, 守田侑真2, 山根晃大2, 杉山奈津子2, 伊東岳2, 前澤佳代子2, 鈴木雅史1,2, 生野登3, 百瀬泰行1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 847-847, 2017.

---

	P0218-4-AM. The pharmacy management by the BSC introduction 白川亮1, 今城江理1, 塩浦真菜1, 結城惠美1, 中莖大輔1, 柳田義一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 848-848, 2017.

---

	P0220-4-AM. Conquest of the pharmacist staff decrease in drugstore job evaluation analysis crisis by the efforts in our hospital 守屋久美代1, 鴛渕るか1, 永里京子1, 内田香織1, 野村秀哉1, 米丸寿幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 848-848, 2017.

---

	P0221-3-PM. Approach to interaction evasion at oral medicine combination 佐藤真奈1, 四方公亮1, 伊東充1, 出雲正治1, 井上由紀1, 佐藤香織1, 長谷川英雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 849-849, 2017.

---

	P0223-3-PM. Efforts ... of the education for patients by examination - hepatic disease classroom about the interaction of the direct action type antiviral drug in hepatitis C treatment 大塚恵子1, 渡部智貴1, 新藤学1, 加藤一郎1, 金田暁2, 杉浦信之3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 850-850, 2017.

---

	P0225-3-PM. One case of the pulmonary embolism history patients who conducted Helicobacter pylori sanitization under the warfarin remedy, and monitored PT-INR 門村将太1, 福田由布子1, 井藤達也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 850-850, 2017.

---

	P0227-3-PM. Effect (the third report) that combination of tramadol in the warfarin remedy patients gives to INR 安部望美1, 細野智美1, 青沼和隆2, 住田孝之2, 平松祐司2, 山崎正志2, 関堂充2, 神林泰行1, 本間真人1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 851-851, 2017.

---

	P0229-3-PM. Examination - using the nutrient for intestinal administration varying in study on effect - property of the diet to give to absorption of rifampicin 大津亜都1, 河野洋平1, 下村斉2, 青山隆夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 851-851, 2017.

---

	P0231-3-PM. The clinical case which the effect reinforcement of the concomitant drug was seen in by macrolide derivative antimicrobial 天海祐紀1, 吉成徹1, 増渕龍一郎1, 石崎憲1, 渡邊紘子1, 赤羽正之1, 岩瀬利康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 852-852, 2017.

---

	P0233-3-PM. Possibility ... of the new interaction through 2 case - protein binding which caused PT-INR extension by pazopanib - warfarin combination 辻本高志1, 上田晃1, 川本由加里1, 後藤仁和1, 村西雄貴2, 山本祥太2, 川口愛2, 千葉博基2, 秋野文臣2, 田中博2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 852-852, 2017.

---

	P0235-3-PM. The effect of antacids to give LDLC drop effect of the rosuvastatin: Rearward medical record investigation 土屋美香1, 立沢正臣1, 小川竜一2, 金素案1, 金城直樹1, 大久保淳史1, 小山内美樹1, 下嶋和代1, 宮崎招久1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 853-853, 2017.

---

	P0237-3-PM. Examination about the pharmacokinetic interaction with tacrolimus and the concomitant drug in renal-transplant recipients 熊谷優1, 加賀谷英彰1, 新岡丈典1, 齋藤満2, 井上高光2, 沼倉一幸2, 羽渕友則2, 佐藤滋3, 三浦昌朋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 853-853, 2017.

---

	P0239-3-PM. One case that predicted voriconazole and drug interaction of the warfarin using PISCS, and was given administration plan 渡辺裕貴1,2, 鷲尾彩菜1,2, 稲垣彩美1,2, 臼田昌弘1,2, 市倉大輔1,2, 縄田修一1,2, 峯村純子1,2, 佐々木忠徳1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 854-854, 2017.

---

	P0241-3-PM. Case of patients with gynecologic cancer which showed effect attenuation of the warfarin after the aprepitant start, and showed the effect reinforcement after the fosfluconazole addition 名和田幸介1, 川中明宏1, 渡邊太朗1, 白野陽正1, 三好生典1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 854-854, 2017.

---

	P0243-3-PM. Examination - in examination - nitroglycerine sublingual tablet of the interaction with the commercial denture adhesive and ethical drug 脇屋義文1, 高木祐輔1, 横井元気1, 武田悠1, 梅村雅之1, 吉田彩乃2, 柳原保2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 855-855, 2017.

---

	P0245-3-PM. Effect on LDL-C by the combination of rosuvastatin and acid-secreting antagonist 臼窪一平1, 横田睦美1, 大橋史嵩1, 丸山卓哉1, 岩堀真弓1, 槙田芳1, 下山あさ子1, 嘉屋則子1, 田畑裕和1, 稲垣育宏1, 小寺隆二1, 柴波明男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 855-855, 2017.

---

	P0222-4-AM. One case that we changed to edoxaban from poor control of the warfarin in the patients whom deep vein thrombosis developed in during pulmonary tuberculosis treatment 原田卓弥1, 奥野昌弘1, 中田学1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 856-856, 2017.

---

	P0224-4-AM. Efficiency of an approach and the reporting of the drug interaction evasion using the automatic prescription checking system 大柿佳織1, 枦秀樹1, 太田哲徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 857-857, 2017.

---

	P0228-4-AM. The current situation investigation in the Mie University faculty of medicine hospital about the use of concomitant drug which should consider direct action type oral anticoagulant drug (DOAC) and weight loss 高崎美和1, 杉本浩子1, 池村健治1, 岩本卓也1, 奥田真弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 858-858, 2017.

---

	P0230-4-AM. Examination about the solubility of the piperazine frame-containing drug which assumed the remedy with the tea leaves drink 阪上彩子1, 福井希1, 中村任1, 岩永一範1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 858-858, 2017.

---

	P0232-4-AM. Evaluation of the drug interaction of Glecaprevir/Pibrentasvir (GLE/PIB) 松永英治1, Rajneet K. Oberoi2, Matthew P. Kosloski2, Andrew Campbell2, Wei Liu2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 859-859, 2017.

---

	P0234-4-AM. 1 case that blood level of tacrolimus increased during the immunosuppressive therapy after the heart transplant by August first of the lunar calendar 中北和樹1,2, 和田恭一1,2, 松田紗知1, 老田章1, 三好英理3, 堀由美子3, 高田充隆2, 瀬口理3, 簗瀬正伸3, 福嶌教偉3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 859-859, 2017.

---

	P0236-4-AM. The effect that esomeprazole gives to an effect of the warfarin 井坂由佳1, 澤近萌1, 土岐浩介1,2, 本間真人1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 860-860, 2017.

---

	P0238-4-AM. Usefulness of the Perampanel blood level monitoring for patients with refractory epilepsy 森美穂1, 山本吉章1,3, 中井正彦1, 臼井直敬2, 賀川義之3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 860-860, 2017.

---

	P0240-4-AM. The effect that the combination of a proton pump inhibitor and the H2 blocker gives to an effect and a side effect of the dasatinib in the chronic myelogenous leukemia 高武嘉道1, 木村修徳2, 鶴崎泰史1, 山形真一1, 中川義浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 861-861, 2017.

---

	P0242-4-AM. Report about the PT-INR measurement in the combination of warfarin potassium and antimicrobial 高橋義弥1, 谷田拓也1, 七尾亮子1, 飯坂美香1, 丸山俊夫1, 高橋豊1, 野々山由香理1, 櫻井正之2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 861-861, 2017.

---

	P0244-4-AM. The effect that aprepitant administration in the hematopoietic stem cell transplantation gives to blood level of tacrolimus 中込早苗1, 中澤佑介1, 安藤尚美1, 五十嵐貴之2, 原田大1, 北村正樹1, 川久保孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 862-862, 2017.

---

	P0246-4-AM. 2 cases that PT-INR extended to by a hyperuricaemia therapeutic agent change in the warfarin remedy patients 鈴木一志1, 松本晃一1, 高橋利幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 862-862, 2017.

---

	P0247-3-PM. Efforts about the examination for protein urine protocol introduction at the bevacizumab ramucirumab administration and future problem 熊谷修一1,2, 目黒聡子1, 酒井由希子1, 野口真利1, 佐藤晃一1, 永倉史子1, 川口裕花1, 渡辺京彦1, 大川真里奈1, 高山裕子2, 山内泰一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 863-863, 2017.

---

	P0249-3-PM. Examination about the effect on OS/PFS of RDI in the stomach cancer ramucirumab + paclitaxel therapy and adverse event 森下拓哉1, 井上裕貴1, 松本修一1, 片岡政人2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 864-864, 2017.

---

	P0251-3-PM. Introduction of short hydration in our hospital and example 神谷力嗣1, 日野澤孝明1, 岡平将志1, 後藤伸之2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 864-864, 2017.

---

	P0253-3-PM. The current situation investigation about weight loss, the discontinuation of the nabPTX + GEM therapy in patients with pancreatic cancer 指宿貴博1, 古川卓也2, 久保田豊2, 深沢健一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 865-865, 2017.

---

	P0255-3-PM. Examination of the usefulness to anticancer agent proper use by the participation of the pharmacist in cancer chemotherapy patients measurement of body weight 元木孝1, 館内謙太郎1, 後藤勝博1, 高柳昌宏1, 千田泰健1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 865-865, 2017.

---

	P0248-4-AM. A treatment result of the KRd therapy for the multiple myeloma in our hospital and examination of the side effect 西村直朗1, 桑村恒夫1, 末松文博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 866-866, 2017.

---

	P0250-4-AM. Construction of the cancer chemotherapy regimen authentication system that a pharmacist consolidated taking the opportunity of hospital integration 伴晶子1,5, 岡戸洋1,5, 筧由紀子1, 山田卓摩1,5, 佐藤知香1,5, 小林和子2,5, 竹内亜由美2,5, 岩本公一3, 小川明男4,5, 小島義博1, 生田宏次4,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 867-867, 2017.

---

	P0252-4-AM. Optimization of anticancer agent preparation duties by the regimen management system (CROSS) introduction 鳥越史宙1, 大西亜以子1, 松本浩明1, 石部由利子1, 奥田敏勝1, 高柳和伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 867-867, 2017.

---

	P0254-4-AM. Analysis of doubt inquiry in the chemotherapy inspection 荒川裕貴1, 桂川健司1, 遠山幸男1, 久田達也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 868-868, 2017.

---

	P0256-4-AM. About the introduction of the electronic medical chart system of the childhood cancer chemotherapy regimen management 坂本有里恵1, 森口沙里1, 宇戸祐介1, 渡邉綾子1, 齋藤あゆみ1, 研真梨子1, 中西有璃1, 野田有貴子1, 乗松耕平1, 籾井佳奈1, 愛甲佳未1, 由良沙央理1, 岸本早百合1, 三輪祐太朗1, 廣瀬晃子1, 藤永仁美1, 大前隆広1, 石田達彦1, 上田里恵1, 加古学1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 868-868, 2017.

---

	P0257-3-PM. About efforts and usefulness for the cancer medical therapy of the pharmacist who collaborated with the physician in the outpatient clinic 青孝明1, 柘植麻里奈1, 杉本恵理1, 粟野恵介1, 山川恵子1, 近藤智彦1, 木村匡男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 869-869, 2017.

---

	P0259-3-PM. Intervention from the treatment preferences of the breast origin phyllodes tumor to side effect management 田代美佳1, 田井浩子1, 大河万顕1, 小畑紋菓1, 瀬名波宏昌1, 川口進一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 870-870, 2017.

---

	P0261-3-PM. Use fact-finding of the ramucirumab for progress, the recurrent gastric cancer which is impossible of curative resection in our hospital 林美和子1, 唐澤綾1, 濱至寛1, 登内盛治1, 五味邦之2, 島田宏2, 三原基弘2, 梶川昌二2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 870-870, 2017.

---

	P0263-3-PM. Can the efforts of the prophylaxis by the multi-type of job relieve dermatopathy by the panitumumab? Investigation ... of the expression situation and the patients background factor of ... dermatopathy 里村藍子1, 永村陽一郎1, 遠藤春野1, 坂榮里絵2, 山口雄3, 中根実3, 日野斉一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 871-871, 2017.

---

	P0265-3-PM. It is ... in the making - nivolumab Pembrolizumab clinical introduction of the immune-mediated side effect measures algorithm 遠藤真理1, 佐藤亜希1, 本田弘1, 中島繁美1, 服部千恵子2, 菅原俊一3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 871-871, 2017.

---

	P0267-3-PM. Expectation from one case of the use of high-dose drug terminally ill patients to a pharmacist associated with team approach in medical care to see 福地祐司1,4, 竹下光弘1,4, 江坂尚枝1, 吉川真一4, 吉田進4, 神崎憲雄2, 江尻友三2, 松田徹3, 早乙女浩之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 872-872, 2017.

---

	P0269-3-PM. Efforts to HBV reactivation measures in our hospital 松本実1, 尾形歩美1, 松井香保里1, 上池和子1, 栗下一義2, 片岡直樹2, 渡辺嵩史3, 吉本拓人1, 岩村伸一4, 溝渕樹1,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 872-872, 2017.

---

	P0271-3-PM. For practice of medical treatment management (PBPM) based on intervention fact-finding - protocol of the pharmacist in the foreign chemotherapy room - 和田依子1, 樋口美奈子1, 佐々木好美1, 岩坪沙奈恵1, 山口竜司1, 中野行孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 873-873, 2017.

---

	P0273-3-PM. HBV reactivation prophylactic efforts (the second report) in the cancer chemotherapy 貝瀬眞由美1, 須田剛士2, 粉川直明1, 柴田真由美3, 小川るり子4, 堀内亮佑5, 寺島健史5,6, 内山聖7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 873-873, 2017.

---

	P0258-4-AM. The regimen choice for enforcement planned patients supports adjuvant chemotherapy after the breast cancer technique 内田美伽1, 原竜太郎1, 濱浦睦雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 874-874, 2017.

---

	P0260-4-AM. The effect that pharmacist outpatient department introduction gives for physician office hours and treatment (patients satisfaction, side effect measures) 秦英司1, 小川勝弘1, 岩本秀人3, 岩井ちさと1, 足立美菜子1, 栢木啓介1, 長谷川一将1, 大谷豊司2, 金田達也1, 椎木芳和1, 高根浩1, 武中篤3, 島田美樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 875-875, 2017.

---

	P0262-4-AM. The activities after the dermatopathy measures team start in the Kyushu cancer center and the future prospects 坂本由希子1, 魚井みゆき1, 宮本聖子1, 三角紳博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 875-875, 2017.

---

	P0264-4-AM. Efforts by the multi-type of job in the cardiac activity evaluation at the anticancer medicine administration with the cardiotoxicity 内田将吾1, 宇都宮節夫2, 見田真紀3, 山関智恵1, 畔柳敏弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 876-876, 2017.

---

	P0266-4-AM. The current situation and problem of the palliative care of our hospital judging from the cancer pain management 久保田綾乃1, 海野亜実1, 牧野和也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 876-876, 2017.

---

	P0268-4-AM. 1 case that a complete response was obtained by R + Devic relief therapy after the R + CHOP therapy in the elderly people with diffuse large B-cell lymphoma 杉原弘記1, 岡本伸也1, 竹井英介1, 川真田修2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 877-877, 2017.

---

	P0272-4-AM. Change of the HBV screening test rate of use after the PBPM introduction 丸田基史1, 山形真一1, 鶴崎泰史1, 宮成信友2, 中川義浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 878-878, 2017.

---

	P0276-4-AM. Construction and evaluation of the simple mark remote inspection system for the anticancer agent preparation 田中裕章1, 高橋功一1, 安宅希美子1, 青木加奈1, 山口佳津騎1, 元木貴大1, 井上達也1, 樋口和子1, 篠原尚樹1, 野崎孝徒1, 辻繁子1, 朝倉正登1, 小坂信二1, 芳地一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 880-880, 2017.

---

	P0278-4-AM. The making of the preparation manual of the anticancer agent administered intraspinally in the Hirosaki University faculty of medicine hospital and introduction of the modi operandi 横山明子1, 照井一史1, 兵藤塁1, 中川潤一1, 細井一広1, 下山律子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 880-880, 2017.

---

	P0280-4-AM. A problem after the use expansion of closed system anesthesia drug transportation system (CSTD) and examination of the countermeasure 柴山匠1, 上村美月1, 中屋優香1, 藤村裕司1, 町田宏美2, 菊池健樹1, 松井孝之1, 寺田伊知郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 881-881, 2017.

---

	P0282-4-AM. Evaluation of anticancer agent exposure measures by the closed system anesthesia drug transportation system "neo-shield" introduction 山下千草1, 川原裕1, 小山紀久美2, 佐野雅昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 881-881, 2017.

---

	P0284-4-AM. One case that gastric cancer SOX therapy was treated with being at home for patients with amyotrophy-related lateral sclerosis, and continued 阿部一仁1, 坪井一人2, 良元和久2, 梶本徹也2, 柏木秀幸2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 882-882, 2017.

---

	P0286-4-AM. For improvement in consciousness for exposure to anticancer medicine measures - safe handling - 坂田茂代1, 山口文子1, 田辺真里1, 佐藤透1, 永田菜美子2, 榊原辰弥2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 882-882, 2017.

---

	P0288-4-AM. An effect and exposure measures in the Abiraterone ester acetate tablets crush remedy 白石童子1, 坂本歩1, 早乙女彩子1, 福地祐司2, 竹下光弘1,2, 早乙女浩之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 883-883, 2017.

---

	P0290-4-AM. Environmental pollution investigation after anticancer agent exposure measures 石嶋麗1, 間瀬広樹1, 杉村勇人1, 小林恵里奈1, 坂倉喜代美2, 嶽加奈子2, 山森ゆみ2, 北俊之3, 秋山哲平1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 883-883, 2017.

---

	P0294-4-AM. Usefulness ... of the anticancer medicine preparation support equipment with new attempt - stock tray of anticancer medicine preparation duties using the anticancer medicine preparation support equipment 榊原隆志1,2, 滝本典夫1,2, 菅原志穂1,2, 神谷幸江1,2, 足立守1, 吉田憲生2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 884-884, 2017.

---

	P0296-4-AM. Investigation about the anticancer medicine pollution around the urinal by the urination in the standing position 江刺晶央1, 土屋雅美1, 村尾知彦1, 下山順士1, 猪岡京子1, 高村千津子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 885-885, 2017.

---

	P0298-4-AM. The resolution removal test with the ozone water of 5-FU pollution gloves and the infusion solution bag surface 古田祐美子1, 土手賢史1, 岩根裕紀1,2, 小林由佳1,2, 成橋和正2, 杉浦伸一2, 中西弘和2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 885-885, 2017.

---

	P0300-4-AM. Examination of the effective formula of the ethanol non-component docetaxel preparation by the warming 杉浦央1, 斎藤由起子1, 浅見祥崇2, 下山哲哉2, 佐々木慎司1, 加藤ゆか1, 横山雄一1, 福田耕太郎1, 伊藤邦彦2, 小林道也2, 近藤覚也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 886-886, 2017.

---

	P0302-4-AM. Reduction effect to the anticancer agent environmental pollution that education to the staff and the introduction of the closed system anesthesia infusion system give 清水潤一1, 田邉直人1, 鈴木裕美2,3, 遠藤玲子2,3, 井上泉子2, 小澤桂子2,3, 古嶋薫3, 加藤敏明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 886-886, 2017.

---

	P0304-4-AM. Drug department office worker, education about the risk by the anticancer agent exposure to medical attendant 山田卓摩1, 伴晶子1, 佐藤知香1, 岡戸洋1, 小林和子1, 竹内亜由美1, 工藤優子1, 小島義博1, 小川明男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 887-887, 2017.

---

	P0306-4-AM. Examination of the need of the knowledge of the pharmacist for the anticancer agent exposure and consciousness and the education 井上龍亮1, 杉山奈津子1,2, 鎌田愛梨2, 森下真旺2, 宮沢唯2, 久保倫美1, 坂口貴大1, 宮内輝人1, 吉成宏顕1, 植松久美子1, 伊東岳2, 加藤芳徳2, 前澤佳代子1,2, 箭内雅実3, 橋本秀雄1, 百瀬泰行1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 887-887, 2017.

---

	P0308-4-AM. Attitude survey about the excretion instruction to patients in the chemotherapy 小山拓弥1, 下川福子1, 賀川義規2, 南原誠1, 船越幸代1, 川嵜英二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 888-888, 2017.

---

	P0310-4-AM. Attitude survey for effect on ward duties by the rotation of anticancer medicine preparation duties in our hospital and preparation duties 古林園子1, 新藤学1, 加藤一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 888-888, 2017.

---

	P0312-4-AM. Efforts of exposure to our hospital measures in anticancer agent (HD) 和賀信継1, 細川友子2, 渋谷丈太郎3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 889-889, 2017.

---

	P0314-4-AM. Examination of the quantity of fluorouracil attaching to a PTP sheet of the Tegafur combination oral medicine 小松原早織1, 武田有紀1, 高見陽一郎1, 浦上知香1, 笹原莉子1, 島田倫栄1, 福島由貴1, 小川壮寛2, 安倉央2, 江川孝3, 島田憲一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 889-889, 2017.

---

	P0316-4-AM. Introduction of anticancer agent automatic preparation device APTOECAchemo and the future prospects 松本浩明1, 奥田敏勝1, 鳥越宙史1, 石部由利子1, 高柳和伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 890-890, 2017.

---

	P0318-4-AM. The value-added examination that is useful in development of the end-point necessary to choose a closed system anesthesia connection appliance and medical security 税所篤行1, 西川直也1, 小山勝真1, 幸田恭治1, 古川裕之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 890-890, 2017.

---

	P0275-3-PM. Inspection of the medical expenses reduction effect by the use of vial multiple times of the injectable anticancer agent 泉智基1, 河添仁1, 沖野真季1, 飛鷹範明1, 田中守1, 田中亮裕1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 891-891, 2017.

---

	P0277-3-PM. The value-added examination that is useful in development of the end-point which is necessary for the injectable equivalence ingredient anticancer medicine choice and medical security 西川直也1, 税所篤行1, 小山勝真1, 幸田恭治1, 古川裕之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 892-892, 2017.

---

	P0279-3-PM. Examination about the CSTD introduction at digestive organ cancer chemotherapy preparation 鈴木直哉1, 地主隆文1, 山田将悟1, 藤田果那1, 山本翔太1, 庄崎沙耶1, 田中耕太1, 木下愛1, 前川英輝1, 藤林遼1, 菊地義明1, 高橋誠1, 青田忠博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 892-892, 2017.

---

P0281-3-PM. Preparation precision comparison ... with new attempt ... anticancer medicine preparation support equipment of anticancer medicine preparation duties using the anticancer medicine preparation support equipment and the person using the inspection system 菅原志穂1,2, 滝本典夫1,2, 榊原隆志1,2, 神谷幸江1,2, 足立守1, 吉田憲生2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 893-893, 2017.

---

	P0283-3-PM. About stocktaking and measures by the anticancer agent exposure investigation 愛知佑香1, 井上裕貴1, 高木理央1, 上床遥1, 吉田美紀2, 松本修一1, 北川智余栄3, 佐藤康幸4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 893-893, 2017.

---

	P0285-3-PM. Examination of the dissolution dilution method for the Pinorubin injection which does not give a flotage 中村江理1, 伊藤綾希子1, 舩木健光1, 佐々木静香1, 鈴木英則1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 894-894, 2017.

---

	P0287-3-PM. Nurse satisfaction investigation in the BD F seal (TM) closed system anesthesia infusion system 田村悟1, 宇都直哉1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 894-894, 2017.

---

	P0289-3-PM. The exposure measures situation investigation in the Nagoya Ekisaikai Hospital 牛膓沙織1, 高取裕司1, 野村翔1, 藤井仁2, 纐纈理香2, 米山文彦3, 池上信昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 895-895, 2017.

---

	P0291-3-PM. Effect of the closed system anesthesia drug transportation system introduction in the cancer chemotherapy 上原友美1, 堀内智裕1, 中松穂菜美1, 鶴永大貴1, 中島理恵1, 中村有莉恵1, 赤星真広1, 石神誠子1, 池増鮎美1, 神門孝典1, 佐多照正1, 奥村浩2, 前之原茂穂2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 895-895, 2017.

---

	P0293-3-PM. Introduction effect of the anticancer agent preparation technology acquisition degree evaluation ladder 片山宏章1, 榊原辰弥1, 増島広幸1, 秋山加菜1, 望月敬浩1, 粂哲雄1, 橋爪孝弘1, 村上ひろみ1, 永田菜美子1, 篠道弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 896-896, 2017.

---

	P0295-3-PM. Examination for the use expansion of the closed system anesthesia drug transportation system in the Shizuoka Prefectural Shizuoka cancer center 永田菜美子1, 榊原辰弥1, 片山宏章1, 宮口貴守1, 伊藤雅子1, 篠道弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 896-896, 2017.

---

	P0297-3-PM. Fact-finding about core ring at anticancer agent preparation 目黒裕史1, 本多伸二1, 内藤舞1, 浜田久美子1, 佐分利美帆子1, 三松史野1, 實光由香1, 大野恵一1, 寸田靖1, 村岡淳二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 897-897, 2017.

---

	P0299-3-PM. Efforts for the use of closed system anesthesia appliance entire surface introduction at anticancer agent preparation 辻亜紀1, 足立充司1, 宮麻紀子1, 六車裕一1, 森岡浩子1, 辻俊美1, 中野静香1, 野村浩英1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 897-897, 2017.

---

	P0301-3-PM. Evaluation of the each closure performance of the closed system anesthesia connection appliance using cyclophosphamide 小林由佳1,2, 岩根裕紀1,2, 古田祐美子1, 成橋和正2, 杉浦伸一2, 中西弘和2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 898-898, 2017.

---

	P0303-3-PM. Abacterial inspection of chemosafe syringe (R) after the anticancer agent preparation 鶴永大貴1, 上原友美1, 堀内智裕1, 中松穂菜美1, 中島理恵1, 中村有莉恵1, 赤星真広1, 石神誠子1, 池増鮎美1, 佐多照正1, 日高好博2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 898-898, 2017.

---

	P0305-3-PM. Is the sampling sheet useful as a rating system of the anticancer medicine cleaning work? 本吉ゆかり1, 高橋喜統1, 多賀允俊1, 荒井涼子1, 鷹見沙八佳1, 西川美香子1, 安田紗奈子1, 山本康人1, 丹羽修1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 899-899, 2017.

---

P0307-3-PM. Efforts for the anticancer medicine exposure measures expansion using the closed system anesthesia drug transportation system and future problem 宮本聖子1, 衛藤智章1, 森田明子1, 魚井みゆき1, 坂本由希子1, 佐々木由香1, 笹川玲奈1, 薮内由里香1, 北原愛子1, 永田祐子1, 松木奈緒子1, 永山智子1, 菊池茜1, 大石博史1, 築田晃直1, 松元俊博1, 古海和博1, 三角紳博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 899-899, 2017.

---

	P0309-3-PM. Comparison between ceremony of investigation - machine and 2-layer-related filter type - about the usability of the closed system anesthesia drug transportation system 井口菜摘1, 鈴木毅1, 石井岳夫1, 難波有智1, 水野いず美2, 門田靜明3, 与那覇房子1, 外間惟夫1, 中村克徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 900-900, 2017.

---

	P0311-3-PM. Economical examination in the introduction expansion of closed system anesthesia drug transportation system (CSTD) 細見誠1, 後藤愛実1, 西原雅美1, 有田由美2, 勝間田敬弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 900-900, 2017.

---

	P0313-3-PM. About the efforts of anticancer agent exposure measures in our hospital 沢仁美1, 山本真史1, 鈴木日奈子2, 末吉博美2, 渡邉昌代2, 廣内真由美2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 901-901, 2017.

---

	P0315-3-PM. About the introduction of the anticancer agent formulations inspection system in our hospital 中尾真美1, 木下圭一2, 森伸子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 901-901, 2017.

---

	P0317-3-PM. Examination of a system, a line of flow, the item aiming at reduction of the occupational exposure with the anticancer medicine in the cottage-hospital out of the district 岸本真1, 長ヶ原琢磨1, 長命章佳1, 大園ゆかり1, 屋敷大輔1, 荻尾夕起子1, 吉村真1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 902-902, 2017.

---

	P0319-3-PM. Side effect management (one patient who detected phlebothrombus of lower extremities) of the regorafenib 高山俊輔1, 小谷野大地1, 増田裕子1, 鍵山智樹1, 土肥大典1, 舘林恵美1, 真壁秀樹1, 佐伯俊昭1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 903-903, 2017.

---

	P0321-3-PM. Examination about the enforcement continuance of preventive treatment and the chemotherapy of the dermatopathy with the antiEGFR antibody medicine 坂本竜平1, 向井淳治2, 小竹優希1, 穴田真奈美1, 濱崎淳哉1, 竹原涼子1, 奥田広志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 904-904, 2017.

---

	P0323-3-PM. An example with suspected nephrotic syndrome by Bevacizumab 米北浩人1, 須藤学拓2, 和泉隆平3, 中村英治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 904-904, 2017.

---

	P0325-3-PM. Possibility of the side effect reduction effect of the Juzentaihoto on colon cancer chemotherapy 小林大祐1, 田中翔子1, 大坪達弥1, 澤田真嗣1, 中村吉隆2, 村木優一3, 岡橋孝侍1, 藤田敦夫1, 友金幹視1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 905-905, 2017.

---

	P0329-3-PM. Effect on endocytosis of the cisplatin by the Mg combination 安田恵1, 岸本修一2, 天野学1, 福島昭二2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 906-906, 2017.

---

	P0331-3-PM. Investigation about infusion reaction by the Trastuzumab emtansine therapy and the thrombocytopenia 中嶋陽一1, 葉田昌生1, 三上忠司1, 柿原圭佑1, 白石亘1, 松崎雄1, 菊池衣里佳1, 寺松早紀1, 蔵王なつか1, 大塚弘子2, 山口美樹2, 藤井裕史1, 田中眞紀2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 906-906, 2017.

---

	P0333-3-PM. The use situation of the peg filgrastim in the dose-denseEC therapy 加藤秀明1, 辻愛美1, 白崎由貴1, 西出洋志1, 坂井伸成1, 宇野美津江1, 森富男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 907-907, 2017.

---

	P0335-3-PM. Study on tardive hypothyroidism development situation after the Nivolumab administration cancellation 堀井徳光1, 高木雄一1, 松本富夫1, 舘脇正充2, 吉田匠生2, 福島康次2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 907-907, 2017.

---

	P0337-3-PM. Examination of the intervention effect of the pharmacist on low Ca blood symptom reduction in the orthopedics ward 佐々木祐太1, 宮田篤1, 小暮友毅1, 槇恒雄1, 山本宏1, 魚谷弘二2, 中田英二2, 杉原進介2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 908-908, 2017.

---

	P0339-3-PM. Examination about the risk factor of the onset of serious neutropenia in the S-1+ cisplatin therapy for patients with progress, recurrent stomach cancer 川地志緒里1, 木村美智男1, 宇佐美英績1, 吉村知哲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 908-908, 2017.

---

	P0341-3-PM. Study on frequency of the enforcement situation and the QT interval prolonged of the electrocardiogram in the Osimertinib administration case 石田善昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 909-909, 2017.

---

	P0343-3-PM. 2 cases that developed systemic dermatopathy by nivolumab 大澤友裕1, 二村洋平2, 石黒崇2, 梅田道1, 安田昌宏1, 水井貴詞1, 堀場あかね2, 吉田勉2, 米田和史3, 澤祥幸4, 後藤千寿1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 909-909, 2017.

---

	P0345-3-PM. One patient whom bevacizumab was continuously administered to after the protein urine expression 関口展貴1, 宮田智陽1, 岩水雅俊1, 篠原佳祐1, 杉山昌秀1, 渡邊将隆1, 油井信明2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 910-910, 2017.

---

	P0347-3-PM. Examination of the use actual situation and usefulness of the G-CSF preparation peg filgrastim in the gynecology of our hospital and problems 小山佐知子1, 山本侑佳1, 成瀬徳彦1, 廣村勝彦2, 水野公雄2, 森一博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 910-910, 2017.

---

	P0349-3-PM. Investigation about an adverse event and the fat-free body mass in the oxaliplatin combination regimen 上田宏1, 大澤万智子1, 五十嵐努1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 911-911, 2017.

---

	P0351-3-PM. Clinical study about the adverse event reduction effect of the elental combination private business agent in DTX + CDDP + 5-FU (DCF therapy) for the cancer of the esophagus 菅原充広1, 堅田親利2, 高橋かおる3, 高橋亜紀子3, 深沢佐恵子4, 坂本泰理5, 小泉和三郎2, 厚田幸一郎1,6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 911-911, 2017.

---

	P0353-3-PM. The onset situation of redness, the eruption in the breast cancer TC therapy and relations with the season 田畑真一1, 大島千佳1, 戸塚孝治1, 新井成俊1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 912-912, 2017.

---

	P0355-3-PM. One case that suffered from correspondence of the vascular pain with the XELOX therapy 澤柳直樹1, 西川隆一1, 藤井友和1, 辻博幸1, 塚本久之1, 楠泰臣2, 大橋紀文3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 912-912, 2017.

---

	P0357-3-PM. Association between genetic polymorphism and neutropenic expression situation of UGT1A1 in patients who received irinotecan-containing regimen 片桐将志1, 石井照樹1, 佐野嘉容子1, 中西順子1, 原田典和1, 加地努1, 向井栄治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 913-913, 2017.

---

	P0359-3-PM. Search of the risk factor of the early onset oxaliplatin-induced erasion neuropathy 清水加奈子1,2, 山田治美1,3, 中村裕義1,2,3, 加藤芳徳3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 913-913, 2017.

---

	P0361-3-PM. Symptom improvement effect of the sodium azulene sulfonate tranexamic acid mouth wash on stomatitis with the anticancer medicine 薮田直希1, 須藤正朝1, 森井博朗1, 野田哲史1, 若杉吉宣1, 山本優1, 井堀仁美1, 河原幸恵1, 中村春香1, 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 914-914, 2017.

---

	P0363-3-PM. Evaluation of the effectiveness of the existing therapeutic drug for anticancer agent-induced stomatitis 原隆裕1, 渡邉真一3, 飛鷹範明3, 田中守3, 高取真吾2, 山内行玄1, 畑晶之1, 田中亮裕3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 914-914, 2017.

---

	P0365-3-PM. An investigation about the hiccups due to cancer chemotherapy and examination of the development factor 津久井千之1, 入岡凌1, 渡部晃裕1, 桑村雅子1, 大塚尚1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 915-915, 2017.

---

	P0367-3-PM. The efforts of the hydration change in the cisplatin-containing regimen and evaluation 谷澤範彦1, 草冨翔太1, 細谷拓史1, 前田太一1, 金森紀幸1, 谷山幸信1, 吉村はる美1, 小川純也1, 斉藤孝次1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 915-915, 2017.

---

	P0369-3-PM. Investigation of the effectiveness of the end of the Goshajinkigan for peripheral neuropathy by the paclitaxel and the Processed Aconite Root 小田薫1, 川尻尚子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 916-916, 2017.

---

	P0320-4-AM. About the use situation of the peg filgrastim in patients who received FEC therapy of our hospital 木内直美1,3, 関根佳代1,3, 辻村秀樹2,3, 熊谷匡也3,4, 大谷美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 917-917, 2017.

---

	P0322-4-AM. Prescription fact-finding of the opioid preparation in patients with oral mucositis onset after chemistry, the radiotherapy 百賢二1, 中原香菜子1, 高木彰子1, 濃沼政美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 918-918, 2017.

---

	P0324-4-AM. Examination of frequencies and the risk factor of the Colin symptom in the FOLFIRINOX therapy 伊藤智代1, 中出順也1, 嶋田努1, 崔吉道1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 918-918, 2017.

---

	P0326-4-AM. Examination of the expression situation and the predictor of the hypomagnesemia with the antiEGFR antibody component regimen in our hospital 森下友紀1, 谷岡洋亮2, 徳山ことみ1, 岡本裕子1, 岡本知久1, 福澤祐幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 919-919, 2017.

---

	P0328-4-AM. Investigation of the neutropenia by the ramucirumab in our hospital 仁田美保子1, 中林真紀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 919-919, 2017.

---

	P0332-4-AM. Questionary survey for peripheral neuropathy with the oxaliplatin administration and making of the Goshajinkigan remedy protocol and the evaluation 奥澤文敏1, 福井圭亮1, 北野恵莉子1, 衣田奈央1, 田中こずえ1, 鈴鹿隆晃1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 920-920, 2017.

---

	P0334-4-AM. An example with suspected immune thrombocytopenia by the nivolumab in our hospital 大田和歩1, 古谷智裕1, 野村実由1, 白木政博1, 柳田祐子1, 北口聡一2, 田中英夫3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 921-921, 2017.

---

	P0336-4-AM. Attempt of the side effect expression situation of nivolumab treated patients and the immune-mediated adverse event check 茂木佳子1, 成田康之1, 遠藤麗2, 佐藤賢1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 921-921, 2017.

---

	P0338-4-AM. Examination of the intervention method of the pharmacist in the adverse event of the nivolumab 稻垣沙織1, 米澤美和1, 久保杏奈1, 小野陽介1, 南憲一1, 安田明子1, 台蔵剛士1, 吉田正暢1, 岡田ちひろ1, 才田絢加1, 南川知央1, 渡辺真梨奈1, 山田千代子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 922-922, 2017.

---

	P0340-4-AM. Safe investigation and patients attitude survey of the nivolumab for the non-small cell lung cancer 中西大介1, 畑地治2, 柳川泰裕1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 922-922, 2017.

---

	P0342-4-AM. The effect that the self-mouth care instruction in the drugstore gives for the onset of oral mucositis with the capecitabine administration 溝口優1, 島田理美1, 関悠人1, 高浦万里江1, 重山昌人1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 923-923, 2017.

---

	P0344-4-AM. Examination of the side effect frequency of the Osimertinib introduction patients in our hospital and the expression factor 東田貴之1, 梅原健吾1, 岡山有希1, 野表しおり1, 岡崎泰香1, 後藤桂輔1, 高田寛奈1, 若本あずさ1, 初山多恵1, 佐藤秀紀2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 923-923, 2017.

---

	P0346-4-AM. Effect on treatment continuation that the efforts of the pharmacist for the supportive care adequacy of the pemetrexed and a delay of the vitamin B12 administration give 光家勉1, 北村登喜生1, 青木桃子1, 中村祐樹1, 米川恭史1, 渡部なおみ1, 富田国男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 924-924, 2017.

---

	P0348-4-AM. The effect that ramucirumab administration under the antihypertensive medications internal use gives to blood pressure 林克剛1, 遠藤尚美1, 小野裕紀1, 鈴木薫1, 菅井博文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 924-924, 2017.

---

	P0350-4-AM. Identification of the risk factor about the neutropenia onset by Cabazitaxel under the prophylaxis of Pegfilgrastim 影山明1, 中澤佑介1, 安藤尚美1, 原田大1, 北村正樹1, 浅野晃司2, 川久保孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 925-925, 2017.

---

	P0352-4-AM. Investigation of the enforcement situation and the onset of hypothyroidism situation of the thyroid function tests in the sunitinib remedy patients 加藤良隆1, 井上渉1, 渡邉愛梨1, 邵仁哲2, 大坪達弥1, 神田英一郎1, 村木優一3, 岡橋孝侍1, 藤田敦夫1, 友金幹視1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 925-925, 2017.

---

	P0354-4-AM. Factor analysis of the impaired renal function protraction at the Docetaxel/Cisplatin/5-fluorouracil combination therapy for the progress cancer of the esophagus case 毛利順一1,2, 堅田親利3, 熊沢加奈1, 植田茉梨絵2, 厚田幸一郎1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 926-926, 2017.

---

	P0356-4-AM. Examination about the safety of the prognostic factor of patients who received progress, recurrent pancreatic cancer chemotherapy and the second treatment (S-1 therapy) 五十川万喜幸1, 木村美智男1, 岩井美奈1, 宇佐美英績1, 吉村知哲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 926-926, 2017.

---

	P0358-4-AM. The proper use of the early period of lenalidomide doses for the multiple myeloma and examination of the treatment continuity 谷川大夢1, 宇佐美英績2, 木村美智男2, 矢野忠1, 吉村智哲2, 市川訓1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 927-927, 2017.

---

	P0360-4-AM. Effect on intensity of treatment with the administration of the primary prophylaxis of the peg filgrastim in the breast cancer chemotherapy 近藤博紀1, 横幕香織1, 上田潤哉1, 黒川愛美1, 河崎一久1, 三露久生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 927-927, 2017.

---

	P0362-4-AM. Effect on oligochromemia with the rasburicase administration in patients with malignant lymphoma 木村雄太1, 三浦清文1, 高田慎也1, 橋下浩紀1, 遠藤雅之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 928-928, 2017.

---

	P0364-4-AM. A risk of developing myelosuppression factor search at postoperative chemotherapy enforcement before breast cancer technique and investigation about the G-CSF proper use condition 古谷智裕1, 柳田祐子1, 野村実由1, 大田和歩1, 白木政博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 928-928, 2017.

---

	P0366-4-AM. Examination of the protective efficacy of the Hangeshashinto mouth wash for stomatitis with the kidney cancer molecules target medicine 水野加奈子1, 吉川英里1, 飯澤泉2, 藤堂由紀2, 浜手ひとみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 929-929, 2017.

---

	P0368-4-AM. Examination of the onset of hypersensitivity situation and the risk factor of the intravenous anticancer agent in our hospital 槇枝大貴1,4, 田中奈緒美2, 岡脇誠3, 山口佳之3, 小野浩重4, 二宮洋子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 929-929, 2017.

---

	P0370-4-AM. Examination about the safety of DOAC for the venous thromboembolism that occurred during bevacizumab administration 田川誠二1, 新谷拓也1, 村地泰1, 勝浦正人1, 門脇裕子1, 水野裕八2, 山口修2, 坂田泰史2, 三輪芳弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 930-930, 2017.

---

	P0371-3-PM. Use experience of nivolumab in the decreased renal function patients 山下悟史1, 岸川春樹1, 長谷悠紀1, 平野真健1, 清水誉志1, 富田敏章1, 町田聖治1, 入江利行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 931-931, 2017.

---

	P0373-3-PM. Polypharmacy fact-finding of patients with cancer 辻俊輔1, 松崎幸司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 932-932, 2017.

---

	P0375-3-PM. Association of the adverse event in melphalan large doses patients and the pharmacokinetic parameter 内山将伸1, 宮崎元康1, 高松泰2, 神村英利3, 松尾宏一1, 今給黎修1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 932-932, 2017.

---

	P0377-3-PM. The hepatitis B screening enforcement situation investigation in the Hekinan Municipal Hospital 伊藤昌美1, 片山広美1, 榊原奈美1, 八並ゆかり1, 鈴木裕之1, 黒田信行1, 永田実1, 加藤直紀1, 鈴木めぐみ1, 天野哲史1, 松本薫1, 石井彩子1, 佐藤篤郎1, 鈴木厚志1, 板倉由縁1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 933-933, 2017.

---

	P0379-3-PM. Effect on neutropenia by the presence or absence of ramucirumab combination in the gastric cancer 鹿沼綾1, 高橋幸三1, 角川幸男1, 金銅葉子1, 中多陽子1, 坂上嘉浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 933-933, 2017.

---

	P0381-3-PM. The adverse event expression of Pembrolizumab situation for the non-small cell lung cancer 田中麻理子1, 井上咲姫1, 櫛田宏幸1, 岸本歩1, 宮地修平1, 砂金秀美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 934-934, 2017.

---

	P0383-3-PM. An example with suspected Trousseau syndrome with the Pembrolizumab administration 柏木佑貴1, 真砂聖1, 藏本裕信1, 依藤健之介1, 足立恵子1, 前田翠1, 井上明香2, 岡田信彦2, 鈴木雄二郎2, 松本章士1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 934-934, 2017.

---

	P0385-3-PM. Pharmacist Proactive Telephone Monitoring (PPTM) system construction for the adverse event early detection of the immune checkpoint inhibitor and the usefulness 吉田光一1, 福土将秀1, 寺川央一1, 木村周古1, 山下恭範1, 小野尚志1, 三嶋一登1, 田崎嘉一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 935-935, 2017.

---

	P0387-3-PM. About an association between EGFR mutation in the gene and dermatopathy in our hospital EGFR-TKI introduction patients 安宅希美子1, 立道貴清1, 越野優希1, 山下紗矢佳1, 大野麻由1, 山口佳津騎1, 田中裕章1, 小坂信二1, 芳地一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 935-935, 2017.

---

	P0389-3-PM. We look at the rear of the effect on patients with malignant melanoma and lung cancer predictor of the nivolumab treatment and examine a mark 細井一広1, 中川潤一1, 兵藤塁1, 阿保成慶1, 照井一史1, 下山律子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 936-936, 2017.

---

	P0391-3-PM. The enforcement situation of the HBV screening test of patients who received cancer chemotherapy in our hospital 掛札聡美1, 石井紀子1, 宍倉啓介1, 山口智1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 936-936, 2017.

---

	P0393-3-PM. One case of the lung adenocarcinoma which developed type I diabetes mellitus during antiPD-1 antibody administration 長谷川英利1, 松井駿亮1, 豊田悠二1, 本田富得1, 古川哲也1, 中泉伸彦2, 前野恭宏2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 937-937, 2017.

---

P0395-3-PM. It is analysis ... of the questionnaire results in the ... 26th Japan cure association annual convention about the needs that a pharmacist engaging in cancer medical care seeks in a company and academia 岩本卓也1, 荻原琢男2, 河原昌美3, 宮本祐司4, 中田雄一郎5, 小島義幸6, 高橋克昌7, 大槻純男8, 宇都口直樹9, 宮崎公一10, 石田竜弘11 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 937-937, 2017.

---

	P0397-3-PM. S-1 proper use investigation in the outside Parliament prescription judging from test value 三村一平1, 秋元知也1, 添田真司1, 唐木田一成2, 高清水眞二3, 坂巻文雄4, 野村栄治5, 齋藤雄紀6, 渡邊昌之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 938-938, 2017.

---

	P0399-3-PM. 1 case that was given mFOLFOX 6 therapy to patients on dialysis 谷村紀代子1, 波多野友希1, 秋吉由利子2, 菊井利伸1, 木村文彦3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 938-938, 2017.

---

	P0401-3-PM. Comparison - of the duties that questionary survey - health insurance pharmacy pharmacist, hospital pharmacist about the medicine medicine cooperation in the foreign cancer chemotherapy demand mutually 石橋正祥1, 長野未来1, 石井正和1, 木内祐二2, 巖本三壽1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 939-939, 2017.

---

	P0403-3-PM. Use results investigation of Ramucirumab in our hospital 前川英輝1, 地主隆文1, 木下愛1, 山本翔太1, 田中耕太1, 庄崎沙耶1, 藤田果那1, 山田将悟1, 菊地義明1, 藤林遼1, 鈴木直哉1, 高橋誠1, 青田忠博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 939-939, 2017.

---

	P0405-3-PM. Examination about the setting of Carboplatin doses depending on renal function in the DeVIC therapy for the non-Hodgkin's lymphoma 山口雄士1, 高木佐矢香1, 近藤章吾1, 佐藤和也1, 松由幸司1, 塚原民夫1, 堀内正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 940-940, 2017.

---

	P0407-3-PM. Rearward investigation about successful execution rate and the pCR (histologic complete fruition) rate in the preoperative chemotherapy 杉山奈津子1, 小川智江1, 柳澤深月1, 久保陽加1, 伊東岳1, 加藤芳徳1, 前澤佳代子1, 齊藤光江2, 百瀬泰行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 940-940, 2017.

---

	P0409-3-PM. Examination of the predictor of the effectiveness of the nivolumab for patients with non-small cell lung cancer in our hospital 川端歩実1, 桂英之1, 高田直子1, 湊明志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 941-941, 2017.

---

	P0372-4-AM. Examination of the risk factor about the serious blood poison-related expression in patients who received Carboplatin pemetrexed combination therapy 荒木良介1,2, 計良貴之1, 加藤加奈恵1, 菱沼隆一1, 高木彰紀2, 増田豊2, 浜本知之2, 田中恒明3, 山田英紀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 942-942, 2017.

---

	P0374-4-AM. Safe comparison of the injectable docetaxel forerunner pharmaceutical products and ethanol non-component docetaxel injection generic medicine 佐藤家恒1, 遠藤征裕2, 佐藤博樹1, 平泉達哉2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 943-943, 2017.

---

	P0376-4-AM. The effect that α-Defensin gives to a pro-discharge transporter 保田元気1, 窪田篤人1, 更科壮太2, 小林正紀3, 井関健3,4, 高橋夏子5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 943-943, 2017.

---

	P0378-4-AM. One patient who made electrolyte revision in the hypocalcemia with the zoledronic acid administration 合原嘉寿1, 福石和久1, 林稔展1, 西野隆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 944-944, 2017.

---

	P0380-4-AM. Investigation about the use situation and the adverse event expression of nivolumab in the Oita Red Cross hospital 安部智英1, 久枝真一郎1, 山添太一朗1, 宗広樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 944-944, 2017.

---

	P0382-4-AM. Examination of the factor influencing onset of cardiovascular disease with the anthracycline anticancer medicine 中里健志1, 土屋裕伴1, 国吉央城1, 新井亘1, 増田裕一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 945-945, 2017.

---

	P0384-4-AM. Examination about Carboplatin for the non-small cell lung cancer in our hospital and the factor of the intensity of treatment drop of the albumin suspension type paclitaxel combination therapy 細川朋弘1, 藤原佑貴1, 塩谷美由紀2, 吉田千尋3, 三崎伯幸3, 河野洋二4, 岸本伸人4, 清水圭子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 945-945, 2017.

---

	P0386-4-AM. One patient who showed PT-INR rise by combination of Osimertinib and warfarin 吉本有里1,2, 小園亜希2, 田川幸1, 諫見圭佑1, 福澤美夕1, 中村康彦1, 山道研1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 946-946, 2017.

---

	P0388-4-AM. Effect of the foreign chemotherapy room permanent residence of the pharmacist specialized in a cancer 藤井友和1, 澤柳直樹1, 西川隆一1, 荒木寛也1, 坂柳悦章1, 辻博幸1, 塚本久之1, 楠泰臣2, 朝倉亮子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 946-946, 2017.

---

	P0390-4-AM. About an association between dose revision and high blood pressure by the weight fluctuation of the bevacizumab in the lung cancer 金澤絵莉1, 谷口潤1, 東島彰人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 947-947, 2017.

---

	P0392-4-AM. About the current situation of the relation of the pharmacist in the fecundity preservation and future possibility 網野一真1, 六波羅孝2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 947-947, 2017.

---

	P0394-4-AM. Efforts to the use situation and the safety management system of nivolumab in our hospital 名坂輝子1, 大和由美子1, 石原真一2, 竹澤豊3, 吉田武史4, 真下陽子5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 948-948, 2017.

---

	P0396-4-AM. One case that bleeding of the cancer of parotid gland with the skin permeation decreased by hydrozincite starch dispersion 伊佐治麻里子1, 鶴谷勝実1, 木村王芳2, 白井博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 948-948, 2017.

---

	P0398-4-AM. Example that was effective by the osimertinib administration using the simple suspension method 荒木邦宏1, 斉藤匡昭1, 大原正之1, 木村正行1, 藤原斉1, 杉山直幸2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 949-949, 2017.

---

	P0400-4-AM. Case of DLBCL given R-GCVP therapy, R-CHOP therapy after the haemodialysis introduction 安森奈緒子1, 林稔展1, 西野隆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 949-949, 2017.

---

	P0402-4-AM. Did the trend of doubt inquiry about the chemotherapy change with improvement of pharmaceutical management in a foreign chemotherapy room and the ward? 及川淳1, 小笠原信敬1, 三浦宏真1, 村上正一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 950-950, 2017.

---

	P0404-4-AM. Usefulness of the each source of information about the renal function of the anticancer agent and the liver function adjustment 溝口由梨香1, 森裕也1, 枦秀樹1, 太田哲徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 950-950, 2017.

---

	P0406-4-AM. Examination of the effect predictor of the immune checkpoint inhibitor nivolumab in the non-small cell lung cancer 藤原聡子1, 東恩納司1, 蔵田靖子1, 北村佳久1, 千堂年昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 951-951, 2017.

---

	P0408-4-AM. One case of the acute myeloid leukemia who had the heart failure that Gemtuzumab ozogamicin was effective 木下滉子1, 稲垣淳2, 菊池隆希2, 諸角一成1, 丹村貴之1, 長谷川和徳1, 大矢美緒1, 川合結乃1, 中村康夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 951-951, 2017.

---

	P0410-4-AM. Consideration about the effect of a blood culture round, the antimicrobial round in our hospital critical care center 前原大輔1, 坂井良美1, 土井本和久1, 横田聖子1, 福井由美子1, 兵頭純子1, 池田覚2, 当麻美樹2, 岩田健太郎3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 952-952, 2017.

---

	P0412-4-AM. A dose and clinical response of micafungin in our hospital, examination about the safety 吉田悦朗1, 臼井和明1, 宇都宮奈々1, 近藤真由1, 長谷川将1, 宗本佐知子1, 上地純子1, 森田佳博1, 白石貴寿1, 面田恵1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 953-953, 2017.

---

	P0414-4-AM. The use situation investigation of the therapeutic drug according to the disease severity of Clostridium difficile-related loose bowels in our hospital 大西優里1, 杢保貴幸1, 徳竹裕貴1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 953-953, 2017.

---

	P0416-4-AM. Examination of the risk factor of thrombocytopenia in linezolid treated patients 酒井幹康1, 成瀬国男1, 渡口賢隆2, 坪井伸治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 954-954, 2017.

---

	P0418-4-AM. Examination of the dose of the daptomycin for the MRSA 鶴山萌子1, 永野真久2, 山科卓也1, 宮田拓周1, 小田原真希1, 松本紗織1, 松尾尚美1, 入江健司1, 三好孝法1, 川俣洋生1, 平木洋一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 954-954, 2017.

---

	P0420-4-AM. Efforts to proper use of the carbapenem-based medicine by the ICT pharmacist 小林薫1, 白坂友基1, 中村満江2, 山本岳雄3, 工藤温子4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 955-955, 2017.

---

	P0422-4-AM. An example of the intractable scabies 高野尊行1, 柿沼博子1, 小林由香1, 石橋楽至1, 中丸朗1, 薄井啓一郎2, 仲澤恵3, 池野義彦4, 阿久津郁夫5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 955-955, 2017.

---

	P0424-4-AM. The effect that an antimicrobial registration system gives to achievement of drug-resistant measures action plan result index 岡冨大輔1,2,3,4,5, 山西紀子1, 宅江良隼1, 芝美代子2, 山水有紀子3, 明見能成4, 谷口雅敏1, 松田裕之5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 956-956, 2017.

---

	P0426-4-AM. The effectiveness and safety of the MEPM6g administration in the bacterial meningitis 栗村淳子1, 新沼佑美1, 阿部誠也1, 関さやか1, 佐藤直也1, 猪狩崇子1, 児山麻佑1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 956-956, 2017.

---

	P0428-4-AM. Consideration about the candidemia in our hospital 飯尾志帆1,2, 小橋文亜紀1, 斎藤良子2, 本木直樹2, 亀山礼子2, 船屋諭史2, 竹原朗2, 川根隆志2, 蛭谷一彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 957-957, 2017.

---

	P0430-4-AM. About an infective endocarditis case in our hospital for the past 7 years 上原奈緒1, 桑村恒夫1, 阿部名月1, 末松文博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 957-957, 2017.

---

	P0432-4-AM. Proper use investigation at beginning to use of the patients whom specific antimicrobial in the Nissei Hospital was used for several times 池田久雄1,2, 平田貴宏1,2, 足立充司1, 古久保有希子1, 森岡浩子1, 大野典子2, 小瀬戸昌博2, 野村浩英1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 958-958, 2017.

---

	P0434-4-AM. Construction of the designated antimicrobial management system which a pharmacist intervenes in positively 吉田美樹1, 細野美幸1, 村岡美彩1, 酒井由貴江1, 山崎千恵1, 中明幹雄1, 高畑英信1, 竹村さおり2, 山本知代美2, 永田肇2, 村本由子3, 又野禎也3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 958-958, 2017.

---

	P0436-4-AM. New efforts in the Akita pharmacist infection control workshop for the antimicrobial proper use support 齊藤伸1, 藤原洋之2, 今村亘3, 高橋満里4, 佐々木修5, 石田良樹6, 後藤敏晴1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 959-959, 2017.

---

	P0438-4-AM. Examination about the staphylococcus aureus bacteremia in the municipal Kushiro General Hospital 鎌田裕介1, 菅野雄太1, 瓜智都1, 菅原大輔1, 竹谷美穂1, 森本淳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 959-959, 2017.

---

	P0440-4-AM. Efforts of the oral third generation cephem-based antimicrobial proper use in the outpatient department and the effect 小曳恵里子1, 平畠正樹1, 三宅里美1, 中浴伸二4, 安藤基純5, 池末裕明1, 平井雄三2, 土井朝子3, 橋田亨1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 960-960, 2017.

---

	P0442-4-AM. Inhibition measures of the tazobactam piperacillin consumption by case intervention and the registration system introduction and the effect 塩田智子1,2, 谷長美菜子1, 高橋一栄1,2, 足立幸人2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 960-960, 2017.

---

	P0444-4-AM. One patient who received a triple-drug therapy for nontuberculous Mycobacterium (NTM) of the subcutaneous abscess 小野寺潤1, 杉山奈々美1, 五味裕介1, 二瓶大輔1, 山際一也1, 杉木正2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 961-961, 2017.

---

	P0446-4-AM. Efforts for the proper use of the carbapenem-based antimicrobial in our hospital 田村直斗1, 佐藤悠太1, 斉藤匡昭1, 木村正行1, 藤原斉1, 進藤誠子2, 袴田陽子3, 金田浩人4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 961-961, 2017.

---

	P0448-4-AM. Proper use investigation of injectable metronidazole in the intraperitoneal infections disease in our hospital and the concomitant drug 平田貴宏1, 池田久雄1, 足立充司1, 野村浩英1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 962-962, 2017.

---

	P0450-4-AM. Examination about the antimicrobial consumption index associated with chemosensitive results 小林義和1,6, 吉岡祐貴1,6, 川崎祥平1,6, 田中伸幸2,6, 山田昌矢3,6, 岩本公一3,4,6, 浅野昌彦5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 962-962, 2017.

---

	P0452-4-AM. The administration situation of the daptomycin in the Kure medical center, Chinese cancer center first aid domain 前田龍人1,2, 竹山知志2, 佐藤岳春1, 渡辺光1, 國原将洋1, 二五田基文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 963-963, 2017.

---

	P0454-4-AM. The effect that the antimicrobial administration support by the pharmacist gave to antimicrobial consumption and Pseudomonas aeruginosa sensitivity 松木祥彦1, 石毛宏治1, 石田雅也1, 金井絵美1, 富田千尋1, 西沢大樹1, 大島香1, 寺田裕1, 小川真美江1, 杉田恵1, 米井万紀子1, 相馬雄介1, 大貫利乃1, 菊地聡美1, 兼村友輔1, 林美樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 963-963, 2017.

---

	P0456-4-AM. Efforts of the dose adequacy of the carbapenem-based medicine by doubt inquiry 田中悠子1, 南和志1, 田村健悦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 964-964, 2017.

---

	P0458-4-AM. Comparison between vonoprazan and effect of the existing proton pump inhibitor in the Helicobacter pylori sanitization treatment 児玉暁人1, 今井兼貴1, 岩田智津子1, 森信介1, 長生幸司2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 964-964, 2017.

---

	P0460-4-AM. Of result and MRSA bacteremia treatment of the use of antiMRSA medicine patients round in the Nagaoka Red Cross hospital, actually 丸山智幸1, 小林謙一1, 西堀武明2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 965-965, 2017.

---

	P0411-3-PM. About an effect of the pharmacist intervention at new hepatitis C therapeutic drug introduction in our hospital 八道智絵1, 井藤あいな1, 桑原冴佳1, 中島早苗1, 吉村一樹1, 木村真衣1, 真鍋詩織1, 中林真紀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 966-966, 2017.

---

	P0413-3-PM. Investigation about the use situation of the carbapenem-based antimicrobial in our hospital 松田凌地1, 榎本俊介1, 山口美奈1, 日戸章人1, 松坂昌宏1, 鈴木寧1, 冨家俊弥1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 967-967, 2017.

---

	P0415-3-PM. Analysis of the antimicrobial choice in the ESBL-producing bacteria detection patients 森田淳介1, 田子尚史1, 國分真理1, 新木美枝1, 山賀章一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 967-967, 2017.

---

	P0417-3-PM. Examination of the dose of Linezolid to the consecutive hemodiafiltration (CHDF) patients 小田原真希1, 山科卓也1, 宮田拓周1, 鶴山萌子1, 松本紗織1, 松尾尚美1, 入江健司1, 三好孝法1, 川俣洋生1, 辻泰弘2, 神村英利3, 加留部善晴3, 平木洋一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 968-968, 2017.

---

	P0419-3-PM. Evaluation of MIC and the effect of treatment of vancomycin 徳山ことみ1,2,3,4,5, 馬生良則2, 小坂紀子2, 二階堂弘美3, 安藤由香4, 矢野朋文5, 福澤祐幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 968-968, 2017.

---

	P0421-3-PM. It is effect on infection after the operation by the antimicrobial internal use cancellation after the operation in the nose endoscopic operation 虎瀬和子1, 南憲一1, 下川千賀子1, 山田千代子1, 渡邉珠代2, 作本真3, 長谷川博紀4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 969-969, 2017.

---

	P0423-3-PM. 1 case that responded to meropenem for Enterobacter agglomerans bacteremia early 綺田尚久1, 藤原信二1, 速水亮一2, 中村忠之3, 原田吉将4, 道智賢市5, 西嶋長1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 969-969, 2017.

---

	P0425-3-PM. Examination of 8 cases that a high dose gave ABPC/MCIPC combination drug to for MSSA infection 菅原隆文1, 吉川明良1, 開浩一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 970-970, 2017.

---

	P0427-3-PM. Evaluation about the antimicrobial consumption according to the clinical department between Rousaibyoin of Kyushu, Yamaguchi District 亀田敬子1, 管田彩乃2, 臼井和明3, 松永智子4, 岩切啓太5, 木本秀樹6, 谷口一成5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 970-970, 2017.

---

	P0429-3-PM. Examination of the use background of the levofloxacin IV infusion of our hospital in the pneumonia practice 菅野小雪1, 續橋明1, 吉田信太郎1, 畑伸一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 971-971, 2017.

---

	P0431-3-PM. Safety assessment of Liposomal-Amphotericin B for the decreased renal function patients 加藤未紗1, 松岡知子1, 大橋健吾1, 篠田康孝1, 吉村知哲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 971-971, 2017.

---

	P0433-3-PM. We look at the rear in the use of daptomycin case of our hospital and examine a mark 宮川貴誌1, 森本裕美1, 渡部久美1, 宮川志穂1, 南仁惠1, 甲斐絢子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 972-972, 2017.

---

	P0435-3-PM. The thrombocytopenia of Linezolid treated patients and investigation of the factor 伊藤貴亮1, 佐藤圭吾1, 菅野和1, 河上昭一1, 西和哉1, 佐賀利英1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 972-972, 2017.

---

	P0437-3-PM. 1 case that gave VCM gradual decrease therapy for intractable Clostridium difficile association enterocolitis repeatedly 小池彩子1,3, 花房伸幸1,3, 河村茉衣1,3, 廣田あゆ子1,3, 橋本健二2, 奥格3, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 973-973, 2017.

---

	P0439-3-PM. Examination about the use situation and the proper use of the metronidazole note in our hospital 浦崎清美1, 玉城哲子1, 城間盛彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 973-973, 2017.

---

	P0441-3-PM. Consideration about the use situation of the daptomycin in our hospital 茂木美香1, 松永真1, 須藤雄太1, 関陽介1, 藤田俊也1, 小林恭子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 974-974, 2017.

---

	P0443-3-PM. Effect of the clinical path introduction for the antimicrobial proper use prophylactic after the operation in a lap product, the female clinical department 渡辺典子1, 相曽啓史1, 鳥羽三佳代2, 佐瀬裕子1, 大島乃里子3, 杉井麻耶1, 石渡泰芳1, 永田将司1, 高橋弘充1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 974-974, 2017.

---

	P0445-3-PM. After the operation about efforts of our hospital in the infection prophylaxis antimicrobial proper use 藤重瑶子1,2, 松本浩1,2, 濱野公俊1,2, 宮地悠輔2, 山崎行敬3, 長島梧郎2, 國島広之3, 坂下裕子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 975-975, 2017.

---

	P0447-3-PM. Efforts of Antimicrobial Stewardship (AS) which adopted inspection and feedback after the prescription by the ward pharmacist and the evaluation 竹川七生1,2, 大畠雅子1, 関戸茜衣1, 小田井剛2, 牧野以佐子1, 前田拓哉1, 三上二郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 975-975, 2017.

---

	P0449-3-PM. Community-acquired pneumonia, examination of the use of antimicrobial with the antiPseudomonas aeruginosa activity in the initial treatment for medical care, care-related pneumonia 加戸義大1, 奥村佳史1, 森田孝子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 976-976, 2017.

---

	P0451-3-PM. Antimicrobial stewardship team intervention and effect 齋藤佑輔1, 海崎佳史2, 塗茂裕一3, 細田清美4, 岩井和之5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 976-976, 2017.

---

	P0453-3-PM. About the prescription actual situation of the detection situation and the faropenem of substrate specific expansion type β - lactamase-producing Escherichia coli in our hospital 大田栄一1, 久保勝1, 由本綾乃2, 中野晃子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 977-977, 2017.

---

	P0455-3-PM. Relation of Antimicrobial Stewardship Team activity and the pharmacist in our hospital 赤沢翼1, 大橋裕丈1, 足立遼子1, 片浪雄一2, 山元佳2, 忽那賢志2, 増田純一1, 目崎和久3, 近藤直樹1, 坂本治彦1, 桑原健1, 大曲貴夫2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 977-977, 2017.

---

	P0457-3-PM. Efforts and problem of the ICT in the blood culture-positive subjects round 高橋真一1, 奥津利晃1, 渡邉あゆみ1, 内藤淳嗣1, 蔭山博之1, 平島徹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 978-978, 2017.

---

	P0459-3-PM. Effect on main antimicrobial AUD by support, the intervention round to the use of carbapenem-based antimicrobial patients 小林謙一1,3, 丸山智幸1,3, 西堀武明2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 978-978, 2017.

---

	P0461-3-PM. Efforts about the cooperation with the activity of the ward pharmacist in the delirium measures of the inpatient and the dementia delirium support team (DST) 市川大介1, 藤野優菜1, 安江佳南1, 小田真澄1, 古谷佳美1, 中田早苗1, 齋藤文佳1, 猪木初枝2, 涌谷陽介3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 979-979, 2017.

---

	P0465-3-PM. Evaluation by the questionary survey of the pharmacist interview before medical examination in the psychiatry outpatient department 進健司1,2, 牛島悠一1, 梅田勇一1, 小林大介2, 川尻雄大2, 金澤康範1, 神村英利3, 島添隆雄2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 980-980, 2017.

---

	P0467-3-PM. About the effect on prescription contents by the Vegetamin cancellation and patients 福山雄卯介1, 林佳奈子1, 後藤史子1, 千代延桜子1, 中村敦士1, 宮崎敦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 981-981, 2017.

---

	P0469-3-PM. One case of patients with intractable schizophrenia that resulted in a sudden liver damage during cataplexy and Clozapine treatment with lithium 石川哲也1, 小林純子1, 金田昌子2, 伊藤誠紀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 981-981, 2017.

---

	P0471-3-PM. Preventive measures against BPSD aggravation by a dementia care team and the ward pharmacist cooperation 佐々木貴寛1, 伊藤香織1, 相馬真志1,2, 中村悦子1, 飯田優太郎1,2, 熊谷英樹3, 小川義敬1, 中嶋俊之4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 982-982, 2017.

---

	P0473-3-PM. About the effect that delirium high risk medicine gives to the delirium onset of patients with dementia 大久保優1,5, 清水一紀2,5, 奥村佳史1, 横谷弘子3,5, 内藤喜隆4,5, 池田知聖5, 森田孝子1,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 982-982, 2017.

---

	P0475-3-PM. The single agent of the antipsychotics for patients with schizophrenia about becoming it 幸邦憲1, 田代早紀1, 吉見幸那1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 983-983, 2017.

---

	P0479-3-PM. The effectiveness of the serotonin reuptake inhibitor in the treatment of patients with depression 18 years or younger and safe evaluation 太田祐里奈1, 嶋田修治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 984-984, 2017.

---

	P0481-3-PM. Fact-finding in benzodiazepine, addition of the suvorexant for patients during the non-benzodiazepine drugs remedy and the change 高取士剛1, 藤井達也1, 菅大地2, 三上大貴1, 久保淳一1, 高木明彦1, 鈴木千波1, 佐藤公人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 984-984, 2017.

---

	P0483-3-PM. Survey about the clinical path in the psychiatry supermarket emergency ward 中武久美子1, 江藤英倫1, 本園奈緒美1, 中川伴子1, 重松淳哉1, 小嶋享二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 985-985, 2017.

---

	P0462-4-AM. Efforts of prescription suggestion and the antipsychotics weight loss using the SCAP method 松田紗祐里1, 熊谷範之1, 伊藤明人1, 宇部太郎1, 千葉芙美1, 村上遥1, 松谷英里1, 佐藤裕大1, 宮本亜希1, 新沼さおり1, 新沼央子1, 熊谷壽美子1, 菊地秋子1, 鵜浦利江1, 三浦清彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 986-986, 2017.

---

	P0464-4-AM. The case that contributed to the medical therapy for the psychiatry outpatient by the pharmacist outpatient department introduction 牛島悠一1, 進健司1,2, 金澤康範1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 987-987, 2017.

---

	P0466-4-AM. About the relation of the pharmacist for patients with eating disorders of the laxative abuse type 山本ゆりえ1,2, 圓岡大典1, 田村奈穂2, 戸田健太2, 長坂久乃3, 北田忍3, 河合啓介2, 廣井明夫1, 水野宏一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 987-987, 2017.

---

	P0468-4-AM. Comparison about a sleep effect of suvorexant and non-benzodiazepine system sleeping drug zolpidem and the effect on delirium 鈴木恵子1, 田中怜1, 松本晃明2, 新里馨3, 篠道弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 988-988, 2017.

---

	P0470-4-AM. Examination for the adequacy of the medical therapy in schizophrenia 麻那古信之1, 山本智也1,2, 立入頌子1, 杉浦知佳1, 勝浦正人1, 門脇裕子1, 田中萌子3, 工藤紀子4, 山森英長3, 安田由華3, 渡邉衡一郎5, 稲田健6, 三輪芳弘1, 橋本亮太3,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 988-988, 2017.

---

	P0472-4-AM. About the relation of the pharmacist in the dementia care team 中田吉則1,2, 亀山隆2, 滝沢なぎさ2, 片野貴大1, 佐藤江莉1, 重共孝一1, 河井良智1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 989-989, 2017.

---

	P0474-4-AM. Examination of the rehospitalization factor in schizophrenia 杉沢諭1, 渡邊直優2, 片岡由衣2, 永井努1, 栗原竜也1, 常岡俊昭3, 田中佐知子2, 木内祐二2, 稲本淳子3, 佐々木忠徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 989-989, 2017.

---

	P0476-4-AM. Efforts for the proper use of the benzodiazepine receptor agonist for hospitalization elderly people 梅元晃美1, 中出奈津子1, 東昌代1, 道下孝恒1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 990-990, 2017.

---

	P0478-4-AM. Introduction of the flowchart in the delirium treatment toward PBPM 吹谷真紀子1, 鈴木ひとみ1, 八代佳子1, 齊藤伸1, 工藤和彦1, 一関美江子1, 篠田和人1, 仙葉悠紀1, 木元健寛1, 金美紀1, 佐藤恵葉1, 水沢重則1, 後藤敏晴1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 990-990, 2017.

---

	P0480-4-AM. The effect that SST - medication self-care program that other types of job cooperate with a pharmacist and perform gives medication awareness 西川幸輝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 991-991, 2017.

---

	P0482-4-AM. The current situation investigation of the serum lithium densitometry in our hospital 小林純子1, 石川哲也1, 伊藤誠紀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 991-991, 2017.

---

	P0484-4-AM. Examination of the usefulness of the ulinastatin vagina suppository in the early or threatened labour 伊藤緑1, 穂苅郷美1, 増田雅行1, 真坂亙1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 992-992, 2017.

---

	P0486-4-AM. Attitude survey of the medical staff about the pharmacist duties in the maternity ward 南雲まい1, 川口寿子1, 仁平陽子1, 影山名織1, 齋藤謙治1, 菅野浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 993-993, 2017.

---

	P0488-4-AM. Relation of the pharmacist in the methotrexate administration therapy of the ectopic pregnancy patients in hope of fecundity preservation 村田文1, 新木美枝1, 伊藤理廣2, 山賀章一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 993-993, 2017.

---

	P0490-4-AM. Drug control instruction to lying in woman and future problem 浅野志津1, 砂場亜希1, 日浦亜実1, 平井淳子1, 林裕治2, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 994-994, 2017.

---

	P0492-4-AM. The actual situation of the antihypertensive medications prescription for the pregnant woman: Examination based on receipt data 小原拓1,2,3, 大久保孝義4, 佐藤倫広5, 石黒真美2,3, 目時弘仁5, 菊谷昌浩2,3, 西郡秀和6, 赤沢学7, 八重樫伸生2,6, 栗山進一2,3,8, 眞野成康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 994-994, 2017.

---

	P0494-4-AM. Examination for the change of Breastfeeding Recommendation at nursing accompanied with revision from the Drugs in Pregnancy and Lactation ninth edition to the tenth edition 増田寛樹1, 野坂真梨子1, 岡田裕子2, 前田恵里2, 溝口優1, 渡邊美智留1, 桑原弘行1, 山口友明3, 鷲見正宏4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 995-995, 2017.

---

	P0496-4-AM. Fact-finding of the use drug in the delactation case 清水彩子1, 渡邉将隆1, 油井信明2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 995-995, 2017.

---

	P0498-4-AM. Examination of the side effect frequency of the generic drug ritodrine hydrochloride infusion liquid varying in an additive 藤谷みなみ1, 吉川明良1, 開浩一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 996-996, 2017.

---

	P0500-4-AM. Attitude survey for "a use drug table" for the patients explanation in our hospital maternity ward 石橋摩耶1, 佐藤綾子1, 佐藤貞子2, 谷川原真吾3, 堤栄二1, 鈴木伸男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 996-996, 2017.

---

	P0502-4-AM. Examination of the onset of itch with the ritodrine administration in patients with pressure style, premature birth 日野光記枝1, 宇佐美英績1, 大橋健吾1, 高田裕子1, 吉村知哲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 997-997, 2017.

---

	P0504-4-AM. 1 case of the pregnant woman whom we produced rhabdomyolysis by ritodrine hydrochloride administration, and congenital myotonica dystrophia was diagnosed in children by 佐藤裕美1, 小山絹子1, 森本雅子1, 福野和治1, 松川雅子1, 西部幸一1, 今井桂子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 997-997, 2017.

---

	P0506-4-AM. Examination of the instruction contents adequacy for folic acid, the carnitine drop by the use of antiepileptic drug 吉井圭佑1,2, 原 (野上) 愛2, 梶俊策3, 見尾光庸2, 杉山哲大1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 998-998, 2017.

---

	P0508-4-AM. Examination about the bronchial asthma merger pregnancy 木藤一美1, 橋本隆信1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 998-998, 2017.

---

	P0510-4-AM. Investigation of the effect to give to a mother's body, the neonates judging from a relation with pharmacist in the gestational diabetes 三上有希1, 澤井麻記1, 野崎歩1, 長嶋一昭2, 藤井剛3, 小林由佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 999-999, 2017.

---

	P0512-4-AM. Making of the pharmaceutical products database (Kitasato version) about a drug and the nursing 花島玲子1, 持田裕子2, 春日井公美2, 厚田幸一郎1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 999-999, 2017.

---

	P0514-4-AM. Examination about the usefulness of the use of pain-killer algorithm based on the aspirin asthma risk assessment 満木由布菜1, 塩見めぐみ1,2, 久嶋則行3, 栗林みどり4, 矢島慶子1, 荒井梨江1, 春山幸子1, 三木明徳3, 尾鳥勝也1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1000-1000, 2017.

---

	P0516-4-AM. A relation and the current situation to a nursing mother taking a psychotropic drug 手島慶子1, 三宅永華1, 奥村理紗1, 三宅沙央莉1, 中谷香織1, 岩城晶文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1000-1000, 2017.

---

	P0518-4-AM. Attitude survey of the health insurance pharmacy for the information communalization in a pregnant woman, the nursing mother medical therapy domain in the Hamamatsu, Shizuoka district 峯田保恵1, 加藤和佳奈1, 宮城明実1, 塩川満1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1001-1001, 2017.

---

	P0520-4-AM. The construction of the neonates withdrawal syndrome check system and intervention as a pregnant woman, the nursing mother medical therapy authorization pharmacist 三好文子1, 松重奈央1, 出雲貴文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1001-1001, 2017.

---

	P0485-3-PM. Efforts about the drug mother's milk transitivity reporting 門倉史枝1, 國東佑美1, 本上ほなみ1, 二星知紗1, 永井浩章1, 井上智恵1, 見上千昭1, 西窪奈津子1, 西尾孝1, 辻本勉1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1002-1002, 2017.

---

	P0487-3-PM. Efforts to bowel control based on the constipation treatment protocol that collaborated with the ward staff in the maternity ward and the evaluation 木村純子1, 高木祥子1, 立松あき2, 江口美智2, 加藤紀子3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1003-1003, 2017.

---

	P0489-3-PM. Collaboration work ... with making and side effect evaluation ... Dr., the nurse midwife of the tool in the use of nifedipine to impending premature birth treatment 杉浦あゆみ1, 小島昌代1, 桑山隼1, 石田直美2, 佐々治紀3, 桜田宏明1, 山村益己1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1003-1003, 2017.

---

	P0491-3-PM. Evaluation of the reporting book to the pregnant woman by the pharmacist 辻村早由稀1, 加賀正基1, 松井乃利子1, 柴山芳之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1004-1004, 2017.

---

	P0493-3-PM. Analysis of questionnaire results and the inquiry example targeted for a physician about a pregnant woman, the nursing mother medical therapy 大野愛1, 伊藤友恵1, 野澤孝子1, 山本恭平1, 岩瀬由枝1, 鶴田昌吾1, 石上仁美1, 猪岡真己1, 久保田敏行1, 杉浦洋二1, 勝見章男2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1004-1004, 2017.

---

	P0495-3-PM. Mother's milk shift prediction - second generation antihistamine of the drug by in silico using ADMET Predictor and metabolite, foreign element - 板垣文雄1, 末松歩1, 秋好悠1, 渡邊真知子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1005-1005, 2017.

---

	P0497-3-PM. Pregnant woman, attitude survey for the medicine in the nursing mother 平澤裕美子1, 羽藤加奈恵1, 上野杏菜1, 田頭尚士1, 常久幸恵2, 多田克彦3, 中村和恵4, 木内司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1005-1005, 2017.

---

	P0499-3-PM. Medical treatment for the high blood pressure that occurred in puerperium 野木山史恭1, 相馬まゆ子1, 佐々木洋一1, 今田愛也2, 猪爪信夫2, 吉田博3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1006-1006, 2017.

---

	P0501-3-PM. It is analgesic effect investigation of the periodical administration of intravenous acetaminophen in the painkilling after the cesarean section 酒井彩乃1, 野洌孝二1, 大岡千寿子1, 久保田理恵1, 池田遼太1, 神田雄史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1006-1006, 2017.

---

	P0503-3-PM. The case that consisted of the treatment enforcement for a feeling of itching with the ritodrine hydrochloride readministration if the pregnancy was possible continuously 巖西真1, 金本賢枝1, 平大樹1, 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1007-1007, 2017.

---

	P0505-3-PM. 1 case that became with positive STS for syphilis, and took amoxicillin for a long term during pregnancy 横山雅子1, 加瀬和也1, 夏目義明1, 中山昌樹2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1007-1007, 2017.

---

	P0507-3-PM. The current situation of the mental disorder merger pregnant medical treatment in our hospital 桐林美緒1, 矢吹恵美1, 後藤明人1, 金田美咲緒1, 三浦裕美子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1008-1008, 2017.

---

	P0509-3-PM. Effect by a pregnant woman, a nursing mother medical therapy authorization pharmacist conducting the pregnancy, the nursing and the introduction education in the medicine domain on business trainee, new face pharmacist 松重奈央1, 三好文子1, 出雲貴文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1008-1008, 2017.

---

	P0511-3-PM. Examination of the factor associated with the perinatal period bleeding of the parturient third oxytocin treated patients 柿沼博子1, 高野尊行1, 小祝梓1, 小林由香1, 柿沼貴広1, 石橋楽至1, 中丸朗1, 太田邦明2, 白石悟2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1009-1009, 2017.

---

	P0513-3-PM. The case that the antiphospholipid syndrome merger pregnancy patients reached the childbirth with aspirin internal use, a heparin calcium self injection safely 後藤紗希1, 和田淳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1009-1009, 2017.

---

	P0515-3-PM. Questionnaire research about the actual situation of recognition and the use for the medicine of a pregnant woman of the third pregnancy trimester or the nursing mother 糸川知江1,2, 角英2, 形部文寛2, 妹尾友美3, 高田薫3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1010-1010, 2017.

---

	P0517-3-PM. Examination about a gestational period and the side effect of tocolytic agent for the early or threatened labour in our hospital 油布朋子1, 服部純尚2, 高橋邦雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1010-1010, 2017.

---

	P0519-3-PM. Efforts for the improvement in drug knowledge of a nurse, the nurse midwife in the maternity ward 加藤和佳奈1, 峯田保恵1, 塩川満1, 中村光世2, 村越毅3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1011-1011, 2017.

---

	P0521-3-PM. Examination of the clinical usefulness of blood emptiness, the blood score for the early or threatened labour 石川未奈子1, 中村卓巨1, 山本高範1, 鬼頭大輔1, 溝口和代1, 紀平力2, 日下秀人2, 前川有香2, 吉村公一2, 前田眞2, 阿部康治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1011-1011, 2017.

---

	P0522-4-AM. Examination about the precision of the disposable-type pen type insulin injection appliance 秋山滋男1,3, 青木智之2,3, 荻原貴之2, 村上正己3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1012-1012, 2017.

---

	P0524-4-AM. Examination about the predictor of the insulin therapy necessity or not at discharge in the type 2 diabetes education inpatient 石田翔1, 吉川明良1, 開浩一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1013-1013, 2017.

---

	P0526-4-AM. Medication adherence by the change to once a week DPP-4 inhibitor, effect on change and treatment result of the diabetes treatment satisfaction questionnaire 西村亮1, 佐藤雄一2, 中田学1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1013-1013, 2017.

---

	P0528-4-AM. Fact-finding about the chic day of patients with diabetes 染谷光洋1, 長沼敬子1, 山崎友里絵1, 石尾有司1, 谷口亮央1, 前田柾幸1, 中島史雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1014-1014, 2017.

---

	P0530-4-AM. Fact-finding about the maneuver after the insulin self injection introduction 高松真依1, 田邉史子1, 松本亜佐美1, 三橋真由美1, 光川由佳子1, 秋本法人1, 小林早苗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1014-1014, 2017.

---

	P0532-4-AM. Search of the patients needs in the SMBG apparatus 飯干茜1, 大石将義1, 古浜健一1, 湯本哲郎2, 稲葉健二郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1015-1015, 2017.

---

	P0534-4-AM. Questionary survey of the usability of the pre-filled type insulin instillator for the insulin initial introduction patients 谷聡美1, 薄元里衣1, 田頭尚士1, 木内司1, 肥田和之2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1015-1015, 2017.

---

	P0536-4-AM. Examination about the patients background of the hypoglycemia case in the emergency visit 猪子美保1, 藤森和則1, 間瀬悟1, 近藤有1, 坪井伸治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1016-1016, 2017.

---

	P0538-4-AM. The effect that a change gives to blood sugar control on gliclazide from glimepiride 中島啓二1, 宇佐美英績1, 臼井一将1, 多賀小枝子1, 新井かおり1, 安部絵里1, 伊藤加代1, 蜜田哲也1, 柴田大河2, 傍島裕司2, 吉村知哲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1016-1016, 2017.

---

	P0540-4-AM. Inspection of the usefulness of the diabetes therapeutic drug Dulaglutide through the self-injection introduction instruction by the pharmacist 石田詞子1,2, 小野達也1,2, 岩田芳枝1, 西田英之1, 徳山尚吾2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1017-1017, 2017.

---

	P0542-4-AM. About the case that contributed to the number of the prescription increase of the Dulaglutide in our hospital 山下大貴1, 重松沙希1, 内山有理香1, 平川雅章1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1017-1017, 2017.

---

	P0544-4-AM. Examination of the usefulness of the low-dose ipragliflozin (25 mg of daily doses) 谷内幸恵1, 織田展成2, 大森亜衣2, 高橋知子2, 奥田理香2, 笹山潔1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1018-1018, 2017.

---

	P0546-4-AM. Examination of the usefulness in the blood sugar control of the sustained Exenatide preparation 尾形朱史鈴1, 若松遼介1, 石塚仁保1, 能登数馬2, 須藤大雄1, 棚谷貢1, 飛澤国広1, 小林龍3, 小原秀治1, 小原郁司1, 渡辺浩明2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1018-1018, 2017.

---

	P0550-4-AM. Examination of the usefulness of the SGLT2 inhibitor in patients with type 2 diabetes 松本尚子1, 早川伸樹1,2, 津川透1,3, 林高弘3,4, 福井愛子1, 亀井浩行1, 松尾悠志2, 吉野寧維2, 鈴木敦詞2, 山田成樹3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1019-1019, 2017.

---

	P0552-4-AM. The use situation investigation of the SGLT-2 inhibitor in our hospital 駒井勇太1, 田仲祐子1, 坂口結斗1, 喜多洋嗣1, 喜多幸子1, 長濱藍1, 仲村亮太1, 森智子1, 人見百合子1, 石井英之1, 氏川郁穂1, 村雲智久1, 石井奈津季1, 久田潤平1, 三浦捺樹1, 峯浩太朗1, 宮川千珠1, 竹治優紀1, 松元あみ1, 水野康平1, 山中愛美1, 吉村美菜1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1020-1020, 2017.

---

	P0554-4-AM. Association of hypoglycemic action and the CPI of patients with type 2 diabetes taking DPP-4 inhibitor (sitagliptin) 土井佳子1, 真井雄規1, 小笠原綾香1, 石田陽美1, 津田雅大1, 佐藤弘康1, 和泉秀明1, 田村広志1, 渡辺浩明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1020-1020, 2017.

---

	P0556-4-AM. Illness medicine cooperation using systems construction and the diabetes cooperation notebook of the diabetes instruction to patient 中嶋直也1, 青山栄司1, 土屋辰司1, 吉田昌樹1, 中澤千寿1, 竹内松美1, 谷知彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1021-1021, 2017.

---

	P0523-3-PM. The effect that all inpatient diabetes practice management (hospital wide diabetes management, HDM) by CDE-J gives to the surgery patients 伊藤隆哉1, 小山貴夫1, 中野和佳1, 矢野目英樹2, 石津美紀3, 太田隆4, 田内克典5, 山下浩6, 山内恵史7, 相澤徹6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1022-1022, 2017.

---

	P0525-3-PM. An understanding degree and education problem of the diabetes education patients 染谷真理子1, 飯嶋友美1, 山下春香1, 引地華子1, 味岡絢子1, 川崎昌子1, 田澤匡1, 辻桃子1, 福田光司1, 原信田努1, 圓崎信也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1023-1023, 2017.

---

	P0527-3-PM. The hypoglycemia effect with the SGLT2 inhibitor and effect on serum uric acid level 櫻井淳二1, 菅原愛美2, 佐藤伸輔1, 渡辺昌子1, 阿部順1, 岡田優1, 野上佳奈子1, 宮内康夫1, 武者栄美子1, 高橋知子2, 大河原雄一2, 石澤文章1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1023-1023, 2017.

---

	P0529-3-PM. Patients understanding degree investigation for the medication counseling to the SGLT2 inhibitor remedy patients 平野陽子1, 渡瀬友貴1, 古俵孝明1, 渡辺享平1,2, 矢野良一1, 塚本仁1, 後藤伸之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1024-1024, 2017.

---

	P0531-3-PM. Investigation of the seriously ill hypoglycemia risk patients based on "blood sugar control target of elderly people diabetes" 長尾彰太1, 吉岡睦展1, 若松雄太1, 杉生雅和1, 石津智司1, 辻隆志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1024-1024, 2017.

---

	P0533-3-PM. Comparison of blood glucose level and HbA1c in once a week preparation and the once a day preparation of the GLP-1 receptor agonist 臼井美佳1, 足立恵子1, 依藤健之介1, 前田翠1, 松本章士1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1025-1025, 2017.

---

	P0535-3-PM. Evaluation - effect of the usefulness of the Dulaglutide on elderly people and examination ... of the side effect factor 山田早1, 土屋裕伴1, 大島聡子1, 新井亘1, 増田裕一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1025-1025, 2017.

---

	P0537-3-PM. Survey of the medical treatment for patients with diabetes during use of anticancer agent of our hospital 永渕学1, 久保壮史1, 植山寛1, 親泊広大1, 春口温子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1026-1026, 2017.

---

	P0539-3-PM. Examination about the association between effectiveness and renal function of the dapagliflozin 石橋楽至1, 小林由香1, 柿沼博子1, 高野尊行1, 中丸朗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1026-1026, 2017.

---

	P0541-3-PM. Fact-finding about the recognition of the blood sugar control target in patients with elderly people diabetes 小鷹篤1, 米川綾1, 安齋沙織1, 佐藤知奈美1, 杉井龍1, 飯塚敏美1, 亀山俊1, 堀口雅巳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1027-1027, 2017.

---

	P0543-3-PM. Examination about the effectiveness and the spin-off of the SGLT2 inhibitor 水谷彰史1, 久保淳一1, 鈴木千波1, 蝦名勇樹1, 佐藤裕資1, 森田眞樹子1, 高木明彦1, 佐藤公人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1027-1027, 2017.

---

	P0545-3-PM. Investigation about the kidney protection effect of the ipragliflozin 坂田美咲1, 秋吉明子1, 平田憲史郎1, 下石和樹1, 陣上祥子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1028-1028, 2017.

---

	P0547-3-PM. Examination of the usefulness of the once a week GLP-1 receptor agonist Dulaglutide introduction patients 久嶋真紀子1, 野口景子1, 葛葉守1, 中野玲子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1028-1028, 2017.

---

	P0549-3-PM. 1 case of the IgG 4 associated diseases that developed steroid diabetes 伊東崇仁1, 水澤清1, 川井龍美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1029-1029, 2017.

---

	P0551-3-PM. Examination of the combined effect of metformin and the DPP-4 inhibitor in patients with type 2 diabetes 福井沙季1, 早川伸樹1,2, 津川透1,3, 林高弘3,4, 福井愛子1, 亀井浩行1, 牧和歌子2, 中山将吾2, 鈴木敦詞2, 山田成樹3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1029-1029, 2017.

---

	P0553-3-PM. Effect - that the band of the need - HbA1c level of the response in consideration for psychology of the patients with diabetes gives to quality of life 千野佑莉1, 中井義人1, 竹平理恵子1, 田畑光久2, 山田悟2, 有田悦子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1030-1030, 2017.

---

	P0555-3-PM. The use situation investigation of the diabetes combination medicine 石橋真実1, 大森麻江1, 金井美緒1, 日浦亜実1, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1030-1030, 2017.

---

	P0557-3-PM. It is examined construction and the usefulness of the pass on the diabetes education hospitalization weekend 中尾ユミ1, 勅使河原眞也1, 森美樹1, 田口あさみ1, 南中二三代2, 和田真明3, 佐久間陽子4, 稲角利彦1, 櫻井美由紀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1031-1031, 2017.

---

	P0558-4-AM. Effect of levocarnitine on anemia of artificial dialysis patients 林智樹1, 磯崎久美子1, 齊田峻1, 佐藤数馬1, 稲本正行1, 井上美津子2, 徳田崇利3, 斎藤明3, 島田慰彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1032-1032, 2017.

---

	P0560-4-AM. Examination about the effect of the proton pump inhibitor on ferritin level of patients on dialysis 小林由香1, 高野尊行1, 柿沼博子1, 石橋楽至1, 中丸朗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1033-1033, 2017.

---

	P0562-4-AM. Blood level management of tacrolimus (TAC) one-month after the kidney transplantation in our hospital 平井さやか1, 菊地明子1, 松本崇史1, 神田茜1, 後藤知美1, 宮坂能乃1, 本橋彩1, 鈴木宏和1, 小熊梢1, 篠原克典1, 近藤正巳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1033-1033, 2017.

---

	P0564-4-AM. Examination of the usefulness with the carnitine preparation chronic administration in patients on dialysis 宮腰恵生1, 星貴薫1, 柳谷束1, 山岡幸1, 寺館圭祐1, 森野太一1, 宮越貴之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1034-1034, 2017.

---

	P0566-4-AM. Water management in the tolvaptan medication situation and the everyday life of patients with polycystic kidney 遠藤彩香1, 佐久間大樹1, 向山明彦1, 花輪和己1, 温井郁夫2, 若杉正清2, 神宮寺禎巳2, 小林義文1, 山本誠一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1034-1034, 2017.

---

	P0568-4-AM. The renal function evaluation in the health insurance pharmacy and proper use of pharmaceutical products 堀川真由美1, 島崎友美1, 志村優衣1, 三枝隼樹1, 弓削史司2, 大野豊3, 大久保淑子3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1035-1035, 2017.

---

	P0570-4-AM. Effect on iron-related test value of the ferric citrate hydrate tablets in haemodialysis patients 植田徹1, 森脇崇1, 田中早紀1, 辻川正彦1, 国府孝敏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1035-1035, 2017.

---

	P0559-3-PM. Examination of the usefulness of the ferric citrate hydrate administration in haemodialysis patients 星貴薫1, 高橋友樹1, 柳谷束1, 福井清奏1, 福村悠太1, 藤澤春香1, 宮腰恵生1, 森野太一1, 宮越貴之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1036-1036, 2017.

---

	P0561-3-PM. The effect that a change of the EPO preparation to use for haemodialysis patients gives to anemia in renal disease control 高嶋祥匡1, 鈴木大介1, 畔柳敏弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1037-1037, 2017.

---

	P0563-3-PM. Effect of treatment examination of the Sucroferric oxyhydroxide 250 mg administration in our hospital outpatient department patients on dialysis a day 花木真美子1, 成山真一2, 高橋仁美1, 澁谷浩二3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1037-1037, 2017.

---

	P0565-3-PM. It is ... through one case of examination - system construction of the intervention point of the pharmacist in the kidney transplantation team setup of our hospital and the initial kidney transplantation 渡辺則夫1, 伊藤正輝1, 横山泰昭1, 鈴木正論1, 安室修1, 舟越亮寛1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1038-1038, 2017.

---

	P0567-3-PM. DSA positive is suspected just before living renal transplantation and is examined the case receiving rituximab in a hurry 是松良隆1, 平井聡史1, 金本人美2, 山本恵美3, 錦建宏4, 橋口裕樹2, 本山健太郎4, 藤永理恵子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1038-1038, 2017.

---

	P0569-3-PM. Attitude survey about the response to renal-transplant recipients of the health insurance pharmacy pharmacist for the medicine medicine cooperation construction 今屋由似1,2, 牛之濱風見1, 中嶋洋生1, 山田保俊2, 菅原英輝1, 武田泰生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1039-1039, 2017.

---

	P0571-3-PM. The use situation of the direct action type oral anticoagulant drug and patients background 荒川桃子1, 櫻田啓介1, 菅大地2, 三上大貴3, 谷口知明1, 藤井達也3, 中山美穂1, 久保淳一3, 樋浦一哉1, 飛澤国広1, 鈴木千波3, 小原秀治1, 佐藤公人3, 小原郁司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1040-1040, 2017.

---

	P0573-3-PM. Inspection and measures of the on-site problems simple suspension method introduction ten years later 山本理香子1, 水野絵莉1, 壁谷めぐみ1, 岡本千晴1, 湯浅周1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1041-1041, 2017.

---

	P0575-3-PM. Example that the changes from a buprenorphine patch to tramadol tablets were able to be given well 長谷康史1, 小島正照1, 荒木良介1, 山田英紀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1041-1041, 2017.

---

	P0577-3-PM. The intervention situation investigation for the polypharmacy 谷口潤1, 渡邊ありさ1, 高田正温1, 東島彰人1, 白川敦規2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1042-1042, 2017.

---

	P0579-3-PM. Effect of the prothrombin complex (factor IX complex) on cerebral hemorrhage complicated during warfarin internal use 辰巳典子1, 槙原克也1, 森川雅史2, 内山ひとみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1042-1042, 2017.

---

	P0581-3-PM. The effectiveness of duloxetine in the chronic lumbago 立石健史1,2, 南里泰弘2, 林博志2, 田中一範2, 西川裕行2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1043-1043, 2017.

---

	P0583-3-PM. Examination about the usefulness of the vonoprazan in the H.pylori sanitization 横山尚美1, 近藤有1, 坪井伸治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1043-1043, 2017.

---

	P0585-3-PM. Basic investigation to aim at quality of life maintenance, the improvement of the hemophilic patients by the pharmacist 阿部憲介1,2, 神尾咲留未1, 近藤旭1, 後藤達也1, 佐々木晃子3, 伊藤ひとみ3, 佐藤功4, 佐藤博2, 伊藤俊広4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1044-1044, 2017.

---

	P0587-3-PM. Factor analysis about the dosage in the ascorbic acid-containing polyethylene glycol electrolyte preparation 佐藤将嗣1, 藤澤千里2, 根岸健一2, 指山浩志3, 大部智栄子4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1044-1044, 2017.

---

	P0589-3-PM. Examination about safety after the DOAC administration in the low weight patients in our hospital and the effectiveness 飯田拓真1, 寺口徹1, 高崎亮宏2, 福永浩也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1045-1045, 2017.

---

	P0591-3-PM. The effect that transfusion history gives in serum iron and ferritin at erythropoietin administration for anemia of prematurity 杉理江1, 松浦優里1, 佐野良輔1, 中山幹子1, 仙波靖士1, 久保井徹2, 林武文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1045-1045, 2017.

---

	P0593-3-PM. Examination of the appropriate medication method of the chronic constipation therapeutic drug agate Pross ton 渡邊瞭1, 濱宏仁1, 田中詳二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1046-1046, 2017.

---

	P0595-3-PM. An example of the pharmacist intervention in patients receiving biopreparation 長岡麻沙美1, 大津貴寛1, 津曲恭一1, 尾之江剛樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1046-1046, 2017.

---

	P0597-3-PM. It is a report about the proper use of the infection prophylaxis antimicrobial after the operation by the intervention of the pharmacist 古谷一平1, 小栗良介1, 土川拓也1, 田中佳子1, 平下智之1, 谷沢克弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1047-1047, 2017.

---

	P0599-3-PM. Associated with the outcome that the increase of the number of the drugs which are not recommended in guidelines is poor: J-MELODIC study subanalysis 志方敏幸1, 福井美保2, 真鍋恵理2, 高本光次郎1, 坂本淳一3, 伊藤都裕4, 増山理2, 辻野健2,3,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1047-1047, 2017.

---

	P0601-3-PM. Efforts to the prescription to set with instructions book instructions in the delirium treatment, preventive preparation 中島彰子1, 出口有佳理1, 野崎純子1, 仁熊敬枝2, 井上真一郎3, 橋本幸子1, 宮川真澄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1048-1048, 2017.

---

	P0603-3-PM. The effectiveness in the early use of the tolvaptan 吉田夕貴1, 大宮寛子1, 三輪耕次1, 田中伸享2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1048-1048, 2017.

---

	P0605-3-PM. DAA (Direct Acting Antivirals) treatment result for the C type chronic liver disease and examination of the initial unsuccessful case 松川雅子1, 佐藤裕美1, 福野和治1, 西部幸一1, 今井桂子1, 古家乾2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1049-1049, 2017.

---

	P0607-3-PM. The postnatal characteristics hemophilia 2 case that we experienced in our hospital 森田雅之1, 荒木佐知子1, 山野惣平1, 松本哲哉1, 月光淳1, 玉置秀成1, 中村智1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1049-1049, 2017.

---

	P0609-3-PM. Inspection of the change of proBNP in the administration of SGLT2 inhibitor 谷口仁孝1, 徳村博子1, 山本彩佳1, 千葉恵美子1, 渡邉美樹1, 坂井愛実1, 前田典子1, 水野稜子1, 松田恵理1, 小原祐子1, 加納みゆき1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1050-1050, 2017.

---

	P0611-3-PM. About the inflection to examination and treatment preferences of the immunoglobulin refractory predictive score for patients with Kawasaki's disease 小笠原蓉子1, 齋藤はるか1, 千葉里菜1, 竹中真衣1, 比毛有理子1, 佐藤圭吾1, 目崎香苗1, 河上昭一1, 西和哉1, 佐賀利英1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1050-1050, 2017.

---

	P0613-3-PM. Inhalational instruction reexamination in the Fujinomiya Municipal Hospital 北村修1, 小林豊1, 勝又一雄1, 川口洋実1, 小林義典1, 加藤祥世1, 旭典之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1051-1051, 2017.

---

	P0615-3-PM. Safety of caffeine for children within 28 weeks 渡辺真梨奈1, 山田留美子1, 下川千賀子1, 山田千代子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1051-1051, 2017.

---

	P0617-3-PM. Change of the number of Functional Independence Measure before and after the rehabilitation enforcement and the use drugs 大坪愛実1, 舘知也1,2, 勝野隼人1, 上野杏莉1, 吉田阿希1, 兼松勇太1, 杉田郁人1, 野口義紘1, 樋島学3, 青山智2, 安田昌宏2, 水井貴詞2, 後藤千寿2, 寺町ひとみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1052-1052, 2017.

---

	P0572-4-AM. Construction of Formulary System about the uric acid generation antagonist based on a systematic review 金井紀仁1, 鈴木義人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1053-1053, 2017.

---

	P0574-4-AM. Example that suffered from glycemic control, a surgical site infection by Polypharmacy 若松雄太1, 吉岡睦展1, 長尾彰太1, 杉生雅和1, 石津智司1, 小林敦子2, 辻隆志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1054-1054, 2017.

---

	P0576-4-AM. Fact-finding of the prescription cascade in patients with dementia 山崎美保1, 谷本愛花1, 楢原史子1, 馬屋原慈理1, 渡辺貴志1, 前田頼伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1054-1054, 2017.

---

	P0578-4-AM. 1 case that we made golimumab introduction for intractable ulcerative colitis 深海広平1, 高田宏文1, 前田直就1, 橋野文花1, 西村実佳1, 稲村勝志1, 南橋薫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1055-1055, 2017.

---

	P0580-4-AM. The effectiveness of the treatment with indacaterol for patients with chronic obstructive pulmonary disease or long time effect type anticholinergic drug and safe evaluation 大島美奈都1, 嶋田修治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1055-1055, 2017.

---

	P0582-4-AM. Analysis about the prescription situation of the anticoagulant in patients with non-valvular atrial fibrillation and the proper use 伊藤あゆみ1, 中川隼一1, 原俊博1, 大貫麻友美1, 蔭山博之1, 平島徹1, 芝田貴裕2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1056-1056, 2017.

---

	P0584-4-AM. Fact-finding of the drug doses confirmation to the decreased renal function patients in our hospital 岡健太郎1, 久松大介1, 石原祥史1, 木村繁和1, 林貴子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1056-1056, 2017.

---

	P0586-4-AM. Comparison of the effect of treatment by the difference of the immunoglobulin preparations in the Kawasaki's disease 堀勇太1, 山口賢一郎2, 浦本邦弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1057-1057, 2017.

---

	P0588-4-AM. Examination about the Edaravone administration for the ALS 櫻塲秀一1, 原弘士1, 五十嵐俊1, 城倉健2, 天野悠3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1057-1057, 2017.

---

	P0590-4-AM. It is ... for the introduction that is smoother by security than relation ... of the pharmacist in the treatment with oral antiHCV medicine 中嶋めぐみ1, 大橋健吾1, 西川智子1, 篠田康孝1, 郷真貴子1, 岩井美奈1, 吉村知哲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1058-1058, 2017.

---

	P0592-4-AM. Examination about the effectiveness and the adverse event of the basiliximab induction therapy in the lung transplantation 川西秀明1, 北村佳久1, 千堂年昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1058-1058, 2017.

---

	P0594-4-AM. Safe examination about the antithrombocytic agent internal use continuation at abdominal aortic aneurysm stent graft interpolation technique enforcement 今尾瑞季1, 阪井祐介1, 千崎康司1, 古森公浩2, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1059-1059, 2017.

---

	P0596-4-AM. The effect that the medication method of the Xa inhibitor in our hospital gives to solidification test value 太田洋貴1, 西村寿貴2, 福島剛志2, 上田賢太郎1, 生島五郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1059-1059, 2017.

---

	P0598-4-AM. The reporting of optimum doses of allopurinol in the decreased renal function patients and change of the uric acid level 大岩拓馬1, 加藤麻理乃1, 福井悠美1, 浅野嘉之1, 伊東和真1, 前田剛司1, 坂田洋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1060-1060, 2017.

---

	P0600-4-AM. RAS family gene, RAP1A are inhibited by miR-101-5p 柴山良彦1, 阪東芳則1, 原友貴1, 久保儀忠1, 井関健2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1060-1060, 2017.

---

	P0602-4-AM. Satisfaction investigation after the sleeping drug remedy in the inpatient 稲川覚子1, 阿藤友美1, 川端志津1, 伊藤真美1, 松元美香1, 大谷道輝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1061-1061, 2017.

---

	P0604-4-AM. 1 case that was improved by combination therapy of the Evolocumab for the FH patients 小澤章裕1, 中山菜実1, 鈴木美帆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1061-1061, 2017.

---

	P0606-4-AM. Introduction of the pharmaceutical management check seat for transluminal treated patients in Nagasaki 松永典子1,2, 樋口則英2,3, 渡辺一章2,4, 井上高彦2,5, 増田淳士2,6, 吉村彰剛2,7, 廣瀬知子2,8, 北原隆志1, 佐々木均1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1062-1062, 2017.

---

	P0608-4-AM. Treatment result of Interferon-free DAAs for chronic hepatitis C in our hospital 植松卓也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1062-1062, 2017.

---

	P0610-4-AM. Example that was given etretinate by the simple suspension method for harlequin ichthyosis 勝弘毅1, 小西友美1, 市野貴信2, 阿部康治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1063-1063, 2017.

---

	P0612-4-AM. Development of the symptom monitoring tool for patients having difficulty in mutual understanding by the language 東恩納司1, 牛尾聡一郎1, 建部泰尚1, 吉田奈々子1, 江角悟1, 小川敦1, 村川公央1, 北村佳久1, 千堂年昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1063-1063, 2017.

---

	P0614-4-AM. Comparison between 24 hours urine collection and renal function evaluation using the Cockcroft-Gault type in patients with cancer 稲秀士1, 宮本拓也1, 鈴木智1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1064-1064, 2017.

---

	P0616-4-AM. Examination of liver function in Sofosbuvir/ribavirin combination therapy and the liver fibrosis improvement effect on C type chronic liver disease 小林真菜1, 瀬尾佳世3, 西條由夏1, 森本愛梨1, 加藤愛梨1, 笹谷佳菜子1, 大谷綾1, 中尾啓子1, 笹瀬典子1, 金啓二1, 金秀基2, 金守良2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1064-1064, 2017.

---

	P0618-4-AM. The "working" behavior modification of the pharmacist makes the main constituent person of illness treatment transform patients 杉原真理1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1065-1065, 2017.

---

	P0619-3-PM. Cooperation with the community pharmacy by the outside Parliament prescription clinical test value notation 佐藤弘1, 岡部真希1, 青柳京子1, 前田江里奈1, 金内幸子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1066-1066, 2017.

---

	P0621-3-PM. Efforts to PBPM enforcement for doubt inquiry decrease for the high quality medical offer 冨岡太一1, 三浦怜1, 山野惣平1, 松本哲哉1, 月光淳1, 玉置秀成1, 中村智1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1067-1067, 2017.

---

	P0623-3-PM. Evaluation by the doubt inquiry simplification of the outside Parliament prescription 町田充1, 伊賀正典1, 興野克典1, 内田隆道1, 亀井陽子1, 後藤孝之1, 河合奈々江1, 田村結美1, 鈴久名成美1, 野田政充2, 岡邦雄2, 堀野忠夫2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1067-1067, 2017.

---

	P0625-3-PM. Inspection of the use actual situation and the benefit of the tracing report in our hospital 奥村宣彦1, 出雲貴文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1068-1068, 2017.

---

	P0627-3-PM. On the basis of the current situation of doubt inquiry utilizing the test value in the outside Parliament prescription and the questionary survey to problem - drugstore pharmacist; and ... 安藤友貴1, 北出紘規1, 森光恵1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1068-1068, 2017.

---

	P0629-3-PM. Attitude survey about the antimicrobial in the health insurance pharmacy 東野愛理1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1069-1069, 2017.

---

	P0631-3-PM. Medical expenses reduction effect in the Residual medicine adjustment in the Saitama Prefectural cancer center 武井大輔1, 丸林万希子1, 大塚公庸1, 中村益美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1069-1069, 2017.

---

	P0633-3-PM. It is efforts of the foreign cancer chemotherapeutic drug medicine cooperation using the prescription notebook to "the pharmacist with a view of the face" 平田司1, 佐藤貴教1, 村井佐和1, 吉田幸史1, 柴田亜由美1, 土谷隆紀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1070-1070, 2017.

---

	P0635-3-PM. Examine CKD disease for the medical treatment management that continued; to construction - prescription notebook of the medicine cooperation renal function information sharing - by the "CKD seal" pasting 矢羽羽雅行1, 松崎幸司1, 吉原真由美2, 小原史生2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1070-1070, 2017.

---

	P0637-3-PM. The current situation of the inhalational instruction in our hospital respiratory organs medical service 今井孝1, 藤原直也1, 佐伯由美子1, 酒井牧子1, 小西龍也2, 河野通盛1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1071-1071, 2017.

---

	P0639-3-PM. Evaluation of the usefulness about the test value, cancer chemotherapy regimen name indication to outside Parliament prescription 大熊実季1, 平手大輔1, 小島雅和1, 平田萌1, 新沼芳文1, 本郷文教1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1071-1071, 2017.

---

P0641-3-PM. Fact-finding of efforts and a pharmacy student to inhalation therapy support utilized the medicine medicine cooperation in our hospital and the inhalational instruction in the neighborhood health insurance pharmacy that we shared 柳澤友希1, 黒須智博1, 稲田佑亮1, 齋藤洋映1, 伊藤優2, 八重樫雅3, 夏目義明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1072-1072, 2017.

---

	P0643-3-PM. Inflection of the outside Parliament prescription addition information and evaluation by patients with cancer 久保田康生1, 齋藤佳敬1, 原田幸子1, 深井敏隆1, 井関健1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1072-1072, 2017.

---

	P0645-3-PM. It is ... from the opinion comparison between ... insurance pharmacist and our hospital pharmacist about the information at discharge demanded by the cooperation with the health insurance pharmacy 高儀佳代子1, 清水けいこ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1073-1073, 2017.

---

	P0647-3-PM. Efforts to the information contact book between institutions in the Hainan Hospital [2] It is ... about the current situation and the task which we saw from ... questionary survey 深澤淑子1, 大谷寧次郎1, 眞野加奈子1, 森健太郎1, 水谷彩伽1, 畔柳敏弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1073-1073, 2017.

---

	P0649-3-PM. Inhalational instruction practical skill class to develop by the multi-type of job 高橋愛由子1, 三木芳晃1, 塚本啓介1, 伊藤絵理1, 大原ひとみ1, 片岡麻美1, 竹田優希1, 松枝奈津子1, 田中昭洋1, 谷岡真帆1, 中村薫子1, 西垣玲奈1, 上田哲也2, 長谷川吉則2, 萱野勇一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1074-1074, 2017.

---

	P0651-3-PM. The use situation investigation about the at-home intravenous feeding in the Kushiro Red Cross hospital 渡邊清人1, 高柳昌宏1, 千田泰健1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1074-1074, 2017.

---

	P0655-3-PM. An evaluation and medicine medicine cooperation for the doubt inquiry correspondence from the health insurance pharmacy that assumed an in-hospital drugstore a window 室井政子1, 柴田昌彦1, 菅田優子1, 竹田健志1, 櫨山葉子1, 山東真寿美1, 高木麻里1, 吉田智江1, 田中恵美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1075-1075, 2017.

---

	P0657-3-PM. A questionnaire and the current situation investigation to a health insurance pharmacy pharmacist about the outside Parliament prescription doubt inquiry correspondence 八木橋美里1, 工藤香澄2, 中野有瑛1, 馬場親紀1, 鈴木常義2, 中村一成1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1076-1076, 2017.

---

	P0659-3-PM. Examine illness using the contact paper between pharmaceutical products institutions; efforts to medicine cooperation 田村和彦1, 財津孝希1, 瀧内瑛輔1, 嶋崎千絵1, 長澤欣弘1, 羽生智宏1, 尾形美絵1, 新関みどり1, 近藤和宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1076-1076, 2017.

---

	P0620-4-AM. Efforts of the doubt inquiry simplification protocol in the outside Parliament prescription of the Saitama Prefectural cancer center 丸林万希子1, 武井大輔1, 大塚公庸1, 中村益美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1077-1077, 2017.

---

	P0622-4-AM. Construction of the new medicine medicine cooperation in our district 一ノ瀬由衣1, 山脇一浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1078-1078, 2017.

---

	P0624-4-AM. Effect on Residual medicine adjustment after the doubt inquiry simplification protocol introduction 島崎友美1, 堀川真由美1, 志村優衣1, 三枝隼樹1, 弓削吏司2, 大野豊3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1078-1078, 2017.

---

P0626-4-AM. Ring - of the medicine medicine cooperation to spread through 12 wards of - Osaka about the efforts in two years in Osaka railroad hospital "meeting of the medicine medicine cooperation promotion" 小牟田豊1, 阿登大次郎1, 齋藤玲奈1, 古谷真依子1, 八代哲也1, 田中博来2, 日高眞理2, 水野直子2, 山田公一3, 栗生正也4, 藤井博昭5, 安永政利6, 林泰広7, 守島繁昭8, 田中雅隆9, 常松明生10, 藤井義博11, 森本定則12, 安部力13, 上田祥子14, 菅野文15, 東海秀吉1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1079-1079, 2017.

---

	P0628-4-AM. The questionnaire results to the health insurance pharmacy about outside Parliament prescription mentions such as the renal function test value, and the like and the need, examination about problems 杉本吉春1, 浅原慶徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1079-1079, 2017.

---

	P0630-4-AM. Questionary survey about the test value utilization situation in efforts and the pharmacy service under health insurance drugstore before leading to the test value printing start to outside Parliament prescription 中野有瑛1, 青柳伸一2, 馬場親紀1, 山田文義2, 中村一成1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1080-1080, 2017.

---

	P0632-4-AM. Difference in consciousness with an insurance pharmacist and the hospital pharmacist as the medicine medicine cooperation disincentive 伊東佳美1, 山口俊司2, 坂東勉1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1080-1080, 2017.

---

	P0634-4-AM. Efforts of the medical treatment management support that a drugstore pharmacist cooperated with the medical care team for peritoneal dialysis patients 福澤翔太1, 矢野亨治1, 山田恵里1, 伊藤文香1, 加藤博史1, 平松哲明2, 高井奈美3, 日比恵美子3, 坂田史子4, 鈴木康弘4, 水野正司4, 伊藤恭彦4, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1081-1081, 2017.

---

	P0636-4-AM. Utilization - of the inhalational instruction training and inhalational evaluation list for regional alliances - health insurance pharmacy pharmacist who aimed at the improvement of asthma and COPD treatment 藤井尚子1, 池末裕明1, 楠田かおり1, 薩摩由香里1, 森本茂文1, 富井啓介2, 橋田亨1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1081-1081, 2017.

---

	P0638-4-AM. For pharmacist-based inhalational instruction and information sharing in connection with a local dispensing pharmacy 畠山義史1, 麻生美佐子1, 田仲奈津美1, 吉川英里1, 浜手ひとみ1, 渡辺彰2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1082-1082, 2017.

---

	P0642-4-AM. Efforts of the medicine medicine cooperation in the Komaki Municipal Hospital 水谷貴樹1,2, 山本泰大1,2, 山本将司1,2, 平野茂樹1,2, 戸田康裕1,2, 浅井宏昭2,3, 川合紀行2,4, 松山苑未2,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1083-1083, 2017.

---

	P0644-4-AM. It is ... about the information at discharge demanded by the cooperation with the health insurance pharmacy from the meeting of the cooperation with ... health insurance pharmacy 清水けいこ1, 高儀佳代子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1083-1083, 2017.

---

	P0646-4-AM. Efforts to the information contact book between institutions in the Hainan Hospital [1] It is ... about the operation of the ... contact book 眞野加奈子1, 大谷寧次郎1, 深澤淑子1, 水谷彩伽1, 森健太郎1, 畔柳敏弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1084-1084, 2017.

---

	P0648-4-AM. One case that we shared the patients information at discharge by a community medical care cooperation system, and it became possible to conduct the medication counseling that continued 小川充恵1,2,3, 山崎肇1, 篠原裕子2, 中野道雄2, 小枝伸行3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1084-1084, 2017.

---

	P0650-4-AM. Efforts aiming at the medicine medicine cooperation promotion using the PDCA cycle 末永亘1, 大窪典子1, 山下典子1, 津曲恭一1, 尾之江剛樹1, 福石和久2, 山本直矢3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1085-1085, 2017.

---

	P0652-4-AM. Efforts about the information sharing of renal function and the glaucoma using a prescription notebook cover 尾崎誠一1,2, 廣子真大2, 河田尚己2, 寺山恵子1,2, 渡辺宗男2, 松久哲章1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1085-1085, 2017.

---

P0654-4-AM. Questionary survey to the health insurance pharmacy about having changed the doubt inquiry window of outside Parliament prescription contents from the physician to the drugstore medicine medicine cooperation room 柴田昌彦1, 室井政子1, 菅田優子1, 竹田健志1, 櫨山葉子1, 山東真寿美1, 高木麻里1, 吉田智江1, 田中恵美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1086-1086, 2017.

---

	P0656-4-AM. Evaluation of the medicine medicine cooperation promotion workshop in Nanto-shi 小川紗知1, 讓原千広1, 波多晶子1, 中澤美樹子1, 橋爪和恵1, 窪田真弓1, 鶴居勝也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1086-1086, 2017.

---

	P0658-4-AM. Operation of the simplification protocol and change of doubt inquiry contents 大久保淑子1, 田中統子1, 堀川真由美2, 石井豪3, 松島綾乃4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1087-1087, 2017.

---

	P0660-4-AM. Questionary survey about the information sharing for the health insurance pharmacy using "the information contact book between institutions for drug proper use" and the future problem 垣越咲穂1, 鈴木亮平1, 脇田恵里1, 佐合健太1, 杉浦有香1, 井上佑美1, 小島あゆみ1, 長岡宏一1, 深津哲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1087-1087, 2017.

---

	P0661-3-PM. Hold a "disaster relief pharmacist" workshop in Nagano Hokushin area; and than ... questionnaire results ... 滝澤康志1,9, 近藤智幸2,9, 追木正人3,9, 小林映子4,9, 下石和樹5,9, 雪本江里子6,9, 安藤和佳子7,9, 森一博8,9 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1088-1088, 2017.

---

	P0663-3-PM. It is ... for enforcement and improvement of the joint disaster training with the neighborhood pharmacy service under health insurance drugstore in disaster-response ability of evaluation - local pharmacist 中谷亮介1, 満田正樹1, 楠本梨賀1, 石本昌裕1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1089-1089, 2017.

---

	P0662-4-AM. Hold correspondence and problem ... great scale disaster correspondence workshop of the pharmaceutical products supply at disaster; and ... 坂田智美1, 渡辺瑞貴1, 家田正子1, 森下彩香1, 中嶋瀬里奈1, 石原慎1, 市村衣梨1, 西之坊実里1, 吉田宏二1, 吉年正宏1, 月岡康行1, 森嶋祥之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1090-1090, 2017.

---

	P0665-3-PM. The palliative care education of the pharmacy school business trainee and examination about the knowledge acquisition 神原諒1, 中山英夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1092-1092, 2017.

---

	P0667-3-PM. An attempt and problem of our hospital for the revision model core curriculum 貝嶋亮1, 大谷木俊吾1, 横田敬之1, 新井優1, 小泉盛1, 野田幸一1, 小岩まの1, 永野浩之1, 宇都宮暁1, 林良行1, 岸野亨1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1093-1093, 2017.

---

	P0669-3-PM. Efforts to the long-term business training along the new core curriculum in our hospital 坂本英之1, 石丸隆之1, 古賀清弘1, 谷川昇1, 田中早穂子1, 野中敏治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1093-1093, 2017.

---

	P0671-3-PM. Questionary survey about the usefulness of the visit to other institutions in the pharmacy business training 先崎郁美1, 児玉暁人1, 今井兼貴1, 高橋文香1, 八尾祥子1, 森信介1, 和田恭一2, 老田章2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1094-1094, 2017.

---

	P0673-3-PM. Examination of the current situation and the task which we saw through pharmacy trainee after graduation course investigation 小野寺健1,2, 松浦誠1,3, 南川賢治1,4, 三浦裕恵1,5, 三浦清明1,6, 三浦俊弘1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1094-1094, 2017.

---

	P0675-3-PM. Pharmacy business training utilizing project learning and the portfolio 形部文寛1, 谷口智美1, 杉山健二郎1, 岡本明日佳1, 橋本修1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1095-1095, 2017.

---

	P0666-4-AM. Efforts of the joint workshop holding about cancer treatment for the hospital in the area and a drugstore pharmacy trainee, a hospital and the drugstore pharmacist 大久保晃樹1,2, 東條唯1, 大野真理1, 横山博久1, 初瀬貴祐1, 上大薗智徳1, 南裕司1, 今奈良明人2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1096-1096, 2017.

---

P0668-4-AM. Accumulation comparison - of the questionnaire for comparison - past seven years of the evaluation of the satisfaction of a student for the hospital training in University of Shizuoka and the instruction pharmacist 内野智信1, 平井啓太2, 宮嵜靖則1, 井上和幸2, 辻大樹2, 谷澤康玄3, 山田浩4, 伊藤邦彦2, 賀川義之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1097-1097, 2017.

---

	P0670-4-AM. To be the best, and to prepare for the exciting stage making (the second report) - of the lube Rick evaluation in the formulations training; ... 渡邉正教1, 日笠淳一1, 中沢修司1, 日比徹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1097-1097, 2017.

---

	P0672-4-AM. Trial investigation of 2 drugstore experiences type business training aiming at equalization of participation, experience-based type training contents 津田真弘1, 大澤史宜1, 山下富義1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1098-1098, 2017.

---

P0674-4-AM. The current situation investigation in the long-term business training in the Kumamoto University faculty of medicine hospital for the revision model core curriculum 中村純平1, 成田勇樹1,2, 城野博史1, 政賢悟1, 西澤裕美1, 清住友香1, 中村有紀子1, 橋口ゆみ1, 山下諒祐1, 山本珠美1, 山辺雄太1, 相澤実里1, 大坪謙一1, 高林学1, 玉野井祥子1, 児島強1, 本田義輝1, 齋藤秀之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1098-1098, 2017.

---

	P0676-4-AM. Effect - that CYP1A2 genetic polymorphism gives to the caffeine pharmacokinetics out of education material study - saliva for family pharmacist upbringing 坂口友唯1, 競和佳2, 今井美穂2, 木下健司2, 村田成範2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1099-1099, 2017.

---

	P0678-4-AM. Examination of the learning result through for the first time annual education and the early on-site training 永田隆之1, 吉田進1, 住谷賢治1, 福地祐司1, 石川暁志1, 吉川真一1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1100-1100, 2017.

---

	P0680-4-AM. Study support for the 6-year pharmacists who are a graduate in our hospital 坂口裕子1, 木本有香1, 舩越真理1, 土谷有美1, 津田正博1, 高松宏治2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1100-1100, 2017.

---

	P0682-4-AM. The pharmacist duties on-site training in "a team approach in medical care on-site training" of the faculty of medicine 1 annual and the effect 鈴木仁志1, 紫桃祐造1, 柴田近2,3, 大野薫3, 薄井健介1,4, 岡田浩司1,4, 渡辺善照1,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1101-1101, 2017.

---

	P0684-4-AM. Efforts to new face educational program in our hospital 一瀬ひろみ1, 立道貴清1, 馬場亨1, 水川奈己1, 鈴木聖1, 辻繁子1, 冨田淳子1, 加地雅人1, 小坂信二1, 芳地一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1101-1101, 2017.

---

	P0686-4-AM. Effects such as pharmaceutical products education or the prevention of drug abuse education, and the like to junior and senior high school students by drug letter distribution and the consultation drugstore setting and a protector 中川璃子1, 大柳賀津夫2, 松下良3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1102-1102, 2017.

---

	P0688-4-AM. Inspection of practice of the case-based active learning using a clicker and the learning effect 仁木一順1, 幡生あすか1, 南園真哉1, 上島悦子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1102-1102, 2017.

---

	P0690-4-AM. Examination of the pharmacist lecture in the heart disease classroom 潟永安亘1, 谷口潤2, 下澤那津2, 東島彰人2, 草葉一友1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1103-1103, 2017.

---

	P0677-3-PM. Summary of case study workshop two years for pharmacists of Okinawa 大澤友二1,2, 潮平英郎3,4, 伊差川サヤカ3,4, 古謝さなえ3,4, 中尾滋久4, 玉城武範4, 小島進4, 砂川智子3,4, 外間登3,4, 外間惟夫3,4, 中村克徳3,4, 小武家優子5, 大光正男5, 吉武穀人5, 亀谷浩昌4, 田場英治4, 神村武之4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1104-1104, 2017.

---

	P0679-3-PM. For postgraduate education enforcement of attitude survey - aromatherapy about the aromatherapy of the pharmacist - 梅田純代1, 柳本ひとみ2, 黒澤菜穂子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1105-1105, 2017.

---

	P0681-3-PM. An attempt of the experience-based Evidence-based Medicine (EBM) education for a pharmacist, pharmacy students and the evaluation 上田昌宏1,2, 豊山美琴3, 大森志保4, 高垣伸匡5, 清水忠4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1105-1105, 2017.

---

	P0683-3-PM. Result and problem of the new face educational program to reach the third year 坂東佳汰1, 山下友也1, 比嘉耕基1, 徳留章1, 早坂敬明1, 木明貴幸1, 武田清孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1106-1106, 2017.

---

	P0685-3-PM. Look back on the holding of "the children medicine classroom" 浦上勇也1, 池田貴司1, 河田由紀子1, 大喜多美智代1, 富田伊津子1, 山本和幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1106-1106, 2017.

---

	P0687-3-PM. Establishment of the new face pharmacist education system by the mentor system 辻村行啓1, 矢部勝茂1, 塩川満1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1107-1107, 2017.

---

	P0689-3-PM. About the clinical pharmacist upbringing curriculum mainly on upbringing of the multicenter case study, independence 寺山義泰1, 舩津久美1, 中村英子1, 白石範子1, 林みどり1, 廣井順子1, 八木原栄1, 石原溶子1, 越田晃1, 松本啓一2, 松本智子2, 城田幹生2, 山村康比古2, 安藤恵2, 山口智2, 塩地園代2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1107-1107, 2017.

---

	P0691-4-PM. Usefulness of the checking prescription based on the clinical test value 鈴木芳1, 大塚恵理子1, 藤原涼1, 佐藤雄己1, 伊東弘樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1108-1108, 2017.

---

	P0693-4-PM. The enforcement situation investigation of doubt inquiry for the foreign prescription in the Iizuka Hospital 長崎皓光1, 山口健志1, 内田守次1, 梅田勇一1, 金澤康範1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1109-1109, 2017.

---

	P0695-4-PM. Analysis of the doubt inquiry contents accompanied with the change to the prescription input on the basis of the quantity of once in the Mie University faculty of medicine hospital 熊野理奈1, 杉本浩子1, 岩本卓也1, 奥田真弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1109-1109, 2017.

---

	P0697-4-PM. The current situation investigation for the simple suspension method introduction 本郷知世1, 加藤一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1110-1110, 2017.

---

	P0699-4-PM. About a stable change when we added an excipient to a tablet crush thing 門野冴美1, 金澤沙衣1, 菅大地1, 稲垣貴裕1, 佐藤弘康1, 和泉秀明1, 田村広志1, 渡辺浩明1, 佐藤隆司2, 渡辺一弘2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1110-1110, 2017.

---

	P0701-4-PM. Examination ... of the validity by confirming all efforts ... order to improve the effectiveness, safety of the medical therapy 吉田明弘1, 枝廣茂樹2, 下山真樹子3, 野村真里1, 藤原洋介1, 山田憲和1, 中村智子1, 吉川知世1, 吉村直人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1111-1111, 2017.

---

	P0703-4-PM. Decrease in false instruction effect by the pharmaceutical instruction to the outpatient using the prescription automatic comparison system 冨岡謙二1, 黒崎由希子1, 小坂若那1, 淀川進也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1111-1111, 2017.

---

	P0705-4-PM. Usefulness of doubt inquiry using the prescription check system of the test value interlocking movement type 冨田猛1, 山本和宏1, 野崎晃1, 宇田篤史1, 阪上倫行1, 西岡達也1, 久米学1, 槇本博雄1, 平井みどり1, 矢野育子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1112-1112, 2017.

---

	P0707-4-PM. Examination of the usefulness of the operation with the checking prescription assist system associated with the clinical test value mention inside the hospital prescription and renal function 齋藤佳奈1, 徳丸隼平1, 山口晃司1, 栗島直希1, 佐々木琢也1, 橋本真也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1112-1112, 2017.

---

	P0709-4-PM. The construction of the formulations record system by Time-lapse photography and inspection of the effectiveness 竹下龍次1, 立石裕樹1, 田中博和1, 井上幸子1, 平川雅章1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1113-1113, 2017.

---

	P0711-4-PM. Efforts of the adequacy of the drug administration to the decreased renal function patients 笠松依子1, 好川隆志1, 中根論士1, 高嶋孝次郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1113-1113, 2017.

---

	P0713-4-PM. [de-] Rebuilding of the 365 days injection formulations system with the injection drug automatic withdrawal device 六波羅孝1, 伊藤賢治1, 下平美紀1, 伊藤陽一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1114-1114, 2017.

---

	P0715-4-PM. Effect of preventive measures against dispensing errors by using formulations inspection system at inspection 多賀小枝子1, 吉村知哲1, 木村美智男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1114-1114, 2017.

---

	P0717-4-PM. Efficiency and usefulness of duties by the powdered medicine formulations robot introduction 岸本幸次1, 吉田咲紀1, 米田勇太1, 田中待紀1, 北野こずえ1, 小川充恵1, 山崎肇1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1115-1115, 2017.

---

	P0719-4-PM. Efforts of the pharmacist in the radioisotope examination 橋沢幸佑1, 前川友宏1, 高橋治樹1, 舟越亮寛1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1115-1115, 2017.

---

	P0721-4-PM. Inspection of the dispensing error prevention effect by the image inspection system introduction 岩田真子1, 青柳和代1, 関口陽子1, 小柳邦弘1, 粉川直明1, 高村誠1, 水野友紀子1, 山岸宏和1, 今成拓1, 五十嵐詠美1, 南場信人1, 鈴木さくら1, 矢吹剛1, 寺口敦1, 中嶋真希1, 貝瀬眞由美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1116-1116, 2017.

---

	P0723-4-PM. Examination of use investigation by the powdered medicine formulations robot (DimeRo) introduction and the effective operation 田畑裕和1, 嘉屋則子1, 稲垣育宏1, 柴波明男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1116-1116, 2017.

---

	P0692-5-AM. Construction of PBPM accompanied with the agent type change at the oral medicine transluminal administration 白坂友基1, 釜澤雄太1, 小林薫1, 伊藤宏彰1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1117-1117, 2017.

---

	P0694-5-AM. A classification and change over time of the contents using the doubt inquiry record function of the electronic medical chart 五十嵐詠美1, 青柳和代1, 関口陽子1, 岩田真子1, 小柳邦弘1, 粉川直明1, 高村誠1, 水野友紀子1, 山岸宏和1, 今成拓1, 南場信人1, 鈴木さくら1, 矢吹剛1, 寺口敦1, 中嶋真希1, 貝瀬眞由美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1118-1118, 2017.

---

	P0696-5-AM. Cost effectiveness about the medical security by the automatic formulations inspection system introduction 波々壁信也1, 飯島夏希1, 石丸勝之1, 村上咲妃1, 望月真太郎1, 山内拓2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1118-1118, 2017.

---

	P0698-5-AM. Result and problem by the compounding of medicines start of the set according to the parenteral injection individual of 24 hours 石井佳代子1, 泉澤友宏1, 関根綾子1, 松本明子1, 島崎博士1, 勝俣はるみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1119-1119, 2017.

---

	P0700-5-AM. Comparison of the formulations loss rate at dosage form change of the levetiracetam with the ketogenic diet therapy 菅寛史1, 矢嶋隆宏1, 山本吉章1, 中井正彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1119-1119, 2017.

---

	P0702-5-AM. The current situation investigation of the checking prescription in Nara Medical University Hospital 田村曉識1, 池田和之1, 吉川一吾1, 辻力夫1, 杉山幸正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1120-1120, 2017.

---

	P0704-5-AM. Study on combination advisability with magnesium oxide at simple suspension of the ACE inhibitor 高野由博1, 西村貴正2, 井戸田陽子2, 小山智志2, 矢野健太郎2, 荻原琢男1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1120-1120, 2017.

---

	P0706-5-AM. The effect that printing of the drug information of the injection prescription gives in prescription checking 中澤香子1, 田邊裕美子1, 三澤昭彦1, 荒川圭子1, 鈴木直人1, 外山聡1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1121-1121, 2017.

---

	P0708-5-AM. Effect of the test value notation to a prescription and doubt inquiry utilized the inspection system 服部真奈1, 杉浦龍也1, 森智規2, 守田覚1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1121-1121, 2017.

---

	P0710-5-AM. Efforts of the drug proper use to the decreased renal function patients in our center 的場美香1, 津田武典1, 川下絵莉香1, 橋本佑香1, 富士芳美1, 立川奈保美1, 高木麻里1, 吉田智江1, 田中恵美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1122-1122, 2017.

---

	P0712-5-AM. Enforcement of the doubt inquiry support protocol by the hospital pharmacist 八島菜摘1, 岡本知子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1122-1122, 2017.

---

	P0714-5-AM. Chemical structural formula evaluation for parenteral injection incompatibility predictions 伊藤哲也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1123-1123, 2017.

---

	P0716-5-AM. Prescription doubt referral efforts carried out based on clinical test value written by a hospitalization prescription 飯田真由巳1, 西條雅美1, 仲則和1, 本田一春1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1123-1123, 2017.

---

	P0718-5-AM. About the effect to usefulness and the preparation duties of the simple suspension method that used ultrasonically vibrating it 土江亜季1, 松尾世為子1, 中尾元紀1, 畝佳子1, 向井啓2, 辻琢己2, 森英人3, 覺野律1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1124-1124, 2017.

---

	P0720-5-AM. About new efforts using the allergic information of the inpatient 本多明香里1, 日高博司1, 中嶋友代1, 齋藤暢人1, 植松翠1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1124-1124, 2017.

---

	P0722-5-AM. Efforts of the drugstore pharmacist for the renal function test value described in outside Parliament prescription 畠山規明1,2, 炭岡孝志2, 鶴田悦子1, 森博美1, 松野英子1, 星谷卓男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1125-1125, 2017.

---

	P0724-5-AM. Proper use of a doubt inquiry and pharmaceutical products by the clinical test value indication to a prescription 北侑未1, 多賀志乃1, 才田絢加1, 山田留美子1, 藤崎幸代1, 台蔵剛志1, 虎瀬和子1, 小野陽介1, 下川千賀子1, 山田千代子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1125-1125, 2017.

---

	P0725-4-PM. Effect to give to serum copper of oral zinc and the zinc injection administration 尾崎正和1, 田中惇一1, 見元尚1, 赤松順1,2, 筒井由佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1126-1126, 2017.

---

	P0727-4-PM. Hospital preparation (the second report) - clinical use report, evaluation - of the intermediate report in the Kitasato University Hospital 東信太朗1, 友田吉則2, 引地文1, 坂倉智子1, 近藤留美子1, 厚田幸一郎1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1127-1127, 2017.

---

	P0729-4-PM. The use situation of voriconazole eye drops in our hospital 高濱啓太1,2, 山田邦夫1, 中村郁勝1, 内田和孝1, 堤孝之2, 光田緑2, 森岡淳子1, 松本光希2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1127-1127, 2017.

---

	P0731-4-PM. Pharmacokinetic examination of the trazodone bougie in healthy adults 八瀬恵理子1, 山下大輔1, 山川宣2, 壷阪直子1, 續木康夫1, 福島昭二3, 関本裕美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1128-1128, 2017.

---

	P0733-4-PM. The risk of the microbial contamination in preservative non-component eye drops of the hospital preparation 下野梨麻1, 税所篤行1, 尾家重治2, 木村和博3, 古川裕之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1128-1128, 2017.

---

	P0735-4-PM. Examination of the medicinal solution change at mixture of the parenteral injection 増渕龍一郎1, 鈴木隆寛1, 中村秀三1, 渡邊紘子1, 赤羽正之1, 岩瀬利康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1129-1129, 2017.

---

	P0737-4-PM. Examination about the improvement of the gel plasticity of the methylcellulose solution 下山哲哉1, 磯貝純1, 伊藤邦彦1, 小林道也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1129-1129, 2017.

---

	P0739-4-PM. A preparation and evaluation of the drug fine particles with the drug release control function to apply to an orally disintegrating tablet 池田有希1, 池内由里1, 村永綾1, 太田美鈴2, 小林文香3, 大貫義則4, 日高慎二2, 大西啓1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1130-1130, 2017.

---

	P0726-5-AM. Stability of right or wrong and the preparation of the borax addition to aluminum chloride liquid hospital preparation prescription 大野修司1, 山内理恵1, 竹場和代2, 川崎智子2, 北岡晃2, 渡邉雅行1, 久保元1, 浅井和範1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1131-1131, 2017.

---

	P0728-5-AM. The effect that difference in preparation composition gives to stability of the indometacin oral cavity spray 田澤佑基1, 鏡圭介1, 渡辺祐子1, 久保田康生1, 原田幸子1, 小林正紀1, 山田武宏1, 井関健1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1132-1132, 2017.

---

	P0730-5-AM. Relation to use results investigation based on a hospital preparation ethic guideline 浦野敦1, 高嶋加奈子1, 小野田稔久1, 佐野君芳1, 真坂亙1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1132-1132, 2017.

---

	P0732-5-AM. It is an example using the Mohs ointment for a skin invasive cancer 高橋未來1, 中田和宏1, 加藤知孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1133-1133, 2017.

---

	P0734-5-AM. The making of the Beclometasone dipropionate enteric coated drug using the aciduric capsule and examination of the quality 工藤香澄1, 工藤唯1, 鈴木裕之2, 内田敬3, 猪岡京子3, 我妻恭行1, 高村千津子3, 中村仁2, 鈴木常義1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1133-1133, 2017.

---

	P0736-5-AM. Evaluation of preparation properties of the morin-containing gelation nano emulsion 松原巧1, 池内由里1, 松原弘明1, 小林文香2, 岩本美絵3, 大西啓1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1134-1134, 2017.

---

	P0738-5-AM. Development of pharmaceutical products off-label use aiming at an offer of the reliable safe medical therapy and the special preparation handling procedure 松本紗織1, 川俣洋生1, 三好孝法1, 矢野篤次郎2, 安部初美2, 入江健司1, 松尾尚美1, 小田原真希1, 鶴山萌子1, 平木洋一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1134-1134, 2017.

---

	P0740-5-AM. Stirring operation to give to the characteristic of the ointment which assumes vaseline a basis and effect of the temperature 三木奏人1, 田路隆了1, 湯谷玲子1, 寺岡麗子1, 坂根稔康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1135-1135, 2017.

---

	P0742-5-AM. Example of the brown alien substance mixture of the tramadol OD tablets that a cause was found to production raw materials by the product objection from a pharmacist 大久保美穂1, 大久保正2,3, 田中真理子3, 大久保七枝4, 大久保節子5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1136-1136, 2017.

---

	P0744-5-AM. For the pharmaceutical products management of the world standard 土肥大典1, 鍵山智樹1, 新屋夏希1, 真壁秀樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1136-1136, 2017.

---

	P0746-5-AM. Effect on indomethacin capsule elution rate of the auxiliary pharmaceutical adjuvant 栗林和美1, 中川慧1, 沼津郁果1, 高畠亨2, 水野恵司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1137-1137, 2017.

---

	P0741-4-PM. Rheology properties of the salicylic acid vaseline ointment accompanied with the mixture with other agents and percutaneous absorption-related change 湯谷玲子1, 田原花奈子1, 宍戸康剛1, 寺岡麗子1, 北河修治2, 坂根稔康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1138-1138, 2017.

---

	P0743-4-PM. Stability of famotidine in the hyperalimentation 久保儀忠1, 大森仁2, 谷口はるか1, 小林大祐1, 柴山良彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1139-1139, 2017.

---

	P0745-4-PM. Advisability of the simple suspension method application of new proton pump inhibitor, Takecab tablets 石田志朗1, 伊藤達哉1, 武藤浩司2, 山川和宣1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1139-1139, 2017.

---

	P0747-4-PM. Viscous and stable evaluation at warming of the ethanol non-component docetaxel preparation 浅見祥崇1, 下山哲哉1, 杉浦央2, 斎藤由起子2, 近藤覚也2, 伊藤邦彦1, 小林道也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1140-1140, 2017.

---

	P0750-5-AM. 1 case that repeated the asthmatic attack with the nonsteroidal antiinflammatory drug 柴田健太1, 本田隼人1, 中田和宏1, 加藤知孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1142-1142, 2017.

---

	P0752-5-AM. Efforts - drug global assessment adjustment addition to the polypharmacy in the convalescent ward increases; or ... 副島將司1, 織田雄一郎1, 北菜奈1, 小川大輔1, 三苫薫梨1, 中野聡1, 嶋彩夏1, 高橋瑞季1, 山本大策1, 海瀬有沙1, 深田充知1, 上野遥香1, 古田裕子1, 越川智子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1142-1142, 2017.

---

	P0754-5-AM. One case that developed drug-related pseudo aldosteronism by Polypharmacy 西山祐美1, 吉岡睦展1, 中川史絵1, 杉生雅和1, 小林敦子2, 辻隆志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1143-1143, 2017.

---

	P0756-5-AM. Attitude survey of the physician for the polypharmacy 佐藤拓行1, 松葉康利1, 野口宣之2, 小田慎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1143-1143, 2017.

---

	P0758-5-AM. In-hospital manual preparation for the dementia night delirium, unrest 里見彩1, 若林厚史1, 辻依利1, 上村円香1, 田畑寛明1, 猿谷淳1, 向一美1, 地野幹子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1144-1144, 2017.

---

	P0760-5-AM. Efforts to the polypharmacy of the elderly inpatient 竹内和沙1, 向井聡志1, 小島佑太1, 岩下尚弘1, 荒井宏人1, 松田俊之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1144-1144, 2017.

---

	P0762-5-AM. Efforts to a fall, the delirium risk reduction with the sleeping drug 古川大樹1, 長谷川雅哉1, 川口美香2, 伊藤孝紀3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1145-1145, 2017.

---

	P0764-5-AM. Consideration from the calculation situation of the discharge drug global assessment adjustment addition in our hospital 高桑直子1, 高橋喜統1, 丹羽修1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1145-1145, 2017.

---

	P0766-5-AM. One consideration about the factor of the polypharmacy in the convalescent rehabilitation ward 保坂早紀1, 林宏行2, 小瀬英司2, 高根貴子1, 細田矢佳1, 岡添進1, 矢嶋美樹3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1146-1146, 2017.

---

	P0768-5-AM. The effect that the inhalational instruction of the pharmacist results in in inhalational adherence 市原真紀1, 加賀正基1, 内山真美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1146-1146, 2017.

---

	P0770-5-AM. Examination of the pharmaceutical intervention in the patients autoregulation pain relief 岩本真拡1, 平田一耕1, 鈴木正論1, 舟越亮寛1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1147-1147, 2017.

---

	P0772-5-AM. Investigation of the pharmaceutical intervention in the cardiovascular surgery ward 原田澪1, 福島将友1, 曽我弘道1, 富田敏章1, 町田聖治1, 入江利行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1147-1147, 2017.

---

	P0774-5-AM. About 1 case that liver function abnormality was seen in by ward drug duties and hyperthyroidism of our hospital 山戸真子1, 佐々木智香1, 久保田厚子1, 末廣勉1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1148-1148, 2017.

---

	P0776-5-AM. Examination about the association of remedy, the discontinuation of the cerebral infarction onset and the antithrombotic drug in the orthopedics surgery in the Kochi medical center 岡崎弘志1, 田中広大1, 門口直仁1, 川田敬1, 山崎好恵1, 橋田真佐1, 段松雅弘1, 岡崎由紀1, 田中聡1, 沼本邦彦2, 時岡孝光2, 宮本典文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1148-1148, 2017.

---

	P0778-5-AM. Examination of the cutoff value of "the medication self-care" which assumed MMSE an index 近藤幸男1, 小西愛1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1149-1149, 2017.

---

	P0780-5-AM. Fact-finding of doubt inquiry to affect the hospitalization and release of the ward pharmacist in our center 早舩美保子1, 衣笠芳1, 瀧川美和1, 佐藤麻美子1, 瀬尾誠1, 甲斐田浩輔1, 谷古宇美佳1, 田中達郎1, 瀧川正紀1, 島崎良知1, 横井妙子1, 森淑子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1149-1149, 2017.

---

	P0782-5-AM. Role vol.2 of the pharmacist in the local inclusion care ward 佐々木優1, 矢倉尚幸1, 加藤鈴1, 湯本哲郎2, 稲葉健二郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1150-1150, 2017.

---

	P0784-5-AM. Efforts of the improvement in medication counseling calculation rate for pharmaceutical products needing safety management 宮森彩香1, 野村理恵1, 新藤学1, 加藤一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1150-1150, 2017.

---

	P0786-5-AM. Contribution of the ward pharmacist for the amiodarone-induced thyroid function abnormality 山田恵里1, 福澤翔太1, 片岡智美1, 千崎康司1, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1151-1151, 2017.

---

	P0788-5-AM. The establishment of the ward drug duties support system and the effect 平下智之1, 谷沢克弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1151-1151, 2017.

---

	P0790-5-AM. About the correspondence in the pharmacist when the health hazard by the side effect occurred 浮池聡子1, 中村愛2, 鶴崎泰史1, 山形真一1, 中川義浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1152-1152, 2017.

---

	P0794-5-AM. Duties improvement effect on number of calculation of drug control instruction charges 梅田勇一1, 加来菜津美1, 水之江早希子1, 崎山美津好1, 宗克彦1, 長崎皓光1, 野相まどか1, 堀井康玄1, 森高啓太1, 渡邉鮎子1, 金澤康範1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1153-1153, 2017.

---

	P0796-5-AM. An example of the prescription of drug suggestion intervention by the multi-type of job cooperation 小島香織1,2,3, 吉岡克幸1, 坂井田梨沙2, 千田沙季3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1153-1153, 2017.

---

	P0749-4-PM. The current situation of ward drug duties in the information on adverse drug reactions collection 池谷有紀子1, 小宮詠子1, 大森采菜1, 山内愛樹1, 赤津真衣子1, 坪谷綾子1, 松本浩1, 濱野公俊1, 坂下裕子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1154-1154, 2017.

---

	P0751-4-PM. The making of the pre-medication manual to the patients with a history of allergy to contrast media and the protective efficacy 清川真美1, 田嶋恭典1, 石田健太郎2, 夛田浩2, 渡邊享平1,3, 矢野良一1, 塚本仁1, 後藤伸之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1155-1155, 2017.

---

	P0753-4-PM. From the viewpoint of intervention effect on convalescent rehabilitation ward inpatient - circulatory organ therapeutic drug of the heart failure measures team - 吉田章悟1, 加藤豊範1, 友原たき子2, 加納直明3,5, 小田高司4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1155-1155, 2017.

---

	P0755-4-PM. Relation of the ward pharmacist in the oral medicine management of elderly people 田村奈美子1, 吉政直美1, 山内健1, 坂梨綾香1, 松本俊治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1156-1156, 2017.

---

	P0757-4-PM. Led by patients with fact-finding - dysphagia about the relation of the pharmacist in the convalescent rehabilitation ward - 大坪博子1,2, 熊木良太1, 赤川圭子1, 倉田なおみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1156-1156, 2017.

---

	P0759-4-PM. Examination - diuretics, H2 receptor blocker about the safe medical therapy of elderly people, efforts ... to the prescription adequacy of the sleeping drug 小松めぐみ1, 西村奈保1, 田島千愛1, 市川麻美1, 田所美和1, 吉岡りえ1, 市吉真貴子1, 八木亜紀子1, 田中照夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1157-1157, 2017.

---

	P0761-4-PM. About efforts to an on admission remedy drug in the circulatory organ medical service and the adequacy 長藤多香美1, 糸川知江1, 佐々木麻里2, 宮森伸一1, 小田登3, 柳田祐子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1157-1157, 2017.

---

	P0763-4-PM. Introduction ... of examination - polypharmacy measures of the ward drug duties in the respiratory chronic disease ward 佐々木文子1, 田中翔一1, 梶井孝洋1, 水口敦子1, 西澤修一1, 西川正直1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1158-1158, 2017.

---

	P0765-4-PM. Efforts for the improvement in quality of duties by the goal setting according to the individual of the ward pharmacist 関口徳志1, 後藤純一1, 有川真理1, 菅原拓也1, 加川美由紀1, 延川正雄1, 松田圭一郎1, 荒井浩一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1158-1158, 2017.

---

	P0767-4-PM. Comparison between evaluation and regular hospital of the prescription representation input duties in the convalescent rehabilitation ward corresponding to PBPM 吉村友里1, 砂金秀美2, 澤村忠輝1, 山階規子1, 鈴木晴久1, 吉野宗宏1, 杉山博3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1159-1159, 2017.

---

	P0769-4-PM. The current situation and effect of medical treatment management (PBPM) based on the protocol 陸丸幹男1, 大塚愛美1, 原尻学志1, 森一生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1159-1159, 2017.

---

	P0771-4-PM. Effect on blood pressure between the drug of the levodopa combination drug 倉林誠1, 冨田昌志1, 阿部孝行1, 池井良貴1, 中山智央2, 伊藤規絵2, 大久保由希子2, 山田英俊1, 千葉進2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1160-1160, 2017.

---

	P0773-4-PM. Efforts and problem to the polypharmacy in the acute phase hospital 菅直恵1, 石橋さやか1, 岡野和真1, 楢原由生未1, 柳本正憲1, 岡本理恵子1, 若松佳子1, 益本周治1, 高柳和伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1160-1160, 2017.

---

	P0775-4-PM. For improvement of the pharmaceutical intervention utilizing the template 満永大輔1, 垣添和弘1, 末武弘至1, 井無田優1, 渡部善博1, 吉原郁夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1161-1161, 2017.

---

	P0777-4-PM. Examination of the optimal dosage form in the childhood transluminal administration using the passage sex test 清水善仁1, 高橋喜統1, 高瀬文超1, 多賀允俊1, 丹羽修1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1161-1161, 2017.

---

	P0779-4-PM. Inspection of the drug control method of the inpatient in our center 團優子1, 合田泰志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1162-1162, 2017.

---

	P0781-4-PM. Evaluation of the pharmaceutical intervention to the polypharmacy in the local inclusion care bed 小玉博一1, 西平和子1, 安田智之1, 井尻香織1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1162-1162, 2017.

---

	P0783-4-PM. Construction and evaluation of the new face pharmacist education system to take ward duties on 大東敏和1, 檜山洋子1, 上代大地1, 柴田ゆうか1, 佐伯康之1, 松尾裕彰1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1163-1163, 2017.

---

	P0785-4-PM. Outcome analysis of the prescription suggestion in the ward duties of the pharmacist 菅原拓也1, 後藤純一1, 関口徳志1, 有川真理1, 延川正雄1, 松田圭一郎1, 荒井浩一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1163-1163, 2017.

---

	P0787-4-PM. Efforts for the current situation and the duties efficiency of the ward pharmacist duties in the urologic ward 高橋隆一1, 関礼輔1, 田島紳介1, 篠原高雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1164-1164, 2017.

---

	P0789-4-PM. Relation to efforts and a nursing necessary degree for the ward drug duties enforcement addition calculation of our hospital 安福平1, 松山哲史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1164-1164, 2017.

---

	P0791-4-PM. We manage the reopening of the antithrombotic drug after the operation in our hospital urology department 久保田聡1, 佐野裕司2, 吉田涼平1, 荒井梨江1, 春山幸子1, 金澤温子1, 満木由布菜1, 塩見めぐみ1,2, 田中庸一1,2, 渋谷清1,2, 久保田理恵1,2, 尾鳥勝也1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1165-1165, 2017.

---

	P0793-4-PM. The intervention of the pharmacist in the perioperative care team and the effect 石久保義紀1, 嶋田紘也1, 平岩知子1, 市川敬太2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1165-1165, 2017.

---

	P0795-4-PM. Survey of doubt inquiry in the ward 稲沢薫1, 小笠原蓉子1, 佐藤圭吾1, 西和哉1, 佐賀利英1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1166-1166, 2017.

---

	P0797-4-PM. Pain evaluation at the erythropoietin preparation hypodermic injection in neonates 戸羽香織1,2,3, 山本枝美1, 長澤朋子2, 葛西香織2, 原山千穂子2, 小野寺幸子3, 内田俊彦3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1167-1167, 2017.

---

	P0799-4-PM. Cooperation with the multi-type of job in the practice of the haemodialysis patients that developed cerebral infarction 徳永貴之1, 槇山翔太1, 河田武志1, 小池恭正1, 濱岡照隆1, 佐藤穣1, 宮田香奈子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1168-1168, 2017.

---

	P0801-4-PM. The serious addition computation in the high care unit 鹿沼奈央1, 増田博也1, 新山綾子2, 久岡清子1, 中村正人3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1168-1168, 2017.

---

	P0803-4-PM. It is ... through the operation of efforts - home discharge pass to improvement of the medication adherence in the stroke acute phase 清水誉志1, 藤野真利子1, 山下悟史1, 福島将友1, 富田敏章1, 町田聖治1, 入江利行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1169-1169, 2017.

---

	P0805-4-PM. Investigation about the effect on pharmaceutical support by the ICU sojourn time of the pharmacist increasing 福島将友1, 前田朱香1, 曽我弘道1, 福地祐亮1, 清水誉志1, 富田敏章1, 町田聖治1, 入江利行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1169-1169, 2017.

---

	P0807-4-PM. Three-drug incompatibility test of the general-purpose injection drug in the critical care center 近藤匡慶1, 小澤正弥2, 玉木綾音2, 菅谷量俊1, 長野槙彦1, 津田充穂1, 田杭直哉1, 田上隆3, 久野将宗3, 畝本恭子3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1170-1170, 2017.

---

	P0809-4-PM. One case of the cardiopulmonary arrest case by the fentanyl patch large quantities pasting 吉川博1, 佐藤智人1, 福島隆宏1, 畝井浩子1, 松尾裕彰1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1170-1170, 2017.

---

P0811-4-PM. Administration of dry people in warfarin administration average blood clotting ninth factor complex experience for the acute subdural hematoma with the ventricular assist device wearing patients 奥村佳史1,5,6, 木村麻奈加1,5,6, 清水亜花音1,5, 浦上悠1,5, 中島康佑2,5,6, 井上航一3,6, 平岡有努3,6, 林田晃寛4,5,6, 森田孝子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1171-1171, 2017.

---

	P0813-4-PM. Experience the hydrogen sulfide inhalation accident by examination - science experiment at a lot of patients with poisoning conveyance for pharmacy; and ... 宮崎雄紀1, 林美和子1, 松原ちはる1, 水谷妙子1, 酒井美香1, 網野一真1, 小口正義1, 登内盛治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1171-1171, 2017.

---

	P0815-4-PM. Intervention of the perioperative drug administration in the myasthenia gravis 野田貴義1, 勝又博司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1172-1172, 2017.

---

	P0798-5-AM. Evaluation of our hospital TPN cipher prescription in the NICU and ward drug duties 新井田サヤカ1, 丸山沙緒里1, 長江美奈1, 松浦詩麻1, 山崎友朗1, 平野桂子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1173-1173, 2017.

---

	P0800-5-AM. Effect to give to pharmaceutical products proper use of the pharmacist permanent residence in NICU, GCU 松崎芙実子1, 細野萌子1, 小山美菜1, 鈴木智尋1, 鈴木文子1, 鈴木博也1, 千田真理巴2, 戸澤和恵2, 佐藤信一3, 佐藤真由美1, 赤坂和俊1, 大平貴子2, 埴田卓志3, 小原拓1, 眞野成康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1174-1174, 2017.

---

	P0802-5-AM. Fact-finding of patients with acute intoxication in our hospital 中村亜由美1, 小守陽介1, 鈴木正論1, 舟越亮寛1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1174-1174, 2017.

---

	P0804-5-AM. The prescription suggestion by the ICU exclusive duty pharmacist and the problem 國廣理菜1, 鈴木早苗1, 安藤和佳子1, 和久裕尚1, 池井健1, 堀部正記1, 遊見裕子1, 山岸雄幸1, 大谷仁士1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1175-1175, 2017.

---

	P0806-5-AM. Efforts to the pharmaceutical products management adequacy in the ICU 森雅之1, 昆貴志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1175-1175, 2017.

---

	P0808-5-AM. Examination about effect of treatment of the thrombomodulin alfa in patients with impaired renal function and the adverse event 岡部賢司1, 今浦将治1, 菅原悠佳1, 大村和也2, 永瀬怜司1, 高橋宏行2, 菅野浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1176-1176, 2017.

---

	P0810-5-AM. Effect on bacteremia examination of the antimicrobial proper use support of the intensive care unit admission patients 津山博匡1, 木村正彦2, 丹羽英智3, 橋場英二3, 廣田和美3, 萱場広之2, 下山律子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1176-1176, 2017.

---

	P0812-5-AM. Fact-finding of the sedative sedative management after the sedative sedative protocol introduction for the artificial respiration management patients in the critical care center 末森千加子1, 酒井美和1, 山田真人1, 太田あづさ1, 塩田恵1, 相生勇作1, 吉田直恵1, 鴻野公伸2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1177-1177, 2017.

---

	P0814-5-AM. About the usefulness of the pharmacist duties in the ICU in rest Sundays and holidays 寺松洋美1, 神一夢1, 冨澤淳1, 小林昌宏1,2, 近藤留美子1, 厚田幸一郎1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1177-1177, 2017.

---

	P0816-5-AM. Use of rasburicase fact-finding in the Shonan Kamakura General Hospital 星吉行1, 長岡和徳1, 仲鉢英夫1, 玉井洋太郎2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1178-1178, 2017.

---

	P0818-5-AM. Change of the use regimen in the Helicobacter pylori triple-drug therapy and sanitization rate 白石貴寿1, 沖田健太郎1, 臼井和明1, 近藤真由1, 松永里香1, 山村真貴子1, 安藤暢彦1, 上地純子1, 森田佳博1, 面田恵1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1179-1179, 2017.

---

	P0820-5-AM. Investigation about the safety, and the like of the suvorexant administration for elderly people 森田春香1, 吉川明良1, 中谷治規1, 開浩一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1179-1179, 2017.

---

	P0822-5-AM. It is ... for the diabetes medical treatment instruction that is better than relation ... of the pharmacist in the outpatient specialized in our hospital diabetes 茂木秀敏1, 金古成美1, 橋場弘武1, 中村保子2, 高玉真光3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1180-1180, 2017.

---

	P0824-5-AM. Memoir about the association of an incident and the sleeping drug of a fall, the fall in our hospital 村岡佑梨子1, 柿本真佑2, 河野修治1,2, 権藤直人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1180-1180, 2017.

---

	P0826-5-AM. The current situation investigation of the polypharmacy in our hospital and future efforts 山本修也1, 村上幸恵1, 今西明2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1181-1181, 2017.

---

	P0828-5-AM. Examination about the effectiveness and the safety of the low-dose orchid geo-roll 佐々木紀彰1, 古元俊徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1181-1181, 2017.

---

	P0830-5-AM. Questionary survey about the understanding degree after the medication counseling of the outpatient 四釜亮太1, 南真進1, 矢島功1, 松浦直嗣1, 小杉隆祥1, 松本直人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1182-1182, 2017.

---

	P0832-5-AM. Comparison ... before and after change - JSH2014 revision of the antihypertensive medications prescription trend in our hospital outpatient department 有木沙織1, 神崎浩孝1, 竹内英実2, 内田治仁2,3, 田中雄太1, 小川敦1, 西原茂樹1, 村川公央1, 和田淳2, 北村佳久1, 千堂年昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1182-1182, 2017.

---

	P0834-5-AM. Efforts (the second report) of the suvorexant introduction for the purpose of the reduction of a fall, the fall risk with the sleeping drug 平松祐哉1, 宮腰千紘1, 木南志朗1, 中島美治1, 伊藤仁1, 石田英明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1183-1183, 2017.

---

	P0836-5-AM. Comparison of the DOAC new prescription situation by the Idarucizumab release in our hospital 門野健二1, 木村順平1, 武田龍馬1, 山田和範2, 山澤裕司2, 本間和加子1, 中村博彦3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1183-1183, 2017.

---

	P0838-5-AM. About the Helicobacter pylori sanitization situation for patients having drug side effect history, and the like in our hospital 猿渡康宏1, 吉丸侑子1, 山本裕子1, 伊藤由希1, 寺本拓哉1, 赤坂綾1, 横山賢二1, 丸田佐知子1, 水本智子1, 平井裕子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1184-1184, 2017.

---

	P0840-5-AM. Attitude survey of patients about the clinical test value provided by a hospital 清水紗弥香1, 富岡佳久2, 庄野あい子3, 山内泰一4, 大木稔也1, 今井博久5, 佐藤秀昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1184-1184, 2017.

---

	P0842-5-AM. Examination about the proper use of combination tablets 松下久美1, 瀧祐介1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1185-1185, 2017.

---

	P0844-5-AM. Can the PTP mis-deglutition prevent it? Fact-finding ... to ... pharmaceutical company 山口美穂1, 遠山幸男1, 小島庸子1, 堀田菜摘1, 糖塚理恵1, 笠原大輔2, 西川佳友2, 久田達也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1185-1185, 2017.

---

	P0846-5-AM. Attitude survey of the protector about childhood bronchial asthma treatment 今野壮太1, 竹平理恵子1, 有田悦子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1186-1186, 2017.

---

	P0848-5-AM. Analysis - that we paid our attention to consciousness, confidence of the drugstore pharmacist for the hypertensive medical treatment support and "worth doing" and associated - "aggressiveness" of the tissue climate 南佐智1, 庄司雅紀1, 恩田光子2, 岡田浩3,4, 中川康司5, 坂根直樹3, 中山健夫4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1186-1186, 2017.

---

	P0850-5-AM. Summary of the use of NS5B polymerase inhibitor case in our hospital 濱里真耶1, 松本みゆき1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1187-1187, 2017.

---

	P0852-5-AM. Comparison between understanding degree of the prescription notebook and use situation investigation - event participation citizen and inpatient - 村中太郎1, 中村郁子2,3, 倉兼広樹1, 清水達矢1, 古川奈緒子1, 遠藤孝1,3, 澁川真由2, 大原宏司2, 高橋将喜3, 北村哲治3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1187-1187, 2017.

---

	P0817-4-PM. Examination about a use trend of the antiPseudomonas aeruginosa medicine and the change of the Pseudomonas aeruginosa-resistant rate 臼井和明1, 栗原江未1, 安河内寿成1, 吉田悦朗1, 大石丸美1, 宇都宮奈々1, 松永里香1, 宗本佐知子1, 白石貴寿1, 面田恵1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1188-1188, 2017.

---

	P0819-4-PM. Use stocktaking of the daptomycin in the orthopedics domain 新木貴大1, 磯辺浩和1, 島田泉1, 吉田謙介1, 鈴木直人1, 外山聡1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1189-1189, 2017.

---

	P0821-4-PM. Prescription investigation for the antidepressant and evaluation of the clinical pharmacy 片山陽介1, 小坂隆介1, 有川仁1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1189-1189, 2017.

---

	P0823-4-PM. Attitude survey ... for incompatibility ... nurses with the magnesium oxide preparation at simple suspension 長谷川彩1, 河原陽介1, 御子柴智聖1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1190-1190, 2017.

---

	P0825-4-PM. Investigation about the actual situation and the patients awareness of the polypharmacy in the health insurance pharmacy 亀山俊1, 重谷英寿1, 足立朋子1, 米川綾1, 佐藤知奈美1, 佐次田惇1, 村田まり子1, 早川美恵子1, 飯塚敏美1, 堀口雅巳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1190-1190, 2017.

---

	P0827-4-PM. Effect on osteoporosis treatment rate after the proximal thighbone bone fracture by the osteoporotic liaison service introduction 森崎崇文1, 星野輝彦1, 塩津和則1, 清田克彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1191-1191, 2017.

---

	P0829-4-PM. About the DOAC proper use situation investigation in the Saiseikai Futsukaichi Hospital 辻村啓史1, 中野祐樹1, 横尾賢乗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1191-1191, 2017.

---

	P0831-4-PM. Questionary survey about the medication refusal of the pediatric steroid internal use for medical persons 喜多朝菜1, 矢野涼子1, 熊木真理子1, 齋藤讓一1, 間瀬広樹1, 秋山哲平1, 溝神文博2, 太田和秀3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1192-1192, 2017.

---

	P0833-4-PM. The current situation investigation of the assist use for effective inhalational instruction 前澤佳代子1,2, 石畑耕士1, 田村拓也1, 原由梨香1, 加藤芳徳1, 伊東岳1, 杉山奈津子1,2, 白木晶3, 駒瀬裕子4, 百瀬泰行1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1192-1192, 2017.

---

	P0835-4-PM. The use of anticoagulant situation in patients with cerebral hemorrhage at admission 新沼佑美1, 阿部誠也1, 関さやか1, 佐藤直也1, 猪狩崇子1, 児山麻佑1, 栗村淳子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1193-1193, 2017.

---

	P0837-4-PM. Current situation - of the inhalant re-instruction in construction - fourth report Suita-shi of the inhalational instruction cooperation in Suita-shi 駒居真紀子1, 児玉暁人1, 森信介1, 辻文生2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1193-1193, 2017.

---

	P0839-4-PM. Effect (the second report) that the ketogenic diet therapy in patients with epilepsy (Atkins food strange law) gives to a combination antiepileptic drug 矢嶋隆宏1, 山本吉章1, 中井正彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1194-1194, 2017.

---

	P0841-4-PM. Start clinical test value mention to outside Parliament prescription; and attitude survey - of the local pharmacist by - questionnaire 田畑佳祐1, 森田紗代1, 垣尾尚美1, 玉置尚1, 南のどか1, 中須賀基1, 入江優美1, 植木彩1, 瀬川和子1, 辻本純子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1194-1194, 2017.

---

	P0843-4-PM. Fact-finding about the off-label use of pharmaceutical products in the Nagasaki University Hospital 黒崎友亮1, 室高広1, 橋詰淳哉1, 馬場安里1, 黄智剛1, 松丸由美1, 増山優紀1, 安岡しおり1, 中村忠博1, 佐々木均1, 北原隆志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1195-1195, 2017.

---

	P0845-4-PM. Can you discover the PTP mis-deglutition with X-rays? Inspection ... of an investigation and the radiolucency of ... PTP materials 小島庸子1, 遠山幸男1, 山口美穂1, 堀田菜摘1, 糠塚理恵1, 笠原大輔2, 山田将大3, 西川佳友2, 久田達也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1195-1195, 2017.

---

	P0847-4-PM. The taking drug situation affecting the relation of the pharmacist in the urination care team and the lower urinary tract function in the urination independence intervention patients 越野優希1, 田井達也1, 小川真梨1, 安宅可南美1, 山下紗矢佳1, 冨田淳子1, 加地雅人1, 朝倉正登1,2, 小坂信二1, 芳地一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1196-1196, 2017.

---

	P0849-4-PM. Analysis of inquiry contents about the subcutaneous infusion put than the pharmaceutical person concerned 佐々木美由紀1, 堀越由里1, 竹林佑花1, 津田朋枝1, 松田直子1, 星泉1, 吉岡小都子1, 岡崎哲也1, 福田まゆみ1, 河野裕則1, 岩原良晴1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1196-1196, 2017.

---

	P0851-4-PM. About the use situation of the Evolocumab in our hospital 山本諭1, 小田剛史1, 野井亜佐美1, 岩本佳代子1, 稲村勝志1, 南橋薫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1197-1197, 2017.

---

	P0853-4-PM. About the temporarily suspended attitude survey and current situation 鈴木美威瑠1,2, 滝澤大樹2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1197-1197, 2017.

---

	P0854-5-AM. Fact-finding - about the bringing of the drug in consideration of cancellation, a change of bringing medicine for elderly inpatient fact-finding - administration 諏訪万里菜1, 渋谷文則2, 新倉卓2, 高橋信2, 清海杏奈1, 中島由紀1, 杉浦宗敏1, 山村康比古2, 越田晃3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1198-1198, 2017.

---

	P0856-5-AM. The bringing medicine differentiation duties that collaborated with the nurse in the area short of pharmacists 竹谷美穂1, 菅野雄太1, 瓜智都1, 森本淳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1199-1199, 2017.

---

	P0858-5-AM. Examination about the drug proper use for elderly patients judging from bringing medicine differentiation in the medical service 千田紗弓1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1199-1199, 2017.

---

	P0860-5-AM. Prescription suggestion ... utilizing efforts - PIMs screening of the hospital pharmacist for the polypharmacy 佐藤由美1, 宮彩子1, 蛭川智晴1, 柴田彩佳1, 川井由貴1, 似内和也1, 佐藤裕司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1200-1200, 2017.

---

	P0862-5-AM. Development and duties improvement effect of the new bringing medicine input system in conjunction with a medical affairs system 三坂恒1, 原祐輔1, 岡本紘一2, 山岡紳介2, 嶋田努1, 崔吉道1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1200-1200, 2017.

---

	P0864-5-AM. Change investigation of the bringing medicine availability ratio before and after the bringing medicine center setting 二見早希1, 伊藤磨美1, 長谷川紗菜恵1, 原田千菜美1, 川口恵1, 北村悠里子1, 谷本香奈杏1, 村山蘭1, 吉住優里1, 土本寛子1, 石田あい1, 松下比奈子1, 久保智士1, 山崎瑞貴1, 鶴崎亮1, 今市沙有美1, 岡紗智子1, 木村真策1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1201-1201, 2017.

---

	P0866-5-AM. The construction of the bringing medicine differentiation system using Microsoft Excel and examination of the usefulness 川原裕1, 松本芳信1, 佐野雅昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1201-1201, 2017.

---

	P0868-5-AM. Efforts to medical security by the oral medicine management of the pharmacist 池田秀優1, 和田智美1, 宮内孝博1, 緒方雅章1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1202-1202, 2017.

---

	P0870-5-AM. Construction of the unitary administration management system which the bringing medicine to the electronic medical chart top included 本田弘1, 佐藤亜希1, 菅野照2, 高城大作2, 馬場義徳2, 加島典子3, 中島繁美1, 石山秀一4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1202-1202, 2017.

---

	P0855-4-PM. About operation of the bringing medicine in the Nagasaki medical center 綱脇徹意1,2, 植村隆1, 前田茂人2, 高田正温1, 東島彰人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1203-1203, 2017.

---

	P0857-4-PM. Participation of current situation investigation - hospital pharmacist of the polypharmacy of the elderly people who saw it from bringing medicine in our hospital and future problem ... 平野史1, 馬場亮一1, 岡田昌之1, 杉本悠花1, 成末まさみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1204-1204, 2017.

---

	P0859-4-PM. Effect to prescription temporary registration duties of the bringing medicine by the pharmacist and medical security 坪田有未1,2, 新谷智則1, 山下慎司1, 清川真美1, 五十嵐敏明1, 古俵孝明1, 渡邊享平1,2, 矢野良一1, 塚本仁1, 後藤伸之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1204-1204, 2017.

---

	P0861-4-PM. Is going to be operated on; examination for an evaluation and the subject clinical department expansion of the discontinuation instruction before operation in the patients 山崎夕貴1, 宮崎雄紀1, 水谷妙子1, 神戸千紘1, 田中文1, 唐澤綾1, 藤森和江1, 網野一真1, 小口正義1, 登内盛治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1205-1205, 2017.

---

	P0863-4-PM. Fact-finding study of the medication compliance in the elderly inpatient 中島章雄1,2, 坂元佑哉1, 藤木将勝1, 高瀬友美1,2, 宮崎元康1, 金子朋博1, 内山将伸1, 後藤美和1, 川原義弘1, 松尾宏一1,2, 今給黎修1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1205-1205, 2017.

---

	P0867-4-PM. 1 case of the transient complete atrioventricular block which was able to evade a pacemaker shrubbery by pharmacist intervention 花田聖典1, 下澤那津1, 高田正温1, 植村隆1, 東島彰人1, 松尾崇史2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1206-1206, 2017.

---

	P0869-4-PM. Participation in change and incident accident of the bringing medicine evaluation method in the Secomedic Hospital 渡辺孔明1, 吉田有貴子1, 長澤宏之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1207-1207, 2017.

---

	P0871-4-PM. About the search hit number of health hazard suspicion change until the day when a notice of MHLW is given by the penciled eyebrow 佐藤亜希子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1208-1208, 2017.

---

	P0873-4-PM. Efforts for the use situation and proper use of the health food 合田泰志1, 團優子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1209-1209, 2017.

---

	P0875-4-PM. Fact-finding about the use of health food of a university student, the high school student 荒井國三1, 橋本佳奈1, 柴田実香1, 玉田実花1, 浦田航希1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1209-1209, 2017.

---

	P0877-4-PM. The supplement which raises solubility of celecoxib 武田有紀1, 高見陽一郎1, 小松原早織1, 浦上知香1, 笹原莉子1, 島田倫栄1, 福島由貴1, 小川壮寛2, 安倉央2, 江川孝3, 島田憲一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1210-1210, 2017.

---

	P0872-5-AM. The supplement intake in general local inhabitants: Kakegawa cohort study 菊池大輔1,2, 小原拓1,3,4, 永井雅人4, 石黒真美4, 松原博子5, 水野聖士4, 山中千鶴4, 菊谷昌浩1,4, 渡辺善照2, 栗山進一1,4,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1211-1211, 2017.

---

	P0874-5-AM. About the attitude survey about the health food of the health food management person society citizen open lecture participant 山本勇樹1, 水谷一寿2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1212-1212, 2017.

---

	P0876-5-AM. Effect of the chitosan on uptake to Caco-2 cells of losartan potassium 岩崎綾乃1, 岡田弦也1, 阿部真理子1, 今井公江1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1212-1212, 2017.

---

	P0878-5-AM. Elution behavior and preparation evaluation of the general Famotidine orally disintegrating tablet based on a plasma concentration change after the oral administration to a rat 斉藤佑治1, 浅野由佳1, 加藤美紀1, 灘井雅行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1213-1213, 2017.

---

	P0880-5-AM. Trial manufacture of an attitude survey and the communication tool of the foreign tourist about pharmaceutical products made in Japan 木下淳1, 高橋稔1, 苫田彩佳1, 山田純也1, 松尾実菜1, 中村任2, 佐野智行3, 奥田寛3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1214-1214, 2017.

---

	P0882-5-AM. The current situation investigation of recognition and the expectation of local inhabitants for "the healthy support by the pharmacist" 畔原篤1, 後藤亮平2, 前野哲博2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1214-1214, 2017.

---

	P0879-4-PM. A study on proper use of the nonprescription drug: About the private brand of the pain-killer 宮地佑佳1, 横山沙和1, 仲山千佳1, 大嶋耐之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1215-1215, 2017.

---

	P0881-4-PM. Tension-type headache of the OTC medicine for the headache, effect on migraine headache, comparison of the user satisfaction 本屋敏郎1, 島居夏美2, 山下尚子3, 前薗裕美4, 倉澤克樹2, 田畑光一4, 吉村貴秀1, 河内明夫1, 園田純一郎1, 鳴海恵子1, 下堂薗権洋1, 佐藤圭創1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1216-1216, 2017.

---

	P0883-4-PM. Time of compounding, remedy-related evaluation accompanied with the drug agent type change to children 霍間尚樹1, 樋口利晴1, 池田考介1, 石川貢1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1217-1217, 2017.

---

	P0885-4-PM. Dissolution evaluation of the cabergoline tablets in the generic drug quality information review meeting 阿部康弘1, 吉田寛幸1, 伊豆津健一1, 合田幸広1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1218-1218, 2017.

---

	P0887-4-PM. Dissolution evaluation by the flow through cell method of the different ingredient preparation of the dosage form 永田佳子1, 石倉由紀子1, 藤木健行1, 金澤秀子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1218-1218, 2017.

---

	P0889-4-PM. Evaluation of the price range of the medicine charge in pharmaceutical products mixed with in-hospital adopted pharmaceutical products at a drugstore at a hospital 舘知也1,2, 齊藤康介1, 江崎宏樹1, 兼松勇汰1, 吉田阿希1, 杉田郁人1, 野口義紘1, 牧野哲平2, 梅田道2, 安田昌宏2, 水井貴詞2, 後藤千寿2, 寺町ひとみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1219-1219, 2017.

---

	P0891-4-PM. Effective and safe comparison of the starting pharmaceutical products and generic medicine of tacrolimus for the ulcerative colitis 今由香莉1,2, 船田茜1, 友寄旬1, 山下友輝1, 山本千秋2, 田中悠季1, 飛澤国広1, 小原秀治1, 小原郁司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1219-1219, 2017.

---

	P0893-4-PM. It is examination about the vascular pain in the change of the gemcitabine infusion liquid "Hospira" from the one for gem Saar injection 遠藤征裕1, 山田郁恵1, 平泉達哉1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1220-1220, 2017.

---

	P0884-5-AM. It is ... using an efforts ... simple type generic medicine comparison list in our hospital for 80% of generic medicine amount ratios 長岡麻由1, 船津洋子2, 藤原香2, 林田美香2, 岸本早苗2, 古川資啓3, 藤元公成4, 川浪泰男4, 山口真三志6, 小池城司5, 勝田洋輔5, 壁村哲平6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1221-1221, 2017.

---

	P0886-5-AM. Study on difference in crush properties between a zolpidem tartrate tablets innovator drug, the generic drug 稲葉一訓1, 大家才治2, 大竹裕子2, 井上知美2, 小竹武2, 長井紀章2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1222-1222, 2017.

---

	P0888-5-AM. The current situation and problem about the change to generic medicine in our hospital 恒川朋子1, 太田真美1, 武藤達也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1222-1222, 2017.

---

	P0890-5-AM. Risk factor investigation of the blood vessel-related complications by the generic medicine change in the Tri-Weekly TC (paclitaxel + Carboplatin) therapy 新田健太郎1, 武田浩文1, 鳥羽三佳代2, 永田将司1, 高橋弘充1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1223-1223, 2017.

---

	P0892-5-AM. Different innovator drug of the dosage form of the gemcitabine hydrochloride, comparison of the adverse event with the generic drug 久保果央莉1, 元茂拓法2, 橋下浩紀1, 遠藤雅之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1223-1223, 2017.

---

	P0894-5-AM. The effectiveness, safe comparison with a precedent article in the insulin glargine preparation in our hospital and the following article 近藤沙耶1, 多留木崇志1, 大橋正和1, 小野勝1, 村岡淳二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1224-1224, 2017.

---

	P0896-5-AM. Examination about the effectiveness in the comparison with the innovator drug of the filgrastim bio follower product 山下剛史郎1, 柴田千保1, 西村美佳1, 鶴田和樹1, 馬島務1, 廣瀬孝一1, 小田剛史1, 田中恵美子1, 稲村勝志1, 南橋薫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1225-1225, 2017.

---

	P0898-5-AM. Functional analysis of a preparation and the acquisition antibody of the rat single strand Fv library for the seeds acquisition of antibody pharmaceutical products 加藤芳徳1, 重本佳予子1, 篠崎拓哉1, 長谷川奈菜1, 遠藤和輝1, 細川悠悟1, 山田治美1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1225-1225, 2017.

---

	P0895-4-PM. Examination about the effectiveness, the safety of the filgrastim note bio follower product for the purpose of the peripheral blood stem cell sampling 石井一也1, 上泰大1, 荻原好章1, 神原康佑1, 大塚識稔1, 原景子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1226-1226, 2017.

---

	P0899-4-PM. Efforts ... which is associated with a drug needing side effect monitor activity - periodical examination in the impartial kindness society 丸岡真琴1, 松本ミユキ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1228-1228, 2017.

---

	P0901-4-PM. An example with suspected collagen fiber-related colitis with lansoprazole 三浦恵理1, 奥野昌宏1, 吉村弥緒2, 中浴伸二1, 中田学1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1229-1229, 2017.

---

	P0903-4-PM. Safe profile associated with the bleeding of the direct action type oral anticoagulant drug in patients with atrial fibrillation 中村彰子1, 松井美月1, 東野真弓1, 穂積智美1, 宮本渚2, 須永登美子1, 稲本真弓3, 間瀬浩4, 若月大輔4, 下島桐4, 向後麻里3, 江波戸美緒4, 鈴木洋4, 渡邊徹1, 佐々木忠徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1229-1229, 2017.

---

	P0905-4-PM. Examination of collection, correspondence, joint ownership, the management method of the information on adverse drug reactions through ward duties in Rousaibyoin, Yamaguchi 下向井唯希1, 柴田文規1, 小川丈彦1, 梅野尚生1, 岡村智文1, 神谷真悟1, 管田彩乃1, 尾川友佳1, 田口みどり1, 竹田克明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1230-1230, 2017.

---

	P0907-4-PM. 1 case that led to a cardiac arrest from crown spastic angina induced by aspirin asthma 大辻陽子1, 榎屋友幸1, 石倉健2, 佐々木典子1, 岩本卓也1, 今井寛2, 奥田真弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1230-1230, 2017.

---

	P0909-4-PM. Evaluation of the side effect in patients hospitalized for the side effect of pharmaceutical products and the severity 勝野隼人1, 舘知也1,2, 青山智2, 大澤友裕2, 上野杏莉1, 大坪愛実1, 杉田郁人1, 兼松勇汰1, 吉田阿希1, 野口義紘1, 安田昌宏2, 水井貴詞2, 後藤千寿2, 寺町ひとみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1231-1231, 2017.

---

	P0913-4-PM. It is examined the use situation of the tolvaptan after the surgery of the cardiovascular surgery and frequency and the risk factor of the high Na blood symptom in Gifu comprehensive medical care center 小寺聖1, 平下智之1, 谷沢克弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1232-1232, 2017.

---

	P0915-4-PM. Local difference of the recognition about "the safe information report systems such as pharmaceutical products, medical equipment, and the like" in the pharmacist and the practice 小林智徳1, 赤坂和俊1, 小原拓1,2, 山口浩明1, 松浦正樹1, 村井ユリ子1,2, 土屋文人3, 北田光一3, 眞野成康1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1232-1232, 2017.

---

	P0917-4-PM. The side effect occurrence situation in the linezolid 又吉樹1, 森口真衣1, 吉川眞維樹1, 安田章太郎1, 駒井勇太2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1233-1233, 2017.

---

	P0921-4-PM. One patient whom the hepatic encephalopathy that was thought to be due to 5-FU during mFOLFOX6 therapy developed in 近藤万友美1, 正置耕一1, 澁谷奈穂1, 吉岡睦展1, 高瀬直人2, 辻隆志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1234-1234, 2017.

---

	P0923-4-PM. Examination about akathisia expression with prochlorperazine and the antiemesis effect 熊谷卓博1, 齋藤佳敬1, 山田武宏1, 小林正紀1, 熊井正貴1, 笠師久美子1, 小松嘉人2, 井関健3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1234-1234, 2017.

---

	P0925-4-PM. Evaluation of cardiac disorders by the nivolumab using domestic adverse event spontaneous report database (JADER) 岡田浩司1, 薄井健介1, 渡辺善照1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1235-1235, 2017.

---

	P0929-4-PM. An example of the hepatitis fulminant that it was thought that it was caused by Abiraterone ester acetate tablets 松本ミユキ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1236-1236, 2017.

---

	P0931-4-PM. 1 case of the type 2 diabetes merger non-small cell lung cancer that blood sugar control worsened after the nivolumab administration 長田知子1, 世古口典子1, 大西真裕2, 大西悠紀3, 日置三紀1, 岩本卓也1, 小林哲2, 奥田真弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1236-1236, 2017.

---

	P0933-4-PM. About onset of organ derangement by the difference in daily doses of ampicillin/sulbactam 今西嘉生里1, 中蔵伊知郎1, 坂倉広大1, 福田利明1, 佐光留美1, 山崎邦夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1237-1237, 2017.

---

	P0935-4-PM. Examination about the safety when sulfamethoxazole trimethoprim is given for pneumocystis pneumonia onset inhibition 青山智1, 大澤友裕1, 梅田道1, 長谷川貴昭2, 石黒崇3, 堀場あかね3, 二村洋平3, 吉田勉3, 澤祥幸4, 後藤千寿1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1237-1237, 2017.

---

	P0937-4-PM. Side effect of consciousness and the weight gain of the pharmacist for the weight change in the SGLT2 inhibitor 蓮見和也1, 佐藤宏樹2, 三浦康正3, 高橋一之4, 小島孝一4, 藤原真理子5, 堀里子2, 澤田康文2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1238-1238, 2017.

---

	P0939-4-PM. One case that caused hypoglycemia by levofloxacin internal use 塚田寛子1, 明時凡子1, 一ノ瀬由衣1, 床島英雄1, 三砂義敬1, 田中基稔1, 近藤譲1, 宮崎靖之1, 山脇一浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1238-1238, 2017.

---

	P0941-4-PM. One patient whom aciclovir encephalopathy developed in after the valacyclovir administration 柳川智子1, 倉橋基尚1, 椿尾薫1, 青木里紗1, 卜部和美1, 澤崎高志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1239-1239, 2017.

---

	P0943-4-PM. Examination of the deep vein thrombosis (DVT) treatment with rivaroxaban in our center and warfarin 渡邊なお子1, 大塚公庸1, 中村益美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1239-1239, 2017.

---

	P0947-4-PM. Hospitalization and side effect investigation of the Yokukansan in patients with foreign going to hospital dementia 藤矢実那美1, 光岡里奈1, 矢野義孝1, 三浦誠2, 本橋秀之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1240-1240, 2017.

---

	P0949-4-PM. Evaluation of preventive measures against low Ca blood symptoms in the osteoporosis treatment denosumab administration 黒川瑠璃子1,2, 木全司1, 高原悠子1, 鬼頭克暢1, 鵜飼淳一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1241-1241, 2017.

---

	P0951-4-PM. Efforts to the bone fracture risk in patients with steroidal osteoporosis using FRAX 高澤麻美1, 土田美奈子1, 細沼万衣1, 丹羽直人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1241-1241, 2017.

---

	P0953-4-PM. About the side effect of Thyradin (R) S tablets which we experienced in our hospital 山口千晶1, 野中榮夫1, 寺澤友基子1, 横塚智1, 仲田三佐子1, 北川亘2, 伊藤公一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1242-1242, 2017.

---

	P0955-4-PM. 1 case of the haemodialysis patients that disturbance of consciousness was prolonged after the blood aciclovir levels drop 澤田麻旺1, 榎屋友幸1, 新堂晃大2, 池村健治1, 佐々木典子1, 岩本卓也1, 今井寛2, 奥田真弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1242-1242, 2017.

---

	P0900-5-AM. Examination of the bleeding risk after the direct action type oral anticoagulant drug administration in deep vein thrombosis, the pulmonary thromboembolism 松井美月1,2, 清水朋美3, 東野真弓1,2, 穂積智美1,2, 高橋典子1,2, 中村彰子1,2, 宮本渚1, 須永登美子1,2, 向後麻里3, 江波戸美緒4, 鈴木洋4, 渡邊徹1,2, 佐々木忠徳2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1243-1243, 2017.

---

	P0902-5-AM. One case that showed a side effect of the hair loss of lansoprazole 高橋雄也1, 森本健幹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1244-1244, 2017.

---

	P0904-5-AM. One case with suspected agranulocytosis due to the mesalazine granule 山村知紗1, 梶原洋文1, 山田雅也1, 錦織英史2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1244-1244, 2017.

---

	P0906-5-AM. 1 case that polypharmacy was improved by pharmaceutical intervention 菊地義明1, 高橋誠1, 庄崎沙耶1, 藤田果那1, 田中耕太1, 木下愛1, 山本翔太1, 山田将悟1, 前川英輝1, 藤林遼1, 鈴木直哉1, 地主隆文1, 森田高行1, 青田忠博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1245-1245, 2017.

---

	P0908-5-AM. Examination about the cancellation reason of the foreign chemotherapy in our hospital 五月女拓也1, 外山智章1, 坂本鉄弥1, 野沢三枝子1, 上野恵美1, 石濱洋美1, 本田雅巳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1245-1245, 2017.

---

	P0910-5-AM. Association between oversedation and obesity by the new insomnia therapeutic drug suvorexant 鳥井栄貴1,2, 上池沙弥華1, 山本美和1, 安田大将1, 清水るみ子1, 平岡義範1, 橋田亨2, 久米典昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1246-1246, 2017.

---

	P0912-5-AM. The situation investigation of the GI bleeding due to a drug 清原めぐみ1, 川尻尚子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1246-1246, 2017.

---

	P0914-5-AM. Association of proton pump inhibitor administration and the side effect "hypomagnesemia" in our hospital and the consideration 伊集院聖司1, 水谷駿介2, 田中和子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1247-1247, 2017.

---

	P0916-5-AM. As compared with use comparison - Xa inhibitor of the anticoagulant, a Doac4 agent ... 中井聖子1, 佐藤倫由2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1247-1247, 2017.

---

	P0918-5-AM. Examination - case subject study - of the factor associated with the pseudoaldosteronism onset 小松旺広1, 吉野鉄大2, 佐野恵1, 中村智徳1, 金井隆典3, 渡辺賢治2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1248-1248, 2017.

---

	P0920-5-AM. It is ... mainly on the case that became the introduction hospitalization in characteristic - National Cardiovascular Center of the anthracyclines-induced myocardial disorder 平田尚人1,2, 小松稔典2, 栗林真理子2, 山田隆一1, 加藤文香1, 片桐玲奈1, 矢嶋明1, 下枝貞彦3, 戸塚信之2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1248-1248, 2017.

---

	P0922-5-AM. Example that developed an immune-mediated adverse event by the nivolumab in our hospital 小竹優希1, 坂本竜平1, 向井淳治2, 吉田太映子1, 岸本典子1, 上西剛史1, 松山しま子3, 長谷川喜一4, 奥田広志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1249-1249, 2017.

---

	P0924-5-AM. It is a case using the azacitidine therapy for myelodysplastic syndrome treatment-related in our hospital 蓮尾憲作1, 村本慎悟1, 眞田功2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1249-1249, 2017.

---

	P0926-5-AM. Examination about the allergic reaction with oxaliplatin in our hospital 山下愛登1, 堀勇太1, 後藤隆2, 浦本邦弘1, 豊福篤志3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1250-1250, 2017.

---

	P0928-5-AM. Frequencies and expression factor of infusion reaction in the rituximab new administration method 北風晶子1, 辰己純代2, 飯田洋子2, 田久保慎吾2, 田中邦佳2, 柳井美奈2, 木村健2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1250-1250, 2017.

---

	P0930-5-AM. Effect on renal function with the voriconazole IV preparation in the blood-forming organ tumor case 安武夫1, 小沼貴晶2, 黒田誠一郎1, 高橋聡2, 東條有伸2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1251-1251, 2017.

---

	P0932-5-AM. Fact-finding of the hyperkalemia in the low-dose ST medical mixture remedy patients 加藤翔大1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1251-1251, 2017.

---

	P0934-5-AM. An example of the infective endocarditis with suspected serious neutropenia with the daptomycin administration 牛島智子1, 西村文宏1, 宮村重幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1252-1252, 2017.

---

	P0936-5-AM. The effect that tazobactam/piperacillin combination gives to renal function in the patients receiving vancomycin 小林将文1, 島田泉1, 新木貴大1, 鈴木直人1, 外山聡1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1252-1252, 2017.

---

	P0938-5-AM. Cytotoxic comparison with the SGLT2 inhibitor in the cell line derived from human keratinocytes 松本彩夏1, 辻本雅之1, 折方琴音1, 白土恵理1, 辻本美菜1, 峯垣哲也1, 河渕真治2, 伊藤由佳子2, 栄田敏之2, 山本和宏3, 錦織千佳子4, 西口工司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1253-1253, 2017.

---

	P0940-5-AM. An example of patients on dialysis of recurrent pericarditis that developed rhabdomyolysis by colchicine 伊藤和幸1, 平嶋由貴1, 中村くみこ1, 長谷川彩1, 浦崎圭太1, 河井和子1, 磯谷聡1, 余語美奈2, 加田賢治2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1253-1253, 2017.

---

	P0942-5-AM. Consideration about the drug eruption accompanied with the pylori sanitization 真鍋健一1, 西田初博1, 甲斐真理子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1254-1254, 2017.

---

	P0948-5-AM. In patients with non-valvular atrial fibrillation is weighed hemorrhagic side effect frequencies of oral anticoagulant drug (DOAC) directly 河村真歩1, 門口直仁1, 山崎真妃呂1, 橋田真佐1, 田中聡1, 宮本典文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1255-1255, 2017.

---

	P0950-5-AM. About an adverse event report system in our hospital 村松奈緒美1, 山田倭花1, 内山乃映1, 大窪真理絵1, 伊代田萌子1, 丸岡浩太1, 梅澤仁美1, 河村紳介1, 小林誠一1, 坂口修治1, 富沢裕之1, 山下敦志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1256-1256, 2017.

---

	P0952-5-AM. It is one patient with suspected bullous pemphigoid during sitagliptin internal use 千場美奈1,2, 山下克也1, 津曲恭一2, 山崎恵子1, 山道研1, 中村康彦1, 福澤美夕1, 田川幸1, 諌見圭佑1, 吉本有里1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1256-1256, 2017.

---

	P0954-5-AM. Examination of the effect that renal function in the eribulin mesilate gives for onset of neutropenia 鈴木訓史1, 村上寛知1, 橋下浩紀1, 遠藤雅之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1257-1257, 2017.

---

	P0956-5-AM. Quantity of glycyrrhizic acid of the study on crude drug ingredient (7) Glycyrrhiza combination Chinese medicine of Chinese medicine 黒田明平1, 社本典子1, 木下歩美1, 椎崇1,2, 三巻祥浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1257-1257, 2017.

---

	P0957-4-PM. The cardiovascular events risk assessment of the HMG-CoA reductase inhibitor and analysis of the CYP2J2 inhibitory action 伊東久貴1,2, 山折大1,2, 上条しのぶ2, 大森栄1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1258-1258, 2017.

---

	P0959-4-PM. Making of the Excel template performing the blood level simulation at absorption rate fixed number estimate of the drug based on package insert information and repeated doses 西田孝洋1, 徳永彩子1, 宮元敬天1, 井手陶子1, 谷口麻里子1, 麓伸太郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1259-1259, 2017.

---

	P0961-4-PM. Modeling & Simulation for the purpose of the acute and subchronic nephrotoxic expression prediction at Cisplatin repeated doses 岡田章1, 藤田まい1, 中西真那1, 本田朱李1, 福島恵造1, 杉岡信幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1259-1259, 2017.

---

	P0963-4-PM. Examination about the internal change of the fexofenadine in the acute renal failure rat 武田芙蓉1, 武田瑛司1, 鎌田芽衣1, 三好そよ香1, 市村祐一1, 小田雅子1, 武田清孝2, 齊藤浩司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1260-1260, 2017.

---

	P0958-5-AM. The effect that the pharmaceutical products with the cAMP activity effect give to a drug metabolizing enzyme 高杉俊行1, 山下将司1, 田山剛崇1, 花野藍1, 西村さとみ1, 前田志津子1, 覚前美希1, 三宅勝志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1261-1261, 2017.

---

	P0960-5-AM. An internal change of 5-fluorouracil and effect of metronidazole giving it to onset of metabolism enzyme 山岸喜彰1, 前川遥1, 荻野晃大1, 金川一成1, 合田ひとみ1, 吉見猛1,2, 工藤敏之1, 伊藤清美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1262-1262, 2017.

---

	P0962-5-AM. About a change of the stable isotope ratio and selenium of nitrogen, carbon out of the hair by the ingredient nutrient preparation remedy 小笠原英樹1, 井上純孝2, 木村治3, 遠藤哲也3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1262-1262, 2017.

---

	P0964-5-AM. The dysfunction of the MATE transporter taking tubular secretion of dopamine produced in a kidney local site causes fluid retention 梶原望渡1,2, 伴毅2, 中西洋一3, 松原和夫2, 増田智先1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1263-1263, 2017.

---

	P0965-4-PM. About effect by the generic medicine introduction of amiodarone hydrochloride tablets 大谷拓也1, 池野洋平1, 戸田純司1, 藤本明子1, 室岡邦彦1, 中里祐二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1264-1264, 2017.

---

	P0967-4-PM. Pharmacokinetic analysis of the case given amikacin intravenously for peritoneal dialysis patients 篠田康孝1, 中島啓二1, 松岡知子1, 大橋健吾1, 新井かおり1, 竹中梨恵1, 加藤未紗1, 吉村知哲1,2, 杉山正2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1265-1265, 2017.

---

	P0969-4-PM. Examination of the haemodialysis clearance predictive model by quantitative structure - pharmacokinetic correlative analysis 鈴木大輔1, 中島準紀1, 青山隆彦1, 宮本葵1, 赤穂由望奈2, 吉川明良2, 開浩一2, 松本宜明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1265-1265, 2017.

---

	P0971-4-PM. Pharmacokinetics of Glecaprevir/Pibrentasvir (GLE/PIB) in healthy Japanese, whites and the Han race Chinese 内山尚孝1, Rajneet K. Oberoi2, Chih-Wei Lin2, Andrew Campbell2, Wei Liu2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1266-1266, 2017.

---

	P0973-4-PM. The population pharmacokinetics analysis in patients with gonococcal urethritis and evaluation of the effectiveness of sustained release azithromycin by the simulation 曽田翠1, 長瀬泉1, 松丸直樹2, 伊藤晋3,4, 安田満4, 塚本桂2, 出口隆4, 北市清幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1266-1266, 2017.

---

	P0975-4-PM. Pharmacokinetics, safety of Glecaprevir/Pibrentasvir (GLE/PIB) in the foreign patients, a liver damage and nephropathic effect on tolerability 杉本義幸1, Rajneet K. Oberoi2, Matthew P. Kosloski2, Federico Mensa2, Wei Liu2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1267-1267, 2017.

---

	P0966-5-AM. An example of the haemodialysis patients that blood level of the ceftriaxone showed high level, and presented a chorea symptom 横山泰昭1, 工藤敏之2, 合田ひとみ2, 伊藤清美2, 鈴木正論1, 細川直登3, 舟越亮寛1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1268-1268, 2017.

---

	P0968-5-AM. The forerunner of the Teicoplanin, comparison about blood trough level that is in a steady state between patients receiving generic drug 中川光1, 住吉健太1, 山口佳津騎1, 磯部芳江1, 谷久美子1, 綾野武司1, 木村純夫1, 加地雅人1, 小坂信二1, 芳地一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1269-1269, 2017.

---

	P0970-5-AM. Can you utilize the correlation of cibenzoline blood level measurements and BNP level for medication counseling? 大久保七枝1, 大久保正2,3, 田中真理子3, 大久保節子4, 大久保美穂5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1269-1269, 2017.

---

	P0972-5-AM. Examination of the factor influencing a rise in serum creatinine level of sulfamethoxazole-trimethoprim 山上聡子1, 山本智也1,2, 勝浦正人1, 門脇裕子1, 三輪芳弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1270-1270, 2017.

---

	P0974-5-AM. Analysis of the antiinflammatory effect of adalimumab on Crohn's disease 木村耕二1, 高柳理早1, 山田安彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1270-1270, 2017.

---

	P0976-5-AM. Examination about the predictive precision of the Teicoplanin blood level analysis to stop by according to renal function index 後藤総太郎1, 木下理恵1, 大村由紀子1, 白石範子1, 関谷紀貴2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1271-1271, 2017.

---

	P0978-5-AM. One case that measured serum and vancomycin levels out of the cerebral fluid for MRSA meningitis 猪岡真己1,2, 鈴木穂奈美1, 河野一実1, 奥平正美1, 杉浦洋二1, 勝見章男2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1272-1272, 2017.

---

	P0980-5-AM. Error factor investigation of blood vancomycin levels predicted value and the actual value in first aid, the intensive care domain 佐脇久美1, 山代栄士1, 末延道太1, 河村聡志1, 原尻学志1, 森一生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1272-1272, 2017.

---

	P0982-5-AM. Examination of blood caffeine levels in the nonprescription drug large quantities remedy patients 佐藤一真1, 豊口禎子1, 鏡優貴1, 杉浦明日美2, 屋代祥典3, 白石正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1273-1273, 2017.

---

	P0984-5-AM. Establishment of the blood ganciclovir levels assay by a very small amount of drawing blood 須賀未稀1, 百賢二1, 杉浦優香1, 林潤1, 大澤拓郎1, 金崎祐哉1, 徳丸翔大1, 安武夫2, 長岡和徳3, 仲鉢英夫3, 高木彰子1, 濃沼政美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1273-1273, 2017.

---

	P0986-5-AM. Examination of the sunitinib therapeutic range area in renal carcinoma treatment of Japanese people 高崎新也1, 川崎芳英2, 菊地正史1, 田中雅樹1, 鈴鹿雅人1, 野田あおい1, 内野由紀子1, 佐藤祐司1, 木皿重樹1, 山口浩明1, 伊藤明宏2, 荒井陽一2, 眞野成康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1274-1274, 2017.

---

	P0988-5-AM. One case of the children who suffered from blood level control in the switches therapy from voriconazole parenteral injection to a dry syrup 楠川侑吾1, 村田龍宣1, 村岡淳二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1274-1274, 2017.

---

	P0990-5-AM. Comparison of the blood level trough value after the loading of an innovator drug of the Teicoplanin and the generic drug 竹中梨恵1, 篠田康孝1, 松岡知子1, 大橋健吾1, 吉村知哲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1275-1275, 2017.

---

	P0992-5-AM. It is analyzed the frequency indicating the false-negative by the phenytoin blood level measurement by ARCHITECT 藤吉正哉1, 鈴木貴明2, 石井伊都子1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1275-1275, 2017.

---

	P0994-5-AM. Examination of cyclosporine and the factor affecting the Everolimus blood level measurements 佐藤汐莉1, 赤嶺由美子1, 加賀谷英彰1, 佐藤滋2, 三浦昌朋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1276-1276, 2017.

---

	P0996-5-AM. Examination of the risk factor that a trough value increases early in vancomycin hydrochloride administration by IV drip 宮崎祐介1, 長谷川浩司1, 石坂忠博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1276-1276, 2017.

---

	P0998-5-AM. Antimicrobial administration to the decreased renal function patients who took revised edition antimicrobial TDM guidelines into account 更谷和真1,2, 中澤明日香1, 徳濱潤一1, 原田晴司1, 更谷由夏2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1277-1277, 2017.

---

	P1000-5-AM. Association of a trough value and the effectiveness of the Teicoplanin for the febrile neutropenia that occurred during the treatment of the blood medical disease 内山数貴1, 田澤佑基1, 今井俊吾1, 鏡圭介1, 杉田純一3, 鳴海克哉2, 山田武宏1, 笠師久美子1, 小林正紀2, 豊嶋崇徳3, 井関健1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1277-1277, 2017.

---

	P1002-5-AM. Usefulness of the pharmacist intervention through the vancomycin initial administration plan for patients with MRSA bacteremia 春木祐人1, 広本篤2, 毎熊隆誉2, 手嶋大輔2, 杉山哲大1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1278-1278, 2017.

---

	P1004-5-AM. Investigation about various parameter changes of the vancomycin (VCM) treated patients before and after the TDM guidelines revision 小椋大1, 花房喜子1, 小森亮子1, 鈴木ゆきえ1, 荒川裕明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1278-1278, 2017.

---

	P1006-5-AM. Is the initial administration plan using "a voriconazole TDM calculation tool" under the situation that genetic polymorphism is unknown useful? 土本大輔1, 桑原悠里1, 山本泰大1, 宮川佐和子1, 宇都宮純平1, 戸田康裕1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1279-1279, 2017.

---

	P1008-5-AM. Examination of the blood level in the case that a high dose before dialysis of the amikacin was given in 森章典1, 芳賀友輔1, 石田隆浩1, 渡邉絢史2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1279-1279, 2017.

---

	P1010-5-AM. Examination for the efforts of the VCM TDM analysis by the ward pharmacist in our hospital 坂口晋哉1, 牧陽介2, 杉枝里香1, 松尾圭祐3, 木村滋1, 合原嘉寿1, 林稔展1, 西野隆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1280-1280, 2017.

---

	P1012-5-AM. Examination of a dose and the blood level of vancomycin in patients with blood tumor and patients with solid tumor 森紗世子1, 島田泉1, 小林将文1, 磯辺浩和1, 新木貴大1, 鈴木直人1, 外山聡1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1280-1280, 2017.

---

	P1014-5-AM. Intervention to initial administration plan for vancomycin hydrochloride proper use and the usefulness 横山晋一郎1, 塚原優太1, 横山香保2, 本田富得1, 古川哲也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1281-1281, 2017.

---

	P1016-5-AM. Dose investigation of the case that an initial trough value of vancomycin was less than 10 μg/mL 直朋弘1, 島田真理1, 本上ほなみ1, 大原沙織1, 梶田祐三子1, 石井恵理香1, 若松亮1, 馬場奈津美1, 大谷美奈子1, 見上千昭1, 西窪奈津子1, 西尾孝1, 辻本勉1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1281-1281, 2017.

---

	P1018-5-AM. Examination of the usefulness of the peak value measurement in case of the blood vancomycin levels monitoring based on the Bayesian method 今西義紀1, 千田紗弓1, 加藤義章1, 伊藤久美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1282-1282, 2017.

---

	P1020-5-AM. In the diabetic nephropathy, the adjustment of the drug dose depending on a decreased renal function is often overlooked 百瀬公博1, 笹岡直輝1, 荒木真2, 秋月茂樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1282-1282, 2017.

---

	P1022-5-AM. Safe examination of the vancomycin loading dose in patients with impaired renal function 粟屋真理子1, 田中広紀1, 鈴木絢子2, 市川剛4, 楠裕美子1, 戸村和希1, 須永登美子1, 藤原久登1, 並木美加子2, 田中佐知子4, 渡邊徹1, 池田裕一3, 佐々木忠徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1283-1283, 2017.

---

	P1024-5-AM. Optimization of plasma carbapenem-based antimicrobial system of measurement using LC/MS-MS 村井晴香1, 長瀬泉1, 脇田瑠璃1, 三谷健人1, 土井光則2, 曽田翠1, 小倉真治3, 伊藤善規4, 北市清幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1283-1283, 2017.

---

	P1026-5-AM. We look at the rear about the causation of a blood tacrolimus levels change and the red blood cell count change in the hematopoietic stem cell transplantation patients and analyze a mark 吉川直樹1, 奥村学1, 平原康寿1, 岩切智美1, 池田龍二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1284-1284, 2017.

---

	P0977-4-PM. Efforts to improvement in blood level measurement rate of patients receiving vancomycin and TDM analysis rate 山脇一浩1, 大石裕樹2, 坂口晋哉2, 西野隆2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1285-1285, 2017.

---

	P0979-4-PM. Evaluation of the blood vancomycin drug levels monitoring by the ward pharmacist 東千夏1, 上原佳子1, 平田やよい1, 浜元善仁1, 翁長真一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1286-1286, 2017.

---

	P0983-4-PM. Establishment of the ganciclovir urine concentration assay 杉浦優香1, 百賢二1, 須賀未稀1, 林潤1, 大澤拓郎1, 金崎祐哉1, 徳丸翔大1, 安武夫2, 長岡和徳3, 仲鉢英夫3, 高木彰子1, 濃沼政美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1287-1287, 2017.

---

	P0985-4-PM. Establishment of the plasma lamotrigine densitometry system using the LC-MS/MS 板橋昇吾1, 西科舞香1, 尾藤里奈1, 福本真己1, 曽田翠1, 北市清幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1287-1287, 2017.

---

	P0987-4-PM. Examination ... by predictive - Monte Carlo simulation of the Cpeak arrival time for arbekacin 山口佳津騎1, 阿部武由2, 竹内敏己3, 渡邊政博4, 土屋浩一郎5, 猪川和朗6, 福岡憲泰7, 加地雅人1, 田中裕章1, 朝倉正登1, 小坂信二1, 芳地一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1288-1288, 2017.

---

	P0989-4-PM. An evaluation of the administration plan nomogram according to the VCM renal function in antimicrobial TDM guidelines and examination of the factor having an influence on the initial trough value 石井英俊1,2, 平井啓太2, 神戸宏憲1, 木苗あゆみ1, 須山由佳子1, 杉山恭平1, 伊藤邦彦2, 木村緑1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1288-1288, 2017.

---

	P0991-4-PM. Making of the administration plan assist sheet of imipenem/cilastatin using the minimal inhibitory concentration distribution in the institution 斎藤厚太1, 谷川浩司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1289-1289, 2017.

---

	P0993-4-PM. Significance of the blood level measurement in the use of foreign voriconazole patients 鴫田江理嘉1, 垰越崇範1, 冨田隆志1, 久保有子1, 佐伯康之1, 松尾裕彰1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1289-1289, 2017.

---

	P0995-4-PM. About the safety of the administration of Teicoplanin note method in our hospital 阪野和重1, 中西俊介1, 奥本真巳1, 武内恭範1, 篝忠宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1290-1290, 2017.

---

	P0997-4-PM. 2 cases that dose adjustment depending on renal function of the linezolid was useful 松田翔平1,2, 木村竜司1, 久保有子3, 今津智子1, 久賀谷幸昌1, 福澤正隆1, 渡邉貴志1, 前田頼伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1290-1290, 2017.

---

	P0999-4-PM. An example of childhood meningitis given concentrations simulation out of the cerebral fluid at vancomycin intraventricular administration 古庄弘和1, 平田憲史郎1, 陣上祥子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1291-1291, 2017.

---

	P1001-4-PM. The current situation of the vancomycin TDM in our hospital and the future prospects 猿谷淳1,2, 里見彩1, 上村円香1, 田畑寛明1, 向一美1, 地野幹子1, 伊藤博徳2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1291-1291, 2017.

---

	P1003-4-PM. Factor analysis of the low trough level of vancomycin in the neurosurgical patients 岩村直矢1, 池田祐輔1, 曽根本恵美1, 溝口晶子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1292-1292, 2017.

---

	P1005-4-PM. Effect of the vancomycin maintenance doses design by the pharmacist 坂倉広大1, 中蔵伊知郎1, 今西嘉生里1, 福田利明1, 佐光留美1, 山崎邦夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1292-1292, 2017.

---

	P1007-4-PM. Examination of the patients background that blood vancomycin levels and predicted value become estranged 濱野有里1, 中川千恵美1, 牧賢利1, 小山朋子1, 内畠久美子1, 中村孝佑1, 板野亨1, 相良義弘1, 堀田修次2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1293-1293, 2017.

---

	P1009-4-PM. One case that blood level of vancomycin became the high level in the patients after the thigh resection enforcement 田中雄介1, 磯辺浩和1, 五十嵐洋平1, 鈴木直人1, 外山聡1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1293-1293, 2017.

---

	P1011-4-PM. Examination of the patients background to influence blood level of vancomycin 片岡達夫1, 垰越崇範1, 福島隆宏1, 吉川博1, 鴫田江理嘉1, 冨田隆志1, 佐伯康之1, 松尾裕彰1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1294-1294, 2017.

---

	P1013-4-PM. Examination about the adaptation to our hospital of the antimicrobial TDM guidelines on vancomycin hydrochloride note 2016 recommendation doses in the initial administration plan 小林裕平1, 木幡雄至1, 石福奈々1, 菅野浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1294-1294, 2017.

---

	P1015-4-PM. Examination about the initial administration plan based on the vancomycin actual survey trough value 菅原大輔1, 菅野雄太1, 瓜智都1, 鎌田裕介1, 竹谷美穂1, 森本淳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1295-1295, 2017.

---

	P1017-4-PM. Construction - pharmacist-led efforts to 100% of TDM analysis rate of use of the TDM enforcement system for Antimicrobial stewardship promotion and analysis ... of TDM analysis contents 田中裕子1, 渡部智貴1, 新藤学1, 加藤一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1295-1295, 2017.

---

	P1019-4-PM. Examination of the case indicating the blood level low level in the TDM of the vancomycin hydrochloride 城尾晃太1, 山西彩香1, 植田実佐1, 長橋かよ子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1296-1296, 2017.

---

	P1021-4-PM. Examination about the precision of the renal function estimation type in elderly people 薗田晃弘1, 岩下佳敬1, 中尾承司1, 岩崎公美1, 兒玉麻代1, 川畑綾1, 高田侑那1, 浜園龍1, 宝来留美1, 久永あゆみ1, 登尾一平2, 石田和久1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1296-1296, 2017.

---

	P1023-4-PM. Efforts to the Teicoplanin proper use in elderly people 有冨航平1, 笠田高志1, 木本弘江1, 高倉栄治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1297-1297, 2017.

---

	P1025-4-PM. Existing prediction-style comparison of blood vancomycin levels in the neonates department domain 大橋隼人1, 花井雄貴1,2, 松尾和廣2, 吉尾隆2, 横山智子1, 草野歩1, 坂本真紀1, 西澤健司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1297-1297, 2017.

---

	P1027-4-PM. Examination of the dose of irinotecan based on UGT1A1 genetic polymorphism in the FOLFIRI therapy 高田遼1, 山崎将英1, 國本雄介1, 益子寛之1, 木明智子1, 中田浩雅1, 野田師正1, 宮本篤1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1298-1298, 2017.

---

	P1029-4-PM. The effect that a combination of CYP3A4 in the lung transplantation patients and 3A5 genetic polymorphism gives to the tacrolimus blood trough level/doses ratio 須野学1, 内嶺陽平2, 伊藤明花2, 中西里佳2, 伊藤雄大2, 宮内成美2, 松本准2, 有吉範高2, 大谷真二3, 大藤剛宏3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1299-1299, 2017.

---

	P1031-4-PM. About the linkage disequilibrium of the STAT3 - base variant in patients with tuberculosis 山下祐生1, 寳迫祐史1, 浅川亜梨紗1, 南利彩子1, 桂木聡子1, 大野雅子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1299-1299, 2017.

---

	P1033-4-PM. Examination about the incidence of the STAT3 genetic polymorphism in patients with tuberculosis 寳迫祐史1, 南利彩子1, 浅川亜梨紗1, 山下祐生1, 桂木聡子1, 大野雅子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1300-1300, 2017.

---

	P1028-5-AM. Examination of racial differences in the genetic polymorphism frequency to be involved in sensitivity of the gemcitabine and a change 長田莉花1, 辻大樹1, 中森春美1, 松本恵実1, 佐原由莉1, 松澤明希1, 伊藤邦彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1301-1301, 2017.

---

	P1030-5-AM. Effect of the genetic polymorphism on effect of treatment of azathioprine in the childhood Crohn's disease 南利彩子1, 浅川亜梨紗1, 寳迫祐史1, 桂木聡子1, 大野雅子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1302-1302, 2017.

---

	P1032-5-AM. An episode of care and genetic polymorphism of the ulcerative colitis of children using azathioprine 浅川亜梨紗1, 南利彩子1, 寳迫祐史1, 桂木聡子1, 大野雅子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1302-1302, 2017.

---

	P1034-5-AM. About the pharmacist outpatient department for patients with cancer construction and current situation report - of - first report operation 高橋文香1, 児玉暁人1, 今井兼貴1, 岡明美1, 八尾祥子1, 森信介1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1303-1303, 2017.

---

	P1036-5-AM. Relation of the pharmacist for the combination of oral molecular target medicine and acid-secreting antagonist 後藤美穂1,2, 藤村浩司1,2, 吉村拓也2, 青木翔太1,2, 川原田祐貴2, 中村敏史2, 岩田智樹2, 川合甲祐2, 遠山幸男1,2, 山口智江2, 中根茂喜2, 板倉由縁3, 木村和哲4, 久田達也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1304-1304, 2017.

---

	P1038-5-AM. Start the activity in the foreign cancer chemotherapy room; and the current situation and a problem of our hospital 串田康弘1,2, 牧賢利2, 中川千恵美2, 中山やちよ2, 相良義弘2, 木内司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1304-1304, 2017.

---

	P1040-5-AM. Discussion analysis with the pharmacist specialized in a cancer 延川正雄1, 松田圭一郎1, 菅原拓也1, 齋藤順1, 有川真理1, 関口徳志1, 後藤純一1, 荒井浩一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1305-1305, 2017.

---

	P1042-5-AM. Attitude survey of usefulness and the pharmacist of the brochure about the prevention of anticancer agent exposure in the patients home 徳留章1,3, 前田健太2, 石井貴大3, 南盛一3, 和野雅治3, 木明貴幸1, 太田智之3, 齊藤浩司4, 武田清孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1305-1305, 2017.

---

	P1044-5-AM. About the case that was available for the 10 cycles administration enforcement by FOLFIRINOX therapy 佐藤数馬1, 稲本正之1, 島田慰彦1, 石黒智也2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1306-1306, 2017.

---

	P1046-5-AM. Fact-finding of the emergency consultation in the foreign cancer chemotherapy 大神正宏1, 小島寛2, 黒澤豊彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1306-1306, 2017.

---

	P1048-5-AM. The change of the information sharing tool about the cancer domain prescription in the medicine medicine cooperation 中村久美1, 淺野未代子2, 鬼窪利英1,2, 大輪武司2, 小野里直彦2, 杉澤哲2, 平林克博2, 松澤直樹2, 松原重征2, 向山百合1,2, 村田稔弥2, 吉澤貴代美2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1307-1307, 2017.

---

	P1035-4-PM. The inquired current situation of the folinate Tegafur uracil therapy put by a pharmacist 杉山清子1, 伊藤友里1, 大矢根守1, 加藤みち代1, 近藤康則1, 種子田善仁1, 堀真理1, 櫻庭円1, 豕瀬悟1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1308-1308, 2017.

---

	P1037-4-PM. Inspection of the use effect of the assessment sheet in the cancer chemotherapy 内山有理香1, 手嶋由加1, 村田智弘1, 市川美佳1, 竹下龍次1, 吉武摩耶1, 横田沙紀1, 山内省吾2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1309-1309, 2017.

---

	P1039-4-PM. Explanation documentation about an administration, the excrement management, and the like of the oral anticancer medicine for the patients family 鮎田利恵1,2, 後藤宏明1, 平島ゆか1, 石原溶子1, 上野翠2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1309-1309, 2017.

---

	P1041-4-PM. Efforts and use experience of the Nivolumab treatment for the non-small cell lung cancer 小西史子1, 濱武清範1, 足立那々緒1, 飯田有香1, 岩井真里絵1, 梶美里1, 中西輝1, 松本弘誠1, 仲忠士1, 美和孝之1, 小島一晃1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1310-1310, 2017.

---

	P1043-4-PM. Prostate-specific antigen (PSA) in the Enzalutamide weight loss-response case-lowering effect 村上礼隆1, 開浩一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1310-1310, 2017.

---

	P1045-4-PM. One case with suspected arterial thrombosis by the administration regimen enforcement including the cisplatin 南真進1, 新海愛子1, 相澤雄介1, 小杉隆祥1, 松本直人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1311-1311, 2017.

---

	P1047-4-PM. 2 cases that a pharmacist intervened in in the patients with Lenvatinib remedy thyroid cancer 遠藤一江1, 齋藤美香1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1311-1311, 2017.

---

	P1049-4-PM. Tendency to communication of the pharmacist for sensitive contents 町村裕香1, 竹平理恵子1, 有田悦子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1312-1312, 2017.

---

	P1050-5-AM. Evaluation after the aprepitant addition for retching, vomiting with the irinotecan combination regimen in the colon cancer chemotherapy 篠原佳祐1, 宮田智陽1, 杉山昌秀1, 渡邉将隆1, 油井信明2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1313-1313, 2017.

---

	P1052-5-AM. Fact-finding about the proper use of the antiemetic drug in the chemotherapy of stomach and the cancer of the esophagus 宇都宮奈々1, 沖田健太郎1, 植中英恵1, 長谷川将1, 末武亜依子1, 安河内寿成1, 近藤真由1, 吉田悦朗1, 白石貴寿1, 面田恵1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1314-1314, 2017.

---

	P1054-5-AM. Examination of dexamethasone doses and the antiemesis effect in patients who received breast cancer AC therapy 安達志乃1, 木村美智男1, 宇佐美英績1, 岡田和智1, 岩井美奈1, 浅野裕紀1, 伊藤大輔1, 川地雄基1, 守屋昭宏1, 栗林未帆1, 竹中翔也1, 西川智子1, 亀井桂太朗2, 吉村知哲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1314-1314, 2017.

---

	P1056-5-AM. Effect of olanzapine on prominence-related retching, vomiting 齋藤浩司1, 安部一弥1, 横澤大輔1, 太田拓希1, 小島俊彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1315-1315, 2017.

---

	P1058-5-AM. Look at the rear about retching, vomiting at lung cancer amrubicin monotherapy enforcement; mark investigation 近藤綾子1, 山本泰大1, 水谷貴樹1, 福岡麻実1, 宇都宮純平1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1315-1315, 2017.

---

	P1060-5-AM. Relative examination with the chemotherapy-induced retching, vomiting expression and hyperemesis gravidarum in patients with female breast cancer 松本恵実1, 辻大樹1, 金容壱2, 山本圭祐3, 中森春美1, 長田莉花1, 佐原由莉1, 松澤明希1, 中道秀徳3, 塩川満3, 伊藤邦彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1316-1316, 2017.

---

	P1062-5-AM. Effect of the Aprepitant + Palonosetron + Dexamethasone triple-drug therapy on retching, vomiting at the Carboplatin combination therapy in patients with gynecologic cancer 松尾尚美1, 三好孝法1, 鶴田南奈子1, 川俣洋生1, 弓削乃利人1, 平木洋一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1316-1316, 2017.

---

	P1051-4-PM. Evaluation of the antiemesis therapy change in the colon cancer chemotherapy of the moderate emetic risk 柏宗伸1, 北岡由里子2, 田畑智丈3, 千野佳秀3, 佐藤功3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1317-1317, 2017.

---

	P1053-4-PM. Examination about steroid sparing by the aprepitant combination to Weekly TC therapy 神田紘介1, 室高広1, 黄智剛1, 橋詰淳哉1, 兒玉幸修1, 三浦清典2, 金内優典2, 増崎英明2, 佐々木均1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1318-1318, 2017.

---

	P1055-4-PM. Comparison of the effect on calculation of the pharmacokinetics parameter in the rat of the Rikkunshito bougie and retching, vomiting 鎌田武志1, 内藤千鶴1, 川崎浩範1, 古河義行1, 岩田萌子1, 村田勇1, 井上裕1, 金本郁男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1318-1318, 2017.

---

	P1059-4-PM. Effect of antiemetic changes from granisetron in the THP-COP therapy to palonosetron 水岡大策1, 山口佳津騎1, 香西真衣1, 本田由紀1, 山本理恵1, 山本高成1, 久保智美1, 加地雅人1, 小坂信二1, 芳地一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1319-1319, 2017.

---

	P1061-4-PM. Fact-finding of the use of antiemetic drug according to the emetic risk in the cancer chemotherapy 野口直美1, 三宅秀敏1, 石川奈保子1, 永井和正1, 嶋崎悦子2, 善家恵美2, 佐藤瑞枝1, 古賀恭子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1320-1320, 2017.

---

	P1063-4-PM. Example that we were able to control with palonosetron hydrochloride without using dexamethasone for vomiting due to radiotherapy combination temozolomide internal use 章勇気1, 才野壽子1, 伊藤陽子1, 國原将洋1, 田阪武志1, 二五田基文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1320-1320, 2017.

---

	P1064-5-AM. Examination of the hydration method with the cisplatin (CDDP) preparation administration 嘉村基樹1, 福島ゆかり1, 岩崎ユリ2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1321-1321, 2017.

---

	P1066-5-AM. The case that was treated effectively with tramadol for vascular pain with dacarbazine 北御門由依1, 植村隆1, 糸永昇平1, 東島彰人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1322-1322, 2017.

---

	P1068-5-AM. It is adaptation expectation ... to ... chemotherapy-induced thrombocytopenia about an increased number of platelets effect of the Kamikihito 加藤敦1, 石川雄大1, 龍伸和1, 三村泰彦1, 足立伊佐雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1322-1322, 2017.

---

	P1070-5-AM. About renal failure inhibitory effect by the magnesium supplement in the cisplatin combination chemoradiation treatment 秋吉尚雄1, 桑村恒夫1, 末松文博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1323-1323, 2017.

---

	P1072-5-AM. Reduction effect of fexofenadine and the bepotastine on infusion reaction with rituximab 松井頌明1, 難波優里1, 玉木宏樹1, 西村信弘1, 直良浩司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1323-1323, 2017.

---

	P1074-5-AM. Neutropenia of the paclitaxel + ramucirumab combination therapy for progress, the recurrent gastric cancer which is impossible of curative resection, investigation of the onset situation of the febrile neutropenia 仲野宏紀1, 庄野裕志1, 福田利明1, 佐光留美1, 山崎邦夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1324-1324, 2017.

---

	P1076-5-AM. Analysis of the effect on malignant lymphoma factor to give to an excretion delay of the high-dose methotrexate therapy 豕瀬諒1, 高橋克之1, 永山勝也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1324-1324, 2017.

---

	P1078-5-AM. Examination - weekly paclitaxel therapy ... of the effectiveness of the d- chlorpheniramine note 喜多由紀1, 中川雅史1, 西出貴義1, 中村純子1, 泉本裕美1, 岸孝行1, 樫葉利人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1325-1325, 2017.

---

	P1080-5-AM. The current situation and problem of oral mucositis with the chemoradiotherapy for head and neck cancer 大坪達弥1, 河村佳奈1, 三木有咲1, 城月智帆1, 林曜子1, 堀内あす香1, 神田英一郎1, 岡橋孝侍1, 藤田敦夫1, 村木優一2, 友金幹視1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1325-1325, 2017.

---

	P1082-5-AM. Effect of intraoral hypothermia (cryotherapy) on oral mucosa disorder in patients receiving idarubicin 森健太郎1, 深澤淑子1, 鈴木大介1, 矢野寛樹2, 畔柳敏弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1326-1326, 2017.

---

	P1084-5-AM. Safe examination according to the treatment line with the eribulin administration 田頭尚士1, 小野友香1, 上野杏菜1, 羽藤加奈恵1, 秋山一郎2, 臼井由行2, 木内司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1326-1326, 2017.

---

	P1086-5-AM. 1 case that paclitaxel + bevacizumab treatment was able to continue for recurrent metastatic breast cancer by pharmacist intervention 浦瀬剛嗣1, 川原和也1, 木場重徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1327-1327, 2017.

---

	P1088-5-AM. Safe inspection of short hydration at the cisplatin administration that substituted existing infusion preparation 久枝真一郎1, 宗広樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1327-1327, 2017.

---

	P1090-5-AM. Examination of the effect to give during an expression of resorption of bone antagonist association necrosis of the jaw bone (ARONJ) period in denosumab treated patients 大嶋美咲1, 中尾將彦1, 木村仁美1, 山崎直樹1, 吉田徹也1, 村田みどり1, 竹内昌司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1328-1328, 2017.

---

	P1092-5-AM. Ca preparation in the decreased renal function patients during denosumab administration and V. Examination about the onset of optimal dose of the D preparation and low Ca blood symptom risk factor 芳尾正悟1, 鈴木小夜1, 高木彰紀1, 木村元範2, 望月眞弓1,2, 中村智徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1328-1328, 2017.

---

	P1094-5-AM. Fact-finding of the elevated blood pressure in the Ramucirumab administration for the gastric cancer and search of the risk factor 菊池茜1, 魚井みゆき1, 三角紳博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1329-1329, 2017.

---

	P1096-5-AM. Investigation of the usefulness of the sustained G-CSF preparation in the FEC therapy for breast cancer treatment 吉田将之1, 平下智之1, 谷沢克弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1329-1329, 2017.

---

	P1098-5-AM. About the use situation and an adverse event of the nivolumab in our hospital 沖田健太郎1, 植中英恵1, 長谷川将1, 末武亜依子1, 安河内寿成1, 栗原江未1, 大石丸美1, 岩武幹乃1, 白石貴寿1, 面田恵1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1330-1330, 2017.

---

	P1100-5-AM. Examination of the effectiveness of the loperamide prophylaxis for the Afatinib diarrhea onset 金子裕美1, 和田啓伸2, 鈴木秀海2, 中島崇裕2, 中村貴子1, 鈴木貴明1, 吉野一郎2, 石井伊都子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1330-1330, 2017.

---

	P1102-5-AM. Comparison of the effect of treatment of the osteocopic expression patients and non-expression patients with the G-CSF 三田恭平1, 荒木良介1, 宇野崇之1, 山田英紀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1331-1331, 2017.

---

	P1104-5-AM. Examination of the correspondence method after the onset of interstitial lung disease by the nivolumab 櫻下弘志1, 泉谷悟1, 西垣内亮1, 村瀬哲也1, 佐伯康之1, 松尾裕彰1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1331-1331, 2017.

---

	P1106-5-AM. Examination of the peg filgrastim administration within 24 hours after the end of the anticancer agent administration in our hospital 丸岡浩太1, 内山乃映1, 村松奈緒美1, 山田倭花1, 大窪真理絵1, 伊代田萌子1, 梅澤仁美1, 小林誠一1, 河村紳介1, 坂口修治1, 富沢裕之1, 山下敦志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1332-1332, 2017.

---

	P1108-5-AM. Intervention effect of the pharmacist about the HBV at cancer chemotherapy enforcement-related measurement 青木鈴加1, 小柴聖史1, 木下史一1, 小林淳司1, 勝又博司1, 菅尾高裕1, 小池道明1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1332-1332, 2017.

---

	P1110-5-AM. Search of the onset of proteinuria factor in the molecular target medicine which assumed vascular endothelium growth factor (VEGF), vascular endothelium growth factor receptor (VEGFR) a target 福井梨乃1, 槙原克也1, 寺沢匡史1, 内山ひとみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1333-1333, 2017.

---

	P1112-5-AM. Examination about the validity of the administration of the PEG-GCSF preparation primary prophylaxis in the breast cancer perioperative adjuvant setting 足立茂樹1, 一川悦子1, 谷沢克弥2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1333-1333, 2017.

---

	P1114-5-AM. Examination of the RAS inhibitor for the protein urine of the antiVEGF preparation 柳下博信1, 北條文啓1, 佐久間淳一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1334-1334, 2017.

---

	P1116-5-AM. The use situation and evaluation after the type B infection virus reactivation prophylactic system operation in the electronic medical chart 三枝都1, 石井直子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1334-1334, 2017.

---

	P1065-4-PM. Effect on peripheral neuropathy with the taxane system anticancer agent which serum erythropoietin concentrations give it to 小山なつの1, 山崎桃子1, 高木千明1, 里村藍子2, 永村陽一郎2, 日野斉一2, 中川沙織3, 大和進3, 太田伸1, 下枝貞彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1335-1335, 2017.

---

	P1067-4-PM. Examination of progress, the factor making the effect extend to the onset of hypomagnesemia in the cetuximab therapy for recurrent colon cancer 伊藤大輔1, 浅野裕紀1, 岩井美奈1, 安達志乃1, 岡田和智1, 木村美智男1, 吉村知哲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1336-1336, 2017.

---

	P1069-4-PM. Usefulness evaluation of the Moxifloxacin hydrochloride prior prescription for the febrile neutropenia during chemotherapy for the breast cancer perioperative period 高橋正也1, 高橋克之1, 小川和樹1, 高島勉2, 光川康子1, 柏木伸一郎2, 野田諭2, 小野田尚佳2, 大平雅一2, 永山勝也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1336-1336, 2017.

---

	P1071-4-PM. Effect on renal failure frequency by the short hydration method introduction at the cisplatin administration 樋口美奈子1, 和田依子1, 佐々木好美1, 岩坪沙奈恵1, 山口竜司1, 中野行孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1337-1337, 2017.

---

	P1073-4-PM. Investigation about the development situation of stomatitis for chemotherapy patients and the measures 草信晴美1, 塚本絢子1, 水嶋萌美1, 渡辺麻里子1, 監物英男1, 佐藤陽子2, 田中知子2, 笹本奈美2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1337-1337, 2017.

---

	P1075-4-PM. Analysis of the risk factor of the onset of cholinergic syndrome in patients who received FOLFIRINOX 川原田祐貴1, 片岡智美1, 石井沙也加1, 宮崎雅之1, 熊倉康郎1, 宮川泰宏1, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1338-1338, 2017.

---

	P1077-4-PM. The cardiac function diagnostic procedures situation of the use of trastuzumab patients in our hospital 坂野博紀1, 石川元章1, 町支優和1, 原田哲彦1, 村上仁志1, 石田隆浩1, 吉原基2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1338-1338, 2017.

---

	P1079-4-PM. Look at the rear about peripheral neuropathy by nab-Paclitaxel; mark investigation 野澤寿吉1, 松野由華1, 廣上典和1, 網谷智輝1, 朱亀進司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1339-1339, 2017.

---

	P1081-4-PM. The use situation of oxaliplatin and pregabalin for peripheral neuropathy by the paclitaxel 長瀬友樹1, 安室修2, 羽山幸子1, 舟越亮寛2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1339-1339, 2017.

---

	P1083-4-PM. Efforts - in the pharmacist outpatient department in the preventive measures against hepatitis B reactivation (the second report) - internal use anticancer agent in the cancer chemotherapy 伊藤弘美1, 浅野寿規1, 川瀬洋次1, 杉野善彦1, 竹田優作1, 大島有美子1, 桜田宏明1, 山村益己1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1340-1340, 2017.

---

	P1085-4-PM. One case that experienced DIC during chemotherapy in our hospital, and was given pharmaceutical intervention 相内尚也1, 津山博匡1, 工藤正純1, 下山律子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1340-1340, 2017.

---

	P1087-4-PM. Onset after the bevacizumab administration of cardiac hypertrophy and the factor analysis 有松冴1, 須川由理子1, 水谷薫1, 原美由紀1, 伊藤朱里1, 佐宗智之1, 出口賀奈子1, 川崎好人1, 出口裕之1, 橋本陽1, 小出哲朗1, 石川久高1, 鈴木秀郎2, 町支秀樹2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1341-1341, 2017.

---

	P1089-4-PM. Examination about the current situation and measures of Hypersensitive reaction in Oxaliplatin 渥美仁1, 浅井澄子1, 中山貴美子1, 澤口和代1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1341-1341, 2017.

---

	P1091-4-PM. About the skin management with the antiEGFR analogous drug in our hospital 石井紀子1, 岡野芳彦1, 篠崎亮介1, 山口智1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1342-1342, 2017.

---

	P1093-4-PM. Examination about the antiviral prophylaxis for the herpes zoster of patients with multiple myeloma 田中早穂子1, 原友子1, 松下尚弘1, 大畠綾子1, 石丸隆之1, 町田梨絵子1, 野中敏治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1342-1342, 2017.

---

	P1095-4-PM. Use results of the peg filgrastim in our hospital 山本輝尚1, 小沼大祐1, 新藤学1, 加藤一郎1, 中野茂治2, 鈴木正人2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1343-1343, 2017.

---

	P1097-4-PM. Effective evaluation of the polaprezinc for the zinc deficiency-related taste disturbance that occurred in patients who received cancer chemotherapy 若林雅人1, 上野真由美2, 矢嶋明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1343-1343, 2017.

---

	P1099-4-PM. Practice - HBV reactivation measures - of PBPM which systems construction realized 高田あゆみ1, 合津貴志1, 高橋紗英子1, 伊與田友和1, 渡邊弘枝1, 渡部照美1, 関根悠1, 田崎政則1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1344-1344, 2017.

---

	P1101-4-PM. Examination about safety and the effectiveness in FOLFIRINOX therapy and the peg filgrastim combination 竹内麻理子1, 野崎圭佑1, 澤井祐樹1, 杉本貴洋1, 清水克次1, 角川幸男1, 中多陽子1, 坂上嘉浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1344-1344, 2017.

---

	P1103-4-PM. The use situation of the peg filgrastim in our hospital 町支優和1, 原田哲彦1, 坂野博紀1, 村上仁志1, 石川元章1, 石田隆浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1345-1345, 2017.

---

	P1105-4-PM. About the safety of the ramucirumab + paclitaxel (RAM + wPTX) therapy for patients with old gastric cancer 加藤雅斗1, 宮澤憲治1, 早川裕二1, 溝神文博1, 平野隆司1, 高橋朗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1345-1345, 2017.

---

	P1107-4-PM. Examination of the drug used for hiccups at the cancer chemotherapy 水口敦子1, 綾田翔1, 井筒理子1, 田中翔一1, 佐々木文子1, 宮川貴行1, 梶井孝洋1, 西澤修一1, 西川正直1, 松久哲章2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1346-1346, 2017.

---

	P1109-4-PM. About the relations of paronychia and the effect by the Afatinib 北爪賀子1, 牧原玲子1, 先山奈緒美1, 石曽根好雅1, 関口昌利1, 橋本浩伸1, 寺門浩之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1346-1346, 2017.

---

	P1111-4-PM. One case of the bladder cancer which presented CDDP low Na blood symptom dangerously ill after administration 宮本康平1, 平井成和1, 土井啓員1, 増田雅行1, 佐野君芳1, 真坂亙1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1347-1347, 2017.

---

	P1113-4-PM. Effect on chronic peripheral neuropathy examination of the saccinia virus inoculation rabbit inflammation skin extract-containing preparation of oxaliplatin 柿本智広1, 三浦ひとみ3, 寺嶋圭子3, 大迫政彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1347-1347, 2017.

---

	P1115-4-PM. The effect that a suggestion timing from the pharmacy gives to an HBV-related examination item measurement rate 森善洋1, 吉岡大樹1, 佐道紳一1, 竹本智子2, 小坂幹子2, 峯孝志3, 樋口則英1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1348-1348, 2017.

---

	P1117-4-PM. 2 cases that was effective using formula (viscosity adjustment) and that of Mohs ointment in our hospital 荒木杏奈1, 島三保子1, 松永智子1, 中村泰士1, 山口和記2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1349-1349, 2017.

---

	P1119-4-PM. Effect of the continuous pharmacist intervention by by medical examination front to patients with foreign cancer pain 上野理恵1, 山田正実1, 地丸裕美1, 松村千佳子1,2, 矢野義孝2, 高橋一栄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1350-1350, 2017.

---

	P1121-4-PM. Polypharmacy fact-finding of patients with end-stage cancer which a palliative care team intervened in 佐々木理絵1, 今多亮介1, 林晋太郎1, 新沼芳文1, 本郷文教1, 松本美奈2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1350-1350, 2017.

---

	P1123-4-PM. We input chart making for the adequacy of the relation opioid analgesic sustained injection of the pharmacist in the cancer support team, the lump of prescription, instructions 鳥井祥子1,2, 谷大輔1,2, 福島智子1,2, 有江宏樹1,2, 宮内紗和子3, 小木曽照子2, 土生康司3, 端裕之2, 小林政彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1351-1351, 2017.

---

	P1125-4-PM. It is ... based on introduction of investigation - periphery-related μ opioid antagonists naldemedine of the use of laxative situation of the use of opioid patients 齊藤未希1, 山崎理恵1, 桑野譲2, 清水綾子3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1351-1351, 2017.

---

	P1127-4-PM. Examination of a stress relaxation effect and the immunity reinforcement effect by the mind Fournet's meditation who assumed the IgA out of saliva an index 輿石泰良1,2, 岡元ちよみ1, 小山なつの1, 宮坂英徳1, 深澤みく1, 中川沙織2, 大和進2, 太田伸1, 下枝貞彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1352-1352, 2017.

---

	P1129-4-PM. Multicenter study on effect on fentanyl patch to give to a bowel movement by opioid switching from oral oxycodone 衛藤智章1, 林稔展2, 福山雄卯介3, 築田晃直1, 仲田浩成1, 山下愛登4, 糸永昇平5, 小薮真紀子6, 三角紳博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1352-1352, 2017.

---

	P1131-4-PM. One patient who a pharmacist played a key role of the team, and associated with patients with childhood cancer, a family 前田弘志1, 野妻俊也1, 櫻木佳代子2, 塩満多華子2, 新小田雄一3, 福岡龍一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1353-1353, 2017.

---

	P1133-4-PM. Examination about the effect of the continuous pharmacist intervention on use of opioid analgesic of patients with foreign cancer pain 廣中佑香1, 松村千佳子1, 山田正実2, 地丸裕美2, 上野理恵2, 矢野義孝1, 高橋一栄2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1353-1353, 2017.

---

	P1135-4-PM. In consideration of effect attenuation with rifampicin, it is ... through a case during one case - tuberculosis ward hospitalization that intervened in a drug choice of the chemotherapy for head and neck cancer 山崎彬史1, 奥野昌宏1, 中田学1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1354-1354, 2017.

---

	P1137-4-PM. A preparation of the pregabalin intrarectal administration preparation which added absorbefacient and evaluation of the bioavailability 土井裕貴1, 林克典1, 熱田直也1, 村田勇1, 井上裕1, 山本泰大2, 金本郁男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1354-1354, 2017.

---

	P1139-4-PM. The use situation and problem of the fentanyl citrate buccal tablet 川嵜真太郎1, 堀敦雄1, 藤原信二1, 西嶋長1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1355-1355, 2017.

---

	P1141-4-PM. The case that morphine sustained administration was effective for the headache due to the metastatic brain tumor 鈴木駿介1,3, 高柳論也1,3, 平井栄一2,3, 小林恵美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1355-1355, 2017.

---

	P1143-4-PM. Attitude survey about the drug for the medical care of the nurse 薦田理恵1, 森田早貴1, 安原景子1, 阿部真寿美1, 華房幸代1, 二宮洋子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1356-1356, 2017.

---

	P1145-4-PM. Relation of the pharmacist in opioid rounds aiming at early symptom relaxation 藤原歩1,2, 赤瀬博文1,2, 濱宏仁1, 西尾智尋2, 田中詳二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1356-1356, 2017.

---

	P1147-4-PM. One patient who worked on an evaluation of the strength of the pain of patients with cancer using BPS 杉浦龍也1,4, 守山浩子2,4, 守田覚1, 岡田祐二3,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1357-1357, 2017.

---

	P1149-4-PM. Use experience in the tapentadol hydrochloride tablets administration in our hospital 谷口智美1, 形部文寛1, 升味紀子1, 橋本修1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1357-1357, 2017.

---

	P1151-4-PM. The use situation of the opioid for the mucous membrane disorder at the head and neck cancer radiotherapy 下村純子1, 富井真一1, 伏見久美子1, 塚本真裕子1, 酒井郁美1, 藤堂未央1, 向山郁美1, 津田正博1, 古谷誠一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1358-1358, 2017.

---

	P1153-4-PM. Use investigation of the steroid for the inappetence in the cancer terminal phase 鳥居昌太1,2, 伊藤昌美2, 上田旭美1,2, 江崎秀樹1,2, 杉浦龍也2, 後藤健志2, 遠山幸男2, 岩田智樹2, 川合甲祐2, 山口智江2, 中根茂喜2, 足立守1, 板倉由縁3, 木村和哲4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1358-1358, 2017.

---

	P1155-4-PM. 2 cases that we switched to other opioid pain-killers from methadone 松下尚弘1, 永山淳2, 福島由紀3, 岐部綾子1, 河野吟美1, 野中敏治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1359-1359, 2017.

---

	P1157-4-PM. Examination of the index to be useful for treatment in the terminal phase with infusion and prognostic grasp 宮本朋佳1, 福山紘基1, 畑中重克2, 天生浩子1, 富士谷昌典1, 小泉祐一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1359-1359, 2017.

---

	P1159-4-PM. Examination of the effectiveness by the combination of the opioid analgesic 鈴木景就1, 石渡明子2,4, 村川麻里子1,4, 明石浩史3,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1360-1360, 2017.

---

	P1161-4-PM. An effect and problem of 1 case using the fentanyl immediate release in being at home 藤井武1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1360-1360, 2017.

---

	P1163-4-PM. Opioid consumption pulse-taking of the cancer palliative care patients in the Tokyo Women's Medical University east medical center 周治由香里1,2, 金杉恵1,2, 山賀亮祐1,3, 河越祐哉1,3, 古澤利紗1,3, 藤田亜希子1,3, 冨永春子2, 矢野有紀2, 伊東俊雅1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1361-1361, 2017.

---

	P1118-5-AM. Stomatitis measures using the indometacin spray by the chemotherapy radiotherapy in patients with head and neck cancer 藤田靖之1, 後藤慎一2, 岩永亜紀3, 原田周平1, 入江貞治1, 上原智1, 井上知哉1, 池田能利子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1362-1362, 2017.

---

	P1120-5-AM. Effect of the use situation investigation of the tumor internal medicine Abstral sublingual tablet and the pharmacist intervention 尾関あゆみ1,2, 礒部博隆2,3, 安永浩子2,4, 中川義浩1, 山本春風2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1363-1363, 2017.

---

	P1122-5-AM. The current situation of the drug self-care for the medical care in our hospital and the problem 古川登記子1, 南雲恵美2, 樋口伸子2, 村山貴子3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1363-1363, 2017.

---

	P1124-5-AM. The use situation of the tapentadol hydrochloride extended-release in our hospital 小角麻衣1, 瀬名波宏昌1, 中西晶子1,2, 村山洋子1,2, 音地真理2, 滝本佳予2, 大山覚照2, 名徳倫明3, 川口進一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1364-1364, 2017.

---

	P1126-5-AM. Examination of the stress caused by mind Fournet's meditation relaxation effect who assumed oxytocin out of saliva an index 岡元ちよみ1, 輿石泰良1, 高木千明1, 中川沙織2, 大和進2, 太田伸1, 下枝貞彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1364-1364, 2017.

---

	P1130-5-AM. Clinical evaluations of the pregabalin bougie in patients with cancerous pain 山本泰大1, 犬塚涼子2, 斎藤寛子2, 築山郁人3, 西原真理4, 新井健一4, 金本郁男5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1365-1365, 2017.

---

	P1132-5-AM. The sedative current situation and problem of the cancer terminally ill patients in the Toho University medical center Ohashi Hospital 木村麗砂1, 吉田小百合1, 堀孔美恵1, 中村陽一1, 日浦寿美子2, 小林秀樹2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1366-1366, 2017.

---

	P1134-5-AM. 1 case that we switched from a buprenorphine patch to an oxycodone slow-release preparation, and pain control came to have good 築田晃直1, 三角紳博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1366-1366, 2017.

---

	P1136-5-AM. It is tried an evaluation and the set prescription making of a feeling of resistance of facing each other in the opioid analgesic prescription of the physician 端裕之1, 谷大輔2, 松村友和2, 田村訓子2, 瀬奈波暢子2, 鳥井祥子2, 小林政彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1367-1367, 2017.

---

	P1138-5-AM. Contribution degree investigation of the current situation and the charge pharmacist about the palliative care of the national hospital mechanism (the third report) 八本久仁子1, 形部文寛2, 中村孝祐3, 林俊吾4, 山崎富士子5, 武智宣佳6, 小野友香7, 波多江崇8, 八本聖秀9 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1367-1367, 2017.

---

	P1140-5-AM. Examination about the effect reinforcement of the warfarin with the fentanyl tape 基村佳世1, 槙原克也1, 内山ひとみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1368-1368, 2017.

---

	P1142-5-AM. Relation of the pharmacist to cancer palliative care patients 堀敦雄1, 久保寺祐季1, 川嵜真太郎1, 西嶋長1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1368-1368, 2017.

---

	P1144-5-AM. It is examination ... about the relation from a consultation example about need - relaxation of the pharmacist interview in the foreign chemotherapy room 伊東美歩1, 泉雄介1, 海老原貴之1, 川本拓馬1, 平原一也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1369-1369, 2017.

---

	P1146-5-AM. Use experience of the duloxetine hydrochloride for the peripheral neuropathy-related pain 安田明子1, 台蔵剛志1, 山田千代子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1369-1369, 2017.

---

	P1148-5-AM. The situation investigation of the continuous sedation using the midazolam in the multi-institution 高岡龍蔵1,2, 冨田祐作2, 久米初枝2, 柴田里美2, 杉山和弥2, 渡邉彰己2, 後藤健志2, 遠山幸男1,2, 岩田智樹2, 川合甲祐2, 山口智江2, 中根茂喜2, 板倉由縁3, 木村和哲4, 久田達也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1370-1370, 2017.

---

	P1150-5-AM. The mild medical current situation investigation in patients who received foreign chemotherapy 金井亮太1, 吉岡由理1, 大杉法子1, 春田貴史1, 大塚健太1, 安藤恵1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1370-1370, 2017.

---

	P1152-5-AM. Example that intervened in the local management of the progress breast cancer metastases to skin part 後藤純一1, 有川真理1, 木村裕子2, 角田孝彦3, 関口徳志1, 菅原拓也1, 延川正雄1, 松田圭一郎1, 荒井浩一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1371-1371, 2017.

---

	P1154-5-AM. About the sedative current situation for the purpose of the painful relaxation in our hospital palliative care unit 後藤義之1, 角紀一郎1, 岡田久美1, 石崎真由美1, 本田太朗1, 松岡未紗1, 光井彩1, 茶野下貴恵1, 島崎沙織1, 青木理恵1, 森戸敏志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1371-1371, 2017.

---

	P1156-5-AM. Case report about the differentiation of dementia and the delirium of the cancer terminally ill patients which we examined from the viewpoint of pharmacist 比嘉仁1, 増田多加子1, 船橋英樹2, 杉浦宗敏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1372-1372, 2017.

---

	P1158-5-AM. Examination of the case that conducted palliation by sedation by the midazolam 間瀬広樹1,2, 小林恵里奈2, 吉尾敬登1,2, 石嶋麗1,2, 江戸稚香子1,3, 三村優仁1,4, 秋山哲平2, 鵜浦雅志1,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1372-1372, 2017.

---

	P1160-5-AM. Usefulness of the hydrozincite starch in the at-home relaxation medical care 相良克海1, 森山愛子1, 横溝明美2, 小田慎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1373-1373, 2017.

---

	P1162-5-AM. Filling ... of efforts - PCA pump of the hospital pharmacist for the at-home palliative care 海老根香里1, 神谷未加2, 神賀正博3, 関利一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1373-1373, 2017.

---

	P1164-5-AM. Examination about the possibility that ward exclusive duty pharmacist placement contributes to the effectiveness, safety in the SP therapy 大久保聡1,2, 奈良克彦1, 山下裕玄2, 瀬戸泰之2, 高田龍平1, 鈴木洋史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1374-1374, 2017.

---

	P1166-5-AM. The use situation and side effect report of the nivolumab in the non-small cell lung cancer 菊池亮大1, 高橋典哉1, 淺沼優美1, 及川嵩人1, 城戸直人1, 菊池昌之1, 本庄伸輔1, 守義明2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1375-1375, 2017.

---

	P1168-5-AM. Examination of the rasburicase dosing period for the high-risk tumor lysis syndrome of patients with adult blood-forming organ malignant tumor 小林俊介1, 安武夫1, 佐藤圭1, 黒田誠一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1375-1375, 2017.

---

	P1170-5-AM. Examination of the tumor lysis syndrome (Tumor lysis syndrome: TLS) onset risk factor in the small cell lung cancer 平野真健1, 山下悟史1, 岸川春樹1, 丸子浩1, 富田敏章1, 町田聖治1, 入江利行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1376-1376, 2017.

---

	P1172-5-AM. Proteinuria frequencies and blood pressure fluctuation by the ramucirumab 祖父江伸匡1, 川嵜真太郎1, 堀敦雄1, 西嶋長1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1376-1376, 2017.

---

	P1176-5-AM. Efforts for the duties improvement by the cancer chemotherapy grouping and the future prospects 齊藤有希1, 近藤泰礼1, 志賀隆1, 石川達也1, 重野芳1, 畠山織江1, 朝倉弘太1, 馬場喜弓1, 佐藤邦義1, 荒川隆太郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1377-1377, 2017.

---

	P1178-5-AM. Examination about the effect on effectiveness and side effect of relative intensity of treatment in the gemcitabine + albumin suspension type paclitaxel combination therapy 大登剛1, 土屋裕伴1, 新井亘1, 増田裕一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1378-1378, 2017.

---

	P1180-5-AM. It is side effect expression and the medication situation of hormonal therapies after the operation for patients with postmenopausal breast cancer 芦埜和幸1, 大澤千鶴子1, 黒田晋平1, 齋藤善広2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1378-1378, 2017.

---

	P1182-5-AM. Effect of sex differences to give it to the blood toxicity of the use of rituximab patients in the non-Hodgkin's lymphoma 小林学1, 中村豪志1, 柳井美奈1, 吉原哲2, 岡田昌也3, 木村健1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1379-1379, 2017.

---

	P1184-5-AM. It is evaluated an investigation and the weight loss of the enforcement situation of the adjuvant chemotherapy after the gastric cancer technique 中市里実1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1379-1379, 2017.

---

	P1186-5-AM. Search of the cisplatin dosage factor in the head and neck cancer chemoradiotherapy 前田愛1, 藤本保志2, 藤野泰孝1, 木下沙織1, 矢野亨治1, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1380-1380, 2017.

---

	P1188-5-AM. Examination about intensity of treatment and the safety in CHOP enforcement DLBCL patients 65 years or older 中村裕一1, 三本松泰孝1, 佐藤弘康1, 和泉秀明1, 田村広志1, 渡辺浩明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1380-1380, 2017.

---

	P1190-5-AM. 1 case that was involved in the returning home support of patients with end-stage cancer of the foreign family register in the municipal hospital 岡田七津子1, 今村諭2, 市田千佳1, 高橋賢成1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1381-1381, 2017.

---

	P1192-5-AM. Usefulness of the EGFR mutation in the gene as the effect predictor of the nivolumab in patients with non-small cell lung cancer 藤井良平1, 田中雅幸1, 今井雄介1, 打谷和記1, 岡崎和一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1381-1381, 2017.

---

	P1194-5-AM. Effective investigation of the trabectedin by the pathological classification 岩西雄大1, 角川幸男1, 脇條靖治1, 金銅葉子1, 中多陽子1, 坂上嘉浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1382-1382, 2017.

---

	P1196-5-AM. Examination of the cytomegalovirus (CMV) infection risk factor of transplant non-adaptation adult T-cell leukemia-lymphoma (ATLL) patients 福石和久1, 吉田裕生2, 津曲恭一3, 高田正温4, 川俣洋生5, 牛島知実1, 木村修徳6, 衛藤智章7, 齋田翌美8, 林稔展1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1382-1382, 2017.

---

	P1198-5-AM. Efforts of "the regimen cafe" which aimed at the improvement of cancer medicine medicine cooperation in the Mie University faculty of medicine hospital 日置三紀1, 石橋美紀1, 岩本卓也1, 奥田真弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1383-1383, 2017.

---

	P1200-5-AM. Examination of the medical economics of the FOLFIRINOX, GEM + nabPTX, GEM for progress, recurrent pancreatic cancer and S-1 therapy 三岡麻千子1, 木村美智男1, 岩井美奈1, 宇佐美英績1, 吉村知哲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1383-1383, 2017.

---

	P1165-4-PM. It is the number of investigation in the survival month of patients with progress, recurrent colon, rectal cancer which is impossible of curative resection in the Higashi-Asahikawa Hospital 里見眞知子1, 河野透2, 山崎弘貴3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1384-1384, 2017.

---

	P1167-4-PM. Investigation of the onset situation and the risk factor of the hypomagnesemia by Panitumumab 西和哉1, 川田彰彦1, 高橋舞1, 佐々木崇1, 中澤泰子2, 高橋秀和2, 安田勝洋2, 大堀久詔2, 佐賀利英1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1385-1385, 2017.

---

	P1169-4-PM. Investigation of the cancer chemotherapy cancellation reason in the Shiga University of Medical Science faculty of medicine hospital 河原幸恵1, 須藤正朝1, 野田哲史1, 若杉吉宣1, 藪田直希1, 山本優1, 井堀仁美1, 中村春香1, 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1385-1385, 2017.

---

	P1171-4-PM. The effect that steroid used for cancer chemotherapy gives to bone density 早川怜花1, 山本花菜1, 澤木明2, 林高弘1,3, 安藤洋介3,4, 太田秀基3,4, 山田成樹3,4, 河田健司2, 安田公夫1, 池田義明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1386-1386, 2017.

---

	P1175-4-PM. Evaluation of the nutritional status using the Prognostic nutritional index in patients who received head and neck cancer CDDP+RT therapy 藤原大一朗1,2, 眞下惠次1,2, 木村佳世1, 星田唯史1, 森本奈緒美1, 和田祥明1, 野田明宏1, 多喜和夫1, 武田朋也2, 椿正寛2, 西田升三2, 阪口勝彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1387-1387, 2017.

---

	P1177-4-PM. 2 cases with suspected drug-related pulmonary disorder by Nivolumab 松浦暢子1, 小西千尋1, 南野智志1, 草薙みか1, 山本倫数1, 青山瑛里子1, 洪鉉寿2, 瓜生恭章2, 大里恭章1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1387-1387, 2017.

---

	P1179-4-PM. The effect that BMI gives to thrombocytopenia in the Carboplatin treatment 田中千裕1, 塩内淑予1, 安藤洋介2,3, 林高弘1,2, 堀場瑠莉2,3, 宮田七帆2,3, 太田秀基2,3, 澤木明4, 河田健司4, 安田公夫1, 池田義明1, 山田成樹2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1388-1388, 2017.

---

	P1181-4-PM. Comparison ... by neutropenic frequency - first treatment at GN therapy enforcement for patients with pancreatic cancer and the second treatment 力丸理菜1, 槇田崇志1, 神崎浩孝1, 堀口繁2, 加藤博也2, 堤康一郎2, 田中雄太1, 小川敦1, 西原茂樹1, 村川公央1, 北村桂久1, 千堂年昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1388-1388, 2017.

---

	P1183-4-PM. Examination of the immune-mediated adverse event in the nivolumab treatment of the non-small cell lung cancer 白井敦史1, 埋橋賢吾1, 薮田ゆみ1, 中島恵子1, 橋本佳浩1, 近藤丈博2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1389-1389, 2017.

---

	P1185-4-PM. Examination of the onset of dermatopathy risk by the eosinophil count before the nivolumab administration 井上誠二1, 大澤友裕1, 梅田道1, 渡邊久高1, 牧野哲平1, 長屋雄大1, 甲田明英1, 堀晃代1, 田中和秀1, 安田昌宏1, 水井貴詞1, 澤祥幸2, 後藤千寿1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1389-1389, 2017.

---

	P1187-4-PM. About lymphocytopenia of the EC therapy every every 21st and 14th in the postoperative chemotherapy before breast cancer technique 阿部多一1, 住谷達也1, 柳内亮祐1, 井口恵美子1, 猪股克彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1390-1390, 2017.

---

	P1189-4-PM. About a side effect and the effect of the case given nab-PAC+GEM therapy to treatment pancreatic cancer impossible of excision in every other week 石崎文子1, 相原敏彦1, 増尾昌則1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1390-1390, 2017.

---

	P1191-4-PM. About the effectiveness and safety judging from difference in Afatinib initial dosage by the 1stLine treatment 坂田幸雄1,2, 村永諒1, 齋藤淳2, 山添雅巳2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1391-1391, 2017.

---

	P1193-4-PM. It is searched for recurrent predictor in the adjuvant chemotherapy after the colon cancer technique 星田唯史1, 藤原大一朗1, 眞下惠次1, 森本奈緒美1, 和田祥明1, 野田明宏1, 多喜和夫1, 阪口勝彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1391-1391, 2017.

---

	P1195-4-PM. The detection bacteria situation investigation from patients with multiple myeloma and an each regimen 清水幸宏1,2, 井上博章1, 松本直人1, 庄司優2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1392-1392, 2017.

---

	P1197-4-PM. Evaluation of the usefulness of the elderly people usability test in the cancer chemotherapy management for patients with old gastric cancer 齊藤雅代1, 奈良克彦1, 山下裕玄2, 大久保聡1, 山本武人3, 高田龍平1, 瀬戸泰之2, 鈴木洋史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1392-1392, 2017.

---

	P1199-4-PM. Examination of administration cancellation, the postponement reason of the cancer chemotherapy 丸山昌広1, 定盛理純1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1393-1393, 2017.

---

	P1201-4-PM. Use fact-finding of the pharmaceutical products in the cancer domain out of the adaptation 文靖子1,3, 米盛勧2, 砂土居寛子3, 寺門浩之3, 藤原康弘2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1393-1393, 2017.

---

	P1202-5-AM. Efforts for use fact-finding and the proper use of the disinfectant of the foreign clinical department management 中田一孝1, 冨田有香1, 蚊野純代2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1394-1394, 2017.

---

	P1204-5-AM. Examination about the adequacy of the antimicrobial therapy in the ophthalmology perioperative period 青山響1, 上村賢介1, 須佐充1, 簔口紗織2, 風間伸介3, 中村裕介4, 大矢佳美5, 安藤伸朗4, 内坪誉歳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1395-1395, 2017.

---

	P1206-5-AM. Fact-finding of hepatitis B measures at colon cancer postoperative chemotherapy start using big data 室高広1, 福重友理1, 馬場安里1, 今村政信1, 中川博雄1, 北原隆志1, 佐々木均1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1395-1395, 2017.

---

	P1208-5-AM. Construction of the count system for the trend grasp of the oral antimicrobial medicine consumption 加藤善章1, 山本雅人1, 永井拓1, 八木哲也2, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1396-1396, 2017.

---

	P1210-5-AM. The use situation investigation aiming at peramivir treatment standardization in our hospital 浅川杏子1, 清水忠洋1, 齊藤安昌1, 鎌田泉1, 曾根原亘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1396-1396, 2017.

---

	P1212-5-AM. Use of injection antimicrobial pulse-taking in our hospital 近藤提1, 杵渕貴洋2, 山根知1, 藤岡亮司1, 庄司雅代3, 上坂知佳3, 山路亜弓2, 角谷不二雄4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1397-1397, 2017.

---

	P1214-5-AM. Examination of the initial treatment in the fungemia 北川誠子1, 藤井哲英1, 二宮洋子1, 勝村登美子2, 平田早苗3,6, 石松昌己4, 河口豊4, 大石智洋5,6, 寺田喜平5,6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1397-1397, 2017.

---

	P1216-5-AM. Relation of AST to a febrile neutropenia case at the breast cancer chemotherapy 寺松早紀1, 蔵王なつか1, 菊池衣里佳1, 中嶋陽一1, 松崎雄1, 白石亘1, 柿原圭佑1, 三上忠司1, 葉田昌生1, 藤井裕史1, 大塚弘子2, 山口美樹2, 田中眞紀2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1398-1398, 2017.

---

	P1218-5-AM. Effect on use of antimicrobial situation and Pseudomonas aeruginosa before and after the antimicrobial round start-sensitive rate 小林誠一1, 丸岡浩太1, 内山乃映1, 村松奈緒美1, 山田倭花1, 大窪真理絵1, 伊代田萌子1, 梅澤仁美1, 河村紳介1, 坂口修治1, 富沢裕之1, 山下敦史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1398-1398, 2017.

---

	P1220-5-AM. We work on antimicrobial appropriate support based on bacteria test result 堤克成1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1399-1399, 2017.

---

	P1222-5-AM. Role of Candida Bundle compliance and the pharmacist in our hospital 林幹也1, 山元紀世子2, 後藤志典1, 伊藤美登里3, 白井雅美3, 赤崎淳子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1399-1399, 2017.

---

	P1224-5-AM. Inspection of the effectiveness of Tamiflu in the influenza infection prophylaxis measures our hospital 勝又一雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1400-1400, 2017.

---

	P1226-5-AM. Efforts and effect of Antimaicrobial Stewardship Team (AST) aiming at the shift to an initial support type 尾花祥世1,5, 吉田朱里1,5, 地守絢子2,5, 桑名良和2,5, 上野一枝3,5, 山本光成4,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1400-1400, 2017.

---

	P1228-5-AM. It is efforts for the one for infection prophylaxis antimicrobial senior envoy after the operation in the cardiovascular surgery 花房喜子1,3, 小椋大1,3, 小森亮子1,3, 鈴木ゆきえ1,3, 荒川裕明1,3, 藤宮剛2, 入江嘉仁2, 高木賢司3, 蛭田留里子3, 林靖子3, 中山晴夫3, 猪爪信夫4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1401-1401, 2017.

---

	P1230-5-AM. An in-hospital study session in the norovirus infection and investigation about the understanding degree 伊藤嘉英1, 清水智也1, 森広輔2, 長谷川雅哉1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1401-1401, 2017.

---

	P1232-5-AM. Intervention effect of the ICT on patients that Candida was detected than blood culture 石田茂伸1,2, 山田加代子2, 藤原大亮1,2, 笹谷純平2,3, 竹村陽介2,3, 田中まこと2,3, 川村真代2,3, 星育子1, 中井由佳1, 楠本茂雅4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1402-1402, 2017.

---

	P1234-5-AM. The prescription situation investigation of the oral cephalosporin antimicrobial in the ambulatory practice of the Iizuka Hospital 内田守次1, 梅田勇一1, 長崎皓光1, 進健司1, 牛島悠一1, 金澤康範1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1402-1402, 2017.

---

	P1236-5-AM. Investigation about the development of Clostridium difficile infection and the association of the antimicrobial proper use 小嶋希望1, 坪田晃司1, 宮本康史1, 竹内里哉1, 上野英文1, 齊藤拓也2, 長島明美2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1403-1403, 2017.

---

P1238-5-AM. About antibiotic consumption by the aspiration pneumonia pass introduction and a change of the mean hospitalization 村雲智久1, 長濱藍1, 仲村亮太1, 新里勇二2, 与古田美智代3, 喜多洋嗣1, 喜多幸子1, 森智子1, 駒井勇太1, 小松祐輔1, 泉優貴1, 近藤理美1, 坂口勇斗1, 石井奈津季1, 久田潤平1, 三浦捺樹1, 峯浩太朗1, 宮川千珠1, 竹治優紀1, 松元あみ1, 水野康平1, 山中愛美1, 吉村美菜1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1403-1403, 2017.

---

	P1240-5-AM. Cause investigation and measures of the influenza mass outbreak 吉原涼子1, 溝田繁治1, 中村みさ2, 東島彰人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1404-1404, 2017.

---

	P1242-5-AM. An effect of the AST intervention in staphylococcus aureus bacteremia treatment and study on pre-rear predictor 平野龍一1,2, 三橋達郎1,3,4, 北澤淳一1,5, 山本章二2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1404-1404, 2017.

---

	P1244-5-AM. Antimicrobial proper use support in the small and medium size hospital 仲井修一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1405-1405, 2017.

---

	P1246-5-AM. Questionary survey about the antiHIV medicine storage management at needle pad accident in the Tokushukai group Hospital and body fluid exposure 手嶋由加1, 田中博和1, 井上幸子1, 平川雅章1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1405-1405, 2017.

---

	P1248-5-AM. Intervention example of the pharmacist in the prophylaxis at influenza outbreak 中島一1, 今村陽子1, 大石貴裕1, 池田浩和1, 高橋浩二郎1, 吉田綾2, 山中直子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1406-1406, 2017.

---

	P1250-5-AM. Examination of the antibody acquisition with the hepatitis B vaccination derived from a different antigen 山下克也1, 津曲恭一3, 尾田一貴5, 小園亜希4, 田中亮子2, 中村光与子2, 山道研1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1406-1406, 2017.

---

	P1252-5-AM. The MRSA rate of detection that antimicrobial consumption AUD and hand hygiene give, effect on separation rate 溝田繁治1, 吉原涼子1, 谷口潤1, 大野直義1, 永吉洋介1, 岩永直樹1, 中村みさ1, 江島遥1, 藤岡ひかる1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1407-1407, 2017.

---

	P1203-4-PM. Examination of the change over time at injectable vancomycin and furosemide injection combination under the acid condition 山岡真理子1, 笹原里美1, 畑勝友2, 宗像千恵3,4, 渕上由貴4, 萩森政頼4, 立木秀尚1, 川上茂4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1408-1408, 2017.

---

	P1205-4-PM. Examination about the MSSA blood culture-positive example in our hospital 川尻さおり1, 脇川富美子2, 橋口浩二3, 町田毅1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1409-1409, 2017.

---

	P1207-4-PM. Construction and evaluation of the software making antimicrobial data as a table 堀尾秀明1, 土本大輔1, 宮川佐和子1, 宇都宮純平1, 戸田康裕1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1409-1409, 2017.

---

	P1209-4-PM. Comparison of the use of antimicrobial situation by the use of specific antimicrobial report method change 海野亜実1, 久保田綾乃1, 牧野和也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1410-1410, 2017.

---

	P1211-4-PM. Sensitivity change of efforts and Pseudomonas aeruginosa for the use of antimicrobial in our hospital 石毛宏治1, 松木祥彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1410-1410, 2017.

---

	P1213-4-PM. Evaluation of safety and the effectiveness of the influenza 4 values vaccination in the healthcare worker 赤坂和俊1, 小原拓1, 遠藤史郎2, 池田しのぶ3, 十日市文子1, 鈴木博也1, 久道周彦1, 山口浩明1, 賀来満夫3, 眞野成康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1411-1411, 2017.

---

	P1215-4-PM. Investigation about the effect to the infection control area by the assignment of the infection control authorization pharmacist in our hospital 高橋淳一1, 田中克幸1, 大沼明子1, 大箭彰1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1411-1411, 2017.

---

	P1217-4-PM. The current situation investigation for the drug-resistant measures action plan of a hospital medical doctor in hospital and the health insurance pharmacy pharmacist 坂本拓也1,2, 川村ひとみ1,2, 土佐直子1, 小川洋司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1412-1412, 2017.

---

	P1219-4-PM. What are the measures really necessary for an AMR measures action plan? Antimicrobial proper use approach ... to search for from ... drug resistance trend 小林岳1, 小林綾1,3, 町田浩晃1, 坂本光男2,3, 飯島尚志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1412-1412, 2017.

---

	P1221-4-PM. Review of the perioperative clinical path based on practice guidelines for infection prophylaxis antimicrobial proper use after the operation 小野雅文1,5, 藤原百々子4,5, 菅原麻貴3,5, 園部ゆかり3,5, 塩出昌弘2,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1413-1413, 2017.

---

	P1223-4-PM. The effect that a change of the prophylactic antimicrobial by the ICT intervention gives to an SSI incidence and medical expenses in the oral surgery surgery 吉田謙介1, 鈴木直人1, 新木貴大1, 磯辺浩和1,3, 西川敦2, 児玉泰光2, 高木律男2, 田邊嘉也3, 外山聡1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1413-1413, 2017.

---

P1225-4-PM. Promotion of surgical-site infections surveillance and the perioperative infection prophylaxis antimicrobial proper use in the ICT 小関崇文1,4, 大貫敏明1,4, 日向早苗1,3, 湊栄治2, 安田麻美4, 高橋優香4, 杉浦健一4, 藤岡敬子4, 小林健太郎4, 西關由梨子4, 芦澤由佳4, 笠井洋輝4, 安西美咲4, 加藤由紀4, 小杉英恵4, 伊藤早紀4, 梅庭万理子4, 篠原成美4, 横山翔一4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1414-1414, 2017.

---

P1227-4-PM. About effect on use of antimicrobial density (AUD) and antimicrobial administration days (DOT) by the introduction of the carbapenem-based antimicrobial registration system using the registration of patient 高野温志1, 向井夏紀1, 伊賀正典1, 大川直美1, 牧俊一1, 神山治郎1, 田口茂正1, 天野雅子1, 町田充2, 高屋俊樹3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1414-1414, 2017.

---

	P1229-4-PM. Economic effect by the pharmacist of the infection measures team becoming the leadership, and intervening in the use of antiMRSA medicine patients 中野祐樹1, 大竹野久雄1, 船津康弘2, 熊谷康司3, 尾形博子4, 末安禎子5, 横尾賢乗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1415-1415, 2017.

---

	P1231-4-PM. The current situation and problem of AST of the JCHO Kurume General Hospital 蔵王なつか1, 寺松早紀1, 菊池衣里佳1, 中嶋陽一1, 松崎雄1, 白石亘1, 柿原圭佑1, 三上忠司1, 葉田昌生1, 藤井裕史1, 北里裕彦2, 田中眞紀3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1415-1415, 2017.

---

	P1233-4-PM. Efforts to the antimicrobial proper use for blood culture, endotoxin-positive patients 植竹宣江1, 長藤多香美1, 増田博久1, 宮森伸一1, 柳田祐子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1416-1416, 2017.

---

	P1235-4-PM. Examination of the understanding degree investigation of the pharmacist for hand washing and the infection control 清水智也1, 伊藤嘉英1, 長谷川雅哉1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1416-1416, 2017.

---

	P1237-4-PM. Efforts for antimicrobial proper use in our hospital 坂口結斗1, 仲村亮太1, 新里勇二2, 与古田美智代3, 喜多洋嗣1, 喜多幸子1, 長濱藍1, 森智子1, 駒井勇太1, 小松祐輔1, 泉優貴1, 近藤理美1, 石井奈津季1, 久田潤平1, 三浦捺樹1, 峯浩太朗1, 宮川千珠1, 竹治優紀1, 松元あみ1, 水野康平1, 山中愛美1, 吉村美菜1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1417-1417, 2017.

---

	P1239-4-PM. Trend of the carbapenem-based antimicrobial after the antimicrobial proper use support team start 梅林良英1, 三木芳晃1, 塚本啓介1, 渡邉優子1, 山口みなみ1, 岡千恵1, 安井良則2, 萱野勇一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1417-1417, 2017.

---

	P1241-4-PM. Investigation of the antimicrobial consumption after the antimicrobial appropriate support team introduction 齊田峻1, 松山良平1, 佐藤数馬1, 林智樹1, 稲本正之1, 鈴木徹士1, 大谷享央1, 塩練秀一2, 梅田真之3, 島田慰彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1418-1418, 2017.

---

	P1243-4-PM. Pulse-taking of methicillin-resistant staphylococcus aureus in our hospital and the antimicrobial consumption 原田大1,2, 中南秀将1, 北村好申2, 川久保孝2, 野口雅久1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1418-1418, 2017.

---

	P1245-4-PM. Effect of the pharmacist intervention in the antimicrobial prescription 杉浦右真1, 志野訓之1, 野村泰生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1419-1419, 2017.

---

	P1247-4-PM. Effective evaluation of the oseltamivir five days postexposure prophylaxis administration for the roommate, Look at the rear; a mark observational study 田中博和1, 手嶋由加1, 片渕由貴2, 宮津大輔1, 伊藤恭子2, 平川雅章1, 松林直2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1419-1419, 2017.

---

	P1249-4-PM. Grasp of the hand rough weather situation of the nurse using the original hand rough weather evaluation scale and examination of preventive measures against hand rough weather 吉井千菊1,2,3, 岡村吏華1, 棚田真紀1, 渡辺恵美1, 星野智美1, 波能満理惠1, 脇田真之1, 伊藤ひろみ2, 加藤勤3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1420-1420, 2017.

---

	P1251-4-PM. Activity for antimicrobial report rate improvement 森田啓嗣1, 川上恭弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1420-1420, 2017.

---

	P1253-4-PM. Consciousness and problem of the environmental hygiene in the ethical pharmacy staff 西澤健太1, 熊谷美穂1, 高嶋健太1, 北原昌和1, 染谷光洋1, 谷口亮央1, 宮本雄大1, 中島史雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1421-1421, 2017.

---

	P1254-5-AM. Advisability of the simple suspension method application of two kinds of antiHIV medicine containing the prodrug of the tenofovir 出口千裕1, 寺岡麗子1, 矢倉裕輝2, 湯谷玲子1, 坂根稔康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1422-1422, 2017.

---

	P1258-5-AM. Change of the use situation and the serum creatinine level of antiHIV medicine FTC/TAF in our hospital 南川知央1, 安田明子1, 下川千賀子1, 山田千代子1, 渡邉珠代2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1423-1423, 2017.

---

	P1255-4-PM. 1 case that examined hemo filter clearance of the tenofovir during the sustained hemofiltration dialysis enforcement 築地茉莉子1, 山崎伸吾1, 鈴木達也1, 櫻井隆之2, 谷口俊文2, 中村貴子1, 鈴木貴明1, 猪狩英俊2, 石井伊都子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1425-1425, 2017.

---

	P1257-4-PM. About the relation of the pharmacist in the antiHIV medicine prescription situation and HIV ambulatory practice in our hospital 成田綾香1, 鈴木直人1, 外山聡1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1426-1426, 2017.

---

	P1259-4-PM. Relation of the pharmacist for the HIV infection pregnant woman 下川千賀子1, 安田明子1, 南川知央1, 米澤美和1, 山田千代子1, 渡邉珠代2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1426-1426, 2017.

---

	P1261-4-PM. About a choice and a change of the antiHIV medicine in patients with HIV infection in our hospital 赤木圭太1, 加藤一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1427-1427, 2017.

---

	P1262-5-AM. Investigation of the infusion composition at hyperalimentation start in the neonatal intensive care unit 館内謙太郎1, 元木孝1, 高柳昌宏1, 千田泰健1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1428-1428, 2017.

---

	P1264-5-AM. Investigation about the combination of the PPI in the use of Heine E gel patients 重久友紀1, 柴田由香里1, 中目順子1, 深水知英1, 菅原英輝1, 武田泰生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1429-1429, 2017.

---

	P1266-5-AM. Having been able to see it from use of antimicrobial fact-finding for the nourishment support team rounds enforcement patients of our hospital 中村新1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1429-1429, 2017.

---

	P1268-5-AM. One case that overall status improved by NST intervention 西村尚芳1, 津曲恭一1, 尾之江剛樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1430-1430, 2017.

---

	P1263-4-PM. A pharmacist can do it from the viewpoint of search - NST intervention of a fall, the fall risk factor using DPC data, use drug 鈴木統子1, 細谷龍一郎1, 平野享子2, 宗山真梨奈1, 黒川美知代3, 日野斉一1, 鎌田智幸4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1431-1431, 2017.

---

	P1265-4-PM. 1 case that a change of the rate of application was effective for the patients whom chyle was found in by lipid microsphere administration 河野大希1, 中嶋浩太郎1, 岩尾卓朗1, 則松郁香1, 鈴木寛人1, 上原智博1, 鈴田浩孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1432-1432, 2017.

---

	P1267-4-PM. Examination of the fluid therapy of patients with end-stage cancer 川野壮一1, 組橋由記1, 吉田郁子1, 松尾あずさ1, 鈴江朋子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1432-1432, 2017.

---

	P1269-4-PM. The investigation of the intervention effect by the pharmacist on polypharmacy of patients admitted to the digestive organ surgery ward: Single institution rearward observational study 小野塚和人1, 吉廣尚大1, 礒貝明彦1, 岡野愛子1, 中光篤志2, 橋本佳浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1433-1433, 2017.

---

	P1271-4-PM. Examination of the self-care introduction using the RCS, FIM to patients with old forming disease in the convalescent rehabilitation ward 遠藤秀竜1, 堀浩子1, 細野真吾1, 加藤貴由1, 河村千晶1, 山崎崇1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1434-1434, 2017.

---

	P1273-4-PM. Examination for an evaluation of the drug consumption in elderly people and the future pharmaceutical intervention 竹下秀司1, 佐野一也1, 久保田倫代1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1434-1434, 2017.

---

	P1275-4-PM. The prescription situation investigation of the sleeping drug to elderly people 今村陽子1, 安河内亮太1, 池田浩和1, 高橋浩二郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1435-1435, 2017.

---

	P1277-4-PM. The use actual situation of the drug needing the careful administration in elderly patients 75 years or older 羽賀智宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1435-1435, 2017.

---

	P1279-4-PM. Relation of the pharmacist by dementia care team rounds ソディ保子1, 高橋美和子2, 瀧本裕3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1436-1436, 2017.

---

	P1281-4-PM. Relation of an activity and the pharmacist of the dementia care team in our hospital 松本哲哉1, 土屋秀樹1, 月光淳1, 山野惣平1, 玉置秀成1, 中村智1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1436-1436, 2017.

---

	P1283-4-PM. Summary of the intervention case of the dementia care team and the prescription suggestion 菊池健1, 土屋早苗2, 澤野亜矢子3, 塩川哲男4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1437-1437, 2017.

---

	P1285-4-PM. The enforcement situation of the participation in planning of the pharmacist to the dementia care team and the pharmaceutical care 原口佳子1, 松崎真理子2, 本田省二3, 畦地なつき4, 星野輝彦1, 塩津和則1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1437-1437, 2017.

---

	P1287-4-PM. Efforts for the elderly people multiple drug prescription adequacy by pharmacist - physician collaboration 上田由貴1, 堀之内登2, 塩田星児2, 高倉健2, 島添陽子1, 山代栄士1, 和田祐一郎1, 森一生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1438-1438, 2017.

---

	P1289-4-PM. Development of the medication aid using 3D printer 大嶋耐之1, 田中美帆1, 廣瀬悠1, 千賀香織1, 宮地佑佳1, 仲山千佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1438-1438, 2017.

---

	P1291-4-PM. Efforts of the prescription adequacy for the elderly people in house type pay nursing home 中川友之1, 丸一泰雅1, 角佳亮1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1439-1439, 2017.

---

	P1293-4-PM. Efforts (one case report) to the prescription adequacy by the polypharmacy reduction team 真野澪1, 宮澤憲治1, 溝神文博1, 早川裕二1, 加藤雅斗1, 平野隆司1, 荒井秀典2, 高橋朗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1439-1439, 2017.

---

	P1295-4-PM. Fact-finding of the drug global assessment adjustment addition in our hospital 芦田理沙1, 四方純子1, 上羽沙綾1, 佐賀嘉英1, 門脇隼也1, 奥村智晴1, 塩見明日香1, 谷田有花1, 足立圭司1, 村上由樹1, 川見里奈1, 堀雅博1, 足垣亮介1, 宮谷正哉1, 山本真世1, 立道直美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1440-1440, 2017.

---

	P1270-5-AM. An evaluation and analysis of the ability for medication of elderly people using J-RACT and RCS in the convalescent rehabilitation ward 河村千晶1, 遠藤秀竜1, 細野真吾1, 堀浩子1, 加藤貴由1, 山崎崇1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1441-1441, 2017.

---

	P1272-5-AM. Pharmacist independent intervention for improvement in rheumatic patients medication adherence 舩木文子1, 河越祐哉1, 高木香恵2, 井上靖雄3, 伊東俊雅1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1442-1442, 2017.

---

	P1274-5-AM. Questionary survey for proper use manual preparation of the drug for the purpose of the sedation 渡辺智康1, 難波良平1, 山崎恵1, 高取孝一1, 安藤哲信1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1442-1442, 2017.

---

	P1276-5-AM. Effect with the use drug in the dementia care support team consultation example 西川裕美1, 伊藤匡伸1, 大野愛1, 大西邦明2, 桑山結子1, 杉浦真3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1443-1443, 2017.

---

	P1278-5-AM. One case of the composite topalgia syndrome that Yokukansan was effective for chronic intractable pain 江草徳幸1, 藤本雅宣1, 下岡由紀1, 安原昌子1, 堀川俊二1, 清水良2, 瀬浪正樹3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1443-1443, 2017.

---

	P1280-5-AM. Relation of the pharmacist to dementia in the diabetes outpatient 中司梨紗1, 杉本悠花1, 成末まさみ1, 福田康恵2, 平瀬万里3, 世羅康徳4, 赤澤昭一4, 田川雅浩5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1444-1444, 2017.

---

	P1282-5-AM. Consideration of the risk factor associated with the onset of the elderly people delirium 長谷川豊則1, 小野翔太郎1, 水谷加代子1, 金澤克洋1, 柴田紗希1, 鈴木彩美1, 中川由紀子1, 加賀香織1, 籾山智美1, 兼子結衣1, 山田実咲1, 板倉充沙1, 長谷川瑛美1, 松井千恵1, 加藤貴代1, 白上昇1, 上田周平1, 鵜飼克行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1444-1444, 2017.

---

	P1284-5-AM. Role of the pharmacist in the dementia care team 大波芙実子1, 富樫映一子2, 前田伸也3, 平岩知子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1445-1445, 2017.

---

	P1286-5-AM. We regard future efforts as a summary of the medical therapy in the intervention of our hospital urination care team through an investigation of the effect of treatment 吉田諒1, 庄司知摩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1445-1445, 2017.

---

	P1288-5-AM. The inhalational instruction example that cooperated with the welfare tool planner 酒井孝征1, 中島宏文2, 乾武広3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1446-1446, 2017.

---

P1290-5-AM. Relation to the dentistry prescription in elderly patients except the hospitalization by the hospital pharmacist in connection with the multi-type of job to be engaged in community medical care 岩尾一生1,2, 及川孝司1,2, 末永智美3, 竹田瑞菜3, 吉野夕香4, 仲尾源太5, 丹羽正太5, 金本路5, 尾立光5,6, 遠藤泰1,2, 會田英紀5,6, 川上智史5,6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1446-1446, 2017.

---

	P1292-5-AM. Examination of the press through pack for the use drug to patients with dementia 佐多照正1, 堀内智裕1, 中松穂菜美1, 鶴永大貴1, 中島理恵1, 中村有莉恵1, 赤星真広1, 上原友美1, 石神誠子1, 池増鮎美1, 西憲文2, 花木とき子3, 前之原茂穂4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1447-1447, 2017.

---

	P1294-5-AM. The current situation investigation of the polypharmacy in the convalescent rehabilitation ward and intervention effect by the pharmacist 小澤礼奈1, 金澤弥子1, 山崎理恵1, 鈴川活水2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1447-1447, 2017.

---

	P1296-5-AM. Continuous instructional activity for the improvement in knowledge of the medical staff by the monthly distribution of "medicine for "bedsore" newspaper" 朝倉寛達1, 池田直樹1, 秋山真二2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1448-1448, 2017.

---

	P1299-4-PM. Resident the pharmacist to a community medical care room is consideration ... about - inquiry duties 新康憲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1450-1450, 2017.

---

	P1301-4-PM. Investigation about the cooperation with the drugstore in a hospital and the medical office 伊野陽子1, 舘知也2, 上野杏莉2, 大坪愛実2, 勝野隼人2, 杉田郁人2, 兼松勇汰2, 吉田阿希2, 野口義紘2, 堺千紘1, 井口和弘1, 川上ちひろ3, 藤崎和彦3, 寺町ひとみ2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1450-1450, 2017.

---

	P1303-4-PM. The enforcement situation of patients with stroke cooperation support system and the simple suspension method of the Kaga, Ishikawa district 高波太1, 川手佳幸1, 作田広幸1, 示野哲也1, 西山郁雄1, 大田栄一1, 久保勝1, 下野典子2, 白崎直樹2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1451-1451, 2017.

---

	P1305-4-PM. An advantage and problem of the visit drug control instruction to the terminally ill patients whom hospital pharmacist receives 長友孝純1, 的場つかさ1, 楠本結香1, 高橋唯1, 森江遥1, 平田有佳理1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1451-1451, 2017.

---

	P1307-4-PM. For the at-home mild medical care with community medical care cooperation - connection in the health insurance pharmacy 西村美和1, 舛甚路子1, 阿部恵1, 阿部伸也1, 岡田早苗1, 臺丸谷卓1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1452-1452, 2017.

---

	P1309-4-PM. An activity and problem of the diabetes medical treatment instruction person (CDEJ, CDEL) 伊東健一1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1452-1452, 2017.

---

	P1311-4-PM. The effect that a medication adjuvant product gives to the disintegration of the levofloxacin orally disintegrating tablet and dissolution 福井嵩浩1, 鷹觜彩香1, 山口亜希子2, 西村奈緒恵3, 平舩寛彦1, 千葉健史1, 立木秀尚3, 富田隆1, 工藤賢三1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1453-1453, 2017.

---

	P1313-4-PM. Effect on medical therapy of the patients in the division formulations of the long-term prescription 小林庸祐1, 佐藤秀昭2, 金親正知1, 富岡佳久3, 中尾裕之4, 今井博久5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1453-1453, 2017.

---

	P1315-4-PM. Cooperation with the physician through efficacy, the side effect monitoring for the adrenal cortical steroid introduction patients 井堀仁美1, 大石和美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1454-1454, 2017.

---

	P1319-4-PM. One case that home discharge was enabled as patients who received hospitalization cancer chemotherapy that had difficulty in diet intake received introduction of HPN and side effect monitoring 前田康裕1, 坂谷英亨1, 木村嘉明1, 平賀貴志1, 高畠栄一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1455-1455, 2017.

---

	P1321-4-PM. Activity as the pharmacist of the local inclusion care ward 川村大輔1, 吉川真央1, 松田喜美子3, 水澤佑介3, 山口明美2, 久岡清子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1455-1455, 2017.

---

	P1323-4-PM. Example that the multi-type of job cooperation made possible home care 角佳亮1, 中野真理子1, 河村洋平太1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1456-1456, 2017.

---

	P1325-4-PM. Quantitative evaluation about the takeoff operation from the PTP sheet of pharmaceutical products 村上雅裕1, 安田恵1, 前田初男1, 新村健2, 天野学1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1456-1456, 2017.

---

	P1327-4-PM. Duties to the at-home medicine for the purpose of the problems search by the multi-type of job cooperation and attitude survey 柳本ひとみ1, 櫻井秀彦2, 黒澤菜穂子3, 古田精一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1457-1457, 2017.

---

	P1329-4-PM. Intervention of the multi-type of job cooperation in the day care care and the institution pharmacist 中野匡介1, 浅見友一1, 峰川久美子2, 池田えり子2, 飯塚敏美1, 原広子2, 堀口雅巳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1457-1457, 2017.

---

	P1331-4-PM. It is ... for multi-type of job cooperation - area inclusion care bed in our hospital 横山知美1, 副島啓司1, 古海和博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1458-1458, 2017.

---

	P1298-5-AM. At-home life return support ... by participation - prescription adequacy and the regional alliances of the pharmacist in the local inclusion care ward 中島美紀1, 原竜太郎1, 濱浦睦雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1459-1459, 2017.

---

	P1300-5-AM. Elucidation of the enforcement factor of the cooperation with the drugstore in the medical office 上野杏莉1, 舘知也1, 伊野陽子2, 大坪愛実1, 勝野隼人1, 杉田郁人1, 兼松勇汰1, 吉田阿希1, 野口義紘1, 堺千紘2, 井口和弘2, 川上ちひろ3, 藤崎和彦3, 寺町ひとみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1460-1460, 2017.

---

	P1302-5-AM. Literature review about the intervention effect of the pharmacist in the treatment at home 片原憂斗1, 高橋信洋1, 藤田健二2, 串田一樹3, 川口崇1, 竹内裕紀1, 畝崎榮1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1460-1460, 2017.

---

	P1304-5-AM. Possibility of the person of brain cardiovascular procedure disease risk grasp by the establishment of the screening technique of blood glucose level spikes in the community pharmacy 長谷川利幸1, 岡田昌浩2, 土谷大樹3, 梶原敏道4, 山田真弘5, 長崎信浩6, 小嶋英二朗6, 横田いつ子7, 数野博8, 徳毛孝至9, 杉原成美6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1461-1461, 2017.

---

	P1306-5-AM. Outcome evaluation of the visit drug control instruction duties in the health insurance pharmacy 柴田賢三1, 宇野達也1, 山田直也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1461-1461, 2017.

---

	P1308-5-AM. New role of the health insurance pharmacy pharmacist to see from the voice of the patients with dementia caregiver 谷博子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1462-1462, 2017.

---

	P1310-5-AM. The current situation of the treatment at home activity by the drugstore pharmacist and future problem 今西孝至1, 山本康平1, 高山明1, 楠本正明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1462-1462, 2017.

---

	P1314-5-AM. Measurement ... of new role - oral cavity function of the pharmacist in the super-aged society with a low birth rate 渡部雅俊1, 横山俊介1, 松村久男2, 藤原邦彦2, 榊原幹夫3, 久保田洋子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1463-1463, 2017.

---

	P1316-5-AM. Until we work on the appropriate management of pharmaceutical products from efforts 1 - action start of the pharmacist in the care old man health healthcare facility 久岡清子1, 増田博也1, 合田さやか1, 佐々木健志1, 澤口友紀1, 亀岡喬1, 間千晴1, 鹿沼奈央1, 川村大輔1, 大荒政志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1464-1464, 2017.

---

	P1318-5-AM. Enforcement of reporting, the education about the drug to efforts 3 - nursing facility staff of the pharmacist in the care health insurance for aged institution 増田博也1, 久岡清子1, 合田さやか1, 佐々木健志1, 澤口友紀1, 亀岡喬1, 間千晴1, 鹿沼奈央1, 川村大輔1, 大荒政志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1464-1464, 2017.

---

	P1320-5-AM. Efforts of regional alliances through the inhalational instruction 鈴木絢子1, 小菅健志1, 椿佳子2, 大島幸徳2, 平山明子2, 関水康成2, 山崎秀之2, 鹿間裕介3, 渡邊徹1,4, 佐々木忠徳4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1465-1465, 2017.

---

	P1322-5-AM. Efforts to instruction joint at the discharge of the insurance pharmacist participation type that we can transfer to treatment at home smoothly 川路明子1, 水井貴詞1, 堀晃代1, 渡邉成子2, 高橋健2, 後藤千寿1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1465-1465, 2017.

---

	P1324-5-AM. 1 case that a drugstore pharmacist became the pivot of the cooperation in the shift to treatment at home 杉浦聡1, 懸山啓太2, 亀田祥代2, 安野和浩2, 岡野美香2, 薮本佳弘2, 守安洋子1, 高橋正志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1466-1466, 2017.

---

	P1326-5-AM. Efforts for the home care patient visit drug control instruction charges calculation 明時凡子1, 三砂義敬1, 出口裕子2, 一ノ瀬由衣1, 床島英雄1, 田中基稔1, 塚田寛子1, 近藤譲1, 宮崎靖之1, 山脇一浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1466-1466, 2017.

---

	P1328-5-AM. About the effectiveness of the medication support in being at home using the medication support system 末松菜月1, 菊池千草1, 神林純二2, 野本愼一3, 鈴木隆博4, 澤田砂織5, 鈴木匡1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1467-1467, 2017.

---

	P1330-5-AM. Relation of the hospital pharmacist in the case that death in being at home was hoped for 川見里奈1, 四方純子1, 上羽沙綾1, 佐賀嘉英1, 門脇隼也1, 奥村智晴1, 塩見明日香1, 谷田有花1, 足立圭司1, 村上由樹1, 堀雅博1, 足垣亮介1, 宮谷正哉1, 山本真世1, 立道直美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1467-1467, 2017.

---

	P1332-5-AM. Pollen scattering reporting by the number of the cedar genus and the Cupressaceae pollen scattering measurement 岡田和智1, 田中孝治1, 森万希子1, 多賀小枝子1, 馬淵将吾1, 長屋貴昭1, 竹中翔也1, 吉田真也1, 日野光記枝1, 宇佐美英績1, 吉村知哲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1468-1468, 2017.

---

	P1333-4-PM. Introduction of the formulations support system for the purpose of the risk aversion 後藤千寿1, 土田陽子1, 梅田道1, 甲田明英1, 水井貴詞1, 小林健司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1469-1469, 2017.

---

	P1335-4-PM. Investigation (the third report) of the dispensing error accompanied with the outside Parliament outpatient department prescription issuance 添田真司1, 尾崎昌大1, 三村一平1, 渡邊昌之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1470-1470, 2017.

---

	P1337-4-PM. Efforts to the stock rearranging of ward storage pharmaceutical products in connection with a medical safety management room 永倉優子1, 橋本恵津子1, 村田雅子1, 高島伸也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1470-1470, 2017.

---

	P1339-4-PM. Efforts for an unlicensed drug, the medicine in the general hospital out of the adaptation 徳山洋子1, 瓦比呂子1, 西本好児1, 松本圭司1, 野口裕介1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1471-1471, 2017.

---

	P1341-4-PM. Approach of a recognition enlightenment activity of the staff for the high-risk medicine and the improvement in drug control instruction rate of use 入江健司1, 宮田拓周1, 川俣洋生1, 三好孝法1, 小田原真希1, 松尾尚美1, 松本紗織1, 鶴山萌子1, 平木洋一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1471-1471, 2017.

---

	P1343-4-PM. Evaluation of the resuscitation class in the JCHO Kyushu Hospital 吉国健司1, 宮本愛子1, 白石史遠1, 井上英一2, 中野政弘3, 中村英樹4, 松本一志5, 海野聡美6, 川地尚子7, 古賀和代8, 冨田美砂8, 馬渡由紀子8, 中嶋恭子8, 松隈眞紀子8, 百名洋平9, 宮田健二9, 末松文博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1472-1472, 2017.

---

	P1345-4-PM. Construction of the prescription limit system of medicine contraindicated to the pregnant woman using the order ring system in our hospital and the allergic origin medicine 上西幸治1, 奥貫裕美1, 星野伸夫1, 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1472-1472, 2017.

---

	P1347-4-PM. Understanding degree analysis ... about the high-risk medicine of the nurse by understanding degree investigation - questionnaire about the high-risk medicine 岡村吏華1, 吉井千菊1, 渡辺恵美1, 棚田真紀1, 星野智美1, 波能満理惠1, 脇田真之1, 加治江利子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1473-1473, 2017.

---

	P1349-4-PM. Example ... of problem and solution - Bukta (R) combination lock of the checking prescription system 木村洸1,2, 吉開晶一1, 北村智哉1, 村山慶2, 益本周治1, 亀井健人1, 赤木晋介1, 徳田衡紀1, 高柳和伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1473-1473, 2017.

---

P1351-4-PM. Activity report 2 - of observance situation monitoring - pharmaceutical products safety management team of the operational procedure of midazolam parenteral injection and the flunitrazepam parenteral injection 吉開晶一1, 木村洸1, 北村智哉1, 西田麻以1, 益本周治1, 亀井健人1, 赤木晋介1, 徳田衡紀1, 高柳和伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1474-1474, 2017.

---

	P1353-4-PM. It is examined a factor search of the delirium and a sleeping drug and the association of the delirium onset after the operation 大南貴裕1, 野元裕1, 中西雅之1, 日野真美1, 高取真吾1, 檜垣宏美2, 内舛健2, 田中守2, 田中亮裕2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1474-1474, 2017.

---

	P1355-4-PM. The information management system and the development situation investigation about the interaction of pharmaceutical products and the medical equipment 中村浩規1, 眞野成康2, 杉浦伸一3, 鮎澤純子4, 佐藤景二5, 嶋森好子6, 配島由二7, 藤盛啓成8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1475-1475, 2017.

---

	P1357-4-PM. Relations with the sleeping drug internal use situation and a fall, the fall of elderly people 酒井牧子1, 今井孝1, 福間勇2, 菱本敏美2, 河野通盛1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1475-1475, 2017.

---

	P1359-4-PM. Investigation of potential risk and problems in the foreign perioperative drug control before anesthesiology technique 米澤龍1, 宮坂善之1, 上嶋浩順2, 石川恵美子3, 川上由香子3, 吉田雅子3, 栗原竜也1, 大嶽浩司2, 佐々木忠徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1476-1476, 2017.

---

	P1361-4-PM. About the association of the risk with fact-finding and the sleeping drug of a fall, the fall of the inpatient in our hospital 大久保翔1, 井上結夏1, 福澤祐幸1, 宇都直哉2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1476-1476, 2017.

---

	P1363-4-PM. Efforts of one "fire pharmacy Action Card development" 田原雅子1, 平昭圭介1, 花田徳子1, 新谷茂之1, 熊本拓也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1477-1477, 2017.

---

	P1365-4-PM. Efforts (the second report) to medical security using an incident calendar 今井祐貴子1, 熱海幸恵1, 大川藍子1, 李娜1, 大野翔子1, 添田真司1, 金渕一雄2, 渡邊昌之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1477-1477, 2017.

---

	P1367-4-PM. Efforts of the pharmacist in the JCI certification acquisition 喜多幸子1, 長濱藍1, 森智子1, 小松祐輔1, 人見百合子1, 石井英之1, 田仲祐子1, 泉優貴1, 氏川郁穂1, 近藤理美1, 石井奈津季1, 久田潤平1, 宮川千珠1, 三浦捺樹1, 峯浩太朗1, 竹治優紀1, 山中愛美1, 吉村美菜1, 松元あみ1, 水野康平1, 羽山紗樹乃1, 喜多洋嗣1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1478-1478, 2017.

---

	P1334-5-AM. As for every injection drug 1 application about operation of our hospital about the set and the contribution of the latest ampoule picker 小沼大祐1, 畑下真希1, 新藤学1, 加藤一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1479-1479, 2017.

---

P1336-5-AM. The actual situation of the prevention of false administration of muscle relaxant seen by an attitude survey and the institution investigation about the understanding in the prefecture lower hospital of the Yamaguchi prefecture pharmacist 藏田康秀1,2,, 伊東真由子1,3, 岡智之1,4,, 尾崎正和1,5,, 木下英樹1,6, 塚原邦浩1,7, 平岡ひろ子1,8, 光末尚代1,9, 山本武史1,10, 佐藤真也1,11, 古川裕之1,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1480-1480, 2017.

---

	P1338-5-AM. Efforts to analysis and the damage example decrease in damage cause of pharmaceutical products in our hospital 友池和敬1, 中島文1, 和佐野英子1, 合原嘉寿1, 福石和久1, 林稔展1, 山脇一浩2, 西野隆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1480-1480, 2017.

---

	P1340-5-AM. The analysis of the incident report in the duties change period of the pharmacist and future problem 帖地伸子1, 宮本彩1, 徳竹裕貴1, 香西久美子2, 福本由美子2, 阿河直子2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1481-1481, 2017.

---

	P1346-5-AM. Medical safety measures of the pharmacist in the acute phase hospital leading emergency lifesaving center 田中敏1, 我妻雄太1, 村上久美2, 最首俊夫2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1482-1482, 2017.

---

	P1348-5-AM. Analysis of the potentially serious medical errors example about the infusion preparation 岩原良晴1, 乾賢一1, 坂口至1, 早田和生1, 福岡誠次1, 田中修一1, 藤冨徹1, 多田義孝1, 籾井明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1483-1483, 2017.

---

	P1350-5-AM. Activity report 3 - of proper use situation - pharmaceutical products safety management team of the zoledronic acid hydrate 西田麻以1, 大熊沙代子1, 長尾由佳1, 小林宏太朗1, 北村智哉1, 吉開晶一1, 木村洸1, 益本周治1, 亀井健人1, 赤木晋介1, 徳田衡紀1, 高柳和伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1483-1483, 2017.

---

P1352-5-AM. Activity report 1 - of observance situation monitoring - pharmaceutical products safety management team of incident investigation and the handling official regulations of the highly-concentrated electrolyte solution that pharmaceutical products are associated with 北村智哉1, 吉開晶一1, 木村洸1, 西田麻以1, 益本周治1, 亀井健人1, 赤木晋介1, 徳田衡紀1, 高柳和伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1484-1484, 2017.

---

	P1354-5-AM. The "natto taboo" of the diet in the hospital offered to the warfarin potassium tablet remedy patients setting situation investigation 金井隆安1, 加藤一雅1, 篠原高雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1484-1484, 2017.

---

	P1356-5-AM. Conduct the allergy history investigation of allergic possession situation ... nurse of the healthcare worker; and ... 野毛一郎1, 長谷川雅紀1, 福本康之1, 佐藤雅也1, 川上典子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1485-1485, 2017.

---

	P1358-5-AM. Efforts to hepatitis B reactivation measures by the multi-type of job cooperation 大岡千寿子1, 野洌孝二1, 中村俊之1, 平良薫2, 藤田忠夫3, 堀江智美4, 神田雄史1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1485-1485, 2017.

---

	P1360-5-AM. Participation of the pharmacist in drug allergy information check function at prescription, injection order input 鈴木めぐみ1, 片山広美1, 佐藤篤郎1, 鈴木厚志1, 板倉由縁1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1486-1486, 2017.

---

	P1362-5-AM. The current situation and problem of "the protocol about the doubt inquiry simplification in the outside Parliament prescription" of our hospital 森光恵1, 山本裕実子2, 藤本淑子3, 村本恵美子3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1486-1486, 2017.

---

	P1364-5-AM. Consideration of the role of the pharmacist in the nurse new face education and the effective training method 水木麻里1, 石井大志1, 後藤康平1, 中川博之1, 長江萌菜美1, 河野大嗣1, 竹原香織1, 中條恭孝1, 大村ふみ1, 福井伸也1, 中川朱美1, 野田好典1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1487-1487, 2017.

---

	P1366-5-AM. Evaluation according to the new point of view of doubt inquiry for the foreign chemotherapy 川岸亨1, 久保田康生1, 原田幸子1, 松浦泰寛1, 菅原亮輔1, 吉川佳那1, 堤竹蔵1, 笠師久美子1, 山田武宏1, 小林正紀1, 井関健1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1487-1487, 2017.

---

	P1368-5-AM. Needs of the lecture judging from the student attending a lecture questionnaire results of the pharmacist lecture specialized in Nagano hospital pharmacist society 三浦篤史1, 佐藤勝治1,3, 六波羅孝1,4, 成田芳昭1,5, 田中健二1,6, 竹澤崇1,7, 鬼窪利英1,2, 林美和子1,8, 堀勝幸1,6, 町田忍1,9 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1488-1488, 2017.

---

	P1370-5-AM. An evaluation and problem of the new face education system in the Kanazawa Medical University hospital pharmacy 宮東利恵1, 西田祥啓1, 高瀬文超1, 丹羽修1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1489-1489, 2017.

---

	P1372-5-AM. Construction - third report ... of the education system for the early duties acquisition for the new adoption pharmacist 佐藤仁宣1, 保田未奈子1, 小沼大祐1, 本郷知世1, 古林園子1, 新藤学1, 加藤一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1489-1489, 2017.

---

	P1374-5-AM. Role of the cancer clinical pharmacy workshop in the Tokyo Women's Medical University Hospital resident education 大平優1,4, 石丸睦美1,4, 只見智恵子1, 塚川麻利子1,4, 柏瀬しのぶ1,4, 深谷寛1,4, 伊東俊雅2, 小林恵美子3, 浜田幸宏1, 木村利美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1490-1490, 2017.

---

	P1376-5-AM. Approach ... experience type learning 2017 ... of the Saitama hospital pharmacist society area training sectional meeting west block 唐澤匠太1,7, 新井成俊2,7, 鍵山智樹3,7, 黒下龍二4,7, 古高裕子5,7, 加藤剛6,7, 北澤貴樹8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1490-1490, 2017.

---

	P1378-5-AM. The academic place of exchange of the young pharmacist? Establishment of ... multicenter young pharmacist workshop and future problem ... 齋藤雅俊1, 安武夫2, 堀井剛史3, 林太祐4, 原田大5, 津田泰正6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1491-1491, 2017.

---

P1369-4-PM. Efforts - for activity report - infection control authorization, specialized pharmacist upbringing of the specialized pharmacist Board of Education infection control sectional meeting in the Aichi hospital pharmacist society 奥平正美1,2, 稲垣孝行1,2, 梅村拓巳1,2, 小林義和1,2, 塩田有史1,2, 中根茂喜1,2, 坂野昌志1,2, 森健1,2, 板倉由縁2, 山田清文2, 木村哲和2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1492-1492, 2017.

---

	P1371-4-PM. Make use of reflection of construction - last year of new face education system; and ... 樋本繭子1, 清水愛1, 檀和貴1, 日原章詔1, 松岡詩子1, 高瀬尚武1, 中田日早枝1, 室井延之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1493-1493, 2017.

---

	P1373-4-PM. Examination - of the education technique with high learning effect on upbringing thirteenth report - new face pharmacist of the pharmacist carrying the next generation 小川瑶子1, 久保和子1, 猪田宏美1, 北村佳久1, 千堂年昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1493-1493, 2017.

---

	P1375-4-PM. Efforts to postgraduate education for the purpose of the acquisition of the basic clinical medicine knowledge 山田雅也1,2,3, 力武隆浩2, 森一生3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1494-1494, 2017.

---

	P1377-4-PM. To make use of the voice of the clinical drug settings training - settings by the researcher of the pharmaceutical company in a preparation study; ... 瀬野淳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1494-1494, 2017.

---

	P1379-4-PM. Result of the balun strike scorecard introduction that continued in the Yokohama General Hospital and efforts this year 廣瀬直樹1, 佐村優1, 小川寿子1, 倉田武徳1, 鯉淵寛之1, 高田啓介1, 仙内光子1, 内田仁樹1, 関根寿一1, 金田昌之2, 赤瀬朋秀2,4, 佐藤透3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1495-1495, 2017.

---

	IP01. Activities of hospital pharmacists in ambulatory care in Japan - Admission support division - Atsumi Nishikori1, Yusuke Igawa1, Hiromi Ida1, Hideki Nawa1, Yoshihisa Kitamura1, Toshiaki Sendo1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1510-1511, 2017.

---

	IP02. Nicotine alter cognitive impairment and anxiety-like behavior in chemotherapeutic model of rats Yoshihisa Kitamura1,2, Misaki Sugimoto2, Erika Kanemoto2, Ayumi Machida2, Yuka Nakamura2, Nanami Naito2, Toshiaki Sendo1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1511-1511, 2017.

---

	IP03. NST Pharmacists' Approaches in a University Hospital - Through Collaboration with Ward Pharmacists - Hideki Nawa1, Hayato Hino1, Yoshihisa Kitamura1, Toshiaki Sendo1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1512-1512, 2017.

---

	IP04. Effects of Parenteral Nutrition Support with NST in Critically Ill Patients Lee Jeeyang1, Seo Kyunghee1, Lee Sohyun1, Kim Youngmi1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1513-1513, 2017.

---

	IP05. Evaluation of antibiotic dosing regimens in patients with impaired renal function Mi Hye Park1, Kyong Nam Ye1, Kyung Ju Jung1, Jung Tae Kim1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1513-1514, 2017.

---

	IP06. Comparison of effects and safety profiles between Sevelamer HCl and Sevelamer carbonate in patients on dialysis In Hye Park1, Jin Joo Kim1, Hye Young Kim1, Eyn Young Kwon1, Soon Joo Kim1, Shin Yi Hwangbo1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1514-1514, 2017.

---

	IP07. Comparison of Clinical Efficacy and Safety between Roflumilast 250mcg and 500mcg daily dose in Chronic Obstructive Pulmonary Disease Soo Kyung Lee1, Jae Eun Sim1, Hye Lim Ahn1, Sun Choi1, Soon Joo Kim1, Shin Yi Hwangbo1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1515-1515, 2017.

---

	IP08. Contamination of the Used Blister Packs by Lenalidomide in Clinical Situation Akiko Kaneta1, Yuta Takahashi1,2,3, Hideaki Yashima1,2, Tadashige Abe1, Takuya Araki1,2, Koujirou Yamamoto1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1516-1516, 2017.

---

	IP09. A Pharmacists-Led Quality Control Improved Chemotherapy Induced Febrile Neutropenia in Proton and Heavy Ion Radiation Oncology Setting in CHINA Qiong Du1,2,3, Zi-Han Guo1,2,3, Xian-Chun Dai3, Bo Yu1,2,3, Qing Zhai1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1516-1516, 2017.

---

	IP10. A study on collaboration between hospitals and community pharmacies Saki Kimura1, Ran Satoh1, Takao Orii1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1517-1517, 2017.

---

	IP11. Efficacy and safety of lapatinib in Chinese breast cancer patients: A real-world study Xuan Ye1,2, Bo Yu1,2, Qing Zhai1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1517-1517, 2017.

---

	IP12. In vitro and in vivo effects of 1-(2-chlorine) phenyl-9-butyl-β-carboline against Echinococcus granulosus Gao Hui-Jing1, Chen Bei1, Zhao Jun1, Wang Jian-Hua Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1518-1518, 2017.

---

	IP13. Practice of Clinical Pharmacists in The Drug Treatment of Patients with Heat Stroke Li Li1, Li Zhuo1, Zhu Ya-Ning1, Zhang Peng1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1518-1518, 2017.

---

	IP14. The Document Analysis of Health Popularization Research in China for 20 Years Wu Yibo1, Xing Yunhui1, Liu Zhe1, Li Xia1, Li Yingying1, Zhang Yue1, Jia Shuxian1, Yang Yujie1, Gao Wenzhen1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1519-1519, 2017.

---

	IP15. Working Modes and Analysis by Pharmacist of Safety Surveillance Model of Post-marketing Drugs Yadan Chen1, Xiujuan Fu1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1519-1519, 2017.

---

	IP16. Regulation of tumor associated genes and cytokines expression by Venetoclax in AML Zhao Shuang1, Song Yianqing1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1520-1520, 2017.

---

	IP17. Current Sedation Practice in Pediatric Intensive Care Unit Mi Hee Yang1, Ji Eon Park1, Ae Hee Jung1, Jung Mi Lim1, Sun Hoi Jung1, Sung Yun Suh1, Hyeon Joo Hahn1, Yoon Sook Cho1, Yu Hyun Choi2, Jun Dong Park2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1520-1521, 2017.

---

	IP18. A retrospysis ective analof vancomycin pharmacokinetics in Korean neonates Hyun Jung Shin1, Moon Jin Kim1, Ae Hee Jung1, Jung Mi Lim1, Sun Hoi Jung1, Sung Yun Suh1, Hyeon Joo Hahn1, Yoon Sook Cho1, Seung Han Shin2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1521-1521, 2017.

---

	IP19. Analysis on cardiovascular combination drug usage in a single hospital Yujin Hur1, Danhee Choi1, Yonghwa Lee1, Sunhoi Jung1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1522-1522, 2017.

---

	New paradigm construction - education, clinical duties, study ... for sustained evolution of the clinical pharmacy 千堂年昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 142-142, 2018.

---

	Innovation of the lung transplantation 大藤剛宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 143-143, 2018.

---

	Integration of clinical pharmacy services : implementation, research, outcomes, sustainability Sandra Leal1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 144-145, 2018.

---

	Septicemic pathologic new understanding and therapy development 西堀正洋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 146-146, 2018.

---

	Medical communication: Significance in the curative medicine 中野重行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 147-147, 2018.

---

	From the position of pharmacist residency specialized in a family practice and pharmacist education - family doctor in the primary care domain - 松下明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 148-148, 2018.

---

	Study of the clinical pharmaceutics on oral preparation, parenteral injection 内田享弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 149-149, 2018.

---

	Study on pharmaceutical factor to give it to outcome of the rehabilitation in the convalescent rehabilitation ward 小瀬英司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 150-150, 2018.

---

	For improvement in usefulness of eye drops: The applied nature of the eye drops evaluation based on pharmaceutics properties and nanopharmaceutical products 長井紀章1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 151-151, 2018.

---

	Study on theoretical dose design for the patients with acute renal failure, hemocatharsis therapy introduction patients 山本武人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 152-152, 2018.

---

	Study of the clinical pharmacy on improvement in treatment management in the cancer medical therapy 北澤文章1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 153-153, 2018.

---

	Elucidation of cisplatin origin-related nephropathic protective efficacy with the magnesium administration and the mechanism 齋藤佳敬1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 154-154, 2018.

---

	Exploring therapeutic strategy and prognostic biomarker of malignant breast cancer 相良篤信1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 155-155, 2018.

---

	Development of the optimal antiemesis therapy in the highly emetic chemotherapy including the cisplatin 鈴木賢一1, 辻大樹2, 伊藤邦彦2, 山本信之3, 濱敏弘1, 加藤裕久4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 156-156, 2018.

---

	Clinical outcome of the treatment with multi-type of job team support in patients with bacteremia and study on prognosis-related factor 前田真之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 157-157, 2018.

---

	23-3-SP-1. Directionality and problems of the AI utilization in the DI room 若林進1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 158-159, 2018.

---

	23-3-SP-2. Request of suggestion and the participation in planning made with structure about the AI utilization to be useful for the field of future pharmacy 木村隆夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 160-160, 2018.

---

	23-3-SP-3. Research and development about the pharmacist support system utilizing the artificial intelligence (AI) 湯本哲郎1, 亀井淳三1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 161-161, 2018.

---

	23-3-SP-4. Introduce "a type drug information offer support system mounted with AI" into hospital DI room inquiry duties; and from an example of - Okayama University hospital pharmacy - 神崎浩孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 162-162, 2018.

---

	23-3-SP-5. Expectation to the artificial intelligence utilization in pharmacist duties 望月伸夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 163-163, 2018.

---

	CJK-1. Immunotherapeutic Agents for the Treatment of Refractory Pediatric Acute Lymphoblastic Leukemia Jennifer Thackray1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 164-164, 2018.

---

	CJK-2. Nutrition Support Pharmacists in Cancer Patients Bo Yu1,2, Qing Zhai1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 165-165, 2018.

---

	CJK-3. The role of pharmacists in nutrition therapy - As a chef of parenteral nutrition - Keiichiro Higashi1, Kiyoshi Sasayama1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 166-166, 2018.

---

	CJK-4. Management and Use of Opioid Analgesics and Pathway Sharing of Cancer Pain Homecare Li Ran1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 167-167, 2018.

---

	CJK-5. Efforts to cooperate with community pharmacists and hospital pharmacists Yasuko Kurata1, Yoshihisa Kitamura1, Toshiaki Sendo1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 168-168, 2018.

---

	23-10-IS1-1. Facilitating collaboration between pharmacy schools and hospitals to foster future pharmacist-clinical scientists Makiko Iwasawa1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 169-170, 2018.

---

	23-10-IS1-2. Pharmacy Practice Model in Thailand Surakit Nathisuwan1,2, Amnouy Preukpakpoom1, Thida Ninsananda1, Pranee Pinyowattayakorn1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 171-171, 2018.

---

	23-10-IS1-3. Brief Introduction of Pharmaceutical Services in China Sun Lulu1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 172-172, 2018.

---

	23-10-IS1-4. Specialty Pharmacy Residency : The Importance of Training and Advancing Next Generation of Specialized Pharmacists Jennifer Thackray1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 173-173, 2018.

---

	23-10-IS2-1. Overseas clinical rotation and exchange program of pharmacy students in Keio University Takeshi Akiyoshi1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 174-175, 2018.

---

	23-10-IS2-2. Future Perspectives of Clinical Pharmacists in Oncology Care Masami Tsuchiya1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 176-176, 2018.

---

	23-10-IS2-3. Establishing individualized cancer therapy based on clinical molecular pathogenesis - Clinical significance of tumor suppressor CYLD downregulation in malignant tumors - Hirofumi Jono1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 177-177, 2018.

---

	23-10-IS2-4. Approach Made by Pharmacy Pharmacists to Increase the Generic Use Hiromi Shinohara1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 178-178, 2018.

---

	23-10-IS2-5. Labeling in Asia : What are the labeling regulations for Healthcare Professionals (HCPs) & Patients, and how the labeling information is delivered in Asia? Rie Matsui1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 179-179, 2018.

---

	23-1-S1-1. Expectation to the pharmacist in the AST activity 三鴨廣繁1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 180-181, 2018.

---

	23-1-S1-2. Role of the pharmacist in AST of the university hospital 浦上宗治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 182-182, 2018.

---

	23-1-S1-3. Role of the pharmacist in AST of the large-scale hospital 梅村拓巳1,2, 武藤義和2,3, 位田陽史2,4, 大竹有里2, 石原誉志美2,4, 小崎耕自1, 須川真規子2, 鷹見繁宏1, 市原利彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 183-183, 2018.

---

	23-1-S1-4. Role of the pharmacist in AST of the small and medium size hospital 片山歳也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 184-184, 2018.

---

	23-1-S1-5. Role of the pharmacist in AST which we saw from the university pharmacy school 村木優一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2018.

---

	23-1-S2-1. We attack AMR from the situation of hospital pharmacist and AST! 前田真之1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2018.

---

	23-1-S2-2. We attack AMR measures from the position of the drugstore pharmacist! 宮崎長一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2018.

---

	23-1-S2-3. We attack AMR measures from the situation of the pharmacy education! 松元一明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2018.

---

	23-1-S2-4. We attack AMR measures from the situation of the fundamental researches of medicine-based university! 小田真隆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2018.

---

	23-1-S2-5. We attack AMR measures from the situation of the pharmaceutical company! 野村伸彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2018.

---

	23-1-S2-6. What do you seek in a pharmacy for AMR measures? 松永展明1, 具芳明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2018.

---

	23-2-S3-2. How to catch and evaluation of the adverse event of the anticancer medicine to expect of a pharmacist 田村和夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2018.

---

	23-2-S3-3. The management of the adverse event with the cancer medical therapy 池末裕明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2018.

---

	23-2-S3-4. High blood pressure that a pharmacist evaluates it and manages 藤堂真紀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2018.

---

	23-2-S3-5. Diarrhea that a pharmacist evaluates it and manages 大橋養賢1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2018.

---

	23-2-S3-6. Hypothyroidism that a pharmacist evaluates it and manages 土手賢史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2018.

---

	23-2-S4-1. From "adverse drug reaction assessment" to securing of safety of medicine 宇野勝次1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-199, 2018.

---

	23-2-S4-2. Interview point - not to worry - patients how you hear a side effect symptom 小茂田昌代1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2018.

---

	23-2-S4-3. Circulatory organ disorder assessment 佐藤光利1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2018.

---

	23-2-S4-4. Main point - of the medication counseling of mind, neuropathy assessment - psychiatry analogous drug 三輪高市1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2018.

---

	23-2-S4-5. Dermatopathy assessment 蒲原毅1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2018.

---

	23-2-S5-1. ... which sends rearward clinical record research - results of research to learn as evidence from zero 河添仁1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-205, 2018.

---

	23-2-S5-2. Statistical analysis utilizing the tendency score in clinical studies 魚住龍史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2018.

---

	23-2-S5-3. It is ... through a multicenter double-blind randomized phase II study of dispatch - olanzapine of the evidence by the prospective clinical study 矢内貴子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2018.

---

	23-2-S5-4. Introduction of the study support of the pharmacist with the Japanese cancer supportive care study group 橋本浩伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2018.

---

	23-3-S7-1. We expect it of a pharmacist from ... administration to the activation of the adverse event report 太田美紀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2018.

---

	23-3-S7-2. Efforts of the adverse event report by the Hiratsuka Naka-gun pharmacist society method 飯塚敏美1,3, 鈴木優司2, 平本要3, 今井裕久3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2018.

---

	23-3-S7-3. Efforts - as - pharmaceutical company contributing to the risk management of pharmaceutical products 大箸義章1,2, 田中慎一3, 野村誠3, 富澤志帆3, 田端秀日朗3, 吉田真3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2018.

---

	23-3-S7-4. Role - of activated - hospital pharmacist of the adverse event report by the medicine medicine cooperation 鈴木優司1,2,3, 奥村伊代1, 矢野裕士1, 江川裕之1, 吉澤美香1, 飯塚敏美2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2018.

---

	23-4-S8-1. Is the pharmacist used to the pivot from disaster occurrence to revival? 渡邉暁洋1, 高田洋介1, 山田太平2, 中尾博之1, 中尾篤典2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-220, 2018.

---

	23-4-S8-3. Problem of the cooperation in the disaster medical care 若井聡智1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2018.

---

	23-5-S9-1. Picture of HIV-related nerve cognitive impairment (HAND) in Japanese: From J-HAND results report 木内英1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-225, 2018.

---

	23-5-S9-2. Development situation of the Residual medicine and "we intended to take medicine case" 大石裕樹1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2018.

---

	23-5-S9-3. Efforts of the improvement in medication adherence to patients with HIV infection that caused the cognitive dysfunction in the health insurance pharmacy 小川和彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2018.

---

	23-5-S9-4. Art - psychological tests inflection technique ... of the medication management success 辻麻理子1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2018.

---

	23-5-S10-1. The effectiveness and stability of the indometacin gargle for the pain control of oral mucositis with the cancer chemotherapy 安武夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2018.

---

	23-5-S10-2. It is ... from study - theme setting of the clinical pharmacy by the cooperation with ethical pharmacy and university to an article contribution 山本佳久1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2018.

---

	23-5-S10-3. Efforts - that university cooperated with clinical studies - municipal hospital of the diabetes domain using receipt data 堀井剛史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2018.

---

	23-5-S10-4. The need of data in the medication counseling at the drugstore 福田春香1, 山本佳久2, 鈴木豊史3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2018.

---

	23-5-S10-5. Fact-finding of the polypharmacy in the Tokyo suburbs 百賢二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2018.

---

	23-5-S11-1. Development and problem of IPE in Chiba University 石井伊都子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2018.

---

	23-5-S11-2. Approach in the current situation and the Gifu University faculty of medicine of the multi-type of job cooperation education in the medical education 藤崎和彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2018.

---

	23-5-S11-3. Clinical IPE of student nurse and the pharmacy student by the Miyagi IPE project 大塚眞理子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2018.

---

	23-5-S11-4. Efforts of multi-type of job cooperation education (IPE) in the specialty college 渡部一宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2018.

---

	23-6-S12-1. Associated - of eating deglutition, the nourishment particularly correspondence - to eating dysphagia in being at home 戸原玄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2018.

---

	23-6-S12-2. All associated <fruits of nourishment, the pressure sore are> together with oneself 塚田邦夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2018.

---

	23-6-S12-3. The effect that food for the use actual situation of the food for the thickness adjustment at medication and the general-purpose thickness adjustment gives to the collapse of the tablet 富田隆1, 幸田幸直2, 工藤賢三1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2018.

---

	23-6-S12-4. Because a pharmacist becomes a specialist of the community medical care 小原道子1,2, 林秀樹2,3, 生木庸寛1,2, 福田英二4, 杉山正2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 241-241, 2018.

---

	23-6-S13-1. Usefulness of the balun strike scorecard in the non profit organization 赤瀬朋秀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-244, 2018.

---

	23-6-S13-2. ... which makes the practice - hard drug agent part of the drug section management utilizing BSC 井口恵美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2018.

---

	23-6-S13-3. Tochigi Prefectural cancer center pharmacy BSC and in-hospital BSC meeting 小林尚加1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2018.

---

	23-6-S13-4. Growth strategy using the balun strike scorecard in the middle scale hospital 佐藤大輔1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2018.

---

	23-6-S14-1. Importance of the heart failure team approach in medical care 佐藤幸人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2018.

---

	23-6-S14-2. From the position of importance - nurse of "tying it" that support patients with heart failure - 辻井由紀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2018.

---

	23-6-S14-3. Medical treatment of the heart failure to bring up in the multi-type of job and patients 野崎歩1, 奥川寛1, 馬橋美由季1, 堀内望1, 深見智子2, 小林由佳1, 中村茂3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2018.

---

	23-6-S14-4. We think about the relation pharmacist in the local inclusion care that fixed its eyes on a heart failure pandemic 西村知晃1, 大山亜梨沙1, 坂田美紀1, 田上治美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2018.

---

	23-6-S14-5. We prevent rehospitalization of the heart failure in an area! ... which suggests the new role of ... health insurance pharmacy 土岐真路1, 磯崎弘恵2,4, 八田重雄3,4, 前田幹広1, 坂上逸孝1, 田中恒明1, 木田圭亮5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2018.

---

	23-7-S15-1. Children in this country, the current situation and problem of the fecundity preservation for patients with puberty, juvenile generation cancer 鈴木直1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2018.

---

	23-7-S15-2. It is ... from the team cooperation with practice - pharmacist of construction and the fecundity preservation therapy of a cancer, the reproductive medicine network of Mie to the cooperation with the cancer practice hospital 前沢忠志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2018.

---

	23-7-S15-3. It is the efforts as the pharmacist for fecundity preservation 赤阪未来1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2018.

---

	23-7-S15-4. Approach about the gestation period cancer medical therapy and the example 土屋雅美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2018.

---

	23-7-S16-1. We think about the role of the pharmacist from the position of the manager in the hospitalization and release support section 鬼塚伸也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2018.

---

	23-7-S16-2. We think about the role of the pharmacist from the position of the nurse of the central role in the management of the hospitalization and release support section 足羽孝子1,2, 猪田宏美2, 井川祐輔2, 錦織淳美2, 名和秀起2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2018.

---

	23-7-S16-3. Efforts ... of the pharmacist in the usefulness - hospitalization preconditioning center of the early intervention by the pharmacist before the hospitalization 奥貞智1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2018.

---

	23-7-S16-4. We regard pharmaceutical intervention as confirmation of common use medicine in perioperative care 山口洪樹1, 中村貴子1, 柴田みづほ1, 鈴木貴明1, 石井伊都子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2018.

---

	23-7-S17-1. The basics, flow of acute intoxication treatment, the point that the pharmacist is associated with 堀寧1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2018.

---

	23-7-S17-2. A role and usage of the Japanese poison control center 遠藤容子1, 波多野弥生1, 高野博徳1, 三瀬雅史1, 飯田薫1, 黒木由美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2018.

---

	23-7-S17-3. Charm of analysis and the case report 芳澤朋大1,2, 鈴木善樹1,2, 栗原弘紀1,2, 上條吉人2, 岸野亨1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2018.

---

	23-7-S17-4. An outline and example of the caffeinism 安藤基純1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2018.

---

	23-7-S17-5. Authorized clinical toxicologist and pharmacist 峯村純子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2018.

---

	23-8-S18-1. Prevention and treatment - overview - of the delirium 和田健1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-267, 2018.

---

	23-8-S18-2. Prophylactic intervention for the delirium by the liaison team pharmacist leadership 進健司1,2, 小林大介2, 川尻雄大2, 金澤康範1, 島添隆雄2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2018.

---

	23-8-S18-3. Delirium measures to work on from the outpatient department 河野佐代子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2018.

---

	23-8-S18-4. It is delirium inhibitory effect after the relation and the operation of the pharmacist in the Okayama University Hospital delirium measures team 江角悟1, 村川公央1, 北村佳久1, 千堂年昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2018.

---

	23-8-S19-1. Introduction to DDIs : Guidelines and Guidance in Western Countries David Back1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2018.

---

	23-8-S19-2. About drug interactions guidelines for pharmaceutical products development and appropriate reporting 石黒昭博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2018.

---

	23-8-S19-3. Risk assessment of the drug interactions in the healthcare setting utilizing PISCS 大野能之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2018.

---

	23-8-S19-4. Way of thinking of drug interactions from position of the hospital pharmacist 増田純一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2018.

---

	23-8-S20-1. The point that hesitates about the clinical judgment in patients in CKD 吉田拓弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-276, 2018.

---

	23-8-S20-2. The point that hesitates about a clinical judgment in renal disease treatment 林八恵子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2018.

---

	23-8-S20-3. Gap ... to feel to be ... settings hearing the voice of the kidney in the emergency care 門口直仁1, 河村真歩1, 田中聡1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2018.

---

	23-8-S20-4. Viewpoint ... which leads to ... clinical practice for kidney and remote organ protection 成田勇樹1, 門脇大介2, 平田純生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2018.

---

	23-8-S20-5. We hear the voice of the kidney in the antimicrobial therapy 高根浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2018.

---

	23-16-S21-2. Of the clinical utilization of "the IPCD method", actually 井上幸枝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2018.

---

	23-16-S21-4. Risk and prevention ... in patients with hypokalemia - cardiovascular disease with the Glycyrrhiza 高井靖1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2018.

---

	23-16-S22-1. A case conference aim and request for clinical reasoning 川口崇1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-286, 2018.

---

	23-16-S22-2. The 80s woman that presented dehydration, disturbance of consciousness during hospitalization for pneumonia 梶原洋文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2018.

---

	23-16-S22-3. The men whom purulent spondylitis, bacteremia due to the MRSA was treated, and a rash appeared in 70s 西海一生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2018.

---

	23-16-S22-4. The women who were urgently taken by disturbance of consciousness with the fever in 90s 今井徹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2018.

---

	23-16-S22-5. With a viewpoint of way - medical education of the effective education conference to change to learn experience - 岸田直樹1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2018.

---

	23-16-S23-1. For essence and multi-type of job cooperation - anyone of the treatment at home, what do you do for what? 川添哲嗣1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-292, 2018.

---

	23-16-S23-2. Role of treatment at home and the team 小原道子1,2, 生木庸寛1,2, 林秀樹1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2018.

---

	23-16-S23-3. As one method to learn program construction - treatment at home of the multi-type of job cooperation education in pro-medical care university ... 川上ちひろ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2018.

---

	23-16-S23-4. Construction of the local leader authorization pharmacist system in the drugstore attached to Gifu Pharmaceutical University 寺町ひとみ1,3, 伊野陽子2,4, 野口義紘1,2, 堺千紘2,4, 山下修司2,5, 玉木啓史2,4, 舘知也1,2, 井口和弘2,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2018.

---

	23-16-S23-5. With the at-home pharmacist sought from the settings of the treatment at home 船戸崇史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2018.

---

	24-1-S24-1. Advance care planning and continuous pharmaceutical support to patients with cancer in the pharmacist outpatient department 祝千佳子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-298, 2018.

---

	24-1-S24-2. Message to the comprehensive patients support in blood-forming organ tumor and a next-generation pharmacist 内田まやこ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2018.

---

	24-1-S24-3. The patients support that problems and the pharmacist whom patients with cancer of the AYA generation have should work on 後藤愛実1, 上田育子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2018.

---

	24-1-S24-4. Practice and the prospects of the advance care planning in the university hospital by the cancer nursing clinical nurse specialist 角裕子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2018.

---

	24-1-S24-5. Expect it of the current situation and a pharmacist of the at-home palliative care 渡辺剛1, 八杉まゆみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2018.

---

	24-1-S25-1. Authorized examination results and trends such as pharmacists, and the like specialized in a 2017 cancer 濱敏弘1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2018.

---

	24-1-S25-2. Summary (1) of the case summary: Colon cancer 亀岡春菜1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2018.

---

	24-1-S25-3. Summary (2) of the case summary: Malignant lymphoma 栗林未帆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2018.

---

	24-1-S25-4. Summary (3) of the case summary: Pancreatic cancer 高橋新次1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2018.

---

	24-1-S25-5. Summary (4) of the case summary: Multiple myeloma 村上仁志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2018.

---

	24-1-S25-6. Summary (5) of the case summary: Unknown primary cancer 葉山達也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2018.

---

	24-1-S26-1. For the personalized medicine of antibody pharmaceutical products 米澤淳1,2, 松原和夫2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2018.

---

	24-1-S26-2. The blood level measurement of antibody pharmaceutical products and clinical significance 内藤隆文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2018.

---

	24-1-S26-3. The measurement of the antidrug antibody and clinical significance 石井明子1, 柴田寛子1, 西村和子1, 中村亮介2, 斎藤嘉朗2, 川合眞一3, 山田壮一4, 南木敏宏4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2018.

---

	24-1-S26-4. An evaluation of the Biosimilar: About safety, the effectiveness 早狩誠1,2, 増井翔2, 佐野信介2, 米澤淳2, 松原和夫2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2018.

---

	24-2-S27-1. To show "a pharmacist power" by clinical duties 吉村知哲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2018.

---

	24-2-S27-2. Theory and practice - about the personnel training in behavior properties - medical care of the pharmacist who can do it 赤瀬朋秀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2018.

---

	24-2-S27-3. Drug information utilization technique of the pharmacist who can do it 林昌洋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2018.

---

	24-2-S27-4. Power to examine the patients of the pharmacist who can do it 川口崇1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2018.

---

	24-2-S27-5. Postgraduate education for possible pharmacist upbringing 佐々木忠徳1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2018.

---

	24-2-S28-1. It is ... from ... cancer genomic medicine to think about from this now of the personalized medicine to primary care: Purpose explanation 山本和宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2018.

---

	24-2-S28-2. An examination for gene panel and drug choice in the cancer genomic medicine 玉谷卓也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2018.

---

	24-2-S28-3. The future of personalized medicine and the community medical care by the medical healthy big data and AI 内野詠一郎1, 奥野恭史2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2018.

---

	24-2-S28-4. Attempt - in the genetic information referral - Tohoku medical megabank plan for the realization of personalized medicine, the individualization prevention 福島明宗1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2018.

---

	24-2-S28-5. The health, specimen measurement business to connect with medical individual optimization service to watch at a drugstore 岡崎光洋1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2018.

---

	24-2-S29-1. Improvement of the clinical business by the clinical pharmacy that a pharmacist takes 吉山友二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2018.

---

	24-2-S29-2. Mainly on point - research of data count and the analysis - 波多江崇1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2018.

---

	24-2-S29-3. Precaution of clinical studies and the article making that business of the community pharmacy becomes the theme 渡邉文之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2018.

---

	24-2-S29-4. The Japanese alphabet of the article making not to readily listen to 大谷壽一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2018.

---

	24-3-S30-1. The preparation and approach for the onset extension risk reduction of diabetic complications 藤井博之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2018.

---

	24-3-S30-2. Practice of the medicine for external application therapy in the diabetes foot lesion 西村博之1, 吉田陽1, 塩山由紀1, 守田彩文1, 高田雅文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2018.

---

	24-3-S30-3. Practice of the medical therapy in elderly people diabetes indicating delicate health characteristics 深野光司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2018.

---

	24-3-S30-4. For inhibition of the onset, the extension of practice - nephropathy, cardiovascular disease of the medical therapy in diabetic kidney disease (DKD) - 竹内裕紀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2018.

---

	24-3-S31-1. The actual situation of quality information and the offer of the generic drug which a pharmacist buys 恩田光子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-333, 2018.

---

	24-3-S31-2. Feedback for confirmation and the improvement of the quality in the public testing institution 伊豆津健一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2018.

---

	24-3-S31-3. The pharmaceutical products quality information that a generic drug company provides to a pharmacist 立木秀尚1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2018.

---

	24-3-S31-4. When we change it to a generic drug 寺川伸江1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2018.

---

	24-3-S32-1. With the side effect spontaneous report found by the pharmaceutical person concerned? 沼生智晴1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2018.

---

	24-3-S32-2. Collection of information on adverse drug reactions in foreign countries 原梓1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2018.

---

	24-3-S32-3. For the uniform management of the side effect report in the community medical care cooperation 舟越亮寛1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2018.

---

	24-3-S32-4. We think about standards such as the information on adverse drug reactions, and the like that you should report based on safe information report systems such as pharmaceutical products, medical equipment, and the like 佐藤倫広1, 小原拓2,3, 目時弘仁1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2018.

---

	24-3-S32-5. Creation of the pharmaceutical products safety information by the pharmacist 小原拓1, 眞野成康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2018.

---

	24-4-S33-1. It is ... from ... custom to reconsider fluid therapy to evidence 井上真1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2018.

---

	24-4-S33-2. History and problems - so strange fluid therapy - of the fluid therapy for children 鶴知光1, 高瀬麻以2, 阿部浩子2, 上坂英二2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2018.

---

	24-4-S33-3. Infusion management of change ... perioperative period of the fluid therapy 石橋生哉1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2018.

---

	24-4-S33-4. With the fluid therapy to revise the balance of the seriously ill patients 野崎歩1, 奥川寛1, 堀内望1, 小林由佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2018.

---

	24-4-S33-5. Efforts of the fluid therapy of patients with end-stage cancer in our hospital 今井一輝1, 東口高志2, 二村昭彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2018.

---

	24-4-S34-1. The current situation of the medical treatment for intractable amyloidosis and the future prospects 城野博史1,2, 安東由喜雄3, 齋藤秀之1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2018.

---

	24-4-S34-2. Approach to a mechanism elucidation and resistance conquest of the anticancer medicine resistance 奥村学1,4, 岩切智美1, 長友隆雄1, 吉川直樹1, 綾部貴典2,4, 関屋裕史1, 平原康寿1, 中村都英3,4, 池田龍二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2018.

---

	24-4-S34-3. Challenge to a diagnosis, the treatment of the Niemann-Pick disease C type which assumed clinical chemistry a base 前川正充1, 成田綾2, 崎山快夫3, 山口浩明1, 眞野成康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2018.

---

	24-4-S34-4. Reverse translational research aiming at conquest of schizophrenia 永井拓1, 尾崎紀夫2, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2018.

---

	24-4-S34-5. Molecular mechanism and therapeutic drug front of Alzheimer's dementia 武田泰生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2018.

---

	24-4-S35-1. Interaction of the oral molecular target anticancer medicine through the transporter 山口浩明1, 眞野成康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-353, 2018.

---

	24-4-S35-2. Pharmacokinetic interaction of the antitumor agents which macrolide derivative antimicrobial and an azole-based antifungal agent participate in 新岡丈典1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2018.

---

	24-4-S35-3. Interaction with an antihistamine and the luxury goods at eruption measures 赤嶺由美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2018.

---

	24-4-S35-4. Drug interactions of the tyrosine kinase inhibitor 大神正宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2018.

---

	24-4-S35-5. Interaction of antiemetic drug aprepitant 大野能之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2018.

---

	24-5-S36-1. - that problems - neonates medical care of the medical therapy peculiar to children is history of the adverse event 河田興1,2, 小西麗子1, 眞島崇1, 向井啓1, 小森浩二1, 小村純子1, 日下隆2, 伊藤進2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-359, 2018.

---

	24-5-S36-2. Problems of the use to codeine phosphate and the children such as antibiotics, and the like 冨家俊弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2018.

---

	24-5-S36-3. The current situation and measures of the mis-deglutition of the medicine 石川洋一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2018.

---

	24-5-S36-4. Problems (mainly on fecundity) of the cancer chemotherapy to children 米村雅人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2018.

---

	24-5-S37-1. What happens? With the experience-based training demanded at a middle scale hospital 段林正明1, 高橋一栄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-364, 2018.

---

	24-5-S37-2. Do you show drug intoxication - anything to learn on the site? How do you charm him? ... 田村亮1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2018.

---

	24-5-S37-3. Basic form of the multi-type of job cooperation to learn in an intensive care unit and an infection control area 澤田真嗣1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2018.

---

	24-5-S37-4. With the balance of a theory and the practice of the nutrition therapy with high education effect 神谷貴樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2018.

---

	24-5-S37-5. To bring up medical therapy of the heart failure; learn 野崎歩1, 奥川寛1, 馬橋美由季1, 堀内望1, 深見智子3, 小林由佳1, 中村茂2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2018.

---

	24-5-S37-6. Think with a pharmacy student; a role of the hospital pharmacist to "a cancer, palliative care" 辻井聡容1,2, 松原一磨1, 加茂由比子1, 上坂君子1, 中嶋正博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2018.

---

	24-5-S37-7. About the future of a revision model core curriculum and the pharmacy education 平田收正1, 村岡未彩1, 西野隆雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2018.

---

	24-5-S38-2. Efforts to the problem solving utilized the logical thought in drugstore duties 斉藤美月1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2018.

---

	24-5-S38-3. Leader ship education in the medical person 島久美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2018.

---

	24-5-S38-4. We make use of wisdom of MBA in the tissue management 山田正実1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2018.

---

	24-5-S38-5. Fusion of drugstore administration and MBA 田宮謙三1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2018.

---

	24-6-S39-1. Pharmaceutical products safety assessment utilizing MID-NET and the significance 佐藤大作1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-378, 2018.

---

	24-6-S39-2. Relation to study using the medical information database and MID-NET of the hospital pharmacy 堀雄史1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2018.

---

	24-6-S39-3. As a pharmacist of relation ... cooperation medical institution to MID-NET 江本晶子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2018.

---

	24-6-S39-4. Relation to inflection of real world data and MID-NET in the municipal hospital 野村浩子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2018.

---

	24-6-S39-5. Governance to maintain administrative data-based quality about pharmaceutical products: Quality control activity in MID-NET 高田敦史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2018.

---

	24-6-S40-1. From the viewpoint of importance - critical care center working full time pharmacist of the evidence to create from the clinical question in clinical drug duties - 今井徹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-384, 2018.

---

	24-6-S40-2. Basic examination for the clinical question of first aid, the intensive care domain 榎屋友幸1,4, 今井寛2, 丸山一男3, 奥田真弘4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2018.

---

	24-6-S40-3. Knowledge - obtained from study - TDM duties for the optimal administration of antimicrobial method establishment for sepsis 中馬真幸1, 今井徹2, 栃倉尚広2, 鈴木慎一郎2, 岩渕聡2, 関本真雄2, 中山貴裕2, 座間味義人3,4, 武智研志1, 今西正樹3, 岡田直人3, 合田光寛3, 近藤正輝3, 菊池憲和5, 吉田善一2, 石澤啓介3,4, 楊河宏章1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2018.

---

	24-6-S40-4. Problem to the individual administration plan of the drug in the sustained kidney alternative therapy 尾田一貴1, 城野博史1, 齋藤秀之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2018.

---

	24-6-S40-5. How does the onset of pharmacokinetics, efficacy, adverse effect change in the seriously ill patients? - Through a study of the sedative sedative, antimicrobial - 八木達也1, 田中紀章1, 三浦基靖1, 内藤隆文1, 川上純一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2018.

---

	24-6-S40-6. Translational research utilizing the medical information database large-scale in the first aid, the intensive care domain 座間味義人1,2, 石澤有紀3, 新村貴博1, 今西正樹2, 武智研志4, 中馬真幸4, 堀ノ内裕也3, 池田康将3, 桐野靖2, 中村敏己2, 寺岡和彦2, 石澤啓介1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2018.

---

	24-6-S41-1. Efforts in relation Hokkaido from the ER to intensive care 齋藤靖弘1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-391, 2018.

---

	24-6-S41-2. Efforts in the ICU bridging JA Hiroshima General Hospital in the sedative painkilling 吉廣尚大1, 櫻谷正明2, 小野塚和人1, 無漏田香穂1, 加藤之紀2, 河村夏生2, 高場章宏2, 稲田淑江1, 吉田研一2, 橋本佳浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2018.

---

	24-6-S41-3. Activity of a fact of the in-hospital medicine medicine cooperation by Medication Reconciliation and the pharmacist in Kyushu 甲斐光1, 柴田啓智1, 田上治美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2018.

---

	24-6-S41-4. Clinic of the pharmacist resident who assumed intensive care a base 田村亮1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2018.

---

	24-6-S41-5. Fix the eyes on PICS (Post Intensive Care Syndrome) and after pharmacist - discharge; and ... 前田幹広1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2018.

---

	24-8-S42-1. The clinical pharmacy study that clinical pharmacy arts and sciences Committee leads 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2018.

---

	24-8-S42-2. Relation to the drug interactions in the healthcare setting (the academic first subcommittee) 伊藤清美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2018.

---

	24-8-S42-3. Research for domestic base construction of the precision medicine based on a pharmaceutical viewpoint: About a summary and progress 寺田智祐1, 斎藤嘉朗2, 莚田泰誠3, 三浦昌朋4, 辻大樹5, 平大樹6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2018.

---

	24-8-S42-4. Clinical studies support platform architectural efforts - by the pharmacist in activity - cancer domain of the Japanese cure association academic third subcommittee 宮崎雅之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2018.

---

	24-8-S43-1. Feedback to taking childhood preparation-related quantification and clinical practice 内田享弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-401, 2018.

---

	24-8-S43-2. The pharmaceutical products dosage form which children seek is the world in - Japan; - 石川洋一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2018.

---

	24-8-S43-3. A world tide in the pediatric preparation development and problem of this country 原田努1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2018.

---

	24-8-S44-1. Relation for heart failure treatment as the pharmacist 安部敏生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2018.

---

	24-8-S44-2. Cardiovascular side effect of anticancer medicine 倉橋基尚1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2018.

---

	24-8-S44-3. Relation of the pharmacist for the cardiotoxicity with the chemotherapy 上田浩貴1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2018.

---

	24-8-S44-4. Role of the tumor circulatory organ team (Onco-Cardiology Team) in the cancer practice 向井幹夫1, 岡亨1, 清水克次2, 迫田由佳梨2, 南美穂2, 坂上嘉浩2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2018.

---

	24-16-S45-1. Individualization therapy in antipsychotics 赤嶺由美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-409, 2018.

---

	24-16-S45-2. Individualization treatment of the dementia therapeutic drug 山本吉章1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2018.

---

	24-16-S45-3. Efforts to the proper use of the sleeping drug for the individualization therapy 高橋結花1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2018.

---

	24-16-S45-4. Individualization therapy in the antidepressant 猿渡淳二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2018.

---

	24-16-S45-5. For personalized medicine in the psychiatry: Viewpoint from a clinician 古郡規雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2018.

---

	24-16-S46-1. Do you not have trouble with problems - these thing of the case conference? - 上塚朋子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2018.

---

	24-16-S46-2. What you should know for preparations for the case conference 矢野良一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2018.

---

	24-16-S46-3. To deepen case conference public performance - discussion 内田まやこ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2018.

---

	24-16-S46-4. The instruction method to look back, and to connect with - improvement of the case conference 湊川紘子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2018.

---

	24-16-S47-1. It is ... through a relation ... own omen case in the nervous disease domain 宮津大輔1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2018.

---

	24-16-S47-2. Relation circulatory organ domain to medical therapy 馬場安里1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2018.

---

	24-16-S47-3. Intervention example as the pharmacist for the medical therapy of the chylopoietic disease 北原裕子1, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2018.

---

	24-16-S47-4. The condition of a patient grasp and the problem solving type thought that are demanded from a pharmacist specialized in medical therapy 北原加奈之1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2018.

---

	24-16-S47-5. How to use right case summary to a form and medical therapy by the PAPO method 河原昌美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2018.

---

	25-1-S48-1. Make the evidence of the change factor in the pharmacokinetics, tell, use 内田信也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2018.

---

	25-1-S48-2. The interaction between drug - drink which was due to a change change for gastrointestinal inland waters and the quantitative prediction 白坂善之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2018.

---

	25-1-S48-3. It is timely and conveys the evidence of the change factor in the pharmacokinetics obtaining in a pharmaceutical company in various forms clearly in the healthcare setting 田島武志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2018.

---

	25-1-S48-4. We use the pharmacokinetic evidence by clinical practice and make evidence from clinical data 木村丈司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2018.

---

	25-1-S48-5. Medicine to think of from the settings of lifesaving first aid, the intensive care 宮川幸子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2018.

---

	25-2-S49-1. About a guideline (the general remarks edition) of the pharmaceutical products proper use of elderly people 溝神文博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-429, 2018.

---

	25-2-S49-2. Polypharmacy measures in the neurology domain 林祐一1, 西田承平2, 鈴木昭夫2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2018.

---

	25-2-S49-3. Polypharmacy measures in the department education 水野智博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2018.

---

	25-2-S49-4. Polypharmacy and pharmacoepidemiology 浜田将太1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2018.

---

	25-2-S49-5. ... which thinks about polypharmacy measures ... patients to develop-centered polypharmacy measures 樋口恵子1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2018.

---

	25-2-S50-1. "It is underlying", "is hard to write it"? To the thing which is more imminent by an evaluation and a record of the fluid therapy! 黒沢秀夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2018.

---

	25-2-S50-2. The intervention to patients with renal failure is not difficult and puts it on ... evaluation pattern and will think about an instruction record to reach it 浦嶋和也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2018.

---

	25-2-S50-3. Can we take this medicine during the pregnancy, the nursing? The trouble of ... mom and the trouble of the pharmacist. ... that a team thinks about a plain record 木村初1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2018.

---

	25-2-S50-4. As for thing - way of thinking that a physician would like to read the most necessary information in a short time, same as presentation; is three report method ... 辻川正彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2018.

---

	25-3-S51-1. What happens in immune response with cancer microenvironment? 西川博嘉1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-439, 2018.

---

	25-3-S51-2. What is irAE? 各務博1, 山口央1, 毛利篤人1, 塩野文子1, 内田貴裕1, 三浦雄1, 橋本康佑1, 西原冬実1, 村山芳武1, 小林国彦1, 解良恭一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2018.

---

	25-3-S51-3. Reactions of drugs and effect, side effect, interaction of the immune checkpoint inhibitor 牧野好倫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2018.

---

	25-3-S51-4. Are the relations of the immune checkpoint inhibitor and antitumor agents additive? Is it synergistic? 鈴木賢一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2018.

---

	25-3-S52-2. RMP in the anticancer agent (immune checkpoint inhibitor) 竹本信也1, 千葉俊1, 村木輝2, 田中邦彦2, 山田華那2, 渡部さやか2, 石原由美2, 吉田真1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2018.

---

	25-3-S52-3. We think about use and application of RMP from the experience of the anticancer medicine trial 坂口裕美1, 渡邊裕之1, 増田智先1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2018.

---

	25-3-S52-4. Use and application of RMP after the marketing of the anticancer medicine 幸田恭治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2018.

---

	25-3-S52-5. The thing which RMP aims at in clinical settings 米村雅人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2018.

---

	25-4-S53-1. Inevitability - knowledge of knowing the kidney is ... across a domain 平田純生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-449, 2018.

---

	25-4-S53-2. Way of thinking about the kidney to keep alive in a cancer domain 山本和宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2018.

---

	25-4-S53-3. Approach of the specialized pharmacist in infection treatment of patients in CKD 三星知1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2018.

---

	25-4-S53-4. Way of thinking about the kidney to make use of in drug information 大野能之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2018.

---

	25-4-S53-5. Way of thinking about the kidney to keep alive in a pediatric domain 諏訪淳一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 453-453, 2018.

---

	25-4-S53-6. Way of thinking about the kidney to keep alive in first aid, an intensive care domain 柴田啓智1, 田上治美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 454-454, 2018.

---

	25-4-S54-1. Need - of - team approach in medical care to examine heart failure 川村一太1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-455, 2018.

---

	25-4-S54-2. Relation ... to patients with ward duties - heart failure in HCU 八代佳子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 456-456, 2018.

---

	25-4-S54-3. Individualization and systematization of the heart failure medical treatment to think about by a heart team 土岐真路1, 高木瑛美1, 大矢小百合1, 倉田浩2, 石阪光央2, 矢島裕徳2, 嶋田巧2, 前田幹広1, 木田圭亮3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-457, 2018.

---

	25-4-S54-4. Is this a diuretic-resistant? How will the pharmacist intervene then? 芦川直也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 458-458, 2018.

---

	25-4-S54-5. Approach ... for patients with heart rehabilitation - heart failure of the pharmacist viewpoint 吉国健司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2018.

---

	25-4-S54-6. About palliative care of the terminal heart failure 寺崎展幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-460, 2018.

---

	25-6-S55-1. Clinical studies of the drugstore pharmacist 中山健夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2018.

---

	25-6-S55-2. Epidemiologic studies of the drugstore pharmacist 横井正之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 462-462, 2018.

---

	25-6-S55-3. A question born through a support task of the inhalation therapy is one step of the beginning 腰山節子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 463-463, 2018.

---

	25-6-S55-4. Research in the Nagasaki pharmacist society and experience of the idea culture 宮崎長一郎1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 464-464, 2018.

---

	25-6-S55-5. A drugstore is university and university hospital pharmacy and the merit of collaborating it 野田敏宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 465-465, 2018.

---

	25-6-S56-1. About the background of the foreign patients who should be careful in medication counseling and the measures 池浦恵1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 466-467, 2018.

---

	25-6-S56-2. Efforts to foreign correspondence in the community pharmacy 雨宮淑子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 468-468, 2018.

---

	25-6-S56-3. Role of the pharmacist whom we saw from residence foreigner medical care 入野真規子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 469-469, 2018.

---

	25-6-S56-4. From an experience of the interpreter of the foreign patients in our hospital 上田彩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 470-470, 2018.

---

	25-6-S56-5. To train the pharmacist who can play an active part in the global viewpoint 黒澤菜穂子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 471-471, 2018.

---

	25-7-S57-1. The academic D tailor ascertains evidence and inflects and makes the evidence 小茂田昌代1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 472-472, 2018.

---

	25-7-S57-2. To wear a literature evaluation skill 小川竜一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 473-473, 2018.

---

	25-7-S57-3. Practice: We ascertain evidence of the medical treatment of dyslipidemia 花井雄貴1,2, 松尾和廣2, 吉尾隆2, 西澤健司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 474-474, 2018.

---

	25-7-S57-4. Practice: We ascertain evidence of the medical treatment of type 2 diabetes 佐村優1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 475-475, 2018.

---

	25-7-S57-5. The examination of pharmaceutical products adoption and the off-label use: Shake in evidence and the interval of the clinical ethic 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 476-476, 2018.

---

	25-8-S58-1. Mainly on basic knowledge - allergic property side effect of the adverse drug reaction - 継田雅美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 477-478, 2018.

---

	25-8-S58-2. One consideration ... about prescription real ... allergic check using a drug information database of a check 宮崎美香1, 岩田一史1, 秋吉明子1, 陣上祥子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 479-479, 2018.

---

	25-8-S58-3. Allergic management judging from medical security 町谷安紀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 480-480, 2018.

---

	25-8-S58-4. Patients information management for the drug allergy (side effect) recurrent prevention 冨岡謙二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 481-481, 2018.

---

	25-8-S58-5. A system and the problem to manage an allergy and the side effect 野村浩子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 482-482, 2018.

---

	25-8-S58-6. Pharmaceutical products allergy measures to work on by a team 木下元一1, 岸真司2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 483-483, 2018.

---

	25-13-S59-1. Role, responsibility of team approach in medical care and the pharmacist in the cancer medical care 大野真司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 484-485, 2018.

---

	25-13-S59-2. The training of the study mind-oriented pharmacist in the advanced business training 高取真吾1, 田中亮裕2, 飛鷹範明2, 田中守2, 秋山伸二1, 坂本宜俊1, 野元裕1, 荒木博陽2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 486-486, 2018.

---

25-13-S59-3. Effect - that disseminating information to process of the knob medicine bag motion and further development - Residual medicine adjustment and a physician results 島添隆雄1, 小林大介1, 窪田敏夫2, 川浪望恵1, 小柳香織3, 加崎哲夫4, 國武雅弘5, 竹下文明6, 安東恵津子7, 中芝高彦8, 永富茂8, 郡司清志3, 金子絵里奈3, 林田諭3, 吉井瞳3, 三井所尊正3, 高木淳一3, 木原太郎3, 瀬尾隆3, 田中泰三3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 487-487, 2018.

---

	25-13-S59-4. Efforts to polypharmacy by the cooperation with the physician in the psychiatry domain 亀井浩行1, 岩田仲生2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 488-488, 2018.

---

	25-13-S59-5. The multi-type of job cooperation in the field of disaster medical care utilized the pharmacist professional ability 江川孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 489-489, 2018.

---

	25-13-S60-1. Pregnancy and diabetes - commentary ... 和栗雅子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 490-491, 2018.

---

	25-13-S60-2. Use of metformin during pregnancy 中島研1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 492-492, 2018.

---

	25-13-S60-3. Recent trend ... of medical therapy - diabetes therapeutic drug of diabetes in the gestation period 西村あや子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 493-493, 2018.

---

	25-13-S60-4. Of the medication counseling of the pharmacist for the carbohydrate metabolism abnormality merger pregnant woman actually arrive 中川友恵1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 494-494, 2018.

---

	25-14-S61-1. The thing which treatment with specific drug management charges 2 aims at that TERMS, RevMate aims 遠藤一司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 495-496, 2018.

---

	25-14-S61-2. Patients program (the video screening) including the contents which are sensitive (contraception, sexual intercourse) 伊藤忠明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 497-497, 2018.

---

	25-14-S61-3. Having been understood from sensitive communication education scenario making 柏村友一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 498-498, 2018.

---

	25-14-S61-4. Of the patients communication in TERMS, RevMate, actually 小室雅人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 499-499, 2018.

---

	25-14-S62-1. Is it a side effect of medicine? We aim at the pharmacist who grasps the state of patients, and reasons in a side effect 今井徹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 500-500, 2018.

---

	25-14-S62-2. Practice of the side effect management by the clinical practice 石川寛1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 501-501, 2018.

---

	25-14-S62-3. Development of the clinical pharmacy study for the construction of the side effect management mainly composed of the expression prevention 岡田直人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 502-502, 2018.

---

	25-14-S62-4. Study aiming at countermeasure establishment of peripheral neuropathy with the anticancer medicine 川尻雄大1, 小林大介1, 宮城杏奈1, 清水栞1, 重松奈央1, 座間味義人2,3, 牛尾聡一郎4, 新村貴博3, 北村佳久4, 千堂年昭4, 石澤啓介2,3, 島添隆雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 503-503, 2018.

---

	25-14-S62-5. Search of the preventive preparation for the drug-related myocarditis utilizing a large-scale medical information database and the gene expression database 新村貴博1, 座間味義人1,2, 石澤有紀3, 齊藤広海1, 西牟田剛広1, 今西正樹2, 武智研志4, 中馬真幸4, 福島圭穣5, 堀ノ内裕也3, 池田康将3, 藤野裕道5, 土屋浩一郎6, 石澤啓介1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 504-504, 2018.

---

	25-14-S62-6. Risk assessment and risk management by medical treatment and the renal failure pharmacist 矢野貴久1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 505-505, 2018.

---

25-15-S63-1. Offer - of the latest safe information depending on the reporting system (1) - characteristic of the patient from the pharmaceutical company 竹本信也1, 吉田由以子1, 千葉俊1, 富谷聡学1, 田端秀日朗1, 富澤志帆1, 梅津恒星1, 若井真人2, 加藤弘之2, 大寺昭雄2, 梶山達也2, 石部竜大2, 山口岳裕3, 小田育子4, 金澤恵美4, 中島美保5, 内海奈穂子5, 近藤育絵5, 田中里和5, 結城陽二郎5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 506-506, 2018.

---

	25-15-S63-2. About an effective drug information offer system using ICT 慶徳一浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 507-507, 2018.

---

	25-15-S63-3. How is a pharmacist one of "making" information for the artificial intelligence era? 幸田恭治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 508-508, 2018.

---

	25-15-S63-4. With "medical information system that is necessary to save it to make" information? 池田和之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 509-509, 2018.

---

	25-15-S64-1. Guess, evaluation, correspondence of the pain accompanied with the energy intake 菅幸生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 510-510, 2018.

---

	25-15-S64-2. Perioperative care and diet 柴田ゆうか1, 松尾裕彰1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 511-511, 2018.

---

	25-15-S64-3. Inappetence and electrolyte abnormality in patients with cancer 菅原英輝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 512-512, 2018.

---

	25-15-S64-4. Appetite decreased of the patients who developed unexpected glaucomatous attack during chemotherapy 池田博昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 513-513, 2018.

---

	25-15-S64-5. A change and invention of "the meal" to support hope to the death 萬谷摩美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 514-514, 2018.

---

	25-15-S64-6. The seamless patients care that a pharmacist works on 内田まやこ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 515-515, 2018.

---

	25-16-S65-1. A perioperative care team and anesthesiologist 齋藤繁1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 516-517, 2018.

---

	25-16-S65-2. Reporting ... to the medical institution through efforts report ... patients to patients undergoing the surgery in the health insurance pharmacy 柄澤忍1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 518-518, 2018.

---

	25-16-S65-3. We think about the multi-type of job cooperation, regional alliances in perioperative care 猪田宏美1, 井川祐輔1, 錦織淳美1, 名和秀起1, 千堂年昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 519-519, 2018.

---

	25-16-S65-4. The prospects to usefulness and medicine - medicine cooperation of the pharmacist preoperation patients interview in the perioperative medical security 宮田祐一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 520-520, 2018.

---

	25-16-S65-5. Seamless relation of the pharmacist for the perioperative patients in the university hospital 柴田みづほ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 521-521, 2018.

---

	25-16-S66-1. Pharmacist activity by the ASEAN disaster medical care cooperation reinforcement project 江川孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 522-523, 2018.

---

	25-16-S66-2. If a pharmacist continues searching international health, in a global health department store 奥村順子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 524-524, 2018.

---

	25-16-S66-3. One pharmacist person fulfils the responsibility as the professional for the world. Role ... which is sought by the pharmacist in ... NGO 青山寿美香1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 525-525, 2018.

---

	25-16-S66-4. The change and the current situation of the Japan Team for Disaster Relief medical care team in the international community 渡邉暁洋1, 高田洋介1, 山田太平2, 中尾博之1, 中尾篤典2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 526-526, 2018.

---

	25-16-S66-5. Role of the pharmacist in the Red Cross 雪本江里子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 527-527, 2018.

---

	The diet, exercise method for the dementia prevention that Oriental medicine and Western medicine recommend 菱川望1, 高橋依子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 528-528, 2018.

---

	Academic F1-1. The participation of the pharmacist starting polypharmacy measures and research of the usefulness 武藤浩司1, 小田慎2, 佐藤康一3, 澁田憲一4, 樋島学5, 別所千枝6, 吉岡睦展7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 529-529, 2018.

---

	Academic F1-2. "Research about the handling of the medical information of the pharmacist accompanied with the revision of the Personal Information Protection Law" (final report) 池田和之1, 岡橋孝侍2, 小枝伸行3, 高田敦史4, 関谷泰明5, 青柳吉博6, 黒田知宏7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 530-530, 2018.

---

	Academic F2-1. Participation of the hospital pharmacist in medical therapy in the convalescence in the local inclusion care system and research of the usefulness 岸本真1, 荒川隆之2, 宮川哲也3, 溝神文博4, 藤原久登5,6, 酒向幸7, 川崎美紀8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 531-531, 2018.

---

	Academic F2-2. The construction of the pharmaceutical products safety management system for the proper use of an unlicensed drug, the medicine out of the adaptation and role of the pharmacist 近藤直樹1, 濃沼政美2, 阿部直樹3, 中澤寛仁4, 米村雅人5, 山口拓洋6,7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 532-532, 2018.

---

	Academic F2-4. We conduct research for becoming it the marketing of the drug necessary for the healthcare setting 渡辺享平1, 大津史子2, 後藤伸之1, 佐々木忠徳3, 原田幸子4, 山川雅之5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 534-534, 2018.

---

	MS1-1. About systems construction and the possibility and problems to be useful for the medicine industry using the artificial intelligence (AI) 木村隆夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 541-541, 2018.

---

	MS1-2. Research and development of the new pharmaceutical products inquiry system utilizing the artificial intelligence (AI) 里香世子1, 亀井淳三1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 542-542, 2018.

---

	MS1-3. Research and development of the new DI reporting system about herbal medicinal products utilizing the artificial intelligence (AI) 南絢子1,2, 亀井淳三1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 543-543, 2018.

---

	MS2. Collaboration ... of a physician, the pharmacist to realize the proper use of physician, pharmacist cooperation guide - drug for multiple drug prescription reviews of elderly people 竹屋泰1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 544-545, 2018.

---

	MS3. We think about the traceability of pharmaceutical products 芳地一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 546-546, 2018.

---

	MS4. Team approach in medical care in the immune checkpoint inhibitor 田端雅弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 547-547, 2018.

---

	MS5. It is ... from revision breast cancer practice guidelines for treatment strategy - 2,018 years of metastasis, the recurrent breast cancer 土井原博義1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 548-548, 2018.

---

	MS6. Heart failure to examine in an area: Importance of the body fluid management 伊藤浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 549-549, 2018.

---

	MS7. Future discussion for Biosimilar latest knowledge and the use promotion 坂巻弘之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 550-550, 2018.

---

	MS8. Management of DDIs by a Clinical Pharmacist in Patients Prescribed Hepatitis C Virus Treatment. David J Back1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 551-551, 2018.

---

	MS9. The medical security that a pharmacist needs now 長田理1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 552-552, 2018.

---

	MS10. Prescription support ... by the scientific viewpoint to join ... basics that an academic D tailing turns prescription behavior into together for clinical practice 小茂田昌代1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 553-553, 2018.

---

	MS11. Proper use of the latest treatment and drug for the hormone acceptor-positive HER2-negative progress recurrent breast cancer 徳永えり子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 554-554, 2018.

---

	MS12. Epilepsy, antiepileptic drug, neurologic manifestation 山田了士1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 555-555, 2018.

---

	MS13. With the optimal antiemesis therapy made in the viewpoint of patients? 村上通康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 556-556, 2018.

---

	MS15-1. It is ... for optimization of impact ... treatment of the immune checkpoint inhibitor 田中洋史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 558-558, 2018.

---

	MS15-2. To confront immune therapy; will be ... ... "from now on" "until now" 吉野真樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 559-559, 2018.

---

	MS16. Practice of biomedicine Quality Assurance for pharmacists 舟越亮寛1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 560-560, 2018.

---

	MS17-1. Introduction of the call center support system which used Watson possibility of the AI utilization to spread 朝生祐介1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 561-561, 2018.

---

	MS17-2. About the expandability by the combination of usefulness and speech recognition of the AI question-answering system by the natural language recognition 橋爪康知1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 562-562, 2018.

---

	MS18. Understanding of gastric cancer treatment guidelines sought by the multi-type of job 山口研成1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 563-563, 2018.

---

	MS19-1. It is ... mainly on medical therapy - FOLFOXIRI + BV therapy in unresectable progress recurrence colon cancer 仁科智裕1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 564-564, 2018.

---

	MS19-2. Chemotherapy management and pharmacist in the Shikoku cancer center 小暮友毅1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 565-565, 2018.

---

	MS20. Economic evaluation - of the Chinese medicine utilizing medical economy and Chinese medicine - medical care big data 赤瀬朋秀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 566-566, 2018.

---

	MS22. Resistant bacteria infection treatment up to date 松元一明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 568-568, 2018.

---

	MS23. The current situation and the point at issue of the biomedicine 益山光一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 569-569, 2018.

---

	MS24. With the significance of oral mucositis measures in the cancer chemotherapy, actually 曽我賢彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 570-570, 2018.

---

	MS25. Cancer-related thrombosis treatment - strange with tumor angiocardiology - medicine 吉田賢司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 571-571, 2018.

---

	MS26. Simple; is duties reduction, management improvement by the management of the adoption medicine! It is ... for ... proper use promotion 小池博文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 572-572, 2018.

---

	MS27. It is Hazardous Drug in healthcare Settings Road to Compliance to USP 800 Fred Massomi1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 573-573, 2018.

---

	MS29. Because menopausal women shine; clinical correspondence ... to complaints peculiar to ... woman characteristics 後山尚久1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 575-575, 2018.

---

	MS30. - to think from guidelines on art - new chronic constipation of constipation treatment not to listen to now 中島淳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 576-576, 2018.

---

	MS31-1. Pharmaceutical care - dysfunction thyroid and diabetes, hyperglycemia ... to patients receiving immune checkpoint inhibitor done from tomorrow 土手賢史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 577-577, 2018.

---

	MS31-2. With the risk assumed by the treatment of the immune checkpoint inhibitor in patients with collagenosis? 鈴木賢一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 578-578, 2018.

---

	MS32-2. A medical lawsuit and medical security 三村まり子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 580-580, 2018.

---

	MS33. Virus safety measures - past, present, future - of the plasma derivative 柚木幹弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 581-581, 2018.

---

	MS34. Want to tell you; is an ad usum externum therapy city legend! 安部正敏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 582-582, 2018.

---

	MS35. One or ... that regulation of the Biosimilar and the Biosimilar of current situation - monoclonal antibody are approved how 荒戸照世1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 583-583, 2018.

---

	MS36. Alleviation of fever, analgesic ABC 鈴木聡1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 584-584, 2018.

---

	MS37. It is ... from the current situation of the medication support of patients with role - HIV infection of the pharmacist for the chronic disease in the ambulatory practice 矢倉裕輝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 585-585, 2018.

---

	MS38. Basic knowledge of the biomedicine that we want to know only this 若林進1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 586-586, 2018.

---

	MS40. Pharmaceutical management of CKD-MBD utilized the pharmacist power 木村健1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 588-588, 2018.

---

	MS41. High blood pressure treatment that fixed its eyes on a heart failure pandemic 土肥薫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 589-589, 2018.

---

	MS42. Search - of the new index of bowel control - pharmacist duties of home care patients 荒井國三1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 590-590, 2018.

---

	MS43. Progress of the breast cancer molecules target treatment 田口哲也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 591-591, 2018.

---

	23-9-O1-1. Research about the regulations item of the medication guide for patients for the safe examination matter in the pharmaceutical products risk management plan of the antineoplastic 市江敏和1,2, 浅川博翔2, 鈴木大介1,2, 寺崎嘉正1, 林秀樹2, 畔柳敏弥1, 杉山正2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 615-615, 2018.

---

	23-9-O1-2. Safe investigation by the PCSK9 inhibitor continuation 大宮寛子1, 内藤成美1, 吉田夕貴1, 川井悦嗣1, 三輪耕次1, 田中伸享2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 616-616, 2018.

---

	23-9-O1-3. The effectiveness of the acetaminophen IV infusion liquid appointed hour administration in the colon cancer post-operative pain 堀田栄治1, 高橋裕治1, 高嶋孝次郎1, 斎藤健一郎2, 高嶋吉浩2, 宗本義則2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 616-616, 2018.

---

	23-9-O1-4. The off-label use situation of DOAC and safe fact-finding 福井里佳1, 平大樹1,2, 國津侑貴1, 磯野哲一郎1, 田淵陽平1, 生野芳博1,3, 伊藤英樹3,4, 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 617-617, 2018.

---

	23-9-O1-5. Usefulness of the efforts of the pharmacy for the appropriate administration of dry concentration person prothrombin complex preparation (Kay Saint lah) 中西裕明1, 大山翔1, 西崎恵利1, 澤田真嗣1, 小森玉緒1, 岡橋孝侍1, 藤田敦夫1, 友金幹視1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 617-617, 2018.

---

	23-9-O2-1. Use experience of the SGLT2 inhibitor for the decreased renal function patients during Hiroshima City Hiroshima Municipal Hospital circulatory organ internal medicine hospitalization 菅原隆文1, 吉川明良1, 開浩一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 618-618, 2018.

---

	23-9-O2-2. The effect that a dialysis period gives to the effectiveness of the levocarnitine preparation on anemia in renal disease 植田徹1, 井上敬之1, 辻川正彦1, 国府孝敏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 619-619, 2018.

---

	23-9-O2-3. Effect on anemia in renal disease with the long-term levocarnitine intravenous administration for haemodialysis patients 長谷川裕矢1, 青木真矢2, 矢島隆宏3, 荒尾舞子3, 松本利恵1, 野田孝夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 619-619, 2018.

---

	23-9-O2-4. Examination of the efficacy titer of Etelcalcetide Hydrochloride and the cinacalcet by our hospital case 安部真一1, 相原瞳1, 中村江理1, 鈴木英則1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 620-620, 2018.

---

	23-9-O2-5. We look at the rear about a conventional dose of DOAC and the initial dose setting and search for a mark 馬替仁1, 白承婀1, 西脇龍広1, 原田光枝1, 實川東洋1, 宮内靖史2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 620-620, 2018.

---

	23-9-O3-1. The need and problem of the patients with diabetes pharmacist outpatient department in the non-diabetes special hospital 大西順子1, 坪井仁美1, 石松義人2, 湯本英一朗2, 渡辺佑介2, 冨岡憲明2, 渡辺伸一郎2, 渡辺哲夫2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 621-621, 2018.

---

	23-9-O3-2. Efforts and results of the diabetes rounds team in the convalescent hospital ソディ保子1, 富山正俊2, 早苗広人3, 小杉正4, 松田光栄5, 永山友美5, 和田達也5, 武田千賀子1, 畔立子6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 622-622, 2018.

---

	23-9-O3-3. Patient factors and cancellation drug to consider in the case of the cancellation of the hypoglycemic agent for patients with type 2 diabetes by the diabetologist 金井紀仁1,2, 櫛山暁史3, 庄野あい子2, 宮下紗季2, 小泉聖人2, 米川拓渡2, 仙石悠紀子2, 沖村悠希2, 梶山里奈2, 森田修司2, 菊池貴子3, 山崎広貴4, 谷口洸亮2, 末永みどり2, 赤沢学2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 622-622, 2018.

---

	23-9-O3-4. The diabetes medical treatment that is optimal for an individual 富岡節子1, 山崎勝弘2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 623-623, 2018.

---

	23-9-O3-5. Instillator in the type 2 diabetes self injection introduction and investigation - instruction time, erroneous operation about the instruction time required and post hoc analysis of usability, the use satisfaction 朝倉俊成1, 荒西利彦2, 鈴木秀一2, 蔡志紅2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 623-623, 2018.

---

	23-9-O4-1. Effect (examination using Fib4-index) that SGLT-2 inhibitor gives for the liver function of patients with type 2 diabetes 西垣賢1, 米田勝晃2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 624-624, 2018.

---

	23-9-O4-2. Evaluation of the hypoglycemia risk by the combination of repaglinide and clopidogrel 赤木祐貴1, 池滝晶子1, 木村晴奈1, 松平有希1, 捧敬子1, 小澤孝美1, 西村富啓2, 高橋省三1, 重松絵理奈3,4, 宇治原誠3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 625-625, 2018.

---

	23-9-O4-3. Examination of the diet endurance test using the FreeStyle livret 野口景子1, 葛葉守1, 久嶋真紀子1, 中野玲子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 625-625, 2018.

---

	23-9-O4-4. Effect of Hb1Ac by the Residual medicine of the oral antidiabetic drug 平井利幸1, 寺門祐介1, 関利一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 626-626, 2018.

---

	23-9-O4-5. Association with effect on liver function after the liraglutide administration in patients with type 2 diabetes and the body-mass index 塩見めぐみ1,2, 田中庸一1,2, 高田哲秀3, 尾鳥勝也1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 626-626, 2018.

---

	23-9-O5-1. The regional alliances reinforcement that made full use of multiple drug adjustment system development and a system 杉生雅和1, 吉岡睦展1, 高子優子1, 石津智司1, 長尾彰太1, 若松雄太1, 山本真由美1, 根上朋子1, 波多野友美1, 西山祐美1, 小川佳美1, 馬淵英一郎2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 627-627, 2018.

---

	23-9-O5-2. One case that an at-home visit by the hospital pharmacist was able to contribute to extension during a home care period of the cancer-carrying patient 徳永奈都子1, 生川晃子1, 米田勝晃1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 628-628, 2018.

---

	23-9-O5-3. Correspondence in the discharge conference for treatment at home to be provided smoothly and the problem that it seemed 松下智侑1, 藤岡記代子1, 尾崎麻理1, 松尾早穂1, 四方奏1, 海野憲郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 628-628, 2018.

---

	23-9-O5-4. Future prospects ... of the result of Residual medicine cancellation effect - two years by the Residual medicine cancellation PBPM introduction of the regional alliances base Hospital that assumed ICT a base 寺門祐介1, 平井利幸1, 関利一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 629-629, 2018.

---

	23-9-O5-5. About the effect that clinical test value indication gives to a doubt inquiry on outside Parliament prescription 小牟田豊1, 齋藤玲奈1, 衛藤広士1, 中井優作1, 八代哲也1, 東海秀吉1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 629-629, 2018.

---

	23-9-O6-1. Study on medicine medicine cooperation and patients outcome 高井靖1, 前田雄太郎1, 木本珠美1, 松岡佳子1, 伊藤涼子1, 梶間勇樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 630-630, 2018.

---

	23-9-O6-2. Efforts of the medicine medicine cooperation in the Yachiyo medical center attached to Tokyo Women's Medical University 鈴木駿介1, 高柳論也1, 大場ちはる1, 小林恵美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 631-631, 2018.

---

	23-9-O6-3. Approach from approach - hospital pharmacist to medicine medicine cooperation 丸岡由貴1, 見元尚1, 筒井由佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 631-631, 2018.

---

	23-9-O6-4. Efforts of the medicine medicine cooperation that we collaborated with NST in the short bowel syndrome case and joined together to treatment at home 宗村雅男1, 土肥麻貴子1, 久保理美2, 中川素子2, 藤原智美1, 鶴谷茂1, 伊藤次郎3, 水本素子4, 室井延之1, 橋田亨1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 632-632, 2018.

---

	23-9-O6-5. Consideration of the fact-finding of the illness medicine cooperation inhalation instruction system and the inhalational error contributing factor 天谷拓也1, 正木克宜2, 大野凜太朗1, 仲地一郎2, 稲見正幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 632-632, 2018.

---

	23-13-O7-1. Fact-finding of the prescription suggestion by the pharmacist at physician rounds company and the order support to a physician 木本絵理華1, 近藤麻衣1, 荒川隆之1, 坪井俊之2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 633-633, 2018.

---

	23-13-O7-2. Usefulness and problem of the holiday ward duties by the pharmacist 真志田絵美子1, 柴田ゆうか1, 土井舞子1, 佐伯康之1, 松尾裕彰1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 634-634, 2018.

---

	23-13-O7-4. We look back on a physician, the conference with the nurse and information sharing-related importance than a pharmaceutical intervention case 坂井孝行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 635-635, 2018.

---

	23-13-O7-5. Efforts in our hospital in the regimen management including the nonrecognition anticancer agent 安藤洋介1, 西部星来1, 加藤さや香1, 河田健司2, 山田成樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 635-635, 2018.

---

	23-13-O8-1. The application support system of the Relief System for Sufferers from Adverse Drug Reactions that linked ward drug duties 中川義浩1, 浮池聡子1, 中村愛2, 中山洋輔3, 鶴崎泰史1, 花田聖典1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 636-636, 2018.

---

	23-13-O8-2. The use investigation of the immune checkpoint inhibitor and construction of the drug control system for irAE 早坂州生1, 岩本浩史1, 出町拓也1, 北山秀則1, 田中宏尚1, 芦崎雅之1, 平田力1, 竹内公美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 637-637, 2018.

---

	23-13-O8-3. Intervention to the inappropriate prescription that combined the safe medical therapy guidelines on elderly people 2015 with STOPP criteria version 2 藤田弥佐1, 木村丈司1, 清水倫子1, 久保萌子1, 住吉霞美1, 番匠咲帆1, 三島唯1, 戸田飛鳥1, 松本久美子1, 大本暢子1, 西岡達也1, 矢野育子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 637-637, 2018.

---

	23-13-O8-4. Investigation about the pharmacist intervention at perioperative medical treatment and discharge in the catheter ablation 寺島純一1,2, 石山由香1, 山田哲也1, 中村直人1, 鷹見繁宏1, 長内宏之2, 浅野博2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 638-638, 2018.

---

	23-13-O8-5. Medical treatment intervention to the steroid therapy for patients with acute renal failure due to the cholesterol embolisation 小野田稔久1, 増田雅行1, 真坂亙2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 638-638, 2018.

---

	23-13-O9-1. Enforcement and performance evaluation of the in-hospital blood level measurement with the new HPLC fixed-quantity system which is applicable to medicine targeted for the TDM of the multi-item 森川剛1, 深海和人2, 反町美穂3, 土屋達寛3, 田村和季3, 守岩友紀子3, 東海林敦3, 半田幸雄2, 岡澤香津子1, 柳田顕郎3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 639-639, 2018.

---

	23-13-O9-2. Quantitative evaluation of blood behavior of an endogenous marker of the CYP3A activity in puerperium women and amlodipine 田口怜奈1, 内藤隆文1, 久保野尚子1, 小川法良2, 伊東宏晃3, 川上純一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 640-640, 2018.

---

	23-13-O9-3. It is ... based on relationship - part-specific PK-PD analysis with blood level and the fascial tissue density of cefazolin in the total hip replacement 小松敏彰1, 夏目祐衣2, 坂之上和実2, 川村充史2, 友田吉則2, 池田信介2, 内山勝文3, 高山陽子1, 厚田幸一郎2,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 640-640, 2018.

---

	23-13-O9-4. Change over time of the tacrolimus body change in the lung transplantation patients who used itraconazole together 川本雄士1, 片田佳希1, 中川俊作1, 杉本充弘1, 糸原光太郎1, 山本由貴1, 福井彩香1, 松田裕也1, 松村勝之1, 大村友博1, 米澤淳1,2, 中川貴之1, 長尾美紀3, 陳豊史4, 伊達洋至4, 松原和夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 641-641, 2018.

---

	23-13-O9-5. Study on development change model and covariates of the anticoagulant effect in the childhood warfarin therapy 田村理香1, 渡辺直1, 中村早稀1, 芳村直樹2, 小澤綾佳3, 廣野恵一3, 市田蕗子3, 田口雅登1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 641-641, 2018.

---

	23-13-O10-1. Relations of blood level and the treatment result of the gefitinib in patients with non-small cell lung cancer 横田隼人1, 小林裕幸1, 佐藤一洋2, 坂本祥2, 中山勝敏2, 三浦昌朋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 642-642, 2018.

---

	23-13-O10-2. About an association between weight loss, cancellation and pharmacokinetics of the Erlotinib of the Erlotinib in patients with progress non-small cell lung cancer 長谷川一将1, 山本達郎1, 渡部裕紀1, 武田賢一2, 田中那津美2, 清水英治2, 島田美樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 643-643, 2018.

---

	23-13-O10-3. Effect of the drug transportation transporter genetic polymorphism giving it to a pathological complete response after the nedaplatin +5-FU therapy in the cancer of the esophagus 藤田一馬1, 本山悟2,3, 佐藤雄亮2, 三浦昌朋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 643-643, 2018.

---

	23-13-O10-4. The establishment of the optical isomer simultaneous measurement method of human blood tramadol and the demethyl metabolite and stereoselective evaluation in the CYPs metabolism 鈴木光路1,2, 内藤隆文1, 田中達也1, 山田康秀3, 伊藤邦彦2, 川上純一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 644-644, 2018.

---

	23-13-O10-5. Calculation of the cutoff value of the adrenal cortical steroid dose to affect eGFRcys/eGFRcreat 津下遥香1, 田中遼大1, 鈴木陽介1, 佐藤雄己1, 伊東弘樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 644-644, 2018.

---

	23-13-O11-1. Examination about the dose setting of irinotecan based on the UGT1A1 genetic polymorphism in patients with colon cancer 山田友奈美1, 藤井宏典1, 渡辺大地1, 松橋延壽2, 高橋孝夫2, 吉田和弘2, 鈴木昭夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 645-645, 2018.

---

	23-13-O11-2. A search of the new preventive preparation for the cisplatin-induced renal failure and inspection of the effectiveness 合田光寛1, 斉家和仁2, 伊勢諒3, 新村貴博2, 石澤有紀3, 座間味義人1,2, 中馬真幸4, 濱野裕章1, 岡田直人1, 武智研志4, 今西正樹1,2, 堀ノ内裕也3, 池田康将3, 桐野靖1, 中村敏己1, 寺岡和彦1, 石澤啓介1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 646-646, 2018.

---

	23-13-O11-3. Effect on renal function by cisplatin and the antihypertensive medications combination in patients with cancer of the esophagus 熊谷優1, 赤嶺由美子1, 安倍明2, 和田優貴2, 戸沢智樹2, 笹嶋素子2, 熊谷聡2, 橋本学2, 三浦昌朋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 646-646, 2018.

---

	23-13-O11-4. Examination about onset of vascular pain and the effect of treatment by the dissolution liquid increase in quantity of bendamustine 森川花絵1, 石田茂1, 杉尾健志2, 森康雄2, 渡邊裕之1, 江頭伸昭1, 宮本敏浩2, 増田智先1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 647-647, 2018.

---

	23-13-O11-5. Effect of the serotonin receptor blocker on retching, vomiting of the temozolomide combination radiotherapy 熊倉康郎1, 亀川弥那1, 渡邉美菜子1, 石井沙也加1, 井上理香子1, 高木麻衣1, 大岡史治2, 本村和也2, 夏目敦至2, 藤井正純2, 若林俊彦2, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 647-647, 2018.

---

	23-13-O12-1. Examination about the exposure risk at use of anticancer agent division 中山季昭1, 内田礼人1, 片山明香1, 嶋崎幸也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 648-648, 2018.

---

	23-13-O12-2. The exposure investigation of the anticancer medicine disposal container and examination of the storage management method 橋本昂介1, 入佐俊弘1, 石田茂1, 秦晃二郎1, 中嶋一惠1, 渡邊裕之1, 辻敏和1, 江頭伸昭1, 増田智先1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 649-649, 2018.

---

	23-13-O12-3. The anticancer medicine scattering situation investigation to the preparation environment outside and evaluation of the usefulness of preventive measures against exposure 後藤優理1, 鈴木貴明1, 中村貴子1, 石井伊都子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 649-649, 2018.

---

	23-13-O12-4. Multicenter study on fact-finding of the quantity of nivolumab disposal in Hokkaido and cancellation policy (NEWHOPE STUDY) - final report - 福土将秀1, 石川良太1, 相馬亮太1, 吉田光一1, 木村周古1, 新田悠一朗1, 小枝正吉1, 三嶋一登1, 小野尚志1, 田崎嘉一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 650-650, 2018.

---

	23-14-O13-1. We see the rear of the factor to reduce response rate of tazobactam/piperacillin and the effect on elderly people pneumonia treatment and examine a mark 宗村盛1, 尾田一貴2, 太田景子1, 坂本直治3, 鈴木豊史4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 651-651, 2018.

---

	23-14-O13-2. Clarithromycin-resistant H. The effect that a choice of the antimicrobial gives to a sanitization rate on pylori infection 深津昌弘1, 水野貴仁1, 梅村拓巳1, 岩津慎次郎1, 河邊智久2, 新家卓郎2, 竹中宏之2, 黒岩正憲2, 鷹見繁宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 652-652, 2018.

---

	23-14-O13-3. An initial therapeutic drug for the MRSA bacteremia and prognostic relations 吉田三矢1, 川上智久1, 南翔大1, 三浦菜々子1, 山口崇臣1, 畝佳子1, 政道修二1, 志馬伸朗2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 652-652, 2018.

---

	23-14-O13-4. Sensitivity analysis of the oral antimicrobial including the cefaclor for cefazolin-resistant Escherichia coli 片野田朋美1,2, 尾田一貴1,2, 山本景一2,3, 福嶋理香2,3, 野坂生郷2, 齋藤秀之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 653-653, 2018.

---

	23-14-O13-5. Effect of Antifungal Stewardship (AFS) on surgical system, Candida blood symptom in the intensive care domain 伊藤亮太1, 渡邊卓嗣1, 星野祐太1, 菊地未由1, 菅野和彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 653-653, 2018.

---

	23-14-O14-1. Intervention for the oral third generation cephalosporin medicine consumption reduction in the antimicrobial proper use 久保田健1, 宮澤衣鶴1, 小池恵理1, 森川剛1, 岡澤香津子1, 千秋智重2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 654-654, 2018.

---

	23-14-O14-2. Clinical outcome evaluation by the expansion targeted for the surveillance from report antimicrobial to the use of all injectable antimicrobial patients 大橋健吾1, 松岡知子1, 篠田康孝1,2, 新井かおり1, 森卓之1, 吉田真也1, 林秀樹2,3, 杉山正2,3, 吉村知哲1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 655-655, 2018.

---

	23-14-O14-3. Should we assume consumption as of the past when an index in the antimicrobial-sensitive monitoring? 岡村祐嗣1,3, 東野優花1, 津山博匡1,3, 木村正彦2,3, 齋藤紀先2,3, 萱場広之2,3, 新岡丈典1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 655-655, 2018.

---

	23-14-O14-4. Intervention effect of Antimicrobial Stewardship Team based on process index and outcome index 平山晴奈1, 倉本恵里子1, 藤田拓俊1, 平畠正樹1, 安藤基純5, 小倉明子2, 奈須聖子3, 土井朝子4, 池末裕明1, 室井延之1, 橋田亨1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 656-656, 2018.

---

	23-14-O14-5. Use trend ... by the proper use ... oral third generation cephem permission system of the childhood SSI prevention antimicrobial 渡邉稜子1, 野田有貴子1, 山田真人1, 三輪祐太朗1, 石田達彦1, 上田理恵1, 福井由美子1, 伊藤雄介2, 笠井正志2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 656-656, 2018.

---

	23-14-O15-1. The proper use support effect to a carbapenem-based antimicrobial chronic administration case in our hospital and role of the pharmacist 赤沢翼1, 茂野絢子1, 原量平1, 大橋裕丈1, 守山祐樹2,3, 太田雅之2, 高谷紗帆2, 山元佳2, 日馬由貴3, 増田純一1, 目崎和久4, 早川佳代子2,3, 忽那賢志2, 寺門浩之1, 大曲貴夫2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 657-657, 2018.

---

	23-14-O15-2. Examination about the acute renal failure risk by vancomycin and the tazobactam piperacillin combination drug combination 稲毛俊介1, 中村翔太郎1, 礒江雄人1, 岡本早織1, 植竹将1, 村上美聖1, 山口礼華1, 森島雅世2, 根井貴仁2, 伊勢雄也1, 片山志郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 658-658, 2018.

---

	23-14-O15-3. Examination about the usefulness of the initial loading dose of vancomycin for the renal function normalcy case 植田貴史1, 竹末芳生1, 中嶋一彦1, 一木薫1, 石川かおり1, 和田恭直1, 山田久美子1, 土田敏恵1, 高橋佳子2, 石原美佳2, 木村健2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 658-658, 2018.

---

	23-14-O15-4. Search of the index to sort patients requiring administration of high-dose vancomycin 可児紘子1, 田中雄大1, 山口諒1, 山本武人1,2, 鈴木洋史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 659-659, 2018.

---

	23-14-O15-5. Result analysis of Antimicrobial Stewardship by the cooperation of a pharmacist and the medical technologist in the municipal hospital 小島さおり1, 片山歳也1, 井上靖浩2, 町田祐子3, 野田晋司1, 三好美穂4, 三宅真人4, 伊藤佐知子5, 木枝秀人6, 松田浩明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 659-659, 2018.

---

	23-14-O16-1. From hospital preparation to clinical experimental medicine production role - of the hospital pharmacist by the - sirolimus gel preparation development 中村歩1,2, 前田真一郎3, 大石雅子5, 三輪芳弘1, 斎藤勝久2, 金田眞理4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 660-660, 2018.

---

	23-14-O16-2. Examination of the new quality docimasy in the hospital preparation selenium injection 鈴木英二1, 吾妻貴司2, 熊谷静香1, 牧内里衣3, 堀勝幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 661-661, 2018.

---

	23-14-O16-3. Basic study of the pregabalin bougie which was hard to take medicine, and aimed at the pain control of the patients 矢島領1,2, 松元一明2, 横野加那子2, 渡部佑樹2, 榎木裕紀2, 田口和明2, 伊勢雄也1, 片山志郎1, 木津純子3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 661-661, 2018.

---

	23-14-O16-4. For improvement in convenience of the Mohs ointment: Fluid improvement effect with usefulness and the shear stress of the cryopreservation 岡本広世1, 吉川知宏1, 竹内健太1, 松岡寛1, 出口粧央里2, 畠中優斗2, 川畑篤史2, 長井紀章2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 662-662, 2018.

---

	23-14-O16-5. Sustained ... of elution of development - amphotericin B of the amphotericin B-containing gum preparation and the effect 小田原瑛理1, 大川杏果1, 村山信浩1, 原田努1, 中村明弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 662-662, 2018.

---

	23-14-O17-1. Construction of the rating system that considered the sex differences of the drug induced hepatic injury onset risk by the tazobactam piperacillin in the ward for acute phase 雨宮貴洋1, 本間雅1, 長瀬幸恵1, 鈴木洋史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 663-663, 2018.

---

	23-14-O17-2. The onset of liver damage during Eltrombopag administration attenuates an increased number of platelets effect 柳町直哉1,2, 小原直3, 錦井秀和3, 坂田麻実子3, 長谷川雄一3, 千葉滋3, 土岐浩介1,2, 本間真人1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 664-664, 2018.

---

	23-14-O17-3. Examination of the risk factor of the effectiveness and retching of the prophylactic antiemetic drug for retching, vomiting at oxycodone introduction 市川洋一1, 守田和憲1, 徳永晃己1, 佐々扶美1, 山下愛子1, 田上治美1, 坂本慎弥2, 大山高廣2, 中村和美2, 政賢悟2, 齋藤秀之2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 664-664, 2018.

---

	23-14-O17-4. The construction of the safe information management system of the immune checkpoint inhibitor and search of the clinical factor associated with the immune-mediated adverse event expression 板井進悟1, 川岸篤史1, 川上貴裕1, 速水良恵1, 菅幸生2, 原祐輔1, 嶋田努1, 崔吉道1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 665-665, 2018.

---

	23-14-O17-5. Analysis of an appearance ratio and the risk factor of the steroid-induced mental disorder in patients with children, young adults blood-forming organ tumor スタッブ由紀子1,2, 菅幸生2, 伊川泰広3, 坪内清貴4, 橋本美紀恵4, 川岸篤史4, 嶋田努4, 崔吉道4, 松下良2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 665-665, 2018.

---

	23-14-O18-1. Construction of side effect monitoring duties utilizing pharmaceutical products risk management plan (RMP) 高田裕介1, 和田陽子2, 中村美代子1, 秋山伸二2, 難波弘行2, 飛鷹範明1, 田中守1, 田中亮裕1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 666-666, 2018.

---

23-14-O18-2. It is prospective study about the association with the protein urine creatinine ratio with protein urine fixed-quantity in urine collection for 24 hours in patients with antiVEGF antibody-related protein urine appearance at any time 阪田安彦1, 北本真一2, 水上皓喜1, 阿部圭輔1, 妹尾啓司1, 岩本康男3, 松尾宏一4, 開浩一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 667-667, 2018.

---

	23-14-O18-3. Relation of the pharmacist before the non-fixed form sustained-release parenteral injection (LAI) introduction using Shared Decision Making (SDM) 小林真美1,2, 庄司優2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 667-667, 2018.

---

	23-14-O18-4. Construction of the onset of impaired renal function ratio estimate model with vancomycin using the data mining technique 今井俊吾1, 山田武宏1, 笠師久美子1, 新沼悠介1, 小林正紀1, 井関健1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 668-668, 2018.

---

	23-14-O18-5. Cover suspicion medicine by effect - database analysis that treatment with anticancer agent gives to a male sexual function pharmacologic examination - using the rat 片岡智哉1, 真川明将2, 鈴木純3, 武藤樹也4, 堀田祐志3, 前田康博3, 川出義浩3, 頭金正博4, 木村和哲1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 668-668, 2018.

---

	23-15-O19-1. The effectiveness and safety of the olanzapine combination for the standard antiemesis therapy of breast cancer chemotherapy-induced retching, vomiting: Tendency score analysis 河添仁1, 魚住龍史2, 村上朱里3, 山下美智子3, 田口加奈3, 日下恵梨菜3, 山澤令菜3, 薬師神芳洋4, 亀井義明3, 中村智徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 669-669, 2018.

---

	23-15-O19-2. Effect to give blood glucose level of Olanzapine to use for an antiemesis purpose by chemotherapy for the breast cancer perioperative period 友松拓哉1, 平出誠1, 青山剛1, 鈴木賢一1, 伊藤良則2, 濱敏弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 670-670, 2018.

---

	23-15-O19-3. It is evaluated the antiemesis therapy using three drugs of palonosetron, aprepitant, the dexamethasone for the CapOX therapy after the stomach cancer technique 萩野茜1, 青山剛1, 横川貴志1, 中野泰寛1, 樋口秀太郎1, 柴田直樹1, 鈴木賢一1, 若槻尊2, 山口研成2, 濱敏弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 670-670, 2018.

---

	23-15-O19-4. Examination ... about the need of retching, anorectic expression situation investigation - antiemesis therapy reinforcement due to platinum-containing cancer chemotherapy 杉山弘樹1, 中田淳也1, 市村菜穂2, 原田晴司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 671-671, 2018.

---

	23-15-O19-5. The effectiveness of the peg filgrastim second prophylactic administration in the small cell lung cancer chemotherapy and safe examination 櫻下弘志1, 佐伯康之1, 泉谷悟1, 畝井浩子1, 松尾裕彰1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 671-671, 2018.

---

	23-15-O20-1. Establishment of the proper use of the expression situation according to the CINV risk factor with the breast cancer anthracycline regimen and olanzapine 小暮俊明1, 佐々木俊則1, 水谷三浩2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 672-672, 2018.

---

	23-15-O20-2. Examination of the olanzapine relief dosage effect to retching with the chemotherapy including the anthracycline anticancer agent on patients with breast cancer 渡邉大毅1, 高田慎也2, 橋下浩紀2, 鶴山辰1, 遠藤雅之2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 673-673, 2018.

---

	23-15-O20-3. Extra effect of aprepitant on delayed-action retching, vomiting at the CBDCA initial administration in the lung cancer 細川祐岐1, 新谷拓也1, 斎藤由佳1, 村地康1, 山本智也1, 門脇裕子1, 勝浦正人1, 平田陽彦2, 長友泉2, 木田博2, 三輪芳弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 673-673, 2018.

---

	23-15-O20-4. Appropriate mild cathartic choice for the intractable constipation in blood cancer chemotherapy patients 川田敬1, 太田剛史2, 小笠原瑞穂1, 津野文香1, 山崎好恵1, 藤澤康代1, 段松雅弘1, 今井利2, 田中聡1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 674-674, 2018.

---

	23-15-O20-5. An oral Mg agent and effect of the antacid administration to give to onset of low Mg blood symptom due to the antiEGFR antibody 佐藤淳也1, 石川寛1, 田中怜1, 篠道弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 674-674, 2018.

---

	23-15-O21-1. Investigation of the expression situation of edema at the docetaxel administration to patients with breast cancer and the associated factor 宇野健一1,2, 高田慎也2, 橋下浩紀2, 遠藤雅之2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 675-675, 2018.

---

	23-15-O21-2. Elucidation of the onset of phlebitis mechanism by Fosaprepitant and the epirubicin combination 山崎美保1, 木村竜司1, 馬屋原慈理1, 前田頼伸1, 西田俊博2, 小田啓祐3, 森信博3, 村上照夫3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 676-676, 2018.

---

	23-15-O21-3. The onset of vascular pain situation investigation accompanied with the gemcitabine solution change 中田淳也1, 杉山弘樹1, 市村菜穂2, 原田晴司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 676-676, 2018.

---

	23-15-O21-4. The onset of oral mucosa disorder situation with the immune checkpoint inhibitor in the single institution 金子忍1, 塩飽英二1, 土手賢史1, 古田祐美子1, 野崎歩1, 小林由佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 677-677, 2018.

---

	23-15-O21-5. Risk factor analysis of the febrile neutropenia in nedaplatin, the 5-FU combination therapy 橋詰淳哉1, 松丸由美1, 金澤絵莉2, 樋口則英3, 黄智剛1, 神田絋介1, 山崎拓也4, 本田琢也5,6, 日高重和7, 佐々木均1, 室高広1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 677-677, 2018.

---

	23-15-O22-1. One case of acute hepatitis B that caused the HBV reactivation that occurred five years after malignant lymphoma completion of treatment 上ノ段友里1, 大森薫2, 富田珠美1, 福山康朗3, 横田昌樹2, 縄田好一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 678-678, 2018.

---

23-15-O22-2. It is randomized controlled trial (AEOLUS) about the improvement in adjuvant chemotherapy successful execution after the S-1 gastric cancer technique by the adverse event reduction of the lafutidine 木村仁1,2, 寺島雅典3, 多久佳成4, 大門貴志5, 安井博史3, 野崎功雄6, 福島紀雅7, 高金明典8, 金容壱9, 滝口伸浩10, 高木正和4, 三澤一成11, 木村泰生12, 前田賢人13, 金井俊和14, 太田光彦15, 横山日出太郎16 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 679-679, 2018.

---

	23-15-O22-3. Examination about the effectiveness of the polaprezinc for the cancer chemotherapy-induced taste disturbance 廣瀬智恵美1, 藤井宏典1, 石原正志1, 飯原大稔1, 今井寿2, 松橋延壽2, 高橋孝夫2, 山口和也2, 吉田和弘2, 鈴木昭夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 679-679, 2018.

---

	23-15-O22-4. Study on search of a clinical course and the risk factor of the case that paclitaxel caused eye disorders 野口裕介1, 川島悠吾1, 丸山恵未1, 瓦比呂子1, 徳山洋子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 680-680, 2018.

---

	23-15-O22-5. The combination of irinotecan hydrochloride and killer cells-related anticancer medicine is a risk factor of the cholinergic syndrome 坪谷綾子1,2, 藤田健一3, 久保田祐太郎4, 石田博雄4, 滝伊織1, 亀井大輔1, 岩井信市1, 佐々木康綱3,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 680-680, 2018.

---

	23-15-O23-1. Search of new urinary biomarker to detect onset of acute rejection of renal-transplant recipients 田島壮一郎1, 付饒2, 末次王卓1,2, 土本晃裕3, 岡部安博4, 増田智先1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 681-681, 2018.

---

	23-15-O23-2. Examination of the blood pressure independence-like kidney protection effect by PDE5 inhibitor Tadalafil 冨田なつみ1, 堀田祐志1, 内木綾2, 片岡智哉3, 前田康博1, 高橋智2, 木村和哲1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 682-682, 2018.

---

	23-15-O23-3. It is ... for investigation - effect-like Rincon trawl about the inorganic phosphorus content in oral medicine, the supplement which haemodialysis patients take 下石和樹1, 安楽誠2, 庵原大輔2, 平山文俊2, 小田切優樹2, 陣上祥子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 682-682, 2018.

---

	23-15-O23-4. Search of the new liver function improvement medicine by the choler phosphatide discharge promotion effect 池田義人1, 森田真也1, 波多野亮2, 辻徳治1, 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 683-683, 2018.

---

	23-15-O23-5. Examination of the risk factor becoming poor in pain control after opioid switching from oxycodone tablets to fentanyl patch 森川記道1, 笠原庸子2, 高橋裕子1, 西原昌幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 683-683, 2018.

---

	23-15-O24-1. The study on factor to give it to malpractice: About powders formulations 大嶋耐之1, 水野まい1, 宮地佑佳1, 仲山千佳1, 廣嶋尚美2, 舟橋智美2, 長芝計代2, 木下功2, 大西正文2, 斎藤寛子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 684-684, 2018.

---

	23-15-O24-2. A risk factor about the administration of non-fixed form antipsychotics in the Parkinson's disease patients and relative evaluation with the length of stay 池谷怜1,2, 今井志乃ぶ2, 堀口裕正2, 古島大資1, 伏見清秀2, 山田浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 685-685, 2018.

---

	23-15-O24-3. Clinical background associated with under dose of the direct action type oral anticoagulant drug for the atrial fibrillation 宮崎元康1, 坂元佑哉1, 三崎桃子1, 松尾宏一1, 内山将伸1, 浦田秀則2, 仲村佳彦3, 今給黎修1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 685-685, 2018.

---

	23-15-O24-4. Examination of the onset risk of dyslipidemia with the antiepileptic drug using the large-scale cohort 鈴木亮平1, 近藤芳皓2, 柴田晋弥3, 深見和宏3, 石嶋麗4, 中出恵里奈4, 山本吉章5, 林誠2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 686-686, 2018.

---

	23-15-O24-5. Case report about the safety assessment to transitivity out of the mother's milk of antibody preparation Tocilizumab and an infant at breast 齊藤順平1, 八鍬奈穂2, 高井千夏2, 中島研2, 金子佳代子3, 後藤美賀子2,3, 山谷明正1, 石川洋一4, 村島温子2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 686-686, 2018.

---

	24-9-O25-1. The current situation of establishment and duties of the pharmacist outpatient department 大窪典子1, 津曲恭一1, 尾之江剛樹2, 北島久義1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 687-687, 2018.

---

	24-9-O25-2. Pharmacist outpatient department establishment in our hospital and evaluation of prescription suggestion contents 村地康1, 細川祐岐1, 堀野沙耶1, 山本智也1, 三輪芳弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 688-688, 2018.

---

24-9-O25-3. Examination of proper use and the medication counseling to psychotropic drug polypharmacy, the long-term prescription patients by the pharmacist of the circulatory organ internal medicine outpatient department 上野良夫1, 玉木真紀子2, 伊原木沙智代1, 三枝貢1, 眞鍋伸次1,2, 石川真也3, 村尾敏4, 高木雄一郎5, 前田剛6, 森由弘6, 厚井文一6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 688-688, 2018.

---

	24-9-O25-4. Evaluation of efforts and the usefulness of the pharmacist outpatient department in the idiopathic pulmonary fibrosis therapeutic drug 薩摩由香里1, 楠田かおり1, 池末裕明1, 室井延之1, 森令法2, 古郷摩利子2, 富井啓介2, 橋田亨1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 689-689, 2018.

---

	24-9-O25-5. Examination of intervention contents in the chemotherapy center permanent residence type pharmacist outpatient department 後藤由起子1,2, 鶴崎泰史2, 眞弓健介2, 丸田基史3, 大橋邦夫2, 藤田強記2, 横田千明2, 山室蕗子1, 末吉栄志1, 中川義浩2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 689-689, 2018.

---

	24-9-O26-1. Evaluation of efforts for improvement in methotrexate medication adherence for outpatients and the usefulness 雪矢良輔1, 奥田佳子1, 松岡里枝1, 梶田貴司1, 中島亜梨沙1, 石丸裕康2, 八田和大2, 上田睦明1, 奥野智之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 690-690, 2018.

---

	24-9-O26-2. Discontinuation instruction duties before operation of the antithrombotic drug by the outpatient department pharmacist and fact-finding of the instruction observance situation 森亜沙美1, 赤嶺聡彦1, 冨澤淳1, 椎崇1, 近藤留美子1, 厚田幸一郎1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 691-691, 2018.

---

	24-9-O26-3. About dose setting and adherence of the bringing medicine in the anticoagulation patients 鳥谷部翔1, 清藤一輝1, 岩崎友美1, 石田瑞穂1, 花田和大1, 高瀬公子1, 倉内寿孝1, 萩井譲士2, 清野聡2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 691-691, 2018.

---

	24-9-O26-4. Analysis - of economic effect - Pharmaceutical Intervention Record (pharmaceutical intervention report) of a test value check, the bringing medicine check 味澤香苗1, 鈴木学1,2, 林由依1, 國府田真綾1, 金地夏実1, 林秀樹1,3, 小原道子3, 棚瀬友啓2, 土屋照雄2, 杉山正1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 692-692, 2018.

---

	24-9-O26-5. Future problem about the inflection of the prescription notebook found from the bringing medicine for patients with direct hospital admission of emergency confirmation 松本乃里子1, 加藤隆寛1, 竹内正幸1, 山之内博明1, 大西正文1, 斎藤寛子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 692-692, 2018.

---

	24-9-O27-1. Internal change of the lamotrigine when we supplemented with valproic acid 山本吉章1, 石川哲也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 693-693, 2018.

---

	24-9-O27-2. Pharmacokinetics of apixaban, dabigatran, the edoxaban of elderly patients in our hospital and the rivaroxaban 西岡美穂1,2, 小菊実2, 岸博久2, 野田昌幸2, 遠藤純男2, 竹川充2, 太田美樹1, 野津祐貴1, 清水万紀子1, 山崎浩史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 694-694, 2018.

---

	24-9-O27-3. The establishment of the simultaneous assay of aprepitant out of the human plasma and the metabolite and evaluation of the CYP3A subfamily in the metabolic process 鈴木祐介1, 内藤隆文1, 柴田海斗1, 土屋未来広1, 岡村純2, 細川誠二2, 峯田周幸2, 川上純一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 694-694, 2018.

---

	24-9-O27-4. Evaluation of the OATP1B activity after the living renal transplantation that assumed Coproporphyrin-I an index 小野寛之1, 鈴木陽介1,2, 田中遼大1, 佐藤文憲3, 佐藤雄己1, 三股浩光3, 大野恵子2, 伊東弘樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 695-695, 2018.

---

	24-9-O27-5. Association between serum paraoxonase 3 levels and lactone type drug hydrolysis activity in normal adults 尾形浩1, 三坂眞元1, 鎌村美歩1, 阿部理1, 小野委成1, 色摩弥生2, 下村健寿1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 695-695, 2018.

---

	24-9-O28-1. Association between Everolimus blood level and adverse event investigation in renal carcinoma treatment 高崎新也1, 川崎芳英2, 菊地正史1, 田中雅樹1, 山口浩明1, 伊藤明宏2, 眞野成康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 696-696, 2018.

---

	24-9-O28-2. It is 3 ingredients simultaneous assay establishment of 5-FU, the uracil Tegafur in the UFT/LV combination therapy and clinical application after the hepatectomy for colon cancer liver metastases 白岩健1, 鈴木陽介1, 岩男元志1, 田中遼大1, 佐藤雄己1, 岩下幸雄2, 内田博喜2, 多田和裕2, 猪股雅史2, 伊東弘樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 697-697, 2018.

---

	24-9-O28-3. The rate of use of the blood level measurement and the renal function analyses in the digoxin user 千手綾香1, 大場延浩1, 安部恵1, 渡邉文之1, 西銘千絵1, 萩原紫乃1, 福岡憲泰1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 697-697, 2018.

---

	24-9-O28-4. The effect that PTH gives to the tacrolimus doses in renal-transplant recipients and blood level 平田憲史郎1, 渡邊博志2, 杉本龍星2, 丸山徹2, 陣上祥子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 698-698, 2018.

---

	24-9-O28-5. 1 case of the children who succeeded in blood tacrolimus levels control by using cimetidine together 楠川侑吾1, 村田龍宣1, 村岡淳二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 698-698, 2018.

---

	24-10-O29-1. Fact-finding about knowledge for the hemorrhoids in the dweller and the remedial behavior and the consciousness 小堀宅郎1, 仲田博貴1, 榎本恭子1, 沖津孝幸1, 今井康平1, 八木誠次2, 荻野勇人2, 若林修1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 699-699, 2018.

---

	24-10-O29-2. The effect that cerebral infarction disease severity and the arteriosclerosis risk management in patients in CKD give 安泰成1, 松永佳誉子1, 浦田大樹1, 近藤佑紀1, 入岡隆2, 吉川明彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 700-700, 2018.

---

	24-10-O29-3. Use fact-finding of the oral antimicrobial in the Kitasato University Hospital 小泉朱乃1, 小松敏彰2, 瀬戸良教1, 大川原裕樹1, 和田達彦2, 高山陽子2, 厚田幸一郎1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 700-700, 2018.

---

	24-10-O29-4. Efforts aiming at proper use of the ad usum externum local anesthesia preparation used for patients on dialysis 亀山直哉1, 玉木真紀子1, 伊原木沙智代1, 三枝貢1, 眞鍋伸次1, 川原勁介2, 笠井雅実2, 松原啓介3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 701-701, 2018.

---

	24-10-O29-5. Investigation of anxiety and the depression by the treatment cancellation of patients with chronic myelogenous leukemia 祖川倫太郎1,2, 木村早希子1, 矢ヶ部良太1, 溝上泰仁1, 田崎正信1, 荒金尚子1,2, 成澤寛1,3, 木村晋也2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 701-701, 2018.

---

	24-10-O30-1. Contribution of the pharmacist in the urgent medical support team 仲里泰太郎1, 佐藤尚子2, 井上陽平3, 山地優依子1, 雪本江里子1, 中出雅治4, 小林政彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 702-702, 2018.

---

	24-10-O30-2. The current situation of the common use medicine storage situation for the large-scale disaster that it showed from patients questionary survey 原田大1, 中込早苗1, 影山明1, 加藤潤一郎1, 川久保孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 703-703, 2018.

---

	24-10-O30-5. Enforcement of the training correspondence at the system failure in the electronic medical chart and examination of problems 南目祐希1, 富山直敏1, 渡辺美恵子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 704-704, 2018.

---

	24-10-O31-1. Study on input method and indication of the discharge drug control instruction information to electronic edition prescription notebook 中村貴子1, 横山威一郎1, 渡辺健太1, 山口洪樹1, 鈴木貴明1, 田中政吉2, 野本禎3, 石井伊都子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 705-705, 2018.

---

	24-10-O31-2. Automation of the inventory control by an electronic medical chart system and the management of material distribution system cooperation 阿部剛1, 竹野孝慶1, 左迫間昭一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 706-706, 2018.

---

	24-10-O31-3. [by the ward drug duties enforcement addition acquisition] The need of the pharmaceutical products material by the ward pharmacist improves. 塚口真穂登1, 多川洋史1, 北峯あづみ1, 伊藤晶子1, 鈴木直人1, 外山聡1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 706-706, 2018.

---

	24-10-O31-4. Efforts of the case conference which a drug information management room conducts by leadership 横山香保1, 加藤亜紀1, 鈴木晴久1, 吉野宗宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 707-707, 2018.

---

	24-10-O31-5. Construction and evaluation of the anticancer agent regimen check system having pharmaceutical products risk management plan (risk management plan: RMP) information 尾崎正和1, 田中翔子1, 清永智子1, 幸田恭治1, 北原隆志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 707-707, 2018.

---

	24-10-O32-1. The difference in elution, crush properties between a zolpidem innovator drug, the generic drug: Function of additive macrogol 稲葉一訓1, 大家才治2, 大竹裕子2, 井上知美2, 小竹武2, 長井紀章2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 708-708, 2018.

---

	24-10-O32-2. Investigation ... which paid its attention to contents of quality information comparison between starting pharmaceutical products and generic drug - pharmaceutical products interview form 松井友希1, 浅山美穂1, 大谷智也1, 恩田光子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 709-709, 2018.

---

	24-10-O32-3. Medical expenses reduction effect of the outside Parliament prescription which wrote clinical test value 保ヶ辺雄也1, 横山威一郎1, 石川雅之1, 齊藤美聡1, 山口洪樹1, 山崎香織1, 新井さやか1, 中村貴子1, 鈴木貴明1, 石井伊都子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 709-709, 2018.

---

	24-10-O32-4. Cost effect analysis of the neuraminidase inhibitor in the influenza virus infection 中川直人1, Leanne Lai2, 金澤幸訓3, 森川昭正3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 710-710, 2018.

---

	24-10-O32-5. Coping - from a point of view of running it in the hospital targeted for DPC to the adoption item choice second report - generic medicine amount base new calculation method 脇田真之1, 岡村吏華1, 人見智香子1, 吉井千菊1, 渡辺恵美1, 棚田真紀1, 星野智美1, 波能満理惠1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 710-710, 2018.

---

	24-10-O33-1. Safe examination of the direct action type oral anticoagulant drug (DOAC) administration for elderly people 川根誉代1, 渡邉操1, 土井崇1, 岡祐介1, 佐合裕子1, 芦川直也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 711-711, 2018.

---

	24-10-O33-2. Associated factor of pharmaco-frailty in the elderly inpatient 松井瑛子1, 大山茜2, 竹屋泰2, 中嶋恒男2, 竹屋美幸2, 武田朱公3, 鷹見洋一2, 立入頌子1, 渡邊梓1, 山本智也1, 杉本研2, 山本浩一2, 三輪芳弘1, 樂木宏実2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 712-712, 2018.

---

	24-10-O33-3. Examination - using use experience - G8 score of the immune checkpoint inhibitor in elderly people 山本泰大1, 宇都宮純平1, 福岡智宏1, 高木真由美2, 溝口真巨2, 戸田康裕1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 712-712, 2018.

---

	24-10-O33-4. Association between actual situation and fall, fall accident of the polypharmacy in the care health center for the elderly 竹村有美1, 塚原邦浩1, 居塚しのぶ1, 久保田厚子1, 小倉秀美1, 山下智省2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 713-713, 2018.

---

	24-10-O33-5. Efforts for the prescription adequacy of elderly people in the JCHO Kyushu Hospital 阿部名月1, 吉国健司1, 末松文博1, 折口秀樹2, 中村哲郎3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 713-713, 2018.

---

	24-10-O34-1. Construction of the infusion formulation study software in our hospital adoption medicine 博田舞子1, 大橋啓子1, 平岩知子1, 後藤亨2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 714-714, 2018.

---

	24-10-O34-2. The effect that cerebral damage gives to an internal change of zinc 冨澤淳1, 片岡祐一2, 近藤留美子1, 厚田幸一郎1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 715-715, 2018.

---

	24-10-O34-3. One case of short bowel syndrome that resulted in hyperferremia by chronic administration of the commercial trace element preparation 石井康世1,2, 中島康裕1,2, 畠中英理子1,2, 城村なる乃2, 角田すみ代2, 福原真美2, 辻井悟2,3, 池西政幸1, 雪矢良輔1, 梶田貴司1, 上田睦明1, 生島繁樹1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 715-715, 2018.

---

	24-10-O34-4. Effect of indometacin giving it to the volume of urine of the patent ductus arteriosus premature infant and serum electrolyte 大久保翔1, 赤嶺由美子1, 安達裕行2, 高橋勉2, 三浦昌朋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 716-716, 2018.

---

	24-10-O34-5. One case that protein doses adjustment by the NST intervention contributed to improvement of the overall status for hepatic portal region cholangiocarcinoma postoperative AKI 巽道代1, 渡辺祐子1, 笠師久美子1, 片山真育1, 平井志明1, 本田愛子1, 熊谷聡美2, 村上壮一3, 七戸俊明3, 武田宏司4, 井関健1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 716-716, 2018.

---

	24-11-O35-1. About development of the bar code authentication system to support "the internal use Distribution of medicine management" of the nurse in the pharmaceutical products proper use cycle and the usefulness 内海敦志1, 田辺友也1, 原田靖子1, 尾崎仁美2, 西原昌幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 717-717, 2018.

---

	24-11-O35-2. It is analyzed the source of information associated with inquiry contents and pharmaceutical products in doubt inquiry 金子絵里奈1, 高木博子2, 石橋久1, 園田正信1, 家入一郎2, 山野徹3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 718-718, 2018.

---

	24-11-O35-3. Safe evaluation with the injection drug inspection support system which we introduced newly in the JCHO Kyushu Hospital 居塚しのぶ1, 藤村弥生2, 小倉秀美1, 末松文博2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 718-718, 2018.

---

	24-11-O35-4. Efforts of the ban on use medicine administration prevention utilizing the electronic medical chart tag function 佐々木弘好1, 松村みどり1, 大塚さとみ2, 阿部佳史2, 福島美由紀1, 関沢祐一2, 松浦弘司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 719-719, 2018.

---

	24-11-O35-5. Examination of the intervention to the perioperative care by the health insurance pharmacy 笹原侑祐1, 鈴木裕司2, 村上恵一3, 井田美香子4, 板垣幸太郎5, 村田勇人6, 武田郁子7, 田島亮8, 小橋斉彬9 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 719-719, 2018.

---

	24-11-O36-2. The reinforcement of the medical safety management system and the evaluation 木全司1, 吉田弘樹1, 三輪奈津貴1, 高木祥子1, 三輪めぐみ1, 今井視保子1, 鬼頭克暢1, 加藤康子1, 木下元一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 721-721, 2018.

---

	24-11-O36-3. Efforts to proper use of the benzodiazepine system medicine 伊東健一1, 川崎伸子2, 渡辺朋子2, 松尾剛志3, 白尾一定4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 721-721, 2018.

---

	24-11-O36-4. The sleeping drug remedy in the non-surgery elderly patients by the case cross-over study and allied evaluation of the fall 鳥井栄貴1, 冨田秀明2, 安藤基純3, 田中茉歩子1, 藤本一秀1, 小原智子1, 清水るみ子1, 池末裕明2, 奥貞智2, 橋田亨2, 久米典昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 722-722, 2018.

---

	24-11-O36-5. Adequacy of the use of sleep agent by the collaboration with the dementia support team 平田備子1,7,8, 岡本奈美2,8, 中島昌二3,8, 大西聖子3,8, 藤原彩音4,8, 松葉薫里5,8, 木南佐織6,7, 大西尚6,7, 吉田俊一6,8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 722-722, 2018.

---

	24-11-O37-1. Fact-finding of polypharmacy in patients with heart failure of our hospital 太田友樹1, 衣笠良治2, 山本達郎1, 加藤雅彦2, 小川勝弘1, 秦英司1, 山本一博2, 島田美樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 723-723, 2018.

---

	24-11-O37-2. Examination about the bleeding risk of the direct action type oral anticoagulant drug in patients with non-valvular atrial fibrillation 渡辺圭1, 林太祐1, 矢島領1, 飯田謙司1, 伊勢雄也1, 片山志郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 724-724, 2018.

---

	24-11-O37-3. Effect of treatment judgment of the diuretics using the BIA method in patients with chronic cardiac insufficiency 黒岩亮平1, 井口恵美子1, 倉林学2, 猪股克彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 724-724, 2018.

---

	24-11-O37-4. The case that was treated effectively with sodium valproate, topiramate, a triple-drug therapy of stiripentol to patients with Dravet syndrome 森本真仁1, 島川清司1, 橋本俊顕1, 浜田茂明1, 北岡泰介2, 京谷庄二郎2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 725-725, 2018.

---

	24-11-O37-5. Decision of the optimal inhalational method that paid its attention to particle diameter between the preparation in the fixed-quantity aerosol-type inhalant 平大樹1,2, 水谷彩乃2, 冨田奈央2, 水野愛2, 角本幹夫1, 岡野友信1, 奥田知将2, 岡本浩一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 725-725, 2018.

---

	24-11-O38-1. Fact-finding about the quantity of conversion from oral medicine of the levodopa-containing preparation in the Parkinson's disease treatment to an injection drug 和久津稔1, 三浦由貴1, 田中敏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 726-726, 2018.

---

	24-11-O38-2. One patient who responded to Tadalafil for the diffuse scleroderma with the skin ulcer 佐藤伸輔1, 櫻井淳二1, 山川香織2, 佐々木美織1, 岡田優1, 野上佳奈子1, 渡辺昌子1, 宮内康夫1, 阿部順1, 高橋知子2, 石澤文章1, 佐々木毅3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 727-727, 2018.

---

	24-11-O38-3. 1 case that ileus developed during hepatitis C treatment, and was able to continue treatment by the simple suspension method 細川宜嗣1, 原田恭江1, 和田望2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 727-727, 2018.

---

	24-11-O38-4. One patient who was able to continuously administer tolvaptan in the elderly people safely 内藤成美1, 大宮寛子1, 吉田夕貴1, 川井悦嗣1, 三輪耕次1, 田中伸享2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 728-728, 2018.

---

	24-11-O38-5. It is an enforcement report for an efforts first stage of the improvement in quality of the inhalation therapy by the instruction to the inhalational instruction video using the QR cord with letter 倉田香織1, 小林豊2, 上路彩芽3, 鈴木高弘3, 伊丹一海4, 渡邊剛彦5, 橋爪敦弘3, 土橋朗1, 北村修2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 728-728, 2018.

---

	24-11-O39-1. Examination in examination II isosorbide dinitrate of the interaction with the commercial denture adhesive and ethical drug and the nt roll spray 梅村雅之1, 福谷勇真1, 池上雄貴1, 吉田彩乃2, 柳原保3, 脇屋義文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 729-729, 2018.

---

	24-11-O39-2. Quantitative mechanism analysis of the interaction between drug - drink which was due to environment for gastrointestinal inland waters 竹村美由記1, 白坂善之1, 鮒井悠汰1, 石原麻梨華1, 一條一貴1, 岸本久直1, 井上勝央1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 730-730, 2018.

---

	24-11-O39-3. Examination about the elution durability of the minocycline-containing medical cement 丸尾陽成1, 牛尾聡一郎1, 江角悟1, 小川敦1, 沖田駿治2, 村川公央1, 北村佳久1, 千堂年昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 730-730, 2018.

---

	24-11-O39-4. Basic examination about the amyloidogenesis of the insulin analog 大野由依1, 江川祐哉1, 三木涼太郎1, 細谷治1, 関俊暢1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 731-731, 2018.

---

	24-11-O39-5. Safety assessment of the caffeine administration for premature birth, the premature baby 田口雅登1, 勝眞愛梨沙1, 川崎裕香子2, 足立雄一2, 吉田丈俊2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 731-731, 2018.

---

	24-11-O40-1. Examination of the effect that a lot of thickness agents give to an elution rate in the collapse time for tablet for the internal use 江畠麗1, 藤田吉明1, 原田努1, 中村明弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 732-732, 2018.

---

	24-11-O40-2. Press through pack with the mount in consideration of convenience 神田修子1, 山之内崇紘2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 733-733, 2018.

---

	24-11-O40-3. Development of the new mount press through pack that is superior in opening characteristics 山之内崇紘1, 神田修子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 733-733, 2018.

---

	24-11-O40-4. Study on optimization of a preparation, the preservation condition of the hospital preparation L- thyroxine sodium injection 益田佑輔1, 蛭子小春2, 山崎由夏2, 長井紀章2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 734-734, 2018.

---

	24-11-O40-5. Bioequivalent study about the quetiapine inside the hospital bougie 落合秀1, 行成美1, 神原諒2, 早川太郎2, 河渕真治1, 伊藤由佳子1, 栄田敏之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 734-734, 2018.

---

	24-12-O41-1. Precision investigation of the formulations technical aid to use at tablet division formulations 山脇優輝1, 佐藤淳也1, 遠藤恵1, 土屋貴之1, 賀茂佳子1, 石川寛1, 篠道弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 735-735, 2018.

---

	24-12-O41-2. Effect on duties by the automation of formulations 福本勝政1, 平田龍司1, 井上真理1, 横田淳子1, 宅間大祐1, 岩崎裕昭3, 京谷庄二郎2, 濱田篤秀1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 736-736, 2018.

---

	24-12-O41-3. Examination of an effect prospective for oral medicine 1st by formulations and the change of the duties time 松井友里恵1, 五十嵐敏明1, 松嶋あづさ1, 高橋翠1, 山本大1, 重森美奈1, 林咲希1, 矢野良一1, 塚本仁1, 後藤伸之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 736-736, 2018.

---

	24-12-O41-4. Examination about the usefulness of the simple suspension method using the method to agitate to be ground with the rotation, the revolution mixer 中尾元紀1, 田邨保之1, 永井聡子1, 覺野律1, 竹本晃佑2, 高塚隆之2, 橋本直文2, 大竹裕子3, 長井紀章3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 737-737, 2018.

---

	24-12-O41-5. Examination about the usefulness of the simple suspension method that used ultrasonically vibrating it 中尾元紀1, 松尾世為子1, 田邨保之1, 永井聡子1, 覺野律1, 大竹裕子2, 長井紀章2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 737-737, 2018.

---

	24-12-O42-1. Inspection of the usefulness using a medication stand scan hi-vision camera for patients 遠藤瑠里1, 湧井宣行1,2, 町田昌明1, 吉澤有紀子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 738-738, 2018.

---

	24-12-O42-2. Relation of the pharmacist for the red blood cell hematopoietic stimulation preparation (ESA) use proper use for the anemia in renal disease 永江寛子1, 舌間清晃1, 谷田繁夫1, 林聡子1, 山本瞳1, 中島有里子1, 田村明子1, 長岡麻由1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 739-739, 2018.

---

	24-12-O42-3. Overlap administration prevention, a side effect and onset of allergic reaction prediction of the Chinese medicine that we consider a constitution crude drug 古澤正司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 739-739, 2018.

---

	24-12-O42-4. Analysis of doubt inquiry one-year after the prescription issuance with the test value 上津沙織1, 釘原瑶子1, 山澤結季1, 吉国健司1, 桑村恒夫1, 末松文博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 740-740, 2018.

---

	24-12-O42-5. Approach of PBPM where it is assumed that doubt inquiry to a specialist in prescription in the general Tokyo Hospital is not necessary 守屋瑞穂1, 外石昇1, 田籠美保子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 740-740, 2018.

---

	24-12-O43-1. Classification evaluation ... about "nursing and analysis (the second report) - nursing of consultation contents in the medicine" outpatient department 小西久美1, 前島多絵1, 梅澤理恵子1, 小畠真奈2, 濱田洋実2, 本間真人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 741-741, 2018.

---

	24-12-O43-2. Analysis of the inquiry example about the pregnancy, the nursing and the use of drug 深谷さおり1, 宇野英理子1, 野々垣知行1, 黒瀬優輔1, 大西正文1, 山之内博明1, 斎藤寛子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 742-742, 2018.

---

	24-12-O43-3. Examination about the possibility of the allergic conditions control by the exosome derived from milk 太田知沙1, 田中祥子1, 油谷遥1, 遠藤美緒2, 櫻井基一郎2, 水野克己2, 恩田健二1, 杉山健太郎1, 平野俊彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 742-742, 2018.

---

	24-12-O43-5. Example that suffered from the digoxin administration plan to a pregnant woman 楠美克紀1, 久米央子1, 奥ヶ谷教1, 佐藤陽1, 松岡佳吾1, 細井智弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 743-743, 2018.

---

	24-12-O44-1. Medication support for improvement in adherence for the low vision patients 柴谷直樹1,2, 藤田和美1,2, 田中郁壮1,2, 別府あかね3, 室井延之1,2, 栗本康夫4, 橋田亨2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 744-744, 2018.

---

	24-12-O44-2. Development of the method "OMOTENASHI" which aimed at the foreign patients using medicine appropriately prototype model and evaluation in the ethical pharmacy 鈴木渉太1,2, 佐藤恵子2, 譽田真子2, 加藤恵理2, 劉金梁2, 小林学司2, 桑原佳宏2, 保野慎治2, 桝田出3, 山川紘希4, 笠原正登1, 上嶋健治2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 745-745, 2018.

---

	24-12-O44-3. The talks instruction by the patients-based medical practice to hear causes sick-role behavior transformation and realizes 100 million total achievement society 杉原真理1, 中島佳子2, 石垣洋次郎2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 745-745, 2018.

---

	24-12-O44-4. Effect on drugstore pharmacist - by the difference by change - prescription meeting a demand frequency of the consciousness by the patients with psychiatry consultation communication workshop enforcement 成井繁1,2, 野澤玲子2, 三田充男2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 746-746, 2018.

---

24-12-O44-5. Examination - from the inspection of strategic construction - United States Houston medical center aiming at the edition academic D tailing spread in Japan 尾関理恵1,2, 和田猛1,2, 西川元也1,2, 後藤惠子1,2, 青山隆夫1,2, 真野泰成1,2, 根岸健一1,2, 宮崎智1,2, 嶋田修治1,2, 吉澤一巳1,2, 高澤涼子1,2, 河野洋平1,2, 江角浩安2,3, 寺下真人2,4, 宮崎美子2,5, 山本美智子1,2, 小茂田昌代1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 746-746, 2018.

---

	24-12-O45-1. Response to 8 representative diseases in the trial drugstore business training 松下隼士1, 高木淳一1, 松村千晶2, 小林大介2, 川尻雄大2, 岸田義博1, 小柳香織1, 勢島充1, 吉田理1, 山野徹1, 園田正信1, 吉川学1, 島添隆雄2, 田中泰三1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 747-747, 2018.

---

	24-12-O45-2. Examination about the evaluation method of the prescription analysis program for business trainees 阿登大次郎1, 齋藤玲奈1, 小竹武2, 小森浩二3, 森山博由4, 井上知美2, 三田村しのぶ3, 清水忠5, 日高眞理6, 廣瀬隆7, 吉田彰彦8, 小牟田豊1, 東海秀吉1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 748-748, 2018.

---

	24-12-O45-3. From the questionary survey by relation - trainee of the pharmacist CRC in the trial business training - 西田佳苗1, 谷大輔1, 辻井佳代1, 小林政彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 748-748, 2018.

---

	24-12-O45-4. Attitude survey about understanding and the medication counseling of the hearing loss for rational consideration to the hearing person with a disability for pharmacy school fifth graders 俵口奈穂美1, 窪田敏夫2, 大光正男2, 芦原美咲2, 大津屋美咲2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 749-749, 2018.

---

24-12-O45-5. Participation in planning - of the medicine trainee to "training program of the pharmacist taking local team approach in medical care" medicine pharmacy cooperation community medical care business training (Yao model) - Epinephrine autoinjector classroom 竹村美穂1, 篠原裕子2, 奥村隆司2, 中野道雄2, 小川充恵3, 小枝伸行3, 山崎肇3, 大里恭章4, 小竹武5, 村岡未彩1, 西野隆雄1, 平田收正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 749-749, 2018.

---

	24-12-O46-1. Specialist job cooperation education with the School of Nursing student that we conducted through a true case during pharmacy school Hospital training period 薄井健介1,2, 岡田浩司1,2, 紫桃裕造2, 上岡泰弘2, 渡辺善照1,2, 瀬戸初江3, 大塚眞理子4, 高橋知子1, 小嶋文良1, 吉村祐一1, 柴田信之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 750-750, 2018.

---

	24-12-O46-2. Significance - second report ... of the continuous new face training to conduct one year after accession 新井亘1, 増田裕一1, 矢嶋美樹2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 751-751, 2018.

---

	24-12-O46-3. Introduction - making and evaluation of the education material of the parenteral injection domain for new face pharmacists 亀田悠1, 稲秀士1, 山口紗緒里1, 荒畑和博1, 宮本拓也1, 鈴木智1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 751-751, 2018.

---

	24-12-O46-4. Development of the standard education model for pharmacist upbringing to take mild medical care on 山田真裕1, 内田まやこ2, 葉田昌生3, 因間大悟4, 有吉俊二4, 青木和子4, 井上章治4, 島添隆雄4,5, 満生清士4, 原口亨4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 752-752, 2018.

---

24-12-O46-5. Attempt ... for the purpose of practice of the 2-day hospital practice training for health insurance pharmacy pharmacists and the promotion of evaluation - community medical care cooperation 炭昌樹1, 長谷川千晶1, 森井博朗1, 星野伸夫1, 奥貫裕美1, 金本賢枝1, 堀江美弥1, 岡本陽香1, 藪田直希1, 松田雅史1, 神谷貴樹1, 須藤正朝1, 増田恭子1, 宮口美由紀1, 岩下由梨2, 松田佳織2, 本岡芳子2, 平大樹1,3, 森田真也1, 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 752-752, 2018.

---

	24-13-O47-1. Effect of the taking Abiraterone timing in the onset of liver damage 守田和憲1, 徳永晃己1, 北岡朋子1, 山下愛子1, 田上治美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 753-753, 2018.

---

	24-13-O47-2. Examination about proteinuria in the progress recurrent gastric cancer ramucirumab treatment 藤井千賀1, 柳下祐貴子1, 鶴島克将1, 小川直希1, 木村豊2, 間狩洋一3, 三上城太3, 安井友佳子1, 石坂敏彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 754-754, 2018.

---

	24-13-O47-3. Examination of the onset factor of the venous thromboembolism in patients with ovarian cancer given adjuvant chemotherapy after the operation 佐藤雄己1, 鈴木芳1, 中原良介1, 伊東弘樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 754-754, 2018.

---

	24-13-O47-4. Multicenter observational, prospective study about retching, vomiting in the non-extensive emetic antitumor agents combination therapy 杉浦央1, 有賀久晃2, 斎藤由起子1, 鎌田恵子3, 瀬川満3, 辻俊輔4, 松岡佳吾5, 石井裕人6, 辻康秀3, 坂田幸雄2, 小林道也7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 755-755, 2018.

---

	24-13-O47-5. Examination about blood poison characteristics of the Carboplatin + etoposide combination therapy in the decreased renal function patients and the tolerability 高木淳平1, 奈良克彦1, 大野能之1, 永徳孝介1, 鹿毛秀宣2, 鈴木洋史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 755-755, 2018.

---

	24-13-O48-1. Examination about the oxaliplatin readministration using the high-dose dexamethasone regimen for oxaliplatin hypersensitivity in patients with colon cancer 金子明日美1,2, 洞澤智至2, 小谷大輔2, 坂東英明2, 中嶌明香1, 吉野孝之2, 川崎敏克1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 756-756, 2018.

---

	24-13-O48-2. About the allergic expression situation with the oxaliplatin-containing regimen and the usefulness of the measures regimen 原田桂作1,2,3, 鴨志田武4, 山内健太郎1, 末吉宏成1,2, 福永聡5, 野口純也2,6, 上原智仁2,6, 山吉隆友2,6, 村本眞由美1, 篠道弘4, 木戸川秀生2,6, 名倉弘哲3, 岡本好司2,6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 757-757, 2018.

---

	24-13-O48-3. Association between decreased renal function and side effect expression in patients with colon cancer received oxaliplatin 渡辺大地1, 藤井宏典1, 山田友奈美1, 松橋延壽2, 高橋孝夫2, 吉田和弘2, 鈴木昭夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 757-757, 2018.

---

	24-13-O48-4. Inspection of the pyrogenic neutropenic prediction by the AUC estimate of the docetaxel 槙原克也1, 内山ひとみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 758-758, 2018.

---

	24-13-O48-5. Examination of the predictor of myelosuppression of S-1 平井利典1, 山賀亮佑1, 伊東俊雅1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 758-758, 2018.

---

	24-13-O49-1. Examination of the onset of eruption predictor by various test value before the checkpoint inhibitor administration of immunity 井上誠二1, 大澤友裕1, 梅田道1, 甲田明英1, 堀晃代1, 田中和秀1, 安田昌宏1, 水井貴詞1, 後藤千寿1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 759-759, 2018.

---

	24-13-O49-2. Relative examination of dry skin and the horny cell layer ceramide level by the Erlotinib remedy 冨士野ひより1, 内野智信1, 宮嵜靖則1, 神谷大地1, 鈴木誠規1, 水野初2, 轟木堅一郎2, 白井敏博3, 朝田和博3, 八木宏明4, 佐野悠子4, 森木睦4, 木村緑5, 賀川義之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 760-760, 2018.

---

	24-13-O49-3. Comparison according to the radiation field of thrombocytopenia frequencies after the G-CSF preparation administration in patients who received chemoradiotherapy 尾関智子1, 今井一博2, 南谷佳弘2, 三浦昌朋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 760-760, 2018.

---

	24-13-O49-4. Study on association of a side effect of wPTX + Rmab therapy and total bilirubin levels 奈良克彦1, 山本武人1,2, 高田龍平1, 鈴木洋史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 761-761, 2018.

---

	24-13-O49-5. Study about the usefulness of the patients treatment diary in the side effect evaluation of the treatment with anticancer agent 實川東洋1, 中田千博1, 下川陽子1, 澤山絢子1, 廣永和也1, 三上麻衣2, 高市直子2, 瀬谷知子3, 横瀬紀夫4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 761-761, 2018.

---

	24-13-O50-1. The effectiveness and safety of the EGFR tyrosine kinase inhibitor 濱武清範1, 小西史子1, 美和孝之1, 松本弘誠1, 中西輝1, 酒井ちひろ1, 野間敏也1, 足立那々緒1, 後藤仁美1, 仲忠士1, 小島一晃1, 北英夫2, 菅理晴3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 762-762, 2018.

---

	24-13-O50-2. Safe examination of the cisplatin weight loss method for the decreased renal function patients 河野光1, 龍島靖明1, 荒井将至2, 内田康光2, 金井邦光2, 門間哲雄2, 高橋邦雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 763-763, 2018.

---

	24-13-O50-3. How do you choose new anticancer agent + lenalidomide dexamethasone combination regimen for the multiple myeloma? 小島一晃1, 濱武清範1, 小西史子1, 中西輝1, 松本弘誠1, 奥村優介1, 山村裕佳子1, 梶美里1, 酒井ちひろ1, 野間敏也1, 仲忠士1, 美和孝之1, 安斎尚之2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 763-763, 2018.

---

	24-13-O50-4. Use fact-finding of Talaporfin sodium in the primary malignant brain tumor 外賀真佑美1, 浜田幸宏1, 丸山隆志2, 寺島華江2, 都築俊介2, 齋藤太一2, 新田雅之2, 村垣善浩2, 川俣貴一2, 木村利美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 764-764, 2018.

---

	24-13-O50-5. Examination about the factor that CD34-positive cells of the number of the aims cannot gather in the peripheral blood stem cell transplantation 大畑紘一1,2, 加藤寛子1, 山内智世1, 小林亮1, 松本拓郎2, 中村信彦2, 北川順一2, 兼村信宏2, 清水雅仁2, 鈴木昭夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 764-764, 2018.

---

24-13-O51-1. Unresectable progress, examination about the effect that an event of the bevacizumab-induced elevated blood pressure gives the prognostic difference of right and left of the primary tumor in recurrent colon cancer 梅原健吾1, 高田慎也2, 高田寛奈1, 若本あずさ1, 佐川保3, 橋下浩紀2, 遠藤雅之2, 初山多恵1, 佐藤秀紀4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 765-765, 2018.

---

	24-13-O51-2. Examination (multicenter fact-finding) second report for the commonization of the confirmation item of the pharmacist in the cancer medical therapy regimen 小沼大祐1, 太田貴洋2, 鈴木真也2, 篠原旭2, 植木大介3, 大橋養賢4, 龍島靖明5, 宇田川涼子6, 吉野名穂子2, 川崎敏克2, 山口正和6, 加藤一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 766-766, 2018.

---

	24-13-O51-3. Usefulness of CARG SCORE in the adjuvant chemotherapy of the elderly people breast cancer 佐々木俊則1, 小暮俊明1, 水谷三浩2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 766-766, 2018.

---

	24-13-O51-4. Investigation of the use situation of the Lenvatinib for the unresectable hepatocellular carcinoma 佐久間大樹1, 若月淳一郎1, 松本香織1, 花輪和己1, 小林義文1, 山本誠一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 767-767, 2018.

---

	24-13-O51-5. Effect of the mTOR genetic polymorphism giving it to maintenance doses and a quantity of internal exposure of the Everolimus 加賀谷英彰1, 井上高光2, 齋藤満2, 沼倉一幸2, 羽渕友則2, 佐藤滋3, 三浦昌朋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 767-767, 2018.

---

	24-13-O52-1. Evaluation after the anticancer agent preparation robot introduction in the Matsue Municipal Hospital 今井孝1, 佐伯由美子1, 酒井牧子1, 河野通盛1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 768-768, 2018.

---

	24-13-O52-2. Efforts to the anticancer agent exposure measures introduction in the angiography room 佐々木紀彰1, 唯間和博2, 安部奈央1, 古岡真菜1, 古元俊徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 769-769, 2018.

---

	24-13-O52-3. Safety cabinet in the anticancer agent preparation using the chemosafe, personal protector, infusion solution bag, exposure investigation about the coinfusion Exit cap 渡邊裕之1, 宮本拓2, 梅田瞳1, 三上知佳1, 木村錦子1, 松本公佑1, 藤金永美1, 治田匡平1, 神野正敏3, 杉山幸正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 769-769, 2018.

---

	24-13-O52-4. Examination of the introduction of the closed system anesthesia connection appliance in the request for consumption of the bevacizumab preparation 中村暢彦1, 楠本正明1, 中嶋江美2, 木下里紗2, 岡田知子2, 森田直2, 谷本祐子2, 小林政彦2, 矢野義孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 770-770, 2018.

---

	24-14-O53-1. Efforts to dentistry internal use antimicrobial proper use in the Sapporo Tokushukai Hospital 星貴薫1, 宮越貴之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 771-771, 2018.

---

	24-14-O53-2. The examination of the risk factor of epidemiology and the 30th death of the bloodstream infection: University hospital single institution retrospective study 服部はるか1,2, 前田真之1, 長友安弘3, 詫間隆博3, 二木芳人3, 内藤結花2, 佐々木忠徳2, 石野敬子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 772-772, 2018.

---

	24-14-O53-3. Change of the Antimicrobial Stewardship activity of the Hiroshima City Funairi municipal hospital and the oral antimicrobial prescription in pediatric outpatients 田中和行1, 綾部ゆか1, 政本伸二2, 渡辺美和1, 松原啓太3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 772-772, 2018.

---

	24-14-O53-4. About AST activity by the cooperation with an ICT pharmacist and the microorganism test engineer 宮崎浩光1,2, 小池祐史2, 櫻田玲子2, 長谷川功1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 773-773, 2018.

---

	24-14-O53-5. 1 case that experienced false extension of the APTT with aminoglycoside drugs in the ECMO management patients 長原新太郎1, 坂野博之1, 平井瑞希1, 三浦義彦1, 伊勢雄也1, 片山志郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 773-773, 2018.

---

	24-14-O54-1. Effect of the carbapenem-based antimicrobial proper use patients support intervention round that ICT conducted 小林謙一1, 丸山智幸1, 西堀武明2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 774-774, 2018.

---

	24-14-O54-2. AS activity ... which adult oral third generation cephem adoption cancellation - green hospital (99 beds) started 酒向聡子1,4, 亀山聡美1,4, 今西正人1,4, 太田淳2,4, 森逸治3,4, 岩井雄司2,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 775-775, 2018.

---

	24-14-O54-3. A problem and the future prospects that we were able to see in 1 year after AST setup 石塚友一1, 本田勝亮1, 武地大維2, 渥美位知子1, 釋悦子3, 石原冬馬3, 安間有希4, 齊藤一仁2, 渡邊卓哉2, 矢部勝茂1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 775-775, 2018.

---

	24-14-O54-4. Examination about antimicrobial proper use support team (AST) and the activity contents 池谷修1, 上蓑義典1,2, 高野八百子1, 石川春樹1,3, 宇野俊介1, 新庄正宜1,4, 荒美幸1,2, 長谷川直樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 776-776, 2018.

---

	24-14-O54-5. Efforts of Shizuoka drug resistant bacterium control team - Antibiotic Awareness, Shizuoka - 望月敬浩1,12, 倉井華子2,12, 荘司貴代3,12, 本康宗信4,12, 田中敏博5,12, 日馬由貴6,12, 神戸宏憲7,12, 更谷和真8,12, 滝久司9,12, 土屋憲10,12, 後藤幹生11,12, 篠道弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 776-776, 2018.

---

	24-14-O55-1. Individual differences factor of blood behavior of the isolation form daptomycin that paid its attention to a bond change of the serum albumin in patients with MRSA infection 宮寺友香里1, 内藤隆文1, 山田尚広1, 川上純一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 777-777, 2018.

---

	24-14-O55-2. Clinical analysis of PK/PD parameter target value about the effectiveness, the safety of vancomycin 伊地知由樹1, 佐古兼一1, 伊賀正典2, 高野温志2, 町田充2, 猪川和朗1, 千代谷大志1, 藤掛佳男1, 松田佳和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 778-778, 2018.

---

	24-14-O55-3. Examination of the optimal vancomycin initial blood level in patients with blood disorder in consideration of the effectiveness and safety 岡田直人1, 中馬真幸2, 座間味義人1,3, 今西正樹1, 武智研志2, 桐野靖1, 中村敏己1, 寺岡和彦1, 石澤啓介1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 778-778, 2018.

---

	24-14-O55-4. It is a 1 case receiving vancomycin for patients with sepsis during the sustained resistance haemodialysis (SLED) enforcement 安達昂一郎1, 吉水浩史1, 白井祐也1, 小田亮介1, 中野一也1, 池上洋平1, 山下大輔1, 粉川俊則1, 本田芳久1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 779-779, 2018.

---

	24-14-O55-5. Intervention effect on loading dose of the Teicoplanin by the ward permanent residence pharmacist 水岡大策1, 山口佳津騎1, 元木貴大1, 田中裕章1, 加地雅人1, 小坂信二1, 芳地一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 779-779, 2018.

---

	24-14-O56-1. Usefulness of the vancomycin nomogram in the Augmented renal clearance expression patients 杉山恭平1, 石井英俊1,2, 平井啓太2, 中谷英仁3,4, 伊藤邦彦2, 木村緑1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 780-780, 2018.

---

	24-14-O56-2. Examination of the search of the population pharmacokinetics model of the meropenem in Augmented renal clearance and the optimal administration plan 玉造竜郎1, 大林真幸1, 佐々木杏理1, 神山紀子1, 小林靖奈2, 山元俊憲3, 福田賢一郎4, 中村俊介5, 三宅康史6, 土肥謙二4, 向後麻里1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 781-781, 2018.

---

	24-14-O56-3. Factor about initial blood level after the Teicoplanin loading dose enforcement 檜山洋子1, 片岡達夫1, 冨田隆志1, 宮本佳奈1, 垰越崇範1, 松尾裕彰1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 781-781, 2018.

---

	24-14-O56-4. Examination about the combination reversibility after the vancomycin tissue cells combination 岩崎也奈1, 山田智之2, 大畑彩也香1, 山田整司1, 椋木菫1, 浦嶋庸子1, 廣谷芳彦1, 池田賢二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 782-782, 2018.

---

	24-14-O56-5. It is the difference in cefotaxime cerebral fluid shift by the indwelling drain part after the subarachnoid hemorrhage technique 近藤匡慶1, 高島勇基2, 長野槙彦1, 柴田あみ4, 工藤小織3, 金子純也3, 佐藤慎3, 北原章子3, 田上隆3, 久野将宗3, 畝本恭子3, 菅谷量俊1, 花田和彦2, 高瀬久光1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 782-782, 2018.

---

	24-14-O57-1. The doubt inquiry rate of use investigation about the clinical test value from the health insurance pharmacy 山崎香織1, 横山威一郎1, 山口洪樹1, 齊藤美聡1, 新井さやか1, 中村貴子1, 鈴木貴明1, 石井伊都子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 783-783, 2018.

---

	24-14-O57-2. Efforts to outside Parliament prescription doubt inquiry simplification 富施哲也1, 須賀宏之1, 麻生一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 784-784, 2018.

---

	24-14-O57-3. Questionary survey about the efforts about the information sharing of impaired renal function and the glaucoma using a prescription notebook cover 尾崎誠一1,2, 廣子真大2, 中村嘉孝2, 河田尚己2, 渡辺宗男2, 松久哲章2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 784-784, 2018.

---

24-14-O57-4. Analysis ... of the prescription suggestion by effect - pharmacist whom the medication reporting book to the physician by the drugstore pharmacist gives to drug proper use 郡司清志1, 木原太郎1, 小柳香織1, 金子絵里奈1, 林田諭1, 吉井瞳1, 鶴田達也1, 朝原寛子1, 川浪望恵2, 都築加奈2, 高山浩太郎2, 高木淳一1, 小林大介2, 窪田敏夫3, 島添隆雄2, 田中泰三1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 785-785, 2018.

---

	24-14-O57-5. Approach for the qualitative improvement of the interactive tracing report in the treatment with oral anticancer agent 川勝勇樹1, 長谷川晃司1, 関奈緒子1, 春名康裕1, 東碧1, 武田智子1, 和田淳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 785-785, 2018.

---

	24-14-O58-1. Efforts of the medicine decreasing by it to the NSAIDs chronic administration patients by the drugstore pharmacist who collaborated with a physician 高橋祐介1, 水野千里1, 笠原のぞみ1, 金澤香里1, 駒形美結1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 786-786, 2018.

---

	24-14-O58-2. Practice inspection of the continuous locomotive syndrome prophylactic activity to be carried out at a drugstore 山口京子1, 鈴木匡2, 小嶋雅代3, 浅井治行4, 大竹芳房5, 中尾理香6, 永田隼也7, 堀場亜佐子8, 松波晋平9, 菊池千草2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 787-787, 2018.

---

	24-14-O58-3. Collection and analysis of the information on adverse drug reactions in the health insurance pharmacy 矢野脩一朗1,2, 山本巌1, 新雪乃1, 青木淳子2, 佐藤弘希3, 岡山善郎3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 787-787, 2018.

---

	24-14-O58-4. It is ... around Residual medicine fact-finding - psychiatry domain by four person (pharmacist society, medical association, university, administration) cooperation 加藤剛1,2,5,6, 大塚正征2,5, 斉藤祐次2,5, 安達秀夫2,5, 赤津拓彦3,5, 酒見文人3,5, 三浦省吾3,5, 菅野敦之4,5, 赤沢学4,5, 鈴木順子6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 788-788, 2018.

---

	24-15-O59-1. How can you increase the prescription suggestion number? 西川隆一1, 荒木寛也1, 坂柳悦章1, 澤柳直樹1, 藤井友和1, 永田治1, 塚本久之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 789-789, 2018.

---

	24-15-O59-2. It is investigated the bone fracture risk using the patients information in the initial interview at hospitalization 江藤祥子1, 久保みさき1, 戸邊隆夫1,2, 戸田貴洋1, 林高弘1,2, 山田成樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 790-790, 2018.

---

	24-15-O59-3. The effect that the intervention by the pharmacist gives to the incidence of nausea post-operative vomiting and the prophylaxis decision of the anesthesiologist 猪狩賢蔵1, 鈴木信也1, 外園弥生1, 関博志2, 志熊亜美1, 野村嘉奈子1, 吉田蘭子1, 伊藤智一1, 荒瀬透3, 林誠一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 790-790, 2018.

---

	24-15-O59-4. Approach - to improvement in medication adherence by effect - pharmacist whom the medication self-care in the psychopathic ward gives in medication adherence 坂東寛1, 武智研志3, 今西正樹1, 中馬真幸3, 座間味義人1,2, 桐野靖1, 中村敏己1, 寺岡和彦1, 石澤啓介1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 791-791, 2018.

---

	24-15-O59-5. Examination of the usefulness of the pharmacist-led psychiatry measures team in the convalescent rehabilitation ward 加藤豊範1, 吉田章悟1, 鈴木絢子1, 町田祐実子1, 小田高司2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 791-791, 2018.

---

	24-15-O60-1. Role of the pharmacist for the pharmaceutical products management in the Aichi Medical University Hospital operating room 野村知世1, 野々垣知行1, 前仲亮宏1, 林良亮1, 大西正文1, 斎藤寛子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 792-792, 2018.

---

	24-15-O60-2. We look at the rear of the treatment with extensive critical care center charge pharmacist intervention effect and examine a mark 三浦義彦1, 礒江雄人1, 坂野博之1, 長原新太郎1, 久保村優1, 平井瑞希1, 岡本早織1, 植竹将1, 風間彩1, 伊勢雄也1, 片山志郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 793-793, 2018.

---

	24-15-O60-3. Risk of developing hypophosphatemia associated with Refeeding Syndrome in the intensive care domain and search of the effect factor 中川貴弘1, 泉野浩生2, 小野恵2, 北庄司敦久1, 西井拓人1, 若林里絵1, 森朝紀文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 793-793, 2018.

---

	24-15-O60-4. An example of the collaboration serious case cellulitis with the ER doc in the initial treatment room 佐野邦明1, 高木雄一1, 松本富夫1, 杉木大輔2, 松島久雄2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 794-794, 2018.

---

	24-15-O60-5. The analysis of the risk factor of the delirium generating after the cardiovascular surgery surgery and evaluation of the usefulness of the delirium check sheet 西村文宏1, 牛島智子1, 梅田景子2, 三嶋あかね2, 杉野由起子2, 宮村重幸3, 工藤未来4, 鬼木健太郎4, 猿渡淳二4, 柳茂樹5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 794-794, 2018.

---

	24-15-O61-1. Examination of the risk factor of the onset of acute renal failure by the levetiracetam 西田麻以1, 長尾由佳1, 大熊沙代子1, 奥田敏勝1, 赤木晋介1, 高柳和伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 795-795, 2018.

---

	24-15-O61-2. One case that there were no allergic symptoms in vancomycin during treatment, but resulted in an anaphylactoid symptom just after a change to Teicoplanin 中山裕一1, 山口寛和2, 檜山紀子2, 松本順2, 竹島英之3, 田中昌代1, 加藤敏明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 796-796, 2018.

---

	24-15-O61-3. The adult cirrhosis case that hyperammonemia improved by pivoxil group-containing antimicrobial cancellation 吉野走1, 山根理恵子1, 佐道紳一1, 本吉康英2, 市川辰樹2, 樋口則英1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 796-796, 2018.

---

	24-15-O61-4. Investigation about the onset of eruption in patients receiving lenalidomide 松尾彩音1, 田久保慎吾2, 飯田洋子2, 鈴木健太2, 田中邦佳2, 柳井美奈2, 吉原哲3, 吉原享子3, 木村健2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 797-797, 2018.

---

	24-15-O61-5. Examination ... from a bleeding case during use of ... heparin Ca for choosing wisely of the DVT prevention in the internal medicine domain 榎本貴一1,4, 舘林和樹1, 小坂鎮太郎2,4, 木村泰3,4, 福永貴志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 797-797, 2018.

---

	24-15-O62-1. Rearward investigation about the dermatopathy risk reduction effect by the low-dose introduction of the lamotrigine 森田陽介1, 渡邉享平1,2, 斎木明子1, 矢野良一1, 塚本仁1, 後藤伸之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 798-798, 2018.

---

	24-15-O62-2. Efforts for a change and the adverse event evasion of the sleeplessness indicator in the orthopedics ward 江草徳幸1, 丸谷佳代1, 安原昌子1, 堀川俊二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 799-799, 2018.

---

	24-15-O62-3. Search of hypoglycemic frequency by Sulfamethoxazole - Trimethoprim and the risk factor 森田直1, 岡本賢一2, 吉野秀紀1, 松平有加2, 木下理紗1, 井上知美2, 石渡俊二2, 北小路学2, 大鳥徹2, 小竹武2, 小林政彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 799-799, 2018.

---

	24-15-O62-4. One case that seemed to present hyponatremia by lansoprazole remedy 光崎亜弥1, 川井悦嗣1, 三輪耕次1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 800-800, 2018.

---

	24-15-O62-5. Investigation about the hypokalemia due to beta 2 receptor stimulation inhalant 山崎彬史1, 濱宏仁1, 中浴伸二1, 森本茂文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 800-800, 2018.

---

	24-15-O63-1. The use trend of the new antiepileptic drug and examination about side effect expression 真鍋健一1, 西田初博1, 甲斐真理子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 801-801, 2018.

---

	24-15-O63-2. Questionary survey about BRONJ for a dentist and the pharmacist 佐藤一求1, 江草徳幸1, 安原昌子1, 堀川俊二1, 伊藤翼2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 802-802, 2018.

---

	24-15-O63-3. An example of patients with sickle cell disease that showed withdrawal symptoms of the opioid 新江裕貴1, 生駒忠史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 802-802, 2018.

---

	24-15-O63-5. Examination of the inhibitory effect for opioid-induced retching of the naldemedine 志田敏宏1,3, 田中総一郎1, 細谷順1, 山川真由美2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 803-803, 2018.

---

24-15-O64-2. Examination ... of the usefulness in efforts ... multi-type of job cooperation of the oral anticancer agent at-home medication management system introduction utilizing the ICT and the foreign cancer instruction to patient 久田真規子1, 桑田直樹1, 河野葵1, 村田充弘1, 秦真由美2, 広田将司3, 長瀬博次3, 川瀬朋乃3,4, 今村博司3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 805-805, 2018.

---

	24-15-O64-3. The example that we intervened in the examination of the prescription menu for a discharge from all over the hospitalization, and we used it, and a visit pharmacist enabled home medical treatment three pumps 中村薫1, 川崎博行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 805-805, 2018.

---

	24-15-O64-4. Efforts to questionary survey and education about the effect on fecundity with the anticancer agent 日野亜莉沙1, 土屋裕伴1, 国吉央城1, 新井亘1, 増田裕一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 806-806, 2018.

---

	24-15-O64-5. Examination about the proper use of the renal excretion type anticancer agent by the making of in-hospital standard criteria 中島誠1,2, 新上香奈子1, 三浦ひとみ3, 大迫政彦4, 林秀樹2,5, 杉山正2,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 806-806, 2018.

---

	25-5-O65-1. About usefulness of the pharmacist intervention in the on admission interview with the palliative care unit 長谷部千夏1, 兼松友紀1, 宮部芳之1, 塚原民夫1, 堀内正1, 伊藤浩明2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 807-807, 2018.

---

	25-5-O65-2. The opioid analgesic gradual decrease situation investigation after the head and neck cancer RT-CDDP therapy 前勇太郎1, 竹野伸洋1, 三木真梨杏1, 長谷川聡子1, 鈴木亘1, 根本真記1, 鈴木賢一1, 渡邉大至1, 利安隆史2, 高橋俊二3, 濱敏弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 808-808, 2018.

---

	25-5-O65-3. Fact-finding of the patients that rescue is a high dose for an oxycodone daily dose 岩崎愛里1, 竹野伸洋1, 古谷良太1, 中山博文2, 鈴木賢一1, 濱敏弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 808-808, 2018.

---

	25-5-O65-4. Result of the improvement in mild medical knowledge of the pharmacist by the mild medical regional pharmacist training workshop (2017) 松本高広1,2, 金子健2, 熱海幸恵2, 上島健太郎2, 柏原由佳2, 岸田悦子2, 塚川麻利子2, 鳥越一宏2, 藤掛沙織2, 森理保2, 宮里明芽2, 山内由美子2, 和田紀子2, 片山志郎2, 鈴木勉2, 伊東俊雅2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 809-809, 2018.

---

	25-5-O65-5. Intervention effect by the medicine medicine cooperation using the mutual reporting book in the use of drug patients for the ambulatory care 山口文子1,2, 鈴木澪1,2, 佐々木美理1,2, 佐藤透1, 土井千春2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 809-809, 2018.

---

25-5-O66-1. Making and evaluation of cancer chemotherapy support tool "gastrointestinal carcinoma Reference book" which can conjugate for normal business routine 伊藤文香1,2, 神谷幸江2, 兼子詩布2, 北川佳奈子2, 切畑麻那2, 嶋洋将2, 鈴木大介2, 竹内美緒2, 玉置彩奈2, 冨田庸介2, 丹村亜梨朱2, 丹羽侑理奈2, 伊藤夕貴2, 平松久典2, 鵜飼麻由2, 川合甲祐2, 岩田智樹2, 遠山幸男2, 山口智江2, 中根茂喜2, 山田清文1, 板倉由縁3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 810-810, 2018.

---

	25-5-O66-2. The current situation of the drug control in the chic day during the cancer chemotherapy enforcement and the future prospects 重田和也1, 奈良由里絵1, 花村菜月1, 後藤博1, 松本利恵1, 野田孝夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 811-811, 2018.

---

	25-5-O66-3. A relation and effect as the pharmacist to the safe treatment of the immune checkpoint inhibitor 内山将伸1, 井上貴文1, 松尾宏一1, 平野公一2, 前川隆文2, 宮崎元康1, 今給黎修1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 811-811, 2018.

---

	25-5-O66-4. Rearward controlled trial of the intervention effect by Oncology Pharmacist and non-Oncology Pharmacist in the foreign cancer chemotherapy 嘉屋道裕1, 中村和代1, 永峰槙子1, 須山由佳子1, 中條倫成1, 内田亮1, 萩倉翔1, 神田藍1, 杉山恭平1, 杉山理奈1, 中垣繁1, 木村緑1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 812-812, 2018.

---

	25-5-O66-5. Relation ... to proteinuria in the medical treatment management (PBPM) - VEGF inhibitor based on the protocol in the foreign chemotherapy center 佐分利美帆子1, 本多信二1, 内藤舞1, 三松史野1, 目黒裕史1, 實光由香1, 大野恵一1, 寸田靖1, 村岡淳二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 812-812, 2018.

---

	25-9-O67-1. The construction of the doubt inquiry information sharing system and the utilization report 古野孝明1, 万徳真子1, 吉國淑子1, 平田直奈1, 中川和成1, 田中皓正1, 太田絵莉1, 山平和博1, 黒飛謙次1, 藤川亜衣1, 川根良太1, 富田哲夫1, 川原邦仁1, 川口健1, 出口明日香1, 半田寛1, 今井圭介1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 813-813, 2018.

---

	25-9-O67-2. Examination about the association between use and glaucoma development of statin using receipt data 岩橋麗羅1, 野上暁子1, 田代結女1, 寺田柚花1, 木内智美1, 福岡憲泰1, 大場延浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 814-814, 2018.

---

	25-9-O67-3. Usefulness evaluation of the side effect of pharmaceutical products uniform management system which we built in the middle scale hospital 安島秀友1, 松崎貴志1, 澤藤園子2, 有木宏宗2, 田中恒明2, 横山美恵子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 814-814, 2018.

---

	25-9-O67-4. 80% of drugstore pharmacists have trouble with acquisition, an evaluation, inflection of the drug information 惠谷誠司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 815-815, 2018.

---

	25-9-O67-5. Fact-finding of the patients drug allergy registration in the electronic medical chart system 瀬戸良教1, 坂倉智子1, 菅原充広1, 近藤留美子1, 厚田幸一郎1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 815-815, 2018.

---

	25-9-O68-1. Examination of the side effect expression of Shakuyakukanzoto situation using adverse event spontaneous report database (JADER) 野々垣知行1, 宇野英理子1, 深谷さおり1, 大西正文1, 斎藤寛子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 816-816, 2018.

---

	25-9-O68-2. Study on onset of progressive multifocal leukoencephalopathy situation using FDA Adverse Event Reporting System 鈴木剛史1, 矢島功1, 相澤雄介1, 南真進1, 井上博章1, 小杉隆祥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 817-817, 2018.

---

	25-9-O68-3. Search of the new kidney protective utilizing real world big data 堀ノ内裕也1, 池田康将1, 福島圭穣2, 濱野裕章3, 今西正樹3, 石澤有紀1, 座間味義人3,4, 武智研志5, 藤野裕道2, 石澤啓介3,4, 土屋浩一郎6, 玉置俊晃1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 817-817, 2018.

---

	25-9-O68-5. As for the receipt information, specific medical examination, and the like, it is epidemiologic studies about the domestic use situation of the palonosetron hydrochloride using information database (NDB) opening data 岡田浩司1,2, 薄井健介1,2, 菊池大輔2, 高橋将典2, 渡辺善照1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 818-818, 2018.

---

	25-10-O69-1. Work-style reform of the pharmacist using quantity of duties investigation 和泉早智子1, 加藤遥平1, 千崎可奈子1, 中脇誠一1, 長谷川美栄子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 819-819, 2018.

---

	25-10-O69-2. Efforts for the drug global assessment adjustment addition calculation 西迫多重1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 820-820, 2018.

---

	25-10-O69-3. Efforts to the polypharmacy by the ward pharmacist 村上翔梧1, 境泰樹1, 佐古守人1, 黒沢秀夫1, 芳竹美帆1, 東珠美1, 板並優里1, 吉田綾子1, 野村剛久1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 820-820, 2018.

---

25-10-O69-4. Before and after handling study session of a drug, the psychotropic drug and three months later, a correct answer rate change of the issue of knowledge confirmation of the nurse six months later and inspection of the difference by the years of experience 菊地寛隆1, 鈴木真也1, 太田貴洋1, 久松大祐1, 竹野美沙樹1, 鎌田隼1, 上本剛1, 小室亜由美1, 五十嵐隆志1, 中嶌明香1, 松山千容1, 奥中真白1, 石黒太造1, 森下滉己1, 仁熊久美1, 原田まなみ1, 末永亘1, 石原淑子1, 瀬戸裕美子1, 金子明日美1, 岩本義弘1, 山口正和2, 川崎敏克1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 821-821, 2018.

---

	25-10-O69-5. Management of the oral medicine with the administration cart in the ward which the bringing medicine included and the evaluation 加藤遥平1, 和泉早智子1, 中脇誠一1, 二井矢ひとみ2, 高橋都3, 長谷川美栄子4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 821-821, 2018.

---

	25-10-O70-1. Consideration to connect with pharmacist duties foreign than the examination of the SGLT2 inhibitor remedy cancellation patients 久保田厚子1, 塚原邦浩1, 居塚しのぶ1, 竹村有美1, 小倉秀美1, 野田薫2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 822-822, 2018.

---

	25-10-O70-2. Examination about the medication situation's confirmation and cancellation, continuation instruction before hospitalization of the pharmacist in the perioperative care team 森泰子1, 野村直幸1, 平見明浩1, 小山朋子1, 中村孝佑1, 山本淳平1, 板野亨1, 相良義弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 823-823, 2018.

---

	25-10-O70-4. The case that there was a request for outpatient oneself decrease medicine, and suggested drug adjustment 若松雄太1, 杉生雅和1, 高子優子1, 長尾彰太1, 石津智司1, 吉岡睦展1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 824-824, 2018.

---

	25-10-O70-5. New efforts of the pharmacist duties in the foreign general support center 上嶋和代1, 北原加奈之1,2, 金正興1, 杉田栄樹1,2, 鈴木康介1,2, 玉造竜郎1,2, 若林仁美1,2, 清水久範1,2, 白井敦1, 佐々木忠徳1,2, 桑原靖子3, 樋口比登実4, 小田原良子3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 824-824, 2018.

---

	25-12-O71-1. Establishment and clinical application of the assay of cefotaxime plasma and in cerebrospinal fluid and the active metabolite 高島勇基1, 近藤匡慶2, 長野槙彦2, 柴田あみ4, 工藤小織3, 金子純也3, 佐藤慎3, 北橋章子3, 田上隆3, 畝本恭子3, 高瀬久光2, 花田和彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 825-825, 2018.

---

	25-12-O71-2. Drug population pharmacokinetics analysis of the Teicoplanin in neonates, infants and comparison between actual value and estimate 宮川泰宏1, 岸里奈1, 永井拓1, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 826-826, 2018.

---

	25-12-O71-3. About vancomycin initial administration plan and the intervention effect of the pharmacist on examination of blood culture-positive patients 町田聖治1, 宮崎博章2, 大井慈文3, 山下恵美2, 戸根智和2, 福島将友1, 入江利行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 826-826, 2018.

---

	25-12-O71-4. Examination about the dose setting in consideration of renal function of vancomycin in the NICU 西條純1, 鈴木英二1, 藤原香織1, 堀勝幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 827-827, 2018.

---

	25-12-O71-5. Examination of optimum doses of vancomycin in continuous hemodialysis enforcement children 小林翼1, 佐々木剛1, 高辻未来1, 福島優美1, 山崎直樹1, 森宏幸1, 笠松悠2, 白野倫徳2, 後藤哲志2, 村田みどり1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 827-827, 2018.

---

	25-12-O72-1. About the effect that obesity-related genetic screening brings a citizen 池田佳代1, 細井徹1, 三浦常代2, 春日真由3, 高畑真由子3, 龍春花2, 幾田美紀2, 谷口智昭2, 天崎あゆみ2, 吉井美智子1, 杉山政則4, 大谷純一2, 若生あき3, 小澤光一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 828-828, 2018.

---

	25-12-O72-2. Making and evaluation of the information sheet to alert for pharmaceutical products proper use by the analysis of administrative data 永田健一郎1, 村岡香代子1, 石田茂1, 齊藤麻美1, 辻敏和1, 渡邊裕之1, 金谷朗子1, 増田智先1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 829-829, 2018.

---

	25-12-O72-3. Comparison between analysis and true clinical practice ... that is robust of "The Paper Surgeon" - clinical article 鳥居良太1, 内藤雅人1, 下雅意彩1, 竹村敏也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 829-829, 2018.

---

	25-12-O72-4. Relations with the Residual medicine generating situation of the antiHIV medicine and the cognitive function 合原嘉寿1,2,3, 大石裕樹1,2,3, 辻麻理子2,3, 西脇香4, 福田雪絵4, 古田加菜恵4, 三浦真貴子4, 浦上秀刀4, 加留部信介5, 山本政弘2,3,6, 西野隆1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 830-830, 2018.

---

	25-12-O72-5. Pharmacy clinical studies to experience the course of the development of the medicine 中谷友香1, 金岩未紗1, 西村美和1, 杉澤湖希1, 恒岡麗華1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 830-830, 2018.

---

	P0001-23-PM. Effect on water content by the illegally parked condition of the ketoprofen poultice 山本佳久1, 星加織1, 神原澪奈1, 山内理恵2, 大野修司2, 浅井和範2, 深水啓朗3, 小出達夫4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 832-832, 2018.

---

	P0003-23-PM. The study on eye irritation-related prediction of commercial eye drops: The in vitro eye irritation study that assumed a pH change an index 長井紀章1, 本多公貴1, 大竹裕子1, 岡本紀夫2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 833-833, 2018.

---

	P0005-23-PM. Making of in-hospital guidelines about an infusion filter in our hospital and the administration route 二村哲未1, 岡崎敬之介1,2, 中山泰葉1,2, 嶋崎真耶1,2, 中野裕佳子1,2, 阿部誠治1,4, 城所扶美子3, 佐々木忠徳1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 833-833, 2018.

---

	P0007-23-PM. The effect that mixed formulations give to the skin permeability of a characteristic of the salicylic acid vaseline ointment and the principal ingredient 宍戸康剛1, 湯谷玲子1, 寺岡麗子1,2, 坂根稔康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 834-834, 2018.

---

	P0009-23-PM. Photodegradation ... of color change - bromocriptine of Parlodel tablets by the difference in lighting 山下修司1,2, 井口和弘2,3, 野口義紘2,4, 堺千紘2,3, 玉木啓文2,3, 伊野陽子2,3, 林秀樹1, 寺町ひとみ2,4, 酒向孫市5, 杉山正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 834-834, 2018.

---

	P0011-23-PM. Quality fact-finding of the do-it-yourself importing metformin preparation Shu Zhu1, 吉田直子1, 松下良2, 木村和子3, 坪井宏仁1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 835-835, 2018.

---

	P0002-24-AM. About the stability comparison for the one for TERAL vicine injection and the Pinorubin injection 岩根裕紀1,2, 小林由佳1,2, 成橋和正2, 杉浦伸一2, 中西弘和2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 836-836, 2018.

---

	P0004-24-AM. Factorial experiments about the filter obstruction at the liquid antibody preparation administration 矢田部恵1, 小川千晶1,3, 井上元基2, 長山佳之1, 五味緩子1, 中舘和彦2, 足立茂2, 伊藤智夫3, 谷地豊1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 837-837, 2018.

---

	P0006-24-AM. Stability of the dexamethasone in the hyperalimentation 久保儀忠1, 大森仁2, 戸口拓弥1, 柴山良彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 837-837, 2018.

---

	P0008-24-AM. Effect of the storage temperature to give it to the rheology properties of the hydrozincite ointment and the mixed nature 加藤薫1, 湯谷玲子1, 寺岡麗子1,2, 坂根稔康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 838-838, 2018.

---

	P0010-24-AM. A viscosity properties of matter change by the high temperature preservation of the tacrolimus ointment and effect on preparation uniformity 浜口雅史1, 藤井美佳2, 山本佳久3, 小出達夫4, 深見啓朗2, 林祥弘1, 大貫義則1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 838-838, 2018.

---

	P0016-24-AM. Duties improvement example by the analysis of a drug incident, the dispensing error 森田淳介1, 新木美枝1, 鈴木達宙1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 840-840, 2018.

---

	P0018-24-AM. About the efforts of the inspection potentially serious medical errors example report and the measures 山田宜和1, 岩田真子1, 青柳和代2, 貝瀬眞由美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 841-841, 2018.

---

	P0020-24-AM. Efforts ... for safety management of construction, introduction - pharmaceutical products of the operational system of the system contraindicated to the name of disease 中川碧1, 上西幸治1, 炭昌樹1, 國津侑貴1, 星野伸夫1, 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 841-841, 2018.

---

	P0022-24-AM. The sleeping drug remedy in the elderly people at the acute phase hospital by the case cross-over study and allied evaluation with the fall 小原智子1, 鳥井栄貴1, 安藤基純2, 冨田秀明3, 田中茉歩子1, 藤本一秀1, 清水るみ子1, 池末裕明3, 奥貞智3, 橋田亨3, 久米典昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 842-842, 2018.

---

	P0024-24-AM. Fall rate investigation of the sleeping drug in the inpatient 磯崎僚1, 栗島彬1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 842-842, 2018.

---

	P0026-24-AM. About the association with risk score and the use drug of the fall fall of the inpatient 藤盛真衣1, 藤松美希1, 高垣志保1, 室岡邦彦1, 中里祐二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 843-843, 2018.

---

	P0028-24-AM. Examination about the number of the fall, the falls decrease in S zopiclone in the sleeplessness indicator 稲田佑亮1, 原青穂1, 津田尚始1, 夏目義明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 843-843, 2018.

---

	P0030-24-AM. Relation of the pharmacist about the use drug at cardiac catheter ablation 井岡瑞樹子1, 福田裕子1, 道下佳子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 844-844, 2018.

---

	P0032-24-AM. Attempt ... of the improvement in understanding degree by the designation of understanding degree investigation second report - emphasis high risk medicine about the high-risk medicine 岡村吏華1, 吉井千菊1, 人見智香子1, 渡辺恵美1, 棚田真紀1, 星野智美1, 波能満理惠1, 脇田真之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 844-844, 2018.

---

	P0034-24-AM. Construction of the information management system of a specialist in nonrecognition newcomer medicine in our hospital and the contraindicated use patients out of the adaptation 丘龍祥1, 金野昇2, 富永綾2, 高橋信明2, 細谷順2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 845-845, 2018.

---

	P0036-24-AM. Examination of the tool which is available for the foreign patients having difficulty in Japanese correspondence 掛札聡美1, 阿多郁子2, 池浦恵3, 入野真規子4, 森田直美5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 845-845, 2018.

---

	P0017-23-PM. The evaluation of the administration management system from an incident report and improvement and measures 折戸融1, 沼田諒1, 梶原彩香1, 小野歩1, 阿部和恵1, 比毛有理子1, 石井勇太1, 片山潤1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 847-847, 2018.

---

	P0019-23-PM. It is reduced the number of formulations potentially serious medical errors by the use of calculation electronic calculator because we were suitable for calculation compounding of medicines 土屋貴之1, 佐藤淳也1, 川岸佐和子1, 鈴木恵子1, 望月敬浩1, 篠道弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 848-848, 2018.

---

	P0021-23-PM. Examination of the effect that a background color gives to the discrimination of the tablet in formulations one package 岩佐昌広1, 横田秀一1, 矢野忠1, 八木圭太2, 市川訓1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 848-848, 2018.

---

	P0023-23-PM. A fall, the fall in the hospital inpatient basic for acute phase and relations of the drug 西村健二1, 亀井健人1, 赤木晋介1, 高柳和伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 849-849, 2018.

---

	P0025-23-PM. A fall fall is examined by remedy medicine 田中善子1, 木下宏美1, 兼島恭子1, 寺田さやか1, 松濱志保里1, 谷崎百合子1, 西崎翔太1, 西海理絵1, 丁子江利1, 山下ゆみ2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 849-849, 2018.

---

	P0027-23-PM. Effect on fall, fall with the sleeping drug 角田健1, 小室治孝1, 喜古康博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 850-850, 2018.

---

	P0029-23-PM. Efforts ... to adequacy of the efforts - benzodiazepine drugs prescription to a fall, the fall prevention 金古成美1, 茂木秀敏1, 橋場弘武1, 酒井秀二1, 高玉真光1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 850-850, 2018.

---

	P0031-23-PM. Efforts for injectable potassium preparation administration wrong prevention 角井碧1, 中島恵子1, 村中好美2, 徳毛宏則2, 橋本佳浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 851-851, 2018.

---

	P0033-23-PM. Quantification of the analogous change by the examination cutting apart of the appearance similarity of the PTP sheet 向井淳治1, 面谷幸子1, 初田泰敏1, 名徳倫明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 851-851, 2018.

---

	P0035-23-PM. Contraindications use classification of medicine and efforts to management in inside the hospital 北山知里1, 上田彩1, 有木宏宗1, 坂上逸孝1, 井上莊一郎2, 長谷川泰弘3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 852-852, 2018.

---

	P0037-23-PM. Relation to the allergic information of the pharmacist 鈴木拓磨1, 關基成1, 堀場圭1, 尾崎昌大1, 添田真司1, 渡邊昌之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 852-852, 2018.

---

	P0038-24-AM. The effect that one package of carved seal tablets and both sides printing tablets gives to inspection duties efficiency 松元一明1, 大森栄2, 石井伊都子2,3, 川久保孝4, 神田博仁2, 鈴木貴明3, 横山威一郎3, 中澤一純5, 木津純子6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 853-853, 2018.

---

	P0040-24-AM. A rose lock by the inspection system introduction at tablet automatic packeted plane filling pre-; the establishment of the inspection system to produce 山田倭花1, 内山乃映1, 中島のぞみ1, 上田奈緒美1, 大窪真理絵1, 伊代田萌子1, 丸岡浩太1, 梅澤仁美1, 河村紳介1, 小林誠一1, 坂口修治1, 富沢裕之1, 山下敦志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 854-854, 2018.

---

	P0042-24-AM. Pharmacist attitude survey ... for way - package formulations of the formulations which are new from anti-thing duties to interpersonal duties 近藤澄子1, 豊田彬1, 田中直哉2, 加藤誠一2, 寺戸靖2, 矢島毅彦3, 田中秀和2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 854-854, 2018.

---

	P0044-24-AM. About the current situation evaluation after efforts and the introduction for the simple suspension method introduction in our hospital 馬見新ちとせ2, 山内浩子1, 八木秀明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 855-855, 2018.

---

	P0046-24-AM. Taste bitter inhibition evaluation of the drug with the γ-polyglutamate high mud gel using the taste sensor 小島穂菜美1, 市川聽奈1, 井上由梨1, 原口珠実1, 吉田都1, 内田享弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 855-855, 2018.

---

	P0048-24-AM. Investigation of doubt inquiry accompanied with renal function test value mention to an injection prescription 関綾香1, 長岡匠1, 恩田寿美子1, 臼井悟1, 本田雅巳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 856-856, 2018.

---

	P0050-24-AM. Analysis of the doubt inquiry contents by test value mention to in the hospital and outside Parliament prescription 森河内彩1, 國津侑貴1, 平大樹1,2, 十亀裕子3, 増田恭子1, 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 856-856, 2018.

---

	P0052-24-AM. Attitude survey (the second report) about the occupational exposure of the pharmacist at pharmaceutical products formulations 前田志津子1, 杉原数美1, 田山剛崇1, 三宅勝志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 857-857, 2018.

---

	P0039-23-PM. Examination about the change of the injection drug withdrawal method (from a medicine bag division into four of trays) in our hospital 桶谷純子1, 佐々木利佳1, 畠山いずみ1, 堀田瑞絵1, 丹羽修1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 858-858, 2018.

---

	P0041-23-PM. Construction of the formulations inspection system avoiding an amount mistake and pharmaceutical products mistake 後藤千寿1, 土田陽子1, 大野佑城1, 甲田明英1, 梅田道1, 水井貴詞1, 小林健司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 859-859, 2018.

---

	P0043-23-PM. Prospects ... of package formulations to see from way - data analysis of new formulations from anti-thing duties to interpersonal duties 田中直哉1, 豊田彬2, 町田匡俊2, 加藤誠一2, 寺戸靖2, 近藤澄子2, 矢島毅彦3, 田中秀和2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 859-859, 2018.

---

	P0045-23-PM. It is examined the drug indicating the alkalinity at simple suspension 中田一孝1, 冨田有香1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 860-860, 2018.

---

	P0047-23-PM. Drug elution behavior when we suspended an unstable drug with magnesium oxide preparation for alkali temporarily 森雅俊1, 下山哲哉1, 伊藤邦彦1, 小林道也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 860-860, 2018.

---

	P0049-23-PM. Effective evaluation of the alert indication to evade the mug Koror P administration to patients with severe impaired renal function 山本恭平1, 鶴田昌吾1, 岩瀬由枝1, 中村和行1, 伊藤友恵1, 大野愛1, 久保田敏行1, 杉浦洋二1, 勝見章男2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 861-861, 2018.

---

	P0051-23-PM. Construction and evaluation of the protocol according to the physician of doubt inquiry in the outside Parliament prescription 村井宗正1, 新妻由花1, 西村恵里子1, 阿藤友美2, 吉田遥香1, 林由紀子1, 本多秀俊1, 並木路広1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 861-861, 2018.

---

	P0053-23-PM. It is improved the drug loss rate by forming it the pulse eat of the levetiracetam crush 菅寛史1, 矢嶋隆宏1, 山本吉章1, 杉山尭紀1, 加藤浩充1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 862-862, 2018.

---

	P0054-24-AM. The manufacture of the hospital preparation "tacrolimus bougie" in our hospital and the evaluation 辻和美1, 濱野有里1, 小山朋子1, 相良義弘1, 佐藤英治2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 863-863, 2018.

---

	P0056-24-AM. Design of the intraoral gelation solution using methylcellulose 石屋和浩1, 磯貝純1, 三上龍生1, 下山哲哉1, 伊藤邦彦1, 小林道也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 864-864, 2018.

---

	P0058-24-AM. It is ... for the TPN adjustment that is clean for bioclean - 365 days in the culture 72 hours after the TPN no bacteria adjustment 外間健吾1, 奥野靖隆1, 妻鹿宏美1, 永田文恵1, 小西愛1, 近藤幸男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 864-864, 2018.

---

	P0060-24-AM. Examination of new herbal medicinal products aiming at Chinese medicine remedy improvement 亀田愛華1, 杉山育美1, 佐塚泰之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 865-865, 2018.

---

	P0055-23-PM. Safe examination of the 20% serum eye drops hospital preparation 前田知穂1, 藤後恭二2, 大神隆行1, 後藤正道3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 866-866, 2018.

---

	P0057-23-PM. Development of the leuprorelin percutaneous absorption type preparation 小幡誉子1, 新井裕子1, 表萌々1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 867-867, 2018.

---

	P0059-23-PM. Design of the oral jelly agent using xyloglucan 金子寧々1, 下山哲哉1, 伊藤邦彦1, 小林道也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 867-867, 2018.

---

	P0061-23-PM. Inspection of the need of the ward drug duties in the medical treatment ward 町田裕実子1, 加藤豊範1, 吉田章悟1, 鈴木絢子1, 小田高司2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 868-868, 2018.

---

	P0063-23-PM. Rebuilding and management of the pharmaceutical products safety management system as ward drug duties 高木祥子1, 三輪奈津貴1, 木全司1, 荒木憲昭1, 木下元一1, 小笠原智彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 869-869, 2018.

---

	P0065-23-PM. Having been able to see it than a ward drug duties intervention example 渡邉悦子1, 佐野邦明1, 高木雄一1, 松本富夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 869-869, 2018.

---

	P0067-23-PM. Establishment of the quantity of duties rating system for the appropriate staff placement in ward drug duties 只見智恵子1, 佐藤美絵1, 宮崎雅子1, 金田純子1, 木村桂子1, 藤本裕子1, 浜田幸宏1, 木村利美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 870-870, 2018.

---

	P0069-23-PM. Usefulness of ward drug duties judging from a pharmaceutical correspondence example (DI record) 小野元久1, 中田吉則1, 安田早織1, 山口智江1, 宮原兼二1, 佐藤美砂1, 万塩倫子1, 永田和裕1, 渡久川敦子1, 平松久典1, 片野貴大1, 上田知靖1, 佐藤江莉1, 伊藤彰洋1, 荒川正悟1, 竹内美緒1, 兼子詩布1, 丹村亜梨朱1, 藤井哲也1, 徳田富妃子1, 旭将来1, 鵜飼麻由1, 重共孝一1, 伊藤功治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 870-870, 2018.

---

	P0071-23-PM. Examination about the factor to disturb the remedy observance in being at home in the circulatory organ internal medicine inpatient 菅直恵1, 西村健二1, 亀井健人1, 赤木晋介1, 高柳和伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 871-871, 2018.

---

	P0073-23-PM. About the current situation of the palliative care in the terminal phase of the heart failure in our hospital 伊藤和幸1, 平嶋由貴1, 中村くみこ1, 植村太志1, 浦崎圭太1, 河井和子1, 磯谷聡1, 青木満子2, 石黒久美子3, 加藤美紀3, 杉本隆一3, 三好美奈4, 加藤寛之4, 村上央4, 加田賢治4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 871-871, 2018.

---

	P0075-23-PM. The effect that a pharmacist interview before hospitalization gives in an initial interview at hospitalization 五十嵐文1, 市田千佳1, 山本郁生1, 高橋賢成1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 872-872, 2018.

---

	P0077-23-PM. The analysis results of the prescription suggestion example for the person of decreased renal function in ward duties and future problem 和田朋海1, 鈴木光幸1, 小野田佳子1, 小竹泰子1, 中村愛1, 須佐充1, 上村賢介1, 高橋成博1, 茂木武1, 間宵聖太1, 肥田野綾1, 内坪誉歳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 872-872, 2018.

---

	P0079-23-PM. The current situation and problem of the in-hospital manual operation to face each other at delirium, unrest in the dementia night 辻依利1, 若林厚史1, 里見彩1, 田畑寛明1, 猿谷淳1, 向一美1, 地野幹子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 873-873, 2018.

---

	P0081-23-PM. Efforts about the patients autoregulation pain relief (patient controlled analgesia: PCA) instruction 垣本光未1, 宮本那央1, 大谷寧次郎1, 畔柳敏弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 873-873, 2018.

---

	P0083-23-PM. Enforcement of the active drug control instruction for patients during high-risk medicine remedy 鈴田浩孝1, 則松郁香1, 吉田翔平1, 小坂隆介1, 古川和弘1, 桑原貴美子1, 河野大希2, 中島浩太郎3, 岩尾卓朗4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 874-874, 2018.

---

	P0085-23-PM. Relation to the oral cyclophosphamide therapy introduction and drug control to children 前原美桜1, 綾部ゆか1, 佐古有紀1, 河瀬志保1, 松本俊治2, 渡辺美和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 874-874, 2018.

---

	P0087-23-PM. About intervention to the clinical department crossing-like polypharmacy by the pharmacist 入江優美1, 藤本倫正1, 南のどか1, 玉置尚1, 中須賀基1, 田畑佳祐1, 籾井佳奈1, 瀬川和子1, 垣尾尚美1, 辻本純子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 875-875, 2018.

---

	P0091-23-PM. A circulatory organ, the intervention to the Distribution of medicine set duties of the pharmacist in the thoracic surgery ward and the evaluation 奥村蕗子1, 山口高雅1, 浜口真徳1, 酌井敏伸1, 世古口拓也1, 夏目尚子1, 竹上愛1, 三宅知宏1, 谷村学1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 876-876, 2018.

---

	P0093-23-PM. A role and intervention case of the pharmacist in the urination care team 川地雄基1, 宇佐美英績1, 藤本佳則2, 吉村知哲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 876-876, 2018.

---

	P0095-23-PM. The current situation of the correspondence to the foreign patients in the obstetrics and gynecology department ward 加藤結1, 後藤祥子1, 大谷寧次郎1, 畔柳敏弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 877-877, 2018.

---

	P0062-24-AM. Investigation about the intervention effect of the local inclusion care system, hospital pharmacist in the convalescence 岸本真1, 荒川隆之1, 川崎美紀1, 酒向幸1, 藤原久登1, 溝神文博1, 宮川哲也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 878-878, 2018.

---

	P0064-24-AM. It is efforts ... in ... circulatory organ ward about the efficiency of medication management instruction duties in the understaffing of the pharmacist, ward drug control duties 杉本吉春1, 池田佳子2, 浅原慶徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 879-879, 2018.

---

	P0066-24-AM. The current situation and future problem judging from the number of the drug control instruction of our hospital 井上真緒1, 安福平1, 松山哲史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 879-879, 2018.

---

	P0068-24-AM. Efforts to ward drug duties efficiency in the University of Occupational and Environmental Health Hospital 川道直子1, 稲村由香1, 竹中美紗1, 花沢直子1, 井手健太1, 篠原義剛1, 植木哲也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 880-880, 2018.

---

	P0070-24-AM. Examination for intervention investigation and the duties improvement of the pharmacist to medical treatment depending on renal function in our hospital 望月丈裕1, 山本美智子1, 平松健人1, 加藤淳美1, 遠藤さゆり1, 村山奈千1, 深澤努1, 上原君男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 880-880, 2018.

---

	P0072-24-AM. Relation of the pharmacist to the heart failure team in our hospital 大石晶子1, 米田奈美2, 筒井景子1, 山内浩子1, 八木秀明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 881-881, 2018.

---

	P0074-24-AM. Significance (the first report) of the drug control instruction duties for the taking antithrombocytic agent patients 益田玲1, 北英士1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 881-881, 2018.

---

	P0076-24-AM. Analysis and evaluation of the intervention example of problems about the drug control before operation and the ward pharmacist 吉岡紗由1, 小久江伸介1, 大野能之1, 長瀬幸恵1, 鈴木洋史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 882-882, 2018.

---

	P0078-24-AM. Clinical manifestations of patients with cerebrospinal fluid reducing symptom that we examined from a ward pharmacist 中里直美1, 鈴木高広2,3, 北條祥子4,5, 菅野洋6, 篠永正道6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 882-882, 2018.

---

	P0080-24-AM. Questionary survey ... to practice - enforcement situation investigation and a cooperation institution of the reporting utilizing the drug control summary for the hospital transfer patients 藤井美紀1, 満田正樹1, 石川裕大1, 本郷志帆1, 稲葉静香1, 中谷亮介1, 奥下梨賀1, 野際俊希1, 瀧浪靖子1, 松本篤1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 883-883, 2018.

---

	P0082-24-AM. Examination about the osteoporosis therapeutic drug remedy continuation support in ward drug duties 土屋貴1, 倉田賢生1, 荒木弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 883-883, 2018.

---

	P0084-24-AM. Introduction of the inhalational check list which we made by a review for ward duties 寺山和利1, 岡田侑子1, 加藤菊郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 884-884, 2018.

---

	P0086-24-AM. Efforts of the pharmacist in the childhood cancer ward 岩崎剛士1, 丸山紗緒里1, 三枝美和1, 平野桂子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 884-884, 2018.

---

	P0088-24-AM. Efforts and the current situation to polypharmacy measures in our hospital comprehensive medical care medical service 鈴木善樹1, 芳澤朋大1, 栗原弘紀1, 伊藤護之1, 永野浩之1, 林良行1, 岸野亨1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 885-885, 2018.

---

	P0090-24-AM. Relation of our hospital pharmacy in "the disease severity, medical care, nursing necessary degree" for the medical service fees revision 安福平1, 松山哲史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 885-885, 2018.

---

	P0092-24-AM. Team approach in medical care in short bowel syndrome and pharmaceutical example that intervened 山本真由美1, 西山祐美1, 森田聡子1, 細見真世1, 有延早弥香1, 杉生雅和1, 橋口具世2, 宇多優吾3, 今中秀光4, 吉岡睦展1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 886-886, 2018.

---

	P0094-24-AM. An activity and result of the pharmacist in the urination care team 脇田恵里1,2, 梅村拓巳1,2, 浅野真美2, 中村直人1, 鷹見繁宏1, 武田宗万2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 886-886, 2018.

---

	P0096-24-AM. Suit from the patients in the drugstore, the effect that an interview gives in change of prescription on patients 林由依1, 鈴木学1,2, 味澤香苗1, 金地夏実1, 國府田真綾1, 林秀樹1,3, 小原道子3, 棚瀬友啓2, 土屋照雄2, 杉山正1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 887-887, 2018.

---

	P0097-23-PM. About the evaluation for the pharmacist duties of the operating room in our hospital 濱浦弘光1, 高橋弘泰1, 大谷寧次郎1, 畔柳敏弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 888-888, 2018.

---

	P0099-23-PM. Efforts and problem of the ward drug duties in the NICU ward 渡邊清人1, 近江令司1, 高柳昌宏1, 千田泰健1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 889-889, 2018.

---

	P0101-23-PM. Evaluation of the pharmacist leadership multi-type of job team rounds in the intensive care unit 立石裕樹1, 宮津大輔1, 後藤貴央1, 平川雅章1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 889-889, 2018.

---

	P0105-23-PM. About the making of the in-hospital general use manual of non-active form 4 factor-containing prothrombin complex preparation (4F-PCC) and the observance situation 長谷悠紀1, 清水誉志1, 藤野真理子1, 福島将友1, 丸子浩1, 富田敏章1, 町田聖治1, 入江利行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 890-890, 2018.

---

	P0107-23-PM. Efforts evaluation for the early intervention of the working full time pharmacist in the ER type first aid system (North American type ER) 須賀明輝1, 宮田祐一1, 上野栞1, 岩崎睦1, 大村史1, 鬼村紀子1, 吉田萌絵1, 和田健太郎1, 仲鉢英夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 891-891, 2018.

---

	P0109-23-PM. The current situation of the pharmaceutical intervention in our hospital critical care center Initial doctor's office 小守陽介1, 中村亜由美1, 鈴木正論1, 舟越亮寛1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 891-891, 2018.

---

	P0111-23-PM. The use of herbal medicinal products situation investigation in the critical care center 佐藤史織1, 河村聡志1, 佐脇久美1, 末延道太1, 原尻学志1, 森一生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 892-892, 2018.

---

	P0098-24-AM. Efforts of the drug fixed number placement in the operating room 大橋洵1, 福田聖啓1, 早見知浩1, 渡辺繭子1, 長谷川直美2, 水井貴詞1, 飯沼宏和3, 大畠博人3, 後藤千寿1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 893-893, 2018.

---

	P0100-24-AM. The angiopathic fact-finding with the nicardipine injection in the pediatric intensive care unit and examination of the risk factor 三浦寄子1, 大穂祐介1, 三大寺紀子1, 宇野千晶1, 赤羽三貴1, 壷井伯彦2, 奥田裕美3, 持丸奈央子4, 吉田和恵4, 山谷明正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 894-894, 2018.

---

	P0102-24-AM. The making of the parenteral injection incompatibility chart in ICU and HCU and evaluation of the usefulness 高野温志1, 道場勇真1, 齋藤彩子1, 亀井陽子1, 伊賀正典1, 町田充1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 894-894, 2018.

---

	P0104-24-AM. The use situation of the sedative drug sustained after the operation that aimed at the comprehensive pain control 野村亜衣1, 山本智也1, 原伸輔1, 武本梨沙1, 山上聡子1, 勝浦正人1, 門脇裕子1, 三輪芳弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 895-895, 2018.

---

	P0106-24-AM. Relation of making and the pharmacist of the alteplase (rt-PA) administration flowchart in super acute phase cerebral infarction treatment 木元健寛1, 齊藤伸1, 水沢重則1, 篠田和人1, 仙葉悠紀1, 工藤和彦1, 吹谷真紀子1, 金美紀1, 佐藤恵葉1, 鈴木ひとみ1, 八代佳子1, 後藤敏晴1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 895-895, 2018.

---

	P0108-24-AM. Evaluation of the type of the side effect in the patients who received an emergency visit for the side effect of pharmaceutical products and the severity 松山卓矢1, 舘知也1,2, 青山智2, 大澤友裕2, 勝野隼人1, 古山愛紗1, 杉岡まゆ子1, 村山あずさ1, 大坪愛実1, 上野杏莉1, 野口義紘1, 安田昌宏2, 水井貴詞2, 後藤千寿2, 寺町ひとみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 896-896, 2018.

---

	P0110-24-AM. Effect of the pharmacist intervention in emergency/intensive care domain 小林洋平1, 山岡怜央1, 山崎浩二郎1, 熊井正貴1, 笠師久美子1, 山田武宏1, 井関健1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 896-896, 2018.

---

	P0112-24-AM. The current situation report (the third report) of the foreign inhalational instruction in the Komaki Municipal Hospital 水谷貴樹1, 山本将司1, 櫻井美来1, 戸田康裕1, 小島英嗣2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 897-897, 2018.

---

	P0114-24-AM. Efforts to the prescription adequacy for foreign polypharmacy patients by the cooperation with the physician and the evaluation 加賀富貴枝1, 細野真吾1, 近藤裕樹2, 山崎崇1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 898-898, 2018.

---

	P0116-24-AM. The efforts about the hospitalization support task in the hospitalization and release support center and the evaluation 井戸田麻由1, 石川ゆり1, 竹内正幸1, 山之内博明1, 大西正文1, 斎藤寛子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 898-898, 2018.

---

	P0118-24-AM. Efforts of the pharmacist intervention to the hospitalization support center in our hospital 中原萌子1, 塚田寛子1, 山下典子1, 山脇一浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 899-899, 2018.

---

P0120-24-AM. Change of prescription ... before the hospitalization by the in front of securing of safety - pharmacist technique outpatient department of the perioperative medical therapy utilizing the uniform management system of a side effect, the allergic information 荒木良介1, 三田恭平1, 宇野崇之1, 加藤加奈恵1, 長谷康史1, 小幡薫1, 菱沼隆一1, 山田英紀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 899-899, 2018.

---

	P0122-24-AM. Effect of the pharmacist intervention that we gave to the obstetrics and gynecology department surgery cancellation number 古賀祥子1, 村上翔一1, 畑瀬圭佐1, 高倉栄治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 900-900, 2018.

---

	P0124-24-AM. Is going to perform operations in the middle scale hospital; is intervention to stopping medicine confirmation during the preoperation of the outpatient 譲原千広1, 小川紗知1, 波多晶子1, 中澤美樹子1, 橋爪和恵1, 窪田真弓1, 鶴居勝也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 900-900, 2018.

---

	P0126-24-AM. Investigation of the discontinuation evaluation enforcement situation before operation of the orthopedics ward and the discontinuation compliance 石井有紀1, 水谷妙子1, 池田大地1, 田中文1, 登内盛治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 901-901, 2018.

---

	P0128-24-AM. Examination about the order change case in the foreign cancer chemotherapy on that day 平池美香子1, 川俣洋生1, 西野隆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 901-901, 2018.

---

	P0130-24-AM. Establishment of the pharmacist outpatient department for patients with cancer depending on the ambulatory practice system 村上賢次1, 水本恵梨花1, 早坂大1, 宅和真由美1, 平田敦宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 902-902, 2018.

---

	P0113-23-PM. "Efforts (the third report) for grasp and the improvement of the use of inhalant situation in our hospital in inhalational adherence" 荒木寛也1, 久田明日香1, 福井愛1, 坂柳悦章1, 長谷康志1, 森井涼子1, 加藤裕隆1, 辻博幸1, 塚本久之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 903-903, 2018.

---

	P0115-23-PM. Construction of the pharmacist ambulatory service in the kidney internal medicine 小宅典子1, 井口恵美子1, 栗原佳奈子1, 男全昭紀1, 藤澤一2, 猪股克彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 904-904, 2018.

---

	P0117-23-PM. Efforts of the pharmacist in the admitting department establishment 宮部泰輔1, 北野祐香1, 上田善美1, 十田達也1, 石野佑樹1, 田中奈桜1, 窪田彩花1, 藤井克至1, 生越由美1, 黒川拓也1, 東達也1, 田村憲昭1, 井上敦介1, 廣畑和弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 904-904, 2018.

---

	P0119-23-PM. Intervention of the pharmacist in the admitting department 木村康人1, 廣原成1, 今井祐貴子1, 村田茉央1, 内藤久志1, 橋本友希1, 尾崎昌大1, 添田真司1, 渡邊昌之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 905-905, 2018.

---

	P0121-23-PM. Review of pharmacist outpatient department establishment and allied duties 吉田崇志1, 板垣美保1, 遠藤清香1, 渋江泉1, 板垣有紀1, 羽太光範1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 905-905, 2018.

---

	P0123-23-PM. Foreign efforts before pharmacist technique for the urologic surgery patients 長島真洋1, 安村吉彦1, 澤村愼吾1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 906-906, 2018.

---

	P0125-23-PM. Is going to be operated on; examination about the usefulness of by hospitalization front and the medicine medicine cooperation by the pharmacist to the patients 瀧祐介1, 山崎愛子1, 岩水陽子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 906-906, 2018.

---

	P0127-23-PM. Is going to be operated on; the intervention after the encounter of the ward pharmacist for the patients 松岡未紗1, 後藤義之1, 角紀一郎1, 岡田久美1, 石崎真由美1, 茶野下貴恵1, 光井彩1, 青木理恵1, 島崎沙織1, 戸田翔子1, 森戸敏志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 907-907, 2018.

---

	P0129-23-PM. The examination that how contributes to the surgery enforcement that a pharmacist interview in the support center before hospitalization is safe 野村勇太1, 上田覚1, 藤澤彰宏1, 高田知正1, 三井克巳1, 尾上雅英1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 907-907, 2018.

---

	P0131-23-PM. Trend of the medicine decreasing by it after the drug global assessment adjustment addition new establishment 菅井千尋1, 原島久美1, 箱崎かおり1, 飯山久美子1, 田上明子1, 関本聡子1,2, 屋宮由季1, 中舘朝未1, 安藤浩巳1, 水村恒雄1, 串田一樹2, 廣原正宜2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 908-908, 2018.

---

	P0133-23-PM. Consideration about the need of confirmation of bringing medicine in consideration of renal function 甲元大樹1, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 909-909, 2018.

---

	P0135-23-PM. Role of the pharmacist in the hospitalization and release adjustment room 高氏秀展1, 神谷武司1, 岡崎博2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 909-909, 2018.

---

	P0132-24-AM. We began Masuda Japan Red Cross, a polypharmacy measures project! 山崎祐子1, 俵早紀1, 山藤千晶1, 赤石憲俊1, 大谷崇仁1, 宅江孝修1, 吉田勝好1, 郷原学1, 安木恵一2, 桐田郁3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 910-910, 2018.

---

	P0134-24-AM. Can you depend on prescription notebook (medicine feeling) for the medication information (bringing medicine report)? 小口正義1, 宮崎雄紀1, 水谷妙子1, 酒井美香1, 山崎夕貴1, 田中文1, 登内盛治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 911-911, 2018.

---

	P0136-24-AM. About the change of ward drug duties contents before and after the "confirmation of bringing medicine before hospitalization" duties introduction 宮井明日香1, 美濃佳代子1, 清水けいこ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 911-911, 2018.

---

	P0137-23-PM. About the usefulness of duties by pharmaceutical products SPD out of the fixed form 関屋裕史1, 友宗直樹2, 緒方豊2, 梶原隆弘3, 福永洋子3, 森木豊栄3, 長友隆雄1, 保田和哉1, 池田龍二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 912-912, 2018.

---

	P0139-23-PM. Attempt ... to utilize analysis - Chinese medicine of the interview using "mind" of the Chinese medicine for health care 日置智津子1, 伊藤エミ2, 宇高一郎2, 中井賀世子2, 村重史子2, 椎名昌美1, 武田卓1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 913-913, 2018.

---

	P0141-23-PM. Result of the management that we continued a balun strike scorecard in the Yokohama General Hospital and used 廣瀬直樹1, 佐村優1, 小川寿子1, 倉田武徳1, 高田啓介1, 稲垣和幸1, 井上純樹1, 関根寿一1, 金田昌之2, 佐藤透3, 赤瀬朋秀4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 913-913, 2018.

---

	P0143-23-PM. Consideration about the pharmacist duties in the small and medium size hospital judging from 2017 "current situation investigation of the hospital pharmacy gate" 樋島学1,2, 田中協1, 荒川隆之1, 荒木隆一1, 岩崎雅弘1, 兼重晋1, 佐村優1, 濱浦睦雄1, 久岡清子1, 渡邊学1, 賀勢泰子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 914-914, 2018.

---

	P0145-23-PM. Objective evaluation of the duties system using job satisfaction measure JOBSS-HP27 for hospital pharmacist 永倉史子1, 陶山明日香1, 濃沼政美2, 大久保淑子1, 小田慎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 914-914, 2018.

---

	P0138-24-AM. Efforts of the prescription representation that was able to achieve the duties burden reduction of the physician and duties efficiency of the pharmacy at the same time 中村伸也1, 安山泰1, 寺前祐樹1, 二宮大樹1, 野村祥子1, 谷山康子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 915-915, 2018.

---

	P0140-24-AM. Work-life balance and career plan of the female pharmacist in upper Goto 小徳由梨絵1,2, 大島聖也1, 湯川浩一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 916-916, 2018.

---

	P0142-24-AM. Efforts and result twelfth report for the balun strike scorecard introduction for hospital pharmacist 藤田明宏1,2, 赤瀬朋秀2, 井口恵美子2, 上原君男2, 岡添進2, 小林岳2, 関口信香2, 大幸淳2, 中村葉月2, 小田切正美2, 吉田博史2, 金田昌之2, 金田光正2, 佐藤透2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 916-916, 2018.

---

	P0144-24-AM. Literature examination of the job satisfaction study in the pharmacist 小串興平1, 濃沼政美2,3, 高木彰子3, 中村均2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 917-917, 2018.

---

	P0146-24-AM. With an adverse event spontaneous report database and individual pharmaceutical products link; is ... using the ingredient dictionary including ... life science dictionary 寺内恭平1, 宮村信輝1, 酒井幸1, 阿部純子1, 杉平直子1, 金子周司2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 918-918, 2018.

---

	P0148-24-AM. Investigation about the way of the reporting about the driving using PMDA exhibition data 越野早紀1, 渡辺浩明1, 田村広志1, 和泉秀明1, 佐藤弘康1, 三本松泰孝1, 亀井浩二郎1, 金住麻子1, 福島麻里乃1, 菅大地1, 島津智行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 919-919, 2018.

---

	P0150-24-AM. Fact-finding about the use of antiepileptic drug in women of the childbearing age based on administrative data 菊池大輔1,2, 小原拓2,3,4, 三浦良祐1, 宍戸可成子1, 城坂理紗1, 渡辺善照1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 919-919, 2018.

---

	P0152-24-AM. The making of the system to extract the decreased renal function patients, and to show an optimal dose to and the evaluation 松本薫1, 佐藤篤郎1, 片山広美1, 伊藤昌美1, 深谷詩織1, 天野哲史1, 加藤奈美1, 八並ゆかり1, 鈴木厚志1, 板倉由縁1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 920-920, 2018.

---

	P0154-24-AM. About information on adverse drug reactions collection by the search by keyword in the electronic medical chart record 奈良美波1, 岩田あすか1, 橋口文乃1, 中石真由美1, 久野薫1, 下田寿子1, 林明子1, 橋井祐子1, 佐藤和生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 920-920, 2018.

---

	P0156-24-AM. Examination about the drug repositioning of digoxin using the large-scale database 横山聡1, 杉本泰浩1, 細見光一1, 高田充隆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 921-921, 2018.

---

	P0158-24-AM. Examination of the adverse event expression of EGFR-TKI situation using adverse drug reaction database (JADER) 中山敏光1, 堤大輔1, 安部恵1, 渡邉文之1, 林宏行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 921-921, 2018.

---

	P0160-24-AM. Usefulness examination of search database Lexicomp Online of the drug information resource in the Aichi Medical University Hospital 生田智宏1, 野々垣知行1, 宇野英理子1, 深谷さおり1, 大西正文1, 斎藤寛子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 922-922, 2018.

---

	P0162-24-AM. Making and evaluation of the injection drug incompatibility search tool in the hospital basic for acute phase 小林晃子1, 仁熊宏樹1, 小倉志保1, 西村健二1, 有澤礼子1, 亀井健人1, 赤木晋介1, 高柳和伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 922-922, 2018.

---

	P0164-24-AM. Trial report of the side effect check list which we applied RMP to 杉尾由希子1, 宮下裕央1, 杉町代1, 大窪典子1, 津曲恭一1, 尾之江剛樹2, 北島久義1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 923-923, 2018.

---

	P0166-24-AM. Inquired analysis about the incompatibility in infusion put to the infusion DI center 佐々木美由紀1, 堀越由里1, 竹林佑花1, 津田朋枝1, 松田直子1, 吉岡小都子1, 福田まゆみ1, 河野裕則1, 岩原良晴1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 923-923, 2018.

---

	P0168-24-AM. Usefulness evaluation of the improved version ut for medication guides for patients 間宮愛子1, 西村春香1, 橋本梨紗1, 米田杏寿美1, 角山香織1, 中村敏明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 924-924, 2018.

---

	P0170-24-AM. Inspection of the cancer onset protective efficacy with statin drugs for patients with dyslipidemia 西川寛来1, 高木将行1, 石川秀樹2, 武藤倫弘3, 真野泰成1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 924-924, 2018.

---

	P0172-24-AM. It is ... using analysis ... simple suspension advisability information sharing system data of simple suspension accumulation data 原田恭江1, 細川宜嗣1, 五郎丸剛2, 世良庄司3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 925-925, 2018.

---

	P0147-23-PM. Estimate of the factor affecting the medical measures use or nonuse in database analysis - pharmaceutical products-related report of the business such as mishaps in medical practice intelligence, and the like 室高広1, 中川博雄1,2, 中村忠博1, 佐々木均1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 926-926, 2018.

---

	P0149-23-PM. Relative analysis with α 1 receptor blockade and the faint using the adverse drug reaction database and the previous faint symptom 大山勝宏1, 古本真也1, 杉浦宗敏1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 927-927, 2018.

---

	P0151-23-PM. Of the quantity of magnesium oxide prescription for the person of decreased renal function based on medical examination, receipt data, actually 高橋愛1, 佐藤倫広2, 薄井健介1,3, 岡田浩司1,3, 村上任尚2, 目時弘仁2, 渡辺善照1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 927-927, 2018.

---

	P0153-23-PM. Examination of the usefulness of the NCGM drug interactions search (hepatitis therapeutic drug) system 瀬戸恵介1, 赤沢翼1, 増田純一1, 近藤直樹1, 坂本治彦1, 小林明信1, 寺門浩之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 928-928, 2018.

---

	P0155-23-PM. Construction of the drug information database in our hospital 渡邉美樹1, 谷口仁孝1, 山本彩佳1, 千葉恵美子1, 前川知子1, 坂井愛実1, 前田典子1, 水野稜子1, 小原祐子1, 徳村博子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 928-928, 2018.

---

	P0157-23-PM. Examination - utilizing effect - large scale medical care information that nicorandil gives for the prognosis of patients with cardiopulmonary arrest 新村貴博1, 座間味義人1,2, 石澤有紀3, 今西正樹2, 武智研志4, 福島圭穣5, 堀ノ内裕也3, 池田康将3, 藤野裕道5, 土屋浩一郎6, 玉置俊晃3, 石澤啓介1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 929-929, 2018.

---

	P0159-23-PM. Prediction of the side effect of machine learning using adverse drug reaction database (JADER) 小野田良1, 松井大樹2, 山下由依亜1, 中村武夫1, 伊藤栄次1, 大内秀一1, 和田哲幸1, 八軒浩子1, 大星直樹2, 松野純男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 929-929, 2018.

---

	P0161-23-PM. The analysis of an inquiry, the inquiry example accumulated in our hospital pharmacy and examination of results 中島のぞみ1, 山田倭花1, 内山乃映1, 上田奈緒美1, 大窪真理絵1, 伊代田萌子1, 丸岡浩太1, 梅澤仁美1, 河村紳介1, 小林誠一1, 坂口修治1, 富沢裕之1, 山下敦志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 930-930, 2018.

---

P0163-23-PM. Development ... of I-system which assumes construction - frequent use spreadsheet Excel of the contraindicated medicine prescription check system a base at renal failure utilizing the electronic medical chart search feature 元木貴大1, 井上達也1, 立道貴清1, 水岡大策1, 田中裕章1, 加地雅人1, 小坂信二1, 芳地一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 930-930, 2018.

---

	P0165-23-PM. For the exhibition of the collection of information about the quality (blue book) and the inflection of the generic drug 阿部康弘1, 吉田寛幸1, 伊豆津健一1, 合田幸広1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 931-931, 2018.

---

	P0167-23-PM. Investigation for the inflection of the pharmaceutical products risk management plan 本郷知世1, 加藤一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 931-931, 2018.

---

	P0169-23-PM. Construction of the questions and answers record portal site corresponding to the needs of the pharmacist 長尾由佳1, 赤木晋介1, 奥田敏勝1, 大熊沙代子1, 西田麻以1, 高柳和伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 932-932, 2018.

---

	P0171-23-PM. Comparison of herbal medicinal products "Kakkonto" which is medical use and a nonprescription drug 成橋和正1, 齋藤唯衣1, 藏所志穂1, 津江南瑠海1, 中村憲夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 932-932, 2018.

---

	P0173-23-PM. Investigation about the apothecaries measure before and after the dissolution in the lyophilized products of the injectable antimicrobial, antifungal agent 杉田裕貴1, 細見健悟1, 小牧佐知子1, 稲田智子1, 増本憲生1, 高子優子2, 大槻裕朗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 933-933, 2018.

---

	P0176-24-AM. Fact-finding of the magnesium oxide administration depending on the renal function in elderly patients 藤崎正宏1, 山田邦夫1, 山田充宏1, 棚橋美里1, 和泉孝2, 鈴島仁3, 森岡淳子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 935-935, 2018.

---

	P0178-24-AM. H. in our hospital The current situation of the pylori sanitization therapy 岩田佳菜子1, 栗崎貴啓1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 935-935, 2018.

---

	P0180-24-AM. Side effect fact-finding of five kinds of pain-killers in the Kumamoto function hospital 武藤崇1, 星野輝彦1, 下田賢一郎1, 塩津和則1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 936-936, 2018.

---

	P0182-24-AM. Questionary survey about taking OROS type controlled release control preparation Methylphenidate Concerta 中野歩美1, 杉山育美1, 遠山明宏2, 東透2, 佐塚泰之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 936-936, 2018.

---

	P0184-24-AM. The use situation of the oral anticoagulant drug in elderly people in the triple heart center 松岡佳子1, 前田雄太郎1, 木本珠美1, 伊藤涼子1, 梶間勇樹1, 高井靖1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 937-937, 2018.

---

	P0186-24-AM. Consideration from a viewpoint of running it of the DPC Hospital in the choice of the generic medicine 北岡晃1, 榎木瑞穂1, 西村理恵子1, 竹場和代1, 小倉敬史1, 藤井隆2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 937-937, 2018.

---

	P0192-24-AM. Effect to bone density by the use of each osteoporosis therapeutic drug 酒井祐1, 永江朋子1, 秋元朝行1, 高橋泰久1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 939-939, 2018.

---

	P0194-24-AM. Hold attitude survey - Epinephrine autoinjector class for the adrenalin self injection drug; and ... 浅野志津1, 小原香那1, 日浦亜実1, 森英樹2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 939-939, 2018.

---

	P0196-24-AM. Analysis of the factor to have an influence on the adherence of the agent for hyperlipidemia through "knob medicine bag motion" 川浪望恵1, 小林大介1, 窪田敏夫2, 川尻雄大1, 丸山真実1, 都築加奈1, 三井所尊正3, 瀬尾隆3, 小柳香織3, 高木淳一3, 木原太郎3, 田中泰三3, 島添隆雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 940-940, 2018.

---

	P0198-24-AM. The review of the placement drug of the emergency cart and future problem 杉本恵理1, 堀部緑1, 柘植麻里奈1, 寺田雄亮2, 荒木朋浩3, 斎藤誉宏4, 木村匡男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 940-940, 2018.

---

	P0175-23-PM. The prescription change of the antiepileptic drug 杉山尭紀1, 山本吉章1, 加藤浩充1, 矢嶋隆宏1, 菅寛史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 941-941, 2018.

---

	P0177-23-PM. The prescription situation of the laxative in our center 淀川進也1, 黒崎由希子1, 冨岡謙二1, 古澤一成2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 942-942, 2018.

---

	P0179-23-PM. The difference that it showed from fact-finding of hospitalized lansoprazole famotidine 竹澤唯1, 中川左理1,2, 粕谷香1, 波多野彩美1, 見田秋与志2, 岡本禎晃2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 942-942, 2018.

---

	P0181-23-PM. The use actual situation of the sleeping drug in our hospital orthopedics ward 土元研史1, 安田礼子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 943-943, 2018.

---

	P0183-23-PM. The use situation of the morphine note for the terminal heart failure in the Kasugai Municipal Hospital 伊東和真1, 大岩拓馬1, 田中伸明1, 鈴木大吾1, 前田剛司1, 坂田洋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 943-943, 2018.

---

	P0185-23-PM. Use investigation of the anticoagulant in the convalescent rehabilitation ward 小土井亮介1, 酒井照美1, 西塚亨1, 峯浦一喜2, 白川真3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 944-944, 2018.

---

	P0187-23-PM. Research about the appropriateness doses of the direct action type oral anticoagulant drug 井上朋彦1, 相澤政明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 944-944, 2018.

---

	P0189-23-PM. Questionary survey about the medication adherence for patients with cardiovascular disease and the chief physician 大津友紀1,2, 甲斐麻美子2, 清見文明3, 末松保憲4, 朔啓二郎4, 三浦伸一郎4, 神村英利1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 945-945, 2018.

---

	P0193-23-PM. The use situation investigation for the purpose of the folinic acid preparation proper use 末延道太1, 佐藤史織1, 川元崇志1, 上田由貴1, 稲垣芙美佳1, 山代栄士1, 原尻学志1, 森一生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 946-946, 2018.

---

	P0195-23-PM. Examination of the administration cancellation reason in the tolvaptan new introduction patients 千葉貴志1, 早坂美希1, 上村新吾1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 946-946, 2018.

---

	P0197-23-PM. The current situation of the osteoporotic liaison service in the care mix hospital and future problem 森崎崇文1, 星野輝彦1, 塩津和則1, 清田克彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 947-947, 2018.

---

	P0199-23-PM. Fact-finding of how to work on patients about the medication situation and the medication 天海祐紀1, 岩瀬利康1, 赤羽正之1, 渡邊紘子1, 丸山林土1, 吉成徹1, 半田淑子1, 石崎憲1, 鈴木隆寛1, 和貝益男2, 松田美和3, 田中浩太郎4, 安隆則5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 947-947, 2018.

---

	P0200-24-AM. Effect to medical expenses reduction by the intervention of the pharmacist on medical treatment 四方公亮1, 篠原梨沙1, 桝早紀子1, 伊東充1, 佐藤香織1, 勝俣はるみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 948-948, 2018.

---

	P0202-24-AM. Inspection of the medical expenses reduction effect by the Residual medicine return handling of hospitalization prescription 小野優紀恵1, 渡部寿康1, 大竹麻衣子1, 古賀彩織1, 菊地洋平1, 安齋英里1, 我妻禎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 949-949, 2018.

---

	P0204-24-AM. The results of a doubt inquiry, the prescription suggestion in our hospital and the medical economic effect 芝琴奈1, 益子里美1, 岡田宜和1, 福山博務1, 山崎智世1, 飯嶋歩1, 鎭目晶子1, 安田陽子1, 藤谷竜磨1, 滝島さやか1, 高久聡子1, 目黒正明1, 真柴友紀1, 塩地園代1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 949-949, 2018.

---

	P0206-24-AM. Effect of thrombomodulin and the antithrombin III preparation combination on DIC patients derived from an infection 中野貴文1,2, 佐藤啓介1, 森脇典弘1, 仲村佳彦3, 兼重晋1, 緒方憲太郎1,2, 神村英利1,2, 江川孝1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 950-950, 2018.

---

	P0208-24-AM. Fact-finding about the medical therapy of local elderly people: Examination - of the effect factor to give to Nakajimacho study - medication adherence 徳用百合奈1, 石田奈津子2, 菅幸生2, 松下良2, 石崎純子2, 篠原もえ子3, 駒井清暢4, 山田正仁3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 950-950, 2018.

---

	P0201-23-PM. Drug costs reduction effect by the hospitalization prescription return medicine for pharmacist management 橋本磨里奈1, 村山綾那1, 高柳論也1, 小林恵美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 951-951, 2018.

---

	P0203-23-PM. Examination about the disposal situation and the medical expenses reduction at anticancer agent preparation 鈴木敦詞1, 前田剛司1, 坂田洋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 952-952, 2018.

---

	P0205-23-PM. Examination of the need of the new preparation standard in consideration of a dose of the albumin suspension type paclitaxel 中井將人1, 北本真一2, 吉川明良1, 開浩一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 952-952, 2018.

---

	P0207-23-PM. Local population properties and the pharmacist distribution influence ethical drug sales; or analysis - of the medical economics using - Lorentz curve 安藤崇仁1, 井上和男2, 安原眞人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 953-953, 2018.

---

	P0209-23-PM. Examination of the Similar effect medicine with the in-hospital adoption medicine 田所正年1, 東島幸道1, 鳥山純司1, 梅本啓史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 953-953, 2018.

---

	P0210-24-AM. Questionary survey about the pharmaceutical products quality reporting for the generic drug company 大谷智也1, 浅山美穂1, 松井友希1, 笹原里美2, 木暮晃士2, 立木秀尚2, 恩田光子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 954-954, 2018.

---

	P0212-24-AM. The current situation of the change to the generic medicine in the Soka Municipal Hospital outside Parliament prescription and the evaluation 源川良一1, 村社計寿1,2, 高橋雅弘2, 木村直也1, 越前宏俊2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 955-955, 2018.

---

	P0211-23-PM. Pharmaceutical products interview form and company homepage publication information for the purpose of the quality intelligence of the generic drug 浅山美穂1, 大谷智也1, 松井友希1, 恩田光子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 956-956, 2018.

---

	P0213-23-PM. Investigation about the use of drugstore situation in Japan of the visit to Japan foreigner and the own country and the purpose 吉田舞衣1, 村重勇輔1, スミス朋子2, 楠瀬健昭2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 957-957, 2018.

---

	P0215-23-PM. Proposal to problems and the remedy in outer box information and the package insert of the general Bacillus natto-containing preparation with the high-risk medicine warfarin and interaction 大塚邦子1,2, 桑原諒1, 鈴木啓太郎1, 細野哲司1, 安原一3, 内田直樹2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 958-958, 2018.

---

	P0214-24-AM. Study on comparisons such as regulation, and the like such as Sweden, Germany, the advisability, and the like of the pharmaceutical products online sale in Canada 赤川圭子1, 長谷川洋一2, 中尾裕之3, 今井博久4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 959-959, 2018.

---

	P0216-24-AM. The use situation investigation of the biofollowing article of insulin glargine in our hospital 坂柳悦章1, 荒木寛也1, 西川隆一1, 澤柳直樹1, 藤井友一1, 辻博幸1, 塚本久之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 960-960, 2018.

---

	P0218-24-AM. We look at the rear about the safety of the rituximab Biosimilar and examine a mark 服部有希1, 坂本靖宜1, 太田一郎1, 渡邉美知子1, 鈴木絢子1, 山本幸二郎1, 若杉正1, 小池博文1, 佐橋幸子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 961-961, 2018.

---

	P0217-23-PM. Investigation about the use situation and the infusion reaction expression of rituximab bio follower product in patients with malignant lymphoma 兼松哲史1, 中村英明1, 吉田均2, 伊藤貴彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 962-962, 2018.

---

	P0219-23-PM. Reevaluation of the chemotherapy regimen accompanied with the electronic medical chart shift 大野梨絵1, 浦田修平1, 千阪智美1, 北畑恵理子1, 高橋沙季1, 竹迫明子1, 是枝秀彦1, 森山徳文1, 関屋裕史1, 平原康寿1, 岩切智美1, 奥村学1, 池田龍二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 963-963, 2018.

---

	P0221-23-PM. Efforts for the infusion set unionization in the regimen 西畑友尋1, 松岡葉子1, 稲見有1, 森正一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 964-964, 2018.

---

	P0220-24-AM. Regimen management of blood hematopoiesis tumor using the literature evaluation sheet 坂本竜平1, 向井淳治1,2, 浦瀬文明3, 奥田広志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 965-965, 2018.

---

	P0222-24-AM. Efforts for the medical security at cancer chemotherapy regimen re-registration accompanied with the electronic medical chart shift 浦田修平1, 大野梨絵1, 千阪智美1, 北畑恵理子1, 高橋沙季1, 竹迫明子1, 是枝秀彦1, 森山徳文1, 関屋裕史1, 平原康寿1, 岩切智美1, 奥村学1, 池田龍二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 966-966, 2018.

---

	P0223-23-PM. Efforts of our hospital by the multi-type of job cooperation aiming at proper use of S1 三島江津子1, 永松秀紹1, 榊原洋一1, 吉川直利1, 竹内由佳2, 村上照幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 967-967, 2018.

---

	P0225-23-PM. Pharmacist duties in the treatment with immune checkpoint inhibitor support team 中野友寛1, 原田嵩大1, 大下守得1, 篠原由紀1, 玉井宏一1, 渡部早苗1, 久保さつき1, 奥津武志1, 田房恭子2, 山下広恵2, 武田千津2, 井上考司3, 中西徳彦3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 968-968, 2018.

---

	P0227-23-PM. Efforts - second report - of the multi-type of job cooperation in the blood medical service 今井美沙1, 伊藤佳織1,2, 冨田章裕2, 稲熊容子2, 入山智沙子2, 柘植雅大1, 島戸茜1, 全並美穂1, 出羽薫3, 楠照香理3, 村木由加里3, 山田成樹1, 恵美宜彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 968-968, 2018.

---

	P0229-23-PM. Examination of problems and measures to promote medicine medicine cooperation about the cancer chemotherapy in the Gunma Chumo district 千吉良幸子1,9, 西場弘美1,9, 松浦雅人2,9, 須藤弥生3,9, 真下晴菜3,9, 増野貴司4,9, 名坂輝子5,9, 中村浩規6,9, 矢島俊介7,9, 相川潤7,9, 鈴木達宙1, 大林恭子8,9 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 969-969, 2018.

---

	P0224-24-AM. Efforts ... by the multi-type of job to ensure oral surgery consultation before safe administration - administration of zoledronic acid hydrate, the denosumab 森健太郎1, 内田将吾1, 西口浩明2, 北島聖晃3, 加藤有香4, 山関智恵1, 畔柳敏弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 970-970, 2018.

---

	P0226-24-AM. Role of the pharmacist in the making of the immune checkpoint inhibitor proper use manual 新玉紗理奈1, 山下典子1, 原田愛子1, 柳井美奈1, 木村健1, 今村美智子2, 三好康雄2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 971-971, 2018.

---

	P0228-24-AM. The case that was successful in the patients for staying out support and discharge support by the multi-type of job cooperation for cancer terminal phase 小林義典1, 川口洋実1, 勝又一雄1, 北村修1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 971-971, 2018.

---

	P0230-24-AM. Efforts about the cancer medical therapy training acceptance of the health insurance pharmacy pharmacist in the Sapporo east Tokushukai Hospital 徳留章1, 谷口亮央2, 西澤健太2, 秋山恵里佳1, ファジオ恵里3, 鈴木奈緒3, 新舎里絵3, 吉江昌代3, 佐藤仁昭1, 木明貴幸1, 武田契巳1, 南盛一3, 武田清孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 972-972, 2018.

---

	P0233-23-PM. Fact-finding of the pharmaceutical intervention in the foreign cancer chemotherapy of the pharmacist 藤井友和1, 澤柳直樹1, 西川隆一1, 荒木寛也1, 坂柳悦章1, 塚本久之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 974-974, 2018.

---

	P0235-23-PM. Evaluation of the physician for a cancer medical therapy authorization pharmacist attending patients with cancer encounter 陸丸幹男1, 大塚愛美1, 福山薫子1, 原尻学志1, 森一生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 974-974, 2018.

---

	P0237-23-PM. The current situation and factorial experiments of doubt inquiry of the cancer chemotherapy in our hospital 山崎将英1, 黒田千里1, 藤井怜史1, 山下亜友1, 吉岡薫1, 牧野新輝1, 北川学1, 木明智子1, 中田浩雅1, 宮本篤1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 975-975, 2018.

---

	P0239-23-PM. Fact-finding of the emergency visit consultation in patients who received cancer chemotherapy 横山美里1, 榊原崇芳1, 間瀬悟1, 佐々木英雄1, 三宅芳男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 975-975, 2018.

---

	P0241-23-PM. Importance of the medication counseling (Stop and Go) by the pharmacist outpatient department in the Everolimus exemestane combination therapy for progress, recurrent breast cancer 郷真貴子1, 川地志緒里1, 五十川万喜幸1, 宇佐美英績1, 木村美智男1, 亀井桂太郎2, 吉村知哲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 976-976, 2018.

---

	P0243-23-PM. Example that we were able to lead to the discovery of MTX-LPD from an intraoral algetic suit at medication counseling 足立奈緒子1, 宮崎俊明1, 筒井由佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 976-976, 2018.

---

	P0245-23-PM. Fact-finding about the dose of the foreign chemotherapy for the elderly aged 75 or over (75 years or older) 内藤舞1, 本多伸二1, 佐分利美帆子1, 三松史野1, 目黒裕史1, 實光由香1, 大野恵一1, 寸田靖1, 村岡淳二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 977-977, 2018.

---

	P0232-24-AM. The PBPM introduction to hepatitis B reactivation measures in the cancer chemotherapy and the effect 冨田敦和1, 種村繁人1, 惠谷里奈1, 今井邦行1, 小玉幸与1, 野田直樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 978-978, 2018.

---

	P0234-24-AM. 1 case that a crown spastic angina contraction attack with irinotecan was suggested 岡野芳彦1, 吉田優1, 掛札聡美1, 宍倉啓介1, 篠崎亮介1, 石井紀子1, 寺山義泰1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 979-979, 2018.

---

	P0236-24-AM. Advisory about the change of the pharmaceutical intervention for the foreign cancer chemotherapy 鈴木隆宏1, 草野元1, 渡部智文1, 佐藤かおり1, 池田友香1, 松田明宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 979-979, 2018.

---

	P0238-24-AM. Efforts to the improvement of the drug reporting book in the foreign chemotherapy 今井陽子1, 寺岡綾1, 一色靖洋1, 生島五郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 980-980, 2018.

---

	P0240-24-AM. Construction of the order substitution input procedure by efforts - pharmacist for the rise in HBV-DNA fixed-quantity examination rate of use and effect ... 山中義裕1, 臼井崇1, 小島愛1, 横山正人1, 朝日恵美2, 日比知志3, 田村圭浩4, 岡本好史5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 980-980, 2018.

---

	P0242-24-AM. Efforts in our hospital in alerting it for the driving, and the like of foreign cancer chemotherapy patients 棚田訓彰1, 渡瀬美登里1, 高浪優紀1, 今村陽子1, 柏田匡広1, 大石貴裕1, 池田浩和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 981-981, 2018.

---

	P0244-24-AM. About renal carcinoma, usefulness of by medical examination front for treated patients of the prostate cancer 堀晃代1, 田中和秀1, 板津直美1, 大澤友裕1, 安田昌宏1, 水井貴詞1, 米田尚生2, 後藤千寿1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 981-981, 2018.

---

	P0246-24-AM. Gather, and is given a preparation an anticancer herbalist, for exposure measures until the disposal without interruption 坂田茂代1, 平野聡子1, 山口文子1, 名和亜利沙1, 佐藤透1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 982-982, 2018.

---

	P0248-24-AM. Environmental pollution investigation of the anticancer agent exposure 杉村勇人1, 間瀬広樹1, 石嶋麗1, 中出恵里奈1, 本井悠子2, 嶽加奈子2, 坂倉喜代美2, 北俊之3, 秋山哲平1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 983-983, 2018.

---

	P0250-24-AM. Introduction ... of the cleaning method using consideration - ozone water from anticancer agent exposure findings in our hospital 八重樫允徳1, 高橋喜統1, 荒井涼子1, 山本康人1, 丹羽修1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 983-983, 2018.

---

	P0252-24-AM. Efforts of the administration route introduction of the anticancer agent exposure measures closed system anesthesia system in the pediatric hospital 小川沙夕里1, 小森桂子1, 寺岡知香1, 浅原章裕1, 藤川郁世1, 大津由美子1, 藤田敬子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 984-984, 2018.

---

	P0256-24-AM. Effect of the cost side by the introduction of the closed system anesthesia mixture adjustment appliance 清水浩幸1, 中野歩1, 前田祥花1, 廣岡賢輔1, 米田栄子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 985-985, 2018.

---

	P0258-24-AM. The current situation and problem of the introduction of the closed system anesthesia drug transportation system chemosafe in our hospital 冨山成章1, 田實裕介1, 松ヶ野聡美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 985-985, 2018.

---

	P0260-24-AM. Efforts of exposure measures by the closed system anesthesia appliance entire surface introduction at anticancer agent preparation 陣田剛志1, 岡田悠加1, 佐倉小百合1, 藤原康浩1, 國東ゆかり1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 986-986, 2018.

---

	P0262-24-AM. Attitude survey about an effective evaluation and the anticancer agent exposure for nurses to priming enforcement in the pharmacy 井口菜摘1, 鈴木毅1, 石井岳夫1, 難波有智1, 水野いず美2, 門田靜明2, 与那覇房子1, 外間惟夫1, 中村克徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 986-986, 2018.

---

	P0264-24-AM. Pollution investigation by the cyclophosphamide exposure to restroom in being at home 加藤雅斗1, 宮澤憲治2, 早川裕二1, 溝神文博1, 平野隆司1, 關留美子3, 勝見章4, 小林智晴1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 987-987, 2018.

---

	P0247-23-PM. Examination about the error of the quantity of preparation in the anticancer agent no bacteria preparation of the lyophilized products 北出紘規1, 宮永和美1, 示野哲也1, 西山郁雄1, 大田栄一1, 久保勝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 988-988, 2018.

---

	P0249-23-PM. Follow-up ... of environmental monitoring - five years for the anticancer medicine exposure in the new hospital 三宅知宏1, 野口祥紀1, 服部公紀1, 中西由衣1, 小川晃宏1, 内田早弓1, 和田亜希1, 谷村学1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 989-989, 2018.

---

	P0251-23-PM. Participate in actual situation and problems - national hospital mechanism network collaborative investigation of the exposure situation obtained from the anticancer medicine exposure findings; and ... 玉木慎也1, 高田慎也1, 鈴木訓史1, 高橋由美2, 渡邊健一3, 遠藤雅之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 989-989, 2018.

---

	P0253-23-PM. About the efforts of anticancer agent exposure measures in our hospital 太田哲徳1, 溝口由梨香1, 永田愛子2, 南雲里美2, 染谷美佐2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 990-990, 2018.

---

	P0255-23-PM. Use fact-finding for the drug costs reduction by the Drug Vial Optimization introduction of the injection anticancer agent 目黒聡子1, 永倉史子1, 熊谷修一1, 佐々木裕花1, 糸井彩乃1, 渡辺京彦1, 大川真里奈1, 大久保淑子1, 田中統子2, 小田慎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 990-990, 2018.

---

P0259-23-PM. Duties burden investigation to hang over the core ring incidence and product made in reshaping at anticancer agent preparation using the closed system anesthesia drug transportation system 矢野安樹子1, 濟川聡美1, 白石沙弥1, 中井昌紀1, 安永大輝1, 高田裕介1, 乗松真大1, 坂本宜俊2, 飛鷹範明1, 田中守1, 田中亮裕1, 薬師神芳洋3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 991-991, 2018.

---

	P0261-23-PM. Attitude survey of the preparation staff by the anticancer medicine preparation inspection system introduction in our hospital 古林園子1, 小沼大祐1, 神長雅浩1, 加藤一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 992-992, 2018.

---

	P0263-23-PM. Pollution fact-finding of the anticancer medicine in the chemotherapy room restroom 景秀典1, 井野川徹1, 河野友昭1, 高山慎司1, 後藤一美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 992-992, 2018.

---

	P0265-23-PM. Fact-finding of the edematous expression in the docetaxel 鈴木博1, 後藤孝之1, 深谷一2, 樋口徹3, 有澤文夫3, 斎藤毅3, 佐竹清1, 興野克典1, 町田充1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 993-993, 2018.

---

	P0267-23-PM. The case that induced cancer treatment-related heart failure in our hospital 蓮尾憲作1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 994-994, 2018.

---

	P0269-23-PM. One case with the heart failure attributable to the estracyt which we took for ten years 後藤健志1, 竹尾恵理子1, 酒井欣嗣2, 石川真平1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 994-994, 2018.

---

	P0271-23-PM. The effect that hypoalbuminemia at the paclitaxel + ramucirumab combination therapy gives to neutropenias Grade3 or more on gastric cancer 中澤佑介1, 影山明1, 原田大1, 北村正樹1, 三森教雄2, 川久保孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 995-995, 2018.

---

	P0273-23-PM. It is an example with suspected cefepime encephalopathy during febrile neutropenia treatment after the cancer chemotherapy 小川智子1, 明石直子1, 萬浪綾乃1, 清水彩加1, 庄野裕志1, 大谷陽子2, 宮部貴識1, 佐光留美1, 増田慎三2, 山崎邦夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 995-995, 2018.

---

	P0275-23-PM. Examination for the effect of the paclitaxel nab-paclitaxel to give thrombocytopenia expression of Carboplatin 西部幸一1, 森本雅子1, 佐藤裕美1, 松村翔太1, 稲井邦宏1, 高橋奈々恵1, 小山絹子1, 福野和治1, 松川雅子1, 今井桂子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 996-996, 2018.

---

	P0277-23-PM. 2 case ... which was restored from denosumab administration ... dangerously ill low Ca blood symptom to the haemodialysis patients with metastases to bone 宿谷光則1, 小林俊博1, 中島敦美1, 坪谷綾子1, 松本浩1, 伊藤由香1, 相田紘一郎2, 吉岡まき2, 瀧康洋3, 冨永直人3, 坂下裕子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 996-996, 2018.

---

	P0281-23-PM. One case that interstitial pneumonia and hypersensitivity complicated during the adjuvant chemotherapy CapeOX enforcement after the operation 菊地義明1, 高橋誠1, 藤林遼1, 庄崎沙耶1, 藤田果那1, 朝倉幹己1, 田中耕太1, 木下愛1, 山本翔太1, 山田将悟1, 前川英輝1, 鈴木直哉1, 青田忠博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 997-997, 2018.

---

	P0283-23-PM. Comparison of the onset of vascular pain situation in lyophilized products of the gemcitabine and the solution 橋本浩季1, 村上通康1, 宮崎実千芸1, 山口恭平1, 佐伯恵2, 福岡沙知2, 東千恵2, 玉井恭子2, 川口英俊3, 白石猛4, 西崎隆5, 仙波昌三1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 998-998, 2018.

---

	P0285-23-PM. Consumption investigation of Pregabalin for chemotherapy-induced peripheral neuropathy (CIPN) and examination of the cancellation influence factor 粟井明日香1, 山本智也1, 新谷拓也1, 麻那古信之1, 今中良1, 原伸輔1, 勝浦正人1, 門脇裕子1, 三輪芳弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 998-998, 2018.

---

	P0287-23-PM. The expression situation and the correspondence situation investigation of Oxaliplatin hypersensitivity 谷口潤1, 金澤絵莉1, 村上摩利2, 佐伯哲3, 橋本雅司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 999-999, 2018.

---

	P0291-23-PM. Effect on endocytosis of the cisplatin by the Mg combination 安田恵1, 岸本修一2, 天野学1, 福島昭二2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1000-1000, 2018.

---

	P0293-23-PM. Research of the treatment continuation factor of the gemcitabine cisplatin therapy for the elderly people urothelial carcinoma 八木聡美1, 藤野泰孝1, 福澤翔太1, 佐々直人2, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1000-1000, 2018.

---

	P0295-23-PM. A GFR estimation type in the Carboplatin doses setting in the gynecologic cancer TC therapy of Japanese people and investigation about the side effect 吉川英里1, 田辺公一3, 水野加奈子1, 飯澤泉2, 藤堂由紀2, 麻生美佐子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1001-1001, 2018.

---

	P0297-23-PM. Use fact-finding of the Carboplatin desensitization 柴田直樹1, 川上和宜1, 中村匡志1, 平出誠1, 竹野伸洋1, 吉岡秀哲1, 鈴木賢一1, 温泉川真由2, 竹島信宏3, 濱敏弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1001-1001, 2018.

---

	P0299-23-PM. Examination about the effect that dysgeusia by adjuvant chemotherapy S-1 gives for treatment after the gastric cancer technique 石川寛1, 佐藤淳也1, 若林茜1, 宮口貴守1, 増島広幸1, 田中怜1, 金子美智子1, 鴨志田武1, 篠道弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1002-1002, 2018.

---

	P0301-23-PM. Attempt of the information storage every regimen for nourishment intervention of the effective cancer chemotherapy by the ward pharmacist 丸岡浩太1, 中島のぞみ1, 山田倭花1, 内山乃映1, 村松奈緒美1, 大窪真理絵1, 伊代田萌子1, 梅澤仁美1, 河村伸介1, 小林誠一1, 坂口修治1, 富沢裕之1, 山下敦志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1002-1002, 2018.

---

	P0303-23-PM. Investigation about start doses and continuance of lenalidomide for the multiple myeloma and the dermatopathy 永田和美1, 正置耕一1, 高子優子1, 澁谷奈穂1, 近藤万友美1, 吉岡睦展1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1003-1003, 2018.

---

	P0305-23-PM. Look at the rear about the usefulness of the antithrombotic therapy at the multiple myeloma therapeutic drug IMiDs treatment; mark investigation 隅田英幸1, 槙枝大貴1, 二宮洋子1, 佐野史典2, 近藤英生2, 和田秀穂2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1003-1003, 2018.

---

	P0307-23-PM. Examination of the risk factor of the immune-mediated adverse event expression with the immune checkpoint inhibitor 古田裕幸1, 今津邦智1, 中田恭子1, 長尾宣宏1, 大畑広貴1, 石川暢久2, 篠崎勝則3, 土井美帆子3, 林聖二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1004-1004, 2018.

---

	P0309-23-PM. Example that intervened pharmaceutical for the adrenal disorder that occurred by nivolumab administration 波々壁信也1, 須田智1, 望月真太郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1004-1004, 2018.

---

	P0311-23-PM. Examination about allergic related conditions in the antiPD-1 antibody medicine 星田唯史1, 森本奈緒美1, 藤原大一朗1, 眞下惠次1, 和田祥明1, 野田明宏1, 多喜和夫1, 阪口勝彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1005-1005, 2018.

---

	P0313-23-PM. Side effect case of the use of Pembrolizumab situation and the dermatopathy of our hospital 森脇典子1, 平良智1, 山本紗織1, 福大哉1, 稲嶺盛佳1, 長濱照美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1005-1005, 2018.

---

	P0315-23-PM. Investigation of the intervention situation of the pharmacist for the antihypertensive therapy accompanied with the use of neovascularisation inhibitor in our hospital 上杉章紀1, 羽田野翔太1, 木内貴章1, 水野奈穂子1, 加藤良治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1006-1006, 2018.

---

	P0317-23-PM. Examination of protein urine and the adverse event in bevacizumab ramucirumab treated patients 丸田基史1, 山科卓也1, 藤田強記2, 高武嘉道2, 中川義浩2, 平木洋一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1006-1006, 2018.

---

	P0319-23-PM. We read the side effect expression of patients with TAS-102 medication situation from liver function and renal function 古橋隆久1, 鈴木善貴1, 杉山みづほ1, 丸山昌広1, 中村希和子1, 加藤裕子1, 加藤愛実1, 伏見英晃1, 河内沙織1, 小林さやか1, 氷見敬嗣1, 鳥山琴美1, 加藤知加依1, 河西愛美1, 板垣千華1, 野中梨恵1, 門井実1, 定盛理純1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1007-1007, 2018.

---

	P0321-23-PM. Fact-finding about menstruation after the LH-RH agonist preparation administration in patients with premenopausal hormone acceptor-positive breast cancer and the side effect 冨田奈々1, 平野公美1, 宮本康敬1, 遠藤拓未1, 杤久保順平2, 細川優子2, 渡邉進士1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1007-1007, 2018.

---

	P0323-23-PM. Chemical depression of the side effect of EGFR tyrosine kinase inhibitor 大森紀和1, 米澤穂波1, 上原至雅1, 西谷直之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1008-1008, 2018.

---

	P0266-24-AM. Search of the factor about the onset of neutropenia in the Ramucirumab + Paclitaxel therapy 鈴木弘文1, 千葉健史2, 柳生千代子3, 青木毅一4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1009-1009, 2018.

---

	P0268-24-AM. The onset situation of FN by the fresh food intake in the solid carcinoma chemotherapy 渡部寿康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1010-1010, 2018.

---

	P0270-24-AM. About the blood toxicity in the breast cancer technique aftercare TC therapy 阿部多一1, 住谷達也1, 井口恵美子1, 清水大輔2, 猪股克彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1010-1010, 2018.

---

	P0272-24-AM. It is an example with suspected the HBV activation by nab-paclitaxel administration 井ノ口岳洋1, 輪湖哲也1, 田中弘人1, 中村博子1, 敦賀剛気1, 片山志郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1011-1011, 2018.

---

	P0274-24-AM. Investigation of the angular stomatitis development situation in the use of capecitabine patients 北澤美里1, 今野慶一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1011-1011, 2018.

---

	P0276-24-AM. Present with serious myelosuppression and mucous membrane disorder; one case with suspected capecitabine intolerance 小池彩子1, 出宮千聖1, 中尾なつみ1, 永原照也2, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1012-1012, 2018.

---

	P0278-24-AM. Starting pharmaceutical products of the oxaliplatin infusion liquid, comparison of the vascular pain frequency between the generic medicine 田中康弘1, 宮原強1, 松永尚1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1012-1012, 2018.

---

	P0280-24-AM. Questionary survey about the current situation of the pharmacist intervention for CIPN 石嶋麗1, 中出恵里奈1, 間瀬広樹1, 杉村勇人1, 齋藤讓一1, 秋山哲平1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1013-1013, 2018.

---

	P0282-24-AM. Search of the factor associated with the constipation aggravation after the palonosetron administration 木村早希子1, 細矢和久1, 緒方健二1, 古野龍也1, 祖川倫太郎1, 田崎正信1, 川口淳2, 柏田知美3, 荒金尚子1,4, 能城浩和5, 倉富勇一郎6, 横山正俊7, 野口満8, 安西慶三9, 山下佳雄10, 木村晋也2,3, 成澤寛1,11 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1013-1013, 2018.

---

	P0284-24-AM. Examination about a relation and the safety of the pharmacist for the short hydration method introduction of the cisplatin 光家勉1, 久保緑1, 北村登喜生1, 米川恭史1, 渡部なおみ1, 富田国男1, 吉田友紀2, 塘賢二郎3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1014-1014, 2018.

---

	P0286-24-AM. The side effect expression situation investigation of the use of cisplatin regimen in elderly people 高田遼1, 山下亜友1, 吉岡薫1, 山崎将英1, 國本雄介1, 北川学1, 木明智子1, 中田浩雅1, 宮本篤1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1014-1014, 2018.

---

	P0288-24-AM. Polypharmacy measures in the chemotherapy including the cisplatin 山田千代子1, 米澤美和1, 久保杏奈1, 虎瀬和子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1015-1015, 2018.

---

	P0290-24-AM. One case that a hypersensitivity symptom by the doxorubicin developed during adjuvant chemotherapy after the breast cancer technique 井上徹雄1, 松高秀昭1, 稲角利彦1, 田中一穂2, 櫻井美由紀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1015-1015, 2018.

---

	P0292-24-AM. Examination of Nedaplatin doses according to the renal function in the bladder cancer GN therapy 山本悠樹1, 稲野寛1, 米山大志1, 厚田幸一郎1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1016-1016, 2018.

---

	P0296-24-AM. Investigation for the use situation of the Drd therapy in the Naha Municipal Hospital and the side effect expression 比嘉大輔1, 永井賢作1, 金城雄一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1017-1017, 2018.

---

	P0298-24-AM. Examination of the effect of the side effect expression situation investigation and the use of the immune checkpoint inhibitor in our hospital of steroid 永松秀紹1, 三島江津子1, 榊原洋一1, 中野里佳2, 竹内由佳2, 村上照幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1017-1017, 2018.

---

	P0300-24-AM. Examination of frequency and the clinical features of the immune-mediated side effect of nivolumab in the non-small cell lung cancer 金崎修平1, 中尾將彦2, 長底利恵1, 木村仁美1, 山崎直樹1, 吉田徹也1, 坪口裕子3, 津谷あす香3, 駄賀晴子3, 村田みどり1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1018-1018, 2018.

---

	P0302-24-AM. Examination about the safety of the Osimertinib in the non-small cell lung cancer 中西大介1, 畑地治2, 柳川泰裕1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1018-1018, 2018.

---

	P0304-24-AM. About a change of blood pressure, proteinuria by the bevacizumab and a change of the renal function 長岡麻沙美1, 津曲恭一1, 北島久義1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1019-1019, 2018.

---

	P0306-24-AM. About the introduction of the protein urine/creatine ratio at use of antiVEGF antibody medicine in our hospital and examination of the usefulness 斎藤恭正1, 北川和男2, 淺利知1, 戸田裕太1, 宇井可奈枝1, 三橋平2, 山本秀巨3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1019-1019, 2018.

---

	P0308-24-AM. Use fact-finding about Lenvatinib proper use in patients with thyroid cancer 大野千尋1, 石橋麻衣2, 浜田幸宏1, 外賀裕次郎1, 川辺桂太郎1, 岡本高宏3, 木村利美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1020-1020, 2018.

---

	P0310-24-AM. The current situation investigation of the rasburicase administration in our hospital 石井一也1, 中村豪志1, 荻原好章1, 神原康佑1, 大塚識稔1, 原景子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1020-1020, 2018.

---

	P0312-24-AM. Examination about the difference in onset of infusion reaction by the dilution level of rituximab 松本浩明1, 益本周治1, 高柳和伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1021-1021, 2018.

---

	P0314-24-AM. About the onset of adverse event situation by the rituximab Biosimilar 田中裕章1, 水岡大策1, 山口佳津騎1, 高橋功一1, 安宅希美子1, 本田由紀1, 元木貴大1, 加地雅人1, 朝倉正登1, 小坂信二1, 芳地一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1021-1021, 2018.

---

	P0316-24-AM. We look at the rear of the regorafenib for unresectable progress colon cancer and are examined the use situation and the medication method by the mark investigation 小谷野大地1, 高山俊輔1, 増田裕子1, 土肥大典1, 鍵山智樹1, 玉木秀子2, 真壁秀樹1, 濱口哲弥3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1022-1022, 2018.

---

	P0318-24-AM. Investigation about the Palbociclib administration in the Brest peer Miyazaki Hospital 永友由里子1, 三根明1, 駒木幹正2, 齋藤智和2, 船ケ山まゆみ2, 前田資雄2, 柴田伸弘3, 中原浩4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1022-1022, 2018.

---

	P0320-24-AM. Risk factor investigation of the onset of liver function abnormality by the Erlotinib 梅田道1, 大澤友裕1, 甲田明英1, 大野佑城1, 安田昌宏1, 水井貴詞1, 後藤千寿1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1023-1023, 2018.

---

	P0324-24-AM. It is examined fatigue, the lassitude improvement in the change in an Enzalutamide remedy timing 関永彩夏1, 吉川明良1, 村上礼隆1, 開浩一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1024-1024, 2018.

---

	P0327-23-PM. Economic evaluation of 5-HT3 receptor blocker palonosetron in the CHOP therapy 黒田真希1, 木村雄太2, 高田慎也1, 橋下浩紀1, 遠藤雅之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1026-1026, 2018.

---

	P0329-23-PM. Evaluation of the effectiveness of olanzapine for retching, vomiting that cancer medical therapy causes 平野翔子1, 嶋田修治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1026-1026, 2018.

---

	P0331-23-PM. Use investigation before and after the well-known application of "the digestive organ symptom with the antineoplastic administration" of olanzapine 松本和樹1, 橋本早苗1, 廣畑秀記1, 酒井克紀1, 福田英克1, 南波勝栄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1027-1027, 2018.

---

	P0333-23-PM. Examination about the effectiveness of the antiemetic in the gemcitabine hydrochloride + nab-paclitaxel combination therapy (GEM + nab-PTX therapy) 深井靖大1, 楠本将裕2, 横田崇1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1027-1027, 2018.

---

	P0335-23-PM. The proper use promotion of the antiemetic drug in the chemotherapy of stomach and the cancer of the esophagus and improvement of the compliance 宇都宮奈々1, 沖田健太郎1, 長谷川将1, 安河内寿成1, 松永里香1, 中道亜依子1, 白石貴寿1, 面田恵1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1028-1028, 2018.

---

	P0326-24-AM. Effect on antiemesis effect by the presence or absence of aprepitant administration in the Carboplatin - albumin-binding paclitaxel therapy 西村亮1, 中西真也1, 吉野新太郎1, 原田卓弥1, 中浴伸二1, 濱宏仁1, 森本茂文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1029-1029, 2018.

---

	P0328-24-AM. Effect of the ramosetron as retching vomiting measures with the azacitidine administration on myelodysplastic syndrome 山田政典1, 田中彩2, 黒岩三佳3,4, 大徳真也3, 潟永安亘2, 安谷屋源2, 後藤隆2,4, 草葉一友2,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1030-1030, 2018.

---

	P0330-24-AM. Antiemesis therapy investigation under the use of olanzapine in our hospital 鈴木俊一1, 根本昌彦1, 岩山竜大1, 阿部春果1, 原田悠介1, 小川竜徳1, 坂本莉紗1, 山元麻衣1, 佐藤渉1, 四十物由香1, 齋藤祥子1, 青山芳文1, 大河原悠2, 名和健2, 品川篤司2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1030-1030, 2018.

---

	P0332-24-AM. Investigation about the use actual situation of non-fixed form antipsychotics (olanzapine) in the antiemesis treatment of cancer chemotherapy patients 坂倉智子1, 岩澤真紀子2, 柳澤優里2, 瀬戸良教1, 椎崇1, 厚田幸一郎1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1031-1031, 2018.

---

	P0334-24-AM. Usefulness evaluation of the antiemesis supportive care using "a treatment diary" for the purpose of the symptom grasp of foreign cancer chemotherapy patients 福長豊己1, 森川記道1, 西倉教子1, 西原昌幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1031-1031, 2018.

---

	P0336-24-AM. About the CINV expression situation of a gynecologic cancer of our hospital and the Carboplatin-containing regimen in the lung cancer domain 岩村高弘1, 藤井秀一1, 森光保武1, 神原史織1, 尾高登美枝1, 福場夕起1, 岡本直樹1, 高田悠作1, 前原健司1, 池田敦1, 岩永崇志1, 杉原義彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1032-1032, 2018.

---

	P0337-23-PM. The effect that peg filgrastim gives to docetaxel therapy in castration-resistant prostate cancer treatment 高武嘉道1, 鶴崎泰史1, 藤田強記1, 花田聖典1, 中川義浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1033-1033, 2018.

---

	P0339-23-PM. Examination of the peg filgrastim administration time for the R-CHOP therapy to elderly people 佐々木美織1, 櫻井淳二1, 野澤寿吉2, 佐藤伸輔1, 宮内康夫1, 阿部順1, 阿部正理3, 野村順3, 石澤文章1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1034-1034, 2018.

---

	P0343-23-PM. About effect of the UGT1A1 genetic polymorphism giving it to the irinotecan administration in the digestive organ cancer case 高橋健太1, 浦田理華1, 浅野順治1, 太宰昌佳2, 関沢祐一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1035-1035, 2018.

---

	P0345-23-PM. One case that received FOLFOX therapy for patients with progress gastric cancer during haemodialysis 松尾尚美1, 鶴山萌子3, 横山知美1, 鶴田南奈子1, 三好孝法1, 丸田基史1, 田尻裕匡2, 江頭明典2, 川中博文2, 平木洋一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1035-1035, 2018.

---

	P0347-23-PM. Effect of the diabetes merger on prognosis of patients with nabPTX + GEM therapy enforcement pancreatic cancer 林明希1, 武智研志1,2, 中馬真幸1,2, 岡田直人1, 今西正樹1, 座間味義人1,3, 桐野靖1, 中村敏己1, 寺岡和彦1, 石澤啓介1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1036-1036, 2018.

---

	P0349-23-PM. The use situation of antiPD-1 antibody Pembrolizumab in our hospital 石崎文子1, 相原敏彦1, 増尾昌則1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1036-1036, 2018.

---

	P0351-23-PM. Development of clinical test value check system (LDCS) in the cancer chemotherapy and examination of the usefulness 本田由紀1, 井上達也1, 安宅希美子1, 高橋功一1, 山口佳津騎1, 田中裕章1, 加地雅人1, 小坂信二1, 芳地一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1037-1037, 2018.

---

	P0353-23-PM. Factor analysis to have an influence on the infusion reaction expression at the Rituximab administration 小川晃宏1, 野口祥紀1, 三宅知宏1, 谷村学1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1037-1037, 2018.

---

	P0355-23-PM. We look at the effectiveness of Daratumumab in the Japanese recurrent or refractory multiple myeloma and the rear about the safety and examine a mark 小倉宏之1, 中川雄介1, 伊勢崎竜也1, 鈴木正論1, 安室修1, 小林宏紀2, 舟越亮寛1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1038-1038, 2018.

---

	P0357-23-PM. Examination of the bevacizumab addition effect after the monotherapy PD judgment of the trifluridine Tipiracil hydrochloride 桝茂典1, 成廣哲史2, 岡田悠美1, 安藤尚美1, 中川隼一1, 櫻井彩乃1, 高橋苑子1, 高橋真一1, 蔭山博之1, 平島徹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1038-1038, 2018.

---

	P0359-23-PM. 1 case that was treated effectively with a 1% alum water continuation perfusion therapy for hemorrhagic cystitis with cyclophosphamide in patients with acute severe renal failure 岡崎敏幸1, 吉井圭佑1, 春木祐人1, 江草太郎1, 山下真弘2, 杉山哲大1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1039-1039, 2018.

---

	P0361-23-PM. The effectiveness of the Hangeshashinto gargle for stomatitis by the Everolimus 阿部圭輔1, 阪田安彦1, 吉川明良1, 開浩一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1039-1039, 2018.

---

	P0363-23-PM. Examination about the safety of the PCC therapy for oral cancer 鈴木訓史1, 河村奈々美1, 田中寛之1, 橋下浩紀1, 遠藤雅之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1040-1040, 2018.

---

	P0365-23-PM. Fact-finding of the antimicrobial prescription after the foreign chemotherapy enforcement 仁尾祐太1,2, 杉田栄樹1,2, 奥村和子3, 清水久範1,2, 佐々木忠徳1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1040-1040, 2018.

---

	P0367-23-PM. The current situation investigation, a cause and measures of the omission of calculation of the foreign chemotherapy addition in the Ina center Hospital 六波羅孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1041-1041, 2018.

---

	P0338-24-AM. The comparison that enforced peg filgrastim in the breast cancer dose dense AC therapy in day2 or day4 生田智基1, 亀岡春菜1, 筒井陽子1, 小暮友毅1, 槇恒雄1, 小池恭正1, 宇野摩耶2, 三好雄一郎2, 高橋三奈2, 原文堅2, 高嶋成輝2, 青儀健二郎2, 大住省三2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1042-1042, 2018.

---

	P0340-24-AM. Examination of the usefulness of the peg filgrastim in the amrubicin therapy for the small cell lung cancer 杉野善彦1, 浅野寿規1, 桜田宏明1, 山村益己1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1043-1043, 2018.

---

	P0342-24-AM. Comparison every disease about the possibility of the interaction judging from the content of the use drug in patients with blood-forming organ tumor 武内偲乃1, 大里洋一1, 五味緩子1, 長山佳之1, 大塚健太郎1, 大橋養賢1, 谷地豊1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1043-1043, 2018.

---

	P0344-24-AM. The effect that dose setting in consideration of age and degree of corpulence gives to the cancer chemotherapy of blood-forming organ tumor 白井雄大1, 槇枝大貴1, 植木春香1, 亀尾剛士1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1044-1044, 2018.

---

	P0346-24-AM. Elucidation of the clinical significance of the cancer-restraining gene CYLD expression drop in the breast cancer medical therapy 西郷智香1, 平井ちか2, 桑野明香理2, 林光博3, 岩瀬弘敬4, 齋藤秀之1, 城野博史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1044-1044, 2018.

---

	P0348-24-AM. Effect of the renal function on RDI of the gemcitabine in the GC therapy 関口展貴1, 杉山昌秀1, 宮田智陽1, 篠原佳祐1, 岩水雅俊1, 渡邉将隆1, 関戸大司2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1045-1045, 2018.

---

	P0350-24-AM. The effectiveness of pancreatic cancer chemotherapy GS therapy in our hospital, FOLFIRI-NOX therapy, the GEM + nabPTX therapy and safe examination 服部豊1, 齊藤麻衣子1, 安孫子瞳1, 山澤真之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1045-1045, 2018.

---

	P0352-24-AM. The use situation of antiPD-L1 antibody atezolizumab for the non-small cell lung cancer 成田綾香1, 米澤美和1, 山田千代子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1046-1046, 2018.

---

	P0354-24-AM. Examination of the medication method of the daratumumab 松林麻里子1, 石原溶子1, 大橋一輝2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1046-1046, 2018.

---

	P0356-24-AM. Comparison of KRd therapy and the IRd therapy in the recurrent or refractory multiple myeloma 淺野肇1, 宮本大嗣1, 森嶋祥之1, 芦田隆司2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1047-1047, 2018.

---

	P0360-24-AM. One case that we became in desensitization for etoposide hypersensitivity suspicion if treatment was possible continuously 松本友香理1, 多賀谷光2, 福嶋知樹1, 橋本晃樹1, 菊池良介1, 中澤一磨1, 橘田文彦1, 手塚春樹1, 河田圭司1, 鈴木正彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1048-1048, 2018.

---

	P0362-24-AM. Pharmacist attitude survey questionnaire before and after the educational program enforcement for oral mucositis of patients with cancer 吉田謙介1, 勝良剛詞2, 島田泉1, 田中雄介1, 鈴木直人1, 高木律男3, 外山聡1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1048-1048, 2018.

---

	P0364-24-AM. Examination about the use of opioid for oral mucositis with the head and neck cancer chemoradiotherapy 永谷明子1,2, 高橋典子1,2, 松井美月1,2, 須永登美子1,2, 渡邊徹1,2, 佐々木忠徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1049-1049, 2018.

---

	P0366-24-AM. Investigation of the onset of low Mg blood symptom situation and the Mg supply situation with the Cetuximab administration for head and neck cancer 田代紘士1, 平池美香子1, 牛島知実1, 坂口晋哉1, 堤国章1, 川俣洋生1, 林稔展2, 西野隆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1049-1049, 2018.

---

	P0368-24-AM. Investigation, examination of doubt inquiry in anticancer agent preparation duties and prescription confirmation contents 山村真貴子1, 沖田健太郎1, 安河内寿成1, 上地純子1, 宗本佐知子1, 三村英恵1, 白石貴寿1, 面田恵1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1050-1050, 2018.

---

	P0369-23-PM. Attitude survey using the attitude scale (FATCOD-Form B-J) about the terminal care for a hospital, drugstore pharmacists 熊井正貴1, 加藤信太郎1, 小柳遼1, 久保田康生1, 古堅彩子2, 鳴海克哉2, 小林正紀1, 笠師久美子1, 土居由有子3, 郡修徳4, 井関健1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1051-1051, 2018.

---

	P0371-23-PM. Search study of the factor influencing the necessity or not of the tight military ration of the fentanyl oral mucosa absorbent 藤本英哲1, 中村めぐみ1, 藤村昭太1, 大矢浩之1, 佐野元彦1, 近藤正巳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1052-1052, 2018.

---

	P0377-23-PM. 1 case with suspected attenuation of serving mild sufferings from breathing of the opioid by combination of the naldemedine 小島正照1, 宇野崇之1, 荒木良介1, 山田英紀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1053-1053, 2018.

---

	P0379-23-PM. Examination about the effectiveness of the tapentadol for the metastases to bone-related pain 西村美馨子1,2, 奥苑朱加2, 高岡龍蔵2, 中村智絵2, 後藤健志1,2, 遠山幸男2, 岩田智樹2, 川合甲祐2, 山口智江2, 中根茂喜2, 石川真平1, 板倉由縁3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1054-1054, 2018.

---

	P0381-23-PM. The use situation of the drug for the medical care for the pain due to mucositis in the advanced head and neck cancer 村上郁1,2, 市倉大輔1,2, 縄田修一1,2, 峯村純子1,2, 佐々木忠徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1054-1054, 2018.

---

	P0383-23-PM. Efforts to the self-care operation of the drug for the medical care 西澤圭祐1, 山関智恵1,4, 飯田昭宏1,4, 岩本貴子3,4, 青木佐知子2,4, 田嶋学2, 畔柳敏弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1055-1055, 2018.

---

	P0385-23-PM. The current situation of bisphosphonate injection preparation and the onset of necrosis of the jaw bone 伊藤友一1, 今岡寛美1, 森住誠1, 石原美加1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1055-1055, 2018.

---

	P0387-23-PM. One case that a pharmacist intervened in the palliation of the colon cancer peritoneum dissemination patients, and was able to leave the hospital 勝又一雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1056-1056, 2018.

---

	P0389-23-PM. Role of the pharmacist attending the medical examination of the physician in the palliative care outpatient department 饗庭孝一1, 近藤結1, 小澤祐介1, 小池健太1, 岡平将志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1056-1056, 2018.

---

	P0391-23-PM. Contribution degree investigation of the current situation and the charge pharmacist about the palliative care in the national hospital mechanism (the fourth report) 中村孝佑1,2, 形部文寛2, 武智宣佳2, 小野友香2, 波多江崇3, 八本久仁子2,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1057-1057, 2018.

---

	P0393-23-PM. We look back on the end-of-life approach for patients with heart failure who had colon cancer 隅田美紀1,4, 粥川真衣1, 小木曽正輝1, 亀山祐行2,4, 林和徳3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1057-1057, 2018.

---

	P0370-24-AM. Comparison between betamethasone and dexamethasone about the lassitude improvement in patients with terminal cancer 水越千晶1, 高野尊行1, 倉井由香1, 柿沼博子1, 長尾結花1, 中丸朗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1058-1058, 2018.

---

	P0372-24-AM. Examination of the usefulness for the analgesic effect of the fentanyl sublingual tablet for the cancer pain 和田紀子1,2, 半田智子2, 山本仁美2, 樋口比登実3, 佐々木忠徳1,4, 加藤裕久2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1059-1059, 2018.

---

	P0374-24-AM. About the use situation and usefulness of the naldemedine 南貴之1, 若月淳一郎1, 花輪和己1, 小林義文1, 山本誠一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1059-1059, 2018.

---

	P0376-24-AM. Use fact-finding of the naldemedine for the opioid-induced constipation in patients with cancer 久枝真一郎1, 西明子1, 宗広樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1060-1060, 2018.

---

	P0378-24-AM. An example with suspected ileus by the naldemedine 高橋未來1, 宇田竜也1, 中田和宏1, 加藤知孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1060-1060, 2018.

---

	P0380-24-AM. 1 case that an elimination of pain effect and tolerability were shown in by pain control by the high-dose tapentadol 宇野崇之1, 小島正照1, 荒木良介1, 菱沼隆一1, 山田英紀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1061-1061, 2018.

---

	P0382-24-AM. Efforts of the pharmacist outpatient department for the use of drug patients for the medical care 郷治久美1,2, 深津昌弘1, 水元弥生2, 熊澤尚美2, 澤田憲朗2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1061-1061, 2018.

---

	P0384-24-AM. National survey about the actual situation of the internal use rescue medicine (drug) self-care of the inpatient for the cancer practice cooperation base Hospital, and the like 杉浦礼菜1, 中村和行2, 野田実希2, 黒野俊介1, 杉浦洋二2, 長谷川洋一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1062-1062, 2018.

---

	P0386-24-AM. About difference in dose setting of the acetaminophen preparation in adults less than 50 kg in weight, we examine validity from the presence of the liver damage after the administration 高野陽平1, 上野英文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1062-1062, 2018.

---

	P0388-24-AM. An example of the young breast cancer that suffered from pain relief though we gave medical therapy in consideration of a lifework 前田晶美1, 柏木佑貴1, 足立恵子1, 前田翠1, 依藤健之介1, 松本章士1, 山神和彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1063-1063, 2018.

---

	P0390-24-AM. About a setup of the palliative care unit in the small and medium size special hospital and pharmacist duties 寺本拓哉1, 吉丸侑子1, 山本裕子1, 猿渡康宏1, 伊藤由希1, 赤坂綾1, 横山賢二1, 丸田佐知子1, 水本智子1, 平井裕子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1063-1063, 2018.

---

	P0392-24-AM. The preparations situation of the palliative care-related drug in the regional alliances institution 鈴木景就1, 村川麻里子1, 石渡明子2, 明石浩史3, 木村雅美4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1064-1064, 2018.

---

	P0394-24-AM. Two patients who responded to mexiletine hydrochloride internal use for rectal tenesmus 山下千草1, 川原裕1, 佐野雅昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1064-1064, 2018.

---

	P0395-23-PM. After the operation in the cardiovascular surgery efforts (the third report) for use of infection prophylaxis antimicrobial aptitude 吉川慧1,3, 鈴木ゆきえ1,3, 花房喜子1,3, 小森亮子1,3, 小椋大1,3, 渡部智文1, 松田明宏1, 吉川真一4, 吉田進4, 高木賢司3, 飯高祐子3, 林靖子3, 中山晴夫3, 入江嘉仁2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1065-1065, 2018.

---

	P0397-23-PM. Investigation about the incidence of the use actual situation and SSI of the antimicrobial in the foreign normal tooth extraction 金子奨太1, 吉田謙介1, 磯辺浩和1, 鈴木直人1, 児玉泰光2, 高木律男2, 外山聡1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1066-1066, 2018.

---

	P0399-23-PM. Antimicrobial proper use evaluation before operation in the operation under laparoscopy of the uterine myoma 井上彩花1, 枦秀樹1, 太田哲徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1066-1066, 2018.

---

	P0401-23-PM. It is the use situation investigation of the infection prophylaxis antimicrobial after the oral art in the cataract surgery 臼井和明1, 大石丸美1, 岩武幹乃1, 山村真貴子1, 安藤暢彦1, 森田佳博1, 白石貴寿1, 面田恵1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1067-1067, 2018.

---

	P0403-23-PM. The effect that a pharmacist-led antimicrobial proper use support activity gives to antibiotic exposure 林幹也1, 後藤志典1, 吉本和代1, 山元紀世子2, 白井雅美3, 伊藤美登里3, 赤崎淳子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1067-1067, 2018.

---

	P0405-23-PM. Relation of the pharmacist in the antimicrobial proper use support team 岡野翔1, 高橋詩織1, 岩崎正宏1, 清水勇基1, 重成大介1, 野田師正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1068-1068, 2018.

---

	P0407-23-PM. About AST activity in our hospital 小野寺潤1, 石井美千代2, 間地知子3, 武内悠里子4, 片山順平5, 中川基人6, 山田健一朗7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1068-1068, 2018.

---

	P0409-23-PM. About the activity of the antimicrobial proper use support team and the result 山本圭城1, 安井友佳子1, 大谷典子1, 中野剛志1, 飯田大貴1, 石坂敏彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1069-1069, 2018.

---

	P0411-23-PM. Antimicrobial Stewardship (AS) activity in our hospital using the antimicrobial proper use support sheet that linked an electronic medical chart and the evaluation 長谷川恭子1, 末永拓也1, 岩尾恭寛1, 工藤真裕1, 大庭奈未代2, 新島奈津子3, 高橋康一4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1069-1069, 2018.

---

	P0413-23-PM. Intervention to antimicrobial proper use support of the small and medium size hospital pharmacist 緒方雅章1, 山本諒子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1070-1070, 2018.

---

	P0415-23-PM. Satisfaction investigation about the antimicrobial proper use support (AS) activity in the pharmacy 西本辰徳1, 山崎恵子1, 中村康彦1, 清水裕彰1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1070-1070, 2018.

---

	P0417-23-PM. Investigation of the use of oral antimicrobial situation in the ambulatory practice 田沼道也1, 田中昌代1, 田澤庸子2, 入口慎史1, 加藤敏明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1071-1071, 2018.

---

	P0419-23-PM. Adoption rearranging of the third generation oral cephalosporin 佐々木康弘1, 金丸亜佑美2, 山口明子3, 高安博史4, 矢野雅隆5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1071-1071, 2018.

---

	P0421-23-PM. Examination about the adoption situation of the carbapenem-based antimicrobial in the medical institution in Niigata 佐藤智功1, 三星知2, 継田雅美3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1072-1072, 2018.

---

	P0423-23-PM. Effect by the intervention point change to the use of carbapenem-based antimicrobial patients 徳山ことみ1, 馬生良則2, 横山恵三2, 二階堂弘美3, 安藤由香4, 矢野朋文5, 竹田克明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1072-1072, 2018.

---

	P0425-23-PM. Change of the rate of use of the appropriate culture test by the revision of the use of meropenem report vote 根本将徳1, 瀧澤幸三1, 黒金悦子1, 氣賀澤郁1, 加藤愛1, 山本航大1, 横田伸幸1, 濱野圭子1, 吉永芽以1, 山下創平1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1073-1073, 2018.

---

	P0427-23-PM. Examination about a background factor and the vital prognosis associated with the renal function recovery after the onset of renal failure with vancomycin 植木哲也1,2,5, 實松絵美子1, 古谷頼和1, 篠原義剛1, 村上由花2, 宮崎晶2, 坂本佳子2, 眞柴晃一3, 中嶋弥穂子4, 中嶋幹郎5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1073-1073, 2018.

---

	P0429-23-PM. Comparison of the impaired renal function in injectable vancomycin and the injectable antimicrobial combination 萩原大樹1, 佐藤啓介1, 森脇典弘1, 兼重晋1, 神村英利1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1074-1074, 2018.

---

	P0431-23-PM. 1 case that infective endocarditis due to the MRSA was able to be treated with combination of vancomycin and daptomycin conservatively 天野哲史1,2, 生田幸江1,3, 山崎均1,4, 稲塚信郎1,5, 八並ゆかり2, 船戸優佑6, 服部晃左6, 杉浦厚司6, 板倉由縁2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1074-1074, 2018.

---

	P0433-23-PM. Thrombocytopenia by the linezolid, examination of the serum Na level drop 森村春菜1, 秋場孝則1, 貝塚朋恵1, 小野田弘崇1, 塚本宏夢1, 中野一男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1075-1075, 2018.

---

	P0435-23-PM. The effect that an adoption standard change of the antimicrobial gives to medication method and drug costs 山崎洋平1, 山田彩加1, 新沼芳文1, 本郷文教1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1075-1075, 2018.

---

	P0437-23-PM. The effect that anti-VAIO gram and antimicrobial administration support using the critical path give to antimicrobial proper use 松木祥彦1, 石毛宏治1, 石田雅也1, 金井絵美1, 西沢大樹1, 富田千尋1, 大島香1, 杉田恵1, 長谷川雄介1, 米井万紀子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1076-1076, 2018.

---

	P0439-23-PM. Presence and prognosis of the antibiotic exposure in the patients with non-serious case 10 case that is higher than C-reactive protein 40 mg/dL 福田哲也1, 伊東伶子1, 水越寛2, 山下知子2, 蓮見章太2, 八代智子1, 吉田誠也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1076-1076, 2018.

---

	P0441-23-PM. The onset of hepatic dysfunction situation investigation with voriconazole 吉原涼子1, 溝田繁治1, 松竹紀子1, 谷口潤1, 橋本雅司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1077-1077, 2018.

---

	P0443-23-PM. It is one patient using the colistin for the MDRP bacteremia of patients with congenital solitary kidney 井田真仁1,2, 鈴木伸志1,2, 岡村彰子2, 小林義正2, 飯草正実2, 本田なつ絵2, 松田直人2, 春木宏介2, 松本富夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1077-1077, 2018.

---

	P0445-23-PM. Evaluation of the effectiveness of the antimicrobial for the pyelonephritis case 池本雅章1, 岡村和彦1, 佐々木雄啓1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1078-1078, 2018.

---

	P0447-23-PM. The case that took a ciprofloxacin high dose for purulent spondylitis 小澤拓1,2, 若松雄太1,2, 石津智司1,2, 小林敦子2, 高子優子1, 小川佳美1, 正置耕一1, 吉岡睦展1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1078-1078, 2018.

---

	P0449-23-PM. 1 case that suffered from negative pressure closed treatment and antibiotic exposure for MRSA mediastinitis that occurred after the coronary arteries bypass operation 山西彩香1, 城尾晃太1, 植田実佐1, 長橋かよ子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1079-1079, 2018.

---

	P0451-23-PM. Administration case ... by the simple suspension method that administration experience - exposure and the disposal loss of the valganciclovir to neonates in the municipal hospital were considered 寺崎玲香1, 後藤敏也1, 鈴木宏明2, 遠藤彰3, 正木銀三1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1079-1079, 2018.

---

	P0396-24-AM. The postoperative infection event occurrence situation in the cardiovascular surgery surgery of our hospital 三橋未帆1, 杉尾和昭1, 小野田稔久1, 宮本康平1, 藺藤佑哉2, 齋藤綾2, 本村昇2, 増田雅行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1080-1080, 2018.

---

	P0398-24-AM. The perioperative glycemic control and surgical-site infections (Surgical site infection, SSI) prevention 森美奈子1, 日下部華子1, 中島みゆき1, 金内幸子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1081-1081, 2018.

---

	P0400-24-AM. It is efforts of the infection prophylaxis antimicrobial proper use after the operation in the child surgery 中山澄香1, 枦秀樹1, 太田哲徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1081-1081, 2018.

---

	P0402-24-AM. It is effect of the infection prophylaxis antimicrobial cancellation after the onset situation of the infection and the oral art after the operation in the percutaneous transluminal coronary angioplasty 白石貴寿1, 臼井和明1, 栗原江未1, 宇都宮奈々1, 吉田悦朗1, 近藤真由1, 羽山千尋1, 面田恵1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1082-1082, 2018.

---

	P0404-24-AM. Pharmacist-led antimicrobial proper use support team 古川大樹1, 伊藤嘉英1, 林房江2, 菱田志乃3, 長谷川雅哉1, 中尾彰宏4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1082-1082, 2018.

---

	P0406-24-AM. Efforts ... for antimicrobial proper use support activity - specific antimicrobial consumption decrease by the infection measures team 倍味亜矢子1, 中川典子1, 佐武喜美子1, 高岸ひろみ1, 岩田亜里1, 足立哲也1, 川口祐司1, 若林亜希子1, 桝屋根佳子1, 辻本吉広2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1083-1083, 2018.

---

	P0408-24-AM. Report of the Antimicrobial Steward ship Team activity in the Tomigusuku center Hospital 小杉卓大1, 新垣里奈1, 新垣淑大1, 長嶺結奈2, 安里彩子2, 島添亜依子3, 大嵩昌子3, 石川美根子3, 村山知生4, 橋本孝夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1083-1083, 2018.

---

	P0410-24-AM. About an activity of antimicrobial proper use support team (AST) of our hospital and the effect 平野典子1, 杉浦龍也1, 川瀬将紀1, 伊藤広樹1, 守田覚1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1084-1084, 2018.

---

	P0412-24-AM. Practice and evaluation of the infection related to antimicrobial proper use support team early monitoring 中谷亮介1, 満田正樹1, 石川裕大1, 太田かおり2, 奥野千晶3, 松本篤1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1084-1084, 2018.

---

	P0414-24-AM. Use turn of eventss of PIPC/TAZ by the AST intervention 平賀八重子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1085-1085, 2018.

---

	P0416-24-AM. Questionary survey ... for attitude survey - hospital pharmacist and the health insurance pharmacy pharmacists of the pharmacist about the drug-resistant (AMR) action plan 加藤渓1,6, 満田正樹2,6, 久保健児3,6, 阪口勝彦5,6, 稲葉眞也4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1085-1085, 2018.

---

	P0418-24-AM. The use of oral antimicrobial situation investigation in our hospital 甲斐達夫1, 川俣洋生1, 福石和久1, 西野隆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1086-1086, 2018.

---

	P0420-24-AM. Fact-finding of the coagulation disorder by the cefmetazole in our hospital 百瀬公博1, 荒木真2, 秋月茂樹1, 伏見幸浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1086-1086, 2018.

---

	P0422-24-AM. The use situation of the carbapenem-based antimicrobial of our hospital guessed by a report of use of designated antimicrobial 檜山瑠美1, 阿部佳史1, 門間貴大1, 向平亨1, 齋藤裕輝1, 青木裕香1, 作田重人1, 関沢祐一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1087-1087, 2018.

---

	P0424-24-AM. Carbapenem-based antimicrobial prescription pulse-taking after the Antimicrobial Stewardship Team activity reinforcement in the Iizuka Hospital 内田守次1,2, 梅田勇一1,2, 長崎皓光1, 的野多加志2,3, 金澤康範1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1087-1087, 2018.

---

	P0426-24-AM. Gram-negative bacilli, validity evaluation of the early period of meropenem doses for patients with bacteremia 河本和1, 川崎仁央1, 半田愛1, 藤井哲英1, 北川誠子1, 勝村登美子1, 二宮洋子1, 河口豊2, 桑原篤憲3, 大石智洋4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1088-1088, 2018.

---

	P0428-24-AM. Search of the factor accompanied with the protraction of the drug-related impaired renal function with vancomycin 綺田尚久1, 藤原信二1, 伊藤美咲1, 西嶋長1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1088-1088, 2018.

---

	P0430-24-AM. Examination of vancomycin doses in patients with blood tumor of the decreased renal function case 島田泉1, 森紗世子1, 小林将文1, 鈴木直人1, 外山聡1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1089-1089, 2018.

---

	P0432-24-AM. 1 case of the purulent spondylitis due to the MRSA that a therapy with vancomycin and fosfomycin was effective 吉野秀紀1, 森田直1, 堤良祐2, 畔柳弥生1, 木下里紗1, 紙谷公彦1, 坂本武志2, 小林政彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1089-1089, 2018.

---

	P0434-24-AM. One patient who evaded thrombocytopenia by weight loss administration of the linezolid 亀田圭輔1, 北村友乃1, 渡来和宏3, 小森功夫2, 生島五郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1090-1090, 2018.

---

	P0436-24-AM. Difficulty of deleting the adoption antimicrobial 福本康之1, 森下和美1, 川上典子1, 佐野克典2, 白井保子3, 飯岡義教4, 吉田康秀4, 近藤昌子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1090-1090, 2018.

---

	P0438-24-AM. About the diachronic correlation of antimicrobial consumption and the chemosensitive rate 藤島哲大1, 佐藤家恒1, 高橋幸1, 小川信二1, 佐藤博樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1091-1091, 2018.

---

	P0440-24-AM. The current situation investigation of the antimicrobial administration for the animal bite for the medical institutions in the catchment area 吉田悦朗1, 白石貴寿1, 臼井和明1, 宇都宮奈々1, 栗原江未1, 長谷川将1, 中島信能1, 岩本幸英1, 面田恵1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1091-1091, 2018.

---

	P0442-24-AM. To beta-lactam derivative antimicrobial beta lactam agent readministration - fact-finding - to the patients with allergy 井澤香1, 土井啓員1, 増田雅行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1092-1092, 2018.

---

	P0444-24-AM. About the use situation of the multidrug-resistant antiphthisic drug Delamanid in our hospital 小迫晶寛1, 加茂章弘1, 江原正博1, 植村隆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1092-1092, 2018.

---

	P0446-24-AM. Intervention effect to medical treatment on Clostridium difficile-related loose bowels (CDAD) 久田瑛吉1, 加藤洋介1, 牧野勇1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1093-1093, 2018.

---

	P0448-24-AM. One case of the acute suppurative thyroiditis with the cyst of thyroid infection by Staphylococcus epidermidis 竹内祐介1, 小泉祐一1, 王恩2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1093-1093, 2018.

---

	P0450-24-AM. One case that intervened immediately from the intervention mass spectrography of the AST pharmacist to the bacteremia in the decreased renal function patients 更谷和真1, 中澤明日香1, 徳濱潤一1, 奥村愉美子1, 原田晴司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1094-1094, 2018.

---

	P0452-24-AM. Look at the blood poison-related rear with ganciclovir; mark investigation 保田和哉1, 平原康寿1, 吉川直樹1, 外山智章1, 浦田修平1, 池田龍二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1094-1094, 2018.

---

	P0453-23-PM. Introduction and problems of the report of use of specific antimicrobial system 小澤章裕1, 中山菜実1, 鈴木美帆1, 石毛佑樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1095-1095, 2018.

---

	P0455-23-PM. A report and evaluation of the antimicrobial proper use promotion activity in our hospital with several clinical departments 豊福泰代1, 岡田隆文2, 松原始朗3, 仙波靖士1, 立花広志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1096-1096, 2018.

---

	P0457-23-PM. Relative examination with use of antimicrobial density AUD and the MRSA separation rate 溝田繁治1, 吉原涼子1, 谷口潤1, 大野直義1, 中村みさ1, 江島遥1, 藤岡ひかる1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1096-1096, 2018.

---

	P0459-23-PM. Including the consumption comparison of attitude survey - hand disinfectants of the pharmacist for the hand hygiene - 伊賀正典1, 高野温志1, 亀井陽子1, 齋藤彩子1, 井上朋子1, 町田充1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1097-1097, 2018.

---

	P0461-23-PM. Fact-finding of the blood culture follow-up in the bacteremia case of our hospital 成島俊輔1, 鯉沼縁1, 岡田絵梨子1, 青山美恵子2, 井坂彰一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1097-1097, 2018.

---

	P0463-23-PM. Quinolone-resistant E. Examination of pulse-taking and measures of coli 加藤一雲1, 近藤晃史1, 坂野昌志1, 寺井文廣1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1098-1098, 2018.

---

	P0465-23-PM. Investigation of the HBV reactivation screening test for the immunosuppressive drug in the orthopedics domain 廣岡賢輔1, 木村和幸2, 満田朱理3, 清水浩幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1098-1098, 2018.

---

	P0467-23-PM. Examination about the association between antimicrobial administration, nutritional status and PT-INR change 野口悠高1, 南木伸基2, 西尾貴之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1099-1099, 2018.

---

	P0469-23-PM. Use pulse-taking of the antifungal agent in Japan from 2006 through 2015 河邊絢子1, 石井沙季1, 胡井愛1, 後藤良太1, 村木優一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1099-1099, 2018.

---

	P0471-23-PM. Use trend of the antiMRSA medicine based on the volume in Japan from 2006 through 2015 後藤良太1, 石井沙季1, 胡井愛1, 河邊絢子1, 村木優一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1100-1100, 2018.

---

	P0454-24-AM. Efforts to report of use of specific antimicrobial submission rate improvement using an electronic medical chart system 森下和美1, 福本康之1, 長山晃1, 平野雄一1, 川上典子1, 近藤昌子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1101-1101, 2018.

---

	P0456-24-AM. The effect that the antimicrobial proper use round in the infection specialist absence institution gives in outcome index 大戸祐治1,4,5, 新井祐司2,4, 岡田壮令3,4, 田中克巳1,5, 佐々木忠徳5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1102-1102, 2018.

---

	P0458-24-AM. Efforts of the ICU person in charge of hand hygiene index pharmacist for the improvement 明石岩雄1, 須田奈美1, 山本律子1, 影山明1, 北村正樹1, 北村好申1,2, 川久保孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1102-1102, 2018.

---

	P0460-24-AM. Pollution status investigation ... formulations apparatus of the formulations apparatus by an examination of bacteria and the ATP analysis is really beautiful; or ... 植松卓也1, 松浦亨1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1103-1103, 2018.

---

	P0462-24-AM. Examination of the initial antimicrobial and mortality in patients with blood culture-positive rheumatic disease 川上智久1, 吉田三矢1, 南翔大1, 三浦菜々子1, 山口崇臣1, 畝佳子1, 政道修二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1103-1103, 2018.

---

	P0464-24-AM. Examination of the background that affected the number of the Klebsiella oxytoca detection increase 木村順平1, 武田龍馬1, 池田大騎1, 山田和範3, 山澤裕司3, 本間和加子1, 中村博彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1104-1104, 2018.

---

	P0466-24-AM. Appropriate management of the endoscope based on culture results by the ICT 青木康二1,5, 中嶋里佳1,5, 森章哉1,5, 小林百合2,5, 別所裕二3,5, 村田哲也4,5, 河村雅人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1104-1104, 2018.

---

	P0468-24-AM. Examination of the incompatibility based on the pH change of the antibiotic 平野剛1, 滝川裕基1, 高村茂生1, 櫻田渉1, 中山章1, 吉田栄一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1105-1105, 2018.

---

	P0470-24-AM. Use trend (2006-2015) of the antimicrobial with the antiPseudomonas aeruginosa effect in Japan 胡井愛1, 石井沙季1, 河邉絢子1, 後藤良太1, 村木優一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1105-1105, 2018.

---

	P0472-24-AM. A use trend of the antimicrobial to use for Clostridium difficile infection in Japan and effect of the treatment guideline 石井沙季1, 胡井愛1, 河邊絢子1, 後藤良太1, 村木優一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1106-1106, 2018.

---

	P0473-23-PM. Idea to make use of the presence of the pharmacist in the medical care of patients with mental disorder [the first report] - Mental disease zone - 梅田賢太1, 父田智子1, 松本伊都子1, 荒木博陽2, 園部漢太郎3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1107-1107, 2018.

---

	P0475-23-PM. The current situation and tendency of the drug global assessment adjustment addition calculation in the psychopathic ward 黒川拓也1, 生越由美1, 宮部泰輔1, 井上敦介1, 廣畑和弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1108-1108, 2018.

---

	P0477-23-PM. Prescription fact-finding (compare 2017 with 2013) of the medical therapy about patients with schizophrenia in the university hospital 松崎遥菜1, 波多野正和1,2, 山田成樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1108-1108, 2018.

---

	P0479-23-PM. Examination of the effect on quantity of olanzapine prescription by the smoking 赤瀬川豊1, 有村洋平2, 井上雅文3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1109-1109, 2018.

---

	P0481-23-PM. 1 case that developed hyponatremia during S citalopram internal use 矢野真弓1, 木村由紀子1,2, 大礒宏昭1, 下地晶1, 池田郁子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1109-1109, 2018.

---

	P0483-23-PM. Investigation about the background of conveyed patients emergency for acute drug intoxication 藤田強記1, 高武嘉道1, 鶴崎泰史1, 丸田基史2, 中川義浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1110-1110, 2018.

---

	P0485-23-PM. Evaluation of the medication adherence in DAI-10 in the psychology educational program enforcement patients 岡本和之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1110-1110, 2018.

---

	P0487-23-PM. Evaluation of the treatment flowchart introduction effect in the delirium 吹谷真紀子1, 齊藤伸1, 工藤和彦1, 仙葉悠紀1, 木元健寛1, 一関美江子1, 金美紀1, 篠田和人1, 山崎恵葉1, 鈴木ひとみ1, 八代佳子1, 水沢重則1, 後藤敏晴1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1111-1111, 2018.

---

	P0474-24-AM. About the activity of the pharmacist in the mental hospital outpatient department D care 正井淳子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1112-1112, 2018.

---

	P0476-24-AM. Efforts to the psychotropic drug adjustment cooperation addition 南憲一1, 下川千賀子1, 竹中克之1, 中川里弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1113-1113, 2018.

---

	P0480-24-AM. Patients satisfaction investigation in the Asenapine sublingual tablet 福山雄卯介1, 江崎肇2, 宮崎敦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1114-1114, 2018.

---

	P0482-24-AM. One patient who was treated effectively with a sublingual tablet for the symptom control of patients of the traumatic perforation of small intestine 松下隆行1, 佐野彩女1, 兼松友紀1, 長谷部千夏1, 塚原民夫1, 堀内正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1114-1114, 2018.

---

	P0484-24-AM. The side effect situation investigation of the Perampanel hydrate and examination of the associated factor 松竹紀子1, 高田正温1, 橋本雅司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1115-1115, 2018.

---

	P0486-24-AM. The effect that DELTA program introduction gives in the prescription trend of the delirium analogous drug 清水善仁1, 西田祥啓1, 高瀬文超1, 高橋喜統1, 宮東剛文2, 中井有里3, 橋本玲子4, 新田佑輔4, 川崎康弘4, 丹羽修1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1115-1115, 2018.

---

	P0488-24-AM. Examination about the risk factor that a remedy drug affects the fall in the psychopathic ward 宮本亜季1, 日笠真一2, 岡本ちはる2, 島袋翔多2, 田中邦佳2, 柳井美奈2, 三上ひとみ3, 清野仁美4, 松永寿人4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1116-1116, 2018.

---

	P0489-23-PM. Examination about a dose of the genetically-modified thrombomodulin in the decreased renal function patients and the prognosis 角真太郎1, 南智香子1, 宮本由貴1, 緒方健二1, 西順也1, 祖川倫太郎1, 江本晶子1, 田崎正信1, 阪本雄一郎3, 成澤寛1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1117-1117, 2018.

---

	P0491-23-PM. The effect that the cinacalcet administration in maintenance patients on dialysis gives to a serum P concentration 石田翔1, 吉川明良1, 開浩一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1118-1118, 2018.

---

	P0493-23-PM. The current situation investigation of the central venous hyperalimentation for haemodialysis patients in our hospital and future problem 先崎貴洋1, 田原温1, 野口周作1, 宮田広樹1, 笠原英城1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1118-1118, 2018.

---

	P0495-23-PM. Investigation of the effect on serum phosphorus concentration by the dosage form change of the lanthanum carbonate hydrate 久松大介1, 木村繁和1, 林貴子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1119-1119, 2018.

---

	P0490-24-AM. Consciousness reform of the member for drug doses doubt inquiry in the decreased renal function patients 二上佳世子1, 高野由美子1, 松森智士1, 前田志帆1, 大越美根子1, 小堀勝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1120-1120, 2018.

---

	P0492-24-AM. Improvement of the polypharmacy by the CKD education hospitalization 小澤慶祐1, 國津佑貴1, 磯野哲一郎1, 藪田直希1, 増田恭子1, 平大樹2, 大澤紀之3, 荒木信一3, 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1121-1121, 2018.

---

	P0494-24-AM. Effective and safe evaluation with calcium-containing preparation and Seve Lamar for the high phosphorus blood symptom merged with patients on dialysis 石田理絵子1, 嶋田修治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1121-1121, 2018.

---

	P0496-24-AM. Examination of the renal function improvement in the agate Pross ton remedy 廣瀬浩一1, 松井健一1, 高橋理寛1, 齋田正和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1122-1122, 2018.

---

	P0497-23-PM. Sugar, a serum lipid metabolism change and medication counseling effect on patients with DPP-4 inhibitor administration diabetes 玉井祐馬1, 江月優1, 瀧田優樹1, 中村由香2, 行宗千裕2, 泉京江2, 武田未佳2, 大橋綾子3, 三浦剛4, 佐々木英久1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1123-1123, 2018.

---

	P0501-23-PM. The use situation of the ipragliflozin in our hospital 石橋真実1, 大森麻江1, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1124-1124, 2018.

---

	P0503-23-PM. Inspection of the usefulness of the diabetes therapeutic drug Dulaglutide through the self-injection introduction instruction by the pharmacist 石田詞子1, 小野達也1, 西田英之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1125-1125, 2018.

---

	P0505-23-PM. Significance of the pharmacist intervention in the changes, and the like to the SAP (Sensor Augmented Pump) with a hypoglycemia prediction, the interruption function in the insulin pump therapy 米元治朗1, 白川葉子1, 片山知子1, 毛利有美子1, 田中祐希2, 宮前至博2, 玉城成雄2, 笠原督2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1125-1125, 2018.

---

	P0509-23-PM. Association between diabetes image and medication adherence of patients with type 2 diabetes 浦田航希1, 吉田綾乃1, 玉田実花1, 堀内礼子2, 山秋直人3, 八木邦公4, 橋本昌子1, 荒井國三1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1126-1126, 2018.

---

	P0511-23-PM. The effect that hospitalization of the convalescent rehabilitation gives to diabetes treatment 佐々木麻里1, 辻倫子1, 内薗令子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1127-1127, 2018.

---

	P0513-23-PM. About the perioperative blood sugar control situation of the diabetes education inpatient 伊東崇仁1, 川井龍美1, 祝田靖2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1127-1127, 2018.

---

	P0515-23-PM. Investigation about Miyagi diabetes medical treatment instruction, a pharmacy workshop start and the diabetes medical treatment instruction in the pharmacist 鈴木さとみ1,7, 佐藤伸輔2,7, 本田弘3,7, 堤栄二4,7, 渥美久義5,7, 松本健司6,7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1128-1128, 2018.

---

	P0498-24-AM. Significance of the change of prescription to the allogeneic medicine for patients with DPP-4 inhibitor administration diabetes 瀧田優樹1, 玉井祐馬1, 江月優1, 中村由香2, 行宗千裕2, 泉京江2, 武田未佳2, 大橋綾子3, 三浦剛1, 佐々木英久1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1129-1129, 2018.

---

	P0500-24-AM. Extraction of the important factor affecting the change and the treatment result of HbA1c of the SGLT2 inhibitor Empagliflozin remedy patients 宮田絵莉加1, 黒川彰太1, 岡村和彦1, 藤本孝則1, 池本雅章1, 佐々木雄啓1, 長廣由美佳2, 小河潮美2, 木村幸司2, 佐和章弘2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1130-1130, 2018.

---

	P0502-24-AM. The effectiveness of the GLP-1 receptor agonist Dulaglutide 0.75 mg once a week preparation in patients with type 2 diabetes and safe examination 玉城由実加1,2, 宇都宮励子1, 結城由恵2, 廣田憲威1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1130-1130, 2018.

---

	P0504-24-AM. The effectiveness of the glinide medicine in patients with type 2 diabetes and safe examination 鈴木喬也1, 早川伸樹1,2, 津川透1,3, 福井愛子1, 亀井浩行1, 牧和歌子2, 増田富2, 鈴木敦詞2, 山田成樹3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1131-1131, 2018.

---

	P0506-24-AM. Efforts of the pharmacist in the pump therapy (SAP) introduction with the sensor in patients with type I diabetes mellitus and the data analysis 毛利有美子1, 片山知子1, 白川葉子1, 米元治朗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1131-1131, 2018.

---

	P0510-24-AM. It is ... about taking pharmaceutical products needing attention for ... renal function about the combination drug of patients with diabetes in our hospital 平岡陽一1, 橋本隆信1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1132-1132, 2018.

---

	P0512-24-AM. Investigation about the blood sugar change every dexamethasone doses in patients with diabetes during cancer chemotherapy 室伏孔樹1, 秋本純矢1, 好川瑛美子1, 大久保紀宏1, 内藤淳嗣1, 馬島碧子1, 中川隼一1, 蔭山博之1, 平島徹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1133-1133, 2018.

---

	P0514-24-AM. About patients questionary survey in the class for diabetics of our hospital 立花慧千1, 小林薫1, 伊藤宏彰1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1133-1133, 2018.

---

	P0516-24-AM. Example that a drug administration design succeeded for patients with type 2 diabetes that fixed its eyes on being at home 平島麻由美1, 佐藤晃1, 池田舞1, 中野里美1, 持田知志1, 堀竜2, 堀裕貴也3, 齊藤幹夫4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1134-1134, 2018.

---

	P0517-23-PM. Tentative plan of use of psychotropic drug guidelines for a pregnant woman, the nursing mother in our hospital 藤尾容子1, 佐藤岳春1, 安部裕美1, 中島理絵1, 國原将洋1, 八本聖秀1, 神垣伸2, 長島信行2, 朝倉岳彦2, 大盛航2, 板垣圭2, 竹林実2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1135-1135, 2018.

---

	P0519-23-PM. To the intervention to mother of the baby-friendly hospital authorization institution mental disorder 宮井絢美1, 別府博仁1, 関本裕美1, 木下かすみ2, 吉田愛3, 小林明子4, 武内享介3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1136-1136, 2018.

---

	P0521-23-PM. Examination of the zinc transitivity to the whole first milk in the Wilson disease merger mother's body during high-dose zinc acetate remedy 松田紘子1, 杉本浩子1, 鳥谷部邦明2, 田中博明2, 岩本卓也1, 奥田真弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1136-1136, 2018.

---

	P0523-23-PM. Case report about the fetal transitivity of amiodarone 西中川遥1, 生駒歌織1, 池田麗1, 越智純子1, 中北和樹1, 橋詰宏美1, 寺川伸江1, 川端一功1, 老田章1, 月永理恵2, 神谷千津子2, 岩永直子2, 吉松淳2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1137-1137, 2018.

---

	P0525-23-PM. Examination about the puerperium rubella vaccine inoculation in our hospital 木藤一美1, 橋本隆信1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1137-1137, 2018.

---

	P0527-23-PM. The current situation of rubella antibody titers in early pregnancy and the postpartum vaccination 松下久美1, 瀧祐介1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1138-1138, 2018.

---

	P0529-23-PM. The effect that magnesium-containing preparation combination gives for retching vomiting expression in the early or threatened labour pregnant woman 柿沼博子1, 高野尊行1, 倉井由香1, 柿沼貴広1, 水越千晶1, 長尾結花1, 中丸朗1, 白石悟2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1138-1138, 2018.

---

	P0531-23-PM. Importance of the pharmaceutical management of the blood clotting factor IX preparation in the hemophilia B carrier pregnant woman 森田靖代1, 森田聡美2, 榎本麻里子1, 東香歩1, 八木祐助1, 常風興平1, 松島幸生2, 池上信夫2, 前田長正2, 宮村充彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1139-1139, 2018.

---

	P0533-23-PM. It is unified the doubt correspondence of the OTC medicine for a pregnant woman, the nursing mother in our hospital 三原瑞貴1, 芦澤穂波1, 富永紗菜恵1, 北村悠里子1, 石田あい1, 木村真策1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1139-1139, 2018.

---

	P0535-23-PM. An attitude survey about the pregnant woman prescription of the resident in the night, the holiday and making of the pregnant woman prescription support tool 鈴木秀明1, 佐藤寛子1, 伊藤有美1, 滝本典夫1, 足立守1, 梅津朋和2, 小山勝志3, 山本真一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1140-1140, 2018.

---

	P0518-24-AM. Relation of the actual situation and the pharmacist of the medical treatment of the puerperant complicated with a mental disorder 桐林美緒1, 佐藤千比呂1, 金田美咲緒1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1141-1141, 2018.

---

	P0520-24-AM. Reporting about the mother's milk transitivity of the remedy drug of expectant mothers and the effect 春名柚佳1, 木村佳代子1, 都築仁美1, 谷香苗1, 小野尚志1, 山下恭範1, 田崎嘉一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1142-1142, 2018.

---

	P0522-24-AM. 2 cases that was given mother's milk childcare during cyclosporine internal use 山川恵1, 三島唯1, 北島美有1, 藤原尚子1, 橋本真梨1, 松本久美子1, 大本暢子1, 久米学1, 森實真由美2, 矢野育子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1142-1142, 2018.

---

	P0524-24-AM. Change - of the risk recognition to investigation - teratogenesis and fetuses about the counseling in the medical therapy of the pregnant woman and the pregnancy continuation intention 今岡美紀子1, 布野優子1, 横手克樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1143-1143, 2018.

---

	P0526-24-AM. Become the meningitis suspicion for second pregnancy trimester; a case using vancomycin 門倉史枝1, 大庫百代1, 本上ほなみ1, 二星知紗1, 永井浩章1, 大谷美奈子1, 廣瀬晃子1, 井上智恵1, 見上千昭1, 本間久美子1, 西尾孝1, 辻本勉1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1143-1143, 2018.

---

	P0528-24-AM. Study on pregnancy outcome of the ST medical mixture remedy pregnant woman 三井由加子1, 加藤沙織1, 堀亜也子1, 亀田谷和将1, 小澤明香1, 長山直実1, 齋藤健一1, 谷島春江2, 小野義久3, 側島久典4, 近藤正巳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1144-1144, 2018.

---

	P0530-24-AM. Effect of the corpus luteum hormone on ritodrine doses in the impending premature birth treatment 日野光記枝1, 大橋健吾1, 吉田真也1, 宇佐美英績1, 吉村知哲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1144-1144, 2018.

---

	P0532-24-AM. Study on pregnancy outcome of the dyslipidemia therapeutic drug remedy pregnant woman 長谷川まゆみ1, 加藤沙織1, 和智りべか1, 宮原菜生1, 鈴木千明1, 小澤明香1, 長山直実1, 齋藤健一1, 谷島春江2, 小野義久3, 側島久典4, 近藤正巳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1145-1145, 2018.

---

	P0534-24-AM. Questionary survey of the proper use of the pharmaceutical products to a nursing mother 磯崎遥1, 岡部愛子4, 門馬恵1,2, 越塚宏美1,2, 阿部久瑠美1,2, 小林麻美2,3, 柏原由佳1,2, 田中克巳1,2, 佐々木忠徳2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1145-1145, 2018.

---

	P0536-24-AM. The taking psychotropic drug situation to see from a consultation example of "the pregnancy and the medicine outpatient department" of our hospital 渡邊真理恵1,2, 川邉桂1,2, 勝亦秀樹1, 栗城紘子2, 浜之上はるか2, 小池博文1, 平原史樹4, 伊藤秀一2,3, 佐橋幸子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1146-1146, 2018.

---

	P0537-23-PM. Efforts (the second report) for the elderly people multiple drug prescription adequacy by pharmacist - physician collaboration 稲垣芙美佳1, 上田由貴1, 山代栄士1, 川元崇志1, 鴛海太郎2, 塩田星児2, 高倉健2, 森一生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1147-1147, 2018.

---

	P0539-23-PM. It is ... about the operation of the drug adjustment report at a discharge at the polypharmacy Team activity report - adjustment in the elderly people special hospital 小原朋也1, 羽田慶子1, 瀧川美和1, 島崎良知1, 森淑子1, 石川譲治2, 岩切理歌3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1148-1148, 2018.

---

	P0541-23-PM. About the medical treatment intervention example of the pharmacist in the dementia support team (DST) 濱邊秋芳1, 嶋田聖子1, 納富貴子1, 有川菜木沙1, 永田真二郎2, 豊里悦子2, 大平康智3, 田渕真理子4, 徳安清昭5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1148-1148, 2018.

---

	P0543-23-PM. About the efforts for the drug becoming the precipitants of the delirium in dementia care rounds 曽我弘道1, 前田朱香1, 富田敏章1, 清水誉志1, 町田聖治1, 入江利行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1149-1149, 2018.

---

	P0545-23-PM. Preventive measures against elderly people polypharmacy and follow-up in the cerebral surgery acute phase hospital 曽和鮎美1,2, 山崎みどり1, 山田佳奈1, 山田愛1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1149-1149, 2018.

---

	P0547-23-PM. The use actual situation of the active form vitamin D3 medicine in elderly people and current situation investigation about the measurement frequency of serum calcium concentrations 伴具也1, 尾浜直子1, 大森清孝1, 三浦誠1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1150-1150, 2018.

---

	P0538-24-AM. An evaluation of the drug consumption of the elderly people in the medical treatment ward and pharmaceutical intervention 竹下秀司1, 佐野一也1, 久保田倫代1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1151-1151, 2018.

---

	P0540-24-AM. Use fact-finding of sedative hypnotic, the antianxiety drug in the care health center for the elderly attached to our hospital 佐藤裕美1, 柴田麻里子1, 高橋奈々恵1, 林みさ1, 松村翔太1, 福野和治1, 森本雅子1, 松川雅子1, 西部幸一1, 今井桂子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1152-1152, 2018.

---

	P0542-24-AM. Efforts of the drugstore in dementia support Committee 安田美奈子1, 秋元凌1, 栃原龍宏1, 五藤里奈1, 白川舞1, 熊田克幸1, 小川嘉久1, 荒井圭二2, 東佐恵子2, 三輪嘉明3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1152-1152, 2018.

---

	P0544-24-AM. Factor search of the polypharmacy in the elderly aged 75 or over 宮前文明1, 福田和希1, 竹山知志1, 小川喜通1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1153-1153, 2018.

---

	P0546-24-AM. The use situation of magnesium oxide in our hospital care department and serum magnesium level 森光恵1, 中川貴史1, 新田千恵1, 西出直人2, 臼倉幹哉3, 鈴木邦彦4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1153-1153, 2018.

---

	P0548-24-AM. Evaluation about the detection of drug (PIMs) inappropriate potentially using the medical therapy guidelines in elderly people 亀田敬子1, 佐古渚1, 高橋えりか1, 木本信介1, 山田周平1, 西田直史1, 福澤祐幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1154-1154, 2018.

---

	P0549-23-PM. Onset of combination situation of the antiulcer agent in the aspirin Enteric tablet taking our hospital patients and upper gastrointestinal bleeding situation investigation 関奈緒子1, 和田淳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1155-1155, 2018.

---

	P0551-23-PM. Factor investigation of the drug induced hepatic injury by the clexane 佐々木優1, 曽根麻里奈1, 湯本哲郎2, 稲葉健二郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1156-1156, 2018.

---

	P0553-23-PM. The dose course investigation between the side effect expression of pregabalin group for the neuropathic pain 小田剛史1, 山本諭1, 岩本佳代子1, 柴田千保1, 浅井茂夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1156-1156, 2018.

---

	P0555-23-PM. 1 case of the mixed connective tissue disease that developed an AV block during hydroxychloroquine sulfate remedy 濱走優人1, 小野友加里1, 安高勇気1,2, 兼重晋1, 緒方憲太郎1,2, 氷室尚子3, 三宅勝久3, 中島衡3, 神村英利1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1157-1157, 2018.

---

	P0557-23-PM. The effect that administration before operation of the dexamethasone in the gynecologic operation under laparoscopy gives for nausea post-operative vomiting 伊藤千裕1,2, 大島葵1, 井上岳1,2, 上野哲生3, 松原肇1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1157-1157, 2018.

---

	P0559-23-PM. Analysis of the use situation and the onset of vascular disorder situation of the nicardipine injection in patients with cerebral hemorrhage 綿貫陽一1, 和田麻季子1, 木村麗砂1, 日浦寿美子1, 小林秀樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1158-1158, 2018.

---

	P0561-23-PM. 2 cases that was called off by hypernatremia after the tolvaptan administration, and was given it during the hospitalization again 谷口仁孝1, 小原祐子1, 山本彩佳1, 前川知子1, 千葉恵美子1, 渡邉美樹1, 坂井愛実1, 前田典子1, 水野稜子1, 徳村博子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1158-1158, 2018.

---

	P0563-23-PM. One case with suspected induction of Guillain-Barre syndrome by the etanercept 山本飛翔1, 殿岡久美子2, 前田幹広1, 有木宏宗1, 坂上逸孝1, 高桑由希子2, 川畑仁人2, 田中恒明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1159-1159, 2018.

---

	P0565-23-PM. A false high level case of the blood sugar accepted by pralidoxime iodide (PAM) administration and the consideration 小林由里愛1, 遠藤愛樹1, 花輪和己1, 小林義文1, 山本誠一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1159-1159, 2018.

---

	P0567-23-PM. For the appropriate enforcement of the thyroid function tests in patients receiving amiodarone 井上大樹1, 山口優子1, 上田賢太郎1, 高橋憲二1, 生島五郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1160-1160, 2018.

---

	P0569-23-PM. Efforts for the photo-allergy prevention with the aminolevulinic acid hydrochloride granule in the urology department 高嶋祥匡1, 高橋弘泰1, 大谷寧次郎1, 窪田裕樹2, 畔柳敏弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1160-1160, 2018.

---

	P0550-24-AM. Investigation of the discontinuation situation and the adverse event of anticoagulation, the antithrombocytic agent in the proximal thighbone bone fracture 宇佐美伶奈1, 伊藤匡伸1, 米山英二1, 鈴木真子1, 松下義弘1, 小林恵果1, 岩瀬由枝1, 井野裕美1, 木村友美1, 小口武2, 杉浦洋二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1161-1161, 2018.

---

	P0552-24-AM. Drug causation evaluation of 1 case that sinus bradycardia was induced by the use of carteolol hydrochloride/latanoprost combination eye drops 飯田慎也1, 山本譲1, 大滝康一1,2, 山下恭範1, 小野尚志1, 三嶋一登1, 福土将秀1, 田崎嘉一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1162-1162, 2018.

---

	P0554-24-AM. Example that produced skin necrosis with the blistering during vasopressin a very small amount of sustained intravenous administration for the central diabetes insipidus that occurred by a brain tumor 森永光1, 中川祐紀子1, 坪内清貴1, 中出順也1, 板井進悟1, 加納美優2, 宮下勝吉3, 嶋田努1, 崔吉道1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1162-1162, 2018.

---

	P0556-24-AM. An example of orthostatic hypotension in the use of cyclophosphamide 立花京香1, 後藤健志1, 竹尾恵理子1, 石川真平1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1163-1163, 2018.

---

	P0558-24-AM. Preoperative renin-angiotensin system inhibitor remedy and perioperative hypotensive relative examination 芦田郁実1, 柏宗伸1, 田中玖実1, 増地淳1, 西橋正芳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1163-1163, 2018.

---

	P0560-24-AM. Examination of the onset of hypokalemia time at the amphotericin B administration in children 長谷川彩薫1, 歌野智之1, 文靖子1, 大隅朋生2, 加藤元博2, 富澤大輔2, 松本公一2, 山谷明正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1164-1164, 2018.

---

	P0562-24-AM. Example that accepted free air in abdominal cavity by chronic administration of the tolvaptan 金子睦志1, 渡辺一也1, 篭島正浩1, 高橋祥史2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1164-1164, 2018.

---

	P0564-24-AM. Investigation about the onset of hepatic dysfunction by the high-dose prescription of acetaminophen 小笠原綾香1, 足立智洋1, 真井雄規1, 村上智香1, 石田陽美1, 門脇督1, 土井佳子1, 三本松泰孝1, 佐藤弘康1, 和泉秀明1, 田村広志1, 渡辺浩明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1165-1165, 2018.

---

	P0566-24-AM. Example that the diarrhea symptom that occurred with colchicine of the familial mediterranean fever therapeutic drug improved by the intervention of the pharmacist 内山乃映1, 上田奈緒美1, 山田倭花1, 大窪真理絵1, 中島のぞみ1, 伊代田萌子1, 丸岡浩太1, 梅澤仁美1, 河村紳介1, 小林誠一1, 坂口修治1, 富沢裕之1, 山下敦志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1165-1165, 2018.

---

	P0568-24-AM. Exhaustive analysis of our hospital phlebitis development factor with the periphery drip to be able to put 遠山泰崇1, 井上真1, 福島祐子1, 堀光愛子1, 柴田麻美1, 幸沙和1, 末延裕海1, 新宮裕美1, 福田智哉1, 武石優哉1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1166-1166, 2018.

---

	P0570-24-AM. Evaluation of the Adverse Drug Event detection method using Adverse drug event trigger tool 土肥大典1,2, 平山美津江1, 坂本優介1, 杉本直樹1, 小関信吾1, 川井信孝1, 鍵山智樹2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1166-1166, 2018.

---

	P0571-23-PM. Investigation about the blood hypercoagulability time in Warfarin and the S-1 combination patients 遠藤晋吾1,2, 小竹武2, 石渡俊二2, 井上知美2, 村田彩純2, 小川直希1, 鶴島克将1, 安井友佳子1, 石坂敏彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1167-1167, 2018.

---

	P0573-23-PM. Examination about the concomitant drug which affected the warfarin doses during our hospital hospitalization 千葉里菜1, 佐藤陽介1, 小笠原蓉子1, 西館俊介1, 佐藤圭吾1, 追木正人1, 西和哉1, 佐賀利英1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1168-1168, 2018.

---

	P0575-23-PM. One case that blood level of voriconazole increased under the miconazole gel combination 福田正悟1, 中田英夫1, 石川春樹1, 池谷修1, 木村元範1, 宇賀村文3, ちょ柏松3, 村松博1, 望月眞弓1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1168-1168, 2018.

---

	P0577-23-PM. Blood itraconazole in the lung transplantation patients and tacrolimus levels management under the rifabutin combination 福井彩香1, 中川俊作1, 片田佳希1, 糸原光太郎1, 杉本充弘1, 山本由貴1, 石橋直哉1, 傳田将也1, 深津祥央1, 米澤淳1, 中川貴之1, 長尾美紀2, 野口実紗3, 濱路政嗣3, 青山晃博3, 陳豊史3, 伊達洋至3, 松原和夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1169-1169, 2018.

---

	P0579-23-PM. The effect of antacids to give LDL-C drop effect of the rosuvastatin: Rearward medical record investigation second report 立沢正臣1, 小川竜一2, 金素安1, 金城直樹1, 大久保淳史1, 小山内美樹1, 土屋美香1, 住吉正孝1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1169-1169, 2018.

---

	P0581-23-PM. Effect of esomeprazole giving it to metabolism of proguanil and the vonoprazan 中内佳奈1, 中林勇1, 合田ひとみ1, 舟越亮寛2, 山岸喜彰1, 工藤敏之1, 伊藤清美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1170-1170, 2018.

---

	P0583-23-PM. One case with suspected hypothyroid coma onset by the combination of LT4 preparation and calcium polystyrene sulfonate 甲斐知美1, 梶原洋文1, 玉井文洋2, 生山祥一郎3, 山田雅也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1170-1170, 2018.

---

	P0572-24-AM. The effect that the end of the combination of warfarin and rifampicin gives to PT-INR 安部圭紀1, 五十嵐文1, 山本郁生1, 高橋賢成1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1171-1171, 2018.

---

	P0574-24-AM. The case that showed a rise, subcutaneous haemorrhage of the INR by combination of capecitabine and warfarin 池崎友明1, 坂東翔1, 坂井晴香1, 武内仁美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1172-1172, 2018.

---

	P0576-24-AM. One case that CYP3A4 conduction with rifampicin had a long-term influence on the internal change of voriconazole 和地徹1, 佐々木崇1, 齋藤はるか1, 菅野和1, 小笠原蓉子1, 鈴木雄太1, 小原拓2, 石田雅嗣3, 小林誠一3, 矢内勝3, 佐賀利英1,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1172-1172, 2018.

---

	P0578-24-AM. Examination for the adverse event associated with drug interactions of vincristine and the itraconazole private business liquid 野崎千暁1, 田村賢士1, 金子誠1, 寺田伊知郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1173-1173, 2018.

---

	P0580-24-AM. Example that a neutrophil count decrease in imatinib and clarithromycin by the drug interaction was found in 宮田智陽1, 和佐本諭2, 杉山昌秀1, 篠原佳祐1, 関口展貴1, 渡邊将隆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1173-1173, 2018.

---

	P0582-24-AM. Effect of the vitamin D3 preparation giving it to solubility of celecoxib 高見陽一郎1,2, 武田有紀2, 福島由貴2, 島田倫栄2, 小松原早織2, 浦上知香2, 笹原莉子2, 小川壮寛1, 安倉央1, 江川孝3, 島田憲一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1174-1174, 2018.

---

	P0584-24-AM. 1 case that intervened by ward pharmacist duties and TDM for the interaction of antiepileptic drug and the MAC therapeutic drug 吉川直樹1, 田崎智也1, 畑中真理1, 関屋裕史1, 平原康寿1, 池田龍二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1174-1174, 2018.

---

	P0585-23-PM. Examination of the effect that carvedilol after acute myocardial infarction gives to a left ventricular ejection fraction 齋藤晶仁1, 石田耕太1, 池ノ内浩2, 鈴木憲史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1175-1175, 2018.

---

	P0587-23-PM. Examination of the renal function at the DOAC change of patients with fault valve-related atrial fibrillation in our hospital outpatient department 早坂美希1, 千葉貴志1, 上村新吾1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1176-1176, 2018.

---

	P0589-23-PM. Fact-finding about the apixaban initial dosage in patients with venous thromboembolism 滝田美紀子1, 小林加寿子1, 日浦寿美子1, 小林秀樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1176-1176, 2018.

---

	P0591-23-PM. A use case of the Eppikajutsuto and the effect on herpes zoster treatment 嶋田聖子1, 濱邊秋芳1, 納富貴子1, 有川菜木沙1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1177-1177, 2018.

---

	P0593-23-PM. A use actual situation evaluation in the inhalant and examination of the future evaluation method 西正浩1, 三角ひかる1, 萩原里美1, 東久美子1, 羽田野あゆみ1, 松本健吾1, 坂本一貴1, 畑加奈子1, 向井光一朗1, 松井法子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1177-1177, 2018.

---

	P0595-23-PM. Effective evaluation of the carnitine preparation for the hyperammonemia associated with the cirrhosis 田杭直哉1, 黒田香織1, 近藤匡慶1, 菅谷量俊1, 津久井拓2, 高瀬久光1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1178-1178, 2018.

---

	P0597-23-PM. It is examination about the effectiveness of the pain-killer commuter pass internal use of the fixed quantity in patients after the operation of the knee anterior cruciate ligament reconstruction 恒川朋子1, 土屋篤志1, 長谷川一行1, 武藤達也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1178-1178, 2018.

---

	P0599-23-PM. Examination of the risk factor about retching, vomiting that occurred after the surgery of the orthopedics domain in the Kokura medical center 堀勇太1, 趙成三2, 松尾待池3, 山口泰弘3, 山下愛登4, 坂本峰代3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1179-1179, 2018.

---

	P0601-23-PM. Relation of the pharmacist for the Nusinersen Na intraspinal injection enforcement in our hospital 川谷梨紗1, 徳井志野1, 山口泰弘1, 赤崎大恭1, 中村敦士1, 浦本邦弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1179-1179, 2018.

---

	P0586-24-AM. The effectiveness in the long-term use of the drug elution stent for patients who received percutaneous coronary intervention and safe evaluation 廣田佳美1, 嶋田修治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1180-1180, 2018.

---

	P0588-24-AM. Comparison of the bleeding risk by the clopidogrel start time in patients receiving argatroban 長尾結花1, 高野尊行1, 倉井由香1, 柿沼博子1, 中丸朗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1181-1181, 2018.

---

	P0590-24-AM. Examination of the DIC secession rate in the use of antithrombin gamma case that used recombinant thrombomodulin together 井上大奨1, 濱崎翔平1, 水町純一1, 花田聖典1, 鶴崎泰史1, 中川義浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1181-1181, 2018.

---

	P0592-24-AM. The case that drainage decreased by inhibition of the intestinal tract peristalsis, and an artificial anus trouble improved 古川和弘1, 中山真紀2, 緒方優子2, 唐原和秀3, 鈴田浩孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1182-1182, 2018.

---

	P0594-24-AM. The effectiveness of the colchicine administration in the treatment of postpericardiotomy syndrome (PPS) of children 高藤由紀子1, 齋藤裕里奈1, 長井美樹1, 赤羽三貴1, 真船亮2, 小野博2, 賀藤均2, 山谷明正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1182-1182, 2018.

---

	P0596-24-AM. Study on microRNA associated with a non-alcoholic lipid liver disease 柴山良彦1, 久保儀忠1, 中川勉1, 長野正信2, 藤井暁2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1183-1183, 2018.

---

	P0598-24-AM. Example that conducted pharmaceutical intervention for patients with copper deficiency anemia, and was improved 宮明佑輔1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1183-1183, 2018.

---

	P0600-24-AM. Examination of the effect that the number of the remedy drugs gives in rehabilitation after cerebrovascular disease treatment 高本光次郎1,2, 和田陽介3, 上田昌宏1, 近藤純1, 坂本淳一2, 志方敏幸1, 辻野健2,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1184-1184, 2018.

---

	P0602-24-AM. Intervention to selenium lack, the excretion control in neonates with intestinal tract imperfection 瀬戸口誠1,2, 指宿卓也1,2, 野妻俊也1,2, 武藤充2,3, 大橋宏史2,3, 鈴木恵美子2,4, 久保美佐子2,4, 真方美紀2,5, 福岡龍一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1185-1185, 2018.

---

	P0604-24-AM. Correspondence of our hospital pharmacy for intravenous alimentation-related liver damage (PNALD) 樋口眞宏1,2, 中村優3, 瀬川恵1, 八田理絵2, 山本佳奈子2, 小原史織2, 仁田美由希2, 宇野敦子1, 野村一之1,2, 荒金英樹2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1186-1186, 2018.

---

	P0608-24-AM. Making and operation of the central venous hyperalimentation check sheet 市原航1, 福井宗憲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1187-1187, 2018.

---

	P0603-23-PM. Rearward observational study to examine appetite enhancement effect of olanzapine and the Rikkunshito in our hospital 宮森彩香1, 柳澤京子1, 阿部宏美2, 嶋田健3, 豊田康義4, 森嶋友一4, 加藤一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1188-1188, 2018.

---

	P0605-23-PM. Examination of the risk factor about the onset of hypophosphatemia after the hyperalimentation preparation introduction for the renal failure 兼平暖1, 田邉直人1, 村山暢子1, 入口慎史1, 市橋孟1, 高野浩彦1, 加藤敏明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1189-1189, 2018.

---

	P0607-23-PM. Effect to give to the glycemic control of patients with stroke that sugar adjustment liquid food is complicated with diabetes 茂木孝裕1,2, 鈴木慶介1,2, 木村直也1, 源川良一1, 高橋暁3, 副島誠4, 高橋雅弘5, 越前宏俊5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1189-1189, 2018.

---

	P0609-23-PM. Construction of the simultaneous assay of plasma voriconazole using the column switching LC-MS/MS method and voriconazole N- oxide 山本達郎1, 森木邦明1, 島田美樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1190-1190, 2018.

---

	P0611-23-PM. Examination about the pharmacokinetics of mycophenolic acid in liver-transplant recipients 杉本充弘1, 木全柾典1, 佐藤裕紀1, 糸原光太郎1, 佐藤夕紀1, 中川俊作1, 米澤淳1, 中川貴之1, 穴澤貴行2, 伊藤孝司2, 岡島英明2, 海道利実2, 上本伸二2, 松原和夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1191-1191, 2018.

---

	P0613-23-PM. Rearward investigation about the effect on renal function of the early period of vancomycin doses 田端志帆1, 吉村真理1, 平野陽子1, 前田彩菜1, 末廣陽子1, 新谷智則1, 東高士1, 渡辺享平1,2, 矢野良一1, 塚本仁1, 後藤伸之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1191-1191, 2018.

---

	P0615-23-PM. Factor investigation to have an influence on the initial blood level of the vancomycin hydrochloride 鈴木絢子1,2, 田中広紀3, 柳原麻里1, 池田裕一2,4, 渡邊徹3, 佐々木忠徳3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1192-1192, 2018.

---

	P0617-23-PM. It is evaluated the proper use as a pharmacist intervenes in TDM analysis of vancomycin for patients with blood tumor 原田好子1, 立沢正臣1, 森本景子1, 土屋美香1, 小山内美樹1, 住吉正孝1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1192-1192, 2018.

---

	P0619-23-PM. Efforts to improvement in blood level measurement rate of antiMRSA medicine (vancomycin, Teicoplanin) treated patients and TDM analysis rate 福石和久1, 甲斐達夫1, 坂口晋哉1, 西野隆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1193-1193, 2018.

---

	P0621-23-PM. Examination of the Teicoplanin loading dose in patients with blood tumor 後藤総太郎1, 赤瀬麻希1, 木下理恵1, 石原溶子1, 関谷紀貴2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1193-1193, 2018.

---

	P0610-24-AM. Development of the simple and easy serum mitotane levels assay with the HPLC 若井恵里1,2, 池村健治1, 小田都紀子1, 岩本卓也1,2, 奥田真弘1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1194-1194, 2018.

---

	P0612-24-AM. Report of 1 case that a blood level drop of the sudden Everolimus was found in by taking clotrimazole cancellation 宇野貴哉1,4, 和田恭一3, 松田紗知1, 西野料司1, 竹中裕美1, 寺川伸江1, 老田章1, 高田充隆4, 渡邉琢也2, 熊井優人2, 黒田健輔2, 中島誠子2, 瀬口理2, 簗瀬正伸2, 福嶌教偉2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1195-1195, 2018.

---

	P0614-24-AM. Examination of the vancomycin maintenance doses for the renal function normalcy patients 今西嘉生里1, 中藏伊知郎1, 宮部貴識1, 佐光留美1, 山崎邦夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1195-1195, 2018.

---

	P0616-24-AM. Examination about the parameter at the vancomycin administration in patients with burn 小濱弥眞斗1, 坂本修1, 宇野洋司1, 椙山聡一郎1, 橋本真也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1196-1196, 2018.

---

	P0618-24-AM. Correlation of eGFR and vancomycin clearance (CLVCM) in the cancer-carrying patient 森岡悠紀1, 田中寛之1, 橋下浩紀1, 遠藤雅之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1196-1196, 2018.

---

	P0620-24-AM. Comparison of the blood level in the use of Teicoplanin high dose regimen case 青木洋平1, 恒川朋子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1197-1197, 2018.

---

	P0622-24-AM. A change of the Teicoplanin doses by the guidelines revision in the Kariya Toyota General Hospital and the blood level and future problem 小野沙百合1, 小嶋俊輝1, 柴田大地1, 滝本典夫1, 足立守1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1197-1197, 2018.

---

	P0623-23-PM. Participation of the uptake transporter in cytotoxicity of the ipragliflozin in human keratinocytes HaCaT cells 白土恵理1, 辻本雅之1, 折方琴音1, 辻本美菜1, 松本彩夏1, 田中慎子1, 松下望1, 河渕真治2, 栄田敏之2, 峯垣哲也1, 西口工司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1198-1198, 2018.

---

	P0625-23-PM. Effect of various CYP2D6 inhibitors including the antidepressant on dopamine generation activity by human cytochrome P450 (CYP) 2D6 杉本静也1, 柳井檀1, 山野花織1, 雫真里菜1, 丹羽俊朗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1199-1199, 2018.

---

	P0627-23-PM. Effect by the active testosterone 6 β - hydroxylation by the human cytochrome P450 3A subfamily and endogenous steroid hormone 岡本綾香1, 小林恭子1, 丹羽俊朗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1199-1199, 2018.

---

	P0629-23-PM. Effect of periphery tissue inflammation to give to anesthetic action of the central nervous system depressant 鈴木啓一郎1, 岡田淳芳1, 原啓介2, 松本和也1, 神志那萌子1, 合葉哲也2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1200-1200, 2018.

---

	P0624-24-AM. A non-linear internal change of lithium in the rat: Does saturation of the renal tubular reabsorption with the phosphate transporter cause it? 上井優一1, 川嵜達也1, 鍋倉智裕1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1201-1201, 2018.

---

	P0626-24-AM. Effect of the endogenous steroid hormone on tolbutamide hydroxylation activity by human cytochrome P450 (CYP) 2C9 and CYP2C19 田内和寛1, 安田沙希1, 丹羽俊朗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1202-1202, 2018.

---

	P0628-24-AM. Internal change and efficacy analysis of the diabetes therapeutic drug nateglinide in the acute tissue inflammation condition of a patient 神志那萌子1, 西脇あかね1, 鈴木啓一郎1, 藤本和貴1, 合葉哲也2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1202-1202, 2018.

---

	P0630-24-AM. Predictive precision criteria using the population average parameter of the daptomycin 山科卓也1, 入江健司1, 鶴山萌子2, 丸田基史1, 西尾公志1, 尾上知佳3, 辻泰弘3, 平木洋一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1203-1203, 2018.

---

	P0632-24-AM. The effect that a plasma exchange gives to blood level of fosphenytoin 西田承平1, 林祐一2, 平井啓太3, 小林亮1, 丹羽隆1, 林秀樹1,3,4, 杉山正4, 下畑享良2, 鈴木昭夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1204-1204, 2018.

---

	P0631-23-PM. teceleukin, ch14. for the intractable neuroblastoma Pharmacokinetic study of teceleukin in 18 combination 深谷寛1, 浜田幸宏1, 丸山拓実1, 木村利美1, 伏見咲子2, 仁谷千賀3, 吉村健一4, 河本博5, 原純一3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1205-1205, 2018.

---

	P0633-23-PM. nivolumab exposure evaluation of patients with non-small cell lung cancer in the true clinical practice 岡田章1, 入江慶2,3, 岡田裕2, 秦明登4, 加地玲子4, 鈴木浩史1, 福島昭二3, 永井尚美1, 片上信之4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1206-1206, 2018.

---

	P0635-23-PM. One case receiving the warfarin after the small intestine total excision 栗島彬1, 林基高2, 飯島明2, 小山洋伸3, 山形誠一3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1206-1206, 2018.

---

	P0636-24-AM. Efforts to improvement in inhalational maneuver utilizing regional alliances 山本圭祐1, 石塚友一1, 河野雅人2, 宮下晃一2, 廣瀬勝也1, 鈴木理恵1, 笹野知海1, 澤昇平1, 三木良浩2, 橋本大2, 中村秀範2, 矢部勝茂1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1207-1207, 2018.

---

	P0638-24-AM. Report about the regional alliances activity that Kurashiki center hospital pharmacy works on 阿曽沼和代1, 徳田衡紀1, 赤木晋介1, 高柳和伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1208-1208, 2018.

---

	P0640-24-AM. Role of the discharge support by the ward pharmacist in our hospital 持田知志1, 佐藤晃1, 池田舞1, 中野里美1, 平島麻由美1, 堀竜2, 堀裕貴也3, 齊藤幹夫4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1208-1208, 2018.

---

	P0642-24-AM. Parenteral injection administration case for the home care patient in our drugstore 秋元義幸1, 玉井典子2, 尾崎裕一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1209-1209, 2018.

---

	P0644-24-AM. Intervention to patients with dementia in the treatment at home 宗岡美紗1, 浅野陽子1, 日高良昌1, 岡敦子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1209-1209, 2018.

---

	P0646-24-AM. In attitude survey - at-home medicine about the vital sign collection by the pharmacist and the effect on medical therapy of the examination for dip stick - 柳本ひとみ1, 櫻井秀彦2, 古田精一1, 黒澤菜穂子3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1210-1210, 2018.

---

	P0648-24-AM. Factor to have an influence on the test result report submission to the drugstore by patients 清水紗弥香1, 佐藤秀昭1, 富岡佳久2, 中村哲也3, 小田慎3, 大木稔也1, 今井博久4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1210-1210, 2018.

---

	P0650-24-AM. About the situation of hospital pharmacist duties before and after the drugstore opening of an office in the site and a future problem 郷原学1, 山藤千晶1, 俵早紀1, 山崎祐子1, 赤石憲俊1, 大谷崇仁1, 村上裕葵1, 大霜玲子1, 脇浦勇樹1, 宅江孝修1, 吉田勝好1, 田原明子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1211-1211, 2018.

---

	P0637-23-PM. Construction - of the interactive information sharing system using regional alliances - medication reporting about the inhalational instruction 松元芽久美1, 山本圭城1, 面谷幸子5, 河村亜美1, 柳澤有子1, 大谷典子1, 宇高歩1, 宮川道英4, 石坂敏彦2, 郷間厳3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1212-1212, 2018.

---

	P0639-23-PM. Improvement effect of the doubt introduction duties with the efforts (the sixth report) for joint medical treatment (CDTM) in the community medical care positive list 小川壮寛1, 松下明2, 守安洋子1, 山崎桃子1, 懸山啓太1, 河南真依1, 田中綾1, 中尾直1, 江川孝3, 島田憲一4, 高見陽一郎1, 高橋正志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1213-1213, 2018.

---

	P0641-23-PM. At-home support and information sharing ... in connection with practice and evaluation - pharmacy service under health insurance drugstore of the conference before discharge that aimed at the seamless medical therapy 満田正樹1, 尾崎加織1, 松本篤1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1213-1213, 2018.

---

	P0643-23-PM. Protect patients making use joining information of the hospitalized medicine together; is reporting book ... between 2 ... institutions 川村大輔1, 久岡清子1, 増田博也1, 澤口友紀1, 亀岡喬1, 鹿沼奈央1, 大荒政志1, 吉川真央1, 松浦亜梨紗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1214-1214, 2018.

---

	P0645-23-PM. Shift to being at home of the cancer terminally ill patients 吉川三保子1, 玉田太志1, 平木精一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1214-1214, 2018.

---

	P0647-23-PM. About the diachronic intervention contents of the drugstore pharmacist in the treatment at home 杉浦聡1,2, 北村佳久1, 高橋正志2, 千堂年昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1215-1215, 2018.

---

	P0649-23-PM. Competitive review about the collection situation of the drug information in Hokkaido District and drugstore pharmacists of the whole country 梅田純代1, 柳本ひとみ2, 古田精一2, 黒澤菜穂子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1215-1215, 2018.

---

	P0651-23-PM. About promotion of the medicine medicine cooperation in our hospital 河原香織1, 太田あづさ1, 西窪奈津子1, 塩田恵1, 吉田直恵1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1216-1216, 2018.

---

	P0653-23-PM. Efforts and questionnaire evaluation of the medicine medicine cooperation in the Ichinomiya City municipal hospital 染原渉1, 浅野祥子1, 亀重貴弘1, 三浦愛美1, 杉野善彦1, 川瀬洋次1, 吉田昌子1, 堀田敏之1, 桜田宏明1, 山村益己1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1217-1217, 2018.

---

	P0655-23-PM. Is the protocol utilization effective for a hospital and the cooperation of the health insurance pharmacy? 高橋友里1, 金子実央1, 津田尚始1, 夏目義明1, 伊藤由美2,8, 高橋雄大3,8, 杉浦早紀4,8, 高木健司5,8, 市川浩6,8, 坂本悟7,8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1217-1217, 2018.

---

	P0657-23-PM. Introduction and the multi-type of job cooperation of the heart failure community medical care cooperation pass in our hospital 廣田あゆ子1, 藤江郁1, 新城唯1, 藤茂登希2, 加藤礼子2, 東郷和美3, 松川彰4, 橘大輔5, 福家聡一郎6, 齋藤博則6,7, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1218-1218, 2018.

---

	P0659-23-PM. Examine illness in making and whole city operation - Takarazuka-shi of the glaucoma seal; medicine scrum - 石居美和1, 辻隆志1, 笹岡幸夫2,3, 柴田哲夫3,4, 松井眞理子1, 尾形公子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1218-1218, 2018.

---

	P0661-23-PM. Efforts aiming at qualification of the cancer treatment authorization pharmacist foreign by regional alliances 袰岩靖子1, 熊谷史由1, 高松謙1, 羽川典江1, 伊藤美子2, 新谷裕子2, 岩倉大介2, 菅野和彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1219-1219, 2018.

---

	P0663-23-PM. About the instruction to patient cooperation with the health insurance pharmacy including the XELOX therapy 安藤志帆1, 豊田真史1, 若林千草1, 川島千夏1, 夏目真美2, 益子里美3, 松本啓一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1219-1219, 2018.

---

	P0665-23-PM. About the use situation of the electronic edition prescription notebook in the Himeji Branch 田中美早1, 櫛田宏幸1, 森保貴典2, 藤田佳典2, 浦上文男2, 砂金秀美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1220-1220, 2018.

---

	P0667-23-PM. An evaluation and problem of the tracing report utilization situation in our hospital 近藤智彦1, 粟野萌1, 上林愛1, 木村匡男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1220-1220, 2018.

---

	P0669-23-PM. About a method of the reporting to the health insurance pharmacy 清水けいこ1, 細川朋弘1, 美濃佳代子1, 三輪あゆみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1221-1221, 2018.

---

	P0671-23-PM. Doubt inquiry contents analysis from the pharmacy service under health insurance drugstore for the outside Parliament prescription 守内匡1, 守内典子1, 田中治1, 冨岡美悠1, 松井ひろみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1221-1221, 2018.

---

	P0673-23-PM. Efforts of the doubt inquiry simplification protocol based on the agreement of a health insurance pharmacy and the hospital 木下隆市1, 山崎友里絵1, 廣田等1, 染谷光洋1, 谷口亮央1, 中島史雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1222-1222, 2018.

---

	P0677-23-PM. Efforts for the discharge instruction reinforcement in our hospital 馬場啓貴1, 馬場親紀1, 中村一成1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1223-1223, 2018.

---

	P0679-23-PM. The current situation investigation after the clinical test value mention start to outside Parliament prescription 村田諭1, 夘月博和1, 平野享1, 大木孝夫1, 秋山明美2, 中村祐大3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1223-1223, 2018.

---

P0681-23-PM. Unification and evaluation ... of the efforts - kidney, liver function test value-related inquiry standard for the inflection of the outside Parliament prescription with the test value by the collaboration with the neighborhood drugstore 中村健一1, 寺谷俊昭1, 辻本高志1, 末永美由紀1, 大下直宏1, 加納宏樹1, 高橋強1, 上田晃1, 川本由加里1, 後藤仁和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1224-1224, 2018.

---

	P0652-24-AM. Efforts of the medicine medicine cooperation that aimed at the seamless relaxation medical care from a hospital to being at home from a hospital 八本久仁子1,2, 大棚貴史3,4, 永田博幸3,5, 吉田弘太郎2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1225-1225, 2018.

---

	P0654-24-AM. Efforts to medicine medicine cooperation by the patients follow-up system construction 高島伸也1, 牧陽介1, 村田雅子2, 鈴山直人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1226-1226, 2018.

---

	P0656-24-AM. Dermatopathy management utilizing the medicine medicine cooperation 浦川龍太1,2, 橋本早苗3, 廣畑秀記3, 酒井克紀3, 松浦佳代4, 福田英克3, 南波勝栄3, 上島悦子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1226-1226, 2018.

---

	P0658-24-AM. Efforts of the authorized system aiming at standardization of the pediatric inhalational instruction 大野愛1, 桑村彩加1, 井上智喜1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1227-1227, 2018.

---

	P0660-24-AM. About the study operation of the internal use anticancer medicine check seat 牧陽介1, 村田雅子2, 末長芽以1, 緒方康之3, 宇土隆4, 鈴山直人1, 高島伸也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1227-1227, 2018.

---

	P0662-24-AM. Attitude survey about the division formulations of the long-term prescription of patients receiving cancer chemotherapy 鈴木洋子1, 小田慎2, 大木稔也1, 神隆浩1, 阿蘇拡樹1, 今井博久3, 佐藤秀昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1228-1228, 2018.

---

	P0664-24-AM. It is telephone hearing ... by ... insurance pharmacist about side effect of medicine medicine cooperation monitoring of the oral anticancer medicine 菱沼隆一1, 三田恭平1, 長谷康史1, 荒木良介1, 井上邦彦2, 岡本大介3, 土井瑛博4, 山田英紀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1228-1228, 2018.

---

	P0666-24-AM. Comparison in the operation of the medication reporting book with EHR and the FAX 小川充恵1, 植田真理1, 井上麻衣1, 山崎肇1, 小枝伸行2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1229-1229, 2018.

---

	P0668-24-AM. Inflection case study of the tracing report in our center 岩西雄大1, 角川幸男1, 川田知加1, 濱谷佳名子1, 下辻恒久1, 高木麻里1, 金銅葉子1, 坂上嘉浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1229-1229, 2018.

---

	P0670-24-AM. Efforts for the "pharmacy management summary" for patients information sharing operation 大内友季江1, 安達寛成1, 佐藤千穂1, 番匠理絵1, 遠藤武弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1230-1230, 2018.

---

	P0672-24-AM. Doubt inquiry from the health insurance pharmacy and inquired efficiency and the effect 山口美樹1, 渡嘉敷俊介1, 山内拓1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1230-1230, 2018.

---

	P0674-24-AM. Examination of an effect and the problem of the Residual medicine adjustment in the doubt inquiry simplification protocol 齋田正和1, 廣瀬浩一1, 松井健一1, 下村真野1, 高橋理寛1, 岡本智枝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1231-1231, 2018.

---

	P0676-24-AM. Holding and the current situation investigation of the pharmaceutical cooperation combination study session for polypharmacy measures by the questionnaire 秋山恵里1, 木村丈司1, 山本和宏1, 飯田真之1, 藤田弥佐1, 清水倫子1, 久保萌子1, 住吉霞美1, 番匠咲帆1, 三島唯1, 戸田飛鳥1, 宇田篤史1, 矢野育子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1231-1231, 2018.

---

	P0678-24-AM. The current situation investigation about mention contents of the prescription notebook in the discharge instruction 塚田寛子1, 塚田正之2, 山下典子1, 山脇一浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1232-1232, 2018.

---

	P0680-24-AM. New approach not to put test value on a prescription 設樂誉1, 設樂美紗子1, 千葉光1, 阿部優1, 鈴木康弘1, 佐藤真凡1, 熊谷智惠子1, 佐藤昌博1, 齋藤利彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1232-1232, 2018.

---

	P0682-24-AM. Problem of our hospital for the revision model core curriculum introduction in the pharmacy business training 山下花南恵1, 鎌田里紗1, 松岡勇作1, 池末裕明1, 奥貞智1, 室井延之1, 橋田亨1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1233-1233, 2018.

---

	P0684-24-AM. Fix the eyes on hospital business training in conformity with revision core Cali; and evaluation - of making and the trial training of the - lube Rick evaluation list 國津侑貴1, 上田智弘1, 増田恭子1, 平大樹1,2, 森田真也1, 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1234-1234, 2018.

---

	P0686-24-AM. Current situation investigation - of the super acute phase ward training using upbringing 17th report - text mining of the pharmacist carrying the next generation 平松未智瑠1, 大川恭昌1, 川端崇義1, 田坂健1, 大月理恵子1, 井上知美1, 井上誠子1, 川西秀明1, 久保和子1, 猪田宏美1, 北村佳久1, 千堂年昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1234-1234, 2018.

---

	P0683-23-PM. Base construction of the pharmacy education system for the revision model core curriculum accomplishment 菊地未由1, 大友眞菜1, 星野祐太1, 渡邊卓嗣1, 菅野和彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1236-1236, 2018.

---

	P0685-23-PM. Analysis - from medical therapy for 8 representative disease experience situation in upbringing 16th report - drugstore, the hospital business training of the pharmacist carrying the next generation 久保和子1, 猪田宏美1, 小川瑶子1, 北村佳久1, 千堂年昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1237-1237, 2018.

---

	P0687-23-PM. Efforts ... of the training introduction about upbringing 18th report - postoperative pain management of the pharmacist carrying the next generation 槇田崇志1, 森下陽介1, 晴田佑介1, 浅澤大樹1, 国富泰介1, 川島理沙1, 猪田宏美1, 久保和子1, 岡崎昌利1, 北村佳久1, 千堂年昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1237-1237, 2018.

---

	P0689-23-PM. ... that we do it exaggeratedly if making (the third report) - oneself of the lube Rick evaluation in the checking prescription thinks about the approximate age, and praising it is just good 渡邉正教1, 日比徹1, 中沢修司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1238-1238, 2018.

---

	P0690-24-AM. Consciousness change of the pharmacy student for the medical care in remote area by the on-site training 吉岡三郎1, 岡祥太郎1, 瀬川正昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1239-1239, 2018.

---

	P0692-24-AM. Practice of the multi-type of job cooperation education in the pharmacy school that does not have a medical system department: Stage, continuous educational program 野田幸裕1,6, 半谷眞七子2,6, 末松三奈3,6, 岡崎研太郎3,6, 高橋徳幸3,6, 福井愛子2, 亀井浩行2, 渕田英津子4,6, 阿部恵子5,6, 吉見陽1,6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1240-1240, 2018.

---

	P0694-24-AM. The effect that the distribution continuation of the information paper for student, protectors and the holding of the business trip conference give to the pharmaceutical products education supplement, and the like to a junior high student 仲田里穂1, 喜友名侑舞1, 岡本晃典1, 大柳賀津夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1240-1240, 2018.

---

	P0696-24-AM. Because is sports fur better strike "; an activity and the future with" meaning to conduct 杉山育美1, 佐塚泰之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1241-1241, 2018.

---

	P0691-23-PM. Usefulness of the training about a prior learning "evaluation of the medical treatment based on the case" for the hospital business training 飛田夕紀1, 平山武司2, 川野千尋2, 厚田幸一郎2, 黒山政一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1242-1242, 2018.

---

	P0693-23-PM. Current situation - of the study on basic social skill -4 annual student sought by a new face pharmacist 中尾幸代1,2, 村田明子1,3, 松田裕子1, 南恵理子1,4, 山中智香1,5, 沼田千賀子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1243-1243, 2018.

---

	P0695-23-PM. A study on non-language communication: Examination of distance, the angle between optimal patients - pharmacists using the autonomic nerve usability test 立松紗枝1, 仲山千佳1, 宮地佑佳1, 大嶋耐之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1243-1243, 2018.

---

	P0697-23-PM. Efforts of the sports fur better strike through the anti-doping lecture for the high school student athlete 遠藤進一1, 中村健志1, 玉木宏樹1, 西村信弘1, 直良浩司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1244-1244, 2018.

---

	P0698-24-AM. Progress and package insert comparison of the genome biomarker study on severe drug eruption in the laboratory of national keep 斎藤嘉朗1,2, 今任拓也1, 佐井君江1, Research Group Jsar2, 中村亮介1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1245-1245, 2018.

---

	P0699-23-PM. Effect on temperament, character that Synaptic Vesicle Protein 2A genetic polymorphism gives 守屋友加1, 白井麻奈1, 杉浦礼菜1, 森理乃1, 平川菜実2, 齋藤邦明2, 鍋島俊隆2, 毛利彰宏2, 今西宏之3, 伊東亜紀雄1, 黒野俊介1, 松本修一1, 長谷川洋一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1246-1246, 2018.

---

	P0700-24-AM. 1 case that worked on the delivery of the HIV infection pregnant woman who became pregnant by freeze thaw embryo transplantation by the multi-type of job 住吉健太1, 冨田淳子1, 加地雅人1, 田中裕章1, 元木貴大1, 小坂信二1, 窪田良次2, 芳地一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1247-1247, 2018.

---

	P0701-23-PM. It is ... mainly on an example about analysis - HIV infection of the exposure accident in our hospital 大道淳二1, 石橋真実1, 横田幸子1, 佐久川亮2, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1249-1249, 2018.

---

	P0703-24-PM. An investigation and inspection of the incident report before and after the simple suspension method manual revision 山本理香子1, 湯浅周1, 壁谷めぐみ1, 近藤奈央子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1250-1250, 2018.

---

	P0705-24-PM. We effectively utilize it with the current situation of the dead stock psychotropic drug 中村武夫1, 蒲谷亘2, 増田信也2, 佐藤優子2, 木村えり2, 近澤生2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1251-1251, 2018.

---

	P0707-24-PM. Effect accompanied with the trend of the use of selected patients drug in our hospital and the change of the application method 藤田謙1, 大竹満博1, 鐘司光貴1, 菅原克也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1251-1251, 2018.

---

	P0709-24-PM. Examination of the modi operandi in the cool place medicine inventory control system introduction using an IC tag 堀尾秀明1, 立田愛実1, 林宏樹1, 櫻井愛菜1, 福岡麻実1, 平野茂樹1, 戸田康裕1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1252-1252, 2018.

---

	P0704-25-AM. Intervention to fact-finding and quality control of the pharmaceutical products management in inside the hospital 笠井翼1, 榊原伸1, 佐藤大輔1, 安田知弘1, 水谷麻希子1, 天野杏南1, 木全司1, 木下元一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1253-1253, 2018.

---

	P0706-25-AM. Consideration about fact-finding and adequacy measures of pharmaceutical products management, the giving and receiving in the drugstore 長谷川洋一1, 赤川圭子2, 中尾裕之3, 今井博久4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1254-1254, 2018.

---

	P0708-25-AM. Evaluation of the operability of the new packing container (medication support container) of the tablet 永井晶大1, 内田信也1, 柏倉康治1, 石坂優佳1, 田中紫茉子1, 鈴木寛2, 山内克哉2, 伊藤譲3, 並木徳之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1254-1254, 2018.

---

	P0710-25-AM. Duties improvement investigation by the storage of designated medicine injection ordering management system introduction 朝岡裕樹1, 笹尾武史1, 神谷洋子1, 川澄清孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1255-1255, 2018.

---

	P0715-24-PM. Evaluation of the analysis of the incident about the drug for the medical care and the measures 戸田陽香1, 井門敬子1, 乗松真大1, 飛鷹範明1, 田中守1, 田中亮裕1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1257-1257, 2018.

---

	P0717-24-PM. Efforts of our hospital for the potentially serious medical errors and future problem 近藤健太1, 近藤倫成1, 杉本恵理1, 青孝明1, 寺田雄亮2, 木村匡男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1258-1258, 2018.

---

	P0719-24-PM. Inspection of drug duties based on JCI certification update 三浦篤史1, 鬼窪利英1, 中野和佳1, 中村久美1, 上條泰弘1, 伊藤隆哉1, 高木洋明1, 細川理博1, 荻無里千史2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1258-1258, 2018.

---

	P0721-24-PM. Association of a fall, a fall and the use drug in the inpatient 友寄旬1, 松木有莉1, 荒川桃子1, 八幡弘子1, 中村裕一1, 田中悠季1, 飛澤国広1, 小原秀治1, 伊藤香苗2, 小原郁司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1259-1259, 2018.

---

	P0723-24-PM. Fall rate investigation in the classification of the sleeping drug 八木遥1, 山本義貴1, 臼窪一平1, 中村友香1, 下山あさ子1, 東修司1, 田畑裕和1, 稲垣育宏1, 小寺隆二1, 柴波明男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1259-1259, 2018.

---

	P0725-24-PM. Suvorexant for the purpose of the reduced risk of a fall, the fall, introduction effect of S zopiclone 野村洋恵1, 塚本裕貴1, 川崎千尋1, 大田典正1, 後藤紅音1, 園田佳保里1, 福田浩之2, 二神咲子1, 山田正紀1, 由井薗陽一1, 槇林智子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1260-1260, 2018.

---

	P0727-24-PM. Participation in planning to efforts - medical care security to tube self withdrawal, delirium-related risk reduction: ... which tests medical therapy from the viewpoint of the pharmacist 柴田博子1, 横田聖子1, 兵頭純子1, 永井佳代2, 西田真由美3, 西脇正美3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1260-1260, 2018.

---

	P0729-24-PM. Efforts for the proper use of the sedative in the Fujita Health University Hospital 加藤さや香1, 榊原有季子1, 加藤滉基1, 守作美咲1, 福永綾奈1, 桑原碧1, 大島晴佳1, 山田成樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1261-1261, 2018.

---

	P0731-24-PM. Effect of pharmaceutical products safety measures in the medical safety management center placement of the manager for pharmaceutical products safety management 澤野純子1,2, 井上美樹1, 藤井一美1, 植田忠一1, 塩賀朋子2,3, 安井友佳子1, 石坂敏彦4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1261-1261, 2018.

---

	P0733-24-PM. Report of the pharmaceutical intervention in the decreased renal function patients 松石裕也1, 宮下裕央1, 津曲恭一1, 大津貴寛2, 北島久義1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1262-1262, 2018.

---

	P0735-24-PM. Do-it-yourself importing and health hazard of the ethical drug for the purpose of the disease therapeutic drug 岸本桂子1, 福本真理子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1262-1262, 2018.

---

	P0714-25-AM. Efforts to prevention of incident occurrence about the hospitalized self-care medicine by the collaboration with the nurse 鵜飼茜1, 松村若菜1, 新海大智1, 粟田浩文1, 土井裕一1, 澤田和久1, 奥平正美1, 鈴木鏡穂2, 鈴木真由美2, 杉浦洋二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1264-1264, 2018.

---

	P0716-25-AM. Count and analysis about the formulations incident of level 0 和田芙由子1, 吉田和子2, 篠原裕1, 矢作紘子1, 則武隆佑1, 山本明璃1, 蒲原範子1, 水沼知彦1, 米本佳代1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1264-1264, 2018.

---

	P0718-25-AM. About securing of risk accompanied with the once quantity input change and appropriate prescription order 室井政子1, 柴田昌彦1, 橋本佑香1, 岩本明日香1, 綛谷哲也1, 岩田浩幸1, 的場美香1, 山東真寿美1, 吉田智江1, 田中恵美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1265-1265, 2018.

---

	P0722-25-AM. Fact-finding of a fall example and the use drug in our hospital 永松美穂1, 松原美紀1, 長内佐斗子2, 石田耕太1, 加藤啓一3, 鈴木憲史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1266-1266, 2018.

---

	P0724-25-AM. The fall prophylaxis of the inpatient by the proper use promotion of the sleeping drug and the evaluation 大谷道輝1, 稲川覚子1, 信澤弘美1, 松元美香1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1266-1266, 2018.

---

	P0726-25-AM. Examination about the usefulness of the suvorexant judging from a fall rate 伊藤夕貴1, 高岡龍蔵1, 藤井智美1, 伊藤裕美子1, 杉村聡1, 遠山幸男1, 久田達也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1267-1267, 2018.

---

	P0728-25-AM. Can you use the companies prefilled syringe with a terfusion small size syringe pump? - Second report - 荒川昌史1, 高倉祐希1, 羽金智彦1, 小林亮1, 須藤俊明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1267-1267, 2018.

---

	P0730-25-AM. Epidemiologic study about the taking inpatient factor to affect it to be wrong 小久保友美1, 杉本崇1, 中村安孝1, 永山勝也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1268-1268, 2018.

---

	P0732-25-AM. It is Hospital Evaluation of function general hospital 1 <3rd G from a viewpoint of the medical security: Ver. Efforts of 2.0> auditee 田原雅子1, 平昭圭介1, 花田徳子1, 新谷茂之1, 熊本拓也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1268-1268, 2018.

---

	P0734-25-AM. The current situation of the proper use in the outside Parliament prescription of the drug requiring a renal function evaluation 小川実華1, 金城俊之介1, 坂本拓也1, 土佐直子1, 小川洋司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1269-1269, 2018.

---

	P0736-25-AM. Effect of the dispensing error reduction by the analysis of the medical accident to occur in pharmacy and the introduction of the bar code authentication system 木村洸1, 北村智哉1, 村山慶2, 益本周治1, 亀井健人1, 徳田衡紀1, 高柳和伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1270-1270, 2018.

---

	P0738-25-AM. The example that formulations recorder was useful in the formulations act 上田紘子1, 戸田史恵1, 山中佑合子1, 高安敏子1, 浦川龍太1, 上田幹子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1271-1271, 2018.

---

	P0740-25-AM. Design of the aluminum pillow packing product for the purpose of the improvement in workability at formulations 溝江拓人1, 西田雅也1, 荻野哲也2, 大村朋幸1, 鈴木徹也1, 杉本昌陽1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1271-1271, 2018.

---

	P0742-25-AM. Research for the usability of the new tablet packing ESOP (easy seal open pack) and the improvement 佐藤夕紀1, 梨本俊亮2, 武隈洋2, 平野卓哉3, 野田敏宏3, 須田範行4, 井関健4, 盛本修司5, 菅原満2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1272-1272, 2018.

---

	P0744-25-AM. Correlative evaluation of taste bitter and the properties of matter of the list of essential drugs publication drug for children in WHO 原口珠実1, 小島穂菜美1, 村上絢香1, 堀恵里加1, 西川知花1, 井上穂南1, 吉田都1, 内田享弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1272-1272, 2018.

---

	P0746-25-AM. Making of a dissolution conversion table and the injection instructions book template for the preparation wrong prevention of the injection antimicrobial in the pediatric ward 古庄弘和1, 陣上祥子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1273-1273, 2018.

---

	P0748-25-AM. Analysis of the reuse, disposal of return of goods medicine situation and future efforts 岩田真子1, 貝瀬眞由美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1273-1273, 2018.

---

	P0737-24-PM. The study on factor to give it to malpractice: About picking work 大西正文1, 竹内正幸1, 長芝計代1, 島田博之1, 木下功1, 水野まい2, 宮地佑佳2, 仲山千佳2, 斎藤寛子1, 大嶋耐之2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1274-1274, 2018.

---

	P0739-24-PM. Compounding of medicines duties efficiency by the powdered medicine formulations robot DimeRo introduction 船田茜1, 石塚仁保1, 尾形朱史鈴1, 坂本和央1, 北川裕也1, 樋浦一哉1, 飛澤国広1, 小原秀治1, 小原郁司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1275-1275, 2018.

---

	P0741-24-PM. Questionary survey for the development of the oral solution single remedy container for children 渡邉穣1, 成光大紀1, 岩田梨江1, 三輪朋也1, 濱田光宏1, 三田村しのぶ1, 菊田真穂1, 高田雅弘1, 首藤誠1, 垣野由佳理2, 菱川慶裕2, 山下伸二3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1275-1275, 2018.

---

	P0743-24-PM. Examination of the usefulness of the simple suspension method using the vortex 野口智宏1, 山内浩子1, 馬見新ちとせ2, 八木秀明1, 小杉雅史3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1276-1276, 2018.

---

	P0745-24-PM. Usefulness evaluation of the flavor enhancing peptide as the taste bitter inhibitor of the drug 内田享弘1, 森本栞1, 春名麻美1, 小島穂菜美1, 原口珠実1, 吉田都1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1276-1276, 2018.

---

	P0747-24-PM. Fact-finding of the germfree mixed preparation duties of the injection drug by the pharmacist 榎本英明1, 大森崇行1, 阿部猛1, 川名賢一郎1, 後藤一美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1277-1277, 2018.

---

	P0749-24-PM. About the fact-finding of doubt inquiry aiming at the safety improvement of patients 加藤佑治1, 田中昌代1, 上田文子1, 河野真由1, 高野浩彦1, 加藤敏明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1277-1277, 2018.

---

	P0750-25-AM. Properties of matter of the methylcellulose solution which made a drug suspended 下山哲哉1, 田辺将1, 伊藤邦彦1, 小林道也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1278-1278, 2018.

---

	P0752-25-AM. An example of the salivary hypersecretion in the seriously disabled child treated effectively with scopolamine ointment 下村香菜1, 田村賢士1, 藤村裕司1, 菊池健樹1, 木口智之2, 寺田伊知郎1, 下平雅之2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1279-1279, 2018.

---

	P0754-25-AM. Use fact-finding of the Yokukansan bougie 横田睦美1, 高橋直也1, 阿部千秋1, 岩堀真弓1, 及川華代1, 田畑裕和1, 稲垣育宏1, 小寺隆二1, 柴波明男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1279-1279, 2018.

---

	P0756-25-AM. Clinical preparation (hospital preparation) - based on suggestion - PDCA cycle from the Academy of Pharmaceutical Science and Technology, Japan clinical preparation focus group 花輪剛久1,9, 山内仁史2,9, 米持悦生3,9, 河野弥生1,9, 百賢二4,9, 宮嵜靖則5,9, 中島孝則6,9, 小林賢滋7,9, 笹津備尚3,9, 河田圭司8,9 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1280-1280, 2018.

---

	P0751-24-PM. Usefulness and safety of the ulinastatin vagina bougie for the early or threatened labour 佐竹清1,2, 岩田政則2, 中島孝則2, 宮本純孝3, 中村学3, 安藤昭彦3, 町田充1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1281-1281, 2018.

---

	P0753-24-PM. Evaluation of preservation stability of the 8% hydroquinone ointment and properties of matter 大野修司1, 山内理恵1, 金子加奈1, 斉藤和花1, 久保元1, 竹場和代2, 小林稔2, 川崎智子2, 北岡晃2, 浅井和範1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1282-1282, 2018.

---

	P0755-24-PM. Examination of the use of incompetent water effectiveness to be able to put of the persimmon to the intractable hiccups patients 五井はるか1, 鷲見実咲1, 川田彰彦1, 藤井梨沙1, 佐々木崇1, 西和哉1, 及川崇紀2, 成川孝一2, 加藤量広2, 佐賀利英1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1282-1282, 2018.

---

	P0757-24-PM. About bacteria pollution after dividing it of ω 3 system fatty acid preparation (Omegaven) 洲脇薫1, 下村祥子1, 中家清隆2, 中村安孝1, 大西聡3, 濱崎孝史3, 掛屋弘2, 永山勝也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1283-1283, 2018.

---

	P0758-25-AM. The establishment of the enforcement system of ward drug duties and the evaluation 小川紗知1, 譲原千広1, 波多晶子1, 中澤美樹子1, 橋爪和恵1, 窪田真弓1, 鶴居勝也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1284-1284, 2018.

---

	P0760-25-AM. It is ... for the visualization of ... ultimate about efforts and the result of ward drug duties of the municipal Otsu Municipal Hospital 神原諒1, 山中理1, 中山英夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1285-1285, 2018.

---

	P0762-25-AM. The system construction and effect for the improvement of pharmaceutical instruction 佐多照正1, 堀之内志織1, 中松穂菜美1, 鶴永大貴1, 中村有莉恵1, 堀内智裕1, 赤星真広1, 上原友美1, 池増鮎美1, 吉井美保2, 徳重浩一3, 西島浩雄2,3, 前之原茂穂3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1285-1285, 2018.

---

	P0764-25-AM. About effect to give patients satisfaction and medication adherence by the medication counseling 大登剛1, 土屋裕伴1, 諸橋賢人1, 日野亜莉沙1, 塩野このみ1, 師藤成美1, 齋藤由貴1, 青島彩香1, 中村友真1, 梁瀬加寿子1, 新井亘1, 増田裕一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1286-1286, 2018.

---

	P0766-25-AM. Medical treatment management (PBPM) introduction and evaluation based on the protocol in the division of cardiovascular disease ablation treatment 村木佑子1, 澤海健作1, 金高悠哉1, 山口春奈1, 長谷川芳裕1, 佐々木豪貴1, 増田宏章1, 佐藤康弘2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1286-1286, 2018.

---

	P0768-25-AM. Efforts for the reporting of the QT prolonged patients for physicians, and the like 石原裕介1, 伊藤太一1, 陶山裕平1, 原妃紗子1, 原直之1, 安食健一1, 横手克樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1287-1287, 2018.

---

	P0770-25-AM. Fact-finding of the discontinuation management before operation for antithrombotic drugs 三崎桃子1, 宮崎元康1, 松尾宏一1, 内山将伸1, 中島章雄1, 高瀬友美1, 今給黎修1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1287-1287, 2018.

---

	P0772-25-AM. The effect second report that the involved site of patients with cerebrovascular disorder gives for medication self-discipline 藤原久登1,2, 後藤慧也3, 田中絵里子1, 高木桂子1, 泉真由美1, 東野真弓2, 中村彰子2, 須永登美子2, 川手信行4, 川添和義3, 渡邊徹2, 佐々木忠徳2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1288-1288, 2018.

---

	P0774-25-AM. The need of one and the pharmacist in the medical treatment ward successful by the pharmacist intervention for the medical treatment ward patients who detected a sleep disorder 篠原裕1, 小滝和代2, 田畑美海2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1288-1288, 2018.

---

	P0776-25-AM. About a comparison with examination of the periarticular cocktail for the Total Knee Arthroplasty in our hospital and the continuous epidural analgesia 栗崎貴啓1, 相方靖史2, 井上雅文3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1289-1289, 2018.

---

	P0778-25-AM. Efforts for the general electrolyte abnormality in the middle scale hospital 清水忠洋1, 浅川真由美1, 浅川杏子1, 城綾香1, 齊藤安昌1, 曾根原亘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1289-1289, 2018.

---

	P0780-25-AM. It is examination of becoming it assessment improvement of high-risk medicine 池田理沙1, 中田一孝1, 山本美沙1, 森住誠1, 坂井建樹1, 橋本佑樹1, 須原良海1, 本間暢1, 白石祐子1, 石原美加1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1290-1290, 2018.

---

	P0782-25-AM. Establishment of efforts and duties to polypharmacy in our hospital 木下照常1, 柴田大地1, 菅原さやか1, 伊藤有美1, 宮田知世1, 木村優里1, 本間崇正1, 足立守1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1290-1290, 2018.

---

	P0784-25-AM. Efforts for the drug global assessment adjustment addition calculation in the existence floor medical office 渡部直樹1, 宮田恵里子1, 布谷直美1, 三道悦子1, 小島千裕1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1291-1291, 2018.

---

	P0786-25-AM. Efforts to the injection drug mixed preparation by the ward placement pharmacist 吉澤雅恵1, 渡辺孔明1, 長澤宏之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1291-1291, 2018.

---

	P0788-25-AM. Result of importance and the activity of the pharmacist in the urination care team 林剛史1, 古川大樹1, 長谷川雅哉1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1292-1292, 2018.

---

	P0790-25-AM. Relation of the pharmacist in the osteoporotic liaison service using "a re-bone fracture prevention notebook" 打矢貴子1, 垣越咲穂1, 鈴木亮平1, 中村あゆみ1, 金子真理子2, 長岡宏一1, 深津哲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1292-1292, 2018.

---

	P0759-24-PM. Role of the pharmacist of the local inclusion care ward in the extensive acute phase hospital 早瀬友和1, 吉川依里1, 新木智映子1, 池上信昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1293-1293, 2018.

---

	P0763-24-PM. With expectation to real - future of the ward exclusive duty pharmacist - 竹野孝慶1, 阿部剛1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1294-1294, 2018.

---

	P0765-24-PM. It is comparison between prescription intervention and doubt inquiry ... by ... ward pharmacist about prescription intervention utilized the specialty of the pharmacist by ward drug duties 尾内陽香1, 青孝明1, 川口奈緒美1, 堀部緑1, 上林愛1, 木村匡男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1295-1295, 2018.

---

	P0767-24-PM. The intervention situation investigation about the drug at discharge in patients admitted to the circulatory organ internal medicine 石山由香1, 寺島純一1, 山田哲也1, 中村直人1, 鷹見繁宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1295-1295, 2018.

---

	P0769-24-PM. Participation in medical therapy ... in prescription suggestion - circulatory organ ward of the diuretic in consideration of results of the echocardiography 塗木勇介1, 橘淳1, 原竜太郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1296-1296, 2018.

---

	P0771-24-PM. The use results and proper use of the thrombomodulin alfa preparation for the disseminated intravascular coagulation syndrome 山田峻史1, 丹保亜希仁4, 眞鍋貴行2, 櫻庭好祐1, 小野尚志1, 田原克寿3, 粟屋敏雄3, 田崎嘉一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1296-1296, 2018.

---

	P0773-24-PM. For improvement in quality of the pharmaceutical participation associated with stroke complications in our hospital 水谷彩伽1, 眞野加奈子1, 高橋弘泰1, 大谷寧次郎1, 畔柳敏弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1297-1297, 2018.

---

	P0775-24-PM. One case of the rheumatoid arthritis with suspected drug-related pancytopenia by the levetiracetam 山村亮太1, 藤井一憲1, 中村祐太2, 永野俊玲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1297-1297, 2018.

---

	P0777-24-PM. Efforts to the standardization of the sleeplessness dose of medicine by the choice method construction of the ward drug for household delivery to use at sleeplessness 西川直也1, 豊田貴美子1, 渡邊正規1, 清永智子1, 高砂美和子1, 幸田恭治1, 北原隆志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1298-1298, 2018.

---

	P0779-24-PM. Rearward investigation about the pharmaceutical intervention of the ward pharmacist for patients with multiple myeloma admitted to the blood internal medicine 門村将太1, 下口谷貴1, 川本康太郎1, 藤井達郎1, 鈴木智子1, 福田由布子1, 井藤達也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1298-1298, 2018.

---

	P0781-24-PM. Inhalational support by the inhalational device choice using PBPM 安積奈々美1, 夏目義明1, 黒須智博1, 伊藤聖子1, 恩田愛子1, 朝日晶子1, 柳澤友希1, 金子実央1, 太野垣陽子1, 渡辺未紗子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1299-1299, 2018.

---

	P0783-24-PM. For the material making about the administration method to children 伊藤泰代1, 加藤結1, 後藤祥子1, 大谷寧次郎1, 畔柳敏弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1299-1299, 2018.

---

	P0785-24-PM. Fact-finding of the multiple drug prescription based on the operational situation of the ward drug duties enforcement addition 今井一輝1,2, 二村昭彦1, 伊東知美1, 上葛義浩1, 前川ゆか1, 吉岡京子1, 岩佐雅子1, 山田成樹2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1300-1300, 2018.

---

	P0787-24-PM. It is efforts to adequacy and medical expenses reduction of the infection prophylaxis antimicrobial after the ward pharmacist-led operation 木村純子1, 高木祥子1, 吉田弘樹1, 田宮真一1, 木下元一1, 加藤紀子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1300-1300, 2018.

---

	P0789-24-PM. A fact of the pharmacist intervention in the breathing care team activity and future problem 海老井佳織1, 野口周作1, 宮田広樹1, 笠原英城1, 大川陽平2, 高柳佳津紗2, 加藤和久2, 中村康一3, 小林和陽4, 唐木文江5, 齋藤佳輔5, 上野訓子5, 齋藤浩子5, 山口貴子5, 月岡悦子5, 高木聡5, 板倉潮人6, 吾妻安良太6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1301-1301, 2018.

---

	P0791-24-PM. Fact-finding about the bringing medicine for ward pharmacist confirmation duties for the direct hospital admission of emergency case in the cancer special hospital 原田まなみ1, 鈴木真也1, 太田貴洋1, 久松大祐1, 菊地寛隆1, 五十嵐隆志1, 岩本義弘1, 末永亘1, 石原淑子1, 瀬戸裕美子1, 金子明日美1, 川崎敏克1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1301-1301, 2018.

---

	P0792-25-AM. Investigation of drug-related incident contents before and after the ward drug duties start in NICU/GCU ward 瑞慶山にいな1, 砂川由佳1, 伊差川サヤカ1, 大田久美子1, 与那覇房子1, 外間惟夫1, 中村克徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1302-1302, 2018.

---

	P0794-25-AM. Doubt contents investigation about the proper use of the perioperative drug in HCU 森理保1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1303-1303, 2018.

---

	P0796-25-AM. Ward drug duties in the intensive care unit and evaluation of drug information offer contents 山口晃司1, 徳丸隼平1, 川上佳那子1, 坂本修1, 小杉三弥子1, 大塚将秀2, 橋本真也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1303-1303, 2018.

---

	P0798-25-AM. Making and operation of the dry concentration person prothrombin complex (Kay Saint lah) dosage manual 河村聡志1, 佐脇久美1, 薬師寺寿世1, 陸丸幹男1, 平松眞澄2, 稲垣伸洋3, 森一生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1304-1304, 2018.

---

	P0800-25-AM. Examination of the conversion ratio accompanied with the switching from an orchid geo-roll continuous intravenous infusion to a bisoprolol patch 昆貴志1, 小椋玲奈1, 森雅之1, 栃窪克行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1304-1304, 2018.

---

	P0802-25-AM. 2 cases that produced drug-related sinus arrest or cardiopulmonary arrest though blood pilsicainide levels were slight high level 種田靖久1, 松村知洋1, 宇佐美英績1, 吉村知哲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1305-1305, 2018.

---

	P0804-25-AM. The effect that the introduction of the corresponding flowchart gives to treatment on status epilepticus in the Anjo rebirth hospital critical care center 森理乃1, 山本恭平2, 鶴田昌吾2, 岩瀬由枝2, 奥明美2, 伊藤友恵2, 大野愛2, 久保田敏行2, 杉浦洋二2, 長谷川洋一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1305-1305, 2018.

---

	P0793-24-PM. Efforts about the proper use of the injection drug in the pediatric intensive care unit 小野寺みさき1, 小川隆弘1, 花島玲子1, 本間雅士1, 小林昌宏1,2, 坂倉智子1, 近藤留美子1, 厚田幸一郎1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1306-1306, 2018.

---

	P0795-24-PM. The current situation and problem of ward drug duties in SCU of our hospital and the pharmaceutical intervention to patients with stroke 中村和美1, 山之上真央1, 坂井恵理子1, 中村純平1, 松下裕子1, 中島誠2, 河野隆幸3, 安東由喜雄2, 武笠晃丈3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1307-1307, 2018.

---

P0797-24-PM. Development of drug control, the evaluation system based on the evaluation according to the organ system which pointed to standardization, the efficiency of the duties in drug control, the evaluation of ICU patients 内田淳1, 米山早紀1, 寺田芳弘1, 内藤沙紀1, 須田沙也加1, 橘田文彦1, 河田圭司1, 鈴木正彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1307-1307, 2018.

---

	P0799-24-PM. The case that inhalant was given than the tracheotomy tube of patients during the respirator wearing, and helped the ventilator weaning 佐藤琢磨1, 二神諒子1, 中村敏史1, 山岡貴花1, 山田真史2, 池上信昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1308-1308, 2018.

---

	P0801-24-PM. The blood pressure management situation using the vasopressor drug for the low blood pressure during the operation of the angiotensin II receptor antagonist continuation patients 西千恵子1, 宇夛裕基1, 加畑千春2, 河原昌美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1308-1308, 2018.

---

	P0803-24-PM. 1 case that evaluated amikacin blood pleural effusion during the CART enforcement and filtration concentrate levels 西川嘉広1, 小出哲朗1, 鷲見香織2, 今西義紀1, 川崎好人1, 橋本陽1, 芳川史嗣3, 大村崇3, 伊藤久美子1, 登内仁1,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1309-1309, 2018.

---

	P0805-24-PM. It is ... for examination ... people about the usefulness in I-System in the critical care center and the hybrid duties of the machine 立道貴清1, 井上達也1, 元木貴大1, 山口佳津騎1, 田中裕章1, 加地雅人1, 小坂信二1, 芳地一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1309-1309, 2018.

---

	P0806-25-AM. About the usefulness of the duties that the encounter of the pharmacist in the digestive organ internal medicine sits 齋藤由貴1, 大登剛1, 土屋裕伴1, 新井亘1, 増田裕一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1310-1310, 2018.

---

	P0808-25-AM. Comparison ... with usefulness - other types of job of the pharmacist duties in the admitting department 小倉弥生1, 吉田千秋1, 若月秀明1, 大木孝夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1311-1311, 2018.

---

	P0810-25-AM. Examination of the pharmacist duties improvement accompanied with the hospitalization and release support center new establishment 男全昭紀1, 小宅典子1, 平田周祐1, 井口恵美子1, 猪股克彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1311-1311, 2018.

---

	P0812-25-AM. Consideration - that we maintain role - outpatient department bringing medicine for pharmacist differentiation in the support before hospitalization 内山幸子1, 伊原明宏1, 永江隆二1, 佐田竜尚1, 西田和代2, 福山貴子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1312-1312, 2018.

---

P0814-25-AM. Examination of the pharmacist intervention effect on patients with invasive maneuver (surgery and biopsy, endoscopic treatment, and the like to be carried out by local anesthesia) plan in the hospitalization and release support center 鈴木誠麗1, 安田寛1, 横山智子1, 吾月遥1, 清水皓一1, 西澤広介1, 坂本真紀1, 西澤健司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1312-1312, 2018.

---

	P0816-25-AM. Efforts for the discontinuation management before operation in the loanword before pharmacist technique 山中洋1, 杉山健二郎1, 錦織良平1, 河相景子1, 倉本成一郎1, 土井克史2, 八本久仁子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1313-1313, 2018.

---

	P0818-25-AM. Examination about the factor of the observance situation and discontinuation mistake of the discontinuation before operation in the existence floor medical office 宮田恵里子1, 布谷直美1, 渡部直樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1313-1313, 2018.

---

	P0820-25-AM. Intervention effect before operation of the pharmacist in the surgery preparations outpatient department 阿部正人1, 下野智美1, 今浦将治1, 西村瑞紀1, 武田康平1, 永瀬怜司1, 澤柳ユカリ2, 谷口英喜2, 菅野浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1314-1314, 2018.

---

	P0822-25-AM. Effect to physician burden reduction by the pharmacist intervention using the pharmaceutical products management tool in the perioperative period 田中里奈1, 石田俊介1, 今西正樹1, 座間味義人1,2, 桐野靖1, 中村敏己1, 寺岡和彦1, 石澤啓介1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1314-1314, 2018.

---

	P0824-25-AM. Pharmacist intervention in the treatment with specific drug management charges 2 calculation 阿部一仁1, 藤井常宏2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1315-1315, 2018.

---

	P0826-25-AM. The expression situation of nausea post-operative, vomiting in the female surgery patients and future problem 下野智美1, 阿部正人1, 今浦将治1, 西村瑞紀1, 武田康平1, 永瀬怜司1, 澤柳ユカリ2, 谷口英喜2, 菅野浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1315-1315, 2018.

---

	P0828-25-AM. Association with the participation in medical treatment consciousness of the communication frequency between patients - pharmacists through the prescription notebook and contents and patients 北潟和也1,2,3, 庄司雅紀2, 荒川行生3, 恩田光子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1316-1316, 2018.

---

	P0807-24-PM. Analysis about cost and the medical service fees of pharmacist duties for asthmatic treatment management charges 2 田辺就子1, 藤岡貴光1, 柴田壮一1, 松原肇1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1317-1317, 2018.

---

	P0809-24-PM. Examination about the effect that the information sharing in the hospitalization and release control center gives to the quality of the pharmacist interview 吉武由華1, 梶田志保1, 小倉功1, 横井尋和1, 河合俊樹1, 坪井千明1, 巽昭代1, 小野田奈々1, 坪井美知恵1, 松山哲史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1318-1318, 2018.

---

	P0811-24-PM. Examination of the usefulness of the pharmacist intervention in the hospitalization support task 伊藤有美1, 高木早紀1, 小早川佳子1, 木下照常1, 鈴木優里1, 北川加寿子1, 小嶋俊輝1, 矢部知子1, 宮田知世1, 佐原祥子1, 柴田大地1, 滝本典夫1, 足立守1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1318-1318, 2018.

---

	P0813-24-PM. Examination about the usefulness of confirmation of common use medicine before hospitalization by the pharmacist 梅田将光1, 藤村由梨香1, 矢島領1, 渡邉裕次1, 稲毛俊介1, 林太祐1, 伊勢雄也1, 片山志郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1319-1319, 2018.

---

	P0815-24-PM. Making (including ARB, hormone drug, the immunosuppressive drug, and the like) of the drug report in the perioperative period 渡部智子1, 中川貴史1, 森光恵1, 中川浩子2, 坪川雅子3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1319-1319, 2018.

---

	P0817-24-PM. New role of the foreign pharmacist in front of the art 青木洸英1, 鍵山智樹1, 土肥大典1, 吉田悟史1, 真壁秀樹1, 佐伯俊昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1320-1320, 2018.

---

	P0819-24-PM. Inspection of the effect that the intervention by the preoperative pharmacist outpatient gives to management of the stopping medicine during preoperation 米澤龍1, 横山桃子2, 伊東亜莉紗2, 宮坂善之3, 杉沢諭1, 上嶋浩順4, 刑部月5, 石川恵美子6, 川上由香子6, 柴田由美5, 栗原竜也1, 向後麻里2, 大嶽浩司4, 佐々木忠徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1320-1320, 2018.

---

	P0821-24-PM. Efforts of the pharmacist in the loanword before PFM (Patient Flow Management) and anesthesiology technique 稲村澄子1, 山田美映子1, 西村恵里子1, 本多秀俊1, 林由紀子1, 並木路広1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1321-1321, 2018.

---

	P0823-24-PM. Intervention of the pharmacist for the stop medicine in front of the art of the perioperative patients 井無田優1, 江良円佳1, 渡部善博1, 吉原郁夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1321-1321, 2018.

---

	P0825-24-PM. Consideration about a fact and the cancer instruction to patient management charges 3 calculation of the number of oral anticancer agent intervention in the ambulant treatment 橋本直弥1, 立松三千子1,2, 稲熊一英1, 梶田正樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1322-1322, 2018.

---

	P0829-24-PM. The rebuilding of the bringing medicine bag issuance system and the evaluation 伊賀久美1, 安永大輝1, 檜垣宏美1, 飛鷹範明1, 田中守1, 田中亮裕1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1323-1323, 2018.

---

	P0831-24-PM. Evaluation in introduction and the operation of the bringing medicine differentiation system in connection with an electronic medical chart 小松めぐみ1, 乾朱里1, 西内祥子1, 木村美保子1, 田島千愛1, 市川麻美1, 田所美和1, 吉岡りえ1, 市吉真貴子1, 八木亜紀子1, 田中照夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1324-1324, 2018.

---

	P0833-24-PM. Efforts in the prehospital common use medicine intelligence and bringing medicine management 佐藤涼子1, 渡辺克明1, 鈴木さとみ1, 田村淳1, 吉田昌弘2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1324-1324, 2018.

---

	P0830-25-AM. About the nurse satisfaction investigation in the bringing medicine differentiation book change and the change of the false medicine incidence 田村悟1, 宇都直哉1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1325-1325, 2018.

---

	P0832-25-AM. Relation to operational start and other types of job, medicine medicine cooperation of the bringing medicine for planned inpatient confirmation duties in the outpatient department 後藤敏也1, 高屋敷奈々1, 松原大祐1, 正木銀三1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1326-1326, 2018.

---

	P0834-25-AM. Relation ... of the pharmacist judging from "convalescent rehabilitation hospital" - prescription content 島児佳孝1, 中西祥子2, 津波古晶子1, 佐藤晴彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1326-1326, 2018.

---

	P0835-24-PM. Construction of the pharmaceutical support system in the RI private business therapy using the radium chloride (<SUP> 223 </SUP> Ra) injection 鈴木恵子1, 佐藤淳也1, 宮口貴守1, 田中怜1, 池ヶ谷優美2, 中村昌史3, 篠道弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1327-1327, 2018.

---

	P0837-24-PM. Koto hospital pharmacy growth strategy of 2018 using the balun strike scorecard 黒田健吾1, 佐藤大輔1, 寺山和利1, 岡田侑子1, 若木麻由1, 田中美都子1, 加藤菊郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1328-1328, 2018.

---

	P0839-24-PM. The cascade to the drug section of the hospital balun strike scorecard and consideration about the congruity of the balun strike scorecard for hospital pharmacist 金田昌之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1328-1328, 2018.

---

	P0836-25-AM. For the expansion of preparation, quality control duties of the radioactive medicines by the pharmacist 山本孝幸1, 藤森博1, 今井綾乃1, 高澤佳江3, 小手康博4, 明星智洋2, 大澤浩2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1329-1329, 2018.

---

	P0838-25-AM. Examination - current situation survey ... of BSC (balun strike scorecard) utilization characteristics by job satisfaction measure (JOBSS-HP27) for hospital pharmacist 陶山明日香1, 永倉史子1, 濃沼政美2, 大久保淑子1, 小田慎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1330-1330, 2018.

---

	P0840-25-AM. Consideration about the usefulness of the balun strike scorecard in the duties construction of the drug section 稲葉健二郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1330-1330, 2018.

---

	P0841-24-PM. Analysis about the amiodarone-induced thyroid function abnormality using the adverse event spontaneous report database 木下佐昌子1, 細見光一2, 横山聡2, 高田充隆2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1331-1331, 2018.

---

	P0843-24-PM. Upper respiratory infection risk review of the DPP-4 inhibitor using the medical database (receipt, spontaneous report) 多門啓子1, 五島誠1, 吉井利郎2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1332-1332, 2018.

---

	P0845-24-PM. About the usefulness of the medical information cooperation system (Fukui medical net) 平賀貴志1,2, 木村嘉明1, 坂谷英亨1, 嶋田千穂1, 有田奈美1, 山口洋枝1, 服部はるか1, 篠田秀幸2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1332-1332, 2018.

---

	P0847-24-PM. Development of the use and application ~ side effect accumulation database of the information on adverse drug reactions in the foreign cancer chemotherapy and applied ~ 鈴木直哉1, 山田将悟1, 杉山豪2, 藤林遼1, 菊地義明1, 前川英輝1, 高橋誠1, 青田忠博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1333-1333, 2018.

---

	P0849-24-PM. Introduction to development and the pharmacist duties of the drug information offer support tool using the artificial intelligence (AI) 西原茂樹1, 神崎浩孝1, 堤絵利子2, 瀧下哲也2, 西広規2, 佐藤晶子1, 田中雄太1, 村川公央1, 北村佳久1, 木村隆夫2, 千堂年昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1333-1333, 2018.

---

	P0851-24-PM. Adverse event analysis of the neuropathic pain therapeutic drug using FDA adverse event report system (FAERS) 槇田潤1, 地嵜悠吾1, 松村千佳子1, 矢野義孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1334-1334, 2018.

---

	P0853-24-PM. It is ... about a side effect of examination - NSAIDs of the side effect risk in elderly people using NDB opening data and JADER 伊東岳1, 箕輪篤志1, 武田大将1, 中野渡恵1, 齊藤啓熙1, 杉山奈津子1, 加藤芳徳1, 前澤佳代子1, 倉本敬二1, 百瀬泰行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1334-1334, 2018.

---

	P0855-24-PM. Examination - of the structure which is available in - simpleness and easiness to utilize drug information by electronic prescription notebook 折井孝男1, 田代朋子2, 本田卓也2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1335-1335, 2018.

---

	P0857-24-PM. Development of the database supporting proper use of the antimicrobial medicine 雨宮理1, 大野逸子1, 杉平直子1, 尾関理恵2, 小茂田昌代2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1335-1335, 2018.

---

	P0859-24-PM. The pharmaceutical products safety information report utilizing the severity classification standard of the side effects such as pharmaceutical products, and the like and the evaluation 関谷泰明1, 平下智之1, 谷沢克弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1336-1336, 2018.

---

	P0861-24-PM. Construction of the web system aiming at the effective detection of the polypharmacy and the cooperation with the health insurance pharmacy 野崎晃1, 山本和宏1, 木村丈司1, 松田美玖1, 高橋知子1, 小倉史愛1, 矢野育子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1336-1336, 2018.

---

	P0863-24-PM. Consideration about the cause of the heavy stomach with the Rehmannia Root from literatures 柏崎友紀江1, 稲葉健二郎2, 岩本淳平2, 定村洋士1, 赤瀬朋秀3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1337-1337, 2018.

---

	P0865-24-PM. Comparison of the adverse event expression of non-benzodiazepine system sleeping drug and benzodiazepine system sleeping drug tendency 野口義紘1, 大坪愛実1, 古山愛紗1, 上野杏莉1, 松山卓矢1, 戸田有美1, 勝野隼人1, 杉岡まゆ子1, 村山あずさ1, 舘知也1, 土屋照雄2, 寺町ひとみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1337-1337, 2018.

---

	P0867-24-PM. Efforts of the problem solving about intermittent administration medicine in our hospital 池田光1, 松田一駿1, 武田和也1, 眞木秀子1, 伊藤正昭1, 羽太光範1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1338-1338, 2018.

---

	P0869-24-PM. The report that was involved in the medical therapy of the athlete 緒方有記1, 黒崎文広1, 木下礼児1, 松木俊明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1338-1338, 2018.

---

	P0842-25-AM. Examination of the seasonal variation of the contrast media side effect occurrence situation using the in-hospital side effect report data set 本多立1, 北村麻理愛1, 奥田真弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1339-1339, 2018.

---

	P0844-25-AM. The drug interactions onset actual situation (the second report) of the oral molecular target medicine using receipt data 小林秋景1, 百賢二1, 安武夫1, 伊倉由夏2, 濃沼政美2, 黒田誠一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1340-1340, 2018.

---

	P0846-25-AM. Significance of the magnesium administration for the cisplatin-induced renal failure by the meta-analysis 山崎智司1, 浜田幸宏1, 山田真由美2, 丸山拓実1, 木村利美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1340-1340, 2018.

---

	P0848-25-AM. Development of the database using a documentation function (Excel) and the joint ownership folder of the electronic medical chart 入江健司1, 山科卓也1, 鶴田南奈子1, 鶴山萌子3, 小田原真希1, 松本紗織1, 松尾尚美1, 金原沙織2, 川俣洋生3, 平木洋一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1341-1341, 2018.

---

	P0850-25-AM. Examination of the safety measures using the mishaps in medical practice database accompanied with the clinical department new establishment 小竹優希1, 向井淳治1,2, 奥田広志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1341-1341, 2018.

---

	P0852-25-AM. Fact-finding of eye disorders with the anticancer medicine using adverse drug reaction database (JADER) 北見紀明1, 川澄賢司1, 川崎敏克1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1342-1342, 2018.

---

	P0854-25-AM. Analysis ... of the inquiry database to put on development and clinical application - system of the drug information offer support tool using the artificial intelligence (AI) 神崎浩孝1, 西原茂樹1, 瀧下哲也2, 堤絵利子2, 西広規2, 黒田智1, 田中雄太1, 佐藤晶子1, 村川公央1, 北村佳久1, 木村隆夫2, 千堂年昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1342-1342, 2018.

---

	P0856-25-AM. Efforts to the efficiency of DI duties associated with the collection of pharmaceutical products making 濱口翔太1, 岸川悦子1, 清水佐良子1, 平綿洋子1, 矢野忠1, 市川訓1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1343-1343, 2018.

---

	P0858-25-AM. Fact-finding such as possession, the offer, and the like of the drug information about the simple suspension method in the pharmaceutical company and the tablet crush 新井克明1, 秋山滋男2, 輿石徹3, 石田志朗4, 倉田なおみ5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1343-1343, 2018.

---

	P0860-25-AM. International comparison of the pharmaceutical products safety information report for medical persons 門田佳子1,2, 幕田里奈1, 仲谷玲亜1, 植田かれん1, 加藤友希1, 平田絵里子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1344-1344, 2018.

---

	P0864-25-AM. Platinum system anticancer agent and impaired renal function 島田和代1, 長沼美紗1, 元岡佑美1, 笹岡沙也加1, 畠平春奈1, 長谷川栞1, 福田昌穂1, 中尾智史1, 平出耕石2, 森卓之3, 吉村知哲3, 加藤武司2, 中村光浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1345-1345, 2018.

---

	P0866-25-AM. About association of Dipeptidyl Peptidase-4 inhibitor and the autoimmune disease 戸田有美1, 野口義紘1, 勝野隼人1, 江崎宏樹1,2, 松山卓矢1, 上野杏莉1, 大坪愛実1, 古山愛紗1, 杉岡まゆ子1, 村山あずさ1, 舘知也1, 寺町ひとみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1345-1345, 2018.

---

	P0868-25-AM. The doping inquiry system in the health insurance pharmacy and correspondence example 川島大希1, 高橋祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1346-1346, 2018.

---

	P0872-25-AM. Adequacy of the prescription of the PPI using the PPI decrease medicine algorithm 長橋かよ子1, 段昭江1, 中川尚1, 浅澤友希1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1348-1348, 2018.

---

	P0874-25-AM. Prescription change of the sleep inducer in our hospital 岡林真由1, 宮崎俊明1, 筒井由佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1348-1348, 2018.

---

	P0876-25-AM. Efforts to use of acetaminophen promotion for the purpose of the pain-killer proper use 長澤欣弘1, 財津孝希1, 瀧内瑛輔1, 羽生智宏1, 尾形美絵1, 田村和彦1, 新関みどり1, 近藤和宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1349-1349, 2018.

---

	P0878-25-AM. The use of mild cathartic in the use of drug patients for the medical care, bowel movement situation investigation 佐々木美理1, 坂田茂代1, 山口文子1, 鈴木澪1, 佐藤透1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1349-1349, 2018.

---

	P0880-25-AM. Is it used as use comparison - second prevention of the anticoagulant appropriately? ... 中井聖子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1350-1350, 2018.

---

	P0882-25-AM. About the use situation of the Kay Saint lah in our hospital 濱端綾太1, 橋本貴史1, 礒元啓吾1, 大谷美奈子1, 前原大輔1, 見上千昭1, 本間久美子1, 西尾孝1, 辻本勉1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1350-1350, 2018.

---

	P0886-25-AM. Use fact-finding of the Sucroferric oxyhydroxide 大橋史嵩1, 田中壮周1, 越智裕太1, 丸山卓哉1, 後藤悠1, 嘉屋則子1, 田畑裕和1, 稲垣育宏1, 小寺隆二1, 柴波明男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1351-1351, 2018.

---

	P0888-25-AM. The use situation of the tolvaptan in patients with our hospital cirrhosis 内田和孝1,2, 山田邦夫1, 山田聖浩1, 束野奈津己2, 宮瀬志保2, 藤山重俊2, 森岡淳子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1352-1352, 2018.

---

	P0890-25-AM. Through efforts - health Festival for the improvement in recognition of the hospital pharmacist duties for local inhabitants - 長谷川雅紀1, 福本康之1, 川上典子1, 近藤昌子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1352-1352, 2018.

---

	P0892-25-AM. Is RMP utilized in the healthcare setting? Suggestion of the utilization situation of RMP and the further use and application method 飯塚啓人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1353-1353, 2018.

---

	P0894-25-AM. Prescription fact-finding of the drug with the pharmaceutical products risk management plan 千田泰健1, 元木孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1353-1353, 2018.

---

	P0871-24-PM. About use fact-finding of gentamicin in our hospital 沢仁美1, 中島才博1, 近藤智子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1354-1354, 2018.

---

	P0873-24-PM. The use situation investigation of the agate Pross ton in the ambulatory practice of the Iizuka Hospital 長崎皓光1, 内田守次1, 梅田勇一1, 金澤康範1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1355-1355, 2018.

---

	P0875-24-PM. About the situation investigation of the long-term prescription of the benzodiazepine (BZ) receptor agonist in our hospital and measures 本多明香里1, 中嶋友代1, 齋藤暢人1, 武下恭子1, 日高博司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1355-1355, 2018.

---

	P0877-24-PM. Standardization of the use of in-hospital sedative and investigation of the observance situation 森谷康志1, 益本周治1, 亀井健人1, 徳田衡紀1, 中山克洋3, 山下茂樹2, 高柳和伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1356-1356, 2018.

---

	P0879-24-PM. The use situation investigation of the naldemedine and usefulness, safe examination 木村桃子1, 長尾由佳1, 岡野和真1, 亀井健人1, 高柳和伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1356-1356, 2018.

---

	P0881-24-PM. It is an investigation about the proper use of the oral anticoagulant drug directly 猿川麻希子1, 瀬尾達朗1, 池上幸子1, 福本由美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1357-1357, 2018.

---

	P0883-24-PM. For patients with cardioembolic is an investigation about the efforts of the proper use by renal function mention of the use situation and the prescription of the oral anticoagulant drug directly 山本涼子1, 中村友哉1, 枦秀樹1, 太田哲徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1357-1357, 2018.

---

	P0885-24-PM. Glecaprevir, an effect of the Pibrentasvir and safe investigation 如田真貴1, 後藤渉1, 森田祐輔2, 大江真里2, 大穂有恒2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1358-1358, 2018.

---

	P0887-24-PM. About contribution to improvement of the ADL with the erythropoietin preparation administration 川瀬準也1, 尾田健志1, 里村恭子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1358-1358, 2018.

---

	P0889-24-PM. Efforts for the use situation investigation of the oral hepatitis C virus therapeutic drug to kick in our hospital and the intervention of the hospital pharmacist 筒井景子1, 山内浩子1, 八木秀明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1359-1359, 2018.

---

	P0891-24-PM. The effect that an attitude survey of the antibiotic exposure and an in-hospital workshop give on cold syndrome on our hospital staff 浅尾直哉1, 岩本遼1, 山田晃義1, 藤村裕之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1359-1359, 2018.

---

P0893-24-PM. Situation ... of the pharmacist participation in the reinforcement of 2017 Kanagawa hospital pharmacist party duties survey - polypharmacy, antimicrobial proper use, the pharmaceutical products management 芦塚拓也1,2, 濃沼政美3, 稲葉健二郎1, 飯田純一1, 瀧本淳1, 河原英子1, 江島慎太郎1, 小串興平1, 柏崎友紀江1, 佐々木寿子1, 白鳥千穂1, 古川大輔1, 渡邊美智留1, 菅野浩1, 金田光正1, 佐藤透1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1360-1360, 2018.

---

	P0895-24-PM. Use case report of the direct action type antiviral drug in our hospital 長谷川豊則1, 小野翔太郎1, 水谷加代子1, 金澤克洋1, 柴田紗希1, 鈴木彩美1, 中川由紀子1, 加賀香織1, 籾山智美1, 兼子結衣1, 山田実咲1, 板倉充沙1, 長谷川瑛美1, 竹内詩乃1, 小田切英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1360-1360, 2018.

---

	P0896-25-AM. Examination of the drug costs reduction effect by the pharmaceutical intervention of the pharmacist 瀧浪靖子1, 三宅美有紀1, 細直子1, 大本奈緒子1, 野際俊希1, 奥下梨賀1, 中谷亮介1, 稲葉静香1, 藤井美紀1, 本郷志帆1, 石川裕大1, 石本昌裕2, 松本篤1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1361-1361, 2018.

---

	P0898-25-AM. Economical effect by the use of division of a biological drug in our hospital and the anticancer agent 山下貴史1, 脇由香里1, 江原亜沙子1, 野田晋司1, 相松伸哉1, 藤戸淳夫1, 片山歳也1, 松田浩明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1362-1362, 2018.

---

P0900-25-AM. Investigation of the new pharmaceutical products medicine charge calculation situation using the Central Social Insurance Medical Council exhibition material (about the medicine charge publication of pharmaceutical products) 向井梨々香1, 長谷川栞1, 加藤大和1, 松井利亘1, 畠平春奈1, 笹岡沙也加1, 元岡佑美1, 中尾智史1, 島田和代1, 上田夏実1, 中村光浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1362-1362, 2018.

---

	P0902-25-AM. Risk review with the use situation and the combination drug of the laxative in our hospital at admission 河村紳介1, 中島のぞみ1, 山田倭花1, 内山乃映1, 村松奈緒美1, 大窪真理恵1, 伊代田萌子1, 丸岡浩太1, 梅澤仁美1, 小林誠一1, 坂口修治1, 富沢裕之1, 山下敦志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1363-1363, 2018.

---

	P0904-25-AM. About approach of the polypharmacy in the Care health center for the elderly 安部一秀1,2, 阿部真弓1, 渡部雄哉1, 柳田慎一1, 佐藤昌克1, 渡辺実2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1363-1363, 2018.

---

	P0897-24-PM. Examination for the medical expenses reduction by economic loss by the Residual medicine disposal of anticancer agent and the Drug Vial Optimization (DVO) introduction 櫻田啓介1, 佐藤加菜1, 中野裕介1, 棚谷貢1, 飛澤国広1, 小原秀治1, 小原郁司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1364-1364, 2018.

---

	P0899-24-PM. Possibility and problem of current situation and drug vial adequacy (DVO) of the quantity of disposal of injectable anticancer agent in the small and medium size hospital 高橋久樹1, 古川佳奈子1, 今野武志1, 柿崎貴昭1, 菅野絢子1, 小野寺佑実1, 佐藤浩保1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1365-1365, 2018.

---

	P0901-24-PM. Does it become in the red in cancer chemotherapy regimen and what kind of relative - case with the amount of DPC medical service fees? - 堀川佳津美1, 吉田直樹1, 菅谷量俊1, 高瀬久光1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1365-1365, 2018.

---

	P0903-24-PM. Effect of the Residual medicine in the drug control of foreign maintenance haemodialysis patients 上野雅代1, 上本慶子1, 斉藤喬雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1366-1366, 2018.

---

	P0905-24-PM. Efforts of the duties improvement using KPI 高橋俊明1, 高橋恵2, 廣原正宜3, 串田一樹3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1366-1366, 2018.

---

	P0906-25-AM. Comparison between starting pharmaceutical products and generic medicine between the preparation in sedative antiinflammatory tapes 金丸達哉1, 北風日向1, 河地勇樹1, 内田昌希1, 八巻努1, 夏目秀視1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1367-1367, 2018.

---

	P0908-25-AM. Comparison about rheology properties in the forerunner of the infusion ointment and the generic medicine 谷健太郎1,2, 小川千晶1, 畑山賢輔1, 矢田部恵1, 井上元基2, 谷地豊1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1368-1368, 2018.

---

	P0907-24-PM. Policy for the current situation and promotion of the use of generic medicine in Iwate 藤村哲雄1,3, 田村剛1,3, 佐塚泰之2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1369-1369, 2018.

---

	P0909-24-PM. Safe investigation accompanied with the change to generic medicine of the tazobactam sodium/piperacillin sodium preparation 島井沙貴子1, 高野秀仁1, 鈴木正論1, 清田憲吾1, 石塚寛和1, 舟越亮寛1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1370-1370, 2018.

---

	P0910-25-AM. Examination about the quality evaluation of the trophicity food containing zinc 村上雅裕1, 吉田敦哉1, 寺内真理1, 安田恵1, 天野学1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1371-1371, 2018.

---

	P0912-25-AM. Effect on doxorubicin-induced cytotoxicity analysis with the chromophyll anthocyanin 竹林裕美子1, 數原由理恵1, 山崎智加1, 永井純也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1372-1372, 2018.

---

	P0911-24-PM. Dietary fiber and examination - using blood change in interaction - rat of metformin and Caco-2 cells 岩崎綾乃1, 喜多雄飛1, 山本賀奈栄1, 金子侑史1, 猿渡隆信1, 大西優斗1, 今井公江1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1373-1373, 2018.

---

	P0913-24-PM. Introduction of a "peg filgrastim" regimen registration system and the use consent system 松田圭一郎1, 延川正雄1, 齋藤順1, 菅原拓也1, 荒井浩一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1374-1374, 2018.

---

	P0915-24-PM. Making, operation of the protocol for the methotrexate therapy for central nervous system origin malignant lymphoma and the evaluation 福井圭亮1, 澤井陽1, 山下恵梨香1, 田中こずえ1, 鈴鹿隆晃1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1375-1375, 2018.

---

	P0917-24-PM. The observance situation investigation after the use of denosumab guideline revision in our hospital and the evaluation 高原悠子1, 吉田弘樹1, 鈴木雅人1, 三上沙織1, 牧原明秀1, 木全司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1375-1375, 2018.

---

	P0914-25-PM. Efforts about the reduction of the cancer chemotherapy regimen that the use results have few 野田実希1, 杉山惠亮1, 川井正光1, 濱石華乃子1, 志賀有雅1, 森巧一1, 若原美沙紀1, 竹澤茜1, 杉浦洋二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1376-1376, 2018.

---

	P0916-25-AM. Making of the unification, administration manual of the anticancer agent administration procedure 佐藤友昭1, 富田浩史1, 筒井道彰1, 堀大1, 渡明美2, 岩永一郎3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1377-1377, 2018.

---

	P0918-25-AM. Relation of the pharmacist in team establishment and the activity for the proper use of the immune checkpoint inhibitor in our hospital 伊藤幸男1, 波多野聡子1, 中根論士1, 山岸利隆1, 五十嵐弘幸1, 中川敦子2, 藤田弘子2, 白崎浩樹3, 中山俊3, 高嶋孝次郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1378-1378, 2018.

---

	P0920-25-AM. Examination about the effect of the chemo support by a pharmacist, the nurse cooperation 遠藤征裕1, 鈴木円花3, 齋藤雅隆2, 平泉達哉2, 国安美和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1379-1379, 2018.

---

	P0922-25-AM. Inspection of the usefulness of the administration management of the stomach cancer SP therapy utilizing a medicine medicine cooperation tool and the Hand-off sheet 小笠原信敬1, 三浦宏真1, 高橋慎太郎1, 城戸直人2, 及川淳2, 福山真希子1, 三浦清彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1379-1379, 2018.

---

	P0919-24-PM. Efforts to immune-mediated adverse event expression situation in our hospital and clinical department cross-sectional cooperation 三谷泰広1, 原口久義1, 國領俊之1, 江上優1, 山川雅之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1381-1381, 2018.

---

	P0921-24-PM. Establishment of the cancer chemotherapy that is certain by security by the other types of job combination 堀友美1,2, 吉村恵子2, 友末和子2, 河上卓弥1, 松谷洋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1382-1382, 2018.

---

	P0925-24-PM. The frequency investigation of the cholinergic symptom with the irinotecan administration and usefulness evaluation of CDTM about the supportive care 青木万穂1, 宮崎俊明1, 筒井由佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1383-1383, 2018.

---

	P0927-24-PM. Is the pre-medication of onset of Colin symptom situation investigation - anticholinergic drug with irinotecan necessary? ... 伊藤慎二1, 山田純子1, 加藤千里1, 勝村佳代1, 村瀬貴子1, 小林沙矢香1, 磯貝潤一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1384-1384, 2018.

---

	P0929-24-PM. Efficiency and current situation ... in the intervention - cancer instruction to patient management charges 3 calculation of the pharmacist in foreign chemotherapy patients 上原友美1, 堀ノ内志織1, 中松穂菜美1, 鶴永大貴1, 須賀理恵1, 中村有莉恵1, 堀内智裕1, 赤星真広1, 石神誠子1, 池増鮎美1, 佐多照正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1384-1384, 2018.

---

	P0931-24-PM. Efforts of the foreign cancer chemotherapy instruction to patient in our hospital and future problem 又吉里佳1, 川上博瀬1, 浜元善仁1, 翁長真一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1385-1385, 2018.

---

	P0933-24-PM. Improvement in rate of use by the relation of the pharmacist to HBV screening during cancer chemotherapy 岩下佳敬1, 高田侑那1, 薗田晃弘1, 中尾承司1, 兒玉麻代1, 浜園龍1, 宝来留美1, 久永あゆみ1, 森永知沙1, 石田和久1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1385-1385, 2018.

---

	P0935-24-PM. About the disaster brochure manufacture for patients receiving cancer chemotherapy, palliative care 水木麻里1, 塩江さつき1, 後藤康平1, 石井大志1, 長江萌菜美1, 河野大嗣1, 中條恭孝1, 森吉雅代1, 大村ふみ1, 中川博之1, 福井伸也1, 中川朱美1, 野田好典1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1386-1386, 2018.

---

	P0937-24-PM. Investigation of intervention contents to the cancer chemotherapy of the pharmacist in the surgery ward 木村佳弘1, 木元慎一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1386-1386, 2018.

---

	P0926-25-AM. Usefulness of the prescription support system by the medical examination attendance in the foreign cancer chemotherapy 吉田真人1, 深尾彰平1, 淡路健作1, 村野萌美1, 近藤匡慶1, 青木利恵2, 高瀬久光1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1387-1387, 2018.

---

	P0928-25-AM. Investigation of the cancer instruction to patient management charges 3 calculation situation in the Red Cross hospitals of the whole country 村上通康1,11, 伊賀正典2,11, 小林政彦3,11, 大川浩子4,11, 堀大5,11, 佐賀利英6,11, 千田泰建7,11, 森一博8,11, 森英樹9,11, 谷村学10,11 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1388-1388, 2018.

---

	P0930-25-AM. Efforts to the antineoplastic prescription management addition in our hospital 長芝計代1, 黒瀬優輔1, 江尻将之1, 佐久間晶基1, 木下功1, 大西正文1, 斉藤寛子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1388-1388, 2018.

---

	P0932-25-AM. Relation of the pharmacist for the hepatitis B screening enforcement situation and the improvement in rate of use 流石智恵子1, 小暮宗介1, 石橋正祥2, 梅谷直享3, 折井孝男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1389-1389, 2018.

---

	P0934-25-AM. It is the significance of the pharmacist interview in the adjuvant chemotherapy after the gastric cancer technique containing oxaliplatin 鈴木貴之1, 猪野達也1, 松本涼子1, 堀部聖1, 関根貴之1, 長谷川匡史1, 小針美佳1, 池上幸子1, 福本由美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1389-1389, 2018.

---

	P0936-25-AM. Evaluation of the pharmaceutical intervention example about the cancer chemotherapy by the ward pharmacist 檀和貴1, 樋本繭子1, 荻原沙知1, 日原章詔1, 川上辰三1, 田中智也1, 新免徹1, 高瀬尚武1, 三木育子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1390-1390, 2018.

---

	P0938-25-AM. Fact-finding of the medication adherence in the treatment with oral anticancer agent of patients with old cancer 市田泰彦1, 五十嵐隆志2, 山口正和3, 小川朝生4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1390-1390, 2018.

---

	P0939-24-PM. Participate in findings of the anticancer medicine preparation environment in our hospital and consideration - national hospital mechanism network collaborative investigation; and - 新島大輔1, 矢田部恵1, 小川千晶1, 軍司剛宏1, 松井哲2, 青儀健二郎3, 谷地豊1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1391-1391, 2018.

---

	P0943-24-PM. The drug resolution removal test with the ozone water of the anticancer medicine pollution injection label surface 古田祐美子1, 土手賢史1, 岩根裕紀1,2, 小林由佳1,2, 成橋和正2, 杉浦伸一2, 中西弘和2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1392-1392, 2018.

---

	P0945-24-PM. The anticancer agent using the closed system anesthesia drug transportation system pre-; the promotion of exposure measures by the making to prepare it 若林茜1, 永田菜美子1, 片山宏章1, 榊原辰弥1, 後藤真実1, 宮口貴守1, 伊藤雅子1, 佐藤淳也1, 篠道弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1393-1393, 2018.

---

	P0949-24-PM. Efforts for the full-scale introduction of the closed system anesthesia preparation appliance by the anticancer medicine preparation 西村雅次1, 板垣美保1, 石垣俊樹1, 羽太光範1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1394-1394, 2018.

---

	P0951-24-PM. Inspection about the preparation cost cut of fluorouracil and cyclophosphamide using closed system anesthesia drug transportation system (CSTD) 加藤淳平1, 立田真也1, 石田耕太1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1394-1394, 2018.

---

	P0953-24-PM. Efforts to the use expansion of the obstruction-type drug transportation system in the anticancer agent adjustment and the evaluation 山崎博子1, 林幹也1, 赤崎淳子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1395-1395, 2018.

---

	P0955-24-PM. Introduction effect of the anticancer agent preparation training evaluation table 田辺真里1, 坂田茂代1, 山口文子1, 佐藤透1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1395-1395, 2018.

---

	P0957-24-PM. Examination of the cleaning method for the environmental exposure after the crush formulations of methotrexate tablets 青木学一1,2, 今野友貴2, 大和田真未2, 小田さつき1, 久保田聡2, 横田訓男2, 柴崎淳2, 渋谷清1,2, 尾鳥勝也1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1396-1396, 2018.

---

	P0959-24-PM. Examination of the usefulness of the simple suspension method of sirolimus tablets in the umbrella Bach merit syndrome of infants 津本有梨1, 小森桂子1, 寺岡知香1, 浅原章裕1, 大津由美子1, 藤田敬子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1396-1396, 2018.

---

	P0940-25-AM. Transfer the mitomycin C preparation duties in efforts - surgery center of the occupational exposure reduction with the anticancer agent to the drug department; and ... 大村花菜1, 横山正人1, 山中義裕1, 朝日恵美2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1397-1397, 2018.

---

	P0942-25-AM. Anticancer agent pollution investigation and measures in our hospital 田村淳1, 高橋明子2, 森屋智美3, 高木宏和1, 蒲生真紀夫4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1398-1398, 2018.

---

	P0944-25-AM. Evaluation of the pollution area zoning in anticancer agent exposure measures 田頭尚士1, 松本拓真1, 串田康弘1, 吉田昭昌1, 山本宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1398-1398, 2018.

---

P0946-25-AM. Vascular pain onset frequency investigation of the gemcitabine hydrochloride accompanied with the powdery preparation prior dissolution after the closed system anesthesia drug transportation system introduction 永田菜美子1, 片山宏章1, 榊原辰弥1, 若林茜1, 後藤真実1, 宮口貴守1, 伊藤雅子1, 佐藤淳也1, 篠道弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1399-1399, 2018.

---

	P0948-25-AM. Abacterial examination in the vial under the preparation environment for the development of the DVO country enforcement standard 小野尚志1, 新田悠一朗1, 木村周古1, 相馬亮太1, 川田悠貴1, 仲谷彰規1, 三嶋一登1, 福土将秀1, 田崎嘉一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1399-1399, 2018.

---

	P0952-25-AM. Closed system anesthesia drug transportation system (CSTD) introduction, the current situation report of northeastern Rousaibyoin 菅野和彦1, 高松謙1, 袰岩靖子1, 羽川典江1, 熊谷史由1, 片谷憲子2, 濱中直美2, 穂積史朗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1400-1400, 2018.

---

	P0954-25-AM. Efforts before and after the closed system anesthesia preparation appliance introduction to all antineoplastic and the future prospects 大森義朗1, 藤井佑実1, 越智達郎1, 萩山博史1, 佐藤真也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1401-1401, 2018.

---

	P0956-25-AM. Usefulness of an attitude survey and the prevention of anticancer agent exposure enlightenment to the excretion of the person of patients, family, medical care about cancer chemotherapy at the home 齊藤直美1, 佐藤順子2, 阿部悟3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1401-1401, 2018.

---

	P0958-25-AM. It is the application to a note for an anticancer agent by note device (UG-XAD1) for radium chloride 大瀧翔太1, 継田雅美2, 古川智康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1402-1402, 2018.

---

	P0960-25-AM. Examination about the associated factor of an AUC estimate and the febrile neutropenia of the etoposide 山中礼子1, 槙原克也1, 内山ひとみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1403-1403, 2018.

---

	P0962-25-AM. 1 case that was able to accomplish BEP therapy by desensitization of the etoposide 深沢健一1, 久保田豊1, 古川卓也1, 西澤千津恵2, 勝山善彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1404-1404, 2018.

---

	P0964-25-AM. Usefulness of the neutrophilic/lymphocytes ratio as the side effect expression predictor in nivolumab treated patients, the lymphocytes/monocyte ratio, the platelet/lymphocytes ratio 服部公紀1, 三宅知宏1, 野口祥紀1, 和田亜希1, 中西由衣1, 小川晃宏1, 内田早弓1, 谷村学1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1404-1404, 2018.

---

	P0966-25-AM. The current situation investigation about intensity of treatment and the blood toxicity of patients with old lung cancer 伊佐治麻里子1, 桑山果織1, 白井博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1405-1405, 2018.

---

P0968-25-AM. Efforts to the HBV reactivation measures of the internal use anticancer agent remedy patients utilizing the hepatitis B monitoring paper 與田賢作1, 松浦徹1, 桑名寿幸1, 内山有理香1, 奥野美和1, 田原裕希乃1, 山下大貴1, 立石裕樹1, 安部由起子1, 市川美佳1, 後藤貴央1, 大汐欣輝1, 日高美緒1, 村田智弘1, 重松由加1, 宮津大輔1, 田中博和1, 井上幸子1, 平川雅章1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1405-1405, 2018.

---

	P0970-25-AM. Investigation about the onset of vascular pain risk at the gemcitabine administration 伊藤健史1, 眞野翔太1, 足立牧子1, 井上壽江1, 谷沢克弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1406-1406, 2018.

---

	P0972-25-AM. The Ergo thionein relieves peripheral neuropathy by inhibiting accumulation of oxaliplatin in the rat dorsal root ganglia 長澤一樹1, 大石晃弘1, 西田健太朗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1406-1406, 2018.

---

	P0974-25-AM. Examination of the objective evaluation using Trace test and the grip measurement for oxaliplatin-induced peripheral neuropathy 原口久義1, 三谷泰広1, 國領俊之1, 江上優1, 山川雅之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1407-1407, 2018.

---

	P0976-25-AM. Investigation about the case that the use situation and interstitial pneumonia of the Pembrolizumab in our hospital developed 田中裕子1, 古林園子1, 神長雅浩1, 加藤一郎1, 安田直史2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1407-1407, 2018.

---

	P0978-25-AM. Inspection of the effectiveness of the fenofibrate for the cisplatin-induced renal failure 斉家和仁1, 合田光寛2, 伊勢諒3, 新村貴博1, 石澤有紀3, 座間味義人1,2, 中馬真幸4, 濱野裕章2, 岡田直人2, 武智研志4, 今西正樹1,2, 堀ノ内裕也3, 池田康将3, 土屋浩一郎5, 石澤啓介1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1408-1408, 2018.

---

	P0980-25-AM. Fact-finding of the side effect of the liver arterial infusion chemotherapy, low-dose 5-FU+ cisplatin therapy in the unresectable progress hepatocellular carcinoma 道家雄太郎1, 藪田直希1, 上田智弘1, 長谷川千晶1, 野田哲史1, 平大樹1, 飯田洋也2, 谷眞至2, 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1408-1408, 2018.

---

	P0982-25-AM. Side effect expression of FOLFIRINOX investigation for the unresectable progress pancreatic cancer in our hospital 中ノ内唯可1, 板倉祥嗣1, 土谷有美1, 津田正博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1409-1409, 2018.

---

	P0984-25-AM. Effect of the amino acid derivative on 5-fluorouracil-induced liver damage 福野修平1, 吉田咲紀1, 長井克仁1, 小西廣己1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1409-1409, 2018.

---

	P0986-25-AM. Adverse event investigation of the GC therapy in the urologic domain 西山裕也1, 網代真史1, 谷口由理1, 窪田奈津子1, 敦見真由美1, 中谷孝史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1410-1410, 2018.

---

	P0988-25-AM. Examination of a risk factor and the preventive preparation of the thromboembolism in patients with Japanese multiple myeloma using lenalidomide 坂本健一1, 村瀬哲也2, 上野千奈美1, 西垣内亮2, 木村優美2, 櫻下弘志2, 泉谷悟2, 佐伯康之2, 松尾裕彰2, 谷口雅敏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1410-1410, 2018.

---

	P0990-25-AM. Effect by the irAE check list introduction in the side effect monitoring of the immune checkpoint inhibitor 井上加菜子1, 近藤博紀1, 木下千恵美2, 上田潤哉1, 横幕香織1, 大野勝則1, 三露久生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1411-1411, 2018.

---

	P0992-25-AM. Look at the rear of the onset of interstitial pneumonia risk factor of nivolumab/Pembrolizumab for patients with lung cancer; trial ... in mark examination ... single institution 橋本貴尚1, 高橋克史1, 丸山香代子1, 本明孝広1, 飯島秀弥2, 栃窪克行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1411-1411, 2018.

---

	P0994-25-AM. Examination of the cancellation reason of the immune checkpoint inhibitor in the University of Occupational and Environmental Health Hospital 竹村知1, 長原功騎1, 久保田政二郎1, 徳丸一郎1, 麻生忠弘1, 横山雄一2, 蒲池英博2, 篠原義剛2, 西原豊1, 植木哲也2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1412-1412, 2018.

---

	P0996-25-AM. Protein urine by the ramucirumab, fact-finding about the onset of high blood pressure situation 澤柳直樹1, 荒木寛也1, 坂柳悦章1, 西川隆一1, 藤井友和1, 辻博幸1, 塚本久之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1412-1412, 2018.

---

	P0998-25-AM. 4 cases receiving the daratumumab for the recurrent or refractory multiple myeloma 宮本大嗣1, 芦田隆司2, 森嶋祥之1, 淺野肇1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1413-1413, 2018.

---

	P1000-25-AM. Side effect measures and evaluation for the daratumumab administration 安宅希美子1, 水岡大策1, 田中裕章1, 山口佳津騎1, 元木貴大1, 加地雅人1, 小坂信二1, 芳地一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1413-1413, 2018.

---

	P1002-25-AM. Side effect expression of sorafenib investigation in our hospital 寺尾勇紀1, 内田将吾1, 大谷寧次郎1, 高橋弘康1, 畔柳敏弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1414-1414, 2018.

---

	P1004-25-AM. Factor analysis of the onset of low Mg blood symptom with the antiEGFR monoclonal antibody medicine in patients with metastasis, recurrent colon cancer 深井雄太1, 高田慎也1, 橋下浩紀1, 遠藤雅之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1414-1414, 2018.

---

	P1006-25-AM. The side effect of breast cancer therapeutic drug Palbociclib expression situation investigation 木村美甫1, 角川幸男1, 川田知加1, 高木麻里1, 金銅葉子1, 坂上嘉浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1415-1415, 2018.

---

	P1008-25-AM. Relation of the pharmacist in the onset of use actual situation and side effect of the Palbociclib in our hospital 山崎富士子1, 長島由紀子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1415-1415, 2018.

---

	P1012-25-AM. Effect of the febuxostat combination on side effect expression at the a large quantity of methotrexate therapy 篠木優里1, 池村健治1, 俵功2, 岩本卓也1, 片山直之2, 奥田真弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1416-1416, 2018.

---

	P1014-25-AM. Usefulness of myelosuppression frequency and the CARG score of patients who received elderly people chemotherapy in our hospital 畠山智明1, 篠原一宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1417-1417, 2018.

---

	P1016-25-AM. Inspection of the usefulness of the CTCAE test value grading tool using eXChart 阿部史誉1, 山中理1, 中山英夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1417-1417, 2018.

---

	P0963-24-PM. A neutropenia with the GC therapy in patients with progressive urothelium cancer and the neutrophilic/lymphocytes ratio and related examination with the survival period 笹野知海1, 山本圭祐1, 辻大樹2, 石塚友一1, 都甲海1, 中道秀徳1, 米田達明3, 矢部勝茂1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1419-1419, 2018.

---

	P0965-24-PM. Blood poison-related evaluation of the unresectable ramucirumab in progress, patients with recurrent stomach cancer 岩井美奈1, 伊藤大輔1, 浅野裕紀1, 安達志乃1, 岡田和智1, 宇佐美英績1, 木村美智男1, 吉村知哲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1419-1419, 2018.

---

	P0967-24-PM. Efforts of hepatitis B revival measures with the chemotherapy 結城正幸1, 村山恵智子2, 稲葉行男3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1420-1420, 2018.

---

	P0969-24-PM. Example that caused phlebitis, induration by Carfilzomib administration 木瀬大輔1, 大垣孝文1, 中永かおり1, 霜倉智子1, 上坂一行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1420-1420, 2018.

---

	P0971-24-PM. Examination of the onset of vascular pain by changes from the one for gem Saar injection to gemcitabine infusion liquid "NK" 鶴永大貴1, 上原友美1, 堀内智裕1, 中松穂菜美1, 須賀理恵1, 堀ノ内志織1, 中村有莉恵1, 赤星真広1, 石神誠子1, 池増鮎美1, 佐多照正1, 奥村浩2, 前之原茂穂2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1421-1421, 2018.

---

	P0973-24-PM. Association with the quantity of oxaliplatin per body-surface area during the early onset oxaliplatin-induced peripheral neuropathy and chemotherapy regimen 加藤芳徳1, 清水加奈子2,3, 中村裕義2,3, 山田治美1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1421-1421, 2018.

---

	P0975-24-PM. About the bullous pemphigoid onset of patients who received gemcitabine 杉町代1, 津曲恭一1, 西村尚芳1, 北島久義1, 尾之江剛樹2, 中山文子3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1422-1422, 2018.

---

	P0977-24-PM. Analysis of the risk factor of the impaired renal function at the cisplatin (CDDP) administration 津曲恭一1, 三好孝法2, 魚井みゆき3, 大村芙佑希4, 田川幸5, 横田千明6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1422-1422, 2018.

---

	P0979-24-PM. 2 cases that developed ischemic enteritis during the adjuvant chemotherapy cisplatin + vinorelbine enforcement after the operation 高取裕司1, 牛膓沙織1, 吉村拓也1, 新井孝文1, 山本雅史2, 池上信昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1423-1423, 2018.

---

	P0981-24-PM. Analysis of the exacerbation factor for the sensory nerve disorder of vincristine in patients who received R-CHOP/R-THP-COP therapy 松谷直樹1, 豊田倫之1, 岡安伸晃1, 麻生一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1423-1423, 2018.

---

	P0983-24-PM. Relative dose intensity and side effect investigation of the gemcitabine + albumin suspension type paclitaxel combination therapy in the pancreatic cancer 植松俊成1, 幸田恭治1, 北原隆志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1424-1424, 2018.

---

	P0985-24-PM. Investigation about the hiccups expression during the FP therapy in patients with cancer of the esophagus 平岡佳子1, 熊澤里美1, 山田成樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1424-1424, 2018.

---

	P0987-24-PM. 1 case that a steroid rotation was effective for hiccups by the dexamethasone during S-1+CDDP therapy 細川浩輝1, 霜田英明1, 石井貴之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1425-1425, 2018.

---

	P0989-24-PM. Factor to have an influence on the blood sugar control after the goserelin administration in patients with prostate cancer 有松冴1, 桐生浩子1, 伊藤朱里1, 原美由紀1, 佐宗智之1, 小松由佳1, 加藤義章1, 出口賀奈子1, 西川嘉広1, 近藤加奈子1, 橋本陽1, 今西義紀1, 小出哲朗1, 須川由理子1, 堀田康広2, 木瀬英明3, 伊藤久美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1425-1425, 2018.

---

	P0991-24-PM. Examination of the backward field about the elevated blood pressure with the ramucirumab administration 中川雅史1, 泉本裕美1, 毛利萌1, 喜多由紀1, 宮内実奈絵1, 狩谷佳寛1, 樫葉利人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1426-1426, 2018.

---

	P0993-24-PM. Side effect investigation of the high blood pressure in ramucirumab treated patients 入江良之1, 廻千晴1, 光川由佳子1, 波多野真弓1, 江口善美1, 石井茂1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1426-1426, 2018.

---

	P0995-24-PM. Investigation about the use situation and the side effect expression of immune checkpoint inhibitor 長能優子1, 浜屋正志1, 米山栄司1, 河岸由紀夫2, 佐々木良子3, 本元浩和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1427-1427, 2018.

---

	P0997-24-PM. About the use actual situation of the immune checkpoint inhibitor in our hospital respiratory division domain 榊間絢子1, 水谷妙子1, 田中文1, 横山征史1, 濱至寛1, 登内盛治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1427-1427, 2018.

---

	P0999-24-PM. Comparison between examination of proteinuria qualitative analysis and protein urine creatinine ratio (UPC) measurement 安藤純子1, 小松順子1, 建持岳史2, 足立茂樹3, 國枝克行4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1428-1428, 2018.

---

	P1001-24-PM. Fact-finding of protein urine measures at use of bevacizumab in our hospital 川原裕1, 山下千草1, 佐野雅昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1428-1428, 2018.

---

	P1003-24-PM. Examination about proteinuria with the neovascularisation inhibitor 宮本拓人1, 鈴木大介2, 大山英明2, 川澄清孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1429-1429, 2018.

---

	P1005-24-PM. About anemia with trifluridine Tipiracil hydrochloride combination tablets 柿本智広1, 三浦ひとみ2, 尾積時敬子1, 武田恵視1, 川床優子1, 岩元富有子1, 前田加奈子1, 枚田明1, 中島誠2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1429-1429, 2018.

---

	P1007-24-PM. The administration situation and side effect investigation of four multiple myeloma receiving the daratumumab 中嶋紘文1, 村永諒1, 外山裕晃1, 有賀久晃1, 坂田幸雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1430-1430, 2018.

---

	P1009-24-PM. One patient whom the acute necrotic esophagitis that Afatinib introduction was serious early developed in 荒井早穂1, 真砂聖1, 藏本裕信1, 足立恵子1, 前田翠1, 依藤健之介1, 井上明香2, 門田和也2, 松本章士1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1430-1430, 2018.

---

	P1013-24-PM. Strength of an onset of tumor part and the dermatopathy in patients with colon cancer receiving cetuximab, examination about the association of the survival period 田初夏苗1, 高田慎也1, 橋下浩紀1, 遠藤雅之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1431-1431, 2018.

---

	P1015-24-PM. One case that resulted in heart failure during Cmab + mFOLFOX6 therapy 浦川美採1, 倉橋基尚1, 藤本冬佳1, 片桐茜1, 山岡真由美1, 松本涼1, 門田友貴1, 卜部和美1, 澤崎高志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1432-1432, 2018.

---

	P1017-24-PM. Comparison with the 5-FU note for the blood vessel-related adverse event of fluorouracil note "Towa" 原かをり1, 前田章光1, 尾瀬功2, 稲熊一英1, 梶田正樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1432-1432, 2018.

---

	P1018-25-AM. The current situation investigation about the effectiveness of palonosetron in the Carboplatin combination therapy for the lung cancer 吉村拓也1, 高取裕司1, 牛膓沙織1, 池上信昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1433-1433, 2018.

---

	P1020-25-AM. An antiemesis effect and safety by granisetron for retching, vomiting in the ABVD therapy or palonosetron alone and the corticosteroid combination 内田まやこ1,2, 中村任2, 秦晃二郎1, 渡邊裕之1, 森康雄3, 加藤光次3, 宮本敏浩3, 細畑圭子2, 増田智先1, 赤司浩一3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1434-1434, 2018.

---

	P1022-25-AM. The use situation investigation of olanzapine for the digestive organ symptom (retching, vomiting) with the antineoplastic administration 猪股浩介1, 片山瑞補1, 陣田剛志1, 岡田悠加1, 佐倉小百合1, 藤原康浩1, 國東ゆかり1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1434-1434, 2018.

---

	P1024-25-AM. It is association with onset of retching and the surgery in the adjuvant chemotherapy after the S-1 technique 川地志緒里1, 郷真貴子1, 木村美智男1, 宇佐美英績1, 吉村知哲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1435-1435, 2018.

---

	P1026-25-AM. About a drug costs reduction effect obtained by the antiemesis therapy review of the chemotherapy regimen 永石浩貴1, 松尾圭祐1, 林淳一郎1, 尾之江剛樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1435-1435, 2018.

---

	P1019-24-PM. Investigation about the effectiveness of the antiemesis therapy with aprepitant in the low-dose cisplatin divided doses for the testicular germ cell carcinoma 蛯江裕美1, 城間由奈1, 吉見陽1,2, 宮崎雅之2, 山田清文2, 野田幸裕1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1436-1436, 2018.

---

	P1021-24-PM. Dose comparison of granisetron for patients with lung cancer 宮川貴行1, 田中翔一1, 水口敦子1, 梶井孝洋1, 西澤修一1, 西川正直1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1437-1437, 2018.

---

	P1023-24-PM. The use situation of olanzapine for retching, vomiting with the cancer chemotherapy 山本英晶1, 原一樹1, 渡邉浩人1, 草谷朋子1, 藤森浩美1, 川上恭弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1437-1437, 2018.

---

	P1025-24-PM. Of the steroid supportive care in the highly emetic risk regimen single; and is weighed divided doses 大柿滋1, 牛島智子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1438-1438, 2018.

---

	P1027-24-PM. Make use of a - national hospital mechanism Kyushu block multicenter study about efforts for the antiemesis therapy standardization for LEC of our hospital; and - 松尾圭祐1, 永石浩貴1, 林淳一郎1, 尾之江剛樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1438-1438, 2018.

---

	P1028-25-AM. About usefulness of the sustained G-CSF preparation peg filgrastim for the breast cancer AC therapy 谷口賢二1, 和田祐一1, 鈴木美世利1, 福永浩也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1439-1439, 2018.

---

	P1030-25-AM. Investigation of the effect to give the use situation of the sustained G-CSF preparation peg filgrastim in our hospital and intensity of treatment 磯貝潤一1, 伊藤慎二1, 村瀬貴子1, 小林沙矢香1, 大橋武司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1440-1440, 2018.

---

	P1032-25-AM. One case of patients with ALL that blood catharsis was useful for the extensive excretion delay after the Methotrexate massive dose therapy and acute renal failure 森紗世子1, 難波亜矢子2, 後藤千尋2, 柴崎康彦2,3, 増子正義3, 曽根博仁2, 後藤佐和子4, 細島康宏4, 山本卓4, 成田一衛4, 島田泉1, 鈴木直人1, 外山聡1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1440-1440, 2018.

---

	P1034-25-AM. Consideration after the Carboplatin + etoposide therapy for haemodialysis patients 牛膓沙織1, 高取裕司1, 野村翔1, 浅井美穂1, 山本雅史2, 池上信昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1441-1441, 2018.

---

	P1036-25-AM. Investigation of progress, the factor that eribulin therapy gives to extension for patients with recurrent breast cancer liver metastases for a survival period 小倉千奈1, 生田智基2, 武良卓哉3, 槇恒雄2, 橋本修1, 小川喜通4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1441-1441, 2018.

---

	P1038-25-AM. Examination about the triple-drug therapy in the cancer of the esophagus preoperative chemotherapy of our hospital 曽根千晶1, 淺野肇1, 佐々侑寿香1, 藤原季美子1, 家田正子1, 月岡康行1, 森嶋祥之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1442-1442, 2018.

---

	P1040-25-AM. Comparison after the second treatment of the nivolumab for the non-small cell lung cancer and the third treatment 大野裕之1, 田中佳子1, 平下智之1, 谷沢克弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1442-1442, 2018.

---

	P1042-25-AM. About pre-medication examination and an evaluation for infusion reaction prevention in the Daratumumab administration 網野一真1, 赤坂知香1, 柏原佑香1, 江口彩香1, 登内盛治1, 内山倫宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1443-1443, 2018.

---

	P1044-25-AM. One case that a transmistake came to have good by prescribing it, and supporting VRd therapy for the multiple myeloma to be complicated with impaired renal function 宮下裕央1, 津曲恭一1, 大津貴寛2, 北島久義1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1443-1443, 2018.

---

	P1046-25-AM. Research about the maintenance therapy of the pemetrexed in our hospital respiratory division 安田将樹1, 野洌孝二1, 大岡千寿子1, 高山直樹1, 中村俊之1, 神田雄史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1444-1444, 2018.

---

	P1048-25-AM. Usefulness of the Hangeshashinto for oral mucositis in the head and neck cancer TPF therapy 出町拓也1, 北山秀則1, 城ケ崎怜奈1, 千葉里織1, 和田由美1, 芦崎雅之1, 平田力1, 早坂州生1, 竹内公美1, 渡邉昭仁2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1444-1444, 2018.

---

	P1050-25-AM. It is an example using the indometacin gargle for oral mucositis with the cancer chemotherapy 堀井麻衣1, 百賢二1, 安武夫1, 黒田誠一郎1, 横山和明2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1445-1445, 2018.

---

	P1052-25-AM. It is examined the protective efficacy of low-dose oral aciclovir for the herpes zoster after the hematopoietic stem cell transplantation enforcement of children 建部泰尚1, 江角悟1, 真鍋洋平1, 牛尾聡一郎1, 小川敦1, 村川公央1, 北村佳久1, 千堂年昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1445-1445, 2018.

---

	P1054-25-AM. Evaluation about the usability of the constant infusion pump for exclusive use of the anticancer medicine and the accuracy of the 5-FU discharge completion time 横山雄一1, 篠原義剛1, 植木哲也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1446-1446, 2018.

---

	P1029-24-PM. Examination of the clinical response of the G-CSF primary prophylaxis in the ramucirumab + docetaxel treatment 小山田聡1, 久松直樹1, 小島純子1, 野村明広2, 井坂彰一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1447-1447, 2018.

---

	P1031-24-PM. About usefulness of the pegfilgrastim administration in the relief chemotherapy for the malignant lymphoma 島田惇司1, 伊藤やす江1, 五十嵐貴之1, 岡田和博1, 泉澤友宏1, 島崎博士1, 鈴木一史2, 西脇嘉一2, 長谷川英雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1448-1448, 2018.

---

	P1033-24-PM. Examination about the association between serum zinc levels and peripheral blood lymphocyte counts in patients with first malignant lymphoma 守作美咲1, 伊藤佳織1,2, 岡本昌隆2, 今井美沙1, 全並美穂1, 柘植雅大1, 稲熊容子2, 徳田倍将2, 恵美宜彦2, 加藤さや香1, 山田成樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1448-1448, 2018.

---

	P1035-24-PM. 1 case that was given paclitaxel/Carboplatin combination therapy for patients with lung adenocarcinoma during the haemodialysis enforcement 松本拓真1, 田頭尚士1, 竹原基晴1, 吉田昭昌1, 山本宏1, 尾関太一2, 南大輔2, 柴山卓夫2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1449-1449, 2018.

---

	P1037-24-PM. Change analysis of the serum hepcidin concentrations in cisplatin treated patients 中村任1, 新潟里歩2, 山下和彦3, 久米学4, 安井裕之2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1449-1449, 2018.

---

	P1039-24-PM. We look at the rear of patients with progress, recurrence colon cancer which is impossible of curative resection in the single institution chemotherapy center and analyze a mark 里見眞知子1, 河野透2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1450-1450, 2018.

---

	P1041-24-PM. Efforts for the use situation investigation and the proper use of the immune checkpoint inhibitor 三好孝法1, 吉村幸永2, 高野由香里2, 鶴田南奈子1, 上野拓也3, 福山誠一4, 深田陽子5, 甲斐宜貴6, 清崎邦洋7, 鶴田悟8, 光尾邦彦9, 矢野篤次郎4, 平木洋一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1450-1450, 2018.

---

	P1043-24-PM. Investigation about the Infusion Reaction expression at the Daratumumab administration 安森奈緒子1, 川俣洋生1, 福石和久1, 西野隆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1451-1451, 2018.

---

	P1045-24-PM. A treatment result of the KRd therapy for a recurrence, the intractable multiple myeloma in the JCHO Kyushu Hospital and examination of the side effect 西村直朗1, 桑村恒夫1, 末松文博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1451-1451, 2018.

---

	P1047-24-PM. The use situation investigation of the ramucirumab combination regimen in our hospital 小西史子1, 濱武清範1, 美和孝之1, 松本弘誠1, 中西輝1, 酒井ちひろ1, 野間敏也1, 足立那々緒1, 後藤仁美1, 仲忠士1, 小島一晃1, 神田直樹2, 恒松一郎3, 北英夫4, 菅理晴5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1452-1452, 2018.

---

	P1049-24-PM. An example of ovarian cancer successful in Carboplatin desensitization by examination of the pre-medication 松山千容1, 馬見新佳那子1, 松井礼子1, 原野謙一2, 川崎敏克1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1452-1452, 2018.

---

	P1051-24-PM. Effect of the pre-treatment to give it to onset of oral mucositis at the allogeneic hematopoietic stem cell transplantation and disease severity 吉越静香1, 北澤文章1, 村山和子1, 森本拓也1, 上田久美1, 中山優子3, 高良恒史3, 佐原敏之1, 淵田真一2, 島崎千尋2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1453-1453, 2018.

---

	P1053-24-PM. Protective efficacy of the dexamethasone ointment for stomatitis by the Everolimus 下川福子1, 小山拓弥2, 林洋平2, 澤田奈津子2, 清水裕行2, 原田沙枝子2, 船越幸代3, 柄川千代美4, 川嵜英二2, 前田頼伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1453-1453, 2018.

---

	P1055-24-PM. Effect of the oral Mg agent giving it to onset of low Mg blood symptom by the cisplatin 賀茂佳子1, 佐藤淳也1, 田中怜1, 石川寛1, 篠道弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1454-1454, 2018.

---

	P1057-24-PM. Fact-finding about the proper use of the fentanyl citrate sublingual tablet after the protocol introduction 藤岡貴光1, 斎藤太寿1, 小林義和1, 齋藤雅俊1, 柴田壮一1, 松原肇1,2, 中山莊平3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1455-1455, 2018.

---

	P1059-24-PM. Use stocktaking of the naldemedine in our hospital 松藤敬佑1, 原茉梨絵1, 築田晃直1, 仲田浩成1, 三角紳博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1456-1456, 2018.

---

	P1061-24-PM. The investigation for the change of the laxative in the null Medellin administration and analysis of the factor 中島隆良1, 植松卓也1, 菅尾高裕1, 玄田拓哉1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1456-1456, 2018.

---

	P1063-24-PM. It is ... using the examination - palliative care self-assessment vote of the risk factor of opioid-induced retching, vomiting (OINV) and an emetic risk factor evaluation 三浦愛美1, 吉田昌子1, 山中規明1, 桜田宏明1, 山村益己1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1457-1457, 2018.

---

	P1065-24-PM. Examination of the use situation of hydromorphone in our hospital and examination of the use situation of the once a day oral morphine slow-release preparation 原圭子1, 山下秀之1, 山口伸二1, 田畑貴康1, 中村徹志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1457-1457, 2018.

---

	P1067-24-PM. Quality of life change of patients with cancer by the intervention of the health insurance pharmacy pharmacist 佐藤由美1,2, 粂和彦1, 大澤匡弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1458-1458, 2018.

---

	P1069-24-PM. Use actual situation evaluation of duloxetine in patients not to deceive 辻茉莉香1, 五十嵐文1, 佐藤弘子1, 市田千佳1, 澤村公志1, 山本郁生1, 高橋賢成1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1458-1458, 2018.

---

	P1071-24-PM. 1 case that pain and the bad smell of the cancerous skin ulcer due to the breast cancer were improved by use of the metronidazole gel, and became available for weight loss of the opioid 村上幸恵1, 山本修也1, 金井紀江2, 伊達和俊3, 藤田亘浩3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1459-1459, 2018.

---

	P1073-24-PM. One case that we were able to connect with palliative care patients from foreign going to hospital, inpatient care to home care by the intervention of the pharmacist smoothly 元木孝1, 菊池謙宏1, 泉谷理恵2, 高柳昌宏1, 千田泰健1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1459-1459, 2018.

---

	P1075-24-PM. The current situation and problem of the palliative care team which we saw from request time 礒貝明彦1,2, 小川智恵子1,2, 藤原俊輔1,2, 吉田玲1, 小松弘尚2, 橋本佳浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1460-1460, 2018.

---

	P1077-24-PM. Making of the mild medical therapy manual for pharmacists 中永かおり1, 大垣孝文1, 木瀬大輔1, 霜倉智子1, 上坂一行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1460-1460, 2018.

---

	P1079-24-PM. Investigation of the use of psychotropic drug situation after the initial cancer medical therapy start of patients with breast cancer 波多野優希1, 波多野正和1,2, 山田成樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1461-1461, 2018.

---

	P1081-24-PM. For a feeling of dyspnea of patients with terminal heart failure, it is one case that continuously administering it was effective of the morphine hydrochloride from a hospitalization early stage 前田朱香1, 曽我弘道1, 福島将友1, 清水誉志1, 富田敏章1, 町田聖治1, 入江利行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1461-1461, 2018.

---

	P1058-25-AM. One case with suspected hyperalgesia with the fentanyl tape 今野耕英1,4, 倉繁愛1,4, 大竹隆晴1,4, 大江奈美子2,4, 佐藤彩2,4, 阿部立也3,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1462-1462, 2018.

---

	P1060-25-AM. Attitude survey to the current situation and a physician of the fentanyl patch prescription to opioid-free patients 世古口拓也1, 濱口容子1, 三宅知宏1, 谷村学1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1463-1463, 2018.

---

	P1062-25-AM. Investigation about the use situation of the naldemedine and the side effect expression situation 田島紳介1, 関礼輔1, 篠原高雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1463-1463, 2018.

---

	P1064-25-AM. Use fact-finding of the naldemedine tosyl acid salt for the opioid-induced constipation and examination about the usefulness 北野祐香1, 東達也1, 井上敦介1, 岡本明子2, 廣畑和弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1464-1464, 2018.

---

	P1066-25-AM. Investigation about the role of the palliative care team at introduction of naldemedine tosyl acid salt tablets of our hospital and the use situation and the effect 高木茂実1,2, 宮本幸雄2,3, 野村朋子2,4, 土田真樹子2,4, 米田杏子2,5, 吉田絵美2,5, 林みどり1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1464-1464, 2018.

---

	P1068-25-AM. One patient who was treated effectively with neurodestruction by the intrathecal phenol block for the cancerous pain to suffer from 赤石憲俊1, 吉田勝好1,3, 郷原学1, 片桐浩2, 土佐めぐみ3, 斉藤操3, 服部晋司3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1465-1465, 2018.

---

	P1070-25-AM. In-hospital instructions examination in the use of opioid preparation half a dose 北村修1, 勝又一雄1, 川口洋実1, 小林義典1, 小林豊1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1465-1465, 2018.

---

	P1072-25-AM. Relation to the patients who cannot express pain well 堀敦雄1, 久保寺祐季1, 川嵜真太郎1, 西嶋長1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1466-1466, 2018.

---

	P1074-25-AM. The preparation of the duloxetine bougie and evaluation of the bioavailability 山田龍之介1, 大門拓実2, 清水翔太1, 滕真由美1, 村田勇1, 井上裕1, 金本郁男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1466-1466, 2018.

---

	P1076-25-AM. One patient who was treated effectively with Mohs paste for a breast cancer disintegration wound 渡部智文1, 根本紀子2, 吉川慧1, 吉川真一3, 吉田進3, 松田明宏1, 川口信哉2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1467-1467, 2018.

---

	P1078-25-AM. Consideration about the factor becoming the wall of the active pharmacy management instruction for the cancerous pain relief therapy case 畝佳子1, 覚野律2, 政道修二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1467-1467, 2018.

---

	P1080-25-AM. Contribution degree investigation of the current situation and the charge pharmacist about the palliative care of the national hospital mechanism (the fifth report) 形部文寛1, 中村孝祐2, 林俊吾3, 山崎富士子3, 八本聖秀4, 波多江崇5, 八本久仁子6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1468-1468, 2018.

---

	P1082-25-AM. Relations of a dose and the SSI incidence per weight of prophylactic antimicrobial in the elective lower digestive tract surgery 入口慎史1, 田中昌代1, 加藤敏明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1469-1469, 2018.

---

	P1084-25-AM. Efforts and results to proper use of the prophylactic antimicrobial based on results of the surveillance of the perioperative infection 小関崇文1, 日向早苗3, 大貫敏明1, 安田麻美1, 笠井洋輝1, 西關由梨子1, 芦澤由佳1, 加藤由紀1, 伊藤早紀1, 大場雄一4, 湊栄治2, 小舛修三2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1470-1470, 2018.

---

	P1086-25-AM. Examination of the effect by having unified infection prophylaxis antimicrobial after the operation of our hospital orthopedics surgery in CEZ 梅木拡嵩1, 森伸子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1470-1470, 2018.

---

	P1088-25-AM. Examination of the usefulness of the administration before kanamycin in the colon cancer surgery and metronidazole technique 馬島務1, 浅井茂夫1, 稲村勝志1, 深海広平1, 高田宏文1, 小田剛史1, 山下剛史郎1, 山本諭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1471-1471, 2018.

---

	P1090-25-AM. Approach ... from the pharmacist using the use of efforts - identification antimicrobial questionnaire to the antimicrobial proper use with the medical institution which cannot organize AST 白川哲1, 松尾明子1, 四元華奈1, 佐藤肇1, 松尾啓1, 中村忠之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1471-1471, 2018.

---

	P1092-25-AM. Invention of the hospital infection measures education in the small and medium size hospital obtained from the staff questionnaire and problem of the pharmacist 浅井憲和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1472-1472, 2018.

---

	P1094-25-AM. Effect by the pharmacist round start for the blood culture submission patients 岡平将志1, 北村卓麿1, 近藤結1, 播磨里美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1472-1472, 2018.

---

	P1096-25-AM. Efforts of our hospital in the drug-resistant measures action plan 並木孝哉1, 枦秀樹1, 太田哲徳1, 織田錬太郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1473-1473, 2018.

---

	P1098-25-AM. Examination about efforts and the education effect to the antimicrobial proper use by the antibacterial chemotherapy workshop (Osaka ABC) for young pharmacists 安井友佳子1, 上田覚2, 行本拓史3, 眞継賢一4, 山田智之5, 伊藤千恵6, 吉野秀紀7, 石坂敏彦8, 関雅文9 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1473-1473, 2018.

---

	P1100-25-AM. Efforts and enforcement results of Antimi-crobial Stewardship Program for antimicrobial proper use in our hospital 須山由佳子1, 神戸宏憲2, 神田藍1, 杉山恭平1, 鈴木清美2, 大石和伸3, 袴田康弘2, 木村緑1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1474-1474, 2018.

---

	P1102-25-AM. About intervention of Antimicrobial stewardship team for the purpose of the antibacterial chemotherapy adequacy 梅坪翔太1, 望月敬浩1, 櫻井美満1, 押田幸恵2, 杉山知代2, 市川美香2, 山本泰正3, 明貝路子3, 伊東直哉3, 堤直之3, 倉井華子3, 篠道弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1474-1474, 2018.

---

	P1104-25-AM. Effect ... by the intervention of attitude survey - antimicrobial proper use support team about the antimicrobial proper use support for ward pharmacists 弓長藤佳1, 渡部智貴1, 加藤一郎1, 金田暁2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1475-1475, 2018.

---

	P1106-25-AM. Use fact-finding of the antimicrobial in the emergency pediatric service outpatient department 吉田真也1, 松岡知子1, 大橋健吾1, 日野光記枝1, 安田茉緒1, 森万希子1, 黒田彩夏1, 宇佐美英績1, 鹿野博明2, 吉村知哲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1475-1475, 2018.

---

	P1108-25-AM. Prescription investigation of the oral antimicrobial in the outpatient department and future problem 松島菜々1,2, 鈴木千博1, 村山将也1,2, 關直子1, 辻晋也2, 藤井奨2, 吉見猛1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1476-1476, 2018.

---

	P1110-25-AM. The prescription situation investigation of levofloxacin for the internal use in the Iizuka Hospital 梅田勇一1, 内田守次1, 長崎皓光1, 金澤康範1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1476-1476, 2018.

---

	P1112-25-AM. Consumption evaluation of the carbapenem-based antimicrobial using Days of therapy (DOT) 長尾柚香1, 近藤晃史1, 坂野昌志1, 寺井文廣1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1477-1477, 2018.

---

	P1114-25-AM. Evaluation of the meropenem proper use judging from PK/PD parameter 松崎玲奈1, 近藤晃史1, 坂野昌志1, 寺井文廣1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1477-1477, 2018.

---

	P1116-25-AM. Comparison about the safety between meropenem hydrate generic medicine two drugs 中蔵伊知郎1,2, 今西嘉生里1,2, 宮部貴識1, 佐光留美1, 山崎邦夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1478-1478, 2018.

---

	P1118-25-AM. Factorial experiments of the acute renal failure onset by the combination of vancomycin and tazobactam/piperacillin 上瀧喬仁1, 酒井義朗1, 樋口恭子1, 三輪涼子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1478-1478, 2018.

---

	P1120-25-AM. Fact-finding about the vancomycin administration situation under the peritoneal dialysis 中川裕介1, 島田泉1, 小林将文1, 袖山健吾1, 鈴木直人1, 外山聡1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1479-1479, 2018.

---

	P1122-25-AM. Correlation of thrombocytopenia expression and dose in the linezolid administration 石井奈津季1, 喜多洋嗣1, 喜多幸子1, 長濱藍1, 仲村亮太1, 森智子1, 駒井勇太1, 人見百合子1, 石井英之1, 田仲祐子1, 府川祥子1, 村雲智久1, 近藤理美1, 坂口結斗1, 白木萌1, 三浦捺樹1, 峯浩太朗1, 宮川千珠1, 中村麗紗1, 山中愛美1, 吉村美菜1, 岸本実優1, 北池祥子1, 小久保綾乃1, 又吉樹2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1479-1479, 2018.

---

	P1124-25-AM. An example of the seriously ill burn patients who were able to be treated with linezolid and ST medical mixture combination therapy for daptomycin-resistant MRSA bacteremia 神戸宏憲1, 宮川赳平2, 三宅章公2, 春田浩一2, 吉岡良造2, 成田知大2, 牧信行2, 吉田裕2, 大石和伸3, 木村緑1, 登坂直規2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1480-1480, 2018.

---

	P1126-25-AM. Relation of the pharmacist in the clinical path making of the aspiration pneumonia 伊藤隆哉1, 青木静恵2, 手島憲一3, 吉池昭一4, 小田切範晃5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1480-1480, 2018.

---

	P1128-25-AM. Stocktaking of the Bundle compliance for the MRSA bacteremia in the Tsushima Municipal Hospital 清水智也1, 伊藤嘉英2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1481-1481, 2018.

---

	P1130-25-AM. Fact-finding of the liver damage of the antimicrobial in the Kumamoto function hospital 塚本康代1, 星野輝彦1, 下田賢一郎1, 塩津和則1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1481-1481, 2018.

---

	P1132-25-AM. Comparison - with examination - Pseudomonas aeruginosa case of the two-drug resistant Pseudomonas aeruginosa case 鈴木美華1, 平岩歳久1, 寺澤宏紀1, 鈴木竜太1, 山田茂樹1, 石井潤一3, 石川清仁2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1482-1482, 2018.

---

	P1134-25-AM. The current situation of the antimicrobial administration for the acute respiratory tract infection in our hospital 唐芳浩太1, 菅原秀悦1, 吉田和美1, 阿部憲介1, 後藤達也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1482-1482, 2018.

---

	P1136-25-AM. A bacterial brain abscess by the pharmacist participation is ... using one - injection antimicrobial which we healed and internal use antimicrobial 杉田尚子1, 遠藤愛樹1, 花輪和己1, 小林義文1, 山本誠一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1483-1483, 2018.

---

	P1138-25-AM. The case that infection treatment was provided by local gentamicin sustained administration from intra-Sectional Antibiotics Perfusion (iSAP) 松尾麻美1, 中島一1, 今村陽子1, 柏田匡広1, 大石貴裕1, 池田浩和1, 福田文雄2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1483-1483, 2018.

---

	P1083-24-PM. Analysis of the perioperative infection risk factor in the cardiovascular surgery surgery of our hospital 河村真歩1, 門口直仁1, 橋田真佐1, 三宅陽一郎2, 田中聡1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1485-1485, 2018.

---

	P1085-24-PM. Examination of the appropriate antimicrobial usage of the perioperative infection prophylaxis 今井雅之1, 石崎均1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1486-1486, 2018.

---

	P1087-24-PM. It is examined the infection prophylaxis antimicrobial proper use after the operation in our hospital otolaryngology 有延早弥香1, 吉岡睦展1,2, 岡秀樹3, 小澤拓1,2, 山本真由美1, 細見真世1, 若松雄太1,2, 石津智司1,2, 森田聡子1, 西山祐美1, 小林敦子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1486-1486, 2018.

---

P1089-24-PM. The oral antimicrobial administration cancellation having been appropriate after examination ... operation about the usefulness of AMR measures in the central part Rousaibyoin obstetrics and gynecology department or ... 丹村亜梨朱1, 山口智江1,4, 中根茂喜2, 宮原兼二1,4, 平松久典1,4, 兼子詩布1, 片野貴大1, 荒川正悟1, 菅もも3, 藤原多子3, 石川真弓4, 福原順子4, 町田和彦4, 伊藤功治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1487-1487, 2018.

---

	P1091-24-PM. Analysis of the factor affecting the evaluation and the suggestion acceptance rate of the antimicrobial proper use support (AS) activity by the pharmacist 齊藤伸1, 木元健寛1, 仙葉悠紀1, 工藤和彦1, 吹谷真紀子1, 一関美江子1, 金美紀1, 篠田和人1, 山崎恵葉1, 鈴木ひとみ1, 八代佳子1, 水沢重則1, 後藤敏晴1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1487-1487, 2018.

---

	P1093-24-PM. Efforts of the antimicrobial proper use support team conference in our hospital 佐藤圭吾1,2, 佐藤陽介1, 伊藤貴亮1, 菅野和1, 茄子川智子2, 永沼結花3, 尾池泰典2,3, 松本亜紀2, 井上顕治2,4, 篠崎滋5, 小林誠一6, 矢内勝2,6, 佐賀利英1,7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1488-1488, 2018.

---

	P1095-24-PM. The change of the antimicrobial proper use promotion activity in the public west Chita General Hospital: Comparison of antimicrobial proper use team activity three years 小林義和1,2, 川崎祥平1, 吉岡祐貴1, 長谷川万里子1, 新美太祐1,2, 伊藤靖2, 生田宏次2, 浅野昌彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1488-1488, 2018.

---

	P1097-24-PM. An antimicrobial proper use support activity in our hospital and the evaluation 北村好申1, 大川華代2, 篠崎陽一2, 北村正樹2, 中澤靖1, 川久保孝2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1489-1489, 2018.

---

	P1099-24-PM. Construction of AST duties using the specific drug monitoring system 伊藤新司1, 坂井孝行1, 六波羅孝1, 内木義泰1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1489-1489, 2018.

---

	P1101-24-PM. AST activity in our hospital and effect on use of CDI therapeutic drug actual situation 松本芳樹1, 三木芳晃1, 塚本啓介1, 梅林良英1, 山口みなみ1, 渡邉優子1, 西垣玲奈1, 山下加珠美1, 川口尚子2, 萱野勇一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1490-1490, 2018.

---

	P1103-24-PM. Antimicrobial medicine proper use investigation in the night emergency visit 田中一平1, 加籐智之1, 中村友香1, 浜田吉昭1, 日野斉一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1490-1490, 2018.

---

	P1105-24-PM. Investigation by the monitoring system construction of the quantity of oral antimicrobial prescription in the respect and affection society 玉城哲子1, 浦崎清美1, 城間盛彦1, 仲吉亜依美1, 武富美貴子1, 長濱照美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1491-1491, 2018.

---

	P1107-24-PM. The use situation of the internal use antibiotic in the seriously disabled child (person) 川原茉莉1, 脇田恵里1, 伊藤洋貴1, 佐藤賛治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1491-1491, 2018.

---

	P1109-24-PM. Examination about the use situation of the wide area antimicrobial by carbapenem-based antimicrobial proper use measures 河村茉衣1, 花房伸幸1, 小池彩子1, 廣田あゆ子1, 奥格2, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1492-1492, 2018.

---

	P1111-24-PM. The reporting by the antimicrobial proper use support team for the purpose of the meropenem proper use support and use turn of eventss with it 浅野嘉之1, 伊東和真1, 大岩拓馬1, 加藤麻理乃1, 水草博希1, 前田剛司1, 坂田洋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1492-1492, 2018.

---

	P1113-24-PM. Grasp and comparison between public west Chita General Hospital and use of meropenem (MEPM) situation between the regional alliances institution of the Chita Peninsula demographic division of medical services 川崎祥平1, 野澤正徳2, 外山昌伸3, 吉岡祐貴1, 小林義和1, 生田宏次1, 浅野昌彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1493-1493, 2018.

---

	P1115-24-PM. Examination of the impaired renal function that vancomycin and tazobactam/piperacillin combination cause 袖山健吾1, 島田泉1, 小林将文1, 鈴木直人1, 外山聡1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1493-1493, 2018.

---

	P1117-24-PM. Suggestion of the alternative agent in consideration of the cross reactivity for the patients who presented with neutropenia during vancomycin administration 勝綾香1, 中薗健一1, 末永桂子1, 横山美恵子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1494-1494, 2018.

---

	P1119-24-PM. Inspection of the causation of the vomiting expression in linezolid treated patients 堤竹蔵1, 今井俊吾1, 堤佳那1, 山田武宏1, 笠師久美子1, 小林正紀1, 井関健1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1494-1494, 2018.

---

	P1121-24-PM. We look at the rear of the factor affecting the thrombocytopenia with the linezolid administration and examine a mark 向山直樹1, 向山麻衣子1, 成瀬徳彦1, 黒野康正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1495-1495, 2018.

---

	P1123-24-PM. About the making of the aspiration pneumonia pass for the purpose of the antimicrobial proper use and the usefulness 山田富美子1, 滝雪歩1, 安原昌宏1, 原田靖子1, 大成洋二郎2, 西原昌幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1495-1495, 2018.

---

	P1125-24-PM. Can you plan the proper use of the antimicrobial by antimicrobial proper use bundle? 井出和男1, 寶福誠1, 小井土啓一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1496-1496, 2018.

---

	P1127-24-PM. The intervention example that we conducted a certain grounds suggestion according to a principle for patients with animal bite, and a transmistake became good 西村尚芳1, 津曲恭一1, 尾之江剛樹2, 古郷修一郎3, 北島久義1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1496-1496, 2018.

---

	P1129-24-PM. One patient who they presented with febrile neutropenia and meningitis due to multidrug-resistant Pseudomonas aeruginosa after the chemotherapy, and obtained recovery 浅川杏子1, 清水忠洋1, 齊藤安昌1, 曾根原亘1, 太田光2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1497-1497, 2018.

---

	P1131-24-PM. Look at the rear of the treatment case of multidrug-resistant tuberculosis in our hospital; mark investigation 柴田有希子1, 内藤靖雄1, 赤沢翼1, 増田純一1, 近藤直樹1, 坂本治彦1, 小林明信1, 寺門浩之1, 高崎仁2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1497-1497, 2018.

---

	P1133-24-PM. The case that suggested appropriate antimicrobial for a brain abscess 安冨佑思1, 津曲恭一1, 尾ノ江剛樹2, 北島久義1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1498-1498, 2018.

---

	P1135-24-PM. Bacillus sp. which developed in patients with myelodysplastic syndrome during azacitidine therapy One case of the bacteremia to depend on this 大島千佳1, 奥田拓也1, 伊東克郎2, 新井成俊1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1498-1498, 2018.

---

	P1137-24-PM. One patient who was able to connect to the interaction evasion of VRCZ for the purulent omarthritis that presented βD glucan high level 千葉博暁1, 富樫ふみ2, 古田島聡3, 村上衛4, 狩野太郎5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1499-1499, 2018.

---

	P1139-24-PM. One case that we resumed warfarin during use of miconazole gel, and a PT-INR level caused abnormal high level 永松翔1, 岩下龍史2, 寺師守彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1499-1499, 2018.

---

	P1141-24-PM. Evaluation of the antimicrobial consumption of the Saiseikai Futsukaichi Hospital using the use of antimicrobial pulse-taking system (the JACS) 秀島久美子1, 中野祐樹1, 大竹野久雄1, 猪口陽子1, 蓮輪博嗣1, 横尾賢乗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1500-1500, 2018.

---

	P1143-24-PM. Efforts to antimicrobial proper use support addition calculation in the Hashima Municipal Hospital 伊藤真也1, 山本英治1, 鈴木俊敬1, 濱田陽子1, 丹羽伊紀詠1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1501-1501, 2018.

---

P1145-24-PM. Comparison of the MRSA detection situation and the use of hand disinfectants situation in the Niigata public welfare consecutive 15 institution, comparison of skin disinfectant at blood culture and the blood culture-positive rate 霍間尚樹1,2, 細川浩輝2, 渡辺一也2, 丸山弘朗2, 山田加代子2, 江口裕子2, 岩田昌英2, 山岸綾子2, 笹原一裕2, 石川光教2, 庭野旬子2, 結城杏子2, 相田有美子2, 石川昭子2, 赤塚孝宏2, 本間絵美2, 佐藤宏2, 山本修也2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1501-1501, 2018.

---

	P1147-24-PM. Infection measures class of the practice pattern for the drugstore desk work that aimed at the alteration of consciousness 石原義久1, 竹内正幸2, 里山雅子1, 永田梨奈1, 柏木宏仁1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1502-1502, 2018.

---

	P1149-24-PM. Examination about the onset of de-escalation and infection lifesaving rate of the antimicrobial in blood culture-positive patients and antimicrobial-related loose bowels situation 岡崎萌水1, 柳澤成佳1, 八木祐助1, 森田靖代1, 宮村充彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1502-1502, 2018.

---

	P1151-24-PM. Epidemiologic studies about the drug resistance of the Haemophilus influenzae derived from the children in the single teaching hospital of Japan 原直己1,2, 田中愛海2, 落合翔子2, 瀬山翔史3, 輪島丈明2, 野口雅久2, 夏目義明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1503-1503, 2018.

---

	P1153-24-PM. Evaluation about the infection prevention effect of peroxymonosulfuric acid hydrogen potassium combination sanitization, the cleaner to Clostridioides difficile infection 今井清隆1, 一幡結1, 上坂一行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1503-1503, 2018.

---

	P1155-24-PM. Attitude survey of the healthcare worker for the antimicrobial prescription to cold syndrome 川島渉1,2, 詫間章俊2, 市村丈典1,2, 高田昂輔1,2, 市倉大輔1,2, 縄田修一1,2, 峯村純子1,2, 佐々木忠徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1504-1504, 2018.

---

	P1157-24-PM. Local joint surveillance about antimicrobial consumption and the resistant bacteria separation rate in the Toyama prefecture 26 institution 細野美幸1, 飯尾志帆1, 高野雄介1, 高橋慎太郎1, 脇田真之1, 守内匡1, 加藤貴子1, 窪田佳代子1, 杉田真理子1, 船本哲生1, 辻泰弘2, 山本善裕3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1504-1504, 2018.

---

	P1142-25-AM. Efforts of an investigation and the pharmacist of the use of antimicrobial situation for the AMR measures promotion 中市里実1, 澤田美穂2, 善積司行1, 岩佐沙希子1, 楠本民彌1, 三浦絢1, 前田智佳子1, 長野有沙1, 台野佳代1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1505-1505, 2018.

---

	P1144-25-AM. Participate in AMR measures - infection measures network in the psychiatry single department hospital; and - 津倉由里1, 上中敦1, 大尾充剛1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1506-1506, 2018.

---

	P1146-25-AM. Fact-finding about the maneuver of the hand hygiene in Japanese Foundation for Cancer Research Ariake hospital pharmacy duties 川村舞雪1, 山田玲子1, 庄司大悟1, 鈴木強志1, 濱敏弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1506-1506, 2018.

---

	P1148-25-AM. An example and the hospital infection measures that were treated for meningococcus meningitis by the ICT 森章哉1,5, 中嶋里佳1,5, 青木康二1,5, 小林百合2,5, 別所裕二3,5, 村田哲也4,5, 河村雅人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1507-1507, 2018.

---

	P1150-25-AM. Inflection of the bloodstream infections management bundle aiming at standardization of the bloodstream infections prevention 奥平正美1,2, 犬塚和久1,3, 大曲貴夫1,4, 笠井正志1,5, 日馬由貴1,4, 松島由実1,6, 村木優一1,7, 村松有紀1,8, 八木哲也1,9, 三鴨廣繁1,10 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1507-1507, 2018.

---

	P1152-25-AM. Study on risk factor of the Respiratory Syncytial Virus infection patients of the 2017 season 丹代恭太1, 工藤晋1, 鈴木弘文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1508-1508, 2018.

---

	P1154-25-AM. Stocktaking of the Bundle compliance for the Candida bacteremia in our hospital 伊藤嘉英1, 清水智也2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1508-1508, 2018.

---

P1156-25-AM. Use of antimicrobial density (AUD) under Okinawa and use days (DOT) surveillance - Okinawa hospital pharmacist meeting infection subcommittee multicenter study ... 座間味丈人1,2, 潮平英郎1,2, 上地幸平2,3, 小杉卓大4, 新垣淑大4, 喜舎場知香5, 伊波寛史5, 喜友名朝史5, 入月健6, 與那原希6, 島袋友香子7, 小橋川健枝7, 高良秀史8, 吉本尚志9, 新崎さや乃9, 宜保潤10, 浜元善仁11, 平田やよい11, 戸北浩志12, 玉城哲子13, 城間盛彦13, 金城亜衣美13, 川平浩子5, 外間惟夫1, 藤田次郎2,14 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1509-1509, 2018.

---

	P1158-25-AM. Chronic kidney disease and renal function evaluation in rheumatic disease methotrexate chronic administration patients 大津貴寛1, 松石裕也2, 宮下裕央2, 津曲恭一2, 橋本雅司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1510-1510, 2018.

---

	P1160-25-AM. Problems of the pharmaceutical products proper use of patients in CKD in the health insurance pharmacy 長谷川浩三1, 西竜二郎1, 門脇大介2, 宮村重幸3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1511-1511, 2018.

---

	P1162-25-AM. Effect examination to the iron-deficiency anemia of the dialysis introduction patients in the ferric citrate hydrate 藤崎来夢1, 枦秀樹1, 太田哲徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1511-1511, 2018.

---

	P1164-25-AM. Examination about the combined effect of a lipid dysbolism therapeutic drug and the high phosphorus blood symptom therapeutic drug using the high fat diet rat 小田雅子1, 佐々木環凪1, 角能佑樹1, 染木拓也1, 市村祐一1, 齊藤浩司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1512-1512, 2018.

---

	P1159-24-PM. About safety of the eplerenone administration for the decreased renal function patients 西尾洋平1, 藤吉里紗1, 奥村浩樹1, 渡部実咲1, 田中佳子1, 平下智之1, 谷沢克弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1513-1513, 2018.

---

	P1161-24-PM. For problems extraction and the solution to drug proper use program - current situation for patients in CKD which an insurance pharmacist founds 島祐子1, 有山知代1, 山森直子1, 梅野明子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1514-1514, 2018.

---

	P1163-24-PM. Effect on anemia-related index with the ferric citrate hydrate administration in haemodialysis patients 西崎文祥1, 増田展利1, 杉山哲大2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1514-1514, 2018.

---

	P1165-24-PM. About the combined effect of DPP-4 inhibitor and the SGLT-2 inhibitor 田仲祐子1, 喜多洋嗣1, 喜多幸子1, 長濱藍1, 仲村亮太1, 森智子1, 駒井勇太1, 人見百合子1, 府川祥子1, 村雲智久1, 近藤理美1, 坂口結斗1, 石井英之1, 三浦捺樹1, 峯浩太朗1, 宮川千珠1, 水野康平1, 山中愛美1, 吉村美菜1, 岸本実優1, 北池祥子1, 小久保綾乃1, 白木萌1, 中村麗紗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1515-1515, 2018.

---

	P1167-24-PM. Sugar, a serum lipid metabolism change and medication counseling effect on patients with SGLT2 inhibitor ipragliflozin administration diabetes 江月優1, 玉井祐馬1, 瀧田優樹1, 中村由香2, 行宗千裕2, 泉京江2, 武田未佳2, 三浦剛3, 佐々木英久1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1516-1516, 2018.

---

	P1169-24-PM. Investigation of the change of the blood glucose level accompanied with Dulaglutide and the liraglutide introduction of the GLP-1 receptor agonist 鳥居葵1, 村瀬瑞希1, 和田祐一郎1, 坂井裕美1, 穂積廣1, 加藤香奈1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1516-1516, 2018.

---

	P1171-24-PM. Comparison between precedent biomedicine and effect of the Biosimilar of insulin glargine 中山潤美1, 加藤まゆ1, 大谷寧次郎1, 畔柳敏弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1517-1517, 2018.

---

	P1179-24-PM. Usefulness evaluation as the biomarker of the plasma kiss peptin concentration in the diabetes diagnosis 片桐文彦1, 小谷仁人2, 木村耕二1, 高柳理早1, 山田安彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1519-1519, 2018.

---

	P1181-24-PM. Ophthalmology consultation encouragement for the diabetic retinopathy prevention by the drugstore pharmacist 夏山絢子1, 小西秀平1, 吉田恭子1, 河島大介1, 木下大輔1, 石橋正次1, 兼重晋1, 山村伸也1, 古賀友一郎1, 高木淳一1, 鷲山厚司1, 虎石顕一1, 田中泰三1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1519-1519, 2018.

---

	P1168-25-AM. Effect and examination of the risk factor to give HbA1c of the SGLT2 inhibitor kana glyph rosin remedy patients 亀田美保1, 水永耀子1, 横田智美1, 町田加純1, 黒川彰太1, 岡村和彦1, 佐々木雄啓1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1521-1521, 2018.

---

	P1170-25-AM. Usefulness of the Dulaglutide in patients with type 2 diabetes and safe examination 橋本公貴1, 早川伸樹1,2, 津川透1,3, 福井愛子1, 亀井浩行1, 吉野寧維2, 岡本慧子2, 鈴木敦詞2, 山田成樹3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1521-1521, 2018.

---

	P1172-25-AM. It is versatility and effect ... of the administration extended ... insulin Degludec of the treatment with insulin choice to elderly people three times a week 安部絵里1, 中島啓二1, 臼井一将1, 多賀小枝子1, 新井かおり1, 伊藤加代1, 蜜田哲也1, 宇佐美英績1, 柴田大河2, 傍島裕司2, 吉村知哲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1522-1522, 2018.

---

	P1174-25-AM. Examination about the diabetes self injection drug in elderly people 糸川貴之1, 斉藤芳敬1, 西村栄一1, 近藤智幸1, 村上達也1, 鈴木正樹1, 簑島弓未子1, 橋本光生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1522-1522, 2018.

---

	P1176-25-AM. About carrying of the sugar at the hypoglycemia 木元慎一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1523-1523, 2018.

---

	P1178-25-AM. 1 case that developed heart failure during pioglitazone remedy 村瀬瑞季1, 鳥居葵1, 和田祐一郎1, 坂井裕美1, 穂積廣1, 加藤香奈1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1523-1523, 2018.

---

	P1180-25-AM. Relationship of serum Zn and HbA1c 森田啓嗣1, 川上恭弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1524-1524, 2018.

---

	P1182-25-AM. It is ... about the inflection of current situation - diabetes conversation map (TM) of the use of antidiabetic drug situation investigation and the diabetes medical treatment instruction of the Kanagawa Saiseikai young grass hospital 宮永幸実1, 小杉満孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1524-1524, 2018.

---

	P1183-24-PM. Intervention of a pregnant woman, the nursing mother medical therapy authorization pharmacist for the mental disorder merger pregnant woman 松本侑季1, 星裕也1, 石井紀子1, 寺山義泰1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1525-1525, 2018.

---

	P1185-24-PM. Blood level measurement ... of case - pregnant woman of the breast-fed infant of the zonisamide remedy patients and neonates 三上有希1, 澤井麻記1, 野崎歩1, 前田万里紗2, 澤田彩李4, 澤田眞智子3, 小林由佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1526-1526, 2018.

---

	P1187-24-PM. Counseling contents until the drug blood level change of mother children in the case given the pregnancy, the nursing after the tacrolimus internal use and the nursing start 伊差川サヤカ1, 大田久美子1, 瑞慶山にいな1, 潮平英郎1, 与那覇房子1, 外間惟夫1, 中村克徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1526-1526, 2018.

---

	P1189-24-PM. The pregnancy outcome by the presence or absence of influenza immunization of the pregnant woman and effect on fetuses 星野裕子1, 関澤真人1, 高津戸敬1, 渡辺尚2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1527-1527, 2018.

---

	P1191-24-PM. 1 case of the initial infection pregnant woman who needed the enforcement situation investigation of the cytomegalovirus antibody screening and treatment 遠藤千夏1, 國本雄介1, 伊藤彩子1, 景山ますみ1, 北川学1, 木明智子1, 中田浩雅1, 水内将人2, 宮本篤1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1527-1527, 2018.

---

	P1193-24-PM. Examination about the presence or absence of effect accompanied with the abolition of postpartum prophylactic methylergometrine and the antimicrobial internal use administration 森本めぐみ1, 中浴伸二1, 濱宏仁1, 森本茂文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1528-1528, 2018.

---

	P1195-24-PM. The effect that ritodrine hydrochloride doses give to a rise in serum creatine kinase value 出口賀奈子1, 伊藤朱里1, 桐生浩子1, 原美由紀1, 西川嘉広1, 橋本陽1, 今西義紀1, 小出哲朗1, 須川由理子1, 本橋卓2, 伊藤久美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1528-1528, 2018.

---

	P1197-24-PM. Efforts for pharmacist intervention in the obstetrics and gynecology department ward of the Sapporo Tokushukai Hospital 山岡幸1, 宮腰恵生1, 藤澤春香1, 宮越貴之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1529-1529, 2018.

---

	P1199-24-PM. Efforts of the current situation and our hospital of questions and answers about the medical therapy of a pregnant woman, the nursing mother 伊藤緑1, 佐藤直子1, 土井啓員1, 増田雅行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1529-1529, 2018.

---

	P1201-24-PM. The gestation period, lactational medicine consultation foreign current situation in our hospital 前田早織1, 小林映子1, 藤岡泉2, 笠井靖代2, 石田耕太1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1530-1530, 2018.

---

	P1184-25-AM. Attempt - of the pharmacist by instruction management - multi-type of job cooperation to the expectant mothers who had the mental disorder 伏見友里1, 榎澤彩1, 春岡美姫1, 古川ゆかり1, 松永理恵1, 大澤優里1, 神下大佑1, 藤本和利1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1531-1531, 2018.

---

	P1186-25-AM. Mother's milk childcare case by the blood level monitoring in a mother's body and neonates during lamotrigine remedy 早川朋子1, 大橋拓人1, 藤井尚子1, 君野沙紀1, 須田奈美1, 加藤潤一郎1, 生駒直寛2, 田辺行敏2, 上出泰山3, 川久保孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1532-1532, 2018.

---

	P1188-25-AM. Caffeine concentration out of consciousness and the mother's milk for the caffeine intake of mother at one month medical examination 香西祥子1,2, 加藤育子2, 田中彩2, 白澤彩香2, 河西邦浩1, 岡田仁2, 日下隆2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1532-1532, 2018.

---

	P1190-25-AM. For drug evaluation - Drugs in Pregnancy and Lactation (G.G.Briggs et al.) revision for taking Amoxicillin at pregnancy - 増田寛樹1, 中野志乃1, 前田恵里2, 岡田裕子2, 溝口優1, 山口友明3, 鷲見正宏4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1533-1533, 2018.

---

	P1192-25-AM. Efforts for right knowledge enlightenment about the vaccination of the gestation period 佐藤寛子1, 伊藤有美1, 鈴木秀明1, 滝本典夫1, 足立守1, 今井夏子2, 長船綾子3, 梅津朋和3, 山本真一3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1533-1533, 2018.

---

	P1194-25-AM. IgA nephropathy merger pregnant example that evaded dialysis introduction by the intervention of the pharmacist 加藤沙織1, 長谷川まゆみ1, 三井由加子1, 小野義久2, 長谷川元3, 近藤正巳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1534-1534, 2018.

---

	P1196-25-AM. One patient whom the myotonica dystrophia of mother children was diagnosed in with the rhabdomyolysis onset after the ritodrine hydrochloride oral administration 豊田容子1, 関谷泰明1, 平下智之1, 谷沢克弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1534-1534, 2018.

---

	P1198-25-AM. Analysis of pharmaceutical management intervention contents in the use of supplement for hospitalized pregnant women 安達真紀子1, 高橋亜樹子1, 孝田佳子1, 井上和子1, 高根浩1, 島田美樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1535-1535, 2018.

---

	P1200-25-AM. Investigation using the questionnaire targeted for a physician about the effect by the electronic medical chart publication of a pregnant woman, the nursing mother medical therapy material 大野愛1, 伊藤友恵1, 伊藤孝子1, 山本恭平1, 岩瀬由枝1, 鶴田昌吾1, 石上仁美1, 猪岡真己1, 久保田敏行1, 杉浦洋二1, 勝見章男2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1535-1535, 2018.

---

	P1202-25-AM. Attitude survey to the medication of the nursing mother 足立易子1, 杉本芙美1, 浜田凌介1, 神谷量子1, 銭瑶子1, 澤井健太1, 多賀野正嗣1, 堀哲史1, 伊藤公博1, 竹田和也1, 藤村保夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1536-1536, 2018.

---

	P1203-24-PM. Proper use investigation of the psychotropic drug for BPSD in the medical treatment ward 渡辺智康1, 難波良平1, 山崎恵1, 高取孝一1, 安藤哲信1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1537-1537, 2018.

---

	P1205-24-PM. Association of the physical factor, therapeutic drug of the fall fall in the middle scale hospital 80 years or older inpatient 今井芳1, 福田哲也1, 大越千紘1, 加藤由起子1, 藤田詩織1, 大熊玲子1, 伊藤祥子1, 野本友妃子2, 八代智子1, 吉田誠也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1538-1538, 2018.

---

	P1207-24-PM. Fact-finding of the medical therapy in the delirium patients whom a dementia care team intervened in 薄雅人1,9, 市川竜太郎1,9, 塩川幸子2,9, 高野直人3,9, 内田美子4,9, 小嶋紀子5,9, 豊島遼太郎6,9, 滝久司1, 高木亮1, 黒田勝宏7,9, 溝口功一8,9 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1538-1538, 2018.

---

	P1209-24-PM. The results of the pharmacist for the polypharmacy in the care ward 矢倉尚幸1, 佐々木優1, 大森那美1, 渡辺智之1, 湯本哲郎2, 稲葉健二郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1539-1539, 2018.

---

	P1211-24-PM. Pharmaceutical management of DOAC depending on the renal function in the convalescent rehabilitation ward 山本清子1, 門脇大介2, 森伸子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1539-1539, 2018.

---

	P1213-24-PM. We examine our hospital screening tabulation for PIMs 田畑寛明1, 若林厚史1, 辻依利1, 里見彩1, 猿谷淳1, 向一美1, 地野幹子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1540-1540, 2018.

---

	P1204-25-AM. Inspection of the clinical usefulness and economic effect of the prescription suggestion that a pharmacist makes at the Care health center for the elderly rounds of the physician 須藤寛1, 新井克明2, 青木洋平3, 大庭建三4, 倉田なおみ5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1541-1541, 2018.

---

	P1206-25-AM. Efforts for fall risk assessment and the proper use of benzodiazepine drugs 森伸子1, 森直樹2, 猿渡淳二3, 門脇大介4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1542-1542, 2018.

---

	P1208-25-AM. Role of the pharmacist in the dementia care team 佐賀嘉英1, 梅原祐奈1, 大西真由1, 生井太基1, 四方純子1, 上羽沙綾1, 門脇隼也1, 奥村智晴1, 塩見明日香1, 谷田有花1, 芦田理沙1, 村上由樹1, 足立圭司1, 川見里奈1, 堀雅博1, 足垣亮介1, 宮谷正哉1, 山本真世1, 立道直美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1542-1542, 2018.

---

	P1210-25-AM. About the current situation and a problem in the polypharmacy of the inpatient, the intervention effect of the dementia delirium support team (DST) 市川大介1, 藤野優菜1, 小田真澄1, 中田早苗1, 齋藤文佳1, 古谷佳美1, 安江佳南1, 河本紫帆1, 涌谷洋介2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1543-1543, 2018.

---

	P1212-25-AM. Current situation investigation (1) of the medical therapy to have an influence on the aspiration pneumonia of elderly people 渡邊梓1, 西川満則1, 勝浦正人1, 三輪芳弘1, 大石雅子1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1543-1543, 2018.

---

	P1214-25-AM. The effect that an ad usum externum basis (macrogol, water absorption cream) gives to STZ rat healing of wound process 大竹裕子1, 出口粧央里1, 上田純也1, 坂本竜祐1, 野田康弘2, 長井紀章1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1544-1544, 2018.

---

	P1216-25-AM. Need - pharmacists involved in a drug and the prevention that can become the "skin-tear" origin, please know "the skin-tear"; ... 益成宏1, 原田清美2, 秋元夕希2, 松永美明2, 弘中真紀2, 柳澤知子2, 佐古純子3, 寺尾隆4, 竹本朱美5, 中野純二5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1545-1545, 2018.

---

	P1215-24-PM. Examination about the usefulness of the material for in-hospital reading in pressure sore treatment and the refinement 篠原梨沙1, 中野由希子1, 岩本剛志1, 中川はる奈1, 四方公亮1, 井上由紀1, 佐藤香織1, 勝俣はるみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1546-1546, 2018.

---

	P1219-24-PM. About effect to give to the test value that the number of the taking antiepileptic drug agents before and after the hospitalization brings 矢嶋隆宏1, 山本吉章1, 加藤浩充1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1548-1548, 2018.

---

	P1221-24-PM. It is a 1 case with suspected cholinergic crisis onset with distigmine bromide under the fast instructions 花房伸幸1, 甲元大樹1, 松井美紗子1, 河村茉衣1, 竹中皇2, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1548-1548, 2018.

---

	P1223-24-PM. Intervention to the bone fracture risk in the outside patients targeted for efforts FRAX to the bone fracture risk in patients with steroidal osteoporosis 細沼万衣1, 高澤麻美1, 木立美奈子1, 丹羽直人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1549-1549, 2018.

---

	P1225-24-PM. It is investigated the end reason of the epidural anaesthesia after the operation in our hospital 五十嵐詠美1, 貝瀬眞由美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1549-1549, 2018.

---

	P1227-24-PM. Change of the serum potassium level by the Shakuyakukanzoto remedy 服部真奈1, 杉浦龍也1, 川瀬将紀1, 伊藤広樹1, 守田覚1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1550-1550, 2018.

---

	P1229-24-PM. An example of the young woman whom hypercalcemia developed in by eldecalcitol 佐藤誠一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1550-1550, 2018.

---

	P1231-24-PM. About a pemphigoid case by the DPP-4 inhibitor internal use in elderly people 高木彩菜1, 溝神文博1, 真野澪1, 天白宗和1, 加藤雅斗1, 高嶋理穂1, 安部匡生1, 戸上博昭1, 平島学1, 早川裕二1, 森下瑞穂1, 木ノ下智康1, 平野隆司1, 磯貝善蔵1, 小林智晴1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1551-1551, 2018.

---

	P1233-24-PM. Report of the adverse event by the Ustekinumab administration by IV drip 久保靖憲1, 大滝康一1,2, 三嶋一登1, 小野尚志1, 山下恭範1, 福土将秀1, 田崎嘉一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1551-1551, 2018.

---

	P1235-24-PM. One case of the allergic contact dermatitis with aminocaproic acid included in OTC eye drops 川本英子1, 小池彩子1, 石橋真実1, 山口麻里2, 妹尾明美2, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1552-1552, 2018.

---

	P1237-24-PM. Search of the cells which are optimal for High-Sensitive Allergy Test (HiSAT) 安高勇気1,2, 芝口浩智2,3, 神村英利1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1552-1552, 2018.

---

	P1218-25-AM. Examination about the postoperative PT-INR rise in the warfarin remedy patients 森下友紀1, 徳山ことみ1, 井上結夏1, 藤里駿1, 猪股英幸1, 竹田克明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1553-1553, 2018.

---

	P1220-25-AM. An example in the children whom acute renal failure with gabapentin was suspected in 在本麻由加1, 伊藤俊和1, 三宅麻文1, 尾上雅英1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1554-1554, 2018.

---

	P1222-25-AM. About 2 cases suggestive of the amantadine poisoning 福田裕子1, 田中裕貴子1, 森田貴子1, 道下佳子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1554-1554, 2018.

---

	P1224-25-AM. One case that presented an anaphylactic symptom by a methylprednisolone succinic acid ester sodium 40 mg IV infusion 山中祐美1, 加賀正基1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1555-1555, 2018.

---

	P1226-25-AM. An example of the brain abscess that presented metronidazole-induced encephalopathy by a high dose for a long term 小西喜昭1, 九鬼大作1, 河村雅人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1555-1555, 2018.

---

	P1228-25-AM. Examination of the factor influencing the serum magnesium level of the magnesium oxide preparation internal use patients 兼石誠1, 岡村智文1, 柴田茂貴1, 松岡佳歩1, 松永愛1, 柴田文規1, 田口みどり1, 船越幸代1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1556-1556, 2018.

---

	P1230-25-AM. It is an example with suspected onset of Collagenous Colitis with lansoprazole after the regular hospital change ridge from the ICU 武田佳子1, 土倉史香1, 大木伸泰1, 中野貴文1, 兼重晋1, 緒方憲太郎1, 神村英利1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1556-1556, 2018.

---

	P1232-25-AM. About effect on blood glucose level of fixed-quantity and the KK-Ay mouse of the saccharide of the study on crude drug ingredient (11) - Daikenchuto of Chinese medicine - 椎崇1,2, 米倉萌笑1, 松尾侑希子1, 黒田明平1, 稲葉二朗1, 三巻祥浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1557-1557, 2018.

---

	P1234-25-AM. About safety of the vonoprazan administration for the stress ulcer prevention 高橋弘泰1, 大谷寧次郎1, 畔柳敏弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1557-1557, 2018.

---

	P1238-25-AM. Examination - of the screening not to limit introduction of the HBV screening system and effect - subject drug to chemotherapy 初鹿野達也1, 沖田直美1, 菅原早織1, 原愛1, 山本康仁2, 舩津久美3, 城田幹生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1558-1558, 2018.

---

	P1239-24-PM. Effect to give to antimicrobial activity and warfarin of the etoposide on Bacteroides fragilis group 吉田宣政1, 白土亮子2, 福原佐知1, 檜山智子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1559-1559, 2018.

---

	P1241-24-PM. 1 case that caused PT-INR extension by a complex factor 田中裕貴子1, 福田裕子1, 森田貴子1, 道下佳子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1560-1560, 2018.

---

	P1243-24-PM. An administration change of voriconazole and α-GI is one case with suspected induction of the liver damage by drug interaction 佐藤晃1, 池田舞1, 中野里美1, 平島麻由美1, 堀竜2, 堀裕貴也3, 齊藤幹夫4, 持田知志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1560-1560, 2018.

---

	P1245-24-PM. One case of the purulent spondylitis that showed hypernatremia, polyuria during tolvaptan, fosfluconazole combination 佐脇久美1, 山代栄士1, 原尻学志1, 中島竜太2, 稲垣伸洋2, 森一生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1561-1561, 2018.

---

	P1247-24-PM. Effect on Pemetrexed treated patients investigation of the non-steroidal anti-inflammatory drug combination 西和哉1, 川田彰彦1, 鈴木雄太1, 佐々木崇1, 佐藤ひかり2, 石田雅嗣2, 小野学2, 花釜正和2, 小林誠一2, 矢内勝2, 佐賀利英1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1561-1561, 2018.

---

	P1249-24-PM. Effect on active ingredient Aripiprazole dosage by the incompatibility with the drinking water of 0.1% of prawns rephi private business liquid 石田志朗1, 浜田茂明2, 森本真仁2, 田中成枝1,3, 鈴江朋子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1562-1562, 2018.

---

	P1251-24-PM. 1 case that produced the hypoglycemia which combined repaglinide with the cyclosporin A remedy patients, and was prolonged 河村美弥子1, 田代将貴1, 松原大祐1, 上甲佳奈1, 佐藤潤2, 妹川史朗2, 正木銀三1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1562-1562, 2018.

---

	P1240-25-AM. Analysis of the PT-INR rise factor during the antimicrobial administration in the warfarin remedy patients 武田龍馬1, 半澤里佳1, 木村順平1, 山田和範2, 本間和加子1, 上山憲司3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1563-1563, 2018.

---

	P1242-25-AM. Examination of the thrombotic event occurrence situation by the interaction of an antithrombocytic agent and the proton pump inhibitor in patients with peripheral arterial disease 松田璃沙1, 小原直紘1, 池上洋平2, 田路章博3, 山口崇臣1, 畝佳子1, 政道修二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1564-1564, 2018.

---

	P1244-25-AM. Examination about drug interactions with tacrolimus and voriconazole after the hematopoietic stem cell transplantation 太田涼介1, 平田敦士1, 能登啓介1, 福井愛子1, 横山聡2, 細見光一2, 高田充隆2, 松岡寛1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1564-1564, 2018.

---

	P1246-25-AM. Examination of the serum potassium rise factor of patients receiving sulfamethoxazole/trimethoprim 館内謙太郎1, 元木孝1, 高柳昌宏1, 千田泰健1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1565-1565, 2018.

---

	P1248-25-AM. Examination of frequencies and the risk factor of the hypokalemia at the aminophylline injection administration 小寺聖1, 田中佳子1, 平下智之1, 谷沢克弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1565-1565, 2018.

---

	P1250-25-AM. Magnesium preparation and PPI, examination of the bowel movement effect by the combination of H2bloker 新保一1, 浅見友美子1, 勝俣寛成1, 関川敬1, 伊東秀幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1566-1566, 2018.

---

	P1252-25-AM. Construction of the quantitative drug interactions calculation tool using the CR-IR method 福田祥子1, 黒崎一博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1566-1566, 2018.

---

	P1253-24-PM. Effect by safety and the decreased renal function of transdermal absorbing form bisoprolol in the acute heart disease 奥川寛1, 馬橋美由季1, 野崎歩1, 小林由佳1, 小林智子2, 中村茂2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1567-1567, 2018.

---

	P1255-24-PM. About examination of the THA/TKA postoperative edoxaban start time 野中葉月1, 岡村央1, 若杉正1, 小池博文1, 佐橋幸子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1568-1568, 2018.

---

	P1257-24-PM. Efforts including pharmacist intervention to anagrelide medication continuation for the essential thrombocythaemia 磯知輝1, 小柴聖史2, 小池道明3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1568-1568, 2018.

---

	P1259-24-PM. An example of the levodopa carbidopa hydrate combination drug therapy intervention for the jejunum administration in our hospital 垣沼智之1, 木下史一1, 野田貴義1, 菅尾高裕1, 玄田拓哉1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1569-1569, 2018.

---

	P1261-24-PM. Effective and safe examination of caffeine for patients with apnea of prematurity within week number 28 weeks for gestational ages 長郷あかね1,2, 中村公紀3, 神村英利1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1569-1569, 2018.

---

	P1263-24-PM. add-on effect of the Rifaximin in hepatic encephalopathy treatment 加藤愛梨1, 大谷綾1, 西條由夏1, 笹瀬典子1, 中尾啓子1, 上田愛梨1, 塙久瑠実1, 白井ゆりか1, 金秀基2, 金守良2, 井本勉2, 金啓二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1570-1570, 2018.

---

	P1265-24-PM. Intervention ... for promotion - pregabalin duloxetine of the drug proper use based on a renal function evaluation 貝塚朋恵1, 秋場孝則1, 小野田弘崇1, 森村春菜1, 中野一男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1570-1570, 2018.

---

	P1267-24-PM. Investigation about the use actual situation and the adverse event of the prophylactic ST medical mixture for patients with collagenosis 西尾公志1, 三好孝法1, 山科卓也1, 小林宇太郎1, 山下克也1, 平木洋一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1571-1571, 2018.

---

	P1269-24-PM. HbA1c change in the direct action type antivirus combination therapy and relations of the patients background 友野絵里加1, 平井利典1, 舩木文子1, 伊東俊雅1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1571-1571, 2018.

---

	P1254-25-AM. Search of the factor to control real introduction advisability for the heart failure exacerbation patients meeting a tolvaptan introduction standard 白井麻奈1, 澤田和久2, 鵜飼茜2, 新海大智2, 粟田浩文2, 伊東亜紀雄1, 杉浦洋二2, 長谷川洋一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1572-1572, 2018.

---

	P1256-25-AM. Effective and safe examination of the Edoxaban tosilate acid salt hydrate weight loss administration in patients who underwent lower limbs orthopedics surgery 栗城政子1, 鶴崎大1, 川畑舞佐子1, 深滝利也1, 菊池憲和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1573-1573, 2018.

---

	P1258-25-AM. Examination about the skin irritation reduction effect by the pasting method of the hot compress 近藤綾子1,4, 山本泰大1,4, 出口裕子1,4, 平野茂樹1,4, 櫻井愛菜1,4, 奥村佳美2,4, 公文章子2,4, 浅井泰行3,4, 小田切拓也3,4, 渡邊紘章3,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1573-1573, 2018.

---

	P1260-25-AM. Efforts for the unification of inhalational instruction contents 中西有璃1, 堀本智香1, 渡邉稜子1, 齋藤あゆみ1, 乗松耕平1, 野田有貴子1, 研真梨子1, 尾向紗由理1, 愛甲佳未1, 由良沙央理1, 坂本有里恵1, 山田真人1, 三輪祐太朗1, 藤永仁美1, 大前隆広1, 石田達彦1, 上田里恵1, 福井由美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1574-1574, 2018.

---

	P1262-25-AM. The administration of zinc acetate hydrate preparation (Novell gin) results to the serum zinc level drop patients in cirrhosis and the gastric cancer 山本文哉1, 金田知詞1, 鈴木麻里子1, 横手信昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1574-1574, 2018.

---

	P1264-25-AM. Use fact-finding of the zinc acetate hydrate for the hypozincaemia of patients with cirrhosis 若松遼介1, 飯田美紅1, 道貝優太1, 須藤大雄1, 村中一大1, 飛澤国広1, 小原秀治1, 小関至2, 小原郁司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1575-1575, 2018.

---

	P1266-25-AM. About the use actual situation and the effectiveness of the pain-killer in patients with rheumatoid arthritis and the sedative adjuvant 金澤沙衣1, 渡辺浩明1, 田村広志1, 和泉秀明1, 佐藤弘康1, 三本松泰孝1, 晴山知拓1, 能登数馬1, 蝦名勇樹1, 門野冴美1, 池田龍一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1575-1575, 2018.

---

	P1268-25-AM. About a mucous membrane lesion and the revival predictor of the 5-ASA preparation internal use UC patients 藤林遼1, 鈴木直哉1, 朝倉幹己1, 藤田果那1, 木下愛1, 庄崎沙耶1, 田中耕太1, 山本翔太1, 前川英輝1, 山田将悟1, 菊地義明1, 高橋誠1, 青田忠博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1576-1576, 2018.

---

	P1270-25-AM. The need of the NST intervention in treated patients of the chemoradiotherapy to head and neck cancer 山本明日香1, 岡見英里香1, 辻本高志1, 寺谷俊昭1, 山田純一1, 上田晃1, 川本由加里1, 後藤仁和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1577-1577, 2018.

---

	P1272-25-AM. Efforts for the rate of application adequacy of the lipid microsphere 田村健1,2, 川口友理1,2, 鎗田陽子1,3, 飯島顕子1,2, 長嶋亜希子1,4, 島村圭二2, 高石聡1,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1578-1578, 2018.

---

	P1274-25-AM. Evaluation about the onset of impaired renal function by the use of amino acid addition sugar electrolyte infusion 矢野愛理1, 深水知英1, 柴田由香里1, 寺薗英之1, 武田泰生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1578-1578, 2018.

---

	P1276-25-AM. The current situation and problem of the glycemic control at TPN enforcement in the Tomigusuku center hospital surgery department ward 上原千晶1, 赤嶺千秋1, 國分千代1, 洲鎌陽子2, 橋本孝夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1579-1579, 2018.

---

	P1271-24-PM. It is examined the role of the ward pharmacist in the nourishment management than the pharmaceutical intervention example to the patients targeted for NST 片岡聡1, 吉本孝1, 岩崎要人1, 林基世1, 三宅佑美1, 奥村智子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1580-1580, 2018.

---

	P1273-24-PM. One consideration and examination for the transluminal tube occlude evasion of the nutrient for intestinal administration with the drug 田井達也1, 山口佳津騎1, 山本高成1, 香西真衣1, 本田由紀1, 元木貴大1, 田中裕章1, 加地雅人1, 森照茂2, 星川広史2, 大北仁裕3, 奥山浩之3, 辻晃仁3, 小坂信二1, 芳地一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1581-1581, 2018.

---

	P1275-24-PM. Clinical examination of the alimentation by the preoperative oral nutrient for intestinal administration of immunity 鈴木彰人1, 白尾一定2, 本吉佳世3, 武田朋子3, 花牟禮富美雄4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1581-1581, 2018.

---

P1277-24-PM. Comparison ... with evaluation - ampicillin-sulbactam of the administration method according to the renal function based on the human prostatic glandular tissue-specific PK/PD analysis of Piperacillin-tazobactam 松山侑未1, 猪川和朗1, 黒田明1, 小田川周平1, 山田和奈1, 中村小源太2, 西川源也2, 小林郁生2, 住友誠2, 森川則文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1582-1582, 2018.

---

	P1279-24-PM. An example of the childhood epilepsy syndrome associated with the administration plan of the potassium bromide 片桐光1, 平良木由布1, 波多野亘1, 島田祐子1, 堀寧1, 山田徹1, 眞柄慎一2, 川島英志3, 塚野真也3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1583-1583, 2018.

---

	P1281-24-PM. The effect that a high trough value in the treatment with initial vancomycin gives for onset of impaired renal function 春木祐人1, 広本篤2, 毎熊隆誉2, 手嶋大輔2, 春木麻衣1, 杉山哲大1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1583-1583, 2018.

---

	P1283-24-PM. Rearward inspection of the vancomycin administration plan in patients with obesity 猪口陽子1, 中野祐樹1, 大竹野久雄1, 秀島久美子1, 蓮輪博嗣1, 横尾賢乗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1584-1584, 2018.

---

	P1285-24-PM. Vancomycin administration plan in patients with febrile neutropenia 倉重靖子1, 山本彩雅1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1584-1584, 2018.

---

	P1287-24-PM. Exhaustive preliminary examination of the estrangement factor from the population mean of the Teicoplanin blood trough level 小林亮1, 荒川昌史1, 須藤俊明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1585-1585, 2018.

---

	P1289-24-PM. The use situation investigation of the antiMRSA medicine in our hospital for the antimicrobial proper use support team activity start 北山秀則1, 坪内孝敏1, 出町拓也1, 田中宏尚1, 村紗苗1, 芦崎雅之1, 平田力1, 岩本浩史1, 早坂州生1, 竹内公美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1585-1585, 2018.

---

	P1278-25-AM. One case that suffered from blood tacrolimus levels management after the hematopoietic cells transplant by the interaction of the concomitant drug 黒岩勇人1, 伊藤武志1, 眞継賢一1, 塚本泰彦1, 濱口良彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1586-1586, 2018.

---

	P1280-25-AM. The current situation of our hospital in the TDM duties of the antiarrhythmic drug 秋場孝則1, 森村春菜1, 小野田弘崇1, 菅原翼1, 塚本宏夢1, 中野一男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1587-1587, 2018.

---

	P1282-25-AM. Examination about the inflection of TDM guidelines in the initial administration plan on vancomycin 中川恭宏1, 丸山久美子1, 奥美和1, 谷口一成1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1587-1587, 2018.

---

	P1284-25-AM. It is ... through construction and the evaluation - MRSA bacteremia case of the TDM enforcement system of vancomycin by the ward pharmacist 牧田亮1, 関谷泰明1, 平下智之1, 谷沢克弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1588-1588, 2018.

---

	P1286-25-AM. Examination of the neonates case that VCM blood level became the high level than predicted value 杉理江1, 佐野良輔1, 松浦優里1, 仙波靖士1, 久保井徹2, 立花広志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1588-1588, 2018.

---

	P1288-25-AM. Examination about the effectiveness and the safety of the high-dose regimen in the Teicoplanin initial administration plan 山嶋仁実1, 片田佳希1, 中川俊作1, 杉本充弘1, 木全柾典1, 都築徹教1, 福井彩香1, 今井哲司1, 米澤淳1,2, 深津祥央1, 中川貴之1, 長尾美紀3, 松原和夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1589-1589, 2018.

---

	P1290-25-AM. Evaluation of the validity of antimicrobial TDM duties of our hospital 杉本誠1, 安泰成1, 安道代1, 梅澤貴志1, 笠原千草1, 金子憲太郎1, 川村僚一朗1, 島田雅人1, 竹永文子1, 松永佳誉子1, 茂木まどか1, 森井理貴1, 吉川明彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1589-1589, 2018.

---

	P1291-24-PM. Minor contribution of cytochrome P450 3A5 to the metabolism of hepatitis C NS5B inhibitor beclabuvir in vitro Su Nwe San1, 松本准2, 斎藤祐実4, 小池雅子4, 坂上弘明3, 加藤芳徳4, 藤吉正哉2, 有吉範高2, 山田治美1,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1590-1590, 2018.

---

	P1293-24-PM. Effect of aldehyde oxidase giving it to Nicotine metabolism and CYP2A6 田山剛崇1, 西村さとみ1, 前田志津子1, 杉原数美1, 北村繁幸2, 佐和章弘1, 三宅勝志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1591-1591, 2018.

---

	P1295-24-PM. Examination of the microemulsion preparation for the purpose of the bioavailability improvement of cannabidiol 中野裕佳子1,2, 森田まみ1, 冨田みさと1, 田島正教1, 杉山恵理花1, 佐々木忠徳2, 佐藤均1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1591-1591, 2018.

---

	P1292-25-AM. Effect of melatonin giving it to Xanthine oxidase activity 西村さとみ1, 田山剛崇1, 喜多智夫1, 大松秀明1, 覚前美希1, 前田志津子1, 佐和章弘1, 三宅勝志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1592-1592, 2018.

---

	P1294-25-AM. An internal change of the morphine in the rat inflammatory model and examination of the analgesia 玉田実花1, 木村嘉明1, 柴田実香1, 浦田航希1, 橋本昌子1, 尾崎紀之2, 荒井國三1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1593-1593, 2018.

---

	P1296-25-AM. Relations with an Afatinib blood level trough value and the renal function test value 高橋毅行1,2, 寺薗英之1, 菅原英輝1, 新田美奈1, 中嶋洋生1, 水野圭子2, 井上博雅2, 武田泰生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1594-1594, 2018.

---

	P1298-25-AM. Anticipatory evaluation of the interaction by the FDA drug interaction guidance model using clinical study data at grapefruit juice drinking 高橋雅弘1, 越前宏俊1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1595-1595, 2018.

---

	P1297-24-PM. Predictive - based on effect - physics chemical property of the diet to give to pharmacokinetics of the oral antitumor agents 大町蕗子1, 金子昌樹1, 飯島亮介1, 板垣文雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1596-1596, 2018.

---

	P1299-24-PM. Example that the maintenance of the therapeutic range was thought to be necessary for a defibrillation effect of bepridil 藤本明子1, 戸田純司1, 大谷拓也1, 室岡邦彦1, 中里祐二1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1597-1597, 2018.

---

	P1300-25-AM. Examination (the second report) for the cooperation of a ward pharmacist and the nursing facility using cooperation support tool "pharmacist summary" 田中成枝1, 合田貴史1, 白石剛一1, 越智大輔1, 毎熊隆誉3, 広本篤3, 手嶋大輔3, 大西順子1, 山地教代2, 近藤祥代1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1598-1598, 2018.

---

	P1302-25-AM. Intervention of the pharmacist in the hemophilic harmful effect case that we worked on by the multi-type of job community medical care cooperation system 田上直美1, 高林学1, 永居えい子2, 高木雅敏3, 原田薫4, 中田浩智5, 内場光浩6, 松下修三7, 齋藤秀之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1599-1599, 2018.

---

	P1304-25-AM. Protect patients making use joining information of the hospitalized medicine together; is 1 ... prescription notebook ... 久岡清子1, 増田博也1, 合田さやか1, 佐々木健志1, 澤口友紀1, 間千晴1, 川村大輔1, 平野真衣1, 井上萌1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1599-1599, 2018.

---

	P1306-25-AM. Investigation about the cooperation with medical facilities, the nursing facility, and the like in the drugstore 伊野陽子1, 舘知也2, 島内あかり1, 野口義紘2, 堺千紘1, 加納亜紀3, 寺町ひとみ2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1600-1600, 2018.

---

	P1308-25-AM. Difference with efforts and the hospital pharmacist to the at-home duties as the insurance pharmacist 岡部真季1, 浅野陽子1, 宗岡美紗1, 日高良昌1, 岡敦子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1600-1600, 2018.

---

	P1310-25-AM. Effect to give to a self-care continuance rate after the rehabilitation ward discharge convalescent a change of the number of the internal use drugs and the number of medication 山田潤也1, 吉川舞1, 清水岳広1, 宮川哲也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1601-1601, 2018.

---

	P1312-25-AM. Fact-finding in the health insurance pharmacy for foreigner 高橋恵美利1, 高橋良徳2, 佐藤ひろみ3, 大林恭子1, 武智洋一郎4, 高橋謙造5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1601-1601, 2018.

---

	P1301-24-PM. Operational investigation of the medical cooperation system "blue bank link" 金子郁子1,3, 山口真衣子1, 田淵沙織1, 中村真理1,3, 西川浩子1,3, 吉田薫1,3, 岩城久弥1,3, 山本景一2, 稲葉眞也3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1602-1602, 2018.

---

	P1303-24-PM. We saw it in the making of efforts - citizen health meet to the community medical care in the Chiba medical center 畑下真希1, 田中裕子1, 新藤学2, 加藤一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1603-1603, 2018.

---

	P1305-24-PM. Efforts of the tuberculosis patient discharge conference in our hospital 脇田恵里1, 山田英理1, 伊藤洋貴1, 佐藤賛治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1603-1603, 2018.

---

	P1307-24-PM. Analysis of the enforcement factor of the cooperation with medical facilities, the nursing facility, and the like in the drugstore 島内あかり1, 舘知也2, 伊野陽子1, 野口義紘2, 堺千紘1, 加納亜紀3, 寺町ひとみ2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1604-1604, 2018.

---

	P1309-24-PM. Type of the drug in the home care patient visit drug control instruction, change of the number of the agents 滝澤康志1, 西澤さとみ1, 久保田令枝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1604-1604, 2018.

---

	P1311-24-PM. Examination about the role of the pharmacist in the treatment at home to be able to see from the change of medical service fees 村瀬惇1, 松野純男1, 幸松健二1,2, 大鳥徹1, 北小路学1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1605-1605, 2018.

---

	P1313-24-PM. We work on enlightenment of "the medicine" to local inhabitants that we turn on a "home delivery of cooked foods lecture" "health Meister training cram school" 野田学1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1605-1605, 2018.

---

	P1314-25-AM. Efforts of the medicine medicine cooperation promotion in the Takaoka demographic division of medical services 北澤英徳1, 脇田真之2, 麻生美佐子3, 小堀勝4, 山本一郎5, 永野康巳6, 浜野邦彦7, 藤森毅至8, 鈴木博幸9, 飴谷伸貴10 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1606-1606, 2018.

---

	P1318-25-AM. Good use of pharmaceutical cooperation monitoring seat in hepatitis C treatment 横田千明1, 吉本辰暁1, 四郎園巧2, 本村奈津子3, 鶴崎泰史1, 中川義浩1, 杉和洋4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1607-1607, 2018.

---

	P1320-25-AM. Efforts for the improvement in dentistry consultation in the bisphosphonate system medicine remedy patients 渡邉真一1,2, 渡部覚氏3, 込山武弘1, 宮内芳郎3, 田中亮裕2,4, 山口巧1,2, 田中守2,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1608-1608, 2018.

---

	P1322-25-AM. Attitude survey for the medicine medicine cooperation of cancer practice cooperation base Hospital and the meeting a demand drugstore 伊東佳美1, 山口俊司2, 林昌広3, 坂東勉1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1608-1608, 2018.

---

	P1324-25-AM. Efforts to booklet making for patients who received anticancer agent which fixed its eyes on medicine medicine cooperation 今井陽介1, 石川星1, 齋藤良子1, 土橋俊文1, 松林和幸1, 佐伯潤1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1609-1609, 2018.

---

	P1326-25-AM. Evaluation - by making and the pharmacist of the standardization (1) - "medication counseling tool" of the medication counseling to patients with dementia by the medicine medicine cooperation 小松原雄士1, 宮田広樹2, 清海杏奈1, 入澤将人3, 奥田裕子4, 片山直子5, 杉浦宗敏1, 笠原英城2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1609-1609, 2018.

---

	P1328-25-AM. Evaluation of the cooperation with the medical institution using the tracing report 高倉夕季1, 内藤聡1, 緒形富雄2, 栗山建志2, 前田守3, 長谷川佳孝3, 月岡良太3, 森澤あずさ3, 大石美也3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1610-1610, 2018.

---

	P1330-25-AM. Examine illness using the contact paper between pharmaceutical products institutions; efforts (the second report) to medicine cooperation 新関みどり1, 財津孝希1, 瀧内瑛輔1, 長澤欣弘1, 羽生智宏1, 尾形美絵1, 田村和彦1, 近藤和宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1610-1610, 2018.

---

	P1332-25-AM. Inspection about doubt inquiry duties by the use of FAX with the pharmacy service under health insurance drugstore in the local basic hospital 岩崎珠実1, 田中敏1, 佐藤志帆1, 武藤健史1, 根本詩織1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1611-1611, 2018.

---

	P1334-25-AM. Evaluation for the effect of the prior agreement protocol operation about the doubt in the outside Parliament prescription 吉本辰暁1, 鶴崎泰史1, 山形真一2, 中川義浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1611-1611, 2018.

---

	P1336-25-AM. Investigation ... from role - medical service fees calculation item of the pharmacist in the local inclusion care system 大久保淑子1,4, 大塚昌孝2,5, 勝俣はるみ3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1612-1612, 2018.

---

	P1338-25-AM. For the proper use of evaluation - seamless drug from the ethical pharmacy about the discharge drug reporting book - 浜田凌介1, 伊藤公博1, 竹田和也1, 堀哲史1, 多賀野正嗣1, 足立易子1, 澤井健太1, 銭瑶子1, 神谷量子1, 杉本芙美1, 藤村保夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1612-1612, 2018.

---

	P1340-25-AM. Efforts of our hospital for the clinical test value notation to outside Parliament prescription 溝口百合香1, 古川卓也1, 久保田豊1, 木賀田亮介1, 勝山善彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1613-1613, 2018.

---

	P1342-25-AM. Efforts of the medicine medicine cooperation for the inflection of the clinical test value and the effect 設樂美紗子1, 設樂誉1, 千葉光1, 阿部優1, 鈴木康弘1, 佐藤真凡1, 熊谷智惠子1, 佐藤昌博1, 齋藤利彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1613-1613, 2018.

---

	P1315-24-PM. Construction of the medicine medicine cooperation system in consideration of man power 岡崎正彦1, 森真人1, 松岡克俊1, 土居友紀1, 石村明子1, 松原栄治1, 白石太朗1, 星川仁美1, 矢野勝之1, 藤井玲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1614-1614, 2018.

---

	P1317-24-PM. Approach of medicine, the medicine medicine cooperation for CKD, renal-transplant recipients 太田あづさ1, 大島沙紀1, 河原香織1, 西窪奈津子1, 塩田恵1, 吉田直恵1, 福田清人2, 山下雅代2, 佐伯みずほ3, 藤井直彦3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1615-1615, 2018.

---

	P1319-24-PM. Attitude survey about the cooperation of rheumatoid arthritis treatment for hospital pharmacist and drugstore pharmacists 亀山俊1, 本間丈士1,2, 飯塚敏美1, 堀口雅巳1, 杉山健太郎2, 平野俊彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1615-1615, 2018.

---

	P1321-24-PM. Effect by the inhalational introduction not to contact as the pharmaceutical cooperation tool 宮崎俊明1, 石田正之2, 片岡大輔3, 上田真弓4, 筒井由佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1616-1616, 2018.

---

	P1323-24-PM. Making of the tool which we unified in an area for the treatment with breast cancer hormone 鬼窪利英1, 中村久美1, 松原重征2, 野村香織3, 馬場麻里子3, 村田稔弥4, 西瀬直美4, 三浦篤史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1616-1616, 2018.

---

	P1325-24-PM. Attitude survey about the use of medicine notebook in the cancer medical therapy 大川真里奈1, 永倉史子1, 熊谷修一1, 目黒聡子1, 小田慎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1617-1617, 2018.

---

	P1327-24-PM. Inspection - of the utilization situation grasp of questionary survey - information sharing tool about the medicine medicine cooperation in the foreign cancer chemotherapy and the usefulness 川畑舞佐子1, 鶴崎大1, 深滝利也1, 菊池憲和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1617-1617, 2018.

---

	P1329-24-PM. Examination of the usefulness by the illness medicine cooperation using the medication information report (tracing report) 伊藤聡一郎1, 寺島純一1, 伊藤晴也1, 勝野晋哉1, 山田哲也1, 水野草平2, 鷹見繁宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1618-1618, 2018.

---

	P1331-24-PM. Doubt inquiry simplification and operational report of the tracing report 上田昌宏1, 貴田聡史2, 高本光次郎1, 近藤純1, 志方敏幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1618-1618, 2018.

---

	P1333-24-PM. An evaluation and problem after the outside Parliament prescription doubt inquiry simplification protocol introduction 後藤義之1, 角紀一郎1, 岡田久美1, 石崎真由美1, 松岡未紗1, 茶野下貴恵1, 光井彩1, 島崎沙織1, 青木理恵1, 戸田翔子1, 森戸敏志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1619-1619, 2018.

---

	P1335-24-PM. The doubt inquiry simplification protocol introduction of the outside Parliament prescription and the evaluation 田中奈桜1, 十田達也1, 石野佑樹1, 藤井克至1, 北野祐香1, 窪田彩花1, 生越由美1, 黒川拓也1, 宮部泰輔1, 東達也1, 上田善美1, 田村憲昭1, 井上敦介1, 廣畑和弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1619-1619, 2018.

---

	P1337-24-PM. About a job evaluation in the outside Parliament prescription doubt inquiry simplification protocol introduction 内藤睦1, 小寺由香1, 中野静香1, 辻俊美1, 足立充司1, 野村浩英1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1620-1620, 2018.

---

	P1339-24-PM. The case that the reporting at discharge to the family drugstore led to the proper use of the drug 根上朋子1, 杉生雅和1, 高子優子1, 大嶋浩一2, 小川佳美1, 吉岡睦展1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1620-1620, 2018.

---

	P1341-24-PM. Examination of the efforts of the discharge drug control reporting book grant to the family drugstore and the problems 佐々木佳世子1, 佐藤弘1, 金内幸子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1621-1621, 2018.

---

	P1343-24-PM. Efforts to the outside Parliament prescription introduction that displayed clinical test value 潟永安亘1, 後藤隆1, 草葉一友1, 山口善久2, 馬場渉3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1621-1621, 2018.

---

	P1344-25-AM. About training schedule construction and the participation that fixed their eyes on a revision core curriculum in 8 representative diseases 山中俊哉1, 井上壽江1, 谷沢克弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1622-1622, 2018.

---

	P1346-25-AM. Questionary survey analysis about the enforcement situation of 8 representative diseases in the long-term business training 吉田都1, 内田享弘1, 桑原晶子1, 豊原朋子1, 片岡和三郎1, 原口珠実1, 小島穂菜美1, 福田侑梨子1, 綿本有希子1, 藤原由梨1, 波多江崇2, 三木知博1, 中林利克1, 篠塚和正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1623-1623, 2018.

---

	P1348-25-AM. Attempt of the multiple hospital cooperation business training with a university hospital and the municipal hospital 日比陽子1,2,4, 西出景子1,3,4, 江崎哲夫4, 森下修行3, 中村康夫2, 木村和哲4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1623-1623, 2018.

---

	P1350-25-AM. Recognition for the need of the participation in nutrition therapy of the pharmacist of the current situation and the pharmacy student of the nutrition therapy education in the business training 石橋正祥1,2, 早川沙樹2, 石井正和1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1624-1624, 2018.

---

	P1345-24-PM. Efforts for the patients intervention of "the representative disease" in the revision model core curriculum and the evaluation 染谷洋和1, 大久保淑子1, 小串興平3, 木村健次郎4, 岩上健司2, 小田慎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1625-1625, 2018.

---

	P1347-24-PM. A response to long-term business training "F pharmacy clinical practice" in the angel Hospital and future problem 相馬まゆ子1, 今田愛也2, 平野剛3, 佐々木洋一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1626-1626, 2018.

---

	P1349-24-PM. Change of the recognition for the simple suspension method of the pharmacy student before and after the business training 蓮元憲祐1, 横井正之1,2, 平大樹1, 角本幹夫1, 岡野友信1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1626-1626, 2018.

---

	P1351-24-PM. Effect of the adverse event (AE) training that we introduced into pharmacy business training 奥村伊代1, 矢野裕士1, 飯塚敏美2, 外川陽子2, 木下大輔3, 鈴木優司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1627-1627, 2018.

---

	P1352-25-AM. Education effect of the training program of the pharmacy student which adopted long-term physician-driven clinical study support duties 福井愛子1, 半谷眞七子1, 津川透1,2, 林高弘3, 山田成樹2, 亀井浩行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1628-1628, 2018.

---

	P1354-25-AM. Practice and evaluation of the specialist job cooperation education aiming at upbringing of the specialist job that could contribute to the field of local health medical care welfare 内海美保1, 奥井順子1, 山原弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1629-1629, 2018.

---

	P1356-25-AM. From comparison - entrance to school of the Japan-Korea pharmacist from an economic viewpoint to employment - 矢嶋幸一1, 犬伏彩夏1, 光家早紀1, 宮本凪美1, 吉岡三郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1629-1629, 2018.

---

	P1353-24-PM. Change of the pharmacy student by the internship system enforcement in the hospital 大森清孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1630-1630, 2018.

---

	P1355-24-PM. Comparison between study - settings pharmacist and student - about the basic social skill sought by a new face pharmacist 村田明子1,2, 中尾幸代1,3, 松田裕子1, 南恵理子1,4, 山中智香1,5, 沼田千賀子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1631-1631, 2018.

---

	P1357-24-PM. Can the business trip conference that school pharmacist conducts in a health room become the environment that a high school student is easy to talk about with a pharmacist? 喜友名侑舞1, 仲田里穂1, 岡本晃典1, 大柳賀津夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1631-1631, 2018.

---

	P1358-25-AM. Efforts and problem to the duties improvement by "the young pharmacist meeting" led by the 6-year course pharmacist 岩津慎次郎1, 梅村拓巳1, 水野貴仁1, 寺本真弓1, 渡邊絵里1, 中村直人1, 鷹見繁宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1632-1632, 2018.

---

	P1360-25-AM. Efforts to ward duties training curriculum revision for the Shinnyu staff who focused on work experience 宮下博幸1, 小林義和1, 齋藤雅俊1, 松原肇1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1633-1633, 2018.

---

	P1362-25-AM. It is ... about new face educational program in our hospital in reference to ... NHOPAD 谷口智美1, 岡本明日香2, 形部文寛1, 橋本修1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1633-1633, 2018.

---

	P1364-25-AM. The present situation report of the medical therapy workshop by University of Shizuoka, hospital, the community pharmacy cooperation of 2017 内野智信1,2, 谷澤康玄1,2, 伊藤邦彦2, 井上達秀2, 河西きよみ2, 北村修2, 木村緑2, 黒川絢子2, 柴山芳之2, 名倉基雄2, 並木徳之2, 平野桂子2, 松山耐至2, 森本達也2, 山田静雄2, 山田浩2, 賀川義之1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1634-1634, 2018.

---

P1366-25-AM. Efforts - for activity report - HIV infection medical therapy authorized specialized pharmacist upbringing of the specialized pharmacist Board of Education HIV sectional meeting in the Aichi hospital pharmacist society 平野淳1,2, 奥平正美2,3, 塩田有史2,4, 加藤善章2,5, 戸上博昭2,6, 板倉由縁7,9, 山田清文5,9, 木村和哲8,9 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1634-1634, 2018.

---

	P1368-25-AM. Efforts about the improvement in workplace communication by the training using Myers-Briggs Type Indicator 大里洋一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1635-1635, 2018.

---

	P1361-24-PM. The new face pharmacist education that pointed to team approach in medical care 垣内祥宏1, 緑川拓也1, 渥美弘美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1637-1637, 2018.

---

	P1363-24-PM. An evaluation and problem of the roof tile type new face education system in the Kanazawa Medical University hospital pharmacy 田紗永子1, 西田祥啓1, 宮東利恵1, 丹羽修1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1637-1637, 2018.

---

	P1365-24-PM. Efforts (the second report) to postgraduate education for the purpose of the acquisition of the basic clinical medicine knowledge 山田雅也1, 力武隆浩2, 森一生3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1638-1638, 2018.

---

P1367-24-PM. Approach ... antimicrobial TDM analysis software experience type learning ... of the Saitama hospital pharmacist society area training sectional meeting 鍵山智樹1,12, 新井成俊2,12, 荒木淳一3,12, 古高裕子4,12, 唐澤匠太5,12, 黒下龍二6,12, 加藤剛7,12, 木村好伸8,12, 長谷部忠史9,12, 岩崎充10,12, 濱浦睦雄11,12, 北澤貴樹13 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1638-1638, 2018.

---

	P1369-24-PM. Outcome evaluation by the electronic terminal introduction in the institutional review board 蜜田哲也1, 中島啓二1, 宇佐美英績1, 吉村知哲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1639-1639, 2018.

---

	P1371-24-PM. Efforts to quick intelligence at Serious Adverse Event occurrence in the trial 川端奈緒美1,2, 三浦佳江1,2, 村上正樹1,2, 宇越郁子1, 渡部真紀1, 小谷麻衣子1, 小村晃子1, 佐藤恵美1, 野畑亜希子1, 西村信弘2, 直良浩司1,2, 田島義証1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1640-1640, 2018.

---

	P1373-24-PM. The current situation investigation of the IRB in the medical association joint use institution 薬師寺寿世1, 加藤博和1, 末延道太1, 川元崇志1, 森一生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1640-1640, 2018.

---

	P1375-24-PM. Examination of the clinical experimental medicine storage temperature en bloc management in the pediatric trial site 宮部祐子1,2, 松原侑紀1, 山崎美智子2, 平野慎也2, 藤田敬子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1641-1641, 2018.

---

	P1377-24-PM. Duties improvement by the trial concomitant drug check system introduction using the YJ cord 村瀬哲也1,2, 小林真理1,2, 深川恵美子1,2, 永田剛志1, 田中惇子1,2, 藤井健司1,2, 木村優美1,2, 角山政之1,2, 松尾裕彰2, 梅本誠治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1641-1641, 2018.

---

	P1379-24-PM. Efforts for the self-check in "the ethic guideline about the medical system study for people" 久米学1,2, 山崎純子2, 石田裕紀1,2, 村上冴2, 筧康正2, 永井洋士2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1642-1642, 2018.

---

	P1381-24-PM. Examination of the need of the explanation to the subjects of survey patients in the use results investigation support task by the ward pharmacist 有馬秀樹1, 豊田貴美子1, 吉本久子1, 矢賀和子1, 越智文也1, 西川直也1, 谷澤香名子1, 幸田恭治1, 北原隆志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1642-1642, 2018.

---

	P1370-25-AM. About the inquiry response to adverse event report in the trial 斉田翌美1,2, 筒井和美1,3, 吉野裕統1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1643-1643, 2018.

---

	P1372-25-AM. About the cooperation with the CRC duties in the infection trial and other departments 川野智美1, 佐藤暁子1, 阿部亜貴子1, 川瀬佳織1, 赤井真侑子1, 山下愛登1, 平木洋一1, 久保徳彦2, 川中博文3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1644-1644, 2018.

---

	P1374-25-AM. Efforts to the system construction about the clinical experimental medicine temperature management in the JCHO Kyushu Hospital 大西利彦1,2, 川久保充章1,2, 有吉美幸1,2, 古田彰1,3, 末松文博1,2, 山本英雄1,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1644-1644, 2018.

---

	P1376-25-AM. About correspondence at clinical experimental medicine temperature deviation 田島実弥1,2, 高崎紘臣2, 衛藤智章2, 笹川玲奈2, 松元俊博1, 三角紳博1, 瀬戸貴司2, 江崎泰斗2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1645-1645, 2018.

---

	P1378-25-AM. Analysis of mention of the clinical positioning of the report by a deliberative committee 渡邊伸一1, 大泉麗子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1645-1645, 2018.

---

	P1380-25-AM. The actual situation and attitude survey of trial, clinical studies duties in the hospital pharmacist 鶴丸雅子1,2, 近藤直樹1,3, 黒田智1,4, 寺元剛1,5, 酒井隆浩1,6, 水井貴詞1,7, 石塚良子1,8, 渡部一宏1,9, 武田泰生1,10, 田崎嘉一1,11, 松原和夫1,8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1646-1646, 2018.

---

	P1382-25-AM. Health monitoring of the stricken area inhabitants utilizing outside Parliament prescription data 松浦誠1, 中村桃子1, 栗山あかな1, 谷川夏紀1, 中田義仁2, 金野良則3, 湊谷寿邦4, 高橋寛1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1647-1647, 2018.

---

	P1384-25-AM. The establishment of the temporary drugstore in the in-hospital disaster training and activity report of the pharmacist 小武和正1, 則武有美1, 田窪和樹1, 池田佳織1, 川上恭弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1648-1648, 2018.

---

	P1386-25-AM. Evaluation of the training about the pharmacist duties at large-scale disaster 五十嵐崇1, 齋藤謙治1, 菅野浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1648-1648, 2018.

---

	P1383-24-PM. Enforcement and evaluation of the training using the disaster action card according to the department in the pharmacy 岡田雅弥1, 満田正樹1, 中谷亮介1, 松本篤1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1649-1649, 2018.

---

	P1385-24-PM. Introduction and evaluation of the disaster support drugstore vehicle mobile pharmacy in university 林秀樹1,2, 羽山希2, 福田純久2, 生木庸寛2, 山下修司1, 小原道子2, 杉山正1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1650-1650, 2018.

---

	IP01. Safety re-evaluation on the concomitant use of the contraindicated chloral hydrate-furosemide combination in pediatric patients Seung Hyun Lee1, Bilee Chwi Seo1, Ae Hee Jung1, Sun Hoi Jung1, Yoon Sook Cho1, Yun Jung Choi2, Dong In Suh2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1652-1652, 2018.

---

	IP02. Clinical profiles of adverse drug reactions spontaneously reported at a single Korean hospital dedicated to children with complex chronic conditions Bomi Kim1, Sunwha Zara Kim1, Jin Lee1, Ae Hee Jung1, Sun-Hoi Jung1, Hyeon-Joo Hahn1, Hye RyunKang1, Dong In Suh1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1653-1653, 2018.

---

	IP04. Clinical Use of Delamanid in patients with Multidrug-resistant Pulmonary Tuberculosis M. Kim1, S. Bae1, J. Mok2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1654-1654, 2018.

---

	IP05. Evaluation of the Adequacy of the Dosage Conversion Ratio in Switching from Twice-Daily Tacrolimus to Once-Daily Extended-Release Tacrolimus Jeong Yi Yoon1, Hye Young Kim1, So Yeon Park1, Mi Ran Oh1, Sung Min Lee1, Soon Joo Kim1, Shin Yi Hwangbo1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1655-1655, 2018.

---

	IP06. Safe information use of Electronic medical record Saki Kimura1, Takao Orii1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1656-1656, 2018.

---

	IP07. Retrospective Study of Risk Factors Associated with Hepatic Dysfunction Induced by Daclatasvir / Asunaprevir Naoki Yoshikawa1, Kazuhiro Kitahata1, Manabu Okumura1, Tomomi Iwakiri1, Hiroshi Sekiya1, Kazuhiko Arimori1, Yuko Yonezawa2, Yasuji Arimura2, Ryuji Ikeda1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1656-1656, 2018.

---

	IP08. A novel method to identify proliferative cells in heterogenetic cell population Hideyuki Terazono1, Yukiko Kobae1, Takayuki Takahashi1, Yasuo Takeda1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1657-1657, 2018.

---

	IP09. Linking Hospital and Community Pharmacy : The value of laboratory values stored in QR code prescription Kazuto Mishima1, Tomoki Adachi1, Hirokazu Terakawa1, Sachiko Kasamo2, Ko-Ichi Ohtaki1,3, Takashi Ono1, Masahide Fukudo1, Toshio Awaya1,4, Yoshikazu Tasaki1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1657-1658, 2018.

---

IP10. Application of Journal Club Trainings for Pharmacy Students and Hospital Pharmacists in Japan Naoto Nakagawa1, Yuriko Murai2, Taku Obara3,4, Hiroshi Ohara1, Sachiyo Kurita5, Makiko Yoshida3, Hiroyuki Suzuki2, Yuta Ishii6, Yuji Sato3, Hisaki Suzuki3, Leanne Lai7, Nariyasu Mano3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1658-1659, 2018.

---

	IP11. The stability evaluation of hospital prepared eye drops Ayumu Nagamine1,2, Hideaki Yashima1,2, Kana Ebisawa1, Tadashige Abe1, Takuya Araki1,2, Koujirou Yamamoto1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1659-1659, 2018.

---

	IP12. Consideration of appropriate anticancer drug mixing on the anticancer drug mixing time analysis Sohei Ohshima1, Hideaki Yashima1,2, Tadashige Abe1, Takuya Araki1,2, Kohjiro Yamamoto1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1660-1660, 2018.

---

	IP13. Magnesium Oxide may Reduce Antidepressant-like Effects of Duloxetine via interactions in absorption Satoru Esumi1, Yoshihisa Kitamura1, Hitomi Yokota-Kumasaki1, Soichiro Ushio1, Akane Yamada-Takemoto1, Ryo Nagai1, Atsushi Ogawa1, Yoichi Kawasaki1, Toshiaki Sendo1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1661-1661, 2018.

---

	IP14. Effects of benzodiazepine medications on the pentobarbital-induced sleep behavior after the inflammatory reaction in mice Yoshihisa Kitamura1, Ayumi Okada1, Shiho Hongo1, Kanami Otsuki1, Akihisa Miki1, Toshiaki Sendo1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1661-1661, 2018.

---

	IP15. Analysis of current situation of antibiotics use in obstetrics and gynecology in China and suggestions for rational application Zhou Boya1, Yue Wang1, Xin Feng1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1662-1663, 2018.

---

	IP16. Efflux pump transfer : a novel mechanism of tigecycline resistance Xue Zhong1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1663-1663, 2018.

---

	IP17. Effects of CYP2D6*10 polymorphism on tamoxifen pharmacokinetics in patients with breast cancer in Asia : A meta-analysis Yu Bai1, Hai-Wei Wu1, Yan-Hua Zhang1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1664-1665, 2018.

---

	IP18. The role of clinical pharmacist in pharmaceutical care in the treatment team of Department of neurosurgery Liu Xianjun1, Shiqi Zheng2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1665-1666, 2018.

---

	CPL. It is concentration ... of the wisdom of ... pharmacy from this of the clinical pharmacy to take the new times on 武田泰生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1-1, 2019.

---

	SL1. Expect it of hospital pharmacist 安川孝志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2-2, 2019.

---

	SL2. A global perspective on the future of pharmaceutical healthcare in hospital related settings Robert J. Moss1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 3-3, 2019.

---

	Medical seminar 1. How the pharmacist should be concerned with oral anticancer agent-treated patients; is ... MS01-1 led by ... Abemaciclib-treated patients 伊藤充矢1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 4-4, 2019.

---

	Medical seminar 1. How the pharmacist should be concerned with oral anticancer agent-treated patients; is ... MS01-2 led by ... Abemaciclib-treated patients 阪田安彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 5-5, 2019.

---

	Symposium 1. The evaluation of drug interactions, the condition of a patient time change that a drug transporter and a metabolism enzyme are involved in: Inflection of the biomarker 杉山雄一, 吉門崇 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 6-6, 2019.

---

	2-01-S01-1. Drug interaction (DDI) risk assessment based on the internal biomarker, Introduction 杉山雄一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 7-7, 2019.

---

	2-01-S01-2. Endogenous biomarker search to predict kidney transporter-mediated drug interactions 楠原洋之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 8-8, 2019.

---

	2-01-S01-3. Prediction based on the internal biomarker of DDI through the liver transporter 吉門崇1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 9-9, 2019.

---

	2-01-S01-4. Evaluation of the CYP3A activity at impaired renal function that assumed 4β-Hydroxycholesterol an index 鈴木陽介1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 10-10, 2019.

---

	Symposium 2. - pharmacist knows it for cancer genomic medicine new age 縄田修一, 櫻井洋臣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 11-11, 2019.

---

	2-01-S02-1. The current situation of the cancer genomic medicine and future problem 四十物絵理子1, 西原広史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 12-12, 2019.

---

	2-01-S02-2. Role of a cancer genomic medicine coordinator in the cancer genomic medicine core base Hospital and the pharmacist 竹野美沙樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 13-13, 2019.

---

	2-01-S02-3. To snuggle up to patients and the family who choose possible side effect - treatment by knowing the genetic information; - 鈴木美慧1, 深野智華1, 大川恵1,2, 出森彩乃1,2, 金井久子1,2, 山内英子1,3, 山中美智子1,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 14-14, 2019.

---

	2-01-S02-4. Efforts for the personnel training of the pharmacist concerned with cancer genomic medicine 櫻井洋臣1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 15-15, 2019.

---

	2-01-S02-5. It is ... mainly on the making of role - system of the pharmacist to refer patients in hope of an examination for cancer genome panel to a testable medical institution, education 縄田修一1,2,3, 西川徹3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 16-16, 2019.

---

	Symposium 3. Precaution and point - based on the example of advice - observational study of the study to be able to be carried out by clinical practice 百賢二, 城田幹生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 17-17, 2019.

---

	2-02-S03-1. About clinical studies about Antimicrobial Stewardship Program (we work on antimicrobial proper use support) 村上修太郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 18-18, 2019.

---

	2-02-S03-2. Example of the observational study in the blood-forming organ tumor domain 安武夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 19-19, 2019.

---

	2-02-S03-3. Experience an observational study for the proper use of the pharmaceutical products that safe breaking news was delivered 石田耕太1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 20-20, 2019.

---

	2-02-S03-4. Research activities in the civilian Hospital thinking from the position of the young pharmacist 上野栞1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 21-21, 2019.

---

	2-02-S03-5. Observational study - about the medication adherence evaluation that added advice observational study - dosage form of medicine 百賢二1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 22-22, 2019.

---

	Symposium 4. Pharmaceutical approach through the example to a pregnant woman, a nursing mother with a mental disorder 赤嶺由美子, 伊差川サヤカ, 香西祥子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 23-23, 2019.

---

	2-02-S04-1. Fact-finding of the psychotropic drug medical treatment for a pregnant woman, the nursing mother 伊差川サヤカ1, 諸見牧子1, 与那覇房子1, 中村克徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 24-24, 2019.

---

	2-02-S04-2. Antipsychotics and pregnant woman, nursing mother 山根律子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 25-25, 2019.

---

	2-02-S04-3. An antiepileptic drug (mood stabilizer) and pregnant woman, nursing mother 赤嶺由美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 26-26, 2019.

---

	2-02-S04-4. To protect a pregnant woman and a baby; is ... about ... benzodiazepine system medicine 前田雅之1, 宮原芽久美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 27-27, 2019.

---

	2-02-S04-5. Luxury goods and pregnant woman, nursing mother with antidepressant and pregnant woman, nursing mother/mentation 香西祥子1,2,3, 河西邦浩1, 加藤育子3, 岡田仁3, 日下隆3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 28-28, 2019.

---

	Symposium 5. Dispatch ... from ... convalescent bed to test a role of the hospital pharmacist in the local inclusion care system 島田美樹, 菅原満 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 29-29, 2019.

---

	2-02-S05-1. The academic first subcommittee final report "participation of the hospital pharmacist in medical therapy in the convalescence and research of the usefulness in the local inclusion care system" 岸本真1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 30-30, 2019.

---

	2-02-S05-2. Role of the pharmacist in the local inclusion care ward 三澤貴美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 31-31, 2019.

---

	2-02-S05-3. Role - medication support of the pharmacist in the convalescence and at-home support ... 茂木徹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 32-32, 2019.

---

	2-02-S05-4. Prescription suggestion ... to medical care, the care environment after role - discharge of the pharmacist in the convalescence 藤原久登1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 33-33, 2019.

---

	Medical seminar 2. Antimicrobial proper use MS02 in 80% of GE pharmaceutical products posts era 北原隆志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 34-34, 2019.

---

	Symposium 1. The roles of pharmacists in the quality, efficacy, and safety of pharmaceuticals Yoshikazu Tasaki, Ryuji Ikeda, Bo Yu, Jung-Tae Kim, Hisashi Urushihara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 35-35, 2019.

---

	2-03-IS01-1. The role of hospital pharmacists in ensuring the quality, efficacy, and safety of pharmaceutical therapy in Japan Atsumi Nishikori1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 36-36, 2019.

---

	2-03-IS01-2. Information technology helps the safety of medication during pregnancy Yong Yang1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 37-37, 2019.

---

	2-03-IS01-3. The evaluation of drug utilization review on potentially inappropriate medications for elderly patients in a tertiary hospital Yeo Hyang Cho1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 38-38, 2019.

---

	2-03-IS01-4. Transforming the Pharmacy Landscape in Singapore Lita Chew1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 39-39, 2019.

---

	Symposium 2. The roles of pharmacists in the quality, efficacy, and safety of pharmaceuticals Yoshikazu Tasaki, Ryuji Ikeda, Takeshi Akiyoshi, Makiko Iwasawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 40-40, 2019.

---

2-03-IS02-1. Retrospective analysis of the correlation between tacrolimus whole blood concentrations and variations in blood cell counts in patients undergoing allogeneic haematopoietic stem cell transplantation Naoki Yoshikawa1, Shuhei Urata1, Kazuya Yasuda1, Hiroshi Sekiya1, Yasutoshi Hirabara1, Manabu Okumura1, Ryuji Ikeda1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 41-41, 2019.

---

	2-03-IS02-2. Study of Exposures to Pharmaceutical Dust After Grinding Tablets Takenori Tamaki1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 42-42, 2019.

---

	2-03-IS02-3. The role and meaning of Japanese pharmacist working in Developing country for UHC and SDGs Mitsuru Otsuka1, Kouji Okahashi1, Kanji Tomogane1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 43-43, 2019.

---

	2-03-IS02-4. Certified pharmacists in U.S.A., and training programs and certified pharmacists in Thailand Shinichi Masuda1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 44-44, 2019.

---

	2-03-IS02-5. Pharmacist-driven clinical studies on chemotherapy-induced nausea and vomiting Toshinobu Hayashi1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 45-45, 2019.

---

	Symposium 6. I want to go home even if I have medical care - Now is the time for pediatric home medical care where the true value of drug-drug cooperation is questioned - 串田一樹, 廣原正宜 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 46-46, 2019.

---

	2-04-S06-1. The current situation and problems of the childhood treatment at home 森脇浩一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 47-47, 2019.

---

	2-04-S06-2. Role of the hospital pharmacist in the childhood treatment at home 丹沢彩乃1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 48-48, 2019.

---

	2-04-S06-3. About relation of the childhood treatment at home 長谷川寛1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 49-49, 2019.

---

	2-04-S06-4. Problem of the childhood treatment at home 串田一樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 50-50, 2019.

---

	Medical seminar 3. It is ... MS03 based on relation ... medical institution of the pharmacist to the outpatient department chemotherapy that is safer, and is reliable and the cooperation between health insurance pharmacies 松井礼子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 51-51, 2019.

---

	Symposium 7. Replacement ... one or ... that what will occur in the drug section then of an electronic medical chart and the formulations system which cannot go when we avoid it 小枝伸行, 若林進 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 52-52, 2019.

---

	2-04-S07-1. Electronic medical chart not to be able to be accepted when we avoid it and ... to learn from replacement - success example of the formulations system, a failure example 若林進1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 53-53, 2019.

---

	2-04-S07-2. Do the function, truth need it? Approach ... at ... system update 岡橋孝侍1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 54-54, 2019.

---

	2-04-S07-3. As it is not used for update example - system of the drug section system in the AI era 佐藤弘康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 55-55, 2019.

---

	2-04-S07-4. The system update is a chance of new duties construction and the problem rearranging 木村好伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 56-56, 2019.

---

	2-04-S07-5. Is it the pharmaceutical products order that you do for what? ... single dose, advice ... of the use standardization 池田和之1,2, 和田良浩1,2, 川崎裕貴1, 小林慎治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 57-57, 2019.

---

	Symposium 8. Prepare for a disaster! Let's think about the role of pharmacists and their education in the event of a disaster - BRIDGE OVER TROUBLED WATER - 高山和郎, 小林政彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 58-58, 2019.

---

	2-04-S08-1. Disaster medical care and pharmacist support to spread 渡邉暁洋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 59-59, 2019.

---

	2-04-S08-2. A role and cooperation of the pharmacist at disaster [efforts of Osaka] 若井聡智1, 辻野悦次2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 60-60, 2019.

---

	2-04-S08-3. Efforts from a time of peace when a pharmacist should do it for a disaster 谷大輔1, 小林政彦1, 中出雅治2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 61-61, 2019.

---

	2-04-S08-4. Refuge administration simulation education to specialty and a pharmacy student, a pharmacist of the disaster medical care education 安原智久1, 永田実沙1, 串畑太郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 62-62, 2019.

---

	Symposium 9. Proposal ... from ... pharmaceutical products proper use study to rise in the scientific viewpoint, and to ride out the perioperative period safely 畝井浩子, 北村佳久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 63-63, 2019.

---

	2-05-S09-1. Pharmaceutical intervention point 畝井浩子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 64-64, 2019.

---

	2-05-S09-2. Perioperative infection measures 矢野貴久1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 65-65, 2019.

---

	2-05-S09-3. What a pharmacist can do for perioperative delirium - Past efforts and future considerations - 吉川明良1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 66-66, 2019.

---

	2-05-S09-4. Pharmacoepidemiology study in the perioperative domain utilizing the large-scale medical information database 座間味義人1,2, 石澤有紀3, 新村貴博1, 小山敏広4, 濱野裕章2, 岡田直人2, 合田光寛2, 武智研志5, 中馬真幸5, 堀ノ内裕也6, 桐野靖2, 中村敏己2, 寺岡和彦2, 石澤啓介1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 67-67, 2019.

---

	2-05-S09-5. Promotion ... of mentation change in the inflammatory state associated with the perioperative period and efficacy change - pharmaceutical products proper use of the central nerve agent 北村佳久1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 68-68, 2019.

---

	Medical seminar 4. Current situation of the cancer cachexia practice and fine-view MS04 高山浩一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 69-69, 2019.

---

	Symposium 10. ... which reconsiders central charge and crosstalk - efficiency and the cooperation with the ward charge pharmacist 赤嶺由美子, 三浦昌朋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 70-70, 2019.

---

	2-05-S10-1. Purpose explanation 三浦昌朋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 71-71, 2019.

---

	2-05-S10-2. The thing which the collaboration of a dispensary charge pharmacist and the ward charge pharmacist brings 大本暢子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 72-72, 2019.

---

	2-05-S10-3. Cooperation - with dispensary, efficiency in anticancer agent preparation duties and safe reinforcement - ward pharmacist 濱口直美1, 杉本浩子1, 世古口典子1, 岩本卓也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 73-73, 2019.

---

	2-05-S10-4. Therapeutic drug monitoring in the ward drug duties that a study laboratory supports 尾田一貴1, 岩村耕次1, 片野田朋美1, 成田勇樹1, 田上直美1, 城野博史1, 齋藤秀之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 74-74, 2019.

---

	2-05-S10-5. Cooperation with the central in the ward charge pharmacist viewpoint 加賀谷英彰1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 75-75, 2019.

---

	2-05-S10-6. It is the efforts of the institution mainly on operation ground or an injection, and the like 清川真美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 76-76, 2019.

---

	Symposium 11. It is not finished without knowing it globalization ... of the use of pharmaceutical products. How is opposite to carrying out travel and the regulation pharmaceutical products of the drug for the medical care; ... 石原千春, 橋本直弥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 77-77, 2019.

---

	2-05-S11-1. About reporting of the pharmaceutical products regulation that we saw from a correspondence example to the carrying out travel of the drug for the medical care in the health insurance pharmacy and problems 石原千春1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 78-78, 2019.

---

	2-05-S11-2. With invention at drug carrying import and export permission application in our hospital, actually 橋本直弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 79-79, 2019.

---

	2-05-S11-3. About a system of the export by the carrying of drug for the medical care and medical psychotropic drugs and the import 坂西義史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 80-80, 2019.

---

	2-05-S11-4. Regulation by the international treaty of the sleeping drug 鈴木勉1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 81-81, 2019.

---

	Symposium 12. Efforts and fusion by the basics, the clinical practice that aimed at the countermeasure of peripheral neuropathy with the cancer chemotherapy 江頭伸昭, 川尻雄大 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 82-82, 2019.

---

	2-06-S12-1. Clinical on-site problem and countermeasure 川上和宜1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 83-83, 2019.

---

	2-06-S12-2. The onset mechanism analysis and drug repositioning study of peripheral neuropathy with the cancer chemotherapy 中川貴之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 84-84, 2019.

---

	2-06-S12-3. Fundamental researches and the future prospects aiming at reduction, inhibition of peripheral neuropathy with oxaliplatin 川尻雄大1, 小林大介1, 牛尾聡一郎2, 江頭伸昭3, 島添隆雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 85-85, 2019.

---

	2-06-S12-4. Preventive preparation search for oxaliplatin-induced peripheral neuropathy utilizing the large-scale medical information database 合田光寛1,2, 座間味義人1,2, 新村貴博2, 川尻雄大3, 武智研志4, 中馬真幸4, 萱野純史1, 濱野裕章1, 岡田直人1, 小林大介3, 島添隆雄3, 石澤有紀5, 桐野靖1, 中村敏己1, 寺岡和彦1, 石澤啓介1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 86-86, 2019.

---

	2-06-S12-5. Inhibition of anticancer agent-induced peripheral neuropathy with the renin-angiotensin system inhibitor 高取真吾1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 87-87, 2019.

---

	Medical seminar 5. Bottom line MS05 of heart failure practice guidelines that a pharmacist knows it and is helpful 筒井裕之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 88-88, 2019.

---

	SL3. Change and security risk and mental attitude ... which the healthcare worker of thing - all whom DX brings in the medical settings should recognize 小屋松美佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 89-89, 2019.

---

	SL4. Medical care of the AI era 木村通男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 90-90, 2019.

---

	Symposium 13. Clinical pharmacy study to take the new times utilizing medical big data on 千堂年昭, 石澤啓介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 91-91, 2019.

---

	2-06-S13-1. The study general remarks using medical big data 樋之津史郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 92-92, 2019.

---

	2-06-S13-2. Study example by the data inflection of the National level 小山敏広1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 93-93, 2019.

---

	2-06-S13-3. The database analysis study that started from the true clinical practice 今井徹1, 鈴木慎一郎1, 鷲巣晋作1, 木村高久1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 94-94, 2019.

---

	2-06-S13-4. From a viewpoint of attempt - psychiatry medical therapy of the application to pharmacist duties of large-scale side effect database - 江角悟1, 牛尾聡一郎1, 北村佳久1, 千堂年昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 95-95, 2019.

---

	2-06-S13-5. The mechanism elucidation of the drug-related side effect that fused with medical big data analysis in fundamental researches and development of the therapeutic drug 新村貴博1, 座間味義人1,2, 石澤有紀3, 合田光寛2, 武智研志4, 中馬真幸4, 福島圭穣5, 堀ノ内裕也6, 池田康将6, 藤野裕道5, 土屋浩一郎7, 石澤啓介1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 96-96, 2019.

---

	Medical seminar 6. It is MS06 about a factor and the prevention of the quality drop of the biomedicine 内山進1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 97-97, 2019.

---

	Medical seminar 7. Medical therapy MS07 of the Reiwa era 竹屋泰1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 98-98, 2019.

---

	Medical seminar 8. Latest medical treatment and drug proper use MS08-1. for the progress recurrence breast cancer The latest medical treatment for the progress recurrence breast cancer 徳永えり子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 99-99, 2019.

---

	Medical seminar 8. Latest medical treatment and drug proper use MS08-2. for the progress recurrence breast cancer Efforts for the drug proper use in the Kyushu cancer center 衛藤智章1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 100-100, 2019.

---

	Medical seminar 9. Local formula reenforcement and methodology MS09 今井博久1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 101-102, 2019.

---

	Medical seminar 10. Proper use - MS10-1. of challenge - thrombomodulin alfa to septicemic death ZERO We think about optimal treatment of the sepsis-related DIC 鈴木泰1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 103-103, 2019.

---

	Medical seminar 10. Proper use - MS10-2. of challenge - thrombomodulin alfa to septicemic death ZERO Contribution to proper use of genetically-modified thrombomodulin (rTM) in the sepsis-related DIC 安藝敬生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 104-104, 2019.

---

	Symposium 14. Suggestion from the clinical pharmacy for the clinical application of the examination for pharmacogenomics 寺田智祐, 斎藤嘉朗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 105-105, 2019.

---

	2-12-S14-1. Personalized medicine and pharmacogenomics - current situation and problem ... 斎藤嘉朗1, 塚越絵里1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 106-106, 2019.

---

	2-12-S14-2. Prediction of the side effect of examination for HLA expression risk 莚田泰誠1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 107-107, 2019.

---

	2-12-S14-3. The latest PGx study: Side effect of STAT3 genetic polymorphism and the molecular target type anticancer medicine 山本和宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 108-108, 2019.

---

	2-12-S14-4. Sensitivity to NUDT15 genetic polymorphism and thiopurine preparation 田中庸一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 109-109, 2019.

---

	2-12-S14-5. The inflection situation of the examination for pharmacogenomics in the true clinical practice 平大樹1, 辻大樹2, 齋藤嘉朗3, 莚田泰誠4, 三浦昌朋5, 寺田智祐6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 110-110, 2019.

---

	Medical seminar 11. Proper use of transfusion and the plasma derivative and future fine-view MS11 米村雄士1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 111-111, 2019.

---

	Symposium 15. What a pharmacist should really send him out for for optimal antithrombotic therapy in consideration of risk benefit? 石井伊都子, 土岐真路 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 112-112, 2019.

---

	2-12-S15-1. Adherence aid of the blood rustle to have liked to ask a pharmacist for from a physician 南圭祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 113-113, 2019.

---

	2-12-S15-2. Key to solution that "a pharmacist" regards as a current problem over the antithrombotic therapy 土岐真路1, 横溝綾子1, 北山知里1, 浅海夕貴1, 前田幹広1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 114-114, 2019.

---

	2-12-S15-3. Proper use of DOAC in consideration of PK / PD - Thoroughly DOAC and PK / PD - 山口洪樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 115-115, 2019.

---

	2-12-S15-4. How should the pharmacist step into the combination of antithrombocytic agent and anticoagulant? What changes by ... guidelines revision? ... 芦川直也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 116-116, 2019.

---

	2-12-S15-5. How do you think about new problem of the DOAC era, Overdose/Underdose? 堀内望1, 野崎歩1, 小林由佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 117-117, 2019.

---

	2-12-S15-6. Term ... of the magic that fact/pharmacist of the understanding degree of ... patients hangs local power aiming at the adherence improvement of the antithrombotic drug 宮崎元康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 118-118, 2019.

---

	Symposium 16. The revision of "the duties manual for use of security of pharmaceutical products" and the utilization 小枝伸行, 岸本真 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 119-119, 2019.

---

	2-12-S16-1. Point to keep in mind about the use and application of "the duties manual making manual revised edition" on the basis of revisions, and the like of the medicine machine method, the Pharmacist Law 土屋文人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 120-120, 2019.

---

	2-12-S16-2. Visualization - of the duties manual with inflection - process flowchart of the medical safe manual in the small and medium size hospital 酒向幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 121-121, 2019.

---

	2-12-S16-3. Duties manual revision work for safe use of the pharmaceutical products which we performed in cooperation with medical safe Management Department and future problem 高橋弘充1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 122-122, 2019.

---

	2-12-S16-4. About the simplification that suppressed the key point of the pharmaceutical products safety management manual in the cottage-hospital in the medical treatment type 近藤幸男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 123-123, 2019.

---

	Symposium 17. A role and the future prospects of the current pharmaceutical products source of information in the objective pharmaceutical products evaluation 後藤伸之, 冨田隆志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 124-124, 2019.

---

	2-13-S17-1. The revision point of the package insert mention point and utilization method to expect 後藤伸之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 125-125, 2019.

---

	2-13-S17-2. The revision point of the interview form mention point and utilization method to expect 冨田隆志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 126-126, 2019.

---

	2-13-S17-3. It is ... from ... pharmaceutical products evaluation making use of RMP to patients care 川名真理子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 127-127, 2019.

---

	2-13-S17-4. We read and untie a report by a deliberative committee, an application material summary some other time 荒義昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 128-128, 2019.

---

	Medical seminar 12. How to use front line - palonosetron and aprepitant - MS12 of the supportive care for Chemotherapy Induced Nausea and Vomiting 吉田直久1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 129-129, 2019.

---

	Symposium 18. The leading viewpoint that a study leader should have to solve a clinical problem in the cancer chemotherapy 橋本浩伸, 河添仁 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 130-130, 2019.

---

	2-13-S18-1. Encounter with the study leader before pharmacy school life making a clinical problem the article 内田真美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 131-131, 2019.

---

	2-13-S18-2. As the education person in charge, obtained it by the study instruction for the young pharmacist; learn 橋本浩伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 132-132, 2019.

---

	2-13-S18-3. Strategy to publish a rearward observational study in the learned journal with high impact factor 河添仁1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 133-133, 2019.

---

	2-13-S18-4. Point ... of know-how - manuscript making of the article contribution and the revice 大谷壽一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 134-134, 2019.

---

	Symposium 19. It is ... from the discovery of extract - side effect to manage an allergy, the side effect of patients well to management, a report 小枝伸行, 関谷泰明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 135-135, 2019.

---

	2-13-S19-1. Side effects, and the like about the use, and the like of the summary of the report system and the reported information 岩崎麻美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 136-136, 2019.

---

	2-13-S19-2. What kind of side effect should you report? Inflection method in the clinical practice of the side effect report 土屋雅美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 137-137, 2019.

---

	2-13-S19-3. About the inflection of collection and data of the information on adverse drug reactions 望月伸夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 138-138, 2019.

---

	2-13-S19-4. A collection activity of the information on adverse drug reactions for the early detection and future efforts 男全昭紀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 139-139, 2019.

---

	2-13-S19-5. Problems in uniform management and the system management of the side effect in the pharmacy 高橋正明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 140-140, 2019.

---

	Symposium 20. How do you confront the needs of the pharmacist that the future of the international contribution of the pharmacist is required word no hearing - disaster relief and development cooperation? 小林政彦, 折井孝男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 141-141, 2019.

---

	2-14-S20-1. In the case of change - Medecins Sans Frontieres of the medical assistance settings for the urgent humanitarian crisis 黒崎伸子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 142-142, 2019.

---

	2-14-S20-2. Than experience in role - Middle East and Africa as venture management and the health coordinator in the humanitarian support of the International Red Cross 五十嵐真希1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 143-143, 2019.

---

	2-14-S20-3. An example of the carrier management of the small and medium size scale hospital pharmacist participating in an overseas medical assistance activity 榊原英朗1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 144-144, 2019.

---

	2-14-S20-4. Work work balance in a challenge and personnel training - normal business routine and international relief duties to medical logistics in the disaster relief 小林映子1, 石田耕太2, 細谷治2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 145-145, 2019.

---

	Medical seminar 13. One or ... MS13 where there is what as - pharmacist in the cancer genomic medicine first year 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 146-146, 2019.

---

	Symposium 21. Development of the hospitalization and release support task by all pharmacists connecting to the living of patients 室井延之, 荒木隆一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 147-147, 2019.

---

	2-14-S21-1. Role of medical therapy and the pharmacist connecting to the area from a hospital 室井延之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 148-148, 2019.

---

	2-14-S21-2. Way of thinking, process of role - medical care cooperation ... of the hospital pharmacist supporting community medical care 荒木隆一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 149-149, 2019.

---

	2-14-S21-3. From Hyogo to the whole country, we think about new cooperation from drugstore vision business 吉田昌弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 150-150, 2019.

---

	2-14-S21-4. ... to tie medical care, care cooperation - pharmaceutical support by the inflection of the drug control summary at a discharge, and to tie to the living of patients 澁田憲一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 151-151, 2019.

---

	Symposium 22. Examination modality ... necessary for an evaluation of competency - medical therapy that went step further sought by the pharmacist of the circulatory organ domain 柴田啓智, 志賀剛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 152-152, 2019.

---

	2-14-S22-1. Pharmacist activity brought about by Modality - Echo possibility - 柴田啓智1, 甲斐光1, 大山亜梨沙1, 西村知晃1, 田上治美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 153-153, 2019.

---

	2-14-S22-2. An electrocardiogram evaluation and the arrhythmic pharmaceutical management that are demanded from a pharmacist 梶原洋文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 154-154, 2019.

---

	2-14-S22-3. The condition of a patient evaluation of patients to arrest from a medical history, physical examination, vital sign generally and the pharmaceutical management 北原加奈之1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 155-155, 2019.

---

	2-14-S22-4. Competency of the circulatory organ medical therapy to expect of a pharmacist 志賀剛1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 156-156, 2019.

---

	Symposium 23. [cure association arts and sciences Committee] Upbringing of the ability for drug interactions management in the healthcare setting 米澤淳, 伊藤清美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 157-157, 2019.

---

	2-15-S23-1. Making - academic first subcommittee activity report ... of "the relation guide to the drug interactions in the healthcare setting" 伊藤清美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 158-158, 2019.

---

	2-15-S23-2. Activity plan ... of the upbringing - clinical pharmacy academic fourth subcommittee of the ability for drug interactions management in the healthcare setting 米澤淳1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 159-159, 2019.

---

	2-15-S23-3. Inflection method of PISCS in the drug interactions management 大野能之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 160-160, 2019.

---

	2-15-S23-4. Utilization and problem of the drug interactions evidence in clinical settings 木村丈司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 161-161, 2019.

---

	2-15-S23-5. The management utilizing the DDI database 増田純一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 162-162, 2019.

---

	Medical seminar 14. Dr. Efficiency MS14-1 of the JOY X intelligence 村松博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 163-163, 2019.

---

	Symposium 24. Basic medical treatment in the intensive care that we want to hold down now 加藤隆寛, 原直己 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 164-164, 2019.

---

	2-15-S24-1. Basic medical treatment in patients with cerebral hemorrhage 若杉和美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 165-165, 2019.

---

	2-15-S24-2. Is the evidence usable? Medical treatment of acute myocardial infarction 奥川寛1, 馬橋美由季1, 堀内望1, 野崎歩1, 小林由佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 166-166, 2019.

---

	2-15-S24-3. Mainly on prophylactic medical therapy - stress ulcer, deep vein thrombosis - 川邊一寛1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 167-167, 2019.

---

	2-15-S24-4. A pharmacist can do it; with evidence of the nourishment management, actually! 川口奈奈子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 168-168, 2019.

---

	2-15-S24-5. With the viewpoint of the pharmacist who is necessary for PADIS management? 勝綾香1, 中薗健一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 169-169, 2019.

---

	2-15-S24-6. Where is the medical treatment in the intensive care standardized to? 加藤隆寛1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 170-170, 2019.

---

	Symposium 25. Art to write a record to be handed down to offer better medical treatment 寺沢匡史, 坂野昌志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 171-171, 2019.

---

	2-15-S25-1. From a viewpoint of thing - medical care security sought by a record to be handed down definitely - 高野秀仁1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 172-172, 2019.

---

	2-15-S25-2. Art of mention of "A" (assessment) not to be troubled with anymore 寺沢匡史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 173-173, 2019.

---

	2-15-S25-3. Art - to tell DI and cooperation and mention - necessary information of the ward pharmacist of the record at reporting to a physician precisely 佐村優1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 174-174, 2019.

---

	2-15-S25-4. With the art of the record to be able to make use of in ward drug duties? 眞継賢一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 175-175, 2019.

---

	2-15-S25-5. It is ... based on the intervention example to patients with ... outpatient department cancer that a book asks for seamless records from hospitalization to the outpatient department 菅野雄太1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 176-176, 2019.

---

	2-15-S25-6. Drug control summary for cooperation between institutions to tell him/her about from the southernmost tip 小杉卓大1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 177-177, 2019.

---

	Symposium 26. What would you do at such time? The blood sugar control that a specialized pharmacist thinks about 厚田幸一郎, 竹内裕紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 178-178, 2019.

---

	2-16-S26-1. Of duties for the safety management of the blood glucose level is annual, and consider - aging; and ... 藤井博之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 179-179, 2019.

---

	2-16-S26-2. Diabetes and cancer Aiming for a well-balanced therapeutic relationship 根本真記1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 180-180, 2019.

---

	2-16-S26-3. Advice of the blood sugar control practice depending on renal function to change 堀井剛史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 181-181, 2019.

---

	2-16-S26-4. What would you do at such time? Blood sugar control in the perioperative period 柴田啓智1, 吉田愛1, 北岡朋子1, 田中忠宏1, 田上治美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 182-182, 2019.

---

	Symposium 27. It is ... by the intervention that one step stepped into for hypogonadism with contribution ... treatment of the pharmacist to patients with AYA generation cancer 米村雅人, 日置三紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 183-183, 2019.

---

	2-16-S27-1. Team approach in medical care of AYA generation cancer 清水千佳子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 184-184, 2019.

---

	2-16-S27-2. Contribution of the pharmacist to the male AYA patients 小室雅人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2019.

---

	2-16-S27-3. Contribution of the pharmacist to the female AYA patients 日置三紀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2019.

---

	2-16-S27-4. Simulated patient (SP) participation type education for medication support in deference to communication ... patients including sensitive contents 有田悦子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2019.

---

	Symposium 28. Wide achievement of the pharmacist in the pediatric domain 冨家俊弥, 小高賢一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2019.

---

	2-16-S28-1. In the settings of AMR measures 由留部圭伍1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2019.

---

	2-16-S28-2. The team approach in medical care that an NICU ward pharmacist aims at 灘谷直実1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2019.

---

	2-16-S28-3. Relation of the pharmacist in the childhood palliative care 坂田和佳子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2019.

---

	2-16-S28-4. A pharmacist can do it through allergic disease for children 上荷裕広1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2019.

---

	Symposium 29. It is each role for/Precision Medicine from this of the hospital pharmacist taking cancer personalized medicine 野村久祥, 辻大樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2019.

---

	3-01-S29-1. Experience of the examination for gene panel in the national cancer research center east Hospital 向原徹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2019.

---

	3-01-S29-2. As a pharmaceutical support cancer genomic medicine coordinator to personalized medicine 上本剛1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2019.

---

	3-01-S29-3. Personalized medicine of the pharmaceutical viewpoint by the clinical pharmacist 野村久祥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2019.

---

	3-01-S29-4. It is ... for a case by a risk factor search of individualization - neutropenia of the side effect management in the cancer chemotherapy 矢野良一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2019.

---

	3-01-S29-5. Individualization for the supportive care of the cancer medical therapy 辻大樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2019.

---

	Medical seminar 15. Development MS15 of innovative antibody pharmaceutical products by the evolution of the antibody engineering technique and the adaptation 根津淳一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2019.

---

	Symposium 30. Secret ... which intervenes in the multidrug therapy of patients in polypharmacy - CKD to cut in "kidney" 平田純生, 浦田元樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2019.

---

	3-01-S30-1. Overview: Are the patients in CKD polypharmacy? 浦田元樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2019.

---

	3-01-S30-2. The secret of the need and the management of the multidrug therapy of the preservation period CKD patients to think about from evidence 鈴木大介1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2019.

---

	3-01-S30-3. The secret to learn in an example, and to intervene in the polypharmacy of patients with CKD for the preservation period 小林豊1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2019.

---

	3-01-S30-4. The secret to learn in an example, and to intervene in the polypharmacy of patients on dialysis 早川兼司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2019.

---

	3-01-S30-5. It is a topic and the phosphate binder that it is in the polypharmacy of patients on dialysis re-inspection 吉田拓弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2019.

---

	Symposium 31. Foundations of antiinfection medicine which a pharmacist should know and practical how to use antimicrobial proper use support team 松元一明, 西圭史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2019.

---

	3-01-S31-1. Antimicrobiogram and anti-VAIO gram 浦上宗治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2019.

---

	3-01-S31-2. Use and administration plan of the MRSA infection therapeutic drug 植田貴史1, 竹末芳生1, 中嶋一彦1, 一木薫1, 石川かおり1, 高井喜子1, 和田恭直1, 山田久美子1, 土田敏恵1, 高橋佳子2, 石原美佳2, 木村健2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2019.

---

	3-01-S31-3. ESBL-producing infection treatment up to date 松元一明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2019.

---

	3-01-S31-4. Practice of CDI infection treatment 茂見茜里1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2019.

---

	3-01-S31-5. Mainly on a spectrum and the use - azole system medicine of the antifungal agent - 浜田幸宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2019.

---

	Symposium 32. Drug discovery, Ikuyaku study - image of future pharmacist ... which solves the problems that we found in the viewpoint of the pharmacist building evidence by oneself 松元一明, 永田将司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2019.

---

	3-02-S32-1. The pharmacist image that is sought in the future from the present by a hospital, a drugstore pharmacist 安川孝志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2019.

---

	3-02-S32-2. Consideration through the activity by the pharmaceutical viewpoint with the drugstore in the area as a base 手嶋無限1,2,4, 中嶋幹郎2,4, 徳永仁3,4, 狭間研至4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2019.

---

	3-02-S32-3. Clinical pharmacy study in the drugstore 堀里子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2019.

---

	3-02-S32-4. Mission of the hospital pharmacist contributing to medical therapy 永田将司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2019.

---

	3-02-S32-5. ... that clinical pharmacy study - package insert in the hospital becomes the hint of the study 高田龍平1, 山梨義英1, 伊藤(松岡)紗代1, 豊田優1, 山本武人1, 鈴木洋史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2019.

---

	Medical seminar 16. Device MS16 of the medication counseling of the Chinese medicine 船戸元子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2019.

---

	Symposium 33. It is ... for role - seamless pharmaceutical intervention of the pharmacist corresponding to the drugstore with the extensive pharmaceutical function in the cancer domain 松井礼子, 安原眞人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2019.

---

	3-02-S33-1. ... which looks back on the cooperation with the drugstore than the purpose of ... symposium than position of the hospital pharmacist 松井礼子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2019.

---

	3-02-S33-2. Than an administrative viewpoint "the pharmacist of a drugstore and the hospital coping by the revisions such as the medicine machine methods, and the like" 三山由芙子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2019.

---

	3-02-S33-3. Than position of the hospital pharmacist is ... around medical cooperation - PBPM in the cancer chemotherapy with the neighborhood ethical pharmacy 縄田修一1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2019.

---

	3-02-S33-4. Than the position of the health insurance pharmacy pharmacist 久田健登1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2019.

---

	Symposium 34. ... which thinks about pharmaceutical care of role - cardiovascular disease of the pharmacist in the heart rehabilitation 吉国健司, 神村英利 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2019.

---

	3-02-S34-1. About the role of the pharmacist whom the role physician of the pharmacist in the heart rehabilitation expects 折口秀樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2019.

---

	3-02-S34-2. A role and exercise drug linkage of the physical therapist in the heart rehabilitation 花田智1, 岩切弘直2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2019.

---

	3-02-S34-3. "Pharmacist of medical treatment and heart rehabilitation and the bedside" - ward pharmacist and collaboration - that the heart rehabilitation is wonderful 土岐真路1, 武市尚也2, 木田圭亮3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2019.

---

	3-02-S34-4. Adjustment ... of the medicine about relation ... coronary risk factor of the pharmacist to foreign heart rehabilitation 向井一樹1, 無漏田香穂1, 大原由希子1, 橋本佳浩1, 本間智明2, 小林平2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2019.

---

	Symposium 35. We will consider the optimal direction for uses of the inhalant as multidirectional approach - pharmacist aiming at proper use of the inhalant 長井紀章, 平大樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2019.

---

	3-03-S35-1. Respiratory illness that inhalation therapy plays a key role of the medical therapy 福岡和也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2019.

---

	3-03-S35-2. Role of the hospital pharmacist in the inhalational instruction 尾上雅英1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2019.

---

	3-03-S35-3. Inhalational cooperation "Shiga inhalation therapy cooperation forum" in Shiga 永井智宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2019.

---

	3-03-S35-4. Practice of the inhalant study aiming at clinical on-site utilization 平大樹1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2019.

---

	3-03-S35-5. Transpulmonary applied - of the recent transpulmonary DDS development status - drug carrier 田原耕平1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2019.

---

	Medical seminar 17. New stem cell preparation (products such as regenerative therapy, and the like) MS17 for patients with spinal cord injury 佐々木祐典1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2019.

---

	Symposium 36. Importance of the moisturizing preparation in clinical settings and transdermal application preparation 内野智信, 徳留嘉寛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2019.

---

	3-03-S36-1. Importance of the moisture retention in the skin physiology 正木仁1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2019.

---

	3-03-S36-2. How to use right moisturizer forming strong skin 大谷道輝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2019.

---

	3-03-S36-3. Efforts for the dry skin care in EGFR tyrosine kinase inhibitor (EGFR-TKI) 瀧口友美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2019.

---

	3-03-S36-4. Dosage form design of the moisturizing preparation which a pharmaceutical company thinks about 小澤洋介1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2019.

---

	3-03-S36-5. A moisturizing product and the design that cosmetics company thinks about 坂田修1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 241-241, 2019.

---

	3-03-S36-6. Coming percutaneous absorption type preparation (containing the moisturizing preparation) 杉林堅次1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2019.

---

	Symposium 37. Should do what to provide relief, safe medical therapy at rebuilding - small scale hospital of the drug duties in the small hospital; or ... 賀勢泰子, 荒木隆一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2019.

---

	3-03-S37-1. Some viewpoints that hospital pharmacist in the future should face each other 小枝伸行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2019.

---

	3-03-S37-2. Cottage-hospital pharmacist being able to do it as making match to being at home ... from the duties revolution acute phase of the cottage-hospital duty pharmacist, the thing that you should do 園田利広1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2019.

---

	3-03-S37-3. The future of the medical therapy support for elderly people 森直樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2019.

---

	3-03-S37-4. Evidence construction ... from efforts - clinical duties, study to offer safe medical therapy to the seriously disabled child person 森本真仁1, 浜田茂明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2019.

---

	3-03-S37-5. The future of the small hospital pharmacist judging from drug section management 上野山周雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2019.

---

	3-03-S37-6. Message to small scale hospital pharmacist taking community medical care 荒木隆一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2019.

---

	Symposium 38. To bring up the young person who can play an active part in the clinical duties 安武夫, 伊藤佳織 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2019.

---

	3-04-S38-1. Young upbringing of the ward pharmacist using the Step-up system 伊藤佳織1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2019.

---

	3-04-S38-2. "Advice" for upbringing of a student and the young pharmacist 柏倉康治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2019.

---

	3-04-S38-3. Foreign cancer medical therapy: Yell from a mom pharmacist 藤堂真紀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2019.

---

	3-04-S38-4. Clinical questions found in clinical practice 百賢二1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2019.

---

	3-04-S38-5. Let's review On-the-Job Training 土手賢史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2019.

---

	Medical seminar 18. Have a pharmacist know it by short statue treatment; drum and - short stature and problem of the heart, Biosimilar - MS18 堀川玲子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2019.

---

	Symposium 39. It is ... expecting the development of a TDM study, the clinical application by solution to clinical question - clinical pharmacist utilizing the TDM 尾田一貴, 三浦昌朋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2019.

---

	3-04-S39-1. Usefulness of the TDM in the oral molecular target anticancer agent of the blood-forming organ tumor domain 鐙屋舞子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2019.

---

	3-04-S39-2. Solution to clinical question by the clinical operation of the TDM enforcement system utilizing the HPLC 尾田一貴1,2, 岩村耕次1, 片野田朋美1,2, 成田勇樹1, 野坂生郷2, 城野博史1, 齋藤秀之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2019.

---

	3-04-S39-3. The example that deepened understanding to the pharmacokinetics of the patients individual by TDM, and was able to contribute to treatment strategy decision 八島秀明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2019.

---

	3-04-S39-4. Practice of the TDM which intended the medical treatment management 潮平英郎1, 伊差川サヤカ1, 諸見牧子1, 与那覇房子1, 中村克徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2019.

---

	3-04-S39-5. The clinical question and consideration which were found by a case of the acute drug intoxication 榎屋友幸1, 今井寛2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2019.

---

	Symposium 40. Do you not feel anxiety for correspondence to the foreign patients? To step forward to initial one step? What should I do? 高田勝利, 吉山友二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2019.

---

	3-04-S40-1. The concentration of the wisdom for the correspondence to the foreign patients who will be helpful from now on 吉山友二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2019.

---

	3-04-S40-2. The foreign patients correspondence in the national international medical research center hospital and efforts of the pharmacy 坂本治彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2019.

---

	3-04-S40-3. Even if only Japanese is possible, let's use the help item, and and, at first, OK will step forward one step happily! 池浦恵1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2019.

---

	3-04-S40-4. Because a foreign player receives medical care in Japan, have a pharmacist 笠師久美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2019.

---

	3-04-S40-5. Intellect understands a medical interpreter. We help with the potentially serious medical errors cancellation of the workplace. 森田直美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2019.

---

	Symposium 41. Pharmaceutical products safety measures: - to think about the use and application of - big data "from now on" because "we came to here" 折井孝男, 高田敦史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2019.

---

	3-05-S41-1. About the situation of administration, the management of MID-NET 金子明依1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2019.

---

	3-05-S41-2. Evaluation of a pharmacoepidemiology study and the pharmacist duties using the medical database 小原拓1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2019.

---

	3-05-S41-3. Expectation ... from data mapping to need of the standardization that we were able to see and process - big data use and application 横山威一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2019.

---

	3-05-S41-4. Possibility and expectation of the common understanding and same method of the person concerned concerned with "the next-generation medical base method" 佐々木正大1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2019.

---

	Medical seminar 19. Merit - MS19 of treatment strategy - Biosimilar medicine for HER2-positive breast cancer 新田吉陽1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2019.

---

	Symposium 42. Viewpoint of the pharmacist of the intensive care domain for the yew logic emergency and the pharmacist of the cancer domain 土手賢史, 前田幹広 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2019.

---

	3-05-S42-1. Approach to patients with solid carcinoma of sepsis 東加奈子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2019.

---

	3-05-S42-2. Cardiotoxicity of the anticancer medicine becoming a cause, the precipitants for heart failure 土手賢史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2019.

---

	3-05-S42-3. Patients with cancer are ... from the situation of septic shock - intensive care to meet 安藝敬生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2019.

---

	3-05-S42-4. Acute heart failure to develop in anticancer medicine-treated patients 原直己1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2019.

---

	Symposium 43. Measures to immune-mediated adverse event (irAE) with the immune checkpoint inhibitor and medical cooperation 渡邊裕之, 林祐一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2019.

---

	3-05-S43-1. Immune-mediated adverse event (irAE) and the measures 池末裕明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2019.

---

	3-05-S43-2. It is ... from practice of the team approach in medical care in efforts - Gifu University faculty of medicine hospital of the pharmacist to the immune-mediated adverse event management 飯原大稔1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2019.

---

	3-05-S43-3. The irAE management by regional alliances 南晴奈1, 渡邊裕之1, 池田宗彦1, 秦晃二郎1, 増田智先1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2019.

---

	3-05-S43-4. Diagnosis, treatment for medical understanding about irAE and serious irAE 林祐一1, 飯原大稔2, 鈴木昭夫2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2019.

---

	PL. Efforts and problem for the further development of the Japanese cure association 奥田真弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2019.

---

	About the review of authorization, the specialized pharmacist system in the Japanese cure association and a new system design 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2019.

---

	Medical seminar 20. Characteristic and how to use MS20 of the antiparkinsonism drug 橋口昭大1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2019.

---

	SL5. Cerebral cortex neural circuit reorganization at the condition of a patient due to the glia cells: Mainly on chronic pain 鍋倉淳一1,2, 竹田育子1, 江藤圭1,2, 和氣弘明3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2019.

---

	SL6. Medication Safety in a Complex Oncology Landscape Stephen Harnicar1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-290, 2019.

---

	SL7. History and the future of the lung cancer medical therapy 中西洋一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2019.

---

	Medical seminar 21. Effect MS21 that a deglutition adjuvant product gives to the disintegration of various tablets 富田隆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2019.

---

	Medical seminar 22. New development MS22 of the HER2-positive breast cancer medical therapy 高野利実1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2019.

---

	Medical seminar 23. Thing - MS23 to think of as ... pharmacist about use of magnesium oxide 堀美智子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2019.

---

	Medical seminar 24. It is ... MS24-1 mainly on real - standard treatment and adverse event management of the digestive organ cancer medical therapy 山崎健太郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2019.

---

	Medical seminar 24. It is ... MS24-2 mainly on real - standard treatment and adverse event management of the digestive organ cancer medical therapy 石川寛1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2019.

---

	Symposium 44. Pharmaceutical products safe sexological advice - pharmacist playing a clinical role on the site is ... from this aiming 佐藤光利, 宇野勝次 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2019.

---

	3-12-S44-1. We aim at the social contribution through pharmacist (DSSP) specialized in pharmaceutical products safety 宇野勝次1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2019.

---

	3-12-S44-2. Medical therapy support in consideration of pharmacokinetics 前田頼伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2019.

---

	3-12-S44-3. Drug-related nephropathic assessment 平田純生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2019.

---

	3-12-S44-4. Side effect measures of pharmaceutical products using PK/PD/PGx analysis 北市清幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2019.

---

	3-12-S44-5. Because a drugstore pharmacist secures safety of medicine, can do it 近藤悠希1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2019.

---

	Medical Seminar 25. Formulary - A New Role for Pharmacists - MS25 神村英利1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2019.

---

	Symposium 45. We think about a theory of the multidrug therapy across a disease from a pharmaceutical point of view 竹内裕紀, 井上岳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2019.

---

	3-12-S45-1. - to think about application to usefulness - immunologic renal disease of the multidrug therapy of the immunosuppressive drug in the kidney transplantation 竹内裕紀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2019.

---

	3-12-S45-2. Way of thinking of the multidrug therapy of the anticancer medicine 石川寛1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2019.

---

	3-12-S45-3. Multidrug therapy in the diabetes therapeutic drug 井上岳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2019.

---

	3-12-S45-4. The Chinese medicine is the origin of the multidrug therapy 山田陽城1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2019.

---

	3-12-S45-5. Problems of the multidrug therapy in the mental disorder 赤嶺由美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2019.

---

	Symposium 46. It is ... for duties development with ... added value to think about improvement in efficiency, productivity of pharmacist duties 吉村知哲, 外山聡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2019.

---

	3-12-S46-1. Efforts for efficiency and the improvement by the pharmacy tissue management in productivity 吉村知哲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2019.

---

	3-12-S46-2. Efficiency of pharmacist duties in the Hokkaido area 粟屋敏雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2019.

---

	3-12-S46-3. Streamline pharmacist work and improve productivity through task sharing and task shifting 舟越亮寛1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2019.

---

	3-12-S46-4. For the effectiveness of hospital pharmacist duties by the other types of job cooperation, value-added improvement 萱野勇一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2019.

---

	3-12-S46-5. Utilization and duties efficiency of the medical information using IT 下堂薗権洋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2019.

---

	Medical seminar 26. Antiepileptic drug MS26 to regard as the mechanism of action from a side effect 花谷亮典1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2019.

---

	Symposium 47. Ergonomy and cooperation - of a hospital, the health insurance pharmacy in line with cooperation and pharmacy management - local fact in the community medical care 赤瀬朋秀, 金田昌之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2019.

---

	3-14-S47-1. We drop the strategy of the hospital into the pharmacy 植木哲也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2019.

---

	3-14-S47-2. Practice of the pharmacy management in the university-affiliated drugstore to contribute to a local inclusion care system 寺町ひとみ1,2,3, 井口和弘3,4, 伊野陽子3,4, 野口義紘1,3, 玉木啓文3,4, 山下修司3,5, 舘知也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2019.

---

	3-14-S47-3. Balun strike scorecard ... which new attempt - hospital pharmacist for the sustainable medicine medicine cooperation and a local pharmacist conduct by collaboration 須賀宏之1, 内田隆通1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2019.

---

	3-14-S47-4. Practice of the regional pharmacy management in the local construction 舟越亮寛1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2019.

---

	3-14-S47-5. The pursuit of the sustainability in the community medical care and role of the pharmacist 赤瀬朋秀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2019.

---

	Medical Seminar 27. Wimins Health and Female Hormones - Potential for Equol - MS27 中村隆文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2019.

---

	Symposium 48. The basics and practice to work on a clinical pharmacy study 伊藤清美, 田崎嘉一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2019.

---

	3-14-S48-1. For the first clinical pharmacy study Japanese alphabet - of - study plan and the article making 池田龍二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2019.

---

	3-14-S48-2. A point and precaution of the study ethic to work on clinical studies 渡邉達也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2019.

---

	3-14-S48-3. As we are not confused by statistics mind - p value necessary for a clinical pharmacy study 山村重雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2019.

---

	3-14-S48-4. Need - pharmacy education of clinical studies and clinical mediation - with settings 園田純一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2019.

---

	3-14-S48-5. Significance and the prospects of the clinical studies in the drugstore 恩田光子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2019.

---

	Symposium 49. "How do you addicted to an acute poison in medicine thing cope?" 堀寧, 峯村純子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2019.

---

	3-14-S49-1. Drug-related arrhythmia in the acute drug intoxication! We think about pharmaceutical approach from a case 今井徹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2019.

---

	3-14-S49-2. About poison in medicine thing analysis duties carried out now 波多野亘1, 五十嵐大輝1, 寺島達也1, 平良木由布1, 島田祐子1, 堀寧1, 広瀬由和2, 廣瀬保夫2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2019.

---

	3-14-S49-3. Relation of the pharmacist to the patients whom colchicine poisoning developed in by a Colchicum autumnale false meal 矢内一成1, 鈴木博也1, 小林正和2, 赤坂和俊1, 山口浩明3, 眞野成康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2019.

---

	3-14-S49-4. The early diagnosis that is addicted to distigmine bromide by the ER permanent residence pharmacist 齋藤靖弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2019.

---

	3-14-S49-5. A poisoning case of our hospital and the correspondence 佐藤智人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2019.

---

	Symposium 50. From the viewpoint of problems and measures - eating deglutition of the subnutrition in the community medical care, infusion management, pressure sore, cancer care - 倉田なおみ, 小原道子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2019.

---

	3-15-S50-1. Purpose of this symposium 倉田なおみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2019.

---

	3-15-S50-2. The intraoral situation that is an entrance of the dietary intake and the improvement 戸原玄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2019.

---

	3-15-S50-3. What the current situation and a pharmacist of a quantity of nourishment in the infusion nourishment, the nourishment composition should do 東敬一朗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2019.

---

	3-15-S50-4. We know the onset cause of the pressure sore, and let's collaborate by the multi-type of job 塚田邦夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2019.

---

	3-15-S50-5. Viewpoint of the caring at home that we were able to see from subnutrition and intraoral environment 小原道子1,2, 林秀樹2,3, 生木庸寛2,4, 松川泰治5, 加藤梨那5, 池野隆光1, 鈴木大7, 古島大資6, 山田浩6, 杉山正2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2019.

---

	Medical seminar 28. Dr. JOY X valuable MR MS28-1 若林進1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2019.

---

	Symposium 51. Skill ... which looks at the patients in ... anticancer treatment to think about the side effect management of the pharmacist carrying the new times 松尾宏一, 川上和宜 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2019.

---

	3-15-S51-1. Diagnosis of exclusion ... not to make significance - easiness to conduct the side effect management that a pharmacist conducts be associated with medicine 松尾宏一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2019.

---

	3-15-S51-2. How do consider whether is judgment - side effect of the side effect of pharmacist; ... 川口崇1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2019.

---

	3-15-S51-3. Point - of the adverse event evaluation that a tumor physician conducts on cancer medical therapy and the observation to expect of differential diagnosis - pharmacist 柴田伸弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2019.

---

	3-15-S51-4. Adverse event evaluation for the medical staff 山口拓洋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2019.

---

	3-15-S51-5. Example introduction 川上和宜1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2019.

---

	Symposium 52. Art of the summary of a viewpoint and the case summary of the pharmaceutical intervention of the pharmacist specialized in a cancer 河原昌美, 濱敏弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2019.

---

	3-15-S52-1. About the pharmacist examination situation and a trend specialized in a cancer of 2018 河原昌美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2019.

---

	3-15-S52-2. The case that was involved in the supportive care for the malignant lymphoma with suspected merger of the SIADH がけ晋太郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2019.

---

	3-15-S52-3. The case that was involved in a regimen choice in consideration of the overall status of patients with pancreatic cancer 藺上圭子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2019.

---

	3-15-S52-4. Pharmaceutical intervention for patients with liposarcoma 山口恭平1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2019.

---

	3-15-S52-5. The case that intervened that is prophylactic for the VTE becoming severe of patients with lung cancer 西部星来1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2019.

---

	3-15-S52-6. Pharmaceutical intervention for the diarrhea symptom of patients with recurrent stomach cancer 松井裕典1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2019.

---

	Symposium 53. Scientific approach for proper use of the Chinese medicine 礒濱洋一郎, 本間真人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2019.

---

	3-16-S53-1. The Chinese medicine which contributes to improvement of the quality of life of patients with cancer: Appropriate prescription choice based on the basics, clinical studies 上園保仁1,2, 宮野加奈子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2019.

---

	3-16-S53-2. Immunodepression cells (MDSC) derived from an immunostimulation effect and marrow of the Chinese medicine 礒濱洋一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2019.

---

	3-16-S53-3. Effect of the Chinese medicine on decrease in quantity of muscle 大澤匡弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2019.

---

	3-16-S53-4. Adverse event of herbal medicinal products 本間真人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2019.

---

	Receiving a prize -1. Study on pharmaceutical intervention for the clinical problem solution and outcome evaluation 橋田亨1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2019.

---

	Receiving a prize -2. Evidence creation and clinical application about the use of perinatal pharmaceutical products, supplement 小原拓1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2019.

---

	Receiving a prize -3. Study on evaluation of the usefulness of the pharmacist intervention aiming at pharmaceutical products proper use 木村丈司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2019.

---

	Receiving a prize -4. The development of the inhalational instruction tool which pointed to individualization inhalation therapy and clinical usefulness evaluation 平大樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2019.

---

	Medical seminar 29. It is - MS29-1. making use of ICI by the cooperation of combo X combo - pharmacist and the physician Wanting a pharmacist to know it being the current situation of ICI 岩澤俊一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2019.

---

	Medical seminar 29. It is - MS29-2. making use of ICI by the cooperation of combo X combo - pharmacist and the physician For the ICI cooperation that we saw from a pharmacist 今井千晶1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2019.

---

	Medical seminar 29. It is - MS29-3-1. making use of ICI by the cooperation of combo X combo - pharmacist and the physician Real examination that we maintain a case 今井千晶1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2019.

---

	Symposium 54. It is ... for the active treatment participation of practice - pharmacist of PBPM (medical treatment management based on the protocol) in the clinical nutrition 井上真, 伊東弘樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2019.

---

	4-01-S54-1. We regard PBPM as the change of the pharmacist duties in the clinical nutrition domain 井上真1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2019.

---

	4-01-S54-2. What can a pharmacist do now? Thing - that it is seen in the point of - work-style reform by an original action now 鶴知光1, 小野沙織2, 長嶋フクヱ2, 高瀬麻衣3, 阿部浩子3, 上坂英二3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2019.

---

	4-01-S54-3. Of PBPM in the clinical nutrition therapy to give on the site, actually 野崎歩1, 堀内望1, 奥川寛1, 馬橋美由季1, 小林由佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2019.

---

	4-01-S54-4. PBPM for the purpose of the clinical department cross-sectional intervention in the electrolyte management 梶原洋文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2019.

---

	Symposium 55. Relation to hospitalization and release support and medical cooperation - perioperative patients security and high quality medical care 舟越亮寛, 柴田ゆうか Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2019.

---

	4-02-S55-1. The perioperative care team member training business of Japanese Society of Anesthesiologists 齋藤繁1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2019.

---

	4-02-S55-2. Adjustment ... that in front of efforts ... art discontinuation standard review and a clinical department characteristic in the outpatient department in front of the art were considered 石塚良子1, 尾崎淳子1, 松原和夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2019.

---

	4-02-S55-3. The bringing medicine center operation in the local core hospital and good use of perioperative duties check seat 日江井和英1, 土本暁斗1, 安田翔1, 武冨佳那子1, 水野楓子1, 佐藤和也1, 塚原民夫1, 宇佐見文隆1, 堀内正1, 加納久美子2, 山崎潤二3, 梶川真樹4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2019.

---

	4-02-S55-4. It is ... from efforts - medicine support center about the perioperative medical security in the Kyoto second Red Cross hospital to the hospitalization and release support center 福田喬士1, 野口裕介1, 堀内あす香1, 神田英一郎1, 友金幹視1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2019.

---

	Medical seminar 30. It is ... MS30 mainly on current situation - dementia, Parkinson's disease of a problem and the development of the neurodegenerative disease therapeutic drug 野元正弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2019.

---

	PA-1. Development of the quantitative evaluation model of the adverse drug reaction expression risk using the data mining technique 今井俊吾1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2019.

---

	PA-2. Examination of the daptomycin (DAP) loading dose using the femoral MRSA infection mouse model 加藤秀雄1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2019.

---

	PA-3. Basic study on elucidation of the injury risk based on the pathological evaluation of the extravasation of thiopental and the propofol and effect of the application of a poultice 柴田ゆうか1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2019.

---

	PA-4. Identification of new EGFR-TKI acquisition of resistance factor eIF3c and elucidation of the clinical significance 新谷拓也1,2, 東阪和馬2,3, 前田真貴子2, 濱田将矢2, 辻亮介2, 川崎桂輔4, 山本智也1, 前田真一郎1,2, 森井英一4, 熊ノ郷敦5, 堤康央2, 長友泉5, 藤尾慈2, 奥田真弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2019.

---

	PA-5. Study on blood poison-related expression mechanism with antipsychotics 鳥居綾1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2019.

---

	PA-6. Study on risk factor of the hiccups using the clinical information and treatment 細谷龍一郎1,2, 田中一平1, 石坂範子1, 永村陽一郎1, 野澤(石井)玲子3, 網野猛4, 鎌田智幸4, 日野斉一1, 加賀谷肇5, 植沢芳広2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2019.

---

	PA-7. Search of the new preventive preparation for anticancer medicine oxaliplatin-induced peripheral neuropathy 山本将大1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2019.

---

	Medical seminar 31. Treatment strategy for the unresectable progress, recurrent gastric cancer to read from evidence and true clinical practice and in the future fine-view MS31 有上貴明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2019.

---

	Medical seminar 32. Of rheumatoid arthritis treatment will be MS32 from now on until now 押領司健介1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2019.

---

	Symposium 56. For improvement of the infection with pharmacist practice support 塩田有史, 三鴨廣繁 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2019.

---

	4-05-S56-1. Infection practice support of the pharmacist in the university hospital (there is an infection department) 塩田有史1,2, 浅井信博1,3, 小泉祐介1,3, 山岸由佳1,3, 三鴨廣繁1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2019.

---

	4-05-S56-2. Infection practice support of the pharmacist in the university hospital (there is no infection department) 茂見茜里1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2019.

---

	4-05-S56-3. Infection practice support of the pharmacist in the large-scale hospital 奥平正美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2019.

---

	4-05-S56-4. Infection practice support of the pharmacist in the middle scale hospital 木村匡男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2019.

---

	4-05-S56-5. University pharmacy school 継田雅美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2019.

---

	Medical seminar 33. Drug choice - MS33 which we saw from a new positioning - fruit clinical viewpoint of the bony formation accelerant 中條悟1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-395, 2019.

---

	Symposium 57. For practice and the development of the TDM study after the revised medical law enforcement 谷川原祐介, 増田智先 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2019.

---

	4-05-S57-1. Practice of the TDM precision management in conformity with the revised medical law 谷川原祐介1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2019.

---

	4-05-S57-2. Precision management and standardization in the laboratory study 滝野寿1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2019.

---

	4-05-S57-3. TDM precision management whole country survey: Immunosuppressive drug 増田智先1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2019.

---

	4-05-S57-4. The thing which TDM standardization and a Japanese TDM association aim at 栄田敏之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2019.

---

	Symposium 58. A medical guidepost to tie safely in the mild medical care! 高瀬久光, 井手口直子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2019.

---

	4-06-S58-1. National fact-finding about the intervention of the pharmacist for the polypharmacy in the mild medical domain 内田まやこ1,9, 鈴木真也2,9, 菅幸生3,9, 菅原英輝4,9, 国分秀也5,9, 植沢芳広6,9, 中川貴之7,9, 高瀬久光8,9 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2019.

---

	4-06-S58-2. Observational, prospective study about the pharmacist intervention effect in the polypharmacy 鈴木真也1,9, 内田まやこ2,9, 菅幸生3,9, 菅原英輝4,9, 国分秀也5,9, 植沢芳広6,9, 中川貴之7,9, 高瀬久光8,9 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2019.

---

	4-06-S58-3. Contribution to medical safety from the perspective of pre-avoid reports 金子健1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2019.

---

	4-06-S58-4. From the position of medical safe ... pharmacist 鷲山厚司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2019.

---

	4-06-S58-5. From the situation of medical safe ... physician 岡村知直1, 皆元文恵2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2019.

---

	4-06-S58-6. Communication for medical security 井手口直子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2019.

---

	Medical seminar 34. - MS34 which is like - efficiency, and thinks about the way of high drug duties of the productivity from the current situation analysis of pharmacist duties to be able to employ according to hospital functions 武田泰生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2019.

---

	Medical seminar 35. Medical treatment MS35. of the retinopathy Medical treatment of the retinopathy 寺崎寛人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2019.

---

	Medical seminar 36. Dr. Work-style reform MS36-1 of a utilization method and the pharmacist of the efficiency JADER side effect search of the JOY X intelligence 萱野勇一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2019.

---

	Symposium 59. [cure association health insurance pharmacy WG] In the interval of - generalist and the specialist thinking about the specialty of the drugstore pharmacist - 宮崎長一郎, 出石啓治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2019.

---

	4-10-S59-1. Expect the medicine machine methods, and the like in the specialty of the pharmacist in the revision 境啓満1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2019.

---

	4-10-S59-2. About the specialty of the drugstore pharmacist in the local inclusion care 吉田力久1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2019.

---

	4-10-S59-3. With the specialist whom a drugstore pharmacist aims at 伊藤譲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2019.

---

	4-10-S59-4. With the authorized pharmacist, specialized pharmacist demanded from a drugstore pharmacist 竹内尚子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2019.

---

4-10-S59-5. Performing PBPM of the oral anticancer medicine medical therapy, and having thought about specialty acquisition of the anticancer medicine medical therapy in the drugstore pharmacist 中村優1,2, 天本耕一郎1,2, 手嶋無限1,2, 池田理恵1, 中村忠博1,3, 山形浩介1,2, 井手陽一1,2, 水崎直文1, 宮崎彰宣1, 秋吉隆治1, 有澤賢二4, 宮崎長一郎4, 安原眞人5, 佐々木均1,3, 田代浩幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2019.

---

	4-10-S59-6. Role of clinical pharmacy and the pharmacy education which a drugstore pharmacist carries 吉山友二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2019.

---

	Medical seminar 37. Not medication counseling the medication support? ... MS37-1. to think about from ... HIV infection team approach in medical care Medication support by the pharmacist in the foreign team approach in medical care 矢倉裕輝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2019.

---

	MS37-2. The medication support that a change and a pharmacist of the medication awareness in the long-term medication patients are available for 大石裕樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2019.

---

	Symposium 60. The change, needs, the prospects of the pharmacist authorization system in the infection domain to think about now 北原隆志, 村木優一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2019.

---

	4-10-S60-1. The participation in infection control foundation period of the pharmacist 白石正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2019.

---

	4-10-S60-2. The specialized pharmacist birth period 継田雅美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2019.

---

	4-10-S60-3. What should the pharmacist practice in the hospital infection measures team? 中川博雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2019.

---

	4-10-S60-4. Participation in AMR era AST 橋本麻衣子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2019.

---

	4-10-S60-5. Role, the prospects of the authorized system and pharmacist in the infection domain 北原隆志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2019.

---

	Symposium 61. Term of the organizer regarding pregnancy treatment and the safety assessment of the drug as rheumatism 中島研, 山根律子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2019.

---

	4-11-S61-1. How do you examine patients with rheumatoid arthritis of the request for fertility? 後藤美賀子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2019.

---

	4-11-S61-2. The pregnancy and rheumatic medicine 中島研1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2019.

---

	4-11-S61-3. It is mainly ... about a biological drug safe information and evaluation ... in the use during the pregnancy of the antirheumatic drug 村岡香代子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2019.

---

	4-11-S61-4. The effect on children of the new antirheumatic drug and efforts in our country 八鍬奈穂1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2019.

---

	Medical seminar 38. Outline MS38 of the Fabry's disease judging from circulatory organ medicine 上原吉就1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2019.

---

	Symposium 62. How does the pharmacist face each other for a disease without relation ... definitive therapy of the pharmacist in intractable disease treatment? Term of ... organizer 池田龍二, 城野博史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2019.

---

	4-11-S62-1. Applied development from the development of the Alzheimer's disease model mouse 斉藤貴志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2019.

---

	4-11-S62-2. It is ... for treatment of contribution - Gaucher's disease to the clinical department as the pharmacist by system of measurement establishment of the intractable disease diagnosis 寺薗英之1,2, 日高朋1, 高橋毅行1,2, 奥津果優3, 吉満誠4, 武田泰生1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2019.

---

	4-11-S62-3. Effect of the STAT3 antagonist on hereditary renal disease Alport's syndrome 横田翼1,2, Suico Maryann2, 首藤剛2, 甲斐広文2, 池田龍二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2019.

---

	4-11-S62-4. How should you face each other as a pharmacist (pharmacy researcher) to overcome an inborn character lipid dysbolism Niemann-Pick disease C type? 石塚洋一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2019.

---

	4-11-S62-5. Analysis of a foresight, the prophylaxis hard to hear that environmental factors influence 大神信孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2019.

---

	Symposium 63. We conduct the affairs, and how is it helpful? Fix the eyes on the evaluation for ... medical service fees, the reflection to a policy with the demanded outcome; and the term of ... organizer 林稔展, 松尾宏一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2019.

---

	4-12-S63-1. It is ... for the new role of clinical studies - pharmacist beginning with usual duties 川田敬1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2019.

---

	4-12-S63-2. Efforts and outcome evaluation of the pharmacist outpatient department for the oral anticancer medicine 郷真貴子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2019.

---

	4-12-S63-3. For the achievement of the pharmacist in the life 100 years times 中井清人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2019.

---

	4-12-S63-4. A hospital, medical office pharmacist duties and medical service fees evaluation 川上純一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2019.

---

	MS39. ... including the proof report of at-home telemedicine utilizing the ICT and the online medication counseling by cooperation - pharmacist of the pharmacist 高野秀雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2019.

---

	Symposium 64. It is the term of ... organizer with the function of the pharmacist whom it is demanded from by the multi-type of job cooperation to support information cooperation - community medical care that hospital pharmacist should work on now 岸本真, 小枝伸行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2019.

---

	4-12-S64-1. It is ... from the viewpoint of expectation - medical care cooperation practitioner to the pharmacist in the local inclusion care system 木佐貫篤1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2019.

---

	4-12-S64-2. From position of the nurse cooperation mind community medical care cooperation room bought by an area and a leading in-hospital pharmacist 塚本知恵子1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2019.

---

	4-12-S64-3. The medical cooperation that started from the patients information sharing before hospitalization in the Gifu comprehensive medical care center 谷沢克弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2019.

---

	4-12-S64-4. We utilize drug control summary to spin a story of the medical therapy of patients to support community medical care and share drug information 賀勢泰子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-448, 2019.

---

	Medical seminar 40. Cooperation - MS40 of proper use - antimicrobial proper use support team of infection measures and the antimicrobial which fixed their eyes on control of the drug resistant bacterium 高田徹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 449-449, 2019.

---

	Symposium 65. Term of the organizer thinking about the gender equality in the field of pharmacist, clinical pharmacy and work-style reform 川上純一, 賀勢泰子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2019.

---

	4-14-S65-1. Is flexible - freely towards the pharmacy where I think, "want to work here!", efforts - of the Chikamori society group 筒井由佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2019.

---

	4-14-S65-2. It is an efforts example of the - Shizuoka hospital pharmacist society and community hospital automation Koga Hospital for the making of society which can play an active part regardless of men and women lively 渡邉学1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2019.

---

	4-14-S65-3. Approach - of - AWA support center toward Tokushima University where men and women can play an active part together 石澤有紀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 453-453, 2019.

---

	4-14-S65-4. Thing to see from a way of working and the way of thinking of the gender equality in a health insurance pharmacy and the pharmacist society, and the like 宮原富士子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 454-454, 2019.

---

	Symposium 66. With the infusion education to practice the periphery fluid therapy mainly on water, the electrolyte? Term of the organizer 名徳倫明, 佐古守人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-455, 2019.

---

	4-15-S66-1. The current situation and problem of the infusion education in university 名徳倫明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 456-456, 2019.

---

	4-15-S66-2. Education and practice of the periphery fluid therapy to think about from dehydration 佐古守人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-457, 2019.

---

	4-15-S66-3. We think about periphery fluid therapy education from body fluid adjustment homeostatic mechanism 梶原洋文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 458-458, 2019.

---

	4-15-S66-4. With the intervention to periphery fluid therapy to seek to a pharmacist? It is ... from the situation of ... physician 錦織英史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2019.

---

	IO01. Availability of Medicine and Universal Health Coverage in Laos Risako Inoue1, Keisuke Seto1, Tomoo Ito2, Hiroyuki Terakado1, Chiaki Miyoshi2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-461, 2019.

---

	IO02. Research on the Science Needs on the Internet Related to Gene Editing Baby Event Based on Search Data Xiao-Wen XING1, Yi-Bo WU2, Ze-Yu JIANG1, Cun-Yi KU1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2019.

---

	IO03. Effect of Wechat precision health communication on medication compliance of patients with hypertension Hai-Bin WEI1, Chen-Xin QUAN2, Ya-Qi DENG2, Yuan HU2, Wen-Yang TAN2, Yi-Bo WU3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 462-462, 2019.

---

	IO04. Research on the Structure and Characteristics of Adolescent Health Popularization Needs based on Search Data Shu-Xian JIA1, Jie WANG1, Jin-Yi MENG2, Tao WANG3, Yi-Bo WU4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 462-462, 2019.

---

IO05. Continuous Medication Consultation for Patients by Private Pharmacists in Community Pharmacies : An Attempt to Introduce a Care Plan Program Keiko Naganuma1, Satoshi Hatazawa1, Kaori Ogawa1, Ryuichi Kinoshita1, Takuro Matsubara1, Mitsuhiro Someya1, Ryouo Taniguchi1, Fumio Nakajima1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 463-463, 2019.

---

	IO06. The Efficacy of Asilol in the Treatment of Severe Hand-foot-mouth Disease in Children : A Systematic Review and Meta-analysis Fang SHI1, Yi-Bo WU2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 464-464, 2019.

---

	2-7-O01-1. One case that led to the use of the Relief System for Sufferers from Adverse Drug Reactions by the intervention of the pharmacist 笠原真理1, 井下田充洋2, 吉倉明枝3, 鶴谷勝実1, 笹川嘉久4, 高丸勇司4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 465-465, 2019.

---

	2-7-O01-2. Proper use and current status of nintedanib at Osaka Habikino Medical Center 和田宜久1, 石樋康浩1, 岩田浩幸1, 上田理絵1, 木村貴1, 嶋津史恵1, 友井理恵子1, 富士芳美1, 松下一樹1, 水口侑子1, 盛谷友梨1, 木澤成美1, 金銅葉子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 466-466, 2019.

---

	2-7-O01-3. One patient who evaluated pilsicainide doses in the pseudo ventricular tachycardia using an electrocardiogram 柴田麻美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 466-466, 2019.

---

	2-7-O01-4. Examination of the factor to have an influence on the self-care using ability for medication judgment study (J-RACT) in the convalescent rehabilitation ward 遠藤秀竜1, 小瀬英司2, 堀浩子1, 細野真吾1, 河村千晶1, 児玉雄大1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 467-467, 2019.

---

	2-7-O02-1. Search of the factor on the reviewer side resulting in a change in the evaluation of the instillation maneuver and the patients side 島田拓弥1, 中川祐紀子1, 菅幸生2, 嶋田努1, 崔吉道1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 468-468, 2019.

---

	2-7-O02-2. The current situation and problem of the HBV reactivation measures for patients receiving immunosuppressive drug 松原菜美1, 冨士原あゆみ1, 馬橋美由季1, 土手賢史1, 小林由佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 469-469, 2019.

---

	2-7-O02-3. Usefulness of the inhalational evaluation of the on admission inhalant continuation patients by the pharmacist and the re-instruction 菅原拓也1, 鈴木麻友1, 荒井潤1, 延川正雄1, 松田圭一郎1, 荒井浩一1, 岩渕勝好2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 469-469, 2019.

---

	2-7-O02-4. Development and efforts of the "ML ward duties search" to make ward duties standardization, the efficiency section system 柏瀬しのぶ1, 浜田幸宏1, 本郷彰也2, 縣宗彦1, 有賀三希子1, 金田純子1, 河本拓哉1, 倉重梓1, 坂田志保1, 菅原直子1, 只見智恵子1, 橋本直人1, 古越冴香1, 丸山拓実1, 山崎智司1, 吉田まり絵1, 高森祥大1, 木村利美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 470-470, 2019.

---

	2-7-O03-1. Response to participation experience type training in the drugstore business training in revision core Cali 松下隼士1,2, 松村千晶2, 小林大介2, 川尻雄大2, 高木淳一1, 岸田義博1, 小柳香織1, 勢島充1, 吉田理1, 山野徹1, 園田正信1, 吉川学1, 島添隆雄2, 田中泰三1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 471-471, 2019.

---

	2-7-O03-2. Education effect of the antimicrobial proper use by the antibacterial chemotherapy workshop (Osaka ABC) for the young hospital pharmacist 山田智之1, 上田覚2, 安井友佳子3, 行本拓史4, 眞継賢一5, 村井千恵6, 吉野秀紀7, 竹内祐介8, 角谷龍哉9, 石坂敏彦10, 関雅文11 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 472-472, 2019.

---

	2-7-O03-3. Attitude survey of the pharmacy student in the learning of the cancer medical therapy utilizing the smartphone game application 児玉暁人1, 今井兼貴1, 高橋文香1, 岩田智津子1, 水庫彩1, 勝浦正人1, 森信介1, 小竹武2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 472-472, 2019.

---

	2-7-O03-4. Examination and evaluation of the held contents of the workshop-style workshop for the purpose of the local cancer medical therapy elimination by the Saitama cancer medical therapy workshop 龍島靖明1, 芝崎由美子2, 武井大輔3, 大島宗平4, 伊藤剛貴5, 鈴木貴之6, 新津京介7, 新井隆広8, 畠山朋樹9, 中山季昭10, 佐野元彦11 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 473-473, 2019.

---

	2-7-O04-1. It is the multicenter questionary survey about the check system of the stopping medicine during the preoperation by the pharmacist 花田聖典1, 鶴崎泰史1, 井上大奨1, 松尾香奈子1, 坂田光平1, 水町純一1, 中川義浩1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 474-474, 2019.

---

	2-7-O04-2. The effect that the number of the drugs in the on admission bringing medicine and prescription complexity give to effect of treatment of the high blood pressure 若井恵里1, 池村健治1, 加藤千佳1, 岩本卓也1, 奥田真弘2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 475-475, 2019.

---

	2-7-O04-3. One case of the sprue-like enteropathy that valsartan that detailed drug history investigation with the prescription notebook was the opportunity of the diagnosis was thought to be associated with 山下祐果1, 松浦仁志1, 岸渕正典2, 吉岡克宣3, 石倉久美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 475-475, 2019.

---

	2-7-O04-4. Efforts of the change of the bringing medicine management method 中田一孝1, 冨田有香1, 池田理沙1, 加田昌宏1, 須原良海1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 476-476, 2019.

---

	2-7-O05-1. 1 case that filgrastim Biosimilar preparation administration was effective for the serious neutropenia that occurred by azathioprine 大塚恵理子1, 津下遥香1, 佐藤雄己1, 田中遼大1, 尾崎貴士2, 前島圭佑2, 柴田洋孝2, 伊東弘樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 477-477, 2019.

---

	2-7-O05-2. Therapeutic safe comparison between precedent biomedicine and biofollowing article of rituximab 安達和宏1, 佐藤雄己2, 龍田涼佑2, 中原良介2, 磯田祥3, 本室貴子1, 伊東弘樹2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 478-478, 2019.

---

	2-7-O05-3. The infusion reaction expression situation at the rituximab Biosimilar initial administration 原茉梨絵1, 三角紳博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 478-478, 2019.

---

	2-7-O05-4. Use experience report to the super elderly people before and after the Biosimilar preparation change of rituximab 今野奈央子1, 多田則道2, 千葉健哉1, 小野垣富美1, 長岡城子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 479-479, 2019.

---

	2-7-O06-1. Comparison of the chemical behavior after starting pharmaceutical products, a saline in the generic medicine docetaxel non-alcohol preparation and the 5% dextrose in water dilution 小川千晶1,2,3,4, 矢田部恵3, 井上元基4, 足立茂4, 伊藤智夫2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 480-480, 2019.

---

	2-7-O06-2. Importance of the cutoff value in the generic medicine introduction and medical economic effect 関屋裕史1, 緒方豊2, 梶原隆広3, 福永洋子3, 森木豊栄3, 池田龍二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 481-481, 2019.

---

	2-7-O06-3. Examination of the case that changed the mesalazine Enteric tablet (hemp call) to the generic medicine 細川宜嗣1, 原田恭江1, 軸原温2, 江藤精二3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 481-481, 2019.

---

	2-7-O06-4. An attempt of the generic name prescription spread by the pharmacist based on the in-hospital protocol and the evaluation 宮崎元康1, 内山将伸1, 松尾宏一1, 鵜木亜矢子1, 島田安希子1, 森由夏子1, 今給黎修1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 482-482, 2019.

---

	2-8-O07-1. Investigation about the background of conveyed patients emergency for lithium poisoning 飛田修康1, 祖川倫太郎1, 木村早希子1, 田崎正信1, 阪本雄一郎3, 成澤寛2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 483-483, 2019.

---

	2-8-O07-2. About safety of the oseltamivir phosphate prophylaxis in the mental disorder 亀井進太郎1, 岩田裕明1, 佐藤雄己1, 伊東弘樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 484-484, 2019.

---

	2-8-O07-3. An adverse event and search of the associated factor to influence tolerability at the Clozapine administration 麻那古信之1, 山本智也1, 渡邊梓1, 門脇裕子1, 奥田真弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 484-484, 2019.

---

	2-8-O07-4. Examination of the effectiveness of the Elobixibat for the chronic constipation in patients with mental disorder 中村奈央1, 幸邦憲1, 大井裕貴1, 中村民生2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 485-485, 2019.

---

	2-8-O08-1. Objective oxidative stress evaluation of children with autistic spectrum disorder using d-ROMs, BAP 北岡泰介1,2, 森本真仁3, 橋本俊顕3, 津田芳見3, 中津忠則3, 京谷庄二郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 486-486, 2019.

---

	2-8-O08-2. Examination of the insomniac frequencies in patients with hospitalized brain tumor and the risk factor 菅野ゆみか1, 関根佳代1, 岩田理恵1, 大谷美子1, 井内俊彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 487-487, 2019.

---

	2-8-O08-3. 1 case of patients consulting the several outpatients who bach is difficult, and were admitted to the mental hospital 加藤剛1, 宗像彩香1, 澤口真紀1, 鈴木順子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 487-487, 2019.

---

	2-8-O08-4. Efforts of the benzodiazepine receptor agonist decrease medicine by the stamp pasting to an electronic medical record and the evaluation 進健司1,2, 小林大介1, 川尻雄大1, 猪狩圭介3, 光安博志3, 村上智哉3, 堤一樹3, 金澤康範2, 神村英利4, 島添隆雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 488-488, 2019.

---

	2-8-O09-1. Examination of the incompatibility in the coadministration of Fosaprepitant and the magnesium preparation using the high performance liquid chromatography 尾崎正和1, 幸田恭治1, 北原隆志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 489-489, 2019.

---

	2-8-O09-2. It is effectively utilized anticancer agent inspection support system "chemo assistant" 佐竹清1,2, 井上朋子1, 後藤孝之1, 亀井陽子1, 中島孝則2, 町田充1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 490-490, 2019.

---

	2-8-O09-3. Efforts for the elimination of the regimen confirmation matter in the cancer chemotherapy 粂哲雄1, 野村光永1, 佐藤淳也1, 梅坪翔太1, 安田陽子1, 鴨志田武1, 石川寛1, 篠道弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 490-490, 2019.

---

	2-8-O09-4. The actual situation of the HBV infection that became clear by screening before cancer chemotherapy 樋口芙蓉子1, 有野徹1, 清水淳一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 491-491, 2019.

---

	2-8-O10-1. Examination of the medical expenses reduction effect by the use of division of the anticancer medicine 浅野舞美1, 小林一男1, 山端悠介1, 横川貴志1, 鈴木亘1, 平出誠1, 三木真梨杏1, 岩崎愛理1, 濱敏弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 492-492, 2019.

---

	2-8-O10-2. Examination about the sterilitas at eight days storage in the multiple use of the single-use vial 森はづき1, 多賀允俊1, 高橋喜統1, 藤本俊祐1, 政氏藤玄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 493-493, 2019.

---

	2-8-O10-3. Examination of the exposure measures method that we evaluated from anticancer medicine environmental pollution investigation 高山慎司1, 河野友昭1, 景秀典1, 二階堂恵子1, 池田優子1, 高野めぐみ1, 渡邊由紀子1, 増渕敬久1, 山内照夫2, 後藤一美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 493-493, 2019.

---

	2-8-O10-4. It is ... about the handling and the foreign chemotherapy room of efforts ... anticancer agent of the pharmacy for the JCI certification 與田賢作1, 奥野美和1, 松浦徹1, 内山有理香1, 山下大貴1, 立石裕樹1, 市川美佳1, 大汐欣輝1, 後藤貴央1, 後藤美緒1, 村田智弘1, 重松由加1, 宮津大輔1, 田中博和1, 平川雅章1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 494-494, 2019.

---

	2-8-O11-1. Introduction of the side effect evaluation tool in the foreign chemotherapy center of the middle scale hospital 新美政樹1, 菊池正和2, 尾畑景子3, 谷口結基1, 森智世1, 田中美帆1, 太田達也1, 田中章郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 495-495, 2019.

---

	2-8-O11-2. Outpatient treatment Examination of contribution to treatment by a system (Ringlenbima) including telephone consultation support for patients with hepatocellular carcinoma 坂田幸雄1, 松丸亜紀2, 伊藤由貴子2, 伊藤淳3, 山本義也3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 496-496, 2019.

---

	2-8-O11-3. Attitude survey about the side effect with the appearance change in anticancer agent ambulant treatment patients 鈴木絢子1, 渡邉美知子1,2, 坂本靖宜1, 山下美乃里1, 服部有希1, 小池博文1, 佐橋幸子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 496-496, 2019.

---

	2-8-O11-4. Examination about the transformation of the reporting of the medical person about the effect on fecundity with the cancer medical therapy 馬見新佳那子1, 岩本彩2, 内藤陽一3, 細野亜古3, 南陽介4, 向原徹3, 米村雅人3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 497-497, 2019.

---

	2-8-O12-1. Examination about the effect that the liver, a decreased renal function gives to onset of ifosfamide-related central nerve symptom 志水真也1, 林祐一2, 西田承平1, 藤井宏典1, 小林亮1, 鈴木昭夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 498-498, 2019.

---

	2-8-O12-2. Evaluation ... of the hypersensitivity protective efficacy by onset of hypersensitivity situation investigation - DEX9.9mg by PTX at obstetrics and gynecology department tri-weekly PTX + CBDCA therapy enforcement 杉山弘樹1, 中田淳也1, 原田晴司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 499-499, 2019.

---

	2-8-O12-3. Construction and maintenance doses investigation of the cooperation system for the Palbociclib administration 柿原圭佑1, 三上忠司1, 野田聖奈子1, 武田なつか1, 原田智子1, 篠崎千尋1, 松本美紅1, 藤井裕史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 499-499, 2019.

---

	2-8-O12-4. About a quality of life improvement effect by the analysis of the adverse event to have an influence on the quality of life of patients in the foreign cancer chemotherapy and the pharmaceutical intervention 藤井宏典1, 廣瀬智恵美1, 飯原大稔1, 石原正志1, 大畑紘一1, 関谷久美子1, 北洞美佳1, 鈴木昭夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 500-500, 2019.

---

	2-9-O13-1. Fluid replacement weight loss in the BEP therapy for the germ cell neoplasm, renal function with the aprepitant day3-7 administration, investigation about the effect on nausea vomiting 渡邊裕之1, 木村錦子1, 村田政軌1, 田村曉識1, 神野正敏2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 501-501, 2019.

---

	2-9-O13-2. Strategy - of the - LEC antiemesis therapy proper use thinking about Steroid Sparing 井上靖隆1, 寺谷俊昭1, 辻本高志1, 加納宏樹1, 上田晃1, 川本由加里1, 村井太一2, 曽根孝之2, 中村路夫2, 後藤仁和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 502-502, 2019.

---

	2-9-O13-3. Phase II clinical study to examine the effect of 5 mg of olanzapine on prominence-related retching, vomiting at chemotherapy enforcement including the Carboplatin 吉田弘樹1, 前田章光2, 井上裕貴3, 江尻将之4, 山口智江5, 櫛原秀之6, 山本泰大7, 安藤洋介8, 佐藤由美子9, 田代雄祐10, 尾瀬功11, 清水淳市12 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 502-502, 2019.

---

	2-9-O13-4. Study on factor analysis of GEM+nab-PTX therapy in patients with pancreatic cancer-induced retching 左高史織1, 大畑紘一1, 加藤寛子1, 藤井宏典1, 飯原大稔1, 上村真也2, 岩下拓司2, 清水雅仁2, 鈴木昭夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 503-503, 2019.

---

	2-9-O14-1. Examination of the usefulness of 5 mg of olanzapine for the hematopoietic stem cell transplantation pre-treatment treatment containing melphalan 原田知彦1, 大野瑞穂1, 齋藤圭佑1, 新本小百合1, 安藤太基2, 鈴木泰生2, 立花崇孝2, 田中正嗣2, 金森平和2, 林稔展3, 岸本有佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 504-504, 2019.

---

	2-9-O14-2. Examination of the medical economics about the G-CSF administration at lung cancer treatment by DTX+RAM 鈴木寛人1, 築田晃直1, 山形真一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 505-505, 2019.

---

	2-9-O14-3. Look at onset in the gefitinib monotherapy of hepatic dysfunction and the rear about the association of the BMI; mark investigation 古野龍也1, 木村早希子1, 荒金尚子1,2, 田崎正信1, 成澤寛1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 505-505, 2019.

---

	2-9-O14-4. The use situation investigation of the Fosaprepitant in patients with childhood cancer 甲斐維子1, 加戸奈穂美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 506-506, 2019.

---

	2-9-O15*-1. Effect of the pharmacist intervention based on antimicrobial TDM guidelines on use of aminoglycoside derivative medicine patients 篠田康孝1,2, 大橋健吾1, 松岡知子1, 新井かおり1, 加藤未紗1, 杉山正2, 吉村知哲1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 507-507, 2019.

---

	2-9-O15*-2. Knowledge - that we were able to see it from examination - chronicity kidney disease model of the kidney protection with the PDE5 inhibitor and a nephrotic model 冨田なつみ1, 堀田祐志1, 内木綾2, 吉川麻優1, 片岡智哉3, 高橋智2, 木村和哲3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 508-508, 2019.

---

	2-9-O15*-3. Relative examination of the trace minerals in the acute renal failure and living body after the use of heart-lung machine 松田夏鈴1, 堀田祐志2, 冨田なつみ2, 片岡智哉3, 伊藤秀和4, 山本優子5, 祖父江和哉4, 木村和哲1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 508-508, 2019.

---

	2-9-O15*-4. Consideration ... from the adverse event signal detection with research - sleeping drug about the proper use of the medicine of elderly people 泉澤恵1, 菊地智貴1, 上野晃汰1, 金谷潔史2, 羽生春夫2, 亀井美和子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 509-509, 2019.

---

	2-9-O16*-1. Usefulness evaluation of the infliximab blood level measurement in rheumatoid arthritis treatment using real world data 中江一統1,2, 米澤淳1,2, 傳田将也1,2, 増井翔1,2, 橋本求3, 田中真生3, 伊藤宣3, 岩本典子4, 嶋田崇史4, 中川俊作1, 池見泰明1, 早狩誠1, 松原和夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 510-510, 2019.

---

	2-9-O16*-2. A. semi-mechanistic PK/PD analysis ... of construction - time-kill properties of the sulbactam optimal administration method for the baumannii infection 横山雄太1, 猪川和朗2, 松元一明3, 中村智徳1, 森川則文2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 511-511, 2019.

---

	2-9-O16*-3. Effect of CYP3A5 giving it to blood change of the tolvaptan in patients with heart failure and endogenous CYP3A activity marker and the ABCB1 mutation in the gene 星川昂平1, 内藤隆文1, 阿久津駿太1, 早乙女雅夫2, 前川裕一郎2, 川上純一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 511-511, 2019.

---

	2-9-O16*-4. Analysis of the genetic factor influencing an internal change and side effect of the Afatinib in patients with non-small cell lung cancer 福田純久1, 林秀樹1,2,3, 飯原大稔2,3, 廣瀬智恵美3, 上森将吾2, 北洞美佳3, 佐藤幸奈3, 大澤友裕4, 垣内大蔵5, 柳瀬恒明5, 遠渡純輝5, 澤祥幸6, 大野康5, 鈴木昭夫2,3, 杉山正1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 512-512, 2019.

---

	2-9-O17*-1. Economical effect by the intervention of the ICU exclusive duty pharmacist in painkilling, the sedative domain 安部敏生1, 才穂亮介2, 高井信幸3, 鹿島秀明4, 田中太郎5, 丸川征四郎3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 513-513, 2019.

---

	2-9-O17*-2. Renal function attention medicine efforts using bringing medicine differentiation data of a check 延藤勇1, 豊濱隆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 514-514, 2019.

---

	2-9-O17*-3. Quantitative evaluation about the intrapulmonary drug delivery at problems extraction and inhaler erroneous operation at use of inhalant 末永佳奈1, 石戸恵理1, 平大樹1,2, 小出博義2, 上島智1, 奥田知将3, 山口将史4, 岡本浩一3, 岡野友信1, 中野恭幸4, 寺田智祐2, 角本幹夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 514-514, 2019.

---

2-9-O17*-4. Of "stopping medicine management Web application during preoperation" development and the effectiveness, safe inspection 木村早希子1,2, 江本晶子2, 嘉村知子2, 祖川倫太郎2, 田崎正信2, 吉村麻里子1, 有水弘太3, 川口淳3, 水田貴久美1,4, 田篭康洋1,4, 夏秋政浩5, 梶原正貴5, 鶴岡ななえ6, 薬師寺祐介7, 檀上敦8, 谷川義則9, 高松千洋1,9, 平川奈緒美10, 蒲原啓司11, 野口満12, 能城浩和13, 坂口嘉郎10, 末岡榮三朗14, 成澤寛15, 木村晋也1,16 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 515-515, 2019.

---

	2-9-O18*-1. Result of the multi-type of job collaboration by the interstitial pneumonia pharmacist outpatient department: Extension of the medication continuance 薩摩由香里1, 楠田かおり1, 池末裕明1, 前田真美1, 室井延之1, 古郷摩利子2, 立川良2, 富井啓介2, 橋田亨1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 516-516, 2019.

---

	2-9-O18*-2. Effect examination of the foreign inhalational instruction using the lung function test value 安達圭織1, 相良克海4, 定村洋士1, 廣澤達哉2, 小田慎4, 松永康二郎3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 517-517, 2019.

---

	2-9-O18*-3. In the insomnia patients whom a benzodiazepine system sleeping drug is given to for a long term, weight loss/change is sleep and effect to give to anxiety 圓東寛基1, 重面雄紀1, 今井哲司1, 中川貴之1, 鶴身孝介2, 杉田尚子2, 磯部昌憲2, 村井俊哉2, 松原和夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 517-517, 2019.

---

	2-9-O18*-4. The association between hypoglycemia and combination drug with the sitagliptin administration in patients with Japanese type 2 diabetes: Than subanalysis results of multicenter cohort study SPIRITS-J 齋藤智之1,2, 大村寛敏1, 野尻宗子3, 代田浩之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 518-518, 2019.

---

	2-10-O19-1. It is compared the adverse event profile in the use of Osimertinib patients after the primary and second treatment 大柿滋1, 牛島智子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 519-519, 2019.

---

	2-10-O19-2. Search of the new preventive preparation for the lithium-induced renal failure using medical big data 坂東寛1, 合田光寛1, 神田将哉1, 武智研志3, 中馬真幸3, 座間味義人1,2, 桐野靖1, 中村敏己1, 寺岡和彦1, 石澤啓介1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 520-520, 2019.

---

	2-10-O19-3. Evaluation of the aspiration pneumonia onset risk using Anticholinergic Risk Scale 小瀬英司1, 平井利幸2, 関利一2, 安野伸浩1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 520-520, 2019.

---

	2-10-O19-4. Investigation about the delirium onset in patients during the steroid pulse enforcement 高橋葵1, 吉川明良1, 波多江崇2, 宮森伸一1, 開浩一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 521-521, 2019.

---

	2-10-O20-1. Effect of the combination of the P-glycoprotein inhibitor giving it to a bleeding risk of the dabigatran and the renal function 横田裕之1, 川上智恵子1, 土岐浩介1,2, 家田真樹2, 青沼和隆2, 本間真人1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 522-522, 2019.

---

	2-10-O20-2. Examination of the onset of carbohydrate metabolism abnormality drug prediction by the genetic analysis using the human hepatocytes chimera mouse 北原隆志1, 榎本初音2, 立木秀尚2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 523-523, 2019.

---

	2-10-O20-3. Analysis of the side effect of rosuvastatin and Bezafibrate combination case 井坂江吏香1, 神鳥周也2, 細野智美1, 土岐浩介1,2, 西山博之2, 本間真人1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 523-523, 2019.

---

	2-10-O20-4. Association of use and the fall event of suvorexant and the ramified microglia 石郷友之1, 近藤蕗1, 高田遼1, 立石莉穂1, 伊部裕太1, 藤居賢1, 北川学1, 木明智子1, 中田浩雅1, 宮本篤1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 524-524, 2019.

---

	2-10-O21*-1. Elucidation of the occurrence of formulations error mechanism based on the eyes trend of the pharmacist using the eye-tracking technique 辻敏和1, 永田健一郎1, 佐々木恵一2, 末次王卓1, 渡邊裕之1, 金谷朗子1, 増田智先1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 525-525, 2019.

---

	2-10-O21*-2. Investigation about the usefulness of the drug control summary in the medicine medicine cooperation 高井靖1, 前田雄太郎1, 木本珠美1, 松岡佳子1, 伊藤涼子1, 梶間勇樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 526-526, 2019.

---

	2-10-O21*-3. Interactive illness medicine cooperation with the health insurance pharmacy through the district pharmacist society 壁谷めぐみ1, 日比聡1, 長岡雅敏1, 岡本千晴1, 湯浅周1, 粥川哲2, 伊奈研次2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 526-526, 2019.

---

	2-10-O21*-4. Effect on test value by the adherence which we saw from Residual medicine adjustment report data obtained by Residual medicine cancellation PBPM 寺門祐介1, 平井利幸1, 関利一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 527-527, 2019.

---

	2-10-O22*-1. Administration adherence of mother of the preschooler and relation - administration environmental examination - of the actual situation and the pharmacist of the administration in the nursery school for appropriate medical treatment 柳奈津代1, 佐藤宏樹1,2, 澤田康文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 528-528, 2019.

---

	2-10-O22*-2. Investigation of the polypharmacy-related factor in Takarazuka city limits 吉岡睦展1, 杉生雅和1, 細見光一2, 門田憲亮3, 佐藤聖子3, 中出勝也3, 若松雄太1, 高子優子1, 横山聡2, 高田充隆2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 529-529, 2019.

---

	2-10-O22*-3. Cost effect analysis of the Durvalumab as the maintenance treatment for the unresectable local progress non-small-cell lung cancer 日高諒1, 古林健吾1, 前田知美1, 森脇健介1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 529-529, 2019.

---

	2-10-O22*-4. Tendency to onset of proteinuria with the VEGF inhibitor using JADER and nephrotic syndrome analysis 森川記道1, 内海敦志1, 横山匠太1, 大山展弘1, 西倉教子1, 原田靖子1, 西原昌幸2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 530-530, 2019.

---

	2-10-O23*-1. Look at the rear about the risk factor of the onset of diarrhea in naldemedine treated patients; mark investigation 岡本明大1, 水谷栄梨1,2, 池村健治1, 岩本卓也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 531-531, 2019.

---

	2-10-O23*-2. Effect on antibody mark rate of ZEVALIN(R) Yttrium (90Y) by the quantity of antibody solution addition 鈴木秀隆1, 加納大輔1, 望月伸夫1, 大橋周平2, 中神佳宏3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 532-532, 2019.

---

	2-10-O23*-3. We look at true doses of the regorafenib and the rear of the effect of treatment and examine a mark 羽鳥正浩1, 川上和宜1, 若槻尊2, 青山剛1, 中野泰寛1, 小林一男1, 鈴木賢一1, 山口研成2, 濱敏弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 532-532, 2019.

---

	2-10-O23*-4. Examination of cisplatin weight loss method and RDI for the decreased renal function patients in the GC therapy 河野光1, 龍島靖明1, 内田康光2, 金井邦光2, 門間哲雄2, 高橋邦雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 533-533, 2019.

---

	2-10-O24*-1. A randomized phase III controlled trial to test the usefulness of 5 mg of olanzapine for retching, the vomiting prevention at the cisplatin administration: J-FORCE study 矢内貴子1, 石川寛2, 中尾將彦3, 武井大輔4, 阪田安彦5, 藤田行代志6, 西村知恭7, 國米由希8, 古川美緒9, 見野靖晃10, 坂田幸雄11, 飯原大稔12, 橋本浩伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 534-534, 2019.

---

	2-10-O24*-2. Examination of the adverse event expression time with the bortezomib administration using the adverse drug reaction database 坂部彩1, 頭金正博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 535-535, 2019.

---

	2-10-O24*-3. The serious neutropenia in patients received high-dose irinotecan and examination about the serum bilirubin 大畑紘一1, 藤井宏典1, 左高史織1, 山田友奈美1, 加藤寛子1, 上村真也2, 岩下拓司2, 清水雅仁2, 鈴木昭夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 535-535, 2019.

---

	2-10-O24*-4. Examination - of male hormone levels after the medication to give effect - men hypogonadism that treatment with anticancer agent gives to a rat sex glandular function 片岡智哉1, 真川明将2, 鈴木純3, 中島晃3, 堀田祐志3, 前田康博4, 木村和哲1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 536-536, 2019.

---

	2-11-O25-1. Examination about the use of the antimicrobial with the antiPseudomonas aeruginosa activity at the COPD exacerbation 太田愛子1, 梅村拓巳1, 武藤義和2, 宮島紀彦1, 中村直人1, 山田哲也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 537-537, 2019.

---

	2-11-O25-2. Report of the AST activity first year in the Nagaoka Red Cross hospital 小林謙一1,3, 丸山智幸1,3, 西堀武明2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 538-538, 2019.

---

	2-11-O25-3. Practice and effect of the antimicrobial proper use support by the working full time pharmacist leadership 本田勝亮1,6, 石塚友一1,6, 柏原道志1,6, 長岡翔1,6, 釋悦子2,6, 石原冬馬2,6, 真壁利枝3,6, 宮木祐一郎4,6, 武地大維5,6, 齊藤一仁5,6, 渡邊卓哉5,6, 矢部勝茂1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 538-538, 2019.

---

	2-11-O25-4. Examination of the optimal blood level of vancomycin in MRCNS bacteremia treatment 竹内祐介1, 宮本朋佳1, 小泉祐一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 539-539, 2019.

---

	2-11-O26-1. Role of the pharmacist in the proper use support team about the antifungal agent 木全柾典1, 中川俊作1, 片田佳希1, 杉本充弘1, 吉田優子1, 糸原光太郎1, 深津祥央1, 佐藤夕紀1, 今井哲司1, 米澤淳1,2, 中川貴之1, 松村康史3, 長尾美紀3, 松原和夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 540-540, 2019.

---

	2-11-O26-2. Compatible examination in a renal failure development factor and the renal failure prediction-type Japanese after the cholistine sulfomethate sodium administration 田沼道也1, 田中昌代1, 中山裕一1, 加藤敏明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 541-541, 2019.

---

	2-11-O26-3. Aggressive intervention ... to introduction - blood culture-positive patients of pharmacist-led Antimicrobial Stewardship Program 佐々木康弘1,8, 天野美里1,8, 山口明子2,8, 金丸亜佑美3,8, 鈴木みき4,8, 知念直史5,8, 高安博史6,8, 矢野雅隆7,8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 541-541, 2019.

---

	2-11-O26-4. An example of the eyes corneal ulcer that the intervention by the pharmacist was useful 柴田祐一1,2, 萩原真生2, 塩田有史1,2, 斎藤寛子1, 大西正文1, 浅井信博2,3, 小泉祐介2,3, 山岸由佳2,3, 三鴨廣繁2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 542-542, 2019.

---

	2-11-O27-1. Efforts for the quinolone antibacterial prescription reduction to UTIs 野田学1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 543-543, 2019.

---

	2-11-O27-2. Acute renal failure by vancomycin and piperacillin/tazobactam combination in febrile neutropenia treatment of patients with blood tumor 漣航平1,2, 土手賢史1, 堀内望1, 伊藤菜浪1, 村木優一2, 小林由佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 544-544, 2019.

---

	2-11-O27-3. The use situation investigation of the oral antimicrobial in the foreign prescription for AMR measures 藤居賢1, 藤井怜史1, 清治翔伍1, 國本雄介1, 野々山雅俊1, 北川学1, 木明智子1, 中田浩雅1, 宮本篤1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 544-544, 2019.

---

	2-11-O27-4. An antimicrobial proper use plan and resistant bacteria decrease effect in our hospital 野口周作1,2, 吉田奈央1, 先崎貴洋1, 望月徹2, 笠原英城1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 545-545, 2019.

---

	2-11-O28-1. It is examined the usefulness of the cefazolin alternative agent for the infection prophylaxis after the operation 宇都健太1, 小牧誉典1, 中野公1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 546-546, 2019.

---

	2-11-O28-2. Infection treatment support of blood culture-positive patients 吉田奈央1, 野口周作1,2, 先崎貴洋1, 望月徹2, 笠原英城1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 547-547, 2019.

---

	2-11-O28-3. Does becoming it need non-adoption of the oral third generation cephem-based antimicrobial? Use situation ... after ... reduction failure 長谷川浩司1, 宮崎祐介1, 岩本里味1, 岩城晃一1, 石坂忠博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 547-547, 2019.

---

	2-11-O28-4. Goal setting and evaluation of the use number of patients of the carbapenem medicine in the antimicrobial proper use support team (AST) activity per day 小野祐志1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 548-548, 2019.

---

	2-11-O29-1. Investigation about the initial therapeutic drug of the MRSA infection in the large Hannan medical center 吉田三矢1, 南翔大1, 田川知津子1, 三浦菜々子1, 鴨田夏実1, 辰巳晃造1, 畝佳子1, 政道修二1, 志馬伸朗2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 549-549, 2019.

---

	2-11-O29-2. Change of the use of antimicrobial trend in inside the hospital accompanied with the supply stop of the cefazolin 池谷修1, 高野八百子1, 長谷川直樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 550-550, 2019.

---

	2-11-O29-3. It is the hand hygiene observance situation investigation of the ward pharmacist by the pharmacy school business trainee using the observation method directly 多賀允俊1, 高橋喜統1, 政氏藤玄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 550-550, 2019.

---

	2-11-O29-4. Evaluation of making of the blood culture sampling support protocol to patients with S.aureus bacteremia and the operation 片岡優1, 瀬戸崇光1, 小田怜1, 松村友和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 551-551, 2019.

---

	2-11-O30*-1. The proton pump inhibitor is associated with iron-metabolism abnormality through hepcidin 濱野裕章1, 池田康将2, 堀ノ内裕也2, 合田光寛1, 座間味義人1,3, 桐野靖1, 中村敏己1, 寺岡和彦1, 石澤啓介1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 552-552, 2019.

---

	2-11-O30*-2. Examination about onset of dyslipidemia time and the risk factor in Everolimus remedy renal-transplant recipients 佐藤汐莉1, 赤嶺由美子1, 加賀谷英彰1, 佐藤滋2, 三浦昌朋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 553-553, 2019.

---

	2-11-O30*-3. Fistulation by the Lenvatinib in thyroid cancer and analysis of the associated factor of the tumor-related bleeding スタッブ由紀子1, 西山明宏2, 菅幸生3, 藤田未来也3, 松下良3, 矢野聖二2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 553-553, 2019.

---

	2-11-O30*-4. The effect that the polypharmacy of children gives to Adverse Drug Event expression 杉岡まゆ子1, 舘知也1,2, 古山愛紗1, 村山あずさ1, 青山智2, 大澤友裕2, 勝野隼人1, 松山卓也1, 野口義紘1, 安田昌宏2, 水井貴詞2, 後藤千寿2, 寺町ひとみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 554-554, 2019.

---

	3-7-O31-1. Efforts of the adoption pharmaceutical products adequacy in the small hospital 堀内賢一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 555-555, 2019.

---

	3-7-O31-2. Examination of the optimal consumption adjustment method at antimicrobial supply restrictions 宇夛裕基1, 藺上圭子1, 今井富紀子1, 小路晃平1, 鳥羽英理子1, 中野智尋1, 松永典子1, 吉田芙美1, 竹田和喜1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 556-556, 2019.

---

	3-7-O31-3. Stability evaluation by the cryopreservation of the hospital preparation "poor roasting liquid of the persimmon" 中村仁美1, 加納大輔1, 馬見新佳那子1, 鈴木秀隆1, 望月伸夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 556-556, 2019.

---

	3-7-O31-4. Efforts aiming at hospital preparation duties improvement in the Nagoya University Hospital 宮崎雅之1, 熊倉康郎1, 藤野泰孝1, 矢野亨治1, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 557-557, 2019.

---

	3-7-O32-1. Realization of the ideal inventory control by the Cubixx (refrigerator with the RFID function) introduction 阿登大次郎1, 津崎秀斗1, 濱口健一1, 八代哲也1, 東海秀吉1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 558-558, 2019.

---

	3-7-O32-2. About the abolition of the "increase and decrease" rule and the impact of establishing a formulary committee on the adoption of in-hospital drugs 城山めぐみ1, 細田未紀1, 千原里美1, 上田宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 559-559, 2019.

---

	3-7-O32-3. Duties improvement effect by the drug management system introduction 大屋和福1, 児玉雄大1, 見尾谷昇1, 遠藤秀竜1, 細野真吾1, 堀浩子1, 山崎崇1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 559-559, 2019.

---

	3-7-O32-4. Participation situation of current situation investigation - AST and guidelines on perioperative prophylactic antimicrobial compliance - in the Gifu medical institution 松岡知子1,6, 上田秀親2,6, 平下智之3,6, 丹羽隆4,6, 青山智5,6, 吉村知哲1,6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 560-560, 2019.

---

	3-7-O33-1. Economical evaluation of formal doubt inquiry calculated than doubt inquiry investigation 田中秀和1, 若林進2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 561-561, 2019.

---

	3-7-O33-2. Construction of the doubt inquiry system aiming at appropriate prescription depending on renal function 山本高範1, 朝居祐貴1, 鈴山直寛1, 阿部康治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 562-562, 2019.

---

	3-7-O33-3. Analysis of the factor to contribute to the origin of doubt inquiry in the drugstore and a cause 加藤木俊廣1, 佐藤宏樹1,2, 柳奈津代1, 八木下敏彰3, 久住茂3, 月岡良太3, 森澤あずさ3, 大石美也3, 澤田康文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 562-562, 2019.

---

	3-7-O33-4. Efforts to the TPN no bacteria preparation by the pharmacist in the pediatric hospital 石井美野里1, 加藤千枝子1, 清水祐一1, 福原悠太1, 浅井翔子1, 加戸奈穂美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 563-563, 2019.

---

	3-7-O34-1. Video image analysis of success and the failure case of the instillation self-medication 池田博昭1,2, 高本彩音1, 岩崎順也1, 中妻章1, 徳村忠一1, 飯原なおみ1, 二宮昌樹1, 池田純子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 564-564, 2019.

---

	3-7-O34-2. Exploring of the new healthy fair enforcement method based on an attitude survey to self-medication 池田佳代1, 細井徹1, 三浦常代2, 吉井美智子1, 杉山政則3, 野村祐仁4, 豊見雅文2, 小澤光一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 565-565, 2019.

---

	3-7-O34-4. Through the introduction example to efforts - treatment at home clinic to the remedy drug adjustment support charges as the family pharmacist - 江口真理子1,2, 長崎悦子1, 汐待加織2, 吉田恭子2, 橋野勇一2, 中堀亮一3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 566-566, 2019.

---

	3-7-O35-1. Attitude survey of the physician for the inquiry simplification of the neighborhood 5 Hospital unification 奥薗春奈1, 谷本祐子1, 木下里紗1, 吉良俊彦1, 石倉久美子2, 森田智子3,6, 村田久枝4, 真常美紀5, 津田宜志7,8, 堀越博一7,9, 中島由利恵10, 村西泰法10, 土生康司11, 但馬重俊3,12, 小林政彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 567-567, 2019.

---

	3-7-O35-2. Analysis and evaluation of the inhalational instruction, results contact vote with a hospital cooperating with a health insurance pharmacy 小松正典1, 小松桐子1, 中村道代1, 浅野涼子1, 浅山美智子1, 山口直子1, 前田竜太郎1, 泊口豊1, 福森淳1, 寺脇康文1, 樫田祐一2, 中村伸也2, 山下義仁2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 568-568, 2019.

---

	3-7-O35-3. One case that hospital pharmacist and a health insurance pharmacy pharmacist cooperated with a pharmacist outpatient using a telephone follow-up, and intervened 加藤良隆1, 江島智彦1, 松本有咲1, 溝口貴大2, 村上怜3, 友金幹視1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 568-568, 2019.

---

3-7-O35-4. It is ... through the medicine medicine cooperation between examination - drugstore, the hospital about the adherence of the oral 5-ASA preparation for patients with inflammatory bowel disease 鈴木景子1, 藤井宏典1, 山内智世1, 加藤寛子1, 石原正志1, 飯原大稔1, 安田浩二1, 伊野陽子2, 玉木啓文2, 山下修司2, 井口和弘2, 野田義紘2, 寺町ひとみ2, 鈴木昭夫2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 569-569, 2019.

---

	3-7-O36-1. Result and the problem that continued Nanto-shi medicine medicine cooperation promotion workshop for four years 鶴居勝也1, 小川紗知1, 讓原千広1, 波多晶子1, 中澤美樹子1, 橋爪和恵1, 窪田真弓1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 570-570, 2019.

---

	3-7-O36-2. About the actual situation of the Residual medicine coordinated based on the prior agreement protocol in the outside Parliament prescription of our hospital 永山浩司1, 松村高志1, 安田亜矢1, 大森清孝1, 三浦誠1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 571-571, 2019.

---

	3-7-O36-3. About the operational construction of the tracing report for the purpose of the information sharing with the health insurance pharmacy 大谷寧次郎1, 畔柳敏弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 571-571, 2019.

---

	3-7-O36-4. For the promotion of the inquiry-free protocol in the prior agreement item 前田貴子1, 堀内あす香1, 池田芽衣1, 田中佳奈1, 大坪達弥1, 野口裕介1, 神田英一郎1, 岡橋孝侍1, 藤田敦夫1, 友金幹視1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 572-572, 2019.

---

	3-8-O37-1. Comparison ... with establishment - regular hospital of the quantity of duties rating system for the appropriate staff placement in the ward drug duties of the intensive care domain 只見智恵子1, 浜田幸宏1, 佐藤美絵1, 宮崎雅子1, 木村桂子1, 金田純子1, 藤本裕子1, 木村利美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 573-573, 2019.

---

	3-8-O37-2. Evaluation of the drug information contents which we provided in the multi-type of job by the intensive care unit working full time pharmacist 宮田祐一1, 藤村一軌1, 須賀明輝1, 岩崎睦1, 上野栞1, 大塚秀人1, 桃井歩1, 中村雅敏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 574-574, 2019.

---

	3-8-O37-3. After the intensive care unit discharge an investigation about the self-discipline of patients, Single institution rearward observational study 吉廣尚大1, 冨田隆志2, 櫻谷正明3, 無漏田香穂1, 小野塚和人1, 向井一樹1, 橋本佳浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 574-574, 2019.

---

	3-8-O37-4. Contribution of the pharmacist by the use actual situation and the set operation of the antiarrhythmic drug at the cardiopulmonary resuscitation 篠田健一1, 芝田和輝1, 新家由莉1, 立川一匡1, 濱田竜治1, 庵弘幸2, 大原一将2, 野々村誠2, 亀山智樹2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 575-575, 2019.

---

	3-8-O38-1. Study on intervention effect of the pharmacist to the medical therapy in the pediatric intensive care unit 津田浩和1, 井上暁輝子1, 由留部圭伍1,2, 増井裕亮1,2, 大和由佳1, 安河内尚登1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 576-576, 2019.

---

	3-8-O38-2. Investigation of the drug having an influence on nausea, vomiting (PONV) after the operation 菊地義明1,2, 高橋誠1, 藤田果那1, 庄崎沙耶1, 朝倉幹己1, 田中耕太1, 木下愛1, 山本翔大1, 山田将悟1, 前川英輝1, 藤林遼1, 鈴木直哉1, 青田忠博1, 小林道也2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 577-577, 2019.

---

	3-8-O38-3. About the current situation of a doubt inquiry by the ICU ward permanent residence of the pharmacist and the consultation meeting a demand 伊藤博美1, 野々内裕紀1, 河野恵1, 真継賢一1, 濱口良彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 577-577, 2019.

---

	3-8-O38-4. About the head trauma instruction situation by the acute phase response of the patients with head trauma during antithrombotic drug remedy and the pharmacist 中西裕明1, 瀬下貴大1, 西崎恵利1, 荻野仁未1, 岡橋孝侍1, 藤田敦夫1, 友金幹視1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 578-578, 2019.

---

	3-8-O39-1. Drug history investigation of the follow with the telephone after the formulations which the antiinfluenza medicine remedy patients received 笹原侑祐1, 高橋渉2, 池貴幸3, 板垣幸太郎2, 長沼未加2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 579-579, 2019.

---

	3-8-O39-2. Effective evaluation of the inhalational device choice protocol by the pharmacist for patients with climax COPD 塩飽英二1, 土手賢史1, 金子忍1, 岩田敏之2, 西村尚志2, 野崎歩1, 小林由佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 580-580, 2019.

---

	3-8-O39-3. Approach to JMIP (the foreign patients acceptance medical institution certification system) in our hospital drug department 安田陽子1, 益子里美1, 浅利貴奈1, 福山博務1, 真柴友紀1, 三村雅一2, 塩地園代1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 580-580, 2019.

---

	3-8-O39-4. The effect that polypharmacy gives to Functional Independence Measure (FIM) 村山あずさ1, 舘知也1,2, 大坪愛実1, 勝野隼人1, 上野杏莉1, 野口義紘1, 樋島学3, 青山智2, 安田昌宏2, 水井貴詞2, 後藤千寿2, 寺町ひとみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 581-581, 2019.

---

	3-8-O40-1. Introduction of PBPM by hospitalization support room duties and duties development of a wide variety of pharmacists 妹尾啓司1, 吉川明良1, 水上皓喜1, 伊藤実里1, 岡崎夏実1, 阪田安彦1, 開浩一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 582-582, 2019.

---

	3-8-O40-2. Examination of the at-home self-injection instruction of the pharmacist outpatient department pharmacist by the in-house prescription 上野良夫1, 玉木真紀子2, 伊原木沙智代1, 三枝貢1, 眞鍋伸次1,2, 石川真也3, 村尾敏4, 高木雄一郎5, 前田剛6, 森由弘6, 厚井文一6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 583-583, 2019.

---

	3-8-O40-3. Efforts for the hospitalization support manual preparation in the drugstore 鈴木由佳1, 佐野麻璃奈1, 田中富美1, 瀬戸洋行1, 阿部元昭1, 出口佳奈美1, 山田佳代1, 出口華子1, 高田恭子1, 渡邊裕子1, 安田美代子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 583-583, 2019.

---

	3-8-O40-4. About the duties of the pharmacist in the hospitalization and release support center 岡村礼江1, 藤田祐規子1, 河田麻美1, 前田昌徳1, 笠原庸子1, 林聖二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 584-584, 2019.

---

	3-8-O41-1. Investigation about the medication situation of the prescription pharmaceutical products in the cancer perioperative patients and the intake situation of the supplement 渡部大介1, 水頭望1, 齊藤由記1, 日比野英幸1, 近江一太1, 橋本浩伸1, 関口昌利1, 近野健一1, 牧野好倫1, 山口正和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 585-585, 2019.

---

	3-8-O41-3. Evaluation of the working full time system in the foreign chemotherapy room in the pharmacist 小川智孝1, 小椋千絵1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 586-586, 2019.

---

	3-8-O41-4. The need and construction of the pharmacist outpatient department in the hospital pharmacist 大西順子1, 坪井仁美1, 澤之珠1, 岩野大輔2, 石松義人2, 湯本英一郎2, 渡辺佑介2, 冨岡憲明2, 渡辺伸一郎2, 渡辺哲夫2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 587-587, 2019.

---

	3-8-O42-1. Role of the pharmacist in the perioperative pharmaceutical management in the medicine confirmation outpatient department 吉川里香1, 川島佳恵1, 石本学司1, 奥野昌宏1, 田中詳二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 588-588, 2019.

---

	3-8-O42-2. An index and the threshold to evaluate the appropriate tablet, shape of the capsule for patients 佐藤宏樹1,2, 壁矢健司3, 堀里子4, 三浦康正5, 澤田康文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 589-589, 2019.

---

	3-8-O42-3. Examination of efforts and the problem to the polypharmacy measures that started from the hospitalization and release support center in our hospital 大森清孝1, 藤田葵1, 長谷川広樹1, 尾浜直子1, 櫻井登代子1, 大津山裕美子1, 三浦誠1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 589-589, 2019.

---

	3-8-O42-4. The perioperative pharmaceutical management intervention improves quality metrics and affects the decrease in complication rate in the aftercare 平田一耕1, 原田佳弘2, 大友謙太朗2, 早坂磨優1, 寺口徹1, 船木麻美1, 岩本真拡1, 石塚寛和1, 小林収4, 舟越亮寛1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 590-590, 2019.

---

	3-9-O43-1. Association with adverse effect expression and the blood level in daptomycin treated patients 山下祐二1, 山田孝明1, 西田留梨子2, 三宅典子2, 下野信行2, 戸石七海3, 下田遥香3, 曽田翠3, 北市清幸3, 石田茂1, 渡邊裕之1, 江頭伸昭1, 増田智先1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 591-591, 2019.

---

	3-9-O43-2. Evaluation of antimicrobial consultation meeting a demand, the suggestion contents of the antimicrobial proper use support team in the southern part of Saiseikai Yokohama-shi Hospital 畠山英司1, 松本勝城1, 村田明子1, 山崎彩華1, 深沢貴志1, 川嶋郁2, 藤田浩之3, 加藤一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 592-592, 2019.

---

	3-9-O43-3. Intervention and antimicrobial proper use support to the otolaryngology perioperative clinical path in the pediatric special hospital 福原悠太1, 中村悠佳1,2, 川端未祈1, 渡邉真菜実1, 甲斐維子1, 加戸奈穂美1, 井上真規3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 592-592, 2019.

---

	3-9-O43-4. Examination about the dose of the ST medical mixture in the pneumocystis pneumonia prophylaxis of HIV non-infection patients on dialysis 山下花南恵1, 池末裕明1, 室井延之1, 吉本明弘2, 橋田亨1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 593-593, 2019.

---

	3-9-O44-1. Efforts to pass inspection intervention for the proper use of the perioperative antimicrobial included in the clinical path 馬場安里1, 中川博雄1, 岸川礼子1, 今村政信1,2, 赤松隼人1, 福重友理1, 藤田あゆみ2, 田代将人2, 田中健之2, 兒玉幸修1, 中村忠博1, 泉川公一2, 佐々木均1, 室高広1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 594-594, 2019.

---

	3-9-O44-2. The need evaluation of the prophylactic antimicrobial in front of the art in the cataract surgery 後藤裕美子1, 柴田祐一1, 大西正文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 595-595, 2019.

---

	3-9-O44-3. A review of the prophylactic antimicrobial oral after the surgery and the evaluation 田中広紀1, 粟屋真理子1, 戸村和希1, 鈴木絢子2, 島本一志1, 柳原麻里2, 横江琢也3, 池田裕一4, 渡邊徹1, 佐々木忠徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 595-595, 2019.

---

	3-9-O44-4. Effect on treatment of the Candida blood symptom accompanied with the enforcement of Antifungal stewardship 藤田将輝1,2, 澤田真嗣1,2, 大山翔1, 村木優一3, 友金幹視1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 596-596, 2019.

---

	3-9-O45-1. It is examined shortening in the administration days in the oseltamivir prophylaxis for the roommate 杉山昌宏1,2, 照沼保徳1,2, 西畑利恵子2, 宮澤正紹2, 佐々島朋美2, 田井真弓2, 皆川陽子2, 佐藤弘子2, 梶原徹1, 宇都直哉1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 597-597, 2019.

---

	3-9-O45-2. Investigation of the use of oral antimicrobial trend after the adoption item reduction of the third generation oral cephalosporin medicine 小林正拓1, 鵜野竜馬1, 上野太佑1, 長原しのぶ1, 寺谷俊昭1, 大下直宏1, 上田晃1, 川本由加里1, 後藤仁和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 598-598, 2019.

---

	3-9-O45-3. Activity evaluation (comparison with pharmacist-led AS) of antimicrobial proper use support team (AST) 遠山泰崇1, 堀光愛子1, 福島祐子1, 新宮裕美1, 柴田麻美1, 小野友香理1, 福田智哉1, 武石優哉1, 野村一馬1, 村上里穂1, 後藤友里絵1, 井上真1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 598-598, 2019.

---

	3-9-O45-4. Efforts ... mainly on the hospital crossing-like AST-related activity - blood culture examination suggestion in the middle scale medical treatment type hospital 行本拓史1, 田中千恵2, 佐近滝実子2, 赤川聡美2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 599-599, 2019.

---

	3-9-O46-1. Examination about the dose of fosphenytoin in children 岡本剛1, 橋本磨里奈1, 古谷絵茉里1, 安川久美2, 小林恵美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 600-600, 2019.

---

	3-9-O46-2. Correlative analysis of trough level/doses of sirolimus and tacrolimus in the lung transplantation patients 菊地正史1,2, 重田健介1, 田中雅樹2, 高崎新也2, 秋場美紀3, 大石久4, 佐渡哲4, 松田安史4, 野田雅史4, 山口浩明4, 岡田克典3,4, 眞野成康1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 601-601, 2019.

---

	3-9-O46-3. The construction of blood drug concentration predictive model of zonisamide: Examination by the population pharmacokinetics analysis in consideration of enzyme induction 金子哲也1, 鬼木健太郎1, 古郡規雄2, 石津棟暎3,4, 猿渡淳二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 601-601, 2019.

---

	3-9-O46-4. Association of blood level and a side effect, the clinical response of the hepatocytes cancer therapeutic drug Lenvatinib 野田哲史1, 若杉吉宣1, 藪田直希1, 須藤正朝1, 平大樹1,2, 飯田洋也3, 大崎理英4, 藤本剛英4, 谷眞至3, 安藤朗4, 森田真也1, 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 602-602, 2019.

---

	3-9-O47-1. Evaluation of the blood level change by the changes from voriconazole parenteral injection to an oral formulation 原田紗希1, 丹羽隆1, 星野佑介1, 伊藤朱里1, 藤林彩里1, 鈴木昭夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 603-603, 2019.

---

	3-9-O47-2. The effect that onset of diarrhea during voriconazole remedy gives to blood level, an absorption factor drop 中山裕一1, 折井孝男1, 臼杵憲祐2, 加藤敏明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 604-604, 2019.

---

	3-9-O47-3. Examination about the initial administration plan of vancomycin between young people and elderly people 高田容希1, 小川智孝1, 小椋千絵1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 604-604, 2019.

---

	3-9-O47-4. It is comparison ... of ... analysis software and guidelines recommendation doses about administration plan in the vancomycin initial administration 永光華菜1, 森田真樹子1, 迫田英樹1, 橋本未雷2, 谷口潤1, 尾之江剛樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 605-605, 2019.

---

	3-9-O48-1. Examination of the effect factor to give to a trough level of the rivaroxaban in patients with atrial fibrillation 飯塚芽依2, 金城貴彦2, 中川潤一1, 上野桂代1, 富田泰史2, 新岡丈典1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 606-606, 2019.

---

	3-9-O48-2. Effect of the pharmacokinetics-related genetic polymorphism giving it to blood level of the Perampanel 大久保翔1, 赤嶺由美子1, 菊池結花2, 三島和夫2, 三浦昌朋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 607-607, 2019.

---

	3-9-O48-3. The development of the LC-MS/MS method for human serum nivolumab densitometry using the immunoglobulin G refinement to immobilize and the trypsin digestion and the clinical application 阿部一樹1, 柴田海斗1, 内藤隆文1, 柄山正人2, 前川真人3, 須田隆文4, 山田康秀2, 川上純一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 607-607, 2019.

---

	3-9-O48-4. Basic examination for the construction of the simultaneous assay of the psychotropic drug by LC-MS/MS using Insource CID 小林大典1, 前川正充1, 鈴鹿雅人1, 岩渕理子1, 高崎新也1, 菊地正史1,2, 塚本多矩3, 早川禎宏3, 小倉次郎1, 佐藤祐司1, 眞野成康1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 608-608, 2019.

---

	3-10-O49-1. Elucidation of the digestive organ toxicity expression of metformin mechanism due to a serotonin change change 奈良部友花1, 白坂善之1, 内山弘貴1, 鷹野遥1, 岸本久直1, 井上勝央1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 609-609, 2019.

---

	3-10-O49-2. The effect of the drink giving it to the gastrointestinal absorption change of oral pharmaceutical products and the quantitative mechanism analysis 鮒井悠汰1, 白坂善之1, 竹村美由記1, 田中裕己1, 川喜多佑香1, 澤村定1, 岸本久直1, 井上勝央1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 610-610, 2019.

---

	3-10-O49-3. Itraconazole and effect of the metabolite concentrations to give to the serum creatinine level 井元優美1, 内藤隆文1, 小野孝明2, 川上純一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 610-610, 2019.

---

	3-10-O49-4. Pharmacokinetic analysis - vancomycin infusion ... using the artificial intelligence (Support Vector Regression) 山口泰弘1,4, 中村敦士1, 浦本邦弘1, 高城沙也香2, 小柳悟3, 大戸茂弘4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 611-611, 2019.

---

	3-10-O50-1. Establishment of the high sensitive assay of free form pazopanib concentrations using UPLC-MS/MS 松本麻美1,2, 白岩健1, 鈴木陽介2, 田中遼大1, 佐藤雄己1, 伊東弘樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 612-612, 2019.

---

	3-10-O50-2. - that effect - sebum that skin surface environment gives to the transdermal absorbency of the commercial fentanyl patch disturbs absorption of the fentanyl 林友典1, 高科結衣2, 川口陽奈子2, 永福紡2, 松岡寛1, 川畑篤史2, 長井紀章2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 613-613, 2019.

---

	3-10-O50-3. The effect that oral anticancer medicine and intestinal tract immune function give to pro-discharge transporter expression 保田元気1, 小林正紀2, 窪田篤人1, 更科壮太1, 鳴海克哉2, 古堅彩子2, 鈴木裕治3, 鈴木夏子3, 井関健2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 613-613, 2019.

---

	3-10-O50-4. Relations with a change of the CYP3A activity in the asthmatic patients and inflammatory related molecules 鈴木裕也1, 平井啓太1, 下敷領貴之1, 木村朋起1, 白井敏博2, 伊藤邦彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 614-614, 2019.

---

	3-10-O51-1. Medical economic effect by test value mention to a prescription 國津侑貴1, 森河内彩1, 平大樹1,2, 十亀裕子3, 上西幸治1, 星野伸夫1, 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 615-615, 2019.

---

	3-10-O51-2. Costs comparison depending on a treatment strategy choice in the terminal phase of patients with cancer at admission 橋本悠生1,4, 三ツ木英子1, 川名賢一郎1, 後藤一美1, 林章敏2, 利根川崇3, 五十嵐中4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 616-616, 2019.

---

	3-10-O51-4. Comparison of the tendency to detection of the signal detection algorithm of the pharmaceutical products interaction 野口義紘1, 舘知也1, 寺町ひとみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 617-617, 2019.

---

	3-10-O52-1. Examination of the medical economics about the way of the outside Parliament prescription in the night emergency visit 寺井大輝1,2,3, 大石学2, 村田雄介1, 江川孝3, 遠城寺宗近3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 618-618, 2019.

---

	3-10-O52-3. Cost effectiveness analysis of the Lenvatinib as the primary treatment for unresectable stem cell cancer 古林健吾1, 日高諒1, 前田知美1, 森脇健介1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 619-619, 2019.

---

	3-10-O52-4. Attempt of the cost effectiveness evaluation of the nivolumab + ipilimumab combination therapy as the primary treatment for progressive nephrocyte cancer 前田知美1, 日高諒1, 古林健吾1, 森脇健介1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 620-620, 2019.

---

	3-10-O53-1. Analysis of the factor having an influence on the extra effect and liver function test value improvement of the SGLT2 inhibitor 竹澤崇1, 鳥居慶子1, 三村享1, 本木絵梨奈1, 山折大1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 621-621, 2019.

---

	3-10-O53-2. Efforts and results of rounds team and the pharmacist for the medical therapy of patients with old diabetes ソディ保子1, 森あさひ1, 弓場優佳1, 大西暁枝1, 山本里香1, 松山温子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 622-622, 2019.

---

	3-10-O53-3. Safety [longitudinal study] of the sustained GLP-1 receptor agonist for the dialysis case 前川志穂1, 谷口靖樹1, 田中勝正1, 前川純一1, 中島和喜1, 羽田麻希1, 松浦史佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 622-622, 2019.

---

	3-10-O53-4. Relation of a change and the pharmacist of blood glucose level, the insulin dose of the pregnant woman who experienced gestational diabetes, the diabetes merger pregnancy 三上有希1, 澤井麻記1, 山野言2, 前田万里紗3, 野崎歩1, 長嶋一昭2, 藤井剛3, 小林由佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 623-623, 2019.

---

	3-10-O54-1. Diabetes medical therapy of each patients to choose among pharmacokinetics 富岡節子1, 山崎勝弘2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 624-624, 2019.

---

	3-10-O54-2. Examination about the usefulness of the DPP-4 inhibitor in the pancreatic cancer postoperative blood sugar treatment 上代大地1, 大東敏和1, 林華代1, 平田かおり1, 佐伯康之1, 垰越崇範1, 中川直哉2, 上村健一郎2, 村上義昭2, 松尾裕彰1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 625-625, 2019.

---

	3-10-O54-3. Examination of the antidiabetic drug used in our hospital for a blood sugar rise at use of steroid 安部真一1, 中村江理1, 高橋友佳1, 鈴木英則1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 625-625, 2019.

---

	3-10-O54-4. The comparison between participant and HbA1c level of the nonparticipant to the meeting (we instruct it continuously) to review and change of the number of the drugs 滝澤康志1, 曽山恭子1, 鈴木隆子1, 久保田令枝1, 山谷秀喜2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 626-626, 2019.

---

	3-11-O55-1. Evaluation of the in-hospital correspondence of the eye disorders by the anticancer medicine tears shift and the lacrymal duct ophthalmology practice cooperation flow construction 関根佳代1,2, 大谷美子1, 辻村秀樹2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 627-627, 2019.

---

	3-11-O55-2. The case that was taking Abiraterone ester acetate tablets, and showed protraction of the hypokalemia 大野凜太郎1, 森清人2, 菊地隆之3, 沢仁美1, 斎藤和悦1, 稲見正幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 628-628, 2019.

---

	3-11-O55-3. Obesity, the overweight is an aggravation risk factor of the hypertriglyceridemia by the bexarotene 真川明将1,2, 早川智章1, 須藤遥1,2, 森悠香梨2, 堀田祐志2, 近藤勝弘1, 木村和哲1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 628-628, 2019.

---

	3-11-O55-4. Fundamental researches about the inhibitory effect of the alogliptin for anticancer medicine-induced peripheral neuropathy 重松奈央1, 川尻雄大1, 清水栞1, 峯圭佑1, 小林大介1, 島添隆雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 629-629, 2019.

---

	3-11-O56-1. Example that rheumatoid arthritis aggravated after the Lenvatinib for the hepatocellular carcinoma, the sorafenib administration 野坂陽子1, 樋口純一1, 上野真行2, 西村健二1, 森谷康志1, 亀井健人1, 高柳和伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 630-630, 2019.

---

	3-11-O56-2. The onset of thromboembolism situation in the patients who received Pembrolizumab therapy 磯田祥1,2,3, 佐藤雄己2, 龍田涼佑2, 中原良介2, 安達和宏3, 縄田好一1, 伊東弘樹2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 631-631, 2019.

---

	3-11-O56-3. Relations with expression situation and RDI of peripheral neuropathy in the rhabdomyosarcoma vincristine + actinomycin D+ cyclophosphamide therapy 前勇太郎1, 三木真梨杏1, 横川貴志1, 渡邉大至1, 友松純一2, 高橋俊二2, 濱敏弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 631-631, 2019.

---

	3-11-O56-4. One case that developed a drug-related aortitis syndrome by peg filgrastim subcutaneous injection 石井聡一郎1, 櫻下弘志1, 真志田絵美子1, 佐伯康之1, 松尾裕彰1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 632-632, 2019.

---

	3-11-O57-1. The effect that a decreased renal function gives in the effectiveness of oxaliplatin and safety 渡辺大地1, 藤井宏典1, 山田友奈美1, 松橋延壽2, 高橋孝夫2, 吉田和弘2, 鈴木昭夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 633-633, 2019.

---

	3-11-O57-2. The examination of the risk factor of the hyponatremia by the cisplatin: Case control study 畠山史朗1,2, 志田敏宏1, 山口浩明1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 634-634, 2019.

---

	3-11-O57-3. Examination of the early risk of death factor in patients with non-small cell lung cancer which Pembrolizumab monotherapy was given in 七尾谷充1, 森彩夏1, 宮坂優人1, 稲野寛1, 菅原充広1, 厚田幸一郎1,2, 西成田詔子3, 楠原政一郎3, 石原未希子3, 日吉康弘3, 笠島真志3, 福井朋也3, 井川聡3, 横場正典4, 三藤久5, 久保田勝3, 片桐真人4, 猶木克彦3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 634-634, 2019.

---

	3-11-O57-4. Inspection of the symptom improvement effect with the current situation and the medical therapy of eye disorders due to docetaxel 野口裕介1,2, 川島悠吾2, 丸山恵未2, 瓦比呂子2, 徳山洋子2, 友金幹視1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 635-635, 2019.

---

	3-11-O58-1. About the possibility that proteinuria to develop early in administration in the bevacizumab administration for patients with breast cancer becomes the effect of treatment predictor 田中裕章1, 高橋功一1, 山口佳津騎1, 安宅希美子1, 本田由紀1, 元木貴大1, 加地雅人1, 小坂信二1, 芳地一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 636-636, 2019.

---

	3-11-O58-2. Effect of various 5-HT3 receptor blockers on cisplatin-induced renal failure 神田将哉1,2, 合田光寛1,2, 村井陽一2, 吉田愛美2, 新村貴博2, 石澤有紀3, 座間味義人1,2, 中馬真幸4, 濱野裕章1, 岡田直人1, 武智研志4, 堀ノ内裕也5, 池田康将5, 桐野靖1, 中村敏己1, 寺岡和彦1, 石澤啓介1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 637-637, 2019.

---

	3-11-O58-3. Examination about the effect that a decreased liver function gives to side effect of TS-1 expression 柴田有紀1, 安藤洋介2, 西部星来2, 石原拓磨3, 平嶋一貴2, 田中千裕1, 池田義明1, 林高弘1,2, 河田健司4, 山田成樹2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 637-637, 2019.

---

	3-11-O58-4. An example of the onset of hand-and-foot syndrome in standard quantity cytarabine 森智世1, 伊藤公人2, 尾畑景子3, 新美政樹1, 谷口結基1, 田中美帆1, 太田達也1, 田中章郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 638-638, 2019.

---

	3-11-O59-1. Use investigation of the peg filgrastim in the docetaxel cisplatin, 5-FU therapy for head and neck cancer 橘川奈生1, 祖川倫太郎1, 山内盛泰2, 古野龍也1, 木村早希子1, 田崎正信1, 倉富勇一郎2, 成澤寛1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 639-639, 2019.

---

	3-11-O59-2. Association between immune-mediated adverse event expression of Pembrolizumab and effect of treatment in the urothelial carcinoma 小林一男1,3, 鈴木賢一2, 青山剛1, 横川貴志1, 式部さあ里1, 平出誠1, 橋本幸輝1, 飯倉佑介1, 湯浅健3, 佐藤均4, 杉山恵理花4, 田島正教4, 米瀬淳二3, 濱敏弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 640-640, 2019.

---

	3-11-O59-3. An immune-mediated adverse event of the renal carcinoma nivolumab and association with the overall survival 飯倉佑介1, 小林一男1,4, 青山剛1, 横川貴志1, 式部さあ里1, 平出誠1, 橋本幸輝1, 鈴木賢一2, 湯浅健3, 佐藤均4, 杉山恵理花4, 田島正教4, 米瀬淳二3, 濱敏弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 640-640, 2019.

---

	3-11-O59-4. Effect on anticoagulant ability of the warfarin by the capecitabine combination and examination about the time 齋藤豪1, 赤嶺由美子2, 三浦昌朋2, 平泉達哉1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 641-641, 2019.

---

	3-11-O60-1. One consideration - about the requirements that enabled a judgment and the policy conversion of - palliative care team when patients explained to that we could not leave the hospital hoped for home discharge 隅田美紀1, 曽我みゆき2, 田邊裕3, 松本卓也4,5, 関谷正徳3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 642-642, 2019.

---

	3-11-O60-2. Examination of naldemedine administration start time and the efficacy to opioid-induced constipation 奥田泰考1,2, 三瓶裕貴1, 品田誠1, 高倉祐希1, 菅留理1, 齋藤賢宏1, 毛塚ちひろ1, 星ちはる1, 小林直人1, 藤井博文2, 須藤俊明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 643-643, 2019.

---

	3-11-O60-3. Efforts about the proper use promotion of the Abstral sublingual tablet using e- learning 尾崎誠一1, 荒神一博2, 片山恵美子1, 三好浩一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 643-643, 2019.

---

	3-11-O60-4. Efforts of our hospital for the terminal heart failure 橋本百世1, 江頭佐都美2, 橋野陽子2, 金井菜穂子3, 西山菜々子4, 古野史子4, 菅由美2, 山下由紀子5, 大前隆仁3, 松田良信3, 田中育子1, 端山明子1, 仁木一順6, 岡本禎晃1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 644-644, 2019.

---

	3-11-O61-1. Example that a pharmacist was involved in for the delirium in the use of opioid patients 荒川真萌1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 645-645, 2019.

---

	3-13-O61-2. One patient who is addicted to amantadine who was discovered by the pharmaceutical intervention of the pharmacist 山本麻里子1, 井出直仁1, 松島暁2, 三上智3, 伊藤政治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 646-646, 2019.

---

	3-13-O61-3. Relation to a side effect report and the Relief System for Sufferers from Adverse Drug Reactions of the ward exclusive duty pharmacist 中川義浩1, 鶴崎泰史1, 花田聖典1, 井上大奨1, 横田千明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 646-646, 2019.

---

	3-13-O61-4. The case that PT-INR fluctuated with a change, the cancellation of the tube feeding agent under the warfarin administration remarkably 松本徳人1, 山本達郎1, 島田美樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 647-647, 2019.

---

	3-13-O62-1. Questionary survey about recognition, the knowledge of the drug for the rehabilitation staff 小松めぐみ1, 乾朱里1, 西内祥子1, 木村美保子1, 田島千愛1, 西村奈保1, 田所美和1, 吉岡りえ1, 市吉真貴子1, 八木亜紀子1, 田中照夫1, 藤本弘昭2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 648-648, 2019.

---

	3-13-O62-2. The effect that a positional information game for smartphones gives to the clinical test value and medical treatment of the user 名倉慎吾1, 佐藤宏樹2,3, 柳奈津代2, 堀里子4, 澤田康文2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 649-649, 2019.

---

	3-13-O62-3. Enforcement of the case conference for the purpose of the RMP utilization to the clinical settings and the effect 岩崎克也1, 森谷康志1, 上田夏瑞1, 渡邊翔太1, 井元裕夏1, 野坂陽子1, 亀井健人1, 赤木晋介1, 高柳和信1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 649-649, 2019.

---

	3-13-O62-4. Questionary survey about the current situation of the instillation maneuver of the satisfaction to an instillation container and patients 小野優子1, 衛藤大樹1, 佐藤雄己1, 伊東弘樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 650-650, 2019.

---

	3-13-O63-1. Remedy medicine for osteoporotic fracture investigation about primary prophylaxis 久保みさき1, 渡邊瑞加2, 戸邊隆夫1,2, 江藤祥子1, 戸田貴洋1, 林高弘1,2, 山田成樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 651-651, 2019.

---

	3-13-O63-2. Examination about the effectiveness and the safety of the chronic administration of hydroxychloroquine 小武和正1, 板野理沙子1, 田平明哲1, 山足佳奈1, 川上恭弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 652-652, 2019.

---

	3-13-O63-3. The in-hospital adoption reduction of the benzodiazepine system sleeping drug for the sleeping drug proper use and the effect 下田賢一郎1, 星野輝彦1, 塩津和則1, 杉山留美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 652-652, 2019.

---

	3-13-O63-4. Change of the potassium level in the ARB user 大石愛海1, 荒井希文2, 佐々木祐樹2, 福島栄2, 福岡憲泰1, 大場延浩1, 菊池憲和2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 653-653, 2019.

---

	3-13-O64-1. The effect that adherence of the 5-ASA preparation in the ulcerative colitis gives in an endoscopic image for remission 宮武賢司1, 上出紗栄加1, 長橋かよ子1, 福知工1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 654-654, 2019.

---

	3-13-O64-2. It is examination ... from a fact of the administration in ... our hospital for anticoagulation adequacy after the cesarean section 上森恵里1, 松岡順子1, 宮田広樹1, 海老井佳織1, 今村真沙美1, 川田桂子1, 野口周作1, 笠原英城1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 655-655, 2019.

---

	3-13-O64-3. Intervention to a psychotropic drug, antipsychotics, the antidepressant of patients with terminal cancer 今井一輝1, 二村昭彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 655-655, 2019.

---

	3-13-O65-1. Usefulness of the tetraapproach to a renal excretion type drug 山中理1,2,3, 山村篤史1, 中山英夫1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 657-657, 2019.

---

	3-13-O65-2. The construction of the prescription order system supporting generic name prescription and the evaluation 河崎尚史1, 松山真範1, 北島正大1, 名村隆2, 金桂洙3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 658-658, 2019.

---

	3-13-O65-3. Efforts for a problem, needs grasp and the improvement by the "voice of the customer" analysis 大町成樹1, 有和泰子1, 中井徹1, 竹村卓哉1, 酒井保浩1, 太田和人1, 京井由加利1, 高野修一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 658-658, 2019.

---

	3-13-O65-4. The use situation of the system for exclusive use of construction and insulin of the instructions input screen of the hospitalization insulin hypodermic injection 金内幸子1, 青柳京子1, 小谷野圭子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 659-659, 2019.

---

	3-13-O66-2. An association between use and cataractogenesis of statin: Analysis using receipt data 高科桃子1, 田口みなみ1, 大場延浩1, 福岡憲泰1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 661-661, 2019.

---

	3-13-O66-3. The effect on uric acid level by the use of antihypertensive medications: Analysis using the medical information data of the hospital 麻生洋哉1,2, 大場延浩1, 依馬理咲子1, 荒井希文2, 佐々木祐樹2, 福島栄2, 福岡憲泰1, 菊池憲和2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 661-661, 2019.

---

	3-13-O66-4. Search of the signal of the drug affecting the cognitive function in the patients with chronic kidney disease utilizing the association analysis 長澤宏之1,2, 野口義紘1, 舘知也1, 寺町ひとみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 662-662, 2019.

---

	4-3-O67-1. The study on factor to give it to malpractice: Inspection duties 宮地佑佳1, 小粥夏日1, 堀場崇志1, 仲山千佳1, 磯貝正人2, 田村摩紀2, 杉浦奈美3, 中澤直美3, 加藤美樹4, 舟橋智美4, 長芝計代4, 大西正文4, 松浦惠子2, 斎藤寛子4, 大嶋耐之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 663-663, 2019.

---

	4-3-O67-2. Efforts to the analysis of the incident accident report associated with the drug for the medical care and recurrent prevention 田中怜1,2, 飯島久子3, 青山隆夫2, 石川寛1, 佐藤淳也1, 川岸佐和子1, 梅坪翔太1, 佐藤哲1, 篠道弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 664-664, 2019.

---

	4-3-O67-3. System construction and use experience ... of usefulness examination (the first report) - formulations inspection duties about the improvement in quality of the medical security using the camera solution with the voice recording 久保田綾乃1, 牧野和也1, 海野亜実1, 鈴木高弘2,3, 平澤典保2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 664-664, 2019.

---

	4-3-O68-1. Analysis of the potentially serious medical errors example about the internal use self-care medicine 舘合慶一1, 川上和宜1, 森本重輝1, 二木翔平2, 保田知生2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 666-666, 2019.

---

	4-3-O68-2. Attitude survey about a design element and the misunderstanding to contribute to the appearance resemblance of the PTP sheet 北村美帆1, 佐藤宏樹2,3, 柳奈津代2, 澤田康文2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 667-667, 2019.

---

	4-3-O68-3. Intelligence and evaluation ... by the multi-type of job collaboration utilizing construction - interview sheet of a side effect, the uniform management system of the allergic information which was outpatient subject 荒木良介1,2, 加藤加奈恵1, 浜本知之2, 田中恒明3, 山田英紀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 667-667, 2019.

---

	4-3-O68-4. Increase of the major bleeding event by the edoxaban off-label use 福井里佳1, 平大樹1,2, 國津侑貴1, 磯野哲一郎1, 田淵陽平1, 生野芳博1,3, 上島智2, 伊藤英樹3,4, 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 668-668, 2019.

---

	4-3-O69-1. Characteristic every institution of the incident associated with the medication in the assisted-living pay nursing home 木崎速人1, 堤桃花1, 山本大輔2, 馬来秀行2, 益子幸太郎2, 小西ゆかり2, 浅井康平2, 佐藤宏樹3,4, 澤田康文3, 堀里子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 669-669, 2019.

---

	4-3-O69-3. Effect on fall with the sleep inducing drug 大谷徹1, 永田裕章1, 野口祥紀1, 荒木康羽1, 世古口拓也1, 井田諭2, 金児竜太郎2, 谷村学1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 670-670, 2019.

---

	4-3-O69-4. The effectiveness of the pharmacist intervention in the community pharmacy 玉城武範1,2, 吉山友二2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 671-671, 2019.

---

	4-3-O70-1. Effect on drug costs of doubt inquiry associated with the renal function 中島誠1,2, 桐野玲子1, 瀧下恭子1, 高橋武士1, 中木原由佳1, 新上香奈子1, 福元裕介1, 川添希1, 林秀樹2, 杉山正2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 672-672, 2019.

---

	4-3-O70-2. Effective and safe examination accompanied with changes from cinacalcet to Evocalcet 辻卓矢1, 渡邊泰子1, 佐藤みのり2, 有元克彦3, 佐々木緑1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 673-673, 2019.

---

	4-3-O70-3. Attitude survey about the renal function evaluation for the nurse 竹内陽亮1, 森本健幹1, 高橋雄也1, 宮脇洋平1, 長島裕樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 673-673, 2019.

---

	4-3-O70-4. Examination of the effect on glomerulonephritis expression factor in the adrenal cortical steroid monotherapy 森田真樹子1, 永光華菜1, 鳥山陽子1, 谷口潤1, 尾之江剛樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 674-674, 2019.

---

	4-4-O71-1. Investigation about the prescription change of the antiepileptic drug in the pregnant woman based on administrative data 塩澤誠1, 菊池大輔1,2, 千葉紗耶花1, 城坂理紗1, 三浦良祐1, 小原拓2,3, 渡辺善照1,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 675-675, 2019.

---

	4-4-O71-2. The actual situation of the antimicrobial prescription for the pregnant woman: Examination based on the receipt database 高木秀侑1, 石川智史2, 大柳元1,3,4, 野田あおい1,3,4, 小原拓1,3,4, 眞野成康1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 676-676, 2019.

---

	4-4-O71-3. Theoretical consideration about the safety at mother's milk shift and nursing of cefpodoxime proxetil 大久保正1,2, 田中真理子2, 大久保七枝3, 大久保節子4, 大久保美穂5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 676-676, 2019.

---

	4-4-O71-4. A mother's milk shift and placental passage of the lamotrigine 宮原芽久美1, 成瀬勝彦2, 前田雅之1, 八幡郁子1, 谷川恵子1, 小川恵美子1, 池田和之1, 吉川一吾1, 辻力夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 677-677, 2019.

---

	4-4-O72-1. Questionnaire research about the medication of the nursing mother having infants during children's ward hospitalization 松岡順子1, 上森恵理1, 森角裕貴1, 川田桂子1, 宮田広樹1, 島義雄2, 笠原英城1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 678-678, 2019.

---

	4-4-O72-2. About contrast media administration and the reporting to a nursing mother, the efforts 桐林美緒1, 佐藤千比呂1, 金田美咲緒1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 679-679, 2019.

---

	4-4-O72-3. Attitude survey of a pregnant woman and the spouse for the medical therapy of the gestation period 吉井圭佑1, 芦田直子1, 原 (野上) 愛2, 見尾光庸2, 杉山哲大1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 679-679, 2019.

---

	4-4-O72-4. One patient who responded to olanzapine in serious hyperemesis gravidarum 土井由布子1, 中田和宏1, 矢口絢子1, 木村美由喜1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 680-680, 2019.

---

	4-4-O73-1. The actual situation of the medical therapy to patients with dementia that entered a nursing facility 浜田将太1, 小島太郎2, 石井伸弥2, 大河内二郎3, 秋下雅弘2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 681-681, 2019.

---

	4-4-O73-2. The number of the on admission remedy drugs has an influence on the ADL of the rehabilitation at discharge 山元孝俊1, 小瀬英司1, 榎本弘美1, 渡部多真紀1,3, 河村剛至1,3, 安井洋一2, 河野博隆2, 渡邊真知子3, 安野伸浩1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 682-682, 2019.

---

	4-4-O73-3. Relation - example report - of the pharmacist to the prescription contents of patients with dementia 谷博子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 682-682, 2019.

---

	4-4-O73-4. Evaluation about the need of the pharmacist in the dementia support team 山本早絵1,4, 林田颯志1, 佐道紳一1, 吉野走1,4, 川原隆2,4, 六倉和生3,4, 樋口則英1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 683-683, 2019.

---

	4-4-O74-1. Dr. in the neurosurgical acute phase hospital Follow-up of the elderly people polypharmacy using SUPERMAN 曽和鮎美1,2, 山崎みどり1, 伊藤愛1, 大石雅子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 684-684, 2019.

---

	4-4-O74-2. Of the drug proper use promotion in the multi-type of job polypharmacy measures team, actually 田中成枝1, 越智大輔1, 木下玄子1, 大西順子1, 白石剛一1, 村上雅基2, 田中陽子3, 加地七彩4, 合田貴史1, 山崎宙5, 近藤祥代1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 685-685, 2019.

---

	4-4-O74-3. Effect accompanied with the acceptance duties start of the prescription information 津曲恭一1, 大窪典子1, 杉尾由希子1, 雪竹英志1, 植村ちひろ1, 平峯侑恵1, 上丸祥恵1, 安富佑思1, 杉町代1, 宮下裕央1, 松石裕也1, 西村尚芳2, 長岡麻沙美3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 685-685, 2019.

---

	4-4-O74-4. Efforts to the held method and attendance up of the medical safe workshop 平田備子1,6, 磯弓子1,6, 小椋千絵2,6, 森島毅3,6, 長野英樹4,6, 大西尚5,6, 戸部智5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 686-686, 2019.

---

	4-7-O75-1. A supplement effect of zinc acetate and effect of the inhibitor on zinc deficiency disorders 細野真吾1,2, 森光輝2, 廣瀬達也2, 中島彩子1, 細野亜由美1, 宇佐美英績2, 吉村知哲2, 山崎崇1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 687-687, 2019.

---

	4-7-O75-2. Examination of the drug influencing an outcome of the rehabilitation that we provided after the crisis of cerebral apoplexy 松崎貴志1, 安島秀友1, 新嶋茂正1, 勝田雄太1, 最上谷拓磨2, 笠原酉介2, 森みさ子3, 川畑亜加里3, 豊崎祥子4, 清水朋子4, 小野寺英孝5, 植草秀介6, 松尾和廣6, 田中恒明1, 吉尾隆6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 688-688, 2019.

---

	4-7-O75-3. 1 case that a change made possible improvement of the asthmatic control and the secession from oral steroid from Mepolizumab to Benralizumab administration 渡辺昌子1, 設楽芙月2, 狭間翔平2, 櫻井淳二3, 佐藤伸輔3, 高橋知子2, 石澤文章3, 渡辺善照1, 高橋識至4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 688-688, 2019.

---

	4-7-O75-4. Pain, association between postoperative complications and frailty after the gastrectomy 西健太郎1, 守田和憲1, 田上治美1, 高森啓史2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 689-689, 2019.

---

	4-7-O76-1. Analysis about the drug which the Residual medicine in the knob medicine bag motion is easy to produce and the area difference 木原太郎1, 小林大介2, 小柳香織1, 窪田敏夫3, 川尻雄大2, 金子絵里奈1, 都築加奈2, 高山浩太郎2, 脇山えりか2, 加崎哲夫4, 國武雅弘4, 竹下文明5, 安東恵津子6, 馬場智弘7, 浅尾一夫8, 濱野明子8, 高木淳一1, 田中泰三1, 島添隆雄2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 690-690, 2019.

---

	4-7-O76-2. Results of use and application promotion - video training of the medication reporting book and future problem ... 荒井玲美1, 伊藤昌裕1, 渡邉泰崇1, 田井中絹代1, 福岡勝志1, 弓削吏司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 691-691, 2019.

---

	4-7-O76-3. Fact-finding of the use of test value that we described in outside Parliament prescription 荒井久暢1, 長谷川晃司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 691-691, 2019.

---

	4-7-O76-4. The development of the multiple drug adjustment system and inspection of the usefulness 杉生雅和1, 吉岡睦展1, 石津智司1, 根上朋子1, 若松雄太1, 長尾彰太1, 河岡真由美1, 小川佳美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 692-692, 2019.

---

	4-7-O77-1. Examination of the factor associated with the quality of life drop of patients with chronic hepatitis C given LDV/SOF therapy 四十物由香1,2, 神山紀子1, 山元俊憲3, 鴨志田敏郎4, 齋藤祥子2, 青山芳文2, 向後麻里1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 693-693, 2019.

---

	4-7-O77-2. Comparison between Baloxavir and neuraminidase inhibitor three drugs at the health insurance pharmacy of the symptom lightness ratio in the influenza season 高橋渉1, 笹原侑祐2, 池貴幸3, 板垣幸太郎1, 長沼未加1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 694-694, 2019.

---

	4-7-O77-4. Comparison of the method of DVO at preparation of the injection drug anticancer agent 吉野裕梨佳1, 齋藤智之2, 近藤泰礼2, 小嶋伸二2, 佐藤邦義2, 荒川隆太郎2, 久保田理恵1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 695-695, 2019.

---

	4-7-O78-1. Attempt of the medication management capability evaluation by the multi-type of job cooperation 横山敏紀1, 佐藤未季1, 澤岡理咲1, 大野育美1, 伊藤明美2, 永田宏樹3, 永田学4, 櫻井秀彦5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 696-696, 2019.

---

	4-7-O78-2. Significance of the adverse event report investigation for care jobs and the pharmacist intervention in care settings 浅見友一1, 藤田茂起1, 飯塚敏美1, 柳下早苗2, 原広子2, 堀口雅巳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 697-697, 2019.

---

	4-7-O78-3. Analysis of the incident accompanied with the medication assistance in the house for elderly people with the service 池田百合香1, 佐藤宏樹2, 柳奈津代2, 益子幸太郎3, 木崎速人4, 山本大輔3, 馬来秀行3, 小西ゆかり3, 浅井康平3, 堀里子4, 澤田康文2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 697-697, 2019.

---

	4-7-O78-4. Development for method "OMOTENASHI" which aimed at the foreign patients wanting to be prescribed, and using a pickpocket appropriately application 鈴木渉太1,2, 山川紘希3, 宮本敬子4, 原田祐希4, 岡田浩2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 698-698, 2019.

---

	4-8-O79-1. Is acetaminophen a really safe pain-killer? - Examination - of the risk factor of the liver enzyme rise 廣瀬正幸1,2, 田島康介3, 瀬川悠史3, 小川広晃3, 坂崎多佳夫3, 新垣大智3, 廣末美幸3, 平川昭彦4, 山田成樹1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 699-699, 2019.

---

	4-8-O79-2. Safe comparison between an innovator drug, the generic drug of tazobactam/piperacillin combination drug 中蔵伊知郎1, 森幸代1, 田中裕貴子1, 森田貴子1, 北澤文章1, 辻川正彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 700-700, 2019.

---

	4-8-O79-3. Search of the factor associated with the onset of impaired renal function by Liposomal amphotericin B 高橋悠1, 片田佳希1, 中川俊作1, 杉本充弘1, 吉田優子1, 木全柾典1, 糸原光太郎1, 北田徳昭1, 深津祥央1, 米澤淳1, 中川貴之1, 松村康史2, 長尾美紀2, 松原和夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 700-700, 2019.

---

	4-8-O79-4. One case of the elderly people whom aciclovir nephropathy and encephalopathy usually developed in in the dose of valacyclovir 野々内裕紀1, 眞継賢一1, 津崎光司2, 猪川和朗3, 森川則文3, 濱口良彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 701-701, 2019.

---

	4-8-O80-1. Inflection to an investigation and drugstore duties of the adverse event (AE) report that we collected at a health insurance pharmacy 飯塚敏美1, 浅見友一1, 藤田茂起1, 堀口雅巳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 702-702, 2019.

---

	4-8-O80-2. Association between study (1) - DRPs and source of information and outcome ... about Drug Related Problems (DRPs) of drugstore doubt inquiry 高木博子1, 金子絵里奈2, 石橋久2, 園田正信2, 山野徹2, 家入一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 703-703, 2019.

---

	4-8-O80-3. Comparison ... of an expression example and the evasion example of the side effect based on study on Drug Related Problems (DRPs) (2) - MedDRA classification of drugstore doubt inquiry 金子絵里奈1, 高木博子2, 石橋久1, 園田正信1, 家入一郎2, 山野徹3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 703-703, 2019.

---

	4-8-O80-4. Efforts to the construction of the in-hospital side effect report system for the purpose of the uniform management of information on adverse drug reactions, the allergic drug registration 西迫多重1, 伊藤加津枝2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 704-704, 2019.

---

	4-8-O81-1. The drug interactions management of protocol and DOAC utilizing the drug section system 平山陽奈1, 木村丈司1, 高橋知子1, 冨田猛1, 野崎晃1, 山本和宏1, 大本暢子1, 大村友博1, 矢野育子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 705-705, 2019.

---

	4-8-O81-2. We elucidate a case with suspected interaction of Lenvatinib and the warfarin and the mechanism in the patients with hepatocytes cancer 柳下博信1, 加藤正太郎1, 赤嶺由美子1, 南慎一郎2, 高橋健一2, 千葉充2, 飯島克則2, 三浦昌朋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 706-706, 2019.

---

	4-8-O81-4. The effect that the combination of a proton pump inhibitor or the H2 receptor blocker gives to an effect and a side effect of the dasatinib on chronic myelogenous leukemia 永石浩貴1, 高武嘉道2,3, 谷口潤4, 安森奈緒子2, 衛藤智章5, 徳井志野6, 深澤真実7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 707-707, 2019.

---

	4-8-O82-1. One case of seriously ill febrile thrombocytopenia syndrome (SFTS) due to the ixodid bite 上ノ段友里1, 池田元彦2, 辛島正信3, 富田珠美1, 縄田好一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 708-708, 2019.

---

	4-8-O82-2. The treatment outcome of patients with rheumatoid arthritis receiving treatment with biological drug and relations of the BMI 平井利典1, 舩木文子1, 村上公美1, 花田和彦2, 伊東俊雅1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 709-709, 2019.

---

	4-8-O82-3. Examination of the factor affecting antiXa activity in the edoxaban administration 太田洋貴1, 西村寿貴2, 小野亮平3, 生島五郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 709-709, 2019.

---

	4-8-O82-4. Effect on side effect and effect of treatment of MTX accompanied with the change of the folate remedy method in patients with rheumatoid arthritis (we look at the rear mark investigation) 佐々木恵一1, 辻敏和2, 柳原有希1, 益口賢1, 近森綾子2, 渡邊裕之2, 橋本昌文1, 木本泰孝3, 堀内孝彦3, 増田智先2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 710-710, 2019.

---

	4-9-O83-1. Evaluation of the opioid gradual decrease program by the pharmacist after the head and neck cancer chemoradiotherapy successful execution 堀之内藍1,2,3, 鈴木真也2, 鎌田隼2, 金子明日美2, 藤澤孝夫3, 上田百合3, 榎田智弘3, 伊東和恵3, 岡野晋3, 真壁秀樹1, 川崎敏克2, 田原信3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 711-711, 2019.

---

	4-9-O83-2. Search of the factor to give the event of the rise in serum creatinine level in patients with non-small cell lung cancer given maintenance therapy by the pemetrexed 梅原健吾1, 小池希望2, 後藤桂輔1, 岡山有希1, 野表しおり1, 岡崎泰香1, 若本あずさ1, 初山多恵1, 佐藤秀紀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 712-712, 2019.

---

	4-9-O83-3. Effect of the polypharmacy to give it to onset of febrile neutropenia by the docetaxel 槙原克也1, 松村友和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 712-712, 2019.

---

	4-9-O83-4. Examination about an adverse event and the treatment continuity according to the hippopotamus diTaki cell (CBZ) initial dosage 森本江美1, 清水克次2, 金銅葉子2, 藤田敬子2, 坂上嘉浩3, 伊丹祥隆4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 713-713, 2019.

---

	4-9-O84-1. Investigation about the Infusion Reacution expression situation with the Daratumumab administration 井上勝光1, 藤田強記1, 鶴崎泰史1, 花田聖典1, 中川義浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 714-714, 2019.

---

	4-9-O84-2. Examination of an onset of proteinuria risk factor and the administration pronephros function with the Bevacizumab administration 村地康1,2, 坂井大介2, 山本智也1, 西田尚弘2, 佐藤太郎2, 奥田真弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 715-715, 2019.

---

	4-9-O84-3. Comparison about the pre-medication at the Obinutuzumab initial administration in our hospital 佐々侑寿香1, 淺野肇1, 竹上学1, 芦田隆司2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 715-715, 2019.

---

	4-9-O84-4. Analysis of the infusion reaction expression risk factor by the trastuzumab 松本咲耶1, 高橋正也1, 高橋克之1, 高島勉2, 柏木伸一郎2, 野田諭2, 小野田尚佳2, 大平雅一2, 永山勝也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 716-716, 2019.

---

	4-9-O85-1. We evaluate usefulness of the G-CSF prophylaxis in the adjuvant chemotherapy (EC therapy) after the operation in preoperation of the breast cancer 櫻田巧1, 柴田高洋1, 井上貴久1, 山川祐介1, 合田光寛1, 座間味義人2, 桐野靖1, 中村敏己1, 寺岡和彦1, 石澤啓介1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 717-717, 2019.

---

	4-9-O85-2. Fact-finding of the administration cancellation by the immune-mediated adverse event in the immune checkpoint inhibitor 早坂州生1, 岩本浩史1, 出町拓也1, 田中宏尚1, 芦崎雅之1, 平田力1, 北山秀則1, 竹内公美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 718-718, 2019.

---

	4-9-O85-3. Examination about the effectiveness and the economic effect of the low-dose Atovaquone in the pneumocystis pneumonia prevention for patients with blood-forming organ tumor 杉富行1, 串亮太1, 才郷博久1, 花井誉1, 萩原政夫2, 高畠啓輔1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 718-718, 2019.

---

	4-9-O85-4. Examination for the pseudo renal failure with rim parser tablets 今村牧夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 719-719, 2019.

---

	4-9-O86-1. The effectiveness and safety of the laterality in colon cancer treatment 濱武清範1, 小西史子1, 酒井ちひろ1, 野間敏也1, 後藤仁美1, 宮西將之1, 松本弘誠1, 中西輝1, 仲忠士1, 美和孝之1, 小島一晃1, 神田直樹2, 恒松一郎3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 720-720, 2019.

---

	4-9-O86-2. Reactivity of the antiEGFR antibody by the colon cancer part distinction in Real World Data 鳥居良太1, 内藤雅人1, 下雅意彩1, 竹村敏也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 721-721, 2019.

---

	4-9-O86-3. Participation of the nutritional status in neutropenias Grade3 developing just after a ramucirumab paclitaxel combination therapy start for the gastric cancer or more 佐々木紀彰1, 古元俊徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 721-721, 2019.

---

	4-9-O86-4. Rearward observational study about the clinical response by the presence or absence of Bevacizumab combination in the TAS-102 therapy for patients with metastatic colon cancer 北洞美佳1, 藤井宏典1, 廣瀬智恵美1, 山田友奈美1, 渡辺大地1, 飯原大稔1, 松橋延壽2, 高橋孝夫2, 吉田和弘2, 鈴木昭夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 722-722, 2019.

---

	4-13-O87-1. Search of the estrangement factor of propofol blood level target value and the actual value in patients with obesity 中山紗里1, 平大樹1, 米田茉由1, 栗原二葉2, 小田真也2, 上島智1, 岡野友信1, 川前金幸2, 角本幹夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 723-723, 2019.

---

	4-13-O87-2. Population pharmacokinetics analysis of the rivaroxaban in patients with atrial fibrillation 上島智1, 平大樹1,2, 桑田健司1, 平田華鈴1, 田淵陽平2, 伊藤英樹3,4, 小澤友哉3, 中川義久3, 堀江稔3,5, 寺田智祐2, 桂敏也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 724-724, 2019.

---

	4-13-O87-3. Effect of STAT3 genetic polymorphism and the quantity of internal exposure in the effect of treatment of the gefitinib 横田隼人1, 佐藤一洋2, 坂本祥2, 奥田佑道2, 中山勝敏2, 三浦昌朋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 724-724, 2019.

---

	4-13-O87-4. Blood level and side effect of the Lenvatinib, study on change-related genetic polymorphism 尾関智子1, 長濱充二2, 鈴木章文2, 杉野公則2, 伊藤公一2, 藤田一馬1, 三浦昌朋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 725-725, 2019.

---

	4-13-O88-1. Analysis of the effect of NSAIDs giving it to cisplatin origin-related renal failure based on reverse translational research 岡本敬介1,2, 齋藤佳敬3, 小林正紀4, 古堅彩子4, 鳴海克哉4, 井関健4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 726-726, 2019.

---

	4-13-O88-2. The onset of adverse event in the foreign pancreatic cancer chemotherapy and examination about the quality of life drop 國府田真綾1, 藤井宏典2, 廣瀬智恵美2, 大畑紘一2, 林秀樹1, 杉山正1, 鈴木昭夫2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 727-727, 2019.

---

	4-13-O88-3. Progress, the effect that a proton pump inhibitor gives to a low Mg blood symptom of the panitumumab in recurrent colon cancer and the effectiveness 桂英之1, 菅幸生2, 久保杏奈3, 杉村勇人4, 熊谷要5, 春木一伸6, 米澤美和3, 成田綾香3, 石嶋麗4, 小川依1, 坂野ひとみ1, 石田外樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 727-727, 2019.

---

	4-13-O88-4. 1 case that HBV screening test became false-positive by immunoglobulin preparations 間瀬悟1, 平岩いずみ1, 加藤潤1, 古田美里1, 榊原崇芳1, 近藤有1, 佐々木英雄1, 三宅芳男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 728-728, 2019.

---

	4-13-O89-1. Clinical significance of the CYP2D6 genetic polymorphism measurement in the analgesic effect of tramadol 神谷貴樹1, 中島亮2, 平大樹3, 元持杏津子1, 森河内彩1, 篠田和葉3, 米田真悟4, 今井晋二4, 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 729-729, 2019.

---

	4-13-O89-2. Examination about the correlation of diarrhea and the genetic polymorphism by the Afatinib 祖川倫太郎1, 中島千穂2, 中村朝美2, 竹内耕治1, 木村早希子1, 小宮一利2, 成澤寛1,3, 木村晋也2, 荒金尚子1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 730-730, 2019.

---

	4-13-O89-3. The effect that GST genetic polymorphism in the hematopoietic stem cell transplantation children patient gives to pharmacokinetics of busulfan 茂見茜里1, 西川拓朗2, 猪川和朗3, 山口博樹4, 中山一隆4, 東英里香1, 宮原恵弥子2, あべ松貴成2, 中川俊輔2, 児玉祐一2, 田邊貴幸2, 新小田雄一2, 岡本康裕2, 河野嘉文2, 武田泰生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 730-730, 2019.

---

	4-13-O89-4. Examination of the genetic factor associated with the survival period in patients with AC therapy enforcement breast cancer 佐原由莉1, 辻大樹1, 金容壱3, 中道秀徳2, 山本圭祐2, 塩川満2, 伊藤邦彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 731-731, 2019.

---

	4-13-O90-1. The usability test of elderly people in the foreign chemotherapy and fact-finding of the treatment 大神正宏1, 小島寛2, 山下真以1, 市塚亜由美1, 五耒佳央里1, 坪山勝平1, 小島友恵1, 鈴木美加1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 732-732, 2019.

---

	4-13-O90-2. The development of the oral anticancer agent checking prescription tool and examination of the usefulness 石川星1, 松林和幸1, 佐伯潤1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 733-733, 2019.

---

	4-13-O90-4. Trend after a quantity of volatilization and the volatilization of cyclophosphamide 小竹武1, 山本理恵1, 大森優花里1, 光野真理子1, 遠藤晋吾1, 益子高1, 井上知美1, 石渡俊二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 734-734, 2019.

---

	P0001-2-AM. The effect that the introduction of the formulations inspection system gives for an incident 元持杏津子1, 神谷貴樹1, 中屋友紀子1, 小澤慶祐1, 森河内彩1, 上田智弘1, 福井里佳1, 上西幸治1, 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 735-735, 2019.

---

	P0003-2-AM. Comparison between pharmacist and variation index between the persons except the pharmacist in the half lock division act 太田栄亮1, 榎原健1, 外山智章1, 田城泰則1, 井上陽晶1, 本田雅巳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 736-736, 2019.

---

	P0005-2-AM. About the preservation stability of the divided powder Belsomra (R) tablets which we did 中島孝則1, 菊池蘭1, 伊藤創馬1, 太田美鈴2,3, 日高慎二3, 瀧沢裕輔1, 栗田拓朗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 736-736, 2019.

---

	P0007-2-AM. An investigation of the proper use situation depending on renal function of the edoxaban in our hospital and future problem 甲元大樹1, 小原香那1, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 737-737, 2019.

---

	P0009-2-AM. Role of the pharmacist concerned with TPN prescription checking of the NICU 松澤麻紀子1, 鈴木英二1, 西條純1, 堀勝幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 737-737, 2019.

---

	P0002-2-PM. The effect that the information sharing of doubt inquiry contents gave to a young pharmacist 中屋友紀子1, 柏木優花1, 神谷貴樹1, 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 738-738, 2019.

---

	P0004-2-PM. Mixed comparison - between between the examination (2) - equivalence basis of the factor influencing the mixed nature of the semisolid preparation and the different basis 湯谷玲子1, 山地佑太1, 今坂優希1, 河野真希1, 安福泉1, 田中晶子1, 古林呂之1, 坂根稔康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 739-739, 2019.

---

	P0006-2-PM. Quantity of duties analysis for the staff standardization in compounding of medicines duties of the private medical college Hospital 深谷寛1, 大野祥2, 浜田幸宏1, 木村利美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 739-739, 2019.

---

	P0008-2-PM. Analysis of the injection drug anticancer agent doubt inquiry example after the anticancer agent regimen registration system introduction 橋本充広1, 筑田和豊1, 木場真樹1, 臼井勇治1, 小野恭平1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 740-740, 2019.

---

	P0011-2-AM. Analysis of the reuse, disposal of return of goods medicine situation and future efforts (the second report) 岩田真子1, 貝瀬眞由美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 741-741, 2019.

---

	P0013-2-AM. About duties burden reduction and economic effect when we introduced Cubixx(R) into inventory control of the expensive cool place medicine 田端香1, 市毛智子1, 飯田敬一1, 石和田遼1, 浅子恵利1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 742-742, 2019.

---

	P0015-2-AM. The current situation report after the inventory control system introduction using RFID in the poison anticancer agent injection of the cool place preservation 齋藤圭佑1, 戸津舞衣子1, 岸本有佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 742-742, 2019.

---

	P0017-2-AM. Formula reconstruction of the erythropoietin preparation 澤田雄太1, 佐藤光2, 金井紀仁3, 安藤正純4, 宮崎美子5,6, 齋藤俊夫6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 743-743, 2019.

---

	P0019-2-AM. Examination about the administrative work of the hospital preparation which we applied GS1 code to 高柳聡子1, 新谷智則1, 田端志帆1, 大岡由朋1, 五十嵐敏明1, 笠松眞吾2, 矢野良一1, 塚本仁1, 後藤伸之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 744-744, 2019.

---

	P0021-2-AM. Preservation effect test in eye drops of the hospital preparation 奥田亜希子1, 山田陽一2, 佐藤可奈1, 木村真菜2, 塩田澄子2, 高柳和伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 745-745, 2019.

---

	P0023-2-AM. Relations with air-fuel ratio and the stability in the mixture of betamethasone butyric acid ester propionate ester ointment and the heparinoid from animal organ oil-related cream 尾堤文音1, 小出達夫2, 深水啓朗3, 山本佳久1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 746-746, 2019.

---

	P0025-2-AM. Evaluation of the usefulness of the stock pharmaceutical products management in the ward exclusive duty pharmacist 伊藤真美1, 松元美香1, 小林寛典1, 信澤弘美1, 大谷道輝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 747-747, 2019.

---

	P0027-2-AM. Efforts of NICU in our hospital and PICU resident duties 岩本悠花1, 寺岡知香1, 浅原章裕1, 飯野香菜子1, 辻有梨1, 伊地知政美1, 外山真理奈1, 大垣智子1, 岸田美和1, 望月千枝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 748-748, 2019.

---

	P0029-2-AM. Report about the duties contents of the pharmacist demanded from medical staff in an emergency ward 坂井孝行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 748-748, 2019.

---

	P0031-2-AM. Usefulness ... of the screening by practice - ward exclusive duty pharmacist of the discharge support of the hospitalization early stage when we aimed at the seamless medical therapy 稲葉静香1, 満田正樹1, 岡田雅弥1, 石川裕大1, 本郷志帆1, 藤井美紀1, 中谷亮介1, 奥下梨賀1, 野際俊希1, 尾崎加織1, 松本篤1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 749-749, 2019.

---

	P0033-2-AM. Information sharing ... utilizing the writing a postscript operation of efforts - drug control summary of the changing hospital information sharing that aimed at the seamless medical therapy 藤井美紀1, 満田正樹1, 岡田雅弥1, 石川裕大1, 本郷志帆1, 稲葉静香1, 中谷亮介1, 奥下梨賀1, 野際俊希1, 尾崎加織1, 松本篤1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 749-749, 2019.

---

P0035-2-AM. Effect ... to give the blood sugar control of patients with practice - diabetes of the continuation instruction after the discharge in the pharmacist outpatient who aimed at the seamless medical therapy 満田正樹1, 尾崎加織1, 野際俊希1, 岡田雅弥1, 石川裕大1, 本郷志帆1, 藤井美紀1, 稲葉静香1, 中谷亮介1, 奥下梨賀1, 松本篤1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 750-750, 2019.

---

	P0037-2-AM. An effect and inspection in the aggressive participation in before discharge conference in ward drug duties to be enabled at a small and medium size scale hospital 土屋貴1, 倉田賢生1, 荒木弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 750-750, 2019.

---

	P0039-2-AM. It is setup ... of ... drug adequacy conference team looking for the role of the further pharmacist in the convalescent ward 副島將司1, 織田雄一郎1, 小川大輔1, 三苫薫梨1, 中野聡1, 嶋彩夏1, 山本大策1, 海瀬有沙1, 深田充知1, 上野遙香1, 齋藤千秋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 751-751, 2019.

---

	P0041-2-AM. The introduction of the drug control instruction duties in the medical treatment type hospital and the result 鈴木直志1, 藤井美由紀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 751-751, 2019.

---

	P0043-2-AM. Making - clinical path utilization case ... of the list of management for the standardization of the pharmaceutical management, medication counseling 辻本高志1, 中村健一1, 上野太佑1, 住川麻美1, 檜山亜由美1, 加納宏樹1, 上田晃1, 川本由加里1, 後藤仁和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 752-752, 2019.

---

	P0045-2-AM. For patients with cardioembolic associated with the non-valvular atrial fibrillation is examination about prescription situation and off-label under dose of the oral anticoagulant drug directly 川崎夏海1, 清水敦子1, 青木洸英1, 土肥大典1, 鍵山智樹1, 丸山元1, 加藤裕司2, 出口一郎2, 高尾昌樹2, 真壁秀樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 752-752, 2019.

---

	P0047-2-AM. Efforts of our hospital for the benzodiazepine receptor agonist weight loss 若林厚史1, 辻依利1, 高橋彩1, 田畑寛明1, 猿谷淳1, 向一美1, 地野幹子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 753-753, 2019.

---

	P0049-2-AM. Role of the atopic classroom in atopic dermatitis treatment 吉田遥香1, 鈴木理子1, 江藤隆史2, 大谷道輝3, 本多秀俊1, 並木路広1, 杉浦宗敏4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 753-753, 2019.

---

	P0051-2-AM. The current situation investigation about the treatment continuance rate of the teriparatide day after day preparation in our hospital 薄田百合子1, 垣本光未1, 大谷寧次郎1, 畔柳敏弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 754-754, 2019.

---

	P0053-2-AM. Examination of an investigation and the risk prevention of the risk drug-related at a discharge at the pharmacist absence 若原美沙紀1, 高木竜一1, 宇佐美伶奈1, 井野裕美1, 森巧一1, 伊藤匡伸1, 濱石華乃子1, 久保田敏行1, 杉浦洋二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 754-754, 2019.

---

	P0055-2-AM. Ward duties to be carried out by a team 玉置むつみ1, 木村成一1, 松井綾香1, 平井梨紗子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 755-755, 2019.

---

	P0057-2-AM. Contribution to appropriate oral medicine self-care of the inpatient using the internal use self-care assessment sheet 常松柚希1, 高谷甲波1, 西村恵里子1, 稲村澄子1, 本多秀俊1, 林由紀子1, 並木路広1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 755-755, 2019.

---

	P0059-2-AM. Efforts of the ward drug duties in the convalescent rehabilitation hospital 雨森祐貴1, 中野克哉1, 筒井由佳2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 756-756, 2019.

---

	P0061-2-AM. Study on behavior of the injection drug when we stood in a row and used a syringe pump 篠崎浩司1, 土屋香代子1, 山本正子1, 内山真一郎2, 千葉義彦3, 稲野祥宗1, 仲佐啓詳1,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 757-757, 2019.

---

	P0063-2-AM. It is ... for improvement of ward drug duties - pharmaceutical intervention in the NICU 木村純子1, 小穴真貴1, 高木祥子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 758-758, 2019.

---

	P0065-2-AM. Evaluation of the usefulness of the protocol introduction for painkilling, the abatement of ICU admission in intubated patients 小牧誉典1, 帖佐俊行2, 井上尊文3, 花田歩4, 徳永綾乃4, 迫田耕輔1, 中野公1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 758-758, 2019.

---

	P0067-2-AM. Look at the rear of the intervention contents by the ward pharmacist in EICU; mark investigation 尾田未来1, 宇野洋司1, 坂本修1, 椙山聡一郎1, 小濱弥眞斗1, 小杉三弥子1,2, 竹内一郎2, 橋本真也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 759-759, 2019.

---

	P0069-2-AM. Investigation for the sorting of the catheter lock drug in the ICU 上田昌宏1, 日笠真一1, 堀直人2, 木村健1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 759-759, 2019.

---

	P0071-2-AM. Efforts of the foreign pharmacist in the IMiDs checking prescription 寺本真弓1, 水野貴仁1, 堀田磨理1, 小崎耕自1, 梶口智弘2, 山田哲也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 760-760, 2019.

---

	P0073-2-AM. Aggressive intervention (2) to the pharmaceutical management of the perioperative patients in our hospital 山田奈緒1, 左右田和恵1, 滝川亜弥1, 太田久美子1, 田村睦弘2, 清水歩3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 761-761, 2019.

---

	P0075-2-AM. It is tested the effectiveness of the stopping medicine management Web application during the preoperation in the medical support center 嘉村知子1,2, 祖川倫太郎1,2, 江本晶子1, 木村早希子1, 田崎正信1, 成澤寛1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 761-761, 2019.

---

	P0077-2-AM. Evaluation of the contribution degree to efforts and the ward drug duties to a hospitalization support task in the pharmacist outpatient department 大登剛1, 土屋裕伴1, 塩野このみ1, 塚田昌樹1, 沖田彩1, 諸橋賢人1, 齋藤由貴1, 新井亘1, 増田裕一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 762-762, 2019.

---

	P0079-2-AM. Construction of the new bringing medicine management system accompanied with the PFM introduction 原田彩加1, 藤田將嗣1, 枝崎香織1, 清水久美子1, 渡辺優希1, 福澤正隆1, 川嵜英二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 762-762, 2019.

---

	P0081-2-AM. The efforts to the hospitalization and release support center in the on call system and the evaluation 伊藤真也1, 濱田陽子1, 細川佐智子1, 河出摩由璃1, 丹羽伊紀詠1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 763-763, 2019.

---

	P0083-2-AM. It is a physician instructions observance investigation in the stopping medicine confirmation during the prehospital preoperation by the pharmacist 辻亜紀1, 池田久雄1, 古久保有希子1, 足立充司1, 野村浩英1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 763-763, 2019.

---

	P0085-2-AM. Role of the pharmacist in the hospitalization support ambulatory service 起塚美沙1, 西岡敬貴1, 大上寛子1, 黄前尚樹2, 中村美樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 764-764, 2019.

---

	P0087-2-AM. The activity result of the pharmacist in the urination care team and new efforts 林剛史1, 古川大樹1, 長谷川雅哉1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 765-765, 2019.

---

	P0089-2-AM. The inflection of the balun strike scorecard in our hospital and effect on member 林哲哉1, 男全昭紀1, 阿部多一1, 井口恵美子1, 猪股克彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 766-766, 2019.

---

	P0091-2-AM. Approach "construction by an anti-VAIO gram automatic making system" aiming at the automation of duties 山田将悟1, 鈴木直哉1, 朝倉幹己1, 藤田果那1, 田中耕太1, 庄崎沙耶1, 木下愛1, 山本翔太1, 前川英輝1, 菊地義明1, 藤林遼1, 高橋誠1, 青田忠博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 767-767, 2019.

---

	P0093-2-AM. The construction of the system for the generic name prescription introduction and the evaluation 鈴山直寛1, 春田桃歩1, 山本高範1, 阿部康治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 768-768, 2019.

---

	P0095-2-AM. Change of DI duties by the pharmaceutical products data update using the Internet line 冨岡謙二1, 淀川進也1, 堀江信彦2, 三宅健郎3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 769-769, 2019.

---

	P0097-2-AM. Consideration (for ... 2020 Tokyo cage Para ...) of fact-finding and the number of the making increase of the bookmark of the English version medicine 黒川寛之1, 栗原理1, 工藤香代子1, 平林文子1, 橋口佳恵1, 池田薫1, 野村香織2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 770-770, 2019.

---

	P0099-2-AM. Side effect analysis of "the hyperkalemia" using PMDA side effect database (JADER) 門口直仁1, 森田有香1, 濱本真歩1, 段松雅弘1, 田中聡1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 770-770, 2019.

---

	P0101-2-AM. Associated - with the number of the prescription drugs which we looked at according to analysis - side effects about the polypharmacy utilizing real world data 馬渕賢幸1,2, 細見光一1, 丸野なつみ1, 森田真央1, 横山聡1, 村田卓2, 高田充隆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 771-771, 2019.

---

	P0103-2-AM. Examination of the effect that an oral antidiabetic drug gives in the onset of unexpected side effect risk of amiodarone using the adverse event spontaneous report database 木下佐昌子1, 細見光一2, 横山聡2, 高田充隆2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 771-771, 2019.

---

	P0105-2-AM. The prescription situation of the fomentation for the inpatient 鈴木健1, 水野翼1, 野田絢子1, 岩澤瞳1, 藤井晶子1, 舟橋智美1, 大西正文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 772-772, 2019.

---

	P0107-2-AM. Efforts to duties improvement in the shift system introduction in the Fukuoka University Nishijin Hospital 舌間清晃1, 永江寛子1, 谷田繁夫1, 山本瞳1, 安部亜紀子1, 萩原大樹1, 田村明子1, 岐部七子2, 長岡麻由2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 773-773, 2019.

---

	P0109-2-AM. It is investigated the delirium prevention after the ramified microglia, the operation by the suvorexant 土元研史1, 安田礼子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 773-773, 2019.

---

	P0111-2-AM. Use fact-finding of the measurement situation and statin of the LDL-C level in patients with ST rising type myocardial infarction of our hospital 長戸優也1, 多留木崇志1, 村田龍宣1, 村岡淳二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 774-774, 2019.

---

	P0113-2-AM. Introduction of the representation answer protocol for doubt inquiry from the outside Parliament health insurance pharmacy in the wide area medical institution and the evaluation 山田真由美1, 石井真理子1, 柳下祥子1, 佐々木真理1, 高橋勇人1, 山谷明正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 774-774, 2019.

---

	P0115-2-AM. Age-specific analysis according to the type of job of the person concerned with investigation - medical care of the inflection situation about the package insert of the ethical drug 青木良子1, 鈴木奈穂1, 鈴木美佳1, 今任拓也1, 佐井君江1, 斎藤嘉朗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 775-775, 2019.

---

	P0119-2-AM. Efforts to the proper use of the hypozincaemia therapeutic agent 日野裕子1, 延藤勇1, 豊濱隆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 776-776, 2019.

---

	P0121-2-AM. The use situation investigation of the saccharated iron oxide injection in the Oita Oka Hospital 武石優哉1, 井上真1, 遠山泰崇1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 776-776, 2019.

---

	P0123-2-AM. Use fact-finding of the Lenvatinib for hepatocytes cancer 浅見祥崇1, 大下瑚姫1, 船田茜1, 尾形朱史鈴1, 須藤大雄1, 村中一大1, 須藤美穂子1, 鈴木千波1, 小原秀治1, 小原郁司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 777-777, 2019.

---

	P0125-2-AM. Change of the practice process outcome index for antimicrobial proper use promotion 河原陽介1, 木内貴章1, 森川貴弘2, 入澤奈津江2, 加藤良治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 777-777, 2019.

---

	P0127-2-AM. Examination of the factor to affect the determination of pharmaceutical products stock 坂井優希1, 安酸建二2, 松野純男1, 北小路学1, 大鳥徹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 778-778, 2019.

---

	P0129-2-AM. It is efforts of the reduction of attendant drug costs for a change of the extracellular fluid sending it from a ward pharmacist 影本渉1, 磯谷聡1, 伊藤和幸1, 浦崎圭太1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 779-779, 2019.

---

	P0131-2-AM. Characteristic - of the checking prescription for the purpose of analysis - Residual medicine adjustment of the checking prescription in the ethical pharmacy 上田祐稀乃1, 鈴木学1,2, 海野茜1, 味澤香苗1, 林由依1, 林秀樹1,2,3,4, 小林篤史3, 生木庸寛4, 甲斐絢子3, 小原道子4, 棚瀬友啓2, 杉山正1,2,3,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 780-780, 2019.

---

P0133-2-AM. Examination ... based on the data utilization that cooperated with operational construction - bringing medicine outpatient department of the bringing medicine for digestive organ surgery hospitalization planned patients instructions input before hospitalization 藤田菜緒1, 後藤敏也1, 正木銀三1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 781-781, 2019.

---

	P0135-2-AM. The change of the pharmacist intervention method in the hospitalization and release management room and the evaluation 高橋希美1, 鈴木さとみ1, 本田和則1, 田村淳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 781-781, 2019.

---

	P0137-2-AM. Interaction - with fact-finding - pharmaceutical products about the use of the supplement 吉岡三郎1, 犬伏彩夏1, 柴田愛2, 宮崎恭治2, 三好博子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 782-782, 2019.

---

	P0139-2-AM. Comparison of the clinical benefit in the starting pharmaceutical products and generic medicine of the loxoprofen sodium for patients with chronic pain 植松卓也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 783-783, 2019.

---

	P0143-2-AM. Further search of the factor having an influence on thrombocytopenia of the linezolid 宮原宣博1, 永野浩之1, 小岩まの1, 野田幸一1, 貝嶋亮1, 谷水達也1, 鈴木善樹1, 林良行1, 岸野亨1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 785-785, 2019.

---

	P0145-2-AM. Evaluation of serum cystatin C and the serum magnesium level in the magnesium oxide preparation internal use patients 馬場美咲1, 高武嘉道1, 川俣洋生1, 福石和久1, 高島伸也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 785-785, 2019.

---

	P0147-2-AM. About the issuance of drug allergy (side effect) card in our hospital 山田倭花1, 中島のぞみ1, 内山乃映1, 上田奈緒美1, 大窪真理絵1, 丸岡浩太1, 伊代田萌子1, 梅澤仁美1, 原幸子1, 河村紳介1, 小林誠一1, 富沢裕之1, 土佐直子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 786-786, 2019.

---

	P0149-2-AM. The effect that combination of TAZ/PIPC and VCM in the critical care center gives for renal function 岡崎弘志1, 橋田真佐1, 濱田一成1, 田中広大1, 公文登代1, 段松雅弘1, 田中聡1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 786-786, 2019.

---

	P0151-2-AM. Clinical application of the antithrombotic drug information on adverse drug reactions using the artificial intelligence 川上準子1, 林玄健2, 林誠一郎3, 星憲司1, 青木空眞1, 佐藤憲一1, 渡部輝明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 787-787, 2019.

---

	P0153-2-AM. Using cyclopedic analysis - adverse event spontaneous report database of the adverse event with the antithrombotic drug - 小松唯可1, 細見光一1, 横山聡1, 高田充隆1, 近畿大学 薬学部1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 787-787, 2019.

---

	P0155-2-AM. The use of anticoagulant situation investigation of patients with cerebral hemorrhage in our hospital 白坂友基1, 小林薫1, 伊藤宏彰1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 788-788, 2019.

---

	P0157-2-AM. The use actual situation of the Osimertinib in the non-small cell lung cancer and safe examination 藤本亜弓1, 山崎直樹1, 大嶋美咲1, 木村仁美1, 中尾將彦2, 吉田徹也1, 駄賀晴子3, 村田みどり1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 788-788, 2019.

---

	P0159-2-AM. Change of the bleeding rate by off-period shortening before antithrombotic drug technique in endoscopic mucosal resection (EMR) 山田健太郎1, 島谷桜子1, 工藤真弓1, 松本浩1, 伊藤由香1, 坂下裕子1, 末谷敬吾2, 奥瀬千晃2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 789-789, 2019.

---

	P0161-2-AM. Examination of the development situation and the risk factor of the hypermagnesemia 岡村和彦1, 藤本孝則1, 谷村隼人2, 秦良輝2, 木村孝司2, 佐和章弘2, 佐々木雄啓1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 789-789, 2019.

---

	P0163-2-AM. 1 case that linezolid caused neurologic symptoms 穂積廣1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 790-790, 2019.

---

	P0165-2-AM. The onset of hypersensitivity situation of the injection antitumor agents and validity of measures 合澤啓二1, 岩田一史1, 西上依里1, 陣上祥子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 790-790, 2019.

---

	P0167-2-AM. One case that conducted readministration for nivolumab patients with head and neck cancer which caused thrombocytopenia after administration 藤川史子1, 木崎秀和1, 本間信次1, 大植謙一1, 岡崎和一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 791-791, 2019.

---

	P0169-2-AM. Diabetes marker 1 in the rat, internal kinetic analysis of 5-anhydroglucitol 竹林裕美子1, 志熊真理1, 西岡千晶1, 木村遥華1, 井辻真由1, 本橋秀之1, 宮崎誠2, 永井純也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 792-792, 2019.

---

	P0171-2-AM. Clinical analysis of PK/PD parameter about the effectiveness, the safety of vancomycin by the new construction model 千代谷大志1, 佐古兼一1, 伊賀正典2, 高野温志2, 榊拓人1, 町田充2, 藤掛佳男1, 松田佳和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 793-793, 2019.

---

	P0173-2-AM. Examination of the adsorption of the antimicrobial for the AN69ST membrane 稲野祥宗1, 熊野諒太1, 篠崎浩司1, 三浦剛2, 仲佐啓詳1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 794-794, 2019.

---

	P0177-2-AM. One patient whom a rise of PT-INR was found in by combination of Rifaximin and warfarin 鶴永大貴1, 堀ノ内志織1, 中松穂菜美1, 堀内智裕1, 中村有莉恵1, 赤星真広1, 上原友美1, 池増鮎美1, 佐多照正1, 最勝寺晶子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 795-795, 2019.

---

	P0179-2-AM. 1 case that we combined metronidazole with the warfarin remedy patients, and PT-INR extended to 河村美弥子1, 田代将貴1, 佐藤潤2, 妹川史朗2, 正木銀三1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 796-796, 2019.

---

	P0181-2-AM. Effect of the cyclodextrin handling of grapefruit deuce to give to CYP3A activity inhibition 山崎啓之1, 小山陽子1, 西崎成美1, 河津誠太郎1, 庵原大輔1,2, 田口和明1,3, 門脇大介1,2, 小田切優樹1,2, 瀬尾量1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 796-796, 2019.

---

	P0183-2-AM. Initial blood level of vancomycin by the ward pharmacist in our hospital and safe evaluation 大森淳史1, 今村陽子1, 柏田匡広1, 大石貴裕1, 池田浩和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 797-797, 2019.

---

	P0185-2-AM. Examination about a blood level monitoring clinical response and the side effect of the Perampanel 山本吉章1,2, 臼井直敬1, 西田拓司1, 今井克美1, 賀川義之2, 高橋幸利1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 798-798, 2019.

---

	P0189-2-AM. An investigation of VCM doses for the children patient, the dosage interval and anticipatory examination of the blood level 宿谷光則1, 小林俊博1, 大森春采1, 藤重瑶子1, 島谷桜子1, 赤津真衣子1, 松本浩1, 伊藤由香1, 宮地悠輔2, 品川文乃2, 森内巧2, 宮本雄策2, 坂下裕子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 799-799, 2019.

---

	P0191-2-AM. Analysis of the blood vancomycin levels in children and the pharmacokinetic parameter and the change factor 岡崎美香1, 立岡美穂1, 三浦佳江1, 石原慎之1, 玉木宏樹1, 矢野貴久1, 西村信弘2, 直良浩司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 799-799, 2019.

---

	P0193-2-AM. Examination of the vancomycin hydrochloride blood level change factor in patients with congenital heart disease 金井梓1, 青木洸英1, 鍵山智樹1, 森弘樹1, 唐牛春香1, 土肥大典1, 連翔太2, 小林俊樹2, 真壁秀樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 800-800, 2019.

---

	P0195-2-AM. Are blood level and the effectiveness, the side effect of the tyrosine kinase inhibitor associated with ABCG2 genetic polymorphism? 齋藤健一1,2, 小野塚真理1,2, 佐野元彦1, 井上嘉余子1, 近藤正巳1, 金子怜奈2, 吉田瑛里奈2, 佐野和美2, 花田和彦2, 岸野亨3, 木村勇太4, 得平道英4, 木崎昌弘4, 池上洋二2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 801-801, 2019.

---

	P0197-2-AM. Examination about the adsorption of the bevacizumab for the infusion filter in the paclitaxel + bevacizumab therapy 小林優奈1, 牛尾聡一郎2, 蔵田靖子2, 江角悟2, 北村佳久1,2, 千堂年昭2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 802-802, 2019.

---

	P0199-2-AM. Medical expenses reduction effect of the use of anticancer medicine division at use of preparation robot 澤田広樹1, 志田敏宏1, 山口浩明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 803-803, 2019.

---

	P0201-2-AM. Construction of the follow-up system between hospital - health insurance pharmacies in the Lenvatinib 中井昌紀1, 越智理香1, 佐々木優1, 越智友美1, 濟川聡美1, 飛鷹範明1, 田中守1, 田中亮裕1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 804-804, 2019.

---

	P0203-2-AM. Fact-finding of the side effect management in patients who received Pembrolizumab 和田依子1, 樋口美奈子1, 佐々木好美1, 山口竜司1, 児玉沙奈恵1, 檜山智子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 805-805, 2019.

---

	P0205-2-AM. Duties ... of the pharmacist in the other types of job collaboration - outpatient department chemotherapy room for security and effective chemotherapy practice 樋口美奈子1,2, 和田依子1, 山口竜司1, 佐々木好美1, 児玉沙奈恵1, 檜山智子1, 花田清彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 805-805, 2019.

---

	P0207-2-AM. Inspection of the optimal vial standard for the cost cut of the wasted drug in the trastuzumab 中村暢彦1, 一島知樹2, 武田智子2, 長谷川晃司2, 矢野義孝1, 楠本正明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 806-806, 2019.

---

	P0209-2-AM. The effect that the use of the closed system anesthesia drug transportation system gives at anticancer medicine preparation time 江崎翔平1, 横山雄一1, 篠原義剛1, 植木哲也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 807-807, 2019.

---

	P0211-2-AM. Cost cut effect by the injectable anticancer agent division preparation in our hospital 夘月博和1, 若月秀明1, 佐達勇之1, 平野享1, 大木孝夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 807-807, 2019.

---

	P0213-2-AM. Exposure measures effect by the closed system anesthesia drug transportation system full-scale introduction in the foreign chemotherapy 小笹英祐1, 計良貴之1, 秋山七海1, 竹端琴美1, 圓山絵理1, 湊川紘子1, 田中恒明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 808-808, 2019.

---

	P0215-2-AM. Examination of the effect by duties efficiency and the RMP introduction with the cancer consultation in chemotherapy support tool 小林智徳1, 佐藤祐司1, 菊地正史1, 小原拓1, 眞野成康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 809-809, 2019.

---

	P0217-2-AM. 1 case of the lung adenocarcinoma which a pharmacist intervened in for immune-mediated adverse event suspicion after the Pembrolizumab administration 宇都宮奈々1, 沖田健太郎1, 長谷川将1, 安河内寿成1, 山村真貴子1, 羽山千尋1, 安藤暢彦1, 三村英恵1, 白石貴寿1, 中村泰士1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 810-810, 2019.

---

	P0219-2-AM. An example of platinum-resistant recurrent ovarian cancer which complicated idiopathic thrombocytopenic purpura 平山拓史1, 木本真司1, 河原史明1, 安齊泰裕1, 香内綾1, 原田伸彦1, 塩川秀樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 810-810, 2019.

---

	P0221-2-AM. Formulations support tool making and the prescription situation aiming at Abemaciclib proper use 西崎成美1, 須古杏子1, 大佐古智文2, 奥村恭博2, 中野正啓2, 藤末真実子2, 西村令喜2, 森岡淳子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 811-811, 2019.

---

	P0223-2-AM. The expression situation investigation of sickness/nausea, vomiting by having switched from palonosetron to 3 mg of granisetron 矢吹剛1, 山田宜和1, 貝瀬眞由美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 812-812, 2019.

---

	P0225-2-AM. Evaluation of the supportive care in the breast cancer adjuvant chemotherapy 祖父江彰1, 山本桂子1, 渡辺早也佳1, 堀内保孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 813-813, 2019.

---

	P0227-2-AM. Investigation of irinotecan doses by the UGT1A1 genetic polymorphism analysis and the neutropenic expression situation 坂柳悦章1, 荒木寛也1, 西川隆一1, 澤柳直樹1, 藤井友和1, 辻博幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 814-814, 2019.

---

	P0229-2-AM. The use situation and irAE measures of the immune checkpoint inhibitor in our hospital 村上幸恵1, 竹野裕晶1, 桑原玄樹1, 樋口利晴1, 樋口理恵1, 本間健道1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 815-815, 2019.

---

	P0231-2-AM. Examination of the early onset of high blood pressure and effect factor of the Lenvatinib therapy for unresectable hepatocytes cancer 高田遼1, 相神智宏1, 石郷友之1, 山崎将英1, 國本雄介1, 北川学1, 木明智子1, 中田浩雅1, 宮本篤1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 815-815, 2019.

---

	P0233-2-AM. Risk factor search of the diachronic renal function aggravation by the cisplatin 興梠靖幸1, 甲斐晃弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 816-816, 2019.

---

	P0235-2-AM. Fact-finding of the venous thromboembolism with the bevacizumab administration in patients with gynecologic cancer 宇佐美友佳子1, 近藤篤1, 三宅麻文1, 尾上雅英1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 816-816, 2019.

---

	P0237-2-AM. Cockcroft-Gault type estimate Ccr revision in the Carboplatin doses calculation for the initial TC therapy for gynecologic cancer patients and investigation about the side effect 北本真一1, 古谷智裕1, 白木政博1, 野村実由1, 金田公平1, 松本俊治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 817-817, 2019.

---

	P0239-2-AM. Examination of the volume of infusion weight loss of the cisplatin for the intraarterial injection before administration 川島悠吾1, 徳山洋子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 817-817, 2019.

---

	P0241-2-AM. Examination of the clinical characteristic in efforts and the side effect for the proper use of the immune checkpoint inhibitor in our hospital 向山龍司1,2,3,4, 里村藍子1, 永村陽一郎1, 坂榮里絵2, 八木太門3, 山口雄4, 中根実4, 日野斉一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 818-818, 2019.

---

	P0243-2-AM. The proper use of the immune checkpoint inhibitor in the small and medium size hospital and examination of immune-mediated adverse event measures 渡邉絵美1, 増田尚子2, 唐澤匠太1, 荒川基記4, 日高慎二4, 山田博文3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 818-818, 2019.

---

	P0245-2-AM. Activity by the multi-type of job team for the side effect of the immune checkpoint inhibitor 宮本康敬1, 小笠原隆2, 神谷智子3, 平野公美1, 遠藤拓未1, 川口千香1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 819-819, 2019.

---

	P0247-2-AM. Inventory survey about the usefulness of the cutaneous symptom care handbook in the Miyagi Prefectural cancer center 嶺岸なつみ1, 土屋雅美1, 江刺晶央1, 猪岡京子1, 高村千津子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 819-819, 2019.

---

	P0249-2-AM. It is a new choice to improvement in quality of life for oral mucositis at cancer treatment 丸林万希子1, 武井大輔1, 柵木信男2, 中村益美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 820-820, 2019.

---

	P0251-2-AM. Usefulness of the irAE supporting program in the Takeda synthesis hospital 原田伸彦1, 木本真司1, 河原史明1, 香内綾1, 安齊泰裕1, 平山拓史1, 成田浩気1, 星美奈子1, 山田麻帆1, 遠宮賢二1, 塩川秀樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 820-820, 2019.

---

	P0253-2-AM. Examination of the usefulness of the test for glucose in urine paper for the purpose of the early detection of type I diabetes mellitus through immune checkpoint inhibitor 鎌田宏和1,2, 清水克次1, 高橋幸三1, 角川幸男1, 中野寛之1, 高木麻里1, 藤田敬子1, 井上貴子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 821-821, 2019.

---

	P0255-2-AM. The low Mg blood symptom management by Panitumumab using PBPM 鈴木直哉1, 菊地義明1, 藤林遼1, 前川英輝1, 山田将悟1, 朝倉幹己1, 藤田果那1, 山本翔太1, 庄崎沙耶1, 田中耕太1, 木下愛1, 高橋誠1, 青田忠博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 821-821, 2019.

---

	P0259-2-AM. 1 case that the drug continuation subcutaneous injection after the hospital transfer was able to continue by inflection of the drug control summary smoothly 千葉芙美1, 福島真実1, 熊谷範之1, 小笠原信敬1, 鵜浦利江2, 熊谷敏宏1, 村上雅彦3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 823-823, 2019.

---

	P0261-2-AM. Use of Elobixibat hydrate tablets fact-finding for the constipation during use of drug for the medical care 細田奈七恵1, 松本晃一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 824-824, 2019.

---

	P0263-2-AM. The use situation investigation of the fentanyl oral mucosa absorbent in the Saiseikai Hospital of the whole country 尾形美絵1,2, 中村槙一郎1, 財津孝希1, 瀧内瑛輔1, 長澤欣弘1, 羽生智宏1, 田村亜矢子1, 田村和彦1, 新関みどり1, 近藤和宏1, 曽我部直美2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 824-824, 2019.

---

	P0265-2-AM. We examine the effect of methadone on analgesic effect insufficiency case in strong opioid 石川敬祐1, 伊藤慎二1, 磯貝潤一1, 小林沙矢香1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 825-825, 2019.

---

	P0267-2-AM. One case that opioid switching was effective for the delirium after the oxycodone preparation start 熱海幸恵1, 李娜1, 添田真司1, 渡邊昌之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 825-825, 2019.

---

	P0269-2-AM. Constipation improvement effect of the naldemedine in patients with opioid-induced constipation 世古口拓也1, 野口祥紀1, 永田裕章1, 三宅知宏1, 谷村学1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 826-826, 2019.

---

	P0271-2-AM. Example that was given Osimertinib by the simple suspension method in the patients with lung cancer of the ileus concurrence due to the cancerous peritonitis 三屋良太1, 鈴木雅人1, 牧原明秀1, 高原悠子1, 吉田弘樹1, 土方寿聡2, 木全司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 827-827, 2019.

---

	P0273-2-AM. Examination of the usefulness of the pharmaceutical management for the long-term continuation in the foreign chemotherapy room 菅井瞳1, 有田仁紀1, 今川未紀1, 川上達也1, 越川一誠1, 渡辺和美1, 坂本真紀1, 西澤健司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 828-828, 2019.

---

	P0275-2-AM. Use experience of the Olaparib for patients with platinum in our hospital-sensitive recurrent ovarian cancer 立花京香1, 後藤健志1, 竹尾恵理子1, 酒井欣嗣2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 828-828, 2019.

---

	P0277-2-AM. The allergic expression of oxaliplatin preparation situation investigation accompanied with the generic medicine maker change 横田千明1, 花田聖典1, 鶴崎泰史1, 中川義浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 829-829, 2019.

---

	P0279-2-AM. The expression situation of the adverse event in study on adverse event frequency - our hospital of the immune checkpoint inhibitor and the continuation situation of the treatment 丸山昌広1, 梅村雅之2, 定盛理純1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 829-829, 2019.

---

	P0281-2-AM. Examination of the onset of adverse event situation of the treatment with temozolomide preparation and bevacizumab preparation in the malignant glioma of the first 堀江美香子1,2, 熊澤里美1,2, 西山悠也3, 大場茂生3, 廣瀬雄一3, 山田成樹1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 830-830, 2019.

---

	P0283-2-AM. 1 case that neutropenia developed after nivolumab ipilimumab combination therapy 加藤潤1, 橋本良博2, 佐々木英雄1, 三宅芳男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 830-830, 2019.

---

	P0285-2-AM. Investigation about the antiPD-L1 antibody administration and influenza immunization in patients with non-small cell lung cancer 八瀬恵理子1, 高橋政成1, 山本理恵2, 田路章博1, 南山啓吾1, 砂金秀美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 831-831, 2019.

---

	P0287-2-AM. One case of the serious dermatopathy that Osimertinib causes 渡邉紘章1, 伊與田友和1, 安藤真弘2, 高橋紗英子1, 高田あゆみ1, 田崎政則1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 831-831, 2019.

---

	P0289-2-AM. Effect of the antimicrobial giving it to the clinical response of the antiPD-1 antibody 南島拓矢1, 肥田裕丈1, 今俊介1, 千崎康司1, 永井拓1, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 832-832, 2019.

---

	P0291-2-AM. One case of renal cell carcinoma which developed serious hepatic dysfunction, and maintained high pazopanib blood level 柏倉正太1, 鈴木裕之2, 大内竜介1, 薄井健介1,3, 岡田浩司1,3, 佐藤信4, 海法康裕4, 伊藤淳4, 阿南剛4, 岩村大径4, 村井ユリ子4, 中村仁4, 渡辺善照1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 832-832, 2019.

---

	P0295-2-AM. Efforts in the enforcement situation and our hospital of the colon cancer chemotherapy in elderly people 中市里実1, 善積司行1, 前田智佳子1, 楠本臣彌1, 岩佐沙希子1, 山本紗世1, 藤本明由美1, 岡本悠紀1, 溝端友希1, 三浦絢1, 台野佳代1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 833-833, 2019.

---

	P0297-2-AM. The HBV reactivation measures situation and problems of patients who received chemotherapy 阿部多一1, 住谷達也1, 林哲哉1, 井口恵美子1, 猪股克彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 834-834, 2019.

---

	P0299-2-AM. Efforts to HBV reactivation measures with immunodepression, the chemotherapy 山下千草1, 川原裕1, 佐野雅昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 834-834, 2019.

---

P0301-2-AM. It is examination about the difference in evaluation of Performance Status between a pharmacist, a physician, nurses at the beginning of the medical treatment of the unresectable progress, recurrent lung cancer 長田志織1, 米田太郎2, 木場隼人2, 田中伸佳3, 城座圭子4, 桂英之1, 柴田結希乃1, 小川依1, 石田外樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 835-835, 2019.

---

	P0303-2-AM. Example that performed Carboplatin desensitization for patients with recurrent ovarian cancer of Carboplatin hypersensitivity, and was able to continue treatment 樋口裕哉1,2, 大島宗平1, 八島秀明1,2, 平川隆史3, 岩瀬明3, 阿部正樹1, 荒木拓也1,2, 山本康次郎1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 835-835, 2019.

---

	P0305-2-AM. Fact-finding about the pharmacist duties of the foreign cancer treatment section in the cancer practice cooperation base Hospital, and the like 花香淳一1, 堤大輔2, 脇本麻美3, 村田勇人4, 丹原由希5, 中田千博6, 河野友昭7, 林啓文8, 川澄賢司6, 櫻井洋臣9, 濃沼政美10, 近藤直樹3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 836-836, 2019.

---

	P0307-2-AM. Clinical difference of the mutation in the gene in the EGFR mutation in the gene-positive non-small cell lung cancer 滝澤苑美1, 有山智博1, 田中博之1, 木下雅子1, 藤枝正輝1, 磯部和順2, 石井敏浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 836-836, 2019.

---

	P0309-2-AM. The antimicrobial proper use promotion for the AMR measures action plan and future measures 外山智章1,2, 平原康寿1,2, 岩尾千紘2, 中山雄貴2, 荒武舞2, 山田明輝2, 高城一郎2, 岡山昭彦2, 池田龍二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 837-837, 2019.

---

	P0311-2-AM. After the operation in the backbone laminectomy about the use situation of the cefazolin as the infection prophylaxis antimicrobial 吉田悦朗1, 白石貴寿1, 臼井和明1, 山村真貴子1, 大石丸美1, 上前里香1, 近藤真由1, 宇都宮奈々1, 森田佳博1, 中村泰士1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 838-838, 2019.

---

	P0313-2-AM. Consideration about the current situation of the antimicrobial prescription for acute upper respiratory infection of children and the background factor 臼井和明1, 吉田悦朗1, 宇都宮奈々1, 安藤暢彦1, 安河内寿成1, 岩武幹乃1, 栗原江未1, 沖田健太郎1, 白石貴寿1, 中村泰士1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 838-838, 2019.

---

	P0315-2-AM. The current situation of the antimicrobial administration for the treatment of the peritoneal dialysis-related peritonitis in our hospital 永松翔1, 東里美1, 岩下龍史2, 寺口記代2, 上山逹典2, 寺師守彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 839-839, 2019.

---

	P0317-2-AM. Analysis of the factor having an influence on the thrombocytopenia of the linezolid 小久保綾乃1, 中村麗紗1, 喜多洋嗣1, 仲村亮太1, 駒井勇太1, 人見百合子1, 石井奈津季1, 峯浩太郎1, 吉村美菜1, 鈴木里香1, 野下綾子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 839-839, 2019.

---

	P0319-2-AM. Examination about the integration of the amikacin population pharmacokinetics model in neonates and the optimal administration 岡田章1, 鈴木匠1, 竹内祐斗1, 永井尚美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 840-840, 2019.

---

	P0321-2-AM. Effect on aim concentrations arrival rate and effect of treatment by a pharmacist being concerned with initial administration plan of the Teicoplanin 片岡達夫1, 冨田隆志1, 檜山洋子1, 宮本佳奈1, 久保有子1,2, 佐伯康之1, 垰越崇範1, 松尾裕彰1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 840-840, 2019.

---

	P0323-2-AM. Approach ... to realize speedy staphylococcemia treatment by antimicrobial proper use support team ... multi-type of job cooperation in our hospital 古川大樹1, 伊藤嘉英1, 大橋武司1, 林房枝2, 寺島恭子2, 菱田志乃3, 長谷川雅哉1, 中尾彰宏4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 841-841, 2019.

---

	P0325-2-AM. Effective evaluation of the cefaclor for UTIs in our hospital 立石忠昭1, 濱田洋平2, 山下義巳1, 岩根紳治1, 藤岡康彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 841-841, 2019.

---

	P0327-2-AM. The change situation from intravenous antimicrobial in our hospital to internal use antimicrobial and the effect 佐々英也1, 冨田敦和1, 内山耕作1, 鈴川誠1, 平尾祐樹1, 三浦毅1, 今西忠宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 842-842, 2019.

---

	P0329-2-AM. It is efforts to adequacy of the infection prophylaxis antimicrobial after the operation in the clinical path 佃晶子1,2, 三橋未帆1,2, 杉尾和昭1,2, 増田雅行2, 寺井幸子1, 内野卯津樹1, 長島誠1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 842-842, 2019.

---

	P0331-2-AM. Examination about the renal failure by the combination of vancomycin hydrochloride and tazobactam/piperacillin 染谷雅弘1, 篠崎陽一1, 明石岩雄1, 長澤仁志1, 加藤潤一郎1, 赤石和久1, 川久保孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 843-843, 2019.

---

	P0335-2-AM. Intervention by the antimicrobial proper use support team to a case using Tazobactam/Piperacillin more than six days 佐藤陽介1, 伊藤貴亮1, 菅野和1, 佐藤圭吾1,2, 茄子川智子2, 永沼結花3, 川村直美3, 尾池泰典2,3, 松本亜紀2, 井上顕治2,4, 篠崎滋5, 小林誠一6, 矢内勝2,6, 佐賀利英1,7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 844-844, 2019.

---

	P0337-2-AM. It is impact statement to the infection prevention after the operation by the antimicrobial review of the cataract surgery clinical path 福原佐知1, 吉田宣政1, 江嶋祐樹1, 檜山智子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 844-844, 2019.

---

	P0339-2-AM. Cooperation in the AS activity of AST charge pharmacist and the ward charge pharmacist 大林巧志1, 舩越真理1, 津田正博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 845-845, 2019.

---

	P0341-2-AM. As a result of internal use observance situation questionary survey in the oseltamivir prophylactic internal use to the staff 莊司智和1,2, 松村大樹1,2, 入倉悠2, 窪川佳世2, 荻原真二2, 内田幹2, 井上修2, 波呂浩孝2, 河田圭司1, 鈴木正彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 846-846, 2019.

---

	P0343-2-AM. Normal tooth extraction and investigation examination of the prophylactic use of antimicrobial actual situation and SSI development situation to an outpatient for the extraction of impacted wisdom teeth 吉田謙介1, 鈴木直人1, 磯辺浩和1,2, 金子奨太1, 齋藤千愛1, 山田瑛子3, 児玉泰光3, 高木律男3, 外山聡1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 846-846, 2019.

---

	P0345-2-AM. About antibody titers of our hospital staff for four kinds of epidemicity virus disease and the vaccination situation 小迫晶寛1, 黒田紘生1, 加茂章弘1, 上村豪1, 古市由香2, 植村隆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 847-847, 2019.

---

	P0347-2-AM. Evaluation of the AST activity judging from a viewpoint of the medical economy 阿部純也1, 小島安紀子1, 松本朋美2, 堀内保孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 847-847, 2019.

---

	P0349-2-AM. The effectiveness of the cefazolin sodium intravenous administration in the cataract surgery perioperative period and safe examination 新海永梨奈1, 鶴崎大1, 深滝利也1, 中静裕之2, 菊池憲和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 848-848, 2019.

---

	P0351-2-AM. Experimental inspection of the effect factor to give to the calcium salt formation based on the findings of the gallstones-related disorder expression tendency by the ceftriaxone 田口和明1, 伊藤瑠衣1, 吉田亜沙美1, 榎木裕紀1, 松元一明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 848-848, 2019.

---

	P0353-2-AM. Examination of the effect that an antimicrobial proper use support activity gives to the use situation of the antimicrobial 立石翼1, 滝波昇悟1, 安尾哲郎1, 松田真哉2, 田口剛士2, 矢島尚子3, 濱野政弘3, 大村正恵3, 友田恒一4, 羽井佐実5, 監物英男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 849-849, 2019.

---

	P0355-2-AM. The effect that an activity of AST gives for use of in-hospital antimicrobial 山村翔1, 荒木良介1, 山田英紀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 849-849, 2019.

---

	P0357-2-AM. Effect to the process index by the activity of the antimicrobial proper use support team 山崎晃憲1,2, 駒澤宏紀1,2, 猫宮由美子2, 松坂俊2, 芹沢良幹2, 安保義恭2, 本郷文教1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 850-850, 2019.

---

	P0359-2-AM. The current situation evaluation and problem of the antimicrobial proper use round by Antimicrobial stewardship team 高野温志1,2, 伊賀正典1,2, 神山治郎1, 大川直美1, 阿保一茂1, 町田充2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 850-850, 2019.

---

	P0361-2-AM. How did the acquisition of the preventive measures against infection addition and the authorized number of the pharmacists, the intervention situation change in 2010 and 2,016 years? : Comparison using the JACS 田中真幸1, 村木優一1, 日馬由貴2,3,4, 石金正裕2,3, 大曲典夫2,3,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 851-851, 2019.

---

	P0363-2-AM. About a preparation of the suspension of the antiHIV medicine that crush is necessary for the simple suspension method application 寺岡麗子1, 橋本佳那子1, 高橋稔1, 河野奨2, 白木孝2, 矢倉裕輝3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 852-852, 2019.

---

	P0365-2-AM. Prescription situation and tendency ... of the antiHIV medicine in efforts (1) - our hospital for the outside Parliament shift of the prescription containing the antiHIV medicine in our hospital 保戸塚里美1, 井手頌美1, 南谷奈々1, 朽木絵美1, 黒木あかね1, 前波麻里子1, 井戸澤弘美1, 山形亜紀子1, 林みどり1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 853-853, 2019.

---

	P0367-2-AM. Change of the D dimer with the lipid microsphere administration 大塚淳一1, 石倉あゆみ1, 山口祐希1, 伊藤圭介1, 湯浅瑠美2, 笹木織絵2, 松村暁3, 島崎博士1, 長谷川英雄1, 坪井一人5, 尾高真5, 内山幹4, 藤岡秀一5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 854-854, 2019.

---

	P0369-2-AM. Efforts to the use current situation and the proper use of the dose of medicine to the long-term inpatient in the psychopathic ward 新保一1, 苗田洋生1, 浅見友美子1, 関川敬1, 伊東秀幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 855-855, 2019.

---

	P0371-2-AM. Role - of the pharmacist in efforts - multi-type of job interview for the discharge to patients with schizophrenia during long-term hospitalization 小林泰子1, 大塚桂子1, 馬場元2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 856-856, 2019.

---

	P0373-2-AM. Attempt for the pharmaceutical products proper use in dementia, the elderly people ward 福山雄卯介1, 福山順子2, 宮崎敦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 856-856, 2019.

---

	P0375-2-AM. How does attitude survey - psychiatry pharmacist about the medication counseling to patients with schizophrenia arrest him? 五味和彦1,2, 竹平理恵子2, 有田悦子2, 和田美由紀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 857-857, 2019.

---

	P0377-2-AM. Inspection of the delirium protective efficacy by the ramified microglia suvorexant internal use 石塚雅人1, 奥村知香2, 岡本和之1, 山内拓1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 857-857, 2019.

---

	P0379-2-AM. Comparison of ritodrine and the progesterone vaginal tablet which a canalis cervicis uteri shortening pregnant woman can put 日野光記枝1, 大橋健吾1, 吉田真也1, 宇佐美英積1, 吉村知哲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 858-858, 2019.

---

	P0381-2-AM. About the need that a pharmacist is associated with after initial diagnosis for the pregnant woman with suspected teratogenic increased risk 古久保有希子1, 辻亜紀1, 岡藤博2, 橋本奈美子2, 田中篤志3, 野村浩英1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 859-859, 2019.

---

	P0383-2-AM. Efforts to the mother's milk childcare support of the woman in childbed in the medical treatment in our hospital 村田文1, 新木美枝1, 安部和子2, 河野美幸3, 伊藤理廣2, 鈴木達宙1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 859-859, 2019.

---

	P0385-2-AM. Making of the administration drug table to a pregnant woman 七田和佳子1, 内藤哲哉1, 酒井義朗1, 樋口恭子1, 福江弘子1, 橋本温美1, 三輪涼子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 860-860, 2019.

---

	P0387-2-AM. Example that by having introduced the SAP therapy with the PLGS function into patients with 3 years old type I diabetes mellitus said to that it was hard to accept it from a nursery school, made possible going to kindergarten 石原祥子1, 水野彩1, 大谷寧次郎1, 畔柳敏弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 861-861, 2019.

---

	P0389-2-AM. Examination of the use situation of the SGLT-2 inhibitor of diabetes internal medicine, the circulatory organ internal medicine in our hospital 石橋真実1, 大森麻江1, 向井めぐみ1, 宮下雄博2, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 862-862, 2019.

---

	P0391-2-AM. Examination about the concomitant drug of the GLP-1 receptor agonist choice patients 井上稚枝子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 862-862, 2019.

---

	P0393-2-AM. About a change of HbA1c after the sustained blood sugar determination introduction in our hospital 近藤理美1, 田中祐子1, 岸本実優1, 喜多洋嗣1, 森智子1, 府川祥子1, 白木萌1, 市原麻友子1, 井上千尋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 863-863, 2019.

---

	P0395-2-AM. Report about the use situation of the ipragliflozin in our hospital 中山潤美1, 加藤まゆ1, 大谷寧次郎1, 畔柳敏弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 863-863, 2019.

---

	P0397-2-AM. About the course after having conducted sitagliptin weight loss about patients with moderate or severe impaired renal function 塚本名奈子1, 安居佐織1, 小西敦子1, 田路章博1, 南山啓吾1, 砂金秀美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 864-864, 2019.

---

	P0399-2-AM. Examination of the factor to have an influence on the dissection of eGFRcre and eGFRcys 山崎翔太1, 菅原浩介1, 鈴木英則1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 865-865, 2019.

---

	P0401-2-AM. The effect that the number of daily administration of ampicillin/sulbactam in patients with old pneumonia gives to the effectiveness 鈴木朋克1,2, 高橋京香2, 田島正教2, 杉山恵理花2, 吉井雅美1, 鈴木秀則1, 佐藤均2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 866-866, 2019.

---

	P0403-2-AM. Practice of fact-finding of the prescription inappropriate potentially using STOPP-J and the reporting to a physician 山田航輔1, 大久保駿一1, 笹木拓郎1, 岡本麻里子1, 横川祐美1, 船木映二1, 橋本義宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 867-867, 2019.

---

	P0405-2-AM. About the effect that polypharmacy measures in the normal business routine in the convalescent ward give in ADL 前田悠里1, 阪本久未子1, 樺木美香1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 867-867, 2019.

---

	P0407-2-AM. Efforts of the multiple drug prescription adequacy for the special elderly nursing home entering patients 上田由貴1, 稲垣芙美佳1, 山代栄士1, 川元崇志1, 宮村友梨子1, 平賀愛実1, 森一生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 868-868, 2019.

---

	P0409-2-AM. Examination about prescription fact-finding and the proper use of the laxative in our aging garden to go ahead through 阪元孝志1, 下地厚子1, 松原洋孝2, 知念一3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 868-868, 2019.

---

	P0411-2-AM. Comparison of the anesthesia management propofol buprenorphine fentanyl during atrial fibrillation ablation technique 木下照常1, 柴田大地1, 足立守1, 原田光徳2, 杢野晋司2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 869-869, 2019.

---

	P0413-2-AM. Effect to be vital, and to give after switching from transdermal type bisoprolol to the titer oral form 馬橋美由季1, 奥川寛1, 堀内望1, 野崎歩1, 小林由佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 870-870, 2019.

---

	P0415-2-AM. The prevention of recurrence prescription support that was carried out for atherothrombotic cerebral infarction and a cardioembolic concurrence case 原田百華1, 薬師寺寿世1, 河村聡志1, 森一生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 870-870, 2019.

---

	P0417-2-AM. The effectiveness of antiIL-5 monoclonal antibody medicine for the COPD with many blood eosinophil counts and antiIL-5 receptor α monoclonal antibody medicine and safe evaluation 山崎優1, 嶋田修治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 871-871, 2019.

---

	P0419-2-AM. Effect of treatment of the SGLT2 inhibitor for patients with heart failure that left ventricle shrinkage ability was maintained 堀部聖1, 猪野達也1, 瀬尾達朗1, 鈴木貴之1, 池上幸子1, 福本由美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 871-871, 2019.

---

	P0421-2-AM. Examination about the medication counseling of the Tokishakuyakusan for the anosmia 岩瀬裕治1, 小野恵美子1, 丹羽直人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 872-872, 2019.

---

	P0423-2-AM. Effect on pain that the acetaminophen administration from all over the operation in patients who underwent hip joint replacement gives 松井美月1, 須永登美子1, 神崎浩二2, 桑迫勇登3, 渡邊徹1, 佐々木忠徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 872-872, 2019.

---

	P0425-2-AM. Lipid management for patients with acute coronary syndrome based on arteriosclerotic disease prevention guidelines 2017 岩堀真弓1, 中田絵梨1, 八木遥1, 東修司1, 田畑裕和1, 稲垣育宏1, 小寺隆二1, 柴波明男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 873-873, 2019.

---

	P0427-2-AM. Practice of the polypharmacy measures by the multi-type of job collaboration team 越智大輔1, 木下玄子1, 大西順子1, 田中成枝1, 白石剛一1, 須々木健太郎1, 南薗淳1, 白髪恵美1, 村上雅基2, 田中陽子3, 中村和美4, 山崎宙5, 近藤祥代1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 873-873, 2019.

---

	P0429-2-AM. Blinding-related maintenance method at the formulations in the placebo-controlled double-blind randomized third phase controlled trial to test usefulness of olanzapine for CINV 秋山加菜1, 増島広幸1, 櫻井美満1, 石川寛1, 篠道弘1, 安部正和2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 874-874, 2019.

---

	P0431-2-AM. Visualization of the ethic examination necessity or not about the outside announcement of our hospital pharmacy 小川博史1, 川本晃男1, 川島弓枝1, 大隅規充1, 山本博美1, 友金幹視1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 875-875, 2019.

---

	P0433-2-AM. Characteristic and economic effect - of the checking prescription which assumed analysis - drug cancellation of the checking prescription in the ethical pharmacy results 海野茜1,2,3,4, 鈴木学1,2, 上田祐稀乃1, 林由依1, 味澤香苗1, 林秀樹1,2,3,4, 生木庸寛3, 小林篤史4, 小原道子3, 甲斐絢子4, 棚瀬友啓2, 杉山正1,2,3,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 876-876, 2019.

---

P0435-2-AM. Questionary survey about the multi-type of job cooperation patients support system utilizing the ICT for the setting type ventricular assist device wearing patients 河野紀子1, 菊田紋華1, 山田恵里1, 倉地茜1, 宮川泰宏1, 矢野亨治1, 佐伯純2, 池本千春2, 水野久美子2, 日比恵美子2, 相木一輝3, 後藤和大3, 竹内晴美4, 藤本和朗5, 六鹿雅登5, 碓氷章彦5, 近藤徹6, 奥村貴裕6, 室原豊明6, 笹山哲7, 野本愼一8, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 877-877, 2019.

---

	P0437-2-AM. Qualitative analysis ... by SCAT of current situation and problem - focus group about the cooperation with the pharmacist judging from Care manager 市之川彩花1, 竹平理恵子1, 小倉未来1, 有田悦子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 877-877, 2019.

---

	P0439-2-AM. Led by a relation - seamless for relaxation case to be hospitalized, and to be at home to the community medical care of the pharmacist in the Saiseikai young grass hospital and at-home visit practice - 宮永幸実1, 西野美沙1, 高梨明恵1, 仲田涼1, 小杉満孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 878-878, 2019.

---

	P0441-2-AM. Efforts to improvement in adherence of patients by the medicine medicine cooperation 工藤誠一朗1, 小笠未遥1, 森野太一1, 駒澤愛1, 多田知弘1, 久保悠1, 小財弘己1, 今田深雪1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 879-879, 2019.

---

	P0443-2-AM. About the problem on the prescription order system obtained from the doubt inquiry information of the outside Parliament prescription 廣井順子1, 早船真弘1, 肥沼理映子1, 藤波薫1, 羽瀬悟聖2, 平井健3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 880-880, 2019.

---

P0445-2-AM. Usefulness of the in front of hospitalization confirmation of the drug taking medicine which fixed its eyes on after construction - discharge of the medical cooperation to think about from a support task before hospitalization 久岡清子1, 増田博也1, 合田さやか1, 佐々木健志1, 澤口友紀1, 亀岡喬1, 大荒政志1, 間千晴1, 鹿沼奈央1, 川村大輔1, 坂本真衣1, 吉川真央1, 松浦亜里沙1, 井上萌1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 880-880, 2019.

---

	P0447-2-AM. For construction - medicine for drug control instruction duties medicine cooperation promotion utilizing eXChart - 深澤真実1, 兵藤沙耶1, 潟永安亘1, 草葉一友1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 881-881, 2019.

---

	P0449-2-AM. Efforts of the patients follow-up for the Lenvatinib remedy patients 津村紗代1, 井上光鋭1, 福江弘子1, 樋口恭子1, 三輪涼子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 881-881, 2019.

---

	P0451-2-AM. About making, the operation of "the doubt inquiry protocol in the outside Parliament prescription" 出口幾文1, 末永拓也1, 岩尾恭寛1, 工藤真裕1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 882-882, 2019.

---

	P0453-2-AM. Operational report of the outside Parliament prescription doubt inquiry simplification protocol 水野康平1, 喜多洋嗣1, 長濱藍1, 石井英之1, 久田潤平1, 三浦捺樹1, 宮川千珠1, 山中愛美1, 宇根良祐1, 喜友名侑舞1, 田仲祐子1, 棚田雅貴2, 濱口武司3, 松田絵理菜4, 南保智宏5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 882-882, 2019.

---

	P0455-2-AM. About operation of the doubt inquiry simplification protocol in the outside Parliament prescription 田中誠1, 甲斐達夫1, 中禮希咲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 883-883, 2019.

---

	P0457-2-AM. Questionary survey to the drugstore pharmacist about test value mention to outside Parliament prescription 喜多朝菜1, 石嶋麗1, 間瀬広樹1, 綿谷敏彦2, 村田世里子2, 齋藤讓一1, 秋山哲平1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 883-883, 2019.

---

	P0459-2-AM. Investigation of the inflection situation in the destination of the pharmacy management summary 宮川幸典1, 宮崎俊明1, 川村知子1, 筒井由佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 884-884, 2019.

---

	P0461-2-AM. Efforts to the anti-stress reinforcement of the pharmacist at disaster occurrence 角田健1, 小室治孝1, 喜古康博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 885-885, 2019.

---

	P0463-2-AM. Efforts in our hospital to make we accumulate a potentially serious medical errors report, and an incident report have degression 和田祐一郎1, 新居亜里沙1, 成田慧未1, 坂井裕美1, 穂積廣1, 加藤香奈1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 886-886, 2019.

---

	P0465-2-AM. Making of the management sheet of injection antimicrobial six drugs in the Chiba west general hospital 加藤紗耶香1, 香取哲哉1, 小林亜貴子1, 小川直紀1, 谷古宇修平1, 出雲貴文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 887-887, 2019.

---

	P0467-2-AM. Construction - of the monitoring system of corresponding - hospital preparation to high relative difficulty medical care support, pharmaceutical products off-label use 片岡晃一1, 白石佳世1, 平田歩1, 石田七生1, 石田智滉1, 伊東睦弘1, 上田真由美1,3, 北岡裕章2,3, 常風興平1, 門田亜紀1, 森田靖代1, 宮村充彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 887-887, 2019.

---

	P0471-2-AM. Efforts of the allergic cover suspicion drug control by the cooperation with the nursing department 橋本晴香1, 佐藤史織1, 菅田佳子1, 佐脇久美1, 陸丸幹男1, 原尻学志1, 森一生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 888-888, 2019.

---

	P0473-2-AM. Current situation investigation (2) of the medical therapy to have an influence on the aspiration pneumonia of elderly people 渡邊梓1, 西川満則1, 山本智也1, 大石雅子1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 889-889, 2019.

---

	P0475-2-AM. Fact-finding for the appropriate simple suspension method enforcement and future problem 大野峻1, 武田元樹1, 菊池健1, 角谷直志1, 尾又玲伊1, 相馬貴史1, 佐々木啓1, 鶴山辰1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 889-889, 2019.

---

	P0477-2-AM. The safety management report analysis of the pharmacy business trainee and medical safety education 佐瀬裕子1,2, 加藤能子1, 永田将司1, 鳥羽三佳代2,3, 尾林聡2, 高橋弘充1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 890-890, 2019.

---

P0479-2-AM. Factor analysis to give to an understanding degree, a global assessment of contents of the hospital business training based on student questionary survey and the significance 小島穂菜美1, 吉田都1, 内田享弘1, 桑原晶子1, 豊原朋子1, 濱宏仁1, 辻本勉1, 片岡和三郎1, 綿本有希子1, 田崎眞生1, 波多江崇2, 森山賢治1, 三木知博1, 篠塚和正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 891-891, 2019.

---

	P0481-2-AM. Attitude survey of the business training student about the perinatal medical care 曽我部直美1, 北畑智英1, 植松和子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 891-891, 2019.

---

	P0483-2-AM. Analysis - of the training contents which a student using upbringing 19th report - text mining of the pharmacist who carried the next generation learned 川端崇義1, 猪田宏美1, 久保和子1, 北村佳久1, 千堂年昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 892-892, 2019.

---

	P0485-2-AM. How does upbringing 20th report - student of the pharmacist carrying the next generation learn about "cancer" during business training? - 久保和子1, 川端崇義1, 猪田宏美1, 北村佳久1, 千堂年昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 892-892, 2019.

---

	P0487-2-AM. About a source of information using it for questionary survey - paper chase about study other than Buddhism Osamu at the time of the pharmacy student - 幡生あすか1, 上田幹子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 893-893, 2019.

---

	P0489-2-AM. Education contents of "an evaluation and the prescription suggestion of the medical treatment based on the case" evaluate prior learning for the hospital business training (the second report) 飛田夕紀1, 平山武司1,2, 厚田幸一郎2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 894-894, 2019.

---

	P0491-2-AM. Approach (cancer medical care domain) to train a specialty, an authorized pharmacist of the Kanagawa hospital pharmacist society 宮田広樹1,10, 菅原充広2,10, 縄田修一3,10, 原田知彦4,10, 湊川紘子5,10, 相澤康子6, 門谷靖裕7, 橋口宏司8, 厚田幸一郎2,10, 橋本真也9,10, 佐藤透10 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 895-895, 2019.

---

	P0493-2-AM. It is ... about efforts - high alert medicine of the pharmacy for the JCI certification 立石裕樹1, 宮津大輔1, 村田智弘1, 柏木亜子1, 横田沙紀1, 田中博和1, 井上幸子1, 平川雅章1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 896-896, 2019.

---

	P0495-2-AM. Findings report about a shape and the materials of the infusion solution bag 岡田圭史1, 隅田徹1, 石川元章1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 897-897, 2019.

---

	P0497-2-AM. Change of the prescription suggestion by the DST intervention after the dementia support team (DST) organization and activity start 宮城景1, 高本早希1, 北村悠里子1, 木村真策1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 897-897, 2019.

---

	P0499-3-AM. Intervention of the drugstore pharmacist for the dose adequacy of the renal excretion type DPP-4 inhibitor 入澤佑紀1, 恩田幸憲2, 石黒貴子2, 前田守3, 長谷川佳孝3, 月岡良太3, 森澤あずさ3, 大石美也3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 898-898, 2019.

---

	P0501-3-AM. It is (1) about the appropriate medication methods such as problems and OD tablets, and the like of the medication with the thickness agent of the eating deglutition person with a disability 倉本敦夫1, 島崎学2, 大越すみ江1, 五十嵐玲子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 899-899, 2019.

---

	P0503-3-AM. The effectiveness of the Residual medicine adjustment using the doubt inquiry simplification protocol 西岡茉奈1, 宮崎俊明1, 筒井由佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 899-899, 2019.

---

	P0505-3-AM. Epicritic evaluation - of the prescription product needing discontinuation before epicritic evaluation - surgery, examination of the tablet, capsule body 岩佐昌広1, 矢野忠1, 市川訓1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 900-900, 2019.

---

	P0507-3-AM. Application to the analysis of the doubt inquiry record and effective and safe medical therapy enforcement 大石美奈子1, 上田紘子1, 戸田史恵1, 山中佑合子1, 足立亜希子1, 幡生あすか2, 上田幹子2, 浦川龍太1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 900-900, 2019.

---

	P0509-3-AM. The factorial experiments of the in-hospital return of goods drug and future problem 野田絢子1, 加藤美樹1, 後藤裕美子1, 舟橋智美1, 手塚剛彦1, 大西正文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 901-901, 2019.

---

	P0511-3-AM. The effect that was obtained by adequacy of the emergency cart drug for household delivery of the radiation department 普賢淳子1, 神谷貴樹1, 星野伸夫1, 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 902-902, 2019.

---

	P0513-3-AM. Formula reconstruction of the fibrate drugs for convalescent rehabilitation wards 橋本貴史1, 金井紀仁1, 鈴木義人1, 宮崎美子2,3, 齋藤俊夫3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 902-902, 2019.

---

	P0515-3-AM. Correspondence of our hospital in the preparation supply stop for the cefazolin Na injection 弓長藤佳1, 廣田侑真1, 小沼大祐1, 神長雅浩1, 大塚知信1, 金田暁2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 903-903, 2019.

---

	P0517-3-AM. Examination about the incompatibility of the cocktail injection to use for pain relief after the total hip replacement (THA) 山内理恵1, 大野修司1, 中島りり子1, 井上信宏1, 久保元1, 竹場和代2, 川崎智子2, 北岡晃2, 浅井和範1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 904-904, 2019.

---

	P0519-3-AM. Introduction of the 1.6% peppermint suspension preparation in the endoscopy 米田奈美1, 白川敦規2, 末松直幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 905-905, 2019.

---

	P0521-3-AM. Investigation of the regulations temperature retention time of the para-cool injection drug under the room temperature environment 百瀬麻子1, 丹勝弘1, 安藤井達1, 木村元範2, 青森達2, 村松博2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 906-906, 2019.

---

	P0523-3-AM. An evaluation between the preparation of herbal medicinal products, the Kakkonto extract for the medical care: The difference in quantity of insoluble particulate matter in the water and ultrafine presence 稲葉一訓1,2, 福岡侑也1, 大竹裕子1, 井上知美1, 石渡俊二1, 小竹武1, 長井紀章1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 907-907, 2019.

---

	P0527-3-AM. Relation of the pharmacist in the Lenvatinib cecal fistula administration for hepatocytes cancer 久保靖憲1, 山本譲1, 大滝康一1,2, 三嶋一登1, 小野尚志1, 山下恭範1, 福土将秀1, 田崎嘉一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 909-909, 2019.

---

	P0529-3-AM. The making of the template of the drug management instruction record and examination about the usefulness 神原諒1, 山中理1, 杉山由紀子1, 中山英夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 909-909, 2019.

---

	P0531-3-AM. Evaluation - of the medical treatment protocol in importance - cataract surgery clinical path of the pharmacist participation for the clinical path operation 船戸裕樹1, 清水倫子1, 依岡千恵子1, 柳澤成佳1, 垣内綾乃1, 岡崎萌水1, 野村政孝1, 八木祐助1, 常風興平1, 門田亜紀1, 森田靖代1, 宮村充彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 910-910, 2019.

---

	P0533-3-AM. The case that was given blood sugar control of the type I diabetes mellitus children patient using three kinds of insulin preparation 福田葉月1, 井上和子1, 門脇美智子1, 加藤隆之1, 植木智美1, 島田美樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 910-910, 2019.

---

	P0535-3-AM. Examination - creatinine and cystatin C - of the operation pronephros usability test method of the cardiovascular surgery 伊藤悠里子1, 菅野貴寛1, 池上久貴1, 高野純希1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 911-911, 2019.

---

	P0537-3-AM. Examination about polypharmacy and a fall, the delirium in our center 竹林佳菜1, 中込哲1, 野呂竜太郎1, 田村亜優夏1, 坂上達也2, 江守沙奈恵3, 中村香織3, 熊木良太4, 池田敦1, 南郷栄秀5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 911-911, 2019.

---

	P0539-3-AM. Polypharmacy-related factor investigation 遠藤晋吾1,2, 山本圭城1, 安井友佳子1, 石坂敏彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 912-912, 2019.

---

	P0541-3-AM. We challenge medical therapy adequacy in a convalescent rehabilitation ward 伊藤真紀子1, 細木慈子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 912-912, 2019.

---

	P0543-3-AM. The first step of the efforts to make an adverse event evaded in protocol 宇佐美初雄1, 加藤洋介1, 櫻井英俊1, 前田直希1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 913-913, 2019.

---

	P0545-3-AM. Evaluation of the activity contents of the pharmacist in the heart failure team and the pharmaceutical management 三浦佳江1, 立岡美穂1, 岡崎美香1, 牧野華子1, 石原慎之1, 玉木宏樹1, 矢野貴久1, 大内武2, 佐藤寛大2, 遠藤昭博2, 田邊一明2, 直良浩司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 913-913, 2019.

---

	P0547-3-AM. About the intervention of the aspirin-containing drug rate of use and ward pharmacist to patients with acute myocardial infarction 成田桃子1, 村谷美帆1, 廣井順子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 914-914, 2019.

---

	P0549-3-AM. To realize ward drug duties to snuggle up to 1 ... patients about the importance of the ward round; ... 澤口友紀1, 井上萌1, 大荒政志1, 久岡清子1, 西村善也2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 914-914, 2019.

---

	P0551-3-AM. Efforts of our hospital for the polypharmacy correction 西川桃子1, 田中こずえ1, 上條美咲1, 福井圭亮1, 山下恵梨香1, 北野恵莉子1, 澤井陽1, 河邉瑶子1, 陶山美穂1, 松本友希1, 本田友生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 915-915, 2019.

---

	P0553-3-AM. The use situation of the morphine hydrochloride for the palliation of a feeling of dyspnea of patients with heart failure 前田朱香1, 曽我弘道1, 上村澪1, 波多江沙織1, 木原慶子1, 富田敏章1, 入江利行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 915-915, 2019.

---

	P0555-3-AM. Role of the ward pharmacist in the local inclusion care ward 宇賀尚子1, 川尻尚子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 916-916, 2019.

---

	P0557-3-AM. Through the pharmacist intervention at discharge in the orthopedics ward 高木春乃1, 石黒貴洋1, 彦坂紗世1, 生田知子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 916-916, 2019.

---

	P0559-3-AM. About the participation of the pharmacist in discharge prescription in the University of Occupational and Environmental Health Hospital mixture ward 川道直子1, 稲村由香1, 竹中美紗1, 篠原義剛1, 植木哲也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 917-917, 2019.

---

	P0561-3-AM. The development of the medication confirmation check seat for safe enforcement of surgery, the examination in the stroke care unit and the usefulness 福田裕子1, 伊東里紗1, 森あやか1, 今井裕美3, 井岡瑞樹子1, 道下佳子1, 稲場純子1, 池野智子2, 冨家幸子2, 長谷川由美子2, 田中雅美2, 酒井和江2, 中藏伊知郎1, 北澤文章1, 辻川正彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 917-917, 2019.

---

	P0563-3-AM. Relation of the pharmacist in the intensive care unit 湯村健一1, 佐野邦明1, 上野正夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 918-918, 2019.

---

	P0565-3-AM. For measures establishment of nausea post-operative vomiting in our hospital 濱浦弘光1, 高橋弘泰1, 大谷寧次郎1, 畔柳敏哉1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 919-919, 2019.

---

	P0567-3-AM. Content analysis of the ward drug duties for the bacteremia case during intensive care unit (ICU) admission 大山翔1, 澤田真嗣1,2, 中西裕明1, 藤田将輝1,2, 村木優一3, 岡橋孝侍1, 藤田敦夫1, 友金幹視1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 919-919, 2019.

---

	P0569-3-AM. Construction ... of the cooperation system of efforts first report - perinatal ward and NICU to drug control instruction in the NICU 湖城由佳1, 丹沢彩乃1, 三浦寄子1, 柳下祥子1, 川崎裕世1, 三大寺紀子1, 高山寿里1, 石井真理子1, 山谷明正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 920-920, 2019.

---

	P0571-3-AM. Blood pressure fluctuation and the postoperative acute nephropathic evaluation that angiotensin converting enzyme inhibitors, an angiotensin receptor blocker in the perioperative period gives 大柿佳織1, 豊島慶太1, 枦秀樹1, 山本涼子1, 太田哲徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 920-920, 2019.

---

	P0573-3-AM. About efforts and the problem of the pharmacist in the hospitalization and release support center 植松夏子1, 桜井美咲子1, 加藤潤1, 近藤有1, 戸田州俊1, 間瀬悟1, 井上健1, 三宅芳男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 921-921, 2019.

---

	P0575-3-AM. Efforts and evaluation of the hospitalization and release support room in our hospital 加藤幸三1, 山垣貴士1, 清水豊子1, 岡本卓也1, 島村圭二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 922-922, 2019.

---

	P0577-3-AM. Usefulness evaluation of the pharmacist outpatient department intervention in the Lenvatinib therapy for the hepatocellular carcinoma 高橋克之1, 高橋正也1, 打田佐和子2, 周防舞仁2, 小田桐直志2, 吉田香奈子2, 小谷晃平2, 元山宏行2, 萩原淳司2, 藤井英樹2, 森川浩安2, 榎本大2, 田守昭博2, 河田則文2, 永山勝也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 922-922, 2019.

---

	P0579-3-AM. The role of the pharmacist in the diabetes dialysis prevention outpatient department and future problem 佐藤淳子1, 田杭直哉1, 菅谷量俊1, 高瀬久光1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 923-923, 2019.

---

	P0581-3-AM. The need of the continuation instruction in the pharmacist diabetes instruction outpatient department 中村敏史1, 大屋有夏2, 福岡一貴2, 高橋典男2, 吉田昌則2, 池上信昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 923-923, 2019.

---

	P0583-3-AM. Treatment support in the pharmacist outpatient department and the effect on patients with inflammatory bowel disease 中村健志1, 平町隆明1, 石原慎之1, 西村信弘2, 玉木宏樹1, 矢野貴久1, 直良浩司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 924-924, 2019.

---

	P0585-3-AM. Efforts for the prevention of nausea post-operative, vomiting by the collaboration of an anesthesiologist and the pharmacist 西村瑞紀1, 高橋真理1, 武田康平1, 今浦将治1, 永瀬怜司1, 菅規久子2, 佐藤智行2, 澤柳ユカリ3, 谷口英喜3, 菅野浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 924-924, 2019.

---

	P0587-3-AM. The change of hospitalization and release support center duties 小宅典子1, 井口恵美子1, 猪股克彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 925-925, 2019.

---

	P0589-3-AM. Investigation of the inoculation situation of the influenza vaccine of the patients whom antiinfluenza medicine was prescribed for at Qol drugstore and the disease severity 池貴幸1,2,3, 高橋渉2, 板垣幸太郎2, 笹原侑祐3, 長沼未加2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 926-926, 2019.

---

	P0591-3-AM. Result of the management that we continued a balun strike scorecard in the Yokohama General Hospital and used 高田啓介1, 廣瀬直樹1,2, 倉田武徳1, 稲垣和幸1, 仙内光子1, 小町和樹1, 長屋美香子1, 佐村優1, 関根寿一1, 金田昌之2, 佐藤透3, 赤瀬朋秀4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 927-927, 2019.

---

	P0593-3-AM. Of the drug information for data-processing it 奥野真里絵1, 松本泰子1, 大谷優希1, 蛭谷一彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 928-928, 2019.

---

	P0595-3-AM. Pulse-taking of the number of generic name prescription accompanied with the prescription order system update 松山真範1, 河崎尚史1, 北島正大1, 名村隆2, 金桂洙3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 929-929, 2019.

---

	P0597-3-AM. The relative examination of α 1 receptor blockade and the faint using FAERS: Difference due to concurrent disease 大山勝宏1, 堀祐輔1, 杉浦宗敏1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 930-930, 2019.

---

	P0599-3-AM. Evaluation of the tendency to adverse event expression of the D-VRd therapy using the correspondence analysis 堀口悠太1, 向井淳治1,2, 坂本竜平1, 小竹優希1, 竹原涼子1, 奥田広志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 931-931, 2019.

---

	P0601-3-AM. 2 cases that a pharmacist was associated with about a tuberculosis therapeutic drug prescribed abroad 白川敦規1,2, 米田奈美1, 末松直幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 931-931, 2019.

---

	P0603-3-AM. Examination of the new antiepileptic drug utilizing big data 定作奈津美1, 高橋志門2,3, 武智研志4, 中馬真幸4, 合田光寛3, 座間味義人2,3, 石澤有紀5,6, 堀ノ内裕也6, 池田康将6, 土屋浩一郎7, 石澤啓介2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 932-932, 2019.

---

	P0605-3-AM. About formula remaking being aware of emergency correspondence in the municipal hospital 岡田七津子1, 森田徹1, 市田千佳1, 高橋賢成1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 932-932, 2019.

---

	P0607-3-AM. Efforts and the use of antimicrobial situation investigation for antimicrobial proper use in our hospital 古賀みゆ1, 山村梨菜1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 933-933, 2019.

---

	P0609-3-AM. Comparison about the long-term use situation and the patients background factor of the sitagliptin in the outpatient and the linagliptin 安藤暢彦1, 近藤真由1, 上前里香1, 岩武幹乃1, 木本秀樹1, 三村英恵1, 大石丸美1, 上地純子1, 白石貴寿1, 中村泰士1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 934-934, 2019.

---

	P0611-3-AM. The use situation investigation for the non-cancerous pain of the opioid analgesic patch in our hospital 澁谷恵美子1, 石田詞子1, 小野達也1, 西田英之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 934-934, 2019.

---

	P0613-3-AM. Use of opioid preparation fact-finding for dyspnea in patients with terminal heart failure 中村眞梨1, 芝崎由美子1, 中村智弘2, 野村淳1, 石田岳史2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 935-935, 2019.

---

	P0615-3-AM. Use fact-finding (the second report) of the pain therapeutic drug of patients with amyotrophic lateral sclerosis 北川莉穂1, 石田奈津子1, 八田裕之2, 座光寺伸幸3, 蛭谷牧子3, 山本吉章4, 鈴木亮平5, 花満裕6, 菅幸生1, 石崎純子1, 松下良1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 935-935, 2019.

---

	P0617-3-AM. About the use actual situation of the morphine hydrochloride note for patients with heart failure in our hospital 榊原洋一1, 伊藤実優1, 平野貴志1, 吉川直利1, 永松秀紹1, 横田学1, 村上照幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 936-936, 2019.

---

	P0619-3-AM. Risk factor analysis of the inhalational maneuver error in patients with bronchial asthma 大隅智之1, 小室治孝1, 田中大1, 西川正憲2, 喜古康博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 936-936, 2019.

---

	P0621-3-AM. Use experience of hepatitis C therapeutic drug Glecaprevir/Pibrentasvir combination drug in our hospital 江原美里1, 宮城和代1, 宮部貴識1, 佐光留美1, 山内一恭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 937-937, 2019.

---

	P0623-3-AM. The use situation investigation of DOAC for the venous thromboembolism 洲山佳寛1, 菅原隆文1, 吉川明良1, 開浩一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 937-937, 2019.

---

	P0625-3-AM. It is ... through way - health Festival of the pharmacist whom we saw from the attitude survey of local inhabitants 長谷川雅紀1, 芦川春菜1, 福本康之1, 川上典子1, 近藤昌子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 938-938, 2019.

---

	P0627-3-AM. It is ... for construction of the drug protocol that a risk in effect - Tomigusuku center Hospital of the sleeping drug in a fall, the fall patients was considered 平識善彦1, 宮良遥奈1, 赤嶺千秋1, 國分千代1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 938-938, 2019.

---

	P0629-3-AM. Sex differences in the association with an oral anticoagulant drug and the osteoporosis 横山聡1, 長野未来1, 岩瀬真1, 細見光一1, 高田充隆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 939-939, 2019.

---

	P0631-3-AM. Fact-finding of the combination drug rate of use that planned drug costs reduction 浜園龍1, 岩下佳敬1, 薗田晃弘1, 中尾承司1, 兒玉麻代1, 高田侑那1, 久永あゆみ1, 森永知沙1, 上堀正博1, 柴田奨1, 岩下裕美1, 石田和久1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 940-940, 2019.

---

	P0633-3-AM. Effect to give medical expenses reduction effect and institution profit by DVO 橋本浩季1, 村上通康1, 宮崎実千芸1, 山口恭平1, 仙波昌三1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 940-940, 2019.

---

	P0635-3-AM. The medication situation of patients with stroke that we examined from on admission bringing medicine 押尾洋佑1, 高橋美咲2, 有山智博2, 田中博之2, 山本加奈子1, 深山歩美1, 亀田大介1, 矢吹優圭1, 羽山紗樹乃1, 鈴木知佳1, 本多佳也1, 朝生弓実1, 高橋佐和士1, 石井敏浩2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 941-941, 2019.

---

	P0637-3-AM. The back direction multicenter study of the prescription background associated with the polypharmacy in elderly people 早川裕二1, 溝神文博1, 鈴木亮平2, 平野淳3, 間瀬広樹4, 平野隆司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 942-942, 2019.

---

	P0639-3-AM. Efforts to the safe medical treatment that conducted bringing medicine differentiation in the hospitalization and release support center 浦更紗1, 小迫晶寛1, 上村豪1, 植村隆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 942-942, 2019.

---

	P0641-3-AM. Effect on protective efficacy of the high hardness deep-ocean water for the inflammatory bowel disease and gut flora 長澤一樹1, 河本実季1, 浅田あゆみ1, 大嶋廉之1, 宮永佳代1, 鈴木杏1, 安川岳志2, 森本博俊2, 魚住嘉伸2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 943-943, 2019.

---

	P0643-3-AM. Elderly people purchasing trend of the sleep improvement medicine using the ID-POS data of the drugstore and the problems 小林華奈1, 菊池千草1,2, 渡邊崇2,3, 鈴木匡1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 944-944, 2019.

---

	P0645-3-AM. Safe comparison between starting pharmaceutical products and generic medicine in the docetaxel 川原裕1, 山下千草1, 佐野雅昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 945-945, 2019.

---

	P0647-3-AM. Consideration - from attenuation - elution behavior of the effect of treatment by changes from the starting pharmaceutical products of mesalazine tablets to generic medicine 原田恭江1, 細川宜嗣1, 軸原温2, 平岡憲侍3, 羽山薗泉3, 五郎丸剛3, 前田頼伸3, 江藤精二3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 946-946, 2019.

---

	P0649-3-AM. Examination about the effectiveness and the safety of the filgrastim bio follower product in patients with recurrence, intractable malignant lymphoma 奥野護1,2, 関菜摘子2, 五百蔵武士2, 丹田雅明2, 西岡達也2, 久米学2, 槇本博雄2, 矢野育子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 947-947, 2019.

---

	P0651-3-AM. The improvement of vascular pain measures at the dacarbazine administration and the effect 緑川智代1, 白石童子1, 福地祐司2, 竹下光弘1, 早乙女浩之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 948-948, 2019.

---

	P0653-3-AM. About the expression situation and a risk factor of immune-mediated adverse event (irAE) by nivolumab and the Pembrolizumab 道貝優太1, 坂東香織1, 飯田美紅1, 友寄旬1, 坂本和央1, 棚谷貢1, 桂川みき1, 鈴木千波1, 小原秀治1, 小原郁司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 949-949, 2019.

---

	P0655-3-AM. One patient whom systemic erythema multiforme developed in during Abemaciclib administration 杉原弘記1, 樫野かおり2, 岡田昌浩1, 岡本伸也1, 村上史承1, 岡崎和子1, 田代操1, 川真田修3, 竹井英介1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 949-949, 2019.

---

	P0657-3-AM. The side effect expression of immune checkpoint inhibitor situation 森本奈緒美1, 星田唯史1, 藤原大一朗1, 眞下惠次1, 和田祥明1, 野田明宏1, 多喜和夫1, 阪口勝彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 950-950, 2019.

---

	P0659-3-AM. Analysis of the risk factor of the MTX excretion delay with the a large quantity of methotrexate (MTX) therapy for the central nervous system origin malignant lymphoma 今井雄介1, 田中雅幸1, 藤井良平1, 打谷和記1, 村中達也1, 岡崎和一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 950-950, 2019.

---

	P0661-3-AM. Example that caused serious hypomagnesemia during cisplatin for the intraarterial injection and the liver arterial infusion chemotherapy enforcement using 5-fluorouracil 山崎直希1, 佐藤圭吾1, 西和哉1, 藤坂泰之2, 赤羽武弘2, 佐賀利英1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 951-951, 2019.

---

	P0663-3-AM. The onset of adverse event situation in the immune checkpoint inhibitor 作山悠里1, 上森美和子1, 星野茂則2, 米田勉2, 杉浦孝司3, 黒川幸典4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 951-951, 2019.

---

	P0665-3-AM. Examination of the hyperuricaemia with pyrazinamide 小坂隆介1, 則松郁香1, 山崎貴史1, 三浦麻耶1, 桑原貴美子1, 鈴田浩孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 952-952, 2019.

---

	P0667-3-AM. One case that caused drug-related renal failure in intra-medullary antibiotics perfusion (iMAP) using the gentamicin sulfate injection (GM) 宮内英俊1, 加賀正基1, 山内拓1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 952-952, 2019.

---

	P0669-3-AM. Examination of the inhibitory effect for the indometacin-induced gastric ulcer by the nutrient for intestinal administration 吉見猛1,2, 須田恵1, 金川一成1, 齊木玲1, 合田ひとみ1, 山岸喜彰1, 工藤敏之1, 伊藤清美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 953-953, 2019.

---

	P0671-3-AM. One case that vildagliptin caused pemphigoid 東里美1, 永松翔1, 岩下龍史2, 寺口記代2, 上山逹典2, 寺師守彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 953-953, 2019.

---

	P0673-3-AM. 1 case of the Gitelman syndrome which became the QT prolonged by clarithromycin 高橋雄也1, 森本健幹1, 竹内陽亮1, 宮脇洋平1, 長嶋裕樹1, 米田託成2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 954-954, 2019.

---

	P0675-3-AM. Risk factor analysis of the onset of acute renal failure by the Edaravone 松山淳史1,2, 八牟禮沙織1, 國師奈緒美1, 岩元美樹1, 木下大夢1, 橋本直美1, 帖佐弘子1, 神田直昭2, 鬼丸俊司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 954-954, 2019.

---

	P0677-3-AM. 1 case with suspected autoimmune hepatitis onset type I by isoniazid internal use 川原茉莉1, 脇田恵里1, 伊藤洋貴1, 佐藤賛治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 955-955, 2019.

---

	P0679-3-AM. About a risk factor of the deep vein thrombosis embolism in the artificial joint replacement 谷聡美1, 吉田昭昌1, 山本宏1, 宗政充2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 955-955, 2019.

---

	P0681-3-AM. Examination of the factor in the circadian rhythm of Xanthine oxidase and xanthine dehydrogenase 喜多智生1, 西村さとみ1, 田山剛崇1, 岡村友理香2, 大松秀明1, 覚前美希1, 前田志津子1, 佐和章弘1, 三宅勝志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 956-956, 2019.

---

	P0683-3-AM. Application to a search and the administration plan of the factor influencing an internal change of the levetiracetam 佐々木祐樹1, 荒井希文1, 大場延浩2, 福岡憲泰2, 菊池憲和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 957-957, 2019.

---

	P0685-3-AM. Physiologic pharmacokinetics model analysis of the rise in Esomeprazole and blood proguanil levels by the vonoprazan combination 大久保健二郎1, 石本麻帆1, 中内佳奈1, 田中亜希実1, 中林勇1, 合田ひとみ1, 舟越亮寛2, 山岸喜彰1, 工藤敏之1, 伊藤清美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 958-958, 2019.

---

	P0687-3-AM. One case with suspected blood level change by the interaction of tacrolimus and the fat-containing enteral feeding product 手塚千裕1, 佐藤祐司1, 小林大典1, 前嶋隆弘1, 小倉次郎1, 佐藤真由美1, 前川正充1, 眞野成康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 959-959, 2019.

---

	P0689-3-AM. 1 case that became able to be controlled by the adjustment of the concomitant drug for blood voriconazole levels abnormality high level 赤羽理也1, 平大樹1,2, 磯野哲一郎1, 森田真也1, 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 959-959, 2019.

---

	P0693-3-AM. Examination of the effect with the concomitant drug on effect of the immune checkpoint inhibitor in the non-small cell lung cancer 三浦華歩1,3, 佐野慶行1, 川澄賢司1, 望月伸夫1, 仁保誠治2, 葉清隆2, 松本慎吾2, 善家義貴2, 宇田川響2, 桐田圭輔2, 池田喬哉2, 後藤功一2, 川崎敏克1, 花田和彦3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 960-960, 2019.

---

	P0695-3-AM. Examination about the factor affecting the NICU, the blood level of vancomycin in the GCU ward hospitalization case 星島祐美子1, 田頭尚士1, 平澤裕美子1, 上野杏菜1, 山本宏1, 影山操2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 961-961, 2019.

---

	P0697-3-AM. Initial administration plan analysis of the glycopeptide-based antimicrobial in the Kurume University Hospital 内藤哲哉1, 酒井義朗1, 七田和佳子1, 岩見修一1, 内田貴之1, 鈴木美佳1, 三輪涼子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 962-962, 2019.

---

	P0699-3-AM. Fact-finding of the loading dose method of the Teicoplanin in Juntendo Clinic attached to the Juntendo University faculty of medicine 岡村美里1, 笹野央1, 吉澤寿宏1, 松本博志1, 青嶋瑞樹1, 佐藤邦義1, 荒川隆太郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 962-962, 2019.

---

	P0701-3-AM. Examination of vancomycin doses in patients with blood-forming organ tumor 島田泉1, 小林敬裕1, 小林将文1, 鈴木直人1, 外山聡1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 963-963, 2019.

---

	P0703-3-AM. Is the nourishment evaluation useful in a VCM doses prediction? 北條文啓1, 太田口義智1, 菊田燎1, 中野洸大1, 宗田一記1, 猪狩政則1, 佐久間淳一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 963-963, 2019.

---

	P0705-3-AM. Examination of the effect on initial administration plan of the vancomycin note by the difference in different software 門脇督1, 小笠原綾香1, 能登数馬1, 亀井浩二郎1, 三本松泰孝1, 佐藤弘康1, 和泉秀明1, 田村広志1, 渡辺浩明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 964-964, 2019.

---

	P0707-3-AM. Participation of the pharmacist for the cumulative dose grasp of the anthracycline anticancer agent 松谷直樹1, 中山潤平1, 岡安伸晃1, 内田隆通1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 965-965, 2019.

---

	P0709-3-AM. Efforts of our hospital in the regimen management using the electronic medical chart system of the cancer medical therapy in childhood blood-forming organ tumor 薮内絵里加1, 西山徳人1, 今井雄介1, 藤井良平1, 田中雅幸1, 打谷和記1, 村中達也1, 岡崎和一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 966-966, 2019.

---

	P0711-3-AM. Examination of early detection of Oxaliplatin hypersensitivity and the initial correspondence 谷口潤1, 橋本雅司2, 尾之江剛樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 967-967, 2019.

---

	P0713-3-AM. Fact-finding of the tracing report operation situation in the cancer domain 川澄賢司1, 中嶌明香1, 佐藤信恵1, 久松大祐1, 松井礼子1, 川崎敏克1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 968-968, 2019.

---

	P0715-3-AM. About making of the representation input protocol of the examination of the cancer chemotherapy item in a digestive organ, the surgery ward 西村栄一1, 近藤智幸1, 簑島弓未子1, 荻野健吾1, 斎藤芳敬1, 鈴木正樹1, 牧瀬英知1, 白府敏弘1, 橋本光生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 968-968, 2019.

---

	P0717-3-AM. It is introduction ... of ... closed system anesthesia administration route "BD F seal (TM) spikes set" for CSTD introduction to all anticancer medicine 横山敦1, 橋口宏司1, 平賀久仁子2, 佐伯朋哉1, 石田梨沙1, 佐藤佑美2, 木村真美2, 上原万里奈2, 神谷武伺1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 969-969, 2019.

---

	P0719-3-AM. Change of the injectable anticancer agent multiple consumption by the closed system anesthesia connection appliance introduction 若松俊希1, 鈴木由紀子1, 草野元1, 松田明宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 970-970, 2019.

---

	P0721-3-AM. Effect of the closed system anesthesia preparation appliance introduction to all anticancer agents in anticancer agent exposure measures 田頭尚士1, 田坂友紀1, 串田康弘1, 吉田昭昌1, 山本宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 970-970, 2019.

---

	P0723-3-AM. Examination of the actual situation of the Residual medicine destruction in the anticancer medicine preparation and the multiple use 守屋昭宏1, 宇佐美英績1, 廣瀬達也1, 竹中翔也1, 浅野裕紀1, 岡田和智1, 吉村知哲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 971-971, 2019.

---

	P0725-3-AM. Closed system anesthesia connection appliance compatibility evaluation in the company anticancer medicine lineup 吉田智子1, 前澤早苗2, 戸田麗香2, 高橋史章1, 高野聡之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 971-971, 2019.

---

	P0727-3-AM. The total drug dose upper limit measures of the anthracycline anticancer agent 藤井友和1, 澤柳直樹1, 西川隆一1, 荒木寛也1, 坂柳悦章1, 鈴木宏2, 辻博幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 972-972, 2019.

---

	P0729-3-AM. It is the investigation about the therapy choice of patients in the adjuvant chemotherapy after the colon cancer technique 木下英樹1, 藤田亜弓1, 平尾郁1, 尼崎正路1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 973-973, 2019.

---

	P0731-3-AM. About importance of the current situation and the pharmacist intervention of the Obinutuzumab + bendamustine therapy in our hospital 橋本直美1, 堀口大輔1, 帖佐弘子1, 鬼丸俊司1, 中野伸亮2, 伊藤能清2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 973-973, 2019.

---

	P0733-3-AM. Investigation of the use situation of the G-CSF preparation in our hospital 篠原美紀1, 赤堀真佑子1, 川合麻未1, 山内拓1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 974-974, 2019.

---

	P0735-3-AM. Pharmaceutical products proper use for the digestive organ symptom improvement effect of olanzapine 畑賢太1, 斉藤俊英1, 神垣輝美1, 藤村拓也1, 相馬まゆ子1, 今田愛也1,2, 佐々木洋一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 975-975, 2019.

---

	P0737-3-AM. An effect of aprepitant on chemotherapy-induced retching, vomiting in the CHASER therapy and safe examination 大橋邦央1, 眞弓健介2, 藤田強記2, 横田千明2, 松元俊博1, 大久保博史1, 三角紳博1, 中川義浩2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 975-975, 2019.

---

	P0739-3-AM. Examination of the expression situation and the risk factor of the hypersensitivity reaction with oxaliplatin 大森義朗1, 藤井佑実1, 國次葉月1, 佐藤真也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 976-976, 2019.

---

	P0741-3-AM. Hypothyroidism during lenalidomide therapy: Observational, prospective study 奥野雅樹1, 土手賢史1, 小林由佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 977-977, 2019.

---

	P0743-3-AM. One case of the squamous cell carcinoma of lung which showed a rise of PT-INR by warfarin and the interaction of the Tegafur gimeracil oteracil potassium combination drug 間瀬広樹1, 有原大貴1, 新屋智之2, 北俊之2, 秋山哲平1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 977-977, 2019.

---

	P0745-3-AM. Fact-finding of the use of Palbociclib in the Shonan Kamakura General Hospital 星吉行1, 島愛美1, 長岡和徳1, 門谷靖裕1, 中村雅敏1, 下山ライ2, 永田好香3, 田中久美子3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 978-978, 2019.

---

	P0747-3-AM. Examination about drug instruction contents at EGFR-TKIswitching 中村俊之1, 大岡千寿子1, 野洌孝二1, 小室太郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 978-978, 2019.

---

	P0749-3-AM. Examination about the effectiveness of the S-1 imbalance administration in patients with colon cancer and the safety 岩田一史1, 合澤啓二1, 小野達昌1, 陣上祥子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 979-979, 2019.

---

	P0751-3-AM. Search of the factor predicting tolerability of the oxaliplatin combination chemotherapy for patients with elderly people gastric cancer 小池尚弘1, 奈良克彦1, 山本武人1,2, 高田龍平1, 鈴木洋史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 979-979, 2019.

---

P0753-3-AM. Examination of antibacterial in front of pharmaceutical affair prescription for the febrile neutropenia during adjuvant chemotherapy after in front of art, the operation and an usefulness evaluation and the proper use of the G-CSF preparation prophylaxis 野田祐紀子1, 鍛治園誠2, 北村佳久1,2, 千堂年昭2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 980-980, 2019.

---

	P0755-3-AM. The infusion reaction expression situation investigation in PER/HER combination therapy and examination of the expression risk factor 成岡里紗1,2, 中垣繁2, 中條倫成2, 内田亮2, 浅原慶徳1, 木村緑2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 980-980, 2019.

---

	P0757-3-AM. - that the check system utilizing efforts - PBPM in the study implementation for immune-mediated adverse event early detection provides safe chemotherapy 鈴木敦詞1, 伊東沙紀1, 福井悠美1, 村山まりこ1, 前田剛司1, 服部芳明1, 坂田洋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 981-981, 2019.

---

	P0759-3-AM. Investigation of a volume of infusion and the use in cisplatin treated patients of furosemide injection 佐々木好美1, 樋口美奈子1, 児玉沙奈恵1, 和田依子1, 山口竜司1, 檜山智子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 981-981, 2019.

---

	P0761-3-AM. A serious neutropenia in the ramucirumab + paclitaxel combination therapy for the progress recurrence stomach cancer and prognostic association 川嵜真太郎1, 宇佐美英績2, 木村美智男2, 祖父江伸匡1, 堀敦雄1, 吉村知哲2, 西嶋長1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 982-982, 2019.

---

	P0763-3-AM. Cause by 1 case - literature documentation that anticholinergic drug administration to dysarthria with the FOLFIRINOX therapy was invalid and examination ... of measures 後藤敏也1, 高屋敷奈々1, 正木銀三1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 982-982, 2019.

---

	P0767-3-AM. Examination of the prescription actual situation of the allopurinol gargle water for stomatitis due to fluorouracil and the protective efficacy 東郁子1, 大塚亮1, 矢内貴子1, 橋本浩伸1, 関口昌利1, 近野健一1, 牧野好倫1, 山口正和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 983-983, 2019.

---

	P0769-3-AM. One case that resulted in disturbance of consciousness due to the hyperammonemia after 5-FU + nedaplatin administration for patients with chronic renal failure merger cancer of the esophagus 山本泰大1, 原田雄太2, 大西克浩1, 櫻井愛菜1, 奥村允基1, 平井孝典2, 宮田章弘2, 戸田康裕1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 984-984, 2019.

---

	P0771-3-AM. Effective and safe evaluation of the dexamethasone with the Abiraterone ester acetate (ZYTIGA tablets) 立沢正臣1, 金城直樹1, 金素安1, 坂本善郎2, 住吉正孝1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 984-984, 2019.

---

	P0773-3-AM. Investigation about the side effect frequency of the immune checkpoint inhibitor in the Saint servant Mikatagahara Hospital 井口晴加1, 赤堀真佑子1, 川合麻未1, 山内拓1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 985-985, 2019.

---

	P0775-3-AM. The use situation investigation of the naldemedine for the use of mild cathartic guideline making, examination report 茂原圭佑1, 岡田悠美1, 中川隼一1, 櫻井彩乃1, 高橋真一2, 秋本純矢1, 皆川卓也1, 蔭山博之1, 平島徹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 986-986, 2019.

---

	P0777-3-AM. 1 case that tapentadol showed an effect for neuropathic pain 糸永昇平1, 小山田純治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 987-987, 2019.

---

	P0779-3-AM. Somnolence is an example with difficulties for pain control by a cause 堀敦雄1, 橋本拓郎1, 藪田翼1, 西嶋長1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 987-987, 2019.

---

	P0781-3-AM. A clinical benefit of hydromorphone for the respiratory symptom relaxation of patients with cancer: We look at the single institution rear and examine a mark 守作美咲1, 伊藤佳織1, 覚前有希子1, 牧原俊康1, 山田成樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 988-988, 2019.

---

	P0783-3-AM. Examination for the use situation of the hydromorphone hydrochloride parenteral injection and the usefulness 井上敦介1, 岡本明子2, 田中奈桜1, 杉山喜久1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 988-988, 2019.

---

	P0787-3-AM. About effect by the difference in dose at the anticancer agent initial administration in elderly people 澤柳直樹1, 坂柳悦章1, 荒木寛也1, 西川隆一1, 藤井友和1, 辻博幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 990-990, 2019.

---

	P0789-3-AM. Investigation, examination of the onset of clot situation in anticancer medicine-treated patients 田島実弥1, 三角紳博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 990-990, 2019.

---

	P0791-3-AM. Investigation about the dysfunction thyroid in the treatment with immune checkpoint inhibitor 小泉綾乃1,2, 藤堂真紀1, 蝦名彩也佳1, 中島理津子2, 石川詩帆1, 眞壁秀樹1, 栗原進2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 991-991, 2019.

---

	P0793-3-AM. Use of Olaparib situation in our hospital and adverse event expression investigation 高原悠子1, 吉田弘樹1, 鈴木雅人1, 牧原明秀1, 三屋良太1, 木全司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 991-991, 2019.

---

	P0795-3-AM. We look at the ramucirumab for patients with unresectable progress recurrence stomach cancer and neutropenia in the paclitaxel combination therapy and the rear about the effect of treatment and examine a mark 桂川健司1, 荒川裕貴1, 高取裕司2, 後藤美穂1, 遠山幸男1, 久田達也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 992-992, 2019.

---

	P0797-3-AM. Investigation about the injection site reaction with the azacitidine hypodermic injection 藤田強記1, 高武嘉道2, 鶴崎泰史1, 花田聖典1, 中川義浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 992-992, 2019.

---

	P0799-3-AM. Fact-finding of the immune-mediated adverse event with the immune checkpoint inhibitor in our hospital 嶋戸理子1, 渡瀬美登里1, 柏田匡広1, 大石貴裕1, 池田浩和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 993-993, 2019.

---

	P0801-3-AM. Search of the predictor of the severity of anemia by the Olaparib 久保果央莉1, 黒田真希1, 玉木慎也1, 田中寛之1, 橋下浩紀1, 遠藤雅之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 993-993, 2019.

---

	P0803-3-AM. The use of Pembroliazumab situation in our hospital: Change after unifying an effect, an adverse event, routine examination items 石崎文子1, 相原敏彦1, 増尾昌則1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 994-994, 2019.

---

	P0805-3-AM. Analysis according to the mutation in the gene of the side effect of EGFR-TKI given to patients with EGFR mutation in the gene-positive lung cancer 有山智博1, 滝澤苑美1, 菅野裕一朗2, 磯部和順3, 石井敏浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 994-994, 2019.

---

	P0807-3-AM. Example that developed acute renal failure in the nivolumab administration first time that became the problem submission of measures of irAE in our hospital 杉崎涼子1,2,3,4, 種市亜澄2, 綾部由紀乃1, 但木太3, 清家和裕4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 995-995, 2019.

---

	P0809-3-AM. The case that produced serious myelosuppression with Tegafur/uracil combination drug 宮田智陽1, 篠原佳祐1, 関口展貴1, 吉池麻衣1, 杉山昌秀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 995-995, 2019.

---

	P0811-3-AM. Analysis of the occurrence of adverse event in the Lenvatinib and the factor 中島隆良1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 996-996, 2019.

---

	P0813-3-AM. Examination of the cancer chemotherapy enforcement situation within 30th before death in patients with our hospital cancer 鈴木拓也1, 佐藤真生1, 石栗由佳2, 伊藤勇樹2, 西崎初美2, 篠原一宏1, 磯部宏3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 996-996, 2019.

---

	P0815-3-AM. The qualitative test of urine protein in patients receiving neovascularisation inhibitor and study on correlation of the protein urine/creatinine ratio 吉村仁志1, 横山雄一1, 篠原義剛1, 植木哲也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 997-997, 2019.

---

	P0817-3-AM. Examination of safety and the effectiveness of the killer cells-related anticancer medicine after the checkpoint inhibitor administration of immunity 相川晴彦1, 酒井鉄平1, 嶋田烈1, 上野正夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 997-997, 2019.

---

	P0819-3-AM. It is the examination about the nourishment evaluation about the prognosis at the beginning of the cancer chemotherapy 田村悟1, 中村智1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 998-998, 2019.

---

	P0821-3-AM. It is use fact-finding of adjuvant chemotherapy S-1 after the pancreas malignant tumor technique 上ノ山和弥1, 三宅麻文1, 河原宏之1, 石川弘子1, 尾上雅英1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 998-998, 2019.

---

	P0823-3-AM. Pharmacist led antimicrobial proper use support and patients outcome in the small and medium size Hospital not to be able to conduct specialist in infection absence, an examination of bacteria outside order, Gram stain 西海一生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 999-999, 2019.

---

	P0825-3-AM. The effect that AS activity of the carbapenem-based antimicrobial in our hospital gives for use of antimicrobial surveillance of the wide area antimicrobial 田井達也1, 山口佳津騎1, 元木貴大1, 田中裕章1, 横田恭子2, 加地雅人1, 小坂信二1, 芳地一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1000-1000, 2019.

---

	P0827-3-AM. Operational - utilizing the template function of efforts - electronic medical chart to use dose adequacy of the carbapenem-based antimicrobial which cooperated with a ward pharmacist 山口佳津騎1, 田井達也1, 元木貴大1, 田中裕章1, 横田恭子2, 加地雅人1, 小坂信二1, 芳地一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1000-1000, 2019.

---

	P0829-3-AM. Investigation about the blood culture effective time in the use of wide area antimicrobial to patients with cholangitis and cholecystitis 秋本純矢1, 片山頌子1, 内藤淳嗣1, 大貫麻友美1, 渡邉あゆみ1, 中川隼一1, 鈴木祥江1, 奥津利晃1, 蔭山博之1, 平島徹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1001-1001, 2019.

---

	P0831-3-AM. As compared with the SSI incidence of efforts and evaluation - JANIS to perioperative antimicrobial proper use, the standardization infection ratio ... 田中真衣1, 池崎友明1, 村上真樹1, 坂東翔1, 片山聡子1, 北島比香里1, 竹内都子1, 北澤英徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1001-1001, 2019.

---

	P0833-3-AM. An example of the syphilis Jarisch-Herxheimer response found out by the syphilis development situation and screening of our hospital 小池彩子1, 花房伸幸1, 大道淳二1, 河村茉衣1, 廣田あゆ子1, 山口麻里2, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1002-1002, 2019.

---

	P0835-3-AM. Antimicrobial investigation used for empiric therapy for the aspiration pneumonia in the time when sulbactam/ampicillin was unusable 池田久雄1, 平田貴宏1, 神原弘和1, 森岡浩子1, 足立充司1, 野村浩英1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1002-1002, 2019.

---

	P0837-3-AM. Problem of the AST activity judging from the use of carbapenem-based antimicrobial actual situation 古庄弘和1, 陣上祥子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1003-1003, 2019.

---

	P0839-3-AM. The use situation investigation of the peramivir in our hospital 後藤健志1, 立花京香1, 鎌田理紗子1, 竹尾恵理子1, 酒井欣嗣2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1003-1003, 2019.

---

	P0841-3-AM. To urge proper quantum rectum prescription on thing - physician who start AST, and noticed; ... 福本康之1, 深井幸恵1, 長山晃1, 森下和美1, 川上典子1, 近藤昌子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1004-1004, 2019.

---

	P0843-3-AM. Examination of the effect that Antimicrobial Stewardship Team (AST) activity gives for the antimicrobial choice of the clinician 上田覚1,2, 高橋有1,2, 小林和博1,2, 羽田敦子2,3, 尾上雅英1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1004-1004, 2019.

---

	P0845-3-AM. Efforts (the second report) for the proper use of the carbapenem-based antimicrobial in our center 田村直斗1, 加賀谷明日美1, 木村正行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1005-1005, 2019.

---

	P0847-3-AM. Use turn of eventss by the early intervention to the use of carbapenem-based antimicrobial patients 吉川雅之1,2, 岡本まとか1,2, 内藤結花2,3, 前田真之4, 石野敬子4, 宇賀神和久5, 長友安弘6, 詫間隆博6, 時松一成6, 二木芳人6, 佐々木忠徳2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1005-1005, 2019.

---

	P0849-3-AM. AST activity and use of oral antimicrobial situation ... in promotion and current situation - our hospital of the antimicrobial proper use support program 芝田和輝1,2, 深川裕1,2, 篠田健一1, 井上清子2, 谷内隆浩2, 清水哲朗2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1006-1006, 2019.

---

	P0851-3-AM. 3 cases of cholelithiasis that it was thought that it was caused by administration of ceftriaxone (CTRX) for children 國遠孝斗1, 鬼頭佳子1, 小嶋俊輝1, 柴田大地1, 鈴木秀明1, 滝本典夫1, 足立守1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1006-1006, 2019.

---

	P0853-3-AM. Effect on use of MEPM trend by our hospital AST activity 城間盛彦1, 玉城哲子1, 浦崎清美1, 武富美貴子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1007-1007, 2019.

---

	P0855-3-AM. Examination about the procalcitonin measurement in Sapporo Medical University Hospital 伊部裕太1, 藤居賢1, 石郷友之1, 北川学1, 木明智子1, 中田浩雅1, 宮本篤1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1008-1008, 2019.

---

	P0857-3-AM. About AST activity in our hospital and the evaluation 宮崎美穂1, 桑村恒夫1, 坪内和哉1, 芳賀由美1, 森本麗華1, 末松文博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1009-1009, 2019.

---

	P0859-3-AM. Efforts of antimicrobial proper use support team (AST) and future problem 木村博史1,2, 矢野賢明1,2, 越智史博2, 末盛浩一郎2, 飛鷹範明1, 田中守1, 田中亮裕1, 田内久道2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1009-1009, 2019.

---

	P0861-3-AM. The use of antimicrobial situation investigation of the carbapenem-resistant Pseudomonas aeruginosa detection patients 田中慎1, 寺本晴美1, 坂口朋美1, 湧上大介1, 馬瀬久宜1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1010-1010, 2019.

---

	P0863-3-AM. The efforts of the working full time pharmacist in AST and the evaluation 塩田智子1,2,3, 谷長美菜子1,2, 段林正明1,2, 村瀬大翔1,2, 高橋一栄1,3, 足立幸人2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1010-1010, 2019.

---

	P0865-3-AM. Effect to give to consumption of the antimicrobial by the AS (Antimicrobial Stewardship) activity and the rate of detection of resistant Pseudomonas aeruginosa 小林和博1, 高橋有1, 上田覚1, 尾上雅英1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1011-1011, 2019.

---

	P0867-3-AM. About a clinical investigation of the ESBL-producing infection in our hospital 大橋武司1, 伊藤嘉英1, 古川大樹1, 林房江2, 寺島恭子2, 菱田志乃3, 中尾彰宏4, 長谷川雅哉1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1011-1011, 2019.

---

	P0869-3-AM. Change of the use of injection antimicrobial before and after the antimicrobial proper use support team intervention in our hospital 坂口晋哉1, 福石和久1, 川俣洋生1, 高島伸也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1012-1012, 2019.

---

	P0871-3-AM. About effect of the electronic medical chart introduction in the AST activity 菅原浩介1, 山崎翔太1, 鈴木英則1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1012-1012, 2019.

---

	P0873-3-AM. The result of the antimicrobial proper use support activity in our hospital and future problem 樋口聖人1,2, 山崎信也1, 横山茂1, 小林翔2, 小山洋子2, 小口弘子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1013-1013, 2019.

---

	P0875-3-AM. Examination of the usefulness of the antimicrobial proper use support round that a pharmacist played a key role 大戸祐治1,4,5, 新井祐司2,4, 岡田壮令3,4, 田中克巳1,5, 佐々木忠徳5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1013-1013, 2019.

---

	P0877-3-AM. Effect of the use of antimicrobial situation and the antimicrobial proper use support in the care mix hospital 阿部慎太郎1, 村田唯1, 吉田桃子1, 細田あゆみ1, 八重樫渉1, 中島稔也1, 大森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1014-1014, 2019.

---

P0879-3-AM. Unionization ... of the patients support for the expansion of the efforts (2) - person in charge of prescription possibility pharmacist for the outside Parliament shift containing the antiHIV medicine in our hospital 井手頌美1, 保戸塚里美1, 南谷奈々1, 朽木絵美1, 黒木あかね1, 前波麻里子1, 井戸澤弘美1, 山形亜紀子1, 林みどり1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1015-1015, 2019.

---

	P0883-3-AM. Development of the nourishment assessment tool in the pediatric domain 佐々木真理1, 笠原沙耶香1, 今泉仁美1, 文靖子1, 山谷明正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1017-1017, 2019.

---

	P0885-3-AM. One case that resulted in electrolyte abnormality by lack of administration fluid volume at the semisolid liquid food administration 菊井伴美1, 木村香織1, 矢野絢子1, 伊藤有佳子1, 池田桂子1, 行本拓史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1018-1018, 2019.

---

	P0887-3-AM. Examination of a clue of the delirium patients early detection for clinical application and the drug that it is 松尾待池1, 山口泰弘1, 野田圭吾1, 千代延桜子1, 中村敦士1, 浦本邦弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1019-1019, 2019.

---

	P0889-3-AM. Efforts of the TDM enforcement of vancomycin in the mental hospital 北侑未1, 南憲一1, 竹中克之1, 下川千賀子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1020-1020, 2019.

---

	P0891-3-AM. 1 case that responded to citicoline for patients with Lewy bodies type dementia which a cognitive function decreased by general cold preparation internal use 中村隆志1, 遠藤唯1, 広瀬和之2, 鈴木伸男1, 只野文基3, 太田章三4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1020-1020, 2019.

---

	P0893-3-AM. 1 case that Yokukansan was effective for a sleeplessness symptom of the bipolar disorder 川中理香子1, 亀井進太郎1, 佐藤雄己1, 釘宮毅2, 河野健太郎2, 寺尾岳2, 伊東弘樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1021-1021, 2019.

---

	P0897-3-AM. Efforts for the current situation investigation and the revision of the drug nursing advisability confirmation system 高木祥子1, 木村純子1, 立松あき2, 山形ルミ子2, 久保田由美2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1022-1022, 2019.

---

	P0899-3-AM. The antiepileptic drug prescription situation investigation in the epilepsy merger pregnancy patients 安達るい1, 木村萌美1, 山田裕理1, 西田初博1, 真鍋健一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1023-1023, 2019.

---

	P0901-3-AM. Fact-finding of the consultation situation about the glaucoma therapeutic drug in the pregnancy and the medicine information center 宇野千晶1,2, 八鍬奈穂1,2, 肥沼幸2, 後藤美賀子2,3, 鈴木朋2,4, 伊藤直樹2,5, 山谷明正1,2, 村島温子2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1023-1023, 2019.

---

	P0903-3-AM. Examination about the pregnancy-induced hypertension syndrome 木藤一美1, 橋本隆信1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1024-1024, 2019.

---

	P0905-3-AM. Search of the clinical factor of the cancellation by the adverse event of the torr recity 中山佳代子1, 佐藤夕紀1, 中川俊作1, 吉田優子1, 傳田将也1, 木全柾典1, 今井哲司1, 米澤淳1, 中川貴之1, 稲垣暢也2, 原田範雄2, 小倉雅仁2, 松原和夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1025-1025, 2019.

---

	P0907-3-AM. Examination of the factor affecting the use of insulin fact-finding and the blood glucose level in patients with gestational diabetes 真井雄規1, 渡辺浩明1, 田村広志1, 和泉秀明1, 佐藤弘康1, 三本松泰孝1, 津田雅大1, 石田陽美1, 晴山知拓1, 村上冴美1, 喜多力1, 荒井理乃1, 久保萌美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1026-1026, 2019.

---

	P0909-3-AM. Investigation of the onset of digestive organ symptom situation and the administration continuance rate with the Dulaglutide administration 福森あや1, 梅崎裕子1, 中垣春美1, 三輪涼子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1026-1026, 2019.

---

	P0911-3-AM. Effect of the Empagliflozin administration on decreased renal function patients 中尾なつみ1, 石橋真実1, 大森麻江1, 宮下雄博2, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1027-1027, 2019.

---

	P0913-3-AM. Evaluation including chronic administration of the once a week DPP-4 inhibitor Omarigliptin 葛葉守1, 野口景子1, 久嶋真紀子1, 中野玲子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1027-1027, 2019.

---

	P0915-3-AM. Examination of the VCM administration for the extensive decreased renal function patients 増田章秀1, 大林巧志1, 宮川由季1, 山本美智1, 舩越真理1, 津田正博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1028-1028, 2019.

---

	P0917-3-AM. The acute interstitial nephritis that developed after VCM internal use and TEIC infusional combination 小出哲朗1, 加藤公人1, 川崎好人1, 不破朱里1, 原美由紀1, 池口麻由子1, 今西義紀1, 橋本陽1, 森実優1, 出口賀奈子1, 有松冴1, 桐生浩子1, 西川嘉広1, 西田順二2, 伊藤久美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1029-1029, 2019.

---

	P0919-3-AM. Change by the actual situation and the hospitalization of the medical therapy in patients with dementia 白根達彦1, 大野能之1, 服部ゆかり2, 小島太郎2, 小久江伸介1, 長瀬幸恵1, 秋下雅弘2, 鈴木洋史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1030-1030, 2019.

---

	P0921-3-AM. One patient who tried medicine, the adjustment that it decreased by it from polypharmacy in our hospital during rehabilitation length of stay 佐藤智功1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1031-1031, 2019.

---

	P0923-3-AM. 2 cases that the restless symptom of patients with dementia improved by the intervention of the pharmacist 淺井俊平1, 佐藤裕介1, 池上信昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1031-1031, 2019.

---

	P0925-3-AM. ... which thinks about importance of the drug adjustment for approach ... delirium, the dementia behavior to the appropriate medical therapy promotion to elderly people 柴田博子1, 塩田恵1, 兵頭純子1, 足立洋子2, 田中宏和3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1032-1032, 2019.

---

	P0927-3-AM. Treatment by prescription suggestion participation in planning of the pharmacist in the dementia care team 森光輝1, 宇佐美英績1, 吉田光代2, 鈴木弥生2, 富田顕旨3, 吉村知哲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1032-1032, 2019.

---

	P0929-3-AM. Investigation about the blood zinc levels in patients with hospitalization pressure sore and the nutritional status 小松裕里1, 八城瑞穂1, 相澤政明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1033-1033, 2019.

---

	P0931-3-AM. Effect, safe comparison of the antiarrhythmic drug after the catheter ablation enforcement in patients with sustained or chronic atrial fibrillation 古野喬志1, 小林賢滋1, 泉麻祐子1, 村井いずみ1, 渡邊さくら1, 仲村佳典2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1034-1034, 2019.

---

	P0933-3-AM. Examination about the stability of the pharmaceutics of the tacrolimus slow-release preparation which we made a de-capsule 金聖暎1, 牛尾聡一郎1, 岩田直大1, 江角悟1, 小川敦1, 村川公央1, 北村佳久1, 千堂年昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1035-1035, 2019.

---

	P0935-3-AM. Examination of the effect of the number of the drugs to give the warfarin control in patients with atrial fibrillation 高本光次郎1,2, 坂本淳一2, 近藤純1, 志方敏幸1, 伊藤都裕3, 辻野健2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1035-1035, 2019.

---

	P0937-3-AM. Correlative ... with examination - nutritional status of the factor to influence effect of treatment of the tolvaptan 大矢智則1,4, 前澤佳代子1,3,4, 柳谷将俊3, 松本玄紀3, 宮崎紗愛3, 平尾蘭3, 杉山奈津子1,3, 伊東岳3, 加藤芳徳3, 倉本敬二3, 柴信行2, 武田守彦2, 百瀬泰行1,3,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1036-1036, 2019.

---

	P0939-3-AM. 1 case that symptom improvement was seen in by an erythromycin IV infusion for acute dilatation of stomach after the catheter ablation for the atrial fibrillation 千葉貴志1, 上村新吾1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1036-1036, 2019.

---

	P0943-3-AM. Study on constipation improvement effect of herbal medicinal products, the Mashiningan 能登啓介1, 平田敦士1, 太田涼介1, 松岡寛1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1037-1037, 2019.

---

	P0945-3-AM. Association of anticholinergic/sedative agonistic medication and body function improvement in the cerebrovascular rehabilitation 小川ゆかり1, 二瓶太志2, 田中惣治2, 伊藤憲次3, 佐藤裕太3, 酒向正春4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1038-1038, 2019.

---

	P0947-3-AM. One case that a change was able to be given from a buprenorphine patch to tramadol/acetaminophen combination tablets well by a simple schedule 峰村智子1, 小島正照1, 荒木良介1, 山田英紀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1038-1038, 2019.

---

	P0949-3-AM. About the total drug dose of hospitalizations and the drug of patients with heart failure in our hospital 川上莉奈1, 原田桂作1, 村本眞由美1, 原田敬2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1039-1039, 2019.

---

	P0953-3-AM. The current situation of the information sharing of the hospital pharmacist in regional alliances to see for Japanese Society of Hospital Pharmacists "current situation investigation of the hospital pharmacy gate" 津山昌子1, 園田純一郎2, 河内明夫3, 下堂薗権洋2, 池田龍二4, 武田泰生5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1041-1041, 2019.

---

	P0957-3-AM. Examination of the specialty of "the family pharmacist" to the patients who introduced the division formulations and the outcome 清水紗弥香1, 佐藤秀昭2, 神隆浩1, 野口宣之1, 小田慎3, 今井博久4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1042-1042, 2019.

---

	P0961-3-AM. About the inflection of the tracing report at the Lenvatinib administration 武田なつか1, 藤井裕史1, 三上忠司1, 柿原圭佑1, 白石亘1, 野田聖奈子1, 松崎雄1, 原田智子1, 篠崎千尋1, 松本美紅1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1044-1044, 2019.

---

	P0963-3-AM. Attitude survey for the relation with patients with familial tumor 直井美萌1, 武井大輔1, 山田遥子2, 大塚公庸1, 中村益美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1044-1044, 2019.

---

	P0965-3-AM. The multicenter inhalational instruction medicine medicine cooperation that we worked on together in the neighbor 関口愛1, 内田裕之1, 黒須智博3, 柳澤友希3, 小長井あゆみ1, 伊藤優4, 平居義裕2, 山下敦志3, 中田吉則1, 河井良智1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1045-1045, 2019.

---

	P0967-3-AM. It is instruction ... at the discharge using the information contact book between 1 efforts - institutions to the patients information sharing with the health insurance pharmacy pharmacist 高橋由紀奈1, 角田菜緒1, 宮崎美穂1, 秋吉尚雄1, 阿部名月1, 釘原瑶子1, 矢川結香1, 末松文博1, 星野正俊2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1045-1045, 2019.

---

	P0969-3-AM. The effect that the inhalational instruction in the health insurance pharmacy using the inhalational instruction contact vote gives for the clinical response of patients with asthma 浦上勇也1, 山地康文2, 篠永浩3, 山本和幸5, 飯原なおみ4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1046-1046, 2019.

---

	P0971-3-AM. Illness medicine cooperation (the second report) of the inhalation therapy in the childhood bronchial asthma 平岡陽一1, 中尾明日香1, 竹内亜紀3, 中村奈巳2, 橋本隆信1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1046-1046, 2019.

---

	P0973-3-AM. It is practiced the community medical care cooperation with the medication reporting book for medical care trusted by patients 市川康子1, 濱田政司1, 上淵未来1, 藤井浩毅1, 守田尚史1, 古田洋一1, 大岡建太郎1, 藤井憲一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1047-1047, 2019.

---

	P0975-3-AM. Pharmaceutical management information sharing in Tennoji-ku 5 Hospital and the Tennoji-ku health insurance pharmacy 森田智子1,2, 小林政彦3, 村田久枝4, 石倉久美子5, 真常美紀6, 津田宜志7,8, 堀越博一7,9, 村西泰法10, 但馬重俊11 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1047-1047, 2019.

---

	P0977-3-AM. Public health effort in the Japan Team for Disaster Relief medical care team medical care support activity for the cyclone damage in Mozambique 加藤あゆみ1, 宮本純子2, 青木正志3, 南島友和4, 神谷睦美5, 笹村晶紀6, 中込悠7, 斉藤忠男8, 伊勢雄也1, 中森知毅9 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1048-1048, 2019.

---

	P0979-3-AM. Examination of the new notification of network operational training means based on results urgent at a disaster 西山裕也1, 宮脇舞1, 中谷孝史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1049-1049, 2019.

---

	P0983-3-AM. Search of the sleeping drug which can become the risk factor of the fall fall 岩田華奈1, 細谷龍一郎1, 鈴木統子1, 宗山真梨奈1, 芝裕美子1, 日野斉一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1051-1051, 2019.

---

	P0985-3-AM. Practice of the medication management during the medication period based on the pharmaceutical products risk management plan in the health insurance pharmacy 加藤正久1, 石橋久1, 井手純司1, 吉川学1, 園田正信1, 山野徹2, 田中泰三2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1051-1051, 2019.

---

	P0987-3-AM. Examination about the effect that the insomnia therapeutic drug gives on fall, fall incident/accident 矢野裕士1, 鈴木優司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1052-1052, 2019.

---

	P0989-3-AM. Examination ... of efforts - S zopiclone of the prevention of fall, fall by the change of the sleep inducing drug 樺山智一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1052-1052, 2019.

---

	P0991-3-AM. Hold the medical safe joint workshop with efforts (the second report) - neighborhood drugstore of the medical security in the medicine medicine cooperation; and - 飯田真弓1, 熱海幸恵1, 今井祐貴子1, 大川藍子1, 李娜1, 大野翔子1, 添田真司1, 渡邊昌之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1053-1053, 2019.

---

	P0993-3-AM. Efforts to analysis and the prevention of development of the incident about the drug for the medical care in our hospital 中村るみ1, 長井砂都美2, 尾上博隆1, 田邉徹1, 永浜良章1, 平川尚宏1, 南裕司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1053-1053, 2019.

---

	P0995-3-AM. Inspection of the medical expenses reduction effect by the TABSORT introduction 島津智行1, 佐藤弘康1, 和泉瑞恵1, 猪谷朱理1, 河端真以1, 越野早紀1, 金住麻子1, 田中悠季1, 三本松泰孝1, 和泉秀明1, 田村広志1, 渡辺浩明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1054-1054, 2019.

---

	P0997-3-AM. Trial of the ward training corresponding to revision core Cali 田村賢士1, 池田由美1, 田沼弥紅1, 角田結菜1, 櫻井美月1, 加藤さやか1, 川端康太1, 中屋優香1, 栗原直貴1, 野崎千暁1, 本木龍二1, 前田力丸1, 山野邉裕子1, 澤田唯美1, 下村香菜1, 金子智一1, 寺田伊知郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1055-1055, 2019.

---

	P0999-3-AM. Change - from the post-questionary survey - long term business training start that we conducted for pharmacy school life about hospital business training of 8 years 大久保正人1,2, 増田和司1,2, 小林由佳1,2, 中村貴子1, 鈴木貴明1,2, 石井伊都子1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1056-1056, 2019.

---

	P1001-3-AM. The construction of the business training program for upbringing of the clinical pharmacist and the evaluation 鎌田里紗1, 柴谷直樹1,2, 冨田秀明1, 山下花南恵1, 松岡勇作1, 奥貞智1, 室井延之1,2, 橋田亨1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1056-1056, 2019.

---

	P1003-3-AM. The attempt of the joint Small discussion with a hospital, the health insurance pharmacy in the Yao district and the usefulness 大里恭章1, 小川充恵2, 横山靖法1, 奥村隆司3, 木村玲子4, 篠原裕子5, 中野道雄6, 山崎肇2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1057-1057, 2019.

---

	P1005-3-AM. Consciousness change for patients, the family of the student before the business training by the patients with hepatitis B lecture in the clinical propaedeutic in the Setsunan University pharmacy school 岩崎綾乃1, 曽根知道1, 奥村秀二2, 牧亮太3, 河野武幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1058-1058, 2019.

---

	P1007-3-AM. The present situation of the medical therapy workshop by University of Shizuoka, hospital, the community pharmacy cooperation 辻大樹1,2, 平井啓太1,2, 伊藤邦彦1,2, 伊藤譲2, 井上達秀2, 河西きよみ2, 北村修2, 木村緑2, 黒川絢子2, 櫻井健史2, 並木徳之2, 平野桂子2, 松山耐至2, 森本達也2, 山田静雄2, 山田浩2, 賀川義之2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1059-1059, 2019.

---

	P1009-3-AM. Construction of the initial educational program in the Tomigusuku center Hospital drug department 三田井菜菜子1, 小杉卓大1, 國分千代1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1060-1060, 2019.

---

	P1011-3-AM. Construction of the new face educational program from a business training curriculum 日比陽子1,2, 長水正也1, 神田光司1, 久田宜範1, 諸角一成1, 佐藤由美子1, 中村康夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1061-1061, 2019.

---

	P1013-3-AM. The improvement of the TDM duties using the PDCA cycle and future problem 酌井敏伸1, 淵田悠一郎1, 服部公紀1, 野口祥紀1, 三宅知宏1, 谷村学1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1062-1062, 2019.

---

	P1015-3-AM. Research of recognition, the interest of the healthcare worker in aromatherapy 増渕龍一郎1,2, 秋元美咲1, 佐藤忠章2, 百瀬泰行1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1063-1063, 2019.

---

	P1017-3-AM. Support pharmacist system utilized the local pharmacist, cooperation with the community pharmacy 川那邊佐和子1, 原直己1, 徳丸歩子1, 小池玲江1, 石田明子1, 内田佳菜子1, 山下敦志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1063-1063, 2019.

---

	P1018-4-AM. Examination of the representation correction contents by the pharmacist for the duties burden reduction of the physician and efficiency 深井駿成1, 山本涼子1, 枦秀樹1, 太田哲徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1064-1064, 2019.

---

	P1019-4-AM. Fact-finding of the pharmaceutical products inspection that the bar code certification of the PTP at fraction formulations is not possible 後藤千寿1, 池上遼1, 小椋奈央子1, 勝野隼人1, 高井綾乃1, 森田美穂1, 梅田道1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1065-1065, 2019.

---

	P1020-4-AM. Fact-finding of doubt inquiry in the convalescent rehabilitation hospital 島児佳孝1, 佐藤晴彦1, 津波古晶子1, 西村洸之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1065-1065, 2019.

---

	P1021-4-AM. Examination of the pharmaceutical intervention situation before and after the ward drug duties enforcement addition calculation start in Tagawa-Shiritsubyoin 竹村知1, 麻生忠弘1, 長原功騎1, 久保田政二郎1, 重藤直哉1, 大須賀保人1, 松元康人1, 徳丸一郎1, 西原豊1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1066-1066, 2019.

---

	P1022-4-AM. Efforts to the medical therapy adequacy for the decreased renal function patients 前田和彦1, 西原誠子1, 岡本知子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1066-1066, 2019.

---

	P1023-4-AM. Efforts to urgent intubation drug set withdrawal operation 嘉数亜紀1, 平田やよい1, 浜元善仁1, 翁長真一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1067-1067, 2019.

---

	P1024-4-AM. Efforts of the medical cost cut to reuse the cancellation pharmaceutical products of the inpatient 水谷麻希子1, 木全司1, 吉田弘樹1, 木下元一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1068-1068, 2019.

---

	P1025-4-AM. Evaluation of the usefulness of the cubic sushi stem through the chronic administration experience of the blood clotting factor preparation 岡村央1, 小池博文1, 古川大輔1, 佐橋幸子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1068-1068, 2019.

---

	P1026-4-AM. Examination about the effectiveness of the cubic sushi stem in the pharmaceutical products inventory control 中尾倫子1, 中川雅史1, 井出朋子1, 吉岡厚子1, 宮内実奈絵1, 狩谷佳寛1, 樫葉利人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1069-1069, 2019.

---

	P1027-4-AM. The development of the drug inventory control system using the machine learning and effective evaluation 福原直樹1, 齋藤智之1, 藤林和俊2, 高橋明大3, 大塩悠貴4, 橋爪康知3, 内藤俊夫2, 佐藤邦義1, 荒川隆太郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1069-1069, 2019.

---

	P1028-4-AM. Efficacy evaluation of the 0.2% minocycline drug for external use for the epidermis, the soft tissue MRSA infection 田村和彦1, 中村槙一郎1, 財津孝希1, 瀧内瑛輔1, 長澤欣弘1, 羽生智宏1, 尾形美絵1, 新関みどり1, 近藤和宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1070-1070, 2019.

---

	P1029-4-AM. Preparation of the methylcellulose solution which assumed acetaminophen preparation of various kinds of dosage form a principal ingredient 下山哲哉1, 上嶋麻葵1, 赤石結菜1, 伊藤邦彦1, 小林道也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1071-1071, 2019.

---

	P1030-4-AM. Efforts about the review of the regime of the hospital preparation 坂田光平1, 花田聖典1, 鶴崎泰史1, 中川義浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1071-1071, 2019.

---

	P1031-4-AM. It is the real condition investigation of ward drug duties contents in the present just after ward drug duties start 早舩美保子1, 島崎良知1, 瀧川正紀1, 衣笠芳1, 横井妙子1, 森淑子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1072-1072, 2019.

---

	P1032-4-AM. Prescription support of the pharmacist in the urologic ward 高橋恭平1, 竹田瞳1, 大山展弘1, 森川記道1, 西倉教子1, 原田靖子1, 西原昌幸2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1073-1073, 2019.

---

	P1033-4-AM. Introduction of the antithrombotic drug resumption protocol after the surgery 立石昂偲1, 山崎伯都1, 柏木麻紀1, 井無田優1, 吉原郁夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1073-1073, 2019.

---

	P1034-4-AM. Can the reporting that a pharmacist conducts by ward duties contribute to the medical security of other types of job? 瀬上直輝1, 石光一幾1, 此原美佐江2, 佐藤真也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1074-1074, 2019.

---

	P1035-4-AM. Introduction effect of the periodical prescription input support task by the pharmacist 鈴木寿樹1, 黒澤桂子1, 白木美香1, 田中雅樹1, 赤井文香1, 横枕史1, 赤坂和俊1, 眞野成康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1074-1074, 2019.

---

	P1036-4-AM. About the efforts of the drug control instruction duties for patients who received ERCP (endoscopic retrograde cholangiopancreatography) 出口華子1, 渡邊裕子1, 益田聖1, 瀬戸洋行1, 阿部元昭1, 鈴木由佳1, 田中富美1, 出口佳奈美1, 山田佳代1, 佐野麻璃奈1, 高田恭子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1075-1075, 2019.

---

	P1037-4-AM. The effect that deletion of the internal use antimicrobial in the cataract surgery clinical path gives 加藤結1, 荒川泰代1, 高橋弘泰1, 大谷寧次郎1, 畔柳敏弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1075-1075, 2019.

---

	P1038-4-AM. Outcome evaluation of the pharmacist ward permanent residence in the convalescent rehabilitation ward 阪東芳則1, 武田元樹2, 稲村千尋2, 布施順子2, 菊池健2, 相馬貴史2, 宮田列寧1, 鶴山辰2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1076-1076, 2019.

---

	P1039-4-AM. Effect of the exclusive drug reporting book making in the clinical path 三浦幸太1, 北條文啓1, 岩上泰崇1, 猪狩政則1, 景山亮平1, 宗田一記1, 中野洸大1, 鈴木実1, 松本和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1076-1076, 2019.

---

	P1040-4-AM. After the operation in the cardiovascular surgery ward one package for improvement in adherence of patients about the usefulness of formulations 波多江沙織1, 石躍華奈1, 友納保幸1, 前田朱香1, 富田敏章1, 入江利行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1077-1077, 2019.

---

	P1041-4-AM. Pharmacist, oral medicine management method decision standard unification and fact-finding by the nurse collaboration 守谷有美1, 河村聡志1, 橋本晴香1, 薬師寺寿世1, 平松眞澄2, 森一生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1077-1077, 2019.

---

	P1042-4-AM. Result of PBPM of the edoxaban by the pharmacist for the purpose of the VTE generating prevention in patients who underwent lower limbs orthopedics surgery 松木克仁1, 平野淳1, 松岡梨恵1, 藤巻伊織1, 相澤佑佳1, 林誠1, 竹内正紀1, 金子敦2, 中井正彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1078-1078, 2019.

---

	P1043-4-AM. Relations with the appropriateness doses by a side effect (bleeding, thrombogenesis) and the renal function evaluation of the antithrombotic drugs (edoxaban) after the lower limbs surgery 徳永晃1,2, 貞嶋栄司2, 前隆男3, 松永尚1, 佐野雅彦1, 田中康弘1, 植松大智1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1078-1078, 2019.

---

	P1044-4-AM. Example that the suggestion by the ward pharmacist who started from the bringing medicine's confirmation led to treatment decision 寺島純一1, 谷口俊洋1, 中村直人1, 山田哲也1, 長内宏之2, 味岡正純3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1079-1079, 2019.

---

	P1045-4-AM. Investigation of the effect that intervened about instructions as PBPM at sleeplessness in consideration for a fall, the delirium risk of elderly people, unrest time 井上卓治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1079-1079, 2019.

---

	P1046-4-AM. Revision of the pain-killer usage by the pharmacist intervention and effect to early ambulation 森谷康志1, 本田徹郎2, 亀井健人1, 赤木晋介1, 高柳和伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1080-1080, 2019.

---

	P1047-4-AM. Efforts to improvement in quality of ward duties by the joint ownership of the clinical record items mentioned 中村久美1, 伊藤隆哉1, 鬼窪利英1, 三浦篤史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1080-1080, 2019.

---

	P1048-4-AM. Establishment and content analysis of the continuous extracting method of the pharmaceutical intervention using DWH 倉橋基尚1, 松本涼1, 是枝哲平1, 土谷裕貴1, 羽鹿成人1, 浦川美採1, 小松万恵1, 菰池春奈1, 山岡真由美1, 柳川智子1, 卜部和美1, 三井秀紀1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1081-1081, 2019.

---

	P1049-4-AM. Efforts for the proper use of the dry concentration person prothrombin complex 坂口結斗1, 友利隆一郎2, 又吉美重4, 長嶺あずさ3, 喜多洋嗣1, 喜多幸子1, 村雲智久1, 北池祥子1, 有銘千賀子1, 生野夢子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1082-1082, 2019.

---

	P1050-4-AM. Making and introduction of the clinical ladder about operating room pharmacist duties 亀田皓介1, 石関華子1, 野本祐介1, 増田大輔1, 上野正夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1083-1083, 2019.

---

	P1051-4-AM. Evaluation by the cardiopulmonary resuscitation participation of the pharmacist in the critical care center and the questionary survey for a physician, the nurse 遠藤啓之1, 野上裕介1, 坂本亮1, 大塚潔1, 長谷部忠史1, 柏浦正広2, 海老原貴之2, 守谷俊2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1083-1083, 2019.

---

	P1052-4-AM. The field where it is useful that a pharmacist is concerned in an intensive care domain (ICU/HCU) to think about from the intervention example that led to change of prescription 長谷川裕矢1, 黒川恵理1, 黒宮浩嗣1, 竹村恵里奈1, 松本利恵1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1084-1084, 2019.

---

	P1053-4-AM. Patients death ratio investigation in the pharmaceutical intervention of the intensive care unit permanent residence pharmacist 並木孝哉1, 鈴木俊一郎1, 山本涼子1, 枦秀樹1, 太田哲徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1084-1084, 2019.

---

	P1054-4-AM. Pharmaceutical intervention effect of the pharmacist to all patients team rounds in the ICU 種田靖久1, 松岡知子1, 堀田奈央1, 川地志緒里1, 宇佐美英績1, 吉村知哲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1085-1085, 2019.

---

	P1055-4-AM. Is going to perform the operations that included the on admission support addition pertinence patients in; efforts of the in front of pharmacist technique outpatient department for the patients 澤村愼吾1, 安村吉彦1, 本藤真太郎1, 長島真洋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1086-1086, 2019.

---

	P1056-4-AM. Efforts of the pharmacist in the hospitalization and release support center 藤井達郎1, 佐々木静香1, 下口谷貴1, 山川拓1, 川本康太郎1, 野田聖奈子1,2, 森本雅子1, 門村将太1, 井藤達也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1087-1087, 2019.

---

	P1057-4-AM. Development of the confidence measure of the medication counseling for patients with depression of the pharmacist and inspection of the validity 庄司雅紀1, 藤原篤子2, 恩田光子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1087-1087, 2019.

---

	P1058-4-AM. Intervention and role of the pharmacist to medicine management targeted for perioperative cancellation prepared one package in "medicine confirmation outpatient department" 川島佳恵1, 吉川里香1, 石本学司1, 奥野昌宏1, 田中詳二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1088-1088, 2019.

---

	P1059-4-AM. The establishment of the perioperative pharmacist outpatient in the middle scale hospital and the efforts 赤星璃1, 栗崎貴啓1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1088-1088, 2019.

---

	P1060-4-AM. Relation of the pharmacist to treatment with growth hormone in our hospital 梅村実希1, 岩田怜奈1, 脇田恵理1, 伊藤洋貴1, 佐藤賛冶1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1089-1089, 2019.

---

	P1061-4-AM. About the reconsideration of the drug release pattern from a dry powder inhaler and inhalational instruction 近藤哲理1, 増尾昌則1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1089-1089, 2019.

---

	P1062-4-AM. Pharmacist permanent residence system ... in importance - admitting department of patients intervening before a pharmacist is hospitalized 徳山洋子1, 西本好児1, 松本圭司1, 丸山美香2, 清水義博3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1090-1090, 2019.

---

	P1063-4-AM. Formula remaking ... of rebuilding - convalescent rehabilitation hospital of the RAS inhibitor in TMG formula reexamination WG 永瀬真理子1, 金井紀仁2, 佐藤光3, 宮崎美子4,5, 齋藤俊夫5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1091-1091, 2019.

---

	P1064-4-AM. Role of the pharmacist in dyschezia measures team "team Rodin" 堀川康裕1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1092-1092, 2019.

---

	P1065-4-AM. It is development ... of the stopping medicine management Web application during construction - preoperation of the stopping medicine management database during preoperation 江本晶子1, 木村早希子1,2, 吉村麻里子2, 有水弘太3, 末岡榮三朗4, 成澤寛1,5, 木村晋也2,6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1093-1093, 2019.

---

	P1066-4-AM. The current situation of the in-hospital side effect report collection system and the future prospects 齋藤雅俊1, 左右田和枝1, 松原肇1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1094-1094, 2019.

---

	P1067-4-AM. The mention situation investigation of the clinical study information in the pharmaceutical products interview form 冨田隆志1, 畝井浩子1, 松尾裕彰1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1094-1094, 2019.

---

	P1068-4-AM. Investigation of the discontinuation situation by the confirmation of a use drug before examination of the pancreatic outer secretion test bentiromide (PFD) study vote making 寺口敦1, 関口陽子1, 貝瀬眞由美1, 須田剛士2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1095-1095, 2019.

---

P1069-4-AM. The cognitive function in local elderly people and the relations with the anticholinergic agent: The making of the evaluation standard based on the Nakajimacho study - package insert information and the evaluation 橋本恵幸1, 吉川由華1, 丸一泰雅1, 石田奈津子1, 菅幸生1, 松下良1, 石崎純子1, 篠原もえ子2, 駒井清暢3, 山田正仁2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1095-1095, 2019.

---

	P1070-4-AM. Consideration - judging from the occupation years of experience of evaluation - nurse for the simple suspension method introduction in the acute phase hospital 伊賀正典1, 齋藤彩子1, 高野温志1, 町田充1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1096-1096, 2019.

---

	P1071-4-AM. eGFR change ten years after the staff of a school clinical survey 守内匡1, 松井ひろみ1, 守内典子1, 西恵子1, 木南今日子1, 冨岡未悠1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1097-1097, 2019.

---

	P1072-4-AM. Investigation about the effect to give discontinuation and blood pressure of ACE inhibitor/ARB in the perioperative period 中村水紀1, 猪田宏美2, 錦織淳美2, 井川祐輔2, 北村佳久1,2, 千堂年昭2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1097-1097, 2019.

---

	P1073-4-AM. Questionary survey about the polypharmacy to a medical practitioner cooperating with our hospital 鷲尾浩司1, 太田しおぢ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1098-1098, 2019.

---

	P1074-4-AM. Fact-finding of the Chinese medicine prescription in our hospital 坂本亮1, 大塚潔1, 遠藤啓之1, 長谷部忠史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1098-1098, 2019.

---

	P1075-4-AM. Recognition, understanding degree investigation of the term which a pharmacist uses for patients in clinical settings 兼古絵里菜1, 市原航1, 福井宗憲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1099-1099, 2019.

---

	P1076-4-AM. A successive change of the number of oral third generation cephem system antimicrobial prescription: Case series study 金沢有希1,2, 山越萌1, 藤原帆波1, 藤井哲英1, 北川誠子1, 勝村登美子1, 小林美代子1, 庵谷千恵子2, 桑原篤憲2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1099-1099, 2019.

---

	P1077-4-AM. The use situation investigation of the constipation therapeutic drug 清水誉志1, 福島将友1, 前田朱香1, 北島聖也1, 友納保幸1, 木原慶子1, 入江利行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1100-1100, 2019.

---

	P1078-4-AM. Investigation of the medication situation of our hospital Parkinson's disease patients judging from on admission bringing medicine's confirmation 北浦円1,2, 佐々木萌1, 大竹将司1, 齊藤勇二2, 渡辺章功1, 高崎雅彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1100-1100, 2019.

---

	P1079-4-AM. The investigation about the clinical studies of the pharmacist working in local base Hospital: Questionary survey 小野塚和人1, 吉廣尚大1, 只佐正嗣2, 堀川俊二3, 橋本佳浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1101-1101, 2019.

---

	P1080-4-AM. The use situation investigation of the antiemetic for the vomiting post-operative prevention in our hospital pediatric surgery 楠川侑吾1, 多留木崇志1, 村田龍宣1, 村岡淳二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1101-1101, 2019.

---

	P1082-4-AM. Examination of the drug which you should watch closely on delirium patients early detection 野田圭吾1, 山口泰弘1, 松尾待池1, 千代延桜子1, 中村敦士1, 浦本邦弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1103-1103, 2019.

---

	P1083-4-AM. Cost effect analysis of the oral triptan preparation in migraine headache treatment 中川直人1, 今野瑞葉1, 井上忠夫1, Leanne Lai2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1103-1103, 2019.

---

	P1086-4-AM. Fact-finding of the Residual medicine which we saw from on admission bringing medicine and search of the development factor 高橋美咲1, 押尾洋佑2, 有山智博1, 田中博之1, 木下雅子1, 藤枝正輝1, 高橋佐和士2, 石井敏浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1105-1105, 2019.

---

	P1087-4-AM. 1 case that a convulsive seizure was thought to be caused by the cefmetazole administration in patients on dialysis 吉田美奈1, 井上敬之1, 田中早紀1, 中城宏子1, 栗田聡2, 国府孝敏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1106-1106, 2019.

---

	P1088-4-AM. Examination of the onset of metronidazole-induced peripheral neuropathy risk in the inflammatory bowel disease 高塚博一1, 平山友里1, 内田雅士1, 山崎伸吾1, 鈴木貴明1, 石井伊都子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1107-1107, 2019.

---

	P1089-4-AM. Example that we were able to guess about the cause of the side effect by the measurement of cystatin C 片桐光1, 内山真理子1, 堀寧1, 山田徹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1107-1107, 2019.

---

	P1090-4-AM. An example of the children whom an orbital pseudotumor developed in as an adverse event of the leuprorelin acetate 眞栄城安貴1, 金城雄一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1108-1108, 2019.

---

	P1091-4-AM. Efforts to proper use of the magnesium oxide preparation for the elderly people with the decreased renal function 井桁和佳菜1, 鶴崎大2, 森川莉沙2, 澤村典子2, 深滝利也2, 荒川基記1, 日高慎二1, 菊池憲和2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1108-1108, 2019.

---

	P1092-4-AM. Examination about the effect to give to the milk sugar intolerance patients of the milk sugar included in the preparation 草村把奈1, 丹沢彩乃2, 高田裕奈1, 安武夫1, 石川洋一1, 深水啓朗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1109-1109, 2019.

---

	P1093-4-AM. Search of the factor about the onset of low blood pressure during the operation in the perioperative period 芦田郁実1, 田中玖実1, 柏宗伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1109-1109, 2019.

---

	P1094-4-AM. Examination and the system construction of the Relief System for Sufferers from Adverse Drug Reactions application support procedure 杉尾由希子1, 津曲恭一1, 北島久義1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1110-1110, 2019.

---

	P1095-4-AM. 1 case that operated on the patients with the anaphylactic history for an anesthetic 大道淳二1, 笠原なつみ1, 奈良葵1, 石橋真実1, 小林浩之2, 山口麻里3, 妹尾明美3, 森山重治4, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1110-1110, 2019.

---

	P1097-4-AM. One case that was restored without introducing adrenocortical steroid therapy into fallen leaves form pemphigus 小園亜希1, 島田秀一3, 中島聡子2, 佐保正直1, 野上玲子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1111-1111, 2019.

---

	P1098-4-AM. Effect on adverse event accompanied with the quantification for the fixation of the nivolumab in our hospital 光家勉1, 上田豊実1, 吉田友紀2, 塘賢二郎3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1112-1112, 2019.

---

	P1099-4-AM. Example that disturbance of consciousness by the ceftriaxone was suspected during the infective endocarditis (IE) treatment of the decreased renal function patients and improved by cancellation 高橋淳一1,2, 田中克幸3, 羽田彩萌1, 田邊恭彦5, 田邊嘉也2,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1112-1112, 2019.

---

	P1100-4-AM. About the administration situation and the onset of side effect situation of the levetiracetam in the Kasugai Municipal Hospital 大岩拓馬1, 竹内健吾1, 加藤麻理乃1, 水草博希1, 浅野嘉之1, 伊東和真1, 服部芳明1, 前田剛司1, 坂田洋2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1113-1113, 2019.

---

	P1101-4-AM. One case with suspected antiHMGCR antibody-positive necrotic line symptom with the statin administration 山本飛翔1, 櫻井恵一2, 前田幹広1, 有木宏宗1, 坂上逸孝1, 鈴木豪2, 川畑仁人2, 田中恒明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1113-1113, 2019.

---

	P1102-4-AM. Investigation about the association of warfarin and serum albumin and the nutritional status 森下怜美1, 武田元樹2, 渡邊英樹2, 菊池健2, 川瀬亜希子2, 佐々木啓2, 郡淳二3, 鶴山辰2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1114-1114, 2019.

---

	P1103-4-AM. Effect on blood pressure by the drug interaction of rifampicin and amlodipine 佐藤誠一1, 中島勝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1115-1115, 2019.

---

	P1104-4-AM. Effect (the fourth report) that combination of tramadol in the warfarin remedy patients gives to INR 花井誠1, 細野智美1, 青沼和隆2, 住田孝之2, 平松祐司2, 山崎正志2, 関堂充2, 神林泰行1, 本間真人1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1115-1115, 2019.

---

	P1105-4-AM. Examination IV isosorbide dinitrate of the interaction with the commercial denture adhesive and ethical drug, consideration in the mechanism of the interaction in the nitroglycerine 梅村雅之1, 伊藤友一1, 松葉圭祐1, 池上雄貴1, 吉田彩乃2, 柳原保3, 脇屋義文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1116-1116, 2019.

---

	P1106-4-AM. The present situation investigation about the tazobactam piperacillin combination during warfarin administration 土井啓員1, 井澤香1, 増田雅行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1116-1116, 2019.

---

	P1107-4-AM. The current situation of the vancomycin loading dose to elderly people 橋本浩之1, 行縄文彦1, 小野村直紀1, 田邉智行1, 金杉真也1, 佐藤大希1, 今井慎也1, 西哲弘1, 江口善美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1117-1117, 2019.

---

	P1108-4-AM. Comparison between LC-MS/MS and sirolimus levels out of the whole blood with ACMIA in patients with lymph vessels myoma symptom 重田健介1, 菊地正史1,2, 大石久3, 佐渡哲3, 松田安史3, 野田雅史3, 岡田克典3, 眞野成康1,2, 山口浩明1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1118-1118, 2019.

---

	P1109-4-AM. Development and evaluation of the analytical procedure using the antiepileptic drug simultaneous analysis kit for the LC-MS/MS 池村真弓1, 石橋美紀1, 池村健治1, 岩本卓也1, 奥田真弘2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1118-1118, 2019.

---

	P1110-4-AM. One case that was given medical treatment by the linezolid based on consideration from literatures for a pregnant woman of the bacterial meningitis with suspected the Augmented renal clearance phenomenon 田中遼大1, 岩男元志1, 佐藤雄己1, 伊東弘樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1119-1119, 2019.

---

	P1111-4-AM. Examination of optimum doses based on the blood level measurement of the amikacin in respiratory illness 神戸宏憲1, 石井英俊1, 須山由佳子1, 杉山恭平1, 伊藤健太2, 袴田康弘3, 木村緑1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1119-1119, 2019.

---

	P1112-4-AM. Population pharmacokinetics analysis of the daptomycin in patients with renal failure and examination of the optimal administration method 榎木裕紀1, 山本理紗子1, 佐村優1,2, 伊藤勇人1, 高田啓介2, 倉田武徳2, 南雲史雄2, 内田仁樹2, 田口和明1, 関根寿一2, 松元一明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1120-1120, 2019.

---

	P1113-4-AM. Relation of the immune checkpoint inhibitor side effect measures team "KIT" setup and pharmacist in our hospital 古田祐美子1, 塩飽英二1, 藤村晋也2, 森井淳子2, 山口大介3, 西村尚志4, 土井章一3,5, 土手賢史1, 小林由佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1121-1121, 2019.

---

	P1114-4-AM. The role of the multi-type of job cooperation and the pharmacist in the cancer genomic medicine and problem 平出耕石1,3,4, 宮本義浩1,3, 加藤武司1, 石原哲2,3,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1122-1122, 2019.

---

	P1115-4-AM. With mild measures of the going to hospital treatment room with consecutive holidays long-term in 2019, as a result 六波羅孝1,4, 工藤亜紀子2,4, 白鳥伊久代2,4, 高砂敬一郎3,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1122-1122, 2019.

---

	P1116-4-AM. The enforcement situation of the foreign nourishment diet advice which a foreign chemotherapy room asks for and the effect 野口善久1,2, 高橋真純1,2, 小池あい子1,3, 坂元有紀1,3, 川尻成美1,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1123-1123, 2019.

---

	P1117-4-AM. Fact-finding of the occupational exposure measures in the anticancer agent preparation duties in 29, Rousaibyoin institutions of the whole country 柳澤友希1, 黒須智博1, 山下敦志1, 夏目義明2, 清野敏一3, 伊佐間和郎3, 西村哲治3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1124-1124, 2019.

---

	P1118-4-AM. Fact-finding (additional investigation) of the anticancer agent exposure 宮川貴行1, 古谷幸子1, 井筒理子1, 梶井孝洋1, 水口敦子1, 西澤修一1, 大倉裕祐1, 小嶋麻衣子2, 山本伸弥2, 近森研一3, 武良卓哉4, 松久哲章4, 中川麻子5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1125-1125, 2019.

---

	P1119-4-AM. Role of the pharmacist in occupational exposure to oral anticancer medicine measures 福永千佳子1, 河野えみ子1, 鍜治谷玲子1, 三箇山宏樹1, 馬場綾2, 關壽人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1125-1125, 2019.

---

P1120-4-AM. Examination about the change of the quantity of duties and anticancer medicine exposure to anticancer medicine preparation measures of the pharmacist before and after the anticancer medicine preparation support equipment DARWIN-Chemo operation 入佐俊弘1, 秦晃二郎1, 辻敏和1, 渡邊裕之1, 江頭伸昭1, 増田智先1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1126-1126, 2019.

---

	P1121-4-AM. Exposure measures in the safety cabinet by three kinds of cleaning methods 土橋俊文1, 今井陽介1, 石川星1, 箱島基貴1, 服部多映子1, 松林和幸1, 佐伯潤1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1126-1126, 2019.

---

	P1122-4-AM. The effect that discontinuation, weight loss of TAS102 in elderly people and overall status delinquent patients gives an effect 吉池麻衣1, 杉山昌秀1, 篠原佳祐1, 関口展貴1, 宮田智陽1, 渡邉将隆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1127-1127, 2019.

---

	P1123-4-AM. Making and evaluation of the record template for standardization, the efficiency of cancer chemotherapy medication counseling duties 堀智貴1, 中川智章1, 武知理菜子1, 三宅純子1, 樽井静香1, 吉岡奈津恵1, 福森洋之1, 生島繁樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1128-1128, 2019.

---

	P1124-4-AM. The questionary survey for the health insurance pharmacy pharmacist in the cancer medical therapy and examination of the usefulness of the anticancer medicine instruction contents information report 今川未紀1, 有田仁紀1, 菅井瞳1, 川上達也1, 渡辺和美1, 坂本真紀1, 西澤健司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1128-1128, 2019.

---

	P1125-4-AM. Correspondence ... based on efforts - PBPM of the medicine medicine cooperation in the anticancer agent prescription 秋葉由華1, 長谷川晃司2, 武田智子2, 春名康裕2, 中村暢彦3, 佐野由美子4, 佐村頼寿5, 蓑輪圭一郎6, 小林篤史7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1129-1129, 2019.

---

	P1126-4-AM. Examination of 5 mg of olanzapine to three-drug antiemesis therapy (dex 1) additional effect on CINV in the AC regimen of the breast cancer 末廣真理維1, 計良貴之1, 竹端琴美1, 池川貴和子1, 湊川紘子1, 田中恒明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1130-1130, 2019.

---

	P1127-4-AM. Fact-finding of retching, vomiting in the Carboplatin (AUC >= 4)-containing regimen 富士芳美1, 植田有希2, 和田宜久1, 友井理恵子1, 木村貴1, 木澤成美1, 金銅葉子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1131-1131, 2019.

---

	P1128-4-AM. Examination of the antiemesis effect of palonosetron on Carboplatin 植木大介1, 青野智恵美2, 稲生和彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1131-1131, 2019.

---

	P1129-4-AM. Usefulness investigation of the Goshajinkigan for peripheral neuropathy in patients with Weekly PTX + Bev application breast cancer 東野友貴1, 岩西雄大1, 立川奈保美1, 足立茜子1, 津幡あつ実1, 木村美甫1, 金澤真里1, 寺嶋香奈1, 迫田由佳梨1, 角川幸男1, 高木麻里1, 吉田智江1, 金銅葉子2, 藤田敬子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1132-1132, 2019.

---

	P1130-4-AM. 1 case of the gastric cancer which developed nephrotic syndrome by Ramcirumab 藤林遼1, 鈴木直哉1, 朝倉幹己1, 藤田果那1, 木下愛1, 庄崎沙耶1, 田中耕太1, 山本翔太1, 前川英輝1, 山田将悟1, 菊地義明1, 高橋誠1, 青田忠博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1133-1133, 2019.

---

	P1131-4-AM. Effect of the side effect on treatment continuation of the IRd therapy in the multiple myeloma 森秋子1, 石田耕太2, 加藤淳平2, 立田真也2, 廣澤伊織1, 渡部一宏1, 廣原正宜1, 鈴木憲史3, 細谷治2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1133-1133, 2019.

---

	P1132-4-AM. Effect of the infusion increase in quantity on vascular pain at the oxaliplatin periphery intravenous administration 伊藤実里1, 阪田安彦1, 妹尾啓司1, 岡崎夏実1, 水上皓喜1, 吉川明良1, 宮森伸一1, 開浩一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1134-1134, 2019.

---

	P1133-4-AM. Making ... of education and duties support ... "tool that a side effect is removed" to a pharmacist engaged in cancer chemotherapy 高木麻衣1,2, 伊藤文香2, 鵜飼麻由2, 神谷幸江2, 切畑麻那2, 嶋洋将2, 鈴木大介2, 玉置彩奈2, 冨田庸介2, 川合甲祐2, 山田清文1, 板倉由縁2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1134-1134, 2019.

---

	P1134-4-AM. Elucidation of the onset of phlebitis mechanism by the interaction of Fosaprepitant and the epirubicin 山崎美保1, 和泉寿紀1, 水口真利江1, 前田頼伸2, 小田啓祐3, 森信博3, 村上照夫3, 面田恵1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1135-1135, 2019.

---

	P1135-4-AM. Examination of the expression situation and the risk factor of the neutropenia in the lung cancer nab-paclitaxel + Carboplatin therapy 米山大志1, 岡本美穂2, 佐々木寿子1, 菅原充広1, 佐々木治一郎3, 猶木克彦4, 厚田幸一郎1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1135-1135, 2019.

---

	P1136-4-AM. Examination about the effect that low blood pressure gives to renal failure by the cisplatin 近野祐里1, 中島彰信1, 八尾尚樹1, 大辻貴司1, 中村直美1, 塩田哲広2, 北居千明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1136-1136, 2019.

---

	P1137-4-AM. Search of the nephropathic progress prediction at the cisplatin repeated treatment and effect factor 堀田拓海1, 井澤春香1, 福島恵造1, 池村舞1, 安藤基純1, 富井啓介3, 池末裕明2, 橋田亨2, 杉岡信幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1136-1136, 2019.

---

	P1138-4-AM. Investigation of the effect that administration of anticholinergic drug atropine gives to neutropenia of irinotecan 田中広大1, 胎中博行1, 中井梨郁1, 市川知加子1, 段松雅弘1, 田中聡1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1137-1137, 2019.

---

	P1139-4-AM. Relative investigation with the hand-and-foot syndrome incidence of docetaxel treated patients and disease severity and the indoor environment 内田敬1, 土屋雅美1, 猪岡京子1, 村川康子2, 高村千津子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1137-1137, 2019.

---

	P1140-4-AM. Analysis - from background investigation - PMDA adverse drug reaction database (JADER) of the patients who developed peripheral neuropathy by Oxaliplatin 橋本竜1,2, 前澤佳代子1,2,3, 三浦遥花3, 本多珠里都3, 車田聡美3, 櫻井梨那3, 佐藤晴香3, 杉山奈津子1,3, 伊東岳2,3, 加藤芳徳3, 倉本敬二2,3, 百瀬泰行1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1138-1138, 2019.

---

	P1141-4-AM. Examination about HBV reactivation measures in the cancer chemotherapy 稲葉真実1, 彦坂麻美1, 田代匠1, 市川竜太郎1, 鬼木紘実1, 滝久司1, 高木亮1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1138-1138, 2019.

---

	P1142-4-AM. About an approach of our hospital for the hand-and-foot syndrome in the side effect management team of the liver cancer treatment molecules target medicine 田中智啓1, 近藤理絵1, 太田あづさ1, 河原香織1, 日生下美紀1, 西窪奈津子1, 吉田直恵1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1139-1139, 2019.

---

	P1143-4-AM. Factor to have an influence on the serum lipid after the goserelin administration in men with prostate cancer 桐生浩子1, 有松冴1, 池口麻由子1, 近藤加奈子1, 原美由紀1, 不破朱里1, 今西義紀1, 橋本陽1, 小出哲朗1, 堀田康広2, 木瀬英明3, 伊藤久美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1139-1139, 2019.

---

	P1144-4-AM. Neutropenia with the FP therapy in patients with cancer of the esophagus, investigation about the FN onset 熊澤里美1, 松岡宏2, 平岡佳子1, 村松直幸1, 山田成樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1140-1140, 2019.

---

	P1145-4-AM. Effect on peripheral blood humans immune system of Chinese medicine - supplementary agent - used for patients with cancer and comparison of the characteristic between the preparation maker 清海杏奈1, 松田彩花1, 今井志乃ぶ1, 杉浦宗敏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1140-1140, 2019.

---

	P1146-4-AM. Bowel control intervention effect of the ward pharmacist in the CHOP and THP - COP therapy 水岡大策1, 山口佳津騎1, 高橋功一1, 元木貴大1, 鈴木聖1, 田中裕章1, 加地雅人1, 小坂信二1, 芳地一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1141-1141, 2019.

---

	P1147-4-AM. The expression situation investigation of the dermatopathy in the liver, the pancreas domain gemcitabine and examination of the risk factor 永松秀紹1, 三島江津子1, 榊原洋一1, 小林明日美1, 中野里佳2, 村上照幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1141-1141, 2019.

---

	P1148-4-AM. Association between hypothyroidism and neutrophilic/lymphocytes ratio (NLR) by the nivolumab 元日田阿子1, 中澤佑介1, 影山明1, 川久保孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1142-1142, 2019.

---

	P1149-4-AM. The use situation of pregabalin duloxetine in patients with cancer 下村真代1, 濱野麻子1, 廣田紘子2, 吉野裕統1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1143-1143, 2019.

---

	P1150-4-AM. Examination about the association with the blood test value of patients with end-stage cancer and a painful symptom and the prognosis 小山菜々子1,2,3,4, 松村千佳子1, 佐古守人2, 黒沢秀夫2, 野村剛久2, 江口由紀3, 矢野義孝1, 大場一輝4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1144-1144, 2019.

---

	P1151-4-AM. Use situation investigation of the antimicrobial for the cancer terminally ill patients which discontinued the active treatment with the anticancer agent aiming at antimicrobial proper use promotion 城山亮輔1,2, 山口諒1, 山本武人1,3, 長瀬幸恵1, 高田龍平1, 鈴木洋史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1144-1144, 2019.

---

	P1152-4-AM. The current situation of the heart failure palliative care screening in our hospital and future problem 舟木ひかる1,2, 鈴木澪1,2, 佐々木美理1,2, 山崎幸子1,2, 柏原千草1,2, 平山道乃1,2, 江原晶子1,2, 木村尚子1,2, 嶋中ますみ1,2, 加藤一郎1,2, 土井千春1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1145-1145, 2019.

---

	P1153-4-AM. Effect of the pharmacist education by a problem and the practical skill seminar of the use of Patient-Controlled Analgesia pump in the at-home relaxation medical care 山田正実1,2, 地丸裕美1, 鳥井小莉1, 松村千佳子1,2, 高橋一栄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1145-1145, 2019.

---

	P1154-4-AM. About the efforts to the palliative care unit system in the drug department in our hospital and the role 矢嶋美樹1, 安田麻美1, 松木浩子1, 高橋優香1, 杉浦健一1, 藤岡敬子1, 西関由梨子1, 小林健太郎1, 小関崇文1, 鈴木由佳1, 笠井洋輝1, 加藤由紀1, 安西美咲1, 小杉英恵1, 伊藤早紀1, 横山翔一1, 大橋香菜子1, 鐘司侑希1, 大貫敏明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1146-1146, 2019.

---

	P1155-4-AM. Before and after exploratory single group controlled trial of the improvement effect on lassitude of patients with end-stage cancer with the L-carnitine preparation 中西順子1, 片桐将志1, 篠永浩1, 原田典和1, 加地努1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1146-1146, 2019.

---

	P1156-4-AM. One case of the small-cell lung cancer given VP-16+CBDCA therapy under the haemodialysis 三好孝法1, 松尾尚美1, 鶴田南奈子1, 福山誠一2, 平木洋一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1147-1147, 2019.

---

	P1157-4-AM. We look at the rear of the factor associated with the effectiveness of the immune checkpoint inhibitor and examine a mark 長井宏文1, 戸塚弘幸1, 高橋喜統1, 政氏藤玄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1148-1148, 2019.

---

	P1158-4-AM. Competitive review of the paclitaxel administration method + ramucirumab therapy a week and the albumin suspension type paclitaxel + ramucirumab therapy for the gastric cancer 西和哉1, 川田彰彦1, 高橋舞1, 佐々木崇1, 安田勝洋2, 大堀久詔2, 佐賀利英1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1148-1148, 2019.

---

	P1159-4-AM. About the effectiveness of the Cetuximab administration method a week and the every other week administration method and safety 木村祐子1,2, 市村丈典1,2, 市倉大輔1,2, 縄田修一1,2, 澤田成彦3, 峯村純子1,2, 佐々木忠徳2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1149-1149, 2019.

---

	P1160-4-AM. Use experience of the tolvaptan for the SIADH of patients with lung cancer 桑山果織1, 伊佐治麻里子1, 白井博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1149-1149, 2019.

---

	P1161-4-AM. Efforts for the prescription trend of the CDK4/6 inhibitor and the side effect management 越智良明1, 石井弘幸1, 大渕徹2, 雨宮厚2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1150-1150, 2019.

---

	P1162-4-AM. Promotion of the treatment with safe anticancer agent using the anticancer agent test value list 羽生智宏1, 中村槙一郎1, 財津孝希1, 瀧内瑛輔1, 長澤欣弘1, 田村亜矢子1, 尾形美絵1, 田村和彦1, 新関みどり1, 近藤和宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1150-1150, 2019.

---

	P1163-4-AM. Construction of the Olaparib administration system in consideration for a genetic information 原田智子1, 柿原圭佑1, 三上忠司1, 野田聖奈子1, 白石亘1, 松崎雄1, 武田なつか1, 篠崎千尋1, 松本美紅1, 藤井裕史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1151-1151, 2019.

---

	P1164-4-AM. Efforts and usefulness evaluation of "the clinical academic working group" 徳留章1,2, 齋藤靖弘1,2, 齋藤駿太1, 金崎修治1, 出内秀樹1, 木曽陽一1, 木明貴幸1, 武田清孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1151-1151, 2019.

---

	P1165-4-AM. The current situation investigation about the HBV reactivation measures in patients who received chemotherapy 水嶋萌美1, 塚本絢子1, 渡辺麻里子1, 草信晴美1, 滝波昇悟1, 監物英男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1152-1152, 2019.

---

	P1166-4-AM. Metabolic loam analysis of the metabolite out of the renal carcinoma tissue 高崎新也1, 佐藤友紀2, 川崎芳英2, 前川正充1, 三枝大輔1,3, 伊藤明宏2, 眞野成康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1152-1152, 2019.

---

	P1167-4-AM. Investigation about the factor enabling long-term continuation of the unresectable progress pancreatic cancer GEM + nabPTX therapy 小竹正晃1, 坂井由紀1, 新木貴大1, 鈴木直人1, 外山聡1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1153-1153, 2019.

---

	P1168-4-AM. Cytotoxic comparison for F11 cells derived from sensory nerve with oxaliplatin and fluorouracil 山下郁太1, 入江圭一1, 山口愛貴1, 池帆花1, 下川拓郎1, 松尾宏一2, 林稔展2, 高瀬友美2, 三島健一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1153-1153, 2019.

---

	P1169-4-AM. Examination of the factor that a pharmacist racks the brains about in the communication between patients with cancer - pharmacists 亀田祥代1, 北村佳久1,2, 正岡康幸2, 藤本みなみ1, 千堂年昭1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1154-1154, 2019.

---

	P1170-4-AM. A treatment result of Nivolumab for progress, the recurrent gastric cancer in our hospital and examination of the effect predictor 小山加奈世1, 阿部史誉1, 中山英夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1154-1154, 2019.

---

	P1171-4-AM. Examination of the effect that a history of cigarette smoking gives for an effect of the antiPD-1 antibody medicine 小中健1,2, 斉藤辰彦1,2, 宮森弘子1,2, 森剛志1, 森本美由樹2, 柿内聡司3, 伏谷秀治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1155-1155, 2019.

---

	P1172-4-AM. Efforts of the appearance care team pharmacist 小林華南子1, 岡部真実1, 向井さや香2, 山本智子2, 玉井恭子2, 三好真由子2, 仙波昌三1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1155-1155, 2019.

---

	P1173-4-AM. Recognition investigation for the pharmacist specialized in cancer in the cancer special hospital 藤田行代志1, 新井隆広1, 三島八重子1, 齊藤妙子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1156-1156, 2019.

---

	P1174-4-AM. A preparation comparison of the vascular pain by the gemcitabine and examination of the risk factor 田路章博1, 田中麻理子1, 八瀬恵理子1, 西村真美1, 南山啓吾1, 砂金秀美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1156-1156, 2019.

---

	P1175-4-AM. Fact-finding about the quantity of duties of a cancer chemotherapy preparation room and the cancer chemotherapy center 稲野寛1, 森元能仁2, 佐々木寿子1, 長澤知徳3, 臼井浩明3, 吉田正3, 渡部一宏3, 廣原正宜3, 篠原高雄3, 厚田幸一郎1,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1157-1157, 2019.

---

	P1176-4-AM. Examination of the renal function improvement effect accompanied with the chemotherapy enforcement for patients with first multiple myeloma 中川隼一1, 大場理恵2, 岡田悠美1, 安藤尚美1, 桝茂典1, 高橋苑子1, 茂原圭佑1, 皆川卓也1, 蔭山博之1, 土橋史明2, 平島徹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1157-1157, 2019.

---

	P1177-4-AM. 1 case with suspected drug fever with the antimicrobial 渡貫悠1,2,3,4, 霍間尚樹2, 岩田昌英3, 山本剛4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1158-1158, 2019.

---

	P1178-4-AM. About efforts and the evaluation of the antimicrobial proper use support team activity 管田彩乃1, 下向井唯希1, 神谷真悟1, 岡村智文1, 梅野尚生1, 小川丈彦1, 田口みどり1, 船越幸代1, 田代紀陸2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1159-1159, 2019.

---

	P1179-4-AM. An approach and the effect that we applied to adequacy of the infection prophylaxis antimicrobial after the operation in our hospital 中川綾1, 伊藤智一1, 阪上貴子1, 鈴木信也1, 林誠一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1159-1159, 2019.

---

	P1180-4-AM. Efforts to proper use of the oral antimicrobial in the association of government official cooperative association society Rokko Hospital 宮川裕子1,2, 安保博文2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1160-1160, 2019.

---

	P1181-4-AM. Efforts to proper use of the oral third cephem-based antimicrobial 横田学1, 片岡万里奈1, 榊原洋一1, 村上照幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1160-1160, 2019.

---

	P1182-4-AM. Investigation of the use of oral antimicrobial situation of the Anjo rebirth hospital for the AMR measures action plan 神谷祥世1, 奥平正美1, 伊藤友恵1, 澤田和久1, 土井裕一1, 鵜飼茜1, 小野内拓也1, 杉浦洋二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1161-1161, 2019.

---

	P1183-4-AM. Effect on marker HMGB1 examination of the thrombomodulin derived from sepsis using QCM 中野貴文1,2,3, 松山清4, 安村真子2, 西上知佐2, 野田尚子2, 入江圭一2, 山下郁太2, 仲村佳彦5, 兼重晋3, 神村英利1,3, 三島健一2, 江川孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1161-1161, 2019.

---

P1184-4-AM. Examination about the effectiveness of the antiMRSA medicine in the perioperative period of the artificial joint reimplantation for the delayed-action artificial joint neighborhood infection 高田昂輔1,2, 染谷梨沙1,2, 六鹿和子3, 田中佐知子3, 詫間章俊1,2, 内倉健1, 縄田修一1,2, 前田昭彦4, 川崎恵吉4, 木村聡5, 峯村純子1,2, 佐々木忠徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1162-1162, 2019.

---

	P1185-4-AM. One patient who experienced treatment with voriconazole for Scedosporium apiospermum infection 元木貴大1, 松永圭司2, 山口佳津騎1, 山下紗矢佳1, 水岡大策1, 田井達也1, 加地雅人1, 小坂信二1, 南野哲男2, 芳地一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1162-1162, 2019.

---

	P1186-4-AM. Efforts for the current situation investigation and the antimicrobial adequacy of the perioperative clinical path 上田秀親1, 嶋俊弥1, 高橋麻衣子1, 政井恵1, 小林和正1, 若田達朗1, 和田泰明1, 小島圭太郎2, 石塚恭平3, 高橋洋城4, 白子順子5, 西尾優5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1163-1163, 2019.

---

	P1187-4-AM. Clostridioides difficile infection (CDI) treatment algorithm making and the evaluation 久田瑛吉1, 加藤洋介1, 前田直樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1163-1163, 2019.

---

	P1189-4-AM. The organized activity by the ICT including the promotion of the antimicrobial proper use can improve chemosensitivity of Pseudomonas aeruginosa 山本稔1,2, 中野紗央里1,2, 峯麻紀子1,5, 山口誠1,3, 北原美江1,3, 松原祐一1,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1164-1164, 2019.

---

	P1190-4-AM. Examination about the use of daptomycin for the methicillin-resistant Staphylococcus epidermidis (MRSE) bacteremia 平山忍1,2, 太田登志子1,2, 白根尚子1,2, 松尾和廣3, 中山晴雄2, 日浦寿美子1, 松瀬厚人2, 小林秀樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1165-1165, 2019.

---

	P1191-4-AM. Effective evaluation of the cefmetazole for ESBL-producing bacteria 門野健二1, 天野祐太1, 齊藤彩子1, 武田龍馬1, 本間和加子1, 山澤裕司1, 中村博彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1165-1165, 2019.

---

	P1192-4-AM. It is made the infection prophylaxis antimicrobial adequate after the operation of the ward pharmacist-led clinical path 平野美優1, 巽弥生1, 奥野昌宏1, 田中詳二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1166-1166, 2019.

---

	P1193-4-AM. Examination about the epidemiological clinical features and prognostic factor of the Candida bloodstream infection 塚本仁1, 東高士1, 新谷智則1, 末廣陽子1, 五十嵐敏明1, 古俵孝明1, 上谷幸男1, 渡邉享平1,2, 矢野良一1, 飛田征男3, 岩崎博道4, 後藤伸之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1167-1167, 2019.

---

	P1194-4-AM. The effect on antimicrobial choice of the acute biliary tract infection based on a protocol and clinical outcome evaluation 杢保貴幸1, 大西優里1, 石井康友2, 植田宏治3, 松岡裕士4, 徳竹裕貴1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1167-1167, 2019.

---

	P1195-4-AM. Making and evaluation of the vomit processing set manual in the pharmacy service under health insurance drugstore which aimed at the appropriate vomit processing and the education tool 石原義久1, 竹内正幸2, 石原知香枝1, 柏木宏仁2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1168-1168, 2019.

---

	P1196-4-AM. Investigation of the use of antimicrobial situation after the antimicrobial proper use support team activity start in our hospital 吉田愛1, 山口泰弘1, 中嶋浩太郎1, 中村敦士1, 浦本邦弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1168-1168, 2019.

---

	P1197-4-AM. Efforts of the AST activity using the balun strike scorecard 遠藤修司1, 吉田ミチル1, 斎藤菜穂子1, 冨樫真澄1, 高山芙実子1, 青山寿美香1, 平岩知子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1169-1169, 2019.

---

	P1198-4-AM. 2 cases of the adult Still disease that led to early diagnosis with the consultation to the antimicrobial proper use support team 天野哲史1,2, 生田幸江1,3, 太田晃成1,4, 稲塚信郎1,5, 大橋禎史1,6, 服部晃左1,7, 板倉由縁2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1169-1169, 2019.

---

	P1199-4-AM. An effect after the AS activity start and future problem 久保智士1, 芦澤穂波1, 土本寛子1, 鶴崎亮1, 木村真策1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1170-1170, 2019.

---

	P1200-4-AM. Antimicrobial Stewardship led by the ward pharmacist 杉沢拓磨1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1170-1170, 2019.

---

	P1201-4-AM. About an activity of antimicrobial proper use support team (AST) in the Osaka acute phase, comprehensive medical care center 岩崎瑛子1, 濱名哲大1, 奥村直生1, 綛谷哲也1, 村井千恵1, 坂上嘉浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1171-1171, 2019.

---

	P1202-4-AM. Chemosensitive tendency and trend of Staphylococcus lugdunensis isolates 小林宇太郎1, 金内弘志2, 後藤彰公2, 小山田純治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1171-1171, 2019.

---

	P1203-4-AM. Examination of the perioperative prophylactic antimicrobial of the urologic domain by the cefazolin supply difficulty 根上朋子1, 吉岡睦展1, 杉生雅和1, 石津智司1, 古倉浩次2, 福井浩二2, 大嶋浩一2, 赤木直紀2, 小林敦子3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1172-1172, 2019.

---

	P1204-4-AM. It is ... for adequacy of the Antimicrobial Stewardship activity ... oral antimicrobial of our hospital 石津智司1, 吉岡睦展1, 若松雄太1, 小澤拓1, 杉生雅和1, 高子優子1, 小林敦子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1172-1172, 2019.

---

	P1205-4-AM. The HIV merger product womb pregnant woman case's experience 二星知紗1, 門倉史枝1, 大谷美奈子1, 見上千昭1, 本間久美子1, 西尾孝1, 國東ゆかり1, 松尾裕央2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1173-1173, 2019.

---

	P1206-4-AM. It is the experience using the zidovudine injection drug for the fetomaternal infection prevention of the HIV product womb pregnant woman 門倉史枝1, 二星知紗1, 大谷美奈子1, 見上千昭1, 本間久美子1, 西尾孝1, 國東ゆかり1, 松尾裕央2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1174-1174, 2019.

---

	P1207-4-AM. The current situation investigation of the polypharmacy in the HIV infected person 治田匡平1, 青井博志1, 川崎裕貴1, 古西満2, 辻力夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1174-1174, 2019.

---

	P1208-4-AM. A dose choice of central venous hyperalimentation and the amino acid preparation in the small and medium size hospital and effect on PT-INR 清水忠洋1, 城綾香1, 浅川真由美1, 斎藤安昌1, 曽根原亘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1175-1175, 2019.

---

	P1209-4-AM. Nourishment management of the gastrointestinal carcinoma perioperative period: Effect of the nutrient preparation containing the fatty acid of n-3 origin 鈴木彰人1, 白尾一定2, 本吉佳世3, 武田朋子3, 花牟禮富美雄4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1176-1176, 2019.

---

	P1210-4-AM. Look at the rear of the hypozincaemia-induced possibility drug remedy situation for the blood zinc low level patients; mark investigation 大塚愛美1, 河村聡志1, 森一生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1176-1176, 2019.

---

	P1211-4-AM. About practice and the effect of the medication self-care module 佐合絵里1, 川崎早容1, 川崎智弘2, 西川満里子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1177-1177, 2019.

---

	P1212-4-AM. Prescription pulse-taking of the aperient for the antipsychotics-induced gastrointestinal disorder in our hospital 谷口美紘1, 波多野正和1,2, 松崎遥菜1, 深谷麻実1, 山田成樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1178-1178, 2019.

---

	P1213-4-AM. Population pharmacokinetics analysis of Clozapine and the active metabolite: Hospitalization, foreign effect 小岸かれん1,2, 大村友博1,3, 山本将太1, 中川俊作1, 米澤淳1,2, 糸原光太郎1,2, 竹内理人1,2, 松尾研志1,2, 橋本凱朝1,2, 諏訪太朗4, 佐藤夕紀1, 今井哲司1, 中川貴之1, 村井俊哉4, 矢野育子1,3, 松原和夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1178-1178, 2019.

---

	P1214-4-AM. The night delirium case that quetiapine succeeded 谷口結基1, 白水将憲1, 森智世1, 田中美帆1, 太田達也1, 田中章郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1179-1179, 2019.

---

	P1216-4-AM. Analysis of the factor to require iron medicine, folic acid combined treatment in anemia of the pregnancy treatment of the early or threatened labour patients needing ritodrine intravenous feeding 長谷川京子1, 神田紘介1, 長谷川ゆり1, 三浦清徳1, 橋詰淳哉1, 兒玉幸修1, 中村忠博1, 佐々木均1, 室高広1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1180-1180, 2019.

---

	P1217-4-AM. It is a 1 case using tacrolimus for autoimmune disease during pregnancy 加島朱梨1, 藤川郁世1, 永井絵里子1, 松原侑紀1, 庵森靖弘1, 三島芳枝1, 大津由美子1, 望月千枝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1181-1181, 2019.

---

	P1218-4-AM. One case of the heparin calcium self injection for the obstructive venous thrombosis merger pregnancy patients 廣田あゆ子1, 出宮千聖1, 新城唯1, 河村茉衣1, 松本和也1, 渋川昇平2, 田中正道3, 福家聡一郎3, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1181-1181, 2019.

---

	P1219-4-AM. Relations with an effect factor and the nicardipine cumulative dose of the postpartum hypertension emergency symptom onset 野木山史恭1, 大谷弥生1, 山崎布美子1, 相馬まゆ子1, 佐々木洋一1, 今田愛也2, 猪爪信夫2, 永井匠3, 能代究3, 藤枝聡子3, 計良光昭3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1182-1182, 2019.

---

	P1220-4-AM. Examination of the kidney protection according to the CKD classification in the dapagliflozin 西村功史1, 花井雄貴1, 山西由里子1, 松尾和廣2, 坂本真紀1, 西澤健司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1183-1183, 2019.

---

	P1221-4-AM. The effectiveness of change cases from the DPP-4 inhibitor in patients with type 2 diabetes to Dulaglutide and safe examination 吉野さつき1, 早川伸樹1,2, 津川透1,3, 福井愛子1, 亀井浩行1, 牧野真樹2, 良元亮2, 鈴木敦詞2, 山田成樹3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1184-1184, 2019.

---

	P1222-4-AM. Examination of the lipid improvement effect of the SGLT2 inhibitor on patients with type 2 diabetes 田中壮周1, 大橋史嵩1, 臼窪一平1, 丸山卓哉1, 及川華代1, 田畑裕和1, 稲垣育宏1, 小寺隆二1, 柴波明男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1184-1184, 2019.

---

	P1223-4-AM. The usefulness of the SGLT2 inhibitor in patients with type 2 diabetes and safe examination 小林雅弘1, 早川伸樹1,2, 津川透1,3, 福井愛子1, 亀井浩行1, 吉野寧維2, 岡本慧子2, 鈴木敦詞2, 山田成樹3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1185-1185, 2019.

---

	P1224-4-AM. Dispatch to the area that it merged on efforts world diabetes day in our hospital for diabetes 河村紳介1, 那須田沙織3, 丸井志織3, 原田雅子3, 中村正光5, 芝原裕和5, 岡本貴美子6, 鈴木聡史4, 安江誠人4, 槇野裕也2, 大石祐子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1185-1185, 2019.

---

	P1225-4-AM. The attitude survey about the hypoglycemia measures of patients with diabetes and future problem 岸孝行1, 中尾倫子1, 間宮知子1, 吉岡厚子1, 山田初美2, 森下加惠3, 政次健3, 樫葉利人1, 花岡郁子3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1186-1186, 2019.

---

	P1226-4-AM. Relation of the pharmacist to the patients whom an insulin ball developed in by long-term insulin administration 古川佳子1, 西村信弘1,2, 玉井杏奈1, 倉永勇希1, 古家紗希1, 山口亜里沙1, 宗像千恵1,2, 塚本真大3, 和泉賢一3, 小野恭裕3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1186-1186, 2019.

---

	P1227-4-AM. Efforts of the pharmacist in the dementia care team 中野剛志1, 安井友佳子1, 階堂三砂子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1187-1187, 2019.

---

	P1228-4-AM. About the effect that the anticholinergic agent in the polypharmacy patients, medicine decreasing by it of the benzodiazepine system medicine give for rehabilitation outcome 高田恵司1, 鬼木健太郎2, 松本庄平3, 横田美有1, 畑田雄一1, 猿渡淳二2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1188-1188, 2019.

---

	P1229-4-AM. Taking benzodiazepine drugs in the femur fracture inpatient and the current situation of the polypharmacy 小原朋也1, 片原憂斗1, 瀧川美和1, 島崎良知1, 森淑子1, 石川讓治2, 岩切理歌3, 時村文秋4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1188-1188, 2019.

---

	P1230-4-AM. Examination about the renal function evaluation in elderly people less than serum creatinine level 0.6 mg/dL 田畑貴康1, 福田もえ1, 宮本晃輔1, 岸本千絵1, 山口伸二1, 原圭子1, 山下秀之1, 中村徹志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1189-1189, 2019.

---

	P1231-4-AM. Of the bone fracture protective efficacy after the teriparatide administration actually arrive 城戸美恵子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1190-1190, 2019.

---

	P1233-4-AM. It is a 2 case using Apixaban after the transcatheter aortic valve replacement enforcement 水野稜子1, 谷口仁孝1, 山本彩佳1, 千葉恵美子1, 渡邉美樹1, 前川知子1, 坂井愛実1, 前田典子1, 小原祐子1, 徳村博子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1191-1191, 2019.

---

	P1234-4-AM. Examination of the clinical response of the Hochuekkito after the pneumonectomy 廣瀬達也1, 黒田彩夏1, 篠田康孝1,2, 三岡麻千子1, 森光輝1, 川地雄基1, 守屋昭宏1, 田中孝治1, 竹田亜子1, 宇佐美英績1, 杉山正2, 吉村知哲1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1192-1192, 2019.

---

	P1235-4-AM. Factor examination, analysis of the cerebrovascular spasm onset under the cilostazol administration in patients with subarachnoid hemorrhage 天野祐太1, 門野健二1, 吉田美咲1, 武田龍馬1, 山澤裕司2, 本間和加子1, 上山憲司3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1192-1192, 2019.

---

	P1236-4-AM. Examination about the predictive index of the weight and the BNP decrease in tolvaptan introduction case for the heart failure 篠田梨恵1, 篠田康孝1, 森卓之1, 吉村知哲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1193-1193, 2019.

---

	P1237-4-AM. About the relation of the pharmacist to proximal thighbone bone fracture re-bone fracture prevention support service in our hospital 富樫博敬1, 河原香織1, 日生下美紀1, 西窪奈津子1, 吉田直恵1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1193-1193, 2019.

---

	P1238-4-AM. After the operation with participation - perioperative care of the pharmacist in the anesthesia management of the atrial fibrillation ablation effect on awakening - 黒岩亮平1,3, 平尾龍彦2, 井口恵美子1, 加藤裕久3, 猪股克彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1194-1194, 2019.

---

	P1239-4-AM. A report and examination of the minocycline infusion sclerotherapy through the drainage tube in the huge hepatic cyst 竹野孝慶1, 本田博樹2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1194-1194, 2019.

---

	P1240-4-AM. Usefulness of the morphine injection drug in patients with terminal heart failure, - including the investigation - impaired renal function merger case about the safety 西村健二1, 小林晃子1, 亀井健人1, 高柳和伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1195-1195, 2019.

---

	P1241-4-AM. Efforts in the area for the local inclusion care systems construction 伊東健一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1196-1196, 2019.

---

	P1242-4-AM. Pharmacist dispatch from a university hospital aiming at community medical care cooperation to the community hospital 龍田涼佑1, 炭本隆宏1, 田中遼大1, 中原良介1, 佐藤雄己1, 伊東弘樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1197-1197, 2019.

---

	P1243-4-AM. It is ... through discharge support in thing - NICU/GCU which is made to connect to the treatment at home 大西知絵1, 勝弘毅1, 溝口和代1, 阿部康治1, 内薗広匡2, 栗本淳子3, 林眞砂子4, 寺田幸司5, 小林竜也5, 石垣孝5, 服部文乃5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1197-1197, 2019.

---

	P1244-4-AM. Questionary survey about the infection measures for drugstore pharmacists 中山雅裕1, 安田恵1, 天野学1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1198-1198, 2019.

---

	P1245-4-AM. The number of doubt inquiries after the prior agreement protocol operation of the outside Parliament prescription 矢野涼子1, 間瀬広樹1, 室谷理沙1, 杉村勇人1, 河崎文洋1, 坂野由宇希2, 村田世里子2, 齋藤讓一1, 秋山哲平1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1199-1199, 2019.

---

	P1246-4-AM. Effect on health insurance pharmacy duties of the outside Parliament prescription inquiry simplification protocol 村川公央1, 猪田宏美1, 西原茂樹1, 北村佳久1, 千堂年昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1200-1200, 2019.

---

	P1247-4-AM. Comparison of the medication reporting book in the community-acquired acute phase hospital 小川充恵1, 大里恭章3, 井上麻衣1, 小枝伸行2, 山崎肇1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1200-1200, 2019.

---

	P1248-4-AM. Efforts (the second report) of the medicine medicine cooperation in the Komaki Municipal Hospital 水谷貴樹1,2, 山本泰大1,2, 山本将司1,2, 戸田康裕1,2, 仲井伸子2,3, 松山苑未2,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1201-1201, 2019.

---

	P1249-4-AM. Efforts of the medicine medicine cooperation through the prescription analysis in the Soka medical therapy workshop 村社計寿1,10,11, 森田元2,10,11, 山崎あすか3,10,11, 増田怜平1,10, 青木悠一4,10,11, 大石卓也5,10,11, 葉山智恵6,10,11, 岸岡奈実7,10,11, 鮎澤道代8,10,11, 木村直也1,10,11, 須鴨一正9,10,11, 源川良一1,10,11 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1201-1201, 2019.

---

	P1250-4-AM. About the improvement of duties by the protocol making of doubt inquiry 豊田悠希1, 小松沙妃1, 加藤あゆみ1, 武方みなみ1, 松本大輝1, 篠原正樹1, 星加寿子1, 矢野琢也1, 谷崎文彦1, 福岡竜逸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1202-1202, 2019.

---

	P1251-4-AM. About the doubt inquiry protocol making in the outside Parliament prescription 鈴山直人1, 高島伸也2, 湊本康則1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1202-1202, 2019.

---

	P1252-4-AM. About outside Parliament prescription doubt inquiry simplification protocol introduction in the Kyoritsu Kanbara General Hospital and the effect 渡辺俊輔1, 竹下秀司1, 久保田倫代1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1203-1203, 2019.

---

	P1253-4-AM. Role of the issue of Residual medicine and the hospital pharmacist whom an outpatient has 松田一駿1, 堀絵理1, 中村雄太郎1, 眞木秀子1, 板垣有紀1, 羽太光範1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1203-1203, 2019.

---

	P1254-4-AM. How did doubt inquiry change by the test value printing of the outside Parliament prescription? 小島一晃1, 松永富美代2, 山村裕佳子1, 森川智子1, 林愛華1, 濱武清範1, 野間敏也1, 酒井ちひろ1, 松本弘誠1, 中西輝1, 小西史子1, 仲忠士1, 美和孝之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1204-1204, 2019.

---

	P1255-4-AM. Efforts for the proper use of the potassium preparation in our hospital 丘龍祥1,2, 稲毛あずさ1, 金野昇1, 山口浩明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1205-1205, 2019.

---

	P1257-4-AM. Efforts of the potentially serious medical errors recurrent prevention in our hospital pharmacy 佐倉小百合1, 大前隆広1, 上田里恵1, 國東ゆかり2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1206-1206, 2019.

---

	P1258-4-AM. Search of the factor factor of the potentially serious medical errors in the health insurance pharmacy 佐々木善信1, 羽田明浩2, 平山武司1,3, 厚田幸一郎1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1207-1207, 2019.

---

	P1259-4-AM. Efforts about the management of the use of pharmaceutical products such as nonrecognition, and the like in Kanazawa University Hospital 板井進悟1, 山本奈歩1, 川岸篤史1, 原祐輔1, 増江俊子1,2, 嶋田努1, 崔吉道1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1207-1207, 2019.

---

	P1261-4-AM. Participation of the medical drug incident report example and pharmacist in the palliative care hospital 椎崎正秀1,2, 原口勝3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1208-1208, 2019.

---

	P1262-4-AM. Investigation about the result of a doubt inquiry for the prescription of the resident in the emergency visit and the efforts of the pharmacy 向山直樹1, 向山麻衣子1, 成瀬徳彦1, 黒野康正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1209-1209, 2019.

---

	P1263-4-AM. The learning effect using the monitoring sheet of 8 representative diseases in the ward training and evaluation of the satisfaction 安藤久美子1, 島忠光1, 河島雄大1, 浅木知子1, 中島圭佑1, 榎本弘美1, 渡部多真紀1,2, 河村剛至1,2, 安野伸浩1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1210-1210, 2019.

---

	P1264-4-AM. Because when the business training in the new core curriculum begins, ... student participates in team approach in medical care, by all means from a visit to an experience 渡邉正教1, 中沢修司1, 日比徹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1211-1211, 2019.

---

	P1265-4-AM. Establishment of the system of the outline evaluation based on the diachronic instruction record of person in charge of ward training patients 新井亘1, 土屋裕伴1, 増田裕一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1211-1211, 2019.

---

	P1266-4-AM. The effect that the number of the experience of 8 representative diseases in the pharmacy business training gives for an outline evaluation 清宮啓介1, 池淵由香1, 津田壮一郎1, 別府紀子1, 青森達1,2, 鈴木小夜3, 地引綾3, 横山雄太3, 河添仁3, 岩田紘樹3, 小林典子3, 藤本和子3, 早川智久1, 山浦克典3, 中村智徳3, 村松博1, 望月眞弓2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1212-1212, 2019.

---

	P1267-4-AM. The effect that the early clinical experience in the hospital gives to the occupational interest of the first annual student 永田実沙1, 串畑太郎1, 上田昌宏1, 栗尾和佐子1, 安原智久1, 曽根知道1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1213-1213, 2019.

---

	P1268-4-AM. The effect that the communication education utilizing the simulated patient gives in a skill, the manner in the practice curriculum of the pharmacy student in 4 annual 福井愛子1, 半谷眞七子1, 伊東亜紀雄1, 黒野俊介1, 野田幸裕1, 吉見陽1, 亀井浩行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1214-1214, 2019.

---

	P1269-4-AM. Significance of the anti-doping education utilizing the active learning for the pharmacy school student 杉山育美1, 佐塚泰之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1214-1214, 2019.

---

	P1270-4-AM. It is ... including the duties cooperation with ... nursing department about the review of the duties contents by the change of the injection drug withdrawal device 小山晃生1, 谷口朝香1, 前北章衣1, 江藤恭子1, 木村泰巳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1215-1215, 2019.

---

	P1271-4-AM. In examination - construction fourth year of new face education system in our hospital, we were able to see it from reflection 樋本繭子1, 日原章詔1, 木村有子1, 新免徹1, 高瀬尚武1, 三木育子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1216-1216, 2019.

---

	P1272-4-AM. It is ... about a qualification and the staff education of efforts ... staff of the pharmacy for the JCI certification 田中博和1, 山下大貴1, 馬島礼1, 立石裕樹1, 後藤貴央1, 與田賢作1, 秋吉正貴1, 宮津大輔1, 井上幸子1, 平川雅章1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1216-1216, 2019.

---

	We improve a pharmacist power supporting medical care with patients 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 101-101, 2020.

---

	Efforts and problem for the further development of the Japanese cure association 奥田真弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 102-102, 2020.

---

	SL1. Medical therapy of the gastric cancer to examine in gastric cancer treatment guidelines 小寺泰弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 103-103, 2020.

---

	SL3. Contribution to society of the pharmaceutical company which fixed its eyes on the medical future 手代木功1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 105-105, 2020.

---

	SL4. We regard the present and the future of pharmacologic - AI as medical care 池谷裕二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 106-106, 2020.

---

	EL1. The current situation of the genomic medicine and future directionality 尾崎紀夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 107-107, 2020.

---

	EL2. Personalized medicine: TDM vs. genomic medicine 谷川原祐介1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 108-108, 2020.

---

	EL3. Pharmacist duties of one day are not everlasting pharmacist duties 松原和夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 109-109, 2020.

---

	EL4. The current situation and the future of the Alzheimer therapeutic drug 服部光治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 110-110, 2020.

---

	EL5. It is ... with ... pharmacist protecting patients from mishaps in medical practice 長尾能雅1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 111-111, 2020.

---

	ES1-1. From the situation of the physician who was the practice of COVID-19 忽那賢志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 113-113, 2020.

---

	ES1-2. From the position of the pharmacist of the medical institution which gave medical care of COVID-19 梅村拓巳1, 武藤義和2, 太田愛子1, 伊藤雄紀1, 伊藤晴也1, 小崎耕自1, 位田陽史2, 石原誉志美2, 小林有里2, 須川真規子2, 市原利彦2, 山田哲也1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 114-114, 2020.

---

	International Symposium 1. Efficient and productive pharmacist profession in the future - Point of view of Pharmaceutical Care, Education, Research and Social Contribution-1 Yasuo Takeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 121-121, 2020.

---

	IS01-3. Pharmacist Education and Professionalism in Japan and the United States Misuko Onda1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 123-124, 2020.

---

	IS01-4. Role of Pharmacist in Primary Care Setting During Covid-19 Pandemic : Thailand's Experience Jatuporn Thong-Im1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 125-126, 2020.

---

	IS02-SP. Establishment of the Clinical Pharmacist Okayama Simulation Training for Next - generation Pharmacists Toshiaki Sendo1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 127-128, 2020.

---

	IS02-1. Pharmaceutical GS1 barcodes for patient safety: preventing picking error and improving traceability Koichi Uemura1, Takao Orii2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 129-129, 2020.

---

	IS02-2. Developing a Japanese version of the "Scale of Attitudes Toward Pharmacist-Physician Collaboration" Kanayuki Kitahara1, Takeshi Uchikura1, Yuta Nio1, Satoko Katsuragi1, Keinosuke Okazaki1, Yoshiko Nishi2, Takashi Kawaguchi3, Takuhiro Yamaguchi4, Tadanori Sasaki1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 130-130, 2020.

---

IS02-3. Analysis of immune-related adverse events caused by immune checkpoint inhibitors using the Japanese Adverse Drug Event Report database Shiori Hasegawa1,2, Hiroaki Ikesue1, Satoshi Nakao2, Kazuyo Shimada2, Ririka Mukai2, Mizuki Tanaka2, Kiyoka Matsumoto2, Misaki Inoue2, Riko Satake2, Yuu Yoshida2, Fumiya Goto2, Tohru Hashida1, Mitsuhiro Nakamura2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 131-131, 2020.

---

	Symposium 1. [practice] How do you make use of infection measures cooperation common platform (J-SIPHE) in drug-resistant (AMR) measures? 北原隆志, 大曲貴夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 132-132, 2020.

---

	S01-1. A summary of J-SIPHE and future directionality 村木優一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 134-134, 2020.

---

	S01-2. The utilization situation in the Nagoya district 加藤善章1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 135-135, 2020.

---

	S01-3. Inflection report of J-SIPHE about the improvement in hand hygiene in JCHO 片山歳也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 136-136, 2020.

---

	S01-4. The utilization situation between the national and public universities Hospital 浦上宗治1, 加賀谷英彰1, 山崎伸吾1, 沖畠里恵1, 丹羽隆1, 冨田隆志1, 徳江豊1, 高山和郎1, 村上啓雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 137-137, 2020.

---

	S01-5. Activities by the cooperation between areas in capital disease medicine, Shinjuku-ku 木村利美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 138-138, 2020.

---

	Symposium 2. [Medical care] Onco-Cardiology Let's learn science - task sharing, demonstrating pharmacist power to manage in the shift era - 向井幹夫, 藤堂真紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 139-139, 2020.

---

	S02-1. With the tumor angiocardiology? Demand it from a pharmacist in clinical settings 向井幹夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 141-141, 2020.

---

	S02-2. Result report of the research of the field of Onco-Cardiology where a pharmacist sends it to 平出誠1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 142-142, 2020.

---

	S02-3. About the side effect regime of the anticancer medicine which a setup and a pharmacist can play for Onco-Cardiology team 藤堂真紀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 143-143, 2020.

---

	S02-4. How can the pharmacist play an active part in the settings of Onco-Cardiology? We think about this 中埜信太郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 144-144, 2020.

---

	Symposium 3. [practice] ... which learns which renal function you should use for administration plan from a ... pit fall case 平田純生, 竹内裕紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 145-145, 2020.

---

	S03-1. Evaluation of the renal function of frailty sarcopenia elderly people 平田純生1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 147-147, 2020.

---

	S03-2. Pit fall of the renal function notation of the package insert 竹内裕紀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 148-148, 2020.

---

	S03-3. Usefulness and pit fall of the serum creatinine level 浦田元樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 149-149, 2020.

---

	S03-4. Use and pit fall of estimation CCr, eGFR 川上倫子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 150-150, 2020.

---

	S03-5. Usefulness and pit fall of cystatin C 津下遥香1, 田中遼大1, 龍田涼佑1, 伊東弘樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 151-151, 2020.

---

	S03-6. Usefulness and pit fall of the round up method 大谷知子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 152-152, 2020.

---

	Symposium 4. [practice] How should the pharmacist work to prevent the becoming severe of the immune-mediated adverse event? 渡邊裕之, 池田宗彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 153-153, 2020.

---

	S04-1. Relation of the pharmacist in the irAE management 藤堂真紀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 155-155, 2020.

---

	S04-2. Multicenter collaboration aimed at safe cancer treatment practiced by pharmacists - Kagoshima Cancer Immunotherapy Support Network KISnet - 上原友美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 156-156, 2020.

---

	S04-3. The need of regional alliances of the irAE management that we were able to see by an activity of Kyushu University Hospital team ICI 南晴奈1, 池田宗彦1, 秦晃二郎1, 渡邊裕之1, 家入一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 157-157, 2020.

---

	S04-4. "Thing - "which is necessary for ... drugstore pharmacist to support ICI proper use 古賀友一郎1, 村田峰生1, 林田諭1, 加藤周子1, 石橋正次1, 川本健司1, 高木淳一1, 鷲山厚司1, 田中泰三1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 158-158, 2020.

---

	Symposium 5. [education] Upbringing of the next-generation leader solving a clinical problem in the cancer chemotherapy 橋本浩伸, 河添仁 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 159-159, 2020.

---

	S05-1. The study achievements that are demanded from a pharmacist specialized in a cancer 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 160-160, 2020.

---

	S05-2. Difference between study and clinical studies that the 6-year pharmacist who is a graduate feels that is a graduate 馬場楓1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 161-161, 2020.

---

	S05-3. Importance of rationale in the instruction of the study (the study that is a graduate) by the pharmacy student 橋本浩伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 162-162, 2020.

---

	S05-4. That the purpose studying creates evidence and returns it to future patients 河添仁1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 163-163, 2020.

---

	S05-5. Step ... to fight ... weak conquest without the end with English presentation, the English article 大谷壽一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 164-164, 2020.

---

	Symposium 6. [study] For the creation of the innovative therapeutic drug which rose in the viewpoint of drug discovery study - clinical pharmacy that academic hospital automation pharmacy challenged - 齋藤秀之, 石澤啓介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 165-165, 2020.

---

	S06-1. Study on uric acid transporter and uric acid descent medicine found by genome analysis 高田龍平1, 宮田大資1, 豊田優1, 鈴木洋史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 167-167, 2020.

---

	S06-2. Creation of the high affinity chaperone compound which is optimal for lysosomal disease treatment to function as a structure stabilizer of the mutation enzyme 加藤敦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 168-168, 2020.

---

	S06-3. Strategy for prophylactic/therapeutic drug development for cancer chemotherapy-induced peripheral neuropathy 中川貴之1, 荻原孝史1, 小柳円花1, 今井哲司1, 松原和夫1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 169-169, 2020.

---

	S06-4. Search of the renal failure extension inhibition therapeutic drug which assumed production responsibility enzyme SULT1A1 of the sulfuric acid conjugation type urine toxin a target 齋藤秀之1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 170-170, 2020.

---

	S06-5. Drug repositioning study utilizing medical big data 座間味義人1,2, 新村貴博1, 石澤有紀3, 合田光寛2, 濱野裕章2, 岡田直人2, 八木健太4, 中馬真幸4, 桐野靖2, 中村敏己2, 石澤啓介1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 171-171, 2020.

---

	Symposium 7. [contribution to society] The clinical reasoning in the acute intoxication medical care 堀寧, 峯村純子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 172-172, 2020.

---

	S07-1. Nearby caffeinism! The appropriate management is a duty of the pharmacist 今井徹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 174-174, 2020.

---

	S07-2. Diphenhydramine poisoning to feel from clinical manifestations 佐藤智人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 175-175, 2020.

---

	S07-4. The clinical reasoning of the acute methanol poisoning with the unidentified metabolic acidosis 波多野亘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 177-177, 2020.

---

	S07-5. Toxic side effect to assume kidney origin 平田純生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 178-178, 2020.

---

	Symposium 8. [education] To build rehabilitation nourishment and the knowledge ... elderly people with rehabilitation drug society which want to know full of life; ... 中村直人, 東敬一朗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 179-179, 2020.

---

	S08-1. About sarcopenia frailty - elderly people society and medical therapy - 中村直人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 181-181, 2020.

---

	S08-2. - to make use from - tomorrow in duties about rehabilitation nourishment, a rehabilitation drug 東敬一朗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 182-182, 2020.

---

	S08-3. Mainly on activity place and multi-type of job cooperation - polypharmacy efforts example of the pharmacist - 中道真理子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 183-183, 2020.

---

	S08-4. Than the workshop of the practice rehabilitation drug - country bionomics classification working in an area ... 久保田恵理1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 184-184, 2020.

---

	S08-5. We expect it of rehabilitation nourishment and fine-view - pharmacist of the rehabilitation drug 若林秀隆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2020.

---

	Symposium 9. [study] The clinical application of the mechanism elucidation of the internal change change by fundamental researches: When we end it in phenomenalism, it is a waste! 内田信也, 工藤敏之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2020.

---

	S09-1. Fundamental researches of the internal change change mechanism aiming at clinical application 工藤敏之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2020.

---

	S09-2. Clinical practice and basic pharmaceutic integration study aiming at an interaction mechanism elucidation of the polypharmacy 黄倉崇1, 志保美月1, 中谷絵理子1, 赤下学1, 山田静雄2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2020.

---

	S09-3. Quantitative analysis based on the mechanism of drug interactions: Inflection of OATP substrate medicine (probe) and the internal substrate 吉門崇1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2020.

---

	S09-4. Factor elucidation of the individual difference to give the effectiveness, safety of the fentanyl percutaneous absorption type preparation 嶋田努1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2020.

---

	S09-5. Application to medical treatment of the internal change information 乾直輝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2020.

---

	Symposium 10. [Social contribution] New knowledge required for pharmacists in cancer and reproductive medicine - Up to date Oncofertility for Pharmacist - 米村雅人, 網野一真 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2020.

---

	S10-1. The support system about the generative function preservation of patients with children, AYA generation cancer, Mainly on importance of the multi-type of job cooperation 古井辰郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2020.

---

	S10-2. Viewpoint ... from the current situation of the guidelines on patients receiving anticancer medicine development in the contraception and the difference between problem - country 米村雅人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2020.

---

	S10-3. Knowledge ... from change - fundamental researches of the sexual function after the treatment with anticancer agent 片岡智哉1, 木村和哲1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2020.

---

	S10-4. It is ... from the viewpoint of bridge - pregnant woman, nursing mother medical therapy authorization pharmacists from "the pregnancy and medicine consultation are foreign" to "fecundity preservation is foreign" 長谷川まゆみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2020.

---

	Symposium 11. [practice] Progress of inflammatory bowel disease - medical therapy and role of the pharmacist, problem ... 八木澤啓司, 中村健志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2020.

---

	S11-1. Expectation - to importance and a pharmacist of progress - MDT of the medical therapy in the inflammatory bowel disease 新崎信一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2020.

---

	S11-2. Relation ... current situation and problem ... of the pharmacist to the IBD patients 八木澤啓司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2020.

---

	S11-3. Relation of the pharmacist to an inpatient 中村健志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2020.

---

	S11-4. Relation of the pharmacist to an outpatient 宇田川雄也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2020.

---

	S11-5. Relation of the IBD patients and the pharmacist of the childhood onset nemaline myopathy 笠原沙耶香1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2020.

---

	Symposium 12. [education] Ring - of the childhood medical therapy to widen in other types of job from importance and current situation - pharmacist of the pediatric medical therapy education 冨家俊弥, 石川洋一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2020.

---

	S12-1. Education to a physician 詫間梨恵1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2020.

---

	S12-2. It is the instructional activity for other types of job, the patients family from a pharmacist in university hospital NICU, GCU 若林仁美1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2020.

---

	S12-3. From the position of the nurse of the NICU: Wanting a pharmacist to tell, being taught it, and being helpful 井出由美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2020.

---

	S12-4. Education from the pharmacist in the university hospital public children to other types of job 松岡順子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2020.

---

	S12-5. Education from the pharmacist in the children in general hospital domain to other types of job 鈴木秀明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2020.

---

	Symposium 13. [study] Next-generation medical care ... which drug discovery, Ikuyaku study - clinical pharmacist from approach of the clinical pharmacy opens up 城野博史, 兒玉幸修 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2020.

---

	S13-1. Creation of a nucleic acid, gene medicine which assumes the multifunctional type DDS preparation which we designed by a viewpoint of the clinical pharmacy a base 兒玉幸修1, 佐々木均1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2020.

---

	S13-2. Creation of next-generation multitarget type super molecule RNAi medicine based on clinical needs of intractable disease treatment 城野博史1,2, 安東由喜雄3, 齋藤秀之1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2020.

---

	S13-3. Drug repositioning study for the side effect of drug resistant bacterium therapeutic drug prevention which obtained an idea from clinical studies 中馬真幸1, 座間味義人2,3, 合田光寛3, 八木健太1, 濱野裕章3, 岡田直人3, 近藤正輝1, 楊河宏章1, 石澤啓介2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2020.

---

	S13-4. Search of the new treatment, preventive preparation based on biomarker of anticancer agent-induced peripheral neuropathy and the pathogenesis 今井哲司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2020.

---

	Symposium 14. [contribution to society] We regard the way of the intelligence as the reporting activity under "the guidelines about the sale reporting activity on ethical drug" 林昌洋, 後藤伸之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2020.

---

	S14-1. Process and aim of the guidelines development 江野英夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2020.

---

	S14-2. Original role, mission of the significance of existence and the MR of the MR which we saw by the enforcement of guidelines 近澤洋平1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2020.

---

	S14-3. A reporting activity and intelligence under the sale reporting activity guidelines judging from the position of the pharmacist specialized in drug information 冨田隆志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2020.

---

	S14-4. - From the position of the hospital duty pharmacist - 坂田洋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2020.

---

	Symposium 15. [practice] Pit fall of the elderly people medical treatment 大井一弥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2020.

---

	S15-2. Precaution in the infection medical therapy in elderly people 榎屋友幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2020.

---

	S15-3. A way of thinking and evaluation of the elderly people cancer medical therapy 松尾宏一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2020.

---

	S15-4. It is ... from the current situation than prescription suggestion ... "suit of the symptom" of the pharmacist in the elderly people medical therapy with much "test value" prescription intervention that we started from 柴田ゆうか1, 松尾裕彰2, 伊藤英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2020.

---

	S15-5. As for the basis of the pressure sore treatment medicine for external application, ... basis characteristic to have the effect that is equivalent to medicinal properties is associated with extracellular matrix complexation; and is promotion ... for healing 古田勝経1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2020.

---

	Symposium 16. [practice] The patients support that is seamless until after a discharge before PFM (Patient Flow Management), hospitalization 竹内正幸, 大木剛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2020.

---

	S16-1. A role and problem of the ethical pharmacy in PFM 永井尭範1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2020.

---

	S16-2. Hospitalization and release information cooperation ... utilizing efforts - ICT of Yao-shi toward PFM 小川充恵1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2020.

---

	S16-3. Medicine medicine cooperation using Dr.JOY 林信至1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2020.

---

	S16-4. Problems and problem of the drug summary judging from MSW 青木美典1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2020.

---

	Symposium 17. [practice] Proposal about drug duties of the heart failure palliative care 高井靖, 寺崎展幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2020.

---

	S17-1. Role ... of process, the pharmacist of process of heart failure palliative care - making about drug duties 高井靖1,10, 芦川直也2,10, 櫻下弘志3, 志方敏幸4,10, 寺崎展幸5,10, 土岐真路6,10, 前田朱香7,10, 吉国健司8, 佐藤幸人9,10 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2020.

---

	S17-2. The current situation and directionality of the heart failure palliative care 佐藤幸人1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2020.

---

	S17-3. About process of heart failure palliative care - breathing pain, lassitude about drug duties - 寺崎展幸1,10, 高井靖2,10, 芦川直也310, 櫻下弘志4,10, 志方敏幸5,10, 土岐真路6,10, 前田朱香7,10, 吉国健司8, 佐藤幸人9,10 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 241-241, 2020.

---

	S17-4. About process of heart failure palliative care - delirium, sleeplessness about drug duties - 前田朱香1,10, 土岐真路2,10, 芦川直也3,10, 櫻下弘志4, 志方敏幸5,10, 高井靖6,10, 寺崎展幸7,10, 吉国健司8, 佐藤幸人9,10 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2020.

---

	S17-5. About process of heart failure palliative care - pain, inappetence about drug duties - 志方敏幸1,10, 高井靖2,10, 芦川直也3,10, 櫻下弘志4, 寺崎展幸5,10, 土岐真路6,10, 前田朱香7,10, 吉国健司8, 佐藤幸人9,10 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2020.

---

	Symposium 18. [study] Use and application does real world data for database investigation/study after the production and sales 青木事成, 折井孝男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2020.

---

	S18-2. The reliability of data: Efforts - of standardization and the validation - Kagawa University Hospital 樋口和子1, 谷川雅俊2, 横井英人2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2020.

---

	S18-3. Conducting data management to secure high quality 高田敦史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2020.

---

	S18-4. Is Class B gourmet? Cookery ... of ... real world data 青木事成1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2020.

---

	Symposium 19. [practice] Know-how of the medical cooperation to support of the medical diversification 室井延之, 荒木隆一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2020.

---

	S19-1. From an advanced example of know-how - whole country of the hospitalization and release support task by the pharmacist connecting to the living of patients - 室井延之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2020.

---

	S19-2. We think about the regional alliances that fixed their eyes on 2040 荒木隆一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2020.

---

	S19-3. From medical cooperation - inside the hospital that a pharmacist sends to the area - 筒井由佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2020.

---

	Symposium 20. [practice] You evaluate what, and, at which antithrombotic therapy ... point in time in the perioperative period, how do you cope? ... 柴田ゆうか, 芦川直也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2020.

---

	S20-1. Catheterization and antithrombotic therapy of the ischemic heart disease 前田朱香1, 入江利行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2020.

---

	S20-2. Cardiac Surgery and antithrombotic therapy 鈴木正論1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2020.

---

	S20-3. After all, is it new that a pharmacist supports by intervention and antithrombotic therapy - new treatment to arrhythmia and heart structural disease (SHD)? - 土岐真路1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2020.

---

	S20-4. The neutralization medical treatment that is used at the emergency surgery of the use of antithrombotic drug patients 原直己1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2020.

---

	S20-5. Around way of thinking and antithrombotic drug management - Noncardiac Surgery of bleeding and the clot risk of the perioperative patients - 柴田ゆうか1, 松尾裕彰2, 伊藤英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2020.

---

	Symposium 21. [study] - Japan and China medical society cosponsorship symposium - to regard proper use as science of the Chinese medicine 礒濱洋一郎, 本間真人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2020.

---

	S21-1. Pharmacologic action of the Chinese medicine and close relations of the aquaporin: Mainly on Goreisan 礒濱洋一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2020.

---

	S21-2. Side effect of the Glycyrrhiza, search of the cause ingredient of the pseudoaldosteronism 牧野利明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2020.

---

	S21-3. The use actual situation and adverse event of the Chinese medicine 本間真人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2020.

---

	S21-4. About package insert information to contribute to proper use of the Chinese medicine 袴塚高志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2020.

---

	Symposium 22. [study] Pit fall in a theory and the pharmacy study of the signal detection 漆原尚巳, 後藤伸之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2020.

---

	S22-1. A fact and problem of the safety of medicine report 後藤伸之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2020.

---

	S22-2. Spontaneous report (side effect report) in the pharmaceutical company and database - scenery and utilization - 宮崎真1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2020.

---

	S22-3. The signal detection, starting farming for the year 漆原尚巳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2020.

---

	S22-4. The matter which should note it in a data mining study using JADER 酒井隆全1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2020.

---

	Symposium 23. [study] We think and let's tie it! The way of the pharmacy education which university, a hospital, a drugstore cooperates and should aim at 高橋一栄, 平田收正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2020.

---

	S23-1. About nature and before graduation, postgraduate education sought by a pharmacist engaged in emergency care 今井徹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2020.

---

	S23-2. Nature and education of the pharmacist sought by emergency intensive care, disaster medical care 吉川博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2020.

---

	S23-3. About the cooperation of university in the before graduation pharmacy education and the clinical pharmacist 佐古守人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2020.

---

	S23-4. Pharmacy student and - to think, and to support community medical care as role - medical care person of the hospital pharmacist to "a cancer, palliative care" 辻井聡容1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2020.

---

	S23-5. From a prescription proposer to a corporate strategy planner 野崎歩1, 堀内望1, 奥川寛1, 馬橋美由季1, 小林由佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2020.

---

	S23-6. Hospital, drugstore cooperation business training by the pharmacist training program to take local team approach in medical care on 平田收正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2020.

---

	Symposium 24. [study] ... that the use and application of ... AI/ICT to make use of a next-generation ICT technique in pharmacist duties advances to here 神崎浩孝, 千堂年昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2020.

---

	S24-1. Work-style reform (patients correspondence, drug information management edition) of the pharmacist utilizing AI/ICT 望月伸夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2020.

---

	S24-2. The example of efforts - Tokushukai group to improvement in medical quality using data for the cause - 野村浩子1,2, 藤村義明2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2020.

---

	S24-3. It is effectively utilized pharmacist X programming inside the hospital information assets 佐古卓人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2020.

---

	S24-4. Use and application - of - pharmaceutical products information management system "AI-PHARAMA" sharing knowledge, the pharmacist's experience using ICT 神崎浩孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2020.

---

	Symposium 25. [contribution to society] One or ... which there is what for approach ... people from the situation of each ALL pharmacist for the current situation of the regulation pharmaceutical products in foreign countries 石原千春, 橋本直弥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2020.

---

	S25-1. About the response of the pharmacist in the regulation pharmaceutical products of the current situation report and the foreign tour of the member investigation of the Japanese mild cure association 石原千春1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2020.

---

	S25-2. Invention at efforts - application to conduct drug carrying import and export permission application for the medical care smoothly and problem ... which was seen 橋本直弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2020.

---

	S25-3. Prescription situation of corresponding - regulation pharmaceutical products in the dispensing pharmacy with much use of visit to Japan foreigner patients and future problem - 鈴木渉太1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2020.

---

	S25-4. About a system of the export by the carrying of drug for the medical care and medical psychotropic drugs and the import 竹内大輔1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2020.

---

	S25-5. We work on the proper use promotion of the drug for the medical care 鈴木勉1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2020.

---

	Symposium 26. [practice] In Patient Empowerment a breakthrough! : New keyword in the cancer practice of the Reiwa era 森田一, 小室雅人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2020.

---

	S26-1. Process of the Patient Empowerment Program (PEP) setup 東光久1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2020.

---

	S26-2. Thing to bring for an implication, treatment for cancer of Patient Empowerment 石井均1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2020.

---

	S26-3. "Workshop for improvement in "patients power" whom a medical person leads" case introduction 下村昭彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2020.

---

	S26-4. Practice of "Patient Empowerment" from tomorrow participates in "the improvement in patients power workshop whom a medical person leads" as ... pharmacist 堀之内藍1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2020.

---

	S26-5. Participate in PEP workshop as thing - facilitator that there is a pharmacist to give medical care with high satisfaction; and ... 小室雅人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2020.

---

	Symposium 27. [practice] It is ... in the times to aim at the symbiosis with cancer by ... evolving cancer treatment to realize effective treatment by security by the intervention of the pharmacist specialized in a cancer 河原昌美, 中多陽子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2020.

---

	S27-1. About the pharmacist examination situation and a trend specialized in a cancer of 2019 河原昌美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2020.

---

	S27-2. Pharmaceutical intervention for patients with gastric cancer with suspected 5-FU encephalopathy 内谷加江1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2020.

---

	S27-3. Pharmaceutical intervention for peripheral neuropathy of patients with progress gastric cancer 金子忍1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2020.

---

	S27-4. Intervention to patients with lung cancer that it is hard to take 木村滋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2020.

---

	S27-5. Picture of the future ... which activity and efforts ... specialists of the subcommittee aiming at the improvement of the pharmacist specialized in a cancer of the cancer medical therapy to develop describe it in 三宅知宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2020.

---

	S27-6. Efforts of the training subcommittee for pharmacist upbringing and the skill up specialized in a cancer 中多陽子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2020.

---

	Symposium 28. [practice] Expectation to a pharmacist in the treatment that we gave priority to the quality of life of patients with breast cancer over 寺町ひとみ, 平井みどり Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2020.

---

	S28-1. We can do it, and what should do what for diversifying breast cancer treatment, patients? 二村学1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2020.

---

	S28-2. The effect that pharmacist intervention gives to patients quality of life and medical economy 田中和秀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2020.

---

	S28-3. It is ... through ... other types of job cooperation for a smile of patients 大野(川井)朋子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2020.

---

	S28-4. About formulation of basic knowledge and the Mohs paste of the cancerous wound care 重山昌人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2020.

---

	S28-5. It is education ... full of a sense of reality in ... University for the pharmacist who can suggest prescription 寺町ひとみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2020.

---

	Symposium 29. [practice] About the role emergency response of the pharmacist prospective for securing of patients security and the activity of the time of peace 梅村朋, 岩本卓也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2020.

---

	S29-1. About the current situation including role - law revision of the medical (patients) pharmacist sought safely, the revision of medical service fees - 舟越亮寛1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2020.

---

	S29-2. The pharmaceutical products safety management system in the Mie University Hospital: Unlicensed drug, contraindicated medicine out of the adaptation 水谷栄梨1,2, 向原里佳1, 兼児敏浩2, 岩本卓也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2020.

---

	S29-3. Efforts of the municipal hospital about the medical safe system 菅野浩1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2020.

---

	S29-4. It is the role of the pharmacist in (emergency) at medical accident occurrence 山本崇1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2020.

---

	S29-5. The relation of an emergency in the patients security and the pharmacist in the time of peace and the future prospects 梅村朋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2020.

---

	Symposium 30. [education] We reconsider small and medium size hospital drug duties from a point of view of running it 荒川隆之, 小枝伸行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2020.

---

	S30-1. With the directionality that future ... small and medium size hospital pharmacist of small and medium size hospital drug duties should advance to? 樋島学1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2020.

---

	S30-2. In "form by the attractive duties of the small and medium size hospital! - The making of structure which also produces the securing of pharmacist and outcome in the hospital management now! -" 新井克明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2020.

---

	S30-3. Efforts for the realization of pharmacist duties expected in Itsukaichi memorial hospital 荒川隆之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2020.

---

	S30-4. Policy suggestion ... to the hospital administration that visualization and PBPM utilization technique - sustained growth of the medical information by the hospital pharmacist are possible 関利一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2020.

---

	S30-5. Expectation to small and medium size hospital pharmacist judging from a viewpoint of the community medical care cooperation 木佐貫篤1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2020.

---

	Symposium 31. [contribution to society] Let's talk now; is baton ... to professionalism - next generation of the pharmacist 細谷治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2020.

---

	S31-1. What is the element necessary for the professionalism of the pharmacist? 細谷治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2020.

---

	S31-3. A college of pharmacy, a pharmacy school having to change now 杉林堅次1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2020.

---

	S31-4. Professionalism of the pharmacist in the medical management 赤瀬朋秀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2020.

---

	S31-5. Specialty of the pharmacist judging from a law 赤羽根秀宜1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2020.

---

	S31-6. Structural conversion from the professionalism thing of the pharmacist to a person 永田泰造1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2020.

---

	Symposium 32. [Social Contribution] Don't Lose to Disasters! Receiving Aid and Countermeasures Learned from the Disaster Chronicle - To protect ourselves and save you in the event of a disaster - 小林政彦, 高山和郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2020.

---

	S32-1. We think from an unexpected disaster record 眞野成康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2020.

---

	S32-2. Step ... from description of heavy rain disaster experience - damage to revival 角南敦史1, 本島和典1, 谷本ひとみ1, 佐藤友里加1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2020.

---

	S32-3. Attempt for importance of drugstore BCP in the local support at disaster that it showed from a support authorization pharmacist system at a disaster and the effectiveness-related BCP development that there is 北川太郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2020.

---

	S32-4. Experiencing receiving support for the 2016 Kumamoto earthquake 岡村直樹1, 宮田昭1, 陣上祥子2, 下石和樹2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2020.

---

	Symposium 33. [practice] To show a pharmacist power at the place of ... clinical nutrition to reconsider clinical application of the intravenous lipid microsphere; ... 井上真, 伊東弘樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2020.

---

	S33-1. We think about utilization of the intravenous lipid microsphere: Problems and measures at the clinical place 千葉正博1, 中山泰葉2, 若林仁美2, 杉沢諭2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2020.

---

	S33-2. Clinical application of the intravenous lipid microsphere for haemodialysis patients 藤谷竜磨1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2020.

---

	S33-3. Should be usable more; the lipid microsphere for the IV infusion! - Efforts - at the acute phase hospital 茂木孝裕1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2020.

---

	S33-4. ... which makes use of ... inquiry content in clinical practice to use intravenous lipid microsphere appropriately 岩原良晴1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2020.

---

	S33-5. Individualization rate of application design by the pharmacokinetic analysis of the lipid microsphere 福島恵造1, 大村健二2, 合志聡3, 岡田章1,4, 田中求2, 辻本貴江1, 入山圭二5, 杉岡信幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2020.

---

	Symposium 34. [education] Efforts to problem and the Pharmacist-Scientist training of ... pharmacy education thinking about a pharmacist image of the new age 北市清幸, 吉村知哲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2020.

---

	S34-1. The current situation and the prospects of hospital pharmacist duties judging from the public welfare labor science study and an investigation of the Japanese Society of Hospital Pharmacists 外山聡1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2020.

---

	S34-2. A challenge and the current situation to a new six years system in the Osaka University pharmacy school 堤康央1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2020.

---

	S34-3. Newly 6-year introduction in Gifu Pharmaceutical University and the significance 北市清幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2020.

---

	S34-4. Can a pharmacy, the pharmacist survive? ... which thinks about ... some other time 6-year pharmacy education 政田幹夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2020.

---

	Symposium 35. [study] We think about a trial and the relation of the pharmacist 池田龍二, 城野博史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2020.

---

	S35-1. It is ... including the correspondence to a ... open-label pharmacist setting test about the role of the pharmacist in the clinical experimental medicine administrative work 黒田智1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2020.

---

	S35-2. About a relation to the ethic examination as the pharmacist 寺元剛1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2020.

---

	S35-3. Relation ... of role ... Dr. of the pharmacist in the clinical development-led investigational enforcement system construction, trial adjustment secretariat administration and the pharmacist 二川俊隆1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2020.

---

	S35-4. It is efforts ... of our hospital in ... Kumamoto earthquake correspondence and the subsequent system construction from the situation of the pharmacist CRC 成田さわな1, 上田泰子1, 伊藤祐子1, 川瀬美紀1, 城野博史1,2, 松岡雅雄2,3, 齋藤秀之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2020.

---

	S35-5. About the relation of the pharmacist in the trial of the antitumor agents 大野梨絵1,2, 池田龍二1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2020.

---

	Symposium 36. [education] About the way of the after graduation initial training of the pharmacist 山田清文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2020.

---

	S36-1. Problem of the postgraduate training of the pharmacist thinking from the clinical practice system of the physician or an American pharmacist resident system 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2020.

---

	S36-2. The current situation and problem judging from a national survey about the postgraduate training 橋田亨1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2020.

---

	S36-3. We think about the way of the training from the situation of the drugstore in the early period of after graduation of the pharmacist 宮崎長一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2020.

---

	S36-4. Expectation and request from the pharmacy school 中村明弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2020.

---

	Symposium 37. [practice] Essential specialty of the pharmacist who can contribute to psychiatry clinical practice 賀勢秦子, 梅田賢太 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2020.

---

	S37-1. Expect it of a pharmacist in psychiatry clinical practice 園部漢太郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2020.

---

	S37-2. The past, the present, the future of psychiatry pharmacist duties 天正雅美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2020.

---

	S37-3. Local shift and pharmacist of the psychiatric practice 長浜恭史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2020.

---

	S37-4. Point of view ... of treatment participation ... sustained-release parenteral injection utilization of the pharmacist who makes possibility of continuing it 横森順1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2020.

---

	S37-5. It is the idea making use of the pharmacist from the viewpoint of mind and body both sides in the psychiatry domain 梅田賢太1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2020.

---

	Symposium 38. [education] Strategic - tissue management leadership, personnel training - to show a pharmacist power in the clinical study 吉村知哲, 石井伊都子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2020.

---

	S38-1. The leadership and the management in the non profit organization 赤瀬朋秀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2020.

---

	S38-2. The pharmacy management to realize an organizational reform 筒井由佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2020.

---

	S38-3. Fusion ... of drug department management - Toyota ism utilizing the Toyota way and the medical person mind 遠山幸男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2020.

---

	S38-4. The leadership competency which is pursued in the medical domain 相馬孝博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2020.

---

	Symposium 39. [study] It is ... expecting development of a clinical question and the TDM by creation - clinical pharmacist of the evidence which a TDM study finds 三浦昌朋, 尾田一貴 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2020.

---

	S39-1. TDM study aiming at the conquest of the clinical problem of the oral multi-kinase inhibitor 野田哲史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2020.

---

	S39-2. We challenge the clinical question of the infection in antimicrobial TDM 浦上宗治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2020.

---

	S39-3. To send Clozapine more safely; approach - from - TDM 北川航平1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2020.

---

	S39-4. Usefulness of TDM and the genetic polymorphism information of the immunosuppressive drug in the kidney transplantation domain 加賀谷英彰1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2020.

---

	S39-5. For the further development of the TDM study by the clinical pharmacist 榎屋友幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2020.

---

	Symposium 40. [contribution to society] Let's get on in the current of the times of the task share shift! - - to make the new age by utilizing a pharmacist power to a change of society, the medical environment 松尾宏一, 林稔展 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2020.

---

	S40-1. Promotion of task shifting by pharmacists 川上純一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2020.

---

	S40-2. Clinical problem solution to pharmacist specialty - by display - pharmaceutical intervention in response to a task shift 橋田亨1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2020.

---

	S40-3. Achievement - of a pharmacist and the pharmacist of role allotment - life 100 years times of the physician 中井清人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2020.

---

	Symposium 41. [Medical] Intensive care, ready! - Let's start with the completion of the position paper Let's expand the intensive care unit work - 入江利行, 柴田啓智 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2020.

---

	S41-1. Position paper and efforts of the pharmacist in the local support hospital 立石裕樹1, 宮津大輔1, 後藤貴央1, 宮内善豊2, 江田陽一2, 平川雅章1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2020.

---

	S41-2. Position paper and efforts (from a university hospital) of the own institution 橋本麻衣子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2020.

---

	S41-3. Stare at the future of the pharmacist in the intensive care 今浦将治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2020.

---

	S41-4. Thought of the corporate strategy to cultivate by polishing a skill in an intensive care domain 野崎歩1, 堀内望1, 奥川寛1, 馬橋美由季1, 小林由佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2020.

---

	S41-5. The expectation to the pharmacist in the intensive care unit: From the position of the specialist in intensive care 志馬伸朗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2020.

---

	Symposium 42. [study] For the establishment of the study support system of the pharmacist in the cancer medical therapy [cure association academic third subcommittee plan] 板倉由縁, 久田達也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2020.

---

	S42-1. For the establishment of the study support platform in the cancer domain efforts - of - Aichi 宮崎雅之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2020.

---

	S42-2. To keep study support system and problem ... limited human resources in the cancer medical therapy of Mie alive; ... 三宅知宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2020.

---

	S42-3. Efforts of personnel training and the study support system in the Gifu cancer-related training institution 宇佐美英績1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2020.

---

	S42-4. Activity and result - of the pharmacist team specialized in construction - Ishikawa cancer of education, the study support system in Ishikawa 菅幸生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2020.

---

	S42-5. It is efforts ... of ... Saitama cancer medical therapy workshop for the construction of the study support system in Saitama 佐野元彦1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2020.

---

	Symposium 43. [education] The current situation of the pharmacy common use study OSCE in the pharmacy education and future problem 野田幸裕, 橋詰勉 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2020.

---

	S43-1. Pharmacy common use study OSCE and pharmacy education 福島哉史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2020.

---

	S43-3. A pharmacy education: New problem and OSCE 橋詰勉1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2020.

---

	S43-4. It is efforts - aim and problem of the OSCE (Post-CC OSCE) after the practice participation type bedside teaching of the Showa University faculty of medicine 土屋静馬1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2020.

---

	Symposium 44. [study] With the clinical pharmacy study found in the times of the Reiwa 内藤隆文, 三浦昌朋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2020.

---

	S44-1. The improvement of medical technology that is necessary at a drug administration design for becoming it 三浦昌朋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2020.

---

	S44-2. Significance and importance of research activities 池田龍二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2020.

---

	S44-3. - to forge a study to become the base of contribution - clinical power to the team approach in medical care utilized the pharmacist power 石澤啓介1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2020.

---

	S44-4. Of the clinical pharmacy study "have just begun" "until now": Efforts of the Hamamatsu University School of Medicine hospital pharmacy 内藤隆文1, 川上純一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2020.

---

	Symposium 45. [practice] The perioperative medical therapy management that we catch in patients security viewpoint again 舟越亮寛, 柴田ゆうか Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2020.

---

	S45-1. Expectation from an anesthesiologist to a pharmacist 齋藤繁1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2020.

---

	S45-2. Approach about the medical security in the perioperative period as GRM 柴田みづほ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2020.

---

	S45-3. Efforts of the perioperative pharmacy management 島田雅人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2020.

---

	S45-4. Patients security by the perioperative care team pharmacist 竹之内正記1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2020.

---

	S45-5. Consideration about the discontinuation failure case of the cancellation medicine before surgery, examination 和地徹1, 佐賀利英2,3, 柳田真樹子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2020.

---

	Symposium 46. [practice] Scrummaging with aggravation prevention - multi-type of job of diabetes and the chronic kidney disease to work on in ONE TEAM 井上岳, 三宅健文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2020.

---

	S46-1. Expectation to a pharmacist in chronic kidney disease (CKD) and the diabetic kidney disease (DKD) team approach in medical care 安田宜成1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2020.

---

	S46-2. Problem future with going in a hospital and an area to prevent that diabetes is aggravated 古田麻衣子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2020.

---

	S46-3. Explore cooperation with diabetes aggravation prophylactic role - medical institution as the health insurance pharmacy pharmacist; and ... 森貴幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2020.

---

	S46-4. Being carried out in a hospital and an area that diabetic nephropathy is aggravated and prevents a shift to artificial dialysis 大岩拓馬1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2020.

---

	S46-5. Going in a drugstore and an area that diabetic nephropathy is aggravated and prevents a shift to artificial dialysis 松下智侑1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2020.

---

	S46-6. What a pharmacist scrummaging with the multi-type of job for the aggravation prevention of diabetes in the area and the chronic kidney disease should do 三宅健文1, 辻芙美1, 植村有加1, 谷崎泰広1, 安田早織1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2020.

---

	Symposium 47. [practice] The management promotion (the academic fourth subcommittee) utilizing "the relation guide to the drug interactions in the healthcare setting" 米澤淳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2020.

---

	S47-1. Public announcement of "the relation guide to the drug interactions in the healthcare setting" 伊藤清美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2020.

---

	S47-2. Way of thinking of evasion and the management of drug interactions 大野能之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2020.

---

	S47-3. A report and problem of the drug interactions management in the healthcare setting 木村丈司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2020.

---

	S47-4. The drug interactions management for patients with the specific background 岩本卓也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2020.

---

	S47-5. The drug interactions study that a clinical pharmacist conducts 百賢二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2020.

---

	S47-6. A prediction and inspection of drug interactions 樋坂章博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2020.

---

	Symposium 48. [education] Sailing of the new specialty pharmacist system 奥田真弘, 寺田智祐 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-448, 2020.

---

	S48-1. An idea and system design of the new specialty pharmacist system 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 449-449, 2020.

---

	S48-2. Need ... of pharmacist - clinical results specialized in clinical pharmacy 百瀬泰行1, 青山隆夫2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2020.

---

	S48-3. Pharmacist ... further directional ... specialized in a cancer 河原昌美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2020.

---

	S48-4. Development of the pharmacist specialized in medical therapy 石井伊都子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2020.

---

	S48-5. The foundation of the pharmacist system specialized in local pharmacy care and future expectation 宮崎長一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 453-453, 2020.

---

	Symposium 49. [practice] Pharmacist duties and the risk management which transform with the extension of AI and the robot 斎藤寛子, 築山郁人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-455, 2020.

---

	S49-1. For information management and the joint ownership of the pharmacist development - of - pharmaceutical products information management system "AI-PHARAMA" using the digital technology 神崎浩孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 458-458, 2020.

---

	S49-2. Challenge to development - formulations mistake zero of the smart dispensary (robot drugstore), waiting time zero 渡部正之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2020.

---

	S49-3. Drug duties to transform by the inflection of AI, the robot 青森達1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-460, 2020.

---

	S49-4. With the knowledge that the next-generation pharmacist who can play an active part in the AI era comes to need? ! 宮川隆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2020.

---

	Symposium 50. [practice] Medicine medicine cooperation to promote patients-oriented separation of pharmacy and clinic 賀川義之, 植兆満 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 463-463, 2020.

---

	S50-1. Efforts of the medicine medicine cooperation about proper use of the drug for the medical care 伊藤譲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 465-465, 2020.

---

	S50-2. Hospital pharmacist is ... through technique and an example of the effect - Kagawa west inscription area "joining community medical care together" 篠永浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 466-466, 2020.

---

	S50-4. About education - model core curriculum - before graduation education and the future 平田收正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 468-468, 2020.

---

	Symposium 51. [education] Regional alliances for upbringing of the pharmacist as the healthy manager of the town 平松正行, 牛田誠 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 469-469, 2020.

---

	S51-1. The way of a drugstore, the pharmacist whom a dispensing fee revision turns in notice of 0402, revised medicine machine method, 2020 狭間研至1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 472-472, 2020.

---

	S51-2. - From position of the hospital pharmacist - 坂田洋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 473-473, 2020.

---

S51-3. The system of the Furukawa model that we thought about the solution to local problem from multi-type of job collaboration type - goal by all drugstore participation is made one or ... how 宇田和夫1,2,3, 高橋真吾1,4, 吉田聡1,5, 田村美帆1,6, 樅山徳幸1,7, 加藤大貴1,8, 川島与輝1,8, 坂本希実1,9, 山下美妃1,10, 赤荻榮一11,12 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 474-474, 2020.

---

	S51-4. Upbringing (approach at university) of the pharmacist as the healthy manager of the town 牛田誠1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 475-475, 2020.

---

	Symposium 52. [study] A pharmacist being sought now by mild medical study promotion 佐藤淳也, 宮崎雅之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 476-476, 2020.

---

	S52-1. A Pharmacist's Perspective Utilized in Research on Palliative Medicine 槙原克也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 479-479, 2020.

---

	S52-2. Intervention - of the pharmacists from the normal business routine of the health insurance pharmacy to the at-home palliative care case using observational study - PCA pump which we originated 田邉一尊1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 480-480, 2020.

---

	S52-3. From the situation of collaboration - relaxation care physician in mild medical clinical studies and the guidelines making 森雅紀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 481-481, 2020.

---

	S52-4. Participate in the revision of latest evidence - respiratory symptom guidelines on medical therapy for dyspnea; and ... 山本泰大1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 482-482, 2020.

---

	Symposium 53. [study] Development to discovery and the clinical studies of the clinical question in pharmacist specialties 鈴木昭夫, 中馬真幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 483-483, 2020.

---

	S53-1. Know-how and invention to push forward the clinical studies of the intensive care domain 中馬真幸1, 座間味義人2,3, 合田光寛3, 八木健太1, 岡田直人3, 濱野裕章3, 近藤正輝3, 楊河宏章1, 石澤啓介2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 484-484, 2020.

---

	S53-2. To show specialty by clinical studies - team approach in medical care to solve an on-site problem; ... 川田敬1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 485-485, 2020.

---

	S53-3. Observational study ... which plays for embodiment - idea of the clinical question in the relaxation domain 佐藤淳也1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 486-486, 2020.

---

	S53-4. Rearward clinical studies based on the drug duties for clinical question solutions in the cancer chemotherapy 藤井宏典1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 487-487, 2020.

---

	S53-5. Statistical analysis in the observational study 吉田寿子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 488-488, 2020.

---

	Symposium 54. [Social Contribution] Recommending Regional Formularies to Support Patients and Medical Care in the Integrated Community Care System with Evidence 岸本真, 小枝伸行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 489-489, 2020.

---

	S54-1. Discussions and Basic Ideas Concerning Formularies 川上純一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 491-491, 2020.

---

	S54-2. Efforts for a local formularies in the Awa region of Chiba Prefecture 舟越亮寛1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 492-492, 2020.

---

	S54-3. Formulation of in-hospital formularies and future developments at regional medical support hospitals - Aiming for interlocking with PBPM and regional collaboration paths - 小枝伸行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 493-493, 2020.

---

	S54-4. Role and future prospects of pharmacists in formularies 磯部総一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 494-495, 2020.

---

	Symposium 55. [study] We create new diagnosis, therapy and challenge the conquest of the intractable disease 永井拓 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 496-496, 2020.

---

	S55-1. Development of the rare cancer cell high sensitivity detecting method by the microdroplet culture 寺薗英之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 498-498, 2020.

---

	S55-2. Application to the basics, the clinical studies of all new phosphatide class high sensitivity assays 森田真也1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 499-499, 2020.

---

	S55-3. Challenge of the behavioral pharmacology researcher to dementia early detection and drug discovery 溝口博之1, 山中宏二2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 500-500, 2020.

---

	S55-4. Development of the new therapy for schizophrenia based on the objective diagnosis 永井拓1,2, 尾崎紀夫3, 山田清文2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 501-501, 2020.

---

	Symposium 56. [practice] For construction of the medical therapy for the comeback to normal life of schizophrenia 亀井浩行, 野田幸裕 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 502-502, 2020.

---

	S56-1. Summary of the medical therapy for the comeback to normal life of schizophrenia 野田幸裕1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 504-504, 2020.

---

	S56-2. The condition of a patient elucidation and diagnostic technique development of schizophrenia 吉見陽1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 505-505, 2020.

---

	S56-3. A choice and proper use of antipsychotics to think about from dosage form 波多野正和1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 506-506, 2020.

---

	S56-4. Polypharmacy of the multi-type of job and patients with cooperation, schizophrenia to face each other while supplementing it 定岡邦夫1, 定岡摩利1, 沖村里咲1, 加藤秀明2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 507-507, 2020.

---

	S56-5. The schizophrenia medical therapy that fixed its eyes on a long term prognosis 岩本邦弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 508-508, 2020.

---

	S56-6. We think about a stigma 亀井浩行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 509-509, 2020.

---

	Symposium 57. [practice] Multifaceted ability of the pharmacist shown by kidney disease medical treatment instruction 山田成樹, 田中章郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 510-510, 2020.

---

	S57-1. Pit fall of the medicine to use frequently in the decreased renal function patients 伊藤さおり1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 511-511, 2020.

---

	S57-2. Kidney disease medical treatment instruction to practice in an alimentary division gastrointestinal division ward 宗山真梨奈1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 512-512, 2020.

---

	S57-3. We try to make use of the skill of the kidney disease medical treatment instruction person in an urologic ward 荒川悠樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 513-513, 2020.

---

	S57-4. Story of the medicine about the kidney transplantation that a pharmacist wants to know 安田知弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 514-514, 2020.

---

	S57-5. Precaution when we take the medicine for the circulatory organ to patients in CKD 富田敏章1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 515-515, 2020.

---

	Symposium 58. [practice] Heart failure pandemic - exercise and nourishment and drug ... to face by the multi-type of job cooperation 吉国健司, 入江利行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 516-516, 2020.

---

	S58-1. Role to fulfil of the condition of a patient and the heart rehabilitation of the heart failure 井澤英夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 518-518, 2020.

---

	S58-2. From the position of - physical therapist who understand other types of job, and practices the multi-type of job cooperation - 佐藤憲明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 519-519, 2020.

---

	S58-3. Efforts ... in nourishment management and multi-type of job cooperation - heart failure team in patients with heart failure 吉内佐和子1,5, 田中雅幸2,3, 森下瞬4, 田中千春4, 宮内拓史5, 藤井彩5, 大北亜紀6, 久保田ナナ6, 伊藤駿7, 木村穣8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 520-520, 2020.

---

	S58-4. A drug and nourishment in the intensive care 野崎歩1, 堀内望1, 奥川寛1, 馬橋美由季1, 小林由佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 521-521, 2020.

---

	S58-5. About the role of the pharmacist in the heart rehabilitation team 太田友樹1, 山本達郎1, 松本麻里1, 孝田佳子1, 渡部裕紀1, 衣笠良治2, 加藤雅彦3, 山本一博2, 島田美樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 522-522, 2020.

---

	S58-6. Rehabilitation nourishment and rehabilitation drug 中村直人1, 若林秀隆2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 523-523, 2020.

---

	Symposium 59. [study] The basics and practice to work on a clinical pharmacy study 伊藤清美, 田崎嘉一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 524-524, 2020.

---

	S59-1. A pharmacist think through past clinical studies - article making in the municipal hospital ninth year 篠田康孝1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 525-525, 2020.

---

	S59-2. It is ... for study support ... senior pharmacist who can rely in the general hospital which learns together, and accompanies it 池末裕明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 526-526, 2020.

---

	S59-3. It is multi-type of job cooperation ... with education, research activities - student to perform as a clinical system teacher 林秀樹1,2,3,4,5, 廣瀬智恵美4,5, 飯原大稔1,4,5, 鈴木昭夫1,4,5, 河合琢良2,5, 生木庸寛2,5, 小原道子2,5, 小林篤史3,5, 甲斐絢子3,5, 日比野靖5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 527-527, 2020.

---

	S59-4. The beginning is a beginner of the study in anyone 杉山雄一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 528-528, 2020.

---

	Symposium 60. [study] It is ... from the study of ... these days to think about lower urinary tract dysfunction to treatment 木村和哲, 堀田祐志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 529-529, 2020.

---

	S60-1. Relation of the urologic ward exclusive duty pharmacist for the lower urinary tract dysfunction 杉山洋介1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 530-530, 2020.

---

	S60-2. Recent treatment for the lower urinary tract dysfunction 濱川隆1, 窪田泰江2, 安井孝周3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 531-531, 2020.

---

	S60-3. Search of the functional ingredient that an effect is expected for an urination disorder 伊藤由彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 532-532, 2020.

---

	S60-4. Intracerebral molecules group - associated with the urination control that we were able to see from effect - stress reaction study that stress gives to an urination function 清水孝洋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 533-533, 2020.

---

	Symposium 61. [contribution to society] We think about the career path of word no hearing - pharmacist in a gender equality genuinely 塚本有子, 三宅健文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 534-534, 2020.

---

	S61-1. About the promotion of the gender equality in technology, the arts and sciences 福田明美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 535-535, 2020.

---

	S61-2. About the workplace environment that is necessary about the stability of improvement in consciousness and the duties of the field of clinical pharmacy being attractive as a pharmacist 吉田紀子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 536-536, 2020.

---

	S61-3. The workplace and hope and anxiety that are easy to act in the future 荒川真萌1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 537-537, 2020.

---

	S61-4. I continue carrier in this way in a renal disease domain 林八恵子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 538-538, 2020.

---

	S61-5. I continue carrier in this way in a cancer domain 後藤愛実1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 539-539, 2020.

---

	S61-6. Gap between a gender equality plan and the store in the company 川原哲也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 540-540, 2020.

---

	S61-7. "Ikubo's declaration" to work on work-life balance 三宅健文1, 國枝亜矢香1, 辻芙美1, 安田早織1, 東野公亮1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 541-541, 2020.

---

	Symposium 62. [education] For improvement in quality of clinical pharmacy education - pharmacy business training to bring up a pharmacist supporting the future - 鈴木匡, 長谷川洋一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 542-542, 2020.

---

	S62-1. Look back on business training of 2019; and - result and problem - 伊東明彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 545-545, 2020.

---

	S62-2. Invention and problem of the business training in the university hospital 津川透1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 546-546, 2020.

---

	S62-3. Oldness and training to be carried out by regional alliances 小林潤1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 547-547, 2020.

---

	S62-4. Consideration from the business training University in conformity with the revision model core curriculum 鈴木匡1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 548-548, 2020.

---

	Symposium 63. [contribution to society] Jump out of an own institution, and is a pharmacist associated with how local infection measures? 高山和郎, 高田勝利 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 549-549, 2020.

---

	S63-1. Pharmacist Law Article 1 at the cut end called infection measures 高山和郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 550-550, 2020.

---

	S63-2. Activity of the school pharmacist for the purpose of the infection measures in the area 荒川隆之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 551-551, 2020.

---

	S63-3. Let's turn our eyes to the community from within the hospital - Actions aimed at local AMR countermeasures thought by a pharmacist - 上ノ段友里1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 552-552, 2020.

---

	S63-4. Participation in local infection measures to be possible in the position of the university teacher 継田雅美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 553-553, 2020.

---

	S63-5. Antimicrobial proper use support team (AST) to bring up in an area 國島広之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 554-554, 2020.

---

	A workshop. It is the pharmaceutical approach to the patients with the compound disease (2) - practice to improve the pharmacist power as ... generalist 日本医療薬学会 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 555-555, 2020.

---

	O1-1. Effective and safe compounding of medicines duties improvement by the construction of the drug assistant educational program 松田貴子1, 鈴木慎二1, 渡辺智美1, 山田恭子1, 齊藤暢子1, 鈴木孝幸1, 山田成樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 557-557, 2020.

---

	O1-2. Effect about prescription mention of test value for the pharmaceutical products proper use and the check item 依光奈津美1, 梅村晃子1, 平野公美1, 宮本康敬1, 川口千香1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 558-558, 2020.

---

	O1-3. Usefulness evaluation of the prescription suggestion support system for the promotion of the proper use of the renal excretion type drug 薗田晃弘1, 近藤悠希2, 岩下佳敬1, 中尾承司1, 石田和久1, 石塚洋一2, 入江徹美2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 558-558, 2020.

---

	O2-1. In-hospital formulary introduction of oral proton pump inhibitors in general hospitals and examination of its effects 後藤健志1, 竹尾恵理子1, 酒井欣嗣2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 559-559, 2020.

---

	O2-2. The setting of the pharmaceutical products ward placement standard and the effect 大竹慶尭1, 菅野ゆみか1, 大谷美子1, 丸山智弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 560-560, 2020.

---

	O3-1. Examination of the usefulness of the open clean bench (super clean generation device KOACH) in the parenteral injection no bacteria preparation 佐東未咲1, 菅原拓也1, 延川正雄1, 松田圭一郎1, 西村孝一郎1, 木村東子2, 長岡純二2, 荒井浩一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 561-561, 2020.

---

	O3-2. For the further spread of simple suspension methods: Development of the tablet crush technology with the rotation, the revolution mixer 長井紀章1, 後藤涼花1, 宇野樹1, 東尚希1, 中尾元紀2, 橋本直文3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 562-562, 2020.

---

	O4-2. Education effect of the audit enforcement aiming at improvement in quality of ward duties 真志田絵美子1, 吉川博1, 片岡達夫1, 佐伯康之1, 松尾裕彰1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 564-564, 2020.

---

	O4-3. Analysis - using effect - tendency score matching that a pain-killer after the total prostatectomy gives for renal function after the operation 西村文宏1, 牛島智子1, 原一正2, 門脇大介3, 宮村重幸3, 鬼木健太郎4, 猿渡淳二4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 564-564, 2020.

---

	O4-4. Evaluation of the intervention effect of the ward pharmacist in the blood medical service 金子憲太郎1, 川口文誉1, 内藤たから1, 杉本誠1, 豊田茂雄2, 土井路子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 565-565, 2020.

---

	O4-5. Fact-finding about the subjective adherence evaluation of patients by Visual analogue scale 宮崎元康1, 小野千花1, 内山将伸1, 松尾宏一1, 鵜木亜矢子1, 中島章雄1, 後藤美和1, 今給黎修1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 565-565, 2020.

---

	O4-6. An investigation about the efforts for the polypharmacy reduction in the digestive organ surgery ward: Single institution rearward observational study (the second report) 岡野愛子1, 吉廣尚大1, 小野塚和人1, 礒貝明彦1, 中光篤志2, 橋本佳浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 566-566, 2020.

---

	O4-7. The multi-type of job conference for patients with symptomatic heart failure shows the main harmful cardiovascular events protective efficacy after the discharge 櫻下弘志1, 石井聡一郎1, 佐伯康之1, 畝井浩子1, 松尾裕彰1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 566-566, 2020.

---

	O5-1. Activity in the pre-hospital automation of the emergency resident pharmacist for the abuse of the nonprescription drug 広瀬正幸1,2, 平川昭彦3, 田島康介4, 山田成樹1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 567-567, 2020.

---

	O5-2. The case that patients who received plasma exchange and haemodialysis underwent TDM of VCM, and control came to have good 赤羽理也1, 福井里佳1, 下村春奈1, 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 568-568, 2020.

---

	O5-3. Efforts utilizing the ICT in the super acute phase stroke primary care 平岩歳久1, 加藤貴大1, 岩崎仁志1, 廣瀬正幸1, 松本省二2, 中原一郎2, 山田成樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 568-568, 2020.

---

	O5-4. Examination about the intervention effect of the pharmacist in the nutrition therapy in the intensive care domain 中川貴弘1, 北庄司敦久1, 西井拓人1, 西田愉可利1, 若林里絵1, 森朝紀文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 569-569, 2020.

---

	O6-1. Validity evaluation of the confirmation before hospitalization of the antirheumatic drug by the pharmacist for the orthopedics surgery planned patients 中西一志1, 安島秀友1, 美馬朱美1, 杉本涼佳1, 松崎貴志1, 田中恒明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 570-570, 2020.

---

	O6-2. The current situation and pharmacist sleep consultation foreign efforts of the sleeping drug prescription 今井圭介1, 黒飛謙次1, 藤川亜衣1, 富田哲夫1, 古野孝明1, 川口健1, 半田寛1, 難波康男2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 571-571, 2020.

---

	O6-3. Effect of the foreign inhalational instruction by the pharmacist in the acute phase hospital 平山優花1, 内田有紀1, 廣澤達哉1, 松永康二郎2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 571-571, 2020.

---

	O6-4. Usefulness of the pharmacist outpatient department mainly on the drug for the medical care 辻村行啓1, 荒川大輔1, 古橋侑樹1, 飯塚美有1, 清水真弓1, 矢部勝茂1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 572-572, 2020.

---

	O6-5. Examination about the effect of the Chinese medicine improving going emptiness 上野良夫1, 眞鍋聡太3, 小原依里3, 玉木真紀子2, 伊原木沙智代1, 三枝貢1, 眞鍋伸次1, 飯原なおみ3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 572-572, 2020.

---

	O7-1. Usefulness of the medical information system training 山中理1,2,3, 山村篤史1, 中村真樹4, 横幕香織4, 中山英夫1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 574-574, 2020.

---

	O7-2. Activity of the pharmacist in the JCHO Nankai medical center eating deglutition support team 道野南風1, 葉田昌生1, 川勝美里1, 北村仁1, 佐々木達也1, 海部真代1, 谷口公章1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 575-575, 2020.

---

	O7-3. Contents and the result that received the medical information system training by the medical information engineer pharmacist 中村真樹1, 山中理2,3,4, 山村篤史2, 横幕香織1, 茂籠茂彦1,5, 近藤博紀1, 中山英夫2,4, 大野勝則1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 575-576, 2020.

---

O7-4. Medicine review meeting ... by the information sharing of the post of post of construction - pharmacist, nursing of the multi-type of job cooperation model who aimed at the appropriate medical treatment of the nursing facility resident, care 石坂優奈1, 柳奈津代2, 佐藤宏樹2, 三木晶子2, 馬来秀行3, 川村耕平3, 西川英里3, 木村貴史3, 小西ゆかり3, 岡本勝樹3, 雨宮潤美3, 澤田康文2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 576-576, 2020.

---

	O7-5. Cooperation possibility - of examination - child-care facility and the drugstore of the support to expect of the difficult feeling and drugstore pharmacist of the administration of the nursery staff in the nursery school institution 柳奈津代1, 佐藤宏樹1,2, 澤田康文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 577-577, 2020.

---

	O8-1. The detection of excessive quantity, the too few order of pharmaceutical products using the machine learning 永田健一郎1, 辻敏和1, 村岡香代子1, 渡邊裕之1, 金谷朗子1, 江頭伸昭1, 家入一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 578-578, 2020.

---

	O9-1. Analysis of the nonsteroidal antiinflammatory drug using the domestic adverse event spontaneous report database and the acetaminophen-related thrombo embolic event 菅原英輝1, 有馬太陽1, 寺薗英之1, 武田泰生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 579-579, 2020.

---

	O9-2. Efforts for problem grasp and the improvement for improvement in customer satisfaction in the inquiry correspondence, and the like 太田和人1, 大町成樹1, 有和泰子1, 平松理郁子1, 中井徹1, 京井由加利1, 吉實弘樹1, 高野修一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 580-580, 2020.

---

	O9-3. Examination - about the risk factor of the pseudoaldosteronism in evaluation (the first report) - Yokukansan user of safety of medicine, the effectiveness using the medical information 石田智滉1, 川田敬1,2, 森沢惇平1,2, 常風興平1, 森田靖代1, 宮村充彦1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 580-580, 2020.

---

	O9-4. Analysis results ... of side effect database FEARS of ... world's largest of hiccups and nicotine concerned 細谷龍一郎1,2, 日野斉一1, 野澤(石井)玲子2, 植沢芳広3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 581-581, 2020.

---

	O9-5. Investigation about the use situation of the use according to a good use standard 川崎裕貴1, 和田良浩1, 谷田彩1, 小川恵美子1, 吉川一吾1, 池田和之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 581-581, 2020.

---

	O9-6. Fact-finding about package insert mention about the effect on transitivity and infants to human mother's milk by the medication of the antidepressant 久保野尚子1, 相曽明日香1, 佐野慎亮1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 582-582, 2020.

---

	O9-7. Onset of dysfunction thyroid situation evaluation with the molecular target anticancer medicine using the adverse drug reaction database 松井頌明1, 石原慎之2, 玉木宏樹2, 矢野貴久2, 幸田恭治1, 直良浩司2, 北原隆志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 582-582, 2020.

---

	O9-8. Construction and evaluation of the injection drug incompatibility search system which is browsable on an electronic medical chart 樽野麻依1, 梶田貴司1,2, 西島美佳2, 戎浦規文1, 雪矢良輔1, 黒松誠1, 西川豊1, 奥野智之1, 金子嘉志2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 583-583, 2020.

---

	O9-9. Exhaustive examination of the drug-related necrosis of the jaw bone based on JADER 鳥海真也1,2, 小林明信1, 植沢芳広2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 583-583, 2020.

---

	O10-1. Experience and attitude survey about clinical studies of the hospital pharmacist 高武嘉道1, 川俣洋生1, 大石裕樹1, 福石和久1, 高島伸也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 584-584, 2020.

---

	O10-2. Identification of the factor involved in the secession of the disseminated intravascular coagulation syndrome with the administration of the thrombomodulin alfa 小武和正1, 田平明啓1, 新見奈々1, 羽井佐郁恵1, 川上恭弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 585-585, 2020.

---

	O10-3. Multicenter large-scale fact-finding of the medication adherence of the direct action type oral anticoagulant drug for patients with non-valvular atrial fibrillation 三浦誠1, 尾濱直子1, 関利一2, 秋山裕史2, 杉山哲大3, 翁長真一郎4, 宮里弥篤4, 新谷歩5, 吉田寿子5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 585-585, 2020.

---

	O10-4. The use situation investigation for the proper use of the dry concentration person prothrombin complex preparation 花田聖典1, 鶴崎泰史1, 中川義浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 586-586, 2020.

---

	O10-5. Validity evaluation of the third generation cephalosporin antimicrobial deletion of the cataract surgery clinical path 杉本涼佳1, 安島秀友1, 美馬朱美1, 中西一志1, 松崎貴志1, 田中恒明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 586-586, 2020.

---

	O10-6. How the pharmacist can be concerned in a long-term viewpoint for the pharmaceutical products after formulations; is ... through the expiration date of ... nitro pen sublingual tablet 木元英之1, 鴨田健1, 阿部真也3, 丸谷晴子2, 谷口智則4, 今村かおり5, 正木匠6, 茨目彩耶7, 河野慈子7, 佐藤卓也8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 587-587, 2020.

---

	O10-7. Adherence and drug economics investigation of the use of liquid patients for the Efinaconazole movement of the feet 徳山智治1, 磯尾優子1, 穴見江梨子2, 坂本豊伸3, 塚本賢児4, 天方奉子5, 稲葉一郎5, 宮野恭彰6, 木戸宏幸6, 湯川栄二6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 587-587, 2020.

---

	O10-8. Examination of the usefulness by clinical test value mention to outside Parliament prescription 吉永光辰1, 尾之江剛樹1, 谷口潤1, 迫田英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 588-588, 2020.

---

	O10-9. Effect on prescription situation and blood toxicity investigation of the silver sulfadiazine cream 山根靖弘1, 山根紗希子1, 梅田清隆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 588-588, 2020.

---

	O10-10. Attitude survey for the role of the drugstore of the health insurance pharmacy pharmacist and the family pharmacist 長沼敬子1, 木下隆市1, 染谷光洋1, 谷口亮央1, 中島史雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 589-589, 2020.

---

	O10-11. Grasp and content analysis of the use situation of the contraindicated medicine in the Mie University Hospital 白石ちひろ1, 杉本浩子1, 水谷栄梨1, 向原里佳1, 加藤千佳1, 篠木優里1, 岩本卓也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 589-589, 2020.

---

	O11-1. Cost effectiveness of the Japanese progress, nivolumab in recurrence cancer of the esophagus second treatment 近藤有1, 榊原崇芳1, 加藤潤1, 渡邊雅史1, 西村栄輝1, 實安健市1, 下野大貴1, 間瀬悟1, 三宅芳男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 590-590, 2020.

---

	O11-2. Outcome evaluation of the proper use guideline (rea formula) introduction in the antiinfluenza medicine 片田佳希1,2, 米澤淳1, 杉本充弘1, 木全柾典1, 吉田優子1, 糸原光太郎1, 中川俊作1, 北田徳昭1, 今井哲司1, 池見泰明1, 深津祥央1, 中川貴之1, 松村康史2,3, 長尾美紀2,3, 松原和夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 591-591, 2020.

---

	O11-3. Evaluation of the drug economic usefulness by the sleeplessness indicator standardization 税所篤行1,2, 高砂美和子1, 若林和貴1, 秋山真里1, 幸田恭治1, 松永和人2, 石田博3, 北原隆志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 591-591, 2020.

---

	O11-4. Drug costs reduction effect by the storage period extension of the multiple use vial 藤本俊祐1, 中村はづき1, 多賀允俊1, 野崎香於利1, 中田早音1, 高橋喜統1, 政氏藤玄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 592-592, 2020.

---

	O11-5. Evaluation of the impact of warning display at the time of prescription order on formulary promotion 安島秀友1, 松崎貴志1, 美馬朱美1, 田中恒明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 592-592, 2020.

---

	O11-6. Factorial experiments about medication of the patients whom cerebral infarction developed in during anticoagulant remedy 赤木祐貴1, 池滝晶子1, 中村玲子1, 高橋竜哉2, 遠藤美乃里3, 盛川敬介3, 太田貴洋4, 及川瞬5, 辰己晋平6, 鈴木隆史7, 水島淳裕8, 山村重雄9, 小井土啓一1, 高橋省三1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 593-593, 2020.

---

	O11-7. Examination of the usefulness of the use of perioperative statin using the National receipt database 黒田侑花1, 落部達也2, 秋田彩佑1, 頭金正博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 593-593, 2020.

---

	O11-8. Medical economic effect by DVO and the Dose Banding introduction simulation of the injection anticancer medicine 本永正矩1, 板村亮1, 小林遼平1, 寺谷祐亮1, 佐伯康之1, 松尾裕彰1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 594-594, 2020.

---

	O12-1. Functions and usefulness of the polypharmacy system made by Yuyama Co., Ltd. 上田宏1, 細田未紀1, 畑将弘1, 石谷理紗1, 山根正也1, 千原里美1, 伊東範尚2, 三宅建郎3, 野村俊至4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 595-595, 2020.

---

	O12-2. Examination about the construction of the prescription adequacy support system and the effect 竹村有美1, 濱崎千尋1, 山田健一1, 塚原邦浩1, 小倉秀美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 596-596, 2020.

---

	O13-1. About reporting about the safety of the health food in the anti-doping education for the professional athlete 武山和也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 597-597, 2020.

---

	O14-1. "A healthy fair" utilizing obesity, the alcohol metabolism-related genetic screening for citizens 池田佳代1, 細井徹1, 三浦常代2,3, 島崎一郎4, 春日真由5, 高畑真由子5, 島田和美5, 田中信江5, 龍春花3, 幾田美紀3, 谷口智昭3, 天崎あゆみ3, 吉井美智子1, 杉山政則6, 大谷純一3, 重留佳代子5, 若生あき5, 中野真豪7, 野村祐仁7, 豊見雅文8, 小澤光一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 598-598, 2020.

---

	O15-1. The effectiveness and safety of the breast cancer trastuzumab follower product in real world data 佐々木俊則1, 水谷三浩2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 599-599, 2020.

---

	O16-1. One case of the diffuse scleroderma that resulted in a pulmonary oedema by bosentan administration 今井雄介1, 田中雅幸1,2, 打谷和記1, 諏訪惠信3, 村中達也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 600-600, 2020.

---

	O16-2. Development of the onset of non-expression side effect prediction law using the distance between drug - side effects and inspection of the validity 渡部輝明1, 川上準子1, 星憲司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 601-601, 2020.

---

	O16-3. The establishment of the onset of fatal adverse event risk rating system with the immune checkpoint inhibitor in patients with lung cancer: Risk assessment of the interstitial lung disease 岡田直人1, 松岡里英1, 櫻田巧1, 合田光寛1, 中馬真幸2, 武智研志3, 座間味義人1,4, 桐野靖1, 中村敏己1, 西岡安彦5, 石澤啓介1,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 601-601, 2020.

---

	O16-4. One case that presented a serious neutropenia in the FOLFIRI + bevacizumab therapy of Lacosamide treated patients 松沼悟1, 輿石徹1, 川辺千苗美1, 須永茂樹2, 吉元公一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 602-602, 2020.

---

	O16-5. 1 case with suspected vasculitis with duloxetine 中川義浩1, 鶴崎泰史1, 花田聖典1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 602-602, 2020.

---

	O16-6. Study on risk factor analysis of the blood eosinophil count ratio increase for the early detection of eosinophilic pneumonia through daptomycin 梅村晃子1, 早川慎哉1, 平野公美1, 宮本康敬1, 川口千香1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 603-603, 2020.

---

	O16-7. Association between expression of Infusion Reaction and allergic disease and allergy history with rituximab 深田耕司1, 宮本真由1, 犬飼萌乃1, 前田真一郎1,2,3, 前田真貴子1,2,4, 藤尾慈1,2,4, 廣部祥子1,2,3,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 603-603, 2020.

---

	O16-8. Examination about the effect on CK with the daptomycin high dose 上田真也1, 田代匠1, 早川裕二3, 深見和宏1, 近藤芳皓4, 朝居祐貴5, 鈴木亮平6, 細江慎吾7, 薄雅人4, 間瀬広樹3, 山本吉章2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 604-604, 2020.

---

	O16-9. Risk factor evaluation of the checkpoint inhibitor-related fatal adverse event of immunity 新村貴博1, 座間味義人1,2, 合田光寛2, 中馬真幸3, 八木健太3, 福島圭穣4, 石澤有紀5, 藤野裕道4, 石澤啓介1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 604-604, 2020.

---

	O16-10. Effect on cognitive function of the non-ergot system dopamine agonist in the Parkinson's disease patients 中村友紀1, 重面雄紀1, 中川貴之1, 今井哲司1, 樽野陽亮2, 澤村正典2, 大村友博3, 松原和夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 605-605, 2020.

---

	O16-11. Case of the complete atrioventricular block by the azelnidipine that an eternal pacemaker shrubbery was evaded by pharmaceutical intervention 井出直仁1, 望月彩加1, 伊藤政治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 605-605, 2020.

---

	O16-12. Two cases of the pulmonary thromboembolism that occurred during antipsychotics remedy 甲斐真己都1, 山村亮太1, 河野浩之1, 田中遼大1, 龍田涼佑1, 伊東弘樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 606-606, 2020.

---

	O16-13. The combination of the P-glycoprotein inhibitor giving it to a bleeding risk of the dabigatran and nephropathic effect (the third report) 横田裕之1, 川上智恵子1, 土岐浩介1,2, 青沼和隆2, 家田真樹2, 本間真人1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 606-606, 2020.

---

	O16-14. About side effect collection based on the law such as pharmaceutical products medical equipment, and the like in the Aichi Medical University Hospital 宇野英理子1, 野々垣知行1, 佐久間晶基1, 近藤あゆみ1, 深谷さおり1, 竹内正幸1, 大西正文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 607-607, 2020.

---

	O16-15. Evaluation of the bleeding-related adverse event in Avastin and the DOAC combination 中村宗一郎1, 坂野博紀1, 町支優和1, 石川元章1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 607-607, 2020.

---

	O16-16. Does the Donepezil raise a side effect risk of amantadine? 薄井健介1,2, 岡田浩司1,2, 宇野尭2, 小塚脩平3, 高瀬照人3, 大内竜介1,2, 鈴木映二3, 渡辺善照1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 608-608, 2020.

---

	O16-17. The onset of tubulointerstitial nephritis situation with the immune checkpoint inhibitor: Analysis using Japanese Adverse Drug Event Report database 岡田浩司1,2, 薄井健介1,2, 大内竜介1,2, 宇野尭2, 高橋将典2, 菊池大輔2, 渡辺善照1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 608-608, 2020.

---

	O17-1. Construction of the physiologic pharmacokinetics model in consideration of a complicated non-linear internal change of the hepatitis C therapeutic drug Grazoprevir 志田紗恵子1, 吉門崇1,2, 年本広太2, 杉山雄一2, 千葉康司1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 609-609, 2020.

---

	O17-2. Examination of the species difference in the oxidative metabolism response of the regorafenib 曽我部鮎果1, 加藤美紀2, 小島綾華1, 榊原有季子2, 灘井雅行2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 610-610, 2020.

---

	O17-3. The effect that a multi-kinase inhibitor gives to the expression of human skin drug transporter 小島綾華1, 加藤美紀1, 榊原有季子1, 灘井雅行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 610-610, 2020.

---

	O18-1. Consideration - case report about the index to guess a cerebral fluid extraction rate of vancomycin at meningitis 山形真一1, 狩野亘平2, 白澤宏美3, 原田正公2, 鶴崎泰史3, 中川義浩3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 611-611, 2020.

---

	O18-2. Do pharmacokinetic-related genetic polymorphisms affect inter-individual variability in trough concentrations of oral factor Xa inhibitors? 中川潤一1, 金城貴彦2, 飯塚芽依1, 上野桂代1, 富田泰史2, 新岡丈典1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 612-612, 2020.

---

O18-3. The peripheral blood lymphocyte counts in patients with advanced cancer, serum IgG behavior and anticipatory evaluation of serum nivolumab concentrations that paid their attention to the cachectic condition of a patient 阿部一樹1, 柴田海斗1, 内藤隆文1, 柄山正人2, 大塚篤史3, 前川真人4, 山田康秀2, 三宅秀明3, 須田隆文5, 川上純一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 612-612, 2020.

---

	O18-4. Effect on arbekacin clearance due to the febrile neutropenia 中山貴裕1, 中馬真幸1, 栃倉尚広1, 岩渕聡1, 鈴木慎一郎1, 松本千明1, 今井徹1, 吉田善一1, 濱田高志2, 中川優2, 高橋宏通2, 内野慶人2, 三浦勝浩2, 入山規良2, 八田善弘2, 武井正美2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 613-613, 2020.

---

	O18-5. Rationalization of very high blood flecainide levels in patients with cirrhosis merger end stage renal failure using the physiologic pharmacokinetics model 土岐浩介1, 久賀圭祐2, 青沼和隆2, 家田真樹2, 本間真人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 613-613, 2020.

---

	O18-6. The diabetes medical therapy that is optimal for an individual 富岡節子1, 山崎直毅2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 614-614, 2020.

---

	O18-7. Population pharmacokinetics/genome pharmacologic analysis of the edoxaban in patients with atrial fibrillation 上島智1, 平大樹1,2, 道籏梨央1, 田淵陽平2, 伊藤英樹3,4, 小澤友哉3, 中川義久3, 堀江稔3,5, 寺田智祐2, 桂敏也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 614-614, 2020.

---

	O19-1. Effect of the dihydropyridine-based calcium-channel blocker on side effect expression of the Ramucirumab/Paclitaxel therapy 川口萌実1, 友松拓哉1, 青山剛1, 川上和宜1, 平出誠1, 山口研成2, 濱敏弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 615-615, 2020.

---

	O19-2. Effect - that the enzyme induction of patients with refractory epilepsy and polypharmacy - antiepileptic drug gives to antipsychotics 福島悠太郎1, 山本吉章1,2, 賀川義之2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 616-616, 2020.

---

	O19-3. Examination about drug interactions and the polypharmacy during cancer pain treatment 鈴木訓史1, 齋藤一樹1, 一戸集平1, 後藤達也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 616-616, 2020.

---

	O19-4. Effect on effect of treatment of the rosuvastatin by the taking magnesium oxide timing 小山勝真1, 税所篤行1, 幸田恭治1, 北原隆志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 617-617, 2020.

---

	O19-5. Examination by in vitro of the interaction through cytochrome P450 of voriconazole and aprepitant 石田真紗子1, 熊谷健2, 進藤佐和子2, 鈴木裕之3, 山本達郎1, 森木邦明1, 永田清2, 島田美樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 617-617, 2020.

---

	O20-1. Examination of the renal function evaluation method using the serum creatinine level in patients with amyotrophic lateral sclerosis 野々内裕紀1, 眞継賢一1, 王宏維1, 濱口良彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 618-618, 2020.

---

	O20-2. Association between age-related body composition change and metabolism of the liver metabolism type drug in elderly people 蕪木素代子1, 吉村恵理2, 宮本康史2, 今井俊吾3, 柏木仁3, 上野英文2, 菅原満3,4, 武隈洋4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 619-619, 2020.

---

	O20-3. Assay establishment of high sensitive free form Lenvatinib concentrations using UPLC-MS/MS 末繁嘉朗1, 白岩健1, 田中遼大1, 本田浩一2, 齋藤衆子2, 岩尾正雄2, 荒川光江2, 遠藤美月2, 龍田涼佑1, 村上和成2, 伊東弘樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 619-619, 2020.

---

	O20-4. We look at the rear about Teicoplanin maintenance doses aiming at 15-30 μg/mL of trough values and examine a mark 近藤昭志1, 尾田一貴1,2, 片野田朋美1,2, 成田勇樹1, 岩村耕次1, 野坂生郷2, 城野博史1, 齋藤秀之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 620-620, 2020.

---

	O20-5. Construction of the blood level simultaneous analytical procedure of CDK4/6 inhibitor in the breast cancer and the hormonal therapies medicine 佐藤裕1, 重田健介2, 平澤天晴2, 菊地正史1,2, 佐藤紀宏1, 小倉次郎1, 前川正充1,2, 江幡明子3, 濱中洋平3, 多田寛3, 石田孝宣3, 眞野成康1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 620-620, 2020.

---

	O20-6. Search of the optimal loading dose of the Teicoplanin in patients with hypoalbuminemia 吉瀬絵理1, 小松敏彰1, 宮坂優人1, 厚田幸一郎1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 621-621, 2020.

---

	O20-7. Examination about the blood level at the amiodarone continuous intravenous infusion for children 牧野宏美1, 諏訪淳一1, 植村明日香1, 鹿山祐梨1, 藤田幹生1, 山口智1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 621-621, 2020.

---

	O20-8. The LC-MS/MS assay development of human serum tocilizumab concentrations using the trypsin digestion to immobilize and the clinical application 望月啓志1, 柴田海斗1, 内藤隆文1, 下山久美子2, 小川法良2, 川上純一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 622-622, 2020.

---

	O20-9. Exploratory evaluation of the change factor of the plasma GlcNAc concentration in patients with rheumatoid arthritis 今江陽1, 坪井声示1,2, 松本拓也2, 南雲達1, 谷澤康玄1, 大澤隆志1, 賀川義之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 622-622, 2020.

---

	O20-10. In-hospital algorithmic compliance and evaluation in the TDM of vancomycin 瀬戸良教1, 奥脇達也2, 小松敏彰2, 高山陽子1, 厚田幸一郎2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 623-623, 2020.

---

	O20-11. Establishment of the simultaneous assay of the each optical isomer of plasma tolvaptan in patients with heart failure and the hydroxylated metabolite 阿久津駿太1, 内藤隆文1, 星川昂平1, 早乙女雅夫2, 前川裕一郎2, 川上純一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 623-623, 2020.

---

	O21-1. The construction method of the examination for NUDT15 genetic polymorphism measurement 磯野哲一郎1, 平大樹1,2, 中村吉伸1, 辻徳治1, 赤羽理也1, 河原真大3, 森田真也1, 安藤朗3, 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 624-624, 2020.

---

	O21-2. Usefulness of the microRNA as the effect prediction biomarker of the Benralizumab in patients with severe asthma 上原星輝子1, 平井啓太1, 良知優花1, 木村朋起1, 白井敏博2, 伊藤邦彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 625-625, 2020.

---

	O22-1. Examination of optimal non-duration of use becoming the freeze standard of the registration regimen in the cancer chemotherapy, Multicenter investigation 渡邊裕之1, 槙原克也2, 中野寛之3, 倉橋基尚4, 近藤篤5, 村上賢次6, 中尾將彦7, 足立充司8, 萱野勇一郎9, 平井三保子10, 尾上雅英5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 626-626, 2020.

---

	O22-2. Examination of medication adherence and the effect of treatment of TAS102 奥田泰考1, 三瓶祐貴1, 品田誠1, 齋藤賢宏1, 毛塚ちひろ1, 星ちはる1, 小林直人1, 山口博紀2, 藤井博文2, 須藤俊明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 627-627, 2020.

---

	O23-1. Approach at the drugstore for the HBOC patients 宇田雅実1, 松久知由1, 金澤哲也1, 坂川興規2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 628-628, 2020.

---

	O23-2. Efforts to foreign cancer chemotherapy with high quality through the cancer medicine medicine cooperation 基村佳世1, 槙原克也1, 福井梨乃1, 奥澤文敏1, 井上聖夜子1, 松村友和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 629-629, 2020.

---

	O24-1. The anticancer medicine exposure situation investigation before and after the closed system anesthesia drug transportation system introduction 立原茂樹1, 大神正宏1, 市塚亜由美1, 石川洋輔1, 島田浩和1, 小島友恵1, 柴このみ1, 山下真以1, 坪山勝平1, 千葉布季子1, 鈴木麻紗子1, 鈴木美加1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 630-630, 2020.

---

	O24-2. Translocation of Anticancer Drugs to Drainage by Hemodialysis and Continuous Hemodiafiltration in Patients Administered with Pomalidomide and Cyclophosphamide 古賀和馬1, 田頭尚士1, 山本宏1, 中尾亮太2, 有安祥訓2, 大野開成2, 吉田磨2, 太田康介3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 631-631, 2020.

---

	O24-3. Examination about the attitude survey in anticancer medicine exposure measures and the use expansion of the closed system anesthesia drug transportation system 横山雄一1, 井上潔1, 古谷頼和1, 植木亮磨1, 吉村仁志1, 江崎翔平1, 宇野由紀子1, 篠原義剛1, 植木哲也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 631-631, 2020.

---

	O24-4. Analysis of the factor influencing the anxiety to injectable anticancer agent preparation duties in the hospital pharmacist 柳澤友希1,2, 黒須智博1, 夏目義明4, 清野敏一2, 伊佐間和郎2, 西村哲治3, 山下敦志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 632-632, 2020.

---

	O24-5. Evaluation of the occupational exposure measures at preparation by the anticancer agent exposure investigation 佐藤由美子1, 諸角一成1, 恒川有里1, 權田結乃1, 長水正也1, 日比陽子1, 森下修行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 632-632, 2020.

---

	O25-1. Regional alliances for irAE measures 坂川興規1, 金澤哲也1, 松久知由1, 宇田雅実1, 村上通康2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 633-633, 2020.

---

	O25-2. Efforts to the making of information sharing base of the medicine medicine cooperation in the cancer medical care 中村久美1,2, 淺野未代子2, 有井太郎2, 井出貴之2, 大輪武司2, 鬼窪利英2, 小野里直彦2, 野村充俊2, 平林克博2, 松澤直樹2, 松原重征2, 三浦篤史2, 向山百合2, 村田稔弥2, 吉澤貴代美2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 634-634, 2020.

---

O25-3. Efforts ... of the education, duties support activity - Aichi hospital pharmacist society cancer sectional meeting tool making group to a pharmacist engaged in cancer medical therapy 鈴木大介1,2, 朝岡裕樹2, 伊藤友哉2, 伊藤文香2, 鵜飼麻由2, 越智富美江2, 加藤奈波2, 神谷幸江2, 切畑麻那2, 小杉菜々子2, 嶋洋将2, 末松菜月2, 玉置彩奈2, 袴田杏紗2, 山田卓摩2, 高木麻衣2, 冨田庸介2, 川合甲祐2, 板倉由縁2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 634-634, 2020.

---

	O25-4. Examination of the factor having an influence on the improvement of the understanding degree for the cancer medical therapy in the outpatient department 豊里星来1, 安藤洋介1, 小出菜優1, 松田日出三1, 辻井奈保1, 柘植雅大1, 河田健司2, 山田成樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 635-635, 2020.

---

	O25-5. It is the current situation investigation about the tolerability of S-1 in the adjuvant chemotherapy after the pancreatic cancer technique 野口裕介1, 加藤良隆1, 大坪達弥1, 鹿浦香織1, 神田英一郎1, 小林大祐1, 眞釼彩子1, 江島智彦1, 豕瀬諒2, 村木優一2, 友金幹視1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 635-635, 2020.

---

	O26-1. Comparison of the antiemesis effect of granisetron and palonosetron under the NK1 receptor blocker combination on chemotherapy of the moderate emetic risk 三好孝法1, 松尾尚美1, 小田原真希1, 堀南奈子1, 平木洋一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 636-636, 2020.

---

	O27-1. Device of the light subtraction of the liquid preparations gemcitabine-induced vascular pain which paid their attention to a dilution 内山数貴1, 齋藤佳敬1, 坂本達彦1, 菅野亮太1, 小松嘉人2, 武隈洋1, 菅原満1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 637-637, 2020.

---

	O27-2. Search of the patients background to be associated with the onset of the adverse event of the MPB therapy for the multiple myeloma 坂部彩1, 亀位涼1, 中嶋琢人1, 頭金正博1, 李政樹2, 飯田真介2, 丸山大2, 大佐賀智2, 飛内賢正2, 福原規子2, 宮崎香奈2, 南陽介2, 塚本憲史2, 辻村秀樹2, 吉満誠2, 宮本憲一2, 塚崎邦弘2, 永井宏和2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 638-638, 2020.

---

	O27-3. Basic examination about the usefulness of the cystine theanine oral administration for oxaliplatin-induced peripheral neuropathy 川尻雄大1, 小林大介1, 江頭伸昭2, 島添隆雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 638-638, 2020.

---

	O27-4. It is ... for the early detection of telephone follow-up ... serious cardiovascular system adverse event for patients with multiple myeloma during IMiDs administration 西垣賢1, 生川賀代2, 米田勝晃2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 639-639, 2020.

---

	O27-5. Basic and clinical evaluation about the usefulness of the proton pump inhibitor for the cisplatin origin-related renal failure 平松駿一1, 池村健治2, 藤澤豊3, 岩本卓也1, 奥田真弘2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 639-639, 2020.

---

	O27-6. Investigation about the nasal meatus irritative symptom at the cyclophosphamide administration in the breast cancer chemotherapy 桑村恒夫1, 上津沙織1, 小笠裕斗1, 末松文博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 640-640, 2020.

---

	O27-7. About neutropenia and the patient background factor with bendamustine 大谷豊司1, 南目祐希1, 河角康1, 渡辺美恵子1, 新宮行雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 640-640, 2020.

---

	O27-8. Examination about the onset of thrombocytopenia with nutritional status and the oxaliplatin + S-1 therapy of patients with gastric cancer 中澤佑介1, 影山明1, 北村正樹1, 三森教雄2, 川久保孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 641-641, 2020.

---

	O27-9. The effectiveness of the mirogabalin for peripheral neuropathy in the gynecologic TC therapy and safe examination 馬場華菜1, 谷口潤1, 尾之江剛樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 641-641, 2020.

---

	O27-10. Inspection of the effectiveness of the naldemedine in the poor Performance Status group of patients 加藤信太郎1, 小野田紘子1, 齋藤佳敬1, 今井俊吾2, 熊井正貴1, 敦賀健吉3, 渡辺祐子1, 武隈洋1, 菅原満1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 642-642, 2020.

---

	O27-11. Fact-finding of the administration cancellation by irAE of the ICI combination chemotherapy in the lung cancer 早坂州生1, 岩本浩史1, 北山秀則1, 竹内公美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 642-642, 2020.

---

	O27-12. Investigation about the onset of the interstitial lung disease associated with the immune checkpoint inhibitor using the adverse drug reaction database and the outcome 横井茉里1,2, 米澤淳2, 中川俊作2, 半田知宏3,4, 老本名津子1,2, 北田徳昭2, 中川貴之2, 松原和夫2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 643-643, 2020.

---

	O27-13. Patients with postmenopausal breast cancer have high onset, aggravation risk of paclitaxel-induced peripheral neuropathy 宮本朋佳1,3, 富士谷昌典1, 畑中重克2, 小泉祐一1, 川畑篤史3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 643-643, 2020.

---

	O27-14. Inspection of GARG Toxicity SCORE of elderly people cancer treatment in Japanese 藤村浩司1,9, 伊藤夕貴1,9, 大島有美子2,9, 平松久典3,9, 向山直樹4,9, 佐々木俊則5,9, 山口智江3,9, 佐藤由美子6,9, 堀田和男7,9, 久田達也1,9, 板倉由縁8,9 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 644-644, 2020.

---

	O27-15. Serum beta 2 - microglobulin is a risk factor of the cisplatin-induced acute renal failure onset for patients with cancer of the esophagus 古原優也1, 高橋克之1, 豕瀬諒1, 高橋正也1, 永山勝也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 644-644, 2020.

---

	O27-16. About onset of electrolyte abnormality to occur after Cetuximab administration 山城海渡1,2, 平田敦士2, 太田涼介2, 緒方文彦1, 中村武浩1, 川崎直人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 645-645, 2020.

---

	O27-17. Extension of the no oxaliplatin association hypersensitivity reaction survival period with the antihistamine pre-medication 板倉祥嗣1, 土手賢史2, 古田祐美子2, 塩飽英二2, 金子忍2, 津田正博1, 小林由佳2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 645-645, 2020.

---

	O27-18. The effectiveness, safe examination of precedent biomedicine of the filgrastim for the salvage chemotherapy of the malignant lymphoma and the following article 島野玲菜1, 那須いずみ1, 内田ゆみ子1, 柏村友一郎1, 藤井博之1, 谷口修一2, 伊藤忠明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 646-646, 2020.

---

	O27-19. Fact-finding about the administration timing of the peg filgrastim in patients with gynecologic cancer 小島友恵1, 大神正宏1, 谷中敦美1, 立原茂樹1, 市塚亜由美1, 石川洋輔1, 島田浩和1, 柴このみ1, 渡邊雅明2, 花井誠2, 島田浩明2, 鈴木嘉治2, 本田真人2, 鈴木美加1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 646-646, 2020.

---

	O27-20. Prospective clinical study of the steroid prophylaxis for the eruption by the pemetrexed 櫻田巧1, 柴田高洋1, 濱野裕章1, 山川祐介1, 合田光寛1, 座間味義人1,2, 桐野靖1, 中村敏己1, 軒原浩3, 西岡安彦3, 石澤啓介1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 647-647, 2020.

---

	O27-21. Examination of the adverse event risk by ICI and the chemotherapy combination 金永進1, 南貴之1, 若月淳一郎1, 小林寛明2, 松本香織1, 筒井俊晴2, 柿崎有美子2, 花輪和己3, 小林みつ恵1, 宮下義啓2, 小林義文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 647-647, 2020.

---

	O27-22. Examination of the onset risk of venous thromboembolism (VTE) in patients with cancer which received bevacizumab (BEV) 西村明莉1,2, 満間綾子2, 池田義明1, 安藤雄一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 648-648, 2020.

---

	O28-1. Use fact-finding of the opioid-induced constipation therapeutic drug naldemedine tosyl acid salt 戸田温子1, 飛鷹範明2, 坂本宣俊1, 田中守2, 田中亮裕2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 649-649, 2020.

---

	O28-2. Examination of the effectiveness of the midazolam a little sustained administration for the nausea symptom of patients with end-stage cancer 鈴木のどか1, 打田佑人2, 松本篤季3, 山本孝枝1, 河内若代1, 三宅浩子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 650-650, 2020.

---

	O28-3. Examination about the use situation of bringing medicine and the rescue medicine for patients with cancer 江草徳幸1, 萬光沙紀1, 井口奈美1, 安原昌子1, 堀川俊二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 650-650, 2020.

---

	O28-4. Relations of the quantity of drug application for disease severity of oral mucositis every irradiation part of the radiation in patients with head and neck cancer and the pain 山本和輝1, 星川昂平1, 堀雄史1, 八木達也2, 神谷正貴3, 川上純一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 651-651, 2020.

---

	O29-1. One case that performed a dose design of induction therapy and the consolidation chemotherapy of the acute promyelocytic leukemia in haemodialysis patients, and succeeded 林田颯志1, 佐道紳一1, 岩村直也1, 對馬秀樹1, 一瀬将広1, 樋口則英1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 652-652, 2020.

---

	O29-2. Attenuation effect of the nicorandil for high blood pressure and the antitumor effect with the neovascularisation inhibitor 海老名一樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 653-653, 2020.

---

	O29-3. Look at TPS in the use of Pembrolizumab patients and the rear about the autoimmune disease-related side effect; a mark multicenter study 水上皓喜1, 北本真一2, 武良卓哉3, 妹尾啓司1, 阪田安彦1, 開浩一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 653-653, 2020.

---

	O29-4. An effect of EGFR-TKI in the EGFR mutation in the gene-positive non-small cell lung cancer and effect of the body-surface area on side effect 小田桐功武1, 高木香菜子2, 鷲巣晋作1, 細谷幸紀1, 内池明博1, 坪井伸也1, 葉山達也1, 権寧博3, 林宏行2, 木村高久1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 654-654, 2020.

---

	O29-5. Antitumor effect and antimicrobial ... of effect - immunity checkpoint inhibitor to give to cancer immune therapy of the non-small cell lung cancer 貝野裕也1, 北澤文章1, 前野有紀1, 大井隆広1, 坂野玲子1, 中藏伊知郎1, 中村孝人2, 辻川正彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 654-654, 2020.

---

O29-6. Relative examination with a survival period and the onset of patients with extensive-stage small-cell lung cancer of neutropenia: Multicenter study 宮城壮裕1, 辻大樹1, 川崎洋平2, 石川寛3, 中尾將彦4, 中垣繁5, 林稔展6, 原田知彦7, 鮎原秀明8, 玉木慎也9, 前田章光10, 大橋養賢11, 藤田行代志12, 荒川雄一郎13, 山本圭祐14, 矢野琢也15, 宮本康敬16, 伊藤邦彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 655-655, 2020.

---

	O29-7. Examination - interim report - about the effect factor of the diarrhea by the Abemaciclib 杉山理奈1, 嘉屋道裕1, 大滝由美1, 坂田茂代1, 杉山恭平1, 鈴木麻里子1, 冨士野ひより1, 堤正人1, 相磯佳歩1, 平野桂子1, 木村緑1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 655-655, 2020.

---

	O29-8. The warfarin combination case that we were thought to need for the recovery of the CYP2C9 conduction by the Enzalutamide for several months 山田麻衣子1, 奈良克彦1, 大野能之1, 田中雄大1, 鈴木洋史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 656-656, 2020.

---

	O29-9. Examination of the effect that PPI at the Cetuximab administration in patients with craniocervical part cancer gives to a low Mg blood symptom 谷本憲哉1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 656-656, 2020.

---

	O29-10. Examination about a weight loss before the administration in the administration of immune checkpoint inhibitor and the association of the survival period 槙原克也1, 松村友和1, 紙森隆雄2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 657-657, 2020.

---

	O29-11. A CDDP-induced nephropathic reduction effect by Caffeine and elucidation of the enhancement of the antitumor effect 菊池優貴乃1, 河野洋平1, 小池翼1, 野原萌1, 齋藤めぐみ1, 上原佳奈枝1, 青山隆夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 657-657, 2020.

---

	O29-12. The severe immune-mediated adverse event with the immune checkpoint inhibitor is high, and it develops in patients without a previous history of treatment 冨士原あゆみ1, 土手賢史1, 塩飽英二1, 古田祐美子1, 金子忍1, 松原菜美1, 小林由佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 658-658, 2020.

---

	O29-13. Fatigue, lassitude by the Lenvatinib, examination of the anorectic expression risk factor 土屋直彦1, 佐野周生2, 若林雅人1, 中田伸司2, 森宏光3, 和田秀一3, 浜善久4, 牛山利昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 658-658, 2020.

---

	O29-14. The effectiveness and safety of the checkpoint inhibitor combination therapy of immunity 濱武清範1, 小西史子1, 松田ちひろ1, 野間敏也1, 奥村優介1, 橋本浩明1, 北英夫2, 菅理晴3, 小島一晃1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 659-659, 2020.

---

	O29-15. The effect that BMI gives for expression and effect of treatment of the serious thrombocytopenia of the Carboplatin + etoposide 根來寛1, 重森美奈1, 小島すみれ1, 山下慎司1, 渡邉享平1,2, 矢野良一3, 塚本仁1, 後藤伸之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 659-659, 2020.

---

	O30-1. Establishment of use of standardization carbapenem system medicine metrics based on DPC data, Correlation with predictive DDDs and the usability test coefficient 前田真之1, 村木優一2, 安濃侑桂1, 佐和章弘3, 日馬由貴4, 石金正裕4, 大曲貴夫4, 大毛宏喜5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 660-660, 2020.

---

	O30-2. The linezolid-resistant enterococcal new detection decrease and drug costs reduction effect by the linezolid consumption drop 岡冨大輔1, 山西紀子1, 片山雄太2, 谷口雅敏1, 松田裕之3, 石野敬子4, 福地邦彦5, 二木芳人6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 661-661, 2020.

---

	O30-3. The effect that the feedback of the culture sampling rate before the wide area antimicrobial administration gives for narrowing of the antimicrobial 下平智秀1,2, 町田征己1, 藤田裕晃1, 奥川麻美1, 中村造1, 添田博1,2, 前彰2, 渡邉秀裕1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 661-661, 2020.

---

	O30-4. Drug costs reduction effect by the intervention of the pharmacist to the use of all injectable antimicrobial patients 大橋健吾1, 篠田康孝1, 松岡知子1, 新井かおり1, 西村未紗1, 長瀬泉1, 森卓之1, 吉田真也1, 吉村知哲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 662-662, 2020.

---

	O30-5. Efforts of the education to the resident by the antibacterial chemotherapy authorization pharmacist 中田一孝1, 冨田有香1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 662-662, 2020.

---

	O30-6. Evaluation of the AST activity led by the pharmacist judging from antimicrobial consumption investigation 星野僚介1, 木村繁和1, 松本智史1, 林貴子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 663-663, 2020.

---

	O30-7. Report - infective endocarditis surgical treatment case - of the cooperation situation of AST and the cardiovascular surgery in the Tomigusuku center Hospital 小杉卓大1, 姫野智子1, 運天雅1, 中島里奈1, 新垣淑大1, 大嵩昌子2, 石川美根子2, 西平守邦3, 山内昭彦4, 國分千代1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 663-663, 2020.

---

	O30-8. Consideration about the dose at renal failure of favipiravir and liver damage from literatures 池谷修1, 高野八百子1, 長谷川直樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 664-664, 2020.

---

	O31-1. Effect of the antimicrobial proper use support activity at the small and medium size scale hospital 中村聡志1,2, 有馬隆司1,3, 田代良一1,4, 安水里美1,5, 愛甲隼人2, 渡邉恵美2, 中島隆司2, 長友優歩2, 柿元郁代2, 本屋敏郎2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 665-665, 2020.

---

	O31-2. Spreading effect to the education effect of the hand hygiene on ward pharmacist and the pharmacy school business trainee as the reviewer 柴田京香1, 飯田真之1, 宇田篤史1,3, 出田理恵2,3, 八幡眞理子2,3, 大本暢子1, 山本和宏1, 大村友博1, 矢野育子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 666-666, 2020.

---

	O31-3. About the usefulness of the study session about the infection for the purpose of the pharmacist education 佐々木暢琢1, 川口奈緒美1, 近藤健太1, 木村匡男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 666-666, 2020.

---

	O31-4. Comparison between cefazolin and surgical-site infections protective efficacy of the cefmetazole in the orthopedics domain 中島一1, 桑村恒夫1, 芳賀由美2, 土屋邦善3, 末松文博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 667-667, 2020.

---

	O31-5. Examination about the consumption change of the beta-lactam system medicine accompanied with the adoption review of the oral antimicrobial 多賀允俊1, 高瀬文超1, 中村はづき1, 政氏藤玄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 667-667, 2020.

---

	O31-6. Usefulness of the AST activity utilizing MALDI-TOFMS 石塚友一1, 本田勝亮1, 柏原道志1, 長岡翔1, 石原冬馬2, 釋悦子2, 齊藤一仁5, 武地大維5, 真壁利枝3, 宮木祐一郎4, 澤昇平1, 山本圭祐1, 松川陽央1, 鈴木真理子1, 石野清亮1, 渡邊卓哉5, 矢部勝茂1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 668-668, 2020.

---

	O31-7. Evaluation of the effect that bacteremia due to drug-resistant Escherichia coli gives for clinical outcome 三村亘1, 佐藤夏津1, 福田治久2, 庄野あい子3, 赤沢学1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 668-668, 2020.

---

	O31-8. Allied analysis of the UTIs in the SGLT2 inhibitor using adverse drug reaction database (JADER) 角真太郎1, 久保利樹1, 祖川倫太郎1, 江本晶子1, 田崎正信1, 入江裕之1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 669-669, 2020.

---

	O31-10. An example of the enforcement situation and the problem of the infection management strategy in the health insurance pharmacy 玉城武範1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 670-670, 2020.

---

	O31-11. Examination of the usefulness using practice support system "Vitalook" online for the medical treatment support of patients with contagious infection 長澤宏之1, 田口雅彦2, 土屋良成2, 東納重隆2, 小松淳3, 野口邦晴3, 星誠一郎2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 670-670, 2020.

---

	O32-1. Sialoschesis at nasogastric tube tube long-term custody: Examination with the amitriptyline administration 山岸紀子1,3, 松浦佳代1, 林祥子1,3, 中村優1,3, 中澤実紀1,3, 帆足萌1,3, 島本和巳2,3, 鷹羽頼勝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 671-671, 2020.

---

	O32-2. Study on prehospital drug control and nutritional status 田原温1, 綿屋朋子1, 宮内秀典1, 野口周作1, 笠原英城1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 672-672, 2020.

---

	O32-3. Consideration about the use situation of the medicine for the central nervous system in patients with dysphagia and the effect 光武瑞穂1, 金子正博2, 福嶋浩一1, 越智達哉3, 巽弥生1, 尾鼻俊弥4, 岡本知子5, 辻佳穂里6, 後藤昭一7, 河合峰雄8, 西田哲也8, 菅生教文9, 石本学司1, 奥野昌宏1, 田中詳二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 672-672, 2020.

---

	O32-4. Efforts to nutrition therapy standardization using a nourishment assessment sheet 只見智恵子1,2, 佐藤美絵1,2, 高橋史織1, 菅原直子1, 柏瀬しのぶ1, 深谷寛1, 浜田幸宏1, 木村利美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 673-673, 2020.

---

	O33-1. Subjective assessment in patients with schizophrenia taking brexpiprazole 横井里奈1, 波多野正和1,2,3, 森田葵1, 福井愛子1, 半谷眞七子1, 津川透2, 山田成樹2, 岸太郎3, 岩田仲生3, 亀井浩行1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 674-674, 2020.

---

	O33-2. Efforts for proper use of sleeping pills combining in-hospital formulary and NDB open data 加藤豊範1, 小暮俊明1, 町田祐実子1, 吉田章悟1, 鈴木絢子1, 酒井美理1, 小田高司2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 675-675, 2020.

---

	O33-3. Open-label randomized clinical trial about the effectiveness by the sleeping drug change for the insomnia to be complicated for the depression that is not as effective to a benzodiazepine system sleeping drug 重面雄紀1, 今井哲司1, 中川貴之1, 上田敬太2, 圓東寛基1, 中川俊作1, 村井俊哉2, 松原和夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 675-675, 2020.

---

	O33-4. Examination of the antidepressant for patients with end-stage cancer which coexisted for a depression symptom 今井一輝1, 二村昭彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 676-676, 2020.

---

	O33-5. Under the antidepressant combination is examined the bleeding risk with the oral anticoagulant drug directly 小島悠輔1, 片田佳希1, 中川俊作1, 重面雄紀1, 圓東寛基1, 山本将太1, 米澤淳1, 中川貴之1, 杉田尚子2, 村井俊哉2, 松原和夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 676-676, 2020.

---

	O33-6. 3 cases that developed deep vein thrombosis after the lithium poisoning 祖川倫太郎1, 飛田修康1, 村川徹2, 阪本雄一郎3, 門司晃2, 入江裕之1,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 677-677, 2020.

---

	O33-7. Effect of the psychology education by the pharmacist for the purpose of the medication self-care in the medical observation method ward 坂本靖之1, 助川鶴平2, 佐藤康一1, 堀浩政1, 槇恒雄1, 山口博之3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 677-677, 2020.

---

	O33-8. The new digital that can realize inhibition of cognitive functional decline, BPSD cera; is medical care application ... of spare examination - VR for the Thich development with a zing 岡本美緒1, 仁木一順1, 矢原恵美1, 上野慶太2, 田中寛之2, 野村麻衣3, 吉田啓太3, 奥田赳視3, 内藤泰男2, 石井良平2, 上田幹子1, 伊藤壽記1,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 678-678, 2020.

---

	O33-9. It is ... about efforts ... prospective role of the exclusive duty pharmacist in the psychiatry liaison team and the present problem 高橋治樹1, 仲田明弘2, 齋藤千紘3, 平野桂子1, 木村緑1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 678-678, 2020.

---

	O34-1. Prednisolone, verapamil to a nursing mother, the body kinetic consideration in correspondence and the infants from a specialist in prescription about the advisability to the question with famotidine administration 大久保正1,2, 田中真理子2, 大久保七枝3, 大久保節子4, 大久保美穂5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 679-679, 2020.

---

	O34-2. Relations with the umbilical blood, mother's body blood drug concentration and neonatal drug withdrawal syndrome in the duloxetine remedy pregnant woman 田口怜奈1, 内藤隆文1, 鈴木光路1, 伊東宏晃2, 川上純一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 680-680, 2020.

---

	O34-3. Efforts of the improvement in vaccination rate of the pharmacist in our hospital maternity ward 石橋摩耶1, 堤栄二1, 鈴木伸男1, 佐藤貞子2, 柳田純子3, 佐藤多代3, 鈴木久也3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 680-680, 2020.

---

O34-4. It is the use significance of the change and "the mother's milk instructions vote of 12 years of the medication patients" after the nursing instructions system construction in our center 大津由美子1, 和栗雅子2, 藤川郁世1, 永井絵里子1, 松原侑紀1, 長瀧谷美樹1, 加島朱梨1, 外山真理奈1, 庵森靖弘1, 紺屋まりや1, 渡邊宏美1, 小森桂子1, 望月千枝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 681-681, 2020.

---

	O34-5. Efforts of a change and the pharmacist of the pregnant medical treatment in the mental disorder merger pregnancy 桐林美緒1, 佐藤千比呂1, 近藤真寿美1, 金田美咲緒1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 681-681, 2020.

---

	O34-6. It is ... for efforts - pregnancy, the nursing and the medicine consultation outpatient department establishment of a pregnant woman, the nursing mother medical therapy authorization pharmacist in our hospital 上森恵里1, 松岡順子1, 川田桂子1, 海老井佳織1, 野口周作1, 笠原英城1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 682-682, 2020.

---

	O35-1. Retrospective cohort study about the effect of the anticoagulant giving it to onset of diabetic peripheral neuropathy 冨田詩織1,2, 田中雅幸1, 打谷和記1, 村中達也1, 川畑篤史2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 683-683, 2020.

---

	O35-2. Evaluation of the usefulness of the confirmation of a pharmacist for proper use promotion of the agent for diabetes in the outside Parliament drugstore sheet 小俣江利果1, 長内理大1,2, 小長谷奈美1, 伊野陽子1,2, 玉木啓文1,2, 山下修司2,3, 野口義紘2,4, 井口和弘1,2, 寺町ひとみ2,4,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 684-684, 2020.

---

	O35-4. Clinical response for the serum lipid of the Dulaglutide 高橋怜史1, 山口亜矢1, 中村千里1, 大川浩子1, 喜多祐樹2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 685-685, 2020.

---

	O36-1. Search of urinary biomarker reflecting renal failure in the cancer medical therapy of patients with lung cancer 田島壮一郎1, 渡邊裕之1, 福田未音1, 田川慎二1, 佐田裕子1, 槇原洋子1, 秦晃二郎1, 辻敏和1, 岡本勇2, 増田智先3, 江頭伸昭1, 家入一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 686-686, 2020.

---

	O36-2. Development and operation of the side effect long-term management sheet of the immunosuppressive drug for renal-transplant recipients in the ethical pharmacy 小長谷奈美1, 長内理大1,2, 小俣江利果1, 伊野陽子1,2, 玉木啓文1,2, 山下修司2,3, 野口義紘2,4, 井口和弘1,2, 寺町ひとみ2,4,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 687-687, 2020.

---

	O37-1. The anticholinergic load has an influence on the eating deglutition function in the convalescent rehabilitation ward 小瀬英司1, 平井利幸2, 関利一2, 安野伸浩1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 688-688, 2020.

---

	O37-2. Search of the effect on renal function factor in patients operated on for the osteoarthritis of elderly people 山元孝俊1, 小瀬英司1, 榎本弘美1, 渡部多真紀1,3, 河村剛至1,3, 安井洋一2, 河野博隆2, 安野伸浩1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 689-689, 2020.

---

	O37-3. Efforts of the prescription adequacy for the drug global assessment adjustment addition calculation situation and the elderly people in our hospital circulatory organ ward 廣田あゆ子1, 新城唯1, 河村茉衣1, 松本和也1, 小池彩子1,2, 黒田忍2, 福家聡一郎3, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 689-689, 2020.

---

	O37-4. Efforts ... as investigation of the use of drug about deglutition function in patients with aspiration pneumonia and team intervention - pharmacist 宮崎雄紀1, 岡本梨江2, 百瀬将晃2, 古清水元子3, 唐澤綾1, 矢嶋直子1, 跡部治1, 登内盛治1, 巨島文子4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 690-690, 2020.

---

	O38-1. Comparison of an effective case of the steroid initial treatment in the idiopathic thrombocytopenic purpura and the invalid case 大野峻1, 武田元樹2, 菊池健2, 渡邉大毅2, 北島聖也2, 相馬貴史2, 佐々木啓2, 名達陽一2, 鶴山辰2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 691-691, 2020.

---

	O38-2. The effectiveness and tolerability of the morphine water (hospital preparation) for dyspnea due to the cryptogenic fibrosing alveolitis 南貴之1, 若月淳一郎1, 松本香織1, 花輪和己2, 小林みつ恵1, 小林義文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 692-692, 2020.

---

	O38-3. Examination of oxidative stress before and after the medical treatment in autistic spectrum children coexisting for attention deficit hyperactivity disorder and the evaluation score 森本真仁1, 橋本俊顕1, 津田芳見1, 浜田茂明1, 北岡泰介2, 京谷庄二郎2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 692-692, 2020.

---

	O38-4. Making of conversion tables from the use situation and a Parkinson's disease internal use therapeutic drug of the Levodopa injection preparation in Nagoya Memorial Hospital to Levodopa injection preparation 近藤奈央子1, 壁谷めぐみ1, 湯浅周1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 693-693, 2020.

---

	O38-5. The effectiveness in the long-term use of the hyperammonemia therapeutic drug Rifaximin and safe examination 福井愛子1,2, 川部直人2, 三井有紗2, 宮地洋平2, 宮地小百合2, 越智友花2, 田中浩敬2, 中岡和徳2, 中野卓二2, 葛谷貞二2, 宮原良二2, 橋本千樹2, 吉岡健太郎2, 廣岡芳樹2, 亀井浩行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 693-693, 2020.

---

	O38-6. About a change of the lipid-related test value with the Elobixibat tablets in patients without a dyslipidemia anamnesis 高多瞭治1, 多賀允俊1, 西佳子1, 政氏藤玄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 694-694, 2020.

---

	O38-7. Examination of the medication support based on Health Assessment Questionnaire in patients with rheumatoid arthritis 柳原有希1, 佐々木恵一2, 益口賢1, 狭間淳輔1, 加藤貴子1, 木本泰孝3, 堀内孝彦3, 橋本昌文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 694-694, 2020.

---

	O38-8. Effect of the CYP3A5 genetic polymorphism giving it to renal graft tissue level of tacrolimus in renal-transplant recipients 重松智博1,2, 田島壮一郎1, 張夢雨2, 末次王卓1, 岡部安博3, 増田智先4, 江頭伸昭1,2, 家入一郎1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 695-695, 2020.

---

	O38-9. The use situation investigation of the morphine for patients with terminal heart failure 高城沙也香1, 鳥山陽子1, 永石浩貴2, 松尾圭祐1, 江崎瞳1, 谷口潤1, 尾之江剛樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 695-695, 2020.

---

	O38-10. New treatment strategy for the obliterative bronchiolitis that assumed carbon monoxide a base 渡部佑樹1, 田口和明1, 榎木裕紀1, 酒井宏水2, 丸山徹3, 小田切優樹4, 河野光智5, 松元一明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 696-696, 2020.

---

O39-1. Rearward controlled trial ... about the effect of DAAs under the enforcement of the multicenter study and the true clinical practice from a manager for study to patients with problems - HCV which we saw 嘉屋道裕1, 中村和代1, 杉山恭平1, 木苗あゆみ1, 山口紘生2, 浮田浩利3, 氏家智香5, 加藤純6, 影山富士人7, 名倉真理子8, 松下久美9, 杉上香織10, 石田紘基11, 名波章子12, 小田切圭一4, 木村緑1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 697-697, 2020.

---

	O40-1. Construction and pharmacist activity of the outside Parliament other types of job cooperation in the local inclusion care system 長谷川豊1, 中本政容2, 駒井壽美3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 698-698, 2020.

---

	O40-2. How do you report bad news to pubertal children? 岡野聡1, 長谷川寛1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 699-699, 2020.

---

	O40-4. Success ... of the prescription reduction that polypharmacy formation - pharmacist by the medication assistance suggested 坂本直大1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 700-700, 2020.

---

	O40-5. Qualitative study on instruction for patients with life-style related diseases of the drugstore pharmacist of Miyagi 小野寺亮1, 富永敦子1,2, 佐藤健太1,2, 土佐貴弘3, 澁谷和彦3, 男澤貴子4, 北村哲治4, 一條宏2, 平澤典保1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 700-700, 2020.

---

	O40-6. An incident accompanied with the medication assistance in the house 1 institution for elderly people with the service and analysis of the factor 池田百合香1, 佐藤宏樹2, 柳奈津代2, 益子幸太郎3, 木崎速人4, 山本大輔3, 馬来秀行3, 小西ゆかり3, 雨宮潤美3, 堀里子4, 澤田康文2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 701-701, 2020.

---

	O40-7. About usefulness of the pharmaceutical intervention and information sharing in the early stage of the at-home shift 杉浦聡1,2, 北村佳久1,3, 高橋正志2, 千堂年昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 701-701, 2020.

---

	O40-8. It is efforts of becoming it the outside Parliament prescription of the medical care in remote area organization in connection with a local health insurance drugstore 堀内賢一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 702-702, 2020.

---

	O41-1. Fact-finding about the telephone follow during a medication period 荒井玲美1, 伊藤昌裕1, 渡邉泰崇1, 田井中絹代1, 宮田広樹1, 福岡勝志1, 弓削吏司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 703-703, 2020.

---

	O41-2. We examine illness in the cancer medical therapy and strengthen medicine cooperation 近藤元三1,2,3, 沼田朋和1, 森山健一2, 西千春3, 佐藤みづき3, 中村初美3, 大山高廣4, 田中由起子5, 山室蕗子5, 合澤啓二6, 陣上祥子6, 天方奉子1, 稲葉一郎1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 704-704, 2020.

---

	O41-3. Evaluation of the usefulness of the tracing report specialized in a regimen in the foreign cancer chemotherapy 有田仁紀1, 宮川ありす1, 菅井瞳1, 柳野紗智子1, 石川曜平1, 渡辺和美1, 坂本真紀1, 西澤健司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 704-704, 2020.

---

	O41-4. It is ... using efforts - tracing report of the medical cooperation in northeastern Rousaibyoin 菅野和彦1, 麻生敦子2, 新谷裕子2, 塚本弘美2, 小川彰子3, 相澤智子4, 袰岩靖子1, 高松謙1, 熊谷史由1, 中川こはる1, 佐藤真衣1, 横山咲稀1, 駒林幸太郎1, 大友眞菜1, 菊地未由1, 小笠原綾子1, 日野美穂1, 星野祐太1, 伊藤亮太1, 渡邊卓嗣1, 中嶋丈晴1, 穂積史朗1, 大月沢雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 705-705, 2020.

---

	O41-5. Intervention to the examination for HBV non-enforcement patients utilizing test value notation and the tracing report to a prescription 岩崎真衣1, 糀谷望1, 堀越慶一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 705-705, 2020.

---

O41-6. The current situation investigation on the hospital side for the giving and receiving of the information sharing sheet with the health insurance pharmacy for hospitalization and release information sharing 吉良俊彦1, 陣在ひと美1, 本城綾子1, 谷本祐子1, 木下里紗1, 辻井佳代1, 石倉久美子2, 真常美紀3, 村田久枝4,5, 津田宜志6,7, 堀越博一6,8, 小林政彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 706-706, 2020.

---

	O41-7. Construction and operation of in-hospital formularies in cooperation with university hospital pharmacists and regional hospital pharmacists 渡辺善照1, 菊池大輔1, 三浦良祐1, 栃窪克行2, 佐竹成一3, 遠藤武弘4, 佐藤真由美5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 706-706, 2020.

---

	O41-9. Usefulness investigation of the advanced course in the inhalational instruction network 竹内まどか1,2, 加藤秀紀1, 後藤佳奈1, 大橋一輝1, 片岡智哉1,3, 木村和哲1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 707-707, 2020.

---

	O41-10. Correspondence ... of the prescription issuance with new coronavirus infection spread preventive measures - telephone practice 堀内あす香1, 岡橋孝侍1, 岸本美紀子1, 友金幹視1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 708-708, 2020.

---

	O41-11. Patients attitude survey before and after the change to the prescription notebook "Aizu prescription notebook" which we unified in an area 木本真司1, 河原史明1, 香内綾1, 安齊泰裕1, 鈴木涼子2, 小室幹男3, 市橋淳4, 西郷竹次5, 下山田博久6, 塩川秀樹1,6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 708-708, 2020.

---

	O41-13. Making of the protocol for the purpose of doubt inquiry investigation and the duties burden reduction of the outside Parliament prescription in our hospital 橋本知樹1, 眞継賢一1, 濱口良彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 709-709, 2020.

---

	O42-1. Making of the drug department manual at the disaster dispatch psychiatric care team (DPAT) advance party dispatch 中山洋輔1, 高田正温1, 矢口武廣1, 渡邉彩友美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 710-710, 2020.

---

	O42-2. Pharmaceutical response to COVID-19 infection that spread in a large Cruise ship 森崎愛夢1, 小松優佳1, 相川実穂1, 渡邉暁洋2, 勝田恵1,3, 中野貴文1, 林稔展1, 江川孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 711-711, 2020.

---

	O42-3. The development of COVID-19 infection situation that spread in a large Cruise ship 小松優佳1, 森崎愛夢1, 相川実穂1, 渡邉暁洋2, 勝田恵1,3, 中野貴文1, 林稔展1, 江川孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 711-711, 2020.

---

	O43-1. Efforts to venous thromboembolism prophylaxis in our hospital 平田備子1,3, 磯弓子1,3, 前岡瑞希4, 林太郎2,3, 木南佐織2,3, 大西尚2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 712-712, 2020.

---

	O43-2. It is ... for fixation of the medical therapy corresponding to the prevention, the treatment of liaison team activity report - delirium 鶴崎泰史1,2,3,4, 藤田強記2, 中川義浩2, 堂園千代子3, 山下建昭4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 713-713, 2020.

---

	O43-3. The efforts of the request for medical safe report input for doubt inquiry to an initial clinical resident and the effect 阿部宏志1, 瀬上航平1,2, 山田浩史1,3, 朝野隆之1,2, 大岡正道1,4, 坂上逸孝5, 田中恒明5, 安田宏1,6, 大坪毅人1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 713-713, 2020.

---

	O43-4. Analysis about the inflection situation of the medication reporting book in the drugstore 金子絵里奈1, 小林大介2, 高山浩太郎2, 小柳香織1, 林田論1, 郡司清志1, 鶴田達也1, 脇山えりか2, 古賀友一郎1, 小松公秀1, 高木淳一1, 木原太朗1, 窪田敏夫3, 島添隆雄2, 田中泰三1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 714-714, 2020.

---

	O43-5. Use of sleep inducing drug flowchart introduction for sleeplessness indicator standardization and the evaluation 高砂美和子1, 秋山真里1, 若林和貴1, 税所篤行1,2, 松永和人2, 北原隆志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 714-714, 2020.

---

	O43-6. Usefulness evaluation of the test value according to the pharmaceutical products which we wrote in outside Parliament prescription 横山威一郎1, 山口洪樹1, 山崎香織1, 関谷美聡1, 新井さやか1, 中村貴子1, 鈴木貴明1, 石井伊都子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 715-715, 2020.

---

	O43-7. Evaluation about the Distribution of medicine confirmation enforcement by the ward pharmacist 藤里駿1, 生駒結夏1, 横田瑠美1, 岡本裕子1, 小田貴子1, 太田雅俊1, 猪股英幸1, 大橋美由紀2, 竹田克明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 715-715, 2020.

---

	O43-8. Prediction of the origin of doubt inquiry that accepted a medical institution, a physician using the machine learning 佐藤宏樹1,2, 加藤木俊廣1, 松村敦子3, 月岡良太3, 柳奈津代1, 森澤あずさ3, 大石美也3, 澤田康文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 716-716, 2020.

---

	O43-9. Of the preparation in the ethical drug package insert is sustained release; to show, and to prevent the accident with investigation - sustained release drug about 長谷部歩1, 山形真一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 716-716, 2020.

---

	O43-10. Examination of the factor to have an influence on the fall occurrence of the inpatient 松本有加1, 小田真司2, 坂本宜俊1, 渡邉真一1, 田母神淳1, 秋山伸二1,2, 大塚尚2, 奈良敏文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 717-717, 2020.

---

	O43-11. Analysis of the effect that resident background gives to incident occurrence about the medication in the nursing facility 宗方伸樹1, 木崎速人1, 益子幸太郎2, 山本大輔2, 馬来秀行2, 小西ゆかり2, 佐藤宏樹3,4, 澤田康文3, 堀里子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 717-717, 2020.

---

	O43-12. Outcome after a factor to have an influence on the fall of galanthamine treated patients and the pharmaceutical intervention 池口麻由子1, 松田千裕1, 桐生浩子1, 有松冴1, 不破朱里1, 加藤公人1, 森実優1, 橋本陽1, 今西義紀1, 小出哲朗1, 大達清美2, 伊藤久美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 718-718, 2020.

---

	O43-13. Construction of the appearance similarity ratio evaluation model of the PTP sheet using the automatic encoder 北村美帆1, 佐藤宏樹2,3, 川上玲3,4, 玉木啓文2, 柳奈津代2, 苗村健3,4, 澤田康文2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 718-718, 2020.

---

	O44-1. Of 25 trainees "look back one week"; the role of the instruction pharmacist from the viewpoint of all human medical care in the meeting 奥野昌宏1, 田中詳二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 719-719, 2020.

---

	O44-2. For the enforcement system investigation of 8 representative diseases in the pharmacy business training in the 2019 Nagoya Univ. hospital pharmacy and construction 羽田和弘1, 千崎康司1, 宮川泰宏1, 等浩太郎2, 白松貴子3, 吉見陽4, 野田幸裕4, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 720-720, 2020.

---

	O44-3. Participation experience type training situation third report in the drugstore business training in revision core Cali 松下隼士1, 川尻雄大2, 岸田義博1, 小柳香織1, 吉田理1, 園田正信1, 小林大介2, 高木淳一1, 木原太郎1, 山野徹1, 島添隆雄2, 田中泰三1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 720-720, 2020.

---

O44-4. Evaluation of the operational system and education effect of the collaboration type medicine pharmacy cooperation class with business training instruction pharmacist and the university teacher 岡田守弘1, 野村政明1, 石川和宏1, 大本まさのり1, 大柳賀津夫1, 杉山朋美1, 岡本晃典1, 高野克彦1, 興村桂子1, 荒川由紀美1, 佐藤栄子1, 多賀允俊2, 坪内清貴3, 川口典子4, 笹山潔5, 長浜潤6, 浜野邦彦7, 杉本智美8, 後藤義之9, 久保杏奈10, 嶋田千穂11 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 721-721, 2020.

---

	O44-5. Effect of the knowledge acquirement on antimicrobial medicine proper use of the pharmacy student by the problem using the true case 中村はづき1, 多賀允俊1, 高瀬文超1, 北川奈津子1, 柘植乙葉1, 二見和由美1, 高橋喜統1, 政氏藤玄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 721-721, 2020.

---

	O45-1. The extraction of problems by the text mining using the questionnaire about the harmful effect education teaching materials and examination 大和幹枝1, 松野純男2, 土肥弘久1, 長南謙一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 722-722, 2020.

---

	O46-1. Effect to result in in confidence of practice and the medication counseling of the consideration to the hearing person with a disability with the comics brochure 俵口奈穂美1, 鎌内朋子1, 星野正俊2, 窪田敏夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 723-723, 2020.

---

	O46-2. Behavior change investigation of the student attending a lecture two years after the postgraduate training for pharmacist upbringing in the cancer relaxation medical care 葉田昌生1, 山田真裕2, 内田まやこ3, 因間大悟5, 有吉俊二5, 神村英利4,5, 原口亨5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 724-724, 2020.

---

	O46-3. Introduction and problem of the practice type educational program for new face pharmacists 田村亮1, 山下花南恵1, 室井延之1, 橋田亨1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 724-724, 2020.

---

	O46-4. Analysis of the "drugstore pharmacist training program (cancer domain) to show extensive pharmacy management function" by the text mining training report 婦川貴博1,2, 毛利順一1,2, 坂倉智子2, 東山倫子1,2, 稲野寛2, 冨澤淳2, 本間雅士2, 厚田幸一郎1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 725-725, 2020.

---

	O46-5. Approach - of the clinical ladder making confluent by construction (the first report) - competency theory of the hospital pharmacist staff education system 小山郁美1, 稲野寛1, 坂倉智子1, 近藤留美子1, 婦川貴博1,2, 厚田幸一郎1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 725-725, 2020.

---

	O46-6. The current situation of the research activities to see inconsistently of the items mentioned in the poster announcement 田中秀和1, 若林進2, 一ノ瀬照子3, 田村かおり4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 726-726, 2020.

---

	O46-7. Attempt of the self-assessment of the pharmacist resident program in the Nagoya University faculty of medicine hospital and the outside evaluation 千崎康司1, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 726-726, 2020.

---

	P1-1. Efforts to drug adjustment depending on the renal function in the door front drugstore of the small hospital 吉永里香子1, 柳瀬京子1, 植木香子1, 新山尚子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 728-728, 2020.

---

	P1-2. Elucidation - multivariate analysis and Bayesian net work - of the faith allele to influence prescription suggestion and the teamwork in doubt inquiry and stress 林剛1, 舘知也1, 高岡みらい1, 野口義紘1, 寺町ひとみ1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 729-729, 2020.

---

	P1-3. The second-year PPT activity in our hospital 手塚博文1, 山本輝代1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 729-729, 2020.

---

	P1-4. Introduction effect by the operational change accompanied with the injection drug withdrawal system update 水野純男1, 村井良平1, 酒井克紀1, 福田英克1, 南波勝栄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 730-730, 2020.

---

	P1-5. Examination about all automatic PTP sheet withdrawal device introduction 宮崎美香1, 陣上祥子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 730-730, 2020.

---

	P1-6. It is evaluated innovativeness and the usefulness of the powdered medicine identification inspection system after the divided powder using far-red spectrometry 亀井健人1, 森山圭2,3, 徳田衡紀1, 赤木晋介1, 高柳和伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 731-731, 2020.

---

	P1-7. The current situation of doubt inquiry at hospitalization prescription change of the bringing medicine and future problem 平川寛之1, 有馬遥太朗1, 柏倉正太1, 高橋将典1, 紫桃裕造1, 渡邊善照1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 731-731, 2020.

---

	P1-8. An attempt of the doubt inquiry input simplification by the template utilization and the effect 伊藤早織1, 神谷貴樹1, 増田恭子1, 上西幸治1, 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 732-732, 2020.

---

	P1-9. The current situation investigation about doubt inquiry utilizing the doubt inquiry sheet in the in-hospital prescription 戸嶋彩乃1, 渡邉美菜子1, 吉田祥子1, 太田小織1, 千崎康司1, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 732-732, 2020.

---

	P1-10. Doubt inquiry contents of the drug that renal function by the test value notation to a prescription becomes the prescription determinant 宮森伸一1, 吉川明良1, 阿部圭輔1, 開浩一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 733-733, 2020.

---

	P1-11. The effect that is in indication form of the pharmaceutical products in the inspection system using GS1 Data Bar 荒井理乃1, 蝦名勇樹1, 能登数馬1, 福島麻里乃1, 亀井浩二郎1, 和泉秀明1, 三本松泰孝1, 佐藤弘康1, 田村広志1, 渡辺浩明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 733-733, 2020.

---

	P1-13. Effect of the pharmacy aiming at the improvement of interpersonal duties in ratio vs. the thing duties systematization 横幕香織1,2, 中村真樹1, 山中理3, 米谷領太1, 茂籠邦彦1,4, 近藤博紀1, 安原智久2, 大野勝則1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 734-734, 2020.

---

	P1-14. Effect of development and the international standard tube (ISO80369-3) introduction of the formulations support system corresponding to the tube size by the simple suspension method 安藤哲信1, 渡辺智康1, 難波良平1, 高取孝一1, 山崎恵1, 塩飽郁雄2, 飯田寿彦3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 735-735, 2020.

---

	P1-15. About the effect on compounding of medicines duties by the setting of the manual attachment standard at formulations 山田宜和1, 岩田真子1, 高村誠1, 渡辺真希1, 仁谷美希1, 関口陽子1, 貝瀬眞由美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 735-735, 2020.

---

	P1-16. The misunderstanding of pharmaceutical products and relative evaluation of a name, efficacy, the appearance similarity 赤澤佑理1, 國津侑貴1, 上田智弘1, 田淵陽平1, 平大樹1,2, 上西幸治1, 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 736-736, 2020.

---

	P1-17. About the effect that a universal cassette gives one package to formulations 猪谷朱理1, 金澤沙衣1, 越野早紀1, 晴山知拓1, 津田雅大1, 三本松泰孝1, 佐藤弘康1, 和泉秀明1, 田村広志1, 渡辺浩明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 736-736, 2020.

---

	P1-18. Examination ... of the pharmaceutical products exposure at pharmaceutical products exposure investigation - ointment mixed formulations of the pharmacist 前田志津子1, 藤瀬晟1, 佐々木まい1, 田山剛崇1, 杉原数美1, 三宅勝志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 737-737, 2020.

---

	P1-19. Efforts to injection drug compounding of medicines duties efficiency 恒川有里1, 岡本奈緒1, 山田知世1, 長水正也1, 佐藤由美子1, 日比陽子1, 中村康夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 737-737, 2020.

---

	P1-20. Efforts of the injection room for the improvement in productivity 前勇太郎1, 吾妻慧一1, 橋本幸輝1, 渡部秀一1, 川口萌実1, 井上彩花1, 田瀬徹1, 瀧口友美1, 清水久範1, 濱敏弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 738-738, 2020.

---

	P1-21. Examination of the operation by all automatic powdered medicine divided powder planes (Di-32Ct) new introduction and use investigation 吉村和真1, 青井博志1, 谷田彩1, 小川恵美子1, 吉川一吾1, 池田和之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 738-738, 2020.

---

	P1-22. Inspection about the drop prevention effect of the quantity of active ingredient by the difference in light blocking effect of the medicine bag 井上智咲1, 田崎眞生1, 桑原晶子1, 豊原朋子1, 大川恭子1, 辻本勉1, 森良江2, 森本茂文2, 濱宏仁1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 739-739, 2020.

---

	P1-24. Pharmaceutical consideration about the case conveyed to our hospital by aciclovir encephalopathy 吉田晴菜1, 東野愛1, 高橋佐和1, 宮崎俊明1, 筒井由佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 740-740, 2020.

---

	P1-25. Comparison of the formulations mistake change by making formulations support system link an electronic medical chart order ring system, and having decreased a care power 海老原貴之1, 伊東美歩1, 竹内英樹1, 馬渡貴之1, 山崎和音1, 矢嶋香歩1, 岡本和也1, 平原一也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 740-740, 2020.

---

	P1-26. A case of preavoid of ultrashort-acting sleeping pills in elderly patients 山本雅裕1, 藤田あゆみ2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 741-741, 2020.

---

	P1-27. Investigation about the test value information described in outside Parliament prescription 畠山規明1, 川角和彦1, 松野英子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 741-741, 2020.

---

	P1-28. Development and clinical evaluations of the multifunctional deployment type "pharmacist electronic calculator" based on the pharmaceutical point of view 鈴木茉莉子1, 佐藤淳也1,2, 吉澤博明3, 小山永3, 前澤佳代子1,2, 百瀬泰行1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 742-742, 2020.

---

	P1-29. Prescription grounds of cefditoren pivoxil (CDTR-Pl) used for patients with acute otitis media incidence children short bowel syndrome 世古敬一1, 藤田あゆみ2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 742-742, 2020.

---

	P1-30. Comparison before and after the medical treatment plan (PBPM) revision based on the protocol in the in-house prescription 山崎伊織1, 小倉弥生1, 大木孝夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 743-743, 2020.

---

	P1-31. Problems in the medication of magnesium oxide tablets using the thickness adjustment food 島崎学1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 743-743, 2020.

---

	P1-32. Starting pharmaceutical products and comparison with the generic medicine judging from accuracy of the tablet division 村上雅裕1, 安田恵1, 天野学1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 744-744, 2020.

---

	P1-33. Relation of the pharmacist for patients with a history of convulsions or epilepsy 竹下恵理子1, 今井陽子1, 竹下治範2, 南雅子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 744-744, 2020.

---

	P2-1. Examination for a return drug and the handling in inside the hospital 藤田健太1, 横山貴幸1, 小田明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 745-745, 2020.

---

	P2-2. Examination about duties burden reduction and the economic effect in the cool place pharmaceutical products management system introduction 升田万祐子1, 大橋正和1, 楠川侑吾1, 藤田博巳1, 村田龍宣1, 村岡淳二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 746-746, 2020.

---

	P2-3. Usefulness of the pharmaceutical products management using the traceability system 小林亮1, 石田将之1, 山田紘嗣1, 小森善文1, 安田浩二1, 鈴木昭夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 746-746, 2020.

---

	P2-4. A generic drug change and non-pharmacist duties in 300 beds of public hospitals 磯貝一成1, 佃尚紀2, 森谷卓子1, 神保雄一1, 細田好宏1, 三國貴子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 747-747, 2020.

---

	P2-5. A review of the ward fixed number drug for household delivery accompanied with the new hospital move and the effect 綿貫陽一1, 木村麗砂1, 日浦寿美子1, 小林秀樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 747-747, 2020.

---

	P2-6. Impact on prescription amount and drug cost by efforts to reduce ARB-adopted items with awareness of formulary creation 神田藍1, 中村和代1, 南智1, 鈴木貴也1, 平野桂子1, 木村緑1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 748-748, 2020.

---

	P2-7. Effect of the pharmaceutical products SPD introduction in the Okayama Red Cross hospital 森英樹1, 花房伸幸1, 小池彩子1, 大道淳二1, 横田幸子1, 石橋真実1, 諏訪耕三1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 748-748, 2020.

---

	P2-8. The current situation investigation about the polypharmacy in the JCHO Kurume General Hospital care health center for the elderly 篠崎千尋1, 野田聖奈子1, 柿原圭佑1, 松本美紅1, 原田智子1, 松崎雄1, 白石亘1, 三上忠司1, 藤井裕史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 749-749, 2020.

---

	P2-9. Efforts for the enforcement situation investigation and the manual preparation of the pentamidine isethionate inhalation 南場信人1, 今成拓1, 関口陽子1, 山田宜和1, 矢吹剛1, 五十嵐詠美1, 小森裕1, 勝又稔2, 山田竜2, 飯塚美和子3, 青木香子3, 甲田亮4, 伊藤竜5, 関義信6, 貝瀬眞由美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 749-749, 2020.

---

	P2-10. Duties improvement with the simple ordering support seat using Microsoft Corporation Excel 平山武宏1, 市川志穂1, 金井貴充1, 荒義昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 750-750, 2020.

---

	P2-11. Farewell temperature control sheet - Thus, we were released from the temperature control record of pharmaceutical products - 垣内祥宏1, 緑川拓也1, 岡陽子1, 渥美弘美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 750-750, 2020.

---

	P2-12. Progress report after introduction of formulary for erythropoietin preparations 澤田雄太1,2,3,4,5,6,7, 佐藤光2, 金井紀仁3, 安藤正純4, 宮崎美子5, 濃沼政美6, 齋藤俊夫7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 751-751, 2020.

---

	P2-13. Medical economic evaluation in the efforts for the stock adequacy of the blood clotting factor preparation for hemophilic patients 神農麻里奈1, 岡田直人1, 中村信元2, 三木浩和2, 渡辺浩良3, 合田光寛1, 中馬真幸4, 座間味義人1,5, 桐野靖1, 中村敏己1, 安倍正博2, 石澤啓介1,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 751-751, 2020.

---

	P2-14. Visualization of injection drug return of goods duties using bar code and a section system 磯田和也1, 橋本さつき1, 原祐輔1, 嶋田努1, 崔吉道1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 752-752, 2020.

---

	P3-1. Effect on clinical practice by the raw materials change of the ulinastatin vagina bougie 飯塚美帆1, 宮内英俊1, 片桐麻未1, 滝浪由季乃1, 宇津裕章2, 山内拓1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 753-753, 2020.

---

	P3-2. Comparison between roasting law and IPCD method that it is the way it goes in the Daiokanzoto 津江南瑠海1, 齋藤唯衣1, 天池菜都実1, 白石かれん1, 中村憲夫2, 成橋和正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 754-754, 2020.

---

	P3-3. Examination about stability of the chief ingredient shikonin of the Shiunko and the stability at mixture 藏所志穂1, 岩本奈留実1, 中村憲夫2, 成橋和正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 754-754, 2020.

---

	P3-4. Examination about the quantity of decoction of the difference in crude drug decoction method of Kakkonto and the glycyrrhizic acid in the extract preparation 齋藤唯衣1, 津江南瑠海1, 末原百萌花1, 中村憲夫2, 成橋和正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 755-755, 2020.

---

	P3-5. Examination of the granulating condition to enable the granulating of the tablet crush thing 高田慎一朗1, 宮嵜靖則1, 内野智信1, 賀川義之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 755-755, 2020.

---

	P3-6. Fact-finding of the hospital preparation management situation in medical facilities under Ehime 山本真由香1, 乗松真大2, 飛鷹範明2, 田中守2, 野元裕1, 田中亮裕2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 756-756, 2020.

---

	P3-7. Six months lability test of hospital preparation 0.5% Denosine eye drops 鈴木麻文1, 引地文1, 友田吉則2, 厚田幸一郎1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 756-756, 2020.

---

	P3-8. Evaluation of skin irritation characteristics of the 8% hydroquinone ointment which prescribed it, and was improved and percutaneous absorption characteristics 山内理恵1, 大野修司1, 竹場和代2, 小林稔2, 川崎智子2, 北岡晃2, 井上信宏1, 久保元1, 浅井和範1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 757-757, 2020.

---

	P3-9. Inspection of the usefulness of the injection drug no bacteria mixed preparation by the pharmacist in the satellite 江川奈央1, 村上賢次1, 宅和真由美1, 平田敦宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 757-757, 2020.

---

	P3-10. The preparation evaluation of the hypodermic injection preparation histidine copper injection drug which we prepared inside the hospital and the clinical effectiveness 伊藤藍1, 榎本弘美1, 土屋雅勇1, 児玉浩子2, 石垣しのぶ3, 古川泰司3, 渡部多真紀1,4, 河村剛至1,4, 安野伸浩1,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 758-758, 2020.

---

	P3-11. Preparation of the solution for the methylcellulose oral cavity for the purpose of stomatitis treatment 下山哲哉1, 赤石結菜1, 田辺将1, 上嶋麻葵1, 伊藤邦彦1, 小林道也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 758-758, 2020.

---

	P3-12. Preparation evaluation of the childhood silverberry preparation using the 3D bio printer 田上辰秋1, 伊藤恵里奈1, 木田理沙子1, 野田剛弘1, 尾関哲也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 759-759, 2020.

---

	P3-13. Hospital preparation vancomycin, ganciclovir, stable evaluation in keeping it for a long time of micafungin eye drops 武田真実1, 横山雄太1, 渡邉武明2, 地引綾1, 河添仁1, 鈴木小夜1, 門田佳子2, 中村智徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 759-759, 2020.

---

	P4-1. Effect - of objective evaluation - PTP of the color change of the pharmaceutical products under the LED light 山下修司1,2, 井口和弘2,3,7, 野口義紘2,4, 玉木啓文2,3, 長内理大2,3, 伊野陽子2,3, 林秀樹1,6,7, 寺町ひとみ2,4,6, 酒向孫市5, 杉山正1,6,7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 760-760, 2020.

---

	P4-2. The effect that preservation after the packing opening of the Tulobuterol tape gives to preparation properties 岩波歩実1, 池内由里1, 太田美鈴2, 日高慎二3, 田嶋美幸2, 大西啓1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 761-761, 2020.

---

	P4-3. In vitro drug permeability evaluation of the ad usum externum tapes which we kept in a looseness state 阿部康弘1, 臼井明子1, 吉田寛幸1, 伊豆津健一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 761-761, 2020.

---

	P4-4. Stable examination of the metoclopramide in the dextrose in water 久保儀忠1, 大森仁2, 宮脇梨夏1, 中川勉1, 柴山良彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 762-762, 2020.

---

	P4-5. Quality evaluation of magnesium oxide tablets using the far-red spectrometry 山本佳久1, 鈴木佳菜子1, 深水啓朗2, 小出達夫3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 762-762, 2020.

---

	P4-6. Evaluation about the Mitsuyasu qualitative analysis of the nicardipine hydrochloride parenteral injection 斉藤佑治1, 竹内正幸1, 加藤隆寛1, 野々垣知行1, 齋藤寛子1, 大西正文1, 築山郁人1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 763-763, 2020.

---

	P5-1. What does "the long-term hand washing rate of use" in ward drug duties influence? 高田正弘1, 前田龍人1, 坂井原美希1, 星川果南1, 芳野由奈2, 佐藤岳春1, 國原将洋1, 松久哲章1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 764-764, 2020.

---

	P5-3. About the side effect monitoring of the gonarthrosis postoperative pain-killer and the continuation of the antiemetic drug 谷前朝海1, 島田実咲1, 橋本理恵子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 765-765, 2020.

---

	P5-4. Side effect report to the drug information management room in ward drug duties 渡辺智康1, 難波良平1, 山崎恵1, 高取孝一1, 安藤哲信1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 766-766, 2020.

---

	P5-5. Relation of the pharmacist in the at-home self-injection introduction with the human normal immunoglobulin preparation for the subcutaneous injection for chronic inflammatory demyelinating polyneuritis (CIDP) 森あやか1, 福田裕子1, 伊東里紗1, 井岡瑞樹子1, 稲場純子1, 酒井和江2, 中藏伊知郎1, 北澤文章1, 辻川正彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 766-766, 2020.

---

	P5-6. Effective and safe comparison in change examples from an IV preparation for chronic inflammatory demyelinating polyradiculoneuritis (CIDP) to subcutaneous injection preparation 伊東里紗1, 福田裕子1, 森あやか1, 井岡瑞樹子1, 島袋尚紀2, 安田由香2, 高田和城3, 中藏伊知郎1, 北澤文章1, 辻川正彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 767-767, 2020.

---

	P5-7. Effect inspection - blood internal medicine, digestive organ medical service - of ward duties in the pharmacist two permanent residence 高木昭佳1, 近岡伸悟1, 屋木佑太1, 小野敦央1, 加藤敦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 767-767, 2020.

---

	P5-8. A feasibility study for the drug global assessment adjustment addition calculation and future efforts 中原萌子1, 糸永昇平2, 山下典子2, 小山田純治2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 768-768, 2020.

---

	P5-9. Efforts to improvement in drug control instruction rate of patients receiving new high-risk medicine using new high risk check list and RPA 景山修介1, 石原裕介1, 島田杏子1, 勝部直美1, 安食健一1, 園山智宏1, 横手克樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 768-768, 2020.

---

	P5-10. Activity report of PBPM by the task sharing of physician duties 岩田佳菜子1, 栗崎貴啓1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 769-769, 2020.

---

	P5-11. Pharmaceutical support for ward pharmacist duties in the future 空田洋祐1, 中尾圭裕1, 野田麻希1, 岡智之1, 山崎博史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 769-769, 2020.

---

	P5-12. Economic effects of pharmacist-initiated drug reduction 猿谷淳1, 若林厚史1, 辻依利1, 高橋彩1, 田畑寛明1, 向一美1, 地野幹子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 770-770, 2020.

---

	P5-13. Efforts by the multi-type of job for patients with heart failure 林あゆみ1, 荒木千香子1, 内山耕作1, 田中佳代2, 村上安香音3, 冨田敦和1, 今西忠宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 770-770, 2020.

---

	P5-14. The drug fever that use of antimicrobial (MINO) caused is non-the case that became apparent by use of drug for household delivery 酒向聡子1, 亀山聡美1, 今西正人1, 鈴木圭2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 771-771, 2020.

---

	P5-15. Efforts of the side effect discovery using a preservation drawing blood specimen 田中伸明1, 沢田俊朗1, 小川英也1, 伊東和真1, 服部芳明1, 坂田洋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 771-771, 2020.

---

	P5-16. Template making of the drug control instruction record aiming at improvement of the pharmaceutical patients care 松本宏美1, 石橋楽至1, 倉井由香1, 小祝梓1, 高野尊行1, 中丸朗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 772-772, 2020.

---

	P5-17. Efforts to the medication self-care for the discharge 安里祐美1, 平田やよい1, 浜元善仁1, 翁長真一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 772-772, 2020.

---

	P5-18. Examination of the operation of medication monitoring report < renal function > and intervention of the pharmacist 橋詰真緒1, 佐藤渉1, 角谷あい子1, 山元麻衣1, 齋藤祥子1, 青山芳文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 773-773, 2020.

---

	P5-19. The use situation investigation of the drug for chronic subdural haematoma (CSDH) in our hospital neurosurgery 森崎真理子1, 水谷彩伽1, 高橋弘泰1, 大谷寧次郎1, 三浦毅1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 773-773, 2020.

---

	P5-20. Consciousness, behavior modification about the clinical reasoning of the pharmacist with the CRP card 竹内祐介1, 小泉祐一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 774-774, 2020.

---

	P5-21. About an investigation of the effect by the antimicrobial review of the obstetrics and gynecology department domain pass of our hospital 水谷汐里1, 荒川泰代1, 高橋弘泰1, 中山潤美1, 大谷寧次郎1, 三浦毅1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 774-774, 2020.

---

	P5-22. The patients individualization intervention based on the evaluation of medication compliance measure and the medication adherence influence factor and the effect 鷲見悠介1, 峠雄太2, 飛鷹範明2, 橋本麻央2, 中井昌紀2, 木村博史2, 井門敬子2, 田中守2, 中島光業1, 田中亮裕2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 775-775, 2020.

---

	P5-23. Evaluation of the usage of the morphine preparation for the purpose of the palliative care of the heart failure 西尾洋平1, 古谷一平1, 田中佳子1, 関谷泰明1, 井上壽江1, 平下智之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 775-775, 2020.

---

	P5-24. Examination of drug duties improvement from hospitalization support to discharge drug reporting 池田朋世1, 大西希1, 越智あいり1, 福嶋杏奈1, 吉川由梨1, 鈴木薫1, 長美保1, 一本木之人1, 島田明彦1, 宮地磨砂美1, 廣畑和弘1, 高田耕蔵1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 776-776, 2020.

---

	P5-25. The delirium assessment using the delirium risk assessment list and efforts of the ward exclusive duty pharmacist 森早紀1, 本多秀俊1, 高尾斎昭1, 稲村澄子1, 林由紀子1, 並木路広1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 776-776, 2020.

---

	P5-26. About the current situation of pharmacist duties to participate in a local inclusion care ward 横山貴幸1, 藤田健太1, 小田明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 777-777, 2020.

---

	P5-27. Fact-finding of the Chinese medicine jelly sherbet operation in the Chita public welfare hospital 佐藤友世1, 齋藤宏明1, 丹村敏則1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 777-777, 2020.

---

	P5-28. Research about duties contents of the hospital pharmacist whom patients seek 長田莉花1, 赤堀真佑子1, 滝浪由季乃1, 松井乃利子1, 上田真隆1, 大和田怜那1, 岡本和之1, 大井優1, 山内拓1, 中道秀徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 778-778, 2020.

---

	P5-29. Examination of the associated factor influencing the medication management method of patients with heart failure 大和田怜那1, 渡嘉敷俊介1, 江藤公美1, 鈴木志歩1, 山内拓1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 778-778, 2020.

---

	P5-30. The activity report of the urination care team and role of the pharmacist 林剛史1, 古川大樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 779-779, 2020.

---

	P5-31. Efforts by ward drug duties for the prevention of the steroidal osteoporosis 瀧内瑛輔1, 中村槙一郎1, 財津孝希1, 長澤欣弘1, 羽生智弘1, 尾形美絵1, 田村和彦1, 新関みどり1, 近藤和宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 779-779, 2020.

---

	P5-32. Questionary survey about pharmacist duties in the medical service 伊藤史依1, 戸川麻理奈1, 生田知子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 780-780, 2020.

---

	P5-33. Examination of the anti-thing duties efficiency in the ward by the formulations assistant introduction 伊藤晴也1, 高島直樹1, 深津昌弘1, 水野尚章1, 山田哲也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 780-780, 2020.

---

	P5-34. Evaluation ... of the pharmacist duties that we saw from ... physician about pharmacist duties associated with the physician burden reduction 重成大介1, 渡部正太1, 山下慶人1, 北田衛1, 奥村美佑1, 梅原さくら1, 尾崎良輔1, 山形里奈1, 高橋詩織1, 大村侑平1, 佐賀美裕樹1, 太田明秀1, 岡野翔1, 野田師正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 781-781, 2020.

---

	P5-35. Intervention to the case that renal function aggravated by multiple factors 浦嶋和也1, 井上敬之1, 植田徹2, 中城宏子1, 国府孝敏3, 鈴木朗4, 老田章1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 781-781, 2020.

---

	P5-36. Effect on consciousness for the medical treatment of patients by efforts and the instruction of the pharmacist in the heart failure classroom 岩崎睦1, 宮田祐一1, 上野栞1, 須賀明輝1, 大塚秀人1, 小沼俊也1, 橋本貴広1, 中村雅敏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 782-782, 2020.

---

	P5-37. Relation to infection treatment of the ward pharmacist in ward drug duties 川口奈緒美1, 荻原陽香1, 刀根理香子1, 近藤健太1, 近藤倫成1, 粟野恵介1, 堀部緑1, 上林愛1, 佐々木暢琢1, 木村匡男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 782-782, 2020.

---

	P5-38. The effect that epidural anaesthesia composition in the laparotomy gynecology surgery gives for nausea post-operative, vomiting and postoperative pain 舛田悠介1, 中井將人1, 吉川明良1, 宮森伸一1, 開浩一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 783-783, 2020.

---

	P5-39. About the calculation situation of the drug comprehensive evaluation adjustment addition at our hospital and the tendency of the drug to be reduced 坂本卓也1, 齋藤和悦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 783-783, 2020.

---

	P5-40. What is necessary for comprehensive evaluation of pharmacotherapy - Part 2 吉川真央1, 澤口友紀1, 増田博也1, 久岡清子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 784-784, 2020.

---

	P5-41. Look back on the change -5 year of the activity of the pharmacist in the Kusatsu General Hospital; and - 村瀬沙織1, 松浦佳代1, 鷹羽頼勝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 784-784, 2020.

---

	P5-42. What is necessary for comprehensive evaluation of pharmacotherapy - part 1 鹿沼奈央1, 増田博也1, 久岡清子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 785-785, 2020.

---

	P5-43. Utilization and evaluation ... of the construction - bringing medicine assessment sheet of the drug extraction system for the calculation of the drug global assessment adjustment addition 稲葉静香1, 満田正樹1, 岡田雅弥1, 富山志帆1, 藤井美紀1, 中谷亮介1, 奥下梨賀1, 野際俊希1, 松本篤1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 785-785, 2020.

---

	P5-44. Usefulness of Yuyama Co., Ltd.'s Polypharmacy System in Polypharmacy Countermeasures 細田未紀1, 畑将弘1, 石谷理紗1, 山根正也1, 千原里美1, 上田宏1, 伊東範尚2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 786-786, 2020.

---

	P5-45. Investigation of the pharmaceutical intervention contents in the SCU ward 榎本尚哉1, 北村桃子1, 竹田匡志1, 増渕幸二1, 牧瀬英知1, 近藤智幸1, 橋本光生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 786-786, 2020.

---

	P5-46. About the inflection of the brochure for patients with heart failure in the palliative care team of our hospital 藤原舞子1, 佐伯剛史1, 團優子1, 寺崎展幸1, 汐谷恵1, 本間久美子1, 坂下明大2, 大石醒悟3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 787-787, 2020.

---

	P5-47. About a factor to have an influence on study on distance, angle - distance between optimal patients - pharmacists at medication counseling - 仲山千佳1, 渡辺久美子2, 近藤梨央2, 水口日南野2, 牛膓沙織2,3,4, 宮地佑佳2, 大嶋耐之2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 787-787, 2020.

---

	P5-48. The need of the pharmacist permanent residence to a local inclusion care ward judging from the drug global assessment adjustment addition 矢倉尚幸1, 小俣文香1, 佐々木喬哉1, 湯本哲郎2, 稲葉健二郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 788-788, 2020.

---

	P5-49. Efforts for the number of discharge drug information management instruction increase in the small and medium size scale hospital and the effect 土屋貴1, 倉田賢生1, 荒木弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 788-788, 2020.

---

	P5-50. It is an example of the pharmaceutical intervention for the infection after the forming procedures 松村真裕1, 長谷川和恵1,2, 西野多江子2,3, 甲斐幸代2,4, 福盛達也2,5, 立石耕介7, 服部英喜2,6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 789-789, 2020.

---

	P5-51. Examination for the stocktaking of the inhalational maneuver in the ward and inhalational instruction promotion 島崎沙織1, 西川達也1, 梅下翔1, 清水翔子1, 青木理恵1, 光井彩1, 茶野下貴恵1, 松岡美紗1, 古本真由美1, 岡田久美1, 角紀一郎1, 後藤義之1, 森戸敏志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 789-789, 2020.

---

	P5-52. Effect of the drug duties burden reduction by PBPM of the prescription correction 松木克仁1, 平野淳1, 松岡梨恵1, 前田玲於奈1, 薄雅人1, 中井正彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 790-790, 2020.

---

	P5-53. The current situation of the ward pharmacist in the convalescent rehabilitation ward and future problem 前田悠里1, 阪本久未子1, 樺木美香1, 高橋佳代1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 790-790, 2020.

---

	P5-54. The ward duties management by the inflection such as a ward log book and the analysis system, and the like 泉川博子1, 八代哲也1, 東海秀吉1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 791-791, 2020.

---

	P5-55. The potentiality effect of the multi-type of job polypharmacy conference 林八恵子1, 山本圭恵1, 徳田嘉仁2, 原将之3, 遠藤正憲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 791-791, 2020.

---

	P5-56. In-hospital oral antithrombotic drug resumption guideline making and evaluation 陸丸幹男1, 佐藤史織1, 大塚愛美1, 福山薫子1, 原尻学志1, 佐藤朋子2, 高倉健3, 森一生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 792-792, 2020.

---

	P6-1. About the active intervention of the pharmacist for the operating room duties at the middle scale hospital and the evaluation 栗崎貴啓1, 北窓正孝1, 相方靖史2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 793-793, 2020.

---

	P6-2. To the pharmaceutical administrative work improvement by the operating room working full time pharmacist work 日江井和英1,2,3,4, 土本暁斗1, 武冨佳那子1, 新井大地1, 金森祐紀子1, 水野楓子1, 佐藤和也1, 宇佐見文隆1, 塚原民夫1, 甲斐三由紀2, 山崎潤二3, 梶川真樹4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 794-794, 2020.

---

	P6-4. The current situation and evaluation of the operating room no bacteria preparation by the pharmacist 山中洋1, 杉山健二郎1, 河相景子1, 藤田憲一1, 家岡昌弘1, 串崎浩行2, 八本久仁子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 795-795, 2020.

---

	P6-5. About the effect of delirium and the benzodiazepine system medicine for patients with severe infection 赤星璃1, 栗崎貴啓1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 795-795, 2020.

---

	P6-6. Analysis of the seriously ill hypoglycemia patients in our hospital 青山剛一1, 宮川ありす1, 坂本真紀1, 西澤健司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 796-796, 2020.

---

	P6-7. Usefulness of the buprenorphine in painkilling, the sedative protocol of intubated patients 磯崎僚1, 栗島彬1, 塩田朋子1, 米倉一郎2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 796-796, 2020.

---

	P6-8. Evaluation of the pharmaceutical contribution by the operating room exclusive duty pharmacist 長田一晃1, 吉川昌子1, 森川記道1, 田邊晴香1, 田辺友也1, 原田靖子1, 西原昌幸2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 797-797, 2020.

---

	P6-10. Securing of adequacy of the medical treatment by the intensive care unit exclusive duty pharmacist and medical security 永倉史子1, 大久保淑子1, 小田慎1, 加藤剛2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 798-798, 2020.

---

	P6-11. Examination of the case that received our hospital for drug intoxication 石橋真実1, 甲元大樹1, 向井めぐみ1, 平井淳子1, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 798-798, 2020.

---

	P6-12. Diuresis effect by the low-dose carperitide 宮川泰宏1, 稲垣孝行1, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 799-799, 2020.

---

	P6-13. Examination about the timing of the blood level measurement of vancomycin during the sustained hemocatharsis enforcement 小林洋平1, 中川貴弘1, 藪内新平1, 安達晋吾2, 中尾彰太2, 森朝紀文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 799-799, 2020.

---

	P7-1. One case that rheumatoid arthritis improved using Remy check Q in the pharmacist outpatient department 平田一耕1,2, 稲垣孝規3, 六反田諒4, 舟越亮寛3,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 800-800, 2020.

---

	P7-3. Medication support in the drugstore using QR cord 谷田弘1, 赤嶺美奈2,3, 赤嶺有希子2, 加納美知子2,3, 澤井一3, 田中祥子2,3, 姜惠元2,3, 吉原澄吉1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 801-801, 2020.

---

	P7-4. Establishment ... of preoperative evaluation - anesthesiology outpatient department by the multi-type of job 島谷桜子1, 高田将季1, 小宮詠子1, 伊藤由香1, 坂下裕子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 802-802, 2020.

---

	P7-5. Investigation of duties contents in the patients support center for the purpose of the duties efficiency 淵田悠一郎1, 森慶喜1, 柴田慎子1, 永嶌一紀1, 野口祥紀1, 三宅知宏1, 谷村学1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 802-802, 2020.

---

	P7-6. Pharmacist intervention to the perioperative patients in the patients support center 吉田愛1,2, 田中泉1, 喜多岡洋樹1, 田中由起子1, 楠本将裕1, 橋本知佳1, 山室蕗子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 803-803, 2020.

---

	P7-7. Relation of the pharmacist to the PCSK9 inhibitor introduction patients in the Saiseikai Futsukaichi Hospital 秀島久美子1, 中野祐樹1, 大竹野久雄1, 岡亜矢子1, 蓮輪博嗣1, 横尾賢乗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 803-803, 2020.

---

	P7-8. Efforts for cancellation and the benzodiazepine receptor agonist reduction in the psychosomatic medicine outpatient department 渡久川敦子1, 永田和裕1, 芦原睦2, 前田わかな2, 宮崎貴子2, 伊藤功治3, 栗原康彰1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 804-804, 2020.

---

	P7-10. Efforts of the pharmacist outpatient department for the sleeping drug decrease medicine using PBPM 岡平将志1, 饗庭孝一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 805-805, 2020.

---

	P7-11. The problem that we were able to see from efforts and the staff questionnaire of the pharmacist in the patients support center 奥田智子1, 山本麻央1, 依藤健之介1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 805-805, 2020.

---

	P7-12. Pharmaceutical intervention in by practice support - surgery front and by endoscopy front by the outpatient department charge pharmacist and evaluation ... 増田博也1, 久岡清子1, 大荒政志1, 佐々木健志1, 間千晴1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 806-806, 2020.

---

	P7-13. Examination of Pharmacy Service at Hospitalization and Discharge Support Center - Efforts for Sharing Patient Information - 田中真衣1, 竹内晴香1, 片山聡子1, 池崎友明1, 北澤英徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 806-806, 2020.

---

	P7-14. Examination of the current situation and problems of the inhalational maneuver establishment by the intervention of the foreign inhalational support team 高安芽衣子1, 大宜見真希1, 宮島佳菜子1, 大久保真理1, 國分千代1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 807-807, 2020.

---

	P7-15. Efforts in the pharmacist outpatient department in our hospital for the cancer medical therapy 吉田茜1, 渡邉貴子1, 藤掛麻希1, 清美奈1, 石原溶子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 807-807, 2020.

---

	P7-16. A tendency and analysis of the consultation example in "the pregnancy and medicine outpatient department" 中村早織1, 藤井恵1, 松本祐子1, 原伸輔1, 渡邊梓1, 山本智也1, 門脇裕子1, 三宅達也2, 柿ヶ野藍子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 808-808, 2020.

---

	P7-17. Three months later follow-up of the foreign patients-adaptive workshop student attending a lecture 水沼麻1, 高橋恵美利1, 高橋雄太1, 池浦恵2, 入野真規子3, 大林恭子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 808-808, 2020.

---

	P7-18. The current situation in the smoking cessation outpatient of the Okayama Red Cross hospital 大道淳二1, 花房伸幸1, 甲元大樹1, 別所昭宏2, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 809-809, 2020.

---

	P7-19. Efforts of the pharmacist by the support before hospitalization 水落翔太1, 渡邊歩1, 堀部聖1, 瀬尾達朗1, 長谷川匡史1, 池上幸子1, 福本由美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 809-809, 2020.

---

	P7-20. The tendency of the pharmaceutical intervention case in the hospitalization support task and the evaluation 國遠孝斗1, 伊藤有美1, 柴田大地1, 滝本典夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 810-810, 2020.

---

	P7-21. Analysis of the factor affecting nausea post-operative, vomiting in the female surgery patients 丸山真一1, 冨永麻里子1, 永瀬怜司1, 今浦将治1, 小西康博2, 菅野浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 810-810, 2020.

---

	P7-22. Communalization and effect of the instruction record in the foreign cancer chemotherapy 桂川みき1, 湯澤美和2, 中村裕一1, 須藤大雄1, 坂本和央1, 鈴木千波1, 小原秀治1, 柴波明男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 811-811, 2020.

---

	P7-24. Patients questionary survey for family pharmacist duties 藤井雅裕1, 安藤伸一郎1, 白澤芙美1, 中村海里1, 新谷祐佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 812-812, 2020.

---

	P7-25. Search of the factor of patients requiring re-instruction of the inhalational operation 長谷川真由1, 岩永周子1, 伊藤貴博1, 内田美月1, 吉見陽1, 山田清文2, 若原恵子3, 橋本直純3, 野田幸裕1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 812-812, 2020.

---

	P7-26. Example that clinical practice applied aromatherapy to to a fibromyalgia outpatient 増渕龍一郎1,2, 秋元美咲1, 佐々木信子1, 前澤佳代子2, 佐藤忠章2, 有山淳4, 倉橋清泰3,4, 百瀬泰行1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 813-813, 2020.

---

	P7-27. What is necessary for comprehensive evaluation of pharmacotherapy - Part 3 久岡清子1, 大荒政志1, 佐々木健志1, 増田博也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 813-813, 2020.

---

	P7-28. Aggressive intervention (3) to the pharmaceutical management of the perioperative patients in our hospital 山田奈緒1, 左右田和恵1, 滝川亜弥1, 太田久美子1, 田村睦弘2, 清水歩3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 814-814, 2020.

---

	P7-30. Establishment and efforts of the perioperative pharmacist outpatient in our hospital 平原康寿1, 椎葉萌1, 畑中真理1, 岩田円夏1, 高森大樹2, 川谷彩百合3, 池田龍二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 815-815, 2020.

---

	P7-31. The effect that a change gives for the clinical manifestations of patients with asthmatic condition of a patient merger chronic obstructive pulmonary disease on 3 distribution of the ingredients inhalants 浦上勇也1, 山地康文2, 久家哲也1, 河田由紀子1, 原田亜記1, 山本和幸1, 飯原なおみ3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 815-815, 2020.

---

	P7-32. Intervention effect of the pharmacist in the hospitalization and release support center 竹内恵1, 飛田里美1, 末松耕輔1, 森川仁美1, 剣彰彦2, 佐藤清治2, 草葉一友1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 816-816, 2020.

---

	P7-33. Construction of an anti-doping system at Oita City Medical Association Almeida Hospital 河村聡志1, 大塚愛美1, 陸丸幹男1, 沖田美玖1, 松本善企2, 森一生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 816-816, 2020.

---

	P7-34. Efforts and problem of the pharmacist to a hospitalization support task in our hospital 片野貴大1, 佐藤美砂1, 荒川正悟1, 木南志朗1, 伊藤功治2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 817-817, 2020.

---

	P7-35. Investigation about the cause of the discontinuation instructions unobservance before operation 高橋真理1, 木田有里子1, 今浦将治1, 澤柳ユカリ2, 谷口英喜2, 菅野浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 817-817, 2020.

---

	P7-36. About problems and the correspondence that we were able to see from the different case example of the approval dose in the health insurance pharmacy 石原千春1, 生田このみ1, 大嶋沙希1, 澤村陽子1, 村田瑠衣1, 伊東公一2, 岩佐治典2, 澤木進2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 818-818, 2020.

---

	P7-37. Relation of the pharmacist of the Lenvatinib treatment for thyroid cancer in our hospital 廣岡賢輔1, 清水浩幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 818-818, 2020.

---

	P7-38. Cooperation with hospital pharmacy and the neighborhood ethical pharmacy using prescription notebook about the cancellation medicine before examination, surgery 藤井達郎1, 佐々木静香1, 下口谷貴1, 久保瞳1, 川本康太郎1, 森本雅子1, 門村将太1, 井藤達也1, 馬場隆彰2, 栗田克美3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 819-819, 2020.

---

	P8-1. Community medical care cooperation for dementia early detection in the health insurance pharmacy 早田佳生1, 甲斐麻美子2, 石橋久1,3, 安倉央2,4, 安部綾2, 中野貴文2, 林稔展2, 冨永宏冶2, 高橋正志4, 飯田仁志5, 尾籠晃司6, 川嵜弘詔5, 江川孝2, 園田正信1, 山野徹3, 田中泰三3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 820-820, 2020.

---

	P8-2. One patient who succeeded in famotidine reduction by the healthy practice classroom participation in the drugstore 吉岡遼1,2,3, 水野智博2, 浅井敦子1, 水野祐果1, 梅田洋子3, 梅田孝3, 浅井治行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 821-821, 2020.

---

	P8-3. Intervention based on the multi-theory integration model of the pharmacist in the Kure-shi osteoporosis aggravation prevention project 覚前美希1, 羽山順子2, 松村智子3, 濱崎匡史4, 要田弥生5, 金子富美6, 津田彰7, 大塚幸三8, 三宅勝志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 821-821, 2020.

---

	P8-4. About usefulness of BSC in the pharmacy management of our hospital 若木麻由1, 佐藤大輔1, 黒田健吾1, 岡田侑子1, 寺島清文1, 加藤菊郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 822-822, 2020.

---

	P8-5. Pilot study (the second report) for the development of the new medication support law of children utilizing Virtual reality 安井麻姫1, 仁木一順1,2, 井口舞香1, 磯野友美1, 影山寛人1, 上田幹子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 822-822, 2020.

---

	P8-6. Result of the management that we continued a balun strike scorecard in the Yokohama General Hospital and used 高田啓介1, 廣瀬直樹1,2, 倉田武徳1, 仙内光子1, 小町和樹1, 鯉淵寛之1, 南雲史雄1, 金田昌之2, 赤瀬朋秀3, 佐村優1, 谷川浩司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 823-823, 2020.

---

	P8-7. Task shifting to pharmacists for in-hospital management work 脇田真之1, 波能満理恵1, 星野智美1, 棚田真紀1, 渡辺恵美1, 吉井千菊1, 岡村吏華1, 大坪愛実1, 人見智香子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 823-823, 2020.

---

	P8-8. About effect to give pharmacist duties by the introduction of the drug assistant 沼田諒1, 梶原彩香1, 小野歩1, 阿部和恵1, 比毛有理子1, 折戸融1, 石井勇太1, 片山潤1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 824-824, 2020.

---

	P8-9. About enforcement of the continuous medication support utilizing the telephone after the medication attitude survey - of - pharmacist 鬼木薫1, 河口剛之2, 伊佐珠2, 藤井雅裕3, 平田聡美4, 安藤伸一郎5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 824-824, 2020.

---

	P8-10. Inspection of duties contents by the duties introduction of the formulations assistant in the convalescent hospital ソディ保子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 825-825, 2020.

---

	P8-11. Usefulness of being led by a ward pharmacist, and practicing medication based on protocol 大池恵生1, 奥苑朱加1, 杉野晃希1, 山室栄一1, 遠山幸男1, 久田達也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 825-825, 2020.

---

	P8-12. Consideration vol.2 about the usefulness of the balun strike scorecard in the drug section duties construction 稲葉健二郎1, 古浜健一1, 河野健1, 矢倉尚幸1, 佐々木優1, 大石将義1, 酒井梨帆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 826-826, 2020.

---

	P8-13. Consideration about the individual making and cascade of a hospital balun strike scorecard and the balun strike scorecard for hospital pharmacist 金田昌之1, 米澤禎貴1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 826-826, 2020.

---

	P9-1. Usefulness evaluation of the prescription check system contraindicated to the name of disease in conjunction with an electronic medical chart system 國津侑貴1, 平大樹1,2, 上西幸治1, 炭昌樹1, 森田真也1, 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 827-827, 2020.

---

	P9-2. Improvement effect of duties burden and the drug regime of the physician by the communication route introduction from a drug system to an electronic medical chart 内田佳菜子1, 高梨愛1, 越後憲之2, 田中敏幸3, 日野祥幸3, 田中淳4, 山下敦志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 828-828, 2020.

---

	P9-3. The making of the drug dose calculation tool according to the renal function using Microsoft Excel VBA and examination (the third report) of the usefulness 後藤純一1, 菅原拓也1, 荒井浩一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 828-828, 2020.

---

	P9-4. Promotion (the first report) - formulation study support systems construction of the pharmaceutical products proper use cycle utilizing the ICT and usefulness - 西田基紀1, 川田敬1, 柳澤成佳1, 川添哲嗣1, 船戸裕樹1, 上田真由美1, 門田亜紀1, 常風興平1, 森田靖代1, 宮村充彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 829-829, 2020.

---

	P9-5. Combination contraindications in the University of Occupational and Environmental Health Hospital, efforts of the prescription for the drug allergy 實松絵美子1, 河野紗羅1, 一木孝治2, 植木哲也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 829-829, 2020.

---

	P10-1. Inquiry analysis of the infusion to use for patients on dialysis put to the infusion DI center 掛水瑞芳1, 竹林佑花1, 松田直子1, 吉岡小都子1, 星泉1, 福田まゆみ1, 河野裕則1, 岩原良晴1, 沢田憲彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 830-830, 2020.

---

	P10-2. Difference in suicide/self-harm association adverse event signal in AMPA receptor blocker Perampanel hydrate and other antiepileptic drugs 堀江美香子1,2, 古関竹直2, 熊澤里美2,3, 山田成樹2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 831-831, 2020.

---

	P10-3. Reporting of the active injection drug by the intervention of the pharmacist 大竹由莉1, 鈴木善貴1, 野田千笑2, 冨田妙鶴2, 柚原昌典2, 室田智代2, 大沼哲朗3, 定盛理純1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 831-831, 2020.

---

	P10-4. Reconstruction of the formulary for uric acid production inhibitors 宮本拓也1, 金井紀仁2, 濃沼政美3, 宮崎美子4, 齋藤俊夫5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 832-832, 2020.

---

	P10-5. About an investigation of the blood pressure in the Lenvatinib taking our hospital patients for the hepatocellular carcinoma 近藤理絵1, 田中智啓1, 日生下美紀1, 西窪奈津子1, 吉田直恵1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 832-832, 2020.

---

	P10-6. Difference in adverse event signal of antipsychotics and signal in non-elderly people, elderly people 古関竹直1,2, 中林哲夫3, 山田成樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 833-833, 2020.

---

	P10-7. The improvement of problems of the subset of pharmaceutical products interaction analysis for the signal detection and the inspection 野口義紘1, 林剛1, 高岡みらい1, 舘知也1, 寺町ひとみ1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 833-833, 2020.

---

	P10-8. Analysis ... according to effect - Gender that the presence or absence of breakfast intake gives to body-mass index (BMI), the generation 初岡玲奈1, 真野泰成2, 鈴木立紀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 834-834, 2020.

---

	P10-9. Examination in the association between PSA level change and prostate cancer onset using the administrative data base 西川寛来1, 真野泰成1, 武藤倫弘2, 松山裕2, 石川英樹3, 上村博司4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 834-834, 2020.

---

	P10-10. Examination about the in-hospital formula reintroduction example and pharmaceutical products costs reduction effect in our hospital 川邉桂1, 志村明日香1, 畠山成寛1, 古川大輔1, 小池博文1, 戸谷義幸2, 佐橋幸子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 835-835, 2020.

---

	P10-11. Usefulness of the inquiry record communalization of the drug information room 飯田彩花1, 小林加寿子1, 日浦寿美子1, 小林秀樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 835-835, 2020.

---

	P10-12. Research - Rabeprazole about the description about the inhibition style of the proton pump inhibitor in the drug information is reversible, or is it irreversible? - 高島佳央理1, 青山隆夫1, 小茂田昌代1, 斎藤顕宜1, 高橋秀依1, 西川元也1, 嶋田修治1, 鈴木立紀1, 真野泰成1, 尾関理恵1, 高澤涼子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 836-836, 2020.

---

	P10-13. The handling of the safe information in the call center of the off patent pharmaceutical products (OPD) maker: Evaluation by KPI (thank you score) 西山悠1, 有賀美穂1, 井上香織1, 河合孝1, 尾崎好夫1, 門田靜明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 836-836, 2020.

---

	P10-14. Search of the encephalopathic inducer based on large-scale side effect database JADER 瀬山友香1, 細谷龍一郎1,2, 加藤智之1, 日野斉一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 837-837, 2020.

---

	P10-15. The discontinuation using the drug check list contraindicated to aminolevulinic acid hydrochloride granule combination and investigation of the side effect expression situation 関口陽子1, 寺口敦1, 高村誠1, 今成拓1, 矢吹剛1, 南場信人1, 貝瀬眞由美1, 原昇2, 西山勉2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 837-837, 2020.

---

	P10-16. Investigation about mention contents of the inhalational instruction material for patients whom a pharmaceutical company made 中田英夫1, 山田悠加1, 青森達1,2, 望月眞弓1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 838-838, 2020.

---

	P10-17. Database ... which can confirm development - intersection allergy medicine of the database which can conduct registration of the drug allergy information appropriately 宮村信輝1, 阿部純子1, 杉平直子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 838-838, 2020.

---

	P10-18. Association analysis of the concomitant drug in patients with Stevens Johnson's syndrome using big data, toxic epidermal necrolysis onset 山崎智久1, 寺薗英之1, 中嶋洋生2, 武田泰生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 839-839, 2020.

---

	P10-20. Examination - using analysis of effect - JADER that antipsychotics give to the onset of the breast cancer and exacerbation and the human breast cancer cultured cell 前島多絵1, 飯島亮介1, 渡邊真知子1, 板垣文雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 840-840, 2020.

---

	P10-22. "The secant design" of the tablet judging from a package insert, interview form of the mirtazapine preparation 若林進1, 田中秀和2, 藤澤哲也3, 三上彰貴子4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 841-841, 2020.

---

	P10-23. Search of the insomnia risk with pharmaceutical products by Sequence Symmetry Analysis using electronic drug history data 佐野由奈1, 酒井隆全1, 近藤貴志2, 横地浩次2, 田辺公一1, 大津史子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 841-841, 2020.

---

	P10-24. Introduction of Formulary in Toda Central Medical Group - Efforts in Totsuka Area - 安藤正純1, 金井紀仁2, 鈴木智3, 濃沼政美4, 宮崎美子5, 齋藤俊夫6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 842-842, 2020.

---

	P10-25. Analysis of the after giving birth depression using American adverse event spontaneous report database (FAERS) 羽根由基1,2, 堀部めぐみ3,4, 阿部純子5, 松井利亘1,6, 加藤大和1,7, 上田夏実1,8, 笹岡沙也加1,9, 元岡佑美1, 畠平春奈1,10, 長谷川栞1,11, 紀ノ定保臣1,12, 原英彰4, 中村光浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 842-842, 2020.

---

	P10-26. Consideration about the usefulness of the new drug information offer tool from the pharmaceutical company under "the guidelines about the sale reporting activity on ethical drug" 田中里和1, 分銅淑1, 五十嵐美和1, 森田健司1, 中島美保1, 佐々木洋1, 塩原ひとみ1, 結城陽二郎1, 串戸徳彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 843-843, 2020.

---

	P11-1. Approach to psycho status of patient for the polypharmacy 原田彩1,3, 岡本禎晃2, 中島園美3, 力武良行3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 844-844, 2020.

---

	P11-2. Investigation of the factor to have an influence on the palliation of patients with glossodynia, the improvement in quality of life 赤嶺美奈1, 佐久間美里2, 田中祥子1, 山本美智子1, 赤嶺有希子1, 吉原澄吉3, 澤井一2,3, 谷田弘3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 845-845, 2020.

---

	P11-3. Investigation about the recognition about the term to use at medication counseling 赤嶺有希子1, 田中祥子1, 赤嶺美奈1, 山本美智子1, 高木正信1, 加納美知子2, 佐久間美里2, 平野陽子1, 姜惠元2, 吉原澄吉3, 澤井一2, 谷田弘3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 845-845, 2020.

---

	P11-4. Prescription trend of the oral anticancer agent used for foreign cancer chemotherapy 杉山純子1, 齋藤翔太2, 田中美幸3, 佐藤展宏4, 長谷川佳孝5, 月岡良太5, 森澤あずさ5, 大石美也5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 846-846, 2020.

---

	P11-5. Effect according to the area of the drug-resistant (AMR) measures action plan to give to prescription meeting a demand of the third generation cephem system antimicrobial 河田直也1, 片山珠季2, 前田守3, 長谷川佳孝3, 月岡良太3, 森澤あずさ3, 大石美也3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 846-846, 2020.

---

	P11-6. Use fact-finding of the antimicrobial in the childhood acute respiratory tract infection 伊藤綾花1,2, 阿部久瑠美1,2, 渡邊亜矢子1,2, 江畠麗1,2, 伊波樹1,2, 越塚宏美1,2, 柏原由佳1,2, 田中克巳1,2, 佐々木忠徳2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 847-847, 2020.

---

	P11-8. If disease insight, medicational self-understanding is not associated even if a pharmacist chooses an individual treatment-related expensive inhalational device as for the lung function of patients with COPD, we do not improve it 塩飽英二1, 土手賢史1, 金子忍1, 野崎歩1, 小林由佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 848-848, 2020.

---

	P11-9. The choice of the infusion pump for improvement in quality of life of patients 古橋隆久1, 鈴木善貴1, 板垣千華1, 堀部弘子2, 西村千賀子2, 野田千笑2, 定盛理純1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 848-848, 2020.

---

	P11-10. Questionnaire results about the operability of the Teriparatide automatic injector 松嶋奈那美1, 城戸美恵子1, 杉知子1, 松尾昭代1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 849-849, 2020.

---

	P11-11. Use fact-finding of the antiinfluenza medicine in the drugstore 白川貴章1, 白川夕紀子1, 白川加代子1, 白川憲廣1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 849-849, 2020.

---

	P11-12. The use situation investigation of biological drug, the JAK inhibitor to patients with rheumatoid arthritis in our hospital 根橋佳奈1, 橋本浩之1, 松本亜佐美1, 秋本法人1, 江口善美1, 藤井淳平2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 850-850, 2020.

---

	P11-13. A survey on the use of brexpiprazole in our hospital 下地晶1, 高橋嘉寛1, 矢野真弓1, 池田郁子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 850-850, 2020.

---

	P11-15. Investigation about the prescription trend of the oral laxative 廣瀬靖章1, 小山貴史2, 前田守3, 長谷川佳孝3, 月岡良太3, 森澤あずさ3, 大石美也3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 851-851, 2020.

---

	P11-17. The use of sleeping drug situation investigation to elderly people before and after the manual introduction 長澤欣弘1, 中村槙一郎1, 財津孝希1, 瀧内瑛輔1, 羽生智宏1, 尾形美絵1, 田村和彦1, 新関みどり1, 近藤和宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 852-852, 2020.

---

	P11-18. The use situation investigation of hydromorphone in the metropolitan Komagome hospital 小林崇史1, 吉田茜1, 宮澤真帆1, 石原溶子1, 田中桂子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 853-853, 2020.

---

	P11-19. Analysis of the factor giving it to the medication adherence of patients who received hormonal therapies after the breast cancer technique 櫻井雄太1, 武田真央1, 中村裕義1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 853-853, 2020.

---

	P11-20. About shortening of the anti-thing duties time of the pharmacist by the introduction of the return of goods medicine withdrawal device 深津昌弘1, 高島直樹1, 齊藤将之1, 水野尚章1, 山田哲也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 854-854, 2020.

---

	P11-21. Investigation about the prescription situation of antidepressant and the antianxiety drug in the Nagoya University faculty of medicine hospital psychiatry outpatient 野田幸裕1,2, 野口健1, 磯貝里奈1, 吉見陽1,2, 山田清文2, 尾崎紀夫3, 肥田裕丈1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 854-854, 2020.

---

	P11-22. Tasting party report of the medicine by a physician, the pharmacist aiming at improvement in medication adherence of children 加覧みなみ1, 清水祐一1, 渡邉真菜実1, 甲斐維子1, 加戸奈穂美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 855-855, 2020.

---

	P11-24. It is ... for pharmacist intervention of use situation investigation - perioperative period of iv-PCA after the TKA technique 宮島佳菜子1, 大城匡史1, 國分千代1, 藤村泰三1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 856-856, 2020.

---

	P11-26. Association with HADS and the medication adherence in patients with rheumatoid arthritis 中村郁勝1, 須古杏子1, 森岡淳子1, 高岡宏和2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 857-857, 2020.

---

	P11-27. Change of the patients awareness by the pharmaceutical intervention to the patients targeted for percutaneous transluminal coronary angioplasty 大津友紀1,2, 末松保憲3, 神村英利1,2, 三浦伸一郎3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 857-857, 2020.

---

	P11-28. Role of the new pharmacist to examine from the use situation of the autoimmunity skin disease therapeutic drug 内田和孝1, 須古杏子1, 高濱啓太1, 徳澄亜紀2, 松尾敦子2, 城野昌義2, 今泉文子3, 堀川達史3, 森岡淳子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 858-858, 2020.

---

	P11-29. The development of the Child-Resistance container as preventive measures against pharmaceutical products mis-deglutition accidents and questionary survey for the pharmacist for the purpose of the spread enlightenment 山田真由美1, 高藤由紀子1, 岩橋香奈1, 山谷明正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 858-858, 2020.

---

	P11-30. Use of pain-killer investigation after the autoregulation epidural analgesia interruption in the surgery patients 神原弘和1, 池田久雄1, 平田亜紀1, 森岡浩子1, 足立充司1, 野村浩英1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 859-859, 2020.

---

	P11-31. Use investigation for the proper use of the magnesium oxide preparation 高橋麻衣1, 山口恵輔1, 新枦義之1, 岩城康子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 859-859, 2020.

---

	P11-32. Fact-finding of the delirium onset in the inpatient 土元研史1, 安田礼子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 860-860, 2020.

---

	P11-33. The prescription situation investigation of the number of patients of the acute respiratory tract infection and the oral antimicrobial 平田貴宏1, 池田久雄1, 足立充司1, 野村浩英1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 860-860, 2020.

---

	P11-34. The development of the Child-Resistance container as preventive measures against pharmaceutical products mis-deglutition accidents and questionary survey for the protector for the purpose of the spread enlightenment 高藤由紀子1, 山田真由美1, 岩橋香奈1, 山谷明正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 861-861, 2020.

---

	P11-35. Comparison - of 2014 and 2019 by the prescription of current situation analysis - antidementia medicine of the medical therapy of elderly people 田窪真行1, 松本憲昭1, 榊原幹夫1, 白石成明2, 鈴木裕介3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 861-861, 2020.

---

	P11-36. The use situation of the chronic constipation therapeutic drug in our hospital 山野邉裕子1, 栗原直貴1, 角田結菜1, 田村賢士1, 金子智一1, 金子誠1, 寺田伊知郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 862-862, 2020.

---

	P11-37. Speech therapist and efforts for the simple suspension method for the collaboration of the pharmacist 岩井厚希1, 大野峻2, 角谷直志1, 菊池健1, 武田元樹1, 相馬貴史1, 佐々木啓1, 名達陽一1, 鶴山辰1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 862-862, 2020.

---

	P11-38. Use fact-finding of the directly oral effect type anticoagulant in the on admission 福浦啓史1, 青孝明1, 木村匡男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 863-863, 2020.

---

	P11-39. Examination to the prescription situation investigation and drugstore pharmacist intervention in the anticoagulation of the heart failure 山本美智子1, 赤嶺美奈1, 佐久間美里1, 高木正信1, 松尾律子1, 加納美知子1, 田中祥子1, 赤嶺有希子1, 澤井一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 863-863, 2020.

---

	P11-40. Evaluation of clinical efficacy and safety of topiroxostat in patients with severe renal impairment 佐藤加菜1, 菊田絵梨華1, 坂東香織1, 道貝優太1, 高畠弘樹1, 三浦綾華1, 北川裕也1, 寺原史貴2, 中村裕一1, 鈴木千波1, 小原秀治1, 柴波明男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 864-864, 2020.

---

	P11-41. Attitude survey for the Japanese Society of Hospital Pharmacists hospital pharmacy authorization pharmacist system of the Yamanashi hospital pharmacist 橘田文彦1,2, 河田圭司1, 鈴木正彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 864-864, 2020.

---

	P11-43. The use situation of Emicizumab in our hospital adults haemophilia A 近藤旭1, 阿部憲介1, 神尾咲留未1, 後藤達也1, 鈴木美絵子2, 佐々木晃子2, 今村淳治3, 伊藤俊広3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 865-865, 2020.

---

	P11-44. Extraction of the problem about adoption, the prescription at questionary survey - hospital to a specialist about the Biosimilar 青木良子1, 勝田由紀子1, 鈴木美佳1, 佐井君江1, 石井明子2, 斎藤嘉朗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 866-866, 2020.

---

	P11-45. Mainly on drug remedy situation investigation - fall of elderly patients with proximal thighbone bone fracture, the risk measures of the fall - 大塚愛美1, 平賀愛実1, 河村聡志1, 上田由貴1, 稲垣芙美佳1, 原田百華1, 森一生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 866-866, 2020.

---

	P11-46. About the use of mirogabalin situation of our hospital 沢仁美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 867-867, 2020.

---

	P12-2. Examination about an effect of the pharmacist intervention in patients with foreign cancer pain and the evaluation of the medical economics 沼田裕也1, 松村千佳子1, 山田正実2, 地丸裕美2, 鳥井小莉2, 矢野義孝1, 高橋一栄2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 869-869, 2020.

---

	P12-3. The medical expenses inhibitory effect that we can see from the interpersonal duties of the ward pharmacist 高野温志1, 石井志保1, 松井奈々江1, 高野明香1, 伊賀正典1, 町田充1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 869-869, 2020.

---

	P12-4. Changes in generic drug usage and drug costs due to in-hospital formulary formulation of proton pump inhibitors 竹下和輝1, 渡辺桃子1, 小野奈緒1, 浜本千明1, 八木心平1, 巽昭代1, 横井尋和1, 松山哲史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 870-870, 2020.

---

	P12-6. Examination of the quantity of exposure at the fixed dose administration of immune checkpoint inhibitor utilizing the Pharmacometrics 岡田章1, 小原真穂1, 永井尚美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 871-871, 2020.

---

	P12-7. Examination about the corporate strategy development of the drug section by the inflection of the balun strike scorecard 松崎貴志1, 安島秀友1, 多田純平1, 森田一1, 小形桂子1, 中薗健一1, 杉村春奈1, 百合野祐子1, 田中恒明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 871-871, 2020.

---

	P12-8. Fact-finding of the hypermagnesemia with magnesium oxide in the opioid analgesic remedy patients 飛鷹範明1, 馬塲彩織2, 田中守1, 秋山伸二2, 田中亮裕1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 872-872, 2020.

---

	P12-9. Investigation (the second report) about the drug intervention by the pharmacist participating in the breathing care team, Observational study after the single institution suitable for 島田萌美1, 吉廣尚大1, 埋橋賢吾1, 櫻谷正明2, 荒田晋二3, 白井敦1, 角井碧1, 向井一樹1, 小野塚和人1, 橋本佳浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 872-872, 2020.

---

	P12-10. Comparison of prescribing conditions, drug costs, and safety of proton pump inhibitors before and after formulary introduction 塩田朋子1, 栗島彬1, 磯崎僚1, 森下慎二2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 873-873, 2020.

---

	P12-11. Cost-effectiveness analysis of baloxavir and marboxil for the treatment of influenza virus infection 原田悟1, 金澤幸訓2, 森川昭正2, 中川直人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 873-873, 2020.

---

	P12-12. It is ... from the situation of cost effect analysis - society of the neuraminidase inhibitor 森田聖仁1, 金澤幸訓2, 森川昭正2, 中川直人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 874-874, 2020.

---

	P12-13. Investigation of the quantity of disposal of the injectable anticancer agent in our hospital and the medical expenses reduction effect of the vial multiple times utilization time 佐藤家恒1, 津嶋那奈1, 清水優依1, 藤島哲大1, 高橋幸1, 小川信二1, 佐藤博樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 874-874, 2020.

---

	P12-14. Comparison about the use of drug in Japan and France 山田治美1, 加藤芳徳1, 平尾卓也1, 手塚千裕1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 875-875, 2020.

---

	P12-15. Investigation of the blood test rate of use before the medication with the HBV reactivation risk 北村葵1, 阪井祐介1, 成瀬亮1, 千崎康司1, 山本雅人1, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 875-875, 2020.

---

	P12-16. Cost effect analysis of the allergic rhinitis therapeutic drug 江川慧1, 柏原正美2, 高畑篤2, 中川直人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 876-876, 2020.

---

	P12-17. Than simulation of the consumption investigation of the hippopotamus diTaki cell and medical economic evaluation - 40 mg preparation ... 星田唯史1, 森本奈緒美1, 藤原大一朗1, 眞下惠次1, 和田祥明1, 野田明宏1, 多喜和夫1, 阪口勝彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 876-876, 2020.

---

	P13-2. We work on analysis for the reduction in the use of bringing medicine days in the Fukuoka Red Cross hospital 竹野智彦1, 橋本華1, 藤永理恵子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 878-878, 2020.

---

	P13-3. Effect of the bringing medicine lecture on medical student by the pharmacist 齋藤靖弘1, 民谷健太郎2, 武田清孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 878-878, 2020.

---

	P13-4. Efforts of the bringing medicine administration cart set duties by the pharmacist 近藤美祥1, 北村渉1, 尾崎昌大1, 林政和1, 添田真司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 879-879, 2020.

---

	P13-5. Efforts to accident evasion at bringing medicine continuation in the orthopedics ward 川本英子1, 大道淳二1, 奈良葵1, 甲元大樹1, 小池彩子1, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 879-879, 2020.

---

	P13-7. Efforts of the bringing medicine for electronic medical chart and bringing medicine management system management by the interlocking movement 城戸美恵子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 880-880, 2020.

---

	P13-8. Role of the ward pharmacist in the bringing medicine information communalization by the electronic medical chart 酒井梨帆1, 杉山央輔1, 古浜健一1, 湯本哲郎2, 稲葉健二郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 881-881, 2020.

---

	P13-9. The security utilizing the IT technique and construction and evaluation of the effective bringing medicine differentiation system 岡田雅弥1, 中谷亮介1, 満田正樹1, 稲葉静香1, 奥下梨賀1, 尾崎加織1, 野際俊希1, 藤井美紀1, 本郷志帆1, 松本篤1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 881-881, 2020.

---

	P13-10. The serotonin syndrome that was diagnosed by the drug differentiation at the change ridge by the pharmacist early: Case report 藤野怜美1, 吉廣尚大1, 築家秀和2, 橋本佳浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 882-882, 2020.

---

	P13-11. Enforcement of the bringing medicine prescription representation input by the pharmacist based on the protocol and the evaluation 池田澪樺1, 仲田浩成1, 薮内由里香1, 松元俊博1, 三角紳博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 882-882, 2020.

---

	P13-12. On admission bringing medicine discriminant problem and evaluation in the pediatric special hospital 鈴木美穂1, 鈴木英二1, 小林恵子1, 小口真美1, 上條早奈美1, 石川友貴1, 熊谷静香1, 松澤麻紀子1, 尾坂早苗1, 西條純1, 堀勝幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 883-883, 2020.

---

	P13-13. The content analysis of the pharmaceutical intervention example performed with bringing medicine differentiation and examination of the countermeasure 加藤千佳1, 杉本浩子1, 水谷栄梨2, 篠木優里1, 白石ちひろ1, 岩本卓也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 883-883, 2020.

---

	P14-1. The higher anthocyanin-containing cassis extract improves behavior disorder of dementia model mouse SAMP8 島田美理1, 前多隼人2, 七島直樹3, 山田清文4, 中島晶2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 884-884, 2020.

---

	P14-3. Arteriosclerosis inhibitory effect of the go stone tea using the Apolipoprotein E loss mouse 石田七生1, 石田智滉1, 森沢惇平1,2, 飯塚美知郎1, 八木祐助1, 常風興平1, 森田靖代1, 受田浩之3, 宮村充彦1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 885-885, 2020.

---

	P15-1. Proposal to inspection and drugstore duties of the proper use situation of the dihydrocodeine-containing antitussive liquid for internal use using drugstore ID-POS data 小林華奈1, 渡邊崇2,3, 菊池千草1,2, 鈴木匡1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 886-886, 2020.

---

	P16-1. Use and application of examination NDB opening data and the financial statements of the choice method of the excellent generic medicine judging from a viewpoint of running it 石坂敏彦1, 安瀬淳1, 遠藤晋吾1, 安井友佳子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 887-887, 2020.

---

	P16-2. Attempt of the drug information streaming for employees in the off patent drug (OPD) pharmaceutical products company 筧真実1,2, 林恵理子1, 河合孝1, 伊藤秀明2, 門田靜明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 888-888, 2020.

---

	P17-1. Comparison of infusion reaction frequency in a precedence product and the Biosimilar of rituximab and the disease severity 大谷隼斗1,2, 花井雄貴1, 越川一誠1, 三井ゆりか2, 長瀬大輔2, 入田博史2, 廣田愛2, 名取一彦2, 坂本真紀1, 西澤健司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 889-889, 2020.

---

	P17-2. Examination about the infusion reaction at the initial rituximab Biosimilar administration in the treatment of patients with first non-Hodgkin's lymphoma 鈴木康之1, 齋藤雅隆2, 遠藤征裕3, 工藤直嗣1, 斉藤匡昭4, 大野謙太郎2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 890-890, 2020.

---

	P17-3. Therapeutic safe comparison between precedent biomedicine and biofollowing article of the trastuzumab 龍田涼佑1, 炭本隆宏1, 中原良介1, 田中遼大1, 伊東弘樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 890-890, 2020.

---

	P18-1. One patient whom an erythema multiforme severe form developed in after the influenza HA vaccine inoculation 杉原弘記1, 樫野かおり2, 岡田昌浩1, 岡本伸也1, 村上史承1, 岡崎和子1, 岡田麻衣子1, 田代操1, 竹井英介1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 891-891, 2020.

---

	P18-2. Superiority for the current preparation of the change of prescription esflurbiprofen Mentha Oil preparation (SFP tape) 遠藤継良1,2, 佐藤潤一2, 川鰭昌吾2, 有馬和範1, 桐畑佑香1, 寺坂修一1, 今野芳浩1, 山口順一1, 八田羽幾子1, 山田清文3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 892-892, 2020.

---

	P18-3. What is necessary to further increase the adverse event report of the pharmacist? : Consideration judging from the number according to the type of job of JADER of reporters and content 高谷瑞穂1, 豕瀬諒1, 村木優一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 892-892, 2020.

---

	P18-4. The case that developed a side effect by the additive included in pharmaceutical products 田中祥子1,2, 赤嶺美奈1,2, 赤嶺有希子1, 加納美知子1,2, 高木正信1,2, 松尾律子1,2, 澤井一2, 吉原澄吉3, 谷田弘3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 893-893, 2020.

---

	P18-5. One patient who developed an allergic symptom by multiple antimicrobial 安高勇気1,2, 神村英利1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 893-893, 2020.

---

	P18-6. Examination of somnolence, the oversedation expression risk in the delirium time Risperidone administration 矢野裕士1,2, 鈴木優司2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 894-894, 2020.

---

	P18-7. Acute renal failure and hypoglycemic one patient with the concomitant drug who had the onset just after voriconazole administration 松田翔平1, 水口真利江1, 楢原史子1, 馬屋原慈理1, 木村竜司1, 今津智子1, 下川福子1, 面田恵1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 894-894, 2020.

---

	P18-8. A hypereosinophilic syndrome with pericarditis that occurred with dobutamine: Case report 無漏田香穂1, 吉廣尚大1, 石橋直樹1, 橋本佳浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 895-895, 2020.

---

	P18-9. 1 case of the drug-related pleurisy with mesalazine 柴田健太1, 白川直人1, 中田和宏1, 木村美由喜1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 895-895, 2020.

---

	P18-10. The side effect expression situation investigation of pulmonary MAC symptom treatment in central part Rousaibyoin 旭将来1, 荒川正悟1, 平松久典1, 山口智江1, 宮原兼二1, 木南志朗1, 伊藤功治2, 石川真弓3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 896-896, 2020.

---

	P18-11. Elucidation of the uptake mechanism that is skin-specific of the ipragliflozin in human keratinocytes HaCaT cells 高畑洋平1, 辻本雅之1, 伴野靖奈1, 堀優香1, 折方琴音1, 白土恵理1, 辻本美菜1, 河渕真治2, 栄田敏之2, 峯垣哲也1, 西口工司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 896-896, 2020.

---

	P18-12. Examination of the usefulness of ALBI Grade in the occurrence of adverse event prediction by the Lenvatinib 松本由季1, 榎本大智1, 山本和宏1, 大村友博1, 小松昇平2, 矢野嘉彦3, 矢野育子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 897-897, 2020.

---

	P18-13. Efforts aimed at increasing the number of preavoid reports and their results 甲元大樹1, 横田幸子1, 向井めぐみ1, 花房伸幸1, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 897-897, 2020.

---

	P18-14. One case with suspected drug-related pulmonary disorder by the Vonoprazan fumarate 五十川達哉1, 中村祐太2, 瀬口優里1, 荒金裕敏1, 三浦光年3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 898-898, 2020.

---

	P18-15. It is one patient with suspected dihydropyrimidine dehydrogenase deficiency in the capecitabine internal use patients 屋敷大輔1, 田中恭人1, 豊留麻衣1, 北園幸大1, 中野一馬1, 山本梢1, 岸本真1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 898-898, 2020.

---

	P18-16. Examination and comparison between hemoglobin level and effect on anemia frequencies with the antiandrogen 廣部開斗1, 玉木啓文1,2, 伊野陽子1,2, 長内理大1,2, 山下修司2,3, 野口義紘2,4, 井口和弘1,2, 寺町ひとみ2,4,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 899-899, 2020.

---

	P18-17. The serum magnesium densitometry for the magnesium oxide preparation internal use patients which the renal function based on the protocol decreased and chronic constipation measures 田畑真一1, 中島麻有1, 戸塚孝治1, 新井成俊1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 899-899, 2020.

---

	P18-18. 1 case that had a diagnosis of dabigatran origin-related esophagitis during hospitalization of the congestive heart failure 川成昂1, 高田正弘1, 景山康二郎1, 氏原弘洋1, 國原将洋1, 松久哲章1, 杉野浩2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 900-900, 2020.

---

	P18-19. Look at the rear of the risk factor of the onset of impaired renal function by Liposomal-amphotericin B; mark investigation 横田翼1, 吉川直樹1, 有森和彦1, 池田龍二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 900-900, 2020.

---

	P18-20. Reexamination about the adverse event expression including the photo-allergy in the aminolevulinic acid hydrochloride granule internal use patients of our hospital urology department 標真里絵1, 高嶋祥匡1, 大谷寧次郎1, 三浦毅1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 901-901, 2020.

---

	P18-21. Adverse event report contents of hospital pharmacist and the insurance pharmacist 奥村伊代1,2,3, 矢野裕士1, 江川裕之1, 岡本祐二1, 岡安弘樹1, 千葉詩織1, 今井裕久2, 平本要2, 吉澤美香3, 鈴木優司3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 901-901, 2020.

---

	P18-22. New digital to contribute to side effect prevention, reduction of the TC therapy cera; see the rear about preliminary examination - adverse event for the Thich development with a zing; mark investigation ... 森本彩香1, 仁木一順1, 原伸輔2, 奥田真弘2,3, 上田幹子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 902-902, 2020.

---

	P18-23. The digestive tract function in patients with intensive care unit admission serious case and internal behavior of blood neuroendocrine system peptide 三宅優美1, 道原あやな1, 高田千明1, 白川真1, 後藤孝治2, 佐藤雄己1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 902-902, 2020.

---

	P18-24. Comparison of bleeding frequency between clopidogrel and prasugrel with DAPT therapy after PCI 濱田恵輔1, 門口直仁1, 濱本真歩1, 森田有香1, 田中広大1, 段松雅弘1, 田中聡1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 903-903, 2020.

---

	P18-25. Examination of the factor to have an influence on the onset of cutaneous symptom that vancomycin is due to 森幸代1, 中蔵伊知郎1, 福田裕子1, 本多美悠1, 吉本咲貴1, 北澤文章1, 辻川正彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 903-903, 2020.

---

	P18-26. Examination of the factor having an influence on weight loss, the cancellation of the dose by the drop of serum Ca level and PTH-intact in the Evocalcet administration 土江学1, 西原昌幸1, 森川記道2, 吉原統1, 伊豆優美子1, 稲艸優生子1, 藤田啓子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 904-904, 2020.

---

	P18-27. One case that a drugstore pharmacist utilized the prescription test value of the basic hospital, and evaluated the another hospital medical treatment, and fed back 原田祐希1,2, 鈴木渉太2,3, 中川素子1, 中川道昭1, 岡田浩2, 中山健夫2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 904-904, 2020.

---

	P18-28. Evaluation of the side effect report system of pharmaceutical products in the Gifu comprehensive medical care center 小寺聖1, 関谷泰明1, 井上壽江1, 平下智之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 905-905, 2020.

---

	P18-29. Examination of the hTHTR2 inhibitory action with metronidazole using hTHTR2 expression MDCK II cells 山岸喜彰1, 白坂善之2,3, 鮒井悠汰2,3, 橋本光弘1, 工藤敏之1, 井上勝央2, 伊藤清美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 905-905, 2020.

---

	P18-30. The effect that NSAIDs gives to healing of wound 長崎裕1, 中居肇1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 906-906, 2020.

---

	P18-31. Examination of the risk factor associated with the acute side effect of nonionic contrast media 鶴見裕美1, 冨田敦和1, 國分祐介1, 飛永あゆみ1, 今西忠宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 906-906, 2020.

---

	P18-32. It is the onset of immune-mediated adverse event situation until one year after checkpoint inhibitor administration of immunity 岩田一史1, 合澤啓二1, 小野達昌1, 陣上祥子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 907-907, 2020.

---

	P18-33. The effect that the polypharmacy with the adverse event spontaneous report database gives to the fall risk of elderly people 畠平春奈1,2, 長谷川栞1, 笹岡沙也加1, 加藤大和1, 阿部純子3, 元岡佑美1, 福田昌穂1, 長沼美紗1, 中尾智史1, 向井梨々香1, 島田和代1, 平出耕石2, 加藤武司2, 中村光浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 907-907, 2020.

---

	P18-34. One case that caused metformin-related lactic acidosis after the alcohol large quantity drinking 平識善彦1, 小杉卓大1, 座覇明子2, 嘉数敦3, 國分千代1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 908-908, 2020.

---

	P18-35. Investigation of the observance situation of "asking in case of pharmaceutical products safety information report mention" that PMDA delivered it 関谷泰明1, 井上壽江1, 平下智之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 908-908, 2020.

---

	P18-36. Drug adverse event risk of the elderly people whom we recognized from bringing medicine investigation 大野陽平1, 石川めぐみ1, 吉見猛1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 909-909, 2020.

---

	P18-37. A Case of Hepatitis B Virus Reactivation with Pomalidomide + Dexamethasone Therapy 設楽愛美1, 美馬禎俊1, 村上達也1, 竹田祐加1, 牧瀬英知1, 近藤智幸1, 橋本光生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 909-909, 2020.

---

	P18-38. Association between expression situation and age of the red man syndrome with vancomycin 富島喜朗1, 古庄弘和1, 渡邊瑛理1, 陣上祥子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 910-910, 2020.

---

	P18-39. Examination about the association of PK/PD parameter and the lower urinary tract symptom frequency that we calculated using QSAR 伊東岳1, 湯山円晴2, 飯山夏海1, 慶野綾子1, 平岡優里菜1, 荒井裕美子2, 金谷貴行2, 杉山奈津子1, 加藤芳徳1, 前澤佳代子1, 倉本敬二1, 栗原正明2, 百瀬泰行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 910-910, 2020.

---

	P18-40. Efforts for the prescription situation and the mesenterial vein sclerosis early detection of the gardenia fruit-containing Chinese medicine 磯野礼果1, 林彩矢香1, 遠藤秀竜1, 堀浩子1, 山崎崇1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 911-911, 2020.

---

	P18-41. Use experience of the Lenvatinib in our hospital 西條由夏1, 大谷綾1, 亀井健人1, 塙久瑠実1, 上田愛梨1, 中尾啓子1, 笹瀬典子1, 藤井貴子2, 金秀基2, 金守良2, 金啓二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 911-911, 2020.

---

	P18-42. Use fact-finding of distigmine bromide tablets in our hospital 山根紗希子1, 山根靖弘1, 梅田清隆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 912-912, 2020.

---

	P18-43. Investigation about the introduction of the hyperuricaemia therapeutic drug for patients with chronic kidney disease 山下功祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 912-912, 2020.

---

	P18-45. An example of allergy to α-gal which we experienced in our hospital 小池彩子1,2, 出宮千聖1, 山口麻里2, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 913-913, 2020.

---

	P18-46. An attitude survey about the side effect relief system for the pharmacists of the health insurance pharmacy and examination of the problems 秋山滋男1, 土井信幸2, 淺野未代子3,9, 福澄重泰4,10, 高橋真吾5, 鈴木勝俊6, 小川憲治7,10, 宮本悦子8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 914-914, 2020.

---

	P18-47. The current situation of Adverse Drug Event in the Baptist health center for the elderly and the problem 東原和美1, 梅村道代2, 福田美沙子2, 中田裕久1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 914-914, 2020.

---

	P18-48. Examination about the onset risk of the diarrhea by the naldemedine in our hospital 向井淳治1, 坂本竜平1, 小竹優希1, 氏川郁穂1, 奥田広志1, 名徳倫明2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 915-915, 2020.

---

	P18-49. Pediatric case with suspected symptom central at voriconazole administration 小野寛之1, 田中遼大1, 木村裕香2, 平野直樹2, 末延聡一2, 龍田涼佑1, 伊東弘樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 915-915, 2020.

---

	P18-50. Fact-finding of the intracranial hemorrhage that occurred during oral anticoagulant drug (DOAC) remedy directly 天野祐太1, 門野健二1, 武田龍馬1, 池田大騎1, 片倉佐都子1, 高橋紀恵1, 野本祐香1, 本間和加子1, 上山憲司2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 916-916, 2020.

---

	P18-51. Search of the infusion reaction expression risk factor of the daratumumab 小野達昌1, 岩田一史1, 合澤啓二1, 森優1, 陣上祥子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 916-916, 2020.

---

	P18-52. Infection frequencies in EORA and examination of the expression time 西本辰徳1, 千場美奈2, 山部美千子2, 木村修徳2, 小園亜希2, 清水裕彰2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 917-917, 2020.

---

	P18-53. Effect analysis of the antipyretics analgesic giving it to cisplatin-induced acute renal failure using adverse drug reaction database (JADER) 奥村啓樹1, 南島拓矢1, 宮崎雅之1, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 917-917, 2020.

---

	P18-54. In vitro assessment of tubular toxicity of the BRAF inhibitor vemurafenib 真川明将1,2, 森菜々香2, 冨田なつみ2, 堀田祐志2, 木村和哲1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 918-918, 2020.

---

	P18-55. The effect that long-term proton pump inhibitor (PPI) internal use gives for the renal function of elderly people 後藤早衿1, 北川佳奈子1, 倉地茜1, 松原匡希1, 宮川泰宏1, 千崎康司1, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 918-918, 2020.

---

	P18-56. The detection of the pharmaceutical products safety signal about the miscarriage using FAERS 弓長隆太1, 酒井隆全1, 田辺公一1, 大津史子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 919-919, 2020.

---

	P19-1. Examination of circadian variation in xanthine oxidase and xanthine dehydrogenase activity 田山剛崇1, 喜多智生1, 西村さとみ1, 岡本友理香2, 前田志津子1, 杉原数美1, 三宅勝志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 920-920, 2020.

---

	P19-2. Steroid hormone hydrocarbon hydroxylase by the human cytochrome P450 3A subfamily 谷美咲1, 岡本綾香1, 成田華苗1, 豊田愛実1, 丹羽俊朗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 921-921, 2020.

---

	P19-3. Effect to give to human cytochrome P450 activity of various antimicrobial 石井里沙1, 佐々木笙子1, 丹羽俊朗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 921-921, 2020.

---

	P19-4. Effect of steroid hormone and related compounds on testosterone hydrocarbon hydroxylase by the human cytochrome P450 3A subfamily 川崎日向子1, 岡本綾香1, 豊田愛実1, 丹羽俊朗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 922-922, 2020.

---

	P19-5. Dopamine generation with human CYP2D6 and effect of steroid hormone and related compounds 田中麻友1, 丹羽俊朗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 922-922, 2020.

---

	P19-6. It is effect of various antidepressant on dopamine generation from p-tyramine by human cytochrome P450 (CYP) 2D6 道廣有里奈1, 杉本静也1, 丹羽俊朗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 923-923, 2020.

---

	P19-7. Pharmacokinetic examination in the rat of the redie fen relative using the HPLC 角岡映1, 千森隆靖1, 坂本祐輔1, 土谷香穂2, 酒井博遥3, 古川実季1, 小林正樹1, 樋上賀一1, 長原礼宗3, 椎名勇2, 真野泰成1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 923-923, 2020.

---

	P19-8. The effect that 5-fluorouracil administration gives to substrate drug metabolism activity of liver CYP3A and the internal change 福野修平1, 藤池麻衣1, 佐々木雄哉1, 長井克仁1, 小西廣己1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 924-924, 2020.

---

	P19-9. Effect of the selective serotonin reuptake inhibitor (SSRI) on intracerebral progesterone 21 - hydrocarbon hydroxylase 佐々木笙子1, 丹羽俊朗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 924-924, 2020.

---

	P19-10. Establishment and application of the plasma concentration system of measurement of the antidementia medicine by the HPLC-MS/MS method 道原あやな1, 三宅優美1, 白川真1, 山本浩一2, 佐藤雄己1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 925-925, 2020.

---

	P20-1. Estimate of the plasma concentration measurement of apixaban in patients with severe impaired renal function and the internal change 市川祐依1, 内田信也1, 小幡由佳子2, 三浦基靖1, 田中紫茉子1, 柏倉康治1, 乾直輝3, 渡邉裕司3, 並木徳之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 926-926, 2020.

---

	P20-2. Pharmacokinetic analysis of vancomycin in patients with childhood febrile neutropenia 海士野恵理乃1, 田中遼大1, 小野寛之1, 龍田涼佑1, 伊東弘樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 927-927, 2020.

---

	P20-3. Population pharmacokinetics analysis of gentamicin in Japanese children 石原慎之1, 猪川和朗2, 大仁田哲修1,2, 玉木宏樹1, 矢野貴久1, 森川則文2, 直良浩司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 927-927, 2020.

---

	P20-4. Investigation about the change of the serum albumin level for initial INR at warfarin introduction and the arrival INR that is in a steady state 西山貴章1, 加藤善章1, 菊田紋華1, 千崎康司1, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 928-928, 2020.

---

	P21-1. Drug interaction potentiation simulation when multiple CYP was inhibited at the same time 伊藤哲也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 929-929, 2020.

---

	P21-2. Change of low-density lipoprotein cholesterol (LDL-C) by the combination of rosuvastatin and magnesium oxide 高橋尊1, 門田祥吾1, 梅田慎也1, 永井滉士1, 南雲徳昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 930-930, 2020.

---

	P21-4. Validity of the cocktail study as the quantitative rating system in the drug interactions detection 三浦基靖1,2, 内田信也1, 田中紫茉子1, 神谷千明3, 片山直紀3, 袴田晃央3, 小田切圭一3, 乾直輝3, 川上純一2, 渡邉裕司3, 並木徳之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 931-931, 2020.

---

	P21-5. Search of the factor affecting warfarin potassium, PT-INR of the amiodarone hydrochloride combination patients 眞崎晃1, 大津友紀1,2, 梅崎靖弘1, 神村英利1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 931-931, 2020.

---

	P21-6. Interaction of the antiMRSA medicine and warfarin at ventricular assist device wearing 井倉恵1, 中北和樹1, 宇野貴哉1, 竹中裕美1, 松田紗知1, 小田亮介1, 和田恭一2, 中村任2, 服部雄司1, 早川直樹1, 簗瀬正伸3, 福嶌教偉3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 932-932, 2020.

---

	P21-7. A case in which voriconazole pharmacokinetics were affected by changes in letermovir absorption due to vomiting 大石博史1,2, 三角紳博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 932-932, 2020.

---

	P21-8. Medicine - for study on drug (the second report) - central nervous system which takes it in, and can be inhibited by a combination of magnesium oxide 吉田久博1, 楠本正明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 933-933, 2020.

---

	P21-9. A color change and content change after a crush, the divided powder with Mercazole tablets (thiamazole) and Magmitt tablets (magnesium oxide) 石田志朗1, 邊恩守1, 鈴江朋子1, 山本曉2, 山岸美貴2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 933-933, 2020.

---

	P21-10. Examination about the drug interactions of tacrolimus in the childhood hematopoietic stem cell transplantation patients and the azole-based antifungal agent 持田裕子1, 清水祐一1, 宇野倫弘1, 甲斐維子1, 加戸奈穂美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 934-934, 2020.

---

	P21-11. It is examined the safety of atorvastatin in patients after the kidney transplantation during the cyclosporine internal use 原林六華1, 高橋正也1, 高橋克之1, 杉本崇1, 内田潤次2, 永山勝也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 934-934, 2020.

---

	P21-12. One case that blood tacrolimus levels increased by vonoprazan internal use after the living renal transplantation 池田ゆり絵1, 中村絢香1, 小阪直史1, 原田俊平2, 牛込秀隆2, 四方敬介1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 935-935, 2020.

---

	P21-13. The effect of menthol on killing effect of the paclitaxel with human liver cancer HepG2 cells and vincristine: Association with the CYP3A expression control 長井克仁1, 福野修平1, 大間知杏奈1, 三浦健2, 小西廣己1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 935-935, 2020.

---

	P21-14. 1 case that absorption of the cyclosporine micro emulsion preparation was promoted by combination of the bile acid preparation conspicuously 竹島秀美1, 吉川直樹1, 秋月渓一2, 日高智徳2, 下田和哉2, 池田龍二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 936-936, 2020.

---

	P21-15. The establishment and evaluation of the angiotensin II receptor knockout cells using the CRISPR/Cas9 system 本山瑞季1, 池尻朱里1, 伊達和輝1, 小島美駒1, 齋藤僚2, 平大樹1, 上島智1, 蓮元憲祐1, 岡野友信1, 角本幹夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 936-936, 2020.

---

	P22-1. Examination of the drug clearance of vancomycin in patients with malignant tumor 泉澤友宏1,3, 金子知由1, 涌井宣行2, 齋藤大輔3, 今井正彦3, 島崎博士1, 高橋典子3, 長谷川英雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 937-937, 2020.

---

	P22-2. DAP pharmacokinetics analysis in patients who received CHDF 山科卓也1, 入江健司4, 辻泰弘2, 山本善裕3, 平木洋一4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 938-938, 2020.

---

	P22-3. Relation - after pharmacist intervention effect - initial formulations in the Teicoplanin initial administration plan based on guidelines 崎山良1, 岡村智文1, 管田彩乃1, 柴田茂貴1, 兼石誠1, 松永愛1, 田口みどり2, 船越幸代1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 938-938, 2020.

---

	P22-4. Comparison between ingredient ratio and measurements between the Teicoplanin preparation by the LATIA method 太田千代枝1, 松永典子1, 里加代子2, 黒崎友亮2, 兒玉幸修1, 佐々木均1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 939-939, 2020.

---

	P22-5. Attempt of the "vancomycin daily standard quantity" in our hospital development 木村三奈美1, 成田久美1, 吉本咲智子1, 戸田純司1, 室岡邦彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 939-939, 2020.

---

	P22-6. Examination of the risk factor that a blood level trough value becomes the high level in the TDM of vancomycin in our hospital 竹田晃輝1, 中井健人1, 田中利夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 940-940, 2020.

---

	P22-7. Examination about the usefulness of the vancomycin initial administration plan nomogram 綿貫真優1, 島崎信夫1, 鈴木洋平1, 梅田清隆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 940-940, 2020.

---

	P22-8. Stable examination for the pharmacokinetic pro-evaluation establishment of the meropenem by LC-MS/MS 堀田奈央1, 長瀬泉1, 森光輝1, 種田靖久1, 松岡知子1, 宇佐美英績1, 吉村知哲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 941-941, 2020.

---

	P22-9. Evaluation of the bisoprolol patch in patients with sepsis that developed tachycardiac atrial fibrillation 里加代子1, 安藝敬生1, 関野元祐2, 東島潮2, 黒崎友亮1, 内田隆寛1, 兒玉幸修1, 佐々木均1, 北原隆志3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 941-941, 2020.

---

	P22-10. Age-specific investigation about the second trough value of vancomycin 今西嘉生里1, 水本知宏1, 井後星哉1, 宮部貴識1, 佐光留美1, 山内一恭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 942-942, 2020.

---

	P22-11. 1 case that showed high level by the VCM trough value drawing blood from a periphery insertion central venous catheter 浜元善仁1, 平田やよい1, 東千夏1, 益田菜月1, 親富祖翔太郎1, 岸本卓1, 翁長真一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 942-942, 2020.

---

	P22-12. Effect examination of the TDM study session in our hospital 石田有希1, 清水善仁1, 長井宏文1, 多賀允俊1, 高瀬文超1, 山本康彦1, 政氏藤玄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 943-943, 2020.

---

	P22-13. Evaluation of measurements by blood level measuring equipment "LM1010" (evaluation machine) by the HPLC method 尾田一貴1,2, 岩村耕次1, 片野田朋美1, 成田勇樹1,2, 内野翔太2, 黒木香吉2, 堀川真衣2, 松本直也2, 米丸興2, 山口綾水2, 城野博史1,2, 齋藤秀之1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 943-943, 2020.

---

	P22-14. 1 example of the renal renal failure attributable to the levetiracetam 水口真利江1, 松田翔平1, 丸本彩加1, 谷本愛花1, 久賀谷幸昌1, 中村護1, 下川福子1, 面田恵1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 944-944, 2020.

---

	P22-15. It is a one case using the levetiracetam for an epileptic seizure complicated for short bowel syndrome 小澤拓1, 吉岡睦展1, 饒平名長武1, 高子優子1, 小川佳美1, 児島正道2, 岡田敏弘2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 944-944, 2020.

---

	P22-16. Examination about vancomycin initial administration plan using the nomogram and the effect 村田翔1, 川崎亮輔1, 相原敏彦1, 増尾昌則1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 945-945, 2020.

---

	P22-17. Evaluation of the practical usefulness that blood antimicrobial levels measurement order registration and the injection drug temporary registration by the pharmacist bring 村川亜光1,2, 山本和宏1, 石井順子1, 阪上倫行1, 清水倫子1, 槇本博雄1, 大村友博1, 坂根稔康2, 國正淳一2, 宮田興子2, 矢野育子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 945-945, 2020.

---

	P22-18. Evaluation of the predictive performance in the Japanese patients of the warfarin kinetic-pharmacodynamic model 青山隆彦1, 平井利典2, 辻泰弘3, 宮本葵1, 伊東俊雅2, 松本宜明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 946-946, 2020.

---

	P22-21. Usefulness and problem of the vancomycin administration regimen standardization 加藤渓1, 山下悠希1, 山田和弘1, 中山博文1, 奥村麻佐子1, 阪口勝彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 947-947, 2020.

---

	P22-24. Making of the dose adjustment nomogram using initial doses in the vancomycin administration and the initial actual survey trough value and the evaluation 種茂いずみ1, 片岡優1, 尾田一貴2, 山田智之3, 小田怜1, 瀬戸崇光1, 松村友和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 949-949, 2020.

---

	P22-25. Improvement of the aim trough value achievement quotient by the standardization of the initial administration plan method of vancomycin 左野亜規子1, 水野裕治1, 西田初博1, 西野隆1, 三嶋一登1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 949-949, 2020.

---

	P23-1. The effect that the inflammatory response in patients receiving voriconazole gives to CYP2C19 activity 相内尚也1, 中川潤一1, 上野桂代1, 木村正彦2, 萱場広之3, 新岡丈典1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 950-950, 2020.

---

	P23-3. Association between trough level change and onset of renal failure situation and CYP3A5 genetic polymorphism after the tacrolimus administration in the autoimmune disease patients 兵藤塁1, 櫻庭裕丈2, 中川潤一1, 蓮井桂介2, 渡邊里奈2, 東野優花1, 福田眞作2, 新岡丈典1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 951-951, 2020.

---

	P24-1. Fact-finding of the anticancer agent doses setting in consideration of economy 稲野寛1, 植田茉梨絵1, 菅原充広1, 佐々木治一郎2, 厚田幸一郎1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 952-952, 2020.

---

	P24-2. Making of the anticancer agent preparation sheet using Microsoft Excel 東島幸道1, 尾崎紗緒理1, 飯田優美1, 吉本有里2, 佐澤卓哉3, 大坪輝行1, 伊南裕子1, 山脇一浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 953-953, 2020.

---

	P24-3. The effectiveness of nivolumab and the Pembrolizumab in patients with lung cancer, safe examination 吉見峻祐1, 加藤博史1, 冨安真史1, 松尾モモ1, 千崎康司1, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 953-953, 2020.

---

	P24-4. It is efforts in our hospital for the cisplatin base regimen promotion in the adjuvant chemotherapy and the effect after the lung cancer technique 高原彩1, 光永義治1, 長門芳2, 田中嘉一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 954-954, 2020.

---

	P24-5. Usefulness evaluation of the injection anticancer medicine check seat in the prescription checking 松尾拓馬1, 原田浩明1, 後藤総太郎1, 石原溶子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 954-954, 2020.

---

	P24-6. The effect that the introduction of the regimen check sheet results in for a doubt inquiry at checking prescription time 堀真悠子1, 吉田幹宜1, 土屋亜祐美1, 長尾嘉真1, 佐藤吉一1, 島貫裕実子1, 田中万穂1, 小川千晶1, 増田純一1, 近藤直樹1, 寺門浩之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 955-955, 2020.

---

	P24-7. About duties improvement of the foreign chemotherapy center for patients waiting time cancellation 鈴木敦詞1, 伊東沙紀1, 村山まりこ1, 前田剛司1, 中釜浩美2, 坂田洋1, 服部芳明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 955-955, 2020.

---

	P24-8. Analysis of doubt introduction contents in the cancer chemotherapy of our hospital 河野大希1, 牧陽介1, 橋本雅司1, 林淳一郎1, 横田千明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 956-956, 2020.

---

	P24-9. Inspection of the significance of prior doubt inquiry in the regimen inspection of the foreign chemotherapy 冨原莉穗子1, 新谷拓也1, 原伸輔1, 山本智也1, 門脇裕子1, 奥田真弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 956-956, 2020.

---

	P24-10. Efforts to the administration of oral pyrimidine system anticancer agent adequacy with the off-period fluoride 村上幸恵1, 桑原玄樹1, 奥井美加子1, 本間健道1, 竹野裕晶2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 957-957, 2020.

---

	P25-1. Efforts and problem for the multiple hospitals in the area in the cancer domain and the cooperation of the health insurance pharmacy 村田稔弥1,2, 淺野未代子1,3, 有井太郎1,4, 井出貴之1,5, 大輪武司1,6, 鬼窪利英1,7, 小野里直彦1,8, 中村久美1,7, 野村充俊1,7, 平林克博1,9, 松澤直樹1,10, 松原重征1,11, 三浦篤史1,12, 向山百合1,7, 吉澤貴代美1,13 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 958-958, 2020.

---

	P25-2. Job evaluation by the RevMate pharmacist outpatient department introduction 河村勇介1, 水上皓喜1, 伊藤実里1, 岡崎夏実1, 妹尾啓司1, 阪田安彦1, 開浩一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 959-959, 2020.

---

	P25-3. Efforts to the cooperation full addition acquisition of "the meeting thinking about the medicine medicine cooperation of the Chita Peninsula area" 小田浩史1, 伴晶子2, 土井直美2, 佐藤知香2, 古田麻衣子2, 森田奨2, 早川裕二3, 加藤雅斗3, 大平勇二4, 石川奈央佳4, 三島江津子5, 永松秀紹5, 奥田佳苗6, 堀崎和美7, 服部聡8, 上地小与里9 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 959-959, 2020.

---

	P25-4. Usefulness of PBPM by the cooperation of hospital pharmacist and the drugstore pharmacist for the hand-and-foot syndrome of the capecitabine: Multicenter retrospective study 白岩泰祈1, 中村暢彦1, 春名康裕2, 一島知樹2, 武田智子2, 長谷川晃司2, 矢野義孝1, 楠本正明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 960-960, 2020.

---

	P25-5. Evaluation of the effect that the cutaneous symptom of the capecitabine remedy patients in the health insurance pharmacy gives in quality of life 喜多日向子1, 中村暢彦1, 春名康裕2, 一島知樹2, 武田智子2, 長谷川晃司2, 矢野義孝1, 楠本正明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 960-960, 2020.

---

	P25-6. Intervention ... of the pharmacist with the medical institution that there is not efforts - gene therapy specialist job for examination for MSI in central part Rousaibyoin, the BRCA1/2 genetic screening 山口智江1, 鵜飼麻由1, 伊藤功治2, 後藤真澄3, 柴原真由子3, 宿輪和孝4, 坂口憲史5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 961-961, 2020.

---

	P25-7. Efforts to support patients receiving treatment with oral anticancer agent in an area 上林崇1, 工藤滉大1, 立花慧千2, 平島郁2, 伊藤宏彰2, 奥山裕子3, 佐々木雄太4, 大久保幸子5, 中村一成1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 961-961, 2020.

---

	P25-8. Example of the cooperation of hospitalization support room pharmacist and the chemotherapy center pharmacist 牛膓沙織1,2, 安田愛実1, 新井孝文1, 加藤幾1,2, 野村翔1,2, 丸山あずさ1, 早川正哉2, 池上信昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 962-962, 2020.

---

	P25-9. Telephone follow-up to patients with Abemaciclib remedy carried out at a health insurance pharmacy 新谷裕子1, 塚本弘美1, 熊谷史由2, 袰岩靖子2, 高松謙2, 麻生敦子3, 菅野和彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 962-962, 2020.

---

	P25-10. It is ... about efforts - joint conference enforcement with the health insurance pharmacy for the patients information communalization of the cancer medical therapy and the evaluation 青孝明1, 福浦啓史1, 近藤智彦1, 粟野萌1, 木村匡男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 963-963, 2020.

---

	P25-11. Efforts of making, the operation of the reporting tool for the cooperation full addition calculation 森由佳里1, 齋藤裕子1, 高橋庄太1, 倉田奈央子1, 山内雅仁1, 塩澤誠1, 岡田浩司1,2, 渡邊善照1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 963-963, 2020.

---

	P25-12. The case that led to side effect reduction by an interview before medical examination by the pharmacist 米倉正樹1, 丹羽直人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 964-964, 2020.

---

	P25-13. Example that became the treatment continuation in cooperation with a medical institution by the adverse event management for patients with progress recurrent hepatocellular carcinoma 尾形晶子1, 藤田尚宏1, 櫻井裕子1, 小泉浩司1, 大上満1, 松浦綾子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 964-964, 2020.

---

	P25-14. Cancer board in Osaka University School of Dentistry Hospital 浦川龍太1, 上田紘子1, 戸田史恵1, 山中佑合子1, 足立亜希子1, 上田幹子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 965-965, 2020.

---

	P25-15. Examination about the intervention example of the dermatopathy measures team for the anticancer agent of our hospital 山田卓摩1, 伴晶子1, 竹内亜由美2, 伊藤裕子2, 濱本ますみ2, 井上智子3, 野尻基4, 伊藤靖5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 965-965, 2020.

---

	P25-16. One case that collaborated with a division of cardiovascular disease physician for warfarin control during capecitabine remedy, and contributed to the evasion of the bleeding sign by the warfarin 須賀明輝1, 門谷靖裕1, 宮田祐一1, 中村雅敏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 966-966, 2020.

---

	P25-17. About efforts of the cooperation full addition in the foreign cancer chemotherapy in our hospital 益子里美1, 鎮目晶子1, 藤谷竜磨1, 真柴友紀1, 福山博務1, 塩地園代1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 966-966, 2020.

---

	P26-2. About the use situation of the Residual medicine in the anticancer agent preparation of our hospital 松田真一郎1, 岡林悠1, 田中慎1, 安田優子1, 宮崎大生1, 庄中高哉1, 松尾和馬1, 安原翔大1, 湧上大介1, 小瀬弘尚1, 馬瀬久宜1, 寺本晴美2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 968-968, 2020.

---

	P26-3. Anticancer agent pollution status of the IVR room in the hepatic artery chemistry embolus therapy enforcement institution using the epirubicin 前田章光1, 稲葉吉隆2, 保坂彰子3, 長谷川貴章2, 長谷川彩子1, 稲熊一英1, 梶田正樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 968-968, 2020.

---

	P26-4. The costs investigation every prescription accompanied with the closed system anesthesia connection appliance introduction and examination of the economic modi operandi 計良貴之1, 小笹英祐1, 湊川紘子1, 田中恒明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 969-969, 2020.

---

	P26-5. An investigation of the time required for an anticancer medicine preparation and examination 後藤総太郎1, 木下理恵1, 小林美佳1, 石原溶子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 969-969, 2020.

---

	P26-6. Conduct in-hospital exposure to anticancer medicine investigation (the third report) 長山晃1, 平野雄一1, 森下和美1, 川上典子1, 近藤昌子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 970-970, 2020.

---

	P26-7. Efforts of the pharmacy to an anticancer agent preparation in the liver arterial infusion chemotherapy 柘植雅大1, 安藤洋介2, 伊藤佳織1, 山田成樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 970-970, 2020.

---

	P26-8. The current situation investigation of the environmental pollution situation utilizing the anticancer medicine quantitative analysis system and evaluation of exposure measures 鈴木寿樹1, 小林美奈子1, 高崎新也1, 横田則子2, 菊地正史1, 前川正充1, 眞野成康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 971-971, 2020.

---

	P26-9. Development of the injection kit preparation in consideration of prevention of exposure, handiness 盛本修司1, 川崎浩延1, 野崎雅男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 971-971, 2020.

---

	P26-10. Exposure investigation in the anticancer agent preparation environment 中田絵梨1, 渡邉愛悠1, 田中壮周1, 丸山卓哉1, 槙田芳1, 後藤悠1, 小寺隆二1, 久保淳一1, 嘉屋則子1, 和泉秀明1, 田畑裕和1, 小原郁司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 972-972, 2020.

---

	P26-11. Examination of the cleaning agent at safety cabinet cleaning at use of closed system anesthesia drug transportation system 小笹英祐1, 計良貴之1, 湊川紘子1, 田中恒明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 972-972, 2020.

---

P26-12. Grasping the contamination status when dispensing 6-mercaptopurine hydrate 10% powder and comparing the residual amount generated by the cleaning method of the powder packing machine 比嘉朋子1, 具志堅優美絵1, 宇地原萌1, 奥野聖子1, 寺本奈都子1, 屋良愛1, 三上まどか1, 比嘉豊1, 古堅直也1, 久場良亮1, 石田浩1, 當真房子1, 又吉拓舟1, 比嘉浩一1, 佐藤雅美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 973-973, 2020.

---

	P26-13. Effect ... obtained from occupational exposure to anticancer medicine measures (the second report) ... anticancer medicine exposure findings 疋田絵梨1, 大崎真美1, 黒木あかね1, 賀川智子1, 林みどり2, 城田幹生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 973-973, 2020.

---

	P26-14. General efforts of anticancer agent exposure measures using an online self-assessment tool 高山俊輔1, 玉木秀子2, 高山裕樹1, 黒沢由歌理2, 吉井紀子2, 眞壁秀樹1, 前田智也3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 974-974, 2020.

---

	P26-15. Introduction and evaluation of the anticancer agent mixing remote inspection support system 戸田史恵1, 上田紘子1, 山中佑合子1, 足立亜希子1, 浦川龍太1, 大石美奈子2, 上田幹子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 974-974, 2020.

---

	P26-16. It is ... about CSTD introduction in the preparation, administration of all occupational exposure to anticancer medicine measures (the first report) ... anticancer medicine management 大崎真美1, 疋田絵梨1, 黒木あかね1, 賀川智子1, 林みどり2, 城田幹生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 975-975, 2020.

---

	P26-17. It is ... about use to preparation for examination - subcutaneous injection of the medical economics by the use of CSTD 奥主仁1, 樋口裕樹1, 有山智博2, 今井桂子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 975-975, 2020.

---

	P26-18. Effect to give the medical material cost of an administration appliance accompanied with the coverage expansion of the closed system anesthesia connection appliance and the personal protector 橋本浩季1, 山口恭平1, 宮崎実千芸1, 村上通康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 976-976, 2020.

---

	P26-19. Efforts to occupational exposure measures 奥村智子1, 岩崎要人1, 三宅佑美1, 大西一嘉2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 976-976, 2020.

---

	P27-1. Pharmacist support to raise the adherence of the oral anticancer agent 里見眞知子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 977-977, 2020.

---

	P27-2. Significance by the relation to cancer treatment of our hospital pharmacist outpatient department 中道秀徳1,2, 都甲海2, 山本圭祐2, 松川陽央2, 北畠千種2, 荒川大輔2, 清水真弓2, 澤昇平2, 飯塚美有2, 瀧口晶子2, 矢部勝茂2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 978-978, 2020.

---

	P27-3. Efforts to calculate "cancer patient guidance management fee c" at Narita Memorial Hospital 鈴木善貴1, 野田千笑2, 神谷厚3, 藤原裕之4, 小林将貴4, 栗本昌明4, 小出修司4, 佐藤寛子5, 定盛理純1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 978-978, 2020.

---

	P27-4. Efforts for the follow-up system construction of the oral anticancer medicine remedy patients 藤田強記1, 眞弓健介1, 鶴崎泰史1, 花田聖典1, 中川義浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 979-979, 2020.

---

	P27-5. Examine intervention and the illness to patients with foreign chemotherapy enforcement in our hospital; efforts to medicine cooperation reinforcement 西千春1, 佐藤みづき1, 井口有紀1, 遠山潤1, 櫻間啓基1, 中村初美1, 古閑悠輝2, 甲斐豊3, 近藤元三4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 979-979, 2020.

---

	P27-6. 2 cases that reached the pharmaceutical intervention by telephone medication support and medicine medicine cooperation in foreign cancer treatment utilizing the feedback report 堀龍太郎1, 武田照幸1, 山崎友里恵1, 田中寿和1, 長沼敬子1, 木下隆市1, 染谷光洋1, 長内泰憲1, 宮岡勝弘1, 谷口亮央1, 中島史雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 980-980, 2020.

---

	P27-7. Aiming to develop medical professionals involved in cancer treatment - Efforts of Ain Pharmacy Nishi-Shinjuku Nishi-Shinjuku Cancer Treatment Research Group - (Fifth Report) 畔柳裕一1, 亀谷奈広1, 友清えりか1, 島津真衣1, 石黒貴子2, 前田守3, 長谷川佳孝3, 月岡良太3, 森澤あずさ3, 大石美也3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 980-980, 2020.

---

	P27-8. Operation and evaluation of the use of internal use anticancer medicine report in the respiratory domain 北口梨紗1, 花房伸幸1, 河村茉衣1, 松本和也1, 田村安希1, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 981-981, 2020.

---

	P27-9. Usefulness evaluation of the side effect table for the purpose of the grade evaluation unification in the cancer medical therapy 宍戸桃子1, 辻本高志1, 井上靖隆1, 寺谷俊昭1, 山本明日香1, 加納宏樹1, 上田晃1, 川本由加里1, 後藤仁和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 981-981, 2020.

---

	P27-10. Effect of the pharmacist intervention on oral anticancer agent prescription patients 後藤美穂1, 荒川裕貴1, 桂川健司1, 大田亜希子2, 遠山幸男1, 久田達也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 982-982, 2020.

---

	P27-11. Usefulness evaluation of the pharmacist outpatient department for patients with Enzalutamide remedy prostate cancer 岩間弓奈1, 池末裕明1, 平畠正樹1, 三浦理恵子1, 入江慶1,2, 室井延之1, 川喜田睦司3, 橋田亨1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 982-982, 2020.

---

	P27-12. Efforts of our hospital for the high then tiger (TM) of patients with blood-forming organ tumor at-home introduction 森本隼多1, 鮎原秀明1, 藤本涼子1, 金子亜希子1, 赤羽大悟2, 竹内裕紀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 983-983, 2020.

---

	P27-13. About the current situation and usefulness of the prescription suggestion in the pharmacist outpatient department 村上賢次1, 橋本恵梨花1, 中川のどか1, 早坂大1, 宅和真由美1, 平田敦宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 983-983, 2020.

---

	P27-14. Investigation about the effect to give to immune checkpoint inhibitor alone and an immune-mediated adverse event by the killer cells-related anticancer drug combination on lung cancer in our hospital 勝啓子1, 近藤篤1, 中多陽子1, 尾上雅英1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 984-984, 2020.

---

	P27-15. The current situation and problem of the efforts of the intervention before medical examination of the pharmacist for foreign chemotherapy patients 永峰槙子1, 中垣繁1, 中條倫成1, 杉山理奈1, 鈴木貴也1, 常泉道子2, 多久佳成3, 木村緑1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 984-984, 2020.

---

	P27-16. Efforts of the pharmacist outpatient department for the use of oral anticancer agent patients in the municipal hospital 永井大地1, 小森由理子1, 岡崎周大1, 高橋一栄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 985-985, 2020.

---

	P27-17. Example that we utilized a tracing report for exclusive use of the Lenvatinib mesilate preparation and conducted a side effect report 藤田尚宏1, 尾形晶子1, 櫻井裕子1, 小泉浩司1, 大上満1, 松浦綾子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 985-985, 2020.

---

	P27-18. Pharmaceutical intervention for pediatric patients with cervical spinal cord tumor treated with entrectinib 浅葉有紀1, 柊元美優1, 小阪直史1, 四方敬介1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 986-986, 2020.

---

	P27-19. One case that grasp of the onset of low back pain just after the nilotinib remedy start contributed to early CML remission 藤田あゆみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 986-986, 2020.

---

	P27-20. Efforts to medicine medicine cooperation and the cooperation full addition acquisition utilized the pharmacist outpatient department 河原史明1, 木本真司1, 香内綾1, 安齊泰裕1, 原田伸彦1, 平山拓史1, 成田浩気1, 星美奈子1, 山田麻帆1, 木村俊介1, 塩川秀樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 987-987, 2020.

---

	P27-21. The effect that the suit of patients gives in discovery of irAE in the nivolumab monotherapy 木村周古1, 高橋典哉1, 及川淳1, 黒田祥嗣1, 及川嵩人1, 工藤琢身1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 987-987, 2020.

---

	P27-22. One case that we followed up after the medication for patients receiving foreign cancer chemotherapy (XELOX + BV therapy) 吉田達司1, 藤田あゆみ2, 末次加代子1, 矢部和昭1, 庄瀬篤志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 988-988, 2020.

---

	P27-23. It is efforts for the calculation by the cooperation full addition in our hospital 新行内健一1, 栗原りか1, 川村勇太1, 佐藤亜希穂1, 中沢亜弓1, 葛岡朋代1, 直井隆浩1, 松井雄太1, 根岸由貴1, 海老原卓志1, 飯合等1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 988-988, 2020.

---

	P28-1. Effect on retching by the abbreviation of the dexamethasone after the second day in the Dose-dense EC therapy 阿部多一1, 住谷達也1, 林哲哉1, 井口恵美子1, 清水大輔2, 猪股克彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 989-989, 2020.

---

	P28-2. Evaluation of the digestive organ symptom protective efficacy with aprepitant at paclitaxel + Carboplatin therapy enforcement in gynecologic cancer 渡辺祐子1, 齋藤佳敬1, 加藤信太郎1, 三田村卓2, 武隈洋1, 菅原満1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 990-990, 2020.

---

	P28-3. Effect of treatment of olanzapine as the relief therapeutic drug for retching with the hematopoietic stem cell transplantation pre-treatment 宮原強1, 武富光希1, 松永尚1, 草葉一友1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 990-990, 2020.

---

	P28-4. 2 cases that mirtazapine was effective for retching vomiting with the chemotherapy 原田沙枝子1, 林洋平1, 櫻井美由紀1, 川嵜英二1, 鹿間良弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 991-991, 2020.

---

	P28-5. Comparison of granisetron and palonosetron in retching, the vomiting prevention at the GEM + nab-PTX therapy 藤本友季1, 三好孝法1, 堀南奈子1, 松尾尚美1, 平木洋一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 991-991, 2020.

---

	P28-6. Effect of the NK1 receptor blocker in the side effect expression of the ICE therapy 當麻丹香1, 宮崎雅之1, 中井剛1, 渡邉美菜子1, 石井沙也加1, 千崎康司1, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 992-992, 2020.

---

	P28-7. We look at the rear about the risk factor of crizotinib-induced vomiting and prophylactic antiemesis therapy and examine a mark 熊谷康平1, 畑裕基1, 中野一也1, 山下大輔1, 別府博仁1, 本田芳久1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 992-992, 2020.

---

	P28-8. Examination of the usefulness of the side effect management using the liver residual function metrics ALBI score in the gemcitabine + albumin suspension type paclitaxel combination therapy 永松秀紹1, 三島江津子1, 植田明日美1, 榊原洋一1, 竹内由佳2, 村上照幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 993-993, 2020.

---

	P28-9. Comparison of the antiemesis effect before and after the antiemesis supportive care change on TC therapy in gynecologic cancer 内山知乃1, 八島秀明2, 大島宗平2, 高橋恵美利1, 高橋雄太1, 大林恭子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 993-993, 2020.

---

	P28-10. Use fact-finding of the peg filgrastim for patients who received FEC therapy in the Kitasato University Hospital 小原悠1, 田村和敬1, 佐々木寿子1, 厚田幸一郎1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 994-994, 2020.

---

	P28-11. Antiemesis effect at the dexamethasone mint condition in the antiemesis therapy at highly emetic chemotherapy enforcement for breast cancer 鈴木亘1, 川上和宜1, 青山剛1, 横川貴志1, 杉崎崇人1, 小林一男1, 柴田直樹1, 羽鳥正浩1, 鈴木賢一2, 伊藤良則3, 濱敏弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 994-994, 2020.

---

	P28-12. Of the side effect expression situation and the side effect management with the Olaparib administration in our hospital, actually 福泉智子1, 衛藤智章1, 三角紳博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 995-995, 2020.

---

	P28-13. Examination about the use actual situation of aprepitant in patients who received use of Carboplatin regimen and the effectiveness 先名健太1, 石塚仁保1, 櫻田啓介1, 船田茜1, 友寄旬1, 松本由香莉1, 山下友輝1, 村中一大1, 鈴木千波1, 小原秀治1, 柴波明男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 995-995, 2020.

---

	P28-14. Examination of the effect of treatment of aprepitant in the induction therapy for acute myeloid leukemia 武富光希1, 草葉一友1, 宮原強1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 996-996, 2020.

---

	P28-15. Example that a 5-HT3 receptor blocker was effective for vomiting with the IRd therapy 加藤良隆1, 丸浜暢子1, 大坪達弥1, 鹿浦香織1, 野口裕介1, 神田英一郎1, 岡橋孝侍1, 藤田敦夫1, 友金幹視1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 996-996, 2020.

---

	P29-1. Examination about the risk factor of the dermatopathy with before docetaxel for the breast cancer or the postoperative chemotherapy 志村裕介1, 菅幸生2, 嶋田努1, 原祐輔1, 辻千明1, 三坂恒1, 崔吉道1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 997-997, 2020.

---

	P29-2. Examination of optimal lipid doses in the nourishment management early after the allogeneic hematopoietic stem cell transplantation 筒井佑紀1, 渡部大介1, 中島寿久1, 橋本浩伸1, 牧野好倫1, 金成元2, 福田隆浩2, 山口正和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 998-998, 2020.

---

	P29-3. One case that a low Ca blood symptom was prolonged in the patients who had ileus after the denosumab administration 野尻雅人1, 清水雅子1, 宮崎徹1, 高瀬美咲枝2, 塚田健一郎3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 998-998, 2020.

---

	P29-4. Fact-finding about the immune-mediated adverse event of the ipilimumab nivolumab combination therapy in metastatic nephrocyte cancer 増田竜大1,2, 野口祥紀2, 三宅知宏2, 服部公紀2, 中西由衣2, 小川晃宏2, 内田早弓2, 高尾雄介1, 谷村学2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 999-999, 2020.

---

	P29-5. Examination of the protective efficacy of the Goshajinkigan for peripheral neuropathy by the docetaxel 菅野亮太1, 齋藤佳敬1, 谷口理1, 山下啓子2, 武隈洋1, 菅原満1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 999-999, 2020.

---

	P29-6. The gemcitabine liquid preparations increase vascular pain frequency as compared with lyophilized products: Clinical outcome and suggestion of vascular pain measures 河添仁1, 森奈月2, 井門静香2, 魚住龍史3, 恒岡菊江2, 竹内茜2, 松尾真由美2, 山内美砂子2, 薬師神芳洋4, 吉浦誠海1, 地引綾1, 横山雄太1, 鈴木小夜1, 中村智徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1000-1000, 2020.

---

	P29-7. The side effect expression of immune checkpoint inhibitor situation in the Gifu comprehensive medical care center 眞野翔太1, 宮崎公輔1, 伊藤健史1, 村田庄司1, 井上壽江1, 平下智之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1000-1000, 2020.

---

	P29-8. One case that we showed an immune-mediated adverse event after the Atezolizumab administration and changed a drug of to Pembrolizumab 岡田淳芳1, 中村豪志1, 神原康佑1, 石井一也1, 大塚識稔1, 玄馬顕一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1001-1001, 2020.

---

	P29-9. Construction of the Abemaciclib administration system utilizing the medication reporting book 柿原圭佑1, 三上忠司1, 原田智子1, 武田なつか1, 野田聖奈子1, 篠崎千尋1, 松本美紅1, 藤井裕史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1001-1001, 2020.

---

	P29-10. About the association between Tumor Proportion Score and immune-mediated adverse event in the Pembrolizumab administration 藤本愛理1, 高武嘉道1, 木村滋1, 川俣洋生1, 福石和久1, 高島伸也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1002-1002, 2020.

---

	P29-11. Risk factor search about the onset of neutropenia in patients who received cisplatin + vinorelbine combination therapy 村山三佳1, 丹羽洋介1, 竹内佐織1, 千崎康司1, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1002-1002, 2020.

---

	P29-12. An evaluation and measures of the vascular pain with the gemcitabine administration 菅野雄太1, 坂野昌志1, 山田洋治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1003-1003, 2020.

---

	P29-13. Examination about the association between neutrophil count and onset of febrile neutropenia before the administration in the EC or FEC therapy 深見安希1, 槙原克也1, 松村友和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1003-1003, 2020.

---

	P29-14. Examination of the neutropenic protective efficacy by peg filgrastim administration day in the breast cancer adjuvant chemotherapy 高原悠子1, 吉田弘樹1, 鈴木雅人1, 牧原明秀1, 三屋良太1, 木全司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1004-1004, 2020.

---

	P29-15. Examination about the safety of the oral VEGF course inhibitor in the low cardiac activity case 新谷拓也1,2, 横山晴香2, 渡邊梓1, 山本智也1, 門脇裕子1, 藤尾慈2, 奥田雅弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1004-1004, 2020.

---

	P29-16. Examination about Infusion reaction measures of Obinutuzumab in our hospital 坂本竜平1, 向井淳治1,2, 小竹優希1, 竹原涼子1, 濱崎淳哉1, 奥田広志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1005-1005, 2020.

---

	P29-17. One case that developed severe dermatopathy during chemotherapy including the Pembrolizumab 元茂拓法1, 森永大亮2, 高橋知宏1, 廣崎邦紀3, 須甲憲明2, 内山英二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1005-1005, 2020.

---

	P29-18. Associated analysis of a low NA blood symptom and retching that occurred after CDDP administration of patients with head and neck cancer 金澤絵莉1, 橋本雅司1, 田中藤信2, 木村滋3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1006-1006, 2020.

---

	P29-19. The onset situation and factor search of the neutropenia in patients who received DLd therapy 野村実由1, 古谷智裕1, 武井秀樹1, 金田公平1, 白木政博1, 北本真一1, 松本俊治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1006-1006, 2020.

---

	P29-20. The diabetes management at the cancer chemotherapy 中村敏史1, 高橋典男2, 牛膓沙織1,3, 早川正哉3, 吉田昌則2, 池上信昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1007-1007, 2020.

---

	P29-21. One case of autoimmune encephalitis with the Atezolizumab discovered by monitoring of the treatment support application alone 桂英之1, 米田太郎2, 木場隼人2, 坂野ひとみ1, 高田直子1, 石田外樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1007-1007, 2020.

---

	P29-22. Comparison of the dermatopathy frequency of Minomycin and the concomitant drug in patients receiving antiEGFR antibody medicine 馬島務1, 小田剛史1, 山下剛史郎1, 廣瀬孝一1, 鶴田和樹1, 金田典子1, 北村瑞穂1, 稲村勝志1, 浅井茂夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1008-1008, 2020.

---

	P29-23. Use experience of five patients who injected bortezomib in the mantle cell lymphoma hypodermically 伊勢崎竜也1, 湯山聡1, 成田健太郎3, 舟越亮寛1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1008-1008, 2020.

---

	P29-24. Fact-finding at use of mycophenolate mofetil for steroid refractoriness, the intractable allied adverse event of immunity 三浦華歩1,2, 望月伸夫1, 川崎敏克1, 花田和彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1009-1009, 2020.

---

	P29-25. Consideration ... of the effect with the association of fact-finding - taste disturbance and serum zinc levels of the taste disturbance at breast cancer AC therapy enforcement and the zinc replacement therapy 坂井由紀1, 山内可南子1, 星野直人1, 永橋昌幸2, 西條康夫3, 外山聡1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1009-1009, 2020.

---

	P29-26. Examination of the risk factor of the side effect of Lenvatinib administration expression 石田友規1,2, 宮崎雅之2, 福澤翔太2, 松永安未2, 千崎康司2, 永井拓2, 山田清文2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1010-1010, 2020.

---

	P29-27. Example that became the treatment continuation by adverse event management by the pharmaceutical medicine cooperation to progress recurrent breast cancer S1 monotherapy patients 松浦綾子1, 尾形晶子1, 藤田尚宏1, 櫻井裕子1, 小泉浩司1, 大上満1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1010-1010, 2020.

---

	P29-28. It is a 1 case who had autoimmune pancreatitis and the colitis by a therapy with Nivolumab and Ipilimumab 木村竜司1, 一瀬貴史1, 馬屋原慈理1, 山崎美保1, 西園寺真二1, 下川福子1, 面田恵1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1011-1011, 2020.

---

	P29-29. About the onset of immune-mediated adverse events, and the like in the nivolumab administration 山田剛1, 筒井洋子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1011-1011, 2020.

---

	P29-30. Efforts of the interview before medical examination for patients with foreign cancer chemotherapy enforcement 村上由樹1, 上羽沙綾1, 谷千鶴佳1, 西山翼1, 大西真由1, 四方純子1, 奥村智晴1, 佐賀嘉英1, 谷田有花1, 芦田理沙1, 足立圭司1, 川見里奈1, 足垣亮介1, 宮谷正哉1, 山本真世1, 立道直美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1012-1012, 2020.

---

P29-31. Investigation about relations of the expression situation and the moisturizer consumption of the hand-and-foot syndrome in the capecitabine treated patients using the cutaneous symptom assessment sheet 久保萌美1, 島津智行1, 村上冴美1, 門脇督1, 土井佳子1, 田中悠季1, 三本松泰孝1, 佐藤弘康1, 和泉秀明1, 田村広志1, 渡辺浩明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1012-1012, 2020.

---

	P29-32. Nephropathic risk factor analysis with the cisplatin combination radiotherapy 小出博義1, 野田哲史1, 奥貫裕美1, 中多祐介2, 大脇成広2, 清水猛史2, 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1013-1013, 2020.

---

	P29-33. About an investigation and measures of the onset of oxaliplatin hypersensitivity situation in the chemotherapy 和田康弘1, 伴晶子1, 岡戸洋1, 森田奨1, 山田卓麿1, 竹内亜由美2, 小林和子2, 野尻基3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1013-1013, 2020.

---

	P29-34. Analysis of the risk factor to be involved in protein urine expression by the ramucirumab 廣上典和1, 松野由華1, 舟瀬和美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1014-1014, 2020.

---

	P29-35. Making and inspection of the new metrics for the oxaliplatin origin-related feeling cold hypersensitivity symptom 橋本竜1,2,3, 佐藤淳也1,2,3, 石黒洋4, 杉山奈津子1,3, 伊東岳2,3, 加藤芳徳3, 倉本啓二2,3, 前澤佳代子1,2,3, 百瀬泰行1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1014-1014, 2020.

---

	P29-36. Examination about the use actual situation of the naldemedine tosyl acid salt for the opioid-induced constipation and the effectiveness, the safety 飯田美紅1, 大久保凜花1, 大下瑚姫1, 若松遼介1, 中野裕介1, 小笠原綾香1, 岩本朱史鈴1, 須藤大雄1, 寺原史貴1, 樋浦一哉1, 鈴木千波1, 小原秀治1, 柴波明男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1015-1015, 2020.

---

	P29-37. Questionary survey about the onset of nail disorder with the trastuzumab administration 山本龍世1, 草野淳一1, 吉田理1, 赤木秀子2, 嶋田昌彦3, 林誠一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1015-1015, 2020.

---

	P29-38. Through inspection before denosumab administration in efforts - pharmacy to use of aptitude in the denosumab administration - 北本真一1, 古谷智裕1, 白木政博1, 野村実由1, 金田公平1, 松本俊治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1016-1016, 2020.

---

	P29-39. The effect that a vascular endothelium growth factor receptor inhibitor gives to a left ventricular dilatation function 横山晴香1, 新谷拓也2,3, 前田真一郎2,3, 廣部祥子2,3,4, 前田真貴子2,4, 藤尾慈2,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1016-1016, 2020.

---

	P29-40. Examination of the workaround of the interaction of Fosaprepitant and the epirubicin 山崎美保1, 一瀬貴史1, 胡雅貴1, 前田頼伸2, 小田啓祐3, 森信博3, 村上照夫3, 面田恵1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1017-1017, 2020.

---

	P29-41. Examination of the effect that calcium-channel blocker gives in the ramucirumab + paclitaxel therapy 木本大樹1, 槙原克也1, 松村友和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1017-1017, 2020.

---

	P29-43. The HBV-DNA monitoring enforcement situation investigation after the hematopoietic stem cell transplantation in the HBV history infected person 浅野岳人1, 松村若菜1, 築山奈央1, 志賀有雅1, 野田実希1, 杉浦礼菜1, 杉山惠亮1, 米山英二1, 杉浦洋二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1018-1018, 2020.

---

	P29-44. Investigation about the effect on renal function by the hydration change in the chemotherapy, radiotherapy simultaneous combination therapy for patients with head and neck cancer 熊崎満菜1, 岩西雄大2, 中野寛之1, 高木麻里1, 吉田智恵1, 藤田敬子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1019-1019, 2020.

---

	P29-45. Investigation about proteinuria of the bevacizumab 工藤直嗣1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1019-1019, 2020.

---

	P29-46. Importance of the blood pressure management in the Carfilzomib administration continuation 網野一真1,2, 江口彩香1, 前澤優圭1, 柏原佑香1, 水谷妙子1, 横山征史1, 粟野原幸恵1, 濱至寛1, 登内盛治1, 内山倫宏2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1020-1020, 2020.

---

	P29-47. About correlation of fact-finding of the vocal disorder with the neovascularisation inhibitor administration and VEGF receptor inhibitory action and the frequency 輿石徹1, 西岡菜々子1, 吉元公一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1020-1020, 2020.

---

	P29-48. Examination of the effectiveness of mirogabalin for chemotherapy-induced peripheral neuropathy 吉田真人1, 青木利恵2, 菅谷量俊1, 牧野浩司3, 高瀬久光1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1021-1021, 2020.

---

	P29-49. Use fact-finding of a low Mg blood symptom and the Mg preparation with the antiEGFR antibody medicine in the foreign chemotherapy center 内藤舞1, 本多伸二1, 佐分利美帆子1, 三松史野1, 目黒裕史1, 實光由香1, 大野恵一1, 寸田靖1, 村岡淳二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1021-1021, 2020.

---

	P29-50. Examination about the risk factor of the onset of proteinuria with the bevacizumab administration in patients with gynecologic tumor 村上正樹1, 北郷真史1, 石原慎之1, 玉木宏樹1, 矢野貴久1, 直良浩司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1022-1022, 2020.

---

	P29-51. 1 case of the prostate cancer which developed SIADH after hippopotamus diTaki cell administration 戸塚弘幸1, 長井宏文1, 高橋喜統1, 中澤佑介2, 近沢逸平2, 政氏藤玄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1022-1022, 2020.

---

	P29-52. Examination of the adverse event of the Durvalmab therapy for NSCLC 小竹優希1, 向井淳治1, 坂本竜平1, 竹原涼子1, 濱崎淳哉1, 奥田広志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1023-1023, 2020.

---

	P29-53. Comparison of the blood toxicity expression situation of RAM+PTX therapy and the RAM+nab-PTX therapy in the progress recurrent gastric cancer 大澤美紗1, 中條倫成1, 多久佳成2, 木村緑1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1023-1023, 2020.

---

	P29-54. Examination of the effect with frequency and the concomitant drug of the hypomagnesemia with the antiEGFR medicine in our hospital 川島悠吾1, 村嶋彩加1, 宗本尚子1, 鳥居奈央1, 鶴島真子1, 瓦比呂子1, 徳山洋子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1024-1024, 2020.

---

	P29-55. Comparison of the single institution backsight of the number of follow before and after the observance confirmation intervention of irAE measures by the pharmacist 前田和輝1, 藤田真穂1, 新川実季1, 永井浩章1, 見上千昭1, 本間久美子1, 西尾孝1, 片岡裕貴2, 國東ゆかり1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1024-1024, 2020.

---

	P29-56. Examination about the association between taste disturbance and zinc concentration in pancreatic cancer chemotherapy patients 加藤寛子1, 藤井宏典1, 大畑紘一1, 左高史織2, 上村真也2, 岩下拓司2, 清水雅仁2, 鈴木昭夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1025-1025, 2020.

---

	P29-57. Effect on renal function accompanied with the hydration change in the cancer of the esophagus FP therapy 西馬怜1, 山本幸子2, 中野寛之1, 高木麻里1, 吉田智江1, 藤田敬子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1025-1025, 2020.

---

	P29-58. One patient who experienced vocal disorder after the Lenvatinib administration for a hepatocellular carcinoma 西岡菜々子1, 輿石徹1, 吉元公一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1026-1026, 2020.

---

	P29-59. It is examined the usefulness of the peg filgrastim primary prophylaxis administration in the AP therapy after the endometrial cancer technique 古川卓也1, 久保田豊1, 深沢健一1, 勝山善彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1026-1026, 2020.

---

	P29-60. Examination of the risk factor of Infusion reaction in the trastuzumab initial administration 有原大貴1, 間瀬広樹2, 宗本将義3, 秋山哲平1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1027-1027, 2020.

---

	P29-61. Immune-mediated adverse event investigation with the immune checkpoint inhibitor at the medical corporation Meiwa hospital 照瀬美紗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1027-1027, 2020.

---

	P29-62. Examination of the gemcitabine initial dosage in the adjuvant chemotherapy before total cystectomy 小栗良介1, 大野裕之1, 関谷泰明1, 井上壽江1, 平下智之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1028-1028, 2020.

---

	P29-63. 1 case that developed salts loss nephropathy by the Carboplatin 生出亘1, 井上靖隆1, 辻本高志1, 奥田衣理1, 宍戸桃子1, 加納宏樹1, 上田晃1, 川本由加里1, 後藤仁和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1028-1028, 2020.

---

	P29-64. Examination about the expression situation of the diarrhea by the bortezomib and the measures 武井秀樹1, 古谷智裕1, 金田公平1, 野村実由1, 白木政博1, 北本真一1, 松本俊治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1029-1029, 2020.

---

	P29-65. Search of the risk factor of the liver damage by the regorafenib 田口尋子1, 新谷拓也1, 原伸輔1, 山本智也1, 門脇裕子1, 坂井大介2, 佐藤太郎2, 奥田真弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1029-1029, 2020.

---

	P29-66. The use situation and side effect expression investigation of the Abemaciclib in the Okayama Red Cross hospital 新城唯1, 笠原なつみ1, 奈良葵1, 甲元大樹1, 森川希実2, 原享子2, 吉富誠二2, 辻尚志2, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1030-1030, 2020.

---

	P29-67. Examination of the risk factor of the onset of proteinuria with the ramucirumab administration for the progress recurrent gastric cancer 渡部秀一1, 平出誠1, 青山剛1, 川上和宣1, 若槻尊2, 山口研成2, 濱敏弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1030-1030, 2020.

---

	P29-68. Investigation about the nutritional status before a neutropenia with the FP therapy in patients with cancer of the esophagus, the FN onset and the chemotherapy start 村松直幸1,2, 熊澤里美1,2, 古関竹直2, 山田成樹1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1031-1031, 2020.

---

	P29-69. Examination about the effectiveness of the second prophylaxis of the peg filgrastim in patients with non-Hodgkin's lymphoma given R-CHOP and R-THP-COP 小中健1, 斉藤辰彦1,2, 宮森弘子1,2, 森剛志1, 森本美由樹2, 橋本年弘3, 伏谷秀治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1031-1031, 2020.

---

	P29-70. Example that the telephone follow of the insurance pharmacist was effective for early detection of decreased visual acuity through S-1 田中越1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1032-1032, 2020.

---

	P29-71. The expression situation and severity evaluation of the adverse event by the ramucirumab in the hepatocellular carcinoma 熊澤里美1,3, 村松直幸1,3, 加藤滉基1,3, 安田顕2, 棚橋義直2, 古関竹直3, 山田茂樹1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1032-1032, 2020.

---

	P29-72. Nutritional status in the EPOCH (-R) therapy and association of the side effect expression 菊池健1,2, 小谷瑠星2, 武田元樹1, 渡邉大毅1, 鶴山辰1, 佐藤秀紀2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1033-1033, 2020.

---

	P29-73. Efforts of the infection prophylaxis internal use in the hospitalization chemotherapy for blood-forming organ tumor 北野勝義1, 岸本大裕1, 田中嘉一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1033-1033, 2020.

---

	P29-74. Search of the infusion reaction expression situation at the pertuzumab combination cancer chemotherapy administration and the factor 田渕祐輔1, 峯垣哲也3, 清水大生1, 柴田かおり1, 中嶋佑樹1, 小阪直史1, 菅谷和子2, 石川剛2, 辻本雅之3, 西口工司3, 田口哲也2, 四方敬介1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1034-1034, 2020.

---

	P29-75. Risk factor analysis about the digestive organ toxicity expression of duloxetine in nab-PTX-induced peripheral neuropathy of patients with unresectable pancreatic cancer 森下滉己1, 鈴木秀隆1, 川崎敏克1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1034-1034, 2020.

---

	P29-76. Preventive measures against hepatitis B reactivation - HBs with the chemotherapy or efforts ... of the pharmacist for the HBV-DNA fixed-quantity examination of the HBc antibody positive case 光家勉1, 中村緑1, 上田豊実1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1035-1035, 2020.

---

	P29-77. The current situation investigation of the immune-mediated adverse event with the immune checkpoint inhibitor (the second report) 樋口浩輔1, 斉藤佑輔1, 福田愛弓1, 木村謙吾1, 加藤浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1035-1035, 2020.

---

	P29-78. The use situation and safety of the Palbociclib for patients with old breast cancer in our hospital 鈴木拓也1, 遠藤未央1, 畠山智明1, 中田昌樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1036-1036, 2020.

---

	P29-79. 1 case of the use of immune checkpoint inhibitor which dissipated by carbocisteine internal use cancellation immediately-related erythema multiforme type drug eruption 成田綾香1, 中積広貴2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1036-1036, 2020.

---

	P29-80. Fact-finding of the onset of myelosuppression situation in the castration-resistant prostate cancer docetaxel therapy 赤羽根純1, 魚住真哉1, 門田佳子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1037-1037, 2020.

---

	P29-81. Inspection of the risk factor for the side effect expression situation and the chronic administration with the ramucirumab administration 渡部智文1,2, 五十嵐信智2, 吉川慧1, 山中光1, 今理沙子2, 酒井寛泰2, 亀井淳三2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1037-1037, 2020.

---

	P29-82. Severity investigation of the dermatopathy in the use of panitumumab patients and search of the risk factor 石田貴啓1, 寺尾勇紀1, 内田将吾1, 高橋弘泰1, 大谷寧次郎1, 三浦毅1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1038-1038, 2020.

---

	P29-83. A nephropathic evaluation by the cisplatin in patients with lung cancer and search of the risk factor 坪井久美1, 塩入理子1, 井上嘉余子1, 平井さやか1, 松本嵩史1, 亀田谷和将1, 羽鳥椋吾1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1038-1038, 2020.

---

	P29-84. Cockcroft-Gault-style estimated Ccr revision in the Carboplatin doses setting for gynecologic TC therapy patients and investigation about the side effect 橋本優里1, 北本真一1, 廣中佑香1, 松本俊治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1039-1039, 2020.

---

	P29-85. Dabrafenib, fever by the Trametinib, the CK rise may be caused at high frequency than an existing report 坂口智己1, 山下恭範1, 小野尚志1, 小林直貴1, 谷香苗1, 小竹斗志之1, 松浦泰寛1, 田崎嘉一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1039-1039, 2020.

---

	P29-86. One case that became controllable by oneself by changing an agent type of the antidiarrheal drug for the diarrhea symptom of the Abemaciclib to a tablet 矢部和昭1, 藤田あゆみ2, 杉浦伸哉2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1040-1040, 2020.

---

	P29-87. Consideration - about the control of Blinatumomab administration example - side effect symptom in our hospital 石嶋麗1, 有原大貴1, 杉村勇人1, 間瀬広樹2, 三村優仁3, 秋山哲平1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1040-1040, 2020.

---

	P29-88. Usefulness of the peg filgrastim in the non-Hodgkin's lymphoma chemotherapy 嘉村基樹1, 福島ゆかり1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1041-1041, 2020.

---

	P29-89. The use situation of the mirogabalin for peripheral neuropathy with the anticancer agent 河原陽介1, 水野奈穂子1, 加藤良治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1041-1041, 2020.

---

	P29-90. Example that desensitization introduction made possible readministration for eruption, fever with lenalidomide 多田純平1, 中薗健一1, 松崎貴志1, 田中恒明1, 井上靖之2, 佐野文明2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1042-1042, 2020.

---

	P29-91. The use situation investigation of the Palbociclib in the Shizuoka Prefectural general hospital and examination of the factor about neutropenia 佐久間大樹1, 中垣繁2, 嘉屋道裕2, 木村緑2, 常泉道子3, 小林義文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1042-1042, 2020.

---

	P29-92. Intervention at the health insurance pharmacy for foreign cancer-treated patients, analysis and evaluation examination of tracing report contents 下村直樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1043-1043, 2020.

---

	P29-93. Comparison of the side effect expression situation for the non-small cell lung cancer of the Osimertinib after primary treatment and the second treatment 小橋来海1, 梅原健吾2, 若本あずさ2, 初山多恵2, 佐藤秀紀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1043-1043, 2020.

---

	P29-94. Examination of the risk factor of the febrile neutropenia in CHOP therapy, the THP-COP therapy 敦賀剛気1, 輪湖哲也1, 田中弘人1, 井ノ口岳洋1, 久保村優1, 久保田馨1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1044-1044, 2020.

---

	P29-95. About usefulness of the supportive care for the hand-and-foot syndrome by the capecitabine 八木聡美1, 片岡智美1, 加藤善章1, 藤野泰孝1, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1044-1044, 2020.

---

	P29-96. Approach of the medical department dentistry cooperation in our hospital 宮川貴行1, 梶井孝洋1, 水口敦子1, 形部文寛1, 大倉裕祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1045-1045, 2020.

---

	P29-97. Risk factor search of the serious neutropenia due to CPT-11 鈴木直哉1, 菊地義明1, 藤林遼1, 山田将悟1, 朝倉幹己1, 藤田果那1, 山本翔太1, 庄崎沙耶1, 田中耕太1, 前川英輝1, 高橋誠1, 青田忠博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1045-1045, 2020.

---

	P29-98. Efforts to improvement in bone density measurement in patients during aromatase inhibitor remedy 渡辺富美子1, 下村直樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1046-1046, 2020.

---

	P29-99. Examination of the cisplatin inducible nephropathic protective efficacy with the administration before Mg 8mEq 岩村高弘1, 大野晃和1, 尾高登美枝1, 神原史織1, 水馬佑輔1, 森光保武1, 藤井秀一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1046-1046, 2020.

---

	P30-1. One case of the ureter cancer metastases to lung that fentanyl patch was effective for a feeling of dyspnea 中村俊貴1, 田辺就子1, 小林由布子1, 斎藤太寿1, 柴田壮一1, 松原肇1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1047-1047, 2020.

---

	P30-2. Examination of the usefulness of various pre-back prediction tools in patients with end-stage cancer 下清水義博1, 小山菜々子1, 松村千佳子1, 佐古守人2, 黒沢秀夫2, 野村剛久2, 江口由紀3, 矢野義孝1, 大場一輝4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1048-1048, 2020.

---

	P30-3. The point of evaluation, item template operation after the drug application and the effect on cancerous pain 伊東美歩1, 海老原貴之1, 岡本和也1, 川本拓馬1, 高柳雅恵1, 竹内英樹1, 小沼由香2, 田中紀子2, 平原一也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1048-1048, 2020.

---

	P30-4. Examination of the timing of the route of administration change of the use of opioid patients and the reason 今中智子1, 鈴木佳寿子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1049-1049, 2020.

---

	P30-5. To support the life like polypharmacy measures ... person in our hospital palliative care unit; ... 宮武望1, 長谷川喜一1,2, 岡田芙美子1,3, 岩谷理佳子1,3, 佃博1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1049-1049, 2020.

---

	P30-6. Fact-finding of the situation and the adverse event of the supportive care at oxycodone extended-release introduction to opioid naive patients 萩原諒一1, 小林礼子2, 中山弘道3, 花香淳一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1050-1050, 2020.

---

	P30-7. A relative evaluation of the painful symptom and blood test value in patients with end-stage cancer and examination about the usefulness as the pre-rear predictor 小山菜々子1, 松村千佳子1, 佐古守人2, 黒沢秀夫2, 野村剛久2, 江口由紀3, 矢野義孝1, 大場一輝4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1050-1050, 2020.

---

	P30-8. Examination about the usefulness of the mirogabalin for chemotherapy-induced peripheral neuropathy 淺野肇1, 山脇誉央1, 藤本伸一郎1, 平本志於里1,2, 川口明範1, 藤原季美子1, 月岡康行1, 竹上学1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1051-1051, 2020.

---

	P30-9. One patient who was treated effectively with the epidural pain relief that we combined with opioid for the pain of lower extremities due to metastases to bone 今関尊司1, 工藤三果1, 古川博則1, 長嶋真美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1051-1051, 2020.

---

	P30-10. Investigation of the usefulness of the octreotide 600μg/day administration for the gastrointestinal obstruction in patients with end-stage cancer 矢部雅子1,2, 久間田佳彦1,2, 野澤大輔1,2, 長島智子1, 藤井宏一2,3, 邉見光利1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1052-1052, 2020.

---

	P30-11. Introduction and effect of the opioid switching assistance system 松木有莉1, 宮村有貴1, 浅見祥崇1, 荒川桃子1, 坂本和央1, 寺原史貴2, 須藤美穂子1, 桂川みき1, 鈴木千波1, 小原秀治1, 柴波明男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1052-1052, 2020.

---

	P30-12. Analysis of the delirium expression by the oral opioid of patients with cancer using the adverse drug reaction database 石橋廉司1, 杉本智哉1, 高岡龍蔵1, 山室栄一1, 遠山幸男1, 久田達也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1053-1053, 2020.

---

	P30-13. A retrospective study on drug reduction in a palliative care ward - 2nd report - 井口舞香1, 仁木一順1,2, 岡本禎晃2, 田中育子2, 橋本百世2, 大前隆仁3, 松田良信3, 上田幹子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1053-1053, 2020.

---

	P30-14. The pharmaceutical intervention of the pharmacist for the palliative care team intervention patients and evaluation (the second report) of the medical economics 安永大輝1, 飛鷹範明1, 田中守1, 田中亮裕1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1054-1054, 2020.

---

	P30-15. Of the initial dosage of a fentanyl sublingual tablet, buccal tablet and methadone appropriateness-related: National fact-finding using DPC data 染野里奈1, 田辺公一1, 佐藤一樹2, 宮下光令3, 石川ベンジャミン光一4, 森田達也5, 伏見清秀6, 内富庸介7, 酒井隆全1, 大津史子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1054-1054, 2020.

---

	P30-16. Investigation about the prescription participation of the pharmacist in the palliative care team 山関智恵1,2, 岩本貴子2, 青木佐知子2, 三浦毅1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1055-1055, 2020.

---

	P30-17. Effect on predictive precision by the cancer species of the pre-back prediction using Palliative Prognostic Index for the palliative care team intervention patients 岩津慎次郎1,2, 深津昌弘1,2, 高島直樹1, 寺本真弓1, 熊澤尚美2, 水元弥生2, 山田哲也1, 澤田憲朗3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1055-1055, 2020.

---

	P30-18. 2 cases that suffered from switching of the hydromorphone preparation 宮原兼二1,2, 竹内美緒1,2, 荒川正悟1, 丹村亜梨朱1, 古山しのぶ2,3, 森山裕紀子2,4, 坂口憲史2,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1056-1056, 2020.

---

	P30-19. Examination about the prescription suggestion of the pharmacist in the mild medical care of the regular hospital 清川明慶1, 矢田康司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1056-1056, 2020.

---

	P30-20. The use fact-finding of the hydromorphone note in the palliation of our hospital and evaluation of the usefulness for the dyspnea symptom 沖田彩1, 土屋裕伴1, 諸橋賢人1, 大登剛1, 新井亘1, 増田裕一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1057-1057, 2020.

---

	P30-21. Pain relief effect for peripheral neuropathy of the cancer chemotherapy with the 1.5% ketamine aqueous cream 久保靖憲1, 山本譲1, 山本香緒里1, 大滝康一1,2, 山下恭範1, 小野尚志1, 田崎嘉一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1057-1057, 2020.

---

	P30-22. Consideration about the use situation investigation of the naldemedine and the prophylactic use 元木孝1, 渡邊清人1, 高柳昌宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1058-1058, 2020.

---

	P30-23. Examination of the usefulness of the side effect of pharmacist monitoring for the methadone initial introduction patients 土田隼之祐1, 川名真理子1, 舟越亮寛1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1058-1058, 2020.

---

	P30-24. Use situation of the hydromorphone hydrochloride note and side effect investigation 御澤勝将1, 渡部多真紀1,2, 榎本弘美1, 安野伸浩1,2, 有賀悦子3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1059-1059, 2020.

---

	P30-25. Examination of the protective efficacy of the antiemetic drug for retching, vomiting by the oxycodone hydrochloride hydrate extended-release 奈良悠汰1, 福原東美1, 渕上俊介1, 車塚千穂1, 今井隆人1, 小林龍1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1059-1059, 2020.

---

	P30-26. Use of fen toss tape fact-finding 岡田悠加1, 小林真弓1, 仲野笑美1, 大前隆広1, 佐倉小百合1, 上田里恵1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1060-1060, 2020.

---

	P30-27. Factor analysis for the tramadol analgesic effect insufficiency in patients with cancer 島本一志1,2, 戸村和希1,2, 藤宮龍祥1,2, 松井美月1,2, 渡邊徹1,2, 中山博文3, 市川度3, 佐々木忠徳2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1060-1060, 2020.

---

	P30-28. Effect on use situation of the hydromorphone preparation and dyspnea symptom 奥野亜弓1, 山東真寿美1, 口分田章典1, 岩崎瑛子1, 桂明里1, 戸島心1, 竹田健志1, 井上聡子1, 坂上嘉浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1061-1061, 2020.

---

	P30-29. Survey of usage of hydromorphone hydrochloride extended-release tablets and immediate-release tablets 臼井哲宏1, 土井田愛1, 田中佳子1, 関谷泰明1, 井上壽江1, 平下智之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1061-1061, 2020.

---

	P30-30. Literature documentation about the use report of the hospital preparation Mohs paste for the purpose of the control of the skin disintegration wound due to the malignant tumor 田口真穂1, 佐藤淳也2, 紅谷梨央1, 清原祥夫3, 山田博章1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1062-1062, 2020.

---

	P30-31. The effectiveness, safe examination of the naldemedine 野田拓誠1, 村津圭治1, 田中亮1, 山下大輔1, 別府博仁1, 本田芳久1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1062-1062, 2020.

---

	P30-32. Example that joint instruction made possible the smooth at-home shift of patients with end-stage cancer at a discharge of the multi-type of job cooperation 相宮幸典1, 吉岡聖子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1063-1063, 2020.

---

	P30-33. Efforts of the instruction contents standardization in the telephone follow-up of the cancerous pain control 川崎祐介1, 渡辺富美子1, 新谷菜々子1, 関根聖子1, 鈴尾美紗1, 遠藤珠実1, 小溝雪江1, 金子実樹1, 高野幸泉1, 栗原千晶1, 下村直樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1063-1063, 2020.

---

	P30-34. About the medication situation in our center palliative care unit 木村佳世1, 木村朋未1, 西山恵理2, 松村早希子1, 多喜和夫1, 筒井一成3, 阪口勝彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1064-1064, 2020.

---

	P30-35. Study on change to the Nrf2 expression in the peripheral-blood mononuclear cells which aromatherapy gives it to for a short term 高木千明1, 堀真紀子1, 岡元ちよみ1, 畔蒜祐一郎1, 平田尚人1, 下枝貞彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1064-1064, 2020.

---

	P30-36. Use investigation of fentanyl patch 0.5 mg 高橋智恵子1,2, 後藤愛実1,2, 南愛衣1, 浅石健2, 長えき美奈子2, 今井麻里子2, 西原雅美1, 内山和久1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1065-1065, 2020.

---

	P31-1. - close about the nourishment support to the foreign chemotherapy patients in the drugstore as a result of nourishment evaluation by - MUST 熊谷岳文1,2, 山根孝太3, 小畑志保3, 森大輔3, 柴田愛美3, 吉田知香3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1066-1066, 2020.

---

	P31-2. Evaluation of frequencies and the disease severity of peripheral neuropathy in FOLFIRINOX therapy and the GEM+nab-PTX therapy 長田大河1, 松井頌明1, 牧野華子1, 石原慎之1, 玉木宏樹1, 矢野貴久1, 直良浩司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1067-1067, 2020.

---

	P31-3. Two cases of nephrocyte cancer which developed a serious liver damage after the change to a tyrosine kinase inhibitor from an immune checkpoint inhibitor 北出紘規1, 宮永和美1, 高波太1, 西野正義1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1067-1067, 2020.

---

	P31-4. Use experience of the human mesenchyma system stem cell (hMSC: TEMCELL (R) HS note) for acute GVHD after the childhood hematopoietic stem cell transplantation 小森桂子1, 寺岡知香2, 飯野香菜子1, 浅原章裕1, 辻有梨3, 岩本悠花1, 倉本侑香1, 運天奈緒美1, 澤井勇希1, 大垣智子1, 伊地知政美1, 岸田美和1, 大津由美子1, 望月千枝1, 安井昌博4, 井上雅美4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1068-1068, 2020.

---

	P31-5. The current situation of the foreign cancer chemotherapy to see in the meeting a demand situation of the oral anticancer agent in the health insurance pharmacy 田中美幸1, 杉山純子2, 齋藤翔太3, 佐藤展宏4, 前田守5, 長谷川佳孝5, 月岡良太5, 森澤あずさ5, 大石美也5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1068-1068, 2020.

---

P31-6. Grasp and efforts of the patients needs about patients with cancer for the drugstore function enhancement that considered specialized medical institution cooperation drugstore authorization 澤井一1, 赤嶺美奈1,2, 赤嶺有希子2, 加納美知子1,2, 佐久間美里1,2, 高木正信1,2, 田中祥子1,2, 松尾律子1,2, 山本美智子1,2, 吉原澄吉3, 谷田弘3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1069-1069, 2020.

---

	P31-7. Fact-finding (2) of the pharmaceutical intervention in the foreign cancer chemotherapy of the pharmacist 藤井友和1, 澤柳直樹1, 西川隆一1, 荒木寛也1, 坂柳悦章1, 辻博幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1069-1069, 2020.

---

	P31-8. Fact-finding of the administration schedule of the regorafenib in our hospital 吉池麻衣1, 杉山昌秀1, 篠原佳祐1, 関口展貴1, 宮田智陽1, 原あや乃1, 渡邉将隆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1070-1070, 2020.

---

	P31-9. Recognition of the pharmacist specialized in a cancer judging from ethical pharmacy user questionnaire 斎藤大祐1, 石橋正祥2,3, 関悠斗3, 石井正和3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1070-1070, 2020.

---

P31-10. The effect that adaptation addition gives for foreign cancer chemotherapy preparation duties on non-small cell lung cancer of the immune checkpoint inhibitor: Joint investigation with this country 4 institution 森元能仁1, 稲野寛2, 石丸博雅3, 河合祐輔4, 長澤知徳5, 尾崎正隆5, 臼井浩明5, 田村勝彦5, 吉田正5, 吉成清志5, 篠原高雄5, 渡部一宏5, 廣原正宜5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1071-1071, 2020.

---

	P31-11. We conduct an investigation into administration and the five days administration by azacitidine therapy for myelodysplastic syndrome in our hospital for seven days 蓮尾憲作1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1071-1071, 2020.

---

	P31-12. Effect of HBV screening PBPM on cancer chemotherapy application patients 鈴木寛人1, 築田晃直1, 平田亮介1, 上原智博1, 仲本敦2, 河崎英範3, 渡嘉敷崇4, 山形真一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1072-1072, 2020.

---

	P31-13. Problems and countermeasures during administration of blinatumomab in the pediatric ward of our hospital 楠川侑吾1, 田村優衣1, 三松史野1, 本多伸二1, 村田龍宣1, 村岡淳二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1072-1072, 2020.

---

	P31-14. The CDDP administration situation investigation in craniocervical part cancer CCRT and examination about the dose 松尾圭祐1, 鳥山陽子1, 森田真樹子1, 馬場華菜1, 永石浩貴1, 谷口潤1, 尾之江剛樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1073-1073, 2020.

---

	P31-16. Safe examination in the rapid administration of rituximab 若月淳一郎1, 佐久間大樹1, 松本香織1, 花輪和己3, 飯野昌樹2, 小林みつ恵1, 小林義文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1074-1074, 2020.

---

	P31-17. Dosing period and cancellation reason in Pembrolizumab treated patients 75 years or older 石原泰子1, 小林宏太朗1, 亀井健人1, 仁科慎一2, 高柳和伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1074-1074, 2020.

---

	P31-18. The case that presented endocrinopathy, various immune-mediated adverse events including the enterocolitis by Nivolumab administration 松浦暢子1, 小西千尋1, 南野智志2, 草薙みか2, 山本倫数2, 大里恭章2, 洪鉉寿3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1075-1075, 2020.

---

	P31-19. Prescription trend of the oral anticancer agent for patients with female cancer 齋藤翔太1, 田中美幸2, 杉山純子3, 佐藤展宏4, 前田守5, 長谷川佳孝5, 月岡良太5, 森澤あずさ5, 大石美也5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1075-1075, 2020.

---

	P31-20. Analysis (as part of reduction of the drug-related near miss) of anticancer agent-related doubt inquiry contents in our hospital 石崎文子1, 相原敏彦1, 増尾昌則1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1076-1076, 2020.

---

	P31-21. The effect of the eribulin administration on patients with progress, recurrent breast cancer and investigation of the neutrophils, lymphocytes ratio 西和哉1, 川田彰彦1, 高橋舞1, 佐々木崇1, 佐賀利英1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1076-1076, 2020.

---

	P31-22. Examination of starting dose of ixazomib for relapsed or refractory multiple myeloma 畑中由香子1, 大里勇二1, 瀧真由子1, 島田健1, 平松靖史2, 中村進一郎1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1077-1077, 2020.

---

	P31-23. The intervention of the pharmacist is the case of the recurrence after the colon cancer technique which was able to contribute to complete response and long-term continuation of Regorafenib 小西千尋1, 松浦暢子1, 南野智志2, 草薙みか2, 山本倫数2, 大里恭章2, 村上修3, 洪鉉寿4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1077-1077, 2020.

---

	P31-24. It is an investigation about the successful execution situation of the XELOX therapy as the adjuvant chemotherapy after the colon cancer technique in elderly people 脇由香里1, 江原亜沙子1, 松田浩明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1078-1078, 2020.

---

	P31-25. Role of the genome charge pharmacist in the Kyushu cancer center cancer genomic medicine system 衛藤智章1,2, 高崎紘臣2, 田中麻紀子1,2, 松元俊博2, 薦田正人3, 織田信弥1, 江崎泰斗1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1078-1078, 2020.

---

	P31-26. Association of a blood pressure change and the effect of treatment before and after the administration in the ramucirumab paclitaxel combination therapy 森田真樹子1, 鳥山陽子1, 松尾圭祐1, 江崎瞳1, 谷口潤1, 尾之江剛樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1079-1079, 2020.

---

	P31-27. Accumulation of the immune-mediated adverse event that led to cancellation after the use of immune checkpoint inhibitor single agent in the Ariake district 小薮真紀子1, 緒方進2, 陣内優3, 前田健一4, 川瀬大輝5, 出水みいる6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1079-1079, 2020.

---

	P31-28. Search of the risk factor to affect the side effect expression of Osimertinib 前野有紀1, 大井隆広1, 柿花美沙紀1, 貝野裕也1, 坂野玲子1, 中藏伊知郎1, 北澤文章1, 中村孝人2, 辻川正彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1080-1080, 2020.

---

	P31-29. Comparison of the acceptability of pancreatic cancer recurrent after the operation in the Gemcitabine+nab-Paclitaxel therapy and the unresectable progress pancreatic cancer 有馬絵美1, 梅村拓巳1, 深津昌弘1, 水野貴仁1, 伊藤聡一郎1, 小崎耕自1, 山田哲也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1080-1080, 2020.

---

	P31-30. The effect that initial dose setting in consideration of renal function of S1 and the capecitabine gives to effect of treatment and adverse event expression 三宅真史1, 久保木千晴1, 松島彩音1, 佐々木健介1, 亀尾剛士1, 山下真史1, 藤井哲英1, 二宮洋子2, 小林美代子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1081-1081, 2020.

---

	P31-31. Treatment fact-finding of the CapeOX therapy that we provided as adjuvant chemotherapy after the colon cancer technique in our hospital 土屋亜祐美1, 吉田幹宜1, 長尾嘉真1, 佐藤吉一1, 島貫裕実子1, 田中万穂1, 小川千晶1, 増田純一1, 近藤直樹1, 寺門浩之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1081-1081, 2020.

---

	P31-32. Example that caused a myocardium harm-related event of immunity by the nivolumab ipilimumab combination therapy that we used for patients with progressive renal cell carcinoma 田井達也1, 渡邊政博2, 山下紗矢佳1, 水岡大策1, 元木貴大1, 山口佳津騎1, 鈴木聖1, 田中裕章1, 芳地一3, 小坂信二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1082-1082, 2020.

---

	P31-33. Examination about the validity of FOLFIRINOX therapy and the GEM+nabPTX therapy in the primary treatment for unresectable pancreatic cancer 荒川裕貴1, 桂川健司1, 後藤美穂1, 大田亜希子2, 遠山幸男1, 久田達也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1082-1082, 2020.

---

	P31-34. Consideration about the application patients in the initial transplantation of autologous hematopoietic stem cells of the multiple myeloma 島田惇司1, 五十嵐貴之1, 岡田和博1, 島崎博士1, 鈴木一史2, 西脇嘉一2, 長谷川英雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1083-1083, 2020.

---

	P31-35. Efforts of the pharmacist for the examination for HBV compliance with the cancer chemotherapy 福田愛弓1, 稲塚菜摘1, 斉藤佑輔1, 樋口浩輔1, 木村謙吾1, 加藤浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1083-1083, 2020.

---

	P31-36. Investigation about the drug-related interstitial lung disease onset in patients receiving immune checkpoint inhibitor 岩下昂平1, 山田成樹1, 熊澤里美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1084-1084, 2020.

---

	P31-37. Comparison of the side effect of Pembrolizumab single agent in the non-small cell lung cancer and cytotoxic anticancer agent combination 大野裕之1, 田中佳子1, 関谷泰明1, 井上壽江1, 平下智之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1084-1084, 2020.

---

	P31-38. The decreased renal function deteriorates the blood toxicity of the Carboplatin 高木賢太郎1, 南一典1, 上田要一1, 真下聡文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1085-1085, 2020.

---

	P31-39. 2 cases that low-dose gemcitabine succeeded for a long term 桂川健司1, 荒川裕貴1, 後藤美穂1, 遠山幸男1, 久田達也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1085-1085, 2020.

---

	P31-40. Reports of the side effect occurrence situation such as the use situation investigation of the Lenvatinib for the unresectable hepatocellular carcinoma and TSH rise, and the like 川崎彰彦1, 林洋平1, 福澤正隆1, 川嵜英二1, 鹿間良弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1086-1086, 2020.

---

	P31-41. Progressive form type I diabetes mellitus slow during Durvalumab administration and 1 case that was diagnosed 堀友紀1, 的場美香1, 口分田章典1, 高橋愛未1, 井上聡子1, 山東真寿美1, 坂上嘉浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1086-1086, 2020.

---

	P31-42. 4 cases that was treated with cancer chemotherapy to patients on dialysis 新居亜里紗1, 和田祐一郎1, 坂井裕美1, 穂積廣1, 加藤香奈1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1087-1087, 2020.

---

	P31-43. Search of the factor to give it to a relative dose intensity of the breast cancer adjuvant chemotherapy in the North Kyoto area 山本皓介1, 峯垣哲也2, 越野勝博3, 坂下透子1, 堀口裕美1, 田渕祐輔4, 新宮秀昭1, 小阪直史4, 西口工司2, 四方敬介4, 土淵尚也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1087-1087, 2020.

---

	P31-44. Search of the treatment target which paid its attention to the carbohydrate metabolism Reprography and Consultant gram in the cells of chronic myelogenous leukemia cells at exposure to Bcr-Abl tyrosine kinase inhibitor 平尾卓也1, 齊藤諒1, 青木重樹2, 加藤芳徳1, 手塚千裕1, 山田治美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1088-1088, 2020.

---

	P31-45. Examination of the effect to give to pazopanib and the treatment of the sarcoma under the gastric-acid secretion antagonist combination 菅野仁美1, 伊勢崎竜也1, 安室修1, 舟越亮寛1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1088-1088, 2020.

---

	P31-46. The current situation investigation at chemotherapy new introduction in elderly people 三沢あずさ1, 水谷妙子1, 粟野原幸恵1, 網野一真1, 浜至寛1, 登内盛治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1089-1089, 2020.

---

	P31-47. Efforts of "the NCGM pharmacy cancer drill" for the improvement in knowledge about the anticancer medicine 永田麻子1, 吉田幹宜1, 熊木絵美1, 土屋亜祐美1, 長尾嘉真1, 島貫裕実子1, 佐藤吉一1, 田中万穂1, 小川千晶1, 増田純一1, 近藤直樹1, 寺門浩之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1089-1089, 2020.

---

	P31-48. Examination ... about the association of analysis ... anticancer agent and PIMs prescription of the cancer medical therapy for elderly people 松本憲昭1, 榊原幹夫1, 白石成明2, 鈴木裕介3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1090-1090, 2020.

---

	P31-49. Comparison of the physiological response of the person of anticancer agent preparation using two kinds of gowns 五月女拓也1, 外山智章1, 日向野理輝1, 押坂勇志3, 石濱洋美2, 臼井悟1, 本田雅巳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1090-1090, 2020.

---

	P31-50. Search (interim report) of the risk factor about the neutropenia in the ramucirumab + albumin suspension type paclitaxel 永田彩加1,2, 足立茂樹2, 大池恵生2, 小田浩史2, 川原田祐貴2, 小玉幸与1,2, 佐久間晶基2, 杉野晃希2, 中井剛2, 永松秀紹2, 間瀬広樹2, 宮崎雅之2, 中根茂喜2, 今西忠宏1, 久田達也2, 板倉由縁2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1091-1091, 2020.

---

	P31-51. Examination of the effect on hepatocellular carcinoma factor about the treatment continuation of the Lenvatinib therapy 柴野雅仁1, 高橋克之1, 高橋正也1, 永山勝也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1091-1091, 2020.

---

	P31-52. 1 consideration about the role of the specialized medical institution cooperation pharmacist in the cancer medical therapy 泊口豊1,2, 徳山尚吾2, 浅野涼子1, 前田竜太郎1, 小松正典1, 福森淳1, 寺脇康文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1092-1092, 2020.

---

	P31-53. Questionary survey to the health insurance pharmacy in the cancer chemotherapy regimen seal pasting to prescription notebook 宮崎晃臣1, 米村匡平1, 新岡琢也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1092-1092, 2020.

---

	P31-54. Construction and practice of preventive measures against HBV reactivation by the pharmacist 天川佳洋1, 足立匠1, 徳留雄太1, 武井優輝1, 土屋雅勇1, 榎本弘美1, 渡部多真紀1,2, 河村剛至1,2, 安野伸浩1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1093-1093, 2020.

---

	P31-55. Exploration study in the association of castration acquisition of fastness of the prostate cancer and the clinical factor 林友典1, 宮本朋佳2, 平田敦士1, 長井紀章3, 川畑篤史3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1093-1093, 2020.

---

	P31-56. We look at the rear about the onset of hand-and-foot syndrome of the use of sorafenib patients in the pediatric domain and examine a mark 時澤秀明1, 宇野倫弘1, 清水祐一1, 甲斐維子1, 加戸奈穂美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1094-1094, 2020.

---

	P31-57. Analysis about the risk factor of the neutropenia by the Osimertinib 黒部健太郎1,2, 塩川裕美1, 岩永健太郎2, 松永尚1, 草葉一友1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1094-1094, 2020.

---

	P31-58. About infusion reaction in the first time of cetuximab and the reintroduction 大里勇二1, 島田健1, 石井雅人1, 畑中由香子1, 上野聖子1, 中村進一郎2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1095-1095, 2020.

---

	P31-59. Effect of the checkpoint inhibitor history of treatment to give to the effectiveness of the DTX+RAM combination therapy in patients with non-small cell lung cancer and safety of immunity 松尾モモ1, 片岡智美1, 熊倉康郎1, 加藤善章1, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1095-1095, 2020.

---

	P31-60. Relative investigation with a hand-and-foot syndrome and the capecitabine consumption in the health insurance pharmacy 當真房子1, 三上まどか1, 阿嘉さゆり1, 鬼木華歩1, 砂川信子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1096-1096, 2020.

---

	P31-61. A neutropenic risk factor search with the oil xanthan gum + gemcitabine (GnP) therapy in patients with unresectable progress pancreatic cancer and effect on antitumor effect 道家雄太郎1, 野田哲史1, 平大樹3, 前平博充2, 谷眞至2, 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1096-1096, 2020.

---

	P31-62. Job analysis by having started pharmacist dental auxiliary duties for patients with chronic myelogenous leukemia of the blood internal medicine outpatient department 高橋典哉1,2, 及川淳1, 木村周古1, 及川嵩人1, 山澤望1, 村井一範2, 菊池英1, 菊地英行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1097-1097, 2020.

---

	P31-63. Investigation according to the foreign hospitalization of incident/accident evasion example by the chemotherapy room charge pharmacist using the effect degree classification 三井満里奈1, 森田一1, 平田藍1, 松崎貴志1, 田中恒明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1097-1097, 2020.

---

	P31-64. We look at the rear of the predictor about the extension for duration of treatment of the Palbociclib by the multicenter combination and search for a mark 小川喜通1, 小倉千奈2, 亀岡春菜2, 宮前文明1, 槙恒雄3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1098-1098, 2020.

---

	P31-65. Pharmaceutical intervention for the Abemaciclib in the cancer pharmacist outpatient department 米谷頼人1, 石井隆義1, 松田亜希子1, 藤谷千紘1, 坂本佳子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1098-1098, 2020.

---

	P31-66. Examination of dose intensity of the Lenvatinib in the hepatocellular carcinoma 魚井みゆき1, 杉本理恵2, 三角紳博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1099-1099, 2020.

---

	P31-67. Example that we finished passing and exchanged oral from hypodermic injection sustained by the home care start of the uterine cancer terminal patient 砂川信子1, 當真房子1, 石田浩1, 三上まどか1, 阿嘉さゆり1, 鬼木華歩1, 坂本政文1, 喜屋武芳美1, 佐藤雅美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1099-1099, 2020.

---

	P31-68. Examination of the Infusion reaction expression of trastuzumab risk factor 森本奈緒美1, 阪口勝彦1, 多喜和夫1, 野田明宏1, 和田祥明1, 眞下惠次1, 藤原大一朗1, 星田唯史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1100-1100, 2020.

---

	P31-69. Investigation of the factor to give adjuvant chemotherapy introduction after the pancreatic cancer technique 菊地義明1,2, 鈴木直哉1, 朝倉幹己1, 藤田果那1, 庄崎沙耶1, 田中耕太1, 木下愛1, 山本翔太1, 山田将悟1, 前川英輝1, 藤林遼1, 高橋誠1, 青田忠博1, 上野峰2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1100-1100, 2020.

---

	P31-70. 1 case that reintroduced Afatinib into Osimertinib after the change from Afatinib for reasons of other than the drug resistance, and continued a partial response 岸本真1,2, 屋敷大輔1,2, 田中恭人1,2, 森永崇史2, 池沢若菜2, 豊留麻衣2, 北園幸大2, 中野一馬2, 山本梢2, 淵脇ゆかり2, 徳丸章佳2, 長ヶ原琢磨2, 荻尾夕起子2, 三阪高春1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1101-1101, 2020.

---

	P31-71. Fact-finding of the lung cancer medical therapy after the checkpoint inhibitor approval in the foreign cancer medical therapy of immunity 藤原大一朗1, 星田唯史1, 森本奈緒美1, 眞下惠次1, 和田祥明1, 野田明宏1, 多喜和夫1, 阪口勝彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1101-1101, 2020.

---

	P31-72. It is current situation and problem ... of ... pharmaceutical intervention about a reason of the direct hospital admission of emergency in cancer chemotherapy patients 木元慎一郎1, 木村佳弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1102-1102, 2020.

---

	P32-1. Investigation about antimicrobial proper use guidelines 阪野和重1, 中西俊介1, 谷畑悠起子1, 武内恭範1, 奥本真巳1, 篝忠宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1103-1103, 2020.

---

	P32-2. For the patients with CDI initial infection about 2 cases received the Fidaxomicin 平野貴志1, 安部一秀1, 畑伸一1, 長澤雄大2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1104-1104, 2020.

---

	P32-3. Approach for the antimicrobial proper use in our hospital 安田陽子1, 福山博務1, 松元謙治2, 眞柄雄樹2, 小倉健一3, 高田淳子4, 杉田知妹5, 塩地園代1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1104-1104, 2020.

---

	P32-4. A case where tedizolid (TZD) was effective in persistent MRSA bacteremia 瀬戸崇光1, 片岡優1, 小田怜1, 杉田裕貴1, 松村友和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1105-1105, 2020.

---

	P32-5. As a result of proper use of the perioperative infection prophylaxis antimicrobial in the surgery 小関崇文1,2, 大貫敏明1,2, 日向早苗1,3, 足立智子1,3, 大場雄一1,4, 鈴木由佳2, 加藤由紀2, 田紗永子2, 小舛修三1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1105-1105, 2020.

---

	P32-6. The effect that cefazolin understock resulted in 佐多照正1,2, 八汐祥恵1, 堀之内志織1, 鶴永大貴1, 中村有莉恵1, 赤星真広1, 上原友美1, 池増鮎美1,2, 秋山久美2,3, 副島賢忠2,3, 宮原宏典3, 徳重浩一3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1106-1106, 2020.

---

	P32-7. Effect by the empiric treatment enforcement of vancomycin on patients with bacterial meningitis 中野貴文1,2, 水野寧子1, 江口幸臣1,2, 池内忠宏1, 兼重晋1, 緒方憲太郎1,2, 神村英利1,2, 林稔展1,2, 江川孝2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1106-1106, 2020.

---

	P32-9. Efforts to oral antibiotic deescalation in patients with hospitalizing pyelonephritis 村上礼隆1, 菅原隆文2, 吉川明良2, 宮森伸一2, 開浩一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1107-1107, 2020.

---

	P32-10. Cross-sectional study about the quantity of duties necessary for an antimicrobial use of medicine case and proper use support activity 川崎祥平1,3, 小林義和1,3, 松倉拓哉1,3, 伊藤靖2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1108-1108, 2020.

---

	P32-11. The effect that quick PCR introduction gives in the antimicrobial prescription trend of patients with staphylococcus aureus bacteremia 渡邊雅史1, 酒井幹康1, 三宅芳男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1108-1108, 2020.

---

	P32-13. Efforts to vancomycin initial trough blood level adequacy by the antimicrobial proper use support team (AST) exclusive duty pharmacist intervention 木賀田亮介1, 丸山晴生1, 金子泰也1, 小沼恵莉1, 勝山善彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1109-1109, 2020.

---

	P32-14. An example of the necrotising fasciitis by Aeromonas hydrophila caused by the wound part infection related to West Japan heavy rain disaster 池本雅章1, 藤本孝則1, 宮田絵莉加1, 横田智美1, 岡村和彦1, 佐々木雄啓1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1110-1110, 2020.

---

	P32-15. Association of a period and the treatment prognosis to deescalation in the substrate specific expansion type β - lactamase (ESBL)-producing Enterobacteriacae bacteria bacteremia case 中蔵伊知郎1, 田中裕貴子1, 森幸代1, 森あやか1, 北澤文章1, 辻川正彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1110-1110, 2020.

---

	P32-16. Effect of the patients with bacteremia all cases intervention by the antimicrobial proper use support team working full time pharmacist 須山由佳子1,2, 伊藤健太3, 神戸宏憲1, 佐々木理恵4, 鈴木清美2, 袴田康弘2,5, 平野桂子1, 木村緑1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1111-1111, 2020.

---

	P32-17. It is the 1 case receiving the colistin for meningitis by the multidrug-resistant Acinetobacter 吉原涼子1, 橋本雅司2, 吉野裕統1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1111-1111, 2020.

---

	P32-18. Pharmacist-led approach ... to realize antimicrobial proper use support team - speedy yellow staphylococcemia treatment 古川大樹1, 伊藤嘉英1, 大橋武司1, 林房江2, 菱田志乃3, 長谷川雅哉1, 中尾彰宏4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1112-1112, 2020.

---

	P32-19. Effect on use situation of the specific antimicrobial by the registration system introduction of TAZ/PIPC 松田理湖1, 久田瑛吉1, 加藤洋介1, 前田直希1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1112-1112, 2020.

---

	P32-20. The effect that AS activity of MEPM using the length of therapy (LOT) /t > MIC gave in use of MEPM frequency of the low-dose level 小林義和1,2,3, 川崎祥平1,2,3, 松倉拓哉1,2,3, 伊藤靖1,2,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1113-1113, 2020.

---

	P32-21. It is compared administration and the 2nd administration after the operation of the Total Knee Arthroplasty on cefazolin 1st in the infection prophylaxis 田川誠二1, 小林俊介1, 安武夫2, 小倉敬史1, 柳澤克昭3, 松原正明3, 北岡晃1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1113-1113, 2020.

---

	P32-22. Examination and evaluation of the intervention effect by AST 片山聡子1,2, 松木悠平3, 池崎友明1,2, 村上真樹1,2, 坂東翔1,2, 北澤英徳2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1114-1114, 2020.

---

	P32-23. Efficacy and safety of tenofovir alafenamide for hepatitis B virus reactivation due to treatment for malignant lymphoma 谷口潤1, 松尾圭祐1, 櫻井一宏2, 尾之江剛樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1114-1114, 2020.

---

	P32-24. Involvement of Newly Appointed Pharmacists in the Proper Use of Antibiotics - From a Study of Preavoid Cases - 牧田亮1, 古谷一平1, 田中佳子1, 関谷泰明1, 井上壽江1, 平下智之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1115-1115, 2020.

---

	P32-25. Antimicrobial choice to substrate specific expansion type beta lactamase (ESBL)-producing bacteria-positive patients in the urine culture 杉田裕貴1, 小田怜1, 片岡優1, 瀬戸崇光1, 松村友和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1115-1115, 2020.

---

	P32-26. The effect that supply restrictions of ampicillin sulbactam gave for aspiration pneumonia treatment 関口愛1, 内田裕之1, 杉沢拓麿1, 中島美治1, 本郷偉元2, 丹羽一貴3, 河井良智1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1116-1116, 2020.

---

	P32-27. Efforts of the pharmacist of the antimicrobial proper use in the medical treatment ward of our hospital 重里幸枝1, 滝川亜弥1, 太田久美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1116-1116, 2020.

---

	P32-30. Usefulness of GNRI in the VCM trough aim area individualization 松木祥彦1, 松本遥奈2, 佐古兼一2, 矢嶋美樹3, 渡部多真紀4, 渡辺茂和5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1118-1118, 2020.

---

	P32-32. AST activity in our center 山下悠希1, 山田和弘1, 中山博文1, 阪口勝彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1119-1119, 2020.

---

	P32-33. Can the result index be accomplished by use situation investigation - 2020 of the oral antimicrobial targeted for AMR action plan in our hospital? ... 南波勝栄1, 尾崎絢果1, 吉田朱里1, 尾花祥世1, 福田英克1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1119-1119, 2020.

---

	P32-34. Analysis of the clinical outcome for the AS activity in the small and medium size hospital for 2 years 沢田佳祐1, 中谷丈之1, 上山孝太2, 篠原晃子3, 福田康二4, 河野修治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1120-1120, 2020.

---

	P32-35. Intervention effect of AST on antimicrobial supply difficulty 中村麗紗1, 喜多洋嗣1, 喜多幸子1, 仲村亮太1, 森智子1, 駒井勇太1, 人見百合子1, 田仲祐子1, 近藤理美1, 府川祥子1, 坂口結斗1, 久田潤平1, 宮川千珠1, 水野康平1, 山中愛美1, 吉村美菜1, 岸本実優1, 北池祥子1, 小久保綾乃1, 白木萌1, 有銘千賀子1, 宇根良祐1, 石木仁美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1120-1120, 2020.

---

	P32-37. A change of the antimicrobial consumption accompanied with the cefazolin supply stop and investigation about the chemosensitivity 田子尚史1, 國分真理1, 鈴木達宙1, 新後閑俊之2, 武谷洋子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1121-1121, 2020.

---

	P32-38. Correspondence of our hospital accompanied with the cefazolin supply stop and the inspection 岩田真子1, 山田宜和1, 山岸宏和1, 五十嵐詠美1, 鈴木さくら1, 寺口敦1, 種村瞭1, 貝瀬眞由美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1122-1122, 2020.

---

	P32-39. Effect of the Time above MIC calculation in Meropenem 畑中祐磨1, 本舘諭1, 田村麻衣1, 中居肇1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1122-1122, 2020.

---

	P32-40. The construction of the oral antimicrobial prescription grasp system in the outpatient department and the current situation report of the prescription situation 小川暁生1, 三上友寛1, 門居久嗣1, 淵上尚彦1, 桐畑美里1, 近澤秀己1, 伊庭雅代1, 遠藤正憲1, 高橋良一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1123-1123, 2020.

---

	P32-41. About a factor affecting it during the antibiotic exposure period (Duration of Antimicrobial Treatment: DAT) of blood culture-positive patients 安原昌子1,2, 栗原晋太郎1,2, 井上雄平1,2, 佐藤一求1,2, 藤本雅宣1,2, 江草徳幸2, 本田智洋1,3, 徳本和哉2, 堀川俊二1,2, 佐和章宏4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1123-1123, 2020.

---

	P32-42. Efforts to oral antimicrobial proper use 田中博和1, 安永実沙1, 松浦徹1, 山下大貴1, 立石裕樹1, 安部由起子1, 後藤貴央1, 與田賢作1, 秋吉正貴1, 宮津大輔1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1124-1124, 2020.

---

	P32-43. Examination about the initial therapeutic drug choice about the MRSA bacteremia 吉田三矢1, 土江亜季1, 白崎佑磨1, 辰巳晃造1, 田路章博1, 吉野宗宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1124-1124, 2020.

---

	P32-44. Antimicrobial proper use investigation for acute cholangitis, cholecystitis treatment judging from a viewpoint of the TAZ/PIPC consumption reduction 長山優介1,2, 高橋英加1,2, 藤垣俊介1, 村田久枝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1125-1125, 2020.

---

	P32-45. By a supply stop of the cefazolin, we changed the prophylactic antimicrobial of surgical-site infections, but anti-VAIO gram of MSSA did not have the change 長野響1, 平田貴大1, 小野寺隆記2, 黄前尚樹3, 起塚美沙1, 中村美樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1125-1125, 2020.

---

	P32-46. Examination of the effect of Antimicrobial Stewardship on bacteremia with the Enterococcus genus 伊藤亮太1, 渡邊卓嗣1, 星野祐太1, 菊地未由1, 大月沢雄1, 菅野和彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1126-1126, 2020.

---

	P33-1. About a usage review and efforts of the surgical-site infections (Surgical site infection: SSI) prevention antimicrobial in our hospital cardiovascular surgery 久保悠1, 今田深雪1, 岩朝静子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1127-1127, 2020.

---

	P33-2. Surveillance of the use of antimicrobial in the area guessing from a trend of the antimicrobial consumption of the prescription 坪内理恵子1, 谷合英太郎2, 吉住和樹2, 小林岳3, 大倉輝明4, 宮崎美子5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1128-1128, 2020.

---

	P33-3. Evaluation of the disease severity classification using the MN standard for the patients with suspected the Clostridioides difficile infection 山田楊太1, 宮崎元康1, 松尾宏一1, 内山将伸1, 小宮ゆきえ2, 永田忍彦3, 今給黎修1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1128-1128, 2020.

---

	P33-4. About the effect of the third generation oral cephalosporin antimicrobial adoption cancellation suggestion on pediatrician by the antimicrobial proper use support team 池田浩幸1,2, 松島実2, 池田恵子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1129-1129, 2020.

---

	P33-5. For CEZ supply stop, it is evaluated AS utilizing ABPC/SBT for the perioperative period 伊藤悠里子1,3, 高野純希1,3, 塩谷光彦2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1129-1129, 2020.

---

	P33-6. Efforts to consumption reduction of the third generation oral cephalosporin medicine 森田眞由1, 大橋正和1, 本多あずさ1, 村田龍宣1, 村岡淳二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1130-1130, 2020.

---

	P33-7. Examination about the usefulness of the participation of AST at antimicrobial supply restrictions 佐々木貴之1,2, 加藤恵一1, 佐々木香織1, 山川智一1, 中園裕利華1, 福本真己1, 白木克哉2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1130-1130, 2020.

---

	P33-8. Correspondence of our hospital AST for the supply stop of the cefazolin sodium antimicrobial 蔵地章仁1, 高桑実希1, 二宮茂光2, 寺西太3, 早川繁子4, 石黒早織4, 都築菜美5, 棚田愛5, 南條明徳5, 河内若代1, 三宅浩子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1131-1131, 2020.

---

	P33-9. Consideration about the evaluation of the AST activity by the point of view of the AWaRe classification and the future action program 田中雄大1, 山口諒1, 山本武人1,2, 鈴木洋史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1131-1131, 2020.

---

	P33-10. Efforts to fact-finding and improvement for the hand hygiene of the ward charge pharmacist in enforcement 仲俣桃華1, 玉城哲子1, 城間盛彦1, 浦崎清美1, 武富美貴子1, 仲吉亜依美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1132-1132, 2020.

---

	P33-11. After the operation by the prophylactic oral antimicrobial cancellation in the cataract surgery about the effect of the adverse event incidence 高橋有1, 小林和博1, 上田覚1, 岡田麻佑1, 尾上雅英1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1132-1132, 2020.

---

	P33-12. Inspection of the improvement in number of hand washing by the enlightenment activity for the pharmacist 檜山洋子1, 鴫田江理嘉1, 小澤智紀1, 久保有子1, 冨田隆志1, 佐伯康之1, 松尾裕彰1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1133-1133, 2020.

---

	P33-13. Foreign prescription fact-finding of the oral antimicrobial for acute respiratory tract infection and the acute diarrhea 南真進1, 松浦直嗣1, 小杉隆祥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1133-1133, 2020.

---

	P33-14. Relationship of the use situation and the drug resistant bacterium detection situation of the finger disinfectant in our hospital 佐藤智功1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1134-1134, 2020.

---

	P33-15. Efforts for the efficiency of AST duties 横手克樹1, 伊藤太一1, 雫文子1, 森山史就1, 安食健一1, 園山智宏1, 松原康博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1134-1134, 2020.

---

	P33-18. About the effect that the issue of steady supply of the antibiotic gave 仲井修一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1136-1136, 2020.

---

	P33-21. Examination of the perioperative prophylactic antimicrobial in the orthopedics domain with the cefazolin supply difficulty 坂梨綾香1, 高田百合菜1, 植竹宣江1, 松本俊治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1137-1137, 2020.

---

P33-22. Changes such as the hospitalization, and the like by the change of the clinical path with the supply difficulty of the antibiotic cefazolin 長濱藍1, 和泉勝一1, 喜友名侑舞1, 生野夢子1, 白木萌1, 小久保綾乃1, 北池祥子1, 岸本実優1, 吉村美菜1, 山中愛美1, 水野康平1, 宮川千珠1, 久田潤平1, 坂口結斗1, 近藤理美1, 府川祥子1, 田仲祐子1, 人見百合子1, 駒井勇太1, 森智子1, 仲村亮太1, 喜多幸子1, 喜多洋嗣1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1138-1138, 2020.

---

	P33-23. Change of the De-escalation rate by the antimicrobial proper use support intervention to blood culture-positive patients 上村真由1, 河村一郎2, 澤井祐樹1, 立川奈保美1, 長谷川聡司1, 中野寛之1, 高木麻里1, 吉田智江1, 藤田敬子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1138-1138, 2020.

---

	P33-24. Effect on prescription trend by the in-hospital manual revision of influenza treatment 宮内英俊1, 渡嘉敷俊介1, 大井優1, 加賀正基1, 志智大介2, 山内拓1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1139-1139, 2020.

---

	P33-25. Efforts for oral antimicrobial proper use in our hospital outpatient department section and the effect 倉田賢生1, 堀内寿志2, 井上昇3, 斧沢京子4, 荒木弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1139-1139, 2020.

---

	P33-26. Effect on surgical-site infections of the chemosensitive rate of the microbe by the cefazolin supply stop and the cardiovascular surgery 迫田英樹1,2,3, 馬場華菜1, 栗脇千春2, 山下正治3, 山口俊3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1140-1140, 2020.

---

	P33-27. The procalcitonin for sepsis of the intensive care unit admission patients or the pre-back prediction and usability of the pre-sepsine 伊部裕太1, 石郷友之1, 清治翔伍1, 稲村広敏1, 藤居賢1, 北川学1, 木明智子1, 中田浩雅1, 宮本篤1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1140-1140, 2020.

---

	P33-28. Intervention of AST for patients with MRSA bacteremia in Nagoya Memorial Hospital and the result 吉田祐理1,2, 岡本千晴1,2, 長岡雅敏1,2, 鈴木道雄2,3, 関原恵利子2,4, 北原陽子2,5, 湯浅周1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1141-1141, 2020.

---

	P33-29. Factor analysis of Clostridioides difficile infection recurrence 木下大夢1, 岡崎椋子1, 御牧夕紀子1, 帖佐弘子1, 松山淳史1, 鬼丸俊司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1141-1141, 2020.

---

	P33-30. Intervention and evaluation to the pneumonia inpatient in the antimicrobial proper use support team 竹内陽亮1,2,3,4, 高橋雄也1, 辻文生2, 東浦壮志2, 高鷲智美3, 砂田梨穂4, 大谷将弘4, 長島裕樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1142-1142, 2020.

---

	P33-31. Comparison of the use of antimicrobial situation before and after the antimicrobial proper use support team start in our hospital 海野亜実1, 久保田綾乃1, 北村修1, 牧野和也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1142-1142, 2020.

---

	P33-32. One patient whom ventriculitis to assume Corynebacterium striatum origin bacteria developed in 松下永利子1, 戸田智美1, 太田雄一郎2, 荒木勇人2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1143-1143, 2020.

---

	P33-33. Evaluation of the AST activity of the pharmacist in the staphylococcal bacteremia 中市里実1, 澤田美穂2, 溝端友希1, 三浦絢1, 前田智佳子1, 藤本明由美1, 岡本悠紀1, 山本紗世1, 楠本臣彌1, 台野佳代1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1143-1143, 2020.

---

	P33-34. Having been understood from a medical interpreter, the questionary survey by the tuberculosis workshop for staff of Japanese school 山崎彬史1, 中浴伸二1, 森本茂文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1144-1144, 2020.

---

P33-35. Construction ... of the prescription situation investigation system of the oral antimicrobial accompanied with prescription situation investigation - medical service fees revision of the foreign oral antimicrobial for acute respiratory tract infection and the acute diarrhea 中谷亮介1, 満田正樹1, 岡田雅弥1, 太田かおり2, 奥野千晶3, 松本篤1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1144-1144, 2020.

---

	P33-36. Relation Vol.2 of the hospital pharmacist to vaccination recommendation 渡辺智之1, 大石将義1, 古浜健一1, 湯本哲郎2, 稲葉健二郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1145-1145, 2020.

---

	P33-37. Examination of the factor associated with the onset of Clostridioides difficile-related loose bowels 沢田裕介1, 古畑光司1, 三戸香央里1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1145-1145, 2020.

---

	P33-39. The current situation of the bundle observance rate of the staphylococcus aureus bacteremia in Rousaibyoin, China 今津智子1, 大上亜樹1, 福田結彩1, 濱崎浩一1, 福原伸治1, 下川福子1, 小濱邦彦2, 前田頼伸3, 面田恵1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1146-1146, 2020.

---

	P33-40. Analysis of the factor involved in the resistant bacteria detection in the acute pyelonephritis 島田茉侑1, 堀川洋平2, 柳田真樹子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1147-1147, 2020.

---

	P33-41. Infection measures about environment and the hand hygiene in the dispensary 小西寿子1,2, 橋本直人1, 海老原文哉1, 前浩史1, 浜田幸宏1, 木村利美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1147-1147, 2020.

---

	P33-42. The effect that acute nephropathic disease severity gives to a pre-sepsine level 石郷友之1, 伊部裕太1, 藤居賢1, 北川学1, 木明智子1, 中田浩雅1, 宮本篤1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1148-1148, 2020.

---

	P33-43. It is the change of the AST (antimicrobial proper use support team) activity by becoming it the working full time of the pharmacist 植竹宣江1, 竹之内誠1, 立川文崇1, 松本俊治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1148-1148, 2020.

---

	P33-44. Examination of a pollution status and the contact infection prophylaxis of the medication window by the adenosine triphosphate assay 瀬山翔史1, 山吉康子1, 津田壮一郎1, 池谷修2, 柏村祥子3, 西村知泰4, 高野八百子2, 長谷川直樹2, 村松博1, 青森達1,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1149-1149, 2020.

---

	P33-45. Examination of the use of hand hygiene evaluation application for the evaluation of the hand hygiene 清水智也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1149-1149, 2020.

---

	P33-46. The current situation and problem in the scale hospital out of one of Clostridioides difficile infection 安田美奈子1, 河本大輝1, 五藤里奈1, 白川舞1, 熊田克幸1, 岡田美智代1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1150-1150, 2020.

---

	P33-47. Adequacy of Clostridioides difficile infection treatment by use of antimicrobial aptitude support team (AST) and the examination 中野祐樹1,2, 大竹野久雄1,2, 船津康弘2, 井上真太郎2, 末安禎子2, 横尾賢乗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1150-1150, 2020.

---

	P33-48. Usefulness of infection measures cooperation common platform (J-SIPHE) in the use of antimicrobial situation investigation 遠藤美緒1, 早川佳代子1,2, 田島太一1, 藤井直樹1, 坂口みきよ1, 浅井雄介1, 都築慎也1, 松永展明1, 大曲貴夫1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1151-1151, 2020.

---

	P33-49. Examination of the patients with Candida bacteremia outcome that use of antifungal agent aptitude in the scale hospital (Antifungal Stewardship: AFS) gives 星貴薫1, 浅利伸朗1, 井畑理沙1, 大島美保1, 西條正二1, 冨所愛佳1, 松田まなぶ1, 宮腰恵生1, 和田直樹1, 中川麗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1151-1151, 2020.

---

	P33-51. Successive change of the practice guidelines on perioperative antimicrobial conformity rate by the AST intervention 高野雅己1, 稲垣孝行1, 南島拓矢1, 松原匡希1, 渡部亨平1, 千崎康司1, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1152-1152, 2020.

---

	P33-52. Fact-finding of the use of perioperative antimicrobial in the childhood spinal fusion 栗島彬1, 塩田朋子1, 磯崎僚1, 田島幸子2, 小野貴司3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1153-1153, 2020.

---

	P33-53. The current situation investigation about the infusional antimicrobial proper use for nurses of our hospital 後藤義之1, 角紀一郎1, 岡田久美1, 古本真由美1, 松岡未紗1, 茶野下貴恵1, 光井彩1, 島崎沙織1, 青木理恵1, 清水翔子1, 西川達也1, 梅下翔1, 森戸敏志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1153-1153, 2020.

---

	P33-54. Can put it in our hospital; and quantity of oral antimicrobial prescription investigation of the next acute respiratory tract infection 花房伸幸1, 小池彩子1, 廣田あゆ子1, 河村茉衣1, 奥格2, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1154-1154, 2020.

---

	P33-55. Efforts to the antimicrobial proper use of the AST pharmacist in the Matsusaka center general hospital 木平香織1, 飯田拓真1, 森章哉1, 福永浩也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1154-1154, 2020.

---

	P33-56. The current situation and problem for the foreign antimicrobial proper use 西村清孝1, 山本貢1, 清水浩幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1155-1155, 2020.

---

	P33-58. Activity report for the new coronavirus infection in the pharmacy service under health insurance drugstore Japan pharmacy 中村翔吾1, 赤木太一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1156-1156, 2020.

---

	P34-1. A Case of Pharmacological Management in Dolutegravir + Lamivudine Dual Therapy as Initial Treatment for AIDS Patients with Decreased Renal Function 松本慎太郎1, 石田茂1, 渡邊裕之1, 辻敏和1, 松本佑慈2, 江頭伸昭1, 家入一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1157-1157, 2020.

---

	P34-2. Effect of change to dolutegravir on intra-individual variation in estimated glomerular filtration rate 日笠真一1, 島袋翔多1, 秀田恭子1, 日笠聡2, 澤田暁宏2, 徳川多津子2, 田中邦佳1, 柳井美奈1, 木村健1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1158-1158, 2020.

---

	P34-3. Investigation about the malignant tumor merger HIV patients in our hospital 合原嘉寿1,2,3, 大石裕樹1,2,3, 高島伸也1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1158-1158, 2020.

---

	P34-4. A Case of Renal Dysfunction Caused by Dolutegravir + Tenofovir Alafenamide/Emtricitabine Combination Therapy 齋藤巨樹1,4, 三原智2, 大石裕樹3, 小森敦正4, 橋本雅司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1159-1159, 2020.

---

	P34-5. Making of the hearing questionnaire by the pharmacist to aim at the improvement in quality of life of patients with HIV infection with unheated blood products (harmful effect HIV infection victim) 阿部憲介1, 近藤旭1, 神尾咲留未1, 赤木麻衣2, 鈴木美絵子2, 佐々木晃子2, 鈴木智子2, 今村淳治2, 後藤達也1, 伊藤俊広2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1159-1159, 2020.

---

	P35-1. Examination about the carnitine supplement in the seriously disabled child person 小野美沙紀1, 室博也1, 垣越咲穂1, 中村曜子1, 服部昇二1, 吉田知由1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1160-1160, 2020.

---

	P35-3. A side effect, an effect and effect factor of the oral phosphorus preparation administration for the hypophosphatemia of adults 土川拓也1, 古谷一平1, 田中佳子1, 関谷泰明1, 井上壽江1, 平下智之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1161-1161, 2020.

---

	P35-4. Study on association of lipid microsphere administration and the malnutrition risk in the childhood TPN patients 池田隆史1, 藤田紀子1, 安河内尚登1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1162-1162, 2020.

---

	P35-6. Application to NST duties using an action card 青木まりあ1, 山本高範1, 谷口朋子2, 長田文子2, 前田篤史3, 松田明敏4, 阿部康治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1163-1163, 2020.

---

	P36-1. About the burden on patients degree in diabetes treatment with the mental disorder examination - using - Problem Areas In Diabetes Survey 福山雄卯介1, 宮崎敦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1164-1164, 2020.

---

	P36-2. Attempt of the antipsychotics decrease medicine for patients with dementia 大谷達郎1, 藤渕大樹1, 田中文江1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1165-1165, 2020.

---

	P36-3. Example that a pharmacist intervened in for the weight loss of the high-dose benzodiazepine receptor agonist remedy patients early 植田有希1, 原田学1, 宇野葉子1, 杉本貴洋1, 下村好子1, 大橋郷子2, 仲谷佳高3, 四方佳美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1165-1165, 2020.

---

	P36-4. Investigation about the usability of the blonanserin patch in patients with schizophrenia 當真菜央1, 竹内一平3, 波多野正和1,2,4, 横井里奈1, 半谷眞七子1, 宇野準二3, 藤田潔3, 岩田仲生4, 亀井浩行1,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1166-1166, 2020.

---

	P36-5. The actual situation of the consultation behavior for the drugstore pharmacist of patients with depression and the interference factor 野田久美子1, 後藤奨一1, 櫻井秀彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1166-1166, 2020.

---

	P36-6. About the effectiveness of the schizophrenia therapeutic drug blonanserin patch in the true clinical practice 宇佐美伶奈1, 竹内一平1,2, 半谷眞七子1, 宇野準二2, 藤田潔2, 亀井浩行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1167-1167, 2020.

---

	P36-7. The effect that efforts for the proper use of the sleeping drug gives for the fall fall incident of the inpatient 坂田将貴1, 堀田彰悟1,5, 奥村啓樹1, 村上佳人1, 肥田裕丈1,5, 太田小織1, 山本雅人1, 梅村朋2,5, 長尾能雅2, 鈴木裕介3, 尾崎紀夫4, 野田幸裕5, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1167-1167, 2020.

---

	P36-8. Investigation about the current situation of the stigma for patients with schizophrenia of the pharmacist working in the health insurance pharmacy in Aichi 成瀬友葵1, 藤井知郎1,2, 室谷健太3, 半谷眞七子1, 亀井浩行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1168-1168, 2020.

---

	P36-9. A case of an alcoholic patient who became bromo-poisoning due to an overdose of the over-the-counter drug Wutt 高見澤誠1, 市川裕平1, 篠原徹1, 箕輪勇紀1, 池田知也1, 島谷晴美2, 渡邉将隆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1168-1168, 2020.

---

	P36-10. Use experience of trazodone for the delirium in our hospital 谷口結基1, 森智世1, 田中美帆1, 太田達也1, 田中章郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1169-1169, 2020.

---

	P36-11. Examination of the fall risk with the medicine before sleep in the inpatient 中原友1, 後藤志典1, 林幹也1, 赤崎淳子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1169-1169, 2020.

---

	P36-12. Investigation of the drug causing the delirium onset in the ICU admission patients after the cardiovascular surgery technique 中田麻里1,2, 喜田昌記1,2, 越塚宏美1,2, 柏原由佳1,2, 田中克巳1,2, 佐々木忠徳2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1170-1170, 2020.

---

	P36-13. Rehospitalization of the bipolar disorder and participation of the pharmacist 山内茜1, 酒井要1, 西嶋長1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1170-1170, 2020.

---

	P36-14. It is the examination of the risk factor in the delirium after the operation that produced opening type stent graft interpolation postoperatively 石川めぐみ1, 大野陽平1, 菅原依里1, 吉見猛1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1171-1171, 2020.

---

	P36-15. Examination of the risk factor of a white blood cell, the neutropenia in Clozapine treated patients 竹内小百合1, 中村奈央1, 幸邦憲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1171-1171, 2020.

---

	P36-16. Examination about the patients adherence judging from the change of the antipsychotics prescription dose before and after the sustained-release parenteral injection introduction in schizophrenia treatment 阿部友江1, 落合理路2,3, 河合真理子1, 榎本了三2, 梁川剛生2, 早坂俊亮4, 鈴木立紀1,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1172-1172, 2020.

---

	P37-1. Relation to the perinatal medical care of the pharmacist specialized in a pregnant woman, a nursing mother in the general hospital 香西祥子1,2, 河西邦浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1173-1173, 2020.

---

	P37-2. Examination about the thyroid disease merger pregnancy 木藤一美1, 橋本隆信1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1174-1174, 2020.

---

	P37-3. 1 case that was given a transplacental prenatal treatment for fetal congenital heart block which antiSS-A antibody-positive pregnant woman had 長瀧谷美樹1, 加島朱梨1, 外山真理奈1, 渡邊宏美1, 紺屋まりや1, 松原侑紀1, 永井絵里子1, 庵森靖弘1, 藤川郁世1, 大津由美子1, 石井陽一郎2, 和栗雅子3, 望月千枝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1174-1174, 2020.

---

	P37-4. Trend of the antiepileptic drug for women of the childbearing age in our hospital 伊藤有美1, 佐藤寛子1, 鈴木秀明1, 滝本典夫1, 池田昇平2,3, 丹羽央佳2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1175-1175, 2020.

---

	P37-5. Using study - fetal movement acceleration measurement recorder (FMAM recorder) of the effect that ritodrine hydrochloride tablets give to fetal movement - 世永由里子1,2, 梁栄治2, 八木慶太2, 森田政義2, 瀬戸理玄2, 鎌田英男2, 渡辺達也1, 伊東明彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1175-1175, 2020.

---

	P37-6. Examination of the effect that a DHA-containing supplement gives to postpartum bleeding 佐藤寛子1, 伊藤有美1, 鈴木秀明1, 滝本典夫1, 石川優子2, 長船綾子3, 梅津朋和3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1176-1176, 2020.

---

	P37-7. The effect that the nursing in our hospital and the current situation and counseling of the foreign counseling about the medicine give in a mother's milk childcare choice 小澤秀介1, 小岩井祥1, 山折大1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1176-1176, 2020.

---

	P37-8. Relations with BMI and the insulin resistance in the carbohydrate metabolism abnormality pregnant woman and the secretion ability 相馬まゆ子1, 野木山史恭1, 山崎布美子1, 佐々木洋一1, 今田愛也2, 山本浩史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1177-1177, 2020.

---

	P37-9. Outcome investigation after the reporting by "the pregnancy, the nursing and medicine consultation duties" 清宮啓介1, 小谷宙1, 三浦あす美1, 鈴木靖奈1, 村松博1, 青森達1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1177-1177, 2020.

---

	P38-1. Questionary survey about the "insulin preparation, GLP-1 receptor agonist chart" making 亀岡大樹1, 金子玲美2, 小幡舞2, 谷聡美2, 宮前文明3, 中野良4, 才野壽子5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1178-1178, 2020.

---

	P38-2. The effect that metformin and proton pump inhibitor combination give to glycemic control 石田翔1, 吉川明良1, 開浩一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1179-1179, 2020.

---

	P38-3. The effectiveness of the SGLT2 inhibitor supplementation in patients with type I diabetes mellitus and safe examination 正村怜那1, 早川伸樹1,2, 津川透1,3, 福井愛子1, 亀井浩行1, 桑原宏貴3, 公文尚子2, 鈴木敦詞2, 山田成樹3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1179-1179, 2020.

---

	P38-4. About the introduction of the osteoporotic allied lecture in the diabetes education inpatient 加藤泉希1,2,3, 石丸隆之1, 野中敏治1, 渡邉洋子2, 馬渡太郎3, 平松真祐2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1180-1180, 2020.

---

	P38-5. One patient who conducted the medication counseling of patients with foreign diabetes that had difficulty in Japanese communication デニヤ智子1, 荒木良介1, 山田英紀1, 石田悠人2, 高橋謙一郎2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1180-1180, 2020.

---

	P38-7. Example that led to healing by medicine for external application therapy and harness wearing for the ulcer of the sole part 西村博之1, 吉田陽1, 塩山由紀1, 守田彩文1, 高田雅文1, 鈴木知子2, 栗並昇2, 稗島州雄2, 梶原敬三2, 杉山正悟2, 陣内克紀2, 陣内冨男2, 陣内秀昭2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1181-1181, 2020.

---

	P38-8. Effect to give a fact and patients of the glycemic control of patients with type 2 diabetes using the FreeStyle livret 宮田絵莉加1, 佐々木雄啓1, 岡村和彦1, 高橋栄子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1182-1182, 2020.

---

	P38-9. Examination of the effectiveness for the liver function improvement of the dapagliflozin and the contributing factor 西村功史1, 花井雄貴1, 山西由里子1, 志村翔大1, 伊藤優紀1, 原敬一3, 松尾和廣2, 坂本真紀1, 西澤健司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1182-1182, 2020.

---

	P38-10. Search of the fact-finding of the clinical inertia in patients with type 2 diabetes and effect factor 喜多力1, 真井雄規1, 村上智香1, 石田陽美1, 金住麻子1, 三本松泰孝1, 佐藤弘康1, 和泉秀明1, 田村広志1, 渡辺浩明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1183-1183, 2020.

---

	P38-11. Dispatch ... to the area that it merged on efforts 2019 - world diabetes day in our hospital for diabetes 河村紳介1, 丸井志織3, 原田雅子3, 中村正光4, 芝原裕和4, 鈴木聡史5, 安江誠人5, 山下香織6, 朝井康雄7, 槇野裕也2, 大石裕子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1183-1183, 2020.

---

	P38-12. Difference in recognition degree between the multi-types of job in the insulin consultation in the team approach in medical care 氏川郁穂1, 向井淳治1,2, 竹原涼子1, 木村実央1, 奥田広志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1184-1184, 2020.

---

	P38-13. One case of patients with type 2 diabetes that developed diabetic ketoacidosis during SGLT2 inhibitor internal use 新屋友理1, 太田充2, 野村暢彦1, 安田浩一朗2, 高橋一栄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1184-1184, 2020.

---

	P38-14. Attitude survey about the internal use drug control in our hospital diabetes education inpatient 田口諒1, 高柳昌宏1, 渡邊清人1, 元木孝1, 綱島道子1, 目谷莉紗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1185-1185, 2020.

---

	P38-16. Establishment of the exact assay of diabetes marker 1,5-anhydroglucitol by the high-speed liquid chromatograph tandem mass spectrography 本橋秀之1, 木村遥華1, 井辻真由1, 竹林裕美子1, 永井純也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1186-1186, 2020.

---

	P38-17. Examination about the stability under a high temperature bottom of insulin glargine and the non-shading 辻本勉1, 井上智咲1, 田崎眞生1, 濱宏仁1, 大川恭子1, 豊原朋子1, 桑原晶子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1186-1186, 2020.

---

	P38-19. Investigation about the effect of oral hypoglycemics on sugar toxicity cancellation in patients with type 2 diabetes 丹代恭太1, 工藤晋1, 鈴木弘文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1187-1187, 2020.

---

	P39-1. Evaluation of the PCSK9 inhibitor Evolocumab for dyslipidemia in chronic kidney disease (CKD) patients 田杭直哉1, 佐藤淳子1, 近藤匡慶1, 菅谷量俊1, 高瀬久光1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1188-1188, 2020.

---

	P39-2. Examination of renal function evaluation after administration of romosozumab subcutaneous injection 田村悟1, 中村智1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1189-1189, 2020.

---

	P39-3. Examination of the usefulness in the pharmacist company of foreign maintenance dialysis rounds 伊藤真史1, 木下照常2, 近藤洋一2, 滝本典夫2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1189-1189, 2020.

---

	P39-4. Investigation about the phosphorus content in pharmaceutical products prescribed for haemodialysis patients 柏倉康治1, 内田信也1, 茂木麻里奈1, 瀬戸川陸1, 鈴木寛1,2, 田中紫茉子1, 山内克哉2, 影山慎二3, 並木徳之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1190-1190, 2020.

---

	P39-5. Questionary survey about the medical cooperation using the CKD seal 佐藤淳子1,2,3, 田杭直哉1, 柴田まり子2, 浅井梨沙3, 菅谷量俊1, 金子朋広3, 高瀬久光1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1190-1190, 2020.

---

	P39-6. Association between effect on patients with childhood nephrotic syndrome and side effect of the mycophenolate mofetil 小林未佳1, 長嶺歩1,2, 八島秀明2, 高橋恵美利1, 高橋雄太1, 大林恭子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1191-1191, 2020.

---

	P39-7. Roxadustat use experience in hospitalized patients 乙竹慧未1, 寺尾育恵1, 穂積廣1, 加藤香奈1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1191-1191, 2020.

---

	P39-8. Effect on renal function of the SGLT-2 inhibitor in patients with diabetic nephropathy third 北條文啓1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1192-1192, 2020.

---

	P39-9. Effect of the pamphlet in the CKD prophylactic enlightenment exercise 中澤幸恵1, 石川若菜2, 高木春香2, 小路麻梨恵2, 菊池舞子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1192-1192, 2020.

---

	P39-10. The elucidation of the multifaceted effect of the Neurotropin and application to renal disease 門脇大介1,2, 福永雅樹1,3, 内田朱美1, 末吉美優1,3, 前田仁志3, 成田勇樹3, 渡邊博志3, 丸山徹3, 瀬尾量1,2, 平田純生3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1193-1193, 2020.

---

	P40-1. Brochure making and understanding degree investigation for elderly people for frailty common knowledge 杉山朋美1, 布井祥映1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1194-1194, 2020.

---

	P40-2. Examination of confirmation of the drug-taking behavior of the elderly patients by the pharmacist using the electronic medication calendar and the effect 田中李奈1, 菊池千草1,2, 小田切州広1, 松波晋平3, 鈴木匡1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1195-1195, 2020.

---

	P40-3. Efforts to polypharmacy improvement using STOPP criteria in our hospital convalescent rehabilitation ward 三島直也1, 猪木摩耶子1, 坂本健太郎1, 光山忠史1, 桶東愛史1, 桑田益希1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1195-1195, 2020.

---

	P40-4. Efforts to the benzodiazepine receptor agonist consumption decrease in patients with old cancer 橋本未雷1, 松藤敬佑1, 薮内由里香1, 池田澪樺1, 松元俊博1, 三角紳博1, 西嶋智洋2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1196-1196, 2020.

---

	P40-5. Participation of the pharmacist in bringing medicine hearing in the local inclusion care ward and medical security 新見奈々1, 川上恭弘1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1196-1196, 2020.

---

	P40-6. Relations with frailty and the medical therapy in local elderly people: Nakajimacho study 吉川由華1, 丸一泰雅1, 石田奈津子1, 菅幸生1, 松下良1, 石崎純子1, 横川正美2, 篠原もえ子3, 駒井清暢4, 山田正仁3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1197-1197, 2020.

---

	P40-7. Association between blood vessel function (CAVI) and frailty in the medical examination testee 櫻井穂香1, 新木美枝1,2, 高橋恵美利1, 高橋雄太1, 林邦彦3, 大林恭子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1197-1197, 2020.

---

	P40-8. Of the polypharmacy team activity in the acute phase hospital where is specialized in elderly people, actually 小原朋也1, 片原憂斗1, 瀧川美和1, 島崎良知1, 森淑子1, 石川讓治2, 岩切理歌3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1198-1198, 2020.

---

	P40-9. Fact-finding of the drug global assessment addition in the acute phase hospital 宮田知世1, 伊藤有美1, 小笠原理恵1, 木下照常1, 本間崇正1, 林睦菜1, 柴田大地1, 菅原さやか1, 滝本典夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1198-1198, 2020.

---

	P40-10. The effect that the polypharmacy of elderly people gives to hospitalizations 中野智尋1, 宇夛裕基1, 竹田和喜1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1199-1199, 2020.

---

	P40-11. Factor analysis to influence multiple drug prescription and prescription complexity in the medical therapy of elderly people 亀田敬子1, 佐古渚1, 小川沙織1, 木本信介1, 山田周平1, 西田直史1, 福澤祐幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1199-1199, 2020.

---

	P40-12. Adequacy and economic effect of the medication in the care health center for the elderly 浅野志津1, 川上隆弘1, 日浦亜実2, 江尻東伍3, 近藤昭3, 横山祐二3, 森英樹2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1200-1200, 2020.

---

	P40-13. One case that medication compliance and ADL improved by the home medical treatment management instruction by the community pharmacy pharmacist 早川貴司1, 田中淳2, 藤田あゆみ3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1200-1200, 2020.

---

	P41-1. Background investigation of patients with acute acetaminophen poisoning in our hospital 平良木由布1, 波多野亘1, 島田祐子1, 川上陽介1, 寺島達也1, 五十嵐大輝1, 堀寧1, 広瀬保夫2, 吉田暁2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1201-1201, 2020.

---

	P41-2. Questionary survey about the medication adherence of the patients with the cardiovascular system disease 菅原隆文1, 吉川明良1, 薮田理子1, 洲山佳寛1, 開浩一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1202-1202, 2020.

---

	P41-3. It is an example with suspected adrenal insufficiency onset with the internal use cancellation of betamethasone/d- chlorpheniramine maleate combination drug (celestamine combination tablets) 宮下博幸1, 斎藤太寿2, 松原肇1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1202-1202, 2020.

---

	P41-4. Five examination that were able to achieve the LDL-C management that continued by PCSK9 inhibitor administration 山本高範1, 田中剛史2, 阿部康治1, 後藤浩之2, 福岡秀介3, 川崎敦3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1203-1203, 2020.

---

	P41-5. Examination about the heart failure improvement effect of the tolvaptan 松尾有美1, 宮川泰宏1, 岸里奈1, 千崎康司1, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1203-1203, 2020.

---

	P41-7. Search of the background factor of patients with upper gastrointestinal bleeding that required endoscopic treatment in our hospital 藤田謙1, 朝倉美加1, 鈴木結利花1, 大竹満博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1204-1204, 2020.

---

	P41-8. The effectiveness, safe comparison of Linaclotide and the agate Pross ton in elderly people 下坪達人1, 石郷友之1, 北川学1, 木明智子1, 中田浩雅1, 宮本篤1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1205-1205, 2020.

---

	P41-9. Effect of the nitrosylation of the Protein disulfide isomerase substrate binding domains in nerve cells 小倉次郎1,2, Lloyd Ruddock2, 眞野成康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1205-1205, 2020.

---

	P41-10. For lower limbs ischemia-related chronic pain of the peripheral arterial disease, it is a case using the fen toss (R) tape 大荒政志1, 坂本真衣1, 増田博也1, 久岡清子1, 勝田真理2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1206-1206, 2020.

---

	P41-11. Examination of the measurement of the inspiratory flow rate by in-checkDIAL and the inhalational management 西村淳1, 玉井典子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1206-1206, 2020.

---

	P41-12. Investigation of the GI bleeding onset situation in patients who underwent PCI 朝倉美加1, 藤田謙1, 鈴木結利花1, 大竹満博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1207-1207, 2020.

---

	P41-13. It is an investigation about the non-proper use of the oral anticoagulant drug directly 石福奈々1, 今浦将治1, 菅野浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1207-1207, 2020.

---

	P41-14. Examination of the initial starting dose of the Elobixibat 荒川正悟1, 旭将来1, 小野元久1, 片野貴大1, 徳田富妃子1, 山口智江1, 宮原兼二1, 木南志朗1, 伊藤功治2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1208-1208, 2020.

---

	P41-15. Problem ... of the pharmacist by acute phase hospital and polypharmacy measures ... multi-type of job team 小倉弥生1, 松本知之1, 下田麻祐子1, 江原可成子1, 大木孝夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1208-1208, 2020.

---

	P41-16. About a change of the gut flora in the social defeat stress load depression model mouse 吉本和佳1, 上村祐介1, 桑垣衣里奈1, 濱野咲佳1, 高畑祐香1, 安川岳志2, 森本博俊2, 魚住嘉伸2, 高山健太郎1, 長澤一樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1209-1209, 2020.

---

	P41-17. Protective efficacy of magnesium oxide for the inflammatory bowel disease onset in the mouse 大嶋廉之1, 浅田あゆみ1, 河本実季1, 宮永佳代1, 高山健太郎1, 長澤一樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1209-1209, 2020.

---

	P41-18. The usefulness evaluation of the standard manual in the inhalational maneuver acquisition and examination of the pit hall 齋藤友里菜1, 高橋恵美利1, 前田恵里1, 岡田裕子1, 高橋雄太1, 土井信幸1, 堀江健夫2, 大林恭子1, 根本明日香3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1210-1210, 2020.

---

	P41-19. About safety of the anticoagulation after the transcatheter left auricle closure technique 友納保幸1, 波多江沙織1, 木原慶子1, 北島聖也1, 前田朱香1, 富田敏章1, 入江利行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1210-1210, 2020.

---

	P41-20. The effect that use of metformin results in for the ADL evaluation of elderly patients admitted to the convalescent rehabilitation ward 花岡峻輔1, 丸野翠1, 林宏行1, 平井利幸2, 関利一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1211-1211, 2020.

---

	P41-22. The role of the pharmacist in the heart failure conference and the future prospects 松田有加1, 萩野佑紀1, 森塚亮太1, 宮崎俊明1, 筒井由佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1212-1212, 2020.

---

	P41-23. It is an example receiving the Empagliflozin for heart failure to assume expansion phase hypertrophic cardiomyopathy primary disease 松村泰斗1, 安島秀友1, 中薗健一1, 松崎貴志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1212-1212, 2020.

---

	P41-24. It is two patients using the continuous intravenous infusion of oxycodone for patients with terminal heart failure who had the severe impaired renal function 高橋未來1, 中田和宏1, 木村美由喜1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1213-1213, 2020.

---

	P41-25. Efforts to the edoxaban proper use in a thighbone trochanter part, the cervical bone fracture surgery pass 西倉教子1, 内海敦志1, 吉川昌子1, 横山匠太1, 長田一晃1, 田中正宏2, 三保成正3, 原田靖子1, 西原昌幸4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1213-1213, 2020.

---

	P41-26. Analysis about the PT-INR level under the warfarin introduction after the prosthetic replacement 森岡朝美1, 清水倫子1, 山本和宏1, 大村友博1, 井上武2, 岡田健次2, 矢野育子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1214-1214, 2020.

---

	P41-27. Use fact-finding of the mirogabalin 佐藤智香1, 寺西真凜1, 高橋直也1, 八木遥1, 大橋史嵩1, 岩堀真弓1, 田中あさ子1, 坂本華代1, 東修司1, 齊藤俊一郎1, 和泉秀明1, 田畑裕和1, 小原郁司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1214-1214, 2020.

---

	P41-28. Examination of the objective pain evaluation of pregabalin using the pain degree measurement for the anal pain derived from neuropathy 猿渡康宏1, 丸田佐知子1, 伊藤由希1, 寺本拓哉1, 水本智子1, 平井裕子1, 中島みどり2, 小林伸行3, 高野正太4, 高野正博4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1215-1215, 2020.

---

	P41-29. Verification of the effect of promoting the use of generic drugs, etc. by formulating in-hospital formularies 森木邦明1, 安達真紀子1, 金田達也1, 島田美樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1215-1215, 2020.

---

	P41-30. Comparison of the analgesic effect of ad usum externum NSAIDs using PainVision 寺山和利1, 渡部多真紀1,2, 安野伸浩1,2, 榎本弘美2, 土屋雅勇2, 渡辺茂和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1216-1216, 2020.

---

	P41-31. One case that hydromorphone immediate-release was effective for dyspnea of patients with terminal heart failure 中村眞梨1, 芝崎由美子1, 中村智弘2, 野村淳1, 石田岳史2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1216-1216, 2020.

---

	P41-32. A serum zinc level in front of the art is ... examining significance of the zinc supplement in addition investigation - preoperation about relations with the hospitalization after the operation 山本文哉1, 金田知詞2, 蟻川勝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1217-1217, 2020.

---

	P41-33. Role of the sea lion microglia as the sensitivity determinant of the mouse for the social defeat stress to induce depression-like behavior and the gut flora 桑垣衣里奈1, 上村祐介1, 濱野咲佳1, 高畑祐香1, 吉本和佳1, 西村周泰2, 高田和幸2, 安川岳志3, 森本博俊3, 魚住嘉伸3, 高山健太郎1, 長澤一樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1217-1217, 2020.

---

	P41-34. Examination of the factor associated with the eye drops adherence in patients with glaucoma 大江泰1,2, 柴谷直樹1,2, 平野達也1,2, 宮坂萌菜1,2, 藤原雅史3, 室井延之1,2, 橋田亨2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1218-1218, 2020.

---

	P41-35. Comparison about the effectiveness, the safety between the JAK inhibitor 白崎佑磨1, 土江亜季1, 吉田三矢1, 辰己晃造1, 田路章博1, 吉野宗宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1218-1218, 2020.

---

	P41-36. Visualization of the evidence of the pharmacist professional ability 高倉和茄1, 酒井隆全1, 田辺公一1, 大津史子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1219-1219, 2020.

---

	P41-37. The prescription situation of the dyslipidemia therapeutic drug for the coronary disease history case before and after the guidelines revision 米屋安佳里1, 小泉桂1, 飯田遼1, 黒澤亮太1, 色川正憲1, 堀越建一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1219-1219, 2020.

---

	P42-1. Approach at trial case arrangement of our hospital 小野田稔久1,2, 佐久間清1, 佐藤啓1, 西澤健司2, 増田雅行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1220-1220, 2020.

---

	P42-2. The case that a clinical experimental medicine and the causation judgment of the adverse event were carried out appropriately 齊田翌美1,2, 市下由美1, 白澤宏美1,2, 宮本聖子1,2, 吉井薫1, 宮本美穂1, 正代敦子1, 花田聖典2, 鶴崎泰史5, 藤本和輝3, 中川義浩1,2, 富田正郎4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1221-1221, 2020.

---

	P42-3. Introduction of the point list for the purpose of the appropriate calculation of the clinical experimental medicine administrative expense 佐藤佑樹1,2, 角山政之1,2, 深川恵美子1,2, 井廻裕美1,2, 木村優美1,2, 小林真理1,2, 上代大地1,2, 田中惇子1,2, 西垣内亮1,2, 村瀬哲也1, 梅本誠治2, 松尾裕彰1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1221-1221, 2020.

---

	P42-4. Investigation about the examination of the prevention of narcotic abuse preparation for the medical care in the United States 松崎哲郎1, 奥村啓樹1, 永井拓2, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1222-1222, 2020.

---

	P42-5. The current situation and problem of the clinical experimental medicine management in the clinical studies core hospital 浅野智央1, 久保晶子1, 佐々木真緒1, 住吉愛1, 平山久美子1, 今泉克明1, 橋本浩伸1, 近野健一1, 山口正和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1222-1222, 2020.

---

	P42-6. Examination about the temperature change of the cooling box (cubic) equipped with a traceability system in the clinical experimental medicine administrative work 遠又未佐子1, 松井周一1, 岡村央1, 勝亦秀樹1, 後藤洋仁1,2, 小池博文1, 佐橋幸子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1223-1223, 2020.

---

	P42-7. Approach for the prevention of protocol deviation in the clinical experimental medicine administrative work of the university hospital 中村夏季1,2, 家田正子1, 川瀬智子1, 井上真理也1, 若林巨樹1, 木寺康裕1, 嶋野裕人1, 福岡和也1, 竹上学2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1223-1223, 2020.

---

	P43-1. Dilemma regarding drug therapy in home palliative care - Possibility of questionnaire survey and gamification 工藤信孝1, 柴田弘子2, 山田貴代加3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1224-1224, 2020.

---

	P43-2. One case that was given the switching from an oxycodone note to a morphine note in the home care of the cancer terminal patient 出口昌孝1, 石橋祐子1, 山本真希1, 伊藤朋子2, 山際健太郎3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1225-1225, 2020.

---

	P43-3. Observational study of the medication situation in being at home 加納美知子1,2, 阿部智子3, 赤嶺有希子2, 田中詳子1,2, 澤井一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1225-1225, 2020.

---

	P43-4. About the way of the reporting at infection problem occurrence for foreign inhabitants with the language barrier 池浦恵1, 入野真規子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1226-1226, 2020.

---

	P43-5. Questionary survey for the person of health insurance pharmacy next situation for the purpose of the treatment at home promotion, and the like 興村桂子1, 大柳賀津夫1, 岡本晃典1, 木下慧1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1226-1226, 2020.

---

	P43-6. Efforts by the pharmacist to choose the optimal thickness agent along the needs of the caregiver 松原つばさ1, 水口真咲美1, 朝倉恵美子1, 武山則行1, 大橋千加1, 大橋哲也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1227-1227, 2020.

---

	P43-7. 1 case that was given pain control by the dose change that the distribution of the drug for the medical care grieved at for New Year holidays 木村拓哉1, 堀里圭2, 田村章子2, 渡邉佐智代2, 安井久美2, 輪嶋美幸2, 櫻井真理子1,2, 森厚司1, 山本有人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1227-1227, 2020.

---

	P43-8. Investigation about the enforcement situation of the online medication counseling in the national strategy special ward 廣部祥子1,2,3,4, 犬飼萌乃2, 横山俊之5, 大門力男5, 松浦伸史5, 田中亮太5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1228-1228, 2020.

---

	P43-9. Role of the drugstore pharmacist by the community medical care to examine from needs of the Care manager 村木紗1, 本舘秀樹2, 永井亜矢子1, 青木雅和1, 山本歩実1, 堀祐輔3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1228-1228, 2020.

---

	P43-10. Education support to the care staff by the pharmacist aiming at pharmaceutical products proper use promotion 伊東佳美1, 坂東勉1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1229-1229, 2020.

---

	P43-11. Association between social index and medical drug consumption about home medical treatment person, the home dead according to the metropolis and districts 杉野若菜1, 田辺公一1, 市橋亮一2, 西城卓也3, 酒井隆全1, 大津史子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1229-1229, 2020.

---

	P43-13. Efforts to osteoporotic risk assessment using FRAX in the Fukugami ethical pharmacy 光岡ゆり1, 安藤伸一郎1, 小庄修明1, 堤葵1,2, 竹尾正典1,3, 大光正男2, 石丸隆之3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1230-1230, 2020.

---

	P43-14. Practice ... of the community medical care cooperation in efforts - NICU/GCU of the pharmacist in the growth medical care 大西知絵1, 溝口和代1, 阿部康治1, 内薗広匡2, 栗本淳子3, 林眞砂子4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1231-1231, 2020.

---

	P43-15. Appropriateness-related inspection (the second report) of constipation and the use in at-home adult patients of laxative 櫻澤恵里香1, 神山瑛美1, 柳澤沙織1, 高橋恵美利1, 高橋雄太1, 岡部美保2, 棚橋さつき2, 大林恭子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1231-1231, 2020.

---

	P43-16. Utilize ICT (hydrangea net) in the terminally ill patients and the low caregiver of Functional status; the efforts case from a discharge to a shift at home that is No stress 鈴木智香子1, 小徳由梨絵1, 岩高美帆1, 大島聖也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1232-1232, 2020.

---

	P43-17. Fact-finding of the inhalational instruction to the home care patient in the Minamikawachi, Osaka district 松下一樹1, 和田宜久1, 木村貴1, 木澤成美1, 金銅葉子1, 松野治2, 源誠二郎2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1232-1232, 2020.

---

	P43-18. Role (the first report) of the insurance pharmacist in the care conference of the care pay nursing home belonging to 塚本賢児1, 徳山智治2, 磯尾優子2, 穴見江梨子3, 坂本豊伸4, 天方奉子5, 稲葉一郎5, 宮野恭彰6, 木戸宏幸6, 湯川栄二6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1233-1233, 2020.

---

	P43-19. About 1 case that felt importance of the medicine medicine cooperation again to connect to being at home 島袋優花1, 浜元善仁1, 翁長真一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1233-1233, 2020.

---

	P43-20. The development of the at-home pharmacy management standard vote to evaluate the duties of the pharmacist by the treatment at home and the current situation investigation 角明香里1,2,3,4, 柴田賢三2, 宇野達也2, 室谷健太3, 坂巻弘之4, 亀井浩行1, 半谷眞七子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1234-1234, 2020.

---

	P43-21. One case that was able to prevent becoming severe by the periodical visit of the community pharmacy pharmacist 土井武司1, 田中淳2, 堀高之1, 三久裕子1, 藤田あゆみ3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1234-1234, 2020.

---

	P43-22. Control improvement case by the device choice of the inhalant in elderly people 飯征士1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1235-1235, 2020.

---

	P43-23. One case that saw symptom improvement by suspecting a side effect in the elderly patients whom culf edema appeared, and prescribing it, and having suggested it 新井尚1, 藤田あゆみ2, 八木澤恭子3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1235-1235, 2020.

---

	P43-24. Usefulness of the Parkinson notebook (symptom diary) in the advanced Parkinson's disease patients 中野雄介1, 藤田あゆみ2, 吉岡聖子2, 杉浦伸哉2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1236-1236, 2020.

---

	P43-25. Example that we were able to conduct appropriate medication by the cooperation with the care job in the local inclusion care system 荻野純基1, 吉岡聖子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1236-1236, 2020.

---

	P43-26. One case that medication management became appropriate by the home visit to the elder-to-elder nursing household by the community pharmacy pharmacist 宮田成康1, 吉岡聖子2, 藤田あゆみ3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1237-1237, 2020.

---

	P43-27. As a member of all human supporters in local palliative care and medicine medicine cooperation - palliative care ... 白石丈也1, 笠原庸子2, 谷川大夢3, 廣原正宜4, 串田一樹4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1237-1237, 2020.

---

	P44-1. Establishment of Drug-Drug Collaboration in Cancer Chemotherapy -Through the Chemo x Cross Roundtable - 嶋田紘也1, 博田舞子1, 藤田美涛1, 荻野未希1, 王恵理佳1, 宮崎有紀2, 大町由佳3, 江島彩子4, 佐久間理紗5, 野村貴一6, 中畔勇一7, 平岩知子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1238-1238, 2020.

---

	P44-2. Regimen information to outside Parliament prescription, change of the patients outcome by the indication of the clinical test value 川口文誉1, 常木隆史1, 金子憲太郎1, 川村僚一朗1, 土井路子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1239-1239, 2020.

---

P44-3. It is ... for the effect of the prescription notebook pasting regimen that we made in "a meeting thinking about the medicine medicine cooperation of the Chita Peninsula area" and the altitude pharmacy management practice of problem - area 奥田佳苗1, 伴晶子2, 土井直美2, 佐藤知香2, 古田麻衣子2, 森田奨2, 早川裕二3, 加藤雅斗3, 大平勇二4, 石川奈央佳4, 小田浩史5, 三島江津子6, 永松秀紹6, 堀崎和美7, 服部聡8, 上地小与里9 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1239-1239, 2020.

---

	P44-4. Evaluation after the setup of the local cancer medicine medicine cooperation workshop and the operational start 片桐将志1, 佐野嘉容子1, 中西順子1, 篠永浩1, 原田典和1, 加地努1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1240-1240, 2020.

---

	P44-5. We investigate a problem to improve the telephone medication follow approval rate to the foreign cancer medical treatment patients in the health insurance pharmacy assuming the medicine medicine cooperation 西村碧1, 横田恵子1, 田中真美1, 難波春香1, 松本久美子1, 田島香1, 門温子1, 吉留実慧子2, 尾上雅英3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1240-1240, 2020.

---

	P44-6. Efforts of "the Sapporo Higashi-ku cancer medical care pharmacist workshop" and usefulness evaluation - medicine medicine cooperation and local overall efforts ... 徳留章1,2,3, 鈴木直哉3,4, 辻裕太3,5, 藤村拓也3,6, 谷口亮央3,7, 菊池健3,8, 武田清孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1241-1241, 2020.

---

	P44-7. Examination ... of the usefulness of the tracing report in the cooperation reinforcement (3) - Swertia Herb station of a health insurance pharmacy and the hospital 清水有由実1, 後藤政之1, 岩井久美子1, 森厚司2, 舩木志保3, 石原祥子4, 大谷寧次郎4, 三浦毅4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1241-1241, 2020.

---

	P44-8. Construction of the drug control instruction record on the basis of drug control summary and PIMs 田畑寛明1, 若林厚史1, 辻依利1, 高橋彩1, 猿谷淳1, 向一美1, 地野幹子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1242-1242, 2020.

---

	P44-9. The effect that a prior agreement protocol gives to the duties reduction of the physician 間瀬広樹1,2, 有原大貴3, 矢野涼子4, 坂野由宇希5, 乙田雅章5, 綿谷敏彦5, 室谷理沙3, 山方基寛3, 齋藤讓一3, 秋山哲平3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1242-1242, 2020.

---

P44-10. Evaluating the usefulness of holding a pharmaceutical-pharmaceutical-collaboration group work-type workshop for the dissemination of the "fava bean sticker", a notification sticker for patients with decreased renal function 飯塚康人1, 佐藤邦宣2, 村井華代3, 藤田雄一4, 溝井武尊5, 永田隆之1, 鈴木隆広6, 赤津雅美5, 吉川真一1, 渡邉義久1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1243-1243, 2020.

---

	P44-11. Efforts to the medicine medicine cooperation using the inhalational instruction manual 吉本有里1, 飯田優美1, 東島幸道1, 佐澤卓哉1, 尾崎紗緒理1, 大坪輝行1, 大丸素子1, 伊南裕子1, 山脇一浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1243-1243, 2020.

---

	P44-12. About the duties burden reduction effect of the outside Parliament prescription doubt inquiry simplification protocol in the Kyoritsu Kanbara General Hospital 渡辺俊輔1, 竹下秀司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1244-1244, 2020.

---

	P44-13. Outcome inspection of the pharmacist cooperation by the interactive information sharing through the tracing report 河本由紀子1,2, 佐久間美佐緒2, 奥貞智2, 増本憲生2, 池末裕明2, 室井延之2, 橋田亨2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1244-1244, 2020.

---

	P44-14. Usefulness of the telephone follow-up for the Lenvatinib remedy patients in the health insurance pharmacy 岡水涼1, 春日真由1, 櫻下弘志2, 佐伯康之2, 畝井浩子2, 松尾裕彰2, 重留佳代子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1245-1245, 2020.

---

	P44-15. The prior agreement doubt inquiry protocol introduction effect in the outside Parliament prescription and personnel expenses reduction effect of the physician 内山将伸1, 宮崎元康1, 佐々木宏子2, 隠地智也3, 田宮彰子4, 横枕正隆5, 鵜木亜矢子1, 後藤美和1, 松尾宏一1, 今給黎修1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1245-1245, 2020.

---

	P44-16. The operation of the practical participation type group discussion pattern study session using the virtual prescription of the cancer domain and the evaluation 三浦篤史1,2,3, 淺野未代子2, 鬼窪利英1,2, 大輪武司2, 中村久美1,2, 野村充俊1,2, 松原重征2, 向山百合1,2, 村田稔弥2, 吉澤貴代美2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1246-1246, 2020.

---

	P44-17. The current situation investigation of the discharge teachers' textbook in the medicine medicine cooperation 稲葉未来1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1246-1246, 2020.

---

	P44-18. It is ... for the current situation investigation and the revision of cooperation reinforcement (1) - inhalation instruction request book, the report of a health insurance pharmacy and the hospital 野村祥子1, 石原祥子1, 大谷寧次郎1, 村松秀樹2, 三浦毅1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1247-1247, 2020.

---

	P44-19. Evaluation of the physician for "the prior agreement protocol in the outside Parliament prescription" 山方基寛1, 間瀬広樹2, 矢野涼子3, 室谷理沙1, 齋藤讓一1, 秋山哲平1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1247-1247, 2020.

---

	P44-20. Operational findings of the offer book such as medication information, and the like in the Kyoritsu Kanbara General Hospital 松本すずか1, 渡辺俊輔1, 竹下秀司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1248-1248, 2020.

---

	P44-21. Efforts (the second report) of the medicine medicine cooperation through foreign cancer treatment in our hospital 塚原邦浩1, 原田晃典1, 小倉秀美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1248-1248, 2020.

---

	P44-22. Evaluation of an investigation and the study session of feelings and the understanding degree of the insurance pharmacist before and after the medicine medicine cooperation study session of the cancer domain 小澤有輝1, 猪狩賢蔵1, 草野淳一1, 山本龍世1, 吉田蘭子1, 林誠一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1249-1249, 2020.

---

P44-23. Efforts ... which collaborated in a health insurance pharmacy pharmacist, hospital pharmacist about health insurance pharmacy and cooperation reinforcement (2) - foreign inhalational instruction of the hospital 山洞直樹1,4,6, 清水有由実1,4, 増田博一1,5, 山田安夫1,4, 前田深佳子1,4, 圓城寺和胤1, 鳥飼明生1, 飯田昭宏1,2, 石原祥子1,2, 濱浦弘光1,2, 野村祥子1,2, 水野彩1,2, 木澤翠1,2, 高橋果歩1,2, 三浦毅1,2, 村松秀樹1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1249-1249, 2020.

---

	P44-24. Efforts report (the second report) - of the meeting thinking about medicine medicine cooperation activity - KAMAKURA medicine medicine cooperation in Kamakura-shi in 2019 宮田祐一1, 門谷靖裕1, 岩崎睦1, 小川亮子2, 鈴木大介2, 金林茂2, 中村雅敏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1250-1250, 2020.

---

	P44-25. An evaluation of the medicine medicine cooperation business in the cancer domain and future problem 大澤友裕1, 安田昌宏1, 梅田道1, 渡邉久高1, 牧野哲平1, 長屋雄大1, 甲田明英1, 堀晃代1, 田中和秀1, 水井貴詞1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1250-1250, 2020.

---

	P44-26. Efforts aiming at improvement of the quality of the prescription notebook seal in the foreign cancer chemotherapy 其田学士1, 岩井裕香1, 森本明美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1251-1251, 2020.

---

	P44-27. Efforts of the hospital pharmacist for the childhood treatment at home 西川真璃絵1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1251-1251, 2020.

---

	P44-28. Cooperation example after the hospital transfer utilizing the drug control summary with the writing a postscript of the multiple drug adjustment system 根上朋子1, 吉岡睦展1, 杉生雅和1, 石津智司1, 若松雄太1, 小澤拓1, 高子優子1, 馬淵英一郎2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1252-1252, 2020.

---

	P44-29. Usefulness of the outside Parliament prescription doubt inquiry simplification protocol 野田聖奈子1, 柿原圭佑1, 原田智子1, 篠崎千尋1, 三上忠司1, 松尾琴美2, 城野美奈子3, 藤井裕史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1252-1252, 2020.

---

	P44-30. About the cooperation of a health insurance pharmacy and the medical institution utilizing the CKD seal 遠藤大介1, 木元慎一郎1, 和田泰明2, 鈴木岳瑠1, 加藤寛史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1253-1253, 2020.

---

	P44-31. Examination of stocktaking and the problem after the doubt inquiry simplification protocol introduction 北田絢子1, 飯塚由佳1, 天野正康1, 富田歩子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1253-1253, 2020.

---

	P44-32. Questionary survey about the test value indication in the outside Parliament prescription 福澤美夕1, 西本辰徳1, 益崎和也1, 山崎恵子1, 清水裕彰1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1254-1254, 2020.

---

	P44-33. The making of the illness medicine cooperation tool in the follow-up to the use of drug patients for the medical care and the effect 山根孝太1, 熊谷岳文2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1254-1254, 2020.

---

	P44-34. About the operation of the local inhalational instruction cooperation system to work on altogether in a hospital, a medical office, the health insurance pharmacy 江口彩香1, 水谷妙子1, 田中文1, 榊間絢子1, 横山征史1, 前澤優圭1, 浜至寛1, 登内盛治1, 蜂谷勤2, 浜峰幸2, 木本昌伸2, 平林太郎2, 高林康樹3, 小松佳道4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1255-1255, 2020.

---

	P44-35. An example of the regional alliances that made at-home return be successful from a local inclusion care ward 川村大輔1, 増田博也1, 久岡清子1, 高塚陽子2, 川口怜子2, 三浦朗子3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1255-1255, 2020.

---

	P44-36. Establishment of Akabeko Net, a local pharmacist network 成田浩気1, 木本真司1, 河原史明1, 香内綾1, 安齊泰裕1, 原田伸彦1, 平山拓史1, 星美奈子1, 山田麻帆1, 木村俊介1, 塩川秀樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1256-1256, 2020.

---

	P44-37. Efforts to the cooperation full addition acquisition for improvement in quality of the foreign cancer chemotherapy 竹田優作1, 川瀬洋次1, 浅野寿規1, 杉野善彦1, 大島有美子1, 堀田敏之1, 桜田宏明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1256-1256, 2020.

---

	P44-38. Count investigation of the doubt inquiry contents for the outside Parliament prescription in our hospital 西澤英之1, 堀智貴1, 吉岡奈津恵1, 福森洋之1, 水川恵2, 生島繁樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1257-1257, 2020.

---

	P44-39. Construction of the local inhalational instruction cooperation system to work on altogether in a hospital, a medical office, the health insurance pharmacy 横山征史1, 水谷妙子1, 田中文1, 榊間絢子1, 江口彩香1, 前澤優圭1, 網野一真1, 登内盛治1, 蜂谷勤2, 濱峰幸2, 木本昌伸2, 平林太郎2, 高林康樹3, 小松佳道4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1257-1257, 2020.

---

	P44-40. A medical institution and the cooperation promotion DVD making of the health insurance pharmacy and evaluation by the audience questionnaire 川澄賢司1, 松井礼子1, 下村直樹2, 縄田修一3, 村田勇人4, 長久保久仁子5, 片倉法明6, 田中康裕7, 遠藤一司8, 安原眞人9 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1258-1258, 2020.

---

	P44-41. Recognition investigation of the family drugstore in the Gifu comprehensive medical care center 田中佳子1, 渡部実咲1, 関谷泰明1, 井上壽江1, 平下智之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1258-1258, 2020.

---

	P44-42. Allergic information sharing using the outside Parliament prescription 畑山未来1, 中野有瑛1, 工藤滉大1, 馬場啓貴1, 西舘尚子1, 坂口修治1, 中村一成1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1259-1259, 2020.

---

	P44-43. The effect that a test value mention gives for use dose adequacy based on renal function on outside Parliament prescription 中野剛志1, 石坂敏彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1259-1259, 2020.

---

	P44-44. Usefulness of the medicine medicine cooperation of the pharmacist in patients with heart failure 萩野佑紀1, 筒井由佳1, 宮崎俊明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1260-1260, 2020.

---

	P44-45. Efforts for the cooperation full addition accompanied with the 2020 medical service fees revision 上淵未来1, 土井裕美子1, 志間裕介1, 伊藤裕美1, 泉勇成1, 西村秀洋2, 市川康子1, 藤井憲一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1260-1260, 2020.

---

	P44-46. Effect of the doubt inquiry prior agreement protocol introduction 鈴木剛1, 中居肇1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1261-1261, 2020.

---

	P44-47. Efforts about the tracing report spread in Iwakuni-shi 尾崎誠一1,2, 廣子真大2, 河田尚己2, 渡辺宗男2, 松久哲章2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1261-1261, 2020.

---

	P44-48. Early effect on in-house prescription issuance of drugstore rate by the establishment in the hospital site 山田哲也1, 河村隆登1, 勝野晋哉1, 小崎耕自1, 水野尚章1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1262-1262, 2020.

---

	P44-49. Is the doubt inquiry simplification protocol introduction useful? 小島一晃1, 松永富美代2, 山村裕佳子1, 森川智子1, 林愛華1, 松本弘誠1, 小西史子1, 仲忠士1, 美和孝之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1262-1262, 2020.

---

	P44-50. Practice second report of the medical treatment management based on the protocol that the hospital pharmacist for doubt inquiry from the health insurance pharmacy receives 工藤滉大1, 中野有瑛1, 馬場啓貴1, 坂口修治1, 中村一成1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1263-1263, 2020.

---

	P45-1. Investigation about the disaster prevention awareness of the drugstore one year after the massive blackout caused by the typhoon 尾関佳代子1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1264-1264, 2020.

---

	P45-2. The prospects of a pharmacist activity report of the quarantine inspection 14th day in the Cruise ship diamond Princess number and future pharmacist duties 坂口晋哉1, 福石和久1, 川俣洋生1, 高島伸也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1265-1265, 2020.

---

	P45-3. Effect as the multi-type of job cooperation disaster medical training of refuge administration game (HUG) 永田実沙1, 安原智久1, 上田昌宏1, 串畑太郎1, 曾根知道1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1265-1265, 2020.

---

	P45-4. Upbringing - diabetes edition ... of the pharmacist who can contribute to disaster relief 滝澤康志1,2, 近藤智之2, 追木正人2, 井上陽平2, 雪本恵理子2, 安藤和佳子2, 下石和樹2, 細谷龍一郎2, 小林映子2, 谷村学2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1266-1266, 2020.

---

	P45-5. The current situation of the anti-disaster measures of the Okayama hospital pharmacy gate after the July, 2018 heavy rain and future problem 槇枝大貴1,2,3, 益本周治1,2,4, 崎代英樹1,2,5, 村川公央1,2,3, 森英樹1,2,6, 千堂年昭1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1266-1266, 2020.

---

	P45-6. Activity of our hospital drug department in Cruise inboard new coronavirus (COVID-19) outbreaks 生地美菜1, 篠田聡1, 野々下拓真2, 橋口宏司1, 有馬一成1, 中島研1, 關野長昭3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1267-1267, 2020.

---

	P46-1. Relationship of a BZD, non-BZD system sleeping drug and a fall, the fall in our hospital 中嶋丈晴1, 菅野和彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1268-1268, 2020.

---

	P46-2. Association of the VTE incidence after risk of developing clot score and the total hip replacement with the VTE prevention enforcement table of our hospital 針木志織1, 赤嶺聡彦1,4, 高平尚伸2,4, 冨澤淳1, 厚田幸一郎1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1269-1269, 2020.

---

	P46-4. - to think from the efficiency of the swing return marks of structure "duties not to put a burden on the duties of" days and the rebuilding of examination - manual which we are apt to leave unattended of the usefulness 野村真里1, 吉田明弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1270-1270, 2020.

---

	P46-5. Examination of the dispensing error decrease effect by the inspection using the pharmaceutical products authentication system 山本恭平1, 奥平正美1, 川井正光1, 杉浦洋二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1270-1270, 2020.

---

	P46-6. Contribution to the doubt inquiry content analysis to a resident and medical security 吉田ミチル1, 會澤玲奈1, 嶋田紘也1, 遠藤修司1, 後藤亨2, 平岩知子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1271-1271, 2020.

---

	P46-7. Side effect, the effect that the uniform management system of the allergic information gives in safety of the medical therapy 荒木良介1, 加藤加奈恵1, 長谷康史1, 山村翔1, 宇野崇之1, 浜本知之2, 田中恒明3, 山田英紀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1271-1271, 2020.

---

	P46-8. The prior efforts which does not make the medical accident by pharmaceutical products or materials, and the like had 伊東健一1, 倉永高樹2, 田中美枝3, 松尾剛志4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1272-1272, 2020.

---

	P46-9. Evaluation from efforts using the OMOTENASHI application to the foreign patients in the health insurance pharmacy and the foreign patients 山川紘希1, 鈴木渉太2,3, 建山和代1, 諏訪由利香1, 垂井由季1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1272-1272, 2020.

---

	P46-10. Drug information offer construction and evaluation for nurses using SafeMaster 森岡淳子1, 須古杏子1, 山田美穂2, 杉松睦美2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1273-1273, 2020.

---

P46-11. Decision ... of the graded medication management method by efforts (the second report) - nursing department and the collaboration for the decision of an evaluation and the education of the oral medicine management method of the inpatient 小野歩1, 比毛有理子1, 阿部智恵子2, 武山陽子2, 守屋幸江2, 梶谷香奈子2, 石井勇太1, 片山潤1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1273-1273, 2020.

---

	P46-12. The cause of the picking error for the human error prevention and consideration of the background factor 國分祐介1, 冨田敦和1, 羽田勝彦1, 今西忠宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1274-1274, 2020.

---

	P46-14. Change (the first report) of the number of the people of remedy situation by the fixed number storage medicine for sleeping drug change and fall, fall 奥鈴花1, 関恭子1, 大西政典1, 長井円香1, 芝本奈々1, 足立聡子1, 宮西有紗1, 盛重あずさ1, 池田咲樹1, 岸井加代子1, 先崎健造1, 長田知子1, 石本昌裕1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1275-1275, 2020.

---

	P46-15. To examine medicine targeted for efforts - doping in our hospital pharmacy for Kagoshima national polity 2020 quickly; ... 中野一馬1, 池沢若菜1, 森永崇史1, 豊留麻衣1, 田中恭人1, 北園幸大1, 山本梢1, 屋敷大輔1, 徳丸章佳1, 淵脇ゆかり1, 長ヶ原琢磨1, 荻尾夕起子1, 岸本真1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1275-1275, 2020.

---

	P46-16. Change of the contents of doubt inquiry by sharing it in a medical safe section 川崎文雄1,2, 若林沙季1, 瀬戸梓1, 与那城知夏1, 奥西美奈1, 小室寿子2, 兒島正裕2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1276-1276, 2020.

---

	P46-17. Examination of the development prevention effect of the medicine blunder by the GS1 cord authentication system introduction 道内玲奈1, 西田承平1, 小森善文1, 丹羽隆1, 津村直樹2, 矢島睦門3, 太田雅弘3, 丹羽道夫3, 飯原大稔1, 小林亮1, 鈴木昭夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1276-1276, 2020.

---

	P47-1. Examination about the duties burden on enforcement situation and staff of the pharmacy education model core curriculum 2013 revised edition pharmacy student business training in the middle scale hospital 宗像千恵1,2, 村山裕一2, 執行優希2, 江口功一2, 西村信弘1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1277-1277, 2020.

---

	P47-2. Investigation about the simple suspension method training in a drugstore, the hospital business training 青山京介1, 舘知也1, 高岡みらい1, 久保賢晃1, 林剛1, 野口義紘1, 寺町ひとみ1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1278-1278, 2020.

---

	P47-3. Research about the basic nature sought as a pharmacist of the student in the business training 久保賢晃1, 舘知也1, 高岡みらい1, 青山京介1, 林剛1, 野口義紘1, 寺町ひとみ1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1278-1278, 2020.

---

	P47-4. Investigation about efforts and the learning turn of eventss for the inclusion of 8 representative diseases 小森智也1, 勝亦秀樹1, 山下美乃里1, 森直樹1, 小池博文1, 佐橋幸子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1279-1279, 2020.

---

	P47-5. The investigation that understanding deepens for the local action of the pharmacist by a pharmacy student acting as the lecturer of the patients briefing session in the long-term business training and examination 森厚司1, クロスビー智美1, 吉田和美1, 櫻井真理子1, 山本有人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1279-1279, 2020.

---

	P47-6. It is a learning effect using refuge administration game (HUG) for a revision pharmacy education model core curriculum "disaster medical care and pharmacist" 徳田衡紀1, 益本周治1, 松山祐1, 谷口恵美1, 高柳和伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1280-1280, 2020.

---

	P47-7. The instruction situation investigation of 8 representative diseases in the pharmacy business training 山中俊哉1, 田中佳子1, 関谷泰明1, 井上壽江1, 平下智之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1280-1280, 2020.

---

	P47-8. Change of the understanding degree of the pharmacy school business trainee through the antitumor agents preparation training 飯塚俊介1, 佐々木祐樹1, 鶴崎大1, 北野徹1, 菊池憲和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1281-1281, 2020.

---

	P47-9. Examination about 8 representative disease learning opportunities by confirmation of the bringing medicine of the pharmacy student 伊賀正典1, 高野温志1, 高野明香1, 前田華奈子2, 横山未来2, 藤掛佳男2, 町田充1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1281-1281, 2020.

---

	P47-10. Other types of job experience-based training introduction to revision pharmacy education business training and the evaluation 小泉盛1, 新井優1, 横田敬之1, 土谷真幹1, 竹沢卓也1, 林良行1, 岸野亨1, 谷島成子2, 川村利江子3, 小峰美仁4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1282-1282, 2020.

---

	P47-11. Drugstore, medication counseling enforcement situation - pharmacist of 8 representative diseases in the hospital training can teach the approach method to a compound disease to a student; or ... 渡邉正教1, 中沢修司1, 日比徹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1282-1282, 2020.

---

	P47-12. Attitude survey of the business trainee for 8 representative diseases of the revision pharmacy education model core curriculum 前川祐美1, 高橋功一1, 立道貴清1, 辻繁子1, 加地雅人1,2, 田中裕章1, 二宮昌樹3, 芳地一1,3, 小坂信二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1283-1283, 2020.

---

	P47-13. After inspection - business training of the hospital training curriculum change with the revision model core curriculum from a comparison of the questionary survey - 高橋里奈1, 本多秀俊1, 林由紀子1, 服部裕子2, 杉浦宗敏2, 並木路広1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1283-1283, 2020.

---

P47-14. Questionnaire analysis about the understanding degree of the trainee in the drugstore business training in conformity with the revision pharmacy education model core curriculum and the satisfaction 吉田都1, 内田享弘1, 大川恭子1, 笠井眞二1, 政田啓子1, 原口珠実1, 藤原由梨1, 池上咲枝里1, 井上智咲1, 波多江崇2, 森山賢治1, 中村一基1, 篠塚和正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1284-1284, 2020.

---

P47-15. Questionnaire analysis about the understanding degree of the trainee in the hospital business training in conformity with the revision pharmacy education model core curriculum and the satisfaction 小島穂菜美1, 吉田都1, 内田享弘1, 桑原晶子1, 豊原朋子1, 濱宏仁1, 辻本勉1, 片岡和三郎1, 綿本有希子1, 田崎眞生1, 波多江崇2, 森山賢治1, 中村一基1, 篠塚和正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1284-1284, 2020.

---

	P47-16. Than outcome and factor analysis - student questionary survey that learned in hospital business training most ... 片岡憲昭1, 倉地果純1, 窪田理沙1, 坂井紀水1, 鈴木典子1, 西原雅美1, 角山香織2, 中村敏明2, 内山和久1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1285-1285, 2020.

---

	P47-17. The construction of the program that pointed to the exhaustive learning of 8 representative diseases and the inspection 麻那古信之1, 嶺尾里奈1, 廣部祥子1,2, 山本智也1, 前田真一郎1,2, 渡邊梓1, 門脇裕子1, 奥田真弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1285-1285, 2020.

---

	P47-18. Efforts and the usefulness for the business training in conformity with the revision pharmacy model core curriculum in the middle scale hospital 蛯子卓也1, 山田航輔1, 高橋雅也1, 船木映二1, 橋本義宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1286-1286, 2020.

---

	P47-19. Introduction and evaluation of physical assessment education in long-term practical training 川崎元弘1, 尾崎誠一1, 三好浩一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1286-1286, 2020.

---

P47-20. Investigation about the current situation and the problem of the long-term business training in our hospital accompanied with the start of the revision model core curriculum 伊東千佳1, 成田勇樹1, 城野博史1, 内田隆1, 伊藤祐子1, 清住友香1, 山下諒祐1, 山辺雄太1, 大坪謙一1, 林明佳1, 榎田裕紀1, 新屋諒1, 吉井美香1, 近藤昭志1, 政賢悟1, 田中順子1, 齋藤秀之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1287-1287, 2020.

---

	P48-1. Research design for formulary workshops aimed at improving ability to evaluate drug information 金井紀仁1, 宮崎美子2, 宮本拓也3, 永瀬真理子4, 安藤正純5, 佐藤光6, 吾妻隼斗7, 澤田雄太8, 奈良部修弘9, 下館桃子10, 吉岡克幸11, 小田慎12, 矢嶋美樹13, 高橋邦雄14, 稲生和彦15, 勝俣はるみ16, 齋藤俊夫17 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1288-1288, 2020.

---

	P48-2. Effect on ability for thought, solution to the problem by the simulation training 福井里佳1, 松田雅史1, 巖西真1, 池田義人1,2, 長谷川千晶1, 日置三紀1, 平大樹1,3, 戸川香代4, 川口晃4, 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1289-1289, 2020.

---

	P48-3. About the cooperation with the veterinary school in the pharmacist education that aimed at professional ability expansion 杉山育美1, 佐塚泰之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1289-1289, 2020.

---

	P48-4. Fourth-year students' awareness survey on drug information and initiatives for formulary education 上田昌宏1, 向井啓2, 串畑太郎1, 永田実沙1, 安原智久1, 曽根知道1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1290-1290, 2020.

---

	P48-5. Usefulness of "the medicine classroom" about the proper use of the medicine as the local community enlightenment activity 中村真理子1, 佐治凪帆1,2, 河西初音1,2, 野口健1,2, 間宮隆吉3,4, 鍋島俊隆4, 野田幸裕1,2,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1290-1290, 2020.

---

	P48-6. ... which behavior of the MR was turned into by a visit to example - pharmacy of the rapid effect that we took example by in the MR education by lube Rick evaluation 日比徹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1291-1291, 2020.

---

	P48-7. A comparison between actual situation and prevention of drug abuse education of the drug abuse in Japan and foreign countries and attitude survey of the student 網岡克雄1, 等浩太郎1, 山下史佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1291-1291, 2020.

---

	P49-1. About efforts of the introduction of IT in the Saitama hospital pharmacist society 田村賢士1,2, 金子智一1,2, 近藤正巳1,3, 中村房子1, 北澤貴樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1292-1292, 2020.

---

	P49-2. Questionary survey for the purpose of the activity support of the healthy support drugstore 本田桃佳1, 水野智博2, 大島秀康3, 梅田孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1293-1293, 2020.

---

	P49-3. New face educational program - result and reflection ... from a business training curriculum 日比陽子1,2, 長水正也1, 神田光司1, 久田宜範1, 諸角一成1, 佐藤由美子1, 中村康夫1, 森下修行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1293-1293, 2020.

---

	P49-4. Attempt of the postgraduate education training of the hospital pharmacist by the collaboration with the pharmacy school 坂倉智子1, 稲野寛1, 小山郁美1, 婦川貴博2, 毛利順一2, 岩澤真紀子2, 堀井剛史2, 東山倫子2, 瀬戸良教1, 寺松洋美1, 山本悠樹1, 近藤留美子1, 平山武司1,2, 厚田幸一郎1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1294-1294, 2020.

---

	P49-5. Usefulness evaluation about the germfree preparation practical skill seminar for health insurance pharmacy pharmacists 音窪麻衣1, 内田まやこ1, 井上薫1, 金美惠子1, 河合悦子2, 中村敏明1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1294-1294, 2020.

---

	P49-6. Focus on upbringing - member of society basic skills of the non-expert skill through the clinical ladder; and ... 新井亘1, 土屋裕伴1, 中里健志1, 増田裕一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1295-1295, 2020.

---

	IP02. A HPLC method for analysis of methotrexate in human cerebrospinal fluid and comparison with the chemiluminescence immunoassay Naoki Yoshikawa1, Ai Yamada2, Tsubasa Yokota1, Hiroshi Moritake2, Yasutoshi Hirabara1, Ryuji Ikeda1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1297-1297, 2020.

---

	IP03. The lifecycle management of pharmaceuticals by using barcodes and RFID tags Takao Orii1,2, Kouichi Uemura2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1298-1298, 2020.

---

	IP04. Effects of dopamine uptake inhibitors and dopamine receptor agonists on motivational behavior using the runway model of intracranial selfstimulation behavior in rats Satoru Esumi1, Yoshihisa Kitamura1,2, Soichiro Ushio1, Yudai Wada1, Yutaka Gomita1, Toshiaki Sendo1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1299-1299, 2020.

---

	IP05. Study for mechanisms of Hochuekkito against inflammation-induced anxiety-like behavior Soichiro Ushio1, Yudai Wada1, Satoru Esumi1, Makoto Kajizono1, Yoshihisa Kitamura1,2, Toshiaki Sendo1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1300-1300, 2020.

---

	IP06. Survey on the Pharmaceutical Industry's Contribution and Perspective for Improving Access to Medicines and Global Health Yukino Yoshida1, Hisashi Urushihara1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1300-1300, 2020.

---

IP07. Reinforced collaboration between community pharmacies and hospital for the management of oral anti-cancer therapy using information sharing tools and team-based learning Risa Ueda1, Masaaki Tanda1, Takahiro Ito1, Ayaka Enomoto1, Masashi Iida1, Naomi Mizuta1, Kazuhiro Yamamoto1, Hiroo Makimoto1, Tomohiro Omura1, Eikuko Yano1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1301-1301, 2020.

---

IP08. Effects of pharmacist-led antimicrobial stewardship programme in urological patients Atsushi Uda1, Katsumi Shigemura2,3,4, Koichi Kitagawa3,5, Kayo Osawa3,6, Ken-Ichiro Onuma2, Shigeaki Inoue7, Joji Kotani7, Yonmin Yan4, Yuzo Nakano4, Tatsuya Nishioka1, Takayuki Miyara2, Masato Fujisawa4, Ikuko Yano1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1301-1301, 2020.

---

	IP12. Association analysis of coadministrated drugs in patients with serotonin syndrome using big data Hideyuki Terazono1, Tomohisa Yamasaki1, Taiyo Arima1, Takayuki Takahashi1, Yasuo Takeda1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1303-1303, 2020.

---

	... that the concentration of the "front line of the team approach in medical care in the cancer chemotherapy" - pharmacist power improves patients power 木本真司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1305-1305, 2020.

---

	The characteristic of the bony formation accelerating agent and future problem 齋藤琢1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1306-1306, 2020.

---

	Clinical ... opioid proper use and side effect management ... of the cancer pain demanded from a generalist 里美絵理子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1307-1307, 2020.

---

	Interim report - from the methodology development - Atsushi trouble special study Imai group of the formula reenforcement of our country 今井博久1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1308-1308, 2020.

---

	The problem of polypharmacy measures and the future prospects 溝神文博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1309-1309, 2020.

---

	Type 2 diabetes treatment - condition of a patient grasp, improvement of the quality of the treatment, reduction - of the patient's share of medical expenses in consideration of patients background 飯塚勝美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1310-1310, 2020.

---

	Role ... of the pharmacist in the tips - HIV team approach in medical care to play an active part as a pharmacist 平野淳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1311-1311, 2020.

---

	Practice from tomorrow! - What pharmacists can contribute to in HIV treatment and what they aim to achieve - 石原正志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1312-1312, 2020.

---

	About the capecitabine treatment of elderly patients 安藤雄一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1313-1313, 2020.

---

	Light and shadow of the antithrombotic therapy 石井秀樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1314-1314, 2020.

---

	Policy ... to improvement in bottom line ... patients satisfaction of the GERD practice 春日井邦夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1315-1315, 2020.

---

	We think about an effective dose of TM alfa for the sepsis-related DIC 今浦将治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1316-1316, 2020.

---

	It is ... about the proper use of insomnia treatment strategy - sleeping drug 内村直尚1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1317-1317, 2020.

---

	Through an appropriate prescription choice based on Chinese medicine - scientific evidence to contribute to side effect reduction of cancer treatment of patients with cancer - 上園保仁1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1318-1319, 2020.

---

	... which thinks about guidelines of the antiemesis therapy Up to Date - world 村上通康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1320-1320, 2020.

---

	The basics and clinical practice of the compound immune therapy 三浦理1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1321-1321, 2020.

---

	irAE measures of the compound immune therapy 吉野真樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1322-1322, 2020.

---

	Challenge to the medical innovation using Muse cells 出澤真理1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1323-1323, 2020.

---

	The current situation and the prospects of the dementia practice 羽生春夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1324-1324, 2020.

---

	Medical system ... to aim at than online practice under the infection spread and cooperation ... past proof example of the online medication counseling in COVID-19 in the future 高野秀雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1325-1325, 2020.

---

	New Developments in Treatment Strategies for HER2-Positive Inoperable or Recurrent Breast Cancer - Ingenuity to bring out the POTENTIAL of Enhertu(R) - 中山貴寛1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1326-1326, 2020.

---

	It is ... mainly on management of the pharmacist outpatient department ... Abemaciclib to begin from tomorrow 橋本直弥1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1327-1327, 2020.

---

	Evidence of Verzenio and experience of its use at our hospital - What pharmacists should know about hormone receptor-positive metastasis and recurrent breast cancer treatment - 吉村章代1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1328-1328, 2020.

---

	It is ... from a comparison with clinical ... inborn character-related hemophilia of acquired hemophilia 朝倉英策1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1329-1329, 2020.

---

	With the role that a pharmacist fulfils for safe cancer treatment? From ... occupation characteristics exposure measures to COVID-19 土屋雅美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1330-1330, 2020.

---

	Role of the multi-type of job team approach in medical care for improvement in patients power in cancer treatment 上野直人1, 小室雅人2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1331-1331, 2020.

---

	It is ... through utilization of the pharmacist outpatient department in role - IMiDs prescription patients of the pharmacist in the ambulatory practice of patients with blood-forming organ tumor 大橋養賢1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1332-1332, 2020.

---

	Role of the JAK inhibitor in rheumatoid arthritis treatment 森信暁雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1333-1333, 2020.

---

	The herpes zoster as the side effect of the JAK inhibitor and the management 渡辺大輔1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1334-1334, 2020.

---

	Treatment of osteoarthritis, spondylosis: Domestic and foreign guidelines and paradigm shifts 川口浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1335-1335, 2020.

---

	Heart failure team approach in medical care (including palliative care) in the super aging society 佐藤幸人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1336-1336, 2020.

---

	ICT and AI (artificial intelligence) which are utilized in the way and the healthcare setting of the drug information in the corona in after 木村隆夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1337-1337, 2020.

---

	The database construction of the own institution is easily possible in digital information administration - AI-PHARMA to bring about valuable information! - 神崎浩孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1338-1338, 2020.

---

	Effect of the equol on development and problem ... women health care of the reproductive medicine 杉浦真弓1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1339-1340, 2020.

---

	It is ... that is necessary for contribution - super-aged society of the pharmacist to the town planning that is kind to dementia 遠藤英俊1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1341-1342, 2020.

---

	About a quality drop and prevention of the biomedicine 内山進1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1343-1343, 2020.

---

	We overlook the pharmaceutical products proper use in consideration of renal function in the outpatient department 近藤悠希1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1344-1344, 2020.

---

	Let's start TDM - Construction and prospects for a new blood concentration measurement system - 尾田一貴1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1345-1346, 2020.

---

	YPL. ... which overlooks the clinical pharmacy for intention in tradition and challenge, evolution - future 齋藤秀之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1-1, 2021.

---

	PL. For further development and contribution to society of the clinical pharmacy: Efforts and problem of this academic conference 奥田真弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2-2, 2021.

---

	SL1. Evidence from the multicenter clinical studies for 25 years 小川久雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 3-3, 2021.

---

	SL2. From current situation and this of the organ reproduction using the bio3D printer 中山功一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 4-4, 2021.

---

	SL3. The pharmaceutical management and preparation development that assumed clinical pharmacy a base 佐々木均 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 5-5, 2021.

---

	SL4. From AIDS therapeutic drug development to the development of hepatitis B and the COVID-19 therapeutic drug 満屋裕明1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 6-6, 2021.

---

	EL1. It is ... from the situation of the role - pharmacy school general medicine specialist who is a graduate of pharmacist in the future 駒ヶ嶺順平 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 7-7, 2021.

---

	EL2. It is ... for practice - continuation-like pharmacy management of the POS 山本雄一郎1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 8-8, 2021.

---

	IL. Current Issues in Oncology Pharmacy Practice Management James G. Stevenson Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 9-9, 2021.

---

	Receiving a prize -1. Effect of pharmacokinetics and the condition of a patient change that a transporter is involved in 井関健 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 11-11, 2021.

---

	Receiving a prize -2. A correlative study with quantity of exposure of the anticancer medicine and effective/toxicity and establishment of the individualization administration based on the quantity of exposure regulations factor 今村知世 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 12-12, 2021.

---

	Receiving a prize -3. Practice of the fur Matthew tical care to patients with cancer 川上和宜 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 13-13, 2021.

---

	Receiving a prize -4. Evidence construction for the side effect evasion of the cancer medical therapy that assumed pharmacokinetic approach a base 池村健治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 14-14, 2021.

---

	Receiving a prize -5. Research of the analysis approach of the clinical pharmacy study by the inflection of data mining technique and big data 今井俊吾 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 15-15, 2021.

---

	Receiving a prize -6. Construction of the treatment stratification marker aiming at precisely medical realization 平井啓太 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 16-16, 2021.

---

	Receiving a prize -7. Development of the efficacy analysis study aiming at the appropriate clinical use and development of pharmaceutical products 山田安彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 18-18, 2021.

---

	Receiving a prize -8. Development of all phosphatide class high sensitivity high throughput assays 森田真也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 19-19, 2021.

---

	Receiving a prize -9. The antimicrobial individualization administration plan that planned drug resistant bacterium infection control 尾田一貴 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 20-20, 2021.

---

	Receiving a prize -10. Study on exposure measures and adherence of the oral anticancer medicine in the cancer medical therapy and side effect management 小林一男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 21-21, 2021.

---

	Receiving a prize -11. Creation of the clinical outcome by the pharmacist specialized in a cancer 齋藤佳敬 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 22-22, 2021.

---

	Receiving a prize -12. Study on infection prevention of the antimicrobial based on Pharmacokinetics/pharmacodynamics and individual optimization in the treatment 横山雄太 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 23-23, 2021.

---

	PA-1. Participation of intracerebral fatty acid - GPR40/FFAR1 in the chronic pain formation mechanism by the repeated stress exposure 相澤風花 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 25-25, 2021.

---

	PA-2. The elucidation of the risk factor of the Clozapine-induced hypersalivation and search of the therapy 石川修平 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 26-26, 2021.

---

	PA-3. Practice of the clinical Pharmacometrics aiming at individual optimization of infection treatment in elderly people 石原慎之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 27-27, 2021.

---

	PA-4. Application to construction and genetic polymorphism variant enzymatic function analysis of the high active cytochrome P450 expression system with the mammal cell line 公文代將希 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 28-28, 2021.

---

	PA-5. Development of the simple, quick LC-MS/MS method for absolute densitometry of human serum cetuximab using trypsin to immobilize 柴田海斗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 29-29, 2021.

---

	PA-6. The study on general strategy for the polypharmacy of patients with chronic kidney disease: Treatment by pre-Io fatty tuna pick effect application of the oxidative stress control 成田勇樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 30-30, 2021.

---

	PA-7. Study on molecular mechanism determining Human monocarboxylate transporter 1, difference in 4 (hMCT1, 4) substrate selectivity 二木悠哉 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 31-31, 2021.

---

	PA-8. Database study for the actual situation analysis and the cancellation on polypharmacy 馬渕賢幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 32-32, 2021.

---

	PA-9. Kinase inhibition by the fusion of a data base and the clinical data and the relative visualization of the adverse event and the clinical application 水野貴仁1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 33-33, 2021.

---

	PA-10. Study on pharmacokinetics of the emergency intensive care domain patients 山崎伸吾 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 34-34, 2021.

---

	PA-11. Analysis of the reaction kinetics of the drug metabolizing enzyme in the organ out of the liver and study on expression change 朝居祐貴 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 36-36, 2021.

---

	PA-12. The clinical pharmacy study that assumed drug metabolism for the proper use of the immunosuppressive drug and interaction a base 宇野貴哉 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 37-37, 2021.

---

	PA-13. Study on usefulness of the establishment of the antimicrobial proper use support system which a pharmacist leads and the intervention of the clinical pharmacy 大橋健吾 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 38-38, 2021.

---

	PA-14. Study on contribution of the pharmacist in the medical treatment management based on the protocol 片田佳希 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 39-39, 2021.

---

	PA-15. Low BMI and the myeloablative pre-treatment regimen extend intravenous alimentation dosing period in the hematopoietic stem cell transplantation 神谷貴樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 40-40, 2021.

---

	PA-16. Study on usefulness elucidation of clinical information, the genetic polymorphism information for the tacrolimus individualization administration plan after the hematopoietic stem cell transplantation 末次王卓 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 41-41, 2021.

---

	PA-17. Development of adverse event management, the individualization medical therapy that pointed to safe improvement in rare cancer treatment スタッブ由紀子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 42-42, 2021.

---

	PA-18. Study on drug resistance of the Haemophilus influenzae 瀬山翔史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 43-43, 2021.

---

	PA-19. Study on venous thromboembolism and anticoagulation in patients with cancer 平出誠 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 44-44, 2021.

---

	PA-20. Effect and relations with those CYP3A activity markers and serum Na level that CYP3A5 genotype gives to pharmacokinetics of the tolvaptan in the patients with heart failure 星川昂平1, 内藤隆文1, 阿久津駿太1, 早乙女雅夫2, 前川裕一郎2, 川上純一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 45-45, 2021.

---

	International Symposium1. Challenge and Evolution of Pharmaceutical Health Care and Sciences for the Next Decade 1 Ikuko Yano, Yasuo Takeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 46-46, 2021.

---

	IS01-1. Role of pharmacist on rational drug use under the DRG payment method in the future in China Dechun Jiang Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 47-47, 2021.

---

	IS01-2. Evaluating Trastuzumab-Related Cardiotoxic Effects : An Example How Features of Real World Data Impact Study Design and Analytical Approaches Hsu-Chih Chien Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 48-48, 2021.

---

IS01-3. Evolving model of care post haematopoietic stem cell transplantation : optimising multidisciplinary care (the PostMAN Clinic) Midori Nakagaki1, Nicole C Gavin2,3, Therese Hayes2, Rebecca Fichera4, Caroline Stewart2, Leonie Naumann5, Justine Brennan6, Natasha Perry2, Emma Foley7, Erin Crofton2, Christie Brown5, Jenni Leutenegger2, Glen A Kennedy2,8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 49-49, 2021.

---

	IS01-4. Pharmacist interventions to improve the safety incancer patients receiving chemotherapy Mayako Uchida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 50-50, 2021.

---

	International Symposium2. Challenge and Evolution of Pharmaceutical Health Care and Sciences for the Next Decade 2 Ikuko Yano, Yasuo Takeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 51-51, 2021.

---

	IS02-1. Pharmaceutical GS1 barcodes for patient safety : Traceability and access to drug information Koich Uemura1, Takao Orii2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 52-52, 2021.

---

	IS02-2. Impact of a board certified pharmacist-led antimicrobial stewardship for patients receiving antimicrobial injection Takashi Niwa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 53-53, 2021.

---

	IS02-3. Evaluation of Palliative Care Pharmacists' Interventions and Outcomes Sari Nakagawa1,2, Yoshiaki Okamoto2, Chika Tokuyama1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 54-54, 2021.

---

	IS02-4. Challenges in the optimization of kidney disease therapy by Nephrology and Pharmacotherapy Specialists Kazuhiro Yamamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 55-55, 2021.

---

	IS02-5. Relationship between CYP3A5 polymorphism and tacrolimus blood concentration changes in allogeneic hematopoietic stem cell transplant recipients during continuous infusion Naoki Yoshikawa, Ryuji Ikeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 56-56, 2021.

---

	Symposium 1. Term of ... organizer regarding palliative treatment as the approach in consideration of renal function in the cancer medical care from ... chemotherapy seamlessly 岸本真, 上ノ段友里 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 59-59, 2021.

---

	S01-1. Invitation to approach "in consideration of renal function in" cancer medical care 岸本真 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 60-60, 2021.

---

	S01-2. Knead on; fluoroGee outline 門脇大介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 61-61, 2021.

---

	S01-3. About the oral anticancer agent and renal function evaluation in the health insurance pharmacy 長久保久仁子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 62-62, 2021.

---

	S01-4. It is ... mainly on renal function evaluation - injection drug in the cancer medical therapy 上ノ段友里 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 63-63, 2021.

---

	S01-5. From the position of the palliative care pharmacist Total Care - at - decreased renal function 森理保 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 64-64, 2021.

---

	Symposium 2. Term of relation intervention and case - organizer to summary ... rare case of the pharmacist specialized in a cancer 河原昌美, 池田龍二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 65-65, 2021.

---

	S02-1. Expect it about the case examination of the pharmacist specialized in a cancer 河原昌美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 66-66, 2021.

---

	S02-2. Interaction evasion case with herb and grapefruit juice and the paclitaxel 大辻貴司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 67-67, 2021.

---

	S02-3. Case of the DPD slow-up symptom that caused Serious ADR of the capecitabine 下川福子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 68-68, 2021.

---

	S02-4. The case that judged the bendamustine administration to patients with renal disease from pharmacokinetic grounds 宮島律子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 69-69, 2021.

---

	S02-5. Pharmaceutical intervention to the patients that chemotherapy falls on a menstrual cycle 小倉真由美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 70-70, 2021.

---

	S02-6. The case that adrenal hypofunction was suspected in nivolumab following dermatopathy 中野泰寛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 71-71, 2021.

---

	S02-7. Relation licensee to the case through the extensive viewpoint 池田龍二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 72-72, 2021.

---

	Symposium 3. It is the term of the organizer for the cancer medical therapy support - cooperation full addition and calculation promotion of specific drug management instruction addition 2 to work on in an area 辻井聡容, 小玉博一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 73-73, 2021.

---

	S03-1. About the cooperation full addition calculation in the university hospital and the problem 丹田雅明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 74-74, 2021.

---

	S03-2. About the cooperation full addition calculation in the local core hospital and the problem 廣畑秀記 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 75-75, 2021.

---

	S03-3. About the cooperation full addition calculation in the small hospital and the problem 岡本勇二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 76-76, 2021.

---

	S03-4. Calculation of specified drug management guidance premium 2 at insurance pharmacies and its issues, and introduction of the Takarazuka-drug collaboration "Takara-tu-ka Association" 畑世剛1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 77-77, 2021.

---

	S03-5. Setting and activity report ... of efforts ... advanced drug duties special committee of the foreign cancer chemotherapy support by the Hyogo hospital pharmacist society, Hyogo pharmacist society 辻井聡容 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 78-78, 2021.

---

	Symposium 4. Examine pharmacist upbringing and illness corresponding to the cancer medical therapy; the term of the construction organizer of the medicine cooperation 近藤元三, 山室蕗子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 79-79, 2021.

---

	S04-1. We examine pharmacist upbringing and illness corresponding to the cancer medical therapy and are built the medicine cooperation 近藤元三 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 80-80, 2021.

---

	S04-2. Efforts and problem of the local prefecture-designated cancer practice cooperation base hospital 西千春 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 81-81, 2021.

---

	S04-3. Efforts in the area cancer practice cooperation base Hospital 合澤啓二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 82-82, 2021.

---

	S04-4. Efforts in the metropolis and districts cancer practice cooperation base Hospital 大山高廣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 83-83, 2021.

---

	S04-5. Efforts in the pharmacist training institution (basic institution) specialized in local pharmacy care 山室蕗子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 84-84, 2021.

---

	S04-6. Efforts in the pharmacist training institution (cooperation institution) specialized in local pharmacy care 稲葉一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 85-85, 2021.

---

	Symposium 5. Term of real - organizer of the cancer reproductive medicine practice to want to know one step in - now to step 日置三紀, 米村雅人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 86-86, 2021.

---

	S05-1. Cancer treatment and generative function, hypogonadism - basics-like way of thinking and recent topic - 日置三紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 87-87, 2021.

---

	S05-2. As a medical person, how do you face each other in the nature of patients with cancer and a generative problem? 安宅大輝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 88-88, 2021.

---

	S05-3. From cancer treatment and position of generative function - hospital pharmacist that a story complies with before treatment 小室雅人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 89-89, 2021.

---

	S05-4. From a cancer and the position of support - family pharmacist to living women that a story complies with in life 宮原富士子1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 90-90, 2021.

---

	Symposium 6. It is the term of the organizer from a viewpoint of the environmental change regional alliances hospitalization and release support remote instruction to think about the strategic intervention by the medication adherence maintenance difficulty case 田上直美, 尾崎淳子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 91-91, 2021.

---

	S06-1. What is made for the explanation medication adherence maintenance difficulty case of the plan purpose? 尾崎淳子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 92-92, 2021.

---

	S06-2. Efforts of our hospital for HIV-positive patients 野田綾香1,2, 野村直幸1,2, 河野泰弘1,2, 倉本成一郎1, 田村浩二1, 山崎由佳2, 飯塚暁子2, 木梨貴博2, 藤原千尋2, 門田悦子2, 齊藤誠司2, 坂田達朗2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 93-93, 2021.

---

	S06-3. Utilization and drug control support of the online medication counseling 宮崎美世 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 94-94, 2021.

---

	S06-4. It is ... from the situation of hospitalization and release support, regional alliances - MSW for medication support of patients 岡本学 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 95-95, 2021.

---

	S06-5. About strategic intervention of the medication adherence in patients with mental disorder 竹林実 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 96-96, 2021.

---

	Symposium 7. Term of new possibility - organizer of the pharmacist sought by challenge - extensive pharmacy management to "HIV infection X cancer chemotherapy X relaxation medical care" 平野淳, 石原千春 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 97-97, 2021.

---

	S07-1. The current situation of "the HIV infection X cancer chemotherapy X relaxation medical care" 平野淳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 98-98, 2021.

---

	S07-2. It is ... from the situation of pharmacist cancer (temporarily) specialized in problems - area pharmacy care of "the HIV infection X cancer chemotherapy X relaxation medical care" in regional alliances 石原千春 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 99-99, 2021.

---

	S07-3. A ratio and interhospital cooperation of patients with HIV infection in the cancer special hospital 橋本浩伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 100-100, 2021.

---

	S07-4. The current situation and problem of patients with HIV infection and "the antiHIV therapy X cancer chemotherapy X relaxation medical care" 矢倉裕輝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 101-101, 2021.

---

	S07-5. The drug interaction management of "the antiHIV medicine X antitumor agents X opioid" 石原正志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 102-102, 2021.

---

	S07-6. Expectation to the pharmacist from the viewpoint of "HIV infection X cancer chemotherapy X relaxation medical care" medical care policy 横幕能行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 103-103, 2021.

---

	Symposium 8. Term of the upbringing organizer of next-generation leader (pharmacist-scientists) intending better cancer medical care 河添仁, 横川貴志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 104-104, 2021.

---

	S08-1. To you to be a pharmacist, a cancer instruction pharmacist specialized in a cancer: The beginning is an abecedarian in anyone 河添仁 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 105-105, 2021.

---

	S08-2. It is ... from the position of own omen case - abecedarian of clinical studies by the hospital pharmacist 島貫裕実子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 106-106, 2021.

---

	S08-3. Significance of a study and the graduation to solve a clinical problem in the cancer chemotherapy 横川貴志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 107-107, 2021.

---

	S08-4. The present and the future prospects that moved from the healthcare setting to academia 林稔展, 中野貴文, 江川孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 108-108, 2021.

---

	S08-5. Gut flora and tumor im-munity 金倫基 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 109-109, 2021.

---

	Symposium 9. Term of clinical studies - organizer performing it in intention in challenge and evolution - future to the side effect management in cancer treatment 川田敬, 林稔展 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 110-110, 2021.

---

	S09-1. We search optimal antiemesis therapy 林稔展 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 111-111, 2021.

---

	S09-2. Development of the quick and safe cancer supportive care that assumed medical big data a base 相澤風花1, 梶本春奈2, 森山大嗣2, 新村貴博1, 合田光寛2,3, 新田綾香1, 高橋志門1, 濱野裕章2, 八木健太3, 石澤有紀4, 座間味義人1,2,5, 石澤啓介1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 112-112, 2021.

---

	S09-3. We think about the appropriate bowel movement management in patients with blood cancer 川田敬 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 113-113, 2021.

---

	S09-4. Pharmacist-led clinical research aimed at improving therapeutic efficacy in cancer chemotherapy - Adverse events as a prognostic predictor - 藤井宏典 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 114-114, 2021.

---

	S09-5. Effect on hemodynamics with the oral medication (5-aminolevulinic acid) for the cancer diagnosis and the pharmacologic action 森沢惇平1,2, 石田智滉1, 川田敬1,2, 常風興平1, 福田仁3, 川西裕3, 中山沢4, 山本新九郎5, 政平訓貴6, 上羽哲也3, 井上啓司4,5, 宮村充彦1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 115-115, 2021.

---

	Symposium 10. Term of the case report organizer whom a clinical pharmacist receives 百賢二, 安武夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 116-116, 2021.

---

	S10-1. The case that was able to deal with drug interaction by medicine - medicine cooperation using the tracing report 渡邊亜矢子1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 117-117, 2021.

---

	S10-2. An example of patients with breast cancer that presented cancer cachexia in the treatment at home 大野朋子1,2, 百賢二3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 118-118, 2021.

---

	S10-3. Example that naldemedine was useful for the bowel control in patients with COVID-19 serious case pneumonia under the artificial respiration management 疋田絵梨 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 119-119, 2021.

---

	S10-4. Making of the case report which a college of pharmacy supports 安武夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 120-120, 2021.

---

	S10-5. A point of the case report and study ethic 百賢二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 121-121, 2021.

---

	Symposium 11. Term of knowledge and the skill organizer of the infection domain demanded from all pharmacists after a corona evil 村木優一, 北原隆志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 122-122, 2021.

---

	S11-1. Skill to practice Antimicrobial stewardship activity and a study 浜田幸宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 123-123, 2021.

---

	S11-2. We think about hospital infection measures necessary for a pharmacist now 中川博雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 124-124, 2021.

---

	S11-3. People and connection, career path of the young pharmacist who is cultivated in science if clinical 花井雄貴1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 125-125, 2021.

---

	S11-4. I was able to do it, too; is practice support and team approach in medical care and a clinical pharmacy study 朝岡みなみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 126-126, 2021.

---

	Symposium 12. Make use of the professional ability of operability - pharmacist of the double blind trial targeted for the placebo in the support/palliative treatment regional study; and the term of ... organizer 米村雅人, 橋本浩伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 127-127, 2021.

---

	S12-1. The clinical studies in support/palliative treatment domain and the system maintenance 全田貞幹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 128-128, 2021.

---

	S12-2. About a way of thinking about the setting of the placebo drug 橋本浩伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 129-129, 2021.

---

	S12-3. Example of the choice of the placebo medicine in the researcher-led clinical study 米村雅人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 130-130, 2021.

---

	S12-4. To conduct a clinical study with high quality using the placebo drug 岡野朋果 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 131-131, 2021.

---

	Symposium 13. Do the sale reporting guidelines inhibit information sharing? Term of the way of the reporting after ... GL and the clinical on-site information needs organizer 吉光寺敏泰, 渡邊伸一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 132-132, 2021.

---

	S13-1. The current situation of the guidelines about the sale reporting activity on ethical drug and the sale reporting activity surveillance business 山本剛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 133-133, 2021.

---

	S13-2. The current situation of the response of the pharmaceutical company to sale reporting activity guidelines 羽田野誠 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 134-134, 2021.

---

	S13-3. The current situation and problem (from the situation of the physician) of the reporting by the pharmaceutical company after the guidelines enforcement 深田雅之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 135-135, 2021.

---

	S13-4. To make current situation and problem (from the position of the pharmacist) "sale reporting activity GL" of the reporting the healthcare setting on the common ruler of the pharmaceutical company 後藤伸之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 136-136, 2021.

---

	S13-5. Found clinical study information, the clinical study information that is not asked for 漆原尚巳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 137-137, 2021.

---

	Symposium 14. Treat the information from the pharmaceutical company for adequacy of the information provided by the pharmaceutical company how in the ... new life era; or the term of ... organizer 若林進, 水八寿裕 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 138-138, 2021.

---

	S14-1. For adequacy of the information provided by the pharmaceutical company 若林進 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 139-139, 2021.

---

	S14-2. It is MR authorization system drastic reform for adequacy of the information provided by MR 近澤洋平 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 140-140, 2021.

---

	S14-3. How should the pharmaceutical company deal for the new life era? 水八寿裕1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 141-141, 2021.

---

	S14-4. Efforts ... of the ... Tokyo hospital pharmacist society evaluating the reporting from the pharmaceutical company definitely 佐々木祐樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 142-142, 2021.

---

	Symposium 15. Realize high quality pharmaceutical approach from the large field; is the term of expectation - organizer to ... specialty pharmacist 樋口則英, 寺田智祐 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 143-143, 2021.

---

	S15-1. Clinical pharmaceutics 兒玉幸修 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 144-144, 2021.

---

	S15-2. Pharmacogenetics to inflect by pharmacogenetics ... true clinical practice 辻大樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 145-145, 2021.

---

	S15-3. Medical therapy of elderly people 木村丈司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 146-146, 2021.

---

	S15-4. The way of thinking of the side effect and the way of correspondence 大野能之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 147-147, 2021.

---

	Symposium 16. Term of team approach in medical care and evidence creation - organizer by pharmacist power ... multi-type of job cooperation tried in Onco-Nephrology 堀松高博, 池見泰明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 148-148, 2021.

---

	S16-1. Role of the kidney physician in Onco-Nephrology 桑原孝成, 神吉智子, 水本輝彦, 向山政志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 149-149, 2021.

---

	S16-2. Anticancer medicine proper use in a decreased renal function, patients on dialysis based on the drug information 大野能之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 150-150, 2021.

---

	S16-3. up to date of renal failure practice guidelines 2016 at the cancer medical therapy 船越太郎, 堀松高博, 武藤学 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 151-151, 2021.

---

	S16-4. Achievement of the pharmacist specialized in cancer in the Onco-Nephrology domain 野田哲史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 152-152, 2021.

---

	Symposium 17. Term of ... latest knowledge and problem - organizer updating the cancer medical therapy of the decreased renal function patients 山本和宏, 藤田行代志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 153-153, 2021.

---

	S17-1. Cancer medical therapy overview of the decreased renal function patients 山本和宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 154-154, 2021.

---

	S17-2. The latest knowledge of the cancer medical therapy for elderly people 藤田行代志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 155-155, 2021.

---

	S17-3. The latest knowledge of the anticancer medicine administration plan for the decreased renal function patients 小泉祐一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 156-156, 2021.

---

	S17-4. The latest knowledge of the anticancer medicine administration plan in patients on dialysis 山本武人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 157-157, 2021.

---

	S17-5. The latest knowledge of the cancer immune therapy in dialysis, renal-transplant recipients 岡田直人1, 座間味義人1,2,3, 石澤啓介1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 158-158, 2021.

---

	S17-6. The latest knowledge of relaxation, the supportive care in the decreased renal function patients 宮本康敬 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 159-159, 2021.

---

	Symposium 18. Term of the current situation, the further spread of Biosimilar in the clinical practice and the problem organizer 斎藤嘉朗, 米澤淳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 160-160, 2021.

---

	S18-1. The current situation, the further spread of Biosimilar in the clinical practice and the problem 米澤淳1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 161-161, 2021.

---

	S18-2. About use of the Biosimilar in the intratumoral science 飯田真介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 162-162, 2021.

---

	S18-3. Consideration about the consciousness of the physician based on the questionnaire findings for physicians who related to four kinds of disease domains about Biosimilar 青木良子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 163-163, 2021.

---

	S18-4. Clinical efforts for the Biosimilar spread 百賢二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 164-164, 2021.

---

	S18-5. Efforts to use of Biosimilar to work on by a one team 関屋裕史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 165-165, 2021.

---

	Symposium 19. A medical treatment intervention practice case and term of the evidence organizer to be able to arrive from the young pharmacist of the front line engaging in infection practice 山田智之, 枦秀樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 166-166, 2021.

---

	S19-1. Activity ... of the Osaka antimicrobial club for education and tradition - young person pharmacist of the antimicrobial proper use support activity in the area 山田智之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 167-167, 2021.

---

	S19-2. Yell ... from treatment intervention and the idea culture - young person to a cyst of thyroid infection case to a young person 竹内祐介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 168-168, 2021.

---

	S19-3. A person from Japan which stood on the shoulder of the giant practiced Antimicrobial Stewardship 枦秀樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 169-169, 2021.

---

	S19-4. COVID-19 and Antimicrobial Stewardship 村上修太郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 170-170, 2021.

---

	S19-5. Pharmacist intervention practice case to infection practice in the ER 齋藤靖弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 171-171, 2021.

---

	S19-6. Optimized Treatment which challenges an infection of a variety of background with every effort 檜山洋子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 172-172, 2021.

---

	Symposium 20. Term of the qualitative improvement and problem organizer of the pharmacist education to take a revision model core curriculum and the next generation on 平田收正, 段林正明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 173-173, 2021.

---

	S20-1. About instruction of the business training utilized the literature evaluation (practice medical treatment) 中田和宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 174-174, 2021.

---

	S20-2. About instruction of the business training in the drug information (DI) 吉田紗理 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 175-175, 2021.

---

	S20-3. About instruction of the business training in the infection domain 植竹宣江 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 176-176, 2021.

---

	S20-4. From the position of the ward pharmacist associated with - COVID-19 thinking about the information utilization that a pharmacist can do with a business trainee - 松本乃里子1, 加藤隆寛1, 竹内正幸1, 塩田有史1,2, 築山郁人3, 大西正文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 177-177, 2021.

---

	S20-5. The current situation and problem of the instruction about the acute phase medical care in the business training 添田博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 178-178, 2021.

---

	S20-6. A problem and the future in the multi-type of job cooperation education 津田真弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 179-179, 2021.

---

	Symposium 21. Where can the innovation - pharmacist of the blood pressure management contribute to? Term of ... organizer 土岐真路, 芦川直也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 180-180, 2021.

---

	S21-1. Here is important! Blood pressure management 岸拓弥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 181-181, 2021.

---

	S21-2. The knowledge that you should know when a pharmacist talks about blood pressure 篠原徹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 182-182, 2021.

---

	S21-3. Efforts to raise awareness of self-assessment of blood pressure at pharmacies - Nagano Prefecture Pharmacists Association's "Let's Measure Blood Pressure" campaign - 高田弘子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 183-183, 2021.

---

	S21-4. Invisible outcome of management method - depression management that considered over high blood pressure and comorbidities and patients background and visible individualization monitoring ... 土岐真路 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 184-184, 2021.

---

	S21-5. We can do it because it is life-style related diseases and blood pressure management - pharmacist of patients with cancer 石井聡一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2021.

---

	Symposium 22. With the viewpoint that a pharmacist should have in the problems over the heart failure management? Term of the organizer 木下照常, 高井靖 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2021.

---

	S22-1. Polypharmacy and medication adherence 西村文宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2021.

---

	S22-2. Drug control in the renal failure merger case 木下照常 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2021.

---

	S22-3. End-of-life drug choice 岡本禎晃 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2021.

---

	S22-4. Care ... which patients with multi-type of job cooperation - heart failure to lead to improvement of the community medical care continued 高井靖 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2021.

---

	S22-5. With the viewpoint that a pharmacist should have in the new heart failure therapeutic drug prescription case? 芦川直也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2021.

---

	Symposium 23. Term of the disincentive of role - electronic edition prescription notebook spread of pharmacists who should carry it out in medical DX being what or - organizer 池田和之, 高田敦史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2021.

---

	S23-1. About functions, and the like to expect what the disincentive of the role electronic edition prescription notebook spread of pharmacists who should carry it out in medical DX is from electronic edition prescription notebook as a user 土屋文人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2021.

---

	S23-2. Digitization and electronic medication notebooks in pharmacies - To cross the chasm - 原口亨 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2021.

---

	S23-3. Current situation and problem - at electronic edition prescription notebook operation - hospital in the hospital which sounds easy, and is difficult 行本拓史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2021.

---

	S23-4. Disincentive of the electronic edition prescription notebook spread judging from a viewpoint of ICT companies 島崎肇 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2021.

---

	Symposium 24. Term of ... organizer for way of thinking, process of study - abecedarians in the healthcare setting 寺田智祐, 石澤啓介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2021.

---

	S24-1. The process of clinical studies: To brighten the healthcare setting more 福間真悟 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2021.

---

	S24-2. Basic knowledge of an ethic guideline and the personal information in clinical studies 八木健太1, 合田光寛1,2, 濱野裕章2, 坂口暁1, 楊河宏章1, 石澤啓介2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2021.

---

	S24-3. Will not do it; is a presentation at the meeting 鈴木渉太1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2021.

---

	S24-4. The viewpoint that a pharmacist of the general hospital duty should have to raise the operability of clinical studies 土手賢史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2021.

---

	S24-5. Efforts ... of the medicine medicine cooperation that aimed at the standardization of the side effect evaluation by clinical studies - dermatopathy measures flow making in the health insurance pharmacy 圓藤晶子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2021.

---

	Symposium 25. Frailty and nourishment measures, term of the challenge organizer of the pharmacist 篠永浩, 倉田なおみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2021.

---

	S25-1. Expectation ... to frailty prevention - pharmacist, the family drugstore as the national strategy 飯島勝矢 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2021.

---

	S25-2. Possibility of the current situation and the pharmacist of potential frailty elderly people 熊木良太 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2021.

---

	S25-3. Polypharmacy and frailty measures 樋島学 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2021.

---

	S25-4. Rehabilitation nourishment, a rehabilitation drug and frailty measures 中道真理子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2021.

---

	S25-5. Hospitalization, outpatient department, an area and leading frailty measures 篠永浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2021.

---

	Symposium 26. Don't allow an infodemic! The role of pharmacists under COVID-19 - Words from the organizers 岡田浩, 鈴木渉太 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2021.

---

	S26-1. How do you make use of the experience of "the drugstore COVID-19 measures project" in the next crisis? 岡田浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2021.

---

	S26-2. It supports geography information and the foreign patients 鈴木渉太1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2021.

---

	S26-3. Handling of the medical information at disaster 西川佳孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2021.

---

	S26-4. Publicity work and access analysis of the COVID-19 measures site 森和明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2021.

---

	Symposium 27. Term of the insatiate challenge organizer for creation, the evolution of the TDM evidence 尾田一貴, 三浦昌朋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2021.

---

	S27-1. Practice of the TDM which assumed AUC of vancomycin an index 尾田一貴 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2021.

---

	S27-2. Construction of the TDM evidence for the psychotropic drug 中村友喜1, 三輪高市2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2021.

---

	S27-3. Importance and practice case of the TDM in the poisoning practice 佐藤智人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2021.

---

	S27-4. Attempt of the individualization administration plan that added therapeutic drug monitoring promotion expansion and a metabolism change factor of voriconazole 新岡丈典 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2021.

---

	S27-5. For the expansion of the drug targeted for the new TDM in the cancer domain 福土将秀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2021.

---

	Symposium 28. Pharmacokinetic clinical practice utilized in the personalized medicine and speech of the fundamental researches organizer 工藤敏之, 嶋田努 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2021.

---

	S28-1. Evidence - of drug interactions - short interaction in patients with the heredity seasonal polymorphism 岩本卓也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2021.

---

	S28-2. Clinical implementation of the examination for pharmacogenomics 寺田智祐1,2, 森田真也2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2021.

---

	S28-3. Application to personalized medicine of the physiologic pharmacokinetics model analysis 土岐浩介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2021.

---

	S28-4. The impact that the genetic polymorphism of a metabolism enzyme, the transporter gives in clinical pharmacokinetics 前田和哉 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2021.

---

	Symposium 29. Do not seem to come using a large-scale medical database; the term of effectiveness of the pharmaceutical products using ... receipt information database and safe evaluation - organizer 頭金正博, 飯原なおみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2021.

---

	S29-1. The usage of the database (NDB) such as anonymity receipt information, and the like and future development 加藤源太 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2021.

---

	S29-2. Studies using the database such as the anonymity receipt information, and the like that a pharmacist receives 飯原なおみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2021.

---

	S29-3. Fact-finding about the examination of blood culture of patients with community-acquired pneumonia 室高広 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2021.

---

	S29-4. Study of the racial difference of the severe drug eruption using the receipt data of the East Asia each country 佐井君江1, 佐藤嗣道2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2021.

---

	Symposium 30. Term of the tracing report utilization organizer for medication follow-up practice to work on for future intention 西原昌幸, 新井克明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2021.

---

	S30-1. Approach of the Hiroshima hospital pharmacist society for the tracing report spread 大東敏和 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2021.

---

	S30-2. Role of the health insurance pharmacy that we saw from the efforts to a tracing report 佐島進 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2021.

---

	S30-3. Inflection of the tracing report for continuous medication follow-ups for the purpose of the ambulatory practice support 稲葉健二郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2021.

---

	S30-4. A problem and expectation to utilize a tracing report 池見泰明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2021.

---

	S30-5. Cooperation with the health insurance pharmacy with the tracing report communalization system and the basic hospital in Fukuoka 山口信也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2021.

---

	S30-6. About community medical care cooperation by the tracing report utilization in the Kurume University Hospital 井上光鋭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2021.

---

	Symposium 31. Term of - organizer who relates skill - efficacy, a side effect necessary for patients follow-up of the medical treatment to laboratory tests and image views, and evaluates it 岩本卓也, 吉村知哲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2021.

---

	S31-1. Skill of the pharmacist necessary for patients follow-up of the medical treatment 吉村知哲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2021.

---

	S31-2. Examination for image which a pharmacist should know in understanding the condition of a patient 永田幹紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2021.

---

	S31-3. Internal secretion metabolism-related examination, one step of the beginning to make use of in a medical treatment evaluation 日置三紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2021.

---

	S31-4. Skill necessary for the medical treatment evaluation of the cardiovascular disease domain 種田靖久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 241-241, 2021.

---

	S31-5. Skill necessary for the medical treatment evaluation of the autoimmune inflammatory disorder domain 五十嵐敏明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2021.

---

	Symposium 32. Aiming to build a regional formulary that supports patients and medical care in a regional comprehensive care system with evidence Organizer's words 岸本真, 小枝伸行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2021.

---

	S32-1. Discussion and basic thinking surrounding formulary 川上純一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2021.

---

	S32-2. Regional in-hospital formulary formulation and future development 小枝伸行1, 小川充恵2, 西岡達也2, 豊口雅子3, 中野道雄3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2021.

---

	S32-3. Current status and issues of regional formulary in the Awa Medical Area, Chiba Prefecture 舟越亮寛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2021.

---

	S32-4. The role of pharmacists in formulary and future prospects 磯部総一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2021.

---

	Symposium 33. Term of a fact and the record organizer of the pharmacy management in the drugstore 出石啓治, 宮崎長一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2021.

---

	S33-1. A viewpoint and record of the pharmacy management in the drugstore 鹿村恵明1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2021.

---

	S33-2. Fact and record - life-style related diseases of the pharmacy management as a case - 山本雄一郎1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2021.

---

	S33-3. Fact and record - cancer of the pharmacy management as a case - 村田稔弥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2021.

---

	S33-4. Fact and record - depression of the pharmacy management as a case - 青木裕明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2021.

---

	S33-5. Fact and record - asthma of the pharmacy management as a case - 堀越博一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2021.

---

	S33-6. A fact and record of the pharmacy management in the drugstore 赤星顕正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2021.

---

	Symposium 34. Term of the latest knowledge organizer who is useful for a strategy of the risk assessment of the pregnant woman nursing mother medical therapy 中島研, 山根律子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2021.

---

	S34-1. Non-clinical gametogenesis toxicity evaluation according to new guidelines 下村和裕 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2021.

---

	S34-2. Placental permeability and drug choice 登美斉俊 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2021.

---

	S34-3. Efforts to transitivity and the evidence creation of the drug to mother's milk 齊藤順平 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2021.

---

	S34-4. Epidemiologic studies and our country first domperidone cohort study 菱沼加代子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2021.

---

	Symposium 35. Term of the organizer to do it how to convey charm of the clinical pharmacy widely, or to regard as a pharmacy student 村木優一, 原田紘行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2021.

---

	S35-1. Efforts of the federation of Japanese pharmacy student 原田紘行1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2021.

---

	S35-2. Experience holding of the Asian Pacific pharmacy student symposium (APPS) 2018 中川翼 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2021.

---

	S35-3. Clinical pharmacy study aiming at the conquest of the multidrug-resistant bacteria infection 田代渉, 松元一明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2021.

---

	S35-4. Encounter with a pharmacy education and the super pharmacist 松元一明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2021.

---

	S35-5. To spend student life to be ... crop towards Pharmacist-Scientist; ... 池村健治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2021.

---

	S35-6. For the further participation in planning to this academic conference activity of the pharmacy student 奥田真弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2021.

---

	Symposium 36. Work style reform and task shifting in emergency intensive care - Words from an organizer 吉川博, 今井徹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2021.

---

	S36-1. Management ... of the prescription support based on task shift share - protocol for the adequacy of the medical therapy in the intensive care unit and the IV line 篠崎浩司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2021.

---

	S36-2. Mainly on cooperation in construction pneumonia treatment of the drug information cooperation from hospitalization to start from the emergency care to the area 高橋佐和, 宮崎俊明, 筒井由佳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2021.

---

	S36-3. Intervention by the multi-type of job using the sedative sedative protocol 安部敏生1, 才穂亮介2, 鹿島秀明3, 田中太郎4, 川手美穂5, 有元秀樹6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2021.

---

	S36-4. Intervention effect of the pharmacist in the ER type first aid system 宮田祐一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2021.

---

	S36-5. A pharmacist and the emergency intensive care that we raise in physicians 太田浩平1, 檜山洋子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2021.

---

	Symposium 37. There having been relation - pharmacist to cancer treatment in the new corona infection season, term of aiming thing - organizer 上ノ段友里, 小枝伸行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2021.

---

	S37-1. Practice of cancer treatment and the infection measures in the corona evil 高山和郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2021.

---

	S37-2. New coronavirus infection correspondence in Osaka and the problem 小枝伸行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2021.

---

	S37-3. Experience two times of effect on cancer treatment - clusters at in-hospital cluster infection; and ... 下村真代 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2021.

---

	S37-4. BCP at new coronavirus infection development in the cancer practice cooperation base Hospital 上ノ段友里 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2021.

---

	S37-5. Follow-up to infection measures and the patients in the health insurance pharmacy with cancer 村田勇人1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2021.

---

	Symposium 38. Term of the cooperation system organizer of a drugstore and the medical institution by the cancer domain demanded now 松井礼子, 安原眞人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2021.

---

	S38-1. The cooperation system (administration expecting it) of a drugstore and the medical institution on the basis of law revision 安川孝志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2021.

---

	S38-2. A role and the problem that are demanded from the scientific organization (academic conference) specialized in a cancer 近藤直樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2021.

---

	S38-3. Change of the cooperation with a health insurance pharmacy and the medical institution 松井礼子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2021.

---

	S38-4. The current situation and problem of the specialized medical institution cooperation drugstore 村田勇人1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2021.

---

	Symposium 39. Term of thing - organizer to see in bottom line - future of the irAE management to realize long-term follow 渡邊裕之, 南晴奈 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2021.

---

	S39-1. Bottom line of the irAE management to become complicated 吉野真樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2021.

---

	S39-2. Bottom line of the management tool making for early detection to support in irAE 武井大輔1, 鈴木栄2, 新井隆広3, 国吉央城4, 鈴木貴之5, 中山季昭1, 佐野元彦6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2021.

---

	S39-3. Bottom line of the registry utilization to discover irAE early 松金良祐 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2021.

---

	S39-4. Bottom line of the illness disease cooperation for the irAE management 與田賢作 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2021.

---

	S39-5. Bottom line of the irAE monitoring in the health insurance pharmacy 田中智枝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2021.

---

	Symposium 40. Term of data science - organizer of the field of practice - clinical pharmacy of the clinical studies utilizing real world data 堀井剛史, 細見光一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2021.

---

	S40-1. Clinical studies in the infection domain utilizing real world data 村木優一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2021.

---

	S40-2. Study on polypharmacy utilizing a variety of medical big data 馬渕賢幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2021.

---

	S40-3. Drug repositioning study utilizing real world data 座間味義人1,2,3, 新村貴博3, 濱野裕章2, 合田光寛2,3, 相澤風花3, 八木健太4, 石澤有紀5, 石澤啓介2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2021.

---

	S40-4. Seamless evidence creation from the basics utilizing the database study to clinical practice 安藤航1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2021.

---

	S40-5. Inspection of the diabetes guidelines utilizing large-scale medical data 堀井剛史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2021.

---

	Symposium 41. Is usable from tomorrow; is the term of the medical care big data analysis organizer for pharmacists 石澤啓介, 座間味義人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2021.

---

	S41-1. Fusion of data science and the fundamental researches technique 濱野裕章1, 座間味義人1,2,3, 合田光寛4, 相澤風花2, 八木健太4, 石澤啓介1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2021.

---

	S41-2. Beginning to the clinical question solution that big data begin to spin 三星知 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2021.

---

	S41-3. Creation of a meta-analysis and the high impact evidence by the fusion of the database analysis 中馬真幸1, 中本亜樹2, 坂東貴司2, 新村貴博2, 岡田直人2, 相澤風花2, 濱野裕章3, 八木健太4, 合田光寛4, 座間味義人2,3, 石澤啓介2,3, 田崎嘉一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2021.

---

	S41-4. Medical big data turn the tomorrow's normal business routine 武智研志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2021.

---

	S41-5. The big data era resulting in a benefit for epidemiologic studies 小山敏広1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2021.

---

	Symposium 42. Term of beginning and process - organizer from polypharmacy measures guideline - tomorrow of elderly people 篠永浩, 溝神文博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2021.

---

	S42-1. Beginning and process - background and purpose ... of the polypharmacy measures of the elderly people in the hospital 道家由行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2021.

---

	S42-2. Utilization method of beginning and process - manual of the polypharmacy measures of the elderly people in the hospital and real efforts example ... 末松文博1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2021.

---

	S42-3. About the development of polypharmacy measures in the Tohoku University Hospital 松浦正樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2021.

---

	S42-4. A role and the process that area base Hospital takes 篠永浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2021.

---

	S42-5. A role and the process that a small and medium size hospital takes 濱浦睦雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2021.

---

	Symposium 43. It is the term of - organizer for the settings of - hospital, drugstore, university thinking about the role of the pharmacist in the COVID-19 correspondence 塩田有史, 三鴨廣繁 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2021.

---

	S43-1. From the side of COVID-19-adaptive - medical treatment in the hospital - 塩田有史1,2,3, 平井潤1,3, 浅井信博1,3, 松本乃里子2, 竹内正幸2, 大西正文2, 三鴨廣繁1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2021.

---

	S43-2. From the side of efforts - infection measures of the hospital pharmacist in the COVID-19 correspondence - 片山歳也, 鈴木朋克 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2021.

---

	S43-3. COVID19 correspondence in the drugstore 瀧藤重道1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2021.

---

	S43-4. Correspondence of COVID-19 in the university pharmacy school 藤村茂 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2021.

---

	S43-5. Condition of a patient, diagnosis, treatment, infection measures of COVID-19 三鴨廣繁 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2021.

---

	Symposium 44. Term of relation ... organizer for the medical treatment life of continuous pharmacy management - Personal Oriented which a hospital, a drugstore pharmacist aims at in a diabetes domain 武藤達也, 朝倉俊成 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2021.

---

	S44-1. Proper use of the diabetes therapeutic drug based on the clinical test value 堀井剛史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2021.

---

	S44-2. Continuous pharmacy management of the use of appropriate insulin injection preparation 朝倉俊成 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2021.

---

	S44-3. Hypoglycemia measures support for appropriate diabetes medical therapy and chic day rule instruction 佐竹正子1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2021.

---

	S44-4. Follow-up of patients with diabetes in the treatment at home 篠原久仁子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2021.

---

	S44-5. Disaster response for continuous pharmacy management of the patients with diabetes 西村博之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2021.

---

	Symposium 45. It is the term of ... organizer with the competency in collaboration - healthcare worker upbringing business of the multi-type of job about patients with at-home cancer 串田一樹, 塩川満 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2021.

---

	S45-1. About cancer disease treatment at home personnel training 蘆野吉和 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2021.

---

	S45-2. Information ... which we want to introduce from a hospital into the area from ... hospital 伊東俊雅 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2021.

---

	S45-3. Information ... which information sharing - drugstore which we pointed from hospitalization to being at home from hospitalization requires 坂本岳志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2021.

---

	S45-4. Collaboration ... such as multi-type of job cooperation ... physician, the nurse in the area, care imitation, a dietician, the pharmacist, and the like 白石丈也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2021.

---

	S45-5. We think about the collaboration of the multi-type of job about patients with at-home cancer from the function of regional alliances drugstore, the specialized medical institution cooperation drugstore 串田一樹1, 谷川大夢1,2, 廣原正宜1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2021.

---

	Symposium 46. (annual convention plan) the term of ... organizer thinking about the pharmaceutical products supply system in the areas from role - disaster cycle acute phase of the pharmacist at disaster to a chronic phase 稲葉一郎, 高山和郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2021.

---

	S46-1. ... which thinks about the pharmaceutical products supply system in the areas from role - disaster cycle acute phase of the pharmacist at disaster to a chronic phase 西名武士 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2021.

---

	S46-2. It is ... about dispatch of the summary of the disaster agreement and the mobile pharmacy from the situation of the ... pharmacist society 金子雅好 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2021.

---

	S46-3. It is ... from experience of the ... Kumamoto earthquake about the pharmaceutical products supply method in the disaster area and the way of the support activity by the pharmacist 稲葉一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2021.

---

	S46-4. The pharmaceutical products supply system in the disaster area and problems and task of the support activity 高山和郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2021.

---

	Symposium 47. (annual convention plan) the term of the strategy organizer to offer collection, joint ownership and inflection - optimal medical therapy of the information at disaster 小林政彦, 高山和郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2021.

---

	S47-1. Intelligence and utilization for duties continuation in the 2016 Kumamoto earthquake 陣上祥子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2021.

---

	S47-2. Development of the application to apply in the distribution information of pharmaceutical products and future application 石渡俊二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2021.

---

	S47-3. About the information at disaster around J-SPEED 江川孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2021.

---

	S47-4. An introduction and inflection of information utilization disaster health medical care caring support system D24H at disaster 市川学 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2021.

---

	S47-5. Problem for intelligence, the joint ownership at disaster and the utilization 片山潤 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2021.

---

	Symposium 48. Term of evolution, deepening, true value - organizer of the ... area pharmacist society activity that the post Nakagyo pharmacist society of the cooperation reinforcement does not stop 黄前尚樹, 寸田靖 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2021.

---

	S48-1. ... that the way - Nakagyo pharmacist society of the local pharmacist society for better cooperation walked it in this way 黄前尚樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2021.

---

	S48-2. It is ... from position of ... hospital pharmacist connecting from a hospital to the area 中村美樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2021.

---

	S48-3. Thing ... which was seen from the making of relations that only patients-centered medicine medicine cooperation ... face obtained 竹家広志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2021.

---

	S48-4. "What you can do from a pharmacy in a small town, not in front of a large hospital - Participating in multidisciplinary collaboration" 片岡礼奈 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2021.

---

	S48-5. It is ... mainly on efforts - outpatient department chemotherapy for the cooperation reinforcement with a hospital and the drugstore 大野恵一, 本多伸二, 目黒裕史, 三松史野, 佐分利美帆子, 寸田靖, 村岡淳二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2021.

---

	Symposium 49. It is the term of the organizer from upbringing - basics, the education of the pharmacist contributing to psychiatry clinical practice to clinical practice 加藤剛, 阿部裕子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2021.

---

	S49-1. Molecular pharmacology and the therapeutic drug front line of mood disorders 武田泰生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2021.

---

	S49-2. It is ... from the position of upbringing ... university teacher of the pharmacist contributing to psychiatry clinical practice 山崎啓之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2021.

---

	S49-3. Significance to do the knowledge in English with one one case one carefully to the idea culture 村田司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2021.

---

	S49-4. And "we are concerned with the national prescription investigation of - antipsychotics keeping statistics person alive on the site -" 加藤剛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2021.

---

	S49-5. A pharmacist is ... from cooperation - hospitalization for psychiatry medical therapy adequacy to connect to the outpatient department 井上裕子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2021.

---

	Symposium 50. Term of psychiatric approach - organizer making use in the general course X psychiatry - public family 坪内清貴, 祖川倫太郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2021.

---

	S50-1. Psychiatry medical treatment and role of the pharmacist that are demanded in a general course 坪内清貴 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2021.

---

	S50-2. Pharmacokinetics and individualization therapy of the psychotropic drug 猿渡淳二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2021.

---

	S50-3. Proper use of the psychotropic drug under the internal disease coexistence 吉川明良 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2021.

---

	S50-4. We consult for a liaison team by the first aid 祖川倫太郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2021.

---

	S50-5. From a viewpoint of the consultation liaison by the psychology job 厚坊浩史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2021.

---

	Symposium 51. Term of the organizer thinking about the career path of gender equality - pharmacist in the field of pharmacist, clinical pharmacy 三宅健文, 塚本有子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2021.

---

	S51-1. The reason why I remain an administrator in the small and medium size hospital 井上潤子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2021.

---

	S51-2. Expect it for the career path construction of the pharmacist in pharmacy education in the future 西村亜佐子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2021.

---

	S51-3. In a cancer domain for carrier hope from - this and uneasy - 西上依里 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2021.

---

	S51-4. The workplace and expectation and anxiety that are easy to act that the pharmacist of the child care generation thinks of in the future 辻芙美, 大竹優樹, 安田早織, 植村有加, 谷崎泰広, 三宅健文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2021.

---

	S51-5. From the 6-year pharmacy school to a doctor (pharmacy): As university teacher the career path of the working woman researcher 高橋未来 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2021.

---

	S51-6. We explore the workplace environment that can support the career path of the pharmacist 三宅健文, 楠斐未, 瀬良郁実, 辻芙美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2021.

---

	Symposium 52. Term of the organizer thinking about career path, a way of working, the future image of the women in the course of a variety of pharmacists 土屋雅美, 河添仁 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2021.

---

	S52-1. Does God of the chance have only a forelock? Carrier formation strategy of the pharmacist specialized in a local cancer 土屋雅美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2021.

---

	S52-2. The career path which we learned from an encounter 文靖子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2021.

---

	S52-3. Career path as the researcher of the pharmaceutical products information science 堀里子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2021.

---

	S52-4. Is decision of the carrier accidental accumulation? 島田美樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2021.

---

	S52-5. The medical secret to act on Sus Tina bulldog throughout the trade is work life balance 大西友美子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2021.

---

	Symposium 53. Is the readiness of the pharmacist called into question? Term of the urgent contraceptive sale organizer at the drugstore 岡田浩, 鈴木渉太 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2021.

---

	S53-1. Kyoto University SPH drugstore information group "drugstore emergency contraceptive sale support project" 岡田浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2021.

---

	S53-2. It is urgently all drugstores with a contraceptive: Efforts of the canola flower drugstore 鈴木達彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2021.

---

	S53-3. Point to be urgently careful about at the grant of the contraceptive that we saw from the obstetrics and gynecology department specialist 池田裕美枝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2021.

---

	S53-4. It is "Sexsual reproductive health and rights (SRHR) in a pharmacy school How do you tell "? 西村亜佐子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2021.

---

	Symposium 54. I think the most difficult aspect of prescription audits right now is the dosage of direct-acting oral anticoagulants (DOACs), so let's think about that Words from an organizer 鈴木大介, 古久保拓 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2021.

---

	S54-1. A viewpoint of underdose from the pharmacist of the circulatory organ domain 木下照常 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2021.

---

	S54-2. A viewpoint of overdose from the pharmacist of the kidney domain 新海大智 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2021.

---

	S54-3. A viewpoint of the drug interaction from a DI charge pharmacist 冨田猛, 木村丈司, 矢野育子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2021.

---

	S54-4. From the viewpoint of the health insurance pharmacy 児島悠史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2021.

---

	Symposium 55. It is the term of - organizer from the analysis of the hospitalization and release support task according to - hospital function to think about the hospitalization and release support corresponding to medical needs and an advanced example 室井延之, 吉村知哲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2021.

---

	S55-1. Analysis of hospitalization and release support task and the example collection about the pharmacist cooperation 室井延之1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2021.

---

	S55-2. Community collaboration efforts to address medication notebook issues - Introducing the Yasadaru Man Card and unified format for providing information at the time of discharge - 今井圭介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2021.

---

	S55-3. Example ... of the counseling before evaluation before hospitalization and release support task - discharge that fixed its eyes on after discharge, ERAS surgery 國永智昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2021.

---

	S55-4. Practice - of the seamless medical therapy using the information contact book between hospital pharmacist and - institutions which share beneficial information in offering medical therapy between local pharmacists 鈴木亮平 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2021.

---

	S55-5. Patients follow, drugstore cooperation after the patients information sharing and discharge before hospitalization utilizing the medical cooperation 平下智之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2021.

---

	Symposium 56. Term of a task shift organizer who should have the original pharmacist in perioperative care 柴田ゆうか, 舟越亮寛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2021.

---

	S56-1. Task sharing in the perioperative period / Promoting team medical care for task shifting 齋藤繁 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2021.

---

	S56-2. Preoperative outpatient workload survey and task shifting issues 千葉陽月, 野口雅美, 井上真由美, 佐藤邦義, 荒川隆太郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2021.

---

	S56-3. Pharmaceutical intervention and evaluation in by practice support - surgery front and by endoscopy front by the outpatient department pharmacist 久岡清子, 増田博也, 佐々木健志, 大荒政志, 川村大輔, 間千晴, 木原俊文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2021.

---

	S56-4. Cooperation with hospital pharmacy and the neighborhood ethical pharmacy using prescription notebook about the cancellation medicine before examination, surgery 藤井達郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2021.

---

	S56-5. A task shift who should have the original pharmacist in perioperative care 猪田宏美, 鍛治園誠 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2021.

---

	Symposium 57. It is the term of the organizer for research activities and improvement of the clinical competence 中村任, 池田龍二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2021.

---

	S57-1. It is ... for education, research activities based on pharmacist system - clinical experience specialized in clinical pharmacy 百瀬泰行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2021.

---

	S57-2. It is ... from the position of creation - clinical pharmacist of the clinical studies mind 郷真貴子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2021.

---

	S57-3. It is ... from the position of creation - clinical system teacher of the clinical studies mind 松下良 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2021.

---

	S57-4. Efforts of pharmacy school and Keio University about the cooperation with the university hospital 青森達1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2021.

---

	Symposium 58. (annual convention plan) is the term of ... organizer for the study development that is like clinical pharmacy different field study - creation that a young researcher joins together 五十嵐裕貴, 三宅俊介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2021.

---

	S58-1. Inspection of the usefulness as the pre-back prediction, the effect predictor of the tumor-suppressor gene CYLD expression disappearance in ovarian cancer 三宅俊介1,2, 齋藤秀之1,2, 城野博史1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2021.

---

	S58-2. Pharmacokinetic model analysis of the sunitinib in patients with renal carcinoma 伊藤雄大1,2, 山本和宏1,2, 大村友博1,2, 矢野育子1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2021.

---

	S58-3. Participation of the derived albumin receptor having an influence on the internal change of Abraxane 濱眞壱 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2021.

---

	S58-4. Reverse translational research utilizing the large-scale medical information database analysis for the anticancer agent side effect prevention 神田将哉1,2, 合田光寛3,4, 吉岡俊彦1,2, 吉田愛美3, 新村貴博2, 櫻田巧2, 小川敦2, 岡田直人2, 相澤風花2, 座間味義人2,3,5, 八木健太4, 濱野裕章3, 石澤有紀6, 石澤啓介2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2021.

---

	S58-5. New suggestion of the condition of a patient analysis using in vivo antigen-antibody reaction 森石麻梨乃 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2021.

---

	S58-6. Effective evaluation for multidrug-resistant bacteria of new β-lactamase inhibitor Nacubactam 五十嵐裕貴, 松元一明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2021.

---

	Symposium 59. Pharmacist duties to meet expectation practice immediately, term of the new development organizer of young person upbringing 尾上雅英, 小林政彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2021.

---

	S59-1. The training acceptance and the prospects of the health insurance pharmacy pharmacist who assumed the acquisition of the cancer medical therapy a base 萱野勇一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2021.

---

	S59-2. Skill up through the innovative duties development in the infection domain 小林和博, 高橋有, 上田覚, 尾上雅英 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2021.

---

	S59-3. For a pharmacist contributing to local medical treatment the dispatch by the pharmacist 吉良俊彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2021.

---

	S59-4. Upbringing and the tissue management of the pharmacist taking medical care in the future 高橋一栄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2021.

---

	Symposium 60. Let's have it now, and how do ride out a wave of the digitization to pharmacist digital transformation - medical care industry; or the term of ... organizer 小枝伸行, 岡橋孝侍 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2021.

---

	S60-1. Is connected because connect it; pass; ... electron package insert and bar code ... 岡橋孝侍 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2021.

---

	S60-2. Inflection of ePath project and the drug information 山下貴範 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2021.

---

	S60-3. Introduction of the online qualification confirmation and the development 佐藤弘康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2021.

---

	S60-4. It is ... for use and application of the health information gathered with securing of drug safety - digital by an electronic prescription and the electronic drug history 宮村信輝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2021.

---

	S60-5. Settings correspondence of the digital transformation 山中理 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2021.

---

	Symposium 61. Term of one or ... organizer that medical therapy - pharmacist is associated with childhood palliative care how 冨家俊弥, 石川洋一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2021.

---

	S61-1. Multiverse of the role of the pharmacist in the childhood palliative care 笹月桃子1,2, 若杉陽子3, 古賀友紀2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2021.

---

	S61-2. Empowering pharmacists to help children who need medical care at homeist 松丸実奈 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2021.

---

	S61-3. Childhood palliative care by the pharmacist in daily relations 笠原庸子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2021.

---

	S61-4. The current situation, role, problem of the pharmacist in the pediatric palliative care team of the pediatric hospital 歌野智之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2021.

---

	Symposium 62. Term of the intervention organizer of the pharmacist for understanding of eating dysphagia and the appropriate medication support 倉田なおみ, 賀勢泰子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2021.

---

	S62-1. Eating dysphagia and dosage form choice, topic to surround the simple suspension method 倉田なおみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2021.

---

	S62-2. The medication situation that a dentist examines 石井良昌 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2021.

---

	S62-3. Calculation ... of cooperation ... transluminal medication support charges of a hospital and the health insurance pharmacy in the simple suspension method 古澤洋子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2021.

---

	S62-4. The simple suspension method introduction example in the health insurance pharmacy 鈴木邦彦1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2021.

---

	S62-5. The simple suspension method judging from dosage form design 原田努 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2021.

---

	S62-6. Incompatibility in the crush and simple suspension method 石田志朗1, 倉田なおみ2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2021.

---

	Symposium 63. Delivering well-being to patients - Robust cardiac rehabilitation and renal medicine, exercise, nutrition, and cardiorenal connections - Words from the organizer 吉国健司, 柴田啓智 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2021.

---

	S63-1. The heart rehabilitation in the super-aged society: It is also a malignant tumor heart, kidney 福本義弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2021.

---

	S63-2. Skill mixture to want a pharmacist to know it from the position of the physical therapist 齊藤正和, 作山晃裕, 森沢知之, 高橋哲也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2021.

---

	S63-3. Skill mixture to want a pharmacist to know it from the position of the dietician 宮島功 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2021.

---

	S63-4. Deep - honeymoon and cross-purposes ... with the heart which kidney talks about concerned 古久保拓 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2021.

---

	S63-5. The heart kidney linkage that a specialist of the heart talks about 櫻下弘志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2021.

---

	Symposium 64. Term of - organizer learning a way of the display of the ability as the pharmacist from the example of quality improvement - others institution of the patients management to push forward by the power of the pharmacist 榎本貴一, 小坂鎮太郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2021.

---

	S64-1. Expectation and the prospects to the pharmacist in the domain of the medical quality, patients security 小坂鎮太郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2021.

---

	S64-2. That maintain Quality Improvement - quality improvement activity to begin with the hospitalization complications measures such as the delirium, and the like; learn; - 榎本貴一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2021.

---

	S64-3. Team Building ... with other types of job through ... polypharmacy measures to do drug rearranging by the multi-type of job, and to promote patients collaboration 中込哲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2021.

---

	S64-4. Importance ... of the pharmacist in the efforts for relation ... quality improvement of the pharmacist in in-hospital overall QI 川名賢一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2021.

---

	Symposium 65. Term of process of pharmacist upbringing - organizer to receive the enforcement of the Basic Law for stroke, cardiovascular disease measures, and to examine ... patients 徳永仁, 高井靖 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2021.

---

	S65-1. Upbringing ... of the pharmacist who they receive the enforcement of the Basic Law for stroke, cardiovascular disease measures, and examines ... patients 高井靖 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2021.

---

	S65-2. Consideration to pharmacist education in the circulatory organ intensive care and the durability 土岐真路 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2021.

---

	S65-3. Upbringing of the pharmacist who can do comprehensive medical treatment instruction in the heart failure team 櫻下弘志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2021.

---

	S65-4. In the circulatory organ domain, what is necessary to bring up a pharmacist looking after patients? 梶原洋文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2021.

---

	S65-5. Simulation education to examine patients 徳永仁1, 園田純一郎1, 緒方賢次2, 興梠靖幸2, 高村徳人2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2021.

---

	Symposium 66. Term of challenge - organizer of the pharmacist showing specialty from ... scientific viewpoint that an academic D tailing turns the future of the clinical pharmacy 小茂田昌代, 宮崎美子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2021.

---

	S66-1. A drug discovery scientist and the academic D tailing which builds the information infrastructure 小茂田昌代 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2021.

---

	S66-2. Practice of PBPM utilizing the constipation therapeutic drug academic D tailing material of patients with cancer 河本怜史1, 青柳友彦1, 都築竜太1, 木村敦1, 香取哲哉1, 出雲貴文1, 小茂田昌代1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2021.

---

	S66-3. Chemical viewpoint in the academic D tailing material development 清水忠 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2021.

---

	S66-4. Practice of the academic D tailing in the circulatory organ domain 古野喬志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2021.

---

	S66-5. Academic D tailing after the business training 伊藤俊将1, 土肥弘久1, 廣澤伊織1, 水谷顕洋1, 宮崎美子1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2021.

---

	S66-6. Education of the academic D tailing in the pharmacy school 青山隆夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-448, 2021.

---

	Symposium 67. Term of thing - organizer who should succeed it to a young generation in professionalism - now of the pharmacist whom we felt to be a corona evil 細谷治, 安野伸浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 449-449, 2021.

---

	S67-1. Through a pharmacist experience in professionalism foreign countries of the pharmacist whom we felt to be a corona evil 若子直也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2021.

---

	S67-2. As a visit pharmacist associated with patients with professionalism - cancer of the pharmacist who felt to be a corona evil ... 川名三知代 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2021.

---

	S67-3. Expect it to become the pharmacist who can cope with a change 安川孝志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2021.

---

	S67-4. As the professionalism University teacher of the pharmacist whom we felt to be a corona evil 荒田洋一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 453-453, 2021.

---

	S67-5. As professionalism hospital pharmacist of the pharmacist whom we felt to be a corona evil 細谷治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 454-454, 2021.

---

	Symposium 68. Term of construction and the use and application organizer of the unified management technique for standardization of the large-scale medical information 折井孝男, 高田敦史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-455, 2021.

---

	S68-1. The present of the standard cord governance center in the MID-NET cooperation medical institution 康東天1, 高田淳史2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 456-456, 2021.

---

	S68-2. The present of MID-NET and standard cord governance in the future 陰山卓哉, 岸塲真理, 大田有佳里, 宇山佳明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-457, 2021.

---

	S68-3. For problem solution to data standardization of the field of pharmaceutical products in clinical settings 横山威一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 458-458, 2021.

---

	S68-4. Of the education about the medical information utilization and coding in pharmacy education settings, actually 室高広 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2021.

---

	Symposium 69. Examining and preparing for the future - What pharmacists have been able to do and what they have not been able to do regarding the new coronavirus infection - Words from the organizers 高田勝利, 高山和郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-460, 2021.

---

	S69-1. It is measures and the correspondence in the corona evil utilizing the infection measures area network by a pinch in a chance 崎本裕治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2021.

---

	S69-2. Upbringing - of the pharmacist who is strong in - infection from With corona to Post corona 中南秀将 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 462-462, 2021.

---

	S69-3. Through the "Namara Simple Project", public health and information dissemination required of pharmacists as seen from the experience of large-scale cluster disasters 長塚健太1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 463-463, 2021.

---

	S69-4. The fact of the pharmacist duties in the COVID-19 ward and the task which we saw 茂野絢子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 464-464, 2021.

---

	S69-5. Expectation to the response to new coronavirus infection and a problem and a pharmacist 緒方剛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 465-465, 2021.

---

	Symposium 70. Want to show - to reconsider an index and a method to visualize ward duties now; is the term of presence - organizer of the pharmacist in the ward 長谷川裕矢, 矢野良一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 466-466, 2021.

---

	S70-1. For the visualization of the clinical index of ward drug duties and the qualitative index 舟越亮寛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 467-467, 2021.

---

	S70-2. Outcome evaluation of the pharmacist in the intensive care unit 前田幹広 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 468-468, 2021.

---

	S70-3. We regard an on-the-job problem as the significance of various indexes from the actual situation that it seemed that we visualize the ward duties of the pharmacist 長谷川裕矢 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 469-469, 2021.

---

	S70-4. What we can do to increase the value of ward pharmacy services - Starting a new business is the best chance to visualize results - 古俵孝明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 470-470, 2021.

---

	S70-5. Advice of a relation and the information cooperation to the multi-type of job that a small and medium size hospital practices 上ノ段友里 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 471-471, 2021.

---

	WS. Pharmacist application case form specialized in medical therapy 石井伊都子, 渡邊裕之, 山崎美保, 細野智美, 樋口則英 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 472-472, 2021.

---

	IO-01. The exploratory and early-stage initiative of emergency medicine pharmacist at limited pharmacist service in Japan. Miku Tamura, Mitsuhiro Ohtake Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 474-474, 2021.

---

	IO-02. Nonsteroidal anti-inflammatory drugs utilization in patients with Parkinson's Disease : a Japanese retrospective claims database study Sachiko Kasamo1, Yoshikazu Tasaki2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 475-475, 2021.

---

IO-03. Clinical significance of therapeutic drug monitoring of sunitinib in patients with metastatic renal cell carcinoma treated with a 2-week-on and 1-week-off schedule Takahiro Ito1, Kazuhiro Yamamoto1, Junya Furukawa2, Kenichi Harada2, Masato Fujisawa2, Tomohiro Omura1, Ikuko Yano1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 476-476, 2021.

---

IO-04. Predictors for development of denosumab-induced hypocalcaemia in cancer patients with bone metastases determined by ordered logistic regression analysis. Yuko Kanbayash1,2, Koichi Sakaguchi3, Fumiya Hongo4, Takeshi Ishikawa2,5, Osamu Ukimura4, Tetsuya Taguchi3, Koichi Takayama2,6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 477-477, 2021.

---

	IO-05. Effect of Underlying Disease on Efficacy of Drugs for Delirium : A Comparison of Cancerous and Non-Cancerous Diseases Tomonori Ohya1,2, Momoka Suda2, Ayumi Ozawa2, Suzuka Umeda1, Mayumi Tsukagoshi3, Yu Yamada4, Junya Sato1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 478-478, 2021.

---

	IO-06. Survey on the Amount of Fugitive Dust when Dispensing Drugs with Formulation Processing for Children with Medical Complexity Takenori Tamaki1, Yuji Yoshiyama2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 479-479, 2021.

---

IO-07. Development and validation of a new LC-MS / MS assay for simultaneous determination of parent compounds and active metabolites of second- / third-generation EGFR-TKIs in human serum, and its clinical application for cancer patients Emi Ishikawa1, Yuta Yokoyama1,2, Haruna Chishima2, Ouki Kuniyoshi3, Itaru Satou4, Naoki Nakaya4, Hideo Nakajima4, Motonori Kimura5, Jun Hakamata5, Naoya Suehiro5, Hideo Nakada5, Shinnosuke Ikemura6,7, Aya Jibiki2, Hitoshi Kawazoe1,2, Hiroshi Muramatsu5, Sayo Suzuki1,2, Tomonori Nakamura1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 480-480, 2021.

---

	YIA1-01. Using existing clinical study data is examined the effectiveness of the oral anticoagulant drug and the racial difference about the safety directly 秋田彩佑1,2, 魏捷2, 安部賀央里1,2, 頭金正博1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 482-482, 2021.

---

	YIA1-02. Liposome about association with the serum electrolyte concentration before the amphotericin B-induced impaired renal function and administration 山城海渡1,2, 平田敦士2, 太田涼介2, 緒方文彦1, 中村武浩1, 川崎直人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 483-483, 2021.

---

	YIA1-03. Manufacture of brain capillary endothelial cells derived from the human iPS cells which are applicable for the condition of a patient elucidation study 山下美紗季1, 青木啓将2, 青山峰芳2, 坡下真大1, 松永民秀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 484-484, 2021.

---

	YIA1-04. Examination of the dose design utilizing the metabolic capacity evaluation by voriconazole in children and the metabolite concentrations 加藤美和1, 横山雄太1, 松山佳奈苗1, 齊藤順平2, 文靖子2, 歌野智之2, 千葉杏子2, 長谷川彩薫2, 地引綾1, 河添仁1, 山谷明正2, 松元一明3, 鈴木小夜1, 中村智徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 485-485, 2021.

---

	YIA1-05. Risk analysis of radiation-induced retching, vomiting in patients with uterine cervix cancer and effective evaluation of the antiemesis therapy 海野茜1, 山本扇里2, 飯原大稔1,2, 藤井宏典1,2, 上田祐稀乃1, 加藤寛子2, 安江萌夏2, 森重健一郎3, 松尾政之3, 鈴木昭夫1,2, 林秀樹1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 486-486, 2021.

---

	YIA1-06. Integration analysis of the genetic factor influencing expression of chemotherapy-induced retching, vomiting 小玉千佳1, 辻大樹1, 山本圭祐2, 米澤樹1, 宮城壮裕1, 中道秀徳3, 矢部勝茂2, 伊藤邦彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 487-487, 2021.

---

	YIA1-07. Look at adverse event spontaneous report database analysis and the rear; protective efficacy of palonosetron for the cisplatin-induced renal failure based on the mark study 竹村美穂1, 池村健治2, 山根章寛1, 仁木一順1, 上田幹子1, 奥田真弘2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 488-488, 2021.

---

	YIA1-08. Participation of the exosome derived from a skeletal muscle in the septicemic condition of a patient exacerbation due to the disuse muscle atrophy 長邑花, 榎木裕紀, 田口和明, 松元一明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 489-489, 2021.

---

	YIA1-09. Antioxidant ability evaluation of the active metabolite of benzbromarone 住吉琴桃1, 前田侑里1, 松本挙典1, 寒水壽朗1, 平田憲史郎1, 岡崎祥子1, 竹下啓蔵1, 佐藤圭創2, 瀬尾量1, 門脇大介1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 490-490, 2021.

---

	YIA2-01. The elucidation of the usefulness of the family pharmacist system and the modifying factor: Retrospective cohort study using receipt data 池谷怜, 此村恵子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 492-492, 2021.

---

	YIA2-02. Comparison between levetiracetam and mental disorder expression of Lacosamide or Perampanel by the combination 松沼悟1, 須永茂樹2, 西岡菜々子1, 輿石徹1, 吉元公一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 493-493, 2021.

---

	YIA2-03. Effect (the second report) that hypertriglyceridemia gives to serum amiodarone levels 橋本直明1, 土岐浩介1,2, 河野了2, 青沼和隆2, 家田真樹2, 本間真人1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 494-494, 2021.

---

	YIA2-04. The discovery of drug interactions at warfarin and tolvaptan combination and elucidation of the mechanism 齊藤将之1,2, 岩尾岳洋2, 前田徹3, 市原利彦4, 味岡正純5, 山田哲也1, 鈴木匡2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 495-495, 2021.

---

	YIA2-05. The effect that mTOR-HIF pathway gives for efficacy of Roxadustat and a side effect 中西正範1,2, 水野智博3, 長野文彦4, 伊藤辰将2, 高橋和男5, 山田成樹1,3, 坪井直毅2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 496-496, 2021.

---

	YIA2-06. Search of the rise in blood vancomycin levels predictor which does not depend on the renal function change 磯田和也1, 中出順也1, 藤田有美1, 菅幸生2, 嶋田努1, 崔吉道1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 497-497, 2021.

---

	YIA2-07. Pharmacologic approach - of the effect of the DPP-4 inhibitor using search - rat of the new therapy on male sexual dysfunction with the vincristine administration 片岡智哉1, 真川明将2, 堀田祐志2, 日比陽子2, 木村和哲1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 498-498, 2021.

---

	YIA2-08. Fact-finding of the Carboplatin desensitization in the gynecologic cancer domain 寺田公介1,2, 宇田川涼子1, 齋藤義正1, 石川光信1, 赤木徹1, 橋本浩伸1, 山口正和2, 古川哲也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 499-499, 2021.

---

	YIA2-09. Examination of the toxicity and the effect of treatment for patients with endometrial cancer in the Carboplatin doses setting using the revision creatinine clearance 片山健太郎1,3, 今村牧夫2, 上原孝3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 500-500, 2021.

---

	YIA3-01. Study on neutrophilic/lymphocytes ratio and effect of treatment in the Palbociclib therapy 鈴木かおり1, 宇田川涼子1, 大塚亮1, 渡部大介1, 石川光信1, 赤木徹1, 橋本浩伸1, 山口正和2, 古川哲也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 502-502, 2021.

---

	YIA3-02. It is a relative dose intensity of the adjuvant chemotherapy and the association of the no recurrence survival period after the non-small cell lung cancer technique: Look at the single institution rear; a mark cohort study 冨士原あゆみ, 塩飽英二, 松原菜美, 土手賢史, 小林由佳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 503-503, 2021.

---

	YIA3-03. It is examined the paclitaxel + Carboplatin therapy as the adjuvant chemotherapy after the operation for the early carcino-sarcoma uterus 後藤千尋1, 片山健太郎1, 仁井寛彦1, 今村牧夫2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 504-504, 2021.

---

	YIA3-04. Correlation analysis with the blood level of the drug which we used for new coronavirus infection (COVID-19) treatment in Tohoku University Hospital and the clinical index 佐藤稔之1, 高崎新也1, 森下啓1, 千葉僚1, 小林大典1, 鈴木博也1, 佐藤裕1, 佐藤紀宏1, 菊地正史1, 早川禎宏2, 杉浦久敏3, 青柳哲史4, 前川正充1, 眞野成康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 505-505, 2021.

---

	YIA3-05. The use actual situation of the daptomycin and safe examination 山口莉穂, 勝又瑛梨奈, 松本勝城, 加藤一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 506-506, 2021.

---

	YIA3-06. Use of the proton pump inhibitor and potassium ion competition type acid blocker and risk review of the Clostridioides difficile infection 渡邉愛悠1, 佐藤智香1, 高取士剛1, 岩堀真弓1, 久保淳一1, 和泉秀明1, 田畑裕和1, 小原郁司1, 樋浦一哉2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 507-507, 2021.

---

	YIA3-07. Effect on discharge dose and drug costs investigation by the TDM of the Clozapine 阿部裕也1, 渡辺研弥1, 野崎啓子2, 陣野大輔1, 平田祥一朗2,3, 鈴木二妙香2,4, 後藤將之2,3, 一瀬瑞絵2, 山本慎之助2,5, 堀越翔2,6, 金子春香2,7, 須藤孝浩1, 黒田純子1, 三浦至2, 矢部博興2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 508-508, 2021.

---

	YIA3-08. Efforts of the discharge drug information cooperation addition in our hospital and evaluation of the health insurance pharmacy 和仁昇1, 大澤琢郎1, 山本和哉1, 洞口拓也1, 小林和正1, 田中知代1, 嶋俊弥1, 政井恵1, 元田美佳1, 近藤佑香1, 長柄智美1, 上田秀親1, 阪口直樹1, 若田達朗1, 和仁寿彦2, 竹中勝信1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 509-509, 2021.

---

	O01-01. The acetaminophen-induced low blood pressure in the septicemic patients: Single institution retrospective cohort study 稲毛俊介, 矢島領, 長原新太郎, 風間彩, 高村萌, 庄司知紘, 門井美香, 田代友紀子, 伊勢雄也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 511-511, 2021.

---

	O01-02. Usefulness evaluation of the drug confirmation before operation of the perioperative care team pharmacist for the surgery rate of discontinuation 白倉由基1,2, 石田茂1,2, 田川慎二1,2, 辛島裕士1,3, 藤吉哲宏1,4, 梅原薫3, 淀川千穂1,5, 渡邊裕之2, 辻敏和2, 江頭伸昭2, 中川尚志1,6, 家入一郎2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 512-512, 2021.

---

	O01-03. Examination of the eye manifestation onset factor with voriconazole 岡冨大輔1, 宮庄杏奈1, 上野千奈美1, 樫本考司1, 片山雄太2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 513-513, 2021.

---

	O01-04. Risk factor analysis of the nonionic iodine adverse reaction to contrast medium onset 上村忠聖1, 茶谷良一2, 鈴木信也3, 小松原江里子1, 林誠一1, 橋口正行2, 木崎速人2, 堀里子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 514-514, 2021.

---

	O01-05. The current situation of the application support system of the Relief System for Sufferers from Adverse Drug Reactions 中川義浩1, 坂田光平2, 藤田強記2, 浮池香奈子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 515-515, 2021.

---

	O02-01. Development of the in vivo intracerebral multiple receptor share simultaneous measurement method that aimed at the effectiveness, the safety assessment of antipsychotics 赤下学, 中谷絵理子, 佐々木渉, 宮下映里果, 黄倉崇 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 517-517, 2021.

---

	O02-02. Factor analysis of the OATP1B activity individual differences that assumed the plasma Coproporphyrin-I concentrations in patients with rheumatoid arthritis an index 小野寛之1, 田中遼大1, 鈴木陽介2, 小田絢子2, 尾崎貴士3, 龍田涼佑1, 大野恵子2, 柴田洋孝3, 伊東弘樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 518-518, 2021.

---

	O02-03. PK-PD-PGx analysis of the factor Xa inhibitor edoxaban and its active metabolite M-4 in patients with atrial fibrillation 中川潤一1, 金城貴彦2, 相内尚也1, 上野桂代1, 富田泰史2, 新岡丈典1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 519-519, 2021.

---

O02-04. The proton pump inhibitor reduces the effectiveness of the capecitabine therapy in patients with early colon cancer: Look at the multicenter rear; a mark observational study 高橋克之1, 北爪賀子2, 河添仁3, 魚住龍史4, 吉澤朝枝5, 飯原大稔6, 藤井宏典6, 新井隆広7, 村地康8,9, 佐藤由美子10, 三上貴弘11, 橋口宏司12, 山崎朋子5, 高橋正也1, 藤田行代志7, 細川祐岐8, 諸角一成10, 土屋雅美11, 横山敦12, 橋本浩伸2, 山口正和13 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 520-520, 2021.

---

	O02-05. Development of human serum Pembrolizumab densitometry by the column switching LC-MS/MS method using the online solid-phase extraction column 清水穂香1, 阿部一樹1, 内藤隆文1, 大塚篤史2, 前川真人3, 三宅秀明2, 川上純一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 521-521, 2021.

---

	O03-01. Construction of the predictive model of the onset of serious neutropenia in patients with AC therapy enforcement breast cancer 宮城壮裕1, 辻大樹1, 仕子優樹2, 山本圭祐3, 中道秀徳3, 矢部勝茂3, 川崎洋平4, 伊藤邦彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 523-523, 2021.

---

	O03-02. It is investigated the adhesion situation of the ingredient in the PTP sheet after taking lenalidomide capsule 小室雅人1, 古屋貴人1, 大橋養賢2, 渡部大介3, 野村久祥4, 小室亜由美4, 田部井彰5, 澤村星吾6, 百武宏志7, 宮澤淑子8, 楠浩子9, 寺門浩之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 524-524, 2021.

---

	O03-03. Relations analysis with blood aprepitant based on the cachectic progress degree in patients with head and neck cancer and the active metabolite levels and antiemesis effect 鈴木祐介1,2, 内藤隆文1, 柴田海斗1, 細川誠二2, 峯田周幸2, 川上純一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 525-525, 2021.

---

	O03-04. Look at the rear about the clinical significance of the appropriate blood pressure management for the proteinuria onset of patients receiving VEGF inhibitor; a mark cohort study 二瓶哲1,2, 朝賀純一1,2, 高橋宏彰1,2, 氏家悠貴3, 青木朋彦1, 大坂紗也佳1, 村里風太1, 佐藤文彦1, 旭浩一4, 前門戸任5, 工藤賢三1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 526-526, 2021.

---

	O03-05. First/II phase study (DGA-study) of the Amitose-DGA-containing cream for the prevention of the hands and feet skin test for patients with renal cell carcinoma taking sunitinib 山本和宏1, 西山智司2, 国定充2, 五百蔵武士1, 飯田真之1, 伊藤雄大1, 槇本博雄1, 大村友博1, 原田健一3, 藤澤正人3, 錦織千佳子2, 矢野育子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 527-527, 2021.

---

	O04-01. We look at the effectiveness in the change and the safe rear in an administration schedule of trifluridine/Tipiracil and are examined a mark 原伸輔1, 坂井大介2, 新谷拓也1, 山本智也1, 佐藤太郎2, 奥田真弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 529-529, 2021.

---

	O04-02. The blood favipiravir levels are associated with the rise in uric acid level depending on a ferritin level 森川剛1, 久保田健1, 近藤大地2, 高梨靖久2, 南聡3, 金城恒道4, 守岩友紀子5, 柳田顕郎5, 岡澤香津子1, 千秋智重2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 530-530, 2021.

---

	O04-03. Examination of the clinical outcome with the dexamethasone administration for the new coronavirus infection 伊部裕太1, 石郷友之1, 北川学1, 木明智子1, 藤谷好弘2, 黒沼幸治3, 藤居賢1, 高橋聡2, 福土将秀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 531-531, 2021.

---

	O04-04. Association between rehospitalization and polypharmacy in patients with heart failure 竹村有美, 樋口裕己, 山田健一, 幸邦憲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 532-532, 2021.

---

	O04-05. Application to extraction and the liver metabolism type drug proper use of patients with potential cirrhosis using the ALBI score 吉井圭佑1, 田坂祐一1, 吉田昭昌2, 田頭尚士3, 星島祐美子4, 田坂友紀4, 杉山哲大5, 山本宏6, 名和秀起1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 533-533, 2021.

---

	MS01. New developments in cancer cachexia treatment - based on experience with Adlumiz - 濱内諭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 536-536, 2021.

---

	MS03. 2021 appearance - of age - antiCGRP antibody of the change of migraine headache treatment 橋本洋一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 538-538, 2021.

---

	MS04. Benefit and problem of the irAE management and the ePRO utilization in the cancer medical therapy 太良哲彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 540-540, 2021.

---

	MS05. It is ... from the medication support of patients with thing - HIV infection to want you to know it being a role of the hospital pharmacist in the ambulatory practice of the chronic disease for "the day" 矢倉裕輝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 542-542, 2021.

---

	MS06. New hematology 柴田啓智 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 544-544, 2021.

---

	MS07-1. Current situation/MS07-2. of the migraine headache therapeutic drug which we looked at from a pharmacist New migraine headache treatment to want all pharmacists to know it 杉上香織, 今井昇 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 546-546, 2021.

---

	MS08-1. Usefulness and safety ... of the JAK inhibitor which we looked at from the glance of rheumatoid arthritis practice ... physician that JAK inhibitor became the main force 三崎健太 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 548-548, 2021.

---

	MS08-2. Role of the pharmacist in rheumatoid arthritis treatment 曽根本恵美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 549-549, 2021.

---

	MS09. From adult T cell leukemia, lymphoma (ATL) - viral infections to malignant transformation, how do also cure; ... 野坂生郷 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 551-551, 2021.

---

	MS10. What is the strongest supportive care to develop every day? Efforts ... of the pharmacist specialized in a cancer about retching, vomiting of ... our hospital 石川寛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 553-553, 2021.

---

	MS11. Understanding and introduction case to Biosimilar 石井伊都子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 555-555, 2021.

---

	MS12-1. Basics of breast cancer treatment and importance/MS12-2. of the team approach in medical care Role of the pharmacist in the team approach in medical care 西村令喜, 森岡淳子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 557-557, 2021.

---

	MS13. About the efforts of the pharmacist for hepatitis B to occur by immunodepression, chemotherapy 水谷栄梨, 宮崎俊明, 谷口潤 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 559-559, 2021.

---

	MS14-1. Basic knowledge of the equol and clinical evidence 内山成人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 561-561, 2021.

---

	MS14-2. Pharmaceutical viewpoint and approach in the breast cancer endocrine therapy 今村知世 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 562-562, 2021.

---

	MS15. Implementation of regional formularies in Japan - Role of hospital pharmacists - 今井博久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 564-564, 2021.

---

	MS16. To realize cooperation of role - truth of the pharmacist sought by community medical care cooperation; ... 伊東弘樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 566-566, 2021.

---

	MS17. Evidence ... which is usable from resistant bacteria infection treatment - today based on scientific grounds 松元一明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 568-568, 2021.

---

	MS18. Should the medical person (physician) think about medical expenses? Significance ... of the generic introduction in ... cancer domain 後藤悌 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 570-570, 2021.

---

	MS19. Role of the pharmacist for a fact of misuse, the abuse of the opioid analgesic and the prevention 細川豊史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 572-572, 2021.

---

	MS20-1. Let's evaluate a pharmacokinetic profile as a pharmacist definitely 大野能之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 574-574, 2021.

---

	MS20-2. How are you associated with medical therapy as a pharmacist? 鈴木貴明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 575-575, 2021.

---

	MS21-1. Supporting "Living with Cancer" - Encounter with Appearance Care - 吉野真樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 577-577, 2021.

---

	MS21-2. Importance ... of symptom management - moisture retention and the skin care for the dermatopathy to be caused by cancer medical therapy 山崎直也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 578-578, 2021.

---

	MS22. Because a pharmacist is concerned with patients lifesaving, read ... clinical practice guidelines to think about the way on drug intervention, and untie it; and ... 吉廣尚大 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 580-580, 2021.

---

	MS23. How to use Chinese medicine in acute phase, the ward 加島雅之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 582-582, 2021.

---

	MS24. About neuromyelitis optica spectrum disorder (NMOSD) 岡本智子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 584-584, 2021.

---

	MS25. Need - of the evaluation from a viewpoint of the medical security at pharmaceutical products adoption and the design evaluation at risk management - pharmaceutical products adoption 菅野浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 586-586, 2021.

---

	MS26. With the information sharing tool which form - all can utilize of the proper use of the oral anticancer agent "thinking about from a gastric cancer case" and the future medical cooperation? 藤堂真紀, 下川友香理, 藤田あゆみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 588-588, 2021.

---

	MS27. Multi-type of job collaboration approach ... to work-style reform - sleeplessness, the delirium of the ward pharmacist by the specialist in hospital synthesis 園田幸生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 590-590, 2021.

---

	MS28. The tide that the medical therapy is new after in front of art of the breast cancer, the operation 山本豊 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 592-592, 2021.

---

	MS29. Reach the ... HIF-PH inhibitor era with the appropriate diagnosis and treatment of the anemia in renal disease; and ... 桑原孝成 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 594-594, 2021.

---

	P01-01. Case of patients during Afatinib remedy given information feedback from the family drugstore to a medical institution 辻真利1, 笹野寿基2, 安川徹2, 竹原美穂2, 吉田貴大3, 山田裕介3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 597-597, 2021.

---

	P01-02. Consideration of problems in the storage of the pharmaceutical products with the bag with the light blocking effect 井上智咲, 田崎眞生, 辻本勉, 桑原晶子, 濱宏仁 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 598-598, 2021.

---

	P01-03. Inspection of the system for the purpose of the efficiency of the drug dose confirmation depending on renal function 住吉恵1,2, 山中紗弥花1, 安森奈緒子1, 大石裕樹2, 川俣洋生1, 花田聖典1, 橋本雅司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 599-599, 2021.

---

	P01-04. About the venous thrombosis prevention in the edoxaban administration after the orthopedics lower limbs surgery 吉山昂佑, 松元大地, 永見康男, 山本和宜 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 600-600, 2021.

---

	P01-05. Examination of the change of the number of doubt inquiries by the default use setting 上松祐貴, 三村享, 関夏望, 中澤佑香, 村井健太郎, 土屋広行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 601-601, 2021.

---

	P01-06. Setting - of the dosage interval every efforts - drug to evade drug interaction by the remedy at the same time 成瀬圭, 升田万祐子, 多留木崇志, 楠川侑吾, 村田龍宣, 村岡淳二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 602-602, 2021.

---

	P01-07. Comparison of the medication counseling time between the antiinfluenza medicine in the health insurance pharmacy 高橋渉1, 伊藤元太2, 藤原正和2, 本郷良泳2, 長沼未加1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 603-603, 2021.

---

	P01-08. Comparison in the sex test to pass a transluminal tube of the loxoprofen sodium infinitesimal grain preparation 高野克彦1, 毎田千恵子1, 秋山滋男2, 石田志朗3, 宮本悦子4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 604-604, 2021.

---

	P01-09. Efforts for the checking prescription by the electronic medium of oral anticancer agent lenalidomide 山中葵1, 有馬崇充1, 住吉愛1, 渡部大介1, 石川光信1, 赤木徹1, 橋本浩伸1, 山口正和2, 古川哲也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 605-605, 2021.

---

	P01-10. Change of the doubt inquiry contents from the health insurance pharmacy before and after the electronic medical chart system change 大谷寧次郎, 三浦毅 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 606-606, 2021.

---

	P01-11. Analysis of doubt inquiry in injection drug formulations 小谷咲, 大澤勇貴, 佐竹美咲, 酒井正博, 木村麗砂, 日浦寿美子, 小林秀樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 607-607, 2021.

---

	P02-01. It is the change of color of telmisartan tablets accompanied with the use of tablet assortment device (TABSORT) and the factor one package 岡崎裕太朗1, 竹下治範2, 藤澤諒子1, 山下和彦1, 山本和宏1, 槇本博雄1, 大村友博1, 國正淳一2, 矢野育子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 609-609, 2021.

---

	P02-02. Investigation about the pharmaceutical products traceability system in temperature-controling it after the drug withdrawal to need cool place preservation 渡邊裕之1,2, 山本大介3, 先崎公祐3, 小島真弥4, 桜沢雅洋5, 石原聖也5, 宅和真由美1, 平田敦宏2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 610-610, 2021.

---

	P02-03. Establishment and implementation of grading management standard for antineoplastic drugs Zhou Muzi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 611-611, 2021.

---

	P02-04. Survey on the reuse of discontinued medicines in one package - With an eye to task shifting in pharmacist work - 阪元孝志, 鳥山純司, 松島静香, 梅本啓史, 吉井景祐 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 612-612, 2021.

---

	P02-05. Making of the pharmaceutical products ordering system using Excel VBA 牧原明秀, 吉田弘樹, 葛谷真理, 今高多佳子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 613-613, 2021.

---

	P02-06. Regarding the usage status of proton pump inhibitors after in-hospital formulary operation 高田恵司, 千葉さくら Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 614-614, 2021.

---

	P02-07. Procedure construction and evaluation of the pharmaceutical products proper use using optimal use promotion guidelines 赤阪未来, 濱口直美, 向原里佳, 岩本卓也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 615-615, 2021.

---

	P02-08. Improvement effect by the general anesthesia set review in the operating room 直井一久, 近藤崇泰, 植竹龍一, 加藤敦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 616-616, 2021.

---

	P02-09. Establishment of a common formulary for co-adopted drugs and economic effects - Focusing on biopharmaceuticals - 武田怜1,2,3, 寺川央一1, 木立康太2, 山本譲1, 安達知輝1, 大滝康一3, 小野尚志1, 田崎嘉一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 617-617, 2021.

---

	P02-10. Clinical application analysis of human albumin during perioperative period of liver transplantation patients Zhang Wei Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 618-618, 2021.

---

	P02-11. Efforts of the pharmaceutical products expiration date for use management 佐藤綾香1, 武藤芳和1, 滝口理菜2, 渡部寿康1, 菊地洋平1, 黒田彩佳1, 矢葺優佳1, 安齋英里1, 大竹麻衣子1, 古賀彩織1, 寺内優紀恵1, 酒井亮1, 井上可奈子1, 二瓶瑶子1, 佐藤南1, 川村早苗1, 緑上淳一1, 我妻禎3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 619-619, 2021.

---

	P02-12. Fact-finding about the voluntary recall of the ethical drug 西順也, 小國正和, 南智香子, 緒方健二, 内田任仁弘, 合原嘉伸, 江本晶子, 島ノ江千里 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 620-620, 2021.

---

	P02-13. Economic effect by the participation of the pharmacist for the pharmaceutical products management in the operating room 小牧誉典1, 井黒俊2, 中野公1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 621-621, 2021.

---

	P03-01. Development and evaluation of "pregel" granule for the purpose of the adherence improvement of children 加藤里菜, 宮嵜靖則, 内野智信, 賀川義之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 623-623, 2021.

---

	P03-02. Quality evaluation of three-drug mixed eye drops to use for cataract surgery pre-treatment 山内理恵1, 大野修司1, 竹場和代2, 川崎智子2, 北岡晃2, 井上信宏1, 久保元1, 浅井和範1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 624-624, 2021.

---

	P03-03. Quality evaluation of the hospital preparation diclofenac gargle by the fixed-quantity NMR 明樂一己1, 野原彩香1, 宇都宮悠花1, 見留英路1, 渡邉真一3, 田中守2, 田中亮裕4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 625-625, 2021.

---

	P03-04. Bitterness masking of the preparation for the children using the seamlessness method 田中咲妃, 草村把奈, 深水啓朗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 626-626, 2021.

---

	P04-01. Examination of the mode of transportation of the cool place preservative to the patients's house 石原優1, 丹勝弘2, 工藤亘2, 浅子恵利3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 628-628, 2021.

---

	P04-02. Evaluation of the dissolution in starting pharmaceutical products of the pH-dependent type mesalazine Enteric tablet and the generic medicine 石田志朗1, 田畑寛明2, 秋山滋男3, 毎田千恵子4, 地野幹子2, 増永高晴5, 宮本悦子6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 629-629, 2021.

---

	P04-03. Preservation stability - of the metoclopramide hydrochloride which we mixed to stability evaluation - Elneopa infusion of the parenteral injection mixture hyperalimentation stored in patients's house 松川美佐子1, 小山紗矢1, 谷田佳香1, 白木孝2, 黒田英津子3, 竹内敦子4, 都出千里4, 中山優子1, 寺岡麗子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 630-630, 2021.

---

	P04-04. Duties efficiency by the Excel macro of the periodical prescription 佐澤卓哉, 黒田絋生, 小迫晶寛, 上村豪, 植村隆 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 631-631, 2021.

---

	P05-01. About pharmacist duties in the respiratory medical service in the corona evil 三屋良太, 佐々弥栄子, 高木裕介, 笠井翼, 木全司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 635-635, 2021.

---

	P05-02. Efforts of a regime and the proper use of the Nusinersen by the other types of job cooperation in our hospital 齊藤綾子1, 宮本晋治1, 小篠史郎2, 政賢悟1, 田中順子1, 齋藤秀之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 636-636, 2021.

---

	P05-03. Effect of the bringing medicine instructions representation duties based on the protocol for the cardiovascular surgery patients 森田祐基1, 中島のぞみ1, 内田佳菜子1, 竹原眞人2, 津丸真一2, 島本健2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 637-637, 2021.

---

	P05-04. Questionary survey to the healthcare worker about the evaluation for the ward resident duties of the pharmacist 新田茜1, 本多秀俊1, 木下淳2, 麻丘真葵2, 稲村澄子1, 林由紀子1, 並木路広1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 638-638, 2021.

---

	P05-05. Effect by the sleeplessness use drug change in the urologic clinical path 平野史, 馬場亮一, 成末まさみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 639-639, 2021.

---

	P05-06. The current situation investigation for the polypharmacy measures in the convalescent rehabilitation hospital 木村早希, 鬼澤ひかり, 渡邉幸子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 640-640, 2021.

---

	P05-07. The receptive current situation investigation of the use situation and the tablet internal use of the oral prednisolone to non-school children in our hospital 久保拓己, 栗原陽介, 赤沢翼, 増田純一, 寺門浩之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 641-641, 2021.

---

	P05-08. Efforts for the polypharmacy in our hospital general medicine ward 戎浦規文1, 雪矢良輔1, 奥田佳子1, 清水悠弥1, 松岡里枝1, 抱恵子1, 梶田貴司1, 奥野智之1, 明保洋之2, 田川竣介2, 真辺諄2, 柏原英里子2, 三宅啓史2, 佐田竜一2, 石丸裕康2, 八田和大2, 熊木郁子3, 中島壽惠3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 642-642, 2021.

---

	P05-09. Efforts to reduce medication for polypharmacy at our hospital 佐藤実由, 古谷智裕, 武井秀樹, 北本真一, 宮森伸一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 643-643, 2021.

---

	P05-10. Examination of the intervention by the pharmacist for the local inclusion care ward inpatient 元木孝, 田口諒, 澁谷基宏, 渡邊清人, 高柳昌宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 644-644, 2021.

---

	P05-11. Efforts of the drug global assessment adjustment addition in the orthopedics ward 松木克仁, 前田玲於奈, 山梨領太, 平野淳, 薄雅人, 林誠, 中井正彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 645-645, 2021.

---

	P05-12. The case report which reached the improvement by a change to vonoprazan for a diarrhea symptom speculated that it was caused by lansoprazole which we combined with low-dose aspirin 岩下裕美, 薗田晃弘, 中尾承司, 兒玉麻代, 高田侑那, 浜園龍, 久永あゆみ, 森永知沙, 上堀正博, 柴田奨, 長島菜子, 岩下佳敬, 石田和久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 646-646, 2021.

---

	P05-13. Examination of a PONV generating factor and measures using the predictive simple score in the surgery 大野凌也1, 佐々木理絵1, 本郷文教1, 木ノ下義宏2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 647-647, 2021.

---

	P05-14. Efforts of the clinical reasoning utilizing the symptom monitoring sheet at the bringing medicine's confirmation 山下諒祐, 遠原大地, 弟子丸恵実, 齊藤綾子, 高林学, 政賢悟, 田中順子, 齋藤秀之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 648-648, 2021.

---

	P05-15. About the intervention situation of the local highly-concentrated antimicrobial perfusion therapy (iSAP, iMAP) TDM facing each other in our hospital 山中俊哉, 小寺聖, 関谷泰明, 井上壽江, 平下智之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 649-649, 2021.

---

	P05-16. Evaluation of the antiemesis effect on cisplatin regimen by having made Fosaprepitant and pre-medication prescription using magnesium adequate 尾崎正和, 幸田恭治, 北原隆志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 650-650, 2021.

---

	P05-17. Pilot study - in study on distance - clinical practice between optimal patients - pharmacists at medication counseling 牛膓沙織1,2,4, 水口日南野2, 中山千佳3, 宮城雪菜2, 宮地佑佳2, 大嶋耐之2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 651-651, 2021.

---

	P05-18. Investigation of the use of constipation therapeutic drug situation in our hospital palliative care unit 後藤義之, 角紀一郎, 岡田久美, 古本真由美, 松岡未紗, 茶野下貴恵, 島崎沙織, 青木理恵, 清水翔子, 西川達也, 梅下翔, 室田恵里, 橋本夏恵, 山下陽夏, 森戸敏志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 652-652, 2021.

---

	P05-19. Making of the "drug needing particularly careful administration" in the drug global assessment adjustment addition extraction system 渡辺智康, 山崎恵, 難波良平, 高取孝一, 安藤哲信 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 653-653, 2021.

---

	P05-20. The effect that the anticholinergic load in patients with elderly people stroke during convalescent rehabilitation ward hospitalization gives to medication self-care 田中絵里子1,2, 藤原久登1,2,3, 鈴木奈緒1,2,3, 中村彰子1,2,3, 高木桂子1,2, 川手信行4, 佐々木忠徳2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 654-654, 2021.

---

	P05-21. Analysis, evaluation ... of role - pharmaceutical intervention example of the pharmacist in the convalescent rehabilitation ward 建部宏子, 藤田裕子, 徳冨江里, 塩川満 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 655-655, 2021.

---

	P05-22. Drug section polypharmacy measures of our hospital which we worked on altogether 山田瑠依, 横田美有, 鬼塚智行, 藤村裕美, 中川伊久美, 井上香奈子, 高田恵司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 656-656, 2021.

---

	P05-23. Efforts for practice and the drug global assessment adjustment addition calculation of the rehabilitation drug in the local inclusion care ward 横田美有, 高田恵司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 657-657, 2021.

---

	P05-24. Challenge ... of the cottage-hospital out of efforts ... of the drug adjustment in the local inclusion care ward using the flowchart 道坂瑳恵, 細木慈子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 658-658, 2021.

---

	P05-25. Investigation about the change of the quality of efforts and pharmacist duties for drug global assessment adjustment addition calculation in our hospital 淺井俊平, 松山陽香, 丸山あずさ, 高取裕司, 池上信昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 659-659, 2021.

---

	P05-26. Study on immunoglobulin refractoriness case prediction in childhood Kawasaki's disease treatment 丹代恭太, 工藤晋, 米内和暉, 冨山育朗, 鈴木弘文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 660-660, 2021.

---

	P05-27. Role of efforts and the pharmacist to the polypharmacy cancellation in the circulatory organ ward 高橋直博, 野澤直史, 中里健志, 新井亘, 増田裕一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 661-661, 2021.

---

	P05-28. Comparison between evaluation - In-Check and In-Check DIAL - before and after the inspiratory flow rate measuring instrument change to use for inhalational instruction 菅原拓也, 鈴木麻友, 志田幸平, 荒井潤, 後藤純一, 関口徳志, 齋藤順, 延川正雄, 松田圭一郎, 荒井浩一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 662-662, 2021.

---

	P05-29. The efforts situation to polypharmacy in our hospital 原田若奈, 長戸優也, 升田万祐子, 三松史野, 小野勝, 村岡淳二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 663-663, 2021.

---

	P05-30. About the activity of the polypharmacy measures team of our hospital and the result 小倉弥生, 生沼仁美, 下田麻祐子, 江原可成子, 大木孝夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 664-664, 2021.

---

	P05-31. The urination care team which intervenes in the viewpoint of the pharmacist 林剛史, 古川大樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 665-665, 2021.

---

	P05-32. Effect of the situation and the drug adjustment of the polypharmacy in the stroke care unit 福田裕子1, 井岡瑞樹子1, 伊東里紗1, 森あやか1, 早崎浩司2, 高橋務3, 北澤文章1, 辻川正彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 666-666, 2021.

---

	P05-33. Practice of the practice flow about the osteoporosis therapeutic drug 親富祖翔太郎, 東千夏, 平田やよい, 川上博瀬, 宮里弥篤, 村田利恵子, 浜元善仁, 翁長真一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 667-667, 2021.

---

	P05-34. Efforts of the proper use promotion by the voriconazole side effect + blood level confirmation tabulation 宮庄杏奈, 岡冨大輔, 上野千奈美, 樫本考司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 668-668, 2021.

---

	P05-35. Examination of the protective efficacy of analysis of the risk factor of nausea, vomiting after the catheter ablation and diphenhydramine/diprophylline combination tablets 有馬智裕, 西村文宏, 牛島智子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 669-669, 2021.

---

	P05-36. Efforts to discharge drug reporting management instruction reinforcement 堀内賢一, 菊池環, 須田裕之, 氣仙早希 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 670-670, 2021.

---

	P05-37. Report of the enforcement situation and the attitude survey of the discharge drug instruction cooperation addition in the Shinshu Ueda medical center 平山武宏, 鈴木春子, 渡辺章功, 荒義昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 671-671, 2021.

---

	P05-38. Changes in ward drug operations and pre-avoid reporting due to the introduction of electronic medical records and medical economic effects 數本直規, 若林雅人, 牛山利昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 672-672, 2021.

---

	P05-39. Making of new efforts - medication situation confirmation flow sheet for the false medicine prevention by the ward pharmacist and evaluation ... 池田隆, 後藤明人, 多田隼起, 佐藤千比呂, 中原慎平, 金田美咲緒 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 673-673, 2021.

---

	P05-40. A change and effect of the duties system aiming at improvement in quality of the pharmacist duties in the ward 越塚宏美1,2, 百賢二1, 喜田昌記1,2, 阿部久瑠美1,2, 柏原由佳1,2, 田中克巳1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 674-674, 2021.

---

	P05-41. Efforts of the video production of the medicine for patients to support a planned inpatient and the usefulness 森あやか1, 北澤文章1, 大橋浩子2, 木立泰子3, 乙名さおり4, 山田真一5, 辻川正彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 675-675, 2021.

---

	P05-42. Examination 2 of the communication analytical procedure using the feelings recognition AI from the viewpoint of feelings level: 宮城雪菜1,3, 河野明莉1, 仲山千佳2, 牛膓沙織1,3,4, 宮地佑佳1, 大嶋耐之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 676-676, 2021.

---

P05-43. The efforts which aimed at the utilization of the metrics of ward duties aiming at the improvement of the patients contribution degree and the consciousness reform of the pharmacist 岸本真1, 中村杏果1, 森永崇史1, 池沢若菜1, 田中恭人1, 豊留麻衣1, 北園幸大1, 中野一馬1, 山本梢1, 屋敷大輔1, 淵脇ゆかり1, 徳丸章佳1, 長ヶ原琢磨1, 荻尾夕起子1, 児玉友和2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 677-677, 2021.

---

	P05-44. Change to calculation by the template making for the record of discharge drug information management instruction charges 淺香圭寛1, 中村俊貴1, 小林彦登1, 南有里1, 幅麻衣子1, 貝沼潤1, 左右田和枝1, 松原肇1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 678-678, 2021.

---

	P05-45. About a characteristic and the discharge outcome of the heart failure conference enforcement patients in our hospital 中島一1, 吉国健司1, 角田菜緒1, 椛島寛子2, 櫻井栄子3, 小倉秀美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 679-679, 2021.

---

	P05-46. In-hospital formula remaking by the working together of a pharmacist, the physician who is a beginning of the drug costs reduction 前万紀子, 山崎彬史, 中浴伸二, 森本茂文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 680-680, 2021.

---

	P05-47. Examination about the personal evaluation method of the number of drug control guideposts in the ward duties enforcement addition calculation institution 高橋史織, 柏瀬しのぶ, 深谷寛, 長谷川由希, 浜田幸宏, 木村利美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 681-681, 2021.

---

	P06-01. Evaluation of the administration situation and the effectiveness of the naldemedine for the constipation during use of fentanyl in the intensive care 中里健志, 赤池沙織, 高橋直博, 新井亘, 増田裕一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 683-683, 2021.

---

	P06-02. The adverse event 2 case that occurred by an injection drug in first aid, an intensive care unit 濱名哲大1, 梅原聡子1, 大瀧あかね1, 寺田椋1, 橋本佑香1, 奥村直生1, 井上聡子2, 坂上嘉浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 684-684, 2021.

---

	P06-03. An evaluation of the pharmaceutical intervention by the pharmacist duties in the ICU and the multi-type of job rounds and future problem 藤戸靖久1, 土井延平1, 橋本宜享1, 福井道彦2, 橋本昌幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 685-685, 2021.

---

	P06-04. The drug information offer by the ICU exclusive duty pharmacist and effect to medical treatment 市原麻友子, 有銘千賀子, 長濱藍, 府川祥子, 坂口結斗, 白木萌, 喜多洋嗣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 686-686, 2021.

---

	P06-05. The case that was able to evade rebleeding by PT-INR reascension and vitamin K2 supplementation after the Kay Saint lah (R) use 柳岡祥太, 松原浩司, 前田直大, 伊佐治麻里子, 木藤貴弘, 白井博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 687-687, 2021.

---

	P06-06. The change of the drug information offer contents accompanied with the exclusive duty pharmacist increase of the staff in the emergency ward and the evaluation 黒岩亮平, 梅森蓉子, 井口恵美子, 猪股克彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 688-688, 2021.

---

	P06-07. The current situation of the drug intoxication with the commercial drug of young people 広瀬正幸1,2, 平川昭彦3, 田島康介4, 山田成樹1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 689-689, 2021.

---

	P06-08. Examination of the adsorption behavior of the antiMRSA medicine for various dialyzer used for sustained hemofiltration dialysis 熊野諒太1, 稲野祥宗1, 土屋香代子1, 仲佐啓詳1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 690-690, 2021.

---

	P06-09. One case that blood vancomycin levels presented false high level by the reflux drawing blood from a central intravenous line 鈴木英二1, 小林恵子1, 伊藤陽一1, 大森教雄2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 691-691, 2021.

---

	P06-10. Intervention to time to administration of wide area antimicrobial start shortening for sepsis or the septic shock patients and the effect 上田実穂1, 田村亮1, 鎌田里紗1, 入江慶1,2, 池末裕明1, 橋田亨1,2, 室井延之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 692-692, 2021.

---

	P06-11. Examination about the crystal separation of the anticoagulant which occurred in an expression membrane type heart-lung machine circuit out of the body 小林恵子, 鈴木英二, 伊藤陽一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 693-693, 2021.

---

	P06-12. The development of in-hospital operation procedures of the highly-concentrated potassium preparation and the safety 上野希望, 山村亮太, 龍田涼佑, 中原良介, 田中遼大, 伊東弘樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 694-694, 2021.

---

	P06-13. Role of the operating room charge pharmacist for safe epidural anaesthesia enforcement 風間彩, 矢島領, 平井瑞希, 三浦義彦, 伊勢雄也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 695-695, 2021.

---

	P07-01. Effect (the first report) of a physician and the pharmacist cooperation in the ambulatory practice of the rheumatoid arthritis 平田一耕1,2, 六反田諒3, 舟越亮寛4,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 697-697, 2021.

---

	P07-02. The current situation investigation of the effect of the pharmacist intervention in the hospitalization and release support center 松尾美怜, 寺沢匡史, 福島綾, 島本沙代, 久保あかね Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 698-698, 2021.

---

	P07-03. Examination about the usefulness of the pharmacist interview before hospitalization by the pharmacist 岸本亜矢子, 山崎彬史, 松尾種代, 中浴伸二, 森本茂文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 699-699, 2021.

---

	P07-04. Introduction of the pharmacist outpatient department for oral anticancer agents and questionary survey for the physician 小澤有輝, 草野淳一, 山本龍世, 矢吹優, 林誠一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 700-700, 2021.

---

	P07-05. Examination of the usefulness of the intervention by the pharmacist in the outpatient department for Lenvatinib treated patients 桂川みき1, 大下瑚姫1, 山田順子1, 大久保凛香1, 松木有莉1, 石塚仁保1, 山下友輝1, 鈴木千波1, 小原秀治1, 柴波明男1, 樋浦一哉2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 701-701, 2021.

---

	P07-06. Investigation, examination about the drug instruction in the going to hospital treatment center 後藤総太郎, 吉田茜, 松尾拓馬, 殿村直也, 清美奈, 石原溶子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 702-702, 2021.

---

	P07-07. Efforts of the effective and effective cooperation full addition in the area cancer practice cooperation base Hospital 金原千明, 村地康, 近藤裕志, 成瀬祐奈, 由田飛馬, 相馬沙希, 高垣佳史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 703-703, 2021.

---

	P07-08. Usefulness of a pharmacist attending it in the palliative care outpatient department 大野凜太郎1,4, 粕田晴之2,4, 伊澤紀子3,4, 斎藤和悦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 704-704, 2021.

---

	P07-09. About the calculation situation of the cooperation full addition in our hospital and a future problem 小笠裕斗, 上津沙織, 柿原圭佑, 吉国健司, 小倉秀美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 705-705, 2021.

---

	P07-10. It is ... in investigation and outcome - harmful effect hemophilia patients of the patients with COVID-19 infection change associated with the medical therapy that occurred under the effect 田上直美1, 高林学1, 高木雅敏2, 中田浩智3, 内場光浩3, 松下修三4, 齋藤秀之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 706-706, 2021.

---

	P07-11. Evaluation of the usefulness by the early intervention of the pharmacist in the patients support center 江島怜那, 小原直紘, 丸山直岳, 別府博仁, 土井敏行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 707-707, 2021.

---

	P07-12. The pharmacist permanent residence to the hospitalization support center about an effect of becoming it 中山潤美, 石原祥子, 鈴木加奈子, 加藤まゆ, 水谷彩伽, 水野淑子, 大谷寧次郎, 三浦毅 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 708-708, 2021.

---

	P07-13. We respond after the medication in the childhood medical therapy 大木潤一, 石田洋介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 709-709, 2021.

---

	P08-01. Enforcement and inspection of the acting pharmacist input protocol in the prescription correction after doubt inquiry 森本芙未1, 坂倉彩香1, 佐伯真澄1, 山吉康子1, 村松博1, 青森達1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 711-711, 2021.

---

	P08-02. Evaluation of the internal use, medicine for external application picking duties by the person except the pharmacist using the bar code collation system 杉野友紀, 濱口直美, 平井利典, 岡本明大, 石橋美紀, 堀内桂子, 向原里佳, 岩本卓也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 712-712, 2021.

---

	P08-03. Effect ... by introduction and usefulness - injection drug management of hospital pharmaceutical products management system "McHIL" 関根祐介, 鈴木篤, 藤本涼子, 宮里明芽, 東加奈子, 金子亜希子, 長尾達哉, 竹内裕紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 713-713, 2021.

---

	P08-04. Effect ... by introduction and usefulness - compounding of medicines duties of hospital pharmaceutical products management system "McHIL" 金子亜希子, 関根祐介, 鈴木篤, 東加奈子, 海野由香子, 鮎原秀明, 北野安紀, 宮城聖子, 竹内裕紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 714-714, 2021.

---

	P08-05. Practice - of medical treatment management (PBPM) based on representation order - protocol of blood, the urinalysis associated with the pharmaceutical products by the pharmacist 宮津大輔, 立石裕樹, 與田賢作, 松浦徹, 山下大貴, 安部由起子, 後藤貴央, 秋吉正貴, 田中博和, 渡邊裕之, 平川雅章 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 715-715, 2021.

---

	P08-06. Flat enforcement ... on efforts ... hospital scale to the prescription support task by the pharmacist 瀬名波暢子, 森田直, 有江宏樹, 上野沙恵子, 数井沙織, 辻井佳代, 小林政彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 716-716, 2021.

---

	P08-07. Efforts about the drug appropriateness by the polypharmacy team using a specific drug, the test value screening system 陶山泰治郎1, 香川瞭子1, 今滝泉1, 佐藤拓洋1, 篠永浩1, 原田典和1, 加地努1, 藤川達也2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 717-717, 2021.

---

	P08-08. Task shifting using PBPM by an inpatient support room pharmacist 安田愛実1, 吉川依里1, 丸山あずさ1, 新井孝文1, 牛膓沙織1, 高橋典男2, 池上信昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 718-718, 2021.

---

	P08-09. Antibiotic Appropriate Use Support Team (AST) task-shifting efforts by managing vancomycin (VCM) concentration in injected blood 古川早矢香1, 高橋希1, 佐藤浩太郎1, 梶野哲1, 丸山伸樹1, 河野綾香1, 渋江寧2, 井口恵美子1, 猪股克彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 719-719, 2021.

---

	P08-10. Examination - Kure-shi osteoporosis aggravation prevention project - of the intervention based on the multi-theory integration model of the pharmacist 覚前美希1, 羽山順子2, 松村智子3, 濱崎匡史4, 要田弥生5, 金子富美6, 津田彰7, 大塚幸三8, 三宅勝志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 720-720, 2021.

---

	P08-11. The operation of the simplification protocol of the formulations act inquiry in the outside Parliament prescription and the evaluation 久保愛美, 深谷寛, 外賀裕次郎, 八田部良子, 吉田まり絵, 浜田幸宏, 木村利美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 721-721, 2021.

---

	P08-12. Effect of the physician duties burden reduction by the prescription support task of the pharmacist and the safe prescription management 喜多洋嗣1, 駒井勇太1, 人見百合子1, 田仲祐子1, 喜多幸子1, 小山淳2, 小畑慎也2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 722-722, 2021.

---

	P08-13. Efforts for the duties reduction of the physician by the prescription deletion of the pharmacist 長友隆雄, 関屋裕史, 吉田桃花, 江藤結花, 江原幸菜, 平田梨沙, 池田龍二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 723-723, 2021.

---

	P09-01. Introduction results of infusion rate of application check system (IAAS-WEB) and examination about effectively utilizing it of the future 伊藤幸男, 堀田栄治, 五十嵐弘幸, 水野賀夫, 佐野正毅 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 725-725, 2021.

---

	P09-02. The input system construction of the doubt inquiry duties utilizing the eXChart function of the electronic medical chart and the effect 高村誠, 種村瞭, 仁谷美希, 関口陽子, 岩田真子, 山岸宏和, 鈴木さくら, 今成拓, 矢吹剛, 寺口敦, 南場信人, 五十嵐詠美, 中島楓, 貝瀬眞由美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 726-726, 2021.

---

	P09-03. The current situation investigation for the new mobile health-related application development aiming at effective medical treatment and improvement in health science 福井一玄, 鈴木小夜, 菊山史博, 横山雄太, 地引綾, 河添仁, 中村智徳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 727-727, 2021.

---

	P09-04. Examination of the standardization of the electronic medical chart use master in the Gifu comprehensive medical care center 関谷泰明, 井上壽江, 平下智之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 728-728, 2021.

---

	P09-05. A comparison between medication counseling support software making and number of drug control instruction before and after the introduction and usefulness evaluation 橋本奈々1, 室宮智彦1, 小野誠志2, 梅田友子1, 堀井雄之介1, 望月友美1, 新田真緒1, 池島健広1, 浜田信太郎1, 藤田昌雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 729-729, 2021.

---

	P09-06. Construction of the antithrombotic drug cancellation patients search system which we connected to electronic medical chart DB and ODBC 岩尾恭寛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 730-730, 2021.

---

	P09-07. A comparison between drug information confirmation software making and number of doubt introductions before and after the introduction and usefulness evaluation 北岡華奈, 室宮智彦, 望月友美, 池島健広, 岡田茉鈴, 橋本奈々, 藤田昌雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 731-731, 2021.

---

	P09-08. Inspection of the system for the purpose of the improvement in rate of use of the HBV screening test to be carried out at chemotherapy 峰山恵理子1, 安森奈緒子1, 大石裕樹2, 川俣洋生1, 花田聖典1, 橋本雅司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 732-732, 2021.

---

	P09-09. Development of the medical treatment place choice support tool using the Analytic Hierarchy Processes visualizing the intention in the choice of the medical treatment place of the patients with end-stage cancer family 永井隼多1, 田辺公一1, 村上望2, 杉浦伸3, 酒井隆全1, 大津史子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 733-733, 2021.

---

	P09-10. About the review of the drug-related system at electronic medical chart replacement in our hospital 倉田徹, 森由香利, 長能優子, 浜屋正志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 734-734, 2021.

---

	P09-11. Efforts about the pharmaceutical products master management standardization 冨岡謙二, 小林愛弓, 松浦奈保子, 原康晃, 長谷川千絵 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 735-735, 2021.

---

	P10-01. Fact-finding about formulations support information mention in the interview form 佐藤弘康, 荒井理乃, 久保萌美, 島津智行, 三本松泰孝, 田村広志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 738-738, 2021.

---

	P10-02. Investigation about the available maximal dose of the nonsteroidal antiinflammatory drug percutaneous absorption type preparation 吉村光弘1, 清家幸土2, 木村圭輔3, 二村直行4, 北谷和之5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 739-739, 2021.

---

	P10-03. Formulary "Primary Insomnia" Construction Procedure - Efforts of Toda Chuo Medical Group - 安藤正純1, 金井紀仁1, 宮本拓也2, 佐藤光3, 吾妻隼人4, 永瀬真理子5, 奈良部修弘6, 澤田雄太7, 中新田朋未8, 下館桃子9, 宮崎美子2, 齋藤俊夫10 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 740-740, 2021.

---

	P10-04. Use and application ... of current situation and problem - smartphone application "recommendation navigator" of pharmacist duties by the package insert computerization 鈴木高弘1,2, 横山佳代子1, 國重勝也1, 小林杏里1, 坂田志保1, 四條めぐみ1, 河野奏1, 橋爪敦弘1, 加茂薫1, 深井克彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 741-741, 2021.

---

	P10-05. Evaluation about the usefulness of the pharmaceutical products master input duties automation using Robotic Process Automation 景山修介, 陶山裕平, 石原裕介, 尾崎俊幸, 頼光翔, 安食健一, 園山智宏, 横手克樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 742-742, 2021.

---

	P10-06. Examination about the onset of lymphocytopenia with bendamustine using JADER 坂本竜平, 向井淳治, 小竹優希, 竹原涼子, 濱崎淳哉, 奥田広志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 743-743, 2021.

---

	P10-07. What kind of effect did the outbreak of COVID-19 result in for a reporting, collection of MR activity? 田中秀和1, 若林進2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 744-744, 2021.

---

	P10-08. Attitude survey about the effect on "usability" that the style revision of the package insert gives it to 十佐近歩実1, 渡邉享平1,2, 今野彩1, 櫻川さほり1, 東高士1, 渡瀬友貴1, 北出結伽1, 奥村直也1, 森下真明1, 寺澤優子1, 佐藤友美3, 鈴木大吾4, 矢野良一5, 古俵孝明1, 塚本仁1, 後藤伸之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 745-745, 2021.

---

	P10-09. About hypertensive development between the fibrate: Analysis using receipt data 関口佳純1, 鈴木奈緒1, 瀬野遥1, 福島栄2, 栃倉尚広2, 大塚進2, 福岡憲泰1, 大場延浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 746-746, 2021.

---

	P10-10. Evaluation of the Clostridioides difficile-related enterocolitis using the adverse event spontaneous report database 升田万祐子1,2, 中尾智史1,3, 長谷川栞1,4, 島田和代1, 向井梨々香1, 田中瑞希1, 松本清香1, 浦西洋彰1,5, 池末裕明4, 橋田亨4, 井口和弘6, 中村光浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 747-747, 2021.

---

	P10-11. Analysis of the factor influencing onset of interstitial lung disease of the methotrexate using adverse drug reaction database JADER 櫻井周斗1, 大久保伸哉1, 大磯茂1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 748-748, 2021.

---

	P10-12. About the possibility that rebamipide results in protective efficacy for NSAIDs origin-related lower digestive tract injury analysis - using the database of - FAERS and JADER two 間勝之, 今井徹, 鈴木慎一郎, 大塚進 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 749-749, 2021.

---

	P10-13. Search of the risk factor of the diarrhea with the drug using adverse drug reaction database (JADER) 小宮実直1, 細谷龍一郎1,2, 宗山真梨奈1, 柴崎功1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 750-750, 2021.

---

	P10-14. Analysis about the delirium risk of the antiulcer agent using adverse drug reaction database (JADER) 橘川奈生, 祖川倫太郎, 角真太郎, 久保利樹, 江口祐子, 江越正芳, 宮本由貴, 飛田修康, 加茂真宏, 島ノ江千里 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 751-751, 2021.

---

	P10-15. Analysis of ward suspicion inquiries, side effect reports, and pre-avoidance case studies with the main purpose of pharmacist education: Focusing on drug-drug interactions 臼井拓也, 佐藤紀宏, 佐藤裕, 前川麻央, 佐藤祐司, 前川正充, 眞野成康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 752-752, 2021.

---

	P10-16. Exploratory study on sex differences of the hiccups using side effect database FEARS 細谷龍一郎1,3, 野澤(石井)玲子2, 黒崎宏太3, 植沢芳広3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 753-753, 2021.

---

	P10-17. Proper use of the antiinfluenza medicine judging from a prescription trend of the Baloxavir 藤原奈緒美1, 藤原崇志2, 伊勢雄也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 754-754, 2021.

---

	P10-18. Evaluation of the taste of various hyperkalemic therapeutic agents by the sensory evaluation 竹下絵梨香, 田杭直哉, 黒田香織, 佐藤淳子, 徳丸翔大, 菅谷量俊, 高瀬久光 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 755-755, 2021.

---

	P10-19. Construction of mineralocorticoid receptor antagonist formulary for heart failure 宮本拓也1, 金井紀仁2, 宮崎美子1, 福田稔1, 齋藤俊夫3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 756-756, 2021.

---

	P10-20. Cooperation - with the new style package insert information made study on inflection - electron of the drug information in the electronic prescription notebook 折井孝男1, 田代朋子2, 下村百合子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 757-757, 2021.

---

	P10-21. Evaluation of the DI offer Web site aiming at the efficiency of the drug information (DI) duties of the drugstore pharmacist 村阪敏規1, 加藤秀雄1,3, 須藤宏文2, 岩本卓也1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 758-758, 2021.

---

	P10-22. The effect that "the guidelines about the sale reporting activity on ethical drug" give for a business activity of the wholesaler of drug 崎野健一1, 鈴木三尚1, 山口聡一1, 古澤陽一1, 諏江裕2, 一條宏2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 759-759, 2021.

---

	P11-01. Possibility observational study of the potential inappropriate prescription in the decreased renal function patients in outpatient department, the inpatient 小林正太郎1,2, 須釜規夫1, 永野浩之2,3, 高橋雅弘2, 櫛山暁史2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 762-762, 2021.

---

	P11-02. The situation investigation of the one increase one decrease rule to affect the dosage form adoption for new children 春岡美姫1, 山谷明正1, 中村秀文2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 763-763, 2021.

---

	P11-03. Examination about the inhalational device choice depending on age in the childhood bronchial asthma 木澤翠, 水野彩, 石原祥子, 大谷寧次郎, 三浦毅 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 764-764, 2021.

---

	P11-04. It is investigated the antithrombotic therapy in the chronic phase from cerebral infarction acute phase 福島将友, 木原慶子, 小林慶子, 村井悠紀, 福地光栄, 前田朱香, 富田敏章, 入江利行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 765-765, 2021.

---

	P11-05. Use fact-finding of the sleeping drug in the inpatient 土元研史, 安田礼子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 766-766, 2021.

---

	P11-06. Formulation of in-hospital formulary for proton pump inhibitors, promotion of generic drug use at our hospital, and effect of reducing drug costs 大澤史宜, 赤坂寛子, 岡崎彰仁, 山根真也, 岩城晃一, 石坂忠博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 767-767, 2021.

---

	P11-08. Creation of an in-hospital formulary and changes in drug usage at Saiseikai Yokohama Nanbu Hospital 上原美佐, 海野明子, 勝又瑛梨奈, 田辺真里, 平間盛吾, 加藤一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 768-768, 2021.

---

	P11-09. Investigation about the demand for support by the use of supplement situation and the pharmacist of patients with cancer 西川隆一1, 中島直彦1, 小笠原章記1, 荒木寛也2, 澤柳直樹2, 藤井友和2, 辻博幸2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 769-769, 2021.

---

	P11-10. Characteristic of patients with Parkinson's disease associated diseases to take a constipation therapeutic drug regularly 安高勇気1,2, 藤岡伸助3, 三嶋崇靖3, 今給黎修1, 坪井義夫3, 神村英利1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 770-770, 2021.

---

	P11-11. The TDM enforcement situation investigation of gentamicin and examination of the renal failure risk factor 唐川聖司, 酒井義朗, 樋口恭子, 三輪涼子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 771-771, 2021.

---

	P11-12. Cases in which ARNI was introduced due to the usage status of angiotensin receptor neprilysin inhibitor (ARNI) at our hospital and prior administration of ivabradine 眞野裕1,2, 長井紀章2, 石田茂伸1, 多胡友絵1, 星育子1, 小泉祐一1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 772-772, 2021.

---

	P11-13. The actual situation and characteristic of the medical therapy for the steroidal osteoporosis prophylaxis 清木静乃1, 鏑木美帆2, 山下修司1,3, 玉木啓文3,4, 野口義紘3,5, 長内理大3,4, 伊野陽子3,4, 井口和弘3,4, 寺町ひとみ2,3,5, 林秀樹1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 773-773, 2021.

---

	P11-14. Efforts to the serum magnesium measurement promotion for the magnesium oxide tablets prescription patients 山本将司1,2, 小谷智美1, 升味紀子1, 濱岡照隆1, 相良義弘1, 藤本剛2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 774-774, 2021.

---

	P11-15. Investigation about the possibility of the drug interaction through prescription situation and CYP of antipsychotics and the concomitant drug 横田真希1, 前川正充1,2, 鈴木直人2, 小林大典2, 鈴鹿雅人2, 佐藤祐司2, 公文代將希2, 佐藤裕2, 佐藤紀宏2, 菊地正史1,2, 眞野成康1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 775-775, 2021.

---

	P11-16. Proper use investigation of metformin depending on renal function 松本貴行, 立石裕樹, 古川桂子, 秋吉正貴, 宮津大輔, 田中博和, 平川雅章, 渡邊裕之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 776-776, 2021.

---

	P11-17. Use of antimicrobial fact-finding as the initial treatment for febrile neutropenia derived from chemotherapy in the Kasugai Municipal Hospital 中川圭司1, 浅野嘉之1, 水草博希1, 鈴木大吾1, 田中伸明1, 中村敏史1, 坂田洋1, 服部芳明2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 777-777, 2021.

---

	P11-18. The use of blonanserin percutaneous absorption type preparation situation, side effect expression situation investigation 藤田強記1, 中川義浩2, 湊本康則1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 778-778, 2021.

---

	P11-19. Participation in planning of the pharmacist for the delirium high risk patients care addition 遠山泰崇, 福島祐子, 赤星一恵, 平山沙和, 末延裕海, 新宮裕美, 小野友香理, 福田智哉, 柴田麻美, 野村一馬, 後藤友里絵, 村上里穂, 矢野由起, 井上真 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 779-779, 2021.

---

	P11-20. Search of the factor to have an influence on the medication adherence of the Kremezin preparation in patients with chronic kidney disease 坪井絵乃1, 柏倉康治1, 茂木麻里奈1, 田中紫茉子1, 内田信也1, 並木徳之1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 780-780, 2021.

---

	P11-21. The polypharmacy fact-finding of elderly people with the chronic kidney disease and a drug inappropriate potentially and examination about the stage 町田加純, 稲艸優生子, 間所萌, 遠竹偲乃, 鈴木智美, 土江学, 藤田啓子, 西原昌幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 781-781, 2021.

---

	P11-22. Improvement of the making of the "instillation method" explanation video and the instillation behavior after the video seeing and hearing 池田博昭1,2,4, 谷本知美1, 池田純子2, 中妻章1, 芳地一1, 森久美子1, 飯原なおみ1, 二宮昌樹1, 河野清尊3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 782-782, 2021.

---

	P11-23. About the use situation of the liquid for the status epilepticus therapeutic drug midazolam oral cavity in our hospital 小迫晶寛, 浦更紗, 佐澤卓哉, 上村豪, 山下典子, 植村隆 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 783-783, 2021.

---

	P11-24. Hit the number of the remedy drugs and the relations with the age group that ketogenic diet therapy results in 矢嶋隆宏, 山本吉章, 福島悠太郎, 古屋裕之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 784-784, 2021.

---

	P11-25. Inspection about the duties improvement effect by the outside Parliament prescription doubt inquiry window change 中川和成, 満武亜弥, 渡邉幸子, 大津有加, 松永蓉子, 石井智子, 本多志保里, 山橋昌代, 細川由起子, 沖島さくら, 深見徹郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 785-785, 2021.

---

	P11-26. Attitude survey of a hearing person with a disability and the pharmacist about the effect that a hearing loss gives for communication by understanding and the medication counseling of how to use medicine 俵口奈穂美1, 吉田力久2, 小倉秀美3, 山崎博史3, 田中泰三4, 窪田敏夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 786-786, 2021.

---

	P11-27. It is ... from a viewpoint of investigation analysis - management of the factor to influence quitting a job intention of the hospital pharmacist 土屋博子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 787-787, 2021.

---

	P12-01. Attempt of the medical economical evaluation of the pharmaceutical intervention in the cancer domain 南谷奈々, 疋田絵梨, 城田幹生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 789-789, 2021.

---

	P12-02. About the incidence of glaucoma in the statin user: Analysis using receipt data 川口優里子, 春藤里海, 冨永光咲, 岸英輝, 福岡憲泰, 大場延浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 790-790, 2021.

---

	P12-03. An association between use and hypertensive development of the fibrate: Retrospective cohort study using receipt data 鈴木奈緒1, 瀬野遥1, 関口佳純1, 中山敏光2, 福岡憲泰1, 大場延浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 791-791, 2021.

---

	P12-04. Use fact-finding and adherence about the imatinib 川邊一寛1,2, 大場延浩2, 中山敏光3, 福岡憲泰2, 坂本靖宜1, 後藤洋仁1, 鈴木太一1, 小池博文1, 佐橋幸子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 792-792, 2021.

---

	P12-05. Effect of reducing drug costs through PPI formulary creation and pharmacist prescription suggestions 寺口敦1, 関口陽子1, 高村誠1, 山田宜和2, 岩田真子1, 山岸宏和1, 鈴木さくら1, 今成拓1, 矢吹剛1, 小森裕3, 五十嵐詠美1, 南場信人1, 種村瞭1, 仁谷美希1, 中島楓1, 貝瀬眞由美1, 須田剛士4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 793-793, 2021.

---

	P12-06. Evaluation after introduction of formulary at Tokyo Women's Medical University Hospital 守矢昌弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 794-794, 2021.

---

	P12-07. Cost effect analysis about the agent-shaped difference of the migraine headache therapeutic drug sumatriptan preparation 菊池朋美1, 柏原正美2, 高畑篤2, 中川直人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 795-795, 2021.

---

	P12-08. Cost effect analysis of the Shoseiryuto to use for allergic rhinitis 佐々木彩花1, 柏原正美2, 高畑篤2, 中川直人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 796-796, 2021.

---

	P12-09. Cost-effectiveness analysis of baloxavir marboxil and oseltamivir in influenza virus infection - from a pharmacy perspective - 金澤幸訓1, 中川直人2, 森川昭正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 797-797, 2021.

---

	P13-01. Examination about the bringing medicine differentiation duties efficiency by the bringing medicine differentiation support equipment introduction 淀川進也1, 橋爪敦弘2, 田口みどり1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 799-799, 2021.

---

	P13-02. Physician for the polypharmacy, attitude survey of the pharmacist 山田充宏, 山田邦夫, 森岡淳子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 800-800, 2021.

---

	P13-03. Through after operation day, operation before relation - operation of the pharmacist in the perioperative period - 徳用百合奈, 金原寛子, 加川公恵, 高本美由喜 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 801-801, 2021.

---

	P14-01. The thing to see from the fact of the OTC pharmaceutical products online sale in the information-technology age? 泉澤恵1, 古山恵美1, 岸優佑1, 木村直寛1, Guyue Tang2, 小山慎一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 803-803, 2021.

---

	P14-02. Fact-finding about the self-medication taxation system for healthy seminar participants 田口和明1, 榎木裕紀1, 有賀聡美2, 榊原幹夫2, 堀里子1, 山浦克典1, 松元一明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 804-804, 2021.

---

	P14-03. Effect of basic knowledge and the medicine education about the proper use of the medicine of the primary schoolchild 寺本里那, 末廣真理恵, 室高広 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 805-805, 2021.

---

	P15-01. Preparation properties change of the ketoprofen tape by the opening preservation 宮崎玉樹, 菅野仁美, 臼井明子, 阿部康弘, 安藤大介, 山本栄一, 吉田寛幸, 伊豆津健一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 807-807, 2021.

---

	P15-02. Change of the quality check results by the public testing institution performed in securing of generic medicine quality measures business 阿部康弘, 吉田寛幸, 栗田麻里, 伊豆津健一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 808-808, 2021.

---

	P15-03. Comparison between innovator drug and side effect frequency of the generic drug in the sulfamethoxazole trimethoprim medical mixture 根上朋子1, 吉岡睦展1, 杉生雅和1, 高子優子1, 今戸健人2, 清水義文2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 809-809, 2021.

---

	P15-04. Pharmaceutical evaluation of Duotrav combination ophthalmic solution and its successor drugs, and study on visibility considering the usability of the ophthalmic container and the color of the ophthalmic nozzle 秋山滋男1, 土井信幸2, 田沼和紀3, 川上彩乃1, 堀祐輔1, 宮本悦子4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 810-810, 2021.

---

	P16-01. Intervention of the pharmacist for changes from a precedent article of the etanercept preparation to Biosimilar 草場さやか, 尾濱直子, 三浦誠 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 812-812, 2021.

---

	P16-02. Comparison between rituximab innovator drug and infusion reaction of the biofollowing article in patients with B-cell lymphoma 上田哲也1,2, 中島寿久1, 福司弥生1, 橋本浩伸1, 伊豆津宏二2, 山口正和1, 古川哲也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 813-813, 2021.

---

	P16-03. Efforts to improvement in Biosimilar rate of use by the pharmacist 奥山裕子, 田村健悦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 814-814, 2021.

---

	P16-04. About the usefulness in the rituximab follower product change in our hospital blood internal medicine and safe examination 山本美智子, 荒瀬弘幸, 大庭理寛, 庭木宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 815-815, 2021.

---

	P16-05. Safety assessment of the CT-P6 initial administration at change from standard drug trastuzumab of 30 minutes: Multicenter observational study 長谷川遥1, 齋藤佳敬2, 玉木慎也3, 高橋健太4, 徳留章5, 高田慎也1, 美濃興三1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 816-816, 2021.

---

	P16-06. It is the attitude survey of the patients at change from an insulin analog squirrel pro note to insulin lispro BS note 鎌田敬志, 松田千佳, 荒井真智子, 田中大輔, 清野由利 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 817-817, 2021.

---

	P17-01. One case of acute myocardial infarction with suspected hoarseness by the enalapril 長澤欣弘, 近藤和宏, 瀧内瑛輔, 尾形美絵, 中村槙一郎, 羽生智宏, 新関みどり, 田村和彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 821-821, 2021.

---

	P17-02. One case that a liver damage was complicated with thrombocytopenia by the minocycline 冨田詩織1, 藤井良平1, 今井雄介1, 西山徳人1, 田中雅幸1,2, 打谷和記1, 村中達也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 822-822, 2021.

---

	P17-03. One case that induced paroxysmal atrial fibrillation by a change of β stimulation inhalant for patients with bronchial asthma 船越晴喜1,2, 百賢二2, 大田進3, 岡崎敬之介1,2, 江波戸貴哉3, 山本成則3, 宇野知輝3, 相良博典3, 佐々木忠徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 823-823, 2021.

---

	P17-04. A case in which a drug reduction approach by a pharmacist for 34 types of hyperpolypharmacy led to improvements in clinical test values and ADL 山元孝俊1, 小瀬英司1, 渡部多真紀1,2, 安野伸浩1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 824-824, 2021.

---

	P17-05. One case with suspected pancytopenia by the retention of the methotrexate accompanied with the heart failure exacerbation 甲元大樹1, 花房伸幸1, 新城唯1, 砂場亜希1, 福島由貴1, 石橋友樹1, 黒田和宏2, 福家聡一郎2, 竹内誠3, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 825-825, 2021.

---

	P17-06. Example that caused PT-INR rise and GI bleeding with antimicrobial administration in the diet intake defectiveness patients 竹田享平, 井上晃汰, 簑島弓未子, 牧瀬英知, 橋本光生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 826-826, 2021.

---

	P17-07. One patient whom we collaborated with the chief physician, and a cause of the fever was able to give a diagnosis of drug fever 佐々木有彩1, 原弘士1, 澤村公志1, 高橋素彦2, 山本郁生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 827-827, 2021.

---

	P17-08. One case that metabolic alkalosis developed by the combination of loop diuretic, thiazide system diuretics, and hypokalemia was prolonged 森田有香, 門口直仁, 濱本真歩, 濱田恵輔, 段松雅弘, 田中聡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 828-828, 2021.

---

	P17-09. Renal function change after the use of iodine contrast media in the renin-angiotensin inhibitor remedy patients undergoing percutaneous transluminal coronary angioplasty 山本恭平1, 二宮直紀1, 鵜飼茜1, 新海大智1, 粟田浩文1, 澤田和久1, 久保田敏行2, 杉浦洋二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 829-829, 2021.

---

	P17-10. One case that reached the enforcement of the temporary pacing by severe sinus bradycardia after two days of the administration of carteolol hydrochloride durability eye drops resumption after the self-interruption 佐古守人, 吉田道治, 大西美香, 美甘早紀, 山本侑弥, 黒沢秀夫, 野村剛久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 830-830, 2021.

---

	P17-11. The type of the side effect for the antirheumatic drug remedy patients and the frequency 大崎俊啓 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 831-831, 2021.

---

	P17-12. About the effect by the years of experience of the current situation and the reporter of the side effect report of pharmaceutical products in the Gifu comprehensive medical care center 小寺聖, 関谷泰明, 井上壽江, 平下智之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 832-832, 2021.

---

	P17-13. 1 case of the folic acid deficiency anemia with suspected nephrogenic diabetes due to the lithium poisoning 田村和彦, 近藤和宏, 中村槙一郎, 瀧内瑛輔, 長澤欣弘, 尾形美絵, 羽生智宏, 新関みどり Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 833-833, 2021.

---

	P17-14. Look at the rear about the blood toxicity with vancomycin; mark investigation 猪股羽矢人1, 前川正充1, 小林智徳1, 石田優理香1, 岩崎瑞生1, 郷内琢也1, 松本侑子1, 小倉次郎2, 眞野成康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 834-834, 2021.

---

	P17-15. CYP3A5 and effect of the genetic polymorphism of CYP2C19 to give to blood change of cilostazol in patients with cerebral infarction and a cardiovascular side effect 横山匡1,2, 山内滋3, 山形桂司3, 金城雄太3, 浦野裕美子3, 村田敬二3, 前田利男2, 浅原慶徳1, 賀川義之2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 835-835, 2021.

---

	P17-16. One patient whom myositis merger myasthenia gravis developed in after the nivolumab administration as gastric cancer third treatment 小林俊博1, 坪谷綾子1, 小宮詠子1, 松本浩1, 小倉孝氏2, 篠原健介3, 伊藤由香1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 836-836, 2021.

---

	P17-17. Effect of the oral cooling for the accumulation on tongue tissue inducing a sweetness-sensitive drop in PEG ornamentation liposome formulation oxaliplatin dosage rat 茂木啓佑1, 平尾彩香1, 阿部礼奈1, 森戸克弥1, 高山健太郎1, 土井祐輔2, 安藤英紀2, 石田竜弘2, 長澤一樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 837-837, 2021.

---

	P17-18. A case of malignant syndrome developed due to abrupt discontinuation of drugs at the terminal stage of cancer 殿垣聖子1, 今井裕子1, 細川舞2, 高寺章代1, 相原直彦3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 838-838, 2021.

---

	P17-19. Examination of the risk factor about the onset of diarrhea by the naldemedine 工藤範子, 島田泉, 新木貴大, 鈴木直人, 外山聡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 839-839, 2021.

---

	P17-20. 1 case of treatment with oxaliplatin rectal cancer that it resulted in cardiopulmonary arrest by the hypersensitivity reaction at the second cycle after reintroducing it into 杉原弘記1, 岡田昌浩1, 岡本伸也1, 村上史承1, 岡崎和子1, 江木美峰2, 渡辺陽子2, 田代操1, 竹井英介1, 村田年弘3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 840-840, 2021.

---

	P17-21. 1 case of the coma type acute hepatic failure that it was thought that it was caused by regorafenib 桑田奈穂子1, 石原泰子1, 松本浩明1, 平大地2, 仁科慎一3, 西村健二1, 亀井健人1, 赤木晋介1, 高柳和伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 841-841, 2021.

---

	P17-22. A case of drug-induced pneumonia caused by bortezomib administered as previous treatment (bortezomib + pomalidomide + dexamethasone therapy) 荻野健吾, 増渕幸二, 西村栄一, 近藤智幸, 美馬禎俊, 設楽愛美, 橋本光生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 842-842, 2021.

---

	P17-23. 4 cases that resulted in neutropenia by vancomycin in the orthopedics domain 高橋諒多, 小林正拓, 辻本高志, 大谷薫, 大下直宏, 上田晃, 川本由加里, 後藤仁和 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 843-843, 2021.

---

	P17-24. One case that drug-related syndrome of inapp ADH secretion was suspected in a pharmacist in patients during antipsychotics remedy and adjusted a drug to 櫻塲絵梨香1, 原弘士1, 澤村公志1, 奈良典子2, 尾久守侑3, 山本郁生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 844-844, 2021.

---

	P17-25. One case that repeated a hallucination, visual hallucination, and suffered from the sleeplessness treatment of patients with Alzheimer's dementia 岩本圭太1, 坂中清香2, 飯征士3, 藤田あゆみ3, 杉浦伸哉3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 845-845, 2021.

---

	P17-26. One case that presented a blood sugar rise during nontuberculous acid-fast bacterium disease treatment 穴見俊祐, 藤井信大郎, 君羅加奈恵, 開発利江, 奥野護 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 846-846, 2021.

---

	P17-27. One patient who conducted a telephone follow-up aiming at sleepiness, the evasion of the quality of life drop by the drift 水野剛1, 八木澤恭子2, 藤田あゆみ3, 杉浦伸哉3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 847-847, 2021.

---

	P17-28. It is fact-finding of hepatic dysfunction after the operation for the gastric cancer excision patients 辻将成1, 小林一男2, 名和亜利沙2, 坂本啓3, 青山剛2, 横川貴志2, 舘合慶一2, 渡部秀一2, 清水久範2, 井田智3, 布部創也3, 山口正和2, 濱敏弘2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 848-848, 2021.

---

	P17-29. One patient whom vein of lower extremity thrombosis developed in for protein S drop by the low dose pill internal use 武田真央1, 山本諭2, 櫻井雄太1, 佐藤裕和1, 中村裕義1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 849-849, 2021.

---

	P17-30. The effect that aspartame included in the preparation gives to the phenylketonuric patients 高田裕奈1, 石川洋一2, 安武夫2, 深水啓朗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 850-850, 2021.

---

	P17-31. The effect that sulfamethoxazole - trimethoprim combination drug gives to serum creatinine, sodium and a potassium level 横山智士1,2, 中川潤一2, 相内尚也2, 清藤達矢1, 新岡丈典2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 851-851, 2021.

---

	P17-32. Case report avoiding the side effect becoming severe of the patients who presented with aciclovir encephalopathy by a pharmacist doubt inquiry 田井達也1, 山口佳津騎1, 新村航1, 松原亜季1, 渡邊政博2, 鈴木聖1, 元木貴大1, 田中裕章1, 芳地一3, 小坂信二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 852-852, 2021.

---

	P17-33. Examination about the effect on lipid abnormality with the lipid microsphere administration in postgastrectomy patients 名和亜利沙1, 小林一男1, 辻将成2, 坂本啓3, 青山剛1, 横川貴志1, 舘合慶一1, 渡部秀一1, 清水久範1, 井田智3, 布部創也3, 山口正和1, 濱敏弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 853-853, 2021.

---

	P17-34. One case of the right lung abscess with suspected drug-related thrombocytopenia with the meropenem 下山雄一朗1, 安東大智1, 牛嶋量一2, 宗広樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 854-854, 2021.

---

	P17-35. Effect of prochlorperazine on retching, vomiting prevention of tramadol in the orthopedics postoperative pain 石井菜紬子, 槙原克也, 松村友和 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 855-855, 2021.

---

	P17-36. Examination about the use situation and the side effect expression situation of the nintedanib 石田早絵1, 前山隆茂2, 柳原豊史2, 野中敏治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 856-856, 2021.

---

	P17-37. Summary of the specialist in citizen of Osaka consecutive side effect Committee 2019 report 新文1, 坂田勝美2, 清水順子3, 平方まり子5, 松本ミユキ6, 山本京4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 857-857, 2021.

---

	P18-01. Establishment of the podocyte differentiation derivative method of human iPS cells for the glomerulus imitation model construction 岩崎萌実, 坡下真大, 岩尾岳洋, 松永民秀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 859-859, 2021.

---

	P18-02. Examination of the sex differences in the oxidative metabolism response of the regorafenib 小島綾華1, 加藤美紀2, 曽我部鮎果2, 灘井雅行2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 860-860, 2021.

---

	P18-03. Regular Tolly science study on functional additive varying in a point of action with the tight junction control activity 杉村早耶香1, 橘敬祐2, 近藤昌夫2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 861-861, 2021.

---

	P18-04. The current situation and problem of the pharmaceutical regulation that paid its attention to drug metabolism by the gut flora 庄真喜子1,2, 橘敬祐1,2, 原田和生1, 平田收正3, 堤康央1, 國澤純1,2,4,5,6,7, 近藤昌夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 862-862, 2021.

---

	P18-05. Immunohistochemical pharmacokinetic study of the alogliptin in the type 2 diabetes model rat 浦叶恵, 齋田哲也, 進正志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 863-863, 2021.

---

	P18-06. Localized analysis study of the Afatinib using the immunohistochemical examination 岡明日輝, 齋田哲也, 進正志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 864-864, 2021.

---

	P18-07. Gene expression analysis in the human skin tissue of drug metabolizing enzyme Cytochrome P450 (CYP) participating in transdermal absorbing form preparation 槇原弘子, 赤瀬智子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 865-865, 2021.

---

	P18-08. Study on rat intestinal tract system of cancer molecular target drug Dacomitinib and localization in the skin and accumulation characteristics 松川拓磨, 進正志, 齋田哲也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 866-866, 2021.

---

	P18-09. Develop-ment research of the enzyme immunity method of measurement (ELISA) of tyrosine kinase inhibitor Sunitinib 片岡裕登, 齋田哲也, 進正志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 867-867, 2021.

---

	P18-10. Examination of circadian fluctuations in plasma xanthine oxidoreductase protein expression 田邉建志1, 田山剛崇1, 前田志津子1, 西村さとみ1, 喜多智生1, 岡本友理香2, 杉原数美1, 三宅勝志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 868-868, 2021.

---

	P18-11. The establishment of the endodermal differentiation method derived from the human iPS cells under the Feeder-free condition and differentiation instruction to small intestine epithelium cells and hepatocytes 白井晃太郎, 邱施萌, 岩尾岳洋, 松永民秀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 869-869, 2021.

---

	P19-01. Examination of the bone fracture risk for patients with refractory epilepsy 福島悠太郎, 山本吉章, 矢嶋隆宏, 古屋裕之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 871-871, 2021.

---

	P19-02. Search of the factor having an influence on the intraindividual variability of blood voriconazole levels for patients with blood malignant disorder 前田悠, 田中遼大, 龍田涼佑, 伊東弘樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 872-872, 2021.

---

	P19-03. Population pharmacokinetics analysis of sildenafil in patients with Japanese pulmonary artery-related pulmonary hypertension and bosentan 粟飯原りりか1, 田中紫茉子1, 神谷千明2, 小田切圭一2, 龍口万里子2, 柏倉康治1, 乾直輝2, 並木徳之1,3, 渡邉裕司2, 内田信也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 873-873, 2021.

---

	P19-04. Population pharmacokinetics analysis of the Lacosamide in patients with Japanese adult epilepsy 上地まお1, 小林大介1, 村木翔太2, 豊瀬裕人1, 末次王卓3, 川尻雄大1, 廣田豪3, 江頭伸昭3, 家入一郎3, 島添隆雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 874-874, 2021.

---

	P19-05. One case that an effect was found in IsaPd therapy in RRMM (recurrent intractable multiple myeloma) where DLd therapy became PD 岡崎将也1, 新谷貴洋2, 吉川明良1, 山内健1, 三村奈美子1, 脇本友絵1, 渡辺美和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 875-875, 2021.

---

	P19-06. Population pharmacokinetics analysis of vancomycin in patients who underwent operation on the heart using the heart-lung machine 朝田瑞穂1, 永田将司1,2, 水野友裕3, 荒井裕国3, 高橋弘充1, 安原眞人2,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 876-876, 2021.

---

	P19-07. Comparison between bisoprolol oral medicine and effect of the patch in elderly people 犬飼友梨, 木下照常, 山岸千恵, 滝本典夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 877-877, 2021.

---

	P19-08. Effect examination of the genetically-modified humans in the impaired renal function merger DIC-soluble thrombomodulin 阿部一仁 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 878-878, 2021.

---

	P20-01. 1 case that PTINR increased by combination of warfarin K and multiple antimicrobial including the ST medical mixture conspicuously 関戸匡恵1,2, 玉造竜郎1,2, 杉田栄樹1,2, 岡田菜津美1,2, 阿部和正1,2, 縄田修一1,2, 楠本壮二郎3, 佐々木忠徳2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 880-880, 2021.

---

	P20-02. Investigation of the potential drug interactions in the rehabilitation ward 立石裕樹, 宮津大輔, 田中博和, 渡邊裕之, 平川雅章 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 881-881, 2021.

---

	P20-03. Drug interactions with azathioprine and allopurinol in the decreased renal function patients: Case accumulation study 平井利典1, 白石ちひろ1, 村田智博2, 岩本卓也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 882-882, 2021.

---

	P20-04. We look at methotrexate and the rear about drug interactions between the proton pump inhibitor and are analyzed a mark evaluation and the interaction mechanism 鳴海克哉1, 上田一奈太1, 佐藤優1, 古堅彩子1, 井関健2, 小林正紀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 883-883, 2021.

---

	P20-05. The effect that doxorubicin administration gives to the metabolism activity of the CYP2C substrate drug and the internal change 福野修平, 長井克仁, 谷村岳洋, 山本弘平, 小西廣己 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 884-884, 2021.

---

	P20-06. Physiologic pharmacokinetics model analysis and comparison of the drug interactions prediction by the CR-IR method 小林萌南1, 大久保健二郎1, 加藤基浩1,2, 山岸喜彰1, 工藤敏之1, 伊藤清美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 885-885, 2021.

---

	P20-07. Functional decline of the organic cationic transportation bearer by the sorafenib in human gastrointestinal epithelium Caco-2 cells 松本優花 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 886-886, 2021.

---

	P20-08. It is one case of children after the hematopoietic stem cell transplantation that accepted a rise in blood level of tacrolimus by voriconazole and a CYP3A4 irreversible inhibitor 高橋勇人, 歌野智之, 高藤由紀子, 山谷明正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 887-887, 2021.

---

	P20-09. A case of lung transplantation in which tacrolimus blood concentration decreased due to combination use of Enoras(R) enteral solution. 青山あづさ1, 小園友明2, 倉橋宏和3, 斉藤佑治2, 竹内正幸2, 大西正文2, 脇田康志1,4, 奥村彰久3, 築山郁人1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 888-888, 2021.

---

	P20-10. The effect that Enzalutamide gives to a depression effect of the calcium-channel blocker 守田和憲, 市川洋一, 山下愛子, 北岡朋子, 田上治美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 889-889, 2021.

---

	P20-11. Effect of the concomitant drug giving it to the effectiveness of the nivolumab in patients with stomach cancer 畠山智明1, 高崎修一2, 梅原健吾3, 佐藤友昭4, 鈴木直哉5, 宇野健一6, 井上靖隆7, 渡邉大毅8, 畠中仁大9, 伊佐治麻里子10, 太田明秀11, 元茂拓法12, 徳留章13, 藤井達郎14, 神垣輝美15 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 890-890, 2021.

---

	P20-12. One case of patients with central nerve origin malignant lymphoma which produced a methotrexate excretion delay 浦田修平1, 吉川直樹1, 齋藤清貴2, 田崎智也1, 大野梨絵1, 竹島秀雄2, 池田龍二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 891-891, 2021.

---

	P20-13. Efforts of the AST person in charge of use of rifampicin case pharmacist for the medical treatment adequacy 森田眞由, 村田龍宣, 村岡淳二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 892-892, 2021.

---

	P20-14. Effect (the second report) of the methylprednisolone giving it to the blood clotting ability of the warfarin remedy patients 大西由莉1, 土岐浩介1,2, 安部沙織2, 臼井丈一2, 齋藤知栄2, 辻浩史2, 森島祐子2, 山崎浩2, 松本功2, 家田真樹2, 玉岡晃2, 檜澤伸之2, 山縣邦弘2, 本間真人1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 893-893, 2021.

---

	P21-01. Levetiracetam blood concentration changes and administration design during pregnancy and after childbirth 平松亜依1,2, 高塚博一1, 山崎伸吾1, 鈴木貴明1, 山口正和2, 石井伊都子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 897-897, 2021.

---

	P21-02. Examination of the VCM adsorption rate due to the AN69ST membrane 入江知美1,2,3, 山科卓也1, 山崎貴史1, 古海和博1, 鶴山萌子2, 平木洋一3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 898-898, 2021.

---

	P21-03. Blood level survey of the TDM recommendation medicine in the outpatient 村瀬正, 畑本慶太 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 899-899, 2021.

---

	P21-04. It is effect on initial blood level after the loading by the Teicoplanin late departure preparation brand change 松永典子1, 山口直夏2, 太田千代枝1, 森塚暁裕1, 塩尻恭平1, 里加代子1, 兒玉幸修1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 900-900, 2021.

---

	P21-05. Attempt of the early period of vancomycin doses weight loss in a piperacillin tazobactam combination drug and the vancomycin combination patients 渡邊瑛理, 古庄弘和, 陣上祥子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 901-901, 2021.

---

	P21-06. The effect that Everolimus in the therapeutic range area gives to cells derived from kidney 白橋佳樹, 平田憲史郎, 門脇大介, 石黒貴子, 宮村重幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 902-902, 2021.

---

	P21-07. Search of the thiamylal therapeutic range area in children 杉田有輝1, 石本まり1, 平田憲史郎1, 小原隆史2, 陣上祥子3, 渡邊博志4, 丸山徹4, 平井克樹5, 石黒貴子1, 宮村重幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 903-903, 2021.

---

	P21-08. Establishment of the simple and easy simultaneous assay of hydromorphone out of the human plasma and the glucuronic acid conjugated compound 鈴木利昌1,2, 内藤隆文1, 柴田海斗1,2, 北嶋諒2, 川上純一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 904-904, 2021.

---

	P21-09. It is ... based on relationship - part specific PK-PD analysis with blood level and the intestinal tract fat concentration of the cefmetazole in the lower digestive tract surgery 小松敏彰1, 森田妃南子2, 高山陽子3, 夏目祐衣4, 友田吉則2, 中村隆俊5, 花木秀明6, 厚田幸一郎1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 905-905, 2021.

---

	P21-10. Precautions for TDM in pediatric patients receiving tacrolimus and voriconazole concomitantly - Lessons learned from cases - 楠川侑吾, 田村優衣, 村田龍宣, 村岡淳二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 906-906, 2021.

---

	P21-11. The current situation of the blood vancomycin levels precision management in subnutrition, the decreased renal function patients 川上智也, 広田瑞季, 飯田有貴, 伊藤玲奈, 宮川春香, 引地華子, 辻桃子, 福田光司, 圓崎信也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 907-907, 2021.

---

	P21-12. Construction of the simple and easy method for measurement of the highly-concentrated cefmetazole using the HPLC for PK/PD evaluation in patients with impaired renal function 並木孝哉1,2, 横山雄太1,3, 枦秀樹2, 地引綾3, 河添仁1,3, 鈴木小夜1,3, 中村智徳1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 908-908, 2021.

---

	P21-13. Establishment of the plasma concentration assay of chronic thrombo embolic pulmonary hypertension therapeutic drug riociguat 砂川由香理1, 田中紫茉子1, 若松しのぶ1, 龍口万里子2, 柏倉康治1, 秋田敬太郎3, 前川裕一郎3, 並木徳之1,4, 渡邉裕司2, 乾直輝2, 内田信也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 909-909, 2021.

---

	P21-14. Development of the assay using the LC-MS/MS of human serum ramucirumab 坂口健太1, 柴田海斗1, 内藤隆文1, 菊池寛利2, 前川真人3, 竹内裕也2, 川上純一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 910-910, 2021.

---

	P21-15. Examination of a loading dose and a therapeutic range achievement quotient of the Teicoplanin and the effectiveness 鈴川誠, 佐々英也, 内山耕作, 平尾祐樹, 冨田敦和, 今西忠宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 911-911, 2021.

---

	P21-16. Establishment of a method for quantifying belimumab in human plasma using UHPLC-MS/MS 吉島千智1, 鈴木陽介1, 田中遼大2, 小野寛之2, 小田絢子1, 尾崎貴士3, 柴田洋孝3, 伊東弘樹2, 大野恵子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 912-912, 2021.

---

	P21-17. 1 case that it was speculated that antimicrobial-related loose bowels by tazobactam/piperacillin inhibited enterohepatic circulation of mycophenolic acid 田中遼大, 鈴木芳, 松本麻美, 龍田涼佑, 伊東弘樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 913-913, 2021.

---

	P21-18. Consideration of the pharmacogenetics of a plasma drug concentration and the drug metabolizing enzyme genetic polymorphism in the metronidazole encephalopathy 上森将吾1, 羽山希2, 山田悠人1,3, 鈴木景子3, 丹羽隆3, 山路文範4, 吉田省造5, 林祐一6, 下畑享良6, 小倉真治5, 鈴木昭夫1,3, 林秀樹1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 914-914, 2021.

---

	P21-19. One case of cancer of maxillary antrum which gave Carboplatin combination chemotherapy under the haemodialysis, and measured the free form platinum concentration 中尾祐貴, 森本隼多, 加藤絢, 樋川珠代, 武居宏樹, 鮎原秀明, 竹内裕紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 915-915, 2021.

---

	P21-20. The case that racked its brains about blood level management using vancomycin for ventilator-associated pneumonia complicated with a new coronavirus infection 喜多岡洋樹1, 中村真希1, 楠本将裕1, 早坂香織1, 吉田愛1, 田中泉1, 田中由起子1, 山室蕗子1, 岩越一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 916-916, 2021.

---

	P21-21. Safe examination with the vancomycin initial loading dose 松本勝城, 奥村梨央, 青木旦未, 鹿島弥生, 小林奈緒, 海野明子, 長澤彩華, 深沢貴志, 加藤一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 917-917, 2021.

---

	P21-22. Examination of the optimal population average parameter in the VCM initial design for patients with neurologic intractable disease 山科卓也1, 山崎貴史1, 小坂隆介2, 古海和博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 918-918, 2021.

---

	P21-23. Predictive precision evaluation of the Teicoplanin blood level by two kinds of parameters for patients with neurologic intractable disease 山崎貴史1, 山科卓也1, 小坂隆介2, 古海和博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 919-919, 2021.

---

	P21-24. Examination about the usefulness of the therapeutic drug monitoring of voriconazole in the ambulatory practice 横尾卓也1, 花井雄貴1,2, 松尾和廣2, 植草秀介2, 大谷真理子1, 下山航平1, 鈴木美香奈1, 草野歩1, 坂本真紀1, 西澤健司1, 松本高広1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 920-920, 2021.

---

	P21-25. Examination of the Teicoplanin administration plan for the sustained hemofiltration dialysis enforcement case to achieve 20 μg/mL of initial trough values or more 植田貴史1, 竹末芳生2,3, 中嶋一彦1,3, 一木薫1, 石川かおり1, 山田久美子1, 土田敏恵1, 高橋佳子4, 石原美佳4, 木村健4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 921-921, 2021.

---

	P21-26. Can the vancomycin-induced renal failure at tazobactam piperacillin combination be avoided by the TDM which assumed area under the curve an index at blood level time? 岡田直人1,2, 中本亜樹1, 泉侑希1, 中馬真幸3, 合田光寛4, 八木健太4, 相澤風花1, 濱野裕章5, 座間味義人1,5, 東桃代2, 石澤啓介1,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 922-922, 2021.

---

	P21-27. Comparison between vancomycin and usefulness of the Teicoplanin in the infectible easily state after the hematopoietic stem cell transplantation 大塚恵子1, 中島寿久1, 大塚亮1, 石川光信1, 赤木徹1, 橋本浩伸1, 福田隆浩2, 山口正和1, 古川哲也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 923-923, 2021.

---

	P21-28. Initial administration plan-style construction of vancomycin in consideration of growth and the comorbidities of children and anticipatory evaluation 小野達昌1, 富島喜朗1, 猿渡淳二2, 陣上祥子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 924-924, 2021.

---

	P21-29. Existing prediction-style comparison of blood vancomycin levels in neonates 大橋隼人1, 花井雄貴1,2, 横尾卓也1, 大谷真理子1, 松尾和廣2, 草野歩1, 坂本真紀1, 松本高広1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 925-925, 2021.

---

	P21-30. The expansion of the vancomycin TDM duties that took advantage of medical service fees revision in 2020 and the effect 村田翔, 木村美咲, 川崎亮輔, 相原敏彦, 増尾昌則 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 926-926, 2021.

---

	P21-31. Examination about shortening of the medical treatment intervention time to MRSA bacteremia by the MALDI-TOF MS introduction 福井温子, 奥平正美, 澤田和久, 杉浦洋二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 927-927, 2021.

---

	P21-32. Development of the levofloxacin levels assay by the ELISA method using the peroxidase label monoclonal antibody 園田恵理1, 大久保伸哉1, 大磯茂1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 928-928, 2021.

---

P21-33. Examination of the validity of the round up method to serum creatinine level 0.6 mg/dL for the purpose of the correction of the renal function overestimate for the quantity of muscle drop patients 内海紗良1, 前田圭介2, 久保田丈太3, 中谷咲良1, 原田義彦1, 成田勇樹1,4, 猿渡淳二1, 近藤悠希1, 石塚洋一1, 入江徹美1, 門脇大介5, 平田純生1,6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 929-929, 2021.

---

	P21-34. The case that was given administration plan support of the law for the cyclosporine micro emulsion preparation (CyA-MEPC) once a day time before a meal for psoriasis vulgaris 小林宇太郎1, 一ノ瀬由衣1, 清原龍士2, 小山田純治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 930-930, 2021.

---

	P22-01. About the examination for NUDT15 genetic polymorphism situation in patients with inflammatory bowel disease of our hospital 屋敷大輔, 中村杏果, 森永崇史, 池沢若菜, 田中恭人, 豊留麻衣, 北園幸大, 中野一馬, 山本梢, 淵脇ゆかり, 徳丸章佳, 長ヶ原琢磨, 荻尾夕起子, 岸本真 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 932-932, 2021.

---

	P22-02. Based on the 2019 version for the fact-finding - colon cancer treatment guidelines on medical therapy physician for unresectable progress recurrence colon cancer - 竹野孝慶 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 933-933, 2021.

---

	P23-01. Efforts to regimen inspection system introduction in the cancer medical therapy 藤井元, 神山知也, 米田航佑, 永井道雄, 上田武司, 鶴田洋平, 石坂忠博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 935-935, 2021.

---

	P23-02. Economic effect by the use adequacy of the closed system anesthesia connection appliance using the existing regimen management system 齊藤安昌, 城綾香, 浅川杏子, 清水忠弘, 島田雅彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 936-936, 2021.

---

	P23-03. Importance of the regimen joint ownership in the foreign cancer chemotherapy 大矢幸恵, 岸川紗江子, 小島友絵, 日野洋子, 山田学 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 937-937, 2021.

---

	P23-04. Inspection of the onset of low Na blood symptom inhibitory effect by the infusion change of the CDDP regimen in head and neck cancer 石原歩実, 木下照常, 鳥居昌太, 江崎秀樹, 榊原隆志, 滝本典夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 938-938, 2021.

---

	P23-05. Evaluation of usefulness in standardizing isatuximab administration method 湯山聡1,2, 伊勢崎竜也1, 舟越亮寛1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 939-939, 2021.

---

	P23-06. Regimen operation and the evaluation that incorporated protein urine qualitative analysis and the examination of the protein urine/creatinine ratio order in the regimen including the neovascularisation inhibitor 前畠一友, 財間富士子, 築地辰典, 中山恵美, 岡崎直樹, 六田湧紀, 鈴木秀平, 最勝寺貴広, 高橋真理 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 940-940, 2021.

---

	P23-07. Examination of safety and the effectiveness in the administration day change of the dexamethasone as eruption measures by the pemetrexed 田川優介1, 多胡友絵1, 星育子1, 小泉祐一1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 941-941, 2021.

---

	P24-01. One case of patients with unresectable progress gastric cancer which is treated with other types of job intervention in the chemo conference appropriately and shifts, and is ready to carry out ambulant treatment continuation 中村美樹1, 大上寛子1, 尾藤展克2, 内山清3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 944-944, 2021.

---

	P24-02. Fact-finding of the operational situation of the tracing report in the cancer medical therapy 文英賢1, 吉田徹也2, 山崎直樹1,2, 木村仁美1, 田坂美咲1, 細川忠士1, 中尾將彦1, 森宏幸1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 945-945, 2021.

---

	P24-03. Usefulness of the side effect situation investigation of the Lenvatinib in hepatocytes cancer and the pharmacist intervention 小武和正1,2, 大月ちひろ1,2, 清水久美子1,2, 池田房雄3, 藤岡真一3, 川上恭弘1,2, 大澤俊哉3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 946-946, 2021.

---

	P24-04. Occupational exposure screening sheet making for home health care practitioners corresponding to foreign cancer chemotherapy patients 齊藤直裕1, 松本佳子1, 高橋淳一2, 林光世2, 堀信弥3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 947-947, 2021.

---

	P24-05. Pharmacist duties (the second report) in the treatment with immune checkpoint inhibitor support team 玉井宏一1, 中野友寛1, 西畑友尋1, 渡部早苗1, 奥津武志1, 田房恭子2, 山下広恵2, 武田千津2, 井上考司3, 中西徳彦3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 948-948, 2021.

---

	P24-06. The current situation investigation of the tracing report of the patients whom cancer medical therapy is given in in outpatient department 河野史子1, 中島亘2, 高田尚子3, 宇都宮あゆみ4, 倉田真子5, 宮原志帆6, 奥村春咲7, 服部亮太8, 重村淳9, 皆谷和弘10 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 949-949, 2021.

---

	P24-07. The intervention of the drugstore pharmacist in the consultation interval between the foreign cancer chemotherapy and effect of the medical cooperation 井上祥平1, 渡邉尚也2, 片山珠季3, 永野悠馬4, 前田守4, 長谷川佳孝4, 月岡良太4, 森澤あずさ4, 金剛圭佑5, 大石美也4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 950-950, 2021.

---

	P24-08. One patient who conducted anticancer agent telephone follow using a check sheet in the health insurance pharmacy 伊野陽子1,4, 小俣江利果1, 山下修司2,4, 玉木啓文1,4, 野口義紘3,4, 長内理大1,4, 井口和弘1,4, 寺町ひとみ3,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 951-951, 2021.

---

	P24-09. It is efforts ... to calculating it the ... cooperation full addition to prescription notebook by an evaluation of the pharmacist outpatient department 合津貴志, 渡部照美, 佐藤真琴, 関根悠, 渡邉紘章, 久保田真生, 田崎政則 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 952-952, 2021.

---

	P24-10. Relation with elderly patients with cancer and the local drugstore 佐藤里穂子1, 疇地拓郎1, 河村香奈子1, 篠崎泉1, 長富範子1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 953-953, 2021.

---

	P24-11. Two cases that were connected for improvement in quality of the foreign cancer chemotherapy by the hospital utilizing a treatment notebook and the tracing report and the cooperation with the health insurance pharmacy 堀川美帆, 齋藤究, 雨山智, 高橋阿希子, 菊地正史, 眞野成康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 954-954, 2021.

---

	P24-12. Efforts ... for the making of the cancer treatment protocol and medicine medicine cooperation and the side effect early detection through telephone follow-up - tracing report 加藤誠一1, 田中直哉2, 近藤澄子1, 寺戸靖1, 篠原祐樹1, 矢島毅彦3, 田中秀和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 955-955, 2021.

---

	P24-13. Efforts for a nurse and the cooperation full addition calculation in the foreign chemotherapy room to be carried out by collaboration 今西義紀1, 桐生浩子1, 池口麻由子1, 寺本朋代2, 中山賀奈子1, 西川嘉広1, 大森加奈子1, 小出哲朗1, 中山真由美2, 伊藤久美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 956-956, 2021.

---

	P24-14. The approach that we conduct while illness examining foreign cancer chemotherapy, and conducting medicine cooperation 齊藤達也, 秋篠夏美, 谷口知明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 957-957, 2021.

---

	P24-15. Efforts to the cooperation full addition by the regimen seal automatic output system utilization for the prescription notebook 目黒裕史, 佐分利美帆子, 三松史野, 大野恵一, 本多伸二, 小野勝, 村岡淳二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 958-958, 2021.

---

	P24-16. It is treatment continuation and the example that it was by illness medicine cooperation on the basis of patients background for medical therapy patients after the breast cancer technique 佐々木操 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 959-959, 2021.

---

	P24-17. Comparison of a foreign cancer chemotherapy reporting book of our hospital and the information that a health insurance pharmacy asks for 北島比香里, 片山聡子, 田中真衣, 橋本沙耶, 池崎友明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 960-960, 2021.

---

	P24-18. Stand on an advantage and the future problem - 1 case of the cancer medicine medicine cooperation drugstore which was obtained by holding a meeting at a hospital and a few drugstores; and ... 細川清史, 河野智子, 長嶌千紘, 伊勢冴江子, 倉富昌子, 古川亜由美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 961-961, 2021.

---

	P24-19. Support of the pharmacist for patients balancing working with foreign chemotherapy 篠原義剛1, 横山雄一1, 植木哲也1, 立石清一郎2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 962-962, 2021.

---

	P24-20. 1 case of the urothelial carcinoma that vitiligo vulgaris develops by Pembrolizumab, and a long-term treatment effect is obtained 杉山弘樹1, 増田容子2, 横山知明2, 臼井幸男3, 原田晴司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 963-963, 2021.

---

	P24-21. One case of medicine medicine cooperation and the area pharmacy care supporting terminal cancer patient discharge refusing a condition notice during the No Visitors ward hospitalization of the corona evil 工藤信孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 964-964, 2021.

---

	P24-22. Example that patients with treated cancer hoped for a discharge, and the at-home staff cooperated with a hospital, and was able to continue early discharge and home care 中村薫, 川崎博行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 965-965, 2021.

---

	P24-23. Attitude survey of patients with cancer affecting the specialized pharmacist placement of the health insurance pharmacy 大東真理子, 竹林由香, 藤田大樹, 湯山ゆきの, 中川直人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 966-966, 2021.

---

	P24-24. One case that received end-of-life care care by the multi-type of job cooperation to patients with at-home terminal cancer of non-notice 松本真緒, 西倉加余, 沼田美奈, 山田千沙江 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 967-967, 2021.

---

	P24-25. Efforts of the correspondence improvement at temporary consultation of the use of immune checkpoint inhibitor patients using the PDCA cycle 日比聡1, 城川優子2, 南谷健吾3, 加藤裕子4, 伊藤紳人1, 吉田嵩5, 丸茂義晃5, 片岡孝江5, 湯浅周1, 粥川哲5, 伊奈研次6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 968-968, 2021.

---

	P24-26. Effect by the relation of the multi-type of job to hepatitis B screening 稲垣貴彦1, 安藤洋介1, 豊里星来1, 太田秀基1, 岡本昌隆2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 969-969, 2021.

---

	P25-01. Evaluation about the usefulness of the reservation preparation function with the anticancer agent automatic preparation robot 外海友規1, 近藤勝弘1, 後藤佳奈1, 竹本将士1, 江崎哲夫1, 木村和哲1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 971-971, 2021.

---

	P25-02. Patients satisfaction investigation of the portable disposable infusion pump to use for colon cancer chemotherapy 山田卓1,2,3, 菊池武友1, 松本浩一1, 堤一貴1, 樋口恭子1, 橋本香代子2, 三輪啓介3, 三輪涼子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 972-972, 2021.

---

	P25-03. Anticancer agent pollution status of anticancer agent preparation front chamber ceiling air conditioning of the Aichi cancer center and the worker 前田章光1, 山内拓也1, 長谷川彩子2, 加藤智子2, 富安直弥2, 加藤正孝1, 稲熊一英2, 松崎雅英1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 973-973, 2021.

---

	P25-04. Attitude survey about the personal protector wearing at anticancer herbalist handling in Saga 古野龍也, 木村早希子, 竹内耕治, 島ノ江千里 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 974-974, 2021.

---

	P25-05. Stability after the medicinal solution preparation in the cytarabine + methotrexate + steroid intraspinal injection therapy 畠中仁大1, 下山哲哉2, 岩崎弘晃1, 佐藤梨奈1, 遠藤貴之1, 伊藤邦彦2, 小林道也2, 泉克明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 975-975, 2021.

---

	P25-06. About an evaluation of the anticancer medicine preparation duties time for the purpose of the closed system anesthesia connection appliance full-scale introduction 明石和也, 増尾直亮, 曾我部直美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 976-976, 2021.

---

	P25-07. Effect in the change on "chemosafe lock" from closed system anesthesia drug transportation system "chemosafe" 上原友美, 末永尚輝, 八汐祥恵, 堀内智裕, 鶴永大貴, 中村有莉恵, 赤星真広, 池増鮎美, 佐多照正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 977-977, 2021.

---

	P25-08. Questionary survey about the operability comparison before and after the changes from chemosafe to a chemosafe lock 鈴木健太1, 原幸稔1, 松本大吾1, 三ツ橋千尋1, 下田純子2, 永野奈美子2, 三宮忠1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 978-978, 2021.

---

	P25-09. Examination of the removal means for the living environment pollution of patients who received foreign chemotherapy 宮澤憲治1,2, 茅野尚希2, 嵐達哉2, 八木下愛華2, 秋山哲平1, 岡田守弘2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 979-979, 2021.

---

	P25-10. CSTD damage with the parenteral injection containing the oil-related solvent 治田匡平, 青井博志, 木村錦子, 岡田和也, 三上知佳, 村田政軌, 松田早代, 佐道花菜, 吉川一吾, 池田和之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 980-980, 2021.

---

	P25-11. Change unsociable drug transportation system (CSTD) 菅野和彦1, 熊谷史由1, 高松謙1, 袰岩靖子1, 片谷憲子2, 濱中直美2, 大友眞菜1, 菊地未由1, 駒林幸太郎1, 中川こはる1, 小笠原綾子1, 横山咲稀1, 伊藤亮太1, 星野祐太1, 渡邊卓嗣1, 中嶋丈晴1, 穂積史朗1, 宮城宣明3, 大月沢雄1, 石本昌裕1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 981-981, 2021.

---

	P25-12. Comparison of the appropriate glove wearing method at anticancer agent preparation 南島拓矢, 宮崎雅之, 藤野泰孝, 片岡智美, 倉地茜, 前田愛, 松本千代, 松永安未, 濱田雄平, 奥村啓樹, 小栗佐織, 細見周平, 西山貴章, 南川友香, 山田清文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 982-982, 2021.

---

	P25-13. Economic effect by the full-scale use of the closed system anesthesia appliance at anticancer agent preparation and safe improvement 藤原未都菜1, 逸見結衣1, 伊勢原祐子1, 村田和歌子2, 井上智恵1, 日生下美紀1, 石田達彦3, 西窪奈津子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 983-983, 2021.

---

	P25-14. Study on resolution, inactivating effect of the anticancer agent with the ozone water 加藤銀次郎1, 見留英路2, 重松沙季2, 宇都宮礼2, 島崎美穂2, 佐々木祐太3, 槇恒雄4, 山本宏5, 田邊知孝2, 舟橋達也2, 波多江典之6, 飛鷹範明7, 田中守7, 明樂一己2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 984-984, 2021.

---

	P25-15. Completely integrated infusion set: Exposure countermeasures and evaluation by introducing Antileak 川田亮, 春原龍矢 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 985-985, 2021.

---

	P25-16. Liquid leakage test of cyclophosphamide at the bottle needle stick/puncture 矢野琢也, 星加寿子, 松本知樹, 松本大輝, 加藤あゆみ, 福岡竜逸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 986-986, 2021.

---

	P26-01. 1 case that was given Dabrafenib + Trametinib combination therapy by BRAF mutation in the gene-positive lung cancer 竹尾恵理子1, 後藤健志1, 伊藤功治1, 岩本公一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 990-990, 2021.

---

	P26-02. Look at the rear about the intensity of treatment of the Osimertinib in our hospital; mark investigation 冨士野ひより1, 嘉屋道裕2, 中村和代1, 中垣繁1, 南智1, 平野桂子1, 鈴木貴也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 991-991, 2021.

---

	P26-03. The case that became available for the pharmaceutical intervention for patients with cancer starting from Residual medicine confirmation 鶴海宏之1, 中村佳代2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 992-992, 2021.

---

	P26-04. Examination of the duties efficiency with the tracing paper chase system about the cancer chemotherapy 西宮祐輔1, 松原慎2, 山路和彦3, 梅原このみ4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 993-993, 2021.

---

	P26-05. Questionary survey for drugstore pharmacists about the application of anticancer agent regimen situation which a medical institution releases 関谷秀, 世取山哲史, 小林義幸, 田所真一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 994-994, 2021.

---

	P26-06. Example that was able to contribute to treatment by cooperation and the medication follow-up with relation ... caregiver of "the family pharmacist" to patients who received cancer chemotherapy 西川育子1, 与那嶺梨香1, 武部若菜1, 早川太朗2, 高井佳江1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 995-995, 2021.

---

	P26-07. Intervention example by the follow-up of the authorities in the rectal cancer postoperative chemotherapy 山田裕介1, 吉田貴大1, 笹野寿基2, 安川徹2, 竹原美穂2, 辻真利3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 996-996, 2021.

---

	P26-08. 1 case that was able to contribute to qualitative improvement of the pharmaceutical management by conducting illness medicine cooperation at patients with cancer hospitalization and release 松本佳子, 齊藤直裕, 北谷豪朗, 川崎友里江 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 997-997, 2021.

---

	P26-09. Evaluation of the telephone follow-up using the oral anticancer agent side effect check seat 福島岳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 998-998, 2021.

---

	P26-10. The current situation investigation for the information sharing method of the side effect in the cooperation full addition and the measures 中村緑, 光家勉, 木津茂, 上田豊実 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 999-999, 2021.

---

	P26-11. 1 case of the breast cancer that adherence improved by a follow-up 島田淳史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1000-1000, 2021.

---

	P26-12. 1 case that prevented the aggravation of the adverse event by the follow-up for adjuvant chemotherapy (DC therapy) patients with endometrial cancer conducting after the foreign cancer technique 中尾紘子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1001-1001, 2021.

---

	P26-13. One case that olanzapine was used in for tardive retching during ddEC therapy 渡部誠士1, 末次加代子2, 藤田あゆみ3, 杉浦伸哉3, 杉浦克典3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1002-1002, 2021.

---

	P26-14. The combination of oral anticancer agent and gastric acid antagonist actual situation that intragastric pH influences absorption properties 政本康成1, 田村渓2, 蓮井雄3, 綿引定成4, 中村京香5, 児矢野なつ美6, 山口弘7, 常世田京子8, 永野悠馬9, 前田守9, 長谷川佳孝9, 月岡良太9, 森澤あずさ9, 大石美也9 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1003-1003, 2021.

---

	P26-15. The combination of aromatase inhibitor and selective estrogen receptor modifier situation 中島直幸1, 青木香奈2, 森山京英3, 片山珠季4, 永野悠馬5, 前田守5, 長谷川佳孝5, 月岡良太5, 森澤あずさ5, 大石美也5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1004-1004, 2021.

---

	P26-16. Treatment of skin disorders caused by apalutamide tablets and experience of new adverse events 野田佳子1, 金城裕美子1, 井上千絵美1, 濱田美輝1, 野田哲史2, 須藤正朝2, 蓑輪圭一郎1, 臼井孝3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1005-1005, 2021.

---

	P26-17. Change of the tracing report of the drugstore pharmacist with "a reporting book about the foreign chemotherapy" whom a hospital issues 佐々木賢輔, 山口陽子, 芳沢寛邦, 今井拓弥, 小田島匡, 筒井志帆, 大坂菜摘, 小谷迅人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1006-1006, 2021.

---

	P26-18. One case that caused hearing loss, ear drum perforation by Axitinib administration 仲野真悟1, 富田雅之2, 岸田充生3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1007-1007, 2021.

---

	P26-19. The case that suggested folic acid prophylaxis after the pemetrexed discontinuation in patients with thymoma using Saga practice information regional alliances system atomic bomb atomic bomb link 竹原美穂1, 辻真利2, 山田裕介3, 笹野寿基1, 吉田貴大3, 安川徹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1008-1008, 2021.

---

	P26-20. One case that tried intervention for the numbness of hands and feet aggravated by FOLFIRI+Bev therapy 菅原大典1, 末次加代子2, 藤田あゆみ3, 田名邊清3, 杉浦伸哉3, 杉浦克典3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1009-1009, 2021.

---

	P26-21. The side effect expression of Abemaciclib situation reported through a tracing report 篠崎千尋1, 桑村恒夫1, 柿原圭佑2, 三上忠司1, 野田聖奈子1, 原田智子1, 中川義浩1, 松尾琴美3, 梅崎りさ4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1010-1010, 2021.

---

	P26-22. Example that an online follow-up utilizing the electronic prescription notebook (prescription notebook plus) in the treatment with anticancer agent was effective 山田真弘, 米山大輔, 小林加奈 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1011-1011, 2021.

---

	P26-23. One case of the capecitabine-induced high neutral hyperlipemia that led to chemotherapy continuation by pharmaceutical intervention 池口麻由子1, 桐生浩子1, 松田千裕1, 田中裕子1, 水谷日花里1, 窪田知仁1, 大矢知立城1, 西川嘉広1, 大森加奈子1, 橋本陽1, 今西義紀1, 小出哲朗1, 森脇健太郎1,3, 山本あゆみ2, 伊藤久美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1012-1012, 2021.

---

	P26-24. An investigation of the effect that a regimen label grant gives to an insurance pharmacist and guess of the behavior modification 浜口将一1, 木村大地2, 清水克次3, 角川幸男3, 高木麻里3, 藤田敬子3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1013-1013, 2021.

---

	P26-25. The effect that presence or absence of hospital duty experience gives to the viewpoint of the drugstore pharmacist on foreign cancer chemotherapy prescription 大熊祐美1, 金井良記2, 森山京英3, 石黒貴子4, 永野悠馬5, 前田守5, 長谷川佳孝5, 月岡良太5, 森澤あずさ5, 大石美也5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1014-1014, 2021.

---

	P26-26. Utilization to visualization and medication counseling by text mining and the network analysis of the word associated with the main complaint about hand-and-foot syndrome at use of anticancer agent 松浦晶子1, 山崎雅恵2, 黒金崇3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1015-1015, 2021.

---

	P26-27. The combination situation of paroxetine in the tamoxifen remedy patients 渡邉尚也1, 中島直幸2, 澤邉陽美3, 山本健士郎4, 森本真貴5, 四百刈敦子6, 片山珠季7, 永野悠馬8, 前田守8, 長谷川佳孝8, 月岡良太8, 森澤あずさ8, 大石美也8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1016-1016, 2021.

---

	P26-28. About the current situation and a problem of the calculation situation of the cancer instruction to patient management charges her cooperation full addition in our hospital 松尾昌治, 溝上和寿, 月原由華, 大野晃子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1017-1017, 2021.

---

	P26-29. A viewpoint and problem of the drugstore pharmacist for the prescription of the foreign cancer chemotherapy 森山京英1, 金井良記2, 大熊祐美3, 石黒貴子4, 永野悠馬5, 前田守5, 長谷川佳孝5, 月岡良太5, 森澤あずさ5, 大石美也5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1018-1018, 2021.

---

	P26-30. ... to think about from patients with inflection method - Palbociclib prescription of the side effect grade for the oral anticancer agent remedy patients 玉田麻利子1, 阿部真也2, 松井洸2, 山口浩2, 今野章之1, 吉町昌子2, 野村和彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1019-1019, 2021.

---

	P26-31. Usefulness of the telephone follow-up for patients with initial foreign cancer chemotherapy enforcement 上原弥未, 武由梨, 柳原桃子, 田中真紀子, 宮原奈央子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1020-1020, 2021.

---

	P26-32. Obinutuzumab, investigation about the side effect of rituximab administration expression situation 宮崎公輔, 安江諒平, 伊藤健史, 眞野翔太, 田中佳子, 井上壽江, 平下智之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1021-1021, 2021.

---

	P26-33. Making and use experience (case report) of the side effect evaluation tool of the kinase inhibitor 城守隆宏, 小野寺奈緒子, 石田千尋, 小竹未絵, 吉田綾那, 木村将綺 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1022-1022, 2021.

---

	P26-34. The current situation and problem of the specific drug management instruction addition 2 calculation utilizing the regimen at the drugstore 小原将太 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1023-1023, 2021.

---

	P26-35. Efforts (case report) of the telephone follow-up for the oral anticancer drug remedy patients in the NIHON CHOUZAI Kitasato drugstore 坪井悠太, 櫻井七恵, 伊熊恵美, 根元明子, 渡邉道代 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1024-1024, 2021.

---

	P26-36. Efforts to medicine medicine cooperation by the cooperation full addition enforcement in the cancer chemotherapy 山田健太郎, 冨山成章, 田實裕介, 松ヶ野聡美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1025-1025, 2021.

---

	P26-37. The situation of the efforts to cancer treatment of the drugstore pharmacist after the specific drug management instruction addition 2 new establishment 平井利幸, 寺門祐介, 高村優太, 秋山裕史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1026-1026, 2021.

---

	P26-38. Medication counseling to the capecitabine remedy patients using the side effect confirmation sheet 澤田千惠1,2, 中村舞1, 高橋由梨1, 中村友香理1, 中川結稀1, 生田佳澄1, 中村光希1, 菅原章弘2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1027-1027, 2021.

---

	P26-39. Attempt of the cooperation reinforcement of a health insurance pharmacy and the cancer practice cooperation base Hospital 森山健一1, 岩下知磨1, 内田貴之1, 西千春2, 佐藤みづき2, 井口有紀2, 遠山潤2, 中村初美2, 桜間啓基2, 近藤元三1,2,3, 天方奉子3, 稲葉一郎1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1028-1028, 2021.

---

	P26-40. The repair of the instruction to patient paper making database for the purpose of the effective enforcement of the cooperation full addition duties and the evaluation 入佐俊弘, 南晴奈, 岩本茉樹, 渡部仁美, 池田宗彦, 池部美緒, 落合秀樹, 島内あかり, 高比良慎, 斎藤麻美, 末次王卓, 金谷朗子, 辻敏和, 江頭伸昭, 家入一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1029-1029, 2021.

---

	P27-01. Examination about the expression situation and the antiemesis therapy of retching, vomiting in the HER2-positive inoperability with a history of the chemotherapy or T-DXd therapy for the recurrent breast cancer 足立紗知1, 北宅良祐2, 宮城和代1, 山下大輔1, 井上敦介1, 宮部貴識3, 吉野宗宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1031-1031, 2021.

---

	P27-02. Examination of the antiemetic drug in the intractable multiple myeloma regimen (D-PACE therapy) 八幡静香1, 野尻雅人1, 高田昌季1, 清水雅子1, 高瀬美咲枝2, 清木ゆう3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1032-1032, 2021.

---

	P27-03. Evaluation of the effectiveness and the economy of the antiemesis therapy standardization in the cancer chemotherapy 水津智樹, 小玉美希子, 鴨田夏実, 佃隆元, 山西香織, 田路章博, 粉川俊則 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1033-1033, 2021.

---

	P27-04. Effective evaluation of the antacids for the cisplatin-induced digestive organ symptom 谷口理1, 齋藤佳敬1, 武隈洋1, 品川尚文2, 木下一郎3, 秋田弘俊3, 菅原満1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1034-1034, 2021.

---

	P27-05. Investigation about the effect of the expression situation of nausea, vomiting in cisplatin hepatic artery chemistry embolus therapy (CDDP-TACE) and the antiemesis therapy 若松遼介1, 金子真弓1, 船田茜1, 櫻田啓介1, 宮村有貴1, 松本由香莉1, 須藤大雄1, 鈴木千波1, 小原秀治1, 柴波明男1, 樋浦一哉2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1035-1035, 2021.

---

	P27-06. Examination about the tolerability of the day after day internal use of the 5-HT3 receptor blocker in the temozolomide combination radiotherapy 關谷久美子, 原田紗希, 後藤咲香, 藤井宏典, 飯原大稔, 小林亮, 鈴木昭夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1036-1036, 2021.

---

	P27-07. Regarding adverse events and antiemetic therapy of trastuzumab deruxtecan at Osaka International Cancer Center 田中佐季, 中村さやか, 高木麻里, 藤田敬子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1037-1037, 2021.

---

	P27-08. Comparison of the antiemesis effect of granisetron and palonosetron under the NK1 receptor blocker combination on retching, vomiting with oxaliplatin 三好孝法1, 宮下裕央2, 松尾尚美2, 小田原真希2, 堀南奈子2, 平木洋一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1038-1038, 2021.

---

	P27-09. An antiemesis effect by the first generation 5-HT3 receptor blocker and NK1 receptor blocker combination on XELOX therapy and examination of the side effect 堀祐貴, 三坂恒, 嶋田努, 崔吉道 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1039-1039, 2021.

---

	P27-10. 1 case that alginate Na was effective for retching vomiting by the imatinib, but blood level of the imatinib decreased 富島喜朗, 陣上祥子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1040-1040, 2021.

---

	P27-11. Randomized controlled trial of injection site reactions of aprepitant and fosaprepitant in TC+-Bev therapy for gynecological tumors 豊里星来1, 安藤洋介1, 鳥居裕2, 市川亮子2, 伊藤佳織3, 松田日出三1, 辻井奈保1, 柘植雅大1, 島戸茜1, 藤井多久磨2, 山田成樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1041-1041, 2021.

---

	P27-12. The current situation investigation of retching, vomiting in the AI therapy for malignant soft part tumor and search of the risk factor 加藤奈波, 熊倉康郎, 山田清文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1042-1042, 2021.

---

	P28-01. One case of patients with lung cancer that baclofen was effective for hiccups to develop for anticancer medicine administration 土本美咲, 福島隆宏, 宮本佳奈, 真志田絵美子, 佐伯康之, 松尾裕彰 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1049-1049, 2021.

---

	P28-02. One case that developed bullous pemphigoid in nivolumab 出町拓也1, 川端貢司1, 北山秀則1, 早坂州生1, 竹内公美1, 木村有貴2, 渡邉昭仁2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1050-1050, 2021.

---

	P28-03. PBPM for construction and inflection of the system for the hepatitis B reactivation prevention with the cancer chemotherapy 流石智恵子1, 石橋正祥2, 小暮宗介1, 原澤秀樹1, 折井孝男3, 梅谷直亨4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1051-1051, 2021.

---

	P28-04. The signal detection of the hyponatremia in the platinum system anticancer medicine administration using JADER 畠山史朗1,2, 加藤祐太3, 丘龍祥1, 志田敏宏1, 小倉次郎1,2, 山口浩明1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1052-1052, 2021.

---

	P28-05. The study implementation situation investigation after the automatic alert system introduction for the hepatitis B reactivation prevention 西谷洋平1,2,3,4, 坂本健一1, 土井憲吾1, 西本沙央里1, 上野千奈美1, 角屋厚子2, 島川龍載3, 今井将洋4, 土井真一4, 谷口雅敏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1053-1053, 2021.

---

	P28-06. Examination about the association between immune-mediated adverse event and neutrophilic/lymphocytes ratio with the immune checkpoint inhibitor for the non-small cell lung cancer 藤本愛理1, 高武嘉道1, 木村滋1, 花田聖典1, 川俣洋生1,2, 福石和久2, 橋本雅司1, 豊川剛二3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1054-1054, 2021.

---

	P28-07. One case that infliximab was effective for immune-mediated pulmonary disorder of the steroid refractoriness 今井雄介1, 藤井良平1, 田中雅幸1,2, 冨田詩織1, 打谷和記1, 村中達也1, 谷川昇1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1055-1055, 2021.

---

	P28-08. Efforts (case report) to nausea, a vomiting expression investigation and the intervention of the oral anticancer agent in the NIHON CHOUZAI Kumamoto drugstore 粟嶋敏, 吉中愛莉, 牛島健太郎, 芥川美波, 田中純怜, 徳岡安見 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1056-1056, 2021.

---

	P28-09. Investigation about the expression of infusion related reaction with antiPD-L1 antibody pharmaceutical products 秦啓子1, 中村圭菜1, 宮本真由1, 犬飼萌乃1, 前田真一郎1,2, 前田真貴子1,3, 藤尾慈1,3, 廣部祥子1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1057-1057, 2021.

---

	P28-10. The expression of infusion related reaction situation investigation by the Pembrolizumab 中村圭菜1, 秦啓子1, 宮本真由1, 犬飼萌乃1, 前田真一郎1,2, 前田真貴子1,3, 藤尾慈1,3, 廣部祥子1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1058-1058, 2021.

---

	P28-11. Association between infusion related reaction expression and precaution at the second administration of rituximab 犬飼萌乃1, 深田耕司1, 宮本真由1, 前田真一郎1,2, 前田真貴子1,3, 藤尾慈1,3, 廣部祥子1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1059-1059, 2021.

---

	P28-12. Fact-finding - second report - of the administration cancellation by irAE of the I-O combination chemotherapy in the lung cancer 早坂州生, 岩本浩史, 北山秀則, 竹内公美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1060-1060, 2021.

---

	P28-13. It is ... mainly on research - lipid abnormality of the late adverse event after childhood cancer treatment 影山寛人1, 野井天音1, 松村泰志2, 橋井佳子3, 上田幹子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1061-1061, 2021.

---

	P28-14. We look at the rear of the raw diet irrigation of eye protective efficacy for the eye manifestation with the Ara-C massive dose therapy and study a mark 角康隆1, 緒方憲太郎1,2, 佐藤啓介1, 佐藤陽菜3, 大倉野将広1, 中島勇太4, 知念祥太郎4, 後藤真喜4, 高松泰4, 神村英利1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1062-1062, 2021.

---

	P28-15. Investigation about hydration and the adverse event expression in the cisplatin-based cancer chemotherapy 北澤沙英1, 中村真理子2, 吉見陽2,3, 肥田裕丈2,3, 宮崎雅之3, 山田清文3, 神野透人1, 野田幸裕2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1063-1063, 2021.

---

	P28-16. An example with suspected Crizotinib and competitive inhibition of the combination drug 稲毛慶子, 溝口由梨香, 枦秀樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1064-1064, 2021.

---

	P28-17. Cause analysis of the excretion delay in methotrexate large doses 金澤直子, 寺薗英之, 武田泰生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1065-1065, 2021.

---

	P28-18. Examination of the prednisolone combination significance to castration-resistant prostate cancer docetaxel therapy 鈴木貴之, 岸高久, 猪野達也, 堀部聖, 池上幸子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1066-1066, 2021.

---

	P28-19. irAE measures in the House of Prefectural University island disease 赤塚千文1, 有馬朱里1, 福山武敏1, 前田裕太1, 小田原正弥1, 中崎聖也1, 橋口雅和1, 右田裕二1, 川路智浩1, 元美江2, 柳田晶彦3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1067-1067, 2021.

---

	P28-20. The case that a drugstore pharmacist taught early self-care to for edema by the docetaxel 中野雄介1, 末次加代子2, 吉岡聖子3, 藤田あゆみ3, 杉浦伸哉3, 杉浦克典3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1068-1068, 2021.

---

	P28-21. Example that a drugstore pharmacist was able to contribute to supportive care reinforcement of the FOLFIRI therapy 田中越 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1069-1069, 2021.

---

	P28-22. Ramucirumab for the non-small cell lung cancer in our hospital, examination of the Erlotinib combination therapy case 中西大介1, 牛田浩司1, 畑地治2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1070-1070, 2021.

---

	P28-23. Example that conducted side effect early detection of elevated blood pressure, hepatic dysfunction during pazopanib tablets internal use 笹野寿基1, 吉田貴大2, 安川徹1, 伊藤智平1, 高木亜由美1, 古瀬由奈1, 山田健人1, 渡邉悠花1, 岩渕有希子1, 小玉実佳1, 横田美沙1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1071-1071, 2021.

---

	P28-24. Pharmacy pre-avoidance case for S-1 side effect lacrimation 丸尾俊博1, 浅野恭平2, 井上祥平3, 古川紗衣子4, 吉田絢5, 仙波瞳6, 片山珠季7, 永野悠馬8, 前田守8, 長谷川佳孝8, 月岡良太8, 森澤あずさ8, 大石美也8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1072-1072, 2021.

---

	P28-25. The enforcement situation of the supportive care for the hand-and-foot syndrome in the capecitabine remedy patients 田村渓1, 政本康成2, 古川紗衣子3, 中村僚宏4, 山口弘5, 常世田京子6, 永野悠馬7, 前田守7, 長谷川佳孝7, 月岡良太7, 森澤あずさ7, 大石美也7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1073-1073, 2021.

---

	P28-26. One patient who contributed to quantity of S-1 prescription adequacy in the cancer chemotherapy foreign the intervention of the drugstore pharmacist 浅野恭平1, 早笋奈美香2, 細谷晃3, 渡部貴子4, 深谷将司5, 金子裕介6, 原井厚子1, 佐藤展宏7, 永野悠馬8, 前田守8, 長谷川佳孝8, 月岡良太8, 森澤あずさ8, 大石美也8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1074-1074, 2021.

---

	P28-27. The role that pharmacists should play in outpatient cancer chemotherapy, as seen in the case of pre-avoidance of patients taking abemaciclib after the Blue Letter was issued 芳賀文香1, 古川紗衣子2, 市ノ渡真史3, 永野悠馬4, 前田守4, 長谷川佳孝4, 月岡良太4, 森澤あずさ4, 大石美也4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1075-1075, 2021.

---

	P28-28. Display of the extensive pharmacy function based on the test value of the drugstore pharmacist in the foreign cancer chemotherapy 早笋奈美香1, 緒形富雄2, 伊藤秀剛2, 岡本怜子3, 佐藤展宏4, 永野悠馬5, 前田守5, 長谷川佳孝5, 月岡良太5, 森澤あずさ5, 大石美也5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1076-1076, 2021.

---

	P28-29. The role that a drugstore pharmacist should fulfil for prevention of side effect aggravation of foreign cancer chemotherapy patients 寺腰崇志1, 青木隆1, 長久保いぶき1, 齋藤希衣1, 川井亜由葉1, 本波茉耶香1, 深井麻利1, 保坂茂2, 小山貴史3, 前田守4, 長谷川佳孝4, 月岡良太4, 森澤あずさ4, 大石美也4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1077-1077, 2021.

---

	P28-30. One case that was able to evade aggravation of stomatitis just after the Everolimus start using the prescription notebook application with the chat consultation function 八木澤恭子1, 矢部和明2, 藤田あゆみ3, 杉浦伸哉3, 杉浦克典3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1078-1078, 2021.

---

	P28-31. Look at the rear of the onset of vascular pain situation in the gemcitabine dosage form change; mark investigation 木村錦子, 松田早代, 村田政軌, 三上知佳, 岡田和也, 岡西康治, 治田匡平, 吉川一吾, 池田和之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1079-1079, 2021.

---

	P28-32. The making of the side effect evaluation tool of the oral anticancer agent and the use experience 安井法美, 坂本光次朗, 雄賀多健吾 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1080-1080, 2021.

---

	P28-33. Example that the image transmission function of the electronic notebook was useful in a judgment of the consultation encouragement 梅山克寿, 岡部未来, 佐藤芽依 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1081-1081, 2021.

---

	P28-34. One case that intervened in side effect management at CVD therapy enforcement for the malignant phaeochromocytoma 三瓶祐貴1, 奥田泰考1, 山口博紀2, 今井靖1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1082-1082, 2021.

---

	P28-35. Examination of the factor associated with the effectiveness and the effect of the zinc acetate hydrate preparation on taste disturbance at cancer chemotherapy enforcement 竹迫秀和1, 瀬戸口誠1, 堀剛2, 有馬純子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1083-1083, 2021.

---

	P28-36. The analysis of the risk factor to affect the onset of dermatopathy with the antiEGFR antibody medicine and examination about the workaround 高橋宏彰1,2, 三浦莉奈1, 山崎華1, 朝賀純一1,2, 平舩寛彦3, 氏家悠貴2,4, 松浦由紀子2, 二瓶哲2, 木村聡元5, 工藤賢三1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1084-1084, 2021.

---

	P28-37. Analysis of the risk factor of the thrombocytopenia at the Azacitidine administration for patients with myelodysplastic syndrome 安田昌宏1,2, 舘知也1,2, 大澤友裕1, 渡邉久高1, 井上誠二1, 牧野哲平1, 長屋雄大1, 森田美穂1, 田中和秀1, 田中佑佳1, 青山智1, 笠原千嗣3, 寺町ひとみ2, 水井貴詞1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1085-1085, 2021.

---

	P28-38. A factor and multicenter observational study about the treatment success period to influence the drug exposure to that mouth nib in patients with non-small cell lung cancer 梅原健吾1, 後藤桂輔2, 畠山智明3, 伊佐治麻里子4, 高田慎也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1086-1086, 2021.

---

	P28-39. It is a one case using the tolvaptan for treatment of the syndrome of inapp ADH secretion (SIADH) with the cancer of the esophagus preoperative chemotherapy 星茜1,2, 百賢二2, 山崎公靖3, 大塚耕司3,4, 青木武士3, 村上雅彦4, 佐々木忠徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1087-1087, 2021.

---

	P28-40. Adverse event investigation of the Lenvatinib administration in the unresectable hepatocellular carcinoma: Reproducible examination - first report - in a proper use assistance tool and the true clinical practice 朝岡裕樹1, 伊藤佳織2, 水野智博3, 宮本拓人1, 古川治郎1, 廣岡芳樹4, 山田成樹2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1088-1088, 2021.

---

	P28-41. The effect that the supportive care of the rash gives to treatment continuation of the Osimertinib 緒形富雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1089-1089, 2021.

---

	P28-42. See the rear about the risk factor of the cytomegalovirus infection when chemotherapy is given in the transplant non-adaptive ATLL patients; a mark investigation 津曲恭一1, 吉田裕生2, 福石和久3, 高田正温4, 川俣洋生5, 牛島知実6, 木村修徳7, 衛藤智章8, 斎田翌美9, 伊藤雄大10, 林稔展11 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1090-1090, 2021.

---

	P28-43. Search of the nourishment predicting neutropenia of the breast cancer FEC therapy and inflammatory marker ratio 中村俊貴1, 左右田和枝1, 松原肇1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1091-1091, 2021.

---

	P28-44. Case experience corresponding to the immune-mediated dermatopathy of the Pembrolizumab treated patients who complicated various skin disease 吉成宏顕1, 橋本竜1,2, 風岡真実1, 高岡栄一郎3, 佐藤淳也1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1092-1092, 2021.

---

	P28-45. Usefulness of the neutrophilic lymphocyte counts ratio as the predictor of the febrile neutropenia onset 熊澤里美1,2, 水野智博2, 村松直幸1,2, 古関竹直2, 松岡宏3, 須田康一3, 宇山一朗3, 山田成樹3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1093-1093, 2021.

---

	P28-46. Fact-finding of serum zinc levels and the taste disturbance in the treatment with 5FU system anticancer agent 戸塚孝治1, 田畑真一1, 高橋威洋2, 市川度2, 新井成俊1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1094-1094, 2021.

---

	P28-47. The effect that presence or absence of antidiarrheal drug, medicine for intestinal disorders combination prescription in the S-1 remedy patients gives to treatment continuation 村上紘世1, 田中直也2, 緒形富雄3, 片山珠季4, 永野悠馬5, 前田守5, 長谷川佳孝5, 月岡良太5, 森澤あずさ5, 大石美也5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1095-1095, 2021.

---

	P28-48. The effect that presence or absence of moisturizer combination prescription in the capecitabine remedy patients gives to treatment continuation 田中直也1,2,3,4,5, 村上紘世2, 緒形富雄3, 片山珠季4, 永野悠馬5, 前田守5, 長谷川佳孝5, 月岡良太5, 森澤あずさ5, 大石美也5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1096-1096, 2021.

---

	P28-49. Examination about the use of Palbociclib and the Abemaciclib which we saw from the viewpoint of side effect 中務ひとみ1, 高橋正也1, 高橋克之1, 高島勉2, 浅野有香2, 森崎珠実2, 柏木伸一郎2, 野田諭2, 中村安孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1097-1097, 2021.

---

	P28-50. Association of peripheral neuropathy and the taste disturbance in patients who received oxaliplatin 河端真以, 田本光莉, 猪谷朱理, 久保萌美, 金澤沙衣, 蝦名勇樹, 村上智香, 晴山知拓, 石田陽美, 三本松泰孝, 佐藤弘康, 田村広志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1098-1098, 2021.

---

	P28-51. Search of the test value that is useful in side effect investigation of the nivolumab in the second treatment of the renal carcinoma and the early detection of the immune-mediated side effect 石田優理香1, 高崎新也1, 安藤咲弥香1, 諸角謙人2, 川崎芳英2, 前川正充1, 伊藤明宏2, 眞野成康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1099-1099, 2021.

---

	P28-52. One case of the breast cancer that was able to accomplish dose-dense AC therapy by the intervention of the pharmacist safely 石川雄大, 谷道あかり, 高橋則正, 格谷美奈子, 加藤敦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1100-1100, 2021.

---

	P28-53. The osteoporosis therapeutic drug combination situation of the Abiraterone remedy patients 塩野美友紀1, 三宅祥太2, 小山貴史3, 永野悠馬4, 前田守4, 長谷川佳孝4, 月岡良太4, 森澤あずさ4, 大石美也4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1101-1101, 2021.

---

	P28-54. Examination of effect of treatment and the side effect of the IsaPd therapy for a recurrence, the intractable multiple myeloma 西村直朗, 柿原圭佑, 吉国健司, 小倉秀美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1102-1102, 2021.

---

	P28-55. One case that an antihistamine succeeded for hypersensitivity by the etoposide 寺坂裕希, 高野温志, 高野明香, 井上朋子, 伊賀正典, 町田充 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1103-1103, 2021.

---

	P28-56. Effect of the pharmacist intervention to give to the hand-and-foot syndrome of the capecitabine internal use patients 高橋恭平1, 福長豊己1, 森川記道1, 堀越友太1, 大山展弘1, 西倉教子1, 原田靖子1, 西原昌幸2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1104-1104, 2021.

---

	P28-57. Look at the rear about the use of the peg filgrastim in the adjuvant chemotherapy after the lung cancer technique; mark investigation 佐多照正1, 末永尚輝1, 八汐祥恵1, 堀ノ内志織1, 堀内智裕1, 鶴永大貴1, 中村有莉恵1, 赤星真広1, 上原友美1, 池増鮎美1, 大塚綱志2, 西島浩雄2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1105-1105, 2021.

---

	P28-58. One case of patients with lung cancer that caused sigmoid diverticulum perforation during Cisplatin+Vinorelbine radiation combination chemotherapy treatment 池下智之, 角川幸男, 野崎圭佑, 清水克次, 井上聡子, 高木麻里, 藤田敬子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1106-1106, 2021.

---

	P28-59. The use situation and side effect report of the Lenvatinib in the Fukuoka Red Cross hospital 大石瑞紀, 川野昭, 大石裕樹, 福重昇吾, 杉慎介, 藤永理恵子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1107-1107, 2021.

---

P28-60. See the rear about the effect accompanied with changes from the first generation of the antihistamine which is the hypersensitivity reaction prevention in the cancer medical therapy to second generation; a mark investigation 柿本秀樹1, 大倉野将広1, 長郷あかね2, 内山将伸3, 川田哲史1, 真島宏太1, 角康隆1, 井上竜一1, 五十嵐保陽1, 武田佳子1, 池内忠宏1, 兼重晋1, 緒方憲太郎1,2, 神村英利1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1108-1108, 2021.

---

	P28-61. The use actual situation of the Pembrolizumab in the non-small cell lung cancer and safe examination 藤本亜弓1, 石坂崚1, 山崎直樹1, 吉田徹也2, 中尾將彦1, 駄賀晴子3, 森宏幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1109-1109, 2021.

---

	P28-62. Comparison of the diuretic tolerability with mannitol in the cancer of the esophagus FP (5-Fu+ cisplatin) therapy or furosemide 北本真一, 白木政博, 古谷智裕, 村上礼隆, 佐藤実由, 金田公平, 宮森伸一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1110-1110, 2021.

---

	P28-63. Possibility of the protection effect with a risk factor and renin-angiotensin axis antihypertensive medications of the onset of proteinuria in patients with Axitinib remedy nephrocyte cancer 山岡健太1, 池末裕明1, 松本彩子1, 平畠正樹1, 室井延之1, 山崎俊成2, 川喜田睦司2, 橋田亨1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1111-1111, 2021.

---

	P28-64. The difference in Carboplatin doses calculation method and relative examination of the thrombocytopenia 松浦徹, 與田賢作, 田中博和, 矢野洋平, 内山有理香, 奥野美和, 平川雅章, 渡邊裕之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1112-1112, 2021.

---

	P28-65. Examination about the febrile neutropenia onset risk after the peg filgrastim administration using JADER 宗岡祐輔, 小山勝真, 伊藤麻結, 幸田恭治, 北原隆志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1113-1113, 2021.

---

	P28-66. It is fact-finding of the febrile neutropenia in the docetaxel/5-fluorouracil/cisplatin therapy in becoming it peg filgrastim combination 松坂章也1, 橋詰淳哉1, 中川博雄1, 原澤仁美1, 中村忠博1, 小林和真2, 佐々木均1, 兒玉幸修1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1114-1114, 2021.

---

P28-67. Examination of the protective efficacy of the febrile neutropenia with administration of G-CSF preparation within 24 hours after the end of the administration in the cancer of the esophagus DCF therapy and the administration of antimicrobial 倉橋真弓1, 鎌田宏和1, 清水克次1, 高木麻里1, 辰見明俊2, 藤田敬子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1115-1115, 2021.

---

	P28-68. About effect on onset of febrile neutropenia in the combination therapy of the small cell lung cancer of immunity 八尾尚樹, 鎌倉政城, 竹内結香, 橋本智咲, 大堀健史, 近野祐里, 美濃部奈都, 庄司高明, 鍬田千草, 中村直美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1116-1116, 2021.

---

	P28-69. Acute nephropathic evaluation associated with the anticancer medicine used in the stomach cancer in the adverse drug reaction database 内田まやこ1,2, 高野碧2, 近藤悠希3, 鈴木真也4, 細畑圭子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1117-1117, 2021.

---

	P28-70. Examination of the risk factor of the hypertensive expression with the pazopanib hydrochloride 國武正幸, 後藤綾, 酒井義朗, 樋口恭子, 三輪涼子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1118-1118, 2021.

---

	P28-71. Examination of the hepatic dysfunction risk factor with the pazopanib hydrochloride 後藤綾, 國武正幸, 酒井義朗, 樋口恭子, 三輪涼子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1119-1119, 2021.

---

	P28-72. Effect on protective efficacy by the magnesium oxide combination of the minocycline for the purpose of the acneform rash prevention in the colon cancer antiEGFR antibody therapy 小柴郁1, 渡部大介1, 大塚亮1, 橋本浩伸1, 齋藤義正1, 石川光信1, 赤木徹1, 山口正和2, 古川哲也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1120-1120, 2021.

---

	P28-73. Use fact-finding of the peg filgrastim in our hospital 谷道あかり, 石川雄大, 高橋則正, 格谷美奈子, 加藤敦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1121-1121, 2021.

---

	P28-74. The onset of dysfunction thyroid situation investigation with the immune checkpoint inhibitor 若井香鈴, 平手大輔, 今多亮介, 本郷文教 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1122-1122, 2021.

---

	P28-75. About effect on renal function by the combination of bortezomib and aciclovir 今多亮介, 平手大輔, 若井香鈴, 大森悠翔, 本郷文教 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1123-1123, 2021.

---

	P28-76. The change of the eosinophil count becomes the useful biomarker predicting the immune-mediated adverse event with the immune checkpoint inhibitor 奈良克彦, 苅谷嘉顕, 雨宮貴洋, 鈴木洋史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1124-1124, 2021.

---

	P28-77. Examination about the onset of neutropenia in patients who received cisplatin + vinorelbine combination therapy 村山三佳, 丹羽洋介, 竹内佐織, 千崎康司, 山田清文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1125-1125, 2021.

---

	P28-78. 1 case of the sensitivity hepatic portal region cholangiocarcinoma which was able to continue gemcitabine + cisplatin therapy by having taken measures 金本卓1, 藤田強記2, 田中誠1, 中川義浩3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1126-1126, 2021.

---

	P28-79. Examination about the risk factor of the taxane origin-related acute pain syndrome under the dexamethasone prophylaxis 坂本達彦1, 齋藤佳敬1, 武隈洋1,2, 小林正紀1,3, 山下啓子4, 菅原満1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1127-1127, 2021.

---

	P28-80. Exhaustive fixed-quantity evaluation of the patients quality of life by the pharmaceutical intervention to supportive care in the foreign cancer chemotherapy 上田祐稀乃1, 藤井宏典1,2, 廣瀬智恵美2, 大畑紘一2, 飯原大稔1,2, 鏑木美帆3, 松橋延壽4, 高橋孝夫5, 吉田和弘6, 鈴木昭夫1,2, 林秀樹1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1128-1128, 2021.

---

	P28-81. Example that conducted antihypertensive agent adjustment for the high blood pressure that occurred after the Cabozantinib introduction, and was a treatment continuation possibility 末松耕輔1, 黒部健太郎1, 宮原強1, 水田秀貴1, 佐野雅彦1, 徳永晃1, 平井良樹2, 諸隈太2, 草葉一友1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1129-1129, 2021.

---

	P28-82. The zinc level measurement of the patients who reported dysgeusia during chemotherapy and examination of the supplementary usefulness 伊東真由子1, 野原真吾1, 中村知子1, 山本和宜1, 瀬山厚司2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1130-1130, 2021.

---

	P28-83. Examination about the effect of the renal function on immune-mediated adverse event of the immune checkpoint inhibitor in urologic cancer 仲野宏紀1, 宮城和代2, 江原美里2, 山本友佳子2, 井上敦介2, 宮部貴識3, 山内一恭4, 福田利明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1131-1131, 2021.

---

	P28-84. 2 cases that we introduced dabrafenib+trametinib combination therapy into as initial treatment for the unresectable progress non-small cell lung cancer with the BRAF V600E mutation in the gene 成田綾香1, 西辻雅2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1132-1132, 2021.

---

	P28-85. Is the pattern of the UGT1A1 genetic polymorphism predictable by a total serum bilirubin level? 鈴川悠利愛, 福井梨乃, 槙原克也, 松村友和 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1133-1133, 2021.

---

	P28-86. Urine qualitative analysis in Bevacizumab-related proteinuria and correlative evaluation of UPCR 鈴木直哉, 山田将悟, 藤林遼, 菊地義明, 高橋誠, 青田忠博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1134-1134, 2021.

---

	P28-87. Side effect of family pharmacist measures of the cancer medical therapy using the nonprescription drug (case report) 正岡麻里 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1135-1135, 2021.

---

	P28-88. Attempt to neutropenic risk assessment of irinotecan by the classification of total bilirubin levels and the UGT1A1 genetic polymorphism 福井梨乃, 鈴川悠利愛, 槙原克也, 松村友和 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1136-1136, 2021.

---

	P28-89. See the rear about the neutropenic expression risk factor of Grade3/4 in patients with breast cancer given eribulin; a mark investigation 高山俊輔1, 高山裕樹1, 松浦一生2, 牧野好倫1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1137-1137, 2021.

---

	P28-90. modified Glasgow prognostic score (mGPS) in colon cancer adjuvant chemotherapy patients and investigation of the survival period 西和哉1, 川田彰彦1, 高橋舞1, 佐々木崇1, 佐賀利英1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1138-1138, 2021.

---

	P28-91. About the effectiveness of mirogabalin and duloxetine for peripheral neuropathy that gynecologic TC therapy causes compare it directly 馬場華菜, 谷口潤, 尾之江剛樹, 山形真一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1139-1139, 2021.

---

	P28-92. Examination of the telephone follow-up using the tracing report for exclusive use of S-1 田村知子1, 都和彦2, 吉岡睦展3, 近藤万友美3, 澁谷奈穂3, 若松雄太3, 細見真世3, 高子優子3, 小溝優子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1140-1140, 2021.

---

	P29-01. Usefulness of polypharmacy measures based on request for medicine that it decreased by it of patients in the palliative care unit 村上翔梧, 野村剛久, 佐古守人, 大西美香 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1144-1144, 2021.

---

	P29-02. Dose investigation at opioid preparation change in our hospital inpatient 田口諒, 元木孝, 澁谷基宏, 渡邊清人, 高柳昌宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1145-1145, 2021.

---

	P29-03. One case of patients with rectal cancer that we conducted pain control with high-dose hydromorphone hydrochloride tablets 増田博也, 間千晴, 佐々木健志, 澤口友紀, 井上萌, 坪田美風, 久岡清子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1146-1146, 2021.

---

	P29-04. Fact-finding of the use of nonopioid pain-killer at opioid introduction of our hospital 稲田佑亮, 立石朝子, 小倉絵里奈, 山下敦志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1147-1147, 2021.

---

	P29-05. Efforts of the proper use promotion of the antiemetic drug for opioid-induced retching, vomiting utilizing the set prescription and the evaluation 杢保貴幸, 浜田真由子, 宮本彩, 徳竹裕貴 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1148-1148, 2021.

---

	P29-06. Fact-finding survey regarding bisphosphonate injection drugs and dental consultations before first administration of denosumab in cancer patients 市原英則, 松田璃沙, 塚原優太, 中澤誉, 別府博仁, 丸山直岳, 土井敏行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1149-1149, 2021.

---

	P29-07. Examination of the night delirium and sleep agent medication situation in our hospital palliative care unit 松岡未紗, 森戸敏志, 後藤義之, 角紀一郎, 岡田久美, 古本真由美, 茶野下貴恵, 島崎沙織, 青木理恵, 清水翔子, 梅下翔, 西川達也, 室田恵里, 橋本夏恵, 山下陽夏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1150-1150, 2021.

---

	P29-08. Investigation about the effect to give renal function at the NSAIDs introduction 枝廣茂樹, 松波寿雄, 大川浩子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1151-1151, 2021.

---

	P29-09. A comparison of the frequency of retching, vomiting at tramadol and oxycodone start and search of the risk factor 村上はる香, 澤昇平, 栗原啓輔, 飯塚美有, 古橋侑樹, 辻村行啓, 清水真弓, 荒川大輔, 山本圭祐, 矢部勝茂 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1152-1152, 2021.

---

	P29-10. About the interaction of the use of opioid preparation patients in the metropolitan east of the Sumida River hospital 黒木あかね1, 高木茂実1, 櫻井琴乃2, 太田博暁2, 丸藤義翔2, 白石麻由子2, 野村有加2, 安武夫2, 城田幹生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1153-1153, 2021.

---

	P29-11. Efforts for the opioid weight loss in palliative care rounds 岩田一史, 合澤啓二, 土屋惠菜, 小野達昌, 陣上祥子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1154-1154, 2021.

---

	P29-12. The case that improved pain control and the compliance of patients with at-home cancer in cooperation with other types of job 鎌滝真永 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1155-1155, 2021.

---

	P29-13. One case that the combination of the pain-killer was effective for Mohs ointment measures postoperative pain of the progress breast cancer 石坂真理1, 高木彩菜1, 長谷川章1, 早川裕二1, 間瀬広樹1, 生野仁美2, 川端康次3, 加藤浩充1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1156-1156, 2021.

---

	P29-14. With this (drug for the medical care), can you go to Singapore? 藤村昭太1, 荒川昌史1,4, 野田達也1, 櫻木雅子2, 赤津理恵3, 清水敦4, 黒崎史朗4, 竹内瑞枝4, 丹波嘉一郎4, 今井靖1,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1157-1157, 2021.

---

	P29-15. About association with polypharmacy and the delirium before and after the palliative care unit hospitalization 野澤(石井)玲子1, 相沢健太1, 菅野智2, 荒井進3, 稲葉裕4, 加賀谷肇5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1158-1158, 2021.

---

	P29-16. The use of opioid situation at head and neck cancer chemoradiotherapy enforcement in our hospital 林良亮, 江尻将之, 春日井悠司, 竹内正幸, 大西正文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1159-1159, 2021.

---

	P29-17. 1 case that it came to have difficulty with opioid analgesic remedy, and withdrawal sign appeared during chemotherapy 藤原麻衣1, 森脇崇1, 志方優子2, 井上敬之1, 中城宏子1, 岩崎輝夫3, 老田章1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1160-1160, 2021.

---

	P29-18. One case that combination of the agate Pross ton was useful in the constipation that accompanied oxycodone increase in quantity 宮田香織1, 渡部誠士2, 藤田あゆみ3, 市川隆之4, 杉浦伸哉3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1161-1161, 2021.

---

	P29-19. The use situation of the constipation therapeutic drug for the use of opioid patients in our hospital inpatient 山野邉裕子1, 田村賢士1, 金子智一1, 金子誠1, 寺田伊知郎1, 立花栄三1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1162-1162, 2021.

---

	P29-20. Use experience of hydromorphone at severe impaired renal function 佐藤和文, 船水祐里, 和賀信継, 佐山英明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1163-1163, 2021.

---

	P29-21. Condition assessment reinforcement and improvement in medical treatment (the third report) by the Audit System introduction for patients with cancer 淡路健作, 深尾彰平, 阿部路, 竹下絵梨香, 近藤匡慶, 菅谷量俊, 高瀬久光 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1164-1164, 2021.

---

	P29-22. 1 case that Kambakutaisoto was effective for pain of the opioid refractoriness 戸島心1, 角川幸男1, 神農理衣1, 西馬怜1, 迫田由佳梨1, 高木麻里1, 池田和世2, 藤田敬子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1165-1165, 2021.

---

	P29-23. Use fact-finding of the laxative for the opioid-induced constipation (OIC) 三松史野, 實光由香, 佐分利美帆子, 内藤舞, 村岡淳二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1166-1166, 2021.

---

	P29-24. 1 case that a midazolam injection was effective for sufferings from treatment-resistant breathing 石川敬祐, 伊藤慎二, 磯貝潤一, 石川沙矢香 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1167-1167, 2021.

---

	P29-25. Examining the pain relief effect of combined use of strong opioid injection and tramadol hydrochloride injection 伊藤慎二, 石川敬祐, 磯貝潤一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1168-1168, 2021.

---

	P29-26. 1 case that was able to reduce opioid by opioid switching for the use of high-dose opioid patients appropriately 竹田優作, 吉田昌子, 江崎宏樹, 大島有美子, 堀田敏之, 桜田宏明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1169-1169, 2021.

---

	P29-27. We look at the rear about the usefulness of the naldemedine prophylaxis to oxycodone-induced constipation and study mark Pilot 折笠瞬, 槙原克也, 嶽小原恵, 松野優紀, 松村友和 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1170-1170, 2021.

---

	P29-28. The current situation of the opioid switch to a morphine hydrochloride note and safe inspection 大池貞治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1171-1171, 2021.

---

	P29-29. The effectiveness of the Lidocain continuous intravenous infusion for the cancerous pain 原田沙枝子, 林洋平, 櫻井美由紀, 鹿間良弥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1172-1172, 2021.

---

	P29-30. Effect of the background factor giving it to the effectiveness of the delirium therapeutic drug of patients who received palliative care 佐藤淳也1,2, 梅田鈴香1,2, 塚越真由美2,3, 山田祐2,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1173-1173, 2021.

---

	P29-31. Confirmation of an effect of the naldemedine and the effect on retching and pain 渡部寿康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1174-1174, 2021.

---

	P29-32. One case of patients with gastric cancer which we changed from a buprenorphine patch to an oxycodone sustained injection 大内竜介1,2, 薄井健介1,2, 倉田奈央子2, 鈴木清寿3, 長尾宗紀3, 児山香3, 岡田浩司1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1175-1175, 2021.

---

	P29-33. The case that hydrozincite starch ad usum externum therapy was effective for breast cancer skin permeation 山崎美保1, 福田結彩1, 木村竜司1, 馬屋原慈理1, 一瀬貴史1, 二井久美2, 高橋護3, 面田恵1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1176-1176, 2021.

---

	P29-34. Investigation about the use of fen toss tape (R) for the cancerous pain to opioid naive patients in our hospital 奥津雄人1, 江原純也1, 立田真也1, 矢野有紀2, 高橋尚子2, 細谷治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1177-1177, 2021.

---

	P29-35. Investigation about the effectiveness and the safety of the morphine for a feeling of dyspnea in patients with cancer and non-cancer 内海尊雄1,2, 大久保正人1,2, 須藤知子1,2, 中村貴子2, 鈴木貴明2, 田口奈津子1,3, 石井伊都子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1178-1178, 2021.

---

	P29-36. The role that the pharmacist fulfils in the medical care, the care in the final stage of the life 岩崎章吾 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1179-1179, 2021.

---

	P29-37. 1 case that we made changes from sustained subcutaneous injection of the hydromorphone hydrochloride to internal use in the home care patient 原田寿1, 犬飼浩子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1180-1180, 2021.

---

	P29-38. The case that a drugstore pharmacist prevented overdose at a route of administration change of the opioid 丸一泰雅, 折戸真澄, 藤丸知佳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1181-1181, 2021.

---

	P29-39. The at-home return in the palliative care unit admission patients and survival period comparison by the palliative care unit medical treatment 吉田健人1, 田辺公一1, 村上望2, 中嶋和仙3, 酒井隆全1, 大津史子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1182-1182, 2021.

---

	P29-40. It is an example corresponding to the taking pain-killer difficulty in the childhood at-home mild medical care 辻裕太 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1183-1183, 2021.

---

	P29-41. It is ... for improvement in knowledge about the medical drug of questionary survey - inside the hospital staff in the palliative care class in inside the hospital 細田奈七恵, 松本晃一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1184-1184, 2021.

---

	P29-42. Construction of the system for the inpatient drug self-care introduction 水谷彰史1, 久保淳一2, 高取士剛2, 高木明彦3, 板橋理絵4, 坂本健一3, 飛澤国広3, 鈴木千波1, 佐藤公人3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1185-1185, 2021.

---

	P30-01. Investigation of doubt inquiry for the outside Parliament prescription of patients with cancer utilizing the clinical test value 仲尾洋子, 土井千亜紀, 森雅也, 三浦尚子, 良玄朋子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1191-1191, 2021.

---

	P30-02. Examination of the factor having an influence on the treatment continuation of the S-1 monotherapy in the adjuvant chemotherapy after the pancreatic cancer technique 野口裕介1, 加藤良隆1, 大坪達弥1, 鹿浦香織1, 神田英一郎1, 小林大祐1, 眞釼彩子1, 江島智彦1, 豕瀬諒2, 村木優一2, 友金幹視1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1192-1192, 2021.

---

	P30-03. The current situation and problem of the cooperation full addition calculation in the foreign chemotherapy room 西上依里, 合澤啓二, 小野達昌, 岩田一史, 陣上祥子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1193-1193, 2021.

---

	P30-04. Fact-finding about the pharmacist duties of the cancer domain in the cancer practice cooperation base Hospital, and the like under the COVID-19 outbreak 櫻井洋臣1, 川澄賢司2, 佐々木駿一1, 脇本麻美3, 餅原弘樹4, 飯塚雄次5, 内坪敬太6, 田島亮7, 本田泰斗8, 石原由起子9, 濃沼政美10, 近藤直樹11, 青森達1,12 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1194-1194, 2021.

---

	P30-05. About the use situation of the CDK4/6 inhibitor in our hospital 長谷川豊則1,2, 窪田智行2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1195-1195, 2021.

---

	P30-06. The PBPM operation situation investigation associated with the cancer medical therapy in our hospital 羽生智宏, 尾形美絵, 近藤和宏, 中村槙一郎, 瀧内瑛輔, 長澤欣弘, 新関みどり, 田村和彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1196-1196, 2021.

---

	P30-07. The effect of menthol on doxorubicin killing effect with human liver cancer HepG2 cells: Possibility of the participation of the P-glycoprotein 長井克仁1, 内野友実子1, 瀬原菜津子1, 田畑竜也2, 山本洋平2, 福野修平1, 小西廣己1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1197-1197, 2021.

---

	P30-08. Investigation of the factor about interruption, cancellation during the Durvalumab dosing period in patients with non-small cell lung cancer 樋口純一, 益本周治, 高柳和伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1198-1198, 2021.

---

	P30-09. Look at the rear of the side effect of sunitinib in renal carcinoma first treatment and pazopanib; a mark investigation 安藤咲弥香1, 高崎新也1, 石田優理香1, 諸角謙人2, 川崎芳英2, 前川正充1, 伊藤明宏2, 眞野成康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1199-1199, 2021.

---

	P30-10. About safety of VEGF inhibitor and the anticoagulant combination in patients with cancer with the thromboembolism 阿部多一, 住谷達也, 林哲哉, 井口恵美子, 猪股克彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1200-1200, 2021.

---

	P30-11. Examination of drug continuation advisability when we used the UPC ratio as an evaluation standard of proteinuria in the bevacizumab administration for colon cancer and the tolerability 柴崎七海1, 金素安1, 大貫奏1, 太田茜1, 立沢正臣1, 宮野省三2, 須郷広之2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1201-1201, 2021.

---

	P30-12. Relative examination of the nutrition index and side effect expression in the EPOCH (-R) therapy and blood corpuscle ingredient ratio 菊池健1, 三坂陽菜2, 武田元樹1, 相馬貴史1, 鶴山辰1, 佐藤秀紀2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1202-1202, 2021.

---

	P30-13. Drug-drug interaction between ixazomib/lenalidomide/dexamethasone (IRd) therapy and antacids - Possibility of attenuating the antitumor effect of IRd therapy - 北澤文章1, 中山優子3, 高良恒史4, 佐原敏之2, 辻川正彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1203-1203, 2021.

---

	P30-14. Blood drug concentration analysis of the case that used clarithromycin together during hippopotamus diTaki cell administration 勝見重昭1,2, 八島秀明1, 荒木拓也1,2, 宮澤慶行3, 鈴木和浩3, 山本康次郎1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1204-1204, 2021.

---

	P30-15. Approach of the dose confirmation with the capecitabine inspection support paper in the health insurance pharmacy 吉田貴大1, 辻真利4, 山田裕介1, 笹野寿基2, 竹原美穂2, 安川徹2, 西阪宏彰3, 辻宗一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1205-1205, 2021.

---

	P30-16. Investigation of the effect of the liver spare function to give the effectiveness of the paclitaxel 松田燦徳, 澤昇平, 北畠千種, 松川陽央, 都甲海, 山本圭祐, 矢部勝茂 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1206-1206, 2021.

---

	P30-17. The effectiveness of the gemcitabine + docetaxel combination therapy as the postoperative chemotherapy for the uterine leiomyosarcoma and safe examination 仁井寛彦1, 片山健太郎1, 後藤千尋1, 今村牧夫2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1207-1207, 2021.

---

	P30-18. To offer cancer treatment reliable safely to the area 小野貴光 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1208-1208, 2021.

---

	P30-19. Good use of HBV infection screening - screening template (the fourth report) ... in the cancer chemotherapy 勝山繁佳1, 大久保真貴1, 渡邊雅明1, 中島正人1, 細野智美1, 土岐浩介1, 関根郁夫2, 本間真人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1209-1209, 2021.

---

	P30-20. Questionary survey about the evaluation of the cooperation (Kagoshima cancer immune therapy support network: KISNet) between institutions for the irAE management reinforcement 松尾圭祐1, 鳥山陽子2, 谷本憲哉2, 谷口潤2, 平木洋一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1210-1210, 2021.

---

	P30-21. Evaluation of the quantity of S-1 prescription for the estimated renal function of foreign cancer chemotherapy patients 玉木麗花1, 伊藤学2, 竹村健志3, 永野悠馬4, 前田守4, 長谷川佳孝4, 月岡良太4, 森澤あずさ4, 大石美也4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1211-1211, 2021.

---

	P30-22. Consideration about the expiration date for use setting for Drug Vial Optimization introduction 濱宏仁1,2, 平畠正樹2, 池末裕明2, 室井延之2, 橋田亨2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1212-1212, 2021.

---

	P30-23. Investigation of an effect contracted at the preparation time by the agent type change to a bendamustine solution and the cost cut effect 種村繁人, 冨田敦和, 今井邦行, 小玉幸与, 今西忠宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1213-1213, 2021.

---

	P30-24. It is a one case receiving the Osimertinib using the suspension method simple for patients with lung cancer with the oesophageal stenosis 江島智彦1, 松本有咲1, 古池志織1, 加藤良隆1, 大坪達弥1, 野口裕介1, 神田英一郎1, 岡橋孝侍1, 藤田敦夫1, 谷望未2, 竹田隆之2, 友金幹視2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1214-1214, 2021.

---

	P30-25. The treatment continuation situation in the foreign cancer chemotherapy of the women using the cyclin-dependent kinase inhibitor 金井良記1, 大熊祐美2, 古川紗衣子3, 石黒貴子4, 永野悠馬5, 前田守5, 長谷川佳孝5, 月岡良太5, 森澤あずさ5, 大石美也5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1215-1215, 2021.

---

	P30-26. Prescription trend of the oral anticancer agent used by the outpatient department cancer chemotherapy of male elderly people 三宅祥太1, 塩野美友紀2, 黒川由紀子3, 永野悠馬4, 前田守4, 長谷川佳孝4, 月岡良太4, 森澤あずさ4, 大石美也4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1216-1216, 2021.

---

	P30-27. The treatment continuation situation in the foreign cancer chemotherapy using the pyrimidine system antimetabolite fluoride 田村真哉1, 津村直孝2, 正野隆3, 松野紀世彦4, 永野悠馬5, 前田守5, 長谷川佳孝5, 月岡良太5, 森澤あずさ5, 大石美也5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1217-1217, 2021.

---

	P30-28. One case of colon cancer which caused chronic thrombocytopenia by oxaliplatin-related splenomegaly and liver damage 倉田玲奈1,2, 信岡祐2, 小島朋大1, 佐藤賛治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1218-1218, 2021.

---

	P30-29. Case of pharmacy pre-avoidance of epidermal growth factor receptor tyrosine kinase inhibitors for skin disorders 伊藤学1, 芳賀文香2, 吉田亜紀2, 中村聡3, 森田晃子4, 原井厚子5, 玉木麗花6, 竹村健志7, 永野悠馬8, 前田守8, 長谷川佳孝8, 月岡良太8, 森澤あずさ8, 大石美也8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1219-1219, 2021.

---

	P30-30. Starting doses design and examination about optimum doses based on the prescription situation of trifluridine Tipiracil hydrochloride combination tablets 小中健1,2, 斉藤辰彦1,2, 伊藤祥子1,2, 森本美由樹2,3, 黒田武志4, 都築大輔1, 伏谷秀治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1220-1220, 2021.

---

	P30-31. The treatment continuation situation in the foreign cancer chemotherapy using the aromatase inhibitor 正野隆1, 津村直孝2, 田村真哉3, 松野紀世彦4, 永野悠馬5, 前田守5, 長谷川佳孝5, 月岡良太5, 森澤あずさ5, 大石美也5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1221-1221, 2021.

---

	P30-32. The treatment continuation situation in the foreign cancer chemotherapy using the tyrosine kinase inhibitor 津村直孝1,2,3,4,5, 田村真哉2, 正野隆3, 松野紀世彦4, 永野悠馬5, 前田守5, 長谷川佳孝5, 月岡良太5, 森澤あずさ5, 大石美也5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1222-1222, 2021.

---

	P30-33. We support the medication on the nourishment side in adjuvant chemotherapy S-1 alone after the stomach cancer technique continuously 安川徹1,2, 笹野寿基1, 伊藤智平1, 高木亜由美1, 古瀬由奈1, 吉田貴大2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1223-1223, 2021.

---

	P30-34. The effectiveness, safe examination of the immune checkpoint inhibitor in patients with old non-small cell lung cancer 宮下裕央1, 三好孝法2, 松尾圭祐1, 堀南奈子1, 松尾尚美1, 平木洋一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1224-1224, 2021.

---

	P30-35. With the skill necessary for the drugstore pharmacist corresponding to patients receiving foreign cancer chemotherapy 秋山真衣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1225-1225, 2021.

---

	P30-36. Analysis (as part of reduction of the drug-related near miss) of anticancer agent-related doubt inquiry contents in our hospital 石崎文子, 相原敏彦, 増尾昌則 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1226-1226, 2021.

---

	P30-37. 3 cases that chills, fever developed after the oxaliplatin administration 里見眞知子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1227-1227, 2021.

---

	P30-38. The effectiveness, safe examination of the mycophenolate mofetil for the steroid-resistant irAE liver damage 藤田敬子, 角川幸男, 野口大倭, 西馬怜, 木村美甫, 池下智之, 野崎圭佑, 高橋幸三, 鎌田宏和, 清水克次, 高木麻里 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1228-1228, 2021.

---

	P30-39. The statin preparation combination situation of the aromatase inhibitor remedy patients 山口弘1, 田村渓2, 政本康成3, 常世田京子4, 永野悠馬5, 前田守5, 長谷川佳孝5, 月岡良太5, 森澤あずさ5, 大石美也5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1229-1229, 2021.

---

	P30-40. The enforcement situation of the supportive care for the osteoporosis accompanied with the use of aromatase inhibitor 青木香奈1, 丸尾俊博2, 井上祥平3, 片山珠季4, 永野悠馬5, 前田守5, 長谷川佳孝5, 月岡良太5, 森澤あずさ5, 大石美也5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1230-1230, 2021.

---

	P30-41. Relation of the pharmacist to the patients whom hepatic dysfunction developed in by the immune therapy for unresectable hepatocytes cancer 臼井孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1231-1231, 2021.

---

	P30-42. "The reactivation measures of HBV with the chemotherapy" are possible by the intervention of the pharmacist to here! 森井悠介1,3, 田井浩子1, 松井駿亮1, 山口唯1, 近谷仁志1, 大河万顕1, 阪口紀子1, 入潮佳子2, 西田升三3, 下村一徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1232-1232, 2021.

---

	P30-43. Effect to give to renal function of the gemcitabine + cisplatin therapy in the biliary cancer 冨山成章, 山田健太郎, 田實裕介, 松ヶ野聡美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1233-1233, 2021.

---

	P30-44. One case that produced immune thrombocytopenic purpura (ITP) by Durvalumab 永井道雄1, 岩本里味1, 辰巳真穂1, 松浦暢子1, 神山知也1, 藤井元1, 米田航佑1, 堀朱矢2, 北山翠3, 山根隆志3, 石坂忠博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1234-1234, 2021.

---

	P30-45. The effect that the administration of proton pump inhibitor gives to a vital prognosis on patients with metastatic or unresectable urothelium cancer which received Pembrolizumab therapy 國光葉子1, 森尾佳代子1, 平田佐智1, 山本和宏1, 大村友博1, 原琢人2, 原田健一2, 藤澤正人2, 矢野育子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1235-1235, 2021.

---

	P30-46. Comparison of the side effect of pleural effusion retention expression of pemetrexed situation 大野裕之, 田中佳子, 関谷泰明, 井上壽江, 平下智之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1236-1236, 2021.

---

	P30-47. Examination of the usefulness of the elderly people evaluation using the G8 score in the gastric cancer chemotherapy 鈴木喬也, 杉本智哉, 奥苑朱加, 山室栄一, 遠山幸男, 久田達也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1237-1237, 2021.

---

	P30-48. Example that gave ATRA+ATO therapy for elderly people APL with comorbidities, and achieved molecular biologic remission 宇佐美友佳子, 近藤篤, 三宅麻文, 尾上雅英 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1238-1238, 2021.

---

P30-49. Look at renal function at the denosumab administration in patients with solid carcinoma and the multicenter rear about the association of the hypocalcemia; a mark observational study 中村和代1, 嘉屋道裕1, 木苗あゆみ1, 久保田佳実1, 柳澤由紀2, 山本圭祐3, 高屋敷奈々4, 浮田浩利4, 名倉真理子5, 杉上香織6, 北島真利子7, 平野公美8, 石田紘基9, 小野田千晴10, 小林豊11, 中谷英仁12, 名波章子13, 小田切圭一14, 鈴木貴也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1239-1239, 2021.

---

	P30-50. Investigation of the potential drug interactions in the use of injectable anticancer medicine patients utilizing the drug interactions detection program 矢野洋平, 立石裕樹, 與田賢作, 大汐欣輝, 楢崎友理, 山本貴一, 田中博和, 松浦徹, 平川雅章, 渡邊裕之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1240-1240, 2021.

---

	P30-51. Examination about myelosuppression of the amrubicin in the decreased renal function patients 重森美奈1, 根來寛1, 小島すみれ1, 渡邉享平1,2, 古俵孝明1, 塚本仁1, 矢野良一3, 後藤伸之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1241-1241, 2021.

---

	P30-52. It is the fact-finding about the S-1 internal use schedule of the adjuvant chemotherapy after the gastric cancer technique 小泉綾乃1, 堀之内藍2, 藤田翔平3, 大矢周一郎3, 椙田浩文3, 神山紗代1, 鍵山智樹1, 坂本寿博1, 牧野好倫1,4, 櫻本信一3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1242-1242, 2021.

---

	P30-53. About the critical care center consultation situation of the cancer chemotherapy enforcement patients in our hospital 小野裕紀, 鈴木薫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1243-1243, 2021.

---

	P30-54. Construction ... of the system accompanied with the update of efforts - electronic medical chart of preventive measures against HBV reactivation with the chemotherapy in our hospital 山口雄士, 金森祐紀子, 新井大地, 安田翔, 近藤章吾, 芝祐輔, 松由幸司, 塚原民夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1244-1244, 2021.

---

	P30-55. What is a factor influencing an excretion delay of the methotrexate therapy in large quantities? 上瀧喬仁, 杉山典子, 堤一貴, 樋口恭子, 三輪涼子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1245-1245, 2021.

---

	P30-56. Examination of the factor to give the cisplatin in patients with lung cancer, Carboplatin-induced hiccups 角南博子1, 田頭尚士2, 田坂友紀1, 唐川雅生1, 大山裕紀子1, 大倉裕祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1246-1246, 2021.

---

	P30-57. Investigation of the adverse event expression situation of dose-dense EC therapy in the breast cancer perioperative period and the EC therapy 石井隆義, 松田亜希子, 藤谷千紘, 米谷頼人, 坂本佳子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1247-1247, 2021.

---

	P30-58. Examination about the effect that antimicrobial gives on treatment with immune checkpoint inhibitor in patients with non-small cell lung cancer 片岡優太1, 佐竹真衣2, 後藤桂輔1, 岡崎泰香1, 岡山有希1, 原田直美1, 高力敦茂1, 橋野泰良1,2, 若本あずさ1, 初山多恵1, 佐藤秀紀2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1248-1248, 2021.

---

	P30-59. After the CapeOX therapy technique about a change of the weight and the nutritional status at chemotherapy start and end in adjuvant chemotherapy patients 丸山昌広, 定盛理純 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1249-1249, 2021.

---

	P30-60. Can GPS and PNI become the biomarker of the immune checkpoint inhibitor in lung cancer treatment? 小山田聡1, 久松直樹1, 小島純子1, 林士元2, 野村明広2, 原信田努1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1250-1250, 2021.

---

	P30-61. Retrospective study on the efficacy and safety of lemborexant for insomnia in cancer patients 鈴木恵子1, 田中怜1,2, 新里馨3, 池内晶哉1, 篠道弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1251-1251, 2021.

---

	P30-62. It is tested the effect by suvorexant for the purpose of the delirium prevention and the ramified microglia combination after the operation of patients with cancer 池内晶哉1, 田中怜1,2, 杉浦禎一3, 新里馨4, 鈴木恵子1, 若林茜1, 篠道弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1252-1252, 2021.

---

	P30-63. Various comparisons and convenience of the elderly people usability test to use at the chemotherapy of patients with old cancer 風岡真実1,2, 橋本竜1,2, 吉成宏顕1, 玉井一也1, 梅田鈴香1, 入野真紀1, 黒崎隆1, 吉田雄貴1,2, 佐藤淳也1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1253-1253, 2021.

---

	P30-64. The enforcement situation investigation of the chemotherapy for patients with elderly people blood-forming organ tumor 東謙司朗1, 平川正宏1, 山田邦夫1, 高岡杏子1, 下村泰三2, 鈴島仁2, 森岡淳子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1254-1254, 2021.

---

	P30-65. Examination of the effect that a proton pump inhibitor gives to an effect of oxaliplatin 橋詰淳哉1,2, 里加代子1, 中川博雄2, 原澤仁美2, 中村忠博2, 兒玉幸修2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1255-1255, 2021.

---

P30-66. Examination about the expression situation of the hypothyroidism with the nivolumab administration in patients with head and neck cancer and the association with the overall survival 池部美緒1, 秦晃二郎1, 益口賢2, 田川慎二1, 池田宗彦1, 松金良祐1, 小澤奈々1, 熊谷史子1, 近森綾子1, 辻敏和1, 渡邊裕之3, 安松隆治4, 松尾美央子4, 中川尚志4, 家入一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1256-1256, 2021.

---

	P30-67. An example of the Pembrolizumab treatment for colon cancer during haemodialysis 新美政樹1, 浅井暁2, 西川貴広3, 福元幸子1, 谷口結基1, 荒川真帆1, 田中美帆1, 太田達也1, 田中章郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1257-1257, 2021.

---

	P30-68. Efforts of placement and the cooperation full addition of the working full time pharmacist in the foreign cancer chemotherapy room 神山知也, 藤井元, 松浦暢子, 永井道雄, 米田航佑, 石坂忠博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1258-1258, 2021.

---

P30-69. Making of "the side effect management book" for the purpose of the elimination of the local cancer medical therapy by the pharmacist team specialized in Ishikawa cancer 藺上圭子1, 宇夛裕基1, 石嶋麗2, 桂英之3, 北出絋規4, 久保杏奈5, 熊谷要6, 志村裕介7, 高橋喜統8, 高林真貴子7, 戸塚弘幸8, 原祐輔7, 平木祥子8, 北国憲剛9, 宮澤憲治10, 山田千代子11, 山本奈歩7, 吉田幸司7, 米澤美和5, 菅幸生12 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1259-1259, 2021.

---

	P30-70. Efforts of a terrorism phone follow-up and the number of tracing reports increase for patients during treatment with anticancer agent to a medical institution 井澤佐知子, 安藤陽子, 前川佳子, 梶原理英子, 小針依里, 庄谷美沙, 園生渚, 近藤範子, 舩塚恵子, 相根千晶, 井上晋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1260-1260, 2021.

---

	P30-71. An evaluation of the calculation situation of the cooperation full addition in the foreign chemotherapy and questionary survey to the health insurance pharmacy about the specific drug instruction addition 2 acquisition situation 有原大貴, 宮澤憲治, 亀井裕明, 中出恵里奈, 間宮公教, 福島信一郎, 秋山哲平 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1261-1261, 2021.

---

	P30-72. Examination of the information that was an opportunity to judge a health insurance pharmacy to have a doubt in prescription of the antineoplastic 小竹優希, 向井淳治, 坂本竜平, 竹原涼子, 濱崎淳哉, 奥田広志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1262-1262, 2021.

---

	P30-73. The effect that acquisition of resistance gives to migration ability and permeation ability on PARP inhibitor in the human breast cancer cell line 湯浅遥菜, 峯垣哲也, 大西蘭, 宮谷茉莉, 木崎優, 新田郁穂, 的場麻知子, 阿部結衣, 中野裕介, 辻本雅之, 西口工司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1263-1263, 2021.

---

	P30-74. Atezolizumab for the unresectable liver cancer, examination about the safety of the bevacizumab combination therapy 山本友佳子1, 江原美里1, 仲野宏紀2, 宮城和代1, 畑裕基1, 山下大輔1, 井上敦介1, 宮部貴識3, 吉野宗宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1264-1264, 2021.

---

	P31-01. The second response situation and survey about the new corona vaccination in our hospital 中村和彦, 中村嘉孝, 塚本友紀江, 横井さおり, 小竹克博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1266-1266, 2021.

---

	P31-02. The current situation of the APTT measurement and the APTT prolonged by the prophylactic anticoagulation using unfractionated heparin in the southern part of Saiseikai Yokohama-shi Hospital 小林奈緒, 藤巻智則, 加藤一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1267-1267, 2021.

---

	P31-03. Side effect investigation in the favipiravir non-loading dose case 長尾彰太1, 正置耕一1, 森田聡子1, 高子優子1, 太田宗幸2, 和智万由子2, 九鬼覚2, 吉岡睦展1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1268-1268, 2021.

---

	P31-04. Search of the internal change change factor of active metabolite GS-441524 of the rem decibuilding by the population pharmacokinetics analysis 助石有沙美1, 糸原光太郎1, 伊藤功朗2, 米澤淳1, 佐藤裕紀1, 松村勝之1, 片田佳希1, 中川貴之1, 井本英志5, 濱田哲2, 田辺直也2, 甲斐慎一3, 大鶴繁4, 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1269-1269, 2021.

---

	P31-05. The drug control system in safe examination and our hospital of the rem decibuilding in the COVID-19 case 岐部このみ1, 日高有美1, 中村大祐1, 吹上絵里香1, 菖蒲沙織1, 八板謙一郎2, 竹内宏樹3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1270-1270, 2021.

---

	P31-06. Preparation of role - vaccine of the pharmacist in the new coronavirus vaccination system construction 松林麻里子1, 初鹿野達也1, 菅原早織1, 廣瀬まい1, 佃征樹1, 田端祥子1, 井岡礼佳1, 鶴野結花理1, 須永雅恵1, 仁井田怜子1, 山村康比古1, 前田義治2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1271-1271, 2021.

---

	P31-07. That it is sought to a ward charge drug in the medical treatment of the COVID-19 infection 牧田亮, 古谷一平, 関谷泰明, 井上壽江, 平下智之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1272-1272, 2021.

---

	P31-08. Use fact-finding of the new coronavirus infection therapeutic drug in our hospital 新崎孝夫1, 三箇山宏樹1, 山本知志1, 五代寛人1, 石田篤世1, 中森靖2, 関寿人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1273-1273, 2021.

---

	P31-09. The effect that renal function at rem decibuilding beginning to use gives to kidney, liver function 齋藤晶仁, 青島直也, 本田和照, 横山登英, 西村康孝, 石田耕太, 細谷治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1274-1274, 2021.

---

	P31-10. Efforts ... for the proper use of the therapeutic drug by the new coronavirus infection (COVID-19) - ward charge pharmacist 朽木絵美1, 増淵麻実1, 石渡宏平1, 疋田絵梨1, 安武夫1,2, 城田幹生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1275-1275, 2021.

---

	P31-11. Examination of the case that the dosing period of the rem decibuilding became within five days 池田久雄1, 平田貴宏1, 神原弘和1, 甲原雄平2, 足立充司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1276-1276, 2021.

---

	P31-12. An example of the patients on dialysis who received treatment with the rem decibuilding for COVID-19 infection 高見澤誠1, 箕輪勇紀1, 市川裕平1, 篠原徹1, 池田知也1, 宮下貴浩1, 嶋崎剛志2, 岡田邦彦2, 関戸大司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1277-1277, 2021.

---

	P31-13. Examination ... in the children utilizing pharmacokinetic - population pharmacokinetics model of the nucleic acid resemblance medicine 岡田章1,2, 中村友海1, 白土愛海1, 世良庄司1,2, 永井尚美1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1278-1278, 2021.

---

	P31-14. Effect and evaluation of the effectiveness by the febuxostat to give to a rise in uric acid level of favipiravir 植田徹1, 中蔵伊知郎2, 柿花美沙紀1, 北澤文章1, 辻川正彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1279-1279, 2021.

---

	P31-15. Safe investigation of the rem decibuilding in the single institution 磯崎僚1, 栗島彬1, 塩田朋子1, 臺裕子1, 清水秀文2, 溝尾朗2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1280-1280, 2021.

---

	P31-16. Effect of the tocilizumab on cytokine storm by COVID-19 田村賢士1, 金子智一1, 金子誠1, 寺田伊知郎1, 羽田憲彦2, 立花栄三1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1281-1281, 2021.

---

	P32-01. Efforts of the pharmacist in the ward (regular hospital) for exclusive use of COVID-19 in our hospital 山田直輝, 山本倫数, 福村真須美, 山本浩二郎, 前田晃佑, 大里恭章 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1284-1284, 2021.

---

	P32-02. Efforts and second response investigation about corona vaccine storage, the filling in our hospital 木元慎一郎, 高橋杏奈, 望月保子, 加藤寛史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1285-1285, 2021.

---

	P32-03. A new coronavirus infection therapeutic drug and correspondence of the pharmacy 前田龍人1, 高田正弘1, 矢野圭悟2, 炭谷容子2, 國原将洋1, 松久哲章1, 田代裕尊2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1286-1286, 2021.

---

	P32-04. Examination about the participation of the pharmacist for the use of favipiravir in COVID-19 中園裕利華1,2, 佐々木貴之1,2, 福本真己1,2, 森尚義3, 加藤恵一1, 白木克哉2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1287-1287, 2021.

---

	P32-05. Relation of the use of therapeutic drug situation and the pharmacist in the new coronavirus infection ward 楠本将裕, 喜多岡洋樹, 毛利昌平, 中村真希, 吉田愛, 橋本知佳, 田中由起子, 田中泉, 山室蕗子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1288-1288, 2021.

---

	P32-06. To conduct the bringing medicine for patients with COVID-19 differentiation safely 外山昌伸, 稲垣喬大, 山中友紀子, 澤田昌司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1289-1289, 2021.

---

	P32-07. The current situation investigation of the infection measures for the new coronavirus infection in the health insurance pharmacy of Akashi-shi 寺沢匡史1, 湊あゆみ2, 福島綾1, 國正淳一2, 笹部洋平3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1290-1290, 2021.

---

	P32-08. Efforts to the in-hospital steady supply by the re-preparation of the ethanol for disinfection donated under COVID-19 outbreak 奥真由1, 宇夛裕基1, 鳥羽英理子1, 奥野由美2, 藺上圭子1, 今井富紀子1, 下平彩乃1, 中野智尋1, 松永典子1, 竹田和喜1, 瀬野晶子3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1291-1291, 2021.

---

	P32-09. About the new corona patients acceptance and infection measures in 57 beds (small scale) of hospitals 仲村裕子1, 澤本佳織1, 提箸純子1, 関根麻友美1, 大山実2, 岡田豪3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1292-1292, 2021.

---

	P32-10. Usefulness of the communication with the patients with evaluation of the pharmacist activity in slight illness, the moderate COVID-19 patients hospitalization ward and iPad (TM) 鈴木寛人1, 津曲恭一1, 山形真一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1293-1293, 2021.

---

	P32-11. Report - of the first -3 wave in role - Kobe Red Cross hospital of the hospital pharmacist for the new coronavirus infection 鈴木早苗1,2, 小玉博一1, 福徳美幸1, 赤石憲俊1, 大津佐和子1, 堀部正記1, 安藤和佳子1, 山岸雄幸1, 津村祐子2, 森下ひろえ2, 惠良有紀子2, 岡本貴大2, 杉本啓介2, 鹿島孝子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1294-1294, 2021.

---

	P32-12. About patients with pneumonia hospitalization turn of eventss accompanied with the new coronavirus infection spread 浅野嘉之1, 水草博希1, 鈴木大吾1, 田中伸明1, 中村敏史1, 坂田洋1, 服部芳明2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1295-1295, 2021.

---

	P32-13. Investigation of the patients information for problem grasp in the telephone practice 栗原啓輔, 山本圭祐, 石塚友一, 矢部勝茂 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1296-1296, 2021.

---

	P32-14. About correspondence of the pharmacy affecting new coronavirus practice 米田奈美1, 鶴崎泰史1, 小林弘美2, 田中将英2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1297-1297, 2021.

---

	P32-15. Intervention of the palliative care team to the COVID-19 patients who had the onset in diamond Princess number 辻茉莉香1,2, 佐藤弘子1, 吉村歩1, 五十嵐俊1,2, 高橋賢成1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1298-1298, 2021.

---

	P32-16. AntiSARS-CoV-2 antibody possession fact-finding of the healthcare worker of the first wave end time of COVID-19 in this country 下村夏穂1, 真野泰成2, 鈴木立紀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1299-1299, 2021.

---

	P32-17. Relation of the pharmacist in the new coronavirus infection cluster generating institution support activity in Okayama 石橋真実1, 畑賢俊2, 杉原功3, 藤原敬作4, 齋藤博則5, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1300-1300, 2021.

---

	P33-01. AS activity by the ward pharmacist in the hospital where AST is not installed in 大塚登志喜, 中根望, 高橋正明, 富島淳司, 中村徹, 長澤法子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1304-1304, 2021.

---

	P33-02. An example of the infective endocarditis that suffered from an antimicrobial choice by an adverse event 塩田亮介, 柏原道志, 本田勝亮, 矢部勝茂 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1305-1305, 2021.

---

	P33-03. Examination of the disease severity classification in the Clostridioides (Clostridium) difficile infection for Japanese 内田和葉, 柏原道志, 澤昇平, 本田勝亮, 矢部勝茂 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1306-1306, 2021.

---

	P33-04. Intervention of the pharmacist for purulent spondylitis, the pacemaker infection of the community-associated MRSA origin 渡辺圭1, 三浦義彦1, 中村翔太郎1,2, 礒江雄人1, 小川惟弘1, 宮城泰雄3, 石井庸介3,4, 伊勢雄也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1307-1307, 2021.

---

	P33-05. 2 cases of a bone, the soft tissue infection with resistant Pseudomonas aeruginosa treated with a highly-concentrated antimicrobial local administration 玉造竜郎1, 田中道子2, 吉川泰司3, 杉田栄樹1, 阿部和正1, 岡田菜津美1, 関戸匡恵1, 縄田修一1, 佐々木忠徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1308-1308, 2021.

---

	P33-06. Approach for the antimicrobial proper use in our hospital 安田陽子1, 福山博務1,6, 小倉健一2,6, 眞柄雄樹3,6, 松元謙治3,6, 高田淳子4,6, 杉田知妹5,6, 塩地園代1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1309-1309, 2021.

---

	P33-07. The use of cephamycin system medicine situation investigation after our hospital AS activity start 成島俊輔1, 鯉沼縁1, 青山美恵子2, 武藤博美3, 原信田努1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1310-1310, 2021.

---

	P33-08. Examination about the effect that a risk factor of the acute renal failure onset in the administration of the ST medical mixture and acute renal failure give to prognosis 清水優貴1, 平井利典2, 山田千祐1, 西野真紀1, 小林恵美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1311-1311, 2021.

---

	P33-09. A case of infection after joint replacement in which linezolid-induced neutropenia was controlled with tedizolid 小林俊介1, 加瀬雅士2, 安武夫3, 野上由佳1, 松原正明2, 北岡晃1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1312-1312, 2021.

---

	P33-10. The effect that tazobactam/piperacillin at vancomycin combination gives for acute renal failure 柏木悠里, 伊部裕太, 石郷友之, 北川学, 木明智子, 藤居賢, 福土将秀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1313-1313, 2021.

---

	P33-11. Effect ... of examination - fetal circulatory failure about the deviation factor of the Gentamicin blood level in neonates 本田勝亮1, 亀井七海1, 神谷早織1, 柏原道志1, 元重京子2, 杉浦弘2, 大木茂2, 矢部勝茂1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1314-1314, 2021.

---

	P33-12. One case that suffered from treatment of MRSA osteomyelitis 赤星璃, 栗崎貴啓 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1315-1315, 2021.

---

	P33-13. The effectiveness every dose of the daptomycin for the gram-positive bacteria infection including the MRSA and safety assessment 田杭直哉1, 近藤匡慶1, 菅谷量俊1, 鈴木美子2, 丸山弘3, 高瀬久光1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1316-1316, 2021.

---

	P33-14. Examination about the administration of genetically-modified thrombomodulin preparation days for the disseminated intravascular coagulation syndrome associated with the infection in the intensive care unit 菅野雄太1, 向井潤一2, 鎌田裕介1, 菅原大輔1, 久保田理恵2, 尾鳥勝也3,4, 高岩徹幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1317-1317, 2021.

---

	P33-15. Efforts and evaluation of the antimicrobial proper use for the clarithromycin-resistant Helicobacter pylori infection 深津昌弘1, 水野貴仁1, 梅村拓巳1, 大口裕美1, 松本茂1, 岩津慎次郎1, 竹中宏之2, 黒岩正憲2, 山田哲也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1318-1318, 2021.

---

	P33-16. Example that was given vancomycin intrathecally for MRSA meningitis after VP shunts 安河内寿成, 中野祐樹, 大竹野久雄, 蓮輪博嗣, 横尾賢乗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1319-1319, 2021.

---

	P33-17. About the active intervention of the AST pharmacist in the middle scale hospital and the evaluation 栗崎貴啓1, 栗田澄香1, 川辺雅美2, 井上耕太郎3, 今村文哉4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1320-1320, 2021.

---

	P33-18. Antimicrobial early monitoring expansion and AST duties improvement effect by the cooperation with the specialist in infection 小川暁生1,2, 三上友寛1,2, 門居久嗣1,2, 淵上尚彦1,2, 桐畑美里2, 近澤秀己2, 伊庭雅代2, 瀬戸康子2, 遠藤正憲1,2, 伊藤貴優2, 高橋良一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1321-1321, 2021.

---

	P33-19. Attempt of the intervention to the blood culture-positive patients by our hospital pharmacist 城間盛彦1, 玉城哲子1, 武富美貴子1, 仲俣桃華1, 久場謙也2, 金城正樹2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1322-1322, 2021.

---

	P33-20. Comparison of the surgical-site infections protective efficacy by the difference of the perioperative antimicrobial in all total hip replacement 河原陽介1, 木内貴章1, 羽田野翔太1, 森川貴弘2, 加藤良治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1323-1323, 2021.

---

	P33-21. Examination of the acute renal failure (AKI) onset risk at vancomycin and tazobactam/piperacillin combination 崎山達矢, 硲貴和子, 井上咲那, 河口義隆, 幸田恭治, 北原隆志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1324-1324, 2021.

---

	P33-22. Usefulness evaluation ... of the support for patients with pharmacist-led antimicrobial proper use support team - yellow staphylococcemia 古川大樹1, 伊藤嘉英1, 大橋武司1, 林房江2, 菱田志乃3, 中尾彰宏4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1325-1325, 2021.

---

	P33-23. Usefulness ... of the long time administration in investigation - bacteremia treatment about the administration of beta-lactam derivative antimicrobial time 中谷亮介1, 岡田雅弥1, 三宅美有紀1, 野際俊希1, 稲葉静香1, 藤井美紀1, 奥野千晶2, 下川福子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1326-1326, 2021.

---

	P33-24. Fact-finding of the antimicrobial therapy for the infectious aortic aneurysm in our hospital 加戸義大1,5, 奥村佳史1,5, 平松梓1,5, 松本健佑4,5, 田村幸二2,5, 平田喜裕3,5, 森田孝子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1327-1327, 2021.

---

	P33-25. One patient who vancomycin moderate degree-resistant staphylococcus aureus was suspected as a causative organism of the purulent spondylitis, and chronically administered linezolid 大上亜樹1, 福原伸治1, 松田翔平1, 今津智子1, 山崎美保1, 小濱邦彦2, 面田恵1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1328-1328, 2021.

---

	P33-26. Investigation about the actual situation of the thrombocytopenia with the oxazolidinone system antiMRSA medicine 中川ちひろ1, 井出和男1, 岡村央3, 勝亦秀樹2, 川邉桂1, 小池博文1, 佐橋幸子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1329-1329, 2021.

---

	P33-27. Examination of impaired renal function frequency and the risk factor of tazobactam/piperacillin in patients with malignant tumor 有馬崇充1,2, 佐野智望1,2, 新藤美香1,2, 石川光信1, 赤木徹1, 橋本浩伸1, 山口正和3, 塩塚美歌2, 小林治2, 岩田敏2, 古川哲也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1330-1330, 2021.

---

	P33-28. Fact-finding ... based on administrative data using prescription situation - MDV analyzer of the oral antimicrobial for acute respiratory tract infection in the outpatient department and the acute diarrhea 椙山聡一郎1,3, 清水博之2, 比嘉令子3, 小杉三弥子1, 工藤誠3, 佐橋幸子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1331-1331, 2021.

---

	P33-29. Association with the MIC distribution rate for %T>MIC and Pseudomonas aeruginosa of the use of meropenem case 川崎祥平1, 小林義和1, 吉原基2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1332-1332, 2021.

---

	P33-30. Effect by the change on fosfomycin from perioperative infection prophylaxis antimicrobial cefazolin 古庄弘和, 陣上祥子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1333-1333, 2021.

---

	P33-31. The antimicrobial proper use support activity evaluation that it is led by the AST working full time pharmacist in the scale hospital in infection specialist absence 沢田佳祐1,2, 中谷丈之1,2, 矢田真理1,3, 上山孝太1,4, 東新1,5, 福田康二1,6, 河野修治2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1334-1334, 2021.

---

	P33-32. Effect on surgical-site infections of the otolaryngology domain by the intervention of the pharmacist and antimicrobial consumption 石野清亮1, 柏原道志1, 本田勝亮1, 岡村純2, 矢部勝茂1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1335-1335, 2021.

---

	P33-33. Intervention of our hospital AST accompanied with vancomycin supply restrictions and the clinical effect 青戸和宏, 幸前里奈, 小阪直史, 四方敬介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1336-1336, 2021.

---

	P33-34. A change of the foreign oral antimicrobial consumption and drug resistant bacterium rate of detection in our hospital and investigation about the correlation 平尾祐樹, 佐々英也, 内山耕作, 鈴川誠, 冨田敦和, 今西忠宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1337-1337, 2021.

---

	P33-35. One case of the infective endocarditis with the Lactobacillus genus 奥村佳史1,5, 加戸義大1,5, 平松梓1,5, 田村幸二2,5, 平田喜裕3,5, 松本健佑4,5, 森田孝子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1338-1338, 2021.

---

	P33-36. Rearward multicenter study about the effect of DAAs under the true clinical practice to the type 1 HCV patients 嘉屋道裕1, 中村和代13, 杉山恭平13, 木苗あゆみ13, 山口紘生2, 浮田浩利3, 氏家智香5, 加藤純6, 影山富士人7, 名倉真理子8, 松下久美9, 杉上香織10, 石田紘基11, 名波章子12, 小田切圭一4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1339-1339, 2021.

---

	P34-01. Efforts for a degree of purity evaluation and hygiene state maintenance of the in-hospital conveyance tray of the injection drug 池淵明美伽, 石原慎之, 高橋由, 山戸和美, 大仁田哲修, 岡崎美香, 尾村賢司, 玉木宏樹, 矢野貴久, 直良浩司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1342-1342, 2021.

---

	P34-02. Evaluation for improvement in hygiene state in the formulations environment 山戸和美, 岡崎美香, 高橋由, 石原慎之, 池淵明美伽, 亀井美穂, 泙誠一, 玉木宏樹, 矢野貴久, 直良浩司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1343-1343, 2021.

---

	P34-03. Efforts for the pneumococcal vaccine inoculation communalization in our hospital 岸本卓, 浜元善仁, 翁長真一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1344-1344, 2021.

---

	P34-04. Efforts for the antimicrobial proper use by the pharmacist in the intensive care unit 友納保幸, 曽我弘道, 福島将友, 町田聖治, 入江利行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1345-1345, 2021.

---

	P34-05. Introduction of the specimen culture test order by the pharmacist based on the protocol in the seriously disabled child person ward and the effect 森本真仁, 浜田茂明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1346-1346, 2021.

---

P34-06. The current situation investigation of the infection with ward charge pharmacist treatment intervention and examination of the usefulness of the pocket edition tool 前田陽平1,2, 松澤弘志2, 菅原早織2, 石田留美2, 秦哲磨2, 梅川誠2, 木下理恵2, 小林崇史2, 丸山真依2, 諏訪淳一2, 大西真央2, 石井瑞2, 川島千夏2, 安田陽子2, 田中義幸2, 陣内博之2, 佐藤直行2, 石原溶子2, 八木原栄2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1347-1347, 2021.

---

	P34-07. Prophylactic oral antimicrobial of mandibular extraction of impacted wisdom teeth in the dentistry outpatient department and the normal tooth extraction and clinical statistics investigation of surgical-site infections 吉田謙介1,2, 児玉泰光2, 永井孝宏2, 金子奨太1, 齋藤千愛1, 高木律男2, 外山聡1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1348-1348, 2021.

---

	P34-08. Questionnaire survey to a drugstore pharmacist in the antimicrobial proper use 青嶋瑞樹1, 笹野央1, 宿利美香1, 梛野健1, 月岡良太2, 宮野康央3, 佐藤卓也3, 荒川隆太郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1349-1349, 2021.

---

	P34-09. Examination of the risk factor about the change of a serum Na level with the antimicrobial administration and the blood pressure 緒方雅章, 井上玲子, 伊藤晴樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1350-1350, 2021.

---

	P34-10. Inflection of J-SIPHE data in the infection measures regional alliances network antimicrobial consumption surveillance 中島貴史1,2, 石田茂1, 山田孝明1, 佐々木恵一1, 山下祐二1, 要幸典1, 金谷朗子1, 辻敏和1, 廣田豪1, 江頭伸昭1, 下野信行2, 家入一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1351-1351, 2021.

---

	P34-11. Efforts for the prophylactic antimicrobial proper use in the larynx microdissection and the effect 鈴木悠斗1, 橋本詠次1,2, 松崎洋海3, 菊池憲和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1352-1352, 2021.

---

	P34-12. Inspection of the intervention effect on staphylococcus aureus bacteremia by the AST exclusive duty of the pharmacist 梶原敬悟1, 河田武志1, 濱岡照隆1, 相良義弘1, 守分正2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1353-1353, 2021.

---

	P34-13. The analysis of the risk factor for the Clostridioides difficile infection (CDI) onset reduction and future problem 守田侑真1,2, 大矢智則1,2,3, 大竹孝明2, 高橋和郎2, 西尾こゆる2, 宮田桃誉2, 佐藤淳也1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1354-1354, 2021.

---

	P34-14. The effect that antimicrobial proper use and the nutritional status of patients give for SSI development in the surgery 小関崇文1,2, 大貫敏明1,2, 日向早苗2,3, 足立智子2,3, 大場雄一2,4, 小舛修三2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1355-1355, 2021.

---

	P34-15. Inspection of the effect of the antimicrobial proper use support round that a pharmacist played a key role 大戸祐治1,2,3, 中田麻里1,3, 新井祐司2, 高久美穂2, 岡田壮令2, 田中克巳1,3, 佐々木忠徳3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1356-1356, 2021.

---

	P34-16. The intervention situation and effect in the bacteremia case of Kure medical center Antimicrobial Stewardship Team (AST) 高田正弘, 前田龍人, 坂井原美希, 星川果南, 川成昂, 田頭尚士, 國原将洋, 松久哲章 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1357-1357, 2021.

---

	P34-17. It is ... through making, the operation of the list of efforts - oseltamivir prophylaxis patients of the pharmacist at seasonal flu outbreak 末永拓也, 岩尾恭寛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1358-1358, 2021.

---

	P34-18. Exploration of factors for SHEA/IDSA severity classification in Clostridioides difficile infection 重成大介1, 岡野翔1, 北田衛1, 高橋詩織1, 太田明秀1, 前田孝則2, 本野純子2, 宮木未果2, 伊東敏弘2, 中田浩雅1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1359-1359, 2021.

---

	P34-19. Change of consumption and resistant bacteria of the oral antimicrobial 石田茂伸1,2, 竹村陽介2,3, 藤原大亮1,2, 田川優介1, 眞野裕1, 多胡友絵1, 星育子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1360-1360, 2021.

---

	P34-20. Usefulness of the early intervention of the pharmacist for blood culture-positive patients 福本真己1,2, 佐々木貴之1,2, 中園裕利華1,2, 海住博之3, 森尚義4, 加藤恵一1, 白木克哉2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1361-1361, 2021.

---

	P34-21. Adherence analysis of the oseltamivir in the influenza postexposure prophylaxis purpose in the healthcare worker 辻中海斗1, 岡田直人1,2, 藤原範子2, 合田光寛3, 八木健太3, 相澤風花1, 濱野裕章4, 櫻田巧1, 桐野靖1, 座間味義人1,4, 東桃代2, 石澤啓介1,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1362-1362, 2021.

---

	P34-22. Report of the use situation according to the preventive measures against infection addition of the 2019 injection antimicrobial in infection measures cooperation common platform (J-SIPHE) 遠藤美緒1, 都築慎也1, 浅井雄介1, 田島太一1, 坂口みきよ1, 藤井直樹1, 松永展明1, 早川佳代子1,2, 大曲貴夫1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1363-1363, 2021.

---

	P34-23. The effect that the continuous intervention of the pharmacist gives for the treatment of patients with Escherichia coli bacteremia on injectable antimicrobial 篠田康孝, 大橋健吾, 松岡知子, 新井かおり, 堀田奈央, 浅野泉, 吉村知哲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1364-1364, 2021.

---

	P34-24. Examination of the contribution of the risk factor in Clostridioides difficile infection recurrence 山根千尋, 岡冨大輔, 山西紀子, 樫本考司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1365-1365, 2021.

---

	P34-25. Improvement of the prophylactic antimicrobial administration timing before operation by the change of the clinical path 田中博和, 早志尚, 内川瞳, 山下大貴, 立石裕樹, 重松由加, 安永実沙, 宮津大輔, 渡邊裕之, 平川雅章 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1366-1366, 2021.

---

	P34-26. For efforts - hepatitis B to vaccination of the staff, measles, rubella, epidemic parotitis, chickenpox - economical and effective vaccination 白川哲1, 山田ゆみ2, 武田朋子2, 中村忠之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1367-1367, 2021.

---

	P34-27. Examination of the risk factor of the patients that carbapenem-resistant Enterobacteriacae bacteria were detected 大石泰也1,2, 宮川雅行1, 佐伯めぐみ1, 山下世知子1, 石丸敏之2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1368-1368, 2021.

---

	P34-28. Comparison between cefmetazole and surgical site-related infection prophylaxis of the flomoxef in the large intestine-related surgery 濱田恵輔, 門口直仁, 田中広大, 濱本真歩, 田中聡, 段松雅弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1369-1369, 2021.

---

	P35-01. About efforts of our hospital for antiHIV Yakuin Todokoro 大道淳二1, 石橋真実1, 岡邊千聖1, 佐久川亮2, 宗好裕子3, 片山久留美4, 東郷和美5, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1371-1371, 2021.

---

	P36-01. Example that dysphagia was improved, and consisted of amantadine reduction if a diet intake was possible 伊東健一1,6, 細山田百梨2,6, 山崎里織3,6, 松尾剛志4,6, 白尾一定5,6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1373-1373, 2021.

---

	P36-02. Fact-finding of the glycemic control in nondiabetic patients during hyperalimentation administration 江端祥世, 川上辰三, 田中智也, 村瀬博子, 新免徹, 樋本繭子, 高瀬尚武, 三木育子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1374-1374, 2021.

---

	P36-03. Investigation of the effect that the diet advice which a drugstore pharmacist receives gives in a potassium level 山下祥史1, 田口浩史1, 福井大樹1, 森岡美行1, 淺井季晴1, 河野未佑1, 小川愛2, 廣瀬隆2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1375-1375, 2021.

---

	P37-01. Fact-finding about delirium high risk patients care addition in our hospital 森川莉沙, 鶴崎大, 佐々木祐樹, 菊池憲和 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1377-1377, 2021.

---

	P37-02. Efforts for the medical treatment investigation of patients with schizophrenia and the improvement in adherence by the pharmacist 石川晋平1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1378-1378, 2021.

---

	P37-03. Attitude survey about the medication counseling to patients with mental disorder for health insurance pharmacy pharmacists 福山雄卯介1,2, 宮崎敦2, 三角紳博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1379-1379, 2021.

---

	P37-04. Decrease of the sleeplessness medicine by the medication time change accompanied with the lights-out extension and the benzodiazepine system sleeping drug 青木竣哉1, 関千帆2, 石川蓮太郎2, 星野達也2, 佐藤尚子2, 高田勝利1, 須鎌建1, 君和田貢1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1380-1380, 2021.

---

	P37-05. About the efficacy and safety of nalmefene in the treatment of alcoholism 北侑未, 竹中克之, 森京子, 山田千代子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1381-1381, 2021.

---

	P37-06. Effect of brexpiprazole on antipsychotic-induced hyperprolactinemia 加藤美穂1, 肥田裕丈1, 小西郁代1, 松永安未1, 岩本邦弘2, 尾崎紀夫2, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1382-1382, 2021.

---

	P37-07. Case report: The change that the antipsychotics reduction from multiple drug large doses gave in heart rate (RHR) at rest 津倉由里1, 宮嶋康人2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1383-1383, 2021.

---

	P37-08. Usefulness inspection of the Clozapine TDM for treatment optimization 渡辺研弥1, 野崎啓子2, 陣野大輔1, 阿部裕也1, 平田祥一朗2, 鈴木二妙香2, 後藤將之2, 一瀬瑞絵2, 山本慎之助2, 堀越翔2,3, 金子春香2, 須藤孝浩1, 黒田純子1, 三浦至2, 矢部博興2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1384-1384, 2021.

---

	P37-09. 1 case that blonanserin tape was effective for the delirium in the patients who were hard to take medicine 中尾なつみ1, 田村安希1, 中島誠2, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1385-1385, 2021.

---

	P37-10. The effect investigation that psychotropic drug weight loss gives to anxiety 五味和彦1, 山本和幸1, 田端真理生1, 福井將郎2, 鵜澤正寛2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1386-1386, 2021.

---

	P37-11. Questionary survey (targeted for a staff of nurse, rehabilitation course) about the understanding degree of the psychotropic drug 清田晃司, 河野明子, 小林玲子, 越田朋美, 竹井純子, 和田こず恵 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1387-1387, 2021.

---

	P37-12. Efforts of the psychiatry liaison team in the acute phase hospital of the regular psychiatrist absence 山本浩二郎, 井上綾子, 山田直輝, 山本倫数, 草薙みか, 大里恭章 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1388-1388, 2021.

---

	P37-13. Examination of the effect that the difference of antipsychotics to use gives to subsequent schizophrenia treatment 河合真梨子1, 落合理路2,3, 榎本了三2, 梁川剛生2, 早坂俊亮4, 鈴木立紀1,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1389-1389, 2021.

---

	P37-14. The significance that introduction of the sustained-release parenteral injection to schizophrenia treatment gives to the adequacy of the prescription dose 沖永慶太1, 落合理路2,3, 河合真梨子1, 榎本了三2, 梁川剛生2, 早坂俊亮4, 鈴木立紀1,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1390-1390, 2021.

---

	P37-15. Early intervention example of the drug-induced extrapyramidal symptoms by the drugstore pharmacist 前原雅樹, 杉山正康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1391-1391, 2021.

---

	P38-01. Investigation about the consciousness to medication during the pregnancy, the nursing 田中優希, 赤坂寛子, 碁盤智子, 西川かおり, 西川須美子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1393-1393, 2021.

---

	P38-02. Relation of the pharmacist to the lactational medical therapy in the maternity ward inpatient 田村美穂, 太田千絢, 石村光, 有近仁美, 坂井康仁, 幸田恭治, 北原隆志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1394-1394, 2021.

---

	P38-03. For each one case that a pharmacist intervened in for the AD/HD patients during atomoxetine methylphenidate remedy at the obstetrics and gynecology department clinic from early pregnancy 野口時恵 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1395-1395, 2021.

---

	P38-04. The case that resulted in neonates maladjustment syndrome to children as a pregnant woman took antidepressant in our hospital 蓮尾憲作1, 森侑治2, 藤井績3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1396-1396, 2021.

---

	P38-05. One patient who measured a milk concentration at perospirone internal use, and examined the effect on children 田川菜緒1,2, 小川泰葉1,2, 若林仁美1,2, 小林麻美1,2, 縄田修一1,2, 田中祥子3, 町田晃一4, 神谷太郎5, 佐々木忠徳1,2, 水野克己5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1397-1397, 2021.

---

	P38-06. The duties results of "the pregnancy and the medicine outpatient department" in the Kumamoto Red Cross hospital 秋吉明子, 陣上祥子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1398-1398, 2021.

---

	P38-07. The in-hospital pharmacist duties in the pregnant woman nursing mother medical therapy domain and questionary survey of the Akashi district health insurance pharmacy 小川智孝, 川崎紀香, 寺沢匡史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1399-1399, 2021.

---

	P38-08. Risk assessment for the use of drug during pregnancy using the case database in the pregnant woman 平澤裕美子1, 田頭尚士2, 上野杏菜1, 田坂友紀1, 山本宏3, 大倉裕祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1400-1400, 2021.

---

	P38-09. Examination of safety in administration of PROPESS vaginal preparation 川田希帆, 寺岡知香, 宮部祐子, 森井絵莉香, 山田敦子, 石川佳澄, 漆崎智香子, 下辻恒久, 山東真寿美, 坂上嘉浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1401-1401, 2021.

---

	P38-10. Theoretical consideration about the safety at mother's milk shift and nursing of loxoprofen 大久保正1,2, 田中真理子2, 大久保七枝3, 大久保節子4, 大久保美穂5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1402-1402, 2021.

---

	P38-11. Safe investigation in the polyethylene glycol preparation administration to a pregnant woman 福井幸, 宮越貴之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1403-1403, 2021.

---

	P38-12. Examination of the dose per weight of the zinc acetate hydrate in the premature baby 寺西真凜1, 先名健太2, 槙田芳1, 東修司1, 和泉秀明1, 田畑裕和1, 小原郁司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1404-1404, 2021.

---

	P38-13. Examination about a risk factor and the correspondence of the postpartum haemorrhage 木藤一美, 池森明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1405-1405, 2021.

---

	P39-01. Rearward observation of the hematopoietic effect with the SGLT2 inhibitor in type 2 diabetes 吉田雄貴1,2, 大矢智則1,2, 橋本竜1, 風岡真実1,2, 吉田明4, 佐藤淳也1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1408-1408, 2021.

---

	P39-02. About pharmacist-led carbohydrate counting introduction and operation (about carbohydrate counting education hospitalization and a setup of the carbohydrate counting outpatient department) 田中こずえ1, 山下恵梨香1, 上西咲穂1, 三宅はなこ2, 佐野結衣子2, 伊藤耕史2, 衛藤直子3, 串本真紀3, 本田友生1, 井戸垣融4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1409-1409, 2021.

---

	P39-03. Examination ... about the background of use situation - high dose patients of the liraglutide in the Komaki Municipal Hospital 水谷貴樹, 奥村允基, 岡村奈保, 戸田康裕 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1410-1410, 2021.

---

	P39-04. Examination - using search - MMAS-8 of the factor affecting the medication adherence of patients with diabetes 久保田樹, 津下遥香, 河野浩之, 田中遼大, 龍田涼佑, 伊東弘樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1411-1411, 2021.

---

	P39-05. Investigation about the risk factor of the patients who presented with carbohydrate metabolism abnormality by inhalational steroid medicine administration for respiratory illness 竹内和貴子, 澤昇平, 内田和葉, 西村英子, 青木勇樹, 山本圭祐, 矢部勝茂 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1412-1412, 2021.

---

	P39-06. Effect (the second report) that metformin and proton pump inhibitor combination give to glycemic control 石田翔1, 吉川明良2, 松本俊治1, 開浩一3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1413-1413, 2021.

---

	P39-07. Examination - decreased renal function speed of the kidney protection of the drug in patients with diabetes for an index ... 守田彩文, 吉田陽, 西村博之, 塩山由紀, 高田雅文, 鈴木知子, 栗並昇, 梶原敬三, 陣内克紀, 稗島州雄, 杉山正悟, 陣内秀昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1414-1414, 2021.

---

	P39-08. Examination of the uric acid-lowering effect with the SGLT2 inhibitor in patients with hyperuricaemia merger diabetes 中嶋丈晴, 菅野和彦, 石本昌裕 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1415-1415, 2021.

---

	P39-09. Examination of the effect to give the early blood pressure, pulse after the Dulaglutide start 武藤崇, 下田賢一郎, 星野輝彦, 杉山留美子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1416-1416, 2021.

---

	P39-10. The effectiveness of the SGLT2 inhibitor supplementation in patients with type I diabetes mellitus and safe examination 加藤芽生子1, 早川伸樹1,2, 津川透1,3, 福井愛子1, 亀井浩行1, 桑原宏貴3, 森川理佐2, 西田康貴2, 鈴木敦詞2, 山田成樹3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1417-1417, 2021.

---

	P39-11. The effectiveness of the therapy with GLP-1 receptor agonist and sustained-release insulin preparation in patients with type 2 diabetes and safe examination 服部翔太1, 早川伸樹1,2, 津川透1,3, 福井愛子1, 亀井浩行1, 桑原宏貴3, 重康裕紀2, 轟木秀親2, 鈴木敦詞2, 山田成樹3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1418-1418, 2021.

---

	P39-12. Examination of the usefulness in the continuation treatment long-term after GLP-1 receptor agonist liraglutide 1.8 mg/day increase in quantity 久嶋真紀子, 野口景子, 葛葉守, 中野玲子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1419-1419, 2021.

---

	P39-13. One case that dehydration of the lack of self-consciousness was hepatic dysfunction, the cause of the sudden rise of the blood glucose level 新井尚1, 八木澤恭子2, 藤田あゆみ3, 杉浦伸哉3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1420-1420, 2021.

---

	P39-14. Example that the medication follow of the pharmacist was able to contribute to prevention of exacerbation of diabetes 坂本和紀1, 藤田あゆみ2, 杉浦伸哉2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1421-1421, 2021.

---

	P39-15. 2 cases that the multi-type of job cooperation and medicine medicine cooperation in the diabetes education hospitalization brought the effective medical therapy after the discharge 土屋貴1,2, 倉田賢生2, 安河内尚登1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1422-1422, 2021.

---

	P39-16. The coronary heart disease incidence prediction-style development of patients with type 2 diabetes and inspection 山下康也1, 野崎洋一1, 北島里奈1, 井上岳1,2, 松原聖1,3, 堀井剛史4,5, 毛利順一4,5, 厚田幸一郎4,5, 松原肇1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1423-1423, 2021.

---

	P39-17. Patients questionary survey about usability and the behavior modification of the FreeStyle livret 喜友名侑舞, 田仲祐子, 久田潤平, 喜多洋嗣, 白木萌 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1424-1424, 2021.

---

	P39-18. Examination of the result of a measurement of free-style livret and the POCT apparatus in the blood sugar determination of patients with postoperative diabetes of the view on femur fracture blood 豊田愛恵, 見尾谷昇, 細野真吾, 堀浩子, 山崎崇 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1425-1425, 2021.

---

	P40-01. Usefulness of the dose evaluation of the antivirus chemotherapeutant by the pharmacist 霍間尚樹, 金子睦志, 池田考介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1427-1427, 2021.

---

	P40-02. Investigation to interview form about the phosphorus content out of the preparation and a manufacturer 鈴木寛1,2, 小川裕子1, 漆畑理帆1, 佐橋貴美子1, 柏倉康治2, 田中紫茉子2, 内田信也2, 並木徳之2,3, 影山慎二4, 山内克哉1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1428-1428, 2021.

---

	P40-03. Search of the factor affecting the medication adherence of patients with chronic kidney disease using MMAS-8 河野浩之, 津下遥香, 久保田樹, 田中遼大, 龍田涼佑, 伊東弘樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1429-1429, 2021.

---

	P40-04. Relative examination of the use situation and P, the Ca of the laxative in patients on dialysis and the phosphate binder 内田朱美1, 續政哉1, 門脇大介2, 奥田佳子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1430-1430, 2021.

---

	P40-05. Examination of the factor affecting the multiple drug remedy in foreign haemodialysis patients 永野浩之1,2, 櫛山暁史2, 小岩まの1, 高橋雅弘2, 眞壁秀樹1, 友利浩司3, 岡田浩一3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1431-1431, 2021.

---

	P40-06. An example of patients in CKD during the eldecalcitol internal use that developed a high Ca blood symptom as Ca intakes derived from a diet increased 藤巻宥紀1, 藤巻浩子1, 松永千広2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1432-1432, 2021.

---

	P40-07. Examination of the copper deficiency risk by zinc deficiency and the supplement in haemodialysis patients 菱田啓介, 中島里菜, 松井治幸, 植優衣, 田村友香, 米澤彩, 末次悠衣, 倉田裕美, 岡田悠子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1433-1433, 2021.

---

	P40-08. Medical treatment evaluation by changes from amino acid preparation for the renal failure in patients on dialysis to general amino acid preparation 花木真美子1, 高橋仁美1, 江尻朋子2, 成山真一2, 澁谷浩二3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1434-1434, 2021.

---

	P40-09. Role elucidation of the indoxyl sulfate in the kidney condition of a patient extension of the ischemic acute renal failure concurrence diabetes model rat 道脇なつみ1, 鵜木隼平1, 小山直子1, 下河優奈1, 桑原孝成2, 向山政志2, 成田勇樹1,3, 城野博史1,3, 齋藤秀之1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1435-1435, 2021.

---

	P40-10. About high blood pressure prevalence, the association between decreased renal function disease severity and remedy antihypertensive medications for patients with coronary disease 町田聖治, 曽我弘道, 友納保幸, 富田敏章, 入江利行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1436-1436, 2021.

---

	P40-11. Examination of timing for determining anemia improvement effect in dialysis patients taking roxadustat 篠原慶次1, 續政哉1, 門脇大介2, 奥田佳子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1437-1437, 2021.

---

	P40-12. Elucidation of the molecular toxicologic role of the indoxyl sulfate in the kidney fibrosis formation 侯慧嫻1, 薮内希実1, 郡田菜緒1, 成田勇樹1,2, 城野博史1,2, 齋藤秀之1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1438-1438, 2021.

---

	P41-01. Fact-finding of the polypharmacy intervention situation judging from the calculation results of the drug global assessment adjustment addition 森崎崇文, 星野輝彦, 下田賢一郎, 杉山留美子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1440-1440, 2021.

---

	P41-02. Investigation about the intervention effect by the dementia care team in patients with stroke 林太祐1, 西野拓也2, 飯田謙司1, 藤村由梨香1, 吉田綾奈1, 庄司知紘1, 伊勢雄也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1441-1441, 2021.

---

	P41-03. Regarding the relationship between drug reduction and readmission rate in geriatric hospitals 片原憂斗1, 小原朋也1, 瀧川美和1, 大堀薫1, 島崎良知1, 石川譲治2, 岩切理歌3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1442-1442, 2021.

---

	P41-04. About an association between drug and injury showing frequent use drug investigation of the fragile bone fracture injury patients, use 益成宏1, 山本学2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1443-1443, 2021.

---

	P41-05. A role and efforts of the pharmacist in the elderly people medical therapy 高吉未奈, 真鍋扶美子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1444-1444, 2021.

---

	P41-06. Change of disintegration and the drug release behavior when we used thickness adjustment food at tablet remedy 下山哲哉, 賀好玲奈, 上田菜々子, 伊藤邦彦, 小林道也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1445-1445, 2021.

---

	P41-07. About the activity of the dementia care team in our hospital 磯田祥, 上ノ段友里, 縄田好一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1446-1446, 2021.

---

	P42-01. Two cases that we changed from other antiepileptic drugs to Perampanel hydrate monotherapy 石原慎, 吉年正宏, 岩崎浩子, 竹上学 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1449-1449, 2021.

---

	P42-02. Efforts for the polypharmacy improvement in our hospital 辻屋朝美, 尾上雅英, 三宅麻文, 上ノ山和弥, 日高貴生, 岡田麻佑, 野村勇太 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1450-1450, 2021.

---

	P42-03. One patient who received clindamycin primaquine combination therapy for pneumocystis pneumonia 梅田鈴香1,2,3, 吉成宏顕1, 入野真紀1, 吉田明2, 佐藤淳也1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1451-1451, 2021.

---

	P42-04. The effect of the RAS inhibitor giving it to anemia of patients with heart failure that a left ventricular ejection fraction was kept: Look at the single institution rear; a mark cohort study 馬橋美由季, 堀内望, 奥川寛, 土手賢史, 小林由佳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1452-1452, 2021.

---

	P42-05. Examination about the effect factor to give to the effectiveness of the disseminated intravascular coagulation syndrome therapeutic drug recombinant thrombomodulin 朝居祐貴, 山本高範, 阿部康治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1453-1453, 2021.

---

	P42-06. An association between low density lipoprotein cholesterol level and re-treatment at follow-up coronarography after the acute coronary syndrome: Case-control study 奥川寛, 堀内望, 土手賢史, 小林由佳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1454-1454, 2021.

---

	P42-07. Examination for the pneumocystis pneumonia onset of patients receiving rheumatoid arthritis therapeutic drug 畝知己1, 前田和彦1, 森脇順子1, 松原菜美1, 渡部里香2, 茂久田翔3, 荒木慧4, 岡井由美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1455-1455, 2021.

---

	P42-08. A case of a familial hypercholesterolemia homozygote who achieved LDL-C control goals with lomitapide low-dose escalation 水谷雅子1, 上原明彦2, 飯塚修3, 田中ありさ4, 高岡弥央子1, 坂口綾香1, 山崎涼也1, 高橋直樹1, 山本秋美1, 有田育子4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1456-1456, 2021.

---

	P42-09. The effect that the interview by the multi-type of job gives to a treatment continuance rate of self-injection preparation (dTPTD) on teriparatide day after day 川田暁1, 船木麻美1, 川上由美2, 安藤羽純2, 石川修平3, 児玉照光4, 相田桃子4, 舟越亮寛1, 久保田基夫5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1457-1457, 2021.

---

	P42-10. Investigation of the antithrombotic therapy in patients who underwent PCI 宗岡美紗1, 前田和彦1, 森脇順子1, 寺川宏樹2, 岡井由美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1458-1458, 2021.

---

	P42-11. Pharmacist intervention in the treatment of the infants hemangioma 森兼愛実, 持田裕子, 上條真菜実, 浅井翔子, 清水祐一, 甲斐維子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1459-1459, 2021.

---

	P42-12. Safety evaluation based on actual usage survey of sacubitril valsartan sodium hydrate tablets at Gifu Prefectural General Medical Center 西尾洋平, 古谷一平, 関谷泰明, 井上壽江, 平下智之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1460-1460, 2021.

---

	P42-13. The effectiveness and safety of the denosumab in patients with male osteoporosis 安土菜美1, 丸井万由香1, 櫻田啓介2, 川口翔平1, 車塚千穂1, 今井隆人1, 小林龍1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1461-1461, 2021.

---

	P42-14. The use situation investigation of the denosumab for patients with male osteoporosis that took advantage of pharmaceutical products risk management plan カワセ彩1, 中島美治1, 佐藤愛1, 内田裕之1, 八木仁史1, 満田正樹1, 東川晶郎2, 河井良智1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1462-1462, 2021.

---

	P42-15. Example that ceftriaxone and gentamicin succeeded for patients on dialysis of recurrent infective endocarditis suspicion by Klebsiella pneumoniae 石井俊一1,2, 宮本渚2,3, 渡邊徹1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1463-1463, 2021.

---

	P42-16. The effect that high fat diet gives to the microRNA expression of mouse liver 柴山良彦, 中川勉, 久保義忠 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1464-1464, 2021.

---

	P42-17. The nalfurafine prescription for the itch and examination of the zinc deficiency 見元尚, 筒井由佳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1465-1465, 2021.

---

	P42-18. 2 cases that was able to evade remedy method improvement and drug exposure by a medication follow-up and a tracing report 白鞘裕子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1466-1466, 2021.

---

	P42-19. It is the medicine charge to a substitute of chronic constipation therapeutic drug magnesium oxide! Choice called DSS 酒向聡子1,4, 亀山聡美1,4, 今西正人1,4, 松井一樹2,4, 岩井雄司3,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1467-1467, 2021.

---

	P42-20. Examination of the effects and side effects of Movicol-containing oral preparation LD for patients with chronic constipation in a ward for severely mentally and physically disabled patients 鶴崎泰史1, 上野知香3, 古川淳2, 陣内紀子2, 丸小野まゆみ2, 江崎由佳1, 山本晃大1, 山本修一3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1468-1468, 2021.

---

	P42-21. Investigation about the administration situation and dermatitis of zinc acetate in the premature baby 末長芽以1, 木村滋1, 藤本愛理1, 川俣洋生1, 福石和久2, 橋本雅司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1469-1469, 2021.

---

	P42-22. The glutathione drying up with the glutamic acid out of the nerve cells induces nitrosylation of Protein disulfide isomerase 小倉次郎1,2, 小野慎司3, 杉浦弘樹3, 山内碧4, 佐藤紀宏2, 前川正充2,3,4, 山口浩明1,2, 眞野成康2,3,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1470-1470, 2021.

---

	P42-23. About the effectiveness and safety of the Pemafibrate 坂東香織1, 菊田絵梨華1, 先名健太1, 道貝優太1, 小笠原綾香1, 水谷彰史1, 北川裕也1, 中村裕一1, 鈴木千波1, 小原秀治1, 柴波明男1, 樋浦一哉2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1471-1471, 2021.

---

	P42-24. The effect that the combination of diuretics and SGLT2 inhibitor gives to renal function 伊藤和, 荻原友里, 吉原正和, 鈴木知則, 楠見彰宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1472-1472, 2021.

---

	P42-25. Effect of the actual situation and the drug of the salivation in patients with intractable neuromuscular disorders 大野隼輔1, 石田奈津子1, 座光寺伸幸2, 鈴木亮平3, 野尻桂2,4, 大月慎之助5, 菅幸生1, 石崎純子1, 松下良1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1473-1473, 2021.

---

	P42-26. The effectiveness, safe comparison of Linaclotide and the Elobixibat 下坪達人, 石郷友之, 北川学, 木明智子, 藤居賢, 福土将秀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1474-1474, 2021.

---

	P42-27. One patient whom we were able to save from poisoning by the colchicine excessive quantity internal use 馬替仁1, 小林正人1, 竹内崇浩1, 宮内秀典1, 野口周作1, 城戸教裕2, 大嶽康介2, 田上隆2, 松田潔2, 笠原英城1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1475-1475, 2021.

---

	P42-28. Examination about the taking aspirin period in patients with Kawasaki's disease 山田敦子, 寺岡知香, 川田希帆, 漆崎智香子, 石川佳澄, 森井絵莉香, 宮部祐子, 岩崎瑛子, 中野寛之, 下辻恒久, 山東真寿美, 坂上嘉浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1476-1476, 2021.

---

	P42-29. Examination of the liver function improvement effect with the Pemafibrate administration 大谷綾1, 金秀基2, 川瀬愛香1, 亀井健人1, 西條由夏1, 上田愛梨1, 中尾啓子1, 笹瀬典子1, 金守良2, 金啓二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1477-1477, 2021.

---

	P43-01. Efforts in our hospital pharmacy about the study drug management support in the clinical studies that a physician leads 遠又未佐子1, 後藤洋仁1,2, 松井周一1, 小池博文1, 佐橋幸子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1479-1479, 2021.

---

	P43-02. Fact-finding about the exhibition of the clinical study information by the pharmaceutical company on the Internet 石橋春奈, 原梓, 漆原尚巳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1480-1480, 2021.

---

	P43-03. Evaluation of CubixxCT in the clinical experimental medicine management 齊田翌美1,2, 宮本聖子1,2, 浮池香奈子1,2, 白澤宏美4, 佐々木幸作2, 中川義浩5, 湊本康則1,2, 富田正郎3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1481-1481, 2021.

---

	P44-01. It is visit instruction and enforcement ... of the pharmacist outpatient department after efforts - discharge of the ward pharmacist who fixed the eyes on the home care after the discharge 岡田雅弥1, 満田正樹2, 中谷亮介1, 大本奈緒子1, 尾崎加織1, 瀧浪靖子1, 富山志帆1, 細直子1, 下川福子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1484-1484, 2021.

---

	P44-02. Examination of the factor contributing to the burden of pharmacist duties in the treatment at home 市橋菜月1, 柴田賢三1,2, 室谷健太3, 坂巻弘之4, 亀井浩行1, 半谷眞七子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1485-1485, 2021.

---

	P44-03. Usefulness of the drug reporting book making between the institutions at hospital transfer by the pharmacist and the evaluation 伊藤有美, 柴田大地, 滝本典夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1486-1486, 2021.

---

	P44-04. Example that we transfused it and prescribed it and suggested at-home based on the information of the community medical care cooperation network 中川友之1,2, 草場大作1, 木村安佳莉1, 丸一泰雅2, 折戸真澄2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1487-1487, 2021.

---

	P44-05. Inquiry analysis about the TPN infusion from the ethical pharmacy 掛水瑞芳, 星泉, 吉岡小都子, 竹林佑花, 松田直子, 佐々木美由紀, 福田まゆみ, 河野裕則, 岩原良晴, 沢田憲彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1488-1488, 2021.

---

	P44-06. Aiming for a regional formulary - Awareness survey results report - 森英樹, 花房伸幸, 小池彩子, 大道淳二, 横田幸子, 石橋真実, 諏訪耕三 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1489-1489, 2021.

---

	P44-07. Effect inspection to the local inhabitants health enhancement of the locomotive syndrome prophylactic activity to be carried out at a drugstore 藤井優里菜1, 菊池千草2,3, 浅井治行4, 大竹芳房5, 大庭紀宏6, 佐々木豊7, 佐藤裕美8, 清水一希9, 供田将志10, 中尾理香11, 藤井麻由12, 松岡良典9, 水野輝雄13, 山本加奈子14, 小嶋雅代15, 鈴木匡2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1490-1490, 2021.

---

	P44-08. 1 case that cooperated with the multi-type of job with at-home PCA introduction 志田友美1,5, 豊田清子2,5, 浮海利枝2,3, 太田学4,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1491-1491, 2021.

---

	P44-09. Problem - in the hospital transfer support of patients with relation - new model coronavirus infection of the community medical care cooperation center pharmacist to the hospital transfer suffering case in the acute phase hospital 三沖大介1, 山本晴菜1, 池末裕明1, 米谷久美子2, 橋田亨1, 室井延之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1492-1492, 2021.

---

	P44-10. One case that was able to start transvenous lipid microsphere administration by the treatment at home by the multi-type of job cooperation and the maneuver instruction to patients family smoothly 伊津田知樹1, 藤田あゆみ2, 川崎優人3, 岡本優也3, 中村友洋3, 杉浦伸哉2, 杉浦克典2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1493-1493, 2021.

---

	P44-11. Fact-finding to evaluate the at-home pharmacy administrative task that a drugstore pharmacist conducts in the nursing facility 遠田宙1,2, 山村恵子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1494-1494, 2021.

---

	P44-12. Study on efficiency improvement of pharmacist duties by the information sharing between a physician, the pharmacists using the glaucoma seal 大迫翔平 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1495-1495, 2021.

---

	P44-13. Approach to the epoprostenol continuous intravenous infusion therapy introduction for patients with pulmonary artery-related pulmonary hypertension in the district hospital 高見澤美紀1, 篠原徹1, 橋詰さやか1, 高見澤誠1, 土屋ひろみ2, 飯島実和子3, 矢崎善一2, 関戸大司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1496-1496, 2021.

---

	P44-14. For medical garbage mixture zero and needle pad accident zero to classification of plastic 磯貝一成1,2,3, 江島姿子1, 細谷雄二2, 井上泰芳2, 高尾満3, 三國貴子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1497-1497, 2021.

---

	P44-15. The current situation investigation about the at-home intravenous alimentation infusion preparation in the Osaka lower dispensing pharmacy 大石雅子1,2, 渡邊梓2, 井上善文3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1498-1498, 2021.

---

	P44-16. The example analysis that "cannot swallow up the medicine" that was taken up in patients consultation desk combination conference 久岡清子1, 増田博也1, 日下部紗穂2, 鹿島由美子3, 下地朝秀4, 城戸あゆみ5, 伊藤克樹4,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1499-1499, 2021.

---

	P44-17. Efforts of the information sharing between a drugstore, the hospital pharmacist at hospitalization and release of patients 大内友季江, 安達寛成, 佐藤千穂, 佐伯里紗, 正垣耕, 遠藤武弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1500-1500, 2021.

---

	P44-18. Development of Quality Indicator measuring the characteristic of the drugstore service 加藤寛菜, 酒井隆全, 田辺公一, 大津史子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1501-1501, 2021.

---

	P44-19. Search of the stressor becoming the stressor of the pharmacist in the treatment at home 淺野七海1,2, 亀井浩行1, 室谷健太2, 半谷眞七子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1502-1502, 2021.

---

	P44-20. Investigation about the number of the staff of the drugstore pharmacist and the at-home duties enforcement situation 上山碧1, 玉木啓文1, 長内理大1, 伊野陽子1, 岩田麻里2,3, 松永俊之4, 中村光浩3, 井口和弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1503-1503, 2021.

---

	P44-21. Significance to accept the outside Parliament prescription of the emergency visit at a health insurance pharmacy 林田大輝1, 天方奉子1, 沼田朋和1, 牛濱直樹1, 佐々木雄一2, 稲葉一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1504-1504, 2021.

---

	P44-22. One case that caused somnolence when we finished passing through oral from hypodermic injection and exchanged hydromorphone 天方奉子, 沼田朋和, 本山有佳子, 稲葉一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1505-1505, 2021.

---

	P45-01. The prescription situation investigation after the discharge of the patients who intervened pharmaceutical in our hospital 中村豪志, 岡田淳芳, 神原康佑, 石井一也, 大塚識稔 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1510-1510, 2021.

---

	P45-02. Investigation, analysis about the discharge drug information cooperation addition in the Oiso Hospital attached to the Tokai University faculty of medicine 横山直, 奥村伊代, 千葉詩織, 岡安弘樹, 山縣彩, 矢野忠 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1511-1511, 2021.

---

P45-03. Efforts ... to medicine medicine cooperation in the cottage-hospital out of modi operandi and calculation situation ... of the drug control summary by the discharge drug information cooperation addition new establishment 岩崎有可里, 奥村謙一, 吉村直人, 野村真里, 藤原洋介, 山田憲和, 中村智子, 吉川知世, 吉田明弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1512-1512, 2021.

---

	P45-04. Community medical care cooperation ... at new efforts - hospitalization for the seamless patients support 澤口友紀, 増田博也, 合田さやか, 大荒政志, 川村大輔, 鹿沼奈央, 坂本真衣, 吉川真央, 井上萌, 小滝亜梨紗, 梶貴裕, 青柿和樹, 黒田悠加, 坪田美風, 久岡清子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1513-1513, 2021.

---

	P45-05. The current situation investigation for the efforts of a medication reporting book (drug summary) and the writing a postscript 阿部響, 福島奈津美, 大上寛子, 起塚美沙, 中村美樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1514-1514, 2021.

---

	P45-06. Survey on the current status of admission phone calls to family pharmacy pharmacists at Rakuwakai Marutamachi Hospital 大村真里奈 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1515-1515, 2021.

---

	P45-07. Active intervention to the discharge medication counseling utilizing the discharge drug reporting book and the effect 荒木遼太, 譲原千広, 小川紗知, 波多晶子, 中澤美樹子, 橋爪和恵, 窪田真弓, 鶴居勝也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1516-1516, 2021.

---

	P45-08. Efforts for the effective discharge drug information cooperation addition calculation 花房伸幸, 甲元大樹, 小池彩子, 大道淳二, 森英樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1517-1517, 2021.

---

	P45-09. Medicine medicine cooperation ... with pharmaceutical intervention of the hospital pharmacist using the tracing report in the foreign cancer chemotherapy and the drugstore in evaluation - site 金剛圭佑1, 刈谷美里1, 井上祥平2, 岡奈津美2, 脇下大樹1, 小寺克典1, 松田ゆかり1, 横町朋子1, 岡田秀明3, 橋本泰明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1518-1518, 2021.

---

	P45-10. It is questionary survey ... to ... drugstore for improvement in quality of the foreign cancer chemotherapy 黒部健太郎, 草葉一友 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1519-1519, 2021.

---

	P45-11. The current situation report fourth report of the foreign inhalational instruction in the Komaki Municipal Hospital 河野美来, 水谷貴樹, 水野彩花, 戸田康裕 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1520-1520, 2021.

---

	P45-12. The introduction of the tracing report in the Osaka University faculty of medicine hospital and evaluation of the usefulness 大西絵梨1, 有持潤子1, 山本智也1, 門脇裕子1, 竹屋泰2, 奥田真弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1521-1521, 2021.

---

	P45-13. Construction of the foreign inhalational instruction follow-up system by the medicine medicine cooperation reinforcement 佐々木陽一, 原大真, 高橋恭平, 長田一晃, 西倉教子, 横山匠太, 原田靖子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1522-1522, 2021.

---

	P45-14. Analysis of issuance of the summary for the prescription notebook using the commercial documentation support system and the writing a postscript from the health insurance pharmacy 下田賢一郎, 星野輝彦, 木村美紗子, 森崎崇文, 杉山留美子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1523-1523, 2021.

---

	P45-15. The use situation investigation of the cooperation document between the institutions in the local basic hospital under Kyoto 三浦誠1,2, 石橋直哉1,3, 板倉祥嗣1,4, 加藤良隆1,5, 楠川侑吾1,6, 田渕祐輔1,7, 伴具也1,2, 岩根裕紀1,8, 土下喜正1,9, 深津祥央1,3, 友沢明徳1,10, 四方敬介1,7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1524-1524, 2021.

---

	P45-16. One patient who was able to evade the becoming severe of the side effect by the illness medicine cooperation through the tracing report 本田修一, 牛島智子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1525-1525, 2021.

---

	P45-17. One case that was able to prevent a dangerously ill low K blood symptom by medicine medicine cooperation 阿部華奈1, 正置耕一2, 西山祐美2, 下村美穂2, 森田聡子2, 高子優子2, 吉岡睦展2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1526-1526, 2021.

---

	P45-18. Efforts (the second report) for the cooperation full addition in the corona evil 上淵未来1, 土井裕美子1, 志間裕介1, 泉勇成1, 金森陽子1, 中村拓真1, 大岡建太郎1, 守田尚史1, 本村美穂1, 西村秀洋2, 市川康子1, 藤井憲一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1527-1527, 2021.

---

	P45-19. The case that was able to confirm an adherence drop of the double cancer internal use treatment by a tracing report 松本美紅1, 桑村恒夫1, 原田智子1, 平田仁美2, 田尻健亮1, 中川義浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1528-1528, 2021.

---

	P45-20. Example avoiding aggravation of pneumonia drug-related by the inflection of the oral anticancer agent fixed form check-type tracing report by the physician starting point 西上真1, 三坂恒1, 志村裕介1, 原祐輔1, 坪内清貴1, 嶋田努1, 石川聡子2, 崔吉道1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1529-1529, 2021.

---

	P45-21. Efforts for the cooperation full addition calculation of the Osaka Red Cross hospital and evaluation from the neighborhood health insurance pharmacy 山瀬大雄, 野村加奈子, 原田慶子, 仲里泰太郎, 林淳雄, 谷大輔, 安田成男, 門馬佳代子, 辻井佳代, 小林政彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1530-1530, 2021.

---

	P45-22. Analysis of the approach situation about the medicine medicine cooperation for improvement in quality of the foreign cancer chemotherapy in Kanagawa 田口真穂, 高橋健太, 阿部竜大, 畚野海, 日原慧, 山田博章 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1531-1531, 2021.

---

	P45-23. We investigate a problem in the current situation confirmation of the foreign chemotherapy regimen joint ownership and the operation at the health insurance pharmacy 西村碧1, 奥埜早紀1, 藤井友美1, 大西優里1, 加藤良子2, 吉留実慧子3, 三宅麻文4, 近藤篤4, 尾上雅英4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1532-1532, 2021.

---

	P45-24. Efforts of the good use of cancer chemotherapy information sharing sheet reinforcement 柴山はる子1,2, 後藤愛実2, 西原雅美2, 服部有紀1, 長田英子1, 家崎加奈1, 鶴田花奈1, 奥本貴廣1, 川端麻衣子1, 國井久美子1, 家里夏子1, 奥田菜由子1, 神吉麻美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1533-1533, 2021.

---

	P45-25. ... which thinks about the way of the cooperation of hospital pharmacist for the "drugstore vision for patients" promotion and the family pharmacist through ... case 村田夕起子1, 向井光一朗2, 濱田健人3, 村本慎悟2, 大山高廣1, 政賢悟1, 齋藤秀之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1534-1534, 2021.

---

	P45-26. Efforts of the medicine medicine cooperation more satisfying by "the cooperation full addition" 川原裕, 田中亮輔, 佐野雅昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1535-1535, 2021.

---

	P45-27. Analysis of contents of the reporting using the information sharing sheet for exclusive use of the Lenvatinib with the University of Miyazaki faculty of medicine hospital 上運天玲子, 櫻井京子, 比惠島有香 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1536-1536, 2021.

---

	P45-28. One case that good pain control was got from by the cooperation of community pharmacy, a door front drugstore, the medical institution 林優希1, 吉留実慧子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1537-1537, 2021.

---

	P45-29. Evaluation of the usefulness of the tool to use for medicine medicine cooperation in the foreign cancer chemotherapy 疋田絵梨1, 大崎真美1, 黒木あかね1, 秦哲磨1, 浦山泰典1, 村上菜月1, 賀川智子2, 安武夫3, 城田幹生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1538-1538, 2021.

---

	P45-30. Questionary survey about the medicine medicine cooperation of the anticancer medicine for health insurance pharmacies of the East Tottori area 廣岡賢輔, 清水浩幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1539-1539, 2021.

---

	P45-31. Side effect follow-up investigation of the anticancer agent in the medicine medicine cooperation 山本浩之, 出口桃子, 堀田千里, 河野修治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1540-1540, 2021.

---

	P45-32. Efforts for the cooperation full addition in the Hekinan Municipal Hospital 伊藤昌美1, 片山広美1, 後藤整一2, 小竹千秋3, 伊藤弥生3, 鈴木崇太4, 鈴木厚志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1541-1541, 2021.

---

	P45-33. Efforts to the cooperation full addition acquisition 米谷頼人, 松田亜希子, 藤谷千紘, 石井隆義, 坂本佳子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1542-1542, 2021.

---

	P45-34. Evaluation about the efforts of the medicine medicine cooperation using "information sharing paper" in the foreign cancer chemotherapy 竹本将士1, 近藤勝弘1, 川出義浩1, 外海友規1, 伊豆田美晴1, 手崎世織1, 井口裕美子1, 後藤佳奈1, 中村大学1, 木村和哲1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1543-1543, 2021.

---

	P45-35. The actual situation grasp of the telephone practice accompanied with the prevention of COVID-19 infection spread in the pediatric special hospital and creation of useful data for the medicine medicine cooperation 長沼明子1,3, 大和由佳1, 郭義胤2,3, 安河内尚登1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1544-1544, 2021.

---

	P45-37. Economic effect in the Residual medicine intervention using a doubt inquiry simplification protocol and the spreading effect 十亀裕子, 西村光子, 小杉奈緒, 野村政子, 柏川紗希, 森加也, 高橋典子, 佐々木尚美, 岸本仁文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1545-1545, 2021.

---

	P45-38. Questionary survey for the purpose of stocktaking and the cooperation reinforcement of the medicine medicine cooperation 白石貴寿, 小西裕二, 坂本拓也, 青柳晴彦, 井上優子, 山田智栄子, 奥田和貴, 渡邊卓巳, 川村ひとみ, 小澤明日香, 小松浩大, 小川実華, 金城俊之介, 井口舞香, 鈴木美和, 荒井宏人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1546-1546, 2021.

---

	P45-39. Efforts (suggestion to medicine medicine cooperation) as the family drugstore for the discharge prescription that it is hard to take of patients on dialysis 山内牧子1, 山邊健司1, 田中みずき1,2, 坂口眞弓1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1547-1547, 2021.

---

	P45-40. Introduction of the case that information sharing with a drugstore pharmacist and the hospital pharmacist led to improvement in adherence of patients 牛尾彰 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1548-1548, 2021.

---

	P45-41. Content analysis of the drug control summary of the Tohoku University Hospital and investigation about the usefulness 小林大典, 黒澤桂子, 田中里奈, 高橋茜, 森下啓, 佐藤稔之, 高崎新也, 佐藤祐司, 松浦正樹, 前川正充, 眞野成康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1549-1549, 2021.

---

	P45-42. Change of tracing report contents before and after the medicine machine law revision 高子優子, 吉岡睦展, 土田裕貴, 石津智司, 下村美穂, 正置耕一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1550-1550, 2021.

---

	P45-43. Efforts for the community medical care cooperation reinforcement using the drug control summary 大竹野久雄, 蓮輪博嗣, 松野知寛, 井上和洋, 辻村啓史, 北村憲雅, 中野祐樹, 安河内寿成, 猪口陽子, 秀島久美子, 横尾賢乗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1551-1551, 2021.

---

	P45-44. The effect that renal excretion type drug inquiry standard introduction by the medicine medicine cooperation gives to drugstore pharmacist checking prescription duties 高村優太1, 平井利幸1, 佐藤和人1, 秋山裕史1, 名越ソッヴィリヤック ヴァッティ3, 大橋雅人4, 樗木昭5, 関利一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1552-1552, 2021.

---

	P45-45. The illness medicine cooperation that a pharmacist of the local government Hospital conducts 片山広美1, 加藤直紀1, 鈴木めぐみ1, 天野哲史1, 鈴木裕之1, 八並ゆかり1, 伊藤昌美1, 加藤奈美1, 渡邉香織1, 山崎典子2, 山端二三子3, 奥村晋平4,6, 板倉由縁1,5, 鈴木厚志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1553-1553, 2021.

---

	P45-46. Consideration for the actual situation and the medicine medicine cooperation of the receipt situation of the drug control summary in the health insurance pharmacy 鈴木すみれ, 佐々木麻里, 須藤寛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1554-1554, 2021.

---

	P45-47. About the operation of the tracing report aiming at the establishment of the polypharmacy community medical care model 天白宗和, 溝神文博, 間瀬広樹, 加藤浩充 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1555-1555, 2021.

---

	P45-48. It is ... using intervention situation investigation - medicine questionnaire by the regional alliances team 石原瑛太郎1, 大嶋成奈優1, 石井照樹1, 沖廣絵里子1, 高橋公子1, 篠永浩1, 原田典和1, 加地努1, 石山晃子2, 中津守人3, 矢野禎浩4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1556-1556, 2021.

---

	P45-49. Inflection of the tracing report in the medication management of the perioperative patients 石原慎之, 玉木宏樹, 望月優里, 大仁田哲修, 北郷真史, 後藤貴樹, 矢野貴久, 直良浩司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1557-1557, 2021.

---

	P45-50. Efforts and problem to the online workshop holding of the medicine medicine cooperation promotion workshop 鶴居勝也, 荒木遼太, 小川紗知, 譲原千広, 波多晶子, 中澤美樹子, 橋爪和恵, 窪田真弓 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1558-1558, 2021.

---

	P45-51. Having been able to see it from the setup of the in-hospital system for the cooperation full addition calculation and the questionnaire to the health insurance pharmacy 原田哲彦, 坂野博紀, 村上仁志, 足立翼, 冨山麻里子, 石川元章, 柳沼妙子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1559-1559, 2021.

---

	P45-52. Usefulness of the cooperation with the drugstore judging from the calculation situation of the cooperation full addition 外山智章1, 五月女拓也1, 日向野理輝1, 大塚瑠里1, 篠崎圭子1, 臼井悟1, 五十嵐爽2, 小貫佐和子2, 木名瀬直樹2, 石濱洋美3, 本田雅巳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1560-1560, 2021.

---

	P46-01. About a problem of the storage pharmaceutical products operation thought about through an in-hospital disaster prevention drill 森川祥彦, 川瀬亮介, 岩本卓也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1562-1562, 2021.

---

	P46-02. Development of the disaster application using package insert computerization for medical care 木村敦1, 松本利恵1, 深澤真吾2, 草深裕光2,3, 松波和寿4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1563-1563, 2021.

---

	P46-03. Effect of the Iburi eastern part earthquake to give change of prescription of the psychiatry 矢田山瑞稀, 大野奈子, 荒井理乃, 喜多力, 真井雄規, 越野早紀, 能登数馬, 門脇督, 田中悠季, 三本松泰孝, 佐藤弘康, 田村広志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1564-1564, 2021.

---

	P46-04. National survey about the introduction situation of the disaster-response pharmaceutical products supply vehicle and the use actual situation 岡村佳奈1, 羽山希1, 生木庸寛1,3, 河合琢良1,3, 小原道子1,3, 林秀樹1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1565-1565, 2021.

---

	P46-05. It is the lesson from Fukushima offing earthquake happened in the tenth year from the Great East Japan Earthquake 須藤孝浩, 永島久義, 渡辺研弥, 石井重亮, 吉田裕美, 鈴木優佳, 五十嵐暁子, 塩谷真奈美, 星正弘, 鳥羽衛, 黒田純子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1566-1566, 2021.

---

	P47-01. Contents and tendency analysis of doubt inquiry in inside the hospital 土井加奈子, 高武嘉道, 鶴山萌子, 永石浩貴, 坂口晋哉, 河野なるみ, 中原萌子, 花田聖典, 川俣洋生, 橋本雅司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1569-1569, 2021.

---

	P47-02. Dispensing error generating inhibitory effect by the picking support system introduction 宇根良祐, 白木萌, 長濱藍, 喜多洋嗣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1570-1570, 2021.

---

	P47-03. Efforts of our hospital about the HBV reactivation prevention in the steroid therapy 高橋真一, 桝早紀子, 四方公亮, 伊東充, 佐藤香織, 勝俣はるみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1571-1571, 2021.

---

	P47-04. Development and evaluation of in-hospital operation procedures of the propofol 龍田涼佑1, 山村亮太1, 中原良介1,3, 衛藤大輝1, 森永裕子1, 田中遼大1, 北野敬明2, 平松和史3, 伊東弘樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1572-1572, 2021.

---

	P47-05. Confirmation duties of the cancellation medicine before surgery, examination and the evaluation 柏原由佳, 柘植縁理佳, 伊波樹, 江畠麗, 佐伯美沙, 田中章久, 前田絵里加, 松崎あい理, 田中克巳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1573-1573, 2021.

---

	P47-06. Our hospital's efforts toward the proper use of omidenepag isopropyl ophthalmic solution 柴谷直樹1, 宮坂萌菜1, 平野達也1, 奥吉博之1, 大江泰2, 藤原雅史3, 室井延之1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1574-1574, 2021.

---

	P47-07. About the response to medication incident in the internal use self-care patients 川崎文雄1,2, 瀬戸梓1, 山ノ内芹南1, 平松美早1, 与那城知夏1, 奥西美奈1, 小室寿子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1575-1575, 2021.

---

	P47-08. Trends in the use of sleeping pills and effects on falls due to the introduction of an insomnia indicator formulary among hospitalized patients 小池彩子1,2,3,4,5, 原田亮2, 畑賢俊3, 山田美智子4, 中島誠5, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1576-1576, 2021.

---

	P47-09. The current situation and problem of a fall, the fall in the Hokuriku center Hospital 守内匡1, 秋元恵子2, 中山詠美2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1577-1577, 2021.

---

	P47-10. Operation of the cancellation medicine before effective and safe hospitalization using the protocol 伊藤隆哉 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1578-1578, 2021.

---

	P47-11. Examination of the information sharing method by the registration situation investigation of the allergy to patients information 保戸塚里美, 疋田絵梨, 城田幹生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1579-1579, 2021.

---

	P47-12. About the injection drug bar code authentication system introduction in ward/emergency room and the usefulness 福長豊己1, 田辺友也1, 高橋恭平1, 原田靖子1, 西原昌幸2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1580-1580, 2021.

---

	P47-13. Examination of the current situation investigation and measures about the registration that an alert of the drug allergy does not function 小澤明日香, 渡邊卓巳, 坂本拓也, 白石貴寿, 荒井宏人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1581-1581, 2021.

---

	P47-14. Introduction effect of the mark to alert on drug requiring attention at a decreased renal function 東春奈, 淺津裕子, 片岡憲昭, 柿迫大樹, 牧野順子, 西原雅美, 内山和久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1582-1582, 2021.

---

	P47-15. ... to look back on from bar code use and application - incident report aiming at medical security and duties efficiency 鈴木良1,2, 折井孝男1, 山口智史2, 杉田匡聡2, 加藤敏明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1583-1583, 2021.

---

	P47-16. Difference in depiction by plain radiography and CT taking picture of drug and PTP sheet 宇野尭1, 高橋庄太1, 田浦将明2, 米田瑞輝2, 薄井健介1,3, 千葉浩生2, 大原貴裕4, 岡田浩司1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1584-1584, 2021.

---

	P47-17. Fact-finding about the misunderstanding of similar pharmaceutical products in clinical settings and the measures 小林彩乃1, 佐藤宏樹2,3, 柳奈津代2, 澤田康文2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1585-1585, 2021.

---

	P47-18. Effect by the efforts of the sleeplessness instructions adequacy 伊藤匡伸1, 寺村由枝1, 西川裕美1, 和田侑輝人1, 足立康則2, 杉浦洋二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1586-1586, 2021.

---

	P47-19. Fall fall risk factorial experiments using the on admission evaluation score, Nested case-control study 石田亮1,3, 赤木晋介2,3, 塩津昭子3,4, 西出康晴3,4, 徳増裕宣1,3, 橋本徹3,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1587-1587, 2021.

---

	P47-20. Making of the citrus fruits eating and drinking advisability card to use for the Erlotinib remedy patients 西川直也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1588-1588, 2021.

---

	P47-21. Duties improvement from the position of the development situation and the pharmacist of the drug-related incident in the southern part of Saiseikai Yokohama-shi Hospital 深沢貴志1,2, 上原美佐2, 澤田真実1, 関根美保1, 南太一1,3, 鈴木康太郎1, 猿渡力1, 加藤一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1589-1589, 2021.

---

	P47-22. Evaluation using the development of the pharmacy student medical care safety education program that adopted active learning and the text mining 木下徳康1,3, 新谷拓也1,3, 廣部祥子1,2, 中村京太3, 前田真一郎1,2, 奥田真弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1590-1590, 2021.

---

	P47-23. Production (the second report) of reporting 4, Tours top comics about the proper use of pharmaceutical products 丸山凜七1, 徳永仁1, 河田実優1, 帳智香1, 園田純一郎1, 興梠靖幸2, 緒方賢次2, 高村徳人2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1591-1591, 2021.

---

	P47-24. Production (the second report) of the animation for the purpose of the improvement in medication adherence 河田実優1, 徳永仁1, 帳智香1, 丸山凜七1, 園田純一郎1, 興梠靖幸2, 緒方賢次2, 伊藤寛3, 高村徳人2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1592-1592, 2021.

---

	P47-25. An effect and problem of the workshop that took in the short play of the pharmaceutical products-related incident example 齊藤直美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1593-1593, 2021.

---

	P47-26. About pharmacist intervention to discontinuation confirmation before surgery in the outpatient department 安田郁稀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1594-1594, 2021.

---

	P47-27. QI activity with the number of incident reports as an index 山本倫数, 前田晃佑, 山本浩二郎, 濱田達志, 山田直輝, 森下夏伎, 大里恭章 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1595-1595, 2021.

---

	P47-28. Usefulness of the e- learning teaching materials about the oral medicine transluminal administration which we made by the multi-type of job collaboration 新谷拓也1,2, 木下徳康1,2, 百田真弓1, 徳永あゆみ1, 新開裕幸1, 北村温美1, 奥田真弘2, 中村京太1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1596-1596, 2021.

---

	P48-01. Attempt - to ward remote training using the pharmacy school long-term business training - online system in the corona evil 曽根千晶, 角野雄亮, 渡辺瑞貴, 久保有佳梨, 吉年正宏, 岩崎浩子, 藤原季美子, 竹上学 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1599-1599, 2021.

---

	P48-02. The effect that contents change of the pharmacy business training in the corona evil gives to a self-assessment arrival degree 青井博志, 岡田和也, 大西健太, 谷田彩, 小川恵美子, 吉川一吾, 池田和之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1600-1600, 2021.

---

	P48-03. Maintain the satisfaction of the student how while combining business training - remote training under the new coronavirus infection outbreak that conducted in our hospital; or ... 善積美佳1, 熊久保さえ香1, 大久保淳史1, 立沢正臣1, 下泰司1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1601-1601, 2021.

---

	P48-04. Extraction of the improvement item by a learning effect and the satisfaction questionnaire of the ward business training under the new coronavirus infection outbreak 道場勇真, 高野明香, 高野温志, 伊賀正典, 町田充 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1602-1602, 2021.

---

	P48-05. Correspondence of the long-term business training in our hospital under the new coronavirus infection outbreak and inspection of the usefulness in the hybrid training 近藤昭志, 成田勇樹, 城野博史, 三宅俊介, 山川祐可子, 大坪謙一, 池田瑞季, 山下諒祐, 清住友香, 末永安司, 成田さわな, 嶋村桃子, 政賢悟, 田中順子, 齋藤秀之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1603-1603, 2021.

---

	P48-06. Business training curriculum corresponding to the clinical practice in the corona evil 大久保有起, 風岡典子, 國廣志保美, 福田英克, 南波勝栄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1604-1604, 2021.

---

	P48-07. Evaluation by the pharmacy student to the business training in the corona evil 佐々木紀彰, 古元俊徳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1605-1605, 2021.

---

	P48-08. It is ... through change of the business training contents accompanied with the corona evil and evaluation - questionary survey 奥野昌宏, 田中詳二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1606-1606, 2021.

---

	P48-09. Questionary survey about the hospital business training under the new coronavirus infection outbreak 久賀谷幸昌1, 西園寺真二1, 中村護1, 濱崎浩一1, 覚前美希2, 田山剛崇2, 三宅勝志2, 山崎美保1, 面田恵1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1607-1607, 2021.

---

	P48-10. Efforts of the hospital training under the new coronavirus infection spread 安達るい, 西田初博, 三嶋一登 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1608-1608, 2021.

---

	P48-11. Inspection of the study Osamu effect that assumed evaluation of achievement of the pharmacy business training under COVID-19 pandemic an index 鈴木小夜1, 平賀ゆい1, 岩田紘樹2, 地引綾1, 横山雄太1, 河添仁1, 小林典子2, 藤本和子2, 中田英夫3, 青森達3, 山浦克典2, 中村智徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1609-1609, 2021.

---

	P48-12. Inspection of the effect on medication counseling training of 8 representative diseases in the business training under COVID-19 pandemic 岩田紘樹1, 地引綾2, 鈴木小夜2, 横山雄太2, 平賀ゆい2, 河添仁2, 小林典子1, 藤本和子1, 中田英夫3, 青森達3, 山浦克典1, 中村智徳2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1610-1610, 2021.

---

	P48-13. Effect of the corona evil analyzed than questionary survey about the drugstore business training 吉田都1, 小島穂菜美1, 宇野莉央1, 内田享弘1, 大川恭子1, 笠井眞二1, 政田啓子1, 池上咲枝里1, 井上智咲1, 波多江崇2, 森山賢治1, 中村一基1, 篠塚和正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1611-1611, 2021.

---

	P48-14. Effect of the corona evil analyzed than questionary survey about the hospital business training 小島穂菜美1, 吉田都1, 宇野莉央1, 内田享弘1, 桑原晶子1, 豊原朋子1, 濱宏仁1, 辻本勉1, 片岡和三郎1, 田崎眞生1, 波多江崇2, 森山賢治1, 中村一基1, 篠塚和正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1612-1612, 2021.

---

	P48-15. Efforts of the pharmacy business training acceptance in the corona evil 新井由希, 伊東充, 高澤千重理, 桝早紀子, 成田瞳, 佐藤香織, 勝俣はるみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1613-1613, 2021.

---

	P48-16. Inspection of the effect of COVID-19 pandemic in the domain evaluating by the business training record 地引綾1, 横山雄太1, 鈴木小夜1, 岩田紘樹2, 平賀ゆい1, 河添仁1, 小林典子2, 藤本和子2, 中田英夫3, 青森達3, 山浦克典2, 中村智徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1614-1614, 2021.

---

	P48-17. The change of training contents in the trial secretariat and the future prospects 綿貫陽一, 白根尚子, 日浦寿美子, 小林秀樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1615-1615, 2021.

---

	P48-18. The visualization of the problem point of the harmful effect education using the text mining and examination 大和幹枝1, 松野純男2, 土肥弘久1, 長南謙一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1616-1616, 2021.

---

	P48-19. Establishment of the education situation grasp system using the duties check seat 土居紋子, 安藤洋介, 上野美幸, 森万奈, 浅井遥, 川波恭子, 太田秀基 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1617-1617, 2021.

---

	P48-20. Where is the charm, the fun of situation - hospital pharmacist of the stature of the student judging from an arrival degree (outline) evaluation in the hospital training? ... 渡邉正教, 中沢修司, 日比徹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1618-1618, 2021.

---

	P48-21. We can measure the performance level of the trainee using the outline evaluation of the lube Rick pattern in the business training in conformity with revision core Cali 河添仁1, 鈴木小夜1, 平賀ゆい1, 横山雄太1, 地引綾1, 岩田紘樹2, 小林典子2, 藤本和子2, 中田英夫3, 青森達3,4, 山浦克典2, 中村智徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1619-1619, 2021.

---

	P48-22. Evaluation of the online training accompanied with the outbreak of COVID-19 judging from the questionnaire results of a student, the pharmacist 石橋正祥, 飯村洋平, 入江杏奈, 伊地知由樹, 古川直樹, 吉森瞳, 石井英里, 山村実佳, 福司佳穂里, 中原規容子, 黒田誠一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1620-1620, 2021.

---

	P48-23. Remoteness in the 2020 hospital business training and efforts about the training with the high Bullitt pattern of the meeting 石原祥子, 大谷寧次郎, 三浦毅 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1621-1621, 2021.

---

	P48-24. The consciousness change investigation of the student by the prevention of drug abuse class and evaluation of the class teaching materials 赤松祐介1, 赤松路子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1622-1622, 2021.

---

	P48-25. Student independent participation type hospital business training and satisfaction investigation 橋本竜1,2, 栃木恵里1, 高橋彩花1,2, 玉井一也1, 宮内輝人1, 吉成宏顕1, 久保倫美1, 鈴木優子1, 大矢智則1,2, 佐藤淳也1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1623-1623, 2021.

---

	P48-26. Evaluation of the bedside teaching pattern that used the on-demand teaching materials together 片岡憲昭1, 倉地果純1, 遠藤久美子1, 坂井紀水1, 畑武生1, 鈴木典子1, 角山香織2, 羽田理恵2, 中村敏明2, 西原雅美1, 内山和久1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1624-1624, 2021.

---

	P49-01. Development and evaluation of the material for the self-learning for the purpose of the basic knowledge acquisition of the checking prescription in a tumor, the immune center 奥村洋平1, 櫻井洋臣1, 笠井雄佑1, 野々宮菜彌1, 吉田加奈1, 津田壮一郎1, 山吉康子1, 村松博1, 青森達1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1626-1626, 2021.

---

	P49-02. The current situation and problem of the pharmacist resident system in our hospital 山本幸二郎1, 畠山成寛1, 岡村央1,2, 川邉桂1, 小池博文1, 佐橋幸子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1627-1627, 2021.

---

	P49-03. Introduction effect of the lube Rick evaluation on pharmacist resident training 綿本有希子, 伊藤雄大, 清水倫子, 栗村朋子, 松本久美子, 谷藤亜希子, 飯田真之, 大本暢子, 久米学, 山本和宏, 大村友博, 矢野育子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1628-1628, 2021.

---

	P49-04. The present situation of the medical therapy workshop by University of Shizuoka, hospital, the community pharmacy cooperation 大澤隆志1, 賀川義之1,2, 伊藤邦彦2, 山田浩2, 森本達也2, 黒川絢子2, 並木徳之2, 矢部勝茂2, 河西きよみ2, 鈴木貴也2, 青島弘明2, 櫻井和子2, 松山耐至2, 井上達秀2, 山田静雄2, 真鍋敬2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1629-1629, 2021.

---

	P49-05. Efforts using the lube Rick evaluation of the compounding of medicines duties in the pharmacist resident 渡邉美菜子, 宮崎典子, 戸嶋彩乃, 田中理子, 矢田郁実, 亀島理沙, 太田小織, 千崎康司, 山田清文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1630-1630, 2021.

---

	P49-06. Carrier design result report of the Hekinan Municipal Hospital pharmacy 渡邉香織1, 片山広美1, 天野哲史1, 石井彩子1, 伊藤昌美1, 八並ゆかり1, 加藤奈美1, 鈴木めぐみ1, 鈴木厚志1, 板倉由縁2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1631-1631, 2021.

---

	P49-07. Examination - of the high performer image in the construction (the second report) - pharmacist version clinical ladder making of the hospital pharmacist staff education system 小山郁美1, 稲野寛1, 婦川貴博2, 坂倉智子1, 近藤留美子1, 谷口陽子3, 厚田幸一郎1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1632-1632, 2021.

---

	P50-01. Final report of the identification results of bacteria detected in the surface of the formulations instrumentation 佐藤亜希子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1634-1634, 2021.

---

	P50-02. It is examination about the reflection to the current situation and the safety measures of the investigation after the production and sales by the all cases investigation in Japan 中尾美波, 前田英紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1635-1635, 2021.

---

	P50-03. Shortening of the doubt inquiry correspondence time by the efforts outside Parliament prescription doubt inquiry simplification protocol (PBPM procedure) introduction to duties improvement 高木洋明1, 鬼窪利英1, 中野和佳1, 三浦篤史2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1636-1636, 2021.

---

	P50-04. Efforts ... for stocktaking and the improvement of the muscat drugstore made from ... drugstore KPI for achievement of drugstore vision for patients of 2 years 高橋正志1, 安倉央1,2, 守安洋子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1637-1637, 2021.

---

	P50-05. Examination about the change factor between the individual of the placebo effect 間宮桐子1, 新井菜々美1, 井澤美苗1, 石川春樹1, 中田英夫2, 青森達1,2, 望月眞弓1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1638-1638, 2021.

---

	P50-06. Pharmaceutic approach for the delirium risk reduction that a dementia care team conducts 瀬古高裕, 辻内喜久雄, 山名知子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1639-1639, 2021.

---

	P50-07. Usefulness evaluation of the intestinal tract organoid derived from human iPS cells for the inflammatory bowel disease healing 渡邊ちひろ1, 中西杏菜2, 小野里太智2, 奥村啓樹2, 坡下真大2, 岩尾岳洋2, 松永民秀2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1640-1640, 2021.

---

	P50-08. A BLS class for citizens and the result 比嘉耕基1, 齋藤靖弘2, 田中寿和1, 木下隆市1, 染谷光洋1, 谷口亮央1, 中島史雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1641-1641, 2021.

---

	P50-09. Effect of the comprehensive prior agreement protocol introduction in the outside Parliament prescription 萩原大樹1, 永江寛子1, 江藤浩平2, 小松公秀2, 兼重晋3, 神村英利3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1642-1642, 2021.

---

	P50-10. Approach - from enforcement and education effect - economic aspect of the cancer education for the high school student 横山郁子1, 河内正二1, 園部愛梨1, 渡邊理乃1, 藤本佳昭2, 沼田千賀子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1643-1643, 2021.

---

	P50-11. Quantity of duties evaluation after the flex time introduction accompanied with the work-style reform 立沢正臣1, 下泰司2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1644-1644, 2021.

---

	IP-01. Pregnancy and Infant Outcomes for Golimumab Therapy for Ulcerative Colitis During the Pregnancy and Lactation Periods : A Retrospective Report Ayami Miyai1, Kozo Tatsumi1, Minoru Kawai1, Hiroyuki Miyazaki2, Kyosuke Takeuchi2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1648-1648, 2021.

---

IP-02. Analysis of polypharmacy effects in older patients using Japanese Adverse Drug Event Report database Mitsuhiro Nakamura1, Junko Abe1,2, Ryogo Umetsu1, Hiroaki Uranishi1, Honami Suzuki1, Yuri Nishibata1, Yamato Kato1, Natsumi Ueda1, Sayaka Sasaoka1, Haruna Hatahira1, Yumi Motooka1, Mayuko Masuta1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1649-1649, 2021.

---

IP-03. Role of symptoms cluster using EORTC QLQ-C15-PAL scores and inflammatory biomarkers in predicting survival in terminally ill patients with cancer Chikako Matsumura1, Nanako Koyama1, Morito Sako2, Hideo Kurosawa2, Takehisa Nomura2, Yuki Eguchi2, Kazuki Ohba2, Yoshitaka Yano1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1650-1650, 2021.

---

	IP-04. Occurrence of encephalitis due to immune checkpoint inhibitors : A pharmacovigilance study Yugo Chisaki1, Hiroki Hata1,2, Chikako Matsumura1, Yoshitaka Yano1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1651-1651, 2021.

---

	IP-05. Risk factors associated with the development of hepatic dysfunction during teicoplanin administration in pediatric patients Kazumasa Narita, Erina Motoki, Akira Mimura, Shusuke Ozawa, Satoshi Yamaori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1652-1652, 2021.

---

	IP-06. Evaluation of risk of long QT syndrome caused by drug-drug interactions using a spontaneous reporting system Jun Matsuo1,2, Satoshi Yamaori1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1653-1653, 2021.

---

IP-07. Impact of substrates and inhibitors of breast cancer resistance protein on apixaban pharmacokinetics in Japanese patients with atrial fibrillation Satoshi Ueshima1, Daiki Hira1,2,3, Karin Hirata1, Yohei Tabuchi2, Tomoya Ozawa1, Hideki Itoh4,5, Yoshihisa Nakagawa4, Minoru Horie4, Tomohiro Terada2,3, Toshiya Katsura1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1654-1654, 2021.

---

IP-08. Impact of silicone oil tamponade on intraocular vancomycin pharmacokinetics after intravitreal injection in cynomolgus monkeys Daiki Hira1,2,3, Tomoya Kitagawa1, Taku Imamura4, Masashi Kakinoki4, Satoshi Ueshima1, Tomonobu Okano1, Masahito Ohji4, Mikio Kakumoto1, Tomohiro Terada2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1655-1655, 2021.

---

	IP-09. A preliminary trial for developing the methodology intended to broaden pharmacy students? global horizons Yoshimi Tomita1, Kinko Tamamaki2, Shoji Kawauchi1, Yoshihiko Tauchi1, Junichi Kunimasa1, Okiko Miyata1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1656-1656, 2021.

---

	IP-10. Predictors of the onset of type 1 diabetes obtained from real-world data analysis in cancer patients treated with immune checkpoint inhibitors Shinya Takada1, Hirokazu Hashishita1, Kayo Yamagishi1, Hideki Sato0, Kozo Mino1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1657-1657, 2021.

---

	IP-11. Evaluation of Appropriateness of Changing Intravenous ImmunoglobulinAdministration Schedule in Pediatric Recipients of Hematopoietic Stem Cell Transplantation Sorah Lee1, Hee Young Geum1, Ae Ryoung Park1, Jeong Yi Yoon1, Jin Suk Kang1, Jae Wook Lee2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1658-1658, 2021.

---

	IP-12. Impact of a multidisciplinary antimicrobial stewardship program for decreasing the duration of prophylactic antibiotic use Atsushi Uda1,2, Kei Ebisawa1,3, Mari Kusuki1, Rie Izuta1, Mariko Yahata1, Kayo Osawa4, Ikuko Yano2, Takayuki Miyara1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1659-1659, 2021.

---

IP-13. Effects of concomitant use of antiemetic drugs on cisplatin-induced renal injury Mitsuhiro Goda1,2,3, Masaya Kanda2,3, Toshihiko Yoshioka2,3, Ami Yoshida2, Takahiro Niimura3, Yoshito Zamami2,3, Fuka Aizawa2,3, Yuki Izawa-Ishizawa4, Kenta Yagi1, Masayuki Chuma5, Hirofumi Hamano2, Naoto Okada3, Keisuke Ishizawa0 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1660-1660, 2021.

---

	IP-14. Revision Pharmaceutical and Medical Device Act, and Pharmaceutical GS1 barcodes utilization for patient safety in Japan Takao Orii1,2, Koichi Uemura3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1661-1661, 2021.

---

	IP-15. P38 MAPK, NF-κB and JAK-STAT3 signaling pathways promoted IL6 or IL8 abnormal expression contributed in capecitabine-induced hand-foot-syndrome Yan Lou, Jiali1, Wang Xiaoyang Lu2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1662-1662, 2021.

---

	IP-16. Clinical applicability of renin-angiotensin system inhibitors in cancer treatment Huirong Jiang1,2,3,4, Zongguang Tai11,2,3, Zhongjian Chen2, Quangang Zhu2, Leilei Bao1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1663-1663, 2021.

---

	IP-17. Huperzine A provides retinal neuroprotection via the M1 mAChR Ping Yu, Wen-Pei Dong, Ya-Bin Tang, Hong-Zhuan Chen, Yong-Yao Cui, Xiao-Lan Bian Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1664-1664, 2021.

---

	IP-18. Construction and validation of real-time PCR based measurement of NUDT15 gene polymorphism Tetsuichiro Isono1, Daiki Hira1,2, Masahiro Kawahara3, Akira Andoh3, Tomohiro Terada1,3, Shin-ya Morita1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1665-1665, 2021.

---

	IP-19. SGLT2 inhibitors in patients with cardiovascular disease or cardiovascular risk : a systematic review and meta-analysis of cardiovascular outcome trials Zinan Zhao1, Yatong Zhang1, Pengfei Jin1, Xin Hu1, Chao Tian3, Deping Liu2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1666-1666, 2021.

---

	IP-20. Presentation of chemotherapy options in cachexia in the literature : a scientometric evaluation Mingnan Cao1, Jingxuan Wu2, Li Wang3, Ruihua Dong2, Zhigang Zhao1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1667-1667, 2021.

---

	IP-21. Correlation between Clock gene methylation and therapeutic effect in patients with depression disorder Ou Yaqing1,2, Zhang Yuan1, Lu Chen1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1668-1668, 2021.

---

	IP-22. The effect of liposomal doxorubicin on liver and renal function in patients with breast cancer Du Jie, Gong Zhicheng Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1669-1669, 2021.

---

	IP-23. Evaluation of a Pharmacist-led Remote Warfarin Management Model Using a Smartphone Application (Yixing) in Improving Patients' Knowledge and Outcomes of Anticoagulation Therapy Pan Chen1, Shudan Jiang1,2, Qiuyi He11, Jiajia Yan1, Liyan Zhao1, Yifan Zheng1, Xiao Chen1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1670-1670, 2021.

---

	IP-24. The design and establishment of prescription pre-examination system based on DRG payment platform Sichao Yan, Jiang Dechun Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1671-1671, 2021.

---

	YPL. Clinical pharmacy of Society 5.0 to weave by fusion of the intellect 山本康次郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 92-92, 2022.

---

	23-01-S01-1. Efforts about the securing of reliability of MID-NET 大田有佳里1), 岸塲真理1), 關野一石1), 宇山佳明1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 93-93, 2022.

---

	23-01-S01-2. It is > through an activity about the < master standardization about the standardization containing the COVID-19-related drug in the medical institution 高田敦史1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 94-94, 2022.

---

	23-01-S01-3. The need of the correspondence data standardization, cooperation to the new coronavirus infection in the drugstore 豊見敦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 95-96, 2022.

---

	23-01-S01-4. Data reliability on conducting epidemiologic studies 幾田慧子1), 中川俊作1), 寺田智祐1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 97-97, 2022.

---

	SL1. Role of a digital medical future image and the in that prospective pharmacist 市川太祐1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 98-98, 2022.

---

	EL1. It is ... mainly on scientific collection, evaluation of the drug information, utilization - pharmacokinetics 大谷壽一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 99-99, 2022.

---

	EL2. Proteomics analysis and data health care based on big data 和賀巌1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 100-100, 2022.

---

	23-02-S02-1. Oncology pharmacist in Japan - Practice, Research, and Future Perspectives 土屋雅美1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 101-102, 2022.

---

	23-02-S02-2. Comparison of Japanese and US Pharmacy Education Systems and Daily Pharmacy Practice Mio Ezura1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 103-104, 2022.

---

	23-02-S02-3. Specialty training in oncology and daily practice of clinical pharmacists in the United States Jeffrey C. Bryan1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 105-106, 2022.

---

	23-02-S03-1. [How to edition] One step of the clinical studies beginning: Of "the kind" of the study find; and a way of raising 岡田直人1), 合田光寛1,2), 石澤啓介1,2,3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 107-107, 2022.

---

	23-02-S03-2. [How to edition] We understand ... regulation and an ethic definitely before beginning clinical studies 金光祥臣1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 108-108, 2022.

---

	23-02-S03-3. [How to edition] A type and precaution of the real world data which can inflect for a study 小原拓1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 109-109, 2022.

---

	23-02-S03-4. [practice edition] From the experience of the clinical studies using the electronic medical chart in ... own institution that general hospital pharmacist can do it 漣航平1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 110-111, 2022.

---

	23-02-S03-5. [practice edition] The thing that we need when a clinical pharmacist conducts a study using JADER 松尾純1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 112-112, 2022.

---

	23-02-S03-6. [practice edition] Make use of the experience of the clinical studies using the database of single institution - home and abroad 八木達也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 113-113, 2022.

---

	23-02-S04-1. DX which we saw from small and medium size hospital pharmacist 荒川隆之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 114-114, 2022.

---

	23-02-S04-2. Has an electronic medical chart not become "the computerization of the paper?" 楢林敦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 115-115, 2022.

---

	23-02-S04-3. Medical DX in the drugstore 豊見敦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 116-116, 2022.

---

	23-02-S04-4. ... which thinks about medical quality, security, management in a viewpoint of approach - hospital pharmacist to visualization of the information necessary for the House of DX woes of the times administration 関利一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 117-117, 2022.

---

	23-02-S04-5. DX which we saw from the settings of the pharmacy education 倉田香織1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 118-118, 2022.

---

	23-03-S05-1. From a viewpoint of improvement in role - infection measures addition 1 of the pharmacist sought by infection control, the infection practice support of the corona evil 塩田有史1), 三鴨廣繁2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 119-119, 2022.

---

23-03-S05-2. ... which makes use of the knowledge that we obtained in the infection preventive measures against new development - corona evils addition of the activity of the municipal hospital pharmacist sought by the improvement in infection measures addition 片山歳也1), 鈴木朋克2), 小島さおり3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 120-121, 2022.

---

	23-03-S05-3. Next-generation antimicrobial proper use by the pharmacy service under health insurance drugstore pharmacist 瀧藤重道1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 122-122, 2022.

---

	23-03-S05-4. Expectation to infection control, a pharmacist in the infection practice support who fixed the eyes on the improvement in infection measures addition 三鴨廣繁1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 123-123, 2022.

---

	23-03-S06-1. The task share that an HIV specialist expects from a pharmacist 柳澤邦雄1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 124-124, 2022.

---

	23-03-S06-2. Task shifting to the pharmacist at the start of treatment 樋口裕哉1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 125-125, 2022.

---

	23-03-S06-3. Pharmacist task shifting in treatment assessment 平野淳1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 126-126, 2022.

---

	23-03-S06-4. Task shifting to pharmacists in long-term care 戸矢崎信也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 127-127, 2022.

---

	23-03-S07-1. About the latest antiemesis therapy evidence (about prophylactic measures, measures of prominence-related retching) 前田章光1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 128-128, 2022.

---

	23-03-S07-2. Evidence of the antiemesis therapy which a pharmacist makes 飯原大稔1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 129-130, 2022.

---

	23-03-S07-3. About the condition of a patient, a drug causing retching, vomiting (the clinical reasoning) 桂川健司1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 131-131, 2022.

---

	23-03-S07-4. About the image views that we want to control by retching, vomiting 田近正洋1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 132-132, 2022.

---

	23-03-S07-5. We think about appropriate retching, vomiting measures from a real intervention case! 橋詰淳哉1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 133-133, 2022.

---

	23-06-S08-1. We challenge a multicenter study 林稔展1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 134-134, 2022.

---

	23-06-S08-2. For the enforcement of the multicenter study across the type of job 武智研志1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 135-135, 2022.

---

	23-06-S08-3. Perform the each study for patients with difference - heart failure with a single institution study and the multicenter study; and - 川田敬1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 136-136, 2022.

---

	23-06-S08-4. The multicenter phase II study that a pharmacist conducts 飯原大稔1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 137-138, 2022.

---

	23-06-S08-5. It is ... from the situation of thing - enforcement medical institution which we worked on to conduct a multicenter study smoothly 玉木慎也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 139-140, 2022.

---

	23-06-S09-1. Cooperation of hospital pharmacist and the opening of an office pharmacist at disaster in Gunma 矢島秀明1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 141-141, 2022.

---

	23-06-S09-2. The pharmaceutical information management at disaster and systems construction for disaster pharmaceutical affairs 江川孝1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 142-142, 2022.

---

	23-06-S09-3. How do win information to become the key to pharmaceutical products supply at disaster; role - of the - Japan Red Cross pharmacist society 小林映子1,2), 細谷龍一郎3), 細谷治1), 森英樹4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 143-144, 2022.

---

	23-06-S09-4. Possibility ... of information sharing system - drug support at disaster 市川学1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 145-145, 2022.

---

	23-06-S09-5. The support system of importance and the Japanese Society of Hospital Pharmacists of the information management at disaster 高山和郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 146-146, 2022.

---

	23-06-S10-1. Efforts of next-generation upbringing to support sustainable career path 土屋雅美1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 147-147, 2022.

---

	23-06-S10-2. In the days when does not show a point, it is ... from the person whom we met, mind not to waver, position of resilience ... best hospital pharmacist 藤堂真紀1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 148-148, 2022.

---

	23-06-S10-3. Career path as the pharmacoepidemiology researcher 原梓1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 149-150, 2022.

---

	23-06-S10-4. A medical way of working sustainable throughout the trade: The secret is work life balance 大西友美子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 151-152, 2022.

---

	23-06-S10-5. Why does pharmacy management go well when we support career path? ... ... which sounding out complies with now in individual True North of the pharmacist 大里洋一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 153-153, 2022.

---

	23-07-IS01-1. Patient-centered Pharmaceutical Care Chun-Yu Wang1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 154-154, 2022.

---

	23-07-IS01-2. Mechanisms of SPP1 / αvβ3 axis mediated enzalutamide resistance in castration-resistant prostate cancer and therapeutic strategy Xiaocong Pang1,2), Xiaojiao Sun3), Yanlun Gu1,2), Xu He1,2), Zhenming Liu3), Song Song3), Jie Xia4), Jixin Zhang5), Yimin Cui1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 155-156, 2022.

---

	23-07-IS01-3. Humanitarian Assistance to Ukrainian Refugees in the Republic of Moldova Takashi Egawa1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 157-158, 2022.

---

	23-07-IS01-4. Selection of immediately disintegrating drugs and improvement of dispensing and administration HeeJin Jeong1), MinHee Kum1), SeoYoung Son1), KyungMi Jung1), SooYeon Lee1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 159-160, 2022.

---

	23-07-IS01-5. Effectiveness of the improved prescription review system for outpatients receiving chemotherapy MiSeon Han1), SunA Lee1), YoungHee Lee1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 161-162, 2022.

---

	23-07-IS02-1. Drug development for Niemann-Pick disease Type C : a mechanistic approach to optimize drug-cholesterol interaction Yusei Yamada1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 163-163, 2022.

---

	23-07-IS02-2. Nationwide survey of pharmacies for trends in antimicrobial use and AMR-reduction measures Hirokazu Horikoshi1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 164-164, 2022.

---

	23-07-IS02-3. Identifying Early Predictive Markers for Immune-Related Adverse Events in Nivolumab-Treated Patients Shinya Takada1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 165-165, 2022.

---

23-07-IS02-4. Association between statin use and daptomycin-related musculoskeletal adverse events Masayuki Chuma1), Aki Nakamoto2), Takashi Bando2), Takahiro Niimura3), Yutaka Kondo4), Hirofumi Hamano5), Naoto Okada2), Mizuho Asada6), Yoshito Zamami5), Kenshi Takechi7), Mitsuhiro Goda8), Koji Miyata8), Kenta Yagi3), Toshihiko Yoshioka2), Yuki Izawa-Ishizawa9), Hiroaki Yanagawa3), Keisuke Ishizawa8), Yoshikazu Tasaki1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 166-167, 2022.

---

	23-07-IS02-5. Clinical application education for integration of drug information and basic pharmacology Masahiro Ueda1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 168-169, 2022.

---

	23-08-S11-1. Task shift task shares from a pharmacist to the person except the pharmacist 岸本真1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 170-170, 2022.

---

	23-08-S11-2. Of task shift/share of the self-injection practical skill instruction for patients with diabetes in the Nishijin Hospital, actually 三宅健文1), 池田未久里1), 植村有加1), 安田早織1), 辻芙美1), 矢野美保2), 牛嶋麻紀1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 171-172, 2022.

---

	23-08-S11-3. Task shift task share by pharmaceutical management PBPM in wards, and the like 篠永浩1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 173-173, 2022.

---

	23-08-S11-4. Task shift task share about the pharmaceutical management, and the like in the perioperative period 舟越亮寛1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 174-174, 2022.

---

	23-08-S11-5. Promotion and team approach in medical care of task shift/share 眞野成康1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 175-175, 2022.

---

	23-08-S12-1. Purpose explanation and the authorized situation and instructions of 2021 河原昌美1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 176-176, 2022.

---

	23-08-S12-2. It is the pharmaceutical intervention for the relapsed patient after the renal pelvis cancer technique which irAE by the Pembrolizumab was suspected in 高橋愛未1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 177-178, 2022.

---

	23-08-S12-3. The heart failure case that resulted in disturbance of consciousness by hyperammonemia due to colon cancer - 5-FU 松尾圭祐1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 179-180, 2022.

---

	23-08-S12-4. The stomach cancer case that examined vomiting during cancer medical therapy and a cause of the oedema lower limb, and was given pharmaceutical intervention 米山大志1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 181-181, 2022.

---

	23-08-S12-5. The case that was able to accomplish allogeneic stem cell transplant in correspondence with fever and TLS at the acute lymphoid leukemia - bridging therapy 渡邉貴子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 182-182, 2022.

---

	23-08-S12-6. About the role that the pharmacist specialized in a cancer takes 池田龍二1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 183-183, 2022.

---

	23-08-S13-1. Try evaluation by organ system! - Tips for circulation management drugs - 西田祥啓1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 184-184, 2022.

---

	23-08-S13-2. According to the organ system: Nerve analogous drug (PADIS) 山本麻里子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2022.

---

	23-08-S13-3. It is kidney edition a challenge for the evaluation according to the organ system in sepsis 今中翔一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2022.

---

	23-08-S13-4. According to the organ system: Infection analogous drug 枦秀樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2022.

---

	23-10-S14-1. Reinforcement of life training and person fortune upbringing of the pharmacist whom Kyoto pharmacist society works on 三浦誠1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2022.

---

	23-10-S14-2. Efforts in the study session for nurses of the nutrition therapy abecedarian who can make use tomorrow, and arrested the characteristic of the adults learner 金子真由美1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2022.

---

	23-10-S14-3. Invention and effect of the multi-type of job nourishment domain study session for young people under 40 years old 矢倉尚幸1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-191, 2022.

---

	23-10-S14-4. Self-study and educational practice in pursuit of the essence of the turnover pharmacists from hospital pharmacist to a drugstore pharmacist 藤田あゆみ1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-193, 2022.

---

	23-10-S14-5. The practical study method that they will make use of knowledge and experience in patients, and worth doing, the growth can realize 長谷川裕矢1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-195, 2022.

---

	23-10-S15-1. From the position of one - clinical practice pharmacist with suspected aciclovir encephalopathy in the elderly men who do not have renal failure in a history - 中嶋宏太1,2,3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-197, 2022.

---

	23-10-S15-2. From the position of one - clinical pharmacist of the Parkinson's disease which an effect of levodopa decreased by a banana - 保戸塚里美1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2022.

---

	23-10-S15-3. From the position of the clinical pharmacist who did graduation in vancomycin and one acute nephropathic - fundamental researches in patients with tazobactam/piperacillin combination cancer - 中谷香織1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2022.

---

	23-10-S15-4. From the position of the teacher of environmental made - college of pharmacy to support case report - 安武夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2022.

---

	23-10-S15-5. From the position of a teacher, the clinical on-site manager of point - college of pharmacy of the case report for abecedarians - 内倉健1), 百賢二1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2022.

---

	23-10-S16-1. How to write clinical results in the pharmacist system specialized in clinical pharmacy 花輪剛久1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-203, 2022.

---

	23-10-S16-2. How to write case report in the pharmacist system specialized in a cancer 三宅知宏1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2022.

---

	23-10-S16-3. How to write case report in the pharmacist system specialized in medical therapy 小川敦1), 関根祐子2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-206, 2022.

---

	23-10-S16-4. How to write case report in the pharmacist system specialized in local pharmacy care 出石啓治1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2022.

---

	23-11-S17-1. The way of the metabolism dietetics education in the pharmacy school 千葉正博1), 唐沢浩二1), 岡本まとか1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2022.

---

	23-11-S17-2. Future - that - rehabilitation nourishment reconsidering the nourishment management by the pharmacist, a rehabilitation drug result 東敬一朗1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2022.

---

	23-11-S17-3. A pharmacist "being able to do it by medical care in remote area in the dietetics" 門脇寛篤1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2022.

---

	23-11-S17-4. A role and challenge of the pharmacist maximizing convalescent nourishment support 松本彩加1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2022.

---

	23-11-S17-5. Relation pharmacist in local one body type NST 近藤宏樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2022.

---

	23-11-S17-6. Role of the drugstore as the healthy station 小黒佳代子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2022.

---

23-11-S18-1. Than a study of the algorithm making to be hard to take medicine, and to support associated with report - deglutition functional decline of the medication situation investigation in the old man insurance institution, the intraoral Residual medicine investigation - 肥田典子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-215, 2022.

---

	23-11-S18-2. Problems of the tablet crush 鈴木慶介1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2022.

---

	23-11-S18-3. Incompatibility in the crush and simple suspension method 石田志朗1), 倉田なおみ2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2022.

---

	23-11-S18-4. We add a role and the eating deglutition function recovery system of the pharmacist in the dysphagia measures team 関谷秀樹1), 石井杏奈1), 山崎香代1), 鷲澤尚宏1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2022.

---

	23-11-S18-5. How to drink medicine guide - to lead from eating dysphagia - diet situation 倉田なおみ1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-220, 2022.

---

	23-11-S19-1. We cope with ... evaluation that you should do if we examine disturbance of consciousness 森安恵実1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2022.

---

	23-11-S19-2. Approach for patients with disturbance of consciousness of the intensive care domain 吉廣尚大1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2022.

---

	23-11-S19-3. Approach for patients with disturbance of consciousness of the cancer domain 東加奈子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2022.

---

	23-11-S19-4. Approach for patients with disturbance of consciousness of the psychiatry domain 加藤隆寛1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2022.

---

	23-12-S20-1. Renal disease study prospective from "renal failure practice guidelines at the revised edition cancer medical therapy" 松原雄1), 柳田素子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2022.

---

	23-12-S20-2. The point that you should seize in the clinical studies enforcement of kidney and the cardiovascular disease 原梓1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2022.

---

	23-12-S20-3. The drug-related nephropathic basics and clinical studies 中川俊作1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2022.

---

	23-12-S20-4. Drug-related nephropathic clinical studies utilizing the database 國津侑貴1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-229, 2022.

---

	23-12-S21-1. Backstage ... of ... upbringing to learn through the cooperation with inside the hospital, the area together 池末裕明1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2022.

---

	23-12-S21-2. Efforts for promotion of clinical studies about the cancer relaxation medical care in connection with medical facilities and upbringing of the coworker 松村千佳子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2022.

---

	23-12-S21-3. Carrier support and personnel training through the member of society postgraduate education of the pharmacist staff 内藤隆文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2022.

---

	23-12-S21-4. Study type pharmacist upbringing strategy - Osaka University Pharm. in all study type 6-year pharmacy education systems D course ... 前田真一郎1,2), 奥田真弘1,2), 藤尾慈1,3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-234, 2022.

---

	23-12-S21-5. Point of review, the article examination to be useful for article making 田崎嘉一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2022.

---

	23-12-S22-1. Hyperkalemic management of patients with kidney disease chronic for the preservation period 吉田紗理1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2022.

---

	23-12-S22-2. Hyperkalemic ... ... which steps, and knows the depth of patients on dialysis 吉田拓弥1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2022.

---

	23-12-S22-3. Hyperkalemic management of renal-transplant recipients 安田知弘1), 恒川龍二1), 木全司1), 長谷川雄基2), 田中慧2), 余西洋明2), 西沢慶太郎2), 二村健太2), 岡田学2), 平光高久2), 後藤憲彦2), 鳴海俊治2), 渡井至彦2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2022.

---

	23-12-S22-4. Management of the hyperkalemia at the health insurance pharmacy 菅原鉄矢1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2022.

---

	23-13-S23-1. The condition of a patient and treatment of respiratory illness with the airflow obstruction 福岡和也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2022.

---

	23-13-S23-2. The onset risk of infection mechanism of COVID-19 and the asthmatic patients: A point and reproduction of the pulmonary tissue judging from the viewpoint of importance and the laboratory study of the appropriate inhalation therapy 山本直樹1,2,3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 241-242, 2022.

---

	23-13-S23-3. Point judging from the pharmacist viewpoint of the acute phase hospital 朝倉佳代子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2022.

---

	23-13-S23-4. Point judging from the pharmacist viewpoint in the regional alliances by the corona evil 尾上雅英1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2022.

---

	23-13-S23-5. A change of the inhalational instruction in the corona evil that we saw from a drugstore pharmacist and future problem 服部静香1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2022.

---

	23-13-S24-1. Heart rehabilitation of the old heart failure 安達仁1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2022.

---

	23-13-S24-2. Physical therapy for the hospitalization-related ability drop prevention of patients with old heart failure and local heart rehabilitation 齊藤正和1), 作山晃裕1), 森沢知之1), 高橋哲也1), 藤原俊之1,2), 代田浩之1,3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2022.

---

	23-13-S24-3. Point when we use ... chronic cardiac insufficiency therapeutic drug to reconsider for the ... heart failure pandemic era for elderly people 中川隼一1), 島崎博士1), 平島徹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2022.

---

	23-13-S24-4. It is ... from the viewpoint of prevention, treatment and palliative care - circulatory organ charge pharmacist of the heart failure in patients with cancer 田中雅幸1,2), 藤井良平2), 諏訪惠信3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-250, 2022.

---

	23-13-S25-1. Health support drugstore, the regional alliances drugstore which supports an area 廣田憲威1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2022.

---

	23-13-S25-2. Cooperation between local drugstores supporting treatment at home 白石丈也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2022.

---

	23-13-S25-3. Support treatment at home; living-in-; supporting; examine; the role of the pharmacist 餅原弘樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2022.

---

	23-13-S25-4. Look back on the home care support of the pharmacist under the pandemic 齊藤直裕1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2022.

---

	23-13-S25-5. It is cooperation ... between ... medical care cooperation and drugstores from "a thing" in the treatment at home to "humans" 串田一樹1), 廣原正宜1), 宮崎生子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2022.

---

	PL. Efforts and problem of the Japanese cure association for the post-corona 山本康次郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2022.

---

	EL3. The Japanese alphabet of the electronic prescription judging from information system 土井俊祐1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2022.

---

	24-01-SP-1. Approach of Ministry of Health, Labour and Welfare in the data health reform 田中彰子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2022.

---

	24-01-SP-2. Structure and the information use and application which can confirm medical information in the whole country 岡田美保子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2022.

---

	24-01-SP-3. A problem and the prospects of standardization in the computerization of the prescription information and the data use and application 大江和彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2022.

---

	24-01-SP-4. Structure and PHR which can utilize own health medical care information 中島直樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-262, 2022.

---

	SL2. Machine learning, standardization, the quantum computing that Society 5.0 of the pharmaceutical study reform began 鳥飼幸太1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2022.

---

	24-02-S26-1. We understand pharmacokinetic analysis software: From a principle to pit fall 佐古兼一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2022.

---

	24-02-S26-2. A further move of the population analysis: Population pharmacokinetics meta analysis 石原慎之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-266, 2022.

---

	24-02-S26-3. We understand essence of the free form drug concentration: What do you mean? Why is it important? 横山雄太1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-268, 2022.

---

	24-02-S26-4. TDM in consideration of the interaction between drug - endogenous material: Distribution to lipoprotein 土岐浩介1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-270, 2022.

---

	24-02-S26-5. Way of thinking of the pharmacokinetic assessment on the basis of pharmacokinetics, physiology, pharmacology 山本武人1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2022.

---

	24-02-S27-1. Challenges from clinical duties to the new study domain utilizing the IT technique to unfold 牛尾聡一郎1), 木村郁哉1), 川端崇義1), 三浦太郎1), 濱野裕章1), 鍛治園誠1), 西原茂樹1), 村川公央1), 座間味義人1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2022.

---

	24-02-S27-2. You utilize data science, and can you solve a clinical question? It is ... with the database study by ... clinical pharmacist 八木達也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2022.

---

	24-02-S27-3. We learned for evidence construction for pharmaceutical products proper use in ... graduate school and clinical settings 小出博義1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-275, 2022.

---

	24-02-S27-4. Study ... about thing - cancer-related duties X cancer drug resistance mechanism that we obtained it by conducting fundamental researches in the position of the clinical pharmacist 高橋理充1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2022.

---

	24-02-S28-1. Challenge to the basics, the intractable disease conquest that assumed a clinical fusion study a breakthrough 城野博史1,2), 齋藤秀之1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2022.

---

	24-02-S28-2. Development of the basics, clinical fusion type study being aware of the strength of the pharmacy 大山要1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2022.

---

	24-02-S28-3. Basic clinical fusion type study by the data science that assumed medical big data a base 座間味義人1), 牛尾聡一郎1), 濱野裕章1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2022.

---

	24-02-S28-4. Expression of circadian rhythm and drug transportation transporter control of the RNA editing enzyme in human proximal tubules cells 小柳悟1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2022.

---

	24-02-S28-5. The basics, clinical studies aiming at the treatment optimization of patients with infection 松元一明1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2022.

---

	24-03-S29-1. Administrative efforts about the pediatric pharmaceutical products development 文靖子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2022.

---

	24-03-S29-2. Proper use promotion of pharmaceutical products in the childhood medical therapy judging from a viewpoint of the academia 石川洋一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2022.

---

	24-03-S29-3. Proper use of pharmaceutical products in the childhood medical therapy judging from the viewpoint of the pharmacist who worked for a pediatric special hospital 齊藤順平1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2022.

---

	24-03-S29-4. We think about pharmaceutical products proper use of the childhood medical therapy in the general hospital from the position of the drug section manager 平下智之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2022.

---

	24-03-S29-5. Proper use of pharmaceutical products in the childhood medical therapy judging from the viewpoint of the pediatrician 河田興1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-287, 2022.

---

	24-03-S30-1. We think about the TDM of the 5-FU system anticancer agent based on evidence 白岩健1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-289, 2022.

---

	24-03-S30-2. TDM of busulfan that creation of the evidence is expected 山崎伸吾1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2022.

---

	24-03-S30-3. Choice of the quantitative analysis technology to extend TDM duties 森川剛1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2022.

---

	24-03-S30-4. Importance of the inflammatory response on performing TDM 榎屋友幸1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2022.

---

	24-03-S30-5. TDM approach by Model-informed precision dosing 尾田一貴1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2022.

---

	24-03-S31-1. The multi-type of job cooperation education in university and connection to business training 津田真弘1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2022.

---

	24-03-S31-2. With the multi-type of job cooperation education in the pharmacy business training in the circulatory organ domain 段林正明1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2022.

---

	24-03-S31-3. Emergency intensive care, Interprofessional Education in the disaster healthcare setting 檜山洋子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2022.

---

	24-03-S31-4. We make use of the infection related to multi-type of job round in a clinic and show a pharmacy student, a medical student the back of the professional 今井徹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-298, 2022.

---

	24-03-S31-5. Pharmacy business training aiming at upbringing of the pharmacist who could collaborate in a cancer chemotherapy team 上ノ段友里1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2022.

---

	24-03-S31-6. When a pharmacist changes, medical care changes: Towards the future to be able to shine 矢野育子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-301, 2022.

---

	24-06-S32-1. Efforts to the construction of the blood drug levels assay utilizing the LC/MS/MS and the therapeutic drug monitoring of the psychiatry domain 前川正充1,2), 佐藤紀宏1), 鈴鹿雅人1), 佐藤祐司1), 菊地正史1,2), 眞野成康1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-303, 2022.

---

	24-06-S32-2. Challenge to the administration of psychotropic drug optimization utilizing a genetic information and blood drug concentration 猿渡淳二1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2022.

---

	24-06-S32-3. The onset prediction marker of the interstitial lung disease with the anticancer medicine 山本和宏1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2022.

---

	24-06-S32-4. Real world data drive type human pharmacology study aiming at optimization of the medical therapy 合田光寛1,2), 神田将哉1,2), 吉岡俊彦1,2), 新村貴博3), 櫻田巧2), 小川敦2), 相澤風花2), 八木健太3), 石澤有紀4), 座間味義人1,5), 石澤啓介1,2,3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2022.

---

	24-06-S32-5. Development to the personalized medicine that assumed pharmacokinetic information under the special condition of a patient a base 田中遼大1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2022.

---

	24-06-S33-1. We will think about CKD and treatment of the heart failure who had anemia 木下照常1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-309, 2022.

---

	24-06-S33-2. We will think about treatment of acute myeloid leukemia in the elderly people who had multiple diseases 阿部史誉1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-311, 2022.

---

	24-06-S34-1. Insurance of the infertility treatment receives becoming it and a start of the fecundity preservation therapy study promotion business 前沢忠志1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2022.

---

	24-06-S34-2. Infertility treatment, assisted reproductive technology and medical therapy: We think about the relation of the pharmacist 日置三紀1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2022.

---

	24-06-S34-3. Practice of the relation of the pharmacist in the cancer reproductive medicine and the pharmaceutical evaluation 佐々木実緒1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-315, 2022.

---

	24-06-S34-4. Pharmaceutical products risk to patients with the reproductive capability 米村雅人1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2022.

---

	24-07-S35-1. Revised point of the GCP affecting a clinical experimental medicine 黒田智1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2022.

---

	24-07-S35-2. Response of the sponsor accompanied with the GCP revision 渡部ゆき子1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2022.

---

	24-07-S35-3. A fact of the management of the use of trial medicine and future problem 老本名津子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2022.

---

	24-07-S35-4. Expectation to a decentralization clinical study 岩崎優1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-321, 2022.

---

	24-07-S35-5. The role of the drug section in the decentralization clinical study and future problem 近藤直樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2022.

---

	24-07-S36-1. Medical therapy depending on the condition of a patient of the pain 中川貴之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2022.

---

	24-07-S36-2. Polypharmacy in the medical therapy of the pain and the correspondence 萬谷摩美子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2022.

---

	24-07-S36-3. Use of inappropriateness of the medicine relieving a pain 成瀬暢也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-326, 2022.

---

	24-07-S36-4. The prescription start that fixed its eyes on the end in the medical therapy of the pain 山口重樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2022.

---

	24-07-S37-1. underdose in the cardiovascular disease judging from the viewpoint of the physician 佐藤宏行1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2022.

---

	24-07-S37-2. The heart rate control in patients with heart failure and problem of Clinical Inertia 高井靖1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2022.

---

	24-07-S37-3. Only dose adequacy of underdose - DOAC in the anticoagulation is not mission; is ... 芦川直也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2022.

---

	24-07-S37-4. ... which thinks about continuation, the start at the underdose - decreased renal function of the renin-angiotensin system inhibitor 大橋泰裕1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2022.

---

	24-08-S38-1. The women whom prominence-related retching with cyclophosphamide developed in in large quantities in 50s 小室雅人1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2022.

---

	24-08-S38-2. The women whom ptosis and weakness of lower extremities developed in during colon cancer treatment in 70s 橋口宏司1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2022.

---

	24-08-S38-3. The women who appealed for intense lassitude in colon cancer treatment in 60s 土屋雅美1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2022.

---

	24-08-S38-4. Men with suspected creatine kinase rise by drug interactions in 70s 藤田行代志1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2022.

---

	24-08-S38-5. It is ... from the position of expectation - primary physician to a pharmacist playing an active part in the cancer domain 岸田直樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2022.

---

	24-08-S39-1. Study development, acquaintances linking the point to the point and next generation upbringing to carry the next generation 河添仁1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2022.

---

	24-08-S39-2. Learning gained from the experience of multi-center joint research and expanding connections with people 那須いずみ1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2022.

---

	24-08-S39-3. To you to be the pharmacist who had study mind and clinical mind 小林一男1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2022.

---

	24-08-S39-4. Fundamental researches to solve a clinical problem in the cancer chemotherapy 川尻雄大1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2022.

---

	24-08-S39-5. Training ... of medical human resources promoting the study of the reverse translational research - clinical problem solving type to work in pharmacy 今井哲司1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2022.

---

	24-08-S40-1. The perioperative care team pharmacist whom Japanese Society of Anesthesiologists expects 松本美志也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2022.

---

	24-08-S40-2. Perioperative care outpatient department, the distance until pharmacist placement 鈴木史絵1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2022.

---

	24-08-S40-3. Struggle to become the member of the operating room 天野杏南1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2022.

---

	24-08-S40-4. We make the evidence of the pharmaceutical intervention with operating room duties 猪狩賢蔵1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2022.

---

	24-08-S40-5. Aim as an operating room pharmacist 柴田みづほ1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-347, 2022.

---

	24-08-S40-6. Know-how of the pharmacist intervention in the postoperative pain management team 長谷川哲也1), 疋田真理1), 坂本真紀1), 松本高広1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-349, 2022.

---

	24-10-S41-1. Promotion of duties efficiency and the task shift by the robot utilization to formulations, preparation duties in the Mie Univ. Hospital 向原里佳1), 岩本卓也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-351, 2022.

---

	24-10-S41-2. It is ... for safety and the efficiency of construction - compounding of medicines duties of new drug duties by the harmony with a robot and the person 高瀬友貴1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-353, 2022.

---

	24-10-S41-3. Challenge ... to development - formulations mistake zero of the robot drugstore, waiting time zero 渡部正之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2022.

---

	24-10-S41-4. Efforts of the DX promotion that intended the construction of advanced drug duties in the university hospital pharmacy 座間味義人1), 牛尾聡一郎1), 濱野裕章1), 鍛治園誠1), 西原茂樹1), 村川公央1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2022.

---

	24-10-S42-1. Relation to patients with sleep loss that complicated the psychiatric care - depression disorder and extrapyramidal symptoms to patients with cancer by the pharmacist 高瀬久光1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-357, 2022.

---

	24-10-S42-2. Role of delirium and the pharmacist in patients with cancer 菅原英輝1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2022.

---

	24-10-S42-3. Intervention to metastases to brain-induced epilepsy 赤嶺由美子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2022.

---

	24-10-S42-4. Intervention to patients with mental disorder of the cancer onset 坪内清貴1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2022.

---

	24-10-S42-5. The point of contact with psychooncology and the kidney 門脇大介1), 橋本麻衣1), 猿渡淳二2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2022.

---

	24-10-S43-1. Personalized medicine and pathophysiology simulation model utilization as the treatment strategy examination base 中田智久1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-363, 2022.

---

	24-10-S43-2. Pharmacokinetic interaction with the Chinese medicine 猿渡淳二1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2022.

---

	24-10-S43-3. How do have an evaluation, clinical application of drug interaction; from the ... clinical studies, clinical pharmacist's experience - 八木達也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2022.

---

	24-10-S43-4. Pharmacoepidemiology study - using fact-finding - medical care big data of the drug interactions based on the clinical viewpoint 濃沼政美1), 百賢二2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2022.

---

	24-11-S44-1. Why is a symposium of the career path necessary now? 川上和宜1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2022.

---

	24-11-S44-2. How are you thinking about the future and the anxiety as the pharmacist? 江頭早紀1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2022.

---

	24-11-S44-3. The middle age thinks of what, and do you try a clinical study hard? 高橋克之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2022.

---

	24-11-S44-4. Experience real - institution transfer of the career path in the general hospital; and - 田頭尚士1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2022.

---

	24-11-S44-5. Career path to talk about from experience of the chief pharmacist of the institution specialized in three cancers 山口正和1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2022.

---

	24-11-S45-1. A summary and the preparations situation of the next revision pharmacy education model core curriculum 本間浩1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2022.

---

	24-11-S45-2. A role of "the clinical pharmacy." "Clinical pharmacy", it is the intermediary to a bedside teaching 小佐野博史1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2022.

---

	24-11-S45-3. The future prospects of a policy and the bedside teaching of the new "clinical pharmacy" education 鈴木匡1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2022.

---

	24-11-S45-4. "The hygiene pharmacy, public sanitation pharmacy" in the revision model core curriculum about "a pharmacy study" 平田收正1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2022.

---

	24-11-S45-5. We think about the medical person professionalism education in the pharmacy education 鈴木小夜1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2022.

---

	24-11-S46-1. How should you think about BCP of the drug section? 高山和郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-378, 2022.

---

	24-11-S46-2. Of BCP in the small and medium size hospital, actually 岸本真1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2022.

---

	24-11-S46-3. Of BCP in the basic hospital, actually 横山泰昭1), 舟越亮寛1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2022.

---

	24-11-S46-4. About efforts as the trade group for "the trust recovery of the generic drug" 田中俊幸1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2022.

---

	24-12-S47-1. Not only, for a medical person, we read an article, but also why is experience to write by oneself necessary? 片岡裕貴1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-383, 2022.

---

	24-12-S47-2. We learned by the first step - letter writing to systematic review writing and participation in open call for participants study 蔵田靖子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2022.

---

	24-12-S47-3. Invention and wall on practicing systematic review & meta-analysis 小武和正1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2022.

---

	24-12-S47-4. We consider the validity of the study to enroll in the process of the systematic review that we experienced in an intensive care domain: Between Diversity and heterogeneity 吉廣尚大1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2022.

---

	24-12-S47-5. Systematic review & meta-analysis of the cancer domain aiming at pharmaceutical products proper use 森尾佳代子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2022.

---

	24-12-S48-1. Cooperation of patients and the multi-type of job and the pharmacy supporting community medical care 吉山友二1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2022.

---

	24-12-S48-2. From the position of role - primary physician of the pharmacist in regional alliances, the team approach in medical care - 木村琢磨1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2022.

---

	24-12-S48-3. Exploring the ideal form of pharmacies that support community medical care: Initiatives at a small pharmacy in a local city, "Jyujin Pharmacy" 野田敏宏1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2022.

---

	24-12-S48-4. Patients follow-up in the community medical care and reporting to a physician 山本雄一郎1,2,3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2022.

---

	24-12-S48-5. A biological clock and chronotherapy 大戸茂弘1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2022.

---

	24-12-S48-6. Team approach in medical care education and attempt of the community medical care pharmacy education 山下美妃1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2022.

---

	24-12-S49-1. Problems from the analysis of the tracing report to the prescription adequacy in the psychiatry domain seeing 土井信幸1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2022.

---

	24-12-S49-2. The information of patients with mental disorder is insufficient, and how does a hurdle of the prescription intervention break the current situation of high ... health insurance pharmacy? 中田裕介1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-396, 2022.

---

	24-12-S49-3. Adequacy of the psychotropic drug prescription: Cooperation ... with the drugstore family for drug global assessment adjustment management ... medical office, a drugstore 加藤剛1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2022.

---

	24-12-S49-4. Interactive relation as polypharmacy measures in the psychiatry medical therapy 須田修輔1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2022.

---

	24-12-S49-5. Polypharmacy measures to catch in a multidirectional viewpoint: Polypharmacy measures in the education 野田幸裕1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-400, 2022.

---

	24-13-S50-1. Operation and inflection of the tracing report in the cancer special hospital 松井礼子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2022.

---

	24-13-S50-2. Construction ... such as area PBPM, TR, and the like which assumed the ICT of - area core hospital made with a base of the community medical care cooperation for the future a base 関利一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2022.

---

	24-13-S50-3. Because a pharmacist of the community pharmacy supports patients with cancer, we think about effective support and cooperation 長久保久仁子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2022.

---

	24-13-S50-4. Patients with cancer support by cooperation construction and the telephone follow-up in the specialized medical institution cooperation drugstore 村田勇人1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-405, 2022.

---

	24-13-S50-5. Expectation for the way and hospital pharmacist and the health insurance pharmacy pharmacist of the information sharing that we saw from patients 山口育子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-407, 2022.

---

	24-13-S51-1. The basics and development of a nuclide, the drug for the Nuclear medicine treatment 久下裕司1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2022.

---

	24-13-S51-2. Relation of the in-hospital introduction and pharmacist of the radioactive medicines for the Nuclear medicine treatment 加納大輔1,2,3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-410, 2022.

---

	24-13-S51-3. About the association between fact and image of the Nuclear medicine treatment 石守崇好1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2022.

---

	24-13-S51-4. About an activity of the Japanese Society of Nuclear Medicine 間賀田泰寛1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2022.

---

	24-13-S52-1. Collaboration with the physician at the ICI administration in the district hospital 矢野琢也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2022.

---

	24-13-S52-2. It is the turn of the drugstore pharmacist! Long-term side effect management of ICI treated patients 下川友香理1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2022.

---

	24-13-S52-3. It is ... for application to adverse event evaluation - common practice of the patients using the immune checkpoint inhibitor by ePRO 東加奈子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2022.

---

	24-13-S52-4. From a health-related quality of life measurement tool in the medicine medicine cooperation than an expectation development example of the irAE early detection information sharing for the irAE management 清水久範1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2022.

---

	24-13-S52-5. Need and problems ... of the study across the fence of the irAE management - health insurance pharmacy pharmacist 辻将成1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2022.

---

	Receiving a prize -1. (winning the Japanese cure prize from an academic society lecture) the application to creation and the clinical pharmacy study of the nerve mental disorder model on the basis of heredity and an environmental agent 山田清文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2022.

---

	Receiving a prize -2. (winning the prize for encouragement lecture) a clinical evaluation of the pharmaceutical intervention about antimicrobial proper use support and antifungal agent proper use support 植田貴史1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2022.

---

	Receiving a prize -3. (winning the prize for encouragement lecture) basic - clinical studies about the medical therapy optimization of Special population mainly on the impaired renal function 近藤悠希1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2022.

---

	Receiving a prize -4. (winning the prize for encouragement lecture) development of the individualization medical therapy in the psychiatry domain 赤嶺由美子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2022.

---

	Receiving a prize -5. (winning the prize for encouragement lecture) an effect of the antimicrobial medicine and a clinical epidemiology study on safety 中川俊作1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2022.

---

	PA-1. The examination of the optimal administration method in elderly people of the daptomycin and factor analysis about the side effect expression 佐村優1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2022.

---

	PA-2. Effect of the COMT Val158Met genetic polymorphism giving it to an internal change of 3-OMD which is L-dopa under the entacapone combination and the metabolite 山本譲1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2022.

---

	PA-3. Comparison between the placenta, the brain barrier of MDR1 for the tissue drug distribution and the BCRP contribution 藤田有美1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-426, 2022.

---

	PA-4. Search of the new protective for the cisplatin-induced renal failure using In Silico and the In Vivo approach 若井恵里1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2022.

---

	PA-5. Inspection of the effect of the cyclooxygenase inhibitor which paid its attention to a side effect and the resistance of the anticancer agent 岡本敬介1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2022.

---

	PA-6. Development of the new therapy of patients with cardiopulmonary arrest utilizing medical big data 新村貴博1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2022.

---

	PA-7. The search of the active body of the small bowels organic anionic transportation polypeptide (OATP) inhibitory action by the juice and examination of the inhibitory activity 森田時生1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2022.

---

	PA-8. Pharmacokinetic/pharmacodynamic analysis of vancomycin in the special group: Examination in extremely-low-birth-weight infants and patients with Enterococcus faecium bacteremia 笹野央1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2022.

---

	PA-9. Adipose gastrointestinal absorption kinetic analysis derived from a diet through cholesterol transporter NPC1L1 梨本俊亮1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2022.

---

	PA-10. Expression of CYP1 gene analysis with an expression profile of cytochrome P450 in MOG-G-CCM cells derived from a human astrocytoma and polycyclic aromatic hydrocarbon and the antiepileptic drug 小澤秀介1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2022.

---

	25-02-S53-1. Expectation and problem of the AI utilization to pharmaceutical products security 佐藤弘康1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2022.

---

	25-02-S53-2. There is a task shift share with information system and humans supporting duties of the hospital pharmacist and thinks 中尾元紀1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2022.

---

	25-02-S53-3. Medical DX and literacy education 池田和之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2022.

---

	25-02-S53-4. Use and application of the large-scale clinical data to raise medical safety 畑武生1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2022.

---

	25-02-S53-5. Digitization and medical security 町谷安紀1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-439, 2022.

---

	25-02-S54-1. The drugstore where an area is supported in a support, the area 寺島健二1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-441, 2022.

---

	25-02-S54-2. About risk management to be useful for regional alliances demanded from a pharmacist now 野村浩夫1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2022.

---

	25-02-S54-3. ... that a visitor tells important thing - hint because a drugstore stays in history 酒井孝征1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2022.

---

	25-02-S54-4. Thought (proposal from the position of the university teacher educating a next-generation pharmacist) of the drugstore pharmacist who succeeded it from father 鈴木匡1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-445, 2022.

---

	25-03-S55-1. A drug discovery study to practice in the viewpoint of clinical reactions of drugs: The translational research which targeted an anticancer agent adverse event 相澤風花1), 岡林亜美2), 森山大嗣2), 薗田悠平1), 高橋志門1), 新村貴博3), 合田光寛1,2), 座間味義人4), 吉岡俊彦1), 八木健太3), 石澤有紀5), 石澤啓介1,2,3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2022.

---

	25-03-S55-2. An Ikuyaku study to practice in the viewpoint of clinical reactions of drugs: Clinical Pharmacometrics 青山隆彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2022.

---

	25-03-S55-3. The individualization medical therapy that assumed human pharmacology a base 平井利典1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-449, 2022.

---

	25-03-S55-4. Inflection of the evidence aiming at optimization of the medical therapy 上田昌宏1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-451, 2022.

---

	25-03-S56-1. Pharmacist specialized in prospective first aid 添田博1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2022.

---

	25-03-S56-2. We think about a role to demand from a pharmacist specialized in first aid from case report, the study examination of the pharmacist system specialized in first aid 服部雄司1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 453-453, 2022.

---

	25-03-S56-3. Role to expect of a pharmacist specialized in first aid from the situation of the physician 織田順1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 454-454, 2022.

---

	25-03-S56-4. Activity as the emergency authorized pharmacist at the small and medium size hospital 齋藤靖弘1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-456, 2022.

---

	25-03-S56-5. Activity as the emergency authorized pharmacist at the large-scale hospital 岡崎裕太朗1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-457, 2022.

---

	25-03-S56-6. Process of clinical pharmacy study in the emergency intensive care domain 尾田一貴1), 齋藤秀之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 458-458, 2022.

---

	25-04-S57-1. Five-Year Plan to Overcome Stroke and Cardiovascular Disease and the Basic Act on Cardiovascular Disease Countermeasures - Birth of the Japan Stroke Medical Care Workers Union for Multidisciplinary Collaboration with Stroke - 橋本洋一郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2022.

---

	25-04-S57-2. Relation ... of ... acute phase hospital pharmacist who supports the medical treatment of patients with stroke, and ties it 甲斐光1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-460, 2022.

---

	25-04-S57-3. Relation of the pharmacist to patients with stroke in the convalescent rehabilitation ward 多胡和樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2022.

---

	25-04-S57-4. Of the pharmaceutical management, instruction for patients with stroke, actually 青木裕明1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 462-463, 2022.

---

	25-04-S58-1. Bridges from discharge support to at-home duties 米田勝晃1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 464-464, 2022.

---

	25-04-S58-2. The patients support for anyone? Efforts to together happy "patients support" "regional alliances" 長谷川まゆみ1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 465-466, 2022.

---

	25-04-S58-3. Efforts of the medicine medicine cooperation to hospitalization and release support in our hospital 安保文恵1), 工藤航也1), 青山聡1), 高橋幸1), 田口勲1), 戸舘輝人1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 467-467, 2022.

---

	25-04-S58-4. Practice ... of the postgraduate training curriculum which adopted ... health insurance pharmacy training to think about upbringing of the pharmacist who took regional alliances 薩摩由香里1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 468-468, 2022.

---

	25-04-S58-5. The drugstore pharmacist training and effect to promote hospitalization and release support on hospital pharmacist 萱野勇一郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 469-469, 2022.

---

	25-05-S59-1. A clinical pharmacist doing it to be found in medical service fees 佐藤邦義1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 470-470, 2022.

---

	25-05-S59-2. Diabetic nephropathy extension prevention business in the health insurance pharmacy 森貴幸1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 471-471, 2022.

---

	25-05-S59-3. Efforts - for inspection - polypharmacy cancellation of the medical service fees revision item by the intervention of the hospital pharmacist 堀井剛史1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 472-472, 2022.

---

	25-05-S59-4. Challenge to the evidence creation by pharmacist-led specific clinical studies 毛利順一1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 473-473, 2022.

---

	25-05-S60-1. Appropriate use and formulary of medicines 紀平哲也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 474-474, 2022.

---

	25-05-S60-2. Construction of a standard formulary as a drug information resource and its usefulness 上田彩1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 475-475, 2022.

---

	25-05-S60-3. Introduction and operation of formulary at Toda Chuo Medical Care Group and aiming for collaboration with Asaka district 安藤正純1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 476-477, 2022.

---

	25-05-S60-4. Positioning and issues of regional formularies in community pharmacies 畑中典子1,2,3,4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 478-478, 2022.

---

	25-05-S60-5. The position and challenges of formularies from the perspective of physicians 菅原重生1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 479-479, 2022.

---

	25-06-S61-1. COVID-19 acute phase, treatment with Chinese medicine evidence 高山真1), 有田龍太郎1), 並木隆雄2), 小田口浩3), 三谷和男4), 矢久保修嗣5), 久永明人6,7), 貝沼茂三郎8), 伊藤隆7) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 480-481, 2022.

---

	25-06-S61-2. The Development and Application of NRICM101 and NRICM102 in the Treatment of COVID-19 蘇奕彰1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 482-483, 2022.

---

	25-06-S61-3. Influenza protective efficacy of the Hochuekkito by the biophylaxis activity 高梨馨太1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 484-484, 2022.

---

	25-06-S61-4. Problem rearranging for Chinese medicine to be used for infection treatment 渡辺賢治1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 485-485, 2022.

---

	25-06-S62-1. Suitable part as a pharmacist and the part of diabetes medical treatment instruction person filler 林太祐1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 486-487, 2022.

---

	25-06-S62-2. Practice ... of role - CKD team approach in medical care of the pharmacist as the kidney disease medical treatment instruction person 飯田浩子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 488-488, 2022.

---

	25-06-S62-3. What should role - when, anyone of the pharmacist in the circulatory organ domain hold? ... 大橋泰裕1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 489-490, 2022.

---

	25-06-S62-4. While seek integration and the leadership of ... heterogeneity that was necessary for me, and the evolution called the heart failure medical treatment instruction person struggles; ... 土岐真路1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 491-492, 2022.

---

	25-07-S63-1. We think about the second carrier of the hospital pharmacist 赤瀬朋秀1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 493-494, 2022.

---

	25-07-S63-2. Relationship - Japan and Britain comparative study - of "a display opportunity of the specialized ability" and "the job satisfaction" of the drugstore pharmacist 三島重顕1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 495-496, 2022.

---

	25-07-S63-3. Comparison between analysis and job satisfaction change between the types of job by the change of job of the "potentiality, actual existence" that hospital pharmacist reaches quitting a job factor 濃沼政美1), 小串興平2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 497-497, 2022.

---

	25-07-S63-4. The second carrier making use of the hospital pharmacist's experience intellect 高地恵市1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 498-498, 2022.

---

	25-07-S63-5. It is ... from the viewpoint of work motivation - human resource administration of the hospital pharmacist 神崎浩孝1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 499-500, 2022.

---

	25-07-S64-1. Why and one step ... to the solution to How - clinical question 山崎美保1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 501-501, 2022.

---

	25-07-S64-2. To solve eating, dysphagia of elderly people and problems of the medicine 森直樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 502-502, 2022.

---

	25-07-S64-3. Information sharing tool "medication notebook for messages" that we aimed at the safe internal use anticancer medicine medical therapy 森光保武1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 503-503, 2022.

---

	25-07-S64-4. About technique to practice preventive measures against incident accident recurrences using the incident management system effectively 冨岡謙二1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 504-504, 2022.

---

	25-08-S65-1. Result and problem of NAP 2016 大曲貴夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 505-505, 2022.

---

	25-08-S65-2. AMR measures to work on for mind of the activity oneself and others mutual prosperity of the non-full-time union official in the small institution out of one of NAP2016 千葉博暁1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 506-506, 2022.

---

	25-08-S65-3. Activity of the full-time union official in the university hospital after NAP2016 河口義隆1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 507-507, 2022.

---

	25-08-S65-4. How should you be associated with the activity in the pharmacy school after NAP2016 as a pharmacist for NAP2023? 村木優一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 508-508, 2022.

---

	25-08-S66-1. Basic knowledge and point to keep in mind of the childhood medical therapy 山田孝明1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 509-509, 2022.

---

	25-08-S66-2. Relation ... communication of vaccine and the pharmacist and medical safe ... 鈴木高弘1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 510-511, 2022.

---

	25-08-S66-3. Health maintenance increase of means of transportation that a pharmacist undergoes 菊池千草1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 512-512, 2022.

---

	25-08-S66-4. The biostatistical basics in the medical system study 稲葉洋介1), 仕子優樹1), 高嶋郁海2), 小澤義人1), 鈴木貴明3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 513-513, 2022.

---

	25-10-S67-1. The duties that a pharmacist performs to use a drug to the situation of the patients individual safely 姜元美1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 514-515, 2022.

---

	25-10-S67-2. Self-care of the rescue medicine to work on by the multi-type of job 曽根敦子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 516-516, 2022.

---

	25-10-S67-3. Community medical care, efforts and task to cooperation which are found by a drugstore pharmacist 前地香奈子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 517-518, 2022.

---

	25-10-S67-4. About the duty of the pharmacist engaged in relaxation medical care to be required by clinical practice 塩川満1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 519-520, 2022.

---

	25-10-S68-1. Practice - of antimicrobial proper use - de-escalation for the drug resistant bacterium 櫻井紀宏1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 521-521, 2022.

---

	25-10-S68-2. Antimicrobial proper use support to utilize a system, and to practice 菅原義紀1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 522-523, 2022.

---

	25-10-S68-3. Analysis ... of Serious ADR using use and application - adverse drug reaction database of medical big data in the antimicrobial proper use 山田智之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 524-524, 2022.

---

	25-10-S68-4. Evidence construction for the antimicrobial proper use by the inflection of the big data and machine learning 今井俊吾1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 525-525, 2022.

---

	25-10-S68-5. Infection control, infection practice support at the health insurance pharmacy 瀧藤重道1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 526-526, 2022.

---

	25-11-S69-1. The handling of an excretion course and the excrement of the anticancer medicine 森田一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 527-527, 2022.

---

	25-11-S69-2. A fact and problem of the instruction to patient in anticancer medicine exposure measures 黒田直子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 528-528, 2022.

---

	25-11-S69-3. Washing method of the clothing of the patients who received cancer medical therapy 谷川大夢1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 529-529, 2022.

---

	25-11-S69-4. Attitude survey of usefulness and the pharmacist of the brochure about the prevention of anticancer medicine exposure in the patients home 徳留章1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 530-531, 2022.

---

	25-11-S69-5. Exposure to simple suspension method measures in the transluminal administration of oral anticancer medicine 青木学一1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 532-533, 2022.

---

	25-11-S70-1. How should we run the DI room? It is ... with ... ward drug duties and the DI duties of Society5.0 若林進1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 534-534, 2022.

---

	25-11-S70-2. How do you manage the miscellaneous information of the DI room? 荒義昭1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 535-535, 2022.

---

	25-11-S70-3. You share it, and how do you utilize the information such as a side effect report, potentially serious medical errors, the incident, and the like? 川名真理子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 536-536, 2022.

---

	25-11-S70-4. How do you devise the information sharing with the ward exclusive duty pharmacist? 中田英夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 537-537, 2022.

---

	25-11-S70-5. How do you devise the DI duties of the small and medium size hospital? 大庭理寛1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 538-538, 2022.

---

	25-12-S71-1. Topic of the migraine headache therapeutic agent (antibody preparation, triptan drugs) 小西久美1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 539-540, 2022.

---

	25-12-S71-2. Topic of the hypercholesterolemic therapeutic agent (antibody preparation, statin system) 岩佐千尋1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 541-541, 2022.

---

	25-12-S71-3. About the effect on fetuses of the ADHD therapeutic drug 山崎香織1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 542-542, 2022.

---

	25-12-S71-4. The latest topic of the multiple sclerosis therapeutic agent 畠山史朗1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 543-543, 2022.

---

	25-13-S72-1. Importance - of problem - multi-type of job cooperation of the mental health which an HIV infected person holds 矢倉裕輝1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 544-544, 2022.

---

	25-13-S72-2. Is the combination rate of the agent for the psychiatry high in the person with positive HIV-positive person and mental disorder - HIV? - 平野淳1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 545-545, 2022.

---

	25-13-S72-3. About the drug dependence case in the health insurance pharmacy and the psychiatry concomitant drug in the HIV domain 石原千春1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 546-547, 2022.

---

	25-13-S72-4. How should the pharmacist face each other for drug dependence? 松井美由紀1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 548-549, 2022.

---

	25-13-S72-5. High-speed antiradiation missile reduction approach for the drug addiction 松本俊彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 550-551, 2022.

---

	25-13-S73-1. Expect it of the condition of a patient and treatment, a pharmacist of alcoholism 松本俊彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 552-553, 2022.

---

	25-13-S73-2. We think about a cancer and relations of the alcohol 岸本真1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 554-554, 2022.

---

	25-13-S73-3. About diabetes and alcohol 堀川俊二1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 555-555, 2022.

---

	25-13-S73-4. Cardiovascular disease and alcohol 高井靖1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 556-556, 2022.

---

	S74-1. Importance and point to keep in mind of heart failure medical therapy (GDMT) in conformity with guidelines 奥村貴裕1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 557-558, 2022.

---

	S74-2. Master the key drugs for heart failure treatment - β-blockers and mineralocorticoid receptor antagonists - 鈴木正論1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 559-559, 2022.

---

	S74-3. How is the pharmacist associated with drug "ARNI needing invention in" introduction and up titration? 芦川直也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 560-560, 2022.

---

	S74-4. Should use the SGLT2 inhibitor Q&A - SGLT2 inhibitor for all cases; or ... 木下照常1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 561-561, 2022.

---

	S75-1. Including the relation to the second emergency patient in the emergency visit, the cooperation with the hospitalization ward 宮田祐一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 562-562, 2022.

---

	S75-2. Importance of the medicine medicine cooperation in the emergency visit and the problem 齊藤将之1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 563-563, 2022.

---

	S75-3. It is construction and evaluation ... of the emergency visit dispatch system through ... poisoning hot line for future emergency visit pharmacist duties 宮崎雄紀1), 松原ちはる1), 横山征史1), 網野一真1), 矢嶋直子1), 小口正義1), 跡部治1), 西澤優子2), 野首元成3), 登内盛治1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 564-565, 2022.

---

	S75-4. Disaster occurrence, possibility of the majority disabled then a pharmacist. 檜山洋子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 566-566, 2022.

---

	S75-5. Hurry to a stroke hot line, an emergency visit; is relation to the thrombolytic therapy by ... pharmacist and effect ... 細谷龍一郎1,2), 一條真彦3), 島智子1), 石川衣里子1), 北島健士1), 柴崎功1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 567-568, 2022.

---

	S76-1. Practical confirmation ... pseudoaldosteronism ... of the side effect 佐古守人1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 569-569, 2022.

---

	S76-2. ... which thinks about confirmation ... drug-related long QT syndrome that the side effect is practical 梶原洋文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 570-570, 2022.

---

	S76-3. Of practical confirmation ... drug eruption of the side effect examine; person, way of thinking ... 松田光弘1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 571-571, 2022.

---

	23-04-O01-1. Effect on formulations incident that formulations robot and formulations support system introduction give and prescription intervention 中西美怜1), 八木達也1), 石田卓矢1), 山本知広1), 三浦文美1), 大澤志保1), 相曽由起子1), 藤田葵1), 山口れな1), 伊藤悠1), 曾布川実里1), 袴田美典1), 丸山早織1), 三浦基靖1), 川上純一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 572-572, 2022.

---

	23-04-O01-2. The current situation of the representation input order system of doubt inquiry investigation and the pharmacist of the hospitalization prescription in our hospital 橋本知樹1), 眞継賢一1), 濱口良彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 573-573, 2022.

---

	23-04-O01-3. Efforts of the duties efficiency of the confirmation of bringing medicine before hospitalization by the medical treatment management introduction based on the protocol outpatient department 嶺豊春1), 中川博雄1), 橋詰淳哉2), 兒玉幸修1), 大山要1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 574-574, 2022.

---

	23-04-O01-4. An approach and problem for the improvement in adherence by the telephone follow-up 安藤美彩1), 岩切智美2), 奥村学3), 池田龍二2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 575-575, 2022.

---

	YIA1-1. Bile acid - drug interactions study in OATP4C1 aiming at the administration plan optimization of the renal excretion type drug at liver damage 山内碧1), 佐藤紀宏2), 大竹彩奈2), 公文代將希2), 佐藤裕2), 菊地正史2), 山口浩明3,4), 阿部高明5,6), 前川正充1,2), 眞野成康1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 576-576, 2022.

---

	YIA1-2. Protective efficacy of the proton pump inhibitor for the capecitabine-induced hand-and-foot syndrome in patients with breast cancer 竹村美穂1), 池村健治2), 吉波哲大3), 豊住勇治1), 新谷拓也2), 上田幹子1), 島津研三3), 奥田真弘2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 577-577, 2022.

---

	YIA1-3. Analysis of the risk factor about the haemorrhage symptom in the apixaban internal use patients 松田清那1), 上島智1), 平大樹1,2,3), 田淵陽平2), 小澤友哉4), 伊藤英樹4,5), 中川義久4), 堀江稔4), 寺田智祐2,3), 桂敏也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 578-578, 2022.

---

	YIA1-4. Interaction study of ritonavir based on comprehensive evaluation of CYP inhibitory activity: Possibility of interaction between DOAC and COVID-19 treatment drug paxlovid 爲本雄太1), 保月静香1), 佐藤洋美1), 樋坂章博1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 579-579, 2022.

---

	YIA1-5. Protection of the coenzyme Q10 emulsion for the tissue disorder by the ischemic reperfusion 池田真由美1), 横山さや香1), 八巻義朗1), 佐藤夕紀2), 柏木仁2), 今井俊吾2), 武隈洋3), 菅原満2,3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 580-580, 2022.

---

	YIA2-1. Timing (the fourth report) of the K-value measurement for low K blood symptom discovery with the Shakuyakukanzoto 嶋田沙織1), 伊藤雅1), 本間真人1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 581-581, 2022.

---

	YIA2-2. The search of the concomitant drug influencing the lamotrigine dermatopathy risk using medical big data and inspection by the multicenter practice information 坂東寛1), 合田光寛1,2), 新田侑生3), 中馬真幸3), 小川敦1), 櫻田巧1), 桐野靖1), 石澤啓介1,2,4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 582-582, 2022.

---

YIA2-3. Possibility of the reduction effect with a risk factor and renin-angiotensin axis antihypertensive medications of the onset of proteinuria with the neovascularisation inhibitor in patients with nephrocyte cancer 松本彩子1,2), 山岡健太1), 池末裕明1), 平畠正樹1), 橋田亨1), 山崎俊成2), 川喜田睦司2), 室井延之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 583-583, 2022.

---

	YIA2-4. The characteristic of elderly people with the atrial fibrillation and the examination that the change of the oral anticoagulant drug or the cancellation is it-related directly 石郷友之1), 相神智宏1), 片野唆敏2), 矢野俊之3), 小山雅之3,4), 神津英至3), 大堀克彦3,5), 中野敬太1), 藤居賢1), 戸田貴大6), 福土将秀1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 584-584, 2022.

---

	YIA2-5. Risk factor analysis of the rise in serum KL-6 value after the Everolimus start after the heart transplant 鈴木悠平1), 折山豊仁1), 山本武人1,2), 高田龍平1), 波多野将3), 網谷英介3), 辻正樹3), 武城千恵3), 小室一成3), 小野稔4), 鈴木洋史1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 585-585, 2022.

---

	YIA3-1. Examination of the acute renal failure incidence by antiMRSA medicine and tazobactam/piperacillin combination 山下佑麻1), 川口博資2,3), 櫻井紀宏3), 中村安孝1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 586-586, 2022.

---

	YIA3-2. Evaluation of the optimal administration method based on PK/PD using the free form CMZ concentrations of the haemodialysis patients for ESBL-producing Enterobacteriacae bacteria 並木孝哉1,2), 横山雄太1,3), 枦秀樹2), 地引綾3), 河添仁1,3), 松元一明4), 鈴木小夜1,3), 中村智徳1,3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 587-587, 2022.

---

	YIA3-3. We look at the onset of renal failure anticipatory rear of an AUC level by the vancomycin one point drawing blood and the trough level and examine a mark 大坪愛実1), 丹羽隆1), 安江萌夏1), 原田紗希1), 山田悠人1), 山田未知1), 松岡芹佳1), 山本泰士1), 鈴木昭夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 588-588, 2022.

---

	YIA3-4. About the effect that febrile neutropenia gives to an internal change of the arbekacin in children 都築仁美1), 中馬真幸1), 寺川央一1), 寒藤雅俊1), 岩山訓典1,3), 山本譲1), 久保靖憲1), 神山直也1,2), 眞鍋貴行1,2), 田崎嘉一1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 589-589, 2022.

---

	YIA3-5. Pharmacokinetic analysis of rem decibuilding in the COVID-19 patients and main metabolite (GS-441524) 室井宏仁1), 入江慶1,2), 中川淳3), 田村亮1), 江藤正明4), 池末裕明1), 橋田亨1,2), 富井啓介3), 室井延之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 590-590, 2022.

---

	YIA4-1. Blood level analysis of active metabolite GS-441524 of the rem decibuilding in sustained hemofiltration patients on dialysis 西川有沙美1), 糸原光太郎1), 伊藤功朗2), 米澤淳1), 佐藤裕紀1), 松村勝之1), 濱田哲2), 田辺直也2), 甲斐慎一3), 松原雄4), 井本英志6), 平井豊博2), 柳田素子4), 大鶴繁5), 寺田智祐1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 591-591, 2022.

---

	YIA4-2. About the acid-proof degradation of lansoprazole OD tablets by the simultaneous suspension of the citrate-containing preparation 中川祐紀子1), 鈴木拓也1), 居林優輝1), 加藤美咲2), 嶋田努1), 崔吉道1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 592-592, 2022.

---

	YIA4-3. Search of the risk factor of the antifungal agent-induced liver damage by the cooperation of a spontaneous report database and electronic medical chart data 朝居祐貴1), 山本高範1), 佐藤賛治1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 593-593, 2022.

---

	YIA4-4. Expression investigation of the hypomagnesemia with the treatment with head and neck cancer cetuximab and effect examination of the Mg prophylaxis 松金良祐1), 一色理沙2), 末次王卓1), 廣田豪1), 辻敏和1), 金谷朗子1), 江頭伸昭1,2), 家入一郎1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 594-594, 2022.

---

	YIA4-5. Examination of the factor affecting the antibody acquisition ability with the new corona vaccine in the patients with the immunodeficiency risk 岡田直人1), 中村信元2), 清水太郎3), 安藤英紀3), 相澤風花1), 新村貴博4), 八木健太4), 合田光寛1,5), 石田竜弘3), 石澤啓介1,4,5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 595-596, 2022.

---

	YIA5-1. Search for unknown target molecules related to renal tubular toxicity of cancer molecular targeting drug vemurafenib 真川明将1), 堀田祐志1), 家田直弥2), 前田康博3), 片岡智哉4), 中川秀彦2), 日比陽子4), 木村和哲1,4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 597-597, 2022.

---

	YIA5-2. The new beclomethasone dipropionate-containing enteric microsphere preparation development that pointed to the selective delivery to large intestine 内田淳1,2), 林勇寿1), 山田幸平1), 佐藤秀行1), 河田圭司2), 尾上誠良1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 598-598, 2022.

---

	YIA5-3. Construction of the cyclopedic and quantitative predictive law of the dialysis extraction coefficient of the drug which we incorporated a dialysis enforcement condition in 荻上尚樹1), 宮田優希1), 山本武人1,2), 鈴木洋史1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 599-599, 2022.

---

	YIA5-4. Medicine mechanic cooperation study for the objective detective law development of the antihistamine-induced in paired performance at driving using eyes measurement 相良篤信1,2), 安喜勇人2), 吉村広輝2), 清水孝恒1), 佐野元彦1), 湯本哲郎1,2), 細江智夫1), 田中健次2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 600-600, 2022.

---

	YIA5-5. Usefulness of the continuation prescription support protocol by the pharmacist-led ward team cooperation 杉本智哉1), 杉野晃希1), 小原里奈1), 山室栄一1), 小園利加2), 木村元宏3), 遠山幸男1), 久田達也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 601-601, 2022.

---

	23-05-O02-1. One case that supported using the clinical reasoning for the diarrhea that developed during Cabozantinib remedy 木村大地1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 602-602, 2022.

---

	23-05-O02-2. From study on distance - clinical on-site investigation between optimal patients - pharmacists at medication counseling - 牛膓沙織1), 鈴木菜生2), 仲山千佳3), 宮城雪菜2,4), 宮地佑佳2), 大嶋耐之2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 603-603, 2022.

---

23-05-O02-3. Effect on cancer medical therapy in the ambulatory practice that new coronavirus infection (COVID-19) outbreak gives and medication counseling 小柳津瞳1,13), 山口智江2,13), 前田章光3,13), 大島有美子4,13), 中井剛5,12,13), 原田哲彦6,13), 藤村浩司7,13), 小西郁代5,13), 坂野博紀6,13), 杉本智哉7,13), 佐々木俊則8,13), 佐藤由美子9,13), 堀田和男10,13), 川合甲祐11,13), 久田達也7,13), 宮崎雅之5,13) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 604-604, 2022.

---

	23-05-O02-4. Problem based on the intervention content analysis of the pharmacist outpatient department for the oral anticancer medicine initial prescription 郷真貴子1), 山田志緒里1), 西村充礼1), 村瀬寛美1), 松山卓矢1), 木村美智男1), 吉村知哲1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 605-605, 2022.

---

	23-05-O02-5. Intervention effect of the pharmacist specialized in a cancer in the trial regimen application 辻千明1,2), 田中祐子1,2), 嶋田努1), 長瀬克彦2), 崔吉道1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 606-606, 2022.

---

	23-05-O03-1. About the cooperation of the system and the ICI proper use team of the use of pharmaceutical products for irAE out of the adaptation 黒田純子1), 伊與田友和1), 大江敬太郎1), 渡邉美保1), 佐々木栄作2), 金沢賢也3), 鈴木弘行4), 佐治重衡2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 607-607, 2022.

---

	23-05-O03-2. Examination of an investigation and the evaluation of the supportive care for chemotherapy-induced peripheral neuropathy in our hospital 林雄一郎1), 奥田遥香2), 西本美淑3), 石部洋一4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 608-608, 2022.

---

	23-05-O03-3. A case of administration of lutetium (177Lu) oxodotreotide to a patient with decreased renal function 鈴木秀隆1), 加納大輔1), 望月伸夫1), 大橋周平2), 森田敬裕3), 今岡大4), 池田公史4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 609-609, 2022.

---

	23-05-O03-4. Fact-finding of recurrent Ewing sarcoma regimen in AYA generation patients 川元愛実1), 馬見新佳那子1), 細野亜古2,4), 馬場楓1), 内藤陽一2,3,5), 中島裕理2,3), 楠原正太2), 船坂知華子2), 仲尾岳大2,3), 近藤千紘2), 原野謙一2,3), 松原伸晃2), 川崎敏克1), 向原徹2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 610-610, 2022.

---

	23-05-O03-5. Questionary survey about the recognition about the immune checkpoint inhibitor for drugstore pharmacists and the immune-mediated adverse event 井上将貴1), 五十嵐隆志1), 三浦智史2), 川崎敏克1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 611-611, 2022.

---

	23-05-O04-1. The effect that inspection before injection prescription issuance by the exclusive duty pharmacist of the intensive care unit gives to adequacy of the medical therapy 上林里絵1), 池村健治2), 若井恵里3), 岡本明大1), 佐々木典子1), 杉本浩子1), 平井利典1), 加藤秀雄1), 向原里佳1), 石倉健4), 今井寛4), 岩本卓也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 612-612, 2022.

---

	23-05-O04-2. Drug economic study in psoriasis treatment with the antibody preparation based on Drug Survival of Real-World 税所篤行1), 山口道也2), 樫部公一3), 石田博3), 平野靖3), 岡智之4), 田村美穂1), 高砂美和子1), 内田豊1), 幸田恭治1), 北原隆志1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 613-613, 2022.

---

	23-05-O04-3. PT-INR change factor analysis after the biliary tract obstruction in the warfarin remedy patients 中澤孝文1,2), 山崎伸吾1), 内田雅士1,2), 鈴木貴明1,2), 中村貴子1), 大塚将之3), 石井伊都子1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 614-614, 2022.

---

	23-05-O04-4. Relations with the hypomagnesemia onset by the long-term use of the proton pump inhibitor in elderly patients 米田夏奈葉1), 中村暢彦1), 肥後孝2), 楠本正明1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 615-615, 2022.

---

	23-05-O04-5. Relations with the diarrhea that is Afatinib blood level and a side effect in the non-small cell lung cancer 横田隼人1), 佐藤一洋2), 坂本祥2), 奥田佑道2), 浅野真理子2), 竹田正秀2), 中山勝敏2), 三浦昌朋1,3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 616-616, 2022.

---

	23-05-O05-1. Examination of the effect of ABCB1 and the ABCG2 genetic polymorphism on internal change of the Abemaciclib metabolite 前田章光1), 入江慶2), 安藤仁3), 橋本直弥1), 福島昭二2), 盛重純一3), 衣斐寛倫4), 加藤正孝5), 内田幸作1), 岩田広治6), 澤木正孝6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 617-617, 2022.

---

	23-05-O05-2. The current situation and the problem that are contraindicated to the combination of the CYP3A inhibitor in the pharmaceutical products package insert 大野能之1), 永井尚美2), 樋坂章博3), 高田龍平1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 618-618, 2022.

---

	23-05-O05-3. Change factor analysis of the OATP1B1 activity that assumed the plasma Coproporphyrin-I concentrations in cyclosporine treated patients an index 渡邉拓真1), 田中遼大1), 鈴木陽介2), 小野寛之1), 根上純2), 吉島千智2), 小田絢子2), 龍田涼佑1), 大野恵子2), 伊東弘樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 619-619, 2022.

---

	23-05-O05-4. Stereoselective interaction of effect and amiodarone of CYP3A5 giving it to the internal change of the tolvaptan optical isomer in patients with heart failure 阿久津駿太1), 見野靖晃1), 内藤隆文1), 星川昂平1), 早乙女雅夫2), 前川裕一郎2), 川上純一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 620-620, 2022.

---

	23-05-O05-5. The exploring of the substitute excipient as a substitute for the milk sugar: Usefulness evaluation of the starch infinitesimal grain 吉川知宏1), 岡本広世1), 竹内健太1), 平田敦士1), 長井紀章2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 621-621, 2022.

---

	23-05-O06-1. Characteristic of patients with second response expression with the COVID-19 vaccination in patients during cancer medical treatment 宇野彩香1), 森脇俊和2), 渡邊雅明1), 長崎茜1), 関健吾1), 中嶋夏海1), 大平愼1), 山本祥之2), 小林真理子2), 本間真人1), 人見重美3), 関根郁夫4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 622-622, 2022.

---

	23-05-O06-2. The development of the flowchart identifying patients needing high-dose vancomycin administration for treatment concentrations area arrival and inspection of the prediction precision 田中雄大1), 山口諒1), 可児紘子1), 山本武人1,2), 鈴木洋史1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 623-623, 2022.

---

	23-05-O06-3. The pharmacodynamics at the antipsychotics combination based on the receptor occupation theory and pharmacokinetic interaction analysis 赤下学1), 中谷絵理子1), 菊池英慧1), 黄倉崇1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 624-624, 2022.

---

	23-05-O06-4. Inspection about the possibility that it becomes a factor that feeling lonely affects the multiple drug remedy of elderly people 多田貴彦1,2), 相川学美1), 高添倫子1), 矢吹洸二1), 後藤結実子1), 小野美歌1), 岡田はるみ1), 寺島茜1), 鈴木達彦2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 625-625, 2022.

---

	23-05-O06-5. About a dose and the effectiveness of the enoxaparin depending on the renal function in patients who received Total Knee Arthroplasty and safety 平町隆明1), 飯島悠希1), 北郷真史1), 石原慎之1), 玉木宏樹1), 矢野貴久1), 直良浩司1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 626-626, 2022.

---

	23-05-O07-1. Effect of the copper transporter genetic polymorphism giving it to a treatment result after the chemoradiotherapy before operation on patients with cancer of the esophagus 藤田一馬1), 本山悟2,3), 佐藤雄亮2), 脇田晃行2), 南谷佳弘2), 三浦昌朋1,4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 627-627, 2022.

---

23-05-O07-2. Examination about the association of AUC and the onset that estimated from a Carboplatin fruit dose had administration plan of by the body-surface area method of the DeVIC therapy of serious platelet count decrease 梅原健吾1), 高田慎也1), 山佳織2), 山岸佳代1), 藤本勝也3), 小林道也4), 佐藤秀紀2), 美濃興三1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 628-628, 2022.

---

	23-05-O07-3. Plasma endothelin -1 predicts the severe proteinuria onset with the bevacizumab administration: Observational, prospective study 二瓶哲1), 池田樹生1), 青木朋彦1), 寺長根大輝1), 村里風太1), 佐藤文彦1), 佐々木章2), 旭浩一3), 工藤賢三1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 629-629, 2022.

---

	23-05-O07-4. Multidirectional evaluation about the second cancer risk of the malignant lymphoma therapeutic drug using the large-scale practice information database 土手賢史1,2), 豕瀬諒2), 後藤良太2), 小林由佳1), 村木優一2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 630-630, 2022.

---

	23-05-O07-5. Search of the actual situation and the risk factor of the lassitude in patients with cancer under treatment in a foreign chemotherapy room 根來寛1), 藤原拓也2), 山下慎司1), 国分秀也3), 佐野元彦4), 矢野良一5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 631-631, 2022.

---

	23-09-O08-1. Promotion of the inhalational instruction information sharing by a general inhalational check sheet in Hiroshima and the template introduction 真志田絵美子1), 櫻下弘志1), 高橋麻里1), 柴田ゆうか1), 岩本博志2), 松尾裕彰1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 632-632, 2022.

---

	23-09-O08-2. Illness inflection ... of one - drug change prescription that we examined it, and HbA1c improved by cooperation, medicine medicine cooperation remarkably 亀山聡美1), 酒向聡子1), 今西正人1), 桑原千春2), 三輪佳余子3), 横山道江3), 川路明人4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 633-633, 2022.

---

	23-09-O08-3. Questionary survey to expand practice and a workshop of the medicine medicine cooperation for health insurance pharmacies 長山佳之1), 新島大輔1), 矢田部恵1), 工藤彰1), 工藤浩史1), 谷健太郎1), 石嶋麗1), 今村有那1), 大塚健太郎1), 小川千晶1), 谷地豊1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 634-634, 2022.

---

23-09-O08-4. Operation of the new tracing report specialized in promotion - cancer chemotherapy of the medicine medicine cooperation that use and application had of ICT and evaluation - 森沢惇平1), 門田亜紀1), 野村政孝1), 岡本茉奈実1), 川田敬1,2), 石田智滉1), 藤田博子1), 田村尚久1,2), 赤垣恵太1), 依岡千恵子1), 川添哲嗣2,3), 常風興平1), 宮村充彦1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 635-635, 2022.

---

	23-09-O08-5. Construction - of the information sharing system utilizing promotion - Web system of the medicine medicine cooperation that use and application had of ICT 上杉粋世1), 上野直哉1), 松本義将1), 東野純一2), 宅間大祐2), 稲本悠3), 森沢惇平4), 野村政孝4), 門田亜紀4), 常風興平4), 西森康夫5), 宮村充彦4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 636-636, 2022.

---

	23-09-O09-1. Weight fluctuation of patients with epilepsy before and after the new coronavirus outbreak 杉山尭紀1,2), 山本吉章2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 637-637, 2022.

---

	23-09-O09-2. Investigation of the use actual situation of the heating-type cigarette for the smokers with rheumatoid arthritis and other chronic diseases and the use reason 伊佐地央明1), 山田清文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 638-638, 2022.

---

	23-09-O09-3. Examination of the characteristic of the patient of the low-dose edoxaban administration pertinence case in the old atrial fibrillation case and the scale 彦坂夏菜1), 川根誉代1), 岡祐介1), 土井崇1), 佐合裕子1), 芦川直也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 639-639, 2022.

---

	23-09-O09-5. Attitude survey of the staff for the polypharmacy in the national cancer research center center Hospital 樫原芽依1), 東郁子1), 渡部大介1), 齋藤義正1), 石川光信1), 赤木徹1), 橋本浩伸1), 古川哲也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 640-640, 2022.

---

	23-09-O10-1. Investigation of the occurrence of adverse events in patients taking venetoclax in combination with azole antifungal drugs 新井瞬1), 有野徹1), 楠見彰宏1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 641-641, 2022.

---

	23-09-O10-2. Incidence of adverse events caused by administration of trastuzumab deruxtecan to HER2-positive breast cancer 桑村恒夫1), 三上忠司1), 山口美樹2), 中川義浩1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 642-642, 2022.

---

	23-09-O10-4. Example that was able to detect renal failure by the nivolumab from adrenal cortical steroid doses and a change of the serum creatinine 和田康弘1), 吉田健也2), 中西亨2), 堀内雅人3), 高田充弘3), 久志本浩子3), 井上智子4), 伴晶子1), 小林義和1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 643-643, 2022.

---

	23-09-O10-5. Examination about the effect that neutropenia in the trifluridine Tipiracil hydrochloride + bevacizumab therapy gives to effect of treatment 大畑紘一1), 藤井宏典1), 松岡芹佳1), 左高史織1), 渡辺大地1), 廣瀬智恵美1), 小林亮1,2), 飯原大稔1), 木山茂3), 牧山明資3), 松橋延壽3), 高橋孝夫3), 吉田和弘3), 鈴木昭夫1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 644-644, 2022.

---

	23-09-O11-1. Evaluation of the prophylactic antiemesis effect at aprepitant supplementation in the Carboplatin + etoposide therapy 門萌子1), 坂本達彦1), 齋藤佳敬1), 内山数貴1), 菅野亮太1), 谷口理1), 武隈洋1), 品川尚文2), 清水康3), 秋田弘俊3), 菅原満1,4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 645-645, 2022.

---

	23-09-O11-2. Examination about patients service property and loperamide optimum doses in the diarrhea symptom management derived from Abemaciclib 橋本直弥1), 村田史子1), 伊藤裕子1), 内田幸作1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 646-646, 2022.

---

	23-09-O11-3. Inspection of the protective efficacy of magnesium oxide for the hypomagnesemia with the antiEGFR antibody medicine for patients with colon cancer 高木淳平1), 奈良克彦1), 荻上尚樹1), 山本武人1,2), 鈴木洋史1), 高田龍平1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 647-647, 2022.

---

	23-09-O11-4. Usefulness (the case report which was able to relieve the adverse event of eyes) of the telephone follow-up for the S-1 remedy patients 徳升晃大1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 648-648, 2022.

---

	23-09-O11-5. 1 case that was regarded as an immune-mediated adverse event by the Atezolizumab which the diarrhea that developed after the irinotecan administration used for previous treatment 杉山弘樹1), 中田淳也1), 更谷和真1), 柴田洋2), 原田晴司1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 649-649, 2022.

---

	23-09-O12-1. Preliminary study for proper use of nirmatrelvir/ritonavir 冨田猛1), 木村丈司1), 山本和宏1), 野崎晃1), 田村直暉1), 藤田浩平1), 飯田真之1), 大村友博1), 矢野育子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 650-650, 2022.

---

	23-09-O12-2. Examination of the effect of the medical therapy for the hiccups that we included the background factor which was easy to accept hiccups during COVID-19 treatment and a steroid rotation in 佐古有紀1), 吉川明良1), 山内健1), 伊藤徳明2), 実綿慶2), 北原良洋2), 沖本真史2), 渡辺美和1), 高蓋寿朗2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 651-651, 2022.

---

	23-09-O12-3. Study on the effectiveness of sotrovimab for Japanese people aged 75 years and older 陳内博之1), 相賀真由1), 奥山友香里1), 沖田直美1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 652-652, 2022.

---

	23-09-O12-4. The effect that COVID-19 vaccination gives to the immune-mediated adverse event of the immune checkpoint inhibitor 関健吾1), 森脇俊和2), 渡邊雅明1), 宇野彩香1), 長崎茜1), 中嶋夏海1), 大平愼1), 山本祥之2), 小林真理子2), 本間真人1), 人見重美3), 関根郁夫4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 653-653, 2022.

---

	23-09-O12-5. Safety of sotrovimab and remdesivir combination therapy in hemodialysis patients with mild to moderate COVID-19 in the 6th wave 浦田元樹1), 岩川真也1), 森住誠1), 大野良晃2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 654-654, 2022.

---

	23-09-O13-1. The relation to the new corona vaccine group inoculation by the pharmacist and economical evaluation 長谷川豊1), 村上佳愛1), 谷垣求1), 中谷健一1), 山内一史1), 金子昌平1), 山田暁代1), 伊藤優子1), 松岡智美1), 谷口嘉宏1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 655-655, 2022.

---

	23-09-O13-2. Examination about the sterilization with the ozone gas of the gown for the prevention of infection in the closure space 小竹武1), 坂下友恵1), 岡本優子1,2), 西光優衣1), 橋本貴子1,3), 日比野泰志1,3), 井上知美1), 石渡俊二1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 656-656, 2022.

---

	23-09-O13-3. Examination about the effect of the new coronavirus vaccine on vital prognosis of patients on dialysis with new coronavirus infection (COVID-19) 田中義輝1), 岡田由加1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 657-657, 2022.

---

	23-09-O13-4. Report of the use situation and Pseudomonas aeruginosa of the medicine carbapenem-based after AST start-sensitive rate for 4 years 小林謙一1,3), 丸山智幸1,3), 品田識博1,3), 西堀武明2,3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 658-658, 2022.

---

	23-09-O13-5. Effects of intravenous lascufloxacin infusion on test values 上田真也1), 植松若那1), 蜂巣寿哉1), 薄雅人2), 松田平和1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 659-659, 2022.

---

	24-04-O14-1. Pharmaceutical intervention of the ward pharmacist in the neurosurgical ward 青山慎1), 伊藤聡一郎1), 谷口俊洋1), 山田哲也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 660-660, 2022.

---

	24-04-O14-3. One case that the evaluation based on the pharmaceutical viewpoint contributed to a definitive diagnosis of the heart failure 村上翔梧1), 野村剛久1), 佐古守人1), 黒沢秀夫1), 西牟田昇吾1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 661-661, 2022.

---

	24-04-O14-4. Evaluation of the effect to patients with heart failure by the system change of the multi-type of job team intervention 小山勝真1,2,3,4), 藤村達大2), 藤田美穂2), 前原達哉3), 村橋千里4), 堀尾桂子5), 幸田恭治1), 北原隆志1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 662-662, 2022.

---

	24-04-O15-1. Questionary survey about the reporting of the medicine using the video for nursing mothers 堀田菫1), 石野清亮1), 夏目章巴1), 杉山奈々美1), 坂田友美1), 桑名諒美1), 瀧口里美1), 矢部勝茂1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 663-663, 2022.

---

	24-04-O15-2. Theoretical consideration about the safety at mother's milk shift and nursing of the Bilastine 大久保正1,2), 田中真理子2), 大久保七枝3), 大久保節子4), 大久保美穂5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 664-664, 2022.

---

	24-04-O15-3. Effect inspection of the active at-home support reporting to the multi-type of job by the drugstore pharmacist 吉永千裕1), 横井杏菜1), 水野正子2), 浅井治行3), 山田葉子3), 三宅宏季4), 石川友康5), 供田将志6), 菊池千草7), 堀英生8), 鈴木匡8) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 665-665, 2022.

---

	24-04-O15-4. A case study of home visits in which drugs were reduced during the terminal stage of cancer and approaches were taken according to changes in condition 鈴木邦彦1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 666-666, 2022.

---

	24-04-O16-1. One case that a severe immune-mediated adverse event (immune-related adverse event: irAE) by the Atezolizumab developed 林田颯志1,2), 森善洋1), 佐道紳一1), 岩村直矢1), 山島美緒2), 樋口則英1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 667-667, 2022.

---

	24-04-O16-2. Evaluation of the usefulness of the multiple prophylaxis of the anticholinergic drug for the irinotecan-induced Colin symptom 渡辺拓也1), 齋藤佳敬1), 武隈洋1), 清水康2), 秋田弘俊2), 小松嘉人3), 菅原満1,4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 668-668, 2022.

---

	24-04-O16-3. 1 case that resulted in hyperammonemia by the Cabozantinib 山本崇弘1), 齋尾真希1), 秦英司1), 藤吉正哉1), 松木由佳子2), 永原天和2), 島田美樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 669-669, 2022.

---

	24-04-O16-4. The effect that peripheral neuropathy of primary treatment oxaliplatin in patients with gastric cancer gives the effectiveness of the second treatment taxane system anticancer agent and safety 左高史織1), 藤井宏典1), 飯原大稔1), 林秀樹2), 味澤香苗2), 奥村直樹3), 牧山明資3), 吉田和弘3), 鈴木昭夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 670-670, 2022.

---

	24-04-O16-5. Example that steroid succeeded as the prevention of the hand-and-foot syndrome with standard quantity cytarabine 谷口結基1), 田中美帆1), 太田達也1), 田中章郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 671-671, 2022.

---

	24-04-O17-1. Examination of the predictor effective for a long term of tramadol for the cancer pain 高武嘉道1), 藤本愛理1), 中原萌子1), 鶴山萌子1), 三好孝法1), 山口泰弘1), 深澤真実1), 川俣洋生1), 花田聖典1), 橋本雅司1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 672-672, 2022.

---

24-04-O17-2. The construction of the multi-type of job collaboration opioid parenteral injection preparation system supporting the at-home shift in the new establishment hospital and investigation about the operational situation 上葛義浩1), 小池良且1), 秋川佳美1), 稲垣美緒1,2), 中山貴美也1), 太田秀基1,2), 山田成樹1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 673-673, 2022.

---

	24-04-O17-4. We look at the rear about dermatopathy frequencies of morphine sustained hypodermic injection and the hydromorphone sustained hypodermic injection and weigh a mark 増田真也1,2), 田中怜2,3), 佐藤哲観4), 賀茂佳子2), 森本重輝2), 鴨志田武2), 石川寛2), 佐藤哲2), 天田斉子2), 近藤美奈5), 高橋健二6), 高橋千恵子6), 篠道弘2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 674-674, 2022.

---

	24-04-O17-5. Look at examination ... multicenter rear about the effect reinforcement of the warfarin by the combination of the fentanyl; mark observational study ... 槙原克也1), 土生康司2), 後藤愛実3), 吉野新太郎4), 三沖大介4), 石原泰子5), 山田正実6), 江島智彦7), 三松史野8), 力武良行2), 宮田興子2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 675-675, 2022.

---

	24-04-O18-1. Examination of the childhood thyroid block - iodine preparation in the iodine 131-radioimmunotherapy treatment 大江敬太郎1), 古内容子1,2), 大堀裕太2), 織内昇3), 志賀哲3), 菅原茂耕3), 佐野秀樹4), 稲野彰洋2), 黒田純子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 676-676, 2022.

---

	24-04-O18-2. Anticancer medicine exposure investigation in the scale hospital out of the district 百瀬公博1), 有賀智美2), 伏見幸浩1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 677-677, 2022.

---

	24-04-O18-3. About the usefulness of the sodium selenite oral cavity collapse tablets in the low selenium blood symptom 桶本幸1,2), 荒川宗徳1), 関本裕美2), 山下大輔2), 小原直紘2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 678-678, 2022.

---

	24-04-O18-4. The making of the preventive measures against occupational exposure manual about internal use Hazardous Drug formulations and attitude survey of the pharmacist 齋藤裕子1), 平川寛之1), 太田潤一1), 岡田浩司1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 679-679, 2022.

---

	24-04-O19-1. Examination of the presence of the change of the FN incidence before and after the COVID-19 outbreak in patients during the febrile neutropenia (FN) high risk regimen enforcement 島貫裕実子1), 下村昭彦2), 小室雅人1), 河村雪乃2), 谷山智子2), 寺門浩之1), 清水千佳子2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 680-680, 2022.

---

	24-04-O19-2. Examination of the factor associated with the overall survival of patients who received gemcitabine + paclitaxel (albumin suspension type) therapy for progress, recurrent pancreatic cancer 伊藤大輔1), 竹中翔也1), 守屋昭宏1), 浅野裕紀1), 岩井美奈1), 宇佐美英績1), 吉村知哲1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 681-681, 2022.

---

	24-04-O19-3. Analysis of the onset of proteinuria risk factor of the Lenvatinib in patients with hepatocellular carcinoma 高橋周平1), 守田和憲1), 北岡朋子1), 徳永晃己1), 柴田啓智1), 田上治美1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 682-682, 2022.

---

	24-04-O19-4. Establishment of the technique of the multiple use of the anticancer medicine lyophilized products and the fact-finding 片原帆奈美1), 鈴木秀隆1), 佐野慶行1), 中田千博1), 加納大輔1), 望月伸夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 683-683, 2022.

---

	24-04-O19-5. Examination about the inflection of the liver volume of the anticancer agent-related cirrhosis atrophy speed in the differentiation 宇野美雪1), 稲井邦博2,3), 西島昭彦3), 法木左近4), 内木宏延2), 後藤伸之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 684-684, 2022.

---

	24-05-O20-1. Prescription fact-finding of olanzapine to patients with diabetes using the receipt database 山下慎介1,2), 今井俊吾3,4), 百賢二5,6), 柏木仁3), 佐藤夕紀3), 菅原満3,7), 武隈洋2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 685-685, 2022.

---

	24-05-O20-2. Shift ... of introduction and the in-house production system of preparations and results - prescription check system IRIS accompanied with the electronic medical chart replacement and MDB 山中理1), 山村篤史2), 早川太朗2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 686-686, 2022.

---

	24-05-O20-3. Fact-finding of the pituitary gland side effect of immune checkpoint inhibitor using the Japanese adverse drug reaction database 浅野裕紀1), 宇佐美英績1), 木村美智男1), 吉村知哲1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 687-687, 2022.

---

	24-05-O20-5. Analysis - of the drug-induced aggressiveness with evaluation - antiepileptic drug of safety of medicine using Spontaneous Reporting System and the effectiveness 中村優李1), 川田敬1,2), 石田智滉1), 常風興平1), 野村政孝1), 丸岡由奈1), 岡本茉奈実1), 岡崎萌水1), 山口真夏1), 吉岡三郎1), 宮村充彦1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 688-688, 2022.

---

	24-05-O21-1. Usefulness evaluation of the all cases check by the pharmacist for the registration of the drug allergy information 坂本拓也1), 渡邊卓巳1), 小澤明日香1), 白石貴寿1), 荒井宏人1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 689-689, 2022.

---

	24-05-O21-2. Efforts ... to push forward with strategic - drug desk work of the duties efficiency for the task shift promotion 篠田健一1), 川原由紀子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 690-690, 2022.

---

	24-05-O21-3. Examining feedback methods from incident and pre-avoid reports 辻井佳代1), 鳥井祥子1), 庄司瑞野1), 瀬名波暢子1), 谷大輔1), 小林政彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 691-691, 2022.

---

	24-05-O21-4. Expansion of efficiency and the ward drug duties of compounding of medicines duties by the mechanization 入江利行1), 町田聖治1), 富田敏章1), 清水誉志1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 692-692, 2022.

---

	24-05-O21-5. 2 cases that became the opportunity to reconsider the significance that an in-hospital pharmacist conducted prescription modified confirmation of the outside Parliament prescription 大津由美子1), 岩西雄大1), 望月千枝1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 693-693, 2022.

---

	24-05-O22-1. Inspection of the drug costs reduction effect with the biofollowing article in University of Toyama Hospital 高木昭佳1), 加藤敦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 694-694, 2022.

---

	24-05-O22-2. Report on the introduction of formulary at Kyoto Daiichi Red Cross Hospital 大林巧志1,2), 増田章秀1,2), 冨島公介1,2), 小森桂子1), 舩越真理1), 土谷有美1), 濱崎佐知子2), 白石淳2), 三神一哉2), 福田亙2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 695-695, 2022.

---

	24-05-O22-3. Fact-finding about the ethical drug which reached the sale cancellation in this country 橋本貴子1,3), 石坂敏彦2), 安井友佳子2), 藤井一美1), 小竹武3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 696-696, 2022.

---

	24-05-O22-4. Prescription adequacy effect of the use of DOAC patients by the formula reoperational start of the oral anticoagulant drug 吉田享平1), 森川剛1), 小池恵理1), 花岡容子1), 清野義一1), 久保田健1), 岡澤香津子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 697-697, 2022.

---

	24-05-O22-5. Consideration of the impact of ARB hospital formulary on outpatient prescriptions 志村明日香1), 川邊一寛1), 畠山成寛1), 川邉桂1), 小池博文1), 佐橋幸子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 698-698, 2022.

---

	24-05-O23-1. It is ... based on efforts - regional alliances under the supply instability of pharmaceutical products 小山晃生1), 赤木和由1), 木村泰巳1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 699-699, 2022.

---

	24-05-O23-2. Examination of the task share of pharmacy and pharmaceutical products SPD for the in-hospital pharmaceutical products steady supply 岩田円夏1), 関屋裕史1), 緒方豊2), 福永洋子3), 森木豊栄3), 長友隆雄1), 岩切智美1), 池田龍二1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 700-700, 2022.

---

	24-05-O23-3. Efforts of our center for the supply restrictions of pharmaceutical products 花房喜子1), 鈴木ゆきえ1), 阿部聡美1), 渡邉幸枝1), 草野元1), 梶山夕美子2), 鈴木通子3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 701-701, 2022.

---

	24-05-O23-4. About effect and the correspondence that the supply anxiety problem of pharmaceutical products gave to adoption medicine 花田聖典1), 高武嘉道1), 永野真久1), 大橋邦央1), 橋本雅司1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 702-702, 2022.

---

	24-05-O23-5. Appropriate management - of efforts - large amount pharmaceutical products of the pharmacy for the hospital management 白石久1), 門田亜紀1), 西村さとみ1), 丸岡由奈1), 森沢惇平1), 岡崎雅史1), 野村政孝1), 川田敬1), 常風興平1), 宮村充彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 703-703, 2022.

---

	24-05-O24-1. Search of the risk factor about the periphery catheterization of vein-related bloodstream infection onset 遠山泰崇1), 福島祐子1), 赤星一恵1), 末延裕海1), 新宮裕美1), 小野友香理1), 野村一馬1), 村上里穂1), 後藤友里絵1), 矢野由起1), 瀬口りか1), 矢野可南子1), 平山沙和1), 井上真1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 704-704, 2022.

---

	24-05-O24-2. Intervention report to infection treatment using the infection surveillance in patients on dialysis 大塚登志喜1), 大井捺美1), 高橋正明1), 長沢法子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 705-705, 2022.

---

	24-05-O24-3. Efforts of our hospital for the proper use of TAZ/PIPC 立花京香1), 後藤健志1), 鎌田理紗子1), 斎藤祥子1), 竹尾恵理子1), 酒井欣嗣2), 伊藤功治1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 706-706, 2022.

---

	24-05-O24-4. Evaluation of the antimicrobial proper use by the cataract surgery clinical path change 平野有紀1), 吉野走1), 岩村直矢1), 佐道紳一1), 澤井豊光2), 小野大地3), 樋口則英1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 707-707, 2022.

---

	24-05-O24-5. One case of the Salmonella bacteremia that improvement was found in by the intervention of the antimicrobial proper use support team 足立参希1), 小武和正2), 中野祐樹3), 重留一貴4), 飛田高志5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 708-708, 2022.

---

	24-05-O25-1. Effect of AST exclusive duty for the antimicrobial proper use in the local third first aid-designated municipal hospital and the joint intervention of the ward exclusive duty pharmacist 熊谷康平1), 宮本祐吾2), 上村和昭3), 川崎貞男4), 木原理絵1), 續木康夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 709-709, 2022.

---

	24-05-O25-2. Efforts to continuous monitoring of the use of antimicrobial that an antimicrobial proper use support team cooperated with pharmacy 矢賀和子1), 河口義隆1,2), 幸田恭治1), 北原隆志1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 710-710, 2022.

---

	24-05-O25-3. Study of the cutoff value of the early clinical response in AUC and the MRSA infection that we calculated from one point of drawing blood of vancomycin and the early impaired renal function 植田貴史1,2), 中嶋一彦1,2), 竹末芳生2,3), 一木薫1), 石川かおり1), 高橋佳子4), 石原美佳4), 木村健4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 711-711, 2022.

---

	24-05-O25-4. Examination about the association between effectiveness and MIC of the VCM treatment for the MRCNS bacteremia 三好真琴1), 櫻井紀宏2), 掛屋弘2,3), 中村安孝1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 712-712, 2022.

---

	24-05-O25-5. Intervention to extracorporeal membrane oxygenation and the vancomycin TDM for the neonates who underwent sustained hemofiltration dialysis 内藤沙紀1), 内田淳1), 輿石泰良1), 須長祐人2), 吉沢雅史2), 河野洋介2), 長谷部洋平2), 戸田孝子2), 橘田文彦1), 犬飼岳史2), 河田圭司1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 713-713, 2022.

---

	24-09-O26-1. Interest degree investigation in the drugstore duties of the pharmacy student 竹増理恵1), 長井克仁2), 富樫由美1), 松岡有利子1), 福野修平2), 浦嶋庸子2), 小西廣己2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 714-714, 2022.

---

	24-09-O26-2. The specialist job cooperation education that we conducted using WEB meeting system during hospital training 薄井健介1,2), 大内竜介1,2), 渡邊卓嗣1,2), 成澤健3), 大塚眞理子3), 岡田浩司1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 715-715, 2022.

---

	24-09-O26-3. Efforts - of our hospital in the construction (the third report) - pharmacist version clinical ladder making of the hospital pharmacist staff education system 小山郁美1), 稲野寛1), 婦川貴博1), 山本悠樹1), 坂倉智子1), 近藤留美子2), 厚田幸一郎2), 尾鳥勝也1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 716-716, 2022.

---

	24-09-O26-4. Effect to confidence of construction and the medication counseling of the hearing loss e-learning system 俵口奈穂美1), 窪田敏夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 717-717, 2022.

---

	24-09-O27-1. Experimental evaluation of the ad usum externum preparation choice in the use of the makeup 亀井貴志1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 718-718, 2022.

---

	24-09-O27-2. Properties of matter change to a rice cake form by the mixture of the ointment for the dexamethasone oral cavity and the commercial oral moisturizer 久土徹也1), 山田直香1), 岡田莉奈1), 松本ゆいこ1), 宮本康敬1), 内藤慶子2), 配島桂子2), 川口千香1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 719-719, 2022.

---

	24-09-O27-3. The effectiveness and safety of the post-operative pain management that added administration to a colon cancer surgery case at the acetaminophen IV infusion liquid appointed hour 堀田栄治1), 高橋裕治1), 佐野正毅1), 斎藤健一郎2), 高嶋吉浩2), 宗本義則2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 720-720, 2022.

---

	24-09-O27-4. Efforts for the polypharmacy in the multi-type of job collaboration team 山崎新平1), 矢川結香1), 秋吉尚雄1), 藤村弥生1), 山戸真子1), 吉岡幹人2), 野口直子3), 吉国健司1), 小倉秀美1), 山口健也4), 折口秀樹5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 721-721, 2022.

---

	24-09-O27-5. Identification of the food and drink drug interaction ingredient through the OATPs inhibition with the citrus fruits bellows 荒井智貴1), 秋好健志1,2), 森田時生1), 片岡寛樹1), 矢島広大1), 植草義徳1), 羽田紀康3), 今岡鮎子1), 大谷壽一1,2,4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 722-722, 2022.

---

	24-09-O28-1. Analysis - using associated - Fib4-index with a liver function improvement effect by the Pemafibrate and impaired glucose tolerance 西垣賢1), 田村圭将2), 米田勝晃3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 723-723, 2022.

---

	24-09-O28-2. Weight loss effect according to the degree of corpulence in the GLP-1 receptor agonist 渡部正太1), 重成大介1), 尾崎良輔1), 奥村美佑1), 北田衛1), 大村侑平1), 太田明秀1), 岡野翔1), 中田浩雅1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 724-724, 2022.

---

	24-09-O28-3. The examination of the intervention effect of the ophthalmology consultation encouragement by the drugstore pharmacist on patients with diabetes: Cluster randomized controlled trial (protocol) 小川愛1), 鈴木達彦2), 須藤寛3), 岡林慎二4), 山本洋介4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 725-725, 2022.

---

	24-09-O28-4. Evaluation of the costs reduction to need for treatment, and the like of Adverse Drug Event by proper use of the medicine for the mental nerve in the psychiatry inpatient 久保賢晃1), 舘知也1,2), 青山京介1), 古山愛紗1), 渡邉繭子2), 青山智2), 野口義紘1), 田中和秀2), 安田昌宏2), 柴田明彦3), 水井貴詞2), 寺町ひとみ1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 726-726, 2022.

---

	24-09-O28-5. One patient whom longtime phenobarbital powder, benzodiazepine addiction by taking etizolam tablets developed in 佐藤裕之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 727-727, 2022.

---

	24-09-O29-1. Evaluation (the second report) of the ward pharmacist duties in the Okayama University Hospital altitude critical care center using the customer satisfaction analysis 大川恭昌1), 真鍋洋平1), 小沼利光1), 山田あかね1), 川西秀明1), 勝部理早1), 井上智美2), 村川公央1), 中尾篤典3), 座間味義人1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 728-728, 2022.

---

	24-09-O29-2. The current situation investigation about the pharmaceutical intervention by the pharmacist who is resident in an emergency visit 中西裕明1), 大山翔1), 熊野瑛巴1), 藤田将輝1), 澤田真嗣1), 野口裕介1), 小森玉緒1), 岡橋孝侍1), 友金幹視1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 729-729, 2022.

---

	24-09-O29-3. Examination of the method to promote improvement in sense of crisis and the behavior modification for the disaster in the drug section 山尾真貴子1), 青木勇樹1), 柏原道志1), 矢部勝茂1), 梶原千里2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 730-730, 2022.

---

	24-09-O29-4. Activity report - as medical support - pharmacist in the hospitalization wait station of the COVID-19-positive person 坂口結斗1), 長濱藍1), 駒井勇太1), 府川祥子1), 白木萌1), 有銘千賀子1), 市原麻友子1), 石木仁美1), 和泉勝一1), 松下貴英1), 安里衣真1), 下村周嗣1), 玉城亜寿香1), 久田潤平1), 喜多洋嗣1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 731-731, 2022.

---

	24-09-O29-5. Contribution of the pharmacist for the electronic medical chart construction for the disaster 仲里泰太郎1,2), 小林政彦2), 中出雅治1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 732-732, 2022.

---

	24-09-O30-1. The effect that a dose of the ST medical mixture gives to the serum creatinine level of renal-transplant recipients 辻本高志1), 鵜野竜馬1), 東亮佑1), 高橋諒多1), 川本由加里1), 高本大路2), 高田祐輔2), 佐々木元2), 田邉起2), 後藤仁和1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 733-733, 2022.

---

	24-09-O30-2. Investigation on TSH level reduction in patients taking roxadustat 西田麻以1), 長尾由佳1), 古谷祥子1), 菅直恵1), 山田菜月1), 藥師径子1), 赤木晋介1), 徳田衡紀1), 高柳和伸1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 734-734, 2022.

---

	24-09-O30-3. Literature survey on the mechanism of nocebo effect and cholecystokinin 加藤未来1), 間宮桐子1), 井澤美苗1), 石川春樹1), 望月眞弓1), 青森達1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 735-735, 2022.

---

	24-09-O30-4. Analysis of 6 cases about the association of choler drainage and the PT-INR change in the warfarin remedy patients 根岸瑠美子1), 中澤孝文1,2), 山崎伸吾1), 内田雅士1,2), 鈴木貴明1,2), 中村貴子1), 大塚将之3), 石井伊都子1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 736-736, 2022.

---

	24-09-O31-1. Search of the vomiting expression factor in linezolid treated patients 堤竹蔵1,2), 今井俊吾3,4), 柏木仁3), 佐藤夕紀3), 菅原満2,3,5), 武隈洋2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 737-737, 2022.

---

	24-09-O31-2. One case in which anamorelin was discontinued due to persistent hyperglycemia 田嶋大輝1), 高木昭佳1), 加藤敦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 738-738, 2022.

---

	24-09-O31-3. One transluminal case that zirconium cyclo sodium silicate hydrate remained in in stomach after administration 後藤伴美1), 山村亮太1), 柴田智隆2), 上野希望1), 龍田涼佑1), 田中遼大1), 坂本照夫2), 伊東弘樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 739-739, 2022.

---

	24-09-O31-4. Search of the factor having an influence on the length of stay in elderly patients operated on for osteoarthritis 三宅優子1), 小瀬英司1), 山元孝俊1), 光永義治1), 安野伸浩1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 740-740, 2022.

---

	24-09-O31-5. The examination of the safe surveillance method for the cholinergic crisis in the use of distigmine patients: Descriptive epidemiology study in the third emergency acute medical institution 森愛絵1), 西村健二1), 石田亮2), 亀井健人1), 赤木晋介1), 徳田衡紀1), 高柳和伸1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 741-741, 2022.

---

IO-01. Clinical utility of infliximab TDM in rheumatoid arthritis management Sho Masui1,2), Atsushi Yonezawa1,2), Kazuto Nakae1,2), Miyuki Nakamura1,2), Motomu Hashimoto3), Akira Onishi3), Hideo Onizawa3), Takayuki Fujii3,4), Kosaku Murakami5), Koichi Murata3,4), Masao Tanaka3), Kotoko Yokoyama6), Noriko Iwamoto6), Takashi Shimada6), Kotaro Itohara1), Shunsaku Nakagawa1), Satoshi Imai1), Takayuki Nakagawa1), Makoto Hayakari1), Shuichi Matsuda4), Akio Morinobu3,7), Kazuo Matsubara1), Tomohiro Terada1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 742-743, 2022.

---

IO-02. Pharmacokinetics and exposure-response analyses of upadacitinib in patients with moderate to severe ulcerative colitis - Analyses of induction and maintenance clinical trials Mohamed-Eslam F. Mohamed1), Ana Victoria Ponce-Bobadilla2), Sven Stodtmann2), Doerthe Eckert2), Wen Zhou1), Wei Liu1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 744-745, 2022.

---

	IO-03. Effects of long-term multiple immunosuppressants on everolimus pharmacokinetics in patients after renal transplantation Tomoyuki Sakaue1), Kazuhiro Yamamoto1), Takahito Endo2), Takeshi Ishimura2), Masato Fujisawa2), Tomohiro Omura1), Ikuko Yano1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 746-747, 2022.

---

	IO-04. Monte Carlo simulation to determine optimal ceftazidime dosing in patients receiving continuous hemodiafiltration Yugo Chisaki1), Manami Mitsuyama1), Miyu Yasukawa1), Yoshitaka Yano1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 748-749, 2022.

---

	IO-05. Lansoprazole exacerbates linezolid-induced thrombocytopenia : potential drug interaction via human organic anion transporter 3 Danni Wang1), Kenji Ikemura1,2), Masahiro Okuda1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 750-751, 2022.

---

	IO-06. Basic Research for the Practice of Reverse Translational Research in Doxorubicin-induced Cardiomyopathy Naoki Yoshikawa1), Tomoko Kamei1), Yuichiro Kurone1), Naoto Hirata1), Sadahiko Shimoeda1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 752-753, 2022.

---

	IO-07. Effectiveness and safety of direct oral anticoagulants versus warfarin during chemotherapy for cancer patients aged 75 or older : A nationwide inpatient database study Chikako Iwai1), Jo Taisuke2,3), Hideo Yasunaga1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 754-755, 2022.

---

	IO-08. Multicenter prospective observational study on hospital pharmacist interventions to reduce inappropriate medications Shinya Suzuki1,7), Mayako Uchida2,7), Hideki Sugawara4,7), Yukio Suga3,7), Takayuki Nakagawa5,7), Hisamitsu Takase6,7) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 756-757, 2022.

---

	IO-09. A survey on the actual status of web-based hospital-pharmacy collaborative case study meetings during the COVID-19 pandemic Michiya Akabane1), Yuki Kunitsu1), Masatomo Sudo1), Masaki Sumi1), Koji Uenishi1), Shin-ya Morita1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 758-759, 2022.

---

	P001-23-PM. 2 cases of the haemodialysis patients that examined a preparation change based on the collapse time for the purpose of taking precipitated calcium carbonate-related improvement 鈴木寛1), 小川裕子1), 柏倉康治2), 内田信也2), 影山慎二3), 山内克哉1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 760-760, 2022.

---

	P002-24-AM. Usefulness evaluation to the prescription support of the default use utilizing the ICT 上松祐貴1), 三村享1), 関夏望1), 中澤佑香1), 村井健太郎1), 土屋広行1), 内藤隆文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 761-761, 2022.

---

	P003-23-PM. Examination of the effect of the injectable antimicrobial, dilution level of antiviral drug and incident preventive measures about the rate of application that paid their attention to an injection prescription 長谷康史1), 荒木良介1), 山田英紀1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 762-762, 2022.

---

	P005-23-PM. The construction of the checking prescription support system depending on renal function and examination about the usefulness 升田万祐子1), 楠川侑吾1), 多留木崇志1), 成瀬圭1), 村田龍宣1), 村岡淳二1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 763-763, 2022.

---

	P006-24-AM. Basic examination about the formulations method of the pediatric dose of a warfarin potassium infinitesimal grain and the granular preparation and the storage method after the medication 秋山滋男1), 中田いちこ2), 宮本悦子3), 齋藤健一4), 政氏藤玄2), 堀祐輔1), 石田志朗5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 764-764, 2022.

---

	P007-23-PM. Efforts for the effective prescription checking using the drug section system in the injection drug requiring attention every administration 伊東冴栄1), 八木仁史1), 石川夕起1), 村澤康平1), 白石俊介1), 内田裕之1), 満田正樹1), 河井良智1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 765-765, 2022.

---

	P008-24-AM. Investigation about the careful administration case in the treatment with hormone replacement therapy medicine 畑賢太1), 山口和奎1), 得地美帆1), 野木山史恭1), 相馬まゆ子1), 今田愛也2), 藤枝聡子3), 山本浩史4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 766-766, 2022.

---

	P009-23-PM. Type of the comparison (2) - instillator about the transluminal tube (ISO80369-3) passage characteristics of the Chinese medicine extract preparation, comparison - by the difference in tube diameter 毎田千恵子1), 中田いちこ2), 秋山滋男3), 高野克彦1), 船坂龍善4,5), 杉田尚寛6), 宮本悦子5,7) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 767-767, 2022.

---

	P010-24-AM. Precision investigation of the evaluation with the rose by the viewing at the powders inspection 染谷健次1), 八島秀明1,2), 正田遊野1), 阿部正樹1), 荒木拓也1,2), 山本康次郎1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 768-768, 2022.

---

	P011-23-PM. About the communalization of the doubt inquiry contents of hospital pharmacist and the drugstore pharmacist 中川義浩1,2,3), 桑村恒夫1), 野田聖奈子1), 篠崎千尋1), 松本美紅1), 梅崎りさ2), 清原珠美3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 769-769, 2022.

---

	P012-24-AM. The current situation investigation about the steady supply system of a factor and the pharmaceutical company which became the supply restrictions of pharmaceutical products 安原昌宏1), 横山匠太1), 森川記道1), 谷保智美1), 大山展弘1), 内海敦志1), 原田靖子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 770-770, 2022.

---

	P013-23-PM. Pharmaceutical products management by a non-working full time pharmacist and the multi-type of job cooperation in the middle scale hospital operating room 細野真吾1), 磯野礼果1), 亀井幹子2), 白井壽子2), 澁田達史3), 山崎崇1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 771-771, 2022.

---

	P014-24-AM. Fact-finding about the transpiration of the infusion preparation 中邨翔太1), 河内佑樹1), 岸川礼子1), 橋詰淳哉1,2), 龍恵美1), 原澤仁美1), 兒玉幸修1), 大山要1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 772-772, 2022.

---

	P015-23-PM. Preparation of the chewing silverberry agent for the dry mouth including the taste ingredient with the 3D bio printer 田上辰秋1), 木田理沙子1), 小川昂輝1), 尾関哲也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 773-773, 2022.

---

	P016-24-PM. A preparation of the hospital preparation propranolol cream for the purpose of infants hemangioma treatment and evaluation of the pharmaceutics 柏倉康治1), 坪井絵乃1), 田中紫茉子1), 並木徳之1,2), 内田信也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 774-774, 2022.

---

	P017-23-PM. Preparation of the foam preparation for oral mucositis treatment as the hospital preparation 渡辺日菜子1,2), 柏倉康治1), 永井日菜1), 芦原まいか1), 大城真理奈1), 田中紫茉子1), 並木徳之1,2), 内田信也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 775-775, 2022.

---

	P018-24-PM. A study on utility improvement of the hospital preparation: The combination of quick bag and cryopreservation raises convenience of the Mohs ointment 岡本広世1), 吉川知宏1), 竹内健太1), 平田敦士1), 出口粧央里2), 長井紀章2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 776-776, 2022.

---

	P019-23-PM. Study on Zetia (R) tablet 10mg one dose package 平山優希1), 長山晃1), 森下和美1), 川上典子1), 近藤昌子1), 金顯凡2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 777-777, 2022.

---

	P020-24-AM. We promote efficiency of a stability evaluation and preparation duties of the note preparation for Omegaven(R) 湖城由佳1), 丹沢彩乃1), 小口敏夫2), 山谷明正1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 778-778, 2022.

---

	P022-24-AM. Efforts of the Clostridioides difficile infection with ward pharmacist screening 岩鼻優1), 佐々木康弘1), 橘淳1), 天野美里1), 益子里美1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 779-779, 2022.

---

	P023-23-PM. Smooth introduction of the simple suspension method that adopted a nurse questionnaire 安富暉浩1), 犬飼千智1), 安田成男1), 辻井佳代1), 小林政彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 780-780, 2022.

---

	P025-23-PM. One case that phenothiazine derivative combination was considered as the toxic symptom onset, a factor in a lithium concentration therapeutic range, and led to the temporary pacemaker insertion 眞野裕1), 石田茂伸1), 多胡友絵1), 星育子1), 小泉祐一1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 781-781, 2022.

---

	P026-24-AM. Fact-finding of the polypharmacy in our clinic 梅庭大地1,2), 今野江梨1), 藤田大智1), 佐々木理絵1), 天間雅美1), 加藤利佳3), 本郷文教1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 782-782, 2022.

---

	P027-23-PM. Activity result of the urination care team in our hospital 林剛史1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 783-783, 2022.

---

P028-24-PM. Efforts aiming at medication counseling system reinforcement by the Commander system introduction in the local inclusion care ward in the ward drug duties non-enforcement institution 岸本真1), 徳丸章佳1), 山本梢1), 中野一馬1), 北園幸大1), 田中恭人1), 豊留麻衣1), 池沢若菜1), 森永崇史1), 中村杏果1), 屋敷大輔1), 淵脇ゆかり1), 長ヶ原琢磨1), 荻尾夕起子1), 児玉友和2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 784-784, 2022.

---

	P029-23-PM. 1 case of the pacemaker lead infection that suffered from a choice of the antiMRSA medicine 内村充志1), 曽我弘道1), 前田朱香1), 福島将友1), 町田聖治1), 入江利行1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 785-785, 2022.

---

	P030-24-AM. The osteoporosis therapeutic drug start situation investigation by the FLS (osteoporotic liaison) pass introduction 後藤千尋1), 宮崎早可1), 田中拓可1), 大城里紗1), 安達嘉織1), 佐野隆大2), 福井由美子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 786-786, 2022.

---

	P031-23-PM. Fact-finding of the bringing medicine for the purpose of the cancellation of the polypharmacy 田本光莉1), 矢田山瑞稀1), 島津智行1), 河端真以1), 蝦名勇樹1), 村上智香1), 田中悠季1), 三本松泰孝1), 佐藤弘康1), 田村広志1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 787-787, 2022.

---

	P033-23-PM. Increased pharmacist intervention in discharge guidance - Utilizing pre-avoid reports - 瀬名波暢子1), 門馬佳代子1), 辻井佳代1), 小林政彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 788-788, 2022.

---

	P034-24-AM. Investigation of the quantity of pain-killer prescription in front and back where a pharmacist intervenes in in the pain control in the orthopedics ward positively 山口茉由夏1), 保志場康人1), 小山奈津実1), 森脇麻希1), 山口徹郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 789-789, 2022.

---

	P035-23-PM. Efforts and evaluation for the drug global assessment adjustment addition in our hospital 伊藤弥紀1), 東恵理1), 永江寛子2), 萩原大樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 790-790, 2022.

---

	P036-24-AM. Examination about the effect on serum zinc levels with the zinc acetate dihydrate administration to a premature infant of the hypozincaemia and serum copper concentrations 伊藤俊和1,2), 上ノ山和弥1), 小林和博1), 角本幹夫3), 水本洋4), 桂敏也2), 尾上雅英1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 791-791, 2022.

---

	P037-23-PM. Efforts of the regional alliances in our hospital drug department utilizing the discharge drug control summary 勝岡美菜1), 小寺菜月1), 若林厚史1), 坂本依利1), 高橋彩1), 田畑寛明1), 猿谷淳1), 向一美1), 地野幹子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 792-792, 2022.

---

	P038-24-AM. Effect to the bleeding event prevention by the pharmacist intervention using Data Ware House on use of warfarin inpatient 山岸千恵1), 木下照常1), 杉山和弥1), 森健司1), 滝本典夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 793-793, 2022.

---

	P039-23-PM. The observance situation of chronic constipation practice guidelines 小林寛典1), 信澤弘美1), 松元美香1), 大谷道輝1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 794-794, 2022.

---

	P040-24-AM. Current status and issues of pre-avoid reporting at Komaki Municipal Hospital 土本大輔1), 桑原悠里1), 河野美来1), 宮川佐和子1), 林浩之1), 戸田康裕1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 795-795, 2022.

---

	P041-23-PM. Examination about the usefulness of MMAS-4 in the medication Adobe alane evaluation 石井照樹1), 大嶋成奈優1), 沖廣絵里子1), 高橋公子1), 石原瑛太郎1), 篠永浩1), 加地努1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 796-796, 2022.

---

	P042-24-AM. Relation of the pharmacist in the neonatal intensive care unit 門倉史枝1), 岡田瑞希1), 松谷春花1), 河原香織1), 藤原康浩1), 合田泰志1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 797-797, 2022.

---

	P043-23-PM. Observational study about the usefulness of the SURPASS (SURgical PAtient Safety System) introduction in the perioperative antithrombotic drug management 堀内保顕1), 加藤里奈1), 加藤秀雄1), 向原里佳1), 世古口典子1), 佐々木典子2), 水谷栄梨1), 大井正貴3), 坂井田寛4), 兼児敏浩2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 798-798, 2022.

---

	P044-24-AM. Efforts and evaluation of the pharmacist to the perioperative delirium measures in the digestive organ surgery domain 宮原強1), 野中美佳1), 草葉一友1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 799-799, 2022.

---

	P045-23-PM. Contribution degree investigation in the pharmacist participation in planning of the heart rehabilitation conference 千葉貴志1), 池田絢絵1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 800-800, 2022.

---

	P046-24-AM. Examination about the tube obstruction risk in the transluminal medication for extremely-low-birth-weight infants 田中悠介1), 金田亜季子1), 石川雄也1), 八島秀明1), 阿部正樹1), 荒木拓也1,2), 山本康次郎1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 801-801, 2022.

---

	P047-23-PM. Medical treatment adequacy mainly on the antimicrobial medicine to patients who received extracorporeal circulation device by the cooperation of a pharmacist and the clinical engineer in the intensive care domain 小林洋平1), 中川貴弘1), 河津敏明1), 荒川昌洋2), 烏野隆博1,3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 802-802, 2022.

---

	P048-24-AM. One case that the hypermagnesemia with advanced magnesium oxide tablets was regarded as a cause of disturbance of consciousness rapidly 藏本裕信1), 樽屋志保1), 権藤直人1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 803-803, 2022.

---

	P049-23-PM. Fact-finding about the use level of injection drug unification in the intensive care unit 立石裕樹1,10), 今井徹2,10), 川邊一寛3,10), 玉造竜郎4,10), 安藝敬生5,10), 今中翔一6,10), 奥川寛7,10), 中馬真幸8,10), 前田幹広9,10) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 804-804, 2022.

---

	P050-24-AM. Efforts to duties construction aiming at the perioperative drug control addition acquisition 日江井和英1), 宮部芳之1), 土本暁斗1), 安田翔1), 中村英嗣1), 大塚祐紀子1), 佐藤和也1), 松由幸司1), 塚原民夫1), 甲斐三由紀2), 山崎潤二3), 梶川真樹4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 805-805, 2022.

---

	P051-23-PM. Introduction and evaluation of the calculation tool for the purpose of the intravenous feeding flow rate adequacy in the emergency care 長澤欣弘1), 中村槙一郎1), 瀧内瑛輔1), 尾形美絵1), 近藤和宏1), 羽生智宏1), 新関みどり1), 田村和彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 806-806, 2022.

---

	P052-24-AM. Effect and a risk factor to acute renal failure of the vancomycin + piperacillin/tazobactam combination therapy for the seriously ill patients: Single institution rearward observational study 濱名哲大1), 大橋明歩1), 片山侑紀1), 梅村穣2), 藤見聡2), 藤田敬子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 807-807, 2022.

---

	P053-23-PM. Examination of the efforts method for the acquisition of the drug global assessment adjustment addition by the intensive care unit permanent residence pharmacist 大塚晋也1), 林隼輔1), 蔭山博之1), 長谷川英雄1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 808-808, 2022.

---

	P055-23-PM. The preoperative statin internal use in the statin drugs common use patients affects the blood pressure at the induction of anaesthesia 土本希1,2), 宮本朋佳1), 木村初1), 小泉祐一1), 森正信2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 809-809, 2022.

---

	P056-24-AM. In the seriously ill COVID-19 patients, look at the rear that evaluated the effectiveness that bowel control by the naldemedine gives; a mark observational study 片山侑紀1), 濱名哲大1), 大橋明歩1), 川田真大2), 梅村穣2), 藤見聡2), 藤田敬子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 810-810, 2022.

---

	P057-23-PM. Examination of the usefulness by a pharmacist conducting an alteplase preparation preparation in the critical care center 小林悠1), 内山耕作1), 種村繁人1), 渡邊晃平1), 芥子川純里1), 冨田敦和1), 今西忠宏1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 811-811, 2022.

---

	P058-24-AM. Medical safety measures by the incompatibility reporting based on the three-drug incompatibility test that assumed turbidity an index 近藤匡慶1), 源平麻衣1), 深尾彰平1), 田杭直哉1), 菅谷量俊1), 柳田顕郎2), 高瀬久光1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 812-812, 2022.

---

	P059-23-PM. Usefulness evaluation for patients with stroke for the acute phase by the ward pharmacist in the emergency visit 石川衣里子1), 細谷龍一郎1,2), 北島健士1), 柴崎功1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 813-813, 2022.

---

	P060-24-AM. Example that a ward pharmacist provided multidisciplinary treatment for emphysematous pyelonephritis and supported 井出和男1), 石村真琴1), 西垣哲太1), 川邊一寛1), 秋田士雄人1), 加藤英明2), 小池博文1), 佐橋幸子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 814-814, 2022.

---

	P061-23-PM. Investigation about the difference of the medication counseling of the female sex hormone preparation by the Gender of the drugstore pharmacist 矢島杏里1), 長内理大1), 伊野陽子1), 玉木啓文1), 井口和弘1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 815-815, 2022.

---

	P062-24-AM. Introduction of the discontinuation explanation seat before surgery, examination with the photograph as the support before hospitalization 濱崎翔平1), 谷本憲哉1), 谷口潤2), 尾ノ上剛樹1), 山形真一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 816-816, 2022.

---

	P064-24-AM. About the role of the pharmacist for the high-risk medicine including diabetes, an antithrombotic drug, the anticancer agent in the hospitalization ambulant treatment support 野村浩夫1,2,3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 817-817, 2022.

---

	P065-23-PM. The introduction of the interview by the pharmacist for patients with foreign cancer and the evaluation 平野公美1), 外山未来1), 大和千穂1), 八木貴彦1), 冨田奈々1), 宮本康敬1), 川口千香1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 818-818, 2022.

---

	P066-24-AM. Elucidation and drugstore investigation ... of the potential element of the labor quality of life (Quality of Working Life) of the drugstore pharmacist in the suburbs of secular variation - Kanto 加藤裕太1,2), 関谷剛1), 石井僚3), 平子庸志3), 佐藤宏樹2), 木村廣道1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 819-819, 2022.

---

	P067-23-PM. Fact-finding of the in front of art discontinuation supplement in the pharmacist interview before hospitalization of the perioperative patients 山川裕司1), 柏村友一郎1), 小田泰弘1), 岩切総子1), 島野玲菜1), 若海大智1), 藤井博之1), 伊藤忠明1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 820-820, 2022.

---

	P068-24-AM. Usefulness of the pharmacist intervention in the hospitalization and release support task of the general support center 小寺聖1,2), 渡部実咲1), 田中佳子1), 関谷泰明1), 井上壽江1), 荒井正純2), 平下智之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 821-821, 2022.

---

	P069-23-PM. Questionary survey to the physician about the evaluation of the pharmacist outpatient department 黒部健太郎1), 宮原強1), 草葉一友1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 822-822, 2022.

---

	P070-24-AM. Usefulness investigation of the pharmacist intervention in the hospitalization support outpatient department of the patients targeted for surgery 早坂美希1), 佐々木順也1), 千葉貴志1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 823-823, 2022.

---

	P071-23-PM. The current situation investigation and problem of the use of prescription notebook situation after the prescription notebook seal introduction and the medication explanation 小野理恵1), 金田亜季子1), 飯塚誠1), 高橋理充1), 長井桃子1), 阿部正樹1), 八島秀明1), 荒木拓也1,2), 山本康次郎1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 824-824, 2022.

---

	P072-24-AM. Usefulness evaluation of the prescription support for the overs and shorts of expendable supplies required for insulin, GLP-1 receptor agonist, SMBG 若原美沙紀1), 中村和行1), 三浦忠将1), 森巧一1), 藤井友和1), 武井貴裕2), 近藤國和3), 水谷直広3), 杉浦洋二1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 825-825, 2022.

---

	P073-23-PM. An effect and evaluation of the insulin instruction to patient by task shift/share 植村有加1), 安田早織1), 辻芙美1), 楠斐未1), 國枝亜矢香1), 矢野美保2), 三宅健文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 826-826, 2022.

---

	P074-24-AM. Intervention results and evaluation - of the promotion of task shift - team approach in medical care 滝澤康志1), 久保田令枝1), 宮崎邦晃1), 西澤さとみ1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 827-827, 2022.

---

	P075-23-PM. About the periodical change of the prescription order representation input quantity of duties before and after transducing it 小野歩1), 沼田諒1), 折戸融1), 石井勇太1), 片山潤1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 828-828, 2022.

---

	P076-24-AM. Effect of reducing the workload on doctors through task shifting using PBPM and ward drug duties 片桐将志1), 十川友那1), 近藤宏樹1), 中西順子1), 篠永浩1), 原田典和1), 加地努1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 829-829, 2022.

---

	P077-23-PM. Support effect on the basis of a pharmaceutical evaluation on secondary fracture prevention of patients with fragile bone fracture accompanied with the 2022 medical service fees revision 佐藤愛1), 中島美治1), 中村彩1), 内田裕之1), 満田正樹1), 河井良智1), 東川晶郎2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 830-831, 2022.

---

P078-24-AM. About the introduction examination of the doubt inquiry simplification protocol by the hospitalization prescription based on the actual situation of doubt inquiry in our hospital 中北朝海1), 臼田昌弘1), 大原展1), 木村綾沙1), 木下護1), 神崎愛乃1), 高田莉里1), 白幡千慧1), 藤田英里子1), 内田裕子1), 大森俊和1), 樋口愛子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 832-832, 2022.

---

	P079-23-PM. Examination about the overtime prescription reduction effect by the prescription support of the pharmacist 菅直恵1), 西村健二1), 石田亮2), 亀井健人1), 赤木晋介1), 徳田衡紀1), 高柳和伸1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 833-833, 2022.

---

	P080-24-AM. Effect on wound development number by the use of drug for external use using PBPM in the ICU ward 竹腰雄真1), 山本浩二郎1), 前田晃佑1), 山本倫数1), 草薙みか1), 山田直輝1), 中出早代1), 裏野千裕1), 竹村姫穂1), 大里泰章1), 濱田達志1), 岩知道美幸1), 吉澤典成1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 834-834, 2022.

---

	P081-23-PM. Relation of the pharmacist to self-injection instruction of the hydrocortisone preparation for the acute adrenal insufficiency 櫻井雄一郎1,2,3), 桧作和子2), 吉田麻里1), 井上美菜1), 西谷千里3), 有馬純子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 835-835, 2022.

---

	P082-24-AM. Effect of the PBPM enforcement for sleeping drug proper use of the inpatient 石谷理紗1), 長谷川啓1), 細田未紀1), 山根正也1), 千原里美1), 上田宏1), 三好崇文2), 伊東範尚3), 中村好男3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 836-836, 2022.

---

	P083-23-PM. Have the pharmaceutical products by the non-pharmacist using the personal digital assistant; efforts to misprevention 寺田公介1), 佐藤公彦1), 吉野麻結1), 中島寿久1), 石川光信1), 赤木徹1), 橋本浩伸1), 古川哲也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 837-837, 2022.

---

	P084-24-AM. Prescription support ... which understood task shift - condition of a patient by the pharmacist in the interstitial pneumonia, pulmonary fibrosis center 関根悠1), 合津貴志1), 渡邉紘章1), 築地洸大1), 杉野圭史2), 田崎政則1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 838-838, 2022.

---

	P085-23-PM. The preparation of the surgery use drug by the pharmacist is the effect to replace it, and to give at time of the surgery patients 土川拓也1), 小倉花菜1), 濱本裕太1), 古谷一平1), 田中佳子1), 関谷泰明1), 井上壽江1), 平下智之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 839-839, 2022.

---

	P086-24-AM. Efforts and evaluation for the appropriate correspondence such as anticoagulants, and the like in the perioperative period 石田智之1), 森美保菜1), 末永尚輝1), 八汐祥恵1), 鶴永大貴1), 中村有莉恵1), 堀内智裕1), 赤星真広1), 森岡友美1), 池増鮎美1), 佐多照正1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 840-840, 2022.

---

	P087-23-PM. Evaluation of the pharmacist duties in the hospitalization and release support center using the satisfaction analysis 竹内恵1), 宮原強1), 山田敦子1), 貞嶋栄司2), 田中聡也3), 草葉一友1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 841-841, 2022.

---

	P088-24-AM. Efforts of the pharmacist about the cancellation medicine before stomach, colonoscopic examination in the outpatient 藤井達郎1), 佐々木静香1), 下口谷貴1), 山川拓1), 久保瞳1), 藤井有貴1), 門村将太1), 森本雅子1), 井藤達也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 842-842, 2022.

---

	P089-23-PM. Inspection of the effect of the prescription input support task by the pharmacist in the orthopedics ward 曽根本恵美1), 溝口晶子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 843-843, 2022.

---

	P090-24-AM. Efficiency of the duties with the drug management system which implemented a prescription injection order automatic uptake function 宮崎美香1), 馬場貴子1), 陣上祥子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 844-844, 2022.

---

	P091-23-PM. Construction and problem of the expiration date inspection using the new bar code in the parenteral injection inspection system 下村一徳1), 高橋勝史1), 瀬名波宏昌1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 845-845, 2022.

---

	P092-24-AM. Current situation investigation (2) for the new mobile health-related application development aiming at effective medical treatment and improvement in health science 斉藤将志1), 福井一玄1), 鈴木小夜1), 横山雄太1), 地引綾1), 河添仁1), 中村智徳1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 846-846, 2022.

---

	P093-23-PM. The effect that the prescription of the drug requiring an examination and exhaustive grasp of the examination situation give to ward drug duties 永野真久1), 住吉恵1), 峰山恵理子1), 高武嘉道1), 花田聖典1), 川俣洋生2), 橋本雅司1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 847-847, 2022.

---

	P094-24-AM. An onset of congenital heart defect vascular disorder risk accompanied with the cross-placental transfer: Analysis using the large-scale database 岡田章1,2), 若林里依1), 世良庄司1,2), 永井尚美1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 848-848, 2022.

---

	P095-23-PM. The prescription situation investigation of capecitabine and the drug for external use in Japan using the NDB opening database 中村俊貴1), 坂本岳志1), 境美智順1), 木村雅彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 849-849, 2022.

---

	P096-24-AM. Effect of the reporting that use and application had of in-hospital big data (DWH) which gave it to proper use of the eldecalcitol 伊東久貴1), 三村享1), 村井健太郎1), 竹澤崇1), 坂上進1), 堀口香織1), 土屋広行1), 内藤隆文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 850-850, 2022.

---

	P097-23-PM. Construction of the positioning database of the medicine for prescription suggestion based on evidence 高嶋理子1), 柴田里枝子1), 石川真代2), 大野逸子1), 杉平直子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 851-851, 2022.

---

P098-24-AM. Relative examination with the urination independence at prescription pattern of the lower urinary tract symptom (LUTS) therapeutic drug vertical section-like for the stage using the stroke regional alliances pass and convalescent discharge 隅屋暦1), 正源寺美穂2), 平子紘平3), 小川依4), 池永康規5), 玉井郁巳6), 増田晃伯7), 橋本昌子8), 藤田有美1,9), 嶋田努1,9), 崔吉道1,9) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 852-852, 2022.

---

	P099-23-PM. Graded approach for formula repenetration 森良江1), 前万紀子1), 堀勇太2), 磯部佳歩1), 中浴伸二3), 森本茂文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 853-853, 2022.

---

	P100-24-AM. Search of the low carnitine blood symptom onset risk factor with the pivoxil group using adverse drug reaction database (JADER)-containing antimicrobial 佐々木稜太1), 服部真也1), 高田慎吾1), 山田武宏1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 854-854, 2022.

---

	P101-23-PM. Efforts of the continuous medication counseling utilizing the telephone follow-up by the health insurance pharmacy pharmacist 長沼敬子1), 上田博史1), 染谷光洋1), 中田祐一1), 谷口亮央1), 中島史雄1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 855-855, 2022.

---

	P102-24-AM. Questionary survey about the online medication counseling for pharmacists 植田光紀1), 大野由紀子1), 石川春樹1), 井澤美苗1), 望月眞弓1), 青森達1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 856-856, 2022.

---

	P103-23-PM. Construction of Kurashiki center Hospital adverse drug reaction database (KADER) 古谷祥子1), 長尾由佳1), 田之上理恵1), 藥師径子1), 赤木晋介1), 徳田衡紀1), 高柳和伸1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 857-857, 2022.

---

	P104-24-AM. Comparative study on basic drug information of authorized generics and brand-name drugs 佐々木咲輝1), 政田一樹1), 古俵孝明1), 渡辺享平2), 塚本仁1), 酒井隆全3), 大津史子3), 後藤伸之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 858-858, 2022.

---

	P105-23-PM. Effects of introducing recommendation function on electronic medical record in formulary operation of G-CSF preparations 山崎瑞季1), 安田浩二1), 木野村元彦1), 櫻井秀司1), 鈴木昭夫1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 859-859, 2022.

---

	P106-24-AM. Strategic research towards in-hospital formulary penetration at Toda Chuo Medical Care Group (TMG) (2nd report) 安藤正純1), 金井紀仁1), 佐藤光2), 宮本拓也3), 澤田雄太4), 奈良部修弘5), 吾妻隼斗6), 永瀬真理子7), 下舘桃子8), 宮崎美子3), 齋藤俊夫9), 濃沼政美10) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 860-860, 2022.

---

	P107-23-PM. Analysis of the effect of the levetiracetam to give a bleeding-related adverse event by oral anticoagulant drug (DOAC) directly using the adverse drug reaction database 濱田雄平1), 奥村啓樹1), 宮崎雅之1), 山田清文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 861-861, 2022.

---

P108-24-AM. Efforts to introduce a sleeping pill formulary at Saitama Medical University Hospital - Based on the experience of multidisciplinary collaboration - 水村亮介1,2), 石川章1,2), 伊藤護之1,2), 宇都宮暁1,2), 眞壁秀樹1,2), 佐美三怜佳2), 須賀建太郎2), 黒澤洋志2), 小和瀬由美子2), 喜屋武玲子2), 草野武2), 鈴木景子2), 松岡孝裕2), 松尾幸治2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 862-862, 2022.

---

	P109-23-PM. Investigation of the pharmaceutical products cord published in "the announcement" of cessation of production, sale cancellation of pharmaceutical products sent by the pharmaceutical company 若林進1), 田中秀和2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 863-863, 2022.

---

	P110-24-AM. Pre-rear investigation of Residual medicine patients with diabetes that we coordinated 青木由華1), 坂田洋1), 田中伸明1), 鈴木大吾1), 中村敏史1), 服部芳明1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 864-864, 2022.

---

	P111-23-PM. Analysis about the delirium risk of the antiepileptic drug 久保利樹1), 祖川倫太郎1), 飛田修康1), 橘川奈生1), 角真太郎1), 島ノ江千里1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 865-865, 2022.

---

	P113-23-PM. Investigation of the prescription situation of the antiallergic agent for spring hay fever during pregnancy 前田恵里1), 星野香澄1), 岡田裕子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 866-866, 2022.

---

	P114-24-AM. Extraction of the high-risk drug by the exhaustive analysis of the potential cardiovascular disturbance risk using side effect spontaneous report database (JADER) 井川祐輔1), 江角悟1), 牛尾聡一郎1), 市川裕規1), 濱野裕章1), 鍛治園誠1), 西原茂樹1), 村川公央1), 座間味義人1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 867-867, 2022.

---

	P115-23-PM. Risk factor of the non-fixed form femur fracture based on JADER, profile of the expression time, examination of the drug interaction 鳥海真也1,2), 三森竜司1), 坂本治彦1), 植沢芳広2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 868-868, 2022.

---

	P116-24-AM. In-hospital formulary at a 300-bed public hospital - Aiming to improve patient outcomes - 磯貝一成1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 869-869, 2022.

---

	P117-23-PM. Drug-induced hiccups and relations of the glucocorticoid receptor 細谷龍一郎1,2), 野澤(石井)玲子3), 植沢芳広2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 870-870, 2022.

---

	P118-24-AM. Use investigation of the ropinirole hydrochloride percutaneous absorption type preparation for the Parkinson's disease patients 安高勇気1,2), 藤岡伸助3), 大藪康平2), 坪井義夫3), 神村英利1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 871-871, 2022.

---

	P119-23-PM. Survey on the current status of formulary implementation and the "formulay introduction procedure manual with Japanese Red Cross Society usage guide" 堀大1,10), 野田明宏2,10), 小口正義3), 伊賀正典4,10), 大川浩子5,10), 小林政彦6,10), 村上通康7,10), 森英樹8,10), 谷村学9,10) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 872-872, 2022.

---

	P120-24-AM. Investigation about the proper use of a bone, the calcium metabolism injection drug 鶴山萌子1), 高武嘉道1), 花田聖典1), 川俣洋生2), 橋本雅司1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 873-873, 2022.

---

	P121-23-PM. Inventory survey about the current situation of the proper use of the oral antimicrobial in the pharmacy service under health insurance drugstore and the consciousness 高木栄希1), 川村ひとみ1), 坂本拓也1), 井上優子1), 伊達悠香1), 高橋里沙1), 駒沢穂乃佳1), 鈴木美和1), 白石貴寿1), 荒井宏人1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 874-874, 2022.

---

	P122-24-AM. Survey on anamorelin usage status in our hospital 高田昌季1), 八幡静香1), 野尻雅人1), 清水雅子1), 高瀬美咲枝2), 柴田和彦3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 875-875, 2022.

---

	P123-23-PM. Use fact-finding of the Mashiningan extract for the constipation 小笠原大祐1), 上田賢太郎1), 下石和樹1), 陣上祥子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 876-876, 2022.

---

	P124-24-AM. Investigation about taking sulfamethoxazole trimethoprim (ST) combination drug small size tablets characteristics in children 山口みほ1), 齊藤順平1), 丹沢彩乃1), 歌野智之1), 千葉杏子1), 清水誠一2), 阪本靖介2), 福田晃也2), 笠原群生2), 山谷明正1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 877-877, 2022.

---

	P125-23-PM. The use situation investigation of oxytocin for induced labor, the weak labor in our hospital 徳力麻希1), 池田久雄1), 古久保有希子1), 森岡浩子1), 神原弘和1), 依田恵美3), 橋本奈美子2), 足立充司1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 878-878, 2022.

---

	P126-24-AM. It is an investigation for the proper use for the combination more than two drugs of an antithrombocytic agent, the anticoagulant 前田安里沙1), 山口章江1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 879-879, 2022.

---

	P128-24-AM. The use situation investigation for the purpose of the adequacy of the drug choice in the hyperuricaemia therapeutic drug 岩田裕明1), 山村亮太1), 龍田涼佑1), 田中遼大1), 伊東弘樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 880-880, 2022.

---

	P129-23-PM. Examination about the effectiveness of the zoledronic acid injection for the bone density drop that occurred during endocrine therapy after the breast cancer technique 鈴木訓史1), 村多杏美1), 内藤義博1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 881-881, 2022.

---

	P130-24-AM. Use fact-finding of olanzapine in the antiemesis treatment of cancer chemotherapy patients 岡田和也1), 荒井雄樹1), 佐道花菜1), 村田政軌1), 三上知佳1), 木村錦子1), 青井博志1), 治田匡平1), 吉川一吾1), 鈴木渉太2), 池田和之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 882-882, 2022.

---

	P131-23-PM. Expectation to a drugstore pharmacist judging from inhabitants awareness to locomotive syndrome 冨永宏治1), 森田一俊1), 甲斐麻美子1), 原口恵子2), 白石遙香1), 高木淳一2), 田中泰三2), 江川孝1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 883-883, 2022.

---

	P132-24-AM. Fact-finding about the off-period of the perioperative antithrombocytic agent in the first generation drug dissolution stenting patients 柘植勇大1), 小松敏彰1), 冨澤淳2), 平井美乃里1), 吉瀬絵理1), 尾鳥勝也1,3), 厚田幸一郎4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 884-884, 2022.

---

	P133-23-PM. The prescription situation investigation of the oral antimicrobial in the outpatient department for children 平田貴宏1), 池田久雄1), 平田亜紀1), 足立充司1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 885-885, 2022.

---

	P134-24-AM. Problems of the simple suspension method in the Handa that we knew from questionary survey City solder hospital neurosurgery ward 吉川直利1), 内藤千里2), 板倉由縁1), 横田学1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 886-886, 2022.

---

	P136-24-AM. Usefulness of the medical application in patients with cancer 峯岸智之1), 木本真司1), 河原史明1), 香内綾1), 齋藤浩司1), 成田浩気1), 富山瑠美1), 塩川秀樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 887-887, 2022.

---

	P137-23-PM. Survey on continuation of osteoporosis treatment after completion of teriparatide and romosozumab at our hospital 城山晴佳1), 冨田敦和1), 今西忠宏1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 888-888, 2022.

---

	P138-24-AM. Use fact-finding of the carboxymaltose second iron injection for patients with iron-deficiency anemia 神志那萌子1), 濱地広毅1), 横溝綾子1), 前田幹広1), 有木宏宗1), 坂上逸孝1), 田中恒明1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 889-889, 2022.

---

	P139-23-PM. About the use of antimicrobial situation of our hospital for the substrate specific expansion type β - lactamase (ESBL)-producing infection 山本亮子1), 梶本佑輔1), 菊地雄基1), 佐藤英和1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 890-890, 2022.

---

	P140-24-AM. Consciousness, knowledge investigation about the anti-doping in the hospital pharmacist 畠山成寛1), 中川ちひろ1), 井出和男1), 川邉桂1), 小池博文1), 佐橋幸子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 891-891, 2022.

---

	P141-23-PM. Medical expenses reduction effect by the bortezomib generic small capacity standard vial introduction 宇佐美英績1,2), 福岡智宏2), 木村美智男1), 吉村知哲1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 892-892, 2022.

---

	P143-23-PM. Improvement of the economic loss by discontinuation instructions confirmation duties before operation 都築竜太1), 出雲貴文1), 深澤佑樹1), 佐藤渚1), 河本怜史1), 三好文子1), 山田晶子1), 柴田由佳1), 吉田裕紀1), 加藤紗耶香1), 松重奈央1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 893-893, 2022.

---

	P145-23-PM. The effectiveness at disease ornamentation-related antirheumatic drug and methotrexate combination by existing clinical study data and safe analysis 吉井優花1), 大西真由1), 秋田彩佑1), 安部賀央里1), 頭金正博1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 894-894, 2022.

---

	P146-24-AM. Evaluation after the in-hospital formula reintroduction in the small and medium size hospital 浅野志津1), 松本和也1), 廣田あゆ子2), 森英樹2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 895-895, 2022.

---

	P147-23-PM. Association between suvorexant and femur fracture in elderly people 齋藤智之1), 野尻宗子1), 葛西隆敏2), 平塚義宗3), 石島旨章4), 代田浩之2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 896-896, 2022.

---

	P149-23-PM. Investigation about a potentially serious medical errors example of the bringing medicine using the technique of the text mining and the measures 瀧内菜々美1), 久保南菜子1), 神田紘介1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 897-897, 2022.

---

	P150-24-AM. Fact-finding about the source of information who used it at the bringing medicine differentiation of the inpatient in our hospital 秦光平1), 相松伸哉1), 野呂菜緒美1), 南川文哉1), 宮崎寛隆1), 石井ゆに香1), 近藤大介1), 脇由香里1), 渡邉明日香1), 江原亜沙子1), 野田晋司1), 小島さおり1), 松田浩明1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 898-898, 2022.

---

	P151-23-PM. About the efforts of the polypharmacy measures team in the municipal Itami Hospital 細田未紀1), 長谷川啓1), 石谷理紗1), 山根正也1), 千原里美1), 上田宏1), 三好崇文2), 伊東範尚3), 中村好男3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 899-899, 2022.

---

	P152-24-AM. About protection of algae fucoidan for the amyloid beta-induced neurotoxicity in SH-SY5Y cells 永田未希1,2,4), 辻まゆみ2), 小口達敬2,3), 門馬佑太郎2,3), 野原哲人2,3), 大橋英朗2,3), 井藤尚仁2,3), 山本謙2,3), 宇高結子2,3), 佐々木晶子2,3), 木内祐二2,3), 沼澤聡2,3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 900-900, 2022.

---

P153-23-PM. The construction of the health food search system and fact-finding of the health food intake situation of the pharmacist interview enforcement patients in front of the art 大久保凜香1), 原祐1), 金子真弓1), 坂東香織1), 若松綾華1), 石塚仁保1), 水谷彰史1), 友寄旬1), 山下友輝1), 須藤大雄1), 村中一大1), 中村裕一1), 鈴木千波1), 小原秀治1), 柴波明男1), 樋浦一哉2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 901-901, 2022.

---

	P154-24-AM. Development of the board game enlightening the role of the drugstore pharmacist in the self-medication 小野寺亮1), 富永敦子1,2), 佐藤健太1,2), 石原研治3), 一條宏2), 平澤典保1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 902-902, 2022.

---

	P155-23-PM. Establishment of the fixed-quantity method of nicotine out of saliva and the metabolite 田山剛崇1), 村上拓弥1), 前田志津子1), 杉原数美1), 佐和章弘1), 三宅勝志1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 903-903, 2022.

---

	P156-24-AM. Understanding degree investigation about instruction required, the package insert of the nonprescription drug that we made by a new layout 杉浦愛子1), 小田武秀2), 石川春樹1), 望月眞弓1), 青森達1,3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 904-904, 2022.

---

	P157-23-PM. An osteoporosis prophylaxis project by the cooperation with the drugstore in the hospital and the result 福島さやか1), 箱田裕貴2), 服部亜紀2), 建本百合香2), 工藤裕美2), 黒江良知2), 鎗水可奈1), 西江美智子1), 亀井健人1), 赤木晋介1), 徳田衡紀1), 高柳和伸1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 905-905, 2022.

---

	P158-24-AM. Investigation of the infusion reaction frequencies in changes from a trastuzumab precedence product to Biosimilar 草野泰輝1), 森善洋1), 吉野走1), 林田颯志1), 山根理恵子1), 山口卓朗1), 岩村直也1), 佐道紳一1), 南恵樹2), 樋口則英1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 906-906, 2022.

---

	P159-23-PM. Comparison between etanercept precedence biomedicine and biofollowing article analysis using real world data 川上智也1), 米澤淳1,2), 増井翔1,2), 大西輝3), 鬼澤秀夫3), 藤井貴之3), 村田浩一3), 田中真生3), 森信暁雄3), 横山琴子4), 岩本典子4), 嶋田崇史4), 中川俊作1), 池見泰明1), 寺田智祐1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 907-907, 2022.

---

	P160-24-AM. The effectiveness of the etanercept bio follower product in rheumatoid arthritis treatment and safe evaluation 抱恵子1,2), 雪矢良輔1), 梶田貴司1), 八田和大2), 奥野智之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 908-908, 2022.

---

	P161-23-PM. About the efforts of the pharmacist for the calculation of the early period of biofollowing article (Biosimilar) introduction addition accompanied with the 2022 medical service fees revision 嶋田紘也1), 大橋啓子1), 木村美貴1), 阿部瑛子1), 池田藍1), 高田あゆみ1), 遠藤修司1), 平岩知子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 909-909, 2022.

---

	P162-24-AM. It is investigated linezolid-induced myelosuppression for the infection after the artificial joint replacement in elderly people 75 years or older 小林俊介1), 安武夫2), 田川誠二1), 小倉敬史1), 北岡晃1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 910-910, 2022.

---

	P163-23-PM. One case with suspected complete atrioventricular block with the vancomycin hydrochloride note 西川祐貴1), 門口直仁1), 宮本千晴1), 森田有香1), 田中聡1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 911-911, 2022.

---

	P164-24-AM. Example that somnolence attributable to palonosetron produced 津久井千之1), 安藤沙耶1), 入岡凌1), 渡部晃裕1), 大塚尚1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 912-912, 2022.

---

	P165-23-PM. An example with suspected side effect of intragastric retention of zirconium cyclo sodium silicate 福島隆宏1), 檜山洋子1), 吉川博1), 佐藤智人1), 大木伸吾2), 松尾裕彰1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 913-913, 2022.

---

	P166-24-AM. The effect that drug interaction with azithromycin gives for an adverse event of tacrolimus 米澤龍1,2), 須永登美子1,3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 914-914, 2022.

---

	P167-23-PM. Evaluation of the adverse event profile of the microscope-related colitis using adverse event spontaneous report database (JADER) 山城海渡1,2), 上田実加2), 尾崎優2), 平田敦士2), 緒方文彦1), 中村武浩1), 川崎直人1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 915-915, 2022.

---

	P168-24-AM. Examination of the factor involved in advisability of the rifabutin introduction in tuberculosis treatment 山崎貴史1), 山科卓也1), 青柳千愛1), 下村真代1), 平木洋一2), 古海和博1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 916-916, 2022.

---

	P169-23-PM. Specialist in citizen of Osaka consecutive side effect Committee 2020 report summary 平方まり子1), 井上千紘2), 坂田勝美3), 清水順子4), 山本京5), 松本ミユキ6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 917-917, 2022.

---

	P170-24-AM. We look at renal failure frequency of tazobactam/piperacillin and the rear of the risk factor and examine a mark 向山直樹1), 伊藤亮太2), 向山麻衣子1), 成瀬徳彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 918-918, 2022.

---

	P171-23-PM. Analysis of the risk factor for the nightmare by the suvorexant 保田和哉1), 池田龍二1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 919-919, 2022.

---

	P172-24-AM. Association between constitution of the patients who took helicobacter pylori sanitization medicine and side effect and IgE high level 尾関佳代子1), 羽田和弘1), 脇屋義文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 920-920, 2022.

---

	P173-23-PM. Investigation about the bevacizumab cancellation by the rise in protein in urine/creatinine ratio in the Atezolizumab bevacizumab combination therapy 藤田強記1), 井上勝光2), 湊本康則2), 清水裕彰1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 921-921, 2022.

---

	P175-23-PM. Risk factor of favipiravir-induced hepatic dysfunction in the COVID-19 patients 潮平英郎1), 奥村悠2), 金城武士3), Jose Carlos Sandoval Tayag4), 石井岳夫1), 諸見牧子1), 藤田次郎3), 中村克徳1,4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 922-922, 2022.

---

	P176-24-AM. A case in which drug eruption developed after switching to bicalutamide after onset of drug-induced lung injury accompanied by drug eruption due to apalutamide 田中菜央1,2), 北原加奈之3), 楠裕美子1,2), 須永登美子1,4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 923-923, 2022.

---

	P177-23-PM. One patient who had a diagnosis of Stevens-Johnson syndrome approximately four months after completion of treatment by Pembrolizumab 松本ミユキ1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 924-924, 2022.

---

	P178-24-AM. Example that the pancytopenia that it was thought that it was caused by low-dose methotrexate for the rheumatoid arthritis was prolonged by ascites 飯田遥1), 石渡泰芳1), 廣瀬藍子1), 永田将司1), 高橋弘充1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 925-925, 2022.

---

	P179-23-PM. Examination of the therapeutic effect of rebamipide formulation using acetic acid-induced hamster stomatitis model 佐藤光利1), 白石拓也1), 高橋美香1), 長谷部沙耶1), 松本知大1), 河野弥生2), 花輪剛久3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 926-926, 2022.

---

	P180-24-AM. An example of the myelofibrosis that drug-related progressive multifocal leukoencephalopathy by the ruxolitinib was suspected in 宇都宮敦子1), 田中雅幸1,2), 西山徳人1), 中山大輔1), 藤井良平1), 打谷和記1), 村中達也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 927-927, 2022.

---

	P182-24-AM. Effect of the polypharmacy on aggravation of urination, the urine collection symptom in the urology department and search of the risk factor 吉澤俊輔1), 舘知也1,2), 高橋優太1), 青山智2), 野口義紘1), 田中和秀2), 安田昌宏2), 米田尚生3), 水井貴詞2), 寺町ひとみ1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 928-928, 2022.

---

	P183-23-PM. Adverse event evaluation of the Olaparib using patients evaluation type outcome (PRO) 佐々木理絵1), 宮下真美1), 本郷文教1), 中島亜矢子2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 929-929, 2022.

---

	P184-24-AM. Using JADER and electronic medical chart data; is the examination of the bleeding risk by the combination of oral anticoagulant drug and oral antiarrhythmic drug directly 小松唯可1,2), 吉年正宏2), 淺野肇2), 柳江正嗣2), 竹上学2), 横山聡1), 細見光一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 930-930, 2022.

---

	P185-23-PM. Safety assessment of the change to the Everolimus combination regimen in heart-transplant recipients 塩見真里奈1), 廣部祥子1,2,3), 前田真貴子1,3), 奥田真弘2), 藤尾慈1,4), 前田真一郎1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 931-931, 2022.

---

	P186-24-AM. 1 case of patients with obesity that caused a creatine kinase rise by daptomycin administration 川西秀明1), 上田久美子1), 勝部理早1), 村川公央1), 座間味義人1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 932-932, 2022.

---

	P187-23-PM. Fact-finding (mainly on internal secretion metabolic derangements) of the immune-mediated adverse event with the immune checkpoint inhibitor in our hospital 家田諒1), 早川伸樹1,2), 津川透1,3), 福井愛子1), 亀井浩行1), 桑原宏貴3), 吉野寧維2), 竹中徳子2), 鈴木敦詞2), 山田成樹3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 933-933, 2022.

---

	P188-24-AM. Examination about the background factor accompanied with the onset of neutropenia in the abemaciclib remedy patients 齊藤俊一郎1), 久保淳一1), 眞山遼太1), 佐藤智香1), 大橋史嵩1), 田畑裕和1), 小林龍1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 934-934, 2022.

---

	P189-23-PM. Treatment success of the MOH patients who took a pain-killer more than 40 years 清水瞭1), 石井亮太郎2), 深沢良輔2), 芝田雄登3), 土淵尚也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 935-935, 2022.

---

	P190-24-AM. A case of cytokine storm due to postoperative discontinuation of upadacitinib 澤野有希世1), 柳江正嗣1), 藤原季美子1), 竹上学1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 936-936, 2022.

---

	P191-23-PM. Example that the acute renal failure that took advantage of infection developed in patients during cibenzoline administration, and caused hypoglycemia 伊波樹1,2), 渡邊亜矢子1,2), 佐伯美沙1,2), 伊藤綾花1,2), 永田卓也1,2), 大戸祐治1,2), 田中克巳2,3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 937-937, 2022.

---

	P192-24-AM. Association between liver residual function and side effect expression before the EGFR-TKI start 安部博宣1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 938-938, 2022.

---

	P193-23-PM. Investigation of blood pressure changes and related factors in response to initial dose of sacubitril valsartan in chronic heart failure 田邉優斗1), 大野峻1), 森下怜美1), 鈴木康崇1), 武田元樹1), 菊池健1), 相馬貴史1), 鶴山辰1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 939-939, 2022.

---

	P194-24-AM. Incidence of nausea and vomiting in patients using letermovir 安田早希1), 冨田敦和1), 榎本翔太1), 村瀬実希1), 今西忠宏1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 940-940, 2022.

---

	P195-23-PM. Effect (case report) that the furosemide combination in the case with suspected vestibular nerve damage with gentamicin sulfate gives 秋山眞太郎1), 鈴木正論1,2), 田邉大明3), 舟越亮寛1,4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 941-941, 2022.

---

	P196-24-AM. The case that drug-related syndrome of inapp ADH secretion (SIADH) improved by having switched from duloxetine to mirogabalin 高橋伸幸1,2), 森友紀子4), 岡本まとか1,2), 葛城怜子1,2), 兼元みずき4), 洲之内あずさ4), 二村明徳4), 山口天士1,2), 笠井英世4), 百賢二3), 村上秀友4), 田中広紀1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 942-942, 2022.

---

	P197-23-PM. One case of the extremely-low-birth-weight infants that blood level of vancomycin showed high level by indometacin combination 松澤菜津子1), 小澤秀介1), 成田一理1), 本木絵梨奈1), 内藤隆文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 943-943, 2022.

---

	P198-24-AM. One case of the acute coronary syndrome (cornice syndrome) accompanied with the allergic reaction with remifentanil 延藤勇1), 豊濱隆1), 庄田裕紀子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 944-944, 2022.

---

	P199-23-PM. The effect that Yokukansan remedy gives to a serum potassium level 守内匡1), 折戸渚紗1), 矢後楓佳1), 守内典子1), 野原今日子1), 松井ひろみ1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 945-945, 2022.

---

	P200-24-AM. An example of colon cancer which was treated with fenofibrate combination for hypertriglyceridemia by the capecitabine, and continued 鈴木優花1), 藤田行代志1), 新井隆広1), 蛭田英里子1), 齊藤妙子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 946-946, 2022.

---

	P201-23-PM. Examination about the side effect expression situation of the ACTH therapy for the West syndrome 原歩未1), 杉井孝綱2), 鈴木英二1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 947-947, 2022.

---

	P202-24-AM. Impact statement of the drug which paid its attention to differentiation, a hormone secretory function of placenta Trophoblast 大山七海1), 古堅彩子2), 澤田理子1), 西村あや子3), 鳴海克哉2), 小林正紀2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 948-948, 2022.

---

	P203-23-PM. Examination about the active change of Xanthine oxidoreductase (XOR) activity and Sirtuin-1 森脇智也1), 田山剛崇1), 前田志津子1), 岡村友理香2), 杉原数美1), 三宅勝志1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 949-949, 2022.

---

	P204-24-AM. Elucidation of the CYP2J2 inhibitory action with the multi-kinase inhibitor 小島綾華1), 加藤美紀1), 村山典恵2), 山崎浩史2), 灘井雅行1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 950-950, 2022.

---

	P205-23-PM. Predictive precision comparison between Scr and VCM concentrations based on CysC in patients with the amyotrophy 山科卓也1), 山崎貴史1), 青柳千愛1), 下村真代1), 古海和博1), 平木洋一2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 951-951, 2022.

---

	P206-24-AM. The impact statement which febrile neutropenia and excessive renal clearance give in blood level of the Teicoplanin and pharmacokinetics 近藤望1), 田中遼大1), 龍田涼佑1), 伊東弘樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 952-952, 2022.

---

	P207-23-PM. PK-PD-PGx analysis of vincristine in patients with CHOP therapy enforcement non-Hodgkin's lymphoma 中川潤一1), 高畑武功2), 兵藤塁1), 斎藤絢介3), 陳豫3), 鎌田耕輔2), 立田卓登2), 山下覚2), 細井一広1), 照井一史1), 上野桂代1), 佐藤温3), 新岡丈典1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 953-953, 2022.

---

	P208-24-AM. Effective evaluation of the migraine headache attack onset inhibition of the antiCGRP receptor antibody preparation by population efficacy kinetic analysis - Model-based meta-analysis (MBMA) 中村昂洋1,2), 藤田唯人3), 松永直哉3), 末次王卓1), 廣田豪1), 江頭伸昭1,2), 家入一郎1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 954-954, 2022.

---

	P209-23-PM. The construction of the population pharmacokinetics model of the piperacillin tazobactam combination drug in Japanese children and examination of the administration method 石原慎之1), 大仁田哲修1,2), 猪川和朗2), 西村信弘3), 玉木宏樹1), 矢野貴久1), 森川則文2), 直良浩司1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 955-955, 2022.

---

	P210-24-AM. One case that warfarin was thought to be adsorbed by the remaining in the gastrointestinal tract of the spherical carbonaceous adsorbent 松沼悟1), 高坂聡1), 大場俊輔2), 田口丈士2), 吉元公一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 956-956, 2022.

---

	P211-23-PM. Gemcitabine administration is the internal change of the CYP2C substrate drug and effect to give to the liver metabolism activity 福野修平1), 笠原恵太2), 高居大樹3), 西本浩子1), 嶋大貴1), 長井克仁1), 小西廣己1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 957-957, 2022.

---

	P212-24-AM. It is safe with tramadol in patients and the effectiveness of the duloxetine combination therapy after the artificial joint replacement 棚町将之1), 森崎崇文1), 星野輝彦1), 杉山留美子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 958-958, 2022.

---

	P213-23-PM. Analysis of the factor affecting the dantrolene-induced hyperkalemia using the adverse event spontaneous report database 椋田千晶1,2), 小川敦1,2), 合田光寛1,3), 吉岡俊彦1,3), 新村貴博1,4), 牛尾聡一郎2), 江角悟2), 岡田直人1), 座間味義人2,3), 石澤啓介1,3,4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 959-959, 2022.

---

	P214-24-AM. Examination about the effect that combination of the CYP2C9 revulsive gives to PT-INR change in the warfarin therapy: Rearward observational study 白石ちひろ1), 平井利典1), 藤田聡2), 土肥薫3), 岩本卓也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 960-960, 2022.

---

	P215-23-PM. One case of the liver-transplant recipients whom blood Everolimus concentrations increased by itraconazole combination remarkably 堀口香織1), 成田一理1), 三田篤義2), 副島雄二2), 内藤隆文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 961-961, 2022.

---

	P216-24-AM. Evaluation of an investigation and the pharmacist intervention of the adverse event of the use of medical drug patients using a CYP3A4 inhibitor together 落合葉子1), 壁谷めぐみ1), 大村妙子1), 鈴木理珠1), 湯浅周1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 962-962, 2022.

---

	P217-23-PM. Example that intervened in the patients who came to have poor control of PT-INR of the warfarin under the voriconazole internal use 杉本佳寿美1), 喜田昌記1), 中田麻里1), 米澤夏里1), 中村裕昌2), 柏原由佳1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 963-963, 2022.

---

	P218-24-AM. Retrospective investigation of the interaction between continuous intravenous tacrolimus infusion and letermovir in combination with azole antifungal drugs 篠木優里1), 平井利典1), 石橋美紀1), 伊野和子2), 俵功2), 岩本卓也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 964-964, 2022.

---

	P219-23-PM. Report of thrombocytopenia caused by concomitant use of clopidogrel and supplements containing Coleus forskohlii extract 平山武宏1), 関口和2,3), 荒義昭1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 965-965, 2022.

---

	P220-24-AM. Comparison between trough value and AUC in the renal failure prediction of vancomycin 原田紗希1), 羽田野励次1), 菅田哲治1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 966-966, 2022.

---

	P221-23-PM. 1 case that was given oral voriconazole for the Candida glabrata infection in patients with short bowel syndrome 柴田健太1), 高橋未来1), 中田和宏1), 関根彩奈1), 細田悠介1), 木村美由喜1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 967-967, 2022.

---

	P222-24-AM. Construction of population change - pharmacodynamic model to predict a high K blood symptom by the ST medical mixture 平井利典1), 白石ちひろ1), 中井すみれ2), 後美海2), 花田和彦2), 岩本卓也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 968-968, 2022.

---

	P223-23-PM. Development of the simultaneous assay of oral molecular target anticancer medicine using the LC/ESI-MS/MS and the metabolite 菊地正史1,2), 平澤天晴1), 高崎新也2), 公文代將希2), 佐藤裕2), 佐藤紀宏2), 前川正充1,2), 眞野成康1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 969-969, 2022.

---

	P224-24-AM. Establishment of blood concentration measurement system for venetoclax using HPLC-UV 丸藤義翔1), 野村有加1), 安武夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 970-970, 2022.

---

	P225-23-PM. One case that developed thrombotic microangiopathy during tacrolimus administration after the kidney transplantation 中野裕貴1), 岩本整1), 今野理1), 木原優1), 赤司勲1), 沖原正章1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 971-971, 2022.

---

	P226-24-AM. Examination of the renal failure risk factor of vancomycin in the AUC-guided TDM 高橋直博1), 小林理栄1), 新井亘1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 972-972, 2022.

---

	P227-23-PM. One case of the pulmonary nocardiosis that administration plan support of the amikacin was useful after the allogeneic hematopoietic stem cell transplantation 水岡大策1,2,3), 越野優希2), 田井達也3), 山口佳津騎1), 田中裕章1), 小坂信二1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 973-973, 2022.

---

	P228-24-AM. 1 case that was able to control blood level by blood tacrolimus levels analysis utilizing the spreadsheet well 齋木雄介1), 山本達郎1), 石田真紗子1), 小玉菜央1), 竹崎正明1), 藤吉正哉1), 島田美樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 974-974, 2022.

---

	P229-23-PM. Evaluation about the substitute measurement of blood theophylline levels in patients with caffeinism 福井里菜1), 平松駿一1), 加藤秀雄1), 森川祥彦1), 佐々木典子1), 岡知加2), 岩本卓也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 975-975, 2022.

---

	P230-24-AM. Construction of the population pharmacokinetics model of the tobramycin in the drug resistant bacterium infection patients 松本直也1), 尾田一貴2), 橋口ゆみ2), 山口綾水3), 城野博史2), 斎藤秀之2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 976-976, 2022.

---

	P231-23-PM. Establishment of a method for simultaneous determination of linezolid and tedizolid concentrations in human plasma using LC/MS/MS 佐藤夕紀1), 大聖貴之2), 柏木仁1), 今井俊吾1), 武隈洋2), 菅原満1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 977-977, 2022.

---

	P232-24-AM. Effect of the VCM proper use support with the 24 hours intervention system of the pharmacist 川崎祥平1), 小林義和1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 978-978, 2022.

---

	P233-23-PM. Example that a rise in blood level of mycophenolic acid was seen in by the live donor liver transplant from a Girbert syndrome suspicion donor 齋藤健一1), 小野塚真理1), 大澤雄一郎1), 田沼周平1), 松本嵩史1), 近藤正巳1), 駒込昌彦2), 牧章2), 別宮好文2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 979-979, 2022.

---

	P234-24-AM. Examination of the factor associated with the blood tacrolimus levels change at diet resumption in patients with ulcerative colitis 長友隆雄1), 吉川直樹1), 谷口裕紀1), 横田翼1), 池田龍二1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 980-980, 2022.

---

	P235-23-PM. Association between blood methotrexate concentrations and effectiveness in the methotrexate massive dose therapy for patients with osteosarcoma 長嶺歩1,2), 八島秀明3), 上村あかね4), 白石卓巳4), 高橋雄太1,2), 高橋恵美利1,4), 荒木拓也2,3), 山本康次郎2,3), 大林恭子1,2,4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 981-981, 2022.

---

	P236-24-AM. Investigation about the coadministration of nanoliposomal type irinotecan and levofolinate 野崎圭佑1), 木村美甫1), 長谷川聡司1), 井上聡子1), 高木麻里1), 高田良司2), 藤田敬子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 982-982, 2022.

---

	P237-23-PM. Efforts and practice to medical security in the cancer medical therapy 林美和子1), 間島知佳子1), 小木曽千春1), 柳沢亮太1), 高林成彰1), 小川陽平1), 粂野真由美1), 太田勝1), 伊藤勇人1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 983-983, 2022.

---

	P239-23-PM. It is the blood poison-related comparison of the obese patients in the adjuvant chemotherapy (AC therapy) and patients with non-obesity after the breast cancer technique 高木竜一1), 杉山恵亮1), 築山奈央1), 志賀有雅1), 浅野岳人1), 阿部彩香1), 本山大夢1), 藤井友和1), 杉浦洋二1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 984-984, 2022.

---

	P240-24-AM. Examination about the effectiveness and the safety of the chemotherapy combination nivolumab therapy for the progress recurrent gastric cancer in our hospital 山下剛史郎1), 呉山友教1), 松浦知博1), 鶴田和樹1), 廣瀬孝一1), 船越幸代1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 985-985, 2022.

---

	P241-23-PM. Investigation of the PBPM enforcement situation in the cancer chemotherapy 小暮宗介1), 田中佑京1), 樋口美波1), 戸坂優花1), 高畠啓輔1), 原澤秀樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 986-986, 2022.

---

	P242-24-AM. Examination about the effect of the examination of the pharmacist representation input in the HBV-related examination for the HBV reactivation prevention 元木孝1), 栗田征幸1), 渡邊清人1), 高柳昌宏1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 987-987, 2022.

---

	P243-23-PM. Efforts of the introduction of the anticancer medicine regimen order system in the childhood cancer chemotherapy 新田美奈1), 高橋毅行1,2), 山崎智久1,2), 寺薗英之1,2), 西川拓朗3), 岡本康裕3), 武田泰生1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 988-988, 2022.

---

	P244-24-AM. Usefulness of the regimen inspection by the check list type 粉川直明1), 長谷川有希子1), 中野彩萌1), 滝澤苑美1), 大沼明子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 989-989, 2022.

---

	P245-23-PM. Regarding liver function decline and thrombocytopenia caused by trastuzumab and emtansine 阿部多一1), 住谷達也1), 林哲哉1), 清水大輔2), 井口恵美子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 990-990, 2022.

---

	P246-24-AM. The new efforts which used standard conversion for the adoption change of the injection anticancer agent 齊藤安昌1), 浅川杏子1), 久保昌孝1), 島田雅彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 991-991, 2022.

---

	P247-23-PM. Examination of the usefulness of the illness medicine cooperation using the tracing report affecting the foreign cancer chemotherapy cooperation full addition 香取祐介1), 稲野寛1), 中込梢1), 佐々木寿子1), 田村和敬1), 佐々木治一郎2), 厚田幸一郎3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 992-992, 2022.

---

	P248-24-AM. Foreign pharmacist activity to lead to cancer patient's share of medical expenses reduction 金澤絵莉1), 村上摩利2), 木村滋3), 三角紳博1), 佐伯哲4), 前田茂人5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 993-993, 2022.

---

	P249-23-PM. Attempt of the intervention before physician practice to foreign cancer chemotherapy patients 西場弘美1), 千吉良幸子1), 小材直人1), 村田文1), 鈴木達宙1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 994-994, 2022.

---

P250-24-AM. Construction and usefulness evaluation of the metastases to bone follow system (team BMA) for the purpose of the early intervention for the metastases to bone of patients with cancer 横山加奈1), 森川花絵1), 秦晃二郎1), 近森綾子1), 南晴奈1), 渡部仁美1), 田川慎二1), 末次王卓1), 廣田豪1), 辻敏和1), 金谷朗子1), 江頭伸昭1), 家入一郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 995-995, 2022.

---

	P251-23-PM. Efforts of the foreign cancer chemotherapy cooperation full addition calculation by the multi-type of job cooperation 中島誠1), 寺嶋圭子2), 本坊俊和3), 大迫政彦4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 996-996, 2022.

---

	P252-24-AM. Investigation about the information sharing tool "medication notebook for messages" of patients about the oral anticancer medicine and a health insurance pharmacy and the hospital 森光保武1), 岩村高弘1), 藤井秀一1), 山本真理2), 池田雅彦2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 997-997, 2022.

---

	P253-23-PM. One case that was able to be treated with injection anticancer agent administration in being at home by the cooperation with the hospital safely 中村薫1), 川崎博行1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 998-998, 2022.

---

	P254-24-AM. Examination of the intervention effect by the efforts of the self-care promotion of the opioid rescue medicine by the palliative care team 久松大祐1,2), 泊由布子2), 田ノ上美依菜2), 今村繭子2), 樋口文子1,2), 岡本正博2,3), 門田芳幸4), 後藤隆1), 清水裕彰1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 999-999, 2022.

---

	P255-23-PM. Well-known efforts to the multi-clinical department of the colon cancer guidelines revision point using CancerBoard 屋敷大輔1,2), 田中恭人1,2), 岸本真1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1000-1000, 2022.

---

	P256-24-AM. Questionary survey about the needle pad exposure at anticancer medicine preparation in the cancer special hospital 佐野慶行1), 鈴木秀隆1), 川崎敏克1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1001-1001, 2022.

---

	P257-23-PM. About use of closed system anesthesia drug transportation system expansion for exposure measures with the anticancer medicine 茂木佳子1), 河口尚史1), 石川大介1), 堀美香1), 佐藤賢1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1002-1002, 2022.

---

	P258-24-AM. Inspection of the anticancer agent resolution effect with the ozone gas 田崎眞生1), 植村有加里1), 大川恭子1), 桑原晶子1), 田内義彦1), 辻本勉1), 濱宏仁1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1003-1003, 2022.

---

	P259-23-PM. Decontamination effect by pollution status and P-CLEAR of the anticancer medicine preparation, administration environment 福岡智宏1), 山本泰大1), 林宏紀1), 宇都宮純平1), 戸田康裕1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1004-1004, 2022.

---

	P260-24-AM. Examination about a 5-fluorouracil removal effect of the ozone water on tap water and the resolution effect 大塚瑠里1), 外山智章1), 五月女拓也1), 日向野理輝1), 押坂勇志3), 別納弘法2), 仁保誠治2), 篠崎桂子1), 臼井悟1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1005-1005, 2022.

---

	P261-23-PM. Environmental exposure investigation by the anticancer agent in the Kanazawa medical center 有原大貴1), 間宮公教2), 森下拓哉1), 宮澤憲治1), 福島信一郎1), 高木亮1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1006-1006, 2022.

---

	P262-24-AM. Densitometry of ifosfamide and the anticancer medicine included in the gas in the infusion solution bag after the paclitaxel preparation 矢野琢也1), 松本知樹1), 星加寿子1), 松本大輝1), 加藤あゆみ1), 豊田悠希1), 藤田高子2), 福岡竜逸1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1007-1007, 2022.

---

	P264-24-AM. Examination of the long-term abacterial maintenance condition using the simulated vial aiming at use of division of the vial preparation 松浦泰寛1), 眞鍋貴行1,2), 新田悠一朗1), 石川良太1), 仲谷彰規1), 久保靖憲1), 山本譲1), 岩山訓典1,3), 神山直也1,2), 中馬真幸1), 小野尚志1), 田崎嘉一1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1008-1009, 2022.

---

	P265-23-PM. Evaluation of the validity in the device change of the infusor pump to use for continuously administering it of 5-FU 大貫奏1), 金素安1), 田中悠理1), 伊代野佐知子2), 立沢正臣1), 下泰司1,3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1010-1011, 2022.

---

	P266-24-AM. An example of the follow-up that we performed in local progress pancreatic cancer impossible of excision for the patients that Conversion Surgery was enabled 中尾紘子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1012-1012, 2022.

---

	P267-23-PM. About the usefulness of the medicine medicine cooperation tool through the prescription notebook 杉浦孝太郎1), 中村洋司1), 磯部紀子1), 藤田珠理1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1013-1013, 2022.

---

	P268-24-AM. The current situation investigation about the calculation situation and the tracing report of the cooperation full addition 住谷真里子1), 高木俊輝1), 松本哲哉1), 中村智1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1014-1014, 2022.

---

	P269-23-PM. The cooperation enhancement addition calculation situation and tracing report contents analysis 杉山昌秀1), 篠原佳祐1), 宮田智陽1), 吉池麻衣1), 原あや乃1), 堀内賢一1), 三浦篤史2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1015-1015, 2022.

---

	P270-24-AM. The example that a pharmacist intervened in for a medication difficulty by the multiple drug prescription during the cancer chemotherapy enforcement 汐待加織1), 小野寺香里1), 浅田美咲1), 高崎颯隼1), 鷹羽絵里子1), 吉原奈津子1), 佐藤絵美1), 吉田恭子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1016-1016, 2022.

---

	P271-23-PM. Questionnaire results report about patient monitoring duties in the treatment with anticancer medicine which the pharmacist by the academic first subcommittee performs in in 2020 森岡友美1), 郷真貴子2), 中島寿久3), 藤堂真紀4), 林稔展5), 松尾宏一6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1017-1017, 2022.

---

	P272-24-AM. The current situation and problem of the efforts for regional alliances in our hospital in the foreign chemotherapy 石崎文子1), 相原敏彦1), 本田晴菜1), 増尾昌則1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1018-1018, 2022.

---

	P273-23-PM. One case that we coped with the dermatopathy of patients with stomach cancer during the S-1 therapy enforcement early, but suffered from 河端明子1), 藤田あゆみ2), 杉浦伸哉2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1019-1019, 2022.

---

	P274-24-AM. A case of increased venetoclax blood concentration due to crushing and taking venetoclax tablets 安西麻衣子1), 疋田絵梨1), 安武夫1,3), 小林真之2), 小杉信晴2), 城田幹生1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1020-1020, 2022.

---

	P275-23-PM. Examination of the medication follow-up usefulness for the use of anticancer agent patients at the health insurance pharmacy 湯澤史弥1), 伊野陽子1,4), 山下修司2,4), 玉木啓文1,4), 野口義紘3,4), 長内理大1,4), 寺町ひとみ3,4), 井口和弘1,4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1021-1021, 2022.

---

	P276-24-AM. Usefulness of the follow-up of the drugstore pharmacist referring to the medical institution medical record for patients with foreign cancer 野村春香1), 西村充司1), 舩木志保2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1022-1022, 2022.

---

	P277-23-PM. Report of the case that was able to contribute to foreign cancer chemotherapy by the medication follow-up by the drugstore pharmacist 吉田理人1), 舩木志保2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1023-1023, 2022.

---

	P278-24-AM. Example that was able to intervene by the cooperation with hospital pharmacist and the health insurance pharmacy pharmacist in the early stage of the side effect 小原貴子1), 元茂拓法1), 岩井あゆみ2), 池上早也香2), 大井佑輝2), 三上祥博1), 橋下浩紀1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1024-1024, 2022.

---

	P279-23-PM. About usefulness of the cancer counseling by the pharmacist 樋口浩輔1), 斎藤祐輔1), 西村愛弓1), 木村謙吾1), 加藤浩1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1025-1025, 2022.

---

	P280-24-AM. One case that we connected Baxter in fuser (5-FU sustained administration) to a route bypass for the TPN, and speed decreased 南有里1), 中村俊貴2), 齋藤雅俊1), 平山武司1,3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1026-1026, 2022.

---

	P281-23-PM. Relation of the drugstore pharmacist using the telephone follow-up that continued for patients with cancer 野嶋芳紀1), 石田潤一郎1), 齋藤聡夫1), 松尾宗一郎1), 邑瀬誠1), 深津英人2), 松井洸2), 阿部真也2), 立石大介2), 山口浩2), 吉町昌子2), 野村和彦2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1027-1027, 2022.

---

	P282-24-AM. Study on effective medication counseling method to reduce the anxiety of the side effect in the lung cancer chemotherapy 大澤友裕1), 長谷川貴昭2), 梅田道1), 牧野哲平1), 青山智1), 安田昌宏1), 吉田勉3), 澤祥幸4), 水井貴詞1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1028-1028, 2022.

---

	P283-23-PM. Evaluation of the blood sugar level fluctuation after the use results of olanzapine in patients who received cisplatin combination chemoradiotherapy and the use 佐々木健介1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1029-1029, 2022.

---

	P284-24-AM. Fact-finding of retching vomiting of patients who received steroid spare ring in the Carboplatin administration and evaluation of the effectiveness 小河原晴香1), 越川一誠1), 大谷隼斗1), 今川未紀1), 佐久間けい1), 川上達也1), 菅井瞳1), 柳野紗智子1), 坂本真紀1), 松本高広1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1030-1030, 2022.

---

	P286-24-AM. The fact-finding about retching, the vomiting expression situation in the use of Olaparib patients and the prophylactic antiemesis therapy and search of retching, the vomiting risk factor 小林芽依1), 石原泰子1), 西村健二1), 石田亮2), 亀井健人1), 赤木晋介1), 徳田衡紀1), 高柳和伸1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1031-1031, 2022.

---

P287-23-PM. Examination about the expression situation of retching vomiting in the trifluridine Tipiracil hydrochloride + bevacizumab combination chemotherapy and the risk factor 松岡芹佳1), 藤井宏典1), 大畑紘一1), 飯原大稔1), 廣瀬智恵美1), 左高史織1), 渡辺大地1), 小林亮1,2), 木山茂3), 牧山明資3), 松橋延壽3), 高橋孝夫3), 吉田和弘3), 鈴木昭夫1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1032-1032, 2022.

---

	P288-24-AM. The effectiveness of the antiemesis therapy by the difference in risk emetic in the gynecologic Paclitaxel + Carboplatin therapy and safe comparison 萩家朱美1), 鎌田宏和1), 清水克次1), 竹田健志1), 辰見明俊2), 高木麻里1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1033-1033, 2022.

---

	P289-23-PM. Look at the actual situation of the digestive organ symptom in the streptozocin administration and the rear about the antiemesis therapy; mark investigation 新藤実香1), 佐野智望1), 西渕由貴子1), 石川光信1), 赤木徹1), 橋本浩伸1), 奥坂拓志2), 古川哲也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1034-1035, 2022.

---

	P290-24-AM. We look at the rear about the effectiveness by the prophylactic antiemesis therapy of olanzapine in the BEP, EP therapy and examine a mark 村井和哉1), 馬見新佳那子1), 楠原正太2), 中島裕理3), 船坂知華子2), 仲尾岳大3), 近藤千紘2), 内藤陽一2), 川崎敏克1), 向原徹2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1036-1036, 2022.

---

	P291-23-PM. The effect of the antiemesis supportive care PD method and the GDA method on TC therapy for gynecologic cancer and comparison of the adverse event 大林恭子1,2), 長嶺歩1), 内山知乃3), 八島秀明3), 大島宗平3), 高橋恵美利1,2), 高橋雄太1), 荒木拓也3,4), 山本康次郎3,4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1037-1037, 2022.

---

	P292-24-AM. One case that it was by steroid combination for the drug-related interstitial nephritis that occurred during the Ipi-Nivo therapy for G-CSF-producing renal cell carcinoma if treatment continuation was possible 中條悠1), 神原諒1), 早川太朗1), 細見俊秀2), 七里泰正2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1038-1038, 2022.

---

	P293-23-PM. Study on risk factor of the immune-mediated adverse event with the immune checkpoint inhibitor 山口敦史1,2), 齋藤佳敬1), 鳴海克哉2), 古堅彩子2), 武隈洋1), 品川尚文3), 秋田弘俊4), 菅原満1,2), 小林正紀2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1039-1039, 2022.

---

	P294-24-AM. Usefulness of the electronic patient-reported outcome monitoring during treatment with immune checkpoint inhibitor 桂英之1), 戸井ひとみ1), 太田浩士1), 高田直子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1040-1040, 2022.

---

	P295-23-PM. Care investigation for a symptom and the symptom of difficulty in swallowing, the taste disturbance of patients with cancer 織戸るり子1), 竜田都加2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1041-1041, 2022.

---

	P296-24-AM. A case of serous retinal detachment during encorafenib + binimetinib + cetuximab therapy 芦埜和幸1), 大澤千鶴子1), 黒田晋平1), 菱沼侑子1), 木村公美1), 横山智2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1042-1042, 2022.

---

	P297-23-PM. The enforcement situation of the examination for UGT1A1 genetic polymorphism before the use of irinotecan preparation in our hospital 林靖久1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1043-1043, 2022.

---

	P298-24-AM. The hiccups expression situation at the dexamethasone single dose in patients with multiple myeloma 兼松哲史1), 山下智穂1), 中村英明1), 吉田均2), 伊藤貴彦2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1044-1044, 2022.

---

	P299-23-PM. About association with surface of a body temperature and the vascular pain at the oxaliplatin administration 志村裕介1), 菅幸生2), 三坂恒1), 澤崎泉3), 岩本礼子4), 海野泰好4), 西川亜沙子4), 伊藤幸津枝4), 村上成美4), 杉本紀子4), 園谷美奈子4), 嶋田努1), 松下良2), 崔吉道1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1045-1045, 2022.

---

	P300-24-AM. The onset of vascular pain situation at dexamethasone injection mixture to oxaliplatin and Fosaprepitant combination 江草徳幸1), 比良大輔2), 佐藤一求2), 栗原晋太郎2), 福家幸子3), 村上利恵3), 徳本和哉4), 別所千枝1), 安原昌子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1046-1046, 2022.

---

	P301-23-PM. Usefulness evaluation of the blood sugar determination based on the protocol in patients with pancreatic cancer during cancer medical treatment 武藤有里子1), 丸山真一1), 永瀬怜司1), 太田恵1), 香取史菜1), 菅野浩1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1047-1047, 2022.

---

P302-24-AM. Examination of the comparison of the adverse event with nal-IRI/5-FU/LV therapy and the existing treatment to be able to establish treatment after the second treatment of the unresectable pancreatic cancer and the measures 松島彩音1), 佐々木健介1), 亀尾剛士1), 三宅真史1), 隅田英幸1), 山下真史1), 藤井哲英1), 小林美代子1), 二宮洋子2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1048-1048, 2022.

---

	P303-23-PM. Comparison of the expression of Infusion Related Reaction risk factor in FL and DLBCL 廣部祥子1,2,3), 犬飼萌乃1), 藤本梨花1), 深田耕司1), 宮本真由1), 前田真一郎1,2), 前田真貴子1,2,3), 藤尾慈1,2,3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1049-1049, 2022.

---

	P304-24-AM. About the adverse event expression of Palbociclib situation 篠崎千尋1), 桑村恒夫1), 三上忠司1), 野田聖奈子1), 原田智子1), 中川義浩1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1050-1050, 2022.

---

	P305-23-PM. It is the current situation investigation about the onset of Serious Adverse Event in the adjuvant chemotherapy after the pancreatic cancer S-1 technique 野口裕介1), 大坪達弥1), 小林大祐1), 加藤良隆1), 豕瀬諒2), 村木優一2), 友金幹視1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1051-1051, 2022.

---

	P306-24-AM. We look at the rear of the risk factor to affect the onset of diarrhea of the Abemaciclib and examine a mark 野田佳加1), 志村裕介1), 嶋田努1), 崔吉道1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1052-1052, 2022.

---

	P307-23-PM. We look at the rear of the onset of thromboembolism risk factor in patients with progress, recurrence colon cancer which is impossible of curative resection and study a mark 高田遼1), 藤原未稀1), 牧賢利1), 高橋洋子1), 田村浩二1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1053-1053, 2022.

---

	P308-24-AM. Examination of the usefulness of the prophylactic oral antibiotic for the febrile neutropenia at DCF therapy enforcement 山口知紀1), 豊田真史1), 深野光司1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1054-1054, 2022.

---

	P309-23-PM. An evaluation and improvement of actions to be taken for the vascular pain with oxaliplatin 瀧本真紀1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1055-1055, 2022.

---

	P310-24-AM. Anamorelin prescription status survey 河原陽介1), 堀合拓貴1), 加藤良治1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1056-1056, 2022.

---

	P311-23-PM. Exploring the incidence and risk factors of skin disorders caused by the prostate cancer treatment drug apalutamide in actual clinical practice 山田佳織1), 入江慶1,2), 平畠正樹1), 池末裕明1), 橋田亨1,2), 川喜田睦司3), 室井延之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1057-1057, 2022.

---

	P312-24-AM. The association that developed in vincristine treated patients between peripheral neuropathy and diabetes 内田敬1), 林克剛1), 猪岡京子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1058-1058, 2022.

---

	P313-23-PM. IR reduction effect with the precedent administration of hypersensitivity measures medicine in the PER+HER+ taxane regimen 阿部彩香1), 杉山恵亮1), 本山大夢1), 高木竜一1), 浅野岳人1), 志賀有雅1), 築山奈央1), 藤井友和1), 杉浦洋二1), 雨宮剛2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1059-1059, 2022.

---

	P315-23-PM. Use fact-finding of the CDK4/6 inhibitor for patients with inoperability or recurrent breast cancer 小関利弥1), 合澤啓二1), 岩田一史1), 陣上祥子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1060-1060, 2022.

---

	P316-24-AM. The example that early intervention to the supportive care of the drugstore pharmacist in the foreign chemotherapy and the follow-up with the telephone contributed to treatment continuation 永井基瑛1), 新藤志津子1), 永野悠馬2), 前田守2), 緒形富雄2), 市ノ渡真史2), 長谷川佳孝2), 月岡良太2), 大石美也2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1061-1061, 2022.

---

	P318-24-AM. Look at the multicenter rear about the dose of the levothyroxine for the hypothyroidism of the immune checkpoint inhibitor; mark investigation 小林美奈子1), 佐藤渉2), 鈴木訓史1), 梅内実穂1), 東敬太1), 内藤義博1), 木皿重樹3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1062-1062, 2022.

---

	P319-23-PM. Efforts to the HBV reactivation prevention that a pharmacist works on 國安和仁1), 中居肇1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1063-1063, 2022.

---

	P320-24-AM. Analysis of the risk factor about the low Ca blood symptom under the prophylactic administration by the denosumab for patients with lung cancer 平井成和1), 大崎莉沙2), 有山智博2), 石井敏浩2), 増田雅行1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1064-1064, 2022.

---

	P322-24-AM. Intervention of the pharmacist by PBPM in HBV reactivation measures 笹岡沙也加1), 清野義一1), 寺島孝徳1), 宮澤衣鶴1), 清水健吾1), 岡澤香津子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1065-1065, 2022.

---

	P323-23-PM. About the effect that a neutropenia with the gemcitabine oil xanthan gum (GnP) therapy gives for the prognosis of patients with unresectable pancreatic cancer 長岡侑里1), 今俊介1), 松崎哲郎1), 溝口博之1), 山田清文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1066-1066, 2022.

---

	P324-24-AM. Example ... that a steroid rotation was effective for case - hiccups that the quality of life of patients in the cancer chemotherapy improved by a tracing report 永田卓也1,2), 渡邊亜矢子1,2), 大戸祐治1,2), 佐伯美沙1,2), 嶋田顕3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1067-1067, 2022.

---

	P325-23-PM. Examination of the usefulness of the skill up training for the disease severity evaluation of the hand-and-foot syndrome 神谷早織1,2,3,4,5), 山本圭祐1), 平川聡史2), 大石大祐1), 佐原由莉1), 澤昇平1), 柏原道志1), 柴崎幾代3), 浅井はるか4), 鈴木英絵4), 森菜採子4), 吉田雅行4), 三木良浩5), 矢部勝茂1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1068-1068, 2022.

---

	P327-23-PM. Search of the risk factor of the eruption in the GC therapy 吉澤祐香里1), 澤昇平1), 石野清亮1), 古橋侑樹1), 佐原由莉1), 山本圭祐1), 矢部勝茂1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1069-1069, 2022.

---

	P328-24-AM. Investigation of the examination for irAE, situation after the checkpoint inhibitor administration in our hospital of immunity 田中昭洋1), 大西翔太1), 高取秀人1), 村富裕貴1), 後藤卓也1), 萱野勇一郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1070-1070, 2022.

---

	P329-23-PM. Fact-finding of the cholinergic syndrome of the irinotecan preparation in patients with pancreatic cancer 眞野翔太1), 宮崎公輔1), 安江諒平1), 伊藤健史1), 田中佳子1), 井上壽江1), 平下智之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1071-1071, 2022.

---

	P330-24-AM. One case that developed duodenitis in irAE with the Pembrolizumab administration 近藤万友美1,2), 吉岡睦展1), 澁谷奈緒1), 高子優子1), 若松雄太1), 細見真世1), 森田聡子1), 西山祐美1), 正置耕一1), 高瀬直人2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1072-1072, 2022.

---

	P331-23-PM. A case in which it was possible to continue treatment at the usual dose with antibiotics and pharmacist intervention for scalp skin disorder that occurred while taking tirabrutinib 溝渕秀敏1), 野毛一郎1), 白石誠一郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1073-1073, 2022.

---

	P333-23-PM. 1 case that resulted in tumor lysis syndrome during the chemotherapy enforcement for rectal cancer 眞弓健介1), 出町健1), 坂東英明2), 川崎敏克1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1074-1074, 2022.

---

	P334-24-AM. Investigation about infusion reaction in the daratumumab subcutaneous injection 吉川直樹1), 萩原綾菜1), 相田和希1), 飯島直美1), 森田光枝1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1075-1075, 2022.

---

	P335-23-PM. Examination of the sleeplessness improvement effect of the steroid hormone DHEA which paid its attention to a clock gene for the sleeplessness to occur by anticancer agent administration 白水翔也1), 牛尾聡一郎1), 江角悟1), 北村佳久2), 座間味義人1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1076-1076, 2022.

---

	P336-24-AM. Effect (the fifth report) that an administration timing of the peg filgrastim gives for febrile neutropenia 大神正宏1), 小島友恵1), 渡邊雅明2), 小島卓也3), 泉玲子4), 平井利幸5), 小山田聡6), 本間真人2), 石井武男3), 岡野知子4), 秋山裕史5), 原信田努6), 鈴木美加1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1077-1077, 2022.

---

	P338-24-AM. A case of non-small cell lung cancer where anticancer drug treatment could be continued with the administration of anamorelin hydrochloride 出口真人1), 小玉幸与1), 冨田敦和1), 今西忠宏1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1078-1078, 2022.

---

	P339-23-PM. Regarding the usage history of enfortumab vedotin at our hospital and the incidence of side effects, etc. 田中亜弥1), 衛藤智章1), 高崎紘臣2), 後藤隆1), 清水裕彰1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1079-1079, 2022.

---

	P340-25-AM. About pain-killer prescription order in cancerous pain treatment and rescue medicine, aperient, the prescription situation of the antiemetic a comparison (the first report) before and after the - guidelines revision 丸山昌広1), 定盛理純1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1080-1080, 2022.

---

	P341-24-PM. Investigation about the effect on elimination of pain situation and everyday life of patients with hospitalization cancer 藤田靖之1), 井上知哉1), 大久保翔1), 駒木真理子1), 宿輪紗世1), 原口智彦1), 馬場麗名1), 荒木正義1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1081-1081, 2022.

---

	P342-25-AM. The effectiveness of the naldemedine tosyl acid salt for the opioid-induced constipation 山田正実1), 地丸裕美1), 鳥井小莉1), 高橋一栄1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1082-1082, 2022.

---

	P343-24-PM. About an on admission bringing drug in our hospital and the operation 伊東美歩1), 岡本和也1), 海老原貴之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1083-1083, 2022.

---

	P344-25-AM. Examination about the effectiveness according to the dose of the mirogabalin for the cancerous pain 地丸裕美1), 山田正実1), 鳥井小莉1), 高橋一栄1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1084-1084, 2022.

---

	P345-24-PM. Medication support by the system construction of the drug self-care for the medical care in the inpatient 畑下真希1,2), 花村藤佳1,2), 朝日仁美1,2), 吉垣亜里沙3), 手渡和子2,3), 牧山稔1), 筒井秀和1), 大塚知信5), 豊田康義2,4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1085-1085, 2022.

---

	P347-24-PM. Clinical examination about the changes from fentanyl patch to a morphine note 工藤佐智子1), 渡邊法男1,2), 吉田知佳子3), 岡村真理子3), 佐藤真由美3), 中島大喜4), 浅井和浩1), 山田卓也5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1086-1086, 2022.

---

	P348-25-AM. The use situation investigation of the oral hydromorphone slow-release preparation 中原萌子1), 高武嘉道1), 藤本愛理1), 花田聖典1), 川俣洋生1), 橋本雅司1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1087-1087, 2022.

---

	P349-24-PM. Example that a change was performed in from parenteral injection only to an oral formulation for the patients who reported intractable pain under the use of high-dose opioid note by methadone tablets combination 高橋典哉1,2,3,4,5,6), 千葉亮祐2), 佐賀雄大3), 鈴木温4), 吉田ひろ子5), 奥尚6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1088-1088, 2022.

---

	P350-25-AM. Two cases that changes from methadone to hydromorphone sustained subcutaneous administration were effective 藤本英哲1), 笠原庸子1), 今津邦智1), 荒谷恭子1), 前田裕行1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1089-1089, 2022.

---

	P351-24-PM. Effect factor of analgesic effect and the side effect of oral methadone in patients with cancer pain 国分秀也1), 瀧川千鶴子2), 千原里美3), 原聡志4), 上園保仁5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1090-1090, 2022.

---

	P352-25-AM. Examination about the opioid combined effect of the tapentadol in the intractable cancer pain 林誠1,2), 松野英美2), 船橋依理子2), 西堀理香2), 岡本典子2), 中井正彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1091-1091, 2022.

---

	P353-24-PM. About association with the pre-back predictive index and steroid in the palliative care team activity 山田直輝1), 里岡達哉2), 青山瑛里子1), 井上悠1), 山本浩二郎1), 大里恭章1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1092-1092, 2022.

---

	P354-25-AM. Examination about the change conversion quantity to hydromorphone parenteral injection 安藤寛子1), 野口美幸1), 渡邉理基1), 熊野光翼1), 大信紀明1), 葉山達也2), 堀越建一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1093-1093, 2022.

---

	P355-24-PM. Verification of changes in feeding status and body weight in hospitalized patients treated with anamorelin hydrochloride 六車裕一1), 藤田真弓1), 宮原阿友美1), 小寺由香1), 宮麻紀子1), 池田久雄1), 足立充司1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1094-1094, 2022.

---

	P356-25-AM. One case that did patients consultation correspondence by a telephone follow-up at opioid introduction by the foreign going to hospital 宮田香織1), 藤田あゆみ2), 杉浦伸哉2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1095-1095, 2022.

---

	P357-24-PM. One case that was able to support drug coinfusion prescription by using it jointly of the dispensary germfree the health insurance pharmacy that does not have clean bench 伊津田知樹1), 赤尾美乃里1), 藤田あゆみ2), 杉浦伸哉2), 杉浦克典2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1096-1096, 2022.

---

	P358-25-AM. One case that was treated with the palliative care that did not have a break until after a discharge from hospitalization by the cooperation of hospital pharmacist and the drugstore pharmacist 土井武司1), 藤田あゆみ2), 三久裕子1), 杉浦伸哉2), 杉浦克典2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1097-1097, 2022.

---

	P359-24-PM. Examination of the patient population where drug introduction for the medical care by the fentanyl patch was suitable for 山脇誉央1), 東真理子1), 淺野肇1), 川口明範1), 藤原季美子1), 竹上学1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1098-1098, 2022.

---

	P360-25-AM. Current status of anamorelin administration in non-small cell lung cancer 東春奈1), 後藤愛実1), 高橋智恵子1), 西原雅美1), 藤阪保仁2), 根尾昌志1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1099-1099, 2022.

---

	P361-24-PM. The use situation investigation for the opioid-induced constipation in our hospital 宮川千珠1), 坂口結斗1), 鈴木ひかり1), 糸山佳奈子1), 知念ほのか1), 喜多幸子1), 森智子1), 人見百合子1), 高江洲夢子1), 井上千尋1), 宇根良祐1), 喜友名舞1), 當間菜央1), 喜多洋嗣1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1100-1100, 2022.

---

	P362-25-AM. Visualization of the problem using an evaluation and the text mining by the drug instruction template introduction 小玉幸与1), 冨田敦和1), 内山耕作1), 鈴川誠1), 今西忠宏1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1101-1101, 2022.

---

	P363-24-PM. Case study about opioid switching from the fentanyl patch in patients of the sedative insufficiency to hydromorphone parenteral injection 脇下大樹1), 金剛圭佑1), 刈谷美里1), 松田ゆかり1), 横町朋子1), 大林加代子2), 橋本泰明1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1102-1102, 2022.

---

	P364-25-AM. The effect that administration of oxycodone gives to a nutrition index on mucous membrane disorder with head and neck cancer treatment 菊田奨之1), 中澤佑介1), 元日田阿子1), 宮沢祐太1), 須田奈美1), 志村英二2), 川久保孝1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1103-1103, 2022.

---

	P365-24-PM. The effectiveness of pregabalin in children and safety 三浦寄子1), 歌野智之1), 余谷暢之2), 山谷明正1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1104-1104, 2022.

---

	P366-25-AM. About the expression situation and the episode of care of the immune-mediated adverse event in the use of immune checkpoint inhibitor 西川豊1), 梶田貴司1), 田中通1), 石田葉月1), 安田早織1), 山口和美1), 黒松誠1), 樽野麻依1), 金松誠1), 奥野智之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1105-1105, 2022.

---

	P367-24-PM. One patient who gave nivolumab + ipilimumab combination therapy in a malignant peritoneal mesothelioma 豊田真史1), 岡野芳彦1), 深野光司1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1106-1106, 2022.

---

	P368-25-AM. Examination of the usefulness of the tracing report in the foreign cancer chemotherapy 中嶋江美1), 山瀬大雄1), 松本早織1), 原田慶子1), 尾本和彦1), 山田邦義1), 辻井佳代1), 小林政彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1107-1107, 2022.

---

	P369-24-PM. Rearward observational study about the effect that a risk factor of the acneform rash with the antiEGFR antibody medicine gives to a survival rate 高橋宏彰1,2), 小池陽聡1), 佐々木悠汰1), 八重樫由紀子2), 齊藤葉子2), 二瓶哲2), 平舩寛彦3), 氏家悠貴2,4), 朝賀純一1,2), 工藤賢三1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1108-1108, 2022.

---

	P370-25-AM. Construction of the plasma concentration assay of the breast cancer therapeutic drug Palbociclib 小玉菜央1), 山本達郎1), 森木邦明1), 門永太一2), 若原誠2), 細谷恵子2), 藤吉正哉1), 島田美樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1109-1109, 2022.

---

	P371-24-PM. The effect that Osimertinib introduction time gives for overall survival on patients with EGFR mutation in the gene-positive non-small cell lung cancer: Single institution cohort study 塩飽英二1), 土手賢史1), 小林由佳1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1110-1110, 2022.

---

	P372-25-AM. It is PTX or RDI of the DTX chemotherapy and the examination about the drug choice after before breast cancer, the operation 高木麻衣1), 中村智絵1), 宮崎雅之1), 山田清文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1111-1111, 2022.

---

	P373-24-PM. It is examination about Axitinib or the continuance of the primary treatment using the sunitinib for patients with renal cell carcinoma with the distant metastasis 松井頌明1), 尾崎正和1), 幸田恭治1), 北原隆志1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1112-1112, 2022.

---

	P374-25-AM. Use fact-finding of the PARP inhibitor in ovarian cancer 黒木百香1), 小関利弥1), 西上依里1), 岩田一史1), 合澤啓二1), 陣上祥子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1113-1113, 2022.

---

	P375-24-PM. Examination of the effect on effect, side effect of probiotics of the immune checkpoint inhibitor 石井岳夫1), 菅原康佑2), Jose Carlos Sandoval Tayag3), 潮平英郎1), 諸見牧子1), 中村克徳1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1114-1114, 2022.

---

	P376-25-AM. One case of the Atezolizumab bevacizumab therapy for patients with unresectable hepatocellular carcinoma with the interstitial pneumonia history 板村亮1), 櫻下弘志1), 吉岡寛美1), 松尾裕彰1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1115-1115, 2022.

---

	P377-24-PM. The effect of menthol on epirubicin killing effect with human liver cancer HepG2 cells: Possibility of the participation of the multidrug-resistant protein MRP 長井克仁1), 田村真由子1), 大谷奎介2), 吉田尚史2), 渡邊利栄2), 福野修平1), 小西廣己1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1116-1116, 2022.

---

	P378-25-AM. 1 case that urinary retention occurred as acute peripheral neuropathy of oxaliplatin 野口祥紀1), 三宅知宏1), 谷村学1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1117-1117, 2022.

---

	P379-24-PM. Examination of the effect of treatment when we gave it just before administration in the FOLFIRI+Aflibercept therapy based on UPCR 花谷直美1), 近藤潤一1), 杉山菜穂1), 津野丈彦1), 小杉三弥子1), 諏訪雄亮2), 渡邉純2), 佐橋幸子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1118-1118, 2022.

---

	P380-25-AM. An example of patients with acute lymphoid leukemia that blood level of the Methotrexate was prolonged by antifungal agent combination 山下智穂1), 兼松哲史1), 伊藤和幸2), 吉田均3), 伊藤貴彦3), 中村英明1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1119-1119, 2022.

---

	P381-24-PM. A renal function evaluation using cystatin C in the TC therapy enforcement case and investigation about myelosuppression 若松綾華1), 田中彩2), 若松遼介1), 山下友輝1), 柴波明男1), 樋浦一哉2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1120-1120, 2022.

---

	P382-25-AM. Fact-finding about the antihypertensive medications internal use situation after bevacizumab completion of treatment and the blood pressure change 村山三佳1), 北村葵1), 奥村啓樹1), 丹羽洋介1), 宮崎雅之1), 溝口博之1), 山田清文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1121-1121, 2022.

---

	P383-24-PM. An example of the dermatomyositis concurrence stomach cancer during cancer medical therapy support - immunosuppressive drug administration for the special population 川上恵1), 北田徳昭1), 岡村みや子1), 尾崎淳子1), 池見泰明1), 中川俊作1), 今井哲司1), 米澤淳1), 中川貴之1), 土井恵太郎2), 武藤学2), 寺田智祐1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1122-1122, 2022.

---

	P384-25-AM. Look at the rear of the infectious adverse event with GB therapy and the BR therapy for the untreated follicular lymphoma; mark investigation 川崎貴蔵1), 伊藤佳織2,3), 山本孝枝1), 冨田章裕3), 山田成樹2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1123-1123, 2022.

---

	P385-24-PM. The onset of immune-mediated adverse event situation after checkpoint inhibitor completion of treatment of immunity 原友子1), 町田梨絵子1), 野中敏治1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1124-1124, 2022.

---

	P386-25-AM. Example of pharmacy pre-avoidance regarding appropriate dosage of S-1 according to patient's renal function 貴田郁美1), 山田美里2), 細谷晃3), 伊藤秀剛4), 永野悠馬5), 前田守5), 緒形富雄5), 市ノ渡真史5), 長谷川佳孝5), 月岡良太5), 大石美也5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1125-1125, 2022.

---

	P387-24-PM. The effect that the function display of the family pharmacist gives to the treatment continuation of the Osimertinib remedy patients 千野直英1), 永野悠馬2), 前田守2), 緒形富雄2), 市ノ渡真史2), 長谷川佳孝2), 月岡良太2), 大石美也2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1126-1126, 2022.

---

	P388-25-AM. Exploratory study on test value before treatment to predict chronic administration of the antiPD-1 antibody medicine 前谷一仁1), 新谷拓也1), 池村健治1), 渡邊梓1), 山本智也1), 奥田真弘1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1127-1127, 2022.

---

	P389-24-PM. The effect that the function display of the family pharmacist gives to the treatment continuation of the capecitabine remedy patients 松崎淳1,2), 永野悠馬2), 前田守2), 緒形富雄2), 市ノ渡真史2), 長谷川佳孝2), 月岡良太2), 大石美也2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1128-1128, 2022.

---

	P390-25-AM. The effect that proton pump inhibitor, vonoprazan give for bevacizumab treatment continuation 八木健太1), 丸尾陽成2), 石田俊介3), 鍛治園誠2), 相澤風花3), 新村貴博1), 石澤有紀4), 濱野裕章2), 合田光寛3,5), 座間味義人2,5), 石澤啓介1,3,5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1129-1129, 2022.

---

	P391-24-PM. Analysis about the dysfunction thyroid with the immune checkpoint inhibitor 鳥山陽子1), 大原義正1), 谷口潤2), 山形真一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1130-1130, 2022.

---

	P392-25-AM. Thyroid cancer, study on adherence of the Lenvatinib for hepatocytes cancer 寺前美乃里1), 舘合慶一2), 川上和宜2), 横川貴志2), 小林一男2), 柴田直樹2), 鈴木亘2), 清水久範2), 福田直樹3), 高橋俊二3), 尾阪将人4), 笹平直樹4), 堀里子1), 山口正和2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1131-1131, 2022.

---

	P393-24-PM. Investigation about the side effect extracted in the pharmacist interview in the foreign chemotherapy room 桂川健司1), 高取裕司1), 高岡龍蔵1), 遠山幸男1), 久田達也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1132-1132, 2022.

---

	P394-25-AM. One case of the cancer of endometrium which myelosuppression of extravasation therapeutic drug dexrazoxane influenced it, and developed febrile neutropenia after the peg filgrastim administration 森本真宗1), 大矢浩之1), 魚谷隆弘2), 長井智則2), 近藤正巳1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1133-1133, 2022.

---

	P395-24-PM. The effect that the function display of the family pharmacist gives to the treatment continuation of the S-1 remedy patients 唐崎奈央子1), 永野悠馬2), 前田守2), 緒形富雄2), 市ノ渡真史2), 長谷川佳孝2), 月岡良太2), 大石美也2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1134-1134, 2022.

---

	P396-25-AM. Episode of care after the regimen change with the temporary missing part of the albumin suspension type paclitaxel 吉藤和也1), 後藤志典1), 山崎博子1), 赤崎淳子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1135-1135, 2022.

---

	P397-24-PM. Analysis - that we paid our attention to a type of - combination PPI about the effect that PPI combination gave for CDDP origin-related renal failure reduction 寺田明里1), 植田有希1), 高橋愛未1), 口分田章典1), 山東真寿美1), 坂上嘉浩1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1136-1136, 2022.

---

	P398-25-AM. About the effect on effect of treatment of the docetaxel after the Enzalutamide administration and side effect 山下慎司1), 光家勉1), 藤森信也1), 西川光1), 篠村恵理子1), 石戸谷哲2), 上田豊実1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1137-1137, 2022.

---

	P399-24-PM. Relative examination of nourishment metrics and the side effect expression in the R-CHOP therapy 菊池健1), 澤田桃香2), 武田元樹1), 相馬貴史1), 鶴山辰1), 佐藤秀紀2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1138-1138, 2022.

---

	P400-25-AM. Survey on the usage status of niraparib and occurrence of adverse events at our hospital 樋口文子1), 衛藤智章1), 清水裕彰1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1139-1139, 2022.

---

	P401-24-PM. A case in which tepotinib was administered to gastric cancer that was confirmed to be positive for MET gene mutation by cancer gene panel test 西岡菜々子1), 松沼悟1), 輿石徹1), 磯貝博之1), 中村洋典1), 青木琢也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1140-1140, 2022.

---

	P402-25-AM. About the inquiry situation of the pharmacist in the foreign chemotherapy and future efforts 大西翔太1), 田中昭洋1), 高取秀人1), 松本芳樹1), 村富裕貴1), 梅林良英1), 坂口奈津子1), 後藤卓也1), 萱野勇一郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1141-1141, 2022.

---

	P403-24-PM. Fact-finding about the end of the nucleic acid analog preparation remedy after the chemotherapy enforcement in patients with HBV infection malignant tumor 應和矢寛1), 有馬崇充1), 田中聖二1), 中島寿久1), 齋藤義正1), 石川光信1), 赤木徹1), 橋本浩伸1), 古川哲也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1142-1142, 2022.

---

	P404-25-AM. 1 case that developed heart failure after the Lenvatinib remedy for thymic carcinoma: Lenvatinib and consideration from blood level of IL-6 関夏望1), 朝倉充俊1), 見野靖晃2), 中津川瑛美2), 小泉知展3), 内藤隆文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1143-1143, 2022.

---

	P405-24-PM. Construction and evaluation of the examination of the hepatitis B-related examination check system aiming at improvement in rate of use 二瓶貴幸1), 松浦正樹1), 堀川美帆1), 前嶋隆弘1), 大柳元1), 赤坂和俊1), 菊地正史1), 前川正充1), 井上隆輔2), 勝見真琴3), 井上淳4), 大内康太5), 高橋雅信5), 石岡千加史5), 眞野成康1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1144-1144, 2022.

---

	P406-25-AM. The effect that the nab- paclitaxel supply anxiety problem in patients with pancreatic cancer gave for treatment preferences 白神霞1), 丸花奈央1), 篠崎浩司1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1145-1145, 2022.

---

	P407-24-PM. Change of tumor marker and the liver residual function with the Atezolizumab bevacizumab combination therapy for the unresectable hepatocellular carcinoma 西和哉1), 川田彰彦1), 佐々木崇1), 佐賀利英1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1146-1146, 2022.

---

	P408-25-AM. Association of Bcr-Abl inhibitor duration of treatment and the alcohol intake in patients with chronic myelogenous leukemia 山川裕介1), 八木健太2), 吉岡俊彦1,3), 佐藤真希3), 丸尾陽成4), 宮田晃志3), 相澤風花1), 國木悠理香3), 新村貴博2), 坂口暁2), 石澤有紀5), 合田光寛1,3), 座間味義人4), 石澤啓介1,2,3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1147-1147, 2022.

---

	P409-24-PM. Relations of a dose and the intensity of treatment of the gemcitabine cisplatin therapy in patients who received adjuvant chemotherapy before total cystectomy 小栗良介1), 関谷泰明1), 井上壽江1), 平下智之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1148-1148, 2022.

---

	P410-25-AM. Search of the risk factor of the dermatopathy of DTX in patients with breast cancer 森本奈緒美1), 星田唯史1), 眞下惠次1), 藤原大一朗1), 木村佳世1), 武田祐子1), 和田祥明1), 野田明宏1), 多喜和夫1), 田辺和史1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1149-1149, 2022.

---

	P411-24-PM. Mean association of the relative dose intensity and neutrophilic/lymphocytes ratio, platelet/lymphocytes ratio in the patients who received adjuvant chemotherapy (XELOX therapy) after the colon cancer technique 林宏紀1), 山本泰大1), 福岡智宏1), 宇都宮純平1), 戸田康裕1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1150-1150, 2022.

---

	P412-25-AM. The effectiveness of the Osimertinib for the elderly people EGFR mutation in the gene-positive non-small cell lung cancer and safe examination 岩崎文香1), 有山智博1), 平井成和2), 増田雅行2), 真坂亙1), 石井敏浩3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1151-1151, 2022.

---

	P413-24-PM. Two patients who conducted dose adjustment of the TC therapy to patients with severe obesity 大城真理奈1,2), 山口芽衣1,2), 中谷香織1,2), 縄田修一1,2), 三村貴志3), 嶋村弘史1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1152-1152, 2022.

---

	P414-25-AM. The case that responded to platinum combination therapy for the extensive-stage small-cell lung cancer of elderly patients again 冨井隆弘1), 松沼悟1), 輿石徹1), 江里口大介2), 吉元公一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1153-1153, 2022.

---

	P415-24-PM. The side effect expression situation of the checkpoint inhibitor combination therapy in the lung cancer of immunity 田口伸1), 渡邊智穂1), 泉谷紘平1), 佐藤優弥1), 和地徹1), 柳田真樹子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1154-1154, 2022.

---

	P416-25-AM. Rearward investigation about the length of stay of patients who received craniocervical part cancer chemoradiotherapy 中尾なつみ1), 北口梨紗1), 甲元大樹1), 河村茉衣2), 竹内彩子2), 森英樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1155-1155, 2022.

---

	P417-24-PM. It is the investigation to the health insurance pharmacy for the improvement of system of the medicine medicine cooperation in the foreign cancer chemotherapy 丸田基史1), 福山雄卯介1), 井上善博2), 三角紳博1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1156-1156, 2022.

---

	P418-25-AM. Recurrence, one case of the intractable multiple myeloma that EPd therapy succeeded by the tenth treatment 西村直朗1), 上津沙織1), 柿原圭佑1), 吉国健司1), 小倉秀美1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1157-1157, 2022.

---

	P419-24-PM. About the use situation of the antimicrobial for the COVID-19 patients in the Tokyo health medical care public corporation 6 Hospital 松澤弘志1), 佐々木康弘2), 福山博務3), 田中義幸4), 陳内博之5), 根岸真利子6), 方岡小百合7), 塩地園代3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1158-1158, 2022.

---

	P420-25-AM. One case that PT-INR increased by combination of rem decibuilding and warfarin 山内健1), 吉川明良1), 佐古有紀1), 伊藤徳明2), 沖本真史2), 渡辺美和1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1159-1159, 2022.

---

	P421-24-PM. The onset of liver damage investigation in patients receiving rem decibuilding and examination of the risk factor 高橋まどか1), 阿部多嘉浩1), 宮崎公爾1), 板谷眞理恵1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1160-1160, 2022.

---

	P422-25-AM. Surveillance and neutralizing antibody monitoring of the adverse event after the new corona vaccination 池田博昭1), 青山さくら1), 井上奈々1), 金子真夕1), 金本奈々1), 大江健人1), 夛田羅勝義2), 藤岡譲2), 池田純子3), 中妻章1), 芳地一1), 森久美子1), 飯原なおみ1), 河野清尊4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1161-1161, 2022.

---

	P423-24-PM. Safety investigation of sotrovimab administration to patients infected with the new coronavirus in late pregnancy at our hospital 上柳汐果1), 池上洋平1), 小原直紘1), 小田亮介1), 丸山直岳1), 土井敏行1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1162-1162, 2022.

---

	P424-25-AM. Effect of the immunosuppressive drug in SARS-CoV-2 antibody titers and the treatment of the COVID-19 patients 新崎孝夫1), 河野えみ子1), 三箇山宏樹1), 關嘉人1), 中森靖2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1163-1163, 2022.

---

	P425-24-PM. Analysis of the second response after the first and the second inoculation of the new corona vaccine of the staff 佐藤智功1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1164-1164, 2022.

---

	P426-25-AM. Use history of sotrovimab (Xevudy) at Chidoribashi Hospital and Tatara Rehabilitation Hospital 岐部このみ1), 松村千晶2), 石橋美希1), 中村大祐1), 菖蒲沙織1), 八板謙一郎3), 有馬泰治4), 駒井孝企4), 山本一視4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1165-1165, 2022.

---

	P427-24-PM. Survey on the use of sotrovimab in COVID-19 patients 中谷亮介1), 岡田雅弥1), 下川福子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1166-1166, 2022.

---

	P428-25-AM. Use fact-finding of the COVID-19 therapeutic drug in our hospital 玉城哲子1), 仲俣桃華1), 城間盛彦1), 木奈崎昭男1), 島袋朝太郎1), 安座間照子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1167-1167, 2022.

---

	P429-24-PM. The second responses of the new corona vaccine third inoculation walk 1, the second and the difference (followup) 中村和彦1), 中村嘉孝1), 塚本友紀江2), 横井さおり3), 小竹克博4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1168-1168, 2022.

---

	P430-25-AM. Sotrovimab use results survey in Covid-19 patients 三宅純子1), 生島繁樹1), 石巻靖弘1), 堀智貴1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1169-1169, 2022.

---

	P431-24-PM. Fact-finding of the renal function test value abnormality with the rem decibuilding administration to patients with severe impaired renal function 山村翔1), 荒木良介1), 山田英紀1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1170-1170, 2022.

---

	P432-25-AM. Usage status of casirivimab/imdevimab [Ronapreve(R)] and sotrovimab [Xevudy] in the treatment of COVID-19 at Nishi Municipal Hospital 石田洋史1), 奥野昌宏2), 中浴伸二1), 田中詳二1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1171-1171, 2022.

---

	P433-24-PM. New coronavirus vaccine: Analysis of side effects caused by Comirnaty intramuscular injection 鈴木一成1), 村田文1), 新木美枝1), 鈴木達宙1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1172-1172, 2022.

---

	P434-25-AM. The examination that a second response is easy to emerge after the third inoculation as for the person whom a second response developed in after the mRNA vaccine 1, the second inoculation 林幹也1), 後藤志典1), 伊藤美登里2,3), 平田貴代美3), 赤崎淳子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1173-1173, 2022.

---

	P435-24-PM. Report of health observation results for patients taking oral molnupiravir 鈴木佑果1), 井本陽子1), 上野花純1), 三木郁帆1), 渡邊裕之1), 宅和真由美1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1174-1174, 2022.

---

	P436-25-AM. About the questionnaire result about efforts and the second response to new coronavirus vaccine third inoculation 篠山淳美1), 三木芳晃1,2), 白戸美希1), 松本芳樹1), 梅林良英1), 川口尚子2), 萱野勇一郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1175-1175, 2022.

---

	P437-24-PM. Second response investigation with the new coronavirus vaccine additional inoculation in the Tohoku University Hospital 佐藤朗1,2), 佐藤裕1), 佐藤智見1), 鷹尾月舟1), 菅原英里奈1), 鈴木博也1,2), 公文代將希1), 佐藤紀宏1), 前川正充1), 徳田浩一2), 眞野成康1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1176-1176, 2022.

---

	P438-25-AM. The expression situation and risk factor analysis of the hyperkalemia with the administration of nafamostat mesilate for COVID-19 小玉健太郎1), 今井徹1), 淺井康夫2), 神津悠2), 林健太郎2), 清水哲夫2), 權寧博2), 大塚進1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1177-1177, 2022.

---

	P439-24-PM. Incidence of hypersensitivity and infusion reactions due to sotrovimab at our hospital and effects on laboratory test values 樽屋志保1), 藏本裕信1), 権藤直人1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1178-1178, 2022.

---

	P440-25-AM. The effect that a second response gives for duties after the inoculation of the new coronavirus vaccine for the medical institution staff 児玉暁人1), 水庫彩1), 今井兼貴1), 勝浦正人1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1179-1179, 2022.

---

	P441-24-PM. Development situation and Sotrovimab iv. of the COVID-19 cluster in our hospital Of this about use experience 林智樹1), 牧野以佐子1), 田中佳代1), 望月惠理子1), 大胡幹子1), 野崎容右1), 伊藤淳雄1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1180-1180, 2022.

---

	P442-25-AM. Attitude survey about the new corona vaccine for the medical institution staff 水庫彩1), 児玉暁人1), 今井兼貴1), 勝浦正人1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1181-1181, 2022.

---

	P443-24-PM. Drug control for the measures of the COVID-19-positive pregnant woman at admission and new drug proper use in the medical therapy 藤井稚奈1), 前川真己1,2), 中園裕利華1,2), 佐々木貴之1,2), 加藤恵一1), 大里和広3), 白木克哉2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1182-1182, 2022.

---

	P444-25-AM. Report of a case of rapid increase in BUN after administration of Molnupiravir 肥後美月1), 渡慶次賀博2), 喜多洋嗣1), 仲村亮太1), 田仲祐子1), 村雲智久1), 近藤理美1), 水野康平1), 吉村美菜1), 野下綾子1), 菅近晴美1), 佐伯星依奈1), 船臺三央1), 又吉嘉寿人1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1183-1183, 2022.

---

P445-24-PM. About effect and the associated factor which everyday life stress of the hospital pharmacist accompanied with the new coronavirus infection pandemic prolongation gives to normal business routine 白石貴寿1), 坂本拓也1), 川村ひとみ1), 小川実華1), 井口舞香1), 高木栄希1), 図師彩音1), 山田智栄子1), 青柳晴彦1), 荒井宏人1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1184-1184, 2022.

---

	P446-25-AM. Duties investigation of the drug section accompanied with the new corona infection expansion in the national capital municipal hospital chief pharmacist council participation institution 喜古康博1,7), 廣井順子2,7), 石坂敏彦3,7), 森本茂文4,7), 本田一春5,7), 山田英紀6,7) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1185-1185, 2022.

---

	P447-24-PM. About the efforts of the community medical care function promotion mechanism (JCHO) pharmacist in Osaka temporary medical facilities of the new coronavirus infection of the disaster grade 東克彌1), 福田裕子2), 森脇崇3), 仲田美智代4), 鈴木朋克5), 秋吉尚雄6), 北澤文章4), 辻川正彦3,8), 片山歳也7,9) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1186-1186, 2022.

---

	P449-24-PM. With COVID-19 serious case center establishment, it is efforts to duties efficiency and prevention of incident by the clinical path introduction 田中こずえ1), 山村智代1), 船引梓2), 谷澤由香2), 武富太郎3), 中川秀光4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1187-1187, 2022.

---

	P450-25-AM. Of new corona vaccination duties by the multi-type of job collaboration, actually 堀口悠太1), 西村真央1), 山本祐聖1), 木村実央1), 裏山悠哉1), 竹原涼子1), 濱崎淳哉1), 向井淳治1,3), 澤田隆吾2), 奥田広志1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1188-1188, 2022.

---

	P451-24-PM. Intervention ... by one ward pharmacist who is not as main duties by response of the ward pharmacist ... infection control at outbreaks development due to the new coronavirus infection 山元孝俊1), 光永義治1), 柴田裕介1), 足立匠1), 岡田雄介1), 河村剛至1,2), 渡部多真紀1,2), 安野伸浩1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1189-1189, 2022.

---

	P452-25-AM. About the oral medicine management method in a new coronavirus infection and the analogous case of a disease patients 吉田朱里1,4), 竹内菜穂1,4), 平沼朋子1), 古川睦2), 上野一枝2,4), 尾花祥世1,4), 福田英克1), 山本光成3,4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1190-1190, 2022.

---

	P453-24-PM. Correspondence to a sedative supply difficulty by the multi-type of job cooperation in the middle scale hospital operating room 磯野礼果1,2,3), 細野真吾1), 亀井幹子2), 白井壽子2), 澁田達史3), 山崎崇1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1191-1191, 2022.

---

	P454-25-AM. Investigation of contraindicated drug cases in patients using nirmatrelvir/ritonavir and countermeasures 沼田裕也1), 沢田佳祐1), 西山晃1), 中谷丈之1), 河野修治1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1192-1192, 2022.

---

	P455-24-PM. Relation of the pharmacist for the new coronavirus infection (COVID-19) therapeutic drug in our hospital 河野透子1), 牛島裕貴1), 福中咲愛1), 今村陽子1), 坂本欣直1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1193-1193, 2022.

---

P456-25-AM. Cooperation of the efforts dispatch pharmacist of the JCHO pharmacist about the pharmacist wide area dispatch to Tokyo temporary medical facilities of the new coronavirus infection and the pharmaceutical specialist job 樋口泰子1), 加藤淳一2), 奥主仁3), 水野宏昭4), 荻野知紀5), 齋藤雄大6), 藤掛沙織7), 我妻央陽3), 佐野真由実7), 菅原真那2), 久保瞳8), 野田美保9), 森田淳介2), 伊藤典子2,10), 片山歳也9,11) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1194-1194, 2022.

---

	P457-24-PM. Examination about the usefulness of the holiday ward drug duties in the COVID-19 ward 相賀真由1), 陳内博之1), 津吹澄1), 沖田直美1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1195-1195, 2022.

---

	P460-25-AM. Pulmonary suppuration due to the Panton-Valentine leukocidin-positive dimethoxyphenyl penicillin which we have the onset, and age 6 was able to save on a day-sensitive staphylococcus aureus 本田勝亮1), 柏原道志1), 長岡翔1), 堤克成1), 菊池新2), 杉浦弘2), 大木茂2), 金子寛3), 中南秀将3), 矢部勝茂1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1196-1196, 2022.

---

	P461-24-PM. Use of antimicrobial turn of eventss by the oral third generation cephem-based adoption reduction 塩田智子1), 谷長美菜子1), 村瀬大翔1), 段林正明1), 高橋一栄1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1197-1197, 2022.

---

	P462-25-AM. Examination of the cefepime dosing period for the affection patients with the blood malignant tumor with unidentified fever 西綾香1,2), 吉川明良1), 増田博久1), 常友盛勝1), 綾部ゆか1), 新谷貴洋2), 渡辺美和1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1198-1199, 2022.

---

	P463-24-PM. About the change of the AST activity in the Kyushu medical center and the effect 橋本雅司1), 高武嘉道1), 山口泰弘1), 坂口晋哉2), 鶴山萌子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1200-1200, 2022.

---

	P464-25-AM. The analysis of the factor about the FLCZ tolerance and examination of the initial drug of choice 青柳千愛1), 山科卓也1), 山崎貴史1), 下村真代1), 兵藤沙耶2), 平木洋一3), 肥山和俊4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1201-1201, 2022.

---

	P465-24-PM. Efforts for the oral third generation cephalosporin antimicrobial consumption reduction by the intervention of the antimicrobial proper use support team 古川大樹1), 伊藤嘉英1), 大橋武司1), 林房枝2), 梶田麻美2), 菱田志乃3), 中尾彰宏4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1202-1202, 2022.

---

	P466-25-AM. Intervention effect ... in efforts - UTI for the consumption reduction of LVFX 福本康之1), 工藤悠翔1), 長山晃1), 森下和美1), 川上典子1), 近藤昌子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1203-1203, 2022.

---

	P467-24-PM. Examination of the acute renal failure onset risk in vancomycin hydrochloride and tazobactam/piperacillin combination therapy of the renal function normalcy patients 高畑智瑛1), 本山大夢1), 澤田和久1), 奥平正美1), 杉浦洋二1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1204-1204, 2022.

---

	P468-25-AM. Survey on the implementation of de-escalation of tazobactam and piperacillin at Handa City Handa Hospital 石川舞依子1), 榊原洋一1), 伊藤実優1), 板倉由縁1), 横田学1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1205-1205, 2022.

---

	P469-24-PM. One case of the hyperviscosity-related Klebsiella pneumoniae bacteremia treated with combination of meropenem 6g/day and levofloxacin 安東大智1), 下山雄一朗1), 後藤俊元1), 宮澤由記子2), 合田智則3), 宗広樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1206-1206, 2022.

---

	P470-25-AM. Examination about the infection prophylaxis effect by the comparison of the single dose group and three times group given mandibular extraction of impacted wisdom teeth in front of the art 齋藤千愛1), 吉田謙介1), 児玉泰光2), 冨原圭2), 外山聡1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1207-1207, 2022.

---

	P471-24-PM. About the efforts by other types of job for the suspension introduction for the amikacin liposome inhalation 水口侑子1), 和田宜久1), 澤井祐樹1), 上田理絵1), 岩田浩幸1), 的場美香1), 木村貴1), 木澤成美1), 金銅葉子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1208-1208, 2022.

---

	P472-25-AM. Intervention of the pharmacist based on PK-PD theory in the use of antimicrobial at the blood culture positive 田村麻衣1), 本舘諭1), 畑中祐磨1), 奈良昇悦2), 越前谷卓磨2), 中居肇1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1209-1209, 2022.

---

	P473-24-PM. About the usefulness of the evaluation using the template to the use of tazobactam/piperacillin patients in our hospital 牧田亮1), 古谷一平1), 田中佳子1), 井上壽江1), 平下智之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1210-1210, 2022.

---

	P474-25-AM. The introduction of "the renal function antiinfection medicine doses list" which we made newly and the evaluation 谷長美菜子1), 塩田智子1), 村瀬大翔1), 段林正明1), 山田正実1), 高橋一栄1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1211-1211, 2022.

---

	P475-24-PM. Examination of the factor that metronidazole was not as effective for Clostridioides difficile infection 臼井和明1), 吉田悦朗1), 大石丸美1), 安藤暢彦1), 和泉寿紀1), 近藤真由1), 長島章1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1212-1212, 2022.

---

	P476-25-AM. Clinical evaluation - of maintenance, the introduction of adequacy - clinical path of aspiration pneumonia treatment by the antimicrobial proper use support team 松岡知子1), 大橋健吾1,4), 篠田康孝1,4), 森卓之1), 横山達郎2,5), 加賀城美智子3,5), 高橋崇真4,5), 吉村知哲1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1213-1213, 2022.

---

	P477-24-PM. Investigation on the onset of cytomegalovirus infection after completion of letermovir administration 加茂真宏1), 角真太郎1), 久保利樹1), 祖川倫太郎1), 島ノ江千里1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1214-1214, 2022.

---

	P478-25-AM. Efforts ... for the proper use of the AS activity - betamethasone valerate gentamicin ointment that a pharmacist can do it 八汐祥恵1), 石田智之1), 森美保菜1), 末永尚輝1), 鶴永大貴1), 中村有莉恵1), 堀内智裕1), 赤星真広1), 森岡友美1), 池増鮎美1), 佐多照正1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1215-1215, 2022.

---

	P479-24-PM. One case with suspected encephalopathic onset metronidazole-induced on the administration start next day 小池彩子1), 花房伸幸1), 川上隆弘1), 田村安希1), 中島誠2), 小橋春彦3), 森英樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1216-1216, 2022.

---

	P480-25-AM. A dose of the antimicrobial in children with suspected community-acquired pneumonia by BLNAR and examination of the dosing period 西尾公志1), 大石博史1), 片山陽介1), 田中誠1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1217-1217, 2022.

---

	P482-25-AM. Examination of the intervention effect on blood culture-positive patients by the antimicrobial proper use support team 中島彰信1), 出羽祐基1), 近野祐里1), 中村直美1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1218-1218, 2022.

---

	P483-24-PM. Efforts in our hospital for the third generation oral cephalosporin antimicrobial proper use 尾花祥世1,5), 吉田朱里1,5), 尾崎絢果1,5), 地守絢子2,5), 桑名良和2,5), 上野一枝3,5), 福田英克1), 山本光成4,5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1219-1219, 2022.

---

	P484-25-AM. The effect that efforts to rate of application adequacy gives for patients outcome on amino acid-containing general electrolyte infusion prescription patients 田井達也1), 山口佳津騎2), 新村航2), 松原亜季2), 渡邊政博3), 間嶋由美子1), 横田恭子1), 田中裕章2), 小坂信二2), 門脇則光1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1220-1220, 2022.

---

	P485-24-PM. Examination about the usefulness of the chemical intestinal tract measures in the colon cancer elective surgery 佐々木康弘1), 橘淳1), 宮本智恵子2), 畑地健一郎3), 手塚徹4), 桂川秀雄3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1221-1221, 2022.

---

	P486-25-AM. The effect of the bacterial species in the outcome of the enterococcus bloodstream infection and examination about the risk of death factor 末廣陽子1,2), 塚本仁1,2), 東高士1,2), 古俵孝明1), 飛田征男3), 岩崎博道2), 後藤伸之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1222-1222, 2022.

---

	P487-24-PM. Examination about the risk factor of the Clostridioides (Clostridium) difficile infection onset 渡邊歩1), 池上幸子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1223-1223, 2022.

---

	P488-25-AM. Investigation of the infective endocarditis case in our hospital 榊原洋一1), 石川舞依子1), 伊藤実優1), 稲葉史恵1), 横田学1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1224-1224, 2022.

---

	P489-24-PM. Questionary survey about the antimicrobial study session enforcement in the pharmacy 末延道太1), 藤野優1), 原尻学志1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1225-1225, 2022.

---

	P490-25-AM. Analysis and evaluation of the efforts of the antimicrobial proper use support team in our hospital 金原加苗1), 藤田昌美1), 藤原加奈子1), 古谷佳美1), 松本文佳1), 矢木真一1), 細田尚美1), 市川大介1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1226-1226, 2022.

---

	P491-24-PM. Examination of the prophylactic antimicrobial for the infection after the transrectal prostatic aspiration biopsy 青山真之1), 岩本里美2), 内藤淳3), 森下真圭4), 金田大生5), 鈴木幹三4,6), 成瀬国男1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1227-1227, 2022.

---

	P493-24-PM. Effect of the antimicrobial proper use support with the infection specialist for blood culture-positive patients 石田茂伸1,2), 山田加代子2), 藤原大亮1,2), 眞野裕1), 多胡友絵1), 星育子1), 小泉祐一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1228-1228, 2022.

---

	P494-25-AM. Problem extraction for search of the use of foreign antimicrobial index using the J-SIPHE antimicrobial count application and the future foreign AMR activity 鈴木朋克1,2), 小島さおり3), 片山歳也2), 田子加代子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1229-1229, 2022.

---

	P495-24-PM. Investigation for catheter-associated bloodstream infections due to B. cereus 田村安希1), 花房伸幸1), 川上隆弘1), 小池彩子1), 香川麻衣2), 奥格3), 森英樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1230-1230, 2022.

---

	P496-25-AM. Efforts to dose adequacy of the meropenem in the Gunma center Hospital 國分真理1), 田子尚史1), 鈴木達宙1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1231-1231, 2022.

---

	P498-25-AM. Look at the rear of the fever work up compliance before the wide area antimicrobial administration in the Okayama University Hospital; mark investigation 東恩納司1,2), 森下陽介1,2), 西原茂樹1,2), 座間味義人1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1232-1232, 2022.

---

	P499-24-PM. Comparison of the blood culture-positive patients round case before and after the outbreak of new coronavirus occurrence 大竹友里恵1), 天野哲史1), 鈴木厚志1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1233-1233, 2022.

---

	P500-25-PM. A comparison of the antiHIV therapy using the treatment satisfaction evaluation from patients: Patient reported outcome multicenter study 日笠真一1), 石原正志2), 築地茉莉子3), 國本雄介4), 登佳寿子5), 木村丈司6), 山本有紀7), 治田匡平8), 柏原陽平9), 藤井健司10), 木村健1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1234-1234, 2022.

---

	P501-24-PM. The use of prescription notebook situation investigation of patients with HIV infection 藤井健司1), 田中まりの1), 石井聡一郎1), 大東敏和1), 春日真由2), 小川和彦2), 重留佳代子2), 畝井浩子2), 山崎尚也3), 藤井輝久3), 松尾裕彰1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1235-1235, 2022.

---

	P502-25-AM. Comparison ... with proper use information - beef lead Pare plus of peripheral venous nutrition therapy infusion energy Freed 倉本敬二1), 大原宏司2), 杉山奈津子1), 伊東岳1), 加藤芳徳1), 前澤佳代子1), 百瀬泰行1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1236-1236, 2022.

---

	P503-24-PM. One - that we showed improvement of the nutritional status by a device choice by role - multi-type of job cooperation of the pharmacist in our hospital NST and enforcement of the TPN 平野龍一1), 井須恭平1), 菅基次1), 曽我和子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1237-1237, 2022.

---

	P504-25-AM. One patient who conducted nourishment management for short bowel syndrome by NST leadership 三宅美有紀1,2), 稲葉静香1), 森友美2), 庄野剛史2), 下川福子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1238-1238, 2022.

---

	P505-24-PM. About the use situation of psychiatry therapeutic drug and the constipation therapeutic drug and association 福山雄卯介1), 宮崎敦2), 三角紳博1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1239-1239, 2022.

---

	P506-25-AM. A fall, the fall in the east of the Sumida River Hospital inpatient and relative investigation of the prescribed medicine 石田留美1), 保戸塚里美1), 疋田絵梨1), 安武夫1,2), 城田幹生1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1240-1240, 2022.

---

	P507-24-PM. The effect that the telephone support of the drugstore pharmacist gives to the treatment continuance rate of SNRI, the SSRI remedy patients 坂井信之1,2,3), 中村友美2), 西面恵太3), 飯塚敏美3), 浦本太一郎1), 西郷勝行1), 渡邉文之2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1241-1241, 2022.

---

	P508-25-AM. The suggestion of the list of delirium risk drugs and examination of the delirium onset factor 冨田優子1), 宮尾眞一2), 武藤達也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1242-1242, 2022.

---

	P509-24-PM. Relative investigation with the medical therapy in patients with schizophrenia using the multivariate analysis and the drug-related constipation 村田晶1,2), 岩田優俊1), 湯川裕光1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1243-1243, 2022.

---

	P510-25-AM. Examination of the patients background factor having an influence on the advisability of the change to TRI (Twelve-weekly Release Injection) 赤瀬川豊1), 甲斐孝弘2), 井上雅文3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1244-1244, 2022.

---

	P511-24-PM. One patient who reintroduced Aripiprazole durability parenteral injection into patients with comorbidities of bipolar disorder and the addiction, and maintained adherence 島田治子1), 西脇健三郎2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1245-1245, 2022.

---

	P512-25-AM. Comparison of the nightmare frequency with the orexin receptor blocker 山崎由夏1), 神原弘和1), 野村暢彦1), 池田久雄1), 足立充司1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1246-1246, 2022.

---

	P513-24-PM. Psychiatry liaison team in the Toyokawa Municipal Hospital: We evaluate the activity of the continuous team 山崎孝佳1,2), 國澤真希子1,2), 渡邉淳子1), 伊藤良和1), 楠井由紀1), 佐々木直子1), 松井亨介1), 古井和雄1), 山本孝枝2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1247-1247, 2022.

---

	P514-25-AM. Survey of the remedy medicine situation in our hospital dementia care team intervention patients 田口諒1), 元木孝1), 土井竜樹1), 渡邊清人1), 高柳昌宏1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1248-1248, 2022.

---

	P516-25-AM. Carbocisteine internal use during pregnancy and examination of the risk of developing congenital anomalies of the child born 磨田真理子1), 左勝則2), 小林瑞希1), 永野浩之1), 山根律子4), 八鍬奈穂3), 後藤美賀子3), 村島温子3), 眞壁秀樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1249-1249, 2022.

---

	P517-24-PM. One case of the pharmaceutical intervention for the AT3 deficiency merger pregnancy 中島春佳1), 片岡達夫1), 三木陽介1), 佐伯康之1), 松尾裕彰1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1250-1250, 2022.

---

	P518-25-AM. 2 cases using the coronavirus therapeutic drug new late in the pregnancy 手島慶子1), 藤川理紗1), 瀬川侑里香1), 木村真策1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1251-1251, 2022.

---

	P519-24-PM. Examination about pharmacist intervention and the after giving birth psychiatry hospitalization to schizophrenia expectant mothers 小泉寿子1), 田久保陽司2), 西悠吾1), 永瀬怜司1), 辻野尚久2), 菅野浩1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1252-1252, 2022.

---

	P520-25-AM. It is ... about an effect of the multicenter LIVE participation type practice using attempt - picture for the enhancement of "the pregnancy, the nursing and the medicine" in the business training 三好文子1), 小林亜貴子1), 稲見彩香1), 岩田みなみ1), 栗原明日香1), 出雲貴文1), 小茂田昌代1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1253-1253, 2022.

---

	P521-24-PM. The medication situation investigation of a pregnant woman, the nursing mother in our hospital 田口舞子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1254-1254, 2022.

---

	P522-25-AM. Examination of 2 cases that led to the pregnancy after the MTX discontinuation of women with the rheumatoid arthritis 赤阪未来1), 平井利典1), 金田倫子2), 西岡美喜子2), 池田智明2), 岩本卓也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1255-1255, 2022.

---

	P523-24-PM. Examination of the SGLT2 inhibitor effect on patients with hyperuricaemia merger diabetes using the tendency score matching 中嶋丈晴1), 石本昌裕1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1256-1256, 2022.

---

	P524-25-AM. Questionary survey about the instruction contents for the injection timing at super quick effect type insulin preparation introduction 上杉章紀1), 河原陽介2), 突田壮平3), 加藤良治2), 田邉文明1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1257-1257, 2022.

---

	P525-24-PM. Investigation about the tendency to onset of adverse event in the incretin analogous drug using the Japanese adverse drug reaction database 青山京介1), 野口義紘1), 久保賢晃1), 吉澤俊輔1), 舘知也1), 寺町ひとみ1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1258-1258, 2022.

---

	P526-25-AM. Example that led to healing by medicine for external application therapy for 2 degrees burn with the boiling water 西村博之1), 吉田陽1), 塩山由紀1), 守田彩文1), 高田雅文1), 栗並昇2), 鈴木知子2), 梶原敬三2), 稗島州雄2), 杉山正悟2), 陣内克紀2), 陣内冨男2), 陣内秀昭2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1259-1259, 2022.

---

	P527-24-PM. Examination - about the factor having an influence on questionary survey - medication compliance about the medication situation in the antidiabetic drug internal use patients 岩村雪菜1), 畑中崇志2), 大田垣奈津美3), 森泰子1), 谷上知絵里1), 田村浩二1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1260-1260, 2022.

---

	P528-25-AM. Evaluation of the efficacy and safety of the new GLP-1 receptor agonist injection semaglutide (Ozempic) in patients with type 2 diabetes mellitus 楊奈月1), 早川伸樹1,2), 津川透1,3), 福井愛子1), 亀井浩行1), 桑原宏貴3), 公文尚子2), 松尾悠志2), 鈴木敦詞2), 山田成樹3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1261-1261, 2022.

---

	P529-24-PM. eGFR investigation and problem of the current situation and the metformin remedy patients of the antidiabetic drug prescription of our hospital 鎌田敬志1), 松田千佳1), 田中大輔1), 清野由利1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1262-1262, 2022.

---

	P530-25-AM. The adverse drug reaction database (JADER) vonoprazan induction nephropathic safe signal detection that we used 石田将之1), 土屋雅美2), 飯原大稔1,8), 内藤順子3), 河添仁4), 渡辺大地1), 野中佑二郎5), 佐野美佳6,8), 境浩康7,8), 熊田恵介8), 大倉宏之3), 清水雅仁7,8), 鈴木昭夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1263-1263, 2022.

---

	P531-24-PM. Efforts of CKD team activity and the CKD education hospitalization 桝屋根佳子1), 倍味亜矢子1), 佐武喜美子1), 足立哲也1), 藤原木綿子2), 右梅貴信3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1264-1264, 2022.

---

	P532-25-AM. The screening of patients in CKD in the health insurance pharmacy: We guess from prescribed medicine 島祐子1), 有山知代1), 那須祥子1), 山森直子1), 萩原睦子1), 川端昌康1), 清川大知1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1265-1265, 2022.

---

	P533-24-PM. Investigation of iron dynamics and Hb levels in hemodialysis patients switched from high-dose erythropoiesis-stimulating factors to roxadustat 野田聖奈子1), 桑村恒夫1), 中川義浩1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1266-1266, 2022.

---

P534-25-AM. One case that intervened pharmaceutical for the constipation of the peritoneal dialysis patients that constructed gastric fistula and hypokalemia 森脇健太郎1,2), 鈴村雅之1), 野々山英人1), 窪田知仁2), 水谷日花里2), 田中裕子2), 大矢知立城2), 松田千裕2), 森実優2), 加藤公人2), 川崎好人2), 西川嘉広2), 橋本陽2), 今西義紀2), 小出哲朗2), 伊藤久美子2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1267-1267, 2022.

---

	P535-24-PM. Seasonal variation of eGFR based on the serum creatinine level of the outpatient 甲元大樹1), 花房伸幸1), 中尾なつみ1), 小池彩子1), 大道淳二1), 森英樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1268-1268, 2022.

---

	P536-25-AM. Change of the trough level by the TEIC inside the hospital regimen revision 加藤渓1), 野呂智晴1), 山下悠希1), 上坊健太1), 田辺和史1), 小林謙一郎2), 久保健児2), 古宮伸洋2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1269-1269, 2022.

---

	P537-24-PM. Examination of the kidney protection by vildagliptin and the kana glyph rosin combination 阿部多嘉浩1), 大橋春香1), 宮越貴之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1270-1270, 2022.

---

	P538-25-AM. Prescription adequacy by the renal function test value confirmation in the ethical pharmacy 山口貴大1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1271-1271, 2022.

---

	P539-24-PM. Effect of the antipsychotics in the deglutition dysfunction patients 長田一晃1), 横山匠太1), 森川記道1), 安原昌宏1), 原田靖子1), 有田裕一2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1272-1272, 2022.

---

	P540-25-AM. The prospects of the efforts of the pharmacist in the elderly people care team for the improvement of the polypharmacy 小山晃紀1), 高山慎司1), 山田宇以2), 西沢幸子3), 齋藤尚子3), 田中万里子3), 田口雅子3), 岡村大介4), 小貫早希4), 並木千裕4), 熊谷三智5), 仲野真由美6), 後藤一美1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1273-1273, 2022.

---

	P541-24-PM. Inspection of the delirium risk screening based on results 永江隆二1), 屋敷久恵2), 中川友樹1), 和泉柚衣3), 塩崎真由3), 内山幸子1), 松田守弘4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1274-1274, 2022.

---

	P542-25-AM. Effect of polypharmacy measures utilizing "elderly people pharmaceutical products proper use promotion business" by Ministry of Health, Labour and Welfare 陶山泰治郎1), 香川瞭子1), 今滝泉1), 佐藤拓洋1), 篠永浩1), 原田典和1), 加地努1), 三河麻里2), 松永徹也3), 合田佳史3), 植松由美子4), 藤川達也5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1275-1275, 2022.

---

	P543-24-PM. Examination of the effect that polypharmacy conference gives to a physician, a nurse 土田真菜1), 古見嘉之1), 鯨井あずさ1), 関根祐介1), 佐藤友彦2), 清水聰一郎2), 竹内裕紀1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1276-1276, 2022.

---

	P545-24-PM. Research about problems of the medication in the special elderly nursing home 勝村紀香1), 幡生あすか2), 亀井章3,4), 大石雅子3), 上田幹子2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1277-1277, 2022.

---

	P546-25-AM. Single institution crossing study of the frailty-related factor in elderly people who received a clinical survey 65 years or older 高橋雄太1), 新木美枝2,3), 大山善昭4), 長嶺歩1), 高橋恵美利1,2), 今井邦彦5), 林邦彦6), 中村哲也4), 倉林正彦7), 大林恭子1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1278-1278, 2022.

---

	P547-24-PM. Meta analysis about pressure sore degree of improvement and the oral serum zinc using the PUSH score 中山裕一1,2), 近藤晃代1,3), 福田愛1,4), 藤村睦子1,3), 首藤哲也1,5), 濱添陽平1,5), 野村美佐子1,6), 五十嵐敦之1,7) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1279-1279, 2022.

---

	P548-25-AM. About the efforts of the pharmacist in the pressure sore measures team 新城唯1), 横田幸子1), 矢野遥子1), 藤岡英子2), 高橋智子3), 東直美4), 馬屋原孝恒5), 杉山成史6), 森英樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1280-1280, 2022.

---

	P549-24-PM. Evaluation of the effectiveness of the naldemedine in the bowel control of the artificial respiration management COVID-19 patients 疋田絵梨1), 城田幹生1), 安武夫2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1281-1281, 2022.

---

	P550-25-AM. Survey on the efficacy and safety of romosozumab in combination with active vitamin D preparations 森崎崇文1), 星野輝彦1), 下田賢一郎1), 杉山留美子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1282-1282, 2022.

---

	P551-24-PM. One case that intervened pharmaceutical for use of DDAVP oral medication to the central diabetes insipidus due to the injury 横澤大輔1,2,3,4), 金子恵未2), 木村相樹3), 水谷雅臣4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1283-1283, 2022.

---

	P552-25-AM. Setup of the palliative care team in the safety net hospital 下村真代1), 赤峰伴子2), 古海和博1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1284-1284, 2022.

---

	P553-24-PM. Factor search to be involved after the operation in Remy masochist lymphangioleiomyomatosis treated patients at awakening time 桑名諒美1), 石野清亮1), 高岡雄一1), 柏原聖人1), 矢部勝茂1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1285-1285, 2022.

---

	P554-25-AM. About the contribution to the medical therapy by the medication follow-up to be carried out and medical economy of the drugstore pharmacist 塚田泰隆1), 中山恵子1), 三部陽司2), 小沼美佐2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1286-1286, 2022.

---

	P555-24-PM. Search of the factor having an influence on the number of the egg collection in the GnRH antagonist method 清水美希1,2), 加藤芳徳1,3), 磯奈津実3), 小山芽衣3), 尾形育恵3), 島袋里沙子3), 齋藤勲2,3), 末永昭彦5,6), 中村裕義1,3,4), 山田治美1,3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1287-1287, 2022.

---

	P556-25-AM. Use experience of the zoledronic acid (once a year preparation) in our hospital 野口直子1), 延藤勇1), 豊浜隆1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1288-1288, 2022.

---

	P557-24-PM. About the development of the foam-formed medication supplement and effect on drug dissolution 瀧川雄太1), 倉家健太朗1), 深谷京子1), 金谷太作1), 中西謙次郎1), 小林正志1), 齊藤順平2), 小村誠2), 阿部浩之3), 山谷明正2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1289-1289, 2022.

---

	P559-24-PM. Change of the Levodopa injection preparation consumption after conversion table making common knowledge from a Parkinson's disease internal use therapeutic drug in Nagoya Memorial Hospital to Levodopa injection preparation 近藤奈央子1), 湯浅周1), 壁谷めぐみ1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1290-1290, 2022.

---

	P560-25-AM. Safe evaluation of dapagliflozin propylene glycol tablets to patients with chronic cardiac insufficiency in the decreased renal function patients 西尾洋平1), 古谷一平1), 関谷泰明1), 井上壽江1), 平下智之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1291-1291, 2022.

---

	P561-24-PM. Stocktaking of the drug adjustment at delirium measures that a dementia care team performs 瀬古高裕1), 辻内喜久雄2), 山名知子3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1292-1292, 2022.

---

	P562-25-AM. Of the polypharmacy activity in the Saiseikai Hiroshima Hospital, actually 佐々木雄啓1), 浜本友絵1), 高橋栄子1), 山田真帆1), 梶山大地1), 山橋昌代1), 岡村和彦1), 松本公治2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1293-1293, 2022.

---

	P563-24-PM. Relation of the pharmacy for patients with congenital afibrinogenemia 石橋真実1), 新城唯1), 矢野遥子1), 大道淳二1), 森英樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1294-1294, 2022.

---

	P564-25-AM. Evaluation of the copper-dependent enzyme activity in the brain tissue of the Menkes disease model animal 平野茉優1), 竹下日南乃1), 鈴木詩菜1), 丸目彩華1), 児玉浩子2), 高橋秀依3), 深水啓朗4), 山岸喜彰1), 工藤敏之1), 伊藤清美1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1295-1295, 2022.

---

	P565-24-PM. Study on substitute end-point (surrogate endpoint) in the cancer clinical study 真貝理子1), 原明日香1), 村井由奈1), 前田英紀1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1296-1296, 2022.

---

	P566-25-AM. Efficiency of trial secretariat duties by the train introduction to magnetize of the trial-related document 秋吉明子1), 早川郁子1), 陣上祥子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1297-1297, 2022.

---

	P567-24-PM. The current situation and problem in the clinical experimental medicine administrative work transfer to the pharmacy 吉川あゆみ1), 伊藤直哉1), 山田彩加1,2), 塚野千尋1), 伊東孝子1,2), 本郷文教1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1298-1298, 2022.

---

	P568-25-AM. The current situation and wish of the pharmacist of the hospital in the home visit practice being able to do it 三浦美香1), 川埼智子1), 齊藤文香1), 新穂裕子1), 吉澤雅恵1), 山田浩介1), 西須永実理1), 前原正規2), 長澤宏之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1299-1299, 2022.

---

P569-24-PM. Community medical care cooperation systems construction first report for the cooperation-based dementia early detection of community-acquired drugstore pharmacist - Primary care physician 甲斐麻美子1), 勢島英2), 冨永宏冶1), 森田一俊1), 林稔展1), 小野和彦1), 山口良介3), 田頭仁美4), 高田真紀子5), 勢島充4), 江川孝1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1300-1300, 2022.

---

	P570-25-AM. Inquiry analysis second report about the TPN from the ethical pharmacy 掛水瑞芳1), 五十嵐遼1), 竹林佑花1), 松田直子1), 吉岡小都子1), 星泉1), 佐々木美由紀1), 福田まゆみ1), 岩原良晴1), 河野裕則1), 沢田憲彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1301-1301, 2022.

---

	P571-24-PM. Intervention of the nutrition education in the community pharmacy for patients with ulcerative colitis 高見陽一郎1), 岩倉沙耶1), 金本拓始1), 神垣真理子1), 松尾陽子1), 松元享平1), 安倉央1), 高橋正志1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1302-1302, 2022.

---

	P572-25-AM. Consideration about a function, the nature of the pharmacist sought by the at-home palliative care support drugstore (tentative name) 高柳論也1), 高橋幸江1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1303-1303, 2022.

---

	P573-24-PM. Attitude survey of the operation situation and physician, pharmacist of the tracing report in Higashi-ku, Sapporo-shi 徳留章1,2), 佐藤彩伽1,2), 鈴木直哉2,3), 藤村拓也2,4), 重成大介2,5), 菊池健2,6), 谷口亮央2,3), 樋浦一哉7), 山下美妃7), 木明貴幸1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1304-1304, 2022.

---

	P574-25-AM. Example that suffered from the bowel control in the home care patient 高木綺1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1305-1305, 2022.

---

	P575-24-PM. An example of the breast cancer terminally ill patients during the home care that olanzapine was effective for nausea, vomiting, inappetence with the cachexia 大野(川井)朋子1,2), 中村仁美3), 清水一樹1), 大田和枝4), 百賢二2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1306-1306, 2022.

---

	P576-25-AM. Good use of check sheet for the outpatient whom a health insurance pharmacy works on 銭田真里1), 二口恵子1), 佐藤麻美子1), 安田留美1), 杉田尚寛2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1307-1307, 2022.

---

	P577-24-PM. Inspection about the usefulness of the new coronavirus study session for support groups as the indirect support to the issue of infection of the alien 池浦恵1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1308-1308, 2022.

---

	P578-25-AM. We want to look at home. Can you come back in this? - - important the preparations until a discharge 荒川昌史1), 遠藤径世1), 堀越亜希子2), 安藤恵3), 竹野信吾4), 小林友稀4), 境美智順5), 藤村昭太1), 小坂仁2), 今井靖1,6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1309-1309, 2022.

---

	P579-24-PM. One case that it ached, and a diary was useful in introduction of the opioid therapy for patients with old cancer during home care 宮田成康1), 藤田あゆみ2), 菅原大典1), 小林徹也1), 杉浦伸哉2), 杉浦克典2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1310-1310, 2022.

---

	P580-25-AM. Fact-finding about PCA pumps, and the like in the at-home palliative care for health insurance pharmacies 飛鷹範明1,3), 宇都宮晴菜2), 河野安3), 縄田幸裕3), 宇田雅実3), 古川清3), 田中守1,3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1311-1311, 2022.

---

	P581-24-PM. The example that tried medicine medicine cooperation about the case that a low Na blood symptom and cognitive impairment occurred by valproic acid prescribed for elderly people epilepsy from the at-home specialization type drugstore 藤原將平1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1312-1312, 2022.

---

	P582-25-AM. Example ... which was able to provide optimal medical therapy by the cooperation with the type of job other than in role - area of the hospital pharmacist in the treatment at home 坂口美智子1), 西村幾美1), 永井聡子2), 宮脇光二3), 服部雄司1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1313-1313, 2022.

---

	P583-24-PM. Problem in the correspondence to the foreign language speaker patients at the health insurance pharmacy 高橋恵美利1), 廣木美玲1), 長谷川史朗2), 大林恭子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1314-1314, 2022.

---

	P584-25-AM. Making and pharmacist questionary survey of the minute assessment-based digestive organ internal medicine TR (tracing report) model 菊地健太1), 松永裕理1), 川村道子1), 元木有加里1), 小栗るみ子1), 川端春乃2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1315-1315, 2022.

---

	P585-24-PM. Illness medicine for patients with COPD cooperation aiming at screening and early diagnosis in the ethical pharmacy 山下祥史1), 小川愛2), 田口浩史1), 犬塚博貴2), 森田みゆき2), 楠富伊織2), 椛田昇治2), 福井大樹1), 森岡美行1), 淺井季晴1), 廣瀬隆2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1316-1316, 2022.

---

	P586-25-AM. Efforts and evaluation by the collaboration with the drugstore pharmacist for the purpose of the medicine medicine cooperation reinforcement in the foreign chemotherapy 北出紘規1), 菅幸生2), 宮永和美1), 西野正義1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1317-1317, 2022.

---

	P587-24-PM. The making of structure to make use of a cancer domain tracing report in improvement in further pharmacist power 中村久美1), 鬼窪利英1), 淺野未代子2), 窪田靖3), 木村紗也加4), 宮澤遥5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1318-1318, 2022.

---

	P588-25-AM. The use situation of the family drugstore in patients in the antiHIV therapy and the prescription notebook 成田綾香1), 高山次代2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1319-1319, 2022.

---

	P589-24-PM. Investigation of contents and the reflection rate of the tracing report from the health insurance pharmacy 村川公央1), 猪田宏美1), 座間味義人1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1320-1320, 2022.

---

	P590-25-AM. Inventory survey about the intervention to the current situation and prescription adequacy of the polypharmacy in the pharmacy service under health insurance drugstore 図師彩音1), 小松浩大1), 井口舞香1), 奥田和貴1), 渡邊卓巳1), 伊達悠香1), 山田智栄子1), 白石貴寿1), 荒井宏人1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1321-1321, 2022.

---

	P591-24-PM. The current situation and the problem of the tracing report in Rousaibyoin, China: Kure, Hiroshima district investigation 富永祥子1), 西園寺真二1), 松田翔平1), 高橋優美1), 森内貴子1), 藤井朋子1), 山崎美保1), 面田恵1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1322-1322, 2022.

---

	P592-25-AM. Construction of the medicine medicine cooperation using "a heart failure follow-up sheet" 大橋泰裕1), 中澤実紀1), 和田厚幸2), 松浦佳代1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1323-1324, 2022.

---

	P593-24-PM. Operation of the doubt inquiry simplification protocol in outside Parliament and the in-hospital prescription 玉置秀成1), 草巻直人1), 丸山奈緒子1), 瀬尾崇識1), 紙谷瑞希1), 三瀬宏海1), 西本美由紀1), 冨岡謙二1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1325-1325, 2022.

---

	P594-25-AM. One case that contributed to treatment of invasive pulmonary aspergillosis by medicine medicine cooperation in the outpatient department 田村知子1), 吉岡睦展2), 高子優子2), 若松雄太2), 石津智司2), 小澤拓2), 饒平名長武2), 岡本忠司3), 小溝優子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1326-1326, 2022.

---

	P595-24-PM. Fact-finding of the necessary information of the information contact book between institutions before hospitalization in the regular hospital such as person with a disability institutions, and the like 木村美紗子1), 星野輝彦1,2), 杉山留美子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1327-1327, 2022.

---

	P596-25-AM. Questionary survey about the drug information sharing system between hospital - health insurance pharmacies at hospitalization and release 前川綾子1), 西村健二1), 石田亮2), 亀井健人1), 赤木晋介1), 徳田衡紀1), 高柳和伸1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1328-1328, 2022.

---

	P597-24-PM. Efforts for the pharmacist training specialized in local pharmacy care in the Kitano Hospital 近藤篤1,2), 西村碧2), 尾上雅英1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1329-1329, 2022.

---

	P598-25-AM. Fact-finding about the medication reporting book 鶴野結花理1), 須永雅恵1), 仁井田怜子1), 堀内美樹博1), 塩地園代1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1330-1330, 2022.

---

	P600-25-AM. Relation of a medication reporting book and the hospital pharmacist 高橋知里1), 麻生美佐子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1331-1331, 2022.

---

	P601-24-PM. Inventory survey about the current situation of the pharmaceutical management in the cancer chemotherapy for the pharmacy service under health insurance drugstore 伊達悠香1), 奥田和貴1), 小澤明日香1), 小松浩大1), 駒沢穂乃佳1), 高木栄希1), 鈴木美和1), 白石貴寿1), 荒井宏人1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1332-1332, 2022.

---

	P602-25-AM. Investigation about the recognition to drug control summary in an insurance pharmacist and the hospital pharmacist 石橋楽至1), 赤羽孝之1), 高野尊行1), 内藤裕之1), 中丸朗1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1333-1333, 2022.

---

	P603-24-PM. Use investigation of "the inhalational instruction enforcement report, reporting book" of the city unification pattern 土田裕貴1,2,3), 吉岡睦展1), 高子優子1), 村上紘世2), 小溝優子2), 田村知子2), 森本愛2), 畑世剛2), 灘波良信3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1334-1334, 2022.

---

	P604-25-AM. Start of the health insurance pharmacy for patients with cancer and the cooperation meeting in the Osaka Red Cross hospital 山瀬大雄1), 藤原洋一2,3), 松本早織1), 中嶋江美1), 原田慶子1), 尾本和彦1), 吉野秀紀1), 谷大輔1), 安田成男1), 門馬佳代子1), 山田邦義1), 辻井佳代1), 岡田錦2,4), 高田光治2,5), 堀越博一6,7), 小林政彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1335-1335, 2022.

---

	P605-24-PM. Inflection of the discharge drug information cooperation summary in the medicine medicine cooperation and the evaluation 津吹澄1), 八木智美2), 陳内博之1), 大塚健太3), 沖田直美1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1336-1336, 2022.

---

	P606-25-AM. The example that prevented the disadvantage of patients by information from hospital pharmacist 浅野陽子1), 日高良昌1), 岡敦子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1337-1337, 2022.

---

	P607-24-PM. The making of the exclusive tracing report for the foreign cancer chemotherapy and examination of the usefulness 丹羽今日子1), 加藤寛子1), 櫻井秀司1), 鈴木景子1,3), 船渡三結1), 西田承平1), 廣瀬智恵美1), 藤井宏典1), 石原正志1), 小林亮1,2), 飯原大稔1), 安田浩二1), 鈴木昭夫1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1338-1338, 2022.

---

	P608-25-AM. As compared with effect investigation - regular hospital that the ward drug duties in the local inclusion care ward give to medication adherence ... 石原瑛太郎1), 大嶋成奈優1), 石井照樹1), 沖廣絵里子1), 高橋公子1), 篠永浩1), 原田典和1), 加地努1), 石山晃子2), 中津守人3), 矢野禎浩4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1339-1339, 2022.

---

	P609-24-PM. The construction of the contact system to the physician for the tracing report and evaluation of the usefulness 櫻井秀司1), 加藤寛子1), 丹羽今日子1), 鈴木景子1,3), 船渡三結1), 西田承平1), 廣瀬智恵美1), 藤井宏典1), 石原正志1), 小林亮1,2), 飯原大稔1), 安田浩二1), 鈴木昭夫1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1340-1340, 2022.

---

	P610-25-AM. It is applied the withdrawal request book one package of the cancellation drug before surgery, examination for the health insurance pharmacy 阿部圭輔1), 妹尾啓司1), 西本早紀1), 河村勇介1), 岡原夏実1), 白木政博1), 渡邊篤1), 松本俊治1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1341-1341, 2022.

---

	P611-24-PM. Investigation about the reception of the tracing report through the cooperation full addition and the in-hospital utilization situation 千葉典子1), 安田真貴子1), 高田美香2), 山下慈2), 小野優紀1), 柴田美代子1), 棟方正樹3), 山本章二1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1342-1342, 2022.

---

	P612-25-AM. Efforts for the introduction of the doubt inquiry simplification protocol for the outside Parliament prescription in children, the perinatal medical special hospital 岩西雄大1), 大津由美子1), 望月千枝1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1343-1343, 2022.

---

	P613-24-PM. The current situation investigation of efforts and the tracing report for medicine medicine cooperation reinforcement to affect cancer chemotherapy 小森智也1), 坂本靖宜1), 川邉桂1), 小池博文1), 佐橋幸子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1344-1344, 2022.

---

	P614-25-AM. Through problem - majority disabled acceptance training of the supply system of the prescription order medicine at disaster - 森川祥彦1), 田坂健1), 赤阪未来1), 寺村文恵2), 家城洋平2), 向原里佳1), 岸和田昌之2), 岩本卓也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1345-1345, 2022.

---

P615-24-PM. Inventory survey for the purpose of the stocktaking of the consciousness about the disaster medical care relief activities in the pharmacy service under health insurance drugstore and regional alliances 駒沢穂乃佳1), 井上優子1), 渡邊卓巳1), 小澤明日香1), 小川実華1), 図師彩音1), 高橋里沙1), 青柳晴彦1), 白石貴寿1), 荒井宏人1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1346-1346, 2022.

---

	P616-25-AM. Uptake to pharmacist upbringing to be engaged in disaster medical care 上田賢太郎1), 下石和樹1), 合澤啓二1), 岩田一史1), 古庄弘和1), 富島喜朗1), 小山勢納1), 陣上祥子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1347-1347, 2022.

---

	P617-24-PM. About night holiday BCP development of the pharmacy and the utilization 杉村沙樹1), 椴山麻紗子1), 中村美月1), 宮井悠里1), 宮本翔子1), 前川真己1), 藤井稚奈1), 青木勇樹1), 寺尾さくら1), 佐々木貴之1), 杉本央司1), 山川智一1), 佐々木香織1), 加藤恵一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1348-1348, 2022.

---

	P618-25-AM. Relation of the pharmacist to the disaster medical care in the Osaka disaster medical care cooperation hospital 福田裕子1), 大井隆広1), 柿花美沙紀1), 森田貴子3), 高橋務2), 北澤文章1), 辻川正彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1349-1349, 2022.

---

	P619-24-PM. Examination of the economic effect that the intervention of the pharmacist by the foreign establishment before operation gives in a hospital 千葉陽月1), 中鏡暁子1), 笹野央1), 井上真由美1), 佐藤邦義1), 荒川隆太郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1350-1350, 2022.

---

	P620-25-AM. Evaluation of the effect about the administration of cover suspicion medicine evasion with the uniform management system of a side effect, the allergic information for outpatients 荒木良介1), 村上春奈1), 加藤加奈恵1), 浜本知之2), 田中恒明3), 山田英紀1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1351-1351, 2022.

---

	P621-24-PM. Efforts to the proper use promotion of the unrest in the ward, sleeplessness indicator 渡邊一史1), 西川まり絵1), 奥沙耶佳1), 栗原陽介1), 大橋養賢1), 増田純一1), 寺門浩之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1352-1352, 2022.

---

	P622-25-AM. The study implementation situation as HBV (HBV) reactivation measures in our hospital 大森悠翔1), 平手大輔1), 今多亮介1), 三間晋也1), 若井香鈴1), 桑島遥1), 小山内大雅1), 本郷文教1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1353-1353, 2022.

---

	P623-24-PM. Introduction of in-hospital formulary for sleeping pills and its effectiveness 萩原大樹1), 伊藤弥紀1), 東恵理1), 永江寛子2), 敷島友喜1), 兼重晋2), 神村英利2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1354-1354, 2022.

---

	P624-25-AM. About a change of the number of near miss by the near miss paper chase 片原憂斗1), 加藤礼奈1), 横井妙子1), 島崎良知1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1355-1355, 2022.

---

	P625-24-PM. The efforts which makes use of a report of incident event level 0 (zero) in improvement 三浦忠将1), 浅野岳人1), 高木竜一1), 阿部彩香1), 白井麻奈1), 杉浦礼菜1), 中村和行1), 奥平正美1), 杉浦洋二1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1356-1356, 2022.

---

	P626-25-AM. It is ... for medical safe activity - fall rate improvement by the sleeping drug formula reintroduction in the friendship medical center 高安芽衣子1), 平識善彦1), 安丸史織1), 小杉卓大1), 大城匡史1), 國分千代1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1357-1357, 2022.

---

	P627-24-PM. Fall fall risk factorial experiments (validity inspection in the validation group) using the on admission evaluation score 石田亮1), 赤木晋介2), 西出康晴3), 塩津昭子3), 徳増裕宣1), 橋本徹3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1358-1358, 2022.

---

	P628-25-AM. The effect that familiarity gives to name similarity and the appearance similarity on pharmaceutical products 村高紫野1), 向井淳治1), 裏山悠哉1), 堀口悠太1), 西村真央1), 木村実央1), 山本裕聖1), 奥田広志1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1359-1359, 2022.

---

	P629-24-PM. It is the examination about the effect by the withdrawal system introduction for oral medicine 1st 田村研太郎1), 橋本光生1), 近藤智幸1), 簑島弓未子1), 増渕幸二1), 鈴木正樹1), 多地貴則1), 斉藤芳敬1), 設楽愛美1), 榎本尚哉1), 荻野健吾1), 武田知佳1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1360-1360, 2022.

---

	P630-25-AM. The system maintenance and the medical economical effect that was obtained on improvement in doubt inquiry rate 松本貴行1), 立石裕樹1), 池田都1), 永田理佳1), 矢野洋平1), 山下大貴1), 宮津大輔1), 田中博和1), 井上幸子1), 渡邊裕之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1361-1361, 2022.

---

	P631-24-PM. Preventive measures against administration day mistake of the peg filgrastim subcutaneous injection in our hospital 西村真央1), 向井淳治1), 小竹優希1), 坂本竜平1), 竹原涼子1), 上田真隆1), 山田佳菜子1), 奥田広志1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1362-1362, 2022.

---

	P632-25-AM. Investigation of suspension pH when we suspended multiple drugs by simple suspension at the same time 大野峻1), 田辺優斗1), 平塚優稀佳1), 武田元樹1), 菊池健1), 鶴山辰1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1363-1363, 2022.

---

	P633-24-PM. The effect that the improvement of drug duties by the pharmacist increase of the staff gives to a medical safe clinical index 松尾裕彰1), 柴田ゆうか1), 佐藤智人1), 泉谷悟2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1364-1364, 2022.

---

	P634-25-AM. Efforts to incident recurrent prevention with the overdose of the heparin Na preparation 青砥孝道1), 陣野大輔1), 小久保博子2), 大塚幹夫2), 黒田純子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1365-1365, 2022.

---

P635-24-PM. One patient whom an allergic symptom developed in with optical resolution pharmaceutical products and the racemic body pharmaceutical products including the same ingredient: Consideration from questionary survey and package insert mention information 市川慶1), 内田裕之1), 満田正樹1), 河井良智1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1366-1366, 2022.

---

	P636-25-AM. Examination about the quantity of upper limit setting of the pediatric dose for the purpose of the overdose prevention 山本崇1), 加藤果林1,2), 松村由美1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1367-1367, 2022.

---

	P637-24-PM. Change (competitive review with 2019) of the doubt inquiry contents in the outside Parliament prescription 高取俊和1), 前田貴人1), 千田純子1), 東山千央1), 岡本知久1), 沖田健太郎1), 竹田克明1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1368-1368, 2022.

---

	P638-25-AM. Investigation about the duties of the pharmacist in the patients support center 竹村充代1), 本名房美1), 高田史1), 勝浦正人1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1369-1369, 2022.

---

	P639-24-PM. Efforts for the injectable potassium preparation proper use from the central veins route in the regular hospital and the evaluation 中山典幸1,2), 八島秀明1), 金田亜季子1), 阿部正樹1), 荒木拓也1), 小松康宏2), 山本康次郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1370-1370, 2022.

---

	P640-25-AM. The personality test Myers-Briggs Type Indicator workshop for the pharmacy student and the outcome 河添仁1,2), 大里洋一3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1371-1371, 2022.

---

	P641-24-PM. Knowledge degree of achievement of the palliative care domain before and after the hospital business training for the pharmacy school student in Miyagi, investigation of the understanding degree 大内竜介1,2), 薄井健介1,2), 渡邊卓嗣1,2), 岡田浩司1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1372-1372, 2022.

---

	P642-25-AM. The effect that the practice about the line design of the injection drug administration gives for the understanding of the pharmacy school business trainee 内海明香里1), 石川雅之1,2), 大久保正人1), 内田雅士1,2), 鈴木貴明1,2), 石井伊都子1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1373-1373, 2022.

---

	P643-24-PM. Attitude survey of the business trainee about the perinatal medical care 曽我部直美1), 植松和子2), 岩佐千尋3), 小泉寿子4), 間宮伸幸5), 楠見彰宏5), 田中嘉一3), 菅野浩4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1374-1374, 2022.

---

	P644-25-AM. Efforts and evaluation for the maintenance of the quality of will and the training of the business trainee in the corona evil 岩切智美1), 関屋裕史1), 大野梨絵1), 畑中真理1), 奥村学2), 保田和哉1), 吉川直樹1), 田崎智也1), 竹島秀美1), 岩田円夏1), 池田龍二1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1375-1375, 2022.

---

	P645-24-PM. Examination of the education effect by the on-line multi-type of job cooperation education in the business training 林太祐1), 安武夫3), 今井亮4), 伊勢雄也1), 横堀將司2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1376-1376, 2022.

---

	P646-25-AM. Approach to the duties improvement in upbringing duties of the new face pharmacist 花房伸幸1), 甲元大樹1), 平良奈々1), 山本水緒1), 小池彩子1), 大道淳二1), 森英樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1377-1377, 2022.

---

	P647-24-PM. The preliminary study of the pneumonia level using the pocket echo for pharmacy students and the attitude survey 庄田卓矢1), 徳永仁1), 吉岡日沙子1), 皆良田吉晶1), 園田純一郎1), 興梠靖幸2), 緒方賢次2), 高村徳人2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1378-1378, 2022.

---

	P648-25-AM. Production of the video teaching materials about the physical assessment training utilizing patients simulator and the synthetic sound 皆良田吉晶1), 徳永仁1), 庄田卓矢1), 吉岡日沙子1), 園田純一郎1), 興梠靖幸2), 緒方賢次2), 高村徳人2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1379-1379, 2022.

---

	P649-24-PM. Student attitude survey about the injection maneuver in the learning before business true lessons 廣澤伊織1), 山本健1), 森元能仁1), 神林弾1), 渡部一宏1), 廣原正宜1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1380-1380, 2022.

---

	P651-24-PM. Efforts for the employment of hospital pharmacist power reinforcement for securing of continuous human resources 田村亮1), 平野達也2), 鎌田里紗1), 藤井尚子1), 木下恵1), 奥吉博之2), 山岡健太1), 杉上裕3), 橋田亨1), 室井延之1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1381-1381, 2022.

---

	P652-25-AM. Efforts of the pharmacy business training in our hospital in the corona evil 村田翔1), 神田純1), 芳山健太郎1), 増尾正則1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1382-1382, 2022.

---

	P654-25-AM. Examination of the hospital training program for drugstore pharmacists 猪田宏美1), 久保和子1), 川西秀明1), 村川公央1), 座間味義人1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1383-1383, 2022.

---

	P655-24-PM. Enforcement example of the pharmacist training specialized in local pharmacy care in the Kurashiki center Hospital 徳田衡紀1), 仁熊宏樹1), 石原泰子1), 菅直恵1), 西田麻以1), 赤木晋介1), 高柳和伸1), 河田英之2), 鶴海宏之3), 難波安紀美4), 西宮祐輔5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1384-1384, 2022.

---

	P656-25-AM. Efforts and problem of the local pharmacy care training of the small and medium size hospital 津曲恭一1), 松田絵理菜2), 上原智博1), 鈴木寛人1), 東盛裕里1), 長谷部歩1), 平田亮介1), 千田祥子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1385-1385, 2022.

---

	P657-24-PM. Generalization of the Tokyo University of Science academic D tailor training program optimizing prescription 小茂田昌代1,2,3), 宮埼美子3,4), 山本美智子5), 宮崎智2), 高橋秀依2), 西川元也2,3), 斎藤顕宜2,3), 和田毅2), 嶋田修治2), 青山隆夫2,3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1386-1386, 2022.

---

	P658-25-AM. Questionary survey about the workshop holding situation in the corona evil and the future held pattern 大野奈子1), 久保萌美1), 喜多力1), 真井雄規1), 越野早紀1), 金澤沙衣1), 能登数馬2), 田中悠季1), 三本松泰孝1), 佐藤弘康1), 田村広志1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1387-1387, 2022.

---

	P659-24-PM. Examination about the significance of the hospital training by the drugstore pharmacist 渡邉尚也1), 猪田宏美2), 長谷川佳孝3), 月岡良太3), 村川公央2), 座間味義人2), 大石美也3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1388-1388, 2022.

---

	P660-25-AM. Construction and evaluation of the postgraduate training curriculum aiming at pharmacist upbringing to practice team approach in medical care 宮崎俊明1), 筒井由佳1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1389-1389, 2022.

---

	P661-24-PM. Effect on cooperation by the intern acceptance of the pharmacist specialized in local pharmacy care 高子優子1), 吉岡睦展1), 土田裕貴1), 細見真世1), 澁谷奈穂1), 若松雄太1), 石津智司1), 近藤万友美1), 森田聡子1), 西山祐美1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1390-1390, 2022.

---

	P662-25-AM. Investigation of the expectation to the managerial class that we obtained from the non expert skill training for eyes for accession 4-6 years 新井亘1), 土屋裕伴1), 増田裕一2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1391-1391, 2022.

---

	P663-24-PM. Consideration ... from efforts - questionnaire results of the health insurance pharmacy pharmacist acceptance in our hospital 高取秀人1), 田中昭洋1), 村富裕貴1), 大西翔太1), 後藤卓也1), 萱野勇一郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1392-1392, 2022.

---

	P664-25-AM. Aim at the attractive acceptance system for introduction process of the pharmacist resident system and result - student; and ... 小池博文1), 川邉桂1), 畠山成寛1), 山本幸二郎1), 佐橋幸子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1393-1393, 2022.

---

	P665-24-PM. PPT activity in our hospital for 4 years 手塚博文1), 川上健司1), 久保田靖子1), 畠山令1), 小林ゆみ1), 高橋佳暉1), 紅野友美子1), 長田真一1), 山本輝代1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1394-1394, 2022.

---

	P666-25-AM. Investigation, analysis about the sale cancellation factor of the ethical drug 伊藤麻結1), 若林和貴1), 矢野瑞紀1), 馬場安里1), 高砂美和子1), 幸田恭治1), 北原隆志1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1395-1395, 2022.

---

	P667-24-PM. Relation of the pharmacist by the osteoporotic liaison service in the secondary fracture prevention after the fragile bone fracture 藤井芳範1), 鬼窪利英1), 小平博之2), 櫻井利康3), 藤澤太一4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1396-1396, 2022.

---

	P668-25-AM. We analyze a factor of the instructions unobservance about the stopping medicine during preoperation 長崎裕也1), 赤嶺聡彦1), 冨澤淳1), 新井万理子1), 厚田幸一郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1397-1397, 2022.

---

	P669-24-PM. Making of the medication adherence guidelines (NICE CG76) Japanese edition 藤宮龍祥1), 川口崇1), 上田彩2), 前田幹広3), 川上和宜4), 増田純一5), 井上岳6), 添石遼平7), 大原里佳8), 益山光一8) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1398-1398, 2022.

---

	P670-25-AM. Medication support tool development and inspection of the usefulness 三枝美和1,2), 澤井珠紀1), 岩下亜希子1), 村田真弓1), 坪井彩香1), 岩崎剛士1), 井原摂子1), 青島広明1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1399-1399, 2022.

---

	P671-24-PM. Result by the balun strike scorecard utilization of 2021 in the Yokohama General Hospital pharmacy 鯉淵寛之1), 稲垣和幸1), 内田仁樹1), 井上純樹1), 倉田武徳1), 廣瀬直樹1), 佐村優1), 谷川浩司1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1400-1400, 2022.

---

P672-25-AM. Consideration - using the current situation findings of examination - Japanese Society of Hospital Pharmacists 2021 hospital pharmacy gate about the current situation and the problem in the drug section duties of the small and medium size hospital 佐村優1), 瀧祐介1), 横山敏紀1), 上野山周雄1), 遠藤武弘1), 大神修一1), 宮川哲也1), 吉田明弘1), 荒川隆之1), 濱浦睦雄1), 筒井由佳1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1401-1401, 2022.

---

	IP-01. Attenuation of cardiac pathological alterations in sulfotransferase 1a1-deficient mice with chronic kidney failure through decreased indoxyl sulfate accumulation Aina Nishigaki1), Yuki Narita1,2), Yuichiro Arima3), Kenichi Tsujita4), Hirofumi Jono1,2), Hideyuki Saito1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1402-1403, 2022.

---

	IP-02. Photoisomerization of Sulindac and Ozagrel Hydrochloride by Vitamin B2 Catalyst Under Visible Light Irradiation Mayuko Suga1), Kosho Makino1), Hidetsugu Tabata2), Tetsuta Oshitari2), Hideaki Natsugari3), Hideyo Takahashi1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1404-1405, 2022.

---

IP-03. Simultaneous quantification of remimazolam and its carboxylic acid metabolite in human plasma using high-performance liquid chromatography-tandem mass spectrometry Kenta Nakaya1), Satoshi Ueshima1), Mayu Kawamura1), Daiki Hira1,2), Yu Matsuura3), Tomonobu Okano1), Kaneyuki Kawamae3), Mikio Kakumoto1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1406-1407, 2022.

---

IP-04. The precision of area under the concentration-time curve of vancomycin by Bayesian approach using creatinine-based equations of estimated kidney function in bedridden elderly Japanese patients Akihiro Sonoda1), Yoshitaka Iwashita1), Yukina Takada1), Ryu Hamazono1), Masahiro Kambori1), Nako Nagashima1), Sho Shibata1), Chisa Morinaga1), Mayo Kodama1), Kazuhisa Ishida1), Hiroshi Imamura2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1408-1409, 2022.

---

	IP-05. Development and Evaluation of Renal Function Monitoring for Vancomycin use Hee Jung Kim1), Eunjin Lee1), Eunkyeong Choi1), Nam kyung Je2), Sung Jin Bae1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1410-1411, 2022.

---

IP-07. Circulating miR-320a-3p and miR-483-5p level associated with pharmacokinetic-pharmacodynamic profiles of rivaroxaban Hanxu Zhang1,2), Zhuo Zhang1), Zhiyan Liu1), Guangyan Mu1), Qiufen Xie1), Shuang Zhou1,2), Zhe Wang1), Yu Cao3), Yunlong Tan4), Xiaohua Wei5), Dongdong Yuan6), Qian Xiang1), Yimin Cui1,2,7) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1412-1413, 2022.

---

	IP-08. Effect of Serum Erythropoietin Concentration on Chemotherapy Induced Peripheral Neuropathy Caused by Weekly Paclitaxel Therapy Chiyomi Okamoto1), Yuichiro Kurone1), Aiko Okuda2), Yoichiro Eimura2), Saori Nakagawa3), Naoto Hirata1), Shin Ohta1), Sadahiko Shimoeda1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1414-1415, 2022.

---

	IP-09. Analysis of Pharmacist Intervention Status for Contraindications of Concomitant Drugs through Drug Utilization Review Sang Hee Lee1), Yu Jeong Lee1), Myoung joo Kim1), Da ei Jung1), Nam kyung Je2), Sung Jin Bae1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1416-1417, 2022.

---

	IP-10. Evaluation of the Effectiveness of Atropine Administration for Prevention of Acute Cholinergic Syndrome Associated with Irinotecan You-Ock Choi1), Eun-Ah Jo1), So-Hee Lee1), Ae-Ryoung Park1), Jeong-Yi Yoon1), Jin-Suk Kang1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1418-1419, 2022.

---

	IP-12. The Association Between the Use of Antibiotics and the Risk of Rash in Children with Infectious Mononucleosis : A Multicenter, Retrospective Cohort Study Jiaxing Zhang1), Juan Xie1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1420-1420, 2022.

---

	IP-13. Association of Orexin Receptor Antagonists with Falls during Hospitalization Rintaro Sogawa1), Akiko Emoto1), Yuki Miyamoto1), Misako Yukawa1), Chisato Shimanoe1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1421-1421, 2022.

---

IP-14. The risk of acute kidney injury following prescription of proton pump inhibitor and macrolide antibiotic use Keiko Ikuta1), Shunsaku Nakagawa1), Chinami Yamawaki1), Kotaro Itohara1), Daiki Hira1), Satoshi Imai1), Atsushi Yonezawa1), Takayuki Nakagawa1), Minoru Sakuragi2,3), Noriaki Sato2,3), Eiichiro Uchino2,3), Motoko Yanagita2), Tomohiro Terada1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1422-1423, 2022.

---

	IP-15. Analysis of adverse events with nintedanib using the Japanese Adverse Event Spontaneous Reporting Database Masaki Fujiwara1,2), Mayako Uchida3), Yoshihiro Uesawa4), Tadashi Shimizu2), Hiroaki Ikesue1), Nobuyuki Muroi1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1424-1425, 2022.

---

	IP-16. Evaluation of Cardiac Adverse Events Associated with Carfilzomib Using a Japanese Real-World Database Shuhei Nakao1), Mayako Uchida2), Aya Satoki1), Kenya Okamoto1), Yoshihiro Uesawa3), Ken-ichi Kiyomiya1), Tadashi Shimizu1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1426-1426, 2022.

---

	IP-17. Intestinal microbiome associated with immune-related adverse events for patients treated with anti-PD-L1 inhibitors, a real-word study Wenhui Liu1,2), Fang Ma3), Bao Sun1,2), Yiping Liu1,2), Zhiying Luo1,2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1427-1428, 2022.

---

	IP-18. Pharmaceutical and Medical Device Act and Traceability of Pharmaceuticals for patient safety in Japan Takao Orii1,2), Koichi Uemura3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1429-1429, 2022.

---

	IP-19. Comprehensive analysis of ixazomib-induced adverse events using the Japanese pharmacovigilance database Kenta Yamaoka1,2), Masaki Fujiwara1,2), Mayako Uchida3), Yoshihiro Uesawa4), Tadashi Shimizu2), Nobuyuki Muroi1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1430-1431, 2022.

---

	MS1. It is ... mainly on a point of invention ... age changes that you should be careful about of nourishment management and the Chinese medicine combination aiming at healthy life expectancy extension 水野英彰 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1438-1438, 2022.

---

	MS2-1. Way - of the drug choice that information sharing with there being the initial treatment for acute heart failure how, and there being it took important - condition of a patient into consideration 佐藤直樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1438-1438, 2022.

---

	MS2-2. New age of the SIADH 森建文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1438-1438, 2022.

---

	MS3. Cancer chemotherapy and hyperuricaemia 山内高弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1439-1439, 2022.

---

	MS4. Supporting player in the sepsis-related DIC practice 安藝敬生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1439-1439, 2022.

---

	MS5-1. Benefit risk of the JAK inhibitor in the rheumatoid arthritis 岡田正人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1440-1440, 2022.

---

	MS5-2. Efforts ... of role - our hospital of the pharmacist by the team approach in medical care for patients with rheumatic disease 松原司, 舟橋惠子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1440-1440, 2022.

---

	MS6. It is ... for ... TS-1 proper use with the appropriate renal function index at dose adjustment for the decreased renal function patients 今村知世 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1441-1441, 2022.

---

	MS7. History of rectal cancer treatment and the latest therapy 野澤宏彰 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1441-1441, 2022.

---

	MS8. Lung cancer perioperative treatment strategy in the new era of immunotherapy - Shin tecentriq lung cancer postoperative adjuvant therapy - 渡部聡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1442-1442, 2022.

---

	MS9. ... which we think about in the case of ... cancer medical therapy to want to become a pharmacist of the interpersonal anti-thing having no restrictions 小井土啓一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1442-1442, 2022.

---

	MS10. Issue of destruction ... of medical expenses and the preparation Residual medicine becoming evolution and pit - remarkable rise of the anticancer medicine 宇佐美英績 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1443-1443, 2022.

---

	MS11-1. Appearance in ... cancer treatment cares to join society together with ... patients 野澤桂子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1443-1443, 2022.

---

	MS11-2. Symptom management ... to work on by dermatopathy ... patients caused by cancer medical therapy-centered team approach in medical care 山崎直也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1443-1443, 2022.

---

	MS12. It is ... from basic ... acute phase of the fluid therapy to think about from protein to elderly people 杉浦伸一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1444-1444, 2022.

---

	MS13-1. In utilizing TDM for infection practice support; is ... through the use of important thing - LM1010 塩田有史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1444-1444, 2022.

---

	MS13-2. Re: It is ... from introduction to operation in TDM life - community care mixture type Hospital to begin with zero 畑本慶太 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1444-1444, 2022.

---

	MS14. About the anti-GD2 antibody Unituxin, a new treatment for neuroblastoma 原純一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1445-1445, 2022.

---

	MS15-1. The cancer cachexia treatment that is full of misunderstanding 尾阪将人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1445-1445, 2022.

---

	MS15-2. Pharmacist intervention to begin with "we have no appetite" 中村匡志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1445-1445, 2022.

---

	MS16. Safe medical therapy and pain control of elderly people 小島太郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1446-1446, 2022.

---

	MS17. Medical treatment in the IBD practice 八木周 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1446-1446, 2022.

---

	MS18. Importance ... of the irAE management ... patients follow in the immune checkpoint inhibitor 駄賀晴子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1447-1447, 2022.

---

	MS19. Including super practical approach - delirium risk measures for the sleeplessness of the inpatient - 井上真一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1447-1447, 2022.

---

	Importance of the HBV reactivation risk management 日本医療薬学会 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1448-1448, 2022.

---

	MS21. A 2022 medical service fees revision and the trend of the pharmaceutical policy: Significance and introduction example of the Biosimilar promotion 川上純一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1449-1449, 2022.

---

	MS22. personalized medicine for PLWH 石原正志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1449-1449, 2022.

---

	MS23. Algorithmic utilization - corresponding to the role - oral & transluminal administration of the pharmacist for the eating deglutition functional decline 倉田なおみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1450-1450, 2022.

---

	MS24. Trend ... of treatment - these days of the malignant lymphoma 塚本憲史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1450-1450, 2022.

---

	MS25. It is ... based on new development ... new antiemetic drug and PBPM of the antiemesis therapy in the cancer medical therapy 橋本直弥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1451-1451, 2022.

---

	MS26. The medical care that is SDGs which big data and science open up 石澤啓介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1451-1451, 2022.

---

	MS27. It is ... for a case in analysis in ... GERD about a cost effectiveness evaluation of the medicine 五十嵐中 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1452-1452, 2022.

---

	MS28-1. We data-process it with knowledge management, the joint ownership about pharmaceutical products done right now 神崎浩孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1452-1452, 2022.

---

	MS28-2. It is ... mainly on introduction - data management of the tip drug information management mechanism, search mechanism 佐古卓人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1452-1452, 2022.

---

	YPL. Of the clinical pharmacy is the message to 12 years after this 三浦昌朋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1-1, 2023.

---

	PL. The activity of the Japanese cure association and future problem 山本康次郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2-2, 2023.

---

	SL1. The pharmacist who plays an active part in the society which greatly undergoes a complete change 大久保正人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 3-3, 2023.

---

	SL2. Challenge of the molecular target therapy for - CML to cure leukemia with oral medication 高橋直人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 4-4, 2023.

---

	SL3. Quantitative prediction and clinical studies of transporter-mediated drug interactions 楠原洋之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 5-5, 2023.

---

	SL4. Personalized medicine of the psychiatry domain 古郡規雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 6-6, 2023.

---

	EL. A role and evidence of medical herbal medicinal products in the cancer supportive care 元雄良治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 7-7, 2023.

---

	Receiving a prize -1. Clinical pharmacy study on individual differences of drug interactions 大谷壽一1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 8-8, 2023.

---

	Receiving a prize -2. Reverse translational study aiming at drug body change control and individual optimization of the medical therapy 崔吉道 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 9-9, 2023.

---

	Receiving a prize -3. Study on outcome evaluation of clinical drug duties by the multi-type of job collaboration in the cancer medical therapy 池末裕明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 10-10, 2023.

---

	Receiving a prize -4. Practice of the clinical pharmacy study that pointed to improvement in patients outcome by the antimicrobial proper use promotion 岡田直人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 11-11, 2023.

---

	Receiving a prize -5. Clinical studies to offer optimal medical therapy to the patients with HIV infection 日笠真一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 12-12, 2023.

---

	Receiving a prize -6. Clinical reactions of drugs study on Drug-drug/Drug-condition interaction based on PK-PD theory and the data science 八木達也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 13-13, 2023.

---

	PA-1. Pharmacometrics study aiming at the proper use of the immunosuppressive drug in the organ transplantation 糸原光太郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 14-14, 2023.

---

	PA-2. Study on functional role of the glial type glutamic acid transporter in the feeling movement of the mental disorder, the cognitive function 内田美月1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 15-15, 2023.

---

	PA-3. Study on nucleic acid pharmaceutical products development that assumed the change control in cells a base 梅村圭祐 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 16-16, 2023.

---

	PA-4. Examination of the economic load in Japanese medical facilities by the drug resistance 莊司智和 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 17-17, 2023.

---

	PA-5. Clinical reactions of drugs study based on blood kinetic analysis of tramadol in patients with head and neck cancer and the optical isomer of the demethylation metabolite 鈴木光路 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 18-18, 2023.

---

	PA-6. Examination about the factor associated with the pancreatic cancer cachexia 鈴木秀隆1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 19-19, 2023.

---

	PA-7. Contribution to medical security by analysis of the Medication errors and the inspection 鈴木亮平 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 20-20, 2023.

---

	PA-8. Construction of the effective rating system of the therapeutic drug based on the change out of the feces using the Clostridioides difficile infection mouse model 田代渉 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 21-21, 2023.

---

	PA-9. Study on effectiveness of the medical therapy in the digestive organ surgery domain and safety 中澤孝文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 22-22, 2023.

---

	PA-10. Construction of the type of cancer cross-sectional registry of the use of immune checkpoint inhibitor patients and study about the prediction of the onset of effect of treatment, immunity-related adverse event 松金良祐 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 23-23, 2023.

---

	A special plan symposium. It is the term of the organizer for the development expansion of the medical technology for Precision dosing 福土将秀, 新岡丈典 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 25-25, 2023.

---

	SP-1. The development of the high-throughput assay of blood drug concentration using the LC-MS/MS and clinical implementation 菊地正史1,2, 眞野成康1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 26-26, 2023.

---

	SP-2. Development of the individualization administration plan based on the PGx analysis and clinical implementation 平大樹, 杉本充弘, 寺田智祐 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 27-27, 2023.

---

	SP-3. Pay the attention to search - CYP3A of the new PK-related biomarker and OATP1B; and ... 炭本隆宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 28-28, 2023.

---

	SP-4. Establishment of the individualization administration that assumed a PK regulations factor an index of anticancer medicine 今村知世 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 29-29, 2023.

---

	SP-5. Development of the individualization administration plan of antibody pharmaceutical products 福土将秀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 30-30, 2023.

---

	International Symposium 1. Messages for Pharmaceutical Health Care and Sciences in the Next Decade 1 Ikuko Yano, Yasuo Takeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 31-31, 2023.

---

	IS01-1. The development and practice of pharmacist-managed clinic in Chinese hospitals Bo Zhang Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 32-32, 2023.

---

	IS01-2. Introduction of Certified Pharmacy Specialists in South Korea Myung Sook Min Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 33-33, 2023.

---

	IS01-3. Comparing the Effectiveness and Safety Profiles of Anticoagulants in Thai Patients with Cancer-Associated Thrombosis : Insights from a Real-World Study Suphat Subongkot1, Kirati Kengkla1,2, Warunsuda Sripakdee3, Surakit Nathisuwan4, Pirun Saelue5, Aumkhae Sookprasert6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 34-34, 2023.

---

	IS01-4. The trajectory of hospital pharmacists and their expected future Yasuo Takeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 35-35, 2023.

---

	International Symposium 2. Messages for Pharmaceutical Health Care and Sciences in the Next Decade 2 Ikuko Yano, Yasuo Takeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 36-36, 2023.

---

	IS02-1. Population pharmacokinetics of vancomycin for special populations Yuko Shimamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 37-37, 2023.

---

	IS02-2. Clinical application of steroid-sparing strategies in cancer patients receiving carboplatin-based chemotherapy Toshinobu Hayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 38-38, 2023.

---

	IS02-3. Leadership of Pharmacists in Cancer Chemotherapy Hirotoshi Iihara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 39-39, 2023.

---

	IS02-4. Effects of proton pump inhibitor use on the risk of acute kidney injury Shunsaku Nakagawa, Keiko Ikuta, Tomohiro Terada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 40-40, 2023.

---

	IS02-5. Critical Care Pharmacists in Japan Mikihiro Maeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 41-41, 2023.

---

Pharmacist Certifying Council plan symposium specialized in a cancer. Term of suggestion - organizer whom one step stepped into from effectively utilizing it and the suit of patients of point - clinical image examination of the pharmaceutical intervention of the pharmacist specialized in a cancer 池田龍二, 河原昌美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 42-42, 2023.

---

	CP1-1. Purpose explanation and the authorized situation of 2022 池田龍二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 43-43, 2023.

---

	CP1-2. A form to be handed down and the point where you should be careful about 佐野元彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 44-44, 2023.

---

	CP1-3. Case ... avoiding the suggestion of breast cancer - cardiac activity evaluation and accidental drug interactions 近森綾子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 45-45, 2023.

---

	CP1-4. Approach ... in consideration of the characteristic of the stomach cancer - cancer species 堀川美帆 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 46-46, 2023.

---

	CP1-5. Correspondence ... to colon cancer - special population 松谷直樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 47-47, 2023.

---

	CP1-6. Correspondence ... to lung cancer - drug-related QT prolonged 平塚公己 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 48-48, 2023.

---

	CP1-7. Approach as the master of specialized pharmacy to cancer medical therapy to diversify 河原昌美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 49-49, 2023.

---

	Clinical studies promotion Committee plan symposium. Utilize excellent ability for study and high specialty, and improve patients outcome; is the term of the organizer 山口浩明, 鈴木小夜 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 50-50, 2023.

---

	CP2-1. Upbringing of the pharmacist with ability for study and the specialty to improve patients outcome 山口浩明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 51-51, 2023.

---

	CP2-2. Efforts for the evidence construction in the nourishment domain 稲毛あずさ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 52-52, 2023.

---

	CP2-3. Pharmacist-led efforts and outcome evaluation in the antimicrobial proper use 宇田篤史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 53-53, 2023.

---

	CP2-4. For patients outcome improvement in the cancer medical therapy 那須いずみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 54-54, 2023.

---

	CP2-5. By power of the medical big data and machine learning, we aim at the patients outcome improvement! 今井俊吾 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 55-55, 2023.

---

	A medical therapy intensive lecture plan, administration subcommittee plan symposium. Let's become a specialist in ... medical therapy to diversify for a high quality specialty pharmacist; is the term of ... organizer 樋口則英, 鈴木貴明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 56-56, 2023.

---

	CP3-1. Drug administration design of the hemocatharsis therapy to understand by clearance 山本武人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 57-57, 2023.

---

	CP3-2. Medical therapy - RCT and RWE - of the attention lack, hyperkinesis symptom (ADHD) 佐々木剛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 58-58, 2023.

---

	CP3-3. Pharmaceutical care of the pharmacist specialized in the medical therapy for the delicate health patients 小川敦1,2, 石澤啓介1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 59-59, 2023.

---

	CP3-4. How do you write it? It is ... with the point of "the case report with the pharmaceutical intervention" from the situation as ... applicant, the leader 八木達也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 60-60, 2023.

---

	Pharmacist Certifying Council plan symposium specialized in local pharmacy care. Term of the present and the future organizer of the pharmacist specialized in local pharmacy care 豊見敦, 宮崎長一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 61-61, 2023.

---

	CP4-1. The improvement of the pharmacist in nature and problem of that purpose 太田美紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 62-62, 2023.

---

	CP4-2. Acquirement of the high specialty to aim at from study throughout the life 高松登 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 63-63, 2023.

---

	CP4-3. - to practice pharmacist training method - oneself specialized in local pharmacy care in the Kanazawa University Hospital, and to learn, and to be brought up together 原祐輔 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 64-64, 2023.

---

	CP4-4. About the present after the pharmacist (cancer) specialized in local pharmacy care provisional authorized acquisition and future directionality 岩崎章吾 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 65-65, 2023.

---

	CP4-5. Efforts for the present and the future after the provisional authorized acquisition 松浦綾子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 66-66, 2023.

---

	CP4-6. About the approach in consciousness and the drugstore necessary for improvement of the local pharmacy care from the position of - drugstore pharmacist 松本由加里 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 67-67, 2023.

---

	Symposium 1. Term of the directional organizer of the pharmacist after this concerned with the infection domain for 12 years 北原隆志, 村木優一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 68-68, 2023.

---

	3-1-S01-1. It is directional ... of the clinical duties for 12 years task shift/share ... in the infection domain after this 足立参希1, 田中鉄也1, 中野祐樹2, 小武和正3, 梅永真弓1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 69-69, 2023.

---

	3-1-S01-2. It is the directionality of the clinical pharmacy study in the infection domain for 12 years after this 岡田直人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 70-70, 2023.

---

	3-1-S01-3. It is directionality of the specialized pharmacist education in the infection domain for 12 years after this 田中昌代 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 71-71, 2023.

---

	3-1-S01-4. It is directionality of the before graduation education in the infection domain for 12 years after this 村木優一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 72-72, 2023.

---

	Symposium 2. Hospital pharmacist, term of the sustainable way of working, research activities and carrier vision organizer of the female pharmacist 祝千佳子, 河添仁 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 73-73, 2023.

---

	3-2-S02-1. Contribution to society wants to extremely do a study from a university hospital pharmacist to the world of the academia 祝千佳子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 74-74, 2023.

---

	3-2-S02-2. My career path which is formed in the connection with people: From hospital pharmacist to a teacher 鈴木景子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 75-75, 2023.

---

	3-2-S02-3. To walk the carrier which can realize a quality of oneself 流石学1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 76-76, 2023.

---

	3-2-S02-4. How to make workplace which both an individual and the organization make a sustainable way of working 大西友美子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 77-77, 2023.

---

	3-2-S02-5. The problem of the healthcare worker judging from hospital management and the future prospects (as MBA holder) 大里洋一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 78-78, 2023.

---

	Symposium 3. Term of the new evidence organizer to "the exposure measures instruction to patient for foreign tumor chemotherapy practice charges" 野村久祥, 中山季昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 79-79, 2023.

---

	3-2-S03-1. Purpose explanation of this symposium 野村久祥1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 80-80, 2023.

---

	3-2-S03-2. Pharmacist duties and exposure instruction of the foreign chemotherapy room 橋口宏司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 81-81, 2023.

---

	3-2-S03-3. Practice of the occupational exposure measures and medication counseling for the oral anticancer medicine 小室雅人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 82-82, 2023.

---

	3-2-S03-4. About an excretion period of cyclophosphamide included in the sweat of the patients who received high-dose cyclophosphamide therapy in the hematopoietic stem cell transplantation pre-treatment 谷川大夢1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 83-83, 2023.

---

	3-2-S03-5. Risk communication about explanation of anticancer medicine second exposure measures 宮澤真帆1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 84-84, 2023.

---

	3-2-S03-6. Exposure to exposure measures measures ... to roll up the Next stage - whole society 中山季昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 85-85, 2023.

---

	Symposium 4. Term of the practice organizer of the medical therapy that assumed a clinical pharmacy study to support community medical care a base 吉山友二, 高橋寛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 86-86, 2023.

---

	3-2-S04-1. Practice and clinical pharmacy of the community medical care 吉山友二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 87-87, 2023.

---

	3-2-S04-2. The training of the medical care person that fixes the eyes on future society and area, and ties a variety of places and people, and can play an active part 大久保正人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 88-88, 2023.

---

	3-2-S04-3. Local pharmacy care and clinical pharmacy study 山本康次郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 89-89, 2023.

---

	3-2-S04-4. Practice of the pharmacy management in the community medical care 山本雄一郎1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 90-90, 2023.

---

	3-2-S04-5. With - pharmacy education model core curriculum revision to think about the way of the clinical pharmacy education in the community medical care near at hand - 根岸健一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 91-91, 2023.

---

	3-2-S04-6. Practice of the health support drugstore bought for community medical care 高橋寛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 92-92, 2023.

---

	Symposium 5. Term of significance - organizer whom ... "cooperation that a DI room develops" to think about new development now of drug information room duties results in 若林進, 大幸淳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 93-93, 2023.

---

	3-3-S05-1. The significance that "the cooperation that a DI room presents" brings 若林進 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 94-94, 2023.

---

	3-3-S05-2. The current situation and DI cooperation of DI duties in our hospital 大竹三保 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 95-95, 2023.

---

	3-3-S05-3. DI cooperation to think about from the hospital of the small and medium size scale 大庭理寛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 96-96, 2023.

---

	3-3-S05-4. A person in charge of drug information room be made in a person in charge of ward 飯村諒 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 97-97, 2023.

---

	3-3-S05-5. Is the DI person in charge lonely? We think about the possibility of the DI duties change by the cooperation 大幸淳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 98-98, 2023.

---

	Symposium 6. Term of the practice lecture organizer that intellect profits and manages drug information 後藤伸之, 高橋一栄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 99-99, 2023.

---

	3-3-S06-1. We will estimate the basic information of pharmaceutical products as a package insert using interview form 金井紀仁 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 100-100, 2023.

---

	3-3-S06-2. Let's gather and evaluate information on medicines for special populations - Taking pregnant and breastfeeding women as an example - 小原拓1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 101-101, 2023.

---

	3-3-S06-3. We collect the information about the pharmaceutical products of nonrecognition, the off-label use and will evaluate it scientifically 鴫田江理嘉, 冨田隆志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 102-102, 2023.

---

	3-3-S06-4. We evaluate safe information using pharmaceutical products risk management plan and will take safety measures 林昌洋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 103-103, 2023.

---

	3-3-S06-5. We collect the information of the real world data about pharmaceutical products and will evaluate it 永田健一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 104-104, 2023.

---

	Symposium 7. It is the term of - organizer with - that purpose to think about the second use of data 折井孝男, 高田敦史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 105-105, 2023.

---

	3-3-S07-1. About the second use of medical data 飯村康夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 106-106, 2023.

---

	3-3-S07-2. Efforts of the standardization necessary for use of data second through MID-NET(R) 岸塲真理1, 大田有佳里1, 村山一茂2, 宇山佳明2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 107-107, 2023.

---

	3-3-S07-3. Including invention of unevenly distributed - collection of names (poking each other) of the hospital pharmacist thinking from the second use of public data - 外山聡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 108-108, 2023.

---

	3-3-S07-4. Problem - to feel where the electronic prescription information can use the back to from - setting and operation 宮森伸一, 北本真一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 109-109, 2023.

---

	3-3-S07-5. It is ... from the viewpoint of the staff of ... secretariat through the current situation investigation of the hospital pharmacy gate 稲富海帆 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 110-110, 2023.

---

	Symposium 8. A beginning is the term of ... organizer whom we advance, and the master of ... way intervenes in in this way from the first time of the interview a game in the first time 守内匡, 寺沢匡史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 111-111, 2023.

---

	3-4-S08-1. A beginning is a merit of the interview enforcement a game in the first time 守内匡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 112-112, 2023.

---

	3-4-S08-2. Information cooperation with hospitalization support and the ward pharmacist of the pharmacist in the perioperative center 阿部猛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 113-113, 2023.

---

	3-4-S08-3. The specialist in kidney disease medical therapy checks here in the first time! 浦田元樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 114-114, 2023.

---

	3-4-S08-4. The specialist in polypharmacy measures checks here in the first time! 武藤浩司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 115-115, 2023.

---

	3-4-S08-5. Art of how to write initial interview record "handed down" 寺沢匡史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 116-116, 2023.

---

	Symposium 9. Term of the organizer that effectively utilizing it optimizes medical treatment of the clinical pharmacy X laboratory study medicine laboratory study 前川正充, 城野博史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 117-117, 2023.

---

	3-4-S09-1. Inspection of the usefulness of the CYP active predictive biomarker measurement in the drug doses design 公文代將希, 前川正充, 眞野成康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 118-118, 2023.

---

	3-4-S09-2. Drug administration design based on the inflammatory marker 中川潤一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 119-119, 2023.

---

	3-4-S09-3. Individualization and laboratory study of the medical therapy 荒木拓也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 120-120, 2023.

---

	3-4-S09-4. Examination for pharmacogenomics (PGx) to connect with achievement of Precision medicine 磯野哲一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 121-121, 2023.

---

	3-4-S09-5. Practice and pit fall of the antibiotic exposure that took clinical test value into account 尾田一貴 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 122-122, 2023.

---

	Symposium 10. Complex case conference - Let's think about drug therapy for complex cases together with professional pharmacists : Message from the organizer 木村丈司, 鈴木大介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 123-123, 2023.

---

	3-4-S10-1. We will think about medical treatment of the cancer X cardiovascular disease 伊勢崎竜也1, 木下照常2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 124-124, 2023.

---

	3-4-S10-2. We will think about acute renal failure and the treatment of patients with rheumatoid arthritis who had the pancytopenia 角田隆紀1, 林八恵子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 125-125, 2023.

---

	Symposium 11. Term of the organizer thinking about the role of the pharmacist in every scene of the psychiatry domain 保田和哉, 加藤剛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 126-126, 2023.

---

	3-5-S11-1. Proper use of the psychiatry therapeutic drug based on blood drug levels, drug interactions 福山雄卯介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 127-127, 2023.

---

	3-5-S11-2. Efforts ... of cancellation risk factor elucidation - - hospital pharmacist of the early period of Clozapine start 築地茉莉子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 128-128, 2023.

---

	3-5-S11-3. Significance ... which sleeping drug formula re... pharmacist to make with the multi-type of job participates in 水村亮介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 129-129, 2023.

---

	3-5-S11-4. Result of the medication adequacy business by four person (medical association, pharmacist society, university, administration) cooperation 加藤剛1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 130-130, 2023.

---

	3-5-S11-5. Expectation to the further achievement of the pharmacist in every scene of the psychiatry domain and the future prospects 土井信幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 131-131, 2023.

---

	Symposium 12. Term of the rehabilitation drug organizer whom a pharmacist challenges 小瀬英司, 中村直人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 132-132, 2023.

---

	3-5-S12-1. Concept of the rehabilitation drug 中道真理子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 133-133, 2023.

---

	3-5-S12-2. Evidence of the rehabilitation drug which we can practice from tomorrow 小瀬英司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 134-134, 2023.

---

	3-5-S12-3. Efforts of the rehabilitation drug in the convalescent ward 藤原久登1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 135-135, 2023.

---

	3-5-S12-4. Efforts (from the position of the pharmacist) of the rehabilitation drug in the convalescent ward 樋島学 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 136-136, 2023.

---

	3-5-S12-5. Role of the nurse in the rehabilitation drug 永野彩乃 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 137-137, 2023.

---

	Symposium 13. That diabetes and the term of stigma - you reach the patients definitely or practice true medical therapy support; the term of ... organizer 大東敏和, 本田一春 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 138-138, 2023.

---

	3-5-S13-1. With Diabetes stigma and the advocacy 田中永昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 139-139, 2023.

---

	3-5-S13-2. I who am ... patients am conscious as a healthcare worker because we do not give patients a stigma 住吉加奈 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 140-140, 2023.

---

	3-5-S13-3. Importance to be engaged as a diabetes team pharmacist in the front line, and to support "a quality of oneself" not instruction to patient for 15 years 大東敏和 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 141-141, 2023.

---

	3-5-S13-4. Introduction of the advocacy activity in the Japanese medicine and diabetes association 朝倉俊成 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 142-142, 2023.

---

	Symposium 14. How to teach formularies in university education? - Examples and ideas for formulary education - : Words from the organizer 岩澤真紀子, 大津史子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 143-143, 2023.

---

	3-6-S14-1. Pharmaceutical information training aimed at formulary formulation in clinical preparation education 上田昌宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 144-144, 2023.

---

	3-6-S14-2. Formulary training during practical training at Kitasato University Hospital 岩澤真紀子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 145-145, 2023.

---

	3-6-S14-3. Formulary preparation training in hospitals 上田智弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 146-146, 2023.

---

	3-6-S14-4. Formulary education in university education : To what extent should it be taught at universities? 大津史子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 147-147, 2023.

---

	Symposium 15. The medication explanation to patients with nursing that we want to convey even if it is not the nursing and medicine - specialty, an authorized pharmacist and term of improvement in skill - organizer 笠原英城, 實川東洋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 148-148, 2023.

---

	3-6-S15-1. In the nursing and a variety of scenes about the medicine, which information can you convey it using to where? 笠原英城 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 149-149, 2023.

---

	3-6-S15-2. Let's move away from the idea of ​​"just to be safe, stop breastfeeding." - Aiming to become a DI representative who can make proposals with confidence - 安島秀友 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 150-150, 2023.

---

	3-6-S15-3. Because do not make stop self to come from agent and nursing - anxiety complex for the mental nerve; ... 鈴木秀明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 151-151, 2023.

---

	3-6-S15-4. One or ... which must put up with single headache pill and nursing - headache 上森恵里 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 152-152, 2023.

---

	3-6-S15-5. Medication explanation ... to control antiepileptic drug and nursing - attack 松岡順子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 153-153, 2023.

---

	Symposium 16. Term of ... organizer who does fusion (merge) in "we give it it" in pharmacist education theory - new age to expect 12 years later saying "we make it" 柴田啓智, 近藤悠希 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 154-154, 2023.

---

	3-6-S16-1. It is ... from the position to know education theory - clinical practice and the education of the department of a pharmacy student and the medicine university graduate in the new age 今井俊吾 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 155-155, 2023.

---

	3-6-S16-2. The reason that I was young, and was able to create evidence 國津侑貴 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 156-156, 2023.

---

	3-6-S16-3. Coexistence ... of bridge ... "(make) growing up" of a player and the manager and "(give) to bring up" 小林一男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 157-157, 2023.

---

	3-6-S16-4. Role of duties system ... that the management gives a young person - learning for new age 北原加奈之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 158-158, 2023.

---

	Symposium 17. Let's start research with the JADER database - Beware of pitfalls! - Organizer's message 土屋雅美, 小原拓 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 159-159, 2023.

---

	3-13-S17-1. Point to keep in mind in a check list and the study accomplishment in the study using JADER 酒井隆全 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 160-160, 2023.

---

	3-13-S17-2. A study using JADER carried out in the healthcare setting and pit fall 岡田直人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 161-161, 2023.

---

	3-13-S17-3. The enforcement of the clinical studies using side effect report data and pit fall (than a study on vaccine) 宮崎真 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 162-162, 2023.

---

	3-13-S17-4. Efforts to a quality evaluation and the improvement of the report included in JADER in quality 土屋雅美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 163-163, 2023.

---

	Symposium 18. It is the term of ... organizer based on role ... latest trend and laws and regulations of the pharmacist to aim at the clinical experimental medicine administration that secured the safety of subjects 鶴丸雅子, 近藤直樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 164-164, 2023.

---

	3-13-S18-1. Of the management of the use of trial medicine that secured quality, actually 老本名津子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 165-165, 2023.

---

	3-13-S18-2. With the role of the open-label pharmacist, actually 森山菜緒 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 166-166, 2023.

---

	3-13-S18-3. Efforts of the Japan Pharmaceutical Manufacturers Association for the appropriate handling of the use of trial medicine 實雅昭1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 167-167, 2023.

---

	3-13-S18-4. About movement of the regulation to affect the current situation of DCT and a problem, an approach and a clinical experimental medicine for the development of the guidance 福田祐介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 168-168, 2023.

---

	3-13-S18-5. New role of the clinical experimental medicine manager on the basis of the trend of the decentralization clinical study and clinical experimental medicine-related laws and regulations 近藤直樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 169-169, 2023.

---

	Symposium 19. Let's use our knowledge of clinical pharmacology to contribute to the proper use of medicines - Evidence and the Three Sacred Treasures - : Words from the organizers 岩本卓也, 本間真人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 170-170, 2023.

---

	3-13-S19-1. Inflection for a close inspection and the individual optimization of the evidence to support standard treatment 上田昌宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 171-171, 2023.

---

	3-13-S19-2. TDM by the interpretation of the free form blood level 花田和彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 172-172, 2023.

---

	3-13-S19-3. Pit fall and interpretation of the genetic polymorphism evaluation 鈴木嘉治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 173-173, 2023.

---

	3-13-S19-4. Quantitative evaluation, pit fall of drug interactions 平井利典 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 174-174, 2023.

---

	Symposium 20. Let's discuss drug interaction management again now - Guide, case studies, and perspectives - : Words from the organizer 米澤淳, 大野能之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 175-175, 2023.

---

	3-14-S20-1. General statement of purpose explanation and the guide 米澤淳1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 176-176, 2023.

---

	3-14-S20-2. Drug interactions of the case conference (an evaluation and the management of DDI) 1-COVID-19 therapeutic drug 木村丈司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 177-177, 2023.

---

	3-14-S20-3. Drug interactions ... with the case conference (an evaluation and the management of DDI) 2 ... antiHIV therapy 増田純一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 178-178, 2023.

---

	3-14-S20-4. Drug interactions ... with the case conference (an evaluation and the management of DDI) 3 - chemotherapy 大野能之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 179-179, 2023.

---

	3-14-S20-5. A limit and the prospects of the drug interactions management 樋坂章博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 180-180, 2023.

---

	Symposium 21. Term of the organizer reconsidering a tablet crush 倉田なおみ, 鈴木慶介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 181-181, 2023.

---

	3-14-S21-1. We reconsider a tablet crush 倉田なおみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 182-182, 2023.

---

	3-14-S21-2. The dosage form design of the tablet and effect of the crush 原田努1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 183-183, 2023.

---

	3-14-S21-3. Point of problems and the oral cavity function observation of the medicine noticing by mouth care 石井良昌 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 184-184, 2023.

---

	3-14-S21-4. The current situation of the tablet crush for children 石川洋一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2023.

---

	3-14-S21-5. It is a challenge to the issue of tablet crush in the hospital juxtaposition type care health center for the elderly from "a thing to humans" 鈴木慶介1, 山嵜真里1, 小林紘子1, 鶴崎亮太1, 齋藤千夏1, 中野博美2, 齋藤真美2, 高橋泰知3, 高梨友花3, 片見厚夫4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2023.

---

	Symposium 22. Term of the kidney disease medical therapy organizer learning from CKD practice guidelines 2023 竹内裕紀, 古久保拓 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2023.

---

	3-14-S22-1. Way of thinking of the renal function estimation type to use for drug doses setting according to the renal function 竹内裕紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2023.

---

	3-14-S22-2. Up to date of the antiherpesvirus therapeutic drug 水野智博1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2023.

---

	3-14-S22-3. Pain-killer choice to patients in elderly people, CKD with the pain 平田純生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2023.

---

	3-14-S22-4. Instruction and medicine medicine cooperation using the concept of the chic day of patients in CKD 田中章郎1, 太田達也1, 伊藤さおり1, 鰐田芽未1, 金子智慈1, 野澤文香1, 高村京香1, 濱田眞里亜1, 平澤菜々子2, 等浩太郎3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2023.

---

	3-14-S22-5. Extension inhibition of the chronic kidney disease with the SGLT2 inhibitor 浦田元樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2023.

---

	Symposium 23. Because a pharmacist will play an active part in the clinical studies from now on; is the term of ... organizer for ... professional ability expansion, evidence creation 萩原宏美, 石澤啓介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2023.

---

	3-15-S23-1. It is ... from a viewpoint of way - CRC of the contribution of the pharmacist in the pharmaceutical products development 山本明子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2023.

---

	3-15-S23-2. Need that ethic knowledge - ethic examination that becomes required when a pharmacist pushes forward clinical studies is why or ... 内倉健 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2023.

---

	3-15-S23-3. An effect and the prospects by hospital pharmacist being engaged in a clinical study 野中祐二朗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2023.

---

	3-15-S23-4. We make use of the experience of the clinical study in the specialty reinforcement of the disease domain: You read, and how do you solve protocol? 萩原宏美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2023.

---

	3-15-S23-5. With the clinical studies aiming at social implementation 八木健太1,2, 新村貴博1,2, 坂口暁1, 石澤啓介1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2023.

---

	Symposium 24. Term of utilization - current situation of pharmacokinetic "modeling & simulation" and future - organizer 工藤敏之, 佐藤正延 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2023.

---

	3-15-S24-1. Proper use of the oral special preparation which drug absorption change simulation brings: Effect of CYP3A/P-gp changing with administration preparation 白坂善之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2023.

---

	3-15-S24-2. Utilization and the prospects of M&S in pediatric clinical settings 齊藤順平 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2023.

---

	3-15-S24-3. Reporting - use dose to a package insert based on M&S, - that we set it in this way 吉次広如 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2023.

---

	3-15-S24-4. New challenge to apply an artificial intelligence (AI) technique to modeling & simulation 辻泰弘1, 関弘翔2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2023.

---

	Symposium 25. Do you not think about the problem of sex differences in the medical therapy? Term of approach - organizer from ... basics and clinical practice 櫻下弘志, 高井靖 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2023.

---

	3-15-S25-1. Point of view of the sex differences in the basic pharmacy study 黒川洵子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2023.

---

	3-15-S25-2. Sex differences in the renal function evaluation 加藤隆児 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2023.

---

	3-15-S25-3. Medical therapy and sex differences of the cancer domain 櫻下弘志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2023.

---

	3-15-S25-4. Medical therapy and sex differences of the circulatory organ domain 高井靖 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2023.

---

	Symposium 26. Term of impact - organizer to give for a tide and the pharmacist duties of - robot that the anticancer agent preparation robot came to here 近藤勝弘, 日比陽子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2023.

---

	4-2-S26-1. From the perspective of manufacturing and supply - Kemoro - The past, present and future of robot preparation 家田啓史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2023.

---

	4-2-S26-2. From the perspective of manufacturing and supply - Roccioni/Apotheca The history of automated preparation of anticancer drugs and the future 樋口耕平, ベレーニ フェデリーコ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2023.

---

	4-2-S26-3. The effects from the viewpoint of the healthcare setting to the pharmacist duties that - Darwin chemo - anticancer medicine preparation robot (DARWIN-Chemo) results in and further expectation 榊原隆志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2023.

---

	4-2-S26-4. From the perspective of the medical field - Apotheca - …Current status and issues of anticancer drug preparation support equipment operation at Yokohama City University Medical Center… 栗島直希 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2023.

---

	4-2-S26-5. From the perspective of the medical field - Kemoro - The use of two types of robots in our hospital and future prospects 外海友規 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2023.

---

	Symposium 27. Is not only cancer pharmacist outpatient department ... medication counseling indicating the result for patients; the term of practice - organizer of the fur Matthew tical care 川上和宜, 原田知彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2023.

---

	4-2-S27-1. Is not only cancer pharmacist outpatient department ... medication counseling indicating the result for patients; practice ... of the fur Matthew tical care 川上和宜 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2023.

---

	4-2-S27-2. The pharmacist outpatient targeted for oral anticancer medicine has the usefulness; or is ... from the analysis of the treatment cancellation case by significance and the side effect of ... Residual medicine confirmation 郷真貴子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2023.

---

	4-2-S27-3. Relation of the pharmacist outpatient offering the adjuvant postoperative treatment that secured intensity of treatment 奥田泰考 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2023.

---

	4-2-S27-4. The prescription suggestion by the pharmacist is side effect management ... from effect - intensity of treatment to bring for treatment continuation 中村匡志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2023.

---

	4-2-S27-5. Cyclopedic fixed-quantity evaluation ... of new value - quality of life that a pharmacist gives for supportive care 藤井宏典 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2023.

---

	Symposium 28. Term of utilization - organizer of IoT for the purpose of the early correspondence of side effect management - side effect of the cancer medical therapy that went step further that fixed its eyes on a point for 12 years 高山慎司, 横川貴志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2023.

---

	4-2-S28-1. Prevent Oncology Emergency; is construction ... of the safety management support system utilizing ... cyclopedic test value extraction application 橋本幸輝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2023.

---

	4-2-S28-2. Experience application introduction and improvement; and ... ideal and reality and wall ... which stands in the way 藤堂真紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2023.

---

4-2-S28-3. That the IT tool from development - this of the electronic patients diary connecting an electronic medical chart and the health insurance pharmacy is "to protect it safely of the medicine"; ... 香取哲哉1, 小茂田昌代1, 河本怜史1, 木村敦1, 石嵜知里2, 遠藤直樹3, 浅野俊彦4, 佐藤大輔4, 山田琴美4, 野村浩子5, 石川大介6, 真辺篤6, 藤村義明6, 出雲貴文1, 柿本應貴7, 岡元るみ子8, 高橋智5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2023.

---

	4-2-S28-4. That online medication counseling results for the side effect management? It is ... based on the follow-up example in ... health insurance pharmacy 木村大地, 山崎綾香, 鎌谷崇弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2023.

---

4-2-S28-5. Fusion and utilization ... of development - medical care cooperation notebook and the prescription notebook of the patients participation type medical care cooperation support system in the treatment with breast cancer hormone 高山慎司1, 田中裕子2, 笠原里紗3, 土田寧恵5, 尹尹玲花4, 山内英子3, 中村清吾3,5, 後藤一美1, 林直輝3,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2023.

---

	Symposium 29. Term of the evidence creation organizer of the infection with young pharmacist domain for drug resistant bacterium measures of the near future 枦秀樹, 山田智之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2023.

---

	4-3-S29-1. About administration plan of vancomycin in first aid, the ICU domain 石郷友之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2023.

---

	4-3-S29-2. Creation of the evidence for the antimicrobial proper use by the cooperation with middle scale hospital and university 並木孝哉1,2, 枦秀樹1, 織田錬太郎3, 横山雄太2,4, 中村智徳2,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2023.

---

	4-3-S29-3. Evidence creation in preventive measures against hospital infection 中出順也1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2023.

---

	4-3-S29-4. Evidence creation of infection measures in the lung transplantation 片田佳希 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2023.

---

	4-3-S29-5. Study on Teicoplanin 24 hours loading dose method utilizing the machine learning 近藤昭志1,2, 尾田一貴1, 金子哲也1, 城野博史1,2, 齋藤秀之1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2023.

---

	Symposium 30. The pharmacist of task shift/share times can make the wonderful future with "career path" "career up"; or the term of the organizer 岸本真, 小枝伸行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2023.

---

	4-3-S30-1. With the career path career up in the pharmacist 眞野成康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2023.

---

	4-3-S30-2. Hint ... from the area to the career path formation of the initial women that it lives in one step in what "is spun" - lissomeness "to spin" who learned 小原道子1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2023.

---

	4-3-S30-3. For hospital pharmacist making the wonderful future 渡邉学1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2023.

---

	4-3-S30-4. Possibility ... to career path - management hospital pharmacist's post 荒木隆一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2023.

---

	4-3-S30-5. The management and career path career up of task shift/shares from a pharmacist to other types of job 岸本真1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2023.

---

	Symposium 31. It is the term of ... organizer from this of balance - hospital pharmacist duties of a task shift and the ward drug duties of the pharmacist 守内匡, 河井良智 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2023.

---

	4-3-S31-1. From environment and this of ward duties surrounding ward duties 守内匡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2023.

---

	4-3-S31-2. Practice of "the task shift of pharmacist duties" 満田正樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 241-241, 2023.

---

	4-3-S31-3. Want to balance it; is ward drug duties and drug control instruction 寺沢匡史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2023.

---

	4-3-S31-4. The management and task shift to calculate ward drug duties enforcement addition 2 木村真策 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2023.

---

	4-3-S31-5. Ward pharmacist who seeks it from a viewpoint of the hospital management in the future 石井富美1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2023.

---

	Symposium 32. It is possible for what to save the children whom there is in relation ... future of the pharmacist to "children, neonates" X "intensive care"; or the term of ... organizer 内田淳, 冨家俊弥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2023.

---

	4-4-S32-1. How do evaluate the medical therapy of relation ... neonates of the pharmacist in the NICU; ... 清水啓道 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2023.

---

	4-4-S32-2. There is it to save a certain child in role - future of the pharmacist in the pediatric intensive care unit 小川隆弘1, 尾鳥勝也1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2023.

---

	4-4-S32-3. It is participation in planning ... to correspondence at an offer of relation ... safe children intensive care of the pharmacist for the childhood intensive care in the ICU where adults are mixed with children and a childhood sudden change 内田淳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2023.

---

	4-4-S32-4. TDM in children, the neonatal intensive care domain 齊藤順平 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2023.

---

	4-4-S32-5. The thing which is bought in the relation of a physician and the pharmacist in the institution specialized in a childhood circulatory organ 藤井隆成 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2023.

---

	Symposium 33. Term of the efforts to the polypharmacy solution that we worked on by the multi-type of job team and the future problem organizer 尾上雅英, 古俵孝明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2023.

---

	4-4-S33-1. From the situation of the corresponding physician to the polypharmacy that became one area 冨田尚希1,2, 村中美千帆1,2, 高野由美1,2, 舘脇康子1,2, 中瀬泰然1,2, 瀧靖之1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2023.

---

	4-4-S33-2. It is ... from position of current situation and problem - hospital pharmacist for the polypharmacy measures area unification 三宅麻文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2023.

---

	4-4-S33-3. Problem for efforts and the regional alliances to a polypharmacy solution 古俵孝明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2023.

---

	4-4-S33-4. Process of pharmaceutical products proper use at the health insurance pharmacy by the cooperation with a hospital and the multi-type of job 畑世剛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2023.

---

	4-4-S33-5. Process of pharmaceutical products proper use by regional alliances 吉岡睦展 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2023.

---

	Symposium 34. Term of the management method organizer for a pharmacist to manage IMiDs in community medical care cooperation appropriately 上ノ段友里, 小枝伸行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2023.

---

	4-4-S34-1. Fetal prevention of exposure of IMiDs and the role that a pharmacist should fulfil for treatment with specific drug management charges 2 遠藤一司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2023.

---

	4-4-S34-2. Importance of the medical security and information to a pharmacist and a medical person to ask for from a harmful effect victim 間宮清 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2023.

---

	4-4-S34-3. The occupational exposure measures from a pharmacist to medical personnel to report and the way of the information sharing 間宮伸幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2023.

---

	4-4-S34-4. It is information sharing for the safety management for the healthcare worker of inside the hospital, the outside Parliament from hospital pharmacist preparing IMiDs 上ノ段友里 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2023.

---

	4-4-S34-5. The example that an insurance pharmacist was concerned with appropriate management of IMiDs in regional alliances 川口敏弘1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2023.

---

	Symposium 35. Let's share how to manage electrolyte abnormalities with pharmaceuticals : Words from the organizers 三宅健文, 門脇大介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2023.

---

	4-5-S35-1. How to for the condition of a patient grasp of the electrolyte abnormality to be helpful when we know it 志水英明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2023.

---

	4-5-S35-2. How to for the condition of a patient grasp of the electrolyte (Ca, P) abnormality 吉田拓弥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2023.

---

	4-5-S35-3. How to for the condition of a patient grasp of the electrolyte (K, Mg) abnormality 平井利典 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2023.

---

	4-5-S35-4. How to for the condition of a patient grasp of the electrolyte (Na, Cl) abnormality 柴田啓智 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2023.

---

	Symposium 36. Term of extension - organizers from - "clinical pharmacy" to think about pharmacy education, pharmacist upbringing in response to social needs to "clinical pharmacy" 松尾宏一, 吉村知哲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2023.

---

	4-5-S36-1. With "the clinical pharmacy" in the pharmacy education model core curriculum 石井伊都子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2023.

---

	4-5-S36-2. How do you make, "it is difficult" education? 川口崇1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2023.

---

	4-5-S36-3. Individual optimization of ability - medical therapy necessary for pharmacist in the future 高橋克之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2023.

---

	4-5-S36-4. Practice ... of education - clinical pharmacy, the clinical pharmacy in the front line about the cancer medical therapy 池末裕明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2023.

---

	Symposium 37. Term of the new development organizer of the postgraduate education for upbringing of the pharmacist carrying the next generation 山田成樹, 高橋一栄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2023.

---

	4-5-S37-1. Postgraduate training and the carrier formation of the pharmacist 山田清文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2023.

---

	4-5-S37-2. About after graduation clinical practice model business and a report, future directionality 石井伊都子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2023.

---

	4-5-S37-3. Core Cali revision: From the pharmacist education at university for an after graduation clinic 鈴木匡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2023.

---

	4-5-S37-4. About the need of a fact and the multi-type of job cooperation education of the postgraduate education of the medical type of job 木内祐二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2023.

---

	Symposium 38. Term of industrialization - organizer of DX strategy - innovation-like technical seeds to realize sustainable pharmacist duties 座間味義人, 村木優一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2023.

---

	4-6-S38-1. Development of medical specialization type EdTech aiming at the visualization of the thought 牛尾聡一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2023.

---

	4-6-S38-2. Medication follow DX with the IoT medicine calendar 佐古卓人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2023.

---

	4-6-S38-3. Until the social implementation of development - results of research of the pharmaceutical products proper use promotion system in consideration of renal function - 近藤悠希 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2023.

---

	4-6-S38-4. Construction of advanced drug duties utilizing DX in the university hospital pharmacy 座間味義人1, 牛尾聡一郎2, 武田達明3, 濱野裕章1, 鍛治園誠1, 西原茂樹1, 村川公央1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2023.

---

	4-6-S38-5. Practice of the advanced clinical pharmacy education utilizing DX in the pharmacy school 村木優一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2023.

---

	Symposium 39. It is the term of ... organizer from the practice of pharmacist duties - ward duties of the small and medium size hospital to think about together to securing of human resources, a local action, cooperation 宮川哲也, 濱浦睦雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2023.

---

	4-6-S39-1. It is ... for the efficiency of PBPM, task shift/share - duties that we can practice at a small and medium size hospital and improvement of the quality 瀧祐介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2023.

---

	4-6-S39-2. Treatment at home and the Advance Care Planning (ACP) activity that we can practice simply because it is a small and medium size hospital 横山敏紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2023.

---

	4-6-S39-3. It is ... about efforts for the improvement in fixation rate of the human resources in the small and medium size hospital towards the workplace with ... worth doing 渡部学 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2023.

---

	4-6-S39-4. Turn connections into power! - Activities of the Nagano Prefecture Hospital Pharmacists Association Small and Medium Hospital Committee - 伴野一樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2023.

---

	4-6-S39-5. With trust and expectation from a large hospital to small and medium size hospital - cooperation which looked at - 筒井由佳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2023.

---

	Symposium 40. How do you make use of the intervention point ... feeling rehabilitation of the pharmacist for the heart failure case and a viewpoint of the medical treatment instruction in there of the prescription suggestion? Term of ... organizer 吉国健司, 芦川直也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2023.

---

	4-6-S40-1. Here is important; is medical treatment instruction and the heart rehabilitation for the heart failure case 西崎公貴 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2023.

---

	4-6-S40-3. How is the monitoring - heart rehabilitation instruction person of patients with heart failure practice? ... 向井一樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2023.

---

	4-6-S40-5. It is ... to the one step of challenge - usual medication counseling of the pharmacist challenging a heart failure pandemic 石井聡一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2023.

---

	Symposium 41. Term of ... organizer that we will think about case report, and the ... pharmacist's experience saves patients from the viewpoint of CARE guidelines 藤宮龍祥, 小澤有輝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2023.

---

	4-12-S41-1. Why case reports now? - Improve the quality of case reports with CARE - 藤宮龍祥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2023.

---

	4-12-S41-2. About the originality that is important in SIADH - case report by the ST medical mixture, message characteristics - 米澤龍1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2023.

---

	4-12-S41-3. Description of liver damage - CARE guidelines on Abemaciclib experience - 小澤有輝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2023.

---

	4-12-S41-4. About a way of thinking of the clinical reasoning sought by case report 鈴木信也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2023.

---

	4-12-S41-5. How to use case report to think about in a viewpoint of CARE 上塚朋子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2023.

---

	Symposium 42. Term of - organizer learning from a successful example for the clinical question which should be settled in - truth aiming at the high quality evidence creation by the pharmacist 石澤啓介, 田崎嘉一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2023.

---

	4-12-S42-1. Method - to test improvement, the change of evaluation - duties of the antimicrobial proper use support task by the pharmacist scientifically 山口諒 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2023.

---

	4-12-S42-2. Secret - of multi-organization collaborative investigation - study planning and the administration to create the evidence of the high level 飯原大稔 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2023.

---

	4-12-S42-3. Examination of the pharmacokinetic allied genetic information application in the Parkinson's disease medical treatment 山本譲, 田崎嘉一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2023.

---

	4-12-S42-4. The new truth to be found by the power of fundamental researches: For solution to clinical question 川田敬1,2, 石田智滉3, 阿部真治1, 合田光寛2,4, 石澤啓介2,4,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2023.

---

	4-12-S42-5. Creation of the clinical evidence by the data science that assumed medical big data utilization a base 濱野裕章1, 牛尾聡一郎2, 松本准3, 新村貴博4, 相澤風花5, 八木健太4, 合田光寛5,6, 石澤啓介4,5,6, 座間味義人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2023.

---

	Symposium 43. Term of - organizer who reviews that we can do it in pharmacy management - now of the orthopedics domain, and thinks about possibility after this 長谷川裕矢, 三浦誠 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2023.

---

	4-12-S43-1. The intervention to an injury, an infection: To prevent Preventable Trauma Disability 檜山洋子1, 大饗和憲2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2023.

---

	4-12-S43-2. Cancer chemotherapy and the multi-type of job cooperation of the orthopedics domain 中川祐紀子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2023.

---

	4-12-S43-3. Efforts of pharmacist duties and the conference according to the Kyoto hospital pharmacist society domain to join together from hospitalization to a discharge 天満智也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2023.

---

	4-12-S43-4. Of the pharmaceutical intervention of the orthopedics domain mainly on a pain-killer, a sleeping drug, the osteoporosis therapeutic drug, actually 長谷川裕矢 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2023.

---

	4-12-S43-5. The osteoporotic liaison service that a pharmacist conducts 長谷奈那子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2023.

---

	Symposium 44. Term of the The progress of international exchange program in oncology pharmacy practice organizer Masami Tsuchiya, Yukiyoshi Fujita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2023.

---

	4-13-S44-1. International exchange programs in pre-graduate pharmacy education at Keio University Faculty of Pharmacy Sayo Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2023.

---

	4-13-S44-2. International Exchange Initiatives at Kameda General Hospital Yukari Kataoka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2023.

---

	4-13-S44-3. Participate in cancer pharmacist training overseas... Yumi Morioka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2023.

---

	4-13-S44-4. International exchange program experience in Thailand Manit Saeteaw Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2023.

---

	Symposium 45. Have of "perioperative drug control" and invention - such a thing in "postoperative pain management team" settings; is the term of ... organizer 舟越亮寛, 柴田ゆうか Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2023.

---

	4-14-S45-1. Fine-view ... future for the task shift from an anesthesiologist for ... perioperative period from a team setup 藤田翔1, 金城勝大1, 宮良遥奈1, 吾津千秋1, 小杉卓大1, 國分千代1, 梶原理恵2, 新里泰一3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2023.

---

	4-14-S45-2. We challenge the pharmaceutical management in the operating room 亀田皓介, 内田会美, 山本卓矢, 増田大輔, 上野正夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2023.

---

	4-14-S45-3. We obtained the map called the Japanese Society of Hospital Pharmacists check list and will begin to row it to the sea called the operating room! 金森麻土香1, 中丸朗1, 柿沼宏幸2, 小島正夫3, 佐藤学1, 金子和生1, 戸村さよ子4, 伊藤裕子4, 遠藤千晴4, 益子ひろみ4, 浅利圭介4, 田村華恵1, 小川結花1, 清水美子4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2023.

---

	4-14-S45-4. For the future of the drug control perioperative from a postoperative pain management team start 小林大祐 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2023.

---

	4-14-S45-5. Relation of the pharmacist in the postoperative pain management team 村川公央, 勝部理早, 小沼利光, 西原茂樹, 座間味義人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2023.

---

	4-14-S45-6. Towards the best postoperative pain management team 竹之内正記 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2023.

---

	Symposium 46. It will be to the pharmacist who prepare for a medical all-out war of 2035, and is connected with thought movement in Warning signs of the sudden change; is the term of the organizer 中薗健一, 今井徹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2023.

---

	4-14-S46-1. Warning signs: Approach to a breathing change 鈴木善樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2023.

---

	4-14-S46-2. The serious illness that did not miss it, and was covered in alteration of consciousness (delirium) 岩内大佑 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2023.

---

	4-14-S46-3. Fever as Warning Sign which we do not overlook fever, and a pharmacist should evaluate 西田祥啓 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2023.

---

	4-14-S46-4. Do not suppress the tachycardia by force, and let's think about every possibility. 若杉和美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2023.

---

	Symposium 47. Term of ... first aid, perioperative period, intensive care, acute phase, community medical care - organizer regarding a macroviewpoint care shift as a micro through 1 case 齋藤靖弘, 吉川博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2023.

---

	4-14-S47-1. Role of the seamless medical therapy and pharmacist beginning with the emergency visit 川島裕明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2023.

---

	4-14-S47-2. It is Zoom out until the issue of care of the Zoom in surgery patients for the issue of postoperative complications 猪狩賢蔵 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2023.

---

	4-14-S47-3. medication reconciliation - evaluation and plan ... which are carried out by an intensive care team 安藝敬生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2023.

---

	4-14-S47-4. To connect to role - community medical care of the pharmacist in the ward for acute phase; ... 菅原隆文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2023.

---

	4-14-S47-5. Pharmaceutical support and cooperation of medical care, the care to spend time in an area 宮坂善之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2023.

---

	Symposium 48. Clinical pharmacists start research into the field of blood cancer - Know-how from on-site realizations to practice - : Words from the organizers 安武夫, 伊藤佳織 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2023.

---

	4-15-S48-1. It is ... from prescription suggestion - clinical duties of the pharmacist in patients with blood-forming organ tumor to a study 南貴之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2023.

---

	4-15-S48-2. We think about the palliative care intervention of the blood cancer domain as a clinical pharmacist 伊藤佳織 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2023.

---

	4-15-S48-3. Let's incorporate a clinical pharmacological perspective into patient observation - To protect patients who are administered a large number of high-alert drugs - 土手賢史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2023.

---

	4-15-S48-4. Drug interactions in the hematopoietic stem cell transplantation judging from the viewpoint of the pharmacist 中島寿久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2023.

---

	4-15-S48-5. Usefulness of the supportive care of the blood cancer domain by the multi-type of job collaboration and safe examination 内田まやこ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2023.

---

	Symposium 49. Term of the current situation and the problem organizer for the clinical implementation of the examination for pharmacogenomics 寺田智祐, 新岡丈典 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2023.

---

	4-15-S49-1. About a proposal about the operation of the examination for pharmacogenetics in the practice 寺田智祐 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2023.

---

	4-15-S49-2. PK-PGx analysis of oral factor Xa inhibitors 中川潤一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2023.

---

	4-15-S49-3. Search of the genetic polymorphism associated with the onset of the drug-related interstitial lung disease 田中庸一1, 福永航也2, 牛木淳人3, 花岡正幸3, 齋藤嘉朗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2023.

---

	4-15-S49-4. The examination for PGx implementation to an electronic medical chart and clinical usefulness 杉本充弘, 平大樹, 寺田智祐 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2023.

---

	4-15-S49-5. Problem for the spread situation of the examination for pharmacogenomics by the true clinical practice and the clinical implementation 辻大樹1, 齋藤嘉朗2, 莚田泰誠3, 三浦昌朋4, 平大樹5, 寺田智祐5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2023.

---

	Symposium 50. Of the past, the present of the TDM look back, is also the term of the development organizer to the next generation 尾田一貴, 榎屋友幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2023.

---

	4-15-S50-1. From this of the TDM in intensive care, the infection domain 尾田一貴 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2023.

---

	4-15-S50-2. Therapeutic drug monitoring in consideration of the maturation value of children 辻泰弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2023.

---

	4-15-S50-3. Therapeutic drug monitoring of the molecular target anticancer medicine 野田哲史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2023.

---

	4-15-S50-4. About therapeutic drug monitoring in the psychiatry domain 猿渡淳二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2023.

---

	4-15-S50-5. The blood level measurement in the acute drug intoxication domain: The current situation and problem 榎屋友幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2023.

---

	Symposium 51. Should do the action that how about us to push on to current situation of the medicine medicine cooperation in the cancer chemotherapy and future ... new step; or the term of ... organizer 杉山弘樹, 木村緑 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2023.

---

	5-1-S51-1. Thought ... which we loaded mission - book symposium holding of the hospital pharmacist concerned with medicine medicine cooperation with 杉山弘樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2023.

---

	5-1-S51-2. With "the information that a drugstore pharmacist wants" to get simply because it is a person who experienced hospital pharmacist? 木村緑 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2023.

---

	5-1-S51-3. "WHY" The true intention of cooperation and the drugstore pharmacist for patients beginning with this 笹原侑祐 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2023.

---

	5-1-S51-4. Usefulness of the reporting from a pharmacist in cancer treatment: From the situation of the on koro distrike 森川直人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2023.

---

	5-1-S51-5. Patients expect it for a pharmacist and medicine medicine cooperation, illness medicine cooperation 西村和佳子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2023.

---

	Symposium 52. How should the pharmacist be engaged in medical care, the care cooperation in the problem in 2040? Term of the organizer 尾上雅英, 辻井聡容 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2023.

---

	5-2-S52-1. From the viewpoint of the teacher of the medical B-school 多湖雅博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2023.

---

	5-2-S52-2. From position of the hospital pharmacist who learned in a medical B-school 尾上雅英 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2023.

---

	5-2-S52-3. Fine-view ... of the health insurance pharmacy future through medical care, current situation and problem - drugstore 3.0 from the situation of the health insurance pharmacy cooperating with care 安里芳人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2023.

---

	5-2-S52-4. From the position of the pharmacist of the area core hospital with the qualification of the care manager 辻井聡容 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2023.

---

	5-2-S52-5. From a viewpoint of the hospital pharmacist conducting the hospitalization and release support addition futuristically 堀内賢一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2023.

---

	Symposium 53. Collaboration between hospital formularies and local formularies - Aiming for better local medical care - Words from the organizers 渡辺善照, 高橋將喜 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2023.

---

	5-2-S53-1. Appropriate use of medicines and expectations of pharmacists - Appropriate use with an eye on medical Dx (including the use of local formularies) - 中井清人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2023.

---

	5-2-S53-2. Formularies in the era of community-based comprehensive care: differentiation, strengthening, and collaboration of medical functions and sustainable treatment management 川上純一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2023.

---

	5-2-S53-3. Outlook for pharmaceutical formularies in Japan 小池博文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2023.

---

	5-2-S53-4. The key to British formula re... pawn and coexistence of the economy 佐々江龍一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2023.

---

	5-2-S53-5. Construction and operation of pharmaceutical formularies in Sendai City 渡辺善照1,2, 男澤貴子2, 菅原茂樹2, 花井拓斗2, 一戸集平3,4, 栃窪克行2,3,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2023.

---

	Symposium 54. It is the term of the fact organizer of the efforts of each institution accompanied with the "proposal (No. 15) for the prevention of recurrence of the mishaps in medical practice" public announcement the safety measures that you do for what 西原雅美, 河瀬留美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2023.

---

	5-3-S54-1. What is the behavior sought to a medical institution associated with a proposal for recurrent prevention of the mishaps in medical practice? 土屋文人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2023.

---

	5-3-S54-2. Receive a proposal (No. 15) for recurrent prevention of the mishaps in medical practice; and is ... from the position of the medical security working full time pharmacist in ... special functioning hospital 菊田裕規1,2, 西原雅美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2023.

---

	5-3-S54-3. Receive a proposal (No. 15) for recurrent prevention of the mishaps in medical practice; and is ... from position of the ex-Emperor ... serious illness 菅野浩1, 齋藤謙治1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2023.

---

	5-3-S54-4. Receive a proposal (No. 15) for recurrent prevention of the mishaps in medical practice; and is ... from the situation of the cottage-hospital out of ... 町谷安紀1,2,3, 東川明子2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2023.

---

	5-3-S54-5. Receive a proposal (No. 15) for recurrent prevention of the mishaps in medical practice; and ... and current situation and efforts ... of the local government Hospital which there is 岸本真 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2023.

---

	Symposium 55. Term of approach - organizer of Tokyo where the breeding of the medicine medicine cooperation aims at relief, the security of ... cancer medical therapy from the standardization of the tracing report 清水久範, 山口正和 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2023.

---

	5-3-S55-1. About the process of the "Tokyo cancer medical therapy council" start 山口正和 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2023.

---

	5-3-S55-2. From the situation of the Tokyo health service bureau 鎌田智之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2023.

---

	5-3-S55-3. From the situation of Tokyo pharmacist society medicine medicine cooperation Committee 島田淳史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2023.

---

	5-3-S55-4. To embody "ideal" of the medicine medicine cooperation; ... ... which thinks about breeding of the medicine medicine cooperation from position of ... hospital pharmacist seriously 小川千晶 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2023.

---

	5-3-S55-5. It is ... from the position of way and problem - drugstore pharmacist of the tracing report which we examined after the hospital training 辻将成 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2023.

---

	Symposium 56. The securing of pharmacist supporting the poor area of medical resources and upbringing, term of the collaboration organizer with the local government 崔吉道, 堀里子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2023.

---

	5-5-S56-1. To push forward the securing of pharmacist supporting the poor area of medical resources and upbringing, the collaboration with the local government 崔吉道 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2023.

---

	5-5-S56-2. The poor local problem of medical resources and role of a drugstore, the pharmacist 堀里子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2023.

---

	5-5-S56-3. About the securing of pharmacist for the unevenly distributed cancellation 眞野成康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2023.

---

	5-5-S56-4. Local one body type business training "Maizuru program" 楠本正明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2023.

---

	5-5-S56-5. Initiatives to secure pharmacists in Ishikawa Prefecture - Ishikawa Prefecture Regional Collaboration Pharmacist Co-education Program - 松下悠希1, 福井優子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2023.

---

	Symposium 57. Will support a back of role - you of the pharmacist in prevention of bedsore, the treatment; is the term of ... organizer 飯塚雄次, 武藤理恵 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2023.

---

	5-5-S57-1. A pressure sore association in Japan expect it from a pharmacist 館正弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2023.

---

	5-5-S57-2. Role of the pharmacist in the medical service fees revision about pressure sore measures 関根祐介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2023.

---

	5-5-S57-3. A pharmacist's perspective directly linked to the pharmaceutical management plan for inpatient bedsores - Topical medication treatment for bedsores utilizing base characteristics and drug retention: Furuta Method - 古田勝経 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2023.

---

	5-5-S57-4. Grasp of the overall status about pressure sore treatment, the prevention 溝神文博1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2023.

---

	5-5-S57-5. Role ... in the at-home pressure sore of thing - drugstore pharmacist that it seemed that a pharmacist intervened in a pressure sore 小黒佳代子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2023.

---

	Symposium 58. Term of efforts - organizer that we go for medical care and current situation report from the DX - healthcare setting of the hospital pharmacist and coming 12 years 高橋正明, 山中理 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2023.

---

	5-6-S58-1. About medical DX including the electronic prescription or future movement, and the like 高橋悠一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2023.

---

	5-6-S58-2. Efforts of the bringing medicine formulations utilizing the YJ cord 田中正臣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2023.

---

	5-6-S58-3. Problem of duties improvement by the inflection of the GS-1 bar code and the hospital pharmacist duties in the super aging society 中尾元紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2023.

---

	5-6-S58-4. Reinforcement of the cooperation between health insurance pharmacy ... hospital using the on admission medication reporting book with the QR cord 五十嵐敏明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2023.

---

	5-6-S58-5. About pharmacist education contents to have simulated experience of true clinical practice utilizing the advanced IT 牛尾聡一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2023.

---

	Symposium 59. It which learn from a side effect case, and protects patients is our mission; the term of the organizer 前田頼伸, 冨岡謙二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2023.

---

	5-6-S59-1. Prescription adequacy by the kinetic analysis of the side effect case 前田頼伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2023.

---

	5-6-S59-2. Information on adverse drug reactions management using an electronic medical chart 冨岡謙二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2023.

---

	5-6-S59-3. Usefulness of the uniform management system of a side effect, the allergic information 荒木良介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2023.

---

	5-6-S59-4. Importance of the proper use judging from a non-supply example in the Relief System for Sufferers from Adverse Drug Reactions 薄井健介1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2023.

---

	5-6-S59-5. How do you protect patients from the health hazard of the pharmaceutical products through the side effect monitor activity in the health insurance pharmacy? 廣田憲威 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2023.

---

	Symposium 60. Term of the organizer regarding upbringing of the pharmacist carrying the next generation as the clinic of cancer 上ノ段友里, 佐藤雄己 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2023.

---

	5-12-S60-1. It is ... from the position of the ... University teacher regarding upbringing of the pharmacist carrying the next generation as the clinic of cancer 佐藤雄己 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2023.

---

	5-12-S60-2. In a cancer special hospital about education system 松井礼子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2023.

---

	5-12-S60-3. What pharmacy of the Osaka cancer practice base Hospital works on 萱野勇一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2023.

---

	5-12-S60-4. The specialty of the pharmacist is ... from the situation of clinic - health insurance pharmacy of cancer to support 久田健登 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2023.

---

	5-12-S60-5. Clinic of cancer to pursue in the healthcare setting to think about from the situation that experienced business training 道原あやな Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2023.

---

	Symposium 61. Term of the efforts organizer of the medical security in the domain mild for an at-home shift 高瀬久光, 井手口直子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2023.

---

	5-12-S61-1. A thought necessary for hospitalization and release cooperation and medical mind 小林篤史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2023.

---

	5-12-S61-2. Point of the medical security at home care patient acceptance 佐久間詠理1, 川内潤也1, 渡邉淳子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2023.

---

	5-12-S61-3. Our being thinking as a health insurance pharmacy accepting patients of the sustained subcutaneous injection enforcement 宇都宮励子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2023.

---

	5-12-S61-4. It is ... for advice - safe injection drug intravenous feeding route choice of the medical drug injection drug combination management based on the incompatibility test in the mild medical care 近藤匡慶 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2023.

---

	5-12-S61-5. Is the intervention that hospital pharmacist can snuggle up to patients on the site now for time left patients with cancer anything? 藤堂真紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2023.

---

	Symposium 62. Term of the adequacy relaxation medical therapy strategy organizer according to the patients unit for pharmacist image specialized palliative care for 2035 to kill the pain of patients 伊東俊雅, 金子健 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2023.

---

	5-13-S62-1. Specialty - of the pharmacist sought in - relaxation medical care domain where a pharmaceutical discussion turns mild medical care into 的場元弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2023.

---

	5-13-S62-2. A skill and problem in the mild medical domain necessary for a clinical pharmacist 山田正実 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2023.

---

	5-13-S62-3. Mild medical care education and problem to see in Tokyo hospital pharmacist society mild medical regional pharmacist training workshop 金子健1,2, 竹内麻理2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2023.

---

	5-13-S62-4. Relaxation cafe - Tokyo Supportive Oncology Pharmacist Pain Board - hospital pharmacy simultaneous educational program administration and the problem 伊東俊雅 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2023.

---

	5-13-S62-5. The thing which is seen from a medical therapy skill and the problem mild medical drugstore certification system design in the mild medical domain necessary for a drugstore pharmacist 小林篤史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2023.

---

	Symposium 63. Term of the problem organizer of an injection drug in the at-home cancer palliative care, the supply of the medical drug and the family function of a pharmacist, the drugstore 串田一樹, 伊東俊雅 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2023.

---

	5-13-S63-1. Drugstore investigation [medicine bacteria] Ergonomy and cooperation of the drugstore in the at-home cancer palliative care to be able to see from this 串田一樹, 廣原正宜, 宮崎生子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2023.

---

	5-13-S63-2. At-home cancer palliative care to be able to see through a visit activity 佐々木健 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2023.

---

	5-13-S63-3. The cooperation between the drugstores in the local inclusion care system and the problem 白石丈也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2023.

---

	5-13-S63-4. Work - of the pharmacist supporting at-home cancer palliative care living-in-; supporting; examine; from the viewpoint of the pharmacist 大須賀悠子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2023.

---

	Symposium 64. Term of the organizer thinking about who should do a discussion to solve the supply anxiety problem of pharmaceutical products where 室井延之, 四方敬介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2023.

---

	5-14-S64-1. To raise ... pharmaceutical products supply information sharing and transparency to think about who should do a discussion to solve the supply anxiety problem of pharmaceutical products where; ... 室井延之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2023.

---

	5-14-S64-2. Usefulness of the effect on inquiry of the outside Parliament prescription of the understock of pharmaceutical products and the simplification protocol for inquiry 高瀬友貴 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2023.

---

	5-14-S64-3. Anti-stress of the current situation and the drugstore team in confrontation with the understock of pharmaceutical products 廣田有紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2023.

---

	5-14-S64-4. Administrative approach to affect the steady supply of pharmaceutical products 浅野智央 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2023.

---

	5-14-S64-5. About efforts of association of generic medicine manufacture for the securing of trust of the generic drug in Japan 川俣知己 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2023.

---

	Symposium 65. The support necessary to conduct clinical studies at a drugstore? - We learn a company and an art of the study support of university! - Term of the organizer 岡田浩, 天野学 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2023.

---

	5-15-S65-1. Clinical studies to develop: Way to foolproof clinical studies 片岡裕貴1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2023.

---

	5-15-S65-2. Problem in the clinical studies enforcement of the drugstore pharmacist 天野学 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2023.

---

	5-15-S65-3. Feel it about study enforcement from the situation of the drugstore 角佳亮 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2023.

---

	5-15-S65-4. Clinical studies to conduct at university and a drugstore 岡田浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2023.

---

	5-15-S65-5. It is = about the study support system in academic activity = companies at the health insurance pharmacy 長谷川佳孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2023.

---

	Symposium 66. It is the term of ... organizer for 12 years to aim with people taking new team Building ... antiHIV medicine in the local inclusion care 阿部憲介, 國本雄介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2023.

---

	5-15-S66-1. It is ... from the local inclusion care system and pharmacist's experience of relation ... cancer practice 岡田浩司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2023.

---

	5-15-S66-2. It is ... from the role of the pharmacist in the HIV practice team and position of medication support - hospital pharmacist in the future 阿部憲介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2023.

---

	5-15-S66-3. The prospects to the role of the health insurance pharmacy in the HIV practice and local inclusion care 田橋美佳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2023.

---

	5-15-S66-4. To live like the person regardless of an activity and expectation - AIDS end and status in the community to a pharmacist of outbreak; ... 岩橋恒太 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2023.

---

	5-15-S66-5. Practice - team building of the team approach in medical care in the HIV practice and joint decision making - 田沼順子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2023.

---

	We will write case report necessary for a pharmacist specialized in medical therapy! 日本医療薬学会 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-448, 2023.

---

	MS01-1. ... that the thought circuit is forged in skill - conference of the pharmacist to see cardiovascular disease 高井靖 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2023.

---

	MS01-2. We do not make pharmaceutical cooperation and task share - heart failure stage of the heart failure practice utilized Fantastic four advance! We will find "passing away feeling imperfection" 佐藤宏行1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2023.

---

	MS02. Pharmacist and the new generation irAE management that ePRO opens up 桂英之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 453-453, 2023.

---

	MS03. Expect generic development with medical economic issue - added value in cancer treatment; ... 宇佐美英績 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-455, 2023.

---

	MS04. Inflection of the Sino-Japanese traditional medicine for the acute phase disease 中永士師明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-457, 2023.

---

	MS05. The pain management and constipation measures 安藤秀明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2023.

---

	MS06. Importance of the postgraduate education mediating between community medical care, health care 井関健 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2023.

---

	MS07. Mainly on initial treatment by treatment strategy - bortezomib of the multiple myeloma on the basis of effect mechanism and a side effect and subsequent treatment preferences 今井陽一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 463-463, 2023.

---

	MS08. Generic drug recommendation medicine choice ... of a role and the steady supply of commentary - hospital pharmacist of the local formula reenforcement guidelines on released academic conference 今井博久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 465-465, 2023.

---

	MS09-1. The basic knowledge "cancer cachexia" that is sought now by a pharmacist 二村昭彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 467-467, 2023.

---

	MS09-2. What pharmacists can do to treat cancer cachexia - It is the Courage to Continue that Counts - 藤井宏典 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 468-468, 2023.

---

	MS10-1. "We can do it at home too!!" - Therapeutic drug monitoring practice and innovations at a single-specialty psychiatric hospital - 阿部裕子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 470-470, 2023.

---

	MS10-2. "Let's extend Here we go, TDM duties"; is introduction and practice case ... of ... LM1010 森川剛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 471-471, 2023.

---

	MS11. The change of the HER2-positive breast cancer medical therapy 石田孝宣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 473-473, 2023.

---

	MS12. The exposure measures at mixed preparation of the antineoplastic and effect to give to medical expenses 佐々木忠徳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 475-475, 2023.

---

	MS13. Significance - of fine-view - multidirectional painkilling and post-operative pain management team analgesic after the operation 飯田宏樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 477-477, 2023.

---

	MS14. Aiming to break away from clinical inertia in migraine treatment - A paradigm shift in migraine treatment with the arrival of Emgality and REYVOW - 小田正哉 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 479-479, 2023.

---

	MS15. Expectation to a pharmacist supporting septicemic DIC treatment strategy community medical care in the future 辻喜久1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 481-481, 2023.

---

	MS16-2. Efforts of the hepatitis B reactivation surveillance that a physician and a pharmacist work on 萱野勇一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 483-483, 2023.

---

	MS17. Characteristic of the TDM in the cyclosporine micro emulsion preparation 竹内裕紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 485-485, 2023.

---

	MS18. ... which thinks about cancer medical care and nourishment management from patients power necessary for a work-style reform model and coimpressive power of an art" - ECAM model, medicine medicine cooperation, PBPM, promotion of PHR 木本真司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 487-487, 2023.

---

	MS19. It is ... led by four vaccine - herpes zoster vaccine thing RIX now necessary for adults and elderly people 渡辺彰1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 489-489, 2023.

---

	MS20. It is ... from the viewpoint of correspondence ... drug interactions to a new coronavirus infection 増田純一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 491-491, 2023.

---

	MS21. ... to think about based on the activity guideline of the pharmacist for way - sepsis-related DIC practice of the pharmacist in the intensive care team 安藝敬生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 493-493, 2023.

---

	MS22. Blanding ... of importance - specialty/authorization pharmacist of HIV infection/specialty pharmacist 小谷宙 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 495-495, 2023.

---

	MS23. Now of the antiemesis therapy in the highly emetic risk medicine 橋本浩伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 497-497, 2023.

---

	MS24. New positioning of new oral medication and psoriasis treatment 渡部大輔 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 499-499, 2023.

---

	MS25. About possibility of breast cancer endocrine therapy - equol which focused on quality of life - 大竹徹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 501-501, 2023.

---

	MS26. It is ... mainly on relation ... side effect measures of the pharmacist to cancer chemotherapy 安室修 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 503-503, 2023.

---

	3-7-O01-1. Efforts of the pharmaceutical products stock amount of money inhibition in the southern part of Saiseikai Yokohama-shi Hospital and the result 深沢貴志, 田辺真里, 飯村諒, 生田和之, 藤巻智則, 平間盛吾, 上原美佐, 加藤一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 505-505, 2023.

---

	3-7-O01-2. Correspondence ... to efforts ... patients with disposal pharmaceutical products reduction in the South Wakayama medical center-limited medicine 喜田孝史, 辻田司, 木原理絵, 古川順章 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 506-506, 2023.

---

	3-7-O01-3. Inspection of the used pharmaceutical products PTP sheet recycling effect with a drugstore, the hospital 田口りか1, 堀英生2, 供田将志3, 神保美紗子4, 浅井治行5, 間瀬定政6, 白川茉由9, 大澤伸夫7, 長谷川照恭8, 鈴木匡2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 507-507, 2023.

---

	3-7-O01-4. Efforts and the result to minimize the pharmaceutical products disposal in the hospital 植木哲也, 實松絵美子, 緒方彰子, 岸本たかね, 川道直子, 篠原義剛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 508-508, 2023.

---

	3-7-O01-5. Factorial experiments to influence pharmaceutical products loss 谷口潤1, 國生道代2, 松田吉憲3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 509-509, 2023.

---

	3-7-O02-1. Problems of the medicine charge revision that we were able to see from standard conversion system operation 齊藤安昌, 喜多村裕子, 島田雅彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 511-511, 2023.

---

	3-7-O02-2. Pulmonary toxic evaluation by bevacizumab using adverse drug reaction database (JADER) 神林祐子1, 内田まやこ2, 柏木美粋2, 秋葉仁美2, 清水忠3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 512-512, 2023.

---

	3-7-O02-3. Investigation of the effect that combination of the steroid in patients with rheumatoid arthritis gives for a change of the molecular target medicine 中川千拓1, 太田涼介2, 平田敦士2, 宇野貴哉1, 横山聡1, 細見光一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 513-513, 2023.

---

	3-7-O02-4. Comparison of patient backgrounds in clinical trials and real-world clinical practice of Sacubitril/Valsartan 伊東愛理, 門口直仁, 公文登代, 段松雅弘, 田中聡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 514-514, 2023.

---

	3-7-O02-5. Do the discharge prescription days and the consultation out of the reservation affect the prognosis in the patients with heart failure? 林太祐1, 久保田芳明2, 岩出佳樹1, 西野拓也3, 橘貴大2, 渡邉将央2, 松田淳也2, 加藤活人4, 太良修平2, 時田祐吉2, 宮地秀樹2, 伊勢雄也1, 岩崎雄樹2, 浅井邦也2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 515-515, 2023.

---

	3-7-O03-1. Precaution - of examination - dose setting about the proper use intervention of direct action type oral anticoagulant drug (DOAC) in the heart failure inpatient 菅原拓也, 荒井潤, 関口徳志, 田中沙織, 岡田美桜, 松田圭一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 517-517, 2023.

---

	3-7-O03-2. Look at the rear about the patients with pharmacist disadvantage who had it after the prescription intervention; a mark investigation 西牟田昇吾, 村上翔梧, 的場麻知子, 佐古守人, 黒沢秀夫, 野村剛久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 518-518, 2023.

---

	3-7-O03-3. Prospective study about medicine, the discontinuation support decreasing by it of the benzodiazepine receptor agonist which we performed as part of a ward activity 齊藤伸, 吹谷真紀子, 木元健寛, 瀬戸亘, 鈴木ひとみ, 仙葉悠紀, 齋藤香織, 篠田和人, 山崎恵葉, 金美紀, 一関美江子, 八代佳子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 519-519, 2023.

---

	3-7-O03-4. The evaluation of pharmacist-led polypharmacy measures and future problem 白戸信行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 520-520, 2023.

---

	3-7-O03-5. Efforts of the heart failure medical treatment instruction person in the revision of the use of morphine manual 藤堂朱香1, 磯谷彰宏2, 大峠敬洋3, 武下千朝3, 町田聖治1, 入江利行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 521-521, 2023.

---

	3-7-O04-1. About contribution to improvement in prescription rate of the osteoporosis therapeutic drug by the secondary bone fracture prevention team 岩城慎平, 山崎彬史, 松岡勇作, 奥野昌宏, 森本茂文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 523-523, 2023.

---

	3-7-O04-2. Examination about the current situation and osteoporosis treatment of patients admitted to the elderly people bone fracture center of our hospital 野口直子, 植田緑, 竹本契史, 延藤勇 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 524-524, 2023.

---

	3-7-O04-3. Examination about an evaluation rate of the prescription suggestion in ward drug duties and the improvement of the quality 志田幸平, 菅原拓也, 有川真理, 五十嵐綾乃, 松田圭一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 525-525, 2023.

---

	3-7-O04-4. The need of the pharmacy care for patients with neuromuscular disease intractable disease 山形真一1, 鈴木寛人2,6, 敦賀叶女3, 阿部香澄3, 渡嘉敷崇4, 津曲恭一5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 526-526, 2023.

---

	3-7-O04-5. Medication adherence and a character trait and association with the decision-making tangle 宮崎元康1,2, 高木聡子1, 三崎桃子1, 森由夏子1, 戸倉歌緒子1, 平田ひとみ1, 佐藤夏季3, 岡島義4, 柳田温子4, 中島章雄1,2, 今給黎修1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 527-527, 2023.

---

	3-7-O05-1. Effect of the efforts for the acquisition of the drug global assessment adjustment addition by the intensive care unit permanent residence pharmacist 大塚晋也, 林隼輔, 関根綾子, 長塚さおり, 長谷川英雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 529-529, 2023.

---

	3-7-O05-2. Questionary survey for the emergency visit attending nurse about the pharmacist duties in the emergency visit 立石裕樹1, 齋藤靖弘2, 宮田祐一3, 坂口結斗4, 山本浩二郎5, 武田瑛司6, 岩崎睦3, 宮崎雄二7, 前川大輔8, 吉川眞維樹9, 竹内陽亮10, 矢野洋平1, 後藤貴央1, 宮津大輔1, 渡邊裕之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 530-530, 2023.

---

	3-7-O05-3. Comparison of patients with acute drug intoxication with the nonprescription drug before and after the COVID-19 outbreak 廣瀬正幸1, 平川昭彦2, 山田成樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 531-531, 2023.

---

	3-7-O05-4. The introduction of the Andexanet alpha administration protocol aiming at operation by the multi-type of job cooperation and the evaluation 加藤公人1, 西川嘉広1, 河村理沙1, 小出哲朗1, 渡辺俊文2, 早川武司3, 濱田和秀4, 伊藤久美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 532-532, 2023.

---

	3-7-O05-5. It is efforts of our hospital for the standardization of the dilution magnification in drugs to use in an intensive care domain 西川嘉広1, 今西義紀1, 河村理沙1, 加藤公人1, 早川武司2, 山田典一2, 大村崇3, 宮原ひろみ4, 濱田和秀5, 湯浅右人6, 伊藤久美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 533-533, 2023.

---

	3-7-O06-1. Efforts and evaluation for the perioperative drug control addition calculation 森脇典弘, 神崎愛, 清水星香, 佐々木史香, 池内忠宏, 兼重晋, 神村英利 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 535-535, 2023.

---

	3-7-O06-2. The operational construction of perioperative drug control duties and the evaluation 田中里奈, 鈴木寿樹, 松浦正樹, 眞野成康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 536-536, 2023.

---

	3-7-O06-3. Effect of the non-pharmacist placement to the surgery region to give it at the duties time of the exclusive duty pharmacist concerned with the perioperative drug control addition 本木絵梨奈, 岩間創, 岩下わかな, 坂上進, 堀口香織, 中内佳奈, 松澤菜津子, 太田早紀, 竹澤崇, 土屋広行, 内藤隆文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 537-537, 2023.

---

	3-7-O06-4. Investigation of the factor associated with response rate and nausea post-operative, vomiting of ondansetron in the gynecologic surgery, operation under laparoscopy, cholecystectomy patients 仲宗根千佳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 538-538, 2023.

---

	3-7-O06-5. The effectiveness of ondansetron for postoperative retching, vomiting poor at general anesthesia 村井陽一1, 天野杏南1, 渕上翔太1, 水谷早希2, 棚橋順治2, 木全司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 539-539, 2023.

---

	3-7-O06-6. Examination of the effectiveness of granisetron and droperidol for postoperative retching, vomiting of the gynecologic surgery 中川義浩1, 桑村恒夫1, 原田智子1, 武田なつか1, 杉山和英2, 園田豪之介3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 540-540, 2023.

---

	3-8-O07-1. Cost-effectiveness of nirmatrelvir/ritonavir in outpatient treatment of COVID-19 patients 水野貴仁, 近藤有, 酒井幹康, 小嶋亮太, 實安健市, 三宅芳男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 542-542, 2023.

---

	3-8-O07-2. Relationship between side effects of nirmatrelvir/ritonavir and patient background 杉田裕貴1,2, 長谷香織1, 小林奈央1, 楠本真子1, 近藤佳奈子1,2, 小田怜1,2, 瀬戸崇光1,2, 吉井直子2,3, 西島正剛2,3, 松村友和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 543-543, 2023.

---

	3-8-O07-3. Evaluation of drug interaction management of nirmatrelvir/ritonavir tablets by pharmacists 渡部紘三, 林豊, 加藤純 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 544-544, 2023.

---

	3-8-O07-4. Study on the effectiveness of pregnancy risk minimization program for outpatients prescribed molnupiravir 池澤直樹, 新井達也, 小川直紀, 大野悠, 谷古宇修平, 佐藤渚, 出雲貴文, 小茂田昌代 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 545-545, 2023.

---

	3-8-O07-5. Drug interactions management - utilizing cooperation - PBPM of a physician, hospital pharmacist, the drugstore pharmacist in the COVID-19 ambulatory practice 小林真也1, 米田和夫1, 田村克也1, 福家麻美1, 原伸行2, 高根沢暢己2, 佐藤智恵美2, 阿部真治2, 松浦大輔3, 近藤彰1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 546-546, 2023.

---

	3-8-O08-1. Safety assessment of the rem decibuilding in patients with COVID-19 infection with the impaired renal function 村瀬大翔1,2, 段林正明3, 山田正実1, 村木優一4, 高橋一栄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 548-548, 2023.

---

	3-8-O08-2. Observational study of a rem decibuilding and the antimicrobial combination use actual situation in the COVID-19 inpatient 風間彩1, 村山彩1, 大穂祐介1, 福田哲也1, 益田博司2, 船木孝則3, 中村知夫2, 大宜見力3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 549-549, 2023.

---

	3-8-O08-3. Pharmacist duties in the ward for exclusive use of the new coronavirus infection in the middle scale hospital 井上大奨, 橋本崇広, 野口亜希子, 小薮真紀子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 550-550, 2023.

---

	3-8-O08-4. One patient who conducted insulin instruction for patients with COVID-19 gestational diabetes using Web meeting service Zoom 高橋怜史1, 増尾昌則1, 内藤裕次2, 三澤晴雄2, 河崎さつき2, 仲鉢英夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 551-551, 2023.

---

	3-8-O08-5. Thought for the influenza vaccine, comparison between COVID-19 vaccine and impression by the social media analysis using the text mining 森喜郎1,2, 宮武伸行2, 鈴木裕美2, 森裕香3, 岡田節雄1, 谷本清隆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 552-552, 2023.

---

	3-8-O09-1. Examination about the usefulness of PBPM for the hypomagnesemia by the panitumumab 小中健1,2, 斉藤辰彦1,2, 森本美由樹2,3, 渡邉貴紀4, 都築大輔1,2, 伏谷秀治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 554-554, 2023.

---

	3-8-O09-3. Evaluation of frequency and the risk factor of the extravasation by the docetaxel using the large-scale insurance claim information 柳澤里奈, 豕瀬諒, 後藤良太, 村木優一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 556-556, 2023.

---

	3-8-O09-4. Study on tendency to anticancer medicine-induced arrhythmic expression using the large-scale side effect database 渡部真由1, 奥中真白1,2, 植沢芳広2, 加納大輔1, 川澄賢司1, 渋谷悠真1, 川崎敏克1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 557-557, 2023.

---

	3-8-O09-5. It is a single institution observational study about the association of a surgical site and the onset in patients who received adjuvant chemotherapy of diarrhea after the colon cancer technique using the capecitabine 掛谷雅之1, 諸角一成2, 原賢康3, 三井章3, 佐藤由美子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 558-558, 2023.

---

	3-8-O10-1. 1 case that caused a lower digestive tract during the chemoradiotherapy enforcement in head and neck cancer 佐藤朗, 佐藤紀宏, 前川正充, 眞野成康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 560-560, 2023.

---

	3-8-O10-2. We look at the estrangement of the dose at Carboplatin enforcement in the Osaka City comprehensive medical care center and the rear for the relationship of the adverse event and search for a mark 石坂崚1,2, 藤本亜弓2, 山崎直樹2, 中尾將彦2, 森宏幸2, 土井克彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 561-561, 2023.

---

	3-8-O10-3. A case which developed steroid-resistant erythema multiforme severe by the Pembrolizumab 清水克次1, 角川幸男1, 竹田健志1, 糀谷嘉起2, 大塚倫之2, 菊澤千秋3, 爲政大幾3, 工藤敏啓2, 高木麻里1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 562-562, 2023.

---

	3-8-O10-4. Intervention effect on patients with head and neck cancer - multicenter prospective cohort study - by the hospital pharmacist for oral mucositis measures receiving chemoradiotherapy 吉田謙介1, 渡邉真一2, 星野直人1, 朴慶純3, 飛鷹範明4, 金野昇5, 中井昌紀4, 安藤智七美5, 矢吹剛6, 鈴木直人1, 勝良剛詞7, 冨原圭8, 外山聡1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 563-563, 2023.

---

	3-8-O10-5. One case that was able to contribute to a diagnosis of the irAE hypoadrenalism by the Pembrolizumab by pharmacist intervention, but suffered from treatment 高木明子, 高本裕子, 津田優里香, 牛丸星, 古川莉彩, 正木拓也, 長島裕樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 564-564, 2023.

---

	3-8-O11-1. Real-world clinical survey of adverse events in PRRT (peptide receptor radionuclide therapy) using lutetium oxodotreotide (177Lu) 黒岩勇人1, 上田綾佳1, 眞継賢一1, 河本泉2, 多代尚広2, 柳原一広3, 板垣康4, 岡田務5, 服部悦子6, 高井剛7, 濱口良彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 566-566, 2023.

---

	3-8-O11-2. Search of patient factors affecting the onset of the antiEGFR antibody medicine-induced dermatopathy 内山数貴1, 齋藤佳敬1,2, 武隈洋1, 小松嘉人3, 菅原満1,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 567-567, 2023.

---

	3-8-O11-3. The anamorelin improves the nutritional status of patients with metastatic urothelium cancer during chemotherapy 小田切州広1, 内木拓2, 杉山洋介1,3, 田崎慶彦1,3, 三村佳久1,3, 飯田萌子1,3, 木村優花3, 伊藤菜浪3, 堀田祐志1,3, 安井孝周2, 日比陽子1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 568-568, 2023.

---

	3-8-O11-4. Fact-finding of the high blood pressure, heart disorder in the Isa-Kd therapy 粂哲雄1, 村田志帆1, 原田翔平1, 徳武和馬1, 深谷真史2, 吉嗣加奈子2, 式郁恵2, 榎並輝和2, 篠道弘1, 池田宇次2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 569-569, 2023.

---

	3-8-O11-5. Protective efficacy of the infusion reaction of the trastuzumab with the dexamethasone pre-medication 後藤愛実1,2,3, 畑武生1, 細見誠1,3, 畑智恵子1, 西原雅美1, 根尾昌志1, 岩本充彦4, 木村光誠4, 後藤昌弘3, 力武良行2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 570-570, 2023.

---

	3-8-O12-1. Analysis ... of the drug interaction using effect - adverse drug reaction database (JADER) of the concomitant drug giving it to the QT prolonged with the tyrosine kinase inhibitor 槙原克也, 基村佳世, 福井梨乃, 木本大樹, 沖礼子, 松村友和 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 572-572, 2023.

---

	3-8-O12-2. The thrombosis onset situation investigation in patients receiving VEGF inhibitor 森川記道, 福長豊己, 西倉教子, 高橋恭平, 大山展弘, 横山匠太, 安原昌宏, 滝雪歩, 原田靖子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 573-573, 2023.

---

	3-8-O12-3. Examination of the risk factor to be involved in side effect of Osimertinib aggravation 元日田阿子1, 中澤佑介1, 内海裕文2, 荒屋潤2, 川久保孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 574-574, 2023.

---

	3-8-O12-4. 1 case that the coinfusion administration of butylscopolamine note was effective for stomachache at the irinotecan administration 板倉祥嗣1,2, 苅田明子1, 藤原恵2, 高橋佳孝1, 島田明日香1, 松岡彩友美2, 山本沙織2, 小森桂子1, 土谷有美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 575-575, 2023.

---

	3-8-O12-5. Evaluation of frequency of the thromboembolism in patients receiving immune checkpoint inhibitor and the risk factor 井出貴之1, 荒木太亮2, 内藤隆文1, 小泉知展3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 576-576, 2023.

---

	3-9-O13-1. Construction of the supply situation contact system of the in-hospital adoption medicine which cooperated, and utilized DSJP (ethical drug supply situation database) and SAFE-DI (drug information offer site) 櫻田穣, 中嶋紘文, 坂田幸雄, 長浜谷耕司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 578-578, 2023.

---

	3-9-O13-2. AI chat bot integration type drug information platform architectural efforts aiming at new reporting - medical care person, pharmaceutical company cooperation 前川正充1, 佐藤紀宏1, 丹羽覚浩2, 蓮見修2, 神崎浩孝2, 小川竜一3, メイジャー真知子3, 上林彩3, 鈴木利享3, 山本誠3, 前川麻央1, 五十嵐敏明1, 松浦正樹1, 大津真理3, 木村隆夫2, 眞野成康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 579-579, 2023.

---

	3-9-O13-3. An investigation and proof experiments such as the drug information database application, and the like of the non-pharmacist common use 鈴木高弘1, 氣賀澤郁1, 寺内恭平2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 580-580, 2023.

---

	3-9-O13-4. A passage-related evaluation to affect the drug transluminal administration to neonates and examination of the remedy 岡野真澄美1, 小森智也1, 小池博文1, 佐橋幸子1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 581-581, 2023.

---

	3-9-O13-5. The deletion situation investigation of the package insert of the before course measures time limit PMDA publication to be able to put 山中理1, 山村篤史2, 早川太朗2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 582-582, 2023.

---

	3-9-O14-1. Examination about the administration of theophylline adequacy in elderly people: Approach based on a large-scale database and the Pharmacometrics 岡田章1,2, 世良庄司1,2, 田口真穂3, 山田博章3, 永井尚美1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 584-584, 2023.

---

	3-9-O14-2. Association between urine sugar and uric acid level before and after the SGLT2 inhibitor remedy in patients with type 2 diabetes 田中侑希1,2, 太田涼介2, 平田士2, 横山聡1, 宇野貴哉1, 細見光一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 585-585, 2023.

---

	3-9-O14-3. A tendency to onset of diabetes-related adverse event with the non-fixed form antipsychotics in patients with dementia: Analysis using JADER 羽渕風雅1, 石田奈津子2, 柏宗伸2, 石崎純子2, 松下良2, 菅幸生2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 586-586, 2023.

---

	3-9-O14-4. Prediction of the transluminal administration advisability by the simple suspension method using the machine learning 友田吉則, 小林昌宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 587-587, 2023.

---

	3-9-O14-5. Application of spontaneous report database aiming at an effective evaluation to the long-term survival of the pulmonary artery-related pulmonary hypertension therapeutic drug 鈴木光路, 八木達也, 川上純一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 588-588, 2023.

---

	3-9-O15-1. Effect by the addition of the thickness adjustment food on vancomycin hydrochloride sprinkling solution 小見暁子1, 秋山滋男2, 石岡大成3, 野澤彰4, 土井信幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 590-590, 2023.

---

	3-9-O15-2. The effect that educational intervention gives to patients prognosis on loading dose of vancomycin based on Antimicrobial Stewardship Program 朝居祐貴1, 小西知美1, 武田紗和1, 近澤香織2, 井端英憲3, 高橋昌明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 591-591, 2023.

---

	3-9-O15-3. The effectiveness of the arbekacin for the childhood febrile neutropenia and safe examination 寺川央一1, 中馬真幸1, 都築仁美1, 寒藤雅俊1, 吉田祐花1, 上杉紘一1, 眞鍋貴行1,2, 神山直也1,2, 岩山訓典1,3, 山本譲1, 田崎嘉一1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 592-592, 2023.

---

	3-9-O15-4. About the relations of aim Time Above MIC achievement quotient and the clinical response of the meropenem in patients with Pseudomonas aeruginosa bacteremia 中島一1, 桑村恒夫2, 芳賀由美3, 宮崎美穂1, 高木祐真1, 小倉秀美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 593-593, 2023.

---

	3-9-O15-5. Efforts and antimicrobial consumption change for proper use promotion of the third generation oral cephalosporin medicine 村山彩1, 風間彩1, 福田哲也1, 大穂祐介1, 庄司健介2, 大宜見力2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 594-594, 2023.

---

	3-9-O16-1. Multifaceted intervention to empiric treatment of the working full time pharmacist-led intravenous antimicrobial in the small municipal hospital 佐々木康弘1, 山口明子2, 梅原亜佑美3, 田頭保彰4, 矢野雅隆5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 596-596, 2023.

---

	3-9-O16-2. The effect that feedback using J-SIPHE gives for proper use of the carbapenem-based medicine 大池恵生1, 渡邊崇平2, 杉村聡2, 高岡龍蔵2, 田中孝正1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 597-597, 2023.

---

	3-9-O16-3. Efforts and result for the drug-resistant (AMR) measures action plan accomplishment of the fluoroquinolone antibacterial 吉村昌紘1, 加藤一雲1, 坂野昌志1, 杉浦茂樹1, 竹内章2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 598-598, 2023.

---

	3-9-O16-4. The effectiveness of the cefmetazole for the large intestine diverticulitis without complications 星野祐太1, 伊藤亮太1, 菊地未由1, 高橋賢一2, 内山弘子1, 外岡久和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 599-599, 2023.

---

	3-9-O16-5. Effective and safe examination - cefepime of the intravenous antimicrobial for the febrile neutropenia vs. tazobactam piperacillin vs. meropenem ... 木原星衣, 湯川真里, 加藤一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 600-600, 2023.

---

	3-9-O17-1. Pulmonary suppuration by Achromobacter xylosoxidans where chronic administration of Sulfamethoxazole/trimethoprim was successful 柏原道志1, 本田勝亮1, 光定健太2, 長岡翔1, 堤克成1, 塩田亮介1, 石野清亮1, 土手尚2, 渥美生弘2, 矢部勝茂1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 602-602, 2023.

---

	3-9-O17-2. The effect that the introduction of the examination of nucleic acid amplification in patients with Clostridioides difficile infection gives for clinical prognosis 山田楊太1,3, 宮崎元康1,3, 串間尚子2,3, 中島章雄1, 小川新1,3, 石井寛1,3, 今給黎修1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 603-603, 2023.

---

	3-9-O17-3. The effect that a meropenem supply stop gave for treatment of the Enterobacter genus 長谷川浩司, 山田真人, 宮崎祐介, 岩本里味 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 604-604, 2023.

---

	3-9-O17-4. Choice of the therapeutic drug for Daptomycin non-sensitivity Staphylococcus capitis subspecies urealyticus isolated from chronic osteomyelitis 西出(山田)景子1,2, 畑中公基3, 武田明4, 木戸裕勝5, 佐川美恵5, 吉川誠一5, 小野伸高5,6, 荒川宜親7,8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 605-605, 2023.

---

	3-9-O17-5. Examination of the use of aztreonam case in our hospital 吉田博昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 606-606, 2023.

---

	3-9-O18-1. Examination of the domestic long-term storage condition of the histidine copper hospital preparation which is a Menkes disease therapeutic drug 上野裕大1, 眞鍋貴行1,2, 新田悠一朗1, 岩山訓典1,3, 神山直也1,2, 小野尚志1, 山本譲1, 中馬真幸1, 田崎嘉一1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 608-608, 2023.

---

	3-9-O18-2. Development of the clinical preparation which pointed to light stability improvement of Sugammadex 阿部雅也1, 内田淳2, 山田幸平1, 佐藤秀行1, 尾上誠良1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 609-609, 2023.

---

	3-9-O18-3. Development and evaluation - of efforts - hospital preparation, the selenium private business FAST-DISINTEGRATING TABLET for the improvement in quality of life of patients with selenium deficiency 赤垣恵太1, 田村尚久1,2, 石田智滉1, 白石久1, 加賀屋陽子1, 門田亜紀1, 山本雅樹3, 森田靖代1, 常風興平1, 藤枝幹也3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 610-610, 2023.

---

	3-9-O18-4. Control ... of the drug absorption speed by basic examination - dosage form to assume a nasal agent the substitute preparation of the oral formulation 古林呂之1, 田中晶子1, 藏屋幸輝1, 岩永一範2, 坂根稔康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 611-611, 2023.

---

	3-9-O18-5. The effect that a combination of eyedropper and medicinal solution of suspensibility eye drops gives in redispersibility 小畑友紀雄1, 出口粧央里2, 吉富丈治2, 浦嶋庸子1, 小堀宅郎1, 細見光一2, 長井紀章2, 中田雄一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 612-612, 2023.

---

	3-10-O19-1. Examination of the skin absorption factor of the forerunner, the generic medicine of the indometacin liniment 寺山和利1, 奥平倫世1, 渡部多真紀1,2, 久保田篤司1, 土屋雅勇2, 安野伸浩1,2, 渡辺茂和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 614-614, 2023.

---

	3-10-O19-2. Examination about the economic effect by the Biosimilar introduction in our hospital 後藤隆, 久松大祐, 石橋由佳, 高野豪, 衛藤智章, 藤田強記, 清水裕彰 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 615-615, 2023.

---

	3-10-O19-3. Examination of the evaluation using the use amount ratio of the Biosimilar introduction effect 橋本美紀恵, 九良賀野司, 高木昭佳, 加藤敦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 616-616, 2023.

---

	3-10-O19-4. One case with suspected allergy of the biofollowing article of the trastuzumab 松由幸司1, 近藤章吾1, 曽根章貴1, 高澤圭輔1, 安田翔1, 生駒辰夫1, 宮部芳之1, 大野元嗣2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 617-617, 2023.

---

	3-10-O19-5. Therapeutic safe comparison between precedent biomedicine and biofollowing article of the bevacizumab 小原直紘1, 関本裕美2,3, 本田芳久2,4, 土井敏行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 618-618, 2023.

---

	3-10-O20-1. Does the presence or absence of discontinuation before SGLT2 inhibitor technique influence perioperative care of the pancreatectomy case? Single institution past starting point cohort study 吉川和美, 土手賢史, 漣航平, 仲原隆史, 松尾基樹, 小林由佳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 620-620, 2023.

---

	3-10-O20-2. The diabetes medical therapy that is optimal for an individual 富岡節子1, 山崎直毅2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 621-621, 2023.

---

	3-10-O20-3. The effect that the complexity of prescription contents gives for achievement of hemoglobin A1c target value of patients with type 2 diabetes 丸山慧, 茂木孝弘, 木村直也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 622-622, 2023.

---

	3-10-O20-4. One case with suspected drug-related hypoglycemia by the paliperidone 中島璃沙, 奥美和, 谷口一成 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 623-623, 2023.

---

	3-10-O20-5. One patient whom normoglycemia diabetic ketoacidosis developed in in start two days of the ipragliflozin 佐古守人, 美甘早紀, 西口真代, 黒沢秀夫, 野村剛久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 624-624, 2023.

---

	3-10-O21-1. Examination of the risk factor of nausea post-operative vomiting in patients who underwent thoracoscopic esophagectomy 村岡健太1,2,4, 里美貴3, 米澤龍4, 栗原竜也5, 樋口慧6,7, 向後麻里3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 626-626, 2023.

---

	3-10-O21-2. Identification of the factor predicting the onset of the antipsychotics-induced weight gain 石川修平1, 橋本直樹2, 大久保亮3, 久住一郎2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 627-627, 2023.

---

3-10-O21-3. The renin-angiotensin system inhibition medicine inhibits the onset of diabetic peripheral neuropathy: Inspection in a retrospective cohort study and the fundamental researches at 3 hospitals 岩根詩織1,2, 根本亙3, 宮本朋佳2,4, 林友典5, 田中雅幸1, 打谷和記1, 小泉祐一6, 平田敦士5, 坪田真帆2, 関口富美子2, 丹野孝一3, 川畑篤史2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 628-628, 2023.

---

	3-10-O21-4. Effect on vital prognosis of the factor which is not associated with the cardiac function in patients with acute decompensated heart failure 丸岡由奈1, 石田智滉1, 川田敬2,3, 濱田知幸4, 門田亜紀1, 森田靖代1, 福田仁5, 久保亨4, 常風興平1, 北岡裕章4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 629-629, 2023.

---

	3-10-O21-5. The effect that a pharmacist outpatient gives for the long-term clinical outcome of the antithrombotic drug remedy patients 栗村朋子1, 山本和宏1, 田中秀和2, 鳥羽敬義2, 木村丈司1, 土生康司3, 糸原光太郎1, 北廣優実1, 大村友博1, 矢野育子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 630-630, 2023.

---

	3-10-O22-1. Identification of the onset time of the excessive renal clearance in the seriously ill patients and duration and the associated factor 三上龍生1,2, 早川峰司3, 今井俊吾4, 菅原満1,2, 武隈洋2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 632-632, 2023.

---

	3-10-O22-2. An evaluation of eGFR slope in the proton pump inhibitor long-term use patients: Vertical section study using DPC Hospital data 室伏琢磨1,2, 八木達也2, 田中達也2, 辻大樹1, 伊藤邦彦1, 川上純一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 633-633, 2023.

---

	3-10-O22-3. Examination of the effect that AUC of mycophenolic acid in renal-transplant recipients gives for side effect expression 佐伯友里1, 福澤翔太1, 鷲野友亮1, 南島拓矢1, 石田昇平2, 加藤真史2, 佐野優太2, 溝口博之1, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 634-634, 2023.

---

	3-10-O22-4. Effect of the vonoprazan giving it to renal function after the radiation combination high dose cisplatin therapy enforcement 辻田彩1, 近藤優義2, 池村健治1, 山本智也1, 奥田真弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 635-635, 2023.

---

	3-10-O22-5. Diabetes aggravates cisplatin origin-related nephrotoxicity 坂本達彦1, 齋藤佳敬1, 武隈洋1, 小林正紀2, 岡本敬介1, 品川尚文3, 清水康4, 木下一郎4, 菅原満1,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 636-636, 2023.

---

	3-10-O23-1. The effectiveness of the new antirheumatic drug by the network meta-analysis and safe comparison 大西真由, 劉臨風, 吉井優花, 安部賀央里, 頭金正博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 638-638, 2023.

---

	3-10-O23-2. The search of pharmacokinetics and the effect on central side effect factor of the mirogabalin: Observational, prospective study 濱口直美1, 岡本明大1, 平井利典1, 高橋梨恵1, 金田真吏2, 川口晃司2,3, 高尾仁二2, 岩本卓也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 639-639, 2023.

---

	3-10-O23-3. The predictor analysis of the immune-mediated adverse event with the checkpoint inhibitor + platinum combination therapy for the non-small cell lung cancer of immunity: Multicenter study 藤本愛理1, 薮内由里香2, 甲斐達夫3, 小園亜希4, 松尾圭祐1, 永田祐子5, 桑原貴美子6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 640-640, 2023.

---

	3-10-O23-4. Hepatotoxic factor analysis in the acute phase of cerebral infarction and the transient cerebral ischemic attack 安高勇気1,2, 藤岡伸助3, 坪井義夫3, 大藪康平1,2, 芝口浩智2, 神村英利1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 641-641, 2023.

---

	3-10-O23-5. Analysis of the risk factor having the asymptomatic bacteriuria onset in patients receiving SGLT2 inhibitor 伊藤亮太1, 渡邊卓嗣2, 星野祐太1, 菊地未由1, 内山弘子1, 外岡久和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 642-642, 2023.

---

	3-10-O24-1. Investigation of factors involved in the development of CMV infection under letermovir prophylaxis 岩男聖弥, 白岩健, 田中遼大, 龍田涼佑, 伊東弘樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 644-644, 2023.

---

	3-10-O24-2. Study on tazobactam/piperacillin using an adverse event spontaneous report database and the medical record and factor of the onset of liver damage with the meropenem 白石ちひろ1, 加藤秀雄1, 小椋透3, 今井寛2, 岩本卓也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 645-645, 2023.

---

	3-10-O24-3. Systematic review for effective antimicrobial choices for the childhood Clostridioides difficile infection, meta analysis 三原貴之1, 田代渉1, 大川力也1, 田中葉子1, 佐村優1,2, 榎木裕紀1, 田口和明1, 松元一明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 646-646, 2023.

---

	3-10-O24-4. PK/PD analysis of ganciclovir in patients with congenital cytomegalovirus infection 糸原光太郎1, 藤中俊輔1, 山本和宏1, 橋本真梨1, 田村直暉1, 北廣優実1, 大村友博1, 藤岡一路2, 矢野育子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 647-647, 2023.

---

	3-10-O24-5. Population pharmacokinetics analysis of vancomycin for neonates and anticipatory comparison with the existing model 赤間田悠刀1, 小松敏彰1, 尾鳥勝也1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 648-648, 2023.

---

	3-11-O25-1. Efforts of the pharmacist to Clozapine introduction 栗原梢, 瀧祐介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 650-650, 2023.

---

	3-11-O25-2. 1 case that treatment-resistant schizophrenia became stable by blood level adjustment of the lithium carbonate under the Clozapine combination 松原寛子, 竹田馨, 高木昭佳, 加藤敦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 651-651, 2023.

---

	3-11-O25-3. Inspection of the pharmacist intervention in the Clozapine TDM 藤江直輝, 青木涼, 原田学, 下村好子, 四方佳美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 652-652, 2023.

---

	3-11-O25-4. Evaluation about the blood level when we gave lamotrigine to patients with bipolar disorder at a dose according to a package insert 坪内清貴1, 金俊孝1, 磯田和也1, 嶋田努1, 内藤暢茂2, 菊知充3, 崔吉道1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 653-653, 2023.

---

	3-11-O25-5. We evaluate the effectiveness for the delirium prevention after the stroke of the melatonin receptor agonist in elderly people and the orexin receptor blocker 三好由希子1, 重面雄紀1, 平大樹1, 眞木崇州2, 杉田尚子3, 川島啓嗣3, 須賀原教子4, 平井真智子1, 圓東寛基1, 川田将義1, 北田徳昭1, 中川俊作1, 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 654-654, 2023.

---

	3-11-O26-1. Sleeplessness and the effect factor (interim report) in middle elderly patients 野田久美子1, 工藤雅史1, 椋本啓介1, 馬場一秀1, 川口啓之1, 横浜吏郎2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 656-656, 2023.

---

	3-11-O26-2. The effect that the efforts of the delirium measures team led by the pharmacist gave for sleep-related prescription and fall 大森俊和, 米内洸, 臼田昌弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 657-657, 2023.

---

	3-11-O26-3. Change of efforts and the prescription trend to sleeping drug proper use by the multi-type of job cooperation in the Chuo, Asahi, Yokohama General Hospital 高橋照明, 小串興平 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 658-658, 2023.

---

	3-11-O26-4. Correspondence and effect on patients investigation accompanied with the supply stop of biperiden tablets 中山洋輔1, 福石和久1, 渡辺健二1, 石井秀明1, 古賀亮次1, 岡辰也1, 藤瀬陽子2, 糸永侑華3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 659-659, 2023.

---

	3-11-O26-5. The relation to dementia, the delirium patients through dementia care team (DCT) and the evaluation 佐藤史織1,2, 橋本晴香1,2, 田原良一2,3, 森永克彦2,4, 陸丸幹男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 660-660, 2023.

---

	3-11-O27-1. The use history of the immune checkpoint inhibitor is association of the interstitial pneumonia of EGFR-TKI: Matched-pair cohort analysis using the national inpatient database 祝千佳子1, 城大祐2,3, 小西孝明1, 藤田あさひ4, 道端伸明2, 松居宏樹1, 康永秀生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 662-662, 2023.

---

	3-11-O27-2. Onset of hypothyroidism prediction by the Pembrolizumab using the neutrophilic/lymphocytes ratio 中澤佑介1, 元日田阿子1, 渡部可奈子1, 内海裕文2, 荒屋潤2, 川久保孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 663-663, 2023.

---

	3-11-O27-3. Look at the rear about the oxaliplatin-induced peripheral neuropathy protective efficacy by the proton pump inhibitor combination; mark clinical studies 峯圭佑1,2, 川尻雄大1, 小林大介1, 森皓平1, 江頭伸昭3,4, 小柳悟2, 大戸茂弘2, 家入一郎3, 島添隆雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 664-664, 2023.

---

	3-11-O27-4. The low four extremities skeletal muscle mass index before the treatment is a risk factor of the febrile neutropenia with the DCF therapy 奈良克彦1, 山本武人1, 佐藤靖祥2, 八木浩一2, 瀬戸泰之2, 高田龍平1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 665-665, 2023.

---

	3-11-O27-5. Examination about the expression of the infusion reaction at the antihistamine non-administration in the ramucirumab + nab-paclitaxel therapy 前田太一1, 根來寛2, 五十嵐弘幸3, 重森美奈2, 田中敏博2, 伊藤幸男3, 谷澤範彦1, 西川翔太1, 小川純也1, 上谷幸男2, 渡邉享平4, 塚本仁2, 後藤伸之2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 666-666, 2023.

---

	3-11-O28-1. Risk assessment of the HBV reactivation in the cancer chemotherapy of the HBV history infection patients: Clinical significance of HBc antibody titers 大久保真貴1, 勝山繁佳1, 土岐浩介1, 鈴木嘉治1, 瀬尾恵美子2, 関根郁夫3, 本間真人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 668-668, 2023.

---

	3-11-O28-2. Improvement of the cancer cachexia with the anamorelin administration and participation in neutrophilic/lymphocytes ratio 渡部可奈子1, 中澤佑介1, 元日田阿子1, 宇和川匡2, 川久保孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 669-669, 2023.

---

	3-11-O28-3. Examination of the side effect of difference frequency of the quantity of hydromorphone introduction 加藤涼子1,8, 高岡龍蔵2,8, 小園友明1,8, 立花京香3,8, 鳥居昌太4,8, 吉田加代3,8, 越野明花3,8, 長戸大空3,8, 齋藤旭美4,8, 後藤健志5,8, 遠山幸男2,8, 築山郁人6,8, 宮崎雅之7,8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 670-670, 2023.

---

	3-11-O28-4. Elucidation of the phenytoin pharmacokinetics change factor at the ketogenic diet therapy for intractable epilepsy 赤下学1,2, 宮川雄一1, 橋本美紀恵3, 中谷絵理子2, 黄倉崇2, 嶋田努1, 崔吉道1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 671-671, 2023.

---

	3-11-O28-5. It is predicted analgesic effect and the respiratory depression effect after the pediatric operation by pentazocine pharmacokinetics/pharmacodynamic model 大森崇行1, 青山隆彦2, 松本宜明2, 辻泰弘2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 672-672, 2023.

---

	3-11-O29-1. A large quantity of ascites in patients with gastrointestinal carcinoma reduces blood level of the ramucirumab 金子卓也1, 土岐浩介1,2, 山田武史3, 山本祥之3, 森脇俊和3, 鈴木嘉治1,2, 本間真人1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 674-674, 2023.

---

	3-11-O29-2. Pharmacokinetic/genome pharmacologic analysis of tramadol in the hepatectomy patients 北川優香1,2,3,4,5, 神谷貴樹2, 山田日向美1, 井手径子3, 上島智1,2, 平大樹1,2,4, 飯田洋也5, 角本幹夫1, 谷眞至5, 森田真也2, 寺田智祐2,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 675-675, 2023.

---

	3-11-O29-3. Pharmacokinetics of the Clozapine in patients with Japanese childhood schizophrenia, an N-demethyl body, the N-oxide body 中村紗緒里1, 猪川和朗1, 浅野芽依1, 岡田瑞希1, 井村友哉1, 村田香奈恵1, 坂田睦2, 堀川直希2, 森川則文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 676-676, 2023.

---

	3-11-O29-4. The effect that the change of the triglyceride level gives to the early period of administration and blood steady-state amiodarone levels 高橋諒多, 辻本高志, 加納宏樹, 川本由加里, 後藤仁和 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 677-677, 2023.

---

	3-11-O29-5. Blood level change of tacrolimus after switching from itraconazole private business liquid to an itraconazole capsule 正木寛1, 宮田大資1, 川島光明2, 此枝千尋2, 佐藤雅昭2, 高田龍平1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 678-678, 2023.

---

	3-11-O30-1. Evaluation ... of the usefulness to result in simultaneous measurement - plasma concentration analysis and the TDM of the Clozapine in patients with schizophrenia, an N-demethyl body, the N-oxide body 井村友哉1, 猪川和朗1, 浅野芽依1, 岡田瑞希1, 中村紗緒里1, 村田香奈恵1, 坂田睦2, 堀川直希2, 森川則文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 680-680, 2023.

---

	3-11-O30-2. Genetic polymorphism and effect of the cachectic progress to give to blood naldemedine concentrations and bowel movement effect at the cancer condition of a patient 中津川瑛美1, 内藤隆文2, 柴田海斗2, 前川真人3, 川上純一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 681-681, 2023.

---

	3-11-O30-3. Effect of the CYP2C19 genetic polymorphism on impaired renal function with lansoprazole 福井里佳1, 野田哲史1,3, 澤山裕一2, 中川義久2, 池田義人1, 森田真也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 682-682, 2023.

---

	3-11-O30-4. Change of gastrointestinal absorption/excretion change of glucose through the transporter with metformin 荻さやか, 白坂善之, 竹村美由記, 玉井郁巳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 683-683, 2023.

---

	3-11-O30-5. Development of the eyelid application troxipide nanopreparation aiming at application to dry eye therapy 小坂太陽1, 渡辺彩花1, 板橋瑞稀1, 油納美和1, 大竹裕子1, 長井紀章1, 岡本紀夫2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 684-684, 2023.

---

	4-7-O31-1. About the questionary survey about the effect of the Saku General Hospital group "outside Parliament prescription inquiry simplification protocol" 堀内賢一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 686-686, 2023.

---

	4-7-O31-2. Periodical prescription input support ... by efforts - pharmacist for the duties burden reduction of the physician 永島久義, 大江敬太郎, 菅野晴香, 石井重亮, 吉田裕美, 星正弘, 須藤孝浩, 黒田純子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 687-687, 2023.

---

	4-7-O31-3. Examination about the usefulness of the prescription support using PBPM in the foreign chemotherapy room 竹本竜平1, 中村大学1, 菱谷まどか1, 大橋一輝1, 外海友規1,2, 手崎世織1, 竹本将士1, 朝岡みなみ1,2, 堀田祐志1,2, 近藤勝弘2,3, 日比陽子1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 688-688, 2023.

---

	4-7-O31-4. Evaluation of task shift/share in the pharmacist outpatient specialized in a cancer utilizing the representation prescription order authority 今村牧夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 689-689, 2023.

---

	4-7-O31-5. Intervention ... of the pharmacist using efforts - clinical path for the secondary bone fracture prevention of patients with proximal thighbone bone fracture 瀬名波暢子1,2, 塚田加奈子1, 吉良俊彦1, 宇野百合香1, 門馬佳代子1, 辻井佳代1, 堤良祐2, 小林政彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 690-690, 2023.

---

	4-7-O32-1. Viewpoint of a specialty, the authorized pharmacist in the attitude survey of the hospital pharmacist about normal business routine, the career plan 坂本靖宜1, 川邊一寛1, 田中利樹2, 川邉桂1, 原広司3, 小池博文1, 佐橋幸子1, 後藤隆久4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 692-692, 2023.

---

	4-7-O32-2. Effect on task shifting and ward drug duties of the examination of vancomycin note (VCM) prescription order representation input by the AST pharmacist 高橋希1, 古川早矢香1, 河野綾香1, 鈴木信也1, 井口恵美子1, 渋江寧2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 693-693, 2023.

---

	4-7-O32-3. It is ... including an effect of the task shifting from evaluation ... physician from the type of job other than the drug control summary making at hospital transfer by the pharmacist 伊藤有美, 水野由紀子, 柴田大地, 滝本典夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 694-694, 2023.

---

	4-7-O32-4. Inspection of the effect in the current situation of the pharmaceutical intervention and the medical security on perioperative patients 小松沙希1, 齋藤豪1, 平泉達哉2, 佐々木良1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 695-695, 2023.

---

	4-7-O32-5. It is improved the vaccination ratio by the vaccination protocol introduction for patients after the splenectomy 堀内望, 土手賢史, 前間優衣, 漣航平, 松尾基樹, 小林由佳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 696-696, 2023.

---

	4-7-O33-1. A case of the children whom tongue black hairy and tooth discoloration occurred in during meropenem, vancomycin intravenous injection administration 山田真由美1, 福田哲也1, 詫間梨恵1, 山尾晶子1, 伊藤栞1, 村山彩1, 庄司健介2, 宇佐美憲一3, 荻原英樹3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 698-698, 2023.

---

	4-7-O33-2. Investigation into blood pressure changes during and after discontinuation of clazosentan sodium administration 瀬戸亘, 齊藤伸, 木元健寛, 吹谷真紀子, 八代佳子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 699-699, 2023.

---

	4-7-O33-3. Research on whether caffeine side effects are explained and the nocebo effect 小島彩香1, 加藤未来1, 泉谷優佳1, 本間遥香1, 井澤美苗1, 清宮啓介1, 石川春樹1,3, 望月眞弓1, 青森達1,3, 大谷壽一1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 700-700, 2023.

---

	4-7-O33-4. Systematic review about the case report which developed a serious liver damage with the Saibokuto and the Chinese medicine-induced liver damage 星茜1, 百賢二2, 船越晴喜1,2, 音山裕美3, 吉田仁3, 佐々木忠徳4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 701-701, 2023.

---

	4-7-O33-5. Drug-related hypoglycemic seasonal inspection using the adverse event spontaneous report database 坂崎友香, 近藤悠希, 福田真依, 石塚洋一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 702-702, 2023.

---

	4-7-O34-1. Survey on the use of iodine contrast media in patients prescribed Imeglimin 延藤勇 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 704-704, 2023.

---

	4-7-O34-2. The current situation investigation of the information collected in an in-hospital side effect report 宇野英理子, 野々垣知行, 川澄紀代, 後藤裕美子, 佐久間晶基, 大西正文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 705-705, 2023.

---

	4-7-O34-3. Fact-finding of the hypersensitivity symptom onset with the contrast media administration 鈴木千愛1, 嶋田沙織1, 篠崎拓哉1, 落合美伽1, 宮田真理子2, 小嶋良幸2, 中島崇仁2,3, 本間真人1,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 706-706, 2023.

---

	4-7-O34-4. Investigation about anemia of the JAK inhibitor in patients with rheumatoid arthritis 小西正晃1, 三木賢人1, 平林弘美2, 竹内洋平3, 徳田道昭3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 707-707, 2023.

---

	4-7-O34-5. Examination about the onset of hepatic dysfunction risk factor by the nintedanib 上田真也1, 植松若那1, 奥隅拓朗1, 成田和希1, 蜂巣寿哉2, 薄雅人3, 山本吉章4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 708-708, 2023.

---

	4-7-O35-1. One patient whom methemoglobinemia developed in after using rasburicase 谷本憲哉1, 杉尾由希子2, 鳥山陽子2, 大窪典子2, 山形真一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 710-710, 2023.

---

	4-7-O35-2. Expression situation and association between infusion related reaction and immune-mediated adverse event investigation by the Pembrolizumab 中村圭菜1,2,3,4, 秦啓子1, 前田真一郎1,2,3, 前田真貴子1,2,3,4, 藤尾慈1,2,3,4, 廣部祥子1,2,3,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 711-711, 2023.

---

	4-7-O35-3. Rate of decline in estimated glomerular filtration rate and lipid metabolism parameters after initiation of tenofovir alafenamide : comparison with abacavir 日笠真一1, 田澤佑基2, 石井聡一郎3, 溝端友希4, 上原仁5, 阿部憲介6, 國本雄介7, 村田龍宣8, 島袋翔多1, 日笠聡9, 木村健1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 712-712, 2023.

---

	4-7-O35-4. One case of the cardiac activity disorder attributable to taking minoxidil 今井雄介1, 田中雅幸1,2, 諏訪惠信3, 尾崎春菜1, 谷口綾1, 宇都宮敦子1, 前田千尋1, 西山徳人1, 打谷和記1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 713-713, 2023.

---

	4-7-O35-5. One case of the lung adenocarcinoma which produced hemorrhagic cystitis during Ipilimumab/Nivolumab combination immune therapy 八瀬恵理子1, 林洋太郎1, 上柳汐果1, 中嶋尚子1, 森本健幹1, 荒木博賢3, 今北卓間2, 小田亮介1, 丸山直岳1, 森吉弘毅4, 奥野博3, 三尾直士2, 土井敏行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 714-714, 2023.

---

	4-7-O36-1. The effect that use of Daikenchuto and the enoxaparin gives for a liver damage 渡辺宏晃, 平井啓太, 中澤佑香, 小池彩花, 土屋広行, 内藤隆文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 716-716, 2023.

---

	4-7-O36-2. Examination of the risk factor about acute renal failure onset in the combination of tazobactam/piperacillin and vancomycin case 村岡理沙子1, 今井雄介1, 岩根詩織1, 田中雅幸1,2, 西山徳人1, 打谷和記1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 717-717, 2023.

---

	4-7-O36-3. A case that the intervention based on "the drugstore vision for patients" contributed to side effect becoming severe evasion 佐藤史也1,2, 薄井健介2, 渡邊卓嗣2, 大内竜介2, 菅原幸乃1, 岡田浩司2, 藤村務2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 718-718, 2023.

---

	4-7-O36-4. The effect that flurbiprofen gives to failure of the sutures after the digestive organ surgery 鈴木喬也, 杉本智哉, 奥苑朱加, 山室栄一, 遠山幸男, 久田達也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 719-719, 2023.

---

	4-7-O36-5. Examination of the new instillation method for the purpose of the reduction of the adverse event out of the eyes 池田博昭1, 河野清尊2, 中妻章1, 芳地一1, 川添哲嗣1, 飯原なおみ1, 池田純子3, 夛田羅勝義4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 720-720, 2023.

---

	4-8-O37-1. Examination about the safety at frequencies and the readministration of fever, the dermatopathy by Gemcitabine 相楽勇人1, 佐々木勇人2, 進藤吉明2, 田中雄一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 722-722, 2023.

---

	4-8-O37-2. Fact-finding of the cardiac troponin level change in the dysfunction thyroid with the immune checkpoint inhibitor 川之辺淳, 渋谷悠真, 鈴木真也, 川崎敏克 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 723-723, 2023.

---

	4-8-O37-3. The effectiveness of the S-1 dose design using eGFR and safe examination: Look at the single institution rear; a mark observational study 吉澤朝枝1, 白川博文2, 櫻澤有紀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 724-724, 2023.

---

	4-8-O37-4. Comparison between risk of developing diarrhea and disease severity by the opioid combination at Abemaciclib start 吉田弘樹, 鈴木雅人, 高原悠子, 牧原明秀, 三屋良太, 近藤舞子, 木全司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 725-725, 2023.

---

	4-8-O37-5. Factorial experiments of the drug-related pulmonary disorder in the breast cancer chemotherapy 大谷豊司, 南目祐希, 谷章子, 北郷真由絵, 松浦智子, 南目梨江, 河角康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 726-726, 2023.

---

	4-8-O38-1. Effect by the manual introduction of the opioid parenteral injection 岩永崇志1,2, 原田未紗1, 荻野裕介1, 池田敦1, 森光保武1, 川波利子2, 寺尾正子2, 岡崎正典3, 藤井秀一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 728-728, 2023.

---

	4-8-O38-2. Inspection about the effect of the naldemedine tosyl acid salt on patients with cancer during hydromorphone tablets internal use 北口剛吉1, 山瀬大雄3, 井幡圭佑2, 大城美希2, 有江宏樹3, 辻井佳代3, 端裕之4, 小林政彦3, 村田久枝1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 729-729, 2023.

---

	4-8-O38-3. Examination of anamorelin for the cancer cachexia and the weight gain-related factor 奥田泰考1, 齋藤賢宏1, 三瓶祐貴1, 品田誠1, 藤村昭太1, 菅留理1, 小林直人1, 中田雅人1, 荒井大地1, 中澤寛仁1, 山口博紀2, 今井靖1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 730-730, 2023.

---

	4-8-O38-4. Elucidation of the effect predictor of the anamorelin using the CONUT score in the cancer cachexia patients during cancer chemotherapy 藤井宏典1, 牧山明資2, 西村佳代子3, 飯原大稔1, 廣瀬智恵美1, 大畑紘一1, 山田友奈美1, 小林亮1,4, 鈴木昭夫1,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 731-731, 2023.

---

	4-8-O38-5. Fact-finding of the intervention instruction to patients with cancer by the mild medical therapy authorization pharmacist and comparison with the non-authorized pharmacist 中川隼一1, 田中怜2,3, 菅幸生4, 宮崎雅之5, 佐藤由美6, 萩原諒一7, 内田まやこ8, 高瀬久光9 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 732-732, 2023.

---

	4-8-O39-1. Investigation about the use actual situation of the combination drug with the fluorouracil system anticancer agent 竹増理恵1, 長井克仁2, 富樫由美1, 福野修平2, 小西廣己2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 734-734, 2023.

---

	4-8-O39-2. Is the CYP3A conduction of the dexamethasone not strong at the high dose either? Consideration ... from the case that used ... tacrolimus together and publication information 大野能之1, 折山豊仁1, 本田晃2, 黒川峰夫2,3, 高田龍平1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 735-735, 2023.

---

	4-8-O39-3. Elucidation of the mechanism of lorlatinib-induced liver injury in combination with rifampicin - Study on immune activation using THP-1 cells - 野田拓誠1,2, 浦嶋和也3, 田中沙織1, 幸田祐佳1, 宮部貴識2, 加藤隆児1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 736-736, 2023.

---

	4-8-O39-4. In vitro analysis about the CYP4F2 metabolic block activity with anti-peptic ulcus agents and the dyslipidemia therapeutic drug 桜木優太, 佐藤裕, 前川正充, 眞野成康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 737-737, 2023.

---

	4-8-O39-5. Effect of osmotic pressure to give to the interaction between drug - drink and OATP and the contribution analysis 竹村美由記, 白坂善之, 玉井郁巳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 738-738, 2023.

---

	4-8-O40-1. A case which rifampicin after the cancellation influenced it, and suffered from control of the optimal blood level of voriconazole 山本幹典, 伊藤雄紀, 梅村拓巳, 河村隆登, 伊藤聡一郎, 山田哲也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 740-740, 2023.

---

	4-8-O40-2. Questionary survey about drug interactions of Warfarin and 5-fluorouracil 國場訓, 外間登, 石井岳夫, 山内祐子, 佐久川卓, 山田智史, 鈴木毅, 難波有智, 潮平英郎, 中村克徳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 741-741, 2023.

---

	4-8-O40-3. Examination of the effect on vancomycin-sensitive enterococcus bloodstream infection index of vancomycin 小松敏彰1, 内藤綾麻2, 赤間田悠刀1, 二本柳伸3, 尾鳥勝也1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 742-742, 2023.

---

	4-8-O40-4. Examination of the interaction of warfarin and the pre-bioThich-containing thickness regulator 若林仁美1,2, 唐沢浩二3, 岡本まとか3, 嶋村弘史1,2, 千葉正博3, 田中克巳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 743-743, 2023.

---

	4-8-O40-5. Fact-finding about the serum selenium concentration in the severeness people experiencing disability taking an antiepileptic drug 桶本幸1, 関本裕美2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 744-744, 2023.

---

	4-8-O41-1. Precision evaluation of blood drug concentration measuring equipment "LM1010" in the own institution for psychiatry drugs 森田和弥1, 阿部裕子1, 小場佐仁美1, 宮崎賢三1, 牧坂ナツミ1, 高橋英範1, 林裕子2, 尾田一貴3, 城野博史3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 746-746, 2023.

---

	4-8-O41-2. We look at the rear of the new predictive model of vancomycin for patients with cancer and examine a mark 伊藤和磨1,2, 田中怜1,3, 相川祐貴1, 森本重輝1, 鴨志田武1, 石川寛1, 佐古兼一4, 篠道弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 747-747, 2023.

---

	4-8-O41-3. Effect ... of analysis - drug liver turnover rate and the genetic polymorphism of the factor affecting the blood posaconazole levels in the hematopoietic stem cell transplantation patients 安井友佳子1,4, 岡山裕介2, 久野雅智2, 康秀男3, 柴多渉4, 掛屋弘4, 安井裕之5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 748-748, 2023.

---

	4-8-O41-4. The effect that renal function and physique give to clearance of the Teicoplanin 朝岡みなみ1,2, 堀田康弘1,2, 堀田祐志1,2, 日比陽子1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 749-749, 2023.

---

	4-8-O41-5. It is an absorption improvement effect of coenzyme Q10 by becoming it the emulsion using the milk ingredient 山内佑紀恵1, 八巻義朗1, 佐藤夕紀2, 柏木仁2, 梨本俊亮2, 武隈洋3, 菅原満2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 750-750, 2023.

---

	4-8-O42-1. Examination of the anticancer agent pollution status investigation and exposure measures effect using the BD(R)HD check system 石川駿1, 西垣玲奈1, 陳美樹1, 宇田川涼子1, 渡部大介1, 齋藤義正1, 赤木徹1, 伊藤暖子2, 近藤俊輔2, 橋本浩伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 752-752, 2023.

---

	4-8-O42-2. Examination of the infusor pump preparation method that is safer, and is effective 細谷潤, 山崎成基, 金子康子, 大手直樹, 下山遥, 大野瑞恵, 大垣友香, 阿部正樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 753-753, 2023.

---

	4-8-O42-3. Conduct in-hospital exposure to anticancer medicine investigation (the fourth report) 平野雄一, 長山晃, 川上典子, 森下和美, 近藤昌子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 754-754, 2023.

---

	4-8-O42-4. Floor anticancer medicine exposure to Aichi cancer center investigation in the environment treated like an anticancer herbalist 堀恭子1, 前田章光2, 曾根裕美子1, 村田史子2, 高野裕佑2, 橋本直弥2, 加藤正孝1, 内田幸作2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 755-755, 2023.

---

	4-8-O42-5. Aseptic inspection of the new cleaning of the safety cabinet with the water generation device water to electrolyze to electrolyze for the medical care 野々宮悠真, 清水久範, 谷口愉香, 岩崎加奈子, 小林一男, 山口正和 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 756-756, 2023.

---

	4-8-O42-6. The quantity of duties change of the pharmacist by the anticancer agent preparation robot introduction and psychological change 坂井紀水, 栗栖章紘, 後藤愛実, 畑武生, 濱田武, 西原雅美, 根尾昌志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 757-757, 2023.

---

	4-9-O43-1. Plant; is effect ... at internal use start time after the examination - direct action type oral anticoagulant drug technique of the risk factor about the formation of hematoma after the type heart electricity device shrubbery 石田有希, 中田早音, 西田祥啓, 多賀允俊, 清水善仁, 政氏藤玄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 759-759, 2023.

---

	4-9-O43-2. It is ... about the spreading effect to role - drug duties of the pharmacist in the postoperative pain management team of our hospital and the prospects 篠田健一, 川原由紀子, 後藤益生, 久保智子, 上坂真依子, 藤井佳奈枝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 760-760, 2023.

---

4-9-O43-3. Examination about the intervention of the suggestion of the bone-salt fixed-quantity examination by the pharmacist leadership for the purpose of the prevention of steroidal osteoporosis and the prescription suggestion of the osteoporosis therapeutic drug 廣瀬達也1, 森光輝1, 木村美智男1, 山下修司2, 林秀樹2, 宇佐美英績1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 761-761, 2023.

---

	4-9-O43-4. Evaluation of the risk of upper gastrointestinal bleeding due to concomitant use of PPIs in aspirin/prasugrel dual antiplatelet therapy and investigation of the optimal PPI 井出悠太郎1, 森川剛1, 吉田享平1, 高野由貴1, 久保田健1, 岡澤香津子1, 安武夫2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 762-762, 2023.

---

	4-9-O43-5. The current situation investigation of the medical treatment for the chronic cardiac insufficiency to be able to put of our hospital 上田浩貴1, 山本奈美2, 山本克己2, 濱口良彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 763-763, 2023.

---

	4-9-O44-1. A case which was able to evade a prescription cascade by the consideration of the drug-related adverse event and pharmacodynamic interaction 伊波樹1, 渡邊亜矢子1,3, 小泉朱里1,3, 米澤夏里2,3, 越塚宏美1,3, 柏原由佳1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 765-765, 2023.

---

	4-9-O44-2. Examination of the effect that rem decibuilding administration gives to estimation glomerular filtration rate 松木克仁1, 平野淳1, 後藤拓也1, 薄雅人1, 林誠2, 吉田知由1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 766-766, 2023.

---

	4-9-O44-3. Verification of the antioxidant effect of topiroxostat in vascular endothelial cells 野田雅人1,2, 武田涼馬3, 堀英生1,3, 近藤勝広2,4, 松永民秀1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 767-767, 2023.

---

	4-9-O44-4. One case that we suggested Teduglutide introduction for the patients with short bowel syndrome and further connected with the medicine medicine cooperation after the discharge 北爪教貴1, 高橋怜史1, 眞壁聡2, 増尾昌則1, 仲鉢英夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 768-768, 2023.

---

	4-9-O44-5. Analysis of the design of the drug controlled release type contact device using Tranilast nanosuspension and the intraocular drug behavior 矢野詩歩1, 衣川美宇1, 田所朋久1, 小早川信一郎2, 松永透3, 檜野栞3, 長井紀章1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 769-769, 2023.

---

	4-9-O45-1. For development of the oral made-to-order type preparation with the 3D printer: The measurement of the making of Rebamipide tablets and the drug behavior 辻極瑞希, 岩上歩紗, 畑見理奈, 和久田耀, 城山空翔, 出口粧央理, 大竹裕子, 長井紀章 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 771-771, 2023.

---

	4-9-O45-2. Evaluation of making of the polyvinyl alcohol gel including rebamipide nanoparticles and the drug release behavior 小松美莉, 西田未来, 和久田耀, 大竹裕子, 長井紀章 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 772-772, 2023.

---

	4-9-O45-3. Search of the crude drug component which can improve zinc deficiency disorders 池田義人1, 山田泰之2, 宗兼将之3, 佐野紘平4, 向高弘4, 神戸大朋5, 士反伸和2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 773-773, 2023.

---

4-9-O45-4. Translational cycle aiming at construction of the safe cholesterol transportation therapy for the congenital dyslipidemia Niemann-Pick disease C type 山田侑世1,2, 西澤まど香2, 西山麻美2, 石井亮良2, 白川愛奈2, 近藤悠希2, 竹尾透3, 中潟直己3, 三輪徹4, 竹田大樹5, 折田頼尚5, 東大志2, 本山敬一2, 有馬英俊6, 関貴弘7, 倉内祐樹2, 香月博志2, 檜垣克美8, 南謙太朗1, 吉川直樹1, 池田龍二1, 松尾宗明9, 入江徹美2, 石塚洋一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 774-774, 2023.

---

	4-9-O45-5. Suggestion of the nanopreparation prescription that assumed Arabian gum a stabilizer: Skin transmission behavior of the indometacin transdermal preparation 大明沙季, 伏木葵, 森玲奈, 大竹裕子, 長井紀章 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 775-775, 2023.

---

	4-9-O46-1. One case with suspected delirium drug-related from adherence improvement of insulin by the famotidine reduction depending on renal function 浅野恭平1, 高木昭佳2, 月岡良太3, 加藤敦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 777-777, 2023.

---

	4-9-O46-2. Comparison of the patients background to give it to adverse event expression to lead to mirogabalin administration cancellation 森住誠, 浦田元樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 778-778, 2023.

---

	4-9-O46-3. Examination of the infusion reaction expression risk factor with the rituximab therapy for the intractable nephrotic syndrome 西浦広将1,2, 高橋正也1,3, 杉本崇1, 森克仁4, 繪本正憲4, 中村安孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 779-779, 2023.

---

	4-9-O46-4. Inspection of the effectiveness of the sodium valproate for the cisplatin-induced acute renal failure 吉岡俊彦1,2, 合田光寛1,2, 神田将哉1,2, 杉本祐悟2, 石澤有紀2, 八木健太2,3, 相澤風花1,2, 宮田晃志2, 新村貴博2,3, 櫻田巧1,2, 石澤啓介1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 780-780, 2023.

---

	4-9-O46-5. The inspection of the factor to be mismatched, and to influence of the estimated eGFR level by the serum creatinine level in elderly people and cystatin C level: Crossing study 足達尚美, 本田篤子, 濱名麻衣子, 小林百合絵, 片岡裕貴 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 781-781, 2023.

---

	4-9-O47-1. Inspection of the number of training, the training time for pharmacist training specialized in local pharmacy care in University of Toyama Hospital 高木昭佳, 高橋則正, 石川雄大, 加藤敦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 783-783, 2023.

---

	4-9-O47-2. Evaluation (evaluation of short-term effects of degree of knowledge and the technical acquisition and the training) of the communication education that collaborated with clinical phycologist 西田麻以1, 今村隆2, 小林宏太朗1, 赤木晋介1, 西村健二1, 長尾由佳1, 古谷祥子1, 藥師径子1, 徳田衡紀1, 高柳和伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 784-784, 2023.

---

	4-9-O47-3. The present situation of the medical therapy workshop by University of Shizuoka, hospital, the community pharmacy cooperation 大澤隆志1, 伊藤邦彦2, 森本達也2, 黒川絢子2, 内田信也2, 矢部勝茂2, 河西きよみ2, 鈴木貴也2, 井原摂子2, 櫻井健史2, 井上達秀2, 山田静雄2, 賀川義之1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 785-785, 2023.

---

	4-9-O47-4. An effect about the personnel training in the pharmacy long-term training of the staff of Pharmaceuticals and Medical Devices Agency and the future prospects 有山真由美1, 増田純一1, 朝倉佑実2, 堀内直哉2, 寺門浩之3, 西村富啓1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 786-786, 2023.

---

	4-9-O47-5. The current situation of a specialty, the authorized pharmacist system in the career path of the pharmacist and future problem 三宅健文1, 柴田啓智2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 787-787, 2023.

---

	4-9-O48-1. Usefulness of the infusion formulation study tool utilization in the nutrition education for the trainee 越智良明, 石井弘幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 789-789, 2023.

---

	4-9-O48-2. The effect that continuous article commentary training gives for improvement in critical examination skill on hospital business trainee 安島秀友1, 美馬朱美1, 杉本涼佳1, 櫻井雄太1, 横山絢香1, 高木彰紀2, 廣原正宜2, 松崎貴志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 790-790, 2023.

---

	4-9-O48-3. ... full the pharmacy business training by the corona evil about invention of accepting it not ... limit 田浦稔基, 山崎直樹, 前川大輔, 小野川明美, 田邉輝, 仲川剛, 松下夏子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 791-791, 2023.

---

	4-9-O48-4. The training result in the investigation examination business participation for the enforcement that the after graduation clinical practice is effective for 2022 and the problem 小松沙裕里1, 小松真紀子1, 赤嶺由美子2, 大越英雄3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 792-792, 2023.

---

	4-9-O48-5. Development of the pharmacist education service that mishaps in medical practice reduction with the medicine aimed at becoming it 木村郁哉1, 牛尾聡一郎2, 川端崇義1, 三浦太郎1, 東恩納司1, 濱野裕章1, 座間味義人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 793-793, 2023.

---

	4-9-O48-6. Activity for clinical studies promotion by the hospital pharmacist 高武嘉道1, 山口泰弘1, 大橋邦央1, 花田聖典2, 橋本雅司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 794-794, 2023.

---

	4-10-O49-1. Aim AUC to evade renal failure by initial administration plan of vancomycin 飯田萌子1,2, 堀田康弘1,2,3, 広瀬永愛4, 朝岡みなみ1,2, 木村理恵2, 大橋一輝2, 加藤秀紀2, 江崎哲夫2, 河原昌美4, 堀田祐志1,2, 中村敦3, 日比陽子1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 796-796, 2023.

---

	4-10-O49-2. Renal failure frequencies and therapeutic range achievement quotient investigation after the clinical introduction of the AUC evaluation of vancomycin 加藤秀紀1, 堀田康弘1,2, 朝岡みなみ1,2, 和知野千春1,2, 飯田萌子1,2, 三村佳久1,2, 杉山洋介1,2, 江崎哲夫1,2, 堀田祐志1,2, 日比陽子1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 797-797, 2023.

---

	4-10-O49-3. Attempt of the blood drug levels cross validation test for the TDM practical use of the antimicrobial linezolid 辻泰弘1, 矢作彩2, 櫻井里咲2, 栗原絵2, 奥田詩織2, 川筋仁史3, 青山隆彦1, 山本善裕3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 798-798, 2023.

---

	4-10-O49-4. Study on blood level monitoring at the gentamicin administration for the infective endocarditis and renal function change 篠田康孝, 大橋健吾, 松岡知子, 新井かおり, 堀田奈央, 宇佐美英績 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 799-799, 2023.

---

	4-10-O49-5. Evaluation of the renal failure frequencies by the change to the TDM based on the vancomycin one point drawing blood AUC level 山田翔也1, 丹羽隆1, 山田悠人1, 小野友利恵2, 鷲見和之1, 大坪愛実1, 丹羽今日子1, 安江萌夏1, 山本泰士1, 小林亮1,2, 鈴木昭夫1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 800-800, 2023.

---

	4-10-O50-1. The voriconazole administration experience to highly obese (BMI47kg/m2) Japanese: A case which obtained an appropriate therapeutic range by ideal weight conversion 岡本朋子1, 中村彩芳2, 眞継賢一1, 伊藤博美1, 南谷晃誠2, 吉見育馬2, 大原房子3, 山下裕史3, 河野千尋3, 松末武雄2, 濱口良彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 802-802, 2023.

---

	4-10-O50-2. The TDM enforcement situation by the prior agreement protocol enforcement of vancomycin 大月慎之助, 鬼頭尚子, 北村幸代, 福島信一郎, 宮澤憲治, 高木亮 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 803-803, 2023.

---

	4-10-O50-3. Comparison of AUC and the trough value by one point of drawing blood in the vancomycin renal failure prediction for the elderly aged 75 or over 原田紗希1, 羽田野励次2, 菅田哲治2, 陸丸幹男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 804-804, 2023.

---

	4-10-O50-4. Clinical practice evaluation of the vancomycin administration plan nomogram according to the renal function 竹内陽亮, 小松原靖二郎, 長島裕樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 805-805, 2023.

---

	4-10-O50-5. A case which caused a blood level drop of oral voriconazole (VRCZ) by nutrient for intestinal administration sustained administration 須山由佳子1, 河野礼2, 杉山恭平1, 古谷翔太1, 神戸宏憲1, 櫻井和子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 806-806, 2023.

---

	4-10-O51-1. Can the large-scale insurance claim information classify infection opportunities of the multidrug-resistant Acinetobacter infection? 上本花南1, 村木優一1, 後藤良太1, 福岡千晴1, 水野香菜子1, 豕瀬諒1, 大毛宏喜2, 大曲貴夫3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 808-808, 2023.

---

4-10-O51-2. It is a prescription suggestion effect of the infection prophylaxis antimicrobial after the operation by the operating room pharmacist in otolaryngology, the head and neck surgery patients: Look at the single institution rear; a mark observational study 北川遼1, 冨澤淳1,2, 瀬戸良教1, 小川隆弘1, 小松敏彰1, 山下拓3, 尾鳥勝也1,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 809-809, 2023.

---

	4-10-O51-3. Problem for consumption reduction in the use situation investigation of the macrolide derivative antimicrobial before and after the COVID-19 outbreak and the drug-resistant measures action plan 高木栄希, 坂本拓也, 川村ひとみ, 中尾耕治, 荒井宏人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 810-810, 2023.

---

4-10-O51-4. A descriptive epidemiology study of the inpatient background that took advantage of aspiration pneumonia: Group characteristic examination for the analytical epidemiology study enforcement on the basis of polypharmacy measures 石田亮1,2, 仁熊宏樹2, 西田麻衣2, 村越千恵2, 松本真由2, 脇本彩2, 西村健二2, 亀井健人2, 赤木晋介2, 徳田衡紀2, 高柳和伸2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 811-811, 2023.

---

	4-10-O51-5. Clinical examination of the antimicrobial lock therapy of the catheter in catheter-associated bloodstream infections 川本莉緒1, 大林巧志1, 弓場達也2, 小森桂子1, 板倉祥嗣1, 苅田明子1, 舩越真理1, 土谷有美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 812-812, 2023.

---

	4-10-O52-1. Evaluation of the effect to give an examination of blood culture pollution rate and antimicrobial consumption by the check list introduction at blood culture sampling utilizing J-SIPHE 米谷領太1, 中谷茉佑香1, 福田俊2, 谷久弥3, 多湖ゆかり3, 岡本菜摘5, 神田健志4, 古俵孝明1, 月野光博5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 814-814, 2023.

---

	4-10-O52-2. About the antimicrobial proper use support to the blood culture-positive patients for cardiovascular surgery inpatients 町田聖治1,2, 福島将友1,2, 曽我弘道1, 入江利行1,2, 宮崎博章2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 815-815, 2023.

---

	4-10-O52-3. Examination about the patients background associated with the Corynebacterium genus bacteremia 小林紀香1, 和知野千春1,2,3, 早川智章1,2, 堀田康弘1,2,3, 堀田祐志1,3, 日比陽子1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 816-816, 2023.

---

	4-10-O52-4. Relative inspection with the appropriate practice rate of the mention situation and the process index of the use of antimicrobial report book under the AST support 田中雄大1,2,3, 山口諒1, 山本武人1, 龍野桂太2,3, 岡本耕3, 森屋恭爾2,3, 高田龍平1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 817-817, 2023.

---

	4-10-O52-5. Investigation about the effect that bacteremia due to the ESBL-producing gram-negative bacteria gives for the treatment outcome of the cardiovascular device custody patients 中蔵伊知郎1, 坂倉広大1,2, 若林智仁1, 山口弥久1, 大畑彩也香1, 佐々木京子1, 高橋彩子2, 佐田誠2, 坂本麻衣1, 中野一也1, 上野智子1, 川端一功1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 818-818, 2023.

---

	4-10-O53-1. The development of the surgical-site infections predictive model in the mandibular extraction of impacted wisdom teeth surgery: Pre-rear predictive model using the technique to resample 山神彰1, 鳴海克也2,3, 齋藤佳敬1, 古堅彩子2, 今井俊吾4, 北川善政5, 大廣洋一6, 高木諒7, 武隈洋1, 菅原満1,8, 小林正紀2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 820-820, 2023.

---

	4-10-O53-2. About clinical path Committee which we intervened in urologic clinical path and led to the quinolone oral antimicrobial consumption decrease, AST combination review meeting 佐藤香子1,6, 平山伸朗1, 曽根理恵2,4, 安部夏紀3,4, 齋藤政子3,4, 及川京子3, 佐藤貞子3,4, 泉美幸5, 栫井成彦5, 角川陽一郎4,7, 三木誠6,7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 821-821, 2023.

---

	4-10-O53-3. The effect that a cataract surgery clinical path change gives to endophthalmitis after the antimicrobial proper use and the operation 西山晃1, 沢田佳祐1,2, 中谷丈之1, 吉川宗光3, 河野修治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 822-822, 2023.

---

	4-10-O53-4. About the effectiveness by the local highly-concentrated antimicrobial continuation perfusion therapy for the bone soft tissue infection in our hospital and safety 松浦紘生, 松下雅昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 823-823, 2023.

---

	4-10-O53-5. It is evaluated the endophthalmitis after the operation accompanied with the intravenous antimicrobial cancellation before operation in the cataract surgery 内田和孝1, 高濱啓太1, 草野雄貴2, 松本光希2, 宮本浩子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 824-824, 2023.

---

	4-10-O54-1. Examination of the effect that an antimicrobial proper use support team activity in connection with infection internal medicine gives to intravenous antimicrobial proper use 杉井麻耶1,2, 山本理紗子1,2, 相曽啓史1,2, 永田将司1, 井手聡2,3, 栗田崇史2,3, 具芳明2,3, 田頭保彰2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 826-826, 2023.

---

	4-10-O54-2. Outcome evaluation in patients with bacteremia by the antimicrobial proper use support team link pharmacist system introduction 吉川結美1, 橋本麻衣子1, 松本剛2, 平井啓太1, 土屋広行1, 内藤隆文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 827-827, 2023.

---

	4-10-O54-3. One step of the beginning of infection with hospital pharmacist measures regional alliances 遠山潤1, 高橋哲2, 佐藤みづき1, 西千春1, 井口有紀1, 平賀洋子1, 中村初美1, 櫻間啓基1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 828-828, 2023.

---

	4-10-O54-4. Efforts in our hospital for the cooperation of ward drug duties and the AST activity 中村佳菜, 藤脇孝哉, 岩倉弥生子, 合田明博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 829-829, 2023.

---

	4-10-O54-5. It is ... for efficiency of usefulness ... patients intelligence in application development and the AST activity for the use situation investigation of the antimicrobial 山田将悟, 藤林遼, 前川英輝, 高橋誠, 田中正臣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 830-830, 2023.

---

	4-11-O55-1. Investigation about the factor of the direct hospital admission of emergency of patients not to deceive in the Kurashiki center Hospital 樋口純一, 小林宏太朗, 友國綾香, 溝部裕介, 宮下佳大, 石原泰子, 徳田衡紀, 高柳和伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 832-832, 2023.

---

	4-11-O55-2. The outcome in the anticancer agent-related eye disorders using the adverse event spontaneous report database and analysis of the onset time 新田侑生1, 中馬真幸1, 新田悠一朗1, 真鍋貴行2, 神山直也2, 岩山訓典1,3, 山本譲1, 小野尚志1, 田崎嘉一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 833-833, 2023.

---

	4-11-O55-3. Cancer gene panel testing status and pharmacist involvement at cancer genome medical collaboration hospitals - Current situation and issues - 佐藤一求1, 世良真愛子1, 川原邦仁1, 比良大輔1, 栗原晋太郎1, 別所千枝1, 安原昌子1, 本永正矩2, 斎藤敦子3, 橋詰淳司3, 檜井孝夫4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 834-834, 2023.

---

	4-11-O55-4. Inspection of the effect that a gastric-acid secretion antagonist gives to effect of treatment and the side effect of the immune checkpoint inhibitor 岡本敬介1, 齋藤佳敬2, 武隈洋1, 菅原満1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 835-835, 2023.

---

	4-11-O55-5. Examination of the effect that SGLT2 inhibitor combination gives to CDDP-induced acute renal failure 石神友介1, 高橋正也1,2, 中務ひとみ1, 西浦広将1,3, 古原優也1, 中村安孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 836-836, 2023.

---

	4-11-O56-1. Serious neutropenia in the amrubicin therapy for recurrent small cell lung cancer and association of the progression-free survival period 石田翔1, 妹尾啓司1, 宮嵜純治1, 中井將人1, 水上皓喜1, 白木政博1, 阪田安彦2, 渡邊篤1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 838-838, 2023.

---

	4-11-O56-2. Usefulness by the true clinical practice of the electronic patient-reported outcome monitoring in the immune checkpoint inhibitor-treated patients by the pharmacist 桂英之, 太田浩士, 高田直子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 839-839, 2023.

---

	4-11-O56-3. Examination of the early infection incidence and risk factor of the Venetoclax+Azacitidine combination therapy in our hospital 金子憲太郎1, 田中圭祐2, 川口文誉1, 川村僚一郎1, 野口果歩1, 岩瀬弘明1, 豊田茂雄3, 小林路子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 840-840, 2023.

---

	4-11-O56-4. Rearward observational study about relations with the relative dose intensity and effect of treatment in the pancreatic cancer gemcitabine +nab paclitaxel combination therapy 中谷祐介1, 平井利典1, 早崎碧泉2, 岸和田昌之2, 岩本卓也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 841-841, 2023.

---

	4-11-O56-5. The effect that a pharmacist outpatient gives in treatment continuity of the Abemaciclib 中村大学1, 近藤勝弘2,3, 堀田祐志2,3, 朝岡みなみ1,3, 外海友規1,3, 手崎世織1, 竹本将士1, 細江昂誠4, 山本清司4, 浦野公彦4, 松浦克彦4, 日比陽子1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 842-842, 2023.

---

	4-11-O57-1. Fact-finding of the foreign cancer medical therapy enforcement situation under the COVID-19 outbreak 島貫裕実子1, 下村昭彦2, 小室雅人1, 西村富啓1, 清水千佳子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 844-844, 2023.

---

	4-11-O57-2. The effectiveness of the cetuximab combination radiotherapy for local progress epithelium squamous head and neck cancer which coexisted for renal failure of the cisplatin intolerance and safe inspection 今井千晶1, 佐伯宏美1, 山本晃平1, 市川彩乃1, 鈴木貴明1, 山崎伸吾1, 滝口裕一2, 花澤豊行3, 石井伊都子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 845-845, 2023.

---

	4-11-O57-3. Examination about the effect of treatment of the immune checkpoint inhibitor which paid attention to an inflammatory marker 大石大祐, 山本圭祐, 矢部勝茂 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 846-846, 2023.

---

	4-11-O57-4. Antineoplastic drug for the multiple liver metastases nodules in the same individual using a triple negative breast cancer liver metastases model-sensitive evaluation 相良篤信1, 里史明1, 小日向晃昇1, 沢結理1, 岡田大地2, 安部智哉2, 平出誠1, 佐野元彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 847-847, 2023.

---

	4-11-O57-5. Effect on ischemic heart disease with the platinum administration 伊藤博美, 上田浩貴, 濱口良彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 848-848, 2023.

---

	4-11-O58-1. Usefulness evaluation of the pharmacist outpatient department for patients with breast cancer to take Abemaciclib 押切華映1, 前川麻央1, 赤井文香1, 岩渕理子1, 田中里奈1, 松浦正樹1, 原田成美2, 菊地正史1, 眞野成康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 850-850, 2023.

---

	4-11-O58-2. Development of the cooperation documentation system in the foreign cancer chemotherapy cooperation full addition 牧原明秀, 近藤舞子, 三屋良太, 高原悠子, 鈴木雅人, 吉田弘樹, 木全司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 851-851, 2023.

---

	4-11-O58-3. Fact-finding of retching, the vomiting situation and the antiemetic contents in patients receiving oxaliplatin 島田浩和1, 大神正宏1, 鈴木嘉治1, 立原茂樹1, 天貝賢二2, 小島寛3, 鈴木美加1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 852-852, 2023.

---

	4-11-O58-4. Comparison of the effect that difference in cancer of gastric cancer, colon cancer gives the CINV onset situation at SOX therapy and CapeOX therapy enforcement and search of the risk factor 平賀七帆1, 安藤洋介2, 豊里星来2, 松岡宏3, 勝野秀稔4, 水野智博2, 河田健司5, 守瀬善一4, 池田義明1, 山田成樹2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 853-853, 2023.

---

	4-11-O58-5. Examination of the factor associated with the retching vomiting expression with the nogitecan administration to patients with lung cancer 川村僚一朗, 川口文誉, 常木隆史, 金子憲太郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 854-854, 2023.

---

	4-11-O59-1. About the effectiveness and safety when we changed it to a generic drug from an azacitidine innovator drug 大野真史, 中村雄亮, 助畑歩, 高橋優聡, 小森均, 深井敏隆 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 856-856, 2023.

---

	4-11-O59-2. The effect that supply restrictions of the albumin suspension type paclitaxel gave to treatment preferences 矢田部恵1, 小川千晶2, 石嶋麗2, 工藤彰2, 大塚知信2, 山岸美奈子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 857-857, 2023.

---

	4-11-O59-3. Safety of the nanoliposomal irinotecan + fluorouracil/levofolinate parallel administration for the pancreatic cancer 若林茜1,2,5,6, 川上武志2, 田中怜1,3,4, 福室友里絵5, 盛啓太6, 石川寛1, 篠道弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 858-858, 2023.

---

	4-11-O59-4. High pharmaceutical care of the quality using a tracing report and the drug remedy history in the oral anticancer medicine remedy patients 林田大輝, 天方奉子, 沼田朋和, 牛濱直樹, 宮本竜太朗, 澤村理英, 宇都直哉, 近藤元三, 稲葉一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 859-859, 2023.

---

	4-11-O59-5. Examination of a factor about a vasculitis caused by vinorelbine and the vascular pain and the prophylactic method 石井俊一1,2, 市村丈典1, 市倉大輔1, 縄田修一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 860-860, 2023.

---

	4-11-O60-1. The efforts which aimed at the security of the quality of on-the-job training and the data of clinical studies 藤井千賀1, 合澤啓二2, 青山剛3, 中島寿久4, 吉川英里5, 松本光史6, 倉田宝保7, 今村知世8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 862-862, 2023.

---

	4-11-O60-2. Usefulness of outpatient pharmacists in preventing the onset of apalutamide-induced skin disorders 梅原健吾1, 高田慎也1, 山岸佳代1, 高田徳容2, 丸山覚2, 原林透2, 佐藤秀紀3, 橋下浩紀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 863-863, 2023.

---

	4-11-O60-3. Inspection of the prognosis-related factor in immune-mediated adverse event (irAE) 小島一晃1, 小西史子1, 濱武清範1, 野間敏也1, 松田ちひろ1, 橋本仁美1, 福井美礼1, 仲忠士1, 美和孝之1, 六車英光2, 神田直樹3, 北英夫4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 864-864, 2023.

---

	4-11-O60-4. 1 case that showed vision blurred during adjuvant chemotherapy after the CAPOX technique in sigmoid colon cancer 沢仁美1,2, 中村暢彦3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 865-865, 2023.

---

	4-11-O60-5. The effect that sarcopenia gives for the checkpoint inhibition therapy in craniocervical part cancer of immunity 西山由紀子1, 中川祐紀子1, 志村裕介1, 山本奈歩1, 菅幸生1,2, 嶋田努1, 崔吉道1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 866-866, 2023.

---

	5-7-O61-1. Doubt inquiry of the drugstore pharmacist utilizing the test value QR cord improves patients outcome 渡邊大貴1, 神山直也2, 安達理恵1, 松野明香1, 佐藤美峰1, 千葉薫1, 田崎嘉一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 868-868, 2023.

---

	5-7-O61-2. The development of the prescription checking support system corresponding to the decreased renal function and the evaluation 眞木秀子, 羽太光範 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 869-869, 2023.

---

	5-7-O61-3. Efforts about the drug inventory control utilizing RPA (Robotic Process Automation) 田口佳奈1, 鍵谷徹1, 安田憲隆1, 宮本義浩1, 榎本真治2, 浅野正太郎3, 村山典久3, 中島純子1, 平出耕石1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 870-870, 2023.

---

	5-7-O61-4. Multicenter questionary survey in Hyogo for the inflection promotion of the electronic prescription notebook 柴谷直樹1,2,6, 鶴田洋平1,3, 浅井浩之4, 福田英克1,5, 平野達也6, 山崎彬史7, 清水倫子1,8, 藤田一弘1,9, 石井雅人1,10, 中村豪志11, 安達嘉織12, 小玉博一1,13, 室井延之1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 871-871, 2023.

---

	5-7-O61-5. Can ChatGPT (GPT-4) become the support of the anticancer agent regimen registration duties? 前田章光, 下村一景, 橋本直弥, 内田幸作 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 872-872, 2023.

---

	5-7-O62-1. It is made the oral tablet for the custom tailoring utilizing the technique freeze dry or 3D printer technique and nano 大迫華乃, 下前憂梨咲, 板東彩香, 和久田耀, 城山空翔, 出口粧央里, 大竹裕子, 長井紀章 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 874-874, 2023.

---

	5-7-O62-2. The actual situation and problem of the proper use of the nonprescription drug in the person of new coronavirus infection seventh wave home medical treatment 藤本卓磨1, 岩田紘樹1,2, 小林典子1,2, 近藤慎吾1,2, 中村友紀1,2, 山浦克典1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 875-875, 2023.

---

	5-7-O62-3. The exploring of the additive candidate contributing to evasion effect extension of DEET: Usefulness of cyclodextrin and the POE-POP butyl ether 松本夏奈1, 川口麻由2, 酒井琢朗1, 吉富丈治1, 笹邉達志2, 延原健二2, 松原晶2, 長井紀章1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 876-876, 2023.

---

	5-7-O62-4. National fact-finding about sexual intercourse in this country and the use of the urgent contraceptive 百賢二1, 前田絵里加1,2, 服部はるか1,3, 磯崎遥1,4, 瀧田寛子5, 諸星北人6, 龍家圭7, 肥田典子8, 三邉武彦9,10, 白土なほ子5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 877-877, 2023.

---

	5-7-O62-5. For the presbyopia prevention: Suggestion of hardening of the crystalline lens with the sodium selenite administration and the rating system 久保田ちか1, 門脇玲太1, 浅井拓己1, 大竹裕子1, 中澤洋介2, 山本直樹3, 長井紀章1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 878-878, 2023.

---

	5-7-O63-1. Fact-finding of the visit drug control instruction by the hospital pharmacist 水野智博1, 長谷川章2, 溝神文博2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 880-880, 2023.

---

	5-7-O63-2. Prediction of the fall risk in nursing facility entering elderly people using the machine learning 中田雄大1, 石坂優奈1, 佐藤宏樹1,2, 柳奈津代1, 澤田康文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 881-881, 2023.

---

	5-7-O63-3. Pharmaceutical intervention effect of the pharmacist in the urination care team 大屋和福, 細野真吾, 堀浩子, 山崎崇 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 882-882, 2023.

---

	5-7-O63-4. The current situation investigation about the frailty in the health insurance pharmacy use patients 面谷幸子1,2, 石坂敏彦2,3, 鈴木利次3, 鹿嶋隆行3, 宮川道英1,3, 初田泰敏1, 名徳倫明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 883-883, 2023.

---

	5-7-O63-5. ... to alert to reporting and the electronic medical chart of the drug influencing deglutition functional decline in relation ... conference of the pharmacist to the eating deglutition support team 宮崎雄紀1, 百瀬将晃2, 古清水元子3, 網野一真1, 登内盛治1, 巨島文子4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 884-884, 2023.

---

	5-8-O64-1. The BD Rowa(TM) system (automatic warehousing, formulations support system) introduction in the health insurance pharmacy and interpersonal duties: Descriptive vertical section study 田中佑樹, 松木史, 片岡剛司, 木村涼子, 松井優子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 886-886, 2023.

---

	5-8-O64-2. The foreign efforts that a pharmacist sits and foreign team approach in medical care 勇内山英暢1, 牛尾幸子1, 八反丸善文2, 小川晃一3, 比田井明憲4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 887-887, 2023.

---

	5-8-O64-3. Investigation (the first report) of the pharmaceutical management of the at-home self-injection instruction in the immune pharmacist outpatient 大場啓貴1,2,3, 平田一耕1,2, 小倉千亮1,2, 森健太郎1,2, 六反田諒4, 舟越亮寛1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 888-888, 2023.

---

	5-8-O64-4. Evaluation of the common use medicine confirmation system by the foreign new establishment before operation of the perioperative charge pharmacist 田村真由子, 野々内裕紀, 仲宗根千佳, 濱口良彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 889-889, 2023.

---

	5-8-O64-5. Examination about the usefulness of the pharmacist permanent residence in the hospitalization support section 村上菜月, 疋田絵梨, 高木茂実, 和田実佳子, 安西麻衣子, 松林明美, 城田幹生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 890-890, 2023.

---

	5-8-O65-1. Zero of the postponement of surgery by evaluation - discontinuation lapse of memory of the risk factor of the patients discontinuation in the admitting department for becoming it - 遠藤愛樹1, 佐久間大樹1, 中根優1, 山本弓子1, 松本香織1, 小林義文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 892-892, 2023.

---

	5-8-O65-2. Doubt inquiry contents in by hospitalization front and the analysis 山崎亮, 渡辺研弥, 須藤孝浩, 黒田純子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 893-893, 2023.

---

	5-8-O65-3. Than pharmacist intervention to the foreign chemotherapy room at the small and medium size hospital and evaluation - questionary survey ... 菅野雄太, 坂野昌志, 杉浦茂樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 894-894, 2023.

---

	5-8-O65-4. The burden reduction of pharmacist duties by the fosnetupitant introduction and investigation about the patients line of flow 澤村彩菜, 橋本浩伸, 齋藤義正, 赤木徹, 渡部大介, 中島寿久, 佐藤公彦, 有馬崇充, 陳美樹, 寺田公介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 895-895, 2023.

---

	5-8-O65-5. Risk factor of the unobservance of the explanation about the discontinuation of a pharmacist and the medicine influencing the surgery that we underwent from other types of job 赤嶺聡彦1, 長崎裕也2, 冨澤淳3, 尾鳥勝也2,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 896-896, 2023.

---

	5-8-O66-1. The example that a pharmacist specialized in local pharmacy care became a family pharmacist, and performed outpatient follow in a telephone and a visit 沖和代, 榊原さやか Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 898-898, 2023.

---

	5-8-O66-2. Spread of anticancer medical use tracing reports and problem - Japan cure association arts and sciences first subcommittee ... to utilization 山本圭祐1, 清水久範2, 月岡良太3, 川口崇4, 加藤肇5, 辻大樹6, 山口拓洋7, 鈴木賢一8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 899-899, 2023.

---

	5-8-O66-3. Examination about the current situation and the problem in the pharmacist (cancer) training specialized in local pharmacy care 近藤元三1, 天方奉子1, 稲葉一郎1, 楠本将裕2, 田中由起子2, 山室蕗子2, 菊川佳敬3, 山崎浩3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 900-900, 2023.

---

	5-8-O66-4. Relations of the pharmaceutical intervention using the tracing report for a communication skill and the polypharmacy patients of the drugstore pharmacist 桜田尚季1, 佐々木麻里2, 土井真喜3, 阿南圭祐4, 紙谷司5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 901-901, 2023.

---

	5-8-O66-5. The correspondence actual situation to the foreign patients in the urban area drugstore: Inventory survey 鈴木渉太1,2,3, 岡田浩1,2, 西川佳孝2, 中山健夫2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 902-902, 2023.

---

	5-9-O67-1. It is the visit actual situation according to the residence place in six months after the visit pharmacist introduction to elderly people living in an area: Medical care, care connection data analysis 田口怜奈1,2, 浜田将太1,3,4, 土屋瑠見子1, 石川智基1, 西田和正1, 北村智美1, 服部真治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 904-904, 2023.

---

	5-9-O67-2. Watch the area by the health insurance pharmacy; an agreement and the effect 佐野稜, 佐々木剛, 植村由香, 中田祐一, 佐藤翼, 澤野剛, 高橋友樹, 伊藤隆紀, 正木雅, 谷藤隼人, 谷口亮央, 中島史雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 905-905, 2023.

---

	5-9-O67-3. One case of the end-stage heart failure that shifted to treatment at home with continuing continuously administering it of the dobutamine injection drug 赤松隼人1, 江藤良2, 黒部昌也2, 山口ゆかり3, 馬場妙子3,4, 桑原薫4, 矢野雄大5, 井川幸子3, 中野国枝3, 中川博雄1, 兒玉幸修1, 大山要1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 906-906, 2023.

---

	5-9-O67-4. The need of the multi-type of job cooperation judging from the actual situation of the drug incident for the medical care in being at home 深田悠花1, 関口亮子1, 石川武雅1, 小玉伽那1, 勝眞久美子1, 笠松弥咲2, 大西真愛2, 齊前裕一郎2, 勝久美月2, 竹下悠子2, 藤井美咲2, 森木友紀2, 糀屋絵理子2, 竹屋泰2, 生田花澄3, 肥後友彰4, 大塚泰葉4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 907-907, 2023.

---

5-9-O67-5. The disposal situation every medical type of industry about the drug for the medical care and comparison of the disposal of Fukuoka-shi and the Kumamoto-shi health insurance pharmacy 原口恵子1, 太田麻美2,4, 立麻香帆4, 猪阪日向子4, 樋口義則2, 西名武士2, 磯野寿光1, 長迫信一1, 藤本拓郎1, 野島実1, 吉田健1, 柴山和弘1, 田中智枝1, 北智之1, 田城涼子1, 高木淳一1, 木原太郎1, 天方奉子3, 稲葉一郎3, 川尻雄大4, 小林大介4, 島添隆雄4, 田中泰三1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 908-908, 2023.

---

	5-9-O68-1. Attitude survey about the acceptance of the childhood treatment at home in the health insurance pharmacy under Mie 中川裕司1,2, 小西友美3, 山本高範3, 小林竜也4, 佐藤賛治3, 加藤秀雄2, 岩本卓也2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 910-910, 2023.

---

	5-9-O68-2. Utilization investigation of effectiveness of the training in the healthy support drugstore training completion person and the training contents 戸井真也1, 棚橋嵩一郎1, 今西孝至2, 長澤吉則1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 911-911, 2023.

---

	5-9-O68-3. Efforts from a pharmacist to the local inclusion care system 栗原弘充 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 912-912, 2023.

---

	5-9-O68-4. It is examined the relative analysis of the medication adherence factor for the medication situation using logistic regression/LightGBM and the importance Masanori 飯野温1, 木崎速人2, 今井俊吾2, 堀里子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 913-913, 2023.

---

5-9-O68-5. Evaluation of the medication follow-up activation of the local demographic division of medical services by the version tracing report business common throughout the prefecture 大東敏和1,2, 里章平2, 岡田博恵1,3, 白井敦史1,4, 舟原宏子1,5, 別所千枝1,6, 村上秀治1,7, 石本新1,8, 大塚茂雄1,9, 竹本貴明1,10, 山田真弘1,11, 竹井英介1,12, 西原昌幸1,13, 先森満子1,14, 松尾裕彰1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 914-914, 2023.

---

	5-9-O69-1. Efforts and evaluation of the pharmacist in the nursing orientation 岡田怜子, 小柳津瞳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 916-916, 2023.

---

	5-9-O69-2. Theoretical consideration about the safety at mother's milk shift and nursing of famciclovir 大久保正1,2, 田中真理子2, 大久保七枝3, 大久保美穂4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 917-917, 2023.

---

	5-9-O69-3. Establish the pregnancy and the nursing medicine consultation desk by the pharmacist 遠藤清香, 渡會明希, 大場有紗, 磯部樹里, 齊藤那奈, 高橋優歩, 田口未菜, 板垣有紀, 羽太光範 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 918-918, 2023.

---

	5-9-O69-4. DHA, 1 case that an anesthesia method of the cesarean section was changed by taking EPA-containing folic acid supplement 山本翔子, 三木陽介, 中島春佳, 石井聡一郎, 真志田絵美子, 柴田ゆうか, 松尾裕彰 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 919-919, 2023.

---

	5-9-O69-5. Analysis of the factor to disturb the voluntary learning of the medication counseling e-learning system to a hearing person with a disability 俵口奈穂美1, 吉田力久2, 小倉秀美3, 山崎博史4, 田中泰三5, 窪田敏夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 920-920, 2023.

---

	5-10-O70-1. Decrease in common use medicine-related incident by conducting pharmacist duties in hospitalization and release support section 山本泰士1, 山田友奈美1, 藤井宏典1, 飯原大稔1, 加藤寛子1, 西田承平1, 星野良1, 丹羽隆1, 小林亮2, 熊田恵介3, 清水雅仁4, 鈴木昭夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 922-922, 2023.

---

	5-10-O70-2. About the way of the effective manual in our hospital 田村曉識, 松井俊典, 谷田彩, 池田和之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 923-923, 2023.

---

5-10-O70-3. Development of groundbreaking audiovisual materials contributing to the prevention of the pharmaceutical products-related incident in a student, the new face pharmacist 松本准1,2, 塩川葉月2, 西原茂樹2, 岡野志のぶ2, 森彩美2, 吉川潤子2, 武田達明1,2, 槇枝大貴2, 小沼利光2, 市川裕規2, 濱野裕章2, 鍛治園誠2, 村川公央2, 有吉範高1, 座間味義人2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 924-924, 2023.

---

	5-10-O70-4. Possibility in the international medical relief of the pharmacist whom we saw in the long-term support for the humanitarian crisis relief in Ukraine 仲里泰太郎1,2, 河合謙佑2, 池田戴子2, 光森健二2, 小林政彦1, 中出雅治2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 925-925, 2023.

---

	5-10-O70-5. Examination of the method to promote behavior modification facing each other at the disaster in the drug section 岡田千賀子1, 梶原千里2, 青木勇樹1, 柏原道志1, 山尾真貴子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 926-926, 2023.

---

	5-10-O71-1. Survey on the actual use of factor Xa inhibitor neutralizers 濱口綾花, 西田麻以, 小林宏太朗, 赤木晋介, 西村健二, 西江美智子, 徳田衡紀, 高柳和伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 928-928, 2023.

---

	5-10-O71-2. Attempt of visualization and the optimization of the use of antimicrobial by the construction of the antimicrobial evaluation support system during the operation 和知野千春1,2,3, 早川智章1,2, 堀田康弘2,3, 小林紀香2, 堀田祐志2,3, 江崎哲夫2, 日比陽子2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 929-929, 2023.

---

	5-10-O71-3. The use of antimicrobial situation and problem of our hospital based on an old and new AMR measures action plan 高多瞭治, 多賀允俊, 西田祥啓, 政氏藤玄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 930-930, 2023.

---

	5-10-O71-4. Expectation to pharmacist intervention judging from results of the osteoporosis therapeutic drug taste investigation 畝知己1, 影本紀子1, 前田和彦1, 松原菜美1, 渡部里香2, 河野紘輝3, 大本卓二3, 荒木慧3, 小林孝明4, 岡井由美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 931-931, 2023.

---

	5-10-O72-1. The benzodiazepine drugs (BEZ) prescription in patients with old cancer during foreign chemotherapy and examination of the fall risk 岡田咲樂1,2, 満間綾子2, 宮崎雅之3, 池田義明1, 安藤雄一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 933-933, 2023.

---

5-10-O72-2. Look at the rear of the intervention example in the role - cancer practice cooperation base Hospital single institution of the pharmacist in the metastases to bone practice team; mark investigation ... 兼平暖1, 橋本光弘1, 鈴木麻由香1, 後藤恵美子2, 大澤まりえ3, 小林伶子3, 内野慶太4, 鈴木正寛5, 豊田達也3, 福田明6, 山田高嗣7, 田中昌代1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 934-934, 2023.

---

5-10-O72-3. The case that utilized ICT in the loss of voice patients during pharyngeal cancer outpatient department chemotherapy, and supported the cooperation with multiple medical institutions and area inclusion support systems and hospitalization 鈴木智香子1, 岩高美帆1, 小徳由梨絵1, 大島聖也1, 赤城優希2, 赤城友章2, 山中國暉1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 935-935, 2023.

---

	5-10-O72-4. Having been able to see it through a tracing report from the cooperation full addition start for three years 大崎真美1, 疋田絵梨1, 鈴木礼乃1, 村上菜月1, 黒木あかね1, 秦哲磨1, 浦山泰典1, 丸藤義翔2, 岡野咲子2, 安武夫2,3, 城田幹生1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 936-936, 2023.

---

	5-10-O72-5. Efforts to internal use anticancer agent proper use of the outside Parliament prescription and the effect 安江萌夏1, 廣瀬智恵美1, 大畑紘一1, 飯原大稔1,2, 藤井宏典1, 加藤寛子1, 關谷久美子1, 北洞美佳1, 菱田史織1, 山本扇里1, 渡辺大地1, 松岡芹佳1, 安田浩二1, 丹羽隆1, 小林亮1,3, 熊田恵介2, 清水雅仁2,4, 鈴木昭夫1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 937-937, 2023.

---

	5-11-O73-1. The effect that the reporting from a hospital to the health insurance pharmacy gives for the heart failure rehospitalization prevention 岸孝行, 間宮知子, 井出朋子, 根来早紀子, 中尾倫子, 樫葉利人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 939-939, 2023.

---

	5-11-O73-2. Confirmation, instruction of the cancellation medicine before surgery to work on by regional alliances 坂根美和子1, 森谷道生1, 田中みずほ1, 上島聖秀1, 能澤真希子1, 高橋慎太郎1, 山本麗央奈1, 飴谷友菜1, 小林奈瑠美2, 原直子2, 三浦唱子2, 稲村勝志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 940-940, 2023.

---

	5-11-O73-3. Local joint ownership of the pharmaceutical products stock information using the Web system 御手洗彰信1, 谷口公章2, 葉田昌生2, 小嶋祐一郎1, 下川要二1, 菅田哲治1, 脇田佳幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 941-941, 2023.

---

	5-11-O73-4. About tracing report use and application by test value, the comment printing every drug to outside Parliament prescription 山本浩史, 延藤勇, 日野裕子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 942-942, 2023.

---

	5-11-O73-5. Effect - to give to the duties of questionary survey - hospital, the health insurance pharmacy pharmacist about the efforts of the illness medicine cooperation in the foreign chemotherapy 齋藤一樹, 二瓶哲, 大坂紗也佳, 後藤慎平, 於本崇志, 朝賀純一, 工藤賢三 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 943-943, 2023.

---

	5-11-O74-1. Attitude survey of the health insurance pharmacy pharmacist for "a reporting book about the foreign chemotherapy" 栗原昌也, 楠原佳那子, 川澄賢司, 川崎敏克, 松井礼子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 945-945, 2023.

---

	5-11-O74-2. Effect by the tracing report operation of the antiHIV medicine 櫛田宏幸, 祝洸太郎, 溝口捺美, 岸田啓太郎, 矢倉裕輝, 村津圭治, 山下大輔, 吉野宗宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 946-946, 2023.

---

	5-11-O74-3. Practice and the prospects of the medicine medicine cooperation in the HIV practice 泉澤友宏, 金子知由, 妹尾裕美子, 長谷川英雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 947-947, 2023.

---

	5-11-O74-4. Efforts of the medicine medicine cooperation utilizing the drug control summary 北侑未, 森京子, 竹中克之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 948-948, 2023.

---

	5-11-O74-5. Investigation about the information necessary for drug control summary in the psychiatry 坂本靖之1,2, 坂井原美希1, 中島綾夏1, 松田将史1, 田頭尚士1, 大塚茂雄2, 鷹橋紀幸2, 大塚幸三2, 藤田秀樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 949-949, 2023.

---

	5-11-O75-1. Effect of the efforts about the steroidal osteoporosis prophylaxis utilizing the tracing report 山下修司1, 石原ののこ2, 清木静乃1, 筒井啓登1, 加藤寛子3, 櫻井秀司3, 丹羽今日子3, 河合琢良4, 鈴木昭夫3,5, 林秀樹1,2,3,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 951-951, 2023.

---

	5-11-O75-2. The effect that the difference of the report pattern of the tracing report in the Residual medicine adjustment gives to subsequent change of prescription 福田喬士, 原田貴子, 渡邉愛梨, 下野紀子, 澤田真嗣, 野口裕介, 神田英一郎, 友金幹視 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 952-952, 2023.

---

	5-11-O75-3. Consideration about the present situation report by the operation of a subtracter formulations and the role of the hospital pharmacist 中村雄太郎, 磯部樹里, 今田良樹, 山下勇輝, 眞木秀子, 西村雅次, 羽太光範 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 953-953, 2023.

---

	5-11-O75-4. 3 cases that a pharmacist interview before hospitalization led to the drug adjustment by the health insurance pharmacy 若松雄太, 杉生雅和, 新康憲, 今西可奈子, 高子優子, 正置耕一, 吉岡睦展 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 954-954, 2023.

---

	5-11-O75-5. Study on polypharmacy screening sheet development to use at a drugstore 神保美紗子1,2,3,4,5, 上野明日香1, 市原千花1, 須田潤1, 溝神文博2, 早川裕二3, 加藤瑛一4, 間瀬広樹5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 955-955, 2023.

---

	IO-01. Effect of early dose reduction of osimertinib on efficacy in the first-line treatment for EGFR-positive non-small cell lung cancer Tomoki Hori1,2, Kazuhiro Yamamoto2, Takefumi Ito3, Shigeki Ikushima1, Kotaro Itohara2, Yumi Kitahiro2, Tomohiro Omura2, Ikuko Yano2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 957-957, 2023.

---

IO-02. Population pharmacokinetic analysis and dosing optimization of tacrolimus in lung transplant recipients with itraconazole Ren Takahashi1, Kotaro Itohara1,2, Shunsaku Nakagawa1, Yoshiki Katada1, Mitsuhiro Sugimoto1, Keisuke Umemura1, Katsuyuki Matsumura1, Yuki Shigetsura1, Natsuki Imayoshi1, Yurie Katsube1, Daiki Hira1, Masahiro Tsuda1, Satoshi Imai1, Atsushi Yonezawa1, Takayuki Nakagawa1, Satona Tanaka3, Akihiro Ohsumi3, Daisuke Nakajima3, Miki Nagao4, Hiroshi Date3, Tomohiro Terada1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 958-958, 2023.

---

IO-03. External Validation of a Risk Prediction Model of Denosumab-Induced Hypocalcemia Developed by Analysis of Hospital-Based Administrative Database Keisuke Ikegami1, Shungo Imai1, Osamu Yasumuro2, Masami Tsuchiya3, Naomi Henmi3, Mariko Suzuki3, Katsuhisa Hayashi3, Chisato Miura3, Haruna Abe3, Hayato Kizaki1, Ryohkan Funakoshi2, Satoko Hori1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 959-959, 2023.

---

IO-04. Use of machine learning for predicting delirium from the Japanese Adverse Drug Event Report database Koumi Miyasaka1, Mika Maezawa1, Sakiko Hirofuji1, Wataru Wakabayashi1, Satoshi Nakao1,2, Mari Iwata1,3, Yuka Nokura1, Moe Yamashita1, Kensuke Matsui1, Nanaka Ichihara1, Koki Mori4, Tomoaki Yoshimura5, Masatoshi Inden6, Kazuhiro Iguchi7, Mitsuhiro Nakamura1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 960-960, 2023.

---

	IO-05. Population Pharmacokinetics of Tacrolimus in Adult Liver Transplant Patients during the Period of 3 Months to 1 Year Post Transplantation Ningjia Tang1, Shinichirou Maeda1,2, Masahiro Okuda1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 961-961, 2023.

---

IO-06. Associations between the use of proton pump inhibitors and immune checkpoint inhibitors and the risk of acute kidney injury : a nested case-control study Keiko Ikuta1, Chinami Yamawaki1, Shunsaku Nakagawa1, Natsuki Imayoshi1, Yurie Katsube1, Yuki Shigetsura1, Daiki Hira1, Masahiro Tsuda1, Shinya Yamamoto2, Takeshi Matsubara2, Mokoto Yanagita2, Tomohiro Terada1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 963-963, 2023.

---

IO-07. Factors associated with failure to undergo secondary examinations after an annual checkup from population-based cohort study (Tsuruoka Metabolomics Cohort Study) Minako Matsumoto, Sei Harada, Miho Iida, Aya Hirata, Kazuyo Kuwabara, Naoko Miyagawa, Tomonori Okamura, Toru Takebayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 964-964, 2023.

---

IO-08. Impact of ALBI grade on lenvatinib treatment discontinuation due to adverse events in hepatocellular carcinoma patients Daichi Enomoto1,2, Kazuhiro Yamamoto2, Yuki Matsumoto2, Asami Morioka2, Tomohiro Omura2, Shohei Komatsu3, Yoshihiko Yano4, Takumi Fukumoto4, Kohji Takara1, Ikuko Yano2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 965-965, 2023.

---

	IO-09. Evaluating the safety and efficiency of robotic dispensing systems Tomoki Takase1, Norio Masumoto1, Naoki Shibatani1, Fumiaki Tanaka1, Masaki Hirabatake1, Itaru Nishioka2, Hiroaki Ikesue1, Tohru Hashida1,3, Naoshi Koide1,4,5, Nobuyuki Muroi1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 966-966, 2023.

---

	IO-10. Respiratory drugs and antibiotics use before and during COVID-19 in asthma and COPD patients : a quasi-experimental study Sherif Eltonsy1,6, Laila Aboulatta1, Emily Barr2, Christine Leong1,3, Kaarina Kowalec1,4, Joseph Delaney1,5, Jamie Falk1, Silvia Alessi-Severini1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 967-967, 2023.

---

	P0001-3-PM1. The case that it was hard to take the soft capsule (eldecalcitol capsule), and the patients became able to take in the tentative plan of "the simple suspension thickness method" with the tablet 朝倉寛達, 橘田章子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 972-972, 2023.

---

	P0002-3-PM2. Analysis of trends in pre-avoidance reports aimed at implementing appropriate ward operations 高橋千紘1, 曽根敦子1, 平綿洋子1, 丸谷善紀2, 鈴木優司2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 973-973, 2023.

---

	P0003-3-PM1. Examination about efforts for the acquisition of the drug global assessment adjustment addition and the evaluation 枝廣茂樹1, 松波寿雄2, 大川浩子2, 河原葉子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 974-974, 2023.

---

	P0004-3-PM2. The establishment of the postoperative pain management team and examination of the usefulness 栗崎貴啓1, 黒田安純1, 赤星璃1, 相方靖史2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 975-975, 2023.

---

	P0005-3-PM1. The making of the injection drug incompatibility chart and evaluation of the usefulness in the ICU 岡林由, 宮崎俊明, 筒井由佳, 丸岡由貴 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 976-976, 2023.

---

	P0006-3-PM2. Fact-finding - of the pharmaceutical intervention that we classified for each relation - anesthesia method of the pharmacist to the perioperative patients 増田博也, 佐々木健志, 川村大輔, 大荒政志, 間千晴, 鹿沼奈央, 梶貴裕, 木原稔文, 青柿和樹, 山崎佳奈, 坪田美風, 松浦克樹, 久岡清子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 977-977, 2023.

---

	P0007-3-PM1. Relation to postoperative pain management in our hospital 黒田幸佑, 浦上知香, 久喜優実, 山野菜穂, 町谷安紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 978-978, 2023.

---

	P0008-3-PM2. Efforts for efficiency and the task shift of ward medication counseling duties 田中こずえ, 高田桃子, 山下恵梨香, 上條美咲, 上西咲穂, 山村智代 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 979-979, 2023.

---

	P0009-3-PM1. It is an effect by the addition of the pain-killer after the operation to perioperative clinical path at the appointed hour 真島美佳, 宮原強, 草葉一友 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 980-980, 2023.

---

	P0010-3-PM2. Efforts from the nurse evaluation for the ward pharmacist in our hospital to a model ward project start 長田明浩1, 高橋怜史1, 中山美加2, 仲鉢英夫1, 亀谷恵美子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 981-981, 2023.

---

	P0011-3-PM1. Evaluation ... using efforts - template for the secondary bone fracture prevention of patients with proximal thighbone bone fracture 塚田加奈子, 吉良俊彦, 宇野百合香, 瀬名波暢子, 門馬佳代子, 辻井佳代, 小林政彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 982-982, 2023.

---

	P0012-3-PM2. In the true clinical practice is the intervention of the pharmacist for the use situation of the Xa inhibitor and the dose adequacy directly 岩本祐子, 森光保武, 藤井秀一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 983-983, 2023.

---

	P0013-3-PM1. Attitude survey of efforts and the pharmacist for the perioperative drug control addition 川瀬由莉, 坂井克也, 後藤梓沙, 堀部一晃, 桑山隼, 犬飼真裕, 中島文男, 岩田智樹, 桜田宏明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 984-984, 2023.

---

	P0014-3-PM2. Change of the adequacy of the instruction record for the high-risk medicine by the drug control instruction record template modification and drug control instruction charges calculation 木城美保, 安達明央, 二階堂恵子, 榎本英明, 高山慎司, 後藤一美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 985-985, 2023.

---

	P0015-3-PM1. Survey on the use of clazosentan sodium in our hospital 櫻塲絵梨香1, 大久保莉菜1, 原弘士1, 澤村公志1, 山本郁生1, 三宅茂太2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 986-986, 2023.

---

	P0016-3-PM2. Questionary survey about the study session for the nurses by the ward pharmacist 齊藤晃司, 阿部美知花, 土橋千夏, 七戸菜月, 伊藤直哉, 門間貴大, 高橋健太, 佐々木弘好 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 987-987, 2023.

---

	P0017-3-PM1. The current state of polypharmacy in convalescent rehabilitation wards and cost changes due to medication reduction 加耒由彩1, 江藤康汰1, 今川知香1, 久保和彦2, 河波豊1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 988-988, 2023.

---

	P0018-3-PM2. Change of the number of the periodical internal use agents in aspiration pneumonia-treated patients 花房伸幸1, 小池彩子1, 甲元大樹2, 大道淳二1, 岡崎英子1, 平良奈々1, 竹内誠3, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 989-989, 2023.

---

	P0019-3-PM1. It is a 1 case with suspected bromism by the long-term continuous use of the nonprescription drug including the bromovalerylurea 濱崎浩一1, 松田翔平1, 竹田凌1, 福原伸治1, 西園寺真二1, 山崎美保1, 津田真莉子2, 木村充2, 面田恵1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 990-990, 2023.

---

	P0020-3-PM2. We look at a syndrome and the rear about the side effect at drug origin-related old age and study a mark 早川裕二1, 溝神文博2, 長谷川章3, 間瀬広樹4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 991-991, 2023.

---

	P0021-3-PM1. Examination of the orthopedics surgery case that presented high blood pressure after the operation in our hospital 樽屋志保, 藏本裕信, 長谷川大悟, 大西貴法, 権藤直人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 992-992, 2023.

---

	P0022-3-PM2. Intervention pharmaceutical for the patients who complicated myopathy for pseudoaldosteronism with the Shakuyakukanzoto and one case that supported the use of adverse drug reaction relief system 棚町将之1, 田山理恵1, 下田賢一郎1, 森崎崇文1, 杉山留美子1, 星野輝彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 993-993, 2023.

---

	P0023-3-PM1. The sleeping drug addition situation investigation in the tuberculosis ward and duties examination of the pharmacist 喜多智生1,2,3, 岩成敬子1, 溝口莉沙1, 廣川萌1, 西本有紘1, 小橋美由紀1, 上野良夫1, 辰巳由美子2, 尾下豪人3, 池上靖彦3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 994-994, 2023.

---

	P0024-3-PM2. The case that resulted in a neuromyelitis optica spectrum disorder by nivolumab therapy for patients with progressive renal cell carcinoma 神原諒, 中條悠, 早川太朗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 995-995, 2023.

---

	P0025-3-PM1. A case which made a fool of a candy as herpes zoster treatment, and accompanied meningitis after the building administration 岩鼻優1, 佐々木康弘1, 小野嘉文2, 益子里美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 996-996, 2023.

---

	P0026-3-PM2. Efforts toward treatment and the domiciliary treatment of the patients with super short bowel syndrome 須賀原知世, 鳥山裕稀, 舛友美緒, 川西綾菜, 徳永由紀, 奥村暢子, 三宅沙央莉, 高松祐子, 長澤祥子, 木村真策 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 997-997, 2023.

---

	P0027-3-PM1. Usefulness evaluation about the delirium study session to the nurse by the pharmacist 北村梨菜, 足立易子, 澤井健太, 多賀野正嗣, 堀哲史, 竹田和也, 藤村保夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 998-998, 2023.

---

	P0028-3-PM2. The relation of the pharmacist in the perinatal medical care "conducts questionary survey in the making of the booklet propelling use of aptitude of the drug" and 鈴木真貴子1, 松本ゆいこ1, 森亜樹1, 平野公美1, 宮本康敬1, 川口千香1, 岡田喜親2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 999-999, 2023.

---

	P0029-3-PM1. Examination of the factor to influence the at-home return using the drug-related factor in the convalescent rehabilitation ward 田中絵里子1, 三井奈緒1,2, 中村彰子1,2, 柳原麻里1, 島本一志1,2, 藤原久登2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1000-1000, 2023.

---

	P0030-3-PM2. Construction of the in-hospital system working on the issue of polypharmacy 関恭子1, 長井円香1, 大西政典1, 奥鈴花1, 土佐直子1, 廣田功平2, 井上聖也2, 佐藤稔2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1001-1001, 2023.

---

	P0031-3-PM1. Attitude survey of the physician about the polypharmacy 長井円香, 関恭子, 大西政典, 奥鈴花, 松浦里穂, 村上知奈美, 松村恵理奈, 宮西有紗, 足立聡子, 盛重あずさ, 池田咲樹, 岸井加代子, 先崎健造, 長田知子, 土佐直子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1002-1002, 2023.

---

	P0032-3-PM2. Efforts to the drug control instruction for a seriously disabled child (person) and the protector 高良恵理, 坂口美智子, 西村幾美, 服部雄司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1003-1003, 2023.

---

	P0033-3-PM1. Classification of medicinal effect and drug costs reduction effect accompanied with the polypharmacy improvement in our hospital 上尾正和1, 近藤博紀1, 松本遼太郎1, 河崎一久1, 二階堂邦夫3, 片桐一彦4, 古俵孝明1, 角田恒2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1004-1004, 2023.

---

	P0034-3-PM2. Efforts of the pharmaceutical management by the pharmacist in the urination care team 眞部遥香1, 臼井麻琴1, 宮本乃ぞみ2, 登立裕美2, 首藤佳代子2, 山田杏奈2, 吉留由紀恵3, 篠崎聡1, 新田茜1, 村井宗正1, 本多秀俊1, 村田太郎4, 並木路広1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1005-1005, 2023.

---

	P0035-3-PM1. Usefulness evaluation of the rate of application tool of the intravenous-feeding solution 朝倉幹己, 山田将悟, 藤林遼, 橋本咲季, 高橋誠, 田中正臣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1006-1006, 2023.

---

	P0036-3-PM2. Maintenance of the information sharing system of the pharmacist for the perioperative drug control addition calculation 河合美凪, 打田由希, 濱浦弘光, 大谷寧次郎, 三浦毅 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1007-1007, 2023.

---

	P0037-3-PM1. A case which suffered from treatment of the diabetes insipidus that craniopharyngioma occurred in postoperatively 吉野禎章1, 高橋彩花1,2, 宮沢唯1, 鶴岡優里1, 菅井一真1, 小川雅史1, 桑原琴1, 秋元敬貴1, 吉若健太郎1, 篠崎浩司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1008-1008, 2023.

---

	P0038-3-PM2. Survey about the effect that the prescription support of the basic therapeutic drug results in to the prescription situation on heart failure inpatient by the pharmacist 小川侑佳, 岩内大佑, 菱田啓介, 三浦誠 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1009-1009, 2023.

---

	P0039-3-PM1. Let's increase to the reporting to issuance situation - institution interval of the drug control summary in our hospital! 久岡清子, 増田博也, 合田さやか, 佐々木健志, 澤口友紀, 大荒政志, 川村大輔, 鹿沼奈央, 坂本真衣, 吉川真央, 小滝亜梨紗, 井上萌, 梶貴裕, 青柿和樹, 山崎佳奈, 坪田美風, 黒田悠加 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1010-1010, 2023.

---

	P0040-3-PM2. Efforts with a ward pharmacist and the discharge adjustment nurse for the discharge 古畑俊英1,2, 林美和1, 松島千明2, 六波羅孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1011-1011, 2023.

---

	P0041-3-PM1. Role of the pharmacist at preparation introduction for the amikacin inhalation 地田凌, 鈴木亮平, 溝口和代, 滝久司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1012-1012, 2023.

---

	P0042-3-PM2. Risk management effect to be obtained as a ward pharmacist confirms medicine set Distribution of medicine 本木邦明, 大澤祐樹, 西久保龍男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1013-1013, 2023.

---

	P0043-3-PM1. Efforts and evaluation to the simple suspension method proper use in the Handa City solder hospital neurosurgery ward 吉川直利, 横田学, 板倉由縁, 伊藤実優 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1014-1014, 2023.

---

	P0044-3-PM2. Intervention to a postoperative pain team round in our hospital 渕上翔太1, 天野杏南1, 村井陽一1, 水谷早希2, 木全司1, 棚橋順治2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1015-1015, 2023.

---

	P0045-3-PM1. Activity result of the urination care team in our hospital 林剛史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1016-1016, 2023.

---

	P0046-3-PM2. About the relation of efforts and the pharmacist of the secondary bone fracture prevention team 野里直子1, 佐藤浩二1,2, 香川雅一1,2, 西岡達也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1017-1017, 2023.

---

	P0047-3-PM1. Fact-finding of the use of postoperative pain-killer situation in the Fukuoka Saiseikai Fukuoka General Hospital gynecology 二神咲子, 由井薗陽一, 槙林智子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1018-1018, 2023.

---

	P0048-3-PM2. Effect on postoperative pain by the use of brochure at PCA explanation 黒田安純, 栗崎貴啓 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1019-1019, 2023.

---

	P0049-3-PM1. Investigation of tablet dysphagia in the person with a physical disability institution using PILL-5 浜田茂明, 山本一輝, 森本真仁 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1020-1020, 2023.

---

	P0050-3-PM1. About fact-finding of the pharmaceutical participation of the ward pharmacist in the perioperative drug control addition calculation patients 濱浦弘光, 河合美凪, 打田由希, 大谷寧次郎, 三浦毅 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1023-1023, 2023.

---

	P0051-3-PM2. Efforts to establish a system for the use of a direct-acting factor Xa inhibitor reversal agent (andexanet alfa) 桃原周杜1, 佐藤誠一1, 坂本広登2, 高野耕一郎1, 小林澄雄3, 前島光廣1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1024-1024, 2023.

---

	P0052-3-PM1. A case which a pharmacist participated in in the multi-type of job ethic conference for the terminal phase in the emergency ward 新井花緒, 植田有希, 中井綾乃, 大橋明歩, 平高拓, 堀友紀, 立川奈保美, 沖山美都子, 山東真寿美, 藤田敬子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1025-1025, 2023.

---

	P0053-3-PM2. Evaluation of Ward Pharmacists' Work in an Open Intensive Care Unit - Verification of Pre-Avoid - 荒川希美, 西田祥啓, 高橋喜統, 政氏藤玄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1026-1026, 2023.

---

	P0054-3-PM1. In the postoperative pain management team in the friendship medical center, the multi-type of job cooperation is a key 小杉卓大1, 金城勝大1, 宮良遥奈1, 藤田翔1, 吾津千秋1, 梶原理恵2, 宜保さと子3, 赤嶺智教3, 新里泰一3, 國分千代1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1027-1027, 2023.

---

	P0055-3-PM2. Fact-finding about the prescription inspection of the thrombomodulin alpha in the infection-related DIC treatment 今浦将治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1028-1028, 2023.

---

	P0056-3-PM1. Efforts of the pharmacist at in-hospital sudden change (Code Blue) in our hospital occurrence 保志場康人, 山口茉由夏, 古賀彩花, 清水和香, 小山奈津実 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1029-1029, 2023.

---

	P0057-3-PM2. Treatment efficiency accompanied with the task sharing practice in the intensive care unit and effect on safety 堤克成1,2,3, 本田勝亮1, 柏原道志1, 長岡翔1, 塩田亮介1, 石野清亮1, 立石実2, 小出昌秋2, 渥美生弘3, 土手尚3, 矢部勝茂1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1030-1030, 2023.

---

	P0058-3-PM1. Duties burden reduction effect of other types of job by the operating room permanent residence of the pharmacist 糸山佳奈子1, 行武由美子1, 小林夕莉1, 當真菜央1, 知念ほのか1, 水摩ひかり1, 有銘千賀子1, 宮川千珠1, 井上理美1, 田仲祐子1, 森智子1, 喜多洋嗣1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1031-1031, 2023.

---

	P0059-3-PM2. Cooperation example of the operating room pharmacist in the perioperative medical therapy 宮本佳奈, 柴田ゆうか, 板村まりの, 三好真希子, 松尾裕彰 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1032-1032, 2023.

---

	P0060-3-PM1. It is one patient with suspected toxicoderma (bromoderma) with disturbance of consciousness by the potassium bromide with pseudo hyperchloremia subsequently 藏本裕信1, 中村英夫2, 濱英雄3, 権藤直人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1033-1033, 2023.

---

	P0061-3-PM2. The current situation and problem of the proton pump inhibitor long-term use patients in the intensive care unit 石木仁美, 横山夏季, 重松舞, 奥迫彩華, 玉城亜寿香, 和泉勝一, 白木萌, 坂口結斗, 府川祥子, 喜多洋嗣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1034-1034, 2023.

---

	P0062-3-PM1. The current situation of the patients who consulted a critical care center by medication in large quantities 榊原洋一, 野崎達也, 伊藤実優, 横田学 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1035-1035, 2023.

---

	P0063-3-PM2. Effect on adsorption of the antiMRSA medicine in the sustained hemofiltration dialysis circuit model using AN69ST membrane hemofilter 稲野祥宗1, 土屋香代子1, 熊野諒太1, 三浦剛1, 仲佐啓詳1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1036-1036, 2023.

---

	P0064-3-PM1. Clinical usefulness evaluation of kit SIGNIFYTMER for the drug intoxication detection 濱田一成 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1037-1037, 2023.

---

	P0065-3-PM2. Examination of the usefulness of the loading dose in the decreased renal function case of the seriously ill section and the sustained hemocatharsis introduction case 小林洋平1, 釜野健太郎1, 中川貴弘1, 河津敏明1, 烏野隆博1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1038-1038, 2023.

---

	P0066-3-PM1. A case which they presented with acute renal failure during purulent gonitis treatment and became the cefepime encephalopathy, and suffered from treatment 鳥海未奈1, 松沼悟1, 吉元公一1, 蒲原英伸2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1039-1039, 2023.

---

	P0067-3-PM2. Operation of the bowel movement protocol in the intensive care unit and the evaluation 畠山英司1, 今浦将治1, 宮田慎也1, 岡部賢司1, 金田明子2, 高橋宏行3, 菅野浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1040-1040, 2023.

---

	P0068-3-PM1. One case of patients with methanol poisoning saved by early ethanol administration 北島健士1, 松木美幸1, 田中一平1, 原俊輔2, 柴崎功1, 原田尚重2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1041-1041, 2023.

---

	P0069-3-PM2. Efforts for the order unionization of the injection high risk medicine in the care unit 西村健二, 亀井健人, 赤木晋介, 徳田衡紀, 高柳和伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1042-1042, 2023.

---

P0070-3-PM1. Evaluation of the super acute phase ward training in the Okayama University hospital pharmacy using the upbringing 22nd report customer satisfaction analysis of the pharmacist carrying the next generation 大川恭昌1, 久保和子1, 真鍋洋平1, 川西秀明1, 上田久美子1, 村尾卓哉1, 宮本朋佳2, 佐田光1, 勝部理早1, 猪田宏美1, 濱野裕章1, 西原茂樹1, 村川公央1, 座間味義人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1043-1043, 2023.

---

	P0071-3-PM2. Satisfaction investigation of the emergency visit (ER) training for the new face pharmacists by the pharmacist engaging in emergency care 高橋雪乃, 宮田祐一, 岩崎睦, 藤村一軌, 中村雅敏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1044-1044, 2023.

---

	P0072-3-PM1. Relation of the pharmacist to postoperative pain management team duties construction 日江井和英1, 土本暁斗1, 安田翔1, 中村英嗣1, 高澤圭輔1, 松由幸司1, 宮部芳之1, 若尾留美2, 山崎潤二3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1045-1045, 2023.

---

	P0073-3-PM1. Inspection of the effect that calculation, the measurement formulations of the injection drug give to a task share 乾佐登子, 郡妙恵, 山田美映子, 篠崎聡, 新田茜, 村井宗正, 本多秀俊, 林由紀子, 並木路広 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1049-1049, 2023.

---

	P0074-3-PM2. About the prescription representation input (PBPM) introduction after doubt inquiry by the pharmacist for the oral anticancer medicine 伴修平, 橋本幸輝, 羽鳥正浩, 鈴木莉羅, 木村俊哉, 古谷良太, 鈴木亘, 蓑輪雄一, 瀧口友美, 川上和宜, 清水久範, 山口正和 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1050-1050, 2023.

---

	P0075-3-PM1. It is ... for the efficiency of the burden reduction of efforts ... physician of the representation correction of the prescription by the pharmacist and the duties of the pharmacist 南利彩子, 増川みなみ, 吉田敏人, 佐々木美緒, 寺沢匡史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1051-1051, 2023.

---

	P0076-3-PM2. The safety assessment after the task shift to a non-pharmacist: Effect on incident incidence by the pharmacist in compounding of medicines duties 齊藤茉子, 安島秀友, 杉村春奈, 松崎貴志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1052-1052, 2023.

---

	P0077-3-PM1. Dose adjustment ... of PBPM introduction effect and the problem - Total Knee Arthroplasty (TKA)/total hip replacement (THA) postoperative edoxaban in the orthopedics domain 森菜々美, 藤井若奈, 多留木崇志, 村田龍宣, 小野勝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1053-1053, 2023.

---

	P0078-3-PM2. It is evaluated the instructions support protocol one package of the in-hospital prescribed medicine by the pharmacist 松本夢実, 宮原強, 草葉一友 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1054-1054, 2023.

---

	P0079-3-PM1. Effect of task shift/share after the substitute suggestion introduction of the bringing medicine by the set input 中川ちひろ, 井出和男, 濃野乃文, 若杉正, 小池博文, 佐橋幸子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1055-1055, 2023.

---

	P0080-3-PM2. Effect of task shift/share in the Shinshu medical center pharmacy 三澤貴美1, 大塚さほり1, 香川貴亮1, 有賀敦1, 田中健二1, 堀勝幸2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1056-1056, 2023.

---

	P0081-3-PM1. Examination about the duties efficiency by a task shifting bringing medicine order issuance from a physician to a pharmacist 菅直恵1, 西村健二1, 石田亮2, 亀井健人1, 赤木晋介1, 徳田衡紀1, 高柳和伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1057-1057, 2023.

---

	P0082-3-PM2. The PBPM introduction results in the Secomedic Hospital and examination about the task share 西須永実理1, 山田浩介1, 勝田良子1, 島盛一郎1, 渡辺孔明1, 長澤宏之1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1058-1058, 2023.

---

	P0083-3-PM1. Task shift/share promotion and effect of the pharmacist duties by the drug duties assistant 西岡達也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1059-1059, 2023.

---

	P0084-3-PM2. Duties efficiency by efforts - task shift to attractive pharmacy construction and central operational ... 吉成宏顕1, 佐藤淳也3, 大矢智則1,2, 玉井一也1, 宮内輝人1, 久保倫美1, 風岡真実1, 入野真紀1, 梅田鈴香1, 守田侑真1, 神坐美弥子1,2, 橋本竜1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1060-1060, 2023.

---

	P0085-3-PM1. Task share with the floor nurse in simple suspension confirmation duties 松西葵1, 川上隆弘1, 松本和也1, 花房伸幸1, 土屋絵莉子1, 河村茉衣1, 平井淳子1, 渡部咲輝2, 三宅裕子2, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1061-1061, 2023.

---

P0086-3-PM2. It is a proper use investigation of the infection prophylaxis antimicrobial after the drug and the operation that cancellation needs preoperatively in the perioperative drug control addition duties of the Nippon Life Insurance Co. Hospital 池田久雄, 平田貴宏, 千原亜紀子, 森岡浩子, 宮原阿友美, 神原弘和, 足立充司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1062-1062, 2023.

---

	P0087-3-PM1. Establishment of the preoperative pharmaceutical intervention system in cooperation with hospitalization and release support section 遠藤栞奈1, 堀之内藍1, 小泉綾乃1, 庄司沙織2, 鈴木しのぶ2, 上野達也2,3, 田中敏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1063-1063, 2023.

---

	P0088-3-PM2. Usefulness evaluation to a task having shifted Distribution of medicine duties to a non-pharmacist 鈴木寛人, 松野真梨子, 板倉愛, 山崎みわ子, 岡部翔太郎, 上地めぐみ, 山城武志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1064-1064, 2023.

---

	P0089-3-PM1. Efforts of the hepatitis measures for patients who received chemotherapy by the pharmacist using PBPM 渡部寿康1, 武藤芳和1, 菊地洋平1, 二階堂雄平2, 佐藤隆昭2, 新國智子3, 野地静香3, 市橋淳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1065-1065, 2023.

---

	P0090-3-PM2. Construction of the input support system of the examination for blood drug concentration order by the critical care center working full time pharmacist 吉川直樹1, 是枝秀彦1, 松崎裕紀1, 宮田千秋1, 畠中健吾2, 平原康寿1, 岩切智美1, 落合秀信2, 池田龍二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1066-1066, 2023.

---

	P0091-3-PM1. Inflection of PBPM for the appropriate enforcement of the vancomycin TDM order in first aid, the intensive care 鎌田里紗1,2, 田村亮1, 藤田拓俊1, 瀬尾龍太郎2, 平畠正樹1, 橋田亨1, 室井延之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1067-1067, 2023.

---

	P0092-3-PM2. Evaluation for the practice of the TDM by PBPM 鶴村真大1, 長山優介1, 井幡圭佑1, 東加奈子1, 島田浩1, 大城美希1, 藤吉徹也1, 大井美和1, 寺本有里2, 藤尾みどり1, 村田久枝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1068-1068, 2023.

---

	P0093-3-PM1. PBPM in the skin care team for the onset of dermatopathy patients in the antiEGFR antibody medicine is one case of rectal cancer that it showed contribution for treatment continuation 久保村優1,2, 輪湖哲也1,2, 伊勢雄也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1069-1069, 2023.

---

	P0094-3-PM2. Attempt of the task shift in chemotherapy duties of our hospital 曽根章貴, 生駒辰夫, 石橋里穂, 大塚祐紀子, 高澤圭輔, 安田翔, 近藤章吾, 山口雄士, 松由幸司, 宮部芳之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1070-1070, 2023.

---

	P0095-3-PM1. Effect of the examination order support based on PBPM in the foreign cancer medical therapy 梁川稔規1, 片岡幸三2, 山下典子1, 柳井美奈1, 田中邦佳1, 板東純子1, 福田知子1, 宮崎美貴子1, 緒方文洪1, 平山未佑1, 久保亜里菜1, 池田正孝2, 木村健1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1071-1071, 2023.

---

	P0096-3-PM2. For practice of PBPM, it is questionary survey about the representation order by the pharmacist 新倉匠, 市川慶, 大谷隆之, 栗山明子, 八木仁史, 高田宏文, 河井良智 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1072-1072, 2023.

---

	P0097-3-PM1. Survey of the vancomycin administration protocol operation situation in our hospital 田口諒, 元木孝, 渡邊清人, 高柳昌宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1073-1073, 2023.

---

	P0098-3-PM2. Efforts of the task shift of the specific antimicrobial report duties by the ward pharmacist 東恩納司, 森下陽介, 川西秀明, 大川恭昌, 村尾卓哉, 平山知美, 大月理恵子, 勝部理早, 濱野裕章, 村川公央, 座間味義人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1074-1074, 2023.

---

	P0099-3-PM1. Investigation of the usefulness of the cartridge for the suspension exercise in the blender operation instruction of the biphasic insulin preparation 鎌田敬志1, 虎石顕一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1075-1075, 2023.

---

	P0100-3-PM2. The current situation and the prospects of the postoperative pain management team activity in the Osaka Red Cross hospital 吉良俊彦, 木下里紗, 吉野秀紀, 辻井佳代, 小林政彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1076-1076, 2023.

---

	P0101-3-PM1. Expansion targeted for the comprehensive prior agreement protocol in the outside Parliament prescription and the effect 吹上勇真1, 宮崎元康1,2, 久留須恭香1, 後藤美和1, 鵜木亜矢子1, 前山明香1, 中島章雄1,2, 今給黎修1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1077-1077, 2023.

---

	P0102-3-PM2. Operation of the doubt inquiry prior agreement protocol in the outside Parliament prescription 最勝寺雅広, 田所正年, 上村豪 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1078-1078, 2023.

---

	P0103-3-PM1. The invention about confirmation of common use medicine before hospitalization aiming at the number of doubt inquiries reduction duties and examination about the usefulness 緒方健二1, 祖川倫太郎1, 湯川美紗子1, 加茂真宏1, 江本晶子1, 木村早希子1, 吉田ひとみ2, 江崎幹宏2, 島ノ江千里1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1079-1079, 2023.

---

	P0104-3-PM2. The effect that prescription support based on the protocol of the ward pharmacist gives for an internal use-related incident 杉本智哉1, 小園利加2, 杉野晃希1, 山田和奈1, 納富智基1, 遠山幸男1, 久田達也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1080-1080, 2023.

---

	P0105-3-PM1. About the efforts of an operating room pharmacist and the ward pharmacist in surgery and the modified type electroconvulsive therapy 水谷妙子, 原かおる, 五味裕大, 杉村博基, 北原和花子, 木村奈波, 佐藤伶奈, 清水颯人, 松尾治樹, 登内盛治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1081-1081, 2023.

---

	P0106-3-PM2. Introduction of the member of functional pharmacy for the purpose of task shift/share from a pharmacist in the cottage-hospital out of the district 岸本真1, 徳丸章佳1, 北園幸大1, 田中恭人1, 池沢若菜1, 森永崇史1, 中村杏果1, 石渡美樹1, 徳永楓果1, 栗田泰樹1, 上野菜巳1, 上野怜良1, 屋敷大輔1, 淵脇ゆかり1, 長ヶ原琢磨1, 荻尾夕起子1, 児玉友和2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1082-1082, 2023.

---

	P0107-3-PM1. Doubt inquiry contents and problems after the outside Parliament prescription doubt inquiry simplification protocol (inside the hospital-adaptive) introduction 山内章嗣, 西村亮, 原田卓弥, 磯部佳歩, 松岡勇作, 奥野昌宏, 森本茂文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1083-1083, 2023.

---

	P0108-3-PM2. Examination of the intervention number of patients after the postoperative pain management team start in our hospital 柏原聖人1, 滝浪素由1, 石田恵章2,3, 鳥羽好恵3, 矢部勝茂1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1084-1084, 2023.

---

	P0109-3-PM1. Examination - in attempt - oral proton pump inhibitor to drug costs reduction by the medicine charge writing together to the drug name on the prescription system 松沼悟, 磯貝博之, 吉元公一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1087-1087, 2023.

---

	P0110-3-PM2. Risk of developing diabetes in the hypertriglyceridemia 藤田和暉, 上條千尋, 関口佳純, 矢島綾美, 米盛由喜, 菅野淳史, 西圭史, 辻泰弘, 大場延浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1088-1088, 2023.

---

	P0111-3-PM1. Effect on chronic kidney disease (CKD) by the use of angiotensin II receptor antagonist (ARB) 市川颯人, 伊与久翼, 中村光穂, 内田菜々子, 菅野淳史, 大場延浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1089-1089, 2023.

---

	P0112-3-PM2. About the expression situation and the folinic acid preparation combination of the methotrexate-related lymphoproliferative disorder 村上正樹, 石原慎之, 玉木宏樹, 矢野貴久, 直良浩司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1090-1090, 2023.

---

	P0113-3-PM1. Costs minimization analysis - using medical economical impact - real world data of the Chinese medicine in comparison with the Western medicine for common cold treatment 赤瀬朋秀1,5, 田中里園2, 新井信3, 湯本哲郎4, 豊島久雄5, 土屋孝範5, 濃沼政美2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1091-1091, 2023.

---

	P0114-3-PM2. Search of the factor affecting the collect rate of the sortation equipment one package 稲垣晃熙, 谷江梨奈, 山本恭平, 植松夏子, 奥平正美, 杉浦洋二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1092-1092, 2023.

---

	P0115-3-PM1. It is evaluated the usefulness about the hospital management of the tablet sortation equipment one package that considered a return working hour 谷江梨奈, 稲垣晃熙, 山本恭平, 植松夏子, 奥平正美, 杉浦洋二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1093-1093, 2023.

---

	P0116-3-PM2. Analysis of the factor to have an influence on the adherence of the dyslipidemia therapeutic drug through "knob medicine bag motion" 立麻香帆1, 猪阪日向子1, 國武さくら1, 小林大介1, 川尻雄大1, 木原太郎2, 高木淳一2, 田中泰三2, 赤嶺裕之3, 阿部みどり3, 濱野明子4, 浅尾一夫4, 島添隆雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1094-1094, 2023.

---

	P0117-3-PM1. Examination of single use of vial multiple times and Residual medicine reduction by the new capacity standard introduction that paid their attention to bendamustine medication method and the exposure risk reduction effect 宇佐美英績1, 浅野裕紀1, 福岡智宏2, 兼松哲史3, 木村美智男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1095-1095, 2023.

---

	P0118-3-PM2. Investigation of the economical effect by the reuse of the disposal factor and the cancellation drug after the anticancer medicine preparation 柳野紗智子1, 菊池由宣2, 有田仁紀1, 渡辺和美1, 宮田祥一1, 菅井瞳1, 坂本真紀1, 島田英昭3, 松本高広1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1096-1096, 2023.

---

P0119-3-PM1. An association between use and inborn character malformation of the child born of the Ephedra-containing Chinese medicine in the early stage of the pregnant woman: Northeastern medical megabank plan three generations cohort study 野田あおい1,2,3, 小原拓1,2,3, 松崎芙実子1,2, 小原竜1,2, 森下啓2, 上野史彦2,3, 篠田元気1,2, 大類真嗣1,2, 村上慶子1,2, 石黒真美1,2, 栗山進一1,2,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1097-1097, 2023.

---

	P0120-3-PM2. A change of the number of the drugs of the at-home visit patients and examination of drug costs 滝澤康志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1098-1098, 2023.

---

	P0121-3-PM1. Time-series analysis of search data of Google about the Web search behavior of the cannabis and Wikipedia 牛尾聡一郎1, 江角悟2, 江口幸臣1,3, 入江圭一1, 佐野和憲1, 三島健一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1099-1099, 2023.

---

	P0122-3-PM2. Cost effect analysis of the glaucoma therapeutic drug 坂本優佳1, 中川直人1, 柏原正美2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1100-1100, 2023.

---

	P0123-3-PM1. Cost effectiveness analysis about the uric acid synthase inhibitor 鈴木拓磨, 中川直人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1101-1101, 2023.

---

	P0124-3-PM2. Cost effect analysis of the antihistamine for the perennial allergic rhinitis 菅野静輝, 中川直人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1102-1102, 2023.

---

	P0125-3-PM1. The effect that loperamide gives to CYP2J2 enzyme activity 加藤美紀, 灘井雅行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1104-1104, 2023.

---

	P0126-3-PM2. Comparison of midazolam metabolism in human liver microsomes under the temperature of temperature management therapy 井上知美, 石橋芙起, 加藤理乃, 中原良太, 石渡俊二, 小竹武 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1105-1105, 2023.

---

	P0127-3-PM1. Examination of the xanthine oxidoreductase activity in the apoplectic easy onset hypertensive spontaneous rat liver 藤井千穂, 田山剛崇, 森脇智也, 前田志津子, 杉原数美, 三宅勝志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1106-1106, 2023.

---

	P0128-3-PM2. Pharmacokinetic characteristic of α 2 receptor agonist dexmedetomidine in the In vivo membrane oxygenator model rat out of the body 佐藤雄己1, 元石恵理奈1, 花田実夢1, 半田 (永塚) 由佳1, 阿部拓也2, 藤井豊2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1107-1107, 2023.

---

P0129-3-PM1. The best case of the non-small cell lung cancer which we suggested the blood level measurement that disturbance of consciousness developed after the sotorasib start and excluded a drug adverse effect, and to evaluate it and connected with administration resumption 仲鉢英夫1, 北爪教貴1, 丸藤義翔2, 安武夫2, 鎌田理子3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1109-1109, 2023.

---

	P0130-3-PM2. Examination about the correlation of the UHPLC-MS/MS, LTIA in blood Everolimus densitometry and ACMIA method 宮城知佳, 白岩健, 田中遼大, 龍田涼佑, 伊東弘樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1110-1110, 2023.

---

	P0131-3-PM1. Blood level prediction of the Teicoplanin based on cystatin C in patients with neurologic intractable disease 山科卓也1, 山崎貴史2, 青柳千愛1, 下村真代1, 平木洋一3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1111-1111, 2023.

---

	P0132-3-PM2. Usefulness of STAT3 genetic polymorphism and the sorafenib blood level for the sorafenib-induced hand-and-foot syndrome in the progress hepatocellular carcinoma 高塚博一1,2, 菅原隆人2, 内田雅士1,2, 山崎伸吾1, 鈴木貴明1,2, 石井伊都子1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1112-1112, 2023.

---

	P0133-3-PM1. Practice of the mycophenolic acid AUC calculation by LSS in heart-transplant recipients and examination of the aim area 永田理香子1, 井倉恵1, 中村任2, 島本裕子1, 上野智子1, 渡邊琢也3, 塚本泰正3, 川端一功1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1113-1113, 2023.

---

	P0134-3-PM2. Transitional evaluation out of correlation with the blood level based on the densitometry out of the brain of the Perampanel and the brain 植田優花1, 川田将義1, 平大樹1, 米澤淳1, 峰晴陽平2, 溝田敏幸3, 山尾幸広2, 古川恵子4, 中川俊作1, 津田真弘1, 荒川芳輝2, 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1114-1114, 2023.

---

	P0135-3-PM1. Frequencies of Augmented Renal Clearance of patients with injury in the critical care center 中野貴文1,2, 弓彩華1, 青柳美紗希1, 仲村佳彦3, 林稔展1, 石倉宏恭3, 神村英利2, 松尾宏一1,2, 江川孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1115-1115, 2023.

---

	P0136-3-PM2. One case that was available for the control of the thyroid hormone level by administration of oral levothyroxine preparation for patients with short bowel syndrome 横山恵里南, 松屋翔太, 林洋平, 兼行由佳, 福澤正隆, 竹田克明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1116-1116, 2023.

---

	P0137-3-PM1. One case of aplastic anemia that intervention to the administration plan of the cyclosporine note was useful for the patients who were hard to be given it orally 水岡大策1,2, 山口佳津騎2, 篠原尚樹1, 元木貴大1, 田中裕章1, 小坂信二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1119-1119, 2023.

---

	P0138-3-PM2. Examination of the clinical factor affecting the early acute renal failure onset in the vancomycin administration 鎌田裕介, 菅野雄太, 斯波将史, 高村誠人, 鈴木奏絵, 吉岡熏, 本川聡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1120-1120, 2023.

---

	P0139-3-PM1. A case which had difficulty in removal of the Teicoplanin by the haemodialysis with the polysulfone membrane 西山菜摘, 青戸和宏, 小阪直史, 四方敬介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1121-1121, 2023.

---

	P0140-3-PM2. Examination for the high sensitive fixed-quantity and blood voriconazole levels prediction of the melatonin using two kinds of stable isotope labeling compounds 藤吉正哉, 山本達郎, 島田美樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1122-1122, 2023.

---

	P0141-3-PM1. Analysis of the background factor requiring the peak blood level measurement in the AUC estimate of patients receiving vancomycin 佐藤ありす, 吉川直樹, 松崎裕紀, 是枝秀彦, 山田侑世, 保田和哉, 平原康寿, 池田龍二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1123-1123, 2023.

---

	P0142-3-PM2. Management of the AUC using C12 obtained by administration in the tacrolimus extended-release night kidney transplantation one year later 高橋優聡1, 中村雄亮1, 大野真史1, 助畑歩1, 三浦正義2, 東山寛2, 小森均1, 深井敏隆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1124-1124, 2023.

---

	P0143-3-PM1. Investigation of the effect that peritonitis gives to the blood level after the vancomycin peritoneal dialysis fluid coinfusion administration of peritoneal dialysis patients 高嶋祥匡, 高橋弘泰, 市江敏和, 三浦毅 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1125-1125, 2023.

---

	P0144-3-PM2. 1 case that blood voriconazole levels decreased by pneumonia symptom improvement complicated with COVID-19 竹崎正明, 山本達郎, 齋木雄介, 小玉菜央, 藤吉正哉, 島田美樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1126-1126, 2023.

---

	P0145-3-PM1. Voriconazole out of the dialytic fluid by the high performance liquid chromatography and phenytoin pro-simultaneous measurement development 青山隆彦, 工藤佑介, 並木一朗, 松本宜明, 辻泰弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1127-1127, 2023.

---

	P0146-3-PM2. Monitoring blood concentrations in patients receiving additional CYP3A4 inhibitors during the venetoclax maintenance phase 久保利樹1, 祖川倫太郎1, 松尾俊佑1, 安武夫2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1128-1128, 2023.

---

	P0147-3-PM1. Development of the assay of the sunitinib in the human nail using the LC-MS/MS analysis 里美貴1, 八島秀明2, 荒木拓也2, 大林真幸1, 神山紀子1, 山本康次郎2, 向後麻里1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1129-1129, 2023.

---

	P0148-3-PM2. Examination about Teicoplanin blood level and the high-dose loading dose 唐川聖司1, 松岡怜1, 酒井義朗1, 國武正幸1, 上瀧喬仁1, 樋口恭子1, 渡邊浩2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1130-1130, 2023.

---

	P0149-3-PM1. Investigation about the estrangement of a trough guide and the AUC guide in the TDM of vancomycin 伊藤悠里子1,2, 久保茜1, 友寄旬1,2, 山下友輝1, 村中一大1, 樋浦一哉3, 棚谷貢1, 船木映二1, 柴波明男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1131-1131, 2023.

---

	P0150-3-PM2. Examination of the usefulness of the Teicoplanin concentrations revision in patients with hypoalbuminemia 多賀野正嗣, 浜田凌介, 澤井健太, 堀哲史, 竹田和也, 藤村保夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1132-1132, 2023.

---

	P0151-3-PM1. Efforts and the current situation report of the TDM which assumed Area under the Blood Concentration Time Curve (AUC) of vancomycin (VCM) in our hospital an index 村田翔, 芳山健太郎, 川崎亮輔, 相原敏彦, 仲鉢英夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1133-1133, 2023.

---

	P0152-3-PM2. Education effect of the AST charge pharmacist on vancomycin initial loading dose 植竹宣江, 立川文崇, 本岡真弥, 國重将大, 村上礼隆, 北本真一, 宮森伸一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1134-1134, 2023.

---

	P0153-3-PM1. The current situation investigation of medication method and the renal failure incidence of vancomycin 鈴川誠, 内山耕作, 平尾祐樹, 芥子川純里, 出口真人, 冨田敦和, 今西忠宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1135-1135, 2023.

---

	P0154-3-PM2. The effectiveness of the loading dose to a decreased renal function case of the Teicoplanin in the Gifu comprehensive medical care center, safe examination 尾藤里奈, 小栗良介, 関谷泰明, 井上壽江, 平下智之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1136-1136, 2023.

---

	P0155-3-PM1. Examination about the difference in administration recommendation quantity of two points of blood vancomycin levels drawing blood and one point of drawing blood using PAT in our hospital 只佐宣子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1137-1137, 2023.

---

	P0156-3-PM2. Examination about the loading dose to patients with severe impaired renal function of the Teicoplanin 川端俊介, 松屋翔太, 福澤正隆, 竹田克明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1138-1138, 2023.

---

	P0157-3-PM1. Usefulness evaluation of new software practical AUC-guided TDM (PAT) in the childhood vancomycin TDM 中村成志, 福元裕介, 東和博, 瀬戸口誠, 有馬純子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1139-1139, 2023.

---

	P0158-3-PM2. 1 case that we performed TDM of vancomycin through before and after childbirth for the infective endocarditis that occurred during pregnancy 渡邊瑛理, 富島喜朗, 古庄弘和, 早野聡史, 陣上祥子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1140-1140, 2023.

---

	P0159-3-PM1. Establishment of a plasma concentration measurement system for vadadustat using HPLC-UV method 横山智士1, 中川潤一1, 島田美智子2, 上野桂代1, 石山雅大3, 中村典雄1,4, 富田泰史5, 新岡丈典1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1141-1141, 2023.

---

	P0160-3-PM2. Blood level during the thiamylal sustained administration in children and the effectiveness, safety assessment 平田憲史郎1, 小原隆史2, 渡邊博志3, 古庄弘和4, 陣上祥子4, 丸山徹3, 平井克樹5, 石黒貴子1, 宮村重幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1142-1142, 2023.

---

	P0161-3-PM1. Development of the quick assay of nintedanib and tacrolimus using LC-MS/MS 鈴木南緒1, 松下紗季2, 山崎瑞季1,3, 廣瀬智恵美3, 山田悠人1,3, 飯原大稔1,3, 柳瀬恒明4, 遠渡純輝4, 山下修司1, 鈴木昭夫1,3, 林秀樹1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1143-1143, 2023.

---

	P0162-3-PM2. Usefulness evaluation of the vancomycin initial administration method nomogram of our hospital making 古川早矢香, 高橋希, 河野綾香, 梶野哲, 佐藤浩太郎, 鈴木信也, 井口恵美子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1144-1144, 2023.

---

	P0163-3-PM1. It is a case receiving LVFX to the low weight patients 野口遥1, 長峰守2, 川端康太1, 村山美輝3, 田村賢士1, 前田佳真3, 立花栄三1,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1145-1145, 2023.

---

	P0164-3-PM1. Fact-finding of the checking prescription affecting the preparation of the immune checkpoint inhibitor 古田裕幸1, 窪田悠希1, 石田晶子1, 米田詩織1, 荒谷恭子1, 前田裕行1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1147-1147, 2023.

---

	P0165-3-PM2. Safe examination of the Pola-R-CHP therapy for DLBCL in our hospital 百瀬貴史, 内山倫宏, 網野一真, 横山征史, 前澤優圭, 北原和花子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1148-1148, 2023.

---

	P0166-3-PM1. Efficiency of the anticancer agent regimen administrative work using VBA of Microsoft Excel 佐澤卓哉, 吉田裕生, 上之将明, 加世田良一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1149-1149, 2023.

---

	P0167-3-PM2. Efforts ... to regimen management - antiemesis supportive care standardization in our hospital cancer chemotherapy 久田真規子1, 竹中智子1, 石田志穂1, 宇佐美順子1, 秦真由美2,3, 川瀬朋乃2,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1150-1150, 2023.

---

	P0168-3-PM1. Preparation and administration procedure for the photoimmunotherapy drug cetuximab sarotalocan and its evaluation 山岡健太1, 浅沼玲美1, 入江慶1,2, 平畠正樹1, 久米学1, 橋田トオル1,2, 室井延之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1151-1151, 2023.

---

	P0169-3-PM2. Efforts for the computerization of the cancer medical therapy regimen management in the Osaka Red Cross hospital 尾本和彦, 山瀬大雄, 湯井政志, 塚田加奈子, 中嶋江美, 原田慶子, 松本早織, 山田邦義, 辻井佳代, 小林政彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1152-1152, 2023.

---

	P0170-3-PM1. Use of premedication fact-finding in the anticancer agent enforcement day 山下敦史, 田本光莉, 金澤沙衣, 石田陽美, 田中悠季, 三本松泰孝, 鈴木千波, 田村広志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1153-1153, 2023.

---

	P0171-3-PM2. A case that Durvalumab after CCRT was not effective in EGFR-positive stage IIIB NSCLC 冨井隆弘1, 輿石徹1, 吉元公一1, 梶原直央2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1154-1154, 2023.

---

	P0172-3-PM1. Attempt of the regimen making for the Blinatumomab outpatient department administration in the childhood cancer base Hospital 賀川智子1, 田中美咲1, 鮎田利恵1, 増田早織1, 松井基浩2, 鈴木喬悟2, 湯坐有希2, 廣井順子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1155-1155, 2023.

---

	P0173-3-PM2. Usefulness investigation of the check list about the screening enforcement before cancer chemotherapy start 伊藤昌美1, 片山広美1, 伊藤弥生2, 山田裕香3, 井上正朗3, 鈴木崇太4, 杉浦誠治5, 鈴木厚志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1156-1156, 2023.

---

	P0174-3-PM1. Attempt of the regimen making for the Blinatumomab hospitalization administration in the childhood cancer base Hospital 鮎田利恵1, 田中美咲1, 賀川智子1, 増田早織2, 峯岸英博2, 松井基弘2, 鈴木喬吾2, 横川裕一2, 湯坐有希2, 廣井順子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1157-1157, 2023.

---

	P0175-3-PM2. Construction of the uniform management system for an injection, the internal use combination regimen aiming at medical security 田中玲奈1, 松谷直樹1, 隅田大己1, 富施哲也1, 岡安伸晃1, 伊藤博2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1158-1158, 2023.

---

	P0176-3-PM1. The effect that oral anticancer agent medication support application gives for medication management 畑中由香子1, 大里勇二1, 北宅良祐1, 江本文代1, 島田健1, 座間味義人2, 平松靖史3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1161-1161, 2023.

---

	P0177-3-PM2. Efforts for an attitude survey and the follow-up promotion for the immune checkpoint inhibitor 金子絵里奈1, 中島佳彦1, 加藤正久1, 五十嵐保陽2, 加留部信介1, 鷲山厚司1, 神村英利2, 田中泰三3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1162-1162, 2023.

---

	P0178-3-PM1. 2 cases that was engaged in adverse event management in the BEACON regimen 河村茉衣1, 小池彩子1, 松本和也1, 花房伸幸1, 諏訪耕三1, 井上雅文2, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1163-1163, 2023.

---

	P0179-3-PM2. Activity report of "the irAE support team" in our hospital 甲谷章1, 市川美紗1, 森祥史1, 浅沼真樹1, 谷村紀代子1, 高谷伸治1, 菊井利伸1, 奥田昌也2, 澤崎美幸3, 秋吉由利子4, 澁谷昌広5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1164-1164, 2023.

---

	P0180-3-PM1. We work in PDCA cycle by a problem of the ACP (Advance Care Planning) 牛膓沙織1, 加藤幾1, 野村翔1, 吉川朝子2, 大場麻里2, 木村晃子3, 内山真子4, 長谷川哲也5, 小島美保6, 加藤祐一郎7, 稲垣正巳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1165-1165, 2023.

---

	P0181-3-PM2. Can do it as significance - ward, outpatient department of the hospital pharmacist, a pharmacist of cancer support, the palliative care team 小山奈津実1,2, 古賀彩花1,2, 秋廣涼雅2, 柳川真有美2, 丸山泰世2, 今留卓2, 石野美恵2, 千葉香織2, 前田彰宏2, 井上和洋2, 小林政義2, 保志場康人1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1166-1166, 2023.

---

	P0182-3-PM1. A change of the calculation situation of the cooperation full addition in our hospital and future problem 柿原圭佑, 上津沙織, 小笠裕斗, 西村直朗, 塚原邦浩, 小倉秀美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1167-1167, 2023.

---

	P0183-3-PM2. Usefulness of the early intervention by the multi-type of job cooperation in the dermatopathy due to EGFR inhibitor 佐野尚平1, 亀位耕平1, 伊藤雄大2, 栩野有輝1, 嶋本めぐみ1, 江川英毅1, 平岡芹菜1, 岸部美和子3, 杉本里美3, 上中智香子4, 山本有紀4, 上田弘樹5, 須野学2, 中川貴之1, 松原和夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1168-1168, 2023.

---

P0184-3-PM1. Observational, prospective study (M-CAST study) first report about the clinical response of the multi-type of job cooperation team activity in patients who received cancer chemotherapy 流石智恵子1, 飯村洋平1, 古川直樹1, 石橋正祥1, 馬場啓介2, 中澤光子3, 佐藤朋子3, 都留由香里3, 吉井栄子3, 冨樫仁美4, 本田友絵4, 松原康朗2,4, 黒田誠一郎1, 朴成和2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1169-1169, 2023.

---

	P0185-3-PM2. The making of the pancreatic cancer pass and the operational situation 小池彩子1, 原田亮2, 畑賢俊3, 東直美4, 山本水緒1, 出宮千聖1, 西長あゆ子1, 山本祥子5, 中尾麻結6, 河野上昌美6, 藤岡香代子6, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1170-1170, 2023.

---

	P0186-3-PM1. Through reinforcement - seminar activity of the support system of children, the AYA generation hosted by a pharmacist - 高橋侑伽1, 佐々木実緒1, 長谷川まゆみ1, 岡村理帆1, 坪井久美1, 鈴木宏和1, 北條隆2, 板谷雪子3, 高井泰3, 近藤正巳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1171-1171, 2023.

---

	P0187-3-PM2. Our hospital's efforts toward outpatient administration of blinatumomab and our experience with its use 桑崎綾子1, 町田梨絵子1, 谷川昇1, 原友子1, 森美都子2, 衛藤徹也3, 野中敏治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1172-1172, 2023.

---

	P0188-3-PM1. It is the role of ... pharmacist about the characteristic of the drug in the light immune therapy and the management 森陽祐, 出町拓也, 平田力 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1173-1173, 2023.

---

	P0189-3-PM2. About the acquisition and operation of the CAR-T therapy institution authorization utilizing the pharmacy sterile preparation room in the Mie University faculty of medicine hospital 川瀬亮介1, 向原里佳1, 山田真帆1, 石橋美紀1, 世古口典子1, 大石晃嗣2,3, 岩本卓也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1174-1174, 2023.

---

	P0190-3-PM1. Examination of the multi-type of job intervention using the anamorelin for the cancer cachexia of elderly people 福泉智子1, 久松大祐2, 西嶋智洋3,4, 後藤隆2, 清水裕彰2, 高田正温1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1175-1175, 2023.

---

	P0191-3-PM2. Intervention of the pharmacist about HBV reactivation measures 清水久美子1,2,3, 頓宮弘子2, 川上恭弘2, 桑木健志3, 児島亨3, 池田房雄3, 藤岡真一3, 則武有美2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1176-1176, 2023.

---

	P0192-3-PM1. Efforts and evaluation of the tracing report for foreign chemotherapy patients in our hospital 野田聖奈子1, 桑村恒夫1, 清原珠美2, 中川義浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1177-1177, 2023.

---

	P0193-3-PM2. The current situation report of the medicine medicine cooperation using the cancer medical treatment tracing report common throughout an area 山本倫数, 中田将基, 濱田達志, 青山瑛里子, 南野智志, 草薙みか, 大里恭章 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1178-1178, 2023.

---

	P0194-3-PM1. Fact-finding of the tracing report in the foreign cancer chemotherapy 小川直希, 鶴島克将, 藤井千賀, 柳下祐貴子, 長楽寿子, 遠藤晋吾, 藤井一美, 安井友佳子, 石坂敏彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1179-1179, 2023.

---

	P0195-3-PM2. Usefulness of the cardiac activity evaluation that manual making and a pharmacist for the myocardial disorder prevention with the anthracycline anticancer agent conduct 高林真貴子1, 増江俊子1,2, 佐藤晃一2, 下島正也3, 岩城憲子4, 武内章彦5, 石川聡子6, 藤木俊寛7, 薄井荘一郎3, 谷内江昭宏2, 崔吉道1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1180-1180, 2023.

---

	P0196-3-PM1. The drug vial optimization introduction using the anticancer medicine preparation robot and the evaluation 佐藤聖, 加藤文美, 内田千瑛, 加藤彩, 山本和輝, 青野浩直, 見野靖晃, 川上純一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1182-1182, 2023.

---

	P0197-3-PM2. Efforts of the cost cut accompanied with the use of CSTD range expansion in our hospital 木村錦子, 治田匡平, 小川恵美子, 池田和之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1183-1183, 2023.

---

	P0198-3-PM1. Investigation about instruction to patient contents for prevention of anticancer medicine exposure 廣原成, 谷川大夢, 平綿洋子, 丸谷善紀, 鈴木優司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1184-1184, 2023.

---

	P0199-3-PM2. Inspection of the chemical resolution effect of cyclophosphamide with the sodium hypochlorite 田崎眞生, 桑原晶子, 植村有加里, 大川恭子, 田内義彦, 辻本勉, 濱宏仁 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1185-1185, 2023.

---

	P0200-3-PM1. Inspection about exposure measures and the effect for 5FU which exposure investigation after the closed system anesthesia drug transportation system full-scale introduction showed 齋藤順, 延川正雄, 松田圭一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1186-1186, 2023.

---

	P0201-3-PM2. Examination of preparation duties of cyclophosphamide using the anticancer medicine preparation robot 菊地佑太, 矢田山瑞稀, 久保萌美, 福島麻里乃, 田中悠季, 三本松泰孝, 鈴木千波, 田村広志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1187-1187, 2023.

---

P0202-3-PM1. About exposure investigation after the closed system anesthesia drug transportation system introduction drug expansion in our hospital outpatient department chemotherapy room (the first report) 庄司美侑1,2, 田中弘人1,2, 井ノ口岳洋1,2, 敦賀剛気1,2, 久保村優1,2, 吉川聡美1, 村上美聖1, 輪湖哲也1,2, 伊勢雄也1, 笠原寿郎2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1188-1188, 2023.

---

	P0203-3-PM2. Examination about the law contracted at albumin suspension type paclitaxel parenteral injection time to redissolve it 久住祐介, 児玉暁人, 森信介, 今井兼貴, 岩田智津子, 西岡啓子, 角明香里, 和田諭可子, 勝浦正人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1189-1189, 2023.

---

	P0204-3-PM1. Examination of the simple removal method using the ozone water of the anticancer agent which attached to a vial 五月女拓也1, 外山智章1, 大塚瑠里1, 日向野理輝1, 太田栄亮1, 押坂勇志2, 白川賢宗3, 井上尚3, 別納弘法3, 仁保誠治3, 篠崎桂子1, 臼井悟1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1190-1190, 2023.

---

	P0205-3-PM2. Examination (the second report) of the effect that an altitude difference gives for vial internal pressure in the anticancer medicine preparation 高野秀仁1, 渡邉航平1, 安室修2, 渡邉浩志1, 舟越亮寛2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1191-1191, 2023.

---

	P0206-3-PM1. Efforts to anticancer agent exposure measures in hepatic artery chemoembolisation (TACE) 長谷悠紀, 町田聖治, 松本彩咲, 平野真健, 千々和未歩, 富田敏章, 入江利行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1192-1192, 2023.

---

	P0207-3-PM2. Comparison of the anticancer agent decontamination effect in a bed bath method using the ozone water and the existing bed bath method 陳美樹1, 西垣玲奈1, 宇田川涼子1, 渡部大介1, 齋藤義正1, 赤木徹1, 山本酉子2, 藤井健太郎2, 橋本浩伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1193-1193, 2023.

---

	P0208-3-PM1. The current situation and problem in the closed system anesthesia appliance expansion 田代聡美1, 川野昭1, 福重昇吾1, 杉慎介1, 百崎やよい2, 藤永理恵子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1194-1194, 2023.

---

	P0209-3-PM2. Understanding degree investigation about exposure to anticancer medicine measures using the video education material in the dustman 森祐佳1, 小林一男1, 川上和宜1, 清水久範1, 森田幾代2, 横井麻珠美2, 長崎礼子2, 黒田直子2, 清水多嘉子2, 山口正和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1195-1195, 2023.

---

	P0210-3-PM1. Introduction of the fosnetupitant to breast cancer EC therapy and the evaluation 篠崎千尋, 桑村恒夫, 三上忠司, 中川義浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1197-1197, 2023.

---

	P0211-3-PM2. Study on effectiveness, safety of the prophylactic antiemesis therapy for the docetaxel + cyclophosphamide therapy in patients with breast cancer 富田温子1, 飯原大稔1,2, 藤井宏典1, 北洞美佳1, 渡邊大地1, 山本扇里1, 市橋菜月1, 徳丸剛久3, 丹羽好美3, 森龍太郎3, 二村学3, 鈴木昭夫1,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1198-1198, 2023.

---

	P0212-3-PM1. Comparison of the antiemesis effect of aprepitant and the fosnetupitant in the EC therapy 村上絢香, 冨田敦和, 今西忠宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1199-1199, 2023.

---

	P0213-3-PM2. The use situation investigation of the fosnetupitant in the Saku medical center 柳澤沙織, 杉山昌秀, 篠原佳祐, 宮田智陽, 吉池麻衣, 征矢あや乃, 堀内賢一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1200-1200, 2023.

---

	P0214-3-PM1. Fosnetupitant introduction and the use results in Tokyo Metropolitan Tama Medical Center 殿村直也, 佐藤香織, 佐野弥里, 山下理菜, 羽田真理子, 宮澤真帆, 寺山義泰 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1201-1201, 2023.

---

	P0215-3-PM2. A case of hepatocellular carcinoma treated with miriplatin transarterial chemoembolization using antiemetic therapy with a high emetogenic risk 石田優理香, 佐藤裕, 森下啓, 佐藤祐司, 眞野成康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1202-1202, 2023.

---

	P0216-3-PM1. The clinical effectiveness, safety assessment after the fosnetupitant chloride hydrochloride parenteral injection introduction 米山栄司1, 吉塚奈美2, 佐々木良子2, 椎名由紀乃2, 長能優子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1203-1203, 2023.

---

	P0217-3-PM2. Investigation of the antiemesis effect by changes from aprepitant to fosnetupitant 鶴田和樹, 中川夕芽, 呉山友教, 廣瀬孝一, 金田典子, 山下剛史郎, 満田正樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1204-1204, 2023.

---

	P0218-3-PM1. Examination about the usefulness of the fosnetupitant in the Carboplatin (AUC >= 4)-containing regimen 千住陽子1,2, 古野龍也1, 桑原淳1, 荒金尚子2, 島ノ江千里1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1205-1205, 2023.

---

	P0219-3-PM2. The use situation investigation of fosnetupitant repeated doses in our hospital: Investigation of injection site reaction and vomiting in the anthracycline anticancer agent periphery administration case 石崎文子, 相原敏彦, 寺島里枝, 芳山健太郎, 北爪教貴, 辻中里穂, 仲鉢英夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1206-1206, 2023.

---

	P0220-3-PM1. Examination about the usefulness of 2.5 mg of olanzapine for AC/EC therapy-induced retching, vomiting 松下尚弘, 古賀清弘, 原友子, 羽田野明子, 田中早穂子, 黒木吟美, 野中敏治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1207-1207, 2023.

---

	P0221-3-PM2. Investigation of the expression situation of retching, vomiting in patients with colon cancer after the fosnetupitant introduction 佐藤優希子, 山村真貴子, 長谷川将, 木本秀樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1208-1208, 2023.

---

	P0222-3-PM1. Evaluation of retching, vomiting of the steroid spare ring for the CAPOX regimen adaptation patients 今田良樹, 佐藤奈実, 吉田崇志, 西村雅次, 羽太光範 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1209-1209, 2023.

---

	P0223-3-PM1. One case of the cancer of the esophagus which developed the hypothyroidism with the CK rise during nivolumab administration 井口仁美, 志野訓之, 野村泰生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1216-1216, 2023.

---

	P0224-3-PM2. Examination about the association between onset of proteinuria and concomitant drug of the bevacizumab using JADER 小竹優希, 向井淳治, 坂本竜平, 竹原涼子, 西村真央, 山田佳菜子, 辻田早紀, 森本亜美, 奥田広志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1217-1217, 2023.

---

	P0225-3-PM1. Questionary survey to patients about Gee raster subcutaneous injection 3.6 mg body pod (R) 加藤幾, 稲垣正巳, 牛膓沙織, 野村翔, 木村桂子, 柴田雅央 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1218-1218, 2023.

---

	P0226-3-PM2. A case of hyperglycemia monitored using an intermittent scanning continuous glucose monitor (isCGM) during administration of enfortumab vedotin in an obese patient 松野知寛, 久原紀子, 井上和洋, 北村憲雅, 中野祐樹, 大竹野久雄, 蓮輪博嗣, 横尾賢乗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1219-1219, 2023.

---

	P0227-3-PM1. 1 case of stage IV renal cell carcinoma which became the pathological complete response by the ipilimumab + nivolumab therapy of 2 courses while accepting multiple serious irAE 高田遼1,2, 藤原未稀1, 牧賢利1, 野村直幸1, 藤田曙2, 行廣和真2, 増本弘史2, 高橋洋子1, 長谷川泰久2, 田村浩二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1220-1220, 2023.

---

	P0228-3-PM2. Examination of the factor involved in Infusion reaction expression by the trastuzumab for patients with breast cancer 黒部健太郎1, 音成結泉1, 白羽根健吾2, 草葉カズトモ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1221-1221, 2023.

---

	P0229-3-PM1. Examination of the risk factor to develop a neutropenia by amrubicin hydrochloride monotherapy for the small cell lung cancer 武良卓哉1, 松本拓真2, 瀬戸美穂1, 荒神一博1, 小川喜通1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1222-1222, 2023.

---

	P0230-3-PM2. 1 case that differentiated a response and hypersensitivity accompanied with the infusion with the fulvestrant administration, and was involved in treatment continuation 藤本亜弓1,2, 石坂崚2, 山崎直樹1, 中尾將彦1, 森宏幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1223-1223, 2023.

---

	P0231-3-PM1. Examination about the immune-mediated adverse event expression accompanied with the combination of immune checkpoint inhibitor and Chinese medicine with the Japanese adverse event spontaneous report database 輿石徹, 吉元公一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1224-1224, 2023.

---

	P0232-3-PM2. The effect on anticancer medicine-induced peripheral neuropathy investigation that the incretin analogous drug gives 宮川真由子1, 稲野寛1, 山本悠樹1,2, 瀬戸良教1, 尾鳥勝也1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1225-1225, 2023.

---

	P0233-3-PM1. Importance of side effect frequency and the pharmacist intervention by the Osimertinib 國安和仁, 中居肇 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1226-1226, 2023.

---

	P0234-3-PM2. Examination of the onset of vascular pain situation of the bendamustine ten minutes administration in our hospital 平池美香子, 松藤敬佑, 馬場結子, 齋藤巨樹, 小園亜希, 湊本康則 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1227-1227, 2023.

---

	P0235-3-PM1. Examination about the effectiveness of the sustained granulocyte colony-stimulating factor preparation administration for hippopotamus diTaki cell weight loss treated patients 村上礼隆, 北本真一, 阪田安彦, 古谷智裕, 佐藤実由, 金田公平, 武井秀樹, 宮森伸一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1228-1228, 2023.

---

	P0236-3-PM2. Effect of in front of dexamethasone administration to give it to infusion reaction occurring at the trastuzumab therapy in patients with breast cancer and the pertuzumab combination 田渕祐輔1, 辻本雅之2, 山本皓介1, 清水瞭3, 小阪直史1, 阪口晃一4, 土淵尚也3, 西口工司2, 四方敬介1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1229-1229, 2023.

---

	P0237-3-PM1. A case of difficulty in controlling pain after completing dinutuximab treatment 日高朋1, 新田美奈1, 西川拓朗2, 岡本康裕2, 武田泰生1,3,4, 寺薗英之1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1230-1230, 2023.

---

	P0238-3-PM2. Participation of the pharmacist for the patients anxiety in resumption of cancer medical therapy stopped by a side effect 亀岡貴哉 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1231-1231, 2023.

---

	P0239-3-PM1. The fact-finding of the cardiac function diagnostic procedures in patients receiving VEGF inhibitor and future problem 小林裕平, 丸山真一, 菅野浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1232-1232, 2023.

---

	P0240-3-PM2. Protective efficacy of the hypothermia to correspond to chemotherapy-induced peripheral neuropathy by the paclitaxel 西長あゆ子1, 杉本綾香1, 河村茉衣1, 小池彩子1, 森川希実2, 原享子2, 吉富誠二2, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1233-1233, 2023.

---

	P0241-3-PM1. The effect that antidiarrheal drug commuter pass prescription gives to treatment continuation on diarrhea to occur early in Abemaciclib administration 大野安里1, 伊藤将2, 前田守2, 市ノ渡真史2, 長谷川佳孝2, 月岡良太2, 大石美也2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1234-1234, 2023.

---

	P0242-3-PM2. Analysis of the adverse event by the Abemaciclib using adverse event spontaneous report database (JADER) 實久茂樹1, 伊藤将2, 前田守2, 市ノ渡真史2, 長谷川佳孝2, 月岡良太2, 大石美也2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1235-1235, 2023.

---

	P0243-3-PM1. A case which type I diabetes mellitus developed during Atezolizumab administration in the patients with dementia, and suffered from blood sugar control 西岡菜々子1, 今井健太郎2, 吉元公一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1236-1236, 2023.

---

	P0244-3-PM2. The effect that a choice of the saline cathartic in consideration of the interaction with the gastric-acid secretion antagonist gives for constipation with palonosetron 土屋直彦1, 中島弘樹2, 浜善久2, 佐野史穂2, 池上悦子1, 小山茂1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1237-1237, 2023.

---

	P0245-3-PM1. A case of skin damage caused by extravasation of enfortumab vedotin 三村一平1, 座光寺秀典2, 添田真司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1238-1238, 2023.

---

	P0246-3-PM2. Factor search to influence the effectiveness of the zinc acetate hydrate preparation for the dysgeusia with the hypozincaemia in patients with cancer during the use of anticancer agent 高岡龍蔵, 桂川健司, 高取裕司, 遠山幸男, 久田達也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1239-1239, 2023.

---

	P0247-3-PM1. Investigation of the HBV reactivation that was due to the anticancer agent which there was not of alerting it in a package insert 浅野寿規, 川瀬洋次, 杉野善彦, 伊藤弘美, 竹田優作, 馬場未沙子, 桜田宏明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1240-1240, 2023.

---

	P0248-3-PM2. Examination about the onset of vascular pain of lyophilized products and liquid preparations of the gemcitabine 北野安紀, 望月かおり, 平田大氣, 丸山寛之, 平野智理, 須藤祥代, 東加奈子, 竹内裕紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1241-1241, 2023.

---

	P0249-3-PM1. Factor analysis to have an influence on the expression of the lymphocytopenia at the Bendamustine administration 小川晃宏, 今西航, 野口祥紀, 三宅知宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1242-1242, 2023.

---

	P0250-3-PM2. The effect that the steroid to preload in the lung cancer compound immune therapy application case gives in a cortisol level 樋口智恵1, 吉野真樹1, 牛膓明広1, 大平直樹1, 佐々木奈穂1, 田川千明1, 田中佳美1, 勝山里佳1, 木村宏之1, 三浦理2, 田中洋史2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1243-1243, 2023.

---

	P0251-3-PM1. For KRAS G12C-positive stage IV non-small cell lung cancer after CheckMate 9LA about the effectiveness, the safety of 2 cases receiving sotorasib 成田綾香1, 中積広貴2, 曽根崇2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1244-1244, 2023.

---

	P0252-3-PM2. Investigation of the enforcement situation of the drug lymphocyte stimulation test of the anticancer medicine in the northeastern Medical and Pharmaceutical University Hospital 平川寛之1, 野上佳奈子1, 鈴木直人1, 山内雅仁1, 高橋将典1, 岡田浩司1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1245-1245, 2023.

---

	P0253-3-PM1. We look at the rear about the effect that dexamethasone supplementation at CDDP + VNR therapy enforcement gives blood poison characteristics and effect of treatment and examine a mark 山下登, 濟川聡美, 飛鷹範明, 田中守 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1246-1246, 2023.

---

	P0254-3-PM2. Related examination of side effect expression and GNRI of the gastric cancer chemotherapy 山口亜由美1, 渡辺一章1, 島田真弥1, 三ツ木健二2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1247-1247, 2023.

---

	P0255-3-PM1. Examination about the effect that dexamethasone coadministration gives to oxaliplatin-induced hypersensitivity reaction 名和田幸介, 古川誠之, 山崎智加, 玉重良樹, 大庭瑠菜, 河濟悠生, 川中明宏, 渡邊太朗, 手嶋ひさ子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1248-1248, 2023.

---

	P0256-3-PM2. Lassitude evaluation of patients with chronic myelogenous leukemia due to BFI (Brief Fatigue Inventory) and the CFS (Cancer Fatigue Scale) 鷲巣晋作1, 葉山達也1, 内池明博1, 坪井伸也1, 長木弓子1, 宮城愛1, 矢萩温子1, 入山規良2, 三浦勝浩2, 大塚進1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1249-1249, 2023.

---

	P0257-3-PM1. The effectiveness of the Goreisan for the diarrhea in the head and neck cancer TPF therapy 出町拓也1, 平田力1, 渡邉昭仁2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1250-1250, 2023.

---

	P0258-3-PM2. Consideration for the effect of pegG-CSF in the dose-dense therapy 服部豊1, 齊藤麻衣子1, 仲嶋祐希1, 鈴木真彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1251-1251, 2023.

---

	P0259-3-PM1. Oral supplementary water liquid OS-1 at the anticancer agent, radiotherapy, questionary survey about the OS-1 jelly receptiveness 中村久美, 鬼窪利英, 古川正光 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1252-1252, 2023.

---

	P0260-3-PM2. We look at the safe rear about the Olaparib and examine a mark 片岡憲昭1, 畑武生1, 細見光一2, 平田敦士3, 藤原聡枝4, 後藤愛実1, 西原雅美1, 大道正英4, 根尾昌志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1253-1253, 2023.

---

	P0261-3-PM1. Efforts of PBPM of antiHER2 antibody medicine-related heart disorder measures 佐藤彩伽1, 徳留章1,2, 樋浦一哉3, 山下美妃3, 木明貴幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1254-1254, 2023.

---

	P0262-3-PM2. Investigation about the effect of the DPP-4 inhibitor on oxaliplatin-induced peripheral neuropathy 藤田隼輔1, 藤田強記2, 清水裕彰2, 山脇一浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1255-1255, 2023.

---

P0263-3-PM1. The frequencies of steroid withdrawal symptoms after the dexamethasone cancellation in the breast cancer perioperative medical therapy and the percent improvement with the gradual decrease administration 藪田直希1, 須藤正朝1, 野田哲史1,2, 若杉吉宣1, 日置三紀1, 中村春香1, 道家雄太郎1, 小出博義1, 森井博朗1, 冨田香3, 森田真也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1256-1256, 2023.

---

	P0264-3-PM2. A case of vascular pain in a patient receiving carfilzomib - A report including a retrospective survey of patients receiving carfilzomib - 阿部史誉, 小山加奈世, 早川太朗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1257-1257, 2023.

---

	P0265-3-PM1. Investigation about the pharmacist intervention for the use situation of the immune checkpoint inhibitor in the International University of Health and Welfare Narita Hospital and the immune-mediated adverse event 長瀬友樹, 嶋臣人, 大石智香, 石岡美樹, 篠崎浩司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1258-1258, 2023.

---

	P0266-3-PM2. About effect of the proton pump inhibitor giving it to onset of hand-and-foot syndrome by the capecitabine 荒神一博1, 松本拓真2, 武良卓哉1, 小倉千奈1, 濱岡照隆1, 小川喜通1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1259-1259, 2023.

---

	P0267-3-PM1. One case that produced a neutropenia by the Avelumab therapy enforcement for patients with urothelial carcinoma 中村朋瑛1, 田中弘人1,2, 井ノ口岳洋1,2, 敦賀剛気1,2, 久保村優1,2, 輪湖哲也1,2, 伊勢雄也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1260-1260, 2023.

---

	P0268-3-PM2. Investigation of the secondary hypogammaglobulinemia in daratumumab treated patients 兼松哲史1, 山下智穂1, 中根茂喜1, 前田芳樹1, 伊藤貴彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1261-1261, 2023.

---

	P0269-3-PM1. 2 cases that we gave entrectinib to patients with ROS1 fused gene-positive old non-small cell lung cancer in every other week and were able to continuously administer for a long term 中西大介1, 藤原研太郎2, 畑地治2, 牛田浩司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1262-1262, 2023.

---

	P0270-3-PM2. Risk factor analysis of anemia in patients with Olaparib administration ovarian cancer 松本彩子1, 山岡健太1,2, 久米学1, 吉野新太郎1, 平畠正樹1, 清水忠2, 林信孝3, 青木卓哉3, 室井延之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1263-1263, 2023.

---

	P0271-3-PM1. CIPN expression investigation of the Pola-R-CHP therapy 山下紗瑛奈, 宮澤憲治, 山田桃子, 杉田郁人, 田代匠, 森下拓哉, 高木亮 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1264-1264, 2023.

---

	P0272-3-PM2. The effect that ifosfamide, fluid replacement of the doxorubicin therapy and dexamethasone weight loss give a side effect on malignant bone soft part tumor 中川祐紀子1, 中村良恵1, 志村裕介1, 吉田幸司1, 板井進悟1, 嶋田努1, 菅幸生2, 崔吉道1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1265-1265, 2023.

---

	P0273-3-PM1. Search of the serious hepatic dysfunction risk factor by the Abemaciclib in patients with hormone acceptor-positive HER2 negative transference-related breast cancer 辰見明俊1, 角川幸男2, 富田遼1, 森藤那理1, 長谷川聡司2, 竹田健志2, 高木麻里2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1266-1266, 2023.

---

	P0274-3-PM2. About the incidence of skin disorders caused by enfortumab vedotin and patient background at our hospital 松藤敬佑, 平池美香子, 馬場結子, 齋藤巨樹, 小園亜希, 湊本康則 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1267-1267, 2023.

---

	P0275-3-PM1. The onset of peripheral neuropathy situation investigation before and after the cancellation of the prophylaxis of the Goshajinkigan for acute peripheral neuropathy of oxaliplatin 和賀信継1, 谷地真亜子2, 鈴木誠規1, 鵜浦利江1, 星田徹3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1268-1268, 2023.

---

	P0276-3-PM2. 2 cases that was able to discover a decreased renal function during lung cancer chemotherapy early by Long term eGFR plot 小山加奈世1, 山中理1, 阿部史誉1, 早川太朗1, 中澤純2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1269-1269, 2023.

---

	P0277-3-PM1. One consideration about the case that developed myositis, myasthenia gravis during Pembrolizumab administration 比嘉真理1, 丸山真一1, 岩田基秀2, 木塚祐太3, 永瀬怜司1, 菅野浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1270-1270, 2023.

---

	P0278-3-PM2. Retrospective investigation of the effects of adding or switching from osmotic laxatives to epithelial function-altering drugs in cancer patients 小澁朝子1, 五十嵐隆志1, 中村真穂1, 熊澤名穂子1, 三浦智史2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1271-1271, 2023.

---

	P0279-3-PM1. A case that the combination of the antidiarrheal drug was effective for diarrhea by the Abemaciclib 山田春香, 加藤良隆, 大坪達弥, 野口裕介, 神田英一郎, 友金幹視 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1272-1272, 2023.

---

	P0280-3-PM2. Effect of the Yokukansan on NTRK fused gene-positive solid carcinoma target new anticancer medicine entrectinib-induced cognitive dysfunction 岩田直大1, 牛尾聡一郎2, 白水翔也1, 田中雄太1, 濱野裕章1, 鍛治園誠1, 座間味義人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1273-1273, 2023.

---

	P0281-3-PM1. Search of the background factor which causes the serious neutropenia onset when we provided RAM + DTX therapy after having used PEG G-CSF together for non-small cell lung cancer 志水優衣1, 安藤洋介2, 林高弘1,2, 小幡由紀1, 水野智博2, 廣瀬正裕3, 今泉和良4, 山田成樹2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1274-1274, 2023.

---

	P0282-3-PM2. The use situation investigation of butylscopolamine bromide for the Colin symptom during irinotecan administration and factorial experiments of the dysarthria 合澤啓二, 西上依里, 小山勢納, 岩田一史, 陣上祥子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1275-1275, 2023.

---

	P0283-3-PM1. We feel the intervention point of the pharmacist to the hypoadrenalism by the immune-mediated adverse event 吉澤季里子1, 秦英司1, 足立美菜子1, 齋尾真希1, 岩井ちさと1, 山本崇弘1, 矢内正晶2, 小谷昌広2, 藤吉正哉1, 島田美樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1276-1276, 2023.

---

	P0284-3-PM2. Side effect investigation of the Pembrolizumab combination FP therapy for head and neck cancer and pharmaceutical intervention 佐東あやめ1, 出町拓也1, 平田力1, 渡邉昭仁2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1277-1277, 2023.

---

	P0285-3-PM1. Search of the factor involved in aggravation of the anticancer medicine extravasation 米谷麻絵1, 新谷拓也1, 渡邊梓1, 吉本綾香2, 田墨恵子3, 竹田充伸4, 山本智也1, 奥田真弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1278-1278, 2023.

---

	P0286-3-PM2. Safety assessment of the old Ixazomib treatment in a recurrence, patients with intractable multiple myeloma 神田友江, 廣瀬達也, 杉山智紀, 竹中翔也, 木村美智男, 宇佐美英績 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1279-1279, 2023.

---

	P0287-3-PM1. Examination of the administration method using a syringe pump in DARZQURO Combination Subcutaneous Injection 松本拓真1, 武良卓哉2, 濱岡照隆2, 升味紀子3, 小川喜通2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1280-1280, 2023.

---

	P0288-3-PM2. Investigation of the hypertensive expression of patients with hepatocellular carcinoma situation in the Lenvatinib administration 袰岩靖子, 熊谷史由, 高松謙, 大友眞菜, 内山弘子, 外岡久和 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1281-1281, 2023.

---

	P0289-3-PM1. Examination about the administration of the primary prophylaxis of PEG-GCSF for the non-elderly people in the regimen docetaxel-containing for the breast cancer perioperative period 鶴島克将, 小川直希, 藤井千賀, 柳下祐貴子, 長楽寿子, 藤井一美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1282-1282, 2023.

---

	P0290-3-PM2. Investigation of the renal function change in the use of immune checkpoint inhibitor patients 水野康平, 高橋利佳子, 秋山留里, 安里衣真, 松下貴英, 宇根良祐, 阿部多嘉浩, 人見百合子, 駒井勇太, 長濱藍, 喜多洋嗣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1283-1283, 2023.

---

	P0291-3-PM1. Association investigation of the neutrophils, lymphocytes ratio in patients receiving immune checkpoint inhibitor and the platelet, lymphocytes ratio and the immune-mediated adverse event expression 佃美穂1, 松本拓真2, 武良卓哉1, 小倉千奈1, 濱岡照隆1, 小川喜通1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1284-1284, 2023.

---

	P0292-3-PM2. A case which suffered from control of the dysarthria with the FOLFIRINOX therapy, and came to have difficulty in treatment continuously 脇田恵里1, 伊藤果奈1, 丹村貴之1, 近藤勝弘1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1285-1285, 2023.

---

	P0293-3-PM1. A case of progress colon cancer that developed drug-related thrombotic microangiopathy by Ramucirumab 坂林加奈子, 吉川英里, 城口将太, 麻生美佐子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1286-1286, 2023.

---

	P0294-3-PM2. Side effect investigation of our hospital of the Atezolizumab + bevacizumab combination therapy 小倉功, 竹下和輝, 山村央, 吉武由華, 熊澤志歩, 堀内ともえ, 松山哲史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1287-1287, 2023.

---

	P0295-3-PM1. Introduction and operation of Gee raster subcutaneous injection 3.6 mg body pod (R) in our hospital 植田真理1, 佐藤浩二1, 井上咲紀1, 小久保祐希1, 島田敏江2, 浅井真由美2, 香川雅一1,4, 西岡達也1, 藤田淳也2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1288-1288, 2023.

---

	P0296-3-PM2. A case that a nutrient for intestinal administration was effective for serious hypomagnesemia by the panitumumab 臼井理央, 平野美優, 野村洋道, 福嶋浩一, 石本学司, 中浴伸二, 田中詳二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1289-1289, 2023.

---

	P0297-3-PM1. Investigation for the onset of vascular pain by the agent type of the gemcitabine hydrochloride 網代真史, 敦見真由美, 窪田奈津子, 緒方優, 谷口由理, 西山裕也, 松井瑞季, 松井一樹, 宮脇舞, 亀本浩司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1290-1290, 2023.

---

	P0298-3-PM2. The expression situation of the constipation in patients with cancer during cancer chemotherapy and future problem 小島晴美, 丸山真一, 菅野浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1291-1291, 2023.

---

	P0299-3-PM1. Search of the risk factor associated with serious anemia in Olaparib treated patients 福井美奈子, 中岡真悠子, 池村健治, 山本智也, 奥田真弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1292-1292, 2023.

---

	P0300-3-PM2. Examination about the onset of neutropenia risk factor at the bendamustine initial administration 岩本大紀, 西村巧, 寳福誠 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1293-1293, 2023.

---

	P0301-3-PM1. Exploratory study of onset of febrile neutropenia by the amrubicin and the effectiveness of the primary prophylaxis 水田秀貴, 黒部健太郎, 塩川裕美, 末松耕輔, 宮原強, 草葉一友 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1294-1294, 2023.

---

	P0302-3-PM2. A case which caused more serious infusion reaction by the second administration in the Rituximab + Bendamustine therapy for follicular lymphoma treatment 大友眞菜, 袰岩靖子, 熊谷史由, 外岡久和 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1295-1295, 2023.

---

	P0303-3-PM1. Biliary cancer GC, the expression situation of the cisplatin hypersensitivity reaction in the GCS therapy and experience of the desensitization 川島悠吾, 平松英司, 宗本尚子, 村嶋彩加, 岩泉奈央, 松本圭司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1296-1296, 2023.

---

	P0304-3-PM2. Two cases that pharmaceutical intervention was useful for a side effect of breast cancer medical therapy 安部一弥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1297-1297, 2023.

---

	P0305-3-PM1. Pharmaceutical intervention to the case that caused hyperammonemia by mFOLFOX6 therapy 合田明博1, 永井海舟1, 山下亜由子1, 益田宏代1, 新原亨2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1298-1298, 2023.

---

	P0306-3-PM2. Magnesium measurement at the cisplatin administration in the Kasugai Municipal Hospital and acute nephropathic fact-finding 竹内健悟, 中村敏史, 田中伸明, 鈴木大吾, 鈴木敦詞, 石黒有希, 坂田洋, 服部芳明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1299-1299, 2023.

---

	P0307-3-PM1. The effect that pertuzumab, trastuzumab, a change of the supportive care medicine in the taxane system anticancer medicine combination therapy give to the onset of side effect 高木海那1,2,3,4, 前田真一郎1,2,3, 前田真貴子1,2,3,4, 藤尾慈1,2,3,4, 廣部祥子1,2,3,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1300-1300, 2023.

---

	P0308-3-PM2. The HMG-CoA reductase inhibitor -GST signal inhibits neuropathy by oxaliplatin and the paclitaxel 相澤風花1, 岡林亜美2, 森山大嗣2, 八木健太1,3, 合田光寛1,2, 新村貴博1,3, 石澤有紀1,4, 石澤啓介1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1301-1301, 2023.

---

	P0309-3-PM1. Two cases of the COVID-19 infection related to rem decibuilding with suspected drug-related liver damage 衛藤大輝, 山村亮太, 森永裕子, 岩男元志, 龍田涼佑, 伊東弘樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1303-1303, 2023.

---

	P0310-3-PM2. Survey on the use of remdesivir and molnupiravir in COVID-19 patients after the Omicron strain epidemic and factors influencing release from isolation 金子真弓1, 先名健太1, 石塚仁保1, 宮村有貴1, 松本由香莉1, 北川裕也1, 坂本和央1, 中村裕一1, 須藤美穂子1, 樋浦一哉2, 棚谷貢1, 船木映二1, 柴波明男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1304-1304, 2023.

---

	P0311-3-PM1. The use of new coronavirus infection therapeutic drug situation in our hospital 石橋真実1, 大道淳二1, 花房伸幸1, 平井淳子1, 別所昭宏2, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1305-1305, 2023.

---

	P0312-3-PM2. Safety of the rem decibuilding administration for patients with impaired renal function 大隅智之1, 中村友里乃1, 川田智子2, 清水博之3, 喜古康博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1306-1306, 2023.

---

	P0313-3-PM1. About the relation of the pharmacist to the oral therapeutic drug in the SARS-CoV-2 infection 百瀬公博, 関口展貴, 有澤佳純, 伏見幸浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1307-1307, 2023.

---

	P0314-3-PM2. The effect single institution retrospective study that new coronavirus patients hospitalization gave for antimicrobial consumption and the resistant bacteria detection 津曲恭一1,2,3,4, 上原智博1, 荒木志乃1, 東盛裕里1, 長谷部歩1, 千田祥子1, 黒原健1, 木下晶惠1, 石新あおい1, 花木祐介2, 長山あゆみ3, 大湾勤子4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1308-1308, 2023.

---

	P0315-3-PM1. The effect that the intervention by the pharmacist gives for oral antiviral drug treatment preferences for the new coronavirus infection (COVID-19) patients 安河内寿成, 中野祐樹, 大竹野久雄, 蓮輪博嗣, 横尾賢乗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1309-1309, 2023.

---

	P0316-3-PM2. Two cases that FGM (Flash Glucose Monitoring) was useful in the medical treatment management for the sudden blood sugar change accompanied with the aggravation of COVID-19 梶原洋文1, 山田雅也1, 生山祥一郎2, 濱口和之2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1310-1310, 2023.

---

	P0317-3-PM1. The actual situation of the rem decibuilding administration for the decreased renal function patients in the COVID-19 practice 彦坂麻美1, 小林将貴2, 清田奈那1, 門井実1, 黒川敬史3, 長谷川森一4, 吉富裕久5, 鈴木善貴1, 定盛理純1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1311-1311, 2023.

---

	P0318-3-PM2. Examination about the effectiveness of the rem decibuilding for elderly people new model coronavirus infections 75 years or older 植田徹1,3, 櫻本稔2,3, 北澤文章1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1312-1312, 2023.

---

	P0319-3-PM1. We look at the rear about the effectiveness of the rem decibuilding in the decreased renal function patients and the safety and examine a mark 小平美優, 池村健治, 山本智也, 奥田真弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1313-1313, 2023.

---

	P0320-3-PM2. Second response analysis after the new corona 2 values vaccination of the staff 佐藤智功 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1314-1314, 2023.

---

	P0321-3-PM1. Rem decibuilding administration experience to the decreased renal function patients in our hospital 矢部雅子, 邉見光利 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1315-1315, 2023.

---

	P0322-3-PM1. Evaluation of the pharmacist intervention effect on drug-related problem in the COVID-19 patients 福澤翔太, 宮川泰宏, 川原田祐貴, 松永安未, 當麻丹香, 西村映里, 溝口博之, 山田清文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1317-1317, 2023.

---

	P0323-3-PM2. Consciousness change before and after the intramuscular injection training participation for pharmacists 高橋恵美利, 高橋雄太, 長嶺歩, 前田恵里, 中村卓郎, 大林恭子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1318-1318, 2023.

---

	P0324-3-PM1. A study on adherence and safety of patients taking Monulpirable Capsules 200mg 福田由紀子1, 細見光一2, 岡野昌平1, 山口貴大1, 新藤祐久1, 奥田大地1, 村田卓1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1319-1319, 2023.

---

	P0325-3-PM2. About effect of COVID-19 in patients not to deceive 中川幸紀1, 岡田雅弥1, 大本奈緒子1, 細直子1, 三宅美有紀1, 中谷亮介2, 阪口臨3, 下川福子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1320-1320, 2023.

---

	P0326-3-PM1. One case of the malignant lymphoma that a new coronavirus infection did not become negative 三宅美有紀1, 阪口臨2, 下川福子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1321-1321, 2023.

---

	P0327-3-PM2. It is ... with the making of system of use situation - early therapeutic drug administration of therapeutic drug for the new coronavirus infection of haemodialysis patients 浦崎清美1, 玉城哲子2, 渡慶次真由美2, 木奈崎昭男2, 安座間照子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1322-1322, 2023.

---

	P0328-3-PM1. Examination of the need of drugstore's original distribution function in the new coronavirus infection medical treatment 安井好次郎, 窪井裕美子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1323-1323, 2023.

---

	P0329-3-PM2. Attempt to proper use at new coronavirus infection related to workflow therapeutic drug prescription 重田純一1, 安田佑紀1, 和田良浩1, 西原悠二2, 今北菜津子2, 笠原敬2, 池田和之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1324-1324, 2023.

---

	P0330-3-PM1. At new coronavirus infection expansion and correspondence in the following palliative care unit 塚本貴庸子1, 中島理絵1, 錦織昌裕1, 五十嵐貴代子2, 村松美樹子3, 伴敏信3, 河嶋亨3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1325-1325, 2023.

---

	P0331-3-PM2. Investigation about the change of the hygiene idea of the hospital pharmacist before and after the new coronavirus infection pandemic 岡田雅弥1, 中谷亮介2, 小山貴久3, 加藤渓4, 野田明宏4, 篝忠宏5, 下川福子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1326-1326, 2023.

---

	P0332-3-PM1. Duties burden investigation of the hospital pharmacist in the corona evil 遠藤可奈子, 田村広志, 鈴木千波, 三本松泰孝, 田中悠季, 渕上俊介, 村上冴美, 越野早紀, 島津智行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1327-1327, 2023.

---

	P0333-3-PM2. Effect of the corona evil analyzed than questionary survey about the drugstore business training 宇野リオ1, 原口珠実1,2, 吉田都1,2, 桑原晶子1, 田内義彦1, 波多江崇2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1328-1328, 2023.

---

	P0334-3-PM1. Effect of the corona evil analyzed than questionary survey about the hospital business training 吉田都1,2, 宇野莉央1, 原口珠実1,2, 桑原晶子1, 田内義彦1, 波多江崇2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1329-1329, 2023.

---

	P0335-3-PM1. Use situation evaluation of the antimicrobial medicine in our hospital using infection measures cooperation common platform (J-SIPHE) 白川敦規1, 坂口晋哉2, 田代紘士2, 桑原貴美子2, 鈴田浩孝2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1334-1334, 2023.

---

	P0336-3-PM2. One case that chose oral antimicrobial administration for infective endocarditis by E.coli, and realized ambulant treatment 甲元大樹1, 花房伸幸1, 石橋友樹1, 砂場亜希1, 森本雅生1, 坂東優希2, 福家聡一郎2, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1335-1335, 2023.

---

	P0337-3-PM1. Survey on Lascufloxacin Hydrochloride administration cases and their progress 鹿島弥生, 木原星衣, 奧村梨央, 青木旦未, 小林奈緒, 松本勝城, 海野明子, 長澤彩華, 深沢貴志, 加藤一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1336-1336, 2023.

---

	P0338-3-PM2. Use of in-hospital antimicrobial turn of eventss accompanied with the meropenem supply stop 吉田悦朗1, 臼井和明1, 安藤暢彦1, 大石丸美1, 近藤真由1, 和泉寿紀1, 谷彩花1, 大倉尚子2, 長島章1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1337-1337, 2023.

---

	P0339-3-PM1. About the change of the appearance ratio of resistant bacteria for other antimicrobial consumption accompanied with the meropenem supply stop and Pseudomonas aeruginosa 河野友里, 西裕美, 上田和明, 藤田隼輔, 小坂隆介, 藤野奈緒, 山脇一浩, 肥山和俊 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1338-1338, 2023.

---

	P0340-3-PM2. Change investigation of AUD and the infection mortality of our hospital under distribution restrictions of the wide area antimicrobial 後藤拓也, 木内丈滉, 梅橋梨永, 田淵克則, 薄雅人, 吉田知由 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1339-1339, 2023.

---

	P0341-3-PM1. Examination of side effect frequency and the risk factor of sulfamethoxazole/trimethoprim combination drug 左高侑奈, 小栗良介, 関谷泰明, 井上壽江, 平下智之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1340-1340, 2023.

---

	P0342-3-PM2. An effect after the vancomycin initial administration plan chart presentation and the compliance 岡平将志, 饗庭孝一, 永川秀徳, 播磨里美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1341-1341, 2023.

---

	P0343-3-PM1. Examination of the vancomycin treatment parameter to use for Enterococcus faecium bacteremia treatment 野田晃洋1, 平山和登2, 中川未菜1, 副島啓司1, 福山雄卯介1, 三角紳博1, 近藤晃3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1342-1342, 2023.

---

	P0344-3-PM2. De-escalation of antibiotics for management of febrile neutropenia in patients with solid tumors : a retrospective study 松本千明1,3, 岩渕聡1,3, 栃倉尚広1,3, 今井徹1, 福島栄1, 大塚進1, 西山宏幸2,3, 梅村啓史3,4, 中山智祥3,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1343-1343, 2023.

---

	P0345-3-PM1. One case of the MRSA bacteremia that we were able to continuously administer by weight loss for patients with impaired renal function that produced linezolid-induced thrombocytopenia 渡辺祐子1, 門村将太1, 稲井邦宏1, 松川雅子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1344-1344, 2023.

---

	P0346-3-PM2. Examination of the Candida blood symptom isolate in the Fukuoka University Hospital for 10 years 萩原大樹1, 鹿志毛信広2, 兼重晋3, 神村英利3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1345-1345, 2023.

---

	P0347-3-PM1. Efforts for the oral third generation cephalosporin antimicrobial consumption reduction by the intervention of the antimicrobial proper use support team 古川大樹1, 伊藤嘉英1, 大橋武司1, 伊藤優子1, 林房枝2, 梶田麻美2, 菱田志乃3, 小林都仁夫4, 中尾彰宏5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1346-1346, 2023.

---

	P0348-3-PM2. Effective evaluation based on AUC/MIC of vancomycin for the Enterococcus faecium bacteremia 清水星香1, 森脇典弘1,2, 中野貴文1,2, 江口幸臣1, 池内忠宏1, 戸川温2,3, 兼重晋1, 神村英利1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1347-1347, 2023.

---

	P0349-3-PM1. Collaboration example with antimicrobial proper use support team (AST) for 1 case of the purulent spondylitis by methicillin-resistant Staphylococcus lugdunensis 石川智子1, 宮田志生1, 野澤寿吉1, 加藤由香里2, 舟瀬和美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1348-1348, 2023.

---

	P0351-3-PM1. Effect to give to efforts and the number for the in-hospital consumption reduction of the third generation oral cephalosporin antimicrobial of foreign antimicrobial prescription 井上敬之1, 松本真衣1, 小井里香2, 日照田敦子3, 福田央子3, 山田寛之4, 長田学2,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1350-1350, 2023.

---

	P0352-3-PM2. Stratagem and effect of the antimicrobial proper use support activity on levofloxacin-resistant rate of Escherichia coli 中村聡志1,2, 有馬隆司2,3, 田代良一2,4, 安水里美2,5, 愛甲隼人1, 中島隆司1, 黒木優歩1, 藤崎崇史1, 東勇希1, 桑波田聡6, 竹中俊宏6, 本屋敏郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1351-1351, 2023.

---

	P0353-3-PM1. Effect of the intervention by the conditional registration system and AST exclusive duty pharmacist in the middle scale hospital 中野祐樹1,2, 安河内寿成1,2, 大竹野久雄1, 辻村啓史1, 浦和也2,3, 末安禎子2,4, 蓮輪博嗣1, 横尾賢乗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1352-1352, 2023.

---

	P0354-3-PM2. Examination of the role demanded from the antimicrobial proper use support team which we saw from a use clinical department and the intervention rate of the carbapenem-based medicine according to the infection 小野祐志, 高久保佑一, 宇佐美順子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1353-1353, 2023.

---

	P0355-3-PM1. About various effect accompanied with the meropenem supply stop 平田亮介, 高武嘉道, 橋本雅司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1354-1354, 2023.

---

	P0356-3-PM2. About efforts to the oral antimicrobial proper use in the chronic phase hospital 富野圭介1, 澤野蒼汰1, 篠原真一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1355-1355, 2023.

---

	P0357-3-PM1. The use of antifungal agent situation after the posaconazole marketing and cause bacterial species of the candidemia 重村明香1, 坂本靖宜1,3, 井出和男1,2, 長谷川拓也1, 渡邉直優1, 畠山成寛1, 西垣哲太1,2, 川邊一寛1, 鈴木智代1,2, 榎木裕紀3, 田口和明3, 小池博文1, 加藤英明2, 松元一明3, 佐橋幸子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1356-1356, 2023.

---

	P0358-3-PM2. The effect analysis of the internal use therapeutic drug for the Clostridioides difficile infection and future problem 足岡秀樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1357-1357, 2023.

---

	P0359-3-PM1. Fact-finding of the oral antimicrobial switch therapy in the use of ceftriaxone case 成島俊輔1, 鈴木智貴1, 鯉沼縁1, 青山美恵子2, 武藤博美3, 原信田努1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1358-1358, 2023.

---

	P0360-3-PM2. Management for the fungemia 伊藤嘉英, 古川大樹, 大橋武司, 伊藤優子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1359-1359, 2023.

---

	P0361-3-PM1. Relative examination of renal failure and the infusion in patients receiving vancomycin 薗部万由香1, 上山雅美1, 奈良悠汰1, 加藤梢2, 晴山知拓1, 安土菜美1, 車塚千穂1, 佐藤弘康1, 今井隆人2, 和泉秀明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1360-1360, 2023.

---

	P0362-3-PM2. Evaluation of the wide area antimicrobial inspection that took advantage of improvement in infection measures addition 1 institution cooperation 中野克哉1, 村澤寛美1, 佐々木康弘2, 常松健一郎3, 上蓑義典4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1361-1361, 2023.

---

	P0363-3-PM1. Investigation into the occurrence of bone marrow suppression during long-term administration of tedizolid 馬島務, 山本諭, 小田剛史, 山下剛史郎, 満田正樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1362-1362, 2023.

---

	P0364-3-PM2. Activity report of AST for the meropenem supply difficulty 佐伯星依奈, 関戸美咲, 菅加奈子, 菅近晴美, 又吉嘉寿人, 船臺三央, 肥後美月, 野下綾子, 喜友名侑舞, 井上千尋, 久田潤平, 村雲智久, 仲村亮太, 喜多洋嗣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1363-1363, 2023.

---

	P0365-3-PM1. A case which was able to heal for Candida endophthalmitis to the macula part early by quick Antifungal stewardship 菊地未由, 星野祐太, 伊藤亮太, 内山弘子, 外岡久和 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1364-1364, 2023.

---

	P0366-3-PM2. The use situation of the preparation for the amikacin sulfate inhalation in our hospital 山内円1, 嶋本藍1, 宇都早希1, 石本学司1, 中浴伸二1, 瀧口純司2, 田中詳二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1365-1365, 2023.

---

	P0367-3-PM1. Automatic mention ... of the long time administration instructions to usefulness - injection prescription of the long time administration of beta-lactam derivative injection antimicrobial 中谷亮介1, 岡田雅弥2, 下川福子2, 森井聖二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1366-1366, 2023.

---

	P0368-3-PM2. Evaluation of the antimicrobial proper use support for the tazobactam piperacillin 向後寧信, 相原由里, 近藤忠 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1367-1367, 2023.

---

	P0369-3-PM1. About carbapenem-based resistance of use and Pseudomonas aeruginosa of the carbapenem-based antimicrobial in neonates 舘林絵茉里, 岡本剛, 伊藤大典, 小林恵美子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1368-1368, 2023.

---

	P0370-3-PM2. Efforts to oral third generation cephalosporin medicine consumption reduction 石山晶子, 本田貴朗, 山下勇輝, 羽太光範 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1369-1369, 2023.

---

	P0371-3-PM1. Result evaluation of the efforts of the wide area antimicrobial surveillance by the antimicrobial proper use support team (AST) activity 堀本厚子, 組橋由記, 保岡尭, 大久保真由美, 森井聖二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1370-1370, 2023.

---

	P0372-3-PM2. About the effect that a choice gives in the early period of antimicrobial on bacteremia due to substrate specific expansion type beta lactamase production bacteria in our hospital 宮田拓周, 山田政典, 吉原涼子, 松下馨介, 稲田夏実, 坂口美也子, 齋藤巨樹, 小園亜希, 湊本康則 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1371-1371, 2023.

---

	P0373-3-PM1. Efforts of our hospital AST for carbapenem-based antimicrobial supply restrictions 近藤貴子1, 盛麻美1, 川村萌人1, 片平雄之3, 門脇雅子2, 大久保博史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1372-1372, 2023.

---

	P0374-3-PM2. The effect that introduction of the blood culture quickness identification technique gives to the use of antimicrobial situation 古庄弘和1, 日高敏哉2, 井村美月1, 陣上祥子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1373-1373, 2023.

---

	P0375-3-PM1. Effect by the oral third generation cephalosporin antimicrobial deletion in the cataract surgery 貞重卓哉1, 七尾大観2, 山下敦志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1374-1374, 2023.

---

	P0376-3-PM2. Use turn of eventss by the use report start of TAZ/PIPC and the oral new quinolone antibacterial 井村美月, 古庄弘和, 徳丸尚人, 陣上祥子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1375-1375, 2023.

---

	P0377-3-PM1. A choice of the antimicrobial for the ESBL-producing bacillaemia style infection and effective evaluation 徳山ことみ1, 藤里駿1, 馬生良則2, 崎田彩弥加2, 二階堂弘美3, 中務陽子4, 矢野朋文5, 沖田健太郎1, 船越幸代1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1376-1376, 2023.

---

	P0378-3-PM2. Evaluation of the contribution to effect of treatment, safety by the observance of the AS pocket guide 中村友里乃1, 大隅智之1, 川田智子2, 清水博之3, 喜古康博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1377-1377, 2023.

---

	P0379-3-PM1. AntiMRSA medicine consumption pulse-taking at the missing part for the vancomycin hydrochloride infusion 高橋有, 小林和博, 上田覚, 尾上雅英 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1378-1378, 2023.

---

	P0380-3-PM2. The treatment of the MRSA continuation bacteremia is difficult in now when multiple new drugs are marketed (case report) 江藤康汰, 石橋美希, 横山裕士, 八板謙一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1379-1379, 2023.

---

	P0381-3-PM1. Fact-finding of the use of antimicrobial situation of terminally ill patients 大矢智則1,2, 守田侑真1, 岩下沙織1, 永岡大輝1,3, 大曽根寛晃1, 神坐美弥子1,2, 橋本竜1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1380-1380, 2023.

---

	P0382-3-PM2. Examination of a renal failure incidence and the aim AUC level at the vancomycin administration 松木祥彦1, 小島雄太郎1, 武田紋奈2, 石毛宏治1, 石田雅也1, 金井絵美1, 長谷川雄介1, 米井万紀子1, 柳恵1, 森木麻未1, 山崎茜1, 石倉裕美1, 大竹千夏1, 藤岡功3, 佐古兼一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1381-1381, 2023.

---

	P0383-3-PM1. About substitution medicine suggestion at the SBT/CPZ understock by the pharmacist 更谷和真, 徳濱潤一, 原田晴司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1382-1382, 2023.

---

	P0384-3-PM2. Relation to the antimicrobial proper use in the situation of a ward charge pharmacist and each infection control team exclusive duty pharmacist 清川明慶1,2, 矢田康司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1383-1383, 2023.

---

	P0385-3-PM1. See 3 all; about the use situation of ceftazidime of patients with CAPD peritonitis of the ward inpatient 森雅俊, 皆木優門, 鈴木正樹, 橋本光生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1384-1384, 2023.

---

	P0386-3-PM2. One patient who showed improvement of the overall status by the prescription suggestion through the AS activity 井須恭平, 平野龍一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1385-1385, 2023.

---

	P0387-3-PM1. Examination about the antimicrobial therapy using the piperacillin for pertussis 大石博史1, 中嶋敏紀2, 片山陽介1, 古海和博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1386-1386, 2023.

---

	P0388-3-PM1. The pharmacist of the perinatal special hospital worked ... children to get over lack of the antimicrobial 運天奈緒美, 浅原章裕, 飯野香菜子, 岩西雄大, 大津由美子, 望月千枝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1390-1390, 2023.

---

	P0389-3-PM2. Effect by monitoring and the feedback enforcement from an early stage of the wide area antimicrobial by the person in charge of ward for the full-time equivalent improvement of the pharmacist 守田侑真, 大矢智則, 岩下沙織, 永岡大輝, 大曽根寛晃, 神坐美弥子, 橋本竜 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1391-1391, 2023.

---

	P0390-3-PM1. Enforcement and activity evaluation of the feedback by the antimicrobial proper use support team utilizing the electronic medical chart approval function 中西剛志1,2,3,4,5, 末吉愛美2, 森松孝文3, 原田美羽3, 磯崎嘉人4, 松尾彩子5, 黒川綾子1, 中牟田翔吾1, 古川和弘1, 川俣洋生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1392-1392, 2023.

---

	P0391-3-PM2. Evaluation of the antimicrobial proper use support (AS) activity that a pharmacist played a key role 保良結1, 森葉子1, 藤田翔1, 姫野智子1, 小杉卓大1, 川門礼子2, 眞境名豊文4, 西平守邦5, 國分千代1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1393-1393, 2023.

---

	P0392-3-PM1. About the bundle observance situation for the candidemia in our hospital 高橋真一, 伊東充, 新井由希, 四方公亮, 鮎川英明, 佐藤香織, 加藤潤一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1394-1394, 2023.

---

	P0393-3-PM2. Investigation about the effect that biological drug administration gives for bacteremia treatment 山下友輝1, 伊藤悠里子1,2, 阿部珠妃3, 柴波明男1, 樋浦一哉3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1395-1395, 2023.

---

	P0394-3-PM1. Examination of risk factors for thrombocytopenia due to tedizolid administration 吉川慧1,2, 小森亮子3, 鈴木ゆきえ3, 花房喜子3, 草野元3, 佐藤陽1,2, 吉川真一1, 松本司1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1396-1396, 2023.

---

	P0395-3-PM2. The study implementation situation investigation to prevent hepatitis B reactivation with the chemotherapy 早川裕里, 指宿貴博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1397-1397, 2023.

---

	P0396-3-PM1. One case of the diabetic foot lesion which caused pancytopenia during vancomycin (VCM) administration 香川真徳1, 土肥有二2, 安藤健明3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1398-1398, 2023.

---

	P0397-3-PM2. Risk factors for the development of azole-reduced Candida bacteremia 洲山佳寛1, 菅原隆文1, 植竹宣江2, 西綾香1, 中野葵1, 竹本嘉恵1, 國重将大2, 竹之内誠3, 立川文崇2, 田中和行1, 宮森伸一2, 松本俊治4, 渡辺篤1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1399-1399, 2023.

---

	P0398-3-PM1. Efforts for the promotion of the antimicrobial doses adequacy and the evaluation 島谷幸希1, 竹内祐介1, 石田茂伸1, 多胡友絵1, 星育子1, 小泉祐一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1400-1400, 2023.

---

	P0399-3-PM2. Levofloxacin of Escherichia coli in our hospital-sensitive trend 中野聡1, 織田雄一郎1, 副島將司1, 山本大策1, 大場久美1, 海瀬有沙1, 上野遥香1, 本堂千秋1, 長澤真利絵1, 泉谷千穂2, 秦有希未2, 小松隼也2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1401-1401, 2023.

---

	P0400-3-PM1. AST activity depending on a consumption trend of the carbapenem-based antimicrobial in the Iizuka Hospital 長崎皓光1, 梅田勇一1, 内田守次1, 長谷川雄一2, 沖中友秀2, 的野多加志2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1402-1402, 2023.

---

	P0401-3-PM2. Findings about the approach of "infection control, the antimicrobial proper use" of the medical institution in Okayama 市川大介1,2,3, 石井澄雄2,3,4, 川端崇義2,3,5, 明田徹2,3,6, 森一徳2,3,7, 山崎恵2,3,8, 森谷康志2,3,9, 西本美淑2,3,10, 森英樹3,11 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1403-1403, 2023.

---

	P0402-3-PM1. An investigation of the foreign oral antimicrobial consumption using J-SIPHE data and inspection of the usefulness 田沼道也1, 櫻井隆之2, 田中昌代1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1404-1404, 2023.

---

	P0403-3-PM2. 1 case that experienced bacteremia by Chryseobacterium indologenes 明石岩雄1, 篠崎陽一1, 李広烈2, 大川華代1, 相馬將一1, 長澤仁志1, 川久保孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1405-1405, 2023.

---

	P0404-3-PM1. The antimicrobial consumption that AST round gave to a secondary medical institution, change of the clinical microbiologic outcome 吉田健人1, 上条泰弘1, 雨宮哲郎2, 伊藤隆哉1, 鬼窪利英1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1406-1406, 2023.

---

	P0405-3-PM2. Effect of the quickness-resistant screening using the cefpodoxime disk in Escherichia coli and the Klebsiella pneumoniae bacteremia 酒井幹康1,2, 酒井隆全3, 永田悠起4, 駒井博子5, 三宅芳男1, 渡口賢隆6, 川端厚5, 大津史子3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1407-1407, 2023.

---

	P0406-3-PM1. Initiatives to optimize treatment of Candida endophthalmitis in our hospital's AST 宮田祐里1, 足立麻美1, 宮川朋子2, 藤原万記子2, 岡田彩3, 藤原典子3, 柏木貴雄4, 佐伯啓介5, 松本憲幸1, 岸本光正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1408-1408, 2023.

---

	P0407-3-PM2. Goal setting in our hospital for the accomplishment of the new drug-resistant measures action plan 坂東翔, 竹原朗, 橋本浩, 亀山礼子, 長枝智子, 林晴美, 齊藤良子, 高柳椋, 猪谷優希, 山口美奈, 川根隆志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1409-1409, 2023.

---

	P0408-3-PM1. Support of antimicrobial proper use support team (AST) for the meropenem supply stop and the evaluation 由井薗陽一1,2, 大田典正1,2, 入江徳俊1,2, 二神咲子1, 槇林智子1, 下村武志2,4, 吉岡知美4, 末永健二2,5, 石原沙代子2,3, 岩崎教子2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1410-1410, 2023.

---

	P0409-3-PM2. Efforts and stocktaking to the antimicrobial proper use of the AST pharmacist in our hospital 平尾祐樹1, 佐々英也2, 内山耕作1, 鈴川誠1, 芥子川純里1, 冨田敦和1, 今西忠宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1411-1411, 2023.

---

	P0410-3-PM1. The in-hospital antimicrobial use turn of eventss that resulted from the supply restrictions of carbapenem drugs 坂口晋哉1, 白川敦規2, 田代紘士1, 桑原貴美子1, 鈴田浩孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1412-1412, 2023.

---

	P0411-3-PM2. Effect on use of antimicrobial situation that meropenem understock gave and inpatient outcome 柳原有希1, 堀内寿志2, 槇恭佑2, 原田由紀子3, 倉田賢生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1413-1413, 2023.

---

	P0412-3-PM1. Attitude survey in the in-hospital training about the antimicrobial proper use of the acute respiratory tract infection 綺田尚久1, 橋本拓郎1, 西野広将2, 北野裕司3, 中村忠之3, 原田吉将4, 吉田紀子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1414-1414, 2023.

---

	P0413-3-PM2. Effect of clinical record mention for the purpose of the proper use of Tazbactam/Piperacilin 譲原千広, 荒木遼太, 小川紗知, 波多晶子, 中澤美樹子, 橋爪和恵, 窪田真弓, 鶴居勝也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1415-1415, 2023.

---

	P0414-3-PM1. Questionary survey about the current situation and the consciousness of the infection measures of the member of Yamanashi hospital pharmacist society institution 神田稔1, 遠藤愛樹2, 莊司智和3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1416-1416, 2023.

---

	P0415-3-PM2. About a use of own institution antimicrobial situation evaluation using J-SIPHE data 葛間慎介1, 佐藤正幸2, 上野哲史1, 岩井中里香1, 卸川紘光1, 松浦しほみ1, 平林鑑1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1417-1417, 2023.

---

	P0416-3-PM1. The making of the enlightenment video for protectors about the antimicrobial proper use of the pediatrics domain and examination of scenario contents 川村ひとみ1,2, 櫻井秀彦3, 坂本拓也1, 荒井宏人1, 直井和之4,5, 津久井理絵4, 巌本三壽6, 相澤まどか7, 岸本桂子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1418-1418, 2023.

---

	P0417-3-PM2. Antibacterial seat (Abyei seat (R)) development and the proof experiment to have both sterilization effect and biofilm formation inhibitory effect 山田陽一1, 林秀樹2, 吉井圭佑1, 加藤久登1, 関谷洋志3, 上田剛慈4, 細田俊1, 工藤季之1, 玉井栄治3, 柴川敏之5, 島田憲一1, 塩田澄子1, 鈴木宗6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1419-1419, 2023.

---

	P0418-3-PM1. Effect on surgical-site infections development by the chemical intestinal tract measures enforcement before operation by the large intestine surgery in the Saiseikai Fukuoka General Hospital 大田典正1, 入江徳俊1, 由井薗陽一1, 二神咲子1, 槇林智子1, 末永健二2, 岩崎教子3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1420-1420, 2023.

---

	P0419-3-PM2. Comparative study of Candida bacteremia bundle compliance by AST practices 末延道太, 藤野優, 原尻学志, 陸丸幹男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1421-1421, 2023.

---

	P0420-3-PM1. AST use of antimicrobial turn of eventss by the change of the activity having a meeting 岩崎修1, 加藤利康1, 山田匡子2, 日谷明裕3, 松田基4, 田中大1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1422-1422, 2023.

---

P0421-3-PM1. Phase II study (T-CRACC study) first report about the protective efficacy of the hydrocortisone drug for external use for the capecitabine-induced hand-and-foot syndrome 古川直樹1, 飯村洋平1, 石橋正祥1, 流石智恵子1, 馬場啓介2, 阿彦友佳3,4, 小野山温那3,4, 柵山尚紀3,4, 愛甲丞3,4, 志田大3,4, 野島正寛5, 黒田誠一郎1, 朴成和2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1424-1424, 2023.

---

	P0422-3-PM2. Efforts of the duties burden reduction utilizing the information and communication technology in the clinical experimental medicine administrative work 吉中千佳, 雨山智, 前嶋隆弘, 寺岡知寿, 佐藤祐司, 前川正充, 佐藤真由美, 眞野成康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1425-1425, 2023.

---

	P0423-3-PM1. It is efforts to magnetizing it the train of the trial-related document using the cloud type document management system 田中瑠美1,2, 田島壮一郎1,2, 三木翔伍1,2, 武田真樹2, 廣田豪2, 家入一郎1,2, 戸高浩司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1426-1426, 2023.

---

	P0424-4-PM1. Effect of the additive in the crush formulations of the film coated tablet 山添絵理子, 伊藤貴章, 田原耕平 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1429-1429, 2023.

---

	P0425-4-PM2. Share of the change of the incident report to stop by if caused by calculation formulations management system (F-WAVE) introduction in our hospital 古谷一平, 田中佳子, 井上壽江, 平下智之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1430-1430, 2023.

---

	P0426-4-PM1. About duties reduction by the PBPM practice in doubt inquiry of the outside Parliament prescription 栗山紘生1, 元茂拓法1, 小原貴子2, 三上祥博1, 川口啓之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1431-1431, 2023.

---

	P0427-4-PM2. Usefulness evaluation of the half lock divider corresponding to oval tablet azosemide tablets and carvedilol tablets 座間亜紀子1, 北口剛吉2, 大竹裕子3, 長井紀章3, 村田久枝1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1432-1432, 2023.

---

P0428-4-PM1. Accurate evaluation of the private business, medicine for external application compounding of medicines duties that the person except a pharmacist by the automatic drug picking device introduction and the pharmacist is associated with 水谷栄梨, 岡本明大, 加藤秀雄, 田坂健, 向原里佳, 岩本卓也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1433-1433, 2023.

---

	P0429-4-PM2. Effect by the operation of representation correction/doubt inquiry PBPM in the in-house prescription 木下三緒, 植田裕美, 庄野裕志, 山西香織, 佐光留美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1434-1434, 2023.

---

	P0430-4-PM1. Effect on prevention of the formulations incident by the introduction of the PDA (personal digital assistant) tool 森健太郎1, 前川友宏2, 田中義人3, 舟越亮寛2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1435-1435, 2023.

---

	P0431-4-PM2. Attitude survey of the compounder about the picking support system introduction 高橋菜生, 渡邊裕之, 立石裕樹, 重松由加, 池田都, 松本貴行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1436-1436, 2023.

---

	P0432-4-PM1. The compounding of medicines duties efficiency that intended ward duties expansion 巖西真, 國津侑貴, 若杉吉宣, 神谷貴樹, 増田恭子, 池田義人, 森田真也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1437-1437, 2023.

---

P0433-4-PM2. The examination of the cleaning method of the disk type powdered medicine divided powder plane in packeted formulations of mercaptopurine powders and pollution status investigations such as the powder wrapping paper, and the like 原祐1, 松原花乃1, 片倉佐都子1, 若松遼介1, 水谷彰史1, 樋浦一哉2, 棚谷貢1, 船木映二1, 柴波明男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1438-1438, 2023.

---

	P0434-4-PM1. About the change by the prescription publication of the drug requiring attention at a decreased renal function 岡本賢一, 吉良俊彦, 安田成男, 谷大輔, 吉野秀紀, 辻井佳代, 小林政彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1439-1439, 2023.

---

	P0435-4-PM2. Examination of the transluminal administration of Novell gin (R) preparation method by the difference in formulations method in the pediatric domain 工藤香澄, 堀望美, 我妻恭行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1440-1440, 2023.

---

	P0436-4-PM1. Contents analysis of a prescription, doubt inquiry not to inject by the pharmacist of Fukuoka Memorial Hospital 魚住秀親, 西村京子, 江藤義和, 下山真智子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1441-1441, 2023.

---

	P0437-4-PM2. Effect of the dispensing error prevention PDA system introduction in the middle scale local government Hospital 高橋直浩, 新康憲, 森田聡子, 西山祐美, 正置耕一, 吉岡睦展 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1442-1442, 2023.

---

	P0438-4-PM1. Evaluation after the dispensing error prevention system introduction 畠山瑞季1, 小島俊彦1, 横澤大輔2, 倉本美紀子1, 松田隆史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1443-1443, 2023.

---

	P0439-4-PM2. Advantage by the combination of problems and image, weight inspection device of the internal use anticancer agent formulations using the PDA terminal 中元隆浩, 古田ゆり, 石原慎之, 泙誠一, 玉木宏樹, 矢野貴久, 直良浩司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1444-1444, 2023.

---

	P0440-4-PM1. Usefulness evaluation of clinical test value for the drug proper use of the in-hospital prescription and the indication to alert 角真太郎, 嘉村知子, 飛田修康, 橘川奈生, 小部亜紗美, 橋本宇矩, 江本晶子, 島ノ江千里 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1445-1445, 2023.

---

	P0441-4-PM2. Examination of the introduction effect of the TPN preparation duties training supporting program 水野翼, 舟橋智美, 塩田有史, 川澄紀代, 大西正文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1446-1446, 2023.

---

	P0442-4-PM1. Without increasing duties efficiency - formulations errors by the review of the duties flow in the out patient dispensing; inspection duties reduction - 青井博志1, 大西健太1, 田村曉識1, 横山江美1, 谷川恵子1, 谷田彩1, 小川恵美子1, 吉川一吾2, 池田和之1, 高野頌3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1447-1447, 2023.

---

P0443-4-PM2. Change of the number by the handwritten prescription introduction at order ring system failure in the Osaka acute phase, comprehensive medical care center of doubt inquiries and contents 飯島聖子1, 管詩歩1, 川田希帆1, 森井絵莉香1, 橋本佑香1, 宮部祐子1, 立川奈保美1, 寺岡知香2, 中野寛之1, 下辻恒久1, 山東真寿美1, 藤田敬子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1448-1448, 2023.

---

	P0444-4-PM1. Change of the duties time by a change and the new introduction for formulations apparatus, system 火口裕弥, 佐々木緑, 有松利恵, 辻卓矢 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1449-1449, 2023.

---

	P0445-4-PM2. Effect of the picking support system introduction for the formulations misreduction 川前隆一, 立石裕樹, 松本貴行, 秋吉正貴, 田原裕希乃, 矢野洋平, 永田理佳, 高木悠資, 佐々木文野, 井上幸子, 渡邊裕之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1450-1450, 2023.

---

	P0446-4-PM1. A case which a local pharmacist received the drug review of the patients on dialysis who consulted multiple medical institutions, and contributed to prescription adequacy in cooperation with a medical institution 小嶋彩貴 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1451-1451, 2023.

---

	P0447-4-PM2. Investigation of doubt inquiry for the injection drug prescription in our hospital 竹内裕理佳, 岡本涼子, 中川喬統, 小田幸奈, 松本恵美, 小田剛史, 深海広平, 山下剛史郎, 満田正樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1452-1452, 2023.

---

	P0448-4-PM1. Medical cost cut effect by the small standard preparation introduction of the propofol kit preparation 見尾谷昇, 細野真吾, 磯野礼果, 山崎崇 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1454-1454, 2023.

---

	P0449-4-PM2. Comparative study of utilization methods of "Cubixx(R)" and "NOVUMN(R)" cold storage drug management systems using RFID tags after one year of use 六波羅孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1455-1455, 2023.

---

	P0450-4-PM1. Examination of the traceability system (Cubixx(R), NOVUMN(R)) introduction effect on pharmaceutical products expiration disposal 宮本翔平, 松島葵, 石井聡一郎, 佐伯康之, 松尾裕彰 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1456-1456, 2023.

---

	P0451-4-PM2. Effect of the cubic introduction 吉田崇志, 遠藤汐梨, 佐藤清貴, 田口未菜, 菅野澄佳, 清水美保, 眞木秀子, 石山晶子, 西村雅次, 羽太光範 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1457-1457, 2023.

---

	P0452-4-PM1. About an evaluation of the pharmaceutical products inventory control by the article management system N2 尾崎誠一, 山中洋, 槇恒雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1458-1458, 2023.

---

	P0453-4-PM2. Efforts to duties efficiency by the in-hospital adoption medicine ABC management 川崎美咲, 後藤一馬, 作山悠里 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1459-1459, 2023.

---

	P0454-4-PM1. A case of spinal muscular atrophy treated with onasemnogene abeparvovec (Zolgensma(R)), a gene therapy vector product 細野萌子1, 猪股羽矢人1, 田中里奈1, 鈴木寿樹1, 及川善嗣2, 青木亜紀2, 菊地正史1, 松浦正樹1, 眞野成康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1460-1460, 2023.

---

	P0455-4-PM2. Duties actual situation change before and after the tablet automatic assortment return device (Genie) introduction 東昌代, 中出奈津子, 石田美由紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1461-1461, 2023.

---

	P0456-4-PM1. From the adoption discussion of high-cost emergency drugs to the establishment of their operation - ONDEXXYA experience - 油屋恵, 松岡勇作, 吉留利香, 赤瀬博文, 奥野昌宏, 森本茂文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1462-1462, 2023.

---

	P0457-4-PM2. Effect and investigation of problems that the situation that the supply of pharmaceutical products was unstable in gave in Aichi Medical University Hospital 杉木壮吉, 野々垣知行, 宇野英理子, 大西正文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1463-1463, 2023.

---

	P0458-4-PM1. Comparison about preparation time for Mohs paste shortening 須藤春香1, 鈴木善貴1, 彦坂麻美1, 長谷川森一2, 定盛理純1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1465-1465, 2023.

---

	P0459-4-PM2. Granulating of the dexamethasone tablet crush thing for the purpose of the remedy-related improvement to children by the taste bitter reduction 山内理恵, 大野修司, 土志田珠希, 井上信宏, 久保元, 浅井和範 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1466-1466, 2023.

---

	P0460-4-PM1. The manufacture of the gelatinous chewable tablet, lyophilization tablet using the pharmaceutical products additive for the 3D printer and mechanical strength evaluation 田上辰秋, 海野桃加, 小川昂輝, 尾関哲也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1467-1467, 2023.

---

	P0461-4-PM2. The case that tried the Mohs strange law which combined zinc oxide ointment with the local control of the head haemangiosarcoma 小林宇太郎1, 佐藤未千世1, 川俣洋生2, 清原龍士3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1468-1468, 2023.

---

	P0462-4-PM1. Preparation and taking hospital preparation Aripiprazole-containing silverberry preparation-related evaluation 河本小百合1, 田中紫茉子1,2, 三浦基靖1, 柏倉康治1, 神谷千明3, 袴田晃央3, 小田切圭一3, 乾直輝3, 渡邉裕司3, 並木徳之1,4, 内田信也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1469-1469, 2023.

---

	P0463-4-PM2. Usefulness of the dialytic fluid potassium level revision using hospital preparation "26% potassium chloride liquid" 清水咲, 徳力麻希, 池田久雄, 平田貴宏, 神原弘和, 足立充司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1470-1470, 2023.

---

	P0464-4-PM1. Preparation of the hospital preparation iodine-containing foam preparation for the purpose of pressure sore treatment 柏倉康治, 山根早紀子, 篠原佑奈, 河本小百合, 三浦基泰, 内田信也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1471-1471, 2023.

---

	P0465-4-PM2. Basic examination - using effect - salivation model rat that an application part of the hospital preparation scopolamine ointment gives to efficacy 桂あやの1, 大嶋祥高1, 石田奈津子1, 嶋田努2,3, 水野智詞3, 荒川大1, 崔吉道2,3, 菅幸生1, 石崎純子1, 松下良1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1472-1472, 2023.

---

	P0466-4-PM1. Examination of alternatives to Methylrosanilinium Chloride for pre- and intraoperative marking 森内貴子1, 高橋優実1, 藤井朋子1, 馬屋原慈理1, 中村護1, 山崎美保1, 小濱邦彦2, 面田恵1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1473-1473, 2023.

---

	P0467-4-PM1. The effect that preservation environment gives to the functional indication food of the tablet shape 栗林和美, 池田彩華, 宇多万紘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1475-1475, 2023.

---

	P0468-4-PM2. Advisability of the simple suspension method application in the administration through the nasal feeding catheter of capsule of the dutasteride and tablet 石田志朗1, 切詰大貴2, 吉松健太3, 安藤哲信4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1476-1476, 2023.

---

	P0469-4-PM1. Examination about the stability of the bromhexine hydrochloride injection 寺岡麗子1, 竹内敦子2, 都出千里2, 松川美佐子1, 中山優子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1477-1477, 2023.

---

	P0470-4-PM1. Promotion of digital transformation (DX) in the drug information (DI) administrative work using the tablet terminal in our hospital pharmacy 稲田顕慶, 杉野太亮, 森本健幹, 小原直紘, 小田亮介, 丸山直岳, 土井敏行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1479-1479, 2023.

---

	P0471-4-PM2. Fact-finding about Accessibility to the in-hospital practice information system of the hospital pharmacy gate 鈴木大吾1, 坂田洋1, 水草博希1, 石黒友希1, 竹内健悟1, 鈴木敦詞1, 田中伸明1, 中村敏史1, 服部芳明2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1480-1480, 2023.

---

	P0472-4-PM1. List of pharmaceutical products adoption making by the RPA utilization 佐藤息吹1, 原田紗希2, 菅田哲治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1481-1481, 2023.

---

	P0473-4-PM2. Medication reporting study to the medical information network using the smartphone 堀川尚嗣1, 横山邦彦2, 杉本修治3, 今井康人4, 伊藤勝彦5, 榊原幹夫6, 金子周一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1482-1482, 2023.

---

	P0474-4-PM1. One consideration for effectively utilizing it of the electronic edition prescription notebook application 奥平誉央1, 松浦誠2, 高橋寛2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1483-1483, 2023.

---

	P0475-4-PM1. Examination about the stability of octreotide in the Elneopa NF1 number infusion which coinfused a Rinderon note 熊谷岳文1, 井上裕文2, 山下純2, 楢原奈穂子2, 佐藤英治2, 木平孝高2, 藤村よしの2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1486-1486, 2023.

---

	P0476-4-PM2. Questionary survey about the recognition of the list of distribution management items in Ehime and the satisfaction 坂本裕哉1,2, 高田裕介1,2, 浅川隆重2, 福岡竜逸2, 村上通康2, 竹内信人2, 大塚尚2, 古川清3, 舟橋達也4, 飛鷹範明1,2, 田中守1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1487-1487, 2023.

---

	P0477-4-PM1. Construction of "the drug database for overDors prevention" which adopted clinical on-site needs 永島一輝1,2, 比留間康二郎3, 中原未結2, 大森あすか2, 中村英里2, 渡邊真知子2, 関根祐子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1488-1488, 2023.

---

	P0478-4-PM2. Development of DPC data extraction, the processing application and examination of new Quality Indicator 天野哲史1, 水草博希2, 鈴木大吾2, 加藤滋宏3, 河村隆登4, 桑原悠里5, 富田いゆき3, 平野貴志6, 水野雄登7, 坂田洋2, 鈴木厚志1, 服部芳明2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1489-1489, 2023.

---

	P0479-4-PM1. The current situation investigation of information mention about the propriety of the simple suspension method to pharmaceutical products interview form 芳野雅巳1, 青木学一2,3, 渋谷清2,3, 新井克明1, 秋山滋男4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1490-1490, 2023.

---

	P0480-4-PM2. About the drug information reading situation by the introduction of the drug reporting service 小川充恵1, 小枝伸行2, 香川雅一1, 西岡達也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1491-1491, 2023.

---

	P0481-4-PM1. Investigation about the source of information of the incompatibility in the questions and answers of the drug information room 若林智仁, 坂倉広大, 安延恵, 向井優太朗, 中蔵伊知郎, 上野智子, 中野一也, 川端一巧 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1492-1492, 2023.

---

	P0482-4-PM2. Usefulness and problem of the straight molding AI in the drug information 松浦誠, 長澤茉依, 関本葵, 高橋寛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1493-1493, 2023.

---

	P0483-4-PM1. Questionary survey to our hospital charge medical representative about the drug information offer activity means under the COVID-19 outbreak 勝弘毅, 平野淳, 田淵克則, 薄雅人, 吉田知由 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1494-1494, 2023.

---

	P0484-4-PM2. Examination, inspection for the database making to guess about the taste information of the ethical drug 尾島稔 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1495-1495, 2023.

---

	P0485-4-PM1. DI duties, national survey subanalysis ... of relationship - medical institution of the duties actual situation and the number of the bed scale, the staff of the detailman 大幸淳1, 内倉健2, 榊原統子3, 大庭理寛4, 鈴木すみれ5, 酒井隆全6, 若林進7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1496-1496, 2023.

---

	P0486-4-PM2. Fact-finding about drug information duties in the metropolis and districts pharmacist society 酒井隆全1, 内倉健2, 大幸淳3, 大庭理寛4, 榊原統子5, 鈴木すみれ6, 若林進7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1497-1497, 2023.

---

	P0487-4-PM1. Investigation about the quantity of prescription of the oral anticoagulant drug according to the renal function based on administrative data 柏倉正太1, 菊池大輔1, 佐々木康太1, 岩井智美1, 飯沼尚己1, 岡田浩司1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1498-1498, 2023.

---

	P0488-4-PM2. Consideration for solving problems in formulary introduction in functional hospital groups 安藤正純1, 金井紀仁1, 佐藤光2, 宮本拓也3, 澤田雄太4, 陣内智美5, 永瀬真理子6, 吾妻隼斗5, 奈良部修弘7, 下舘桃子8, 宮崎美子3, 鈴木智9 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1499-1499, 2023.

---

	P0489-4-PM1. Crossing study - using prescription fact-finding - medical care big data in elderly people with the condition of a patient needing drinking water restrictions 越塚宏美1,2, 百賢二1,2, 渡邊亜矢子1,2, 松崎あい理1,2, 柏原由佳1,2, 田中克巳1,2, 佐々木忠徳3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1500-1500, 2023.

---

	P0490-4-PM2. Onset of liver damage signal search by drug interactions with the nintedanib using JADER 土川拓也, 小寺聖, 関谷泰明, 井上壽江, 平下智之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1501-1501, 2023.

---

	P0491-4-PM1. Examination of a change and the effect after the hospital formula reintroduction of the acid-secreting antagonist 川邊一寛, 畠山成寛, 中村明日香, 川邉桂, 若杉正, 小池博文, 佐橋幸子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1502-1502, 2023.

---

	P0492-4-PM2. Evaluation of the important potential risk associated with the rhabdomyolysis using the adverse event spontaneous report database 竹下和輝1,2, 田坂祐一1, 名和秀起1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1503-1503, 2023.

---

	P0493-4-PM1. Analysis about the hypothyroidism of hypoxia-inducible factor - proline hydroxylase (HIF-PH) inhibitor using adverse drug reaction database (JADER) 鈴木慎一郎, 今井徹, 大塚進 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1504-1504, 2023.

---

	P0494-4-PM2. Drug-induced hiccups and relations of the dopamine D2 receptor 細谷龍一郎1,2, 寺島朝子1, 野澤 (石井) 玲子3, 植沢芳広2, 加賀谷肇1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1505-1505, 2023.

---

	P0495-4-PM1. Analysis of the gender gap in the adverse event expression of DPP-4 inhibitor using Japanese adverse event spontaneous report database (JADER) 宍戸正昂1, 野口義紘1, 舘知也2, 井口和也3,4, 吉村知哲1,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1506-1506, 2023.

---

	P0496-4-PM2. Construction of the pharmacokinetic information database supporting medical treatment management and medication counseling 長尾理乃1, 村田佑香1, 市丸咲紀1, 中村拓己1, 山本祐有1, 雨宮理1, 大野逸子1, 柴崎光太郎1,2, 杉平直子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1507-1507, 2023.

---

	P0497-4-PM1. Prediction of the nuclear receptor, stress reply course to be involved in onset of anticancer medicine-induced diarrhea using the large-scale side effect database 奥中真白1, 植沢芳広2, 加納大輔1, 川崎敏克1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1508-1508, 2023.

---

	P0498-4-PM2. Risk analysis about acute renal failure of the antiSARS-CoV-2 medicine 加茂真宏, 祖川倫太郎, 島ノ江千里 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1509-1509, 2023.

---

	P0499-4-PM1. Effect of the diabetes therapeutic drug on delirium 石橋幸子, 祖川倫太郎, 緒方健二, 島ノ江千里 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1510-1510, 2023.

---

	P0500-4-PM2. Does an effect of the pimobendan include the difference by the left ventricular ejection fraction of patients with heart failure? 岩出佳樹1, 林太祐1, 久保田芳明2, 西野拓也3, 渡邉将央2, 橘貴大2, 松田淳也2, 加藤活人4, 太良修平2, 宮地秀樹2, 時田祐吉2, 伊勢雄也1, 岩崎雄樹2, 浅井邦也2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1511-1511, 2023.

---

	P0501-4-PM1. Examination of the usefulness of the allergic evasion using the auxiliary pharmaceutical adjuvant database 粟野美沙1, 川東祥子1, 奥覚子1, 柴崎光太郎1,2, 栗原輝子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1512-1512, 2023.

---

	P0502-4-PM2. Study on international comparison of the risk management plan of pharmaceutical products approved by a pioneer pharmaceutical products-designated system 中村百合, 前田英紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1513-1513, 2023.

---

	P0503-4-PM1. Efficiency of the delivery such as the material, and the like for the instruction to patient by the "MONITARO-Lite" introduction 渡辺智康, 難波良平, 山崎恵, 高取孝一, 安藤哲信 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1514-1514, 2023.

---

	P0504-4-PM2. Does the drug information administrative work have the introduction effect of the artificial intelligence chat bot? 岩西雄大, 大津由美子, 望月千枝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1515-1515, 2023.

---

	P0505-4-PM1. Comparison of miconazole adhesion tablets and the amphotericin B syrup in oral candidiasis 吉田りほ子, 萩原大樹, 東恵理, 伊藤弥紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1519-1519, 2023.

---

	P0506-4-PM2. Proper use fact-finding of the low-dose edoxaban in our hospital 伊藤弥紀, 東恵理, 萩原大樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1520-1520, 2023.

---

	P0507-4-PM1. Report - about research - institution attribute and the pharmacist duties rate of use about the usefulness of the pharmacist intervention in the convalescent ward 藤原久登1,2, 岸本真1,3, 小瀬英司1,4, 篠永浩1,5, 田中絵里子1,6, 中道真理子1,7, 溝神文博1,8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1521-1521, 2023.

---

	P0508-4-PM2. Usefulness of the use of commercial thickness adjustment food at the mesalazine granular transluminal administration 石田洋史1, 野村洋道2, 中浴伸二2, 田中詳二2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1522-1522, 2023.

---

	P0509-4-PM1. The current situation of the hyperkalemia in the use of mineralocorticoid receptor blocker patients 石原和恭, 冨田敦和, 今西忠宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1523-1523, 2023.

---

	P0510-4-PM2. The use situation of ondansetron in the pediatric intensive care unit 小林恵子, 鈴木英二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1524-1524, 2023.

---

	P0511-4-PM1. The enforcement situation, attitude survey of the patients follow-up during duration of drug use of the canola flower East Japan 伊澤裟実子1, 赤川実久莉2, 奥村郁実3, 竹谷真由子6, 豊田陽子5, 豊東淳美4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1525-1525, 2023.

---

	P0512-4-PM2. About the utilization situation, and the like and a problem of pharmaceutical products risk management plan (RMP) in the healthcare setting 福田小夜子, 八田真美子, 岡本麻依, 漆谷隼, 養老真紀, 清水慧子, 沼田恵理, 田島康則, 大澤智子, 倉持憲路 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1526-1526, 2023.

---

	P0513-4-PM1. Investigation of questions and answers about the interaction of the anticoagulant in the drug information room 安延恵, 坂倉広大, 向井優太朗, 中藏伊知郎, 若林智仁, 中野一也, 上野智子, 川端一功 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1527-1527, 2023.

---

	P0514-4-PM2. The laxative abuse in patients with eating disorders and fact-finding about the quantity of in-hospital laxative prescription 山本ゆりえ1,2, 河合啓介2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1528-1528, 2023.

---

	P0515-4-PM1. Survey of clazosentan use for cerebral vasospasm after subarachnoid hemorrhage surgery in acute care hospitals 高橋謙吾1, 別所千枝1, 安原昌子1, 阿美古将2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1529-1529, 2023.

---

	P0516-4-PM2. Recognition degree investigation about the chic day response of the patients with rheumatoid arthritis 鶴橋智子1, 本岡千佳1, 祖川倫太郎1, 丸山暁人2, 長嶺里美3, 島ノ江千里1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1530-1530, 2023.

---

	P0517-4-PM1. About the use situation and hypothyroidism of the Pembrolizumab in our hospital 木本秀樹, 長谷川将, 山村真貴子, 佐藤優希子, 長島章 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1531-1531, 2023.

---

	P0518-4-PM2. Fact-finding of the cyclosporine adverse event in atopic dermatitis 松下一樹, 和田宜久, 友井理恵子, 的場美香, 木村貴, 木澤成美, 金銅葉子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1532-1532, 2023.

---

	P0519-4-PM1. About the use situation of the anamorelin hydrochloride in our hospital 古賀茜, 藤田謙, 夏目紗恵, 清水俊勝, 大竹満博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1533-1533, 2023.

---

	P0520-4-PM2. Use fact-finding of the anamorelin hydrochloride in our hospital 藤谷千紘, 米谷頼人, 松田亜希子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1534-1534, 2023.

---

	P0521-4-PM1. The current situation investigation of the standard precaution for ward charge pharmacists and the precaution according to the infection route and the evaluation 芥子川純里, 内山耕作, 鈴川誠, 平尾祐樹, 冨田敦和, 今西忠宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1535-1535, 2023.

---

	P0522-4-PM2. The gastrostomosis is the opportunity of the polypharmacy review by being associated with the simple suspension method introduction 熊井梢恵1, 武者薫1, 八子有沙1, 吉沢奈々1, 永野伸郎2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1536-1536, 2023.

---

	P0523-4-PM1. A survey of the use of sacubitril valsartan tablets at the Public Showa Hospital 阿部剛1, 米沢牧子1, 岡田建助3, 峯岸夕紀2, 田中茂博3, 本田一春1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1537-1537, 2023.

---

	P0524-4-PM2. Evaluation after the efforts for the prescription situation and the proper use of the suvorexant in the Anjo rebirth hospital 渡辺裕之1,2, 藤井友和1, 植松夏子1, 野本歩未1, 小島礼菜1, 平野貴大1, 野々山陽子1, 万塩裕之1, 澤田和久1, 木村友美1, 奥平正美1, 中村和行3, 沖哲4, 足立康則4, 鍋島俊隆2, 杉浦洋二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1538-1538, 2023.

---

	P0525-4-PM1. Use fact-finding of the morphine in amyotrophic lateral sclerosis (ALS) patients 杉山尭紀, 中村卓巨, 三井陽二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1539-1539, 2023.

---

	P0526-4-PM2. Study on prophylaxis for the steroidal osteoporosis in children 長郷あかね1,2, 神村英利1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1540-1540, 2023.

---

	P0527-4-PM1. Investigation into fall rates following a change from suvorexant to lemborexant 吉澤典成, 山本浩二郎, 竹村姫穂, 竹腰雄真, 岩知道美幸, 山田直輝, 濱田達志, 山本倫数, 草薙みか, 大里恭章 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1541-1541, 2023.

---

	P0528-4-PM2. The prescription situation investigation of the osteoporosis therapeutic drug for patients with proximal thighbone bone fracture in our hospital 簑島弓未子, 井上晃汰, 荻野健吾, 竹田享平, 増渕幸二, 橋本光生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1542-1542, 2023.

---

	P0529-4-PM1. In the Hashima Municipal Hospital is the investigation about the dose of the type oral anticoagulant drug directly 古澤明朋, 伊藤真也, 浅井和浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1543-1543, 2023.

---

	P0530-4-PM2. The current situation investigation about the PONV precautionary measures for the laparoscopic cholecystectomy patients 金子泰也1, 北川原康子2, 米澤亮1, 山崎信江3, 丸山晴生1, 川上勝弘2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1544-1544, 2023.

---

	P0531-4-PM1. Alteration of consciousness of enforcement and the participant of the enlightenment classroom about the osteoporosis for inhabitants of the TambaSasayama area 橋本佳奈1,2, 木下淳1, 高良恒史1, 高本光次郎2, 志方敏幸2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1545-1545, 2023.

---

	P0532-4-PM2. It is ... for the spread of attitude survey - CKD seals for CKD in the member of Akashi-shi pharmacist society drugstore 岩崎克也1, 山元優輝1, 寺沢匡史1, 米倉由利子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1546-1546, 2023.

---

	P0533-4-PM1. Examination of the laboratory study item to display in outside Parliament prescription 有馬直伸1, 村山由香里1, 松元真哉1, 下野奨平1, 武田泰生1,2, 寺薗英之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1547-1547, 2023.

---

	P0534-4-PM2. The impact of formulary introduction on drug use - the case of sleeping pills - 西野貴仁1, 荒川昌史1, 大平実佳1, 西島秀和1, 小林亮1, 藤村昭太1, 片野昌宏1, 今井靖1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1548-1548, 2023.

---

	P0535-4-PM1. Effect - that inside the hospital notified of efforts - "request for the proper use promotion of the sleeping drug for review of the use of sleeping drug" 大平実佳1, 荒川昌史1, 須田史郎2, 西野貴仁1, 新保昌久3, 片野昌宏1,3, 村林美優1, 大野翼1, 金田颯1, 金井栄里香1, 田村依珠美1, 今井靖1,3,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1549-1549, 2023.

---

	P0536-4-PM2. Patient's share of medical expenses reduction by the refill prescription introduction in our hospital and investigation about the safety 芝田雄登, 牧野洸太朗, 小阪直史, 四方敬介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1550-1550, 2023.

---

	P0537-4-PM1. Investigation about the needs of the pharmacist in the animal hospital 大塚登志喜, 浅井亮太 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1551-1551, 2023.

---

	P0538-4-PM2. Pilot study about the non-proper use of the proton pump inhibitor 大久保佳孝1, 尾形勉1, 小田中啓太2, 中川直人2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1552-1552, 2023.

---

	P0539-4-PM1. The use situation investigation of the morphine hydrochloride for patients with terminal heart failure in Tokyo Metropolitan Tama Medical Center 佐野弥里, 宮澤真帆, 寺山義泰 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1553-1553, 2023.

---

	P0540-4-PM2. Correspondence fact-finding to a foreign inpatient in the hospital pharmacist 細野美幸1, 下村文恵1, 石田誠1, 根角泰生1, 工藤香代子1, 栗原理1, 西野紀子1,2, 津田隆1,2, 俵木登美子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1554-1554, 2023.

---

	P0541-4-PM1. Change after extraction and the measures of problems at opioid introduction in patients with non-cancerous chronic pain 廣田佳美, 大野凜太郎, 斎藤和悦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1555-1555, 2023.

---

	P0542-4-PM1. Quality evaluations such as the anti-peptic ulcus agents, and the like in the generic drug quality information review meeting 森田時生1, 吉田寛幸1, 富田奈緒美1, 稲垣葵1, 伊豆津健一1,2, 佐藤陽治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1557-1557, 2023.

---

	P0543-4-PM2. Clinical comparison by changes from the starting pharmaceutical products of the tolvaptan granule in patients with heart failure to generic medicine 阪元孝志1, 二宮暁代2, 横田千明1, 金澤絵莉1, 糸永昇平1, 神代広平1, 樋口ゆり1, 安藤和雅子1, 園田恵理1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1558-1558, 2023.

---

	P0544-4-PM1. Evaluation about the properties of matter of brimonidine tartrate eye drops and use characteristics 秋山滋男1, 米田正明2, 宮本悦子3, 毎田千恵子4, 石田志朗5, 堀祐輔1, 土井信幸6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1559-1559, 2023.

---

	P0545-4-PM2. Comparative study of patient instruction sheets for oral anticancer drug capecitabine-containing preparations 大滝康一1, 古庄功汰1, 高田珠有1, 岩山訓典1, 谷口亮央2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1560-1560, 2023.

---

	P0546-4-PM1. Efforts to Biosimilar introduction and medical service fees (the introduction addition) 江川友子1, 野口智宏2, 大久保嘉則1, 北御門由衣1, 園田美幸3, 白川敦規4, 桑原貴美子1, 鈴田浩孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1562-1562, 2023.

---

	P0547-4-PM2. Efforts of the early period of biofollowing article introduction addition calculation in the foreign cancer chemotherapy 杉山昌秀, 篠原佳祐, 宮田智陽, 吉池麻衣, 征矢あや乃, 柳澤沙織, 堀内賢一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1563-1563, 2023.

---

	P0548-4-PM1. About effect on Infusion Reaction when we changed it from a trastuzumab bio precedence product to Biosimilar and continued treatment and cardiac activity 安部智哉1, 相良篤信2, 岡田大地1, 松坂和正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1564-1564, 2023.

---

	P0549-4-PM2. Effect to give use investigation and the pharmaceutical products costs of the antiVEGF antibody in colon cancer 小泉宏史, 宇山佳奈, 坂本靖宜, 川邊一寛, 畠山成寛, 長谷川拓也, 中村明日香, 清水絢子, 井出和男, 小池博文, 佐橋幸子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1565-1565, 2023.

---

	P0550-4-PM1. Investigation of the infusion reaction frequencies in changes from a bevacizumab precedence product to Biosimilar 草野泰輝, 吉野走, 山口卓朗, 森善洋, 樋口則英 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1566-1566, 2023.

---

	P0551-4-PM1. The example that intervened pharmaceutical for hypoglycemia with levofloxacin 間瀬尚子, 原弘士, 山口遥, 澤村公志, 山本郁生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1571-1571, 2023.

---

	P0552-4-PM2. One case of the low Mg blood symptom with lansoprazole that diachronic observation of urinary Mg excretion compartmentation was useful in differentiation 安東大智1, 中村駿2, 宗広樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1572-1572, 2023.

---

	P0553-4-PM1. One case that developed anuria by the anticholinergic inhalant for patients with chronic obstructive pulmonary disease 船越晴喜1,2, 百賢二2, 和田紀子1,2, 宮田祐人3, 佐々木忠徳4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1573-1573, 2023.

---

	P0554-4-PM2. 1 case of the necrotising fasciitis with suspected iodine poisoning with the iodoform gauze 竹内耕治1, 池田宏器2, 飛田修康1, 鶴橋智子1, 本岡千佳1, 井上卓也2, 杉田和成2, 島ノ江千里1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1574-1574, 2023.

---

	P0555-4-PM1. About what we experienced the Serious ADR example with lamotrigine tablets and worked on 中島瑞貴1, 白川敦規2, 鈴田浩孝1, 桑原貴美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1575-1575, 2023.

---

	P0556-4-PM2. 3 cases that presented a symptom of the pseudogout by preoperative nourishment management 伊東健一1, 前田歩乃佳1, 井上由似1, 秋吉史久1, 白尾貞樹2, 福久はるひ2, 秦洋一2, 白尾一定2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1576-1576, 2023.

---

	P0557-4-PM1. One case of the small-cell lung cancer that developed adrenal insufficiency by the Durvalumab and joint pain, interstitial pneumonia 中島理絵1, 西田朋洋1, 大田美沙貴1, 田頭尚士1, 坂本靖之1, 藤田秀樹1, 徳永忠浩2, 久保田益亘3, 福原和秀4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1577-1577, 2023.

---

	P0558-4-PM2. A case of anaphylactic shock and relapse after administration of Joyclu(R) - Pharmacokinetic consideration of the cause 勝田雄太1, 大久保綾香1, 中薗健一1, 若竹春明2, 松崎貴志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1578-1578, 2023.

---

	P0559-4-PM1. A case of severe pleural effusion after administration of clazosentan 堺香輔1, 巖西真1, 藤本優貴2, 池田義人1, 辻篤司2, 吉田和道2, 森田真也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1579-1579, 2023.

---

	P0560-4-PM2. About the effect that the acetaminophen intravenous administration time in the intensive care unit gives to blood pressure 浦山泰典1, 小坂慧1, 井手頌美1, 安武夫1,2,3, 城田幹生1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1580-1580, 2023.

---

	P0561-4-PM1. Case series of paradoxical reaction with TNF α inhibitor discovered in immune pharmacist outpatients 平田一耕1,2, 六反田諒3, 舟越亮寛1,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1581-1581, 2023.

---

	P0562-4-PM2. Examination of an allergy, the information on adverse drug reactions registration method to the electronic medical chart that is useful for a prescription check 冨岡謙二1, 太田原顕2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1582-1582, 2023.

---

	P0563-4-PM1. Seamless approach ... by the construction - 3 Hospital combination of the adverse event report education base by the pharmacist in clinical duties 坪谷綾子1,7, 米澤龍2,3,7, 四十物由香4,7, 向後麻里5,7, 須永登美子3,6,7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1583-1583, 2023.

---

	P0564-4-PM2. Fact-finding ... of the consciousness of the pharmacist in the construction - 3 Hospital of the adverse event report education base by the pharmacist in clinical duties and the case report education system 四十物由香1, 米澤龍2,3,7, 坪谷綾子4,7, 向後麻里5,7, 須永登美子5,6,7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1584-1584, 2023.

---

	P0565-4-PM1. National survey ... of consciousness and the case report education system of the pharmacist for construction - adverse event report of the adverse event report education base by the pharmacist in clinical duties 米澤龍1,2,3, 坪谷綾子3,4, 四十物由香3,5, 向後麻里3,6, 須永登美子3,7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1585-1585, 2023.

---

	P0566-4-PM2. Time for onset of fatal arrhythmia analysis associated with the azole-based antifungal agent using JADER 大山勝宏, 秋山翔太, 飯田恵, 石井萌, 堀祐輔 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1586-1586, 2023.

---

	P0567-4-PM1. Comparison between Palbociclib and side effect profile of the Abemaciclib using real world data 武田達明1, 松本准1, 杉本詩歩2, 岩田直大3, 中本秋彦3, 濱野裕章3, 有吉範高1, 座間味義人3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1587-1587, 2023.

---

	P0568-4-PM2. A case with suspected agranulocytosis with the ursodeoxycholanic acid 山村翔, 荒木良介, 山田英紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1588-1588, 2023.

---

	P0569-4-PM1. Survey of side effects of sacubitril valsartan in patients with chronic heart failure at our hospital 犬飼阿弥佳, 薄田百合子, 高嶋祥匡, 高橋弘泰, 三浦毅 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1589-1589, 2023.

---

	P0570-4-PM2. Fact-finding of the hearing loss with the amikacin by nontuberculous acid-fast bacterium disease treatment 光武瑞穂1, 木戸上知弘2, 瀧口純司3, 山内円1, 野村洋道1, 石本学司1, 中浴伸二1, 田中詳二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1590-1590, 2023.

---

	P0571-4-PM1. About the expression of infusion reaction situation in the daratumumab subcutaneous injection preparation 野口唯香, 阿部桂祐, 木村雄太, 高田慎也, 山岸佳代, 橋下浩紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1591-1591, 2023.

---

	P0572-4-PM2. The type of the drug in the fall fall accompanied with the sleeping drug remedy and investigation about the event occurrence time 細野寛貴1, 石川雄也1, 八島秀明1,2, 大島幸菜1, 荒木拓也1,2, 山本康次郎1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1592-1592, 2023.

---

	P0573-4-PM1. One patient who bradycardia by the Lacosamide was suspected by bringing medicine differentiation, and was able to evade the pacemaker custody 門口直仁, 伊東愛理, 段松雅弘, 公文登代, 田中聡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1593-1593, 2023.

---

	P0574-4-PM2. It is one patient with suspected onset of the calcineurin inhibitor-induced pain syndrome by drug interactions after the course for a heart transplant long term 島田泉, 小林将文, 中川裕介, 外山聡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1594-1594, 2023.

---

	P0575-4-PM1. A clinical study on risk factors for hypotension caused by sacubitril valsartan hydrate in patients with chronic heart failure 高橋岳大, 阿部晃太, 石田陽菜, 寺西真凜, 中田絵梨, 川口翔平, 門脇督, 槙田芳, 東修司, 田畑裕和, 今井隆人, 小林龍 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1595-1595, 2023.

---

	P0576-4-PM2. A case which developed erythema multiforme severe by sequential administration of the sorafenib after the Atezolizumab + bevacizumab 岩山竜大1, 四十物由香1, 小川竜徳1, 八木澤昂大1, 齋藤祥子1, 菊池早輝子2, 鴨志田敏郎3, 田村明広1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1596-1596, 2023.

---

	P0577-4-PM1. The construction of the machine learning model predicting a low Na blood symptom during the chemotherapy in patients with malignant tumor and examination of the risk factor 青木優佳1, 安部賀央里1, 頭金正博1, 村島美穂2, 濱野高行2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1597-1597, 2023.

---

	P0578-4-PM2. One patient whom hyperammonemia and irAE developed in after mFOLFOX6 and Nivolumab combination therapy at the same time 鈴木拓也, 迎佳奈, 畠山智明, 遠藤美央, 玉木慎也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1598-1598, 2023.

---

	P0579-4-PM1. Examination of the protective efficacy of magnesium oxide for the cisplatin-induced renal failure and sumatriptan 石井友理1, 藤松成美1, 庄司美貴1, 高田美紀1, 小杉隆祥2, 佐藤光利1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1599-1599, 2023.

---

	P0580-4-PM2. 1 case that a hand-and-foot syndrome developed in the docetaxel triweekly therapy first cycle after the Dose-dense doxorubicin + cyclophosphamide therapy and aggravated 杉本亜弥1, 熊澤里美1, 水野智博1, 松田日出三1, 河田健司2, 喜島裕子3, 山田成樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1600-1600, 2023.

---

	P0581-4-PM1. Examination of one allergic interstitial pneumonia by the paclitaxel 大瀧翔太1, 翁長寛人1, 宗岡克樹2, 古川智康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1601-1601, 2023.

---

	P0582-4-PM2. Frequency of the hypomagnesemia in the gemcitabine cisplatin Necitumumab combination therapy for the squamous cell carcinoma of lung and investigation of the expression time 藤田強記, 衛藤智章, 後藤隆, 高野豪, 清水裕彰 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1602-1602, 2023.

---

	P0583-4-PM1. A case of BRAF mutation-positive colorectal cancer with macular edema and subretinal fluid caused by cetuximab + encorafenib + binimetinib therapy 古川卓也1, 関野康2, 丸山晴生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1603-1603, 2023.

---

	P0584-4-PM2. Examination of the effect that PARP inhibitor gives to the serum creatinine level 有木沙織1, 大西康博2, 山崎明子1, 田中雄太1, 森本志帆2, 和田淳2, 座間味義人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1604-1604, 2023.

---

	P0585-4-PM1. Is giving Entrectinib for progress pancreatic cancer; one case who had gait disturbance and pubic bones, the sacrum fractured 景山康二郎1, 田頭尚士1, 西田朋洋1, 坂本靖之1, 田妻昌2, 藤田秀樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1605-1605, 2023.

---

	P0586-4-PM2. Is taking a multi-kinase inhibitor in the patients with progress renal cell carcinoma; a case with suspected purple spot type drug eruption 道家雄太郎1, 野田哲史1,2, 草場拓人3, 吉田哲也3, 池田義人1, 森田真也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1606-1606, 2023.

---

	P0587-4-PM1. Investigation of the irAE expression situation in the Fukuyama Municipal Hospital 岩村高弘, 森光保武, 藤井秀一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1607-1607, 2023.

---

	P0588-4-PM2. Impaired renal function by the high-dose ST medical mixture that prompt improvement was obtained by administration cancellation, a case of the electrolyte abnormality 橋本拓郎1,2, 綺田尚久1,2, 若森裕生1, 久世彰1, 福永夏実1, 宮田侑季1, 吉田紀子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1608-1608, 2023.

---

	P0589-4-PM1. Meta analysis about the linezolid-induced thrombocytopenia onset factor in the Japanese patients 藤居賢, 石郷友之, 福土将秀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1609-1609, 2023.

---

	P0590-4-PM2. Tazobactam piperacillin and impact statement to renal function at cefepime alone 小原菜美1, 小松敏彰1, 白津和慶1, 赤間田悠刀1, 尾鳥勝也1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1610-1610, 2023.

---

	P0591-4-PM1. The onset of cardiovascular system side effect of guanfacine hydrochloride extended-release situation in patients with childhood attention lack, hyperkinesis symptom 越野優希1,2, 田中裕章3, 田井達也3, 山口佳津騎3, 元木貴大3, 立道貴清1, 小坂信二2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1611-1611, 2023.

---

	P0592-4-PM2. One case that methylergometrine maleate developed cerebral infarction by the cerebrovascular spasm thought to be precipitants 上田彩加1, 渡部真志2, 玉井宏一1, 稲見有1, 烏谷政和1, 倉田知久1, 白岡朗2, 京樂格2, 岡本憲省2, 藤原聡3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1612-1612, 2023.

---

	P0593-4-PM1. Examination of the dementia onset risk by the use of sleeping drug using large-scale receipt data 末吉珠莉亜, 堀井剛史, 三原潔 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1613-1613, 2023.

---

	P0594-4-PM2. Analysis about the mesalazine intolerance in the inflammatory bowel disease case 中野敬太1, 石郷友之1, 風間友江2, 藤居賢1, 仲瀬裕志3, 福土将秀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1614-1614, 2023.

---

	P0595-4-PM1. A case of a patient with a history of hypothyroidism whose thyroid hormone levels fell below normal levels after administration of roxadustat 神村真由, 窪田由夏, 足立充司, 池田久雄, 平田貴宏, 神原弘和 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1615-1615, 2023.

---

	P0596-4-PM2. The side effect occurrence situation of the heart failure therapeutic drug "fantastic four" 近藤和宏, 尾形美絵, 長澤欣弘, 瀧内瑛輔, 中村慎一郎, 羽生智宏, 新関みどり, 田村和彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1616-1616, 2023.

---

	P0597-4-PM1. A case which accepted rapidly progressive anemia attributable to the linezolid 青柿和樹, 大荒政志, 山崎佳奈, 松浦克樹, 増田博也, 久岡清子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1617-1617, 2023.

---

	P0598-4-PM2. Investigation about the effect of the JAK inhibitor on lipid abnormality 中山紗里, 祖川倫太郎, 緒方健二, 島ノ江千里 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1618-1618, 2023.

---

	P0599-4-PM1. One case after the living body lung transplantation with suspected drug fever with tacrolimus 松本恵実, 佐藤裕, 森下啓, 佐藤祐司, 眞野成康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1619-1619, 2023.

---

	P0600-4-PM2. One case of the drug fever that was able to identify two kinds of cover suspicion medicine by the cooperation of a physician and the pharmacist 新城唯1, 岡崎英子1, 樋口俊惠2, 矢野遥子1, 藤原隆行2, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1620-1620, 2023.

---

	P0601-4-PM1. Examination about the adverse event that we showed during ST medical mixture administration for the purpose of the pneumocystis pneumonia prevention 平岩美穂1, 橋本みさき1, 田中雅幸3, 西山徳人1,2, 打谷和記1, 宮下修行2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1621-1621, 2023.

---

	P0602-4-PM2. The case that caused cognitive impairment, tardive dyskinesia and the prescription cascade which led to sialolithiasis by haloperidol prescribed in on admission delirium 藤原將平 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1622-1622, 2023.

---

	P0603-4-PM1. Specialist in citizen of Osaka consecutive side effect Committee 2021 summary 井上千紘1,2,3,4,5,6, 坂田勝美2, 清水順子3, 平方まりこ4, 山本京5, 松本ミユキ6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1623-1623, 2023.

---

	P0604-4-PM2. An investigation and report about a review and the fall occurrence of the sleeplessness indicator 和田翼, 生田智基, 松本拓真, 長谷部匡史, 堀田修次, 森近俊之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1624-1624, 2023.

---

	P0605-4-PM1. Examination ... using search - neural progenitor cells strain PC12 of the neurologic cell line for the in vitro evaluation of the oxaliplatin-induced feeling cold erethism 手塚千裕1,2, 松本萌1, 中田千鶴1, 鈴木春花1, 田中駿也1, 二宮悠佳1, 平尾卓也1, 加藤芳徳1,2, 山田治美1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1625-1625, 2023.

---

	P0606-4-PM1. Effect on bowel control by the combination of magnesium oxide and gastric-acid secretion antagonist 平野徹1,2, 近藤隆瑛2, 松原千明2, 細田雄一郎2, 浅貝健介2, 西口宏一2, 大久保春輝2, 辻涼平2, 中原尚美2, 中江貴彦2, 伊藤達章2, 平原慎太郎2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1628-1628, 2023.

---

	P0607-4-PM2. Prospective cohort study about the effect on clinical response by the combination of rosuvastatin and antacid 戸倉歌緒子1, 三崎桃子1, 宮津大輔2, 中島章雄1,3, 小林邦久4, 浦田秀則5, 渡邊裕之2, 下村英紀6, 宮崎元康1,3, 今給黎修1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1629-1629, 2023.

---

	P0608-4-PM1. Comparison - by effect - tendency score matching of the vonoprazan in the sedation by the midazolam 児玉暁人1, 長生幸司2, 駒居真紀子1, 勝浦正人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1630-1630, 2023.

---

	P0609-4-PM2. A case of an elderly chronic kidney disease patient in whom the combination of vadadustat enhanced the hypoglycemic effect of mitiglinide and sitagliptin, leading to hypoglycemia 高倉歩美1, 平井利典1, 濱口直美1, 向原里佳1, 松本和隆2, 矢野裕2, 岩本卓也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1631-1631, 2023.

---

	P0610-4-PM1. The effect that danazol administration gives to the metabolism enzyme activity of the CYP3A substrate drug and the internal change 福野修平1, 黒飛明美1, 佐堀友紀1, 中川涼1, 野村麗菜1, 笠原恵太2, 長井克仁1, 小西廣己1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1632-1632, 2023.

---

	P0611-4-PM2. Interaction analysis based on the physiologic pharmacokinetics model that incorporated time-dependent inhibition of the proguanil metabolism by the vonoprazan 大久保健二郎1, 工藤敏之1,2, 合田ひとみ1, 山岸喜彰1,2, 伊藤清美1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1633-1633, 2023.

---

	P0612-4-PM1. One case of mitochondrial encephalomyopathy that caused a blood level drop of the phenytoin by ciprofloxacin combination 小笠原明美, 武井桃香, 加藤典子, 高木昭佳, 加藤敦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1634-1634, 2023.

---

	P0613-4-PM2. A case which was able to be given chemotherapy avoiding interaction with the warfarin safely by having switched from aprepitant to fosnetupitant 長縄華子1, 梅村圭祐1, 片田佳希1, 中島大輔2, 伊達洋至2, 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1635-1635, 2023.

---

	P0614-4-PM1. The effect of menthol on irinotecan killing effect with human liver cancer HepG2 cells: Possibility of the participation of breast cancer-resistant protein BCRP 長井克仁1, 大谷奎介2, 吉田尚史2, 渡邊利栄2, 福野修平1, 小西廣己1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1636-1636, 2023.

---

	P0615-4-PM2. Protection effect of theanine on doxorubicin-induced rat renal failure 仲村愛可, 長井克仁, 長峰由樹, 福野修平, 小西廣己 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1637-1637, 2023.

---

	P0616-4-PM1. Investigation about the drug interaction of CYP3A of the oral anticancer agent 吉友葵, 坂本靖宜, 川邊一寛, 畠山成寛, 井出和男, 小池博文, 佐橋幸子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1638-1638, 2023.

---

	P0617-4-PM2. Investigation about the effect on PT-INR level in the TAZ/PIPC administration 竹口真央, 梶原敬悟, 河田武志, 小川喜通 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1639-1639, 2023.

---

	P0618-4-PM1. The example that it was suggested that an effect of the linagliptin was not obtained in an adsorption of the oral spherical carbonaceous adsorbent which we took at the same time 藤田美佐子1, 小田川周平1, 浅野陽子1, 日高良昌1, 小城千枝1, 猪川和朗2, 井上愛梨2, 井村友哉2, 森川則文2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1640-1640, 2023.

---

	P0619-4-PM2. The CKD case that a pharmacist intervened for the TSH rise with the absorption drop drug of the levothyroxine, and was improved 伊藤正輝1, 飯塚雄次1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1641-1641, 2023.

---

	P0620-4-PM1. Effect on probiotic preparation by the at the same time simple suspension with metronidazole 森川祥彦1, 加藤秀雄1, 萩原真生2, 三鴨廣繁3, 岩本卓也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1642-1642, 2023.

---

	P0621-4-PM1. A case of using hydromorphone hydrochloride sustained-release tablets with oxycodone powder as rescue medication, taking into consideration the patient's level of understanding 小林奈緒1, 佐々木美理1, 山口莉穂1, 高山直也1, 木村尚子2, 土井千春2, 加藤一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1646-1646, 2023.

---

	P0622-4-PM2. A case which intervened in a shift of the medication management including the drug for the medical care for being at home 大久保晃樹, 桐原大輝, 中村薫, 鶴田翔大, 岡村俊則 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1647-1647, 2023.

---

	P0623-4-PM1. The system construction of the drug self-care for the medical care in the inpatient subsequently 畑下真希1,2, 朝日仁美1,2, 丹藤千絵2,3, 手渡和子2,3, 市田泰彦1,2, 筒井秀知1, 豊田康義2,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1648-1648, 2023.

---

	P0624-4-PM2. Look at the rear about the search of the risk factor contributing to somnolence expression by the mirogabalin; mark investigation 高橋梨恵1, 平井利典1, 岡本明大1, 濱口直美1, 堀内保顕1, 高尾仁二2, 川口晃司2, 岩本卓也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1649-1649, 2023.

---

	P0625-4-PM1. Effect on frequency investigation of the diarrhea by introducing naldemedine with a strong opioid analgesic start 西本凜1, 松本拓真2, 武良卓哉1, 小倉千奈1, 濱岡照隆1, 小川喜通1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1650-1650, 2023.

---

	P0626-4-PM2. Efforts of the opioid rounds operational change 中原萌子, 高武嘉道, 大橋邦央, 花田聖典, 橋本雅司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1651-1651, 2023.

---

	P0627-4-PM1. A case that mexiletine was effective in the rectal tenesmus due to prostatic small cell cancer 加藤良隆1, 井上渉1,2, 江島智彦1,2, 大坪彩子1,2, 丸浜暢子1, 神田英一郎1,2, 友金幹視1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1652-1652, 2023.

---

	P0628-4-PM2. The case that switched it, and was given pain control opioid from fentanyl patch high-dose during the terminal phase to low-dose oxycodone intravenous feeding 伊東充, 高澤千重理, 高橋真一, 日高あづみ, 向井晴香, 江川朱季, 佐藤香織, 加藤潤一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1653-1653, 2023.

---

	P0629-4-PM1. Use fact-finding of the medical drug in the municipal Kashiwabara Hospital 中市里実, 佐野拓見, 山下幸大, 台野佳代 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1654-1654, 2023.

---

	P0630-4-PM2. Construction of the foreign telephone follow-up system for patients with use of opioid analgesic cancer 森田奈々, 八木貴彦, 宮本康敬, 平野公美, 大和千穗, 外山未来, 野木村藍, 中村拓哉, 川口千香 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1655-1655, 2023.

---

P0631-4-PM1. It is examination ... from stocktaking and the Dr. problem - encounter questionnaire results of the opioid introduction support team for patients with cancer during foreign going to hospital 近藤綾子1,4, 山本泰大1,4, 笠原愛菜1,4, 平野茂樹1,4, 村路留美子2,4, 奥村佳美2,4, 大北淳也3,4, 加藤栄助3,4, 出口裕子1,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1656-1656, 2023.

---

	P0632-4-PM2. Factor investigation to elderly people polypharmacy early intervention with the palliative care unit 宮部貴識, 山口志郎, 野田拓誠, 多田純平, 及川悠衣, 抱勇希, 澤田奈々, 原伸好 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1657-1657, 2023.

---

	P0633-4-PM1. Effect to give to stool characteristics of the naldemedine in patients with opioid-induced constipation 世古口拓也, 三宅知宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1658-1658, 2023.

---

	P0634-4-PM2. The use situation of the opioid in the allogeneic hematopoietic stem cell transplantation 林崎修也1, 中村和代1, 丸山紗緒里1, 大澤美紗1, 齋藤優2, 岸本寛史3, 野吾和宏2, 櫻井和子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1659-1659, 2023.

---

	P0635-4-PM1. The OIC expression situation investigation under the naldemedine prophylaxis at oxycodone extended-release introduction 萩原諒一1, 井上新太1, 中山弘道2, 花香淳一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1660-1660, 2023.

---

	P0636-4-PM2. The enforcement situation after the rescue medicine self-care manual introduction of the drug for the medical care 中西順子, 藤田早季, 篠永浩, 原田典和, 加地努 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1661-1661, 2023.

---

	P0637-4-PM1. About pain-killer prescription order in cancerous pain treatment and rescue medicine, aperient, the prescription situation of the antiemetic a comparison (the second report) before and after the - guidelines revision 丸山昌広, 定盛理純 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1662-1662, 2023.

---

	P0638-4-PM2. One patient who responded to hydromorphone oral administration for dyspnea of patients with pulmonary squamous cancer 毛利早希, 中山昂太, 清水寛将, 白崎由貴, 西出洋志, 加藤秀明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1663-1663, 2023.

---

	P0639-4-PM1. A case which was available for a diet intake while continuously administering the midazolam note for end-of-life retching, vomiting 今中智子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1664-1664, 2023.

---

	P0640-4-PM2. The current situation of the palliative care screening of our hospital which is area cancer practice cooperation base Hospital and future problem 玉井宏一1,5, 末廣拓1, 中野友寛1, 原田嵩大1, 松岡葉子1, 西畑友尋1, 烏谷政和1, 倉田知久1, 渡部早苗2, 外山修子3, 山下広恵3, 岡本千愛3,5, 西谷恵3,5, 武田千津3,5, 椿雅光4,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1665-1665, 2023.

---

	P0641-4-PM1. We look at the rear about patient factors influencing the effectiveness of the anamorelin hydrochloride for the cancer cachexia and study a mark 牧賢利1, 藤原未稀1, 高田遼1, 高橋洋子1, 大塚眞哉2, 田村浩二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1666-1666, 2023.

---

	P0642-4-PM2. 2 cases that an acetaminophen continuous intravenous infusion was effective for the heat generation of patients with end-stage cancer 石川敬祐, 伊藤慎二, 磯貝潤一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1667-1667, 2023.

---

	P0643-4-PM1. 1 case that good elimination of pain was obtained by the combination of the tramadol hydrochloride note for metastases to bone ache 伊藤慎二, 磯貝潤一, 石川敬祐, 清水千晴 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1668-1668, 2023.

---

	P0644-4-PM2. Effect on pain control that we were able to see from questionary survey about the filling of the drug parenteral injection for the medical care and the need of the duties standardization 相田和希1,2, 吉川直樹1,2, 飯島直美1, 森田光枝1, 岡ゆかり2, 宮崎好美2, 井上卓2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1669-1669, 2023.

---

	P0645-4-PM1. Extraction of the factor associated with the antimicrobial administration continuation in the cancer terminally ill patients which discontinued treatment with anticancer agent 油原直乃1, 城山亮輔1,2, 鵜澤友里合1,2, 山口諒1, 山本武人1, 高田龍平1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1670-1670, 2023.

---

	P0646-4-PM2. 1 case corresponding to shifts from cancer pain to chronic pain 加藤あゆみ1,2,3, 岡村由美子1,3,4, 伊勢雄也1,2, 鈴木規仁1,3,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1671-1671, 2023.

---

	P0647-4-PM1. Three cases that nausea developed by anamorelin internal use, and led to internal use cancellation 工藤範子, 島田泉, 新木貴大, 外山聡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1672-1672, 2023.

---

	P0648-4-PM2. An effect of the anamorelin hydrochloride in patients with cancer and investigation about the side effect 鳥井小莉1, 宮本朋佳2, 三羽尚子1, 地丸裕美1, 山田正実1, 高橋一栄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1673-1673, 2023.

---

	P0649-4-PM1. Examination about the conversion ratio when we switch it opioid from hydromorphone parenteral injection 三羽尚子1, 地丸裕美1, 鳥井小莉1, 宮本朋佳2, 山田正実1, 高橋一栄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1674-1674, 2023.

---

	P0650-4-PM2. Efforts for the weight loss in the investigation of the opioid dose before and after the radiotherapy and palliative care rounds 土屋惠菜1, 岩田一史1, 釆田志麻2, 陣上祥子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1675-1675, 2023.

---

	P0651-4-PM1. Efforts for the drug self-care for the medical care 梅田鈴香1, 佐藤淳也2, 塚越真由美3, 神坐美弥子1, 橋本竜1,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1676-1676, 2023.

---

	P0652-4-PM2. About the effect that the administration of immune checkpoint inhibitor gives for analgesic effect with the opioid preparation 中尾優子, 炭本隆宏, 田中遼大, 龍田涼佑, 伊東弘樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1677-1677, 2023.

---

	P0653-4-PM1. About the use of antimicrobial situation in our hospital palliative care unit 後藤義之, 森戸敏志, 角紀一郎, 岡田久美, 古本真由美, 松岡美紗, 茶野下貴恵, 島崎沙織, 青木理恵, 梅下翔, 橋本夏枝, 谷本百恵 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1678-1678, 2023.

---

	P0654-4-PM2. A case of the foreign patients on dialysis who were able to use hydromorphone immediate-release effectively 中野智尋1, 加畑千春2, 埴生由紀恵3, 新谷圭子1, 鳥羽英理子1, 竹田和喜1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1679-1679, 2023.

---

	P0655-4-PM1. One patient whom symptom improvement was found in by the dosage of the hydromorphone hydrochloride continuation subcutaneous injection for dyspnea due to the left lower lobe lung cancer 大内友季江1, 佐伯里紗1, 正垣耕1, 松木司1, 佐藤千穂1, 安達寛成1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1680-1680, 2023.

---

	P0656-4-PM2. The example that reached the pain relief after the at-home shift by a pain evaluation based on information obtained in conference before discharge and prescription suggestion 浅野陽子1, 日高良昌1, 小城千枝1, 猪川和朗2, 中村紗緒里2, 村田香奈恵2, 森川則文2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1681-1681, 2023.

---

	P0657-4-PM1. About the use situation of the transdermal absorbing form continuous pain therapeutic agent in our hospital 芦田理沙, 古橋真理, 足立圭司, 川見里奈 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1682-1682, 2023.

---

	P0658-4-PM2. 1 case ... which used ... PCA pump for the home care of patients with cancer 小寺菜月, 勝岡美菜, 若林厚史, 坂本依利, 高橋彩, 田畑寛明, 猿谷淳, 向一美, 地野幹子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1683-1683, 2023.

---

	P0659-4-PM1. 1 case that showed withdrawal symptoms-like symptom improvement by setting update time two without changing a fentanyl tape daily dose 新名主泰文1,2, 屋地慶子2, 満尾明恵2, 菅原英輝2, 寺薗英之2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1684-1684, 2023.

---

	P0660-4-PM2. Comparison of the pharmaceutical management of the health insurance pharmacy pharmacist for the medical drug of the cancer base Hospital varying in the issuance of foreign prescription style 平井俊明1, 江草徳幸1, 栗原晋太郎2, 礒貝明彦1, 中島恵子1, 安原昌子2, 渡邊英晶3, 山下大介4, 安保圭介5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1685-1685, 2023.

---

	P0661-4-PM1. Investigation ... of the drug needing polypharmacy - careful administration in patients with old end-stage cancer 野村祐司1,2, 櫛原秀之1, 岩永周子1, 平野美枝子2, 中野祐往3, 河合奈津子4, 湯浅典博4, 成瀬徳彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1686-1686, 2023.

---

	P0662-4-PM1. Investigation about use characteristics of the side effect check application in patients receiving immune checkpoint inhibitor 山下みづ穂1, 松下知世2, 北口剛吉3, 島田浩1, 森田有美子1, 猪野彩2, 國正淳一2, 村田久枝1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1693-1693, 2023.

---

	P0663-4-PM2. Search of the effect factor to give to treatment continuance of the Palbociclib + fulvestrant combination therapy 田中通, 黒松誠, 梶田貴司, 西川豊, 奥野智之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1694-1694, 2023.

---

	P0664-4-PM1. The medical expenses reduction simulation which assumed the low-dose standard of the hippopotamus diTaki cell 西村充礼, 浅野裕紀, 木村美智男, 宇佐美英績 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1695-1695, 2023.

---

	P0665-4-PM2. About the effect that bevacizumab bio follower product adoption gives for hospital management 加藤秀明, 中山昂太, 毛利早希, 白崎由貴, 清水寛将, 西出洋志, 新田直美, 辻正宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1696-1696, 2023.

---

	P0666-4-PM1. Efforts and problem for the early period of biofollowing article introduction addition acquisition of the anticancer agent 細川朋弘1,2, 西尾香子1, 塩谷美由紀2, 村井明史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1697-1697, 2023.

---

	P0667-4-PM2. A case of the urothelial carcinoma which interstitial pneumonia by the Pembrolizumab aggravated by readministration 武田真央1, 坪谷綾子1, 伊藤由香1, 吉岡まき2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1698-1698, 2023.

---

	P0668-4-PM1. Safe examination of the docetaxel/ramucirumab therapy for the lung cancer for elderly people 小山田聡1, 久松直樹1, 林士元2, 野村明広2, 原信田努1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1699-1699, 2023.

---

	P0669-4-PM2. A case of multiple myeloma with pulmonary edema caused by daratumumab + carfilzomib + dexamethasone therapy 坂本竜平, 向井淳治, 小竹優希, 竹原涼子, 叶真央, 山田佳菜子, 辻田早紀, 森本亜美, 奥田広志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1700-1700, 2023.

---

	P0670-4-PM1. One patient whom myocarditis, thyrotoxicosis developed in by ipilimumab and nivolumab combination therapy 白崎由貴, 中山昂太, 毛利早希, 清水寛将, 西出洋志, 加藤秀明, 新田直美, 辻正宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1701-1701, 2023.

---

	P0671-4-PM2. Search of the sunitinib optimal relative dose intensity in patients with Japanese renal cell carcinoma 松村謙吾1, 廣部祥子1,2,3, 前田真貴子1,3, 藤尾慈1,4, 前田真一郎1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1702-1702, 2023.

---

	P0672-4-PM1. The side effect expression situation of the nivolumab + chemotherapy for the gastric cancer in our center 森本奈緒美, 星田唯史, 武田祐子, 山口彩樹, 藤原大一朗, 木村佳世, 眞下惠次, 和田祥明, 野田明宏, 多喜和夫, 田辺和史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1703-1703, 2023.

---

	P0673-4-PM2. A comparative study of adverse events associated with trastuzumab deruxtecan in patients with HER2-positive gastric cancer in our hospital with or without ascites 橋口麻依子, 久松大祐, 後藤隆, 清水裕彰 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1704-1704, 2023.

---

	P0674-4-PM1. The effect that the hyperbilirubinemia at administration start in the pancreatic cancer GnP therapy results in for myelosuppression 平井成和1, 任田早紀2, 有山智博2, 真坂亙2, 増田雅行2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1705-1705, 2023.

---

	P0675-4-PM2. Renal function when we used the UPC ratio as an evaluation standard of proteinuria in the bevacizumab administration for colon cancer and long-term effect on following treatment 柴崎七海1, 金素安1, 大貫奏1, 立沢正臣1, 須郷広之2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1706-1706, 2023.

---

	P0676-4-PM1. Usefulness of the inflammatory biomarker for the side effect expression in the nivolumab administration case of patients with gastric cancer and the long-term survival 長谷川将, 木本秀樹, 山村真貴子, 佐藤優希子, 長島章 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1707-1707, 2023.

---

	P0677-4-PM2. A case of relapsed B-cell acute lymphoblastic leukemia in a child weighing 45 kg who experienced side effects due to blinatumomab administration 小園友明1, 野々垣知行1, 下村保人2, 堀壽成3, 大西正文1, 奥村彰久3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1708-1708, 2023.

---

	P0678-4-PM1. Analysis of the tyrosine kinase inhibitor using LC-MS/MS with all automatic pre-treatment equipment 吉川航平, 塚本多矩, 箕畑俊和 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1709-1709, 2023.

---

	P0679-4-PM2. A case which continued the dosage of the sorafenib while measuring blood level for patients with 90-year-old hepatocytes cancer which received haemodialysis 金剛圭佑1, 刈谷美里1, 脇下大樹1, 入江慶2, 福島昭二3, 石田淳4, 橋本泰明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1710-1710, 2023.

---

	P0680-4-PM1. About the effect that oxaliplatin administration gives in Colin symptom frequency of irinotecan 山下慎司1, 光家勉1, 西川光1, 篠村恵理子1, 塘賢二郎2, 上田豊実1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1711-1711, 2023.

---

	P0681-4-PM2. Use of venetoclax + azacitidine therapy in our hospital and pharmacists' involvement in its appropriate use 馬場結子, 平池美香子, 松藤敬佑, 齋藤巨樹, 小園亜希, 湊本康則 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1712-1712, 2023.

---

	P0682-4-PM1. It is the-related examination of the liver damage during ALBI Grade and treatment success period before treatment in the EGFR-TKI treatment of the non-small cell lung cancer 有原大貴1,2, 永松秀紹3, 早川裕二4, 間瀬広樹5, 新屋智之6, 北俊之6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1713-1713, 2023.

---

	P0683-4-PM2. Participation of the situation and the pharmacist of the examination for oncogene panel in the Kyushu cancer center 衛藤智章, 仲田浩成, 藤田強記, 清水裕彰 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1714-1714, 2023.

---

	P0684-4-PM1. Usefulness (lung cancer case report) of blood microRNA-29a-3p and nuclear receptor transcription factor 4a1 mRNA in the evaluation of the impoverishment by the Pembrolizumab of immunity 町田麻依子1, 竹市雄1, 今田愛也1, 山形優華2, 井藤達也2, 相坂治彦3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1715-1715, 2023.

---

	P0685-4-PM2. 1 case that developed an ANCA-related vasculitis after the Lenvatinib remedy for thymic carcinoma: Lenvatinib and consideration from blood level of IL-6 朝倉充俊1, 岩間創1, 見野靖晃2, 中津川瑛美2, 小泉知展3, 内藤隆文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1716-1716, 2023.

---

	P0686-4-PM1. Efforts for proper use promotion of the immune checkpoint inhibitor in our hospital 森岡沙織, 吉藤和也, 後藤志典, 山崎博子, 西美帆, 赤崎淳子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1717-1717, 2023.

---

	P0687-4-PM2. 1 case of the Trousseau syndrome where the suggestion of the heparin Ca self note by the pharmacist made possible going to hospital treatment continuation 藤林遼, 山田将悟, 朝倉幹己, 橋本咲季, 山内萌生, 菊地亮朗, 庄崎沙耶, 田中耕太, 山本翔太, 前川英輝, 菊地義明, 高橋誠, 田中正臣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1718-1718, 2023.

---

	P0688-4-PM1. Efforts of HBV (HBV) reactivation measures 磯貝潤一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1719-1719, 2023.

---

	P0689-4-PM2. Comparison ... in only simulation ... day and the deadline of the medical expenses reduction effect by the use of single vial multiple times with the anticancer medicine preparation robot for one week 守屋昭宏, 浅野裕紀, 竹中翔也, 伊藤大輔, 岩井美奈, 木村美智男, 宇佐美英績 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1720-1720, 2023.

---

	P0690-4-PM1. Examination of the usefulness of the liver residual function evaluation using ALBI score in patients with nonhepatic cell cancer 細見周平, 川原田祐貴, 南島拓矢, 溝口博之, 山田清文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1721-1721, 2023.

---

	P0691-4-PM2. 1 case that the crizotinib administration changed to entrectinib while regulating a dose for ROS1 fused gene-positive patients 比嘉大輔, 金城雄一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1722-1722, 2023.

---

	P0692-4-PM1. One case that ptosis produced by initial administration of oxaliplatin for patients with sigmoid colon cancer 山口卓朗1, 吉野走1, 林田颯志1, 山根理恵子1, 草野泰輝1, 岩村直矢1, 森善洋1, 佐道紳一1, 谷口堅2, 樋口則英1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1723-1723, 2023.

---

	P0693-4-PM2. Usefulness inspection by prescribing anamorelin hydrochloride than a pharmacist, and suggesting it 青木洸英1,2, 佐々木茂樹1, 金井詩織1, 降旗誠2, 杉田和夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1724-1724, 2023.

---

	P0694-4-PM1. Effect of the pharmacist interview introduction before physician medical examination in the foreign cancer chemotherapy at the middle scale hospital 古浜健一1, 清水あかり2, 荻野綺2, 岩本淳平1, 相良篤信2, 稲葉健二郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1725-1725, 2023.

---

	P0695-4-PM2. Quality of life evaluation of patients with foreign cancer 宮澤憲治1, 安藤栞奈2, 山田桃子1, 山下紗瑛奈1, 杉田郁人1, 有原大貴3, 田代匠1, 森下拓哉1, 網岡克維2, 高木亮1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1726-1726, 2023.

---

	P0696-4-PM1. The effect that the display of the family function gives to the medication continuation of the aromatase inhibitor medication patients 田中翔斗1, 永野悠馬2, 前田守2, 市ノ渡真史2, 長谷川佳孝2, 月岡良太2, 大石美也2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1727-1727, 2023.

---

	P0697-4-PM2. Effect to medicine medicine cooperation of the pharmacist outpatient department in the foreign cancer chemotherapy 稲葉健二郎1, 荻野綺2, 清水あかり2, 岩本淳平1, 相良篤信2, 古浜健一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1728-1728, 2023.

---

	P0698-4-PM1. Examination of the factor affecting the effect of treatment of the use of immune checkpoint inhibitor patients in our hospital urology department domain 豊田悠希1, 矢野琢也1, 星加寿子1, 松本大輝1, 加藤あゆみ1, 福岡竜逸1, 篠森健介2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1729-1729, 2023.

---

	P0699-4-PM2. Efforts using PBPM for the hepatitis B reactivation in the cancer chemotherapy 西原夢乃1,2, 阿部桂祐2, 木村雄太1, 高田慎也1, 山岸佳代1, 橋下浩紀1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1730-1730, 2023.

---

	P0700-4-PM1. The effect that the onset of serious neutropenia in the adjuvant chemotherapy gives to prognosis after the S-1 technique on pancreatic cancer 野口裕介1, 大坪達弥1, 小林大祐1, 加藤良隆1, 豕瀬諒2, 村木優一2, 友金幹視1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1731-1731, 2023.

---

	P0701-4-PM2. A case of venetoclax + low-dose cytarabine combination therapy for elderly AML patients who was able to continue treatment while reducing the dose and discontinuing the drug 清水寛将, 中山昂太, 毛利早希, 白崎由貴, 西出洋志, 加藤秀明, 新田直美, 辻正宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1732-1732, 2023.

---

	P0702-4-PM1. Investigation about the safety of the six weeks space Pembrolizumab administration 新村航1,2, 元木貴大1, 吉村知華1, 國方梨乃1, 安宅希美子1, 三崎彩香1, 篠原尚樹1, 水岡大策1, 磯部芳江1, 山口佳津騎2, 田中裕章1, 小坂信二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1733-1733, 2023.

---

	P0703-4-PM2. One case of the TMB-high breast cancer that ICI was curing, and became invalid 大久保節子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1734-1734, 2023.

---

	P0704-4-PM1. A multicenter investigation for the intervention of the pharmacist in the foreign cancer chemotherapy and the evaluation 桑村恒夫1, 柿原圭佑2, 川原和也3, 大森義朗4, 塚原邦浩5, 秋吉史久6, 上淵未来7, 葉田昌生8, 三島直9, 嘉村基樹10, 三上忠司1, 中川義浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1735-1735, 2023.

---

	P0705-4-PM2. Investigation about the risk factor of the onset of dermatopathy with bendamustine in the untreated non-Hodgkin's lymphoma 清水悠太1, 南貴之1, 若月淳一郎1, 飯野昌樹2, 小林義文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1736-1736, 2023.

---

	P0706-4-PM1. Investigation about the incidence of proteinuria, high blood pressure in the Atezolizumab + bevacizumab therapy of patients with hepatocytes cancer 石田友規1, 宮崎雅之1, 伊藤隆徳2, 村山三佳1, 溝口博之1, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1737-1737, 2023.

---

	P0707-4-PM2. Association between treatment continuance rate and nutrition index of the Lenvatinib treated patients for the hepatocellular carcinoma 若松遼介1, 中山瑞貴2, 若松綾華1, 山下友輝1, 須藤大雄1, 桂川みき1, 柴波明男1, 樋浦一哉2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1738-1738, 2023.

---

	P0708-4-PM1. Examination between the delay convalescence in the methotrexate excretion delay of the a large quantity of methotrexate therapy 斉藤瑞歩, 中尾將彦, 古波津美紗, 影山寛人, 森宏幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1739-1739, 2023.

---

	P0709-4-PM2. The use situation investigation of the peg filgrastim preparation in our hospital 青木望, 淺利亜規代, 望月英明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1740-1740, 2023.

---

	P0710-4-PM1. Effect on prognosis that relative intensity of treatment in the cancer of endometrium postoperative chemotherapy gives 桂川健司, 高取裕司, 高岡龍蔵, 遠山幸男, 久田達也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1741-1741, 2023.

---

	P0711-4-PM2. Adverse event comparison of elderly people receiving CapOX therapy after the operation 和久井卓, 水上康弘, 本田和則 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1742-1742, 2023.

---

	P0712-4-PM1. 1 case that presented severe proteinuria and high blood pressure after the ramucirumab + FOLFIRI therapy introduction early 森井悠介, 松井駿亮, 大河万顕, 瀬名波宏昌, 下村一徳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1743-1743, 2023.

---

	P0713-4-PM2. Investigation into the use of asciminib, a novel STAMP inhibitor, for chronic myeloid leukemia 中村雄亮1, 高橋優聡1, 助畑歩1, 大野真史1, 北川瑚姫1, 大聖遥香1, 伊藤史織1, 小森均1, 太田秀一2, 深井敏隆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1744-1744, 2023.

---

	P0714-4-PM1. One case of rectal cancer which came by treatment continuation after the nephrotic syndrome onset by Ramucirumab in Bevacizumab 高取裕司, 桂川健司, 高岡龍蔵, 遠山幸男, 久田達也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1745-1745, 2023.

---

	P0715-4-PM2. Examination about the effectiveness of the Elobixibat in patients with cancer 生田智基, 和田翼, 松本拓真, 武智宣佳, 堀田修次, 森近俊之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1746-1746, 2023.

---

	P0716-4-PM1. 1 case that measured AUC for effective and safe confirmation using MMF for steroid refractoriness irAE 綾野武司1, 水岡大策1, 高本彩音1, 篠原尚樹1, 山口佳津騎2, 元木大貴1, 田中裕章1, 小坂信二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1747-1747, 2023.

---

	P0717-4-PM2. A case which developed type I diabetes mellitus as an immune-mediated adverse event by nivolumab + ipilimumab combination therapy 柿本秀樹1, 福江悠香1, 吹上勇真1, 小川新1, 高木聡子1, 鵜木亜矢子1, 眞崎晃3, 内山将伸3, 宮崎元康1,2, 今給黎修1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1748-1748, 2023.

---

	P0718-4-PM1. The adrenal function test enforcement situation of the use of immune checkpoint inhibitor patients in our hospital 榊原崇芳, 近藤有, 間瀬悟, 三宅芳男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1749-1749, 2023.

---

	P0719-4-PM2. Consideration of the expression situation of the immune-mediated adverse event in the use of immune checkpoint inhibitor patients and the factor 鈴木直人1, 渡邊卓嗣1,2, 飯沼尚己1, 高橋優花1, 塩澤誠1, 山内雅仁1, 有馬遥太朗1, 佐々木高信3, 岡田浩司1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1750-1750, 2023.

---

	P0720-4-PM1. Changes from gemcitabine lyophilized products to a solution, examination about the vascular pain accompanied with the change of the dissolution liquid 足立紗知, 畑祐基, 宮城和代, 長谷川英利, 中橋麻友, 楢本佳代, 青野由依, 吉村芙美, 村津圭治, 山下大輔, 吉野宗宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1751-1751, 2023.

---

	P0721-4-PM2. One case that led to drug-induced thrombocytopenia with oxaliplatin 遠藤美央, 鈴木拓也, 畠山智明, 玉木慎也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1752-1752, 2023.

---

	P0722-4-PM1. Examination of the onset of muscles and bones referred pain factor by a docetaxel combination regimen and the peg filgrastim 水上康弘, 和久井卓, 本田和則 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1753-1753, 2023.

---

	P0723-4-PM2. Relation of the pharmacist to the HBV reactivation prevention in the treatment with anticancer medicine 西村雅次, 佐藤奈実, 今田良樹, 吉田崇志, 羽太光範 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1754-1754, 2023.

---

	P0724-4-PM1. The effect that the effectiveness, safety and body-surface area of Osimertinib give 西馬怜1, 田中佐季1, 田宮基裕2, 高橋幸三1, 高木麻里1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1755-1755, 2023.

---

	P0725-4-PM2. Efforts of the health insurance pharmacy for the "drug for the medical care" outside Parliament prescription acceptance 加藤貴美, 森田京子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1756-1756, 2023.

---

	P0726-4-PM1. It is the correspondence of the carrying out of the prescribed medicine to the foreign tour of patients with cancer 野田佳子1, 浜田美輝1, 房垣圭祐2, 若杉吉宣3, 須藤正朝3, 蓑輪圭一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1757-1757, 2023.

---

	P0727-4-PM2. Use experience of Panitumumab for patients with rectal cancer with the tumor fever 田口玲実1, 伊藤紳人1, 日比聡1, 壁谷めぐみ1, 湯浅周1, 城川優子2, 古田竜一3, 伊奈研次4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1758-1758, 2023.

---

	P0728-4-PM1. One case that suffered from differentiation of the fever, and had difficulty in treatment continuation of colon cancer 山本佳苗1, 松沼悟1, 吉元公一1, 山本圭2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1759-1759, 2023.

---

	P0729-4-PM2. 1 case that performed pertuzumab + trastuzumab combination therapy for HER2-positive colon cancer of progress, the recurrence that was impossible of curative resection 宮内康夫1, 櫻井淳二1, 八島一史1, 岡田優1, 佐々木美織1, 加藤さゆり2, 佐藤伸輔1, 寺澤孝幸4, 松尾幾3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1760-1760, 2023.

---

	P0730-4-PM1. Evaluation of the usefulness of Prognostic Nutritional Index as the checkpoint inhibitor effect predictor in patients with non-small cell lung cancer of immunity 三好孝法1,2, 宮下裕央2, 深澤真実1, 和佐野英子1, 花田聖典1, 大橋邦央1, 橋本雅司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1761-1761, 2023.

---

	P0731-4-PM2. The results HACA-positive a case that suspected rituximab-induced serum sickness during the BR therapy enforcement, and suggested an examination to a physician 石田貴啓, 内田将吾, 大谷寧次郎, 三浦毅 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1762-1762, 2023.

---

	P0732-4-PM1. Nutritional status in the breast cancer preoperative chemotherapy and association of the side effect expression 菊池健1, 城堀陽生2, 武田元樹1, 渡邉大毅1, 相馬貴史1, 佐藤秀紀2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1763-1763, 2023.

---

	P0733-4-PM2. Case investigation about the remedy situation and the effect of treatment of the anamorelin hydrochloride 濱みゆき, 木村雄太, 田初夏苗, 柳瀬真希, 山岸佳代, 橋下浩紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1764-1764, 2023.

---

	P0734-4-PM1. Effect investigation of the effect that anamorelin hydrochloride and Rikkunshito give to cancer cachexia 嶋田真帆1,2, 稲野寛1, 山本悠樹1,2, 瀬戸良教1, 太田智博1, 椎崇1, 尾鳥勝也1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1765-1765, 2023.

---

	P0735-4-PM2. Association with continuity of elderly people usability test and the chemotherapy in patients with cancer and the adverse event 風岡真実1, 佐藤淳也3, 橋本竜1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1766-1766, 2023.

---

	P0736-4-PM1. The effect that the difference in Axitinib in patients with nephrocyte cancer and adverse event profile of the sunitinib gives for effect of treatment 松井頌明1, 尾崎正和2, 岡田直人2, 北原隆志2, 藤井秀一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1767-1767, 2023.

---

	P0737-4-PM2. Examination about the effect of treatment predictor in the Atezolizumab + Bevacizumab combination therapy for the unresectable hepatocellular carcinoma 須藤大雄1, 若松遼介1, 若松綾華1, 山下友輝1, 樋浦一哉2, 柴波明男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1768-1768, 2023.

---

	P0738-4-PM1. One patient whom fulminant type I diabetes mellitus developed in by Nivo + SOX administration 永田未希1,2, 市倉大輔1,2, 縄田修一1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1769-1769, 2023.

---

	P0739-4-PM2. Development of the new medical therapy to patients with poor-prognosis oral cancer based on disappearance, the malignant transformation mechanism of the CYLD expression 米丸興1, 末永尚輝1,4, 吉田晋太郎2,5, 森祥輝1, 勝目泰槙2, 松山果穂2, 新垣ひとみ1, 安東実咲2, 大田雅子2, 齋藤秀之1,3, 城野博史1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1770-1770, 2023.

---

	P0740-4-PM1. Methods for overcoming difficulties in taking venetoclax tablets and their effectiveness - A pharmacist's approach for pediatric patients with acute myeloid leukemia - 小林灯, 岩西雄大, 大津由美子, 望月千枝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1771-1771, 2023.

---

	P0741-4-PM2. Examination about relative dose intensity and effect of treatment of the Olaparib for ovarian cancer and the side effect 片岡加奈恵1, 寺澤美智代1, 本西哲1, 木崎秀和1, 村田紘未2, 打谷和記1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1772-1772, 2023.

---

	P0742-4-PM1. Examination about the appropriateness doses in the elderly people of the CapeOX therapy provided as adjuvant chemotherapy after the colon cancer technique 小笠裕斗, 上津沙織, 柿原圭佑, 塚原邦浩, 小倉秀美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1773-1773, 2023.

---

	P0743-4-PM2. Association of the checkpoint inhibitor and overall survival in patients with distant metastasis-related non-small cell lung cancer with the autoimmune disease of immunity 井原康貴1, 澤兼士2, 今井匠1, 石原朝陽3, 下村由希1, 野々宮悠太1, 新谷歩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1774-1774, 2023.

---

	P0744-4-PM1. A case of hepatic veno-occlusive disease/sinusoidal obstruction syndrome treated with defibrotide sodium after PTCY-Haplo transplantation 佐野雅彦, 水田秀貴, 末松耕輔, 黒部健太郎, 宮原強, 草葉一友 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1775-1775, 2023.

---

P0745-4-PM2. Retrospective study on renal function estimation level and toxicity to use at the Carboplatin doses calculation by the Calvert type 小林美奈子1, 渡邊裕之2, 柴田直樹3, 富士芳美4, 前田剛司5, 橋詰淳哉6, 亀位耕平7, 岡田浩司8, 妹尾啓司9, 三好孝法10, 平野公美11, 政賢悟12, 奥田泰考13, 宮崎実千芸14, 吉田幹宜15, 城口将太16, 藤田行代志17, 齊藤達也18, 山室蕗子19, 天間雅美20 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1776-1776, 2023.

---

	P0746-4-PM1. Study of the behavior factor giving it to the participation in "workshop for improvement in quality of the foreign cancer chemotherapy" 遠藤篤1,5, 佐藤大祐2,5, 石井直人1,5, 塩原慶徳2,5, 内山一成3,5, 露木聡史4,5, 喜古康博2,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1777-1777, 2023.

---

	P0747-4-PM2. Efforts of the HBV reactivation prophylaxis at cancer chemotherapy regimen check by PBPM 中嶋紘文, 吉田壘, 神佳祐, 村永諒, 山本いずみ, 櫻田穣, 坂田幸雄, 長浜谷耕司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1778-1778, 2023.

---

	P0748-4-PM1. Examination of the effective peer support which can meet the needs of the AYA generation cancer experienced person 三浦聡至, 高山俊輔, 牧野好倫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1779-1779, 2023.

---

	P0749-4-PM2. Construction in an overhanging style of the simple and easy isograft model mouse aiming at an efficacy evaluation of cancer driver gene-positive leukemia 平尾卓也1, 榎本竜也1, 寺川眞由1, 青木重樹2, 手塚千裕1,3, 加藤芳徳1,3, 山田治美1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1780-1780, 2023.

---

	P0750-4-PM1. UGT1A1*6/*28 genetic polymorphism and a case which came by administration continuation by weight loss with CPT-11 for patients with colon cancer of the hyperbilirubinemia 一沢麻衣1, 小沼大祐2, 市田泰彦1, 宮村達雄3, 筒井秀知1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1781-1781, 2023.

---

	P0751-4-PM2. Examination of the side effect of treatment with liposomal irinotecan risk factor in patients with pancreatic cancer 伊藤雄大1, 江川英毅2, 平岡芹菜2, 亀位耕平2, 佐野尚平2, 松原和夫1,2, 北野雅之3, 川井学4, 須野学1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1782-1782, 2023.

---

	P0752-4-PM1. Examination of start doses of the colon cancer adjuvant postoperative treatment in elderly people 75 years or older 安藤純子1, 中西博紀3, 衛藤英一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1783-1783, 2023.

---

	P0753-4-PM1. Evaluation of the intervention by the pharmacist for osteoporosis therapeutic drug proper use 守田香織1, 市川大介1, 古谷佳美1, 本田尚也1, 三原夏実1, 高田逸朗2, 平川宏之2, 松尾真二2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1787-1787, 2023.

---

	P0754-4-PM2. We test an effect of the edoxaban 15 mg prophylaxis after the total knee prosthesis, hip joint replacement technique in our hospital 小林華奈, 木下真理子, 薄田百合子, 高嶋祥匡, 市江敏和, 三浦毅 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1788-1788, 2023.

---

	P0755-4-PM1. 1 case that used cyclosporine together with adrenal cortical steroid for patients with childhood autoimmune hepatitis 枝澤瑞記, 藤田大智, 山中崇史, 天間雅美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1789-1789, 2023.

---

	P0756-4-PM2. The introduction situation of the heart failure standard therapeutic drug in the public hospital of the Showa era 米沢牧子1, 阿部剛1, 山崎千愛1, 峯岸夕紀2, 岡田健助3, 田中茂博3, 本田一春1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1790-1790, 2023.

---

	P0757-4-PM1. Use fact-finding of the edoxaban in patients who underwent lower limbs orthopedics surgery and examination of the venous thromboembolism onset risk 岩武幹乃, 吉田悦朗, 臼井和明, 長島章 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1791-1791, 2023.

---

	P0758-4-PM2. One case of the hypokalemia that was resistant to potassium replacement therapy 上杉章紀, 鴇田雅義, 正木拓陽, 高日大介, 田邉文明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1792-1792, 2023.

---

	P0759-4-PM1. Comparison of an infliximab response case of the Kawasaki's disease and the refractory case 長澤祥子, 木村真策 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1793-1793, 2023.

---

	P0760-4-PM2. Examination of the inspiratory flow rate increase by the Nose Clip method 坂野昌志1,2, 菅野雄太1, 吉村昌紘1, 竹内章2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1794-1794, 2023.

---

	P0761-4-PM1. Intervention effect of the pharmacist on heart failure basics medicine introduction 片桐光1, 小林竜司1, 長谷川哲也1, 鶴田瑞葵1, 武藤浩司1, 田中裕子1, 土田圭一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1795-1795, 2023.

---

	P0762-4-PM2. Comparison ... which paid attention to the basic pharmaceutical characteristic of attempt - antihistamine of the hay fever therapeutic drug academic D tailing material making 岡田由美子1, 深澤佑樹1, 三好文子1, 池澤直樹1, 岩田みなみ1, 出雲貴文1, 小茂田昌代1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1796-1796, 2023.

---

	P0763-4-PM1. Effectiveness of corresponding ... trazodone to the delirium in patients with chronic cardiac insufficiency and safety assessment ... 杢保貴幸1, 濱田真由子1, 熊本悠哉2, 徳竹裕貴1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1797-1797, 2023.

---

	P0764-4-PM2. Examination of the effect on nausea post-operative vomiting of the 5-HT3 receptor blocker in the general anesthesia lower obstetrics and gynecology department surgery 蟹江千雛, 酒井幹康, 戸田州俊, 大岩由香里, 三宅芳男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1798-1798, 2023.

---

	P0765-4-PM1. Efforts for the postoperative pain management team start in our hospital 西浦真理, 殿村直也, 中田千晴, 佐野弥里, 宮澤真帆, 寺山義泰, 稲吉梨絵, 山本博俊 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1799-1799, 2023.

---

	P0766-4-PM2. Effect of the prescription intervention based on the 2021 JCS/JHFS guidelines to the heart failure that the left ventricular ejection fraction by the pharmacist decreased on heart failure medical treatment instruction person 秀島久美子1, 中野祐樹1, 岡亜矢子1, 鬼塚健2, 門上俊明2, 横尾賢乗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1800-1800, 2023.

---

	P0767-4-PM1. Effect to give disease severity of the cardiogenic embolism with the anticoagulant remedy 原弘士1, 佐々木有彩1, 村井遥1, 大久保莉菜1, 櫻塲絵梨香1, 澤村公志1, 山本郁生1, 山本正博2, 城倉健1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1801-1801, 2023.

---

	P0768-4-PM2. About medical therapy of the osteoporosis in the seriously ill people experiencing disability 齊田翌美, 林佳奈子, 今田美里, 江崎由佳, 山本晃大, 山崎貴史, 鶴崎泰史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1802-1802, 2023.

---

	P0769-4-PM1. Fact-finding of the statin administration for patients with super old ischemia-related cerebral infarction and examination of the validity 林杏介, 森川剛, 久保田健, 岡澤香津子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1803-1803, 2023.

---

	P0770-4-PM2. Effect of the Ergo thionein in the ulceration of the skin ischemia reperfusion injury mouse 西田健太朗1, 高橋萌香1, 津山陽佳1, 岩崎綾乃1, 久家貴寿2, 田中雅幸3, 北谷和之4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1804-1804, 2023.

---

	P0771-4-PM1. Sounding out plan of the optimal administration time of tPA for the rat septicemic DIC model 竹中リナ1, 富山桃佳1, 山田真也2, 森下英理子2, 菅幸生1, 朝倉英策2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1805-1805, 2023.

---

	P0772-4-PM2. Chic day correspondence in patients with heart failure during SGLT2 inhibitor administration 高橋知里, 麻生美佐子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1806-1806, 2023.

---

	P0773-4-PM1. Ondansetron introduction to the surgery center about PONV measures of the obstetrics and gynecology department surgery and the effect that gave an incidence 打田由希, 濱浦弘光, 大谷寧次郎, 三浦毅 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1807-1807, 2023.

---

	P0774-4-PM2. About possibility of the antitumor effect of the hyperuricaemia therapeutic drug in the castration-resistant prostate cancer 鈴木康裕1,2, 岡本楓1, 鹿俣千裕1, 坂本七虹1, 山平りさ1, 太田昌一郎2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1808-1808, 2023.

---

	P0775-4-PM1. Investigation of DVT under the edoxaban prophylaxis low-dose after TKA and the bleeding event rate 木村修徳, 近藤讓, 田中誠 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1809-1809, 2023.

---

	P0776-4-PM2. It is an investigation about the delirium after the Remy masochist lymphangioleiomyomatosis doses and the operation 藤原純平, 吉田三矢, 苗村彰浩, 佐光留美, 庄野裕志, 山西香織 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1810-1810, 2023.

---

	P0777-4-PM1. One patient who underwent anticoagulation in warfarin for superior mesenteric artery embolism postoperative short bowel syndrome 奥苑朱加1, 杉村聡1, 杉田三郎2, 遠山幸男1, 久田達也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1811-1811, 2023.

---

	P0778-4-PM2. A case that quetiapine was effective for sleeplessness with a feeling of irritation and the excitement of children 野々山陽子1, 渡辺裕之1,2, 藤井友和1, 蜂須賀水絵3, 神谷彩4, 木下薫5, 足立康則6, 宮島雄二5, 杉浦洋二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1812-1812, 2023.

---

	P0779-4-PM1. One patient who was able to contribute to sugar load reduction in pyruvate dehydrogenase complex (PDHC) deficiency as a pharmacist 直井一久, 植竹龍一, 窪田佳代子, 丸山千春, 高木昭佳, 加藤敦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1813-1813, 2023.

---

	P0780-4-PM2. Investigation about the factor to lead to administration of guanfacine cancellation for the ADHD 土井絹華, 祖川倫太郎, 江口祐子, 島ノ江千里 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1814-1814, 2023.

---

	P0781-4-PM1. Effect to result in for the ADL evaluation of patients with stroke that use of the statin-based medicine is admitted to the convalescent rehabilitation ward 花岡峻輔1,2, 平井利幸2, 関利一2, 林宏行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1815-1815, 2023.

---

	P0782-4-PM2. Effect of the antacid to chalasia of magnesium oxide on chronic constipation of the elderly people multiple drug remedy patients 岩井琢1, 高橋寛1, 波多江崇2, 岡崎光洋3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1816-1816, 2023.

---

	P0783-4-PM1. One case of the nerve sarcoidosis patients avoiding becoming severe with ganciclovir-resistant cytomegalovirus infection 岩崎清子1, 安高勇気1,2, 松崎翔平1, 竹下翔3, 藤岡伸助3, 坪井義夫3, 神村英利1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1817-1817, 2023.

---

	P0784-4-PM2. Of the polypharmacy activity in the Saiseikai Hiroshima Hospital, actually 岡村和彦1, 山田真帆1, 浜本友絵1, 玉理千晴1, 高橋栄子1, 笹栗友佳里1, 正田朋佳1, 松本公治2, 佐々木雄啓1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1818-1818, 2023.

---

	P0785-4-PM1. One case that was able to receive good control using the oxycodone extended-release for chronic pain associated with multiple necrosis of four extremities due to the diffuse scleroderma 大内竜介1,2, 鈴木清寿3, 長尾宗紀3, 千葉美枝4, 鈴木直人2, 野上佳奈子2, 薄井健介1,2, 渡邊卓嗣1,2, 児山香3, 岡田浩司1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1819-1819, 2023.

---

	P0786-4-PM2. Examination of the usefulness of flurbiprofen which we used as an alternative agent of the aspirin for Kawasaki's disease acute phase 柳恵, 石毛宏冶, 石田雅也, 金井絵美, 長谷川雄介, 米井万紀子, 山崎茜, 森木麻未, 本田ゆめ, 石坂優太, 大竹千夏, 松木祥彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1820-1820, 2023.

---

	P0788-4-PM2. Examination about the dose of the dapagliflozin for patients with heart failure who had diabetes 眞山遼太, 佐々木稜太, 村岡愛, 高取士剛, 加藤梢, 岩堀真弓, 嘉屋則子, 後藤悠, 久保淳一, 田畑裕和, 今井隆人, 小林龍 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1822-1822, 2023.

---

	P0789-4-PM1. The comparison of the hyperkalemic therapeutic drug of the emergency domain: Rearward investigation of zirconium cyclo sodium silicate and the calcium polystyrene sulfonate 櫻井雄太, 安島秀友, 松崎貴志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1823-1823, 2023.

---

	P0790-4-PM2. Current status of pharmaceutical operations at our hospital and pre-avoidance reports 大荒政志, 増田博也, 久岡清子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1824-1824, 2023.

---

P0791-4-PM1. 1 case that we took medicine for predicted children patient, and a medication difficulty supported about a prednisolone tablet to use for Kawasaki's disease treatment 中村杏果, 池沢若菜, 徳丸章佳, 北園幸大, 田中恭人, 森永崇史, 石渡美樹, 徳永楓果, 米田仁保, 栗田泰樹, 上野菜巳, 上野怜良, 屋敷大輔, 淵脇ゆかり, 長ヶ原琢磨, 荻尾夕起子, 岸本真 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1825-1825, 2023.

---

	P0792-4-PM2. Efforts for the postoperative pain team management addition calculation in the Sasebo-shi comprehensive medical care center 山口健太郎1, 前川拓治2, 岡本智子3, 濱松大吾3, 古賀聖子1, 荻野清子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1826-1826, 2023.

---

P0793-4-PM1. Comparison with the article existing a medication supplement at powders remedy in children 1 year old or older under 15 years old a taking-related improvement effect of "sleeping (R) which grinds it, and sleeps at one gulp to put" 笠原沙耶香1, 齊藤順平1, 山口みほ1, 山田真由美1, 山谷明正2, 赤羽三貴1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1827-1827, 2023.

---

	P0794-4-PM1. Pulse-taking of internal use, the ad usum externum formulations incident by the drug inspection support system introduction 坂倉広大, 中蔵伊知郎, 向井優太朗, 安延恵, 宮部泰輔, 中野一也, 上野智子, 川端一功 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1830-1830, 2023.

---

	P0795-4-PM2. Analysis of the incident that a pharmacist was associated with 後藤一馬, 作山悠里, 川崎美咲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1831-1831, 2023.

---

	P0796-4-PM1. The effect that the number of the drugs per Press Through Package 1 sheet gives to a calculation mistake 山口泰弘, 田村彩織, 溝田愛子, 高武嘉道, 藤瀬陽子, 大橋邦央, 橋本雅司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1832-1832, 2023.

---

	P0797-4-PM2. The standardization promotion of the sleeping drug and the effect 廣田佳孝, 二見慎吾, 堀内麻美, 増田有紀子, 渡辺晴美, 川島美智子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1833-1833, 2023.

---

	P0798-4-PM1. It is efforts for prevention of resumption oblivion of the stopping medicine during surgery, preoperation in our hospital 熊澤里美, 加藤さや香, 友松恵子, 角里恵子, 荒川悠樹, 牧原俊康, 鈴木孝幸, 山田成樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1834-1834, 2023.

---

	P0799-4-PM2. Effect of the benzodiazepine receptor agonist decrease medicine in front of the art for the cardiovascular surgery patients 森田祐基1, 原幸子1, 高梨夕稀2, 内田佳菜子1, 友塚真栄3, 竹原眞人3, 津丸真一3, 島本健3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1835-1835, 2023.

---

	P0800-4-PM1. About making, the operation of the prescription input protocol by the ward pharmacist 喜多えり奈, 西村知恭, 亀位耕平, 島田佳代子, 山口佳那, 佐野尚平, 田淵沙織, 秋月麻友子, 山口真衣子, 嶋本めぐみ, 神谷祐果, 西川浩子, 吉田薫, 中川貴之, 松原和夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1836-1836, 2023.

---

	P0801-4-PM2. Efforts of the medical security for the powders prescription order 間瀬広樹1,2, 稲垣雄一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1837-1837, 2023.

---

	P0802-4-PM1. The current situation of hepatitis B reactivation measures in the Showa University Hospital and problem 田川菜緒1,2,3, 坂木理3, 若林仁美1,2, 古田康之1,2, 吉田仁3, 嶋村弘史1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1838-1838, 2023.

---

	P0803-4-PM2. The angiopathic development situation by the nicardipine judging from an incident report and the effectiveness of the medical care security activity by the pharmacist 向井優太朗1, 中蔵伊知郎1,2, 坂倉広大1, 安延恵1, 中野一也1, 上野智子1, 福峯美智代2, 津田悦子2, 大郷剛2, 川端一功1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1839-1839, 2023.

---

	P0804-4-PM1. It is reported the examination situation of the off-label use of the pharmaceutical products in the hospital for 28 for acute phase, convalescence, a chronic phase 新井亘1, 土屋裕伴1, 海老根卓也2, 矢吹直寛3, 岡平将志4, 増田裕一5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1840-1840, 2023.

---

	P0805-4-PM2. Report about the intervention of the pharmacy in the hospitalization and release support center 山内理世, 大西真奈美, 宮本康史, 上野英文, 小嶋希望 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1841-1841, 2023.

---

	P0806-4-PM1. About correlation with internal use and the fall accident occurrence of the sleeping drug 田口未菜, 羽太光範 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1842-1842, 2023.

---

	P0807-4-PM2. The report of the HBV reactivation case with the cancer chemotherapy in our hospital and analysis 深見優衣1, 諸角一成1, 恒川有里2, 岡田優子1, 杉浦美結1, 佐藤由美子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1843-1843, 2023.

---

	P0808-4-PM1. About the efforts of the fall, fall measures that removed a sleeping drug of BZ origin from drug for household delivery 武藤芳和1, 渡部寿康1, 佐藤隆昭2, 市橋淳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1844-1844, 2023.

---

	P0809-4-PM2. The efforts which decreases a fall, a fall by night of elderly people 伊藤真也, 古澤明朋, 浅井和浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1845-1845, 2023.

---

	P0810-4-PM1. Construction of the medicine confirmation system targeted for discontinuation before operation of the patients participation type 鈴木洋平1, 清水佐良子1, 田辺美恵1, 曽根敦子1, 丸谷善紀2, 鈴木優司2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1846-1846, 2023.

---

	P0811-4-PM2. The effect that the change of the test value reporting style gives to tracing report contents on outside Parliament prescription 元木貴大1, 住吉健太1, 水岡大策1, 新村航1, 松原亜季1, 川北智子1, 越野優希2,3, 山口佳津騎4, 田中裕章1, 小坂信二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1847-1847, 2023.

---

	P0812-4-PM1. Investigation, examination about the GS1 cord indication point for effectively utilizing it of the medicine collation system 後藤総太郎1,2, 濱村有那1, 瀬尾桃子1, 勝野美沙1, 池田香菜子1, 小山内美音1, 諸井良江1, 平野明穂1, 関田彩1, 浅羽遼1, 肥沼理映子1, 山村康比古1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1848-1848, 2023.

---

	P0813-4-PM2. The evaluation of the joint ownership method of the incident that occurred by lack of knowledge: The effect that a notice making up for basic knowledge gives for incident occurrence 小山なつの, 安島秀友, 松崎貴志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1849-1849, 2023.

---

	P0814-4-PM1. Investigation of the patients identification precision by the difference in identifier to put together in patients full name 大久保淳史1, 立沢正臣1, 今村克美2, 下泰司3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1850-1850, 2023.

---

	P0815-4-PM2. The work environment improvement by the 5S activity in the injection department, improvement in effectiveness and review of the stock article 鈴木莉羅, 岩崎加奈子, 杉崎崇人, 中村匡志, 名和亜利沙, 平松亜依, 三木真梨杏, 渡部秀一, 青山剛, 蓑輪雄一, 清水久範, 山口正和 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1851-1851, 2023.

---

	P0816-4-PM1. About the study implementation situation about HBV reactivation measures in our hospital 吉藤和也, 森岡沙織, 後藤志典, 山崎博子, 赤崎淳子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1852-1852, 2023.

---

	P0817-4-PM2. Development of the medication jelly kit for the purpose of relief, security, the simple and easy medication 盛本修司, 川崎浩延, 林茂雄, 澤田拓磨, Adam Jakob Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1853-1853, 2023.

---

	P0818-4-PM1. Extraction of the preventive measures by the incident report analysis 千葉慧1,2, 熊谷学1, 伊藤充子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1854-1854, 2023.

---

	P0819-4-PM2. Efforts for the increase of the incident report submission number in the drug department of our hospital 伊藤実優1, 横田学1, 吉川直利1, 東野斉恵2, 土川由美子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1855-1855, 2023.

---

	P0820-4-PM1. Introduction of the formula reeducational program in the business training of the Kitasato University Hospital 岩澤真紀子1, 春日井公美1, 菅原充広1, 尾鳥勝也1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1858-1858, 2023.

---

	P0821-4-PM2. Examination of the education effect to a pharmacy student for the active prescription suggestion in the Tokushima University Hospital 高橋志門1,2, 相澤風花1,2, 八木健太2,3, 濱野裕章4, 神田将哉1,2, 近藤正輝1,2, 座間味義人4, 新村貴博2,3, 櫻田巧1,2, 桐野靖1,2, 合田光寛1,2, 石澤啓介1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1859-1859, 2023.

---

	P0822-4-PM1. Examination of the usefulness of e-Learning by the dentist for the improvement of knowledge and the consciousness about oral mucositis of the pharmacist in the cancer chemotherapy 星野直人1, 吉田謙介1, 矢吹剛2, 多川洋史1, 古賀雅良1, 鈴木直人1, 貝瀬眞由美3, 外山聡1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1860-1860, 2023.

---

	P0823-4-PM2. Contents construction and evaluation of the disaster pharmacy training 横田敬之, 鈴木善樹, 栗原弘紀, 新井優, 貝嶋亮, 石川章, 小泉盛, 眞壁秀樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1861-1861, 2023.

---

	P0824-4-PM1. Evaluation of the consciousness change of the pharmacy school business trainee before and after our hospital business training program enforcement 梅内実穂1,2,3, 小林美奈子1, 阿部憲介2, 木皿重樹3, 内藤義博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1862-1862, 2023.

---

	P0825-4-PM2. Efforts of the securing of continuous human resources of the hospital pharmacist for the improvement of the pharmacist unevenly distributed 田村亮1, 鎌田里紗1, 平野達也2, 藤井尚子1, 木下恵1, 山岡健太1, 奥吉博之2, 新免紗也1, 杉山峰是1, 東山将己3, 橋田亨1, 室井延之1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1863-1863, 2023.

---

	P0826-4-PM1. Production of the scenario program to support to goal setting ending in failure return marks about physical assessment from the communication with patients 徳永仁1, 緒方恵梨奈1, 岡部愛実1, 尾中宏彰1, 園田純一郎1, 橋本亜衣子1, 緒方賢次2, 興梠靖幸2, 岸本真1,3, 高村徳人2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1864-1864, 2023.

---

	P0827-4-PM2. Effect of the simulation training in the pharmacist 大塚さほり1,2, 有賀敦1, 三澤貴美1, 田中健二1, 瀧沢康裕2, 竹内千景2, 渡辺剛2, 藤森茂晴2, 堀勝幸3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1865-1865, 2023.

---

	P0828-4-PM1. Construction of the student independent participation type hospital business training and investigation of the training satisfaction 橋本竜1,2, 佐藤淳也3, 近江一太1, 玉井一也1, 宮内輝人1, 吉成宏顕1, 久保倫美1, 入野真紀1, 梅田鈴香1, 守田侑真1, 風岡真実1, 大矢智則1,2, 神坐美弥子1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1866-1866, 2023.

---

	P0829-4-PM2. Attitude survey for the carrier vision of the hospital pharmacist 河添仁1, 土屋雅美2, 藤堂真紀3, 原梓4, 大西友美子5, 堀里子6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1867-1867, 2023.

---

	P0830-4-PM1. Examination of the factor to improve the evaluation of achievement of the trainee at the end of the business training 石川春樹1,2, 河添仁1, 岩田紘樹1, 中村友紀1, 地引綾1, 横山雄太1, 小林典子1, 鈴木小夜1, 山浦克典1, 中村智徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1868-1868, 2023.

---

	P0831-4-PM2. Evaluation of online, the practical hybrid training in our hospital judging from the questionnaire results of the pharmacy student 石橋正祥, 飯村洋平, 黒田誠一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1869-1869, 2023.

---

	P0832-4-PM1. Evaluation of the physical assessment practical examination using the simulator for pharmacology fifth graders 緒方賢次1, 高村徳人1, 興梠靖幸1, 園田純一郎2, 徳永仁2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1870-1870, 2023.

---

	P0833-4-PM2. Qualitative study of the I method learning method in development and the National Examination for Pharmacist of the pass probability calculation technique using the I method learning method CHAEHYEOK LEE, 川島裕也, 久保田洋子, 今井信行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1871-1871, 2023.

---

	P0834-4-PM1. It is ... mainly on the formulations section duties using construction and evaluation - PDCA cycle of the new face pharmacist training system by the education training team 小林義政, 三輪奈津貴, 鵜飼一歩, 山里久子, 高木裕介, 牧原明秀, 高原悠子, 鈴木雅人, 榊原恵子, 今井視保子, 葛谷真理, 高木祥子, 吉田弘樹, 今高多佳子, 木全司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1872-1872, 2023.

---

	P0835-4-PM2. Qualitative investigation of the psychology for the research activities of the drugstore pharmacist 田中みのり, 竹平理恵子, 盛岡正博, 有田悦子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1873-1873, 2023.

---

	P0836-4-PM1. Attitude survey about the thought to the study that the pharmacy school life captures 川見麗菜, 竹平理恵子, 盛岡正博, 有田悦子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1874-1874, 2023.

---

	P0837-4-PM2. Evaluation of the hospital business training program using text mining 西村美馨子1, 鎌田理紗子1, 斎藤祥子1, 立花京香1, 榎本晶帆2, 櫻井まりこ1, 白木小百合1, 河野太治1, 金森香澄1, 山本真椰1, 横山裕紀2, 水谷清香1, 長戸大空2, 吉田加代1, 越野明花1, 松本美緒1, 竹尾恵理子1, 酒井欣嗣2, 千崎康司1, 伊藤功治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1875-1875, 2023.

---

	P0838-4-PM1. Investigation about the effect of the new coronavirus infection on "relation" and "medication counseling" number of 8 representative diseases in a hospital, the drugstore business training 西川陽介1,2, 佐藤祥子2, 及川淳子2, 工藤香澄2, 我妻恭行2, 小嶋文良1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1876-1876, 2023.

---

	P0839-4-PM2. Efforts (online visit, online seminar) to securing of staff of the hospital pharmacist in the district and the effect 丸山真理子, 井上知哉, 原田周平, 隈部法子, 宮上桐豪, 大久保翔, 藤田靖之, 池田能利子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1877-1877, 2023.

---

	P0840-4-PM1. Efforts of the participation type workshop enforcement that incorporated the Small group discussion by the multicenter young person pharmacist workshop 外石昇1, 林太佑8,10, 安武夫4,10, 鶴岡翔太5,10, 津田泰正6,10, 原田大2,10, 齋藤雅俊7,10, 堀井剛史9,10, 黒田誠一郎3,10, 川久保孝2,10 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1879-1879, 2023.

---

	P0841-4-PM2. Investigation of the factor associated with the evaluation of the member of society basic skills in the clinical pharmacist 土屋裕伴, 塚田昌樹, 中里健志, 新井亘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1880-1880, 2023.

---

	P0842-4-PM1. Making of the pattern language about the research activities in clinical settings for the purpose of the improvement in ability for study of the pharmacist 渡邉慶剛1, 酒井隆全2, 大津史子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1881-1881, 2023.

---

	P0843-4-PM2. Investigation of the course determinant after the pharmacist resident completion 齋藤千夏1, 枦秀樹2, 井上正久3, 榎本貴一4, 鈴木慶介1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1882-1882, 2023.

---

	P0844-4-PM1. New face pharmacist education utilizing the extra edition number of the medicine-based monthly 垣内祥宏, 緑川拓也, 渥美弘美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1883-1883, 2023.

---

	P0845-4-PM2. Problem - after the construction (the fourth report) - clinical ladder operational start of the hospital pharmacist staff education system 小山郁美1, 稲野寛1, 婦川貴博2, 山本悠樹2, 坂倉智子1, 尾鳥勝也1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1884-1884, 2023.

---

	P0846-4-PM1. Scoping review about the case conference by the healthcare worker 板井進悟1,9, 荒木隆一2,9, 上塚朋子3,9, 長谷川裕矢4,9, 間瀬広樹5,9, 宮脇未来6,9, 矢吹拓7,9, 矢野良一8,9 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1885-1885, 2023.

---

	P0847-4-PM1. Examination about the bar code indication to ethical drug aluminum pillow packing 吉田真也, 宇佐美英績, 木村美智男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1888-1888, 2023.

---

	P0848-4-PM2. Intervention of the pharmacist in the living renal transplantation start 江橋優香1, 小室治孝1, 望月拓2, 喜古康博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1889-1889, 2023.

---

	P0849-4-PM1. Duties efficiency of the hospital pharmacist by the hospital DX promotion using SNS for duties in the HITO MEDICAL CENTER 田中成枝1, 村山公一2, 近藤祥代1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1890-1890, 2023.

---

	P0850-4-PM2. Efforts of our hospital about the perioperative pharmacy management 小島香織, 佃優里, 宮里裕子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1891-1891, 2023.

---

	P0851-4-PM1. Contribution of the pharmacist in the postoperative pain management team 鈴木寿樹1, 田中里奈1, 森下啓1, 本間舞子2, 杉野繁一2, 滝沢香菜3, 高野淳2, 矢吹志津葉2, 鈴木潤2, 松浦正樹1, 眞野成康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1892-1892, 2023.

---

	P0852-4-PM2. Polypharmacy measures in the care health center for the elderly 白髪恵美1, 西岡陽子3, 石川真理2, 近藤祥代1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1893-1893, 2023.

---

	P0853-4-PM1. Fact-finding before and after the protocol operational start of the inquiry simplification in the outside Parliament prescription 長田知子, 村上知奈美, 大西政典, 松浦里穂, 松村恵理奈, 盛重あずさ, 池田咲樹, 先崎健造, 岸井加代子, 関恭子, 土佐直子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1894-1894, 2023.

---

	P0854-4-PM2. Qualitative study - based on a problem in the medical care that the LGBTQ person concerned faces and the interview to real - person concerned of the consideration 駒井優実1, 松下綾1, 宮野康央1, 安原智久2, 永田実沙3, 上田昌宏4, 串畑太郎4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1895-1895, 2023.

---

	P0855-4-PM1. Japan and France comparison about the steady supply measure of pharmaceutical products 山田治美1, 加藤芳徳1,2, 平尾卓也1, 手塚千裕1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1896-1896, 2023.

---

	P0856-4-PM2. Examination of the pharmaceutical intervention investigation of the pharmacist in our hospital and the medical economical evaluation 小園亜希, 馬場結子, 松藤敬佑, 宮田拓周, 平池美香子, 齋藤巨樹, 湊本康則 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1897-1897, 2023.

---

	P0857-4-PM1. Inspection of medical expenses reduction effect of the treatment at home on hospitalization medical care and the improvement in patients quality of life effect 富田悠紀1, 伊東佳美2, 坂東勉2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1898-1898, 2023.

---

	P0858-4-PM2. Factor associated with the atrophy degree of the stomach of the helicobacter pylori sanitization patients with the drinking custom 尾関佳代子, 羽田和弘, 脇屋義文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1899-1899, 2023.

---

	P0859-4-PM1. Efforts of the osteoporotic liaison team in patients with proximal thighbone bone fracture 田村安希1, 岡崎英子1, 畑賢俊2, 森田桂子2, 恩藤友希3, 小西池泰三4, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1900-1900, 2023.

---

	P0860-4-PM2. Efforts and result to securing of pharmacist in the Handa City solder hospital 横田学, 板倉由縁 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1901-1901, 2023.

---

	P0861-4-PM1. The furtherance system to support a project for the purpose of the promotion of the acquisition of the medical pharmacy knowledge and the medical cooperation 高木利之, 宝達寛子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1902-1902, 2023.

---

	P0862-4-PM2. Examination - based on factor - questionary survey to promote the research activities situation and the research activities of the pharmacist 瀧川正紀1, 近藤悠希2, 小林豊3, 飯干茜3,4, 木下雅子1, 石塚洋一2, 増田雅行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1903-1903, 2023.

---

	P0863-4-PM1. Questionnaire findings report about the career path of the pharmacist for people of Japanese cure association withdrawal 安原眞人1, 安藤崇仁1, 宮崎長一郎2, 山本康次郎3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1904-1904, 2023.

---

	P0864-4-PM2. Remedy - of the workplace thinking about how you improve the hospital pharmacist's experience value from - Employee Journey Mapping 榎本貴一1, 岩崎未久1, 小林可奈1, 加藤彩絵1, 八尋彩夏1, 萩原卓也1, 舘林和樹1, 山下徳一郎1, 宮内英里1, 木村泰2, 小坂鎮太郎3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1905-1905, 2023.

---

	P0865-4-PM1. The effect on collect rate that silicone oil at simple suspension method enforcement and temperature give and relations of the physicochemical nature 長崎裕也1, 友田吉則1,2, 宮坂優人1, 小松敏彰1, 春日井公美1,3, 尾鳥勝也1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1906-1906, 2023.

---

	P0866-4-PM2. Comparison of a color and the quantity of fixed-quantity indicator ingredient decoction of the roasting liquid by the difference in extraction in the Daiokanzoto 瓜生津智穂, 天池菜都実, 佐藤純令, 津江南瑠海, 成橋和正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1907-1907, 2023.

---

	P0867-4-PM1. Comparison between color and quantity of fixed-quantity indicator ingredient decoction of the roasting liquid by the difference in extraction method in the Maoto 野本衣那, 園部深央里, 瓜生津智穂, 向美麗, 成橋和正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1908-1908, 2023.

---

	P0868-4-PM2. Comparison of a color and the quantity of fixed-quantity indicator ingredient decoction of the roasting liquid by the difference in extraction in the Orengedokuto 園部深央里, 野本衣那, 瓜生津智穂, 向美麗, 成橋和正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1909-1909, 2023.

---

	P0869-4-PM1. Comparison between color and fixed-quantity indicator ingredient of the roasting liquid by the difference in extraction method in the Shakuyakukanzoto 向美麗, 白石かれん, 瓜生津智穂, 野本衣那, 園部深央里, 成橋和正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1910-1910, 2023.

---

	P0870-4-PM2. Survey about the approach to securing of human resources using a homepage 大成政揮1, 園部祐太1, 豊永風音1, 松原栄治1, 松本善江1, 松下香織1, 小野雅文1, 伊丹元治1, 長嶋一泰2, 松本哲哉1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1911-1911, 2023.

---

	P0871-4-PM1. Activity report of the delirium measures in the dementia care team 瓦侑馬1, 中野美佐2, 福田祥世3, 齋籐健治4, 勝浦正人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1912-1912, 2023.

---

	P0872-5-PM. Inspection of the tracing report utilization example to the patients with the bleeding risk factor during edoxaban remedy 大野伴和, 市川学, 輪島圭二, 松本健春 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1915-1915, 2023.

---

	P0873-5-PM. The effect that the introduction of the prophylaxis protocol in the PONV technique and the intervention by the pharmacist give to PONV incidence 佐藤浩太郎, 高橋希, 近藤真理, 梶野哲, 鈴木信也, 井口恵美子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1916-1916, 2023.

---

	P0874-5-PM. Fact-finding of the common use medicine grasp means of the pharmacist in the emergency visit 岩崎睦, 宮田祐一, 鬼村紀子, 宮下栞, 大村史, 中村雅敏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1917-1917, 2023.

---

	P0875-5-PM. Efforts of the pharmacist in the perioperative discontinuation management 田杭直哉, 吉田真人, 小西健太郎, 徳丸翔大, 源平麻衣, 近藤匡慶, 菅谷量俊, 高瀬久光 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1918-1918, 2023.

---

	P0876-5-PM. Efforts of the medical office pharmacist outpatient department and future problem 坂啓子, 島崎亮司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1919-1919, 2023.

---

	P0877-5-PM. Examination of the usefulness of the pharmacist outpatient department for the task shift in the ambulatory practice of patients with rheumatic disease 野本敦文1, 笹川永里子1, 徳留雄太1, 武井優輝1, 新井理沙1, 川島瑞生1, 三宅優子1, 浅木知子1, 土屋雅勇1, 光永義治1, 渡部多真紀1,2, 安野伸浩1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1920-1920, 2023.

---

	P0878-5-PM. The need of the reevaluation in the inhalation therapy 川村大輔, 久岡清子, 増田博也, 佐々木健志, 大荒政志, 間千晴, 鹿沼奈央, 木原稔文, 坪田美風, 山崎佳奈 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1921-1921, 2023.

---

	P0879-5-PM. Is going to perform operations in our hospital; efforts for a relation and the efficiency of the prehospital pharmacist for the patients 中村孝佑, 船隠恵子, 野村直幸, 森泰子, 高橋洋子, 田村浩二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1922-1922, 2023.

---

	P0880-5-PM. About the current situation of a setup and the operation of the pharmacist outpatient department 村上仁志, 原田哲彦, 坂野博紀, 白井景 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1923-1923, 2023.

---

	P0881-5-PM. Evaluation of the continuous follow-up system for the oral anticancer agent remedy patients through the pharmacist outpatient department 北出紘規, 宮永和美, 西野正義 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1924-1924, 2023.

---

	P0882-5-PM. Intervention effect of the pharmacist outpatient department on regorafenib remedy patients 山崎将英, 深田英嗣, 藤居賢, 福土将秀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1925-1925, 2023.

---

	P0883-5-PM. Medication real-time monitoring system construction of the oral anticancer medicine 川上和宜1,2,3, 小林一男1, 清水久範1, 横川貴志1, 鈴木一洋2, 森祐佳1, 鈴木亘1, 柴田直樹1, 中井恵子3, 竹内資和3, 安藤井達3, 山口正和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1926-1926, 2023.

---

	P0884-5-PM. Patients safety management by the outside Parliament prescription inspection containing the oral anticancer medicine 木村祐子1, 徳永愛美1, 市村丈典1, 縄田修一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1927-1927, 2023.

---

	P0885-5-PM. Analysis of pharmacist duties in the kidney transplantation outpatient department 富島喜朗, 陣上祥子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1928-1928, 2023.

---

	P0886-5-PM. The effect that childcare experience gives to the medication counseling of children in the drugstore pharmacist 寺山香織, 内藤友博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1929-1929, 2023.

---

	P0887-5-PM. An iron deficiency evaluation for the purpose of the thromboembolism prophylaxis of the HIF-PH inhibitor in the circulatory organ special hospital and intervention to iron replacement therapy 戸口拓弥1, 加藤瑞季1, 谷田拓也1, 高橋義弥1, 飯坂美香1, 丸山俊夫1, 野々山由香理1, 櫻井正之2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1930-1930, 2023.

---

	P0888-5-PM. Efforts of the family pharmacist concerned with medical care children 石原直子, 田端康幸, 丹羽直人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1931-1931, 2023.

---

	P0889-5-PM. Efforts to foreign introduction of the preparation for the amikacin sulfate inhalation 井上潤子, 原太一, 形部文寛, 佐々木文子, 井筒理子, 幸原美奈子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1932-1932, 2023.

---

	P0890-5-PM. Investigation about cooperation with the health insurance pharmacy in the support before hospitalization 山田あかね1, 廣江訓子1, 猪田宏美1, 牛尾聡一郎2, 鍛治園誠1, 座間味義人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1933-1933, 2023.

---

	P0891-5-PM. The measures to the surgery postponement example with the drug started after the confirmation of common use medicine before hospitalization and the usefulness 合原嘉伸1,2, 緒方健二1, 祖川倫太郎1, 湯川美紗子1, 加茂真宏1, 江本晶子1, 木村早希子1, 吉田ひとみ2, 江崎幹宏2, 島ノ江千里1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1934-1934, 2023.

---

	P0892-5-PM. Fact-finding after the doubt inquiry protocol operation 増田成美1, 池田愛1, 橋詰宏美1, 瀬戸口由1, 吉川三保子1, 池上良一1, 古川順章2, 田路章博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1935-1935, 2023.

---

	P0893-5-PM. Construction of the cooperation system between a hospital, the drugstores using the oral anticancer agent initial information exchange book in foreign oral cancer treatment 神原康佑, 岡田淳芳, 中村豪志, 石井一也, 大塚識稔 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1936-1936, 2023.

---

	P0894-5-PM. The case that the cooperation of ward - outpatient department pharmacist was important at a care shift 坪田美風, 大荒政志, 青柿和樹, 山崎佳奈, 松浦克樹, 増田博也, 久岡清子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1937-1937, 2023.

---

	P0895-5-PM. Effect of the on admission interview introduction in our hospital 山本彩加, 細野真吾, 見尾谷昇, 磯野礼果, 堀浩子, 山崎崇 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1939-1939, 2023.

---

	P0896-5-PM. It is the review of effectively utilizing it and ward drug duties the bringing medicine under the pharmaceutical products distribution restrictions 内田朱美, 秀徳優美, 北窓正孝, 續政哉 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1940-1940, 2023.

---

	P0897-5-PM. Efforts for the efficiency of bringing medicine differentiation duties using a database 吉田裕生, 佐澤卓哉, 上之将明, 加世田良一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1941-1941, 2023.

---

	P0898-5-PM. Experience the case that made adequate from adequacy - tacrolimus normal preparation of the medical therapy by the pharmaceutical evaluation at the bringing medicine's confirmation to a slow-release preparation; and ... 佐藤洸1, 高濱和弘1, 武田泰生1,2, 寺薗英之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1942-1942, 2023.

---

	P0899-5-PM. The "Yojokun" of the nonprescription drug package insert mention situation investigation 中村仁, 金野太亮, 鈴木裕之, 村井ユリ子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1944-1944, 2023.

---

	P0900-5-PM. Qualitative investigation about the will to the pharmacist consultation in the drugstore 野口奈桜, 竹平理恵子, 盛岡正博, 有田悦子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1945-1945, 2023.

---

	P0901-5-PM. Efforts of the active intervention in a nonprescription drug and the health food consultation for the purpose of the healthy support function enhancement 河田英之, 石尾みほ, 今城慶子, 三牧由依, 高橋絵梨香, 佐々木美佳, 中西友里, 福田久子, 安倉央, 高橋正志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1946-1946, 2023.

---

	P0902-5-PM. Analysis of the drugstore potentially serious medical errors example for proper use promotion in nonprescription drugs, and the like 長谷川浩三1,2,3, 稲葉一郎2, 門脇大介3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1947-1947, 2023.

---

	P0903-5-PM. The situation investigation of efforts and the tracing report to the cooperation full addition acquisition in foreign cancer chemotherapy patients 水口敦子, 宮川貴行, 永井良, 井筒理子, 安達俊江, 形部文寛, 原太一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1951-1951, 2023.

---

	P0904-5-PM. Change of the drug instruction time in the pharmacist accompanied with the diversification of the cancer chemotherapy regimen 本間崇正, 鳥居昌太, 武部幸江, 江崎秀樹, 榊原隆志, 滝本典夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1952-1952, 2023.

---

	P0905-5-PM. HADS to patients with patients evaluation - breast cancer for the interview opportunity addition of the medication support in the initial cancer chemotherapy and inventory survey ... 治田匡平, 木村錦子, 村田政軌, 池田和之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1953-1953, 2023.

---

	P0906-5-PM. Efforts about the reporting (tracing report) to the medical institution for hormonal therapies patients 林広成1, 山岸潔子1, 田中亜弥1, 奥田好香1, 米本眞里1, 増田直樹2, 高村康2, 阿部康治2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1954-1954, 2023.

---

	P0907-5-PM. It is the inspection of the intervention effect by follow and the tool utilization after the medication for patients with cancer treated with various regimens 石田潤一郎1, 野嶋芳紀1, 齋藤聡夫1, 松尾宗一郎1, 邑瀬誠1, 深津英人2, 松井洸2, 阿部真也2, 山口浩2, 野村和彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1955-1955, 2023.

---

	P0908-5-PM. Efforts of the pharmacist associated with foreign tumor chemotherapy practice charges in our hospital 糸満盛尚, 川上博瀬, 村田利恵子, 前泊美保, 知念里佳, 松島亜紀, 島袋優花, 本村恵, 大城将吾, 大城優衣, 浜元善仁 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1956-1956, 2023.

---

	P0909-5-PM. Standardization of the information on adverse drug reactions offer to the hospital in the telephone follow-up for the specific drug management instruction addition 2 calculation patients 汐待加織1, 佐藤絵美1, 小野寺香里1, 高崎隼颯1, 江藤陸1, 西山実菜1, 渡辺涼2, 吉田恭子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1957-1957, 2023.

---

	P0910-5-PM. Why can anamorelin not continue; actual situation ... of the anamorelin administration in ... our hospital 齊藤直美, 赤城佳奈 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1958-1958, 2023.

---

	P0911-5-PM. A case which developed a serious mental disorder by Lorlatinib 田中佐季1, 西馬怜1, 竹田健志1, 國政啓2, 高木麻里1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1959-1959, 2023.

---

	P0912-5-PM. A case which was able to contribute to appropriate treatment by the cooperation with the hospital for patients with renal cell carcinoma of the Lenvatinib + Pembrolizumab combination therapy enforcement 西川育子1, 平田崇代1, 宮崎恵1, 鈴木泰帆1, 森田渚映子1, 早川太朗2, 高井佳江1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1960-1960, 2023.

---

	P0913-5-PM. The limit of the side effect of telephone follow-up evaluation: One case that presented cutaneous symptom during Cabozantinib administration 田村知子1,2, 吉岡睦展2, 高子優子2, 近藤万友美2, 澁谷奈穂2, 細見真世2, 若松雄太2, 狩野佑実1, 小溝優子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1961-1961, 2023.

---

	P0914-5-PM. How to share information and collaborate with newly registered RevMate clinics and affiliated hospitals 鈴木善貴1,2,3,4, 橋本雅子2, 坂野博紀2, 中西慶子2, 倉橋信悟3, 杉浦勇4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1962-1962, 2023.

---

	P0915-5-PM. What Pharmacists Can Do: A Case of HER2-Positive Breast Cancer 菅原茂樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1963-1963, 2023.

---

	P0916-5-PM. The medication follow-up in the chemotherapy enforcement patients, the examination of the factor that is easy to lead to the sending of the tracing report and analysis of sending contents 田中秀幸1, 羽賀真里子1, 西田浩平1, 野村由貴1,3, 玉木啓文2, 井口和弘2,3, 加藤寛子4, 鈴木昭夫4, 佐口弥3,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1964-1964, 2023.

---

	P0917-5-PM. The one instance case that a drugstore pharmacist was able to intervene in the breast cancer supportive care of adherence delinquent patients appropriately 正木研1, 本田雅志2, 下川友香理2, 中村泰朗3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1965-1965, 2023.

---

	P0918-5-PM. Intervention effect to the polypharmacy by the pharmacist on patients with foreign cancer 八木貴彦, 平野公美, 森田奈々, 大和千穂, 外山未来, 中村拓哉, 野木村藍, 宮本康敬, 川口千香 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1966-1966, 2023.

---

	P0919-5-PM. A case which was able to intervene in prescription adequacy for patients during hormonal therapies after the postmenopausal breast cancer technique as a specialized medical institution cooperation drugstore pharmacist 荒井元志1, 原田剛光1, 本田雅志2, 下川友香理2, 石原孝2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1967-1967, 2023.

---

	P0920-5-PM. About the efforts to an immune-mediated adverse event in the use of immune checkpoint inhibitor 石黒友希1, 鈴木敦詞1, 竹内健悟1, 鈴木大吾1, 中村敏史1, 田中伸明1, 坂田洋1, 服部芳明2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1968-1968, 2023.

---

	P0921-5-PM. 2 cases that the telephone follow-up to patients with breast cancer by the health insurance pharmacy pharmacist was useful as a support of the heart 中村俊貴1,2, 爲我井一統1, 坂本岳志1, 境美智順1, 木村雅彦1, 平山武司2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1969-1969, 2023.

---

	P0922-5-PM. Contents investigation ... of role - tracing report of the specialized medical institution cooperation drugstore for foreign cancer chemotherapy patients 和田憲周, 山本侑記, 田中亜優実, 和田恵理, 林智子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1970-1970, 2023.

---

	P0923-5-PM. The cooperation full addition in the foreign cancer chemotherapy of our hospital and the current situation and problem of the medicine medicine cooperation 高橋久樹, 柴田勝弥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1971-1971, 2023.

---

	P0924-5-PM. A case of the therapy with cisplatin and radiation exposure for the locally invasive bladder cancer of the low renal function patients 竹原涼子, 向井淳治, 坂本竜平, 小竹優希, 叶真央, 山田佳菜子, 奥田広志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1972-1972, 2023.

---

	P0925-5-PM. One case that intervened in the anticancer agent internal use patients by a tracing report 小林竜也1, 大野真之1, 阿部康治2, 高村康2, 増田直樹2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1973-1973, 2023.

---

	P0926-5-PM. Relation with specific drug management instruction addition 2 patients with cancer to think about from the current situation of calculating it 玉田麻利子1, 中村文哉2, 松井洸3, 阿部真也3, 山口浩3, 野村和彦3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1974-1974, 2023.

---

	P0927-5-PM. The relation with a drugstore pharmacist and patients with cancer: One case of patients receiving Abemaciclib tablets 森下敦彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1975-1975, 2023.

---

	P0928-5-PM. Fact-finding of the telephone follow-up in the hospitalization chemotherapy 廣岡賢輔, 山下奈津子, 櫻井有紀, 清水浩幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1976-1976, 2023.

---

	P0929-5-PM. Development of pharmacists who can play an active role in interpersonal work and possibilities in the oncology field based on pre-avoidance reports 大森義朗, 川幹子, 松田泰子, 石光一幾, 菅香理, 佐藤真也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1977-1977, 2023.

---

	P0930-5-PM. To contribute as follow-up - specialty medical institution cooperation drugstore to make up for the difference of the staff of drugstore for the chemotherapy; ... 安斎沙織 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1978-1978, 2023.

---

	P0931-5-PM. Examination about the effect that the cooperation full addition gives in instruction duties and the tracing report of the health insurance pharmacy 大野謙太朗, 佐々木良, 遠藤征裕, 齋藤雅隆 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1979-1979, 2023.

---

	P0932-5-PM. The holding of the cooperation enhancement addition web workshop for outside Parliament drugstore pharmacists and future problem 中野友寛1, 末廣拓1, 十亀將輝1, 宇都本孝夫1, 和田伊代1, 新居田能章1, 村井望1, 越智啓介1, 松岡葉子1, 西畑友尋1, 玉井宏一1, 烏谷政和1, 倉田知久1, 渡部早苗2, 山下広恵3, 武田千津3, 井上考司4, 森高智典4, 中西徳彦4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1980-1980, 2023.

---

	P0933-5-PM. Efforts to cooperation full addition calculation in our hospital and future problem 十亀將輝1, 末廣拓1, 中野友寛1, 宇都本孝夫1, 和田伊代1, 新居田能章1, 村井望1, 越智啓介1, 松岡葉子1, 西畑友尋1, 玉井宏一1, 烏谷政和1, 倉田知久1, 渡部早苗2, 山下広恵3, 武田千津3, 井上考司4, 森高智典4, 中西徳彦4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1981-1981, 2023.

---

	P0934-5-PM. Examination about the need of the pharmacist intervention for the oral anticancer agent medication patients in the outpatient department 和田依子, 樋口美奈子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1982-1982, 2023.

---

	P0935-5-PM. Evaluation after the cancer tracing report operational start using the Google form 佐藤奈実, 今田良樹, 吉田崇志, 眞木秀子, 西村雅次, 羽太光範 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1983-1983, 2023.

---

	P0936-5-PM. The current situation and problem of the cooperation full addition in our hospital 高濱啓太1, 中村郁勝1, 山田充宏1, 大佐古智文2, 中野正啓2, 藤末真実子2, 宮本浩子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1984-1984, 2023.

---

	P0937-5-PM. Survey on the occurrence of neuropsychiatric adverse events associated with the initiation of cabotegravir + rilpivirine and analysis using POMS 合原嘉寿1, 大橋邦央1,2, 橋本雅司1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1986-1986, 2023.

---

	P0938-5-PM. Consideration, the operation of the tracing report specialized in the HIV domain aiming at illness medicine cooperation reinforcement and the evaluation 住吉健太1, 水岡大策1, 新村航1, 松原亜季1, 川北智子1, 山口佳津騎2, 元木貴大1, 田中裕章1, 小坂信二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1987-1987, 2023.

---

	P0939-5-PM. 1 case of dialysis patients with HIV infection that we introduced 大道淳二1, 出宮千聖1, 宮下雄博2, 蒲生直幸3, 細川忍4, 佐久川亮4, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1988-1988, 2023.

---

	P0940-5-PM. Examination of the division supply method for the at-home management of the domestic nonrecognition ω 3 system lipid microsphere 瀬戸口誠1, 武藤充2, 福岡龍一3, 有馬純子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1990-1990, 2023.

---

	P0941-5-PM. Efforts to drug proper use using nourishment metrics 石井照樹1,2,3,4, 森黒唯1, 大嶋成奈優1, 沖廣絵里子1, 高橋公子1, 石原瑛太郎1, 篠永浩1, 加地努1, 石山晃子2, 中津守人3, 矢野禎浩4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1991-1991, 2023.

---

	P0942-5-PM. The case that an undernourished patient with the poor intestinal absorption was given infliximab, and was improved 田中恭人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1992-1992, 2023.

---

	P0943-5-PM. A case in which preventive intervention for refeeding syndrome in a severely underweight patient with a BMI of 10.8 led to early improvement in cardiac function 眞野裕1, 迫田弘基2, 石田茂伸1, 多胡友絵1, 徳元一樹3, 星育子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1993-1993, 2023.

---

	P0944-5-PM. Examination of the use situation investigation of the anamorelin hydrochloride in our hospital and the effect 中川こはる, 中嶋丈晴 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1994-1994, 2023.

---

	P0945-5-PM. Survey on the actual use of Kidmin after the package insert was revised 上田真隆, 濱崎淳哉, 裏山悠哉, 村高紫野, 奥田広志, 向井淳治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1995-1995, 2023.

---

	P0946-5-PM. A study on the ENORAS in serum potassium levels after taking Inolas combined enteral liquid 筒井千晴1, 横山千紘1, 川邊一寛1, 松本真琴1, 岡村央2, 小森智也1, 小池博文1, 佐橋幸子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1996-1996, 2023.

---

	P0947-5-PM. Examination of the factor affecting the rise in serum zinc levels of patients on dialysis 細野真吾, 見尾谷昇, 堀浩子, 磯野礼果, 細野亜由美, 早野いずみ, 倉橋実希, 山崎崇 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1997-1997, 2023.

---

	P0948-5-PM. Investigation of the effect that a gastric-acid secretion antagonist gives to a diarrhea improvement effect of the pectin-containing digestion state nutrient preparation 小野達昌, 渡邊瑛理, 陣上祥子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1998-1998, 2023.

---

	P0949-5-PM. Examination of the effect that COVID-19 gives to the frailty of elderly people 近藤宏樹1,2, 篠永浩1,2, 加地努1,2, 矢野禎浩2, 和泉和子3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1999-1999, 2023.

---

	P0950-5-PM. Research for a pharmacist to receive smooth team approach in medical care by NST, pressure sore team 陣内智美1, 宮崎美子2, 吾妻隼斗1, 村田秋緒1, 安齋七生1, 志田貴彦3, 鈴木智4, 濃沼政美4,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2000-2000, 2023.

---

	P0951-5-PM. A case that Teduglutide accepted improvement of the nutritional status by administration for patients with advanced age short bowel syndrome three times a week 大平サラ1, 木村純子1, 白石童子1, 黒川友博2, 酒井敏直1, 鈴木悠里1, 早乙女彩子3, 竹下光弘3, 早乙女浩之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2001-2001, 2023.

---

	P0952-5-PM. Attempt of the benzodiazepine receptor agonist decrease medicine using the support sheet in the psychiatry outpatient department 進健司, 森高啓太, 梅田勇一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2004-2004, 2023.

---

	P0953-5-PM. Effect of the pharmaceutical support by the pharmacist interview before medical examination in the psychiatry outpatient department 森高啓太, 進健司, 梅田勇一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2005-2005, 2023.

---

	P0954-5-PM. Efforts - of the sleeplessness instructions adequacy about activity report - delirium measures of the patients support team in our hospital 濱田昌志1, 字廻祐輔1, 金田好弘2, 志方敏幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2006-2006, 2023.

---

	P0955-5-PM. Intention investigation for the blonanserin patch in patients with ambulatory schizophrenia 土田さおり, 松本早苗, 山本和幸, 五味和彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2007-2007, 2023.

---

	P0956-5-PM. Survey and consideration of lurasidone use for schizophrenia in our hospital 松村俊希, 石川章, 水村亮介, 須貝昌平, 真壁秀樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2008-2008, 2023.

---

	P0957-5-PM. A report of the use of the sleeplessness use drug of the inpatient and participation of the delirium care team 小倉弥生1, 望月温子2, 上原香織3, 石山真3, 大木孝夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2009-2009, 2023.

---

	P0958-5-PM. The investigation of the sleeping drug in the bringing medicine of the Suwa Red Cross hospital and future problem 五味裕大1,4, 松原ちはる1,4, 登内盛治1, 濱優理2,4, 小松智子2,4, 丸山史3,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2010-2010, 2023.

---

	P0959-5-PM. Clinical features and measures of patients with acute drug intoxication with the nonprescription drug 石川章1, 上村永2, 須貝昌平1, 松村俊希1, 水村亮介1, 鈴木善樹1, 眞壁秀樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2011-2011, 2023.

---

	P0960-5-PM. Examination of frequencies and the risk factor of the nightmare by the use of orexin receptor blocker 山下佑麻, 中村安孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2012-2012, 2023.

---

	P0961-5-PM. Search of the associated factor of the side effect that is hard to be manifested in patients with bipolar disorder 清水侑真1, 森康徳2, 竹内一平2,3, 半谷眞七子1,2, 藤田潔3, 亀井浩行1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2013-2013, 2023.

---

	P0962-5-PM. Effect on drug overdosage of COVID-19 pandemic resulted in, hurting itself 冨永麻里子, 菅野浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2014-2014, 2023.

---

	P0963-5-PM. Use experience of the Clozapine for treatment-resistant schizophrenia in our hospital 大治万喜子1, 西村寛1, 神薗淳司2, 山田茂人2, 大治太郎2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2015-2015, 2023.

---

	P0964-5-PM. After the operation of the ramified microglia in the elective operation patients of the digestive organ surgery about an effect of the delirium prevention 片岡美咲1, 水野良祐2, 古野和歌子3, 巽弥生1, 野村洋道1, 石本学司1, 中浴伸二1, 田中詳二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2016-2016, 2023.

---

	P0965-5-PM. Retrospective study about the predictor of a concomitant drug and the fall fall event of the orexin receptor blocker 吹谷真紀子, 齊藤伸, 木元健寛, 瀬戸亘, 鈴木ひとみ, 仙葉悠紀, 齋藤香織, 篠田和人, 山崎恵葉, 金美紀, 一関美江子, 八代佳子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2017-2017, 2023.

---

	P0966-5-PM. About medicine medicine cooperation to affect outside Parliament prescription issuance of the agent Clozapine for treatment-resistant schizophrenia 川崎美雪, 亀井美緒, 廣田竜亮, 大坂祐依, 岡井美可, 木村千尋, 新田直美, 辻正宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2018-2018, 2023.

---

	P0967-5-PM. Investigation about the effect of the sleeping drug on fall fall in the elderly people in our hospital psychiatry ward 佐藤舞由子, 小嶋希望, 渡邊康太, 平井彩也香, 日下陽介, 上野英文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2019-2019, 2023.

---

	P0968-5-PM. Examination of the fall risk with the sleeping drug in the inpatient 中原友 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2020-2020, 2023.

---

	P0969-5-PM. One patient who conducted mother's milk inhibition with the cabergoline 川端加恵1, 柴田雪乃1, 小鳥遊明2, 稲村達生2, 大野真由2, 岸上靖幸2, 小口秀紀2, 遠山幸男1, 久田達也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2023-2023, 2023.

---

	P0970-5-PM. Effect of the pharmaceutical management using the risk assessment list on venous thromboembolism prophylaxis after the cesarean section 杉浦あゆみ1, 水谷友香1, 近藤寿美子1, 山中規明1, 佐々治紀2, 桜田宏明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2024-2024, 2023.

---

	P0971-5-PM. The consultation duties system architectural evaluation by the pharmacist about the lactational medical therapy 太田千絢1, 田村美穂1, 石村光1, 浦田唯1, 有近仁美1, 荒木ちなみ1, 坂井康仁1, 税所篤行1, 村田晋2, 岡田直人1, 北原隆志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2025-2025, 2023.

---

	P0972-5-PM. Intervention after the outpatient department to the antimicrobial choice for the pregnant woman with a history of allergy to beta-lactam derivative antimicrobial 風間静香, 加賀美由有, 遠藤愛樹, 山本弓子, 松本香織, 小林義文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2026-2026, 2023.

---

	P0973-5-PM. Efforts of the pharmacist for the high-risk pregnancy and childbirth lying in woman in our hospital 美馬郁代1, 六車浩史1, 松田麻由2, 増田秋穂2, 梶原志保2, 森陽子3, 後藤真樹3, 岡野愛子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2027-2027, 2023.

---

	P0974-5-PM. Investigation of the drug information offer about a pregnant woman, the nursing mother for the healthcare worker in our hospital pharmacy 伏見久美子, 向山郁美, 三輪茜, 小森桂子, 大林巧志, 舩越真理, 土谷有美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2028-2028, 2023.

---

	P0975-5-PM. The annual use trend of the early or threatened labour therapeutic drug and epidemiologic survey of the side effect 石村淳1, 猪爪信夫1, 大田祥子2, 松田佳和1, 都築稔1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2029-2029, 2023.

---

	P0976-5-PM. The actual situation of the triptan drugs prescription for the pregnant woman: Investigation based on the receipt database 赤坂和俊1, 小原拓1,2,3, 有山智博4, 大柳元1, 森下啓1,2, 小原竜2, 石川智史5, 眞野成康1,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2030-2030, 2023.

---

	P0977-5-PM. Safety assessment about the use of antihistamine during pregnancy 大柳元1, 齋藤颯一郎2, 石川智史3, 小原拓1,4, 岡田裕子5, 高橋信行2,3, 眞野成康1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2031-2031, 2023.

---

	P0978-5-PM. 1 case that rhabdomyolysis developed after the ritodrine hydrochloride administration, and the myotonica dystrophia of the mother's body was diagnosed by 岩澤春奈1, 綾野武司1, 一瀬ひろみ1, 篠原尚樹1, 山口佳津騎2, 元木貴大1, 田中裕章1, 小坂信二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2032-2032, 2023.

---

	P0979-5-PM. Investigation about the safety of the mother's milk childcare during zolpidem remedy 岩渕理子1, 佐藤祐司1, 菊地紗耶2, 小林奈津子2, 松本恵実1, 岡部奈穂1, 前川麻央1, 佐藤信一3, 岩間憲之4, 埴田卓志3, 齋藤昌利4, 富田博秋2, 小原拓1, 眞野成康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2033-2033, 2023.

---

	P0980-5-PM. One patient who evaluated the placenta transitivity of the levetiracetam in the Japanese pregnant woman who had epilepsy 松澤菜津子1, 小澤秀介1, 布施谷千穂2, 菊地範彦2, 内藤隆文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2034-2034, 2023.

---

	P0981-5-PM. Elucidation of the mother's milk shift mechanism of mirtazapine based on the drug transportation experiment 畠山史朗, 小倉次郎, 山口亜耶子, 志田敏宏, 山口浩明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2035-2035, 2023.

---

	P0982-5-PM. About the association between remedy medicine for mental disorder merger mother's body and neonates 木村亜実1, 川田希帆1, 寺岡知香3, 野本貴子1, 北川直1, 立川奈保美1, 下辻恒久1, 山東真寿美1, 藤田敬子1, 白石淳4, 小垣滋豊2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2036-2036, 2023.

---

	P0983-5-PM. Result of a measurement one report of fexofenadine concentrations in human mother's milk 中川朋代1, 堤美帆1, 千葉貴子2, 大坪広美2, 西光優衣3, 森本未緒3, 井上知美3, 石渡俊二3, 小竹武3, 早田憲司4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2037-2037, 2023.

---

	P0984-5-PM. A case of the late child-bearing who had the primary aldosteronism 塚本由佳1, 高島絵里2, 長尾知3, 田村賢士1, 金子智一1, 立花栄三1,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2038-2038, 2023.

---

	P0985-5-PM. Making of the drug control summary that established an emphasis for a maneuver, the management for exclusive use of the insulin injection 伊藤隆哉, 中曽根美香, 東健太郎, 小林愛美, 鬼窪利英 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2041-2041, 2023.

---

	P0986-5-PM. Efforts of usefulness and the drug department of the use of insulin pump (770G) mounted with a smart guard (TM) in the SAP therapy automatic mode 佐藤瞳, 安井景子, 永澤亜貴子, 平尾志帆, 毛利有美子, 米元治朗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2042-2042, 2023.

---

	P0987-5-PM. Examination of the bone fracture risk of metformin in patients with type 2 diabetes using Meta-analysis 坂田仁紀, 益戸智香子, 小川ゆかり, 田島純一, 西牟田章戸, 堀井剛史, 湯浅勝敏, 小清水治太, 高尾良洋, 三原潔 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2043-2043, 2023.

---

	P0988-5-PM. Rearward investigation about the effectiveness of the SGLT2 inhibitor administration for patients with type I diabetes mellitus in the true clinical practice 西村博之1, 吉田陽1, 塩山由紀1, 守田彩文1, 高田雅文1, 栗並昇2, 鈴木知子2, 稗島州雄2, 杉山正悟2, 陣内克紀2, 陣内冨男2, 陣内秀昭2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2044-2044, 2023.

---

	P0989-5-PM. The effectiveness of the oral GLP-1 receptor agonist semaglutide (reBartha's) in patients with type 2 diabetes and safe examination 古市依里菜1, 早川伸樹1,2, 津川透1,4, 桑原宏貴4, 戸邊隆夫3, 伊藤佳織1,3, 平塚いづみ2, 中島優華2, 鈴木敦詞2, 山田成樹3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2045-2045, 2023.

---

	P0990-5-PM. Use fact-finding of the perioperative SGLT2 inhibitor in the Fukuoka Saiseikai Fukuoka General Hospital 力丸奈央, 二神咲子, 由井薗陽一, 槇林智子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2046-2046, 2023.

---

	P0991-5-PM. One-year efficacy and safety of semaglutide (Ozempic), a novel GLP-1 receptor agonist injection, in patients with type 2 diabetes 森青葉1, 早川伸樹1,2, 津川透1,4, 桑原宏貴4, 戸邊隆夫3, 伊藤佳織1,3, 吉野寧維2, 松尾悠志2, 鈴木敦詞2, 山田成樹3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2047-2047, 2023.

---

	P0992-5-PM. One case of the normoglycemia diabetic ketoacidosis that a stomach duodenal ulcer was regarded as an opportunity during use of SGLT2 inhibitor 五十川達哉1, 瀬口優里1, 河野祥三1, 泊秀史2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2048-2048, 2023.

---

	P0993-5-PM. Adverse event investigation during an oral semaglutide tablets remedy period 山崎雄平1,2, 多胡友絵1, 星育子1, 小泉祐一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2049-2049, 2023.

---

	P0994-5-PM. Association of the diabetic kidney disease for the polypharmacy extension in patients with diabetes 永野浩之1,2, 小林正太郎2,4, 宮森彩香2,5, 疋田絵梨6,7, 小岩まの1, 高橋雅弘2, 眞壁秀樹1, 菊池貴子3, 櫛山暁史2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2050-2050, 2023.

---

	P0995-5-PM. Liver, renal function protection of the fruit clinical SGLT2 inhibitor to be able to put, We look at the multicenter rear using Multiple Propensity Score and study a mark 樋浦一哉1, 鈴木千波2, 久保淳一3, 後藤悠3, 高取士剛3, 田中悠季2, 石田陽美2, 山下友輝4, 水谷彰史4, 車塚千穂5, 高木明彦6, 小林龍3, 柴波明男2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2051-2051, 2023.

---

	P0996-5-PM. Comparison judging from blood sugar control and the side effect expression situation by semaglutide and the Dulaglutide in our hospital 人見志保里, 春名康裕, 東碧, 武田智子, 長谷川晃司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2052-2052, 2023.

---

	P0997-5-PM. Two cases of obesity diabetes that led before we aimed at the remission by medical treatment mainly on the semaglutide 吉川貴教1, 山田雅也1, 梶原洋文1, 生山祥一郎2, 濱口和之2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2053-2053, 2023.

---

	P0998-5-PM. Examination about making and the operation of the current situation of telephone medication support (R) and telephone check sheet 染谷光洋1, 石尾有司1, 谷口亮央1, 田中伶奈2, 樋浦一哉2, 山下美妃2, 中島史雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2054-2054, 2023.

---

	P0999-5-PM. Look back on efforts of the diabetes medical treatment instruction team participation in planning in the drug department 佐々木弘好 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2055-2055, 2023.

---

	P1000-5-PM. The screening situation investigation at introduction for the HIF-PH inhibitor proper use 八木亮夕子, 関田和樹, 早船真弘, 宮澤真帆, 寺山義泰 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2057-2057, 2023.

---

	P1001-5-PM. eGFR test value change change investigation before and after the CKD seal pasting in our hospital 元木孝, 渡邊清人, 高柳昌宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2058-2058, 2023.

---

	P1002-5-PM. What has become clear from the results of use of upacicalcet sodium hydrate at our hospital 中村和彦, 中村嘉孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2059-2059, 2023.

---

	P1003-5-PM. Case series study on usefulness of the immunosuppressive drug 4 drug regimen in renal-transplant recipients 二村哲未1, 星茜1,2, 内倉健1, 百賢二1, 杉山恵理花3, 田島正教3, 加藤容二郎4, 吉武理4, 佐々木忠徳5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2060-2060, 2023.

---

	P1004-5-PM. Research about the effect to give the phosphate binder medication adherence of haemodialysis patients 山内牧子1, 田中みずき1,2, 西隆博3, 山川浩子3, 柳直樹1, 山本陽平1, 大部令絵4, 坂口眞弓1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2061-2061, 2023.

---

	P1005-5-PM. A case in which LDL-C was significantly reduced by administration of roxadustat 村上七海1, 佐藤伸輔2, 櫻井淳二2, 高橋健人1, 河野資1, 宮内康夫2, 高橋知子1, 佐藤譲3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2062-2062, 2023.

---

	P1006-5-PM. 1 case of the haemodialysis patients that caused the infection of cytomegalovirus and the small intestine bleeding during rituximab administration 瀬古高裕, 伊田厚輝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2063-2063, 2023.

---

	P1007-5-PM. Study on effect on lipid metabolism with the HIF-PH inhibitor 桐井亜佑美1, 岡田優2, 櫻井淳二2, 佐藤伸輔2, 高橋健人1, 河野資1, 宮内康夫2, 高橋知子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2064-2064, 2023.

---

	P1008-5-PM. Change of the basement membrane ingredient gene expression in the renal function recovery in vitro model 片桐文彦, 佐藤佳苗, 臼井愛友未, 木村耕二, 高柳理早, 山田安彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2065-2065, 2023.

---

	P1009-5-PM. Search of urinary biomarker about extension of subclinical rejection in the kidney transplantation 田島壮一郎1, 小野未央里2, 重松智博1, 荻野敬史1, 廣田豪1, 岡部安博3, 家入一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2066-2066, 2023.

---

	P1010-5-PM. The calculation situation of the drug global assessment adjustment addition and the drug adjustment addition and the change of prescription analysis 山下弘毅, 青柳和代 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2069-2069, 2023.

---

	P1011-5-PM. Effect of prescription suggestion, the representation prescription by the pharmacist in the care health center for the elderly 大熊範和1, 新木美枝1, 宮本卓馬2, 横澤真吾3, 鈴木達宙4, 蟻川勝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2070-2070, 2023.

---

	P1012-5-PM. Investigation about the suggestion contents of the polypharmacy measures team 成田佳奈1, 鶴野結花理1, 齋藤君美佳1, 堀内美樹博1, 米山尚慶2, 小山茂3, 塩地園代1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2071-2071, 2023.

---

	P1013-5-PM. About the efforts of the dementia care support team facing each other at sleeplessness, the unrest of the inpatient in our hospital 加藤蒼生1,2, 小林俊博1,2, 小宮詠子1, 坪谷綾子1, 松本浩1, 吉田香2,3, 佐々木友理加2,4, 三宅誕実2,4, 大熊壮尚2,5, 伊藤由香1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2072-2072, 2023.

---

	P1014-5-PM. Construction of the simple and easy delirium risk screening and inspection of the effectiveness 永江隆二1, 屋敷久恵2, 中川友樹1, 塩崎真由3, 金井弘美2, 内山幸子1, 松田守弘4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2073-2073, 2023.

---

	P1015-5-PM. A consumption change and activity report of a sleeping drug by the dementia care support team intervention and antipsychotics 深尾那実1, 薄雅人1,2, 岡田智子1,2, 田淵克則1,2, 後藤拓也1, 山田泰聖2, 宮本直樹2, 小林麗2, 吉田知由1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2074-2074, 2023.

---

	P1016-5-PM. Pulse-taking of the restless time, sleeplessness indicator after the dementia care team start 上野沙恵子1, 玉木範子2, 奥薗文代2, 水田弘人3, 枌裕二3, 山川健太郎4, 尾崎彰彦4, 辻井佳代1, 小林政彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2075-2075, 2023.

---

	P1017-5-PM. Examination of the pharmaceutical intervention in the care health center for the elderly 笠原なつみ1, 松本和也2, 浅野志津1, 森英樹2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2076-2076, 2023.

---

	P1018-5-PM. A problem and measures to think about from the results of the secondary bone fracture prevention follow-up charges calculation patients 森崎崇文, 杉山留美子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2077-2077, 2023.

---

	P1019-5-PM. Efforts of the pharmacist in the House of care medical care 高井杏弥子, 川崎美紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2078-2078, 2023.

---

	P1020-5-PM. Spreading effect by the cooperation of a care health center for the elderly additional post pharmacist and the prescription adequacy team 陶山泰治郎1, 十川友那1, 近藤宏樹1, 高原紗知子1, 篠永浩1, 原田典和1, 加地努1, 松野美歩2, 福田京子3, 中津守人4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2079-2079, 2023.

---

	P1021-5-PM. Effect of the thickness adjustment food giving it to the collapse of amlodipine OD tablets and drug release 下山哲哉, 竹村あすか, 上田菜々子, 伊藤邦彦, 小林道也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2080-2080, 2023.

---

	P1022-5-PM. The current situation investigation of the hypokalemia onset in Yokukansan internal use patients 65 years or older 辰巳真穂, 田中優希, 植原誠, 金子久美子, 龍田寛子, 橋本美香子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2081-2081, 2023.

---

	P1023-5-PM. Efforts for the drug proper use in the care health center for the elderly 浅野志津1, 笠原なつみ1, 松本和也2, 森英樹2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2082-2082, 2023.

---

	P1024-5-PM. We correspond to the reporting of the pharmacist in mouth care, the eating deglutition team, and it is evaluated by the type of job 岡部賢司1, 今浦将治1, 比嘉真理1, 武田康平1, 木幡雄至1, 宮田慎也1, 畠山英司1, 大和田里菜2, 小峰淳3, 小林理沙4, 星野泰慶5, 渡部真弥5, 雨宮剛志6, 下村忠賛7, 長田麻衣子8, 菅野浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2083-2083, 2023.

---

	P1025-5-PM. Examination of the factor that zinc acetate affects the improvement of the serum zinc level in the elderly people 宗村盛1, 初山佳苗2, 田嶋美幸1, 植木理恵3, 辻泰弘4, 鈴木豊史5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2084-2084, 2023.

---

	P1026-5-PM. Inspection of the validity of the pharmaceutical evaluation by the pharmacist in pressure sore measures 渡邊喜暁, 若林桜子, 香取優介, 沢田裕介, 中島瞳, 久保幸代 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2086-2086, 2023.

---

	P1027-5-PM. About the efforts of the pharmacist in pressure sore treatment by the multi-type of job cooperation 石井麻紗子1, 角井義昌2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2087-2087, 2023.

---

	P1028-5-PM. Investigation of the descriptive epidemiology of the drug associated with the drug-induced pressure sore 日野洋明1, 菊池大輔1, 野上佳奈子1, 星恭子2, 遠藤悠江2, 岡田浩司1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2088-2088, 2023.

---

	P1029-5-PM. Relation of the pharmacist to the pressure sore measures accompanied with the medical service fees revision 藤井実穂, 中村亮博, 櫻井明子, 村田和歌子, 安達嘉織, 合田泰志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2089-2089, 2023.

---

	P1030-5-PM. Evaluation of the pharmaceutical management in the pressure sore practice by the cooperation with a ward exclusive duty pharmacist and the pressure sore measures team 篠崎聡1, 杉山華菜1, 秡川恵子2, 本多秀俊1, 林由紀子1, 三井浩3, 並木路広1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2090-2090, 2023.

---

	P1031-5-PM. Contents examination ... of 1 attempt - two ways type drug control summary of bracken, the Toda district drug information sharing network construction 稲秀士1, 宮崎美子1, 加藤綾乃2, 濱浦睦雄2, 福田稔1, 濃沼政美3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2093-2093, 2023.

---

	P1032-5-PM. Specific example ... of the interactive type drug summary utilization in 2 attempt - bracken municipal hospital of bracken, the Toda district drug information sharing network construction 加藤綾乃1,2,3, 稲秀士2, 宮崎美子2, 福田稔2, 濱浦睦雄1, 濃沼政美3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2094-2094, 2023.

---

	P1033-5-PM. The unevenly distributed of the treatment at home offer drugstore using geographical information system statistics and access-related examination 外山和弥1, 玉木啓文1, 長内理大1, 伊野陽子2, 中村光浩3, 井口和弘1,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2095-2095, 2023.

---

P1034-5-PM. -affiliated examination of "the pharmacist unevenly distributed index" that was shown to by inhabitants cover rate and Ministry of Health, Labour and Welfare which expressed the regional unevenly distributed of the drugstore pharmacist 玉木啓文1, 外山和弥1, 長内理大1, 伊野陽子2, 中村光浩3, 井口和弘1,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2096-2096, 2023.

---

	P1035-5-PM. Effect - interim report ... that continuous medication follow using the application gives to patients 嶋田努1, 山下千佳子2, 赤坂聡之3, 安田圭子3, 山下恵4, 長基健人2, 岡島正2, 橋本昌子3, 沖崎歩4, 工藤知也4, 中尾豊4, 崔吉道1, 玉井郁巳5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2097-2097, 2023.

---

	P1036-5-PM. Questionary survey ... to the medical institution of operational ... area of the drug information contact book between institutions 深津昌弘1, 松本茂1, 湯浅浩之2, 水野大介3, 山田哲也1, 近藤康博4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2098-2098, 2023.

---

	P1037-5-PM. Fact-finding ... of operational ... efforts situation of the drug information contact book between institutions 松本茂1, 深津昌弘1, 湯浅浩之2, 水野大介3, 山田哲也1, 近藤康博4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2099-2099, 2023.

---

	P1038-5-PM. Subjective evaluation of the dispatch physician for the pharmacist engaging in remote island medical care in remote area 宮田祐一1, 宮坂善之2, 中村雅敏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2100-2100, 2023.

---

	P1039-5-PM. Fact-finding of the continuous educational intervention effect in the community pharmacy 根本崇史, 菅原淳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2101-2101, 2023.

---

	P1040-5-PM. Intervention to the adverse event of the pharmacist in the treatment at home 高山翔太1, 三谷貴子1, 秋元義幸2, 玉井典子3, 武藏汐里3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2102-2102, 2023.

---

	P1041-5-PM. It is a study on fact-finding of the information sharing with the type of job other than the drugstore pharmacist in visit drug control instruction duties 高橋寛1, 岡崎光洋2, 溝神文博3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2103-2103, 2023.

---

	P1042-5-PM. Research about the activation of the information sharing by the category analysis of the at-home report between a pharmacist and the multi-types of job 横井杏菜1, 堀英生1,8, 水野正子2,8, 水野紀子2, 浅井治行3, 山田葉子3, 三宅宏季4, 石川友康5, 供田将志6, 菊池千草7, 鈴木匡1,8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2104-2104, 2023.

---

	P1043-5-PM. An evaluation and examination of the duty system in our hospital 樋本繭子, 木村有子, 新免徹, 高瀬尚武 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2105-2105, 2023.

---

	P1044-5-PM. Of inquired analysis ... hospital and dispensing pharmacy of the incompatibility in the TPN put to the infusion DI center is different, and pay the attention; and ... 掛水瑞芳, 五十嵐遼, 竹林佑花, 松田直子, 吉岡小都子, 星泉, 佐々木美由紀, 福田まゆみ, 岩原良晴, 河野裕則, 沢田憲彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2106-2106, 2023.

---

	P1045-5-PM. Efforts and problem to an at-home palliative care shift by the use of PCA pump in the depopulated aging area 鶴居勝也, 荒木遼太, 小川紗知, 讓原千広, 波多晶子, 中澤美樹子, 橋爪和恵, 窪田真弓 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2107-2107, 2023.

---

	P1046-5-PM. A problem and the prospects to see from the support two case in the drug for the treatment at home to other drugstores concerned with as regional alliances drugstore 江口真理子1, 高武華子2, 築地奈々星2, 纉雅仁3, 梶栗直子3, 井上友貴3, 山北哲也3, 佐伯友香3, 児島拓也1, 濱地進吾4, 鄭唯学4, 中堀亮一5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2108-2108, 2023.

---

	P1047-5-PM. It is ... after the information confirmation between hospitalization and release support ... hospital by the pharmacist before the hospitalization 清水利匡, 高根貴子, 坂東めぐみ, 岡添進 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2109-2109, 2023.

---

	P1048-5-PM. The prescription observance situation after the discharge in patients with stroke 福田裕子1,5, 伊東里紗1, 柿花美沙紀1, 金本哲二2, 高橋務3, 佐原敏之1, 辻川正彦4, 恩田光子5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2110-2110, 2023.

---

	P1049-5-PM. For safe medication self-care - self-care flow sheet making and effect - 宮永幸実, 仲田涼, 前かほり, 高梨明恵, 濱田初美, 小杉満孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2111-2111, 2023.

---

	P1050-5-PM. Investigation about the sterile preparation processing in the treatment at home enforcement drugstore 志賀美月1, 伊野陽子1,2, 玉木啓文1, 長内理大1, 井口和弘1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2112-2112, 2023.

---

	P1051-5-PM. Scoping review about the prevention, the enlightenment activity of the osteoporosis in the community pharmacy 庄司雅紀, 寺前成美, 恩田光子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2113-2113, 2023.

---

	P1052-5-PM. Analysis of the factor to have an influence on the use of the home care patient online medication counseling 近藤優歩1, 野々村和哉2,3, 玉木啓文2, 長内理大2, 伊野陽子4, 高島英滋5, 甲斐絢子1, 林秀樹1,6, 井口和弘1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2114-2114, 2023.

---

	P1053-5-PM. Attitude survey about the pharmacist utilization in the timing not to bring a prescription 横倉南, 竹平理恵子, 盛岡正博, 有田悦子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2115-2115, 2023.

---

	P1054-5-PM. About the current situation investigation of the tracing report in our hospital 岡本涼子, 竹内裕理佳, 中川喬統, 小田幸奈, 小田剛史, 松本恵美, 深海広平, 山下剛史郎, 満田正樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2120-2120, 2023.

---

	P1055-5-PM. It is ... from the position of current situation and problem - health insurance pharmacy pharmacist whom we saw from the questionary survey in the tracing report 荻野由華1, 森井悠介2, 松井駿亮2, 大河万顕2, 瀬名波弘昌2, 松野純男3, 宮崎充宏1, 森正彦1, 下村一徳2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2121-2121, 2023.

---

	P1056-5-PM. Duties burden reduction effect of the doubt inquiry simplification protocol in the outside Parliament prescription 鈴木一志, 浦崎圭太, 白崎真由子, 山下由貴, 河井和子, 小川裕美, 久田純生, 伊藤和幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2122-2122, 2023.

---

	P1057-5-PM. Intervention to patients with heart failure utilizing a heart failure notebook, the tracing report 福島奈津美1, 桝本光子1, 白石大理1, 竹家広志2, 小坂香菜子3, 森田悦代4, 中村美樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2123-2123, 2023.

---

P1058-5-PM. It is ... through questionary survey about usefulness of the illness disease cooperation between pharmacists using the changing hospital follow-up request handwriting and the usefulness of the cooperation between example - pharmacists 柿原聡美1,2, 菅原隆文1, 阿部圭輔1, 石田翔1, 田中和行1, 寺岡豊2, 渡邊篤1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2124-2124, 2023.

---

	P1059-5-PM. Contents investigation of the drug control summary about the discharge drug information cooperation addition and questionary survey to the health insurance pharmacy 伊佐治麻里子, 松本琢博, 笠原真理, 前田直大, 鶴谷勝実 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2125-2125, 2023.

---

	P1060-5-PM. Evaluation of the usefulness of the reporting document at discharge using the writing a postscript from the health insurance pharmacy 上野ひとみ, 相澤聡子, 椎葉有樹, 大江彰彦, 小野祐志, 宇佐美順子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2126-2126, 2023.

---

	P1061-5-PM. The introduction of the pharmacist interview before hospitalization for the purpose of the request for on admission drug reporting for the health insurance pharmacy and the effect 新康憲, 若松雄太, 杉生雅和, 高子優子, 正置耕一, 吉岡睦展 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2127-2127, 2023.

---

	P1062-5-PM. Efforts to instruction and the medicine medicine cooperation system construction to foreign cancer medical therapy patients 鎌田恵子, 相原善弥, 瀬川満, 佐藤英二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2128-2128, 2023.

---

	P1063-5-PM. Evaluation of the patients maneuver every device using the inhalant instruction reporting book 鈴木葵1, 原田優1, 横山敦1, 小泉晴美2, 中島研1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2129-2129, 2023.

---

	P1064-5-PM. PBPM satisfaction investigation after the outside Parliament prescription doubt inquiry simplification protocol introduction 十川友那1, 渡邊舞1, 高橋公子1, 加福夏織1, 篠永浩1, 原田典和1, 加地努1, 矢野禎浩2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2130-2130, 2023.

---

	P1065-5-PM. Comparison of the number of Residual medicine adjustment at the health insurance pharmacy that introduced a doubt inquiry simplification protocol and the health insurance pharmacy that we do not transduce 伊藤一馬1, 関川千尋2, 角田洋輔3, 飯山貴子4, 石井弘幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2131-2131, 2023.

---

	P1066-5-PM. Efficiency of the duties operation by construction and the introduction of electronic tracing report service (AAdE-Report) 吉田優子1, 上森美和子1, 池見泰明1, 中川俊作1, 米澤淳1, 黒田知宏2, 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2132-2132, 2023.

---

	P1067-5-PM. The current situation investigation of the tracing report in our hospital 山脇一浩1, 齋藤由紀1, 井上清勝2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2133-2133, 2023.

---

	P1068-5-PM. Questionary survey about the medicine for cardiovascular disease medicine cooperation in Ishikawa 多田郁1, 西田祥啓1, 坂野由宇希2, 丸一泰雅3, 政氏藤玄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2134-2134, 2023.

---

	P1069-5-PM. The current situation and the future task which we saw from the study operation of the tracing report 永井孝正, 鈴川誠, 今井邦行, 内山耕作, 冨田敦和, 今西忠宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2135-2135, 2023.

---

	P1070-5-PM. About efforts for the inflection of the medication reporting book in our hospital and medical economic effect 山田早1, 土屋裕伴1, 本間さとみ1, 大登剛1, 諸橋賢人1, 小林このみ1, 中里健志1, 加藤聡2, 村橋憲2, 水井亮3, 新井亘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2136-2136, 2023.

---

	P1071-5-PM. Effect in the medicine medicine cooperation using the information contact book between institutions before hospitalization about the discontinuation before bloody measures 新町圭央, 大塚識稔, 石井一也, 神原康佑, 中村豪志, 岡田淳芳, 上村拓生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2137-2137, 2023.

---

	P1072-5-PM. Medicine medicine cooperation (case report) using the medication reporting book for the CDK4/6 inhibitor which door front Hospital releases 福島岳1, 安斎沙織1, 宮田広樹2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2138-2138, 2023.

---

	P1073-5-PM. The cooperation full addition in the Hiroshima-shi Asa area and the current situation of specific drug management instruction addition 2 北本真一, 阪田安彦, 古谷智裕, 村上礼隆, 佐藤実由, 金田公平, 宮森伸一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2139-2139, 2023.

---

	P1074-5-PM. Questionary survey about medicine, the medicine cooperation enforcement situation in the foreign chemotherapy for a health insurance pharmacy, patients 阿部まり絵, 済川聡美, 眞鍋綾, 伊賀久美, 矢野安樹子, 飛鷹範明, 田中守 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2140-2140, 2023.

---

	P1075-5-PM. Inspection of the efforts for improvement in collect rate of the tracing report in the foreign cancer chemotherapy 高橋則正, 谷道あかり, 江守勇紀, 石川雄大, 高木昭佳, 加藤敦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2141-2141, 2023.

---

	P1076-5-PM. It is efforts ... in ... Kure district about the introduction of the medicine medicine cooperation tool in irAE measures 田頭尚士1, 西田朋洋1, 景山康二郎1, 坂本靖之1, 大塚茂雄2, 鷹橋紀幸2, 大塚幸三2, 藤田秀樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2142-2142, 2023.

---

	P1077-5-PM. Attitude survey of the pharmacist for cancer locomotive syndrome 直井美萌1, 角坂惟生1, 坂口涼2, 安部智哉1, 松坂和正1, 武井大輔1, 中山季昭1, 大塚公庸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2143-2143, 2023.

---

	P1078-5-PM. It is ... about a role of content analysis - hospital pharmacist of the foreign cancer medical therapy tracing report and a future problem 岡田法子, 長井聡子, 下菊早紀, 植田真理, 北野こずえ, 小川充恵, 香川雅一, 西岡達也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2144-2144, 2023.

---

	P1079-5-PM. Workshop to the health insurance pharmacy that we went with multiple medical institutions 鬼窪利英1, 中村久美1, 渡辺宏晃2, 岩本大紀3, 石曽根好雅3, 内藤隆文2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2145-2145, 2023.

---

	P1080-5-PM. Examination about the acceptance situation and the problems of the outside Parliament prescription containing the antiHIV medicine 平野淳1, 矢倉裕輝2, 増田純一3, 國本雄介4, 田澤佑基5, 井上正朝6, 佐藤萌7, 安井淳子8, 三枝祐美9, 田川尚行10, 成田綾香11, 田中和行12, 西勇治13, 大東敏和14, 合原嘉寿15, 吉田知由1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2146-2146, 2023.

---

	P1081-5-PM. Effect on effect of treatment that the prescription situation and the characteristic of the patient of patients with diabetes utilizing Residual medicine adjustment PBPM give 平井利幸1, 花岡峻輔2, 寺門祐介1, 関利一1, 渡邉文之2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2147-2147, 2023.

---

	P1082-5-PM. Questionary survey ... about DKD, the CKD medical therapy - current situation and the problem of a drugstore, the hospital pharmacist in the Naka area 中西俊介, 阪野和重, 武内恭範, 中川愛理, 野尻真帆 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2148-2148, 2023.

---

	P1083-5-PM. About polypharmacy measures to be carried out by regional alliances (the first report) 上島聖秀1, 山本麗央奈1, 高橋慎太郎1, 坂根美和子1, 飴谷友菜1, 能澤真希子1, 田中みずほ1, 森谷道生1, 石浦嘉之2, 川崎聡3, 畠山規明4, 西尾公秀5, 稲村勝志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2149-2149, 2023.

---

	P1084-5-PM. About polypharmacy measures to be carried out by regional alliances (the second report) 山本麗央奈1, 上島聖秀1, 高橋慎太郎1, 坂根美和子1, 飴谷友菜1, 能澤真希子1, 田中みずほ1, 森谷道生1, 石浦嘉之2, 川崎聡3, 畠山規明4, 西尾公秀5, 稲村勝志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2150-2150, 2023.

---

	P1085-5-PM. Efforts (the third report) of the medicine medicine cooperation in the Komaki Municipal Hospital 水谷貴樹, 山本泰大, 山本将司, 出口裕子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2151-2151, 2023.

---

	P1086-5-PM. Because do not make invention - medical treatment to fix drug summary in a drugstore break off; ... 廣野友祈子1, 山日祐平1, 長井晴教1, 永井洋子2, 狭間研至1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2152-2152, 2023.

---

	P1087-5-PM. The efforts of the illness medicine cooperation workshop aiming at improvement in quality of the community medical care and the evaluation 松尾宗一郎1, 野嶋芳紀1, 佐藤聖2, 田中達也2, 邑瀬誠1, 深津英人3, 松井洸3, 阿部真也3, 山口浩3, 野村和彦3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2153-2153, 2023.

---

	P1088-5-PM. The effect that a tracing report style revision gives to report contents depending on the medical information cooperation network registration of patient situation and evaluation of the style 高村優太1, 平井利幸1, 小橋川祥2, 秋山裕史1, 関利一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2154-2154, 2023.

---

	P1089-5-PM. The investigations of the format used for the sending of the offer book (tracing report) such as medication information, and the like and examination of required specifications 水野桃花1, 玉木啓文1, 長内理大1, 井口和弘1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2155-2155, 2023.

---

	P1090-5-PM. Current situation and problem ... of the tracing report in cooperation reinforcement - our hospital of a health insurance pharmacy and the hospital 野村祥子, 河合美凪, 飯田昭宏, 市江敏和, 大谷寧次郎, 三浦毅 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2156-2156, 2023.

---

	P1091-5-PM. The current situation investigation of recognition and the utilization situation of the tracing report 田村美咲, 稲川智子, 花香淳一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2157-2157, 2023.

---

P1092-5-PM. A report of the efforts which cooperated with a health insurance pharmacy at large-scale system failure, and contributed to the treatment continuation of the outpatient and investigation of doubt inquiry contents 脇條靖治1, 綛谷哲也1, 大橋明歩1, 寺田椋2, 森井絵莉香1, 橋本佑香1, 宮部祐子1, 寺岡知香3, 山東真寿美1, 下辻恒久1, 藤田敬子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2158-2158, 2023.

---

	P1093-5-PM. Research about the mention situation of the patients information of the prescription notebook 野呂菜緒美1, 秦光平1, 脇由香里1, 相松伸哉1, 小島さおり1,2, 松田浩明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2159-2159, 2023.

---

	P1094-5-PM. New efforts to the medicine medicine cooperation in the Kobe low infestation cancer medical center 松田ゆかり1, 平井みどり1, 橋本泰明1, 安部仁人2, 鈴木仁3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2160-2160, 2023.

---

	P1095-5-PM. Efforts of the medicine medicine cooperation using "the heart failure treatment discharge reporting book" for patients with heart failure of our hospital 中村眞梨1, 甲斐真由美1, 芝崎由美子1, 冨田晴樹2, 中村智弘3, 百村伸一3, 野村淳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2161-2161, 2023.

---

	P1096-5-PM. The cooperation actual situation between hospital - drugstores between hospital - hospital in the pharmacist in Saitama 大木稔也1,2, 金井紀仁1,3, 新井真澄1,4, 林野守将1,5, 小川桂1,6, 土屋宏二朗1,7, 若林純平1,8, 眞壁秀樹1,9, 濱浦睦雄1,10, 町田充11,12 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2162-2162, 2023.

---

	P1097-5-PM. Efforts of the medication management through the medicine medicine cooperation to the idiopathic pulmonary fibrosis therapeutic drug remedy patients 川島佳恵1, 野村洋道1, 石本学司1, 中浴伸二1, 冨岡洋海2, 田中詳二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2163-2163, 2023.

---

	P1098-5-PM. It is the present of pharmacist society and the medicine medicine cooperation that we built at a local community medical care support hospital 鶴崎泰史1, 安永麗子2, 江崎由佳1, 齊田翌美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2164-2164, 2023.

---

	P1099-5-PM. Based on operation of the inside the hospital-adaptive doubt inquiry protocol in the outside Parliament prescription of our hospital and the effect by the acquisition difficulty of problems - antiepileptic drug - 福島悠太郎, 矢嶋隆宏, 山本吉章, 古屋裕之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2165-2165, 2023.

---

	P1100-5-PM. Efforts for the construction of the cooperation system at disaster with the door front drugstore 渡邊卓巳1, 坂本拓也1, 中尾耕治1, 白石貴寿2, 荒井宏人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2167-2167, 2023.

---

	P1101-5-PM. Attitude survey to a trainee about the disaster medical care 角田健, 小室治孝, 喜古康博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2168-2168, 2023.

---

	P1102-5-PM. Inspection of development and the attendance effect of the business continuity plan (BCP) development support program that established an axis for the local correspondence at disaster as the pharmacist society 飯沼公英1, 永田実沙2, 上田昌宏3, 木下淳4, 安原智久5, 吉野宗宏6, 福田利明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2169-2169, 2023.

---

	P1103-5-PM. Operational training using the disaster action card in the pharmacy 星野まりや1, 八木仁史1, 満田正樹3, 高田宏文1, 矢尾淳2, 河井良智1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2170-2170, 2023.

---

	IP-01. A Study of Exposure to Drug Dust to Pharmacists While Grinding Tablets Takenori Tamaki1, Yuji Yoshiyama2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2172-2172, 2023.

---

	IP-02. Digitization of ethical drug package inserts and utilization of international code GTIN Takao Orii1, Koichi Uemura2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2173-2173, 2023.

---

	IP-03. Electronic package inserts, benefits and problems from aspect of barcodes use Koichi Uemura1, Takao Orii2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2174-2174, 2023.

---

	IP-04. Effect of Implementing a Monitoring Program on the Safe Use of Zolpidem Dong Young Park, Yu Jeong Lee, Eun Kyeong Choi, Sung Jin Bae Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2175-2175, 2023.

---

	IP-05. Sex- and age-specific all-cause mortality in insomnia with hypnotics : Findings from Japan multi-institutional Collaborative Cohort Study Rintaro Sogawa1, Chisato Shimanoe1, Megumi Hara2, Yuichiro Nishida2, Takuma Furukawa2, Keitaro Tanaka2, J-MICC study group Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2176-2176, 2023.

---

IP-08. P-gp-mediated drug-drug interaction promotes gastrointestinal absorption of pimozide and the risk of QT prolongation due to hERG channel inhibition - Fundamental studies and validation in clinical practice Liyanage Manosika Buddhini Perera1, Hiroki Morishita2,3, Hiroki Sunakawa2, Takuo Ogihara1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2180-2180, 2023.

---

IP-09. Inhibition kinetics of Citrus jabara juice on CYP3A4 activity and identification of its inhibitory components Kana Koinuma1, Kenji Noto2, Tokio Morita1,3, Yoshinori Uekusa1,2, F.Peter Guengerich4, Katsunori Nakamura5, Koujirou Yamamoto6, Ayuko Imaoka1,2, Takeshi Akiyoshi1,2,7, Hisakazu Ohtani1,2,7,8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2181-2181, 2023.

---

	IP-10. Doxorubicin decreases sweet taste sensitivity in mice Keisuke Mogi, Misaki Azuma, Shiori Iwaki, Chisaki Yoshioka, Katsuya Morito, Kentaro Takayama, Kazuki Nagasawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2182-2182, 2023.

---

	IP-11. Monitoring saliva and plasma concentrations of tedizolid and linezolid in rats Yuki Inoue1, Yuki Sato2, Hitoshi Kashiwagi2, Shunsuke Nashimoto2, Mitsuru Sugawara2,3, Yoh Takekuma3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2183-2183, 2023.

---

	IP-12. Population pharmacokinetic analysis of remimazolam in Japanese patients under general anesthesia Satoshi Ueshima1, Serina Nagahara1, Kenta Nakaya1, Mayu Kawamura1, Daiki Hira1,2, Yu Matsuura3, Kaneyuki Kawamae3,4, Mikio Kakumoto1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2184-2184, 2023.

---

IP-13. Verification of a cocktail approach for quantitative drug-drug interaction assessment by a comparative analysis between the results of a single drug and cocktail drug Motoyasu Miura1, Shimako Tanaka1,2, Chiaki Kamiya3, Naoki Katayama3, Akio Hakamata3, Keiichi Odagiri3, Naoki Inui3, Junichi Kawakami4, Hiroshi Watanabe3, Noriyuki Namiki1,5, Shinya Uchida1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2185-2185, 2023.

---

	IP-14. SPK1 / S1P axis confers gastrointestinal stromal tumors (GISTs) resistance of imatinib Yan Chen1,2, Rui Zhang2, Dandan Mi1, Qiuju Wang3, Tingwenli Huang2, Xinwei Dong4, Hongwei Zhang5, Hongtao Xiao2, Sanjun Shi1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2186-2186, 2023.

---

	IP-15. The case of quality control of COVID vaccine by pharmacists in process of vaccination in Yomitan, Okinawa Kikuko Urashima1, Hiroto Urashima1, Akinari Nakama2, Takeshi Gibo2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2188-2188, 2023.

---

	IP-16. Two cases of COVID-19 patients using Paxlovid(R) PACK with concomitant drugs Michiya Akabane1, Hiroyoshi Koide1, Rika Fukui1, Masashi Matsuda1, Satoshi Noda1,2, Masaki Sumi1, Yoshito Ikeda1, Shin-ya Morita1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2189-2189, 2023.

---

	IP-17. Survey on trends in the use of the OTC drug in the recovery accommodation facilities for Covid-19 patients Kikuno Matsukuma1, Soyoka Yamamura1, Ai Nakamura1, Mao Tsuji1, Nao Yoshida1, Ai Kanzaki1, Megumi Katsuta1,2, Takafumi Nakano1, Toshinobu Hayashi1, Takashi Egawa1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2190-2190, 2023.

---

	IP-18. Stillbirth rates before and during the COVID-19 pandemic in Manitoba (Canada) and Japan Laila Aboulatta1, Kenji Momo2, Tadanori Sasaki3, Qier Tan4, Sherif Eltonsy1,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2191-2191, 2023.

---

IP-19. Pediatric and Adolescent Medication Use Before and During COVID-19 : A Population-Based Cohort Study in Manitoba, Canada Christine Vaccaro1, Simran Diocee1, Laila Aboulatta1, Christine Leong1,2, Kaarina Kowalec1,3, Silvia Alessi-Severini1, Joseph Delaney1,4, Katherine Kearns5, Christina Raimondi5, Jamison Falk1, Dan Chateau6, Qier Tan7, Sherif Eltonsy1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2192-2192, 2023.

---

	IP-20. Analysis of the nutritional status of renal failure patients who received CRRT and the intervention effect of the NST Jisu Chung, Minkyun Kang, Sukyung Park, Bomi Kim, Inah Choi, Sungjin Bae Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2194-2194, 2023.

---

	IP-21. Effects of improvement of inhaler medication consultation on medication adherence and understanding of inhaler use Hyo Jung Kang, Ji Young Park, Kyung Duk Kim, Yeon Ji Lee, Jeong Yi Yoon, Jin Suk Kang Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2195-2195, 2023.

---

	IP-22. Report on the Activities and Achievements of Pharmacists in a Respiratory Care Support Team Akihiro Yasutomi, Ai Hirata, Kayoko Momma, Kayo Tsujii, Masahiko Kobayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2196-2196, 2023.

---

	IP-23. Strategies for disaster relief responses by pharmacy students in a disaster situation Nao Yoshida1, Mao Tsuji1, Kikuno Matsukuma1, Soyoka Yamamura1, Ai Nakamura1, Ai Kanzaki1, Megumi Katsuta1,2, Takafumi Nakano1, Toshinobu Hayashi1, Takashi Egawa1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2197-2197, 2023.

---

	IP-24. A Diachronic Comparison of Faculty Publication Trends in a Japanese National University's Pharmaceutical and Medical Faculties Theron Muller, Miho Takano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2198-2198, 2023.

---